PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Madala, SK; Edukulla, R; Phatak, M; Schmidt, S; Davidson, C; Acciani, TH; Korfhagen, TR; Medvedovic, M; LeCras, TD; Wagner, K; Hardie, WD				Madala, Satish K.; Edukulla, Ramakrishna; Phatak, Mukta; Schmidt, Stephanie; Davidson, Cynthia; Acciani, Thomas H.; Korfhagen, Thomas R.; Medvedovic, Mario; LeCras, Timothy D.; Wagner, Kimberly; Hardie, William D.			Dual Targeting of MEK and PI3K Pathways Attenuates Established and Progressive Pulmonary Fibrosis	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; CONDITIONAL EXPRESSION; MOLECULAR-MECHANISMS; FACTOR-ALPHA; ACTIVATION; CONTRACTION; INHIBITION; SURVIVAL; KINASE; TISSUE	Pulmonary fibrosis is often triggered by an epithelial injury resulting in the formation of fibrotic lesions in the lung, which progress to impair gas exchange and ultimately cause death. Recent clinical trials using drugs that target either inflammation or a specific molecule have failed, suggesting that multiple pathways and cellular processes need to be attenuated for effective reversal of established and progressive fibrosis. Although activation of MAPK and PI3K pathways have been detected in human fibrotic lung samples, the therapeutic benefits of in vivo modulation of the MAPK and PI3K pathways in combination are unknown. Overexpression of TGF alpha in the lung epithelium of transgenic mice results in the formation of fibrotic lesions similar to those found in human pulmonary fibrosis, and previous work from our group shows that inhibitors of either the MAPK or PI3K pathway can alter the progression of fibrosis. In this study, we sought to determine whether simultaneous inhibition of the MAPK and PI3K signaling pathways is a more effective therapeutic strategy for established and progressive pulmonary fibrosis. Our results showed that inhibiting both pathways had additive effects compared to inhibiting either pathway alone in reducing fibrotic burden, including reducing lung weight, pleural thickness, and total collagen in the lungs of TGF alpha mice. This study demonstrates that inhibiting MEK and PI3K in combination abolishes proliferative changes associated with fibrosis and myfibroblast accumulation and thus may serve as a therapeutic option in the treatment of human fibrotic lung disease where these pathways play a role.	[Madala, Satish K.; Edukulla, Ramakrishna; Schmidt, Stephanie; Davidson, Cynthia; Wagner, Kimberly; Hardie, William D.] Cincinnati Childrens Hosp Med Ctr, Div Pulm Med, Cincinnati, OH 45229 USA; [Acciani, Thomas H.; Korfhagen, Thomas R.; LeCras, Timothy D.] Cincinnati Childrens Hosp Med Ctr, Div Pulm Biol, Cincinnati, OH 45229 USA; [Phatak, Mukta; Medvedovic, Mario] Univ Cincinnati, Lab Stat Genom & Syst Biol, Cincinnati, OH USA	Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati	Hardie, WD (corresponding author), Cincinnati Childrens Hosp Med Ctr, Div Pulm Med, Cincinnati, OH 45229 USA.	william.hardie@cchmc.org		Le Cras, Timothy/0000-0001-8538-2703	National Institutes of Health [HL107159]; Parker B. Francis Fellowship; NIAMS [1R03AR062832]; AHA [12SDG9130040]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000077] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P50HL107159] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R03AR062832] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Parker B. Francis Fellowship; NIAMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); AHA(American Heart Association); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by National Institutes of Health grant HL107159 (WDH), Parker B. Francis Fellowship (SKM), NIAMS 1R03AR062832 (SKM) and AHA 12SDG9130040 (SKM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. None of the authors has a financial relationship with a commercial entity that has an interest in the subject of this manuscript.	Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Conte E, 2013, LAB INVEST, V93, P566, DOI 10.1038/labinvest.2013.6; Cool CD, 2006, AM J RESP CRIT CARE, V174, P654, DOI 10.1164/rccm.200602-205OC; Duffield JS, 2012, ANN REV PATHOL; Engelman JA, 2008, NAT MED, V14, P1351, DOI 10.1038/nm.1890; Hardie WD, 2004, AM J PHYSIOL-LUNG C, V286, pL741, DOI 10.1152/ajplung.00208.2003; Hardie WD, 2007, AM J RESP CELL MOL, V37, P309, DOI 10.1165/rcmb.2006-0455OC; Hardie WD, 2010, CELL CYCLE, V9, P2769, DOI 10.4161/cc.9.14.12268; Hardie WD, 2009, AM J PATHOL, V175, P3, DOI 10.2353/ajpath.2009.081170; Hinz B, 2012, AM J PATHOL, V180, P1340, DOI 10.1016/j.ajpath.2012.02.004; IHAKA R, 1996, J COMPUTATIONAL GRAP, V5, P299, DOI [10.2307/1390807, DOI 10.1080/10618600.1996.10474713]; Jorissen RN, 2003, EXP CELL RES, V284, P31, DOI 10.1016/S0014-4827(02)00098-8; Kis K, 2011, EXPERT REV MOL MED, V13, DOI 10.1017/S1462399411001967; Le Cras TD, 2010, AM J PATHOL, V176, P679, DOI 10.2353/ajpath.2010.090123; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Madala SK, 2012, AM J RESP CELL MOL, V46, P380, DOI 10.1165/rcmb.2011-0237OC; Madala SK, 2010, J IMMUNOL, V184, P3955, DOI 10.4049/jimmunol.0903008; Madala SK, 2013, AM J RESP C IN PRESS; McCubrey JA, 2007, BBA-MOL CELL RES, V1773, P1263, DOI 10.1016/j.bbamcr.2006.10.001; Moore BB, 2013, AM J RESP CELL MOL, V49, P167, DOI 10.1165/rcmb.2013-0094TR; Morgan M, 2009, BIOINFORMATICS, V25, P2607, DOI 10.1093/bioinformatics/btp450; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Ngo P, 2006, METH MOL B, V341, P103; Noble PW, 2012, J CLIN INVEST, V122, P2756, DOI 10.1172/JCI60323; Papiris SA, 2010, CRIT CARE, V14, DOI 10.1186/cc9241; Shimizu T, 2012, CLIN CANCER RES, V18, P2316, DOI 10.1158/1078-0432.CCR-11-2381; Sisson Thomas H, 2012, Adv Biosci Biotechnol, V3, P657; Sos ML, 2009, P NATL ACAD SCI USA, V106, P18351, DOI 10.1073/pnas.0907325106; Steele MP, 2013, ANNU REV MED, V64, P265, DOI 10.1146/annurev-med-042711-142004; Thannickal Victor J, 2005, Expert Opin Emerg Drugs, V10, P707, DOI 10.1517/14728214.10.4.707; Tichelaar JW, 2000, J BIOL CHEM, V275, P11858, DOI 10.1074/jbc.275.16.11858; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; van Riggelen J, 2010, NAT REV CANCER, V10, P301, DOI 10.1038/nrc2819; Vermeer PD, 2003, NATURE, V422, P322, DOI 10.1038/nature01440; White ES, 2012, J PATHOL; Wynn TA, 2008, J PATHOL, V214, P199, DOI 10.1002/path.2277; Wynn TA, 2012, NAT MED, V18, P1028, DOI 10.1038/nm.2807; Wynn TA, 2011, J EXP MED, V208, P1339, DOI 10.1084/jem.20110551; Xia H, 2004, J BIOL CHEM, V279, P33024, DOI 10.1074/jbc.M313265200; Xia H, 2010, AM J PATHOL, V176, P2626, DOI 10.2353/ajpath.2010.091117; Yoshida K, 2002, J PATHOL, V198, P388, DOI 10.1002/path.1208	41	20	21	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2014	9	1							e86536	10.1371/journal.pone.0086536	http://dx.doi.org/10.1371/journal.pone.0086536			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301BI	24475138	gold, Green Submitted, Green Published			2022-12-25	WOS:000330507300076
J	Okamoto, T; Iwata, S; Yamazaki, H; Hatano, R; Komiya, E; Dang, NH; Ohnuma, K; Morimoto, C				Okamoto, Toshihiro; Iwata, Satoshi; Yamazaki, Hiroto; Hatano, Ryo; Komiya, Eriko; Dang, Nam H.; Ohnuma, Kei; Morimoto, Chikao			CD9 Negatively Regulates CD26 Expression and Inhibits CD26-Mediated Enhancement of Invasive Potential of Malignant Mesothelioma Cells	PLOS ONE			English	Article							DOWN-REGULATION; LUNG-CANCER; TETRASPANINS; GROWTH	CD26/dipeptidyl peptidase IV is a cell surface glycoprotein which consists of multiple functional domains beside its ectopeptidase site. A growing body of evidence indicates that elevated expression of CD26 correlates with disease aggressiveness and invasive potential of selected malignancies. To further explore the molecular mechanisms involved in this clinical behavior, our current work focused on the interaction between CD26 and CD9, which were recently identified as novel markers for cancer stem cells in malignant mesothelioma. We found that CD26 and CD9 co-modulated and co-precipitated with each other in the malignant mesothelioma cell lines ACC-MESO1 and MSTO-211H. SiRNA study revealed that depletion of CD26 led to increased CD9 expression, while depletion of CD9 resulted in increased CD26 expression. Consistent with these findings was the fact that gene transfer of CD26 into CD26-negative MSTO-211H cells reduced CD9 expression. Cell invasion assay showed that overexpression of CD26 or gene depletion of CD9 led to enhanced invasiveness, while CD26 gene depletion resulted in reduced invasive potential. Furthermore, our work suggested that this enhanced invasiveness may be partly mediated by alpha 5 beta 1 integrin, since co-precipitation studies demonstrated an association between CD26 and alpha 5 beta 1 integrin. Finally, gene depletion of CD9 resulted in elevated protein levels and tyrosine phosphorylation of FAK and Cas-L, which are downstream of beta 1 integrin, while depletion of CD26 led to a reduction in the levels of these molecules. Collectively, our findings suggest that CD26 potentiates tumor cell invasion through its interaction with alpha 5 beta 1 integrin, and CD9 negatively regulates tumor cell invasion by reducing the level of CD26-alpha 5 beta 1 integrin complex through an inverse correlation between CD9 and CD26 expression. Our results also suggest that CD26 and CD9 serve as potential biomarkers as well as promising molecular targets for novel therapeutic approaches in malignant mesothelioma and other malignancies.	[Okamoto, Toshihiro; Iwata, Satoshi; Yamazaki, Hiroto; Hatano, Ryo; Komiya, Eriko; Ohnuma, Kei; Morimoto, Chikao] Juntendo Univ, Dept Therapy Dev & Innovat Immune Disorders & Can, Grad Sch Med, Tokyo, Japan; [Okamoto, Toshihiro; Iwata, Satoshi; Yamazaki, Hiroto; Hatano, Ryo; Ohnuma, Kei; Morimoto, Chikao] Univ Tokyo, Inst Med Sci, Div Clin Immunol, Tokyo, Japan; [Dang, Nam H.] Univ Florida, Div Hematol & Oncol, Shands Canc Ctr, Gainesville, FL USA	Juntendo University; University of Tokyo; State University System of Florida; University of Florida	Morimoto, C (corresponding author), Juntendo Univ, Dept Therapy Dev & Innovat Immune Disorders & Can, Grad Sch Med, Tokyo, Japan.	morimoto@ims.u-tokyo.ac.jp			Ministry of Education, Science, Sports and Culture [24591442, 21679005, 24659401]; Ministry of Health, Labor and Welfare, Japan; Program for Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation [07-17]; Grants-in-Aid for Scientific Research [24591442] Funding Source: KAKEN	Ministry of Education, Science, Sports and Culture(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labor and Welfare, Japan(Ministry of Health, Labour and Welfare, Japan); Program for Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation(National Institute of Biomedical Innovation); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by grants-in aid from the Ministry of Education, Science, Sports and Culture (S. I. 24591442, K.O. 21679005, C. M. 24659401), and Ministry of Health, Labor and Welfare, Japan, and by the Program for Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation (C. M. 07-17). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amatya VJ, 2013, ONCOL REP, V29, P21, DOI 10.3892/or.2012.2116; [Anonymous], P NATL ACAD SCI US, V99, P13663; Charrin S, 2003, EUR J IMMUNOL, V33, P2479, DOI 10.1002/eji.200323884; del Pozo MA, 2005, NAT CELL BIOL, V7, P901, DOI 10.1038/ncb1293; Friedl P, 2011, CELL, V147, P992, DOI 10.1016/j.cell.2011.11.016; Funakoshi T, 2003, ONCOGENE, V22, P674, DOI 10.1038/sj.onc.1206106; Furuya M, 2005, CANCER RES, V65, P2617, DOI 10.1158/0008-5472.CAN-04-3123; Guilmain W, 2011, BRIT J CANCER, V104, P496, DOI 10.1038/sj.bjc.6606033; Huang CL, 2006, ONCOGENE, V25, P6480, DOI 10.1038/sj.onc.1209654; Lafleur MA, 2009, MOL BIOL CELL, V20, P2030, DOI 10.1091/mbc.E08-11-1149; Pang R, 2010, CELL STEM CELL, V6, P603, DOI 10.1016/j.stem.2010.04.001; Wary KK, 1998, CELL, V94, P625, DOI 10.1016/S0092-8674(00)81604-9	12	26	28	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2014	9	1							e86671	10.1371/journal.pone.0086671	http://dx.doi.org/10.1371/journal.pone.0086671			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297XI	24466195	Green Published, Green Submitted, gold			2022-12-25	WOS:000330288000132
J	Yoshii, Y; Matsumoto, H; Yoshimoto, M; Furukawa, T; Morokoshi, Y; Sogawa, C; Zhang, MR; Wakizaka, H; Yoshii, H; Fujibayashi, Y; Saga, T				Yoshii, Yukie; Matsumoto, Hiroki; Yoshimoto, Mitsuyoshi; Furukawa, Takako; Morokoshi, Yukie; Sogawa, Chizuru; Zhang, Ming-Rong; Wakizaka, Hidekatsu; Yoshii, Hiroshi; Fujibayashi, Yasuhisa; Saga, Tsuneo			Controlled Administration of Penicillamine Reduces Radiation Exposure in Critical Organs during Cu-64-ATSM Internal Radiotherapy: A Novel Strategy for Liver Protection	PLOS ONE			English	Article							POSITRON-EMISSION-TOMOGRAPHY; HYPOXIA IMAGING AGENT; TUMOR HYPOXIA; IN-VITRO; CU-ATSM; PET; CANCER; CU-60-ATSM; EXPRESSION; MECHANISM	Purpose: Cu-64-diacetyl-bis (N-4-methylthiosemicarbazone) (Cu-64-ATSM) is a promising theranostic agent that targets hypoxic regions in tumors related to malignant characteristics. Its diagnostic usefulness has been recognized in clinical studies. Internal radiotherapy (IRT) with Cu-64-ATSM is reportedly effective in preclinical studies; however, for clinical applications, improvements to reduce radiation exposure in non-target organs, particularly the liver, are required. We developed a strategy to reduce radiation doses to critical organs while preserving tumor radiation doses by controlled administration of copper chelator penicillamine during Cu-64-ATSM IRT. Methods: Biodistribution was evaluated in HT-29 tumor-bearing mice injected with Cu-64-ATSM (185 kBq) with or without oral penicillamine administration. The appropriate injection interval between Cu-64-ATSM and penicillamine was determined. Then, the optimal penicillamine administration schedule was selected from single (100, 300, and 500 mg/kg) and fractionated doses (100 mg/kgx3 at 1- or 2-h intervals from 1 h after Cu-64-ATSM injection). PET imaging was performed to confirm the effect of penicillamine with a therapeutic Cu-64-ATSM dose (37 MBq). Dosimetry analysis was performed to estimate human absorbed doses. Results: Penicillamine reduced Cu-64 accumulation in the liver and small intestine. Tumor uptake was not affected by penicillamine administration at 1 h after Cu-64-ATSM injection, when radioactivity was almost cleared from the blood and tumor uptake had plateaued. Of the single doses, 300 mg/kg was most effective. Fractionated administration at 2-h intervals further decreased liver accumulation at later time points. PET indicated that penicillamine acts similarly with the therapeutic Cu-64-ATSM dose. Dosimetry demonstrated that appropriately scheduled penicillamine administration reduced radiation doses to critical organs (liver, ovaries, and red marrow) below tolerance levels. Laxatives reduced radiation doses to the large intestine. Conclusions: We developed a novel strategy to reduce radiation exposure in critical organs during Cu-64-ATSM IRT, thus promoting its clinical applications. This method could be beneficial for other Cu-64-labeled compounds.	[Yoshii, Yukie; Furukawa, Takako; Morokoshi, Yukie; Sogawa, Chizuru; Zhang, Ming-Rong; Wakizaka, Hidekatsu; Fujibayashi, Yasuhisa; Saga, Tsuneo] Natl Inst Radiol Sci, Mol Imaging Ctr, Chiba 260, Japan; [Matsumoto, Hiroki] Nihon Mediphys Co Ltd, Res Ctr, Chiba, Japan; [Yoshimoto, Mitsuyoshi] East Hosp, Natl Canc Ctr, Div Funct Imaging, Chiba, Japan; [Yoshii, Hiroshi] Natl Inst Radiol Sci, Emergency Radiat Exposure Med Care Res Ctr, Chiba 260, Japan	National Institutes for Quantum Science & Technology; National Cancer Center - Japan; National Institutes for Quantum Science & Technology	Yoshii, Y (corresponding author), Natl Inst Radiol Sci, Mol Imaging Ctr, Chiba 260, Japan.	yukiey@nirs.go.jp		Yoshimoto, Mitsuyoshi/0000-0003-2083-9148	Japan Advanced Molecular Imaging Program from the Ministry of Education, Culture, Sports, Science, and Technology, Japan	Japan Advanced Molecular Imaging Program from the Ministry of Education, Culture, Sports, Science, and Technology, Japan	This work was supported by the Japan Advanced Molecular Imaging Program from the Ministry of Education, Culture, Sports, Science, and Technology, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aft RL, 2003, CANCER RES, V63, P5496; Anderson CJ, 2001, J NUCL MED, V42, P213; [Anonymous], 2007, Ann ICRP, V37, P1, DOI 10.1016/j.icrp.2008.08.001; Bao SD, 2006, NATURE, V444, P756, DOI 10.1038/nature05236; Bowen SR, 2011, NUCL MED BIOL, V38, P771, DOI 10.1016/j.nucmedbio.2011.02.002; Dearling JLJ, 2002, J BIOL INORG CHEM, V7, P249, DOI 10.1007/s007750100291; Dehdashti F, 2008, J NUCL MED, V49, P201, DOI 10.2967/jnumed.107.048520; Dietz DW, 2008, DIS COLON RECTUM, V51, P1641, DOI 10.1007/s10350-008-9420-3; Fauci A., 1998, HARRISONS PRINCIPLES, P525; Fujibayashi Y, 1997, J NUCL MED, V38, P1155; Holland JP, 2009, PHYS MED BIOL, V54, P2103, DOI 10.1088/0031-9155/54/7/017; Jalilian AR, 2009, ACTA PHARMACEUT, V59, P45, DOI 10.2478/v10007-009-0008-9; KHALILMANESH F, 1983, TOXICOLOGY, V26, P325, DOI 10.1016/0300-483X(83)90093-8; KIRSCHNER AS, 1975, J NUCL MED, V16, P248; Laforest R, 2005, EUR J NUCL MED MOL I, V32, P764, DOI 10.1007/s00259-004-1756-x; Lewis JS, 2008, J NUCL MED, V49, P1177, DOI 10.2967/jnumed.108.051326; Lewis JS, 2001, P NATL ACAD SCI USA, V98, P1206, DOI 10.1073/pnas.98.3.1206; Lewis JS, 2001, J NUCL MED, V42, P655; Lewis JS, 1999, J NUCL MED, V40, P177; Liu GT, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-67; Liu ZF, 2009, J NUCL MED, V50, P1168, DOI 10.2967/jnumed.108.061739; Nozu T, 1977, OYO YAKURI, V14, P265; Obata A, 2001, ANN NUCL MED, V15, P499, DOI 10.1007/BF02988502; Obata A, 2005, NUCL MED BIOL, V32, P21, DOI 10.1016/j.nucmedbio.2004.08.012; Obata A, 2003, NUCL MED BIOL, V30, P535, DOI 10.1016/S0969-8051(03)00024-6; Oh M, 2009, NUCL MED BIOL, V36, P419, DOI 10.1016/j.nucmedbio.2009.01.016; Paudyal P, 2010, CANCER SCI, V101, P1045, DOI 10.1111/j.1349-7006.2010.01480.x; SHIMADA H, 1993, TOXICOLOGY, V77, P157, DOI 10.1016/0300-483X(93)90146-J; Siegel GG, 1999, BASIC NEUROCHEMISTRY; Stabin MG, 2005, J NUCL MED, V46, P1023; Tamura K, 2012, J CLIN ONCOL, V30; Tanaka T, 2006, NUCL MED BIOL, V33, P743, DOI 10.1016/j.nucmedbio.2006.05.005; Tsuji AB, 2012, NUCL MED COMMUN, V33, P1058, DOI 10.1097/MNM.0b013e328356efb0; Tsuji AB, 2009, J NUCL MED, V50, P827, DOI 10.2967/jnumed.108.058925; Wadas TJ, 2007, CURR PHARM DESIGN, V13, P3, DOI 10.2174/138161207779313768; Walker LR, 2011, J PREGNANCY, V2011, DOI 10.1155/2011/385767; WALSHE JM, 1964, CLIN SCI, V26, P461; Wong TZ, 2008, AM J ROENTGENOL, V190, P427, DOI 10.2214/AJR.07.2876; Yoshii Y, 2012, NUCL MED BIOL, V39, P177, DOI 10.1016/j.nucmedbio.2011.08.008; Yoshii Y, 2011, NUCL MED BIOL, V38, P151, DOI 10.1016/j.nucmedbio.2010.08.009; Yoshii Y, 2010, NUCL MED BIOL, V37, P395, DOI 10.1016/j.nucmedbio.2009.12.011	41	19	20	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2014	9	1							e86996	10.1371/journal.pone.0086996	http://dx.doi.org/10.1371/journal.pone.0086996			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297VL	24466309	Green Published, gold, Green Submitted			2022-12-25	WOS:000330283100241
J	Atkin, G; Hunt, J; Minakawa, E; Sharkey, L; Tipper, N; Tennant, W; Paulson, HL				Atkin, Graham; Hunt, Jack; Minakawa, Eiko; Sharkey, Lisa; Tipper, Nathan; Tennant, William; Paulson, Henry L.			F-box Only Protein 2 (Fbxo2) Regulates Amyloid Precursor Protein Levels and Processing	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Amyloid Precursor Protein; Neurobiology; Protein Targeting; Synapses; Ubiquitination	ALZHEIMERS-DISEASE; UBIQUITIN LIGASE; BETA; DEGRADATION; TRAFFICKING; DYSFUNCTION; TURNOVER; SURFACE; CHIP; MICE	Background: The amyloid precursor protein (APP) is strongly implicated in the pathogenesis of Alzheimer disease. Results: The loss of Fbxo2, a brain-enriched substrate adaptor for ubiquitin ligases, leads to increased neuronal APP levels and processing. Conclusion: Fbxo2 regulates APP levels in a brain region-specific manner. Significance: These findings suggest a novel mechanism for ubiquitin-mediated regulation of amyloid- production. The amyloid precursor protein (APP) is an integral membrane glycoprotein whose cleavage products, particularly amyloid-, accumulate in Alzheimer disease (AD). APP is present at synapses and is thought to play a role in both the formation and plasticity of these critical neuronal structures. Despite the central role suggested for APP in AD pathogenesis, the mechanisms regulating APP in neurons and its processing into cleavage products remain incompletely understood. F-box only protein 2 (Fbxo2), a neuron-enriched ubiquitin ligase substrate adaptor that preferentially binds high-mannose glycans on glycoproteins, was previously implicated in APP processing by facilitating the degradation of the APP-cleaving -secretase, -site APP-cleaving enzyme. Here, we sought to determine whether Fbxo2 plays a similar role for other glycoproteins in the amyloid processing pathway. We present in vitro and in vivo evidence that APP is itself a substrate for Fbxo2. APP levels were decreased in the presence of Fbxo2 in non-neuronal cells, and increased in both cultured hippocampal neurons and brain tissue from Fbxo2 knock-out mice. The processing of APP into its cleavage products was also increased in hippocampi and cultured hippocampal neurons lacking Fbxo2. In hippocampal slices, this increase in cleavage products was accompanied by a significant reduction in APP at the cell surface. Taken together, these results suggest that Fbxo2 regulates APP levels and processing in the brain and may play a role in modulating AD pathogenesis.	[Atkin, Graham; Hunt, Jack; Minakawa, Eiko; Sharkey, Lisa; Tipper, Nathan; Tennant, William; Paulson, Henry L.] Univ Michigan, Dept Neurol, Ann Arbor, MI 48104 USA	University of Michigan System; University of Michigan	Atkin, G (corresponding author), Rm 4160,Biomed Sci Res Bldg,109 Zina Pitcher Pl, Ann Arbor, MI 48104 USA.	atking@umich.edu; henryp@umich.edu	Hunt, Jack/AAP-3813-2021; Minakawa, Eiko N./AAB-2167-2019	Hunt, Jack/0000-0002-5719-9028; Minakawa, Eiko/0000-0002-6204-9104	National Institutes of Health [RO1 AG034228]; Michigan Alzheimer's Disease Center; NIA, National Institutes of Health [T32-AG000114]; University of Michigan Protein Folding Diseases Initiative; NATIONAL INSTITUTE ON AGING [R01AG034228, T32AG000114] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Michigan Alzheimer's Disease Center; NIA, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); University of Michigan Protein Folding Diseases Initiative; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by National Institutes of Health Grant RO1 AG034228, pilot research funds from the Michigan Alzheimer's Disease Center, and NIA, National Institutes of Health Grant T32-AG000114. This work was also supported by the University of Michigan Protein Folding Diseases Initiative.	Aakalu G, 2001, NEURON, V30, P489, DOI 10.1016/S0896-6273(01)00295-1; Andersen OM, 2005, P NATL ACAD SCI USA, V102, P13461, DOI 10.1073/pnas.0503689102; Bero AW, 2011, NAT NEUROSCI, V14, P750, DOI 10.1038/nn.2801; Bertram L, 2010, NEURON, V68, P270, DOI 10.1016/j.neuron.2010.10.013; Brouwers N, 2006, BRAIN, V129, P2984, DOI 10.1093/brain/awl212; Choy RWY, 2012, P NATL ACAD SCI USA, V109, pE2077, DOI 10.1073/pnas.1208635109; Citron M, 2010, NAT REV DRUG DISCOV, V9, P387, DOI 10.1038/nrd2896; Cousins SL, 2009, J NEUROCHEM, V111, P1501, DOI 10.1111/j.1471-4159.2009.06424.x; De Strooper B, 2000, J CELL SCI, V113, P1857; De Strooper B, 2010, NAT REV NEUROL, V6, P99, DOI 10.1038/nrneurol.2009.218; El Ayadi A, 2012, P NATL ACAD SCI USA, V109, P13416, DOI 10.1073/pnas.1206786109; Escrevente C, 2008, BBA-GEN SUBJECTS, V1780, P905, DOI 10.1016/j.bbagen.2008.03.004; Frisoni GB, 2008, BRAIN, V131, P3266, DOI 10.1093/brain/awn280; Glenn KA, 2008, J BIOL CHEM, V283, P12717, DOI 10.1074/jbc.M709508200; Gong B, 2010, AGING CELL, V9, P1018, DOI 10.1111/j.1474-9726.2010.00632.x; Helenius A, 2004, ANNU REV BIOCHEM, V73, P1019, DOI 10.1146/annurev.biochem.73.011303.073752; Hoe HS, 2009, J BIOL CHEM, V284, P8495, DOI 10.1074/jbc.M900141200; Hooper N.M., 2010, INT J ALZHEIMERS DIS, V2011; Huh KH, 1999, J BIOL CHEM, V274, P151, DOI 10.1074/jbc.274.1.151; Iliff AJ, 2013, HUM MOL GENET, V22, P1180, DOI 10.1093/hmg/dds525; Kamenetz F, 2003, NEURON, V37, P925, DOI 10.1016/S0896-6273(03)00124-7; Kaneko M, 2010, J NEUROSCI, V30, P3924, DOI 10.1523/JNEUROSCI.2422-09.2010; Kato A, 2005, P NATL ACAD SCI USA, V102, P5600, DOI 10.1073/pnas.0501769102; Mattson MP, 1997, PHYSIOL REV, V77, P1081, DOI 10.1152/physrev.1997.77.4.1081; Miller VM, 2005, J NEUROSCI, V25, P9152, DOI 10.1523/JNEUROSCI.3001-05.2005; Morales-Corraliza J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007134; Nelson RF, 2007, J NEUROSCI, V27, P5163, DOI 10.1523/JNEUROSCI.0206-07.2007; Nelson RF, 2006, J BIOL CHEM, V281, P20242, DOI 10.1074/jbc.M602423200; Palop JJ, 2006, NATURE, V443, P768, DOI 10.1038/nature05289; Purro SA, 2012, J NEUROSCI, V32, P3492, DOI 10.1523/JNEUROSCI.4562-11.2012; Puzzo D, 2011, ANN NEUROL, V69, P819, DOI 10.1002/ana.22313; Rovelet-Lecrux A, 2006, NAT GENET, V38, P24, DOI 10.1038/ng1718; Sanchez MM, 2012, BIOL PSYCHIAT, V71, P403, DOI 10.1016/j.biopsych.2011.08.016; Thinakaran G, 2008, J BIOL CHEM, V283, P29615, DOI 10.1074/jbc.R800019200; Thomas-Crusells J, 2003, J NEUROSCI METH, V125, P159, DOI 10.1016/S0165-0270(03)00050-5; Tyan SH, 2012, MOL CELL NEUROSCI, V51, P43, DOI 10.1016/j.mcn.2012.07.009; Wang YJ, 2010, J ALZHEIMERS DIS, V21, P1065, DOI 10.3233/JAD-2010-100195; Yoshida Y, 2002, NATURE, V418, P438, DOI 10.1038/nature00890	38	27	27	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 7	2014	289	10					7038	7048		10.1074/jbc.M113.515056	http://dx.doi.org/10.1074/jbc.M113.515056			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AC3BG	24469452	Green Published, hybrid			2022-12-25	WOS:000332389400063
J	Xu, QD; Xu, FH; Fan, L; Xiong, LP; Li, HY; Cao, SR; Lin, XY; Zheng, ZH; Yu, XQ; Mao, HP				Xu, Qingdong; Xu, Fenghua; Fan, Li; Xiong, Liping; Li, Huiyan; Cao, Shirong; Lin, Xiaoyan; Zheng, Zhihua; Yu, Xueqing; Mao, Haiping			Serum Potassium Levels and Its Variability in Incident Peritoneal Dialysis Patients: Associations with Mortality	PLOS ONE			English	Article							RESIDUAL RENAL-FUNCTION; CHRONIC KIDNEY-DISEASE; HEMODIALYSIS-PATIENTS; CARDIAC DEATH; CAPD PATIENTS; RISK-FACTORS; HYPOKALEMIA; OUTCOMES; TRANSPORT; SURVIVAL	Background: Abnormal serum potassium is associated with an increased risk of mortality in dialysis patients. However, the impacts of serum potassium levels on short-and long-term mortality and association of potassium variability with death in peritoneal dialysis (PD) patients are uncertain. Methods: We examined mortality-predictability of serum potassium at baseline and its variability in PD patients treated in our center January 2006 through December 2010 with follow-up through December 2012. The hazard ratios (HRs) were used to assess the relationship between baseline potassium levels and short-term (<= 1 year) as well as long-term (>1 year) survival. Variability of serum potassium was defined as the coefficient of variation of serum potassium (CVSP) during the first year of PD. Results: A total of 886 incident PD patients were enrolled, with 248 patients (27.9%) presented hypokalemia (serum potassium <3.5 mEq/L). During a median follow-up of 31 months (range: 0.5-81.0 months), adjusted all-cause mortality hazard ratio (HR) and 95% confidence interval (CI) for baseline serum potassium of <3.0, 3.0 to <3.5, 3.5 to <4.0, 4.5 to <5.0, and >= 5.0 mEq/L, compared with 4.0 to <4.5 (reference), were 1.79 (1.02-3.14), 1.15 (0.72-1.86), 1.31 (0.82-2.08), 1.33 (0.71-2.48), 1.28 (0.53-3.10), respectively. The increased risk of lower potassium with mortality was evident during the first year of follow-up, but vanished thereafter. Adjusted all-cause mortality HR for CVSP increments of 7.5% to <12.0%; 12.0% to <16.7% and >= 16.7%, compared with <7.5% (reference), were 1.35 (0.67-2.71), 2.00 (1.05-3.83) and 2.18 (1.18-4.05), respectively. Similar association was found between serum potassium levels and its variability and cardiovascular mortality. Conclusions: A lower serum potassium level was associated with all-cause and cardiovascular mortality during the first year of follow-up in incident PD patients. In addition, higher variability of serum potassium levels conferred an increased risk of death in this population.	[Xu, Qingdong; Xu, Fenghua; Fan, Li; Xiong, Liping; Li, Huiyan; Cao, Shirong; Lin, Xiaoyan; Zheng, Zhihua; Yu, Xueqing; Mao, Haiping] Sun Yat Sen Univ, Affiliated Hosp 1, Key Lab Nephrol, Dept Nephrol,Minist Hlth China, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University	Mao, HP (corresponding author), Sun Yat Sen Univ, Affiliated Hosp 1, Key Lab Nephrol, Dept Nephrol,Minist Hlth China, Guangzhou 510275, Guangdong, Peoples R China.	haipingmao@126.com	cao, shirong/AAX-5688-2021	Mao, Haiping/0000-0002-3608-3851	National Key Technology Research and Development Program of the Ministry of Science and Technology of China [2011BAI10B05]; National Science Fund for Distinguished Young Scholars of China [30925019]; 5010 Clinical Program of Sun Yat-sen University [2007007]; Guangzhou Committee of Science and Technology of China [2010U1-E00831]	National Key Technology Research and Development Program of the Ministry of Science and Technology of China(National Key Technology R&D Program); National Science Fund for Distinguished Young Scholars of China(National Natural Science Foundation of China (NSFC)National Science Fund for Distinguished Young Scholars); 5010 Clinical Program of Sun Yat-sen University; Guangzhou Committee of Science and Technology of China	This work was supported by grants from the National Key Technology Research and Development Program of the Ministry of Science and Technology of China (No. 2011BAI10B05), the National Science Fund for Distinguished Young Scholars of China (No. 30925019), 5010 Clinical Program of Sun Yat-sen University (No. 2007007) and the Guangzhou Committee of Science and Technology of China (No. 2010U1-E00831). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beddhu S, 2002, AM J MED, V112, P696, DOI 10.1016/S0002-9343(02)01097-5; Bleyer AJ, 1999, KIDNEY INT, V55, P1553, DOI 10.1046/j.1523-1755.1999.00391.x; Chan CT, 2008, NEPHROL DIAL TRANSPL, V23, P3061, DOI 10.1093/ndt/gfn280; Chertow GM, 2012, NEW ENGL J MED, V367, P2482, DOI 10.1056/NEJMoa1205624; Chuang YW, 2009, NEPHROL DIAL TRANSPL, V24, P1603, DOI 10.1093/ndt/gfn709; Davies SJ, 2001, J AM SOC NEPHROL, V12, P1046, DOI 10.1681/ASN.V1251046; Dekker FW, 2008, KIDNEY INT, V74, P994, DOI 10.1038/ki.2008.328; Di Iorio B, 2012, NEPHROL DIAL TRANSPL, V27, P4404, DOI 10.1093/ndt/gfs328; Fleischmann EH, 2001, ASAIO J, V47, P74, DOI 10.1097/00002480-200101000-00016; Gao HB, 1999, AM J NEPHROL, V19, P7, DOI 10.1159/000013418; Go AS, 2004, NEW ENGL J MED, V351, P1296, DOI 10.1056/NEJMoa041031; Harrison TR, 1930, J CLIN INVEST, V8, P325, DOI 10.1172/JCI100267; Jung Ji Yong, 2009, Electrolyte Blood Press, V7, P73, DOI 10.5049/EBP.2009.7.2.73; Kainz A, 2010, NEPHROL DIAL TRANSPL, V25, P3701, DOI 10.1093/ndt/gfq287; Kalantar-Zadeh K, 2006, KIDNEY INT, V70, P771, DOI 10.1038/sj.ki.5001514; Kalantar-Zadeh K, 2003, KIDNEY INT, V63, P793, DOI 10.1046/j.1523-1755.2003.00803.x; Khan AN, 1996, PERITON DIALYSIS INT, V16, P652; Konings CJAM, 2003, NEPHROL DIAL TRANSPL, V18, P797, DOI 10.1093/ndt/gfg147; Korgaonkar S, 2010, CLIN J AM SOC NEPHRO, V5, P762, DOI 10.2215/CJN.05850809; Kovesdy CP, 2007, CLIN J AM SOC NEPHRO, V2, P999, DOI 10.2215/CJN.04451206; Kwan BCH, 2012, NAT REV NEPHROL, V8, P501, DOI 10.1038/nrneph.2012.159; Li PKT, 2003, ANN INTERN MED, V139, P105, DOI 10.7326/0003-4819-139-2-200307150-00010; Mcdonald SP, 2003, J AM SOC NEPHROL, V14, P2894, DOI 10.1097/01.ASN.0000091587.55159.5F; Newman L N, 2000, Adv Perit Dial, V16, P134; OREOPOULOS DG, 1982, NEPHRON, V30, P293, DOI 10.1159/000182504; ROCCO MV, 1994, J AM SOC NEPHROL, V5, P1333; ROSTAND SG, 1983, ARCH INTERN MED, V143, P377, DOI 10.1001/archinte.143.2.377; Royston P, 2000, STAT MED, V19, P1831, DOI 10.1002/1097-0258(20000730)19:14<1831::AID-SIM502>3.0.CO;2-1; Sica D A, 2002, J Clin Hypertens (Greenwich), V4, P198, DOI 10.1111/j.1524-6175.2002.01728.x; Szeto CC, 2005, AM J KIDNEY DIS, V46, P128, DOI 10.1053/j.ajkd.2005.03.015; Torlen K, 2012, CLIN J AM SOC NEPHRO, V7, P1272, DOI 10.2215/CJN.00960112; Tziviskou Effie, 2003, International Urology and Nephrology, V35, P429, DOI 10.1023/B:UROL.0000022867.93739.03; vanOlden RW, 1996, J AM SOC NEPHROL, V7, P745; Wang AYM, 2003, J AM SOC NEPHROL, V14, P159, DOI 10.1097/01.ASN.0000038685.95946.83	34	28	32	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2014	9	1							e86750	10.1371/journal.pone.0086750	http://dx.doi.org/10.1371/journal.pone.0086750			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301BI	24475176	Green Published, gold, Green Submitted			2022-12-25	WOS:000330507300107
J	Jia, CY; Carson, MB; Wang, Y; Lin, YF; Lu, H				Jia, Caiyan; Carson, Matthew B.; Wang, Yang; Lin, Youfang; Lu, Hui			A New Exhaustive Method and Strategy for Finding Motifs in ChIP-Enriched Regions	PLOS ONE			English	Article							FACTOR-BINDING SITES; SEQ DATA; TRANSCRIPTION; DISCOVERY; DNA; GENOME; IDENTIFICATION; ALGORITHMS; SEQUENCES; DATABASE	ChIP-seq, which combines chromatin immunoprecipitation (ChIP) with next-generation parallel sequencing, allows for the genome-wide identification of protein-DNA interactions. This technology poses new challenges for the development of novel motif-finding algorithms and methods for determining exact protein-DNA binding sites from ChIP-enriched sequencing data. State-of-the-art heuristic, exhaustive search algorithms have limited application for the identification of short (l, d) motifs (l <= 10, d <= 2) contained in ChIP-enriched regions. In this work we have developed a more powerful exhaustive method (FMotif) for finding long (l, d) motifs in DNA sequences. In conjunction with our method, we have adopted a simple ChIP-enriched sampling strategy for finding these motifs in large-scale ChIP-enriched regions. Empirical studies on synthetic samples and applications using several ChIP data sets including 16 TF (transcription factor) ChIP-seq data sets and five TF ChIP-exo data sets have demonstrated that our proposed method is capable of finding these motifs with high efficiency and accuracy. The source code for FMotif is available at http://211.71.76.45/FMotif/.	[Jia, Caiyan; Wang, Yang; Lin, Youfang] Beijing Jiaotong Univ, Sch Comp & Informat Technol, Beijing, Peoples R China; [Jia, Caiyan; Wang, Yang; Lin, Youfang] Beijing Jiaotong Univ, Beijing Key Lab Traff Data Anal, Beijing, Peoples R China; [Jia, Caiyan; Lu, Hui] Univ Illinois, Dept Bioengn Bioinformat, Chicago, IL USA; [Carson, Matthew B.] Northwestern Univ, Ctr Healthcare Studies, Inst Publ Hlth & Med, Feinberg Sch Med, Chicago, IL 60611 USA; [Carson, Matthew B.] Northwestern Univ, Div Hlth & Biomed Informat, Dept Prevent Med, Feinberg Sch Med, Chicago, IL 60611 USA; [Lu, Hui] Shanghai Jiao Tong Univ, Shanghai Inst Med Genet, Shanghai Childrens Hosp, Shanghai, Peoples R China	Beijing Jiaotong University; Beijing Jiaotong University; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; Shanghai Jiao Tong University	Jia, CY (corresponding author), Beijing Jiaotong Univ, Sch Comp & Informat Technol, Beijing, Peoples R China.	cyjia@bjtu.edu.cn; huilu.bioinfo@gmail.com	Lu, Hui/K-3264-2019	Lin, Youfang/0000-0002-5143-3645; Lu, Hui/0000-0001-8347-0830; Carson, Matthew/0000-0003-4105-9220	National Nature Science Foundation of China [60905029, 61105055, 61105056, 81230086, 31071167]; Beijing Natural Science Foundation [4112046]; Fundamental Research Funds for the Central Universities	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Natural Science Foundation(Beijing Natural Science Foundation); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported in part by National Nature Science Foundation of China (Grant No. 60905029, 61105055, 61105056, 81230086, and 31071167), the Beijing Natural Science Foundation (Grant No. 4112046), and the Fundamental Research Funds for the Central Universities. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Badis G, 2008, MOL CELL, V32, P878, DOI 10.1016/j.molcel.2008.11.020; Bailey T L, 1994, Proc Int Conf Intell Syst Mol Biol, V2, P28; Bailey TL, 2011, BIOINFORMATICS, V27, P1653, DOI 10.1093/bioinformatics/btr261; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Boeva V, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq217; Buhler J, 2002, J COMPUT BIOL, V9, P225, DOI 10.1089/10665270252935430; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; Chin HCL, 2005, P 3 AS PAC BIOINF C, P261; Cowper-Sal-lari R, 2012, NAT GENET, V44, P1191, DOI 10.1038/ng.2416; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Davila J, 2007, IEEE ACM T COMPUT BI, V4, P544, DOI 10.1109/TCBB.2007.70241; Eskin E, 2002, BIOINFORMATICS, V18, pS354, DOI DOI 10.1093/BIOINFORMATICS/18.SUPPL_1.S354.; Guo YC, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002638; He YP, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-S8-S18; Hertz GZ, 1999, BIOINFORMATICS, V15, P563, DOI 10.1093/bioinformatics/15.7.563; Ho ES, 2009, ALGORITHM MOL BIOL, V4, DOI 10.1186/1748-7188-4-14; Hu M, 2010, NUCLEIC ACIDS RES, V38, P2154, DOI 10.1093/nar/gkp1180; Huang CW, 2011, IEEE ACM T COMPUT BI, V8, P959, DOI 10.1109/TCBB.2010.92; Hughes JD, 2000, J MOL BIOL, V296, P1205, DOI 10.1006/jmbi.2000.3519; Johnson DS, 2007, SCIENCE, V316, P1497, DOI 10.1126/science.1141319; Jothi R, 2008, NUCLEIC ACIDS RES, V36, P5221, DOI 10.1093/nar/gkn488; Keich U, 2002, BIOINFORMATICS, V18, P1382, DOI 10.1093/bioinformatics/18.10.1382; Kuksa PP, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-S8-S1; Kulakovskiy IV, 2010, BIOINFORMATICS, V26, P2622, DOI 10.1093/bioinformatics/btq488; LAWRENCE CE, 1993, SCIENCE, V262, P208, DOI 10.1126/science.8211139; Li G, 2010, IEEE ACM T COMPUT BI, V7, P654, DOI 10.1109/TCBB.2009.25; Lupien M, 2008, CELL, V132, P958, DOI 10.1016/j.cell.2008.01.018; Ma XT, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gkr1135; Machanick P, 2011, BIOINFORMATICS, V27, P1696, DOI 10.1093/bioinformatics/btr189; Pachkov M, 2007, NUCLEIC ACIDS RES, V35, pD127, DOI 10.1093/nar/gkl857; Pavesi G, 2004, NUCLEIC ACIDS RES, V32, pW199, DOI 10.1093/nar/gkh465; Pavesi G., 2001, BIOINFORMATICS, V17, pS207; Pevzner P A, 2000, Proc Int Conf Intell Syst Mol Biol, V8, P269; Reid JE, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr574; Rhee S H, 2011, CELL, V147, P480; Robertson G, 2007, NAT METHODS, V4, P651, DOI 10.1038/NMETH1068; Sagot MF, 1998, LECT NOTES COMPUTER, V1380, P111; Sharov AA, 2009, DNA RES, V16, P261, DOI 10.1093/dnares/dsp014; Spivak AT, 2012, NUCLEIC ACIDS RES, V40, pD162, DOI 10.1093/nar/gkr1180; Sun HQ, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-S11-S8; Thomas-Chollier M, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gkr1104; Tompa M, 2005, NAT BIOTECHNOL, V23, P137, DOI 10.1038/nbt1053; van Heeringen SJ, 2011, BIOINFORMATICS, V27, P270, DOI 10.1093/bioinformatics/btq636; Wilbanks EG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011471; Zambelli F, 2013, BRIEF BIOINFORM, V14, P225, DOI 10.1093/bib/bbs016; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zhao Y, 2011, NAT BIOTECHNOL, V29, P480, DOI 10.1038/nbt.1893; Zia A, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-151	48	20	21	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2014	9	1							e86044	10.1371/journal.pone.0086044	http://dx.doi.org/10.1371/journal.pone.0086044			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	298QQ	24475069	Green Published, gold, Green Submitted			2022-12-25	WOS:000330339800023
J	Sutcliffe, CG; van Dijk, JH; Hamangaba, F; Mayani, F; Moss, WJ				Sutcliffe, Catherine G.; van Dijk, Janneke H.; Hamangaba, Francis; Mayani, Felix; Moss, William J.			Turnaround Time for Early Infant HIV Diagnosis in Rural Zambia: A Chart Review	PLOS ONE			English	Review							INFECTION; CARE	Background: Early infant HIV diagnosis is challenging in sub-Saharan Africa, particularly in rural areas where laboratory capacity is limited. Specimens must be transported to central laboratories for testing, leading to delays in diagnosis and initiation of antiretroviral therapy. This study was undertaken in rural Zambia to measure the turnaround time for confirmation of HIV infection and identify delays in diagnosis. Methods: Chart reviews were conducted from 2010-2012 for children undergoing early infant HIV diagnosis at Macha Hospital in Zambia. Relevant dates, receipt of drugs by mother and child for the prevention of mother-to-child transmission (PMTCT), and test results were abstracted. Results: 403 infants provided 476 samples for early infant diagnosis. The median age at the "6-week'' and "6-month'' assessments was 8.1 weeks and 7.0 months, respectively. The majority of mothers (80%) and infants (67%) received PMTCT. The median time between sample collection and arrival at the central laboratory in Lusaka was 17 days (IQR: 10, 28); arrival at the central laboratory to testing was 6 days (IQR: 5, 11); testing to return of results to the clinic was 29 days (IQR: 17, 36); arrival of results at the clinic to return of results to the caregiver was 45 days (IQR: 24, 79). The total median time from sample collection to return of results to the caregiver was 92 days (IQR: 84, 145). The proportion of HIV PCR positive samples was 12%. The total median turnaround time was shorter for HIV PCR positive as compared to negative or invalid samples (85 vs. 92 days; p = 0.08). Conclusions: Delays in processing and communicating test results were identified, particularly in returning results from the central laboratory to the clinic and from the clinic to the caregiver. A more efficient process is needed so that caregivers can be provided test results more rapidly, potentially resulting in earlier treatment initiation and better outcomes for HIV-infected infants.	[Sutcliffe, Catherine G.; Moss, William J.] Johns Hopkins Univ, Dept Epidemiol, Bloomberg Sch Publ Hlth, Baltimore, MD 21218 USA; [van Dijk, Janneke H.; Hamangaba, Francis; Mayani, Felix] Macha Res Trust, Macha Hosp, Choma, Zambia; [van Dijk, Janneke H.] Erasmus Univ, Dept Immunol & Infect Dis, Rotterdam, Netherlands	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Erasmus University Rotterdam	Sutcliffe, CG (corresponding author), Johns Hopkins Univ, Dept Epidemiol, Bloomberg Sch Publ Hlth, Baltimore, MD 21218 USA.	csutclif@jhsph.edu		Sutcliffe, Catherine/0000-0001-8512-8326	Department of Health and Human Services (DHHS)/Centers for Disease Control and Prevention (CDC) [5U2GPS001930-05]	Department of Health and Human Services (DHHS)/Centers for Disease Control and Prevention (CDC)(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	This work was made possible by support from the President's Emergency Plan for AIDS Relief (PEPFAR) through Cooperative Agreement 5U2GPS001930-05 from the Department of Health and Human Services (DHHS)/Centers for Disease Control and Prevention (CDC), Global AIDS Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chatterjee A, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-553; Dube Q, 2012, B WORLD HEALTH ORGAN, V90, P699, DOI 10.2471/BLT.11.100776; Ginwalla R, 2010, EARL INF DIAGN IMPR; Hungu J, 2010, EARL INF DIAGN IMPR; Kiyaga C, 2010, EARL INF DIAGN IMPR; McNairy ML, 2012, J ACQ IMMUN DEF SYND, V62, pe70; Ministry of Health Republic of Zambia, 2010, INT PREV MOTH TO CHI; Nuwagaba-Biribonwoha H, 2010, BMC PEDIATR, V10, DOI 10.1186/1471-2431-10-44; Seidenberg P, 2012, B WORLD HEALTH ORGAN, V90, P348, DOI 10.2471/BLT.11.100032; SISON AV, 1992, CLIN MICROBIOL REV, V5, P238, DOI 10.1128/CMR.5.3.238-247.1992; Sutcliffe CG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029294; UNAIDS, 2012, TOG WE WILL END AIDS; UNICEF, 2012, ZAMB 15 AUG 2012 RAP; van Dijk JH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019006; van Dijk JH, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-169; Wettstein C, 2012, AIDS, V26, P2361, DOI 10.1097/QAD.0b013e328359ab0c; WHO/UNAIDS/UNICEF, 2012, GLOB HIV AIDS RESP E; World Health Organization, 2008, TASK SHIFT RAT RED T; World Health Organization, 2021, ANT DRUGS TREAT PREG; World Health Organization, 2010, ANT THER HIV INF INF; World Health Organization, 2010, UN ACC SCAL PRIOR HI	21	51	51	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2014	9	1							e87028	10.1371/journal.pone.0087028	http://dx.doi.org/10.1371/journal.pone.0087028			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	298QQ	24475214	Green Submitted, Green Published, gold			2022-12-25	WOS:000330339800079
J	Eser, J; Zheng, PS; Triesch, J				Eser, Juergen; Zheng, Pengsheng; Triesch, Jochen			Nonlinear Dynamics Analysis of a Self-Organizing Recurrent Neural Network: Chaos Waning	PLOS ONE			English	Article							PREDICTION; SYSTEMS; MODELS; EDGE	Self-organization is thought to play an important role in structuring nervous systems. It frequently arises as a consequence of plasticity mechanisms in neural networks: connectivity determines network dynamics which in turn feed back on network structure through various forms of plasticity. Recently, self-organizing recurrent neural network models (SORNs) have been shown to learn non-trivial structure in their inputs and to reproduce the experimentally observed statistics and fluctuations of synaptic connection strengths in cortex and hippocampus. However, the dynamics in these networks and how they change with network evolution are still poorly understood. Here we investigate the degree of chaos in SORNs by studying how the networks' self-organization changes their response to small perturbations. We study the effect of perturbations to the excitatory-to-excitatory weight matrix on connection strengths and on unit activities. We find that the network dynamics, characterized by an estimate of the maximum Lyapunov exponent, becomes less chaotic during its self-organization, developing into a regime where only few perturbations become amplified. We also find that due to the mixing of discrete and (quasi-)continuous variables in SORNs, small perturbations to the synaptic weights may become amplified only after a substantial delay, a phenomenon we propose to call deferred chaos.	[Eser, Juergen; Zheng, Pengsheng; Triesch, Jochen] Frankfurt Inst Adv Studies, Frankfurt, Germany		Triesch, J (corresponding author), Frankfurt Inst Adv Studies, Frankfurt, Germany.	triesch@fias.uni-frankfurt.de			European Commission [ICT-IP-231722]; LOEWE-Program Neuronal Coordination Research Focus Frankfurt (NeFF)	European Commission(European CommissionEuropean Commission Joint Research Centre); LOEWE-Program Neuronal Coordination Research Focus Frankfurt (NeFF)	This work was supported by the European Commission 7th Framework Programme (FP7/2007-2013), Challenge 2 - Cognitive Systems, Interaction, Robotics, grant agreement No. ICT-IP-231722, project "IM-CLeVeR-Intrinsically Motivated Cumulative Learning Versatile Robots" and by the LOEWE-Program Neuronal Coordination Research Focus Frankfurt (NeFF, http://www.neff-ffm.de/en/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aihara K, 2010, PHILOS T R SOC A, V368, P4893, DOI 10.1098/rsta.2010.0237; Albers DJ, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.057201; Albers DJ, 1998, INT J BIFURCAT CHAOS, V8, P1463, DOI 10.1142/S0218127498001121; Bertschinger N, 2004, NEURAL COMPUT, V16, P1413, DOI 10.1162/089976604323057443; Bick C, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.244101; CESSAC B, 1994, PHYSICA D, V74, P24, DOI 10.1016/0167-2789(94)90024-8; Chen LN, 1997, PHYSICA D, V104, P286, DOI 10.1016/S0167-2789(96)00302-8; Dauce E, 1998, NEURAL NETWORKS, V11, P521, DOI 10.1016/S0893-6080(97)00131-7; DOYON B, 1994, ACTA BIOTHEOR, V42, P215, DOI 10.1007/BF00709492; Jahnke S, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.048102; Kitzbichler MG, 2013, PLOS COMPUTATIONAL B, V5; Lazar A, 2007, NEURAL NETWORKS, V20, P312, DOI 10.1016/j.neunet.2007.04.020; Lazar A, 2009, FRONT COMPUT NEUROSC, V3, DOI 10.3389/neuro.10.023.2009; Legenstein R, 2007, NEURAL NETWORKS, V20, P323, DOI 10.1016/j.neunet.2007.04.017; Pasemann F, 2002, NETWORK-COMP NEURAL, V13, P195, DOI 10.1088/0954-898X/13/2/303; Potapov A, 2000, PHYS LETT A, V277, P310, DOI 10.1016/S0375-9601(00)00726-X; Priesemann V, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002985; Rajan K, 2010, PHYS REV E, V82, DOI 10.1103/PhysRevE.82.011903; Shew WL, 2013, NEUROSCIENTIST, V19, P88, DOI 10.1177/1073858412445487; Siri B, 2007, J PHYSIOL-PARIS, V101, P136, DOI 10.1016/j.jphysparis.2007.10.003; SOMPOLINSKY H, 1988, PHYS REV LETT, V61, P259, DOI 10.1103/PhysRevLett.61.259; Sprott JC, 2008, AM J PHYS, V76, P474, DOI 10.1119/1.2830540; Sprott JC, 2008, CHAOS, V18, DOI 10.1063/1.2945229; Suzuki H, 2013, SCI REP-UK, V3, DOI 10.1038/srep01610; Vogels TP, 2009, NAT NEUROSCI, V12, P483, DOI 10.1038/nn.2276; Zheng PS, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002848	26	7	7	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2014	9	1							e86962	10.1371/journal.pone.0086962	http://dx.doi.org/10.1371/journal.pone.0086962			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297XI	24466301	Green Published, Green Submitted, gold			2022-12-25	WOS:000330288000177
J	Stanevich, V; Zheng, AP; Guo, F; Jiang, L; Wlodarchak, N; Xing, YN				Stanevich, Vitali; Zheng, Aiping; Guo, Feng; Jiang, Li; Wlodarchak, Nathan; Xing, Yongna			Mechanisms of the Scaffold Subunit in Facilitating Protein Phosphatase 2A Methylation	PLOS ONE			English	Article							A-ALPHA SUBUNIT; CATALYTIC SUBUNIT; TUMOR-ANTIGENS; IN-VIVO; PP2A; BINDING; DEPHOSPHORYLATION; POLYOMAVIRUS; HOLOENZYME; MUTATIONS	The function of the biologically essential protein phosphatase 2A (PP2A) relies on formation of diverse heterotrimeric holoenzymes, which involves stable association between PP2A scaffold (A) and catalytic (C or PP2Ac) subunits and binding of variable regulatory subunits. Holoenzyme assembly is highly regulated by carboxyl methylation of PP2Ac-tail; methylation of PP2Ac and association of the A and C subunits are coupled to activation of PP2Ac. Here we showed that PP2A-specific methyltransferase, LCMT-1, exhibits a higher activity toward the core enzyme (A-C heterodimer) than free PP2Ac, and the A-subunit facilitates PP2A methylation via three distinct mechanisms: 1) stabilization of a proper protein fold and an active conformation of PP2Ac; 2) limiting the space of PP2Ac-tail movement for enhanced entry into the LCMT-1 active site; and 3) weak electrostatic interactions between LCMT-1 and the N-terminal HEAT repeats of the A-subunit. Our results revealed a new function and novel mechanisms of the A-subunit in PP2A methylation, and coherent control of PP2A activity, methylation, and holoenzyme assembly.	[Stanevich, Vitali; Zheng, Aiping; Guo, Feng; Jiang, Li; Wlodarchak, Nathan; Xing, Yongna] Univ Wisconsin, McArdle Lab Canc Res, Dept Oncol, Sch Med & Publ Hlth, Madison, WI 53706 USA; [Stanevich, Vitali; Xing, Yongna] Univ Wisconsin, Biophys Program, Madison, WI USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Xing, YN (corresponding author), Univ Wisconsin, McArdle Lab Canc Res, Dept Oncol, Sch Med & Publ Hlth, 1400 Univ Ave, Madison, WI 53706 USA.	xing@oncology.wisc.edu	Zheng, Aiping/U-5313-2019; Wlodarchak, Nathan/GXH-3756-2022	Zheng, Aiping/0000-0003-4982-0109	American Cancer Society Research Scholar Grant NIH, Clinical and Translational Science Award (CTSA) program [R01 GM096060-01, UL1TR000427]; NATIONAL CANCER INSTITUTE [T32CA009135] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000427] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM096060] Funding Source: NIH RePORTER	American Cancer Society Research Scholar Grant NIH, Clinical and Translational Science Award (CTSA) program; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	American Cancer Society Research Scholar Grant NIH R01 GM096060-01 Clinical and Translational Science Award (CTSA) program UL1TR000427. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Bryant JC, 1999, BIOCHEM J, V339, P241, DOI 10.1042/0264-6021:3390241; Chao Y, 2006, MOL CELL, V23, P535, DOI 10.1016/j.molcel.2006.07.027; Colella S, 2001, INT J CANCER, V93, P798, DOI 10.1002/ijc.1423; Eichhorn PJA, 2009, BBA-REV CANCER, V1795, P1, DOI 10.1016/j.bbcan.2008.05.005; FAVRE B, 1994, J BIOL CHEM, V269, P16311; Fellner T, 2003, GENE DEV, V17, P2138, DOI 10.1101/gad.259903; Grinthal A, 2010, P NATL ACAD SCI USA, V107, P2467, DOI 10.1073/pnas.0914073107; Groves MR, 1999, CELL, V96, P99, DOI 10.1016/S0092-8674(00)80963-0; Guo F, 2014, CELL RES, V24, P190, DOI 10.1038/cr.2013.138; Hombauer H, 2007, PLOS BIOL, V5, P1355, DOI 10.1371/journal.pbio.0050155; Janssens V, 2001, BIOCHEM J, V353, P417, DOI 10.1042/0264-6021:3530417; Jiang L, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2663; LEE J, 1993, J BIOL CHEM, V268, P19192; Lee J, 1996, P NATL ACAD SCI USA, V93, P6043, DOI 10.1073/pnas.93.12.6043; Ogris E, 1997, ONCOGENE, V15, P911, DOI 10.1038/sj.onc.1201259; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; RUEDIGER R, 1994, J VIROL, V68, P123, DOI 10.1128/JVI.68.1.123-129.1994; RUEDIGER R, 1992, MOL CELL BIOL, V12, P4872, DOI 10.1128/MCB.12.11.4872; Ruediger R, 2001, ONCOGENE, V20, P10, DOI 10.1038/sj.onc.1204059; Shi YG, 2009, CELL, V139, P468, DOI 10.1016/j.cell.2009.10.006; Tolstykh T, 2000, EMBO J, V19, P5682, DOI 10.1093/emboj/19.21.5682; Virshup DM, 2009, MOL CELL, V33, P537, DOI 10.1016/j.molcel.2009.02.015; Virshup DM, 2000, CURR OPIN CELL BIOL, V12, P180, DOI 10.1016/S0955-0674(99)00074-5; Wlodarchak N, 2013, CELL RES, V23, P931, DOI 10.1038/cr.2013.77; Xing YN, 2008, CELL, V133, P154, DOI 10.1016/j.cell.2008.02.041; Xing Y, 2006, CELL, V127, P341, DOI 10.1016/j.cell.2006.09.025; Xu YH, 2008, MOL CELL, V31, P873, DOI 10.1016/j.molcel.2008.08.006; Xu YH, 2006, CELL, V127, P1239, DOI 10.1016/j.cell.2006.11.033	29	16	16	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2014	9	1							e86955	10.1371/journal.pone.0086955	http://dx.doi.org/10.1371/journal.pone.0086955			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297XI	24466300	Green Published, Green Submitted, gold			2022-12-25	WOS:000330288000176
J	Valdivia, S; Patrone, A; Reynaldo, M; Perello, M				Valdivia, Spring; Patrone, Anabela; Reynaldo, Mirta; Perello, Mario			Acute High Fat Diet Consumption Activates the Mesolimbic Circuit and Requires Orexin Signaling in a Mouse Model	PLOS ONE			English	Article							VENTRAL TEGMENTAL AREA; NUCLEUS-ACCUMBENS; FOOD REWARD; EATING-DISORDERS; BULIMIA-NERVOSA; INDUCED OBESITY; DRUG-ADDICTION; BRAIN DOPAMINE; NEURONS; OREXIN/HYPOCRETIN	Overconsumption of palatable energy-dense foods has negative health implications and it is associated with obesity and several eating disorders. Currently, little is known about the neuronal circuitries activated by the acute ingestion of a rewarding stimulus. Here, we used a combination of immunohistochemistry, pharmacology and neuronal tracing analyses to examine the role of the mesolimbic system in general, and the orexin neurons in particular, in a simple experimental test in which naive mice are allowed to spontaneously eat a pellet of a high fat diet (HFD) for 2 h. We found that acute HFD activates c-Fos expression in several reward-related brain areas, including the ventral tegmental area (VTA), nucleus accumbens, central amygdala and lateral hypothalamic area. We also found that: i-HFD-mediated orosensory stimulation was required for the mesolimbic pathway activation, ii- acute HFD differentially activates dopamine neurons of the paranigral, parabrachial pigmented and interfascicular sub-regions of the VTA, and iii- orexin neurons of the lateral hypothalamic area are responsive to acute HFD. Moreover, orexin signaling blockade, with the orexin 1 receptor antagonist SB-334867, reduces acute HFD consumption and c-Fos induction in the VTA but not in the other mesolimbic nuclei under study. Finally, we found that most orexin neurons responsive to acute HFD innervate the VTA. Our results show that acute HFD consumption recruits the mesolimbic system and that the full manifestation of this eating behavior requires the activation of orexin signaling.	[Valdivia, Spring; Patrone, Anabela; Reynaldo, Mirta; Perello, Mario] Multidisciplinary Inst Cell Biol CONICET CICPBA, Neurophysiol Lab, La Plata, Buenos Aires, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)	Perello, M (corresponding author), Multidisciplinary Inst Cell Biol CONICET CICPBA, Neurophysiol Lab, La Plata, Buenos Aires, Argentina.	marioperello@yahoo.com		Valdivia, Lesly Spring/0000-0002-4282-2390; Perello, Mario/0000-0003-2114-6765	National Agency of Scientific and Technological Promotion of Argentina [PICT2010-1954, PICT2011-2142]; NIH [R03TW008925-01A1]; FOGARTY INTERNATIONAL CENTER [R03TW008925] Funding Source: NIH RePORTER	National Agency of Scientific and Technological Promotion of Argentina; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	This work was supported by grants of the National Agency of Scientific and Technological Promotion of Argentina (PICT2010-1954 and PICT2011-2142) and the NIH (R03TW008925-01A1) to MP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABERCROMBIE M, 1946, ANAT REC, V94, P239, DOI 10.1002/ar.1090940210; Aston-Jones G, 2010, BRAIN RES, V1314, P74, DOI 10.1016/j.brainres.2009.09.106; Avena NM, 2010, APPETITE, V55, P734, DOI 10.1016/j.appet.2010.09.010; Baldo BA, 2004, EUR J NEUROSCI, V19, P376, DOI 10.1111/j.1460-9568.2004.03093.x; Baldo BA, 2007, PSYCHOPHARMACOLOGY, V191, P439, DOI 10.1007/s00213-007-0741-z; Barson JR, 2013, INT J ENDOCRINOL, V2013, DOI 10.1155/2013/983964; Berridge KC, 2012, EUR J NEUROSCI, V35, P1124, DOI 10.1111/j.1460-9568.2012.07990.x; Berthoud HR, 2011, CURR OPIN NEUROBIOL, V21, P888, DOI 10.1016/j.conb.2011.09.004; Boehm SL, 2002, NEUROSCIENCE, V115, P185, DOI 10.1016/S0306-4522(02)00378-0; Borgland SL, 2006, NEURON, V49, P589, DOI 10.1016/j.neuron.2006.01.016; Borgland SL, 2009, J NEUROSCI, V29, P11215, DOI 10.1523/JNEUROSCI.6096-08.2009; Cabral A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031462; Choi DL, 2010, NEUROSCIENCE, V167, P11, DOI 10.1016/j.neuroscience.2010.02.002; Clegg DJ, 2002, ENDOCRINOLOGY, V143, P2995, DOI 10.1210/en.143.8.2995; Committee for the Update of the Guide for the Care and Use of Laboratory Animals, 2011, GUIDE CARE USE LAB A; Corwin RL, 2004, PHYSIOL BEHAV, V82, P123, DOI 10.1016/j.physbeh.2004.04.036; Dallman MF, 2010, TRENDS ENDOCRIN MET, V21, P159, DOI 10.1016/j.tem.2009.10.004; de Araujo IE, 2012, PHYSIOL BEHAV, V106, P394, DOI 10.1016/j.physbeh.2012.02.026; Di Leone RJ, 2012, NAT NEUROSCI, V15, P1330, DOI 10.1038/nn.3202; Egecioglu E, 2011, REV ENDOCR METAB DIS, V12, P141, DOI 10.1007/s11154-011-9166-4; Ericson M, 2008, J PHARMACOL EXP THER, V326, P76, DOI 10.1124/jpet.108.137489; Fadel J, 2002, NEUROSCIENCE, V111, P379, DOI 10.1016/S0306-4522(02)00017-9; Ferreira JGP, 2008, NEUROSCIENCE, V153, P196, DOI 10.1016/j.neuroscience.2008.02.003; Friederich HC, 2013, INT J EAT DISORDER, V46, P425, DOI 10.1002/eat.22099; Hagan MM, 1997, INT J EAT DISORDER, V22, P411, DOI 10.1002/(SICI)1098-108X(199712)22:4&lt;411::AID-EAT6&gt;3.0.CO;2-P; Hasue RH, 2002, J COMP NEUROL, V454, P15, DOI 10.1002/cne.10420; Hay P, 2013, INT J EAT DISORDER, V46, P462, DOI 10.1002/eat.22103; Huang H, 2006, J NEUROPHYSIOL, V95, P1656, DOI 10.1152/jn.00927.2005; Hyman SE, 2006, ANNU REV NEUROSCI, V29, P565, DOI 10.1146/annurev.neuro.29.051605.113009; Ikemoto S, 2007, BRAIN RES REV, V56, P27, DOI 10.1016/j.brainresrev.2007.05.004; Kaye WH, 2013, BIOL PSYCHIAT, V73, P836, DOI 10.1016/j.biopsych.2013.01.002; Kelley AE, 2005, PHYSIOL BEHAV, V86, P773, DOI 10.1016/j.physbeh.2005.08.066; Kempadoo KA, 2013, J NEUROSCI, V33, P7618, DOI 10.1523/JNEUROSCI.2588-12.2013; Kenny PJ, 2011, NAT REV NEUROSCI, V12, P638, DOI 10.1038/nrn3105; Koob GF, 2010, NEUROPSYCHOPHARMACOL, V35, P217, DOI 10.1038/npp.2009.110; Korotkova TM, 2003, J NEUROSCI, V23, P7; Lammel S, 2011, NEURON, V70, P855, DOI 10.1016/j.neuron.2011.03.025; Lin JY, 2012, BRAIN RES, V1448, P82, DOI 10.1016/j.brainres.2012.02.013; Lundy RF, 2004, J NEUROPHYSIOL, V91, P1143, DOI 10.1152/jn.00840.2003; Lutter M, 2009, J NUTR, V139, P629, DOI 10.3945/jn.108.097618; Mahler SV, 2012, PROG BRAIN RES, V198, P79, DOI 10.1016/B978-0-444-59489-1.00007-0; Manabe Y, 2010, PREFERENCE HIGH FAT; Margolis EB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015222; Nathan PJ, 2009, INT J NEUROPSYCHOPH, V12, P995, DOI 10.1017/S146114570900039X; Palmiter RD, 2007, TRENDS NEUROSCI, V30, P375, DOI 10.1016/j.tins.2007.06.004; Paxinos G., 2001, MOUSE BRAIN; Pecina S, 2010, PHARMACOL BIOCHEM BE, V97, P34, DOI 10.1016/j.pbb.2010.05.016; Perello M, 2010, J NEUROSCI, V30, P11549, DOI 10.1523/JNEUROSCI.2578-10.2010; Perello M, 2010, BIOL PSYCHIAT, V67, P880, DOI 10.1016/j.biopsych.2009.10.030; Peyron C, 1998, J NEUROSCI, V18, P9996; Rada P, 2005, NEUROSCIENCE, V134, P737, DOI 10.1016/j.neuroscience.2005.04.043; Ren XY, 2010, J NEUROSCI, V30, P8012, DOI 10.1523/JNEUROSCI.5749-09.2010; Rodd ZA, 2005, NEUROPSYCHOPHARMACOL, V30, P330, DOI 10.1038/sj.npp.1300561; Sakurai T, 1998, Cell, V92, P696; Salamone JD, 2013, BIOL PSYCHIAT, V73, pE15, DOI 10.1016/j.biopsych.2012.09.027; Salamone JD, 2012, NEURON, V76, P470, DOI 10.1016/j.neuron.2012.10.021; Saper CB, 2002, NEURON, V36, P199, DOI 10.1016/S0896-6273(02)00969-8; Schag K, 2013, OBES REV, V14, P477, DOI 10.1111/obr.12017; Schultz W, 2006, ANNU REV PSYCHOL, V57, P87, DOI 10.1146/annurev.psych.56.091103.070229; Sclafani A, 2012, AM J PHYSIOL-REG I, V302, pR1119, DOI 10.1152/ajpregu.00038.2012; Shabat-Simon M, 2008, J NEUROSCI, V28, P8406, DOI 10.1523/JNEUROSCI.1958-08.2008; Warwick ZS, 1996, NEUROSCI BIOBEHAV R, V20, P155, DOI 10.1016/0149-7634(95)00034-C; White CL, 2005, PEPTIDES, V26, P2331, DOI 10.1016/j.peptides.2005.03.042; Will MJ, 2003, J NEUROSCI, V23, P2882; Wise RA, 2006, PHILOS T R SOC B, V361, P1149, DOI 10.1098/rstb.2006.1854; Zheng H, 2007, J NEUROSCI, V27, P11075, DOI 10.1523/JNEUROSCI.3542-07.2007	66	69	70	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2014	9	1							e87478	10.1371/journal.pone.0087478	http://dx.doi.org/10.1371/journal.pone.0087478			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297XI	24466352	Green Submitted, Green Published, gold			2022-12-25	WOS:000330288000208
J	Espinosa, I; Cuthill, IC				Espinosa, Irene; Cuthill, Innes C.			Disruptive Colouration and Perceptual Grouping	PLOS ONE			English	Article							BACKGROUND COMPLEXITY; VISUAL-PERCEPTION; CAMOUFLAGE; CRYPSIS; PREY; DETECTABILITY; MARKINGS; CONTRAST	Camouflage is the primary defence of many animals and includes multiple strategies that interfere with figure-ground segmentation and object recognition. While matching background colours and textures is widespread and conceptually straightforward, less well explored are the optical 'tricks', collectively called disruptive colouration, that exploit perceptual grouping mechanisms. Adjacent high contrast colours create false edges, but this is not sufficient for an object's shape to be broken up; some colours must blend with the background. We test the novel hypothesis that this will be particularly effective when the colour patches on the animal appear to belong to, not merely different background colours, but different background objects. We used computer-based experiments where human participants had to find cryptic targets on artificial backgrounds. Creating what appeared to be bi-coloured foreground objects on bi-coloured backgrounds, we generated colour boundaries that had identical local contrast but either lay within or between (illusory) objects. As predicted, error rates for targets matching what appeared to be different background objects were higher than for targets which had otherwise identical local contrast to the background but appeared to belong to single background objects. This provides evidence for disruptive colouration interfering with higher-level feature integration in addition to previously demonstrated low-level effects involving contour detection. In addition, detection was impeded in treatments where targets were on or in close proximity to multiple background colour or tone boundaries. This is consistent with other studies which show a deleterious influence of visual 'clutter' or background complexity on search.	[Espinosa, Irene; Cuthill, Innes C.] Univ Bristol, Sch Biol Sci, Bristol, Avon, England	University of Bristol	Espinosa, I (corresponding author), Prescott Coll Kino Bay Ctr Cultural & Ecol Studie, Bahia De Kino, Sonora, Mexico.	i.espinosa.gonzalezgarza@gmail.com			Biotechnology and Biological Sciences Research Council; CONACyT; Biotechnology and Biological Sciences Research Council [BB/E02100X/1] Funding Source: researchfish; BBSRC [BB/E02100X/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); CONACyT(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by a Biotechnology and Biological Sciences Research Council grant to ICC, Tom Troscianko and Neill Campbell, and a CONACyT studentship to IE. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen WL, 2012, AM NAT, V180, P762, DOI 10.1086/668011; Bates D., 2011, PACKAGE LME4 LINEAR; Cott H. B., 1940, ADAPTIVE COLOURATION; Cuthill IC, 2005, NATURE, V434, P72, DOI 10.1038/nature03312; Cuthill IC, 2011, COLOUR ART DESIGN NA; DeVantier L., 2004, CONCEALING COLORATIO; Dimitrova M, 2012, BEHAV ECOL, V23, P384, DOI 10.1093/beheco/arr201; Dimitrova M, 2010, BEHAV ECOL, V21, P176, DOI 10.1093/beheco/arp174; Dimitrova M, 2009, P R SOC B, V276, P1905, DOI 10.1098/rspb.2009.0052; ENDLER JA, 1981, BIOL J LINN SOC, V16, P25, DOI 10.1111/j.1095-8312.1981.tb01840.x; Fraser S, 2007, P ROY SOC B-BIOL SCI, V274, P1325, DOI 10.1098/rspb.2007.0153; Hothorn T, 2008, BIOMETRICAL J, V50, P346, DOI 10.1002/bimj.200810425; Klein J. P., 2003, SURVIVAL ANAL TECHNI; Levi DM, 2008, VISION RES, V48, P635, DOI 10.1016/j.visres.2007.12.009; Merilaita S, 1998, P ROY SOC B-BIOL SCI, V265, P1059, DOI 10.1098/rspb.1998.0399; Merilaita Sami, 2011, P17; Osorio D., 2013, OXFORD HDB PERCEPTUA; PALMER SE, 1992, COGNITIVE PSYCHOL, V24, P436, DOI 10.1016/0010-0285(92)90014-S; Poulton EB, 1890, COLOURS ANIMALS THEI; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Rosenholtz R, 2007, J VISION, V7, DOI 10.1167/7.2.17; Rowland HM, 2009, PHILOS T R SOC B, V364, P519, DOI 10.1098/rstb.2008.0261; Ruxton GD, 2004, AVOIDING ATTACK EVOL; Stevens M., 2011, ANIMAL CAMOUFLAGE ME; Stevens M, 2006, P R SOC B, V273, P2433, DOI 10.1098/rspb.2006.3614; Stevens M, 2006, P R SOC B, V273, P2141, DOI 10.1098/rspb.2006.3556; Stevens M, 2013, BEHAV ECOL, V24, P213, DOI 10.1093/beheco/ars156; Thayer A. H., 1909, CONCEALING COLORATIO; Thayer Abbott H., 1896, AUK, V13, P124, DOI DOI 10.2307/4068693; Tripathy SP, 2002, VISION RES, V42, P2357, DOI 10.1016/S0042-6989(02)00197-9; Troscianko T, 2009, PHILOS T R SOC B, V364, P449, DOI 10.1098/rstb.2008.0218; Wagemans J, 2012, PSYCHOL BULL, V138, P1172, DOI 10.1037/a0029333; Westland S, 2004, COMPUTATIONAL COLOUR	33	18	18	3	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2014	9	1							e87153	10.1371/journal.pone.0087153	http://dx.doi.org/10.1371/journal.pone.0087153			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297VL	24466337	Green Published, gold, Green Submitted			2022-12-25	WOS:000330283100251
J	John, F; Philipp, M; Leiber, RM; Errafi, S; Ringli, C				John, Florian; Philipp, Matthias; Leiber, Ruth-Maria; Errafi, Sanae; Ringli, Christoph			Ubiquitin-Related Modifiers of Arabidopsis thaliana Influence Root Development	PLOS ONE			English	Article							CELL-WALL FORMATION; TRANSFER-RNA; PROTEIN CONJUGATION; SULFUR TRANSFER; URM1; YEAST; PATHWAY; SYSTEM; GROWTH; MUTANT	Ubiquitins are small peptides that allow for posttranslational modification of proteins. Ubiquitin-related modifier (URM) proteins belong to the class of ubiquitin-like proteins. A primary function of URM proteins has been shown to be the sulfur transfer reaction leading to thiolation of tRNAs, a process that is important for accurate and effective protein translation. Recent analyses revealed that the Arabidopsis genome codes for two URM proteins, URM11 and URM12, which both are active in the tRNA thiolation process. Here, we show that URM11 and URM12 have overlapping expression patterns and are required for tRNA thiolation. The characterization of urm11 and urm12 mutants reveals that the lack of tRNA thiolation induces changes in general root architecture by influencing the rate of lateral root formation. In addition, they synergistically influence root hair cell growth. During the sulfur transfer reaction, URM proteins of different organisms interact with a thiouridylase, a protein-protein interaction that also takes place in Arabidopsis, since URM11 and URM12 interact with the Arabidopsis thiouridylase ROL5. Hence, the sulfur transfer reaction is conserved between distantly related species such as yeast, humans, and plants, and in Arabidopsis has an impact on root development.	[John, Florian; Philipp, Matthias; Leiber, Ruth-Maria; Errafi, Sanae; Ringli, Christoph] Univ Zurich, Inst Plant Biol, CH-8008 Zurich, Switzerland	University of Zurich	Ringli, C (corresponding author), Univ Zurich, Inst Plant Biol, Zollikerstr 107, CH-8008 Zurich, Switzerland.	chringli@botinst.uzh.ch			Swiss National Science Foundation [122157, 138472/1]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	Funding by Swiss National Science Foundation Grant Nrs 122157 and 138472/1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baumberger N, 2003, PLANT J, V35, P71, DOI 10.1046/j.1365-313X.2003.01784.x; Baumberger N, 2001, GENE DEV, V15, P1128, DOI 10.1101/gad.200201; BECKER D, 1992, PLANT MOL BIOL, V20, P1195, DOI 10.1007/BF00028908; Bjork GR, 2007, RNA, V13, P1245, DOI 10.1261/rna.558707; Curtis MD, 2003, PLANT PHYSIOL, V133, P462, DOI 10.1104/pp.103.027979; De Smet I, 2012, NEW PHYTOL, V193, P867, DOI 10.1111/j.1469-8137.2011.03996.x; Diet A, 2004, PLANT CELL PHYSIOL, V45, P734, DOI 10.1093/pcp/pch084; Escobar-Restrepo JM, 2007, SCIENCE, V317, P656, DOI 10.1126/science.1143562; Furukawa K, 2000, J BIOL CHEM, V275, P7462, DOI 10.1074/jbc.275.11.7462; GLEAVE AP, 1992, PLANT MOL BIOL, V20, P1203, DOI 10.1007/BF00028910; Goehring AS, 2003, MOL BIOL CELL, V14, P4329, DOI 10.1091/mbc.e03-02-0079; Goehring AS, 2003, EUKARYOT CELL, V2, P930, DOI 10.1128/EC.2.5.930-936.2003; Hochstrasser M, 2009, NATURE, V458, P422, DOI 10.1038/nature07958; Huang SL, 2003, CANCER BIOL THER, V2, P222, DOI 10.4161/cbt.2.3.360; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; Huynh LN, 2010, CELL CYCLE, V9, P3112, DOI 10.4161/cc.9.15.12525; Kerscher O, 2006, ANNU REV CELL DEV BI, V22, P159, DOI 10.1146/annurev.cellbio.22.010605.093503; Kessler D, 2006, FEMS MICROBIOL REV, V30, P825, DOI 10.1111/j.1574-6976.2006.00036.x; Krause K, 2009, TRENDS PLANT SCI, V14, P194, DOI 10.1016/j.tplants.2009.01.005; Leiber RM, 2010, PLANT CELL, V22, P1898, DOI 10.1105/tpc.109.073007; Leidel S, 2009, NATURE, V458, P228, DOI 10.1038/nature07643; MINET M, 1992, GENE, V121, P393, DOI 10.1016/0378-1119(92)90150-N; Miranda HV, 2011, P NATL ACAD SCI USA, V108, P4417, DOI 10.1073/pnas.1018151108; Nakai Y, 2012, J BIOL CHEM, V287, P30874, DOI 10.1074/jbc.M112.350090; Nibau C, 2008, NEW PHYTOL, V179, P595, DOI 10.1111/j.1469-8137.2008.02472.x; Noma A, 2009, NUCLEIC ACIDS RES, V37, P1335, DOI 10.1093/nar/gkn1023; Park HJ, 2011, MOL CELLS, V32, P305, DOI 10.1007/s10059-011-0122-7; Peret B, 2009, TRENDS PLANT SCI, V14, P399, DOI 10.1016/j.tplants.2009.05.002; Petroski MD, 2011, P NATL ACAD SCI USA, V108, P1749, DOI 10.1073/pnas.1019043108; Ren MZ, 2012, PLANT CELL, V24, P4850, DOI 10.1105/tpc.112.107144; Ringli C, 2005, PLANT BIOSYST, V139, P32, DOI 10.1080/11263500500059892; Ringli C, 2010, PLANT J, V63, P662, DOI 10.1111/j.1365-313X.2010.04270.x; Schlieker CD, 2008, P NATL ACAD SCI USA, V105, P18255, DOI 10.1073/pnas.0808756105; Stintzi A, 2000, P NATL ACAD SCI USA, V97, P10625, DOI 10.1073/pnas.190264497; Teschner J, 2010, PLANT CELL, V22, P468, DOI 10.1105/tpc.109.068478; Van der Veen AG, 2011, P NATL ACAD SCI USA, V108, P1763, DOI 10.1073/pnas.1014402108; Vierstra RD, 2012, PLANT PHYSIOL, V160, P2, DOI 10.1104/pp.112.200667; Wang FB, 2011, PROTEIN CELL, V2, P612, DOI 10.1007/s13238-011-1074-6; Wullschleger S, 2006, CELL, V127, P5, DOI 10.1016/j.cell.2006.01.016; Xiong Y, 2012, J BIOL CHEM, V287, P2836, DOI 10.1074/jbc.M111.300749; Xu F, 2012, PLANT J, V70, P916, DOI 10.1111/j.1365-313X.2012.04906.x; Xu JJ, 2006, P NATL ACAD SCI USA, V103, P11625, DOI 10.1073/pnas.0604876103; Zhao YD, 2003, SCIENCE, V301, P1107, DOI 10.1126/science.1084161; Zimmermann P, 2004, PLANT PHYSIOL, V136, P2621, DOI 10.1104/pp.104.046367	44	9	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2014	9	1							e86862	10.1371/journal.pone.0086862	http://dx.doi.org/10.1371/journal.pone.0086862			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297VL	24466270	Green Accepted, Green Published, gold			2022-12-25	WOS:000330283100226
J	Kastner, J; von Knorre, D; Himanshu, H; Erb, M; Baldwin, IT; Meldau, S				Kaestner, Julia; von Knorre, Dietrich; Himanshu, Himanshu; Erb, Matthias; Baldwin, Ian T.; Meldau, Stefan			Salicylic Acid, a Plant Defense Hormone, Is Specifically Secreted by a Molluscan Herbivore	PLOS ONE			English	Article							ARABIDOPSIS-THALIANA; INVERTEBRATE HERBIVORES; LEAF-MINERS; SEED YIELD; GRASSLAND; RESPONSES; INSECT; PHYTOHORMONES; ACCUMULATION; COMPETITION	Slugs and snails are important herbivores in many ecosystems. They differ from other herbivores by their characteristic mucus trail. As the mucus is secreted at the interface between the plants and the herbivores, its chemical composition may play an essential role in plant responses to slug and snail attack. Based on our current knowledge about host-manipulation strategies employed by pathogens and insects, we hypothesized that mollusks may excrete phytohormone-like substances into their mucus. We therefore screened locomotion mucus from thirteen molluscan herbivores for the presence of the plant defense hormones jasmonic acid (JA), salicylic acid (SA) and abscisic acid (ABA). We found that the locomotion mucus of one slug, Deroceras reticulatum, contained significant amounts of SA, a plant hormone that is known to induce resistance to pathogens and to suppress plant immunity against herbivores. None of the other slugs and snails contained SA or any other hormone in their locomotion mucus. When the mucus of D. reticulatum was applied to wounded leaves of A. thaliana, the promotor of the SA-responsive gene pathogenesis related 1 (PR1) was activated, demonstrating the potential of the mucus to regulate plant defenses. We discuss the potential ecological, agricultural and medical implications of this finding.	[Kaestner, Julia; Himanshu, Himanshu; Baldwin, Ian T.; Meldau, Stefan] Max Planck Inst Chem Ecol, Dept Mol Ecol, Jena, Germany; [von Knorre, Dietrich] Univ Jena, Phylet Museum, Jena, Germany; [Erb, Matthias] Max Planck Inst Chem Ecol, Root Herbivore Interact Grp, Jena, Germany	Max Planck Society; Friedrich Schiller University of Jena; Max Planck Society	Meldau, S (corresponding author), Max Planck Inst Chem Ecol, Dept Mol Ecol, Jena, Germany.	smeldau@ice.mpg.de	Erb, Matthias/H-6886-2019; Baldwin, Ian T/K-1809-2013	Erb, Matthias/0000-0002-4446-9834; Baldwin, Ian/0000-0001-5371-2974; Himanshu, Himanshu/0000-0003-2579-1585	European Research Council [293926]; Swiss National Science Foundation [PBNEP3-134930]; Max-Planck-Society	European Research Council(European Research Council (ERC)European Commission); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Max-Planck-Society(Max Planck SocietyFoundation CELLEX)	SM is funded by Advanced Grant No 293926 of the European Research Council to ITB. ME is supported by Swiss National Science Foundation Fellowship PBNEP3-134930. This work is funded by Max-Planck-Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abreu ME, 2007, PHYSIOL PLANTARUM, V131, P590, DOI 10.1111/j.1399-3054.2007.00985.x; Abreu ME, 2009, J EXP BOT, V60, P1261, DOI 10.1093/jxb/ern363; Allan E, 2011, ECOL LETT, V14, P1246, DOI 10.1111/j.1461-0248.2011.01694.x; Barker GM, 2002, MOLLUSCS CROP PESTS; Body M, 2013, J CHEM ECOL, V39, P969, DOI 10.1007/s10886-013-0307-y; Bos JIB, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001216; Bruessow F, 2010, PLANT J, V62, P876, DOI 10.1111/j.1365-313X.2010.04200.x; Bruggink SC, 2010, FAM PRACT, V27, P549, DOI 10.1093/fampra/cmq047; Buschmann H, 2005, FUNCT ECOL, V19, P291, DOI 10.1111/j.1365-2435.2005.00960.x; Cipollini DF, 2002, OECOLOGIA, V131, P514, DOI 10.1007/s00442-002-0909-5; Coskey R J, 1984, Pediatr Dermatol, V2, P71; De Geyter N, 2012, TRENDS PLANT SCI, V17, P349, DOI 10.1016/j.tplants.2012.03.001; DeMeyer G, 1997, PHYTOPATHOLOGY, V87, P588, DOI 10.1094/PHYTO.1997.87.6.588; Diezel C, 2009, PLANT PHYSIOL, V150, P1576, DOI 10.1104/pp.109.139550; Eichenseer H, 2010, J CHEM ECOL, V36, P885, DOI 10.1007/s10886-010-9830-2; Erb M, 2012, TRENDS PLANT SCI, V17, P250, DOI 10.1016/j.tplants.2012.01.003; Falk K, 2013, MOL ECOLOGY IN PRESS; Fariduddin Q, 2003, PHOTOSYNTHETICA, V41, P281, DOI 10.1023/B:PHOT.0000011962.05991.6c; Giron D, 2007, BIOL LETTERS, V3, P340, DOI 10.1098/rsbl.2007.0051; HANLEY ME, 1995, J ECOL, V83, P621, DOI 10.2307/2261630; Hardy James, 1878, FOLK LORE RECORD, V1, P216; Harvey JA, 2007, PLANT ECOL, V189, P117, DOI 10.1007/s11258-006-9204-6; Hulme PE, 1996, J ECOL, V84, P43, DOI 10.2307/2261698; HULME PE, 1994, J ECOL, V82, P873, DOI 10.2307/2261451; Kaiser W, 2010, P ROY SOC B-BIOL SCI, V277, P2311, DOI 10.1098/rspb.2010.0214; Little D, 2007, PLANT PHYSIOL, V143, P784, DOI 10.1104/pp.106.090837; Mithofer A, 2012, ANNU REV PLANT BIOL, V63, P431, DOI 10.1146/annurev-arplant-042110-103854; Orrock JL, 2013, PLOS ONE IN PRESS; Pancheva TV, 1998, J PLANT PHYSIOL, V152, P381, DOI 10.1016/S0176-1617(98)80251-4; Paterson JR, 2008, J AGR FOOD CHEM, V56, P11648, DOI 10.1021/jf800974z; Press CM, 1997, MOL PLANT MICROBE IN, V10, P761, DOI 10.1094/MPMI.1997.10.6.761; REES M, 1992, J ECOL, V80, P353, DOI 10.2307/2261017; Schafer M, 2011, PLANT PHYSIOL, V156, P1520, DOI 10.1104/pp.111.173567; Scott IM, 2004, PLANT PHYSIOL, V135, P1040, DOI 10.1104/pp.104.041293; Slaymaker DH, 2002, P NATL ACAD SCI USA, V99, P11640, DOI 10.1073/pnas.182427699; Sneader W, 2000, BRIT MED J, V321, P1591, DOI 10.1136/bmj.321.7276.1591; Traw MB, 2007, EVOLUTION, V61, P2444, DOI 10.1111/j.1558-5646.2007.00211.x; Walling LL, 2009, ADV BOT RES, V51, P551, DOI 10.1016/S0065-2296(09)51013-0; Wilby A, 2001, OECOLOGIA, V127, P259, DOI 10.1007/s004420000579; YABUTA T HT, 1935, BIOCH STUDIES BAKANA, P17; Yamaguchi H, 2012, NEW PHYTOL, V196, P586, DOI 10.1111/j.1469-8137.2012.04264.x; Zhao YF, 2003, PLANT J, V36, P485, DOI 10.1046/j.1365-313X.2003.01895.x	42	31	33	2	77	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2014	9	1							e86500	10.1371/journal.pone.0086500	http://dx.doi.org/10.1371/journal.pone.0086500			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297VL	24466122	gold, Green Published, Green Submitted			2022-12-25	WOS:000330283100174
J	Takahashi, Y; Soejima, Y; Kumagai, A; Watanabe, M; Uozaki, H; Fukusato, T				Takahashi, Yoshihisa; Soejima, Yurie; Kumagai, Arisa; Watanabe, Masato; Uozaki, Hiroshi; Fukusato, Toshio			Inhibitory Effects of Japanese Herbal Medicines Sho-saiko-to and Juzen-taiho-to on Nonalcoholic Steatohepatitis in Mice	PLOS ONE			English	Article							FATTY LIVER-DISEASE; ENZYME-ALTERED LESIONS; GROWTH-FACTOR-BETA; ACID-DEFINED DIET; METABOLIC SYNDROME; FIBROSIS; INFLAMMATION; KAMPO; RATS; HEPATOCARCINOGENESIS	Although Japanese herbal medicines (JHMs) are widely used in Japan, only a few studies have investigated their effects on nonalcoholic steatohepatitis (NASH). In the present study, we examined the effect of 4 kinds of JHMs [sho-saiko-to (TJ-9), inchin-ko-to (TJ-135), juzen-taiho-to (TJ-48), and keishi-bukuryo-gan (TJ-25)] on a mouse model of NASH. Db/db mice were divided into 6 groups: control diet (control), methionine-and choline-deficient diet (MCD), and MCD diet supplemented with TJ-9, TJ-135, TJ-48, and TJ-25 (TJ-9, TJ-135, TJ-48, and TJ-25, respectively). All mice were sacrificed after 4 weeks of treatment, and biochemical, pathological, and molecular analyses were performed. Serum alanine aminotransferase levels and liver histology, including necroinflammation and fibrosis, were significantly alleviated in the TJ-9 and TJ-48 groups compared with the MCD group. The expression level of transforming growth factor (TGF)-beta 1 mRNA in the liver was significantly suppressed by TJ-48. Although the differences were not statistically significant, the expression levels of tumor necrosis factor (TNF)-alpha and interleukin (IL)-6 were lower, and those of peroxisome proliferators-activated receptor (PPAR)gamma were higher in the TJ-9 and/or TJ-48 groups than in the MCD group. Similarly, even though the results were not statistically significant, malondialdehyde levels in liver tissues were lower in the TJ-9 and TJ-48 groups than in the MCD group. We showed that JHMs, especially TJ-9 and TJ-48, inhibited the necroinflammation and fibrosis in the liver of a mouse model of NASH, even though the mechanisms were not fully elucidated. Further studies are needed in the future to investigate the possibility of clinical application of these medicines in the treatment for NASH.	[Takahashi, Yoshihisa; Soejima, Yurie; Kumagai, Arisa; Watanabe, Masato; Uozaki, Hiroshi; Fukusato, Toshio] Teikyo Univ, Sch Med, Dept Pathol, Tokyo 173, Japan	Teikyo University	Takahashi, Y (corresponding author), Teikyo Univ, Sch Med, Dept Pathol, Tokyo 173, Japan.	ytakaha-tky@umin.ac.jp			Japan Society for the Promotion of Science (JSPS) [23790753]	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by Japan Society for the Promotion of Science (JSPS) Grants-in-Aid for Scientific Research Grant Number 23790753 (URL: http://www.jsps.go.jp/j-grantsinaid/). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anstee QM, 2006, INT J EXP PATHOL, V87, P1, DOI 10.1111/j.0959-9673.2006.00465.x; Asakawa T, 2012, PEDIATR SURG INT, V28, P379, DOI 10.1007/s00383-011-2974-5; Bissell DM, 2001, HEPATOLOGY, V34, P859, DOI 10.1053/jhep.2001.28457; Braunersreuther V, 2012, WORLD J GASTROENTERO, V18, P727, DOI 10.3748/wjg.v18.i8.727; Chen H, 1996, CELL, V84, P491, DOI 10.1016/S0092-8674(00)81294-5; Chowdhry S, 2010, FREE RADICAL BIO MED, V48, P357, DOI 10.1016/j.freeradbiomed.2009.11.007; Cohen JC, 2011, SCIENCE, V332, P1519, DOI 10.1126/science.1204265; Day CP, 1998, GASTROENTEROLOGY, V114, P842, DOI 10.1016/S0016-5085(98)70599-2; Fujimoto M, 2008, EXP BIOL MED, V233, P328, DOI 10.3181/0707-RM-207; Fujimoto M, 2010, ANN NY ACAD SCI, V1190, P151, DOI 10.1111/j.1749-6632.2009.05265.x; Guo HX, 2009, ACTA PHARMACOL SIN, V30, P1505, DOI 10.1038/aps.2009.150; Iizuka A, 2000, J Atheroscler Thromb, V6, P49; Kleiner DE, 2005, HEPATOLOGY, V41, P1313, DOI 10.1002/hep.20701; Kusunose M, 2002, BIOL PHARM BULL, V25, P1417, DOI 10.1248/bpb.25.1417; Larter CZ, 2008, J HEPATOL, V49, P407, DOI 10.1016/j.jhep.2008.03.026; Leclercq IA, 2000, J CLIN INVEST, V105, P1067, DOI 10.1172/JCI8814; Machado M, 2006, CURR OPIN CLIN NUTR, V9, P637, DOI 10.1097/01.mco.0000241677.40170.17; Marchesini G, 2003, HEPATOLOGY, V37, P917, DOI 10.1053/jhep.2003.50161; Mochiki E, 2010, SURG TODAY, V40, P1105, DOI 10.1007/s00595-010-4388-8; Motoo Y, 2011, CHIN J INTEGR MED, V17, P85, DOI 10.1007/s11655-011-0653-y; Nagai T, 2011, EVID-BASED COMPL ALT, V2011; POWELL EE, 1990, HEPATOLOGY, V11, P74, DOI 10.1002/hep.1840110114; Qin S, 2012, J ETHNOPHARMACOL, V140, P131, DOI 10.1016/j.jep.2011.12.046; RAMADORI G, 1991, VIRCHOWS ARCH B, V61, P147; Sakaida I, 2003, J HEPATOL, V38, P762, DOI 10.1016/S0168-8278(03)00094-1; Sakaida I, 1998, J HEPATOL, V28, P298, DOI 10.1016/0168-8278(88)80017-5; Shek FW, 2004, EUR J GASTROEN HEPAT, V16, P123, DOI 10.1097/00042737-200402000-00001; Shiota G, 2002, HEPATOLOGY, V35, P1125, DOI 10.1053/jhep.2002.33066; Tailleux A, 2012, BBA-MOL CELL BIOL L, V1821, P809, DOI 10.1016/j.bbalip.2011.10.016; Takahashi Y, 2012, WORLD J GASTROENTERO, V18, P2300, DOI 10.3748/wjg.v18.i19.2300; Tilg H, 2010, HEPATOLOGY, V52, P1836, DOI 10.1002/hep.24001; Tojima H, 1996, Nihon Kyobu Shikkan Gakkai Zasshi, V34, P904; Tomioka H, 1999, Nihon Kokyuki Gakkai Zasshi, V37, P1013; Tsuchiya M, 2008, INT J CANCER, V123, P2503, DOI 10.1002/ijc.23828; Warren A, 2005, EXP GERONTOL, V40, P807, DOI 10.1016/j.exger.2005.06.012; Yamaoka K, 1990, BYOUIN YAKUGAKU, V16, P168; Yamashiki M, 2000, CLIN SCI, V99, P421, DOI 10.1042/CS20000031; Younossi ZM, 2011, HEPATOLOGY, V53, P1874, DOI 10.1002/hep.24268	38	22	26	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2014	9	1							e87279	10.1371/journal.pone.0087279	http://dx.doi.org/10.1371/journal.pone.0087279			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297VL	24466347	Green Submitted, Green Published, gold			2022-12-25	WOS:000330283100253
J	Levine, JA; Hansen, AM; Michalski, JM; Hazen, TH; Rasko, DA; Kaper, JB				Levine, Jonathan A.; Hansen, Anne-Marie; Michalski, Jane M.; Hazen, Tracy H.; Rasko, David A.; Kaper, James B.			H-NST Induces LEE Expression and the Formation of Attaching and Effacing Lesions in Enterohemorrhagic Escherichia coli	PLOS ONE			English	Article							LONG POLAR FIMBRIAE; TRANSCRIPTIONAL REGULATION; PATHOGENICITY ISLAND; MUTATIONAL ANALYSIS; DNA-BINDING; 5.5 PROTEIN; LOCUS; REGULATOR; GENE; OPERON	Background: Enteropathogenic E. coli (EPEC) and enterohemorrhagic E. coli are important causes of morbidity and mortality worldwide. These enteric pathogens contain a type III secretion system (T3SS) responsible for the attaching and effacing (A/E) lesion phenotype. The T3SS is encoded by the locus of enterocyte effacement (LEE) pathogenicity island. The H-NS-mediated repression of LEE expression is counteracted by Ler, the major activator of virulence gene expression in A/E pathogens. A regulator present in EPEC, H-NST, positively affects expression of H-NS regulon members in E. coli K-12, although the effect of H-NST on LEE expression and virulence of A/ E pathogens has yet-to-be determined. Results: We examine the effect of H-NST on LEE expression and A/ E lesion formation on intestinal epithelial cells. We find that H-NST positively affects the levels of LEE-encoded proteins independently of ler and induces A/ E lesion formation. We demonstrate H-NST binding to regulatory regions of LEE1 and LEE3, the first report of DNA-binding by H-NST. We characterize H-NST mutants substituted at conserved residues including Ala16 and residues Arg60 and Arg63, which are part of a potential DNA-binding domain. The single mutants A16V, A16L, R60Q and the double mutant R60Q/ R63Q exhibit a decreased effect on LEE expression and A/ E lesion formation. DNA mobility shift assays reveal that these residues are important for H-NST to bind regulatory LEE DNA targets. H-NST positively affects Ler binding to LEE DNA in the presence of H-NS, and thereby potentially helps Ler displace H-NS bound to DNA. Conclusions: H-NST induces LEE expression and A/ E lesion formation likely by counteracting H-NS-mediated repression. We demonstrate that H-NST binds to DNA and identify arginine residues that are functionally important for DNA-binding. Our study suggests that H-NST provides an additional means for A/ E pathogens to alleviate repression of virulence gene expression by H-NS to promote virulence capabilities.	[Levine, Jonathan A.; Hansen, Anne-Marie; Michalski, Jane M.; Rasko, David A.; Kaper, James B.] Univ Maryland, Sch Med, Dept Microbiol & Immunol, Baltimore, MD 21201 USA; [Levine, Jonathan A.] Univ Maryland, Grad Program Biochem & Mol Biol, Baltimore, MD 21201 USA; [Hazen, Tracy H.; Rasko, David A.] Univ Maryland, Sch Med, Inst Genome Sci, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore	Kaper, JB (corresponding author), Univ Maryland, Sch Med, Dept Microbiol & Immunol, Baltimore, MD 21201 USA.	jkaper@medicine.umaryland.edu		David, Rasko/0000-0002-7337-7154; Kaper, James/0000-0003-0715-2907	National Institutes of Health [DK58957, AI21657]; National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services [U19 AI090873]; State of Maryland; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI021657, U19AI090873, R37AI021657, R22AI021657] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK058957] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); State of Maryland; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health grants DK58957 and AI21657 to JBK (http://www.niaid.nih.gov). DAR and THH are funded in part by federal funds from the National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services under NIH grant number U19 AI090873 (http://www.niaid.nih.gov), as well as funds from the State of Maryland (http://www.maryland.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali SS, 2013, J BIOL CHEM, V288, P13356, DOI 10.1074/jbc.M113.455378; Ali SS, 2011, J BACTERIOL, V193, P4881, DOI 10.1128/JB.05198-11; Banos RC, 2008, MICROBIOL-SGM, V154, P1281, DOI 10.1099/mic.0.2007/015610-0; Banos RC, 2011, RES MICROBIOL, V162, P382, DOI 10.1016/j.resmic.2011.02.003; Barba J, 2005, J BACTERIOL, V187, P7918, DOI 10.1128/JB.187.23.7918-7930.2005; Bustamante VH, 2001, MOL MICROBIOL, V39, P664, DOI 10.1046/j.1365-2958.2001.02209.x; Campellone KG, 2007, MOL MICROBIOL, V63, P1468, DOI 10.1111/j.1365-2958.2007.05602.x; Caramel A, 1998, J MOL BIOL, V284, P875, DOI 10.1006/jmbi.1998.2191; Cordeiro TN, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002380; Cox WG, 2004, BIOTECHNIQUES, V36, P114, DOI 10.2144/04361RR02; Craven M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041594; De Baere T, 2004, J CLIN MICROBIOL, V42, P4393, DOI 10.1128/JCM.42.9.4393-4395.2004; Donohue-Rolfe A, 2000, J INFECT DIS, V181, P1825, DOI 10.1086/315421; Dorman CJ, 2007, NAT REV MICROBIOL, V5, P157, DOI 10.1038/nrmicro1598; Dorman CJ, 2010, MOL MICROBIOL, V75, P264, DOI 10.1111/j.1365-2958.2009.06996.x; Dorman CJ, 2004, NAT REV MICROBIOL, V2, P391, DOI 10.1038/nrmicro883; Elliott SJ, 2000, INFECT IMMUN, V68, P6115, DOI 10.1128/IAI.68.11.6115-6126.2000; Elliott SJ, 1998, MOL MICROBIOL, V28, P1, DOI 10.1046/j.1365-2958.1998.00783.x; Fang FC, 2008, CURR OPIN MICROBIOL, V11, P113, DOI 10.1016/j.mib.2008.02.011; Garcia J, 2012, NUCLEIC ACIDS RES, V40, P10254, DOI 10.1093/nar/gks846; Gordon BRG, 2011, P NATL ACAD SCI USA, V108, P10690, DOI 10.1073/pnas.1102544108; Goujon M, 2010, NUCLEIC ACIDS RES, V38, pW695, DOI 10.1093/nar/gkq313; Haack KR, 2003, INFECT IMMUN, V71, P384, DOI 10.1128/IAI.71.1.384-392.2003; Hansen AM, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-231; Hansen AM, 2009, MOL MICROBIOL, V73, P446, DOI 10.1111/j.1365-2958.2009.06781.x; HARBURY PB, 1993, SCIENCE, V262, P1401, DOI 10.1126/science.8248779; Hazen TH, 2013, P NATL ACAD SCI USA, V110, P12810, DOI 10.1073/pnas.1306836110; JARVIS KG, 1995, P NATL ACAD SCI USA, V92, P7996, DOI 10.1073/pnas.92.17.7996; KNUTTON S, 1989, INFECT IMMUN, V57, P1290, DOI 10.1128/IAI.57.4.1290-1298.1989; Laaberki MH, 2006, INT J MED MICROBIOL, V296, P197, DOI 10.1016/j.ijmm.2006.02.017; Lai YS, 2013, CELL MICROBIOL, V15, P1796, DOI 10.1111/cmi.12179; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; LIU QY, 1993, P NATL ACAD SCI USA, V90, P1761, DOI 10.1073/pnas.90.5.1761; Lucchini S, 2006, PLOS PATHOG, V2, P746, DOI 10.1371/journal.ppat.0020081; LUCHT JM, 1994, J BIOL CHEM, V269, P6578; Lupas A, 1996, METHOD ENZYMOL, V266, P513; Lupas AN, 2005, ADV PROTEIN CHEM, V70, P37, DOI 10.1016/S0065-3233(04)70003-0; Majowicz SE, 2010, CLIN INFECT DIS, V50, P882, DOI 10.1086/650733; MCDANIEL TK, 1995, P NATL ACAD SCI USA, V92, P1664, DOI 10.1073/pnas.92.5.1664; Mellies JL, 2007, INFECT IMMUN, V75, P4199, DOI 10.1128/IAI.01927-06; Mellies JL, 2011, MICROBIOL-SGM, V157, P1123, DOI 10.1099/mic.0.046094-0; Mellies JL, 2008, MICROBIOL-SGM, V154, P3624, DOI 10.1099/mic.0.2008/023382-0; Mellies JL, 1999, MOL MICROBIOL, V33, P296, DOI 10.1046/j.1365-2958.1999.01473.x; Nataro JP, 1998, CLIN MICROBIOL REV, V11, P403; Navarre WW, 2010, H NS DEFENSE SYSTEM; Perna NT, 1998, INFECT IMMUN, V66, P3810, DOI 10.1128/IAI.66.8.3810-3817.1998; Ramos J, 2006, J AM CHEM SOC, V128, P15499, DOI 10.1021/ja0655284; Rogers MT, 2009, MICROB PATHOGENESIS, V47, P202, DOI 10.1016/j.micpath.2009.07.003; Rojas-Lopez M, 2011, J BACTERIOL, V193, P1622, DOI 10.1128/JB.01082-10; Russell RM, 2007, J BACTERIOL, V189, P5387, DOI 10.1128/JB.00553-07; Sambrook J, 2001, MOL CLONING LAB MANU; Sanchez-SanMartin C, 2001, J BACTERIOL, V183, P2823, DOI 10.1128/JB.183.9.2823-2833.2001; SEEMAN NC, 1976, P NATL ACAD SCI USA, V73, P804, DOI 10.1073/pnas.73.3.804; Sperandio V, 2000, MOL MICROBIOL, V38, P781, DOI 10.1046/j.1365-2958.2000.02168.x; Stone D, 1975, FEBS P, V31, P125; Torres AG, 2008, INFECT IMMUN, V76, P5062, DOI 10.1128/IAI.00654-08; Torres AG, 2007, J BACTERIOL, V189, P5916, DOI 10.1128/JB.00245-07; Tree JJ, 2009, TRENDS MICROBIOL, V17, P361, DOI 10.1016/j.tim.2009.06.001; TUPPER AE, 1994, EMBO J, V13, P258, DOI 10.1002/j.1460-2075.1994.tb06256.x; Ueguchi C, 1996, J MOL BIOL, V263, P149, DOI 10.1006/jmbi.1996.0566; Umanski T, 2002, MICROBIOL-SGM, V148, P2735, DOI 10.1099/00221287-148-9-2735; Williamson HS, 2005, MOL MICROBIOL, V55, P808, DOI 10.1111/j.1365-2958.2004.04421.x; Yerushalmi G, 2008, J BACTERIOL, V190, P7808, DOI 10.1128/JB.00663-08; Zhu B, 2012, P NATL ACAD SCI USA, V109, P8050, DOI 10.1073/pnas.1205990109	64	17	18	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2014	9	1							e86618	10.1371/journal.pone.0086618	http://dx.doi.org/10.1371/journal.pone.0086618			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297GT	24466172	Green Published, Green Submitted, gold			2022-12-25	WOS:000330244500265
J	Shehadah, A; Chen, JL; Pal, A; He, SY; Zeitlin, A; Cui, X; Zacharek, A; Cui, YS; Roberts, C; Lu, M; Hariri, R; Chopp, M				Shehadah, Amjad; Chen, Jieli; Pal, Ajai; He, Shuyang; Zeitlin, Andrew; Cui, Xu; Zacharek, Alex; Cui, Yisheng; Roberts, Cynthia; Lu, Mei; Hariri, Robert; Chopp, Michael			Human Placenta-Derived Adherent Cell Treatment of Experimental Stroke Promotes Functional Recovery after Stroke in Young Adult and Older Rats	PLOS ONE			English	Article							MARROW STROMAL CELLS; SENSORIMOTOR CORTEX LESIONS; CEREBRAL-ARTERY OCCLUSION; TRAUMATIC BRAIN-INJURY; STEM-CELLS; SYNAPTIC PLASTICITY; EMBOLIC STROKE; GENE-EXPRESSION; INFARCT VOLUME; AGED RATS	Background: Human Placenta-Derived Adherent Cells (PDAC (R)) are a novel mesenchymal-like cell population derived from normal human placental tissue. PDA-001 is a clinical formulation of PDAC (R) developed for intravenous administration. In this study, we investigated the efficacy of PDA-001 treatment in a rat model of transient middle cerebral artery occlusion (MCAo) in young adult (2-3 month old) and older rats (10-12 months old). Methods: To evaluate efficacy and determine the optimal number of transplanted cells, young adult Wistar rats were subjected to MCAo and treated 1 day post MCAo with 1x10(6), 4x10(6) or 8x10(6) PDA-001 cells (i. v.), vehicle or cell control. 4x10(6) or 8x10(6) PDA-001 cells were also tested in older rats after MCAo. Treatment response was evaluated using a battery of functional outcome tests, consisting of adhesive-removal test, modified Neurological Severity Score (mNSS) and foot-fault test. Young adult rats were sacrificed 56 days after MCAo, older rats were sacrificed 29 days after MCAo, and lesion volumes were measured using H& E. Immunohistochemical stainings for bromodeoxyuridine (BrdU) and von Willebrand Factor (vWF), and synaptophysin were performed. Results: In young adult rats, treatment with 4x10(6) PDA-001 cells significantly improved functional outcome after stroke (p<0.05). In older rats, significant functional improvement was observed with PDA-001 cell therapy in both of the 4x10(6) and 8x10(6) treatment groups. Functional benefits in young adult and older rats were associated with significant increases in the number of BrdU immunoreactive endothelial cells, vascular density and perimeter in the ischemic brain, as well as significantly increased synaptophysin expression in the ischemic border zone (p<0.05). Conclusion: PDA-001 treatment significantly improved functional outcome after stroke in both young adult and older rats. The neurorestorative effects induced by PDA-001 treatment may be related to increased vascular density and synaptic plasticity.	[Shehadah, Amjad; Chen, Jieli; Cui, Xu; Zacharek, Alex; Cui, Yisheng; Roberts, Cynthia; Chopp, Michael] Henry Ford Hosp, Dept Neurol, Detroit, MI 48202 USA; [Pal, Ajai; He, Shuyang; Zeitlin, Andrew; Hariri, Robert] Celgene Cellular Therapeut, Warren, NJ USA; [Lu, Mei] Henry Ford Hosp, Dept Biostat & Res Epidemiol, Detroit, MI 48202 USA; [Chopp, Michael] Oakland Univ, Dept Phys, Rochester, MI USA	Henry Ford Health System; Henry Ford Hospital; Henry Ford Health System; Henry Ford Hospital; Oakland University	Chen, JL (corresponding author), Henry Ford Hosp, Dept Neurol, Detroit, MI 48202 USA.	jieli@neuro.hfh.edu		Cui, Xu/0000-0002-6937-6191; Shehadah, Amjad/0000-0001-8679-3774	Celgene Cellular Therapeutics, New Jersey, USA	Celgene Cellular Therapeutics, New Jersey, USA	This work was funded by Celgene Cellular Therapeutics, New Jersey, USA. The funders had no role in study design, data collection, analysis or preparation of the manuscript. Study design and decision to publish were approved by the funders.	Adkins DL, 2008, EXP NEUROL, V212, P14, DOI 10.1016/j.expneurol.2008.01.031; BARTH TM, 1990, STROKE, V21, P153; Bohotin Catalina Roxana, 2004, Rom J Physiol, V41, P99; CHEN H, 1991, NEUROLOGY, V41, P1133, DOI 10.1212/WNL.41.7.1133; Chen J, 2006, NEUROSCIENCE, V141, P737, DOI 10.1016/j.neuroscience.2006.04.042; Chen J, 2012, CELL TRANSPLANT; Chen JL, 2001, STROKE, V32, P2682, DOI 10.1161/hs1101.098367; Chen JL, 2002, J NEUROL SCI, V199, P17, DOI 10.1016/S0022-510X(02)00075-8; Chen JL, 2001, STROKE, V32, P1005, DOI 10.1161/01.STR.32.4.1005; Cramer SC, 2000, TRENDS NEUROSCI, V23, P265, DOI 10.1016/S0166-2236(00)01562-9; Cramer SC, 1997, STROKE, V28, P2518, DOI 10.1161/01.STR.28.12.2518; Cui X, 2010, STROKE, V41, P2044, DOI 10.1161/STROKEAHA.110.589333; Ding GL, 2011, STROKE, V42, P3537, DOI 10.1161/STROKEAHA.111.622092; FUTRELL N, 1991, STROKE, V22, P1582, DOI 10.1161/01.STR.22.12.1582; GARCIA JH, 1971, ACTA NEUROPATHOL, V18, P273, DOI 10.1007/BF00688441; Greenberg DA, 2005, NATURE, V438, P954, DOI 10.1038/nature04481; He SY, 2013, BRAIN BEHAV IMMUN, V27, P185, DOI 10.1016/j.bbi.2012.10.015; HERNANDEZ TD, 1988, EXP NEUROL, V102, P318, DOI 10.1016/0014-4886(88)90226-9; Kinnaird T, 2004, CIRCULATION, V109, P1543, DOI 10.1161/01.CIR.0000124062.31102.57; Kolb B, 1999, CAN J EXP PSYCHOL, V53, P62, DOI 10.1037/h0087300; Kranz A, 2010, BRAIN RES, V1315, P128, DOI 10.1016/j.brainres.2009.12.001; KRUPINSKI J, 1994, STROKE, V25, P1794, DOI 10.1161/01.STR.25.9.1794; Li X, 2011, STEM CELLS, V29, P263, DOI 10.1002/stem.572; Li Y, 2001, NEUROLOGY, V56, P1666, DOI 10.1212/WNL.56.12.1666; Li Y, 2009, NEUROSCI LETT, V456, P120, DOI 10.1016/j.neulet.2008.03.096; Lu M, 2003, J NEUROSCI METH, V128, P183, DOI 10.1016/S0165-0270(03)00188-2; Mayer L, 2013, INFLAMM BOWEL DIS, V19, P754, DOI 10.1097/MIB.0b013e31827f27df; Mochizuki N, 2008, EXP NEUROL, V211, P194, DOI 10.1016/j.expneurol.2008.01.027; Nichols RC, 2011, CLIN LUNG CANCER, V12, P252, DOI 10.1016/j.cllc.2011.03.027; Nudo RJ, 2001, MUSCLE NERVE, V24, P1000, DOI 10.1002/mus.1104; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Pratt Phillip F, 2004, Curr Opin Investig Drugs, V5, P952; Rao MS, 2001, MECH AGEING DEV, V122, P713, DOI 10.1016/S0047-6374(01)00224-X; Rempe DA, 2002, NEUROLOGY, V59, P486, DOI 10.1212/WNL.59.4.486; Risau W, 1998, KIDNEY INT, V54, pS3, DOI 10.1046/j.1523-1755.1998.06701.x; SCHALLERT T, 1984, BEHAV NEUROSCI, V98, P518; Schallert T, 2000, NEUROPHARMACOLOGY, V39, P777, DOI 10.1016/S0028-3908(00)00005-8; Stroemer RP, 1998, STROKE, V29, P2381, DOI 10.1161/01.STR.29.11.2381; SWANSON RA, 1990, J CEREBR BLOOD F MET, V10, P290, DOI 10.1038/jcbfm.1990.47; Takahashi K, 2008, BRAIN RES, V1234, P172, DOI 10.1016/j.brainres.2008.07.086; Ujike H, 2002, ANN NY ACAD SCI, V965, P55; Yoon YS, 2005, BIOL CELL, V97, P253, DOI 10.1042/BC20040099; Yu S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076329; Zacharek A, 2010, STROKE, V41, P524, DOI 10.1161/STROKEAHA.109.568881; Zhang L, 2005, STROKE, V36, P847, DOI 10.1161/01.STR.0000158923.19956.73; Zhang ZG, 2002, J CEREBR BLOOD F MET, V22, P379, DOI 10.1097/00004647-200204000-00002; Zhang ZG, 2009, LANCET NEUROL, V8, P491, DOI 10.1016/S1474-4422(09)70061-4	47	28	29	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2014	9	1							e86621	10.1371/journal.pone.0086621	http://dx.doi.org/10.1371/journal.pone.0086621			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297GT	24466174	Green Published, Green Submitted, gold			2022-12-25	WOS:000330244500266
J	Zhi, H; Zahoor, MA; Shudofsky, AMD; Giam, CZ				Zhi, H.; Zahoor, M. A.; Shudofsky, A. M. D.; Giam, C-Z			KSHV vCyclin counters the senescence/G1 arrest response triggered by NF-kappa B hyperactivation	ONCOGENE			English	Article						NF-kappa B hyperactivation; senescence; G1 cyclin-dependent kinase; CDK inhibitors; Kaposi's sarcoma herpesvirus; human T-lymphotropic virus type 1	SARCOMA-ASSOCIATED HERPESVIRUS; T-CELL LEUKEMIA; VIRUS TYPE-I; TAX TRANSFORMING PROTEIN; RIBOSOME ENTRY SITE; KAPOSIS-SARCOMA; IKK-GAMMA; CONSTITUTIVE ACTIVATION; INHIBITORY PROTEIN; MULTIPLE-MYELOMA	Many oncogenic viruses activate nuclear factor-kappa B (NF-kappa B) as a part of their replicative cycles. We have shown recently that persistent and potentially oncogenic activation of NF-kappa B by the human T-lymphotropic virus 1 (HTLV-1) oncoprotein Tax immediately triggers a host senescence response mediated by cyclin-dependent kinase inhibitors: p21(CIP1/WAF1) (p21) and p27(Kip1) (p27) Here we demonstrate that RelA/NF-kappa B activation by Kaposi sarcoma herpesvirus (KSHV) latency protein vFLIP also leads to p21/p27 upregulation and G1 cell cycle arrest. Remarkably, KSHV vCyclin, another latency protein coexpressed with vFLIP from a bicistronic latency-specific mRNA, was found to prevent the senescence and G1 arrest induced by HTLV-1 Tax and vFLIP, respectively. This is because of the known ability of vCyclin/cyclin-dependent kinase 6 complex to resist p21 and p27 inhibition and cause p27 degradation. In KSHV-transformed BCBL-1 cells, sustained vFLIP expression with small hairpin RNAs-mediated vCyclin depletion resulted in G1 arrest. The functional interdependence of vFLIP and vCyclin explains why they are cotranslated from the same viral mRNA. Importantly, deregulation of the G1 cyclin-dependent kinase can facilitate chronic I-kappa B kinases/NF-kappa B activation.	[Zhi, H.; Zahoor, M. A.; Shudofsky, A. M. D.; Giam, C-Z] Uniformed Serv Univ Hlth Sci, Dept Microbiol & Immunol, Bethesda, MD 20814 USA	Uniformed Services University of the Health Sciences - USA	Giam, CZ (corresponding author), Uniformed Serv Univ Hlth Sci, Dept Microbiol & Immunol, 4301 Jones Bridge Rd, Bethesda, MD 20814 USA.	chou-zen.giam@usuhs.edu	Zahoor, Muhammad/ADH-5812-2022	Zahoor, Muhammad/0000-0003-2302-3689	National Institutes of Health [R01CA140963, RO1CA115884]; USU intramural research program [RO73NV]; NATIONAL CANCER INSTITUTE [R01CA115884, R01CA140963] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); USU intramural research program; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Drs Mary Collins, Johnan Kaleeba and Emmy Verschuren for the vFLIP antibody, vFLIP cDNA and vCyclin expression plasmid, respectively. This work was supported by grants from the National Institutes of Health (R01CA140963 and RO1CA115884) and the USU intramural research program (RO73NV).	Bagneris C, 2008, MOL CELL, V30, P620, DOI 10.1016/j.molcel.2008.04.029; Bieleski L, 2001, J VIROL, V75, P1864, DOI 10.1128/JVI.75.4.1864-1869.2001; Cereseto A, 1999, ONCOGENE, V18, P2441, DOI 10.1038/sj.onc.1202567; Cereseto A, 1996, BLOOD, V88, P1551, DOI 10.1182/blood.V88.5.1551.bloodjournal8851551; Chapman MA, 2011, NATURE, V471, P467, DOI 10.1038/nature09837; Chu ZL, 1999, J BIOL CHEM, V274, P15297, DOI 10.1074/jbc.274.22.15297; Dittmer D, 1998, J VIROL, V72, P8309, DOI 10.1128/JVI.72.10.8309-8315.1998; FARRELL PJ, 1991, EMBO J, V10, P2879, DOI 10.1002/j.1460-2075.1991.tb07837.x; Field N, 2003, J CELL SCI, V116, P3721, DOI 10.1242/jcs.00691; Fujimuro M, 2007, REV MED VIROL, V17, P405, DOI 10.1002/rmv.549; Ganem D, 2006, ANNU REV PATHOL-MECH, V1, P273, DOI 10.1146/annurev.pathol.1.110304.100133; Ganem D, 2010, J CLIN INVEST, V120, P939, DOI 10.1172/JCI40567; Godfrey A, 2005, BLOOD, V105, P2510, DOI 10.1182/blood-2004-08-3052; GROSSMAN WJ, 1995, P NATL ACAD SCI USA, V92, P1057, DOI 10.1073/pnas.92.4.1057; Grossmann C, 2006, J VIROL, V80, P7179, DOI 10.1128/JVI.01603-05; Grundhoff A, 2001, J VIROL, V75, P1857, DOI 10.1128/JVI.75.4.1857-1863.2001; Guasparri I, 2004, J EXP MED, V199, P993, DOI 10.1084/jem.20031467; Hasegawa H, 2006, NAT MED, V12, P466, DOI 10.1038/nm1389; Hatta Y, 2002, LEUKEMIA, V16, P1069, DOI 10.1038/sj.leu.2402458; Hayward S Diane, 2006, Sci STKE, V2006, pre4; Jarviluoma A, 2004, BLOOD, V104, P3349, DOI 10.1182/blood-2004-05-1798; Jin DY, 1999, J BIOL CHEM, V274, P17402, DOI 10.1074/jbc.274.25.17402; Koopal S, 2007, PLOS PATHOG, V3, P1348, DOI 10.1371/journal.ppat.0030140; Kuo YL, 2006, EMBO J, V25, P1741, DOI 10.1038/sj.emboj.7601054; Lee JS, 2009, NAT CELL BIOL, V11, P1355, DOI 10.1038/ncb1980; Leida AM, 2012, CELL HOST MICROBE, V11, P167, DOI 10.1016/j.chom.2012.01.005; Liu JY, 2007, J VIROL, V81, P10451, DOI 10.1128/JVI.00804-07; Liu MH, 2008, J VIROL, V82, P8442, DOI 10.1128/JVI.00091-08; Low W, 2001, J VIROL, V75, P2938, DOI 10.1128/JVI.75.6.2938-2945.2001; Mann DJ, 1999, EMBO J, V18, P654, DOI 10.1093/emboj/18.3.654; Matsumoto K, 1997, J VIROL, V71, P4445, DOI 10.1128/JVI.71.6.4445-4451.1997; Matta H, 2004, P NATL ACAD SCI USA, V101, P9399, DOI 10.1073/pnas.0308016101; Mitsiades N, 2002, BLOOD, V99, P4079, DOI 10.1182/blood.V99.11.4079; Ojala PM, 1999, CANCER RES, V59, P4984; Oshiro A, 2006, BLOOD, V107, P4500, DOI 10.1182/blood-2005-09-3801; Rivas C, 2001, J VIROL, V75, P429, DOI 10.1128/JVI.75.1.429-438.2001; Russo JJ, 1996, P NATL ACAD SCI USA, V93, P14862, DOI 10.1073/pnas.93.25.14862; Shimizu A, 2011, J VIROL, V85, P7444, DOI 10.1128/JVI.02337-10; Sun SC, 1999, ONCOGENE, V18, P6948, DOI 10.1038/sj.onc.1203220; Swanton C, 1997, NATURE, V390, P184, DOI 10.1038/36606; Verschuren EW, 2004, J GEN VIROL, V85, P1347, DOI 10.1099/vir.0.79812-0; Verschuren EW, 2002, CANCER CELL, V2, P229, DOI 10.1016/S1535-6108(02)00123-X; Xiao GT, 2000, ONCOGENE, V19, P5198, DOI 10.1038/sj.onc.1203894; Yamada Y, 1997, J CLIN ONCOL, V15, P1778, DOI 10.1200/JCO.1997.15.5.1778; Yamaoka S, 1996, EMBO J, V15, P873, DOI 10.1002/j.1460-2075.1996.tb00422.x; Yamaoka S, 1998, CELL, V93, P1231, DOI 10.1016/S0092-8674(00)81466-X; Yang LP, 2011, J VIROL, V85, P3001, DOI 10.1128/JVI.00086-10; Zhang L, 2006, J VIROL, V80, P7459, DOI 10.1128/JVI.00130-06; Zhi HJ, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002025	49	20	20	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 22	2015	34	4					496	505		10.1038/onc.2013.567	http://dx.doi.org/10.1038/onc.2013.567			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AZ8FU	24469036	Green Accepted			2022-12-25	WOS:000348451300010
J	Berger, AH; Imielinski, M; Duke, F; Wala, J; Kaplan, N; Shi, GX; Andres, DA; Meyerson, M				Berger, A. H.; Imielinski, M.; Duke, F.; Wala, J.; Kaplan, N.; Shi, G-X; Andres, D. A.; Meyerson, M.			Oncogenic RIT1 mutations in lung adenocarcinoma	ONCOGENE			English	Article						lung adenocarcinoma; cancer genetics; RAS pathway; signal transduction; oncogene; GTPase	EML4-ALK FUSION GENE; NEURONAL DIFFERENTIATION; KINASE INHIBITOR; KRAS MUTATIONS; CANCER; GEFITINIB; PROTEIN; SENSITIVITY; ACTIVATION; GENOME	Lung adenocarcinoma is comprised of distinct mutational subtypes characterized by mutually exclusive oncogenic mutations in RTK/RAS pathway members KRAS, EGFR, BRAF and ERBB2, and translocations involving ALK, RET and ROS1. Identification of these oncogenic events has transformed the treatment of lung adenocarcinoma via application of therapies targeted toward specific genetic lesions in stratified patient populations. However, such mutations have been reported in only similar to 55% of lung adenocarcinoma cases in the United States, suggesting other mechanisms of malignancy are involved in the remaining cases. Here we report somatic mutations in the small GTPase gene RIT1 in similar to 2% of lung adenocarcinoma cases that cluster in a hotspot near the switch II domain of the protein. RIT1 switch II domain mutations are mutually exclusive with all other known lung adenocarcinoma driver mutations. Ectopic expression of mutated RIT1 induces cellular transformation in vitro and in vivo, which can be reversed by combined PI3K and MEK inhibition. These data identify RIT1 as a driver oncogene in a specific subset of lung adenocarcinomas and suggest PI3K and MEK inhibition as a potential therapeutic strategy in RIT1-mutated tumors.	[Berger, A. H.; Imielinski, M.; Duke, F.; Wala, J.; Meyerson, M.] Broad Inst Harvard & MIT, Canc Program, Cambridge, MA USA; [Berger, A. H.; Imielinski, M.; Wala, J.; Kaplan, N.; Meyerson, M.] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Imielinski, M.] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Imielinski, M.; Meyerson, M.] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; [Wala, J.] MIT, Harvard MIT Div Hlth Sci & Technol, Cambridge, MA 02139 USA; [Shi, G-X; Andres, D. A.] Univ Kentucky, Coll Med, Dept Mol & Cellular Biochem, Lexington, KY USA	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); University of Kentucky	Meyerson, M (corresponding author), Dana Farber Canc Inst, Ctr Canc Genome Discovery, Dept Med Oncol, 450 Brookline Ave, Boston, MA 02115 USA.	matthew_meyerson@dfci.harvard.edu	Shi, Geng-Xian/AAK-6061-2021	Meyerson, Matthew/0000-0002-9133-8108	American Cancer Society; NCI Training Grant [T32CA9216]; NIH Training Grant [T32HG002295]; NIH [NS045103]; KSCHIRT [12-1A]; University of Kentucky Research Professorship; Department of Defense [W81XWH-12-1-0269]; National Cancer Institute [P01CA154303, R01CA109038]; Uniting Against Lung Cancer; Lung Cancer Research Foundation; American Lung Association; NATIONAL CANCER INSTITUTE [R01CA109038, U24CA143867, T32CA009216, P01CA154303] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [T32HG002295] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS045103, R56NS045103] Funding Source: NIH RePORTER	American Cancer Society(American Cancer Society); NCI Training Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH Training Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); KSCHIRT; University of Kentucky Research Professorship; Department of Defense(United States Department of Defense); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Uniting Against Lung Cancer; Lung Cancer Research Foundation; American Lung Association; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank A. Brooks, P. Choi, H. Gannon, H. Greulich, L. De Waal, B. Kaplan, R. Liao, T. Sharifnia, J. Boehm and A. Koehler for critical advice and discussion. AHB is supported by a postdoctoral fellowship from the American Cancer Society. MI is supported by NCI Training Grant T32CA9216. JW is supported by NIH Training Grant T32HG002295. DAA is supported by NIH NS045103, KSCHIRT 12-1A, and a University of Kentucky Research Professorship. This work was supported by grants from the Department of Defense (#W81XWH-12-1-0269) National Cancer Institute (P01CA154303 and R01CA109038), Uniting Against Lung Cancer, the Lung Cancer Research Foundation and the American Lung Association to MM.	Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Aoki Y, 2013, AM J HUM GENET, V93, P173, DOI 10.1016/j.ajhg.2013.05.021; Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; BARSAGI D, 1985, CELL, V42, P841, DOI 10.1016/0092-8674(85)90280-6; Cai WK, 2011, MOL BIOL CELL, V22, P3231, DOI 10.1091/mbc.E11-05-0400; CLARK GJ, 1995, METHOD ENZYMOL, V255, P395; Forbes S, 2006, BRIT J CANCER, V94, P318, DOI 10.1038/sj.bjc.6602928; Gomez-Segui I, 2013, LEUKEMIA, V27, P1943, DOI 10.1038/leu.2013.179; Hodis E, 2012, CELL, V150, P251, DOI 10.1016/j.cell.2012.06.024; Imielinski M, 2012, CELL, V150, P1107, DOI 10.1016/j.cell.2012.08.029; Janne PA, 2012, J CLIN ONCOL, V30, P878, DOI 10.1200/JCO.2011.39.4197; Ju YS, 2012, GENOME RES, V22, P436, DOI 10.1101/gr.133645.111; Kawazu M, 2013, P NATL ACAD SCI USA, V110, P3029, DOI 10.1073/pnas.1216141110; Koivunen JP, 2008, CLIN CANCER RES, V14, P4275, DOI 10.1158/1078-0432.CCR-08-0168; Krauthammer M, 2012, NAT GENET, V44, P1006, DOI 10.1038/ng.2359; Kwak EL, 2010, NEW ENGL J MED, V363, P1693, DOI 10.1056/NEJMoa1006448; Lamprecht MR, 2007, BIOTECHNIQUES, V42, P71, DOI 10.2144/000112257; Lee CHJ, 1996, J NEUROSCI, V16, P6784; Ley TJ, 2013, NEW ENGL J MED, V368, P2059, DOI 10.1056/NEJMoa1301689; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; Mitsudomi T, 2010, LANCET ONCOL, V11, P121, DOI 10.1016/S1470-2045(09)70364-X; Mok TS, 2009, NEW ENGL J MED, V361, P947, DOI 10.1056/NEJMoa0810699; O'Brien C, 2010, CLIN CANCER RES, V16, P3670, DOI 10.1158/1078-0432.CCR-09-2828; Onozato R, 2009, J THORAC ONCOL, V4, P5, DOI 10.1097/JTO.0b013e3181913e0e; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; Pao W, 2005, PLOS MED, V2, P57, DOI 10.1371/journal.pmed.0020017; Pao W, 2004, P NATL ACAD SCI USA, V101, P13306, DOI 10.1073/pnas.0405220101; Pao W, 2012, NAT MED, V18, P349, DOI 10.1038/nm.2697; Pao W, 2010, NAT REV CANCER, V10, P760, DOI 10.1038/nrc2947; PITTMAN RN, 1993, J NEUROSCI, V13, P3669; Riely Gregory J, 2009, Proc Am Thorac Soc, V6, P201, DOI 10.1513/pats.200809-107LC; Rikova K, 2007, CELL, V131, P1190, DOI 10.1016/j.cell.2007.11.025; Rusyn EV, 2000, ONCOGENE, V19, P4685, DOI 10.1038/sj.onc.1203836; Scheffzek K, 1997, SCIENCE, V277, P333, DOI 10.1126/science.277.5324.333; Seo JS, 2012, GENOME RES, V22, P2109, DOI 10.1101/gr.145144.112; Shao HP, 1999, ARCH BIOCHEM BIOPHYS, V371, P207, DOI 10.1006/abbi.1999.1448; Shi GX, 2006, MOL CELL BIOL, V26, P9136, DOI 10.1128/MCB.00332-06; Shi GX, 2005, MOL CELL BIOL, V25, P830, DOI 10.1128/MCB.25.2.830-846.2005; Soda M, 2007, NATURE, V448, P561, DOI 10.1038/nature05945; Sos ML, 2009, J CLIN INVEST, V119, P1727, DOI 10.1172/JCI37127; Thomas RK, 2007, NAT GENET, V39, P347, DOI 10.1038/ng1975; Yang XP, 2011, NAT METHODS, V8, P659, DOI [10.1038/NMETH.1638, 10.1038/nmeth.1638]; Zenker M, 2007, J MED GENET, V44, P131, DOI 10.1136/jmg.2006.046300	43	57	57	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	AUG 28	2014	33	35					4418	4423		10.1038/onc.2013.581	http://dx.doi.org/10.1038/onc.2013.581			6	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AO2MR	24469055	hybrid, Green Published			2022-12-25	WOS:000341157800006
J	Ma, D; Cardoso, MJ; Modat, M; Powell, N; Wells, J; Holmes, H; Wiseman, F; Tybulewicz, V; Fisher, E; Lythgoe, MF; Ourselin, S				Ma, Da; Cardoso, Manuel J.; Modat, Marc; Powell, Nick; Wells, Jack; Holmes, Holly; Wiseman, Frances; Tybulewicz, Victor; Fisher, Elizabeth; Lythgoe, Mark F.; Ourselin, Sebastien			Automatic Structural Parcellation of Mouse Brain MRI Using Multi-Atlas Label Fusion	PLOS ONE			English	Article							IN-VIVO; NONRIGID REGISTRATION; SEGMENTATION; IMAGE; DATABASE; PROPAGATION; COMBINATION; STRATEGIES; ASYMMETRY; FRAMEWORK	Multi-atlas segmentation propagation has evolved quickly in recent years, becoming a state-of-the-art methodology for automatic parcellation of structural images. However, few studies have applied these methods to preclinical research. In this study, we present a fully automatic framework for mouse brain MRI structural parcellation using multi-atlas segmentation propagation. The framework adopts the similarity and truth estimation for propagated segmentations (STEPS) algorithm, which utilises a locally normalised cross correlation similarity metric for atlas selection and an extended simultaneous truth and performance level estimation (STAPLE) framework for multi-label fusion. The segmentation accuracy of the multi-atlas framework was evaluated using publicly available mouse brain atlas databases with pre-segmented manually labelled anatomical structures as the gold standard, and optimised parameters were obtained for the STEPS algorithm in the label fusion to achieve the best segmentation accuracy. We showed that our multi-atlas framework resulted in significantly higher segmentation accuracy compared to single-atlas based segmentation, as well as to the original STAPLE framework.	[Ma, Da; Cardoso, Manuel J.; Modat, Marc; Powell, Nick; Ourselin, Sebastien] UCL, Ctr Med Imaging Comp, London, England; [Ma, Da; Powell, Nick; Wells, Jack; Holmes, Holly; Lythgoe, Mark F.] UCL, Div Med, Ctr Adv Biomed Imaging, London, England; [Wiseman, Frances; Fisher, Elizabeth] UCL, Inst Neurol, Dept Neurodegenerat Dis, London, England; [Tybulewicz, Victor] MRC Natl Inst Med Res, Div Immune Cell Biol, London, England	University of London; University College London; University of London; University College London; University of London; University College London; MRC National Institute for Medical Research	Ma, D (corresponding author), UCL, Ctr Med Imaging Comp, London, England.	d.ma.11@ucl.ac.uk	Wiseman, Frances K/M-4701-2014; Holmes, Holly/Q-4675-2016; Ma, Da/H-3215-2019; Ma, Da/L-4497-2013; Fisher, Elizabeth MC/C-2168-2008; Ourselin, Sebastien/K-6960-2015; Cardoso, M. Jorge/N-5511-2018	Holmes, Holly/0000-0001-8832-8171; Ma, Da/0000-0002-3542-7798; Ma, Da/0000-0002-3542-7798; Fisher, Elizabeth MC/0000-0003-2850-9936; Powell, Nick/0000-0003-4120-0642; Tybulewicz, Victor/0000-0003-2439-0798; Wells, Jack/0000-0002-4171-3539; Ourselin, Sebastien/0000-0002-5694-5340; Cardoso, M. Jorge/0000-0003-1284-2558; Modat, Marc/0000-0002-5277-8530; Lythgoe, Mark/0000-0002-4945-0171; Wiseman, Frances/0000-0001-9323-3548	Faculty of Engineering funding scheme; Engineering and Physical Science Research Council [EP/H046410/1]; Comprehensive Biomedical Research Centre [168]; National Centre for Replacement, Refinement and Reduction of Animals in Research (NC3Rs); Medical Research Council Doctoral Training Program funding scheme; MRC [U117527252]; Wellcome Trust [080174, 098328]; Engineering and Physical Sciences Research Council [EP/H046410/1] Funding Source: researchfish; Medical Research Council [G0601056, MC_U117527252] Funding Source: researchfish; National Centre for the Replacement [NC/K500276/1] Funding Source: researchfish; EPSRC [EP/H046410/1] Funding Source: UKRI; MRC [MC_U117527252, G0601056] Funding Source: UKRI	Faculty of Engineering funding scheme; Engineering and Physical Science Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Comprehensive Biomedical Research Centre; National Centre for Replacement, Refinement and Reduction of Animals in Research (NC3Rs)(UK Research & Innovation (UKRI)National Centre for the Replacement, Refinement & Reduction of Animals in Research (NC3Rs)); Medical Research Council Doctoral Training Program funding scheme(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Centre for the Replacement; EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was undertaken at UCL, which received a proportion of funding from Faculty of Engineering funding scheme. M. Jorge Cardoso, Marc Modat and Sebastien Ourselin were supported by Engineering and Physical Science Research Council (EP/H046410/1) and the Comprehensive Biomedical Research Centre (Ref. 168). Jack Wells was supported by the Engineering and Physical Science Research Council (EP/H046410/1). Holly Holmes was supported by the National Centre for Replacement, Refinement and Reduction of Animals in Research (NC3Rs). Nick Powell was supported by Medical Research Council Doctoral Training Program funding scheme. Victor Tybulewicz was supported by MRC programme (U117527252) and Wellcome Trust grants (080174 and 098328). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal M, 2012, PROC SPIE, V8314, DOI 10.1117/12.911552; Aljabar P, 2007, LECT NOTES COMPUT SC, V4791, P523; Artaechevarria X, 2008, P SPIE INT SOC OPT P, V69141W-69141W-9; Artaechevarria X, 2009, IEEE T MED IMAGING, V28, P1266, DOI 10.1109/TMI.2009.2014372; Austin CP, 2004, NAT GENET, V36, P921, DOI 10.1038/ng0904-921; Badea A, 2007, NEUROIMAGE, V37, P683, DOI 10.1016/j.neuroimage.2007.05.046; Bai J, 2012, MAGN RESON IMAGING, V30, P789, DOI 10.1016/j.mri.2012.02.010; Batzoglou S, 2000, GENOME RES, V10, P950, DOI 10.1101/gr.10.7.950; Boccardi M, 2013, ALZHEIMERS DEMENT, P1; Bock NA, 2005, MAGNET RESON MED, V54, P1311, DOI 10.1002/mrm.20683; Bowden DM, 2011, J NEUROSCI METH, V195, P170, DOI 10.1016/j.jneumeth.2010.11.028; Calmon G, 2000, MAGN RESON IMAGING, V18, P439, DOI 10.1016/S0730-725X(99)00118-6; Cardoso MJ, 2013, MED IMAGE ANAL, V17, P671, DOI 10.1016/j.media.2013.02.006; Chakravarty MM, 2011, INT SOC MAGN RESON M, V15, P2011; Chuang N, 2011, NEUROIMAGE, V54, P80, DOI 10.1016/j.neuroimage.2010.07.043; Cleary JO, 2011, NEUROIMAGE, V54, P769, DOI 10.1016/j.neuroimage.2010.07.039; Dorr AE, 2008, NEUROIMAGE, V42, P60, DOI 10.1016/j.neuroimage.2008.03.037; Fischl B, 2002, NEURON, V33, P341, DOI 10.1016/S0896-6273(02)00569-X; Hammers A, 2003, HUM BRAIN MAPP, V19, P224, DOI 10.1002/hbm.10123; Heckemann RA, 2006, NEUROIMAGE, V33, P115, DOI 10.1016/j.neuroimage.2006.05.061; Heckemann RA, 2010, NEUROIMAGE, V51, P221, DOI 10.1016/j.neuroimage.2010.01.072; Jiang Y, 2011, NEUROIMAGE, V56, P1235, DOI 10.1016/j.neuroimage.2011.03.031; John JP, 2006, PSYCHIAT RES-NEUROIM, V148, P151, DOI 10.1016/j.pscychresns.2006.05.006; Jones SE, 2000, HUM BRAIN MAPP, V11, P12, DOI 10.1002/1097-0193(200009)11:1<12::AID-HBM20>3.0.CO;2-K; Kempton MJ, 2011, NEUROIMAGE, V58, P1051, DOI 10.1016/j.neuroimage.2011.06.080; Klein A, 2009, NEUROIMAGE, V46, P786, DOI 10.1016/j.neuroimage.2008.12.037; Kohl MM, 2011, NAT NEUROSCI, V14, P1413, DOI 10.1038/nn.2915; Kovacevic N, 2005, CEREB CORTEX, V15, P639, DOI 10.1093/cercor/bhh165; Langerak TR, 2010, IEEE T MED IMAGING, V29, P2000, DOI 10.1109/TMI.2010.2057442; Lee J, 2009, P SPIE INT SOC OPT P, V7259; Lerch JP, 2008, NEUROIMAGE, V41, P243, DOI 10.1016/j.neuroimage.2008.02.019; Leung KK, 2010, NEUROIMAGE, V51, P1345, DOI 10.1016/j.neuroimage.2010.03.018; Liu YX, 1998, P SOC PHOTO-OPT INS, V3338, P1528, DOI 10.1117/12.310886; Ma Y, 2005, NEUROSCIENCE, V135, P1203, DOI 10.1016/j.neuroscience.2005.07.014; Ma Y, 2008, FRONT NEUROANAT, V2, DOI 10.3389/neuro.05.001.2008; Maes F, 1999, LECT NOTES COMPUT SC, V1679, P348; Modat M, 2010, COMPUT METH PROG BIO, V98, P278, DOI 10.1016/j.cmpb.2009.09.002; Natt O, 2002, J NEUROSCI METH, V120, P203, DOI 10.1016/S0165-0270(02)00211-X; Nestor SM, 2013, NEUROIMAGE, V66, P50, DOI 10.1016/j.neuroimage.2012.10.081; Ourselin S, 2000, LECT NOTES COMPUT SC, V1935, P557; Paxinos G, 2004, MOUSE BRAIN STEREOTA; Prima S, 1998, LECT NOTES COMPUT SC, V1496, P770, DOI 10.1007/BFb0056264; Richards K, 2011, NEUROIMAGE, V58, P732, DOI 10.1016/j.neuroimage.2011.06.025; Rohlfing T, 2004, IEEE T MED IMAGING, V23, P983, DOI 10.1109/TMI.2004.830803; Rohlfing T, 2007, IEEE T IMAGE PROCESS, V16, P153, DOI 10.1109/TIP.2006.884936; Rueckert D, 1998, LECT NOTES COMPUT SC, V1496, P1144, DOI 10.1007/BFb0056304; Rueckert D, 1999, IEEE T MED IMAGING, V18, P712, DOI 10.1109/42.796284; Scheenstra AEH, 2009, MOL IMAGING, V8, P35, DOI 10.2310/7290.2009.00004; Sharief AA, 2008, NEUROIMAGE, V39, P136, DOI 10.1016/j.neuroimage.2007.08.028; Sinclair B, 2011, P INT SOC MAG RESON, V19, P702; Sled JG, 1998, IEEE T MED IMAGING, V17, P87, DOI 10.1109/42.668698; Spring S, 2010, NEUROIMAGE, V50, P409, DOI 10.1016/j.neuroimage.2009.12.043; Ullmann JFP, 2013, NEUROIMAGE, V78, P196, DOI 10.1016/j.neuroimage.2013.04.008; Ullmann JFP, 2012, NEUROIMAGE, V62, P1408, DOI 10.1016/j.neuroimage.2012.05.061; Ullmann JP, 2013, BRAIN STRUCT FUNCT, P1; van Eede MC, 2013, NEUROIMAGE, V82, P226, DOI 10.1016/j.neuroimage.2013.06.004; Warfield SK, 2004, IEEE T MED IMAGING, V23, P903, DOI 10.1109/TMI.2004.828354; Wolz R, 2010, NEUROIMAGE, V49, P1316, DOI 10.1016/j.neuroimage.2009.09.069; Zhuang XH, 2010, IEEE T MED IMAGING, V29, P1612, DOI 10.1109/TMI.2010.2047112	59	36	36	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2014	9	1							e86576	10.1371/journal.pone.0086576	http://dx.doi.org/10.1371/journal.pone.0086576			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301BI	24475148	Green Published, Green Submitted, gold			2022-12-25	WOS:000330507300084
J	Vreeman, RC; Scanlon, ML; Mwangi, A; Turissini, M; Ayaya, SO; Tenge, C; Nyandiko, WM				Vreeman, Rachel C.; Scanlon, Michael L.; Mwangi, Ann; Turissini, Matthew; Ayaya, Samuel O.; Tenge, Constance; Nyandiko, Winstone M.			A Cross-Sectional Study of Disclosure of HIV Status to Children and Adolescents in Western Kenya	PLOS ONE			English	Article							SCHOOL-AGE-CHILDREN; HUMAN-IMMUNODEFICIENCY-VIRUS; OF-THE-LITERATURE; ANTIRETROVIRAL THERAPY; INFECTED CHILDREN; ADHERENCE; DEPRESSION; HEALTH; PERCEPTIONS; DIAGNOSIS	Introduction: Disclosure of HIV status to children is essential for disease management but is not well characterized in resource-limited settings. This study aimed to describe the prevalence of disclosure and associated factors among a cohort of HIV-infected children and adolescents in Kenya. Methods: We conducted a cross-sectional study, randomly sampling HIV-infected children ages 6-14 years attending 4 HIV clinics in western Kenya. Data were collected from questionnaires administered by clinicians to children and their caregivers, supplemented with chart review. Descriptive statistics and disclosure prevalence were calculated. Univariate analyses and multivariate logistic regression were performed to assess the association between disclosure and key child-level demographic, clinical and psychosocial characteristics. Results: Among 792 caregiver-child dyads, mean age of the children was 9.7 years (SD = 2.6) and 51% were female. Prevalence of disclosure was 26% and varied significantly by age; while 62% of 14-year-olds knew their status, only 42% of 11-year-olds and 21% of 8-year-olds knew. In multivariate regression, older age (OR 1.49, 95% CI 1.35-1.63), taking antiretroviral drugs (OR 2.27, 95% CI 1.29-3.97), and caregiver-reported depression symptoms (OR 2.63, 95% CI 1.12-6.20) were significantly associated with knowing one's status. Treatment site was associated with disclosure for children attending one of the rural clinics compared to the urban clinic (OR 3.44, 95% CI 1.75-6.76). Conclusions: Few HIV-infected children in Kenya know their HIV status. The likelihood of disclosure is associated with clinical and psychosocial factors. More data are needed on the process of disclosure and its impact on children.	[Vreeman, Rachel C.; Scanlon, Michael L.; Turissini, Matthew] Indiana Univ Sch Med, Dept Pediat, Childrens Hlth Serv Res, Indianapolis, IN 46202 USA; [Vreeman, Rachel C.; Scanlon, Michael L.; Mwangi, Ann; Turissini, Matthew; Ayaya, Samuel O.; Tenge, Constance; Nyandiko, Winstone M.] USAID Acad Model Providing Access Healthcare AMPA, Eldoret, Kenya; [Mwangi, Ann] Moi Univ, Sch Med, Dept Behav Sci, Coll Hlth Sci, Eldoret, Kenya; [Ayaya, Samuel O.; Tenge, Constance; Nyandiko, Winstone M.] Moi Univ, Sch Med, Dept Child Hlth & Paediat, Coll Hlth Sci, Eldoret, Kenya	Indiana University System; Indiana University Bloomington; United States Agency for International Development (USAID); Moi University; Moi University	Vreeman, RC (corresponding author), Indiana Univ Sch Med, Dept Pediat, Childrens Hlth Serv Res, Indianapolis, IN 46202 USA.	rvreeman@iupui.edu	Scanlon, Michael L/P-3556-2016; Cuscó, Xavier Garcia/S-7576-2019	Scanlon, Michael L/0000-0002-0334-5640; Cuscó, Xavier Garcia/0000-0001-7199-6931	NIMH [K23MH087225]; USAID-AMPATH Partnership from the United States Agency for International Development as part of the President's Emergency Plan for AIDS Relief (PEPFAR); NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH099747, K23MH087225] Funding Source: NIH RePORTER	NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); USAID-AMPATH Partnership from the United States Agency for International Development as part of the President's Emergency Plan for AIDS Relief (PEPFAR)(United States Agency for International Development (USAID)United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This research was supported in part by a grant (K23MH087225) to Dr. Rachel Vreeman from the NIMH and by the USAID-AMPATH Partnership from the United States Agency for International Development as part of the President's Emergency Plan for AIDS Relief (PEPFAR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], PROGR REP 2011 GLOB; Bachanas PJ, 2001, J PEDIATR PSYCHOL, V26, P343, DOI 10.1093/jpepsy/26.6.343; Bikaako-Kajura W, 2006, AIDS BEHAV, V10, pS85, DOI 10.1007/s10461-006-9141-3; Blasini I, 2004, J DEV BEHAV PEDIATR, V25, P181, DOI 10.1097/00004703-200406000-00007; Brackis-Cott Elizabeth, 2003, J Pediatr Health Care, V17, P252, DOI 10.1016/S0891-5245(02)88313-4; Brady MT, 2010, JAIDS-J ACQ IMM DEF, V53, P86, DOI 10.1097/QAI.0b013e3181b9869f; Butler AM, 2009, PEDIATRICS, V123, P935, DOI 10.1542/peds.2008-1290; Einterz RM, 2007, ACAD MED, V82, P812, DOI 10.1097/ACM.0b013e3180cc29f1; Ferris M, 2007, AIDS CARE, V19, P1088, DOI 10.1080/09540120701367124; FunckBrentano I, 1995, PSYCHIAT ENFANT, V38, P109; FunckBrentano I, 1997, ARCH PEDIAT ADOL MED, V151, P978, DOI 10.1001/archpedi.1997.02170470012002; Haberer Jessica, 2009, Curr HIV/AIDS Rep, V6, P194, DOI 10.1007/s11904-009-0026-8; Hammami N, 2004, PEDIATRICS, V114, pE591, DOI 10.1542/peds.2004-0085; HAVENS JF, 2002, CHILD ADOL PSYCH CL, P828; John-Stewart GC, 2013, AIDS CARE, V25, P1067, DOI 10.1080/09540121.2012.749333; Kallem S, 2011, AIDS BEHAV, V15, P1121, DOI 10.1007/s10461-010-9741-9; Kroenke K, 2003, MED CARE, V41, P1284, DOI 10.1097/01.MLR.0000093487.78664.3C; Madiba S., 2012, WORLD J AIDS, V2, P212, DOI [10.4236/wja.2012.23027, DOI 10.4236/WJA.2012.23027]; Mahajan AP, 2008, AIDS, V22, pS67, DOI 10.1097/01.aids.0000327438.13291.62; Marhefka SL, 2006, AIDS PATIENT CARE ST, V20, P429, DOI 10.1089/apc.2006.20.429; Mellins CA, 2004, PEDIATR INFECT DIS J, V23, P1035, DOI 10.1097/01.inf.0000143646.15240.ac; Menon A, 2007, JAIDS-J ACQ IMM DEF, V46, P349, DOI 10.1097/QAI.0b013e3181565df0; Monahan PO, 2009, J GEN INTERN MED, V24, P189, DOI 10.1007/s11606-008-0846-z; Murphy DA, 2001, AIDS CARE, V13, P27, DOI 10.1080/09540120020018161; Pinzon-Iregui MC, 2013, J TROP PEDIATRICS, V59, P84, DOI 10.1093/tropej/fms052; Richardson LP, 2010, PEDIATRICS, V125, pE1097, DOI 10.1542/peds.2009-2712; Riekert KA, 1999, CHILD HEALTH CARE, V28, P201, DOI 10.1207/s15326888chc2803_1; Sirikum C., 2013, 5 INT WORKSH HIV PED; Turissini ML, 2013, J PEDIATR INFECT DIS, V2, P136, DOI 10.1093/jpids/pit024; Vreeman RC, 2008, PEDIATR INFECT DIS J, V27, P686, DOI 10.1097/INF.0b013e31816dd325; Vreeman RC, 2013, J INT AIDS SOC, V16, DOI 10.7448/IAS.16.1.18466; Vreeman RC, 2010, AIDS PATIENT CARE ST, V24, P639, DOI 10.1089/apc.2010.0079; Wagner G, 2004, JAIDS-J ACQ IMM DEF, V35, P203, DOI 10.1097/00126334-200402010-00016; Wiener L, 2007, J DEV BEHAV PEDIATR, V28, P155, DOI 10.1097/01.DBP.0000267570.87564.cd; Wilfert C, 1999, PEDIATRICS, V103, P164; World Health Organization, 2011, GUID HIV DISCL COUNS	36	62	62	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2014	9	1							e86616	10.1371/journal.pone.0086616	http://dx.doi.org/10.1371/journal.pone.0086616			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	301BI	24475159	Green Published, gold			2022-12-25	WOS:000330507300095
J	Chen, YH; Lin, WW; Liu, CS; Hsu, LS; Lin, YM; Su, SL				Chen, Ya-Hui; Lin, Wei-Wen; Liu, Chin-San; Hsu, Li-Sung; Lin, Yueh-Min; Su, Shih-Li			Caveolin-1 Provides Palliation for Adverse Hepatic Reactions in Hypercholesterolemic Rabbits	PLOS ONE			English	Article							HIGH-DENSITY-LIPOPROTEIN; MEDIATED CHOLESTEROL EFFLUX; MITOCHONDRIAL BIOGENESIS; CELLULAR CHOLESTEROL; SELECTIVE UPTAKE; SR-BI; ENDOTHELIAL-CELL; EXPRESSION; ATHEROSCLEROSIS; TRANSPORT	Caveolins are an essential component of cholesterol-rich invaginations of the plasma membrane known as caveolae. These flask-shaped, invaginated structures participate in a number of important cellular processes, including vesicular transport, cholesterol homeostasis, and signal transduction. We investigated the effects of CAV-1 on mitochondrial biogenesis and antioxidant enzymes in hypercholesterolemia-affected target organs. A total of eighteen male New Zealand white rabbits were divided into three groups: a normal-diet group, an untreated hypercholesterolemia-induced group, and a hypercholesterolemia-induced group that received intravenous administration of antennapedia-CAV-1 (AP-CAV-1) peptide every 2 days for 2 weeks. Serum biochemistry, CAV-1 distribution, neutral lipid distribution, mitochondrial morphology, biogenesis-mediated protein content, oxidative stress balance, antioxidant enzyme levels, and apoptotic cell death of liver tissue were analysed. Hepatic and circulating cholesterol and low-density lipoprotein cholesterol (LDL-C) levels differed significantly between the three groups (P<0.05). Immunohistochemical staining intensity of CAV-1 was greater in AP-CAV-1-treated rabbits than in untreated rabbits, especially in the vicinity of the liver vasculature. The high levels of neutral lipids, malondialdehyde, peroxisome proliferator-activated receptor-gamma coactive 1 alpha (PGC-1 alpha), and nuclear respiratory factor-1 (NRF-1) seen in untreated hypercholesteremic animals were attenuated by administration of AP-CAV-1 (P<0.05). In addition, mitochondria in animals that received treatment exhibited darker electron-dense matrix and integrated cristae. Furthermore, the levels of ROS modulator 1 (Romo1) and superoxide dismutase (SOD)-2, as well as catalase activity were significantly lower in CAV-1-treated hypercholesterolemic rabbits (P<0.05). AP-CAV-1 treatment also restored mitochondrial respiratory chain subunit protein content (OXPHOS complexes I-V), thereby preserving mitochondrial function (P<0.05). Furthermore, AP-CAV-1 treatment significantly suppressed apoptotic cell death, as evidenced by a reduction in the number of TUNEL-positive cells. Our results indirectly indicate that CAV-1 mediates the negative effects of PGC-1 alpha on hepatic mitochondrial respiratory chain function, promotes the antioxidant enzyme defence system, and maintains mitochondrial biogenesis.	[Chen, Ya-Hui; Liu, Chin-San; Su, Shih-Li] Changhua Christian Hosp, Vasc & Genom Ctr, Changhua, Taiwan; [Chen, Ya-Hui; Hsu, Li-Sung] Chung Shan Med Univ, Inst Biochem & Biotechnol, Taichung, Taiwan; [Lin, Wei-Wen] Taichung Vet Gen Hosp, Dept Internal Med, Div Cardiovasc Ctr, Taichung, Taiwan; [Liu, Chin-San] China Med Univ, Grad Inst Integrat Med, Taichung, Taiwan; [Lin, Yueh-Min] Changhua Christian Hosp, Dept Pathol, Changhua, Taiwan; [Lin, Yueh-Min] Jen Teh Jr Coll Med Nursing & Management, Dept Med Technol, Miaoli, Taiwan; [Su, Shih-Li] Changhua Christian Hosp, Div Endocrinol & Metab, Dept Internal Med, Changhua, Taiwan; [Su, Shih-Li] Chung Shan Med Univ, Inst Med, Taichung, Taiwan	Changhua Christian Hospital; Chung Shan Medical University; Taichung Veterans General Hospital; China Medical University Taiwan; Changhua Christian Hospital; Changhua Christian Hospital; Chung Shan Medical University	Su, SL (corresponding author), Changhua Christian Hosp, Vasc & Genom Ctr, Changhua, Taiwan.	89933@cch.org.tw			Changhua Christian Hospital [98-CCH-IRP-54-92262, 98-CCH-IRP-04-92179]	Changhua Christian Hospital	This work was supported by the Changhua Christian Hospital under grants 98-CCH-IRP-54-92262 and 98-CCH-IRP-04-92179. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arakawa R, 2000, J LIPID RES, V41, P1952; Arduini Alessandro, 2012, Front Biosci (Elite Ed), V4, P2233; Arduini A, 2011, AM J PHYSIOL-GASTR L, V301, pG119, DOI 10.1152/ajpgi.00253.2010; Bosch M, 2011, TRAFFIC, V12, P1483, DOI 10.1111/j.1600-0854.2011.01259.x; Bosch M, 2011, CURR BIOL, V21, P681, DOI 10.1016/j.cub.2011.03.030; Bucci M, 2000, NAT MED, V6, P1362, DOI 10.1038/82176; Chen ZL, 2012, MOL BIOL CELL, V23, P1388, DOI 10.1091/mbc.E11-09-0811; Chowdhury SK, 2012, NEUROBIOL DIS; Chung YM, 2006, BIOCHEM BIOPH RES CO, V347, P649, DOI 10.1016/j.bbrc.2006.06.140; Contreras L, 2010, BBA-BIOENERGETICS, V1797, P607, DOI 10.1016/j.bbabio.2010.05.005; Derossi D, 1996, J BIOL CHEM, V271, P18188, DOI 10.1074/jbc.271.30.18188; Derossi D, 1998, TRENDS CELL BIOL, V8, P84, DOI 10.1016/S0962-8924(97)01214-2; Fielding CJ, 1999, BIOCHEMISTRY-US, V38, P2506, DOI 10.1021/bi981012o; Frank PG, 2004, CURR OPIN LIPIDOL, V15, P523, DOI 10.1097/00041433-200410000-00005; Frank PG, 2002, BIOCHEMISTRY-US, V41, P11931, DOI 10.1021/bi0257078; Frank PG, 2001, AM J PHYSIOL-CELL PH, V280, pC1204, DOI 10.1152/ajpcell.2001.280.5.C1204; Frank PG, 2001, BIOCHEMISTRY-US, V40, P10892, DOI 10.1021/bi0106437; Frank PG, 2008, AM J PHYSIOL-CELL PH, V295, pC242, DOI 10.1152/ajpcell.00185.2008; Frank PG, 2007, CURR PHARM DESIGN, V13, P1761, DOI 10.2174/138161207780831202; Frank PG, 2006, AM J PHYSIOL-HEART C, V291, pH677, DOI 10.1152/ajpheart.01092.2005; Frank PG, 2010, AM J PATHOL, V177, P544, DOI 10.2353/ajpath.2010.100247; Fu Y, 2004, J BIOL CHEM, V279, P14140, DOI 10.1074/jbc.M311061200; Gomes EC, 2012, OXID MED CELL LONGEV, V2012, DOI 10.1155/2012/756132; Jasmin JF, 2006, CIRCULATION, V114, P912, DOI 10.1161/CIRCULATIONAHA.106.634709; Jasmin JF, 2012, ADV EXP MED BIOL, V729, P1, DOI 10.1007/978-1-4614-1222-9; Joyce C, 2003, ARTERIOSCL THROM VAS, V23, P965, DOI 10.1161/01.ATV.0000055194.85073.FF; Li L, 2011, BASIC RES CARDIOL, V106, P1221, DOI 10.1007/s00395-011-0213-9; Li L, 2011, DIABETES, V60, P157, DOI 10.2337/db10-0331; Lin WW, 2006, J HISTOCHEM CYTOCHEM, V54, P897, DOI 10.1369/jhc.5A6869.2006; Lin YC, 2007, CARDIOVASC RES, V75, P575, DOI 10.1016/j.cardiores.2007.04.012; Matveev S, 2001, EUR J BIOCHEM, V268, P5609, DOI 10.1046/j.1432-1033.2001.02496.x; McBride HM, 2006, CURR BIOL, V16, pR551, DOI 10.1016/j.cub.2006.06.054; Moreno M, 2003, HEPATOLOGY, V38, P1477, DOI 10.1016/j.hep.2003.09.011; Pangare Meenal, 2012, Journal of Smooth Muscle Research, V48, P1; Pavlides S, 2012, ADV EXP MED BIOL, V729, P127, DOI 10.1007/978-1-4614-1222-9_9; Piantadosi CA, 2012, BBA-GEN SUBJECTS, V1820, P532, DOI 10.1016/j.bbagen.2012.01.003; Rhainds D, 2003, BIOCHEMISTRY-US, V42, P7527, DOI 10.1021/bi026949a; Santos JM, 2011, FREE RADICAL BIO MED, V51, P1849, DOI 10.1016/j.freeradbiomed.2011.08.017; Smart EJ, 1996, J BIOL CHEM, V271, P29427, DOI 10.1074/jbc.271.46.29427; Sowa G, 2012, FRONT PHYSIOL, V2, DOI 10.3389/fphys.2011.00120; Valle I, 2005, CARDIOVASC RES, V66, P562, DOI 10.1016/j.cardiores.2005.01.026; Wang LB, 2003, J LIPID RES, V44, P807, DOI 10.1194/jlr.M200449-JLR200; Williams TM, 2004, ANN MED, V36, P584, DOI 10.1080/07853890410018899; Williams TM, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-3-214	45	36	37	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2014	9	1							e71862	10.1371/journal.pone.0071862	http://dx.doi.org/10.1371/journal.pone.0071862			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	298QQ	24475013	Green Submitted, Green Published, gold			2022-12-25	WOS:000330339800001
J	Shi, M; Yao, YF; Han, F; Li, YQ; Li, Y				Shi, Ming; Yao, Yuanfei; Han, Fang; Li, Yiqun; Li, Yu			MAP1S Controls Breast Cancer Cell TLR5 Signaling Pathway and Promotes TLR5 Signaling-based Tumor Suppression	PLOS ONE			English	Article							TOLL-LIKE RECEPTORS; AUTOPHAGY; PROLIFERATION; FLAGELLIN; MOUSE; TOLL-LIKE-RECEPTOR-5; TUMORIGENESIS; MACROPHAGES; ACTIVATION; CARCINOMA	Targeting TLR5 signaling in breast cancer represents a novel strategy in cancer immunotherapy. However, the underlying mechanism by which TLR5 signaling inhibits cancer cell proliferation and tumor growth has not been elucidated. In this study, we found TLR5 agonist flagellin inhibited the cell state of activation and induced autophagy, and reported that autophagy protein MAP1S regulated the flagellin/TLR5 signaling pathway in breast cancer cells through enhancement of NF-kappa B activity and cytokine secretion. Remarkably, MAP1S played a critical role in tumor suppression induced by flagellin, and knockdown of MAP1S almost completely abrogated the suppression of tumor growth and migration by flagellin treatment. In addition, elevated expression of MAP1S in response to flagellin feed-back regulated tumor inflammatory microenvironment in the late stages of TLR5 signaling through degradation of MyD88 in autophagy process. These results indicate a mechanism of antitumor activity that involves MAP1S-controlled TLR5 signaling in breast cancer.	[Shi, Ming; Yao, Yuanfei; Han, Fang; Li, Yiqun; Li, Yu] Harbin Inst Technol, Sch Life Sci & Technol, Harbin 150006, Peoples R China	Harbin Institute of Technology	Li, Y (corresponding author), Harbin Inst Technol, Sch Life Sci & Technol, Harbin 150006, Peoples R China.	liyugene@hit.edu.cn						Bhattacharya D, 2012, INT J BREAST CANCER, V2012, DOI 10.1155/2012/716564; Burdelya LG, 2008, SCIENCE, V320, P226, DOI 10.1126/science.1154986; Burdelya LG, 2013, P NATL ACAD SCI USA, V110, pE1857, DOI 10.1073/pnas.1222805110; Cai ZY, 2011, CANCER RES, V71, P2466, DOI 10.1158/0008-5472.CAN-10-1993; Galluzzi L, 2012, ONCOIMMUNOLOGY, V1, P699, DOI 10.4161/onci.20696; Huang B, 2005, CANCER RES, V65, P5009, DOI 10.1158/0008-5472.CAN-05-0784; Iwasaki A, 2010, SCIENCE, V327, P291, DOI 10.1126/science.1183021; Kirkegaard K, 2004, NAT REV MICROBIOL, V2, P301, DOI 10.1038/nrmicro865; Liu LY, 2012, AUTOPHAGY, V8, P278, DOI 10.4161/auto.8.2.18939; Liu LY, 2005, CANCER RES, V65, P4191, DOI 10.1158/0008-5472.CAN-04-3865; Mantovani A, 2009, NATURE, V457, P36, DOI 10.1038/457036b; Mathew R, 2009, CELL, V137, P1062, DOI 10.1016/j.cell.2009.03.048; Ouedraogo R, 2012, J PROTEOMICS, V75, P5523, DOI 10.1016/j.jprot.2012.07.046; Ouedraogo R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013691; Rakoff-Nahoum S, 2009, NAT REV CANCER, V9, P57, DOI 10.1038/nrc2541; Rhee SH, 2008, GASTROENTEROLOGY, V135, P518, DOI 10.1053/j.gastro.2008.04.022; Sanjuan MA, 2007, NATURE, V450, P1253, DOI 10.1038/nature06421; Schmausser B, 2005, INT J MED MICROBIOL, V295, P179, DOI 10.1016/j.ijmm.2005.02.009; Sfondrini L, 2006, J IMMUNOL, V176, P6624, DOI 10.4049/jimmunol.176.11.6624; Shcheblyakov DV, 2010, ACTA NATURAE, V2, P21, DOI 10.32607/20758251-2010-2-3-21-29; Song EJ, 2011, INT J MOL MED, V28, P115, DOI 10.3892/ijmm.2011.656; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Wolska A, 2009, CELL MOL BIOL LETT, V14, P248, DOI 10.2478/s11658-008-0048-z; Xie R, 2011, CANCER RES, V71, P7537, DOI 10.1158/0008-5472.CAN-11-2170; Xie R, 2011, J BIOL CHEM, V286, P10367, DOI 10.1074/jbc.M110.206532; Xu Y, 2008, AUTOPHAGY, V4, P110, DOI 10.4161/auto.5225; Yang ZNJ, 2011, MOL CANCER THER, V10, P1533, DOI 10.1158/1535-7163.MCT-11-0047; Yu L, 2008, CANCER IMMUNOL IMMUN, V57, P1271, DOI 10.1007/s00262-008-0459-8; Yu YT, 2012, CANCER SCI, V103, P716, DOI 10.1111/j.1349-7006.2012.02220.x; Zeng FL, 2011, MOL CELLS, V31, P267, DOI 10.1007/s10059-011-0037-3; Zhang DK, 2004, SCIENCE, V303, P1522, DOI 10.1126/science.1094351	31	19	21	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2014	9	1							e86839	10.1371/journal.pone.0086839	http://dx.doi.org/10.1371/journal.pone.0086839			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297XI	24466264	Green Published, gold, Green Submitted			2022-12-25	WOS:000330288000156
J	Song, XP; Zhang, Y; Liu, YJ				Song, Xiaopeng; Zhang, Yi; Liu, Yijun			Frequency Specificity of Regional Homogeneity in the Resting-State Human Brain	PLOS ONE			English	Article							DEFAULT MODE NETWORK; FUNCTIONAL CONNECTIVITY; CORTICAL NETWORKS; TIME-SERIES; OSCILLATIONS; MRI	Resting state-fMRI studies have found that the inter-areal correlations in cortical networks concentrate within ultra-low frequencies (0.01-0.04 Hz) while long-distance connections within subcortical networks distribute over a wider frequency range (0.01-0.14 Hz). However, the frequency characteristics of regional homogeneity (ReHo) in different areas are still unclear. To examine the ReHo properties in different frequency bands, a data-driven method, Empirical Mode Decomposition (EMD), was adopted to decompose the time series of each voxel into several components with distinct frequency bands. ReHo values in each of the components were then calculated. Our results showed that ReHo in cortical areas were higher and more frequency-dependent than those in the subcortical regions. BOLD oscillations of 0.02-0.04 Hz mainly contributed to the cortical ReHo, whereas the ReHo in limbic areas involved a wider frequency range and were dominated by higher-frequency BOLD oscillations (>0.08 Hz). The frequency characteristics of ReHo are distinct between different parts of the striatum, with the frequency band of 0.04-0.1 Hz contributing the most to ReHo in caudate nucleus, and oscillations lower than 0.02 Hz contributing more to ReHo in putamen. The distinct frequency-specific ReHo properties of different brain areas may arise from the assorted cytoarchitecture or synaptic types in these areas. Our work may advance the understanding of the neural-physiological basis of local BOLD activities and the functional specificity of different brain regions.	[Song, Xiaopeng; Liu, Yijun] Peking Univ, Coll Engn, Dept Biomed Engn, Beijing 100871, Peoples R China; [Zhang, Yi] Xidian Univ, Sch Life Sci & Technol, Xian, Shanxi, Peoples R China	Peking University; Xidian University	Liu, YJ (corresponding author), Peking Univ, Coll Engn, Dept Biomed Engn, Beijing 100871, Peoples R China.	yjliufl@gmail.com	Zhang, Yi/J-7496-2017	Zhang, Yi/0000-0003-0859-9735; Song, Xiaopeng/0000-0003-0074-6489	National Natural Science Foundation of China [61131003, 81271549]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work is supported by the National Natural Science Foundation of China (http://www.nsfc.gov.cn/Portal0/default166.htm) under Grant Nos.61131003 and 81271549. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baria AT, 2011, J NEUROSCI, V31, P7910, DOI 10.1523/JNEUROSCI.1296-11.2011; Baria AT, 2013, NEUROIMAGE; Bassett DS, 2008, J NEUROSCI, V28, P9239, DOI 10.1523/JNEUROSCI.1929-08.2008; Beckmann CF, 2005, PHILOS T R SOC B, V360, P1001, DOI 10.1098/rstb.2005.1634; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Brodmann, 1909, VERGLEICHENDE LOKALI; Buzsaki G, 2004, SCIENCE, V304, P1926, DOI 10.1126/science.1099745; Canolty RT, 2010, TRENDS COGN SCI, V14, P506, DOI 10.1016/j.tics.2010.09.001; Damoiseaux JS, 2006, P NATL ACAD SCI USA, V103, P13848, DOI 10.1073/pnas.0601417103; Friston KJ, 2009, SCIENCE, V326, P399, DOI 10.1126/science.1174521; Fukunaga M, 2006, MAGN RESON IMAGING, V24, P979, DOI 10.1016/j.mri.2006.04.018; He BJ, 2013, J NEUROSCI, V33, P4672, DOI 10.1523/JNEUROSCI.2922-12.2013; He BYJ, 2010, NEURON, V66, P353, DOI 10.1016/j.neuron.2010.04.020; Huang NE, 1998, P ROY SOC A-MATH PHY, V454, P903, DOI 10.1098/rspa.1998.0193; Linkenkaer-Hansen K, 2001, J NEUROSCI, V21, P1370; Liu YY, 1999, NATURE, V400, P364, DOI 10.1038/22547; Long XY, 2008, J NEUROSCI METH, V171, P349, DOI 10.1016/j.jneumeth.2008.03.021; Lv YT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064115; Mason MF, 2007, SCIENCE, V315, P393, DOI 10.1126/science.1131295; Mesulam MM, 1998, BRAIN, V121, P1013, DOI 10.1093/brain/121.6.1013; Mezer A, 2009, NEUROIMAGE, V45, P1117, DOI 10.1016/j.neuroimage.2008.12.015; Niazy RK, 2011, PROG BRAIN RES, V193, P259, DOI 10.1016/B978-0-444-53839-0.00017-X; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Sheline YI, 2009, P NATL ACAD SCI USA, V106, P1942, DOI 10.1073/pnas.0812686106; Siegel M, 2012, NATURE REV NEUROSCIE; TONONI G, 1994, P NATL ACAD SCI USA, V91, P5033, DOI 10.1073/pnas.91.11.5033; Wang L, 2012, NEURON, V76, P1010, DOI 10.1016/j.neuron.2012.09.033; Wu CWW, 2008, NEUROIMAGE, V42, P1047, DOI 10.1016/j.neuroimage.2008.05.035; Xie HB, 2006, COMPUT METH PROG BIO, V82, P114, DOI 10.1016/j.cmpb.2006.02.009; Yu RJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057516; Zang YF, 2004, NEUROIMAGE, V22, P394, DOI 10.1016/j.neuroimage.2003.12.030; Zuo XN, 2010, NEUROIMAGE, V49, P1432, DOI 10.1016/j.neuroimage.2009.09.037	32	56	59	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2014	9	1							e86818	10.1371/journal.pone.0086818	http://dx.doi.org/10.1371/journal.pone.0086818			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297XI	24466256	Green Published, gold, Green Submitted			2022-12-25	WOS:000330288000150
J	Zhu, WL; Kato, Y; Artemov, D				Zhu, Wenlian; Kato, Yoshinori; Artemov, Dmitri			Heterogeneity of Tumor Vasculature and Antiangiogenic Intervention: Insights from MR Angiography and DCE-MRI	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; CONTRAST-ENHANCED MRI; NEOADJUVANT CHEMOTHERAPY; SOLID TUMORS; ANGIOGENIC RESPONSE; BREAST-CANCER; PHASE-III; BEVACIZUMAB; THERAPY; INHIBITOR	Purpose: Solid tumor vasculature is highly heterogeneous, which presents challenges to antiangiogenic intervention as well as the evaluation of its therapeutic efficacy. The aim of this study is to evaluate the spatial tumor vascular changes due to bevacizumab/paclitaxel therapy using a combination approach of MR angiography and DCE-MRI method. Experimental Design: Tumor vasculature of MCF-7 breast tumor mouse xenografts was studied by a combination of MR angiography and DCE-MRI with albumin-Gd-DTPA. Tumor macroscopic vasculature was extracted from the early enhanced images. Tumor microvascular parameters were obtained from the pharmacokinetic modeling of the DCE-MRI data. A spatial analysis of the microvascular parameters based on the macroscopic vasculature was used to evaluate the changes of the heterogeneous vasculature induced by a 12 day bevacizumab/paclitaxel treatment in mice bearing MCF-7 breast tumor. Results: Macroscopic vessels that feed the tumors were not affected by the bevacizumab/paclitaxel combination therapy. A higher portion of the tumors was within close proximity of these macroscopic vessels after the treatment, concomitant with tumor growth retardation. There was a significant decrease in microvascular permeability and vascular volume in the tumor regions near these vessels. Conclusion: Bevacizumab/paclitaxel combination therapy did not block the blood supply to the MCF-7 breast tumor. Such finding is consistent with the modest survival benefits of adding bevacizumab to current treatment regimens for some types of cancers.	[Zhu, Wenlian; Kato, Yoshinori; Artemov, Dmitri] Johns Hopkins Univ, Sch Med, Russell H Morgan Dept Radiol & Radiol Sci, Div Canc Imaging Res, Baltimore, MD 21218 USA; [Kato, Yoshinori; Artemov, Dmitri] Johns Hopkins Univ, Sch Med, Dept Oncol, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins Medicine	Artemov, D (corresponding author), Johns Hopkins Univ, Sch Med, Russell H Morgan Dept Radiol & Radiol Sci, Div Canc Imaging Res, Baltimore, MD 21218 USA.	dmitri@mri.jhu.edu		Kato, Yoshinori/0000-0002-6218-8710	NIH [RO1 CA154738, 2P50CA103175]; NATIONAL CANCER INSTITUTE [R01CA154738] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported by NIH RO1 CA154738 (PI Dmitri Artemov) and NIH 2P50CA103175 (PI Zaver Bhujwalla). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bear HD, 2012, NEW ENGL J MED, V366, P310, DOI 10.1056/NEJMoa1111097; Benjaminsen IC, 2004, MAGN RESON MED, V52, P269, DOI 10.1002/mrm.20149; Bhujwalla ZM, 2003, CLIN CANCER RES, V9, P355; Brubaker LM, 2005, CANCER RES, V65, P8218, DOI 10.1158/0008-5472.CAN-04-4355; Brufsky AM, 2011, J CLIN ONCOL, V29, P4286, DOI 10.1200/JCO.2010.34.1255; Burstein HJ, 2011, J CLIN ONCOL, V29, P1232, DOI 10.1200/JCO.2010.33.2684; Carmeliet P, 2000, NATURE, V407, P249, DOI 10.1038/35025220; Chang YC, 2004, PHYS MED BIOL, V49, P3593, DOI 10.1088/0031-9155/49/16/007; Dvorak HF, 2002, J CLIN ONCOL, V20, P4368, DOI 10.1200/JCO.2002.10.088; Erguvan-Dogan B, 2006, AM J ROENTGENOL, V187, P339, DOI 10.2214/AJR.05.0422; FOLKMAN J, 1963, CANCER, V16, P453, DOI 10.1002/1097-0142(196304)16:4<453::AID-CNCR2820160407>3.0.CO;2-Y; FOLKMAN J, 1990, JNCI-J NATL CANCER I, V82, P4, DOI 10.1093/jnci/82.1.4; Gillies Robert J., 1999, Neoplasia (New York), V1, P197, DOI 10.1038/sj.neo.7900037; Goel S, 2011, PHYSIOL REV, V91, P1071, DOI 10.1152/physrev.00038.2010; Helmlinger G, 1997, NAT MED, V3, P177, DOI 10.1038/nm0297-177; Jackson A, 2007, CLIN CANCER RES, V13, P3449, DOI 10.1158/1078-0432.CCR-07-0238; Kan ZX, 2005, RADIOLOGY, V237, P151, DOI 10.1148/radiol.2363041293; Leach MO, 2005, BRIT J CANCER, V92, P1599, DOI 10.1038/sj.bjc.6602550; Li KL, 2005, J MAGN RESON IMAGING, V22, P511, DOI 10.1002/jmri.20387; Madar-Balakirski N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010282; Marusyk A, 2012, NAT REV CANCER, V12, P323, DOI 10.1038/nrc3261; Miles DW, 2010, J CLIN ONCOL, V28, P3239, DOI 10.1200/JCO.2008.21.6457; Nagy JA, 2012, CLIN EXP METASTASIS; O'Connor JPB, 2007, BRIT J CANCER, V96, P189, DOI 10.1038/sj.bjc.6603515; OKU N, 1994, INT J CANCER, V58, P415, DOI 10.1002/ijc.2910580318; Pathak AP, 2010, ADV GENET, V69, P1, DOI 10.1016/S0065-2660(10)69010-4; Presta LG, 1997, CANCER RES, V57, P4593; Rijken PFJW, 2000, INT J RADIAT ONCOL, V48, P571, DOI 10.1016/S0360-3016(00)00686-6; Robert NJ, 2011, J CLIN ONCOL, V29, P1252, DOI 10.1200/JCO.2010.28.0982; Rose CJ, 2009, MAGN RESON MED, V62, P488, DOI 10.1002/mrm.22003; Shih T, 2006, CLIN THER, V28, P1779, DOI 10.1016/j.clinthera.2006.11.015; Sitohy B, 2012, CANCER RES, V72, P1909, DOI 10.1158/0008-5472.CAN-11-3406; TANNOCK IF, 1972, BRIT J RADIOL, V45, P515, DOI 10.1259/0007-1285-45-535-515; Tofts PS, 1997, JMRI-J MAGN RESON IM, V7, P91, DOI 10.1002/jmri.1880070113; van Vliet M, 2005, RADIOGRAPHICS, V25, pS85, DOI 10.1148/rg.25si055512; von Minckwitz G, 2012, NEW ENGL J MED, V366, P299, DOI 10.1056/NEJMoa1111065; Yang XY, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/732848; Zhu W, 2013, MAGN RESON MAT PHY	38	16	17	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2014	9	1							e86583	10.1371/journal.pone.0086583	http://dx.doi.org/10.1371/journal.pone.0086583			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297XI	24466160	Green Published, Green Submitted, gold			2022-12-25	WOS:000330288000117
J	Davies, JK; Harrison, PF; Lin, YH; Bartley, S; Khoo, CA; Seemann, T; Ryan, CS; Kahler, CM; Hill, SA				Davies, John K.; Harrison, Paul F.; Lin, Ya-Hsun; Bartley, Stephanie; Khoo, Chen Ai; Seemann, Torsten; Ryan, Catherine S.; Kahler, Charlene M.; Hill, Stuart A.			The Use of High-Throughput DNA Sequencing in the Investigation of Antigenic Variation: Application to Neisseria Species	PLOS ONE			English	Article							GONORRHOEAE MS11; GENE FAMILY; RECOMBINATION; MENINGITIDIS; FREQUENCY; PILE; REPERTOIRE; MECHANISM; INFECTION	Antigenic variation occurs in a broad range of species. This process resembles gene conversion in that variant DNA is unidirectionally transferred from partial gene copies (or silent loci) into an expression locus. Previous studies of antigenic variation have involved the amplification and sequencing of individual genes from hundreds of colonies. Using the pilE gene from Neisseria gonorrhoeae we have demonstrated that it is possible to use PCR amplification, followed by high-throughput DNA sequencing and a novel assembly process, to detect individual antigenic variation events. The ability to detect these events was much greater than has previously been possible. In N. gonorrhoeae most silent loci contain multiple partial gene copies. Here we show that there is a bias towards using the copy at the 39 end of the silent loci (copy 1) as the donor sequence. The pilE gene of N. gonorrhoeae and some strains of Neisseria meningitidis encode class I pilin, but strains of N. meningitidis from clonal complexes 8 and 11 encode a class II pilin. We have confirmed that the class II pili of meningococcal strain FAM18 (clonal complex 11) are non-variable, and this is also true for the class II pili of strain NMB from clonal complex 8. In addition when a gene encoding class I pilin was moved into the meningococcal strain NMB background there was no evidence of antigenic variation. Finally we investigated several members of the opa gene family of N. gonorrhoeae, where it has been suggested that limited variation occurs. Variation was detected in the opaK gene that is located close to pilE, but not at the opaJ gene located elsewhere on the genome. The approach described here promises to dramatically improve studies of the extent and nature of antigenic variation systems in a variety of species.	[Davies, John K.; Lin, Ya-Hsun; Khoo, Chen Ai; Ryan, Catherine S.] Monash Univ, Dept Microbiol, Clayton, Vic 3168, Australia; [Harrison, Paul F.; Seemann, Torsten] Monash Univ, Victorian Bioinformat Consortium, Clayton, Vic, Australia; [Bartley, Stephanie; Kahler, Charlene M.] Univ Western Australia, Sch Pathol & Lab Med, Nedlands, WA 6009, Australia; [Kahler, Charlene M.] Univ Western Australia, Marshall Ctr Infect Dis Res & Training, Nedlands, WA 6009, Australia; [Kahler, Charlene M.] Univ Western Australia, Telethon Inst Child Hlth Res, Nedlands, WA 6009, Australia; [Hill, Stuart A.] No Illinois Univ, Dept Biol Sci, De Kalb, IL 60115 USA	Monash University; Monash University; University of Western Australia; University of Western Australia; Telethon Kids Institute; University of Western Australia; Northern Illinois University	Davies, JK (corresponding author), Monash Univ, Dept Microbiol, Clayton, Vic 3168, Australia.	John.Davies@monash.edu	Seemann, Torsten/B-2318-2010; Harrison, Paul/V-6978-2019; Kahler, Charlene M/H-5159-2014	Seemann, Torsten/0000-0001-6046-610X; Harrison, Paul/0000-0002-3980-268X; Kahler, Charlene M/0000-0003-4322-3055	National Institutes of Health [1R15 AI072720-01A1]; Australian National Health and Medical Research Council [546003, 546004]; Amanda Young Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R15AI072720] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Amanda Young Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported by National Institutes of Health (www.nih.gov) grant number 1R15 AI072720-01A1] to SAH, and grants (546003 and 546004) from the Australian National Health and Medical Research Council (www.nhmrc.gov.au) to JKD and CMK. SB was supported by a PhD scholarship from the Amanda Young Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartley SN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055798; BHAT KS, 1991, MOL MICROBIOL, V5, P1889, DOI 10.1111/j.1365-2958.1991.tb00813.x; Bilek N, 2009, J BACTERIOL, V191, P1878, DOI 10.1128/JB.01518-08; Cahoon LA, 2009, SCIENCE, V325, P764, DOI 10.1126/science.1175653; Coutte L, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000293; Criss AK, 2005, MOL MICROBIOL, V58, P510, DOI 10.1111/j.1365-2958.2005.04838.x; FYFE JAM, 1995, J BACTERIOL, V177, P3781, DOI 10.1128/jb.177.13.3781-3787.1995; HAAS R, 1992, MOL MICROBIOL, V6, P197, DOI 10.1111/j.1365-2958.1992.tb02001.x; Hamrick TS, 2001, MICROBIOL-UK, V147, P839, DOI 10.1099/00221287-147-4-839; Helm RA, 2010, J BACTERIOL, V192, P3822, DOI 10.1128/JB.00280-10; Helm RA, 2009, J BACTERIOL, V191, P5613, DOI 10.1128/JB.00535-09; Hobbs MM, 1998, MICROBIOL-UK, V144, P157, DOI 10.1099/00221287-144-1-157; HOBBS MM, 1994, MOL MICROBIOL, V12, P171, DOI 10.1111/j.1365-2958.1994.tb01006.x; KOOMEY M, 1987, GENETICS, V117, P391; Meeus PFM, 2003, MOL MICROBIOL, V47, P633, DOI 10.1046/j.1365-2958.2003.03331.x; Noormohammadi AH, 2000, MOL MICROBIOL, V35, P911, DOI 10.1046/j.1365-2958.2000.01766.x; Pevzner PA, 2001, P NATL ACAD SCI USA, V98, P9748, DOI 10.1073/pnas.171285098; Rohrer MS, 2005, NUCLEIC ACIDS RES, V33, P3363, DOI 10.1093/nar/gki650; Seifert HS, 1997, GENE, V188, P215, DOI 10.1016/S0378-1119(96)00810-4; Virji M, 2009, NAT REV MICROBIOL, V7, P274, DOI 10.1038/nrmicro2097; WAINWRIGHT LA, 1994, MOL MICROBIOL, V13, P75, DOI 10.1111/j.1365-2958.1994.tb00403.x; Zhang JR, 1997, CELL, V89, P275, DOI 10.1016/S0092-8674(00)80206-8	22	11	11	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2014	9	1							e86704	10.1371/journal.pone.0086704	http://dx.doi.org/10.1371/journal.pone.0086704			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297VL	24466206	Green Published, Green Submitted, gold			2022-12-25	WOS:000330283100200
J	Graham, AN; Kalitsis, P				Graham, Alison N.; Kalitsis, Paul			Chromosome Y Centromere Array Deletion Leads to Impaired Centromere Function	PLOS ONE			English	Article							ALPHA-SATELLITE ARRAY; CENP-A; MOUSE; DNA; MICRONUCLEI; MUTATIONS; PROTEINS; IDENTITY	The centromere is an essential chromosomal structure that is required for the faithful distribution of replicated chromosomes to daughter cells. Defects in the centromere can compromise the stability of chromosomes resulting in segregation errors. We have characterised the centromeric structure of the spontaneous mutant mouse strain, BALB/cWt, which exhibits a high rate of Y chromosome instability. The Y centromere DNA array shows a de novo interstitial deletion and a reduction in the level of the foundation centromere protein, CENP-A, when compared to the non-deleted centromere array in the progenitor strain. These results suggest there is a lower threshold limit of centromere size that ensures full kinetochore function during cell division.	[Graham, Alison N.; Kalitsis, Paul] Murdoch Childrens Res Inst, Melbourne, Vic, Australia; [Kalitsis, Paul] Univ Melbourne, Dept Paediat, Melbourne, Vic, Australia	Murdoch Children's Research Institute; University of Melbourne	Kalitsis, P (corresponding author), Murdoch Childrens Res Inst, Melbourne, Vic, Australia.	paul.kalitsis@mcri.edu.au	Kalitsis, Paul/C-1916-2015	Kalitsis, Paul/0000-0001-5569-0609	National Health and Medical Research Council of Australia [APP1010884]; Victorian Government's Operational Infrastructure Support Program	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Victorian Government's Operational Infrastructure Support Program	This work was supported by National Health and Medical Research Council of Australia, project grant APP1010884 and by the Victorian Government's Operational Infrastructure Support Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abruzzo MA, 1996, HUM GENET, V97, P819; Amor DJ, 2004, TRENDS CELL BIOL, V14, P359, DOI 10.1016/j.tcb.2004.05.009; Amor DJ, 2004, P NATL ACAD SCI USA, V101, P6542, DOI 10.1073/pnas.0308637101; Beamer W G, 1978, Basic Life Sci, V12, P195; Bean CJ, 2001, HUM MOL GENET, V10, P963, DOI 10.1093/hmg/10.9.963; Blower MD, 2002, DEV CELL, V2, P319, DOI 10.1016/S1534-5807(02)00135-1; Catalan J, 1998, AM J HUM GENET, V63, P1464, DOI 10.1086/302092; Chan FL, 2012, P NATL ACAD SCI USA, V109, P1979, DOI 10.1073/pnas.1108705109; Courtois A, 2012, J CELL BIOL, V198, P357, DOI 10.1083/jcb.201202135; De Rop V, 2012, CHROMOSOMA, V121, P527, DOI 10.1007/s00412-012-0386-5; EICHER EM, 1980, CYTOGENET CELL GENET, V28, P104, DOI 10.1159/000131518; Fachinetti D, 2013, NAT CELL BIOL, V15, P1056, DOI 10.1038/ncb2805; GAUDET A, 1987, MOL CELL BIOL, V7, P68, DOI 10.1128/MCB.7.1.68; GRIFFIN DK, 1995, HUM MOL GENET, V4, P2227, DOI 10.1093/hmg/4.12.2227; Hasson D, 2011, CHROMOSOMA, V120, P621, DOI 10.1007/s00412-011-0337-6; HEGEMANN JH, 1986, MOL GEN GENET, V205, P305, DOI 10.1007/BF00430443; Hori T, 2012, CHROMOSOME RES, V20, P547, DOI 10.1007/s10577-012-9289-9; Hunt PA, 2008, CHROMOSOME RES, V16, P623, DOI 10.1007/s10577-008-1216-8; Hunt PA, 2008, TRENDS GENET, V24, P86, DOI 10.1016/j.tig.2007.11.010; Irvine DV, 2004, CHROMOSOME RES, V12, P805, DOI 10.1007/s10577-005-5377-4; Kalitsis P, 2005, GENE CHROMOSOME CANC, V44, P29, DOI 10.1002/gcc.20215; Kalitsis P, 2006, P NATL ACAD SCI USA, V103, P8786, DOI 10.1073/pnas.0600250103; Kalitsis P, 2012, CHROMOSOMA, V121, P327, DOI 10.1007/s00412-012-0369-6; KIPLING D, 1991, GENOMICS, V11, P235, DOI 10.1016/0888-7543(91)90128-2; Lo AWI, 1999, GENOME RES, V9, P895, DOI 10.1101/gr.9.10.895; Mann J.R., 2001, METH MOL B, V181, P21; Marshall OJ, 2008, AM J HUM GENET, V82, P261, DOI 10.1016/j.ajhg.2007.11.009; NATH J, 1995, CHROMOSOMA, V103, P725, DOI 10.1007/s004120050085; OAKEY R, 1990, GENOMICS, V7, P325, DOI 10.1016/0888-7543(90)90165-Q; PANZERI L, 1985, EMBO J, V4, P1867, DOI 10.1002/j.1460-2075.1985.tb03862.x; Perpelescu M, 2011, CHROMOSOMA, V120, P425, DOI 10.1007/s00412-011-0330-0; Pertile MD, 2009, GENOME RES, V19, P2202, DOI 10.1101/gr.092080.109; Santaguida S, 2009, EMBO J, V28, P2511, DOI 10.1038/emboj.2009.173; SCHATTEN G, 1985, P NATL ACAD SCI USA, V82, P4152, DOI 10.1073/pnas.82.12.4152; Shang WH, 2013, DEV CELL, V24, P635, DOI 10.1016/j.devcel.2013.02.009; Shang WH, 2010, GENOME RES, V20, P1219, DOI 10.1101/gr.106245.110; SPENCER F, 1992, P NATL ACAD SCI USA, V89, P8908, DOI 10.1073/pnas.89.19.8908; Tyler-Smith C, 1999, AM J HUM GENET, V64, P1440, DOI 10.1086/302380; WHITTEN WK, 1971, SCIENCE, V171, P406, DOI 10.1126/science.171.3969.406; Xue ZG, 2013, NATURE, V500, P593, DOI 10.1038/nature12364; Zeng K, 2004, CHROMOSOMA, V113, P84, DOI 10.1007/s00412-004-0299-z; ZINKOWSKI RP, 1991, J CELL BIOL, V113, P1091, DOI 10.1083/jcb.113.5.1091	42	1	1	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2014	9	1							e86875	10.1371/journal.pone.0086875	http://dx.doi.org/10.1371/journal.pone.0086875			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297VL	24466276	Green Published, gold			2022-12-25	WOS:000330283100229
J	Liu, FF; Wu, X; Zhang, Y; Wang, Y; Jiang, F				Liu, Fang Fang; Wu, Xiao; Zhang, Yun; Wang, Yan; Jiang, Fan			TRAIL/DR5 Signaling Promotes Macrophage Foam Cell Formation by Modulating Scavenger Receptor Expression	PLOS ONE			English	Article							SMOOTH-MUSCLE-CELLS; APOPTOSIS-INDUCING LIGAND; NECROSIS-FACTOR-ALPHA; REGULATE SR-A; NF-KAPPA-B; ENDOTHELIAL-CELLS; SOLUBLE TRAIL; P38 MAPK; ATHEROSCLEROSIS; PROLIFERATION	Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL/Apo2L) has been shown to have protective effects against atherosclerosis. However, whether TRAIL has any effects on expression of macrophage scavenger receptors and lipid uptake has not yet been studied. Macrophage lines RAW264.7 and THP-1, and mouse primary peritoneal macrophages, were cultured in vitro and treated with recombinant human TRAIL. Real-time PCR and western blot were performed to measure mRNA and protein expressions. Foam cell formation was assessed by internalization of acetylated and oxidized low-density lipoproteins (LDL). Apoptosis was measured by terminal deoxynucleotidyl transferase-mediated dUTP nick end labeling. We found that TRAIL treatment increased expression of scavenger receptor (SR)-AI and SR-BI in a time- and dose-dependent manner, and this effect was accompanied by increased foam cell formation. These effects of TRAIL were abolished by a TRAIL neutralizing antibody or in DR5 receptor-deficient macrophages. The increased LDL uptake by TRAIL was blocked by SR-AI gene silencing or the SR-AI inhibitor poly(I:C), while SR-BI blockade with BLT-1 had no effect. TRAIL-induced SR-AI expression was blocked by the inhibitor of p38 mitogen-activated protein kinase, but not by inhibitors of ERK1/2 or JNK. TRAIL also induced apoptosis in macrophages. In contrast to macrophages, TRAIL showed little effects on SR expression or apoptosis in vascular smooth muscle cells. In conclusion, our results demonstrate that TRAIL promotes macrophage lipid uptake via SR-AI upregulation through activation of the p38 pathway.	[Liu, Fang Fang; Wu, Xiao; Zhang, Yun; Jiang, Fan] Shandong Univ, Qilu Hosp, Key Lab Cardiovasc Remodeling & Funct Res, Jinan, Shandong, Peoples R China; [Wang, Yan] Beijing Hosp, Dept Cardiol, Beijing, Peoples R China	Shandong University; Beijing Hospital	Wang, Y (corresponding author), Beijing Hosp, Dept Cardiol, Beijing, Peoples R China.	wywy14598@hotmail.com; fjiang@sdu.edu.cn	Jiang, Fan/B-7753-2013	Jiang, Fan/0000-0001-9466-2192	National 973 Basic Research Program of China [2010CB732605, 2011CB503906]; National Natural Science Foundation of China [81070164, 30900523, 81341013]; National High-Tech Research and Development Program of China [2012AA02A510]; Program of Introducing Talents of Discipline to Universities [B07035]; State Program of National Natural Science Foundation of China for Innovative Research Group [81021001]	National 973 Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National High-Tech Research and Development Program of China(National High Technology Research and Development Program of China); Program of Introducing Talents of Discipline to Universities(Ministry of Education, China - 111 Project); State Program of National Natural Science Foundation of China for Innovative Research Group(National Natural Science Foundation of China (NSFC))	This work was partially supported by the following research grants: the National 973 Basic Research Program of China (2010CB732605 for FJ, 2011CB503906 for YZ); National Natural Science Foundation of China (81070164 for FJ; 30900523 and 81341013 for YW); National High-Tech Research and Development Program of China (2012AA02A510 for YZ); Program of Introducing Talents of Discipline to Universities (B07035 for YZ); and State Program of National Natural Science Foundation of China for Innovative Research Group (81021001 for YZ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bernardi S, 2012, CURR DRUG TARGETS, V13, P1215, DOI 10.2174/138945012802002357; Chen SE, 2007, AM J PHYSIOL-CELL PH, V292, pC1660, DOI 10.1152/ajpcell.00486.2006; Cowburn AS, 2005, BLOOD, V105, P2970, DOI 10.1182/blood-2004-07-2870; de Winther MPJ, 2000, ARTERIOSCL THROM VAS, V20, P290, DOI 10.1161/01.ATV.20.2.290; Di Bartolo BA, 2011, DIABETOLOGIA, V54, P3157, DOI 10.1007/s00125-011-2308-0; Diehl GE, 2004, IMMUNITY, V21, P877, DOI 10.1016/j.immuni.2004.11.008; Doyle SE, 2004, J EXP MED, V199, P81, DOI 10.1084/jem.20031237; FALCONE DJ, 1989, J CELL PHYSIOL, V140, P219, DOI 10.1002/jcp.1041400205; Fitzgerald ML, 2000, J IMMUNOL, V164, P2692, DOI 10.4049/jimmunol.164.5.2692; Greaves DR, 2009, J LIPID RES, V50, pS282, DOI 10.1194/jlr.R800066-JLR200; Guicciardi ME, 2009, FASEB J, V23, P1625, DOI 10.1096/fj.08-111005; Han LH, 2002, WORLD J GASTROENTERO, V8, P1077, DOI 10.3748/wjg.v8.i6.1077; Hashizume M, 2012, EUR J PHARMACOL, V689, P249, DOI 10.1016/j.ejphar.2012.05.035; Hofbauer LC, 2006, RHEUMATOLOGY, V45, P1218, DOI 10.1093/rheumatology/kel108; Horiuchi S, 2003, AMINO ACIDS, V25, P283, DOI 10.1007/s00726-003-0029-5; Hsu HY, 1996, J BIOL CHEM, V271, P7767, DOI 10.1074/jbc.271.13.7767; Jiang F, 2009, BRIT J PHARMACOL, V157, P597, DOI 10.1111/j.1476-5381.2009.00199.x; Kaiser GC, 1997, GASTROENTEROLOGY, V112, P1231, DOI 10.1016/S0016-5085(97)70135-5; Kaplan MJ, 2000, J IMMUNOL, V164, P2897, DOI 10.4049/jimmunol.164.6.2897; Kavurma MM, 2008, BIOCHEM PHARMACOL, V75, P1441, DOI 10.1016/j.bcp.2007.10.020; Kavurma MM, 2008, J BIOL CHEM, V283, P7754, DOI 10.1074/jbc.M706927200; Kimberley FC, 2004, CELL RES, V14, P359, DOI 10.1038/sj.cr.7290236; Li JH, 2003, J IMMUNOL, V171, P1526, DOI 10.4049/jimmunol.171.3.1526; Lub-de Hooge MN, 2005, ANN RHEUM DIS, V64, P854, DOI 10.1136/ard.2004.029058; Lusis AJ, 2000, NATURE, V407, P233, DOI 10.1038/35025203; Marsters SA, 1996, CURR BIOL, V6, P1669, DOI 10.1016/S0960-9822(02)70791-4; McLaren JE, 2010, J IMMUNOL, V184, P5827, DOI 10.4049/jimmunol.0903782; Mietus-Snyder M, 1998, ARTERIOSCL THROM VAS, V18, P1440, DOI 10.1161/01.ATV.18.9.1440; Moore KJ, 2006, ARTERIOSCL THROM VAS, V26, P1702, DOI 10.1161/01.ATV.0000229218.97976.43; Mori K, 2010, THROMB RES, V125, P322, DOI 10.1016/j.thromres.2009.11.024; MOULTON KS, 1994, MOL CELL BIOL, V14, P4408, DOI 10.1128/MCB.14.7.4408; Nikolic D, 2011, BMC IMMUNOL, V12, DOI 10.1186/1471-2172-12-37; Pobezinskaya YL, 2011, J IMMUNOL, V186, P5212, DOI 10.4049/jimmunol.1002374; Sato K, 2006, J EXP MED, V203, P239, DOI 10.1084/jem.20051062; Schaefer U, 2007, FRONT BIOSCI, V12, P3813, DOI 10.2741/2354; Secchiero P, 2003, CIRCULATION, V107, P2250, DOI 10.1161/01.CIR.0000062702.60708.C4; Secchiero P, 2004, CELL MOL LIFE SCI, V61, P1965, DOI 10.1007/s00018-004-4197-6; Secchiero P, 2006, CIRCULATION, V114, P1522, DOI 10.1161/CIRCULATIONAHA.106.643841; Song S, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.103; Spencer DM, 2013, INNATE IMMU IN PRESS; Steinwede K, 2012, J EXP MED, V209, P1937, DOI 10.1084/jem.20120983; Tabas I, 2005, ARTERIOSCL THROM VAS, V25, P2255, DOI 10.1161/01.ATV.0000184783.04864.9f; TSUCHIYA S, 1980, INT J CANCER, V26, P171, DOI 10.1002/ijc.2910260208; van Berkel TJC, 2005, CURR OPIN LIPIDOL, V16, P525, DOI 10.1097/01.mol.0000183943.20277.26; van den Berg JM, 2001, J LEUKOCYTE BIOL, V69, P467; van Leuven SI, 2008, RHEUMATOLOGY, V47, P3, DOI 10.1093/rheumatology/kem202; Wang ZB, 2005, AM J PHYSIOL-HEART C, V288, pH293, DOI 10.1152/ajpheart.00165.2004; Watt V, 2011, ATHEROSCLEROSIS, V215, P348, DOI 10.1016/j.atherosclerosis.2011.01.010; WU H, 1994, MOL CELL BIOL, V14, P2129, DOI 10.1128/MCB.14.3.2129; Xiang Q, 2009, J INT MED RES, V37, P491, DOI 10.1177/147323000903700225; Xu WY, 2007, MOL IMMUNOL, V44, P2315, DOI 10.1016/j.molimm.2006.11.013; Yen ML, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038048; Zhang Xia, 2008, Curr Protoc Immunol, VChapter 14, DOI 10.1002/0471142735.im1401s83	53	13	14	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2014	9	1							e87059	10.1371/journal.pone.0087059	http://dx.doi.org/10.1371/journal.pone.0087059			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297VL	24466325	Green Submitted, Green Published, gold			2022-12-25	WOS:000330283100248
J	Syed, K; Shale, K; Pagadala, NS; Tuszynski, J				Syed, Khajamohiddin; Shale, Karabo; Pagadala, Nataraj Sekhar; Tuszynski, Jack			Systematic Identification and Evolutionary Analysis of Catalytically Versatile Cytochrome P450 Monooxygenase Families Enriched in Model Basidiomycete Fungi	PLOS ONE			English	Article							PHANEROCHAETE-CHRYSOSPORIUM; COMPARATIVE GENOMICS; DIFFERENTIAL EXPRESSION; P450 MONOOXYGENASES; GENE; PROTEINS; SEQUENCE; ENZYMES; TRANSCRIPTOME; BIOSYNTHESIS	Genome sequencing of basidiomycetes, a group of fungi capable of degrading/mineralizing plant material, revealed the presence of numerous cytochrome P450 monooxygenases (P450s) in their genomes, with some exceptions. Considering the large repertoire of P450s found in fungi, it is difficult to identify P450s that play an important role in fungal metabolism and the adaptation of fungi to diverse ecological niches. In this study, we followed Sir Charles Darwin's theory of natural selection to identify such P450s in model basidiomycete fungi showing a preference for different types of plant components degradation. Any P450 family comprising a large number of member P450s compared to other P450 families indicates its natural selection over other P450 families by its important role in fungal physiology. Genome-wide comparative P450 analysis in the basidiomycete species, Phanerochaete chrysosporium, Phanerochaete carnosa, Agaricus bisporus, Postia placenta, Ganoderma sp. and Serpula lacrymans, revealed enrichment of 11 P450 families (out of 68 P450 families), CYP63, CYP512, CYP5035, CYP5037, CYP5136, CYP5141, CYP5144, CYP5146, CYP5150, CYP5348 and CYP5359. Phylogenetic analysis of the P450 family showed species-specific alignment of P450s across the P450 families with the exception of P450s of Phanerochaete chrysosporium and Phanerochaete carnosa, suggesting paralogous evolution of P450s in model basidiomycetes. P450 gene-structure analysis revealed high conservation in the size of exons and the location of introns. P450s with the same gene structure were found tandemly arranged in the genomes of selected fungi. This clearly suggests that extensive gene duplications, particularly tandem gene duplications, led to the enrichment of selective P450 families in basidiomycetes. Functional analysis and gene expression profiling data suggest that members of the P450 families are catalytically versatile and possibly involved in fungal colonization of plant material. To our knowledge, this is the first report on the identification and comparative-evolutionary analysis of P450 families enriched in model basidiomycetes.	[Syed, Khajamohiddin; Shale, Karabo] Cent Univ Technol, Fac Hlth & Environm Sci, Dept Life Sci, Bloemfontein, Free State, South Africa; [Pagadala, Nataraj Sekhar] Univ Alberta, Dept Chem Engn, Edmonton, AB, Canada; [Tuszynski, Jack] Univ Alberta, Dept Phys, Edmonton, AB, Canada	Central University of Technology; University of Alberta; University of Alberta	Syed, K (corresponding author), Cent Univ Technol, Fac Hlth & Environm Sci, Dept Life Sci, Bloemfontein, Free State, South Africa.	khajamohiddinsyed@gmail.com	Syed, Khajamohiddin/L-8774-2013; Tuszynski, Jack/AAA-2073-2020	Syed, Khajamohiddin/0000-0002-1497-3570; Tuszynski, Jack/0000-0001-9976-0429	Central University of Technology (CUT) from the University Research and Innovation fund; Medical Research Council (MRC) of South Africa; Natural Sciences and Engineering Research Council of Canada (NSERC)	Central University of Technology (CUT) from the University Research and Innovation fund; Medical Research Council (MRC) of South Africa(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC))	Syed thanks the Central University of Technology (CUT) for a grant from the University Research and Innovation fund. Shale thanks the Medical Research Council (MRC) of South Africa. Pagadala and Tuszynski are thankful to Natural Sciences and Engineering Research Council of Canada (NSERC) for providing research support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bernhardt R, 2006, J BIOTECHNOL, V124, P128, DOI 10.1016/j.jbiotec.2006.01.026; Binder M, 2013, MYCOLOGIA, V105, P1350, DOI 10.3852/13-003; Butchko RAE, 2006, J AGR FOOD CHEM, V54, P9398, DOI 10.1021/jf0617869; Chen SL, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1923; Chigu NL, 2010, APPL MICROBIOL BIOT, V87, P1907, DOI 10.1007/s00253-010-2616-1; Cresnar B, 2011, BBA-PROTEINS PROTEOM, V1814, P29, DOI 10.1016/j.bbapap.2010.06.020; Doddapaneni H, 2005, MOL GENET GENOMICS, V274, P454, DOI 10.1007/s00438-005-0051-2; Eastwood DC, 2011, SCIENCE, V333, P762, DOI 10.1126/science.1205411; Fernandez-Fueyo E, 2012, P NATL ACAD SCI USA, V109, P5458, DOI 10.1073/pnas.1119912109; Floudas D, 2012, SCIENCE, V336, P1715, DOI 10.1126/science.1221748; Grigoriev I. V., 2011, Mycology - An International Journal on Fungal Biology, V2, P192; Guengerich FP, 2006, AAPS J, V8, pE101, DOI 10.1208/aapsj080112; Guengerich FP, 1995, ENVIRON HEALTH PERSP, V103, P25, DOI 10.2307/3432473; Guengerich FP, 2002, NAT REV DRUG DISCOV, V1, P359, DOI 10.1038/nrd792; Hirosue S, 2011, BIOCHEM BIOPH RES CO, V407, P118, DOI 10.1016/j.bbrc.2011.02.121; Hlavica P, 2013, BBA-PROTEINS PROTEOM, V1834, P205, DOI 10.1016/j.bbapap.2012.09.012; Ichinose H, 2012, ARCH BIOCHEM BIOPHYS, V518, P8, DOI 10.1016/j.abb.2011.12.010; Ide M, 2012, ARCH MICROBIOL, V194, P243, DOI 10.1007/s00203-011-0753-2; Kasai N, 2010, APPL MICROBIOL BIOT, V86, P773, DOI 10.1007/s00253-009-2413-x; Kasai N, 2010, J BIOCHEM, V147, P117, DOI 10.1093/jb/mvp155; Kelly SL, 1997, J BIOL CHEM, V272, P9986, DOI 10.1074/jbc.272.15.9986; Kelly SL, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0476; Kimura M, 2007, BIOSCI BIOTECH BIOCH, V71, P2105, DOI 10.1271/bbb.70183; Lepesheva GI, 2004, MOL CELL ENDOCRINOL, V215, P165, DOI 10.1016/j.mce.2003.11.016; Loftus BJ, 2005, SCIENCE, V307, P1321, DOI 10.1126/science.1103773; MacDonald J, 2011, APPL ENVIRON MICROB, V77, P3211, DOI 10.1128/AEM.02490-10; Martinez AT, 2005, INT MICROBIOL, V8, P195; Martinez D, 2004, NAT BIOTECHNOL, V22, P695, DOI 10.1038/nbt967; Martinez D, 2009, P NATL ACAD SCI USA, V106, P1954, DOI 10.1073/pnas.0809575106; Melo NR, 2008, ANTIMICROB AGENTS CH, V52, P3718, DOI 10.1128/AAC.00446-08; Minami M, 2009, BIOSCI BIOTECH BIOCH, V73, P1722, DOI 10.1271/bbb.80870; Moktali V, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-525; Morin E, 2012, P NATL ACAD SCI USA, V109, P17501, DOI 10.1073/pnas.1206847109; Nakayama N, 1996, J BIOCHEM-TOKYO, V119, P435; NEBERT DW, 1987, DNA-J MOLEC CELL BIO, V6, P1, DOI 10.1089/dna.1987.6.1; Nei M., 2000, MOL EVOLUTION PHYLOG; Nelson DR, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0430; Nelson David R., 2009, Human Genomics, V4, P59; Ragauskas AJ, 2006, SCIENCE, V311, P484, DOI 10.1126/science.1114736; Ralph John, 2004, Phytochemistry Reviews, V3, P29, DOI 10.1023/B:PHYT.0000047809.65444.a4; Rojas MC, 2001, P NATL ACAD SCI USA, V98, P5838, DOI 10.1073/pnas.091096298; RZHETSKY A, 1992, MOL BIOL EVOL, V9, P945; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; SANGLARD D, 1989, GENE, V76, P121, DOI 10.1016/0378-1119(89)90014-0; Shary S, 2008, APPL ENVIRON MICROB, V74, P7252, DOI 10.1128/AEM.01997-08; Suzuki H, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-444; Syed K, 2013, MYCOLOGIA, V105, P1445, DOI 10.3852/13-002; Syed K, 2013, APPL ENVIRON MICROB, V79, P2692, DOI 10.1128/AEM.03767-12; Syed K, 2012, CRIT REV MICROBIOL, V38, P339, DOI 10.3109/1040841X.2012.682050; Syed K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028286; Syed K, 2011, ARCH BIOCHEM BIOPHYS, V509, P26, DOI 10.1016/j.abb.2011.02.023; Syed K, 2010, BIOCHEM BIOPH RES CO, V399, P492, DOI 10.1016/j.bbrc.2010.07.094; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Urlacher VB, 2006, TRENDS BIOTECHNOL, V24, P324, DOI 10.1016/j.tibtech.2006.05.002; Vanden Wymelenberg A, 2009, APPL ENVIRON MICROB, V75, P4058, DOI 10.1128/AEM.00314-09; Wen Y, 2005, APPL ENVIRON MICROB, V71, P3192, DOI 10.1128/AEM.71.6.3192-3198.2005; Wymelenberg AV, 2011, APPL ENVIRON MICROB, V77, P4499, DOI 10.1128/AEM.00508-11; ZUCKERKANDL EMILE, 1965, P97	58	71	75	2	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2014	9	1							e86683	10.1371/journal.pone.0086683	http://dx.doi.org/10.1371/journal.pone.0086683			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297VL	24466198	gold, Green Submitted, Green Published			2022-12-25	WOS:000330283100196
J	Yang, X; Bao, YX; Fu, HH; Li, LL; Ren, TH; Yu, XD				Yang, Xin; Bao, YiXiao; Fu, HuanHuan; Li, LuanLuan; Ren, TianHong; Yu, XiaoDan			Selenium Protects Neonates against Neurotoxicity from Prenatal Exposure to Manganese	PLOS ONE			English	Article							BEHAVIORAL NEUROLOGICAL ASSESSMENT; OXIDATIVE STRESS; BLOOD MANGANESE; BRAIN; RAT; MITOCHONDRIA; METABOLISM; STRIATUM; NEWBORNS; INFANTS	Manganese (Mn) exposure can affect brain development. Whether Selenium (Se) can protect neonates against neurotoxicity from Mn exposure remains unclear. We investigated this issue in 933 mother-newborn pairs in Shanghai, China, from 2008 through 2009. Umbilical cord serum concentrations of Mn and Se were measured and Neonatal Behavioral Neurological Assessment (NBNA) tests were conducted. The scores < 37 were defined as the low NBNA. The median concentrations of cord serum Mn and Se were 4.0 mu g/L and 63.1 mu g/L, respectively. After adjusting for potential confounders, the interaction between Se and Mn was observed. Cord blood Mn levels had different effects on NBNA scores stratified by different cord blood Se levels. With Se < P50 (< 63.1 mu g/L), Mn was negatively associated with NBNA scores (adjusted beta = -1.1, 95% CI: -1.3 to -0.9, p < 0.001) and a higher cord blood Mn level increased the risk of low NBNA (adjusted OR = 5.7, 95% CI: 2.8 to 11.5, p < 0.001). However, the adverse effect of Mn was reduced with Se >= P50 (>= 63.1 mu g/L) (NBNA: adjusted beta = 0.1, 95% CI: -0.3 to 0.5, p = 0.746; Low NBNA: adjusted OR = 4.5, 95% CI: 0.4 to 46.7, p = 0.205). Furthermore, the high Mn exposure group with a low Se level [Mn >= P75 (9.1 mu g/L) and Se >= P50 (63.1 mu g/L)] had much lower NBNA scores than that of high Mn exposure group with a high Se level [Mn >= P75 (9.1 mu g/L) and Se >= P50 (63.1 mu g/L)] (38.0+/-1.6 & 39.5+/-0.9, p < 0.001). Mn/Se ratio and NBNA scores were moderately correlated (r = -0.41, p < 0.001). Our findings suggest that Se has a protective effect on neonates' brain development against neurotoxicity from prenatal exposure to Mn. Se supplementation should be considered during pregnancy, especially in areas with low natural Se.	[Yang, Xin; Fu, HuanHuan; Li, LuanLuan; Ren, TianHong; Yu, XiaoDan] Shanghai Jiao Tong Univ, Sch Med, Xinhua Hosp, MOE Shanghai Key Lab Childrens Environm Hlth, Shanghai 200030, Peoples R China; [Bao, YiXiao] Shanghai Jiao Tong Univ, Sch Med, Xinhua Hosp, Dept Pediat, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University	Yu, XD (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Xinhua Hosp, MOE Shanghai Key Lab Childrens Environm Hlth, Shanghai 200030, Peoples R China.	xd_yu2003@126.com			Chinese National Natural Science Foundation [30600496]; Shanghai Committee of Science and Technology, China [114119a1600, 11ZR1429800]	Chinese National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Shanghai Committee of Science and Technology, China(Shanghai Science & Technology Committee)	This study was funded by Chinese National Natural Science Foundation Grant (No. 30600496) and Shanghai Committee of Science and Technology, China (No. 114119a1600 and No. 11ZR1429800). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALI SF, 1995, NEURODEGENERATION, V4, P329, DOI 10.1016/1055-8330(95)90023-3; Avila DS, 2010, TOXICOL SCI, V115, P194, DOI 10.1093/toxsci/kfq036; BAO XL, 1991, CHINESE MED J-PEKING, V104, P742; BAO XL, 1993, CHINESE MED J-PEKING, V106, P211; Canals J, 2011, ACTA PAEDIATR, V100, P1331, DOI 10.1111/j.1651-2227.2011.02306.x; Cordova FM, 2013, ARCH TOXICOL, V87, P1231, DOI 10.1007/s00204-013-1017-5; Cowan DM, 2009, BIOMARKERS, V14, P3, DOI 10.1080/13547500902730672; de Oliveira MR, 2007, BRAIN RES, V1169, P112, DOI 10.1016/j.brainres.2007.07.008; Dobson AW, 2004, ANN NY ACAD SCI, V1012, P115, DOI 10.1196/annals.1306.009; Dokic I, 2012, GLIA, V60, P1785, DOI 10.1002/glia.22397; Drechsel DA, 2010, J BIOL CHEM, V285, P27850, DOI 10.1074/jbc.M110.101196; Dringen R, 2005, J NEUROSCI RES, V79, P157, DOI 10.1002/jnr.20280; Ericson JE, 2007, NEUROTOXICOL TERATOL, V29, P181, DOI 10.1016/j.ntt.2006.09.020; Erikson KM, 2003, NEUROCHEM INT, V43, P475, DOI 10.1016/S0197-0186(03)00037-8; Farias AC, 2010, J CHILD ADOL PSYCHOP, V20, P113, DOI 10.1089/cap.2009.0073; Furbee B, 2011, NEUROL CLIN, V29, P623, DOI 10.1016/j.ncl.2011.05.007; Gao Y, 2007, ENVIRON RES, V105, P390, DOI 10.1016/j.envres.2007.05.015; Haug Anna, 2007, Microbial Ecology in Health and Disease, V19, P209, DOI 10.1080/08910600701698986; Hazell AS, 2006, NEUROSCI LETT, V396, P167, DOI 10.1016/j.neulet.2005.11.064; Iranpour Ramin, 2009, Zhongguo Dang Dai Er Ke Za Zhi, V11, P513; LICCIONE JJ, 1988, J PHARMACOL EXP THER, V247, P156; Lin YY, 2012, ENVIRON RES, V112, P1, DOI 10.1016/j.envres.2011.11.006; dos Santos APM, 2012, TOXICOL APPL PHARM, V258, P394, DOI 10.1016/j.taap.2011.12.003; MARTINEZFINLEY EJ, 2013, FREE RADIC BIOL MED; Pappas BA, 1997, NEUROTOXICOL TERATOL, V19, P17, DOI 10.1016/S0892-0362(96)00185-7; Parajuli RP, 2012, BIOL TRACE ELEM RES, V147, P75, DOI 10.1007/s12011-011-9309-1; Racette BA, 2012, NEUROTOXICOLOGY, V33, P881, DOI 10.1016/j.neuro.2011.12.010; Rossipal E, 2000, ACTA PAEDIATR, V89, P1190, DOI 10.1080/080352500750027556; SLUIS KB, 1992, PEDIATR RES, V32, P189, DOI 10.1203/00006450-199208000-00013; Steinbrenner H, 2006, FREE RADICAL BIO MED, V40, P1513, DOI 10.1016/j.freeradbiomed.2005.12.022; Takser L, 2003, NEUROTOXICOLOGY, V24, P667, DOI 10.1016/S0161-813X(03)00058-5; Urushidate S, 2010, J TRACE ELEM MED BIO, V24, P236, DOI 10.1016/j.jtemb.2010.06.001; Papp LV, 2007, ANTIOXID REDOX SIGN, V9, P775, DOI 10.1089/ars.2007.1528; Wells EM, 2011, ENVIRON RES, V111, P411, DOI 10.1016/j.envres.2010.12.009; Yokel RA, 2009, NEUROMOL MED, V11, P297, DOI 10.1007/s12017-009-8101-2; Yu XD, 2013, ENVIRON RES, V121, P79, DOI 10.1016/j.envres.2012.11.002; Zhang SR, 2004, TOXICOL IN VITRO, V18, P71, DOI 10.1016/j.tiv.2003.09.002; Zwingmann C, 2004, NEUROTOXICOLOGY, V25, P573, DOI 10.1016/j.neuro.2003.08.002	38	24	24	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2014	9	1							e86611	10.1371/journal.pone.0086611	http://dx.doi.org/10.1371/journal.pone.0086611			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297VL	24466170	Green Published, Green Submitted, gold			2022-12-25	WOS:000330283100188
J	Derraik, JGB; Rademaker, M; Cutfield, WS; Pinto, TE; Tregurtha, S; Faherty, A; Peart, JM; Drury, PL; Hofman, PL				Derraik, Jose G. B.; Rademaker, Marius; Cutfield, Wayne S.; Pinto, Teresa E.; Tregurtha, Sheryl; Faherty, Ann; Peart, Jane M.; Drury, Paul L.; Hofman, Paul L.			Effects of Age, Gender, BMI, and Anatomical Site on Skin Thickness in Children and Adults with Diabetes	PLOS ONE			English	Article							SUBCUTANEOUS FAT THICKNESS; INTRAMUSCULAR INJECTIONS; ECHOGRAPHIC MEASUREMENT; DIFFERENT REGIONS; ULTRASOUND; NEEDLES; TISSUE; LENGTH; RISK; SEX	Objective: We aimed to assess the effects of age, sex, body mass index (BMI), and anatomical site on skin thickness in children and adults with diabetes. Methods: We studied 103 otherwise healthy children and adolescents with type 1 diabetes aged 5-19 years, and 140 adults with type 1 and type 2 diabetes aged 20-85 years. The thicknesses of both the dermis and subcutis were assessed using ultrasound with a linear array transducer, on abdominal and thigh skin. Results: There was an age-related thickening of both dermis (p < 0.0001) and subcutis (p = 0.013) in children and adolescents. Girls displayed a substantial pubertal increase in subcutis of the thigh (+54%; p = 0.048) and abdomen (+68%; p = 0.009). Adults showed an age-related decrease in dermal (p = 0.021) and subcutis (p = 0.009) thicknesses. Pubertal girls had a thicker subcutis than pubertal boys in both thigh (16.7 vs 7.5 mm; p, 0.0001) and abdomen (16.7 vs 8.8 mm; p < 0.0001). Men had greater thigh dermal thickness than women (1.89 vs 1.65 mm; p = 0.003), while the subcutis was thicker in women in thigh (21.3 vs 17.9 mm; p = 0.012) and abdomen (17.7 vs 9.8 mm; p < 0.0001). In boys, men, and women, both dermis and subcutis were thicker on the abdomen compared to thigh; in girls this was only so for dermal thickness. In both children and adults, the skin (dermis and subcutis) became steadily thicker with increasing BMI (p < 0.0001). Conclusions: Skin thickness is affected by age, pubertal status, gender, BMI, and anatomical site. Such differences may be important when considering appropriate sites for dermal/subcutaneous injections and other transdermal delivery systems.	[Derraik, Jose G. B.; Cutfield, Wayne S.; Pinto, Teresa E.; Hofman, Paul L.] Univ Auckland, Liggins Inst, Auckland 1, New Zealand; [Rademaker, Marius] Waikato Hosp, Dept Dermatol, Hamilton, New Zealand; [Cutfield, Wayne S.; Hofman, Paul L.] Gravida Natl Ctr Growth & Dev, Auckland, New Zealand; [Tregurtha, Sheryl; Faherty, Ann; Drury, Paul L.] Auckland Dist Hlth Board, Auckland Diabet Ctr, Auckland, New Zealand; [Peart, Jane M.] Auckland Radiol Grp, Auckland, New Zealand	University of Auckland; Waikato Hospital; Auckland District Health Board	Derraik, JGB (corresponding author), Univ Auckland, Liggins Inst, Auckland 1, New Zealand.	j.derraik@auckland.ac.nz	Derraik, José Guilherme Behrensdorf/A-1925-2008; Rademaker, Marius/H-5764-2019	Derraik, José Guilherme Behrensdorf/0000-0003-1226-1956; Rademaker, Marius/0000-0003-3393-6748	Novo Nordisk	Novo Nordisk(Novo Nordisk)	This research was supported by an unrestricted grant from Novo Nordisk. The funders had any role in study design, data collection and analysis, decision to publish, or preparation of this manuscript.	Birkebaek NH, 1998, DIABETIC MED, V15, P965, DOI 10.1002/(SICI)1096-9136(1998110)15:11<965::AID-DIA691>3.0.CO;2-Y; BLIZNAK J, 1975, RADIOLOGY, V116, P55, DOI 10.1148/116.1.55; BRANCHET MC, 1990, GERONTOLOGY, V36, P28; Burbridge BE, 2007, CAN ASSOC RADIOL J, V58, P72; COLE TJ, 1995, ARCH DIS CHILD, V73, P25, DOI 10.1136/adc.73.1.25; Gibney MA, 2010, CURR MED RES OPIN, V26, P1519, DOI 10.1185/03007995.2010.481203; Hofman PL, 2007, DIABETIC MED, V24, P1400, DOI 10.1111/j.1464-5491.2007.02272.x; Hofman PL, 2010, DIABETES CARE, V33, P1940, DOI 10.2337/dc10-0871; Kanehisa H, 2004, EUR J APPL PHYSIOL, V91, P534, DOI 10.1007/s00421-003-1034-9; Kivitz A, 2007, EXPERT REV MED DEVIC, V4, P109, DOI 10.1586/17434440.4.2.109; Kretsos K, 2004, J PHARM SCI-US, V93, P2820, DOI 10.1002/jps.20187; Lasagni C, 1995, Skin Res Technol, V1, P81, DOI 10.1111/j.1600-0846.1995.tb00022.x; Laurent A, 2007, VACCINE, V25, P6423, DOI 10.1016/j.vaccine.2007.05.046; Lee Y, 2002, SURG RADIOL ANAT, V24, P183, DOI 10.1007/s00276-002-0034-5; Levakov Aleksandra, 2012, Med Pregl, V65, P191; Lo Presti D, 2012, PEDIATR DIABETES, V13, P525, DOI 10.1111/j.1399-5448.2012.00865.x; Mitragotri S, 2011, INT J PHARMACEUT, V418, P115, DOI 10.1016/j.ijpharm.2011.02.023; Olsen L O, 1995, Skin Res Technol, V1, P74, DOI 10.1111/j.1600-0846.1995.tb00021.x; Petrofsky J.S, 2008, J APPL RES CLIN EXP, V8, P55; Petrofsky JS, 2008, DIABETES TECHNOL THE, V10, P487, DOI 10.1089/dia.2008.0009; Ploin D, 2011, VACCINE, V29, P8438, DOI 10.1016/j.vaccine.2011.07.111; Sandby-Moller J, 2003, ACTA DERM-VENEREOL, V83, P410, DOI 10.1080/00015550310015419; Seidenari S, 2000, DERMATOLOGY, V201, P218, DOI 10.1159/000018491; SHUSTER S, 1975, BRIT J DERMATOL, V93, P639, DOI 10.1111/j.1365-2133.1975.tb05113.x; SJOSTROM L, 1972, METABOLISM, V21, P1143, DOI 10.1016/0026-0495(72)90109-6; Smalls LK, 2006, SKIN RES TECHNOL, V12, P43, DOI 10.1111/j.0909-725X.2006.00135.x; SMITH CP, 1991, ARCH DIS CHILD, V66, P879, DOI 10.1136/adc.66.7.879; TAN CY, 1982, BRIT J DERMATOL, V106, P657, DOI 10.1111/j.1365-2133.1982.tb14702.x; Tubiana-Rufi N, 1999, DIABETES CARE, V22, P1621, DOI 10.2337/diacare.22.10.1621; Van Hattem S, 2008, CLEV CLIN J MED, V75, P772, DOI 10.3949/ccjm.75.11.772; Wilkinson SC, 2006, INT ARCH OCC ENV HEA, V79, P405, DOI 10.1007/s00420-005-0056-5; Winter MD, 2013, J FELINE MED SURG	32	55	61	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2014	9	1							e86637	10.1371/journal.pone.0086637	http://dx.doi.org/10.1371/journal.pone.0086637			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297GT	24466182	Green Submitted, Green Published, gold			2022-12-25	WOS:000330244500267
J	Yin, M; Ren, X; Zhang, X; Luo, Y; Wang, G; Huang, K; Feng, S; Bao, X; Huang, K; He, X; Liang, P; Wang, Z; Tang, H; He, J; Zhang, B				Yin, M.; Ren, X.; Zhang, X.; Luo, Y.; Wang, G.; Huang, K.; Feng, S.; Bao, X.; Huang, K.; He, X.; Liang, P.; Wang, Z.; Tang, H.; He, J.; Zhang, B.			Selective killing of lung cancer cells by miRNA-506 molecule through inhibiting NF-kappa B p65 to evoke reactive oxygen species generation and p53 activation	ONCOGENE			English	Article						miR-506; NF-kappa B p65; ROS; p53; lung cancer; selective killing	OXIDATIVE STRESS; APOPTOSIS; INDUCTION; PATHWAY; MODULATION; CARCINOMA; MICRORNAS; MECHANISM; DAMAGE; REQUIREMENT	The tumor suppressor p53, nuclear factor-kappa B (NF-kappa B) and reactive oxygen species (ROS) have crucial roles in tumorigenesis, although the mechanisms of cross talk between these factors remain largely unknown. Here we report that miR-506 upregulation occurs in 83% of lung cancer patients (156 cases), and its expression highly correlates with ROS. Ectopic expression of miR-506 inhibits NF-kappa B p65 expression, induces ROS accumulation and then activates p53 to suppress lung cancer cell viability, but not in normal cells. Interestingly, p53 promotes miR-506 expression level, indicating that miR-506 mediates cross talk between p53, NF-kappa B p65 and ROS. Furthermore, we demonstrated that miR-506 mimics inhibited tumorigenesis in vivo, implicating that miR-506 might be a potential therapeutic molecule for selective killing of lung cancer cells.	[Yin, M.; Ren, X.; Wang, G.; Bao, X.; Wang, Z.; Zhang, B.] Chinese Acad Sci, Guangzhou Inst Biomed & Hlth, State Key Lab Resp Dis, Guangzhou 510530, Guangdong, Peoples R China; [Yin, M.; Ren, X.; He, X.; Zhang, B.] Univ Sci & Technol China, Sch Life Sci, Hefei 230026, Peoples R China; [Zhang, X.; Tang, H.; He, J.] Guangzhou Med Univ, Affiliated Hosp 1, Dept Cardiothorac Surg, Guangzhou, Guangdong, Peoples R China; [Luo, Y.; Huang, K.; Feng, S.] Guangzhou RiboBio Co Ltd, Guangzhou, Guangdong, Peoples R China; [Huang, K.; Liang, P.] Univ Chinese Acad Sci, Beijing, Peoples R China	Chinese Academy of Sciences; Guangzhou Institute of Biomedicine & Health, CAS; State Key Laboratory of Respiratory Disease; Chinese Academy of Sciences; University of Science & Technology of China, CAS; Guangzhou Medical University; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Zhang, B (corresponding author), Chinese Acad Sci, Guangzhou Inst Biomed & Hlth, State Key Lab Resp Dis, 190 Kai Yuan Ave,Sci Pk, Guangzhou 510530, Guangdong, Peoples R China.	drjianxing.he@gmail.com; Zhang_biliang@gibh.org			Introduced Innovative R&D Team Program of Guangdong Province [201001Y0104789252]; 863 Program of China [2012AA022501]; Strategic Emerging Industry Key Technology Project of Guangdong Province [2012A080800006]; National Natural Science Foundation of China [30870535, 90913017]; "Hundred Talents Plan" of Guangzhou Municipality; Combination Project of Guangdong Province; "Hundred Talents Plan" of Guangzhou Municipality and Combination Project of Guangdong Province and the Ministry of Education [2011B090400478]	Introduced Innovative R&D Team Program of Guangdong Province; 863 Program of China(National High Technology Research and Development Program of China); Strategic Emerging Industry Key Technology Project of Guangdong Province; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); "Hundred Talents Plan" of Guangzhou Municipality; Combination Project of Guangdong Province; "Hundred Talents Plan" of Guangzhou Municipality and Combination Project of Guangdong Province and the Ministry of Education	We would like to thank Professor Craig Mello for valuable advice throughout this research, Professor Miguel Esteban for manuscripts revision and renal cell line RCC4, Professor Duanqing Pei for the lung cancer cell line 95D. This research was supported by Introduced Innovative R&D Team Program of Guangdong Province (no. 201001Y0104789252), 863 Program of China (no. 2012AA022501), Strategic Emerging Industry Key Technology Project of Guangdong Province (no. 2012A080800006), the National Natural Science Foundation of China (nos. 30870535 and 90913017), the "Hundred Talents Plan" of Guangzhou Municipality and Combination Project of Guangdong Province and the Ministry of Education (no. 2011B090400478).	Adhikary A, 2010, FEBS LETT, V584, P7, DOI 10.1016/j.febslet.2009.10.081; Amin ARMR, 2009, CANCER PREV RES, V2, P538, DOI 10.1158/1940-6207.CAPR-09-0063; Arora H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064273; Banales JM, 2012, J HEPATOL, V56, pS15, DOI 10.1016/S0168-8278(12)60048-8; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Basseres DS, 2006, ONCOGENE, V25, P6817, DOI 10.1038/sj.onc.1209942; Basseres DS, 2010, CANCER RES, V70, P3537, DOI 10.1158/0008-5472.CAN-09-4290; Bommer GT, 2007, CURR BIOL, V17, P1298, DOI 10.1016/j.cub.2007.06.068; Braun CJ, 2008, CANCER RES, V68, P10094, DOI 10.1158/0008-5472.CAN-08-1569; Chaturvedi MM, 2011, ONCOGENE, V30, P1615, DOI 10.1038/onc.2010.566; Cheng YH, 2009, J MOL CELL CARDIOL, V47, P5, DOI 10.1016/j.yjmcc.2009.01.008; Dai Y, 2005, MOL CELL BIOL, V25, P5429, DOI 10.1128/MCB.25.13.5429-5444.2005; Dey A, 2008, BRIT J CANCER, V98, P4, DOI 10.1038/sj.bjc.6604098; Dey A, 2007, CELL CYCLE, V6, P2178, DOI 10.4161/cc.6.17.4643; Dijsselbloem N, 2007, J IMMUNOL, V178, P5048, DOI 10.4049/jimmunol.178.8.5048; Ebi H, 2009, ONCOGENE, V28, P3371, DOI 10.1038/onc.2009.201; Feng SP, 2011, NUCLEIC ACIDS RES, V39, P6669, DOI 10.1093/nar/gkr232; Gurova KV, 2005, P NATL ACAD SCI USA, V102, P17448, DOI 10.1073/pnas.0508888102; Harris SL, 2005, ONCOGENE, V24, P2899, DOI 10.1038/sj.onc.1208615; He L, 2007, NATURE, V447, P1130, DOI 10.1038/nature05939; Hileman EO, 2004, CANCER CHEMOTH PHARM, V53, P209, DOI 10.1007/s00280-003-0726-5; Hsu YL, 2004, LIFE SCI, V75, P2303, DOI 10.1016/j.lfs.2004.04.027; Inui M, 2010, NAT REV MOL CELL BIO, V11, P252, DOI 10.1038/nrm2868; JARUGA P, 1994, FEBS LETT, V341, P59, DOI 10.1016/0014-5793(94)80240-8; Karin M, 2005, NAT REV IMMUNOL, V5, P749, DOI 10.1038/nri1703; Karin M, 2006, NATURE, V441, P431, DOI 10.1038/nature04870; KEYSE SM, 1989, P NATL ACAD SCI USA, V86, P99, DOI 10.1073/pnas.86.1.99; Lavin MF, 2006, CELL DEATH DIFFER, V13, P941, DOI 10.1038/sj.cdd.4401925; Li F, 2010, BBA-REV CANCER, V1805, P167, DOI 10.1016/j.bbcan.2010.01.002; LINZER DIH, 1979, CELL, V17, P43, DOI 10.1016/0092-8674(79)90293-9; Liu G, 2009, J IMMUNOL, V182, P5063, DOI 10.4049/jimmunol.0803526; Mateescu B, 2011, NAT MED, V17, P1627, DOI 10.1038/nm.2512; Mates JM, 2000, INT J BIOCHEM CELL B, V32, P157, DOI 10.1016/S1357-2725(99)00088-6; Meylan E, 2009, NATURE, V462, P104, DOI 10.1038/nature08462; Montero AJ, 2011, DRUGS, V71, P1385, DOI 10.2165/11592590-000000000-00000; Pelicano H, 2004, DRUG RESIST UPDATE, V7, P97, DOI 10.1016/j.drup.2004.01.004; Perkins ND, 2007, NAT REV MOL CELL BIO, V8, P49, DOI 10.1038/nrm2083; Perkins ND, 2012, NAT REV CANCER, V12, P121, DOI 10.1038/nrc3204; Raj L, 2011, NATURE, V475, P231, DOI 10.1038/nature10167; Ramalingam SS, 2011, CA-CANCER J CLIN, V61, P91, DOI 10.3322/caac.20102; Sethi G, 2008, EXP BIOL MED, V233, P21, DOI 10.3181/0707-MR-196; Streicher KL, 2012, ONCOGENE, V31, P1558, DOI 10.1038/onc.2011.345; Suzuki HI, 2009, NATURE, V460, P529, DOI 10.1038/nature08199; Tang XM, 2006, CANCER, V107, P2637, DOI 10.1002/cncr.22315; Tazawa H, 2007, P NATL ACAD SCI USA, V104, P15472, DOI 10.1073/pnas.0707351104; TOYOKUNI S, 1995, FEBS LETT, V358, P1, DOI 10.1016/0014-5793(94)01368-B; Trachootham D, 2006, CANCER CELL, V10, P241, DOI 10.1016/j.ccr.2006.08.009; Trachootham D, 2009, NAT REV DRUG DISCOV, V8, P579, DOI 10.1038/nrd2803; Vazquez A, 2008, NAT REV DRUG DISCOV, V7, P979, DOI 10.1038/nrd2656; Vidya Priyadarsini R, 2010, Eur J Pharmacol, V649, P84, DOI 10.1016/j.ejphar.2010.09.020; Visconti R, 2009, IDRUGS, V12, P240; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Wang CY, 1998, SCIENCE, V281, P1680, DOI 10.1126/science.281.5383.1680; Weinstein IB, 2002, SCIENCE, V297, P63, DOI 10.1126/science.1073096; Yamakuchi M, 2010, P NATL ACAD SCI USA, V107, P6334, DOI 10.1073/pnas.0911082107; Yang D, 2013, CANCER CELL, V23, P705, DOI 10.1016/j.ccr.2013.04.029; Zhang R, 2007, GENOME RES, V17, P612, DOI 10.1101/gr.6146507	58	73	79	2	5	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB 5	2015	34	6					691	703		10.1038/onc.2013.597	http://dx.doi.org/10.1038/onc.2013.597			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CA4DG	24469051				2022-12-25	WOS:000348853800003
J	Sahasrabuddhe, AA; Chen, X; Chung, F; Velusamy, T; Lim, MS; Elenitoba-Johnson, KSJ				Sahasrabuddhe, A. A.; Chen, X.; Chung, F.; Velusamy, T.; Lim, M. S.; Elenitoba-Johnson, K. S. J.			Oncogenic Y641 mutations in EZH2 prevent Jak2/beta-TrCP-mediated degradation	ONCOGENE			English	Article						EZH2; SCF beta-TrCP ubiquitin ligase; protein degradation; lymphoma	POLYCOMB GROUP PROTEINS; BETA-TRCP; UBIQUITIN LIGASES; MOUSE DEVELOPMENT; STEM-CELLS; CANCER; LYMPHOMA; COMPLEX; BINDING; METHYLATION	EZH2 (enhancer of zeste homolog 2) is a critical enzymatic subunit of the polycomb repressive complex 2 (PRC2), which trimethylates histone H3 (H3K27) to mediate gene repression. Somatic mutations, overexpression and hyperactivation of EZH2 have been implicated in the pathogenesis of several forms of cancer. In particular, recurrent gain-of-function mutations targeting EZH2 Y641 occur most frequently in follicular lymphoma and aggressive diffuse large B-cell lymphoma and are associated with H3K27me3 hyperactivation, which contributes to lymphoma pathogenesis. However, the post-translational mechanisms of EZH2 regulation are not completely understood. Here we show that EZH2 is a novel interactor and substrate of the SCF E3 ubiquitin ligase beta-TrCP (FBXW1). beta-TrCP ubiquitinates EZH2 and Jak2-mediated phosphorylation on Y641 directs beta-TrCP-mediated EZH2 degradation. RNA interference-mediated silencing of beta-TrCP or inhibition of Jak2 results in EZH2 stabilization with attendant increase in H3K27 trimethylation activity. Importantly, the EZH2(Y641) mutants recurrently implicated in lymphoma pathogenesis are unable to bind beta-TrCP. Further, endogenous EZH2(Y641) mutants in lymphoma cells exhibit increased EZH2 stability and H3K27me3 hyperactivity. Our studies demonstrate that beta-TrCP has an important role in controlling H3K27 trimethylation activity and lymphoma pathogenesis by targeting EZH2 for degradation.	[Sahasrabuddhe, A. A.; Chen, X.; Chung, F.; Velusamy, T.; Lim, M. S.; Elenitoba-Johnson, K. S. J.] Univ Michigan, Sch Med, Dept Pathol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Elenitoba-Johnson, KSJ (corresponding author), Univ Michigan, Dept Pathol, 2037 BSRB,109 Zina Pitcher Pl, Ann Arbor, MI 48109 USA.	kojoelen@umich.edu		Elenitoba-Johnson, Kojo/0000-0002-1082-1545; Lim, Megan/0000-0002-0415-2867; Sahasrabuddhe, Anagh/0000-0002-3040-0019	NIH [R01 DE119249, R01 CA136905, R01 CA140806]; NATIONAL CANCER INSTITUTE [R01CA136905, R01CA140806] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by NIH Grants R01 DE119249, and R01 CA136905 to KSJ E-J, R01 CA140806 to MSL.	Argetsinger LS, 2004, MOL CELL BIOL, V24, P4955, DOI 10.1128/MCB.24.11.4955-4967.2004; Beguelin W, 2013, CANCER CELL, V23, P677, DOI 10.1016/j.ccr.2013.04.011; Bodor C, 2013, BLOOD, V122, P3165, DOI 10.1182/blood-2013-04-496893; Chen H, 2013, MOL CELL BIOL, V33, P1139, DOI 10.1128/MCB.01191-12; Ciferri C, 2012, ELIFE, V1, DOI 10.7554/eLife.00005; Dimri M, 2010, CARCINOGENESIS, V31, P489, DOI 10.1093/carcin/bgp305; Emanuele MJ, 2011, CELL, V147, P459, DOI 10.1016/j.cell.2011.09.019; Erhardt S, 2003, DEVELOPMENT, V130, P4235, DOI 10.1242/dev.00625; Frescas D, 2008, NAT REV CANCER, V8, P438, DOI 10.1038/nrc2396; Kaneko S, 2010, GENE DEV, V24, P2615, DOI 10.1101/gad.1983810; Knutson SK, 2013, P NATL ACAD SCI USA, V110, P7922, DOI 10.1073/pnas.1303800110; Knutson SK, 2012, NAT CHEM BIOL, V8, P890, DOI [10.1038/NCHEMBIO.1084, 10.1038/nchembio.1084]; Kotake Y, 2007, GENE DEV, V21, P49, DOI 10.1101/gad.1499407; Liu H, 2007, GENE DEV, V21, P2385, DOI 10.1101/gad.1574507; Margueron R, 2011, NATURE, V469, P343, DOI 10.1038/nature09784; Martin-Perez D, 2010, BLOOD, V116, P5465, DOI 10.1182/blood-2010-05-267096; McCabe MT, 2012, NATURE, V492, P108, DOI 10.1038/nature11606; Mills AA, 2010, NAT REV CANCER, V10, P669, DOI 10.1038/nrc2931; Morey L, 2010, TRENDS BIOCHEM SCI, V35, P323, DOI 10.1016/j.tibs.2010.02.009; Morin RD, 2010, NAT GENET, V42, P181, DOI 10.1038/ng.518; Nakayama KI, 2006, NAT REV CANCER, V6, P369, DOI 10.1038/nrc1881; Pasini D, 2004, EMBO J, V23, P4061, DOI 10.1038/sj.emboj.7600402; Petroski MD, 2005, NAT REV MOL CELL BIO, V6, P9, DOI 10.1038/nrm1547; Piunti A, 2011, FUTURE ONCOL, V7, P57, DOI 10.2217/FON.10.157; Popovic R, 2013, THER ADV HEMATOL, V4, P81, DOI 10.1177/2040620712466864; Richly H, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.84; Sahasrabuddhe AA, 2011, CELL CYCLE, V10, P1322, DOI 10.4161/cc.10.8.15372; Sauvageau M, 2010, CELL STEM CELL, V7, P299, DOI 10.1016/j.stem.2010.08.002; Simon JA, 2013, MOL CELL, V49, P808, DOI 10.1016/j.molcel.2013.02.013; Simon JA, 2009, NAT REV MOL CELL BIO, V10, P697, DOI 10.1038/nrm2763; Soucy TA, 2009, NATURE, V458, P732, DOI 10.1038/nature07884; Surface LE, 2010, CELL STEM CELL, V7, P288, DOI 10.1016/j.stem.2010.08.004; Tan MKM, 2011, MOL CELL BIOL, V31, P3687, DOI 10.1128/MCB.05746-11; Velichutina I, 2010, BLOOD, V116, P5247, DOI 10.1182/blood-2010-04-280149; Velusamy T, 2013, P NATL ACAD SCI USA, V110, P3035, DOI 10.1073/pnas.1214326110; Wu G, 2003, MOL CELL, V11, P1445, DOI 10.1016/S1097-2765(03)00234-X; Yadav AK, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-158; Yu YL, 2013, EMBO MOL MED, V5, P531, DOI 10.1002/emmm.201201783; Zoabi M, 2011, BIOCHEM BIOPH RES CO, V408, P393, DOI 10.1016/j.bbrc.2011.04.025	39	63	64	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 22	2015	34	4					445	454		10.1038/onc.2013.571	http://dx.doi.org/10.1038/onc.2013.571			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AZ8FU	24469040				2022-12-25	WOS:000348451300005
J	Lemmin, T; Dimitrov, M; Fraering, PC; Dal Peraro, M				Lemmin, Thomas; Dimitrov, Mitko; Fraering, Patrick C.; Dal Peraro, Matteo			Perturbations of the Straight Transmembrane alpha-Helical Structure of the Amyloid Precursor Protein Affect Its Processing by gamma-Secretase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Amyloid; Amyloid Precursor Protein; Mass Spectrometry (MS); Molecular Dynamics; Secretases; electron paramagnetic resonance (EPR) spectroscopy; double electron-electron resonance (DEER); metadynamics	MOLECULAR-DYNAMICS SIMULATION; ALZHEIMERS-DISEASE; DISTANCE MEASUREMENTS; FIBRIL FORMATION; GXXXG MOTIF; MEMBRANE; DOMAIN; CHOLESTEROL; RESONANCE; PEPTIDE	Background: Amyloid- neurotoxicity depends on the specificity of the proteolytic cleavage of the amyloid precursor protein (APP) transmembrane domain. Results: The APP transmembrane -helix is straight in a biological membrane bilayer. Conclusion: The flexibility of APP is key for adapting to the lipid environment and modulating proteolytic processing by -secretase. Significance: The dynamic characterization of APP is expected to rationalize the design of -secretase modulators. The amyloid precursor protein (APP) is a widely expressed type I transmembrane (TM) glycoprotein present at the neuronal synapse. The proteolytic cleavage by -secretase of its C-terminal fragment produces amyloid- (A) peptides of different lengths, the deposition of which is an early indicator of Alzheimer disease. At present, there is no consensus on the conformation of the APP-TM domain at the biological membrane. Although structures have been determined by NMR in detergent micelles, their conformation is markedly different. Here we show by using molecular simulations that the APP-TM region systematically prefers a straight -helical conformation once embedded in a membrane bilayer. However, APP-TM is highly flexible, and its secondary structure is strongly influenced by the surrounding lipid environment, as when enclosed in detergent micelles. This behavior is confirmed when analyzing in silico the atomistic APP-TM population observed by residual dipolar couplings and double electron-electron resonance spectroscopy. These structural and dynamic features are critical in the proteolytic processing of APP by the -secretase enzyme, as suggested by a series of Gly(700) mutants. Affecting the hydration and flexibility of APP-TM, these mutants invariantly show an increase in the production of A38 compared with A40 peptides, which is reminiscent of the effect of -secretase modulators inhibitors.	[Lemmin, Thomas; Dal Peraro, Matteo] Ecole Polytech Fed Lausanne, Inst Bioengn, Sch Life Sci, CH-1015 Lausanne, Switzerland; [Dimitrov, Mitko; Fraering, Patrick C.] Ecole Polytech Fed Lausanne, Brain Mind Inst, Sch Life Sci, CH-1015 Lausanne, Switzerland; [Lemmin, Thomas; Dal Peraro, Matteo] Swiss Inst Bioinformat, CH-1015 Lausanne, Switzerland	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Institute of Bioinformatics	Dal Peraro, M (corresponding author), Ecole Polytech Fed Lausanne, EPFL SV IBI LBM, AAB010 Stn 19, CH-1015 Lausanne, Switzerland.	matteo.dalperaro@epfl.ch	Lemmin, Thomas/AAO-7849-2021	Lemmin, Thomas/0000-0001-5705-4964; Fraering, Patrick/0000-0002-5841-5327	Swiss National Science Foundation [200020_138013, 31003A_134938/1]; Swiss National Centres of Competence in Research, Neural Plasticity, and Repair; Strauss Foundation	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Swiss National Centres of Competence in Research, Neural Plasticity, and Repair; Strauss Foundation	This work was supported by Swiss National Science Foundation Grants 200020_138013 (to M. D. P.) and 31003A_134938/1 (to P. C. F.) and by funds from the Swiss National Centres of Competence in Research, Neural Plasticity, and Repair (to P. C. F.) and the Strauss Foundation (to P. C. F.).	Alattia JR, 2013, BIOTECHNOL BIOENG, V110, P1995, DOI 10.1002/bit.24851; Alattia JR, 2011, FASEB J, V25, P2287, DOI 10.1096/fj.10-174078; Barnham KJ, 2003, J BIOL CHEM, V278, P17401, DOI 10.1074/jbc.M300629200; Barrett PJ, 2012, SCIENCE, V336, P1168, DOI 10.1126/science.1219988; Beel AJ, 2008, BIOCHEMISTRY-US, V47, P9428, DOI 10.1021/bi800993c; Bokvist M, 2004, J MOL BIOL, V335, P1039, DOI 10.1016/j.jmb.2003.11.046; Brooks BR, 2009, J COMPUT CHEM, V30, P1545, DOI 10.1002/jcc.21287; BRUNGER A, 1984, CHEM PHYS LETT, V105, P495, DOI 10.1016/0009-2614(84)80098-6; Buchet R, 2000, ACTA BIOCHIM POL, V47, P725, DOI 10.18388/abp.2000_3991; Cacquevel M, 2008, J NEUROCHEM, V104, P210, DOI 10.1111/j.1471-4159.2007.05041.x; COTMAN C, 1969, BIOCHEMISTRY-US, V8, P4606, DOI 10.1021/bi00839a056; Degiacomi MT, 2013, STRUCTURE, V21, P1097, DOI 10.1016/j.str.2013.05.014; Dimitrov M, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3246; FELLER SE, 1995, J CHEM PHYS, V103, P4613, DOI 10.1063/1.470648; Frazier AA, 2002, BIOCHEMISTRY-US, V41, P6282, DOI 10.1021/bi0160821; Georgieva ER, 2008, J AM CHEM SOC, V130, P12856, DOI 10.1021/ja804517m; GRUBMULLER H, 1995, PHYS REV E, V52, P2893, DOI 10.1103/PhysRevE.52.2893; Hagelueken G, 2012, APPL MAGN RESON, V42, P377, DOI 10.1007/s00723-012-0314-0; Hatmal MM, 2012, BIOPOLYMERS, V97, P35, DOI 10.1002/bip.21699; Henin J, 2010, J CHEM THEORY COMPUT, V6, P35, DOI 10.1021/ct9004432; HUBER T, 1994, J COMPUT AID MOL DES, V8, P695, DOI 10.1007/BF00124016; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; JARVIS RA, 1973, IEEE T COMPUT, VC-22, P1025, DOI 10.1109/T-C.1973.223640; Jeschke G, 2007, PHYS CHEM CHEM PHYS, V9, P1895, DOI 10.1039/b614920k; Jeschke G, 2012, ANNU REV PHYS CHEM, V63, P419, DOI 10.1146/annurev-physchem-032511-143716; Ji SR, 2002, J BIOL CHEM, V277, P6273, DOI 10.1074/jbc.M104146200; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Klauda JB, 2010, J PHYS CHEM B, V114, P7830, DOI 10.1021/jp101759q; Laio A, 2002, P NATL ACAD SCI USA, V99, P12562, DOI 10.1073/pnas.202427399; Lemmin T, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002878; Lillington JED, 2011, J MOL BIOL, V405, P427, DOI 10.1016/j.jmb.2010.10.053; Malmberg NJ, 2005, ANNU REV BIOPH BIOM, V34, P71, DOI 10.1146/annurev.biophys.34.040204.144534; MARTIN RC, 1998, C++ REP, V10, P8; Mchaourab HS, 2011, STRUCTURE, V19, P1549, DOI 10.1016/j.str.2011.10.009; Milov AD, 2001, J AM CHEM SOC, V123, P3784, DOI 10.1021/ja0033990; Miyashita N, 2010, QTM PROB WHT NOI, V26, P361, DOI 10.1142/9789814304061_0030; Miyashita N, 2009, J AM CHEM SOC, V131, P17843, DOI 10.1021/ja905457d; Munter LM, 2007, EMBO J, V26, P1702, DOI 10.1038/sj.emboj.7601616; Munter LM, 2010, J BIOL CHEM, V285, P21636, DOI 10.1074/jbc.M109.088005; Nadezhdin KD, 2011, ACTA NATURAE, V3, P69, DOI 10.32607/20758251-2011-3-1-69-76; Osenkowski P, 2009, J MOL BIOL, V385, P642, DOI 10.1016/j.jmb.2008.10.078; Page RM, 2010, J BIOL CHEM, V285, P17798, DOI 10.1074/jbc.M110.103283; Pannier M, 2000, J MAGN RESON, V142, P331, DOI 10.1006/jmre.1999.1944; Pester O, 2013, J AM CHEM SOC, V135, P1317, DOI 10.1021/ja3112093; Pettegrew JW, 2001, NEUROCHEM RES, V26, P771, DOI 10.1023/A:1011603916962; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Renzi F, 2011, J BIOL CHEM, V286, P21440, DOI 10.1074/jbc.M110.193326; Russ WP, 2000, J MOL BIOL, V296, P911, DOI 10.1006/jmbi.1999.3489; Selkoe DJ, 2001, PHYSIOL REV, V81, P741, DOI 10.1152/physrev.2001.81.2.741; Sezer D, 2008, J PHYS CHEM B, V112, P5755, DOI 10.1021/jp711375x; Showalter SA, 2007, J AM CHEM SOC, V129, P4158, DOI 10.1021/ja070658d	51	30	30	1	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 7	2014	289	10					6763	6774		10.1074/jbc.M113.470781	http://dx.doi.org/10.1074/jbc.M113.470781			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AC3BG	24469457	hybrid, Green Published			2022-12-25	WOS:000332389400037
J	Cukuroglu, E; Gursoy, A; Nussinov, R; Keskin, O				Cukuroglu, Engin; Gursoy, Attila; Nussinov, Ruth; Keskin, Ozlem			Non-Redundant Unique Interface Structures as Templates for Modeling Protein Interactions	PLOS ONE			English	Article							HOT-SPOTS; BINDING-ENERGY; SEQUENCE; CLASSIFICATION; SIMILARITIES; PREDICTION; DATABASE; MOTIFS; SITES; ARCHITECTURES	Improvements in experimental techniques increasingly provide structural data relating to protein-protein interactions. Classification of structural details of protein-protein interactions can provide valuable insights for modeling and abstracting design principles. Here, we aim to cluster protein-protein interactions by their interface structures, and to exploit these clusters to obtain and study shared and distinct protein binding sites. We find that there are 22604 unique interface structures in the PDB. These unique interfaces, which provide a rich resource of structural data of protein-protein interactions, can be used for template-based docking. We test the specificity of these non-redundant unique interface structures by finding protein pairs which have multiple binding sites. We suggest that residues with more than 40% relative accessible surface area should be considered as surface residues in template-based docking studies. This comprehensive study of protein interface structures can serve as a resource for the community. The dataset can be accessed at http://prism.ccbb.ku.edu.tr/piface.	[Cukuroglu, Engin; Gursoy, Attila; Keskin, Ozlem] Koc Univ, Ctr Computat Biol & Bioinformat, Istanbul, Turkey; [Cukuroglu, Engin; Gursoy, Attila; Keskin, Ozlem] Koc Univ, Coll Engn, Istanbul, Turkey; [Nussinov, Ruth] NCI, Canc & Inflammat Program, Frederick Natl Lab Canc Res, Leidos Biomed Res Inc, Frederick, MD 21701 USA; [Nussinov, Ruth] Tel Aviv Univ, Sackler Sch Med, Dept Human Genet & Mol Med, Sackler Inst Mol Med, IL-69978 Tel Aviv, Israel	Koc University; Koc University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Tel Aviv University; Sackler Faculty of Medicine	Gursoy, A (corresponding author), Koc Univ, Ctr Computat Biol & Bioinformat, Istanbul, Turkey.	agursoy@ku.edu.tr; okeskin@ku.edu.tr	Gursoy, Attila/Z-4394-2019; Gursoy, Attila/E-9565-2015	Gursoy, Attila/0000-0002-2297-2113; Gursoy, Attila/0000-0002-2297-2113; Nussinov, Ruth/0000-0002-8115-6415	National Cancer Institute, National Institutes of Health [HHSN261200800001E]; NIH, National Cancer Institute, Center for Cancer Research; NATIONAL CANCER INSTITUTE [ZIABC010441, ZIABC010440] Funding Source: NIH RePORTER	National Cancer Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH, National Cancer Institute, Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This project has been funded in whole or in part with Federal funds from the National Cancer Institute, National Institutes of Health, under contract number HHSN261200800001E. The content of this publication does not necessarily reflect the views or policies of the Department of Health and Human Services, nor does mention of trade names, commercial products, or organizations imply endorsement by the U.S. Government. This research was supported (in part) by the Intramural Research Program of the NIH, National Cancer Institute, Center for Cancer Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Aloy P, 2004, NAT BIOTECHNOL, V22, P1317, DOI 10.1038/nbt1018; Aloy P, 2003, BIOINFORMATICS, V19, P161, DOI 10.1093/bioinformatics/19.1.161; Aloy P, 2002, P NATL ACAD SCI USA, V99, P5896, DOI 10.1073/pnas.092147999; Andreeva A, 2008, NUCLEIC ACIDS RES, V36, pD419, DOI 10.1093/nar/gkm993; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkp985, 10.1093/nar/gkr1065]; Benoit V, 2008, BIOCHIMIE, V90, P640, DOI 10.1016/j.biochi.2007.11.008; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bogan AA, 1998, J MOL BIOL, V280, P1, DOI 10.1006/jmbi.1998.1843; Bordner AJ, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-234; Caffrey DR, 2004, PROTEIN SCI, V13, P190, DOI 10.1110/ps.03323604; CLACKSON T, 1995, SCIENCE, V267, P383, DOI 10.1126/science.7529940; Cukuroglu E, 2012, NUCLEIC ACIDS RES, V40, pD829, DOI 10.1093/nar/gkr929; Dafas P, 2004, BIOINFORMATICS, V20, P1486, DOI 10.1093/bioinformatics/bth106; Dayhoff JE, 2010, J MOL BIOL, V395, P860, DOI 10.1016/j.jmb.2009.10.052; De S, 2005, BMC STRUCT BIOL, V5, DOI 10.1186/1472-6807-5-15; Engin HB, 2012, J CHEM INF MODEL, V52, P2273, DOI 10.1021/ci300072q; FREEMAN LC, 1977, SOCIOMETRY, V40, P35, DOI 10.2307/3033543; Gao M, 2010, P NATL ACAD SCI USA, V107, P22517, DOI 10.1073/pnas.1012820107; Gao Y, 2004, J MOL MODEL, V10, P44, DOI 10.1007/s00894-003-0168-3; Garma L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038913; Ghoorah AW, 2011, BIOINFORMATICS, V27, P2820, DOI 10.1093/bioinformatics/btr493; Girvan M, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.031915; Gunther S, 2007, PROTEINS, V69, P839, DOI 10.1002/prot.21746; Hagberg A, 2008, EXPLORING NETWORK ST, P11, DOI DOI 10.25080/ISSN.2575-9752; Hamp T, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002623; Han JDJ, 2004, NATURE, V430, P88, DOI 10.1038/nature02555; Handl J, 2005, BIOINFORMATICS, V21, P3201, DOI 10.1093/bioinformatics/bti517; Headd JJ, 2007, J PROTEOME RES, V6, P2576, DOI 10.1021/pr070018+; HUBBARD SJ, 1991, J MOL BIOL, V220, P507, DOI 10.1016/0022-2836(91)90027-4; Hugo W, 2010, BIOINFORMATICS, V26, P1036, DOI 10.1093/bioinformatics/btq065; Jeong H, 2001, NATURE, V411, P41, DOI 10.1038/35075138; Jones S, 1996, P NATL ACAD SCI USA, V93, P13, DOI 10.1073/pnas.93.1.13; Kar G, 2012, J PROTEOME RES, V11, P1196, DOI 10.1021/pr2009143; Keskin O, 2005, PHYS BIOL, V2, pS24, DOI 10.1088/1478-3975/2/2/S03; Keskin O, 2005, PROTEIN ENG DES SEL, V18, P11, DOI 10.1093/protein/gzh095; Keskin O, 2004, PROTEIN SCI, V13, P1043, DOI 10.1110/ps.03484604; Keskin O, 2008, CHEM REV, V108, P1225, DOI 10.1021/cr040409x; Keskin O, 2007, STRUCTURE, V15, P341, DOI 10.1016/j.str.2007.01.007; Kim WK, 2006, PLOS COMPUT BIOL, V2, P1151, DOI 10.1371/journal.pcbi.0020124; Kortemme T, 2002, P NATL ACAD SCI USA, V99, P14116, DOI 10.1073/pnas.202485799; Krissinel E, 2007, BIOINFORMATICS, V23, P717, DOI 10.1093/bioinformatics/btm006; Kundrotas PJ, 2012, P NATL ACAD SCI USA, V109, P9438, DOI 10.1073/pnas.1200678109; Kundrotas PJ, 2013, PROTEINS; Kuzu G, 2013, J PROTEOME RES, V12, P2641, DOI 10.1021/pr400006k; Lu L, 2002, PROTEINS, V49, P350, DOI 10.1002/prot.10222; Moreira IS, 2007, PROTEINS, V68, P803, DOI 10.1002/prot.21396; Ozbabacan SEA, 2012, J STRUCT BIOL, V179, P338, DOI 10.1016/j.jsb.2012.02.002; Rajamani D, 2004, P NATL ACAD SCI USA, V101, P11287, DOI 10.1073/pnas.0401942101; Reynolds C, 2009, BIOINFORMATICS, V25, P413, DOI 10.1093/bioinformatics/btn584; ROUSSEEUW PJ, 1987, J COMPUT APPL MATH, V20, P53, DOI 10.1016/0377-0427(87)90125-7; Saha RP, 2005, J PROTEOME RES, V4, P1600, DOI 10.1021/pr050118k; Shatsky M, 2004, PROTEINS, V56, P143, DOI 10.1002/prot.10628; Stein A, 2011, NUCLEIC ACIDS RES, V39, pD718, DOI 10.1093/nar/gkq962; Stein A, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000789; Teyra J, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-9; Tsai CJ, 2009, TRENDS BIOCHEM SCI, V34, P594, DOI 10.1016/j.tibs.2009.07.007; Tsai CJ, 1996, J MOL BIOL, V260, P604, DOI 10.1006/jmbi.1996.0424; Tsai CJ, 1996, CRIT REV BIOCHEM MOL, V31, P127, DOI 10.3109/10409239609106582; Tseng YY, 2012, NUCLEIC ACIDS RES, V40, pW435, DOI 10.1093/nar/gks495; Tuncbag N, 2008, J MOL BIOL, V381, P785, DOI 10.1016/j.jmb.2008.04.071; Tuncbag N, 2012, PROTEINS, V80, P1239, DOI 10.1002/prot.24022; Tuncbag N, 2011, NAT PROTOC, V6, P1341, DOI 10.1038/nprot.2011.367; Tyagi M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0028896; Vanhee P, 2009, STRUCTURE, V17, P1128, DOI 10.1016/j.str.2009.06.013; WELLS JA, 1991, METHOD ENZYMOL, V202, P390; Winter C, 2006, NUCLEIC ACIDS RES, V34, pD310, DOI 10.1093/nar/gkj099; Xu QF, 2008, J MOL BIOL, V381, P487, DOI 10.1016/j.jmb.2008.06.002; Xu QF, 2011, NUCLEIC ACIDS RES, V39, pD761, DOI 10.1093/nar/gkq1059; Yogurtcu ON, 2008, BIOPHYS J, V94, P3475, DOI 10.1529/biophysj.107.114835; Zhu H, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001926	71	51	51	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2014	9	1							e86738	10.1371/journal.pone.0086738	http://dx.doi.org/10.1371/journal.pone.0086738			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301BI	24475173	Green Published, Green Submitted, gold			2022-12-25	WOS:000330507300105
J	Lin, TH; Yang, SF; Chiu, CC; Su, HM; Voon, WC; Chai, CY; Lai, WT; Sheu, SH				Lin, Tsung-Hsien; Yang, Sheau-Fang; Chiu, Chaw-Chi; Su, Ho-Ming; Voon, Wen-Chol; Chai, Chee-Yin; Lai, Wen-Ter; Sheu, Sheng-Hsiung			Mitral Tissue Inhibitor of Metalloproteinase 2 Is Associated with Mitral Valve Surgery Outcome	PLOS ONE			English	Article							LEFT-VENTRICULAR DYSFUNCTION; CHORDAE TENDINAE RUPTURE; EXTRACELLULAR-MATRIX; HUMAN HEART; TIMP-2; REGURGITATION; EXPRESSION; HYPERTENSION; PREDICTION; MECHANISM	Background: Matrix metalloproteinases play a role in regulating cardiac remodeling. We previously reported an association between tissue inhibitor of metalloproteinase 2 (TIMP-2) expression and mitral valve (MV) disease. However, the determinants and prognostic value of mitral TIMP2 after MV surgery are unknown. Methods: This retrospective study of 164 patients after MV surgery in a tertiary medical center in Taiwan assessed mitral TIMP2 on a semiquantitative scale (0-2) by immunohistochemical staining. The primary endpoints were the composite of cardiovascular death and heart failure admission. Results: Mean age was 50.4613.7 years. After a mean follow-up period of 101 +/- 59 months, primary endpoints had occurred in 25 (15.2%) subjects. Patients with and without primary endpoint events significantly differed in terms of age (56.6 +/- 14.4 vs. 49.2613.4 years, respectively; p = 0.013) and left ventricular end-systolic diameter (LVESD) (39.7 +/- 8.2 vs. 35.5 +/- 7.5 mm, p = 0.010) at surgery. The TIMP2 had a significant dose-dependent association with development of a primary endpoint (p = 0.002). Kaplan-Meier analysis showed that TIMP2 expression has a significant positive association with primary endpoint-free survival (log-rank test; p = 0.004). Cox regression analysis showed that independent predictors of primary endpoints were TIMP2 (hazard ratio [HR] 0.28; 95% confidence interval [CI] 0.12-0.65; p = 0.003), age (HR 1.05; 95% CI 1.02-1.09; p = 0.003) and LVESD (HR 1.05; 95% CI 1.01-1.10; p = 0.020). Conclusions: The lack of mitral TIMP2 expression is associated with increases in cardiovascular death and heart failure following MV surgery.	[Lin, Tsung-Hsien; Su, Ho-Ming; Voon, Wen-Chol; Lai, Wen-Ter; Sheu, Sheng-Hsiung] Kaohsiung Med Univ, Dept Internal Med, Div Cardiol, Kaohsiung, Taiwan; [Yang, Sheau-Fang; Chai, Chee-Yin] Kaohsiung Med Univ, Dept Pathol, Kaohsiung, Taiwan; [Chiu, Chaw-Chi] Kaohsiung Med Univ, Dept Surg, Div Cardiovasc Surg, Kaohsiung, Taiwan; [Yang, Sheau-Fang] Kaohsiung Med Univ, Kaohsiung Municipal Ta Tung Hosp, Dept Pathol, Kaohsiung Med Univ Hosp, Kaohsiung, Taiwan; [Lin, Tsung-Hsien; Yang, Sheau-Fang; Chiu, Chaw-Chi; Voon, Wen-Chol; Chai, Chee-Yin; Lai, Wen-Ter; Sheu, Sheng-Hsiung] Kaohsiung Med Univ, Fac Med, Kaohsiung, Taiwan	Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Municipal Ta-Tung Hospital; Kaohsiung Medical University	Sheu, SH (corresponding author), Kaohsiung Med Univ, Dept Internal Med, Div Cardiol, Kaohsiung, Taiwan.	sheush@kmu.edu.tw	蘇, 河名/AAE-9843-2019	Yang, Sheau-Fang/0000-0002-1773-3716; Su, Ho-Ming/0000-0003-0247-3250; Lin, Tsung-Hsien/0000-0002-7226-8730; Chai, Chee-Yin/0000-0003-0486-9742	Kaohsiung Medical University [Q097025]	Kaohsiung Medical University	This work was supported by a research grant from the Kaohsiung Medical University (Q097025). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bernardo MM, 2003, BIOCHEM J, V374, P739, DOI 10.1042/BJ20030557; BIRKEDALHANSEN H, 1995, CURR OPIN CELL BIOL, V7, P728, DOI 10.1016/0955-0674(95)80116-2; Bonnema DD, 2007, J CARD FAIL, V13, P530, DOI 10.1016/j.cardfail.2007.04.010; CORCORAN ML, 1995, J BIOL CHEM, V270, P13453, DOI 10.1074/jbc.270.22.13453; Dreger SA, 2002, J HEART VALVE DIS, V11, P875; ENRIQUEZSARANO M, 1994, J AM COLL CARDIOL, V24, P1536, DOI 10.1016/0735-1097(94)90151-1; Haan CK, 2004, ANN THORAC SURG, V78, P820, DOI 10.1016/j.athoracsur.2004.04.003; HAYAKAWA T, 1994, J CELL SCI, V107, P2373; He YY, 2013, J CELL BIOCHEM, V114, P1634, DOI 10.1002/jcb.24505; Heymans S, 2005, CIRCULATION, V112, P1136, DOI 10.1161/CIRCULATIONAHA.104.516963; Icardo JM, 2013, INT J CARDIOL, V167, P1603, DOI 10.1016/j.ijcard.2012.04.092; Kandalam V, 2011, CIRCULATION, V124, P2094, DOI 10.1161/CIRCULATIONAHA.111.030338; Kandalam V, 2010, CIRC RES, V106, P796, DOI 10.1161/CIRCRESAHA.109.209189; KOLKENBROCK H, 1991, EUR J BIOCHEM, V198, P775, DOI 10.1111/j.1432-1033.1991.tb16080.x; Lin TH, 2006, AM J HYPERTENS, V19, P75, DOI 10.1016/j.amjhyper.2005.06.020; Lin TH, 2009, J HYPERTENS, V27, P2079, DOI 10.1097/HJH.0b013e32832f50d8; MATRISIAN LM, 1990, TRENDS GENET, V6, P121, DOI 10.1016/0168-9525(90)90126-Q; Soini Y, 2001, J PATHOL, V194, P225, DOI 10.1002/path.850; Wingfield PT, 1999, J BIOL CHEM, V274, P21362, DOI 10.1074/jbc.274.30.21362; WISENBAUGH T, 1994, CIRCULATION, V89, P191, DOI 10.1161/01.CIR.89.1.191	20	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2014	9	1							e86287	10.1371/journal.pone.0086287	http://dx.doi.org/10.1371/journal.pone.0086287			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301BI	24475101	Green Submitted, Green Published, gold			2022-12-25	WOS:000330507300050
J	Marcolino-Gomes, J; Rodrigues, FA; Fuganti-Pagliarini, R; Bendix, C; Nakayama, TJ; Celaya, B; Molinari, HBC; de Oliveira, MCN; Harmon, FG; Nepomuceno, A				Marcolino-Gomes, Juliana; Rodrigues, Fabiana Aparecida; Fuganti-Pagliarini, Renata; Bendix, Claire; Nakayama, Thiago Jonas; Celaya, Brandon; Correa Molinari, Hugo Bruno; Neves de Oliveira, Maria Cristina; Harmon, Frank G.; Nepomuceno, Alexandre			Diurnal Oscillations of Soybean Circadian Clock and Drought Responsive Genes	PLOS ONE			English	Article							ABSCISIC-ACID; TRANSCRIPTION FACTOR; SIGNAL-TRANSDUCTION; ABIOTIC-STRESS; ARABIDOPSIS; PROTEIN; EXPRESSION; PLANT; TIME; COMPONENTS	Rhythms produced by the endogenous circadian clock play a critical role in allowing plants to respond and adapt to the environment. While there is a well-established regulatory link between the circadian clock and responses to abiotic stress in model plants, little is known of the circadian system in crop species like soybean. This study examines how drought impacts diurnal oscillation of both drought responsive and circadian clock genes in soybean. Drought stress induced marked changes in gene expression of several circadian clock-like components, such as LCL1-, GmELF4- and PRR-like genes, which had reduced expression in stressed plants. The same conditions produced a phase advance of expression for the GmTOC1-like, GmLUX-like and GmPRR7-like genes. Similarly, the rhythmic expression pattern of the soybean drought-responsive genes DREB-, bZIP-, GOLS-, RAB18- and Remorin-like changed significantly after plant exposure to drought. In silico analysis of promoter regions of these genes revealed the presence of cis-elements associated both with stress and circadian clock regulation. Furthermore, some soybean genes with upstream ABRE elements were responsive to abscisic acid treatment. Our results indicate that some connection between the drought response and the circadian clock may exist in soybean since (i) drought stress affects gene expression of circadian clock components and (ii) several stress responsive genes display diurnal oscillation in soybeans.	[Marcolino-Gomes, Juliana; Rodrigues, Fabiana Aparecida; Fuganti-Pagliarini, Renata; Neves de Oliveira, Maria Cristina; Nepomuceno, Alexandre] Brazilian Agr Res Corp, Embrapa Soybean, Londrina, Parana, Brazil; [Marcolino-Gomes, Juliana] Univ Estadual Londrina, Dept Biol, Londrina, Parana, Brazil; [Bendix, Claire; Celaya, Brandon; Harmon, Frank G.] USDA ARS, Ctr Plant Gene Express, Albany, CA 94710 USA; [Bendix, Claire; Celaya, Brandon; Harmon, Frank G.] Univ Calif Berkeley, Dept Plant & Microbial Biol, Berkeley, CA 94720 USA; [Nakayama, Thiago Jonas] Univ Fed Vicosa, Dept Crop Sci, Vicosa, MG, Brazil; [Correa Molinari, Hugo Bruno; Nepomuceno, Alexandre] USDA ARS, Ctr Plant Gene Express, Embrapa LABEX US Plant Biotechnol, Albany, CA 94710 USA	Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA); Universidade Estadual de Londrina; United States Department of Agriculture (USDA); University of California System; University of California Berkeley; Universidade Federal de Vicosa; United States Department of Agriculture (USDA)	Nepomuceno, A (corresponding author), Brazilian Agr Res Corp, Embrapa Soybean, Londrina, Parana, Brazil.	alexandre.nepomuceno@embrapa.br	Fuganti-Pagliarini, Renata/S-6089-2019	Bendix, Claire/0000-0002-4723-8652; Fuganti-Pagliarini, Renata/0000-0001-9282-2826	Embrapa LABEX USA program (Embrapa) [10200.10/0215-9]; CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior) [8075/11-5]; an agency of the Ministry of Education of Brazil. Renata Fuganti-Pagliarini [202639/2011-8]; CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico) [202211/2011-8]; Direct For Biological Sciences [1238048] Funding Source: National Science Foundation; ARS [ARS-0425045] Funding Source: Federal RePORTER	Embrapa LABEX USA program (Embrapa); CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); an agency of the Ministry of Education of Brazil. Renata Fuganti-Pagliarini; CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); ARS(United States Department of Agriculture (USDA)USDA Agricultural Research Service)	This work was supported by Embrapa LABEX USA program (Embrapa cod. 10200.10/0215-9). Juliana Marcolino-Gomes was supported by a scholarship from the CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior) (Process #8075/11-5), an agency of the Ministry of Education of Brazil. Renata Fuganti-Pagliarini (Process #202639/2011-8) and Fabiana A. Rodrigues (Process #202211/2011-8) were supported by scholarships from CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal P, 2009, PLANT MOL BIOL REP, V27, P417, DOI 10.1007/s11105-009-0100-9; Alabadi D, 2001, SCIENCE, V293, P880, DOI 10.1126/science.1061320; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Baerenfaller K, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2012.39; Bento dos Santos T, 2011, PLANT PHYSIOL BIOCH, V49, P441, DOI 10.1016/j.plaphy.2011.01.023; Bieniawska Z, 2008, PLANT PHYSIOL, V147, P263, DOI 10.1104/pp.108.118059; Boneh U, 2012, PLANT SCI, V187, P89, DOI 10.1016/j.plantsci.2012.01.015; Boyko A, 2008, ENVIRON MOL MUTAGEN, V49, P61, DOI 10.1002/em.20347; Boyko A, 2007, NUCLEIC ACIDS RES, V35, P1714, DOI 10.1093/nar/gkm029; Cartharius K, 2005, BIOINFORMATICS, V21, P2933, DOI 10.1093/bioinformatics/bti473; Chen ZZ, 2006, CELL, V125, P691, DOI 10.1016/j.cell.2006.04.024; Choi CS, 2007, MOL GENET GENOMICS, V277, P589, DOI 10.1007/s00438-007-0209-1; Dixon LE, 2011, CURR BIOL, V21, P120, DOI 10.1016/j.cub.2010.12.013; Dong MA, 2011, P NATL ACAD SCI USA, V108, P7241, DOI 10.1073/pnas.1103741108; Farre EM, 2005, CURR BIOL, V15, P47, DOI 10.1016/j.cub.2004.12.067; FEHR WR, 1971, CROP SCI, V11, P929, DOI 10.2135/cropsci1971.0011183X001100060051x; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Fowler SG, 2005, PLANT PHYSIOL, V137, P961, DOI 10.1104/pp.104.058354; Gao SQ, 2011, PLANT MOL BIOL, V75, P537, DOI 10.1007/s11103-011-9738-4; Gendron JM, 2012, P NATL ACAD SCI USA, V109, P3167, DOI 10.1073/pnas.1200355109; Govind G, 2009, MOL GENET GENOMICS, V281, P591, DOI 10.1007/s00438-009-0432-z; Harmer SL, 2000, SCIENCE, V290, P2110, DOI 10.1126/science.290.5499.2110; Hazen SP, 2005, P NATL ACAD SCI USA, V102, P10387, DOI 10.1073/pnas.0503029102; Helfer A, 2011, CURR BIOL, V21, P126, DOI 10.1016/j.cub.2010.12.021; Huang W, 2012, SCIENCE, V336, P75, DOI 10.1126/science.1219075; Hudson KA, 2010, PLANT GENOME-US, V3, P3, DOI 10.3835/plantgenome2009.08.0025; Ibanez C, 2010, PLANT PHYSIOL, V153, P1823, DOI 10.1104/pp.110.158220; Jankanpaa HJ, 2012, PLANT CELL ENVIRON, V35, P1824, DOI 10.1111/j.1365-3040.2012.02519.x; Jian B, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-59; Jiang Y, 2011, RUSS J PLANT PHYSL+, V58, P928, DOI 10.1134/S1021443711040066; Jones MA, 2010, P NATL ACAD SCI USA, V107, P21623, DOI 10.1073/pnas.1014204108; Khanna-Chopra R, 2007, ENVIRON EXP BOT, V60, P276, DOI 10.1016/j.envexpbot.2006.11.004; Kikis EA, 2005, PLANT J, V44, P300, DOI 10.1111/j.1365-313X.2005.02531.x; Kim WY, 2007, NATURE, V449, P356, DOI 10.1038/nature06132; Legnaioli T, 2009, EMBO J, V28, P3745, DOI 10.1038/emboj.2009.297; Li G, 2011, NAT CELL BIOL, V13, P616, DOI 10.1038/ncb2219; Liu B, 2012, PLANT CELL REP, V31, P1021, DOI 10.1007/s00299-011-1220-x; Liu H, 2009, J PLANT PHYSIOL, V166, P278, DOI 10.1016/j.jplph.2008.06.003; Lu SX, 2011, PLANT PHYSIOL, V155, P906, DOI 10.1104/pp.110.167015; Marcolino-Gomes J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062294; Marsh HW, 1998, STRUCT EQU MODELING, V5, P22, DOI 10.1080/10705519809540087; Maruyama K, 2012, DNA RES, V19, P37, DOI 10.1093/dnares/dsr040; McWatters HG, 2007, PLANT PHYSIOL, V144, P391, DOI 10.1104/pp.107.096206; Melcher K, 2009, NATURE, V462, P602, DOI 10.1038/nature08613; Mikkelsen MD, 2009, PLANT J, V60, P328, DOI 10.1111/j.1365-313X.2009.03957.x; Mizoguchi T, 2002, DEV CELL, V2, P629, DOI 10.1016/S1534-5807(02)00170-3; Mizuno T, 2008, PLANT CELL PHYSIOL, V49, P481, DOI 10.1093/pcp/pcn008; Muller AH, 2009, PLANT PHYSIOL, V150, P157, DOI 10.1104/pp.109.135277; Nakamichi N, 2010, PLANT CELL, V22, P594, DOI 10.1105/tpc.109.072892; Oya T, 2004, PLANT PROD SCI, V7, P129, DOI 10.1626/pps.7.129; Pokhilko A, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2012.6; Porter S, 2009, ANAL GENE EXPRESSION; Preuss SB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030717; Pruneda-Paz JL, 2009, SCIENCE, V323, P1481, DOI 10.1126/science.1167206; Quandt K, 1995, NUCLEIC ACIDS RES, V23, P4878, DOI 10.1093/nar/23.23.4878; Raffaele S, 2007, PLANT PHYSIOL, V145, P593, DOI 10.1104/pp.107.108639; Ramos A, 2005, P NATL ACAD SCI USA, V102, P7037, DOI 10.1073/pnas.0408549102; Robertson F, 2009, PLANT MOL BIOL, V69, P419, DOI 10.1007/s11103-008-9407-4; Rodrigues FA, 2012, GENET MOL BIOL, V35, P304, DOI 10.1590/S1415-47572012000200011; Rugnone ML, 2013, P NATL ACAD SCI USA, V110, P12120, DOI 10.1073/pnas.1302170110; Rushton DL, 2012, PLANT BIOTECHNOL J, V10, P2, DOI 10.1111/j.1467-7652.2011.00634.x; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sanchez A, 2011, PLANT SIGNAL BEHAV, V6, P223, DOI 10.4161/psb.6.2.14893; Severin AJ, 2011, PLANT CELL, V23, P3129, DOI 10.1105/tpc.111.089573; Shinozaki K, 2007, J EXP BOT, V58, P221, DOI 10.1093/jxb/erl164; Song YH, 2010, CURR OPIN PLANT BIOL, V13, P594, DOI 10.1016/j.pbi.2010.05.004; Stolf-Moreira R, 2011, PESQUI AGROPECU BRAS, V46, P58, DOI 10.1590/S0100-204X2011000100008; Sullivan S, 2004, PLANT PHYSIOL, V135, P2078, DOI 10.1104/pp.104.042762; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023; Thakare D, 2010, PLANTA, V231, P951, DOI 10.1007/s00425-010-1100-6; Thines B, 2010, P NATL ACAD SCI USA, V107, P3257, DOI 10.1073/pnas.0911006107; Tomii K, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-11; Weltmeier F, 2009, PLANT MOL BIOL, V69, P107, DOI 10.1007/s11103-008-9410-9; Wilkins O, 2010, PLANT J, V63, P715, DOI 10.1111/j.1365-313X.2010.04274.x; Wu FQ, 2009, PLANT PHYSIOL, V150, P1940, DOI 10.1104/pp.109.140731; Ying S, 2012, PLANTA, V235, P253, DOI 10.1007/s00425-011-1496-7; Yuan JS, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-85; Zhang GY, 2009, J EXP BOT, V60, P3781, DOI 10.1093/jxb/erp214; Zhu JK, 2002, ANNU REV PLANT BIOL, V53, P247, DOI 10.1146/annurev.arplant.53.091401.143329	80	79	87	7	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2014	9	1							e86402	10.1371/journal.pone.0086402	http://dx.doi.org/10.1371/journal.pone.0086402			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301BI	24475115	Green Published, Green Submitted, gold			2022-12-25	WOS:000330507300061
J	De Regge, N; Madder, M; Deblauwe, I; Losson, B; Fassotte, C; Demeulemeester, J; Smeets, F; Tomme, M; Cay, AB				De Regge, Nick; Madder, Maxime; Deblauwe, Isra; Losson, Bertrand; Fassotte, Christiane; Demeulemeester, Julie; Smeets, Francois; Tomme, Marie; Cay, Ann Brigitte			Schmallenberg Virus Circulation in Culicoides in Belgium in 2012: Field Validation of a Real Time RT-PCR Approach to Assess Virus Replication and Dissemination in Midges	PLOS ONE			English	Article							BLUETONGUE VIRUS; BITING MIDGES; EXPERIMENTAL-INFECTION; ARBOVIRUSES; CATTLE; ORTHOBUNYAVIRUS; VECTOR; EUROPE; TRANSMISSION; RUMINANTS	Indigenous Culicoides biting midges are suggested to be putative vectors for the recently emerged Schmallenberg virus (SBV) based on SBV RNA detection in field-caught midges. Furthermore, SBV replication and dissemination has been evidenced in C. sonorensis under laboratory conditions. After SBV had been detected in Culicoides biting midges from Belgium in August 2011, it spread all over the country by the end of 2011, as evidenced by very high between-herd seroprevalence rates in sheep and cattle. This study investigated if a renewed SBV circulation in midges occurred in 2012 in the context of high seroprevalence in the animal host population and evaluated if a recently proposed realtime RT-PCR approach that is meant to allow assessing the vector competence of Culicoides for SBV and bluetongue virus under laboratory conditions was applicable to field-caught midges. Therefore midges caught with 12 OVI traps in four different regions in Belgium between May and November 2012, were morphologically identified, age graded, pooled and tested for the presence of SBV RNA by realtime RT-PCR. The results demonstrate that although no SBV could be detected in nulliparous midges caught in May 2012, a renewed but short lived circulation of SBV in parous midges belonging to the subgenus Avaritia occured in August 2012 at all four regions. The infection prevalence reached up to 2.86% in the south of Belgium, the region where a lower seroprevalence was found at the end of 2011 than in the rest of the country. Furthermore, a frequency analysis of the Ct values obtained for 31 SBV-S segment positive pools of Avaritia midges showed a clear bimodal distribution with peaks of Ct values between 21-24 and 33-36. This closely resembles the laboratory results obtained for SBV infection of C. sonorensis and implicates indigenous midges belonging to the subgenus Avaritia as competent vectors for SBV.	[De Regge, Nick; Cay, Ann Brigitte] CODA CERVA, Brussels, Belgium; [Madder, Maxime; Deblauwe, Isra; Demeulemeester, Julie] Inst Trop Med, Dept Biomed Sci, B-2000 Antwerp, Belgium; [Losson, Bertrand; Smeets, Francois] Univ Liege, Dept Infect & Parasit Dis, Liege, Belgium; [Fassotte, Christiane; Tomme, Marie] Walloon Agr Res Ctr CRA W, Dept Life Sci, Gembloux, Belgium; [Madder, Maxime] Univ Pretoria, Dept Vet Trop Dis, ZA-0002 Pretoria, South Africa	Institute of Tropical Medicine (ITM); University of Liege; University of Pretoria	De Regge, N (corresponding author), CODA CERVA, Brussels, Belgium.	nick.deregge@coda-cerva.be	Deblauwe, Isra/C-9725-2010; Deblauwe, Isra/AAH-7680-2019	Deblauwe, Isra/0000-0001-7268-8965	Belgian Federal Agency for the Safety of the Food Chain (FAVV-AFSCA); Federal Public Service of Health, Food Chain Safety and Environment [RF12/6270]; European Union [2012/349/EU]; Union for studies on Schmallenberg virus	Belgian Federal Agency for the Safety of the Food Chain (FAVV-AFSCA); Federal Public Service of Health, Food Chain Safety and Environment; European Union(European Commission); Union for studies on Schmallenberg virus	Monitoring of Culicoides in Belgium in 2012 was financed by the Belgian Federal Agency for the Safety of the Food Chain (FAVV-AFSCA). rRT-PCR analysis of Culicoides for presence of SBV was funded by the Federal Public Service of Health, Food Chain Safety and Environment (RF12/6270) and the European Union as outlined in Council Decision 2012/349/EU concerning a financial contribution by the Union for studies on Schmallenberg virus. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBUSAIDY SM, 1991, EPIDEMIOL INFECT, V106, P403, DOI 10.1017/S095026880004855X; Bayrou C, 2013, VET REC, V172, P296, DOI 10.1136/vr.f1637; Bilk S, 2012, VET MICROBIOL, V159, P236, DOI 10.1016/j.vetmic.2012.03.035; Bryant JE, 2005, AM J TROP MED HYG, V73, P470, DOI 10.4269/ajtmh.2005.73.470; Carpenter S, 2008, VET REC, V163, P589, DOI 10.1136/vr.163.20.589; Chaintoutis SC, 2013, TROP ANIM H IN PRESS; Claine F, 2013, EMERG INFECT DIS, V19, P1115, DOI 10.3201/eid1907.121768; Conraths FJ, 2013, NEW ZEAL VET J, V61, P63, DOI 10.1080/00480169.2012.738403; Conraths FJ, 2013, EMERG INFECT DIS, V19, P513, DOI 10.3201/eid1903.121324; De Regge N, 2012, TRANSBOUND EMERG DIS, V59, P471, DOI 10.1111/tbed.12000; DELECOLLE J.-C., 1985, THESIS U STRASBOURG; Dijkstra E, 2008, VET REC, V162, P422, DOI 10.1136/vr.162.13.422-a; Doceul V, 2013, VET RES, V44, DOI 10.1186/1297-9716-44-31; Elbers ARW, 2015, TRANSBOUND EMERG DIS, V62, P339, DOI 10.1111/tbed.12128; Elbers ARW, 2013, EMERG INFECT DIS, V19, P106, DOI 10.3201/eid1901.121054; European Food Safety Authority, 2013, SUPP PUBL 2013; Fassotte C, 2008, PREV VET MED, V87, P74, DOI 10.1016/j.prevetmed.2008.06.007; Garigliany MM, 2012, ANTIVIR RES, V95, P82, DOI 10.1016/j.antiviral.2012.05.014; GEORGE TDS, 1978, AUST VET J, V54, P558, DOI 10.1111/j.1751-0813.1978.tb02412.x; Goffredo M, 2013, PREV VET MED, V111, P230, DOI 10.1016/j.prevetmed.2013.05.014; Herder V, 2012, VET PATHOL, V49, P588, DOI 10.1177/0300985812447831; Hoffmann B, 2012, EMERG INFECT DIS, V18, P469, DOI 10.3201/eid1803.111905; Larska M, 2013, TRANSBOUND EMERG DIS, V60, P97, DOI 10.1111/tbed.12057; Larska M, 2013, VET MICROBIOL, V166, P467, DOI 10.1016/j.vetmic.2013.07.015; Linden A, 2012, EMERG INFECT DIS, V18, P2006, DOI 10.3201/eid1812.121067; Losson B, 2007, VET REC, V160, P451, DOI 10.1136/vr.160.13.451-b; Mehlhorn H, 2007, PARASITOL RES, V101, P219, DOI 10.1007/s00436-007-0519-6; Meiswinkel R, 2007, VET REC, V161, P564, DOI 10.1136/vr.161.16.564; Mellor PS, 2000, ANNU REV ENTOMOL, V45, P307, DOI 10.1146/annurev.ento.45.1.307; Mellor PS, 2000, J COMP PATHOL, V123, P231, DOI 10.1053/jcpa.2000.0434; Meroc E, 2014, TRANSBOUND EMERG DIS, V61, P425, DOI 10.1111/tbed.12050; Meroc E, 2013, TRANSBOUND EMERG DIS, V60, P4, DOI 10.1111/tbed.12042; Rasmussen LD, 2012, EMERG INFECT DIS, V18, P1204, DOI 10.3201/eid1807.120385; Sailleau C, 2013, EMERG INFECT DIS, V19, P321, DOI 10.3201/eid1902.121281; Scholte EJ, 2014, MED VET ENTOMOL, V28, P110, DOI 10.1111/mve.12010; van den Brom R, 2012, TIJDSCHR DIERGENEESK, V137, P106; Vanbinst T, 2009, TRANSBOUND EMERG DIS, V56, P170, DOI 10.1111/j.1865-1682.2009.01077.x; Venter GJ, 2009, VET PARASITOL, V166, P299, DOI 10.1016/j.vetpar.2009.08.020; Veronesi E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057747; Wernike K, 2013, EMERG INFECT DIS, V19, P1701, DOI 10.3201/eid1910.130622; Wernike K, 2013, VET MICROBIOL, V166, P461, DOI 10.1016/j.vetmic.2013.06.030; Wernike K, 2013, VACCINE, V31, P3558, DOI 10.1016/j.vaccine.2013.05.062; Wernike K, 2013, VET MICROBIOL, V165, P155, DOI 10.1016/j.vetmic.2013.01.040; Wernike K, 2012, VET RES, V43, DOI 10.1186/1297-9716-43-84; Wilson AJ, 2009, PHILOS T R SOC B, V364, P2669, DOI 10.1098/rstb.2009.0091; Yanase T, 2005, J MED ENTOMOL, V42, P63, DOI 10.1603/0022-2585(2005)042[0063:IOBAFC]2.0.CO;2	46	26	28	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2014	9	1							e87005	10.1371/journal.pone.0087005	http://dx.doi.org/10.1371/journal.pone.0087005			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297XI	24466312	Green Published, Green Submitted, gold			2022-12-25	WOS:000330288000184
J	Galicia-Vazquez, G; Di Marco, S; Lian, XJ; Ma, JF; Gallouzi, IE; Pelletier, J				Galicia-Vazquez, Gabriela; Di Marco, Sergio; Lian, Xian J.; Ma, Jennifer F.; Gallouzi, Imed E.; Pelletier, Jerry			Regulation of Eukaryotic Initiation Factor 4AII by MyoD during Murine Myogenic Cell Differentiation	PLOS ONE			English	Article							RNA HELICASE EIF4A; TRANSLATION INITIATION; SKELETAL-MUSCLE; MAMMALIAN TRANSLATION; FUNCTIONAL GENES; EXPRESSION; INHIBITOR; RAPAMYCIN; TARGET; GROWTH	Gene expression during muscle cell differentiation is tightly regulated at multiple levels, including translation initiation. The PI3K/mTOR signalling pathway exerts control over protein synthesis by regulating assembly of eukaryotic initiation factor (eIF) 4F, a heterotrimeric complex that stimulates recruitment of ribosomes to mRNA templates. One of the subunits of eIF4F, eIF4A, supplies essential helicase function during this phase of translation. The presence of two cellular eIF4A isoforms, eIF4AI and eIF4AII, has long thought to impart equivalent functions to eIF4F. However, recent experiments have alluded to distinct activities between them. Herein, we characterize distinct regulatory mechanisms between the eIF4A isoforms during muscle cell differentiation. We find that eIF4AI levels decrease during differentiation whereas eIF4AII levels increase during myofiber formation in a MyoD-dependent manner. This study characterizes a previously undefined mechanism for eIF4AII regulation in differentiation and highlights functional differences between eIF4AI and eIF4AII. Finally, RNAi-mediated alterations in eIF4AI and eIF4AII levels indicate that the myogenic process can tolerate short term reductions in eIF4AI or eIF4AII levels, but not both.	[Galicia-Vazquez, Gabriela; Di Marco, Sergio; Lian, Xian J.; Ma, Jennifer F.; Gallouzi, Imed E.; Pelletier, Jerry] McGill Univ, Dept Biochem, Montreal, PQ, Canada; [Pelletier, Jerry] McGill Univ, Rosalind & Morris Goodman Canc Res Ctr, Montreal, PQ, Canada	McGill University; McGill University	Pelletier, J (corresponding author), McGill Univ, Dept Biochem, Montreal, PQ, Canada.	jerry.pelletier@mcgill.ca		GALICIA VAZQUEZ, GABRIELA/0000-0001-6706-7742; Di Marco, Sergio/0000-0002-4039-0600	Canadian Cancer Society Operating grant [NCIC 018125]; Canadian Institutes of Health Research (CIHR) operating grants [MOP-89798, MOP-106530]; Cole Foundation Fellowship; CIHR Strategic Training Initiative in Chemical Biology	Canadian Cancer Society Operating grant; Canadian Institutes of Health Research (CIHR) operating grants(Canadian Institutes of Health Research (CIHR)); Cole Foundation Fellowship; CIHR Strategic Training Initiative in Chemical Biology(Canadian Institutes of Health Research (CIHR))	This work was supported by the Canadian Cancer Society Operating grant (NCIC 018125) and Canadian Institutes of Health Research (CIHR) operating grants (MOP-89798 to I. E. G. and MOP-106530 to J.P.). G. G. V. was a recipient of a Cole Foundation Fellowship and was also supported by a CIHR Strategic Training Initiative in Chemical Biology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asangani IA, 2008, ONCOGENE, V27, P2128, DOI 10.1038/sj.onc.1210856; Bergstrom DA, 2002, MOL CELL, V9, P587, DOI 10.1016/S1097-2765(02)00481-1; Bordeleau ME, 2008, J CLIN INVEST, V118, P2651, DOI 10.1172/JCI34753; Bordeleau ME, 2006, CHEM BIOL, V13, P1287, DOI 10.1016/j.chembiol.2006.10.005; Bordeleau ME, 2006, NAT CHEM BIOL, V2, P213, DOI 10.1038/nchembio776; Bordeleau ME, 2005, P NATL ACAD SCI USA, V102, P10460, DOI 10.1073/pnas.0504249102; Cencic R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005223; Di Marco S, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1899; Dorrello NV, 2006, SCIENCE, V314, P467, DOI 10.1126/science.1130276; Erbay E, 2001, J BIOL CHEM, V276, P36079, DOI 10.1074/jbc.C100406200; Galicia-Vazquez G, 2012, RNA, V18, P1373, DOI 10.1261/rna.033209.112; Glass DJ, 2003, NAT CELL BIOL, V5, P87, DOI 10.1038/ncb0203-87; GUO K, 1995, MOL CELL BIOL, V15, P3823; Heinemeyer T, 1998, NUCLEIC ACIDS RES, V26, P362, DOI 10.1093/nar/26.1.362; Huang J, 1996, MOL CELL BIOL, V16, P3893; Latres E, 2005, J BIOL CHEM, V280, P2737, DOI 10.1074/jbc.M407517200; Li W, 2001, J BIOL CHEM, V276, P29111, DOI 10.1074/jbc.C100284200; Lindqvist L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001583; Londhe P, 2011, SKELET MUSCLE, V1, DOI 10.1186/2044-5040-1-14; Meijer HA, 2013, SCIENCE, V340, P82, DOI 10.1126/science.1231197; NIELSEN PJ, 1988, EMBO J, V7, P2097, DOI 10.1002/j.1460-2075.1988.tb03049.x; NIELSEN PJ, 1993, MAMM GENOME, V4, P185, DOI 10.1007/BF00352237; PAUSE A, 1994, EMBO J, V13, P1205, DOI 10.1002/j.1460-2075.1994.tb06370.x; ROZEN F, 1990, MOL CELL BIOL, V10, P1134, DOI 10.1128/MCB.10.3.1134; Shu LL, 2002, J BIOL CHEM, V277, P16726, DOI 10.1074/jbc.M112285200; Smale S.T., 2009, COLD SPRING HARB PRO; Sonenberg N, 2009, CELL, V136, P731, DOI 10.1016/j.cell.2009.01.042; Tapscott SJ, 2005, DEVELOPMENT, V132, P2685, DOI 10.1242/dev.01874; Willett M, 2009, CELL SIGNAL, V21, P1504, DOI 10.1016/j.cellsig.2009.05.009; WilliamsHill DM, 1997, ARCH BIOCHEM BIOPHYS, V338, P111, DOI 10.1006/abbi.1996.9804; Yan B, 2013, J EXP BIOL, V216, P447, DOI 10.1242/jeb.076315; YODERHILL J, 1993, J BIOL CHEM, V268, P5566	32	8	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2014	9	1							e87237	10.1371/journal.pone.0087237	http://dx.doi.org/10.1371/journal.pone.0087237			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297XI	24466343	gold, Green Published, Green Submitted			2022-12-25	WOS:000330288000200
J	Rondet, C; Lapostolle, A; Soler, M; Grillo, F; Parizot, I; Chauvin, P				Rondet, Claire; Lapostolle, Annabelle; Soler, Marion; Grillo, Francesca; Parizot, Isabelle; Chauvin, Pierre			Are Immigrants and Nationals Born to Immigrants at Higher Risk for Delayed or No Lifetime Breast and Cervical Cancer Screening? The Results from a Population-Based Survey in Paris Metropolitan Area in 2010	PLOS ONE			English	Article							HEALTH-CARE; WOMEN; MAMMOGRAPHY; FRANCE; NEVER	Objectives: This study aims to compare breast cancer screening (BCS) and cervical cancer screening (CCS) practices of French women born to French parents with those of immigrants and nationals born to immigrants, taking their socioeconomic status into account. Methods: The study is based on data collected in 2010 in the Paris metropolitan area among a representative sample of 3000 French-speaking adults. For women with no history of breast or cervical cancer, multivariate logistic regressions and structural equation models were used to investigate the factors associated with never having undergone BCS or CCS. Results: We confirmed the existence of a strong gradient, with respect to migration origin, for delaying or never having undergone BCS or CCS. Thus, being a foreign immigrant or being French of immigrant parentage were risk factors for delayed and no lifetime screening. Interestingly, we found that this gradient persisted (at least partially) after adjusting for the women's socioeconomic characteristics. Only the level of income seemed to play a mediating role, but only partially. We observed differences between BCS and CCS which suggest that organized CCS could be effective in reducing socioeconomic and/or ethnic inequities. Conclusion: Socioeconomic status partially explained the screening nonparticipation on the part of French women of immigrant origin and foreign immigrants. This was more so the case with CCS than with BCS, which suggests that organized prevention programs might reduce social inequalities.	[Rondet, Claire; Lapostolle, Annabelle; Soler, Marion; Grillo, Francesca; Chauvin, Pierre] INSERM, Perre Louis Inst Epidemiol & Publ Hlth, Dept Social Epidemiol, Paris, France; [Rondet, Claire; Lapostolle, Annabelle; Soler, Marion; Grillo, Francesca; Chauvin, Pierre] Univ Paris 06, Sorbonne Univ, Dept Social Epidemiol, Pierre Louis Inst Epidemiol & Publ Hlth, Paris, France; [Rondet, Claire] Univ Paris 06, Sch Med, Dept Gen Practice, Paris, France; [Parizot, Isabelle] CNRS, Ctr Maurice Halbwachs, Res Team Social Inequal, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; Universite de Franche-Comte; Centre National de la Recherche Scientifique (CNRS)	Rondet, C (corresponding author), INSERM, Perre Louis Inst Epidemiol & Publ Hlth, Dept Social Epidemiol, Paris, France.	rondet@u707.jussieu.fr	Chauvin, Pierre/S-2981-2019; Chauvin, Pierre/G-1095-2015	Chauvin, Pierre/0000-0002-9183-6406; Chauvin, Pierre/0000-0002-9183-6406	French National Cancer Institute (INCa) [2009-1-SHS SP-05-INSERM 6-1]; Institute for Public Health Research (IReSP) [2008-87]; French Interministerial Committee for Urban Affairs [2009-273]	French National Cancer Institute (INCa)(Institut National du Cancer (INCA) France); Institute for Public Health Research (IReSP); French Interministerial Committee for Urban Affairs	This research project on women's cancer prevention was supported by the French National Cancer Institute (INCa) (grant number 2009-1-SHS SP-05-INSERM 6-1; URL: http://www.e-cancer.fr). The SIRS survey was also supported by the Institute for Public Health Research (IReSP) (grant number 2008-87; URL: http://www.iresp.net), and the French Interministerial Committee for Urban Affairs (grant number 2009-273; URL: http://www.ville.gouv.fr/?le-comite-interministeriel-des). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDEM, 1995, PRAT FROTT CERV DEP; Baker D, 2003, J EPIDEMIOL COMMUN H, V57, P417, DOI 10.1136/jech.57.6.417; Blackman D K, 1999, MMWR CDC Surveill Summ, V48, P1; BOSTICK RM, 1993, PREV MED, V22, P65, DOI 10.1006/pmed.1993.1005; Commission europeenne, 2011, RED IN SANT UN; Consedine NS, 2012, J IMMIGR MINOR HEALT, V14, P570, DOI 10.1007/s10903-011-9524-z; Coughlin Steven S, 2004, Prev Chronic Dis, V1, pA04; De Alba I, 2005, PREV MED, V40, P747, DOI 10.1016/j.ypmed.2004.09.018; Dourgnon Paul Jusot Florence Sermet Catherine Silva Jerome, 2009, REC SOINS VILL IMM F; Duport N, 2012, REV EPIDEMIOL SANTE, V60, P421, DOI 10.1016/j.respe.2012.05.006; Duport N, 2008, EUR J CANCER PREV, V17, P218, DOI 10.1097/CEJ.0b013e3282b6fde5; Everett T, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002834.pub2; Fontaine KR, 2001, J WOMEN HEALTH GEN-B, V10, P463, DOI 10.1089/152460901300233939; Gautier arnaud, 2009, BAR MED GEN 2009; Grillo F, 2012, PREV MED, V54, P259, DOI 10.1016/j.ypmed.2012.01.013; Guilbert P, 2006, 2005 HLTH BAROMETER; Han HR, 2011, PSYCHO-ONCOLOGY, V20, P341, DOI 10.1002/pon.1754; Hiatt RA, 2001, PREV MED, V33, P190, DOI 10.1006/pmed.2001.0871; Jones Beth A., 2003, Cancer, V97, P258, DOI 10.1002/cncr.11022; Karliner LS, 2012, MED CARE, V50, P171, DOI 10.1097/MLR.0b013e31822dcf2d; Katz SJ, 2000, AM J PUBLIC HEALTH, V90, P799, DOI 10.2105/AJPH.90.5.799; Lagerlund M, 2002, CANCER CAUSE CONTROL, V13, P73, DOI 10.1023/A:1013978421073; LEGALES C, 1990, BEH, V1, P3; Lopez EDS, 2009, WOMEN HEALTH ISS, V19, P434, DOI 10.1016/j.whi.2009.07.008; MacKinnon D.P., 2012, INTRO STAT MEDIATION; Martin-Fernandez J, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-937; Observatoire regional d'Ile de France, 2011, CANC SEIN IL FRANC; Phillips Janice M, 2005, Semin Oncol Nurs, V21, P278, DOI 10.1016/j.soncn.2005.06.001; Renahy E, 2008, REV EPIDEMIOL SANTE, V56, P117, DOI 10.1016/j.respe.2008.01.009; Rondet C, 2013, PREV MED, V57, P386, DOI 10.1016/j.ypmed.2013.06.016; Vallee J, 2010, HEALTH PLACE, V16, P838, DOI 10.1016/j.healthplace.2010.04.009	31	22	22	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2014	9	1							e87046	10.1371/journal.pone.0087046	http://dx.doi.org/10.1371/journal.pone.0087046			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	297VL	24466323	Green Published, Green Submitted, gold			2022-12-25	WOS:000330283100246
J	Zhang, SD; Ling, LZ				Zhang, Shu-Dong; Ling, Li-Zhen			Genome-Wide Identification and Evolutionary Analysis of the SBP-Box Gene Family in Castor Bean	PLOS ONE			English	Article							TRANSCRIPTION FACTORS; DNA-BINDING; PROTEIN; ARABIDOPSIS; SEQUENCE; RATES; EXPRESSION; REGULATOR; DATABASE; DOMAIN	Genes in the SQUAMOSA promoter-binding-protein (SBP-box) gene family encode transcriptional regulators and perform a variety of regulatory functions that involved in the developmental and physiological processes of plants. In this study, a comprehensive computational analysis identified 15 candidates of the SBP-box gene family in the castor bean (Ricinus communis). The phylogenetic and domain analysis indicated that these genes were divided into two groups (group I and II). The group II was a big branch and was further classified into three subgroups (subgroup II-1 to 3) based on the phylogeny, gene structures and conserved motifs. It was observed that the genes of subgroup II-1 had distinct evolutionary features from those of the other two subgroups, however, were more similar to those of group I. Therefore, we inferred that group I and subgroup II-1 might retain ancient signals, whereas the subgroup II-2 and 3 exhibited the divergence during evolutionary process. Estimation of evolutionary parameters (dN and dN/dS) further supported our hypothesis. At first, the group I was more constrained by strong purifying selection and evolved slowly with a lower substitution rate than group II. As regards the three subgroups, subgroup II-1 had the lowest rate of substitution and was under strong purifying selection. By contrast, subgroups II-2 and 3 evolved more rapidly and experienced less purifying selection. These results indicated that the different evolutionary rates and selection strength caused the different evolutionary patterns of the members of SBP-box genes in castor bean. Taken together, these results provide better insights into understanding evolutionary divergence of the members of SBP-box gene family in castor bean and provide a guide for future functional diverse analyses of this gene family.	[Zhang, Shu-Dong; Ling, Li-Zhen] Chinese Acad Sci, Kunming Inst Bot, Key Lab Biodivers & Biogeog, Kunming, Peoples R China; [Zhang, Shu-Dong; Ling, Li-Zhen] Chinese Acad Sci, Kunming Inst Bot, Plant Germplasm & Genom Ctr, Germplasm Bank Wild Species, Kunming, Peoples R China	Chinese Academy of Sciences; Kunming Institute of Botany, CAS; Chinese Academy of Sciences; Kunming Institute of Botany, CAS	Zhang, SD (corresponding author), Chinese Acad Sci, Kunming Inst Bot, Key Lab Biodivers & Biogeog, Kunming, Peoples R China.	sdchang@mail.kib.ac.cn			National Natural Science Foundation of China [31200172]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the grant of National Natural Science Foundation of China (grant no. 31200172). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Birkenbihl RP, 2005, J MOL BIOL, V352, P585, DOI 10.1016/j.jmb.2005.07.013; Bloom JD, 2006, MOL BIOL EVOL, V23, P1751, DOI 10.1093/molbev/msl040; Cardon G, 1999, GENE, V237, P91, DOI 10.1016/S0378-1119(99)00308-X; Chan AP, 2010, NAT BIOTECHNOL, V28, P951, DOI 10.1038/nbt.1674; Chen XB, 2010, J INTEGR PLANT BIOL, V52, P946, DOI 10.1111/j.1744-7909.2010.00987.x; Cheng C, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-431; Guo AY, 2008, GENE, V418, P1, DOI 10.1016/j.gene.2008.03.016; Guo SG, 2013, NAT GENET, V45, P51, DOI 10.1038/ng.2470; Hou HM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059358; Huang SW, 2009, NAT GENET, V41, P1275, DOI 10.1038/ng.475; Iida K, 2005, DNA RES, V12, P247, DOI 10.1093/dnares/dsi011; Kong HZ, 2004, MOL BIOL EVOL, V21, P117, DOI 10.1093/molbev/msh001; Kropat J, 2005, P NATL ACAD SCI USA, V102, P18730, DOI 10.1073/pnas.0507693102; Letunic I, 2012, NUCLEIC ACIDS RES, V40, pD302, DOI 10.1093/nar/gkr931; Ling Li-Zhen, 2012, Plant Diversity and Resources, V34, P33, DOI 10.3724/SP.J.1143.2012.11117; Luscombe NM, 2000, GENOME BIOL, V1; Riano-Pachon DM, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-42; Riese M, 2007, GENE, V401, P28, DOI 10.1016/j.gene.2007.06.018; Salinas M, 2012, PLANTA, V235, P1171, DOI 10.1007/s00425-011-1565-y; Schmutz J, 2010, NATURE, V463, P178, DOI 10.1038/nature08670; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Toth-Petroczy A, 2011, P NATL ACAD SCI USA, V108, P11151, DOI 10.1073/pnas.1015994108; Velasco R, 2010, NAT GENET, V42, P833, DOI 10.1038/ng.654; Wall DP, 2005, P NATL ACAD SCI USA, V102, P5483, DOI 10.1073/pnas.0501761102; Wang Y, 2010, RUSS J PLANT PHYSL+, V57, P273, DOI 10.1134/S1021443710020160; Xie KB, 2006, PLANT PHYSIOL, V142, P280, DOI 10.1104/pp.106.084475; Yamasaki H, 2009, PLANT CELL, V21, P347, DOI 10.1105/tpc.108.060137; Yamasaki K, 2004, J MOL BIOL, V337, P49, DOI 10.1016/j.jmb.2004.01.015; Yang ZF, 2008, GENE, V407, P1, DOI 10.1016/j.gene.2007.02.034; Yang ZH, 2000, TRENDS ECOL EVOL, V15, P496, DOI 10.1016/S0169-5347(00)01994-7; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088	32	21	24	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2014	9	1							e86688	10.1371/journal.pone.0086688	http://dx.doi.org/10.1371/journal.pone.0086688			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297VL	24466202	Green Published, Green Submitted, gold			2022-12-25	WOS:000330283100197
J	Marquez, LB; Velazquez, N; Repetto, HA; Paton, AW; Paton, JC; Ibarra, C; Silberstein, C				Marquez, Laura B.; Velazquez, Natalia; Repetto, Horacio A.; Paton, Adrienne W.; Paton, James C.; Ibarra, Cristina; Silberstein, Claudia			Effects of Escherichia Coli Subtilase Cytotoxin and Shiga Toxin 2 on Primary Cultures of Human Renal Tubular Epithelial Cells	PLOS ONE			English	Article							HEMOLYTIC-UREMIC SYNDROME; ENDOPLASMIC-RETICULUM STRESS; CHAPERONE BIP; CYCLE ARREST; AB(5) TOXIN; VERO CELLS; APOPTOSIS; DAMAGE; ACTIVATION; RECEPTORS	Shiga toxin (Stx)-producing Escherichia coli (STEC) cause post-diarrhea Hemolytic Uremic Syndrome (HUS), which is the most common cause of acute renal failure in children in many parts of the world. Several non-O157 STEC strains also produce Subtilase cytotoxin (SubAB) that may contribute to HUS pathogenesis. The aim of the present work was to examine the cytotoxic effects of SubAB on primary cultures of human cortical renal tubular epithelial cells (HRTEC) and compare its effects with those produced by Shiga toxin type 2 (Stx2), in order to evaluate their contribution to renal injury in HUS. For this purpose, cell viability, proliferation rate, and apoptosis were assayed on HRTEC incubated with SubAB and/or Stx2 toxins. SubAB significantly reduced cell viability and cell proliferation rate, as well as stimulating cell apoptosis in HRTEC cultures in a time dependent manner. However, HRTEC cultures were significantly more sensitive to the cytotoxic effects of Stx2 than those produced by SubAB. No synergism was observed when HRTEC were co-incubated with both SubAB and Stx2. When HRTEC were incubated with the inactive SubA(A272)B toxin, results were similar to those in untreated control cells. Similar stimulation of apoptosis was observed in Vero cells incubated with SubAB or/and Stx2, compared to HRTEC. In conclusion, primary cultures of HRTEC are significantly sensitive to the cytotoxic effects of SubAB, although, in a lesser extent compared to Stx2.	[Marquez, Laura B.; Velazquez, Natalia; Silberstein, Claudia] Univ Buenos Aires, Fac Med, Inst Fisiol & Biofis Bernardo Houssay IFIBIO Hous, Lab Invest Biomed,Dept Fisiol, Buenos Aires, DF, Argentina; [Repetto, Horacio A.] Univ Buenos Aires, Fac Med, Dept Pediat, Buenos Aires, DF, Argentina; [Paton, Adrienne W.; Paton, James C.] Univ Adelaide, Sch Mol & Biomed Sci, Res Ctr Infect Dis, Adelaide, SA, Australia; [Ibarra, Cristina] Univ Buenos Aires, Fac Med, Inst Fisiol & Biofis Bernardo Houssay IFIBIO Hous, Lab Fisiopatogenia,Dept Fisiol, Buenos Aires, DF, Argentina	University of Buenos Aires; University of Buenos Aires; University of Adelaide; University of Buenos Aires	Silberstein, C (corresponding author), Univ Buenos Aires, Fac Med, Inst Fisiol & Biofis Bernardo Houssay IFIBIO Hous, Lab Invest Biomed,Dept Fisiol, Buenos Aires, DF, Argentina.	csilber@fmed.uba.ar	Ibarra, Cristina/D-6242-2016		Universidad de Buenos Aires [UBACYT M637, M057, M095]; National Agency for Promotion of Science and Technology [ANPCYT- PICT08- 642]	Universidad de Buenos Aires(University of Buenos Aires); National Agency for Promotion of Science and Technology(ANPCyT)	This work was supported by grants to C. Silberstein and C. Ibarra from the Universidad de Buenos Aires (UBACYT M637, M057, and M095), and National Agency for Promotion of Science and Technology (ANPCYT- PICT08- 642). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amaral MM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070431; Bergan J, 2012, TOXICON, V60, P1085, DOI 10.1016/j.toxicon.2012.07.016; Bhattacharjee RN, 2005, FEBS LETT, V579, P6604, DOI 10.1016/j.febslet.2005.10.053; Byres E, 2008, NATURE, V456, P648, DOI 10.1038/nature07428; Chong DC, 2008, CELL MICROBIOL, V10, P795, DOI 10.1111/j.1462-5822.2007.01085.x; Creydt VP, 2006, MICROBES INFECT, V8, P410, DOI 10.1016/j.micinf.2005.07.005; Endo Y, 1988, EUR J BIOCHEM, V171, P335; Galli L, 2010, VET MICROBIOL, V143, P307, DOI 10.1016/j.vetmic.2009.11.028; GIANANTONIO CA, 1964, J PEDIATR-US, V64, P478, DOI 10.1016/S0022-3476(64)80337-1; Irino K, 2010, J CLIN MICROBIOL, V48, P988, DOI 10.1128/JCM.00010-10; Johannes L, 2010, NAT REV MICROBIOL, V8, P105, DOI 10.1038/nrmicro2279; Kaneko K, 2001, NEPHRON, V87, P182, DOI 10.1159/000045909; KARMALI MA, 1985, J INFECT DIS, V151, P775, DOI 10.1093/infdis/151.5.775; Karpman D, 1998, INFECT IMMUN, V66, P636, DOI 10.1128/IAI.66.2.636-644.1998; Keepers TR, 2006, J AM SOC NEPHROL, V17, P3404, DOI 10.1681/ASN.2006050419; Kurmanova A, 2007, BIOCHEM BIOPH RES CO, V357, P144, DOI 10.1016/j.bbrc.2007.03.110; Lentz EK, 2011, INFECT IMMUN, V79, P3527, DOI 10.1128/IAI.05139-11; Lingwood CA, 1996, TRENDS MICROBIOL, V4, P147, DOI 10.1016/0966-842X(96)10017-2; Matsuura G, 2009, INFECT IMMUN, V77, P2919, DOI 10.1128/IAI.01510-08; Morinaga N, 2008, CELL MICROBIOL, V10, P921, DOI 10.1111/j.1462-5822.2007.01094.x; OBRIEN AD, 1987, MICROBIOL REV, V51, P206, DOI 10.1128/MMBR.51.2.206-220.1987; Paton AW, 2006, NATURE, V443, P548, DOI 10.1038/nature05124; Paton AW, 1999, J CLIN MICROBIOL, V37, P3357, DOI 10.1128/JCM.37.10.3357-3361.1999; Paton AW, 2004, J EXP MED, V200, P35, DOI 10.1084/jem.20040392; Pietenpol JA, 2002, TOXICOLOGY, V181, P475, DOI 10.1016/S0300-483X(02)00460-2; Repetto HA, 1997, KIDNEY INT, V52, P1708, DOI 10.1038/ki.1997.508; Repetto HA, 2005, KIDNEY INT, V68, pS102, DOI 10.1111/j.1523-1755.2005.09717.x; Rivas M, 2006, MEDICINA-BUENOS AIRE, V66, P27; SANDVIG K, 1992, NATURE, V358, P510, DOI 10.1038/358510a0; Saydam G, 2003, LEUKEMIA RES, V27, P709, DOI 10.1016/S0145-2126(02)00347-8; Silberstein C., 2008, J EPITHEL BIOL PHARM, V1, P71, DOI DOI 10.2174/1875044300801010071; Silberstein C, 2008, PEDIATR NEPHROL, V23, P1981, DOI 10.1007/s00467-008-0896-9; Silberstein C, 2011, PEDIATR RES, V69, P390, DOI 10.1203/PDR.0b013e318211dd57; SMITH R, 2009, CONSUM REP, V74, P6; Tabas I, 2011, NAT CELL BIOL, V13, P184, DOI 10.1038/ncb0311-184; Taguchi T, 1998, KIDNEY INT, V53, P1681, DOI 10.1046/j.1523-1755.1998.00939.x; Talukder KA, 2012, MICROB PATHOGENESIS, V52, P311, DOI 10.1016/j.micpath.2012.02.007; Tangvoranuntakul P, 2003, P NATL ACAD SCI USA, V100, P12045, DOI 10.1073/pnas.2131556100; Tesh VL, 2012, CELL MICROBIOL, V14, P1, DOI 10.1111/j.1462-5822.2011.01684.x; Tozzoli R, 2010, J CLIN MICROBIOL, V48, P178, DOI 10.1128/JCM.01648-09; Uchida H, 1999, PEDIATR RES, V45, P133, DOI 10.1203/00006450-199901000-00022; Verzola D, 2004, KIDNEY INT, V65, P1252, DOI 10.1111/j.1523-1755.2004.00497.x; Wang H, 2007, J INFECT DIS, V196, P1093, DOI 10.1086/521364; Wolfson JJ, 2008, CELL MICROBIOL, V10, P1775, DOI 10.1111/j.1462-5822.2008.01164.x; Yahiro K, 2006, MOL MICROBIOL, V62, P480, DOI 10.1111/j.1365-2958.2006.05379.x; Yahiro K, 2011, INFECT IMMUN, V79, P617, DOI 10.1128/IAI.01020-10; Yu M, 2005, INFECT IMMUN, V73, P2524, DOI 10.1128/IAI.73.4.2524-2532.2005; Zotta E, 2008, PEDIATR NEPHROL, V23, P559, DOI 10.1007/s00467-007-0727-4	48	21	22	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2014	9	1							e87022	10.1371/journal.pone.0087022	http://dx.doi.org/10.1371/journal.pone.0087022			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297GT	24466317	gold, Green Published, Green Submitted			2022-12-25	WOS:000330244500289
J	Raggioli, A; Junghans, D; Rudloff, S; Kemler, R				Raggioli, Angelo; Junghans, Dirk; Rudloff, Stefan; Kemler, Rolf			Beta-Catenin Is Vital for the Integrity of Mouse Embryonic Stem Cells	PLOS ONE			English	Article							DNA FRAGMENTATION FACTOR; PREVENT DIFFERENTIATION; 40-KDA SUBUNIT; SELF-RENEWAL; PLURIPOTENCY; APOPTOSIS; GENE; ESTABLISHMENT; REQUIREMENT; REPRESSION	beta-catenin mediated Wnt-signaling is assumed to play a major function in embryonic stem cells in maintaining their stem cell character and the exit from this unique trait. The complexity of beta-catenin action and conflicting results on the role of beta-catenin in maintaining the pluripotent state have made it difficult to understand its precise cellular and molecular functions. To attempt this issue we have generated new genetically modified mouse embryonic stem cell lines allowing for the deletion of beta-catenin in a controlled manner by taking advantage of the Cre-ER-T2 system and analyzed the effects in a narrow time window shortly after ablation. By using this approach, rather then taking long term cultured beta-catenin null cell lines we demonstrate that beta-catenin is dispensable for the maintenance of pluripotency associated genes. In addition we observed that the removal of beta-catenin leads to a strong increase of cell death, the appearance of multiple clustered functional centrosomes most likely due to a mis-regulation of the polo-like-kinase 2 and furthermore, alterations in chromosome segregation. Our study demonstrates the importance of beta-catenin in maintaining correct cellular functions and helps to understand its role in embryonic stem cells.	[Raggioli, Angelo; Junghans, Dirk; Rudloff, Stefan; Kemler, Rolf] Max Planck Inst Immunobiol & Epigenet, Emeritus Lab, Freiburg, Germany; [Junghans, Dirk] Univ Basel, Inst Embryol & Stem Cell Biol, Dept Biomedicine, Basel, Switzerland	Max Planck Society; University of Basel	Kemler, R (corresponding author), Max Planck Inst Immunobiol & Epigenet, Emeritus Lab, Freiburg, Germany.	kemler@immunbio.mpg.de		Raggioli, Angelo/0000-0002-6748-0307	Max Planck Society, Munich, Germany	Max Planck Society, Munich, Germany(Max Planck Society)	The study was financed by the Max Planck Society, Munich, Germany. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aladjem MI, 1998, CURR BIOL, V8, P145, DOI 10.1016/S0960-9822(98)70061-2; Anton R, 2007, FEBS LETT, V581, P5247, DOI 10.1016/j.febslet.2007.10.012; Auerbach W, 2000, BIOTECHNIQUES, V29, P1024, DOI 10.2144/00295st04; Bahmanyar S, 2008, GENE DEV, V22, P91, DOI 10.1101/gad.1596308; Bahmanyar S, 2010, J CELL SCI, V123, P3125, DOI 10.1242/jcs.064782; Bakre MM, 2007, J BIOL CHEM, V282, P31703, DOI 10.1074/jbc.M704287200; Block GJ, 2013, HUM MOL GENET; Boiani M, 2005, NAT REV MOL CELL BIO, V6, P872, DOI 10.1038/nrm1744; Brault V, 2001, DEVELOPMENT, V128, P1253; Doble BW, 2007, DEV CELL, V12, P957, DOI 10.1016/j.devcel.2007.04.001; Evans M, 2011, NAT REV MOL CELL BIO, V12, P680, DOI 10.1038/nrm3190; EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0; Feil Susanne, 2009, V530, P343, DOI 10.1007/978-1-59745-471-1_18; Ganem NJ, 2009, NATURE, V460, P278, DOI 10.1038/nature08136; Gaujoux S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055743; HAEGEL H, 1995, DEVELOPMENT, V121, P3529; Hansen PJ, 2011, BIOCHEM BIOPH RES CO, V413, P155, DOI 10.1016/j.bbrc.2011.08.064; Hao J, 2006, DEV BIOL, V290, P81, DOI 10.1016/j.ydbio.2005.11.011; Hoffmeyer K, 2012, SCIENCE, V336, P1549, DOI 10.1126/science.1218370; Huelsken J, 2001, CURR OPIN GENET DEV, V11, P547, DOI 10.1016/S0959-437X(00)00231-8; Huelsken J, 2000, J CELL BIOL, V148, P567, DOI 10.1083/jcb.148.3.567; Iglesias-Guimarais V, 2013, J BIOL CHEM, V288, P9200, DOI 10.1074/jbc.M112.411371; Ihrie RA, 2003, CURR BIOL, V13, P1985, DOI 10.1016/j.cub.2003.10.055; Jiang H, 2009, SCAND J GASTROENTERO, V44, P1452, DOI 10.3109/00365520903342166; Junghans D, 2005, DEV DYNAM, V233, P528, DOI 10.1002/dvdy.20365; Kops GJPL, 2005, NAT REV CANCER, V5, P773, DOI 10.1038/nrc1714; Kuhl S.J., 2012, BIOCHIM BIOPHYS ACTA, V1830, P2297; Lindsley RC, 2006, DEVELOPMENT, V133, P3787, DOI 10.1242/dev.02551; Liu XS, 1998, P NATL ACAD SCI USA, V95, P8461, DOI 10.1073/pnas.95.15.8461; Liu XS, 1997, CELL, V89, P175, DOI 10.1016/S0092-8674(00)80197-X; Lyashenko N, 2011, NAT CELL BIOL, V13, P753, DOI 10.1038/ncb2260; Meissner Alexander, 2009, V482, P3, DOI 10.1007/978-1-59745-060-7_1; Messerschmidt DM, 2010, DEV BIOL, V344, P129, DOI 10.1016/j.ydbio.2010.04.020; Moon RT, 2002, SCIENCE, V296, P1644, DOI 10.1126/science.1071549; Ng HH, 2011, NAT CELL BIOL, V13, P490, DOI 10.1038/ncb0511-490; Nowak M, 2005, CELL DEATH DIFFER, V12, P52, DOI 10.1038/sj.cdd.4401519; Prost S, 1998, FEBS LETT, V425, P499, DOI 10.1016/S0014-5793(98)00296-8; Rudloff S, 2012, DEVELOPMENT, V139, P3711, DOI 10.1242/dev.085597; Sato N, 2004, NAT MED, V10, P55, DOI 10.1038/nm979; Shoshani T, 2002, MOL CELL BIOL, V22, P2283, DOI 10.1128/MCB.22.7.2283-2293.2002; Singla DK, 2006, BIOCHEM BIOPH RES CO, V345, P789, DOI 10.1016/j.bbrc.2006.04.125; Soncin F, 2009, STEM CELLS, V27, P2069, DOI 10.1002/stem.134; Ten Berge D, 2011, NAT CELL BIOL, V13, P1070, DOI 10.1038/ncb2314; Tepass U, 2000, NAT REV MOL CELL BIO, V1, P91, DOI 10.1038/35040042; Wagner RT, 2010, STEM CELLS, V28, P1794, DOI 10.1002/stem.502; Wang ZD, 2011, METHODS MOL BIOL, V770, P529, DOI 10.1007/978-1-61779-210-6_21; Warnke S, 2004, CURR BIOL, V14, P1200, DOI 10.1016/j.cub.2004.06.059; Watanabe K, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2002436; Wodarz A, 1998, ANNU REV CELL DEV BI, V14, P59, DOI 10.1146/annurev.cellbio.14.1.59; Wray J, 2012, TRENDS CELL BIOL, V22, P159, DOI 10.1016/j.tcb.2011.11.004; Wray J, 2011, NAT CELL BIOL, V13, P838, DOI 10.1038/ncb2267; Yi F, 2011, NAT CELL BIOL, V13, P762, DOI 10.1038/ncb2283; Ying QL, 2008, NATURE, V453, P519, DOI 10.1038/nature06968; Zechner D, 2003, DEV BIOL, V258, P406, DOI 10.1016/S0012-1606(03)00123-4; Zhu JJ, 2012, GENESIS, V50, P102, DOI 10.1002/dvg.20799	55	21	22	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2014	9	1							e86691	10.1371/journal.pone.0086691	http://dx.doi.org/10.1371/journal.pone.0086691			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297GT	24466203	Green Published, gold, Green Submitted			2022-12-25	WOS:000330244500274
J	Tseng, CH				Tseng, Chin-Hsiao			Human Insulin Does Not Increase Bladder Cancer Risk	PLOS ONE			English	Article							GROWTH-FACTOR-I; DIABETIC-PATIENTS; PIOGLITAZONE; ACTIVATION; BINDING; ANALOGS; TAIWAN; COHORT; CELLS	Background: Whether human insulin can induce bladder cancer is rarely studied. Methods: The reimbursement databases of all Taiwanese diabetic patients from 1996 to 2009 were retrieved from the National Health Insurance. An entry date was set at 1 January 2004 and a total of 785,234 patients with type 2 diabetes were followed up for bladder cancer incidence until the end of 2009. Users of pioglitazone were excluded and the period since the initiation of insulin glargine (marketed after the entry date in Taiwan) was not included in the calculation of follow-up. Incidences for ever-users, never-users and subgroups of human insulin exposure (using tertile cutoffs of time since starting insulin, duration of therapy and cumulative dose) were calculated and the hazard ratios were estimated by Cox regression. Results: There were 87,940 ever-users and 697,294 never-users, with respective numbers of incident bladder cancer of 454 (0.52%) and 3,330 (0.48%), and respective incidence of 120.49 and 94.74 per 100,000 person-years. The overall hazard ratios (95% confidence intervals) indicated a significant association with insulin in the age-sex-adjusted models [1.238 (1.122-1.366)], but not in the model adjusted for all covariates [1.063 (0.951-1.187)]. There was also a significant trend for the hazard ratios for the different categories of the dose-response parameters in the age-sex-adjusted models, which became insignificant when all covariates were adjusted. Conclusions: This study relieves the concern of a bladder cancer risk associated with human insulin. Appropriate adjustment for confounders is important in the evaluation of cancer risk associated with a medication.	[Tseng, Chin-Hsiao] Natl Taiwan Univ, Coll Med, Dept Internal Med, Taipei, Taiwan; [Tseng, Chin-Hsiao] Natl Taiwan Univ Hosp, Dept Internal Med, Div Endocrinol & Metab, Taipei 100, Taiwan; [Tseng, Chin-Hsiao] Natl Hlth Res Inst, Div Environm Hlth & Occupat Med, Taipei, Taiwan	National Taiwan University; National Taiwan University; National Taiwan University Hospital; National Health Research Institutes - Taiwan	Tseng, CH (corresponding author), Natl Taiwan Univ, Coll Med, Dept Internal Med, Taipei, Taiwan.	ccktsh@ms6.hinet.net		TSENG, CHIN-HSIAO/0000-0001-9545-7123	National Science Council of Taiwan [NSC102-2314-B-002-067]	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan)	The study was supported by the National Science Council (NSC102-2314-B-002-067) of Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cheng TM, 2003, HEALTH AFFAIR, V22, P61, DOI 10.1377/hlthaff.22.3.61; Giovannucci E, 2010, DIABETES CARE, V33, P1674, DOI 10.2337/dc10-0666; Hursting SD, 2009, MOL CARCINOGEN, V48, P671, DOI 10.1002/mc.20548; Jacobs BL, 2010, CA-CANCER J CLIN, V60, P244, DOI 10.3322/caac.20077; Kurtzhals P, 2000, DIABETES, V49, P999, DOI 10.2337/diabetes.49.6.999; Larsson SC, 2006, DIABETOLOGIA, V49, P2819, DOI 10.1007/s00125-006-0468-0; Lewis JD, 2011, DIABETES CARE, V34, P916, DOI 10.2337/dc10-1068; Liu S, 2011, DIABETES RES CLIN PR, V91, P177, DOI 10.1016/j.diabres.2010.11.009; MacKenzie T, 2011, CANCER-AM CANCER SOC, V117, P1552, DOI 10.1002/cncr.25641; Mannucci E, 2010, DIABETES CARE, V33, P1997, DOI 10.2337/dc10-0476; Metalli D, 2010, AM J PATHOL, V176, P2997, DOI 10.2353/ajpath.2010.090904; Ornskov D, 2006, FEBS J, V273, P5479, DOI 10.1111/j.1742-4658.2006.05539.x; Tseng CH, 2011, DIABETOLOGIA, V54, P2009, DOI 10.1007/s00125-011-2171-z; Tseng CH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0053096; Tseng CH, 2013, PANCREAS, V42, P42, DOI 10.1097/MPA.0b013e3182571ba9; Tseng CH, 2012, J ENVIRON SCI HEAL C, V30, P368, DOI 10.1080/10590501.2012.735519; Tseng CH, 2012, J FORMOS MED ASSOC, V111, P123, DOI 10.1016/j.jfma.2011.10.003; Tseng CH, 2009, ANN MED, V41, P371, DOI 10.1080/07853890902729778; van Stralen KJ, 2010, NEPHRON CLIN PRACT, V116, pC143, DOI 10.1159/000315883; Watson JA, 2009, BJU INT, V103, P694, DOI 10.1111/j.1464-410X.2008.08213.x; Zhao H, 2003, J UROLOGY, V169, P714, DOI 10.1016/S0022-5347(05)63999-7	21	6	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2014	9	1							e86517	10.1371/journal.pone.0086517	http://dx.doi.org/10.1371/journal.pone.0086517			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297FH	24466131	Green Published, Green Submitted, gold			2022-12-25	WOS:000330240500136
J	Haldar, AK; Piro, AS; Pilla, DM; Yamamoto, M; Coers, J				Haldar, Arun K.; Piro, Anthony S.; Pilla, Danielle M.; Yamamoto, Masahiro; Coers, Joern			The E2-Like Conjugation Enzyme Atg3 Promotes Binding of IRG and Gbp Proteins to Chlamydia- and Toxoplasma-Containing Vacuoles and Host Resistance	PLOS ONE			English	Article							CELL-AUTONOMOUS IMMUNITY; INTERFERON-GAMMA; MGBP2 CONTROLS; AUTOPHAGY; GTPASES; TRACHOMATIS; MEMBRANE; GONDII; MECHANISM; SUSCEPTIBILITY	Cell-autonomous immunity to the bacterial pathogen Chlamydia trachomatis and the protozoan pathogen Toxoplasma gondii is controlled by two families of Interferon (IFN)-inducible GTPases: Immunity Related GTPases (IRGs) and Guanylate binding proteins (Gbps). Members of these two GTPase families associate with pathogen-containing vacuoles (PVs) and solicit antimicrobial resistance pathways specifically to the intracellular site of infection. The proper delivery of IRG and Gbp proteins to PVs requires the autophagy factor Atg5. Atg5 is part of a protein complex that facilitates the transfer of the ubiquitin-like protein Atg8 from the E2-like conjugation enzyme Atg3 to the lipid phosphatidylethanolamine. Here, we show that Atg3 expression, similar to Atg5 expression, is required for IRG and Gbp proteins to dock to PVs. We further demonstrate that expression of a dominant-active, GTP-locked IRG protein variant rescues the PV targeting defect of Atg3- and Atg5-deficient cells, suggesting a possible role for Atg proteins in the activation of IRG proteins. Lastly, we show that IFN-induced cell-autonomous resistance to C. trachomatis infections in mouse cells depends not only on Atg5 and IRG proteins, as previously demonstrated, but also requires the expression of Atg3 and Gbp proteins. These findings provide a foundation for a better understanding of IRG- and Gbp-dependent cell-autonomous resistance and its regulation by Atg proteins.	[Haldar, Arun K.; Piro, Anthony S.; Pilla, Danielle M.; Coers, Joern] Duke Univ, Med Ctr, Dept Mol Genet, Durham, NC 27710 USA; [Haldar, Arun K.; Piro, Anthony S.; Pilla, Danielle M.; Coers, Joern] Duke Univ, Med Ctr, Dept Microbiol & Immunol, Durham, NC USA; [Yamamoto, Masahiro] Osaka Univ, Dept Microbiol & Immunol, Osaka, Japan	Duke University; Duke University; Osaka University	Coers, J (corresponding author), Duke Univ, Med Ctr, Dept Mol Genet, Durham, NC 27710 USA.	jorn.coers@duke.edu	HALDAR, ARUN/AHA-8902-2022	HALDAR, ARUN/0000-0002-0599-2286; Coers, Jorn/0000-0001-8707-4608	NIH [AI103197]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI103197] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by NIH grant AI103197. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Zeer MA, 2013, AUTOPHAGY, V9, P50, DOI 10.4161/auto.22482; Al-Zeer MA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004588; Bekpen C, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-11-r92; Bernstein-Hanley I, 2006, GENES IMMUN, V7, P122, DOI 10.1038/sj.gene.6364285; Bernstein-Hanley I, 2006, P NATL ACAD SCI USA, V103, P14092, DOI 10.1073/pnas.0603338103; Chang TK, 2013, NAT CELL BIOL, V15, P1067, DOI 10.1038/ncb2804; Coers J, 2008, J IMMUNOL, V180, P6237, DOI 10.4049/jimmunol.180.9.6237; Coers J, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003538; Coers J, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001346; Collazo CM, 2001, J EXP MED, V194, P181, DOI 10.1084/jem.194.2.181; Degrandi D, 2007, J IMMUNOL, V179, P7729, DOI 10.4049/jimmunol.179.11.7729; Degrandi D, 2013, P NATL ACAD SCI USA, V110, P294, DOI 10.1073/pnas.1205635110; Dupont N, 2011, EMBO J, V30, P4701, DOI 10.1038/emboj.2011.398; Ehrt S, 2001, J EXP MED, V194, P1123, DOI 10.1084/jem.194.8.1123; Fentress SJ, 2010, CELL HOST MICROBE, V8, P484, DOI 10.1016/j.chom.2010.11.005; Goujon C, 2013, NATURE, V502, P559, DOI 10.1038/nature12542; Haldar AK, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003414; Henry SC, 2009, J LEUKOCYTE BIOL, V85, P877, DOI 10.1189/jlb.1008599; Holler O, 2009, REV SCI TECH OIE, V28, P219, DOI 10.20506/rst.28.1.1867; Howard JC, 2011, CURR OPIN MICROBIOL, V14, P414, DOI 10.1016/j.mib.2011.07.002; Hunn JP, 2008, EMBO J, V27, P2495, DOI 10.1038/emboj.2008.176; Hwang S, 2012, CELL HOST MICROBE, V11, P397, DOI 10.1016/j.chom.2012.03.002; Khaminets A, 2010, CELL MICROBIOL, V12, P939, DOI 10.1111/j.1462-5822.2010.01443.x; Kim BH, 2012, CELL HOST MICROBE, V12, P432, DOI 10.1016/j.chom.2012.09.007; Kravets E, 2012, J BIOL CHEM, V287, P27452, DOI 10.1074/jbc.M112.379636; Kuma A, 2004, NATURE, V432, P1032, DOI 10.1038/nature03029; Ling YM, 2006, J EXP MED, V203, P2063, DOI 10.1084/jem.20061318; Liu ZL, 2013, CELL HOST MICROBE, V14, P398, DOI 10.1016/j.chom.2013.08.015; Martens S, 2005, PLOS PATHOG, V1, P187, DOI 10.1371/journal.ppat.0010024; Muller JMM, 2002, J CELL BIOL, V157, P1161, DOI 10.1083/jcb.200202082; Nishida Y, 2009, NATURE, V461, P654, DOI 10.1038/nature08455; Papic N, 2008, J BIOL CHEM, V283, P32143, DOI 10.1074/jbc.M804846200; Pawlowski N, 2011, BMC BIOL, V9, DOI 10.1186/1741-7007-9-7; Randow F, 2013, SCIENCE, V340, P701, DOI 10.1126/science.1233028; Rusinova I, 2013, NUCLEIC ACIDS RES, V41, pD1040, DOI 10.1093/nar/gks1215; Sagiv Y, 2000, EMBO J, V19, P1494, DOI 10.1093/emboj/19.7.1494; Sanjuan MA, 2007, NATURE, V450, P1253, DOI 10.1038/nature06421; Scidmore MA, 2001, MOL MICROBIOL, V39, P1638, DOI 10.1046/j.1365-2958.2001.02355.x; Selleck EM, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003320; Slobodkin MR, 2013, ESSAYS BIOCHEM, V55, P51, DOI [10.1042/bse0550051, 10.1042/BSE0550051]; Sou Y, 2008, MOL BIOL CELL, V19, P4762, DOI 10.1091/mbc.E08-03-0309; Springer HM, 2013, J IMMUNOL, V191, P1765, DOI 10.4049/jimmunol.1300641; Steinfeldt T, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000576; Tanida I, 2011, MICROBIOL IMMUNOL, V55, P1, DOI 10.1111/j.1348-0421.2010.00271.x; Taylor GA, 2000, P NATL ACAD SCI USA, V97, P751, DOI 10.1073/pnas.97.2.751; Tietzel I, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006499; Traver MK, 2011, J BIOL CHEM; Virreira Winter S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024434; Wang YB, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002258; Yamamoto M, 2012, IMMUNITY; Zhao ZJ, 2008, CELL HOST MICROBE, V4, P458, DOI 10.1016/j.chom.2008.10.003	51	66	70	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2014	9	1							e86684	10.1371/journal.pone.0086684	http://dx.doi.org/10.1371/journal.pone.0086684			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297EA	24466199	gold, Green Published, Green Submitted			2022-12-25	WOS:000330237000102
J	Dufort, FJ; Gumina, MR; Ta, NL; Tao, YZ; Heyse, SA; Scott, DA; Richardson, AD; Seyfried, TN; Chiles, TC				Dufort, Fay J.; Gumina, Maria R.; Ta, Nathan L.; Tao, Yongzhen; Heyse, Shannon A.; Scott, David A.; Richardson, Adam D.; Seyfried, Thomas N.; Chiles, Thomas C.			Glucose-dependent de Novo Lipogenesis in B Lymphocytes A REQUIREMENT FOR ATP-CITRATE LYASE IN LIPOPOLYSACCHARIDE-INDUCED DIFFERENTIATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Acetyl Coenzyme A; Cell Metabolism; Differentiation; Glucose Metabolism; Lipogenesis; Lipopolysaccharide (LPS)	FUNCTIONALLY RELATED PROTEINS; FATTY-ACID SYNTHASE; ENDOPLASMIC-RETICULUM; CELL DIFFERENTIATION; BRAIN LIPIDS; HUMAN CANCER; IN-VIVO; METABOLISM; MEMBRANE; GLYCOSYLATION	Background: The metabolic requirements underlying B lymphocyte differentiation are poorly understood. Results: Differentiation is accompanied by glucose metabolism into fatty acid and cholesterol synthesis, mediated by ATP-citrate lyase (ACLY). Conclusion: ACLY-dependent lipogenesis is required for several phenotypic changes defining plasma cell differentiation. Significance: This study proposes a critical role for ACLY coupled glucose-dependent de novo lipogenesis in LPS-induced B lymphocyte differentiation. Bacterially derived lipopolysaccharide (LPS) stimulates naive B lymphocytes to differentiate into immunoglobulin (Ig)-secreting plasma cells. Differentiation of B lymphocytes is characterized by a proliferative phase followed by expansion of the intracellular membrane secretory network to support Ig production. A key question in lymphocyte biology is how naive B cells reprogram metabolism to support de novo lipogenesis necessary for proliferation and expansion of the endomembrane network in response to LPS. We report that extracellularly acquired glucose is metabolized, in part, to support de novo lipogenesis in response to LPS stimulation of splenic B lymphocytes. LPS stimulation leads to increased levels of endogenous ATP-citrate lyase (ACLY), and this is accompanied by increased ACLY enzymatic activity. ACLY produces cytosolic acetyl-CoA from mitochondrially derived citrate. Inhibition of ACLY activity in LPS-stimulated B cells with the selective inhibitor 2-hydroxy-N-arylbenzenesulfonamide (compound-9; C-9) blocks glucose incorporation into de novo lipid biosynthesis, including cholesterol, free fatty acids, and neutral and acidic phospholipids. Moreover, inhibition of ACLY activity in splenic B cells results in inhibition of proliferation and defective endomembrane expansion and reduced expression of CD138 and Blimp-1, markers for plasma-like B cell differentiation. ACLY activity is also required for LPS-induced IgM production in CH12 B lymphoma cells. These data demonstrate that ACLY mediates glucose-dependent de novo lipogenesis in response to LPS signaling and identify a role for ACLY in several phenotypic changes that define plasma cell differentiation.	[Dufort, Fay J.; Gumina, Maria R.; Ta, Nathan L.; Heyse, Shannon A.; Seyfried, Thomas N.; Chiles, Thomas C.] Boston Coll, Dept Biol, Chestnut Hill, MA 02467 USA; [Tao, Yongzhen; Scott, David A.; Richardson, Adam D.] Sanford Burnham Med Res Inst La Jolla, La Jolla, CA 92037 USA	Boston College; Sanford Burnham Prebys Medical Discovery Institute	Chiles, TC (corresponding author), Boston Coll, Dept Biol, Chestnut Hill, MA 02467 USA.	chilest@bc.edu	Richardson, Adam D/N-7845-2014	Richardson, Adam D/0000-0003-3646-2584; , Yongzhen/0000-0003-1710-5346; Scott, David/0000-0002-8668-2449; Seyfried, Thomas/0000-0003-1491-3989	National Institutes of Health [5R01AI074687]; Margaret Walsh Faculty Research Fund; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI074687] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Margaret Walsh Faculty Research Fund; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant 5R01AI074687 (to T.C.C.). This work was also supported by the Margaret Walsh Faculty Research Fund (to T.C.C.)	Abramson HN, 2011, J MED CHEM, V54, P5615, DOI 10.1021/jm2005805; Baek RC, 2009, LIPIDS, V44, P197, DOI 10.1007/s11745-008-3268-0; Bauer DE, 2005, ONCOGENE, V24, P6314, DOI 10.1038/sj.onc.1208773; Beigneux AP, 2004, J BIOL CHEM, V279, P9557, DOI 10.1074/jbc.M310512200; Berwick DC, 2002, J BIOL CHEM, V277, P33895, DOI 10.1074/jbc.M204681200; Brewer J. W., 2012, BIOCH RES INT; CALDER PC, 1994, BIOCHEM J, V300, P509, DOI 10.1042/bj3000509; Carr EL, 2010, J IMMUNOL, V185, P1037, DOI 10.4049/jimmunol.0903586; Chu KY, 2010, J BIOL CHEM, V285, P32606, DOI 10.1074/jbc.M110.157172; Chypre M, 2012, BIOCHEM BIOPH RES CO, V422, P1, DOI 10.1016/j.bbrc.2012.04.144; Costello LC, 2005, MOL CELL BIOCHEM, V280, P1, DOI 10.1007/s11010-005-8841-8; DeBerardinis RJ, 2008, CELL METAB, V7, P11, DOI 10.1016/j.cmet.2007.10.002; Doughty CA, 2006, BLOOD, V107, P4458, DOI 10.1182/blood-2005-12-4788; Fagone P, 2007, J BIOL CHEM, V282, P7591, DOI 10.1074/jbc.M608175200; Fagone P, 2009, J BIOL CHEM, V284, P6847, DOI 10.1074/jbc.M807338200; FOLCH J, 1957, J BIOL CHEM, V226, P497; Fox CJ, 2005, NAT REV IMMUNOL, V5, P844, DOI 10.1038/nri1710; Frauwirth KA, 2002, IMMUNITY, V16, P769, DOI 10.1016/S1074-7613(02)00323-0; Garcia-Manteiga JM, 2011, J PROTEOME RES, V10, P4165, DOI 10.1021/pr200328f; Goldfinger M, 2009, J IMMUNOL, V182, P7038, DOI 10.4049/jimmunol.0802990; Guay C, 2007, J BIOL CHEM, V282, P35657, DOI 10.1074/jbc.M707294200; Hanai J, 2012, J CELL PHYSIOL, V227, P1709, DOI 10.1002/jcp.22895; Hatzivassiliou G, 2005, CANCER CELL, V8, P311, DOI 10.1016/j.ccr.2005.09.008; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Icard P, 2012, BBA-REV CANCER, V1825, P111, DOI 10.1016/j.bbcan.2011.10.007; Joseph JW, 2007, J BIOL CHEM, V282, P31592, DOI 10.1074/jbc.M706080200; Karnell FG, 2005, J BIOL CHEM, V280, P25621, DOI 10.1074/jbc.M503162200; Kirk SJ, 2010, J LEUKOCYTE BIOL, V87, P245, DOI 10.1189/jlb.1208774; Krauss S, 2001, IMMUNITY, V15, P497, DOI 10.1016/S1074-7613(01)00205-9; Kuhajda FP, 2000, NUTRITION, V16, P202, DOI 10.1016/S0899-9007(99)00266-X; Le A, 2012, CELL METAB, V15, P110, DOI 10.1016/j.cmet.2011.12.009; LEE WNP, 1994, AM J PHYSIOL, V266, pE699, DOI 10.1152/ajpendo.1994.266.5.E699; Li JJ, 2007, BIOORG MED CHEM LETT, V17, P3208, DOI 10.1016/j.bmcl.2007.03.017; LINN TC, 1979, J BIOL CHEM, V254, P1691; Ma ZP, 2009, J LIPID RES, V50, P2131, DOI 10.1194/jlr.D900008-JLR200; MACALA LJ, 1983, J LIPID RES, V24, P1243; Maddaly R, 2010, FEBS LETT, V584, P4883, DOI 10.1016/j.febslet.2010.08.022; Mashima T, 2009, BRIT J CANCER, V100, P1369, DOI 10.1038/sj.bjc.6605007; McGehee AM, 2009, J IMMUNOL, V183, P3690, DOI 10.4049/jimmunol.0900953; Michalek RD, 2011, J IMMUNOL, V186, P3299, DOI 10.4049/jimmunol.1003613; Migita T, 2008, CANCER RES, V68, P8547, DOI 10.1158/0008-5472.CAN-08-1235; Potapova IA, 2000, BIOCHEMISTRY-US, V39, P1169, DOI 10.1021/bi992159y; Rathmell JC, 2001, J IMMUNOL, V167, P6869, DOI 10.4049/jimmunol.167.12.6869; Romijn EP, 2005, MOL CELL PROTEOMICS, V4, P1297, DOI 10.1074/mcp.M500123-MCP200; RUSH JS, 1991, ARCH BIOCHEM BIOPHYS, V284, P63, DOI 10.1016/0003-9861(91)90264-J; Schug ZT, 2012, ACTA ONCOL, V51, P301, DOI 10.3109/0284186X.2011.643823; Scott DA, 2011, J BIOL CHEM, V286, P42626, DOI 10.1074/jbc.M111.282046; Shaffer AL, 2004, IMMUNITY, V21, P81, DOI 10.1016/j.immuni.2004.06.010; SRERE PA, 1975, ADV ENZYMOL RAMB, V43, P57; SRERE PA, 1959, J BIOL CHEM, V234, P2544; STOCKDALE AM, 1987, J IMMUNOL, V139, P3527; van Anken E, 2003, IMMUNITY, V18, P243, DOI 10.1016/S1074-7613(03)00024-4; WATSON JA, 1969, ARCH BIOCHEM BIOPHYS, V135, P209, DOI 10.1016/0003-9861(69)90532-3; WIEST DL, 1990, J CELL BIOL, V110, P1501, DOI 10.1083/jcb.110.5.1501; Yang C, 2008, METABOLOMICS, V4, P13, DOI 10.1007/s11306-007-0094-y; Yoo H, 2008, J BIOL CHEM, V283, P20621, DOI 10.1074/jbc.M706494200; Yoshii Y, 2009, CANCER SCI, V100, P821, DOI 10.1111/j.1349-7006.2009.01099.x; Zaidi N, 2012, CANCER RES, V72, P3709, DOI 10.1158/0008-5472.CAN-11-4112	58	97	98	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 7	2014	289	10					7011	7024		10.1074/jbc.M114.551051	http://dx.doi.org/10.1074/jbc.M114.551051			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AC3BG	24469453	Green Published, hybrid			2022-12-25	WOS:000332389400061
J	Inoue, A; Kikuchi, S; Hishiki, A; Shao, YM; Heath, R; Evison, BJ; Actis, M; Canman, CE; Hashimoto, H; Fujii, N				Inoue, Akira; Kikuchi, Sotaro; Hishiki, Asami; Shao, Youming; Heath, Richard; Evison, Benjamin J.; Actis, Marcelo; Canman, Christine E.; Hashimoto, Hiroshi; Fujii, Naoaki			A Small Molecule Inhibitor of Monoubiquitinated Proliferating Cell Nuclear Antigen (PCNA) Inhibits Repair of Interstrand DNA Cross-link, Enhances DNA Double Strand Break, and Sensitizes Cancer Cells to Cisplatin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Crystallography; DNA Damage; Small Molecules; Structural Biology; Ubiquitination; PCNA; Interstrand Cross-link	UBIQUITIN-BINDING MOTIFS; POLYMERASE-ZETA; HOMOLOGOUS RECOMBINATION; TRANSLESION SYNTHESIS; ACCESSORY SUBUNITS; STRUCTURAL BASIS; DAMAGE RESPONSE; REV1 PROTEIN; ETA; REPLICATION	Background: Lys-164-monoubiquitinated PCNA is essential for interstrand DNA cross-link (ICL) repair. Results: A small molecule, T2AA, bi-molecularly binds to PCNA at a PIP-box cavity and close to Lys-164. T2AA inhibited monoubiquitinated PCNA interactions and ICL repair and enhanced DNA double strand breaks. Conclusion: An inhibitor of monoubiquitinated PCNA inhibits ICL repair. Significance: Inhibition of monoubiquitinated PCNA could improve chemotherapeutic efficacy. Small molecule inhibitors of proliferating cell nuclear antigen (PCNA)/PCNA interacting protein box (PIP-Box) interactions, including T2 amino alcohol (T2AA), inhibit translesion DNA synthesis. The crystal structure of PCNA in complex with T2AA revealed that T2AA bound to the surface adjacent to the subunit interface of the homotrimer of PCNA in addition to the PIP-box binding cavity. Because this site is close to Lys-164, which is monoubiquitinated by RAD18, we postulated that T2AA would affect monoubiquitinated PCNA interactions. Binding of monoubiquitinated PCNA and a purified pol fragment containing the UBZ and PIP-box was inhibited by T2AA in vitro. T2AA decreased PCNA/pol and PCNA/REV1 chromatin colocalization but did not inhibit PCNA monoubiquitination, suggesting that T2AA hinders interactions of pol and REV1 with monoubiquitinated PCNA. Interstrand DNA cross-links (ICLs) are repaired by mechanisms using translesion DNA synthesis that is regulated by monoubiquitinated PCNA. T2AA significantly delayed reactivation of a reporter plasmid containing an ICL. Neutral comet analysis of cells receiving T2AA in addition to cisplatin revealed that T2AA significantly enhanced formation of DNA double strand breaks (DSBs) by cisplatin. T2AA promoted colocalized foci formation of phospho-ATM and 53BP1 and up-regulated phospho-BRCA1 in cisplatin-treated cells, suggesting that T2AA increases DSBs. When cells were treated by cisplatin and T2AA, their clonogenic survival was significantly less than that of those treated by cisplatin only. These findings show that the inhibitors of monoubiquitinated PCNA chemosensitize cells by inhibiting repair of ICLs and DSBs.	[Inoue, Akira; Evison, Benjamin J.; Actis, Marcelo; Fujii, Naoaki] St Jude Childrens Res Hosp, Dept Chem Biol & Therapeut, Memphis, TN 38138 USA; [Shao, Youming; Heath, Richard] St Jude Childrens Res Hosp, Prot Prod Facil, Memphis, TN 38138 USA; [Kikuchi, Sotaro; Hishiki, Asami; Hashimoto, Hiroshi] Yokohama City Univ, Grad Sch Med Life Sci, Dept Med Life Sci, Yokohama, Kanagawa 2300045, Japan; [Canman, Christine E.] Univ Michigan, Sch Med, Dept Pharmacol, Ann Arbor, MI 48109 USA	St Jude Children's Research Hospital; St Jude Children's Research Hospital; Yokohama City University; University of Michigan System; University of Michigan	Fujii, N (corresponding author), St Jude Childrens Res Hosp, Dept Chem Biol & Therapeut, 262 Danny Thomas Pl, Memphis, TN 38105 USA.	naoaki.fujii@stjude.org	Fujii, Naoaki/I-6423-2013	, Christine/0000-0001-8892-7430; Hashimoto, Hiroshi/0000-0003-1503-6789; Heath, Richard/0000-0002-1795-1254	American Lebanese Syrian Associated Charities; American Cancer Society [RSG CDD-120969]; KAKENHI from MEXT, Japan; NATIONAL CANCER INSTITUTE [P30CA021765] Funding Source: NIH RePORTER	American Lebanese Syrian Associated Charities(American Lebanese Syrian Associated Charities (ALSAC)); American Cancer Society(American Cancer Society); KAKENHI from MEXT, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the American Lebanese Syrian Associated Charities and American Cancer Society Research Scholar Grant RSG CDD-120969 (to N. F.), and KAKENHI from MEXT, Japan (to A. H. and H. H.).	Actis M, 2013, BIOORGAN MED CHEM, V21, P1972, DOI 10.1016/j.bmc.2013.01.022; Baranovskiy AG, 2012, J BIOL CHEM, V287, P17281, DOI 10.1074/jbc.M112.351122; Bomar MG, 2007, EMBO REP, V8, P247, DOI 10.1038/sj.embor.7400901; Centore RC, 2012, MOL CELL, V46, P625, DOI 10.1016/j.molcel.2012.05.020; Collins AR, 2004, MOL BIOTECHNOL, V26, P249, DOI 10.1385/MB:26:3:249; Cortez D, 1999, SCIENCE, V286, P1162, DOI 10.1126/science.286.5442.1162; Deans AJ, 2011, NAT REV CANCER, V11, P467, DOI 10.1038/nrc3088; Despras E, 2012, ENVIRON MOL MUTAGEN, V53, P752, DOI 10.1002/em.21741; Durando M, 2013, NUCLEIC ACIDS RES, V41, P3079, DOI 10.1093/nar/gkt016; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Enoiu M, 2012, NUCLEIC ACIDS RES, V40, P8953, DOI 10.1093/nar/gks670; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Garg P, 2005, P NATL ACAD SCI USA, V102, P18361, DOI 10.1073/pnas.0505949102; Geng LY, 2010, J CELL BIOL, V191, P249, DOI 10.1083/jcb.201005101; Guo CX, 2006, MOL CELL BIOL, V26, P8892, DOI 10.1128/MCB.01118-06; Guo CX, 2006, MOL CELL, V23, P265, DOI 10.1016/j.molcel.2006.05.038; Hanada K, 2006, EMBO J, V25, P4921, DOI 10.1038/sj.emboj.7601344; Hicks JK, 2010, MOL CELL BIOL, V30, P1217, DOI 10.1128/MCB.00993-09; Johnson RE, 2012, P NATL ACAD SCI USA, V109, P12455, DOI 10.1073/pnas.1206052109; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kannouche PL, 2004, MOL CELL, V14, P491, DOI 10.1016/S1097-2765(04)00259-X; Kikuchi S, 2012, J BIOL CHEM, V287, P33847, DOI 10.1074/jbc.M112.396838; Li J, 2013, P NATL ACAD SCI USA, V110, P7672, DOI 10.1073/pnas.1222241110; Li X, 2009, MOL CELL, V36, P704, DOI 10.1016/j.molcel.2009.09.036; Mailand N, 2013, NAT REV MOL CELL BIO, V14, P269, DOI 10.1038/nrm3562; Maiti R, 2004, NUCLEIC ACIDS RES, V32, pW590, DOI 10.1093/nar/gkh477; Makarova AV, 2012, NUCLEIC ACIDS RES, V40, P11618, DOI 10.1093/nar/gks948; Moldovan GL, 2007, CELL, V129, P665, DOI 10.1016/j.cell.2007.05.003; Moldovan GL, 2012, MOL CELL, V45, P75, DOI 10.1016/j.molcel.2011.11.010; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; OLIVE PL, 1991, CANCER RES, V51, P4671; Pierce AJ, 1999, GENE DEV, V13, P2633, DOI 10.1101/gad.13.20.2633; Punchihewa C, 2012, J BIOL CHEM, V287, P14289, DOI 10.1074/jbc.M112.353201; Pustovalova Y, 2013, J MOL BIOL, V425, P3091, DOI 10.1016/j.jmb.2013.05.029; Raschle M, 2008, CELL, V134, P969, DOI 10.1016/j.cell.2008.08.030; Sale JE, 2012, NAT REV MOL CELL BIO, V13, P141, DOI 10.1038/nrm3289; Sarkar S, 2006, EMBO J, V25, P1285, DOI 10.1038/sj.emboj.7600993; Sebesta M, 2013, DNA REPAIR, V12, P691, DOI 10.1016/j.dnarep.2013.05.001; Sengerova B, 2011, CELL CYCLE, V10, P3999, DOI 10.4161/cc.10.23.18385; Sharma NM, 2011, J BIOL CHEM, V286, P33557, DOI 10.1074/jbc.M110.206680; Sharma S, 2012, NUCLEIC ACIDS RES, V40, P682, DOI 10.1093/nar/gkr769; Tan ZQ, 2012, MOL PHARMACOL, V81, P811, DOI 10.1124/mol.112.077735; TSENG BY, 1984, P NATL ACAD SCI-BIOL, V81, P2342, DOI 10.1073/pnas.81.8.2342; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; Watanabe K, 2004, EMBO J, V23, P3886, DOI 10.1038/sj.emboj.7600383; Waters LS, 2009, MICROBIOL MOL BIOL R, V73, P134, DOI 10.1128/MMBR.00034-08; Williams HL, 2012, MOL CELL, V47, P140, DOI 10.1016/j.molcel.2012.05.001; Wojtaszek J, 2012, J BIOL CHEM, V287, P33836, DOI 10.1074/jbc.M112.394841; Wood A, 2007, J BIOL CHEM, V282, P20256, DOI 10.1074/jbc.M702366200; Zhang ZT, 2012, CELL CYCLE, V11, P2128, DOI 10.4161/cc.20595	50	62	63	0	26	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 7	2014	289	10					7109	7120		10.1074/jbc.M113.520429	http://dx.doi.org/10.1074/jbc.M113.520429			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AC3BG	24474685	Green Published, hybrid			2022-12-25	WOS:000332389400070
J	Sun, L; Li, P; Carr, AL; Gorsuch, R; Yarka, C; Li, JL; Bartlett, M; Pfister, D; Hyde, DR; Li, L				Sun, Lei; Li, Ping; Carr, Aprell L.; Gorsuch, Ryne; Yarka, Clare; Li, Jingling; Bartlett, Michael; Pfister, Delaney; Hyde, David R.; Li, Lei			Transcription of the SCL/TAL1 Interrupting Locus (Stil) Is Required for Cell Proliferation in Adult Zebrafish Retinas	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cell Proliferation; Neurons; Oncogene; Retina; Zebrafish	GOLDFISH RETINA; SIL GENE; MULLER GLIA; DOPAMINERGIC-NEURONS; REGENERATION; EXPRESSION; ROD; 6-HYDROXYDOPAMINE; PROGENITORS; LEUKEMIA	Background:Stil is a human oncogene that is involved in cancer cell proliferation and survival. Results: In adult zebrafish retinas, knockdown of Stil expression decreases the rate of cell proliferation after degeneration. Conclusion: Through the Shh signal transduction pathway, Stil plays important roles in regulating cell proliferation. Significance: The results uncover a novel function of Stil in adult tissues, namely neural regeneration. The human oncogene SCL/TAL1 interrupting locus (Stil) is highly conserved in vertebrate species. Previously, we identified a homolog of the Stil gene in zebrafish mutant (night blindness b, nbb), which showed neural defects in the retina (e.g. dopaminergic cell degeneration and/or lack of regeneration). In this research, we examined the roles of Stil in cell proliferation after degeneration in adult zebrafish retinas. We demonstrated that knockdown of Stil gene expression or inhibition of Sonic hedgehog (Shh) signaling transduction decreases the rate of cell proliferation. In contrast, activation of Shh signal transduction promotes cell proliferation. In nbb(+/-) retinas, inhibition of SUFU (a repressor in the Shh pathway) rescues the defects in cell proliferation due to down-regulation of Stil gene expression. The latter data suggest that Stil play a role in cell proliferation through the Shh signal transduction pathway.	[Sun, Lei; Li, Ping; Carr, Aprell L.; Gorsuch, Ryne; Yarka, Clare; Li, Jingling; Bartlett, Michael; Pfister, Delaney; Hyde, David R.; Li, Lei] Univ Notre Dame, Dept Biol Sci, Notre Dame, IN 46556 USA; [Carr, Aprell L.; Gorsuch, Ryne; Li, Jingling; Hyde, David R.; Li, Lei] Univ Notre Dame, Ctr Zebrafish Res, Notre Dame, IN 46556 USA; [Sun, Lei] Nankai Univ, Dept Physiol, Tianjin 370001, Peoples R China	University of Notre Dame; University of Notre Dame; Nankai University	Li, L (corresponding author), 100 Galvin Life Sci Bldg, Notre Dame, IN 46556 USA.	Li.78@nd.edu	Li, Lei/F-5722-2015	Li, Lei/0000-0001-9703-2102	National Institutes of Health [R01-EY013147, R01-EY018417]; Chinese Natural Science Foundation [81171066]; Tianjin Science and Technology Grant [12JCZDJC24000]; University of Notre Dame Center for Zebrafish Research; NATIONAL EYE INSTITUTE [R01EY018417, R01EY013147] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Chinese Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Tianjin Science and Technology Grant; University of Notre Dame Center for Zebrafish Research; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported, in whole or in part, by National Institutes of Health Grants R01-EY013147 and R01-EY018417, Chinese Natural Science Foundation Grant 81171066, Tianjin Science and Technology Grant 12JCZDJC24000, and the University of Notre Dame Center for Zebrafish Research.	APLAN PD, 1990, SCIENCE, V250, P1426, DOI 10.1126/science.2255914; APLAN PD, 1991, MOL CELL BIOL, V11, P5462, DOI 10.1128/MCB.11.11.5462; Arquint C, 2012, J CELL SCI, V125, P1342, DOI 10.1242/jcs.099887; Biehlmaier O, 2007, INVEST OPHTH VIS SCI, V48, P2887, DOI 10.1167/iovs.06-1212; BRAISTED JE, 1992, DEVELOPMENT, V114, P913; BRAISTED JE, 1994, DEVELOPMENT, V120, P2409; BRAISTED JE, 1993, DEV BRAIN RES, V76, P221, DOI 10.1016/0165-3806(93)90210-2; Brockerhoff SE, 2011, CELL MOL LIFE SCI, V68, P651, DOI 10.1007/s00018-010-0563-8; Buttner A, 2012, REPROD TOXICOL, V33, P254, DOI 10.1016/j.reprotox.2011.12.010; Campaner S, 2005, MOL CELL BIOL, V25, P6660, DOI 10.1128/MCB.25.15.6660-6672.2005; Castiel A, 2011, J CELL SCI, V124, P532, DOI 10.1242/jcs.079731; COHEN JL, 1983, BRAIN RES, V264, P307, DOI 10.1016/0006-8993(83)90830-2; CollazoGarcia N, 1995, GENOMICS, V30, P506, DOI 10.1006/geno.1995.1271; Craig SEL, 2010, INVEST OPHTH VIS SCI, V51, P3244, DOI 10.1167/iovs.09-4879; Curry JD, 2003, LEUKEMIA RES, V27, P575, DOI 10.1016/S0145-2126(02)00260-6; Erez A, 2007, CANCER RES, V67, P4022, DOI 10.1158/0008-5472.CAN-07-0064; Feijoo CG, 2011, EUR J NEUROSCI, V33, P589, DOI 10.1111/j.1460-9568.2010.07560.x; Golling G, 2002, NAT GENET, V31, P135, DOI 10.1038/ng896; Gosse NJ, 2009, P NATL ACAD SCI USA, V106, P2236, DOI 10.1073/pnas.0803202106; HITCHCOCK PF, 1994, VISUAL NEUROSCI, V11, P209, DOI 10.1017/S0952523800001577; Izraeli S, 2001, GENESIS, V31, P72, DOI 10.1002/gene.10004; Izraeli S, 1999, NATURE, V399, P691, DOI 10.1038/21429; Izraeli S, 1997, CELL GROWTH DIFFER, V8, P1171; Jusuf PR, 2011, J NEUROSCI, V31, P2549, DOI 10.1523/JNEUROSCI.4713-10.2011; Kasai K, 2008, CANCER RES, V68, P7723, DOI 10.1158/0008-5472.CAN-07-6661; Li JL, 2013, J BIOL CHEM, V288, P886, DOI 10.1074/jbc.M112.417089; Li L, 2000, J NEUROSCI, V20, P1883; Li L, 2000, J NEUROSCI, V20, P1893; Link BA, 2001, DEV BIOL, V236, P436, DOI 10.1006/dbio.2001.0340; Morris AC, 2008, DEV NEUROBIOL, V68, P605, DOI 10.1002/dneu.20610; NEGISHI K, 1991, CELL MOL NEUROBIOL, V11, P639, DOI 10.1007/BF00741451; NEGISHI K, 1985, DEV BRAIN RES, V20, P291, DOI 10.1016/0165-3806(85)90117-8; O'Neil J, 2004, CANCER CELL, V5, P587, DOI 10.1016/j.ccr.2004.05.023; Pfaff KL, 2007, MOL CELL BIOL, V27, P5887, DOI 10.1128/MCB.00175-07; Powell C, 2012, J NEUROSCI, V32, P1096, DOI 10.1523/JNEUROSCI.5603-11.2012; Qin Zhao, 2012, Methods Mol Biol, V884, P255, DOI 10.1007/978-1-61779-848-1_18; Raymond PA, 2006, BMC DEV BIOL, V6, DOI 10.1186/1471-213X-6-36; Stenkamp DL, 2011, PROG RETIN EYE RES, V30, P395, DOI 10.1016/j.preteyeres.2011.06.004; Sugiyama M, 2009, P NATL ACAD SCI USA, V106, P20812, DOI 10.1073/pnas.0906464106; Tang CJC, 2011, EMBO J, V30, P4790, DOI 10.1038/emboj.2011.378; Thummel R, 2008, EXP EYE RES, V87, P433, DOI 10.1016/j.exer.2008.07.009; Thummel R, 2008, DEV NEUROBIOL, V68, P392, DOI 10.1002/dneu.20596; Tyler MJ, 2005, J NEUROSCI, V25, P4565, DOI 10.1523/JNEUROSCI.0588-05.2005; Vihtelic TS, 2000, J NEUROBIOL, V44, P289, DOI 10.1002/1097-4695(20000905)44:3<289::AID-NEU1>3.0.CO;2-H; Vulprecht J, 2012, J CELL SCI, V125, P1353, DOI 10.1242/jcs.104109; WATLING KJ, 1982, BRAIN RES, V253, P334, DOI 10.1016/0006-8993(82)90704-1; Westerfield M., 2007, ZEBRAFISH BOOK GUIDE; Wong KS, 2012, DEV BIOL, V361, P377, DOI 10.1016/j.ydbio.2011.11.004; Zhang XM, 2009, BREAST CANCER RES TR, V115, P505, DOI 10.1007/s10549-008-0093-3	49	12	13	4	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 7	2014	289	10					6934	6940		10.1074/jbc.M113.506295	http://dx.doi.org/10.1074/jbc.M113.506295			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AC3BG	24469449	Green Published, hybrid			2022-12-25	WOS:000332389400053
J	Ahrendt, E; Kyle, B; Braun, AP; Braun, JEA				Ahrendt, Eva; Kyle, Barry; Braun, Andrew P.; Braun, Janice E. A.			Cysteine String Protein Limits Expression of the Large Conductance, Calcium-Activated K+ (BK) Channel	PLOS ONE			English	Article							CSP-ALPHA; SUBUNIT; REVEALS; ROLES; HSC70	Large-conductance, calcium-activated K+ (BK) channels are widely distributed throughout the nervous system and play an essential role in regulation of action potential duration and firing frequency, along with neurotransmitter release at the presynaptic terminal. We have previously demonstrated that select mutations in cysteine string protein (CSP alpha), a presynaptic J-protein and co-chaperone, increase BK channel expression. This observation raised the possibility that wildtype CSP alpha normally functions to limit neuronal BK channel expression. Here we show by Western blot analysis of transfected neuroblastoma cells that when BK channels are present at elevated levels, CSP alpha acts to reduce expression. Moreover, we demonstrate that the accessory subunits, BK beta 4 and BK beta 1 do not alter CSP alpha-mediated reduction of expressed BK alpha subunits. Structure-function analysis reveals that the N-terminal J-domain of CSP alpha is critical for the observed regulation of BK channels levels. Finally, we demonstrate that CSP alpha limits BK current amplitude, while the loss-of-function homologue CSP alpha(HPD-AAA) increases BK current. Our observations indicate that CSP alpha has a role in regulating synaptic excitability and neurotransmission by limiting expression of BK channels.	[Ahrendt, Eva; Braun, Janice E. A.] Univ Calgary, Hotchkiss Brain Inst, Dept Physiol & Pharmacol, Calgary, AB, Canada; [Kyle, Barry; Braun, Andrew P.] Univ Calgary, Fac Med, Libin Cardiovasc Inst, Calgary, AB, Canada	University of Calgary; Libin Cardiovascular Institute Of Alberta; University of Calgary	Braun, JEA (corresponding author), Univ Calgary, Hotchkiss Brain Inst, Dept Physiol & Pharmacol, Calgary, AB, Canada.	braunj@ucalgary.ca		Kyle, Barry/0000-0003-4304-5762	NSERC	NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was funded by an NSERC grant to (JEAB) and an NSERC grant to (APB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benitez BA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026741; Boal F, 2011, FASEB J, V25, P132, DOI 10.1096/fj.09-152033; BRAUN JEA, 1995, NEUROPHARMACOLOGY, V34, P1361, DOI 10.1016/0028-3908(95)00114-L; Braun JEA, 1996, J BIOL CHEM, V271, P25989, DOI 10.1074/jbc.271.42.25989; BUTLER A, 1993, SCIENCE, V261, P221, DOI 10.1126/science.7687074; Chandra S, 2005, CELL, V123, P383, DOI 10.1016/j.cell.2005.09.028; Chen S, 2002, J PHYSIOL-LONDON, V538, P383, DOI 10.1113/jphysiol.2001.013397; Do T, 2007, J NEUROCHEM, V101, P619, DOI 10.1111/j.1471-4159.2006.04388.x; Eisenberg E, 2007, TRAFFIC, V8, P640, DOI 10.1111/j.1600-0854.2007.00568.x; Etherton MR, 2011, EMBO J, V30, P2908, DOI 10.1038/emboj.2011.182; Fernandez-Chacon R, 2004, NEURON, V42, P237, DOI 10.1016/S0896-6273(04)00190-4; Garcia-Junco-Clemente P, 2010, J NEUROSCI, V30, P7377, DOI 10.1523/JNEUROSCI.0924-10.2010; GUNDERSEN CB, 1992, NEURON, V9, P527, DOI 10.1016/0896-6273(92)90190-O; Kyle BD, 2013, SCI REP-UK, V3, DOI 10.1038/srep02447; Leveque C, 1998, J BIOL CHEM, V273, P13488, DOI 10.1074/jbc.273.22.13488; Rozas JL, 2012, NEURON, V74, P151, DOI 10.1016/j.neuron.2012.02.019; Magga JM, 2000, NEURON, V28, P195, DOI 10.1016/S0896-6273(00)00096-9; Natochin M, 2005, J BIOL CHEM, V280, P30236, DOI 10.1074/jbc.M500722200; Nie ZP, 1999, J NEUROSCI, V19, P10270; Noskova L, 2011, AM J HUM GENET, V89, P241, DOI 10.1016/j.ajhg.2011.07.003; Ruiz R, 2008, EUR J NEUROSCI, V27, P3118, DOI 10.1111/j.1460-9568.2008.06301.x; Sakisaka T, 2002, EMBO J, V21, P6125, DOI 10.1093/emboj/cdf603; Schmitz F, 2006, P NATL ACAD SCI USA, V103, P2926, DOI 10.1073/pnas.0510060103; Schubert R, 2001, TRENDS PHARMACOL SCI, V22, P505, DOI 10.1016/S0165-6147(00)01775-2; Sharma M, 2011, NAT CELL BIOL, V13, P30, DOI 10.1038/ncb2131; Shipston MJ, 2011, J BIOL CHEM, V286, P8709, DOI 10.1074/jbc.R110.210005; Shipston MJ, 2001, TRENDS CELL BIOL, V11, P353, DOI 10.1016/S0962-8924(01)02068-2; Shruti S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033429; Swayne LA, 2003, BIOCHEM BIOPH RES CO, V300, P921, DOI 10.1016/S0006-291X(02)02964-9; Velinov M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029729; Walker VE, 2010, J BIOL CHEM, V285, P3319, DOI 10.1074/jbc.M109.024000; Xu FL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011045; Zhang YQ, 2012, NEURON, V74, P136, DOI 10.1016/j.neuron.2012.01.029; Zhao X, 2008, CELL MOL LIFE SCI, V65, P2385, DOI 10.1007/s00018-008-8089-z; ZINSMAIER KE, 1994, SCIENCE, V263, P977, DOI 10.1126/science.8310297	35	15	15	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2014	9	1							e86586	10.1371/journal.pone.0086586	http://dx.doi.org/10.1371/journal.pone.0086586			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301BI	24475152	Green Published, gold, Green Submitted			2022-12-25	WOS:000330507300088
J	Chiu, HE; Hong, YC; Chang, KC; Shih, CC; Hung, JW; Liu, CW; Tan, TY; Huang, CC				Chiu, Hsienhsueh Elley; Hong, Yu-Chiang; Chang, Ku-Chou; Shih, Chun-Chuan; Hung, Jen-Wen; Liu, Chia-Wei; Tan, Teng-Yeow; Huang, Chih-Cheng			Favorable Circulatory System Outcomes as Adjuvant Traditional Chinese Medicine (TCM) Treatment for Cerebrovascular Diseases in Taiwan	PLOS ONE			English	Article							ACUPUNCTURE; STROKE	Background: This study searches the National Health Insurance Research Database (NHIRD) used in a previous project, aiming for reconstructing possible cerebrovascular disease-related groups (DRG), and estimating the costs between cerebrovascular disease and related diseases. Methods and Materials: We conducted a nationwide retrospective cohort study in stroke inpatients, we examined the overall costs in 3 municipalities in Taiwan, by evaluating the possible costs of the expecting diagnosis related group (DRG) by using the international classification of diseases version-9 (ICD-9) system, and the overall analysis of the re-admission population that received traditional Chinese medicine (TCM) treatment and those who did not. Results: The trend demonstrated that the non-participant costs were consistent with the ICD-9 categories (430 to 437) because similarities existed between years 2006 to 2007. Among the TCM patients, a wide variation and additional costs were found compared to non-TCM patients during these 2 years. The average re-admission duration was significantly shorter for TCM patients, especially those initially diagnosed with ICD 434 during the first admission. In addition, TCM patients demonstrated more severe general symptoms, which incurred high conventional treatment costs, and could result in re-admission for numerous reasons. However, in Disease 7 of ICD-9 category, representing the circulatory system was most prevalent in non-TCM inpatients, which was the leading cause of re-admission. Conclusion: We concluded that favorable circulatory system outcomes were in adjuvant TCM treatment inpatients, there were less re-admission for circulatory system events and a two-third reduction of re-admission within ICD-9 code 430 to 437, compared to non-TCM ones. However, there were shorter re-admission duration other than circulatory system events by means of unfavorable baseline condition.	[Chiu, Hsienhsueh Elley; Hong, Yu-Chiang; Huang, Chih-Cheng] Chang Gung Univ Coll Med, Dept TCM, Kaohsiung, Taiwan; [Chiu, Hsienhsueh Elley; Chang, Ku-Chou; Liu, Chia-Wei; Tan, Teng-Yeow] Chang Gung Univ Coll Med, Dept Neurol, Kaohsiung, Taiwan; [Hung, Jen-Wen] Chang Gung Univ Coll Med, Dept Rehabil, Kaohsiung, Taiwan; [Chiu, Hsienhsueh Elley; Hong, Yu-Chiang; Chang, Ku-Chou; Hung, Jen-Wen; Liu, Chia-Wei; Tan, Teng-Yeow] Chang Gung Univ Coll Med, Chang Gung Mem Hosp, Kaohsiung, Taiwan; [Shih, Chun-Chuan] I Shou Univ, Sch Chinese Med Post Baccalaureate, Kaohsiung, Taiwan	Chang Gung University; Chang Gung University; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung University; I Shou University	Chiu, HE (corresponding author), Chang Gung Univ Coll Med, Dept TCM, Kaohsiung, Taiwan.	elleychiu@hotmail.com			Chung Gung Research Project [CMRPG 890961]	Chung Gung Research Project	This study was supported by the Chung Gung Research Project, CMRPG 890961. The corresponding author and the first author had full access to all data in the study and had final responsibility for the decision to submit the paper for publication. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen Z, 1997, J Stroke Cerebrovasc Dis, V6, P361, DOI 10.1016/S1052-3057(97)80219-4; Hackett ML, 2000, STROKE, V31, P440, DOI 10.1161/01.STR.31.2.440; HAN JS, 1982, ANNU REV PHARMACOL, V22, P193, DOI 10.1146/annurev.pa.22.040182.001205; Hess Dean R, 2004, Respir Care, V49, P1171; JANSEN G, 1989, NEUROSCI LETT, V97, P305, DOI 10.1016/0304-3940(89)90615-0; MAGNUSSON M, 1994, STROKE, V25, P1176, DOI 10.1161/01.STR.25.6.1176; Murray CJL, 1997, LANCET, V349, P1269, DOI 10.1016/S0140-6736(96)07493-4; NAESER MA, 1994, ACUPUNCTURE ELECTRO, V19, P227, DOI 10.3727/036012994816357231; O'Mahony PG, 1999, J PUBLIC HEALTH MED, V21, P166, DOI 10.1093/pubmed/21.2.166; Ramsay DJ, 1998, JAMA-J AM MED ASSOC, V280, P1518; Southampton and South West Hampshire Health Commission, 1994, ANN REPORT; Sun H.L., 2001, CHIN ACUPUNCT MOXIBU, V21, P275; Wei YC, 2011, EVID-BASED COMPL ALT, V2011, P1, DOI 10.1155/2011/689813; Wu J N, 1996, J Altern Complement Med, V2, P19, DOI 10.1089/acm.1996.2.19	14	8	8	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2014	9	1							e86351	10.1371/journal.pone.0086351	http://dx.doi.org/10.1371/journal.pone.0086351			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301BI	24475108	gold, Green Published, Green Submitted			2022-12-25	WOS:000330507300056
J	Cui, CH; Kim, JK; Kim, SC; Im, WT				Cui, Chang-Hao; Kim, Jin-Kwang; Kim, Sun-Chang; Im, Wan-Taek			Characterization of a Ginsenoside-Transforming beta-glucosidase from Paenibacillus mucilaginosus and Its Application for Enhanced Production of Minor Ginsenoside F-2	PLOS ONE			English	Article							PANAX-GINSENG; BIOCONVERSION; RD; PHARMACOLOGY; GLYCOSIDASE; EXPRESSION; SEPARATION; CLONING; XVII; RB1	A novel beta-glucosidase (BglPm) was identified from Paenibacillus mucilaginosus KCTC 3870(T) which has ginsenoside converting activity. The gene, termed bglPm, consists of 1,260 bp and belongs to glycoside hydrolase family 1 (GH1). After being overexpressed and purified from Escherichia coli, the enzymatic properties of BglPm were investigated. The enzyme exhibited an optimal activity at 45 degrees C and pH 7.5 and showed high bioconversion ability for major ginsenoside Rb-1 and Rd into ginsenoside F-2. Thus, it was used for mass production of relatively high pure F-2 from relatively abundant protopanaxadiol type ginsenosides mixture (PPDGM) with combined usage of ginsenoside Rc-hydrolyzing enzyme. Scale-up of production using 250 g of the PPDGM resulted in 152 g of F-2 with 80.1% chromatography purity and 95.7% recovery. These results suggest that this enzyme would be useful in the preparation of pharmacologically active ginsenoside F-2 in the functional food and pharmaceutical industries.	[Cui, Chang-Hao; Kim, Sun-Chang] Korea Adv Inst Sci & Technol, Dept Biol Sci, Taejon 305701, South Korea; [Kim, Jin-Kwang; Kim, Sun-Chang; Im, Wan-Taek] Korea Adv Inst Sci & Technol, KAIST Inst Biocentury, Taejon 305701, South Korea; [Kim, Sun-Chang] Intelligent Synthet Biol Ctr, Taejon, South Korea	Korea Advanced Institute of Science & Technology (KAIST); Korea Advanced Institute of Science & Technology (KAIST)	Kim, SC (corresponding author), Korea Adv Inst Sci & Technol, Dept Biol Sci, Taejon 305701, South Korea.	sunkim@kaist.ac.kr; wandra@kaist.ac.kr	Cui, Changhao/ABC-8055-2021; Kim, Sun Chang/C-2026-2011; Kim, Sun/GSN-4867-2022		Intelligent Synthetic Biology Center of Global Frontier Project; Ministry of Education, Science and Technology, Republic of Korea [2011-0031967]	Intelligent Synthetic Biology Center of Global Frontier Project; Ministry of Education, Science and Technology, Republic of Korea(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This work was supported by the Intelligent Synthetic Biology Center of Global Frontier Project funded by the Ministry of Education, Science and Technology (2011-0031967), Republic of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An DS, 2011, INT J SYST EVOL MICR, V61, P2606, DOI 10.1099/ijs.0.028431-0; An DS, 2010, APPL ENVIRON MICROB, V76, P5827, DOI 10.1128/AEM.00106-10; Attele AS, 1999, BIOCHEM PHARMACOL, V58, P1685, DOI 10.1016/S0006-2952(99)00212-9; Cho IH, 2012, J GINSENG RES, V36, P342, DOI 10.5142/jgr.2012.36.4.342; Choi S, 2009, PHARM RES-DORDR, V26, P2280, DOI 10.1007/s11095-009-9944-9; Christensen LP, 2009, ADV FOOD NUTR RES, V55, P1, DOI 10.1016/S1043-4526(08)00401-4; Cleland W W, 1979, Methods Enzymol, V63, P103; Cui CH, 2013, APPL MICROBIOL BIOT, V97, P649, DOI 10.1007/s00253-012-4324-5; Hong H, 2012, J GINSENG RES, V36, P418, DOI 10.5142/jgr.2012.36.4.418; Jia L, 2009, CURR MED CHEM, V16, P2924, DOI 10.2174/092986709788803204; Kang S, 2012, J GINSENG RES, V36, P354, DOI 10.5142/jgr.2012.36.4.354; Kim DH, 2012, J GINSENG RES, V36, P1, DOI 10.5142/jgr.2012.36.1.1; Kim JK, 2013, FOOD CHEM, V141, P1369, DOI 10.1016/j.foodchem.2013.04.012; Kim JK, 2012, J BIOTECHNOL, V161, P294, DOI 10.1016/j.jbiotec.2012.06.021; Kim SK, 2011, J GINSENG RES, V35, P389, DOI 10.5142/jgr.2011.35.4.389; Lee JH, 2011, J GINSENG RES, V35, P375, DOI 10.5142/jgr.2011.35.3.375; Leung K.W., 2010, CHINESE MED, V5, P20; Liu QM, 2013, ANTON LEEUW INT J G, V103, P747, DOI 10.1007/s10482-012-9856-2; Noh KH, 2009, BIOSCI BIOTECH BIOCH, V73, P316, DOI 10.1271/bbb.80525; Park CS, 2010, APPL MICROBIOL BIOT, V87, P9, DOI 10.1007/s00253-010-2567-6; Park HJ, 2012, J GINSENG RES, V36, P225, DOI 10.5142/jgr.2012.36.3.225; Park MW, 2008, BIOL PHARM BULL, V31, P748, DOI 10.1248/bpb.31.748; Shi Y, 2013, FOOD ANAL METHOD, V6, P112, DOI 10.1007/s12161-012-9406-6; Shin JY, 2012, J GINSENG RES, V36, P86, DOI 10.5142/jgr.2012.36.1.86; Mai TT, 2012, CANCER LETT, V321, P144, DOI 10.1016/j.canlet.2012.01.045; Wan JB, 2008, SEP PURIF TECHNOL, V60, P198, DOI 10.1016/j.seppur.2007.08.007; Wang L, 2012, J MICROBIOL BIOTECHN, V22, P311, DOI 10.4014/jmb.1106.06041; Wang L, 2011, J BIOTECHNOL, V156, P125, DOI 10.1016/j.jbiotec.2011.07.024; Ye L, 2010, BIORESOURCE TECHNOL, V28, P857; Yu HS, 2007, CHEM PHARM BULL, V55, P231, DOI 10.1248/cpb.55.231; Yuan CS, 2002, AM J CLIN NUTR, V75, P600, DOI 10.1093/ajcn/75.3.600; Zhao Y, 2007, SEP PURIF TECHNOL, V52, P533, DOI 10.1016/j.seppur.2006.06.008	32	36	38	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2014	9	1							e85727	10.1371/journal.pone.0085727	http://dx.doi.org/10.1371/journal.pone.0085727			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301BI	24475050	Green Submitted, Green Published, gold			2022-12-25	WOS:000330507300023
J	Desai, A; Kevala, K; Kim, HY				Desai, Abhishek; Kevala, Karl; Kim, Hee-Yong			Depletion of Brain Docosahexaenoic Acid Impairs Recovery from Traumatic Brain Injury	PLOS ONE			English	Article							POLYUNSATURATED FATTY-ACID; OMEGA-3-FATTY-ACIDS; NEUROPROTECTION; PROMOTES; IMPACT; CELLS; MODEL; LEADS; RATS	Omega-3 fatty acids are crucial for proper development and function of the brain where docosahexaenoic acid (DHA), the primary omega-3 fatty acid in the brain, is retained avidly by the neuronal membranes. We investigated the effect of DHA depletion in the brain on the outcome of traumatic brain injury (TBI). Pregnant mice were put on an omega-3 fatty acid adequate or deficient diet from gestation day 14 and the pups were raised on the respective diets. Continuation of this dietary regime for three generations resulted in approximately 70% loss of DHA in the brain. Controlled cortical impact was delivered to both groups of mice to produce severe TBI and the functional recovery was compared. Compared to the omega-3 adequate mice, the DHA depleted mice exhibited significantly slower recovery from motor deficits evaluated by the rotarod and the beam walk tests. Furthermore, the DHA deficient mice showed greater anxiety-like behavior tested in the open field test as well as cognitive deficits evaluated by the novel object recognition test. The level of alpha spectrin II breakdown products, the markers of TBI, was significantly elevated in the deficient mouse cortices, indicating that the injury is greater in the deficient brains. This observation was further supported by the reduction of NeuN positive cells around the site of injury in the deficient mice, indicating exacerbated neuronal death after injury. These results suggest an important influence of the brain DHA status on TBI outcome.	[Desai, Abhishek; Kevala, Karl; Kim, Hee-Yong] NIAAA, Lab Mol Signaling, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)	Kim, HY (corresponding author), NIAAA, Lab Mol Signaling, NIH, Bethesda, MD 20892 USA.	hykim@nih.gov			Defense Medical Research and Development Program (DMRDP) [W81XWH-11-2-0074]; National Institute of Alcohol Abuse and Alcoholism, National Institutes of Health; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [ZIAAA000501] Funding Source: NIH RePORTER	Defense Medical Research and Development Program (DMRDP); National Institute of Alcohol Abuse and Alcoholism, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported by the Defense Medical Research and Development Program (DMRDP) (W81XWH-11-2-0074) and Intramural Research Program of the National Institute of Alcohol Abuse and Alcoholism, National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akbar M, 2005, P NATL ACAD SCI USA, V102, P10858, DOI 10.1073/pnas.0502903102; Arsenault D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017397; Bailes JE, 2010, J NEUROTRAUM, V27, P1617, DOI 10.1089/neu.2009.1239; Bazan NG, 2011, MOL NEUROBIOL, V44, P216, DOI 10.1007/s12035-011-8200-6; Belayev L, 2009, STROKE, V40, P3121, DOI 10.1161/STROKEAHA.109.555979; Berman DR, 2009, AM J OBSTET GYNECOL, V200, DOI 10.1016/j.ajog.2009.01.020; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Bousquet M, 2008, FASEB J, V22, P1213, DOI 10.1096/fj.07-9677com; Bousquet M, 2011, AGEING RES REV, V10, P453, DOI 10.1016/j.arr.2011.03.001; Calder PC, 2009, BIOCHIMIE, V91, P791, DOI 10.1016/j.biochi.2009.01.008; Cao DH, 2009, J NEUROCHEM, V111, P510, DOI 10.1111/j.1471-4159.2009.06335.x; Carrie I, 2000, J LIPID RES, V41, P473; CHIN LS, 1995, P NATL ACAD SCI USA, V92, P9230, DOI 10.1073/pnas.92.20.9230; Danthi SJ, 2005, BIOCHEM BIOPH RES CO, V327, P485, DOI 10.1016/j.bbrc.2004.12.033; DeMar JC, 2006, J LIPID RES, V47, P172, DOI 10.1194/jlr.M500362-JLR200; Deng Y, 2007, EXP NEUROL, V205, P154, DOI 10.1016/j.expneurol.2007.01.023; Dhillon HS, 1997, EXP NEUROL, V146, P240, DOI 10.1006/exnr.1997.6524; ENNACEUR A, 1992, BEHAV BRAIN RES, V51, P83, DOI 10.1016/S0166-4328(05)80315-8; Faul M, 2010, TRAUMATIC BRAIN INJU, DOI DOI 10.15620/CDC.5571; Gladman SJ, 2012, J NEUROSCI, V32, P563, DOI 10.1523/JNEUROSCI.3371-11.2012; HAMM RJ, 1994, J NEUROTRAUM, V11, P187, DOI 10.1089/neu.1994.11.187; Homayoun P, 2000, NEUROCHEM RES, V25, P269, DOI 10.1023/A:1007583806138; Hong S, 2003, J BIOL CHEM, V278, P14677, DOI 10.1074/jbc.M300218200; Kim HY, 2011, BIOCHEM J, V435, P327, DOI 10.1042/BJ20102118; Kim HY, 2012, PROSTAGLANDINS LEUKO, V88, P121; King VR, 2006, J NEUROSCI, V26, P4672, DOI 10.1523/JNEUROSCI.5539-05.2006; Lalancette-Hebert M, 2011, STROKE, V42, P2903, DOI 10.1161/STROKEAHA.111.620856; Lengqvist J, 2004, MOL CELL PROTEOMICS, V3, P692, DOI 10.1074/mcp.M400003-MCP200; Lim SY, 2005, J NEUROCHEM, V95, P848, DOI 10.1111/j.1471-4159.2005.03427.x; Loane DJ, 2013, J NEUROTRAUM, V30, P403, DOI 10.1089/neu.2012.2589; Madathil SK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067204; Mondello S, 2010, J NEUROTRAUM, V27, P1203, DOI 10.1089/neu.2010.1278; Moriguchi T, 2000, J NEUROCHEM, V75, P2563, DOI 10.1046/j.1471-4159.2000.0752563.x; Moriguchi T, 2003, J NEUROCHEM, V87, P297, DOI 10.1046/j.1471-4159.2003.01966.x; Mukherjee PK, 2004, P NATL ACAD SCI USA, V101, P8491, DOI 10.1073/pnas.0402531101; NAKASHIMA Y, 1993, J LIPID RES, V34, P239; Pu HJ, 2013, J CEREBR BLOOD F MET, V33, P1474, DOI 10.1038/jcbfm.2013.108; Rashid MA, 2013, J NEUROCHEM, V125, P869, DOI 10.1111/jnc.12255; REEVES PG, 1993, J NUTR, V123, P1939, DOI 10.1093/jn/123.11.1939; Ringger NC, 2004, J NEUROTRAUM, V21, P1443, DOI 10.1089/neu.2004.21.1443; Russell KL, 2013, PROSTAG LEUKOTR ESS, V89, P97, DOI 10.1016/j.plefa.2013.05.004; Sidhu VK, 2011, J PROTEOME RES, V10, P5472, DOI 10.1021/pr2007285; Simopoulos AP, 2011, MOL NEUROBIOL, V44, P203, DOI 10.1007/s12035-010-8162-0; Takeuchi T, 2003, BRAIN RES, V964, P136, DOI 10.1016/S0006-8993(02)04113-6; Wen ZM, 2004, J NEUROCHEM, V89, P1368, DOI 10.1111/j.1471-4159.2004.02433.x; Wu A, 2004, J NEUROTRAUM, V28, P2113; Xiao Y, 2005, BRIT J NUTR, V94, P544, DOI 10.1079/BJN20051539; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407; Zhang WT, 2010, STROKE, V41, P2341, DOI 10.1161/STROKEAHA.110.586081	49	38	40	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2014	9	1							e86472	10.1371/journal.pone.0086472	http://dx.doi.org/10.1371/journal.pone.0086472			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301BI	24475126	Green Published, Green Submitted, gold			2022-12-25	WOS:000330507300068
J	Howe, SE; Lickteig, DJ; Plunkett, KN; Ryerse, JS; Konjufca, V				Howe, Savannah E.; Lickteig, Duane J.; Plunkett, Kyle N.; Ryerse, Jan S.; Konjufca, Vjollca			The Uptake of Soluble and Particulate Antigens by Epithelial Cells in the Mouse Small Intestine	PLOS ONE			English	Article							DENDRITIC CELLS; TRANSPORT; MUCUS; PERMEABILITY; BACTERIA; PATCH; MACROMOLECULES; NANOPARTICLES; ENTEROCYTES; ENDOCYTOSIS	Intestinal epithelial cells (IECs) overlying the villi play a prominent role in absorption of digested nutrients and establish a barrier that separates the internal milieu from potentially harmful microbial antigens. Several mechanisms by which antigens of dietary and microbial origin enter the body have been identified; however whether IECs play a role in antigen uptake is not known. Using in vivo imaging of the mouse small intestine, we investigated whether epithelial cells (enterocytes) play an active role in the uptake (sampling) of lumen antigens. We found that small molecular weight antigens such as chicken ovalbumin, dextran, and bacterial LPS enter the lamina propria, the loose connective tissue which lies beneath the epithelium via goblet cell associated passageways. However, epithelial cells overlying the villi can internalize particulate antigens such as bacterial cell debris and inert nanoparticles (NPs), which are then found co-localizing with the CD11c+ dendritic cells in the lamina propria. The extent of NP uptake by IECs depends on their size: 20-40 nm NPs are taken up readily, while NPs larger than 100 nm are taken up mainly by the epithelial cells overlying Peyer's patches. Blocking NPs with small proteins or conjugating them with ovalbumin does not inhibit their uptake. However, the uptake of 40 nm NPs can be inhibited when they are administered with an endocytosis inhibitor (chlorpromazine). Delineating the mechanisms of antigen uptake in the gut is essential for understanding how tolerance and immunity to lumen antigens are generated, and for the development of mucosal vaccines and therapies.	[Howe, Savannah E.; Lickteig, Duane J.; Konjufca, Vjollca] So Illinois Univ, Dept Microbiol, Carbondale, IL 62901 USA; [Plunkett, Kyle N.] So Illinois Univ, Dept Chem, Carbondale, IL 62901 USA; [Ryerse, Jan S.] St Louis Univ Sch Med, Dept Pathol, St Louis, MO USA	Southern Illinois University System; Southern Illinois University; Southern Illinois University System; Southern Illinois University; Saint Louis University	Konjufca, V (corresponding author), So Illinois Univ, Dept Microbiol, Carbondale, IL 62901 USA.	vjollca@micro.siu.edu		Konjufca, Vjollca/0000-0002-7736-5097	Southern Illinois University	Southern Illinois University	This work was supported by the start up funds provided to Vjollca Konjufca by Southern Illinois University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atuma C, 2001, AM J PHYSIOL-GASTR L, V280, pG922, DOI 10.1152/ajpgi.2001.280.5.G922; Bozzola John J, 2007, Methods Mol Biol, V369, P449; Bu HF, 2010, J CELL PHYSIOL, V222, P658, DOI 10.1002/jcp.21985; Corr SC, 2008, FEMS IMMUNOL MED MIC, V52, P2, DOI 10.1111/j.1574-695X.2007.00359.x; Farache J, 2013, IMMUNITY, V38, P581, DOI 10.1016/j.immuni.2013.01.009; Fihn BM, 2000, GASTROENTEROLOGY, V119, P1029, DOI 10.1053/gast.2000.18148; GIOCONDI MC, 1995, BBA-BIOMEMBRANES, V1234, P197, DOI 10.1016/0005-2736(94)00284-V; Heyman M, 2000, ANN NY ACAD SCI, V915, P304; HEYMAN M, 1982, AM J PHYSIOL, V242, pG558, DOI 10.1152/ajpgi.1982.242.6.G558; Ivanov Andrei I., 2008, V440, P15, DOI 10.1007/978-1-59745-178-9_2; JANI P, 1990, J PHARM PHARMACOL, V42, P821, DOI 10.1111/j.2042-7158.1990.tb07033.x; JANI P, 1989, J PHARM PHARMACOL, V41, P809, DOI 10.1111/j.2042-7158.1989.tb06377.x; Johansson MEV, 2008, P NATL ACAD SCI USA, V105, P15064, DOI 10.1073/pnas.0803124105; Kerneis S, 1997, SCIENCE, V277, P949, DOI 10.1126/science.277.5328.949; Kyd JM, 2008, VACCINE, V26, P6221, DOI 10.1016/j.vaccine.2008.09.061; Lai SK, 2007, BIOMATERIALS, V28, P2876, DOI 10.1016/j.biomaterials.2007.02.021; Lai SK, 2007, P NATL ACAD SCI USA, V104, P1482, DOI 10.1073/pnas.0608611104; Lai SK, 2009, ADV DRUG DELIVER REV, V61, P158, DOI 10.1016/j.addr.2008.11.002; Mathiowitz E, 1997, NATURE, V386, P410, DOI 10.1038/386410a0; McDole JR, 2012, NATURE, V483, P345, DOI 10.1038/nature10863; Menard S, 2010, MUCOSAL IMMUNOL, V3, P247, DOI 10.1038/mi.2010.5; MOOSEKER MS, 1985, ANNU REV CELL BIOL, V1, P209, DOI 10.1146/annurev.cellbio.1.1.209; Neutra MR, 2006, NAT REV IMMUNOL, V6, P148, DOI 10.1038/nri1777; Neutra MR, 1996, CELL, V86, P345, DOI 10.1016/S0092-8674(00)80106-3; NEUTRA MR, 1987, CELL TISSUE RES, V247, P537, DOI 10.1007/BF00215747; Niess JH, 2005, SCIENCE, V307, P254, DOI 10.1126/science.1102901; Olmsted SS, 2001, BIOPHYS J, V81, P1930, DOI 10.1016/S0006-3495(01)75844-4; Primard C, 2010, BIOMATERIALS, V31, P6060, DOI 10.1016/j.biomaterials.2010.04.021; Rejman J, 2004, BIOCHEM J, V377, P159, DOI 10.1042/BJ20031253; Rescigno M, 2001, NAT IMMUNOL, V2, P361, DOI 10.1038/86373; SAVIDGE TC, 1994, PFLUG ARCH EUR J PHY, V428, P391, DOI 10.1007/BF00724523; Tavelin S, 2003, PHARMACEUT RES, V20, P397, DOI 10.1023/A:1022699920043; Zhu Q, 2012, NATURE MED	33	55	56	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2014	9	1							e86656	10.1371/journal.pone.0086656	http://dx.doi.org/10.1371/journal.pone.0086656			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301BI	24475164	gold, Green Published, Green Submitted			2022-12-25	WOS:000330507300099
J	Wang, W; Huang, MH; Dong, XL; Chai, CL; Pan, CX; Tang, H; Chen, YH; Dai, FY; Pan, MH; Lu, C				Wang, Wei; Huang, Mao-Hua; Dong, Xiao-Long; Chai, Chun-Li; Pan, Cai-Xia; Tang, Hui; Chen, Yan-Hong; Dai, Fang-Yin; Pan, Min-Hui; Lu, Cheng			Combined Effect of Cameo2 and CBP on the Cellular Uptake of Lutein in the Silkworm, Bombyx mori	PLOS ONE			English	Article							CAROTENOID-BINDING-PROTEIN; TRANSMEMBRANE PROTEIN; START DOMAIN; TRANSPORT; GENE; CHOLESTEROL; COLORATION; DROSOPHILA; MUTANTS; LARVAE	Formation of yellow-red color cocoons in the silkworm, Bombyx mori, occurs as the result of the selective delivery of carotenoids from the midgut to the silk gland via the hemolymph. This process of pigment transport is thought to be mediated by specific cellular carotenoids carrier proteins. Previous studies indicated that two proteins, Cameo2 and CBP, are associated with the selective transport of lutein from the midgut into the silk gland in Bombyx mori. However, the exact roles of Cameo2 and CBP during the uptake and transport of carotenoids are still unknown. In this study, we investigated the respective contributions of these two proteins to lutein and beta-carotene transport in Bombyx mori as well as commercial cell-line. We found that tissues, expressed both Cameo2 and CBP, accumulate lutein. Cells, co-expressed Cameo2 and CBP, absorb 2 fold more lutein (P<0.01) than any other transfected cells, and the rate of cellular uptake of lutein was concentration-dependent and reached saturation. From immunofluorescence staining, confocal microscopy observation and western blot analysis, Cameo2 was localized at the membrane and CBP was expressed in the cytosol. What's more, bimolecular fluorescence complementation analysis showed that these two proteins directly interacted at cellular level. Therefore, Cameo2 and CBP are necessarily expressed in midguts and silk glands for lutein uptake in Bombyx mori. Cameo2 and CBP, as the membrane protein and the cytosol protein, respectively, have the combined effect to facilitate the cellular uptake of lutein.	[Wang, Wei; Huang, Mao-Hua; Dong, Xiao-Long; Chai, Chun-Li; Pan, Cai-Xia; Tang, Hui; Chen, Yan-Hong; Dai, Fang-Yin; Pan, Min-Hui; Lu, Cheng] Southwest Univ, State Key Lab Silkworm Genome Biol, Chongqing, Peoples R China; [Dai, Fang-Yin; Pan, Min-Hui; Lu, Cheng] Southwest Univ, Key Lab Sericulture Funct Genom & Biotechnol, Minist Agr, Chongqing, Peoples R China; [Wang, Wei] Southwest Univ, Coll Anim Sci & Technol, Chongqing, Peoples R China	Southwest University - China; Ministry of Agriculture & Rural Affairs; Southwest University - China; Southwest University - China	Lu, C (corresponding author), Southwest Univ, State Key Lab Silkworm Genome Biol, Chongqing, Peoples R China.	pmh0476@hotmail.com; lucheng@swu.edu.cn			National High-tech R&D Program of China [2013AA102507]; China Agriculture Research System [CARS-22]; National Natural Science Foundation of China [31001035]; Chongqing Natural Science Foundation of China [cstc2013jcyjA80019]; Central Universities Basic Research Funds [XDJK2012C093]	National High-tech R&D Program of China(National High Technology Research and Development Program of China); China Agriculture Research System; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chongqing Natural Science Foundation of China; Central Universities Basic Research Funds	This work was supported by grants from National High-tech R&D Program of China (No. 2013AA102507), China Agriculture Research System (CARS-22), National Natural Science Foundation of China (No. 31001035), Chongqing Natural Science Foundation of China (No. cstc2013jcyjA80019) and the Central Universities Basic Research Funds (No. XDJK2012C093). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alpy F, 2005, J CELL SCI, V118, P2791, DOI 10.1242/jcs.02485; Alpy F, 2009, M S-MED SCI, V25, P181, DOI 10.1051/medsci/2009252181; Bhosale P, 2007, ARCH BIOCHEM BIOPHYS, V458, P121, DOI 10.1016/j.abb.2006.10.005; Chen XC, 2010, J PHYSIOL-LONDON, V588, P3539, DOI 10.1113/jphysiol.2010.192310; Chino H, 1985, COMPREHENSIVE INSECT; Goldsmith MR, 2005, ANNU REV ENTOMOL, V50, P71, DOI 10.1146/annurev.ento.50.071803.130456; HARIZUKA MASAKI, 1953, BULL SERICUL EXPT STA [JAPAN], V14, P141; Hoekstra M, 2010, WORLD J GASTROENTERO, V16, P5916, DOI 10.3748/wjg.v16.i47.5916; Hu CD, 2006, CURR PROTOC CELL BIO, V21, P21; Kiefer C, 2002, P NATL ACAD SCI USA, V99, P10581, DOI 10.1073/pnas.162182899; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Li BX, 2011, BIOCHEMISTRY-US, V50, P2541, DOI 10.1021/bi101906y; LODISH H, 2003, MOL CELL BIOL; Manunta C., 1937, Archivio Zoologico Italiano Torino, V24, P385; Nakajima M., 1963, B FAC AGR TOKYO, V8, P1; Niu Yan-Shan, 2010, Yichuan, V32, P942, DOI 10.3724/SP.J.1005.2010.00942; O'Sullivan SM, 2004, BRIT J NUTR, V91, P757, DOI 10.1079/BJN20041094; Reboul E, 2005, BIOCHEM J, V387, P455, DOI 10.1042/BJ20040554; Sakudoh T, 2005, BIOCHEM BIOPH RES CO, V336, P1125, DOI 10.1016/j.bbrc.2005.08.241; Sakudoh T, 2007, P NATL ACAD SCI USA, V104, P8941, DOI 10.1073/pnas.0702860104; Sakudoh T, 2013, J LIPID RES, V54, P482, DOI 10.1194/jlr.M032771; Sakudoh T, 2010, J BIOL CHEM, V285, P7739, DOI 10.1074/jbc.M109.074435; Sonnhammer E L, 1998, Proc Int Conf Intell Syst Mol Biol, V6, P175; Tabunoki H, 2004, FEBS LETT, V567, P175, DOI 10.1016/j.febslet.2004.04.067; Tabunoki H, 2002, J BIOL CHEM, V277, P32133, DOI 10.1074/jbc.M204507200; Tazima Y, 1964, GENETICS SILKWORM; Tsuchida K, 2004, J INSECT PHYSIOL, V50, P975, DOI 10.1016/j.jinsphys.2004.08.001; Tsuchida K, 2004, J INSECT PHYSIOL, V50, P363, DOI 10.1016/j.jinsphys.2004.02.006; Tsuchida K, 1998, INSECT BIOCHEM MOLEC, V28, P927, DOI 10.1016/S0965-1748(98)00036-8; Voolstra O, 2006, BIOCHEMISTRY-US, V45, P13429, DOI 10.1021/bi060701u	30	9	10	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2014	9	1							e86594	10.1371/journal.pone.0086594	http://dx.doi.org/10.1371/journal.pone.0086594			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301BI	24475153	Green Submitted, Green Published, gold			2022-12-25	WOS:000330507300089
J	Lou, WC; Wang, XQ; Chen, F; Chen, YX; Jiang, B; Zhang, H				Lou, Wangchao; Wang, Xiaoqing; Chen, Fan; Chen, Yixiao; Jiang, Bo; Zhang, Hua			Sequence Based Prediction of DNA-Binding Proteins Based on Hybrid Feature Selection Using Random Forest and Gaussian Naive Bayes	PLOS ONE			English	Article							RIBOSOMAL-RNA-BINDING; SECONDARY STRUCTURE; EVOLUTIONARY CONSERVATION; FOLD RECOGNITION; IDENTIFICATION; COVARIANCE; RESOLUTION; ACCURATE; RECEPTORS; DOMAINS	Developing an efficient method for determination of the DNA-binding proteins, due to their vital roles in gene regulation, is becoming highly desired since it would be invaluable to advance our understanding of protein functions. In this study, we proposed a new method for the prediction of the DNA-binding proteins, by performing the feature rank using random forest and the wrapper-based feature selection using forward best-first search strategy. The features comprise information from primary sequence, predicted secondary structure, predicted relative solvent accessibility, and position specific scoring matrix. The proposed method, called DBPPred, used Gaussian naive Bayes as the underlying classifier since it outperformed five other classifiers, including decision tree, logistic regression, k-nearest neighbor, support vector machine with polynomial kernel, and support vector machine with radial basis function. As a result, the proposed DBPPred yields the highest average accuracy of 0.791 and average MCC of 0.583 according to the five-fold cross validation with ten runs on the training benchmark dataset PDB594. Subsequently, blind tests on the independent dataset PDB186 by the proposed model trained on the entire PDB594 dataset and by other five existing methods (including iDNA-Prot, DNA-Prot, DNAbinder, DNABIND and DBD-Threader) were performed, resulting in that the proposed DBPPred yielded the highest accuracy of 0.769, MCC of 0.538, and AUC of 0.790. The independent tests performed by the proposed DBPPred on completely a large non-DNA binding protein dataset and two RNA binding protein datasets also showed improved or comparable quality when compared with the relevant prediction methods. Moreover, we observed that majority of the selected features by the proposed method are statistically significantly different between the mean feature values of the DNA-binding and the non DNA-binding proteins. All of the experimental results indicate that the proposed DBPPred can be an alternative perspective predictor for large-scale determination of DNA-binding proteins.	[Lou, Wangchao; Wang, Xiaoqing; Chen, Fan; Chen, Yixiao; Jiang, Bo; Zhang, Hua] Zhejiang Gongshang Univ, Sch Comp & Informat Engn, Hangzhou, Zhejiang, Peoples R China	Zhejiang Gongshang University	Zhang, H (corresponding author), Zhejiang Gongshang Univ, Sch Comp & Informat Engn, Hangzhou, Zhejiang, Peoples R China.	zerozhua@126.com			National Natural Science Foundation of China [61170099]; Zhejiang Provincial Natural Science Foundation of China [Y1110840]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Zhejiang Provincial Natural Science Foundation of China(Natural Science Foundation of Zhejiang Province)	This work was supported by the National Natural Science Foundation of China (grant no. 61170099) and the Zhejiang Provincial Natural Science Foundation of China (grant no. Y1110840). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad S, 2004, J MOL BIOL, V341, P65, DOI 10.1016/j.jmb.2004.05.058; Ahmad S, 2003, PROTEINS, V50, P629, DOI 10.1002/prot.10328; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bhardwaj N, 2005, NUCLEIC ACIDS RES, V33, P6486, DOI 10.1093/nar/gki949; Bhardwaj N, 2007, FEBS LETT, V581, P1058, DOI 10.1016/j.febslet.2007.01.086; Boulesteix AL, 2012, BRIEF BIOINFORM, V13, P292, DOI 10.1093/bib/bbr053; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Buck MJ, 2004, GENOMICS, V83, P349, DOI 10.1016/j.ygeno.2003.11.004; Cai YD, 2003, BBA-PROTEINS PROTEOM, V1648, P127, DOI 10.1016/S1570-9639(03)00112-2; CAJONE F, 1989, BIOCHEM J, V262, P977, DOI 10.1042/bj2620977; Cao J, 2003, BIOINFORMATICS, V19, P234, DOI 10.1093/bioinformatics/19.2.234; Chou CC, 2003, J BACTERIOL, V185, P4066, DOI 10.1128/JB.185.14.4066-4073.2003; Dey S, 2012, NUCLEIC ACIDS RES, V40, P7150, DOI 10.1093/nar/gks405; Dong QW, 2009, BIOINFORMATICS, V25, P2655, DOI 10.1093/bioinformatics/btp500; Ebina T, 2011, BIOINFORMATICS, V27, P487, DOI 10.1093/bioinformatics/btq700; Eickholt J, 2012, BIOINFORMATICS, V28, P3066, DOI 10.1093/bioinformatics/bts598; Fang Y, 2008, AMINO ACIDS, V34, P103, DOI 10.1007/s00726-007-0568-2; Faraggi E, 2012, J COMPUT CHEM, V33, P259, DOI 10.1002/jcc.21968; FREEMAN K, 1995, GENETICS, V141, P1253; Gao M, 2008, NUCLEIC ACIDS RES, V36, P3978, DOI 10.1093/nar/gkn332; Gao M, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000567; Guo YZ, 2008, NUCLEIC ACIDS RES, V36, P3025, DOI 10.1093/nar/gkn159; Guo YZ, 2006, PROTEINS, V65, P55, DOI 10.1002/prot.21097; Han LY, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-549; Huang HL, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-S1-S47; Ivankov DN, 2004, P NATL ACAD SCI USA, V101, P8942, DOI 10.1073/pnas.0402659101; Kumar KK, 2009, J BIOMOL STRUCT DYN, V26, P679, DOI 10.1080/07391102.2009.10507281; Kumar M, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-463; Langlois RE, 2010, NUCLEIC ACIDS RES, V38, P3149, DOI 10.1093/nar/gkq061; Li BS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041629; Lin WZ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024756; Liu LA, 2012, CURR OPIN STRUC BIOL, V22, P397, DOI 10.1016/j.sbi.2012.06.002; MATTHEWS BW, 1975, BIOCHIM BIOPHYS ACTA, V405, P442, DOI 10.1016/0005-2795(75)90109-9; MITCHELL T, 1989, ANNU REV COMPUT SCI, V4, P417; Murakami Y, 2010, BIOINFORMATICS, V26, P1841, DOI 10.1093/bioinformatics/btq302; Nanni L, 2008, AMINO ACIDS, V34, P635, DOI 10.1007/s00726-007-0016-3; Nanni L, 2009, AMINO ACIDS, V36, P167, DOI 10.1007/s00726-008-0044-7; Nimrod G, 2010, BIOINFORMATICS, V26, P692, DOI 10.1093/bioinformatics/btq019; Nimrod G, 2009, J MOL BIOL, V387, P1040, DOI 10.1016/j.jmb.2009.02.023; Pedregosa F, 2011, J MACH LEARN RES, V12, P2825; Raizada RDS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069566; Sarai A, 2005, ANNU REV BIOPH BIOM, V34, P379, DOI 10.1146/annurev.biophys.34.040204.144537; Shao XJ, 2009, J THEOR BIOL, V258, P289, DOI 10.1016/j.jtbi.2009.01.024; Shazman S, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000146; Sonego P, 2008, BRIEF BIOINFORM, V9, P198, DOI 10.1093/bib/bbm064; Stawiski EW, 2003, J MOL BIOL, V326, P1065, DOI 10.1016/S0022-2836(03)00031-7; Szaboova A, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-S10-S3; Szilagyi A, 2006, J MOL BIOL, V358, P922, DOI 10.1016/j.jmb.2006.02.053; Tegge AN, 2009, NUCLEIC ACIDS RES, V37, pW515, DOI 10.1093/nar/gkp305; Touw WG, 2013, BRIEF BIOINFORM, V14, P315, DOI 10.1093/bib/bbs034; Walia RR, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-89; Yu XJ, 2006, J THEOR BIOL, V240, P175, DOI 10.1016/j.jtbi.2005.09.018; Zhang H, 2012, AMINO ACIDS, V42, P271, DOI 10.1007/s00726-010-0805-y; Zhang T, 2012, J BIOMOL STRUCT DYN, V29, P799, DOI 10.1080/073911012010525022; Zhang T, 2008, BIOINFORMATICS, V24, P2329, DOI 10.1093/bioinformatics/btn433; Zhang T, 2010, CURR PROTEIN PEPT SC, V11, P609, DOI 10.2174/138920310794109193; Zhang XY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060559; Zhao HY, 2011, RNA BIOL, V8, P988, DOI 10.4161/rna.8.6.17813; Zhao HY, 2011, NUCLEIC ACIDS RES, V39, P3017, DOI 10.1093/nar/gkq1266; Zhao HY, 2010, BIOINFORMATICS, V26, P1857, DOI 10.1093/bioinformatics/btq295; Zhou WQ, 2011, PROTEOME SCI, V9, DOI 10.1186/1477-5956-9-S1-S1; Zou CX, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-90	63	107	107	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2014	9	1							e86703	10.1371/journal.pone.0086703	http://dx.doi.org/10.1371/journal.pone.0086703			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	298QQ	24475169	Green Published, gold, Green Submitted			2022-12-25	WOS:000330339800055
J	Moskalev, A; Shaposhnikov, M; Snezhkina, A; Kogan, V; Plyusnina, E; Peregudova, D; Melnikova, N; Uroshlev, L; Mylnikov, S; Dmitriev, A; Plusnin, S; Fedichev, P; Kudryavtseva, A				Moskalev, Alexey; Shaposhnikov, Mikhail; Snezhkina, Anastasia; Kogan, Valeria; Plyusnina, Ekaterina; Peregudova, Darya; Melnikova, Nataliya; Uroshlev, Leonid; Mylnikov, Sergey; Dmitriev, Alexey; Plusnin, Sergey; Fedichev, Peter; Kudryavtseva, Anna			Mining Gene Expression Data for Pollutants (Dioxin, Toluene, Formaldehyde) and Low Dose of Gamma-Irradiation	PLOS ONE			English	Article							DROSOPHILA SEMINAL FLUID; MELANOGASTER CYTOCHROME-P450 GENES; ARYL-HYDROCARBON RECEPTOR; GROWTH-FACTOR-BETA; INSECTICIDE-RESISTANCE; OXIDATIVE STRESS; LIFE-SPAN; NEUROBLAST PROLIFERATION; INHALED FORMALDEHYDE; MOLECULAR EVOLUTION	General and specific effects of molecular genetic responses to adverse environmental factors are not well understood. This study examines genome-wide gene expression profiles of Drosophila melanogaster in response to ionizing radiation, formaldehyde, toluene, and 2,3,7,8-tetrachlorodibenzo-p-dioxin. We performed RNA-seq analysis on 25,415 transcripts to measure the change in gene expression in males and females separately. An analysis of the genes unique to each treatment yielded a list of genes as a gene expression signature. In the case of radiation exposure, both sexes exhibited a reproducible increase in their expression of the transcription factors sugarbabe and tramtrack. The influence of dioxin up-regulated metabolic genes, such as anachronism, CG16727, and several genes with unknown function. Toluene activated a gene involved in the response to the toxins, Cyp12d1-p; the transcription factor Fer3's gene; the metabolic genes CG2065, CG30427, and CG34447; and the genes Spn28Da and Spn3, which are responsible for reproduction and immunity. All significantly differentially expressed genes, including those shared among the stressors, can be divided into gene groups using Gene Ontology Biological Process identifiers. These gene groups are related to defense response, biological regulation, the cell cycle, metabolic process, and circadian rhythms. KEGG molecular pathway analysis revealed alteration of the Notch signaling pathway, TGF-beta signaling pathway, proteasome, basal transcription factors, nucleotide excision repair, Jak-STAT signaling pathway, circadian rhythm, Hippo signaling pathway, mTOR signaling pathway, ribosome, mismatch repair, RNA polymerase, mRNA surveillance pathway, Hedgehog signaling pathway, and DNA replication genes. Females and, to a lesser extent, males actively metabolize xenobiotics by the action of cytochrome P450 when under the influence of dioxin and toluene. Finally, in this work we obtained gene expression signatures pollutants (dioxin, toluene), low dose of gamma-irradiation and common molecular pathways for different kind of stressors.	[Moskalev, Alexey; Shaposhnikov, Mikhail; Plyusnina, Ekaterina; Peregudova, Darya; Plusnin, Sergey] RAS, Lab Mol Radiobiol & Gerontol, Inst Biol, Komi Sci Ctr, Syktyvkar, Russia; [Snezhkina, Anastasia; Melnikova, Nataliya; Uroshlev, Leonid; Dmitriev, Alexey; Kudryavtseva, Anna] RAS, Grp Postgen Studies, Engelhardt Inst Mol Biol, Moscow 117901, Russia; [Moskalev, Alexey; Shaposhnikov, Mikhail; Plyusnina, Ekaterina; Plusnin, Sergey] Syktyvkar State Univ, Dept Ecol, Syktyvkar, Russia; [Moskalev, Alexey; Kogan, Valeria; Fedichev, Peter] Moscow Inst Phys & Technol, Lab Genet Aging & Longev, Dolgoprudnyi, Russia; [Uroshlev, Leonid] Vavilov Inst Gen Genet, Dept Computat Syst Biol, Moscow, Russia; [Mylnikov, Sergey] St Petersburg State Univ, Dept Genet, St Petersburg 199034, Russia; [Kogan, Valeria; Fedichev, Peter] Quantum Pharmaceut, Moscow, Russia	Russian Academy of Sciences; Institute of Biology, Komi Scientific Centre, Ural Branch RAS; Komi Science Centre of the Ural Branch of the Russian Academy of Sciences; Russian Academy of Sciences; Engelhardt Institute of Molecular Biology, RAS; Syktyvkar State University; Moscow Institute of Physics & Technology; Russian Academy of Sciences; Vavilov Institute of General Genetics; Saint Petersburg State University	Moskalev, A (corresponding author), RAS, Lab Mol Radiobiol & Gerontol, Inst Biol, Komi Sci Ctr, Syktyvkar, Russia.	amoskalev@ib.komisc.ru	Uroshlev, Leonid/E-7814-2014; Melnikova, Nataliya V./E-5894-2014; Moskalev, Alexey/H-4856-2013; Peregudova, Darya/O-3467-2014; Kudryavtseva, Anna V/C-9032-2014; Proshkina, Ekaterina N/F-7948-2014; Shaposhnikov, Mikhail/M-7514-2013; Mylnikov, Sergey/D-1970-2013; Snezhkina, Anastasiya V./E-6765-2014; Dmitriev, Alexey A./D-6109-2011	Melnikova, Nataliya V./0000-0001-8083-3018; Moskalev, Alexey/0000-0002-3248-1633; Peregudova, Darya/0000-0001-6872-1013; Kudryavtseva, Anna V/0000-0002-3722-8207; Proshkina, Ekaterina N/0000-0003-4558-1796; Shaposhnikov, Mikhail/0000-0002-4625-6488; Mylnikov, Sergey/0000-0001-8611-8218; Dmitriev, Alexey A./0000-0002-6827-9584; fedichev, peter/0000-0003-0404-808X	Ministry of Education and Science [N 14.B37.21.0560]; Presidium of the RAS [N 12-P-4-1005]; CrowdAge.org initiative; Russian Federation for young scientists [MD-1090.2014.4]	Ministry of Education and Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Presidium of the RAS(Russian Academy of Sciences); CrowdAge.org initiative; Russian Federation for young scientists	The work was supported by grant N 14.B37.21.0560 of Federal Target Program "Sientific and scientific-pedagogical personnel of innovative Russia'' by Ministry of Education and Science, grant N 12-P-4-1005, 2012-2014 of Presidium of the RAS "Ecological genetics of the lifespan of model animals (Drosophila melanogaster, Mus musculus)'' and by the CrowdAge.org initiative. Supported by grant of President Of Russian Federation for young scientists MD-1090.2014.4. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amichot M, 2004, EUR J BIOCHEM, V271, P1250, DOI 10.1111/j.1432-1033.2004.04025.x; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Andersen ME, 2008, TOXICOL SCI, V105, P368, DOI 10.1093/toxsci/kfn097; [Anonymous], 1990, COLO MED, V87, P81; Arakane Y, 2009, INSECT BIOCHEM MOLEC, V39, P355, DOI 10.1016/j.ibmb.2009.02.002; ATSDR, 2001, TOL TOX, P32; Bajpe PK, 2008, MOL CELL BIOL, V28, P1606, DOI 10.1128/MCB.01567-07; Banhegyi G, 2003, BIOFACTORS, V17, P37, DOI 10.1002/biof.5520170105; Bartoletti M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049958; Belyaeva OV, 2009, BBA-GEN SUBJECTS, V1790, P1266, DOI 10.1016/j.bbagen.2009.06.002; BIGELOW SW, 1985, ARCH TOXICOL, V56, P219, DOI 10.1007/BF00295157; Blake JA, 2013, NUCLEIC ACIDS RES, V41, pD530, DOI 10.1093/nar/gks1050; Bruskov VI, 2012, FREE RADICAL RES, V46, P1280, DOI 10.3109/10715762.2012.709316; Roman AC, 2009, J BIOL CHEM, V284, P25135, DOI 10.1074/jbc.M109.013292; CASANOVA M, 1991, FUND APPL TOXICOL, V17, P409, DOI 10.1016/0272-0590(91)90230-2; Chen H, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-35; Chen YJ, 2011, INT J RADIAT ONCOL, V80, P851, DOI 10.1016/j.ijrobp.2011.01.003; Chung H, 2009, P NATL ACAD SCI USA, V106, P5731, DOI 10.1073/pnas.0812141106; Consonni D, 2012, ENVIRON INT, V44, P151, DOI 10.1016/j.envint.2012.01.004; Cornman RS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008345; Daborn PJ, 2007, INSECT BIOCHEM MOLEC, V37, P512, DOI 10.1016/j.ibmb.2007.02.008; Daniels RD, 2011, OCCUP ENVIRON MED, V68, P457, DOI 10.1136/oem.2009.054684; Dixit R, 2008, INSECT BIOCHEM MOLEC, V38, P440, DOI 10.1016/j.ibmb.2007.12.002; Dorer DR, 2003, GENETICS, V165, P613; Dunipace L, 2001, CURR BIOL, V11, P822, DOI 10.1016/S0960-9822(01)00258-5; Durinck S, 2005, BIOINFORMATICS, V21, P3439, DOI 10.1093/bioinformatics/bti525; Durinck S, 2009, NAT PROTOC, V4, P1184, DOI 10.1038/nprot.2009.97; EBENS AJ, 1993, CELL, V74, P15, DOI 10.1016/0092-8674(93)90291-W; Fachin AL, 2007, RADIAT RES, V168, P650, DOI 10.1667/RR0487.1; Fakhouri M, 2006, DEV BIOL, V293, P127, DOI 10.1016/j.ydbio.2006.01.028; Faust D, 2013, ARCH TOXICOL, V87, P681, DOI 10.1007/s00204-012-0979-z; Feinendegen LE, 2001, J NUCL MED, V42, p17N; Feng G, 2012, METHODS MOL BIOL, V802, P101, DOI 10.1007/978-1-61779-400-1_7; Fernandez-Ayala DJM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008549; Festucci-Buselli RA, 2005, INSECT MOL BIOL, V14, P69, DOI 10.1111/j.1365-2583.2005.00532.x; Findlay GD, 2009, GENOME RES, V19, P886, DOI 10.1101/gr.089391.108; Findlay GD, 2008, PLOS BIOL, V6, P1417, DOI 10.1371/journal.pbio.0060178; Fletcher N, 2005, TOXICOL SCI, V86, P264, DOI 10.1093/toxsci/kfi183; Fluegel ML, 2006, GENETICS, V172, P185, DOI 10.1534/genetics.105.046565; FSTRAC, 1990, SUMM STAT FED DRINK; GARNER CD, 1995, J TOXICOL ENV HEALTH, V44, P43, DOI 10.1080/15287399509531942; Garrett M, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-489; Goldstein LSB, 2000, J CELL BIOL, V150, pF63, DOI 10.1083/jcb.150.2.F63; Goncalves AC, 2013, TOXICOL IN VITRO, V27, P1542, DOI 10.1016/j.tiv.2013.03.009; Hearn MG, 2002, P NATL ACAD SCI USA, V99, P14554, DOI 10.1073/pnas.202498299; HEMMERICH P, 1993, NUCLEIC ACIDS RES, V21, P223, DOI 10.1093/nar/21.2.223; Hoffmann JA, 2003, NATURE, V426, P33, DOI 10.1038/nature02021; IARC, 1997, POL DIB PAR DIOX POL; Illumina, 2012, TRUSEQ RNA SAMPL PRE, P136; Iorio F, 2013, DRUG DISCOV TODAY, V18, P350, DOI 10.1016/j.drudis.2012.07.014; Janssen D, 2010, J NEUROPHYSIOL, V103, P2587, DOI 10.1152/jn.00466.2009; Jordan KC, 2006, BMC DEV BIOL, V6, DOI 10.1186/1471-213X-6-16; Karpac J, 2013, CELL REP, V4, P1250, DOI 10.1016/j.celrep.2013.08.004; Kim DW, 2000, ONCOGENE, V19, P5498, DOI 10.1038/sj.onc.1203945; Kim KH, 2011, J ENVIRON SCI HEAL C, V29, P277, DOI 10.1080/10590501.2011.629972; Krasnov G S, 2011, Mol Biol (Mosk), V45, P238; Le Vee M, 2010, TOXICOL IN VITRO, V24, P1775, DOI 10.1016/j.tiv.2010.07.001; Liu Y, 2009, J RADIAT RES, V50, P233, DOI 10.1269/jrr.08112; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Marinkovic N, 2010, ARH HIG RADA TOKSIKO, V61, P445, DOI 10.2478/10004-1254-61-2010-2024; Moore AW, 2000, P NATL ACAD SCI USA, V97, P10436, DOI 10.1073/pnas.170301897; Morgan WF, 2013, RADIAT RES, V179, P501, DOI 10.1667/RR3306.1; Moro AM, 2012, MUTAT RES-GEN TOX EN, V746, P42, DOI 10.1016/j.mrgentox.2012.02.007; Moskalev A, 2009, BIOGERONTOLOGY, V10, P3, DOI 10.1007/s10522-008-9147-5; Moskalev AA, 2011, BIOGERONTOLOGY, V12, P253, DOI 10.1007/s10522-011-9320-0; Moskalev A, 2007, BIOGERONTOLOGY, V8, P499, DOI 10.1007/s10522-007-9090-x; Mueller JL, 2007, GENETICS, V175, P777, DOI 10.1534/genetics.106.065318; Mueller JL, 2005, GENETICS, V171, P131, DOI 10.1534/genetics.105.043844; Mueller JL, 2004, P NATL ACAD SCI USA, V101, P13542, DOI 10.1073/pnas.0405579101; Nielsen GD, 2013, ARCH TOXICOL, V87, P73, DOI 10.1007/s00204-012-0975-3; Ortelli F, 2003, BIOCHEM J, V373, P957, DOI 10.1042/BJ20030169; Paik D, 2012, MECH AGEING DEV, V133, P234, DOI 10.1016/j.mad.2012.02.001; Penalva-Arana DC, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-79; Phillips SE, 2008, J NEUROSCI, V28, P6569, DOI 10.1523/JNEUROSCI.5529-07.2008; Picchio L, 2013, HUM MOL GENET, V22, P2795, DOI 10.1093/hmg/ddt127; Plyusnina EN, 2011, BIOGERONTOLOGY, V12, P211, DOI 10.1007/s10522-010-9311-6; Ponton F, 2011, J INSECT PHYSIOL, V57, P840, DOI 10.1016/j.jinsphys.2011.03.014; Reiner A, 2003, BIOINFORMATICS, V19, P368, DOI 10.1093/bioinformatics/btf877; Robertson HM, 2003, P NATL ACAD SCI USA, V100, P14537, DOI 10.1073/pnas.2335847100; Royland JE, 2012, TOXICOL SCI, V126, P193, DOI 10.1093/toxsci/kfr340; Saisawang C, 2012, BIOCHEM J, V442, P181, DOI 10.1042/BJ20111747; Salthammer T, 2010, CHEM REV, V110, P2536, DOI 10.1021/cr800399g; Scharpfenecker M, 2009, INT J RADIAT ONCOL, V73, P506, DOI 10.1016/j.ijrobp.2008.09.052; Segev E, 2001, MECH DEVELOP, V106, P197, DOI 10.1016/S0925-4773(01)00437-3; Senchenko VN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015612; Shaham J, 2003, OCCUP ENVIRON MED, V60, P403, DOI 10.1136/oem.60.6.403; Singh MP, 2011, TOXICOL APPL PHARM, V253, P14, DOI 10.1016/j.taap.2011.03.006; Somogyi K, 2008, MOL BIOL EVOL, V25, P2337, DOI 10.1093/molbev/msn180; STUMMTEGETHOFF BF, 1969, THEOR APPL GENET, V39, P330, DOI 10.1007/BF00281915; Su WX, 2012, INT J RADIAT BIOL, V88, P635, DOI 10.3109/09553002.2012.703362; Sul D, 2007, ARCH TOXICOL, V81, P589, DOI 10.1007/s00204-007-0182-9; Sun JJ, 2008, J CELL BIOL, V182, P885, DOI 10.1083/jcb.200802084; Sykiotis GP, 2008, DEV CELL, V14, P76, DOI 10.1016/j.devcel.2007.12.002; Tsang H, 2012, REPROD TOXICOL, V33, P60, DOI 10.1016/j.reprotox.2011.11.002; Tuchscherer J, 2013, CAN J EMERG MED, V15, P249, DOI 10.2310/8000.2013.130974; UNSCEAR, 2010, REP UN SCI COMM EFF, P106; van Bergeijk P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036539; VARTERASIAN M, 1993, CELL GROWTH DIFFER, V4, P885; Verzi MP, 2002, DEV BIOL, V249, P174, DOI 10.1006/dbio.2002.0753; Vickrey TL, 2011, ACS CHEM NEUROSCI, V2, P723, DOI 10.1021/cn200057k; Walker MJ, 2006, PROTEOME SCI, V4, DOI 10.1186/1477-5956-4-9; Weng RF, 2012, DEVELOPMENT, V139, P1427, DOI 10.1242/dev.075143; Win-Shwe TT, 2010, TOXICOL LETT, V198, P93, DOI 10.1016/j.toxlet.2010.06.022; Wong A, 2012, MOL BIOL EVOL, V29, P229, DOI 10.1093/molbev/msr197; Wu H, 2013, BIOSTATISTICS, V14, P232, DOI 10.1093/biostatistics/kxs033; Yang J, 2013, J TOXICOL SCI, V38, P833; Yang W, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000556; Zinke I, 2002, EMBO J, V21, P6162, DOI 10.1093/emboj/cdf600	108	19	20	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2014	9	1							e86051	10.1371/journal.pone.0086051	http://dx.doi.org/10.1371/journal.pone.0086051			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	298QQ	24475070	gold, Green Submitted, Green Published			2022-12-25	WOS:000330339800024
J	Rizio, AA; Dennis, NA				Rizio, Avery A.; Dennis, Nancy A.			The Cognitive Control of Memory: Age Differences in the Neural Correlates of Successful Remembering and Intentional Forgetting	PLOS ONE			English	Article							PREFRONTAL CORTEX; BRAIN ACTIVITY; OLDER-ADULTS; HEMISPHERIC-ASYMMETRY; INHIBITORY CONTROL; PARIETAL CORTEX; SUPPRESSION; RETRIEVAL; TRUE; FMRI	Successful memory encoding depends on the ability to intentionally encode relevant information (via differential encoding) and intentionally forget that which is irrelevant (via inhibition). Both cognitive processes have been shown to decline in aging and are theorized to underlie age-related deficits in the cognitive control of memory. The current study uses the Directed Forgetting paradigm in conjunction with fMRI to investigate age-related differences in both cognitive processes, with the specific aim of elucidating neural evidence supporting these theorized deficits. Results indicate relatively preserved differential encoding, with age differences consistent with previous models of age-related compensation (i.e., increased frontal and bilateral recruitment). Older adults did display noticeable differences in the recruitment of brain regions related to intentional forgetting, specifically exhibiting reduced activity in the right superior prefrontal cortex, a region shown to be critical to inhibitory processing. However, older adults exhibited increased reliance on processing in right inferior parietal lobe associated with successful forgetting. Activity in this region was negatively correlated with activity in the medial temporal lobe, suggesting a shift in the locus of inhibition compared to the frontally mediated inhibition observed in younger adults. Finally, while previous studies found intentional and incidental forgetting to be dissociable in younger adults, this differentiation appears to be reduced in older adults. The current results are the first to provide neural evidence for an age-related reduction in processes that support intentional forgetting.	[Rizio, Avery A.; Dennis, Nancy A.] Penn State Univ, Dept Psychol, State Coll, University Pk, PA 16802 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Dennis, NA (corresponding author), Penn State Univ, Dept Psychol, State Coll, University Pk, PA 16802 USA.	nad12@psu.edu		Rizio, Avery/0000-0003-1881-4523	NSF [1025709]; American Federation for Aging Research	NSF(National Science Foundation (NSF)); American Federation for Aging Research	Awarded to N.A.D.: Grant Sponsor: NSF; Grant number: 1025709 Portions of this research were conducted while N.A.D. was an AFAR Research Grant recipient from the American Federation for Aging Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson MC, 2004, SCIENCE, V303, P232, DOI 10.1126/science.1089504; Anderson MC, 2012, NEBR SYM MOTIV, V58, P53, DOI 10.1007/978-1-4614-1195-6_3; Anderson MC, 2011, PSYCHOL AGING, V26, P397, DOI 10.1037/a0022505; Anderson ND, 2000, J COGNITIVE NEUROSCI, V12, P775, DOI 10.1162/089892900562598; Basden BH, 1996, MEMORY, V4, P633, DOI 10.1080/741941000; Bastin C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029905; Benoit RG, 2012, NEURON, V76, P450, DOI 10.1016/j.neuron.2012.07.025; BJORK RA, 1970, J VERB LEARN VERB BE, V9, P255, DOI 10.1016/S0022-5371(70)80059-7; Cabeza R, 2000, J COGNITIVE NEUROSCI, V12, P1, DOI 10.1162/08989290051137585; Cabeza R, 2002, NEUROIMAGE, V17, P1394, DOI 10.1006/nimg.2002.1280; Cabeza R, 2002, PSYCHOL AGING, V17, P85, DOI 10.1037//0882-7974.17.1.85; Cabeza R, 2008, NAT REV NEUROSCI, V9, P613, DOI 10.1038/nrn2459; CAVADA C, 1989, J COMP NEUROL, V287, P422, DOI 10.1002/cne.902870403; Collette F, 2009, MEMORY, V17, P104, DOI 10.1080/09658210802574146; CONNELLY SL, 1991, PSYCHOL AGING, V6, P533, DOI 10.1037/0882-7974.6.4.533; Daselaar SM., 2007, CLIN APPL FUNCTIONAL, P115; Davis SW, 2008, CEREB CORTEX, V18, P1201, DOI 10.1093/cercor/bhm155; DEMB JB, 1995, J NEUROSCI, V15, P5870; Dennis N. A., 2008, HDB AGING COGNITION, P1, DOI DOI 10.4324/9780203837665.CH1; Dennis NA, NEUROBIOLOG IN PRESS; Dennis NA, 2008, J COGNITIVE NEUROSCI, V20, P1390, DOI 10.1162/jocn.2008.20096; Dennis NA, 2007, NEUROPSYCHOLOGIA, V45, P3157, DOI 10.1016/j.neuropsychologia.2007.07.003; Dennis NA, 2007, NEUROBIOL AGING, V28, P1749, DOI 10.1016/j.neurobiolaging.2006.07.006; Depue BE, 2007, SCIENCE, V317, P215, DOI 10.1126/science.1139560; Dew ITZ, 2012, CEREB CORTEX, V22, P2542, DOI 10.1093/cercor/bhr334; Dolcos F, 2002, NEUROSCI BIOBEHAV R, V26, P819, DOI 10.1016/S0149-7634(02)00068-4; Dulaney CL, 2004, EXP AGING RES, V30, P95, DOI 10.1080/03610730490251504; Earles JL, 2002, PSYCHON B REV, V9, P383, DOI 10.3758/BF03196297; FORMAN SD, 1995, MAGNET RESON MED, V33, P636, DOI 10.1002/mrm.1910330508; Gabrieli JDE, 1996, PSYCHOL SCI, V7, P278, DOI 10.1111/j.1467-9280.1996.tb00374.x; Garoff-Eaton RJ, 2007, LEARN MEMORY, V14, P684, DOI 10.1101/lm.695707; Goh JOS, 2011, AGING DIS, V2, P30; GRADY CL, 1994, J NEUROSCI, V14, P1450, DOI 10.1523/JNEUROSCI.14-03-01450.1994; Gutchess AH, 2005, J COGNITIVE NEUROSCI, V17, P84, DOI 10.1162/0898929052880048; HARTMAN M, 1991, PSYCHOL AGING, V6, P587, DOI 10.1037/0882-7974.6.4.587; Hasher L, 1997, MEM COGNITION, V25, P286, DOI 10.3758/BF03211284; Hasher L., 1988, PSYCHOL LEARNING MOT, V22, P193, DOI [10.1016/S0079-7421(08)60041-9, DOI 10.1016/S0079-7421(08)60041-9]; Hayes SM, 2008, HDB COGNITIVE AGING, P308; Henson RNA, 1999, J NEUROSCI, V19, P3962; Hogge M, 2008, AGING NEUROPSYCHOL C, V15, P471, DOI 10.1080/13825580701878065; Hsieh LT, 2009, BRAIN RES, V1250, P190, DOI 10.1016/j.brainres.2008.11.016; Langenecker SA, 2003, NEUROIMAGE, V20, P1384, DOI 10.1016/S1053-8119(03)00372-0; Levy BJ, 2012, J NEUROSCI, V32, P16785, DOI 10.1523/JNEUROSCI.2640-12.2012; Logan JM, 2002, NEURON, V33, P827, DOI 10.1016/S0896-6273(02)00612-8; Milham MP, 2001, COGNITIVE BRAIN RES, V12, P467, DOI 10.1016/S0926-6410(01)00076-3; Morcom AM, 2003, BRAIN, V126, P213, DOI 10.1093/brain/awg020; Morrone I, 2010, PSYCHOL AGING, V25, P697, DOI 10.1037/a0019578; Nielson KA, 2002, PSYCHOL AGING, V17, P56, DOI 10.1037//0882-7974.17.1.56; Nowicka A, 2011, CEREB CORTEX, V21, P539, DOI 10.1093/cercor/bhq117; Okado Y, 2003, COGN AFFECT BEHAV NE, V3, P323, DOI 10.3758/CABN.3.4.323; Park DC, 2004, P NATL ACAD SCI USA, V101, P13091, DOI 10.1073/pnas.0405148101; Paz-Alonso PM, 2013, J NEUROSCI, V33, P5017, DOI 10.1523/JNEUROSCI.3459-12.2013; Paz-Caballero MD, 2004, CLIN NEUROPHYSIOL, V115, P369, DOI 10.1016/j.clinph.2003.09.011; PETRIDES M, 1984, J COMP NEUROL, V228, P105, DOI 10.1002/cne.902280110; Prakash RS, 2009, BRAIN COGNITION, V71, P328, DOI 10.1016/j.bandc.2009.07.005; Ranganath C, 2004, NEUROPSYCHOLOGIA, V42, P2, DOI 10.1016/j.neuropsychologia.2003.07.006; Reber PJ, 2002, J NEUROSCI, V22, P9541; Rizio AA, 2013, J COGNITIVE NEUROSCI, V25, P297, DOI 10.1162/jocn_a_00310; Slotnick SD, 2006, NEUROPSYCHOLOGIA, V44, P2874, DOI 10.1016/j.neuropsychologia.2006.06.021; Slotnick SD, 2004, NAT NEUROSCI, V7, P664, DOI 10.1038/nn1252; Slotnick SD, 2003, COGNITIVE BRAIN RES, V17, P75, DOI 10.1016/S0926-6410(03)00082-X; Stebbins GT, 2002, PSYCHOL AGING, V17, P44, DOI 10.1037//0882-7974.17.1.44; Talairach J., 1988, COPLANAR STEREOTAXIC; Ullsperger M, 2000, J COGNITIVE NEUROSCI, V12, P924, DOI 10.1162/08989290051137477; Vallesi A, 2011, J COGNITIVE NEUROSCI, V23, P801, DOI 10.1162/jocn.2010.21490; Van Hooff JC, 2009, BRAIN COGNITION, V71, P153, DOI 10.1016/j.bandc.2009.05.001; Wylie GR, 2008, CEREB CORTEX, V18, P670, DOI 10.1093/cercor/bhm101; YONELINAS AP, 1995, J MEM LANG, V34, P622, DOI 10.1006/jmla.1995.1028; Zacks R. T., 2000, HDB AGING COGNITION, V2nd, P293, DOI DOI 10.3758/S13423-011-0086-9; Zacks RT, 1996, J EXP PSYCHOL LEARN, V22, P143, DOI 10.1037/0278-7393.22.1.143	70	20	22	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2014	9	1							e87010	10.1371/journal.pone.0087010	http://dx.doi.org/10.1371/journal.pone.0087010			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	298QQ	24475211	Green Published, gold			2022-12-25	WOS:000330339800076
J	Tully, PJ; Wittert, G; Selkow, T; Baumeister, H				Tully, Phillip J.; Wittert, Gary; Selkow, Terina; Baumeister, Harald			The Real World Mental Health Needs of Heart Failure Patients Are Not Reflected by the Depression Randomized Controlled Trial Evidence	PLOS ONE			English	Article							QUALITY-OF-LIFE; POSTTRAUMATIC-STRESS-DISORDER; GENERALIZED ANXIETY DISORDER; CORONARY-ARTERY-DISEASE; CLINICAL-PRACTICE; DOUBLE-BLIND; RISK-FACTORS; MYOCARDIAL-INFARCTION; SUICIDAL IDEATION; EUROPEAN-SOCIETY	Introduction: International depression screening guidelines in heart failure (HF) are partly based on depression treatment efficacy from randomized controlled trials (RCTs). Our aim was to test the external validity of depression RCT criteria in a sample of real-world HF patients. Methods: HF patients admitted to 3 hospitals in South Australia were referred to a HF psychologist if not already receiving current psychiatric management by psychologist or psychiatrist elsewhere. Screening and referral protocol consisted of the following; (a). Patient Health Questionnaire >= 10; (b). Generalized Anxiety Disorder Questionnaire >= 7); (c). positive response to 1 item panic attack screener; (d). evidence of suicidality. Patients were evaluated against the most common RCT exclusion criteria personality disorder, high suicide risk, cognitive impairment, psychosis, alcohol or substance abuse or dependency, bi-polar depression. Results: Total 81 HF patients were referred from 404 HF admissions, and 73 were assessed (age 60.6 +/- 13.4, 47.9% female). Nearly half (47%) met at least 1 RCT exclusion criterion, most commonly personality disorder (28.5%), alcohol/substance abuse (17.8%) and high suicide risk (11.0%). RCT ineligibility criteria was more frequent among patients with major depression (76.5% vs. 46.2%, p<.01) and dysthymia (26.5% vs. 7.7%, p = .03) but not significantly associated with anxiety disorders. RCT ineligible patients reported greater severity of depression (M = 16.6 +/- 5.0 vs. M=12.9 +/- 7.2, p = .02) and were higher consumers of HF psychotherapy services (M = 11.5 +/- 4.7 vs. M=8.5 +/- 4.8, p = .01). Conclusion: In this real-world sample comparable in size to recent RCT intervention arms, patients with depression disorders presented with complex psychiatric needs including comorbid personality disorders, alcohol/substance use and suicide risk. These findings suggest external validity of depression screening and RCTs could serve as a basis for level A guideline recommendations in cardiovascular diseases.	[Tully, Phillip J.; Baumeister, Harald] Univ Freiburg, Dept Rehabil Psychol & Psychotherapy, Inst Psychol, D-79106 Freiburg, Germany; [Tully, Phillip J.; Baumeister, Harald] Univ Freiburg, Fac Med, D-79106 Freiburg, Germany; [Tully, Phillip J.; Wittert, Gary] Univ Adelaide, Freemasons Fdn Ctr Mens Hlth, Discipline Med, Sch Med, Adelaide, SA, Australia; [Tully, Phillip J.; Selkow, Terina] Queen Elizabeth Hosp, Heart Failure Support Serv, Woodville, SA 5011, Australia	University of Freiburg; University of Freiburg; University of Adelaide	Tully, PJ (corresponding author), Univ Freiburg, Dept Rehabil Psychol & Psychotherapy, Inst Psychol, Hugstetter Str 55, D-79106 Freiburg, Germany.	phillip.tully@adelaide.edu.au	Tully, Phillip/I-6256-2018; wittert, gary/AAE-2398-2019	Tully, Phillip/0000-0003-2807-1313; Baumeister, Harald/0000-0002-2040-661X; Wittert, Gary/0000-0001-6818-6065	National Health and Medical Research Council of Australia [1053578]; Albert Ludwigs University of Freiburg	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Albert Ludwigs University of Freiburg	Dr Phillip John Tully is supported by the National Health and Medical Research Council of Australia (Neil Hamilton Fairley - Clinical Overseas Fellowship # 1053578). The article processing charge which funded by the Open Access publication fund of the Albert Ludwigs University of Freiburg. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albus C, 2004, EUR J CARDIOV PREV R, V11, P75, DOI 10.1097/01.hjr.0000116823.84388.6c; American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Annunziato RA, 2008, PSYCHOSOMATICS, V49, P386, DOI 10.1176/appi.psy.49.5.386; Ballenger JC, 2001, J CLIN PSYCHIAT, V62, P24; Baumeister H, 2011, PSYCHOTHER PSYCHOSOM, V80, P275, DOI 10.1159/000323404; Borges G, 2010, J CLIN PSYCHIAT, V71, P1617, DOI 10.4088/JCP.08m04967blu; Burton C, 2013, PSYCHOL MED, V43, P529, DOI 10.1017/S0033291712001481; Carney RM, 2009, AM J PSYCHIAT, V166, P410, DOI 10.1176/appi.ajp.2008.08081239; Caro MA, 2012, J CARDIOL, V60, P72, DOI 10.1016/j.jjcc.2012.01.016; Chronic Heart Failure Guidelines Expert Writing Panel, 2011, GUID PREV DET MAN CH; Collins PY, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001434; Cully JA, 2010, PRIM CARE COMPANION, V12; Dharmarajan K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078222; Doerfler LA, 2005, CAN J CARDIOL, V21, P689; Edmondson D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038915; Ferrari AJ, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001547; First M. B., 2007, STRUCTURED CLIN INTE; First M. B., 1997, STRUCTURED CLIN INTE; Fraguas R, 2009, CONTEMP CLIN TRIALS, V30, P205, DOI 10.1016/j.cct.2009.01.007; Gary RA, 2010, J PSYCHOSOM RES, V69, P119, DOI 10.1016/j.jpsychores.2010.01.013; Gottlieb SS, 2007, AM HEART J, V153, P868, DOI 10.1016/j.ahj.2007.02.024; Hasnain M, 2011, J PSYCHOSOM RES, V71, P6, DOI 10.1016/j.jpsychores.2010.10.009; Haworth JE, 2005, EUR J HEART FAIL, V7, P803, DOI 10.1016/j.ejheart.2005.03.001; Herrmann-Lingen C, 2011, J PSYCHOSOM RES, V70, P111, DOI 10.1016/j.jpsychores.2010.09.019; Hoertel N, 2013, J AFFECT DISORDERS, V146, P383, DOI 10.1016/j.jad.2012.09.023; Holzapfel N, 2007, PSYCHOSOMATICS, V48, P112, DOI 10.1176/appi.psy.48.2.112; Holzapfel N, 2009, HEART LUNG, V38, P392, DOI 10.1016/j.hrtlng.2008.11.001; Hood KK, 2012, DIABETES CARE, V35, P2443, DOI 10.2337/dc11-2329; Jaarsma Tiny, 2010, Curr Opin Support Palliat Care, V4, P233, DOI 10.1097/SPC.0b013e328340744d; Jaarsma T, 2010, J AM COLL CARDIOL, V55, P1837, DOI 10.1016/j.jacc.2009.11.082; Jakobsen JC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028299; Jani BD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074610; Jiang W, 2001, ARCH INTERN MED, V161, P1849, DOI 10.1001/archinte.161.15.1849; Jiang W, 2008, AM HEART J, V156, P437, DOI 10.1016/j.ahj.2008.05.003; Jiang W, 2011, AM J CARDIOL, V107, P545, DOI 10.1016/j.amjcard.2010.10.013; Kemp AH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030777; Khan A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041778; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Kroenke K, 2010, GEN HOSP PSYCHIAT, V32, P345, DOI 10.1016/j.genhosppsych.2010.03.006; Lainscak M, 2011, EUR J HEART FAIL, V13, P115, DOI 10.1093/eurjhf/hfq219; Lekakis J, 2010, INT J CARDIOL, V139, P150, DOI 10.1016/j.ijcard.2008.10.010; Lichtman JH, 2008, CIRCULATION, V118, P1768, DOI 10.1161/CIRCULATIONAHA.108.190769; Lossnitzer N, 2009, DEPRESS ANXIETY, V26, P764, DOI 10.1002/da.20587; Lowe B, 2003, J PSYCHOSOM RES, V55, P515, DOI 10.1016/S0022-3999(03)00072-2; Luttik MLA, 2011, EUR J CARDIOVASC NUR, V10, P228, DOI 10.1016/j.ejcnurse.2010.08.005; Luukinen H, 2010, SCAND J CLIN LAB INV, V70, P75, DOI 10.3109/00365510903410548; Masoudi FA, 2003, AM HEART J, V146, P250, DOI 10.1016/S0002-8703(03)00189-3; McManus D, 2005, AM J CARDIOL, V96, P1076, DOI 10.1016/j.amjcard.2005.06.037; McMurray JJV, 2012, EUR J HEART FAIL, V14, P803, DOI 10.1093/eurjhf/hfs105; Mulder RT, 2003, AUST NZ J PSYCHIAT, V37, P265, DOI 10.1046/j.1440-1614.2003.01176.x; O'Connor CM, 2008, ARCH INTERN MED, V168, P2232, DOI 10.1001/archinte.168.20.2232; O'Hea E, 2009, HEART FAIL REV, V14, P13, DOI 10.1007/s10741-008-9081-2; Orth-Gomer K, 2005, INT J BEHAV MED, V12, P132, DOI 10.1207/s15327558ijbm1203_2; Pedersen SS, 2001, SCAND J PSYCHOL, V42, P445, DOI 10.1111/1467-9450.00257; Rollman BL, 2009, JAMA-J AM MED ASSOC, V302, P2095, DOI 10.1001/jama.2009.1670; Rothman K J, 1990, Epidemiology, V1, P43, DOI 10.1097/00001648-199001000-00010; Rothwell PM, 2005, LANCET, V365, P82, DOI 10.1016/S0140-6736(04)17670-8; Ruscio AM, 2006, CLIN PSYCHOL-SCI PR, V13, P146, DOI 10.1111/j.1468-2850.2006.00017.x; Rutledge T, 2006, J AM COLL CARDIOL, V48, P1527, DOI 10.1016/j.jacc.2006.06.055; Samartzis L, 2013, J CARD FAIL, V19, P125, DOI 10.1016/j.cardfail.2012.12.004; Sareen J, 2005, ARCH GEN PSYCHIAT, V62, P1249, DOI 10.1001/archpsyc.62.11.1249; Scherrer JF, 2010, AM HEART J, V159, P772, DOI 10.1016/j.ahj.2010.02.033; Serber ER, 2009, J CARDIOPULM REHABIL, V29, P161, DOI 10.1097/HCR.0b013e3181a33365; Shemesh E, 2011, J CLIN PSYCHIAT, V72, P168, DOI 10.4088/JCP.09m05116blu; Shemesh E, 2009, AM J CARDIOL, V104, P1194, DOI 10.1016/j.amjcard.2009.06.033; Smith DH, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-434; Smolderen KG, 2011, CIRC-CARDIOVASC QUAL, V4, P283, DOI 10.1161/CIRCOUTCOMES.110.960013; Sowden G, 2010, AM HEART J, V159, P780, DOI 10.1016/j.ahj.2010.02.029; Spitzer RL, 1999, JAMA-J AM MED ASSOC, V282, P1737, DOI 10.1001/jama.282.18.1737; Spitzer RL, 2006, ARCH INTERN MED, V166, P1092, DOI 10.1001/archinte.166.10.1092; Sullivan MJ, 2009, AM HEART J, V157, P84, DOI 10.1016/j.ahj.2008.08.033; Thombs BD, 2008, JAMA-J AM MED ASSOC, V300, P2161, DOI 10.1001/jama.2008.667; Thombs BD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052654; Tully PJ, 2013, J HEALTH PSYCHOL, V18, P1601, DOI 10.1177/1359105312467390; Tully PJ, 2013, PSYCHOL HEALTH MED, V18, P627, DOI 10.1080/13548506.2012.749355; Tully PJ, SOC PSYCH P IN PRESS; van der Lem R, 2012, PSYCHOTHER PSYCHOSOM, V81, P226, DOI 10.1159/000330890; Vogels RLC, 2007, EUR J HEART FAIL, V9, P440, DOI 10.1016/j.ejheart.2006.11.001; Wade Victoria, 2005, Aust Fam Physician, V34, P985; Woltz PC, 2012, HEART LUNG, V41, P469, DOI 10.1016/j.hrtlng.2012.06.002; Yeager KR, 2011, HEART FAIL CLIN, V7, P69, DOI 10.1016/j.hfc.2010.08.007; Yu DSF, 2007, GERONTOLOGY, V53, P74, DOI 10.1159/000096427; Zetin M, 2007, J CLIN PSYCHOPHARM, V27, P295, DOI 10.1097/JCP.0b013e318058263f	83	15	15	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2014	9	1							e85928	10.1371/journal.pone.0085928	http://dx.doi.org/10.1371/journal.pone.0085928			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	298QQ	24475060	Green Submitted, Green Published, gold			2022-12-25	WOS:000330339800019
J	Wang, XJ; Guo, JF; Fei, EK; Mu, YF; He, S; Che, XQ; Tan, JQ; Xia, K; Zhang, ZH; Wang, GH; Tang, BS				Wang, Xuejing; Guo, Jifeng; Fei, Erkang; Mu, Yingfeng; He, Shuang; Che, Xiangqian; Tan, Jieqiong; Xia, Kun; Zhang, Zhuohua; Wang, Guanghui; Tang, Beisha			BAG5 Protects against Mitochondrial Oxidative Damage through Regulating PINK1 Degradation	PLOS ONE			English	Article							WILD-TYPE PINK1; UBIQUITIN LIGASE; MUTATIONS; PARKIN; APOPTOSIS; DOMAIN; LOCALIZATION; FREQUENCY; GENOTYPES; SURVIVAL	Mutations in PTEN-induced kinase 1 (PINK1) gene cause PARK6 familial Parkinsonism, and loss of the stability of PINK1 may also contribute to sporadic Parkinson's disease (PD). Degradation of PINK1 occurs predominantly through the ubiquitin proteasome system (UPS), however, to date, few of the proteins have been found to regulate the degradation of PINK1. Using the yeast two-hybrid system and pull-down methods, we identified bcl-2-associated athanogene 5 (BAG5), a BAG family member, directly interacted with PINK1. We showed that BAG5 stabilized PINK1 by decreasing the ubiquitination of PINK1. Interestingly, BAG5 rescued MPP+-and rotenone-induced mitochondria dysfunction by up-regulating PINK1 in vitro. In PINK1-null mice and MPTP-treated mice, BAG5 significantly increased in the substantia nigra pars compacta (SNpc) although PINK1 was decreased. Our findings indicated that BAG5, as a key protein to stabilize PINK1, is a promising therapeutic tool for preventing mitochondrial dysfunction following oxidative stress.	[Wang, Xuejing; Guo, Jifeng; Mu, Yingfeng; He, Shuang; Che, Xiangqian; Tang, Beisha] Cent S Univ, Xiangya Hosp, Dept Neurol, Changsha, Hunan, Peoples R China; [Guo, Jifeng; Tan, Jieqiong; Xia, Kun; Zhang, Zhuohua; Tang, Beisha] State Key Lab Med Genet, Changsha, Hunan, Peoples R China; [Fei, Erkang; Wang, Guanghui] Univ Sci & Technol China, Lab Mol Neuropathol, Natl Lab Phys Sci Microscale, Hefei 230026, Anhui, Peoples R China; [Fei, Erkang; Wang, Guanghui] Univ Sci & Technol China, Sch Life Sci, Hefei 230026, Anhui, Peoples R China; [Guo, Jifeng; Tang, Beisha] Cent S Univ, Human Key Lab Neurodegenerat Disorders, Changsha, Hunan, Peoples R China; [Guo, Jifeng; Tang, Beisha] Cent S Univ, Neurodegenerat Disorders Res Ctr, Changsha, Hunan, Peoples R China	Central South University; Chinese Academy of Sciences; University of Science & Technology of China, CAS; Chinese Academy of Sciences; University of Science & Technology of China, CAS; Central South University; Central South University	Wang, GH (corresponding author), Univ Sci & Technol China, Lab Mol Neuropathol, Natl Lab Phys Sci Microscale, Hefei 230026, Anhui, Peoples R China.	wghui@ustc.edu.cn; bstang7398@163.com	XIA, KUN/AAO-3525-2020; FEI, Erkang/AAI-9825-2021	FEI, Erkang/0000-0002-3581-9521	Major State Basic Research Development Program of China (973 Program) [2011CB510000]; National Natural Science Foundation of China [30900469, 81171198, 81200870, 81000542, 81130021, 81371405, 81361120404]	Major State Basic Research Development Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grant from the Major State Basic Research Development Program of China (973 Program) (2011CB510000), grant from the National Natural Science Foundation of China(30900469,81171198, 81200870, 81000542, 81130021, 81371405, 81361120404). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arakawa A, 2010, STRUCTURE, V18, P309, DOI 10.1016/j.str.2010.01.004; Arndt V, 2005, MOL BIOL CELL, V16, P5891, DOI 10.1091/mbc.E05-07-0660; Beilina A, 2005, P NATL ACAD SCI USA, V102, P5703, DOI 10.1073/pnas.0500617102; Bonifati V, 2005, NEUROLOGY, V65, P87, DOI 10.1212/01.wnl.0000167546.39375.82; Briknarova K, 2001, NAT STRUCT BIOL, V8, P349, DOI 10.1038/86236; Cardoso SM, 2001, FASEB J, V15, P1439, DOI 10.1096/fj.00-0561fje; Demand J, 2001, CURR BIOL, V11, P1569, DOI 10.1016/S0960-9822(01)00487-0; Deng H, 2005, BIOCHEM BIOPH RES CO, V337, P1133, DOI 10.1016/j.bbrc.2005.09.178; Doong H, 2002, CANCER LETT, V188, P25, DOI 10.1016/S0304-3835(02)00456-1; Gegg ME, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004756; Hardy J, 2009, CURR OPIN GENET DEV, V19, P254, DOI 10.1016/j.gde.2009.03.008; Kabbage M, 2008, CELL MOL LIFE SCI, V65, P1390, DOI 10.1007/s00018-008-7535-2; Kalia SK, 2004, NEURON, V44, P931, DOI 10.1016/j.neuron.2004.11.026; Kim Y, 2008, BIOCHEM BIOPH RES CO, V377, P975, DOI 10.1016/j.bbrc.2008.10.104; Klein C, 2006, NEUROLOGY, V66, P1129, DOI 10.1212/01.wnl.0000220157.81513.85; Levites Y, 2001, J NEUROCHEM, V78, P1073, DOI 10.1046/j.1471-4159.2001.00490.x; Luders J, 2000, J BIOL CHEM, V275, P4613, DOI 10.1074/jbc.275.7.4613; Morais VA, 2009, EMBO MOL MED, V1, P99, DOI 10.1002/emmm.200900006; Moriya R, 2000, FEBS LETT, V484, P253, DOI 10.1016/S0014-5793(00)02167-0; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Muqit MMK, 2006, J NEUROCHEM, V98, P156, DOI 10.1111/j.1471-4159.2006.03845.x; Petit A, 2005, J BIOL CHEM, V280, P34025, DOI 10.1074/jbc.M505143200; Plun-Favreau H, 2007, NAT CELL BIOL, V9, P1243, DOI 10.1038/ncb1644; Pridgeon JW, 2007, PLOS BIOL, V5, P1494, DOI 10.1371/journal.pbio.0050172; Rakovic A, 2010, HUM MOL GENET, V19, P3124, DOI 10.1093/hmg/ddq215; Shiba K, 2009, BIOCHEM BIOPH RES CO, V383, P331, DOI 10.1016/j.bbrc.2009.04.006; Silvestri L, 2005, HUM MOL GENET, V14, P3477, DOI 10.1093/hmg/ddi377; Sim CH, 2006, HUM MOL GENET, V15, P3251, DOI 10.1093/hmg/ddl398; Springer W, 2011, AUTOPHAGY, V7, P266, DOI 10.4161/auto.7.3.14348; Tang BS, 2006, HUM MOL GENET, V15, P1816, DOI 10.1093/hmg/ddl104; Um JW, 2009, MOL CELL NEUROSCI, V40, P421, DOI 10.1016/j.mcn.2008.12.010; Valente EM, 2004, ANN NEUROL, V56, P336, DOI 10.1002/ana.20256; Wood-Kaczmar A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002455; Xiong H, 2009, J CLIN INVEST, V119, P650, DOI 10.1172/JCI37617; Xiromerisiou G, 2010, NEUROSURG FOCUS, V28, DOI 10.3171/2009.10.FOCUS09220; Yun J, 2008, J NEUROSCI, V28, P14500, DOI 10.1523/JNEUROSCI.5141-08.2008	36	19	20	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2014	9	1							e86276	10.1371/journal.pone.0086276	http://dx.doi.org/10.1371/journal.pone.0086276			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	298QQ	24475098	Green Submitted, Green Published, gold			2022-12-25	WOS:000330339800038
J	Camacho-Rivera, M; Kawachi, I; Bennett, GG; Subramanian, SV				Camacho-Rivera, Marlene; Kawachi, Ichiro; Bennett, Gary G.; Subramanian, S. V.			Perceptions of Neighborhood Safety and Asthma among Children and Adolescents in Los Angeles: A Multilevel Analysis	PLOS ONE			English	Article							CHILDHOOD ASTHMA; SOCIAL-ENVIRONMENT; COMMUNITY VIOLENCE; INDOOR ALLERGENS; AIR-POLLUTION; MORBIDITY; EXPOSURE; STRESS; DISPARITIES; FAMILY	Background: Research examining the impact of neighborhoods on asthma has shown an increased interest in the role of the psychosocial environment. We examined the associations between various measures of neighborhood safety, individual and family characteristics, and asthma outcomes among children in Los Angeles. Methods: Multilevel logistic regression models were used to analyze data on 3,114 children across 65 neighborhoods from Wave 1 of the Los Angeles Family and Neighborhood Survey (2000 to 2002). Primary caregivers reported asthma outcome and all individual covariates; home environmental characteristics were observed by the interviewer. Results: In fully adjusted models, parents who reported their neighborhood fairly safe or somewhat dangerous had lower odds of reported lifetime asthma compared to those who reported their neighborhood completely safe (OR 0.71; 95% CI 0.52-0.96 and OR 0.60; 95% CI 0.42-0.88 respectively). Conversely, parents who reported they could not trust their neighbors to keep their children safe had a nearly 40% increase in lifetime asthma compared to those who reported they could trust their neighbors to keep their children safe (OR 1.39; 95% CI 1.07-1.81). Conclusions: The study demonstrates a complex pattern between various measures of neighborhood safety and asthma and suggests that these relationships may operate differently in Los Angeles. As an increasing proportion of children are growing up in newer Western and Southwestern cities, which have different physical layouts and residential segregation patterns compared to Northeast and Midwestern cities, future studies should continue to examine neighborhood psychosocial stressors and asthma in diverse contexts.	[Camacho-Rivera, Marlene] North Shore LIJ Hlth Syst, Dept Populat Hlth, Great Neck, NY USA; [Kawachi, Ichiro; Subramanian, S. V.] Harvard Univ, Sch Publ Hlth, Dept Social & Behav Sci, Boston, MA 02115 USA; [Bennett, Gary G.] Duke Univ, Dept Psychol & Neurosci, Durham, NC USA	Northwell Health; Harvard University; Harvard T.H. Chan School of Public Health; Duke University	Subramanian, SV (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Social & Behav Sci, 665 Huntington Ave, Boston, MA 02115 USA.	svsubram@hsph.harvard.edu		Camacho-Rivera, Marlene/0000-0003-2343-2941	National Institutes of Health [NHLBI K25 HL081275]; U.S. Department of Health and Human Services (HRSA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K25HL081275] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); U.S. Department of Health and Human Services (HRSA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	SVS is supported by a National Institutes of Health Career Development Award (NHLBI K25 HL081275). MCR is supported by the U.S. Department of Health and Human Services (HRSA) Public Health Traineeship Grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASHER MI, 1995, EUR RESPIR J, V8, P483, DOI 10.1183/09031936.95.08030483; Blumberg Stephen J, 2012, Vital Health Stat 1, P1; Cagney KA, 2004, J GEN INTERN MED, V19, P229, DOI 10.1111/j.1525-1497.2004.30359.x; Chen E, 2007, AM J RESP CRIT CARE, V176, P644, DOI 10.1164/rccm.200610-1473OC; Clark CR, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-162; Clougherty JE, 2007, ENVIRON HEALTH PERSP, V115, P1140, DOI 10.1289/ehp.9863; Gold DR, 2005, ANNU REV PUBL HEALTH, V26, P89, DOI 10.1146/annurev.publhealth.26.021304.144528; Juhn YJ, 2005, SOC SCI MED, V60, P2453, DOI 10.1016/j.socscimed.2004.11.034; Klinnert MD, 2001, PEDIATRICS, V108, part. no., DOI 10.1542/peds.108.4.e69; Matsui EC, 2006, ANN ALLERG ASTHMA IM, V97, P514, DOI 10.1016/S1081-1206(10)60943-X; Miller RL, 2001, AM J RESP CRIT CARE, V164, P995, DOI 10.1164/ajrccm.164.6.2011107; Mrazek DA, 1999, PEDIATR PULM, V27, P85, DOI 10.1002/(SICI)1099-0496(199902)27:2<85::AID-PPUL4>3.0.CO;2-B; Platts-Mills TAE, 1997, J ALLERGY CLIN IMMUN, V100, pS2, DOI 10.1016/S0091-6749(97)70292-6; Rietveld S, 2000, CLIN EXP ALLERGY, V30, P1058; Sastry N, 2003, WORKING PAPER; Sastry N, 2006, SOC SCI RES, V35, P1000, DOI 10.1016/j.ssresearch.2005.08.002; Shankardass K, 2011, J EPIDEMIOL COMMUN H, V65, P859, DOI 10.1136/jech.2009.102806; Sternthal MJ, 2010, EUR RESPIR J, V36, P1400, DOI 10.1183/09031936.00003010; Subramanian SV, 2007, INT J EPIDEMIOL, V36, P569, DOI 10.1093/ije/dym007; Subramanian SV, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006091; Subramanian SV, 2004, SOC SCI MED, V58, P1961, DOI 10.1016/S0277-9536(03)00415-5; Suglia SF, 2010, J EPIDEMIOL COMMUN H, V64, P636, DOI 10.1136/jech.2008.082842; Turyk ME, 2008, PEDIAT ALLERG IMM-UK, V19, P255, DOI 10.1111/j.1399-3038.2007.00603.x; Vangeepuram N, 2012, J URBAN HEALTH, V89, P758, DOI 10.1007/s11524-012-9679-5; Weil CM, 1999, PEDIATRICS, V104, P1274, DOI 10.1542/peds.104.6.1274; Wilhelm M, 2009, HEALTH PLACE, V15, P25, DOI 10.1016/j.healthplace.2008.02.002; Wright RJ, 1998, THORAX, V53, P1066, DOI 10.1136/thx.53.12.1066; Wright RJ, 2004, J ALLERGY CLIN IMMUN, V113, P1051, DOI 10.1016/j.jaci.2004.03.032; Wright RJ, 2004, AM J PUBLIC HEALTH, V94, P625, DOI 10.2105/AJPH.94.4.625; Wright RJ, 2001, ENVIRON HEALTH PERSP, V109, P1085, DOI 10.2307/3454965; Wright RJ, 2007, CHEST, V132, p757S, DOI 10.1378/chest.07-1904; Wright RJ, 2006, CLIN CHEST MED, V27, P413, DOI 10.1016/j.ccm.2006.04.003	32	10	10	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2014	9	1							e87524	10.1371/journal.pone.0087524	http://dx.doi.org/10.1371/journal.pone.0087524			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	297XI	24466355	Green Submitted, Green Published, gold			2022-12-25	WOS:000330288000211
J	Guo, ZH; Cao, YQ				Guo, Zhaohua; Cao, Yu-Qing			Over-Expression of TRESK K+ Channels Reduces the Excitability of Trigeminal Ganglion Nociceptors	PLOS ONE			English	Article							POTASSIUM CHANNEL; CRYSTAL-STRUCTURE; SENSORY NEURONS; RECEPTOR; PAIN; MIGRAINE; TRPV1; ACTIVATION; MUTATION; CURRENTS	TWIK-related spinal cord K+ (TRESK) channel is abundantly expressed in trigeminal ganglion (TG) and dorsal root ganglion neurons and is one of the major background K+ channels in primary afferent neurons. Mutations in TRESK channels are associated with familial and sporadic migraine. In rats, both chronic nerve injury and inflammation alter the expression level of TRESK mRNA. Functional studies indicate that reduction of endogenous TRESK channel activity results in hyper-excitation of primary afferent neurons, suggesting that TRESK is a potential target for the development of new analgesics. However, whether and how enhancing TRESK channel activity would decrease the excitability of primary afferent neurons has not been directly tested. Here, we over-expressed TRESK subunits in cultured mouse TG neurons by lipofectamine-mediated transfection and investigated how this altered the membrane properties and the excitability of the small-diameter TG population. To account for the heterogeneity of neurons, we further divided small TG neurons into two groups, based on their ability to bind to fluorescently-labeled isolectin B (IB4). The transfected TG neurons showed a 2-fold increase in the level of TRESK proteins. This was accompanied by a significant increase in the fraction of lamotrigine-sensitive persistent K+ currents as well as the size of total background K+ currents. Consequently, both IB4-positive and IB4-negative TG neurons over-expressing TRESK subunits exhibited a lower input resistance and a 2-fold increase in the current threshold for action potential initiation. IB4-negative TG neurons over-expressing TRESK subunits also showed a significant reduction of the spike frequency in response to supra-threshold stimuli. Importantly, an increase in TRESK channel activity effectively inhibited capsaicin-evoked spikes in TG neurons. Taken together, our results suggest that potent and specific TRESK channel openers likely would reduce the excitability of primary afferent neurons and therefore are potential therapeutics for the treatment of migraine and other chronic pain symptoms.	Washington Univ, Sch Med, Washington Univ Pain Ctr, St Louis, MO 63130 USA; Washington Univ, Sch Med, Dept Anesthesiol, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL)	Guo, ZH (corresponding author), Washington Univ, Sch Med, Washington Univ Pain Ctr, St Louis, MO 63130 USA.	caoy@anest.wustl.edu			National Institutes of Health-National Institute of Neurological Disorders and Stroke [R21NS074198]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS074198] Funding Source: NIH RePORTER	National Institutes of Health-National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the National Institutes of Health-National Institute of Neurological Disorders and Stroke (Grant #R21NS074198), http://www.ninds.nih.gov/funding/index.htm. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bautista DM, 2008, NAT NEUROSCI, V11, P772, DOI 10.1038/nn.2143; Brohawn SG, 2012, SCIENCE, V335, P436, DOI 10.1126/science.1213808; Caterina MJ, 2001, ANNU REV NEUROSCI, V24, P487, DOI 10.1146/annurev.neuro.24.1.487; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; Cavanaugh DJ, 2009, P NATL ACAD SCI USA, V106, P9075, DOI 10.1073/pnas.0901507106; Choi JS, 2007, J NEUROPHYSIOL, V97, P1258, DOI 10.1152/jn.01033.2006; Czirjak B, 2004, J BIOL CHEM, V279, P18550, DOI 10.1074/jbc.M312229200; Dobler T, 2007, J PHYSIOL-LONDON, V585, P867, DOI 10.1113/jphysiol.2007.145649; Enyedi P, 2012, MOL CELL ENDOCRINOL, V353, P75, DOI 10.1016/j.mce.2011.11.009; Enyedi P, 2010, PHYSIOL REV, V90, P559, DOI 10.1152/physrev.00029.2009; Evans MS, 2012, HEADACHE, V52, P773, DOI 10.1111/j.1526-4610.2011.02053.x; HARPER AA, 1985, J PHYSIOL-LONDON, V359, P47, DOI 10.1113/jphysiol.1985.sp015574; HARPER AA, 1985, J PHYSIOL-LONDON, V359, P31, DOI 10.1113/jphysiol.1985.sp015573; Huang DY, 2012, MOL PAIN, V8, DOI 10.1186/1744-8069-8-66; Kang D, 2004, J BIOL CHEM, V279, P28063, DOI 10.1074/jbc.M402940200; Kang D, 2008, BIOCHEM BIOPH RES CO, V367, P609, DOI 10.1016/j.bbrc.2008.01.008; Kang D, 2006, AM J PHYSIOL-CELL PH, V291, pC138, DOI 10.1152/ajpcell.00629.2005; Kim S, 2013, BBA-BIOMEMBRANES, V1828, P1131, DOI 10.1016/j.bbamem.2012.11.021; Lafreniere RG, 2010, NAT MED, V16, P1157, DOI 10.1038/nm.2216; Lennertz RC, 2010, J NEUROSCI, V30, P4353, DOI 10.1523/JNEUROSCI.4666-09.2010; Liu CH, 2004, ANESTH ANALG, V99, P1715, DOI 10.1213/01.ANE.0000136849.07384.44; Liu P, 2013, J NEUROSCI, V33, P12810, DOI 10.1523/JNEUROSCI.1237-13.2013; Marsh B, 2012, MOL CELL NEUROSCI, V49, P375, DOI 10.1016/j.mcn.2012.01.002; Miller AN, 2012, SCIENCE, V335, P432, DOI 10.1126/science.1213274; Perez-Reyes E, 2003, PHYSIOL REV, V83, P117, DOI 10.1152/physrev.00018.2002; Rahm AK, 2012, BRIT J PHARMACOL, V166, P764, DOI 10.1111/j.1476-5381.2011.01813.x; Sano Y, 2003, J BIOL CHEM, V278, P27406, DOI 10.1074/jbc.M206810200; Scherrer G, 2009, CELL, V137, P1148, DOI 10.1016/j.cell.2009.04.019; Shimizu T, 2007, BRAIN RES, V1173, P84, DOI 10.1016/j.brainres.2007.07.068; Snider WD, 1998, NEURON, V20, P629, DOI 10.1016/S0896-6273(00)81003-X; Stucky CL, 1999, J NEUROSCI, V19, P6497; Tao J, 2012, J NEUROPHYSIOL, V107, P1666, DOI 10.1152/jn.00551.2011; Tulleuda A, 2011, MOL PAIN, V7, DOI 10.1186/1744-8069-7-30; Yoo S, 2009, NEUROSCI LETT, V465, P79, DOI 10.1016/j.neulet.2009.08.062; Zhou J, 2013, NEUROREPORT, V24, P131, DOI 10.1097/WNR.0b013e32835d8431; Zhou J, 2012, MOL MED REP, V5, P1049, DOI 10.3892/mmr.2012.778	36	109	114	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2014	9	1							e87029	10.1371/journal.pone.0087029	http://dx.doi.org/10.1371/journal.pone.0087029			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297XI	24466320	Green Published, gold			2022-12-25	WOS:000330288000187
J	Lehmiller, JJ; Ioerger, M				Lehmiller, Justin J.; Ioerger, Michael			Social Networking Smartphone Applications and Sexual Health Outcomes among Men Who Have Sex with Men	PLOS ONE			English	Article							SELF-CONTROL; RISK-TAKING; SENSATION SEEKING; BEHAVIOR; INTERNET; GAY; EROTOPHILIA; PERSONALITY; RELIABILITY; PREDICTORS	Several smartphone applications (apps) designed to help men who have sex with men (MSM) find casual sexual partners have appeared on the market recently. Apps of this nature have the potential to impact sexual health and behavior by providing constant access to a large supply of available partners. In this study, the sexual health history, behavior, and personality of MSM who use these apps was compared to MSM who meet partners in other ways. A sample of 110 adult MSM was recruited online to complete a cross-sectional survey. All participants were either single or involved in a nonexclusive romantic relationship. There were no statistically significant differences between app users and non-users in frequency of insertive or receptive anal sex without a condom. However, app users reported significantly more sexual partners and had a higher prevalence of ever being diagnosed with an STI than did non-users. App users did not differ from non-users on any demographic or personality variables (including erotophilia, sensation seeking, and self-control); however, when adjusting lifetime total sex partners for those met specifically through apps, app users still had significantly more partners. This pattern of results suggests that app users may be more sexually active in general. More work is needed to fully understand the association between this emerging technology and potential sexual health risks.	[Lehmiller, Justin J.] Harvard Univ, Dept Psychol, Cambridge, MA 02138 USA; [Ioerger, Michael] Syracuse Univ, Dept Psychol, Syracuse, NY USA	Harvard University; Syracuse University	Lehmiller, JJ (corresponding author), Harvard Univ, Dept Psychol, 33 Kirkland St, Cambridge, MA 02138 USA.	justin.lehmiller@gmail.com	Ioerger, Michael/G-5074-2017	Ioerger, Michael/0000-0002-2282-4022				Adam PCG, 2008, SEX TRANSM INFECT, V84, P463, DOI 10.1136/sti.2008.031351; Bancroft J, 2004, J SEX RES, V41, P181, DOI 10.1080/00224490409552226; Bauermeister JA, 2012, AIDS BEHAV, V16, P1549, DOI 10.1007/s10461-011-0123-8; Benotsch EG, 2002, ARCH SEX BEHAV, V31, P177, DOI 10.1023/A:1014739203657; Carey MP, 1997, COMMUNITY MENT HLT J, V33, P133, DOI 10.1023/A:1022423417304; Elford J, 2001, AIDS, V15, P1409, DOI 10.1097/00002030-200107270-00010; Evans AR, 2007, SEX TRANSM INFECT, V83, P200, DOI 10.1136/sti.2006.023283; EXNER TM, 1992, J SEX RES, V29, P389, DOI 10.1080/00224499209551655; FISHER WA, 1988, J SEX RES, V25, P123, DOI 10.1080/00224498809551448; FISHER WA, 1998, HDB SEXUALITY RELATE, P218; Grosskopf NA, 2011, AM J MENS HEALTH, V5, P378, DOI 10.1177/1557988310372801; Grov C, 2010, ARCH SEX BEHAV, V39, P788, DOI 10.1007/s10508-008-9439-5; Gudelunas D, 2012, SEX CULT, V16, P347, DOI 10.1007/s12119-012-9127-4; Hope TL, 2005, DEVIANT BEHAV, V26, P25, DOI 10.1080/016396290500405; Horvath K. G., 2006, SEXUALITY RES SOCIAL, V3, P77, DOI DOI 10.1525/SRSP.2006.3.4.77; Hoyle RH, 2000, J PERS, V68, P1203, DOI 10.1111/1467-6494.00132; Hoyle RH, 2002, PERS INDIV DIFFER, V32, P401, DOI 10.1016/S0191-8869(01)00032-0; Jenness SM, 2010, AIDS BEHAV, V14, P1353, DOI 10.1007/s10461-010-9769-x; KALICHMAN SC, 1994, J PERS ASSESS, V62, P385, DOI 10.1207/s15327752jpa6203_1; KALICHMAN SC, 1995, J PERS ASSESS, V65, P586, DOI 10.1207/s15327752jpa6503_16; Lehmiller JJ, 2006, PERS SOC PSYCHOL B, V32, P40, DOI 10.1177/0146167205278710; Leobon A, 2011, AIDS CARE, V23, P25, DOI 10.1080/09540121.2010.498866; Lewis MA, 2006, PERS INDIV DIFFER, V40, P985, DOI 10.1016/j.paid.2005.09.015; Li QC, 2012, AIDS BEHAV, V16, P1690, DOI 10.1007/s10461-011-0005-0; Liau A, 2006, SEX TRANSM DIS, V33, P576, DOI 10.1097/01.olq.0000204710.35332.c5; Miller JD, 2004, PERS INDIV DIFFER, V36, P1611, DOI 10.1016/j.paid.2003.06.009; Muraven M, 2000, PSYCHOL BULL, V126, P247, DOI 10.1037/0033-2909.126.2.247; Newcomb ME, 2011, AIDS BEHAV, V15, P565, DOI 10.1007/s10461-010-9832-7; Ogilvie GS, 2008, CAN J PUBLIC HEALTH, V99, P185, DOI 10.1007/BF03405470; Pronk TM, 2011, J PERS SOC PSYCHOL, V100, P827, DOI 10.1037/a0021993; Rosenberger JG, 2011, J SEX MED, V8, P3040, DOI 10.1111/j.1743-6109.2011.02438.x; Tangney JP, 2004, J PERS, V72, P271, DOI 10.1111/j.0022-3506.2004.00263.x; Wright TM, 1997, J RES PERS, V31, P166, DOI 10.1006/jrpe.1997.2177	33	107	108	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2014	9	1							e86603	10.1371/journal.pone.0086603	http://dx.doi.org/10.1371/journal.pone.0086603			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	297XI	24466166	Green Published, gold, Green Submitted			2022-12-25	WOS:000330288000119
J	Mann, E; Schmitz-Esser, S; Zebeli, Q; Wagner, M; Ritzmann, M; Metzler-Zebeli, BU				Mann, Evelyne; Schmitz-Esser, Stephan; Zebeli, Qendrim; Wagner, Martin; Ritzmann, Mathias; Metzler-Zebeli, Barbara U.			Mucosa-Associated Bacterial Microbiome of the Gastrointestinal Tract of Weaned Pigs and Dynamics Linked to Dietary Calcium-Phosphorus	PLOS ONE			English	Article							LACTOBACILLUS-AMYLOVORUS; SP NOV.; PHOSPHATE; ADHESION; HEALTH; AMPLIFICATION; PREVOTELLA; DIVERSITY; INFECTION; NUTRIENTS	Dietary composition largely influences pig's gastrointestinal microbiota and represents a useful prophylactic tool against enteric disturbances in young pigs. Despite the importance for host-microbe interactions and bacterial colonization, dietary responses of the mucosa-associated bacterial communities are less well investigated. In the present study, we characterized the mucosa-associated bacterial communities at the Pars non-glandularis of the stomach, ileum and colon, and identified shifts in these communities in response to different dietary calcium-phosphorus (Ca-P) contents (100% versus 190% of the Ca and P requirements) in combination with two basal diets (wheat-barley-or corn-based) in weaned pigs. Pyrosequencing of 16S rRNA genes from 93 mucosal samples yielded 447,849 sequences, clustering into 997 operational taxonomic units (OTUs) at 97% similarity level. OTUs were assigned to 198 genera belonging to 14 different phyla. Correlation-based networks revealed strong interactions among OTUs at the various gastrointestinal sites. Our data describe a previously not reported high diversity and species richness at the Pars non-glandularis of the stomach in weaned pigs. Moreover, high versus adequate Ca-P content significantly promoted Lactobacillus by 14.9% units (1.4 fold change) at the gastric Pars non-glandularis (P = 0.035). Discriminant analysis revealed dynamic changes in OTU composition in response to dietary cereals and Ca-P contents at all gastrointestinal sites which were less distinguishable at higher taxonomic levels. Overall, this study revealed a distinct mucosa-associated bacterial community at the different gut sites, and a strong effect of high Ca-P diets on the gastric community, thereby markedly expanding our comprehension on mucosa-associated microbiota and their diet-related dynamics in weaned pigs.	[Mann, Evelyne; Schmitz-Esser, Stephan; Wagner, Martin] Vetmeduni Vienna, Dept Farm Anim & Vet Publ Hlth, Inst Milk Hyg, Vienna, Austria; [Zebeli, Qendrim] Vetmeduni Vienna, Dept Farm Anim & Vet Publ Hlth, Inst Anim Nutr & Funct Plant Cpds, Vienna, Austria; [Ritzmann, Mathias; Metzler-Zebeli, Barbara U.] Vetmeduni Vienna, Dept Farm Anim & Vet Publ Hlth, Clin Swine, Vienna, Austria; [Mann, Evelyne; Schmitz-Esser, Stephan; Zebeli, Qendrim; Wagner, Martin; Ritzmann, Mathias; Metzler-Zebeli, Barbara U.] Vetmeduni Vienna, Dept Farm Anim & Vet Publ Hlth, Res Cluster Anim Gut Hlth, Vienna, Austria; [Ritzmann, Mathias] Univ Munich, Clin Swine, Munich, Germany	University of Veterinary Medicine Vienna; University of Veterinary Medicine Vienna; University of Veterinary Medicine Vienna; University of Veterinary Medicine Vienna; University of Munich	Metzler-Zebeli, BU (corresponding author), Vetmeduni Vienna, Dept Farm Anim & Vet Publ Hlth, Clin Swine, Vienna, Austria.	barbara.metzler@vetmeduni.ac.at	Selberherr, Evelyne/AAM-9702-2021; Selberherr, Evelyne/I-3795-2014; Schmitz-Esser, Stephan/AAA-7287-2019	Selberherr, Evelyne/0000-0002-2253-5247; Schmitz-Esser, Stephan/0000-0002-1907-0709; Ritzmann, Mathias/0000-0001-9791-1668; Zebeli, Qendrim/0000-0001-5188-9004	University of Veterinary Medicine Vienna; Austrian Promotion Agency (FFG) [825339]	University of Veterinary Medicine Vienna; Austrian Promotion Agency (FFG)	Financial support was provided by profile line start up funding program at the University of Veterinary Medicine Vienna and Austrian Promotion Agency (FFG) Project Number 825339. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bovee-Oudenhoven IM, 1999, J NUTR, V129, P607, DOI 10.1093/jn/129.3.607; Breves G, 2007, LIVEST SCI, V109, P4, DOI 10.1016/j.livsci.2007.01.021; Buzoianu SG, 2012, APPL ENVIRON MICROB, V78, P4217, DOI 10.1128/AEM.00307-12; CHAUVIERE G, 1992, J GEN MICROBIOL, V138, P1689, DOI 10.1099/00221287-138-8-1689; Collado MC, 2007, J FOOD PROTECT, V70, P2799, DOI 10.4315/0362-028X-70.12.2799; de Lange CFM, 2010, LIVEST SCI, V134, P124, DOI 10.1016/j.livsci.2010.06.117; DeVuyst L, 1996, MICROBIOL-UK, V142, P817, DOI 10.1099/00221287-142-4-817; Dicksved J, 2009, J MED MICROBIOL, V58, P509, DOI 10.1099/jmm.0.007302-0; DORSCH M, 1992, J MICROBIOL METH, V16, P271, DOI 10.1016/0167-7012(92)90017-X; DURAND M, 1988, J NUTR, V118, P249, DOI 10.1093/jn/118.2.249; GfE, 2006, EMPFEHLUNGEN ENERGIE; GOVERS MJAP, 1993, GUT, V34, P365, DOI 10.1136/gut.34.3.365; Griffen AL, 2012, ISME J, V6, P1176, DOI 10.1038/ismej.2011.191; Hayashi H, 2007, INT J SYST EVOL MICR, V57, P941, DOI 10.1099/ijs.0.64778-0; Heo JM, 2013, J ANIM PHYSIOL AN N, V97, P207, DOI 10.1111/j.1439-0396.2012.01284.x; Janczyk P, 2007, FEMS MICROBIOL ECOL, V61, P132, DOI 10.1111/j.1574-6941.2007.00317.x; Joachimiak MP, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-225; Kim JC, 2012, ANIM FEED SCI TECH, V173, P3, DOI 10.1016/j.anifeedsci.2011.12.022; Konstantinov SR, 2006, ENVIRON MICROBIOL, V8, P1191, DOI 10.1111/j.1462-2920.2006.01009.x; Lalles JP, 2007, P NUTR SOC, V66, P260, DOI 10.1017/S0029665107005484; Larsen N, 2007, INT J FOOD MICROBIOL, V114, P113, DOI 10.1016/j.ijfoodmicro.2006.10.033; Lawlor PG, 2005, IRISH VET J, V58, P447, DOI 10.1186/2046-0481-58-8-447; Leser TD, 2002, APPL ENVIRON MICROB, V68, P673, DOI 10.1128/AEM.68.2.673-690.2002; Leser TD, 2009, ENVIRON MICROBIOL, V11, P2194, DOI 10.1111/j.1462-2920.2009.01941.x; Lim SM, 2012, J MICROBIOL BIOTECHN, V22, P1731, DOI 10.4014/jmb.1208.08049; Lu L, 2001, AM J CLIN NUTR, V73, p1124S; Mann E, 2014, APPL ENVIRON MICROB, V80, P193, DOI 10.1128/AEM.03089-13; Metzler BU, 2009, J ANIM PHYSIOL AN N, V93, P130, DOI 10.1111/j.1439-0396.2007.00793.x; Metzler-Zebeli BU, 2010, J ANIM SCI, V88, P147, DOI 10.2527/jas.2008-1560; Metzler-Zebeli BU, 2011, FEMS MICROBIOL ECOL, V75, P402, DOI 10.1111/j.1574-6941.2010.01017.x; Mikkelsen LL, 2007, LIVEST SCI, V109, P153, DOI 10.1016/j.livsci.2007.01.130; NAKAMURA LK, 1981, INT J SYST BACTERIOL, V31, P56, DOI 10.1099/00207713-31-1-56; O'Rourke JL, 2001, GUT, V49, P601, DOI 10.1136/gut.49.5.601; Park SC, 2006, WORLD J MICROB BIOT, V22, P35, DOI 10.1007/s11274-005-4856-2; PARTRIDGE IG, 1978, BRIT J NUTR, V39, P527, DOI 10.1079/BJN19780068; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; Pryde SE, 1999, APPL ENVIRON MICROB, V65, P5372; Roos S, 2000, INT J SYST EVOL MICR, V50, P251, DOI 10.1099/00207713-50-1-251; Schloss PD, 2011, APPL ENVIRON MICROB, V77, P3219, DOI 10.1128/AEM.02810-10; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Schmidt Bettina, 2011, PLoS One, V6, pe28284, DOI 10.1371/journal.pone.0028284; SHAH HN, 1990, INT J SYST BACTERIOL, V40, P205, DOI 10.1099/00207713-40-2-205; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Simpson JM, 1999, J MICROBIOL METH, V36, P167, DOI 10.1016/S0167-7012(99)00029-9; Vahjen W, 2011, J ANIM SCI, V89, P2430, DOI 10.2527/jas.2010-3270; Vahjen W, 2010, APPL ENVIRON MICROB, V76, P6689, DOI 10.1128/AEM.03075-09; VDLUFA, 1976, METH BUCH 3 CHEM U N; Vermoote M, 2011, VET RES, V42, DOI 10.1186/1297-9716-42-51; Walter J, 2011, P NATL ACAD SCI USA, V108, P4645, DOI 10.1073/pnas.1000099107; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Wang XF, 2012, BMC MICROBIOL, V12, DOI [10.1186/1471-2180-12-18, 10.1186/1471-2105-13-113]; WEISBURG WG, 1991, J BACTERIOL, V173, P697, DOI 10.1128/JB.173.2.697-703.1991; Yen J.T., 2001, SWINE NUTR, P21; Zarate G, 2002, CAN J MICROBIOL, V48, P449, DOI 10.1139/W02-036	54	79	84	0	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2014	9	1							e86950	10.1371/journal.pone.0086950	http://dx.doi.org/10.1371/journal.pone.0086950			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297XI	24466298	Green Published, Green Submitted, gold			2022-12-25	WOS:000330288000174
J	Rutten-Jacobs, LCA; Keurlings, PAJ; Arntz, RM; Maaijwee, NAM; Schoonderwaldt, HC; Dorresteijn, LD; van der Vlugt, MJ; van Dijk, EJ; de Leeuw, FE				Rutten-Jacobs, Loes C. A.; Keurlings, Pim A. J.; Arntz, Renate M.; Maaijwee, Noortje A. M.; Schoonderwaldt, Henny C.; Dorresteijn, Lucille D.; van der Vlugt, Maureen J.; van Dijk, Ewoud J.; de Leeuw, Frank-Erik			High Incidence of Diabetes after Stroke in Young Adults and Risk of Recurrent Vascular Events: The FUTURE Study	PLOS ONE			English	Article							TRANSIENT ISCHEMIC ATTACK; FOLLOW-UP; DISEASE; PREVENTION; RATIONALE; PROGNOSIS	Background: Diabetes diagnosed prior to stroke in young adults is strongly associated with recurrent vascular events. The relevance of impaired fasting glucose (IFG) and incidence of diabetes after young stroke is unknown. We investigated the long-term incidence of diabetes after young stroke and evaluated the association of diabetes and impaired fasting glucose with recurrent vascular events. Methods: This study was part of the FUTURE study. All consecutive patients between January 1, 1980, and November 1, 2010 with TIA or ischemic stroke, aged 18-50, were recruited. A follow-up assessment was performed in survivors between November 1, 2009 and January 1, 2012 and included an evaluation for diabetes, fasting venous plasma glucose and recurrent vascular events. The association of diabetes and IFG with recurrent vascular events was assessed by logistic regression analysis, adjusted for age, sex and follow-up duration. Results: 427 survivors without a medical history of diabetes were included in the present analysis (mean follow-up of 10.1 (SD 8.4) years; age 40.3 (SD 7.9) years). The incidence rate of diabetes was 7.9 per 1000 person-years and the prevalence of IFG was 21.1%. Patients with diabetes and IFG were more likely to have experienced any vascular event than those with normal fasting glucose values (OR 3.5 (95% CI 1.5-8.4) for diabetes and OR 2.5 (95% CI 1.3-4.8) for IFG). Conclusions: Diabetes or IFG in young stroke survivors is frequent and is associated with recurrent vascular events. Regular screening for IFG and diabetes in this population, yields potential for secondary prevention.	[Rutten-Jacobs, Loes C. A.; Arntz, Renate M.; Maaijwee, Noortje A. M.; Schoonderwaldt, Henny C.; van Dijk, Ewoud J.; de Leeuw, Frank-Erik] Radboud Univ Nijmegen, Med Ctr, Donders Inst Brain Cognit & Behav, Dept Neurol, NL-6525 ED Nijmegen, Netherlands; [Keurlings, Pim A. J.] Canisius Wilhelmina Hosp, Dept Internal Med, Nijmegen, Netherlands; [Dorresteijn, Lucille D.] Med Spectrum Twente, Dept Neurol, Enschede, Netherlands; [van der Vlugt, Maureen J.] Radboud Univ Nijmegen, Med Ctr, Dept Cardiol, NL-6525 ED Nijmegen, Netherlands	Radboud University Nijmegen; Canisius-Wilhelmina Hospital; Medical Spectrum Twente; Radboud University Nijmegen	de Leeuw, FE (corresponding author), Radboud Univ Nijmegen, Med Ctr, Donders Inst Brain Cognit & Behav, Dept Neurol, NL-6525 ED Nijmegen, Netherlands.	FrankErik.deLeeuw@radboudumc.nl	de Leeuw, Frank-Erik/E-4795-2012; Vlugt, M.J./L-4723-2015; Rutten-Jacobs, Loes/C-7746-2013; van Dijk, Ewoud J/J-7951-2012; de Leeuw, H.F./L-4479-2015	Rutten-Jacobs, Loes/0000-0003-3223-885X; 				ADAMS HP, 1993, STROKE, V24, P35, DOI 10.1161/01.STR.24.1.35; AHO K, 1980, B WORLD HEALTH ORGAN, V58, P113; BOERS GHJ, 1985, NEW ENGL J MED, V313, P709, DOI 10.1056/NEJM198509193131201; Bousser MG, 2009, CEREBROVASC DIS, V27, P509, DOI 10.1159/000212671; BROTT T, 1989, STROKE, V20, P864, DOI 10.1161/01.STR.20.7.864; Dahabreh IJ, 2011, JAMA-J AM MED ASSOC, V305, P822, DOI 10.1001/jama.2011.163; Davis SM, 2012, NEW ENGL J MED, V366, P1914, DOI 10.1056/NEJMcp1107281; Ford ES, 2010, J AM COLL CARDIOL, V55, P1310, DOI 10.1016/j.jacc.2009.10.060; HATANO S, 1976, B WORLD HEALTH ORGAN, V54, P541; Holman RR, 2008, NEW ENGL J MED, V359, P1577, DOI 10.1056/NEJMoa0806470; Kernan WN, 2005, ARCH INTERN MED, V165, P227, DOI 10.1001/archinte.165.2.227; Leys D, 2002, NEUROLOGY, V59, P26, DOI 10.1212/WNL.59.1.26; Poos MJJC, 2011, DIABETES MELLITUS PR; Putaala J, 2011, NEUROLOGY, V76, P1831, DOI 10.1212/WNL.0b013e31821cccc2; Putaala J, 2012, STROKE, V43, P2624, DOI 10.1161/STROKEAHA.112.662866; Putaala J, 2010, ANN NEUROL, V68, P661, DOI 10.1002/ana.22091; Rutten-Jacobs LC, 2013, ANN NEUROL; Rutten-Jacobs LCA, 2013, JAMA-J AM MED ASSOC, V309, P1136, DOI 10.1001/jama.2013.842; Rutten-Jacobs LCA, 2011, BMC NEUROL, V11, DOI 10.1186/1471-2377-11-109; Vermeer SE, 2006, STROKE, V37, P1413, DOI 10.1161/01.STR.0000221766.73692.0b; von Sarnowski B, 2013, STROKE, V44, P119, DOI 10.1161/STROKEAHA.112.665190; Waje-Andreassen U, 2007, CEREBROVASC DIS, V24, P277, DOI 10.1159/000105680	22	12	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2014	9	1							e87171	10.1371/journal.pone.0087171	http://dx.doi.org/10.1371/journal.pone.0087171			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297XI	24466339	Green Published, gold, Green Submitted			2022-12-25	WOS:000330288000197
J	Wu, WZ; Wang, ZW; Xia, HJ; Liu, YX; Qiu, Y; Liu, YJ; Hu, YY; Zhou, X				Wu, Wenzhe; Wang, Zhaowei; Xia, Hongjie; Liu, Yongxiang; Qiu, Yang; Liu, Yujie; Hu, Yuanyang; Zhou, Xi			Flock House Virus RNA Polymerase Initiates RNA Synthesis De Novo and Possesses a Terminal Nucleotidyl Transferase Activity	PLOS ONE			English	Article							HEPATITIS-C VIRUS; VIRAL-RNA; MEMBRANE ASSOCIATION; DROSOPHILA-CELLS; NODAVIRUS RNA; GENOMIC RNA; PROTEIN-A; SUBGENOMIC RNA3; DNA-POLYMERASE; ANIMAL VIRUS	Flock House virus (FHV) is a positive-stranded RNA virus with a bipartite genome of RNAs, RNA1 and RNA2, and belongs to the family Nodaviridae. As the most extensively studied nodavirus, FHV has become a well-recognized model for studying various aspects of RNA virology, particularly viral RNA replication and antiviral innate immunity. FHV RNA1 encodes protein A, which is an RNA-dependent RNA polymerase (RdRP) and functions as the sole viral replicase protein responsible for RNA replication. Although the RNA replication of FHV has been studied in considerable detail, the mechanism employed by FHV protein A to initiate RNA synthesis has not been determined. In this study, we characterized the RdRP activity of FHV protein A in detail and revealed that it can initiate RNA synthesis via a de novo (primer-independent) mechanism. Moreover, we found that FHV protein A also possesses a terminal nucleotidyl transferase (TNTase) activity, which was able to restore the nucleotide loss at the 39-end initiation site of RNA template to rescue RNA synthesis initiation in vitro, and may function as a rescue and protection mechanism to protect the 39 initiation site, and ensure the efficiency and accuracy of viral RNA synthesis. Altogether, our study establishes the de novo initiation mechanism of RdRP and the terminal rescue mechanism of TNTase for FHV protein A, and represents an important advance toward understanding FHV RNA replication.	[Wu, Wenzhe; Wang, Zhaowei; Xia, Hongjie; Liu, Yongxiang; Qiu, Yang; Liu, Yujie; Hu, Yuanyang; Zhou, Xi] Wuhan Univ, Coll Life Sci, State Key Lab Virol, Wuhan 430072, Hubei, Peoples R China	Wuhan University	Zhou, X (corresponding author), Wuhan Univ, Coll Life Sci, State Key Lab Virol, Wuhan 430072, Hubei, Peoples R China.	zhouxi@whu.edu.cn	Xia, Hongjie/M-9241-2019; Qiu, Yang/AAQ-4435-2020	Xia, Hongjie/0000-0002-2520-7038; 	National Basic Research Program of China (973 Program) [2014CB542603]; National Natural Science Foundation of China the National Natural Science Foundation of China [31270190, 81201292, 31270189]; Chinese111 Project [B06018]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China the National Natural Science Foundation of China; Chinese111 Project	This work was supported by the National Basic Research Program of China (973 Program, 2014CB542603), the National Natural Science Foundation of China the National Natural Science Foundation of China (31270190 to XZ, 81201292 to XZ, and 31270189 to YH), and the Chinese111 Project grant No. B06018. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlquist P, 2006, NAT REV MICROBIOL, V4, P371, DOI 10.1038/nrmicro1389; Ahlquist P, 2003, J VIROL, V77, P8181, DOI 10.1128/JVI.77.15.8181-8186.2003; Ahlquist P, 2002, SCIENCE, V296, P1270, DOI 10.1126/science.1069132; ARGOS P, 1988, NUCLEIC ACIDS RES, V16, P9909, DOI 10.1093/nar/16.21.9909; Arnold JJ, 1999, J BIOL CHEM, V274, P37060, DOI 10.1074/jbc.274.52.37060; BALL LA, 1993, J VIROL, V67, P3544, DOI 10.1128/JVI.67.6.3544-3551.1993; BALL LA, 1995, J VIROL, V69, P2722, DOI 10.1128/JVI.69.4.2722-2722.1995; Beerens N, 2007, J VIROL, V81, P8384, DOI 10.1128/JVI.00564-07; Behrens SE, 1996, EMBO J, V15, P12, DOI 10.1002/j.1460-2075.1996.tb00329.x; Binne UK, 2002, J VIROL, V76, P10282, DOI 10.1128/JVI.76.20.10282-10289.2002; Cai DW, 2010, VIRUS RES, V151, P153, DOI 10.1016/j.virusres.2010.04.010; Castorena Kathryn M, 2010, BMC Genomics, V11, P183, DOI 10.1186/1471-2164-11-183; DeFrancesco R, 1996, METHOD ENZYMOL, V275, P58; Denison MR, 2008, PLOS BIOL, V6, P2098, DOI 10.1371/journal.pbio.0060270; Dye BT, 2005, J VIROL, V79, P8909, DOI 10.1128/JVI.79.14.8909-8919.2005; Fukushi S, 2004, J VIROL, V78, P3889, DOI 10.1128/JVI.78.8.3889-3896.2004; Fullerton SWB, 2007, J VIROL, V81, P1858, DOI 10.1128/JVI.01462-06; GALLAGHER TM, 1983, J VIROL, V46, P481, DOI 10.1128/JVI.46.2.481-489.1983; Guan HC, 2000, P NATL ACAD SCI USA, V97, P12451, DOI 10.1073/pnas.97.23.12451; Huang Yi, 2012, Virologica Sinica, V27, P273, DOI 10.1007/s12250-012-3252-y; Ishii K, 1999, HEPATOLOGY, V29, P1227, DOI 10.1002/hep.510290448; Johnson KN, 2001, J GEN VIROL, V82, P1855, DOI 10.1099/0022-1317-82-8-1855; KAMER G, 1984, NUCLEIC ACIDS RES, V12, P7269, DOI 10.1093/nar/12.18.7269; Kampmueller KM, 2005, J VIROL, V79, P6827, DOI 10.1128/JVI.79.11.6827-6837.2005; Kao CC, 2001, VIROLOGY, V287, P251, DOI 10.1006/viro.2001.1039; Kao CC, 1999, VIROLOGY, V253, P1, DOI 10.1006/viro.1998.9517; KOONIN EV, 1991, J GEN VIROL, V72, P2197, DOI 10.1099/0022-1317-72-9-2197; Kopek BG, 2007, PLOS BIOL, V5, P2022, DOI 10.1371/journal.pbio.0050220; Kovalev N, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002537; LARDER BA, 1987, EMBO J, V6, P169, DOI 10.1002/j.1460-2075.1987.tb04735.x; Li HW, 2002, SCIENCE, V296, P1319, DOI 10.1126/science.1070948; Lindenbach BD, 2002, J VIROL, V76, P3905, DOI 10.1128/JVI.76.8.3905-3919.2002; Liu CF, 2006, VIRUS RES, V120, P28, DOI 10.1016/j.virusres.2005.09.003; Lu R, 2005, NATURE, V436, P1040, DOI 10.1038/nature03870; Lu R, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000286; Luo GX, 2000, J VIROL, V74, P851, DOI 10.1128/JVI.74.2.851-863.2000; MAO JCH, 1975, J VIROL, V15, P1281, DOI 10.1128/JVI.15.5.1281-1283.1975; Miller DJ, 2002, J VIROL, V76, P9856, DOI 10.1128/JVI.76.19.9856-9867.2002; Miller DJ, 2001, J VIROL, V75, P11664, DOI 10.1128/JVI.75.23.11664-11676.2001; MILLER WA, 1985, NATURE, V313, P68, DOI 10.1038/313068a0; NEUFELD KL, 1994, J VIROL, V68, P5811, DOI 10.1128/JVI.68.9.5811-5818.1994; OBERG B, 1989, PHARMACOL THERAPEUT, V40, P213, DOI 10.1016/0163-7258(89)90097-1; Paul AV, 1998, NATURE, V393, P280, DOI 10.1038/30529; Poranen MM, 2008, J VIROL, V82, P9254, DOI 10.1128/JVI.01044-08; Qi N, 2012, J VIROL, V86, P5763, DOI 10.1128/JVI.07229-11; Qi N, 2011, J VIROL, V85, P9543, DOI 10.1128/JVI.00785-11; Qiu Y, 2013, VIROLOGY, V439, P140, DOI 10.1016/j.virol.2013.02.010; Qiu Y, 2011, J VIROL, V85, P4440, DOI 10.1128/JVI.02410-10; Ranjith-Kumar CT, 2001, J VIROL, V75, P8615, DOI 10.1128/JVI.75.18.8615-8623.2001; Reigadas S, 2001, EUR J BIOCHEM, V268, P5857, DOI 10.1046/j.0014-2956.2001.02532.x; RODRIGUEZ PL, 1992, J VIROL, V66, P1971, DOI 10.1128/JVI.66.4.1971-1976.1992; Sarin LP, 2012, VIROLOGY, V432, P184, DOI 10.1016/j.virol.2012.05.035; SCHNEEMANN A, 1992, J VIROL, V66, P6728, DOI 10.1128/JVI.66.11.6728-6734.1992; SELLING BH, 1990, P NATL ACAD SCI USA, V87, P434, DOI 10.1073/pnas.87.1.434; Stapleford KA, 2009, J VIROL, V83, P4498, DOI 10.1128/JVI.00040-09; TADDIE JA, 1991, J VIROL, V65, P869, DOI 10.1128/JVI.65.2.869-879.1991; van Dijk AA, 2004, J GEN VIROL, V85, P1077, DOI 10.1099/vir.0.19731-0; Van Wynsberghe PA, 2007, J VIROL, V81, P4633, DOI 10.1128/JVI.02267-06; Vazquez AL, 2001, ARCH VIROL, V146, P59, DOI 10.1007/s007050170191; Venter PA, 2008, CELL MOL LIFE SCI, V65, P2675, DOI 10.1007/s00018-008-8037-y; Wang ZW, 2013, J BIOL CHEM, V288, P30785, DOI 10.1074/jbc.M113.492728; Weeks SA, 2010, J VIROL, V84, P330, DOI 10.1128/JVI.01808-09; Wright S, 2012, J VIROL, V86, P2837, DOI 10.1128/JVI.05168-11; WU SX, 1992, P NATL ACAD SCI USA, V89, P11136, DOI 10.1073/pnas.89.23.11136; WU SX, 1991, VIROLOGY, V183, P392, DOI 10.1016/0042-6822(91)90153-3	65	5	5	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2014	9	1							e86876	10.1371/journal.pone.0086876	http://dx.doi.org/10.1371/journal.pone.0086876			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297XI	24466277	gold, Green Submitted, Green Published			2022-12-25	WOS:000330288000162
J	Zenon, A; Corneil, BD; Alamia, A; Filali-Sadouk, N; Olivier, E				Zenon, Alexandre; Corneil, Brian D.; Alamia, Andrea; Filali-Sadouk, Nabil; Olivier, Etienne			Counterproductive Effect of Saccadic Suppression during Attention Shifts	PLOS ONE			English	Article							FRONTAL EYE FIELD; OBJECT RECOGNITION; SELECTION; PERCEPTION; DYNAMICS; PATHWAY; SIGNALS; AREA; V4	During saccadic eye movements, the processing of visual information is transiently interrupted by a mechanism known as "saccadic suppression" [1] that is thought to ensure perceptual stability [2]. If, as proposed in the premotor theory of attention [3], covert shifts of attention rely on sub-threshold recruitment of oculomotor circuits, then saccadic suppression should also occur during covert shifts. In order to test this prediction, we designed two experiments in which participants had to orient towards a cued letter, with or without saccades. We analyzed the time course of letter identification score in an "attention" task performed without saccades, using the saccadic latencies measured in the "saccade" task as a marker of covert saccadic preparation. Visual conditions were identical in all tasks. In the "attention" task, we found a drop in perceptual performance around the predicted onset time of saccades that were never performed. Importantly, this decrease in letter identification score cannot be explained by any known mechanism aligned on cue onset such as inhibition of return, masking, or microsaccades. These results show that attentional allocation triggers the same suppression mechanisms as during saccades, which is relevant during eye movements but detrimental in the context of covert orienting.	[Zenon, Alexandre; Alamia, Andrea; Filali-Sadouk, Nabil; Olivier, Etienne] Univ Louvain, Inst Neurosci, Brussels, Belgium; [Corneil, Brian D.] Univ Western Ontario, Dept Physiol, London, ON, Canada; [Corneil, Brian D.] Univ Western Ontario, Dept Pharmacol, London, ON, Canada; [Corneil, Brian D.] Robarts Res Inst, London, ON N6A 5C1, Canada	Universite Catholique Louvain; Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario)	Zenon, A (corresponding author), Univ Louvain, Inst Neurosci, Brussels, Belgium.	alexandre.zenon@uclouvain.be	Zénon, Alexandre/AGN-7203-2022; Alamia, Andrea/AAC-3295-2021; Corneil, Brian D/K-6401-2013	Zénon, Alexandre/0000-0001-7989-1261; Corneil, Brian D/0000-0002-4702-7089	Innoviris	Innoviris(Innoviris)	This study was funded by Innoviris. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allison P. D., 1999, MULTIPLE REGRESSION; Anderson JC, 2011, J NEUROSCI, V31, P10872, DOI 10.1523/JNEUROSCI.0622-11.2011; Averbach E, 1961, INFORMATION THEORY, P196; Bisley JW, 2003, SCIENCE, V299, P81, DOI 10.1126/science.1077395; Bremmer F, 2009, J NEUROSCI, V29, P12374, DOI 10.1523/JNEUROSCI.2908-09.2009; BURR DC, 1994, NATURE, V371, P511, DOI 10.1038/371511a0; Castet E, 2002, P NATL ACAD SCI USA, V99, P15159, DOI 10.1073/pnas.232377199; Castet E, 2006, J VISION, V6, P196, DOI 10.1167/6.3.2; Chase C, 2003, VISION RES, V43, P1211, DOI 10.1016/S0042-6989(03)00085-3; Corneil BD, 2010, P NATL ACAD SCI USA, V107, P6070, DOI 10.1073/pnas.0911902107; Cornelissen FW, 2002, BEHAV RES METH INS C, V34, P613, DOI 10.3758/BF03195489; Craighero L, 2005, NEUROBIOLOGY ATTENTI; Deubel H, 1996, VISION RES, V36, P1827, DOI 10.1016/0042-6989(95)00294-4; Deubel H, 2008, PSYCHOL RES-PSYCH FO, V72, P630, DOI 10.1007/s00426-008-0165-3; Diamond MR, 2000, J NEUROSCI, V20, P3449, DOI 10.1523/JNEUROSCI.20-09-03449.2000; Filali-Sadouk N, 2010, J VISION, V10, DOI 10.1167/10.4.21; Gregoriou GG, 2012, NEURON, V73, P581, DOI 10.1016/j.neuron.2011.12.019; Hafed ZM, 2011, J NEUROSCI, V31, P15219, DOI 10.1523/JNEUROSCI.3106-11.2011; Ibbotson MR, 2009, CURR BIOL, V19, pR493, DOI 10.1016/j.cub.2009.05.010; Juan CH, 2008, CEREB CORTEX, V18, P2410, DOI 10.1093/cercor/bhn001; Juan CH, 2004, P NATL ACAD SCI USA, V101, P15541, DOI 10.1073/pnas.0403507101; KAHNEMAN D, 1968, PSYCHOL BULL, V70, P404, DOI 10.1037/h0026731; Klein R, 2000, TRENDS COGNITIVE SCI; Knoll J, 2011, J VISION, V11, DOI 10.1167/11.14.15; Krauzlis RJ, 2013, ANNU REV NEUROSCI, V36, P165, DOI 10.1146/annurev-neuro-062012-170249; Lovejoy LP, 2010, NAT NEUROSCI, V13, P261, DOI 10.1038/nn.2470; Micallef-Roll J, 2001, CLIN NEUROPHARMACOL, V24, P91, DOI 10.1097/00002826-200103000-00004; Montagnini A, 2007, J VISION, V7, DOI 10.1167/7.14.8; NAKAYAMA K, 1989, VISION RES, V29, P1631, DOI 10.1016/0042-6989(89)90144-2; Noudoost B, 2011, NATURE, V474, P372, DOI 10.1038/nature09995; POSNER MI, 1980, J EXP PSYCHOL GEN, V109, P160, DOI 10.1037/0096-3445.109.2.160; Pouget P, 2009, FRONT NEUROANAT, V3, DOI 10.3389/neuro.05.002.2009; Rizzolatti G, 1987, NEUROPSYCHOLOGIA; Ross J, 2001, TRENDS NEUROSCI, V24, P113, DOI 10.1016/S0166-2236(00)01685-4; Schafer RJ, 2011, SCIENCE, V332, P1568, DOI 10.1126/science.1199892; Schutz AC, 2009, VISION RES, V49, P2241, DOI 10.1016/j.visres.2009.05.022; Smith DT, 2012, NEUROPSYCHOLOGIA, V50, P1104, DOI 10.1016/j.neuropsychologia.2012.01.025; SOLOMON JA, 1994, NATURE, V369, P395, DOI 10.1038/369395a0; Wagenmakers EJ, 2007, PSYCHON B REV, V14, P779, DOI 10.3758/BF03194105; Watson TL, 2009, CURR BIOL, V19, P1040, DOI 10.1016/j.cub.2009.04.052; Wurtz RH, 2011, PHILOS T R SOC B, V366, P492, DOI 10.1098/rstb.2010.0186; Zenon A, 2012, NATURE, V489, P434, DOI 10.1038/nature11497; Zenon A, 2009, VISION RES, V49, P1522, DOI 10.1016/j.visres.2009.03.010	43	3	3	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2014	9	1							e86633	10.1371/journal.pone.0086633	http://dx.doi.org/10.1371/journal.pone.0086633			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297XI	24466181	gold, Green Published, Green Submitted			2022-12-25	WOS:000330288000125
J	Zhang, L; Wang, XF; Ma, YS; Xia, Q; Zhang, F; Fu, D; Wang, YC				Zhang, Liang; Wang, Xiao-Feng; Ma, Yu-Shui; Xia, Qing; Zhang, Feng; Fu, Da; Wang, Yi-Chao			Quantitative Assessment of the Influence of TP63 Gene Polymorphisms and Lung Cancer Risk: Evidence Based on 93,751 Subjects	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; SUSCEPTIBILITY LOCUS; TUMOR-SUPPRESSOR; IDENTIFIES 2; METAANALYSIS; SMOKING; P63; ADENOCARCINOMA; POPULATION; JAPANESE	Background: Several genome-wide association studies on lung cancer (LC) have reported similar findings of a new susceptibility locus, 3q28. After that, a number of studies reported that the rs10937405, and rs4488809 polymorphism in chromosome 3q28 has been implicated in LC risk. However, the studies have yielded contradictory results. Methods: PubMed, ISI web of science, EMBASE and the Chinese National Knowledge Infrastructure databases were systematically searched to identify relevant studies. Data were abstracted independently by two reviewers. A meta-analysis was performed to examine the association between rs10937405, rs4488809 polymorphism at 3q28 and susceptibility to LC. Odds ratios (ORs) and 95% confidence intervals (95% CIs) were calculated. Heterogeneity and publication bias were also tested. Results: A total of 9 studies including 35,961 LC cases and 57,790 controls were involved in this meta-analysis. An overall random-effects per-allele OR of 1.19 (95% CI: 1.14-1.25; P<10(-5)) and 1.19 (95% CI: 1.13-1.25; P<10(-5)) was found for the rs10937405 and rs4488809 polymorphism respectively. Similar results were also observed using dominant or recessive genetic model. After stratified by ethnicity, significant associations were found among East Asians (per-allele OR = 1.22, 95% CI: 1.17-1.27; P<10(-5)); whereas no significant associations were found among Caucasians for rs10937405. In the sub-group analysis by sample size, significantly increased risks were found for these polymorphisms in all genetic models. When analyzed according to histological type, the effects of rs10937405, and rs4488809 at 3q28 on the risk of lung cancer were significant mostly for lung adenocarcinoma. Conclusions: Our findings demonstrated that rs10937405-G allele and rs4488809-G allele might be risk-conferring factors for the development of lung cancer, especially for East Asian populations.	[Zhang, Liang; Wang, Xiao-Feng; Xia, Qing; Zhang, Feng; Fu, Da; Wang, Yi-Chao] Fudan Univ, Zhongshan Hosp, Dept Orthopaed, Shanghai 200433, Peoples R China; [Ma, Yu-Shui] Tongji Univ, Sch Med, Shanghai Peoples Hosp 10, Dept Nucl Med, Shanghai 200092, Peoples R China; [Fu, Da] Shanghai Jiao Tong Univ, Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Hlth Sci, Shanghai 200030, Peoples R China	Fudan University; Tongji University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Shanghai Jiao Tong University	Fu, D (corresponding author), Fudan Univ, Zhongshan Hosp, Dept Orthopaed, Shanghai 200433, Peoples R China.	superdafu@hotmail.com; wang_yichao001@126.com	ma, yushui/HGC-6206-2022; Fu, Da/GXF-2656-2022		National Natural Science Foundation of China [81201535, 81302065]; Knowledge Innovation Program of Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences [2012KIP203]; Shanghai Natural Science Foundation [12ZR1436000]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Knowledge Innovation Program of Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences(Knowledge Innovation Program of the Chinese Academy of SciencesChinese Academy of Sciences); Shanghai Natural Science Foundation(Natural Science Foundation of Shanghai)	National Natural Science Foundation of China (81201535, 81302065), the Knowledge Innovation Program of Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences (2012KIP203) and Shanghai Natural Science Foundation (12ZR1436000). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amos CI, 2008, NAT GENET, V40, P616, DOI 10.1038/ng.109; BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; COCHRAN WG, 1954, BIOMETRICS, V10, P101, DOI 10.2307/3001666; Daigo Y, 2008, GEN THORAC CARDIOVAS, V56, P43, DOI 10.1007/s11748-007-0211-x; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Finlan LE, 2007, CELL CYCLE, V6, P1062, DOI 10.4161/cc.6.9.4162; Flores ER, 2007, CELL CYCLE, V6, P300, DOI 10.4161/cc.6.3.3793; Flores ER, 2005, CANCER CELL, V7, P363, DOI 10.1016/j.ccr.2005.02.019; Hecht SS, 2002, LANCET ONCOL, V3, P461, DOI 10.1016/S1470-2045(02)00815-X; Hirschhorn JN, 2002, GENET MED, V4, P45, DOI 10.1097/00125817-200203000-00002; Hosgood HD, 2012, HUM GENET, V131, P1197, DOI 10.1007/s00439-012-1144-8; Hsiao YH, 2010, INT J BIOL SCI, V6, P428; Hu QY, 2014, TUMOR BIOL, V35, P1863, DOI 10.1007/s13277-013-1248-3; Hu ZB, 2011, NAT GENET, V43, P792, DOI 10.1038/ng.875; Hung RJ, 2008, NATURE, V452, P633, DOI 10.1038/nature06885; Katoh I, 2000, ONCOGENE, V19, P3126, DOI 10.1038/sj.onc.1203644; Lan Q, 2012, NAT GENET, V44, P1330, DOI 10.1038/ng.2456; Li DW, 2006, HUM MOL GENET, V15, P1995, DOI 10.1093/hmg/ddl122; McKay JD, 2008, NAT GENET, V40, P1404, DOI 10.1038/ng.254; Miki D, 2010, NAT GENET, V42, P893, DOI 10.1038/ng.667; Munafo MR, 2004, TRENDS GENET, V20, P439, DOI 10.1016/j.tig.2004.06.014; Osann K E, 1998, Curr Opin Pulm Med, V4, P198, DOI 10.1097/00063198-199807000-00002; Petitjean A, 2008, CARCINOGENESIS, V29, P273, DOI 10.1093/carcin/bgm258; Shiraishi K, 2012, NAT GENET, V44, P900, DOI 10.1038/ng.2353; Su XH, 2009, CELL STEM CELL, V5, P64, DOI 10.1016/j.stem.2009.04.003; Thorgeirsson TE, 2008, NATURE, V452, P638, DOI 10.1038/nature06846; Timofeeva MN, 2012, HUM MOL GENET, V21, P4980, DOI 10.1093/hmg/dds334; Vineis P, 2004, JNCI-J NATL CANCER I, V96, P99, DOI 10.1093/jnci/djh014; Walser Tonya, 2008, Proc Am Thorac Soc, V5, P811, DOI 10.1513/pats.200809-100TH; Wang YF, 2011, CANCER EPIDEM BIOMAR, V20, P1453, DOI 10.1158/1055-9965.EPI-11-0042; Wang YF, 2008, NAT GENET, V40, P1407, DOI 10.1038/ng.273; Wu J, 2010, J CELL BIOCHEM, V109, P702, DOI 10.1002/jcb.22449; Zhang YJ, 2012, GENE, V497, P93, DOI 10.1016/j.gene.2012.01.053	34	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2014	9	1							e87004	10.1371/journal.pone.0087004	http://dx.doi.org/10.1371/journal.pone.0087004			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297XI	24466311	gold, Green Published, Green Submitted			2022-12-25	WOS:000330288000183
J	Cazzoli, D; Antoniades, CA; Kennard, C; Nyffeler, T; Bassetti, CL; Muri, RM				Cazzoli, Dario; Antoniades, Chrystalina A.; Kennard, Christopher; Nyffeler, Thomas; Bassetti, Claudio L.; Mueri, Rene M.			Eye Movements Discriminate Fatigue Due to Chronotypical Factors and Time Spent on Task - A Double Dissociation	PLOS ONE			English	Article							TOTAL SLEEP-DEPRIVATION; SACCADIC VELOCITY; PERFORMANCE; OCULOMOTOR; VARIABILITY; IMPAIRMENT; ACTIVATION; PARAMETERS; ATTENTION; RESPONSES	Systematic differences in circadian rhythmicity are thought to be a substantial factor determining inter-individual differences in fatigue and cognitive performance. The synchronicity effect (when time of testing coincides with the respective circadian peak period) seems to play an important role. Eye movements have been shown to be a reliable indicator of fatigue due to sleep deprivation or time spent on cognitive tasks. However, eye movements have not been used so far to investigate the circadian synchronicity effect and the resulting differences in fatigue. The aim of the present study was to assess how different oculomotor parameters in a free visual exploration task are influenced by: a) fatigue due to chronotypical factors (being a 'morning type' or an 'evening type'); b) fatigue due to the time spent on task. Eighteen healthy participants performed a free visual exploration task of naturalistic pictures while their eye movements were recorded. The task was performed twice, once at their optimal and once at their non-optimal time of the day. Moreover, participants rated their subjective fatigue. The non-optimal time of the day triggered a significant and stable increase in the mean visual fixation duration during the free visual exploration task for both chronotypes. The increase in the mean visual fixation duration correlated with the difference in subjectively perceived fatigue at optimal and non-optimal times of the day. Conversely, the mean saccadic speed significantly and progressively decreased throughout the duration of the task, but was not influenced by the optimal or non-optimal time of the day for both chronotypes. The results suggest that different oculomotor parameters are discriminative for fatigue due to different sources. A decrease in saccadic speed seems to reflect fatigue due to time spent on task, whereas an increase in mean fixation duration a lack of synchronicity between chronotype and time of the day.	[Cazzoli, Dario; Antoniades, Chrystalina A.; Kennard, Christopher] Univ Oxford, John Radcliffe Hosp, Nuffield Dept Clin Neurosci, Oxford OX3 9DU, England; [Cazzoli, Dario; Nyffeler, Thomas; Bassetti, Claudio L.; Mueri, Rene M.] Univ Bern, Inselspital, Univ Hosp Bern, Percept & Eye Movement Lab,Dept Neurol, CH-3010 Bern, Switzerland; [Cazzoli, Dario; Nyffeler, Thomas; Bassetti, Claudio L.; Mueri, Rene M.] Univ Bern, Dept Clin Res, Bern, Switzerland; [Nyffeler, Thomas] Luzerner Kantonsspital, Dept Internal Med, Ctr Neurol & Neurorehabil, Luzern, Switzerland	University of Oxford; University of Bern; University Hospital of Bern; University of Bern; Lucerne Cantonal Hospital	Cazzoli, D (corresponding author), Univ Oxford, John Radcliffe Hosp, Nuffield Dept Clin Neurosci, Oxford OX3 9DU, England.	dario.cazzoli@gmail.com	Müri, René M/E-9320-2012	Müri, René M/0000-0001-6990-4188; Antoniades, Chrystalina/0000-0002-1192-3834; Cazzoli, Dario/0000-0001-7217-7153; Nyffeler, Thomas/0000-0003-2504-8935; Bassetti, Claudio/0000-0002-4535-0245	Swiss National Science Foundation [PBBEP3_134978, 320000-108146]; Janggen-Pohn-Foundation; Holcim Foundation	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Janggen-Pohn-Foundation; Holcim Foundation	DC was supported by the Swiss National Science Foundation (Grant No. PBBEP3_134978), the Janggen-Pohn-Foundation, and the Holcim Foundation. This work was supported by the Swiss National Science Foundation (Grant No. 320000-108146). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akerstedt T, 2000, J SLEEP RES, V9, P395; ANDERSON TJ, 1994, BRAIN, V117, P1073, DOI 10.1093/brain/117.5.1073; App E, 1998, ERGONOMICS, V41, P689, DOI 10.1080/001401398186856; Bocca ML, 2006, CLIN NEUROPHYSIOL, V117, P894, DOI 10.1016/j.clinph.2006.01.003; Chaudhuri A, 2004, LANCET, V363, P978, DOI 10.1016/S0140-6736(04)15794-2; Christodoulou C, 2005, ISS CLIN COGN NEUROP, P19; De Gennaro L, 2000, CLIN NEUROPHYSIOL, V111, P1771, DOI 10.1016/S1388-2457(00)00393-X; De Gennaro L, 2001, PHYSIOL BEHAV, V74, P197, DOI 10.1016/S0031-9384(01)00551-0; Di Stasi LL, 2013, NEUROSCI BIOBEHAV R, V37, P968, DOI 10.1016/j.neubiorev.2013.03.011; Dorr M, 2010, J VISION, V10, DOI 10.1167/10.10.28; Everling S, 2000, J NEUROSCI, V20, P387, DOI 10.1523/JNEUROSCI.20-01-00387.2000; Finke C, 2012, J NEUROL, V259, P2656, DOI 10.1007/s00415-012-6565-8; Galley N, 1998, ERGONOMICS, V41, P698, DOI 10.1080/001401398186865; Girard B, 2005, PROG NEUROBIOL, V77, P215, DOI 10.1016/j.pneurobio.2005.11.001; GRANDJEAN E, 1979, BRIT J IND MED, V36, P175; Griefahn B, 2001, SOMNOLOGIE, V5, P71, DOI [10.1046/j.1439-054X.2001.01149.x, DOI 10.1046/J.1439-054X.2001.01149.X]; Hirvonen K, 2010, J NEUROSCI METH, V187, P199, DOI 10.1016/j.jneumeth.2010.01.010; HORNE J A, 1976, International Journal of Chronobiology, V4, P97; KERKHOF GA, 1985, BIOL PSYCHOL, V20, P83, DOI 10.1016/0301-0511(85)90019-5; Lal SKL, 2001, BIOL PSYCHOL, V55, P173, DOI 10.1016/S0301-0511(00)00085-5; Lamond N, 1999, J SLEEP RES, V8, P255, DOI 10.1046/j.1365-2869.1999.00167.x; Lavine RA, 2002, AVIAT SPACE ENVIR MD, V73, P367; Leigh R. J., 2006, NEUROLOGY EYE MOVEME; Lorist MM, 2000, PSYCHOPHYSIOLOGY, V37, P614, DOI 10.1111/1469-8986.3750614; Marek T, 2010, CHRONOBIOL INT, V27, P945, DOI 10.3109/07420528.2010.489400; May CP, 1999, PSYCHON B REV, V6, P142, DOI 10.3758/BF03210822; May CP, 1998, J EXP PSYCHOL HUMAN, V24, P363, DOI 10.1037/0096-1523.24.2.363; MUNOZ DP, 2003, OCULOMOTOR SYSTEM NE, P55; PAUS T, 1993, J NEUROPHYSIOL, V70, P453, DOI 10.1152/jn.1993.70.2.453; Rowland LM, 2005, AVIAT SPACE ENVIR MD, V76, pC104; Russo A, 2003, CLIN NEUROPHYSIOL, V114, P723, DOI 10.1016/S1388-2457(03)00008-7; SAITO S, 1992, ERGONOMICS, V35, P607, DOI 10.1080/00140139208967840; Schleicher R, 2008, ERGONOMICS, V51, P982, DOI 10.1080/00140130701817062; Schmidt C, 2007, COGN NEUROPSYCHOL, V24, P755, DOI 10.1080/02643290701754158; SCHMIDT D, 1979, AVIAT SPACE ENVIR MD, V50, P393; Van Donger P, 2000, PRINCIPLES PRACTICE, P391; West R, 2002, J GERONTOL B-PSYCHOL, V57, pP3, DOI 10.1093/geronb/57.1.P3	37	26	28	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2014	9	1							e87146	10.1371/journal.pone.0087146	http://dx.doi.org/10.1371/journal.pone.0087146			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	297VL	24466334	Green Published, Green Submitted, gold			2022-12-25	WOS:000330283100250
J	Good, AP; Gauthier, MPL; Vannette, RL; Fukami, T				Good, Ashley P.; Gauthier, Marie-Pierre L.; Vannette, Rachel L.; Fukami, Tadashi			Honey Bees Avoid Nectar Colonized by Three Bacterial Species, But Not by a Yeast Species, Isolated from the Bee Gut	PLOS ONE			English	Article							ACETIC-ACID BACTERIA; APIS-MELLIFERA; BUMBLE BEES; SP NOV.; MICROBIAL ATTACK; FLORAL NECTAR; GEN. NOV.; INSECTS; COMMUNITIES; DEFENSE	The gut microflora of the honey bee, Apis mellifera, is receiving increasing attention as a potential determinant of the bees' health and their efficacy as pollinators. Studies have focused primarily on the microbial taxa that appear numerically dominant in the bee gut, with the assumption that the dominant status suggests their potential importance to the bees' health. However, numerically minor taxa might also influence the bees' efficacy as pollinators, particularly if they are not only present in the gut, but also capable of growing in floral nectar and altering its chemical properties. Nonetheless, it is not well understood whether honey bees have any feeding preference for or against nectar colonized by specific microbial species. To test whether bees exhibit a preference, we conducted a series of field experiments at an apiary using synthetic nectar inoculated with specific species of bacteria or yeast that had been isolated from the bee gut, but are considered minor components of the gut microflora. These species had also been found in floral nectar. Our results indicated that honey bees avoided nectar colonized by the bacteria Asaia astilbes, Erwinia tasmaniensis, and Lactobacillus kunkeei, whereas the yeast Metschnikowia reukaufii did not affect the feeding preference of the insects. Our results also indicated that avoidance of bacteria-colonized nectar was caused not by the presence of the bacteria per se, but by the chemical changes to nectar made by the bacteria. These findings suggest that gut microbes may not only affect the bees' health as symbionts, but that some of the microbes may possibly affect the efficacy of A. mellifera as pollinators by altering nectar chemistry and influencing their foraging behavior.	[Good, Ashley P.; Gauthier, Marie-Pierre L.; Vannette, Rachel L.; Fukami, Tadashi] Stanford Univ, Dept Biol, Stanford, CA 94305 USA	Stanford University	Fukami, T (corresponding author), Stanford Univ, Dept Biol, Stanford, CA 94305 USA.	fukamit@stanford.edu	Fukami, Tadashi/A-2934-2010	Fukami, Tadashi/0000-0001-5654-4785; Vannette, Rachel/0000-0002-0447-3468	Department of Biology and the Terman Fellowship of Stanford University; National Science Foundation [DEB1149600]; Division Of Environmental Biology [1149600] Funding Source: National Science Foundation	Department of Biology and the Terman Fellowship of Stanford University; National Science Foundation(National Science Foundation (NSF)); Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	The Department of Biology and the Terman Fellowship of Stanford University and the National Science Foundation (award number: DEB1149600) supported this research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altaye SZ, 2010, J EXP BIOL, V213, P3311, DOI 10.1242/jeb.046953; BAKER HG, 1973, NATURE, V241, P543, DOI 10.1038/241543b0; Basukriadi A., 2010, MICROBIOL INDONES, V4, P44, DOI DOI 10.5454/mi.4.1.9; Belisle M, 2012, MICROB ECOL, V63, P711, DOI 10.1007/s00248-011-9975-8; Brysch-Herzberg M, 2004, FEMS MICROBIOL ECOL, V50, P87, DOI 10.1016/j.femsec.2004.06.003; Carter C, 2004, TRENDS PLANT SCI, V9, P320, DOI 10.1016/j.tplants.2004.05.008; Chalcoff VR, 2006, ANN BOT-LONDON, V97, P413, DOI 10.1093/aob/mcj043; Cox-Foster DL, 2007, SCIENCE, V318, P283, DOI 10.1126/science.1146498; Crotti E, 2010, APPL ENVIRON MICROB, V76, P6963, DOI 10.1128/AEM.01336-10; Crotti E, 2009, ENVIRON MICROBIOL, V11, P3252, DOI 10.1111/j.1462-2920.2009.02048.x; Dillon RJ, 2004, ANNU REV ENTOMOL, V49, P71, DOI 10.1146/annurev.ento.49.061802.123416; Ehlers BK, 1997, FLORA, V192, P223, DOI 10.1016/S0367-2530(17)30787-9; Engel P, 2013, INT J SYST EVOL MICR, V63, P3646, DOI 10.1099/ijs.0.049569-0; Engel P, 2013, J APICULT RES, V52, DOI 10.3896/IBRA.1.52.4.07; Engel P, 2012, P NATL ACAD SCI USA, V109, P11002, DOI 10.1073/pnas.1202970109; Evans JD, 2006, INSECT MOL BIOL, V15, P645, DOI 10.1111/j.1365-2583.2006.00682.x; Gilliam M, 1997, FEMS MICROBIOL LETT, V155, P1; Gould J.L., 1988, HONEY BEE; Herrera CM, 2013, ECOLOGY, V94, P273, DOI 10.1890/12-0595.1; Herrera CM, 2010, P ROY SOC B-BIOL SCI, V277, P747, DOI 10.1098/rspb.2009.1485; Herrera CM, 2009, ANN BOT-LONDON, V103, P1415, DOI 10.1093/aob/mcp026; Hothorn T, 2008, BIOMETRICAL J, V50, P346, DOI 10.1002/bimj.200810425; KEVAN PG, 1988, J APICULT RES, V27, P26, DOI 10.1080/00218839.1988.11100777; Kurtzman CP, 1998, ANTON LEEUW INT J G, V73, P331, DOI 10.1023/A:1001761008817; Kwong WK, 2013, INT J SYST EVOL MICR, V63, P2008, DOI 10.1099/ijs.0.044875-0; Lachance MA, 2001, FEMS YEAST RES, V1, P1; LAMBERT B, 1981, A VAN LEEUW J MICROB, V47, P147, DOI 10.1007/BF02342197; Loncaric I, 2011, APIDOLOGIE, V42, P312, DOI 10.1007/s13592-011-0019-7; Martinson VG, 2011, MOL ECOL, V20, P619, DOI 10.1111/j.1365-294X.2010.04959.x; Marzorati M, 2006, APPL ENVIRON MICROB, V72, P1467, DOI 10.1128/AEM.72.2.1467-1475.2006; Mattila HR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032962; Moran NA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036393; National Research Council of the National Academies, 2007, STAT POLL N AM; Nicolson Susan W., 2007, P289, DOI 10.1007/978-1-4020-5937-7_7; Olesen JM, 1998, NATURE, V393, P529, DOI 10.1038/31128; Palacio-Bielsa A, 2012, TREES-STRUCT FUNCT, V26, P13, DOI 10.1007/s00468-011-0644-9; Parker R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011096; Peay KG, 2012, P ROY SOC B-BIOL SCI, V279, P749, DOI 10.1098/rspb.2011.1230; Perret M, 2001, ANN BOT-LONDON, V87, P267, DOI 10.1006/anbo.2000.1331; Pozo MI, 2011, MICROB ECOL, V61, P82, DOI 10.1007/s00248-010-9682-x; Pozo MI, 2013, THESIS ESTACION BIOL; *R COR DEV TEAM, 2012, R LANG ENV STAT COMP; Rangberg A, 2012, INTEGR COMP BIOL, V52, P89, DOI 10.1093/icb/ics089; Sabree ZL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041250; Sarkar D., 2019, NLME LINEAR NONLINEA; Stefanini I, 2012, P NATL ACAD SCI USA, V109, P13398, DOI 10.1073/pnas.1208362109; Suzuki R, 2010, J GEN APPL MICROBIOL, V56, P339, DOI 10.2323/jgam.56.339; Thornburg RW, 2003, PLANT SYST EVOL, V238, P211, DOI 10.1007/s00606-003-0282-9; Vanengelsdorp D, 2007, AM BEE J, V147, P599; Vannette RL, 2014, ECOL LETT, V17, P115, DOI 10.1111/ele.12204; Vannette RL, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.2601; Vasquez A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033188; Wang Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007401	53	83	86	0	90	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2014	9	1							e86494	10.1371/journal.pone.0086494	http://dx.doi.org/10.1371/journal.pone.0086494			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297VL	24466119	Green Published, Green Submitted, gold			2022-12-25	WOS:000330283100172
J	Gu, XJ; Hu, M; Li, B; Hu, XT				Gu, Xiao-Jing; Hu, Ming; Li, Bing; Hu, Xin-Tian			The Role of Contrast Adaptation in Saccadic Suppression in Humans	PLOS ONE			English	Article							GAIN-CONTROL; EYE-MOVEMENTS; TIME; MECHANISMS; RESPONSES; DYNAMICS; NEURONS; CATS	The idea of retinal and ex-retinal sources of saccadic suppression has long been established in previous studies. However, how they are implemented in local circuit remains unknown. Researchers have suggested that saccadic suppression was probably achieved by contrast gain control, but this possibility has never been directly tested. In this study, we manipulated contrast gain control by contrast-adapting observers with sinusoidal gratings of different contrasts. Presaccadic and fixational contrast thresholds were measured and compared to give estimates of saccadic suppression at different adaptation states. Our results reconfirmed the selective saccadic suppression in achromatic condition, and further showed that, achromatic saccadic suppression diminished as contrast adaptation was accentuated, whereas no significant chromatic saccadic suppression was induced by greater contrast adaptation. Our data provided evidence for the involvement of contrast gain control in saccadic suppression in achromatic channel. We also discussed how the negative correlation between contrast adaptation and saccadic suppression could be interpreted with contrast gain control.	[Gu, Xiao-Jing; Li, Bing; Hu, Xin-Tian] Chinese Acad Sci, Inst Biophys, State Key Lab Brain & Cognit Sci, Beijing 100080, Peoples R China; [Hu, Xin-Tian] Chinese Acad Sci, Kunming Inst Zool, Key Lab Anim Models & Human Dis Mech, Kunming, Yunnan, Peoples R China; [Hu, Ming] Univ Texas Houston, Sch Med, Dept Neurobiol & Anat, Houston, TX 77225 USA; [Gu, Xiao-Jing] Univ Chinese Acad Sci, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Biophysics, CAS; Chinese Academy of Sciences; Kunming Institute of Zoology; University of Texas System; University of Texas Health Science Center Houston; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Li, B (corresponding author), Chinese Acad Sci, Inst Biophys, State Key Lab Brain & Cognit Sci, Beijing 100080, Peoples R China.	lib@sun5.ibp.ac.cn; xthu@mail.kiz.ac.cn			Strategic Priority Research Program of the Chinese Academy of Science [XDB02020000]; 973 program [2012CB825500, 2012CBA01304, 2011CB707800]; 863 program [2012AA020701, KSCX2-EW-J-23, KSCX2-EW-R-11]; National Science Foundation of China NSFC [91332120, 31271167, 31070963, 31271168, 81271495, 31070965]	Strategic Priority Research Program of the Chinese Academy of Science(Chinese Academy of Sciences); 973 program(National Basic Research Program of China); 863 program(National High Technology Research and Development Program of China); National Science Foundation of China NSFC(National Natural Science Foundation of China (NSFC))	This research was supported by the Strategic Priority Research Program of the Chinese Academy of Science XDB02020000, 973 program 2012CB825500, 2012CBA01304 and 2011CB707800, the 863 program 2012AA020701, KSCX2-EW-J-23 and KSCX2-EW-R-11, the National Science Foundation of China NSFC 91332120, 31271167, 31070963, 31271168, 81271495 and 31070965. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbonizio G, 2002, SPATIAL VISION, V16, P45, DOI 10.1163/15685680260433904; Albrecht DG, 2002, J NEUROPHYSIOL, V88, P888, DOI 10.1152/jn.2002.88.2.888; Balboa RM, 2003, VISION RES, V43, P2527, DOI 10.1016/S0042-6989(03)00471-1; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Bremmer F, 2009, J NEUROSCI, V29, P12374, DOI 10.1523/JNEUROSCI.2908-09.2009; BROOKS BA, 1975, VISION RES, V15, P1389, DOI 10.1016/0042-6989(75)90196-0; Bruno A, 2006, J NEUROPHYSIOL, V96, P1011, DOI 10.1152/jn.01179.2005; BURR DC, 1994, NATURE, V371, P511, DOI 10.1038/371511a0; Burr DC, 1996, VISION RES, V36, P2069, DOI 10.1016/0042-6989(95)00282-0; CHEN S, 1995, VISION RES, V35, P2315, DOI 10.1016/0042-6989(94)00308-9; Cornelissen FW, 2002, BEHAV RES METH INS C, V34, P613, DOI 10.3758/BF03195489; Diamond MR, 2000, J NEUROSCI, V20, P3449, DOI 10.1523/JNEUROSCI.20-09-03449.2000; GREENLEE MW, 1988, VISION RES, V28, P791, DOI 10.1016/0042-6989(88)90026-0; GREENLEE MW, 1991, VISION RES, V31, P223, DOI 10.1016/0042-6989(91)90113-J; Guez J, 2013, J VISION, V13, DOI 10.1167/13.8.4; Hu M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025410; Ibbotson MR, 2008, J NEUROSCI, V28, P10952, DOI 10.1523/JNEUROSCI.3950-08.2008; Kagan I, 2008, J VISION, V8, DOI 10.1167/8.14.19; Kohn A, 2007, J NEUROPHYSIOL, V97, P3155, DOI 10.1152/jn.00086.2007; MAATTANEN LM, 1991, EXP BRAIN RES, V87, P205; Macknik SL, 2006, PROG BRAIN RES, V155, P177, DOI 10.1016/S0079-6123(06)55011-3; Nakamura K, 2000, J NEUROPHYSIOL, V84, P677, DOI 10.1152/jn.2000.84.2.677; OHZAWA I, 1985, J NEUROPHYSIOL, V54, P651, DOI 10.1152/jn.1985.54.3.651; OHZAWA I, 1982, NATURE, V298, P266, DOI 10.1038/298266a0; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; Reppas JB, 2002, NEURON, V35, P961, DOI 10.1016/S0896-6273(02)00823-1; RICHMOND BJ, 1980, J NEUROPHYSIOL, V43, P1156, DOI 10.1152/jn.1980.43.4.1156; Ross J, 2001, TRENDS NEUROSCI, V24, P113, DOI 10.1016/S0166-2236(00)01685-4; SCLAR G, 1985, J NEUROPHYSIOL, V54, P668, DOI 10.1152/jn.1985.54.3.668; Wang P, 2011, FRONT HUM NEUROSCI, V5, DOI 10.3389/fnhum.2011.00085; WATSON AB, 1983, PERCEPT PSYCHOPHYS, V33, P113, DOI 10.3758/BF03202828; Watson T, 2011, J NEUROSCI, V31, P6535, DOI 10.1523/JNEUROSCI.6255-10.2011; Wurtz RH, 2011, PHILOS T R SOC B, V366, P492, DOI 10.1098/rstb.2010.0186	33	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2014	9	1							e86542	10.1371/journal.pone.0086542	http://dx.doi.org/10.1371/journal.pone.0086542			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297VL	24466142	Green Published, Green Submitted, gold			2022-12-25	WOS:000330283100181
J	Hao, YP; Ma, XJ; Shen, Y; Ni, J; Luo, YQ; Xiao, YF; Bao, YQ; Jia, WP				Hao, Yaping; Ma, Xiaojing; Shen, Yun; Ni, Jie; Luo, Yuqi; Xiao, Yunfeng; Bao, Yuqian; Jia, Weiping			Associations of Serum 25-Hydroxyvitamin D-3 Levels with Visceral Adipose Tissue in Chinese Men with Normal Glucose Tolerance	PLOS ONE			English	Article							VITAMIN-D STATUS; BODY-MASS INDEX; METABOLIC SYNDROME; D DEFICIENCY; FAT; OBESITY; CALCIUM; ADIPOGENESIS; HOMEOSTASIS; INHIBITION	Objective: Decreased serum vitamin D level is a common observation in obese adults. Since no Chinese population-based study has yet evaluated the relationship between serum vitamin D levels and the accurate adiposity variables, this study investigated the association of serum vitamin D (assessed by 25-hydroxyvitamin D-3 [25(OH)D-3]) levels with precise body fat content and distribution in a cohort of Chinese men. Methods: Serum samples were collected from a total of 567 men with normal glucose tolerance (NGT) for assessment by electrochemiluminescence immunoassay to measure 25(OH)D-3 levels. In addition, each participant underwent bioelectrical impedance analysis to quantify total body fat and magnetic resonance imaging to measure visceral fat area (VFA) and subcutaneous fat area (SFA). Results: Overweight/obese (BMI >= 25 kg/m(2)) subjects had significantly lower serum 25(OH)D-3 levels than non-over weight/non-obese (BMI,25 kg/m(2)) subjects (P = 0.029). Greater fat mass and VFA were accompanied by a downward trend in serum 25(OH)D-3 levels (P for trend,0.01). Among overweight/obese subjects, those with body fat percent >= 25% also had significantly lower serum 25(OH)D-3 levels (P <0.05). Moreover, participants with VFA >= 80 cm(2) had significantly lower serum 25(OH)D-3 (P <0.05), regardless of BMI value. VFA was independently correlated with serum 25(OH) D3 levels (b = 20.023, P,<0.001), even after adjustments for confounding factors. In addition, serum 25(OH)D-3 levels were found to decrease by 0.26 ng/mL per 10 cm(2) increment of VFA.	[Hao, Yaping; Ma, Xiaojing; Shen, Yun; Ni, Jie; Luo, Yuqi; Bao, Yuqian; Jia, Weiping] Shanghai Jiao Tong Univ, Dept Endocrinol & Metab,Shanghai Diabet Inst, Affiliated Peoples Hosp 6,Shanghai Key Lab Diabet, Shanghai Clin Ctr Diabet,Shanghai Key Clin Ctr Me, Shanghai 200030, Peoples R China; [Xiao, Yunfeng] Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 6, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University	Bao, YQ (corresponding author), Shanghai Jiao Tong Univ, Dept Endocrinol & Metab,Shanghai Diabet Inst, Affiliated Peoples Hosp 6,Shanghai Key Lab Diabet, Shanghai Clin Ctr Diabet,Shanghai Key Clin Ctr Me, Shanghai 200030, Peoples R China.	byq522@163.com		Shen, Yun/0000-0002-9850-122X	973 Program of China [2013CB530606]; Key Project of Science and Technology of Shanghai [13XD1403000]; Project of National Natural Science Foundation of China [81100563]; National Key Technology Research & Development Program of China [2012BAI02B03]; Key Discipline of Public Health of Shanghai (Epidemiology) [12GWZX0104]; Drug Innovation Program of National Science and Technology Project [2011ZX09307-001-02]	973 Program of China(National Basic Research Program of China); Key Project of Science and Technology of Shanghai; Project of National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Technology Research & Development Program of China; Key Discipline of Public Health of Shanghai (Epidemiology); Drug Innovation Program of National Science and Technology Project	Funding provided by 973 Program of China (2013CB530606), Key Project of Science and Technology of Shanghai (13XD1403000), Project of National Natural Science Foundation of China (81100563), National Key Technology Research & Development Program of China (2012BAI02B03), Key Discipline of Public Health of Shanghai (Epidemiology) (12GWZX0104) and Drug Innovation Program of National Science and Technology Project (2011ZX09307-001-02). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberti KGMM, 2006, DIABETIC MED, V23, P469, DOI 10.1111/j.1464-5491.2006.01858.x; Anonymous, 2007, Zhonghua Xinxueguanbing Zazhi, V35, P390; Ardawi MSM, 2011, OSTEOPOROSIS INT, V22, P463, DOI 10.1007/s00198-010-1249-7; Arunabh S, 2003, J CLIN ENDOCR METAB, V88, P157, DOI 10.1210/jc.2002-020978; Bao YQ, 2013, J CLIN ENDOCR METAB, V98, P345, DOI 10.1210/jc.2012-2906; Blum M, 2008, ENDOCRINE, V33, P90, DOI 10.1007/s12020-008-9051-4; Botella-Carretero JI, 2007, CLIN NUTR, V26, P573, DOI 10.1016/j.clnu.2007.05.009; Cai ZJ, 1999, WHO TECH REP SER, V887, P1; Chalmers J, 1999, CLIN EXP HYPERTENS, V21, P1009; Cheng S, 2010, DIABETES, V59, P242, DOI 10.2337/db09-1011; Craig CL, 2003, MED SCI SPORT EXER, V35, P1381, DOI 10.1249/01.MSS.0000078924.61453.FB; Dalgard C, 2011, DIABETES CARE, V34, P1284, DOI 10.2337/dc10-2084; Frankenfield DC, 2001, NUTRITION, V17, P26, DOI 10.1016/S0899-9007(00)00471-8; Hart GR, 2006, CLIN LAB, V52, P335; Hypponen E, 2006, DIABETES CARE, V29, P2244, DOI 10.2337/dc06-0946; Kong J, 2006, AM J PHYSIOL-ENDOC M, V290, pE916, DOI 10.1152/ajpendo.00410.2005; Lenders CM, 2009, AM J CLIN NUTR, V90, P459, DOI 10.3945/ajcn.2008.27275; Looker AC, 2005, J CLIN ENDOCR METAB, V90, P635, DOI 10.1210/jc.2004-1765; Lu HK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047264; Lu L, 2009, DIABETES CARE, V32, P1278, DOI 10.2337/dc09-0209; Mai XM, 2012, AM J EPIDEMIOL, V175, P1029, DOI 10.1093/aje/kwr456; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; McCarty MF, 2003, MED HYPOTHESES, V61, P535, DOI 10.1016/S0306-9877(03)00227-5; McGill AT, 2008, NUTR J, V7, DOI 10.1186/1475-2891-7-4; Nam GE, 2012, NUTR RES, V32, P395, DOI 10.1016/j.nutres.2012.05.002; Paschoalin RP, 2012, TRANSPL P, V44, P2588, DOI 10.1016/j.transproceed.2012.09.049; Reis AF, 2005, DIABETES METAB, V31, P318, DOI 10.1016/S1262-3636(07)70200-8; Rodriguez-Rodriguez E, 2010, EUR J CLIN NUTR, V64, P461, DOI 10.1038/ejcn.2010.26; Seo JA, 2012, J AM GERIATR SOC, V60, P700, DOI 10.1111/j.1532-5415.2012.03887.x; Siddiqui SMK, 2008, NUTR RES, V28, P783, DOI 10.1016/j.nutres.2008.08.004; van der Meer IM, 2006, AM J CLIN NUTR, V84, P350; Wang Y, 2012, INT J OBESITY, V36, P1203, DOI 10.1038/ijo.2011.222; Wood RJ, 2008, NUTR REV, V66, P40, DOI 10.1111/j.1753-4887.2007.00004.x; Wortsman J, 2000, AM J CLIN NUTR, V72, P690, DOI 10.1093/ajcn/72.3.690; Xue BZ, 2001, FASEB J, V15, P2527, DOI 10.1096/fj.01-0278fje; Young KA, 2009, J CLIN ENDOCR METAB, V94, P3306, DOI 10.1210/jc.2009-0079	36	31	31	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2014	9	1							e86773	10.1371/journal.pone.0086773	http://dx.doi.org/10.1371/journal.pone.0086773			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297VL	24466233	gold, Green Published, Green Submitted			2022-12-25	WOS:000330283100211
J	Hocking, DJ; Babbitt, KJ				Hocking, Daniel J.; Babbitt, Kimberly J.			Effects of Red-Backed Salamanders on Ecosystem Functions	PLOS ONE			English	Article							LEAF-LITTER DECOMPOSITION; BROOK EXPERIMENTAL FOREST; FLOOR FOOD WEBS; TROPHIC CASCADES; ELEUTHERODACTYLUS-COQUI; DETECTION PROBABILITY; EXPERIMENTAL VENUE; BOTTOM-UP; INVERTEBRATES; TERRESTRIAL	Ecosystems provide a vast array of services for human societies, but understanding how various organisms contribute to the functions that maintain these services remains an important ecological challenge. Predators can affect ecosystem functions through a combination of top-down trophic cascades and bottom-up effects on nutrient dynamics. As the most abundant vertebrate predator in many eastern US forests, woodland salamanders (Plethodon spp.) likely affect ecosystems functions. We examined the effects of red-backed salamanders (Plethodon cinereus) on a variety of forest ecosystem functions using a combined approach of large-scale salamander removals (314-m(2) plots) and small-scale enclosures (2 m(2)) where we explicitly manipulated salamander density (0, 0.5, 1, 2, 4 m(-2)). In these experiments, we measured the rates of litter and wood decomposition, potential nitrogen mineralization and nitrification rates, acorn germination, and foliar insect damage on red oak seedlings. Across both experimental venues, we found no significant effect of red-backed salamanders on any of the ecosystem functions. We also found no effect of salamanders on intraguild predator abundance (carabid beetles, centipedes, spiders). Our study adds to the already conflicting evidence on effects of red-backed salamander and other amphibians on terrestrial ecosystem functions. It appears likely that the impact of terrestrial amphibians on ecosystem functions is context dependent. Future research would benefit from explicitly examining terrestrial amphibian effects on ecosystem functions under a variety of environmental conditions and in different forest types.	[Hocking, Daniel J.; Babbitt, Kimberly J.] Univ New Hampshire, Dept Nat Resources & Environm, Durham, NH 03824 USA	University System Of New Hampshire; University of New Hampshire	Hocking, DJ (corresponding author), Univ New Hampshire, Dept Nat Resources & Environm, Durham, NH 03824 USA.	dhocking@unh.edu	Hocking, Daniel J./O-3658-2018	Hocking, Daniel J./0000-0003-1889-9184	New Hampshire Agricultural Experiment Station; University of New Hampshire Graduate School	New Hampshire Agricultural Experiment Station; University of New Hampshire Graduate School	Partial funding was provided by the New Hampshire Agricultural Experiment Station. This is Scientific Contribution Number 2500. DJH received funding through the University of New Hampshire Graduate School. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2005, EC HUM WELL BEING SY; Auchmoody LR, 1994, PLANTING NO RED OAK, P5; Bailey LL, 2004, J HERPETOL, V38, P370, DOI 10.1670/194-03A; Bailey LL, 2004, J WILDLIFE MANAGE, V68, P14, DOI 10.2193/0022-541X(2004)068[0014:SATVID]2.0.CO;2; Bailey LL, 2004, J WILDLIFE MANAGE, V68, P1, DOI 10.2193/0022-541X(2004)068[0001:EDPPFP]2.0.CO;2; Beard KH, 2003, J TROP ECOL, V19, P607, DOI 10.1017/S0266467403006011; Beard KH, 2002, OECOLOGIA, V133, P583, DOI 10.1007/s00442-002-1071-9; BRAMAN RS, 1989, ANAL CHEM, V61, P2715, DOI 10.1021/ac00199a007; BURTON TM, 1975, ECOLOGY, V56, P1068, DOI 10.2307/1936147; BURTON TM, 1975, COPEIA, P541; Casper G.S., 2005, AMPHIBIAN DECLINES C, P796; Chalcraft DR, 2005, ECOLOGY, V86, P1061, DOI 10.1890/04-0725; Contosta AR, 2011, ECOSPHERE, V2, DOI 10.1890/ES10-00133.1; Daily GC., 1997, ISSUES ECOL, V2, P1; Davic RD, 2004, ANNU REV ECOL EVOL S, V35, P405, DOI 10.1146/annurev.ecolsys.35.112202.130116; Davis TM, 2001, J HERPETOL, V35, P217, DOI 10.2307/1566111; Fox J, 2002, COX PROPORTIONAL HAZ; Frank DA, 2008, OIKOS, V117, P1718, DOI 10.1111/j.1600-0706.2008.16846.x; Gillette Jennifer R., 2001, Herpetological Review, V32, P233; GOSZ JR, 1972, ECOLOGY, V53, P769, DOI 10.2307/1934293; Hairston N. G., 1987, COMMUNITY ECOLOGY SA; HAIRSTON NG, 1980, ECOLOGY, V61, P817, DOI 10.2307/1936752; HANLON RDG, 1981, OIKOS, V36, P362, DOI 10.2307/3544634; Harmon ME, 1999, LT EC RES NETWK SER, V2, P202; Hawlena D, 2012, SCIENCE, V336, P1434, DOI 10.1126/science.1220097; Heemeyer Jennifer L., 2007, Herpetological Review, V38, P425; Hickerson CAM, 2004, BEHAV ECOL, V15, P679, DOI 10.1093/beheco/arh064; Hickerson CAM, 2012, AM MIDL NAT, V168, P30, DOI 10.1674/0003-0031-168.1.30; Homyack JA, 2010, J HERPETOL, V44, P447, DOI 10.1670/09-107.1; Homyack JA, 2010, J THERM BIOL, V35, P143, DOI 10.1016/j.jtherbio.2010.01.006; Huang CY, 2007, J TROP ECOL, V23, P161, DOI 10.1017/S0266467406003932; Irmler U, 2000, PEDOBIOLOGIA, V44, P105, DOI 10.1078/S0031-4056(04)70032-3; Jung RE, 2000, ENVIRON MONIT ASSESS, V63, P65, DOI 10.1023/A:1006413603057; Lenoir L, 2007, BIOL FERT SOILS, V43, P281, DOI 10.1007/s00374-006-0103-8; Maerz JC, 2005, DIVERS DISTRIB, V11, P83, DOI 10.1111/j.1366-9516.2005.00125.x; Milton Y, 2007, OECOLOGIA, V153, P163, DOI 10.1007/s00442-007-0710-6; Mooney KA, 2010, P NATL ACAD SCI USA, V107, P7335, DOI 10.1073/pnas.1001934107; Morin Peter J., 1998, P50; Paul E.A., 2007, SOIL MICROBIOLOGY EC; Peterman William E., 2006, Herpetological Review, V37, P303; Petranka, 1998, SALAMANDERS US CANAD; Petranka JW, 2001, J HERPETOL, V35, P36, DOI 10.2307/1566020; Pollierer MM, 2007, ECOL LETT, V10, P729, DOI 10.1111/j.1461-0248.2007.01064.x; R Development Core Team, 2012, R LANG ENV STAT COMP; Ransom TS, 2012, ECOLOGY, V93, P2198, DOI 10.1890/11-2024.1; Ransom TS, 2011, OECOLOGIA, V165, P745, DOI 10.1007/s00442-010-1775-1; Robertson GP, 1999, LT EC RES NETWK SER, V2, P258; Rooney TP, 2000, P ENTOMOL SOC WASH, V102, P308; Schmitz OJ, 1997, ECOLOGY, V78, P1388, DOI 10.1890/0012-9658(1997)078[1388:BMTCEO]2.0.CO;2; Schmitz OJ, 2000, AM NAT, V155, P141, DOI 10.1086/303311; Schmitz OJ, 2004, ECOL LETT, V7, P153, DOI 10.1111/j.1461-0248.2003.00560.x; Schmitz OJ, 2002, ECOL LETT, V5, P168, DOI 10.1046/j.1461-0248.2002.00311.x; Schmitz OJ, 2008, SCIENCE, V319, P952, DOI 10.1126/science.1152355; SIMS GK, 1995, COMMUN SOIL SCI PLAN, V26, P303, DOI 10.1080/00103629509369298; Sin H, 2008, BIOL INVASIONS, V10, P335, DOI 10.1007/s10530-007-9133-x; Skelly DK, 2002, ECOLOGY, V83, P2097, DOI 10.1890/0012-9658(2002)083[2097:EVAEOI]2.0.CO;2; Southwood TRE, 2000, ECOLOGICAL METHODS; Walton BM, 2006, PEDOBIOLOGIA, V50, P313, DOI 10.1016/j.pedobi.2006.04.001; Walton BM, 2005, PEDOBIOLOGIA, V49, P381, DOI 10.1016/j.pedobi.2005.04.001; Walton BM, 2005, PEDOBIOLOGIA, V49, P51, DOI 10.1016/j.pedobi.2004.07.012; Wyman RL, 1998, BIODIVERS CONSERV, V7, P641, DOI 10.1023/A:1008856402258	61	19	21	1	78	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2014	9	1							e86854	10.1371/journal.pone.0086854	http://dx.doi.org/10.1371/journal.pone.0086854			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297VL	24466269	gold, Green Published			2022-12-25	WOS:000330283100225
J	Kolevzon, N; Nasereddin, A; Naik, S; Yavin, E; Dzikowski, R				Kolevzon, Netanel; Nasereddin, Abed; Naik, Shankar; Yavin, Eylon; Dzikowski, Ron			Use of Peptide Nucleic Acids to Manipulate Gene Expression in the Malaria Parasite Plasmodium falciparum	PLOS ONE			English	Article							MESSENGER-RNA; ANTISENSE OLIGODEOXYNUCLEOTIDES; NUTRIENT-UPTAKE; FIT-PROBES; INHIBITION; SEQUENCE; PHOSPHOROTHIOATES; OLIGONUCLEOTIDES; PROMOTERS; SURFACE	One of the major concerns in treating malaria by conventional small drug molecules is the rapid emergence of drug resistance. Specific silencing of essential genes by antisense oliogomers has been proposed as an alternative approach that may result in antimalarial activity which is not associated with drug resistance. In addition, such an approach could be an important biological tool for studying many genes' function by reverse genetics. Here we present a novel methodology of using peptide nucleic acids (PNAs) as a useful tool for gene silencing in Plasmodium falciparum. PNAs, designed as specific antisense molecules, were conjugated to a cell penetrating peptide (CPP); namely, octa-D-lysine via the C-terminus, to allow facile delivery through cell membranes. PNAs added to P. falciparum cultures were found exclusively in infected erythrocytes and were eventually localized in nuclei of the parasites at all stages of intra erythrocytic development. We show that these PNAs specifically down regulated both a stably expressed transgene as well as an endogenous essential gene, which significantly reduced parasites' viability. This study paves the way for a simple approach to silence a variety of P. falciparum genes as means of deciphering their function and potentially to develop highly specific and potent antimalarial agents.	[Nasereddin, Abed; Dzikowski, Ron] Hebrew Univ Jerusalem, Hadassah Med Sch, Dept Microbiol & Mol Genet, Inst Med Res Israel Canada,Kuvin Ctr Study Infect, Jerusalem, Israel; [Kolevzon, Netanel; Naik, Shankar; Yavin, Eylon] Hebrew Univ Jerusalem, Sch Pharm, Inst Drug Res, IL-91120 Jerusalem, Israel	Hebrew University of Jerusalem; Hebrew University of Jerusalem	Yavin, E (corresponding author), Hebrew Univ Jerusalem, Sch Pharm, Inst Drug Res, IL-91120 Jerusalem, Israel.	eylony@ekmd.huji.ac.il; rond@ekmd.huji.ac.il	Dzikowski, Ron/HHZ-2430-2022; Nasereddin, Abedelmajeed/N-4150-2017; Yavin, Eylon/U-2928-2017	Nasereddin, Abedelmajeed/0000-0001-8162-420X; Yavin, Eylon/0000-0002-3527-3215	Chief Scientist, Ministry of Industry and Commerce [49601]	Chief Scientist, Ministry of Industry and Commerce	This work was supported by the Chief Scientist, Ministry of Industry and Commerce (Kamin program # 49601). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALEY SB, 1984, J EXP MED, V160, P1585, DOI 10.1084/jem.160.5.1585; Armstrong CM, 2007, NAT METHODS, V4, P1007, DOI 10.1038/nmeth1132; Augagneur Y, 2012, P NATL ACAD SCI USA, V109, P6235, DOI 10.1073/pnas.1203516109; Barker RH, 1998, EXP PARASITOL, V88, P51, DOI 10.1006/expr.1998.4192; Barker RH, 1996, P NATL ACAD SCI USA, V93, P514, DOI 10.1073/pnas.93.1.514; Baum J, 2009, NUCLEIC ACIDS RES, V37, P3788, DOI 10.1093/nar/gkp239; Bruxel F, 2011, INT J PHARMACEUT, V416, P402, DOI 10.1016/j.ijpharm.2011.01.048; Calderwood MS, 2003, J BIOL CHEM, V278, P34125, DOI 10.1074/jbc.M213065200; CLARK DL, 1994, MOL BIOCHEM PARASIT, V63, P129, DOI 10.1016/0166-6851(94)90015-9; Dahan-Pasternak N, 2013, J CELL SCI; Desai SA, 2012, CELL MICROBIOL, V14, P1003, DOI 10.1111/j.1462-5822.2012.01790.x; Dzikowski R, 2006, PLOS PATHOG, V2, P184, DOI 10.1371/journal.ppat.0020022; Fogera F, 2006, INT J PHARMACEUT, V319, P139, DOI 10.1016/j.ijpharm.2006.03.034; Frank M, 2006, J BIOL CHEM, V281, P9942, DOI 10.1074/jbc.M513067200; Gardner MJ, 2002, NATURE, V419, P498, DOI 10.1038/nature01097; Giaever G, 2002, NATURE, V418, P387, DOI 10.1038/nature00935; Goldberg DE, 2012, CELL, V148, P1271, DOI 10.1016/j.cell.2012.02.021; Kam Y, 2012, MOL PHARMACEUT, V9, P685, DOI 10.1021/mp200505k; Kanagaratnam R, 1998, INT J BIOCHEM CELL B, V30, P979, DOI 10.1016/S1357-2725(98)00051-X; Knudsen H, 1996, NUCLEIC ACIDS RES, V24, P494, DOI 10.1093/nar/24.3.494; Kohler O, 2005, CHEMBIOCHEM, V6, P69, DOI 10.1002/cbic.200400260; Kummer S, 2012, BIOCONJUGATE CHEM, V23, P2051, DOI 10.1021/bc300249f; Kummer S, 2011, ANGEW CHEM INT EDIT, V50, P1931, DOI 10.1002/anie.201005902; Kyes S, 2000, MOL BIOCHEM PARASIT, V105, P311, DOI 10.1016/S0166-6851(99)00193-0; Lai BS, 2012, P NATL ACAD SCI USA, V109, P14182, DOI 10.1073/pnas.1208775109; Muralidharan V, 2011, P NATL ACAD SCI USA, V108, P4411, DOI 10.1073/pnas.1018449108; Nguitragool W, 2011, CELL, V145, P665, DOI 10.1016/j.cell.2011.05.002; NIELSEN PE, 1991, SCIENCE, V254, P1497, DOI 10.1126/science.1962210; Noonpakdee W, 2003, BIOCHEM BIOPH RES CO, V302, P659, DOI 10.1016/S0006-291X(03)00246-8; Opalinska JB, 2002, NAT REV DRUG DISCOV, V1, P503, DOI 10.1038/nrd837; Ramasamy R, 1996, BIOCHEM BIOPH RES CO, V218, P930, DOI 10.1006/bbrc.1996.0164; RAPAPORT E, 1992, P NATL ACAD SCI USA, V89, P8577, DOI 10.1073/pnas.89.18.8577; Salazar E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039769; Savas JN, 2012, SCIENCE, V335, P942, DOI 10.1126/science.1217421; Siniossoglou S, 1996, CELL, V84, P265, DOI 10.1016/S0092-8674(00)80981-2; Snow RW, 2005, NATURE, V434, P214, DOI 10.1038/nature03342; Wanidworanun C, 1999, MOL BIOCHEM PARASIT, V102, P91, DOI 10.1016/S0166-6851(99)00087-0	37	22	22	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2014	9	1							e86802	10.1371/journal.pone.0086802	http://dx.doi.org/10.1371/journal.pone.0086802			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297VL	24466246	Green Published, gold, Green Submitted			2022-12-25	WOS:000330283100217
J	Li, BQ; Zhang, YC; Huang, GH; Cui, WR; Zhang, N; Cai, YD				Li, Bi-Qing; Zhang, Yu-Chao; Huang, Guo-Hua; Cui, Wei-Ren; Zhang, Ning; Cai, Yu-Dong			Prediction of Aptamer-Target Interacting Pairs with Pseudo-Amino Acid Composition	PLOS ONE			English	Article							SUBCELLULAR-LOCALIZATION; CHEMICAL BIOLOGY; IN-VITRO; PROTEIN; SELECTION; RECOGNITION; SEQUENCES; ENZYME	Aptamers are oligonucleic acid or peptide molecules that bind to specific target molecules. As a novel and powerful class of ligands, aptamers are thought to have excellent potential for applications in the fields of biosensing, diagnostics and therapeutics. In this study, a new method for predicting aptamer-target interacting pairs was proposed by integrating features derived from both aptamers and their targets. Features of nucleotide composition and traditional amino acid composition as well as pseudo amino acid were utilized to represent aptamers and targets, respectively. The predictor was constructed based on Random Forest and the optimal features were selected by using the maximum relevance minimum redundancy (mRMR) method and the incremental feature selection (IFS) method. As a result, 81.34% accuracy and 0.4612 MCC were obtained for the training dataset, and 77.41% accuracy and 0.3717 MCC were achieved for the testing dataset. An optimal feature set of 220 features were selected, which were considered as the ones that contributed significantly to the interacting aptamer-target pair predictions. Analysis of the optimal feature set indicated several important factors in determining aptamer-target interactions. It is anticipated that our prediction method may become a useful tool for identifying aptamer-target pairs and the features selected and analyzed in this study may provide useful insights into the mechanism of interactions between aptamers and targets.	[Huang, Guo-Hua; Cai, Yu-Dong] Shanghai Univ, Inst Syst Biol, Shanghai, Peoples R China; [Li, Bi-Qing] Chinese Acad Sci, Key Lab Syst Biol, Shanghai Inst Biol Sci, Shanghai, Peoples R China; [Zhang, Yu-Chao] Chinese Acad Sci, State Key Lab Med Gen, Inst Hlth Sci, Shanghai Jiaotong Univ Sch Med, Shanghai, Peoples R China; [Zhang, Yu-Chao] Chinese Acad Sci, State Key Lab Med Gen, Inst Hlth Sci, Shanghai Jiaotong Univ,Shanghai Inst Biol Sci, Shanghai, Peoples R China; [Cui, Wei-Ren] CAS MPG, Partner Inst Computat Biol, Shanghai Inst Biol Sci, Shanghai, Peoples R China; [Zhang, Ning] Tianjin Univ, Dept Biomed Engn, Tianjin Key Lab BME Measurement, Tianjin 300072, Peoples R China	Shanghai University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; Shanghai Jiao Tong University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Shanghai Jiao Tong University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Max Planck Society; Tianjin University	Zhang, N (corresponding author), Tianjin Univ, Dept Biomed Engn, Tianjin Key Lab BME Measurement, Tianjin 300072, Peoples R China.	yichuha@163.com; cai_yud@yahoo.com.cn	Huang, Guohua/A-2215-2019	Huang, Guohua/0000-0001-6954-3933; cai, yudong/0000-0001-5664-7979; Zhang, Ning/0000-0002-1559-111X	National Basic Research Program of China [2011CB510102, 2011CB510101]; Innovation Program of Shanghai Municipal Education Commission [12ZZ087]; The First-class Discipline of Universities in Shanghai; National Natural Science Foundation of China [31371335]; National Science Foundation of China [81171342, 81201148]; Independent Innovation Foundation of Tianjin University [60302064, 60302069]; National Research Foundation for the Doctoral Program of Higher Education of China [20120032120073]	National Basic Research Program of China(National Basic Research Program of China); Innovation Program of Shanghai Municipal Education Commission(Innovation Program of Shanghai Municipal Education Commission); The First-class Discipline of Universities in Shanghai; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Independent Innovation Foundation of Tianjin University; National Research Foundation for the Doctoral Program of Higher Education of China(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP))	This work was supported by grants from National Basic Research Program of China (2011CB510102, 2011CB510101), Innovation Program of Shanghai Municipal Education Commission (12ZZ087), the grant of "The First-class Discipline of Universities in Shanghai'', National Natural Science Foundation of China (31371335), National Science Foundation of China (81171342, 81201148), Independent Innovation Foundation of Tianjin University (60302064, 60302069), and the National Research Foundation for the Doctoral Program of Higher Education of China (20120032120073). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angov E, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002189; Atchley WR, 2005, P NATL ACAD SCI USA, V102, P6395, DOI 10.1073/pnas.0408677102; Berezovski M, 2005, J AM CHEM SOC, V127, P3165, DOI 10.1021/ja042394q; Bouchard PR, 2010, ANNU REV PHARMACOL, V50, P237, DOI 10.1146/annurev.pharmtox.010909.105547; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Chen T, 2011, NANOSCALE, V3, P546, DOI 10.1039/c0nr00646g; Choi JS, 2011, J BIOMOL SCREEN, V16, P266, DOI 10.1177/1087057110391787; Chou KC, 2001, PROTEINS, V43, P246, DOI 10.1002/prot.1035; Chou KC, 2008, NAT PROTOC, V3, P153, DOI 10.1038/nprot.2007.494; Chou KC, 2007, ANAL BIOCHEM, V370, P1, DOI 10.1016/j.ab.2007.07.006; Cruz-Toledo J, 2012, DATABASE-OXFORD, DOI 10.1093/database/bas006; Ding YS, 2007, PROTEIN PEPTIDE LETT, V14, P811; Dumontier M, 2005, J MOL BIOL, V350, P1061, DOI 10.1016/j.jmb.2005.05.037; ELLINGTON AD, 1990, NATURE, V346, P818, DOI 10.1038/346818a0; Fang XH, 2010, ACCOUNTS CHEM RES, V43, P48, DOI 10.1021/ar900101s; Fitzkee NC, 2004, PROTEIN SCI, V13, P633, DOI 10.1110/ps.03503304; GAO YF, 2013, MOL BIOSYSTEMS; Garg Aarti, 2008, In Silico Biology, V8, P129; Hoglund A, 2006, BIOINFORMATICS, V22, P1158, DOI 10.1093/bioinformatics/btl002; Iliuk AB, 2011, ANAL CHEM, V83, P4440, DOI 10.1021/ac201057w; Jones S, 1996, P NATL ACAD SCI USA, V93, P13, DOI 10.1073/pnas.93.1.13; Keefe AD, 2010, NAT REV DRUG DISCOV, V9, P537, DOI 10.1038/nrd3141; Kohavi R., 1995, INT JOINT C ART INT, V14, P1137, DOI DOI 10.1067/MOD.2000.109031; KOSHLAND DE, 1958, P NATL ACAD SCI USA, V44, P98, DOI 10.1073/pnas.44.2.98; Krylova SM, 2011, ANAL BIOCHEM, V414, P261, DOI 10.1016/j.ab.2011.03.010; Lee S, 2006, PROTEINS, V62, P1107, DOI 10.1002/prot.20821; Li BQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063494; Li BQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045854; Li BQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043927; Li BQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039308; Li BQ, 2012, J PROTEOMICS, V75, P1654, DOI 10.1016/j.jprot.2011.12.003; Lou XH, 2009, P NATL ACAD SCI USA, V106, P2989, DOI 10.1073/pnas.0813135106; Marson G, 2012, CURR PHARM DESIGN, V18, P2027, DOI 10.2174/138161212799958323; Mayer G, 2009, ANGEW CHEM INT EDIT, V48, P2672, DOI 10.1002/anie.200804643; Mi J, 2010, NAT CHEM BIOL, V6, P22, DOI [10.1038/NCHEMBIO.277, 10.1038/nchembio.277]; Misono TS, 2005, ANAL BIOCHEM, V342, P312, DOI 10.1016/j.ab.2005.04.013; NAKASHIMA H, 1986, J BIOCHEM-TOKYO, V99, P153, DOI 10.1093/oxfordjournals.jbchem.a135454; Noskov SY, 2001, BIOPHYS J, V81, P737, DOI 10.1016/S0006-3495(01)75738-4; Peng HC, 2005, IEEE T PATTERN ANAL, V27, P1226, DOI 10.1109/TPAMI.2005.159; Ramachandran S, 2011, PROTEINS, V79, P261, DOI 10.1002/prot.22879; ROBERTSON DL, 1990, NATURE, V344, P467, DOI 10.1038/344467a0; Roy S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007813; Rubinstein ND, 2009, MOL IMMUNOL, V46, P840, DOI 10.1016/j.molimm.2008.09.009; Russo Krauss I, 2011, NUCLEIC ACIDS RES, V39, P7858, DOI 10.1093/nar/gkr522; Tamura T, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-466; Thiel KW, 2009, OLIGONUCLEOTIDES, V19, P209, DOI 10.1089/oli.2009.0199; Tok J, 2010, ELECTROPHORESIS, V31, P2055, DOI 10.1002/elps.200900543; TUERK C, 1990, SCIENCE, V249, P505, DOI 10.1126/science.2200121; Wang MJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043847; Weinhold F, 2001, NATURE, V411, P539, DOI 10.1038/35079225; WITTEN IH, 2005, DATA MINING PRACTICA; Zhang N, 2012, MOL BIOSYSTEMS; Zhou Y, 2012, MOL BIOSYST, V8, P1396, DOI 10.1039/c2mb05427b; Zichel R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031948	54	41	43	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2014	9	1							e86729	10.1371/journal.pone.0086729	http://dx.doi.org/10.1371/journal.pone.0086729			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297VL	24466214	Green Published, Green Submitted, gold			2022-12-25	WOS:000330283100202
J	Mughini-Gras, L; Bonfanti, L; Mulatti, P; Monne, I; Guberti, V; Cordioli, P; Marangon, S				Mughini-Gras, Lapo; Bonfanti, Lebana; Mulatti, Paolo; Monne, Isabella; Guberti, Vittorio; Cordioli, Paolo; Marangon, Stefano			Environmental Correlates of H5N2 Low Pathogenicity Avian Influenza Outbreak Heterogeneity in Domestic Poultry in Italy	PLOS ONE			English	Article							INFECTIOUS-DISEASES; RISK-FACTORS; VIRUS; EPIDEMIOLOGY; JAPAN; EMERGENCE; DRIVERS; VIETNAM; ECOLOGY; SPREAD	Italy has experienced recurrent incursions of H5N2 avian influenza (AI) viruses in different geographical areas and varying sectors of the domestic poultry industry. Considering outbreak heterogeneity rather than treating all outbreaks of low pathogenicity AI (LPAI) viruses equally is important given their interactions with the environment and potential to spread, evolve and increase pathogenicity. This study aims at identifying potential environmental drivers of H5N2 LPAI outbreak occurrence in time, space and poultry populations. Thirty-four environmental variables were tested for association with the characteristics of 27 H5N2 LPAI outbreaks (i.e. time, place, flock type, number and species of birds affected) occurred among domestic poultry flocks in Italy in 2010-2012. This was done by applying a recently proposed analytical approach based on a combined non-metric multidimensional scaling, clustering and regression analysis. Results indicated that the pattern of (dis) similarities among the outbreaks entailed an underlying structure that may be the outcome of large-scale, environmental interactions in ecological dimension. Increased densities of poultry breeders, and increased land coverage by industrial, commercial and transport units were associated with increased heterogeneity in outbreak characteristics. In areas with high breeder densities and with many infrastructures, outbreaks affected mainly industrial turkey/layer flocks. Outbreaks affecting ornamental, commercial and rural multi-species flocks occurred mainly in lowly infrastructured areas of northern Italy. Outbreaks affecting rural layer flocks occurred mainly in areas with low breeder densities in south-central Italy. In savannah-like environments, outbreaks affected mainly commercial flocks of galliformes. Suggestive evidence that ecological ordination makes sense genetically was also provided, as virus strains showing high genetic similarity clustered into ecologically similar outbreaks. Findings were informed by hypotheses about how ecological interactions among poultry populations, viruses and their environments can be related to the observed patterns of H5N2 LPAI occurrence. This may prove useful in enhancing future interventions by developing site-specific, ecologically-grounded strategies.	[Mughini-Gras, Lapo; Bonfanti, Lebana; Mulatti, Paolo; Monne, Isabella; Marangon, Stefano] IZSVe, Padua, Italy; [Guberti, Vittorio] Inst Environm Protect & Res ISPRA, Bologna, Italy; [Cordioli, Paolo] IZLER, Brescia, Italy	IZS delle Venezie; Italian Institute for Environmental Protection & Research (ISPRA)	Mughini-Gras, L (corresponding author), Natl Inst Publ Hlth & Environm RIVM, Ctr Infect Dis Control CIb, Epidemiol & Surveillance Unit, Bilthoven, Netherlands.	lapo.mughini.gras@rivm.nl	Monne, Isabella/K-7652-2016; Mulatti, Paolo/AFS-0719-2022; Mulatti, Paolo/V-7274-2019	Monne, Isabella/0000-0002-6564-4689; Mulatti, Paolo/0000-0001-8188-997X; Marangon, Stefano/0000-0002-3158-4243				Alexander DJ, 2003, AVIAN DIS, V47, P976, DOI 10.1637/0005-2086-47.s3.976; Boender GJ, 2007, PREV VET MED, V82, P90, DOI 10.1016/j.prevetmed.2007.05.016; Brown JD, 2007, AVIAN DIS, V51, P285, DOI 10.1637/7636-042806R.1; Busani L, 2009, VET J, V181, P171, DOI 10.1016/j.tvjl.2008.02.013; Busani L, 2009, VACCINE, V27, P3655, DOI 10.1016/j.vaccine.2009.03.033; Capua I, 2000, AVIAN PATHOL, V29, P289, DOI 10.1080/03079450050118403; Capua I, 1999, AVIAN PATHOL, V28, P455, DOI 10.1080/03079459994470; Capua I, 2007, VACCINE, V25, P5645, DOI 10.1016/j.vaccine.2006.10.053; Carrel MA, 2012, HEALTH PLACE, V18, P1122, DOI 10.1016/j.healthplace.2012.04.009; Cattoli G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004842; Cecchinato M, 2011, AVIAN DIS, V55, P13, DOI 10.1637/9500-081310-Reg.1; Cecchinato M, 2010, AVIAN DIS, V54, P323, DOI 10.1637/8765-033109-Reg.1; Cox T. F., 2000, MULTIDIMENSIONAL SCA; Gilbert M, 2012, SPAT SPATIO-TEMPORAL, V3, P173, DOI 10.1016/j.sste.2012.01.002; GOWER JC, 1971, BIOMETRICS, V27, P857, DOI 10.2307/2528823; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; HORIMOTO T, 1995, VIROLOGY, V213, P223, DOI 10.1006/viro.1995.1562; Horimoto T, 2001, CLIN MICROBIOL REV, V14, P129, DOI 10.1128/CMR.14.1.129-149.2001; KAWAOKA Y, 1984, VIROLOGY, V139, P303, DOI 10.1016/0042-6822(84)90376-3; Marangon S, 2003, AVIAN DIS, V47, P1006, DOI 10.1637/0005-2086-47.s3.1006; Martin V, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001308; Mayer JD, 2000, SOC SCI MED, V50, P937, DOI 10.1016/S0277-9536(99)00346-9; Mulatti P, 2010, EPIDEMIOL INFECT, V138, P813, DOI 10.1017/S0950268809991038; Nishiguchi A, 2007, ZOONOSES PUBLIC HLTH, V54, P337, DOI 10.1111/j.1863-2378.2007.01074.x; Nishiguchi A, 2009, J VET MED SCI, V71, P979, DOI 10.1292/jvms.71.979; Ogata T, 2008, J EPIDEMIOL, V18, P160, DOI 10.2188/jea.JE2007446; Pfeiffer DU, 2007, VET J, V174, P302, DOI 10.1016/j.tvjl.2007.05.010; Plowright RK, 2008, FRONT ECOL ENVIRON, V6, P420, DOI 10.1890/070086; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Rambaut A, 2007, SEQUENCE ALIGNMENT E; Sartore S, 2010, POULTRY SCI, V89, P1115, DOI 10.3382/ps.2009-00556; WARD JH, 1963, J AM STAT ASSOC, V58, P236, DOI 10.2307/2282967; Wilgenbusch JC, 2003, CURR PROTOC BIOINFOR; Yamazaki Y, 2009, ARCH VIROL, V154, P421, DOI 10.1007/s00705-009-0319-7	34	4	4	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2014	9	1							e86788	10.1371/journal.pone.0086788	http://dx.doi.org/10.1371/journal.pone.0086788			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297VL	24466241	Green Published, Green Submitted, gold			2022-12-25	WOS:000330283100214
J	Soler, J; Cebolla, A; Feliu-Soler, A; Demarzo, MMP; Pascual, JC; Banos, R; Garcia-Campayo, J				Soler, Joaquim; Cebolla, Ausias; Feliu-Soler, Albert; Demarzo, Marcelo M. P.; Pascual, Juan C.; Banos, Rosa; Garcia-Campayo, Javier			Relationship between Meditative Practice and Self-Reported Mindfulness: The MINDSENS Composite Index	PLOS ONE			English	Article							ATTENTION AWARENESS SCALE; PSYCHOMETRIC PROPERTIES; 5 FACETS; COGNITIVE THERAPY; STRESS REDUCTION; QUESTIONNAIRE; VALIDATION; DEPRESSION; INTERNET	Mindfulness has been described as an inherent human capability that can be learned and trained, and its improvement has been associated with better health outcomes in both medicine and psychology. Although the role of practice is central to most mindfulness programs, practice-related improvements in mindfulness skills is not consistently reported and little is known about how the characteristics of meditative practice affect different components of mindfulness. The present study explores the role of practice parameters on self-reported mindfulness skills. A total of 670 voluntary participants with and without previous meditation experience (n = 384 and n = 286, respectively) responded to an internet-based survey on various aspects of their meditative practice (type of meditation, length of session, frequency, and lifetime practice). Participants also completed the Five Facets Mindfulness Questionnaire (FFMQ), and the Experiences Questionnaire (EQ). The group with meditation experience obtained significantly higher scores on all facets of FFMQ and EQ questionnaires compared to the group without experience. However different effect sizes were observed, with stronger effects for the Observing and Non-Reactivity facets of the FFMQ, moderate effects for Decentering in EQ, and a weak effect for Non-judging, Describing, and Acting with awareness on the FFMQ. Our results indicate that not all practice variables are equally relevant in terms of developing mindfulness skills. Frequency and lifetime practice - but not session length or meditation type - were associated with higher mindfulness skills. Given that these 6 mindfulness aspects show variable sensitivity to practice, we created a composite index (MINDSENS) consisting of those items from FFMQ and EQ that showed the strongest response to practice. The MINDSENS index was able to correctly discriminate daily meditators from non-meditators in 82.3% of cases. These findings may contribute to the understanding of the development of mindfulness skills and support trainers and researchers in improving mindfulness-oriented practices and programs.	[Soler, Joaquim; Feliu-Soler, Albert; Pascual, Juan C.] Hosp Santa Creu St Pau, Dept Psychiat, Barcelona, Spain; [Soler, Joaquim; Feliu-Soler, Albert; Pascual, Juan C.] Univ Autonoma Barcelona, CIBERSAM, IIB ST PAU, E-08193 Barcelona, Spain; [Cebolla, Ausias; Banos, Rosa] Ciber Fisiopatol Obesidad Nutr CIBERO, Santiago De Compostela, Spain; [Cebolla, Ausias] Univ Jaume 1, Dept Psicol Basica Clin Psicobiol, Castellon de La Plana, Spain; [Demarzo, Marcelo M. P.] Univ Fed Sao Paulo, Dept Prevent Med, Mente Aberta Brazilian Ctr Mindfulness & Hlth Pro, Sao Paulo, Brazil; [Banos, Rosa] Univ Valencia, Dept Personalitat Avaluacio Tractaments Psicol, Valencia, Spain; [Garcia-Campayo, Javier] Miguel Servet Hosp, Dept Psychiat, Zaragoza, Spain; [Garcia-Campayo, Javier] Univ Zaragoza, Inst Aragones Ciencias Salud, REDIAPP, Zaragoza, Spain	Hospital of Santa Creu i Sant Pau; Autonomous University of Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBERSAM; University of Barcelona; Universitat Jaume I; Universidade Federal de Sao Paulo (UNIFESP); University of Valencia; Miguel Servet University Hospital; University of Zaragoza	Soler, J (corresponding author), Hosp Santa Creu St Pau, Dept Psychiat, Barcelona, Spain.	jsolerri@santpau.cat	Feliu-Soler, Albert/X-4367-2018; Marti, Ausias Cebolla/E-8410-2012; Demarzo, Marcelo/A-7021-2010; Pascual, Juan/M-2559-2014; Feliu-Soler, Albert/AFL-7616-2022; BAÑOS, ROSA MARIA/C-6077-2011; Feliu-Soler, Albert/AAG-7555-2022	Feliu-Soler, Albert/0000-0003-2810-7670; Marti, Ausias Cebolla/0000-0002-3456-9743; Demarzo, Marcelo/0000-0002-7447-1839; Pascual, Juan/0000-0001-8039-9346; Feliu-Soler, Albert/0000-0003-2810-7670; BAÑOS, ROSA MARIA/0000-0003-0626-7665; Feliu-Soler, Albert/0000-0003-2810-7670; Garcia-Campayo, Javier/0000-0002-3797-4218; Soler, Joaquim/0000-0001-8077-3641				Baer R.A., 2009, CLIN HDB MINDFULNESS, P153, DOI DOI 10.1007/978-0-387-09593-6_10; Baer RA, 2006, ASSESSMENT, V13, P27, DOI 10.1177/1073191105283504; Baer RA, 2004, ASSESSMENT, V11, P191, DOI 10.1177/1073191104268029; Baer RA, 2003, CLIN PSYCHOL-SCI PR, V10, P125, DOI 10.1093/clipsy/bpg015; Baer RA, 2008, ASSESSMENT, V15, P329, DOI 10.1177/1073191107313003; Bergomi C, 2013, MINDFULNESS, V4, P18, DOI 10.1007/s12671-012-0102-9; Bishop SR, 2004, CLIN PSYCHOL-SCI PR, V11, P230, DOI 10.1093/clipsy/bph077; Bodhi B., 1984, NOBLE EIGHTFOLD PATH; Brown KW, 2011, PSYCHOL ASSESSMENT, V23, P1023, DOI 10.1037/a0021338; Brown KW, 2003, J PERS SOC PSYCHOL, V84, P822, DOI 10.1037/0022-3514.84.4.822; Cardaciotto L, 2008, ASSESSMENT, V15, P204, DOI 10.1177/1073191107311467; Carmody J, 2008, J BEHAV MED, V31, P23, DOI 10.1007/s10865-007-9130-7; Cebolla A, 2012, EUR J PSYCHIAT, V26, P118, DOI 10.4321/S0213-61632012000200005; Chiesa A, 2011, PSYCHIAT RES, V187, P441, DOI 10.1016/j.psychres.2010.08.011; Creswell JD, 2007, PSYCHOSOM MED, V69, P560, DOI 10.1097/PSY.0b013e3180f6171f; de Bruin EI, 2012, ASSESSMENT, V19, P187, DOI 10.1177/1073191112446654; Dimidjian S, 2003, CLIN PSYCHOL-SCI PR, V10, P166, DOI 10.1093/clipsy/bpg019; Dobkin Patricia L, 2011, Complement Ther Clin Pract, V17, P22, DOI 10.1016/j.ctcp.2010.03.002; Feliu-Soler A, 2013, CLIN PSYCHOL PSYCHOT; Fennell MJV, 2004, BEHAV RES THER, V42, P1053, DOI 10.1016/j.brat.2004.03.002; Fjorback LO, 2011, ACTA PSYCHIAT SCAND, V124, P102, DOI 10.1111/j.1600-0447.2011.01704.x; Fresco DM, 2007, BEHAV THER, V38, P234, DOI 10.1016/j.beth.2006.08.003; Germer C., 2009, MINDFUL PATH SELF CO; Grossman P, 2011, PSYCHOL ASSESSMENT, V23, P1034, DOI 10.1037/a0022713; Hayes SC, 1999, ACCEPTANCE COMMITMEN; Hofmann SG, 2010, J CONSULT CLIN PSYCH, V78, P169, DOI 10.1037/a0018555; Kabat-Zinn J., 1990, FULL CATASTROPHE LIV; Khoury B, 2013, CLIN PSYCHOL REV, V33, P763, DOI 10.1016/j.cpr.2013.05.005; Kongsved SM, 2007, J MED INTERNET RES, V9, DOI 10.2196/jmir.9.3.e25; Leigh J, 2005, ADDICT BEHAV, V30, P1335, DOI 10.1016/j.addbeh.2005.01.010; Lilja JL, 2013, MINDFULNESS, V4, P203, DOI 10.1007/s12671-012-0111-8; Lilja Josefine L., 2011, Cognitive Behaviour Therapy, V40, P291, DOI 10.1080/16506073.2011.580367; Linehan M., 2014, DBT SKILLS TRAINING; Linehan M. M, 1993, COGNITIVE BEHAV THER; MacKillop J, 2007, J PSYCHOPATHOL BEHAV, V29, P289, DOI 10.1007/s10862-007-9045-1; Mitchell JC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070253; Ritter P, 2004, J MED INTERNET RES, V6, P19, DOI 10.2196/jmir.6.3.e29; Sauer S, 2013, MINDFULNESS, V4, P3, DOI 10.1007/s12671-012-0122-5; Segal Z.V., 2002, MINDFULNESS BASED CO; Soler J, 2012, BEHAV RES THER, V50, P150, DOI 10.1016/j.brat.2011.12.002; Teasdale JD, 2002, J CONSULT CLIN PSYCH, V70, P275, DOI 10.1037//0022-006X.70.2.275; TEASDALE JDS, 1995, BEHAV RES THER, V33, P1995; Vettese LC, 2009, J COGN PSYCHOTHER, V23, P198, DOI 10.1891/0889-8391.23.3.198	43	76	77	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2014	9	1							e86622	10.1371/journal.pone.0086622	http://dx.doi.org/10.1371/journal.pone.0086622			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	297VL	24466175	Green Published, gold, Green Submitted			2022-12-25	WOS:000330283100191
J	Fievet, A; Cascales, E; Valette, O; Dolla, A; Aubert, C				Fievet, Anouchka; Cascales, Eric; Valette, Odile; Dolla, Alain; Aubert, Corinne			IHF Is Required for the Transcriptional Regulation of the Desulfovibrio vulgaris Hildenborough orp Operons	PLOS ONE			English	Article							INTEGRATION HOST FACTOR; ESCHERICHIA-COLI; PSEUDOMONAS-PUTIDA; RNA-POLYMERASE; HIMD SUBUNITS; PU PROMOTER; DNA; PROTEIN; COMPLEX; HU	Transcriptional activation of sigma(54)-dependent promoters is usually tightly regulated in response to environmental cues. The high abundance of potential sigma(54)-dependent promoters in the anaerobe bacteria, Desulfovibrio vulgaris Hildenborough, reflects the high versatility of this bacteria suggesting that sigma(54) factor is the nexus of a large regulatory network. Understanding the key players of sigma(54)-regulation in this organism is therefore essential to gain insights into the adaptation to anaerobiosis. Recently, the D. vulgaris orp genes, specifically found in anaerobe bacteria, have been shown to be transcribed by the RNA polymerase coupled to the sigma(54) alternative sigma factor. In this study, using in vitro binding experiments and in vivo reporter fusion assays in the Escherichia coli heterologous host, we showed that the expression of the divergent orp promoters is strongly dependent on the integration host factor IHF. Bioinformatic and mutational analysis coupled to reporter fusion activities and mobility shift assays identified two functional IHF binding site sequences located between the orp1 and orp2 promoters. We further determined that the D. vulgaris DVU0396 (IHF alpha) and DVU1864 (IHF beta) subunits are required to control the expression of the orp operons suggesting that they form a functionally active IHF heterodimer. Interestingly results obtained from the in vivo inactivation of DVU0396, which is required for orp operons transcription, suggest that several functionally IHF active homodimer or heterodimer are present in D. vulgaris.	[Fievet, Anouchka; Valette, Odile; Dolla, Alain; Aubert, Corinne] CNRS, Inst Microbiol Mediterranee, Lab Chim Bacterienne, Marseille, France; [Cascales, Eric] CNRS, Inst Microbiol Mediterranee, Lab Ingn Syst Macromol, Marseille, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite	Aubert, C (corresponding author), CNRS, Inst Microbiol Mediterranee, Lab Chim Bacterienne, Marseille, France.	aubert@imm.cnrs.fr	AUBERT, Corinne/ABF-2576-2020; CASCALES, ERIC/G-7420-2011	CASCALES, ERIC/0000-0003-0611-9179	Agence nationale de la recherche ANR [ANR-12-ISV8-0003-01]	Agence nationale de la recherche ANR(French National Research Agency (ANR))	The Agence nationale de la recherche ANR (ANR-12-ISV8-0003-01) funds this research project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arfin SM, 2000, J BIOL CHEM, V275, P29672, DOI 10.1074/jbc.M002247200; AVIV M, 1994, MOL MICROBIOL, V14, P1021, DOI 10.1111/j.1365-2958.1994.tb01336.x; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Bernard CS, 2011, J BACTERIOL, V193, P2158, DOI 10.1128/JB.00029-11; Bertoni G, 1998, EMBO J, V17, P5120, DOI 10.1093/emboj/17.17.5120; Busby S, 1997, MOL MICROBIOL, V23, P853, DOI 10.1046/j.1365-2958.1997.2771641.x; Calb R, 1996, J BACTERIOL, V178, P6319, DOI 10.1128/jb.178.21.6319-6326.1996; Cheema AK, 1999, J BACTERIOL, V181, P5296, DOI 10.1128/JB.181.17.5296-5302.1999; Chhabra SR, 2011, APPL ENVIRON MICROB, V77, P7595, DOI 10.1128/AEM.05495-11; Chhabra SR, 2006, J BACTERIOL, V188, P1817, DOI 10.1128/JB.188.5.1817-1828.2006; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; DELORENZO V, 1991, EMBO J, V10, P1159, DOI 10.1002/j.1460-2075.1991.tb08056.x; Dolla A, 2000, ARCH MICROBIOL, V174, P143, DOI 10.1007/s002030000183; Dorman CJ, 2009, ADV APPL MICROBIOL, V67, P47, DOI 10.1016/S0065-2164(08)01002-2; Fievet A, 2011, J BACTERIOL, V193, P3207, DOI 10.1128/JB.00044-11; Fournier M, 2004, J BIOL CHEM, V279, P1787, DOI 10.1074/jbc.M307965200; HALES LM, 1994, J BACTERIOL, V176, P2999, DOI 10.1128/JB.176.10.2999-3006.1994; Hansen TA, 1994, ANTON LEEUW INT J G, V66, P168; Heidelberg JF, 2004, NAT BIOTECHNOL, V22, P554, DOI 10.1038/nbt959; Hemme CL, 2004, OMICS, V8, P43, DOI 10.1089/153623104773547480; Hiszczynska-Sawicka E, 1998, PLASMID, V40, P150, DOI 10.1006/plas.1998.1361; Holcroft CC, 2000, J BACTERIOL, V182, P6774, DOI 10.1128/JB.182.23.6774-6782.2000; Lacal J, 2006, P NATL ACAD SCI USA, V103, P8191, DOI 10.1073/pnas.0602902103; LEE EC, 1992, EMBO J, V11, P305, DOI 10.1002/j.1460-2075.1992.tb05053.x; Martinez-Antonio A, 2003, CURR OPIN MICROBIOL, V6, P482, DOI 10.1016/j.mib.2003.09.002; Miller JH., 1975, EXPT MOL GENETICS; Murtin C, 1998, J MOL BIOL, V284, P949, DOI 10.1006/jmbi.1998.2256; Muyzer G, 2008, NAT REV MICROBIOL, V6, P441, DOI 10.1038/nrmicro1892; NASH HA, 1981, J BIOL CHEM, V256, P9246; PerezMartin J, 1997, J BACTERIOL, V179, P2757, DOI 10.1128/jb.179.8.2757-2760.1997; POPHAM DL, 1989, SCIENCE, V243, P629, DOI 10.1126/science.2563595; Postgate J R, 1966, Lab Pract, V15, P1239; Rice PA, 1996, CELL, V87, P1295, DOI 10.1016/S0092-8674(00)81824-3; SASSEDWIGHT S, 1990, CELL, V62, P945, DOI 10.1016/0092-8674(90)90269-K; SCHMID MB, 1990, CELL, V63, P451, DOI 10.1016/0092-8674(90)90438-K; Shingler V, 2011, FEMS MICROBIOL REV, V35, P425, DOI 10.1111/j.1574-6976.2010.00255.x; Sidorova NY, 2010, ELECTROPHORESIS, V31, P648, DOI 10.1002/elps.200900573; Studholme DJ, 2003, J BACTERIOL, V185, P1757, DOI 10.1128/JB.185.6.1757-1767.2003; Swinger KK, 2004, CURR OPIN STRUC BIOL, V14, P28, DOI 10.1016/j.sbi.2003.12.003; WEDEL A, 1995, GENE DEV, V9, P2042, DOI 10.1101/gad.9.16.2042; WERNER MH, 1994, CURR BIOL, V4, P477, DOI 10.1016/S0960-9822(00)00108-1; ZABLEWSKA B, 1995, GENE, V160, P131, DOI 10.1016/0378-1119(95)00252-2; Zhou JZ, 2011, NAT REV MICROBIOL, V9, P452, DOI 10.1038/nrmicro2575; ZULIANELLO L, 1994, EMBO J, V13, P1534, DOI 10.1002/j.1460-2075.1994.tb06415.x	44	8	8	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2014	9	1							e86507	10.1371/journal.pone.0086507	http://dx.doi.org/10.1371/journal.pone.0086507			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297GT	24466126	Green Published, Green Submitted, gold			2022-12-25	WOS:000330244500250
J	Shokhirev, MN; Johnson, AA				Shokhirev, Maxim Nikolaievich; Johnson, Adiv Adam			Effects of Extrinsic Mortality on the Evolution of Aging: A Stochastic Modeling Approach	PLOS ONE			English	Article							NAKED MOLE-RAT; LIFE-SPAN; NEGLIGIBLE SENESCENCE; NATURAL-POPULATIONS; REPRODUCTION; LONGEVITY; GROWTH; AGE	The evolutionary theories of aging are useful for gaining insights into the complex mechanisms underlying senescence. Classical theories argue that high levels of extrinsic mortality should select for the evolution of shorter lifespans and earlier peak fertility. Non-classical theories, in contrast, posit that an increase in extrinsic mortality could select for the evolution of longer lifespans. Although numerous studies support the classical paradigm, recent data challenge classical predictions, finding that high extrinsic mortality can select for the evolution of longer lifespans. To further elucidate the role of extrinsic mortality in the evolution of aging, we implemented a stochastic, agent-based, computational model. We used a simulated annealing optimization approach to predict which model parameters predispose populations to evolve longer or shorter lifespans in response to increased levels of predation. We report that longer lifespans evolved in the presence of rising predation if the cost of mating is relatively high and if energy is available in excess. Conversely, we found that dramatically shorter lifespans evolved when mating costs were relatively low and food was relatively scarce. We also analyzed the effects of increased predation on various parameters related to density dependence and energy allocation. Longer and shorter lifespans were accompanied by increased and decreased investments of energy into somatic maintenance, respectively. Similarly, earlier and later maturation ages were accompanied by increased and decreased energetic investments into early fecundity, respectively. Higher predation significantly decreased the total population size, enlarged the shared resource pool, and redistributed energy reserves for mature individuals. These results both corroborate and refine classical predictions, demonstrating a population-level trade-off between longevity and fecundity and identifying conditions that produce both classical and non-classical lifespan effects.	[Shokhirev, Maxim Nikolaievich] Univ Calif San Diego, Program Bioinformat & Syst Biol, La Jolla, CA 92093 USA; [Johnson, Adiv Adam] Univ Arizona, Physiol Sci Grad Interdisciplinary Program, Tucson, AZ 85721 USA	University of California System; University of California San Diego; University of Arizona	Johnson, AA (corresponding author), Univ Arizona, Physiol Sci Grad Interdisciplinary Program, Tucson, AZ 85721 USA.	adivj@email.arizona.edu						ABRAMS PA, 1993, EVOLUTION, V47, P877, DOI 10.1111/j.1558-5646.1993.tb01241.x; Austad SN, 2010, J COMP PATHOL, V141, pS10, DOI 10.1016/j.jcpa.2009.10.024; Austad SN, 1997, EXP GERONTOL, V32, P23, DOI 10.1016/S0531-5565(96)00059-9; AUSTAD SN, 1993, J ZOOL, V229, P695, DOI 10.1111/j.1469-7998.1993.tb02665.x; Baudisch A, 2012, SCIENCE, V338, P618, DOI 10.1126/science.1226467; Bronikowski AM, 2005, TRENDS ECOL EVOL, V20, P271, DOI 10.1016/j.tree.2005.03.011; Bryant MJ, 2004, AM NAT, V163, P55, DOI 10.1086/380650; Buffenstein R, 2008, J COMP PHYSIOL B, V178, P439, DOI 10.1007/s00360-007-0237-5; Caswell H, 2007, TRENDS ECOL EVOL, V22, P173, DOI 10.1016/j.tree.2007.01.006; Chen HY, 2012, CURR BIOL, V22, P2140, DOI 10.1016/j.cub.2012.09.021; Cichon M, 1997, P ROY SOC B-BIOL SCI, V264, P1383, DOI 10.1098/rspb.1997.0192; Clarke FM, 1997, P ROY SOC B-BIOL SCI, V264, P993, DOI 10.1098/rspb.1997.0137; Congdon JD, 2001, EXP GERONTOL, V36, P813, DOI 10.1016/S0531-5565(00)00242-4; de Magalhaes JP, 2013, NAT REV CANCER, V13, P357, DOI 10.1038/nrc3497; Dowling DK, 2012, CURR BIOL, V22, pR947, DOI 10.1016/j.cub.2012.09.029; Drenos F, 2005, MECH AGEING DEV, V126, P99, DOI 10.1016/j.mad.2004.09.026; Dudycha JL, 2013, J PLANKTON RES, V35, P253, DOI 10.1093/plankt/fbt008; Dudycha JL, 1999, EVOLUTION, V53, P1744, DOI 10.1111/j.1558-5646.1999.tb04559.x; Finch CE, 2011, BIOESSAYS, V33, P27, DOI 10.1002/bies.201000111; Finch CE, 2009, GERONTOLOGY, V55, P307, DOI 10.1159/000215589; Goldsmith TC, 2008, J THEOR BIOL, V252, P764, DOI 10.1016/j.jtbi.2008.02.035; Henry EC, 2007, J EXP BIOL, V210, P261, DOI 10.1242/jeb.02631; Johnson AA, 2012, REJUV RES, V15, P483, DOI 10.1089/rej.2012.1324; KIRKPATRICK S, 1983, SCIENCE, V220, P671, DOI 10.1126/science.220.4598.671; KIRKWOOD TBL, 1979, PROC R SOC SER B-BIO, V205, P531, DOI 10.1098/rspb.1979.0083; Kirkwood TBL, 2005, CELL, V120, P437, DOI 10.1016/j.cell.2005.01.027; Kirkwood TBL, 2002, MECH AGEING DEV, V123, P737, DOI 10.1016/S0047-6374(01)00419-5; KIRKWOOD TBL, 1977, NATURE, V270, P301, DOI 10.1038/270301a0; Kirkwood TBL, 2011, CURR BIOL, V21, pR701, DOI 10.1016/j.cub.2011.07.020; Kramer BH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061813; Le Cunff Y, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002825; Ljubuncic P, 2009, GERONTOLOGY, V55, P205, DOI 10.1159/000200772; Lopez-Otin C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039; Medawar P., 1952, UNSOLVED PROBLEM BIO; Mitteldorf J, 2006, REJUV RES, V9, P346, DOI 10.1089/rej.2006.9.346; Mitteldorf J, 2007, THEOR BIOSCI, V126, P3, DOI 10.1007/s12064-007-0001-0; Moorad JA, 2010, CURR BIOL, V20, pR406, DOI 10.1016/j.cub.2010.03.016; Nussey DH, 2013, AGEING RES REV, V12, P214, DOI 10.1016/j.arr.2012.07.004; Ovaskainen O, 2010, TRENDS ECOL EVOL, V25, P643, DOI 10.1016/j.tree.2010.07.009; Reznick DN, 2004, NATURE, V431, P1095, DOI 10.1038/nature02936; Robert KA, 2010, AM NAT, V175, P147, DOI 10.1086/649595; Roellig K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017744; Shanley DP, 2000, EVOLUTION, V54, P740, DOI 10.1111/j.0014-3820.2000.tb00076.x; Shattuck MR, 2010, P NATL ACAD SCI USA, V107, P4635, DOI 10.1073/pnas.0911439107; Stearns SC, 2000, P NATL ACAD SCI USA, V97, P3309, DOI 10.1073/pnas.060289597; Tozzini ET, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-77; WILLIAMS GC, 1957, EVOLUTION, V11, P398, DOI 10.1111/j.1558-5646.1957.tb02911.x; Williams PD, 2003, EVOLUTION, V57, P1478	48	20	20	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2014	9	1							e86602	10.1371/journal.pone.0086602	http://dx.doi.org/10.1371/journal.pone.0086602			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297GT	24466165	Green Published, gold, Green Submitted			2022-12-25	WOS:000330244500263
J	Zhang, C; Lin, JZ; Liu, WX; Chen, XN; Chen, RC; Ye, KQ				Zhang, Cheng; Lin, Jinzhong; Liu, Weixiao; Chen, Xining; Chen, Rongchang; Ye, Keqiong			Structure of Utp21 Tandem WD Domain Provides Insight into the Organization of the UTPB Complex Involved in Ribosome Synthesis	PLOS ONE			English	Article							RNA; PROCESSOME; PROTEIN; IDENTIFICATION	Assembly of the eukaryotic ribosome requires a large number of trans-acting proteins and small nucleolar RNAs that transiently associate with the precursor rRNA to facilitate its modification, processing and binding with ribosomal proteins. UTPB is a large evolutionarily conserved complex in the 90S small subunit processome that mediates early processing of 18S rRNA. UTPB consists of six proteins Utp1/Pwp1, Utp6, Utp12/Dip2, Utp13, Utp18 and Utp21 and has abundant WD domains. Here, we determined the crystal structure of the tandem WD domain of yeast Utp21 at 2.1 A resolution, revealing two open-clamshell- shaped beta-propellers. The bottom faces of both WD domains harbor several conserved patches that potentially function as molecular binding sites. We show that residues 100-190 of Utp18 bind to the tandem WD domain of Utp21. Structural mapping of previous crosslinking data shows that the WD domains of Utp18 and Utp1 are organized on two opposite sides of the Utp21 WD domains. This study reports the first structure of a UTPB component and provides insight into the structural organization of the UTPB complex.	[Zhang, Cheng] Fudan Univ, Sch Life Sci, Inst Dev Biol & Mol Med, Shanghai 200433, Peoples R China; [Zhang, Cheng; Lin, Jinzhong; Liu, Weixiao; Chen, Xining; Chen, Rongchang; Ye, Keqiong] Natl Inst Biol Sci, Beijing, Peoples R China	Fudan University; National Institute of Biological Sciences, Beijing	Ye, KQ (corresponding author), Natl Inst Biol Sci, Beijing, Peoples R China.	yekeqiong@nibs.ac.cn	Lin, Jinzhong/I-9131-2016; Zhang, Cheng/P-6145-2019	Lin, Jinzhong/0000-0001-5666-8526	National Basic Research Program of China (973 Program) [2010CB835402]; Beijing Municipal Government	National Basic Research Program of China (973 Program)(National Basic Research Program of China); Beijing Municipal Government	This research was supported by the National Basic Research Program of China (973 Program, 2010CB835402) and the Beijing Municipal Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Bartelt-Kirbach B, 2009, NEUROGENETICS, V10, P79, DOI 10.1007/s10048-008-0154-0; Champion EA, 2008, MOL CELL BIOL, V28, P6547, DOI 10.1128/MCB.00906-08; Charette JM, 2010, RNA, V16, P2156, DOI 10.1261/rna.2359810; Dragon F, 2002, NATURE, V417, P967, DOI 10.1038/nature00769; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Grandi P, 2002, MOL CELL, V10, P105, DOI 10.1016/S1097-2765(02)00579-8; Henras AK, 2008, CELL MOL LIFE SCI, V65, P2334, DOI 10.1007/s00018-008-8027-0; Krogan NJ, 2004, MOL CELL, V13, P225, DOI 10.1016/S1097-2765(04)00003-6; Li T, 2006, CELL, V124, P105, DOI 10.1016/j.cell.2005.10.033; Lin JZ, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001669; Lu J, 2013, RNA, V19, P1815, DOI 10.1261/rna.040808.113; Monemi S, 2005, HUM MOL GENET, V14, P725, DOI 10.1093/hmg/ddi068; Murshudov GN, 1999, ACTA CRYSTALLOGR D, V55, P247, DOI 10.1107/S090744499801405X; Osheim YN, 2004, MOL CELL, V16, P943, DOI 10.1016/j.molcel.2004.11.031; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Perez-Fernandez J, 2007, MOL CELL BIOL, V27, P5414, DOI 10.1128/MCB.00380-07; Perez-Fernandez J, 2011, NUCLEIC ACIDS RES, V39, P8105, DOI 10.1093/nar/gkr508; Phipps KR, 2011, WIRES RNA, V2, P1, DOI 10.1002/wrna.57; Reubold TF, 2011, STRUCTURE, V19, P1074, DOI 10.1016/j.str.2011.05.013; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; Stirnimann CU, 2010, TRENDS BIOCHEM SCI, V35, P565, DOI 10.1016/j.tibs.2010.04.003; Tafforeau L, 2013, MOL CELL, V51, P539, DOI 10.1016/j.molcel.2013.08.011; Tarassov K, 2008, SCIENCE, V320, P1465, DOI 10.1126/science.1153878; VANDUYNE GD, 1993, J MOL BIOL, V229, P105, DOI 10.1006/jmbi.1993.1012; Voegtli WC, 2003, J BIOL CHEM, V278, P34373, DOI 10.1074/jbc.M302773200; Vonrhein Clemens, 2007, Methods Mol Biol, V364, P215, DOI 10.1385/1-59745-266-1:215; Watkins NJ, 2000, CELL, V103, P457, DOI 10.1016/S0092-8674(00)00137-9; Wild T, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000522; Yang B, 2012, NAT METHODS, V9, P904, DOI 10.1038/nmeth.2099	30	16	18	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2014	9	1							e86540	10.1371/journal.pone.0086540	http://dx.doi.org/10.1371/journal.pone.0086540			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297GT	24466140	gold, Green Published, Green Submitted			2022-12-25	WOS:000330244500255
J	Bekhuis, T; Tseytlin, E; Mitchell, KJ; Demner-Fushman, D				Bekhuis, Tanja; Tseytlin, Eugene; Mitchell, Kevin J.; Demner-Fushman, Dina			Feature Engineering and a Proposed Decision-Support System for Systematic Reviewers of Medical Evidence	PLOS ONE			English	Review							ALGORITHM; WORKLOAD; ROBUST	Objectives: Evidence-based medicine depends on the timely synthesis of research findings. An important source of synthesized evidence resides in systematic reviews. However, a bottleneck in review production involves dual screening of citations with titles and abstracts to find eligible studies. For this research, we tested the effect of various kinds of textual information (features) on performance of a machine learning classifier. Based on our findings, we propose an automated system to reduce screeing burden, as well as offer quality assurance. Methods: We built a database of citations from 5 systematic reviews that varied with respect to domain, topic, and sponsor. Consensus judgments regarding eligibility were inferred from published reports. We extracted 5 feature sets from citations: alphabetic, alphanumeric(+), indexing, features mapped to concepts in systematic reviews, and topic models. To simulate a two-person team, we divided the data into random halves. We optimized the parameters of a Bayesian classifier, then trained and tested models on alternate data halves. Overall, we conducted 50 independent tests. Results: All tests of summary performance (mean F3) surpassed the corresponding baseline, P<0.0001. The ranks for mean F3, precision, and classification error were statistically different across feature sets averaged over reviews; P-values for Friedman's test were.045,.002, and.002, respectively. Differences in ranks for mean recall were not statistically significant. Alphanumeric(+) features were associated with best performance; mean reduction in screening burden for this feature type ranged from 88% to 98% for the second pass through citations and from 38% to 48% overall. Conclusions: A computer-assisted, decision support system based on our methods could substantially reduce the burden of screening citations for systematic review teams and solo reviewers. Additionally, such a system could deliver quality assurance both by confirming concordant decisions and by naming studies associated with discordant decisions for further consideration.	[Bekhuis, Tanja; Tseytlin, Eugene; Mitchell, Kevin J.] Univ Pittsburgh, Sch Med, Dept Biomed Informat, Pittsburgh, PA 15260 USA; [Demner-Fushman, Dina] US Natl Inst Hlth, Lister Hill Natl Ctr Biomed Commun, Natl Lib Med, Bethesda, MD USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; National Institutes of Health (NIH) - USA; NIH National Library of Medicine (NLM)	Bekhuis, T (corresponding author), Univ Pittsburgh, Sch Med, Dept Biomed Informat, Pittsburgh, PA 15260 USA.	tcb24@pitt.edu	Bekhuis, Tanja/D-4357-2015	Bekhuis, Tanja/0000-0002-8537-9077	US National Library of Medicine, National Institutes of Health [4R00LM010943]; NATIONAL LIBRARY OF MEDICINE [R00LM010943, ZIHLM200888] Funding Source: NIH RePORTER	US National Library of Medicine, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	This research was suppported by the US National Library of Medicine, National Institutes of Health, grant number 4R00LM010943. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abba K, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008122.pub2; [Anonymous], IBM SPSS STAT COMP P; Bastian H, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000326; Bekhuis T, 2013, EDDA STUDY DESIGN TE; Bekhuis T, 2013, 21 COCHR C QUEB CAN; Bekhuis T, 2009, COCHRANE DB SYST REV, DOI 101002/14651858CD003975pub2; Bekhuis T, 2013, J MED LIBR ASSOC, V101, P92, DOI 10.3163/1536-5050.101.2.004; Bekhuis T, 2012, ARTIF INTELL MED, V55, P197, DOI 10.1016/j.artmed.2012.05.002; Bekhuis T, 2010, STUD HEALTH TECHNOL, V160, P146, DOI 10.3233/978-1-60750-588-4-146; Blei DM, 2003, J MACH LEARN RES, V3, P993, DOI 10.1162/jmlr.2003.3.4-5.993; Boudin F, 2010, BMC MED INFORM DECIS, V10, DOI 10.1186/1472-6947-10-29; Chandler J, 2012, METHODOLOGICAL STAND; Cohen AM, 2009, J AM MED INFORM ASSN, V16, P690, DOI 10.1197/jamia.M3162; Cohen Aaron M, 2010, P 1 ACM INT HLTH INF, P376, DOI [10.1145/1882992.1883046, DOI 10.1145/1882992.1883046]; Cohen AM, 2006, J AM MED INFORM ASSN, V13, P206, DOI 10.1197/jamia.M1929; Cohen AM, 2008, AMIA ANN S P; Dalal SR, 2013, MED DECIS MAKING, V33, P343, DOI 10.1177/0272989X12457243; Del Fiol G, 2008, J BIOMED INFORM, V41, P655, DOI 10.1016/j.jbi.2007.11.007; EMBASE, BIOM ANSW; Frunza O, 2011, ARTIF INTELL MED, V51, P17, DOI 10.1016/j.artmed.2010.10.005; Griffiths TL, 2004, P NATL ACAD SCI USA, V101, P5228, DOI 10.1073/pnas.0307752101; Higgins JPT., 2008, COCHRANE HDB SYSTEMA, V1 edn; Hofmann T, 2001, MACH LEARN, V42, P177, DOI 10.1023/A:1007617005950; Huang Xiaoli, 2006, AMIA Annu Symp Proc, P359; Institute of Medicine of the National Academies, 2011, FIND WHAT WORKS HLTH; Jefferson T, 2010, COCHRANE DB SYST REV, DOI 101002/14651858CD004876pub3; Jimeno-Yepes Antonio, 2011, AMIA Annu Symp Proc, V2011, P1583; Keerthi SS, 2005, MACH LEARN, V61, P151, DOI 10.1007/s10994-005-0768-5; Kilicoglu H, 2009, J AM MED INFORM ASSN, V16, P25, DOI 10.1197/jamia.M2996; Klinkenberg R., 2000, ICML, P487; Leeflang MM, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007394; Luce BR, 2010, MILBANK Q, V88, P256, DOI 10.1111/j.1468-0009.2010.00598.x; Manning C.D., 2008, INTRO INFORM RETRIEV; Matwin S, 2010, J AM MED INFORM ASSN, V17, P446, DOI 10.1136/jamia.2010.004325; McCallum A. K., MALLET MACHINE LEARN; McKibbon KA, 2012, J AM MED INFORM ASSN, V19, P22, DOI 10.1136/amiajnl-2011-000304; Mierswa I, 2006, P ACM SIGKDD INT C K; National Institutes of Health, 2012, NLM ADM INF SERV N S; Oremus M, 2008, AHRQ PUBLICATION; Patient Centered Outcomes Research Institute, 2012, PCORI METH STAND, P1; PORTER MF, 1980, PROGRAM-AUTOM LIBR, V14, P130, DOI 10.1108/eb046814; Reeves S, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002213.pub2; Rennie J.D.M., 2003, P 20 INT C MACH LEAR, P616; Steyvers M, 2007, HDB LATENT SEMANTIC; US National Library of Medicine, MESH; US National Library of Medicine, 2009, UMLS REF MAN; Wallace BC, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-55; Wilczynski Nancy L, 2005, BMC Med Inform Decis Mak, V5, P20, DOI 10.1186/1472-6947-5-20; Wilczynski NL, 2013, J AM MED INFORM ASSN, V20, P363, DOI 10.1136/amiajnl-2012-001075; Wilczynski Nancy L, 2011, AMIA Annu Symp Proc, V2011, P1506; Yaffe J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036626; Zeng Qing T, 2012, AMIA Annu Symp Proc, V2012, P1050; Zou Qinghua, 2003, AMIA Annu Symp Proc, P763	53	21	21	3	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2014	9	1							e86277	10.1371/journal.pone.0086277	http://dx.doi.org/10.1371/journal.pone.0086277			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	301BI	24475099	Green Published, gold			2022-12-25	WOS:000330507300049
J	Burney, PR; White, N; Pfaendtner, J				Burney, Patrick R.; White, Nathan; Pfaendtner, Jim			Structural Effects of Methionine Oxidation on Isolated Subdomains of Human Fibrin D and alpha C Regions	PLOS ONE			English	Article							ACUTE TRAUMATIC COAGULOPATHY; FREE-ENERGY LANDSCAPE; MOLECULAR-DYNAMICS; PLASMA-FIBRINOGEN; METHYLENE-BLUE; FORCE-FIELD; SIMULATION; CHAIN; METADYNAMICS; ASSOCIATION	Oxidation of key methionine residues on fibrin leads to altered fibrin polymerization producing severely altered fibrin gel structure and function. This is important because fibrinogen and its modification by oxidative stress have been implicated as key contributors to both pathological thrombotic and hemorrhagic diseases ranging from cardiovascular thrombosis to the acute coagulopathy of trauma. However, how oxidation leads to altered fibrin polymerization remains poorly understood at the molecular level. We have applied a powerful and novel well-tempered ensemble parallel tempering (PT-WTE) technique along with conventional molecular dynamics (MD) simulation to investigate the molecular-level consequences of selective methionine oxidation of fibrinogen. We offer new insights into molecular mechanisms of oxidation-induced changes in fibrin polymerization, while focusing on the D region knob 'B' and hole 'b' interaction and alpha C-domain interactions, both of which are hypothesized to contribute to the lateral aggregation mechanism of fibrin fibrils. Methionine oxidation did not alter the native state or the stability of a bound knob 'B' surrogate when interacting with hole 'b' in the D region. However, applying PT-WTE simulation to a human homology model of the bovine N-terminal subdomain fragment from the alpha C-domain revealed that methionine oxidation altered the conformation of the hairpin-linking region to favor open rather than closed hairpin structures. We attribute this alteration to the disruption of the hairpin-linking region's conformation, with oxidation increasing the radius of gyration for this segment. This result is in agreement with experimental data demonstrating decreased fibrin protofibril lateral aggregation when methionine oxidation is present in the same alpha C-domain fragment. Therefore, single methionine oxidation within the alpha C-domain is a likely molecular mechanism.	[Burney, Patrick R.; Pfaendtner, Jim] Univ Washington, Dept Chem Engn, Seattle, WA 98195 USA; [White, Nathan] Univ Washington, Puget Sound Blood Ctr Res Inst, Seattle, WA 98195 USA; [White, Nathan] Univ Washington, Div Emergency Med, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; Puget Sound Blood Center; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Pfaendtner, J (corresponding author), Univ Washington, Dept Chem Engn, Seattle, WA 98195 USA.	jpfaendt@u.washington.edu			National Science Foundation through TeraGrid resources provided by NICS; HYAK super computer at the University of Washington; National Institutes of Health NCCR-NCATS [KL2 TR000421]; Washington Life Sciences Discovery Fund; University of Washington Coulter Translational Research Award; University of Washington Institute for Translational Health Sciences; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [KL2TR000421] Funding Source: NIH RePORTER	National Science Foundation through TeraGrid resources provided by NICS; HYAK super computer at the University of Washington; National Institutes of Health NCCR-NCATS; Washington Life Sciences Discovery Fund; University of Washington Coulter Translational Research Award; University of Washington Institute for Translational Health Sciences; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	The simulations performed for this research were supported in part by the National Science Foundation through TeraGrid resources provided by NICS and the HYAK super computer at the University of Washington. NJW is supported by National Institutes of Health NCCR-NCATS KL2 TR000421, Washington Life Sciences Discovery Fund, University of Washington Coulter Translational Research Award, University of Washington Institute for Translational Health Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barducci A, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.020603; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Bonomi M, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.190601; Bonomi M, 2009, COMPUT PHYS COMMUN, V180, P1961, DOI 10.1016/j.cpc.2009.05.011; Brohi K, 2003, J TRAUMA, V54, P1127, DOI 10.1097/01.TA.0000069184.82147.06; Brohi K, 2007, CURR OPIN CRIT CARE, V13, P680, DOI 10.1097/MCC.0b013e3282f1e78f; Burton RA, 2007, BIOCHEMISTRY-US, V46, P8550, DOI 10.1021/bi700606v; Bussi G, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2408420; Bussi G, 2006, J AM CHEM SOC, V128, P13435, DOI 10.1021/ja062463w; CARR ME, 1995, BLOOD COAGUL FIBRIN, V6, P79, DOI 10.1097/00001721-199502000-00013; CARR ME, 1989, THROMB HAEMOSTASIS, V61, P230; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; Collet JP, 2005, BLOOD, V106, P3824, DOI 10.1182/blood-2005-05-2150; Deighan M, 2013, LANGMUIR, V29, P7999, DOI 10.1021/la4010664; Deighan M, 2012, J CHEM THEORY COMPUT, V8, P2189, DOI 10.1021/ct300297t; Descamps-Latscha A, 2005, AM J KIDNEY DIS, V45, P39, DOI 10.1053/j.ajkd.2004.09.011; Devore T.L., 2000, PROBABILITY STAT; Doolittle RF, 2007, BIOCHEMISTRY-US, V46, P10033, DOI 10.1021/bi7010916; Frey RS, 2009, ANTIOXID REDOX SIGN, V11, P791, DOI [10.1089/ars.2008.2220, 10.1089/ARS.2008.2220]; Frith D, 2010, J THROMB HAEMOST, V8, P1919, DOI 10.1111/j.1538-7836.2010.03945.x; GLASER CB, 1992, J CLIN INVEST, V90, P2565, DOI 10.1172/JCI116151; Heffron SP, 2009, FREE RADICAL BIO MED, V47, P1140, DOI 10.1016/j.freeradbiomed.2009.07.025; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; JARVIS RA, 1973, IEEE T COMPUT, VC-22, P1025, DOI 10.1109/T-C.1973.223640; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Jorneskog G, 1996, DIABETOLOGIA, V39, P1519, DOI 10.1007/s001250050607; Kashuk JL, 2010, ANN SURG, V252, P434, DOI 10.1097/SLA.0b013e3181f09191; Kirschner KN, 2008, J COMPUT CHEM, V29, P622, DOI 10.1002/jcc.20820; Kollman JM, 2009, BIOCHEMISTRY-US, V48, P3877, DOI 10.1021/bi802205g; Laio A, 2002, P NATL ACAD SCI USA, V99, P12562, DOI 10.1073/pnas.202427399; Le DSNT, 2008, DIABETES RES CLIN PR, V82, P317, DOI 10.1016/j.diabres.2008.08.019; Lindorff-Larsen K, 2010, PROTEINS, V78, P1950, DOI 10.1002/prot.22711; Litvinov RI, 2007, BLOOD, V109, P130, DOI 10.1182/blood-2006-07-033910; Ma J, 1999, J AM COLL CARDIOL, V33, P1347, DOI 10.1016/S0735-1097(99)00007-8; MacLeod JBA, 2003, J TRAUMA, V55, P39, DOI 10.1097/01.TA.0000075338.21177.EF; Medved L, 2009, J THROMB HAEMOST, V7, P355, DOI 10.1111/j.1538-7836.2008.03242.x; METROPOLIS N, 1953, J CHEM PHYS, V21, P1087, DOI 10.1063/1.1699114; Mitra B, 2012, INJURY, V43, P22, DOI 10.1016/j.injury.2010.10.015; MOSESSON MW, 1987, BLOOD, V69, P1073; Nalian A, 2008, THROMB HAEMOSTASIS, V100, P18, DOI 10.1160/TH07-12-0750; Nowak P, 2007, THROMB RES, V121, P163, DOI 10.1016/j.thromres.2007.03.017; Parastatidis I, 2008, J BIOL CHEM, V283, P33846, DOI 10.1074/jbc.M805522200; Ping LF, 2011, BIOCHEMISTRY-US, V50, P9066, DOI 10.1021/bi201094v; Prakash MK, 2011, J CHEM THEORY COMPUT, V7, P2025, DOI 10.1021/ct200208h; Rosen H, 2009, P NATL ACAD SCI USA, V106, P18686, DOI 10.1073/pnas.0909464106; Rourke C, 2012, J THROMB HAEMOST, V10, P1342, DOI 10.1111/j.1538-7836.2012.04752.x; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Selmeci L, 2006, FREE RADICAL RES, V40, P952, DOI 10.1080/10715760600818789; SHACTER E, 1994, FREE RADICAL BIO MED, V17, P429, DOI 10.1016/0891-5849(94)90169-4; Shaw DE, 2007, CONF PROC INT SYMP C, P1, DOI 10.1145/1273440.1250664; Simons KT, 1999, PROTEINS, P171; Suontaka AM, 2003, TRANSFUSION, V43, P568, DOI 10.1046/j.1537-2995.2003.00377.x; Sutto L, 2013, P NATL ACAD SCI USA, V110, P10616, DOI 10.1073/pnas.1221953110; Trzesniak D, 2007, CHEMPHYSCHEM, V8, P162, DOI 10.1002/cphc.200600527; Tsurupa G, 2012, BIOCHEMISTRY-US, V51, P2526, DOI 10.1021/bi2017848; Tsurupa G, 2011, BIOCHEMISTRY-US, V50, P8028, DOI 10.1021/bi2008189; Tsurupa G, 2009, BIOCHEMISTRY-US, V48, P12191, DOI 10.1021/bi901640e; Turrens JF, 2003, J PHYSIOL-LONDON, V552, P335, DOI 10.1113/jphysiol.2003.049478; Vadseth C, 2004, J BIOL CHEM, V279, P8820, DOI 10.1074/jbc.M306101200; WATT KWK, 1979, BIOCHEMISTRY-US, V18, P5410, DOI 10.1021/bi00591a024; Weigandt KM, 2012, BIOPHYS J, V103, P2399, DOI 10.1016/j.bpj.2012.10.036; Weisel JW, 2013, BLOOD, V121, P1712, DOI 10.1182/blood-2012-09-306639	64	25	29	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2014	9	1							e86981	10.1371/journal.pone.0086981	http://dx.doi.org/10.1371/journal.pone.0086981			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301BI	24475207	Green Published, gold, Green Submitted			2022-12-25	WOS:000330507300123
J	Duan, LJ; Takeda, K; Fong, GH				Duan, Li-Juan; Takeda, Kotaro; Fong, Guo-Hua			Hypoxia Inducible Factor-2 alpha Regulates the Development of Retinal Astrocytic Network by Maintaining Adequate Supply of Astrocyte Progenitors	PLOS ONE			English	Article							HYDROXYLASE DOMAIN PROTEIN-2; PRECURSOR CELLS APCS; OPTIC-NERVE; VASCULAR DEVELOPMENT; ENDOTHELIAL-CELLS; VEGF EXPRESSION; BONE-MARROW; MICE; ANGIOGENESIS; HIF-1-ALPHA	Here we investigate the role of hypoxia inducible factor (HIF)-2 alpha in coordinating the development of retinal astrocytic and vascular networks. Three Cre mouse lines were used to disrupt floxed Hif-2 alpha, including Rosa26(CreERT2), Tie2(Cre), and GFAP(Cre). Global Hif-2 alpha disruption by Rosa26(CreERT2) led to reduced astrocytic and vascular development in neonatal retinas, whereas endothelial disruption by Tie2(Cre) had no apparent effects. Hif-2 alpha deletion in astrocyte progenitors by GFAP(Cre) significantly interfered with the development of astrocytic networks, which failed to reach the retinal periphery and were incapable of supporting vascular development. Perplexingly, the abundance of strongly GFAP(+) mature astrocytes transiently increased at P0 before they began to lag behind the normal controls by P3. Pax2(+) and PDGFR alpha(+) astrocytic progenitors and immature astrocytes were dramatically diminished at all stages examined. Despite decreased number of astrocyte progenitors, their proliferation index or apoptosis was not altered. The above data can be reconciled by proposing that HIF-2 alpha is required for maintaining the supply of astrocyte progenitors by slowing down their differentiation into non-proliferative mature astrocytes. HIF-2 alpha deficiency in astrocyte progenitors may accelerate their differentiation into astrocytes, a change which greatly interferes with the replenishment of astrocyte progenitors due to insufficient time for proliferation. Rapidly declining progenitor supply may lead to premature cessation of astrocyte development. Given that HIF-2 alpha protein undergoes oxygen dependent degradation, an interesting possibility is that retinal blood vessels may regulate astrocyte differentiation through their oxygen delivery function. While our findings support the consensus that retinal astrocytic template guides vascular development, they also raise the possibility that astrocytic and vascular networks may mutually regulate each other's development, mediated at least in part by HIF-2 alpha.	[Duan, Li-Juan; Takeda, Kotaro; Fong, Guo-Hua] Univ Connecticut, Ctr Hlth, Ctr Vasc Biol, Dept Cell Biol, Farmington, CT USA	University of Connecticut	Fong, GH (corresponding author), Univ Connecticut, Ctr Hlth, Ctr Vasc Biol, Dept Cell Biol, Farmington, CT USA.	fong@nso2.uchc.edu			NIH [5R01EY019721]; NATIONAL EYE INSTITUTE [R01EY019721] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	The work was supported by NIH grant 5R01EY019721. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bajenaru ML, 2002, MOL CELL BIOL, V22, P5100, DOI 10.1128/MCB.22.14.5100-5113.2002; Caprara C, 2011, INVEST OPHTH VIS SCI, V52, P2109, DOI 10.1167/iovs.10-6222; Carmeliet P, 1998, NATURE, V394, P485, DOI 10.1038/28867; Carmeliet P, 1996, NATURE, V380, P435, DOI 10.1038/380435a0; Chan-Ling T, 2009, GLIA, V57, P39, DOI 10.1002/glia.20733; Chu Y, 2001, FASEB J, V15, P2013, DOI 10.1096/fj.00-0868fje; Criscimanna A, 2013, CANC RES; Dioum EM, 2008, INVEST OPHTH VIS SCI, V49, P2714, DOI 10.1167/iovs.07-1469; Dorrell MI, 2002, INVEST OPHTH VIS SCI, V43, P3500; Duan LJ, 2011, AM J PATHOL, V178, P1881, DOI 10.1016/j.ajpath.2010.12.016; Duan LJ, 2005, CIRCULATION, V111, P2227, DOI 10.1161/01.CIR.0000163580.98098.A3; Epstein ACR, 2001, CELL, V107, P43, DOI 10.1016/S0092-8674(01)00507-4; Ferrara N, 1996, NATURE, V380, P439, DOI 10.1038/380439a0; Fruttiger M, 1996, NEURON, V17, P1117, DOI 10.1016/S0896-6273(00)80244-5; Gerhardt H, 2003, J CELL BIOL, V161, P1163, DOI 10.1083/jcb.200302047; Gregorian C, 2009, J NEUROSCI, V29, P1874, DOI 10.1523/JNEUROSCI.3095-08.2009; Ho VC, 2012, CIRCULATION, V126, P741, DOI 10.1161/CIRCULATIONAHA.112.091603; Kapitsinou PP, 2010, BLOOD, V116, P3039, DOI 10.1182/blood-2010-02-270322; Koni PA, 2001, J EXP MED, V193, P741, DOI 10.1084/jem.193.6.741; Kubota Y, 2008, J CLIN INVEST, V118, P2393, DOI 10.1172/JCI34882; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; Mi HY, 1999, J NEUROSCI, V19, P1049; Mi HY, 2001, J NEUROSCI, V21, P1538, DOI 10.1523/JNEUROSCI.21-05-01538.2001; Miyawaki T, 2004, J NEUROSCI, V24, P8124, DOI 10.1523/JNEUROSCI.2235-04.2004; Morita M, 2003, EMBO J, V22, P1134, DOI 10.1093/emboj/cdg117; Mowat FM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011103; MUDHAR HS, 1993, DEVELOPMENT, V118, P539; Nakamura-Ishizu A, 2012, DEV BIOL, V363, P106, DOI 10.1016/j.ydbio.2011.12.027; Ozaki H, 1999, INVEST OPHTH VIS SCI, V40, P182; Pawlinski R, 2010, BLOOD, V116, P806, DOI 10.1182/blood-2009-12-259267; Peng J, 2000, P NATL ACAD SCI USA, V97, P8386, DOI 10.1073/pnas.140087397; Petros TJ, 2006, MOL CELL NEUROSCI, V32, P49, DOI 10.1016/j.mcn.2006.02.002; Rankin EB, 2005, MOL CELL BIOL, V25, P3163, DOI 10.1128/MCB.25.8.3163-3172.2005; Rey S, 2009, P NATL ACAD SCI USA, V106, P20399, DOI 10.1073/pnas.0911921106; Ryan HE, 1998, EMBO J, V17, P3005, DOI 10.1093/emboj/17.11.3005; Scortegagna M, 2003, NAT GENET, V35, P331, DOI 10.1038/ng1266; Scott A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011863; Seibler J, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng012; Skuli N, 2012, J CLIN INVEST, V122, P1427, DOI 10.1172/JCI57322; Stenzel D, 2011, DEVELOPMENT, V138, P4451, DOI 10.1242/dev.071381; STONE J, 1987, J COMP NEUROL, V255, P35, DOI 10.1002/cne.902550104; Takeda K, 2008, BLOOD, V111, P3229, DOI 10.1182/blood-2007-09-114561; Takeda K, 2007, CIRCULATION, V116, P774, DOI 10.1161/CIRCULATIONAHA.107.701516; Takeda K, 2006, MOL CELL BIOL, V26, P8336, DOI 10.1128/MCB.00425-06; Tang N, 2004, CANCER CELL, V6, P485, DOI 10.1016/j.ccr.2004.09.026; Uemura A, 2006, J CLIN INVEST, V116, P369, DOI 10.1172/JCI25964; WATANABE T, 1988, NATURE, V332, P834, DOI 10.1038/332834a0; Weidemann A, 2010, GLIA, V58, P1177, DOI 10.1002/glia.20997; West H, 2005, DEVELOPMENT, V132, P1855, DOI 10.1242/dev.01732; Zhuo L, 2001, GENESIS, V31, P85, DOI 10.1002/gene.10008	50	21	22	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2014	9	1							e84736	10.1371/journal.pone.0084736	http://dx.doi.org/10.1371/journal.pone.0084736			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301BI	24475033	Green Published, Green Submitted, gold			2022-12-25	WOS:000330507300014
J	Kovacs, K; Banoczi, G; Varga, A; Szabo, I; Holczinger, A; Hornyanszky, G; Zagyva, I; Paizs, C; Vertessy, BG; Poppe, L				Kovacs, Klaudia; Banoczi, Gergely; Varga, Andrea; Szabo, Izabella; Holczinger, Andras; Hornyanszky, Gabor; Zagyva, Imre; Paizs, Csaba; Vertessy, Beata G.; Poppe, Laszlo			Expression and Properties of the Highly Alkalophilic Phenylalanine Ammonia-Lyase of Thermophilic Rubrobacter xylanophilus	PLOS ONE			English	Article							4-METHYLIDENEIMIDAZOLE-5-ONE-CONTAINING TYROSINE AMINOMUTASE; ACTIVE-SITE; BIOCHEMICAL-CHARACTERIZATION; SECONDARY STRUCTURE; CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; AMINO-ACIDS; ENZYME; HISTIDINE; MECHANISM	The sequence of a phenylalanine ammonia-lyase (PAL; EC: 4.3.1.24) of the thermophilic and radiotolerant bacterium Rubrobacter xylanophilus (RxPAL) was identified by screening the genomes of bacteria for members of the phenylalanine ammonia-lyase family. A synthetic gene encoding the RxPAL protein was cloned and overexpressed in Escherichia coli TOP 10 in a soluble form with an N-terminal His(6)-tag and the recombinant RxPAL protein was purified by Ni-NTA affinity chromatography. The activity assay of RxPAL with L-phenylalanine at various pH values exhibited a local maximum at pH 8.5 and a global maximum at pH 11.5. Circular dichroism (CD) studies showed that RxPAL is associated with an extensive alpha-helical character (far UV CD) and two distinctive near-UV CD peaks. These structural characteristics were well preserved up to pH 11.0. The extremely high pH optimum of RxPAL can be rationalized by a three-dimensional homology model indicating possible disulfide bridges, extensive salt-bridge formation and an excess of negative electrostatic potential on the surface. Due to these properties, RxPAL may be a candidate as biocatalyst in synthetic biotransformations leading to unnatural L-or D-amino acids or as therapeutic enzyme in treatment of phenylketonuria or leukemia.	[Kovacs, Klaudia; Banoczi, Gergely; Hornyanszky, Gabor; Poppe, Laszlo] Budapest Univ Technol & Econ, Dept Organ Chem & Technol, Budapest, Hungary; [Kovacs, Klaudia; Zagyva, Imre; Vertessy, Beata G.] Hungarian Acad Sci, Res Ctr Nat Sci, Inst Enzymol, Budapest, Hungary; [Varga, Andrea; Szabo, Izabella; Paizs, Csaba] Univ Babes Bolyai, Biocatalysis Res Grp, R-3400 Cluj Napoca, Romania; [Holczinger, Andras] Budapest Univ Technol & Econ, Dept Appl Biotechnol & Food Sci, Budapest, Hungary	Budapest University of Technology & Economics; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Research Centre for Natural Sciences; Babes Bolyai University from Cluj; Budapest University of Technology & Economics	Poppe, L (corresponding author), Budapest Univ Technol & Econ, Dept Organ Chem & Technol, Budapest, Hungary.	poppe@mail.bme.hu	Paizs, Csaba/C-2111-2011; Poppe, László/B-8398-2008; Vertessy, Beata G/H-6202-2012; Varga, Andrea/ABA-9998-2020	Paizs, Csaba/0000-0002-7403-7098; Poppe, László/0000-0002-8358-1378; Varga, Andrea/0000-0002-4290-9226; Vertessy, Beata G./0000-0002-1288-2982	Hungarian OTKA Foundation [NN-103242]; New Hungary Development Plan; Romanian National Authority for Scientific Research, CNCS - UEFISCDI [PN-II-IDPCE-2011-3-0799]	Hungarian OTKA Foundation(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); New Hungary Development Plan; Romanian National Authority for Scientific Research, CNCS - UEFISCDI(Consiliul National al Cercetarii Stiintifice (CNCS)Unitatea Executiva pentru Finantarea Invatamantului Superior, a Cercetarii, Dezvoltarii si Inovarii (UEFISCDI))	LP and BGV thank the financial support from the Hungarian OTKA Foundation, (http://www.otka.hu/en; Grant: NN-103242) and from the New Hungary Development Plan (http://www.nfu.hu/the_new_hungary_development_plan_; Project: "Development of quality-oriented and harmonized R+D+I strategy and functional model at BME": TAMOP-4.2.1/B-09/1/KMR-2010-0002). CP thanks the financial support from the Romanian National Authority for Scientific Research, CNCS - UEFISCDI (http://www.cncs-nrc.ro/home/; Grant: PN-II-IDPCE-2011-3-0799). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABELL CW, 1973, CANCER RES, V33, P2529; ABELL CW, 1972, CANCER RES, V32, P285; ALLA MMN, 1995, J EXP BOT, V46, P1731, DOI 10.1093/jxb/46.11.1731; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; AMANN RI, 1995, MICROBIOL REV, V59, P143, DOI 10.1128/MMBR.59.1.143-169.1995; ANDRADE MA, 1993, PROTEIN ENG, V6, P383, DOI 10.1093/protein/6.4.383; [Anonymous], 2012, MACROMODEL VERS 9 9; [Anonymous], 2012, MAESTR VERS 9 3 SCHR; [Anonymous], 2006, CURRENT PROTOCOLS BI, DOI DOI 10.1002/0471250953.BI0506S15; APPERT C, 1994, EUR J BIOCHEM, V225, P491, DOI 10.1111/j.1432-1033.1994.00491.x; Apweiler R, 2004, NUCLEIC ACIDS RES, V32, pD115, DOI 10.1093/nar/gkh131; Babich OO, 2013, BIOTECHNOL APPL BIOC, V60, P316, DOI 10.1002/bab.1089; Barredo J.L., 2005, MICROBIAL ENZYMES BI; Bartsch S, 2010, PROTEIN ENG DES SEL, V23, P929, DOI 10.1093/protein/gzq089; Belanger-Quintana A, 2011, MOL GENET METAB, V104, pS19, DOI 10.1016/j.ymgme.2011.08.009; Bezsudnova EY, 2012, BIOCHIMIE, V94, P2628, DOI 10.1016/j.biochi.2012.07.024; Calabrese JC, 2004, BIOCHEMISTRY-US, V43, P11403, DOI 10.1021/bi049053+; Carreto L, 1996, INT J SYST BACTERIOL, V46, P460, DOI 10.1099/00207713-46-2-460; Chan CH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021624; Chesters C, 2012, ANGEW CHEM INT EDIT, V51, P4344, DOI 10.1002/anie.201200669; Christenson SD, 2003, BIOCHEMISTRY-US, V42, P12708, DOI 10.1021/bi035223r; Christenson SD, 2003, J AM CHEM SOC, V125, P6062, DOI 10.1021/ja034609m; Christianson CV, 2007, BIOCHEMISTRY-US, V46, P7205, DOI 10.1021/bi7003685; CHUNG CT, 1989, P NATL ACAD SCI USA, V86, P2172, DOI 10.1073/pnas.86.7.2172; COHEN SN, 1972, P NATL ACAD SCI USA, V69, P2110, DOI 10.1073/pnas.69.8.2110; CONSEVAGE MW, 1990, J BACTERIOL, V172, P2224, DOI 10.1128/jb.172.5.2224-2229.1990; Daniel RM, 2008, EXTREMOPHILES, V12, P51, DOI 10.1007/s00792-007-0089-7; de Lange B, 2011, CHEMCATCHEM, V3, P289, DOI 10.1002/cctc.201000435; Ding YR, 2012, EXTREMOPHILES, V16, P67, DOI 10.1007/s00792-011-0406-z; Duchaud E, 2003, NAT BIOTECHNOL, V21, P1307, DOI 10.1038/nbt886; EMES AV, 1970, CAN J BIOCHEM CELL B, V48, P613, DOI 10.1139/o70-099; Faber K., 2011, BIOTRANSFORMATIONS O, V6th; Ferrer JL, 2008, PLANT PHYSIOL BIOCH, V46, P356, DOI 10.1016/j.plaphy.2007.12.009; Fiser A, 2000, PROTEIN SCI, V9, P1753, DOI 10.1110/ps.9.9.1753; Fiser A, 2000, BIOCHEM BIOPH RES CO, V279, P534, DOI 10.1006/bbrc.2000.3994; Gloge A, 1998, ARCH BIOCHEM BIOPHYS, V359, P1, DOI 10.1006/abbi.1998.0860; HAMILTON BK, 1985, TRENDS BIOTECHNOL, V3, P64, DOI 10.1016/0167-7799(85)90079-4; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Hyun Min Woo, 2011, Mycobiology, V39, P257, DOI 10.5941/MYCO.2011.39.4.257; Imani M, 2010, PHOTOCH PHOTOBIO SCI, V9, P1167, DOI 10.1039/c0pp00105h; KLAUSNER A, 1985, BIO-TECHNOL, V3, P301, DOI 10.1038/nbt0485-301; Kovari J, 2008, PROTEINS, V71, P308, DOI 10.1002/prot.21757; LANGER M, 1994, BIOCHEMISTRY-US, V33, P6462, DOI 10.1021/bi00187a011; Magarvey NA, 2008, ACS CHEM BIOL, V3, P542, DOI 10.1021/cb800085g; Manikandan K, 2006, PROTEIN SCI, V15, P1951, DOI 10.1110/ps.062220206; Marti-Renom MA, 2000, ANNU REV BIOPH BIOM, V29, P291, DOI 10.1146/annurev.biophys.29.1.291; MAVANDAD M, 1990, PLANT PHYSIOL, V94, P671, DOI 10.1104/pp.94.2.671; McGrath B., 2006, DIRECTORY THERAPEUTI; Moffitt MC, 2007, BIOCHEMISTRY-US, V46, P1004, DOI 10.1021/bi061774g; Mutatu W, 2007, BIOCHEMISTRY-US, V46, P9785, DOI 10.1021/bi700691p; Paizs C, 2006, EUR J ORG CHEM, V2006, P1113, DOI 10.1002/ejoc.200500902; Paizs C, 2006, CHEM-EUR J, V12, P2739, DOI 10.1002/chem.200501034; Paizs C, 2011, HETEROCYCLES, V82, P1217, DOI 10.3987/COM-10-S(E)60; Papworth C.B., 1996, STRATEGIES, V9, P3, DOI DOI 10.1080/08924562.1996.11000299; Pilbak S, 2006, FEBS J, V273, P1004, DOI 10.1111/j.1742-4658.2006.05127.x; Poppe L, 2005, ANGEW CHEM INT EDIT, V44, P3668, DOI 10.1002/anie.200461377; Poppe L, 2003, CURR ORG CHEM, V7, P1297, DOI 10.2174/1385272033486440; Poppe L, 2012, METHODS MOL BIOL, V794, P3, DOI 10.1007/978-1-61779-331-8_1; Ratnayake ND, 2011, J AM CHEM SOC, V133, P8531, DOI 10.1021/ja2030728; Rehm HJ, 1998, BIOTECHNOLOGY A, V8a; Rehm HJ, 2000, BIOTECHNOLOGY B, V8b; RENARD G, 1992, BIOTECHNOL LETT, V14, P673, DOI 10.1007/BF01021641; Ritter H, 2004, PLANT CELL, V16, P3426, DOI 10.1105/tpc.104.025288; Rother D, 2000, ANGEW CHEM INT EDIT, V39, P2462, DOI 10.1002/1521-3773(20000717)39:14<2462::AID-ANIE2462>3.0.CO;2-H; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; SCHUSTER B, 1994, FEBS LETT, V349, P252, DOI 10.1016/0014-5793(94)00681-4; Schwede TF, 1999, BIOCHEMISTRY-US, V38, P5355, DOI 10.1021/bi982929q; SHEN RS, 1977, CANCER RES, V37, P1051; Steele CL, 2005, ARCH BIOCHEM BIOPHYS, V438, P1, DOI 10.1016/j.abb.2005.04.012; STITH WJ, 1973, CANCER RES, V33, P966; Teeling H, 2012, BRIEF BIOINFORM, V13, P728, DOI 10.1093/bib/bbs039; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Uchiyama T, 2009, CURR OPIN BIOTECH, V20, P616, DOI 10.1016/j.copbio.2009.09.010; van den Burg B, 2003, CURR OPIN MICROBIOL, V6, P213, DOI 10.1016/S1369-5274(03)00060-2; Vertessy BG, 1996, BIOCHEM BIOPH RES CO, V219, P294, DOI 10.1006/bbrc.1996.0226; Vinther JM, 2011, J AM CHEM SOC, V133, P271, DOI 10.1021/ja105388k; Wahler D, 2001, CURR OPIN CHEM BIOL, V5, P152, DOI 10.1016/S1367-5931(00)00184-8; Walker KD, 2004, J BIOL CHEM, V279, P53947, DOI 10.1074/jbc.M411215200; Wang L, 2005, MOL GENET METAB, V86, P134, DOI 10.1016/j.ymgme.2005.05.012; Wang L, 2008, J MOL BIOL, V380, P623, DOI 10.1016/j.jmb.2008.05.025; Wang YW, 2012, BIORESOURCE TECHNOL, V112, P275, DOI 10.1016/j.biortech.2012.02.092; Whitmore L, 2008, BIOPOLYMERS, V89, P392, DOI 10.1002/bip.20853; Williams JS, 2005, MICROBIOL-SGM, V151, P2543, DOI 10.1099/mic.0.28136-0; Wu BA, 2010, CHEM COMMUN, V46, P8157, DOI 10.1039/c0cc02768e; Xiang LK, 2005, J BACTERIOL, V187, P4286, DOI 10.1128/JB.187.12.4286-4289.2005; YOSHINAKA T, 1973, AGR BIOL CHEM TOKYO, V37, P2269, DOI 10.1080/00021369.1973.10861003; Zhao YJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014608; ZIMMERMANN A, 1975, ARCH BIOCHEM BIOPHYS, V166, P54, DOI 10.1016/0003-9861(75)90364-1	88	23	23	2	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2014	9	1							e85943	10.1371/journal.pone.0085943	http://dx.doi.org/10.1371/journal.pone.0085943			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301BI	24475062	Green Accepted, Green Published, gold, Green Submitted			2022-12-25	WOS:000330507300031
J	Yap, CH; Liu, XQ; Pekkan, K				Yap, Choon Hwai; Liu, Xiaoqin; Pekkan, Kerem			Characterizaton of the Vessel Geometry, Flow Mechanics and Wall Shear Stress in the Great Arteries of Wildtype Prenatal Mouse	PLOS ONE			English	Article							COMPUTATIONAL FLUID-DYNAMICS; BLOOD-FLOW; ENDOTHELIAL-CELLS; GENE-EXPRESSION; OUTFLOW TRACT; PRIMARY CILIA; AORTIC-VALVE; ARCH; DEFORMATION; HYPOPLASIA	Introduction: Abnormal fluid mechanical environment in the pre-natal cardiovascular system is hypothesized to play a significant role in causing structural heart malformations. It is thus important to improve our understanding of the prenatal cardiovascular fluid mechanical environment at multiple developmental time-points and vascular morphologies. We present such a study on fetal great arteries on the wildtype mouse from embryonic day 14.5 (E14.5) to near-term (E18.5). Methods: Ultrasound bio-microscopy (UBM) was used to measure blood velocity of the great arteries. Subsequently, specimens were cryo-embedded and sectioned using episcopic fluorescent image capture (EFIC) to obtain high-resolution 2D serial image stacks, which were used for 3D reconstructions and quantitative measurement of great artery and aortic arch dimensions. EFIC and UBM data were input into subject-specific computational fluid dynamics (CFD) for modeling hemodynamics. Results: In normal mouse fetuses between E14.5-18.5, ultrasound imaging showed gradual but statistically significant increase in blood velocity in the aorta, pulmonary trunk (with the ductus arteriosus), and descending aorta. Measurement by EFIC imaging displayed a similar increase in cross sectional area of these vessels. However, CFD modeling showed great artery average wall shear stress and wall shear rate remain relatively constant with age and with vessel size, indicating that hemodynamic shear had a relative constancy over gestational period considered here. Conclusion: Our EFIC-UBM-CFD method allowed reasonably detailed characterization of fetal mouse vascular geometry and fluid mechanics. Our results suggest that a homeostatic mechanism for restoring vascular wall shear magnitudes may exist during normal embryonic development. We speculate that this mechanism regulates the growth of the great vessels.	[Yap, Choon Hwai] Natl Univ Singapore, Dept Biomed Engn, Singapore 117548, Singapore; [Liu, Xiaoqin] Univ Pittsburgh, Sch Med, Dept Dev Biol, Pittsburgh, PA USA; [Pekkan, Kerem] Carnegie Mellon Univ, Dept Biomed Engn, Pittsburgh, PA 15213 USA	National University of Singapore; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Carnegie Mellon University	Pekkan, K (corresponding author), Carnegie Mellon Univ, Dept Biomed Engn, Pittsburgh, PA 15213 USA.	kpekkan@andrew.cmu.edu	Pekkan, Kerem/P-5038-2019	Pekkan, Kerem/0000-0001-7637-4445				Al-Roubaie S, 2011, AM J PHYSIOL-HEART C, V301, pH2473, DOI 10.1152/ajpheart.00475.2011; Antiga L, 2002, PATIENT SPECI FIC MO; Antiga L., 2009, VASCULAR MODELING TO; Brouzes E, 2004, CURR OPIN GENET DEV, V14, P367, DOI 10.1016/j.gde.2004.06.005; Corrigan N, 2010, REPROD SCI, V17, P147, DOI 10.1177/1933719109348923; Dean WR, 1928, PHILOS MAG, V5, P673; Dean WR, 1927, PHILOS MAG, V4, P208; DeCampli WM, 2012, CARDIOL YOUNG, V22, P800, DOI 10.1017/S1047951112002028; Dempere-Marco L, 2006, LECT NOTES COMPUT SC, V4191, P438; Egorova AD, 2011, CIRC RES, V108, P1093, DOI 10.1161/CIRCRESAHA.110.231860; GODFREY VL, 1991, P NATL ACAD SCI USA, V88, P5528, DOI 10.1073/pnas.88.13.5528; Groenendijk BCW, 2005, CIRC RES, V96, P1291, DOI 10.1161/01.RES.0000171901.40952.0d; Hickey EJ, 2012, J AM COLL CARDIOL, V59, pS43, DOI 10.1016/j.jacc.2011.04.046; Hierck BP, 2008, DEV DYNAM, V237, P725, DOI 10.1002/dvdy.21472; Hiruma T, 2002, J ANAT, V201, P15, DOI 10.1046/j.1469-7580.2002.00071.x; Hoffman JIE, 2002, J AM COLL CARDIOL, V39, P1890, DOI 10.1016/S0735-1097(02)01886-7; HOGERS B, 1995, CIRC RES, V76, P871, DOI 10.1161/01.RES.76.5.871; Hove JR, 2003, NATURE, V421, P172, DOI 10.1038/nature01282; Iomini C, 2004, J CELL BIOL, V164, P811, DOI 10.1083/jcb.200312133; JOHNSTON PM, 1955, AM J PHYSIOL, V183, P365; Jones EAV, 2004, AM J PHYSIOL-HEART C, V287, pH1561, DOI 10.1152/ajpheart.00081.2004; Jopling J, 2009, PEDIATRICS, V123, pE333, DOI 10.1542/peds.2008-2654; Kim TD, 2004, KOREA-AUST RHEOL J, V16, P75; Kohl T, 2000, AM J CARDIOL, V85, P1230, DOI 10.1016/S0002-9149(00)00733-5; Kowalski WJ, 2012, BIOMECH MODEL MECHAN, V11, P1057, DOI 10.1007/s10237-012-0373-z; Langille BL, 1996, CAN J PHYSIOL PHARM, V74, P834, DOI 10.1139/cjpp-74-7-834; Leatherbury Linda, 2003, Birth Defects Research, V69, P83, DOI 10.1002/bdrc.10005; Lee JS, 2006, DEV CELL, V11, P845, DOI 10.1016/j.devcel.2006.09.006; Li YSJ, 2005, J BIOMECH, V38, P1949, DOI 10.1016/j.jbiomech.2004.09.030; LINDERKAMP O, 1992, PEDIATR RES, V32, P97, DOI 10.1203/00006450-199207000-00019; Masumura T, 2009, ARTERIOSCL THROM VAS, V29, P2125, DOI 10.1161/ATVBAHA.109.193185; Morbiducci U, 2009, ANN BIOMED ENG, V37, P516, DOI 10.1007/s10439-008-9609-6; Murray CD, 1926, P NATL ACAD SCI USA, V12, P207, DOI 10.1073/pnas.12.3.207; Nauli SM, 2008, CIRCULATION, V117, P1161, DOI 10.1161/CIRCULATIONAHA.107.710111; Pahakis MY, 2007, BIOCHEM BIOPH RES CO, V355, P228, DOI 10.1016/j.bbrc.2007.01.137; PERONA P, 1990, IEEE T PATTERN ANAL, V12, P629, DOI 10.1109/34.56205; Phoon CKL, 2000, ULTRASOUND MED BIOL, V26, P1275, DOI 10.1016/S0301-5629(00)00278-7; Piccinelli M, 2009, IEEE T MED IMAGING, V28, P1141, DOI 10.1109/TMI.2009.2021652; Porrello ER, 2011, SCIENCE, V331, P1078, DOI 10.1126/science.1200708; Rosenthal Julie, 2004, Birth Defects Res C Embryo Today, V72, P213, DOI 10.1002/bdrc.20023; Roy D, 2009, ANAT REC, V292, P342, DOI 10.1002/ar.20849; Rudolph AM, 2001, CONGENITAL DIS HEART, V2nd; Spurney CF, 2004, J AM SOC ECHOCARDIOG, V17, P893, DOI 10.1016/j.echo.2004.04.028; Steinman David A., 2004, Current Drug Targets - Cardiovascular & Haematological Disorders, V4, P183, DOI 10.2174/1568006043336302; Taylor CA, 2004, ANNU REV FLUID MECH, V36, P197, DOI 10.1146/annurev.fluid.36.050802.121944; Taylor CA, 2013, J AM COLL CARDIOL, V61, P2233, DOI 10.1016/j.jacc.2012.11.083; Tobita K, 2000, AM J PHYSIOL-HEART C, V279, pH959, DOI 10.1152/ajpheart.2000.279.3.H959; Torii R, 2009, BRIT J RADIOL, V82, pS24, DOI 10.1259/bjr/62450556; TURNBULL DH, 1995, P NATL ACAD SCI USA, V92, P2239, DOI 10.1073/pnas.92.6.2239; Tworetzky W, 2004, CIRCULATION, V110, P2125, DOI 10.1161/01.CIR.0000144357.29279.54; Vincent PE, 2011, J R SOC INTERFACE, V8, P1708, DOI 10.1098/rsif.2011.0116; Wang NP, 2006, BIOCHEM BIOPH RES CO, V341, P1244, DOI 10.1016/j.bbrc.2006.01.089; Weinberg PD, 2007, J BIOMECH, V40, P1594, DOI 10.1016/j.jbiomech.2006.07.020; Weninger WJ, 2002, NAT GENET, V30, P59, DOI 10.1038/ng785; Wong MD, 2012, DEVELOPMENT, V139, P3248, DOI 10.1242/dev.082016; Yu Q, 2008, ULTRASOUND MED BIOL, V34, P741, DOI 10.1016/j.ultrasmedbio.2007.11.001	56	20	22	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2014	9	1							e86878	10.1371/journal.pone.0086878	http://dx.doi.org/10.1371/journal.pone.0086878			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301BI	24475188	Green Published, Green Accepted, gold			2022-12-25	WOS:000330507300112
J	Kaur, S; Powell, S; He, LL; Pierson, CR; Parikh, NA				Kaur, Supreet; Powell, Samuel; He, Lili; Pierson, Christopher R.; Parikh, Nehal A.			Reliability and Repeatability of Quantitative Tractography Methods for Mapping Structural White Matter Connectivity in Preterm and Term Infants at Term-Equivalent Age	PLOS ONE			English	Article							TENSOR IMAGING TRACTOGRAPHY; HUMAN BRAIN; IN-VIVO; CORPUS-CALLOSUM; FIBER TRACTOGRAPHY; PREMATURE-INFANTS; AXONAL TRACKING; DT-MRI; DIFFUSION; TRACT	Premature infants exhibit widespread insults and delays in white matter maturation that can be sensitively detected early using diffusion tensor imaging. Diffusion tensor tractography facilitates in vivo visualization of white matter tracts and has the potential to be more sensitive than simpler two-dimensional DTI-based measures. However, the reliability and reproducibility of performing tractography for major white matter tracts in preterm infants is not known. The main objective of our study was to develop highly reliable and repeatable methods for ten white matter tracts in extremely low birth weight infants (birth weight <= 1000 g) at term-equivalent age. To demonstrate clinical utility, we also compared fiber microstructural and macrostructural parameters between preterm and healthy term controls. Twenty-nine ELBW infants and a control group of 15 healthy term newborns were studied. A team of researchers experienced in neuroanatomy/neuroimaging established the manual segmentation protocol based on a priori anatomical knowledge and an extensive training period to identify sources of variability. Intra-and inter-rater reliability and repeatability was tested using intra-class correlation coefficient, within-subject standard deviation (SD), repeatability, and Dice similarity index. Our results support our primary goal of developing highly reliable and reproducible comprehensive methods for manual segmentation of 10 white matter tracts in ELBW infants. The within-subject SD was within 1-2% and repeatability within 3-7% of the mean values for all 10 tracts. The intra-rater Dice index was excellent with a range of 0.97 to 0.99, and as expected, the inter-rater Dice index was lower (range: 0.80 to 0.91), but still within a very good reliability range. ELBW infants exhibited fewer fiber numbers and/or abnormal microstructure in a majority of the ten quantified tracts, consistent with injury/delayed development. This protocol could serve as a valuable tool for prompt evaluation of the impact of neuroprotective therapies and as a prognostic biomarker for neurodevelopmental impairments.	[Kaur, Supreet; Powell, Samuel; He, Lili; Parikh, Nehal A.] Nationwide Childrens Hosp, Res Inst, Ctr Perinatal Res, Columbus, OH 43205 USA; [Pierson, Christopher R.; Parikh, Nehal A.] Ohio State Univ, Coll Med, Dept Pediat, Columbus, OH 43210 USA; [Pierson, Christopher R.; Parikh, Nehal A.] Ohio State Univ, Coll Med, Dept Pathol, Columbus, OH 43210 USA; [Pierson, Christopher R.] Nationwide Childrens Hosp, Dept Pathol & Lab Med, Columbus, OH USA	University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Research Institute at Nationwide Children's Hospital; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; Nationwide Childrens Hospital	Parikh, NA (corresponding author), Nationwide Childrens Hosp, Res Inst, Ctr Perinatal Res, Columbus, OH 43205 USA.	Nehal.Parikh@nationwidechildrens.org	Parikh, Nehal/AAB-9981-2022; Pierson, Christopher/E-3869-2011	Powell, Samuel/0000-0001-7002-2756; Parikh, Nehal/0000-0002-1375-1247	Research Institute at Nationwide Children's Hospital; National Center for Research Resources/Eunice Kennedy Shriver National Institute of Child Health, and Human Development grant [UL1 RR024148-04S3]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000371] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024148] Funding Source: NIH RePORTER	Research Institute at Nationwide Children's Hospital(Ohio State University); National Center for Research Resources/Eunice Kennedy Shriver National Institute of Child Health, and Human Development grant; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported by the Research Institute at Nationwide Children's Hospital, the National Center for Research Resources/Eunice Kennedy Shriver National Institute of Child Health, and Human Development grant UL1 RR024148-04S3 (Best Pharmaceuticals for Children Act) (to NAP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams E, 2010, J PEDIATR-US, V156, P882, DOI 10.1016/j.jpeds.2009.12.030; Alexander AL, 2007, NEUROIMAGE, V34, P61, DOI 10.1016/j.neuroimage.2006.08.032; Bartha AL, 2007, AM J NEURORADIOL, V28, P1015, DOI 10.3174/ajnr.A0521; Bartlett JW, 2008, ULTRASOUND OBST GYN, V31, P466, DOI 10.1002/uog.5256; Basser PJ, 2000, MAGNET RESON MED, V44, P625, DOI 10.1002/1522-2594(200010)44:4<625::AID-MRM17>3.0.CO;2-O; BASSER PJ, 1994, BIOPHYS J, V66, P259, DOI 10.1016/S0006-3495(94)80775-1; Bayer AS, 2004, ATLAS HUMAN CENTRAL; Berman JI, 2005, NEUROIMAGE, V27, P862, DOI 10.1016/j.neuroimage.2005.05.018; Bland JM, 1996, BRIT MED J, V313, P41, DOI 10.1136/bmj.313.7048.41; Catani M, 2003, BRAIN, V126, P2093, DOI 10.1093/brain/awg203; Catani M, 2002, NEUROIMAGE, V17, P77, DOI 10.1006/nimg.2002.1136; Conturo TE, 1999, P NATL ACAD SCI USA, V96, P10422, DOI 10.1073/pnas.96.18.10422; Danielian LE, 2010, NEUROIMAGE, V49, P1572, DOI 10.1016/j.neuroimage.2009.08.062; de Bruine FT, 2011, EUR RADIOL, V21, P538, DOI 10.1007/s00330-010-1945-x; DICE LR, 1945, ECOLOGY, V26, P297, DOI 10.2307/1932409; Dubois J, 2006, NEUROIMAGE, V30, P1121, DOI 10.1016/j.neuroimage.2005.11.022; Dubois J, 2008, HUM BRAIN MAPP, V29, P14, DOI 10.1002/hbm.20363; Fernandez-Miranda JC, 2012, NEUROSURGERY, V71, P430, DOI 10.1227/NEU.0b013e3182592faa; Gong GL, 2009, CEREB CORTEX, V19, P524, DOI 10.1093/cercor/bhn102; Hack M, 2005, PEDIATRICS, V116, P333, DOI 10.1542/peds.2005-0173; Hermoye L, 2006, NEUROIMAGE, V29, P493, DOI 10.1016/j.neuroimage.2005.08.017; Hoon AH, 2002, NEUROLOGY, V59, P752, DOI 10.1212/WNL.59.5.752; Huang H, 2004, MAGN RESON MED, V52, P559, DOI 10.1002/mrm.20147; Huang H, 2005, NEUROIMAGE, V26, P195, DOI 10.1016/j.neuroimage.2005.01.019; Huppi PS, 2006, SEMIN FETAL NEONAT M, V11, P489, DOI 10.1016/j.siny.2006.07.006; Inder TE, 2005, PEDIATRICS, V115, P286, DOI 10.1542/peds.2004-0326; Jones DK, 1999, MAGN RESON MED, V42, P37, DOI 10.1002/(SICI)1522-2594(199907)42:1<37::AID-MRM7>3.0.CO;2-O; Le Bihan D, 2001, J MAGN RESON IMAGING, V13, P534, DOI 10.1002/jmri.1076; Le Bihan D, 2006, J MAGN RESON IMAGING, V24, P478, DOI 10.1002/jmri.20683; Lee SK, 2004, AM J NEURORADIOL, V25, P25; Makris N, 2005, CEREB CORTEX, V15, P854, DOI 10.1093/cercor/bhh186; Malykhin N, 2008, PSYCHIAT RES-NEUROIM, V164, P132, DOI 10.1016/j.pscychresns.2007.11.007; Masutani Y, 2003, EUR J RADIOL, V46, P53, DOI 10.1016/S0720-048X(02)00328-5; Ment LR, 2009, LANCET NEUROL, V8, P1042, DOI 10.1016/S1474-4422(09)70257-1; Ment LR, 2002, PEDIATR RADIOL, V32, P620; Mori S, 2002, MAGN RESON MED, V47, P215, DOI 10.1002/mrm.10074; Mori S, 1999, ANN NEUROL, V45, P265, DOI 10.1002/1531-8249(199902)45:2<265::AID-ANA21>3.0.CO;2-3; Mori S, 2007, AM J PSYCHIAT, V164, P1005, DOI 10.1176/appi.ajp.164.7.1005; Neil J, 2002, NMR BIOMED, V15, P543, DOI 10.1002/nbm.784; NOLTE J, 2002, HUMAN BRAIN INTRO FU; Oishi K, 2011, MRI ATLAS HUMAN WHIT, VSecond; Parikh NA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062804; Partridge SC, 2004, NEUROIMAGE, V22, P1302, DOI 10.1016/j.neuroimage.2004.02.038; Partridge SC, 2005, J MAGN RESON IMAGING, V22, P467, DOI 10.1002/jmri.20410; Pierpaoli C, 2001, NEUROIMAGE, V13, P1174, DOI 10.1006/nimg.2001.0765; Pogribna U, 2013, PLOS ONE IN PRESS; Pogribna U, 2013, AJRN AM J N IN PRESS; Rollins N, 2005, AM J NEURORADIOL, V26, P2148; Rose SE, 2000, J NEUROL NEUROSUR PS, V69, P528, DOI 10.1136/jnnp.69.4.528; RUTHERFORD MA, 1991, J COMPUT ASSIST TOMO, V15, P188, DOI 10.1097/00004728-199103000-00002; SAKUMA H, 1991, RADIOLOGY, V180, P229, DOI 10.1148/radiology.180.1.2052700; Staudt M, 2000, NEUROPEDIATRICS, V31, P257, DOI 10.1055/s-2000-9239; Stieltjes B, 2001, NEUROIMAGE, V14, P723, DOI 10.1006/nimg.2001.0861; Thompson DK, 2012, NEUROIMAGE, V59, P3571, DOI 10.1016/j.neuroimage.2011.11.057; Thompson DK, 2011, NEUROIMAGE, V55, P479, DOI 10.1016/j.neuroimage.2010.12.025; van Kooij BJM, 2012, AM J NEURORADIOL, V33, P188, DOI 10.3174/ajnr.A2723; Volpe JJ, 2009, LANCET NEUROL, V8, P110, DOI 10.1016/S1474-4422(08)70294-1; Wakana S, 2004, RADIOLOGY, V230, P77, DOI 10.1148/radiol.2301021640; Wakana S, 2007, NEUROIMAGE, V36, P630, DOI 10.1016/j.neuroimage.2007.02.049; Yoo SS, 2005, INVEST RADIOL, V40, P110, DOI 10.1097/01.rli.0000149491.69201.cb; Yu XT, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013874; Zhai GH, 2003, RADIOLOGY, V229, P673, DOI 10.1148/radiol.2293021462	62	26	26	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2014	9	1							e85807	10.1371/journal.pone.0085807	http://dx.doi.org/10.1371/journal.pone.0085807			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	298QQ	24475054	Green Published, gold, Green Submitted			2022-12-25	WOS:000330339800017
J	Pegoraro, M; Noreen, S; Bhutani, S; Tsolou, A; Schmid, R; Kyriacou, CP; Tauber, E				Pegoraro, Mirko; Noreen, Shumaila; Bhutani, Supriya; Tsolou, Avgi; Schmid, Ralf; Kyriacou, Charalambos P.; Tauber, Eran			Molecular Evolution of a Pervasive Natural Amino-Acid Substitution in Drosophila cryptochrome	PLOS ONE			English	Article							CLOCK GENE; CIRCADIAN-RHYTHMS; DNA POLYMORPHISM; MELANOGASTER; SELECTION; PROTEIN; LIGHT; PHOTORECEPTOR; MUTATION; PERIOD	Genetic variations in circadian clock genes may serve as molecular adaptations, allowing populations to adapt to local environments. Here, we carried out a survey of genetic variation in Drosophila cryptochrome (cry), the fly's dedicated circadian photoreceptor. An initial screen of 10 European cry alleles revealed substantial variation, including seven non-synonymous changes. The SNP frequency spectra and the excessive linkage disequilibrium in this locus suggested that this variation is maintained by natural selection. We focused on a non-conservative SNP involving a leucine - histidine replacement (L232H) and found that this polymorphism is common, with both alleles at intermediate frequencies across 27 populations surveyed in Europe, irrespective of latitude. Remarkably, we were able to reproduce this natural observation in the laboratory using replicate population cages where the minor allele frequency was initially set to 10%. Within 20 generations, the two allelic variants converged to approximately equal frequencies. Further experiments using congenic strains, showed that this SNP has a phenotypic impact, with variants showing significantly different eclosion profiles. At the long term, these phase differences in eclosion may contribute to genetic differentiation among individuals, and shape the evolution of wild populations.	[Pegoraro, Mirko; Noreen, Shumaila; Kyriacou, Charalambos P.; Tauber, Eran] Univ Leicester, Dept Genet, Leicester LE1 7RH, Leics, England; [Bhutani, Supriya] Natl Brain Res Ctr, Dept Mol & Cellular Neurosci, Manesar, Haryana, India; [Tsolou, Avgi] Democritus Univ Thrace, Dept Mol Biol & Genet, Alexandroupolis, Greece; [Schmid, Ralf] Univ Leicester, Dept Biochem, Leicester LE1 7RH, Leics, England	University of Leicester; Department of Biotechnology (DBT) India; National Brain Research Centre (NBRC); Democritus University of Thrace; University of Leicester	Tauber, E (corresponding author), Univ Leicester, Dept Genet, Univ Rd, Leicester LE1 7RH, Leics, England.	et22@le.ac.uk	Tsolou, Avgi/L-7776-2017; Tauber, Eran/AAA-1562-2022; Tauber, Eran/F-9826-2011; Schmid, Ralf/E-6722-2011; Schmid, Ralf/ABE-1065-2020	Tauber, Eran/0000-0003-4018-6535; Tauber, Eran/0000-0003-4018-6535; Schmid, Ralf/0000-0002-0203-4023; Schmid, Ralf/0000-0002-0203-4023; Pegoraro, Mirko/0000-0001-9381-5249; Bhutani, Supriya/0000-0002-0855-2139	NERC [NE/D012058/1]; BBSRC [BB/K001922/1]; Royal Society Wolfson Research Merit Award; Faculty Development Program (FDP) Scholarships, University of Peshawar; Biotechnology and Biological Sciences Research Council [BB/G02085X/1, BB/K001922/1, BB/F014082/1] Funding Source: researchfish; Natural Environment Research Council [NBAF010003, NE/D012058/1] Funding Source: researchfish; BBSRC [BB/G02085X/1, BBS/E/D/20310000, BB/F014082/1] Funding Source: UKRI; NERC [NBAF010003] Funding Source: UKRI	NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Royal Society Wolfson Research Merit Award(Royal Society of London); Faculty Development Program (FDP) Scholarships, University of Peshawar; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This work was funded by grants from NERC (NE/D012058/1) and BBSRC (BB/K001922/1) to ET and CPK. CPK also acknowledges a Royal Society Wolfson Research Merit Award. SN was funded by the Faculty Development Program (FDP) Scholarships, University of Peshawar. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhtar RA, 2002, CURR BIOL, V12, P540, DOI 10.1016/S0960-9822(02)00759-5; Ayala F.J., 1974, Annual Rev Ecol Syst, V5, P115, DOI 10.1146/annurev.es.05.110174.000555; Bhutani S, 2009, THESIS U LEICESTER L; Charlesworth B, 1997, GENET RES, V70, P155, DOI 10.1017/S0016672397002954; Charlesworth D, 2006, PLOS GENET, V2, P379, DOI 10.1371/journal.pgen.0020064; COSTA R, 1992, P ROY SOC B-BIOL SCI, V250, P43, DOI 10.1098/rspb.1992.0128; Covington MF, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-8-r130; Czarna A, 2013, CELL, V153, P1394, DOI 10.1016/j.cell.2013.05.011; Dissel S, 2004, NAT NEUROSCI, V7, P834, DOI 10.1038/nn1285; Dolezelova E, 2007, GENETICS, V177, P329, DOI 10.1534/genetics.107.076513; Duffield GE, 2003, J NEUROENDOCRINOL, V15, P991, DOI 10.1046/j.1365-2826.2003.01082.x; EDERY I, 1994, P NATL ACAD SCI USA, V91, P2260, DOI 10.1073/pnas.91.6.2260; Emery P, 2000, NATURE, V404, P456, DOI 10.1038/35006558; Emery P, 1998, CELL, V95, P669, DOI 10.1016/S0092-8674(00)81637-2; Fitzpatrick MJ, 2007, NATURE, V447, P210, DOI 10.1038/nature05764; Fuchikawa T, 2010, HEREDITY, V104, P387, DOI 10.1038/hdy.2009.167; GLOOR GB, 1993, GENETICS, V135, P81; Hardin Paul E, 2003, Novartis Found Symp, V253, P140; HARDIN PE, 2003, NOVART FDN SYMP, V253, P150; Hitomi K, 2009, P NATL ACAD SCI USA, V106, P6962, DOI 10.1073/pnas.0809180106; Hudson RR, 2000, GENETICS, V155, P2011; HUDSON RR, 1992, MOL BIOL EVOL, V9, P138; Kolaczkowski B, 2011, GENETICS, V187, P245, DOI 10.1534/genetics.110.123059; Kyriacou CP, 2008, TRENDS GENET, V24, P124, DOI 10.1016/j.tig.2007.12.003; Li YF, 2008, EVOLUTION, V62, P2984, DOI 10.1111/j.1558-5646.2008.00486.x; Long AD, 1998, GENETICS, V149, P999; MCDONALD JH, 1991, NATURE, V351, P652, DOI 10.1038/351652a0; Mealey-Ferrara ML, 2003, J NEUROGENET, V17, P171, DOI 10.1080/01677060390256422; Myers EM, 2003, CURR BIOL, V13, P526, DOI 10.1016/S0960-9822(03)00167-2; Nachman MW, 1996, GENETICS, V142, P953; NEI M, 1981, GENETICS, V97, P145; Partch CL, 2005, PHOTOCHEM PHOTOBIOL, V81, P1291, DOI 10.1562/2005-07-08-IR-607; Pegoraro M, 2011, WIRES RNA, V2, P312, DOI 10.1002/wrna.58; Rosato E, 1997, GENET RES, V69, P89, DOI 10.1017/S001667239700267X; Rosato E, 1997, NUCLEIC ACIDS RES, V25, P455, DOI 10.1093/nar/25.3.455; Sabeti PC, 2002, NATURE, V419, P832, DOI 10.1038/nature01140; Sandrelli F, 2007, SCIENCE, V316, P1898, DOI 10.1126/science.1138426; Sawyer LA, 1997, SCIENCE, V278, P2117, DOI 10.1126/science.278.5346.2117; Somers DE, 1998, SCIENCE, V282, P1488, DOI 10.1126/science.282.5393.1488; Stanewsky R, 1998, CELL, V95, P681, DOI 10.1016/S0092-8674(00)81638-4; TAJIMA F, 1991, J MOL EVOL, V33, P470, DOI 10.1007/BF02103140; TAJIMA F, 1989, GENETICS, V123, P585; Tauber E, 2003, CURR BIOL, V13, P140, DOI 10.1016/S0960-9822(03)00004-6; Tauber E, 2007, SCIENCE, V316, P1895, DOI 10.1126/science.1138412; Thresher RJ, 1998, SCIENCE, V282, P1490, DOI 10.1126/science.282.5393.1490; van der Horst GTJ, 1999, NATURE, V398, P627, DOI 10.1038/19323; Vitaterna MH, 1999, P NATL ACAD SCI USA, V96, P12114, DOI 10.1073/pnas.96.21.12114; WATTERSON GA, 1975, THEOR POPUL BIOL, V7, P256, DOI 10.1016/0040-5809(75)90020-9; Worth CL, 2011, NUCLEIC ACIDS RES, V39, pW215, DOI 10.1093/nar/gkr363; Yagita K, 2002, EMBO J, V21, P1301, DOI 10.1093/emboj/21.6.1301; Yoshii T, 2010, J BIOL RHYTHM, V25, P387, DOI 10.1177/0748730410381962	51	10	10	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2014	9	1							e86483	10.1371/journal.pone.0086483	http://dx.doi.org/10.1371/journal.pone.0086483			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	298QQ	24475129	gold, Green Submitted, Green Published, Green Accepted			2022-12-25	WOS:000330339800048
J	Bjorklund, E; Larsson, TNL; Jacobsson, SOP; Fowler, CJ				Bjorklund, Emmelie; Larsson, Therese N. L.; Jacobsson, Stig O. P.; Fowler, Christopher J.			Ketoconazole Inhibits the Cellular Uptake of Anandamide via Inhibition of FAAH at Pharmacologically Relevant Concentrations	PLOS ONE			English	Article							ACID AMIDE HYDROLASE; ENDOCANNABINOID SYSTEM; THROMBOXANE SYNTHESIS; ENZYMATIC-HYDROLYSIS; TRANSPORT; PROSTATE; CANCER; CANNABINOIDS; RECEPTOR; AGENTS	Background: The antifungal compound ketoconazole has, in addition to its ability to interfere with fungal ergosterol synthesis, effects upon other enzymes including human CYP3A4, CYP17, lipoxygenase and thromboxane synthetase. In the present study, we have investigated whether ketoconazole affects the cellular uptake and hydrolysis of the endogenous cannabinoid receptor ligand anandamide (AEA). Methodology/Principal Findings: The effects of ketoconazole upon endocannabinoid uptake were investigated using HepG2, CaCo2, PC-3 and C6 cell lines. Fatty acid amide hydrolase (FAAH) activity was measured in HepG2 cell lysates and in intact C6 cells. Ketoconazole inhibited the uptake of AEA by HepG2 cells and CaCo2 cells with IC50 values of 17 and 18 mu M, respectively. In contrast, it had modest effects upon AEA uptake in PC-3 cells, which have a low expression of FAAH. In cell-free HepG2 lysates, ketoconazole inhibited FAAH activity with an IC50 value (for the inhibitable component) of 34 mu M. Conclusions/Significance: The present study indicates that ketoconazole can inhibit the cellular uptake of AEA at pharmacologically relevant concentrations, primarily due to its effects upon FAAH. Ketoconazole may be useful as a template for the design of dual-action FAAH/CYP17 inhibitors as a novel strategy for the treatment of prostate cancer.	[Bjorklund, Emmelie; Larsson, Therese N. L.; Jacobsson, Stig O. P.; Fowler, Christopher J.] Umea Univ, Dept Pharmacol & Clin Neurosci, Umea, Sweden	Umea University	Fowler, CJ (corresponding author), Umea Univ, Dept Pharmacol & Clin Neurosci, Umea, Sweden.	cf@pharm.umu.se	Fowler, Christopher J./M-6313-2019	Fowler, Christopher J./0000-0002-6658-7874	Swedish Science Council [12158]; Medical Faculty, Umea University	Swedish Science Council; Medical Faculty, Umea University	The authors thank the Swedish Science Council (Grant no. 12158, medicine) and the Research Funds of the Medical Faculty, Umea University for financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Battista N, 2012, MOL CELL ENDOCRINOL, V355, P1, DOI 10.1016/j.mce.2012.01.014; BEETENS JR, 1986, BIOCHEM PHARMACOL, V35, P883, DOI 10.1016/0006-2952(86)90072-9; Beltramo M, 1997, SCIENCE, V277, P1094, DOI 10.1126/science.277.5329.1094; Beltramo M, 2000, NEUROREPORT, V11, P1231, DOI 10.1097/00001756-200004270-00018; Boldrup L, 2004, J BIOCHEM BIOPH METH, V60, P171, DOI 10.1016/j.jbbm.2004.04.020; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chen YM, 2011, BIOCHEMISTRY-US, V50, P3840, DOI 10.1021/bi102070w; Chicca A, 2012, J BIOL CHEM, V287, P34660, DOI 10.1074/jbc.M112.373241; Day TA, 2001, MOL PHARMACOL, V59, P1369, DOI 10.1124/mol.59.6.1369; DEUTSCH DG, 1993, BIOCHEM PHARMACOL, V46, P791, DOI 10.1016/0006-2952(93)90486-G; Deutsch DG, 2001, J BIOL CHEM, V276, P6967, DOI 10.1074/jbc.M003161200; Di Marzo V, 2009, INT J OBESITY, V33, pS18, DOI 10.1038/ijo.2009.67; Diaz-Laviada I, 2011, NAT REV UROL, V8, P553, DOI 10.1038/nrurol.2011.130; Endsley MP, 2008, INT J CANCER, V123, P1318, DOI 10.1002/ijc.23674; Fowler CJ, 2009, BRIT J PHARMACOL, V156, P412, DOI 10.1111/j.1476-5381.2008.00029.x; Fowler CJ, 2008, PHARMACOL RES, V58, P72, DOI 10.1016/j.phrs.2008.07.002; Fowler CJ, 2013, FEBS J, V280, P1895, DOI 10.1111/febs.12212; Fowler CJ, 2010, CURR TOP MED CHEM, V10, P814; Fowler CJ, 2004, EUR J PHARMACOL, V492, P1, DOI 10.1016/j.ejphar.2004.03.048; Freimuth N, 2010, J PHARMACOL EXP THER, V332, P336, DOI 10.1124/jpet.109.157735; Fu J, 2012, NAT NEUROSCI, V15, P64, DOI 10.1038/nn.2986; Gatta L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031111; Guindon J, 2011, BRIT J PHARMACOL, V163, P1447, DOI 10.1111/j.1476-5381.2011.01327.x; Hermanson DJ, 2013, NAT NEUROSCI, V16, P1291, DOI 10.1038/nn.3480; Hillard CJ, 2005, NEUROPHARMACOLOGY, V48, P1072, DOI 10.1016/j.neuropharm.2004.12.012; Idris Aymen I, 2012, Front Endocrinol (Lausanne), V3, P136, DOI 10.3389/fendo.2012.00136; Kaczocha M, 2009, P NATL ACAD SCI USA, V106, P6375, DOI 10.1073/pnas.0901515106; Karlsson M, 2004, EUR J PHARM SCI, V22, P181, DOI 10.1016/j.ejps.2004.03.009; Kathuria S, 2003, NAT MED, V9, P76, DOI 10.1038/nm803; LELCUK S, 1984, J TRAUMA, V24, P393, DOI 10.1097/00005373-198405000-00004; Leung K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079355; Long JZ, 2009, NAT CHEM BIOL, V5, P37, DOI 10.1038/nchembio.129; Morphy R, 2005, J MED CHEM, V48, P6523, DOI 10.1021/jm058225d; Oddi S, 2009, CHEM BIOL, V16, P624, DOI 10.1016/j.chembiol.2009.05.004; Ortar G, 2003, BIOCHEM PHARMACOL, V65, P1473, DOI 10.1016/S0006-2952(03)00109-6; Ortega-Gutierrez S, 2004, BIOCHEMISTRY-US, V43, P8184, DOI 10.1021/bi049395f; Pisanti S, 2013, TRENDS PHARMACOL SCI, V34, P273, DOI 10.1016/j.tips.2013.03.003; POTTER GA, 1995, J MED CHEM, V38, P2463, DOI 10.1021/jm00013a022; Rakhshan F, 2000, J PHARMACOL EXP THER, V292, P960; Roques BP, 2012, NAT REV DRUG DISCOV, V11, P292, DOI 10.1038/nrd3673; Sai Y, 2000, XENOBIOTICA, V30, P327, DOI 10.1080/004982500237541; Sandberg A, 2005, CHEM PHYS LIPIDS, V134, P131, DOI 10.1016/j.chemphyslip.2004.12.010; Sekar VJ, 2008, BRIT J CLIN PHARMACO, V66, P215, DOI 10.1111/j.1365-2125.2008.03191.x; Snider NT, 2010, PHARMACOL REV, V62, P136, DOI 10.1124/pr.109.001081; Snider NT, 2009, MOL PHARMACOL, V75, P965, DOI 10.1124/mol.108.053439; Starowicz K, 2013, EUR J PHARMACOL, V716, P41, DOI 10.1016/j.ejphar.2013.01.075; Thors L, 2006, BRIT J PHARMACOL, V149, P73, DOI 10.1038/sj.bjp.0706831; Thors L, 2007, BRIT J PHARMACOL, V152, P744, DOI 10.1038/sj.bjp.0707401; Tolle A, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-302; TOLMAN EL, 1983, BIOCHEM PHARMACOL, V32, P3488, DOI 10.1016/0006-2952(83)90383-0; Ueda N, 2013, FEBS J, V280, P1874, DOI 10.1111/febs.12152; Vandevoorde S, 2003, J MED CHEM, V46, P1440, DOI 10.1021/jm0209679; Vasaitis TS, 2011, J STEROID BIOCHEM, V125, P23, DOI 10.1016/j.jsbmb.2010.11.005; Velasco G, 2012, NAT REV CANCER, V12, P436, DOI 10.1038/nrc3247; Warrilow AG, 2013, ANTIMICROB AGENTS CH, V57, P1352, DOI 10.1128/AAC.02067-12; Worthington HV, 2010, COCHRANE DB SYST REV, V2010; Zee YK, 2012, FUTURE ONCOL, V8, P731, DOI [10.2217/fon.12.53, 10.2217/FON.12.53]	57	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2014	9	1							e87542	10.1371/journal.pone.0087542	http://dx.doi.org/10.1371/journal.pone.0087542			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297XI	24466356	Green Submitted, gold, Green Published			2022-12-25	WOS:000330288000212
J	Fang, WT; Chou, JY; Lu, SY				Fang, Wei-Ta; Chou, Jui-Yu; Lu, Shiau-Yun			Simple Patchy-Based Simulators Used to Explore Pondscape Systematic Dynamics	PLOS ONE			English	Article							LAND-USE CHANGE; LOGISTIC-REGRESSION; DRIVING FORCES; COVER CHANGE; SPECIES RICHNESS; SPATIAL-ANALYSIS; PROXIMATE CAUSES; LANDSCAPE; DETERMINANTS; CONSERVATION	Thousands of farm ponds disappeared on the tableland in Taoyuan County, Taiwan since 1920s. The number of farm ponds that have disappeared is 1,895 (37%), 2,667 ponds remain (52%), and only 537 (11%) new ponds were created within a 757 km(2) areain Taoyuan, Taiwan between 1926 and 1960. In this study, a geographic information system (GIS) and logistic stepwise regression model were used to detect pond-loss rates and to understand the driving forces behind pondscape changes. The logistic stepwise regression model was used to develop a series of relationships between pondscapes affected by intrinsic driving forces (patch size, perimeter, and patch shape) and external driving forces (distance from the edge of the ponds to the edges of roads, rivers, and canals). The authors concluded that the loss of ponds was caused by pond intrinsic factors, such as pond perimeter; a large perimeter increases the chances of pond loss, but also increases the possibility of creating new ponds. However, a large perimeter is closely associated with circular shapes (lower value of the mean pond-patch fractal dimension [MPFD]), which characterize the majority of newly created ponds. The method used in this study might be helpful to those seeking to protect this unique landscape by enabling the monitoring of patch-loss problems by using simple patchy-based simulators.	[Fang, Wei-Ta] Natl Taiwan Normal Univ, Grad Inst Environm Educ, Taipei, Taiwan; [Chou, Jui-Yu] Natl Changhua Univ Educ, Dept Biol, Changhua, Taiwan; [Lu, Shiau-Yun] Natl Sun Yat Sen Univ, Dept Marine Environm & Engn, Kaohsiung 80424, Taiwan	National Taiwan Normal University; National Changhua University of Education; National Sun Yat Sen University	Fang, WT (corresponding author), Natl Taiwan Normal Univ, Grad Inst Environm Educ, Taipei, Taiwan.	wtfang@ntnu.edu.tw			National Science Council grants [NSC99-2410-H-216-007, NSC100-2628-H-003-161-MY2, NSC102-2311-B-018-001-MY2]	National Science Council grants	This work was supported by National Science Council grants (NSC99-2410-H-216-007 and NSC100-2628-H-003-161-MY2 to WF; NSC102-2311-B-018-001-MY2 to JC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arrhenius O, 1921, J ECOL, V9, P95, DOI 10.2307/2255763; Aspinall R, 2004, J ENVIRON MANAGE, V72, P91, DOI 10.1016/j.jenvman.2004.02.009; Berkson J, 1944, J AM STAT ASSOC, V39, P357, DOI 10.2307/2280041; Bhattarai K, 2009, J ENVIRON MANAGE, V91, P471, DOI 10.1016/j.jenvman.2009.09.016; Boothby J, 2003, LAND DEGRAD DEV, V14, P227, DOI 10.1002/ldr.551; Braimoh AK, 2007, LAND USE POLICY, V24, P502, DOI 10.1016/j.landusepol.2006.09.001; Burgi M, 2004, LANDSCAPE ECOL, V19, P857, DOI 10.1007/s10980-004-0245-8; CHATFIELD C, 1995, J ROY STAT SOC A STA, V158, P419, DOI 10.2307/2983440; Chowdhury RR, 2006, APPL GEOGR, V26, P129, DOI 10.1016/j.apgeog.2005.11.004; CONNOR EF, 1979, AM NAT, V113, P791, DOI 10.1086/283438; Curado N, 2011, BIOL CONSERV, V144, P1610, DOI 10.1016/j.biocon.2011.02.011; Fang WT, 2012, PROCEDIA ENVIRON SCI, V12, P505, DOI 10.1016/j.proenv.2012.01.310; Fang WT, 2011, ECOL RES MONOGR, P187, DOI 10.1007/978-4-431-87799-8_13; Fang WT, 2009, PADDY WATER ENVIRON, V7, P209, DOI 10.1007/s10333-009-0164-z; Forman RT, 1995, LAND MOSAICS ECOLOGY, DOI 10.1017/9781107050327; Francl KE, 2002, ENVIRON MONIT ASSESS, V73, P67, DOI 10.1023/A:1012615314061; Froneman A, 2001, BIODIVERS CONSERV, V10, P251, DOI 10.1023/A:1008904421948; Geist HJ, 2002, BIOSCIENCE, V52, P143, DOI 10.1641/0006-3568(2002)052[0143:PCAUDF]2.0.CO;2; Gobin A, 2002, AGR ECOSYST ENVIRON, V89, P213, DOI 10.1016/S0167-8809(01)00163-3; Hartel T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063649; HEATH DJ, 1992, AQUAT CONSERV, V2, P267, DOI 10.1002/aqc.3270020306; Helmer EH, 2004, LANDSCAPE ECOL, V19, P29, DOI 10.1023/B:LAND.0000018364.68514.fb; Hersperger AM, 2010, ECOL SOC, V15; Houlahan JE, 2003, CAN J FISH AQUAT SCI, V60, P1078, DOI [10.1139/f03-095, 10.1139/F03-095]; Hull Andrew, 1997, P101; Kadoya T, 2004, ECOL RES, V19, P461, DOI 10.1111/j.1440-1703.2004.00659.x; Lambin EF, 1997, PROG PHYS GEOG, V21, P375, DOI 10.1177/030913339702100303; Lambin EF, 2001, GLOBAL ENVIRON CHANG, V11, P261, DOI 10.1016/S0959-3780(01)00007-3; Leitao AB, 2002, LANDSCAPE URBAN PLAN, V59, P65, DOI 10.1016/S0169-2046(02)00005-1; Lemmens P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072538; Linton S, 2000, AQUAT CONSERV, V10, P77, DOI 10.1002/(SICI)1099-0755(200003/04)10:2<77::AID-AQC391>3.0.CO;2-Y; LUDEKE AK, 1990, J ENVIRON MANAGE, V31, P247, DOI 10.1016/S0301-4797(05)80038-6; MAC ARTHUR ROBERT H., 1967; Machemer PL, 2006, LANDSCAPE RES, V31, P277, DOI 10.1080/01426390600783426; McGarigal K, 2012, FRAGSTATS V4 SPATIAL; Mladenoff DJ, 1999, ECOL APPL, V9, P37, DOI 10.1890/1051-0761(1999)009[0037:PGWLRL]2.0.CO;2; Nong Y, 2011, GEO-SPAT INF SCI, V14, P62, DOI 10.1007/s11806-011-0427-x; Oertli B, 2002, BIOL CONSERV, V104, P59, DOI 10.1016/S0006-3207(01)00154-9; Pampel FC, 2000, QUANTITATIVE APPL SO; Parker DC, 2003, ANN ASSOC AM GEOGR, V93, P314, DOI 10.1111/1467-8306.9302004; PEARMAN PB, 1995, OECOLOGIA, V102, P1, DOI 10.1007/BF00333303; Pontius RG, 2005, ENVIRON PLANN B, V32, P211, DOI 10.1068/b31152; Pontius RG, 2008, ANN REGIONAL SCI, V42, P11, DOI 10.1007/s00168-007-0138-2; Schneider LC, 2001, AGR ECOSYST ENVIRON, V85, P83, DOI 10.1016/S0167-8809(01)00189-X; Serneels S, 2001, AGR ECOSYST ENVIRON, V85, P65, DOI 10.1016/S0167-8809(01)00188-8; Serra P, 2008, APPL GEOGR, V28, P189, DOI 10.1016/j.apgeog.2008.02.001; SIMBERLOFF DS, 1976, SCIENCE, V191, P285, DOI 10.1126/science.191.4224.285; Smith SV, 2002, SCI TOTAL ENVIRON, V299, P21, DOI 10.1016/S0048-9697(02)00222-X; Stephenson CM, 2006, ECOL MODEL, V193, P747, DOI 10.1016/j.ecolmodel.2005.09.007; Strand GH, 2011, ENVIRON MODELL SOFTW, V26, P1150, DOI 10.1016/j.envsoft.2011.03.005; TURNER MG, 1988, APPL MATH COMPUT, V27, P39, DOI 10.1016/0096-3003(88)90097-5; Vanwalleghem T, 2008, GEOMORPHOLOGY, V95, P504, DOI 10.1016/j.geomorph.2007.07.003; Vanwalleghem T, 2008, GEOMORPHOLOGY, V95; Veldkamp A, 2001, AGR ECOSYST ENVIRON, V85, P1, DOI 10.1016/S0167-8809(01)00199-2; Verburg P. H., 2004, GeoJournal, V61, P309, DOI 10.1007/s10708-004-4946-y; Verburg P.H., 2004, COMPUTERS ENV URBAN, V28, P667, DOI [10.1016/j.compenvurbsys.2003.07.001, DOI 10.1016/J.COMPENVURBSYS.2003.07.001]; Verburg PH, 2004, ENVIRON PLANN B, V31, P125, DOI 10.1068/b307; WARD D, 1994, J BIOGEOGR, V21, P595, DOI 10.2307/2846034; Wimberly MC, 2004, LANDSCAPE ECOL, V19, P631, DOI 10.1023/B:LAND.0000042904.42355.f3; Zheng XQ, 2012, LANDSCAPE URBAN PLAN, V106, P51, DOI 10.1016/j.landurbplan.2012.02.006	60	5	6	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2014	9	1							e86888	10.1371/journal.pone.0086888	http://dx.doi.org/10.1371/journal.pone.0086888			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297XI	24466281	Green Published, Green Submitted, gold			2022-12-25	WOS:000330288000165
J	Gao, J; Li, JL; Li, BJ; Yagil, E; Zhang, JS; Du, SJ				Gao, Jie; Li, Junling; Li, Bao-Jun; Yagil, Ezra; Zhang, Jianshe; Du, Shao Jun			Expression and Functional Characterization of Smyd1a in Myofibril Organization of Skeletal Muscles	PLOS ONE			English	Article							ZEBRAFISH EMBRYOS; TRANSCRIPTION FACTOR; HISTONE METHYLTRANSFERASE; MOUSE CD8B; GENE; BOP; EVOLUTION; FISH; DIFFERENTIATION; SEQUENCE	Background: Smyd1, the founding member of the Smyd family including Smyd-1, 2, 3, 4 and 5, is a SET and MYND domain containing protein that plays a key role in myofibril assembly in skeletal and cardiac muscles. Bioinformatic analysis revealed that zebrafish genome contains two highly related smyd1 genes, smyd1a and smyd1b. Although Smyd1b function is well characterized in skeletal and cardiac muscles, the function of Smyd1a is, however, unknown. Methodology/Principal Findings: To investigate the function of Smyd1a in muscle development, we isolated smyd1a from zebrafish, and characterized its expression and function during muscle development via gene knockdown and transgenic expression approaches. The results showed that smyd1a was strongly expressed in skeletal muscles of zebrafish embryos. Functional analysis revealed that knockdown of smyd1a alone had no significant effect on myofibril assembly in zebrafish skeletal muscles. However, knockdown of smyd1a and smyd1b together resulted in a complete disruption of myofibril organization in skeletal muscles, a phenotype stronger than knockdown of smyd1a or smyd1b alone. Moreover, ectopic expression of zebrafish smyd1a or mouse Smyd1 transgene could rescue the myofibril defects from the smyd1b knockdown in zebrafish embryos. Conclusion/Significance: Collectively, these data indicate that Smyd1a and Smyd1b share similar biological activity in myofibril assembly in zebrafish embryos. However, Smyd1b appears to play a major role in this process.	[Gao, Jie; Li, Junling; Li, Bao-Jun; Du, Shao Jun] Univ Maryland, Sch Med, Dept Biochem & Mol Biol, Inst Marine & Environm Technol, Baltimore, MD 21201 USA; [Gao, Jie] Guangzhou Univ Chinese Med, Sch Chinese Mat Med, Guangzhou, Guangdong, Peoples R China; [Yagil, Ezra] Tel Aviv Univ, Dept Biochem, IL-69978 Tel Aviv, Israel; [Zhang, Jianshe] Changsha Univ, Dept Bioengn & Environm Sci, Changsha, Hunan, Peoples R China	University System of Maryland; University of Maryland Baltimore; University of Maryland Center for Environmental Science; Institute of Marine & Environmental Technology; Guangzhou University of Chinese Medicine; Tel Aviv University; Changsha University	Du, SJ (corresponding author), Univ Maryland, Sch Med, Dept Biochem & Mol Biol, Inst Marine & Environm Technol, Baltimore, MD 21201 USA.	sdu@som.umaryland.edu		du, Jim/0000-0001-9227-4153	United States - Israel Binational Agricultural Research and Development Fund [IS-8713-08]; Maryland Stem Cell Research Fund [MSCRFE-0232]; Nature and Science Foundation of China [31230076]	United States - Israel Binational Agricultural Research and Development Fund(US-Israel Binational Science Foundation); Maryland Stem Cell Research Fund; Nature and Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was supported by research grants No IS-8713-08 from the United States - Israel Binational Agricultural Research and Development Fund to YZ and SD, the Maryland Stem Cell Research Fund (MSCRFE-0232) to SD and Nature and Science Foundation of China (#31230076) to JZ and SD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amores A, 1998, SCIENCE, V282, P1711, DOI 10.1126/science.282.5394.1711; Blais A, 2005, GENE DEV, V19, P553, DOI 10.1101/gad.1281105; Codina M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008416; Costantini DL, 2005, CELL, V123, P347, DOI 10.1016/j.cell.2005.08.004; Du SJ, 2008, P NATL ACAD SCI USA, V105, P554, DOI 10.1073/pnas.0707330105; Du SJ, 2006, DEV DYNAM, V235, P3306, DOI 10.1002/dvdy.20984; Etard C, 2008, J CELL BIOL, V180, P1163, DOI 10.1083/jcb.200709128; Gottlieb PD, 2002, NAT GENET, V31, P25, DOI 10.1038/ng866; Hwang I, 1997, J IMMUNOL, V158, P1165; HWANG I, 1995, IMMUNOGENETICS, V42, P353, DOI 10.1007/BF00179396; Just S, 2011, J CELL SCI, V124, P3127, DOI 10.1242/jcs.084772; Leinhart K, 2011, GENES, V2, P210; Li DL, 2009, NUCLEIC ACIDS RES, V37, P7059, DOI 10.1093/nar/gkp773; Li HQ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028524; Meyer A, 1999, CURR OPIN CELL BIOL, V11, P699, DOI 10.1016/S0955-0674(99)00039-3; Nasevicius A, 2000, NAT GENET, V26, P216, DOI 10.1038/79951; OHNO S, 1968, HEREDITAS-GENETISK A, V59, P169; Park CY, 2010, P NATL ACAD SCI USA, V107, P20750, DOI 10.1073/pnas.1013493107; Phan D, 2005, DEVELOPMENT, V132, P2669, DOI 10.1242/dev.01849; Sims RJ, 2002, J BIOL CHEM, V277, P26524, DOI 10.1074/jbc.M204121200; Sirinupong N, 2010, J BIOL CHEM, V285, P40635, DOI 10.1074/jbc.M110.168187; Sun XJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001499; Tan XG, 2006, P NATL ACAD SCI USA, V103, P2713, DOI 10.1073/pnas.0509503103; Thisse C, 2008, NAT PROTOC, V3, P59, DOI 10.1038/nprot.2007.514; Urasaki A, 2006, GENETICS, V174, P639, DOI 10.1534/genetics.106.060244; Yang J, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-101; Zhang GQ, 2011, MAR BIOTECHNOL, V13, P151, DOI 10.1007/s10126-010-9275-1; Zhang JS, 2009, AQUAC RES, V40, P412, DOI 10.1111/j.1365-2109.2008.02109.x	28	16	17	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2014	9	1							e86808	10.1371/journal.pone.0086808	http://dx.doi.org/10.1371/journal.pone.0086808			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297XI	24466251	Green Published, gold, Green Submitted			2022-12-25	WOS:000330288000147
J	Hodzic, E; Imai, D; Feng, SL; Barthold, SW				Hodzic, Emir; Imai, Denise; Feng, Sunlian; Barthold, Stephen W.			Resurgence of Persisting Non-Cultivable Borrelia burgdorferi following Antibiotic Treatment in Mice	PLOS ONE			English	Article							WHITE-FOOTED MICE; LYME-DISEASE; PRACTICE GUIDELINES; GENE-EXPRESSION; INFECTED MICE; ARTHRITIS; PCR; SPIROCHETE; DYNAMICS; JOINTS	The agent of Lyme borreliosis, Borrelia burgdorferi, evades host immunity and establishes persistent infections in its varied mammalian hosts. This persistent biology may pose challenges to effective antibiotic treatment. Experimental studies in dogs, mice, and non-human primates have found persistence of B. burgdorferi DNA following treatment with a variety of antibiotics, but persisting spirochetes are non-cultivable. Persistence of B. burgdorferi DNA has been documented in humans following treatment, but the significance remains unknown. The present study utilized a ceftriaxone treatment regimen in the C3H mouse model that resulted in persistence of non-cultivable B. burgdorferi in order to determine their long-term fate, and to examine their effects on the host. Results confirmed previous studies, in which B. burgdorferi could not be cultured from tissues, but low copy numbers of B. burgdorferi flaB DNA were detectable in tissues at 2, 4 and 8 months after completion of treatment, and the rate of PCR-positive tissues appeared to progressively decline over time. However, there was resurgence of spirochete flaB DNA in multiple tissues at 12 months, with flaB DNA copy levels nearly equivalent to those found in saline-treated mice. Despite the continued non-cultivable state, RNA transcription of multiple B. burgdorferi genes was detected in host tissues, flaB DNA was acquired by xenodiagnostic ticks, and spirochetal forms could be visualized within ticks and mouse tissues by immunofluorescence and immunohistochemistry, respectively. A number of host cytokines were up- or down-regulated in tissues of both saline-and antibiotic-treated mice in the absence of histopathology, indicating host response to the presence of non-cultivable, despite the lack of inflammation in tissues.	[Hodzic, Emir] Univ Calif Davis, Ctr Comparat Med, Sch Med, Davis, CA 95616 USA; Univ Calif Davis, Ctr Comparat Med, Sch Vet Med, Davis, CA 95616 USA	University of California System; University of California Davis; University of California System; University of California Davis	Hodzic, E (corresponding author), Univ Calif Davis, Ctr Comparat Med, Sch Med, Davis, CA 95616 USA.	ehodzic@ucdavis.edu; swbarthold@ucdavis.edu			National Institutes of Health (NIH) [R01 AI26815, T32 OD 011147]; National Research Fund for Tick-Borne Diseases; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI026815] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [T32OD011147] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Research Fund for Tick-Borne Diseases; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by National Institutes of Health (NIH) grants R01 AI26815 (SWB, EH) and T32 OD 011147 (DI), and in part by the National Research Fund for Tick-Borne Diseases. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Veterinary Medical Association (AVMA), 2013, AVMA GUID EUTH AN 20; ARMSTRONG AL, 1992, AM J TROP MED HYG, V47, P249, DOI 10.4269/ajtmh.1992.47.249; BARBOUR AG, 1984, YALE J BIOL MED, V57, P521; Barthold S.W., 2010, BORRELIA MOL BIOL HO, P359; Barthold SW, 2006, INFECT IMMUN, V74, P4817, DOI 10.1128/IAI.00469-06; Barthold SW, 2010, ANTIMICROB AGENTS CH, V54, P643, DOI 10.1128/AAC.00788-09; Barthold SW, 1997, CLIN INFECT DIS, V25, pS9, DOI 10.1086/516166; Barthold SW, 1996, LAB INVEST, V74, P57; BARTHOLD SW, 1993, AM J PATHOL, V143, P959; BATTAFARANO DF, 1993, CLIN ORTHOP RELAT R, P238; Baum E, 2012, MBIO, V3, DOI 10.1128/mBio.00434-12; Bockenstedt LK, 2012, J CLIN INVEST, V122, P2652, DOI 10.1172/JCI58813; Bockenstedt LK, 2002, J INFECT DIS, V186, P1430, DOI 10.1086/345284; BRADLEY JF, 1994, ANN INTERN MED, V120, P487, DOI 10.7326/0003-4819-120-6-199403150-00007; DONAHUE JG, 1987, AM J TROP MED HYG, V36, P92, DOI 10.4269/ajtmh.1987.36.92; Embers M, 2012, PATHOGENIC SPIROCHET, P229; Embers ME, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029914; Feng SL, 1998, INFECT IMMUN, V66, P2827, DOI 10.1128/IAI.66.6.2827-2835.1998; GOODMAN JL, 1991, J CLIN MICROBIOL, V29, P894, DOI 10.1128/JCM.29.5.894-896.1991; Hefty PS, 2002, J CLIN MICROBIOL, V40, P4256, DOI 10.1128/JCM.40.11.4256-4265.2002; Hodzic E, 2003, INFECT IMMUN, V71, P5042, DOI 10.1128/IAI.71.9.5042-5055.2003; Hodzic E, 2002, INFECT IMMUN, V70, P3382, DOI 10.1128/IAI.70.7.3382-3388.2002; Hodzic E, 2008, ANTIMICROB AGENTS CH, V52, P1728, DOI 10.1128/AAC.01050-07; Hodzic E, 2013, VECTOR-BORNE ZOONOT, V13, P694, DOI 10.1089/vbz.2012.1189; Imai DM, 2013, LAB INVEST, V93, P900, DOI 10.1038/labinvest.2013.81; Koomanachai P, 2009, ANTIMICROB AGENTS CH, V53, P5060, DOI 10.1128/AAC.00985-09; Li X, 2011, ARTHRITIS RHEUM-US, V63, P2238, DOI 10.1002/art.30384; MACDONALD AB, 1990, ACTA TROP, V48, P89, DOI 10.1016/0001-706X(90)90047-4; MOODY KD, 1994, ANTIMICROB AGENTS CH, V38, P1567, DOI 10.1128/AAC.38.7.1567; MOODY KD, 1990, AM J TROP MED HYG, V42, P165, DOI 10.4269/ajtmh.1990.42.165; MURSIC VP, 1990, INFECTION, V18, P332, DOI 10.1007/BF01646399; Oksi J, 1999, ANN MED, V31, P225, DOI 10.3109/07853899909115982; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Picha D, 2008, INT J DERMATOL, V47, P1004, DOI 10.1111/j.1365-4632.2008.03709.x; Priem S, 1998, ANN RHEUM DIS, V57, P118, DOI 10.1136/ard.57.2.118; ROBERTS ED, 1995, LAB INVEST, V72, P146; Schutzer SE, 2011, J BACTERIOL, V193, P1018, DOI 10.1128/JB.01158-10; SCHWAN TG, 1988, J CLIN MICROBIOL, V26, P893, DOI 10.1128/JCM.26.5.893-895.1988; SONNESYN SW, 1993, INFECT IMMUN, V61, P4777, DOI 10.1128/IAI.61.11.4777-4784.1993; Straubinger RK, 1997, J CLIN MICROBIOL, V35, P111, DOI 10.1128/JCM.35.1.111-116.1997; Straubinger RK, 1998, WIEN KLIN WOCHENSCHR, V110, P874; Straubinger RK, 2000, J INFECT DIS, V181, P1069, DOI 10.1086/315340; Tunev SS, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002066; Wang EJ, 2005, J ANTIMICROB CHEMOTH, V55, P721, DOI 10.1093/jac/dki085; Wormser GP, 2006, CLIN INFECT DIS, V43, P1089, DOI 10.1086/508667; Wormser GP, 2009, CLIN MICROBIOL REV, V22, P387, DOI 10.1128/CMR.00004-09; Wormser GP, 2000, CLIN INFECT DIS, V31, pS1, DOI 10.1086/314053; Yrjanainen H, 2007, J INFECT DIS, V195, P1489, DOI 10.1086/513873; Yrjanainen H, 2006, MICROBES INFECT, V8, P2044, DOI 10.1016/j.micinf.2006.03.008; Yrjanainen H, 2010, APMIS, V118, P665, DOI 10.1111/j.1600-0463.2010.02615.x	50	71	72	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2014	9	1							e86907	10.1371/journal.pone.0086907	http://dx.doi.org/10.1371/journal.pone.0086907			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297XI	24466286	Green Published, Green Submitted, gold			2022-12-25	WOS:000330288000169
J	Smith, S; Fox, J; Mejia, M; Ruangpradit, W; Saberi, A; Kim, S; Choi, Y; Oh, S; Wang, YC; Choi, K; Li, L; Hendrickson, EA; Takeda, S; Muller, M; Myung, K				Smith, Stephanie; Fox, Jennifer; Mejia, Marco; Ruangpradit, Wanvipa; Saberi, Alihossein; Kim, Sunmi; Choi, Yongjun; Oh, Sehyun; Wang, Yucai; Choi, Kyungho; Li, Lei; Hendrickson, Eric A.; Takeda, Shunichi; Muller, Mark; Myung, Kyungjae			Histone Deacetylase Inhibitors Selectively Target Homology Dependent DNA Repair Defective Cells and Elevate Non-Homologous Endjoining Activity	PLOS ONE			English	Article							STRAND-BREAK-REPAIR; PROTEIN-KINASE; V(D)J RECOMBINATION; CATALYTIC SUBUNIT; MAMMALIAN-CELLS; CANCER-CELLS; HUMAN ELG1; PHOSPHORYLATION; DAMAGE; STABILITY	Background: We have previously used the ATAD5-luciferase high-throughput screening assay to identify genotoxic compounds with potential chemotherapeutic capabilities. The successful identification of known genotoxic agents, including the histone deacetylase inhibitor (HDACi) trichostatin A (TSA), confirmed the specificity of the screen since TSA has been widely studied for its ability to cause apoptosis in cancer cells. Because many cancers have acquired mutations in DNA damage checkpoints or repair pathways, we hypothesized that these cancers may be susceptible to treatments that target compensatory pathways. Here, we used a panel of isogenic chicken DT40 B lymphocyte mutant and human cell lines to investigate the ability of TSA to define selective pathways that promote HDACi toxicity. Results: HDACi induced a DNA damage response and reduced viability in all repair deficient DT40 mutants although ATM-nulls were least affected. The most dramatic sensitivity was observed in mutants lacking the homology dependent repair (HDR) factor BLM or the non-homologous end-joining (NHEJ) and HDR factors, KU/RAD54, suggesting an involvement of either HDR or NHEJ in HDACi-induced cell death. To extend these findings, we measured the frequencies of HDR and NHEJ after HDACi treatment and monitored viability in human cell lines comparably deficient in HDR or NHEJ. Although no difference in HDR frequency was observed between HDACi treated and untreated cells, HDR-defective human cell lines were clearly more sensitive than wild type. Unexpectedly, cells treated with HDACis showed a significantly elevated NHEJ frequency. Conclusions: HDACi targeting drugs induced significant increases in NHEJ activity in human cell lines but did not alter HDR frequency. Moreover, HDR is required for cellular resistance to HDACi therapy; therefore, NHEJ does not appear to be a critical axis for HDACi resistance. Rather, HDACi compounds induced DNA damage, most likely double strand breaks (DSBs), and HDR proficiency is correlated with cell survival.	[Smith, Stephanie; Fox, Jennifer; Kim, Sunmi; Choi, Yongjun; Myung, Kyungjae] NHGRI, Genome Instabil Sect, Genet & Mol Biol Branch, NIH, Bethesda, MD 20892 USA; [Mejia, Marco; Ruangpradit, Wanvipa; Muller, Mark] Univ Cent Florida, Coll Med, Dept Mol Biol & Microbiol, Orlando, FL USA; [Saberi, Alihossein; Kim, Sunmi; Takeda, Shunichi] Kyoto Univ, Sch Med, Dept Radiat Genet, Kyoto 6068501, Japan; [Kim, Sunmi; Choi, Kyungho] Seoul Natl Univ, Dept Environm Hlth Sch Publ Hearth, Seoul, South Korea; [Wang, Yucai; Li, Lei] Univ Texas MD Anderson Canc Ctr, Dept Expt Clin Oncol, Houston, TX 77030 USA; [Li, Lei] Univ Texas MD Anderson Canc Ctr, Dept Genet, Houston, TX 77030 USA; [Wang, Yucai] Univ Texas Houston, Grad Sch Biomed Sci, Houston, TX USA; [Oh, Sehyun; Hendrickson, Eric A.] Univ Minnesota, Sch Med, Dept Biochem Mol Biol & Biophys, Minneapolis, MN 55455 USA	National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); State University System of Florida; University of Central Florida; Kyoto University; Seoul National University (SNU); University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; University of Texas Health Science Center Houston; University of Minnesota System; University of Minnesota Twin Cities	Myung, K (corresponding author), NHGRI, Genome Instabil Sect, Genet & Mol Biol Branch, NIH, Bethesda, MD 20892 USA.	kmyung@mail.nih.gov	choi, kyungho/D-5732-2012; Kim, Sunmi/G-8114-2015	choi, kyungho/0000-0001-7460-792X; Takeda, Shunichi/0000-0002-7924-7991; saberi, Alihossein/0000-0003-4360-9118; Oh, Sehyun/0000-0002-9490-3061; Kim, Sunmi/0000-0001-9699-6532	NIH [GM088351, CA154461, CA127945, CA097175, R03 MH092164-01]; UCF College of Medicine; Ministry of Education, Culture, Sports, Science and Technology of the Japanese Government (MEXT) [20241012]; National Research Foundation of Korea (NRF); Ministry of Education, Science and Technology [357-2011-D00133]; National Human Genome Research Institute; NATIONAL CANCER INSTITUTE [R01CA127945, R01CA154461, P01CA097175] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIAHG200376] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM088351] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [T32AG029796] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UCF College of Medicine; Ministry of Education, Culture, Sports, Science and Technology of the Japanese Government (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This research was supported by the NIH grants GM088351, CA154461 to EAH, the NIH grants CA127945, CA097175 to LL, the UCF College of Medicine to MTM, a grant-in-aid from the Ministry of Education, Culture, Sports, Science and Technology of the Japanese Government (MEXT, number 20241012) to ST, the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (357-2011-D00133), the intramural Research Programs of the National Human Genome Research Institute and NIH R03 MH092164-01 to KM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adimoolam S, 2007, P NATL ACAD SCI USA, V104, P19482, DOI 10.1073/pnas.0707828104; Ai T, 2012, CURR MED CHEM, V19, P475, DOI 10.2174/092986712798918842; Barber LJ, 2008, CELL, V135, P261, DOI 10.1016/j.cell.2008.08.016; BLUNT T, 1995, CELL, V80, P813, DOI 10.1016/0092-8674(95)90360-7; Bunting SF, 2010, CELL, V141, P243, DOI 10.1016/j.cell.2010.03.012; Candotti F, 1997, BLOOD, V90, P3996, DOI 10.1182/blood.V90.10.3996; Chapman JR, 2012, MOL CELL, V47, P497, DOI 10.1016/j.molcel.2012.07.029; Chu WK, 2009, NAT REV CANCER, V9, P644, DOI 10.1038/nrc2682; Cuozzo C, 2007, PLOS GENET, V3, P1144, DOI 10.1371/journal.pgen.0030110; Douglas P, 2005, DNA REPAIR, V4, P1006, DOI 10.1016/j.dnarep.2005.05.003; Evans TJ, 2010, DNA REPAIR, V9, P1292, DOI 10.1016/j.dnarep.2010.09.017; Fattah F, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000855; Fox JT, 2012, P NATL ACAD SCI USA, V109, P5423, DOI 10.1073/pnas.1114278109; Goodarzi AA, 2006, DNA PK AUTOPHOSPHORY; GUNN A, 2012, DNA REPAIR PROTOCOLS, V920, P379; Ho AS, 2013, EPIGENETIC THERAPY U; Hsiao K-Y, 2013, J MOL CELL BIOL; Hu Y, 2007, GENE DEV, V21, P3073, DOI 10.1101/gad.1609107; Jasek E, 2012, ANTICANCER RES, V32, P2791; Kasparek TR, 2011, SEMIN CELL DEV BIOL, V22, P886, DOI 10.1016/j.semcdb.2011.10.007; Kass EM, 2013, P NATL ACAD SCI USA, V110, P5564, DOI 10.1073/pnas.1216824110; KIRCHGESSNER CU, 1995, SCIENCE, V267, P1178, DOI 10.1126/science.7855601; Kotian S, 2011, J BIOL CHEM, V286, P7722, DOI 10.1074/jbc.C110.194233; Krejci L, 2012, NUCLEIC ACIDS RES, V40, P5795, DOI 10.1093/nar/gks270; Krijger PHL, 2011, DNA REPAIR, V10, P438, DOI 10.1016/j.dnarep.2010.12.008; Kuchma MH, 2012, PROTEIN J, V31, P195, DOI 10.1007/s10930-011-9388-z; Lee BY, 2012, NUCLEIC ACIDS RES, V40, P2481, DOI 10.1093/nar/gkr1115; Lee GE, 2010, J BIOL CHEM, V285, P37630, DOI 10.1074/jbc.M110.148536; Lee JH, 2010, P NATL ACAD SCI USA, V107, P14639, DOI 10.1073/pnas.1008522107; Lee KY, 2010, J BIOL CHEM, V285, P10362, DOI 10.1074/jbc.M109.092544; Li D, 2011, CELL DEATH DIFFER, V18, P1904, DOI 10.1038/cdd.2011.71; Lieber MR, 2010, ANNU REV BIOCHEM, V79, P181, DOI 10.1146/annurev.biochem.052308.093131; Mao ZY, 2008, DNA REPAIR, V7, P1765, DOI 10.1016/j.dnarep.2008.06.018; Mathew CG, 2006, ONCOGENE, V25, P5875, DOI 10.1038/sj.onc.1209878; Merolla F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036177; MILLER RD, 1995, P NATL ACAD SCI USA, V92, P10792, DOI 10.1073/pnas.92.23.10792; Moldovan GL, 2012, MOL CELL, V45, P75, DOI 10.1016/j.molcel.2011.11.010; Murr R, 2006, HISTONE ACETYLATION; Nakanishi K, 2005, P NATL ACAD SCI USA, V102, P1110, DOI 10.1073/pnas.0407796102; Nalabothula N, 2011, EPIGENOMICS-UK, V3, P145, DOI 10.2217/EPI.11.12; Oh S, 2013, NUCLEIC ACIDS RES, V41, P1734, DOI 10.1093/nar/gks1326; Olaharski AJ, 2006, TOXICOL SCI, V93, P341, DOI 10.1093/toxsci/kfl068; PETERSON SR, 1995, P NATL ACAD SCI USA, V92, P3171, DOI 10.1073/pnas.92.8.3171; Pierce AJ, 1999, GENE DEV, V13, P2633, DOI 10.1101/gad.13.20.2633; Roy R, 2012, NAT REV CANCER, V12, P68, DOI 10.1038/nrc3181; Sikdar N, 2009, CELL CYCLE, V8, P3199, DOI 10.4161/cc.8.19.9752; Smith S, 2009, YEAST MODEL HUMAN DI, P249; Sommers JA, 2009, J BIOL CHEM, V284, P7505, DOI 10.1074/jbc.M809019200; Tikoo Shweta, 2010, Genome Integr, V1, P14, DOI 10.1186/2041-9414-1-14; Wang YG, 2004, J BIOL CHEM, V279, P37282, DOI 10.1074/jbc.M401217200; Wang YC, 2013, MOL CELL, V49, P997, DOI 10.1016/j.molcel.2012.12.010; Xia B, 2006, MOL CELL, V22, P719, DOI 10.1016/j.molcel.2006.05.022; Yu XC, 2006, GENE DEV, V20, P1721, DOI 10.1101/gad.1431006; Yu YP, 2003, DNA REPAIR, V2, P1239, DOI 10.1016/S1568-7864(03)00143-5	54	20	20	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2014	9	1							e87203	10.1371/journal.pone.0087203	http://dx.doi.org/10.1371/journal.pone.0087203			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297XI	24466340	Green Submitted, Green Published, gold			2022-12-25	WOS:000330288000198
J	El Kebir, D; Damlaj, A; Filep, JG				El Kebir, Driss; Damlaj, Anas; Filep, Janos G.			Toll-Like Receptor 9 Signaling Delays Neutrophil Apoptosis by Increasing Transcription of Mcl-1	PLOS ONE			English	Article							BACTERIAL-DNA; CPG MOTIFS; GRANULOCYTE APOPTOSIS; UP-REGULATION; RESOLUTION; INFLAMMATION; INHIBITION; EXPRESSION; SEPSIS; LUNG	Neutrophils detect bacterial constituents, including bacterial DNA (CpG DNA), which elicits innate immunity and prolongs the functional life span of neutrophils through suppression of apoptosis. Both the anti-apoptotic protein Mcl-1 and activation of NF-kappa B have been implicated in neutrophil survival, but there is no evidence that these are linked in neutrophils. We hypothesized that CpG DNA could simultaneously activate these pathways. High purity CpG DNA (0.4-3.2 mu g/ml) extended the life span of human neutrophils in vitro by delaying apoptosis through altering the rate of Mcl-1 turnover. CpG DNA slightly decreased Mcl-1 protein level in the presence of cyclohexmide and the proteasome inhibitor MG132 had little effect on Mcl-1 expression in CpG DNA-treated neutrophils. In contrast, CpG DNA evoked rapid increases in DNA binding by NF-kappa B/p65 and Mcl-1 mRNA. NF-kappa B inhibitors and the telomere-derived TLR9 inhibitory oligonucleotide 5'-TTT AGG GTT AGG GTT AGG G-3' markedly reduced Mcl-1 protein levels and subsequently abrogated suppression of apoptosis by CpG DNA. Furthermore, CpG DNA attenuated the decreases in Mcl-1 in both cell lysate and nucleus of neutrophils undergoing spontaneous apoptosis and increased Mcl-1 translocation to the mitochondria, leading to preservation of mitochondrial transmembrane potential. These results demonstrate that CpG DNA through toll-like receptor 9 links two survival signaling pathways by delaying apoptosis through induction of NF-kappa B-mediated Mcl-1 gene transcription and promoting Mcl-1 translocation to the mitochondria.	[Filep, Janos G.] Univ Montreal, Maisonneuve Rosemont Hosp, Res Ctr, Montreal, PQ, Canada; Univ Montreal, Dept Pathol & Cell Biol, Montreal, PQ, Canada	Universite de Montreal; Universite de Montreal	Filep, JG (corresponding author), Univ Montreal, Maisonneuve Rosemont Hosp, Res Ctr, Montreal, PQ, Canada.	janos.g.filep@umontreal.ca			Canadian Institutes of Health Research [MOP-97742]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was funded by grant MOP-97742 (to JGF) from the Canadian Institutes of Health Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akgul C, 2000, FEBS LETT, V478, P72, DOI 10.1016/S0014-5793(00)01809-3; Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Bauer S, 2001, P NATL ACAD SCI USA, V98, P9237, DOI 10.1073/pnas.161293498; Catarzi S, 2008, INFLAMM BOWEL DIS, V14, P819, DOI 10.1002/ibd.20397; Deng JC, 2004, J IMMUNOL, V173, P5148, DOI 10.4049/jimmunol.173.8.5148; Derouet M, 2006, J IMMUNOL, V176, P957, DOI 10.4049/jimmunol.176.2.957; Derouet M, 2004, J BIOL CHEM, V279, P26915, DOI 10.1074/jbc.M313875200; Dong L, 2011, ONCOGENE, V30, P3716, DOI 10.1038/onc.2011.87; Dzhagalov I, 2007, BLOOD, V109, P1620, DOI 10.1182/blood-2006-03-013771; El Kebir D, 2008, CIRC RES, V103, P352, DOI 10.1161/01.RES.0000326772.76822.7a; El Kebir D, 2012, P NATL ACAD SCI USA, V109, P14983, DOI 10.1073/pnas.1206641109; El Kebir D, 2010, THESCIENTIFICWORLDJO, V10, P1731, DOI 10.1100/tsw.2010.169; El Kebir D, 2009, AM J RESP CRIT CARE, V180, P311, DOI 10.1164/rccm.200810-1601OC; El Kebir D, 2009, J IMMUNOL, V182, P4386, DOI 10.4049/jimmunol.0803044; Ertel W, 1998, J TRAUMA, V44, P767, DOI 10.1097/00005373-199805000-00005; Fialkow L, 2006, CRIT CARE, V10, DOI 10.1186/cc5090; Francois S, 2005, J IMMUNOL, V174, P3633, DOI 10.4049/jimmunol.174.6.3633; Garlichs CD, 2004, J LEUKOCYTE BIOL, V75, P828, DOI 10.1189/jlb.0703358; Gursel I, 2003, J IMMUNOL, V171, P1393, DOI 10.4049/jimmunol.171.3.1393; Hayashi F, 2003, BLOOD, V102, P2660, DOI 10.1182/blood-2003-04-1078; Hemmi H, 2000, NATURE, V408, P740, DOI 10.1038/35047123; Hornung V, 2010, NAT REV IMMUNOL, V10, P123, DOI 10.1038/nri2690; Itagaki K, 2011, SHOCK, V36, P548, DOI 10.1097/SHK.0b013e3182369fb2; Jonsson H, 2005, NAT MED, V11, P666, DOI 10.1038/nm1248; Jozsef L, 2004, FASEB J, V18, P1776, DOI 10.1096/fj.04-2048fje; Knuefermann P, 2007, RESP RES, V8, DOI 10.1186/1465-9921-8-72; Koedel U, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000461; KOZOPAS KM, 1993, P NATL ACAD SCI USA, V90, P3516, DOI 10.1073/pnas.90.8.3516; Lehtiniemi J, 2005, EUR J CLIN INVEST, V35, P13, DOI 10.1111/j.1365-2362.2005.01440.x; Leitch AE, 2012, CELL DEATH DIFFER, V19, P1950, DOI 10.1038/cdd.2012.80; Maianski NA, 2004, CELL DEATH DIFFER, V11, P143, DOI 10.1038/sj.cdd.4401320; MatuteBello G, 1997, AM J RESP CRIT CARE, V156, P1969, DOI 10.1164/ajrccm.156.6.96-12081; Moulding DA, 1998, BLOOD, V92, P2495, DOI 10.1182/blood.V92.7.2495.2495_2495_2502; Moulding DA, 2001, J LEUKOCYTE BIOL, V70, P783; Nathan C, 2010, CELL, V140, P871, DOI 10.1016/j.cell.2010.02.029; Negrotto S, 2006, J PHARMACOL EXP THER, V319, P972, DOI 10.1124/jpet.106.109389; Pryde JG, 2000, J BIOL CHEM, V275, P33574, DOI 10.1074/jbc.M001008200; Ratanarat R, 2007, BLOOD PURIFICAT, V25, P106, DOI 10.1159/000096406; Rossi AG, 2006, NAT MED, V12, P1056, DOI 10.1038/nm1468; SAVILL JS, 1989, J CLIN INVEST, V83, P865, DOI 10.1172/JCI113970; Schwartz DA, 1997, J CLIN INVEST, V100, P68, DOI 10.1172/JCI119523; Solito E, 2003, FASEB J, V17, P1544, DOI 10.1096/fj.02-0941fje; Sunil VR, 2002, RESP RES, V3, DOI 10.1186/rr171; Takaoka A, 2007, NATURE, V448, P501, DOI 10.1038/nature06013; Thomas LW, 2010, FEBS LETT, V584, P2981, DOI 10.1016/j.febslet.2010.05.061; Trevani AS, 2003, EUR J IMMUNOL, V33, P3164, DOI 10.1002/eji.200324334; Ward C, 2004, BIOCHEM SOC T, V32, P465, DOI 10.1042/BST0320465; Ward C, 1999, J BIOL CHEM, V274, P4309, DOI 10.1074/jbc.274.7.4309; Wardle DJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015768; Weighardt H, 2000, J IMMUNOL, V165, P4537, DOI 10.4049/jimmunol.165.8.4537; Yi AK, 1998, J IMMUNOL, V160, P4755; Zhang Q, 2010, NATURE, V464, P104, DOI 10.1038/nature08780; Zhong Q, 2005, CELL, V121, P1085, DOI 10.1016/j.cell.2005.06.009	53	11	12	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2014	9	1							e87006	10.1371/journal.pone.0087006	http://dx.doi.org/10.1371/journal.pone.0087006			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297VL	24466313	Green Published, gold, Green Submitted			2022-12-25	WOS:000330283100242
J	Huddy, RJ; Coyne, VE				Huddy, Robert J.; Coyne, Vernon E.			Detection and Localisation of the Abalone Probiotic Vibrio midae SY9 and Its Extracellular Protease, VmproA, within the Digestive Tract of the South African Abalone, Haliotis midae	PLOS ONE			English	Article							IN-SITU HYBRIDIZATION; GREEN FLUORESCENT PROTEIN; IMPROVED GROWTH-RATE; OLIGONUCLEOTIDE PROBES; GUT MICROFLORA; DISCUS-HANNAI; BACTERIA; CULTURE; AQUACULTURE; EXPRESSION	Probiotics have been widely reported to increase the growth rate of commercially important fish and shellfish by enhancing the digestion of ingested feed through the production of extracellular enzymes such as proteases and alginases. In order to investigate this further, the objective of this study was to localise the bacterial probiont Vibrio midae SY9 and one of the extracellular proteases it produces in the digestive tract of the South African abalone Haliotis midae. This was accomplished by inserting a promotorless gfp gene into the chromosome of the bacterium which was incorporated in an artificial, fishmeal-based abalone feed. In situ histological comparison of abalone fed either a basal diet or the basal diet supplemented with V. midae SY9::Tn10.52 using a cocktail of DNA probes to the gfp gene localised the probiont to the crop/stomach and intestinal regions of the H. midae digestive tract. Generally, the ingested probiotic bacterium occurred in association with feed and particulate matter within the crop/stomach and intestinal regions, as well as adhered to the wall of the crop/stomach. Histological immunohistochemical examination using polyclonal anti-VmproA antibodies localised an extracellular protease produced by V. midae SY9 to the H. midae crop/stomach and intestine where it appeared to be associated with feed and/or other particulate matter in the abalone gut. Thus the data suggests that V. midae SY9 colonises and/or adheres to the mucous lining of the abalone gut. Furthermore, the close association observed between the bacterium, its extracellular protease and ingested feed particles supports the theory that V. midae SY9 elevates in situ digestive enzyme levels and thus enhances feed digestion in farmed abalone.	[Huddy, Robert J.; Coyne, Vernon E.] Univ Cape Town, Dept Mol & Cell Biol, Cape Town, South Africa	University of Cape Town	Coyne, VE (corresponding author), Univ Cape Town, Dept Mol & Cell Biol, Cape Town, South Africa.	vernon.coyne@uct.ac.za	Coyne, Vernon/E-5641-2010	Coyne, Vernon/0000-0002-2050-8683	National Research Foundation [2053565]; NRF	National Research Foundation; NRF	The study was supported by a National Research Foundation grant (2053565) awarded to VEC through the Conservation and Management of Ecosystems and Biodiversity Focus Area. RJH was supported by a NRF grant-holder linked bursary. Website: www.nrf.ac.za. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMANN RI, 1990, APPL ENVIRON MICROB, V56, P1919, DOI 10.1128/AEM.56.6.1919-1925.1990; Antonio DB, 2000, J INVERTEBR PATHOL, V75, P180, DOI 10.1006/jipa.1999.4906; Asfie M, 2003, FISHERIES SCI, V69, P21, DOI 10.1046/j.1444-2906.2003.00583.x; Ausubel F, 1990, CURRENT PROTOCOLS MO, V1; Balcazar JL, 2006, VET MICROBIOL, V114, P173, DOI 10.1016/j.vetmic.2006.01.009; Bell TA, 1988, HDB NORMAL PENAEID S; CHURCH GM, 1984, P NATL ACAD SCI-BIOL, V81, P1991, DOI 10.1073/pnas.81.7.1991; Egan S, 2002, APPL ENVIRON MICROB, V68, P372, DOI 10.1128/AEM.68.1.372-378.2002; Erasmus JH, 1997, AQUACULTURE, V155, P377, DOI 10.1016/S0044-8486(97)00112-9; Gomez-Gil B, 2000, AQUACULTURE, V191, P259, DOI 10.1016/S0044-8486(00)00431-2; Harris JO, 1998, J SHELLFISH RES, V17, P979; Hayat M. A., 1993, STAINS CYTOCHEMICAL, P63; Hoj L, 2009, AQUACULTURE, V293, P278, DOI 10.1016/j.aquaculture.2009.04.024; Holben WE, 2002, MICROB ECOL, V44, P175, DOI 10.1007/s00248-002-1011-6; Iehata S, 2010, AQUACULTURE, V305, P59, DOI 10.1016/j.aquaculture.2010.04.012; Macey BM, 2005, AQUACULTURE, V245, P249, DOI 10.1016/j.aquaculture.2004.11.031; Macey BM, 2006, MAR BIOTECHNOL, V8, P246, DOI 10.1007/s10126-005-0113-9; Moter A, 2000, J MICROBIOL METH, V41, P85, DOI 10.1016/S0167-7012(00)00152-4; Rengpipat S, 2009, AQUACULT NUTR, V15, P297, DOI 10.1111/j.1365-2095.2008.00594.x; Sawabe T, 2004, SYST APPL MICROBIOL, V27, P527, DOI 10.1078/0723202041748154; SAWABE T, 1995, MICROB ECOL, V30, P193; SIMON R, 1983, BIO-TECHNOL, V1, P784, DOI 10.1038/nbt1183-784; Streit A, 2001, METHODS, V23, P339, DOI 10.1006/meth.2000.1146; Stretton S, 1998, APPL ENVIRON MICROB, V64, P2554; Tanaka R, 2004, AQUACULTURE, V241, P453, DOI 10.1016/j.aquaculture.2004.08.032; Tanaka R, 2003, FISHERIES SCI, V69, P951, DOI 10.1046/j.1444-2906.2003.00712.x; ten Doeschate KI, 2008, AQUACULTURE, V284, P174, DOI 10.1016/j.aquaculture.2008.07.018; Troell M, 2006, AQUACULTURE, V257, P266, DOI 10.1016/j.aquaculture.2006.02.066; Verschuere L, 2000, MICROBIOL MOL BIOL R, V64, P655, DOI 10.1128/MMBR.64.4.655-671.2000; YANISCHPERRON C, 1985, GENE, V33, P103, DOI 10.1016/0378-1119(85)90120-9; ZISCHLER H, 1989, HUM GENET, V82, P227, DOI 10.1007/BF00291160	31	10	10	2	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2014	9	1							e86623	10.1371/journal.pone.0086623	http://dx.doi.org/10.1371/journal.pone.0086623			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297VL	24466176	Green Submitted, Green Published, gold			2022-12-25	WOS:000330283100192
J	Bullejos, FJ; Carrillo, P; Gorokhova, E; Medina-Sanchez, JM; Villar-Argaiz, M				Jose Bullejos, Francisco; Carrillo, Presentacion; Gorokhova, Elena; Manuel Medina-Sanchez, Juan; Villar-Argaiz, Manuel			Nucleic Acid Content in Crustacean Zooplankton: Bridging Metabolic and Stoichiometric Predictions	PLOS ONE			English	Article							HIGH-MOUNTAIN LAKE; GROWTH-RATE; LIFE-HISTORY; FRESH-WATER; DRY-WEIGHT; ULTRAVIOLET-RADIATION; ELEMENTAL COMPOSITION; RNA; PHOSPHORUS; FOOD	Metabolic and stoichiometric theories of ecology have provided broad complementary principles to understand ecosystem processes across different levels of biological organization. We tested several of their cornerstone hypotheses by measuring the nucleic acid (NA) and phosphorus (P) content of crustacean zooplankton species in 22 high mountain lakes (Sierra Nevada and the Pyrenees mountains, Spain). The P-allocation hypothesis (PAH) proposes that the genome size is smaller in cladocerans than in copepods as a result of selection for fast growth towards P-allocation from DNA to RNA under P limitation. Consistent with the PAH, the RNA: DNA ratio was > 8-fold higher in cladocerans than in copepods, although 'fast-growth' cladocerans did not always exhibit higher RNA and lower DNA contents in comparison to 'slow-growth' copepods. We also showed strong associations among growth rate, RNA, and total P content supporting the growth rate hypothesis, which predicts that fast-growing organisms have high P content because of the preferential allocation to P-rich ribosomal RNA. In addition, we found that ontogenetic variability in NA content of the copepod Mixodiaptomus laciniatus (intra-and interstage variability) was comparable to the interspecific variability across other zooplankton species. Further, according to the metabolic theory of ecology, temperature should enhance growth rate and hence RNA demands. RNA content in zooplankton was correlated with temperature, but the relationships were nutrient-dependent, with a positive correlation in nutrient-rich ecosystems and a negative one in those with scarce nutrients. Overall our results illustrate the mechanistic connections among organismal NA content, growth rate, nutrients and temperature, contributing to the conceptual unification of metabolic and stoichiometric theories.	[Jose Bullejos, Francisco; Manuel Medina-Sanchez, Juan; Villar-Argaiz, Manuel] Univ Granada, Fac Sci, Dept Ecol, Granada, Spain; [Carrillo, Presentacion] Univ Granada, Water Res Inst, Granada, Spain; [Gorokhova, Elena] Stockholm Univ, Dept Appl Environm Sci, S-10691 Stockholm, Sweden	University of Granada; University of Granada; Stockholm University	Bullejos, FJ (corresponding author), Univ Granada, Fac Sci, Dept Ecol, Granada, Spain.	fjbc@ugr.es	Medina-Sánchez, Juan Manuel/A-4703-2013; Bullejos Carrillo, Francisco José/K-4971-2015; Carrillo, Presentación/I-1601-2015; Gorokhova, Elena/E-7105-2018	Medina-Sánchez, Juan Manuel/0000-0003-0991-9331; Bullejos Carrillo, Francisco José/0000-0002-0335-3923; Carrillo, Presentación/0000-0003-3794-4294; Gorokhova, Elena/0000-0002-4192-6956	Spanish Ministries of Science and Innovation [CGL2011-23681/BOS]; Environment, Rural and Marine Affairs [OAPN2009/067]	Spanish Ministries of Science and Innovation(Spanish Government); Environment, Rural and Marine Affairs	This research was supported by the Spanish Ministries of Science and Innovation (CGL2011-23681/BOS), and Environment, Rural and Marine Affairs (OAPN2009/067); 'Consejeria de Innovacion, Ciencia y Empresa - Junta de Andalucia (Excelencia CVI-02598; P09-RNM-5376); The Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning (FORMAS) and Stockholm University's strategic marine environmental research program 'Baltic Ecosystem Adaptive Management', and a Spanish government 'Formacion de Profesorado Universitario' fellowship to F.J. Bullejos. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adrian R, 2009, LIMNOL OCEANOGR, V54, P2283, DOI 10.4319/lo.2009.54.6_part_2.2283; ALONSO M, 1991, HYDROBIOLOGIA, V225, P37, DOI 10.1007/BF00028383; Alonso Miguel, 1998, Limnetica, V15, P1; ANDERSEN T, 1991, LIMNOL OCEANOGR, V36, P807, DOI 10.4319/lo.1991.36.4.0807; [Anonymous], 2005, FUNDAMENTALS ECOLOGY; APHA American Public Health Association, 1992, STANDARD METHODS EXA; Arendt JD, 1997, Q REV BIOL, V72, P149, DOI 10.1086/419764; Begon M., 2005, ECOLOGY INDIVIDUALS, V4th ed.; BOTTRELL HH, 1976, NORW J ZOOL, V24, P419; Brown JH, 2004, ECOLOGY, V85, P1771, DOI 10.1890/03-9000; Bullejos FJ, 2013, ECOLOGY IN PRESS; Carrillo P, 2008, GLOBAL CHANGE BIOL, V14, P423, DOI 10.1111/j.1365-2486.2007.01496.x; Carrillo P, 2001, J PLANKTON RES, V23, P537, DOI 10.1093/plankt/23.5.537; CRUZ-PIZARRO L, 1981, ACT 1 C ESP LIMN, P115; CRUZPIZARRO L, 1983, HYDROBIOLOGIA, V107, P97, DOI 10.1007/BF00017425; DUMONT HJ, 1975, OECOLOGIA, V19, P75, DOI 10.1007/BF00377592; Elser JJ, 2006, FUNCT ECOL, V20, P846, DOI 10.1111/j.1365-2435.2006.01165.x; Elser JJ, 1996, BIOSCIENCE, V46, P674, DOI 10.2307/1312897; Elser JJ, 2003, ECOL LETT, V6, P936, DOI 10.1046/j.1461-0248.2003.00518.x; Elser JJ, 2000, ECOL LETT, V3, P540, DOI 10.1046/j.1461-0248.2000.00185.x; Gliwicz Z.M., 1985, Advances in Limnology, V21, P419; Gorokhova E, 2005, LIMNOL OCEANOGR-METH, V3, P143, DOI 10.4319/lom.2005.3.143; Gorokhova E, 2002, J PLANKTON RES, V24, P511, DOI 10.1093/plankt/24.5.511; Gorokhova E, 2002, P ROY SOC B-BIOL SCI, V269, P2373, DOI 10.1098/rspb.2002.2145; Gregory ET, 2008, ANIMAL GENOME SIZE D; Guisande C, 2003, OECOLOGIA, V136, P627, DOI 10.1007/s00442-003-1306-4; Hessen DO, 2008, GENOME, V51, P685, DOI 10.1139/G08-053; Hessen DO, 2010, TRENDS ECOL EVOL, V25, P75, DOI 10.1016/j.tree.2009.08.004; Bullejos FJ, 2010, LIMNOL OCEANOGR, V55, P2549, DOI 10.4319/lo.2010.55.6.2549; Klappenbach JA, 2000, APPL ENVIRON MICROB, V66, P1328, DOI 10.1128/AEM.66.4.1328-1333.2000; LIGNELL R, 1990, MAR ECOL PROG SER, V68, P85, DOI 10.3354/meps068085; Lindman HR., 1974, ANAL VARIANCE COMPLE; MCKEE MJ, 1987, FRESHWATER BIOL, V18, P341, DOI 10.1111/j.1365-2427.1987.tb01318.x; Miracle M.R., 1978, Oecologia Aquatica, V3, P167; Morales-Baquero R., 2006, LIMNETICA, V25, P171; Moya-Larano Jordi, 2008, Web Ecology, V8, P35; Parker BR, 2008, P NATL ACAD SCI USA, V105, P12927, DOI 10.1073/pnas.0806481105; PERSSON G, 1980, ARCH HYDROBIOL, V89, P225; Quinn GP, 2003, EXPT DESIGN DATA ANA; Root TL, 2003, NATURE, V421, P57, DOI 10.1038/nature01333; ROSEN RA, 1981, J FRESHWATER ECOL, V1, P225, DOI 10.1080/02705060.1981.9664034; Shin HC, 2003, MAR FRESHW BEHAV PHY, V36, P295, DOI 10.1080/10236240310001614402; Sibly R. M., 2012, METABOLIC ECOLOGY SC; Smith VH, 2006, LIMNOL OCEANOGR, V51, P351, DOI 10.4319/lo.2006.51.1_part_2.0351; StatSoft Inc., 2011, STAT DAT AN SOFTW SY; Steemann-Nielsen E, 1952, J CONS CONS PERM INT, V18, P117, DOI DOI 10.1093/ICESJMS/18.2.117; Sterner R.W, 2002, ECOLOGICAL STOICHIOM, DOI DOI 10.1086/382444; Sterner RW, 1997, AM NAT, V150, P663, DOI 10.1086/286088; Sterner RW, 2004, ECOLOGY, V85, P1813, DOI 10.1890/03-0724; Thompson R., 2005, J LIMNOL, V64, P139, DOI [10.4081/jlimnol.2005.139, DOI 10.4081/JLIMNOL.2005.139]; Van Geest GJ, 2010, POLAR BIOL, V33, P1255, DOI 10.1007/s00300-010-0814-z; Ventura M, 2005, LIMNOL OCEANOGR, V50, P2043, DOI 10.4319/lo.2005.50.6.2043; Ventura M, 2005, THESIS U BARCELONA B; Ventura M, 2008, FRESHWATER BIOL, V53, P1453, DOI 10.1111/j.1365-2427.2008.01976.x; Ventura M, 2006, MAR ECOL PROG SER, V327, P233, DOI 10.3354/meps327233; Ventura M, 2010, J PLANKTON RES, V32, P1583, DOI 10.1093/plankt/fbq066; Ventura Marc, 2000, Journal of Limnology, V59, P97; Villar-Argaiz M, 2002, ECOLOGY, V83, P1899, DOI 10.2307/3071773; Villar-Argaiz M, 2002, LIMNOL OCEANOGR, V47, P1229, DOI 10.4319/lo.2002.47.4.1229; Villar-Argaiz M, 2001, FRESHWATER BIOL, V46, P1017, DOI 10.1046/j.1365-2427.2001.00734.x; Villar-Argaiz M, 1999, THESIS U GRANADA GRA; Villar-Argaiz M, 2012, LIMNOL OCEANOGR, V57, P235, DOI 10.4319/lo.2012.57.1.0235; Vrede T, 2002, LIMNOL OCEANOGR, V47, P487, DOI 10.4319/lo.2002.47.2.0487; Wagner MM, 2001, MAR ECOL PROG SER, V221, P185, DOI 10.3354/meps221185; Walz N, 1987, THESIS U MUNCHEN MUN; Weider LJ, 2005, ANNU REV ECOL EVOL S, V36, P219, DOI 10.1146/annurev.ecolsys.36.102003.152620; Williamson CE, 2009, SCIENCE, V323, P887, DOI 10.1126/science.1169443; Woods HA, 2003, FUNCT ECOL, V17, P237, DOI 10.1046/j.1365-2435.2003.00724.x	68	17	17	0	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2014	9	1							e86493	10.1371/journal.pone.0086493	http://dx.doi.org/10.1371/journal.pone.0086493			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297GT	24466118	gold, Green Submitted, Green Published			2022-12-25	WOS:000330244500247
J	Tago, K; Funakoshi-Tago, M; Itoh, H; Furukawa, Y; Kikuchi, J; Kato, T; Suzuki, K; Yanagisawa, K				Tago, K.; Funakoshi-Tago, M.; Itoh, H.; Furukawa, Y.; Kikuchi, J.; Kato, T.; Suzuki, K.; Yanagisawa, K.			Arf tumor suppressor disrupts the oncogenic positive feedback loop including c-Myc and DDX5	ONCOGENE			English	Article						Arf; c-Myc; DDX5	RNA HELICASE P68; DEAD-BOX; RIBOSOME BIOGENESIS; TRANSCRIPTIONAL ACTIVITY; CELL-PROLIFERATION; PROTEIN; P53; P19(ARF); PATHWAYS; PROMOTES	Tumor suppressor protein p19(ARF) (Arf; p14(ARF) in humans) functions in both p53-dependent and -independent modes to counteract hyper-proliferative signals caused by proto-oncogene activation, but its p53-independent activities remain poorly understood. Using the tandem affinity purification-tag technique, we purified Arf-containing protein complexes and identified p68 DEAD-box protein (DDX5) as a novel interacting protein of Arf. In this study, we found that DDX5 interacts with c-Myc, and harbors essential roles for c-Myc-mediated transcription and its transforming activity. Furthermore, when c-Myc was forcibly expressed, the expression level of DDX5 protein was drastically increased through the acceleration of protein synthesis of DDX5, suggesting the presence of an oncogenic positive feedback loop including c-Myc and DDX5. Strikingly, Arf blocked the physical interaction between DDX5 and c-Myc, and drove away DDX5 from the promoter of c-Myc target genes. These observations most likely indicate the mechanism by which Arf causes p53-independent tumor-suppressive activity.	[Tago, K.; Yanagisawa, K.] Jichi Med Univ, Sch Med, Dept Biochem, Div Struct Biochem, Shimotsuke, Tochigi 3290498, Japan; [Funakoshi-Tago, M.] Keio Univ, Dept Biochem, Fac Pharm, Minato Ku, Tokyo 108, Japan; [Itoh, H.] Nara Inst Sci & Technol, Grad Sch Biol Sci, Dept Cell Biol, Lab Signal Transduct, Ikoma, Japan; [Furukawa, Y.; Kikuchi, J.] Jichi Med Univ, Ctr Mol Med, Div Stem Cell Regulat, Shimotsuke, Tochigi 3290498, Japan; [Kato, T.; Suzuki, K.] Jichi Med Univ, Saitama Med Ctr, Dept Surg, Omiya Ku, Shimotsuke, Tochigi 3290498, Japan	Jichi Medical University; Keio University; Nara Institute of Science & Technology; Jichi Medical University; Jichi Medical University	Tago, K (corresponding author), Jichi Med Univ, Sch Med, Dept Biochem, Div Struct Biochem, 3311-1 Yakushiji, Shimotsuke, Tochigi 3290498, Japan.	ktago@jichi.ac.jp	Furukawa, Yusuke/Y-1342-2018	Furukawa, Yusuke/0000-0002-7249-6418	MEXT [20770103]; Takeda Science Foundation; Grants-in-Aid for Scientific Research [25118721] Funding Source: KAKEN	MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Takeda Science Foundation(Takeda Science Foundation (TSF)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank Charles Sherr and Martine Roussel for critical advice and reagents, and Michael Washburn of Stowers Institute for Medical Research Proteomics Center for performing MudPIT analysis. This work was supported by a grant-in-aid for scientific research from the MEXT (20770103), MEXT-supported program for the strategic research foundation at private universities (2013-2017) and the Takeda Science Foundation.	Bates GJ, 2005, EMBO J, V24, P543, DOI 10.1038/sj.emboj.7600550; Bertwistle D, 2004, MOL CELL BIOL, V24, P985, DOI 10.1128/MCB.24.3.985-996.2004; Carnero A, 2000, NAT CELL BIOL, V2, P148, DOI 10.1038/35004020; Causevic M, 2001, ONCOGENE, V20, P7734, DOI 10.1038/sj.onc.1204976; Chang DW, 2000, MOL CELL BIOL, V20, P4309, DOI 10.1128/MCB.20.12.4309-4319.2000; Chen DL, 2005, CELL, V121, P1071, DOI 10.1016/j.cell.2005.03.037; Chen LH, 2003, ONCOGENE, V22, P5348, DOI 10.1038/sj.onc.1206851; Dang CV, 2012, CELL, V149, P22, DOI 10.1016/j.cell.2012.03.003; Datta A, 2004, J BIOL CHEM, V279, P36698, DOI 10.1074/jbc.M312305200; Dornan D, 2004, NATURE, V429, P86, DOI 10.1038/nature02514; Dubey P, 1997, J EXP MED, V185, P695, DOI 10.1084/jem.185.4.695; Duran RV, 2012, MOL CELL, V47, P349, DOI 10.1016/j.molcel.2012.05.043; EILERS M, 1991, EMBO J, V10, P133, DOI 10.1002/j.1460-2075.1991.tb07929.x; Eischen CM, 1999, GENE DEV, V13, P2658, DOI 10.1101/gad.13.20.2658; Eymin B, 2001, ONCOGENE, V20, P1033, DOI 10.1038/sj.onc.1204220; Frank SR, 2001, GENE DEV, V15, P2069, DOI 10.1101/gad.906601; Gao P, 2009, NATURE, V458, P762, DOI 10.1038/nature07823; Heinlein UAO, 1998, J PATHOL, V184, P345, DOI 10.1002/(SICI)1096-9896(199804)184:4<345::AID-PATH1243>3.0.CO;2-6; HIRLING H, 1989, NATURE, V339, P562, DOI 10.1038/339562a0; Honda R, 1999, EMBO J, V18, P22, DOI 10.1093/emboj/18.1.22; Itahana K, 2003, MOL CELL, V12, P1151, DOI 10.1016/S1097-2765(03)00431-3; Jacobs AMF, 2007, ONCOGENE, V26, P5866, DOI 10.1038/sj.onc.1210387; Kamijo T, 1998, P NATL ACAD SCI USA, V95, P8292, DOI 10.1073/pnas.95.14.8292; Kamijo T, 1997, CELL, V91, P649, DOI 10.1016/S0092-8674(00)80452-3; Kelly-Spratt KS, 2004, PLOS BIOL, V2, P1138, DOI 10.1371/journal.pbio.0020242; Kuo ML, 2008, CELL CYCLE, V7, P3378, DOI 10.4161/cc.7.21.6930; LANE DP, 1980, NATURE, V288, P167, DOI 10.1038/288167a0; LITTLEWOOD TD, 1995, NUCLEIC ACIDS RES, V23, P1686, DOI 10.1093/nar/23.10.1686; Martelli F, 2001, P NATL ACAD SCI USA, V98, P4455, DOI 10.1073/pnas.081061398; Martin DE, 2006, CELL METAB, V4, P259, DOI 10.1016/j.cmet.2006.09.002; Packham G, 1997, ONCOGENE, V15, P1219, DOI 10.1038/sj.onc.1201273; Qi Y, 2004, NATURE, V431, P712, DOI 10.1038/nature02958; QUELLE DE, 1995, CELL, V83, P993; Reinhardt HC, 2009, CURR OPIN CELL BIOL, V21, P245, DOI 10.1016/j.ceb.2009.01.018; Rocha S, 2003, MOL CELL, V12, P15, DOI 10.1016/S1097-2765(03)00223-5; Saporita AJ, 2011, CANCER RES, V71, P6708, DOI 10.1158/0008-5472.CAN-11-1472; SERRANO M, 1993, NATURE, V366, P704, DOI 10.1038/366704a0; Stevenson RJ, 1998, J PATHOL, V184, P351, DOI 10.1002/(SICI)1096-9896(199804)184:4<351::AID-PATH1235>3.0.CO;2-C; Sugimoto M, 2003, MOL CELL, V11, P415, DOI 10.1016/S1097-2765(03)00057-1; Tago K, 2005, P NATL ACAD SCI USA, V102, P7689, DOI 10.1073/pnas.0502978102; Washburn MP, 2001, NAT BIOTECHNOL, V19, P242, DOI 10.1038/85686; Weber JD, 2000, GENE DEV, V14, P2358, DOI 10.1101/gad.827300; Wise DR, 2008, P NATL ACAD SCI USA, V105, P18782, DOI 10.1073/pnas.0810199105; Xirodimas DP, 2002, FEBS LETT, V528, P207, DOI 10.1016/S0014-5793(02)03310-0; Yang LQ, 2006, CELL, V127, P139, DOI 10.1016/j.cell.2006.08.036; Yang LQ, 2005, MOL CANCER RES, V3, P355, DOI 10.1158/1541-7786.MCR-05-0022; Zhang YP, 1998, CELL, V92, P725, DOI 10.1016/S0092-8674(00)81401-4; Zindy F, 1998, GENE DEV, V12, P2424, DOI 10.1101/gad.12.15.2424	48	21	22	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 15	2015	34	3					310	318		10.1038/onc.2013.561	http://dx.doi.org/10.1038/onc.2013.561			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AZ3RY	24469041				2022-12-25	WOS:000348145500005
J	Gonzalez, MS; De Brasi, CD; Bianchini, M; Gargallo, P; Stanganelli, C; Zalcberg, I; Larripa, IB				Selena Gonzalez, Mariana; Daniel De Brasi, Carlos; Bianchini, Michele; Gargallo, Patricia; Stanganelli, Carmen; Zalcberg, Ilana; Beatriz Larripa, Irene			Improved Diagnosis of the Transition to JAK2(V617F) Homozygosity: The Key Feature for Predicting the Evolution of Myeloproliferative Neoplasms	PLOS ONE			English	Article							TYROSINE KINASE JAK2; POLYCYTHEMIA-VERA; ALLELE BURDEN; ESSENTIAL THROMBOCYTHEMIA; V617F MUTATION; DISORDERS; IDENTIFICATION; JAK2V617F; DISEASE; ASSAYS	Most cases of BCR-ABL1-negative myeloproliferative neoplasms (MPNs), essential thrombocythemia, polycythemia vera and primary myelofibrosis are associated with JAK2(V617F) mutations. The outcomes of these cases are critically influenced by the transition from JAK2(V617F) heterozygosity to homozygosity. Therefore, a technique providing an unbiased assessment of the critical allele burden, 50% JAK2(V617F), is highly desirable. In this study, we present an approach to assess the JAK2(V617F) burden from genomic DNA (gDNA) and complementary DNA (cDNA) using one-plus-one template references for allele-specific quantitative-real-time-PCR (qPCR). Plasmidic gDNA and cDNA constructs encompassing one PCR template for JAK2(V617F) spaced from one template for JAK2 Wild Type were constructed by multiple fusion PCR amplifications. Repeated assessments of the 50% JAK2(V617F) burden within the dynamic range of serial dilutions of gDNA and cDNA constructs resulted in 52.53 +/- 4.2% and 51.46 +/- 4.21%, respectively. The mutation-positive cutoff was estimated to be 3.65% (mean +2 standard deviation) using 20 samples from a healthy population. This qPCR approach was compared with the qualitative ARMS-PCR technique and with two standard methods based on qPCR, and highly significant correlations were obtained in all cases. qPCR assays were performed on paired gDNA/cDNA samples from 20 MPN patients, and the JAK2(V617F) expression showed a significant correlation with the allele burden. Our data demonstrate that the qPCR method using one-plus-one template references provides an improved assessment of the clinically relevant transition of JAK2(V617F) from heterozygosity to homozygosity.	[Selena Gonzalez, Mariana; Daniel De Brasi, Carlos; Beatriz Larripa, Irene] Acad Nacl Med ANM, Natl Res Council CONICET, Inst Med Expt IMEX, Buenos Aires, DF, Argentina; [Daniel De Brasi, Carlos; Gargallo, Patricia; Stanganelli, Carmen; Beatriz Larripa, Irene] ANM, Inst Invest Hematol IIHEMA, Buenos Aires, DF, Argentina; [Bianchini, Michele] Inst Alexander Fleming, Ctr Invest Oncol Fdn Canc CIO FUCA, Buenos Aires, DF, Argentina; [Zalcberg, Ilana] Inst Nacl Canc, Rio De Janeiro, Brazil	Buenos Aires National Academy of Medicine; IMEX - Instituto de Medicina Experimental; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Buenos Aires National Academy of Medicine; IIHEMA - Instituto de Investigaciones Hematologicas; National Cancer Institute (Inca)	Gonzalez, MS (corresponding author), Acad Nacl Med ANM, Natl Res Council CONICET, Inst Med Expt IMEX, Buenos Aires, DF, Argentina.	marianag6@yahoo.com.ar		De Brasi, Carlos Daniel/0000-0003-2379-4379	National Research Council (CONICET); National Agency for Promotion of Science and Technology (ANPCyT)	National Research Council (CONICET)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); National Agency for Promotion of Science and Technology (ANPCyT)(ANPCyT)	This study was supported by grants from the National Research Council (CONICET) and the National Agency for Promotion of Science and Technology (ANPCyT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baxter EJ, 2005, LANCET, V365, P1054, DOI 10.1016/S0140-6736(05)71142-9; Bousquet M, 2006, HUM PATHOL, V37, P1458, DOI 10.1016/j.humpath.2006.05.006; Campbell PJ, 2006, NEW ENGL J MED, V355, P2452, DOI 10.1056/NEJMra063728; Carobbio A, 2009, EXP HEMATOL, V37, P1016, DOI 10.1016/j.exphem.2009.06.006; Chen G, 2006, BEST PRACT RES CL HA, V19, P387, DOI 10.1016/j.beha.2005.07.003; James C, 2005, NATURE, V434, P1144, DOI 10.1038/nature03546; Jones AV, 2005, BLOOD, V106, P2162, DOI 10.1182/blood-2005-03-1320; Jovanovic JV, 2013, LEUKEMIA, V27, P2032, DOI 10.1038/leu.2013.219; Kralovics R, 2005, NEW ENGL J MED, V352, P1779, DOI 10.1056/NEJMoa051113; Levine RL, 2005, CANCER CELL, V7, P387, DOI 10.1016/j.ccr.2005.03.023; Levine RL, 2007, NAT REV CANCER, V7, P673, DOI 10.1038/nrc2210; Lippert E, 2006, BLOOD, V108, P1865, DOI 10.1182/blood-2006-01-013540; Lippert E, 2009, HAEMATOL-HEMATOL J, V94, P38, DOI 10.3324/haematol.13486; Parganas E, 1998, CELL, V93, P385, DOI 10.1016/S0092-8674(00)81167-8; Passamonti F, 2009, HAEMATOL-HEMATOL J, V94, P7, DOI 10.3324/haematol.2008.001271; Quentmeier H, 2006, LEUKEMIA, V20, P471, DOI 10.1038/sj.leu.2404081; Tefferi A, 2005, NEW ENGL J MED, V353, P1416; Tiedt R, 2008, BLOOD, V111, P3931, DOI 10.1182/blood-2007-08-107748; Vainchenker William, 2005, Hematology Am Soc Hematol Educ Program, P195; Vannucchi AM, 2008, LEUKEMIA, V22, pCP5, DOI 10.1038/leu.2008.113; Vannucchi AM, 2007, LEUKEMIA, V21, P1952, DOI 10.1038/sj.leu.2404854; Vannucchi AM, 2006, LEUKEMIA, V20, P1055, DOI 10.1038/sj.leu.2404209; Vardiman JW, 2009, BLOOD, V114, P937, DOI 10.1182/blood-2009-03-209262; Zhao RX, 2005, J BIOL CHEM, V280, P22788, DOI 10.1074/jbc.C500138200	24	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2014	9	1							e86401	10.1371/journal.pone.0086401	http://dx.doi.org/10.1371/journal.pone.0086401			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301BI	24475114	Green Published, gold, Green Submitted			2022-12-25	WOS:000330507300060
J	van den Borne, P; van der Laan, SW; Bovens, SM; Koole, D; Kowala, MC; Michael, LF; Schoneveld, AH; van de Weg, SM; Velema, E; de Vries, JP; de Borst, GJ; Moll, FL; de Kleijn, DPV; Quax, PHA; Hoefer, IE; Pasterkamp, G				van den Borne, Pleunie; van der Laan, Sander W.; Bovens, Sandra M.; Koole, Dave; Kowala, Mark C.; Michael, Laura F.; Schoneveld, Arjan H.; van de Weg, Sander M.; Velema, Evelyn; de Vries, Jean-Paul; de Borst, Gert J.; Moll, Frans L.; de Kleijn, Dominique P. V.; Quax, Paul H. A.; Hoefer, Imo E.; Pasterkamp, Gerard			Leukotriene B4 Levels in Human Atherosclerotic Plaques and Abdominal Aortic Aneurysms	PLOS ONE			English	Article							CARDIOVASCULAR EVENTS; BLT1-DEFICIENT MICE; EXPRESSION; RECEPTORS; B-4; 5-LIPOXYGENASE; INFLAMMATION; INSTABILITY; MECHANISMS; PATHWAY	Background: Leukotriene B4 (LTB4) has been associated with the initiation and progression of atherosclerosis and abdominal aortic aneurysm (AAA) formation. However, associations of LTB4 levels with tissue characteristics and adverse clinical outcome of advanced atherosclerosis and AAA are scarcely studied. We hypothesized that LTB4 levels are associated with a vulnerable plaque phenotype and adverse clinical outcome. Furthermore, that LTB4 levels are associated with inflammatory AAA and adverse clinical outcome. Methods: Atherosclerotic plaques and AAA specimens were selected from two independent databases for LTB4 measurements. Plaques were isolated during carotid endarterectomy from asymptomatic (n = 58) or symptomatic (n = 317) patients, classified prior to surgery. LTB4 levels were measured without prior lipid extraction and levels were corrected for protein content. LTB4 levels were related to plaque phenotype, baseline patient characteristics and clinical outcome within three years following surgery. Seven non-diseased mammary artery specimens served as controls. AAA specimens were isolated during open repair, classified as elective (n = 189), symptomatic (n = 29) or ruptured (n = 23). LTB4 levels were measured similar to the plaque measurements and were related to tissue characteristics, baseline patient characteristics and clinical outcome. Twenty-six non-diseased aortic specimens served as controls. Results: LTB4 levels corrected for protein content were not significantly associated with histological characteristics specific for vulnerable plaques or inflammatory AAA as well as clinical presentation. Moreover, it could not predict secondary manifestations independently investigated in both databases. However, LTB4 levels were significantly lower in controls compared to plaque (p = 0.025) or AAA (p = 0.017). Conclusions: LTB4 levels were not associated with a vulnerable plaque phenotype or inflammatory AAA or clinical presentation. This study does not provide supportive evidence for a role of LTB4 in atherosclerotic plaque destabilization or AAA expansion. However, these data should be interpreted with care, since LTB4 measurements were performed without prior lipid extractions.	[van den Borne, Pleunie; van der Laan, Sander W.; Bovens, Sandra M.; Schoneveld, Arjan H.; van de Weg, Sander M.; Velema, Evelyn; de Kleijn, Dominique P. V.; Hoefer, Imo E.; Pasterkamp, Gerard] Univ Med Ctr Utrecht, Lab Expt Cardiol, Utrecht, Netherlands; [van der Laan, Sander W.; Bovens, Sandra M.; Schoneveld, Arjan H.; de Kleijn, Dominique P. V.; Hoefer, Imo E.; Pasterkamp, Gerard] Interuniv Cardiol Inst Netherlands, Utrecht, Netherlands; [Koole, Dave; de Borst, Gert J.; Moll, Frans L.] Univ Med Ctr Utrecht, Dept Vasc Surg, Utrecht, Netherlands; [Kowala, Mark C.; Michael, Laura F.] Eli Lilly & Co, Lilly Res Labs, Indianapolis, IN 46285 USA; [de Vries, Jean-Paul] St Antonius Hosp, Dept Vasc Surg, Nieuwegein, Netherlands; [de Kleijn, Dominique P. V.] Natl Univ Singapore Hosp, Cardiovasc Res Inst & Surg, Singapore 117548, Singapore; [Quax, Paul H. A.] Leiden Univ Med Ctr, Dept Surg, Leiden, Netherlands; [Quax, Paul H. A.] Leiden Univ Med Ctr, Einthoven Lab Expt Vasc Med, Leiden, Netherlands	Utrecht University; Utrecht University Medical Center; Interuniversity Cardiology Institute of the Netherlands; Utrecht University; Utrecht University; Utrecht University Medical Center; Eli Lilly; St. Antonius Hospital Utrecht; National University of Singapore; Leiden University; Leiden University Medical Center (LUMC); Leiden University; Leiden University Medical Center (LUMC)	van den Borne, P (corresponding author), Univ Med Ctr Utrecht, Lab Expt Cardiol, Utrecht, Netherlands.	p.vandenborne-2@umcutrecht.nl	Quax, Paul/ABD-5294-2020; Quax, Paul/W-8520-2019; van der Laan, Sander W./N-1330-2019	Quax, Paul/0000-0002-6853-5760; van der Laan, Sander W./0000-0001-6888-1404	Dutch Ministry of Economic Affairs, Agriculture and Innovation; Dutch Heart Foundation	Dutch Ministry of Economic Affairs, Agriculture and Innovation; Dutch Heart Foundation(Netherlands Heart Foundation)	This research forms part of the Project P1.03 PENT of the research program of the Biomedical Materials institute, co-funded by the Dutch Ministry of Economic Affairs, Agriculture and Innovation. The financial contribution of the Dutch Heart Foundation is gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahluwalia N, 2007, J IMMUNOL, V179, P691, DOI 10.4049/jimmunol.179.1.691; Aiello RJ, 2002, ARTERIOSCL THROM VAS, V22, P443, DOI 10.1161/hq0302.105593; Allen S, 1998, CIRCULATION, V97, P2406, DOI 10.1161/01.CIR.97.24.2406; Back M, 2005, P NATL ACAD SCI USA, V102, P17501, DOI 10.1073/pnas.0505845102; Back M, 2006, ANN MED, V38, P493, DOI 10.1080/07853890600982737; Capra V, 2012, MED RES REV, P1, DOI [10.1002/med, DOI 10.1002/MED]; Cipollone F, 2005, ARTERIOSCL THROM VAS, V25, P1665, DOI 10.1161/01.ATV.0000172632.96987.2d; de Kleijn DPV, 2010, ARTERIOSCL THROM VAS, V30, P612, DOI 10.1161/ATVBAHA.109.194944; DECATERINA R, 1988, BIOMED BIOCHIM ACTA, V47, pS182; Funk CD, 2001, SCIENCE, V294, P1871, DOI 10.1126/science.294.5548.1871; Hansson GK, 2005, NEW ENGL J MED, V352, P1685, DOI 10.1056/NEJMra043430; Heller EA, 2005, CIRCULATION, V112, P578, DOI 10.1161/CIRCULATIONAHA.105.545616; Hellings WE, 2010, CIRCULATION, V121, P1941, DOI 10.1161/CIRCULATIONAHA.109.887497; Hicks A, 2007, EXPERT OPIN INV DRUG, V16, P1909, DOI 10.1517/13543784.16.12.1909; Houard X, 2009, FASEB J, V23, P1376, DOI 10.1096/fj.08-116202; Huang L, 2004, ARTERIOSCL THROM VAS, V24, P1783, DOI 10.1161/01.ATV.0000140063.06341.09; Hurks R, 2010, EUR SURG RES, V45, P34, DOI 10.1159/000318160; Ionita MG, 2010, ARTERIOSCL THROM VAS, V30, P1842, DOI 10.1161/ATVBAHA.110.209296; Libby P, 2002, CIRCULATION, V105, P1135, DOI 10.1161/hc0902.104353; Murphy RC, 2007, BIOCHEM J, V405, P379, DOI 10.1042/BJ20070289; Peeters W, 2009, ARTERIOSCL THROM VAS, V29, P128, DOI 10.1161/ATVBAHA.108.173658; Peters-Golden M, 2007, NEW ENGL J MED, V357, P1841, DOI 10.1056/NEJMra071371; Qiu H, 2006, P NATL ACAD SCI USA, V103, P8161, DOI 10.1073/pnas.0602414103; Riccioni G, 2008, J LEUKOCYTE BIOL, V84, P1374, DOI 10.1189/jlb.0808476; Sanchez-Galan E, 2009, CARDIOVASC RES, V81, P216, DOI 10.1093/cvr/cvn277; Spagnoli LG, 2007, J NUCL MED, V48, P1800, DOI 10.2967/jnumed.107.038661; Subbarao K, 2004, ARTERIOSCL THROM VAS, V24, P369, DOI 10.1161/01.ATV.0000110503.16605.15; Verhoeven BAN, 2004, EUR J EPIDEMIOL, V19, P1127, DOI 10.1007/s10564-004-2304-6; Yokomizo T, 2011, ADV ENZYME REGUL, V51, P59, DOI 10.1016/j.advenzreg.2010.08.002; Zhao L, 2004, NAT MED, V10, P966, DOI 10.1038/nm1099; Zhou YJ, 2007, BIOCHEM BIOPH RES CO, V363, P30, DOI 10.1016/j.bbrc.2007.08.134	31	12	12	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2014	9	1							e86522	10.1371/journal.pone.0086522	http://dx.doi.org/10.1371/journal.pone.0086522			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301BI	24475136	Green Submitted, Green Published, gold			2022-12-25	WOS:000330507300074
J	Abuduxikuer, K; Wang, JS				Abuduxikuer, Kuerbanjiang; Wang, Jian-She			Zinc Mono-Therapy in Pre-Symptomatic Chinese Children with Wilson Disease: A Single Center, Retrospective Study	PLOS ONE			English	Article							LONG-TERM TREATMENT; ALKALINE-PHOSPHATASE; PEDIATRIC-PATIENTS; DIAGNOSIS; METALLOTHIONEIN; LIVER; TIME; PENICILLAMINE; MONOTHERAPY; EXPERIENCE	Background: There is no official consensus regarding zinc therapy in pre-symptomatic children with Wilson Disease (WD); more data is needed. Objective: To investigate the safety and efficacy of zinc gluconate therapy for Chinese children with pre-symptomatic WD. Methods: We retrospectively analyzed pre-symptomatic children receiving zinc gluconate in a single Chinese center specialized in pediatric hepatology. Short-term follow-up data on safety and efficacy were presented, and effects of different zinc dosages were compared. Results: 30 children (21 males) aged 2.7 to 16.8 years were followed for up to 4.4 years; 26 (87%) children had abnormal ALT at baseline. Most patients (73%) received higher than the currently recommended dose of elemental zinc. Zinc gluconate significantly reduced mean ALT (p<0.0001), AST (p<0.0001), GGT (p<0.0001) levels after 1 month, and urinary copper excretion after 6 months (p<0.0054). Mean direct bilirubin levels dropped significantly at 1 month (p = 0.0175), 3 months (p = 0.0010), and 6 months (p = 0.0036). Serum zinc levels gradually increased and reached a significantly higher level after 6 months (p<0.0026), reflecting good compliance with the therapy. Complete blood count parameters did not change throughout the analysis period. 8 children experienced mild and transient gastrointestinal side effects. The higher zinc dose did not affect treatment response and was not associated with different or increased side effects when compared to conventional zinc dose. Conclusion: In our cohort, zinc gluconate therapy for Chinese children with pre-symptomatic WD was effective, and higher initial dose of elemental zinc had the same level of efficacy as the conventional dose.	[Abuduxikuer, Kuerbanjiang] Fudan Univ, Childrens Hosp, Ctr Liver, Shanghai 200433, Peoples R China; [Wang, Jian-She] Fudan Univ, Jinshan Hosp, Dept Pediat, Shanghai 200433, Peoples R China	Fudan University; Fudan University	Wang, JS (corresponding author), Fudan Univ, Jinshan Hosp, Dept Pediat, Shanghai 200433, Peoples R China.	jshwang@shmu.edu.cn	Abuduxikuer, Kuerbanjiang/T-6521-2019; wang, Jian-She/F-1154-2011	Abuduxikuer, Kuerbanjiang/0000-0003-0298-3269; wang, jianshe/0000-0003-0823-586X	National Natural Science Foundation of China [81070281]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Natural Science Foundation of China, No. 81070281. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1995, METABOLIC BASIS INHE; Brewer G J, 2001, Expert Opin Pharmacother, V2, P1473, DOI 10.1517/14656566.2.9.1473; BREWER G J, 1990, Journal of Trace Elements in Experimental Medicine, V3, P227; BREWER GJ, 1992, MEDICINE, V71, P139, DOI 10.1097/00005792-199205000-00004; BREWER GJ, 1994, J LAB CLIN MED, V123, P849; BREWER GJ, 1983, ANN INTERN MED, V99, P314, DOI 10.7326/0003-4819-99-3-314; Brewer GJ, 1998, J LAB CLIN MED, V132, P264, DOI 10.1016/S0022-2143(98)90039-7; Brewer GJ, 2001, J LAB CLIN MED, V137, P191, DOI 10.1067/mlc.2001.113037; Brewer GJ., 2001, WILSONS DIS CLIN GUI; BULL PC, 1993, NAT GENET, V5, P327, DOI 10.1038/ng1293-327; Castilla-Higuero L, 2000, HEPATOLOGY, V32, P877, DOI 10.1053/jhep.2000.17917; Czlonkowska A, 1996, J NEUROL, V243, P269, DOI 10.1007/BF00868525; Dhawan A, 2005, LIVER INT, V25, P680, DOI 10.1111/j.1478-3231.2005.01072.x; Ferenci P, 2003, LIVER INT, V23, P139, DOI 10.1034/j.1600-0676.2003.00824.x; Ferenci P, 2012, J HEPATOL, V56, P671, DOI 10.1016/j.jhep.2011.11.007; Friedman L S, 1993, Gastroenterology, V104, P1566; GOERING PL, 1985, TOXICOL APPL PHARM, V80, P467, DOI 10.1016/0041-008X(85)90391-6; HOOGENRAAD TU, 1987, J NEUROL SCI, V77, P137, DOI 10.1016/0022-510X(87)90116-X; Hoogenraad TU, 2006, BRAIN DEV-JPN, V28, P141, DOI 10.1016/j.braindev.2005.08.008; Hoogenraad TU, 1998, J LAB CLIN MED, V132, P240, DOI 10.1016/S0022-2143(98)90034-8; HOOGENRAAD TU, 1979, EUR NEUROL, V18, P205, DOI 10.1159/000115077; Lang CJG, 1933, ARCH NEUROL-CHICAGO, V50, P1007; LEE DY, 1989, J LAB CLIN MED, V114, P639; Linn FHH, 2009, HEPATOLOGY, V50, P1442, DOI 10.1002/hep.23182; Marcellini M, 2005, J LAB CLIN MED, V145, P139, DOI 10.1016/j.lab.2005.01.007; Medici V, 2007, DIGEST LIVER DIS, V39, P601, DOI 10.1016/j.dld.2006.12.095; Medici V, 2006, J CLIN GASTROENTEROL, V40, P936, DOI 10.1097/01.mcg.0000225670.91722.59; Mishra D, 2008, INDIAN PEDIATR, V45, P151; Mizuochi T, 2011, J PEDIATR GASTR NUTR, V53, P365, DOI 10.1097/MPG.0b013e31821d5abe; MULDER TPJ, 1992, J HEPATOL, V16, P346, DOI 10.1016/S0168-8278(05)80667-1; Roberts EA, 2008, HEPATOLOGY, V47, P2089, DOI 10.1002/hep.22261; Sadighi A, 2008, SAUDI MED J, V29, P1276; WALSHE JM, 1995, ARCH NEUROL-CHICAGO, V52, P10, DOI 10.1001/archneur.1995.00540250012003; Wiggelinkhuizen M, 2009, ALIMENT PHARM THER, V29, P947, DOI 10.1111/j.1365-2036.2009.03959.x; Wu ZY, 2003, ARCH NEUROL-CHICAGO, V60, P737, DOI 10.1001/archneur.60.5.737; YUZBASIYANGURKAN V, 1992, J LAB CLIN MED, V120, P380; YUZBASIYANGURKAN V, 1989, J LAB CLIN MED, V114, P520	37	15	16	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2014	9	1							e86168	10.1371/journal.pone.0086168	http://dx.doi.org/10.1371/journal.pone.0086168			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	298QQ	24475083	gold, Green Published, Green Submitted			2022-12-25	WOS:000330339800031
J	Haverkamp, THA; Hammer, O; Jakobsen, KS				Haverkamp, Thomas H. A.; Hammer, Oyvind; Jakobsen, Kjetill S.			Linking Geology and Microbiology: Inactive Pockmarks Affect Sediment Microbial Community Structure	PLOS ONE			English	Article							POLYCYCLIC AROMATIC-HYDROCARBONS; DISSOLVED ORGANIC-MATTER; FRESH-WATER; RARE BIOSPHERE; BACTERIAL COMMUNITIES; MARINE-SEDIMENTS; INNER OSLOFJORD; BIOGEOCHEMICAL PROCESSES; GDANSK DEEP; BALTIC SEA	Pockmarks are geological features that are found on the bottom of lakes and oceans all over the globe. Some are active, seeping oil or methane, while others are inactive. Active pockmarks are well studied since they harbor specialized microbial communities that proliferate on the seeping compounds. Such communities are not found in inactive pockmarks. Interestingly, inactive pockmarks are known to have different macrofaunal communities compared to the surrounding sediments. It is undetermined what the microbial composition of inactive pockmarks is and if it shows a similar pattern as the macrofauna. The Norwegian Oslofjord contains many inactive pockmarks and they are well suited to study the influence of these geological features on the microbial community in the sediment. Here we present a detailed analysis of the microbial communities found in three inactive pockmarks and two control samples at two core depth intervals. The communities were analyzed using high-throughput amplicon sequencing of the 16S rRNA V3 region. Microbial communities of surface pockmark sediments were indistinguishable from communities found in the surrounding seabed. In contrast, pockmark communities at 40 cm sediment depth had a significantly different community structure from normal sediments at the same depth. Statistical analysis of chemical variables indicated significant differences in the concentrations of total carbon and non-particulate organic carbon between 40 cm pockmarks and reference sample sediments. We discuss these results in comparison with the taxonomic classification of the OTUs identified in our samples. Our results indicate that microbial communities at the sediment surface are affected by the water column, while the deeper (40 cm) sediment communities are affected by local conditions within the sediment.	[Haverkamp, Thomas H. A.; Jakobsen, Kjetill S.] Univ Oslo, Dept Biosci, Ctr Ecol & Evolutionary Synth, Oslo, Norway; [Hammer, Oyvind] Univ Oslo, Nat Hist Museum, Oslo, Norway; [Jakobsen, Kjetill S.] Univ Oslo, Microbial Evolut Res Grp, Dept Biosci, Oslo, Norway	University of Oslo; University of Oslo; University of Oslo	Haverkamp, THA (corresponding author), Univ Oslo, Dept Biosci, Ctr Ecol & Evolutionary Synth, Oslo, Norway.	thhaverk@gmail.com	Hammer, Øyvind/A-6319-2017; Haverkamp, Thomas H.A./H-2783-2019	Haverkamp, Thomas H.A./0000-0002-3070-9745	VISTA [6503]	VISTA	This work was funded by VISTA grant nr 6503 to KSJ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arp HPH, 2011, ENVIRON TOXICOL CHEM, V30, P843, DOI 10.1002/etc.466; Arp HPH, 2009, ENVIRON SCI TECHNOL, V43, P5576, DOI 10.1021/es9012905; Baldi F, 2010, CONT SHELF RES, V30, P1614, DOI 10.1016/j.csr.2010.06.009; Bartlett R, 2010, HYDROL PROCESS, V24, P726, DOI 10.1002/hyp.7514; Bertics VJ, 2009, ISME J, V3, P1269, DOI 10.1038/ismej.2009.62; Bienhold C, 2012, ISME J, V6, P724, DOI 10.1038/ismej.2011.140; Bohlen L, 2011, GEOCHIM COSMOCHIM AC, V75, P6094, DOI 10.1016/j.gca.2011.08.010; Bowen JL, 2012, ISME J, V6, P2014, DOI 10.1038/ismej.2012.47; Brothers LL, 2011, GEO-MAR LETT, V31, P237, DOI 10.1007/s00367-011-0228-0; Burgin AJ, 2007, FRONT ECOL ENVIRON, V5, P89, DOI 10.1890/1540-9295(2007)5[89:HWOTRO]2.0.CO;2; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Cambon-Bonavita MA, 2009, DEEP-SEA RES PT II, V56, P2248, DOI 10.1016/j.dsr2.2009.04.007; CAROQUINTERO A, 2012, MBIO, V3, DOI DOI 10.1128/MBI0.00025-12; Cathles LM, 2010, MAR PETROL GEOL, V27, P82, DOI 10.1016/j.marpetgeo.2009.09.010; Chand S, 2009, MAR PETROL GEOL, V26, P1035, DOI 10.1016/j.marpetgeo.2008.09.002; CLARKE KR, 1993, AUST J ECOL, V18, P117, DOI 10.1111/j.1442-9993.1993.tb00438.x; Dale AW, 2011, ESTUAR COAST SHELF S, V95, P14, DOI 10.1016/j.ecss.2011.05.016; Dalsgaard T, 2005, RES MICROBIOL, V156, P457, DOI 10.1016/j.resmic.2005.01.011; Dang HY, 2010, APPL ENVIRON MICROB, V76, P7036, DOI 10.1128/AEM.01264-10; DeBruyn JM, 2011, APPL ENVIRON MICROB, V77, P6295, DOI 10.1128/AEM.05005-11; Durbin AM, 2011, ENVIRON MICROBIOL, V13, P3219, DOI 10.1111/j.1462-2920.2011.02544.x; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Eide I, 2011, WATER AIR SOIL POLL, V218, P387, DOI 10.1007/s11270-010-0653-0; Evans J, 2006, J MOL EVOL, V62, P785, DOI 10.1007/s00239-005-0176-2; Fernandez-Gomez B, 2013, ISME J, V7, P1026, DOI 10.1038/ismej.2012.169; Freitag TE, 2006, ENVIRON MICROBIOL, V8, P684, DOI 10.1111/j.1462-2920.2005.00947.x; Fuerst JA, 2011, NAT REV MICROBIOL, V9, P403, DOI 10.1038/nrmicro2578; Fukunaga Y, 2009, J GEN APPL MICROBIOL, V55, P267, DOI 10.2323/jgam.55.267; Gibbons SM, 2013, P NATL ACAD SCI USA, V110, P4651, DOI 10.1073/pnas.1217767110; Gihring TM, 2010, LIMNOL OCEANOGR, V55, P740, DOI 10.4319/lo.2009.55.2.0740; Gittel A, 2012, SYST APPL MICROBIOL, V35, P165, DOI 10.1016/j.syapm.2012.01.003; Gobet A, 2014, ENVIRON MICROBIOL, V16, P2672, DOI 10.1111/1462-2920.12308; GRAF G, 1989, NATURE, V341, P437, DOI 10.1038/341437a0; Gutierrez T, 2013, APPL ENVIRON MICROB, V79, P205, DOI 10.1128/AEM.02833-12; Hamdan LJ, 2013, ISME J, V7, P685, DOI 10.1038/ismej.2012.143; Hammer O, 2010, NORW J GEOL, V90, P79; Hammer O, 2009, GEO-MAR LETT, V29, P269, DOI 10.1007/s00367-009-0140-z; Haritash AK, 2009, J HAZARD MATER, V169, P1, DOI 10.1016/j.jhazmat.2009.03.137; Havelsrud OE, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-203; Hovland M, 2002, GEOFLUIDS, V2, P127, DOI 10.1046/j.1468-8123.2002.00028.x; Hovland M, 2010, MAR PETROL GEOL, V27, P1190, DOI 10.1016/j.marpetgeo.2010.02.005; Huse SM, 2010, ENVIRON MICROBIOL, V12, P1889, DOI 10.1111/j.1462-2920.2010.02193.x; Huse SM, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000255; Jackson CR, 2008, APPL ENVIRON MICROB, V74, P5237, DOI 10.1128/AEM.00923-08; Jacob M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072779; Janssen PH, 2002, INT J SYST EVOL MICR, V52, P1341, DOI 10.1099/ijs.0.02116-0; Jantti H, 2011, AQUAT MICROB ECOL, V63, P171, DOI 10.3354/ame01492; Jetten MSM, 2008, ENVIRON MICROBIOL, V10, P2903, DOI 10.1111/j.1462-2920.2008.01786.x; Jones SE, 2010, P NATL ACAD SCI USA, V107, P5881, DOI 10.1073/pnas.0912765107; Jorgensen SL, 2012, P NATL ACAD SCI USA, V109, pE2846, DOI 10.1073/pnas.1207574109; Judd A., 2007, SEABED FLUID FLOW IM, DOI 10.1017/CBO9780511535918; Julies EM, 2010, GEOMICROBIOL J, V27, P303, DOI 10.1080/01490450903410464; KING LH, 1970, GEOL SOC AM BULL, V81, P3141, DOI 10.1130/0016-7606(1970)81[3141:POTSS]2.0.CO;2; Knab NJ, 2008, GEOCHIM COSMOCHIM AC, V72, P2868, DOI 10.1016/j.gca.2008.03.016; Koster M, 2001, MAR ECOL PROG SER, V214, P25, DOI 10.3354/meps214025; Kraigher B, 2011, J HAZARD MATER, V188, P78, DOI 10.1016/j.jhazmat.2011.01.072; Kristensen E, 2012, MAR ECOL PROG SER, V446, P285, DOI 10.3354/meps09506; Kunin V, 2010, ENVIRON MICROBIOL, V12, P118, DOI 10.1111/j.1462-2920.2009.02051.x; Lanzen A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049334; Laverock B, 2010, ISME J, V4, P1531, DOI 10.1038/ismej.2010.86; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; Lozupone C, 2011, ISME J, V5, P169, DOI 10.1038/ismej.2010.133; Lucker S, 2010, P NATL ACAD SCI USA, V107, P13479, DOI 10.1073/pnas.1003860107; Magurran AE, 2007, MEASURING BIOL DIVER, V5; Manley PL, 2004, LAKE CHAMPLAIN: PARTNERSHIPS AND RESEARCH IN THE NEW MILLENNIUM, P299; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Merkel AY, 2010, MICROBIOLOGY+, V79, P849, DOI 10.1134/S0026261710060196; Mermillod-Blondin F, 2004, AQUAT MICROB ECOL, V36, P271, DOI 10.3354/ame036271; Muller H, 2011, GEO-MAR LETT, V31, P123, DOI 10.1007/s00367-010-0220-0; Nascimento FJA, 2012, LIMNOL OCEANOGR, V57, P338, DOI 10.4319/lo.2012.57.1.0338; Nemergut DR, 2008, ENVIRON MICROBIOL, V10, P3093, DOI 10.1111/j.1462-2920.2008.01735.x; Nogaro G, 2013, HYDROBIOLOGIA, V701, P289, DOI 10.1007/s10750-012-1286-7; Orcutt BN, 2011, MICROBIOL MOL BIOL R, V75, P361, DOI 10.1128/MMBR.00039-10; Pachiadaki MG, 2011, MICROB ECOL, V62, P655, DOI 10.1007/s00248-011-9855-2; Papaspyrou S, 2005, AQUAT MICROB ECOL, V38, P181, DOI 10.3354/ame038181; Parkes RJ, 2000, HYDROGEOL J, V8, P11, DOI 10.1007/PL00010971; Pau M, 2013, MAR GEOL, V346, P262, DOI 10.1016/j.margeo.2013.09.012; Peng RH, 2008, FEMS MICROBIOL REV, V32, P927, DOI 10.1111/j.1574-6976.2008.00127.x; Pereira WE, 1999, MAR CHEM, V64, P99, DOI 10.1016/S0304-4203(98)00087-5; Pimenov NV, 2008, MICROBIOLOGY+, V77, P579, DOI 10.1134/S0026261708050111; Quast C, 2013, NUCLEIC ACIDS RES, V41, pD590, DOI 10.1093/nar/gks1219; Quince C, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-38; Rebata-Landa V, 2006, GEOCHEM GEOPHY GEOSY, V7, DOI 10.1029/2006GC001355; Reed AJ, 2006, EXTREMOPHILES, V10, P199, DOI 10.1007/s00792-005-0488-6; Reed HE, 2013, ISME J, V7, P868, DOI 10.1038/ismej.2012.154; Reeder J, 2009, NAT METHODS, V6, P636, DOI 10.1038/nmeth0909-636; Reese BK, 2013, GEOMICROBIOL J, V30, P160, DOI 10.1080/01490451.2012.659331; Rinke C, 2013, NATURE, V499, P431, DOI 10.1038/nature12352; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Shivaji S, 2011, RES MICROBIOL, V162, P191, DOI 10.1016/j.resmic.2010.09.020; Shubenkova OV, 2010, MICROBIOLOGY+, V79, P799, DOI 10.1134/S0026261710060123; Subramani R, 2012, MICROBIOL RES, V167, P571, DOI 10.1016/j.micres.2012.06.005; Tadonleke RD, 2007, FEMS MICROBIOL ECOL, V59, P543, DOI 10.1111/j.1574-6941.2006.00222.x; Takaki Y, 2010, DNA RES, V17, P123, DOI 10.1093/dnares/dsq005; Tao S, 2000, WATER RES, V34, P1751, DOI 10.1016/S0043-1354(99)00324-3; Thamdrup B, 2012, ANNU REV ECOL EVOL S, V43, P407, DOI 10.1146/annurev-ecolsys-102710-145048; Thimsen CA, 1998, MAR CHEM, V62, P65, DOI 10.1016/S0304-4203(98)00018-8; Tsuboi S, 2013, WORLD J MICROB BIOT, V29, P759, DOI 10.1007/s11274-012-1231-y; Turner JT, 2002, AQUAT MICROB ECOL, V27, P57, DOI 10.3354/ame027057; Urakawa H, 2000, ENVIRON MICROBIOL, V2, P542, DOI 10.1046/j.1462-2920.2000.00137.x; Wang JJ, 2008, ENVIRON MICROBIOL, V10, P2537, DOI 10.1111/j.1462-2920.2008.01678.x; Wang Y, 2012, APPL ENVIRON MICROB, V78, P8264, DOI 10.1128/AEM.01821-12; Ward NL, 2009, APPL ENVIRON MICROB, V75, P2046, DOI 10.1128/AEM.02294-08; Webb KE, 2009, MAR ECOL PROG SER, V387, P15, DOI 10.3354/meps08079; Webb KE, 2009, GEO-MAR LETT, V29, P111, DOI 10.1007/s00367-008-0127-1; Wenzhofer F., 2012, BIOGEOSCIENCES DISCU, V9, P8337, DOI DOI 10.5194/BG-9-5031-2012; White JR, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000352; Whiticar MJ, 2002, MAR GEOL, V182, P29, DOI 10.1016/S0025-3227(01)00227-4; Wildish DJ, 2008, MAR ECOL PROG SER, V357, P51, DOI 10.3354/meps07331; Yunker MB, 2002, ORG GEOCHEM, V33, P489, DOI 10.1016/S0146-6380(02)00002-5; Zeppilli D, 2012, DIVERS DISTRIB, V18, P832, DOI 10.1111/j.1472-4642.2011.00859.x; Zhou JZ, 2013, MBIO, V4, DOI 10.1128/mBio.00324-13; Zhou JZ, 2011, ISME J, V5, P1303, DOI 10.1038/ismej.2011.11; Zinger L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024570	115	9	10	0	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2014	9	1							e85990	10.1371/journal.pone.0085990	http://dx.doi.org/10.1371/journal.pone.0085990			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	298QQ	24475066	Green Published, gold, Green Submitted			2022-12-25	WOS:000330339800021
J	Liu, AM; Xu, Z; Shek, FH; Wong, KF; Lee, NP; Poon, RT; Chen, JF; Luk, JM				Liu, Angela M.; Xu, Zhi; Shek, Felix H.; Wong, Kwong-Fai; Lee, Nikki P.; Poon, Ronnie T.; Chen, Jinfei; Luk, John M.			miR-122 Targets Pyruvate Kinase M2 and Affects Metabolism of Hepatocellular Carcinoma	PLOS ONE			English	Article							LIVER-CANCER; TUMOR; MICRORNA-122; ISOFORM; PKM2; REGULATOR; NETWORK	In contrast to normal differentiated cells that depend on mitochondrial oxidative phosphorylation for energy production, cancer cells have evolved to utilize aerobic glycolysis (Warburg's effect), with benefit of providing intermediates for biomass production. MicroRNA-122 (miR-122) is highly expressed in normal liver tissue regulating a wide variety of biological processes including cellular metabolism, but is reduced in hepatocellular carcinoma (HCC). Overexpression of miR-122 was shown to inhibit cancer cell proliferation, metastasis, and increase chemosensitivity, but its functions in cancer metabolism remains unknown. The present study aims to identify the miR-122 targeted genes and to investigate the associated regulatory mechanisms in HCC metabolism. We found the ectopic overexpression of miR-122 affected metabolic activities of HCC cells, evidenced by the reduced lactate production and increased oxygen consumption. Integrated gene expression analysis in a cohort of 94 HCC tissues revealed miR-122 level tightly associated with a battery of glycolytic genes, in which pyruvate kinase (PK) gene showed the strongest anti-correlation coefficient (Pearson r = -0.6938, p = <0.0001). In addition, reduced PK level was significantly associated with poor clinical outcomes of HCC patients. We found isoform M2 (PKM2) is the dominant form highly expressed in HCC and is a direct target of miR-122, as overexpression of miR-122 reduced both the mRNA and protein levels of PKM2, whereas PKM2 re-expression abrogated the miR-122-mediated glycolytic activities. The present study demonstrated the regulatory role of miR-122 on PKM2 in HCC, having an implication of therapeutic intervention targeting cancer metabolic pathways.	[Liu, Angela M.; Luk, John M.] Natl Univ Singapore, Dept Pharmacol, Singapore 117548, Singapore; [Luk, John M.] Natl Univ Hlth Syst, Dept Surg, Singapore, Singapore; [Xu, Zhi; Chen, Jinfei; Luk, John M.] Nanjing Med Univ, Nanjing Hosp 1, Dept Oncol, Nanjing, Jiangsu, Peoples R China; [Wong, Kwong-Fai; Luk, John M.] Natl Univ Singapore, Canc Sci Inst, Singapore 117548, Singapore; [Liu, Angela M.; Shek, Felix H.; Lee, Nikki P.; Poon, Ronnie T.; Luk, John M.] Univ Hong Kong, Dept Surg, Hong Kong, Hong Kong, Peoples R China	National University of Singapore; National University of Singapore; Nanjing Medical University; National University of Singapore; University of Hong Kong	Xu, Z (corresponding author), Nanjing Med Univ, Nanjing Hosp 1, Dept Oncol, Nanjing, Jiangsu, Peoples R China.	michelle.xuzhi@gmail.com; dr.johnluk@gmail.com	Luk, John/A-4085-2008	Luk, John/0000-0002-6323-7940	National (973) Basic Science Research Program [2013CB911300]; National Natural Science Foundation of China [81128080, 81000880]; Jiangsu Provincial 12th Five-Year Program on Developing Health by Technology and Education Project	National (973) Basic Science Research Program(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Jiangsu Provincial 12th Five-Year Program on Developing Health by Technology and Education Project	This study was supported by grants from National (973) Basic Science Research Program (2013CB911300) (www.973.gov.cn), National Natural Science Foundation of China (www.nsfc.gov.cn) to Dr. JM Luk (Grant No. 81128080) and Dr. Z Xu (Grant No. 81000880), a grant from Jiangsu Provincial 12th Five-Year Program on Developing Health by Technology and Education Project (www.jswst.gov.cn) to Dr. J Chen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anastasiou D, 2011, SCIENCE, V334, P1278, DOI 10.1126/science.1211485; Bai SM, 2009, J BIOL CHEM, V284, P32015, DOI 10.1074/jbc.M109.016774; Boutz DR, 2011, J BIOL CHEM, V286, P18066, DOI 10.1074/jbc.M110.196451; Burchard J, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.58; Chaneton B, 2012, TRENDS BIOCHEM SCI, V37, P309, DOI 10.1016/j.tibs.2012.04.003; Christofk HR, 2008, NATURE, V452, P230, DOI 10.1038/nature06734; Coulouarn C, 2009, ONCOGENE, V28, P3526, DOI 10.1038/onc.2009.211; David CJ, 2010, NATURE, V463, P364, DOI 10.1038/nature08697; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Hitosugi T, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000431; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Jung CJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027740; Kitamura K, 2011, J HEPATOL, V55, P846, DOI 10.1016/j.jhep.2011.01.038; Liu AM, 2010, BIOCHEM BIOPH RES CO, V394, P623, DOI 10.1016/j.bbrc.2010.03.036; Liu LX, 2009, HEPATOLOGY, V50, P1453, DOI 10.1002/hep.23143; Lv L, 2011, MOL CELL, V42, P719, DOI 10.1016/j.molcel.2011.04.025; Sun QA, 2011, P NATL ACAD SCI USA, V108, P4129, DOI 10.1073/pnas.1014769108; Tsai WC, 2012, J CLIN INVEST, V122, P2884, DOI 10.1172/JCI63455; Tsai WC, 2009, HEPATOLOGY, V49, P1571, DOI 10.1002/hep.22806; Vander Heiden MG, 2010, BIOCHEM PHARMACOL, V79, P1118, DOI 10.1016/j.bcp.2009.12.003; Walsh MJ, 2011, BIOORG MED CHEM LETT, V21, P6322, DOI 10.1016/j.bmcl.2011.08.114; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Xu MZ, 2011, ONCOGENE, V30, P1229, DOI 10.1038/onc.2010.504; Xu MZ, 2009, CANCER-AM CANCER SOC, V115, P4576, DOI 10.1002/cncr.24495; Yang WW, 2012, CELL, V150, P685, DOI 10.1016/j.cell.2012.07.018	25	79	82	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2014	9	1							e86872	10.1371/journal.pone.0086872	http://dx.doi.org/10.1371/journal.pone.0086872			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297XI	24466275	Green Submitted, Green Published, gold			2022-12-25	WOS:000330288000161
J	Kuo, SY; Chen, SR; Tzeng, YL				Kuo, Shu-Yu; Chen, Su-Ru; Tzeng, Ya-Ling			Depression and Anxiety Trajectories among Women Who Undergo an Elective Cesarean Section	PLOS ONE			English	Article							POSTTRAUMATIC-STRESS; EARLY POSTPARTUM; SLEEP QUALITY; RISK-FACTORS; PSYCHOMETRIC EVALUATION; ANTENATAL ANXIETY; MATERNAL ANXIETY; PREGNANCY; SYMPTOMS; CHILDBIRTH	Background: Depression and anxiety are important mood changes in childbearing women. However, changes in depression and anxiety over time in women who undergo an elective cesarean section (CS) have not yet been elucidated. We aimed to characterize the trajectories of depressive and anxiety symptoms, and patterns of co-occurrence, and examined the associated predictors of depression and anxiety courses. Methods: A prospective longitudinal study of childbearing women (N = 139) who underwent a CS was conducted. Depressive and anxiety symptoms were respectively assessed using the Edinburgh Postnatal Depression Scale and State Anxiety Inventory, in the third trimester and at 1 day, 1 week, and 1 and 6 months postpartum. Results: Group-based modeling identified three distinct trajectories of depressive symptoms: group 1 (low, 30.9%), group 2 (mild, 41.7%), and group 3 (high, 27.3%). Four group trajectories of anxiety symptoms were identified: group 1 (low, 19.4%), group 2 (mild, 44.6%), group 3 (high, 28.8%), and group 4 (very high, 7.2%). Mild symptoms of both depression and anxiety were the most common joint trajectory. Depression trajectories were significantly related to anxiety trajectories (p < 0.001). Predictors of the joint trajectory included the pre-pregnant body mass index (odds ratio (OR): 2.42, 95% confidence interval (CI): 1.1 similar to 6.3) and a poor sleep score (OR: 3.2, 95% CI: 1.4 similar to 7.3) in the third trimester. Conclusions: Distinctive trajectories and co-occurrence patterns of depressive and anxiety symptoms were identified. Our findings suggest a need for greater attention to continuous assessment of psychological well-being among women who undergo an elective CS.	[Kuo, Shu-Yu; Chen, Su-Ru] Taipei Med Univ, Coll Nursing, Sch Nursing, Taipei, Taiwan; [Tzeng, Ya-Ling] China Med Univ, Sch Nursing, Taichung, Taiwan; [Tzeng, Ya-Ling] China Med Univ Hosp, Dept Nursing, Taichung, Taiwan	Taipei Medical University; China Medical University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan	Tzeng, YL (corresponding author), China Med Univ, Sch Nursing, Taichung, Taiwan.	tyaling@mail.cmu.edu.tw		Chen, Su-Ru/0000-0001-9765-0517; Kuo, Shu-Yu/0000-0003-4221-7673	National Science Council, Taiwan [NSC101-2629-H-038-001]	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan)	This study was supported by a grant (NSC101-2629-H-038-001) from the National Science Council, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alder J, 2007, J MATERN-FETAL NEO M, V20, P189, DOI 10.1080/14767050701209560; Andersen LB, 2012, ACTA OBSTET GYN SCAN, V91, P1261, DOI 10.1111/j.1600-0412.2012.01476.x; Austin MP, 2007, J AFFECT DISORDERS, V101, P169, DOI 10.1016/j.jad.2006.11.015; Bair MJ, 2003, ARCH INTERN MED, V163, P2433, DOI 10.1001/archinte.163.20.2433; Barker ED, 2011, DEPRESS ANXIETY, V28, P696, DOI 10.1002/da.20856; Beck CT, 2008, MCN-AM J MATERN-CHIL, V33, P151, DOI 10.1097/01.NMC.0000318349.70364.1c; Breitkopf CR, 2006, J PSYCHOSOM OBST GYN, V27, P157, DOI 10.1080/01674820500523521; Britton JR, 2008, DEPRESS ANXIETY, V25, P793, DOI 10.1002/da.20325; Bureau of National Health Insurance DoH Yuan. E, 2013, MED SERV QUAL CES SE; Campbell SB, 2007, DEV PSYCHOL, V43, P1202, DOI 10.1037/0012-1649.43.5.1202; Canals J, 2002, PERS INDIV DIFFER, V33, P253, DOI 10.1016/S0191-8869(01)00149-0; Carpenter JS, 1998, J PSYCHOSOM RES, V45, P5, DOI 10.1016/S0022-3999(97)00298-5; Carter AS, 2000, PSYCHOSOM MED, V62, P264, DOI 10.1097/00006842-200003000-00019; Carter FA, 2006, PSYCHOSOM MED, V68, P321, DOI 10.1097/01.psy.0000204787.83768.0c; Chang JJ, 2010, SLEEP MED REV, V14, P107, DOI 10.1016/j.smrv.2009.05.001; Chung SK., 1984, PSYCHOL TESTING, V31, P27; Cote S, 2002, J CHILD PSYCHOL PSYC, V43, P609, DOI 10.1111/1469-7610.00050; Dennis CL, 2005, BIRTH-ISS PERINAT C, V32, P187, DOI 10.1111/j.0730-7659.2005.00368.x; Field T, 2010, INFANT BEHAV DEV, V33, P23, DOI 10.1016/j.infbeh.2009.10.004; Fuglenes D, 2011, AM J OBSTET GYNECOL, V205, DOI 10.1016/j.ajog.2011.03.043; Goyal D, 2007, J PERINAT NEONAT NUR, V21, P123, DOI 10.1097/01.JPN.0000270629.58746.96; Grant KA, 2008, J AFFECT DISORDERS, V108, P101, DOI 10.1016/j.jad.2007.10.002; Heh S, 2001, J NURS RES, V9, P1; Heron J, 2004, J AFFECT DISORDERS, V80, P65, DOI 10.1016/j.jad.2003.08.004; Hiltunen P, 2004, ACTA OBSTET GYN SCAN, V83, P257, DOI 10.1111/j.0001-6349.2004.0302.x; Jones BL, 2001, SOCIOL METHOD RES, V29, P374, DOI 10.1177/0049124101029003005; Kammerer M, 2006, ARCH WOMEN MENT HLTH, V9, P187, DOI 10.1007/s00737-006-0131-2; Ko SH, 2010, J NURS SCHOLARSHIP, V42, P23, DOI 10.1111/j.1547-5069.2009.01326.x; Kraemer HC, 2004, J PSYCHIAT RES, V38, P17, DOI 10.1016/S0022-3956(03)00097-9; Kuo S-Y, 2010, J OBSTET GYNECOL NEO, V41, P216; LaCoursiere DY, 2010, BJOG-INT J OBSTET GY, V117, P1011, DOI 10.1111/j.1471-0528.2010.02569.x; Lau Y, 2010, ARCH WOMEN MENT HLTH, V13, P153, DOI 10.1007/s00737-009-0134-x; Laursen M, 2008, BJOG-INT J OBSTET GY, V115, P354, DOI 10.1111/j.1471-0528.2007.01583.x; Lee AM, 2007, OBSTET GYNECOL, V110, P1102, DOI 10.1097/01.AOG.0000287065.59491.70; Lee SY, 2007, J PERINAT NEONAT NUR, V21, P109, DOI 10.1097/01.JPN.0000270627.73993.b0; Littleton HL, 2007, AM J OBSTET GYNECOL, V196, P424, DOI 10.1016/j.ajog.2007.03.042; Lobel M, 2007, SOC SCI MED, V64, P2272, DOI 10.1016/j.socscimed.2007.02.028; Long Q, 2012, SOC SCI MED, V75, P733, DOI 10.1016/j.socscimed.2012.03.054; MacDorman MF, 2008, CLIN PERINATOL, V35, P293, DOI 10.1016/j.clp.2008.03.007; Markowitz S, 2008, CLIN PSYCHOL-SCI PR, V15, P1, DOI 10.1111/j.1468-2850.2008.00106.x; McCourt C, 2007, BIRTH-ISS PERINAT C, V34, P65, DOI 10.1111/j.1523-536X.2006.00147.x; Mora PA, 2009, AM J EPIDEMIOL, V169, P24, DOI 10.1093/aje/kwn283; Moss KM, 2009, ARCH WOMEN MENT HLTH, V12, P345, DOI 10.1007/s00737-009-0086-1; Nagin D. S., 2005, GROUP BASED MODELING, DOI DOI 10.4159/9780674041318; Nagin DS, 2010, ANNU REV CLIN PSYCHO, V6, P109, DOI 10.1146/annurev.clinpsy.121208.131413; Nagin DS, 2005, ANN AM ACAD POLIT SS, V602, P82, DOI 10.1177/0002716205280565; Nieminen K, 2009, ACTA OBSTET GYN SCAN, V88, P807, DOI 10.1080/00016340902998436; Ramos-Marcuse F, 2010, J AFFECT DISORDERS, V122, P68, DOI 10.1016/j.jad.2009.06.018; Ross LE, 2006, J CLIN PSYCHIAT, V67, P1285, DOI 10.4088/JCP.v67n0818; Skipstein Anni, 2010, BMC Public Health, V10, P589, DOI 10.1186/1471-2458-10-589; Skouteris H, 2009, J AFFECT DISORDERS, V113, P303, DOI 10.1016/j.jad.2008.06.002; Soderquist J, 2009, BJOG-INT J OBSTET GY, V116, P672, DOI 10.1111/j.1471-0528.2008.02083.x; Souza JP, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-71; Storksen HT, 2012, ACTA OBSTET GYN SCAN, V91, P237, DOI 10.1111/j.1600-0412.2011.01323.x; Su KP, 2007, GEN HOSP PSYCHIAT, V29, P436, DOI 10.1016/j.genhosppsych.2007.05.005; Teixeira C, 2009, J AFFECT DISORDERS, V119, P142, DOI 10.1016/j.jad.2009.03.005; Tham V, 2007, ACTA OBSTET GYN SCAN, V86, P1090, DOI 10.1080/00016340701507693; Tsai PS, 2005, QUAL LIFE RES, V14, P1943, DOI 10.1007/s11136-005-4346-x; Waldenstrom U, 2006, BJOG-INT J OBSTET GY, V113, P638, DOI 10.1111/j.1471-0528.2006.00950.x; Weisman O, 2010, ARCH WOMEN MENT HLTH, V13, P505, DOI 10.1007/s00737-010-0169-z; Wiklund I, 2007, ACTA OBSTET GYN SCAN, V86, P451, DOI 10.1080/00016340701217913; Yang SN, 2011, J AFFECT DISORDERS, V132, P158, DOI 10.1016/j.jad.2011.02.009	62	40	40	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2014	9	1							e86653	10.1371/journal.pone.0086653	http://dx.doi.org/10.1371/journal.pone.0086653			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	297VL	24466190	Green Published, Green Submitted, gold			2022-12-25	WOS:000330283100194
J	Zhou, J; Yu, FB; Wang, XM; Yang, Y; Yu, CL; Liu, HJ; Cheng, Y; Yan, CQ; Chen, JP				Zhou, Jie; Yu, Feibo; Wang, Xuming; Yang, Yong; Yu, Chulang; Liu, Hongjia; Cheng, Ye; Yan, Chengqi; Chen, Jianping			Specific Expression of DR5 Promoter in Rice Roots Using a tCUP Derived Promoter-Reporter System	PLOS ONE			English	Article							ENHANCER TRAP LINES; AUXIN RESPONSE; PLANT TRANSFORMATION; CRYPTIC PROMOTER; GENE-EXPRESSION; DROSOPHILA-MELANOGASTER; ARABIDOPSIS-THALIANA; FUNCTIONAL-ANALYSIS; TRANSGENIC PLANTS; MARKER GENE	Variation of transgene expression caused by either position effect at the insertion site or the promoter/enhancer elements employed for the expression of selectable marker genes has complicated phenotype characterization and caused misinterpretation. We have developed a reporter system in rice to analyze the influence of vector configuration, spacer and selectable marker gene promoter on the expression of the promoterless GUS reporter and DR5 promoter. Our results indicate that a spacer inserted between the reversed 35S promoter and the GUS reporter could reduce leaky expression of the reporter but was unable to block the nonspecific expression of DR5::GUS. Stacking the selectable marker unit in head to tail with the GUS reporter aided the gene specific expression of the GUS reporter under the DR5 promoter even when the 35S promoter is used for expression of the selectable marker. Compared to 35S under this configuration, a quick and distinctive expression of DR5:: GUS was observed in the root cap, quiescent center and xylem cells in the root apical meristem by using the tCUP derived promoter (tCUP1) for selection, that is similar to the pattern obtained by a sensitive DR5 variant (DR5rev) in Arabidopsis. These data suggest a conserved property of the tCUP promoter in preventing enhancer-promoter interactions in rice as it does in Arabidopsis, and also demonstrate that an analogous distal auxin maximum exists in roots of rice. Therefore, the tCUP promoter based selection system provides a new strategy for specific expression of transgenes in rice.	[Zhou, Jie; Wang, Xuming; Yang, Yong; Yu, Chulang; Liu, Hongjia; Cheng, Ye; Yan, Chengqi; Chen, Jianping] Zhejiang Acad Agr Sci, State Key Lab Breeding Base Zhejiang Sustainable, MOA Key Lab Plant Protect & Biotechnol, Zhejiang Prov Key Lab Plant Virol, Hangzhou, Zhejiang, Peoples R China; [Yu, Feibo] Zhejiang Normal Univ, Coll Chem & Life Sci, Jinhua, Peoples R China	Zhejiang Academy of Agricultural Sciences; Zhejiang Normal University	Yan, CQ (corresponding author), Zhejiang Acad Agr Sci, State Key Lab Breeding Base Zhejiang Sustainable, MOA Key Lab Plant Protect & Biotechnol, Zhejiang Prov Key Lab Plant Virol, Hangzhou, Zhejiang, Peoples R China.	yanchengqi65@gmail.com; jpchen2001@126.com			Program for Zhejiang Leading Team of Science and Technology Innovation [2009R50032]; Program for Leading Team of Agricultural Research and Innovation of Ministry of Agriculture, China; Program of New Varieties of Genetically Modified Organism Cultivation of China [2011ZX08009-003-001]; National Natural Science Foundation of China for young scholars [30900263, 31101208, 31201482]; Zhejiang Provincial Foundation for Natural Science [LY12C14011, Y310059]	Program for Zhejiang Leading Team of Science and Technology Innovation; Program for Leading Team of Agricultural Research and Innovation of Ministry of Agriculture, China; Program of New Varieties of Genetically Modified Organism Cultivation of China; National Natural Science Foundation of China for young scholars(National Natural Science Foundation of China (NSFC)); Zhejiang Provincial Foundation for Natural Science(Natural Science Foundation of Zhejiang Province)	This work was supported by the Program for Zhejiang Leading Team of Science and Technology Innovation [2009R50032]; the Program for Leading Team of Agricultural Research and Innovation of Ministry of Agriculture, China; the Program of New Varieties of Genetically Modified Organism Cultivation of China [2011ZX08009-003-001]; National Natural Science Foundation of China for young scholars [30900263, 31101208, 31201482] and Zhejiang Provincial Foundation for Natural Science [LY12C14011, Y310059]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barges S, 2000, DEVELOPMENT, V127, P779; BEILMANN A, 1992, PLANT MOL BIOL, V18, P65, DOI 10.1007/BF00018457; Bell AC, 2001, SCIENCE, V291, P447, DOI 10.1126/science.291.5503.447; BEVAN M, 1984, NUCLEIC ACIDS RES, V12, P8711, DOI 10.1093/nar/12.22.8711; Blilou I, 2005, NATURE, V433, P39, DOI 10.1038/nature03184; Brunoud G, 2012, NATURE, V482, P103, DOI 10.1038/nature10791; Campisi L, 1999, PLANT J, V17, P699, DOI 10.1046/j.1365-313X.1999.00409.x; Chen YN, 2012, PLANT BIOTECHNOL J, V10, P139, DOI 10.1111/j.1467-7652.2011.00637.x; Chen YR, 2013, PLANT CELL REP, V32, P453, DOI 10.1007/s00299-012-1378-x; CHUNG JH, 1993, CELL, V74, P505, DOI 10.1016/0092-8674(93)80052-G; Coudert Y, 2010, TRENDS PLANT SCI, V15, P219, DOI 10.1016/j.tplants.2010.01.008; Curtis MD, 2003, PLANT PHYSIOL, V133, P462, DOI 10.1104/pp.103.027979; DeMason DA, 2009, INT J PLANT SCI, V170, P1, DOI 10.1086/593046; Dubrovsky JG, 2011, NEW PHYTOL, V191, P970, DOI 10.1111/j.1469-8137.2011.03757.x; Foster E, 1999, PLANT MOL BIOL, V41, P45, DOI 10.1023/A:1006229501860; FOX PC, 1992, PLANT MOL BIOL, V20, P219, DOI 10.1007/BF00014490; Friml J, 2002, CELL, V108, P661, DOI 10.1016/S0092-8674(02)00656-6; Friml J, 2003, NATURE, V426, P147, DOI 10.1038/nature02085; Gallavotti A, 2008, PLANT PHYSIOL, V147, P1913, DOI 10.1104/pp.108.121541; GAN S, 2002, Patent No. 20060174370; GEYER PK, 1986, EMBO J, V5, P2657, DOI 10.1002/j.1460-2075.1986.tb04548.x; Gudynaite-Savitch L, 2009, PLANT BIOTECHNOL J, V7, P472, DOI 10.1111/j.1467-7652.2009.00416.x; HAJDUKIEWICZ P, 1994, PLANT MOL BIOL, V25, P989, DOI 10.1007/BF00014672; Hansen G, 1999, TRENDS PLANT SCI, V4, P226, DOI 10.1016/S1360-1385(99)01412-0; Hily JM, 2009, PLANT CELL REP, V28, P1095, DOI 10.1007/s00299-009-0700-8; Huo XY, 2006, J PLANT GROWTH REGUL, V25, P156, DOI 10.1007/s00344-005-0106-y; Jagannath A, 2001, MOL BREEDING, V8, P11, DOI 10.1023/A:1011916216191; JEFFERSON RA, 1987, EMBO J, V6, P3901; Kamiya N, 2003, PLANT J, V35, P429, DOI 10.1046/j.1365-313X.2003.01816.x; KAY R, 1987, SCIENCE, V236, P1299, DOI 10.1126/science.236.4806.1299; KELLUM R, 1992, MOL CELL BIOL, V12, P2424, DOI 10.1128/MCB.12.5.2424; KIM SR, 1993, PLANT PHYSIOL, V103, P97, DOI 10.1104/pp.103.1.97; Komari T, 1996, PLANT J, V10, P165, DOI 10.1046/j.1365-313X.1996.10010165.x; LIU CM, 1993, PLANT CELL, V5, P621, DOI 10.1105/tpc.5.6.621; Malik K, 2002, THEOR APPL GENET, V105, P505, DOI 10.1007/s00122-002-0926-0; Ottenschlager I, 2003, P NATL ACAD SCI USA, V100, P2987, DOI 10.1073/pnas.0437936100; Sabatini S, 1999, CELL, V99, P463, DOI 10.1016/S0092-8674(00)81535-4; Santuari L, 2011, CURR BIOL, V21, P1918, DOI 10.1016/j.cub.2011.10.002; Scarpella E, 2003, DEVELOPMENT, V130, P645, DOI 10.1242/dev.00243; She WJ, 2010, GENETICS, V185, P1141, DOI 10.1534/genetics.110.117960; Shen CJ, 2013, PLANT CELL ENVIRON, V36, P607, DOI 10.1111/pce.12001; Singer SD, 2011, PLANT CELL REP, V30, P2013, DOI 10.1007/s00299-011-1109-8; Singer SD, 2011, PLANT CELL REP, V30, P723, DOI 10.1007/s00299-010-0977-7; Tian L, 2002, PLANT CELL REP, V20, P1181, DOI 10.1007/s00299-002-0459-7; Tian LN, 2003, IN VITRO CELL DEV-PL, V39, P193, DOI 10.1079/IVP2002365; TIMMERMANS MCP, 1990, J BIOTECHNOL, V14, P333, DOI 10.1016/0168-1656(90)90117-T; Ulmasov T, 1997, PLANT CELL, V9, P1963, DOI 10.1105/tpc.9.11.1963; Vernoux T, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.39; Wang XF, 2011, MOL PLANT, V4, P289, DOI 10.1093/mp/ssq068; WILSON C, 1990, ANNU REV CELL BIOL, V6, P679, DOI 10.1146/annurev.cellbio.6.1.679; Wu CY, 2003, PLANT J, V35, P418, DOI 10.1046/j.1365-313X.2003.01808.x; Yamamoto Y, 2007, PLANT PHYSIOL, V143, P1362, DOI 10.1104/pp.106.091561; Yang YZ, 2011, PLANT CELL TISS ORG, V105, P405, DOI 10.1007/s11240-010-9880-8; Yoo SY, 2005, PLANTA, V221, P523, DOI 10.1007/s00425-004-1466-4; Zheng XL, 2007, PLANT CELL REP, V26, P1195, DOI 10.1007/s00299-007-0307-x; Zhong XP, 1997, P NATL ACAD SCI USA, V94, P5219, DOI 10.1073/pnas.94.10.5219; Zhou J, 2013, BMC BIOTECHNOL, V13, DOI 10.1186/1472-6750-13-29	57	10	11	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2014	9	1							e87008	10.1371/journal.pone.0087008	http://dx.doi.org/10.1371/journal.pone.0087008			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297VL	24466314	Green Published, gold, Green Submitted			2022-12-25	WOS:000330283100243
J	Sohn, EH; Flamme-Wiese, MJ; Whitmore, SS; Wang, K; Tucker, BA; Mullins, RF				Sohn, Elliott H.; Flamme-Wiese, Miles J.; Whitmore, S. Scott; Wang, Kai; Tucker, Budd A.; Mullins, Robert F.			Loss of CD34 Expression in Aging Human Choriocapillaris Endothelial Cells	PLOS ONE			English	Article							MACULAR DEGENERATION; HUMAN EYES; MACROPHAGES; RETINA; HETEROGENEITY; CCR3	Structural and gene expression changes in the microvasculature of the human choroid occur during normal aging and age-related macular degeneration (AMD). In this study, we sought to determine the impact of aging and AMD on expression of the endothelial cell glycoprotein CD34. Sections from 58 human donor eyes were categorized as either young (under age 40), age-matched controls (>age 60 without AMD), or AMD affected (>age 60 with early AMD, geographic atrophy, or choroidal neovascularization). Dual labeling of sections with Ulex europaeus agglutinin-I lectin (UEA-I) and CD34 antibodies was performed, and the percentage of capillaries labeled with UEA-I but negative for anti-CD34 was determined. In addition, published databases of mouse and human retinal pigment epithelium-choroid were evaluated and CD34 expression compared between young and old eyes. Immunohistochemical studies revealed that while CD34 and UEA-I were colocalized in young eyes, there was variable loss of CD34 immunoreactivity in older donor eyes. While differences between normal aging and AMD were not significant, the percentage of CD34 negative capillaries in old eyes, compared to young eyes, was highly significant (p = 3.8 x 10(-6)). Endothelial cells in neovascular membranes were invariably CD34 positive. Published databases show either a significant decrease in Cd34 (mouse) or a trend toward decreased CD34 (human) in aging. These findings suggest that UEA-I and endogenous alkaline phosphatase activity are more consistent markers of aging endothelial cells in the choroid, and suggest a possible mechanism for the increased inflammatory milieu in the aging choroid.	[Sohn, Elliott H.; Flamme-Wiese, Miles J.; Whitmore, S. Scott; Tucker, Budd A.; Mullins, Robert F.] Univ Iowa, Dept Ophthalmol & Visual Sci, Iowa City, IA 52240 USA; [Sohn, Elliott H.; Flamme-Wiese, Miles J.; Whitmore, S. Scott; Wang, Kai; Tucker, Budd A.; Mullins, Robert F.] Univ Iowa, Stephen A Wynn Inst Vis Res, Iowa City, IA USA; [Wang, Kai] Univ Iowa, Dept Biostat, Iowa City, IA USA	University of Iowa; University of Iowa; University of Iowa	Mullins, RF (corresponding author), Univ Iowa, Dept Ophthalmol & Visual Sci, Iowa City, IA 52240 USA.	Robert-Mullins@Uiowa.Edu	Mullins, Robert F/I-6717-2013	Whitmore, S. Scott/0000-0003-0161-9625; Tucker, Budd/0000-0003-2178-1742; Mullins, Robert/0000-0002-5006-0891; Sohn, Elliott/0000-0002-3778-9362	Elmer and Sylvia Sramek Charitable Foundation, National Institutes of Health [EY017451, 1-DP2-OD007483-01]; Stephen A. Wynn Foundation; Hansjoerg EJW Kolder MD, PhD Professorship for Best Disease; NATIONAL EYE INSTITUTE [R01EY017451] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008629] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD007483] Funding Source: NIH RePORTER	Elmer and Sylvia Sramek Charitable Foundation, National Institutes of Health; Stephen A. Wynn Foundation; Hansjoerg EJW Kolder MD, PhD Professorship for Best Disease; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Supported in part by: the Elmer and Sylvia Sramek Charitable Foundation, National Institutes of Health grants EY017451 and 1-DP2-OD007483-01, the Stephen A. Wynn Foundation, and the Hansjoerg EJW Kolder MD, PhD Professorship for Best Disease. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Aird WC, 2007, CIRC RES, V100, P158, DOI 10.1161/01.RES.0000255691.76142.4a; BARTHEL LK, 1990, J HISTOCHEM CYTOCHEM, V38, P1383, DOI 10.1177/38.9.2201738; Bhutto IA, 2006, BRIT J OPHTHALMOL, V90, P906, DOI 10.1136/bjo.2006.090357; Chen HY, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002339; Cherepanoff S, 2010, BRIT J OPHTHALMOL, V94, P918, DOI 10.1136/bjo.2009.165563; Erusalimsky JD, 2009, J APPL PHYSIOL, V106, P326, DOI 10.1152/japplphysiol.91353.2008; Ezzat MK, 2008, BRIT J OPHTHALMOL, V92, P976, DOI 10.1136/bjo.2007.129742; Gautier L, 2004, BIOINFORMATICS, V20, P307, DOI 10.1093/bioinformatics/btg405; Grossniklaus HE, 2002, MOL VIS, V8, P119; Klement H, 2007, AM J PATHOL, V171, P1342, DOI 10.2353/ajpath.2007.070298; Lutty GA, 2010, EYE, V24, P408, DOI 10.1038/eye.2009.318; Lutty GA, 2005, VISION RES, V45, P3504, DOI 10.1016/j.visres.2005.08.022; Mackman N, 2005, ARTERIOSCL THROM VAS, V25, P2273, DOI 10.1161/01.ATV.0000183884.06371.52; McLeod DS, 2009, INVEST OPHTH VIS SCI, V50, P4982, DOI 10.1167/iovs.09-3639; MCLEOD DS, 1995, AM J PATHOL, V147, P642; Michel CC, 1999, PHYSIOL REV, V79, P703, DOI 10.1152/physrev.1999.79.3.703; Molema G, 2012, SEMIN NEPHROL, V32, P145, DOI 10.1016/j.semnephrol.2012.02.001; Mullins RE, 2011, INVEST OPHTH VIS SCI, V52, P1606, DOI 10.1167/iovs.10-6476; Newman AM, 2012, GENOME MED, V4, DOI [10.1186/gm315, 10.1186/PREACCEPT-1418491035586234]; Nielsen JS, 2008, J CELL SCI, V121, P3683, DOI 10.1242/jcs.037507; PENFOLD PL, 1985, GRAEF ARCH CLIN EXP, V223, P69, DOI 10.1007/BF02150948; ROBERTS WG, 1995, J CELL SCI, V108, P2369; Sene A, 2013, CELL METAB, V17, P549, DOI 10.1016/j.cmet.2013.03.009; Skeie JM, 2009, EYE, V23, P747, DOI 10.1038/eye.2008.206; Skeie JM, 2010, INVEST OPHTH VIS SCI, V51, P5336, DOI 10.1167/iovs.10-5322; Smyth GK., 2005, LIMMA LINEAR MODELS; Steen R, 1998, LEUKEMIA LYMPHOMA, V30, P23, DOI 10.3109/10428199809050926; Takeda A, 2009, NATURE, V460, P225, DOI 10.1038/nature08151; Wang HB, 2011, INVEST OPHTH VIS SCI, V52, P8271, DOI 10.1167/iovs.11-8230; Yeh DC, 2004, INVEST OPHTH VIS SCI, V45, P2368, DOI 10.1167/iovs.03-0981	31	15	16	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2014	9	1							e86538	10.1371/journal.pone.0086538	http://dx.doi.org/10.1371/journal.pone.0086538			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297GT	24466138	Green Published, gold, Green Submitted			2022-12-25	WOS:000330244500254
J	Teneng, I; Tellez, CS; Picchi, MA; Klinge, DM; Yingling, CM; Snider, AM; Liu, Y; Belinsky, SA				Teneng, I.; Tellez, C. S.; Picchi, M. A.; Klinge, D. M.; Yingling, C. M.; Snider, A. M.; Liu, Y.; Belinsky, S. A.			Global identification of genes targeted by DNMT3b for epigenetic silencing in lung cancer	ONCOGENE			English	Article						DNMT3b; lung cancer; DNA methylation; MAL; OLIG2	DE-NOVO METHYLATION; NEURAL STEM-CELLS; DNA METHYLTRANSFERASES; PROMOTER HYPERMETHYLATION; TUMOR-SUPPRESSOR; MAL GENE; EXPRESSION; PROTEIN; EZH2; COMMON	The maintenance cytosine DNA methyltransferase DNMT1 and de novo methyltransferase DNMT3b cooperate to establish aberrant DNA methylation and chromatin complexes to repress gene transcription during cancer development. The expression of DNMT3b was constitutively increased 5-20-fold in hTERT/CDK4-immortalized human bronchial epithelial cells (HBECs) before treatment with low doses of tobacco carcinogens. Overexpression of DNMT3b increased and accelerated carcinogen-induced transformation. Genome-wide profiling of transformed HBECs identified 143 DNMT3b-target genes, many of which were transcriptionally regulated by the polycomb repressive complex 2 (PRC2) complex and silenced through aberrant methylation in non-small-cell lung cancer cell lines. Two genes studied in detail, MAL and OLIG2, were silenced during transformation, initially through enrichment for H3K27me3 and H3K9me2, commonly methylated in lung cancer, and exert tumor suppressor effects in vivo through modulating cancer-related pathways. Re-expression of MAL and OLIG2 to physiological levels dramatically reduced the growth of lung tumor xenografts. Our results identify a key role for DNMT3b in the earliest stages of initiation and provide a comprehensive catalog of genes targeted for silencing by this methyltransferase in non-small-cell lung cancer.	[Teneng, I.; Tellez, C. S.; Picchi, M. A.; Klinge, D. M.; Yingling, C. M.; Snider, A. M.; Liu, Y.; Belinsky, S. A.] Lovelace Resp Res Inst, Lung Canc Program, Albuquerque, NM 87108 USA	Lovelace Respiratory Research Institute	Belinsky, SA (corresponding author), Lovelace Resp Res Inst, 2425 Ridgecrest Dr SE, Albuquerque, NM 87108 USA.	sbelinsk@LRRI.org	Liu, Yushi/A-1533-2014	Liu, Yushi/0000-0003-4185-4187	NIH [R01 ES015262, 1F32 CA157082]; NATIONAL CANCER INSTITUTE [F32CA157082] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES015262] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	Data generated by The Cancer Genome Atlas (TCGA) project established by the NCI and NHGRI were used to validate part of our findings. The dbGaP accession number for TCGA data is phs000178.v8.p7. Information about TCGA and the investigators and institutions that constitute the TCGA research network can be found at http://cancergenome.nih.gov/. We acknowledge the following for technical support: Kieu Do, Randall Willink, Christopher Dagucon and Daniel E Juri. We also thank Dr Shuguang Leng for help with TCGA data acquisition, Dr Xiequn Zhang for help with bioinformatics analyses and Dr Julie Hutt for pathology review of xenografted tumors. This study was supported by NIH Grants R01 ES015262 to SAB and 1F32 CA157082 to IT.	ALONSO MA, 1987, P NATL ACAD SCI USA, V84, P1997, DOI 10.1073/pnas.84.7.1997; Baylin SB, 2000, TRENDS GENET, V16, P168, DOI 10.1016/S0168-9525(99)01971-X; Beaulieu N, 2002, J BIOL CHEM, V277, P28176, DOI 10.1074/jbc.M204734200; Belinsky SA, 2002, CANCER RES, V62, P2370; Belinsky SA, 2003, CANCER RES, V63, P7089; Belinsky SA, 1996, P NATL ACAD SCI USA, V93, P4045, DOI 10.1073/pnas.93.9.4045; Buffart TE, 2008, BRIT J CANCER, V99, P1802, DOI 10.1038/sj.bjc.6604777; Cao W, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-296; Copray S, 2006, STEM CELLS, V24, P1001, DOI 10.1634/stemcells.2005-0239; Damiani LA, 2008, CANCER RES, V68, P9005, DOI 10.1158/0008-5472.CAN-08-1276; ELDEIRY WS, 1991, P NATL ACAD SCI USA, V88, P3470, DOI 10.1073/pnas.88.8.3470; Fan H, 2012, ONCOGENE, V31, P2298, DOI 10.1038/onc.2011.411; Fatemi M, 2002, EUR J BIOCHEM, V269, P4981, DOI 10.1046/j.1432-1033.2002.03198.x; Fuks F, 2000, NAT GENET, V24, P88, DOI 10.1038/71750; Gao Q, 2011, P NATL ACAD SCI USA, V108, P18061, DOI 10.1073/pnas.1114946108; Ghoshal K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010338; Girault I, 2003, CLIN CANCER RES, V9, P4415; Greenlee RT, 2001, CA-CANCER J CLIN, V51, P15, DOI 10.3322/canjclin.51.1.15; Hammerman PS, 2012, NATURE, V489, P519, DOI 10.1038/nature11404; HIRANO T, 1994, AM J PATHOL, V144, P296; Horne HN, 2009, MOL CANCER RES, V7, P199, DOI 10.1158/1541-7786.MCR-08-0314; Janssen-Heijnen MLG, 2003, LUNG CANCER-J IASLC, V41, P245, DOI 10.1016/S0169-5002(03)00230-7; Jones PA, 1999, NAT GENET, V21, P163, DOI 10.1038/5947; Kim GD, 2002, EMBO J, V21, P4183, DOI 10.1093/emboj/cdf401; KIM T, 1995, J NEUROSCI RES, V42, P413, DOI 10.1002/jnr.490420316; Ligon KL, 2007, NEURON, V53, P503, DOI 10.1016/j.neuron.2007.01.009; Linhart HG, 2007, GENE DEV, V21, P3110, DOI 10.1101/gad.1594007; Marsit CJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012334; Mimori K, 2003, ONCOGENE, V22, P3463, DOI 10.1038/sj.onc.1206378; Mokhtari K, 2005, NEUROPATH APPL NEURO, V31, P62, DOI 10.1111/j.1365-2990.2004.00612.x; Niehrs C, 2012, EMBO J, V31, P2705, DOI 10.1038/emboj.2012.124; Okano M, 1999, CELL, V99, P247, DOI 10.1016/S0092-8674(00)81656-6; Pulling LC, 2003, CANCER RES, V63, P4842; Qi W, 2012, P NATL ACAD SCI USA, V109, P21360, DOI 10.1073/pnas.1210371110; Rhee I, 2002, NATURE, V416, P552, DOI 10.1038/416552a; Robert MF, 2003, NAT GENET, V33, P61, DOI 10.1038/ng1068; Saito Y, 2001, HEPATOLOGY, V33, P561, DOI 10.1053/jhep.2001.22507; Sato M, 2013, MOL CANCER RES, V11, P638, DOI 10.1158/1541-7786.MCR-12-0634-T; Shen XH, 2008, MOL CELL, V32, P491, DOI 10.1016/j.molcel.2008.10.016; Tabu K, 2006, J CELL SCI, V119, P1433, DOI 10.1242/jcs.02854; Tabu K, 2007, MOL CANCER RES, V5, P1099, DOI 10.1158/1541-7786.MCR-07-0096; Tellez CS, 2011, CANCER RES, V71, P3087, DOI 10.1158/0008-5472.CAN-10-3035; Tessema M, 2010, ONCOGENE, V29, P5159, DOI 10.1038/onc.2010.255; Tessema M, 2013, J THR ONC IN PRESS; Tessema M, 2009, CARCINOGENESIS, V30, P1132, DOI 10.1093/carcin/bgp114; Vire E, 2006, NATURE, V439, P871, DOI 10.1038/nature04431; Winklmeier A, 2009, CANCER SCI, V100, P261, DOI 10.1111/j.1349-7006.2008.01048.x; Yakushiji T, 2003, INT J ONCOL, V22, P1201; Yoo KH, 2012, INT J BIOL SCI, V8, P59, DOI 10.7150/ijbs.8.59; Zi XL, 2005, CANCER RES, V65, P9762, DOI 10.1158/0008-5472.CAN-05-0103	50	24	25	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 29	2015	34	5					621	630		10.1038/onc.2013.580	http://dx.doi.org/10.1038/onc.2013.580			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CA4DD	24469050				2022-12-25	WOS:000348853500009
J	Aberle, T; Franke, K; Rist, E; Benz, K; Schlosshauer, B				Aberle, Timo; Franke, Katrin; Rist, Elke; Benz, Karin; Schlosshauer, Burkhard			Cell-Type Specific Four-Component Hydrogel	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; GELATIN; FIBRIN; ANGIOGENESIS; MATRIX; CHONDROCYTES; SUBSTRATE; GELS	In the field of regenerative medicine we aim to develop implant matrices for specific tissue needs. By combining two per se, cell-permissive gel systems with enzymatic crosslinkers (gelatin/transglutaminase and fibrinogen/thrombin) to generate a blend (technical term: quattroGel), an unexpected cell-selectivity evolved. QuattroGels were porous and formed cavities in the cell diameter range, possessed gelation kinetics in the minute range, viscoelastic properties and a mechanical strength appropriate for general cell adhesion, and restricted diffusion. Cell proliferation of endothelial cells, chondrocytes and fibroblasts was essentially unaffected. In contrast, on quattroGels neither endothelial cells formed vascular tubes nor did primary neurons extend neurites in significant amounts. Only chondrocytes differentiated properly as judged by collagen isoform expression. The biophysical quattroGel characteristics appeared to leave distinct cell processes such as mitosis unaffected and favored differentiation of sessile cells, but hampered differentiation of migratory cells. This cell-type selectivity is of interest e. g. during articular cartilage or invertebral disc repair, where pathological innervation and angiogenesis represent adverse events in tissue engineering.	[Aberle, Timo; Franke, Katrin; Rist, Elke; Benz, Karin; Schlosshauer, Burkhard] Univ Tubingen, Nat Wissensch & Med Inst, Reutlingen, Germany	Eberhard Karls University of Tubingen	Schlosshauer, B (corresponding author), Univ Tubingen, Nat Wissensch & Med Inst, Reutlingen, Germany.	schlosshauer@nmi.de		Franke, Katrin/0000-0002-8649-4835	German Federal Ministry of Education and Research (BMBF) [01KQ0902R]; OtoPep [13N11302]; Nano4Neuro [13N11036]	German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); OtoPep; Nano4Neuro	Supported by the German Federal Ministry of Education and Research (BMBF) # 01KQ0902R (REGiNA TP15) and in part by 13N11302 (OtoPep) and 13N11036 (Nano4Neuro). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almqvist KF, 2001, ANN RHEUM DIS, V60, P781, DOI 10.1136/ard.60.8.781; Anders JO, 2009, J BONE JOINT SURG BR, V91B, P409, DOI 10.1302/0301-620X.91B3.20869; Anumolu SS, 2010, BIOMATERIALS, V31, P964, DOI 10.1016/j.biomaterials.2009.10.010; Benz K, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-27; Bhang SH, 2013, BIOMATERIALS, V34, P7247, DOI 10.1016/j.biomaterials.2013.06.018; Calcaterra J, 2013, BIOMACROMOLECULES, V14, P169, DOI 10.1021/bm301579p; Chen TH, 2006, J BIOMED MATER RES B, V77B, P416, DOI 10.1002/jbm.b.30439; Del Gaudio C, 2013, BIOMATERIALS, V34, P7754, DOI 10.1016/j.biomaterials.2013.06.040; DeVolder R, 2012, WIRES SYST BIOL MED, V4, P351, DOI 10.1002/wsbm.1174; Dreesmann L, 2008, BIOMED MATER, V3, DOI 10.1088/1748-6041/3/3/034119; Dreesmann L, 2007, BIOMATERIALS, V28, P5536, DOI 10.1016/j.biomaterials.2007.08.040; DVORAK HF, 1987, LAB INVEST, V57, P673; Feng Xiaodong, 2013, Int J Cell Biol, V2013, P231279, DOI 10.1155/2013/231279; Forget A, 2013, P NATL ACAD SCI USA, V110, P12887, DOI 10.1073/pnas.1222880110; Franke K, 2013, NEUROSCI LETT, V541, P248, DOI 10.1016/j.neulet.2013.01.057; Gibas I, 2010, CHEM CHEM TECHOL, V4, P297; Kopecek J, 2007, BIOMATERIALS, V28, P5185, DOI 10.1016/j.biomaterials.2007.07.044; Lietz M, 2006, BIOMATERIALS, V27, P1425, DOI 10.1016/j.biomaterials.2005.08.007; Lippacher A, 2004, EUR J PHARM BIOPHARM, V58, P561, DOI 10.1016/j.ejpb.2004.04.009; Lippacher A, 2000, INT J PHARM, V196, P227, DOI 10.1016/S0378-5173(99)00428-7; Lorand L, 2003, NAT REV MOL CELL BIO, V4, P140, DOI 10.1038/nrm1014; Lum L., 2003, INJECTABLE HYDROGELS, V1; Macaya D, 2012, BIOMED MATER, V7, DOI 10.1088/1748-6041/7/1/012001; Man AJ, 2011, TISSUE ENG PT A, V17, P2931, DOI 10.1089/ten.tea.2011.0030; Pan YS, 2007, J MATER SCI, V42, P5129, DOI 10.1007/s10853-006-1264-4; Rao RR, 2012, ANGIOGENESIS, V15, P253, DOI 10.1007/s10456-012-9257-1; Reno F, 2012, J MATER SCI-MATER M, V23, P565, DOI 10.1007/s10856-011-4519-9; Ribeiro-Resende VT, 2009, BIOMATERIALS, V30, P5251, DOI 10.1016/j.biomaterials.2009.07.007; Sazo REG, 2012, BIOMATERIALS, V33, P8529, DOI 10.1016/j.biomaterials.2012.07.028; Schlosshauer B, 2006, NEUROSURGERY, V59, P740, DOI 10.1227/01.NEU.0000235197.36789.42; Seliktar D, 2012, SCIENCE, V336, P1124, DOI 10.1126/science.1214804; Shainer R, 2010, REGEN MED, V5, P255, DOI 10.2217/RME.09.90; Singh D, 2011, J BIOMAT SCI-POLYM E, V22, P1733, DOI 10.1163/092050610X522486; SUIDAN HS, 1992, NEURON, V8, P363, DOI 10.1016/0896-6273(92)90302-T; Vallon M, 2012, BIOCHEM J, V441, P937, DOI 10.1042/BJ20111682; Wang C, 1999, NATURE, V397, P417, DOI 10.1038/17092; Willcox PJ, 1999, J POLYM SCI POL PHYS, V37, P3438, DOI 10.1002/(SICI)1099-0488(19991215)37:24<3438::AID-POLB6>3.0.CO;2-9; Xie X, 2013, ACTA PHARMACOL SIN, V34, P983, DOI 10.1038/aps.2013.17; Xu FL, 2004, J MATER SCI, V39, P5669, DOI 10.1023/B:JMSC.0000040074.64787.b3; Yuan SJ, 2012, BIOINTERPHASES, V7, DOI 10.1007/s13758-012-0030-1; Zweers MC, 2007, J INVEST DERMATOL, V127, P467, DOI 10.1038/sj.jid.5700546	41	7	7	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2014	9	1							e86740	10.1371/journal.pone.0086740	http://dx.doi.org/10.1371/journal.pone.0086740			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301BI	24475174	Green Submitted, gold, Green Published			2022-12-25	WOS:000330507300106
J	Chung, FH; Chiang, YR; Tseng, AL; Sung, YC; Lu, J; Huang, MC; Ma, NH; Lee, HC				Chung, Feng-Hsiang; Chiang, Yun-Ru; Tseng, Ai-Lun; Sung, Yung-Chuan; Lu, Jean; Huang, Min-Chang; Ma, Nianhan; Lee, Hoong-Chien			Functional Module Connectivity Map (FMCM): A Framework for Searching Repurposed Drug Compounds for Systems Treatment of Cancer and an Application to Colorectal Adenocarcinoma	PLOS ONE			English	Article							CHRONIC LYMPHOCYTIC-LEUKEMIA; GINKGO-BILOBA EXTRACT; ETHACRYNIC-ACID; THAPSIGARGIN; MECHANISMS; OPINION; DEATH; PHARMACOKINETICS; RESISTANCE; INHIBITION	Drug repurposing has become an increasingly attractive approach to drug development owing to the ever-growing cost of new drug discovery and frequent withdrawal of successful drugs caused by side effect issues. Here, we devised Functional Module Connectivity Map (FMCM) for the discovery of repurposed drug compounds for systems treatment of complex diseases, and applied it to colorectal adenocarcinoma. FMCM used multiple functional gene modules to query the Connectivity Map (CMap). The functional modules were built around hub genes identified, through a gene selection by trend-of-disease-progression (GSToP) procedure, from condition-specific gene-gene interaction networks constructed from sets of cohort gene expression microarrays. The candidate drug compounds were restricted to drugs exhibiting predicted minimal intracellular harmful side effects. We tested FMCM against the common practice of selecting drugs using a genomic signature represented by a single set of individual genes to query CMap (IGCM), and found FMCM to have higher robustness, accuracy, specificity, and reproducibility in identifying known anti-cancer agents. Among the 46 drug candidates selected by FMCM for colorectal adenocarcinoma treatment, 65% had literature support for association with anti-cancer activities, and 60% of the drugs predicted to have harmful effects on cancer had been reported to be associated with carcinogens/immune suppressors. Compounds were formed from the selected drug candidates where in each compound the component drugs collectively were beneficial to all the functional modules while no single component drug was harmful to any of the modules. In cell viability tests, we identified four candidate drugs: GW-8510, etacrynic acid, ginkgolide A, and 6-azathymine, as having high inhibitory activities against cancer cells. Through microarray experiments we confirmed the novel functional links predicted for three candidate drugs: phenoxybenzamine (broad effects), GW-8510 (cell cycle), and imipenem (immune system). We believe FMCM can be usefully applied to repurposed drug discovery for systems treatment of other types of cancer and other complex diseases.	[Chung, Feng-Hsiang; Chiang, Yun-Ru; Tseng, Ai-Lun; Ma, Nianhan; Lee, Hoong-Chien] Natl Cent Univ, Inst Syst Biol & Bioinformat, Zhongli, Taiwan; [Chung, Feng-Hsiang; Lee, Hoong-Chien] Natl Cent Univ, Ctr Dynam Biomarkers & Translat Med, Zhongli, Taiwan; [Sung, Yung-Chuan] Cathay Gen Hosp, Div Hematol & Oncol, Taipei, Taiwan; [Lu, Jean] Acad Sinica, Inst Biomed Sci, Taipei, Taiwan; [Huang, Min-Chang; Lee, Hoong-Chien] Chung Yuan Christian Univ, Dept Phys, Zhongli, Taiwan; [Lee, Hoong-Chien] Cathay Gen Hosp, Cathay Med Res Inst, Taipei, Taiwan; [Lee, Hoong-Chien] Natl Ctr Theoret Sci, Div Phys, Hsinchu, Taiwan	National Central University; National Central University; Cathay General Hospital; Academia Sinica - Taiwan; Chung Yuan Christian University; Cathay General Hospital	Chung, FH (corresponding author), Natl Cent Univ, Inst Syst Biol & Bioinformat, Zhongli, Taiwan.	fabian415@gmail.com; mini7ma@gmail.com; hclee12345@gmail.com	Chiang, Yun/GRJ-5251-2022; Ma, Nianhan/AAB-9869-2020	Ma, Nianhan/0000-0003-1800-2306	Strive for the Top Project, Ministry of Education, ROC [101G907-2]; National Central University-Cathay General Hospital United Research Center [101CGH-NCU-A5]	Strive for the Top Project, Ministry of Education, ROC; National Central University-Cathay General Hospital United Research Center	This work is partially funded by grants from the Strive for the Top Project, Ministry of Education (grant no. 101G907-2), ROC, and the National Central University-Cathay General Hospital United Research Center (101CGH-NCU-A5). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlemeyer B, 2003, PHARMACOPSYCHIATRY, V36, pS8; Aizawa S, 2003, CANCER SCI, V94, P886, DOI 10.1111/j.1349-7006.2003.tb01371.x; Alexa A, 2006, BIOINFORMATICS, V22, P1600, DOI 10.1093/bioinformatics/btl140; [Anonymous], 2010, PHARM MED; Aponte MM, 2006, AACR M, V2006, pA106; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Berger SI, 2009, BIOINFORMATICS, V25, P2466, DOI 10.1093/bioinformatics/btp465; Brambilla G, 2006, MUTAT RES-REV MUTAT, V612, P115, DOI 10.1016/j.mrrev.2005.12.002; Chong CR, 2007, NATURE, V448, P645, DOI 10.1038/448645a; Chung FH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065683; DeFeudis FV, 2003, FUND CLIN PHARMACOL, V17, P405, DOI 10.1046/j.1472-8206.2003.00156.x; Douillard JY, 2000, LANCET, V355, P1041, DOI 10.1016/S0140-6736(00)02034-1; Dudley JT, 2011, SCI TRANSL MED, V3; ELLISON RR, 1960, CANCER RES, V20, P435; FREI E, 1958, BLOOD, V13, P1126, DOI 10.1182/blood.V13.12.1126.1126; Garman KS, 2008, P NATL ACAD SCI USA, V105, P19432, DOI 10.1073/pnas.0806674105; Goldkind L, 2006, PHARMACOEPIDEM DR S, V15, P213, DOI 10.1002/pds.1207; HAKII H, 1986, J CANCER RES CLIN, V111, P177, DOI 10.1007/BF00389230; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Harmon CS, 1996, J INVEST DERMATOL, V107, P188, DOI 10.1111/1523-1747.ep12329592; Hill KD, 2012, DRUG AGING, V29, P15, DOI 10.2165/11598420-000000000-00000; Hopkins AL, 2008, NAT CHEM BIOL, V4, P682, DOI 10.1038/nchembio.118; Hornberg JJ, 2006, BIOSYSTEMS, V83, P81, DOI 10.1016/j.biosystems.2005.05.014; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022274; Imming P, 2006, NAT REV DRUG DISCOV, V5, P821, DOI 10.1038/nrd2132; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Issa AM, 2007, CURR DRUG SAF, V2, P177, DOI 10.2174/157488607781668855; Jiang W, 2012, INTEGR CANC THER; Jiang W, 2011, EUR J CANCER PREV, V20, P508, DOI 10.1097/CEJ.0b013e328348fbb7; Kamb A, 2007, NAT REV DRUG DISCOV, V6, P115, DOI 10.1038/nrd2155; Kent LL, 1999, BIOCHEM BIOPH RES CO, V260, P768, DOI 10.1006/bbrc.1999.0891; Khamas A, 2012, CANCER GENOM PROTEOM, V9, P67; Kreeger PK, 2010, CARCINOGENESIS, V31, P2, DOI 10.1093/carcin/bgp261; Kumar N, 2008, MOL PHARMACOL, V73, P1668, DOI 10.1124/mol.107.043794; LACRETA FP, 1994, J PHARMACOL EXP THER, V270, P1186; Lamb J, 2006, SCIENCE, V313, P1929, DOI 10.1126/science.1132939; Lee DI, 2007, ARCH BIOCHEM BIOPHYS, V464, P19, DOI 10.1016/j.abb.2007.03.040; Lin XS, 1997, PROSTATE, V33, P201, DOI 10.1002/(SICI)1097-0045(19971101)33:3<201::AID-PROS9>3.0.CO;2-L; Lu DS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008294; Merino A, 2010, DRUG DISCOV TODAY, V15, P749, DOI 10.1016/j.drudis.2010.06.006; Oprea TI, 2012, AAPS J, V14, P759, DOI 10.1208/s12248-012-9390-1; Pereira M, 2002, MOL CELL BIOCHEM, V229, P163, DOI 10.1023/A:1017972622312; Prasad TSK, 2009, NUCLEIC ACIDS RES, V37, pD767, DOI 10.1093/nar/gkn892; PRUSOFF WH, 1954, CANCER RES, V14, P570; RETTIG RA, 2006, HEALTH AFFAIR, V25, P1446; RHODES T, 1992, BRIT J CANCER, V65, P684, DOI 10.1038/bjc.1992.145; Rogers TB, 1995, BIOSCIENCE REP, V15, P341, DOI 10.1007/BF01788366; Sabates-Beliver J, 2007, MOL CANCER RES, V5, P1263, DOI 10.1158/1541-7786.MCR-07-0267; Schadt EE, 2009, NAT REV DRUG DISCOV, V8, P286, DOI 10.1038/nrd2826; Schoeberl B, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000352; Seyfried J, 1999, NEUROSCI LETT, V264, P1, DOI 10.1016/S0304-3940(99)00107-X; Shi C, 2010, INT J MOL SCI, V11, P107, DOI 10.3390/ijms11010107; Shigemizu D, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002347; Sirota M, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001318; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; TEW KD, 1988, CANCER RES, V48, P3622; Tombal B, 2000, PROSTATE, V43, P303; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Vaidyanathan S, 2006, SPINAL CORD, V44, P188, DOI 10.1038/sj.sc.3101789; Wang GP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014573; Woelkart K, 2010, PHYTOTHER RES, V24, P445, DOI 10.1002/ptr.3074; Xia SH, 2007, CHINESE MED J-PEKING, V120, P922, DOI 10.1097/00029330-200705020-00013; Zhu F, 2012, NUCLEIC ACIDS RES, V40, pD1128, DOI 10.1093/nar/gkr797	65	32	33	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2014	9	1							e86299	10.1371/journal.pone.0086299	http://dx.doi.org/10.1371/journal.pone.0086299			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301BI	24475102	gold, Green Published			2022-12-25	WOS:000330507300051
J	Souza, LD; Camargo, R; Demasi, M; Santana, JM; de Sa, CM; de Freitas, SM				Souza, Larissa da Costa; Camargo, Ricardo; Demasi, Marilene; Santana, Jaime Martins; de Sa, Cezar Martins; de Freitas, Sonia Maria			Effects of an Anticarcinogenic Bowman-Birk Protease Inhibitor on Purified 20S Proteasome and MCF-7 Breast Cancer Cells	PLOS ONE			English	Article							DYNAMIC LIGHT-SCATTERING; PEA VIGNA-SINENSIS; CHYMOTRYPSIN INHIBITOR; MULTICATALYTIC PROTEINASE; 26S PROTEASOME; BETA-SUBUNITS; S PROTEASOME; ACTIVE-SITES; TRYPSIN; APOPTOSIS	Proteasome inhibitors have been described as an important target for cancer therapy due to their potential to regulate the ubiquitin-proteasome system in the degradation pathway of cellular proteins. Here, we reported the effects of a Bowman-Birk-type protease inhibitor, the Black-eyed pea Trypsin/Chymotrypsin Inhibitor (BTCI), on proteasome 20S in MCF-7 breast cancer cells and on catalytic activity of the purified 20S proteasome from horse erythrocytes, as well as the structural analysis of the BTCI-20S proteasome complex. In vitro experiments and confocal microscopy showed that BTCI readily crosses the membrane of the breast cancer cells and co-localizes with the proteasome in cytoplasm and mainly in nucleus. Indeed, as indicated by dynamic light scattering, BTCI and 20S proteasome form a stable complex at temperatures up to 55 degrees C and at neutral and alkaline pHs. In complexed form, BTCI strongly inhibits the proteolytic chymotrypsin-, trypsin-and caspase-like activities of 20S proteasome, indicated by inhibition constants of 10(-7) M magnitude order. Besides other mechanisms, this feature can be associated with previously reported cytostatic and cytotoxic effects of BTCI in MCF-7 breast cancer cells by means of apoptosis.	[Souza, Larissa da Costa; de Freitas, Sonia Maria] Univ Brasilia, Dept Cellular Biol, Biophys Lab, Brasilia, DF, Brazil; [Camargo, Ricardo; de Sa, Cezar Martins] Univ Brasilia, Dept Cellular Biol, Microbiol Lab, Brasilia, DF, Brazil; [Demasi, Marilene] Butantan Inst, Biochem & Biophys Lab, Sao Paulo, Brazil; [Santana, Jaime Martins] Univ Brasilia, Dept Cellular Biol, Lab Pathogen Host Interface, Brasilia, DF, Brazil	Universidade de Brasilia; Universidade de Brasilia; Instituto Butantan; Universidade de Brasilia	de Freitas, SM (corresponding author), Univ Brasilia, Dept Cellular Biol, Biophys Lab, Brasilia, DF, Brazil.	nina@unb.br	Santana, Jaime/H-5319-2013; Demasi, Marilene/E-5873-2012	Demasi, Marilene/0000-0002-3749-1160; Camargo, Ricardo/0000-0003-0592-8396	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Fundacao de Amparo a Pesquisa do Distrito Federal (FAP-DF); Financiadora de Estudos e Projetos (FINEP)	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Distrito Federal (FAP-DF)(Fundacao de Apoio a Pesquisa do Distrito Federal (FAPDF)); Financiadora de Estudos e Projetos (FINEP)(Financiadora de Inovacao e Pesquisa (Finep))	This work was supported by Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES), Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Fundacao de Amparo a Pesquisa do Distrito Federal (FAP-DF) and Financiadora de Estudos e Projetos (FINEP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams J, 1999, CANCER RES, V59, P2615; Adams J, 2004, NAT REV CANCER, V4, P349, DOI 10.1038/nrc1361; An B, 1998, CELL DEATH DIFFER, V5, P1062, DOI 10.1038/sj.cdd.4400436; Armstrong WB, 2000, CLIN CANCER RES, V6, P4684; Ascenzi P, 2003, CURR PROTEIN PEPT SC, V4, P231, DOI 10.2174/1389203033487180; BALDWIN ET, 1986, BIOPHYS J, V49, P47, DOI 10.1016/S0006-3495(86)83587-1; Barbosa JARG, 2007, BIOPHYS J, V92, P1638, DOI 10.1529/biophysj.106.090555; Blackburn C, 2010, BIOCHEM J, V430, P461, DOI 10.1042/BJ20100383; Bochtler M, 1999, ANNU REV BIOPH BIOM, V28, P295, DOI 10.1146/annurev.biophys.28.1.295; BODE W, 1992, EUR J BIOCHEM, V204, P433, DOI 10.1111/j.1432-1033.1992.tb16654.x; Boehm K, 2008, BIOCHEMISTRY-US, V47, P7116, DOI 10.1021/bi800554v; Borissenko L, 2007, CHEM REV, V107, P687, DOI 10.1021/cr0502504; Bossola M, 2003, ANN SURG, V237, P384, DOI 10.1097/00000658-200303000-00013; Carrotta R, 2009, PHYS CHEM CHEM PHYS, V11, P4007, DOI 10.1039/b818687a; Carvalho AF, 2008, BRAZ J BIOL, V68, P149, DOI 10.1590/S1519-69842008000100021; Chen LH, 2008, INT J BIOL MACROMOL, V42, P441, DOI 10.1016/j.ijbiomac.2008.02.005; CHEN P, 1992, J BIOL CHEM, V267, P1990; Chen YW, 2005, CARCINOGENESIS, V26, P1296, DOI 10.1093/carcin/bgi062; CLEMENTE A, 2013, BOWMAN BIRK INHIBITO, DOI DOI 10.5772/51262; Clemente A, 2012, BRIT J NUTR, V108, pS135, DOI 10.1017/S000711451200075X; Clemente A, 2011, CURR PROTEIN PEPT SC, V12, P358, DOI 10.2174/138920311796391133; Codony-Servat J, 2006, MOL CANCER THER, V5, P665, DOI 10.1158/1535-7163.MCT-05-0147; Craiu A, 1997, J BIOL CHEM, V272, P13437, DOI 10.1074/jbc.272.20.13437; Crawford LJA, 2006, CANCER RES, V66, P6379, DOI 10.1158/0008-5472.CAN-06-0605; da Silva LP, 2001, PROTEIN PEPTIDE LETT, V8, P33, DOI 10.2174/0929866013409715; de Bettignies G, 2010, BIOCHIMIE, V92, P1530, DOI 10.1016/j.biochi.2010.06.023; De Leo F, 2002, NUCLEIC ACIDS RES, V30, P347, DOI 10.1093/nar/30.1.347; deFreitas SM, 1997, FEBS LETT, V409, P121, DOI 10.1016/S0014-5793(97)00419-5; Demasi M, 2001, ARCH BIOCHEM BIOPHYS, V389, P254, DOI 10.1006/abbi.2001.2332; Dou QP, 1999, DRUG RESIST UPDATE, V2, P215, DOI 10.1054/drup.1999.0095; Esteves GF, 2007, ACTA CRYSTALLOGR F, V63, P1087, DOI 10.1107/S1744309107056424; FACHETTI HCS, 1984, AN ACAD BRAS CIENC, V56, P311; Franco OL, 2003, PHYTOCHEMISTRY, V63, P343, DOI 10.1016/S0031-9422(03)00108-0; FREITAS SM, 1999, J PROTEIN CHEM, V18, P307; Frisken BJ, 2001, APPL OPTICS, V40, P4087, DOI 10.1364/AO.40.004087; Gavilan E, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.95; Ghobrial IM, 2005, CA-CANCER J CLIN, V55, P178, DOI 10.3322/canjclin.55.3.178; Glickman MH, 1998, MOL CELL BIOL, V18, P3149, DOI 10.1128/MCB.18.6.3149; Gokarn YR, 2009, PROTEIN SCI, V18, P169, DOI 10.1002/pro.20; Griffin TA, 1998, J EXP MED, V187, P97, DOI 10.1084/jem.187.1.97; Groll M, 1999, P NATL ACAD SCI USA, V96, P10976, DOI 10.1073/pnas.96.20.10976; Groll M, 2003, INT J BIOCHEM CELL B, V35, P606, DOI 10.1016/S1357-2725(02)00390-4; Groll M, 1997, NATURE, V386, P463, DOI 10.1038/386463a0; Hanlon AD, 2010, BIOPHYS J, V98, P297, DOI 10.1016/j.bpj.2009.09.061; Hassan PA, 2006, J COLLOID INTERF SCI, V300, P744, DOI 10.1016/j.jcis.2006.04.013; Heinemeyer W, 1997, J BIOL CHEM, V272, P25200, DOI 10.1074/jbc.272.40.25200; Holzl H, 2000, J CELL BIOL, V150, P119, DOI 10.1083/jcb.150.1.119; Hortobagyi Gabriel N, 2005, Clin Breast Cancer, V6, P391, DOI 10.3816/CBC.2005.n.043; IKENAKA T, 1986, PROTEINASE INHIBITOR, V9, P361; Joanitti G.A., 2006, CURR ENZYM INHIB, V2, P199, DOI [10.2174/157340806777934801, DOI 10.2174/157340806777934801]; JOANITTI GA, 2012, THESIS UNB; Joanitti GA, 2010, CANCER LETT, V293, P73, DOI 10.1016/j.canlet.2009.12.017; Kato GJ, 1999, HUM MUTAT, V13, P87, DOI 10.1002/(SICI)1098-1004(1999)13:2<87::AID-HUMU1>3.0.CO;2-K; Kennedy AR, 1998, AM J CLIN NUTR, V68, p1406S, DOI 10.1093/ajcn/68.6.1406S; KENNEDY AR, 1995, CANC RES S, V54, P1999; KENNEDY AR, 1993, PROTEASE INHIBITORS, P9; Kisselev AF, 2002, J BIOL CHEM, V277, P22260, DOI 10.1074/jbc.M112360200; Kisselev AF, 2006, J BIOL CHEM, V281, P8582, DOI 10.1074/jbc.M509043200; Kisselev AF, 2012, CHEM BIOL, V19, P99, DOI 10.1016/j.chembiol.2012.01.003; Kloetzel PM, 2004, CURR OPIN IMMUNOL, V16, P76, DOI 10.1016/j.coi.2003.11.004; KOPP F, 1986, BIOCHIM BIOPHYS ACTA, V872, P253, DOI 10.1016/0167-4838(86)90278-5; Lacerda SHD, 2010, ACS NANO, V4, P365, DOI 10.1021/nn9011187; LASKOWSKI M, 1980, ANNU REV BIOCHEM, V49, P593, DOI 10.1146/annurev.bi.49.070180.003113; Laskowski M, 2000, BBA-PROTEIN STRUCT M, V1477, P324, DOI 10.1016/S0167-4838(99)00284-8; Lee DH, 1998, TRENDS CELL BIOL, V8, P397, DOI 10.1016/S0962-8924(98)01346-4; Li SX, 2004, J BIOL PHYS, V30, P313, DOI 10.1007/s10867-004-0997-z; Liang L, 2004, LANGMUIR, V20, P3333, DOI 10.1021/la035844l; Libich DS, 2003, PROTEIN SCI, V12, P1507, DOI 10.1110/ps.0303603; Loidl G, 1999, P NATL ACAD SCI USA, V96, P5418, DOI 10.1073/pnas.96.10.5418; Lopes UG, 1997, J BIOL CHEM, V272, P12893, DOI 10.1074/jbc.272.20.12893; LUPAS A, 1993, ENZYME PROTEIN, V47, P252, DOI 10.1159/000468684; McBride JD, 2001, CURR MED CHEM, V8, P909, DOI 10.2174/0929867013372832; Mello MO, 2003, MOL PHYLOGENET EVOL, V27, P103, DOI 10.1016/S1055-7903(02)00373-1; MESSINA M, 1991, JNCI-J NATL CANCER I, V83, P541, DOI 10.1093/jnci/83.8.541; MESSINA MJ, 1994, NUTR CANCER, V21, P113, DOI 10.1080/01635589409514310; MORHY L, 1987, AN ACAD BRAS CIENC, V59, P71; Mortenson MM, 2004, CANCER CHEMOTH PHARM, V54, P343, DOI 10.1007/s00280-004-0811-4; O'Connor OA, 2005, J CLIN ONCOL, V23, P676, DOI 10.1200/JCO.2005.02.050; Orlowski M, 2000, ARCH BIOCHEM BIOPHYS, V383, P1, DOI 10.1006/abbi.2000.2036; Park JM, 2013, BIORESOURCE TECHNOL, V135, P1, DOI 10.1016/j.biortech.2013.03.132; PEREIRA MEF, 1996, J BIOL CHEM, V271, P16455; Pickart CM, 2004, NAT REV MOL CELL BIO, V5, P177, DOI 10.1038/nrm1336; Richardson MJ., 1991, METHODS PLANT BIOCH, P259; ROCK KL, 1994, CELL, V78, P761, DOI 10.1016/S0092-8674(94)90462-6; Schmidtke G, 1996, EMBO J, V15, P6887, DOI 10.1002/j.1460-2075.1996.tb01081.x; Shen M, 2013, EXPERT OPIN THER TAR, V17, P1091, DOI 10.1517/14728222.2013.815728; Shiba K, 2010, ANAL SCI, V26, P659, DOI 10.2116/analsci.26.659; Silva LP, 2005, PROTEINS, V61, P642, DOI 10.1002/prot.20646; TANAKA K, 1988, J BIOL CHEM, V263, P16209; Tardioli S, 2010, J COLLOID INTERF SCI, V347, P96, DOI 10.1016/j.jcis.2010.03.017; Thomas AR, 2002, BIOL CHEM, V383, P1267, DOI 10.1515/BC.2002.141; VENTURA MM, 1966, AN ACAD BRAS CIENC, V38, P553; VENTURA MM, 1975, AN ACAD BRAS CIENC, V47, P335; VENTURA MM, 1981, AN ACAD BRAS CIENC, V53, P195; Voges D, 1999, ANNU REV BIOCHEM, V68, P1015, DOI 10.1146/annurev.biochem.68.1.1015; Voorhees PM, 2003, CLIN CANCER RES, V9, P6316; Wehenkel M, 2012, BRIT J CANCER, V107, P53, DOI 10.1038/bjc.2012.243; Xavier Filho J., 1988, Comments of Agriculture and Food Chemistry, V1, P239; YOSHIMURA T, 1993, J STRUCT BIOL, V111, P200, DOI 10.1006/jsbi.1993.1050	99	34	34	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2014	9	1							e86600	10.1371/journal.pone.0086600	http://dx.doi.org/10.1371/journal.pone.0086600			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301BI	24475156	Green Published, Green Submitted, gold			2022-12-25	WOS:000330507300092
J	Wang, D; Zhong, X; Huang, DJ; Chen, R; Bai, GB; Li, Q; Yu, BL; Fan, Y; Sun, XF				Wang, Ding; Zhong, Xuan; Huang, Dongjian; Chen, Rui; Bai, Guibin; Li, Qing; Yu, Bolan; Fan, Yong; Sun, Xiaofang			Functional Polymorphisms of Interferon-gamma Affect Pneumonia-Induced Sepsis	PLOS ONE			English	Article							SINGLE NUCLEOTIDE POLYMORPHISM; IFN-GAMMA; HEPATITIS-C; ORGAN FAILURE; RECEPTOR DEFICIENCY; GENE POLYMORPHISMS; INNATE RESISTANCE; SEPTIC SHOCK; NK-CELLS; T-CELLS	Objective: Sepsis is an inflammatory syndrome caused by infection, and both its incidence and mortality are high. Because interferon-gamma (IFN-gamma) plays an important role in inflammation, this work assessed IFN-gamma single nucleotide polymorphism (SNPs) that may be associated with sepsis. Methods: A total of 196 patients with pneumonia-induced sepsis and 213 age-and sex-matched healthy volunteers participated in our study from July 2012 to July 2013 in Guangzhou, China. Patient clinical information was collected. Clinical pathology was assessed in subgroups defined based on clinical criteria, APACHE II (acute physiology and chronic health evaluation) and SOFA (sepsis-related organ failure assessment) scores and discharge rate. Four functional SNPs, -1616T/C (rs2069705), -764G/C (rs2069707), +874A/T (rs2430561) and +3234C/T (rs2069718), were genotyped by Snapshot in both sepsis patients and healthy controls. Pearson's chi-square test or Fisher's exact test were used to analyze the distribution of the SNPs, and the probability values (P values), odds ratios (OR) and 95% confidence intervals (CIs) were calculated. Results: No mutations in the IFN-gamma -764G/C SNP were detected among the participants in our study. The +874A/T and +3234C/T SNPs were in strong linkage disequilibrium (LD) (r(2) = 0.894). The 21616 TC+TT, +874 AT+AA genotype and the TAC haplotype were significantly associated with sepsis susceptibility, while the CTT haplotype was associated with protection against sepsis incidence. Genotype of -1616 TT wasn't only protective against severity of sepsis, but also against higher APACHE II and SOFA scores as +874 AA and +3234 CC. The TAC haplotype was was protective against progression to severe sepsis either. Conclusion: Our results suggest that functional IFN-gamma SNPs and their haplotypes are associated with pneumonia-induced sepsis.	[Wang, Ding; Li, Qing; Yu, Bolan; Fan, Yong; Sun, Xiaofang] Guangzhou Med Univ, Key Lab Major Obstet Dis Guangdong Prov, Key Lab Reprod & Genet,Affiliated Hosp 3, Guangdong Higher Educ Inst,Expt Dept,Inst Gynecol, Guangzhou, Guangdong, Peoples R China; [Zhong, Xuan; Huang, Dongjian; Bai, Guibin] Guangzhou Med Univ, Dept Intens Care Unit, Affiliated Hosp 3, Guangzhou, Guangdong, Peoples R China; [Chen, Rui] Guangzhou Med Univ, Dept Reprod, Affiliated Hosp 3, Guangzhou, Guangdong, Peoples R China	Guangzhou Medical University; Guangzhou Medical University; Guangzhou Medical University	Wang, D (corresponding author), Guangzhou Med Univ, Key Lab Major Obstet Dis Guangdong Prov, Key Lab Reprod & Genet,Affiliated Hosp 3, Guangdong Higher Educ Inst,Expt Dept,Inst Gynecol, Guangzhou, Guangdong, Peoples R China.	largestone_1984@163.com; xiaofangsun@hotmail.com			Guangdong Provincial Natural Science Foundation [S2013040012649]; Education Ministry [20134423120005]; National Natural Science Funds of China [81202604]; Department of Health of Guangdong Province for young scholars [B2012169]; Doctor startup foundation project from Guangzhou Medical University [2011C41]	Guangdong Provincial Natural Science Foundation(National Natural Science Foundation of Guangdong Province); Education Ministry; National Natural Science Funds of China(National Natural Science Foundation of China (NSFC)); Department of Health of Guangdong Province for young scholars; Doctor startup foundation project from Guangzhou Medical University	This work was supported by Guangdong Provincial Natural Science Foundation S2013040012649, the new teacher project of Education Ministry 20134423120005, the National Natural Science Funds of China 81202604, the Department of Health of Guangdong Province for young scholars B2012169, the Doctor startup foundation project from Guangzhou Medical University 2011C41. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alestig E, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-124; Alimohammadian MH, 2007, MICROBIOL IMMUNOL, V51, P1003, DOI 10.1111/j.1348-0421.2007.tb03984.x; Ansari A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027848; AYALA A, 1994, J SURG RES, V56, P579, DOI 10.1006/jsre.1994.1092; Baldini M, 1999, AM J RESP CELL MOL, V20, P976, DOI 10.1165/ajrcmb.20.5.3494; Bastos KRB, 2007, J INTERF CYTOK RES, V27, P399, DOI 10.1089/jir.2007.0128; Boehm U, 1997, ANNU REV IMMUNOL, V15, P749, DOI 10.1146/annurev.immunol.15.1.749; BONE RC, 1992, CRIT CARE MED, V20, P864, DOI 10.1097/00003246-199206000-00025; Bream JH, 2002, GENES IMMUN, V3, P165, DOI 10.1038/sj.gene.6363870; Carnaud C, 1999, J IMMUNOL, V163, P4647; CHANG CH, 1995, J EXP MED, V181, P765, DOI 10.1084/jem.181.2.765; CHANG CH, 1992, IMMUNOGENETICS, V35, P378; Chang H, 2010, BLOOD CELL MOL DIS, V45, P313, DOI 10.1016/j.bcmd.2010.09.003; Chevillard C, 2003, J IMMUNOL, V171, P5596, DOI 10.4049/jimmunol.171.10.5596; Chong WP, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-82; Crispim JCO, 2010, TRANSPL P, V42, P4505, DOI 10.1016/j.transproceed.2010.10.014; D'Orazio SEF, 2006, J IMMUNOL, V177, P7146, DOI 10.4049/jimmunol.177.10.7146; Dai CY, 2006, TRANSL RES, V148, P128, DOI 10.1016/j.trsl.2006.04.005; Davis RE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034091; de Albuquerque AC, 2012, EUR J CLIN MICROBIOL, V31, P2887, DOI 10.1007/s10096-012-1660-4; Djawe K, 2013, CLIN INFECT DIS, V56, P74, DOI 10.1093/cid/cis841; Erdei E, 2010, CYTOKINE, V51, P18, DOI 10.1016/j.cyto.2010.03.014; ESKDALE J, 1995, IMMUNOGENETICS, V42, P444; Feng CG, 2006, J IMMUNOL, V177, P7086, DOI 10.4049/jimmunol.177.10.7086; Gao Qiu-ju, 2010, Zhonghua Liu Xing Bing Xue Za Zhi, V31, P324; He JR, 2012, J INFECT DIS, V205, P64, DOI 10.1093/infdis/jir710; Ho KM, 2007, ANAESTH INTENS CARE, V35, P515, DOI 10.1177/0310057X0703500409; Huang Y, 2007, P NATL ACAD SCI USA, V104, P985, DOI 10.1073/pnas.0609954104; HUNTER CA, 1995, J IMMUNOL, V155, P4347; ISAACS A, 1957, PROC R SOC SER B-BIO, V147, P258, DOI 10.1098/rspb.1957.0048; Jouanguy E, 1996, NEW ENGL J MED, V335, P1956, DOI 10.1056/NEJM199612263352604; Kang CI, 2011, J INFECTION, V62, P26, DOI 10.1016/j.jinf.2010.10.010; Kim K, 2010, ANN RHEUM DIS, V69, P1247, DOI 10.1136/ard.2009.117572; Koutsounaki E, 2008, J CLIN IMMUNOL, V28, P495, DOI 10.1007/s10875-008-9201-8; Kumar A, 2008, GENES IMMUN, V9, P294, DOI 10.1038/gene.2008.17; Lee HC, 2010, J CLIN IMMUNOL, V30, P68, DOI 10.1007/s10875-009-9330-8; Lee JY, 2001, GENES IMMUN, V2, P254, DOI 10.1038/sj.gene.6363775; Lopez-Cortes LF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0028115; Lorenz E, 2002, ARCH INTERN MED, V162, P1028, DOI 10.1001/archinte.162.9.1028; Louis E, 1998, CLIN EXP IMMUNOL, V113, P401; Mach B, 1996, ANNU REV IMMUNOL, V14, P301, DOI 10.1146/annurev.immunol.14.1.301; Martin GS, 2012, EXPERT REV ANTI-INFE, V10, P701, DOI [10.1586/ERI.12.50, 10.1586/eri.12.50]; MELDRUM DR, 1991, J SURG RES, V51, P158, DOI 10.1016/0022-4804(91)90088-4; Nakao F, 2001, J ALLERGY CLIN IMMUN, V107, P499, DOI 10.1067/mai.2001.113051; PierreAudigier C, 1997, CLIN INFECT DIS, V24, P982, DOI 10.1093/clinids/24.5.982; Qiu G, 2001, SHOCK, V16, P425, DOI 10.1097/00024382-200116060-00004; Robinson CM, 2010, J INNATE IMMUN, V2, P56, DOI 10.1159/000247156; Schluter B, 2002, CRIT CARE MED, V30, P32, DOI 10.1097/00003246-200201000-00005; Schroder K, 2004, J LEUKOCYTE BIOL, V75, P163, DOI 10.1189/jlb.0603252; Shen C, 2013, MOL BIOL REP; Stassen NA, 2002, SURGERY, V132, P289, DOI 10.1067/msy.2002.127167; Su SB, 2007, INVEST OPHTH VIS SCI, V48, P4616, DOI 10.1167/iovs.07-0233; Su Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037275; TARLOW JK, 1993, HUM GENET, V91, P403; Vincent JL, 2006, CRIT CARE MED, V34, P344, DOI 10.1097/01.CCM.0000194725.48928.3A; Vincent JL, 1996, INTENS CARE MED, V22, P707, DOI 10.1007/BF01709751; Walley KR, 2007, CRIT CARE MED, V35, P12, DOI 10.1097/01.CCM.0000249823.44726.4E; Wang Ming, 2006, Zhongguo Wei Zhong Bing Ji Jiu Yi Xue, V18, P74; Wang XS, 2007, J INTERF CYTOK RES, V27, P599, DOI 10.1089/jir.2006.0157; Yin KS, 2005, SHOCK, V24, P396, DOI 10.1097/01.shk.0000175556.03300.c6; YOUNG HA, 1995, J LEUKOCYTE BIOL, V58, P373, DOI 10.1002/jlb.58.4.373; Zabolotskyh I. B., 2012, Anesteziologiya i Reanimatologiya, P55	62	25	27	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2014	9	1							e87049	10.1371/journal.pone.0087049	http://dx.doi.org/10.1371/journal.pone.0087049			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	298QQ	24475220	gold, Green Submitted, Green Published			2022-12-25	WOS:000330339800081
J	Savini, A; Vertino, A; Marchese, F; Beuck, L; Freiwald, A				Savini, Alessandra; Vertino, Agostina; Marchese, Fabio; Beuck, Lydia; Freiwald, Andre			Mapping Cold-Water Coral Habitats at Different Scales within the Northern Ionian Sea (Central Mediterranean): An Assessment of Coral Coverage and Associated Vulnerability	PLOS ONE			English	Article							LOPHELIA-PERTUSA; DEEP; REEFS; PROVINCE; CLASSIFICATION; BIODIVERSITY; BIOLOGY; IMPACTS; MARGIN; CIRCULATION	In this study, we mapped the distribution of Cold-Water Coral (CWC) habitats on the northern Ionian Margin (Mediterranean Sea), with an emphasis on assessing coral coverage at various spatial scales over an area of 2,000 km(2) between 120 and 1,400 m of water depth. Our work made use of a set of data obtained from ship-based research surveys. Multi-scale seafloor mapping data, video inspections, and previous results from sediment samples were integrated and analyzed using Geographic Information System (GIS)-based tools. Results obtained from the application of spatial and textural analytical techniques to acoustic meso-scale maps (i.e. a Digital Terrain Model (DTM) of the seafloor at a 40 m grid cell size and associated terrain parameters) and large-scale maps (i.e. Side-Scan Sonar (SSS) mosaics of 1 m in resolution ground-truthed using underwater video observations) were integrated and revealed that, at the meso-scale level, the main morphological pattern (i.e. the aggregation of mound-like features) associated with CWC habitat occurrences was widespread over a total area of 600 km(2). Single coral mounds were isolated from the DTM and represented the geomorphic proxies used to model coral distributions within the investigated area. Coral mounds spanned a total area of 68 km(2) where different coral facies (characterized using video analyses and mapped on SSS mosaics) represent the dominant macro-habitat. We also mapped and classified anthropogenic threats that were identifiable within the examined videos, and, here, discuss their relationship to the mapped distribution of coral habitats and mounds. The combined results (from multi-scale habitat mapping and observations of the distribution of anthropogenic threats) provide the first quantitative assessment of CWC coverage for a Mediterranean province and document the relevant role of seafloor geomorphology in influencing habitat vulnerability to different types of human pressures.	[Savini, Alessandra; Vertino, Agostina; Marchese, Fabio; Beuck, Lydia; Freiwald, Andre] Milano Bicocca Univ, Dept Geol Sci & Geotechnol, Milan, Italy; [Savini, Alessandra; Vertino, Agostina; Marchese, Fabio; Beuck, Lydia; Freiwald, Andre] Marine Res Dept, Wilhelmshaven, Germany	University of Milano-Bicocca	Savini, A (corresponding author), Milano Bicocca Univ, Dept Geol Sci & Geotechnol, Milan, Italy.	alessandra.savini@unimib.it	Freiwald, Andre/C-2061-2018; Marchese, Fabio/AAT-9175-2020; Savini, Alessandra/C-2264-2019	Freiwald, Andre/0000-0002-2335-4042; Marchese, Fabio/0000-0001-8384-3019; Savini, Alessandra/0000-0002-5818-5947	EU [213144, GOCE-CT-2005-511234]; CoNISMa project RBAU [01RKC7_004 APLABES]; Italian Ministry of University and Research (MIUR); ESF COCARDE Network; Hessian initiative for the development of scientific and economic excellence (LOEWE) at the Biodiversity and Climate Research Centre (BiK-F), Frankfurt, Germany	EU(European Commission); CoNISMa project RBAU; Italian Ministry of University and Research (MIUR)(Ministry of Education, Universities and Research (MIUR)); ESF COCARDE Network; Hessian initiative for the development of scientific and economic excellence (LOEWE) at the Biodiversity and Climate Research Centre (BiK-F), Frankfurt, Germany	The data were collected and analysed within the framework of the EU FP7 project CoralFish (Ecosystem-based management of corals, fish and fisheries in the deep waters of Europe and beyond, Grant agreement number: 213144 - www.eu-fp7-coralfish.net) and the National project MAGIC (Mapping Geohazard along the Italian Coasts - www.magicproject.it). ROV video footage were collected within the framework of the CoNISMa project RBAU 01RKC7_004 APLABES (2004-2006FIRB program) and of the EU FP6 project HERMES (Hotspot Ecosystem Research on the Margins of European Seas, Contract number GOCE-CT-2005-511234). The authors' work also benefited from the RITMARE project, funded by the Italian Ministry of University and Research (MIUR), the ESF COCARDE Network, and the Hessian initiative for the development of scientific and economic excellence (LOEWE) at the Biodiversity and Climate Research Centre (BiK-F), Frankfurt, Germany. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson JT, 2008, ICES J MAR SCI, V65, P1004, DOI 10.1093/icesjms/fsn061; [Anonymous], 2009, IOC MARINE SPATIAL P; Argnani A, 2001, ANN GEOFIS, V44, P527; Baker EK, 2012, ELSEV INSIGHT, P23, DOI 10.1016/B978-0-12-385140-6.00002-5; Benn AR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012730; Blondel P, 2000, INT J REMOTE SENS, V21, P3115, DOI 10.1080/01431160050144983; Boudouresque C.-F, 2004, TRAV SCI PARC NATL P, V20, P97; Brown CJ, 2011, ESTUAR COAST SHELF S, V92, P502, DOI 10.1016/j.ecss.2011.02.007; Budillon G, 2010, DEEP-SEA RES PT II, V57, P441, DOI 10.1016/j.dsr2.2009.08.017; Buhl-Mortensen L, 2012, HYDROBIOLOGIA, V685, P191, DOI 10.1007/s10750-011-0988-6; Clark MR, 2009, DEEP-SEA RES PT I, V56, P1540, DOI 10.1016/j.dsr.2009.04.015; Corselli C, 2010, DEEP SEA RES 2, V57, P345; Costello MJ, 2009, MAR ECOL PROG SER, V397, P253, DOI 10.3354/meps08317; D'Onghia G, 2011, MAR ECOL PROG SER, V443, P95, DOI 10.3354/meps09432; D'Onghia G, 2010, DEEP-SEA RES PT II, V57, P397, DOI 10.1016/j.dsr2.2009.08.022; Danovaro R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011832; Davies AJ, 2008, DEEP-SEA RES PT I, V55, P1048, DOI 10.1016/j.dsr.2008.04.010; Davies AJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018483; Douvere F, 2008, MAR POLICY, V32, P762, DOI 10.1016/j.marpol.2008.03.021; Dundas K, 2009, 200926 GA; Munoz PD, 2012, MAR POLICY, V36, P536, DOI 10.1016/j.marpol.2011.09.005; Munoz PD, 2011, MAR POLICY, V35, P615, DOI 10.1016/j.marpol.2011.01.023; Etiope G, 2010, DEEP-SEA RES PT II, V57, P431, DOI 10.1016/j.dsr2.2009.08.020; Evans I.S., 1990, GEOMORPHOLOGICAL TEC, P44; Fabri MC, 2014, DEEP-SEA RES PT II, V104, P184, DOI 10.1016/j.dsr2.2013.06.016; FAVALI P, 1993, TECTONOPHYSICS, V219, P109, DOI 10.1016/0040-1951(93)90290-Z; Fossa JH, 2002, HYDROBIOLOGIA, V471, P1, DOI 10.1023/A:1016504430684; Freiwald Andre, 2004, P1; Freiwald A, 2009, OCEANOGRAPHY, V22, P58, DOI 10.5670/oceanog.2009.06; Gao DL, 1998, J GEOPHYS RES-SOL EA, V103, P20997, DOI 10.1029/98JB00165; Greene HG, 1999, OCEANOL ACTA, V22, P663, DOI 10.1016/S0399-1784(00)88957-4; Grehan AJ, 2005, AM FISH S S, V41, P819; Guarinello ML, 2010, ENVIRON MANAGE, V45, P793, DOI 10.1007/s00267-010-9430-5; Guinotte JM, 2006, FRONT ECOL ENVIRON, V4, P141, DOI 10.1890/1540-9295(2006)004[0141:WHCISC]2.0.CO;2; Hall-Spencer J, 2002, P ROY SOC B-BIOL SCI, V269, P507, DOI 10.1098/rspb.2001.1910; Halpern BS, 2008, SCIENCE, V319, P948, DOI 10.1126/science.1149345; HARALICK RM, 1973, IEEE T SYST MAN CYB, VSMC3, P610, DOI 10.1109/TSMC.1973.4309314; Harris PT, 2012, ELSEV INSIGHT, P39, DOI 10.1016/B978-0-12-385140-6.00003-7; Howell KL, 2011, BIOL CONSERV, V144, P2656, DOI 10.1016/j.biocon.2011.07.025; Huang Z, 2011, ECOL INFORM, V6, P205, DOI 10.1016/j.ecoinf.2011.01.001; Huehnerbach V, 2008, GEOLOGICAL ASS CANAD, P291; Huvenne VAI, 2002, MAR GEOL, V189, P323, DOI 10.1016/S0025-3227(02)00420-6; Huvenne VAI, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028755; Lo Iacono C, 2008, MAR GEOL, V250, P1, DOI 10.1016/j.margeo.2007.11.004; Lo Iacono C, 2012, ELSEV INSIGHT, P457, DOI 10.1016/B978-0-12-385140-6.00032-3; Malinverno E, 2010, DEEP-SEA RES PT II, V57, P345, DOI 10.1016/j.dsr2.2009.08.025; Manca BB, 2006, CLIM RES, V31, P239, DOI 10.3354/cr031239; Mastrototaro F, 2010, DEEP-SEA RES PT II, V57, P412, DOI 10.1016/j.dsr2.2009.08.021; Mastrototaro F, 2013, MAR ECOL-EVOL PERSP, V34, P313, DOI 10.1111/maec.12017; Merlini S., 2000, B SOC GEOL ITAL, V119, P227; Micallef A, 2007, J GEOPHYS RES-EARTH, V112, DOI 10.1029/2006JF000505; Moore CJ, 2008, ENVIRON RES, V108, P131, DOI 10.1016/j.envres.2008.07.025; Mytilineou Ch, 2013, NEW COLD WATER CORAL, DOI DOI 10.1016/J.DSR2.2013.07.007I; Orejas C, 2009, MAR ECOL PROG SER, V397, P37, DOI 10.3354/meps08314; Palumbi SR, 2009, FRONT ECOL ENVIRON, V7, P204, DOI 10.1890/070135; Pontius RG, 2011, INT J REMOTE SENS, V32, P4407, DOI 10.1080/01431161.2011.552923; Puig P, 2012, NATURE, V489, P286, DOI 10.1038/nature11410; Ramirez-Llodra E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022588; Reed JK, 2002, HYDROBIOLOGIA, V471, P43, DOI 10.1023/A:1016588901551; REED TB, 1989, J GEOPHYS RES-SOLID, V94, P7469, DOI 10.1029/JB094iB06p07469; Rengstorf AM, 2013, J BIOGEOGR, V40, P1702, DOI 10.1111/jbi.12123; Reveillaud J, 2008, FACIES, V54, P317, DOI 10.1007/s10347-008-0138-4; Riding R, 2002, EARTH-SCI REV, V58, P163, DOI 10.1016/S0012-8252(01)00089-7; Roberts JM, 2009, COLD-WATER CORALS: THE BIOLOGY AND GEOLOGY OF DEEP-SEA CORAL HABITATS, P237, DOI 10.1017/CBO9780511581588.009; Roberts JM, 2006, SCIENCE, V312, P543, DOI 10.1126/science.1119861; Roberts JM, 2000, HYDROBIOLOGIA, V441, P173, DOI 10.1023/A:1017550612340; Rogers AD, 1999, INT REV HYDROBIOL, V84, P315; Rosso A, 2010, DEEP-SEA RES PT II, V57, P360, DOI 10.1016/j.dsr2.2009.08.024; Rowden AA, 2010, MAR ECOL-EVOL PERSP, V31, P226, DOI 10.1111/j.1439-0485.2010.00400.x; Sanfilippo R, 2013, FACIES, V59, P663, DOI 10.1007/s10347-012-0356-7; Savini A, 2010, DEEP-SEA RES PT II, V57, P326, DOI 10.1016/j.dsr2.2009.08.014; Savini A, 2009, MAR PETROL GEOL, V26, P1831, DOI 10.1016/j.marpetgeo.2009.04.003; Savini A, 2004, THESIS U MILANO BICO; Schembri PJ, 2007, CAH BIOL MAR, V48, P77; Taviani M, 2005, FACIES, V50, P409, DOI 10.1007/s10347-004-0039-0; Tittensor DP, 2009, J BIOGEOGR, V36, P1111, DOI 10.1111/j.1365-2699.2008.02062.x; Tursi A, 2004, CHEM ECOL, V20, pS107, DOI 10.1080/02757540310001629170; Vertino A, 2010, DEEP-SEA RES PT II, V57, P380, DOI 10.1016/j.dsr2.2009.08.023; Wilson MFJ, 2007, MAR GEOD, V30, P3, DOI 10.1080/01490410701295962; Wood J., 1996, GEOMORPHOLOGICAL CHA; Yoklavich MM, 2000, FISH B-NOAA, V98, P625	81	60	61	2	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2014	9	1							e87108	10.1371/journal.pone.0087108	http://dx.doi.org/10.1371/journal.pone.0087108			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297XI	24466332	gold, Green Published, Green Submitted			2022-12-25	WOS:000330288000192
J	Sugawara, N; Yasui-Furukori, N; Yamazaki, M; Shimoda, K; Mori, T; Sugai, T; Suzuki, Y; Someya, T				Sugawara, Norio; Yasui-Furukori, Norio; Yamazaki, Manabu; Shimoda, Kazutaka; Mori, Takao; Sugai, Takuro; Suzuki, Yutaro; Someya, Toshiyuki			Psychiatrists' Attitudes toward Metabolic Adverse Events in Patients with Schizophrenia	PLOS ONE			English	Article							ANTIPSYCHOTIC MEDICATIONS; CARDIOVASCULAR-DISEASE; DIABETES-MELLITUS; WEIGHT-GAIN; GLUCOSE; PHARMACOTHERAPY; RISPERIDONE; PREVALENCE; OLANZAPINE; INPATIENTS	Background: There is growing concern about the metabolic abnormalities in patients with schizophrenia. Aims: The aim of this study was to assess the attitudes of psychiatrists toward metabolic adverse events in patients with schizophrenia. Method: A brief questionnaire was constructed to cover the following broad areas: the psychiatrists' recognition of the metabolic risk of antipsychotic therapy, pattern of monitoring patients for physical risks, practice pattern for physical risks, and knowledge of metabolic disturbance. In March 2012, the questionnaire was mailed to 8,482 psychiatrists who were working at hospitals belonging to the Japan Psychiatric Hospitals Association. Results: The overall response rate was 2,583/8,482 (30.5%). Of the respondents, 85.2% (2,200/2,581) reported that they were concerned about prescribing antipsychotics that have a risk of elevating blood sugar; 47.6% (1,201/2,524) stated that their frequency of monitoring patients under antipsychotic treatment was based on their own experiences; and only 20.6% (5,22/2,534) of respondents answered that the frequency with which they monitored their patients was sufficient to reduce the metabolic risks. Conclusions: Psychiatrists practicing in Japan were generally aware and concerned about the metabolic risks for patients being treated with antipsychotics. Although psychiatrists should monitor their patients for metabolic abnormalities to balance these risks, a limited number of psychiatrists answered that the frequency with which they monitored patients to reduce the metabolic risks was sufficient. Promotion of the best practices of pharmacotherapy and monitoring is needed for psychiatrists treating patients with schizophrenia.	[Sugawara, Norio; Yasui-Furukori, Norio] Hirosaki Univ, Sch Med, Dept Neuropsychiat, Hirosaki, Aomori 036, Japan; [Sugawara, Norio; Yasui-Furukori, Norio; Shimoda, Kazutaka; Sugai, Takuro; Suzuki, Yutaro; Someya, Toshiyuki] Japanese Soc Clin Neuropsychopharmacol, Tokyo, Japan; [Yamazaki, Manabu; Mori, Takao] Japan Psychiat Hosp Assoc, Tokyo, Japan; [Shimoda, Kazutaka] Dokkyo Med Univ, Sch Med, Dept Psychiat, Mibu, Tochigi, Japan; [Sugai, Takuro; Suzuki, Yutaro; Someya, Toshiyuki] Niigata Univ, Grad Sch Med & Dent Sci, Dept Psychiat, Niigata, Japan	Hirosaki University; Dokkyo Medical University; Niigata University	Sugawara, N (corresponding author), Hirosaki Univ, Sch Med, Dept Neuropsychiat, Hirosaki, Aomori 036, Japan.	nsuga3@yahoo.co.jp	Someya, Toshiyuki/ABD-1878-2021		Eisai Co., Ltd.; Yoshitomi Pharmaceutical Industries, Ltd.; Dainippon Sumitomo Pharma Co., Ltd.; Astellas Pharma Inc.; Meiji Seika Pharma Co., Ltd.; Eli Lilly Japan, K.K.; Otsuka Pharmaceutical Co., Ltd.; GlaxoSmithKelin K.K.; Janssen Pharmaceutical K.K.; MSD K.K.; Shionogi Co., Ltd.; Asahi Kasei Pharma Corporation; Novartis Pharma Co., Ltd.; Takeda Pharmaceutical Co., Ltd.; Tsumura Co.	Eisai Co., Ltd.(Eisai Co Ltd); Yoshitomi Pharmaceutical Industries, Ltd.; Dainippon Sumitomo Pharma Co., Ltd.(Dainippon Sumitomo Pharma Co., Ltd.); Astellas Pharma Inc.(Astellas Pharmaceuticals); Meiji Seika Pharma Co., Ltd.; Eli Lilly Japan, K.K.(Eli Lilly); Otsuka Pharmaceutical Co., Ltd.(Otsuka Pharmaceutical); GlaxoSmithKelin K.K.; Janssen Pharmaceutical K.K.; MSD K.K.(Merck & Company); Shionogi Co., Ltd.; Asahi Kasei Pharma Corporation; Novartis Pharma Co., Ltd.; Takeda Pharmaceutical Co., Ltd.(Takeda Pharmaceutical Company Ltd); Tsumura Co.(Tsumura & Company)	This work was partially supported by Eisai Co., Ltd., Yoshitomi Pharmaceutical Industries, Ltd., Dainippon Sumitomo Pharma Co., Ltd., Astellas Pharma Inc., Meiji Seika Pharma Co., Ltd., Eli Lilly Japan, K.K., Otsuka Pharmaceutical Co., Ltd., GlaxoSmithKelin K.K., Janssen Pharmaceutical K.K., MSD K.K., Shionogi & Co., Ltd., Asahi Kasei Pharma Corporation, Novartis Pharma Co., Ltd., Takeda Pharmaceutical Co., Ltd., and Tsumura & Co. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bobes J, 2007, SCHIZOPHR RES, V90, P162, DOI 10.1016/j.schres.2006.09.025; Buckley PF, 2005, SCHIZOPHR RES, V79, P281, DOI 10.1016/j.schres.2005.04.010; Chaggar PS, 2011, J CLIN PHARMACOL, V51, P631, DOI 10.1177/0091270010368678; DAVIS DA, 1995, JAMA-J AM MED ASSOC, V274, P700; Grundy SM, 1999, AM J CARDIOL, V83, p25F; Henderson DC, 2000, AM J PSYCHIAT, V157, P975, DOI 10.1176/appi.ajp.157.6.975; Hui WS, 2010, EUR J EPIDEMIOL, V25, P375, DOI 10.1007/s10654-010-9459-z; Isomaa B, 2001, DIABETES CARE, V24, P683, DOI 10.2337/diacare.24.4.683; Ketter TA, 2006, CURR MED RES OPIN, V22, P2345, DOI 10.1185/030079906X148616; Lakka HM, 2002, JAMA-J AM MED ASSOC, V288, P2709, DOI 10.1001/jama.288.21.2709; Marder SR, 2004, AM J PSYCHIAT, V161, P1334, DOI 10.1176/appi.ajp.161.8.1334; Meagher DJ, 2010, INT PSYCHOGERIATR, V22, P938, DOI 10.1017/S1041610210000475; Meyer JM, 2002, J CLIN PSYCHIAT, V63, P425, DOI 10.4088/JCP.v63n0509; Meyer JM, 2005, SCHIZOPHR RES, V80, P9, DOI 10.1016/j.schres.2005.07.015; Nasrallah Henry A, 2004, J Clin Psychopharmacol, V24, pS7, DOI 10.1097/01.jcp.0000142282.62336.e9; Newcomer John W, 2004, J Clin Psychopharmacol, V24, pS1, DOI 10.1097/01.jcp.0000142281.85207.d5; Oshima I, 2007, PSYCHIAT CLIN NEUROS, V61, P71, DOI 10.1111/j.1440-1819.2007.01613.x; Sharp Lisa K, 2002, J Contin Educ Health Prof, V22, P103; Statistics and Information Department Minister's Secretariat, 2008, PAT SURV; Sugai T, 2012, J CLIN PSYCHOPHARM, V32, P390, DOI 10.1097/JCP.0b013e3182524393; Sugawara N, 2011, ANN GEN PSYCHIATR, V10, DOI 10.1186/1744-859X-10-21; Sugawara N, 2010, SCHIZOPHR RES, V123, P244, DOI 10.1016/j.schres.2010.08.030; Suzuki Y, 2013, HUM PSYCHOPHARM CLIN, V28, P188, DOI 10.1002/hup.2295; van Os J, 2009, LANCET, V374, P635, DOI [10.1016/S0140-6736(09)60995-8, 10.1016/S0140-6736(15)01121-6]; Wilson PWF, 2005, CIRCULATION, V112, P3066, DOI 10.1161/CIRCULATIONAHA.105.539528; Yasui-Furukori N, 2009, J CLIN PSYCHIAT, V70, P95, DOI 10.4088/JCP.07m03829	26	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2014	9	1							e86826	10.1371/journal.pone.0086826	http://dx.doi.org/10.1371/journal.pone.0086826			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	297XI	24466260	Green Published, Green Submitted, gold			2022-12-25	WOS:000330288000153
J	Takahashi, N; Yamaguchi, K; Ikenoue, T; Fujii, T; Furukawa, Y				Takahashi, Norihiko; Yamaguchi, Kiyoshi; Ikenoue, Tsuneo; Fujii, Tomoaki; Furukawa, Yoichi			Identification of Two Wnt-Responsive Elements in the Intron of RING Finger Protein 43 (RNF43) Gene	PLOS ONE			English	Article							T CELL-FACTOR; BETA-CATENIN; UP-REGULATION; CHROMATIN OCCUPANCY; NEGATIVE REGULATOR; DOWNSTREAM TARGET; HUMAN COLON; EXPRESSION; APC; TRANSCRIPTION	RING finger protein 43 (RNF43), an E3-type ubiquitin ligase, is frequently up-regulated in human colorectal cancer. It has been shown that expression of RNF43 is regulated by the Wnt-signaling pathway. However the regulatory region(s) for its transcriptional activation has not been clarified. In this study, we have shown for the first time that RNF43 is a direct target of TCF4/beta-catenin complex, and that its expression is regulated by a regulatory region containing two Wnt-responsive elements (WREs) in intron2. A reporter gene assay revealed that nucleotide substitutions in the WREs decreased the reporter activity in colon cancer cells, suggesting that both WREs are involved in the transcriptional activation. Knockdown of beta-catenin by siRNA suppressed the reporter activity. In addition, ChIP assay showed that both elements associate with TCF4/beta-catenin complex in colon cancer cells. These data indicate that expression of RNF43 is regulated by the canonical Wnt/beta-catenin pathway through binding of the WREs with TCF4/beta-catenin complex. These findings should be useful for the understanding of the regulatory mechanism of RNF43 and may contribute to the clarification of signaling pathways regulated by RNF43.	[Takahashi, Norihiko; Yamaguchi, Kiyoshi; Ikenoue, Tsuneo; Fujii, Tomoaki; Furukawa, Yoichi] Univ Tokyo, Inst Med Sci, Div Clin Genome Res, Adv Clin Res Ctr, Tokyo, Japan	University of Tokyo	Furukawa, Y (corresponding author), Univ Tokyo, Inst Med Sci, Div Clin Genome Res, Adv Clin Res Ctr, Tokyo, Japan.	furukawa@ims.u-tokyo.ac.jp			Ministry of Education, Culture, Sports, Science and Technology (MEXT) Japan [23310137]	Ministry of Education, Culture, Sports, Science and Technology (MEXT) Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by Grant-in-Aid for Scientific Research (#23310137), and Global COE Program "Center of education and research for the advanced genome-based medicine for personalized medicine and the control of worldwide infectious diseases", from The Ministry of Education, Culture, Sports, Science and Technology (MEXT) Japan (http://www.mext.go.jp/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Behrens J, 1996, NATURE, V382, P638, DOI 10.1038/382638a0; Bottomly D, 2010, NUCLEIC ACIDS RES, V38, P5735, DOI 10.1093/nar/gkq363; Brabletz T, 1999, AM J PATHOL, V155, P1033, DOI 10.1016/S0002-9440(10)65204-2; Crawford HC, 1999, ONCOGENE, V18, P2883, DOI 10.1038/sj.onc.1202627; Fujita M, 2001, CANCER RES, V61, P7722; Furukawa T, 2011, SCI REP-UK, V1, DOI 10.1038/srep00161; Gonzalex-Sancho JM, 2005, ONCOGENE, V24, P1098, DOI 10.1038/sj.onc.1208303; Guichard C, 2012, NAT GENET, V44, P694, DOI 10.1038/ng.2256; Hao HX, 2012, NATURE, V485, P195, DOI 10.1038/nature11019; Hatzis P, 2008, MOL CELL BIOL, V28, P2732, DOI 10.1128/MCB.02175-07; He TC, 1998, SCIENCE, V281, P1509, DOI 10.1126/science.281.5382.1509; He TC, 1999, CELL, V99, P335, DOI 10.1016/S0092-8674(00)81664-5; Hlubek F, 2001, CANCER RES, V61, P8089; Jho EH, 2002, MOL CELL BIOL, V22, P1172, DOI 10.1128/MCB.22.4.1172-1183.2002; Kinzler KW, 1996, CELL, V87, P159, DOI 10.1016/S0092-8674(00)81333-1; Koo BK, 2012, NATURE, V488, P665, DOI 10.1038/nature11308; Laurent-Puig P, 2001, GASTROENTEROLOGY, V120, P1763, DOI 10.1053/gast.2001.24798; Leung JY, 2002, J BIOL CHEM, V277, P21657, DOI 10.1074/jbc.M200139200; Lin YM, 2002, ONCOGENE, V21, P4120, DOI 10.1038/sj.onc.1205518; Lin YM, 2001, CANCER RES, V61, P6345; Lustig B, 2002, MOL CELL BIOL, V22, P1184, DOI 10.1128/MCB.22.4.1184-1193.2002; Mann B, 1999, P NATL ACAD SCI USA, V96, P1603, DOI 10.1073/pnas.96.4.1603; Miwa N, 2001, ONCOL RES, V12, P469, DOI 10.3727/096504001108747477; Molenaar M, 1996, CELL, V86, P391, DOI 10.1016/S0092-8674(00)80112-9; Mosimann C, 2009, NAT REV MOL CELL BIO, V10, P276, DOI 10.1038/nrm2654; Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252; Nelson WJ, 2004, SCIENCE, V303, P1483, DOI 10.1126/science.1094291; Niida A, 2004, ONCOGENE, V23, P8520, DOI 10.1038/sj.onc.1207892; Ong CK, 2012, NAT GENET, V44, P690, DOI 10.1038/ng.2273; Polakis P, 2000, GENE DEV, V14, P1837; Rubinfeld B, 1996, SCIENCE, V272, P1023, DOI 10.1126/science.272.5264.1023; Ryland GL, 2013, J PATHOL, V229, P469, DOI 10.1002/path.4134; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Sugiura T, 2008, EXP CELL RES, V314, P1519, DOI 10.1016/j.yexcr.2008.01.013; Suzuki H, 2004, NAT GENET, V36, P417, DOI 10.1038/ng1330; Takahashi M, 2002, ONCOGENE, V21, P5861, DOI 10.1038/sj.onc.1205755; Tetsu O, 1999, NATURE, V398, P422, DOI 10.1038/18884; van de Wetering M, 2002, CELL, V111, P241, DOI 10.1016/S0092-8674(02)01014-0; Van Der Flier LG, 2007, GASTROENTEROLOGY, V132, P628, DOI 10.1053/j.gastro.2006.08.039; van der Heyden MAG, 1998, J CELL SCI, V111, P1741; Wielenga VJM, 1999, AM J PATHOL, V154, P515, DOI 10.1016/S0002-9440(10)65297-2; Wu J, 2011, P NATL ACAD SCI USA, V108, P21188, DOI 10.1073/pnas.1118046108; Yagyu R, 2004, INT J ONCOL, V25, P1343; Yochum GS, 2007, P NATL ACAD SCI USA, V104, P3324, DOI 10.1073/pnas.0611576104; Yochum GS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018966	45	20	22	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2014	9	1							e86582	10.1371/journal.pone.0086582	http://dx.doi.org/10.1371/journal.pone.0086582			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297VL	24466159	gold, Green Submitted, Green Published			2022-12-25	WOS:000330283100186
J	Rosario, K; Capobianco, H; Ng, TFF; Breitbart, M; Polston, JE				Rosario, Karyna; Capobianco, Heather; Ng, Terry Fei Fan; Breitbart, Mya; Polston, Jane E.			RNA Viral Metagenome of Whiteflies Leads to the Discovery and Characterization of a Whitefly-Transmitted Carlavirus in North America	PLOS ONE			English	Article							COWPEA-MILD-MOTTLE; MULTIPLE SEQUENCE ALIGNMENT; NUCLEOTIDE-SEQUENCE; FAMILY FLEXIVIRIDAE; VIGNA-UNGUICULATA; VIRUS; PLANT; TRANSMISSION; PROTEIN; EVOLUTION	Whiteflies from the Bemisia tabaci species complex have the ability to transmit a large number of plant viruses and are some of the most detrimental pests in agriculture. Although whiteflies are known to transmit both DNA and RNA viruses, most of the diversity has been recorded for the former, specifically for the Begomovirus genus. This study investigated the total diversity of DNA and RNA viruses found in whiteflies collected from a single site in Florida to evaluate if there are additional, previously undetected viral types within the B. tabaci vector. Metagenomic analysis of viral DNA extracted from the whiteflies only resulted in the detection of begomoviruses. In contrast, whiteflies contained sequences similar to RNA viruses from divergent groups, with a diversity that extends beyond currently described viruses. The metagenomic analysis of whiteflies also led to the first report of a whitefly-transmitted RNA virus similar to Cowpea mild mottle virus (CpMMV Florida) (genus Carlavirus) in North America. Further investigation resulted in the detection of CpMMV Florida in native and cultivated plants growing near the original field site of whitefly collection and determination of its experimental host range. Analysis of complete CpMMV Florida genomes recovered from whiteflies and plants suggests that the current classification criteria for carlaviruses need to be reevaluated. Overall, metagenomic analysis supports that DNA plant viruses carried by B. tabaci are dominated by begomoviruses, whereas significantly less is known about RNA viruses present in this damaging insect vector.	[Rosario, Karyna; Ng, Terry Fei Fan; Breitbart, Mya] Univ S Florida, Coll Marine Sci, St Petersburg, FL 33701 USA; [Capobianco, Heather; Polston, Jane E.] Univ Florida, Dept Plant Pathol, Gainesville, FL 32611 USA	State University System of Florida; University of South Florida; State University System of Florida; University of Florida	Rosario, K (corresponding author), Univ S Florida, Coll Marine Sci, St Petersburg, FL 33701 USA.	krosari2@mail.usf.edu	Ng, Terry Fei Fan/H-5305-2019; Breitbart, Mya/B-1366-2009	Ng, Terry Fei Fan/0000-0002-4815-8697; Breitbart, Mya/0000-0003-3210-2899	National Science Foundation [DEB-1025915]; USDA - Tropical-Subtropical Agriculture Research (T-STAR) program	National Science Foundation(National Science Foundation (NSF)); USDA - Tropical-Subtropical Agriculture Research (T-STAR) program	This study was funded through the National Science Foundation Biodiversity Inventories program (DEB-1025915) and the USDA - Tropical-Subtropical Agriculture Research (T-STAR) program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abascal F, 2005, BIOINFORMATICS, V21, P2104, DOI 10.1093/bioinformatics/bti263; Adams MJ, 2004, ARCH VIROL, V149, P1045, DOI [10.1007/s00705-003-0304-0, 10.1007/s00705-004-0304-0]; ALMEIDA AMR, 2005, FITOPATOL BRAS, V30, P191, DOI DOI 10.1590/S0100-41582005000200016; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Anderson PK, 2004, TRENDS ECOL EVOL, V19, P535, DOI 10.1016/j.tree.2004.07.021; Anisimova M, 2006, SYST BIOL, V55, P539, DOI 10.1080/10635150600755453; ANTIGNUS Y, 1987, ANN APPL BIOL, V110, P563, DOI 10.1111/j.1744-7348.1987.tb04174.x; Badge J, 1996, EUR J PLANT PATHOL, V102, P305, DOI 10.1007/BF01877970; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkp985, 10.1093/nar/gkr1065]; Brakta A, 2013, PLANT DIS, V97, P1001, DOI 10.1094/PDIS-10-12-0935-PDN; Brito M, 2012, VIRUSES-BASEL, V4, P3804, DOI 10.3390/v4123804; BRUNT AA, 1973, ANN APPL BIOL, V74, P67, DOI 10.1111/j.1744-7348.1973.tb07723.x; De Barro PJ, 2011, ANNU REV ENTOMOL, V56, P1, DOI 10.1146/annurev-ento-112408-085504; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; FOSTER GD, 1992, RES VIROLOGY, V143, P103, DOI 10.1016/S0923-2516(06)80089-0; Gaspar JO, 2008, J VIROL METHODS, V148, P283, DOI 10.1016/j.jviromet.2007.11.005; GORBALENYA AE, 1989, NUCLEIC ACIDS RES, V17, P8413, DOI 10.1093/nar/17.21.8413; Gray SM, 1999, MICROBIOL MOL BIOL R, V63, P128, DOI 10.1128/MMBR.63.1.128-148.1999; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Harrison BD, 1999, ANNU REV PHYTOPATHOL, V37, P369, DOI 10.1146/annurev.phyto.37.1.369; Hogenhout SA, 2008, ANNU REV PHYTOPATHOL, V46, P327, DOI 10.1146/annurev.phyto.022508.092135; Huson DH, 2011, GENOME RES, V21, P1552, DOI 10.1101/gr.120618.111; IWAKI M, 1982, PLANT DIS, V66, P365, DOI 10.1094/PD-66-365; JEYANANDARAJAH P, 1993, J PHYTOPATHOL, V137, P148, DOI 10.1111/j.1439-0434.1993.tb01334.x; Jones RAC, 2009, VIRUS RES, V141, P113, DOI 10.1016/j.virusres.2008.07.028; King A.M., 2012, VIRUS TAXONOMY, V9; KOONIN EV, 1991, J GEN VIROL, V72, P2197, DOI 10.1099/0022-1317-72-9-2197; LAWRENCE DM, 1995, VIROLOGY, V207, P127, DOI 10.1006/viro.1995.1058; Martelli GP, 2007, ANNU REV PHYTOPATHOL, V45, P73, DOI 10.1146/annurev.phyto.45.062806.094401; Menzel W, 2010, ARCH VIROL, V155, P2069, DOI 10.1007/s00705-010-0821-y; Morozov SY, 2003, J GEN VIROL, V84, P1351, DOI 10.1099/vir.0.18922-0; Naidu RA, 1998, ARCH VIROL, V143, P769, DOI 10.1007/s007050050328; Navas-Castillo J, 2011, ANNU REV PHYTOPATHOL, V49, P219, DOI 10.1146/annurev-phyto-072910-095235; Ng TFF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020579; Ng TFF, 2011, PLOS ONE, V6; Oliveira MRV, 2001, CROP PROT, V20, P709, DOI 10.1016/S0261-2194(01)00108-9; Pardina PER, 2004, AUSTRALAS PLANT PATH, V33, P129, DOI 10.1071/AP03076; Polston JE, 2006, PHYTOPATHOLOGY, V96, P447, DOI 10.1094/PHYTO-96-0447; Power AG, 2000, CURR OPIN PLANT BIOL, V3, P336, DOI 10.1016/S1369-5266(00)00090-X; ROZANOV MN, 1992, J GEN VIROL, V73, P2129, DOI 10.1099/0022-1317-73-8-2129; Schmieder R, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-341; Seal SE, 2006, CRIT REV PLANT SCI, V25, P23, DOI 10.1080/07352680500365257; Simossis VA, 2005, NUCLEIC ACIDS RES, V33, pW289, DOI 10.1093/nar/gki390; Spear A, 2010, VIROLOGY, V404, P304, DOI 10.1016/j.virol.2010.05.015; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tavasoli M., 2009, J GEN MOL VIROL, V1, P7; Wisler GC, 1998, PHYTOPATHOLOGY, V88, P402, DOI 10.1094/PHYTO.1998.88.5.402; Zanardo LG, 2014, PLANT PATHOL, V63, P456, DOI 10.1111/ppa.12092; Zarate SI, 2007, PLANT PHYSIOL, V143, P866, DOI 10.1104/pp.106.090035	49	39	40	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2014	9	1							e86748	10.1371/journal.pone.0086748	http://dx.doi.org/10.1371/journal.pone.0086748			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297GT	24466220	Green Published, gold, Green Submitted			2022-12-25	WOS:000330244500279
J	Xie, LL; Fu, Q; Ortega, TM; Zhou, L; Rasmussen, D; O'Keefe, J; Zhang, KK; Chapes, SK				Xie, Linglin; Fu, Qiang; Ortega, Teresa M.; Zhou, Lun; Rasmussen, Dane; O'Keefe, Jacy; Zhang, Ke K.; Chapes, Stephen K.			Overexpression of IL-10 in C2D Macrophages Promotes a Macrophage Phenotypic Switch in Adipose Tissue Environments	PLOS ONE			English	Article							DIFFERENTIATION; INTERLEUKIN-10; PLASTICITY; CELLS; HETEROGENEITY; POLARIZATION; TRAFFICKING; ADIPONECTIN; ACTIVATION; OBESITY	Adipose tissue macrophages are a heterogeneous collection of classically activated (M1) and alternatively activated (M2) macrophages. Interleukin 10 (IL-10) is an anti-inflammatory cytokine, secreted by a variety of cell types including M2 macrophages. We generated a macrophage cell line stably overexpressing IL-10 (C2D-IL10) and analyzed the C2D-IL10 cells for several macrophage markers after exposure to adipocytes compared to C2D cells transfected with an empty vector (C2D-vector). C2D-IL10 macrophage cells expressed more CD206 when co-cultured with adipocytes than C2D-vector cells; while the co-cultured cell mixture also expressed higher levels of Il4, Il10, Il1 beta and Tnf. Since regular C2D cells traffic to adipose tissue after adoptive transfer, we explored the impact of constitutive IL-10 expression on C2D-IL10 macrophages in adipose tissue in vivo. Adipose tissue-isolated C2D-IL10 cells increased the percentage of CD206(+), CD301(+), CD11c(-) CD206(+) (M2) and CD11c(+)CD206(+) (M1b) on their cell surface, compared to isolated C2D-vector cells. These data suggest that the expression of IL-10 remains stable, alters the C2D-IL10 macrophage cell surface phenotype and may play a role in regulating macrophage interactions with the adipose tissue.	[Xie, Linglin; Fu, Qiang; Zhou, Lun; Rasmussen, Dane; O'Keefe, Jacy] Univ N Dakota, Sch Med & Hlth Sci, Dept Basic Sci, Grand Forks, ND 58201 USA; [Ortega, Teresa M.; Chapes, Stephen K.] Kansas State Univ, Div Biol, Manhattan, KS 66506 USA; [Fu, Qiang; Zhou, Lun] Huazhong Univ Sci & Technol, Dept Gerontol, Tongji Hosp, Wuhan 430074, Peoples R China; [Fu, Qiang; Zhou, Lun] Huazhong Univ Sci & Technol, Dept Oncol, Tongji Hosp, Wuhan 430074, Peoples R China; [Zhang, Ke K.] Univ N Dakota, Dept Pathol, Sch Med & Hlth Sci, Grand Forks, ND 58201 USA; [Zhang, Ke K.] Univ N Dakota, North Dakota IDeA Network, Biomed Res Excellence Bioinformat Core, Grand Forks, ND 58201 USA	University of North Dakota Grand Forks; Kansas State University; Huazhong University of Science & Technology; Huazhong University of Science & Technology; University of North Dakota Grand Forks; University of North Dakota Grand Forks	Xie, LL (corresponding author), Univ N Dakota, Sch Med & Hlth Sci, Dept Basic Sci, Grand Forks, ND 58201 USA.	linglin.xie@med.und.edu			National Center for Research Resources from the National Institutes of Health (NIH) [5P20RR016471-12/8 P20 GM103442-12]; American Heart Association [0950036G, 13SDG14650009]; NIH [AI088070, RR16475, GM103418, RR17686]; Kansas State University Johnson Cancer Center; Kansas Agricultural Experiment Station; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR017686, P20RR016475] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI088070] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103442, P20GM103418] Funding Source: NIH RePORTER	National Center for Research Resources from the National Institutes of Health (NIH); American Heart Association(American Heart Association); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Kansas State University Johnson Cancer Center; Kansas Agricultural Experiment Station; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This project was supported by grants from the National Center for Research Resources (5P20RR016471-12/ 8 P20 GM103442-12) from the National Institutes of Health (NIH). This work was also supported in part by American Heart Association grant 0950036G and 13SDG14650009, NIH grants AI088070, RR16475, GM103418, RR17686, the Kansas State University Johnson Cancer Center, and the Kansas Agricultural Experiment Station. This is Kansas Agriculture Experiment Station publication 13-194-J. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ariel A, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00004; Beharka AA, 1998, IN VITRO CELL DEV-AN, V34, P499; Benoit M, 2008, J IMMUNOL, V181, P3733, DOI 10.4049/jimmunol.181.6.3733; Biswas SK, 2012, IMMUNOL RES, V53, P11, DOI 10.1007/s12026-012-8291-9; Claria J, 2011, FRONT IMMUNOL, V2, DOI 10.3389/fimmu.2011.00049; Cusi K, 2010, CURR DIABETES REP, V10, P306, DOI 10.1007/s11892-010-0122-6; Dib LH, 2013, ENDOCRINOLOGY; Fischer-Posovszky P, 2011, ENDOCRINOLOGY, V152, P3074, DOI 10.1210/en.2011-1031; Fujisaka S, 2009, DIABETES, V58, P2574, DOI 10.2337/db08-1475; GERARD C, 1993, J EXP MED, V177, P547, DOI 10.1084/jem.177.2.547; Gordon S, 2007, J CLIN INVEST, V117, P89, DOI 10.1172/JCI30992; Hart ML, 2003, INFECT IMMUN, V71, P663, DOI 10.1128/IAI.71.2.663-670.2003; Hong EG, 2009, DIABETES, V58, P2525, DOI 10.2337/db08-1261; Ji JD, 2005, RHEUMATOLOGY, V44, P983, DOI 10.1093/rheumatology/keh657; Kim HJ, 2004, DIABETES, V53, P1060, DOI 10.2337/diabetes.53.4.1060; Kowalski GM, 2011, DIABETOLOGIA, V54, P888, DOI 10.1007/s00125-010-2020-5; Li WJ, 2012, ADV DIFFER EQU-NY, DOI 10.1186/1687-1847-2012-97; Lumeng CN, 2007, DIABETES, V56, P16, DOI 10.2337/db06-1076; Lumeng CN, 2007, J CLIN INVEST, V117, P175, DOI 10.1172/JCI29881; Lumeng CN, 2008, DIABETES, V57, P3239, DOI 10.2337/db08-0872; Mantovani A, 2004, TRENDS IMMUNOL, V25, P677, DOI 10.1016/j.it.2004.09.015; Mantovani A, 2012, J PATHOLOGY; Mantovani A, 2007, EUR J IMMUNOL, V37, P14, DOI 10.1002/eji.200636910; Moore KW, 2001, ANNU REV IMMUNOL, V19, P683, DOI 10.1146/annurev.immunol.19.1.683; Morris DL, 2011, CURR OPIN CLIN NUTR, V14, P341, DOI 10.1097/MCO.0b013e328347970b; Nguyen MTA, 2007, J BIOL CHEM, V282, P35279, DOI 10.1074/jbc.M706762200; Ortega MT, 2011, CELL IMMUNOL, V271, P124, DOI 10.1016/j.cellimm.2011.06.012; Pestka S, 2004, ANNU REV IMMUNOL, V22, P929, DOI 10.1146/annurev.immunol.22.012703.104622; Potts BE, 2008, CLIN VACCINE IMMUNOL, V15, P243, DOI 10.1128/CVI.00328-07; Potts BE, 2008, J LEUKOCYTE BIOL, V83, P602, DOI 10.1189/jlb.0607365; Prieur X, 2011, DIABETES, V60, P797, DOI 10.2337/db10-0705; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Takahashi K, 1996, PATHOL INT, V46, P473, DOI 10.1111/j.1440-1827.1996.tb03641.x; Turner JJO, 2010, CLIN EXP IMMUNOL, V162, P487, DOI 10.1111/j.1365-2249.2010.04260.x; Wentworth JM, 2010, DIABETES, V59, P1648, DOI 10.2337/db09-0287; Westcott DJ, 2009, J EXP MED, V206, P3143, DOI 10.1084/jem.20091333; Wu HZ, 2010, ARTERIOSCL THROM VAS, V30, P186, DOI 10.1161/ATVBAHA.109.198044; Xie LL, 2008, BBA-MOL BASIS DIS, V1782, P99, DOI 10.1016/j.bbadis.2007.12.003; Xie LL, 2010, CLIN VACCINE IMMUNOL, V17, P651, DOI 10.1128/CVI.00494-09; Xie LL, 2006, J BIOL CHEM, V281, P7253, DOI 10.1074/jbc.M511313200; Yamanaka Y, 1996, EMBO J, V15, P1557, DOI 10.1002/j.1460-2075.1996.tb00500.x	41	6	6	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2014	9	1							e86541	10.1371/journal.pone.0086541	http://dx.doi.org/10.1371/journal.pone.0086541			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297GT	24466141	Green Published, Green Submitted, gold			2022-12-25	WOS:000330244500256
J	Gould, N; Mor, DE; Lightfoot, R; Malkus, K; Giasson, B; Ischiropoulos, H				Gould, Neal; Mor, Danielle E.; Lightfoot, Richard; Malkus, Kristen; Giasson, Benoit; Ischiropoulos, Harry			Evidence of Native alpha-Synuclein Conformers in the Human Brain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Alpha-Synuclein; Neurodegenerative Diseases; Parkinson Disease; Protein Conformation; Protein Folding; Human Brain; Native State	N-TERMINAL ACETYLATION; ALZHEIMERS-DISEASE; BETA-SYNUCLEIN; WILD-TYPE; IN-VIVO; PROTEIN; BINDING; NMR; OLIGOMERIZATION; STABILIZATION	Background: -Synuclein aggregation is associated with Parkinson disease. The native state of -synuclein in the human brain is unclear. Results: Evidence consistent with the presence of conformationally diverse metastable multimers of -synuclein in the human brain is presented. Conclusion: Multimeric species of -synuclein are present within the human brain. Significance: Understanding the native state of -synuclein in the brain is critical for determining the causes or propensity for aggregation. -Synuclein aggregation is central to the pathogenesis of several brain disorders. However, the native conformations and functions of this protein in the human brain are not precisely known. The native state of -synuclein was probed by gel filtration coupled with native gradient gel separation, an array of antibodies with non-overlapping epitopes, and mass spectrometry. The existence of metastable conformers and stable monomer was revealed in the human brain.	[Gould, Neal; Lightfoot, Richard; Ischiropoulos, Harry] Childrens Hosp Philadelphia, Res Inst, Dept Pediat, Philadelphia, PA 19104 USA; [Gould, Neal; Lightfoot, Richard; Ischiropoulos, Harry] Childrens Hosp Philadelphia, Res Inst, Dept Pharmacol, Philadelphia, PA 19104 USA; [Mor, Danielle E.; Malkus, Kristen; Giasson, Benoit; Ischiropoulos, Harry] Univ Penn, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania	Ischiropoulos, H (corresponding author), Childrens Hosp Philadelphia, Res Inst, Dept Pediat, 3615 Civ Ctr Blvd, Philadelphia, PA 19104 USA.	ischirop@mail.med.upenn.edu	Kashfi, Khosrow/A-4351-2008	Kashfi, Khosrow/0000-0002-4060-7283; Mor, Danielle/0000-0003-3851-5010	National Institutes of Health [AG013966]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007517] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG013966] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grant AG013966 (to H. I.).	Bartels T, 2011, NATURE, V477, P107, DOI 10.1038/nature10324; Bertoncini CW, 2005, P NATL ACAD SCI USA, V102, P1430, DOI 10.1073/pnas.0407146102; Binolfi A, 2012, BIOCHEM SOC T, V40, P950, DOI 10.1042/BST20120096; Burre J, 2013, NATURE, V498, pE4, DOI 10.1038/nature12125; Burre J, 2010, SCIENCE, V329, P1663, DOI 10.1126/science.1195227; Cole NB, 2002, J BIOL CHEM, V277, P6344, DOI 10.1074/jbc.M108414200; Conway KA, 2001, SCIENCE, V294, P1346, DOI 10.1126/science.1063522; Davidson WS, 1998, J BIOL CHEM, V273, P9443, DOI 10.1074/jbc.273.16.9443; Dedmon MM, 2005, J AM CHEM SOC, V127, P476, DOI 10.1021/ja044834j; Dettmer U, 2013, J BIOL CHEM, V288, P6371, DOI 10.1074/jbc.M112.403311; Diao JJ, 2013, ELIFE, V2, DOI 10.7554/eLife.00592; Fauvet B, 2012, J BIOL CHEM, V287, P15345, DOI 10.1074/jbc.M111.318949; GEORGE JM, 1995, NEURON, V15, P361, DOI 10.1016/0896-6273(95)90040-3; Giasson BI, 2000, J NEUROSCI RES, V59, P528, DOI 10.1002/(SICI)1097-4547(20000215)59:4<528::AID-JNR8>3.0.CO;2-0; Giasson BI, 2001, J BIOL CHEM, V276, P2380, DOI 10.1074/jbc.M008919200; Gurry T, 2013, J AM CHEM SOC, V135, P3865, DOI 10.1021/ja310518p; IWAI A, 1995, NEURON, V14, P467, DOI 10.1016/0896-6273(95)90302-X; Kahle PJ, 2000, J NEUROSCI, V20, P6365, DOI 10.1523/JNEUROSCI.20-17-06365.2000; Maltsev AS, 2012, BIOCHEMISTRY-US, V51, P5004, DOI 10.1021/bi300642h; Mazzulli JR, 2007, J BIOL CHEM, V282, P31621, DOI 10.1074/jbc.M704737200; McLean PJ, 2000, J BIOL CHEM, V275, P8812, DOI 10.1074/jbc.275.12.8812; Robotta M, 2011, CHEMPHYSCHEM, V12, P267, DOI 10.1002/cphc.201000815; Souza JM, 2000, FEBS LETT, V474, P116, DOI 10.1016/S0014-5793(00)01563-5; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; Trexler AJ, 2012, PROTEIN SCI, V21, P601, DOI 10.1002/pro.2056; Tsika E, 2010, J NEUROSCI, V30, P3409, DOI 10.1523/JNEUROSCI.4977-09.2010; Ullman O, 2011, J AM CHEM SOC, V133, P19536, DOI 10.1021/ja208657z; Uversky VN, 2002, J BIOL CHEM, V277, P11970, DOI 10.1074/jbc.M109541200; Vogiatzi T, 2008, J BIOL CHEM, V283, P23542, DOI 10.1074/jbc.M801992200; Wang W, 2011, P NATL ACAD SCI USA, V108, P17797, DOI 10.1073/pnas.1113260108; Webb JL, 2003, J BIOL CHEM, V278, P25009, DOI 10.1074/jbc.M300227200; Weinreb PH, 1996, BIOCHEMISTRY-US, V35, P13709, DOI 10.1021/bi961799n; Wersinger C, 2003, NEUROSCI LETT, V340, P189, DOI 10.1016/S0304-3940(03)00097-1; Wittig I, 2005, PROTEOMICS, V5, P4338, DOI 10.1002/pmic.200500081; Woods WS, 2007, J BIOL CHEM, V282, P34555, DOI 10.1074/jbc.M705283200	35	54	55	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 14	2014	289	11					7929	7934		10.1074/jbc.C113.538249	http://dx.doi.org/10.1074/jbc.C113.538249			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AC8CV	24474688	Green Published, hybrid			2022-12-25	WOS:000332761500057
J	Kaur, S; Kroczynska, B; Sharma, B; Sassano, A; Arslan, AD; Majchrzak-Kita, B; Stein, BL; McMahon, B; Altman, JK; Su, B; Calogero, RA; Fish, EN; Platanias, LC				Kaur, Surinder; Kroczynska, Barbara; Sharma, Bhumika; Sassano, Antonella; Arslan, Ahmet Dirim; Majchrzak-Kita, Beata; Stein, Brady L.; McMahon, Brandon; Altman, Jessica K.; Su, Bing; Calogero, Raffaele A.; Fish, Eleanor N.; Platanias, Leonidas C.			Critical Roles for Rictor/Sin1 Complexes in Interferon-dependent Gene Transcription and Generation of Antiproliferative Responses	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Akt PKB; Antiviral Agents; Cell Signaling; Cytokines; Interferon; Gene Regulation; Interferon; Signal Transduction	PROTEIN-KINASE-C; GROWTH-INHIBITORY RESPONSES; DELTA PKC-DELTA; I INTERFERONS; PHOSPHATIDYLINOSITOL 3-KINASE; SERINE PHOSPHORYLATION; IFN RESPONSES; STAT PROTEINS; ACTIVATION; ALPHA	Background: The precise roles for Rictor/Sin1 complexes in IFN signaling remain to be defined. Results: Targeted disruption Rictor/Sin1 results in defects in activation of elements of Stat pathways. These proteins are required for IFN antineoplastic effects on malignant erythroid precursors. Conclusion: Rictor/Sin1 play critical roles in IFN signaling. Significance: This study provides evidence for a key mechanism for gene regulation associated with generation of IFN antineoplastic responses. We provide evidence that type I IFN-induced STAT activation is diminished in cells with targeted disruption of the Rictor gene, whose protein product is a key element of mTOR complex 2. Our studies show that transient or stable knockdown of Rictor or Sin1 results in defects in activation of elements of the STAT pathway and reduced STAT-DNA binding complexes. This leads to decreased expression of several IFN-inducible genes that mediate important biological functions. Our studies also demonstrate that Rictor and Sin1 play essential roles in the generation of the suppressive effects of IFN on malignant erythroid precursors from patients with myeloproliferative neoplasms. Altogether, these findings provide evidence for critical functions for Rictor/Sin1 complexes in type I IFN signaling and the generation of type I IFN antineoplastic responses.	[Kaur, Surinder; Kroczynska, Barbara; Sharma, Bhumika; Sassano, Antonella; Arslan, Ahmet Dirim; Stein, Brady L.; McMahon, Brandon; Altman, Jessica K.; Platanias, Leonidas C.] Northwestern Univ, Sch Med, Robert H Lurie Comprehens Canc Ctr, Chicago, IL 60611 USA; [Kaur, Surinder; Kroczynska, Barbara; Sharma, Bhumika; Sassano, Antonella; Arslan, Ahmet Dirim; Stein, Brady L.; McMahon, Brandon; Altman, Jessica K.; Platanias, Leonidas C.] Northwestern Univ, Sch Med, Div Hematol Oncol, Dept Med, Chicago, IL 60611 USA; [Altman, Jessica K.; Platanias, Leonidas C.] Jesse Brown Vet Affairs Med Ctr, Dept Med, Div Hematol Oncol, Chicago, IL 60612 USA; [Majchrzak-Kita, Beata; Fish, Eleanor N.] Univ Toronto, Univ Hlth Network, Toronto Res Inst, Toronto, ON M5S 2J7, Canada; [Majchrzak-Kita, Beata; Fish, Eleanor N.] Univ Toronto, Dept Immunol, Toronto, ON M5S 2J7, Canada; [Su, Bing] Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT 06520 USA; [Calogero, Raffaele A.] Univ Turin, Dept Biotechnol & Hlth Sci, I-8 Turin, Italy	Ann & Robert H. Lurie Children's Hospital of Chicago; Northwestern University; Robert H. Lurie Comprehensive Cancer Center; Northwestern University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Jesse Brown VA Medical Center; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; Yale University; University of Turin	Platanias, LC (corresponding author), Robert H Lurie Comprehens Canc Ctr, 303 East Super St,Lurie 3-107, Chicago, IL 60611 USA.	l-platanias@northwestern.edu	Calogero, Raffaele/K-9428-2019	Calogero, Raffaele/0000-0002-2848-628X	National Institutes of Health [CA77816, CA155566, CA161796]; Department of Veterans Affairs; NATIONAL CANCER INSTITUTE [R01CA155566, P30CA060553, R01CA077816, T32CA070085, R01CA161796] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Veterans Affairs(US Department of Veterans Affairs); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants CA77816, CA155566, and CA161796. This work was also supported by a merit review grant from the Department of Veterans Affairs and by funds made available to ENF as a Tier 1 Canada Research Chair.	Bancerek J, 2013, IMMUNITY, V38, P250, DOI 10.1016/j.immuni.2012.10.017; Beauchamp EM, 2013, ONCOGENE, V32, P3923, DOI 10.1038/onc.2012.567; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Borden EC, 2007, NAT REV DRUG DISCOV, V6, P975, DOI 10.1038/nrd2422; Bracarda S, 2010, EUR J CANCER, V46, P284, DOI 10.1016/j.ejca.2009.10.013; Choudhury GG, 2004, J BIOL CHEM, V279, P27399, DOI 10.1074/jbc.M403530200; DARNELL JE, 1994, SCIENCE, V264, P1415, DOI 10.1126/science.8197455; Deb DK, 2003, J IMMUNOL, V171, P267, DOI 10.4049/jimmunol.171.1.267; Decker T, 1999, CELL MOL LIFE SCI, V55, P1535, DOI 10.1007/s000180050393; Decker T, 2000, ONCOGENE, V19, P2628, DOI 10.1038/sj.onc.1203481; Dionne KR, 2013, J VIROL, V87, P3447, DOI 10.1128/JVI.02324-12; Dunn GP, 2006, NAT REV IMMUNOL, V6, P836, DOI 10.1038/nri1961; Facchinetti V, 2008, EMBO J, V27, P1932, DOI 10.1038/emboj.2008.120; Fagerlund R, 2002, J BIOL CHEM, V277, P30072, DOI 10.1074/jbc.M202943200; Fuchs SY, 2013, J INTERF CYTOK RES, V33, P211, DOI 10.1089/jir.2012.0117; Ghosh D, 2008, P NATL ACAD SCI USA, V105, P11673, DOI 10.1073/pnas.0803182105; Haller O, 2007, CYTOKINE GROWTH F R, V18, P425, DOI 10.1016/j.cytogfr.2007.06.001; Hervas-Stubbs S, 2011, CLIN CANCER RES, V17, P2619, DOI 10.1158/1078-0432.CCR-10-1114; Ikenoue T, 2008, EMBO J, V27, P1919, DOI 10.1038/emboj.2008.119; Jacinto E, 2006, CELL, V127, P125, DOI 10.1016/j.cell.2006.08.033; Joshi S, 2009, P NATL ACAD SCI USA, V106, P12097, DOI 10.1073/pnas.0900562106; Katsoulidis E, 2009, J BIOL CHEM, V284, P25051, DOI 10.1074/jbc.M109.030445; Kaur S, 2005, EXP HEMATOL, V33, P550, DOI 10.1016/j.exphem.2005.01.014; Kaur S, 2008, J IMMUNOL, V181, P7316, DOI 10.4049/jimmunol.181.10.7316; Kaur S, 2008, P NATL ACAD SCI USA, V105, P4808, DOI 10.1073/pnas.0710907105; Kaur S, 2007, J BIOL CHEM, V282, P1757, DOI 10.1074/jbc.M607365200; Kaur S, 2012, P NATL ACAD SCI USA, V109, P7723, DOI 10.1073/pnas.1118122109; Kiladjian JJ, 2011, BLOOD, V117, P4706, DOI 10.1182/blood-2010-08-258772; Kotenko SV, 2011, CURR OPIN IMMUNOL, V23, P583, DOI 10.1016/j.coi.2011.07.007; Kotredes KP, 2013, J INTERF CYTOK RES, V33, P162, DOI 10.1089/jir.2012.0110; Kroczynska B, 2012, MOL CELL BIOL, V32, P2809, DOI 10.1128/MCB.00310-12; Kroczynska B, 2009, MOL CELL BIOL, V29, P2865, DOI 10.1128/MCB.01537-08; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Levy DE, 2011, CURR OPIN VIROL, V1, P476, DOI 10.1016/j.coviro.2011.11.001; Lim CP, 2006, MOL BIOSYST, V2, P536, DOI 10.1039/b606246f; Piehler J, 2012, IMMUNOL REV, V250, P317, DOI 10.1111/imr.12001; Platanias LC, 2003, BLOOD, V101, P4667, DOI 10.1182/blood-2002-12-3647; Platanias LC, 2005, NAT REV IMMUNOL, V5, P375, DOI 10.1038/nri1604; Platanias LC, 2013, J INTERF CYTOK RES, V33, P143, DOI 10.1089/jir.2013.0019; Qureshi SA, 1996, MOL CELL BIOL, V16, P288; QURESHI SA, 1995, P NATL ACAD SCI USA, V92, P3829, DOI 10.1073/pnas.92.9.3829; Rahman N, 2010, IMMUNOL CELL BIOL, V88, P817, DOI 10.1038/icb.2010.57; Redig AJ, 2009, J BIOL CHEM, V284, P10301, DOI 10.1074/jbc.M807254200; Reich NC, 2013, J INTERF CYTOK RES, V33, P199, DOI 10.1089/jir.2012.0159; Reiner A, 2003, BIOINFORMATICS, V19, P368, DOI 10.1093/bioinformatics/btf877; Sadzak I, 2008, P NATL ACAD SCI USA, V105, P8944, DOI 10.1073/pnas.0801794105; Sanges R, 2007, BIOINFORMATICS, V23, P3406, DOI 10.1093/bioinformatics/btm469; Schattgen SA, 2011, IMMUNOL REV, V243, P109, DOI 10.1111/j.1600-065X.2011.01053.x; Sharma B, 2012, J BIOL CHEM, V287, P42352, DOI 10.1074/jbc.M112.400721; Shiota C, 2006, DEV CELL, V11, P583, DOI 10.1016/j.devcel.2006.08.013; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Stark GR, 2007, CYTOKINE GROWTH F R, V18, P419, DOI 10.1016/j.cytogfr.2007.06.013; Stark GR, 2012, IMMUNITY, V36, P503, DOI 10.1016/j.immuni.2012.03.013; Tahk S, 2007, P NATL ACAD SCI USA, V104, P11643, DOI 10.1073/pnas.0701877104; Takauji R, 2002, J LEUKOCYTE BIOL, V72, P1011; Tefferi A, 2011, J CLIN ONCOL, V29, P573, DOI 10.1200/JCO.2010.29.8711; Uddin S, 1999, J BIOL CHEM, V274, P30127, DOI 10.1074/jbc.274.42.30127; Uddin S, 2002, J BIOL CHEM, V277, P14408, DOI 10.1074/jbc.M109671200; Wang SZ, 2005, BMC EVOL BIOL, V5, DOI 10.1186/1471-2148-5-13; Wang SZ, 2004, ENDOCRINOLOGY, V145, P5820, DOI 10.1210/en.2004-0991; Yanase N, 2012, BMC CELL BIOL, V13, DOI 10.1186/1471-2121-13-7	61	16	17	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 7	2014	289	10					6581	6591		10.1074/jbc.M113.537852	http://dx.doi.org/10.1074/jbc.M113.537852			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AC3BG	24469448	Green Published, hybrid			2022-12-25	WOS:000332389400023
J	Chen, CA; Lu, MY; Peng, SF; Lin, KH; Chang, HH; Yang, YL; Jou, ST; Lin, DT; Liu, YB; Horng, HE; Yang, HC; Wang, JK; Wu, MH; Wu, CC				Chen, Chun-An; Lu, Meng-Yao; Peng, Shinn-Forng; Lin, Kai-Hsin; Chang, Hsiu-Hao; Yang, Yung-Li; Jou, Shiann-Tarng; Lin, Dong-Tsamn; Liu, Yen-Bin; Horng, Herng-Er; Yang, Hong-Chang; Wang, Jou-Kou; Wu, Mei-Hwan; Wu, Chau-Chung			Spatial Repolarization Heterogeneity Detected by Magnetocardiography Correlates with Cardiac Iron Overload and Adverse Cardiac Events in Beta-Thalassemia Major	PLOS ONE			English	Article							CORONARY-ARTERY-DISEASE; MAGNETIC-RESONANCE; MYOCARDIAL IRON; QT DISPERSION; FETAL ARRHYTHMIAS; HEART-DISEASE; LONG QT; DIAGNOSIS; INTERVALS; SURVIVAL	Background: Patients with transfusion-dependent beta-thalassemia major (TM) are at risk for myocardial iron overload and cardiac complications. Spatial repolarization heterogeneity is known to be elevated in patients with certain cardiac diseases, but little is known in TM patients. The purpose of this study was to evaluate spatial repolarization heterogeneity in patients with TM, and to investigate the relationships between spatial repolarization heterogeneity, cardiac iron load, and adverse cardiac events. Methods and Results: Fifty patients with TM and 55 control subjects received 64-channel magnetocardiography (MCG) to determine spatial repolarization heterogeneity, which was evaluated by a smoothness index of QT(c) (SI-QT(c)), a standard deviation of QT(c) (SD-QT(c)), and a QT(c) dispersion. Left ventricular function and myocardial T2* values were assessed by cardiac magnetic resonance. Patients with TM had significantly greater SI-QT(c), SD-QT(c), and QT(c) dispersion compared to the control subjects (all p values<0.001). Spatial repolarization heterogeneity was even more pronounced in patients with significant iron overload (T2*<20 ms, n = 20) compared to those with normal T2* (all p values<0.001). Log(e) cardiac T2* correlated with SI-QT(c) (r = -0.609, p<0.001), SD-QT(c) (r = -0.572, p<0.001), and QT(c) dispersion (r = -0.622, p<0.001), while all these indices had no relationship with measurements of the left ventricular geometry or function. At the time of study, 10 patients had either heart failure or arrhythmia. All 3 indices of repolarization heterogeneity were related to the presence of adverse cardiac events, with areas under the receiver operating characteristic curves (ranged between 0.79 and 0.86), similar to that of cardiac T2*. Conclusions: Multichannel MCG demonstrated that patients with TM had increased spatial repolarization heterogeneity, which is related to myocardial iron load and adverse cardiac events.	[Chen, Chun-An; Lu, Meng-Yao; Lin, Kai-Hsin; Chang, Hsiu-Hao; Yang, Yung-Li; Jou, Shiann-Tarng; Lin, Dong-Tsamn; Wang, Jou-Kou; Wu, Mei-Hwan] Natl Taiwan Univ Hosp, Dept Pediat, Taipei 10016, Taiwan; [Peng, Shinn-Forng] Natl Taiwan Univ Hosp, Dept Med Imaging, Taipei, Taiwan; [Liu, Yen-Bin; Wu, Chau-Chung] Natl Taiwan Univ Hosp, Dept Internal Med, Taipei 100, Taiwan; [Horng, Herng-Er] Natl Taiwan Normal Univ, Inst Electroopt Sci & Technol, Taipei, Taiwan; [Yang, Hong-Chang] Natl Taiwan Univ, Dept Phys, Taipei, Taiwan	National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital; National Taiwan Normal University; National Taiwan University	Wu, CC (corresponding author), Natl Taiwan Univ Hosp, Dept Internal Med, Taipei 100, Taiwan.	chauchungwu@ntu.edu.tw	Lin, Kuosui/F-7945-2011; Chen, Chun-An/AAR-5054-2021	Lin, Kuosui/0000-0003-2917-5261; CHANG, HSIU-HAO/0000-0003-1832-8509; YANG, YUNG-LI/0000-0002-3598-7218; LIN, DONG-TSAMN/0000-0002-5773-3200; CHEN, CHUN-AN/0000-0001-8880-7113; LU, MENG-YAO/0000-0003-4461-9967; LIN, KAI-HSIN/0000-0002-5833-7066; PENG, STEVEN SHINN-FORNG/0000-0002-8177-5187; WU, MEI-HWAN/0000-0002-7074-8087; JOU, SHIANN-TANG/0000-0003-1483-0403; Wang, Jou-Kou/0000-0002-3043-3873	National Science Council, Taiwan [NSC 99-2314-B-002-021-MY3]	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan)	This study was supported by a grant (NSC 99-2314-B-002-021-MY3) from National Science Council, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson LJ, 2001, EUR HEART J, V22, P2171, DOI 10.1053/euhj.2001.2822; Antzelevitch C, 2006, J INTERN MED, V259, P48, DOI 10.1111/j.1365-2796.2005.01587.x; ARNETT EN, 1975, AM HEART J, V90, P777, DOI 10.1016/0002-8703(75)90469-X; BARR CS, 1994, LANCET, V343, P327, DOI 10.1016/S0140-6736(94)91164-9; Bartfay WJ, 1999, CARDIOVASC RES, V43, P892, DOI 10.1016/S0008-6363(99)00040-1; BRITTENHAM GM, 1994, NEW ENGL J MED, V331, P567, DOI 10.1056/NEJM199409013310902; BUJA LM, 1971, AM J MED, V51, P209, DOI 10.1016/0002-9343(71)90240-3; Buxton AE, 2006, CIRCULATION, V114, P2534, DOI 10.1161/CIRCULATIONAHA.106.180199; Chen CA, 2012, INT J CARDIOL; Chern JPS, 2007, PEDIATR BLOOD CANCER, V48, P550, DOI 10.1002/pbc.21028; Comani S, 2004, PACE, V27, P1647, DOI 10.1111/j.1540-8159.2004.00699.x; Davis BA, 2004, BLOOD, V104, P263, DOI 10.1182/blood-2003-08-2841; DAY CP, 1990, BRIT HEART J, V63, P342; Fenici R, 2013, INT J CARDIOL; Gapelyuk A, 2007, J ELECTROCARDIOL, V40, P401, DOI 10.1016/j.jelectrocard.2007.03.013; Ghugre NR, 2006, MAGN RESON MED, V56, P681, DOI 10.1002/mrm.20981; Hailer B, 1999, J ELECTROCARDIOL, V32, P207, DOI 10.1016/S1053-0770(99)90061-7; Kayrak Mehmet, 2012, Adv Hematol, V2012, P170510, DOI 10.1155/2012/170510; Kirk P, 2009, CIRCULATION, V120, P1961, DOI 10.1161/CIRCULATIONAHA.109.874487; Kuryshev YA, 1999, CIRCULATION, V100, P675, DOI 10.1161/01.CIR.100.6.675; Kwong JS, 2013, INT J CARDIOL; Laurita KR, 2003, J LAB CLIN MED, V142, P83, DOI 10.1016/S0022-2143(03)00060-X; Lee YH, 2006, SUPERCOND SCI TECH, V19, pS284, DOI 10.1088/0953-2048/19/5/S25; Lim HK, 2009, AM J CARDIOL, V103, P448, DOI 10.1016/j.amjcard.2008.10.013; LINK G, 1989, J LAB CLIN MED, V113, P103; LOWN B, 1979, AM J CARDIOL, V43, P313, DOI 10.1016/S0002-9149(79)80021-1; Lu MY, 2013, TRANSFUSION MED, V23, P100, DOI 10.1111/tme.12014; Maceira AM, 2006, J CARDIOVASC MAGN R, V8, P417, DOI 10.1080/10976640600572889; Magri D, 2007, EUR J HAEMATOL, V79, P322, DOI 10.1111/j.1600-0609.2007.00921.x; METZ CE, 1984, INFORMATION PROCESSI, P432; MIRVIS DM, 1985, J AM COLL CARDIOL, V5, P625, DOI 10.1016/S0735-1097(85)80387-9; Modell B, 2000, LANCET, V355, P2051, DOI 10.1016/S0140-6736(00)02357-6; Ogata K, 2009, PACE, V32, P516, DOI 10.1111/j.1540-8159.2009.02313.x; OLIVIERI NF, 1994, NEW ENGL J MED, V331, P574, DOI 10.1056/NEJM199409013310903; PAUL T, 1990, AM HEART J, V119, P577, DOI 10.1016/S0002-8703(05)80280-7; Positano V, 2009, NMR BIOMED, V22, P707, DOI 10.1002/nbm.1382; Qureshi N, 2005, ANN NY ACAD SCI, V1054, P476, DOI 10.1196/annals.1345.064; Rothman SA, 2007, J CARDIOVASC ELECTR, V18, P241, DOI 10.1111/j.1540-8167.2006.00729.x; Russo V, 2011, EUR J HAEMATOL, V86, P324, DOI 10.1111/j.1600-0609.2011.01579.x; SANYAL SK, 1975, PEDIATRICS, V55, P336; Schwartz KA, 2002, J APPL PHYSIOL, V93, P746, DOI 10.1152/japplphysiol.01144.2001; Sonakul D, 1988, Birth Defects Orig Artic Ser, V23, P177; Sturm R, 2004, PRENATAL DIAG, V24, P1, DOI 10.1002/pd.764; Tseng WYI, 2002, J CARDIOV MAGN RESON, V4, P443, DOI 10.1081/JCMR-120016383; Ulger Z, 2006, AM J HEMATOL, V81, P901, DOI 10.1002/ajh.20679; Van Leeuwen P, 2003, PACE, V26, P1706, DOI 10.1046/j.1460-9592.2003.t01-1-00256.x; VanLeeuwen P, 1996, PACE, V19, P1894; Westwood M, 2003, J MAGN RESON IMAGING, V18, P33, DOI 10.1002/jmri.10332; Westwood MA, 2007, J MAGN RESON IMAGING, V25, P1147, DOI 10.1002/jmri.20915; Wood JC, 2005, ANN NY ACAD SCI, V1054, P386, DOI 10.1196/annals.1345.047; Wu YW, 2013, CIRC J, V77, P1783, DOI 10.1253/circj.CJ-12-1170; Zeitz O, 2002, CIRC RES, V90, P988, DOI 10.1161/01.RES.0000018625.25212.1E	52	5	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2014	9	1							e86524	10.1371/journal.pone.0086524	http://dx.doi.org/10.1371/journal.pone.0086524			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301BI	24475137	Green Published, gold, Green Submitted			2022-12-25	WOS:000330507300075
J	Halder, S; Cotmore, S; Heimburg-Molinaro, J; Smith, DF; Cummings, RD; Chen, X; Trollope, AJ; North, SJ; Haslam, SM; Dell, A; Tattersall, P; McKenna, R; Agbandje-McKenna, M				Halder, Sujata; Cotmore, Susan; Heimburg-Molinaro, Jamie; Smith, David F.; Cummings, Richard D.; Chen, Xi; Trollope, Alana J.; North, Simon J.; Haslam, Stuart M.; Dell, Anne; Tattersall, Peter; McKenna, Robert; Agbandje-McKenna, Mavis			Profiling of Glycan Receptors for Minute Virus of Mice in Permissive Cell Lines Towards Understanding the Mechanism of Cell Recognition	PLOS ONE			English	Article							SIALIC-ACID BINDING; BOVINE PARVOVIRUS; DEPENDENT EXPRESSION; CANCER METASTASIS; TISSUE TROPISM; GENE-TRANSFER; MOUSE-BRAIN; TRANSDUCTION; STRAIN; ENTRY	The recognition of sialic acids by two strains of minute virus of mice (MVM), MVMp (prototype) and MVMi (immunosuppressive), is an essential requirement for successful infection. To understand the potential for recognition of different modifications of sialic acid by MVM, three types of capsids, virus-like particles, wild type empty (no DNA) capsids, and DNA packaged virions, were screened on a sialylated glycan microarray (SGM). Both viruses demonstrated a preference for binding to 9-O-methylated sialic acid derivatives, while MVMp showed additional binding to 9-O-acetylated and 9-O-lactoylated sialic acid derivatives, indicating recognition differences. The glycans recognized contained a type-2 Gal beta 1-4GlcNAc motif (Neu5Ac alpha 2-3Gal beta 1-4GlcNAc or 3'SIA-LN) and were biantennary complex-type N-glycans with the exception of one. To correlate the recognition of the 3'SIA-LN glycan motif as well as the biantennary structures to their natural expression in cell lines permissive for MVMp, MVMi, or both strains, the N- and O-glycans, and polar glycolipids present in three cell lines used for in vitro studies, A9 fibroblasts, EL4 T lymphocytes, and the SV40 transformed NB324K cells, were analyzed by MALDI-TOF/TOF mass spectrometry. The cells showed an abundance of the sialylated glycan motifs recognized by the viruses in the SGM and previous glycan microarrays supporting their role in cellular recognition by MVM. Significantly, the NB324K showed fucosylation at the non-reducing end of their biantennary glycans, suggesting that recognition of these cells is possibly mediated by the Lewis X motif as in 3'SIA-Le(X) identified in a previous glycan microarray screen.	[Halder, Sujata; McKenna, Robert; Agbandje-McKenna, Mavis] Univ Florida, Dept Biochem & Mol Biol, Gainesville, FL 32610 USA; [Cotmore, Susan; Tattersall, Peter] Yale Univ, Sch Med, Dept Lab Med, New Haven, CT 06510 USA; [Heimburg-Molinaro, Jamie; Smith, David F.; Cummings, Richard D.] Emory Univ, Sch Med, Dept Biochem, Atlanta, GA 30322 USA; [Chen, Xi] Univ Calif Davis, Dept Chem, Davis, CA 95616 USA; [Trollope, Alana J.; North, Simon J.; Haslam, Stuart M.; Dell, Anne] Univ London Imperial Coll Sci Technol & Med, Div Mol Biosci, London, England	State University System of Florida; University of Florida; Yale University; Emory University; University of California System; University of California Davis; Imperial College London	Agbandje-McKenna, M (corresponding author), Univ Florida, Dept Biochem & Mol Biol, Gainesville, FL 32610 USA.	mckenna@ufl.edu	Chen, Xi/H-1811-2018	Chen, Xi/0000-0002-3160-614X; Dell, Anne/0000-0003-1380-2347	National Science Foundation [MCB-0718948]; University of Florida College of Medicine Research Funds; National Institute of Health [CA029303, GM085448, GM076360]; BBSRC [BB/F008309/1, BB/K016164/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/K016164/1, BB/F008309/1] Funding Source: researchfish; NATIONAL CANCER INSTITUTE [R01CA029303] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM062116, P41GM103694, R01GM076360, R01GM085448] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); University of Florida College of Medicine Research Funds; National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Science Foundation [MCB-0718948 to R. M. and M.A-M.], University of Florida College of Medicine Research Funds to [M.A-M.], National Institute of Health [CA029303 to S. C. and P. T., GM085448 to D. F. S., and GM076360 to X. C.]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agbandje-McKenna M, 1998, STRUCT FOLD DES, V6, P1369, DOI 10.1016/S0969-2126(98)00137-3; Allaume X, 2012, J VIROL, V86, P3452, DOI 10.1128/JVI.06208-11; Angata T, 2002, CHEM REV, V102, P439, DOI 10.1021/cr000407m; BALLGOODRICH LJ, 1992, J VIROL, V66, P3415, DOI 10.1128/JVI.66.6.3415-3423.1992; BARBIS DP, 1992, VIROLOGY, V191, P301, DOI 10.1016/0042-6822(92)90192-R; Bell CL, 2011, J CLIN INVEST, V121, P2427, DOI 10.1172/JCI57367; Blackburn SD, 2005, ARCH VIROL, V150, P1477, DOI 10.1007/s00705-005-0496-y; Boisvert M, 2010, J VIROL, V84, P7782, DOI 10.1128/JVI.00479-10; Brockhausen I., 2009, ESSENTIALS GLYCOBIOL; BROWN KE, 1993, SCIENCE, V262, P114, DOI 10.1126/science.8211117; COTMORE SF, 1987, ADV VIRUS RES, V33, P91, DOI 10.1016/S0065-3527(08)60317-6; D'Abramo AM, 2005, VIROLOGY, V340, P143, DOI 10.1016/j.virol.2005.06.019; Di Pasquale G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009336; GARDINER EM, 1988, J VIROL, V62, P2605, DOI 10.1128/JVI.62.8.2605-2613.1988; Handa A, 2000, J GEN VIROL, V81, P2077, DOI 10.1099/0022-1317-81-8-2077; Hernando E, 2000, VIROLOGY, V267, P299, DOI 10.1006/viro.1999.0123; Inoko E, 2010, GLYCOBIOLOGY, V20, P916, DOI 10.1093/glycob/cwq049; IRIMURA T, 1993, SEMIN CANCER BIOL, V4, P319; Johnson FB, 2004, J GEN VIROL, V85, P2199, DOI 10.1099/vir.0.79899-0; Kaludov N, 2001, J VIROL, V75, P6884, DOI 10.1128/JVI.75.15.6884-6893.2001; Kamerling Johannis P., 2006, V347, P69; Kannagi R, 2003, GLYCOCONJUGATE J, V20, P353, DOI 10.1023/B:GLYC.0000033631.35357.41; Kannagi R, 2004, CANCER SCI, V95, P377, DOI 10.1111/j.1349-7006.2004.tb03219.x; KIMSEY PB, 1986, J VIROL, V59, P8, DOI 10.1128/JVI.59.1.8-13.1986; Klein A, 1997, GLYCOBIOLOGY, V7, P421, DOI 10.1093/glycob/7.3.421; Kontou M, 2005, J VIROL, V79, P10931, DOI 10.1128/JVI.79.17.10931-10943.2005; LINSER P, 1977, J VIROL, V24, P211, DOI 10.1128/JVI.24.1.211-221.1977; Liu F, 2001, BRIT J CANCER, V84, P1556, DOI 10.1054/bjoc.2001.1815; Lopez-Bueno A, 2006, J VIROL, V80, P1563, DOI 10.1128/JVI.80.3.1563-1573.2006; MAXWELL IH, 1995, J VIROL, V69, P5829, DOI 10.1128/JVI.69.9.5829-5832.1995; Nam HJ, 2006, J BIOL CHEM, V281, P25670, DOI 10.1074/jbc.M604421200; North SJ, 2010, J BIOL CHEM, V285, P5759, DOI 10.1074/jbc.M109.068353; Olofsson S, 2005, ANN MED, V37, P154, DOI 10.1080/07853890510007340; Previsani N, 1997, J VIROL, V71, P7769, DOI 10.1128/JVI.71.10.7769-7780.1997; Rabinowitz JE, 2002, J VIROL, V76, P791, DOI 10.1128/JVI.76.2.791-801.2002; Ramirez JC, 1996, J VIROL, V70, P8109; RITTER G, 1990, CANCER RES, V50, P1403; Sato C, 2002, J BIOL CHEM, V277, P45299, DOI 10.1074/jbc.M206046200; Sato C, 2000, J BIOL CHEM, V275, P15422, DOI 10.1074/jbc.275.20.15422; Schmidt M, 2006, J VIROL, V80, P5516, DOI 10.1128/JVI.02393-05; Schwegmann-Wessels C, 2006, GLYCOCONJUGATE J, V23, P51, DOI 10.1007/s10719-006-5437-9; Segovia JC, 1999, J VIROL, V73, P1774, DOI 10.1128/JVI.73.3.1774-1784.1999; Seiler MP, 2006, HUM GENE THER, V17, P10, DOI 10.1089/hum.2006.17.10; SEKI T, 1993, J NEUROSCI, V13, P2351, DOI 10.1523/JNEUROSCI.13-06-02351.1993; Shen S, 2011, J BIOL CHEM, V286, P13532, DOI 10.1074/jbc.M110.210922; Song XZ, 2011, J BIOL CHEM, V286, P31610, DOI 10.1074/jbc.M111.274217; Song XZ, 2009, CHEM BIOL, V16, P36, DOI 10.1016/j.chembiol.2008.11.004; SPALHOLZ BA, 1983, J VIROL, V46, P937, DOI 10.1128/JVI.46.3.937-943.1983; Stanley P, 2009, ESSENTIALS GLYCOBIOL; Summerford C, 1998, J VIROL, V72, P1438, DOI 10.1128/JVI.72.2.1438-1445.1998; TATTERSALL P, 1983, J VIROL, V46, P944, DOI 10.1128/JVI.46.3.944-955.1983; TATTERSALL P, 1977, J MOL BIOL, V111, P375, DOI 10.1016/S0022-2836(77)80060-0; Thacker TC, 1998, J GEN VIROL, V79, P2163, DOI 10.1099/0022-1317-79-9-2163; TRESNAN DB, 1995, VIROLOGY, V211, P123, DOI 10.1006/viro.1995.1385; Walters RW, 2001, J BIOL CHEM, V276, P20610, DOI 10.1074/jbc.M101559200; Wang SH, 2013, GLYCOBIOLOGY; Wu Z, 2006, J VIROL, V80, P11393, DOI 10.1128/JVI.01288-06; Wu ZJ, 2006, J VIROL, V80, P9093, DOI 10.1128/JVI.00895-06; Yu Y, 2012, J BIOL CHEM, V287, P44784, DOI 10.1074/jbc.M112.425819	59	11	12	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2014	9	1							e86909	10.1371/journal.pone.0086909	http://dx.doi.org/10.1371/journal.pone.0086909			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301BI	24475195	gold, Green Published, Green Submitted			2022-12-25	WOS:000330507300117
J	Huri, HZ; Xin, CH; Sulaiman, CZ				Huri, Hasniza Zaman; Xin, Chong Hui; Sulaiman, Che Zuraini			Drug-Related Problems in Patients with Benign Prostatic Hyperplasia: A Cross Sectional Retrospective Study	PLOS ONE			English	Article							URINARY-TRACT SYMPTOMS; MEDICATION; POLYPHARMACY; STRATEGIES; INHIBITORS; SAFETY; MEN	Benign Prostatic Hyperplasia (BPH) patients are at risk of acquiring drug-related problems (DRPs), as it is present in the majority of aging men. To date, DRPs among BPH patients have not been well studied. We conducted this retrospective study in a tertiary hospital in Malaysia from January 2009 to June 2012 with the aim of identifying the factors associated with DRPs among BPH patients. The Pharmaceutical Care Network Europe Classification Version (PCNE) 5.01 was used as a tool to classify DRPs. We enrolled 203 patients from 259 hospital admissions. A total of 390 DRPs were found and there was an average of 1.5 +/- 1.3 problems per hospitalization. 76.1% of hospital admissions included at least one DRP. The most common DRP categories encountered were drug choice problems (45.9%), drug interactions (24.9%), and dosing problems (13.3%). Factors such as advanced age (p = 0.005), a hospital stay of more than 6 days (p = 0.001), polydrug treatments (p<0.001), multiple comorbidities (p<0.001), and comorbid cardiovascular disease (p = 0.011), diabetes mellitus(p = 0.001), hypertension (p, 0.001) and renal impairment (p = 0.011) were significantly associated with the occurrence of DRPs. These data indicated that the prevalence of DRPs is high among BPH patients. The identification of different subtypes of DRPs and the factors associated with DRPs may facilitate risk reduction for BPH patients.	[Huri, Hasniza Zaman; Xin, Chong Hui] Univ Malaya, Fac Med, Dept Pharm, Kuala Lumpur, Malaysia; [Huri, Hasniza Zaman] Univ Malaya, Med Ctr, Clin Invest Ctr, Kuala Lumpur, Malaysia; [Sulaiman, Che Zuraini] Univ Malaya, Med Ctr, Dept Pharm, Kuala Lumpur, Malaysia	Universiti Malaya; Universiti Malaya; Universiti Malaya	Huri, HZ (corresponding author), Univ Malaya, Fac Med, Dept Pharm, Kuala Lumpur, Malaysia.	hasnizazh@um.edu.my	HURI, HASNIZA ZAMAN/B-8612-2010	HURI, HASNIZA ZAMAN/0000-0002-6423-8515	Ministry of Science, Technology and Innovation, Malaysia [12-02-03-2097]; University of Malaya, Malaysia [RG428/12HTM]	Ministry of Science, Technology and Innovation, Malaysia(Ministry of Energy, Science, Technology, Environment and Climate Change (MESTECC), Malaysia); University of Malaya, Malaysia(Universiti Malaya)	The authors would like to thank the Ministry of Science, Technology and Innovation, Malaysia (Science fund: 12-02-03-2097) and University of Malaya, Malaysia (RG428/12HTM) for financial and technical support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdullah Dellemin Che, 2004, Malays J Med Sci, V11, P52; American Urological Association (AUA), 2010, GUID MAN BEN PROST H; *AUA PRACT GUID CO, 2003, AUA GUID MAN BEN PRO; Barat I, 2000, EUR J CLIN PHARMACOL, V56, P501, DOI 10.1007/s002280000157; Barber N, 2004, QUAL SAF HEALTH CARE, V13, P172, DOI 10.1136/qshc.2003.005926; Bjorkman IK, 2008, RES SOC ADMIN PHARM, V4, P320, DOI 10.1016/j.sapharm.2007.10.006; British Medical Association and Royal Pharmaceutical Society of Great Britain, 2011, BRIT NAT FORM 62 BNF; Bryant RJ, 2008, SURGERY OXFORD, V26, P150; Chan DC, 2012, ARCH GERONTOL GERIAT, V54, P168, DOI 10.1016/j.archger.2011.02.005; Carneiro SCD, 2011, CLIN DERMATOL, V29, P43, DOI 10.1016/j.clindermatol.2010.07.006; Davies EC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004439; Dicpinigaitis PV, 2006, CHEST, V129, p169S, DOI 10.1378/chest.129.1_suppl.169S; Eckardt KU, 2012, KIDNEY INT SUPPL, V2, P7, DOI 10.1038/kisup.2012.8; Eichenberger PM, 2010, PHARM WORLD SCI, V32, P362, DOI 10.1007/s11096-010-9377-x; Emberton M, 2010, INT J CLIN PRACT, V64, P1425, DOI 10.1111/j.1742-1241.2010.02463.x; Fialova D, 2005, JAMA-J AM MED ASSOC, V293, P1348, DOI 10.1001/jama.293.11.1348; Fick D, 2012, J AM GERIATR SOC, V60, P616, DOI 10.1111/j.1532-5415.2012.03923.x; Fitzpatrick JM, 2006, EUR UROL SUPPL, V5, P997, DOI 10.1016/j.eursup.2006.08.009; Hajjar Emily R, 2003, Am J Geriatr Pharmacother, V1, P82; Hajjar Emily R, 2007, Am J Geriatr Pharmacother, V5, P345, DOI 10.1016/j.amjopharm.2007.12.002; Hanlon Joseph T, 2003, Am J Geriatr Pharmacother, V1, P38, DOI 10.1016/S1543-5946(03)80014-4; Ho CKC, 2011, MED HEALTH-KUALA LUM, V6, P98; Hoke GP, 2008, AM J MED, V121, pS3, DOI 10.1016/j.amjmed.2008.05.021; Huri HZ, 2013, BMC ENDOCR DISORD, V13, DOI 10.1186/1472-6823-13-2; Israels S, 2006, J CAN DENT ASSOC, V72, P827; Juan Yung-Shun, 2004, Kaohsiung Journal of Medical Sciences, V20, P90; Kaplan SA, 2008, J UROLOGY, V180, P47, DOI 10.1016/j.juro.2008.03.027; Koh Yvonne, 2005, Ther Clin Risk Manag, V1, P39, DOI 10.2147/tcrm.1.1.39.53597; LaPointe NMA, 2003, ARCH INTERN MED, V163, P1461, DOI 10.1001/archinte.163.12.1461; Lepor Herbert, 2011, Rev Urol, V13, P20; Levinson J R, 1991, Clin Geriatr Med, V7, P371; Manlucu J, 2005, NEPHROL DIAL TRANSPL, V20, P2376, DOI 10.1093/ndt/gfi025; Maruenda J, 1999, UROLOGY, V53, P7, DOI 10.1016/S0090-4295(98)00533-0; Matthews SJ, 2011, AM J GERIATR PHARMAC, V9, P286, DOI 10.1016/j.amjopharm.2011.07.002; Ministry of Health Malaysia, 2002, HLTH TECHN ASS REP M; Mizokami F, 2012, AM J GERIATR PHARMAC, V10, P123, DOI 10.1016/j.amjopharm.2012.02.003; Moura C, 2009, J PHARM PHARM SCI, V12, P266, DOI 10.18433/J35C7Z; Naslund MJ, 2007, CLIN THER, V29, P17, DOI 10.1016/j.clinthera.2007.01.018; Nichol MB, 2009, J UROLOGY, V181, P2214, DOI 10.1016/j.juro.2009.01.033; Nye HJ, 2011, NEPHRON CLIN PRACT, V118, pC380, DOI 10.1159/000323739; Page Robert L 2nd, 2006, Am J Geriatr Pharmacother, V4, P297; Pharmaceutical Care Network Europe, 2006, PCNE CLASS DRUG REL; Planas LG, 2005, SOC SCI MED, V60, P2393, DOI 10.1016/j.socscimed.2004.10.018; Riechelmann RP, 2005, CANCER CHEMOTH PHARM, V56, P286, DOI 10.1007/s00280-004-0998-4; Roehrborn CG, 2004, J UROLOGY, V171, P1029, DOI 10.1097/01.ju.0000097026.43866.cc; Roehrborn CG, 2002, EUR UROL, V42, P1, DOI 10.1016/S0302-2838(02)00210-5; Salomon L, 2003, INT J QUAL HEALTH C, V15, P331, DOI 10.1093/intqhc/mzg046; Stegemann S, 2010, AGEING RES REV, V9, P384, DOI 10.1016/j.arr.2010.04.005; Stemer G, 2011, BMC NEPHROL, V12, DOI 10.1186/1471-2369-12-35; Thomas MC, 2003, DIABETES CARE, V26, P1164, DOI 10.2337/diacare.26.4.1164; Tulner LR, 2010, DRUG AGING, V27, P831, DOI 10.2165/11539330-000000000-00000; van Roozendaal BW, 2009, PHARM WORLD SCI, V31, P580, DOI 10.1007/s11096-009-9312-1; Verhamme KMC, 2003, EUR UROL, V44, P539, DOI 10.1016/S0302-2838(03)00376-2; Viktil KK, 2007, BRIT J CLIN PHARMACO, V63, P187, DOI 10.1111/j.1365-2125.2006.02744.x; World Health Organization, 2013, Q AS HYP; World Health Organization, 2013, HLTH TOP CARD DIS; World Health Organization, 2013, HLTH TOP STROK CER A; World Health Organization, 2013, HLTH TOP DIAB	58	12	14	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2014	9	1							e86215	10.1371/journal.pone.0086215	http://dx.doi.org/10.1371/journal.pone.0086215			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301BI	24475089	Green Submitted, Green Published, gold			2022-12-25	WOS:000330507300044
J	Ichinose, N; Yada, T; Gotoh, O				Ichinose, Natsuhiro; Yada, Tetsushi; Gotoh, Osamu			Tetrahedral Gray Code for Visualization of Genome Information	PLOS ONE			English	Article							CHAOS GAME REPRESENTATION; DNA-SEQUENCES; METHYLATION	We propose a tetrahedral Gray code that facilitates visualization of genome information on the surfaces of a tetrahedron, where the relative abundance of each k-mer in the genomic sequence is represented by a color of the corresponding cell of a triangular lattice. For biological significance, the code is designed such that the k-mers corresponding to any adjacent pair of cells differ from each other by only one nucleotide. We present a simple procedure to draw such a pattern on the development surfaces of a tetrahedron. The thus constructed tetrahedral Gray code can demonstrate evolutionary conservation and variation of the genome information of many organisms at a glance. We also apply the tetrahedral Gray code to the honey bee (Apis mellifera) genome to analyze its methylation structure. The results indicate that the honey bee genome exhibits CpG overrepresentation in spite of its methylation ability and that two conserved motifs, CTCGAG and CGCGCG, in the unmethylated regions are responsible for the overrepresentation of CpG.	[Ichinose, Natsuhiro] Kyoto Univ, Grad Sch Informat, Dept Intelligence Sci & Technol, Sakyo Ku, Kyoto, Japan; [Yada, Tetsushi] Kyushu Inst Technol, Dept Biosci & Bioinformat, Iizuka, Fukuoka, Japan; [Gotoh, Osamu] Natl Inst Adv Ind Sci & Technol, CBRC, Koto Ku, Tokyo, Japan	Kyoto University; Kyushu Institute of Technology; National Institute of Advanced Industrial Science & Technology (AIST)	Ichinose, N (corresponding author), Kyoto Univ, Grad Sch Informat, Dept Intelligence Sci & Technol, Sakyo Ku, Yoshida Honmachi, Kyoto, Japan.	ichinose@i.kyoto-u.ac.jp			Aihara Project; FIRST program from Japan Society for the Promotion of Science (JSPS); JSPS KAKENHI [221S0002, 22310124]	Aihara Project(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); FIRST program from Japan Society for the Promotion of Science (JSPS); JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This research was supported by the Aihara Project, the FIRST program from Japan Society for the Promotion of Science (JSPS), initiated by CSTP. This work was partially supported by JSPS KAKENHI Grant Numbers 221S0002 and 22310124. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiyama J, 2006, COMP GEOM-THEOR APPL, V34, P2, DOI 10.1016/j.comgeo.2005.07.003; Akiyama J, 2007, AM MATH MON, V114, P602, DOI 10.1080/00029890.2007.11920450; Almeida JS, 2002, BMC BIOINFORMATICS, V3, DOI 10.1186/1471-2105-3-6; Almeida JS, 2001, BIOINFORMATICS, V17, P429, DOI 10.1093/bioinformatics/17.5.429; Basu S, 1997, J MOL GRAPH MODEL, V15, P279, DOI 10.1016/S1093-3263(97)00106-X; COOPER DN, 1989, HUM GENET, V83, P181, DOI 10.1007/BF00286715; de Bruijn N.G., 1946, KONINKLIJKE NEDERLAN, V49, P758; Deschavanne PJ, 1999, MOL BIOL EVOL, V16, P1391, DOI 10.1093/oxfordjournals.molbev.a026048; Duzhin SV, 2004, TRANSFORMATION GROUP; ER MC, 1984, IEEE T COMPUT, V33, P739, DOI 10.1109/TC.1984.5009360; FELDMAN W, 1994, GENOMICS, V23, P233, DOI 10.1006/geno.1994.1482; Feng SH, 2010, P NATL ACAD SCI USA, V107, P8689, DOI 10.1073/pnas.1002720107; Foret S, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-472; Gray Frank, 1947, US Patent, Patent No. 2632058; Gutierrez JM, 2001, PHYSICA A, V300, P271, DOI 10.1016/S0378-4371(01)00333-8; Hao BL, 2000, CHAOS SOLITON FRACT, V11, P825, DOI 10.1016/S0960-0779(98)00182-9; Ichinose N, 2012, BIOINFORMATICS, V28, P25, DOI 10.1093/bioinformatics/btr606; JEFFREY HJ, 1990, NUCLEIC ACIDS RES, V18, P2163, DOI 10.1093/nar/18.8.2163; Kent CF, 2012, P NATL ACAD SCI USA, V109, P18012, DOI 10.1073/pnas.1208094109; Kucharski R, 2008, SCIENCE, V319, P1827, DOI 10.1126/science.1153069; Lyko F, 2000, NATURE, V408, P538, DOI 10.1038/35046205; Lyko F, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000506	22	0	0	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2014	9	1							e86133	10.1371/journal.pone.0086133	http://dx.doi.org/10.1371/journal.pone.0086133			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301BI	24475080	Green Published, Green Submitted, gold			2022-12-25	WOS:000330507300039
J	Ishida, S; Matsu-ura, T; Fukami, K; Michikawa, T; Mikoshiba, K				Ishida, Sachiko; Matsu-ura, Toru; Fukami, Kiyoko; Michikawa, Takayuki; Mikoshiba, Katsuhiko			Phospholipase C-beta 1 and beta 4 Contribute to Non-Genetic Cell-to-Cell Variability in Histamine-Induced Calcium Signals in HeLa Cells	PLOS ONE			English	Article							G-PROTEINS; OSCILLATIONS; HEPATOCYTES; PURIFICATION; ACTIVATION; SUBUNITS; ISOZYME; COMPLEX; GQ	A uniform extracellular stimulus triggers cell-specific patterns of Ca2+ signals, even in genetically identical cell populations. However, the underlying mechanism that generates the cell-to-cell variability remains unknown. We monitored cytosolic inositol 1,4,5-trisphosphate (IP3) concentration changes using a fluorescent IP3 sensor in single HeLa cells showing different patterns of histamine-induced Ca2+ oscillations in terms of the time constant of Ca2+ spike amplitude decay and the Ca2+ oscillation frequency. HeLa cells stimulated with histamine exhibited a considerable variation in the temporal pattern of Ca2+ signals and we found that there were cell-specific IP3 dynamics depending on the patterns of Ca2+ signals. RT-PCR and western blot analyses showed that phospholipase C (PLC)-beta 1, -beta 3, -beta 4, -gamma 1, -delta 3 and -epsilon were expressed at relatively high levels in HeLa cells. Small interfering RNA-mediated silencing of PLC isozymes revealed that PLC-beta 1 and PLC-beta 4 were specifically involved in the histamine-induced IP3 increases in HeLa cells. Modulation of IP3 dynamics by knockdown or overexpression of the isozymes PLC-beta 1 and PLC-beta 4 resulted in specific changes in the characteristics of Ca2+ oscillations, such as the time constant of the temporal changes in the Ca2+ spike amplitude and the Ca2+ oscillation frequency, within the range of the cell-to-cell variability found in wild-type cell populations. These findings indicate that the heterogeneity in the process of IP3 production, rather than IP3-induced Ca2+ release, can cause cell-to-cell variability in the patterns of Ca2+ signals and that PLC-beta 1 and PLC-beta 4 contribute to generate cell-specific Ca2+ signals evoked by G protein-coupled receptor stimulation.	[Ishida, Sachiko; Matsu-ura, Toru; Michikawa, Takayuki; Mikoshiba, Katsuhiko] RIKEN Brain Sci Inst, Dev Neurobiol Lab, Wako, Saitama, Japan; [Fukami, Kiyoko] Tokyo Univ Pharm & Life Sci, Lab Genome & Biosignal, Tokyo, Japan; [Michikawa, Takayuki; Mikoshiba, Katsuhiko] Japan Sci & Technol Agcy, Calcium Oscillat Project, ICORP SORST, Kawaguchi, Saitama, Japan; [Michikawa, Takayuki] RIKEN Brain Sci Inst, Lab Behav Genet, Wako, Saitama, Japan	RIKEN; Tokyo University of Pharmacy & Life Sciences; Japan Science & Technology Agency (JST); RIKEN	Michikawa, T (corresponding author), RIKEN Brain Sci Inst, Dev Neurobiol Lab, Wako, Saitama, Japan.	t-michikawa@brain.riken.jp; mikosiba@brain.riken.jp	Matsu-ura, Toru/P-3461-2017; Mikoshiba, Katsuhiko/N-7943-2015	Matsu-ura, Toru/0000-0002-9876-3086; Ishida, Sachiko/0000-0001-6463-3059	Ministry of Education, Culture, Sports, Science and Technology of Japan [22770227, 20370054, 2022007]	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by grants from the Ministry of Education, Culture, Sports, Science and Technology of Japan to T. Matsu-ura (22770227), T. Michikawa (20370054), and K. Mikoshiba (2022007). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adjobo-Hermans MJW, 2013, CELL SIGNAL, V25, P255, DOI 10.1016/j.cellsig.2012.09.022; Aisiku O, 2011, ARCH BIOCHEM BIOPHYS, V509, P186, DOI 10.1016/j.abb.2011.02.006; Aisiku OR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015001; AMBLER SK, 1988, J BIOL CHEM, V263, P1952; Berridge MJ, 2012, BIOCHEM SOC T, V40, P297, DOI 10.1042/BST20110766; Berridge MJ, 2009, BBA-MOL CELL RES, V1793, P933, DOI 10.1016/j.bbamcr.2008.10.005; Berridge MJ, 2000, NAT REV MOL CELL BIO, V1, P11, DOI 10.1038/35036035; BERRIDGE MJ, 1988, J PHYSIOL-LONDON, V403, P589, DOI 10.1113/jphysiol.1988.sp017266; BERSTEIN G, 1992, CELL, V70, P411, DOI 10.1016/0092-8674(92)90165-9; BLANK JL, 1991, J BIOL CHEM, V266, P18206; Bunney TD, 2011, TRENDS BIOCHEM SCI, V36, P88, DOI 10.1016/j.tibs.2010.08.003; CLAPHAM DE, 1995, CELL, V80, P259, DOI 10.1016/0092-8674(95)90408-5; COBBOLD PH, 1991, CELL CALCIUM, V12, P87, DOI 10.1016/0143-4160(91)90011-3; HAZAMA A, 1985, BIOCHIM BIOPHYS ACTA, V845, P249, DOI 10.1016/0167-4889(85)90183-1; Kim MJ, 1998, J BIOL CHEM, V273, P3618, DOI 10.1074/jbc.273.6.3618; Krumins AM, 2006, J BIOL CHEM, V281, P10250, DOI 10.1074/jbc.M511551200; Kuchtey J, 1996, J CELL PHYSIOL, V166, P643, DOI 10.1002/(SICI)1097-4652(199603)166:3<643::AID-JCP20>3.0.CO;2-6; Matsu-ura T, 2006, J CELL BIOL, V173, P755, DOI 10.1083/jcb.200512141; MIN DS, 1993, J BIOL CHEM, V268, P12207; Morris AJ, 1999, PHYSIOL REV, V79, P1373, DOI 10.1152/physrev.1999.79.4.1373; Nakamura Y, 2005, MOL CELL BIOL, V25, P10979, DOI 10.1128/MCB.25.24.10979-10988.2005; Niepel M, 2009, CURR OPIN CHEM BIOL, V13, P556, DOI 10.1016/j.cbpa.2009.09.015; PRENTKI M, 1988, J BIOL CHEM, V263, P11044; ROONEY TA, 1989, J BIOL CHEM, V264, P17131; Ross EM, 2000, ANNU REV BIOCHEM, V69, P795, DOI 10.1146/annurev.biochem.69.1.795; Spencer SL, 2009, NATURE, V459, P428, DOI 10.1038/nature08012; Sprang SR, 1997, ANNU REV BIOCHEM, V66, P639, DOI 10.1146/annurev.biochem.66.1.639; Suh PG, 2008, BMB REP, V41, P415, DOI 10.5483/BMBRep.2008.41.6.415; THOMAS AP, 1991, CELL CALCIUM, V12, P111, DOI 10.1016/0143-4160(91)90013-5; Uhlen Per, 2004, Sci STKE, V2004, ppl15, DOI 10.1126/stke.2582004pl15; Waldo GL, 2010, SCIENCE, V330, P974, DOI 10.1126/science.1193438; Wettschureck N, 2005, PHYSIOL REV, V85, P1159, DOI 10.1152/physrev.00003.2005; WOODS NM, 1986, NATURE, V319, P600, DOI 10.1038/319600a0; Wu DM, 2003, EUR J NEUROSCI, V17, P1571, DOI 10.1046/j.1460-9568.2003.02591.x; WU DQ, 1992, J BIOL CHEM, V267, P1811	35	10	11	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2014	9	1							e86410	10.1371/journal.pone.0086410	http://dx.doi.org/10.1371/journal.pone.0086410			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301BI	24475116	gold, Green Submitted, Green Published			2022-12-25	WOS:000330507300062
J	Su, J; Zhang, L; Zhang, W; Choi, DS; Wen, JG; Jiang, BN; Chang, CC; Zhou, XB				Su, Jing; Zhang, Le; Zhang, Wen; Choi, Dong Song; Wen, Jianguo; Jiang, Beini; Chang, Chung-Che; Zhou, Xiaobo			Targeting the Biophysical Properties of the Myeloma Initiating Cell Niches: A Pharmaceutical Synergism Analysis Using Multi-Scale Agent-Based Modeling	PLOS ONE			English	Article							CANCER STEM-CELLS; MULTIPLE-MYELOMA; DRUG-RESISTANCE; MATHEMATICAL-MODEL; MICROENVIRONMENT; TRANSPLANTATION; MECHANISMS; PARADIGM; LEUKEMIA; THERAPY	Multiple myeloma, the second most common hematological cancer, is currently incurable due to refractory disease relapse and development of multiple drug resistance. We and others recently established the biophysical model that myeloma initiating (stem) cells (MICs) trigger the stiffening of their niches via SDF-1/CXCR4 paracrine; The stiffened niches then promote the colonogenesis of MICs and protect them from drug treatment. In this work we examined in silico the pharmaceutical potential of targeting MIC niche stiffness to facilitate cytotoxic chemotherapies. We first established a multi-scale agent-based model using the Markov Chain Monte Carlo approach to recapitulate the niche stiffness centric, pro-oncogenetic positive feedback loop between MICs and myeloma-associated bone marrow stromal cells (MBMSCs), and investigated the effects of such intercellular chemo-physical communications on myeloma development. Then we used AMD3100 (to interrupt the interactions between MICs and their stroma) and Bortezomib (a recently developed novel therapeutic agent) as representative drugs to examine if the biophysical properties of myeloma niches are drugable. Results showed that our model recaptured the key experimental observation that the MBMSCs were more sensitive to SDF-1 secreted by MICs, and provided stiffer niches for these initiating cells and promoted their proliferation and drug resistance. Drug synergism analysis suggested that AMD3100 treatment undermined the capability of MICs to modulate the bone marrow microenvironment, and thus re-sensitized myeloma to Bortezomib treatments. This work is also the first attempt to virtually visualize in 3D the dynamics of the bone marrow stiffness during myeloma development. In summary, we established a multi-scale model to facilitate the translation of the niche-stiffness centric myeloma model as well as experimental observations to possible clinical applications. We concluded that targeting the biophysical properties of stem cell niches is of high clinical potential since it may re-sensitize tumor initiating cells to chemotherapies and reduce risks of cancer relapse.	[Su, Jing; Zhou, Xiaobo] Wake Forest Sch Med, Dept Radiol, Winston Salem, NC USA; [Zhang, Le] Southwest Univ, Coll Comp & Informat Sci, Chongqing, Peoples R China; [Zhang, Le] Univ Rochester, Med Ctr, Sch Med & Dent, Rochester, NY 14642 USA; [Zhang, Wen] Baylor Coll Med, Jan & Dan Duncan Neurol Res Inst, Houston, TX 77030 USA; [Choi, Dong Song; Wen, Jianguo] Weill Cornell Med Coll, Methodist Hosp Res Inst, Dept Pathol, Houston, TX USA; [Jiang, Beini] Michigan Technol Univ, Dept Math Sci, Houghton, MI 49931 USA; [Zhou, Xiaobo] Univ Cent Florida, Dept Pathol, Florida Hosp, Orlando, FL 32816 USA	Wake Forest University; Southwest University - China; University of Rochester; Baylor College of Medicine; Cornell University; The Methodist Hospital System; The Methodist Hospital - Houston; The Methodist Hospital Research Institute; Michigan Technological University; Adventist Health Services; AdventHealth; State University System of Florida; University of Central Florida	Zhang, L (corresponding author), Southwest Univ, Coll Comp & Informat Sci, Chongqing, Peoples R China.	Le_Zhang@URMC.Rochester.edu; C.Jeff.Chang.MD@Flhosp.org; xizhou@wakehealth.edu	Zhang, Le/AAD-9104-2019; Zhang, Wen/I-7086-2018	Zhang, Le/0000-0002-3708-1727; Zhang, Wen/0000-0001-7370-4306; Su, Jing/0000-0003-4917-6173	NIH/NLM [5R01LM010185-04]; Natural Science Foundation of China [61372138]; NATIONAL CANCER INSTITUTE [U01CA166886] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [R01LM010185] Funding Source: NIH RePORTER	NIH/NLM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	The authors thank the funding resource: NIH/NLM 5R01LM010185-04. One of the authors, Dr. Le Zhang, is currently supported by the Natural Science Foundation of China under Grant No. 61372138. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alarcon T, 2004, J THEOR BIOL, V229, P395, DOI 10.1016/j.jtbi.2004.04.016; Alon U, 2006, INTRO SYSTEM BIOL DI; Anderson KC, 2007, EXP HEMATOL, V35, P155, DOI 10.1016/j.exphem.2007.01.024; Azab AK, 2009, BLOOD, V113, P4341, DOI 10.1182/blood-2008-10-186668; Bensinger WI, 2009, LEUKEMIA, V23, P442, DOI 10.1038/leu.2008.396; Blade J, 2009, HAEMATOL-HEMATOL J, V94, P163, DOI 10.3324/haematol.2008.002766; Boman BM, 2007, CLIN PHARMACOL THER, V81, P893, DOI 10.1038/sj.clpt.6100202; Caers J, 2008, B CANCER, V95, P301, DOI 10.1684/bdc.2008.0600; Calabrese C, 2007, CANCER CELL, V11, P69, DOI 10.1016/j.ccr.2006.11.020; Chang CC, 2001, MODERN PATHOL, V14, P1015, DOI 10.1038/modpathol.3880427; Dean M, 2005, NAT REV CANCER, V5, P275, DOI 10.1038/nrc1590; Feng YD, 2010, STEM CELLS DEV, V19, P1289, DOI 10.1089/scd.2010.0010; Feng YD, 2010, PROG BIOPHYS MOL BIO, V103, P148, DOI 10.1016/j.pbiomolbio.2009.10.004; Ganguly R, 2006, CELL PROLIFERAT, V39, P3, DOI 10.1111/j.1365-2184.2006.00369.x; Ghosh N, 2008, CANC LETT; Hirschmann-Jax C, 2004, P NATL ACAD SCI USA, V101, P14228, DOI 10.1073/pnas.0400067101; Huff CA, 2008, J CLIN ONCOL, V26, P2895, DOI 10.1200/JCO.2007.15.8428; Jakubikova J, 2011, BLOOD, V117, P4409, DOI 10.1182/blood-2010-02-267344; Joe Conway C-CC, 2008, ARCH PATHOL IN PRESS; Joyce JA, 2005, CANCER CELL, V7, P513, DOI 10.1016/j.ccr.2005.05.024; Keith CT, 2005, NAT REV DRUG DISCOV, V4, P71, DOI 10.1038/nrd1609; Kukreja A, 2006, J EXP MED, V203, P1859, DOI 10.1084/jem.20052136; Kumar S, 2009, CANCER METAST REV, V28, P113, DOI 10.1007/s10555-008-9173-4; LAPIDOT T, 1994, NATURE, V367, P645, DOI 10.1038/367645a0; Loewe S, 1926, N-S ARCH EX PATH PH, V114, P313; Lozoya OA, 2011, BIOMATERIALS, V32, P7389, DOI 10.1016/j.biomaterials.2011.06.042; Matsui W, 2004, BLOOD, V103, P2332, DOI 10.1182/blood-2003-09-3064; Matsui W, 2008, CANCER RES, V68, P190, DOI 10.1158/0008-5472.CAN-07-3096; Michor F, 2005, NATURE, V435, P1267, DOI 10.1038/nature03669; Nara M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056954; Nefedova Y, 2003, LEUKEMIA, V17, P1175, DOI 10.1038/sj.leu.2402924; Peacock CD, 2007, P NATL ACAD SCI USA, V104, P4048, DOI 10.1073/pnas.0611682104; Pilarski LM, 2002, EXP HEMATOL, V30, P221, DOI 10.1016/S0301-472X(01)00788-3; Podar K, 2009, EXPERT OPIN EMERG DR, V14, P99, DOI [10.1517/14728210802676278 , 10.1517/14728210802676278]; Rosen JM, 2009, SCIENCE, V324, P1670, DOI 10.1126/science.1171837; Segovia-Juarez JL, 2004, J THEOR BIOL, V231, P357, DOI 10.1016/j.jtbi.2004.06.031; Serban MA, 2001, CURRENT PROTOCOLS CE; Shabaneh TB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056132; Slepchenko BM, 2002, ANNU REV BIOPH BIOM, V31, P423, DOI 10.1146/annurev.biophys.31.101101.140930; Souza GR, 2010, NAT NANOTECHNOL, V5, P291, DOI 10.1038/nnano.2010.23; Su J, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-350; Tallarida RJ, 2006, J PHARMACOL EXP THER, V319, P1, DOI 10.1124/jpet.106.104117; Wen JG, 2008, BRIT J HAEMATOL, V140, P169, DOI 10.1111/j.1365-2141.2007.06895.x; Wen JG, 2010, LEUKEMIA RES, V34, P85, DOI 10.1016/j.leukres.2009.05.024; Wicha MS, 2006, CANCER RES, V66, P1883, DOI 10.1158/0008-5472.CAN-05-3153; Zhang L, 2007, J THEOR BIOL, V244, P96, DOI 10.1016/j.jtbi.2006.06.034; Zhao L, 2004, CLIN CANCER RES, V10, P7994, DOI 10.1158/1078-0432.CCR-04-1087; Zhu X, 2010, J THEORETIC IN PRESS	48	21	21	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2014	9	1							e85059	10.1371/journal.pone.0085059	http://dx.doi.org/10.1371/journal.pone.0085059			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301BI	24475036	Green Published, Green Submitted, gold			2022-12-25	WOS:000330507300016
J	Vandenhende, MA; Bellecave, P; Recordon-Pinson, P; Reigadas, S; Bidet, Y; Bruyand, M; Bonnet, F; Lazaro, E; Neau, D; Fleury, H; Dabis, F; Morlat, P; Masquelier, B				Vandenhende, Marie-Anne; Bellecave, Pantxika; Recordon-Pinson, Patricia; Reigadas, Sandrine; Bidet, Yannick; Bruyand, Mathias; Bonnet, Fabrice; Lazaro, Estibaliz; Neau, Didier; Fleury, Herve; Dabis, Francois; Morlat, Philippe; Masquelier, Bernard			Prevalence and Evolution of Low Frequency HIV Drug Resistance Mutations Detected by Ultra Deep Sequencing in Patients Experiencing First Line Antiretroviral Therapy Failure	PLOS ONE			English	Article							TREATMENT-NAIVE; VARIANTS; TRANSMISSION; INFECTION; POPULATIONS; MORTALITY; ADHERENCE; MULTIPLE; RISK	Objectives: Clinical relevance of low-frequency HIV-1 variants carrying drug resistance associated mutations (DRMs) is still unclear. We aimed to study the prevalence of low-frequency DRMs, detected by Ultra-Deep Sequencing (UDS) before antiretroviral therapy (ART) and at virological failure (VF), in HIV-1 infected patients experiencing VF on first-line ART. Methods: Twenty-nine ART-naive patients followed up in the ANRS-CO3 Aquitaine Cohort, having initiated ART between 2000 and 2009 and experiencing VF (2 plasma viral loads (VL) >500 copies/ml or one VL >1000 copies/ml) were included. Reverse transcriptase and protease DRMs were identified using Sanger sequencing (SS) and UDS at baseline (before ART initiation) and VF. Results: Additional low-frequency variants with PI-, NNRTI- and NRTI-DRMs were found by UDS at baseline and VF, significantly increasing the number of detected DRMs by 1.35 fold (p<0.0001) compared to SS. These low-frequency DRMs modified ARV susceptibility predictions to the prescribed treatment for 1 patient at baseline, in whom low-frequency DRM was found at high frequency at VF, and 6 patients at VF. DRMs found at VF were rarely detected as low-frequency DRMs prior to treatment. The rare low-frequency NNRTI- and NRTI-DRMs detected at baseline that correlated with the prescribed treatment were most often found at high-frequency at VF. Conclusion: Low frequency DRMs detected before ART initiation and at VF in patients experiencing VF on first-line ART can increase the overall burden of resistance to PI, NRTI and NNRTI.	[Vandenhende, Marie-Anne; Bellecave, Pantxika; Recordon-Pinson, Patricia; Reigadas, Sandrine; Fleury, Herve; Masquelier, Bernard] Univ Bordeaux, UMR 5234, Bordeaux, France; [Vandenhende, Marie-Anne; Bellecave, Pantxika; Recordon-Pinson, Patricia; Reigadas, Sandrine; Fleury, Herve; Masquelier, Bernard] CNRS, UMR 5234, Bordeaux, France; [Bellecave, Pantxika; Recordon-Pinson, Patricia; Reigadas, Sandrine; Fleury, Herve; Masquelier, Bernard] Ctr Hosp Univ Bordeaux, Lab Virol, Bordeaux, France; [Vandenhende, Marie-Anne; Bonnet, Fabrice; Morlat, Philippe] Ctr Hosp Univ Bordeaux, Hop St Andre, Serv Med Interne & Malad Infect, Bordeaux, France; [Bidet, Yannick] Ctr Jean Perrin, Plateforme GINA, EA ERTICa 4677, Clermont Ferrand, France; [Vandenhende, Marie-Anne; Bonnet, Fabrice; Dabis, Francois; Morlat, Philippe] Univ Bordeaux, ISPED, Ctr Inserm Epidemiol Biostat U897, Bordeaux, France; [Vandenhende, Marie-Anne; Bruyand, Mathias; Bonnet, Fabrice; Dabis, Francois; Morlat, Philippe] Ctr Hosp Univ Bordeaux, COREVIH Aquitaine, Bordeaux, France; [Bruyand, Mathias; Dabis, Francois] INSERM, ISPED, Ctr Inserm Epidemiol Biostat U897, Bordeaux, France; [Lazaro, Estibaliz] Ctr Hosp Univ Bordeaux, Hop Haut Leveque, Serv Med Interne & Malad Infect, Bordeaux, France; [Neau, Didier] Ctr Hosp Univ Bordeaux, Hop Pellegrin, Bordeaux, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite de Bordeaux; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite de Bordeaux; CHU Bordeaux; CHU Bordeaux; UNICANCER; Centre Jean Perrin; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; CHU Bordeaux; Institut National de la Sante et de la Recherche Medicale (Inserm); CHU Bordeaux; CHU Bordeaux	Bellecave, P (corresponding author), Univ Bordeaux, UMR 5234, Bordeaux, France.	pantxika_bellecave@yahoo.fr	Recordon-Pinson, Patricia/AAV-1295-2021; Vandenhende, Marie-Anne/T-6625-2019; Bidet, Yannick/O-5753-2019; Bonnet, Fabrice/T-3254-2019; Bruyand, Mathias/AAP-6177-2020; DABIS, FRANCOIS/S-9298-2019	Recordon-Pinson, Patricia/0000-0001-6002-0941; Bidet, Yannick/0000-0002-9624-8195; DABIS, FRANCOIS/0000-0002-1614-8857	European Community [223131]; Agence Nationale de Recherche sur le SIDA et les Hepatites; University Bordeaux Segalen - Centre national de la recherche scientifique UMR	European Community(European Commission); Agence Nationale de Recherche sur le SIDA et les Hepatites; University Bordeaux Segalen - Centre national de la recherche scientifique UMR	This work was supported by the European Community's Seventh Framework Programme (FP7/2007-2013) under the project Collaborative HIV and Anti-HIV Drug Resistance Network (CHAIN) (grant no. 223131), the Agence Nationale de Recherche sur le SIDA et les Hepatites and the University Bordeaux Segalen - Centre national de la recherche scientifique UMR 5234. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Codoner FM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019461; De Luca A, 2003, J INFECT DIS, V187, P1934, DOI 10.1086/375355; Gianella S, 2011, J VIROL, V85, P8359, DOI 10.1128/JVI.02582-10; Goodman DD, 2011, AIDS, V25, P325, DOI 10.1097/QAD.0b013e3283427dcb; Halvas EK, 2010, J INFECT DIS, V201, P672, DOI 10.1086/650542; Hogg RS, 2006, PLOS MED, V3, P1570, DOI 10.1371/journal.pmed.0030356; Jakobsen MR, 2010, CLIN INFECT DIS, V50, P566, DOI 10.1086/650001; Johnson JA, 2008, PLOS MED, V5, P1112, DOI 10.1371/journal.pmed.0050158; Johnson Victoria A, 2011, Top Antivir Med, V19, P156; Lataillade M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030118; Lataillade M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010952; Le T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006079; Li JZ, 2012, AIDS, V26, P185, DOI 10.1097/QAD.0b013e32834e9d7d; Li JZ, 2011, JAMA-J AM MED ASSOC, V305, P1327, DOI 10.1001/jama.2011.375; Lima VD, 2009, JAIDS-J ACQ IMM DEF, V50, P529, DOI 10.1097/QAI.0b013e31819675e9; Metzner KJ, 2011, J CLIN VIROL, V50, P156, DOI 10.1016/j.jcv.2010.10.001; Metzner KJ, 2009, CLIN INFECT DIS, V48, P239, DOI 10.1086/595703; Metzner KJ, 2005, AIDS, V19, P1819, DOI 10.1097/01.aids.0000189878.97480.ed; Mitsuya Y, 2008, J VIROL, V82, P10747, DOI 10.1128/JVI.01827-07; Palella FJ, 1998, NEW ENGL J MED, V338, P853, DOI 10.1056/NEJM199803263381301; Palmer S, 2005, J CLIN MICROBIOL, V43, P406, DOI 10.1128/JCM.43.1.406-413.2005; Paredes R, 2010, J INFECT DIS, V201, P662, DOI 10.1086/650543; Peuchant O, 2008, AIDS, V22, P1417, DOI 10.1097/QAD.0b013e3283034953; Simen BB, 2009, J INFECT DIS, V199, P693, DOI 10.1086/596736; Thiebaut R, 2000, AIDS, V14, P971, DOI 10.1097/00002030-200005260-00008; Thompson MA, 2012, JAMA-J AM MED ASSOC, V308, P387, DOI 10.1001/jama.2012.7961; Vandenbroucke I, 2011, BIOTECHNIQUES, V51, P167, DOI 10.2144/000113733; Vandenbroucke Ina, 2008, Open Virol J, V2, P8, DOI 10.2174/1874357900802010008; Varghese V, 2009, JAIDS-J ACQ IMM DEF, V52, P309, DOI 10.1097/QAI.0b013e3181bca669; Vercauteren J, 2009, J INFECT DIS, V200, P1503, DOI 10.1086/644505; Wang CL, 2007, GENOME RES, V17, P1195, DOI 10.1101/gr.6468307	31	35	37	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2014	9	1							e86771	10.1371/journal.pone.0086771	http://dx.doi.org/10.1371/journal.pone.0086771			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301BI	24475178	Green Submitted, gold, Green Published			2022-12-25	WOS:000330507300108
J	Bezzina, CN; Amiel, JJ; Shine, R				Bezzina, Chalene N.; Amiel, Joshua J.; Shine, Richard			Does Invasion Success Reflect Superior Cognitive Ability? A Case Study of Two Congeneric Lizard Species (Lampropholis, Scincidae)	PLOS ONE			English	Article							PHYLOGEOGRAPHIC DIVERGENCE; LONGITUDINAL DATA; BRAIN; BARRIERS; REVERSAL; BIRDS; SKINK	A species' intelligence may reliably predict its invasive potential. If this is true, then we might expect invasive species to be better at learning novel tasks than non-invasive congeners. To test this hypothesis, we exposed two sympatric species of Australian scincid lizards, Lampropholis delicata (invasive) and L. guichenoti (non-invasive) to standardized maze-learning tasks. Both species rapidly decreased the time they needed to find a food reward, but latencies were always higher for L. delicata than L. guichenoti. More detailed analysis showed that neither species actually learned the position of the food reward; they were as likely to turn the wrong way at the end of the study as at the beginning. Instead, their times decreased because they spent less time immobile in later trials; and L. guichenoti arrived at the reward sooner because they exhibited "freezing" (immobility) less than L. delicata. Hence, our data confirm that the species differ in their performance in this standardized test, but neither the decreasing time to find the reward, nor the interspecific disparity in those times, are reflective of cognitive abilities. Behavioural differences may well explain why one species is invasive and one is not, but those differences do not necessarily involve cognitive ability.	[Bezzina, Chalene N.; Amiel, Joshua J.; Shine, Richard] Univ Sydney, Sch Biol Sci A08, Sydney, NSW 2006, Australia	University of Sydney	Bezzina, CN (corresponding author), Univ Sydney, Sch Biol Sci A08, Sydney, NSW 2006, Australia.	cbez6563@uni.sydney.edu.au			Australian Research Council [FF0561365]; Natural Sciences and Engineering Research Council of Canada; University of Sydney	Australian Research Council(Australian Research Council); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); University of Sydney(University of Sydney)	For funding the authors thank the Australian Research Council (grant #FF0561365), the Natural Sciences and Engineering Research Council of Canada and the University of Sydney. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amiel JJ, 2013, ANIM COGN, DOI [10.1007/s10071-013-0665-4, DOI 10.1007/S10071-013-0665-4)]; Amiel JJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018277; Auersperg AMI, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020231; Ballinger GA, 2004, ORGAN RES METHODS, V7, P127, DOI 10.1177/1094428104263672; Blackburn TM, 2011, TRENDS ECOL EVOL, V26, P333, DOI 10.1016/j.tree.2011.03.023; Blomberg S, 2004, REPTILES; Chapple DG, 2011, ECOL EVOL, V1, P278, DOI 10.1002/ece3.22; Chapple DG, 2012, TRENDS ECOL EVOL, V27, P57, DOI 10.1016/j.tree.2011.09.010; Chapple DG, 2011, J BIOGEOGR, V38, P1761, DOI 10.1111/j.1365-2699.2011.02531.x; Chapple DG, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-191; COOPER WE, 1994, J CHEM ECOL, V20, P439, DOI 10.1007/BF02064449; Cromie GL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034732; Day LB, 1999, ANIM BEHAV, V57, P393, DOI 10.1006/anbe.1998.1007; Gill BJ, 2001, NEW ZEAL J ZOOL, V28, P351, DOI 10.1080/03014223.2001.9518274; GRAVES BM, 1993, J HERPETOL, V27, P33, DOI 10.2307/1564902; Kraus Fred, 2009, V4, P1; Leal M, 2012, BIOL LETTERS, V8, P28, DOI 10.1098/rsbl.2011.0480; Liu RL, 2003, P NATL ACAD SCI USA, V100, P8526, DOI 10.1073/pnas.1332809100; MACPHAIL EM, 1985, PHILOS T ROY SOC B, V308, P37, DOI 10.1098/rstb.1985.0008; Roof RL, 1999, PHYSIOL BEHAV, V68, P81, DOI 10.1016/S0031-9384(99)00162-6; Roth G, 2005, TRENDS COGN SCI, V9, P250, DOI 10.1016/j.tics.2005.03.005; Sih A, 2004, TRENDS ECOL EVOL, V19, P372, DOI 10.1016/j.tree.2004.04.009; Sol D, 2005, P NATL ACAD SCI USA, V102, P5460, DOI 10.1073/pnas.0408145102; Sol D, 2008, AM NAT, V172, pS63, DOI 10.1086/588304; Sol D, 2007, P ROY SOC B-BIOL SCI, V274, P763, DOI 10.1098/rspb.2006.3765; TORR GA, 1993, COPEIA, P850; ZEGER SL, 1988, BIOMETRICS, V44, P1049, DOI 10.2307/2531734	27	20	20	1	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2014	9	1							e86271	10.1371/journal.pone.0086271	http://dx.doi.org/10.1371/journal.pone.0086271			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	298QQ	24475097	Green Published, gold, Green Submitted			2022-12-25	WOS:000330339800037
J	Li, HJ; Leung, KS; Ballester, PJ; Wong, MH				Li, Hongjian; Leung, Kwong-Sak; Ballester, Pedro J.; Wong, Man-Hon			istar: A Web Platform for Large-Scale Protein-Ligand Docking	PLOS ONE			English	Article							EMPIRICAL SCORING FUNCTIONS; BINDING-AFFINITY; PDBBIND DATABASE; AUTODOCK VINA; VALIDATION; DISCOVERY; OPTIMIZATION; CHEMISTRY; DESIGN; ZINC	Protein-ligand docking is a key computational method in the design of starting points for the drug discovery process. We are motivated by the desire to automate large-scale docking using our popular docking engine idock and thus have developed a publicly-accessible web platform called istar. Without tedious software installation, users can submit jobs using our website. Our istar website supports 1) filtering ligands by desired molecular properties and previewing the number of ligands to dock, 2) monitoring job progress in real time, and 3) visualizing ligand conformations and outputting free energy and ligand efficiency predicted by idock, binding affinity predicted by RF-Score, putative hydrogen bonds, and supplier information for easy purchase, three useful features commonly lacked on other online docking platforms like DOCK Blaster or iScreen. We have collected 17,224,424 ligands from the All Clean subset of the ZINC database, and revamped our docking engine idock to version 2.0, further improving docking speed and accuracy, and integrating RF-Score as an alternative rescoring function. To compare idock 2.0 with the state-of-the-art AutoDock Vina 1.1.2, we have carried out a rescoring benchmark and a redocking benchmark on the 2,897 and 343 protein-ligand complexes of PDBbind v2012 refined set and CSAR NRC HiQ Set 24Sept2010 respectively, and an execution time benchmark on 12 diverse proteins and 3,000 ligands of different molecular weight. Results show that, under various scenarios, idock achieves comparable success rates while outperforming AutoDock Vina in terms of docking speed by at least 8.69 times and at most 37.51 times. When evaluated on the PDBbind v2012 core set, our istar platform combining with RF-Score manages to reproduce Pearson's correlation coefficient and Spearman's correlation coefficient of as high as 0.855 and 0.859 respectively between the experimental binding affinity and the predicted binding affinity of the docked conformation. istar is freely available at http://istar.cse.cuhk.edu.hk/idock.	[Li, Hongjian; Leung, Kwong-Sak; Wong, Man-Hon] Chinese Univ Hong Kong, Dept Comp Sci & Engn, Shatin, Hong Kong, Peoples R China; [Ballester, Pedro J.] European Bioinformat Inst, Cambridge, England	Chinese University of Hong Kong; European Molecular Biology Laboratory (EMBL)	Li, HJ (corresponding author), Chinese Univ Hong Kong, Dept Comp Sci & Engn, Shatin, Hong Kong, Peoples R China.	JackyLeeHongJian@Gmail.com; pedro.ballester@ebi.ac.uk	Wong, Man Hon/GOH-0560-2022; Ballester, Pedro/A-1148-2008	Ballester, Pedro/0000-0002-4078-743X				Abreu RMV, 2012, CHEM BIOL DRUG DES, V79, P530, DOI 10.1111/j.1747-0285.2011.01313.x; Abreu RMV, 2010, J CHEMINFORMATICS, V2, DOI 10.1186/1758-2946-2-10; Baba N, 2011, BIOINFORMATION, V6, P387, DOI 10.6026/97320630006387; Ballester PJ, 2012, LECT NOTES COMPUT SC, V7632, P14, DOI 10.1007/978-3-642-34123-6_2; Ballester PJ, 2012, J R SOC INTERFACE, V9, P3196, DOI 10.1098/rsif.2012.0569; Ballester PJ, 2011, J CHEM INF MODEL, V51, P1739, DOI 10.1021/ci200057e; Ballester PJ, 2010, BIOINFORMATICS, V26, P1169, DOI 10.1093/bioinformatics/btq112; Benson ML, 2008, NUCLEIC ACIDS RES, V36, pD674, DOI 10.1093/nar/gkm911; Berman H, 2003, NAT STRUCT BIOL, V10, P980, DOI 10.1038/nsb1203-980; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Breiman L., 2017, CLASSIFICATION REGRE; Chang MW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011955; Chen CYC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015939; Cheng TJ, 2009, J CHEM INF MODEL, V49, P1079, DOI 10.1021/ci9000053; Coleman RG, 2010, J CHEM INF MODEL, V50, P589, DOI 10.1021/ci900397t; Corbeil CR, 2007, J CHEM INF MODEL, V47, P435, DOI 10.1021/ci6002637; DeLano W.L., 2002, PYMOL MOL GRAPHICS S, DOI DOI 10.1007/S10822-016-9944-X; Douguet D, 2005, J MED CHEM, V48, P2457, DOI 10.1021/jm0492296; Dunbar JB, 2011, J CHEM INF MODEL, V51, P2146, DOI 10.1021/ci200363q; Dunbar JB, 2011, J CHEM INF MODEL, V51, P2036, DOI 10.1021/ci200082t; Hongjian Li, 2012, 2012 IEEE Symposium on Computational Intelligence in Bioinformatics and Computational Biology (CIBCB), P77, DOI 10.1109/CIBCB.2012.6217214; Hu LG, 2005, PROTEINS, V60, P333, DOI 10.1002/prot.20512; Irwin JJ, 2005, J CHEM INF MODEL, V45, P177, DOI 10.1021/ci049714+; Irwin JJ, 2012, J CHEM INF MODEL, V52, P1757, DOI 10.1021/ci3001277; Irwin JJ, 2009, J MED CHEM, V52, P5712, DOI 10.1021/jm9006966; Kalyaanamoorthy S, 2011, DRUG DISCOV TODAY, V16, P831, DOI 10.1016/j.drudis.2011.07.006; Khodade P, 2007, J APPL CRYSTALLOGR, V40, P598, DOI 10.1107/S0021889807011053; Korb O, 2011, J CHEM INF MODEL, V51, P865, DOI 10.1021/ci100459b; Korb O, 2009, J CHEM INF MODEL, V49, P84, DOI 10.1021/ci800298z; Lang PT, 2009, RNA, V15, P1219, DOI 10.1261/rna.1563609; Li GB, 2013, J CHEM INF MODEL, V53, P592, DOI 10.1021/ci300493w; Moitessier N, 2008, BRIT J PHARMACOL, V153, pS7, DOI 10.1038/sj.bjp.0707515; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; Morris GM, 1998, J COMPUT CHEM, V19, P1639, DOI 10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B; Nocedal J, 2006, SPRINGER SER OPER RE, P1, DOI 10.1007/978-0-387-40065-5; Norgan AP, 2011, J CHEMINFORMATICS, V3, DOI 10.1186/1758-2946-3-12; Prakhov ND, 2010, BIOINFORMATICS, V26, P1374, DOI 10.1093/bioinformatics/btq149; Sandeep Gaddam, 2011, BMC Res Notes, V4, P445, DOI 10.1186/1756-0500-4-445; Schames JR, 2004, J MED CHEM, V47, P1879, DOI 10.1021/jm0341913; Seeliger D, 2010, J COMPUT AID MOL DES, V24, P417, DOI 10.1007/s10822-010-9352-6; Therrien E, 2012, J CHEM INF MODEL, V52, P210, DOI 10.1021/ci2004779; Truhlar DG, 2007, J COMPUT CHEM, V28, P73, DOI 10.1002/jcc.20529; Tsai TY, 2011, J COMPUT AID MOL DES, V25, P525, DOI 10.1007/s10822-011-9438-9; Wang RX, 2005, J MED CHEM, V48, P4111, DOI 10.1021/jm048957q; Wang RX, 2004, J MED CHEM, V47, P2977, DOI 10.1021/jm030580l; Wang RX, 2002, J COMPUT AID MOL DES, V16, P11, DOI 10.1023/A:1016357811882	48	75	78	1	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2014	9	1							e85678	10.1371/journal.pone.0085678	http://dx.doi.org/10.1371/journal.pone.0085678			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	298QQ	24475049	Green Published, Green Submitted, gold			2022-12-25	WOS:000330339800015
J	Su, HL; Liu, Y; Xu, ZH; Cheng, SQ; Ye, HY; Xu, Q; Liu, QB; Tan, SH; Xu, DP; Liu, YM				Su, Heling; Liu, Yan; Xu, Zhihui; Cheng, Shuquan; Ye, Haiyan; Xu, Qing; Liu, Qingbo; Tan, Shuhong; Xu, Dongping; Liu, Yongming			A Novel Complex A/C/G Intergenotypic Recombinant of Hepatitis B Virus Isolated in Southern China	PLOS ONE			English	Article							GENOTYPE-E STRAINS; VIROLOGICAL CHARACTERISTICS; HEPATOCELLULAR-CARCINOMA; GENOME; SUBGENOTYPES; IDENTIFICATION; REPLICATION; REGION	Hepatitis B virus (HBV) genotypes and subgenotypes may vary in geographical distribution and virological features. Previous investigations, including ours, showed that HBV genotypes B and C were respectively predominant in South and North China, while genotypes A and D were infrequently detected and genotype G was not found. In this study, a novel A/C/G intergenotype was identified in patients with chronic HBV infection in Guilin, a city in southern China. Initial phylogenetic analysis based on the S gene suggested the HBV recombinant to be genotype G. However, extended genotyping based on the entire HBV genome indicated it to be an A/C/G intergenotype with a closer relation to genotype C. Breakpoint analysis using the SIMPLOT program revealed that the recombinant had a recombination with a arrangement of genotypes A, G, A and C fragments. Compared with the HBV recombinants harboring one or two genotype G fragments found in Asian countries, this Guilin recombinant was highly similar to the Vietnam (98-99%) and Long An recombinants (96-99%), but had a relatively low similarity to the Thailand one (89%). Unlike those with the typical genotype G of HBV, the patients with the Guilin recombinant were seropositive for HBeAg. Moreover, a relatively high HBV DNA viral load (>2x10(6) IU/ml) was detected in the patients, and the analysis of viral replication capacity showed that the Guilin recombinant strains had a competent replication capacity similar to genotypes B and C strains. These findings can aid in not only the clarification of the phylogenetic origin of the HBV recombinants with the genotype G fragment found in Asian countries, but also the understanding of the virological properties of these complicated HBV recombinants.	[Su, Heling; Liu, Qingbo; Tan, Shuhong; Liu, Yongming] Guilin Med Univ, Dept Biochem & Mol Biol, Guilin, Guangxi, Peoples R China; [Liu, Yan; Xu, Zhihui; Xu, Dongping] Beijing 302 Hosp, Viral Hepatitis Res Lab, Inst Infect Dis, Liver Failure Med Ctr, Beijing, Peoples R China; [Cheng, Shuquan; Ye, Haiyan] Third Peoples Hosp Guilin, Div Hepatol, Guilin, Guangxi, Peoples R China; [Xu, Qing] Guilin Med Univ, Guangxi Key Lab Mol Med Liver Injury & Repair, Guilin, Guangxi, Peoples R China	Guilin Medical University; Fifth Medical Center of Chinese PLA General Hospital; Guilin Medical University	Xu, DP (corresponding author), Beijing 302 Hosp, Viral Hepatitis Res Lab, Inst Infect Dis, Liver Failure Med Ctr, Beijing, Peoples R China.	xudongping@yahoo.com; liuym@glmc.edu.cn	SU, Heling/ABF-4467-2021		National Nature Science Foundation of China [81271847]; Nature Science Foundation of Guangxi Zhuang Autonomous Region of China [2012GXNSFAA053146]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Nature Science Foundation of Guangxi Zhuang Autonomous Region of China	This work is supported by the grants from the National Nature Science Foundation of China (No. 81271847) (http://www.nsfc.gov.cn/Portal0/default152.htm) and the Nature Science Foundation of Guangxi Zhuang Autonomous Region of China (No. 2012GXNSFAA053146) (http://www.gxst.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Araujo NM, 2013, J GEN VIROL, V94, P150, DOI 10.1099/vir.0.047324-0; Bowyer SM, 2000, J GEN VIROL, V81, P379, DOI 10.1099/0022-1317-81-2-379; Cui CY, 2002, J GEN VIROL, V83, P2773, DOI 10.1099/0022-1317-83-11-2773; Mello FCD, 2012, MEM I OSWALDO CRUZ, V107, P317, DOI 10.1590/S0074-02762012000300005; Fang ZL, 2011, J GEN VIROL, V92, P402, DOI 10.1099/vir.0.026666-0; Garmiri P, 2009, J GEN VIROL, V90, P2442, DOI 10.1099/vir.0.012013-0; Ghosh S, 2013, J VIRAL HEPATITIS, V20, P209, DOI 10.1111/j.1365-2893.2012.01655.x; GUNTHER S, 1995, J VIROL, V69, P5437; Hubschen JM, 2008, J CLIN VIROL, V43, P376, DOI 10.1016/j.jcv.2008.08.018; Huy TTT, 2008, J VIROL, V82, P5657, DOI 10.1128/JVI.02556-07; Ji D, 2011, CLIN CHIM ACTA, V412, P305, DOI 10.1016/j.cca.2010.10.028; Kato H, 2002, J VIROL, V76, P6131, DOI 10.1128/JVI.76.12.6131-6137.2002; Kramvis A, 2005, J MED VIROL, V77, P47, DOI 10.1002/jmv.20412; Kurbanov F, 2008, J VIROL, V82, P8241, DOI 10.1128/JVI.00793-08; Li K, 2007, J VIROL, V81, P9202, DOI 10.1128/JVI.00390-07; Li XD, 2011, CHINESE MED J-PEKING, V124, P4178, DOI 10.3760/cma.j.issn.0366-6999.2011.24.011; Lole KS, 1999, J VIROL, V73, P152, DOI 10.1128/JVI.73.1.152-160.1999; Lusida MI, 2008, J CLIN MICROBIOL, V46, P2160, DOI 10.1128/JCM.01681-07; Morozov V, 2000, GENE, V260, P55, DOI 10.1016/S0378-1119(00)00424-8; Mulyanto, 2012, VIRUS RES, V163, P129, DOI 10.1016/j.virusres.2011.09.002; Norder H, 2004, INTERVIROLOGY, V47, P289, DOI 10.1159/000080872; Owiredu WKBA, 2001, J MED VIROL, V64, P441, DOI 10.1002/jmv.1070; Pourkarim MR, 2011, CLIN MICROBIOL INFEC, V17, P947, DOI 10.1111/j.1469-0691.2010.03374.x; Sanchez LV, 2007, INTERVIROLOGY, V50, P9, DOI 10.1159/000096307; Shi WF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047271; Simmonds P, 2005, J VIROL, V79, P15467, DOI 10.1128/JVI.79.24.15467-15476.2005; Su He-ling, 2009, Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi, V23, P340; Sugauchi F, 2003, GASTROENTEROLOGY, V124, P925, DOI 10.1053/gast.2003.50140; Sugauchi F, 2002, J VIROL, V76, P5985, DOI 10.1128/JVI.76.12.5985-5992.2002; Suwannakarn K, 2005, J GEN VIROL, V86, P3027, DOI 10.1099/vir.0.81241-0; Wang ZH, 2005, J GEN VIROL, V86, P985, DOI 10.1099/vir.0.80771-0; Wang ZH, 2007, J CLIN MICROBIOL, V45, P1491, DOI 10.1128/JCM.02157-06; World Health Organization, 2013, HEP B FACT SHEET; Yang JH, 2013, WORLD J GASTROENTERO, V19, P3861, DOI 10.3748/wjg.v19.i24.3861; Yang J, 2006, J GEN VIROL, V87, P2203, DOI 10.1099/vir.0.81752-0; Yin JH, 2010, CANCER EPIDEM BIOMAR, V19, P777, DOI 10.1158/1055-9965.EPI-09-1001; Yuasa R, 2000, J MED VIROL, V61, P23, DOI 10.1002/(SICI)1096-9071(200005)61:1&lt;23::AID-JMV4&gt;3.0.CO;2-X; Zeng G, 2005, J VIRAL HEPATITIS, V12, P609, DOI 10.1111/j.1365-2893.2005.00657.x	38	11	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2014	9	1							e84005	10.1371/journal.pone.0084005	http://dx.doi.org/10.1371/journal.pone.0084005			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	298QQ	24475029	Green Published, Green Submitted, gold			2022-12-25	WOS:000330339800005
J	Timoneda, O; Nunez-Hernandez, F; Balcells, I; Munoz, M; Castello, A; Vera, G; Perez, LJ; Egea, R; Mir, G; Cordoba, S; Rosell, R; Segales, J; Tomas, A; Sanchez, A; Nunez, JI				Timoneda, Oriol; Nunez-Hernandez, Fernando; Balcells, Ingrid; Munoz, Marta; Castello, Anna; Vera, Gonzalo; Perez, Lester J.; Egea, Raquel; Mir, Gisela; Cordoba, Sarai; Rosell, Rosa; Segales, Joaquim; Tomas, Anna; Sanchez, Armand; Nunez, Jose I.			The Role of Viral and Host MicroRNAs in the Aujeszky's Disease Virus during the Infection Process	PLOS ONE			English	Article							QUANTITATIVE RT-PCR; PSEUDORABIES VIRUS; KYOTO ENCYCLOPEDIA; NONCODING RNAS; WEB SERVER; TARGETS; IDENTIFICATION; EXPRESSION; GENES; BIOGENESIS	Porcine production is a primary market in the world economy. Controlling swine diseases in the farm is essential in order to achieve the sector necessities. Aujeszky's disease is a viral condition affecting pigs and is endemic in many countries of the world, causing important economic losses in the swine industry. microRNAs (miRNAs) are non-coding RNAs which modulates gene expression in animals, plants and viruses. With the aim of understanding miRNA roles during the Aujeszky's disease virus [ADV] (also known as suid herpesvirus type 1 [SuHV-1]) infection, the expression profiles of host and viral miRNAs were determined through deep sequencing in SuHV-1 infected porcine cell line (PK-15) and in an animal experimental SuHV-1 infection with virulent (NIA-3) and attenuated (Begonia) strains. In the in vivo approach miR-206, miR-133a, miR-133b and miR-378 presented differential expression between virus strains infection. In the in vitro approach, most miRNAs were down-regulated in infected groups. miR-92a and miR-92b-3p were up-regulated in Begonia infected samples. Functional analysis of all this over expressed miRNAs during the infection revealed their association in pathways related to viral infection processes and immune response. Furthermore, 8 viral miRNAs were detected by stem loop RT-qPCR in both in vitro and in vivo approaches, presenting a gene regulatory network affecting 59 viral genes. Most described viral miRNAs were related to Large Latency Transcript (LLT) and to viral transcription activators EP0 and IE180, and also to regulatory genes regarding their important roles in the host - pathogen interaction during viral infection.	[Timoneda, Oriol; Balcells, Ingrid; Castello, Anna; Egea, Raquel; Sanchez, Armand] Univ Autonoma Barcelona, Dept Ciencia Anim & Dels Aliments, E-08193 Barcelona, Spain; [Timoneda, Oriol; Balcells, Ingrid; Castello, Anna; Vera, Gonzalo; Cordoba, Sarai; Sanchez, Armand] Univ Autonoma Barcelona, Dept Genet Anim, CRAG, CSIC IRTA UAB UB, E-08193 Barcelona, Spain; [Nunez-Hernandez, Fernando; Munoz, Marta; Rosell, Rosa; Segales, Joaquim; Nunez, Jose I.] UAB IRTA, CReSA, Bellaterra, Cerdanyola Del, Spain; [Perez, Lester J.] Ctr Nacl Sanidad Agr CENSA, Havana, Cuba; [Mir, Gisela] Univ Autonoma Barcelona, CRAG Sci Serv, CRAG, CSIC IRTA UAB UB, E-08193 Barcelona, Spain; [Rosell, Rosa] Dept Agr Ramaderia Pesca Alimentacio & Medi Nat G, Barcelona, Spain; [Segales, Joaquim] Univ Autonoma Barcelona, Dept Sanitat & Anat Anim, E-08193 Barcelona, Spain; [Tomas, Anna] FISIB, Program Infect & Immun, Bunyola, Spain	Autonomous University of Barcelona; Autonomous University of Barcelona; Consejo Superior de Investigaciones Cientificas (CSIC); Centre de Recerca en Agrigenomica (CRAG); IRTA; University of Barcelona; IRTA; Autonomous University of Barcelona; Consejo Superior de Investigaciones Cientificas (CSIC); Centre de Recerca en Agrigenomica (CRAG); IRTA; University of Barcelona; Autonomous University of Barcelona	Timoneda, O (corresponding author), Univ Autonoma Barcelona, Dept Ciencia Anim & Dels Aliments, E-08193 Barcelona, Spain.	oriol.timoneda@cragenomica.es	Egea, Raquel/F-9355-2016; Sanchez, Armand/L-7905-2015; Perez, Lester J./A-1339-2016; Segalés, Joaquim/A-4933-2011; Segalés, Joaquim/AAB-4815-2020; Farré, Anna Castelló/K-9637-2015; Vera, Gonzalo/L-1895-2014; Nuñez, Jose I/M-7141-2018	Egea, Raquel/0000-0002-6201-4112; Sanchez, Armand/0000-0001-9160-1124; Perez, Lester J./0000-0002-5717-5181; Segalés, Joaquim/0000-0002-1539-7261; Segalés, Joaquim/0000-0002-1539-7261; Farré, Anna Castelló/0000-0001-8497-6251; Vera, Gonzalo/0000-0001-6990-0216; Nuñez, Jose I/0000-0001-9890-7695; Cordoba, Sarai/0000-0002-8786-9889; Mir Arnau, Gisela/0000-0002-9005-3485; Rosell, Rosa/0000-0002-8294-1159	Ministerio de Ciencia e Innovacion [AGL2007-66371-C02, AGL2010-22358-C02, CDS2006-00007]; Spanish government	Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Spanish government(Spanish GovernmentEuropean Commission)	This work was supported by the projects AGL2007-66371-C02, AGL2010-22358-C02 and CDS2006-00007 from Ministerio de Ciencia e Innovacion. OT is the recipient of a PhD fellowship (Programa de Formacion al Personal Investigador - FPI) from the Spanish government. The funders had no role in the sutdy design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akkina S, 2011, TRANSL RES, V157, P236, DOI 10.1016/j.trsl.2011.01.011; Ambros V, 2003, RNA, V9, P277, DOI 10.1261/rna.2183803; Ambros V, 2008, NAT MED, V14, P1036, DOI 10.1038/nm1008-1036; Amills M, 2010, ORIGIN GENETIC DIVER; Anselmo A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017374; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Balcells I, 2011, BMC BIOTECHNOL, V11, DOI 10.1186/1472-6750-11-70; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Besecker MI, 2009, J VIROL, V83, P3413, DOI 10.1128/JVI.02419-08; Bortoluzzi S, 2011, TRENDS MOL MED, V17, P473, DOI 10.1016/j.molmed.2011.05.005; Boss IW, 2009, TRENDS MICROBIOL, V17, P544, DOI 10.1016/j.tim.2009.09.002; Burnside J, 2006, J VIROL, V80, P8778, DOI 10.1128/JVI.00831-06; Cullen BR, 2013, NAT IMMUNOL, V14, P205, DOI 10.1038/ni.2537; Cullen BR, 2009, NATURE, V457, P421, DOI 10.1038/nature07757; Enright AJ, 2004, GENOME BIOL, V5; Esteller M, 2011, NAT REV GENET, V12, P861, DOI 10.1038/nrg3074; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112; Grundhoff A, 2006, RNA, V12, P733, DOI 10.1261/rna.2326106; Grundhoff A, 2011, VIROLOGY, V411, P325, DOI 10.1016/j.virol.2011.01.002; Guo HL, 2010, NATURE, V466, P835, DOI 10.1038/nature09267; Hata A, 2013, ANNU REV PHYSIOL, V75, P69, DOI 10.1146/annurev-physiol-030212-183737; Huntzinger E, 2011, NAT REV GENET, V12, P99, DOI 10.1038/nrg2936; Jurak I, 2011, BBA-GENE REGUL MECH, V1809, P641, DOI 10.1016/j.bbagrm.2011.06.010; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kanis E, 2005, J ANIM SCI, V83, P948; Kim J, 2007, SCIENCE, V317, P1220, DOI 10.1126/science.1140481; Kincaid RP, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003018; Klupp BG, 2004, J VIROL, V78, P424, DOI 10.1128/JVI.78.1.424-440.2004; Kozomara A, 2011, NUCLEIC ACIDS RES, V39, pD152, DOI 10.1093/nar/gkq1027; Krol J, 2010, NAT REV GENET, V11, P597, DOI 10.1038/nrg2843; Ma LM, 2013, J GENET GENOMICS, V40, P143, DOI 10.1016/j.jgg.2013.03.002; Maragkakis M, 2009, NUCLEIC ACIDS RES, V37, pW273, DOI 10.1093/nar/gkp292; Maragkakis M, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-295; Nielsen M, 2010, ANIM GENET, V41, P159, DOI 10.1111/j.1365-2052.2009.01981.x; Ouellet DL, 2008, NUCLEIC ACIDS RES, V36, P2353, DOI 10.1093/nar/gkn076; Pejsak ZK, 2006, DIS SWINE, P419; Peltier HJ, 2008, RNA, V14, P844, DOI 10.1261/rna.939908; Pfeffer S, 2004, SCIENCE, V304, P734, DOI 10.1126/science.1096781; Pomeranz LE, 2005, MICROBIOL MOL BIOL R, V69, P462, DOI 10.1128/MMBR.69.3.462-500.2005; Rederstorff M, 2010, CURR OPIN MOL THER, V12, P684; Ruvkun G, 2008, NAT MED, V14, P1041, DOI 10.1038/nm1008-1041; Sayed D, 2011, PHYSIOL REV, V91, P827, DOI 10.1152/physrev.00006.2010; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Shi WY, 2009, NAT STRUCT MOL BIOL, V16, P183, DOI 10.1038/nsmb.1536; Skalsky RL, 2010, ANNU REV MICROBIOL, V64, P123, DOI 10.1146/annurev.micro.112408.134243; Skovgaard K, 2013, INNATE IMMUN-LONDON, V19, P531, DOI 10.1177/1753425912473668; Smoot ME, 2011, BIOINFORMATICS, V27, P431, DOI 10.1093/bioinformatics/btq675; Sullivan CS, 2005, NATURE, V435, P682, DOI 10.1038/nature03576; tenOever BR, 2013, NAT REV MICROBIOL, V11, P169, DOI 10.1038/nrmicro2971; Timoneda O, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055402; Timoneda O, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044413; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wang Y, 2008, CLIN GENET, V74, P307, DOI 10.1111/j.1399-0004.2008.01075.x; Wu YQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030988; Zhang B, 2005, NUCLEIC ACIDS RES, V33, pW741, DOI 10.1093/nar/gki475; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	59	18	20	0	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2014	9	1							e86965	10.1371/journal.pone.0086965	http://dx.doi.org/10.1371/journal.pone.0086965			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	298QQ	24475202	Green Published, Green Submitted, gold			2022-12-25	WOS:000330339800072
J	Wu, B; Qi, X; Xu, K; Ji, H; Zhu, YF; Tang, FY; Zhou, MH				Wu, Bin; Qi, Xian; Xu, Ke; Ji, Hong; Zhu, Yefei; Tang, Fenyang; Zhou, Minghao			Genetic Characteristics of the Coxsackievirus A24 Variant Causing Outbreaks of Acute Hemorrhagic Conjunctivitis in Jiangsu, China, 2010	PLOS ONE			English	Article							MOLECULAR CHARACTERIZATION; IDENTIFICATION; GUANGDONG; EPIDEMIC; TAIWAN	During September 2010, an outbreak of acute hemorrhagic conjunctivitis reemerged in Jiangsu, three years after the nationwide epidemic in China in 2007. In total, 2409 cases were reported, 2118 of which were reported in September; 79.8% of those affected were students or teachers, with a median age of 16 years. To identify and demonstrate the genetic characteristics of the etiological agent, 52 conjunctival swabs were randomly collected from four different cities. After detection and isolation, 43 patients were positive for coxsackievirus A24 variant according to PCR and 20 according to culture isolation. Neither adenovirus nor EV70 was detected. A phylogenetic study of the complete 3Cpro and VP1 regions showed that the Jiangsu isolates clustered into a new lineage, GIV-C5, with two uniform amino-acid mutations that distinguished them from all previous strains. Another new cluster, GIV-C4, formed by Indian isolates from 2007 and Brazilian isolates from 2009, was also identified in this study. Interestingly, our isolates shared greatest homology with the GIV-C4 strains, not with the isolates that were responsible for the nationwide acute hemorrhagic conjunctivitis epidemic in China in 2007. Although all our isolates were closely related, they could be differentiated into two subclusters within GIV-C5. In conclusion, our study suggests that a new cluster of coxsackievirus A24 variant that had already evolved into diverse strains was associated with the acute hemorrhagic conjunctivitis outbreaks in Jiangsu in September 2010. These viruses might have originated from the virus isolated in India in 2007, rather than from the epidemic strains isolated in China in 2007.	[Wu, Bin; Qi, Xian; Xu, Ke; Ji, Hong; Zhu, Yefei; Tang, Fenyang; Zhou, Minghao] Jiangsu Prov Ctr Dis Control & Prevent, Dept Acute Infect Dis Control & Prevent, Nanjing, Jiangsu, Peoples R China	Jiangsu Provincial Center for Disease Control & Prevention	Zhu, YF (corresponding author), Jiangsu Prov Ctr Dis Control & Prevent, Dept Acute Infect Dis Control & Prevent, Nanjing, Jiangsu, Peoples R China.	jszyf@jscdc.cn	zhou, minghao/GZA-7244-2022		Jiangsu Province Health Development Project with Science and Education [ZX201109, RC2011084, RC2011085]	Jiangsu Province Health Development Project with Science and Education	The study was supported by Jiangsu Province Health Development Project with Science and Education (ZX201109, RC2011084 and RC2011085). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ayoub EA, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-96; BABALOLA OE, 1990, BRIT J OPHTHALMOL, V74, P89, DOI 10.1136/bjo.74.2.89; Centers for Disease Control and Prevention (CDC), 2010, MMWR Morb Mortal Wkly Rep, V59, P1024; Chang CH, 2001, CORNEA, V20, P295, DOI 10.1097/00003226-200104000-00011; Chu PY, 2009, J CLIN VIROL, V45, P285, DOI 10.1016/j.jcv.2009.04.013; De W, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-41; Fonseca MC, 2012, J CLIN VIROL, V53, P77, DOI 10.1016/j.jcv.2011.10.006; ISHIKO H, 1992, VIROLOGY, V187, P748, DOI 10.1016/0042-6822(92)90477-7; MIRKOVIC RR, 1974, INTERVIROLOGY, V4, P119, DOI 10.1159/000149850; Mitchell S, 2003, J CLIN VIROL, V26, P331, DOI 10.1016/S1386-6532(02)00082-3; Mu G F, 1989, Zhonghua Yan Ke Za Zhi, V25, P20; Oh MD, 2003, EMERG INFECT DIS, V9, P1010; Shukla D, 2013, ARCH VIROL, V158, P679, DOI 10.1007/s00705-012-1520-7; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tavares FN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023206; Tavares FN, 2006, EMERG INFECT DIS, V12, P495, DOI 10.3201/eid1203.051173; Triki H, 2007, CLIN MICROBIOL INFEC, V13, P176, DOI 10.1111/j.1469-0691.2006.01618.x; Wu D, 2008, J MED VIROL, V80, P1762, DOI 10.1002/jmv.21288; Yan DM, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-138; Yan Ju-ying, 2011, Chinese Journal of Virology, V27, P421; Yang Jing, 2012, Chinese Journal of Virology, V28, P663	21	16	17	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2014	9	1							e86883	10.1371/journal.pone.0086883	http://dx.doi.org/10.1371/journal.pone.0086883			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	298QQ	24475191	gold, Green Published, Green Submitted			2022-12-25	WOS:000330339800068
J	Lee, WC; Wu, HC; Huang, KH; Wu, HP; Yu, HJ; Wu, CC				Lee, Wei-Chia; Wu, Han-Ching; Huang, Kuo-How; Wu, Huey-Peir; Yu, Hong-Jeng; Wu, Chia-Ching			Hyposensitivity of C-fiber Afferents at the Distal Extremities as an Indicator of Early Stages Diabetic Bladder Dysfunction in Type 2 Diabetic Women	PLOS ONE			English	Article							CURRENT PERCEPTION THRESHOLD; OVERACTIVE BLADDER; RISK-FACTORS; NEUROPATHY	Purpose: To investigate the relationship between distal symmetric peripheral neuropathy and early stages of autonomic bladder dysfunction in type 2 diabetic women. Materials and Methods: A total of 137 diabetic women with minimal coexisting confounders of voiding dysfunction followed at a diabetes clinic were subject to the following evaluations: current perception threshold (CPT) tests on myelinated and unmyelinated nerves at the big toe for peroneal nerve and middle finger for median nerve, uroflowmetry, post-void residual urine volume, and overactive bladder (OAB) symptom score questionnaire. Patients presenting with voiding difficulty also underwent urodynamic studies and intravesical CPT tests. Results: Based on the OAB symptom score and urodynamic studies, 19% of diabetic women had the OAB syndrome while 24.8% had unrecognized urodynamic bladder dysfunction (UBD). The OAB group had a significantly greater mean 5 Hz CPT test value at the big toe by comparison to those without OAB. When compared to diabetic women without UBD, those with UBD showed greater mean 5 Hz CPT test values at the middle finger and big toe. The diabetic women categorized as C-fiber hyposensitivity at the middle finger or big toe by using CPT test also had higher odds ratios of UBD. Among diabetic women with UBD, the 5 Hz CPT test values at the big toe and middle finger were significantly associated with intravesical 5 Hz CPT test values. Conclusions: Using electrophysiological evidence, our study revealed that hyposensitivity of unmyelinated C fiber afferents at the distal extremities is an indicator of early stages diabetic bladder dysfunction in type 2 diabetic women. The C fiber dysfunction at the distal extremities seems concurrent with vesical C-fiber neuropathy and may be a sentinel for developing early diabetic bladder dysfunction among female patients.	[Lee, Wei-Chia] Kaohsiung Chang Gung Mem Hosp, Div Urol, Kaohsiung, Taiwan; [Lee, Wei-Chia] Chang Gung Univ, Coll Med, Kaohsiung, Taiwan; [Wu, Han-Ching] Buddhist Tzu Chi Med Fdn, Dalin Tzu Chi Hosp, Dept Urol, Chiayi, Taiwan; [Huang, Kuo-How; Yu, Hong-Jeng] Natl Taiwan Univ, Natl Taiwan Univ Hosp, Coll Med, Dept Urol, Taipei 10764, Taiwan; [Wu, Huey-Peir] Natl Taiwan Univ, Coll Med, Dept Internal Med, Natl Taiwan Univ Hosp, Taipei, Taiwan; [Lee, Wei-Chia] Natl Taiwan Univ, Coll Med, Grad Inst Clin Med, Taipei 10764, Taiwan; [Wu, Chia-Ching] Cheng Shiu Univ, Coll Commerce & Management, Dept Int Business, Kaohsiung, Taiwan	Chang Gung Memorial Hospital; Chang Gung University; Buddhist Tzu Chi General Hospital; Dalin Tzu Chi Hospital; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital; National Taiwan University; Cheng Shiu University	Yu, HJ (corresponding author), Natl Taiwan Univ, Natl Taiwan Univ Hosp, Coll Med, Dept Urol, Taipei 10764, Taiwan.	yhj5251@ntu.edu.tw		YU, HONG-JENG/0000-0003-3287-5736; Lee, Wei-Chia/0000-0003-0701-2285; Huang, Kuo-How/0000-0002-0989-0578				Abrams P, 1999, BJU INT, V84, P14; AMERICAN DA, 2013, DIABETES CARE S1, V36, pS11, DOI DOI 10.2337/DC13-S011; Bansal R, 2011, UROLOGY, V77, P699, DOI 10.1016/j.urology.2010.04.062; Cheng WY, 1999, J NEUROL, V246, P394, DOI 10.1007/s004150050370; Chiu AF, 2012, INT J UROL, V19, P995, DOI 10.1111/j.1442-2042.2012.03095.x; Cockayne DA, 2000, NATURE, V407, P1011, DOI 10.1038/35039519; Daneshgari F, 2009, J UROLOGY, V182, pS18, DOI 10.1016/j.juro.2009.08.070; Fujihara A, 2011, INT J UROL, V18, P341, DOI 10.1111/j.1442-2042.2011.02749.x; Gillespie JI, 2009, BJU INT, V103, P1324, DOI 10.1111/j.1464-410X.2009.08377.x; Haylen BT, 2010, NEUROUROL URODYNAM, V29, P4, DOI 10.1002/nau.20798; HAYLEN BT, 1989, BRIT J UROL, V64, P30, DOI 10.1111/j.1464-410X.1989.tb05518.x; Ho CH, 2010, NEUROUROL URODYNAM, V29, P424, DOI 10.1002/nau.20727; Homma Y, 2006, UROLOGY, V68, P318, DOI 10.1016/j.urology.2006.02.042; Johnston S, 2012, INT J CLIN PRACT, V66, P1042, DOI 10.1111/j.1742-1241.2012.03009.x; Kavoussi P, 2012, CAMPBELL WALSH WEIN, V10th, P67; Kirschner-Hermanns R, 2012, NEUROUROL URODYNAM, V31, P359, DOI 10.1002/nau.22228; Lawrence JM, 2007, DIABETES CARE, V30, P2536, DOI 10.2337/dc07-0262; Lee WC, 2004, J UROLOGY, V172, P989, DOI 10.1097/01.ju.0000136255.83054.0c; Lee WC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045578; Lee WC, 2009, J UROLOGY, V181, P198, DOI 10.1016/j.juro.2008.09.021; Liu RT, 2011, UROLOGY, V78, P1040, DOI 10.1016/j.urology.2011.05.017; Matsutomo R, 2005, J INT MED RES, V33, P442, DOI 10.1177/147323000503300410; Nather A, 2008, J DIABETES COMPLICAT, V22, P126, DOI 10.1016/j.jdiacomp.2006.10.007; Said G, 2007, NAT CLIN PRACT NEURO, V3, P331, DOI 10.1038/ncpneuro0504; Torimoto K, 2004, J UROLOGY, V171, P1959, DOI 10.1097/01.ju.0000121283.92963.05; Ueda T, 1997, J UROLOGY, V157, P580, DOI 10.1016/S0022-5347(01)65209-1; Yamaguchi C, 2007, NEUROUROL URODYNAM, V26, P807, DOI 10.1002/nau.20404; Yamaguchi O, 2009, INT J UROL, V16, P126, DOI 10.1111/j.1442-2042.2008.02177.x; Yang ZG, 2008, BRAIN RES, V1217, P132, DOI 10.1016/j.brainres.2008.03.055; Yoshimura N, 2005, BJU INT, V95, P733, DOI 10.1111/j.1464-410X.2005.05392.x; Yu HJ, 2004, DIABETES CARE, V27, P988, DOI 10.2337/diacare.27.4.988	31	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2014	9	1							e86463	10.1371/journal.pone.0086463	http://dx.doi.org/10.1371/journal.pone.0086463			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297XI	24466107	Green Published, Green Submitted, gold			2022-12-25	WOS:000330288000100
J	Moltedo, B; Hemmers, S; Rudensky, AY				Moltedo, Bruno; Hemmers, Saskia; Rudensky, Alexander Y.			Regulatory T Cell Ablation Causes Acute T Cell Lymphopenia	PLOS ONE			English	Article							AUTOIMMUNE-DISEASE; LOW AVIDITY; FOXP3; MICE; TOLERANCE; ANTIGEN; RECOGNITION; ELIMINATION; THYMECTOMY; MECHANISM	Regulatory T (Treg) cells enforce T cell homeostasis and maintain peripheral T cell tolerance. Here we report a previously unappreciated phenomenon of acute T cell lymphopenia in secondary lymphoid organs and non-lymphoid tissues triggered by Treg cell depletion that precedes the expansion of self-reactive T cells. Lymphopenia affects both neonates and adults indicating a dominant role of Treg cells in maintaining peripheral T cell numbers regardless of the developmental stage. The lymphopenia was neither triggered by caspase-dependent apoptosis nor macrophage-mediated clearance of T cells, nor diminished survival of naive or recently activated T cells due to paucity of IL-7. It is possible that transient lymphopenia associated with congenital or acute Treg cell deficiency may contribute to the development of T cell mediated autoimmune disorders.	[Moltedo, Bruno; Hemmers, Saskia; Rudensky, Alexander Y.] Mem Sloan Kettering Canc Ctr, Howard Hughes Med Inst, New York, NY 10021 USA; [Moltedo, Bruno; Hemmers, Saskia; Rudensky, Alexander Y.] Mem Sloan Kettering Canc Ctr, Program Immunol, New York, NY 10021 USA	Howard Hughes Medical Institute; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center	Rudensky, AY (corresponding author), Mem Sloan Kettering Canc Ctr, Howard Hughes Med Inst, New York, NY 10021 USA.	rudenska@mskcc.org			NIH [R37 AI034206]; Ludwig Center at Memorial Sloan-Kettering Cancer Center; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI034206] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ludwig Center at Memorial Sloan-Kettering Cancer Center; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by an NIH grant R37 AI034206 and Ludwig Center at Memorial Sloan-Kettering Cancer Center (A.Y.R.). A.Y.R. is an investigator with the Howard Hughes Medical Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHMED SA, 1981, EXPERIENTIA, V37, P1341; Anderson MS, 2005, IMMUNITY, V23, P227, DOI 10.1016/j.immuni.2005.07.005; BARRETT SP, 1995, EUR J IMMUNOL, V25, P238, DOI 10.1002/eji.1830250139; Benseler V, 2011, P NATL ACAD SCI USA, V108, P16735, DOI 10.1073/pnas.1112251108; Brunkow ME, 2001, NAT GENET, V27, P68, DOI 10.1038/83784; Chatila TA, 2000, J CLIN INVEST, V106, pR75, DOI 10.1172/JCI11679; Coombes JL, 2007, J EXP MED, V204, P1757, DOI 10.1084/jem.20070590; Esplugues E, 2011, NATURE, V475, P514, DOI 10.1038/nature10228; Fontenot JD, 2017, J IMMUNOL, V198, P986, DOI 10.1038/ni904; Fontenot JD, 2005, J EXP MED, V202, P901, DOI 10.1084/jem.20050784; Gleeson PA, 1996, IMMUNOL REV, V149, P97, DOI 10.1111/j.1600-065X.1996.tb00901.x; Hashimoto D, 2011, J EXP MED, V208, P1069, DOI 10.1084/jem.20101709; Hawiger D, 2001, J EXP MED, V194, P769, DOI 10.1084/jem.194.6.769; Hildeman DA, 2002, IMMUNITY, V16, P759, DOI 10.1016/S1074-7613(02)00322-9; KAPPLER JW, 1987, CELL, V49, P273, DOI 10.1016/0092-8674(87)90568-X; Kim JM, 2007, NAT IMMUNOL, V8, P191, DOI 10.1038/ni1428; Lahl K, 2007, J EXP MED, V204, P57, DOI 10.1084/jem.20061852; Link A, 2007, NAT IMMUNOL, V8, P1255, DOI 10.1038/ni1513; LIU GY, 1995, IMMUNITY, V3, P407, DOI 10.1016/1074-7613(95)90170-1; Maxwell JR, 2004, J IMMUNOL, V172, P248, DOI 10.4049/jimmunol.172.1.248; Min BK, 2003, IMMUNITY, V18, P131, DOI 10.1016/S1074-7613(02)00508-3; POWRIE F, 1993, INT IMMUNOL, V5, P1461, DOI 10.1093/intimm/5.11.1461; SAKAGUCHI N, 1994, J IMMUNOL, V152, P2586; SAKAGUCHI S, 1989, J IMMUNOL, V142, P471; SAKAGUCHI S, 1995, J IMMUNOL, V155, P1151; Singh NJ, 2006, IMMUNITY, V25, P851, DOI 10.1016/j.immuni.2006.12.002; Starr TK, 2003, ANNU REV IMMUNOL, V21, P139, DOI 10.1146/annurev.immunol.21.120601.141107; Sun CM, 2007, J EXP MED, V204, P1775, DOI 10.1084/jem.20070602; Torchinsky MB, 2009, NATURE, V458, P78, DOI 10.1038/nature07781; Waggoner SN, 2012, NATURE, V481, P394, DOI 10.1038/nature10624; Wildin RS, 2002, J MED GENET, V39, P537, DOI 10.1136/jmg.39.8.537; Wing K, 2008, SCIENCE, V322, P271, DOI 10.1126/science.1160062; Zehn D, 2006, IMMUNITY, V25, P261, DOI 10.1016/j.immuni.2006.06.009; Ziegler SF, 2006, ANNU REV IMMUNOL, V24, P209, DOI 10.1146/annurev.immunol.24.021605.090547	34	14	14	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2014	9	1							e86762	10.1371/journal.pone.0086762	http://dx.doi.org/10.1371/journal.pone.0086762			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297XI	24466225	Green Published, Green Submitted, gold			2022-12-25	WOS:000330288000139
J	Baribeau, S; Chaudhry, P; Parent, S; Asselin, E				Baribeau, Sebastien; Chaudhry, Parvesh; Parent, Sophie; Asselin, Eric			Resveratrol Inhibits Cisplatin-Induced Epithelial-to-Mesenchymal Transition in Ovarian Cancer Cell Lines	PLOS ONE			English	Article							TRANSCRIPTION FACTOR SNAIL; E-CADHERIN; BREAST-CANCER; DOWN-REGULATION; SLUG; EXPRESSION; APOPTOSIS; REGULATORS; PHENOTYPE; REPRESSOR	Background: Many patients diagnosed with ovarian cancer experience recurrence and metastasis, two aspects that will often cause their demise. Epithelial-to-mesenchymal transition (EMT) is a key process involved in cancer progression. With increasing evidence linking Cisplatin and EMT, we wanted to identify a compound able to counter EMT progression when cancer cells are treated with Cisplatin. Methodology/Principal Findings: Cell death was evaluated by cytometry with Annexin V/PI staining in A2780 and A2780CP cells. Ovarian cancer cell lines were treated with Cisplatin (24 h, 10 mu M) and different concentrations of Resveratrol to evaluate its effect on Cisplatin-induced EMT using Western Blot and RT-PCR analysis. Morphological studies and wound healing assay to evaluate cell motility were performed using 72 h Cisplatin treatment with A2780 and A2780CP cells. Densitometry was done on Western Blot and PCR results, and statistical significance was determined using One-Way ANOVA followed by Tukey post-hoc test. Our results show that Cisplatin induced EMT-associated morphological changes in the A2780 ovarian cancer cell line and to a lesser extent in its Cisplatin-resistant counterpart A2780CP. Resveratrol caused cell death in A2780 and A2780CP cell lines in an apoptotic-independent manner. Resveratrol inhibited Cisplatin-induced Snail expression by reducing the Erk pathway activation, reverted morphological changes induced by Cisplatin and decreased cell migration. Conclusions: These results indicate that Resveratrol has interesting potential to prevent Cisplatin-induced EMT in ovarian cancer cells. By increasing cell death, it also represents an inviting approach as adjuvant therapy to be used with chemotherapy. Using Erk pathway inhibitors could also prove helpful in ovarian cancer treatment to reduce the risk of metastasis.	[Baribeau, Sebastien; Chaudhry, Parvesh; Parent, Sophie; Asselin, Eric] Univ Quebec Trois Rivieres, Dept Med Biol, Res Grp Mol Oncol & Endocrinol, Trois Rivieres, PQ GA9 5H7, Canada	University of Quebec; University of Quebec Trois Rivieres	Asselin, E (corresponding author), Univ Quebec Trois Rivieres, Dept Med Biol, Res Grp Mol Oncol & Endocrinol, Trois Rivieres, PQ GA9 5H7, Canada.	eric.asselin@uqtr.ca	Chaudhry, Parvesh/I-4417-2015		Canadian Institutes for Health Research [MOP-66987]	Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR))	This work has been supported by a grant from the Canadian Institutes for Health Research (MOP-66987). EA holds a Canadian Research Chair in Molecular-Gyneco-Oncology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aigner K, 2007, ONCOGENE, V26, P6979, DOI 10.1038/sj.onc.1210508; Auersperg N, 2001, ENDOCR REV, V22, P255, DOI 10.1210/er.22.2.255; Bakin AV, 2000, J BIOL CHEM, V275, P36803, DOI 10.1074/jbc.M005912200; Batlle E, 2000, NAT CELL BIOL, V2, P84, DOI 10.1038/35000034; Cal C., 2003, Current Medicinal Chemistry - Anti-Cancer Agents, V3, P77, DOI 10.2174/1568011033353443; Cano A, 2000, NAT CELL BIOL, V2, P76, DOI 10.1038/35000025; Catalgol B, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00141; Chen QM, 2000, J CELL SCI, V113, P4087; Colombo PE, 2013, CRIT REV ONCOL HEMAT; Cui W, 2000, MOL CARCINOGEN, V29, P219, DOI 10.1002/1098-2744(200012)29:4<219::AID-MC1004>3.0.CO;2-D; Du F, 2013, ONCOL REP; Eger A, 2005, ONCOGENE, V24, P2375, DOI 10.1038/sj.onc.1208429; Gescher AJ, 2003, CANCER EPIDEM BIOMAR, V12, P953; Hajra KM, 2002, CANCER RES, V62, P1613; Haslehurst AM, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-91; Heiss EH, 2007, J BIOL CHEM, V282, P26759, DOI 10.1074/jbc.M703229200; Hotz B, 2007, CLIN CANCER RES, V13, P4769, DOI 10.1158/1078-0432.CCR-06-2926; Hu F, 2010, BBA-MOL BASIS DIS, V1802, P301, DOI 10.1016/j.bbadis.2009.12.002; Jang MS, 1997, SCIENCE, V275, P218, DOI 10.1126/science.275.5297.218; Kim A, 2012, J EXP CLIN CANC RES, V31, DOI 10.1186/1756-9966-31-14; Kurrey NK, 2009, STEM CELLS, V27, P2059, DOI 10.1002/stem.154; Kurrey NK, 2005, GYNECOL ONCOL, V97, P155, DOI 10.1016/j.ygyno.2004.12.043; Latifi A, 2011, J CELL BIOCHEM, V112, P2850, DOI 10.1002/jcb.23199; Lee SH, 2009, NEOPLASIA, V11, P22, DOI 10.1593/neo.81006; Lombaerts M, 2006, BRIT J CANCER, V94, P661, DOI 10.1038/sj.bjc.6602996; LOUIE KG, 1985, CANCER RES, V45, P2110; Lu X, 2004, NEOPLASIA, V6, P603, DOI 10.1593/neo.04241; Luo HM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060065; Nieto MA, 2002, NAT REV MOL CELL BIO, V3, P155, DOI 10.1038/nrm757; Opipari AW, 2004, CANCER RES, V64, P696, DOI 10.1158/0008-5472.CAN-03-2404; Park SH, 2008, MOL ENDOCRINOL, V22, P2085, DOI 10.1210/me.2007-0512; Schmeiser K, 1998, FEBS LETT, V433, P51, DOI 10.1016/S0014-5793(98)00850-3; Sexton E, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-45; Society CC, 2011, CAN CANC STAT; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; Tiwari N, 2012, SEMIN CANCER BIOL, V22, P194, DOI 10.1016/j.semcancer.2012.02.013; Vergara D, 2011, CANCER LETT, V310, P1, DOI 10.1016/j.canlet.2011.04.009; Wang HY, 2013, TOXICOLOGY, V303, P139, DOI 10.1016/j.tox.2012.09.017; Wels C, 2011, J INVEST DERMATOL, V131, P1877, DOI 10.1038/jid.2011.142	39	54	56	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2014	9	1							e86987	10.1371/journal.pone.0086987	http://dx.doi.org/10.1371/journal.pone.0086987			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297VL	24466305	gold, Green Submitted, Green Published			2022-12-25	WOS:000330283100240
J	Lee, JA; Halpern, EM; Lovblom, LE; Yeung, E; Bril, V; Perkins, BA				Lee, Justin A.; Halpern, Elise M.; Lovblom, Leif E.; Yeung, Emily; Bril, Vera; Perkins, Bruce A.			Reliability and Validity of a Point-of-Care Sural Nerve Conduction Device for Identification of Diabetic Neuropathy	PLOS ONE			English	Article							PERIPHERAL NEUROPATHY; POLYNEUROPATHY; POPULATION; COSTS	Background: Confirmation of diabetic sensorimotor polyneuropathy (DSP) relies on standard nerve conduction studies (NCS) performed in specialized clinics. We explored the utility of a point-of-care device (POCD) for DSP detection by nontechnical personnel and a validation of diagnostic thresholds with those observed in a normative database. Research Design and Methods: 44 subjects with type 1 and type 2 diabetes underwent standard NCS (reference method). Two nontechnical examiners measured sural nerve amplitude potential (SNAP) and conduction velocity (SNCV) using the POCD. Reliability was determined by intraclass correlation coefficients (ICC [ 2,1]). Validity was determined by Bland-Altman analysis and receiver operating characteristic curves. Results: The 44 subjects (50% female) with mean age 56618 years had mean SNAP and SNCV of 8.0+/-8.6 mu V and 41.5+/-8.2 m/s using standard NCS and 8.0+/-8.2 mV and 49.9+/-11.1 m/s using the POCD. Intrarater reproducibility ICC values were 0.97 for SNAP and 0.94 for SNCV while interrater reproducibility values were 0.83 and 0.79, respectively. Mean bias of the POCD was 20.1+/-3.6 mV for SNAP and + 8.4+/-6.4 m/s for SNCV. A SNAP of <= 6 mV had 88% sensitivity and 94% specificity for identifying age-and height-standardized reference NCS values, while a SNCV of <= 48 m/s had 94% specificity and 82% sensitivity. Abnormality in one or more of these thresholds was associated with 95% sensitivity and 71% specificity for identification of DSP according to electrophysiological criteria. Conclusions: The POCD demonstrated excellent reliability and acceptable accuracy. Threshold values for DSP identification validated those of published POCD normative values. We emphasize the presence of measurement bias - particularly for SNCV - that requires adjustment of threshold values to reflect those of standard NCS.	[Lee, Justin A.; Halpern, Elise M.; Lovblom, Leif E.; Perkins, Bruce A.] Univ Toronto, Dept Med, Div Endocrinol & Metab, Toronto, ON M5S 1A1, Canada; [Yeung, Emily; Bril, Vera] Univ Toronto, Dept Med, Div Neurol, Toronto, ON M5S 1A1, Canada	University of Toronto; University of Toronto	Perkins, BA (corresponding author), Univ Toronto, Dept Med, Div Endocrinol & Metab, Toronto, ON M5S 1A1, Canada.	bperkins@mtsinai.on.ca	Perkins, Bruce A/L-3726-2017; BRIL, vera/ABA-6509-2020	Lovblom, Leif Erik/0000-0002-6774-8924	JDRF [17-2008-715]; Canadian Diabetes Association [OG-3-10-3123-BP]	JDRF(Juvenile Diabetes Research Foundation); Canadian Diabetes Association	Funding was provided by JDRF (Grant Number 17-2008-715) and the Canadian Diabetes Association (Grant Number OG-3-10-3123-BP). Point-of-care device equipment was provided by Neurometrix Inc. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bland JM, 2010, INT J NURS STUD, V47, P931, DOI 10.1016/j.ijnurstu.2009.10.001; Bokan V., 2010, ACTA MEDICA MEDIAN, V49, P19; Boulton AJM, 2005, DIABETES CARE, V28, P956, DOI 10.2337/diacare.28.4.956; Boulton AJM, 2005, CLIN DIABETES, V23, P9, DOI DOI 10.2337/DIACLIN.23.1.9; Bril V, 2013, CAN J DIABETES, V37, pS142, DOI 10.1016/j.jcjd.2013.01.039; Dyck PJ, 2010, MUSCLE NERVE, V42, P157, DOI 10.1002/mus.21661; DYCK PJ, 1993, NEUROLOGY, V43, P817, DOI 10.1212/WNL.43.4.817; England JD, 2005, NEUROLOGY, V64, P199, DOI 10.1212/01.WNL.0000149522.32823.EA; GODDARD DH, 1983, CLIN RHEUMATOL, V2, P169, DOI 10.1007/BF02032175; Gordois A, 2003, DIABETES CARE, V26, P1790, DOI 10.2337/diacare.26.6.1790; Guidelines In Electrodiagnostic Medicine, 1992, MUSCLE NERVE, V15, P229; Herman WH, 2005, DIABETES CARE, V28, P1480, DOI 10.2337/diacare.28.6.1480; Herrera E, 2009, J CLIN NEUROPHYSIOL, V26, P372, DOI 10.1097/WNP.0b013e3181baaaea; Hertz P, 2011, DIABETIC MED, V28, P1253, DOI 10.1111/j.1464-5491.2011.03299.x; Huynh W, 2011, AUST FAM PHYSICIAN, V40, P693; Kirkman MS, 2002, DIABETES CARE, V25, P1946, DOI 10.2337/diacare.25.11.1946; Lesser EA, 2007, PERSPECT BIOL MED, V50, P40, DOI 10.1353/pbm.2007.0007; Malik RA, 2005, DIABETOLOGIA, V48, P578, DOI 10.1007/s00125-004-1663-5; MURAI Y, 1975, J NEUROL NEUROSUR PS, V38, P1187, DOI 10.1136/jnnp.38.12.1187; Neurometrix, 2013, NC STAT DPNCHECK NOR; Oh S., 2002, NORMAL VALUES COMMON; Orszag A, 2011, DIABETES RES CLIN PR, V93, pE71, DOI 10.1016/j.diabres.2011.05.001; PECORARO RE, 1990, DIABETES CARE, V13, P513, DOI 10.2337/diacare.13.5.513; Perkins BA, 2008, DIABETES CARE, V31, P522, DOI 10.2337/dc07-1227; Perkins BA, 2006, DIABETES CARE, V29, P2023, DOI 10.2337/dc08-0500; Perkins BA, 2010, DIABETES CARE, V33, P1549, DOI 10.2337/dc09-1835; Ritzwoller DP, 2009, CURR MED RES OPIN, V25, P1319, DOI 10.1185/03007990902864749; SHAMOON H, 1993, NEW ENGL J MED, V329, P977, DOI 10.1056/nejm199309303291401; SHROUT PE, 1979, PSYCHOL BULL, V86, P420, DOI 10.1037/0033-2909.86.2.420; Sivaskandarajah G, 2013, DIABETES CARE; Smith G, 2012, BALLET REV, V40, P18; Tesfaye S, 2010, DIABETES CARE, V33; Weisman A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058783; WILBOURN AJ, 1994, J CLIN NEUROPHYSIOL, V11, P584, DOI 10.1097/00004691-199411000-00005; Wong MCS, 2013, INT J PUBLIC HEALTH, V58, P269, DOI 10.1007/s00038-012-0364-y; Ziegler D, 2002, INT REV NEUROBIOL, V50, P431	36	47	47	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2014	9	1							e86515	10.1371/journal.pone.0086515	http://dx.doi.org/10.1371/journal.pone.0086515			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297VL	24466129	Green Submitted, Green Published, gold			2022-12-25	WOS:000330283100177
J	Rudraraju, R; Jones, BG; Surman, SL; Sealy, RE; Thomas, PG; Hurwitz, JL				Rudraraju, Rajeev; Jones, Bart G.; Surman, Sherri L.; Sealy, Robert E.; Thomas, Paul G.; Hurwitz, Julia L.			Respiratory Tract Epithelial Cells Express Retinaldehyde Dehydrogenase ALDH1A and Enhance IgA Production by Stimulated B Cells in the Presence of Vitamin A	PLOS ONE			English	Article							MOUSE SPLENIC MACROPHAGES; RETINOIC ACID RECEPTORS; SURFACTANT PROTEIN D; DENDRITIC CELLS; T-CELLS; BINDING PROTEIN; IMMUNE-SYSTEM; IN-VITRO; GM-CSF; GUT	Morbidity and mortality due to viral infections are major health concerns, particularly when individuals are vitamin A deficient. Vitamin A deficiency significantly impairs mucosal IgA, a first line of defense against virus at its point of entry. Previous reports have suggested that CD11c(Hi) dendritic cells (DCs) of the gastrointestinal tract produce retinaldehyde dehydrogenase (ALDH1A), which metabolizes vitamin A precursors to retinoic acid to support normal mucosal immunity. Given that the upper respiratory tract (URT) and gastrointestinal tract share numerous characteristics, we asked if the CD11c(Hi) DCs of the URT might also express ALDH1A. To address this question, we examined both CD11c(Hi) test cells and CD11c(Lo/neg) control cells from nasal tissue. Surprisingly, the CD11c(Lo/neg) cells expressed more ALDH1A mRNA per cell than did the CD11c(Hi) cells. Further evaluation of CD11c(Lo/neg) populations by PCR and staining of respiratory tract sections revealed that epithelial cells were robust producers of both ALDH1A mRNA and protein. Moreover, CD11c(Lo/neg) cells from nasal tissue (and a homogeneous respiratory tract epithelial cell line) enhanced IgA production by lipopolysaccharide (LPS)-stimulated splenocyte cultures in the presence of the retinoic acid precursor retinol. Within co-cultures, there was increased expression of MCP-1, IL-6, and GM-CSF, the latter two of which were necessary for IgA upregulation. All three cytokines/chemokines were expressed by the LPS-stimulated respiratory tract epithelial cell line in the absence of splenocytes. These data demonstrate the autonomous potential of respiratory tract epithelial cells to support vitamin A-mediated IgA production, and encourage the clinical testing of intranasal vitamin A supplements in vitamin A deficient populations to improve mucosal immune responses toward respiratory tract pathogens and vaccines.	[Rudraraju, Rajeev; Jones, Bart G.; Surman, Sherri L.; Sealy, Robert E.; Hurwitz, Julia L.] St Jude Childrens Res Hosp, Dept Infect Dis, Memphis, TN 38105 USA; [Thomas, Paul G.] St Jude Childrens Res Hosp, Dept Immunol, Memphis, TN 38105 USA; [Thomas, Paul G.; Hurwitz, Julia L.] Univ Tennessee, Ctr Hlth Sci, Dept Microbiol Immunol & Biochem, Memphis, TN 38163 USA	St Jude Children's Research Hospital; St Jude Children's Research Hospital; University of Tennessee System; University of Tennessee Health Science Center	Hurwitz, JL (corresponding author), St Jude Childrens Res Hosp, Dept Infect Dis, 332 N Lauderdale St, Memphis, TN 38105 USA.	julia.hurwitz@stjude.org	Thomas, Paul G./H-1063-2018; Hurwitz, Julia/N-2301-2018	Thomas, Paul G./0000-0001-7955-0256; Rudraraju, Rajeev/0000-0003-0080-6728	NIH NIAID [R01 AI088729]; NIH NCI [P30 CA21765]; American Lebanese Syrian Associated Charities; NATIONAL CANCER INSTITUTE [P30CA021765] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI088729] Funding Source: NIH RePORTER	NIH NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIH NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); American Lebanese Syrian Associated Charities(American Lebanese Syrian Associated Charities (ALSAC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was supported in part by Grants NIH NIAID R01 AI088729 and NIH NCI P30 CA21765, and the American Lebanese Syrian Associated Charities. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abreu MT, 2010, NAT REV IMMUNOL, V10, P131, DOI 10.1038/nri2707; Amaral CT, 2013, PEDIATR PULM, V48, P481, DOI 10.1002/ppul.22621; Bahl R, 2002, EUR J CLIN NUTR, V56, P321, DOI 10.1038/sj.ejcn.1601325; BEAGLEY KW, 1989, J EXP MED, V169, P2133, DOI 10.1084/jem.169.6.2133; Brandl K, 2010, P NATL ACAD SCI USA, V107, P19967, DOI 10.1073/pnas.1014669107; BUCK J, 1990, J EXP MED, V171, P1613, DOI 10.1084/jem.171.5.1613; Cantorna MT, 1996, J IMMUNOL, V156, P2674; Cassani B, 2012, MOL ASPECTS MED, V33, P63, DOI 10.1016/j.mam.2011.11.001; CHURCHILL L, 1992, IMMUNOLOGY, V75, P189; Costa-Pereira AP, 2002, P NATL ACAD SCI USA, V99, P8043, DOI 10.1073/pnas.122236099; CROMWELL O, 1992, IMMUNOLOGY, V77, P330; DEFRANCISCO A, 1993, LANCET, V342, P526, DOI 10.1016/0140-6736(93)91648-6; Doss M, 2009, J IMMUNOL, V182, P7878, DOI 10.4049/jimmunol.0804049; Eo SK, 2001, J VIROL, V75, P569, DOI 10.1128/JVI.75.2.569-578.2001; Franchi L, 2012, NAT IMMUNOL, V13, P325, DOI 10.1038/ni.2231; Hancock REW, 2012, NAT REV MICROBIOL, V10, P243, DOI 10.1038/nrmicro2745; HATHCOCK JN, 1990, AM J CLIN NUTR, V52, P183, DOI 10.1093/ajcn/52.2.183; Iwata M, 2004, IMMUNITY, V21, P527, DOI 10.1016/j.immuni.2004.08.011; Iwata M, 2003, INT IMMUNOL, V15, P1017, DOI 10.1093/intimm/dxg101; Jersmann HPA, 2005, IMMUNOL CELL BIOL, V83, P462, DOI 10.1111/j.1440-1711.2005.01370.x; Kanneganti TD, 2010, NAT REV IMMUNOL, V10, P688, DOI 10.1038/nri2851; KAPPLER JW, 1981, J EXP MED, V153, P1198, DOI 10.1084/jem.153.5.1198; Kumar H, 2011, INT REV IMMUNOL, V30, P16, DOI 10.3109/08830185.2010.529976; Lam HS, 2006, PEDIATRICS, V118, P820, DOI 10.1542/peds.2006-0167; Loudon PT, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011021; Mark M, 2006, ANNU REV PHARMACOL, V46, P451, DOI 10.1146/annurev.pharmtox.46.120604.141156; MCCORMACK JM, 1993, J IMMUNOL, V151, P5218; Mora JR, 2008, NAT REV IMMUNOL, V8, P685, DOI 10.1038/nri2378; Mora JR, 2006, SCIENCE, V314, P1157, DOI 10.1126/science.1132742; Mora JR, 2009, SEMIN IMMUNOL, V21, P28, DOI 10.1016/j.smim.2008.08.002; Mora JR, 2003, NATURE, V424, P88, DOI 10.1038/nature01726; Napoli JL, 2012, BBA-MOL CELL BIOL L, V1821, P152, DOI 10.1016/j.bbalip.2011.05.004; Njuguna M, 2009, OPHTHAL EPIDEMIOL, V16, P151, DOI 10.1080/09286580902738183; Ortega-Cava CF, 2003, J IMMUNOL, V170, P3977, DOI 10.4049/jimmunol.170.8.3977; Panee J, 2012, CYTOKINE, V60, P1, DOI 10.1016/j.cyto.2012.06.018; Patke CL, 2000, J ALLERGY CLIN IMMUN, V105, P975, DOI 10.1067/mai.2000.105315; Proud D, 2011, IMMUNOL REV, V242, P186, DOI 10.1111/j.1600-065X.2011.01033.x; PUGIN J, 1993, P NATL ACAD SCI USA, V90, P2744, DOI 10.1073/pnas.90.7.2744; RAMSAY AJ, 1994, SCIENCE, V264, P561, DOI 10.1126/science.8160012; Roy RM, 2012, J IMMUNOL, V189, P2545, DOI 10.4049/jimmunol.1200689; Rudraraju R, 2012, CLIN VACCINE IMMUNOL, V19, P757, DOI 10.1128/CVI.05576-11; Rudraraju R, 2011, VIROLOGY, V410, P429, DOI 10.1016/j.virol.2010.12.017; Rumbo M, 2004, ANN NY ACAD SCI, V1029, P16, DOI 10.1196/annals.1309.003; Samarut E, 2012, MOL CELL ENDOCRINOL, V348, P348, DOI 10.1016/j.mce.2011.03.025; Schleicher RL, 2013, J NUTR, V143, p966S, DOI 10.3945/jn.112.172965; Schuster GU, 2008, J IMMUNOL, V180, P1834, DOI 10.4049/jimmunol.180.3.1834; Shaykhiev R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001393; SHENAI JP, 1981, J PEDIATR-US, V99, P302, DOI 10.1016/S0022-3476(81)80484-2; SOMMER A, 1984, AM J CLIN NUTR, V40, P1090, DOI 10.1093/ajcn/40.5.1090; SOMMER A, 1983, LANCET, V2, P585; STEPHENS D, 1996, PEDIATR NURS, V22, P456; Struyf S, 1998, J LEUKOCYTE BIOL, V63, P364; Surman SL, 2012, VIRAL IMMUNOL, V25, P341, DOI 10.1089/vim.2012.0023; Suzuki Y, 2012, AM J RESP CELL MOL, V46, P773, DOI 10.1165/rcmb.2011-0329OC; TOKUYAMA H, 1993, CELL IMMUNOL, V150, P353, DOI 10.1006/cimm.1993.1203; Tokuyama Y, 1996, CELL IMMUNOL, V170, P230, DOI 10.1006/cimm.1996.0156; Tripathi S, 2013, J GEN VIROL, V94, P40, DOI 10.1099/vir.0.045013-0; Van Amersfoort ES, 2003, CLIN MICROBIOL REV, V16, P379, DOI 10.1128/CMR.16.3.379-414.2003; Wang YW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013607; Willart MAM, 2012, J EXP MED, V209, P1505, DOI 10.1084/jem.20112691; WILSON CM, 1991, J IMMUNOL METHODS, V137, P17, DOI 10.1016/0022-1759(91)90389-W; Xu LL, 1996, J LEUKOCYTE BIOL, V60, P365, DOI 10.1002/jlb.60.3.365; Yokota A, 2009, INT IMMUNOL, V21, P361, DOI 10.1093/intimm/dxp003; Zaki MH, 2010, IMMUNITY, V32, P379, DOI 10.1016/j.immuni.2010.03.003	64	32	32	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2014	9	1							e86554	10.1371/journal.pone.0086554	http://dx.doi.org/10.1371/journal.pone.0086554			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297VL	24466150	gold, Green Published			2022-12-25	WOS:000330283100184
J	Dalen, M; Ivert, T; Holzmann, MJ; Sartipy, U				Dalen, Magnus; Ivert, Torbjorn; Holzmann, Martin J.; Sartipy, Ulrik			Bilateral versus Single Internal Mammary Coronary Artery Bypass Grafting in Sweden from 1997-2008	PLOS ONE			English	Article							30-YEAR FOLLOW-UP; THORACIC ARTERY; MYOCARDIAL REVASCULARIZATION; SURVIVAL BENEFIT; VALIDATION; LOCATION; SOCIETY; DISEASE	Background: Prior observational studies have suggested better outcomes in patients who receive bilateral internal mammary arteries (BIMA) during coronary artery bypass grafting (CABG) compared with patients who receive a single internal mammary artery (SIMA). The aim of this study was to analyze the association between BIMA use and long-term survival in patients who underwent primary isolated CABG. Methods and Results: Patients who underwent primary isolated non-emergent CABG in Sweden between 1997 and 2008 were identified. The SWEDEHEART registry and other national Swedish registers were used to acquire information about patient characteristics and outcomes. Unadjusted and multivariable adjusted regression models were used to estimate the association between BIMA use and early mortality, long-term survival, and a composite of death from any cause or rehospitalization for myocardial infarction, heart failure, or stroke in the overall cohort and in a propensity score-matched cohort. The study population consisted of 49702 patients who underwent CABG with at least one internal mammary artery, and 559 (1%) of those had BIMA grafting. In the adjusted analyses, BIMA use was not associated with better survival compared with SIMA use in the overall cohort (hazard ratio (HR) for death: 1.16, 95% confidence interval (CI): 0.97 to 1.37) or in the matched cohort (HR: 1.04, 95% CI: 0.78 to 1.40). The results were similar for early mortality and the composite endpoint. Reoperation for sternal wound complications was more common among BIMA patients (odds ratio: 1.71, 95% CI: 1.01 to 2.88). Conclusions: BIMA grafting was performed infrequently and was not associated with better outcomes compared with SIMA grafting in patients undergoing non-emergent primary isolated CABG in Sweden during 1997-2008.	[Dalen, Magnus; Ivert, Torbjorn; Sartipy, Ulrik] Karolinska Univ Hosp, Dept Cardiothorac Surg & Anesthesiol, Stockholm, Sweden; [Dalen, Magnus; Ivert, Torbjorn; Sartipy, Ulrik] Karolinska Inst, Dept Mol Med & Surg, Stockholm, Sweden; [Holzmann, Martin J.] Karolinska Univ Hosp, Dept Emergency Med, Stockholm, Sweden; [Holzmann, Martin J.] Karolinska Inst, Dept Internal Med, S-10401 Stockholm, Sweden	Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet	Sartipy, U (corresponding author), Karolinska Univ Hosp, Dept Cardiothorac Surg & Anesthesiol, Stockholm, Sweden.	Ulrik.Sartipy@karolinska.se	Sartipy, Ulrik/E-9780-2014	Sartipy, Ulrik/0000-0003-2707-0263				Berreklouw E, 2001, ANN THORAC SURG, V72, P1535, DOI 10.1016/S0003-4975(01)03040-5; Bridgewater B, 2009, 6 NATL ADULT CARDIAC; Calafiore AM, 2005, ANN THORAC SURG, V80, P888, DOI 10.1016/j.athoracsur.2005.03.077; Carrel T, 1996, ANN THORAC SURG, V62, P1289, DOI 10.1016/0003-4975(96)00627-3; Dorman MJ, 2012, CIRCULATION, V126, P2935, DOI 10.1161/CIRCULATIONAHA.112.117606; ElBardissi AW, 2012, J THORAC CARDIOV SUR, V143, P273, DOI 10.1016/j.jtcvs.2011.10.029; Grau JB, 2012, EUR J CARDIO-THORAC, V41, P770, DOI 10.1093/ejcts/ezr213; Hillis LD, 2011, CIRCULATION, V124, pE652, DOI 10.1161/CIR.0b013e31823c074e; Hirotani T, 2003, ANN THORAC SURG, V76, P2017, DOI 10.1016/S0003-4975(03)01062-2; Ingelsson E, 2005, EUR J HEART FAIL, V7, P787, DOI 10.1016/j.ejheart.2004.12.007; Jernberg T, 2010, HEART, V96, P1617, DOI 10.1136/hrt.2010.198804; Kelly R, 2012, J THORAC CARDIOV SUR, V144, P1408, DOI 10.1016/j.jtcvs.2012.01.030; Kurlansky PA, 2011, ANN THORAC SURG, V91, P1378, DOI 10.1016/j.athoracsur.2011.01.055; Kurlansky PA, 2010, ANN THORAC SURG, V90, P101, DOI 10.1016/j.athoracsur.2010.04.006; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; Little RJ, 2012, NEW ENGL J MED, V367, P1355, DOI 10.1056/NEJMsr1203730; Locker C, 2012, CIRCULATION, V126, P1023, DOI 10.1161/CIRCULATIONAHA.111.084624; Ludvigsson JF, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-450; Ludvigsson JF, 2009, EUR J EPIDEMIOL, V24, P659, DOI 10.1007/s10654-009-9350-y; Lytle BW, 2004, ANN THORAC SURG, V78, P2005, DOI 10.1016/j.athoracsur.2004.05.070; Nashef SAM, 1999, EUR J CARDIO-THORAC, V16, P9, DOI 10.1016/S1010-7940(99)00134-7; Pick AW, 1997, ANN THORAC SURG, V64, P599, DOI 10.1016/S0003-4975(97)00620-6; Puskas JD, 2012, ANN THORAC SURG, V94, P710, DOI 10.1016/j.athoracsur.2012.03.082; Sabik JF, 2008, CIRCULATION, V118, pS210, DOI 10.1161/CIRCULATIONAHA.107.760827; Stevens LM, 2004, J THORAC CARDIOV SUR, V127, P1408, DOI 10.1016/j.jtcvs.2003.10.006; Tabata M, 2009, CIRCULATION, V120, P935, DOI 10.1161/CIRCULATIONAHA.108.832444; Taggart DP, 2010, EUR HEART J, V31, P2470, DOI 10.1093/eurheartj/ehq318; Taggart DP, 2001, LANCET, V358, P870, DOI 10.1016/S0140-6736(01)06069-X; Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS), 2010, Eur Heart J, V31, P2501, DOI 10.1093/eurheartj/ehq277; Tatoulis J, 2011, ANN THORAC SURG, V92, P9, DOI 10.1016/j.athoracsur.2011.03.099; White IR, 2009, STAT MED, V28, P1982, DOI 10.1002/sim.3618	31	15	17	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2014	9	1							e86929	10.1371/journal.pone.0086929	http://dx.doi.org/10.1371/journal.pone.0086929			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297GT	24466293	gold, Green Published, Green Submitted			2022-12-25	WOS:000330244500287
J	Hattori, T; Uchida, C; Takahashi, H; Yamamoto, N; Naito, M; Taya, Y				Hattori, Takayuki; Uchida, Chiharu; Takahashi, Hirotaka; Yamamoto, Naoki; Naito, Mikihiko; Taya, Yoichi			Distinct and Site-Specific Phosphorylation of the Retinoblastoma Protein at Serine 612 in Differentiated Cells	PLOS ONE			English	Article							CYCLIN-DEPENDENT KINASES; GENE-PRODUCT; RETINOIC ACID; LINE U-937; RB; BINDING; P38; PRB; E2F; INHIBITION	The retinoblastoma susceptibility protein (pRB) is a phosphoprotein that regulates cell cycle progression at the G1/S transition. In quiescent and early G1 cells, pRB predominantly exists in the active hypophosphorylated form. The cyclin/cyclin-dependent protein kinase complexes phosphorylate pRB at the late G1 phase to inactivate pRB. This event leads to the dissociation and activation of E2F family transcriptional factors. At least 12 serine/threonine residues in pRB are phosphorylated in vivo. Although there have been many reports describing bulk phosphorylation of pRB, detail research describing the function of each phosphorylation site remains unknown. Besides its G1/S inhibitory function, pRB is involved in differentiation, prevention of cell death and control of tissue fate. To uncover the function of phosphorylation of pRB in various cellular conditions, we have been investigating phosphorylation of each serine/threonine residue in pRB with site-specific phospho-serine/threonine antibodies. Here we demonstrate that pRB is specifically phosphorylated at Ser612 in differentiated cells in a known kinase-independent manner. We also found that pRB phosphorylated at Ser612 still associates with E2F-1 and tightly binds to nuclear structures including chromatin. Moreover, expression of the Ser612Ala mutant pRB failed to induce differentiation. The findings suggest that phosphorylation of Ser612 provides a distinct function that differs from the function of phosphorylation of other serine/threonine residues in pRB.	[Hattori, Takayuki; Naito, Mikihiko] Natl Inst Hlth Sci, Div Biochem & Mol Biol, Setagaya Ku, Tokyo, Japan; [Hattori, Takayuki; Uchida, Chiharu; Taya, Yoichi] Natl Univ Singapore, Canc Sci Inst Singapore, Singapore 117548, Singapore; [Uchida, Chiharu] Hamamatsu Univ Sch Med, Res Equipment Ctr, Hamamatsu, Shizuoka 4313192, Japan; [Takahashi, Hirotaka] Ehime Univ, Div Cell Free Sci, Proteosci Ctr, Matsuyama, Ehime, Japan; [Takahashi, Hirotaka; Yamamoto, Naoki] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Microbiol, Singapore 117595, Singapore; [Taya, Yoichi] Natl Univ Singapore, Dept Biochem, Singapore 117548, Singapore	National Institute of Health Sciences - Japan; National University of Singapore; Hamamatsu University School of Medicine; Ehime University; National University of Singapore; National University of Singapore	Hattori, T (corresponding author), Natl Inst Hlth Sci, Div Biochem & Mol Biol, Setagaya Ku, Tokyo, Japan.	thattori@nihs.go.jp			Cancer Science Institute, National University of Singapore	Cancer Science Institute, National University of Singapore	This work was supported by core grant of the Cancer Science Institute, National University of Singapore. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 1999, MOL CELL BIOL, V19, P1068; Bracken AP, 2004, TRENDS BIOCHEM SCI, V29, P409, DOI 10.1016/j.tibs.2004.06.006; Brugarolas J, 1999, P NATL ACAD SCI USA, V96, P1002, DOI 10.1073/pnas.96.3.1002; CHEN PL, 1989, CELL, V58, P1193, DOI 10.1016/0092-8674(89)90517-5; Dasgupta B, 2009, DEV CELL, V16, P256, DOI 10.1016/j.devcel.2009.01.005; Delston RB, 2011, ONCOGENE, V30, P588, DOI 10.1038/onc.2010.442; Garnovskaya MN, 2004, J BIOL CHEM, V279, P24899, DOI 10.1074/jbc.M311622200; Guo J, 2005, J BIOL CHEM, V280, P35992, DOI 10.1074/jbc.M504583200; Hattori T, 2007, CANCER RES, V67, P10789, DOI 10.1158/0008-5472.CAN-07-2033; HINDS PW, 1992, CELL, V70, P993, DOI 10.1016/0092-8674(92)90249-C; HUANG HJS, 1988, SCIENCE, V242, P1563, DOI 10.1126/science.3201247; Inoue Y, 2007, EMBO J, V26, P2083, DOI 10.1038/sj.emboj.7601652; Kitagawa M, 1996, EMBO J, V15, P7060, DOI 10.1002/j.1460-2075.1996.tb01097.x; Knudsen ES, 1997, MOL CELL BIOL, V17, P5771, DOI 10.1128/MCB.17.10.5771; LOZZIO CB, 1975, BLOOD, V45, P321, DOI 10.1182/blood.V45.3.321.321; LUDLOW JW, 1989, CELL, V56, P57, DOI 10.1016/0092-8674(89)90983-5; Mittnacht S, 2005, EUR J CELL BIOL, V84, P97, DOI 10.1016/j.ejcb.2004.12.012; MITTNACHT S, 1991, CELL, V65, P381, DOI 10.1016/0092-8674(91)90456-9; Nagano K, 2006, ONCOGENE, V25, P493, DOI 10.1038/sj.onc.1208996; Nath N, 2003, ONCOGENE, V22, P5986, DOI 10.1038/sj.onc.1206843; OLSSON I, 1983, CANCER RES, V43, P5862; OLSSON IL, 1982, CANCER RES, V42, P3924; PAHLMAN S, 1984, CELL DIFFER DEV, V14, P135, DOI 10.1016/0045-6039(84)90038-1; RUTHERFORD TR, 1979, NATURE, V280, P164, DOI 10.1038/280164a0; Sawasaki T, 2002, P NATL ACAD SCI USA, V99, P14652, DOI 10.1073/pnas.232580399; SHEW JY, 1990, P NATL ACAD SCI USA, V87, P6, DOI 10.1073/pnas.87.1.6; SUNDSTROM C, 1976, INT J CANCER, V17, P565, DOI 10.1002/ijc.2910170504; Taya Y, 1997, TRENDS BIOCHEM SCI, V22, P14, DOI 10.1016/S0968-0004(96)10070-0; Taya Yoichi, 2003, Methods Mol Biol, V223, P17; TETTEROO PAT, 1984, LEUKEMIA RES, V8, P197, DOI 10.1016/0145-2126(84)90143-7; Wang QE, 2004, CARCINOGENESIS, V25, P1033, DOI 10.1093/carcin/bgh085; Wang S, 1999, EMBO J, V18, P1559, DOI 10.1093/emboj/18.6.1559; Watanabe Y, 1999, BRAIN RES, V842, P342, DOI 10.1016/S0006-8993(99)01844-2; WEINBERG RA, 1995, CELL, V81, P323, DOI 10.1016/0092-8674(95)90385-2; Zarkowska T, 1997, J BIOL CHEM, V272, P12738, DOI 10.1074/jbc.272.19.12738	35	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2014	9	1							e86709	10.1371/journal.pone.0086709	http://dx.doi.org/10.1371/journal.pone.0086709			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297GT	24466208	Green Submitted, Green Published, gold			2022-12-25	WOS:000330244500275
J	Zhao, H; Jiang, T; Zhou, XZ; Deng, YQ; Li, XF; Chen, SP; Zhu, SY; Zhou, X; Qin, ED; Qin, CF				Zhao, Hui; Jiang, Tao; Zhou, Xi-Zhen; Deng, Yong-Qiang; Li, Xiao-Feng; Chen, Shui-Ping; Zhu, Shun-Ya; Zhou, Xi; Qin, E-De; Qin, Cheng-Feng			Induction of Neutralizing Antibodies against Four Serotypes of Dengue Viruses by MixBiEDIII, a Tetravalent Dengue Vaccine	PLOS ONE			English	Article							ENVELOPE DOMAIN-III; PROTECTIVE EFFICACY; IMMUNE-RESPONSE; DNA VACCINE; PROTEIN; RECOMBINANT; TYPE-2; INFECTION; MICE; IMMUNOGENICITY	The worldwide expansion of four serotypes of dengue virus (DENV) poses great risk to global public health. Several vaccine candidates are under development. However, none is yet available for humans. In the present study, a novel strategy to produce tetravalent DENV vaccine based on envelope protein domain III (EDIII) was proposed. Tandem EDIIIs of two serotypes (type 1-2 and type 3-4) of DENV connected by a Gly-Ser linker ((Gly(4)Ser)(3)) were expressed in E. coli, respectively. Then, the two bivalent recombinant EDIIIs were equally mixed to form the tetravalent vaccine candidate MixBiEDIII, and used to immunize BALB/c mice. The results showed that specific IgG and neutralizing antibodies against all four serotypes of DENV were successfully induced in the MixBiEDIII employing Freund adjuvant immunized mice. Furthermore, in the suckling mouse model, sera from mice immunized with MixBiEDIII provided significant protection against four serotypes of DENV challenge. Our data demonstrated that MixBiEDIII, as a novel form of subunit vaccine candidates, might have the potential to be further developed as a tetravalent dengue vaccine in the near future.	[Zhao, Hui; Jiang, Tao; Deng, Yong-Qiang; Li, Xiao-Feng; Chen, Shui-Ping; Zhu, Shun-Ya; Qin, E-De; Qin, Cheng-Feng] Beijing Inst Microbiol & Epidemiol, Dept Virol, State Key Lab Pathogen & Biosecur, Beijing, Peoples R China; [Zhou, Xi-Zhen] Lanzhou Univ, Dept Life Sci, Lanzhou 730000, Peoples R China; [Zhou, Xi] State Key Lab Virol, Wuhan, Peoples R China	Beijing Institute of Microbiology & Epidemiology; Lanzhou University	Qin, ED (corresponding author), Beijing Inst Microbiol & Epidemiol, Dept Virol, State Key Lab Pathogen & Biosecur, Beijing, Peoples R China.	qinede@shou.com; qincf@bmi.ac.cn	Tao, Jiang/AAE-6623-2019; Qin, Cheng-Feng/I-6839-2019	Tao, Jiang/0000-0003-1908-2926; Qin, Cheng-Feng/0000-0002-0632-2807	National Basic Research Plan of China [2012CB518904]; National Natural Science Foundation of China [30972613, 31000083, 81101243, U1132002]	National Basic Research Plan of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Basic Research Plan of China (No. 2012CB518904) and National Natural Science Foundation of China (No. 30972613, No. 31000083, No. 81101243 and No. U1132002). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arora U, 2013, VACCINE, V31, P873, DOI 10.1016/j.vaccine.2012.12.016; Azevedo AS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058357; Babu JP, 2008, VACCINE, V26, P4655, DOI 10.1016/j.vaccine.2008.07.006; Balsitis SJ, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000790; Beckett CG, 2011, VACCINE, V29, P960, DOI 10.1016/j.vaccine.2010.11.050; Beltramello M, 2010, CELL HOST MICROBE, V8, P271, DOI 10.1016/j.chom.2010.08.007; Block OKT, 2010, VACCINE, V28, P8085, DOI 10.1016/j.vaccine.2010.10.004; Chen HW, 2013, ARCH VIROL, V158, P1523, DOI 10.1007/s00705-013-1639-1; Chen SP, 2007, DNA CELL BIOL, V26, P361, DOI 10.1089/dna.2006.0547; Chua AJS, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-129; Clements DE, 2010, VACCINE, V28, P2705, DOI 10.1016/j.vaccine.2010.01.022; Coconi-Linares N, 2013, VACCINE, V31, P2366, DOI 10.1016/j.vaccine.2013.03.009; Coller BAG, 2011, CURR OPIN IMMUNOL, V23, P391, DOI 10.1016/j.coi.2011.03.005; Crill WD, 2004, J VIROL, V78, P13975, DOI 10.1128/JVI.78.24.13975-13986.2004; de Alwis R, 2012, P NATL ACAD SCI USA, V109, P7439, DOI 10.1073/pnas.1200566109; Dejnirattisai W, 2010, SCIENCE, V328, P745, DOI 10.1126/science.1185181; Deng YQ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016059; Durbin AP, 2013, J INFECT DIS, V207, P957, DOI 10.1093/infdis/jis936; Etemad B, 2008, AM J TROP MED HYG, V79, P353, DOI 10.4269/ajtmh.2008.79.353; Gil L, 2009, VIRAL IMMUNOL, V22, P23, DOI 10.1089/vim.2008.0063; Goncalvez AP, 2007, P NATL ACAD SCI USA, V104, P9422, DOI 10.1073/pnas.0703498104; Goncalvez AP, 2004, J VIROL, V78, P12910, DOI 10.1128/JVI.78.23.12910-12918.2004; Gromowski GD, 2008, J VIROL, V82, P8828, DOI 10.1128/JVI.00606-08; Gubler Duane J., 2002, Trends in Microbiology, V10, P100, DOI 10.1016/S0966-842X(01)02288-0; Guzman MG, 2010, EXPERT REV VACCINES, V9, P137, DOI [10.1586/erv.09.139, 10.1586/ERV.09.139]; Harris E, 2012, NAT MED, V18, P1622, DOI 10.1038/nm.2997; Hermida L, 2006, VACCINE, V24, P3165, DOI 10.1016/j.vaccine.2006.01.036; Khanam S, 2006, AM J TROP MED HYG, V74, P266, DOI 10.4269/ajtmh.2006.74.266; Kroeger A, 2006, LANCET, V368, P2193, DOI 10.1016/S0140-6736(06)69873-5; Kuhn RJ, 2002, CELL, V108, P717, DOI 10.1016/S0092-8674(02)00660-8; Kurane I, 2001, REV MED VIROL, V11, P301, DOI 10.1002/rmv.324; Lazo L, 2009, BIOTECHNOL APPL BIOC, V52, P265, DOI 10.1042/BA20080074; Leng CH, 2009, MICROBES INFECT, V11, P288, DOI 10.1016/j.micinf.2008.12.004; Li SH, 2011, IMMUNOL LETT, V138, P156, DOI 10.1016/j.imlet.2011.04.003; Li XQ, 2013, J GEN VIROL; Lindow JC, 2013, VACCINE, V31, P3347, DOI 10.1016/j.vaccine.2013.05.075; Lok SM, 2008, NAT STRUCT MOL BIOL, V15, P312, DOI 10.1038/nsmb.1382; Lu H, 2013, MOL IMMUNOL, V54, P109, DOI 10.1016/j.molimm.2012.11.007; Marcos E, 2013, ARCH VIROL, V158, P225, DOI 10.1007/s00705-012-1471-z; Modis Y, 2004, NATURE, V427, P313, DOI 10.1038/nature02165; MORENS DM, 1994, CLIN INFECT DIS, V19, P500, DOI 10.1093/clinids/19.3.500; Mota J, 2005, VACCINE, V23, P3469, DOI 10.1016/j.vaccine.2004.12.028; Murphy BR, 2011, ANNU REV IMMUNOL, V29, P587, DOI 10.1146/annurev-immunol-031210-101315; Murrell S, 2011, BIOTECHNOL ADV, V29, P239, DOI 10.1016/j.biotechadv.2010.11.008; Nguyen NL, 2013, PROTEIN EXPRES PURIF, V88, P235, DOI 10.1016/j.pep.2013.01.009; Porter KR, 2012, VACCINE, V30, P336, DOI 10.1016/j.vaccine.2011.10.085; Robinson CR, 1998, P NATL ACAD SCI USA, V95, P5929, DOI 10.1073/pnas.95.11.5929; Sabchareon A, 2012, LANCET, V380, P1559, DOI 10.1016/S0140-6736(12)61428-7; Shrestha B, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000823; Simmons M, 2001, AM J TROP MED HYG, V65, P159, DOI 10.4269/ajtmh.2001.65.159; Sukupolvi-Petty S, 2007, J VIROL, V81, P12816, DOI 10.1128/JVI.00432-07; Swaminathan S, 2013, LANCET INFECT DIS, V13, P191, DOI 10.1016/S1473-3099(13)70028-8; Teoh EP, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003888; Thullier P, 2001, J GEN VIROL, V82, P1885, DOI 10.1099/0022-1317-82-8-1885; Vaughn DW, 2000, J INFECT DIS, V181, P2, DOI 10.1086/315215; Wahala WMPB, 2009, VIROLOGY, V392, P103, DOI 10.1016/j.virol.2009.06.037; Wallace D, 2013, CURR OPIN VIROL, V3, P352, DOI 10.1016/j.coviro.2013.05.014; Webster DP, 2009, LANCET INFECT DIS, V9, P678, DOI 10.1016/S1473-3099(09)70254-3; White LJ, 2013, J VIROL, V87, P3409, DOI 10.1128/JVI.02298-12; Wu SF, 2003, VACCINE, V21, P3919, DOI 10.1016/S0264-410X(03)00310-4; Yang J, 2012, CAN J MICROBIOL, V58, P369, DOI [10.1139/W11-137, 10.1139/w11-137]; Yauch LE, 2008, ANTIVIR RES, V80, P87, DOI 10.1016/j.antiviral.2008.06.010; Zellweger RM, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003723; Zhang ZS, 2007, J VIROL METHODS, V143, P125, DOI 10.1016/j.jviromet.2007.02.012	64	27	28	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2014	9	1							e86573	10.1371/journal.pone.0086573	http://dx.doi.org/10.1371/journal.pone.0086573			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297GT	24466156	Green Published, gold, Green Submitted			2022-12-25	WOS:000330244500260
J	Pasmant, E; Gilbert-Dussardier, B; Petit, A; de Laval, B; Luscan, A; Gruber, A; Lapillonne, H; Deswarte, C; Goussard, P; Laurendeau, I; Uzan, B; Pflumio, F; Brizard, F; Vabres, P; Naguibneva, I; Fasola, S; Millot, F; Porteu, F; Vidaud, D; Landman-Parker, J; Ballerini, P				Pasmant, E.; Gilbert-Dussardier, B.; Petit, A.; de Laval, B.; Luscan, A.; Gruber, A.; Lapillonne, H.; Deswarte, C.; Goussard, P.; Laurendeau, I.; Uzan, B.; Pflumio, F.; Brizard, F.; Vabres, P.; Naguibneva, I.; Fasola, S.; Millot, F.; Porteu, F.; Vidaud, D.; Landman-Parker, J.; Ballerini, P.			SPRED1, a RAS MAPK pathway inhibitor that causes Legius syndrome, is a tumour suppressor downregulated in paediatric acute myeloblastic leukaemia	ONCOGENE			English	Article						SPRED1; tumour suppressor gene; childhood leukaemia; Legius syndrome; cafe-au-lait spots; neurofibromatosis type 1	ACUTE MYELOID-LEUKEMIA; ACUTE LYMPHOBLASTIC-LEUKEMIA; SIGNAL-TRANSDUCTION; MUTATIONS; CANCER; PHENOTYPE; GENES; SPECTRUM; DISEASE; PROTEIN	Constitutional dominant loss-of-function mutations in the SPRED1 gene cause a rare phenotype referred as neurofibromatosis type 1 (NF1)-like syndrome or Legius syndrome, consisted of multiple cafe-au-lait macules, axillary freckling, learning disabilities and macrocephaly. SPRED1 is a negative regulator of the RAS MAPK pathway and can interact with neurofibromin, the NF1 gene product. Individuals with NF1 have a higher risk of haematological malignancies. SPRED1 is highly expressed in haematopoietic cells and negatively regulates haematopoiesis. SPRED1 seemed to be a good candidate for leukaemia predisposition or transformation. We performed SPRED1 mutation screening and expression status in 230 paediatric lymphoblastic and acute myeloblastic leukaemias (AMLs). We found a loss-of-function frameshift SPRED1 mutation in a patient with Legius syndrome. In this patient, the leukaemia blasts karyotype showed a SPRED1 loss of heterozygosity, confirming SPRED1 as a tumour suppressor. Our observation confirmed that acute leukaemias are rare complications of the Legius syndrome. Moreover, SPRED1 was significantly decreased at RNA and protein levels in the majority of AMLs at diagnosis compared with normal or paired complete remission bone marrows. SPRED1 decreased expression correlated with genetic features of AML. Our study reveals a new mechanism which contributes to deregulate RAS MAPK pathway in the vast majority of paediatric AMLs.	[Pasmant, E.; Luscan, A.; Gruber, A.; Laurendeau, I.; Vidaud, D.] Univ Paris 05, Sorbonne Paris Cite, Fac Sci Pharmaceut & Biol, UMR INSERM S745, F-75006 Paris, France; [Pasmant, E.; Luscan, A.; Goussard, P.; Vidaud, D.] Hop Cochin, AP HP, Serv Biochim & Genet Mol, F-75674 Paris, France; [Gilbert-Dussardier, B.] CHU Poitiers, Serv Genet, Poitiers, France; [Petit, A.; Deswarte, C.; Fasola, S.; Landman-Parker, J.] Hop A Trousseau, AP HP, Serv Hematol Oncol, Paris, France; [Petit, A.; Deswarte, C.; Fasola, S.; Landman-Parker, J.] Univ Paris 06, Paris, France; [Petit, A.; Lapillonne, H.; Deswarte, C.; Landman-Parker, J.] Univ Paris 06, UMR938, Paris, France; [de Laval, B.; Porteu, F.] Univ Paris 05, CNRS UMR8104, Inst Cochin, INSERM 1016, Paris, France; [Lapillonne, H.; Ballerini, P.] Hop Trousseau, AP HP, Serv Hematol Biol, F-75571 Paris, France; [Uzan, B.; Pflumio, F.; Naguibneva, I.] Univ Paris 07, CEA, UMR967, Fontenay Aux Roses, France; [Brizard, F.] CHU Poitiers, Lab Hematol Biol, Poitiers, France; [Vabres, P.] Univ Bourgogne, CHU Dijon, Serv Dermatol, Dijon, France; [Vabres, P.] Univ Bourgogne, EA 4271, Dijon, France; [Millot, F.] CHU Poitiers, Serv Pediat, Poitiers, France	UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; CHU Poitiers; Universite de Poitiers; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Armand-Trousseau - APHP; UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Armand-Trousseau - APHP; UDICE-French Research Universities; Sorbonne Universite; CEA; UDICE-French Research Universities; Universite Paris Cite; Universite Paris Saclay; CHU Poitiers; Universite de Poitiers; CHU Dijon Bourgogne; Universite de Bourgogne; Institut Agro; AgroSup Dijon; Universite de Bourgogne; CHU Poitiers; Universite de Poitiers	Pasmant, E (corresponding author), Univ Paris 05, Sorbonne Paris Cite, Fac Sci Pharmaceut & Biol, UMR INSERM S745, F-75006 Paris, France.	eric.pasmant@gmail.com; paola.ballerini@trs.aphp.fr	Vabres, Pierre/V-3850-2019; Luscan, Armelle/O-8081-2017; Deswarte, Caroline/H-8018-2017; PORTEU, Françoise/I-8445-2016; Pasmant, Eric/O-7249-2017; Vabres, Pierre/D-3906-2011; A, Petit/H-1633-2011; Pflumio, Francoise/E-2074-2017; VIDAUD, Dominique/O-7357-2017	Vabres, Pierre/0000-0001-8693-3183; Deswarte, Caroline/0000-0002-8775-3368; PORTEU, Françoise/0000-0002-2403-4163; Pasmant, Eric/0000-0002-1881-8762; Vabres, Pierre/0000-0001-8693-3183; A, Petit/0000-0001-8363-1622; UZAN, Benjamin/0000-0001-6323-5737; Pflumio, Francoise/0000-0001-8995-596X; GILBERT-DUSSARDIER, Brigitte/0000-0001-7182-9914; de Laval, Berengere/0000-0002-5616-2338	l'Association pour la Recherche sur les Maladies Hematologiques de l'Enfant (A.R.M.H.E.)	l'Association pour la Recherche sur les Maladies Hematologiques de l'Enfant (A.R.M.H.E.)	This work was supported in part by grant from l'Association pour la Recherche sur les Maladies Hematologiques de l'Enfant (A.R.M.H.E.). We thank the patients and their parents for their participation. We are grateful to Pr. Akihiko Yoshimura for providing anti-Spred-1 antibody, Mrs. Frederique Siotto for expert technical assistance, and Dr. Audrey Sabbagh for her statistical expertise.	Bentires-Alj M, 2006, NAT MED, V12, P283, DOI 10.1038/nm0306-283; Braun BS, 2008, CLIN CANCER RES, V14, P2249, DOI 10.1158/1078-0432.CCR-07-1005; Brems H, 2007, NAT GENET, V39, P1120, DOI 10.1038/ng2113; Brems H, 2012, HUM MUTAT, V33, P1538, DOI 10.1002/humu.22152; Bundschu K, 2006, J BIOL CHEM, V281, P36477, DOI 10.1074/jbc.R600023200; Case M, 2008, CANCER RES, V68, P6803, DOI 10.1158/0008-5472.CAN-08-0101; Christiansen DH, 2005, LEUKEMIA, V19, P2232, DOI 10.1038/sj.leu.2404009; Cutts BA, 2009, BLOOD, V114, P3629, DOI 10.1182/blood-2009-02-205146; Gabert J, 2003, LEUKEMIA, V17, P2318, DOI 10.1038/sj.leu.2403135; Inoue H, 2005, J EXP MED, V201, P73, DOI 10.1084/jem.20040616; Ishizaki T, 2011, GENES CELLS, V16, P803, DOI 10.1111/j.1365-2443.2011.01529.x; Kandoth C, 2013, NATURE, V502, P333, DOI 10.1038/nature12634; Kindler T, 2010, BLOOD, V116, P5089, DOI 10.1182/blood-2010-04-261867; Lapillonne H, 2010, LEUKEMIA, V24, P205, DOI 10.1038/leu.2009.172; Lee W, 2010, NATURE, V465, P473, DOI 10.1038/nature09004; Letourneux C, 2006, EMBO J, V25, P727, DOI 10.1038/sj.emboj.7600980; Levine RL, 2009, NAT GENET, V41, P957, DOI 10.1038/ng0909-957; Messiaen L, 2009, JAMA-J AM MED ASSOC, V302, P2111, DOI 10.1001/jama.2009.1663; Miyoshi K, 2004, ONCOGENE, V23, P5567, DOI 10.1038/sj.onc.1207759; Mizuki M, 2000, BLOOD, V96, P3907, DOI 10.1182/blood.V96.12.3907; Nonami A, 2004, J BIOL CHEM, V279, P52543, DOI 10.1074/jbc.M405189200; Papaemmanuil E, 2009, NAT GENET, V41, P1006, DOI 10.1038/ng.430; Pasmant E, 2009, J MED GENET, V46, P425, DOI 10.1136/jmg.2008.065243; Pasmant E, 2009, BLOOD, V114, P1131, DOI 10.1182/blood-2009-04-218503; Renneville A, 2008, LEUKEMIA, V22, P915, DOI 10.1038/leu.2008.19; Schubbert S, 2007, NAT REV CANCER, V7, P295, DOI 10.1038/nrc2109; Stowe IB, 2012, GENE DEV, V26, P1421, DOI 10.1101/gad.190876.112; Tartaglia M, 2004, BLOOD, V104, P307, DOI 10.1182/blood-2003-11-3876; Trevino LR, 2009, NAT GENET, V41, P1001, DOI 10.1038/ng.432; Wakioka T, 2001, NATURE, V412, P647, DOI 10.1038/35088082; Walter RB, 2010, BLOOD, V116, P2420, DOI 10.1182/blood-2010-05-285387; Yoshida T, 2006, ONCOGENE, V25, P6056, DOI 10.1038/sj.onc.1209635	32	32	34	0	21	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 29	2015	34	5					631	638		10.1038/onc.2013.587	http://dx.doi.org/10.1038/onc.2013.587			8	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CA4DD	24469042				2022-12-25	WOS:000348853500010
J	Basak, NP; Roy, A; Banerjee, S				Basak, Nandini Pal; Roy, Anita; Banerjee, Subrata			Alteration of Mitochondrial Proteome Due to Activation of Notch1 Signaling Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Glutamine; Mitochondria; Notch Pathway; Proteomics; Respiratory Chain; Complex 1	ACUTE LYMPHOBLASTIC-LEUKEMIA; INTRACELLULAR DOMAIN; GLUTAMINE-METABOLISM; CELL-SURVIVAL; CANCER-CELLS; COMPLEX-I; T-CELLS; PROTEINS; GROWTH; MUTATIONS	Background: The role of Notch signaling in regulation of cell metabolism remains to be elucidated. Results: A two-dimensional DIGE study shows Notch signaling activation alters the expression of proteins of various metabolic pathways. Conclusion: Notch signaling activation leads to the remodeling of cellular metabolic pathways. Glutamine catabolism pathway proteins deregulated via canonical Notch pathway. Significance: This study connects an important signaling pathway to cellular metabolism. The Notch signaling pathway, a known regulator of cell fate decisions, proliferation, and apoptosis, has recently been implicated in the regulation of glycolysis, which affects tumor progression. However, the impact of Notch on other metabolic pathways remains to be elucidated. To gain more insights into the Notch signaling and its role in regulation of metabolism, we studied the mitochondrial proteome in Notch1-activated K562 cells using a comparative proteomics approach. The proteomic study led to the identification of 10 unique proteins that were altered due to Notch1 activation. Eight of these proteins belonged to mitochondria-localized metabolic pathways like oxidative phosphorylation, glutamine metabolism, Krebs cycle, and fatty acid oxidation. Validation of some of these findings showed that constitutive activation of Notch1 deregulated glutamine metabolism and Complex 1 of the respiratory chain. Furthermore, the deregulation of glutamine metabolism involved the canonical Notch signaling and its downstream effectors. The study also reports the effect of Notch signaling on mitochondrial function and status of high energy intermediates ATP, NADH, and NADPH. Thus our study shows the effect of Notch signaling on mitochondrial proteome, which in turn affects the functioning of key metabolic pathways, thereby connecting an important signaling pathway to the regulation of cellular metabolism.	[Basak, Nandini Pal; Roy, Anita; Banerjee, Subrata] Saha Inst Nucl Phys, Biophys & Struct Genom Div, Kolkata 700064, India	Saha Institute of Nuclear Physics	Banerjee, S (corresponding author), Saha Inst Nucl Phys, Biophys & Struct Genom Div, 1-AF Bidhannagar, Kolkata 700064, India.	subrata.banerjee@saha.ac.in		Roy, Anita/0000-0002-7297-2920	Integrative Biology on Omics Platform project of Dept. of Atomic Energy, Government of India; Council of Scientific and Industrial Research, Government of India	Integrative Biology on Omics Platform project of Dept. of Atomic Energy, Government of India; Council of Scientific and Industrial Research, Government of India(Council of Scientific & Industrial Research (CSIR) - India)	The work was supported by the Integrative Biology on Omics Platform project of Dept. of Atomic Energy, Government of India.; Recipient of a fellowship from Council of Scientific and Industrial Research, Government of India.	Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; Callahan R, 2004, J MAMMARY GLAND BIOL, V9, P145, DOI 10.1023/B:JOMG.0000037159.63644.81; Candiano G, 2004, ELECTROPHORESIS, V25, P1327, DOI 10.1002/elps.200305844; Carr EL, 2010, J IMMUNOL, V185, P1037, DOI 10.4049/jimmunol.0903586; Chadwick N, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-35; Chang WK, 2002, CLIN IMMUNOL, V104, P151, DOI 10.1006/clim.2002.5257; Cheng P, 2008, IMMUNOL RES, V41, P1, DOI 10.1007/s12026-007-8011-z; Chiarugi A, 2012, NAT REV CANCER, V12, P741, DOI 10.1038/nrc3340; Ciofani M, 2005, NAT IMMUNOL, V6, P881, DOI 10.1038/ni1234; de la Pena P, 2001, NEUROLOGY, V57, P1235, DOI 10.1212/WNL.57.7.1235; Eagar TN, 2004, IMMUNITY, V20, P407, DOI 10.1016/S1074-7613(04)00081-0; Fan X, 2004, CANCER RES, V64, P7787, DOI 10.1158/0008-5472.CAN-04-1446; Gao P, 2009, NATURE, V458, P762, DOI 10.1038/nature07823; Hoefs SJG, 2010, MOL GENET METAB, V100, P251, DOI 10.1016/j.ymgme.2010.03.015; Hoffstrom BG, 2010, NAT CHEM BIOL, V6, P900, DOI [10.1038/nchembio.467, 10.1038/NCHEMBIO.467]; Ishiko E, 2005, J BIOL CHEM, V280, P4929, DOI 10.1074/jbc.M406788200; Iso T, 2001, MOL CELL BIOL, V21, P6080, DOI 10.1128/MCB.21.17.6080-6089.2001; Janssen AJM, 2007, CLIN CHEM, V53, P729, DOI 10.1373/clinchem.2006.078873; Jeon SM, 2012, NATURE, V485, P661, DOI 10.1038/nature11066; Kannan S, 2013, J EXP MED, V210, P321, DOI 10.1084/jem.20121527; Kopan R, 2009, CELL, V137, P216, DOI 10.1016/j.cell.2009.03.045; Landor SKJ, 2011, P NATL ACAD SCI USA, V108, P18814, DOI 10.1073/pnas.1104943108; Leal MC, 2012, BBA-MOL CELL RES, V1823, P227, DOI 10.1016/j.bbamcr.2011.09.014; Lee SF, 2011, J BIOL CHEM, V286, P27447, DOI 10.1074/jbc.M111.243154; Liu HY, 2011, J BIOMED SCI, V18, DOI 10.1186/1423-0127-18-29; Meyer LR, 2013, NUCLEIC ACIDS RES, V41, pD64, DOI 10.1093/nar/gks1048; Nakagawa O, 2000, P NATL ACAD SCI USA, V97, P13655, DOI 10.1073/pnas.250485597; Neupert W, 2007, ANNU REV BIOCHEM, V76, P723, DOI 10.1146/annurev.biochem.76.052705.163409; Oka S, 2012, CIRC RES, V111, P611, DOI 10.1161/CIRCRESAHA.111.247932; Perumalsamy LR, 2009, CELL DEATH DIFFER, V16, P879, DOI 10.1038/cdd.2009.20; Radtke F, 2003, NAT REV CANCER, V3, P756, DOI 10.1038/nrc1186; Rao SS, 2009, CANCER RES, V69, P3060, DOI 10.1158/0008-5472.CAN-08-4295; Rathore MG, 2012, INT J BIOCHEM CELL B, V44, P1448, DOI 10.1016/j.biocel.2012.05.011; Rezaul K, 2005, MOL CELL PROTEOMICS, V4, P169, DOI 10.1074/mcp.M400115-MCP200; Rossignol R, 2004, CANCER RES, V64, P985, DOI 10.1158/0008-5472.CAN-03-1101; Roy A, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.119; Schroeter EH, 1998, NATURE, V393, P382, DOI 10.1038/30756; Shelton LM, 2010, INT J CANCER, V127, P2478, DOI 10.1002/ijc.25431; Taylor SW, 2003, NAT BIOTECHNOL, V21, P281, DOI 10.1038/nbt793; Tyagi M, 2007, EMBO J, V26, P4985, DOI 10.1038/sj.emboj.7601928; Wallace DC, 2012, NAT REV CANCER, V12, P685, DOI 10.1038/nrc3365; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Weng AP, 2004, SCIENCE, V306, P269, DOI 10.1126/science.1102160; Wise DR, 2010, TRENDS BIOCHEM SCI, V35, P427, DOI 10.1016/j.tibs.2010.05.003; Wise DR, 2008, P NATL ACAD SCI USA, V105, P18782, DOI 10.1073/pnas.0810199105; Yin DD, 2009, LEUKEMIA RES, V33, P109, DOI 10.1016/j.leukres.2008.06.023	46	36	40	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 14	2014	289	11					7320	7334		10.1074/jbc.M113.519405	http://dx.doi.org/10.1074/jbc.M113.519405			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AC8CV	24474689	Green Published, hybrid			2022-12-25	WOS:000332761500006
J	Bates, AJ; Sadler, JP; Grundy, D; Lowe, N; Davis, G; Baker, D; Bridge, M; Freestone, R; Gardner, D; Gibson, C; Hemming, R; Howarth, S; Orridge, S; Shaw, M; Tams, T; Young, H				Bates, Adam J.; Sadler, Jon P.; Grundy, Dave; Lowe, Norman; Davis, George; Baker, David; Bridge, Malcolm; Freestone, Roger; Gardner, David; Gibson, Chris; Hemming, Robin; Howarth, Stephen; Orridge, Steve; Shaw, Mark; Tams, Tom; Young, Heather			Garden and Landscape-Scale Correlates of Moths of Differing Conservation Status: Significant Effects of Urbanization and Habitat Diversity	PLOS ONE			English	Article							URBAN-DEVELOPMENT; CLIMATE-CHANGE; BIODIVERSITY; COMMON; LEPIDOPTERA; TEMPERATURE; BUTTERFLIES; EXTINCTION; IMPACT; CITY	Moths are abundant and ubiquitous in vegetated terrestrial environments and are pollinators, important herbivores of wild plants, and food for birds, bats and rodents. In recent years, many once abundant and widespread species have shown sharp declines that have been cited by some as indicative of a widespread insect biodiversity crisis. Likely causes of these declines include agricultural intensification, light pollution, climate change, and urbanization; however, the real underlying cause(s) is still open to conjecture. We used data collected from the citizen science Garden Moth Scheme (GMS) to explore the spatial association between the abundance of 195 widespread British species of moth, and garden habitat and landscape features, to see if spatial habitat and landscape associations varied for species of differing conservation status. We found that associations with habitat and landscape composition were species-specific, but that there were consistent trends in species richness and total moth abundance. Gardens with more diverse and extensive microhabitats were associated with higher species richness and moth abundance; gardens near to the coast were associated with higher richness and moth abundance; and gardens in more urbanized locations were associated with lower species richness and moth abundance. The same trends were also found for species classified as increasing, declining and vulnerable under IUCN (World Conservation Union) criteria. However, vulnerable species were more strongly negatively affected by urbanization than increasing species. Two hypotheses are proposed to explain this observation: (1) that the underlying factors causing declines in vulnerable species (e. g., possibilities include fragmentation, habitat deterioration, agrochemical pollution) across Britain are the same in urban areas, but that these deleterious effects are more intense in urban areas; and/or (2) that urban areas can act as ecological traps for some vulnerable species of moth, the light drawing them in from the surrounding landscape into sub-optimal urban habitats.	[Bates, Adam J.; Sadler, Jon P.] Univ Birmingham, Birmingham, W Midlands, England; [Grundy, Dave; Lowe, Norman; Davis, George; Baker, David; Bridge, Malcolm; Freestone, Roger; Gardner, David; Gibson, Chris; Hemming, Robin; Howarth, Stephen; Orridge, Steve; Shaw, Mark; Tams, Tom; Young, Heather] Garden Moth Scheme, Birmingham, W Midlands, England	University of Birmingham	Bates, AJ (corresponding author), Univ Birmingham, Birmingham, W Midlands, England.	a.j.bates@bham.ac.uk		Sadler, Jonathan/0000-0003-0443-4458; Bates, Adam/0000-0001-7854-5260	National Lottery (UK) through the Big Lottery Fund	National Lottery (UK) through the Big Lottery Fund	The analysis of this data forms part of the OPAL (Open Air Laboratories) project, which is funded by The National Lottery (UK) through the Big Lottery Fund (grant holder JPS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahrne K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005574; Altermatt F, 2012, GLOBAL CHANGE BIOL, V18, P2429, DOI 10.1111/j.1365-2486.2012.02727.x; [Anonymous], 2011, UK NATL ECOSYSTEM AS; Bale JS, 2002, GLOBAL CHANGE BIOL, V8, P1, DOI 10.1046/j.1365-2486.2002.00451.x; Bates AJ, 2013, ENTOMOL EXP APPL, V146, P386, DOI 10.1111/eea.12038; Bates AJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023459; Battin J, 2004, CONSERV BIOL, V18, P1482, DOI 10.1111/j.1523-1739.2004.00417.x; Bergerot B, 2010, LANDSCAPE URBAN PLAN, V96, P98, DOI 10.1016/j.landurbplan.2010.02.007; Bone J, 2012, ENVIRON SCI TECHNOL, V46, P3687, DOI 10.1021/es203880p; BOWDEN J, 1982, B ENTOMOL RES, V72, P535, DOI 10.1017/S0007485300008579; Brodgar, 2010, SOFTWARE PACKAGE DAT; Burnham K.P., 2002, MODEL SELECTION MULT, DOI 10.1007/b97636; Burton E, 2000, URBAN STUD, V37, P1969, DOI 10.1080/00420980050162184; Buse A, 1999, FUNCT ECOL, V13, P74, DOI 10.1046/j.1365-2435.1999.00010.x; Butterfly Conservation, 2007, UK BIOD ACT PLAN MOT; Calkins CO, 1998, J AGR ENTOMOL, V15, P327; Cameron RWF, 2012, URBAN FOR URBAN GREE, V11, P129, DOI 10.1016/j.ufug.2012.01.002; CHAO A, 1987, BIOMETRICS, V43, P783, DOI 10.2307/2531532; Cinzano P, 2004, MON NOT R ASTRON SOC, V353, P1107, DOI 10.1111/j.1365-2966.2004.08132.x; Cinzano P, 2001, MON NOT R ASTRON SOC, V328, P689, DOI 10.1046/j.1365-8711.2001.04882.x; COLWELL RK, 1994, PHILOS T R SOC B, V345, P101, DOI 10.1098/rstb.1994.0091; Conrad KF, 2006, BIOL CONSERV, V132, P279, DOI 10.1016/j.biocon.2006.04.020; Conrad KF, 2004, J INSECT CONSERV, V8, P119; Davey CM, 2012, GLOBAL ECOL BIOGEOGR, V21, P568, DOI 10.1111/j.1466-8238.2011.00693.x; Davies L, 2011, ENVIRON POLLUT, V159, P2203, DOI 10.1016/j.envpol.2011.02.053; Davies ZG, 2009, BIOL CONSERV, V142, P761, DOI 10.1016/j.biocon.2008.12.016; Deguines N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045822; Dennis RLH, 2003, OIKOS, V102, P417, DOI 10.1034/j.1600-0706.2003.12387.x; Dennis RLH, 2001, BIODIVERS CONSERV, V10, P1831, DOI 10.1023/A:1013161522916; Devoto M, 2011, ECOL ENTOMOL, V36, P25, DOI 10.1111/j.1365-2311.2010.01247.x; DWERNYCHUK LW, 1972, CAN J ZOOLOG, V50, P559, DOI 10.1139/z72-076; Elkinton JS, 1996, ECOLOGY, V77, P2332, DOI 10.2307/2265735; FRANK K D, 1988, Journal of the Lepidopterists' Society, V42, P63; Fry R, 2001, AMATEUR ENTOMOLOGIST, V24, P1; Fuentes-Montemayor E, 2011, J APPL ECOL, V48, P532, DOI 10.1111/j.1365-2664.2010.01927.x; Fukami T, 2005, P ROY SOC B-BIOL SCI, V272, P2105, DOI 10.1098/rspb.2005.3277; Gaston KJ, 2007, PROG PHYS GEOG, V31, P213, DOI 10.1177/0309133307076488; Gaston KJ, 2010, SCIENCE, V327, P154, DOI 10.1126/science.1182818; Goddard MA, 2010, TRENDS ECOL EVOL, V25, P90, DOI 10.1016/j.tree.2009.07.016; Gotelli, 2013, ENCY BIODIVERSITY, V5; Gotelli NJ, 2001, ECOL LETT, V4, P379, DOI 10.1046/j.1461-0248.2001.00230.x; Grimm NB, 2008, SCIENCE, V319, P756, DOI 10.1126/science.1150195; Groenendijk D, 2011, J INSECT CONSERV, V15, P95, DOI 10.1007/s10841-010-9326-y; Hardy PB, 1999, BIODIVERS CONSERV, V8, P1261, DOI 10.1023/A:1008984905413; Hernandez J., 2009, CITIES ENV, V2; Howe M. A., 2010, Journal of Coastal Conservation, V14, P91, DOI 10.1007/s11852-009-0055-x; Isaac NJB, 2011, J INSECT CONSERV, V15, P233, DOI 10.1007/s10841-010-9340-0; Johnson JB, 2004, TRENDS ECOL EVOL, V19, P101, DOI 10.1016/j.tree.2003.10.013; Jokimaki J, 2011, LANDSCAPE URBAN PLAN, V100, P383, DOI 10.1016/j.landurbplan.2011.02.001; Kerr JT, 2000, CONSERV BIOL, V14, P1726, DOI [10.1046/j.1523-1739.2000.99275.x, 10.1111/j.1523-1739.2000.99275.x]; Kozlov MV, 1996, J BIOGEOGR, V23, P95, DOI 10.1046/j.1365-2699.1996.d01-219.x; Krebs JR, 1999, NATURE, V400, P611, DOI 10.1038/23127; Kremen C, 2007, ECOL LETT, V10, P299, DOI 10.1111/j.1461-0248.2007.01018.x; Kyba CCM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017307; Leps J, 2003, MULTIVARIATE ANAL EC; Levy JM, 2004, J INSECT CONSERV, V8, P323, DOI 10.1007/s10841-004-0796-7; Lindenmayer DB, 2011, BIOL CONSERV, V144, P1663, DOI 10.1016/j.biocon.2011.02.022; Mattila N, 2006, CONSERV BIOL, V20, P1161, DOI 10.1111/j.1523-1739.2006.00404.x; McCarthy K, 2011, URBAN ECOSYST, V14, P395, DOI 10.1007/s11252-011-0161-z; McGeoch MA, 1997, BIODIVERS CONSERV, V6, P979, DOI 10.1023/A:1018315614085; McKinney M. L., 2008, Urban Ecosystems, V11, P161, DOI 10.1007/s11252-007-0045-4; New TR, 2004, J INSECT CONSERV, V8, P79, DOI 10.1023/B:JICO.0000045807.04047.bd; Niemela J, 2009, LANDSCAPE URBAN PLAN, V92, P65, DOI 10.1016/j.landurbplan.2009.05.016; O'Hara RB, 2010, METHODS ECOL EVOL, V1, P118, DOI 10.1111/j.2041-210X.2010.00021.x; Owen J., 2010, WILDLIFE GARDEN 30 Y; PETTERSSON MW, 1991, J ECOL, V79, P591, DOI 10.2307/2260655; Pinheiro J, 2001, MIXED EFFECTS MODELS; PULLIAM HR, 1988, AM NAT, V132, P652, DOI 10.1086/284880; R Development Core Team, 2006, R LANG ENV STAT COMP; Rich C, 2006, ECOLOGICAL CONSQUENC; Ricketts TH, 2001, CONSERV BIOL, V15, P378, DOI 10.1046/j.1523-1739.2001.015002378.x; Rickman JK, 2003, ECOGRAPHY, V26, P777, DOI 10.1111/j.0906-7590.2003.03345.x; Robinson H. S., 1950, Entomologist's Gazette, V1, P3; Robinson RA, 2002, J APPL ECOL, V39, P157, DOI 10.1046/j.1365-2664.2002.00695.x; Rosch M, 2001, AFR ENTOMOL, V9, P85; Sadler JP, 2006, J BIOGEOGR, V33, P1126, DOI 10.1111/j.1365-2699.2006.01476.x; Small C, 2005, REMOTE SENS ENVIRON, V96, P277, DOI 10.1016/j.rse.2005.02.002; Smith RM, 2006, BIODIVERS CONSERV, V15, P2415, DOI 10.1007/s10531-004-5014-0; Summerville KS, 2004, ECOGRAPHY, V27, P3, DOI 10.1111/j.0906-7590.2004.03664.x; Taylor L.R., 1978, P31; Taylor ME, 2009, AGR ECOSYST ENVIRON, V130, P9, DOI 10.1016/j.agee.2008.11.004; Ter Braak C.J.F., 1998, CANOCO RELEASE 4 REF; Thomas CD, 2004, NATURE, V427, P145, DOI 10.1038/nature02121; TURNER JRG, 1987, OIKOS, V48, P195, DOI 10.2307/3565855; Van Dyck H, 2009, CONSERV BIOL, V23, P957, DOI 10.1111/j.1523-1739.2009.01175.x; van Heezik Y, 2010, BIOL CONSERV, V143, P121, DOI 10.1016/j.biocon.2009.09.013; Vaughan N, 1997, MAMMAL REV, V27, P77, DOI 10.1111/j.1365-2907.1997.tb00373.x; Visser ME, 2006, OECOLOGIA, V147, P164, DOI 10.1007/s00442-005-0299-6; Walker LR, 2010, J ECOL, V98, P725, DOI 10.1111/j.1365-2745.2010.01664.x; Waring P., 2009, FIELD GUIDE MOTHS GR; Warren MS, 2011, J INSECT CONSERV, V15, P321, DOI 10.1007/s10841-010-9356-5; Wood S, 2017, GEN ADDITIVE MODELS, DOI 10.1201/9781315370279	92	44	47	4	196	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2014	9	1							e86925	10.1371/journal.pone.0086925	http://dx.doi.org/10.1371/journal.pone.0086925			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301BI	24475197	gold, Green Submitted, Green Published			2022-12-25	WOS:000330507300118
J	da Silva, JM; Herrel, A; Measey, GJ; Tolley, KA				da Silva, Jessica M.; Herrel, Anthony; Measey, G. John; Tolley, Krystal A.			Sexual Dimorphism in Bite Performance Drives Morphological Variation in Chameleons	PLOS ONE			English	Article							ANTILLEAN ANOLIS LIZARDS; DWARF CHAMELEONS; LACERTID LIZARDS; BODY-SIZE; ECOMORPHOLOGICAL VARIATION; HABITAT USE; HEAD SHAPE; TEMPORAL DIMENSIONS; FORCE PERFORMANCE; SPECIES-DIVERSITY	Phenotypic performance in different environments is central to understanding the evolutionary and ecological processes that drive adaptive divergence and, ultimately, speciation. Because habitat structure can affect an animal's foraging behaviour, anti-predator defences, and communication behaviour, it can influence both natural and sexual selection pressures. These selective pressures, in turn, act upon morphological traits to maximize an animal's performance. For performance traits involved in both social and ecological activities, such as bite force, natural and sexual selection often interact in complex ways, providing an opportunity to understand the adaptive significance of morphological variation with respect to habitat. Dwarf chameleons within the Bradypodion melanocephalum-Bradypodion thamnobates species complex have multiple phenotypic forms, each with a specific head morphology that could reflect its use of either open-or closed-canopy habitats. To determine whether these morphological differences represent adaptations to their habitats, we tested for differences in both absolute and relative bite performance. Only absolute differences were found between forms, with the closed-canopy forms biting harder than their open-canopy counterparts. In contrast, sexual dimorphism was found for both absolute and relative bite force, but the relative differences were limited to the closed-canopy forms. These results indicate that both natural and sexual selection are acting within both habitat types, but to varying degrees. Sexual selection seems to be the predominant force within the closed-canopy habitats, which are more protected from aerial predators, enabling chameleons to invest more in ornamentation for communication. In contrast, natural selection is likely to be the predominant force in the open-canopy habitats, inhibiting the development of conspicuous secondary sexual characteristics and, ultimately, enforcing their overall diminutive body size and constraining performance.	[da Silva, Jessica M.; Measey, G. John; Tolley, Krystal A.] South African Natl Biodivers Inst, Appl Biodivers Res Div, Cape Town, Western Cape Pr, South Africa; [da Silva, Jessica M.] Univ Stellenbosch, Dept Conservat Ecol & Entomol, ZA-7600 Stellenbosch, Western Cape Pr, South Africa; [Herrel, Anthony] Museum Natl Hist Nat, CNRS, Dept Ecol & Gest Biodiversite, Paris, Ile De France, France; [Herrel, Anthony] Univ Ghent, Dept Biol, Evolutionary Morphol Vertebrates Res Grp, B-9000 Ghent, East Flanders, Belgium; [Measey, G. John] Nelson Mandela Metropolitan Univ, Dept Zool, Port Elizabeth, Eastern Cape Pr, South Africa; [Tolley, Krystal A.] Univ Stellenbosch, Dept Bot & Zool, ZA-7600 Stellenbosch, Western Cape Pr, South Africa	South African National Biodiversity Institute; Stellenbosch University; Centre National de la Recherche Scientifique (CNRS); Museum National d'Histoire Naturelle (MNHN); Ghent University; Nelson Mandela University; Stellenbosch University	da Silva, JM (corresponding author), South African Natl Biodivers Inst, Appl Biodivers Res Div, Cape Town, Western Cape Pr, South Africa.	jessica.m.dasilva@gmail.com	DA SILVA, JESSICA/HGA-0333-2022; Herrel, Anthony/C-3712-2013; Measey, John/F-2028-2010; da Silva, Jessica Marie/J-4290-2012	Herrel, Anthony/0000-0003-0991-4434; Measey, John/0000-0001-9939-7615; da Silva, Jessica Marie/0000-0001-8385-1166; Tolley, Krystal/0000-0002-7778-1963	National Research Foundation (NRF) of South Africa (South African Biosystematics Initiative) [UID 69817]; National Research Foundation (NRF) of South Africa (Key International Science Capacity Fund Program) [FA2007022700016]; SANBI-NORAD Threatened Species Program; Jordan Wines; Stellenbosch University; NRF	National Research Foundation (NRF) of South Africa (South African Biosystematics Initiative); National Research Foundation (NRF) of South Africa (Key International Science Capacity Fund Program); SANBI-NORAD Threatened Species Program; Jordan Wines; Stellenbosch University; NRF	The authors thank the National Research Foundation (NRF) of South Africa (South African Biosystematics Initiative - Grant Number UID 69817; Key International Science Capacity Fund Program - Grant Number FA2007022700016) and the SANBI-NORAD Threatened Species Program for financial support, as well as the South African National Biodiversity for logistical support for this work. Jordan Wines, Stellenbosch University, and NRF provided bursaries for JMdS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	ANDERSSON M, 1982, BIOL J LINN SOC, V17, P375, DOI 10.1111/j.1095-8312.1982.tb02028.x; ASPLUND KK, 1974, COPEIA, P695, DOI 10.2307/1442683; Bickel R, 2002, BIOL J LINN SOC, V76, P91, DOI 10.1111/j.1095-8312.2002.tb01717.x; Brana F, 1996, OIKOS, V75, P511, DOI 10.2307/3545893; Burnham KP, 2002, MULTIMODEL INFERENCE; BURRAGE B R, 1973, Annals of the South African Museum, V61, P1; Butler MA, 2000, EVOLUTION, V54, P259, DOI 10.1111/j.0014-3820.2000.tb00026.x; Butler MA, 2002, ECOL MONOGR, V72, P541, DOI 10.1890/0012-9615(2002)072[0541:MSDSSA]2.0.CO;2; Butler MA, 2007, NATURE, V447, P202, DOI 10.1038/nature05774; Clark TE, 1997, J INSECT CONSERV, V1, P221, DOI 10.1023/A:1018472118513; Cuadrado M, 2001, J ZOOL, V255, P425; Da Silva JM, 2013, BIOL J LINN SOC, V109, P113, DOI 10.1111/bij.12045; DeVries PJ, 1999, BIOL J LINN SOC, V68, P333, DOI 10.1111/j.1095-8312.1999.tb01175.x; DeVries PJ, 1997, BIOL J LINN SOC, V62, P343, DOI 10.1111/j.1095-8312.1997.tb01630.x; ENDLER JA, 1983, ENVIRON BIOL FISH, V9, P173, DOI 10.1007/BF00690861; Fleishman Leo J., 2000, P209; FLEISHMAN LJ, 1992, AM NAT, V139, pS36, DOI 10.1086/285304; FLEMING TH, 1991, J MAMMAL, V72, P493, DOI 10.2307/1382132; Gray J. E., 1865, P ZOOL SOC LOND, V1864, P465; Grimbacher PS, 2007, AUSTRAL ECOL, V32, P77, DOI 10.1111/j.1442-9993.2007.01735.x; Herrel A, 2006, PHYSIOL BIOCHEM ZOOL, V79, P31, DOI 10.1086/498193; Herrel A, 2001, J EXP ZOOL, V290, P101, DOI 10.1002/jez.1039; Herrel A, 2001, CAN J ZOOL, V79, P662, DOI 10.1139/cjz-79-4-662; Herrel A, 1999, FUNCT ECOL, V13, P289, DOI 10.1046/j.1365-2435.1999.00305.x; Herrel A, 2004, J EVOLUTION BIOL, V17, P974, DOI 10.1111/j.1420-9101.2004.00758.x; Herrel A, 2008, ZOOLOGY, V111, P467, DOI 10.1016/j.zool.2008.01.002; Herrel A, 2007, BIOL J LINN SOC, V91, P111, DOI 10.1111/j.1095-8312.2007.00772.x; Herrel A, 2006, BIOL J LINN SOC, V89, P443, DOI 10.1111/j.1095-8312.2006.00685.x; Herrel A, 2010, BIOL J LINN SOC, V100, P287, DOI 10.1111/j.1095-8312.2010.01433.x; Husak JF, 2006, COPEIA, P301, DOI 10.1643/0045-8511(2006)6[301:BPPDIM]2.0.CO;2; Huyghe K, 2005, FUNCT ECOL, V19, P800, DOI 10.1111/j.1365-2435.2005.01038.x; Huyghe K, 2009, BIOL J LINN SOC, V96, P13, DOI 10.1111/j.1095-8312.2008.01103.x; Kaliontzopoulou A, 2010, J EVOLUTION BIOL, V23, P1234, DOI 10.1111/j.1420-9101.2010.01984.x; Kaliontzopoulou A, 2012, EVOL ECOL, V26, P825, DOI 10.1007/s10682-011-9538-y; Kotze DJ, 1999, BIODIVERS CONSERV, V8, P1339, DOI 10.1023/A:1008945302029; Kratochvil L, 2003, CAN J ZOOL, V81, P1112, DOI 10.1139/Z03-078; Lailvaux SP, 2007, AM NAT, V170, P573, DOI 10.1086/521234; Lappin AK, 2006, BIOL J LINN SOC, V88, P215, DOI 10.1111/j.1095-8312.2006.00615.x; Lawrence JM, 2002, BIODIVERS CONSERV, V11, P1163, DOI 10.1023/A:1016017114473; Leal M, 2004, AM NAT, V163, P26, DOI 10.1086/379794; Mccoy MW, 2006, OECOLOGIA, V148, P547, DOI 10.1007/s00442-006-0403-6; Measey GJ, 2011, J ZOOL, V285, P247, DOI 10.1111/j.1469-7998.2011.00861.x; Measey GJ, 2009, ZOOLOGY, V112, P217, DOI 10.1016/j.zool.2008.09.005; Miller AK, 2009, AFR ZOOL, V44, P45, DOI 10.3377/004.044.0105; Portner HO, 2008, SCIENCE, V322, P690, DOI 10.1126/science.1163156; Pryke SR, 2003, BIODIVERS CONSERV, V12, P1985, DOI 10.1023/A:1024103527611; RAND AS, 1961, COPEIA, P411; RAW L R G, 1976, Durban Museum Novitates, V11, P139; RIEPPEL O, 1981, REV SUISSE ZOOL, V88, P433, DOI 10.5962/bhl.part.82383; RiversMoore NA, 1996, BIODIVERS CONSERV, V5, P1545, DOI 10.1007/BF00052115; Samways MJ, 1996, AGR ECOSYST ENVIRON, V59, P19, DOI 10.1016/0167-8809(96)01047-X; Schluter D., 2000, ECOLOGY ADAPTIVE RAD; SCHOENER TW, 1967, SCIENCE, V155, P474, DOI 10.1126/science.155.3761.474; Segall M, 2013, J EXP BIOL, V216, P3828, DOI 10.1242/jeb.092353; SHINE R, 1989, Q REV BIOL, V64, P419, DOI 10.1086/416458; Silva da JM, 2013, FUNCTIONAL ECOLOGY; SPSS Inc, 2008, SPSS WIND 17 0; Stuart-Fox D, 2007, J EVOLUTION BIOL, V20, P1073, DOI 10.1111/j.1420-9101.2007.01295.x; Stuart-Fox D, 2008, PLOS BIOL, V6, P22, DOI 10.1371/journal.pbio.0060025; Stuart-Fox D, 2007, AM NAT, V170, P916, DOI 10.1086/522835; Stuart-Fox D, 2006, BIOL J LINN SOC, V88, P437, DOI 10.1111/j.1095-8312.2006.00631.x; Stuart-Fox DM, 2006, ANIM BEHAV, V71, P1263, DOI 10.1016/j.anbehav.2005.07.028; Stuart-Fox DM, 2005, BIOL LETTERS, V1, P231, DOI 10.1098/rsbl.2005.0299; Stuart-Fox DM, 2003, ANIM BEHAV, V66, P541, DOI 10.1006/anbe.2003.2235; Tabachnick B.G., 2007, USING MULTIVARIATE S, VVolume 5, P481; Tilbury C.R., 2010, CHAMELEONS AFRICA AT; Tolley KA, 2006, MOL ECOL, V15, P781, DOI 10.1111/j.1365-294X.2006.02836.x; Tolley KA, 2004, MOL PHYLOGENET EVOL, V30, P354, DOI 10.1016/S1055-7903(03)00211-2; Tolley KA., 2007, CHAMELEONS SO AFRICA; Tolley KA, 2008, J BIOGEOGR, V35, P1402, DOI 10.1111/j.1365-2699.2008.01889.x; Tolley KA, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.0184; Vanhooydonck B, 2011, BIOL J LINN SOC, V102, P91, DOI 10.1111/j.1095-8312.2010.01563.x; Vanhooydonck B, 2010, BIOL J LINN SOC, V101, P461, DOI 10.1111/j.1095-8312.2010.01519.x; Verwaijen D, 2002, FUNCT ECOL, V16, P842, DOI 10.1046/j.1365-2435.2002.00696.x; WASER PM, 1984, BEHAV ECOL SOCIOBIOL, V15, P73, DOI 10.1007/BF00310219	75	17	17	0	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2014	9	1							e86846	10.1371/journal.pone.0086846	http://dx.doi.org/10.1371/journal.pone.0086846			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301BI	24475183	Green Submitted, Green Published, gold			2022-12-25	WOS:000330507300111
J	Wang, LJ; Zeng, YY; Wang, TL; Liu, HY; Xiao, H; Xiang, H				Wang, Lijun; Zeng, Yanyan; Wang, Tianling; Liu, Hongyi; Xiao, Hong; Xiang, Hua			Evaluating the Potential Bioactivity of a Novel Compound ER1626	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; ESTROGEN-RECEPTOR-BETA; BREAST-CANCER; POSTMENOPAUSAL WOMEN; CELL-GROWTH; ER-ALPHA; RALOXIFENE; TAMOXIFEN; RISK; EXPRESSION	Background: ER1626, a novel compound, is a derivate of indeno-isoquinoline ketone. This study was designed to evaluate the biological activity and potential anti-tumor mechanism of ER1626. Method: MTT assay, scratch assay and flow cytometry were used to determine cell proliferation, cell migration and cell cycle distribution as well as cell apoptosis on human breast cancer MCF-7 cells and endometrial cancer Ishikawa cells. We also explored the antiangiogenic effect of ER1626 on HUVEC cells and chicken embryos. The expression of estrogen receptor protein was investigated with western-blot analysis. Results: ER1626 down-regulated the expression of estrogen receptor alpha protein and up-regulated beta protein in MCF-7 and Ishikawa cells. The value of IC50 of ER1626 on MCF-7 and Ishikawa cells were respectively 8.52 and 3.08 mu mol/L. Meanwhile, ER1626 decreased VEGF secretion of MCF-7 and Ishikawa cells, disturbed the formation of VEGF-stimulated tubular structure in HUVEC cells, and inhibited the angiogenesis on the chicken chorioallantoic membrane. Scratch assay revealed that ER1626 suppressed the migration of MCF-7, Ishikawa and HUVEC cells. In addition to induction tumor cell apoptosis, ER1626 arrested cell cycle in G1/G0 phase in MCF-7 cells and G2/M phase in Ishikawa cells. Conclusion: In conclusion, our results demonstrated that ER1626 has favorable bioactivities to be a potential candidate against breast cancer and angiogenesis.	[Wang, Lijun; Zeng, Yanyan; Liu, Hongyi; Xiao, Hong] Nanjing Med Univ, Affiliated Nanjing Brain Hosp, Nanjing, Jiangsu, Peoples R China; [Wang, Tianling; Xiang, Hua] China Pharmaceut Univ, Dept Pharmaceut Chem, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University; China Pharmaceutical University	Xiao, H (corresponding author), Nanjing Med Univ, Affiliated Nanjing Brain Hosp, Nanjing, Jiangsu, Peoples R China.	xhnkyy123@163.com; cpuxianghua@sina.com		Xiao, Hong/0000-0003-4248-3146; Xiang, Hua/0000-0002-8937-4062	Twelfth Five-Year Original New Drug Research Program [2012ZX09103-101-048]; National Natural Science Foundation [81373279]; Jiangsu Province Technology Supporting Plan-Social Development [BE2012745]	Twelfth Five-Year Original New Drug Research Program; National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Jiangsu Province Technology Supporting Plan-Social Development	This work was funded by Twelfth Five-Year Original New Drug Research Program (2012ZX09103-101-048), National Natural Science Foundation (81373279) and Jiangsu Province Technology Supporting Plan-Social Development (BE2012745). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Cancer Society, 2012, CANC FACTS FIG 2012; Applanat MP, 2008, ADV EXP MED BIOL, V617, P437, DOI 10.1007/978-0-387-69080-3_42; Balfe PJ, 2004, EJSO-EUR J SURG ONC, V30, P1043, DOI 10.1016/j.ejso.2004.06.019; Barrett-Connor E, 2006, NEW ENGL J MED, V355, P125, DOI 10.1056/NEJMoa062462; Beral V, 1997, LANCET, V350, P1047, DOI 10.1016/S0140-6736(97)08233-0; Birkhauser Martin, 2012, Ther Umsch, V69, P163, DOI 10.1024/0040-5930/a000269; Brown K, 2009, MUTAGENESIS, V24, P391, DOI 10.1093/mutage/gep022; Clemons M, 2001, NEW ENGL J MED, V344, P276, DOI 10.1056/NEJM200101253440407; Cummings SR, 1999, JAMA-J AM MED ASSOC, V281, P2189, DOI 10.1001/jama.281.23.2189; Dalenc F, 2005, BREAST CANCER RES, V7, pR1159, DOI 10.1186/bcr1357; Dent SF, 2011, BREAST CANCER RES TR, V126, P295, DOI 10.1007/s10549-011-1351-3; Dimmeler S, 2000, FEBS LETT, V477, P258, DOI 10.1016/S0014-5793(00)01657-4; Esser S, 1998, J CELL SCI, V111, P1853; Ettinger B, 1999, JAMA-J AM MED ASSOC, V282, P637, DOI 10.1001/jama.282.7.637; Ferrara N, 2003, NAT MED, V9, P669, DOI 10.1038/nm0603-669; Fima E, 2001, ONCOGENE, V20, P6794, DOI 10.1038/sj.onc.1204885; Fisher B, 1998, J NATL CANCER I, V90, P1371, DOI 10.1093/jnci/90.18.1371; Martin AG, 2010, BREAST CANCER RES TR, V123, P43, DOI 10.1007/s10549-010-1045-2; Guthrie N, 1997, J NUTR, V127, pS544, DOI 10.1093/jn/127.3.544S; Heldring N, 2007, PHYSIOL REV, V87, P905, DOI 10.1152/physrev.00026.2006; Hodges-Gallagher L, 2008, BREAST CANCER RES TR, V109, P241, DOI 10.1007/s10549-007-9640-6; Hu K, 2005, INT J GYNECOL CANCER, V15, P537, DOI 10.1111/j.1525-1438.2005.15321.x; Hua X, 2011, International Patent, Patent No. [WO/2011/047515, 2011047515]; Hua X, 2010, China Patent CN, Patent No. [101693688 A, 101693688]; Kerbel RS, 2008, NEW ENGL J MED, V358, P2039, DOI 10.1056/NEJMra0706596; Kevil CG, 1998, J BIOL CHEM, V273, P15099, DOI 10.1074/jbc.273.24.15099; Leygue E, 1998, CANCER RES, V58, P3197; Mendoza RA, 2011, J ENDOCRINOL, V208, P1, DOI 10.1677/JOE-10-0235; MINCHENKO A, 1994, LAB INVEST, V71, P374; Morris AD, 1997, ANTI-CANCER DRUG, V8, P746, DOI 10.1097/00001813-199709000-00003; Musa MA, 2011, MED CHEM, V7, P112; Nilsson S, 2000, BREAST CANCER RES, V2, P360, DOI 10.1186/bcr81; Paruthiyil S, 2004, CANCER RES, V64, P423, DOI 10.1158/0008-5472.CAN-03-2446; Pinkerton JV, 2010, MENOPAUSE, V17, P642, DOI 10.1097/gme.0b013e3181c4f1d6; SENGER DR, 1983, SCIENCE, V219, P983, DOI 10.1126/science.6823562; Stefanick ML, 2006, NEW ENGL J MED, V355, P190, DOI 10.1056/NEJMe068120; Vogel VG, 2006, JAMA-J AM MED ASSOC, V295, P2727, DOI 10.1001/jama.295.23.joc60074; Wan ZL, 2013, MINI-REV MED CHEM, V13, P1381; Williams-Brown MY, 2011, J STEROID BIOCHEM, V126, P78, DOI 10.1016/j.jsbmb.2011.05.001; Yager JD, 2006, NEW ENGL J MED, V354, P270, DOI 10.1056/NEJMra050776	40	6	6	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2014	9	1							e86509	10.1371/journal.pone.0086509	http://dx.doi.org/10.1371/journal.pone.0086509			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301BI	24475135	Green Published, gold, Green Submitted			2022-12-25	WOS:000330507300073
J	Chen, JP; Qin, ZZ; Jiang, Y; Wang, YR; He, YS; Dai, JC; Jin, GF; Ma, HX; Hu, ZB; Yin, YM; Shen, HB				Chen, Jiaping; Qin, Zhenzhen; Jiang, Yue; Wang, Yanru; He, Yisha; Dai, Juncheng; Jin, Guangfu; Ma, Hongxia; Hu, Zhibin; Yin, Yongmei; Shen, Hongbing			Genetic Variations in the Flanking Regions of miR-101-2 Are Associated with Increased Risk of Breast Cancer	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; LUNG-CANCER; MICRORNA-101; EZH2; BIOGENESIS; CARCINOMA; VARIANTS; HAIRPINS	Genetic variants in human microRNA (miRNA) genes may alter mature miRNA processing and/or target selection, and likely contribute to cancer susceptibility and disease progression. Previous studies have suggested that miR-101 may play important roles in the development of cancer by regulating key tumor-associated genes. However, the role of single nucleotide polymorphisms (SNPs) of miR-101 in breast cancer susceptibility remains unclear. In this study, we genotyped 11 SNPs of the miR-101 genes (including miR-101-1 and miR-101-2) in a case-control study of 1064 breast cancer cases and 1073 cancer-free controls. The results revealed that rs462480 and rs1053872 in the flank regions of pre-miR-101-2 were significantly associated with increased risk of breast cancer (rs462480 AC/CC vs AA: adjusted OR = 1.182, 95% CI: 1.030-1.357, P=0.017; rs1053872 CG/GG vs CC: adjusted OR = 1.179, 95% CI: 1.040-1.337, P=0.010). However, the remaining 9 SNPs were not significantly associated with risk of breast cancer. Additionally, combined analysis of the two high-risk SNPs revealed that subjects carrying the variant genotypes of rs462480 and rs1053872 had increased risk of breast cancer in a dose-response manner (P-trend = 0.002). Compared with individuals with "0-1" risk allele, those carrying "2-4" risk alleles had 1.29-fold risk of breast cancer. In conclusion, these findings suggested that the SNPs rs462480 and rs1053872 residing in miR-101-2 gene may have a solid impact on genetic susceptibility to breast cancer, which may improve our understanding of the potential contribution of miRNA SNPs to cancer pathogenesis.	[Chen, Jiaping; Jiang, Yue; Dai, Juncheng; Jin, Guangfu; Ma, Hongxia; Hu, Zhibin; Shen, Hongbing] Nanjing Med Univ, Sch Publ Hlth, MOE Key Lab Modern Toxicol, Nanjing, Jiangsu, Peoples R China; [Qin, Zhenzhen; Jiang, Yue; He, Yisha; Jin, Guangfu; Ma, Hongxia; Hu, Zhibin; Shen, Hongbing] Nanjing Med Univ, Inst Toxicol, State Key Lab Reprod Med, Nanjing, Jiangsu, Peoples R China; [Chen, Jiaping; Jin, Guangfu; Ma, Hongxia; Hu, Zhibin; Shen, Hongbing] Nanjing Med Univ, Clin Epidemiol Sect, Jiangsu Key Lab Canc Biomarkers Prevent & Treatme, Ctr Canc, Nanjing, Jiangsu, Peoples R China; [Wang, Yanru] Southern Med Univ, Jinling Hosp, Dept Med Oncol, Nanjing, Jiangsu, Peoples R China; [Yin, Yongmei] Nanjing Med Univ, Affiliated Hosp 1, Dept Gen Surg, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University; Nanjing Medical University; Nanjing Medical University; Southern Medical University - China; Nanjing Medical University	Yin, YM (corresponding author), Nanjing Med Univ, Affiliated Hosp 1, Dept Gen Surg, Nanjing, Jiangsu, Peoples R China.	ym.yin@hotmail.com; hbshen@njmu.edu.cn			National Natural Science Foundation of China [81102179, 81071715, 81230067]; Natural Science Foundation of Jiangsu Higher Education Institutions [09KJA330001]; Program for Changjiang Scholars and Innovative Research Team in University [IRT0631]; Priority Academic Program for the Development of Jiangsu Higher Education Institutions (Public Health and Preventive Medicine)	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Jiangsu Higher Education Institutions; Program for Changjiang Scholars and Innovative Research Team in University(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT)); Priority Academic Program for the Development of Jiangsu Higher Education Institutions (Public Health and Preventive Medicine)	Funding support for this project was provided by National Natural Science Foundation of China (grant number 81102179; 81071715), Key Project of the National Natural Science Foundation of China (grant number 81230067), Key Grant of Natural Science Foundation of Jiangsu Higher Education Institutions (09KJA330001), The Program for Changjiang Scholars and Innovative Research Team in University (IRT0631) and the Priority Academic Program for the Development of Jiangsu Higher Education Institutions (Public Health and Preventive Medicine). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Auyeung VC, 2013, CELL, V152, P844, DOI 10.1016/j.cell.2013.01.031; Bae JS, 2012, DIGEST LIVER DIS, V44, P849, DOI 10.1016/j.dld.2012.04.021; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Calin GA, 2004, P NATL ACAD SCI USA, V101, P2999, DOI 10.1073/pnas.0307323101; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Carvalho J, 2012, J PATHOL, V228, P31, DOI 10.1002/path.4032; Coughlin SS, 2009, CANCER EPIDEMIOL, V33, P315, DOI 10.1016/j.canep.2009.10.003; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Frankel LB, 2011, EMBO J, V30, P4628, DOI 10.1038/emboj.2011.331; Han JJ, 2004, GENE DEV, V18, P3016, DOI 10.1101/gad.1262504; Hoffman AE, 2009, CANCER RES, V69, P5970, DOI 10.1158/0008-5472.CAN-09-0236; Hu ZB, 2008, J CLIN INVEST, V118, P2600, DOI 10.1172/JCI34934; Hu ZB, 2009, HUM MUTAT, V30, P79, DOI 10.1002/humu.20837; Lee Y, 2003, NATURE, V425, P415, DOI 10.1038/nature01957; Lichtenstein P, 2000, NEW ENGL J MED, V343, P78, DOI 10.1056/NEJM200007133430201; Long JR, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002532; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Porter P, 2008, NEW ENGL J MED, V358, P213, DOI 10.1056/NEJMp0708307; Qin ZZ, 2013, GENE, V527, P491, DOI 10.1016/j.gene.2013.06.067; Ren G, 2012, CANCER RES, V72, P3091, DOI 10.1158/0008-5472.CAN-11-3546; Ryan BM, 2010, NAT REV CANCER, V10, DOI 10.1038/nrc2885; Sachdeva M, 2011, ONCOGENE, V30, P822, DOI 10.1038/onc.2010.463; Shi TY, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-19; Smits M, 2010, ONCOTARGET, V1, P710, DOI 10.18632/oncotarget.205; Su H, 2009, CANCER RES, V69, P1135, DOI 10.1158/0008-5472.CAN-08-2886; Sun GH, 2009, RNA, V15, P1640, DOI 10.1261/rna.1560209; Thomas G, 2009, NAT GENET, V41, P579, DOI 10.1038/ng.353; Tian T, 2009, CANCER EPIDEM BIOMAR, V18, P1183, DOI 10.1158/1055-9965.EPI-08-0814; Turnbull C, 2010, NAT GENET, V42, P504, DOI 10.1038/ng.586; Varambally S, 2008, SCIENCE, V322, P1695, DOI 10.1126/science.1165395; Wang ML, 2012, CANCER RES, V72, P6173, DOI 10.1158/0008-5472.CAN-12-0688; Wang R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046173; Yang Q, 2012, ONCOGENE, DOI [10.1038/onc.2012.569, DOI 10.1038/0NC.2012.569.[]; Zeng Y, 2005, J BIOL CHEM, V280, P27595, DOI 10.1074/jbc.M504714200; Zheng W, 2009, NAT GENET, V41, P324, DOI 10.1038/ng.318	35	21	22	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2014	9	1							e86319	10.1371/journal.pone.0086319	http://dx.doi.org/10.1371/journal.pone.0086319			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	298QQ	24475105	Green Published, Green Submitted, gold			2022-12-25	WOS:000330339800040
J	Yang, TU; Cheong, HJ; Song, JY; Lee, JS; Wie, SH; Kim, YK; Choi, WS; Lee, J; Jeong, HW; Kim, WJ				Yang, Tae Un; Cheong, Hee Jin; Song, Joon Young; Lee, Jin Soo; Wie, Seong-Heon; Kim, Young Keun; Choi, Won Suk; Lee, Jacob; Jeong, Hye Won; Kim, Woo Joo			Age- and Influenza Activity-Stratified Case Definitions of Influenza-Like Illness: Experience from Hospital-Based Influenza Surveillance in South Korea	PLOS ONE			English	Article							CLINICAL DECISION RULE; VIRUS-INFECTION; DIAGNOSIS; SYMPTOMS; SIGNS	Objectives: This study aims to identify clinical case definitions of influenza with higher accuracy in patients stratified by age group and influenza activity using hospital-based surveillance system. Methods: In seven tertiary hospitals across South Korea during 2011-2012 influenza season, respiratory specimens were obtained from patients presenting an influenza-like illness (ILI), defined as having fever plus at least one of following symptoms: cough, sore throat or rhinorrhea. Influenza was confirmed by reverse transcriptase-polymerase chain reaction. We performed multivariate logistic regression analyses to identify clinical variables with better relation with laboratory-confirmed influenza, and compared the accuracy of combinations. Results: Over the study period, we enrolled 1417 patients, of which 647 had laboratory-confirmed influenza. Patients with cough, rhinorrhea, sore throat or headache were more likely to have influenza (p<0.05). The most accurate criterion across the study population was the combination of cough, rhinorrhea, sore throat and headache (sensitivity 71.3%, specificity 60.1% and AUROC 0.66). The combination of rhinorrhea, sore throat and sputum during the peak influenza activity period in the young age group showed higher accuracy than that using the whole population (sensitivity 89.3%, specificity 72.1%, and AUROC 0.81). Conclusions: The accuracy of clinical case definitions of influenza differed across age groups and influenza activity periods. Categorizing the entire population into subgroups would improve the detection of influenza patients in the hospital-based surveillance system.	[Yang, Tae Un; Cheong, Hee Jin; Song, Joon Young; Choi, Won Suk; Kim, Woo Joo] Korea Univ, Coll Med, Div Infect Dis, Dept Internal Med, Seoul 136705, South Korea; [Yang, Tae Un; Cheong, Hee Jin; Song, Joon Young; Choi, Won Suk; Kim, Woo Joo] APII, Seoul, South Korea; [Lee, Jin Soo] Inha Univ, Sch Med, Dept Internal Med, Div Infect Dis, Inchon, South Korea; [Wie, Seong-Heon] Catholic Univ, Coll Med, St Vincents Hosp, Div Infect Dis,Dept Internal Med, Suwon, South Korea; [Kim, Young Keun] Yonsei Univ, Wonju Coll Med, Div Infect Dis, Dept Internal Med, Wonju, South Korea; [Lee, Jacob] Hallym Univ, Coll Med, Div Infect Dis, Dept Internal Med, Chunchon, South Korea; [Jeong, Hye Won] Chungbuk Natl Univ, Coll Med, Div Infect Dis, Dept Internal Med, Cheongju, South Korea	Korea University; Korea University Medicine (KU Medicine); Inha University; Catholic University of Korea; Yonsei University; Hallym University; Chungbuk National University	Kim, WJ (corresponding author), Korea Univ, Coll Med, Div Infect Dis, Dept Internal Med, Seoul 136705, South Korea.	wjkim@medimail.co.kr	Choi, Won Suk/V-2730-2017; Kim, Woo Joo/D-2733-2015	Choi, Won Suk/0000-0001-5874-4764; Kim, Young Keun/0000-0002-2120-6265; Cheong, Hee Jin/0000-0002-2532-1463; Song, Joon Young/0000-0002-0148-7194; Yang, Tae Un/0000-0001-8229-0977; Kim, Woo Joo/0000-0002-4546-3880	Ministry of Health and Welfare, Republic of Korea [A103001]	Ministry of Health and Welfare, Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea)	This study was supported by a grant of the Korea Healthcare Technology R&D Project, Ministry of Health and Welfare, Republic of Korea (Grant No.: A103001). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], INT GLOB EP SURV STA; Boivin G, 2000, CLIN INFECT DIS, V31, P1166, DOI 10.1086/317425; Call SA, 2005, JAMA-J AM MED ASSOC, V293, P987, DOI 10.1001/jama.293.8.987; Carrat F, 1999, CLIN INFECT DIS, V28, P283, DOI 10.1086/515117; Cheong HJ, 2009, DIS BURDEN SEASONAL; Ebell MH, 2012, J AM BOARD FAM MED, V25, P55, DOI 10.3122/jabfm.2012.01.110161; Ebell MH, 2004, J AM BOARD FAM PRACT, V17, P1, DOI 10.3122/jabfm.17.1.1; Govaert TME, 1998, FAM PRACT, V15, P16, DOI 10.1093/fampra/15.1.16; Hak E, 2001, ARCH INTERN MED, V161, P1351, DOI 10.1001/archinte.161.10.1351; Health Insurance Review & Assessment Service, 2012, POL BEN STAND ANT AG; Korea Centers for Disease Control and Prevention, 2005, STUD POL DEV EFF INF; Mandell GL, 1995, MANDELL DOUGLAS BENN; Montalto NJ, 2003, AM FAM PHYSICIAN, V67, P111; Monto AS, 2000, ARCH INTERN MED, V160, P3243, DOI 10.1001/archinte.160.21.3243; Ong AK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008453; Song JY, 2013, J MED VIROL, V85, P910, DOI 10.1002/jmv.23548; Stein J, 2005, ANN EMERG MED, V46, P412, DOI 10.1016/j.annemergmed.2005.05.020; van den Dool C, 2008, INFECT CONT HOSP EP, V29, P314, DOI 10.1086/529211; Walsh EE, 2002, J AM GERIATR SOC, V50, P1498, DOI 10.1046/j.1532-5415.2002.50404.x; WHO, 2009, INFL SEAS; Woolpert T, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-129	21	13	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2014	9	1							e84873	10.1371/journal.pone.0084873	http://dx.doi.org/10.1371/journal.pone.0084873			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	298QQ	24475034	gold, Green Published, Green Submitted			2022-12-25	WOS:000330339800008
J	Lin, OA; Karim, ZA; Vemana, HP; Espinosa, EVP; Khasawneh, FT				Lin, Olivia A.; Karim, Zubair A.; Vemana, Hari Priya; Espinosa, Enma V. P.; Khasawneh, Fadi T.			The Antidepressant 5-HT2A Receptor Antagonists Pizotifen and Cyproheptadine Inhibit Serotonin-Enhanced Platelet Function	PLOS ONE			English	Article							DEPRESSED-PATIENTS; IN-VIVO; 5-HYDROXYTRYPTAMINE; AGGREGATION; THROMBOSIS; ARTERY; ANTIPLATELET; STIMULATION; PATHWAYS; DISEASE	There is considerable interest in defining new agents or targets for antithrombotic purposes. The 5-HT2A receptor is a G-protein coupled receptor (GPCR) expressed on many cell types, and a known therapeutic target for many disease states. This serotonin receptor is also known to regulate platelet function. Thus, in our FDA-approved drug repurposing efforts, we investigated the antiplatelet activity of cyproheptadine and pizotifen, two antidepressant 5-HT2A Receptor antagonists. Our results revealed that cyproheptadine and pizotifen reversed serotonin-enhanced ADP-induced platelet aggregation in vitro and ex vivo. And the inhibitory effects of these two agents were found to be similar to that of EMD 281014, a 5-HT2A Receptor antagonist under development. In separate experiments, our studies revealed that these 5-HT2A (r)eceptor antagonists have the capacity to reduce serotonin-enhanced ADP-induced elevation in intracellular calcium levels and tyrosine phosphorylation. Using flow cytometry, we also observed that cyproheptadine, pizotifen, and EMD 281014 inhibited serotonin-enhanced ADP-induced phosphatidylserine (PS) exposure, P-selectin expression, and glycoprotein IIb-IIIa activation. Furthermore, using a carotid artery thrombosis model, these agents prolonged the time for thrombotic occlusion in mice in vivo. Finally, the tail-bleeding time was investigated to assess the effect of cyproheptadine and pizotifen on hemostasis. Our findings indicated prolonged bleeding time in both cyproheptadine-and pizotifen-treated mice. Notably, the increases in occlusion and bleeding times associated with these two agents were comparable to that of EMD 281014, and to clopidogrel, a commonly used antiplatelet drug, again, in a fashion comparable to clopidogrel and EMD 281014. Collectively, our data indicate that the antidepressant 5-HT2A antagonists, cyproheptadine and pizotifen do exert antiplatelet and thromboprotective effects, but similar to clopidogrel and EMD 281014, their use may interfere with normal hemostasis.	[Lin, Olivia A.; Karim, Zubair A.; Vemana, Hari Priya; Espinosa, Enma V. P.; Khasawneh, Fadi T.] Western Univ Hlth Sci, Coll Pharm, Dept Pharmaceut Sci, Pomona, CA 91766 USA	Western University of Health Sciences	Khasawneh, FT (corresponding author), Western Univ Hlth Sci, Coll Pharm, Dept Pharmaceut Sci, Pomona, CA 91766 USA.	Fkhasawneh@westernu.edu			College of Pharmacy	College of Pharmacy	This research was supported by funds provided by the College of Pharmacy (to F. T. K). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams JW, 2008, EUR J PHARMACOL, V586, P234, DOI 10.1016/j.ejphar.2007.11.056; Adams JW, 2009, J PHARMACOL EXP THER, V331, P96, DOI 10.1124/jpet.109.153189; Bampalis VG, 2011, J THROMB HAEMOST, V9, P2112, DOI 10.1111/j.1538-7836.2011.04476.x; Basaveswara Rao MV, 2012, CHROMATOGRAPHY RES I, V2012, P5; Bembenek JP, 2012, CLIN APPL THROMB-HEM, V18, P258, DOI 10.1177/1076029611424575; Berry CN, 2001, THROMB HAEMOSTASIS, V85, P521; Breet NJ, 2011, NETH HEART J, V19, P451, DOI 10.1007/s12471-011-0189-y; CENAJEK D, 1980, Acta Physiologica Polonica, V31, P561; Curial M, 2013, CARDIOLOGY RES PRACT, V2013, P8; Delisi SM, 1998, BIOL PSYCHIAT, V43, P327, DOI 10.1016/S0006-3223(97)00377-6; Dowal L, 2010, CURR VASC PHARMACOL, V8, P140, DOI 10.2174/157016110790886938; Droogmans S, 2009, AM J PHYSIOL-HEART C, V296, pH1940, DOI 10.1152/ajpheart.01177.2008; Duerschmied D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032656; ECKERT A, 1993, BIOL PSYCHIAT, V34, P565, DOI 10.1016/0006-3223(93)90201-N; Ergelen M, 2010, AM HEART J, V159, P672, DOI 10.1016/j.ahj.2009.12.032; Fanburg BL, 1997, AM J PHYSIOL-LUNG C, V272, pL795, DOI 10.1152/ajplung.1997.272.5.L795; Ferreiro JL, 2012, CIRC-CARDIOVASC INTE, V5, P433, DOI 10.1161/CIRCINTERVENTIONS.111.966176; GLUSA E, 1984, BIOMED BIOCHIM ACTA, V43, P215; Gray JA, 2001, BRAIN RES BULL, V56, P441, DOI 10.1016/S0361-9230(01)00623-2; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Hargrove V, 2009, J ANAL TOXICOL, V33, P564, DOI 10.1093/jat/33.8.564; HUCKER HB, 1983, J PHARM SCI, V72, P1069, DOI 10.1002/jps.2600720925; Karim ZA, 2013, BLOOD, V121, P4567, DOI 10.1182/blood-2012-11-470468; Kinugawa Toru, 2002, Am Heart J, V144, pE1, DOI 10.1067/mhj.2002.124056; Konopka LM, 1996, BIOL PSYCHIAT, V39, P708, DOI 10.1016/0006-3223(95)00189-1; Kroeze Wesley K., 2002, Current Topics in Medicinal Chemistry, V2, P507, DOI 10.2174/1568026023393796; Laddha G. P., 2012, PHARM LETT, V4, P443; Mamo D, 2004, PSYCHOPHARMACOLOGY, V175, P382, DOI 10.1007/s00213-004-1817-7; Mendelson SD, 2000, J AFFECT DISORDERS, V57, P13, DOI 10.1016/S0165-0327(99)00177-9; Miiller-Schweinitzer E, 1986, J CARDIOVASCULAR PHA, V8, P805; Moerland M, 2011, J CARDIOVASC PHARM, V58, P575, DOI 10.1097/FJC.0b013e31822f6b8d; MORAN A, 1994, BRIT J PHARMACOL, V113, P1358, DOI 10.1111/j.1476-5381.1994.tb17147.x; Murad JP, 2012, BIOCHEM BIOPH RES CO, V421, P456, DOI 10.1016/j.bbrc.2012.04.011; Nagatomo T, 2004, PHARMACOL THERAPEUT, V104, P59, DOI 10.1016/j.pharmthera.2004.08.005; Nascimento EB, 2011, PHARMACOL BIOCHEM BE, V99, P598, DOI 10.1016/j.pbb.2011.06.016; Nishihira K, 2006, J THROMB HAEMOST, V4, P247, DOI 10.1111/j.1538-7836.2005.01702.x; Przyklenk K, 2010, J THROMB HAEMOST, V8, P331, DOI 10.1111/j.1538-7836.2009.03693.x; Raote I, 2007, FRONT NEUROSCI, P105; Saeed SA, 2003, ACTA PHARMACOL SIN, V24, P958; Schins A, 2003, PSYCHOSOM MED, V65, P729, DOI 10.1097/01.PSY.0000088596.42029.10; Shad KF, 2007, EXP BRAIN RES, V183, P411, DOI 10.1007/s00221-007-1133-7; VANHOUTTE PM, 1991, J CARDIOVASC PHARM, V17, pS6; VANZWIETEN PA, 1990, CLIN PHYSIOL BIOCH, V8, P1; Vikenes K, 1999, CIRCULATION, V100, P483, DOI 10.1161/01.CIR.100.5.483; Walsh MT, 2002, LIFE SCI, V70, P3155, DOI 10.1016/S0024-3205(02)01569-2; Watanabe T, 2012, ROLES SEROTONIN ATHE; Watemberg NM, 1999, PEDIATRICS, V103, P158, DOI 10.1542/peds.103.1.158; WILLERSON JT, 1991, J AM COLL CARDIOL, V17, pB101; Xiong YF, 2010, J MED CHEM, V53, P4412, DOI 10.1021/jm100044a; Zendehdel M, 2012, IRAN J VET RES, V13, P100	50	36	38	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2014	9	1							e87026	10.1371/journal.pone.0087026	http://dx.doi.org/10.1371/journal.pone.0087026			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297XI	24466319	gold, Green Submitted, Green Published			2022-12-25	WOS:000330288000186
J	Oliveira, SA; Martinez, PF; Guizoni, DM; Campos, DHS; Fernandes, T; Oliveira, EM; Okoshi, MP; Okoshi, K; Padovani, CR; Cicogna, AC				Oliveira-Junior, Silvio A.; Martinez, Paula F.; Guizoni, Danielle M.; Campos, Dijon H. S.; Fernandes, Tiago; Oliveira, Edilamar M.; Okoshi, Marina P.; Okoshi, Katashi; Padovani, Carlos R.; Cicogna, Antonio C.			AT1 Receptor Blockade Attenuates Insulin Resistance and Myocardial Remodeling in Rats with Diet-Induced Obesity	PLOS ONE			English	Article							PLASMINOGEN-ACTIVATOR INHIBITOR-1; SPONTANEOUSLY HYPERTENSIVE-RATS; ANGIOTENSIN-II; CARDIAC-HYPERTROPHY; HEART-FAILURE; ZUCKER RATS; CROSS-TALK; METABOLIC SYNDROME; FATTY-ACIDS; EXPRESSION	Background: Although obesity has been associated with metabolic and cardiac disturbances, the carrier mechanisms for these responses are poorly understood. This study analyzed whether angiotensin II blockade attenuates metabolic and cardiovascular disorders in rats with diet-induced obesity. Material and Methods: Wistar-Kyoto (n = 40) rats were subjected to control (C; 3.2 kcal/g) and hypercaloric diets (OB; 4.6 kcal/g) for 30 weeks. Subsequently, rats were distributed to four groups: C, CL, OB, and OBL. L groups received Losartan (30 mg/kg/day) for five weeks. After this period we performed in vivo glucose tolerance and insulin tolerance tests, and measured triacylglycerol, insulin, angiotensin-converting enzyme activity (ACE), and leptin levels. Cardiovascular analyzes included systolic blood pressure (SBP), echocardiography, myocardial morphometric study, myosin heavy chain composition, and measurements of myocardial protein levels of angiotensin, extracellular signal-regulated (ERK1/2), c-Jun amino-terminal kinases (JNK), insulin receptor subunit beta (beta IR), and phosphatidylinositol 3-kinase (PI3K) by Western Blot. Results: Glucose metabolism, insulin, lipid, and ACE activity disorders observed with obesity were minimized by Losartan. Moreover, obesity was associated with increased SBP, myocardial hypertrophy, interstitial fibrosis and improved systolic performance; these effects were also minimized with Losartan. On a molecular level, OB exhibited higher ERK, Tyr-phosphorylated beta IR, and PI3K expression, and reduced myocardial angiotensin and JNK expression. ERK and JNK expression were regulated in the presence of Losartan, while angiotensin, Tyr-beta RI, total and Tyr-phosphorylated PI3K expression were elevated in the OBL group. Conclusion: Angiotensin II blockade with Losartan attenuates obesity-induced metabolic and cardiovascular changes.	[Oliveira-Junior, Silvio A.; Martinez, Paula F.; Guizoni, Danielle M.; Campos, Dijon H. S.; Okoshi, Marina P.; Okoshi, Katashi; Cicogna, Antonio C.] Sao Paulo State Univ, Botucatu Med Sch, Botucatu, SP, Brazil; [Oliveira-Junior, Silvio A.; Martinez, Paula F.] Univ Fed Mato Grosso do Sul, Sch Physiotherapy, Campo Grande, Brazil; [Fernandes, Tiago; Oliveira, Edilamar M.] Univ Sao Paulo, Sch Phys Educ & Sport, Sao Paulo, Brazil; [Padovani, Carlos R.] Sao Paulo State Univ, Botucatu Biosci Inst, Botucatu, SP, Brazil	Universidade Estadual Paulista; Universidade Federal de Mato Grosso do Sul; Universidade de Sao Paulo; Universidade Estadual Paulista	Oliveira, SA (corresponding author), Sao Paulo State Univ, Botucatu Med Sch, Botucatu, SP, Brazil.	oliveirajr.ufms@gmail.com	Okoshi, Katashi/A-3955-2011; Martinez, Paula Felippe/X-1673-2019; de Oliveira Júnior, Silvio Assis/G-9995-2014; Martinez, Paula Felippe/C-3079-2012; Oliveira, Edilamar M/AAG-1082-2019; Guizoni, Daniele M/R-6974-2018; Okoshi, Marina Politi/F-4809-2010; Padovani, Carlos Roberto/A-3656-2013	Okoshi, Katashi/0000-0001-8980-8839; Martinez, Paula Felippe/0000-0001-9477-3386; de Oliveira Júnior, Silvio Assis/0000-0002-8895-9456; Martinez, Paula Felippe/0000-0001-9477-3386; Oliveira, Edilamar M/0000-0002-7101-312X; Guizoni, Daniele M/0000-0001-7317-6371; Okoshi, Marina Politi/0000-0001-7728-4505; Padovani, Carlos Roberto/0000-0002-7719-9682; Cicogna, Antonio Carlos/0000-0002-4402-6523	FAPESP [08/55339-4]	FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	Grant support: FAPESP (# 08/55339-4) - www.fapesp.br. The funds were used to purchase consumables needed for research development. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abel ED, 2008, PHYSIOL REV, V88, P389, DOI 10.1152/physrev.00017.2007; Alves MF, 2005, BRAZ J MED BIOL RES, V38, P861, DOI 10.1590/S0100-879X2005000600007; Barauna VG, 2008, AM J PHYSIOL-REG I, V295, pR381, DOI 10.1152/ajpregu.00933.2007; Barry SP, 2008, INT J BIOCHEM CELL B, V40, P2023, DOI 10.1016/j.biocel.2008.02.020; Boustany CM, 2005, AM J PHYSIOL-REG I, V289, pR181, DOI 10.1152/ajpregu.00507.2004; Burchill L, 2008, EXP PHYSIOL, V93, P622, DOI 10.1113/expphysiol.2007.040386; Burrell LM, 2005, EUR HEART J, V26, P369, DOI 10.1093/eurheartj/ehi114; Calegari VC, 2005, ENDOCRINOLOGY, V146, P579, DOI 10.1210/en.2004-0466; Carnes CA, 2004, J APPL PHYSIOL, V97, P446, DOI 10.1152/japplphysiol.00439.2003; Carvalheira JBC, 2003, ENDOCRINOLOGY, V144, P5604, DOI 10.1210/en.2003-0788; Cohn JN, 2000, J AM COLL CARDIOL, V35, P569, DOI 10.1016/S0735-1097(99)00630-0; Cooper SA, 2007, AM J PHYSIOL-HEART C, V293, pH2009, DOI 10.1152/ajpheart.00522.2007; du Toit EF, 2005, BASIC RES CARDIOL, V100, P346, DOI 10.1007/s00395-005-0528-5; Duarte J, 1999, EUR J PHARMACOL, V365, P225, DOI 10.1016/S0014-2999(98)00879-6; Ernsberger P, 2007, AM J HYPERTENS, V20, P866, DOI 10.1016/j.amjhyper.2007.02.015; Feldman R, 2000, CAN J CARDIOL, V16, P41; Fogari R, 2005, HYPERTENS RES, V28, P209, DOI 10.1291/hypres.28.209; Greenfield JR, 2004, CLIN DERMATOL, V22, P289, DOI 10.1016/j.clindermatol.2004.01.011; Gual P, 2005, BIOCHIMIE, V87, P99, DOI 10.1016/j.biochi.2004.10.019; Henriksen EJ, 2001, HYPERTENSION, V38, P884, DOI 10.1161/hy1101.092970; Huisamen B, 2011, MOL CELL BIOCHEM, V349, P21, DOI 10.1007/s11010-010-0656-6; JOHNSON MM, 1993, J ANIM SCI, V71, P753, DOI 10.2527/1993.713753x; Kondoh K, 2007, BBA-MOL CELL RES, V1773, P1227, DOI 10.1016/j.bbamcr.2006.12.002; Kong X, 2011, BIOL PHARM BULL, V34, P693, DOI 10.1248/bpb.34.693; Krenz M, 2007, J BIOL CHEM, V282, P24057, DOI 10.1074/jbc.M704574200; Leopoldo AS, 2011, J CELL PHYSIOL, V226, P2934, DOI 10.1002/jcp.22643; Leopoldo AS, 2010, CAN J CARDIOL, V26, P423, DOI 10.1016/S0828-282X(10)70440-2; Lima-Leopoldo AP, 2011, ARQ BRAS CARDIOL, V97, P232, DOI 10.1590/S0066-782X2011005000061; LITWIN SE, 1995, CIRCULATION, V91, P2642, DOI 10.1161/01.CIR.91.10.2642; Lu H, 2007, AM J PHYSIOL-ENDOC M, V292, pE1280, DOI 10.1152/ajpendo.00277.2006; Maharsy WM, 2007, J RENIN-ANGIO-ALDO S, V8, P59, DOI 10.3317/jraas.2007.011; Martinez PF, 2010, MED SCI MONITOR, V16, pBR374; Masuo K, 2001, AM J HYPERTENS, V14, P530, DOI 10.1016/S0895-7061(00)01279-6; Matsubara LS, 2000, AM J PHYSIOL-HEART C, V279, pH1534, DOI 10.1152/ajpheart.2000.279.4.H1534; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; National Research Council of the National Academies, 2011, COMM UPD GUID CAR US; Okoshi K, 2004, JPN HEART J, V45, P647, DOI 10.1536/jhj.45.647; Olivares-Reyes JA, 2009, MOL CELL ENDOCRINOL, V302, P128, DOI 10.1016/j.mce.2008.12.011; Oliveira Junior SA, 2010, MED SCI MONIT, V16, pBR367; Oliveira SA, 2013, CARDIOVASC DIABETOL, V12, DOI 10.1186/1475-2840-12-65; PFEFFER JM, 1971, J LAB CLIN MED, V78, P957; Qatanani M, 2007, GENE DEV, V21, P1443, DOI 10.1101/gad.1550907; Ran JM, 2004, AM J PHYSIOL-ENDOC M, V287, pE227, DOI 10.1152/ajpendo.00090.2004; Rose BA, 2010, PHYSIOL REV, V90, P1507, DOI 10.1152/physrev.00054.2009; Rundell VLM, 2005, AM J PHYSIOL-HEART C, V288, pH896, DOI 10.1152/ajpheart.00407.2004; SAHN DJ, 1978, CIRCULATION, V58, P1072, DOI 10.1161/01.CIR.58.6.1072; Schrauwen P, 2000, BRIT J NUTR, V84, P417, DOI 10.1017/S0007114500001720; Serra AJ, 2008, EUR J HEART FAIL, V10, P534, DOI 10.1016/j.ejheart.2008.03.016; Shi LJ, 2010, DRUG DISCOV TODAY, V15, P332, DOI 10.1016/j.drudis.2010.02.003; Sica Domenic A, 2006, J Clin Hypertens (Greenwich), V8, P381, DOI 10.1111/j.1524-6175.2005.05141.x; Rosselli MS, 2009, ATHEROSCLEROSIS, V206, P119, DOI 10.1016/j.atherosclerosis.2009.01.026; Swynghedauw B, 2006, J EXP BIOL, V209, P2320, DOI 10.1242/jeb.02084; Toblli JE, 2005, HEART, V91, P80, DOI 10.1136/hrt.2003.022707; Trayhurn P, 2005, ACTA PHYSIOL SCAND, V184, P285, DOI 10.1111/j.1365-201X.2005.01468.x; Umeda M, 2003, HYPERTENS RES, V26, P485, DOI 10.1291/hypres.26.485; Yuan QX, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025167; Zile MR, 2002, CIRCULATION, V105, P1503, DOI 10.1161/hc1202.105290	57	38	39	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2014	9	1							e86447	10.1371/journal.pone.0086447	http://dx.doi.org/10.1371/journal.pone.0086447			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297XI	24466104	Green Submitted, Green Published, gold			2022-12-25	WOS:000330288000098
J	Zhang, W; Hu, XQ; Wang, LQ; Wang, XY				Zhang, Wei; Hu, Xiaoqing; Wang, Liqin; Wang, Xiaoyuan			Reconstruction of the Carotenoid Biosynthetic Pathway of Cronobacter sakazakii BAA894 in Escherichia coli	PLOS ONE			English	Article							BETA-CAROTENE; GENE; ASTAXANTHIN; LYCOPENE; CLONING	Cronobacter sakazakii could form yellow-pigmented colonies. However, the chemical structure and the biosynthetic pathway of the yellow pigments have not been identified. In this study, the yellow pigments of C. sakazakii BAA894 were purified and analyzed. The major components of the yellow pigments were confirmed as zeaxanthin-monoglycoside and zeaxanthin-diglycoside. A gene cluster containing seven genes responsible for the yellow pigmentation in C. sakazakii BAA894 was identified. The seven genes of C. sakazakii BAA894 or parts of them were reconstructed in a heterologous host Escherichia coli DH5 alpha. The pigments formed in these E. coli strains were isolated and analyzed by thin layer chromatography, UV-visible spectroscopy, high performance liquid chromatography, and electron spray ionization-mass spectrometry. These redesigned E. coli strains could produce different carotenoids. E. coli strain expressing all the seven genes could produce zeaxanthin-monoglycoside and zeaxanthin-diglycoside; E. coli strains expressing parts of the seven genes could produce lycopene, beta-carotene, cryptoxanthin or zeaxanthin. This study identified the gene cluster responsible for the yellow pigmentation in C. sakazakii BAA894.	[Zhang, Wei; Hu, Xiaoqing; Wang, Liqin; Wang, Xiaoyuan] Jiangnan Univ, State Key Lab Food Sci & Technol, Wuxi, Peoples R China; [Zhang, Wei] Jiangnan Univ, Sch Biotechnol, Key Lab Ind Biotechnol, Minist Educ, Wuxi, Peoples R China; [Hu, Xiaoqing; Wang, Xiaoyuan] Jiangnan Univ, Synerget Innovat Ctr Food Safety & Nutr, Wuxi, Peoples R China	Jiangnan University; Jiangnan University; Jiangnan University	Wang, XY (corresponding author), Jiangnan Univ, State Key Lab Food Sci & Technol, Wuxi, Peoples R China.	xiaoyuanwang@hotmail.com			National Key Basic Research Program of China [2012CB725202]; National Natural Science Foundation of China [31201290, 31170069]	National Key Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the National Key Basic Research Program of China (2012CB725202), and the National Natural Science Foundation of China (31201290 and 31170069). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berthelot K, 2012, BIOCHIMIE, V94, P1621, DOI 10.1016/j.biochi.2012.03.021; Cazzonelli CI, 2010, TRENDS PLANT SCI, V15, P266, DOI 10.1016/j.tplants.2010.02.003; Chen Weibin, 2012, J WORLD WIDE WEB, P1; Chen YY, 2013, BMC BIOTECHNOL, V13, DOI 10.1186/1472-6750-13-6; Cordero BF, 2012, MAR DRUGS, V10, P2069, DOI 10.3390/md10092069; Harada Hisashi, 2012, Methods Mol Biol, V892, P133, DOI 10.1007/978-1-61779-879-5_6; Heider SAE, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-198; Higuera-Ciapara I, 2006, CRIT REV FOOD SCI, V46, P185, DOI 10.1080/10408690590957188; Johler S, 2010, APPL ENVIRON MICROB, V76, P1053, DOI 10.1128/AEM.01420-09; Kim SH, 2010, APPL ENVIRON MICROB, V76, P5199, DOI 10.1128/AEM.00263-10; Kucerova E, 2010, PLOS ONE, V5, pA51, DOI 10.1371/journal.pone.0009556; Lee PC, 2003, CHEM BIOL, V10, P453, DOI 10.1016/S1074-5521(03)00103-0; Lehner A, 2006, FEMS MICROBIOL LETT, V265, P244, DOI 10.1111/j.1574-6968.2006.00500.x; MISAWA N, 1990, J BACTERIOL, V172, P6704, DOI 10.1128/jb.172.12.6704-6712.1990; Miura Y, 1998, APPL ENVIRON MICROB, V64, P1226; PFANDER H, 1974, HELV CHIM ACTA, V57, P1641, DOI 10.1002/hlca.19740570617; Rivera SM, 2012, J CHROMATOGR A, V1224, P1, DOI 10.1016/j.chroma.2011.12.025; Sambrook J., 2001, MOL CLONING LAB MANU; Sedkova N, 2005, APPL ENVIRON MICROB, V71, P8141, DOI 10.1128/AEM.71.12.8141-8146.2005; Seo YB, 2009, J MICROBIOL BIOTECHN, V19, P1542, DOI 10.4014/jmb.0904.04033; Sestak Z., 2004, CAROTENOIDS, V42, DOI 10.1023/b:phot.0000040641.40049.19,2; TAKAICHI S, 1990, ARCH MICROBIOL, V153, P118, DOI 10.1007/BF00247807; Tardy F, 1997, BBA-BIOMEMBRANES, V1330, P179, DOI 10.1016/S0005-2736(97)00168-5; Tritsch D, 2010, FEBS LETT, V584, P129, DOI 10.1016/j.febslet.2009.11.010; Vachali Preejith, 2012, Methods Mol Biol, V898, P41, DOI 10.1007/978-1-61779-918-1_2; WANG RF, 1991, GENE, V100, P195, DOI 10.1016/0378-1119(91)90366-J; Zhang JH, 2012, FEMS MICROBIOL LETT, V333, P138, DOI 10.1111/j.1574-6968.2012.02604.x	27	15	19	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2014	9	1							e86739	10.1371/journal.pone.0086739	http://dx.doi.org/10.1371/journal.pone.0086739			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297XI	24466219	Green Published, gold, Green Submitted			2022-12-25	WOS:000330288000138
J	Bugnot, AB; Coleman, RA; Figueira, WF; Marzinelli, EM				Bugnot, Ana B.; Coleman, Ross A.; Figueira, Will F.; Marzinelli, Ezequiel M.			Patterns of the Non-Indigenous Isopod Cirolana harfordi in Sydney Harbour	PLOS ONE			English	Article							BIOLOGICAL INVASIONS; HOMOGENIZATION; ESTUARINE; DYNAMICS; IMPACTS	Biological introductions can alter the ecology of local assemblages and are an important driver of global environmental change. The first step towards understanding the impact of a non-indigenous species is to study its distribution and associations in the invaded area. In Sydney Harbour, the non-indigenous isopod Cirolana harfordi has been reported in densities up to 0.5 individuals per cm(2) in mussel-beds. Abundances of this species have, however, been largely overlooked in other key habitats. The first aim of this study was to evaluate the abundances and distribution of C. harfordi across different habitats representative of Sydney Harbour. Results showed that C. harfordi occurred in oyster and mussel-beds, being particularly abundant in oyster-beds. We also aimed to determine the role of C. harfordi as a predator, scavenger and detritus feeder by investigating the relationships between densities of C. harfordi and (i) the structure of the resident assemblages, and (ii) deposited organic matter in oyster-beds. Densities of C. harfordi were not related to the structure of the assemblages, nor amounts of deposited organic matter. These findings suggested little or no ecological impacts of C. harfordi in oyster-beds. These relationships may, however, affect other variables such as growth of individuals, or be disguised by high variability of assemblages among different locations. Future studies should, therefore, test the impacts of C. harfordi on the size of organisms in the assemblage and use manipulative experiments to control for spatial variation. This study is the first published work on the ecology of the invasion of C. harfordi and provides the starting-point for the study of the impacts of this species in Sydney Harbour.	[Bugnot, Ana B.; Coleman, Ross A.; Figueira, Will F.] Univ Sydney, Sch Biol Sci, Sydney, NSW 2006, Australia; [Marzinelli, Ezequiel M.] Sydney Inst Marine Sci, Mosman, NSW, Australia; [Marzinelli, Ezequiel M.] Univ New S Wales, Sch Biol Earth & Environm Sci, Sydney, NSW, Australia	University of Sydney; Sydney Institute of Marine Science; University of New South Wales Sydney	Bugnot, AB (corresponding author), Univ Sydney, Sch Biol Sci, Sydney, NSW 2006, Australia.	ana.bugnot@sydney.edu.au	Bugnot, Ana/E-9519-2011; Bugnot, Ana/GQA-3017-2022; Figueira, Will/A-5163-2009; Marzinelli, Ezequiel/AAH-2906-2019; Coleman, Ross/B-1314-2008	Bugnot, Ana/0000-0001-6451-0307; Figueira, Will/0000-0001-9472-8710; Marzinelli, Ezequiel/0000-0002-3762-3389; Coleman, Ross/0000-0003-4136-5914	International Postgraduate Research Scholarship; Sydney Institute of Marine Science Doctoral Fellowship; Centre for Research on Ecological Impacts of Coastal Cities	International Postgraduate Research Scholarship(Australian Government); Sydney Institute of Marine Science Doctoral Fellowship; Centre for Research on Ecological Impacts of Coastal Cities	International Postgraduate Research Scholarship (www.sydney.edu.au); Sydney Institute of Marine Science Doctoral Fellowship (www.sims.org.au); Centre for Research on Ecological Impacts of Coastal Cities (self funded). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahyong ST, 2011, INVAD NAT SPRING SER, V6, P451, DOI 10.1007/978-94-007-0591-3_16; Anderson MJ, 2004, MAR ECOL PROG SER, V272, P33, DOI 10.3354/meps272033; Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; BELL SS, 1991, HABITAT STRUCTURE PH; BOWMAN T E, 1981, Journal of Crustacean Biology, V1, P545, DOI 10.2307/1548131; Bruce N.L., 1986, CIROLANIDAE CRUSTACE; BRUCE NL, 1981, J NAT HIST, V15, P67, DOI 10.1080/00222938100770061; Bunting D, 2011, THESIS U SYDNEY SYDN; CARLTON JT, 1989, CONSERV BIOL, V3, P265, DOI 10.1111/j.1523-1739.1989.tb00086.x; Chapman MG, 1998, MAR ECOL PROG SER, V162, P71, DOI 10.3354/meps162071; Cole VJ, 2007, J EXP MAR BIOL ECOL, V348, P191, DOI 10.1016/j.jembe.2007.05.001; Cole VJ, 2010, MAR ECOL PROG SER, V416, P127, DOI 10.3354/meps08772; CROWDER LB, 1982, ECOLOGY, V63, P1802, DOI 10.2307/1940122; DANTONIO CM, 1992, ANNU REV ECOL SYST, V23, P63, DOI 10.1146/annurev.es.23.110192.000431; Elton C. S., 1958, ECOLOGY INVASIONS AN; Gotelli NJ, 2001, ECOL LETT, V4, P379, DOI 10.1046/j.1461-0248.2001.00230.x; Hewatt W. G., 1937, AM MIDL NAT, V18, P161, DOI DOI 10.2307/2420496; Irigoyen AJ, 2011, BIOL INVASIONS, V13, P1521, DOI 10.1007/s10530-010-9910-9; JOHNSON WS, 1976, MAR BIOL, V36, P343, DOI 10.1007/BF00389196; LODGE DM, 1993, TRENDS ECOL EVOL, V8, P133, DOI 10.1016/0169-5347(93)90025-K; LOTKA ALFRED J., 1932, JOUR WASHINGTON ACAD SCI, V22, P461; Luczak C, 1997, HYDROBIOLOGIA, V345, P87, DOI 10.1023/A:1002902626798; Matias MG, 2007, J ANIM ECOL, V76, P986, DOI 10.1111/j.1365-2656.2007.01277.x; McArdle BH, 2001, ECOLOGY, V82, P290, DOI 10.1890/0012-9658(2001)082[0290:fmmtcd]2.0.co;2; McKinney ML, 1999, TRENDS ECOL EVOL, V14, P450, DOI 10.1016/S0169-5347(99)01679-1; Molnar JL, 2008, FRONT ECOL ENVIRON, V6, P485, DOI 10.1890/070064; Moore JC, 2004, ECOL LETT, V7, P584, DOI 10.1111/j.1461-0248.2004.00606.x; Rahel FJ, 2002, ANNU REV ECOL SYST, V33, P291, DOI 10.1146/annurev.ecolsys.33.010802.150429; Rilov Gil, 2009, V204, P261; Rodriguez LF, 2006, BIOL INVASIONS, V8, P927, DOI 10.1007/s10530-005-5103-3; Ruiz GM, 1999, LIMNOL OCEANOGR, V44, P950, DOI 10.4319/lo.1999.44.3_part_2.0950; Sax DF, 2003, TRENDS ECOL EVOL, V18, P561, DOI 10.1016/S0169-5347(03)00224-6; Sax DF, 2002, AM NAT, V160, P766, DOI 10.1086/343877; Simberloff D, 2005, J AGR ENVIRON ETHIC, V18, P595, DOI 10.1007/s10806-005-2851-0; Summerhayes SA, 2009, J EXP MAR BIOL ECOL, V379, P60, DOI 10.1016/j.jembe.2009.08.006; Thomson M, 2013, J MICROSC IN PRESS; Underwood A.J., 1997, EXPT ECOLOGY THEIR L, DOI DOI 10.1017/CBO9780511806407; Usio N, 2009, BIOL CONSERV, V142, P1480, DOI 10.1016/j.biocon.2009.02.016; Vila M, 2010, FRONT ECOL ENVIRON, V8, P135, DOI 10.1890/080083; Vitousek PM, 1996, AM SCI, V84, P468; Volterra V, 1926, NATURE, V118, P558, DOI 10.1038/118558a0	41	8	8	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2014	9	1							e86765	10.1371/journal.pone.0086765	http://dx.doi.org/10.1371/journal.pone.0086765			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297VL	24466227	Green Submitted, gold, Green Published			2022-12-25	WOS:000330283100209
J	Wu, YC; Dai, J; Zhang, WL; Yan, R; Zhang, YW; Ruan, CG; Dai, KS				Wu, Yicun; Dai, Jin; Zhang, Weilin; Yan, Rong; Zhang, Yiwen; Ruan, Changgeng; Dai, Kesheng			Arsenic Trioxide Induces Apoptosis in Human Platelets via C-Jun NH2-Terminal Kinase Activation	PLOS ONE			English	Article							ACUTE PROMYELOCYTIC LEUKEMIA; HEPATOCELLULAR-CARCINOMA; RETINOIC ACID; HEMATOPOIESIS; AS2O3; DEATH; TRIAL	Arsenic trioxide (ATO), one of the oldest drugs in both Western and traditional Chinese medicine, has become an effective anticancer drug, especially in the treatment of acute promyelocytic leukemia (APL). However, thrombocytopenia occurred in most of ATO-treated patients with APL or other malignant diseases, and the pathogenesis remains unclear. Here we show that ATO dose-dependently induces depolarization of mitochondrial inner transmembrane potential (Delta Psi m), up-regulation of Bax and down-regulation of Bcl-2 and Bcl-X-L, caspase-3 activation, and phosphotidylserine (PS) exposure in platelets. ATO did not induce surface expression of P-selectin and PAC-1 binding, whereas, obviously reduced collagen, ADP, and thrombin induced platelet aggregation. ATO dose-dependently induced c-Jun NH2-terminal kinase (JNK) activation, and JNK specific inhibitor dicumarol obviously reduced ATO-induced Delta Psi m depolarization in platelets. Clinical therapeutic dosage of ATO was intraperitoneally injected into C57 mice, and the numbers of circulating platelets were significantly reduced after five days of continuous injection. The data demonstrate that ATO induces caspase-dependent apoptosis via JNK activation in platelets. ATO does not incur platelet activation, whereas, it not only impairs platelet function but also reduces circulating platelets in vivo, suggesting the possible pathogenesis of thrombocytopenia in patients treated with ATO.	[Wu, Yicun; Zhang, Weilin; Yan, Rong; Zhang, Yiwen; Ruan, Changgeng; Dai, Kesheng] Soochow Univ, Affiliated Hosp 1, Jiangsu Inst Hematol, Key Lab Thrombosis & Hemostasis,Minist Hlth, Suzhou, Peoples R China; [Dai, Jin] Peking Univ, Sch Life Sci, Beijing 100871, Peoples R China	Soochow University - China; Peking University	Dai, KS (corresponding author), Soochow Univ, Affiliated Hosp 1, Jiangsu Inst Hematol, Key Lab Thrombosis & Hemostasis,Minist Hlth, Suzhou, Peoples R China.	kdai@suda.edu.cn			National Nature Science Foundation of China [NSFC 81130008]; National Key Basic Research Program of China [2012CB526600]; Jiangsu Province's Outstanding Medical Academic Leader program; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD); Jiangsu Province's Key Medical Center [ZX201102]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Basic Research Program of China(National Basic Research Program of China); Jiangsu Province's Outstanding Medical Academic Leader program; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD); Jiangsu Province's Key Medical Center	This work was supported by a grant from National Nature Science Foundation of China (NSFC 81130008 to KD), National Key Basic Research Program of China (2012CB526600 to KD), Jiangsu Province's Outstanding Medical Academic Leader program (KD), Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD), and Jiangsu Province's Key Medical Center (ZX201102). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen GQ, 1997, BLOOD, V89, P3345; Chen G, 2012, INT J ONCOL, V40, P139, DOI 10.3892/ijo.2011.1210; Chen K, 2009, BRAIN RES, V1279, P131, DOI 10.1016/j.brainres.2009.04.054; Cohen MH, 2001, ONCOLOGIST, V6, P4, DOI 10.1634/theoncologist.6-1-4; Dai KS, 2005, BLOOD, V106, P1975, DOI 10.1182/blood-2005-01-0440; Davis RJ, 2000, CELL, V103, P239, DOI 10.1016/S0092-8674(00)00116-1; Davison K, 2004, BLOOD, V103, P3496, DOI 10.1182/blood-2003-05-1412; Fluttert M, 2000, LAB ANIM, V34, P372, DOI 10.1258/002367700780387714; Fox E, 2008, BLOOD, V111, P566, DOI 10.1182/blood-2007-08-107839; Green DR, 1998, SCIENCE, V281, P1309, DOI 10.1126/science.281.5381.1309; Hussein MA, 2004, BRIT J HAEMATOL, V125, P470, DOI 10.1111/j.1365-2141.2004.04941.x; Kim KB, 2005, CANCER-AM CANCER SOC, V104, P1687, DOI 10.1002/cncr.21386; Kumar Siragam Vinaya, 2001, Journal of Environmental Pathology Toxicology and Oncology, V20, P65; Lallemand-Breitenbach V, 1999, J EXP MED, V189, P1043, DOI 10.1084/jem.189.7.1043; Larochette N, 1999, EXP CELL RES, V249, P413, DOI 10.1006/excr.1999.4519; Leytin V, 2006, J THROMB HAEMOST, V4, P2656, DOI 10.1111/j.1538-7836.2006.02200.x; Li S, 2010, J THROMB HAEMOST, V8, P341, DOI 10.1111/j.1538-7836.2009.03653.x; Lin CC, 2007, INVEST NEW DRUG, V25, P77, DOI 10.1007/s10637-006-9004-9; Lin KH, 2010, TRANSL RES, V155, P97, DOI 10.1016/j.trsl.2009.08.005; Lin QD, 2013, ANN HEMATOL, V92, P431, DOI 10.1007/s00277-012-1605-0; Mathews V, 2002, AM J HEMATOL, V70, P292, DOI 10.1002/ajh.10138; Mathews V, 2011, MEDITERR J HEMATOL I, V3, DOI 10.4084/MJHID.2011.056; Park WH, 2012, MOL BIOL REP, V39, P4311, DOI 10.1007/s11033-011-1218-z; Redondo-Munoz J, 2010, CLIN CANCER RES, V16, P4382, DOI 10.1158/1078-0432.CCR-10-0072; Saulle E, 2006, BLOOD CELL MOL DIS, V36, P59, DOI 10.1016/j.bcmd.2005.10.005; Schiller GJ, 2006, J CLIN ONCOL, V24, P2456, DOI 10.1200/JCO.2005.03.7903; Shen ZX, 1997, BLOOD, V89, P3354, DOI 10.1182/blood.V89.9.3354; Shigeno K, 2005, INT J HEMATOL, V82, P224, DOI 10.1532/IJH97.05044; Shinjo K, 2005, INTERNAL MED, V44, P818, DOI 10.2169/internalmedicine.44.818; van Engeland M, 1998, CYTOMETRY, V31, P1, DOI 10.1002/(SICI)1097-0320(19980101)31:1<1::AID-CYTO1>3.0.CO;2-R; Wang ZY, 2008, BLOOD, V111, P2505, DOI 10.1182/blood-2007-07-102798; Wang ZC, 2010, THROMB RES, V125, P340, DOI 10.1016/j.thromres.2010.02.001; Westervelt P, 2001, BLOOD, V98, P266, DOI 10.1182/blood.V98.2.266; Zhang WL, 2012, THROMB RES, V130, P81, DOI 10.1016/j.thromres.2012.02.013	34	13	16	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2014	9	1							e86445	10.1371/journal.pone.0086445	http://dx.doi.org/10.1371/journal.pone.0086445			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297VL	24466103	Green Submitted, Green Published, gold			2022-12-25	WOS:000330283100168
J	Kunkel, J; Asuri, P				Kunkel, Jeffrey; Asuri, Prashanth			Function, Structure, and Stability of Enzymes Confined in Agarose Gels	PLOS ONE			English	Article							MOLECULAR CONFINEMENT; PROTEIN AGGREGATION; CROWDED ENVIRONMENTS; SERUM-ALBUMIN; ELECTROPHORESIS; INTERMEDIATE; TEMPERATURE; GALLERIES; SPHERES; SHAPE	Research over the past few decades has attempted to answer how proteins behave in molecularly confined or crowded environments when compared to dilute buffer solutions. This information is vital to understanding in vivo protein behavior, as the average spacing between macromolecules in the cell cytosol is much smaller than the size of the macromolecules themselves. In our study, we attempt to address this question using three structurally and functionally different model enzymes encapsulated in agarose gels of different porosities. Our studies reveal that under standard buffer conditions, the initial reaction rates of the agarose-encapsulated enzymes are lower than that of the solution phase enzymes. However, the encapsulated enzymes retain a higher percentage of their activity in the presence of denaturants. Moreover, the concentration of agarose used for encapsulation had a significant effect on the enzyme functional stability; enzymes encapsulated in higher percentages of agarose were more stable than the enzymes encapsulated in lower percentages of agarose. Similar results were observed through structural measurements of enzyme denaturation using an 8-anilinonaphthalene-1-sulfonic acid fluorescence assay. Our work demonstrates the utility of hydrogels to study protein behavior in highly confined environments similar to those present in vivo; furthermore, the enhanced stability of gel-encapsulated enzymes may find use in the delivery of therapeutic proteins, as well as the design of novel strategies for biohybrid medical devices.	[Kunkel, Jeffrey; Asuri, Prashanth] Santa Clara Univ, Dept Bioengn, Santa Clara, CA 95053 USA	Santa Clara University	Asuri, P (corresponding author), Santa Clara Univ, Dept Bioengn, Santa Clara, CA 95053 USA.	asurip@scu.edu			School of Engineering, Santa Clara University	School of Engineering, Santa Clara University	This project funded by the School of Engineering, Santa Clara University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bismuto E, 2002, BIOPOLYMERS, V67, P85, DOI 10.1002/bip.10058; Bolis D, 2004, J MOL BIOL, V336, P203, DOI 10.1016/j.jmb.2003.11.056; Calamai M, 2005, BIOPHYS J, V89, P4201, DOI 10.1529/biophysj.105.068726; Du F, 2006, J MOL BIOL, V364, P469, DOI 10.1016/j.jmb.2006.09.018; Eggers DK, 2001, PROTEIN SCI, V10, P250, DOI 10.1110/ps.36201; Ellis RJ, 2001, TRENDS BIOCHEM SCI, V26, P597, DOI 10.1016/S0968-0004(01)01938-7; Finn TE, 2012, J BIOL CHEM, V287, P21530, DOI 10.1074/jbc.M112.372961; Gabellieri E, 2003, BIOPHYS J, V85, P3214, DOI 10.1016/S0006-3495(03)74739-0; GRIESS GA, 1993, BIOPHYS J, V65, P138, DOI 10.1016/S0006-3495(93)81072-5; GRIESS GA, 1989, BIOPOLYMERS, V28, P1475, DOI 10.1002/bip.360280811; GUHA S, 1995, BIOCHEMISTRY-US, V34, P6925, DOI 10.1021/bi00021a003; Homouz D, 2008, P NATL ACAD SCI USA, V105, P11754, DOI 10.1073/pnas.0803672105; Jones F, 2002, APPL BIOCHEM BIOTECH, V98, P627, DOI 10.1385/ABAB:98-100:1-9:627; Juarez J, 2009, BIOPHYS J, V96, P2353, DOI 10.1016/j.bpj.2008.12.3901; Kayser V, 2011, MABS-AUSTIN, V3, P408, DOI 10.4161/mabs.3.4.15677; Kim J, 2006, BIOTECHNOL ADV, V24, P296, DOI 10.1016/j.biotechadv.2005.11.006; Kumar CV, 2002, CHEM COMMUN, P2382, DOI 10.1039/b206988a; Kumar CV, 2000, J AM CHEM SOC, V122, P830, DOI 10.1021/ja993310u; Liang JF, 2000, J PHARM SCI, V89, P979, DOI 10.1002/1520-6017(200008)89:8<979::AID-JPS2>3.0.CO;2-H; Liu HH, 2004, BIOSENS BIOELECTRON, V20, P294, DOI 10.1016/j.bios.2004.01.015; Mahajan R, 2010, INDIAN J PHARM SCI, V72, P223, DOI 10.4103/0250-474X.65010; Morelli MJ, 2011, BIOPHYS J, V101, P2882, DOI 10.1016/j.bpj.2011.10.053; Munishkina LA, 2008, BIOCHEMISTRY-US, V47, P8993, DOI 10.1021/bi8008399; Nwamba C. O., 2012, ENZYME RES, V2012; Pastor I, 2011, J PHYS CHEM B, V115, P1115, DOI 10.1021/jp105296c; RAO SVR, 1993, BIOCHEM MOL BIOL INT, V29, P63; Rivas G, 2001, P NATL ACAD SCI USA, V98, P3150, DOI 10.1073/pnas.051634398; Samiotakis A, 2009, INT J MOL SCI, V10, P572, DOI 10.3390/ijms10020572; Sasahara K, 2003, J MOL BIOL, V326, P1227, DOI 10.1016/S0022-2836(02)01443-2; SCOPES RK, 1995, CLIN CHIM ACTA, V237, P17, DOI 10.1016/0009-8981(95)06060-Q; SEMISOTNOV GV, 1991, BIOPOLYMERS, V31, P119, DOI 10.1002/bip.360310111; Singh SM, 2010, PROTEINS, V78, P2625, DOI 10.1002/prot.22778; Yadav SC, 2011, PEPTIDES, V32, P173, DOI 10.1016/j.peptides.2010.10.003; Yuan JM, 2008, PROTEIN SCI, V17, P2156, DOI 10.1110/ps.037325.108; Zhou HX, 2008, ANNU REV BIOPHYS, V37, P375, DOI 10.1146/annurev.biophys.37.032807.125817; Zhou HX, 2013, FEBS LETT, V587, P394, DOI 10.1016/j.febslet.2013.01.030; Zhou HX, 2008, ARCH BIOCHEM BIOPHYS, V469, P76, DOI 10.1016/j.abb.2007.07.013	37	21	21	1	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2014	9	1							e86785	10.1371/journal.pone.0086785	http://dx.doi.org/10.1371/journal.pone.0086785			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297GT	24466239	Green Published, gold, Green Submitted			2022-12-25	WOS:000330244500286
J	Collins, DC; Cocchiglia, S; Tibbitts, P; Solon, G; Bane, FT; McBryan, J; Treumann, A; Eustace, A; Hennessy, B; Hill, AD; Young, LS				Collins, D. C.; Cocchiglia, S.; Tibbitts, P.; Solon, G.; Bane, F. T.; McBryan, J.; Treumann, A.; Eustace, A.; Hennessy, B.; Hill, A. D.; Young, L. S.			Growth factor receptor/steroid receptor cross talk in trastuzumab-treated breast cancer	ONCOGENE			English	Article						human epidermal growth factor receptor; estrogen receptor; Myc; SMRT; trastuzumab; cross talk	ACQUIRED-RESISTANCE; OPEN-LABEL; REPRESSION; LAPATINIB; HER2; SENSITIVITY; MECHANISMS; INHIBITOR; COMPLEX; DRIVEN	Treatment with tyrosine kinase inhibitors (TKIs) including trastuzumab has revolutionized the management of HER2-positive breast cancer. Recent evaluation of clinical trial data suggests that a subset of HER2/ER double-positive cancers may not receive significant benefit from the TKI therapy. Here we investigate the cross talk between HER2 and ER in breast cancer and monitor the effect of trastuzumab on the tyrosine kinase effector transcription factor Myc. In HER2-positive breast cancer patients treated with neoadjuvant trastuzumab, steroid receptor-negative status (ER and PR negative) of pre-treatment biopsies predicted pathological complete response (pCR) (n = 31 patients, P = 0.0486), whereas elevated Myc protein inversely associated with pCR (P = 0.0446). Liquid chromatography mass spectrometry identified the corepressor SMRT as a novel Myc-interacting protein. Trastuzumab treatment enhanced Myc-SMRT interactions in HER2-overexpressing breast cancer cells (LCC1) and inhibited expression of the Myc target gene survivin. In HER2-low, ER-positive steroid-dominant cells (MCF7), trastuzumab therapy repressed Myc-SMRT interactions and upregulated survivin expression. Trastuzumab treatment induced ER-CBP interactions, enhanced ER transcriptional activity and upregulated expression of the ER target gene pS2. The absence of pS2 expression in pre-treatment biopsies predicted pCR to neoadjuvant trastuzumab in breast cancer patients (n = 25, P = 0.0089) and pS2 expression associated with residual cancer burden (P = 0.0196). Furthermore, metastatic tissues from patients who had failed trastuzumab therapy were pS2 positive. In HER2-overexpressing cells, trastuzumab treatment can repress Myc transcriptional activity and clinical response is favorable. However, with co-expression of the steroid pathway, this inhibition is lost and response to treatment is often poor.	[Collins, D. C.; Cocchiglia, S.; Tibbitts, P.; Solon, G.; Bane, F. T.; McBryan, J.; Hill, A. D.; Young, L. S.] Royal Coll Surgeons Ireland, Dept Surg, Dublin 2, Ireland; [Treumann, A.] Royal Coll Surgeons Ireland, Dept Mass Spectrometry Unit, Dublin 2, Ireland; [Eustace, A.; Hennessy, B.] Royal Coll Surgeons Ireland, Dept Med, Dublin 2, Ireland	Royal College of Surgeons - Ireland; Royal College of Surgeons - Ireland; Royal College of Surgeons - Ireland	Young, LS (corresponding author), Royal Coll Surgeons Ireland, Dept Surg, York House,York St, Dublin 2, Ireland.	lyoung@rcsi.ie		Hennessy, Bryan/0000-0002-7871-6477; McBryan, Jean/0000-0002-7568-2208; Eustace, Alex/0000-0002-4092-1360; Treumann, Achim/0000-0002-9417-3505	Science Foundation Ireland [08-IN1-B1853]; Health Research Board of Ireland [HRB/POR/2012/101]; Irish Cancer Society Collaborative Cancer Research Centre grant [CCRC13GAL]	Science Foundation Ireland(Science Foundation IrelandEuropean Commission); Health Research Board of Ireland; Irish Cancer Society Collaborative Cancer Research Centre grant	We thank Lance Hudson for his technical expertise and thank Dr Robert Clarke, Georgetown, Washington, for his kind gift of the LCC1 cells. We kindly acknowledge the funding support from Science Foundation Ireland (08-IN1-B1853) and the Health Research Board of Ireland (HRB/POR/2012/101). This material is also based on works supported by the Irish Cancer Society Collaborative Cancer Research Centre grant, CCRC13GAL.	Adams BD, 2009, MOL ENDOCRINOL, V23, P1215, DOI 10.1210/me.2009-0062; Baselga J, 2012, LANCET, V379, P633, DOI 10.1016/S0140-6736(11)61847-3; Brennan K, 2013, ONCOGENE, V32, P2799, DOI 10.1038/onc.2012.276; Chakrabarty A, 2013, CANCER RES, V73, P1190, DOI 10.1158/0008-5472.CAN-12-2440; Chen FL, 2008, CLIN CANCER RES, V14, P6730, DOI 10.1158/1078-0432.CCR-08-0581; Chen JD, 1996, P NATL ACAD SCI USA, V93, P7567, DOI 10.1073/pnas.93.15.7567; Coombes RC, 2013, ANN ONCOL, V24, P924, DOI 10.1093/annonc/mds594; Cosgrave N, 2006, J MOL ENDOCRINOL, V37, P377, DOI 10.1677/jme.1.02118; Guarneri V, 2012, J CLIN ONCOL, V30, P1989, DOI 10.1200/JCO.2011.39.0823; Junttila TT, 2009, CANCER CELL, V15, P429, DOI 10.1016/j.ccr.2009.03.020; Kim C, 2005, BREAST CANCER RES TR, V94, pS6; Leary AF, 2010, CLIN CANCER RES, V16, P1486, DOI 10.1158/1078-0432.CCR-09-1764; Lobo VJSA, 2013, ONCOGENE, V32, P5261, DOI 10.1038/onc.2012.621; Massarweh S, 2008, CANCER RES, V68, P826, DOI 10.1158/0008-5472.CAN-07-2707; McBryan J, 2012, CANCER RES, V72, P548, DOI 10.1158/0008-5472.CAN-11-2073; Nagy L, 1997, CELL, V89, P373, DOI 10.1016/S0092-8674(00)80218-4; Nahta R, 2012, BREAST CANCER RES TR, V135, P39, DOI 10.1007/s10549-012-2067-8; Osborne CK, 2011, ANNU REV MED, V62, P233, DOI 10.1146/annurev-med-070909-182917; Peck B, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00096; Perez EA, 2011, J CLIN ONCOL, V29, P651, DOI 10.1200/JCO.2010.30.2125; Pinzone JJ, 2004, MOL CELL BIOL, V24, P4605, DOI 10.1128/MCB.24.11.4605-4612.2004; Rexer Brent N., 2012, Critical Reviews in Oncogenesis, V17, P1; Sabnis G, 2009, CANCER RES, V69, P1416, DOI 10.1158/0008-5472.CAN-08-0857; Sankar N, 2008, ONCOGENE, V27, P5717, DOI 10.1038/onc.2008.181; Stoica A, 2000, J ENDOCRINOL, V165, P371, DOI 10.1677/joe.0.1650371; Xia W, 2006, P NATL ACAD SCI USA, V103, P7795, DOI 10.1073/pnas.0602468103	26	18	18	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 22	2015	34	4					525	530		10.1038/onc.2013.586	http://dx.doi.org/10.1038/onc.2013.586			6	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AZ8FU	24469058				2022-12-25	WOS:000348451300013
J	Behring, JB; Kumar, V; Whelan, SA; Chauhan, P; Siwik, DA; Costello, CE; Colucci, WS; Cohen, RA; McComb, ME; Bachschmid, MM				Behring, Jessica B.; Kumar, Vikas; Whelan, Stephen A.; Chauhan, Pratibha; Siwik, Deborah A.; Costello, Catherine E.; Colucci, Wilson S.; Cohen, Richard A.; McComb, Mark E.; Bachschmid, Markus M.			Does reversible cysteine oxidation link the Western diet to cardiac dysfunction?	FASEB JOURNAL			English	Article						oxidative post-translational modifications; reactive oxygen and nitrogen species; obesity; metabolic heart disease	NICOTINAMIDE NUCLEOTIDE TRANSHYDROGENASE; OBESITY; MOUSE; HEART	Using a novel cysteine thiol labeling strategy coupled with mass spectrometric analysis, we identified and quantified the changes in global reversible cysteine oxidation of proteins in the left ventricle of hearts from mice with metabolic syndrome-associated diastolic dysfunction. This phenotype was induced by feeding a high-fat, high-sucrose, type-2 diabetogenic diet to C57BL/6J mice for 8 mo. The extent of reversible thiol oxidation in relationship to the total available (free and reducible) level of each cysteine could be confidently determined for 173 proteins, of which 98 contained cysteines differentially modified 1.5-fold by the diet. Our findings suggest that the metabolic syndrome leads to potentially deleterious changes in the oxidative modification of metabolically active proteins. These alterations may adversely regulate energy substrate flux through glycolysis, -oxidation, citric acid (TCA) cycle, and oxidative phosphorylation (oxphos), thereby contributing to maladaptive tissue remodeling that is associated with, and possibly contributing to, diastolic left ventricular dysfunction.Behring, J. B., Kumar, V., Whelan, S. A., Chauhan, P., Siwik, D. A., Costello, C. E., Colucci, W. S., Cohen, R. A., McComb M. E., Bachschmid, M. M. Does reversible cysteine oxidation link the Western diet to cardiac dysfunction?	[Behring, Jessica B.; Kumar, Vikas; Chauhan, Pratibha; Cohen, Richard A.; McComb, Mark E.; Bachschmid, Markus M.] Boston Univ, Sch Med, Whitaker Cardiovasc Inst, Vasc Biol Sect, Boston, MA 02118 USA; [Siwik, Deborah A.; Colucci, Wilson S.] Boston Univ, Sch Med, Whitaker Cardiovasc Inst, Myocardial Unit, Boston, MA 02118 USA; [Whelan, Stephen A.; Costello, Catherine E.; McComb, Mark E.] Boston Univ, Sch Med, Ctr Biomed Mass Spectrometry, Cardiovasc Prote Ctr, Boston, MA 02118 USA	Boston University; Boston University; Boston University	Bachschmid, MM (corresponding author), Boston Univ, Sch Med, Whitaker Cardiovasc Inst, Vasc Biol Sect, Boston, MA 02118 USA.	mccomb@bu.edu; bach@bu.edu	Whelan, Stephen A/I-9502-2012; McComb, Mark E/I-3193-2014	Whelan, Stephen A/0000-0002-4740-0795; Whelan, Stephen A/0000-0002-5439-6501; Bachschmid, Markus Michael/0000-0002-0748-5528; /0000-0002-1070-6408; Costello, Catherine/0000-0003-1594-5122; /0000-0002-4249-485X; /0000-0002-7166-327X	National Heart, Lung, and Blood Institute, National Institutes of Health (NIH), U.S. Department of Health and Human Services [HHSN268201000031C]; NIH [P01-HL-068758, R37-HL-104017, HL-064750, HL-31607]; DIVISION OF HEART AND VASCULAR DISEASES [N01HV028178] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL068758, T32HL007501, R01HL031607, R01HL064750, R37HL104017] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM104603] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute, National Institutes of Health (NIH), U.S. Department of Health and Human Services; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DIVISION OF HEART AND VASCULAR DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors thank David R. Pimentel and Aaron L. Sverdlov for many helpful discussions and editing of the manuscript. This work was supported by the National Heart, Lung, and Blood Institute, National Institutes of Health (NIH), U.S. Department of Health and Human Services, under contract HHSN268201000031C, as well as by NIH grants P01-HL-068758, R37-HL-104017, HL-064750, and HL-31607, and its contents are solely the responsibility of the authors and do not represent the official views of the awarding offices. The authors declare no conflicts of interest.	Benderdour M, 2003, J BIOL CHEM, V278, P45154, DOI 10.1074/jbc.M306285200; Freeman H, 2006, CELL METAB, V3, P35, DOI 10.1016/j.cmet.2005.10.008; GARDNER PR, 1992, J BIOL CHEM, V267, P8757; Jeong J., 2011, MOL CELL PROTEOMICS, V10, P1; Kumar V, 2013, FREE RADICAL BIO MED, V58, P109, DOI 10.1016/j.freeradbiomed.2013.01.021; LOCONTE M, 2013, OXIDATIVE STRESS RED; Murray CI, 2012, CIRC RES, V111, P1253, DOI 10.1161/CIRCRESAHA.112.278721; Murray CI, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.013441; Nicholson A, 2010, OBESITY, V18, P1902, DOI 10.1038/oby.2009.477; Petro AE, 2004, METABOLISM, V53, P454, DOI 10.1016/j.metabol.2003.11.018; Qin FZ, 2012, CIRCULATION, V125, P1757, DOI 10.1161/CIRCULATIONAHA.111.067801; Reisz JA, 2013, FEBS J, V280, P6150, DOI 10.1111/febs.12535; Rosiers CD, 2011, CARDIOVASC RES, V90, P210, DOI 10.1093/cvr/cvr055; Sharma V, 2010, MOL CELL BIOCHEM, V337, P223, DOI 10.1007/s11010-009-0303-2; Wu RH, 2011, NAT METHODS, V8, P677, DOI [10.1038/nmeth.1636, 10.1038/NMETH.1636]	15	28	28	0	16	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2014	28	5					1975	1987		10.1096/fj.13-233445	http://dx.doi.org/10.1096/fj.13-233445			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	AG3RA	24469991	Green Published			2022-12-25	WOS:000335336000003
J	Goettel, W; Liu, ZR; Xia, J; Zhang, WX; Zhao, PX; An, YQ				Goettel, Wolfgang; Liu, Zongrang; Xia, Jing; Zhang, Weixiong; Zhao, Patrick X.; An, Yong-Qiang (Charles)			Systems and Evolutionary Characterization of MicroRNAs and Their Underlying Regulatory Networks in Soybean Cotyledons	PLOS ONE			English	Article							SMALL RNAS; TARGET GENES; ARABIDOPSIS-LYRATA; PLANT; IDENTIFICATION; MIRNAS; GENOME; MIR159; BIOGENESIS; MECHANISMS	MicroRNAs (miRNAs) are an emerging class of small RNAs regulating a wide range of biological processes. Soybean cotyledons evolved as sink tissues to synthesize and store seed reserves which directly affect soybean seed yield and quality. However, little is known about miRNAs and their regulatory networks in soybean cotyledons. We sequenced 292 million small RNA reads expressed in soybean cotyledons, and discovered 130 novel miRNA genes and 72 novel miRNA families. The cotyledon miRNAs arose at various stages of land plant evolution. Evolutionary analysis of the miRNA genes in duplicated genome segments from the recent Glycine whole genome duplication revealed that the majority of novel soybean cotyledon miRNAs were young, and likely arose after the duplication event 13 million years ago. We revealed the evolutionary pathway of a soybean cotyledon miRNA family (soy-miR15/ 49) that evolved from a neutral invertase gene through an inverted duplication and a series of DNA amplification and deletion events. A total of 304 miRNA genes were expressed in soybean cotyledons. The miRNAs were predicted to target 1910 genes, and form complex miRNA networks regulating a wide range of biological pathways in cotyledons. The comprehensive characterization of the miRNAs and their underlying regulatory networks at gene, pathway and system levels provides a foundation for further studies of miRNAs in cotyledons.	[Goettel, Wolfgang; An, Yong-Qiang (Charles)] ARS, USDA, Plant Genet Res Unit, Donald Danforth Plant Sci Ctr, St Louis, MO 63120 USA; [Liu, Zongrang] ARS, USDA, Appalachian Fruit Res Stn, Kearneysville, WV USA; [Xia, Jing; Zhang, Weixiong] Washington Univ, Dept Comp Sci & Engn, St Louis, MO USA; [Zhao, Patrick X.] Samuel Roberts Noble Fdn Inc, Div Plant Biol, Ardmore, OK 73402 USA	Donald Danforth Plant Science Center; United States Department of Agriculture (USDA); United States Department of Agriculture (USDA); Washington University (WUSTL); Noble Research Institute	An, YQ (corresponding author), ARS, USDA, Plant Genet Res Unit, Donald Danforth Plant Sci Ctr, St Louis, MO 63120 USA.	yong-qiang.an@ars.usda.gov		Zhao, Patrick Xuechun/0000-0002-3460-5564; Zhang, Weixiong/0000-0002-4998-9791	USDA-ARS; United Soybean Board; Direct For Biological Sciences [0960897] Funding Source: National Science Foundation	USDA-ARS(United States Department of Agriculture (USDA)USDA Agricultural Research Service); United Soybean Board; Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This research is supported by funds from USDA-ARS and the United Soybean Board to Yong-qiang Charles An. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen E, 2004, NAT GENET, V36, P1282, DOI 10.1038/ng1478; Allen RS, 2007, P NATL ACAD SCI USA, V104, P16371, DOI 10.1073/pnas.0707653104; Aukerman MJ, 2003, PLANT CELL, V15, P2730, DOI 10.1105/tpc.016238; Axtell MJ, 2007, PLANT CELL, V19, P1750, DOI 10.1105/tpc.107.051706; Axtell MJ, 2013, ANNU REV PLANT BIOL, V64, P137, DOI 10.1146/annurev-arplant-050312-120043; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Brodersen P, 2008, SCIENCE, V320, P1185, DOI 10.1126/science.1159151; Carrington JC, 2003, SCIENCE, V301, P336, DOI 10.1126/science.1085242; Carthew RW, 2009, CELL, V136, P642, DOI 10.1016/j.cell.2009.01.035; Chen K, 2007, NAT REV GENET, V8, P93, DOI 10.1038/nrg1990; Chen KG, 2006, J INTEGR PLANT BIOL, V48, P591, DOI 10.1111/j.1744-7909.2006.00270.x; Chen XM, 2004, SCIENCE, V303, P2022, DOI 10.1126/science.1088060; Cui HC, 2007, SCIENCE, V316, P421, DOI 10.1126/science.1139531; Cuperus JT, 2011, PLANT CELL, V23, P431, DOI 10.1105/tpc.110.082784; Dugas DV, 2008, PLANT MOL BIOL, V67, P403, DOI 10.1007/s11103-008-9329-1; Fahlgren N, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000219; Fahlgren N, 2010, PLANT CELL, V22, P1074, DOI 10.1105/tpc.110.073999; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; HOFACKER IL, 1994, MONATSH CHEM, V125, P167, DOI 10.1007/BF00818163; Jones-Rhoades MW, 2006, ANNU REV PLANT BIOL, V57, P19, DOI 10.1146/annurev.arplant.57.032905.105218; Joshi T, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-S1-S14; Kim VN, 2005, NAT REV MOL CELL BIO, V6, P376, DOI 10.1038/nrm1644; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Kozomara A, 2011, NUCLEIC ACIDS RES, V39, pD152, DOI 10.1093/nar/gkq1027; Kulcheski FR, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-307; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lee Y, 2004, EMBO J, V23, P4051, DOI 10.1038/sj.emboj.7600385; Lelandais-Briere C, 2009, PLANT CELL, V21, P2780, DOI 10.1105/tpc.109.068130; Li BS, 2011, J EXP BOT, V62, P3765, DOI 10.1093/jxb/err051; Li H, 2010, PLANT PHYSIOL, V153, P1759, DOI 10.1104/pp.110.156950; Li Y, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-122; Lin JY, 2010, PLANT CELL, V22, P2545, DOI 10.1105/tpc.110.074229; Ma ZR, 2010, PLANT CELL, V22, P1090, DOI 10.1105/tpc.110.073882; McClean PE, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-184; Meyers BC, 2008, PLANT CELL, V20, P3186, DOI 10.1105/tpc.108.064311; Mi SJ, 2008, CELL, V133, P116, DOI 10.1016/j.cell.2008.02.034; Millar AA, 2005, PLANT CELL, V17, P705, DOI 10.1105/tpc.104.027920; Nozawa M, 2012, GENOME BIOL EVOL, V4, P230, DOI 10.1093/gbe/evs002; Okamura K, 2008, NAT STRUCT MOL BIOL, V15, P354, DOI 10.1038/nsmb.1409; Okamura K, 2009, MOL CELL, V36, P431, DOI 10.1016/j.molcel.2009.09.027; Ori N, 2007, NAT GENET, V39, P787, DOI 10.1038/ng2036; Palatnik JF, 2007, DEV CELL, V13, P115, DOI 10.1016/j.devcel.2007.04.012; Palatnik JF, 2003, NATURE, V425, P257, DOI 10.1038/nature01958; Park W, 2002, CURR BIOL, V12, P1484, DOI 10.1016/S0960-9822(02)01017-5; Rajagopalan R, 2006, GENE DEV, V20, P3407, DOI 10.1101/gad.1476406; Reese TA, 2010, J VIROL, V84, P10344, DOI 10.1128/JVI.00707-10; Reyes JL, 2007, PLANT J, V49, P592, DOI 10.1111/j.1365-313X.2006.02980.x; Rhoades MW, 2002, CELL, V110, P513, DOI 10.1016/S0092-8674(02)00863-2; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Schmutz J, 2010, NATURE, V463, P178, DOI 10.1038/nature08670; Schommer C, 2008, PLOS BIOL, V6, P1991, DOI 10.1371/journal.pbio.0060230; Shamimuzzaman M, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-310; Song QX, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-5; Subramanian S, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-160; Sunkar R, 2004, PLANT CELL, V16, P2001, DOI 10.1105/tpc.104.022830; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Thimm O, 2004, PLANT J, V37, P914, DOI 10.1111/j.1365-313X.2004.02016.x; Turner M, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-169; Vaucheret H, 2008, TRENDS PLANT SCI, V13, P350, DOI 10.1016/j.tplants.2008.04.007; Xia R, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-6-r47; Xie ZX, 2005, PLANT PHYSIOL, V138, P2145, DOI 10.1104/pp.105.062943; Zhai JX, 2011, GENE DEV, V25, P2540, DOI 10.1101/gad.177527.111; Zhang BH, 2008, PLANTA, V229, P161, DOI 10.1007/s00425-008-0818-x; Zhang LF, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000716; Zhang Weixiong, 2012, Methods Mol Biol, V883, P221, DOI 10.1007/978-1-61779-839-9_17; Zhou XF, 2007, PLOS COMPUT BIOL, V3, P412, DOI 10.1371/journal.pcbi.0030037	66	29	69	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2014	9	1							e86153	10.1371/journal.pone.0086153	http://dx.doi.org/10.1371/journal.pone.0086153			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301BI	24475082	Green Published, gold, Green Submitted			2022-12-25	WOS:000330507300040
J	Soler, M; Perez-Contreras, T; Peralta-Sanchez, JM				Soler, Manuel; Perez-Contreras, Tomas; Manuel Peralta-Sanchez, Juan			Mirror-Mark Tests Performed on Jackdaws Reveal Potential Methodological Problems in the Use of Stickers in Avian Mark-Test Studies	PLOS ONE			English	Article							SELF-RECOGNITION; CONVERGENT EVOLUTION; CROWS; CHIMPANZEES; BEHAVIOR; IMAGE; AWARENESS; RESPONSES; CORVIDS; BRAIN	Some animals are capable of recognizing themselves in a mirror, which is considered to be demonstrated by passing the mark test. Mirror self-recognition capacity has been found in just a few mammals having very large brains and only in one bird, the magpie (Pica pica). The results obtained in magpies have enormous biological and cognitive implications because the fact that magpies were able to pass the mark test meant that this species is at the same cognitive level with great apes, that mirror self-recognition has evolved independently in the magpie and great apes (which diverged 300 million years ago), and that the neocortex (which is not present in the bird's brains) is not a prerequisite for mirror self-recognition as previously believed. Here, we have replicated the experimental design used on magpies to determine whether jackdaws (Corvus monedula) are also capable of mirror self-recognition by passing the mark test. We found that our nine jackdaws showed a very high interest towards the mirror and exhibited self-contingent behavior as soon as mirrors were introduced. However, jackdaws were not able to pass the mark test: both sticker-directed actions and sticker removal were performed with a similar frequency in both the cardboard (control) and the mirror conditions. We conclude that our jackdaws' behaviour raises non-trivial questions about the methodology used in the avian mark test. Our study suggests that the use of self-adhesive stickers on sensitive throat feathers may open the way to artefactual results because birds might perceive the stickers tactilely.	[Soler, Manuel; Perez-Contreras, Tomas] Univ Granada, Fac Ciencias, Dept Zool, Granada, Spain; [Soler, Manuel; Perez-Contreras, Tomas; Manuel Peralta-Sanchez, Juan] Univ Granada, CSIC, Unidad Asociada, Grp Coevoluc, Granada, Spain; [Manuel Peralta-Sanchez, Juan] Univ Granada, Fac Ciencias, Dept Microbiol, E-18071 Granada, Spain; [Manuel Peralta-Sanchez, Juan] Knight Lab, Boulder, CO USA	University of Granada; Consejo Superior de Investigaciones Cientificas (CSIC); University of Granada; University of Granada	Soler, M (corresponding author), Univ Granada, Fac Ciencias, Dept Zool, Granada, Spain.	msoler@ugr.es	Pérez-Contreras, Tomás/M-8065-2014; Peralta-Sanchez, Juan M/L-3159-2017; Pérez-Contreras, Tomás/N-2523-2019	Pérez-Contreras, Tomás/0000-0002-2271-1706; Peralta-Sanchez, Juan M/0000-0003-4648-7988; Pérez-Contreras, Tomás/0000-0002-2271-1706	Ministerio de Educacion and Consejeria de Innovacion; C 420 iencia y Empresa under International Excellence Campus Program (CEI Granada); Ministerio de Educacion y Ciencia [CGL2011-25634]	Ministerio de Educacion and Consejeria de Innovacion; C 420 iencia y Empresa under International Excellence Campus Program (CEI Granada); Ministerio de Educacion y Ciencia(Spanish Government)	JMPS was funded by Ministerio de Educacion and Consejeria de Innovacion, C 420 iencia y Empresa under International Excellence Campus Program (CEI Granada) and TPC was funded by Ministerio de Educacion y Ciencia by a postdoctoral contract from the project CGL2011-25634. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMSTERDAM B, 1972, DEV PSYCHOBIOL, V5, P297, DOI 10.1002/dev.420050403; Bard KA, 2006, INFANCY, V9, P191, DOI 10.1207/s15327078in0902_6; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BERTENTHAL BI, 1978, DEV PSYCHOL, V14, P44; Bugnyar T, 2005, P ROY SOC B-BIOL SCI, V272, P1641, DOI 10.1098/rspb.2005.3144; Clayton NS, 1999, J COMP PSYCHOL, V113, P403, DOI 10.1037/0735-7036.113.4.403; Clayton NS, 2003, NAT REV NEUROSCI, V4, P685, DOI 10.1038/nrn1180; COOMBS F, 1978, CROWS STUDY CORVIDS; Cornell HN, 2012, P ROY SOC B-BIOL SCI, V279, P499, DOI 10.1098/rspb.2011.0957; Dally JM, 2006, SCIENCE, V312, P1662, DOI 10.1126/science.1126539; Darwin G., 1871, P423; de Veer MW, 1999, ANIM BEHAV, V58, P459, DOI 10.1006/anbe.1999.1166; de Waal FBM, 2005, P NATL ACAD SCI USA, V102, P11140, DOI 10.1073/pnas.0503935102; Emery NJ, 2004, SCIENCE, V306, P1903, DOI 10.1126/science.1098410; GALLUP GG, 1970, SCIENCE, V167, P86, DOI 10.1126/science.167.3914.86; Gallup GG, 1998, BEHAV PROCESS, V42, P239, DOI 10.1016/S0376-6357(97)00079-X; Griesser M, 2008, CURR BIOL, V18, P69, DOI 10.1016/j.cub.2007.11.069; Griesser M, 2009, P R SOC B, V276, P2887, DOI 10.1098/rspb.2009.0551; Griffin D.R., 1992, ANIMAL MINDS; Gunturkun O, 2012, PSYCHOL RES-PSYCH FO, V76, P212, DOI 10.1007/s00426-011-0377-9; Gunturkun O, 2005, CURR OPIN NEUROBIOL, V15, P686, DOI 10.1016/j.conb.2005.10.003; HEALY SD, 1992, P ROY SOC B-BIOL SCI, V248, P241, DOI 10.1098/rspb.1992.0068; Heinrich B, 1995, AUK, V112, P994, DOI 10.2307/4089030; Heschl A, 2009, INT J COMP PSYCHOL, V22, P221; Iglesias TL, 2012, ANIM BEHAV, V84, P1103, DOI 10.1016/j.anbehav.2012.08.007; Iwaniuk AN, 2005, BRAIN BEHAV EVOLUT, V65, P40, DOI 10.1159/000081110; JERISON HJ, 1969, AM NAT, V103, P575, DOI 10.1086/282627; Kusayama T, 2000, ANIM COGN, V3, P61, DOI 10.1007/s100710050051; LETHMATE J, 1973, Zeitschrift fuer Tierpsychologie, V33, P248; Lorenz K, 1982, HABLABA CON BESTIAS; Marzluff J. M., 2007, CO CROWS RAVENS; Marzluff JM, 2010, ANIM BEHAV, V79, P699, DOI 10.1016/j.anbehav.2009.12.022; Medina FS, 2011, ANIM BEHAV, V82, P981, DOI 10.1016/j.anbehav.2011.07.033; Morin A, 2011, LATERALITY, V16, P367, DOI 10.1080/13576501003702648; Paz-y-Mino G, 2004, NATURE, V430, P778, DOI 10.1038/nature02723; PEPPERBERG IM, 1995, J COMP PSYCHOL, V109, P182, DOI 10.1037/0735-7036.109.2.182; Plotnik JM, 2006, P NATL ACAD SCI USA, V103, P17053, DOI 10.1073/pnas.0608062103; POVINELLI DJ, 1993, J COMP PSYCHOL, V107, P347, DOI 10.1037/0735-7036.107.4.347; Prior H, 2008, PLOS BIOL, V6, P1642, DOI 10.1371/journal.pbio.0060202; R Core Team, 2021, R LANG ENV STAT COMP; Raby CR, 2007, NATURE, V445, P919, DOI 10.1038/nature05575; Rajala AZ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012865; Reiss D, 2001, P NATL ACAD SCI USA, V98, P5937, DOI 10.1073/pnas.101086398; ROELL A, 1978, BEHAVIOUR, V64, P1; Schilhab TSS, 2004, BIOL PHILOS, V19, P111, DOI 10.1023/B:BIPH.0000013249.23475.1f; Seed AM, 2007, CURR BIOL, V17, P152, DOI 10.1016/j.cub.2006.11.025; Soler M, 2011, ADAPTIVE BEHAV UNDER; Suddendorf T, 2009, P R SOC B, V276, P1671, DOI 10.1098/rspb.2008.1754; Taylor AH, 2009, P R SOC B, V276, P247, DOI 10.1098/rspb.2008.1107; WALRAVEN V, 1995, PRIMATES, V36, P145, DOI 10.1007/BF02381922; Watanabe S, 2002, BEHAV PROCESS, V60, P35, DOI 10.1016/S0376-6357(02)00094-3; Weir AAS, 2002, SCIENCE, V297, P981, DOI 10.1126/science.1073433	52	42	44	0	84	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2014	9	1							e86193	10.1371/journal.pone.0086193	http://dx.doi.org/10.1371/journal.pone.0086193			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301BI	24475085	Green Published, gold, Green Submitted			2022-12-25	WOS:000330507300042
J	Tseng, CK; Lin, CK; Chang, HW; Wu, YH; Yen, FL; Chang, FR; Chen, WC; Yeh, CC; Lee, JC				Tseng, Chin-Kai; Lin, Chun-Kuang; Chang, Hsueh-Wei; Wu, Yu-Hsuan; Yen, Feng-Lin; Chang, Fang-Rong; Chen, Wei-Chun; Yeh, Chi-Chen; Lee, Jin-Ching			Aqueous Extract of Gracilaria tenuistipitata Suppresses LPS-Induced NF-kappa B and MAPK Activation in RAW 264.7 and Rat Peritoneal Macrophages and Exerts Hepatoprotective Effects on Carbon Tetrachloride-Treated Rat	PLOS ONE			English	Article							LIVER-INJURY; MOLECULAR-MECHANISMS; SIGNALING PATHWAYS; CELL-SURVIVAL; NITRIC-OXIDE; INFLAMMATION; LIPOPOLYSACCHARIDE; DAMAGE; HOMEOSTASIS; INHIBITION	In addition to the previous investigations of bioactivity of aqueous extract of the edible Gracilaria tenuistipitata (AEGT) against H2O2-induced DNA damage and hepatitis C virus replication, the purpose of this study is to evaluate the potential therapeutic properties of AEGT against inflammation and hepatotoxicity using lipopolysaccharide (LPS)-stimulated mouse RAW 264.7 cells, primary rat peritoneal macrophages and carbon tetrachloride (CCl4)-induced acute hepatitis model in rats. AEGT concentration-dependently inhibited the elevated RNA and protein levels of inducible nitric oxide synthase and cyclooxygenase-2, thereby reducing nitric oxide and prostaglandin E2 levels, respectively. Moreover, AEGT significantly suppressed the production of LPS-induced proinflammatory cytokines, including interleukin (IL)-1 beta, IL-6 and tumor necrosis factor-alpha. These inhibitory effects were associated with the suppression of nuclear factor-kappa B activation and mitogen-activated protein kinase phosphorylation by AEGT in LPS-stimulated cells. In addition, we highlighted the hepatoprotective and curative effects of AEGT in a rat model of CCl4-intoxicated acute liver injury, which was evident from reduction in the elevated serum aspartate aminotransferase and alanine aminotransferase levels as well as amelioration of histological damage by pre-treatment or post-treatment of AEGT. In conclusion, the results demonstrate that AEGT may serve as a potential supplement in the prevention or amelioration of inflammatory diseases.	[Tseng, Chin-Kai] Natl Cheng Kung Univ, Coll Med, Inst Basic Med Sci, Tainan 70101, Taiwan; [Tseng, Chin-Kai] Natl Cheng Kung Univ, Coll Med, Ctr Infect Dis & Signaling Res, Tainan 70101, Taiwan; [Lin, Chun-Kuang] Natl Sun Yat Sen Univ, Doctoral Degree Program Marine Biotechnol, Kaohsiung 80424, Taiwan; [Chang, Hsueh-Wei] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Dept Biomed Sci & Environm Biol, Ctr Canc, Kaohsiung, Taiwan; [Wu, Yu-Hsuan; Lee, Jin-Ching] Kaohsiung Med Univ, Dept Biotechnol, Coll Life Sci, Kaohsiung, Taiwan; [Yen, Feng-Lin] Kaohsiung Med Univ, Dept Fragrance & Cosmet Sci, Coll Pharm, Kaohsiung, Taiwan; [Chen, Wei-Chun] Kaohsiung Med Univ, Grad Inst Med, Coll Med, Kaohsiung, Taiwan; [Chang, Fang-Rong; Yeh, Chi-Chen; Lee, Jin-Ching] Kaohsiung Med Univ, Grad Inst Nat Prod, Coll Pharm, Kaohsiung, Taiwan	National Cheng Kung University; National Cheng Kung University; National Sun Yat Sen University; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University	Lee, JC (corresponding author), Kaohsiung Med Univ, Dept Biotechnol, Coll Life Sci, Kaohsiung, Taiwan.	jclee@kmu.edu.tw	Chang, Hsueh-Wei/C-9654-2009	Chang, Hsueh-Wei/0000-0003-0068-2366; Lee, Jin-Ching/0000-0003-0729-9589; Wu, Yu-Hsuan/0000-0002-2175-3867; Chang, Fang-Rong/0000-0003-2549-4193	National Science Council of Taiwan [NSC 101-2311-B-037-002-MY3, NSC 101-2622-B-037-001-CC3]; Kaohsiung Medical University Research Foundation, Taiwan [KMUER014]; Department of Health, Executive Yuan, Taiwan [DOH102-TD-C-111-002]	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan); Kaohsiung Medical University Research Foundation, Taiwan; Department of Health, Executive Yuan, Taiwan	This work was funded by grants from the National Science Council of Taiwan (NSC 101-2311-B-037-002-MY3 and NSC 101-2622-B-037-001-CC3), Kaohsiung Medical University Research Foundation, Taiwan (KMUER014) and The Department of Health, Executive Yuan, Taiwan (DOH102-TD-C-111-002). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AJISAKA T, 1993, HYDROBIOLOGIA, V261, P335; APPLEBY SB, 1994, BIOCHEM J, V302, P723, DOI 10.1042/bj3020723; Beauparlant Pierre, 1996, Cytokine and Growth Factor Reviews, V7, P175, DOI 10.1016/1359-6101(96)00020-2; Chan ED, 2001, AM J PHYSIOL-CELL PH, V280, pC441, DOI 10.1152/ajpcell.2001.280.3.C441; CHANG KP, 1976, SCIENCE, V193, P678, DOI 10.1126/science.948742; Chen GY, 2010, NAT REV IMMUNOL, V10, P826, DOI 10.1038/nri2873; Chen KJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057704; Crispe IN, 2009, ANNU REV IMMUNOL, V27, P147, DOI 10.1146/annurev.immunol.021908.132629; Feldmann M, 2008, J CLIN INVEST, V118, P3533, DOI 10.1172/JCI37346; Fujihara M, 2003, PHARMACOL THERAPEUT, V100, P171, DOI 10.1016/j.pharmthera.2003.08.003; Ghosh S, 2008, NAT REV IMMUNOL, V8, P837, DOI 10.1038/nri2423; Gonciarz M, 2010, J PHYSIOL PHARMACOL, V61, P705; Jaeschke H, 2011, J GASTROEN HEPATOL, V26, P173, DOI 10.1111/j.1440-1746.2010.06592.x; Javed S, 2011, ALTERN MED REV, V16, P239; Jeong JB, 2011, ARCH PHARM RES, V34, P2109, DOI 10.1007/s12272-011-1214-9; JOHNSON SJ, 1992, J PATHOL, V166, P351, DOI 10.1002/path.1711660406; Kaminska B, 2005, BBA-PROTEINS PROTEOM, V1754, P253, DOI 10.1016/j.bbapap.2005.08.017; Kawai T, 2011, IMMUNITY, V34, P637, DOI 10.1016/j.immuni.2011.05.006; Kim JK, 2012, INFLAMM RES, V61, P319, DOI 10.1007/s00011-011-0413-7; Kim MM, 2009, PHYTOTHER RES, V23, P628, DOI 10.1002/ptr.2674; KOOP DR, 1992, FASEB J, V6, P724, DOI 10.1096/fasebj.6.2.1537462; Krakauer Teresa, 2004, Current Drug Targets - Inflammation and Allergy, V3, P317; Lee CW, 2012, J AGR FOOD CHEM, V60, P4662, DOI 10.1021/jf2050137; Lee JC, 2011, ANTIVIR RES, V89, P35, DOI 10.1016/j.antiviral.2010.11.003; Lin AW, 1996, J BIOL CHEM, V271, P11911, DOI 10.1074/jbc.271.20.11911; LIU RH, 1995, MUTAT RES-REV GENET, V339, P73, DOI 10.1016/0165-1110(95)90004-7; Medzhitov R, 2009, NAT REV IMMUNOL, V9, P692, DOI 10.1038/nri2634; Muriel P, 2009, J APPL TOXICOL, V29, P91, DOI 10.1002/jat.1393; Pasparakis M, 2009, NAT REV IMMUNOL, V9, P778, DOI 10.1038/nri2655; Patrick L, 2006, ALTERN MED REV, V11, P114; Piva R, 2006, ANTIOXID REDOX SIGN, V8, P478, DOI 10.1089/ars.2006.8.478; Pradhan SC, 2006, INDIAN J MED RES, V124, P491; Ren K, 2009, BRAIN RES REV, V60, P57, DOI 10.1016/j.brainresrev.2008.12.020; Ryan S, 2011, PHYTOTHER RES, V25, P765, DOI 10.1002/ptr.3309; Sasaki S, 2002, EUR J IMMUNOL, V32, P3197, DOI 10.1002/1521-4141(200211)32:11<3197::AID-IMMU3197>3.0.CO;2-1; SLATER TF, 1985, PHILOS T R SOC B, V311, P633, DOI 10.1098/rstb.1985.0169; SLATER TF, 1984, BIOCHEM J, V222, P1; Tacke F, 2009, CLIN REV ALLERG IMMU, V36, P4, DOI 10.1007/s12016-008-8091-0; Veres B, 2004, J PHARMACOL EXP THER, V310, P247, DOI 10.1124/jpet.104.065151; Yang JI, 2012, MOLECULES, V17, P7241, DOI 10.3390/molecules17067241	40	31	32	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2014	9	1							e86557	10.1371/journal.pone.0086557	http://dx.doi.org/10.1371/journal.pone.0086557			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301BI	24475143	Green Published, gold, Green Submitted			2022-12-25	WOS:000330507300080
J	Brockman-Schneider, RA; Pickles, RJ; Gern, JE				Brockman-Schneider, Rebecca A.; Pickles, Raymond J.; Gern, James E.			Effects of Vitamin D on Airway Epithelial Cell Morphology and Rhinovirus Replication	PLOS ONE			English	Article							RESPIRATORY-TRACT INFECTION; PROLINE-RICH PROTEIN; ANTIMICROBIAL PEPTIDES; SQUAMOUS METAPLASIA; D DEFICIENCY; ANTAGONIZES; INDUCTION; CYTOKINES; DEFENSE; DISEASE	Vitamin D has been linked to reduced risk of viral respiratory illness. We hypothesized that vitamin D could directly reduce rhinovirus (RV) replication in airway epithelium. Primary human bronchial epithelial cells (hBEC) were treated with vitamin D, and RV replication and gene expression were evaluated by quantitative PCR. Cytokine/chemokine secretion was measured by ELISA, and transepithelial resistance (TER) was determined using a voltohmmeter. Morphology was examined using immunohistochemistry. Vitamin D supplementation had no significant effects on RV replication, but potentiated secretion of CXCL8 and CXCL10 from infected or uninfected cells. Treatment with vitamin D in the form of 1,25(OH)(2)D caused significant changes in cell morphology, including thickening of the cell layers (median of 46.5 mu m [35.0-69.0] vs. 30 mu m [24.5-34.2], p<0.01) and proliferation of cytokeratin-5-expressing cells, as demonstrated by immunohistochemical analysis. Similar effects were seen for 25(OH) D. In addition to altering morphology, higher concentrations of vitamin D significantly upregulated small proline-rich protein (SPRR1 beta) expression (6.3 fold-induction, p<0.01), suggestive of squamous metaplasia. Vitamin D treatment of hBECs did not alter repair of mechanically induced wounds. Collectively, these findings indicate that vitamin D does not directly affect RV replication in airway epithelial cells, but can influence chemokine synthesis and alters the growth and differentiation of airway epithelial cells.	[Brockman-Schneider, Rebecca A.; Gern, James E.] Univ Wisconsin, Dept Pediat & Med, Madison, WI 53715 USA; [Pickles, Raymond J.] Univ N Carolina, Dept Microbiol & Immunol, Chapel Hill, NC USA	University of Wisconsin System; University of Wisconsin Madison; University of North Carolina; University of North Carolina Chapel Hill	Brockman-Schneider, RA (corresponding author), Univ Wisconsin, Dept Pediat & Med, Madison, WI 53715 USA.	rabrockm@wisc.edu			NIH [P01 HL070831-06A1]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL070831] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by NIH grant #P01 HL070831-06A1 (http://www.nih.gov/). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bals R, 1998, P NATL ACAD SCI USA, V95, P9541, DOI 10.1073/pnas.95.16.9541; Banerjee A, 2012, CURR OPIN PHARMACOL, V12, P266, DOI 10.1016/j.coph.2012.01.014; Bartley J, 2010, J LARYNGOL OTOL, V124, P465, DOI 10.1017/S0022215109992684; Beard JA, 2011, J CLIN VIROL, V50, P194, DOI 10.1016/j.jcv.2010.12.006; Binkley N, 2000, NUTR REV, V58, P138, DOI 10.1111/j.1753-4887.2000.tb01848.x; Brogden KA, 2005, NAT REV MICROBIOL, V3, P238, DOI 10.1038/nrmicro1098; Feskanich D, 2002, JAMA-J AM MED ASSOC, V287, P47, DOI 10.1001/jama.287.1.47; Ginde AA, 2009, ARCH INTERN MED, V169, P384, DOI 10.1001/archinternmed.2008.560; Gray TE, 1996, AM J RESP CELL MOL, V14, P104, DOI 10.1165/ajrcmb.14.1.8534481; Hansdottir S, 2008, J IMMUNOL, V181, P7090, DOI 10.4049/jimmunol.181.10.7090; Hansdottir S, 2010, J IMMUNOL, V184, P965, DOI 10.4049/jimmunol.0902840; Hayes DP, 2010, MED HYPOTHESES, V74, P831, DOI 10.1016/j.mehy.2009.12.002; Herfs M, 2012, AM J RESP CELL MOL, V47, P67, DOI 10.1165/rcmb.2011-0353OC; Hu R, 1998, LUNG CANCER, V20, P25, DOI 10.1016/S0169-5002(97)00097-4; IGARASHI Y, 1993, J ALLERGY CLIN IMMUN, V92, P722, DOI 10.1016/0091-6749(93)90016-9; Jakiela B, 2008, AM J RESP CELL MOL, V38, P517, DOI 10.1165/rcmb.2007-0050OC; Konno S, 2002, AM J RESP CELL MOL, V26, P594, DOI 10.1165/ajrcmb.26.5.4438; Lachowicz-Scroggins ME, 2010, AM J RESP CELL MOL, V43, P652, DOI 10.1165/rcmb.2009-0244OC; Lau Derick, 2003, Methods Mol Med, V75, P397; Li S, 2008, INVEST OPHTH VIS SCI, V49, P34, DOI 10.1167/iovs.07-0685; Lin R, 2004, BIOESSAYS, V26, P21, DOI 10.1002/bies.10368; Mosser AG, 2005, AM J RESP CRIT CARE, V171, P645, DOI 10.1164/rccm.200407-970OC; Rohde CM, 2005, J NUTR, V135, P1647, DOI 10.1093/jn/135.7.1647; Rohde CM, 1999, J NUTR, V129, P2246, DOI 10.1093/jn/129.12.2246; Sabetta JR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011088; Schauber J, 2009, J ALLERGY CLIN IMMUN, V124, pR13, DOI 10.1016/j.jaci.2009.07.014; Schroth MK, 1999, AM J RESP CELL MOL, V20, P1220, DOI 10.1165/ajrcmb.20.6.3261; Schwalfenberg GK, 2011, MOL NUTR FOOD RES, V55, P96, DOI 10.1002/mnfr.201000174; Wang JH, 2009, LARYNGOSCOPE, V119, P1406, DOI 10.1002/lary.20498; Wang TT, 2004, J IMMUNOL, V173, P2909, DOI 10.4049/jimmunol.173.5.2909; Weiss ST, 2011, AM J RESP CRIT CARE, V183, P1286, DOI 10.1164/rccm.201101-0160ED; Wildman KAH, 2003, BIOCHEMISTRY-US, V42, P6545, DOI 10.1021/bi0273563; Yim S, 2007, J CYST FIBROS, V6, P403, DOI 10.1016/j.jcf.2007.03.003; Zosky GR, 2011, AM J RESP CRIT CARE, V183, P1336, DOI 10.1164/rccm.201010-1596OC	34	54	56	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2014	9	1							e86755	10.1371/journal.pone.0086755	http://dx.doi.org/10.1371/journal.pone.0086755			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	298QQ	24475177	Green Published, gold, Green Submitted			2022-12-25	WOS:000330339800060
J	Chagniel, L; Bergeron, Y; Bureau, G; Massicotte, G; Cyr, M				Chagniel, Laure; Bergeron, Yan; Bureau, Genevieve; Massicotte, Guy; Cyr, Michel			Regulation of Tyrosine Phosphatase STEP61 by Protein Kinase A during Motor Skill Learning in Mice	PLOS ONE			English	Article							LONG-TERM POTENTIATION; MOLECULAR CHARACTERIZATION; NUCLEUS-ACCUMBENS; DEPENDENT MEMORY; DORSAL STRIATUM; BASAL GANGLIA; ADULT-RAT; INHIBITION; EXPRESSION; PLASTICITY	Recently, striatal-enriched protein tyrosine phosphatase (STEP) and its upstream regulator protein kinase A (PKA) have been suspected to play a role in the intracellular mechanisms of fear conditioning and spatial memory. However, whether they contribute to the learning and memory of motor skills is totally unknown. In this study, we have investigated the role of STEP and PKA activities during motor skill learning associated with the accelerating rotarod task. We observed that learning the rotarod task differentially modulated the levels of phosphorylated STEP61 at serine 221, a site directly regulated by PKA, in the hippocampus, motor cortex and striatum. In a second set of experiments, we have pharmacologically inhibited PKA by the injection of Rp-cAMPS directly into the dorsal striatum of mice before rotarod trainings. PKA phosphorylation of STEP prevents the dephosphorylation of STEP substrates, whereas inhibition of PKA promotes STEP activity. Striatal PKA inhibitions dose-dependently impaired mice performances on the accelerating rotarod task. General motor abilities testing revealed an intact motor control in mice treated with 5 and 20 mu g of Rp-cAMPS, but not at the highest dose of 40 mu g. This suggested that motor learning was selectively affected by PKA inhibition at lower doses. Most notably, striatal inhibition of PKA reduced the levels of phosphorylated STEP61 at serine 221. Our data support that inactivation of STEP61 by the PKA activity is part of the molecular process associated with motor skill learning.	[Chagniel, Laure; Bergeron, Yan; Bureau, Genevieve; Massicotte, Guy; Cyr, Michel] Univ Quebec Trois Rivieres, Grp Rech Neurosci, Dept Med Biol, Trois Rivieres, PQ GA9 5H7, Canada	University of Quebec; University of Quebec Trois Rivieres	Cyr, M (corresponding author), Univ Quebec Trois Rivieres, Grp Rech Neurosci, Dept Med Biol, Trois Rivieres, PQ GA9 5H7, Canada.	cyrmi@uqtr.ca			Natural Sciences and Engineering Research Council of Canada [311763, 105942]; Canada Research Chair in Molecular Neuropharmacology; Fonds de Recherche du Quebec, Nature et Technologies (FQRNT)	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canada Research Chair in Molecular Neuropharmacology; Fonds de Recherche du Quebec, Nature et Technologies (FQRNT)	This work was supported by the Natural Sciences and Engineering Research Council of Canada (MC: #311763 and GM: #105942) and the Canada Research Chair in Molecular Neuropharmacology (MC). LC was the holder of a doctoral research merit scholarship from the Fonds de Recherche du Quebec, Nature et Technologies (FQRNT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abel T, 1997, CELL, V88, P615, DOI 10.1016/S0092-8674(00)81904-2; Abel T, 2008, PROG BRAIN RES, V169, P97, DOI 10.1016/S0079-6123(07)00006-4; ABRAMS TW, 2009, ENCY NEUROSCIENCE, P265; Baldwin AE, 2002, NEUROBIOL LEARN MEM, V77, P44, DOI 10.1006/nlme.2000.4002; Blume SR, 2009, EXP NEUROL, V219, P208, DOI 10.1016/j.expneurol.2009.05.017; BOULANGER LM, 1995, J NEUROSCI, V15, P1532; Braithwaite SP, 2006, EUR J NEUROSCI, V23, P2847, DOI 10.1111/j.1460-9568.2006.04837.x; Braithwaite SP, 2006, TRENDS NEUROSCI, V29, P452, DOI 10.1016/j.tins.2006.06.007; Brandon EP, 1998, J NEUROSCI, V18, P3639; Bureau G, 2010, NEUROBIOL LEARN MEM, V94, P107, DOI 10.1016/j.nlm.2010.04.008; Chagniel L, 2012, BEHAV BRAIN RES, V228, P9, DOI 10.1016/j.bbr.2011.11.019; D'Amours G, 2011, BEHAV BRAIN RES, V221, P108, DOI 10.1016/j.bbr.2011.02.030; Doyon J, 2009, BEHAV BRAIN RES, V199, P61, DOI 10.1016/j.bbr.2008.11.012; Fitzpatrick CJ, 2011, FRONT NEUROANAT, V5, DOI 10.3389/fnana.2011.00047; Gerdjikov TV, 2007, PSYCHOPHARMACOLOGY, V190, P65, DOI 10.1007/s00213-006-0590-1; Goebel-Goody SM, 2012, PHARMACOL REV, V64, P65, DOI 10.1124/pr.110.003053; Isiegas C, 2006, J NEUROSCI, V26, P12700, DOI 10.1523/JNEUROSCI.2743-06.2006; Kheirbek MA, 2009, J NEUROSCI, V29, P12115, DOI 10.1523/JNEUROSCI.3343-09.2009; Kleim JA, 2004, J NEUROSCI, V24, P628, DOI 10.1523/JNEUROSCI.3440-03.2004; Kleim JA, 1997, J NEUROSCI, V17, P717; Kleim JA, 1996, J NEUROSCI, V16, P4529; Lebel M, 2009, NEUROPHARMACOLOGY, V57, P392, DOI 10.1016/j.neuropharm.2009.06.041; Lemay-Clermont J, 2011, BEHAV NEUROSCI, V125, P714, DOI 10.1037/a0025213; LOMBROSO PJ, 1993, J NEUROSCI, V13, P3064; LOMBROSO PJ, 1991, P NATL ACAD SCI USA, V88, P7242, DOI 10.1073/pnas.88.16.7242; Luft AR, 2004, J NEUROSCI, V24, P6515, DOI 10.1523/JNEUROSCI.1034-04.2004; Meyer DA, 2008, P NATL ACAD SCI USA, V105, P18561, DOI 10.1073/pnas.0806078105; OGAWA N, 1987, EUR NEUROL, V26, P16, DOI 10.1159/000116351; Olausson P, 2012, NEUROSCIENCE, V225, P1, DOI 10.1016/j.neuroscience.2012.07.069; Palkovits  M., 1983, BRAIN MICRODISSECTIO, P1; Paul S, 2003, NAT NEUROSCI, V6, P34, DOI 10.1038/nn989; Paul S, 2000, J NEUROSCI, V20, P5630, DOI 10.1523/JNEUROSCI.20-15-05630.2000; Paul S, 2007, BIOL PSYCHIAT, V61, P1049, DOI 10.1016/j.biopsych.2006.08.005; Paxinos G., 2001, MOUSE BRAIN STEREOTA; Pelkey KA, 2002, NEURON, V34, P127, DOI 10.1016/S0896-6273(02)00633-5; Schafe GE, 2000, J NEUROSCI, V20, part. no., DOI 10.1523/JNEUROSCI.20-18-j0003.2000; Sedelis M, 2001, BEHAV BRAIN RES, V125, P109, DOI 10.1016/S0166-4328(01)00309-6; Sedelis M, 2000, BEHAV GENET, V30, P171, DOI 10.1023/A:1001958023096; SEEDS NW, 1995, SCIENCE, V270, P1992, DOI 10.1126/science.270.5244.1992; Sharifzadeh M, 2005, J NEUROSCI RES, V79, P392, DOI 10.1002/jnr.20358; Ungerleider LG, 2002, NEUROBIOL LEARN MEM, V78, P553, DOI 10.1006/nlme.2002.4091; Venkitaramani DV, 2011, EUR J NEUROSCI, V33, P2288, DOI 10.1111/j.1460-9568.2011.07687.x; Wachter T, 2010, EXP BRAIN RES, V200, P319, DOI 10.1007/s00221-009-2027-7; Willuhn I, 2006, NEUROPSYCHOPHARMACOL, V31, P2669, DOI 10.1038/sj.npp.1300995	44	15	16	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2014	9	1							e86988	10.1371/journal.pone.0086988	http://dx.doi.org/10.1371/journal.pone.0086988			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297XI	24466306	Green Published, Green Submitted, gold			2022-12-25	WOS:000330288000179
J	Ou, Y; Xu, SY; Zhu, DD; Yang, XG				Ou, Yu; Xu, Shuya; Zhu, Dandan; Yang, Xuegan			Molecular Mechanisms of Exopolysaccharide from Aphanothece halaphytica (EPSAH) Induced Apoptosis in HeLa Cells	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; MITOCHONDRIAL-MEMBRANE; TUMOR MICROENVIRONMENT; FAMILY-MEMBERS; CANCER; DEATH; PERMEABILIZATION; CHROOCOCCALES; GRP78/BIP; PATHWAYS	The present study aims to investigate the pharmacological effect of the exopolysaccharides from Aphanothece halophytica GR02 (EPSAH) on the HeLa human cervical cancer cell line. HeLa cells were cultured in RPMI-1640-10% FBS medium containing with or without different concentrations of EPSAH. Cell viability was assessed by methylthiazol tetrazolium (MTT) assay. Cell apoptosis was elevated with Wright-Giemsa staining, AO/EB double staining, and DNA fragmentation assay. Apoptosis-associated molecules from cultured HeLa cells were quantified using Western blot analysis. Our results suggest that EPASH induces apoptosis in HeLa cells by targeting a master unfolded protein response (UPR) regulator Grp78. Grp78 further promotes the expression of CHOP and downregulates expression of survivin, which leads to activate mitochondria-mediated downstream molecules and p53-survivin pathway, resulting in caspase-3 activation and causing apoptosis. These findings provide important clues for further evaluating the potential potency of EPSAH for use in cancer therapy.	[Ou, Yu; Xu, Shuya; Zhu, Dandan; Yang, Xuegan] China Pharmaceut Univ, Sch Life Sci & Technol, Nanjing 210009, Peoples R China	China Pharmaceutical University	Ou, Y (corresponding author), China Pharmaceut Univ, Sch Life Sci & Technol, Nanjing 210009, Peoples R China.	ouyu2008@126.com			Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	This work was funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altieri DC, 2013, CANCER LETT, V332, P225, DOI 10.1016/j.canlet.2012.03.005; Backer MV, 2011, METHOD ENZYMOL, V491, P37, DOI 10.1016/B978-0-12-385928-0.00003-1; Baytekin F, 2011, UROL ONCOL-SEMIN ORI, V29, P502, DOI 10.1016/j.urolonc.2009.09.001; Borowitzka M., 1988, MICROALGAL BIOTECHNO, P456; Chipuk JE, 2004, SCIENCE, V303, P1010, DOI 10.1126/science.1092734; Dong DZ, 2008, CANCER RES, V68, P498, DOI 10.1158/0008-5472.CAN-07-2950; Dong DZ, 2011, CANCER RES, V71, P2848, DOI 10.1158/0008-5472.CAN-10-3151; DUBOIS M, 1956, ANAL CHEM, V28, P350, DOI 10.1021/ac60111a017; Green DR, 2005, CELL, V121, P671, DOI 10.1016/j.cell.2005.05.019; Green DR, 1998, SCIENCE, V281, P1309, DOI 10.1126/science.281.5381.1309; Gross A, 1999, GENE DEV, V13, P1899, DOI 10.1101/gad.13.15.1899; Grutter MG, 2000, CURR OPIN STRUC BIOL, V10, P649, DOI 10.1016/S0959-440X(00)00146-9; Hong DY, 2011, INT J MOL SCI, V12, P7652, DOI 10.3390/ijms12117652; Leite M, 1999, ANAL CELL PATHOL, V19, P139, DOI 10.1155/1999/176515; Li PF, 2001, J APPL PHYCOL, V13, P71, DOI 10.1023/A:1008109501066; Li YA, 2012, TOXICOLOGY, V300, P121, DOI 10.1016/j.tox.2012.06.004; Li ZW, 2012, BBA-REV CANCER, V1826, P13, DOI 10.1016/j.bbcan.2012.02.001; Madesh M, 2001, J CELL BIOL, V155, P1003, DOI 10.1083/jcb.200105057; Ou Y, 2009, CHEM-BIOL INTERACT, V179, P103, DOI 10.1016/j.cbi.2008.10.039; Qi FH, 2011, CANCER SCI, V102, P951, DOI 10.1111/j.1349-7006.2011.01900.x; Sheikh MS, 2000, J CELL PHYSIOL, V182, P171, DOI 10.1002/(SICI)1097-4652(200002)182:2<171::AID-JCP5>3.0.CO;2-3; Tabas I, 2011, NAT CELL BIOL, V13, P184, DOI 10.1038/ncb0311-184; Tanimura A, 2009, LEUKEMIA RES, V33, P924, DOI 10.1016/j.leukres.2009.01.027; Waditee R, 2001, J BIOL CHEM, V276, P36931, DOI 10.1074/jbc.M103650200; Xing XM, 2011, ACTA HISTOCHEM, V113, P777, DOI 10.1016/j.acthis.2010.11.006; YOPP JH, 1978, PHYCOLOGIA, V17, P172, DOI 10.2216/i0031-8884-17-2-172.1; Zheng WF, 2006, INT IMMUNOPHARMACOL, V6, P1093, DOI 10.1016/j.intimp.2006.01.020	28	17	18	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2014	9	1							e87223	10.1371/journal.pone.0087223	http://dx.doi.org/10.1371/journal.pone.0087223			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297XI	24466342	Green Published, gold, Green Submitted			2022-12-25	WOS:000330288000199
J	Leclerc, M; Dore, T; Gilligan, CA; Lucas, P; Filipe, JAN				Leclerc, Melen; Dore, Thierry; Gilligan, Christopher A.; Lucas, Philippe; Filipe, Joao A. N.			Estimating the Delay between Host Infection and Disease (Incubation Period) and Assessing Its Significance to the Epidemiology of Plant Diseases	PLOS ONE			English	Article							RHIZOCTONIA-SOLANI; ROOT-ROT; COMPARTMENTAL-MODELS; DYNAMICS; TIME; PATHOGENICITY; ANASTOMOSIS; ECOLOGY; RATES; CROWN	Knowledge of the incubation period of infectious diseases (time between host infection and expression of disease symptoms) is crucial to our epidemiological understanding and the design of appropriate prevention and control policies. Plant diseases cause substantial damage to agricultural and arboricultural systems, but there is still very little information about how the incubation period varies within host populations. In this paper, we focus on the incubation period of soilborne plant pathogens, which are difficult to detect as they spread and infect the hosts underground and above-ground symptoms occur considerably later. We conducted experiments on Rhizoctonia solani in sugar beet, as an example pathosystem, and used modelling approaches to estimate the incubation period distribution and demonstrate the impact of differing estimations on our epidemiological understanding of plant diseases. We present measurements of the incubation period obtained in field conditions, fit alternative probability models to the data, and show that the incubation period distribution changes with host age. By simulating spatially-explicit epidemiological models with different incubation-period distributions, we study the conditions for a significant time lag between epidemics of cryptic infection and the associated epidemics of symptomatic disease. We examine the sensitivity of this lag to differing distributional assumptions about the incubation period (i.e. exponential versus Gamma). We demonstrate that accurate information about the incubation period distribution of a pathosystem can be critical in assessing the true scale of pathogen invasion behind early disease symptoms in the field; likewise, it can be central to model-based prediction of epidemic risk and evaluation of disease management strategies. Our results highlight that reliance on observation of disease symptoms can cause significant delay in detection of soil-borne pathogen epidemics and mislead practitioners and epidemiologists about the timing, extent, and viability of disease control measures for limiting economic loss.	[Leclerc, Melen; Lucas, Philippe] Univ Rennes 1, Inst Natl Rech Agronom, Inst Genet Environm & Plant Protect, UMR 1349, Le Rheu, France; [Leclerc, Melen] Inst Natl Rech Agronom, Biostat & Spatial Proc Unit, UR 546, Avignon, France; [Leclerc, Melen] Inst Natl Rech Agronom, Unit Impacts Ecolog Innovat Prod Vegetale, UAR 1240, Thiverval Grignon, France; [Dore, Thierry] AgroParisTech, UMR Agron 211, Thiverval Grignon, France; [Dore, Thierry] Inst Natl Rech Agronom, UMR Agron 211, Thiverval Grignon, France; [Gilligan, Christopher A.; Filipe, Joao A. N.] Univ Cambridge, Epidemiol & Modelling Grp, Dept Plant Sci, Cambridge, England	INRAE; Universite de Rennes; INRAE; INRAE; AgroParisTech; UDICE-French Research Universities; Universite Paris Saclay; AgroParisTech; INRAE; University of Cambridge	Leclerc, M (corresponding author), Univ Rennes 1, Inst Natl Rech Agronom, Inst Genet Environm & Plant Protect, UMR 1349, Agrocampus Ouest, Le Rheu, France.	melenleclerc@gmail.com		Filipe, Joao/0000-0002-2353-7981; Leclerc, Melen/0000-0002-5314-461X	Institut Technique francais de la Betterave industrielle (ITB); UK's Biotechnology and Biological Sciences Research Council (BBSRC)	Institut Technique francais de la Betterave industrielle (ITB); UK's Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	ML thanks the Institut Technique francais de la Betterave industrielle (ITB) for funding this project. CAG and JANF were funded by the UK's Biotechnology and Biological Sciences Research Council (BBSRC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON R M, 1991; Aoyagi T, 1998, PLANT DIS, V82, P857, DOI 10.1094/PDIS.1998.82.8.857; Bailey N. T. J., 1964, ELEMENTS STOCHASTIC; BLYTHE SP, 1988, IMA J MATH APPL MED, V5, P1; Brown LB, 2009, FOREST ECOL MANAG, V257, P1271, DOI 10.1016/j.foreco.2008.11.030; Burdon JJ, 2006, ANNU REV PHYTOPATHOL, V44, P19, DOI 10.1146/annurev.phyto.43.040204.140238; CAIRNS AJG, 1990, IMA J MATH APPL MED, V7, P219; CHADOEUF J, 1993, FOREST SCI, V39, P41; Chan M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050972; Cobb RC, 2012, J ECOL, V100, P712, DOI 10.1111/j.1365-2745.2012.01960.x; Cunniffe NJ, 2012, PHYTOPATHOLOGY, V102, P365, DOI 10.1094/PHYTO-12-10-0338; DURRETT R, 1994, PHILOS T ROY SOC B, V343, P329, DOI 10.1098/rstb.1994.0028; Filipe JAN, 2004, B MATH BIOL, V66, P373, DOI 10.1016/j.bulm.2003.09.002; Filipe JAN, 1998, PHILOS T R SOC B, V353, P2153, DOI 10.1098/rstb.1998.0354; Filipe JAN, 2007, PLOS COMPUT BIOL, V3, P2569, DOI 10.1371/journal.pcbi.0030255; Filipe JAN, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002328; Fraser C, 2004, P NATL ACAD SCI USA, V101, P6146, DOI 10.1073/pnas.0307506101; Gibson GJ, 1998, IMA J MATH APPL MED, V15, P19; Gilligan CA, 2002, ADV BOT RES, V38, P1, DOI 10.1016/S0065-2296(02)38027-3; Gilligan CA, 2007, J R SOC INTERFACE, V4, P925, DOI 10.1098/rsif.2007.1019; Gottwald TR, 2010, ANNU REV PHYTOPATHOL, V48, P119, DOI 10.1146/annurev-phyto-073009-114418; Hillnhutter C, 2012, J EXP BOT, V63, P319, DOI 10.1093/jxb/err273; Jeger MJ, 2000, PLANT PATHOL, V49, P651, DOI 10.1046/j.1365-3059.2000.00522.x; JOHNSON KB, 1990, PHYTOPATHOLOGY, V80, P416, DOI 10.1094/Phyto-80-416; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Keeling MJ., 2008, MODELING INFECT DIS, DOI [DOI 10.1515/9781400841035, 10.1515/9781400841035]; Kermack WO, 1927, P R SOC LOND A-CONTA, V115, P700, DOI 10.1098/rspa.1927.0118; Kiewnick S, 2001, PLANT DIS, V85, P718, DOI 10.1094/PDIS.2001.85.7.718; Kramer A, 2009, MODERN INFECT DIS EP; lbe O. C., 2009, MARKOV PROCESSES STO; Leclerc M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063003; Lloyd AL, 2001, THEOR POPUL BIOL, V60, P59, DOI 10.1006/tpbi.2001.1525; Lovell DJ, 2004, PLANT PATHOL, V53, P705, DOI 10.1111/j.1365-3059.2004.01097.x; Lucas P, 2006, EPIDEMIOLOGY PLANT D; Lunn D, 2009, STAT MED, V28, P3049, DOI 10.1002/sim.3680; Mack RN, 2000, ECOL APPL, V10, P689, DOI 10.1890/1051-0761(2000)010[0689:BICEGC]2.0.CO;2; Madden L.V., 2007, STUDY PLANT DIS EPID; Motisi N, 2013, PLANT PATHOL, V62, P69, DOI 10.1111/j.1365-3059.2012.02618.x; Nandris D, 1996, EUR J FOREST PATHOL, V26, P25; Newman KB, 2006, ECOL APPL, V16, P74, DOI 10.1890/04-0592; Oerke EC, 2006, J AGR SCI, V144, P31, DOI 10.1017/S0021859605005708; OGOSHI A, 1987, ANNU REV PHYTOPATHOL, V25, P125, DOI 10.1146/annurev.py.25.090187.001013; Otten W, 2003, ECOLOGY, V84, P3232, DOI 10.1890/02-0564; Perez-Reche FJ, 2012, J R SOC INTERFACE, V9, P2085, DOI 10.1098/rsif.2012.0130; Quesada-Ocampo LM, 2009, PLANT DIS, V93, P135, DOI 10.1094/PDIS-93-2-0135; R Core Team, 2022, R LANG ENV STAT COMP; Raaijmakers JM, 2009, PLANT SOIL, V321, P341, DOI 10.1007/s11104-008-9568-6; Reynolds GJ, 2012, PLANT DIS, V96, P497, DOI 10.1094/PDIS-11-10-0831; Schick RS, 2008, ECOL LETT, V11, P1338, DOI 10.1111/j.1461-0248.2008.01249.x; Soubeyrand S, 2009, B MATH BIOL, V71, P318, DOI 10.1007/s11538-008-9363-9; Thrall PH, 1997, J ECOL, V85, P313, DOI 10.2307/2960504; Tsror L, 2010, J PHYTOPATHOL, V158, P649, DOI 10.1111/j.1439-0434.2010.01671.x; van der Plank J.E., 1963, PLANT DIS, P1; Vergu E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009371; Wearing HJ, 2005, PLOS MED, V2, P813, DOI 10.1371/journal.pmed.0020320; Wilkinso D.J., 2006, STOCHASTIC MODELLING; WINDELS CE, 1989, PHYTOPATHOLOGY, V79, P83, DOI 10.1094/Phyto-79-83	57	34	34	0	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2014	9	1							e86568	10.1371/journal.pone.0086568	http://dx.doi.org/10.1371/journal.pone.0086568			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297VL	24466153	Green Submitted, gold, Green Published			2022-12-25	WOS:000330283100185
J	Kitayama, J; Emoto, S; Yamaguchi, H; Ishigami, H; Watanabe, T				Kitayama, Joji; Emoto, Shigenobu; Yamaguchi, Hironori; Ishigami, Hironori; Watanabe, Toshiaki			CD90(+) Mesothelial-Like Cells in Peritoneal Fluid Promote Peritoneal Metastasis by Forming a Tumor Permissive Microenvironment	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; UMBILICAL-CORD BLOOD; STROMAL CELLS; GASTRIC-CANCER; PROGENITOR CELLS; TISSUE-CULTURE; BONE-MARROW; TGF-BETA; IN-VITRO; ADIPOSE-TISSUE	The peritoneal cavity is a common target of metastatic gastrointestinal and ovarian cancer cells, but the mechanisms leading to peritoneal metastasis have not been fully elucidated. In this study, we examined the roles of cells in peritoneal fluids on the development of peritoneal metastasis. We found that a minor subset of human intraperitoneal cells with CD90(+)/CD45(2) phenotype vigorously grew in culture with mesothelial-like appearance. The mesothelial-like cells (MLC) displayed the characteristics of mesenchymal stem cell, such as differentiating into adipocytes, osteocytes, and chondrocytes, and suppressing T cell proliferation. These cells highly expressed type I collagen, vimentin, alpha-smooth muscle actin and fibroblast activated protein-a by the stimulation with TGF-beta, which is characteristic of activated myofibroblasts. Intraperitoneal co-injection of MLCs with the human gastric cancer cell line, MKN45, significantly enhanced the rate of metastatic formation in the peritoneum of nude mice. Histological examination revealed that many MLCs were engrafted in metastatic nodules and were mainly located at the fibrous area. Dasatinib, a potent tyrosine kinase inhibitor, strongly inhibited the proliferation of MLCs but not MKN45 in vitro. Nevertheless, oral administration of Dasatinib significantly inhibited the development of peritoneal metastasis of MKN45, and resulted in reduced fibrillar formation of metastatic nodules. These results suggest floating MLCs in the peritoneal fluids support the development of peritoneal metastasis possibly through the production of the permissive microenvironment, and thus the functional blockade of MLCs is a reasonable strategy to treat recurrent abdominal malignancies.	[Kitayama, Joji; Emoto, Shigenobu; Yamaguchi, Hironori; Ishigami, Hironori; Watanabe, Toshiaki] Univ Tokyo, Dept Surg Oncol, Tokyo, Japan	University of Tokyo	Kitayama, J (corresponding author), Univ Tokyo, Dept Surg Oncol, Tokyo, Japan.	kitayama-1SU@h.u-tokyo.ac.jp	Yamaguchi, Hironori/AAA-3642-2022	Yamaguchi, Hironori/0000-0002-8371-9410	Ministry of Education, Science, Sports and Culture of Japan; Ministry of Health and Welfare of Japan	Ministry of Education, Science, Sports and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan)	This work was supported by a Grant-in-Aid for Scientific Research from the Ministry of Education, Science, Sports and Culture of Japan, and a Grant from the Ministry of Health and Welfare of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdollahi A, 2005, J EXP MED, V201, P925, DOI 10.1084/jem.20041393; Akhmetshina A, 2008, FASEB J, V22, P2214, DOI 10.1096/fj.07-105627; Albini A, 2007, NAT REV CANCER, V7, P139, DOI 10.1038/nrc2067; Barcellos-Hoff MH, 2005, NAT REV CANCER, V5, P867, DOI 10.1038/nrc1735; BETJES MGH, 1991, PERITON DIALYSIS INT, V11, P22; Bianco P, 2008, CELL STEM CELL, V2, P313, DOI 10.1016/j.stem.2008.03.002; CAILLEAU R, 1974, CANCER RES, V34, P801; Daniels CE, 2004, J CLIN INVEST, V114, P1308, DOI 10.1175/JCI200419603; DOBBIE JW, 1992, PERITON DIALYSIS INT, V12, P14; Egeblad M, 2010, CURR OPIN CELL BIOL, V22, P697, DOI 10.1016/j.ceb.2010.08.015; Erices A, 2000, BRIT J HAEMATOL, V109, P235, DOI 10.1046/j.1365-2141.2000.01986.x; Fang CC, 2000, KIDNEY INT, V57, P2626, DOI 10.1046/j.1523-1755.2000.00123.x; Fidler IJ, 2002, DIFFERENTIATION, V70, P498, DOI 10.1046/j.1432-0436.2002.700904.x; Foley-Comer AJ, 2002, J CELL SCI, V115, P1383; FRIEDENSTEIN AJ, 1974, TRANSPLANTATION, V17, P331, DOI 10.1097/00007890-197404000-00001; Gordon JK, 2010, CURR OPIN RHEUMATOL, V22, P690, DOI 10.1097/BOR.0b013e32833f1105; Gronthos S, 2000, P NATL ACAD SCI USA, V97, P13625, DOI 10.1073/pnas.240309797; Herrick SE, 2004, INT J BIOCHEM CELL B, V36, P621, DOI 10.1016/j.biocel.2003.11.002; Ho CM, 2012, J BIOMED SCI, V19, DOI 10.1186/1423-0127-19-23; in 'tAnker PS, 2003, BLOOD, V102, P1548, DOI 10.1182/blood-2003-04-1291; Iwamoto N, 2011, CURR RHEUMATOL REP, V13, P21, DOI 10.1007/s11926-010-0142-x; Karnoub AE, 2007, NATURE, V449, P557, DOI 10.1038/nature06188; Kern S, 2006, STEM CELLS, V24, P1294, DOI 10.1634/stemcells.2005-0342; Koenig A, 2006, CANCER RES, V66, P4662, DOI 10.1158/0008-5472.CAN-05-2804; KOGA S, 1984, J CANCER RES CLIN, V108, P236, DOI 10.1007/BF00402474; Kuznetsov SA, 2001, J CELL BIOL, V153, P1133, DOI 10.1083/jcb.153.5.1133; Lv ZD, 2013, MOL CELL BIOCHEM, V377, P177, DOI 10.1007/s11010-013-1583-0; Lv ZD, 2011, INT J MOL MED, V27, P187, DOI 10.3892/ijmm.2010.574; Martinet L, 2010, INT J CANCER, V126, P2143, DOI 10.1002/ijc.24881; Mueller MM, 2004, NAT REV CANCER, V4, P839, DOI 10.1038/nrc1477; Mutsaers SE, 2002, RESPIROLOGY, V7, P171, DOI 10.1046/j.1440-1843.2002.00404.x; Mutsaers SE, 2004, INT J BIOCHEM CELL B, V36, P9, DOI 10.1016/S1357-2725(03)00242-5; Nabha SM, 2008, INT J CANCER, V122, P2482, DOI 10.1002/ijc.23431; Pasquet M, 2010, INT J CANCER, V126, P2090, DOI 10.1002/ijc.24886; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Rafii A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003894; Rampino T, 2001, AM J PATHOL, V159, P1275, DOI 10.1016/S0002-9440(10)62514-X; Rodriguez EF, 2013, CYTOJOURNAL, V10, DOI 10.4103/1742-6413.111080; Sally ML, 2011, J CELL MOL MED, V15, P2095, DOI 10.1111/j.1582-4934.2010.01212.x; SINGH G, 1978, ACTA CYTOL, V22, P487; Sodek KL, 2012, CANCER METAST REV, V31, P397, DOI 10.1007/s10555-012-9351-2; Spaeth EL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004992; Spaggiari GM, 2006, BLOOD, V107, P1484, DOI 10.1182/blood-2005-07-2775; Spaggiari GM, 2008, BLOOD, V111, P1327, DOI 10.1182/blood-2007-02-074997; Studeny M, 2002, CANCER RES, V62, P3603; Tolar J, 2010, STEM CELLS, V28, P1446, DOI 10.1002/stem.459; Tsukada T, 2012, INT J ONCOL, V41, P476, DOI 10.3892/ijo.2012.1490; Uccelli A, 2008, NAT REV IMMUNOL, V8, P726, DOI 10.1038/nri2395; Wang SN, 2005, FASEB J, V19, P1, DOI 10.1096/fj.04-2370com; WHITEHEAD RH, 1975, BRIT J CANCER, V32, P512, DOI 10.1038/bjc.1975.254; Yanagidani S, 1997, J BIOCHEM-TOKYO, V121, P626; Yanez-Mo M, 2003, NEW ENGL J MED, V348, P403, DOI 10.1056/NEJMoa020809; Zuk PA, 2001, TISSUE ENG, V7, P211, DOI 10.1089/107632701300062859	53	18	21	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2014	9	1							e86516	10.1371/journal.pone.0086516	http://dx.doi.org/10.1371/journal.pone.0086516			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297GT	24466130	Green Submitted, gold, Green Published			2022-12-25	WOS:000330244500251
J	Carpenter, RL; Paw, I; Dewhirst, MW; Lo, HW				Carpenter, R. L.; Paw, I.; Dewhirst, M. W.; Lo, H-W			Akt phosphorylates and activates HSF-1 independent of heat shock, leading to Slug overexpression and epithelial-mesenchymal transition (EMT) of HER2-overexpressing breast cancer cells	ONCOGENE			English	Article						Slug; EMT; Akt; HSF-1; HER2; phosphorylation	TRANSCRIPTION FACTOR SNAIL; GROWTH-FACTOR RECEPTOR; E-CADHERIN; UP-REGULATION; PROTEIN; GENE; FACTOR-1; BINDING; TARGET; INHIBITOR	Epithelial-mesenchymal transition (EMT) is an essential step for tumor progression, although the mechanisms driving EMT are still not fully understood. In an effort to investigate these mechanisms, we observed that heregulin (HRG)-mediated activation of HER2, or HER2 overexpression, resulted in EMT, which is accompanied with increased expression of a known EMT regulator Slug, but not TWIST or Snail. We then investigated how HER2 induced Slug expression and found, for the first time, that there are four consensus HSF sequence-binding elements (HSEs), the binding sites for heat shock factor-1 (HSF-1), located in the Slug promoter. HSF-1 bound to and transactivated the Slug promoter independent of heat shock, leading to Slug expression in breast cancer cells. Mutation of the putative HSEs ablated Slug transcriptional activation induced by HRG or HSF-1 overexpression. Knockdown of HSF-1 expression by siRNA reduced Slug expression and HRG-induced EMT. The positive association between HSF-1 and Slug was confirmed by immunohistochemical staining of a cohort of 100 invasive breast carcinoma specimens. While investigating how HER2 activated HSF-1 independent of heat shock, we observed that HER2 activation resulted in concurrent phosphorylation of Akt and HSF-1. We then observed, also for the first time, that Akt directly interacted with HSF-1 and phosphorylated HSF-1 at S326. Inhibition of Akt using siRNA, dominant-negative Akt mutant, or small molecule inhibitors prevented HRG-induced HSF-1 activation and Slug expression. Conversely, constitutively active Akt induced HSF-1 phosphorylation and Slug expression. HSF-1 knockdown reduced the ability of Akt to induce Slug expression, indicating an essential role that HSF-1 plays in Akt-induced Slug upregulation. Altogether, our study uncovered the existence of a novel Akt-HSF-1 signaling axis that leads to Slug upregulation and EMT, and potentially contributes to progression of HER2-positive breast cancer.	[Carpenter, R. L.; Paw, I.; Lo, H-W] Duke Univ, Sch Med, Dept Surg, Div Surg Sci, Durham, NC 27710 USA; [Dewhirst, M. W.] Duke Univ, Sch Med, Dept Radiat Oncol, Durham, NC 27710 USA; [Dewhirst, M. W.; Lo, H-W] Duke Univ, Sch Med, Duke Canc Inst, Durham, NC 27710 USA	Duke University; Duke University; Duke University	Lo, HW (corresponding author), Duke Univ, Sch Med, Duke Canc Inst, Div Surg Sci,Dept Surg, Box 3156,423 MSRB 1,103 Res Dr, Durham, NC 27710 USA.	huiwen.lo@duke.edu	Dewhirst, Mark/Q-1302-2019	Dewhirst, Mark/0000-0003-3459-6546; Carpenter, Richard/0000-0001-9986-6493	NIH [K01-CA118423]; US Department of Defense [W81XWH-11-1-0600]; Beez Foundation; Intramural Division of Surgical Sciences; Dani P. Bolognesi PhD Award; Clarence Gardner PhD Award; NATIONAL CANCER INSTITUTE [K01CA118423, P30CA014236] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS087169] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US Department of Defense(United States Department of Defense); Beez Foundation; Intramural Division of Surgical Sciences; Dani P. Bolognesi PhD Award; Clarence Gardner PhD Award; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We are thankful to Dr Mong-Hong Lee at MD Anderson Cancer Center who provided CA-Akt and DN-Akt constructs. This study was supported by the NIH grant K01-CA118423, and W81XWH-11-1-0600 from the US Department of Defense, the Beez Foundation and the Intramural Division of Surgical Sciences grants, Dani P. Bolognesi PhD Award and Clarence Gardner PhD Award.	Anckar J, 2011, ANNU REV BIOCHEM, V80, P1089, DOI 10.1146/annurev-biochem-060809-095203; Batlle E, 2000, NAT CELL BIOL, V2, P84, DOI 10.1038/35000034; Cano A, 2000, NAT CELL BIOL, V2, P76, DOI 10.1038/35000025; Cheng JC, 2013, BIOCHEM BIOPH RES CO, V434, P81, DOI 10.1016/j.bbrc.2013.03.062; Chou SD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039679; Ciocca DR, 2013, ARCH TOXICOL, V87, P19, DOI 10.1007/s00204-012-0918-z; Cobaleda C, 2007, ANNU REV GENET, V41, P41, DOI 10.1146/annurev.genet.41.110306.130146; De Craene B, 2013, NAT REV CANCER, V13, P97, DOI 10.1038/nrc3447; DSOUZA B, 1994, P NATL ACAD SCI USA, V91, P7202, DOI 10.1073/pnas.91.15.7202; Fujita N, 2003, CELL, V113, P207, DOI 10.1016/S0092-8674(03)00234-4; Gabai VL, 2012, MOL CELL BIOL, V32, P929, DOI 10.1128/MCB.05921-11; Giordano A, 2012, MOL CANCER THER, V11, P2526, DOI 10.1158/1535-7163.MCT-12-0460; Guettouche Toumy, 2005, BMC Biochemistry, V6, DOI 10.1186/1471-2091-6-4; Hajra KM, 2002, CANCER RES, V62, P1613; Hynes NE, 2009, CURR OPIN CELL BIOL, V21, P177, DOI 10.1016/j.ceb.2008.12.010; Khaleque MA, 2005, ONCOGENE, V24, P6564, DOI 10.1038/sj.onc.1208798; KROEGER PE, 1994, MOL CELL BIOL, V14, P7592, DOI 10.1128/MCB.14.11.7592; Li YM, 2004, CANCER CELL, V6, P459, DOI 10.1016/j.ccr.2004.09.027; Lo HW, 2008, CLIN CANCER RES, V14, P6042, DOI 10.1158/1078-0432.CCR-07-4923; Lo HW, 2008, MOL CANCER RES, V6, P843, DOI 10.1158/1541-7786.MCR-07-2105; Lo HW, 2007, CANCER RES, V67, P9066, DOI 10.1158/0008-5472.CAN-07-0575; Lo HW, 2010, MOL CANCER RES, V8, P232, DOI 10.1158/1541-7786.MCR-09-0391; Lo HW, 2009, CANCER RES, V69, P6790, DOI 10.1158/0008-5472.CAN-09-0886; Lo HW, 2005, CANCER CELL, V7, P575, DOI 10.1016/j.ccr.2005.05.007; Mendillo ML, 2012, CELL, V150, P549, DOI 10.1016/j.cell.2012.06.031; Meng L, 2010, ONCOGENE, V29, P5204, DOI 10.1038/onc.2010.277; Ohnishi K, 2004, INT J RADIAT BIOL, V80, P607, DOI 10.1080/09553000412331283470; Rhim AD, 2012, CELL, V148, P349, DOI 10.1016/j.cell.2011.11.025; Santagata S, 2011, P NATL ACAD SCI USA, V108, P18378, DOI 10.1073/pnas.1115031108; Savagner P, 1997, J CELL BIOL, V137, P1403, DOI 10.1083/jcb.137.6.1403; Sekulic A, 2000, CANCER RES, V60, P3504; SLAMON DJ, 1989, SCIENCE, V244, P707, DOI 10.1126/science.2470152; SLAMON DJ, 1987, SCIENCE, V235, P177, DOI 10.1126/science.3798106; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Trimboli AJ, 2008, CANCER RES, V68, P937, DOI 10.1158/0008-5472.CAN-07-2148; Ursini-Siegel J, 2007, NAT REV CANCER, V7, P389, DOI 10.1038/nrc2127; Wang XZ, 2003, MOL CELL BIOL, V23, P6013, DOI 10.1128/MCB.23.17.6013-6026.2003; Westerheide SD, 2006, J BIOL CHEM, V281, P9616, DOI 10.1074/jbc.M512044200; Xi CX, 2012, J BIOL CHEM, V287, P35646, DOI 10.1074/jbc.M112.377481; Yang J, 2004, CELL, V117, P927, DOI 10.1016/j.cell.2004.06.006; Yarden Y, 2001, NAT REV MOL CELL BIO, V2, P127, DOI 10.1038/35052073; Yoon YJ, 2011, J BIOL CHEM, V286, P1737, DOI 10.1074/jbc.M110.179440; Zhao RY, 2013, CELL CYCLE, V12, P935, DOI 10.4161/cc.23883; Zhu H, 2010, CANCER LETT, V294, P101, DOI 10.1016/j.canlet.2010.01.028	44	68	72	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 29	2015	34	5					546	557		10.1038/onc.2013.582	http://dx.doi.org/10.1038/onc.2013.582			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CA4DD	24469056	Green Accepted			2022-12-25	WOS:000348853500002
J	Yu, T; Li, J; Yan, M; Liu, L; Lin, H; Zhao, F; Sun, L; Zhang, Y; Cui, Y; Zhang, F; Li, J; He, X; Yao, M				Yu, T.; Li, J.; Yan, M.; Liu, L.; Lin, H.; Zhao, F.; Sun, L.; Zhang, Y.; Cui, Y.; Zhang, F.; Li, J.; He, X.; Yao, M.			MicroRNA-193a-3p and -5p suppress the metastasis of human non-small-cell lung cancer by downregulating the ERBB4/PIK3R3/mTOR/S6K2 signaling pathway	ONCOGENE			English	Article						NSCLC; miR-193a-3p; miR-193a-5p; target genes; metastasis	COLORECTAL-CANCER; EXPRESSION; GENE; INVASION; GROWTH; PROLIFERATION; INHIBITION; MICRORNAS; MIGRATION; MIR-193A	The metastatic cascade is a complex and multistep process with many potential barriers. Recent evidence has shown that microRNAs (miRNAs) are involved in carcinogenesis and tumor progression in non-small-cell lung cancer (NSCLC). In this study, by comparing the miRNA expression profiles of SPC-A-1sci (high metastatic) and SPC-A-1 (weakly metastatic) cells, we demonstrated that the downregulation and function of miR-193a-3p and miR-193a-5p in NSCLC metastasis and the expression of these miRNAs was suppressed in NSCLC compared with corresponding non-tumorous tissues. Decreased miR-193a-3p/5p expression was significantly associated with tumor node metastasis (TNM) and lymph node metastasis. Furthermore, functional assays showed that the overexpression of miR-193a-3p/5p inhibited NSCLC cell migration, invasion and epithelial-mesenchymal transition (EMT) in vitro and lung metastasis formation in vivo. In addition, we discovered that ERBB4 and S6K2 were the direct targets of miR-193a-3p and that PIK3R3 and mTOR were the direct targets of miR-193a-5p in NSCLC. We also observed that miR-193a-3p/5p could inactivate the AKT/mTOR signaling pathway. Thus, miR-193a-3p/5p functions as a tumor suppressor and has an important role in NSCLC metastasis through ERBB signaling pathway.	[Yu, T.; Li, J.; Yan, M.; Liu, L.; Lin, H.; Zhao, F.; Sun, L.; Zhang, Y.; Cui, Y.; Zhang, F.; Li, J.; He, X.; Yao, M.] Shanghai Jiao Tong Univ, Renji Hosp, Sch Med, Shanghai Canc Inst,State Key Lab Oncogenes & Rela, Shanghai 200032, Peoples R China	Shanghai Jiao Tong University	Yao, M (corresponding author), Shanghai Jiao Tong Univ, Renji Hosp, Sch Med, Shanghai Canc Inst,State Key Lab Oncogenes & Rela, 25-2200 Xietu Rd, Shanghai 200032, Peoples R China.	myao@shsci.org	He, Xianghuo/I-1497-2014; Yu, Tao/GLN-8283-2022; Zhang, Fang/HHN-2153-2022	He, Xianghuo/0000-0001-8872-668X; Yu, Tao/0000-0001-5330-2086; 	Shanghai Science and Technology Developing Program [12140901500, 13140900502]	Shanghai Science and Technology Developing Program	This work was supported by Shanghai Science and Technology Developing Program (12140901500, 13140900502). We thank Deshui Jia and QiangTan for the kind suggestions and technical assistance.	Almeida MI, 2012, GASTROENTEROLOGY, V142, P886, DOI 10.1053/j.gastro.2011.12.047; Almeida MI, 2011, MUTAT RES-FUND MOL M, V717, P1, DOI 10.1016/j.mrfmmm.2011.03.009; Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Calin GA, 2006, CANCER RES, V66, P7390, DOI 10.1158/0008-5472.CAN-06-0800; Farazi TA, 2011, J PATHOL, V223, P102, DOI 10.1002/path.2806; Feng B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043452; Goldberger N, 2013, CANCER RES, V73, P2671, DOI 10.1158/0008-5472.CAN-12-3513; Gulhati P, 2011, CANCER RES, V71, P3246, DOI 10.1158/0008-5472.CAN-10-4058; Hegde GV, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3004438; Heist Rebecca S, 2012, Cancer Cell, V21, DOI 10.1016/j.ccr.2012.03.007; Heller G, 2012, CLIN CANCER RES, V18, P1619, DOI 10.1158/1078-0432.CCR-11-2450; Hu HJ, 2012, ACTA BIOCH BIOPH SIN, V44, P424, DOI [10.1093/abbs/gms018, 10.1093/abbs/gms018.]; Iliopoulos D, 2011, CANCER RES, V71, P5144, DOI 10.1158/0008-5472.CAN-11-0425; Imbert AM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043752; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Jia DS, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-364; Lai WW, 2001, ANN THORAC SURG, V72, P1868, DOI 10.1016/S0003-4975(01)03207-6; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li YH, 2013, BLOOD, V121, P499, DOI 10.1182/blood-2012-07-444729; Lin CW, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2876; Lin HC, 2013, J PROTEOME RES, V12, P3423, DOI 10.1021/pr400273z; Mendoza-Naranjo A, 2013, EMBO MOL MED, V5, P1087, DOI 10.1002/emmm.201202343; Meng W, 2013, CLIN CANCER RES, V19, P5423, DOI 10.1158/1078-0432.CCR-13-0320; Minami A, 2013, J BIOL CHEM, V288, P11845, DOI 10.1074/jbc.M112.405993; Muraoka-Cook RS, 2008, MOL ENDOCRINOL, V22, P2307, DOI 10.1210/me.2008-0055; Polyak K, 2009, NAT REV CANCER, V9, P265, DOI 10.1038/nrc2620; Sasaki H, 2007, CLIN LUNG CANCER, V8, P429, DOI 10.3816/CLC.2007.n.027; Sharieff W, 2013, CLIN ONCOL-UK, V25, P697, DOI 10.1016/j.clon.2013.07.011; Sridharan S, 2011, CANCER RES, V71, P2590, DOI 10.1158/0008-5472.CAN-10-3253; Starr A, 2006, INT J CANCER, V119, P269, DOI 10.1002/ijc.21818; Tao ZH, 2013, J EXP MED, V210, P789, DOI 10.1084/jem.20120153; Tomizawa Kenji, 2010, J Thorac Oncol, V5, P1859, DOI 10.1097/JTO.0b013e3181f1c433; Trask MC, 2012, DEV BIOL, V368, P273, DOI 10.1016/j.ydbio.2012.05.031; Uhlmann S, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2011.100; Wander SA, 2013, BREAST CANCER RES TR, V138, P369, DOI 10.1007/s10549-012-2389-6; Wu X, 2014, ONCOGENE, V33, P1506, DOI 10.1038/onc.2013.108; Xu L, 2013, MOL BIOL CELL, V24, P42, DOI 10.1091/mbc.E12-07-0519; Yang H, 2013, HEPATOLOGY, V58, P205, DOI 10.1002/hep.26315; Yang X, 2013, CANCER LETT, V341, P265, DOI 10.1016/j.canlet.2013.08.020; Yang Y, 2013, ONCOGENE, V32, P3432, DOI 10.1038/onc.2012.360; Zheng BQ, 2011, CLIN CANCER RES, V17, P7574, DOI 10.1158/1078-0432.CCR-11-1714	44	214	222	3	59	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 22	2015	34	4					413	423		10.1038/onc.2013.574	http://dx.doi.org/10.1038/onc.2013.574			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AZ8FU	24469061				2022-12-25	WOS:000348451300002
J	Cadet, JL; Brannock, C; Ladenheim, B; McCoy, MT; Krasnova, IN; Lehrmann, E; Becker, KG; Jayanthi, S				Cadet, Jean Lud; Brannock, Christie; Ladenheim, Bruce; McCoy, Michael T.; Krasnova, Irina N.; Lehrmann, Elin; Becker, Kevin G.; Jayanthi, Subramaniam			Enhanced Upregulation of CRH mRNA Expression in the Nucleus Accumbens of Male Rats after a Second Injection of Methamphetamine Given Thirty Days Later	PLOS ONE			English	Article							CORTICOTROPIN-RELEASING-FACTOR; CENTRAL-NERVOUS-SYSTEM; CONDITIONED PLACE PREFERENCE; MESOLIMBIC DOPAMINERGIC SYSTEM; MEDIAL PREFRONTAL CORTEX; PITUITARY-ADRENAL AXIS; STRESS-INDUCED RELAPSE; BEHAVIORAL SENSITIZATION; RIBONUCLEIC-ACID; GENE-EXPRESSION	Methamphetamine (METH) is a widely abused amphetamine analog. Few studies have investigated the molecular effects of METH exposure in adult animals. Herein, we determined the consequences of an injection of METH (10 mg/kg) on transcriptional effects of a second METH (2.5 mg/kg) injection given one month later. We thus measured gene expression by microarray analyses in the nucleus accumbens (NAc) of 4 groups of rats euthanized 2 hours after the second injection: saline-pretreated followed by saline-challenged (SS) or METH-challenged (SM); and METH-pretreated followed by saline-challenged (MS) or METH-challenged (MM). Microarray analyses revealed that METH (2.5 mg/kg) produced acute changes (1.8-fold; P<0.01) in the expression of 412 (352 upregulated, 60 down-regulated) transcripts including cocaine and amphetamine regulated transcript, corticotropin-releasing hormone (Crh), oxytocin (Oxt), and vasopressin (Avp) that were upregulated. Injection of METH (10 mg/kg) altered the expression of 503 (338 upregulated, 165 down-regulated) transcripts measured one month later (MS group). These genes also included Cart and Crh. The MM group showed altered expression of 766 (565 upregulated, 201 down-regulated) transcripts including Avp, Cart, and Crh. The METH-induced increased Crh expression was enhanced in the MM group in comparison to SM and MS groups. Quantitative PCR confirmed the METH-induced changes in mRNA levels. Therefore, a single injection of METH produced long-lasting changes in gene expression in the rodent NAc. The long-term increases in Crh, Cart, and Avp mRNA expression suggest that METH exposure produced prolonged activation of the endogenous stress system. The METH-induced changes in oxytocin expression also suggest the possibility that this neuropeptide might play a significant role in the neuroplastic and affiliative effects of this drug.	[Cadet, Jean Lud; Brannock, Christie; Ladenheim, Bruce; McCoy, Michael T.; Krasnova, Irina N.; Jayanthi, Subramaniam] NIDA, Mol Neuropsychiat Res Branch, Intramural Res Program, NIH, Baltimore, MD USA; [Lehrmann, Elin; Becker, Kevin G.] NIA, Intramural Res Program, Gene Express & Genom Unit, NIH, Baltimore, MD 21224 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); NIH National Institute on Drug Abuse (NIDA); National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA)	Cadet, JL (corresponding author), NIDA, Mol Neuropsychiat Res Branch, Intramural Res Program, NIH, Baltimore, MD USA.	jcadet@intra.nida.nih.gov	Jayanthi, Subramaniam/ABI-4023-2020	Lehrmann, Elin/0000-0002-9869-9475; Ladenheim, Bruce/0000-0001-9124-6994; Jayanthi, Subramaniam/0000-0002-5209-303X	Intramural Research Program of the DHHS/NIH/NIDA; NATIONAL INSTITUTE ON AGING [ZICAG000616] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [ZIADA000551, ZIADA000552] Funding Source: NIH RePORTER	Intramural Research Program of the DHHS/NIH/NIDA; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by funds of the Intramural Research Program of the DHHS/NIH/NIDA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilera G, 2011, EXP GERONTOL, V46, P90, DOI 10.1016/j.exger.2010.08.023; Arima H, 2000, J NEUROENDOCRINOL, V12, P833, DOI 10.1046/j.1365-2826.2000.00528.x; Armario A, 2010, TRENDS PHARMACOL SCI, V31, P318, DOI 10.1016/j.tips.2010.04.005; Bale TL, 2004, ANNU REV PHARMACOL, V44, P525, DOI 10.1146/annurev.pharmtox.44.101802.121410; Bale TL, 2000, NAT GENET, V24, P410, DOI 10.1038/74263; Balkan B, 2012, BRAIN RES, V1432, P56, DOI 10.1016/j.brainres.2011.11.006; Baracz SJ, 2012, BEHAV BRAIN RES, V228, P185, DOI 10.1016/j.bbr.2011.11.038; Baskerville TA, 2010, CNS NEUROSCI THER, V16, pe92, DOI 10.1111/j.1755-5949.2010.00154.x; Binder EB, 2010, MOL PSYCHIATR, V15, P574, DOI 10.1038/mp.2009.141; Boutrel B, 2008, BRIT J PHARMACOL, V154, P343, DOI 10.1038/bjp.2008.133; Burbach JPH, 1995, CELL MOL NEUROBIOL, V15, P573, DOI 10.1007/BF02071318; Burkett JP, 2012, PSYCHOPHARMACOLOGY, V224, P1, DOI 10.1007/s00213-012-2794-x; Bustamante D, 2002, J NEUROCHEM, V83, P645, DOI 10.1046/j.1471-4159.2002.01171.x; Cadet JL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015643; Cadet JL, 2010, CNS NEUROL DISORD-DR, V9, P526; Cadet JL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007812; Cadet JL, 2001, SYNAPSE, V41, P40, DOI 10.1002/syn.1058; Caldwell HK, 2008, PROG NEUROBIOL, V84, P1, DOI 10.1016/j.pneurobio.2007.10.007; Carson DS, 2013, J PSYCHOPHARMACOL, V27, P231, DOI 10.1177/0269881112473788; Carson DS, 2010, ADDICT BIOL, V15, P448, DOI 10.1111/j.1369-1600.2010.00247.x; Carson DS, 2010, NEUROPHARMACOLOGY, V58, P38, DOI 10.1016/j.neuropharm.2009.06.018; Clark KH, 2013, NEUROTOX RES, V23, P174, DOI 10.1007/s12640-012-9334-7; Cornish JL, 2001, J ADDICT DIS, V20, P43, DOI 10.1300/J069v20n03_05; Cornish JL, 1997, NEUROSCIENCE, V81, P69, DOI 10.1016/S0306-4522(97)00157-7; CORNISH JL, 1995, BRAIN RES, V701, P28, DOI 10.1016/0006-8993(95)00967-X; Cox BM, 2013, PSYCHONEUROENDOCRINO; CUMMINGS S, 1983, J NEUROSCI, V3, P1355; Danaceau JP, 2007, EUR J PHARMACOL, V559, P46, DOI 10.1016/j.ejphar.2006.11.045; DESOUZA EB, 1985, J NEUROSCI, V5, P3189; DEVRY J, 1988, LIFE SCI, V42, P2709, DOI 10.1016/0024-3205(88)90247-0; Dominguez G, 2004, ANN NY ACAD SCI, V1025, P363, DOI 10.1196/annals.1316.044; Donaldson ZR, 2008, SCIENCE, V322, P900, DOI 10.1126/science.1158668; Douglass J, 1996, GENE, V169, P241, DOI 10.1016/0378-1119(96)88651-3; DOUGLASS J, 1995, J NEUROSCI, V15, P2471; DRAGO F, 1986, PHARMACOL BIOCHEM BE, V24, P1185, DOI 10.1016/0091-3057(86)90168-1; DUVIGNEAUD V, 1953, J BIOL CHEM, V205, P949; Fagergren P, 2007, PHYSIOL BEHAV, V92, P218, DOI 10.1016/j.physbeh.2007.05.027; Frankel PS, 2007, PHARMACOL BIOCHEM BE, V86, P511, DOI 10.1016/j.pbb.2007.01.012; Giardino WJ, 2011, GENES BRAIN BEHAV, V10, P78, DOI 10.1111/j.1601-183X.2010.00641.x; Giardino WJ, 2012, PSYCHOPHARMACOLOGY, V219, P1055, DOI 10.1007/s00213-011-2433-y; Grignaschi G, 2004, EUR J NEUROSCI, V20, P2833, DOI 10.1111/j.1460-9568.2004.03712.x; Gysling K, 2012, BIOCHEM PHARMACOL, V83, P1, DOI 10.1016/j.bcp.2011.07.101; Hauger Richard L., 2006, CNS & Neurological Disorders-Drug Targets, V5, P453, DOI 10.2174/187152706777950684; Herman JP, 2005, PROG NEURO-PSYCHOPH, V29, P1201, DOI 10.1016/j.pnpbp.2005.08.006; Hubert GW, 2010, NEUROSCIENCE, V165, P179, DOI 10.1016/j.neuroscience.2009.10.013; Hubert GW, 2008, BIOCHEM PHARMACOL, V75, P57, DOI 10.1016/j.bcp.2007.07.028; Imaki T, 1996, MOL BRAIN RES, V38, P166, DOI 10.1016/0169-328X(96)00011-3; Insel TR, 2010, NEURON, V65, P768, DOI 10.1016/j.neuron.2010.03.005; Jankord R, 2008, ANN NY ACAD SCI, V1148, P64, DOI 10.1196/annals.1410.012; Jayanthi S, 2005, P NATL ACAD SCI USA, V102, P868, DOI 10.1073/pnas.0404990102; Jayanthi S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006092; JOSEPH SA, 1983, NEUROSCI LETT, V35, P135, DOI 10.1016/0304-3940(83)90540-2; KALIVAS PW, 1993, J PHARMACOL EXP THER, V267, P486; KELLER RW, 1992, SYNAPSE, V11, P28, DOI 10.1002/syn.890110105; Kelly KA, 2012, J NEUROCHEM, V122, P995, DOI 10.1111/j.1471-4159.2012.07864.x; Kim JH, 2003, NEUROPEPTIDES, V37, P369, DOI 10.1016/j.npep.2003.10.001; Kim S, 2007, REGUL PEPTIDES, V144, P6, DOI 10.1016/j.regpep.2007.07.003; Koob GF, 2010, CURR OPIN INVEST DR, V11, P63; Koshimizu TA, 2012, PHYSIOL REV, V92, P1813, DOI 10.1152/physrev.00035.2011; KOVACS GL, 1990, NEUROPHARMACOLOGY, V29, P365, DOI 10.1016/0028-3908(90)90095-9; Krasnova IN, 2013, NEUROBIOL DIS, V58, P132, DOI 10.1016/j.nbd.2013.05.009; Krasnova IN, 2009, BRAIN RES REV, V60, P379, DOI 10.1016/j.brainresrev.2009.03.002; KUCZENSKI R, 1995, J NEUROSCI, V15, P1308; Kuhar MJ, 2005, AAPS J, V7, pE259, DOI 10.1208/aapsj070125; Le AD, 2000, PSYCHOPHARMACOLOGY, V150, P317, DOI 10.1007/s002130000411; Lee HJ, 2009, PROG NEUROBIOL, V88, P127, DOI 10.1016/j.pneurobio.2009.04.001; Liberzon I, 1997, NEUROPSYCHOPHARMACOL, V17, P353, DOI 10.1016/S0893-133X(97)00070-5; Liu J, 2005, J NEUROSCI, V25, P577, DOI 10.1523/JNEUROSCI.4196-04.2005; Liu Y, 2003, NEUROSCIENCE, V121, P537, DOI 10.1016/S0306-4522(03)00555-4; Locatelli V, 2010, ENDOCR DEV, V17, P108, DOI 10.1159/000262533; MAKINO S, 1995, ENDOCRINOLOGY, V136, P4517, DOI 10.1210/en.136.10.4517; MAKINO S, 1995, ENDOCRINOLOGY, V136, P3299, DOI 10.1210/en.136.8.3299; Mameli M, 2011, NEUROPHARMACOLOGY, V61, P1052, DOI 10.1016/j.neuropharm.2011.01.036; Mansi JA, 1996, ENDOCRINOLOGY, V137, P4619, DOI 10.1210/en.137.11.4619; Martin TA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034236; Maze I, 2010, MOL INTERV, V10, P219, DOI 10.1124/mi.10.4.5; McCoy MT, 2011, PSYCHOPHARMACOLOGY, V215, P353, DOI 10.1007/s00213-010-2146-7; McEwen BS, 2012, DEV NEUROBIOL, V72, P878, DOI 10.1002/dneu.20968; McGregor IS, 2012, HORM BEHAV, V61, P331, DOI 10.1016/j.yhbeh.2011.12.001; MERCHENTHALER I, 1982, AM J ANAT, V165, P385, DOI 10.1002/aja.1001650404; Meyer-Lindenberg A, 2011, NAT REV NEUROSCI, V12, P524, DOI 10.1038/nrn3044; Muller MB, 2003, NAT NEUROSCI, V6, P1100, DOI 10.1038/nn1123; Nestler Eric J, 2012, Clin Psychopharmacol Neurosci, V10, P136, DOI 10.9758/cpn.2012.10.3.136; Neumann ID, 2008, J NEUROENDOCRINOL, V20, P858, DOI 10.1111/j.1365-2826.2008.01726.x; Orozco-Cabal L, 2008, J NEUROSCI, V28, P529, DOI 10.1523/JNEUROSCI.2666-07.2008; PAULSON PE, 1995, SYNAPSE, V19, P56, DOI 10.1002/syn.890190108; PERIS J, 1987, PHARMACOL BIOCHEM BE, V27, P533, DOI 10.1016/0091-3057(87)90361-3; Piechota M, 2012, GENES BRAIN BEHAV, V11, P404, DOI 10.1111/j.1601-183X.2012.00777.x; Piechota M, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-5-r48; POTTER E, 1994, P NATL ACAD SCI USA, V91, P8777, DOI 10.1073/pnas.91.19.8777; Qi J, 2008, N-S ARCH PHARMACOL, V376, P441, DOI 10.1007/s00210-007-0245-8; Qi J, 2009, NEUROPHARMACOLOGY, V56, P856, DOI 10.1016/j.neuropharm.2009.01.010; RabadanDiehl C, 1996, ENDOCRINOLOGY, V137, P3808, DOI 10.1210/en.137.9.3808; RIVIER C, 1982, ENDOCRINOLOGY, V110, P272, DOI 10.1210/endo-110-1-272; ROBINSON TE, 1982, BRAIN RES, V253, P231, DOI 10.1016/0006-8993(82)90690-4; Robinson TE, 2008, PHILOS T R SOC B, V363, P3137, DOI 10.1098/rstb.2008.0093; Rodriguez-Borrero E, 2010, NEUROPHARMACOLOGY, V58, P88, DOI 10.1016/j.neuropharm.2009.06.040; Rogge G, 2008, NAT REV NEUROSCI, V9, P747, DOI 10.1038/nrn2493; Sabol KE, 2001, BRAIN RES, V892, P122, DOI 10.1016/S0006-8993(00)03244-3; SARNYAI Z, 1991, NEUROPEPTIDES, V19, P51, DOI 10.1016/0143-4179(91)90073-R; SARNYAI Z, 1994, PSYCHONEUROENDOCRINO, V19, P85, DOI 10.1016/0306-4530(94)90062-0; Segal DS, 2003, NEUROPSYCHOPHARMACOL, V28, P1730, DOI 10.1038/sj.npp.1300247; Shahrokh DK, 2010, ENDOCRINOLOGY, V151, P2276, DOI 10.1210/en.2009-1271; Shalev U, 2010, BRAIN RES, V1314, P15, DOI 10.1016/j.brainres.2009.07.028; Skuse DH, 2009, TRENDS COGN SCI, V13, P27, DOI 10.1016/j.tics.2008.09.007; Smith SM, 2004, ENDOCRINOLOGY, V145, P5202, DOI 10.1210/en.2004-0708; Steketee JD, 2011, PHARMACOL REV, V63, P348, DOI 10.1124/pr.109.001933; SWAAB DF, 1975, J NEURAL TRANSM, V36, P195, DOI 10.1007/BF01253126; Thomas DM, 2004, J NEUROCHEM, V88, P380, DOI 10.1046/j.1471-4159.2003.02182.x; Ungless MA, 2001, NATURE, V411, P583, DOI 10.1038/35079077; VALE W, 1981, SCIENCE, V213, P1394, DOI 10.1126/science.6267699; Van Pett K, 2000, J COMP NEUROL, V428, P191, DOI 10.1002/1096-9861(20001211)428:2<191::AID-CNE1>3.0.CO;2-U; Vanderschuren LJMJ, 1999, J NEUROSCI, V19, P9579, DOI 10.1523/jneurosci.19-21-09579.1999; VANREE JM, 1988, LIFE SCI, V42, P1091, DOI 10.1016/0024-3205(88)90565-6; Waselus M, 2009, BIOL PSYCHIAT, V66, P76, DOI 10.1016/j.biopsych.2009.02.014; Willuhn I, 2010, CURR TOP BEHAV NEURO, V3, P29, DOI 10.1007/7854_2009_27; Wise RA, 2009, TRENDS NEUROSCI, V32, P517, DOI 10.1016/j.tins.2009.06.004; Wood SK, 2013, BIOL PSYCHIAT, V73, P1087, DOI 10.1016/j.biopsych.2013.01.026; Xi ZX, 2009, NEUROSCIENCE, V161, P392, DOI 10.1016/j.neuroscience.2009.03.060; Yang MH, 2008, MOL CELLS, V26, P121; Zhou Y, 2005, NEUROSCIENCE, V134, P1391, DOI 10.1016/j.neuroscience.2005.05.032; Zhou Y, 2011, NEUROPSYCHOPHARMACOL, V36, P2062, DOI 10.1038/npp.2011.97	122	29	30	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2014	9	1							e84665	10.1371/journal.pone.0084665	http://dx.doi.org/10.1371/journal.pone.0084665			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301BI	24475032	Green Published, gold, Green Submitted			2022-12-25	WOS:000330507300013
J	Dube, K; Zango, A; van de Wijgert, J; Meque, I; Ferro, JJ; Cumbe, F; Chen, PL; Ma, S; Jolles, E; Fumo, A; Robb, ML; Feldblum, PJ				Dube, Karine; Zango, Arlinda; van de Wijgert, Janneke; Meque, Ivete; Ferro, Josefo J.; Cumbe, Fidelina; Chen, Pai Lien; Ma, Sabrina; Jolles, Erik; Fumo, Afonso; Robb, Merlin L.; Feldblum, Paul J.			HIV Incidence in a Cohort of Women at Higher Risk in Beira, Mozambique: Prospective Study 2009-2012	PLOS ONE			English	Article							CONDOM USE; GENDER; SEX	Background: HIV is prevalent in Sofala Province, Mozambique. To inform future prevention research, we undertook a study in the provincial capital (Beira) to measure HIV incidence in women at higher risk of HIV and assess the feasibility of recruiting and retaining them as research participants. Methods: Women age 18-35 were recruited from schools and places where women typically meet potential sexual partners. Eligibility criteria included HIV-seronegative status and self-report of at least 2 sexual partners in the last month. History of injection drug use was an exclusion criterion, but pregnancy was not. Participants were scheduled for monthly follow-up for 12 months, when they underwent face-to-face interviews, HIV counseling and testing, and pregnancy testing. Results: 387 women were eligible and contributed follow-up data. Most were from 18-24 years old (median 21). Around one-third of participants (33.8%) reported at least one new sexual partner in the last month. Most women (65.5%) reported not using a modern method of contraception at baseline. Twenty-two women seroconverted for a prospective HIV incidence of 6.5 per 100 woman-years (WY; 95% confidence interval (CI): 4.1-9.9). Factors associated with HIV seroconversion in the multivariable analysis were: number of vaginal sex acts without using condoms with partners besides primary partner in the last 7 days (hazard ratio (HR) 1.7; 95% CI: 1.2-2.5) and using a form of contraception at baseline other than hormonal or condoms (vs. no method; HR 25.3; 95% CI: 2.5-253.5). The overall retention rate was 80.0% for the entire follow-up period. Conclusions: We found a high HIV incidence in a cohort of young women reporting risky sexual behavior in Beira, Mozambique. HIV prevention programs should be strengthened. Regular HIV testing and condom use should be encouraged, particularly among younger women with multiple sexual partners.	[Dube, Karine; Chen, Pai Lien; Ma, Sabrina; Jolles, Erik; Feldblum, Paul J.] FHI 360, Durham, NC USA; [Dube, Karine; Robb, Merlin L.] Henry M Jackson Fdn Adv Mil Med Inc HJF, US Mil HIV Res Program, Bethesda, MD USA; [Zango, Arlinda; Meque, Ivete; Ferro, Josefo J.; Cumbe, Fidelina; Fumo, Afonso] Univ Catolica Mocambique Catholic Univ Mozambique, Centro Investigac Doencas Infecciosas Res Ctr Inf, Beira, Mozambique; [van de Wijgert, Janneke] Amsterdam Inst Global Hlth & Dev AIGHD, Amsterdam, Netherlands; [van de Wijgert, Janneke] Univ Amsterdam, Acad Med Ctr, NL-1105 AZ Amsterdam, Netherlands; [van de Wijgert, Janneke] Univ Liverpool, Inst Infect & Global Hlth, Liverpool L69 3BX, Merseyside, England	FHI 360; Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc; Walter Reed Army Institute of Research (WRAIR); University of Amsterdam; Academic Medical Center Amsterdam; University of Liverpool	Dube, K (corresponding author), FHI 360, Durham, NC USA.	karinedube2003@gmail.com	Fumo, Afonso Mazine Tiago/R-4248-2018	Fumo, Afonso Mazine Tiago/0000-0002-3097-8785; van de Wijgert, Janneke H.H.M./0000-0003-2728-4560	U.S. Agency for International Development (USAID) [GPO-A-00-05-00022-00]; Contraceptive and Reproductive Health Technologies Research and Utilization (CRTU) Program; Preventive Technologies Agreement (PTA); European and Developing Countries Clinical Trials Partnership (EDCTP) through the AfrEVacc project; U.S. Military HIV Research Program (MHRP)/Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. (HJF);  [GHO-A-00-09-00016-00]; FOGARTY INTERNATIONAL CENTER [D43TW001038, D43TW009753] Funding Source: NIH RePORTER	U.S. Agency for International Development (USAID)(United States Agency for International Development (USAID)); Contraceptive and Reproductive Health Technologies Research and Utilization (CRTU) Program; Preventive Technologies Agreement (PTA); European and Developing Countries Clinical Trials Partnership (EDCTP) through the AfrEVacc project; U.S. Military HIV Research Program (MHRP)/Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. (HJF); ; FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	The UCM/CIDI site development project and the HIV incidence study were partly funded by the U.S. Agency for International Development (USAID), under Cooperative Agreement No. GPO-A-00-05-00022-00, the Contraceptive and Reproductive Health Technologies Research and Utilization (CRTU) Program, and Cooperative Agreement No. GHO-A-00-09-00016-00, the Preventive Technologies Agreement (PTA). The study also received funding from the European and Developing Countries Clinical Trials Partnership (EDCTP) through the AfrEVacc project. The study also received funding from the U.S. Military HIV Research Program (MHRP)/Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. (HJF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agha S, 2012, REPROD HEALTH, V9, DOI 10.1186/1742-4755-9-20; [Anonymous], 2011, WORLD AIDS DAY REP; Bandali S, 2011, CULT HEALTH SEX, V13, P575, DOI 10.1080/13691058.2011.561500; CIA, 2013, WORLD FACTBOOK; Collins C, 2006, MOZAMBIQUES HIV AIDS; Feldblum PJ, 2011, CONTEMP CLIN TRIALS, V32, P512, DOI 10.1016/j.cct.2011.03.008; Gouws E, 2008, AIDS, V22, pS5, DOI 10.1097/01.aids.0000341773.86500.9d; Instituto Nacional de Saude (INS) Instituto Nacional de Estatistica (INE) e ICF Macro, 2010, NAT SURV PREV BEH RI; Karim QA, 2012, AIDS BEHAV, V16, P1870, DOI 10.1007/s10461-012-0209-y; Machel JZ, 2001, REPROD HEALTH MATTER, V9, P82, DOI 10.1016/S0968-8080(01)90011-4; MacPherson EE, 2012, J INT AIDS SOC, V15, DOI 10.7448/IAS.15.3.17364; National Institute of Statistics, 2013, DEM IMP HIV AIDS MOZ; Pinkerton SD, 2002, JAIDS-J ACQ IMM DEF, V31, P71, DOI 10.1097/00126334-200209010-00010; Prata N, 2006, INT FAM PLAN PERSPEC, V32, P192, DOI 10.1363/3219206; Scorgie F, 2012, AIDS BEHAV, V16, P920, DOI 10.1007/s10461-011-9985-z; *UNAIDS WHO, 1999, TRENDS HIV INC PREV; USAID Mozambique, 2013, HIV AIDS HLTH PROF; World Bank, 2010, CHANG HIV AIDS LANDS; Zango A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063427	19	18	18	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2014	9	1							e84979	10.1371/journal.pone.0084979	http://dx.doi.org/10.1371/journal.pone.0084979			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	301BI	24475035	gold, Green Submitted, Green Published			2022-12-25	WOS:000330507300015
J	Harjanto, S; Ng, LFP; Tong, JC				Harjanto, Sumitro; Ng, Lisa F. P.; Tong, Joo Chuan			Clustering HLA Class I Superfamilies Using Structural Interaction Patterns	PLOS ONE			English	Article							SECONDARY ANCHOR RESIDUES; T-CELL EPITOPE; PEPTIDE-BINDING; VACCINE DESIGN; MHC SUPERTYPES; IDENTIFICATION; SEQUENCE; DEFINITION; PREDICTION; HLA-A2.1	Human leukocyte antigen (HLA) class I molecules are critical components of the cell-mediated immune system that bind and present intracellular antigenic peptides to CD8(+) T cell receptors. To understand the interaction mechanism underlying human leukocyte antigen (HLA) class I specificity in detail, we studied the structural interaction characteristics of 16,393 nonameric peptides binding to 58 HLA-A and -B molecules. Our analysis showed for the first time that HLA-peptide intermolecular bonding patterns vary among different alleles and may be grouped in a superfamily dependent manner. Through the use of these HLA class I 'fingerprints', a high resolution HLA class I superfamily classification schema was developed. This classification is capable of separating HLA alleles into well resolved, non-overlapping clusters, which is consistent with known HLA superfamily definitions. Such structural interaction approach serves as an excellent alternative to the traditional methods of HLA superfamily definitions that use peptide binding motifs or receptor information, and will help identify appropriate antigens suitable for broad-based subunit vaccine design.	[Harjanto, Sumitro] Duke Natl Univ Singapore Grad Med Sch, Singapore, Singapore; [Ng, Lisa F. P.; Tong, Joo Chuan] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Biochem, Singapore 117595, Singapore; [Ng, Lisa F. P.] Agcy Sci Technol & Res, Singapore Immunol Network, Singapore, Singapore; [Tong, Joo Chuan] Agcy Sci Technol & Res, Inst High Performance Comp, Singapore, Singapore	National University of Singapore; Agency for Science Technology & Research (A*STAR); A*STAR - Singapore Immunology Network (SIgN); Agency for Science Technology & Research (A*STAR); A*STAR - Institute of High Performance Computing (IHPC)	Tong, JC (corresponding author), Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Biochem, Singapore 117595, Singapore.	victor@bic.nus.edu.sg		Ng, Lisa/0000-0003-4071-5222	Agency for Science, Technology and Research (A*STAR); A*STAR's Joint Council Office (JCO) Research Grant [CCOGA02_008_2008]	Agency for Science, Technology and Research (A*STAR)(Agency for Science Technology & Research (A*STAR)); A*STAR's Joint Council Office (JCO) Research Grant(Agency for Science Technology & Research (A*STAR))	This study was supported by the intramural research funds by Agency for Science, Technology and Research (A*STAR), and also by A*STAR's Joint Council Office (JCO) Research Grant (grant number: CCOGA02_008_2008). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cano P, 1998, IMMUNOGENETICS, V48, P324, DOI 10.1007/s002510050439; Chelvanayagam G, 1996, IMMUNOGENETICS, V45, P15, DOI 10.1007/s002510050162; DELGUERCIO MF, 1995, J IMMUNOL, V154, P685; Doytchinova IA, 2005, J IMMUNOL, V174, P7085, DOI 10.4049/jimmunol.174.11.7085; Doytchinova IA, 2004, J IMMUNOL, V172, P4314, DOI 10.4049/jimmunol.172.7.4314; FALK K, 1991, J EXP MED, V174, P425, DOI 10.1084/jem.174.2.425; FALK K, 1991, NATURE, V351, P290, DOI 10.1038/351290a0; Felsenstein J., 1989, CLADISTICS, V5, P164, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; FITCH WM, 1967, SCIENCE, V155, P279, DOI 10.1126/science.155.3760.279; HENIKOFF S, 1992, P NATL ACAD SCI USA, V89, P10915, DOI 10.1073/pnas.89.22.10915; Hertz T, 2007, BIOINFORMATICS, V23, pE148, DOI 10.1093/Bioinformatics/btl324; HUNT DF, 1992, SCIENCE, V255, P1261, DOI 10.1126/science.1546328; Kangueane P, 2005, FRONT BIOSCI-LANDMRK, V10, P879, DOI 10.2741/1582; Kobayashi H, 2001, CANCER RES, V61, P7577; KONDO A, 1995, J IMMUNOL, V155, P4307; Lefranc MP, 2001, T CELL RECEPTOR FACT; Lund O, 2004, IMMUNOGENETICS, V55, P797, DOI 10.1007/s00251-004-0647-4; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; MCDONALD IK, 1994, J MOL BIOL, V238, P777, DOI 10.1006/jmbi.1994.1334; McKenzie LM, 1999, GENES IMMUN, V1, P120, DOI 10.1038/sj.gene.6363648; Panigada M, 2002, INFECT IMMUN, V70, P79, DOI 10.1128/IAI.70.1.79-85.2002; RAMMENSEE HG, 1993, ANNU REV IMMUNOL, V11, P213, DOI 10.1146/annurev.iy.11.040193.001241; Reche Pedro A., 2007, V409, P163, DOI 10.1007/978-1-60327-118-9_11; Robinson J, 2001, NUCLEIC ACIDS RES, V29, P210, DOI 10.1093/nar/29.1.210; ROTZSCHKE O, 1991, EUR J IMMUNOL, V21, P2891, DOI 10.1002/eji.1830211136; RUPPERT J, 1993, CELL, V74, P929, DOI 10.1016/0092-8674(93)90472-3; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; SCHNEIDER TD, 1990, NUCLEIC ACIDS RES, V18, P6097, DOI 10.1093/nar/18.20.6097; Sette A, 2001, BIOLOGICALS, V29, P271, DOI 10.1006/biol.2001.0297; Sette A, 2002, TISSUE ANTIGENS, V59, P443, DOI 10.1034/j.1399-0039.2002.590601.x; Sette A, 1999, IMMUNOGENETICS, V50, P201, DOI 10.1007/s002510050594; Sidney J, 2008, BMC IMMUNOL, V9, DOI 10.1186/1471-2172-9-1; Thomsen M, 2013, IMMUNOGENETICS, V65, P655, DOI 10.1007/s00251-013-0714-9; Tong Joo Chuan, 2006, Appl Bioinformatics, V5, P111, DOI 10.2165/00822942-200605020-00005; Tong Joo Chuan, 2006, Immunome Res, V2, P1, DOI 10.1186/1745-7580-2-1; Veerassamy S, 2003, J COMPUT BIOL, V10, P997, DOI 10.1089/106652703322756195; Vita R, 2010, NUCLEIC ACIDS RES, V38, pD854, DOI 10.1093/nar/gkp1004; WALLACE AC, 1995, PROTEIN ENG, V8, P127, DOI 10.1093/protein/8.2.127; Westbrook J, 2002, NUCLEIC ACIDS RES, V30, P245, DOI 10.1093/nar/30.1.245; Zhang C, 1998, J MOL BIOL, V281, P929, DOI 10.1006/jmbi.1998.1982; Zhao B, 2003, HUM IMMUNOL, V64, P718, DOI 10.1016/S0198-8859(03)00078-8; Zhu SF, 2006, BIOINFORMATICS, V22, P1648, DOI 10.1093/bioinformatics/btl141	42	15	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2014	9	1							e86655	10.1371/journal.pone.0086655	http://dx.doi.org/10.1371/journal.pone.0086655			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301BI	24475163	Green Published, Green Submitted, gold			2022-12-25	WOS:000330507300098
J	Lim, YY; Villemagne, VL; Laws, SM; Ames, D; Pietrzak, RH; Ellis, KA; Harrington, K; Bourgeat, P; Bush, AI; Martins, RN; Masters, CL; Rowe, CC; Maruff, P				Lim, Yen Ying; Villemagne, Victor L.; Laws, Simon M.; Ames, David; Pietrzak, Robert H.; Ellis, Kathryn A.; Harrington, Karra; Bourgeat, Pierrick; Bush, Ashley I.; Martins, Ralph N.; Masters, Colin L.; Rowe, Christopher C.; Maruff, Paul		AIBL Res Grp	Effect of BDNF Val66Met on Memory Decline and Hippocampal Atrophy in Prodromal Alzheimer's Disease: A Preliminary Study	PLOS ONE			English	Article							MILD COGNITIVE IMPAIRMENT; NEUROTROPHIC FACTOR; AMYLOID-BETA; A-BETA; POLYMORPHISM; ASSOCIATION	Objective: Cross-sectional genetic association studies have reported equivocal results on the relationship between the brain-derived neurotrophic factor (BDNF) Val66Met and risk of Alzheimer's disease (AD). As AD is a neurodegenerative disease, genetic influences may become clearer from prospective study. We aimed to determine whether BDNF Val66Met polymorphism influences changes in memory performance, hippocampal volume, and A beta accumulation in adults with amnestic mild cognitive impairment (aMCI) and high A beta. Methods: Thirty-four adults with aMCI were recruited from the Australian, Imaging, Biomarkers and Lifestyle (AIBL) Study. Participants underwent PiB-PET and structural MRI neuroimaging, neuropsychological assessments and BDNF genotyping at baseline, 18 month, and 36 month assessments. Results: In individuals with aMCI and high A beta, Met carriers showed significant and large decline in episodic memory (d = 0.90, p = .020) and hippocampal volume (d = 0.98, p = .035). BDNF Val66Met was unrelated to the rate of A beta accumulation (d = -0.35, p = .401). Conclusions: Although preliminary due to the small sample size, results of this study suggest that high A beta levels and Met carriage may be useful prognostic markers of accelerated decline in episodic memory, and reductions in hippocampal volume in individuals in the prodromal or MCI stage of AD.	[Lim, Yen Ying; Villemagne, Victor L.; Ellis, Kathryn A.; Harrington, Karra; Bush, Ashley I.; Masters, Colin L.; Maruff, Paul] Univ Melbourne, Florey Inst Neurosci & Mental Hlth, Parkville, Vic 3052, Australia; [Villemagne, Victor L.; Rowe, Christopher C.] Austin Hlth, Dept Nucl Med, Heidelberg, Vic, Australia; [Villemagne, Victor L.; Rowe, Christopher C.] Austin Hlth, Ctr PET, Heidelberg, Vic, Australia; [Villemagne, Victor L.; Rowe, Christopher C.] Univ Melbourne, Austin Hlth, Dept Med, Heidelberg, Vic, Australia; [Laws, Simon M.; Martins, Ralph N.] Edith Cowan Univ, Sch Med Sci, Ctr Excellence Alzheimers Dis Res & Care, Joondalup, WA, Australia; [Laws, Simon M.; Martins, Ralph N.] Hollywood Private Hosp, Sir James McCusker Alzheimers Dis Res Unit, Perth, WA, Australia; [Laws, Simon M.] Cooperat Res Ctr Mental Hlth, Carlton, Australia; [Ames, David; Ellis, Kathryn A.] Univ Melbourne, Dept Psychiat, Acad Unit Psychiat Old Age, Kew, Vic, Australia; [Ames, David; Ellis, Kathryn A.] Natl Ageing Res Inst, Parkville, Vic, Australia; [Pietrzak, Robert H.] Yale Univ, Sch Med, Dept Psychiat, New Haven, CT USA; [Bourgeat, Pierrick] Australian E Hlth Res Ctr BioMedIA, Commonwealth Sci Ind Res Org Preventat Hlth Natl, Brisbane, Qld, Australia; [Maruff, Paul] CogState Ltd, Melbourne, Vic, Australia	Florey Institute of Neuroscience & Mental Health; University of Melbourne; Austin Research Institute; Florey Institute of Neuroscience & Mental Health; Austin Research Institute; Florey Institute of Neuroscience & Mental Health; Austin Research Institute; Florey Institute of Neuroscience & Mental Health; University of Melbourne; Edith Cowan University; University of Western Australia; University of Melbourne; National Ageing Research Institute; Yale University; Commonwealth Scientific & Industrial Research Organisation (CSIRO); CogState Limited	Lim, YY (corresponding author), Univ Melbourne, Florey Inst Neurosci & Mental Hlth, Parkville, Vic 3052, Australia.	y.lim@mhri.edu.au	Rowe, Christopher/AAX-8748-2021; Bush, Ashley/Y-2457-2019; Bourgeat, Pierrick T/A-1419-2010; Bush, Ashley I/A-1186-2007; Villemagne, Victor/AAC-5406-2019; Maruff, Paul/ABA-1673-2020; Maruff, Paul/AAD-2454-2021; Laws, Simon/C-2858-2014	Bush, Ashley/0000-0001-8259-9069; Bourgeat, Pierrick T/0000-0002-2605-4766; Bush, Ashley I/0000-0001-8259-9069; Villemagne, Victor/0000-0002-5832-9875; Maruff, Paul/0000-0002-6947-9537; Laws, Simon/0000-0002-4355-7082; Lim, Yen Ying/0000-0002-0308-5156; Martins, Ralph/0000-0002-4828-9363; Suwal, Bhim Raj/0000-0003-4097-1154; Ellis, Kathryn/0000-0001-9097-9037	Australian Commonwealth Scientific Industrial and research Organization; Edith Cowan University; Mental Health Research institute; Alzheimer's Australia; National Ageing Research Institute; Austin Health; CogState Ltd.; Hollywood Private Hospital; Sir Charles Gardner Hospital; National Health and Medical Research Council; Dementia Collaborative Research Centres program; Science and Industry Endowment Fund; Cooperative Research Centre for Mental Health; Australian Government	Australian Commonwealth Scientific Industrial and research Organization; Edith Cowan University; Mental Health Research institute; Alzheimer's Australia; National Ageing Research Institute; Austin Health; CogState Ltd.(CogState Limited); Hollywood Private Hospital; Sir Charles Gardner Hospital; National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Dementia Collaborative Research Centres program; Science and Industry Endowment Fund; Cooperative Research Centre for Mental Health(Australian GovernmentDepartment of Industry, Innovation and ScienceCooperative Research Centres (CRC) Programme); Australian Government(Australian GovernmentCGIAR)	Funding for the study was provided in part by the study partners [Australian Commonwealth Scientific Industrial and research Organization, Edith Cowan University, Mental Health Research institute, Alzheimer's Australia), National Ageing Research Institute, Austin Health, CogState Ltd., Hollywood Private Hospital, Sir Charles Gardner Hospital]. The study also received support from the National Health and Medical Research Council and the Dementia Collaborative Research Centres program, as well as ongoing funding from the Science and Industry Endowment Fund. The authors also acknowledge the financial support of the Cooperative Research Centre for Mental Health, from the Australian Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. PM is a full-time employee of CogState Ltd. SML is supported by the Cooperative Research Centre for Mental Health, which is an Australian Response to Reviewers government initiative. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Albert MS, 2011, ALZHEIMERS DEMENT, V7, P270, DOI 10.1016/j.jalz.2011.03.008; Baker LD, 2010, ARCH NEUROL-CHICAGO, V67, P71, DOI 10.1001/archneurol.2009.307; Bertram L, 2007, NAT GENET, V39, P17, DOI 10.1038/ng1934; Bueller JA, 2006, BIOL PSYCHIAT, V59, P812, DOI 10.1016/j.biopsych.2005.09.022; Caselli RJ, 2009, NEW ENGL J MED, V361, P255, DOI 10.1056/NEJMoa0809437; Chetelat G, 2012, NEUROLOGY, V78, P477, DOI 10.1212/WNL.0b013e318246d67a; Collins DL, 1998, IEEE T MED IMAGING, V17, P463, DOI 10.1109/42.712135; Egan MF, 2003, CELL, V112, P257, DOI 10.1016/S0092-8674(03)00035-7; Ellis KA, 2009, INT PSYCHOGERIATR, V21, P672, DOI 10.1017/S1041610209009405; Fahnestock M, 2011, FUTUR NEUROL, V6, P627, DOI 10.2217/FNL.11.44; Garzon DJ, 2007, J NEUROSCI, V27, P2628, DOI 10.1523/JNEUROSCI.5053-06.2007; Hariri AR, 2003, J NEUROSCI, V23, P6690, DOI 10.1523/jneurosci.23-17-06690.2003; Lee ST, 2012, ANN NEUROL, V72, P269, DOI 10.1002/ana.23588; Lim YY, 2013, NEUROBIOL AGING, V34, P2457, DOI 10.1016/j.neurobiolaging.2013.05.006; Lim YY, 2013, J ALZHEIMERS DIS, V33, P1167, DOI 10.3233/JAD-121771; Lim YY, BRAIN; Lu B, 2013, NAT REV NEUROSCI, V14, P401, DOI 10.1038/nrn3505; Masters C. L., 2012, BIOL ALZHEIMERS DIS, P181; Ourselin S, 2001, IMAGE VISION COMPUT, V19, P25, DOI 10.1016/S0262-8856(00)00052-4; Peng SY, 2005, J NEUROCHEM, V93, P1412, DOI 10.1111/j.1471-4159.2005.03135.x; Petersen RC, 1999, ARCH NEUROL-CHICAGO, V56, P303, DOI 10.1001/archneur.56.3.303; Reiman EM, 2009, P NATL ACAD SCI USA, V106, P6820, DOI 10.1073/pnas.0900345106; Rowe CC, 2010, NEUROBIOL AGING, V31, P1275, DOI 10.1016/j.neurobiolaging.2010.04.007; Ventriglia M, 2002, MOL PSYCHIATR, V7, P136, DOI 10.1038/sj.mp.4000952; Villemagne VL, 2011, ANN NEUROL, V69, P181, DOI 10.1002/ana.22248; Voineskos AN, 2011, ARCH GEN PSYCHIAT, V68, P198, DOI 10.1001/archgenpsychiatry.2010.194; Winblad B, 2004, J INTERN MED, V256, P240, DOI 10.1111/j.1365-2796.2004.01380.x	27	60	64	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2014	9	1							e86498	10.1371/journal.pone.0086498	http://dx.doi.org/10.1371/journal.pone.0086498			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301BI	24475133	gold, Green Published			2022-12-25	WOS:000330507300072
J	Smalheiser, NR; Lugli, G; Zhang, H; Rizavi, H; Cook, EH; Dwivedi, Y				Smalheiser, Neil R.; Lugli, Giovanni; Zhang, Hui; Rizavi, Hooriyah; Cook, Edwin H.; Dwivedi, Yogesh			Expression of microRNAs and Other Small RNAs in Prefrontal Cortex in Schizophrenia, Bipolar Disorder and Depressed Subjects	PLOS ONE			English	Article							POSTSYNAPTIC DENSITIES; BRAIN; DYSREGULATION; INDIVIDUALS; HIPPOCAMPUS; NETWORKS; DICER	Because of the role played by miRNAs in post-transcriptional regulation of an array of genes, their impact in neuropsychiatric disease pathophysiology has increasingly been evident. In the present study, we assessed microRNA expression in prefrontal cortex (Brodmann area 10) of a well-characterized cohort of major depressed, bipolar, and schizophrenia subjects (obtained from Stanley Neuropathology Consortium; n = 15 in each group), using high throughput RT-PCR plates. Discrete miRNA alterations were observed in all disorders, as well as in suicide subjects (pooled across diagnostic categories) compared to all non-suicide subjects. The changes in the schizophrenia group were partially similar to those in the bipolar group, but distinct from changes in depression and suicide. Intriguingly, those miRNAs which were down-regulated in the schizophrenia group tended to be synaptically enriched, whereas up-regulated miRNAs tended not to be. To follow this up, we purified synaptosomes from pooled samples of the schizophrenia vs. control groups and subjected them to Illumina deep sequencing. There was a significant loss of small RNA expression in schizophrenia synaptosomes only for certain sequence lengths within the miRNA range. Moreover, 73 miRNAs were significantly downregulated whereas only one was up-regulated. Strikingly, across all expressed miRNAs in synaptosomes, there was a significant inverse correlation between the fold-change of a given miRNA seen in schizophrenia and its synaptic enrichment ratio observed in controls. Thus, synaptic miRNAs tended to be down-regulated in schizophrenia, and the more highly synaptically enriched miRNAs tended to show greater down-regulation. These findings point to some deficit in miRNA biogenesis, transport, processing or turnover in schizophrenia that is selective for the synaptic compartment. A novel class of ncRNA-derived small RNAs, shown to be strongly induced during an early phase of learning in mouse, is also expressed in man, and at least one representative (SNORD85) was strongly down-regulated in schizophrenia synaptosomes.	[Smalheiser, Neil R.] Univ Illinois, Dept Psychiat, Chicago, IL 60612 USA; Univ Illinois, Inst Psychiat, Chicago, IL USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Smalheiser, NR (corresponding author), Univ Illinois, Dept Psychiat, Chicago, IL 60612 USA.	neils@uic.edu		Cook, Edwin/0000-0002-5848-5114; Smalheiser, Neil/0000-0003-1079-3406	NIH [P50 HD055751, R01082802, R21MH091509, R01MH100616];  [UIC-CCTS-0512-03]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P50HD055751] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R21MH091509, R01MH101890, R01MH100616] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This study was supported by NIH P50 HD055751, R01082802, R21MH091509, R01MH100616; UIC-CCTS-0512-03. Stanley Medical Research Institute. American Foundation for Suicide Prevention. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bandyopadhyay S, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-163; Berezikov E, 2006, NAT GENET, V38, P1375, DOI 10.1038/ng1914; Berrettini W, 2004, NEUROMOL MED, V5, P109, DOI 10.1385/NMM:5:1:109; Beveridge NJ, 2010, MOL PSYCHIATR, V15, P1176, DOI 10.1038/mp.2009.84; Beveridge NJ, 2008, HUM MOL GENET, V17, P1156, DOI 10.1093/hmg/ddn005; Beveridge NJ, 2012, NEUROBIOL DIS, V46, P263, DOI 10.1016/j.nbd.2011.12.029; de Faria Omar Jr., 2012, Frontiers in Genetics, V3, P46, DOI 10.3389/fgene.2012.00046; Eipper-Mains JE, 2011, RNA, V17, P1529, DOI 10.1261/rna.2775511; Fenelon K, 2011, P NATL ACAD SCI USA, V108, P4447, DOI 10.1073/pnas.1101219108; Feng JN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006121; Hsu R, 2012, MOL CELL NEUROSCI, V50, P283, DOI 10.1016/j.mcn.2012.06.002; Hu HY, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002327; Humphreys DT, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt485; Kim AH, 2010, SCHIZOPHR RES, V124, P183, DOI 10.1016/j.schres.2010.07.002; Kocerha J, 2009, P NATL ACAD SCI USA, V106, P3507, DOI 10.1073/pnas.0805854106; Lee EJ, 2011, RNA, V17, P1090, DOI 10.1261/rna.2565011; Lee I, 2009, GENOME RES, V19, P1175, DOI 10.1101/gr.089367.108; Li ZH, 2012, NUCLEIC ACIDS RES, V40, P6787, DOI 10.1093/nar/gks307; Lugli G, 2005, J NEUROCHEM, V94, P896, DOI 10.1111/j.1471-4159.2005.03224.x; Lugli G, 2008, J NEUROCHEM, V106, P650, DOI 10.1111/j.1471-4159.2008.05413.x; Lugli G, 2012, J NEUROCHEM, V123, P459, DOI 10.1111/j.1471-4159.2012.07921.x; Mellios N, 2009, BIOL PSYCHIAT, V65, P1006, DOI 10.1016/j.biopsych.2008.11.019; Miller BH, 2012, P NATL ACAD SCI USA, V109, P3125, DOI 10.1073/pnas.1113793109; Moreau MP, 2011, BIOL PSYCHIAT, V69, P188, DOI 10.1016/j.biopsych.2010.09.039; Nicolas FE, 2012, FEBS LETT, V586, P1226, DOI 10.1016/j.febslet.2012.03.026; Perkins DO, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r27; Pichardo-Casas I, 2012, BRAIN RES, V1436, P20, DOI 10.1016/j.brainres.2011.12.001; Potkin SG, 2010, NEUROIMAGE, V53, P839, DOI 10.1016/j.neuroimage.2010.06.036; Ripke S, 2011, NAT GENET, V43, P969, DOI 10.1038/ng.940; Risbud RM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053464; Santarelli DM, 2011, BIOL PSYCHIAT, V69, P180, DOI 10.1016/j.biopsych.2010.09.030; Smalheiser NR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033201; Smalheiser NR, 2011, MITOCHONDRION, V11, P994, DOI 10.1016/j.mito.2011.08.014; Smalheiser NR, 2011, RNA, V17, P166, DOI 10.1261/rna.2123811; Smalheiser NR, 2008, BIOL DIRECT, V3, DOI 10.1186/1745-6150-3-44; Torrey EF, 2000, SCHIZOPHR RES, V44, P151, DOI 10.1016/S0920-9964(99)00192-9; Wang WX, 2011, ACTA NEUROPATHOL, V121, P193, DOI 10.1007/s00401-010-0756-0	37	122	130	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2014	9	1							e86469	10.1371/journal.pone.0086469	http://dx.doi.org/10.1371/journal.pone.0086469			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301BI	24475125	gold, Green Submitted, Green Published			2022-12-25	WOS:000330507300067
J	Wang, YL; Li, DS; Wang, Y; Wang, ZY; Ji, QH				Wang, Yu-Long; Li, Duan-Shu; Wang, Yu; Wang, Zhuo-Ying; Ji, Qing-Hai			Lymph Node Ratio for Postoperative Staging of Laryngeal Squamous Cell Carcinoma with Lymph Node Metastasis	PLOS ONE			English	Article							POSITIVE BREAST-CANCER; LOCALLY ADVANCED HEAD; NECK CANCERS; SURGERY	Background: Lymph node metastasis has a significant impact on laryngeal cancer prognosis. The role of lymph node ratio (LNR, ratio of metastatic to examined nodes) in the staging of laryngeal cancer was not reported. Patients and Methods: Records of laryngeal cancer patients with lymph node involvement from Surveillance, Epidemiology, and End Results database (SEER, training set, N = 1963) and Fudan University Shanghai Cancer Center (FDSCC, validating set, N = 27) were analyzed for the prognostic value of LNR. Kaplan-Meier survival estimates, the Log-rank x 2 test and Cox proportional hazards model were used for univariate and multivariate analysis. Optimal LNR cutoff points were identified by X-tile. Results: Optimal LNR cutoff points classified patients into three risk groups R1 (<= 0.09), R2 (0.09-0.20) and R3 (>0.20), corresponding to 5-year cause-specific survival and overall survival in SEER patients of 55.1%, 40.2%, 28.8% and 43.1%, 31.5%, 21.8%, 2-year disease free survival and disease specific survival in FDSCC patients of 74.1%, 62.5%, 50.0%, and 67.7%, 43.2%, 25.0%, respectively. R3 stratified more high risk patients than N3 with the same survival rate, and R classification clearly separated N2 patients to 3 risk groups and N1 patients to 2 risk groups (R1-2 and R3). Conclusions: R classification is a significant prognostic factor of laryngeal cancer and should be used as a complementary staging system of N classification.	[Wang, Yu-Long; Li, Duan-Shu; Wang, Yu; Wang, Zhuo-Ying; Ji, Qing-Hai] Fudan Univ, Canc Hosp, Dept Head & Neck Surg, Shanghai 200433, Peoples R China; [Wang, Yu-Long; Li, Duan-Shu; Wang, Yu; Wang, Zhuo-Ying; Ji, Qing-Hai] Fudan Univ, Shanghai Med Coll, Dept Oncol, Shanghai 200433, Peoples R China	Fudan University; Fudan University	Ji, QH (corresponding author), Fudan Univ, Canc Hosp, Dept Head & Neck Surg, Shanghai 200433, Peoples R China.	jiqinghai@shca.org.cn	Wang, Yu-Long/AEF-9362-2022	Wang, Yu-Long/0000-0002-3830-7257	National Science Foundation of China [81001204, 30872958]	National Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Science Foundation of China (81001204 to YLW, 30872958 to QHJ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bernier J, 2005, HEAD NECK-J SCI SPEC, V27, P843, DOI 10.1002/hed.20279; Bernier J, 2005, ONCOLOGIST, V10, P215, DOI 10.1634/theoncologist.10-3-215; Buckley JG, 2000, HEAD NECK-J SCI SPEC, V22, P380, DOI 10.1002/1097-0347(200007)22:4<380::AID-HED11>3.0.CO;2-E; Camp RL, 2004, CLIN CANCER RES, V10, P7252, DOI 10.1158/1078-0432.CCR-04-0713; CANDELA FC, 1990, ARCH OTOLARYNGOL, V116, P432; Ceelen W, 2010, ANN SURG ONCOL, V17, P2847, DOI 10.1245/s10434-010-1158-1; Harrell FE, 1996, STAT MED, V15, P361, DOI 10.1002/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4; Howlader N, 2011, SEER CANC STAT REV 1; Hu M, 2012, LARYNGOSCOPE, V122, P565, DOI 10.1002/lary.22489; Langendijk JA, 2005, CANCER-AM CANCER SOC, V104, P1408, DOI 10.1002/cncr.21340; Pfister DG, 2011, J NATL COMPR CANC NE, V9, P596, DOI 10.6004/jnccn.2011.0053; Posner MR, 2010, ANN ONCOL, V21, P246, DOI 10.1093/annonc/mdq291; Redaelli de Zinis LO, 2002, HEAD NECK-J SCI SPEC, V24, P913, DOI 10.1002/hed.10152; Spillane AJ, 2011, ANN SURG, V253, P109, DOI 10.1097/SLA.0b013e3181f9b8b6; Suarez C, 2012, HEAD NECK; Vinh-Hung V, 2010, ONCOLOGIST, V15, P1050, DOI 10.1634/theoncologist.2010-0044; Vinh-Hung V, 2009, J CLIN ONCOL, V27, P1062, DOI 10.1200/JCO.2008.18.6965; Wang W, 2011, ANN ONCOL, V22, P2049, DOI 10.1093/annonc/mdq716; Weinstein GS, 2012, LARYNGOSCOPE, V122, P1701, DOI 10.1002/lary.23294	19	1	2	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2014	9	1							e87037	10.1371/journal.pone.0087037	http://dx.doi.org/10.1371/journal.pone.0087037			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301BI	24475216	Green Published, gold, Green Submitted			2022-12-25	WOS:000330507300127
J	Jamroz-Wisniewska, A; Gertler, A; Solomon, G; Wood, ME; Whiteman, M; Beltowski, J				Jamroz-Wisniewska, Anna; Gertler, Arieh; Solomon, Gili; Wood, Mark E.; Whiteman, Matthew; Beltowski, Jerzy			Leptin-Induced Endothelium-Dependent Vasorelaxation of Peripheral Arteries in Lean and Obese Rats: Role of Nitric Oxide and Hydrogen Sulfide	PLOS ONE			English	Article							LARGE-SCALE PREPARATION; HYPERPOLARIZING FACTOR; RELAXATION; EDHF; HYPERTENSION; EXPRESSION; ADIPOKINES; RESISTANCE; ADIPONECTIN; DYSFUNCTION	Adipose tissue hormone leptin induces endothelium-dependent vasorelaxation mediated by nitric oxide (NO) and endothelium-derived hyperpolarizing factors (EDHF). Previously it has been demonstrated that in short-term obesity the NO-dependent and the EDHF-dependent components of vascular effect of leptin are impaired and up-regulated, respectively. Herein we examined the mechanism of the EDHF-dependent vasodilatory effect of leptin and tested the hypothesis that alterations of acute vascular effects of leptin in obesity are accounted for by chronic hyperleptinemia. The study was performed in 5 groups of rats: (1) control, (2) treated with exogenous leptin for 1 week to induce hyperleptinemia, (3) obese, fed highly-palatable diet for 4 weeks, (4) obese treated with pegylated superactive rat leptin receptor antagonist (PEG-SRLA) for 1 week, (5) fed standard chow and treated with PEG-SRLA. Acute effect of leptin on isometric tension of mesenteric artery segments was measured ex vivo. Leptin relaxed phenylephrine-preconstricted vascular segments in NO-and EDHF-dependent manner. The NO-dependent component was impaired and the EDHF-dependent component was increased in the leptin-treated and obese groups and in the latter group both these effects were abolished by PEG-SRLA. The EDHF-dependent vasodilatory effect of leptin was blocked by either the inhibitor of cystathionine gamma-lyase, propargylglycine, or a hydrogen sulfide (H2S) scavenger, bismuth (III) subsalicylate. The results indicate that NO deficiency is compensated by the up-regulation of EDHF in obese rats and both effects are accounted for by chronic hyperleptinemia. The EDHF-dependent component of leptin-induced vasorelaxation is mediated, at least partially, by H2S.	[Jamroz-Wisniewska, Anna; Beltowski, Jerzy] Med Univ Lublin, Dept Pathophysiol, Lublin, Poland; [Jamroz-Wisniewska, Anna] Med Univ Lublin, Dept Neurol, Lublin, Poland; [Gertler, Arieh; Solomon, Gili] Hebrew Univ Jerusalem, Inst Biochem Food Sci & Nutr, IL-76100 Rehovot, Israel; [Wood, Mark E.] Univ Exeter, Coll Life & Environm Sci, Exeter, Devon, England; [Whiteman, Matthew] Univ Exeter, Sch Med, Exeter, Devon, England	Medical University of Lublin; Medical University of Lublin; Hebrew University of Jerusalem; University of Exeter; University of Exeter	Beltowski, J (corresponding author), Med Univ Lublin, Dept Pathophysiol, Lublin, Poland.	jerzy.beltowski@umlub.pl	Beltowski, Jerzy/AAH-4692-2020; Whiteman, Matthew/C-6079-2009	Beltowski, Jerzy/0000-0001-7903-8121; Whiteman, Matthew/0000-0002-6583-6779; Wood, Mark/0000-0002-2674-6981	EU	EU(European Commission)	The study was supported by the EU Project "The equipment of innovative laboratories doing research on new medicines used in the therapy of civilization and neoplastic diseases" within the Operational Program Development of Eastern Poland 2007 - 2013, Priority Axis I Modern Economy, Operations I.3 Innovation Promotion. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baragatti B, 2013, AM J PHYSIOL-HEART C, V304, pH927, DOI 10.1152/ajpheart.00718.2012; Baylie RL, 2011, ACTA PHYSIOL, V203, P99, DOI 10.1111/j.1748-1716.2010.02217.x; Beltowski J, 2006, LIFE SCI, V79, P63, DOI 10.1016/j.lfs.2005.12.041; Beltowski J, 2010, PEPTIDES, V31, P155, DOI 10.1016/j.peptides.2009.10.012; Beltowski J, 2009, LIFE SCI, V85, P557, DOI 10.1016/j.lfs.2009.08.002; Benkhoff S, 2012, ARTERIOSCL THROM VAS, V32, P1605, DOI 10.1161/ATVBAHA.112.251140; Chapnik N, 2013, J ENDOCRINOL, V217, P283, DOI 10.1530/JOE-13-0033; Cheng YQ, 2004, AM J PHYSIOL-HEART C, V287, pH2316, DOI 10.1152/ajpheart.00331.2004; Chrostowska M, 2013, BEST PRACT RES CL EN, V27, P147, DOI 10.1016/j.beem.2013.01.004; Elinav E, 2009, HEPATOLOGY, V49, P278, DOI 10.1002/hep.22584; Feletou M, 2009, CLIN SCI, V117, P139, DOI 10.1042/CS20090096; Finkel T, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002943; Fortuno A, 2010, J HYPERTENS, V28, P1944, DOI 10.1097/HJH.0b013e32833c21af; Gertler A, 1998, FEBS LETT, V422, P137, DOI 10.1016/S0014-5793(97)01613-X; Haddock RE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016423; Hall JE, 2010, J BIOL CHEM, V285, P17271, DOI 10.1074/jbc.R110.113175; Han J, 2013, J PHARMACOL SCI, V121, P318, DOI 10.1254/jphs.12277FP; Iserentant H, 2005, J CELL SCI, V118, P2519, DOI 10.1242/jcs.02386; Jackson-Weaver O, 2011, CIRC RES, V108, P1439; Jain SK, 2010, ANTIOXID REDOX SIGN, V12, P1333, DOI 10.1089/ars.2009.2956; KAHN BB, 1993, ENDOCRINOLOGY, V132, P13, DOI 10.1210/en.132.1.13; Kohn C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041951; Korda M, 2008, AM J PHYSIOL-HEART C, V295, pH1514, DOI 10.1152/ajpheart.00479.2008; Li L, 2008, CIRCULATION, V117, P2351, DOI 10.1161/CIRCULATIONAHA.107.753467; Linden DR, 2012, BRIT J PHARMACOL, V165, P2178, DOI 10.1111/j.1476-5381.2011.01681.x; Mathew AV, 2011, CURR DIABETES REV, V7, P41, DOI 10.2174/157339911794273928; Mathieu P, 2009, HYPERTENSION, V53, P577, DOI 10.1161/HYPERTENSIONAHA.108.110320; Mattu HS, 2013, J ENDOCRINOL, V216, pT17, DOI 10.1530/JOE-12-0232; Miehle K, 2012, CLIN ENDOCRINOL, V76, P2, DOI 10.1111/j.1365-2265.2011.04234.x; Momin AU, 2006, EUR HEART J, V27, P2294, DOI 10.1093/eurheartj/ehi831; Moon HS, 2013, ENDOCR REV, V34, P377, DOI 10.1210/er.2012-1053; Morris DL, 2009, AM J PHYSIOL-ENDOC M, V297, pE1247, DOI 10.1152/ajpendo.00274.2009; Mustafa AK, 2011, CIRC RES, V109, P1259, DOI 10.1161/CIRCRESAHA.111.240242; Niv-Spector L, 2012, PROTEIN EXPRES PURIF, V81, P186, DOI 10.1016/j.pep.2011.10.003; Ntaios G, 2013, ATHEROSCLEROSIS, V227, P216, DOI 10.1016/j.atherosclerosis.2012.12.029; PACE CN, 1995, PROTEIN SCI, V4, P2411, DOI 10.1002/pro.5560041120; Payne GA, 2010, ARTERIOSCL THROM VAS, V30, P1711, DOI 10.1161/ATVBAHA.110.210070; Salomon G, 2006, PROTEIN EXPRES PURIF, V47, P128, DOI 10.1016/j.pep.2005.09.016; Sandowski Y, 2002, J BIOL CHEM, V277, P46304, DOI 10.1074/jbc.M207556200; Schleifenbaum J, 2010, J HYPERTENS, V28, P1875, DOI 10.1097/HJH.0b013e32833c20d5; Shpilman M, 2011, J BIOL CHEM, V286, P4429, DOI 10.1074/jbc.M110.196402; Simonds SE, 2013, TRENDS NEUROSCI, V36, P121, DOI 10.1016/j.tins.2013.01.004; Stankevicius E, 2011, J PHARMACOL EXP THER, V339, P842, DOI 10.1124/jpet.111.179242; STIPANUK MH, 1979, J NUTR, V109, P2126, DOI 10.1093/jn/109.12.2126; Tang GH, 2013, ANTIOXID REDOX SIGN, V19, P1634, DOI 10.1089/ars.2012.4805; Tokuda F, 2008, INTERNAL MED, V47, P1843, DOI 10.2169/internalmedicine.47.1035; Triggle CR, 2012, CAN J PHYSIOL PHARM, V90, P713, DOI [10.1139/Y2012-073, 10.1139/y2012-073]; Whiteman M, 2010, DIABETOLOGIA, V53, P1722, DOI 10.1007/s00125-010-1761-5; Whiteman M, 2010, ANTIOXID REDOX SIGN, V12, P1147, DOI 10.1089/ars.2009.2899; Wojcicka G, 2011, PHARMACOL RES, V63, P68, DOI 10.1016/j.phrs.2010.10.011; Zhou YJ, 2013, FRONT MED-PRC, V7, P207, DOI 10.1007/s11684-013-0263-5	51	42	43	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2014	9	1							e86744	10.1371/journal.pone.0086744	http://dx.doi.org/10.1371/journal.pone.0086744			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	298QQ	24475175	gold, Green Published, Green Submitted			2022-12-25	WOS:000330339800058
J	Wang, SH; Nan, R; Accardo, MC; Sentmanat, M; Dimitri, P; Elgin, SCR				Wang, Sidney H.; Nan, Ruth; Accardo, Maria C.; Sentmanat, Monica; Dimitri, Patrizio; Elgin, Sarah C. R.			A Distinct Type of Heterochromatin at the Telomeric Region of the Drosophila melanogaster Y Chromosome	PLOS ONE			English	Article							POSITION-EFFECT VARIEGATION; CHROMATIN-STRUCTURE; EPIGENETIC REGULATION; SILENCING MECHANISM; GENE; PROTEIN; RNAI; DOMAINS; ROLES; HP1	Heterochromatin assembly and its associated phenotype, position effect variegation (PEV), provide an informative system to study chromatin structure and genome packaging. In the fruit fly Drosophila melanogaster, the Y chromosome is entirely heterochromatic in all cell types except the male germline; as such, Y chromosome dosage is a potent modifier of PEV. However, neither Y heterochromatin composition, nor its assembly, has been carefully studied. Here, we report the mapping and characterization of eight reporter lines that show male-specific PEV. In all eight cases, the reporter insertion sites lie in the telomeric transposon array (HeT-A and TART-B2 homologous repeats) of the Y chromosome short arm (Ys). Investigations of the impact on the PEV phenotype of mutations in known heterochromatin proteins (i.e., modifiers of PEV) show that this Ys telomeric region is a unique heterochromatin domain: it displays sensitivity to mutations in HP1a, EGG and SU(VAR)3-9, but no sensitivity to Su(z)2 mutations. It appears that the endo-siRNA pathway plays a major targeting role for this domain. Interestingly, an ectopic copy of 1360 is sufficient to induce a piRNA targeting mechanism to further enhance silencing of a reporter cytologically localized to the Ys telomere. These results demonstrate the diversity of heterochromatin domains, and the corresponding variation in potential targeting mechanisms.	[Wang, Sidney H.; Nan, Ruth; Sentmanat, Monica; Elgin, Sarah C. R.] Washington Univ, Dept Biol, St Louis, MO 63130 USA; [Accardo, Maria C.; Dimitri, Patrizio] Univ Roma La Sapienza, Dipartimento Biol & Biotecnol Charles Darwin, I-00185 Rome, Italy; [Accardo, Maria C.; Dimitri, Patrizio] Univ Roma La Sapienza, Ist Pasteur Fdn Cenci Bolognetti, I-00185 Rome, Italy	Washington University (WUSTL); Sapienza University Rome; Fondazione Cenci Bolognetti; Sapienza University Rome	Elgin, SCR (corresponding author), Washington Univ, Dept Biol, Campus Box 1137, St Louis, MO 63130 USA.	selgin@biology.wustl.edu		Elgin, Sarah C. R./0000-0002-5176-2510	Howard A. Schneiderman Fellowship; NIH [GM068388]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068388] Funding Source: NIH RePORTER	Howard A. Schneiderman Fellowship; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work is supported by Howard A. Schneiderman Fellowship (SHW) and by NIH grant GM068388 (to SCRE). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berloco M, 2005, CYTOGENET GENOME RES, V110, P124, DOI 10.1159/000084944; Biessmann H, 2005, GENETICS, V171, P1767, DOI 10.1534/genetics.105.048827; Brower-Toland B, 2007, GENE DEV, V21, P2300, DOI 10.1101/gad.1564307; Brower-Toland B, 2009, GENETICS, V181, P1303, DOI 10.1534/genetics.108.100271; Cenci G, 2003, NAT CELL BIOL, V5, P82, DOI 10.1038/ncb902; Cheutin T, 2004, MOL CELL BIOL, V24, P3157, DOI 10.1128/MCB.24.8.3157-3167.2004; Clough E, 2007, DEVELOPMENT, V134, P157, DOI 10.1242/dev.02698; Cryderman DE, 1999, EMBO J, V18, P3724, DOI 10.1093/emboj/18.13.3724; Dalai Y, 2007, P NATL ACAD SCI USA, V104, P15974, DOI 10.1073/pnas.0707648104; Dimitri P, 2004, METH MOL B, V260, P29, DOI 10.1385/1-59259-755-6:029; DIMITRI P, 1989, GENETICS, V122, P793; Doheny JG, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003864; Ebert A, 2004, GENE DEV, V18, P2973, DOI 10.1101/gad.323004; EISSENBERG JC, 1990, P NATL ACAD SCI USA, V87, P9923, DOI 10.1073/pnas.87.24.9923; Elgin SCR, 1996, CURR OPIN GENET DEV, V6, P193, DOI 10.1016/S0959-437X(96)80050-5; Fagegaltier D, 2009, P NATL ACAD SCI USA, V106, P21258, DOI 10.1073/pnas.0809208105; Girton JR, 2008, ADV GENET, V61, P1, DOI 10.1016/S0065-2660(07)00001-6; Gowen JW, 1934, GENETICS, V19, P0189; GRIGLIATTI T, 1991, METHOD CELL BIOL, V35, P587; Haynes KA, 2007, GENETICS, V175, P1539, DOI 10.1534/genetics.106.066407; Haynes KA, 2006, CURR BIOL, V16, P2222, DOI 10.1016/j.cub.2006.09.035; JAMES TC, 1989, EUR J CELL BIOL, V50, P170; JAMES TC, 1986, MOL CELL BIOL, V6, P3862, DOI 10.1128/MCB.6.11.3862; Kharchenko PV, 2011, NATURE, V471, P480, DOI 10.1038/nature09725; Lee YS, 2004, CELL, V117, P69, DOI 10.1016/S0092-8674(04)00261-2; Lemos B, 2010, P NATL ACAD SCI USA, V107, P15826, DOI 10.1073/pnas.1010383107; LOCKE J, 1988, GENETICS, V120, P181; Okamura K, 2004, GENE DEV, V18, P1655, DOI 10.1101/gad.1210204; Pal-Bhadra M, 2004, SCIENCE, V303, P669, DOI 10.1126/science.1092653; Paredes S, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001376; Paredes S, 2009, P NATL ACAD SCI USA, V106, P17829, DOI 10.1073/pnas.0906811106; Peng JC, 2008, CURR OPIN GENET DEV, V18, P204, DOI 10.1016/j.gde.2008.01.021; Perrini B, 2004, MOL CELL, V15, P467, DOI 10.1016/j.molcel.2004.06.036; R Core Team, 2012, R LANG ENV STAT COMP; Riddle NC, 2008, GENETICS, V178, P1177, DOI 10.1534/genetics.107.081828; Schoeftner S, 2009, EMBO J, V28, P2323, DOI 10.1038/emboj.2009.197; Schotta G, 2003, SEMIN CELL DEV BIOL, V14, P67, DOI 10.1016/S1084-9521(02)00138-6; Sentmanat MF, 2012, P NATL ACAD SCI USA, V109, P14104, DOI 10.1073/pnas.1207036109; Seum C, 2007, GENETICS, V177, P1955, DOI 10.1534/genetics.107.078220; Seum C, 2007, PLOS GENET, V3, P709, DOI 10.1371/journal.pgen.0030076; SHAFFER CD, 1994, METHOD CELL BIOL, V44, P99, DOI 10.1016/S0091-679X(08)60908-5; Stabell M, 2006, HEREDITAS, V143, P177, DOI 10.1111/j.2006.0018-0661.01970.x; Stabell M, 2006, NUCLEIC ACIDS RES, V34, P4609, DOI 10.1093/nar/gkl640; Sun FL, 2004, MOL CELL BIOL, V24, P8210, DOI 10.1128/MCB.24.18.8210-8220.2004; TARTOF KD, 1984, CELL, V37, P869, DOI 10.1016/0092-8674(84)90422-7; Tzeng TY, 2007, P NATL ACAD SCI USA, V104, P12691, DOI 10.1073/pnas.0705534104; Verdel A, 2004, SCIENCE, V303, P672, DOI 10.1126/science.1093686; Volpe TA, 2002, SCIENCE, V297, P1833, DOI 10.1126/science.1074973; WALLRATH LL, 1995, GENE DEV, V9, P1263, DOI 10.1101/gad.9.10.1263; Wang SH, 2011, P NATL ACAD SCI USA, V108, P21164, DOI 10.1073/pnas.1107892109; WUSTMANN G, 1989, MOL GEN GENET, V217, P520, DOI 10.1007/BF02464926; Yasuhara JC, 2006, TRENDS GENET, V22, P330, DOI 10.1016/j.tig.2006.04.008; Zhou J, 2012, P NATL ACAD SCI US	53	9	9	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2014	9	1							e86451	10.1371/journal.pone.0086451	http://dx.doi.org/10.1371/journal.pone.0086451			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	298QQ	24475122	Green Published, Green Submitted, gold			2022-12-25	WOS:000330339800046
J	Zhu, Z; Yin, FF; Liu, XP; Hou, DH; Wang, J; Zhang, L; Arif, B; Wang, HL; Deng, F; Hu, ZH				Zhu, Zheng; Yin, Feifei; Liu, Xiaoping; Hou, Dianhai; Wang, Jun; Zhang, Lei; Arif, Basil; Wang, Hualin; Deng, Fei; Hu, Zhihong			Genome Sequence and Analysis of Buzura suppressaria Nucleopolyhedrovirus: A Group II Alphabaculovirus	PLOS ONE			English	Article							NUCLEAR POLYHEDROSIS-VIRUS; SINGLE-NUCLEOCAPSID NUCLEOPOLYHEDROVIRUS; BOMBYX-MORI NUCLEOPOLYHEDROVIRUS; FIBROBLAST-GROWTH-FACTOR; ENVELOPE FUSION PROTEIN; OS INFECTIVITY FACTOR; NUCLEOTIDE-SEQUENCE; DNA-REPLICATION; BACULOVIRUS; GENE	The genome of Buzura suppressaria nucleopolyhedrovirus (BusuNPV) was sequenced by 454 pyrosequencing technology. The size of the genome is 120,420 bp with 36.8% G+C content. It contains 127 hypothetical open reading frames (ORFs) covering 90.7% of the genome and includes the 37 conserved baculovirus core genes, 84 genes found in other baculoviruses, and 6 unique ORFs. No typical baculoviral homologous repeats (hrs) were present but the genome contained a region of repeated sequences. Gene Parity Plots revealed a 28.8 kb region conserved among the alpha- and beta-baculoviruses. Overall comparisons of BusuNPV to other baculoviruses point to a distinct species in group II Alphabaculovirus.	[Zhu, Zheng; Yin, Feifei; Liu, Xiaoping; Hou, Dianhai; Wang, Jun; Zhang, Lei; Wang, Hualin; Deng, Fei; Hu, Zhihong] Chinese Acad Sci, Wuhan Inst Virol, State Key Lab Virol, Wuhan, Peoples R China; [Zhu, Zheng; Yin, Feifei; Liu, Xiaoping; Hou, Dianhai; Wang, Jun; Zhang, Lei; Wang, Hualin; Deng, Fei; Hu, Zhihong] Chinese Acad Sci, Wuhan Inst Virol, China Ctr Virus Culture Collect, Wuhan, Peoples R China; [Arif, Basil] Great Lakes Forestry Ctr, Canadian Forest Serv, Sault Ste Marie, ON, Canada	Chinese Academy of Sciences; Wuhan Institute of Virology, CAS; Chinese Academy of Sciences; Wuhan Institute of Virology, CAS; Natural Resources Canada; Canadian Forest Service; Great Lakes Forestry Centre	Hu, ZH (corresponding author), Chinese Acad Sci, Wuhan Inst Virol, State Key Lab Virol, Wuhan, Peoples R China.	huzh@wh.iov.cn	Hu, Zhihong/AAS-2215-2020; ZHU, ZHENG/P-2173-2016	Hu, Zhihong/0000-0002-1560-0928; ZHU, ZHENG/0000-0002-2035-0804	National Science Foundation of China [31130058, 31321001]; Chinese Academy of Sciences [2012T1S0019]; Wuhan Institute of Virology for Virus Resources and Bioinformatics Center	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Academy of Sciences(Chinese Academy of Sciences); Wuhan Institute of Virology for Virus Resources and Bioinformatics Center	The research was supported in part by the National Science Foundation of China (31130058,31321001), Chinese Academy of Sciences visiting professorship for senior international scientists (2012T1S0019 to B. A.), and Wuhan Institute of Virology for Virus Resources and Bioinformatics Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Carstens EB, 2009, ARCH VIROL, V154, P1181, DOI 10.1007/s00705-009-0400-2; Carstens EB, 2007, J GEN VIROL, V88, P114, DOI 10.1099/vir.0.82384-0; CHISHOLM GE, 1988, J VIROL, V62, P3193, DOI 10.1128/JVI.62.9.3193-3200.1988; CHOI J, 1995, J VIROL, V69, P4548, DOI 10.1128/JVI.69.7.4548-4551.1995; CHUKHRY MG, 1989, ACTA VIROL, V33, P559; Conant GC, 2008, BIOINFORMATICS, V24, P861, DOI 10.1093/bioinformatics/btm598; Detvisitsakun C, 2007, VIROLOGY, V365, P70, DOI 10.1016/j.virol.2007.03.027; Ferrelli ML, 2012, BACULOVIRAL GENOME; Georgievska L, 2010, J INVERTEBR PATHOL, V104, P44, DOI 10.1016/j.jip.2010.01.008; GOMBART AF, 1989, VIROLOGY, V169, P182, DOI 10.1016/0042-6822(89)90054-8; GUARINO LA, 1986, J VIROL, V60, P224, DOI 10.1128/JVI.60.1.224-229.1986; Guarino LA, 1998, J VIROL, V72, P7985, DOI 10.1128/JVI.72.10.7985-7991.1998; Hayakawa T, 1999, VIROLOGY, V262, P277, DOI 10.1006/viro.1999.9894; Hefferon KL, 1999, VIROLOGY, V258, P455, DOI 10.1006/viro.1999.9758; Hilton S, 2008, ARCH VIROL, V153, P1527, DOI 10.1007/s00705-008-0148-0; Hu ZH, 1998, J GEN VIROL, V79, P2841, DOI 10.1099/0022-1317-79-11-2841; Hu ZH, 1997, VIRUS RES, V47, P91, DOI 10.1016/S0168-1702(96)01406-2; Hu ZH, 1999, J GEN VIROL, V80, P1045, DOI 10.1099/0022-1317-80-4-1045; HU ZH, 1993, J GEN VIROL, V74, P1617, DOI 10.1099/0022-1317-74-8-1617; Hu ZH, 1998, VIRUS RES, V55, P71, DOI 10.1016/S0168-1702(98)00029-X; Huang H, 2013, J VIROLOGY; Huang HC, 2012, VIROLOGY, V427, P217, DOI 10.1016/j.virol.2012.01.022; IJkel WFJ, 2000, VIROLOGY, V275, P30, DOI 10.1006/viro.2000.0483; Garavaglia MJ, 2012, J VIROL, V86, P12069, DOI 10.1128/JVI.01873-12; Jehle JA, 2006, ARCH VIROL, V151, P1257, DOI 10.1007/s00705-006-0763-6; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275, DOI 10.1093/bioinformatics/8.3.275; Kang WY, 1999, J VIROL, V73, P10339, DOI 10.1128/JVI.73.12.10339-10345.1999; KEDDIE BA, 1989, SCIENCE, V243, P1728, DOI 10.1126/science.2648574; KOOL M, 1993, J GEN VIROL, V74, P2661, DOI 10.1099/0022-1317-74-12-2661; Lauzon HAM, 2004, J VIROL, V78, P7023, DOI 10.1128/JVI.78.13.7023-7035.2004; Li K, 2010, J VIROL, V84, P7857, DOI 10.1128/JVI.00174-10; Luo SJN, 2011, J GEN VIROL, V92, P1324, DOI 10.1099/vir.0.029116-0; Luria N, 2012, VIRUSES-BASEL, V4, P761, DOI 10.3390/v4050761; Marek M, 2011, J VIROL, V85, P5350, DOI 10.1128/JVI.00035-11; Means JC, 2010, P NATL ACAD SCI USA, V107, P9825, DOI 10.1073/pnas.0913582107; Miele Solange Ana Belen, 2011, Int J Evol Biol, V2011, P379424, DOI 10.4061/2011/379424; Mikhailov VS, 2003, MOL BIOL+, V37, P250, DOI 10.1023/A:1023349706186; Monsma SA, 1996, J VIROL, V70, P4607, DOI 10.1128/JVI.70.7.4607-4616.1996; Nie YC, 2012, J VIROL, V86, P3985, DOI 10.1128/JVI.06849-11; OREILLY DR, 1990, J VIROL, V64, P1321, DOI 10.1128/JVI.64.3.1321-1328.1990; OREILLY DR, 1989, SCIENCE, V245, P1110, DOI 10.1126/science.2505387; Pearson MN, 2000, J VIROL, V74, P6126, DOI 10.1128/JVI.74.13.6126-6131.2000; Reuter JS, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-129; RODEMS SM, 1995, J VIROL, V69, P5368, DOI 10.1128/JVI.69.9.5368-5375.1995; Rohrmann G.F., 2019, BACULOVIRUS MOL BIOL; Sanderson MJ, 2000, SYST BIOL, V49, P671, DOI 10.1080/106351500750049761; Simon O, 2012, J INVERTEBR PATHOL, V111, P260, DOI 10.1016/j.jip.2012.08.013; SLACK JM, 1995, J GEN VIROL, V76, P1091, DOI 10.1099/0022-1317-76-5-1091; Slavicek JM, 2005, J VIROL, V79, P10578, DOI 10.1128/JVI.79.16.10578-10588.2005; Solovyev VV, 1999, NUCLEIC ACIDS RES, V27, P248, DOI 10.1093/nar/27.1.248; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Thumbi DK, 2011, VIRUSES-BASEL, V3, P2301, DOI 10.3390/v3112301; van Oers MM, 1998, J GEN VIROL, V79, P1553, DOI 10.1099/0022-1317-79-6-1553; Vanarsdall AL, 2006, J VIROL, V80, P1724, DOI 10.1128/JVI.80.4.1724-1733.2006; Wang P, 1997, P NATL ACAD SCI USA, V94, P6977, DOI 10.1073/pnas.94.13.6977; WHITT MA, 1988, VIROLOGY, V163, P33, DOI 10.1016/0042-6822(88)90231-0; WILLIAMS GV, 1989, J GEN VIROL, V70, P187, DOI 10.1099/0022-1317-70-1-187; Wu WB, 2010, J VIROL, V84, P12351, DOI 10.1128/JVI.01598-10; Wu YT, 1996, J VIROL, V70, P6967, DOI 10.1128/JVI.70.10.6967-6972.1996; Yang S, 1998, VIROLOGY, V245, P99, DOI 10.1006/viro.1998.9152; Yang X.Y., 1981, CHECK LIST FOREST IN; Zemskov EA, 2000, J VIROL, V74, P6784, DOI 10.1128/JVI.74.15.6784-6789.2000; Zhou JB, 2012, VIRUS GENES, V44, P539, DOI 10.1007/s11262-012-0721-1	63	17	21	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2014	9	1							e86450	10.1371/journal.pone.0086450	http://dx.doi.org/10.1371/journal.pone.0086450			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	298QQ	24475121	Green Submitted, Green Published, gold			2022-12-25	WOS:000330339800045
J	Barylski, J; Nowicki, G; Gozdzicka-Jozefiak, A				Barylski, Jakub; Nowicki, Grzegorz; Gozdzicka-Jozefiak, Anna			The Discovery of phiAGATE, A Novel Phage Infecting Bacillus pumilus, Leads to New Insights into the Phylogeny of the Subfamily Spounavirinae	PLOS ONE			English	Article							COMPLETE GENOME SEQUENCE; GRAM-POSITIVE BACTERIA; POLY-GAMMA-GLUTAMATE; CEREUS BACTERIOPHAGE; FUNCTION PREDICTION; GROWTH PROMOTION; SUBTILIS; SPORULATION; EVOLUTION; GENES	The Bacillus phage phiAGATE is a novel myovirus isolated from the waters of Lake Goreckie (a eutrophic lake in western Poland). The bacteriophage infects Bacillus pumilus, a bacterium commonly observed in the mentioned reservoir. Analysis of the phiAGATE genome (149844 base pairs) resulted in 204 predicted protein-coding sequences (CDSs), of which 53 could be functionally annotated. Further investigation revealed that the bacteriophage is a member of a previously undescribed cluster of phages (for the purposes of this study we refer to it as "Bastille group") within the Spounavirinae subfamily. Here we demonstrate that these viruses constitute a distinct branch of the Spounavirinae phylogenetic tree, with limited similarity to phages from the Twortlikevirus and Spounalikevirus genera. The classification of phages from the Bastille group into any currently accepted genus proved extremely difficult, prompting concerns about the validity of the present taxonomic arrangement of the subfamily.	[Barylski, Jakub; Nowicki, Grzegorz; Gozdzicka-Jozefiak, Anna] Adam Mickiewicz Univ, Dept Mol Virol, Fac Biol, Poznan, Poland	Adam Mickiewicz University	Barylski, J (corresponding author), Adam Mickiewicz Univ, Dept Mol Virol, Fac Biol, Poznan, Poland.	jakub.barylski@gmail.com		Barylski, Jakub/0000-0001-6630-6932; Gozdzicka-Jozefiak, Anna/0000-0002-3900-686X	National Science Centre of Republic of Poland [NCN 2011/01/N/NZ9/00760]	National Science Centre of Republic of Poland	This work was supported by grant NCN 2011/01/N/NZ9/00760 from National Science Centre of Republic of Poland (http://www.ncn.gov.pl/?language=en). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams MJ, 2013, RATIFICATION VOTE TA; Agren J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039107; Alikhan NF, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-402; Alonso JC, 1997, GENE, V204, P201, DOI 10.1016/S0378-1119(97)00547-7; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Aunpad R, 2007, CURR MICROBIOL, V55, P308, DOI 10.1007/s00284-006-0632-2; Aziz RK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-75; BARRY GT, 1951, J EXP MED, V94, P387, DOI 10.1084/jem.94.5.387; BRAMUCCI MG, 1977, J VIROL, V24, P194, DOI 10.1128/JVI.24.1.194-200.1977; Budinoff CR, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-168; Burton BM, 2007, CELL, V131, P1301, DOI 10.1016/j.cell.2007.11.009; Candela T, 2006, MOL MICROBIOL, V60, P1091, DOI 10.1111/j.1365-2958.2006.05179.x; Carlton RM, 2005, REGUL TOXICOL PHARM, V43, P301, DOI 10.1016/j.yrtph.2005.08.005; Casjens Sherwood R., 2009, V502, P91, DOI 10.1007/978-1-60327-565-1_7; Chibani-Chennoufi S, 2004, J BACTERIOL, V186; Chitale M, 2009, BIOINFORMATICS, V25, P1739, DOI 10.1093/bioinformatics/btp309; Comeau AM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040102; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; CREGG JM, 1978, VIROLOGY, V86, P530, DOI 10.1016/0042-6822(78)90091-0; Cui Z, 2012, J VIROL, V86; Darling AE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011147; Darriba D, 2011, BIOINFORMATICS, V27, P1164, DOI 10.1093/bioinformatics/btr088; De Souza MJBD, 2000, INDIAN J MAR SCI, V29, P48; de Vienne DM, BIOINFORMATICS, V23, P7; Delcher AL, 2007, BIOINFORMATICS, V23, P673, DOI 10.1093/bioinformatics/btm009; Drulis-Kawa Z, 2011, APPL MICROBIOL BIOT, V90, P1333, DOI 10.1007/s00253-011-3149-y; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Edwards U, 1989, NUCL ACIDS RES, V17; Fouts DE, 2006, J BACTERIOL, V188, P3402, DOI 10.1128/JB.188.9.3402-3408.2006; Frickey T, 2004, BIOINFORMATICS, V20, P3702, DOI 10.1093/bioinformatics/bth444; From C, 2007, INT J FOOD MICROBIOL, V115, P319, DOI 10.1016/j.ijfoodmicro.2006.11.005; Galal A.A., 2006, EGYPT J PHYTOPATHOL, V34, P17; Goldsmith DB, 2011, APPL ENV MICROBIOL, V77; Gu JM, 2012, J VIROL, V86, P8914, DOI 10.1128/JVI.01313-12; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Gutierrez D, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-228; Hawkins T, 2006, PROTEIN SCI, V15, P1550, DOI 10.1110/ps.062153506; Hendrix RW, 2002, THEOR POPUL BIOL, V61, P471, DOI 10.1006/tpbi.2002.1590; Hernandez JP, 2009, EUR J SOIL BIOL, V45, P88, DOI 10.1016/j.ejsobi.2008.08.004; Hill JE, 2009, J FISH DIS, V32, P1007, DOI 10.1111/j.1365-2761.2009.01084.x; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; Imai K, 1969, IFO RES COMMUN, V14, P5; Jaouadi NZ, 2012, BIORESOURCE TECHNOL, V105, P142, DOI 10.1016/j.biortech.2011.11.115; Joo GJ, 2004, BIOTECHNOL LETT, V26, P487, DOI 10.1023/B:BILE.0000019555.87121.34; Kaur A, 2010, BIORESOUR TECHNOL, V101; KEGGINS KM, 1978, J VIROL, V27, P819, DOI 10.1128/JVI.27.3.819-822.1978; Kilcher S, 2010, J BACTERIOL, V192, P5441, DOI 10.1128/JB.00709-10; Kimura K, 2003, APPL ENVIRON MICROB, V69, P2491, DOI 10.1128/AEM.69.5.2491-2497.2003; King A.M.Q., 2011, VIRUS TAXONOMY, V1st ed; Klumpp J, 2008, J BACTERIOL, V190, P5753, DOI 10.1128/JB.00461-08; Klumpp J, 2010, ARCH VIROL, V155, P1547, DOI 10.1007/s00705-010-0783-0; Kvachadze L, 2011, MICROB BIOTECHNOL, V4, P643, DOI 10.1111/j.1751-7915.2011.00259.x; Kwan T, 2005, P NATL ACAD SCI USA, V102, P5174, DOI 10.1073/pnas.0501140102; Lavigne R, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-224; Lee JH, 2012, J VIROL, V86, P637, DOI 10.1128/JVI.06520-11; Lobocka M, 2012, ADV VIRUS RES, V83, P143, DOI 10.1016/B978-0-12-394438-2.00005-0; LOGAN NA, 1984, J GEN MICROBIOL, V130, P1871; LOVETT PS, 1974, J VIROL, V13, P81, DOI 10.1128/JVI.13.1.81-84.1974; Lukashin AV, 1998, NUCLEIC ACIDS RES, V26, P1107, DOI 10.1093/nar/26.4.1107; Marvasi M, 2010, FEMS MICROBIOL LETT, V313, P1, DOI 10.1111/j.1574-6968.2010.02085.x; Meijer WJ, 2001, MICROBIOL MOL BIOL R, V65; Minakhin L, 2005, J MOL BIOL, V354, P1, DOI 10.1016/j.jmb.2005.09.052; Mobberley J, 2010, APPL ENVIRON MICROB, V76, P829, DOI 10.1128/AEM.01710-09; Nagar S, 2010, J IND MICROBIOL BIOT, V37, P71, DOI 10.1007/s10295-009-0650-8; Nithya C, 2011, BIOFOULING, V27, P519, DOI 10.1080/08927014.2011.586127; Nithya C, 2010, RES MICROBIOL, V161, P293, DOI 10.1016/j.resmic.2010.03.002; O'Flaherty S, 2004, J BACTERIOL, V186, P2862, DOI 10.1128/JB.186.9.2862-2871.2004; Park J, 2012, FEMS MICROBIOL LETT, V332, P76, DOI 10.1111/j.1574-6968.2012.02578.x; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; Sabehi G, 2012, P NATL ACAD SCI USA, V109, P2037, DOI 10.1073/pnas.1115467109; Satyanarayana T., 2012, MICROORGANISMS SUSTA; Sayers EW, 2012, NUCLEIC ACIDS RES, V40, pD13, DOI [10.1093/nar/gkr1184, 10.1093/nar/gks1189, 10.1093/nar/gky1069]; Schattner P., 2005, NUCL ACIDS RES, V33, pW868; Schuch R, 2006, J BACTERIOL, V188, P3037, DOI 10.1128/JB.188.8.3037-3051.2006; Serwer P, 2007, VIROL J, V4, DOI 10.1186/1743-422X-4-30; Sillankorva S, 2008, BMC BIOTECHNOL, V8, DOI 10.1186/1472-6750-8-80; Soares SC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053818; Solovyev VV, 1999, NUCLEIC ACIDS RES, V27, P248, DOI 10.1093/nar/27.1.248; Stewart CR, 2009, J MOL BIOL, V388, P48, DOI 10.1016/j.jmb.2009.03.009; Sullivan MB, 2008, ENVIRON MICROBIOL, V10, P2810, DOI 10.1111/j.1462-2920.2008.01702.x; Swanson MM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040683; Tena D, 2007, CLIN INFECT DIS, V44, pE40, DOI 10.1086/511077; Tetart F, 2001, J BACTERIOL, V183, P358, DOI 10.1128/JB.183.1.358-366.2001; Thompson JE, 2010, J BIOL CHEM, V285, P23963, DOI 10.1074/jbc.M110.127571; Turner S, 1999, J EUKARYOT MICROBIOL, V46, P327, DOI 10.1111/j.1550-7408.1999.tb04612.x; Uchiyama J, 2008, APPL ENVIRON MICROB, V74, P4149, DOI 10.1128/AEM.02371-07; Uchiyama J, 2008, FEMS MICROBIOL LETT, V278, P200, DOI 10.1111/j.1574-6968.2007.00996.x; Vandersteegen K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024418; Venkateswaran K, 2001, SYST APPL MICROBIOL, V24, P311, DOI 10.1078/0723-2020-00018; Vos P., 2009, BERGEYS MANUAL SYSTE, V3; Wang HY, 2007, LETT APPL MICROBIOL, V44, P1, DOI 10.1111/j.1472-765X.2006.02039.x; Weisburg W.G., 1991, J BACTERIOL, V173; Xie Guanghui, 1998, Weishengwu Xuebao, V38, P480; Yee LM, 2011, BIOSCI BIOTECH BIOCH, V75, P944, DOI 10.1271/bbb.100921; Yuan YH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037557; Zdobnov EM, 2001, BIOINFORMATICS, V17, P847, DOI 10.1093/bioinformatics/17.9.847	96	28	28	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2014	9	1							e86632	10.1371/journal.pone.0086632	http://dx.doi.org/10.1371/journal.pone.0086632			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297XI	24466180	Green Published, Green Submitted, gold			2022-12-25	WOS:000330288000124
J	Fugere, A; Seguin, DL; Mitchell, G; Deziel, E; Dekimpe, V; Cantin, AM; Frost, E; Malouin, F				Fugere, Alexandre; Seguin, David Lalonde; Mitchell, Gabriel; Deziel, Eric; Dekimpe, Valerie; Cantin, Andre M.; Frost, Eric; Malouin, Francois			Interspecific Small Molecule Interactions between Clinical Isolates of Pseudomonas aeruginosa and Staphylococcus aureus from Adult Cystic Fibrosis Patients	PLOS ONE			English	Article							SMALL-COLONY VARIANTS; ANTIBIOTIC-RESISTANCE; GENETIC ADAPTATION; BACTERIAL BIOFILMS; LUNG INFECTION; LASR MUTANTS; COMMUNICATION; 4-HYDROXY-2-ALKYLQUINOLINES; GROWTH; IDENTIFICATION	Pseudomonas aeruginosa and Staphylococcus aureus are the most prevalent pathogens in airway infections of cystic fibrosis (CF) patients. We studied how these pathogens coexist and interact with each other. Clinical isolates of both species were retrieved from adult CF patients. Culture supernatants from 63 P. aeruginosa isolates triggered a wide range of biofilm-stimulatory activities when added to the culture of a control S. aureus strain. The extent of biofilm formation by S. aureus was positively correlated to the levels of the 2-alkyl-4-(1H)-quinolones (AQs) Pseudomonas Quinolone Signal (PQS) and 2-heptyl-4-hydroxy quinoline N-oxide (HQNO) produced by the P. aeruginosa isolates. Supernatants from P. aeruginosa isogenic mutants deficient in PQS and HQNO production stimulated significantly less biofilm formation by S. aureus than that seen with the parental strain PA14. When studying co-isolated pairs of P. aeruginosa and S. aureus retrieved from patients showing both pathogens, P. aeruginosa supernatants stimulated less biofilm production by the S. aureus counterparts compared to that observed using the control S. aureus strain. Accordingly, some P. aeruginosa isolates produced low levels of exoproducts and also some of the clinical S. aureus isolates were not stimulated by their co-isolates or by PA14 despite adequate production of HQNO. This suggests that colonization of the CF lungs promotes some type of strain selection, or that co-existence requires specific adaptations by either or both pathogens. Results provide insights on bacterial interactions in CF.	[Fugere, Alexandre; Seguin, David Lalonde; Mitchell, Gabriel; Malouin, Francois] Univ Sherbrooke, Fac Sci, Dept Biol, CEVDM, Sherbrooke, PQ J1K 2R1, Canada; [Deziel, Eric; Dekimpe, Valerie] INRS Inst Armand Frappier, Laval, PQ, Canada; [Cantin, Andre M.] Univ Sherbrooke, Fac Med & Sci Sante, Dept Med, Serv Pneumol, Sherbrooke, PQ J1K 2R1, Canada; [Frost, Eric] Univ Sherbrooke, Dept Microbiol & Infectiol, Fac Med & Sci Sante, Sherbrooke, PQ J1K 2R1, Canada	University of Sherbrooke; University of Quebec; Institut national de la recherche scientifique (INRS); University of Sherbrooke; University of Sherbrooke	Malouin, F (corresponding author), Univ Sherbrooke, Fac Sci, Dept Biol, CEVDM, Sherbrooke, PQ J1K 2R1, Canada.	Francois.Malouin@USherbrooke.ca	Déziel, Eric/A-7678-2008	Déziel, Eric/0000-0002-4609-0115; Malouin, Francois/0000-0001-5031-345X; Frost, Eric/0000-0001-8958-4388	Cystic Fibrosis Canada; Canadian Institutes of Health Research (CIHR) [MOP-97888]	Cystic Fibrosis Canada; Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR))	This study was supported by a grant from Cystic Fibrosis Canada. Work in ED lab was supported by Canadian Institutes of Health Research (CIHR) operating grant MOP-97888. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Archibald LK, 1997, INFECT DIS CLIN N AM, V11, P245, DOI 10.1016/S0891-5520(05)70354-8; Beenken KE, 2003, INFECT IMMUN, V71, P4206, DOI 10.1128/IAI.71.7.4206-4211.2003; Boles BR, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000052; Brogden KA, 2005, LANCET, V365, P253, DOI 10.1016/S0140-6736(05)70155-0; Chalmers JD, 2012, MOL IMMUNOL; Ciofu O, 2005, ANTIMICROB AGENTS CH, V49, P2276, DOI 10.1128/AAC.49.6.2276-2282.2005; Ciofu O, 2010, MICROBIOL-SGM, V156, P1108, DOI 10.1099/mic.0.033993-0; Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318; CysticFibrosisCanada, 2010, CAN CYST FIBR PAT DA; CysticFibrosisCanada, 2011, CAN CYST FIBR PAT DA; D'Argenio DA, 2007, MOL MICROBIOL, V64, P512, DOI 10.1111/j.1365-2958.2007.05678.x; Davies D, 2003, NAT REV DRUG DISCOV, V2, P114, DOI 10.1038/nrd1008; Dekimpe V, 2009, MICROBIOL-SGM, V155, P712, DOI 10.1099/mic.0.022764-0; Deziel E, 2004, P NATL ACAD SCI USA, V101, P1339, DOI 10.1073/pnas.0307694100; Gomes MZD, 2012, FOOD CONTROL, V25, P441, DOI 10.1016/j.foodcont.2011.11.025; Duan KM, 2003, MOL MICROBIOL, V50, P1477, DOI 10.1046/j.1365-2958.2003.03803.x; Dusane DH, 2010, COLLOID SURFACE B, V81, P242, DOI 10.1016/j.colsurfb.2010.07.013; Goerke C, 2010, INT J MED MICROBIOL; Haba E, 2003, BIOTECHNOL BIOENG, V81, P316, DOI 10.1002/bit.10474; HAMMERSCHLAG MR, 1980, J CLIN MICROBIOL, V11, P552, DOI 10.1128/JCM.11.6.552-557.1980; Harrison F, 2008, ISME J, V2, P49, DOI 10.1038/ismej.2007.96; Harrison F, 2007, MICROBIOL-SGM, V153, P917, DOI 10.1099/mic.0.2006/004077-0; Hendricks KJ, 2001, J BONE JOINT SURG AM, V83A, P855, DOI 10.2106/00004623-200106000-00006; Hoffman LR, 2006, P NATL ACAD SCI USA, V103, P19890, DOI 10.1073/pnas.0606756104; Hubert D, 2013, J CYST FIBROS; Hwang SY, 2007, INT J FOOD MICROBIOL, V117, P99, DOI 10.1016/j.ijfoodmicro.2007.02.013; Irie Y, 2005, FEMS MICROBIOL LETT, V250, P237, DOI 10.1016/j.femsle.2005.07.012; Kerem E, 2006, REGISTRY REPORT 2003; Kesarwani M, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002192; Kim JH, 2008, J MICROBIOL BIOTECHN, V18, P28; Lepine F, 2004, J AM SOC MASS SPECTR, V15, P862; Lepine F, 2010, T QUORUM SENSING, P61; Lepine F, 2011, METHODS MOL BIOL, V692, P61, DOI 10.1007/978-1-60761-971-0_5; Liberati NT, 2006, P NATL ACAD SCI USA, V103, P2833, DOI 10.1073/pnas.0511100103; Lyczak JB, 2002, CLIN MICROBIOL REV, V15, P194, DOI 10.1128/CMR.15.2.194-222.2002; MACHAN ZA, 1992, J ANTIMICROB CHEMOTH, V30, P615, DOI 10.1093/jac/30.5.615; Mashburn LM, 2005, J BACTERIOL, V187, P554, DOI 10.1128/JB.187.2.554-566.2005; Mitchell G, 2012, CYSTIC FIBROSIS, P550; Mitchell G, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-33; Mitchell G, 2010, MICROB PATHOGENESIS, V48, P18, DOI 10.1016/j.micpath.2009.10.003; Mitchell G, 2008, MOL MICROBIOL, V70, P1540, DOI 10.1111/j.1365-2958.2008.06511.x; MURAKAMI K, 1991, J CLIN MICROBIOL, V29, P2240, DOI 10.1128/JCM.29.10.2240-2244.1991; Oliver A, 2000, SCIENCE, V288, P1251, DOI 10.1126/science.288.5469.1251; Oliver A, 2010, CLIN MICROBIOL INFEC, V16, P798, DOI 10.1111/j.1469-0691.2010.03250.x; Paixao VA, 2010, BRAZ J INFECT DIS, V14, P406, DOI 10.1590/S1413-86702010000400016; Palmer KL, 2005, J BACTERIOL, V187, P5267, DOI 10.1128/JB.187.15.5267-5277.2005; Pihl M, 2013, PATHOG DIS, V67, P192, DOI 10.1111/2049-632X.12035; Qazi S, 2006, INFECT IMMUN, V74, P910, DOI 10.1128/IAI.74.2.910-919.2006; RAHME LG, 1995, SCIENCE, V268, P1899, DOI 10.1126/science.7604262; Riedel K, 2001, J BACTERIOL, V183, P1805, DOI 10.1128/JB.183.5.1805-1809.2001; Ryan RP, 2008, MICROBIOL-SGM, V154, P1845, DOI 10.1099/mic.0.2008/017871-0; Sabat A, 2003, J CLIN MICROBIOL, V41, P1801, DOI 10.1128/JCM.41.4.1801-1804.2003; Sibley CD, 2008, P NATL ACAD SCI USA, V105, P15070, DOI 10.1073/pnas.0804326105; Smith EE, 2006, P NATL ACAD SCI USA, V103, P8487, DOI 10.1073/pnas.0602138103; Stewart PS, 2002, INT J MED MICROBIOL, V292, P107, DOI 10.1078/1438-4221-00196; Stoodley P, 2002, ANNU REV MICROBIOL, V56, P187, DOI 10.1146/annurev.micro.56.012302.160705; Straight PD, 2009, ANNU REV MICROBIOL, V63, P99, DOI 10.1146/annurev.micro.091208.073248; Stressmann FA, 2012, THORAX, V67, P867, DOI 10.1136/thoraxjnl-2011-200932; Valle J, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002843; Weaver VB, 2004, J BACTERIOL, V186, P2376, DOI 10.1128/JB.186.8.2376-2384.2004; Wilder CN, 2009, INFECT IMMUN, V77, P5631, DOI 10.1128/IAI.00755-09; Xiao GP, 2006, MOL MICROBIOL, V62, P1689, DOI 10.1111/j.1365-2958.2006.05462.x; Yang L, 2011, FEMS IMMUNOL MED MIC, V62, P339, DOI 10.1111/j.1574-695X.2011.00820.x	63	56	61	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2014	9	1							e86705	10.1371/journal.pone.0086705	http://dx.doi.org/10.1371/journal.pone.0086705			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297XI	24466207	Green Published, Green Submitted, gold			2022-12-25	WOS:000330288000134
J	Montero-Marin, J; Demarzo, MMP; Pereira, JP; Olea, M; Garcia-Campayo, J				Montero-Marin, Jesus; Demarzo, Marcelo Marcos Piva; Pereira, Joao Paulo; Olea, Marina; Garcia-Campayo, Javier			Reassessment of the Psychometric Characteristics and Factor Structure of the 'Perceived Stress Questionnaire' (PSQ): Analysis in a Sample of Dental Students	PLOS ONE			English	Article							EXPLORATORY FACTOR-ANALYSIS; CONNOR-DAVIDSON RESILIENCE; LEAST-SQUARES ESTIMATION; PARALLEL ANALYSIS; JOB STRESS; PROMOTING RESILIENCE; DEPRESSIVE SYMPTOMS; NURSING-STUDENTS; SPANISH VERSION; CD-RISC	Background: The training to become a dentist can create psychological distress. The present study evaluates the structure of the 'Perceived Stress Questionnaire' (PSQ), its internal consistency model and interrelatedness with burnout, anxiety, depression and resilience among dental students. Methods: The study employed a cross-sectional design. A sample of Spanish dental students (n = 314) completed the PSQ, the 'Goldberg Anxiety and Depression Scale' (GADS), 'Connor-Davidson Resilience Scale' (10-item CD-RISC) and 'Maslach Burnout Inventory-Student Survey' (MBI-SS). The structure was estimated using Parallel Analysis from polychoric correlations. Unweighted Least Squares was the method for factor extraction, using the Item Response Theory to evaluate the discriminative power of items. Internal consistency was assessed by squaring the correlation between the latent true variable and the observed variable. The relationships between the PSQ and the other constructs were analysed using Spearman's coefficient. Results: The results showed a PSQ structure through two sub-factors ('frustration' and 'tenseness') with regard to one general factor ('perceived stress'). Items that did not satisfy discriminative capacity were rejected. The model fit were acceptable (GFI = 0.98; RSMR = 0.06; AGFI = 0.98; NFI = 0.98; RFI = 0.98). All the factors showed adequate internal consistency as measured by the congeneric model (>= 0.91). High and significant associations were observed between perceived stress and burnout, anxiety, depression and resilience. Conclusions: The PSQ showed a hierarchical bi-factor structure among Spanish dental students. Using the questionnaire as a uni-dimensional scale may be useful in perceived stress level discrimination, while the sub-factors could help us to refine perceived stress analysis and improve therapeutic processes.	[Montero-Marin, Jesus; Olea, Marina] Univ Zaragoza, Fac Hlth & Sport Sci, Zaragoza, Spain; [Demarzo, Marcelo Marcos Piva] Univ Fed Sao Paulo, Dept Prevent Med, Sao Paulo, Brazil; [Pereira, Joao Paulo] Inst Super Maia, Dept Psychol, Castelo Da Maia, Portugal; [Garcia-Campayo, Javier] Miguel Servet Univ Hosp, Zaragoza, Spain; [Montero-Marin, Jesus; Garcia-Campayo, Javier] Primary Care Prevent & Hlth Promot Res Network Re, Zaragoza, Spain	University of Zaragoza; Universidade Federal de Sao Paulo (UNIFESP); Instituto Universitario da Maia (ISMAI); Miguel Servet University Hospital	Montero-Marin, J (corresponding author), Univ Zaragoza, Fac Hlth & Sport Sci, Zaragoza, Spain.	jmontero@unizar.es	Demarzo, Marcelo/A-7021-2010; Montero-Marin, Jesus/ABG-8919-2020	Demarzo, Marcelo/0000-0002-7447-1839; Montero-Marin, Jesus/0000-0001-5677-1662; Garcia-Campayo, Javier/0000-0002-3797-4218	Research Network on Preventative Activities and Health Promotion [RD06/0018/0017]; Aragon Health Sciences Institute; Faculty of Health and Sports (University of Zaragoza); Faculty of Medicine and Dentistry (University of Santiago de Compostela)	Research Network on Preventative Activities and Health Promotion; Aragon Health Sciences Institute; Faculty of Health and Sports (University of Zaragoza); Faculty of Medicine and Dentistry (University of Santiago de Compostela)	This study was supported by the Research Network on Preventative Activities and Health Promotion (RD06/0018/0017), Aragon Health Sciences Institute, Faculty of Health and Sports (University of Zaragoza)and Faculty of Medicine and Dentistry (University of Santiago de Compostela). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Ghazaleh SB, 2011, J DENT EDUC, V75, P1107; Ahola K, 2006, J OCCUP ENVIRON MED, V48, P1023, DOI 10.1097/01.jom.0000237437.84513.92; Alzahem AM, 2011, EUR J DENT EDUC, V15, P8, DOI 10.1111/j.1600-0579.2010.00640.x; Araya R, 2013, BMC PSYCHIATRY, V13, DOI 10.1186/1471-244X-13-122; Barreto Ramon P, 1998, Aten Primaria, V22, P491; Bentler PM, 1977, PSYCHOMETRIKA, V59, P567, DOI DOI 10.1007/BF02294054; BOLLEN KA, 1986, PSYCHOMETRIKA, V51, P375, DOI 10.1007/BF02294061; Briggs NE, 2003, MULTIVAR BEHAV RES, V38, P25, DOI 10.1207/S15327906MBR3801_2; BUJA A, 1992, MULTIVAR BEHAV RES, V27, P509, DOI 10.1207/s15327906mbr2704_2; Byrne B. M., 2001, STRUCTURAL EQUATION; Campbell-Sills L, 2007, J TRAUMA STRESS, V20, P1019, DOI 10.1002/jts.20271; Campos Juliana Alvares Duarte Bonini, 2012, Rev. bras. epidemiol., V15, P155, DOI 10.1590/S1415-790X2012000100014; Carvalho VAMD, 2006, PSICOTHEMA, V18, P791; Dahlin M, 2011, BMC MED EDUC, V11, DOI 10.1186/1472-6920-11-92; de Oliveira GS, 2013, ANESTH ANALG, V117, P182, DOI 10.1213/ANE.0b013e3182917da9; Dragano N, 2008, SOC PSYCH PSYCH EPID, V43, P72, DOI 10.1007/s00127-007-0267-z; Dunn LB, 2008, ACAD PSYCHIATR, V32, P44, DOI 10.1176/appi.ap.32.1.44; Dyrbye LN, 2006, ACAD MED, V81, P354, DOI 10.1097/00001888-200604000-00009; Everly George S Jr, 2008, Int J Emerg Ment Health, V10, P185; Fertleman C, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f5266; Fliege H, 2005, PSYCHOSOM MED, V67, P78, DOI 10.1097/01.psy.0000151491.80178.78; Gil-Monte PR, 2007, BURNOUT SYNDROME PRO; GOLDBERG D, 1988, BRIT MED J, V297, P897, DOI 10.1136/bmj.297.6653.897; Gorter RC, 2007, INT DENT J, V57, P279; Grafton E, 2010, ONCOL NURS FORUM, V37, P698, DOI 10.1188/10.ONF.698-705; Graham JM, 2006, EDUC PSYCHOL MEAS, V66, P930, DOI 10.1177/0013164406288165; Hayton JC, 2004, ORGAN RES METHODS, V7, P191, DOI 10.1177/1094428104263675; HORN JL, 1965, PSYCHOMETRIKA, V30, P179, DOI 10.1007/BF02289447; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; Humphris G, 1998, Dent Update, V25, P392; Ferrando PJ, 2010, PAPEL PSICOL, V31, P18; Joreskog KG., 1977, MATH METHODS DIGITAL, P125; King G, 2003, INT STUDIES PERSPECT, V4, P100, DOI DOI 10.1111/1528-3577.04105; KNOL DL, 1991, MULTIVAR BEHAV RES, V26, P457, DOI 10.1207/s15327906mbr2603_5; Larrabee JH, 2010, WESTERN J NURS RES, V32, P81, DOI 10.1177/0193945909343293; Lazarus R.S., 1984, STRESS APPRAISAL COP; Ledasma R.D., 2007, PRACTICAL ASSESSMENT, V12, DOI [10.7275/wjnc-nm63, DOI 10.7275/WJNC-NM63]; Lee CT, 2012, MULTIVAR BEHAV RES, V47, P314, DOI 10.1080/00273171.2012.658340; Levenstein S, 2000, AM J GASTROENTEROL, V95, P1213, DOI 10.1111/j.1572-0241.2000.02012.x; LEVENSTEIN S, 1993, J PSYCHOSOM RES, V37, P19, DOI 10.1016/0022-3999(93)90120-5; Levy J, 2006, MODELIZACION CON EST, P21; Lorenzo-Seva U, 2003, PSYCHOMETRIKA, V68, P49, DOI 10.1007/BF02296652; MARDIA KV, 1974, SANKHYA SER B, V36, P115; Martinez Bernardos R, 1999, Aten Primaria, V23, P285; Maslach C, 2001, ANNU REV PSYCHOL, V52, P397, DOI 10.1146/annurev.psych.52.1.397; Maslach C., 1996, MASLACH BURNOUT INVE; Mathias S, 2005, J AM DENT ASSOC, V136, P1388, DOI 10.14219/jada.archive.2005.0052; Mazurkiewicz R, 2012, PSYCHOL HEALTH MED, V17, P188, DOI 10.1080/13548506.2011.597770; Mealer M, 2012, INT J NURS STUD, V49, P292, DOI 10.1016/j.ijnurstu.2011.09.015; Monton C, 1993, Aten Primaria, V12, P345; Muniz J., 2005, ANALISIS ITEMS; MURAKI E, 1990, APPL PSYCH MEAS, V14, P59, DOI 10.1177/014662169001400106; MUTHEN B, 1992, BRIT J MATH STAT PSY, V45, P19, DOI 10.1111/j.2044-8317.1992.tb00975.x; Norris FH, 2008, AM J COMMUN PSYCHOL, V41, P127, DOI 10.1007/s10464-007-9156-6; Notario-Pacheco B, 2011, HEALTH QUAL LIFE OUT, V9, DOI 10.1186/1477-7525-9-63; Park SG, 2009, INT ARCH OCC ENV HEA, V82, P397, DOI 10.1007/s00420-008-0347-8; PARRY CDH, 1991, APPL PSYCH MEAS, V15, P35, DOI 10.1177/014662169101500105; Pines EW, 2012, J ADV NURS, V68, P1482, DOI 10.1111/j.1365-2648.2011.05875.x; Pohlmann K, 2005, Eur J Dent Educ, V9, P78, DOI 10.1111/j.1600-0579.2004.00359.x; Rada RE, 2004, J AM DENT ASSOC, V135, P788, DOI 10.14219/jada.archive.2004.0279; Rajab L D, 2001, J Dent Educ, V65, P232; Raykov T, 1997, APPL PSYCH MEAS, V21, P173, DOI 10.1177/01466216970212006; RECKASE MD, 1985, APPL PSYCH MEAS, V9, P401, DOI 10.1177/014662168500900409; Reise SP, 2010, J PERS ASSESS, V92, P544, DOI 10.1080/00223891.2010.496477; Rodr?guez G., 2000, ANALISIS FACTORIAL; Russett B, 2003, INT STUDIES PERSPECT, V4, P88; RUTTER M, 1985, BRIT J PSYCHIAT, V147, P598, DOI 10.1192/bjp.147.6.598; Sanz-Carrillo C, 2002, J PSYCHOSOM RES, V52, P167, DOI 10.1016/S0022-3999(01)00275-6; Schaufeli W., 1998, BURNOUT COMPANION ST; Schaufeli WB, 2002, J CROSS CULT PSYCHOL, V33, P464, DOI 10.1177/0022022102033005003; Schaufeli WB, 2004, J ORGAN BEHAV, V25, P293, DOI 10.1002/job.248; SCHMID J, 1957, PSYCHOMETRIKA, V22, P53, DOI 10.1007/BF02289209; Shah M, 2010, BMC MED EDUC, V10, DOI 10.1186/1472-6920-10-2; Timmerman ME, 2011, PSYCHOL METHODS, V16, P209, DOI 10.1037/a0023353; Tisdelle D A, 1984, J Dent Educ, V48, P196; Toker S, 2005, J OCCUP HEALTH PSYCH, V10, P344, DOI 10.1037/1076-8998.10.4.344; Tsukamoto K, 1995, Sangyo Eiseigaku Zasshi, V37, P329; Watson R, 2008, INT J NURS STUD, V45, P1534, DOI 10.1016/j.ijnurstu.2007.11.003; Zhong J, 2009, PSYCHOL REP, V105, P1248, DOI 10.2466/PR0.105.F.1248-1254	79	37	43	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2014	9	1							e87071	10.1371/journal.pone.0087071	http://dx.doi.org/10.1371/journal.pone.0087071			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	297XI	24466330	Green Published, Green Submitted, gold			2022-12-25	WOS:000330288000191
J	Nakamura, S; Ochiai, K; Ochi, A; Yabushita, H; Abe, A; Kishi, S; Sunden, Y; Umemura, T				Nakamura, Sayuri; Ochiai, Kenji; Ochi, Akihiro; Yabushita, Hiroki; Abe, Asumi; Kishi, Sayaka; Sunden, Yuji; Umemura, Takashi			Cardiac Pathology and Molecular Epidemiology by Avian Leukosis Viruses in Japan	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; GLIOMA-INDUCING VIRUS; FOWL GLIOMA; LYMPHOID LEUKOSIS; LAYER CHICKENS; INFECTION; HEART; MYOCARDITIS; RETROVIRUS; TUMORS	Epidemiological studies suggest that retroviruses, including human immunodeficiency virus type 1, are associated with cardiomyopathy and myocarditis, but a causal relationship remains to be established. We encountered unusual cardiomyocyte hypertrophy and mitosis in Japanese native fowls infected with subgroup A of the avian leukosis viruses (ALVs-A), which belong to the genus Alpharetrovirus of the family Retroviridae and mainly induce lymphoid neoplasm in chickens. The affected hearts were evaluated by histopathology and immunohistochemistry, viral isolation, viral genome sequencing and experimental infection. There was non-suppurative myocarditis in eighteen fowls and seven of them had abnormal cardiomyocytes, which were distributed predominantly in the left ventricular wall and showed hypertrophic cytoplasm and atypical large nuclei. Nuclear chains and mitosis were frequently noted in these cardiomyocytes and immunohistochemistry for proliferating cell nuclear antigen supported the enhancement of mitotic activity. ALVs were isolated from all affected cases and phylogenic analysis of envSU genes showed that the isolates were mainly classified into two different clusters, suggesting viral genome diversity. In ovo experimental infection with two of the isolates was demonstrated to cause myocarditis and cardiomyocyte hypertrophy similar to those in the naturally occurring lesions and cardiac hamartoma (rhabdomyoma) in a shorter period of time (at 70 days of age) than expected. These results indicate that ALVs cause myocarditis as well as cardiomyocyte abnormality in chickens, implying a pathogenetic mechanism different from insertional mutagenesis and the existence of retrovirus-induced heart disorder.	[Nakamura, Sayuri; Ochiai, Kenji; Kishi, Sayaka; Sunden, Yuji; Umemura, Takashi] Hokkaido Univ, Lab Comparat Pathol, Grad Sch Vet Med, Sapporo, Hokkaido, Japan; [Ochi, Akihiro] Japan Racing Assoc, Miho Training Ctr, Utsunomiya, Tochigi, Japan; [Yabushita, Hiroki] Okayama Univ, Sch Med, Okayama 700, Japan; [Abe, Asumi] Kenpoku Meat Hyg Inspect Inst, Ohtawara, Tochigi, Japan	Hokkaido University; Okayama University	Ochiai, K (corresponding author), Hokkaido Univ, Lab Comparat Pathol, Grad Sch Vet Med, Sapporo, Hokkaido, Japan.	k-ochiai@vetmed.hokudai.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan [B22380162, 23658249]; Japan Society for the Promotion of Science for Young Scientists [2172]	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science for Young Scientists(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This research was supported in part by Grants-in-Aid for Scientific Research (B22380162) and Grants-in-Aid for Challenging Exploratory Research (23658249) from the Ministry of Education, Culture, Sports, Science and Technology of Japan, and Research Fellowships of the Japan Society for the Promotion of Science for Young Scientists (2172). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beard J. W., 1980, Viral oncology, P55; Benyounes N, 2012, ARCH CARDIOVASC DIS, V105, P442, DOI 10.1016/j.acvd.2012.01.009; Bowles NE, 1996, HUM GENE THER, V7, P1735, DOI 10.1089/hum.1996.7.14-1735; Brellou GD, 2007, J COMP PATHOL, V136, P27, DOI 10.1016/j.jcpa.2006.10.001; DECASTRO S, 1994, J AM COLL CARDIOL, V24, P1018, DOI 10.1016/0735-1097(94)90864-8; Dorn GW, 2005, J CLIN INVEST, V115, P527, DOI 10.1172/JCI200524178; GILKA F, 1991, AVIAN PATHOL, V20, P637, DOI 10.1080/03079459108418803; GILKA F, 1990, AVIAN DIS, V34, P174, DOI 10.2307/1591349; GILKA F, 1985, AM J VET RES, V46, P1953; GrantMaxie M, 2007, JUBB KENNEDY PALMERS, P1; GRODY WW, 1990, AM J CARDIOL, V66, P203, DOI 10.1016/0002-9149(90)90589-S; Hatai H, 2008, AVIAN PATHOL, V37, P127, DOI 10.1080/03079450801898815; HEIDRICH JE, 1987, VET IMMUNOL IMMUNOP, V15, P267, DOI 10.1016/0165-2427(87)90088-2; Hull S, 2012, VIRUS GENES, V45, P508, DOI 10.1007/s11262-012-0793-y; Iwata N, 2002, J VET MED SCI, V64, P395, DOI 10.1292/jvms.64.395; JACOB AJ, 1992, BRIT HEART J, V68, P549, DOI 10.1136/hrt.68.12.549; Lewis W, 2005, LAB INVEST, V85, P182, DOI 10.1038/labinvest.3700222; Maeda N, 2008, REV MED VIROL, V18, P387, DOI 10.1002/rmv.592; MILLER L. M., 2012, PATHOLOGIC BASIS VET, P539; Motitschke A, 2010, BIOLOGICALS, V38, P389, DOI 10.1016/j.biologicals.2010.01.002; NAKAMURA K, 1988, AVIAN PATHOL, V17, P3, DOI 10.1080/03079458808436423; Nakamura K, 2007, AVIAN PATHOL, V36, P53, DOI 10.1080/03079450601110007; Nakamura S, 2011, AVIAN PATHOL, V40, P499, DOI 10.1080/03079457.2011.605783; Ochi A, 2012, AVIAN PATHOL, V41, P299, DOI 10.1080/03079457.2012.684373; Ono M, 2004, AVIAN DIS, V48, P940, DOI 10.1637/7162-020204R; Rebolledo MA, 1998, CIRC RES, V83, P738, DOI 10.1161/01.RES.83.7.738; ROLDAN EO, 1987, ARCH PATHOL LAB MED, V111, P943; SAULE S, 1987, P NATL ACAD SCI USA, V84, P7982, DOI 10.1073/pnas.84.22.7982; Schoen FJ, 2004, ROBBINS COTRAN PATHO, P529; Shannon RP, 2000, CIRCULATION, V101, P185, DOI 10.1161/01.CIR.101.2.185; Shivaprasad HL, 2009, AVIAN DIS, V53, P523, DOI 10.1637/8916-050309-Reg.1; Stedman NL, 2002, VET PATHOL, V39, P161, DOI 10.1354/vp.39-1-161; TANIMOTO T, 1995, VIRCHOWS ARCH, V427, P213; Tomioka Y, 2004, J GEN VIROL, V85, P647, DOI 10.1099/vir.0.79778-0; Tomioka Y, 2003, AVIAN PATHOL, V32, P617, DOI 10.1080/03079450310001610640; TSUKAMOTO K, 1991, J VET MED SCI, V53, P399, DOI 10.1292/jvms.53.399; Zavala G, 2003, VIROLOGY, V312, P95, DOI 10.1016/S0042-6822(03)00205-8	37	5	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2014	9	1							e86546	10.1371/journal.pone.0086546	http://dx.doi.org/10.1371/journal.pone.0086546			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297XI	24466146	gold, Green Published, Green Submitted			2022-12-25	WOS:000330288000111
J	Yuan, F; Snapp, EL; Novikoff, PM; Suadicani, SO; Spray, DC; Potvin, B; Wolkoff, AW; Stanley, P				Yuan, Fei; Snapp, Erik L.; Novikoff, Phyllis M.; Suadicani, Sylvia O.; Spray, David C.; Potvin, Barry; Wolkoff, Allan W.; Stanley, Pamela			Human Liver Cell Trafficking Mutants: Characterization and Whole Exome Sequencing	PLOS ONE			English	Article							TO-GOLGI TRANSPORT; RAB GTPASES; PROTEIN; MECHANISMS; MUTATION; GENOME	The HuH7 liver cell mutant Trf1 is defective in membrane trafficking and is complemented by the casein kinase 2 alpha subunit CK2 alpha ''. Here we identify characteristic morphologies, trafficking and mutational changes in six additional HuH7 mutants Trf2-Trf7. Trf1 cells were previously shown to be severely defective in gap junction functions. Using a Lucifer yellow transfer assay, remarkable attenuation of gap junction communication was revealed in each of the mutants Trf2-Trf7. Electron microscopy and light microscopy of thiamine pyrophosphatase showed that several mutants exhibited fragmented Golgi apparatus cisternae compared to parental HuH7 cells. Intracellular trafficking was investigated using assays of transferrin endocytosis and recycling and VSV G secretion. Surface binding of transferrin was reduced in all six Trf2-Trf7 mutants, which generally correlated with the degree of reduced expression of the transferrin receptor at the cell surface. The mutants displayed the same transferrin influx rates as HuH7, and for efflux rate, only Trf6 differed, having a slower transferrin efflux rate than HuH7. The kinetics of VSV G transport along the exocytic pathway were altered in Trf2 and Trf5 mutants. Genetic changes unique to particular Trf mutants were identified by exome sequencing, and one was investigated in depth. The novel mutation Ile34Phe in the GTPase RAB22A was identified in Trf4. RNA interference knockdown of RAB22A or overexpression of RAB22AI34F in HuH7 cells caused phenotypic changes characteristic of the Trf4 mutant. In addition, the Ile34Phe mutation reduced both guanine nucleotide binding and hydrolysis activities of RAB22A. Thus, the RAB22A Ile34Phe mutation appears to contribute to the Trf4 mutant phenotype.	[Yuan, Fei; Snapp, Erik L.; Novikoff, Phyllis M.; Spray, David C.; Potvin, Barry; Wolkoff, Allan W.; Stanley, Pamela] Albert Einstein Coll Med, Marion Bessin Liver Res Ctr, New York, NY 10019 USA; [Yuan, Fei; Potvin, Barry; Stanley, Pamela] Albert Einstein Coll Med, Dept Cell Biol, New York, NY USA; [Snapp, Erik L.; Wolkoff, Allan W.] Albert Einstein Coll Med, Dept Anat & Struct Biol, New York, NY USA; [Novikoff, Phyllis M.] Albert Einstein Coll Med, Dept Pathol, New York, NY USA; [Suadicani, Sylvia O.; Spray, David C.] Albert Einstein Coll Med, Dept Neurosci, New York, NY USA; [Spray, David C.; Wolkoff, Allan W.] Albert Einstein Coll Med, Dept Med, New York, NY USA; [Suadicani, Sylvia O.] Albert Einstein Coll Med, Dept Urol, New York, NY USA	Yeshiva University; Yeshiva University; Yeshiva University; Yeshiva University; Yeshiva University; Yeshiva University; Yeshiva University	Stanley, P (corresponding author), Albert Einstein Coll Med, Marion Bessin Liver Res Ctr, New York, NY 10019 USA.	pamela.stanley@einstein.yu.edu	Snapp, Erik Lee/H-7152-2019	Snapp, Erik Lee/0000-0001-9482-2272; Spray, David/0000-0001-8368-5073	NIH; NIDDK; Liver Center [DK041296]; PPG [DK041918, RO1 DK023026]; NATIONAL CANCER INSTITUTE [P30CA013330] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK041296, R01DK023026, R01DK098408, P01DK041918] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Liver Center; PPG; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by grants from the NIH funded by NIDDK (http://www2.niddk.nih.gov/) including Liver Center grant DK041296, PPG DK041918 and RO1 DK023026. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Cingolani P, 2012, FLY, V6, P80, DOI 10.4161/fly.19695; Doherty GJ, 2009, ANNU REV BIOCHEM, V78, P857, DOI 10.1146/annurev.biochem.78.081307.110540; Eathiraj S, 2005, NATURE, V436, P415, DOI 10.1038/nature03798; Erlich Y, 2011, GENOME RES, V21, P658, DOI 10.1101/gr.117143.110; Grant BD, 2009, NAT REV MOL CELL BIO, V10, P597, DOI 10.1038/nrm2755; Gromov PS, 1998, CELL BIOLOGY - A LABOARATORY HANDBOOK, 2ND EDITION, VOL 4, P454; Hilgard P, 2004, AM J PHYSIOL-GASTR L, V287, pG192, DOI 10.1152/ajpgi.00507.2003; Huang TM, 2002, J BIOL CHEM, V277, P37798, DOI 10.1074/jbc.M204786200; Hutagalung AH, 2011, PHYSIOL REV, V91, P119, DOI 10.1152/physrev.00059.2009; Kauppi M, 2002, J CELL SCI, V115, P899; Lamb CA, 2013, BIOESSAYS, V35, P34, DOI 10.1002/bies.201200130; LEFRANCOIS L, 1982, VIROLOGY, V121, P157, DOI 10.1016/0042-6822(82)90125-8; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; LO CW, 1979, CELL, V18, P399, DOI 10.1016/0092-8674(79)90059-X; MacGurn JA, 2012, ANNU REV BIOCHEM, V81, P231, DOI 10.1146/annurev-biochem-060210-093619; Magadan JG, 2006, MOL CELL BIOL, V26, P2595, DOI 10.1128/MCB.26.7.2595-2614.2006; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Mesa R, 2001, J CELL SCI, V114, P4041; Mizuno-Yamasaki E, 2012, ANNU REV BIOCHEM, V81, P637, DOI 10.1146/annurev-biochem-052810-093700; Ng PC, 2003, NUCLEIC ACIDS RES, V31, P3812, DOI 10.1093/nar/gkg509; Ng SB, 2010, NAT GENET, V42, P30, DOI 10.1038/ng.499; NOVIKOFF AB, 1977, HISTOCHEM J, V9, P525, DOI 10.1007/BF01002901; Pedelacq JD, 2006, NAT BIOTECHNOL, V24, P79, DOI 10.1038/nbt1172; Persico A, 2009, FEBS LETT, V583, P3857, DOI 10.1016/j.febslet.2009.10.077; Pfeffer SR, 2005, J BIOL CHEM, V280, P15485, DOI 10.1074/jbc.R500003200; Presley JF, 1997, NATURE, V389, P81, DOI 10.1038/38001; Rodriguez MA, 2000, MOL BIOCHEM PARASIT, V108, P199, DOI 10.1016/S0166-6851(00)00216-4; Roth MG, 2004, PHYSIOL REV, V84, P699, DOI 10.1152/physrev.00033.2003; Shi XY, 2001, J BIOL CHEM, V276, P2075, DOI 10.1074/jbc.M008583200; Stenmark H, 2009, NAT REV MOL CELL BIO, V10, P513, DOI 10.1038/nrm2728; Stockert RJ, 2007, BBA-BIOMEMBRANES, V1768, P1741, DOI 10.1016/j.bbamem.2007.04.004; STOCKERT RJ, 1995, J BIOL CHEM, V270, P16107, DOI 10.1074/jbc.270.27.16107; Stockert RJ, 1999, HEPATOLOGY, V30, P740, DOI 10.1002/hep.510300304; Szperl AM, 2011, CLIN GENET, V80, P138, DOI 10.1111/j.1399-0004.2011.01714.x; Thi MM, 2010, AM J PHYSIOL-CELL PH, V299, pC994, DOI 10.1152/ajpcell.00544.2009; Wang TL, 2002, MOL BIOL CELL, V13, P4317, DOI 10.1091/mbc.E02-05-0280; Watson P, 2005, BBA-MOL CELL RES, V1744, P304, DOI 10.1016/j.bbamcr.2005.03.003; Weigert R, 2004, MOL BIOL CELL, V15, P3758, DOI 10.1091/mbc.E04-04-0342; Westbroek W, 2008, MOL GENET METAB, V94, P248, DOI 10.1016/j.ymgme.2008.02.009; Yi X, 2010, SCIENCE, V329, P75, DOI 10.1126/science.1190371	41	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2014	9	1							e87043	10.1371/journal.pone.0087043	http://dx.doi.org/10.1371/journal.pone.0087043			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297XI	24466322	Green Submitted, Green Published, gold			2022-12-25	WOS:000330288000188
J	Murakami, T; Aida, Y				Murakami, Tomoyuki; Aida, Yoko			Visualizing Vpr-Induced G2 Arrest and Apoptosis	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; CELL-CYCLE ARREST; NUCLEAR IMPORT; G(2) ARREST; CASPASE-3 ACTIVATION; ACCESSORY PROTEIN; UBIQUITIN LIGASE; HIV-1; GENE; INDUCTION	Vpr is an accessory protein of human immunodeficiency virus type 1 (HIV-1) with multiple functions. The induction of G2 arrest by Vpr plays a particularly important role in efficient viral replication because the transcriptional activity of the HIV-1 long terminal repeat is most active in G2 phase. The regulation of apoptosis by Vpr is also important for immune suppression and pathogenesis during HIV infection. However, it is not known whether Vpr-induced apoptosis depends on the ability of Vpr to induce G2 arrest, and the dynamics of Vpr-induced G2 arrest and apoptosis have not been visualized. We performed time-lapse imaging to examine the temporal relationship between Vpr-induced G2 arrest and apoptosis using HeLa cells containing the fluorescent ubiquitination-based cell cycle indicator2 (Fucci2). The dynamics of G2 arrest and subsequent long-term mitotic cell rounding in cells transfected with the Vpr-expression vector were visualized. These cells underwent nuclear mis-segregation after prolonged mitotic processes and then entered G1 phase. Some cells subsequently displayed evidence of apoptosis after prolonged mitotic processes and nuclear mis-segregation. Interestingly, Vpr-induced apoptosis was seldom observed in S or G2 phase. Likewise, visualization of synchronized HeLa/Fucci2 cells infected with an adenoviral vector expressing Vpr clearly showed that Vpr arrests the cell cycle at G2 phase, but does not induce apoptosis at S or G2 phase. Furthermore, time-lapse imaging of HeLa/Fucci2 cells expressing SCAT3.1, a caspase-3-sensitive fusion protein, clearly demonstrated that Vpr induces caspase-3-dependent apoptosis. Finally, to examine whether the effects of Vpr on G2 arrest and apoptosis were reversible, we performed live-cell imaging of a destabilizing domain fusion Vpr, which enabled rapid stabilization and destabilization by Shield1. The effects of Vpr on G2 arrest and subsequent apoptosis were reversible. This study is the first to characterize the dynamics of the morphological changes that occur during Vpr-induced G2 arrest and apoptosis.	[Murakami, Tomoyuki; Aida, Yoko] RIKEN, Viral Infect Dis Unit, Wako, Saitama, Japan; [Murakami, Tomoyuki; Aida, Yoko] Univ Tokyo, Lab Viral Infect Dis, Dept Med Genome Sci, Grad Sch Frontier Sci, Wako, Saitama, Japan	RIKEN; University of Tokyo	Aida, Y (corresponding author), RIKEN, Viral Infect Dis Unit, Wako, Saitama, Japan.	aida@riken.jp			Ministry of Health, Labor and Welfare of Japan	Ministry of Health, Labor and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan)	This work was supported by a Health Sciences Research Grant from the Ministry of Health, Labor and Welfare of Japan (Research on HIV/AIDS: http://www.jhsf.or.jp/English/index_e. html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aida Y, 2009, CURR HIV RES, V7, P136, DOI 10.2174/157016209787581418; Andersen JL, 2006, PLOS PATHOG, V2, P1106, DOI 10.1371/journal.ppat.0020127; Arokium H, 2009, J VIROL, V83, P11283, DOI 10.1128/JVI.00756-09; Ayyavoo V, 1997, NAT MED, V3, P1117, DOI 10.1038/nm1097-1117; Azuma A, 2006, MICROBES INFECT, V8, P670, DOI 10.1016/j.micinf.2005.09.002; Banaszynski LA, 2006, CELL, V126, P995, DOI 10.1016/j.cell.2006.07.025; Belzile JP, 2007, PLOS PATHOG, V3, P882, DOI 10.1371/journal.ppat.0030085; Belzile JP, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001080; Castedo M, 2004, ONCOGENE, V23, P4362, DOI 10.1038/sj.onc.1207572; de Noronha CMC, 2001, SCIENCE, V294, P1105, DOI 10.1126/science.1063957; DeHart JL, 2007, VIROL J, V4, DOI 10.1186/1743-422X-4-57; DIMARZIO P, 1995, J VIROL, V69, P7909, DOI 10.1128/JVI.69.12.7909-7916.1995; Felzien LK, 1998, P NATL ACAD SCI USA, V95, P5281, DOI 10.1073/pnas.95.9.5281; Goh WC, 1998, NAT MED, V4, P65, DOI 10.1038/nm0198-065; GOTTLIEB MS, 1981, NEW ENGL J MED, V305, P1425, DOI 10.1056/NEJM198112103052401; Hashizume C, 2007, MICROBES INFECT, V9, P490, DOI 10.1016/j.micinf.2007.01.013; Hrecka K, 2007, P NATL ACAD SCI USA, V104, P11778, DOI 10.1073/pnas.0702102104; Huang CY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033657; Jacotot E, 2000, J EXP MED, V191, P33, DOI 10.1084/jem.191.1.33; JOWETT JBM, 1995, J VIROL, V69, P6304, DOI 10.1128/JVI.69.10.6304-6313.1995; Kamata M, 2005, J VIROL, V79, P3557, DOI 10.1128/JVI.79.6.3557-3564.2005; Kino T, 2002, J VIROL, V76, P9724, DOI 10.1128/JVI.76.19.9724-9734.2002; Klockow LC, 2013, VIROLOGY, V444, P191, DOI 10.1016/j.virol.2013.06.010; Kuramitsu M, 2005, MICROBES INFECT, V7, P1150, DOI 10.1016/j.micinf.2005.03.022; Le Rouzic E, 2007, CELL CYCLE, V6, P182, DOI 10.4161/cc.6.2.3732; Lum JJ, 2003, J CLIN INVEST, V111, P1547, DOI 10.1172/JCI200316233; Luo KQ, 2001, BIOCHEM BIOPH RES CO, V283, P1054, DOI 10.1006/bbrc.2001.4896; Majumder B, 2009, CURR HIV RES, V7, P169, DOI 10.2174/157016209787581445; Maudet C, 2011, J BIOL CHEM, V286, P23742, DOI 10.1074/jbc.M111.220780; Nagai T, 2004, BIOCHEM BIOPH RES CO, V319, P72, DOI 10.1016/j.bbrc.2004.04.147; Nishino Y, 1997, BIOCHEM BIOPH RES CO, V232, P550, DOI 10.1006/bbrc.1997.6186; Nishizawa M, 2000, VIROLOGY, V276, P16, DOI 10.1006/viro.2000.0534; Nishizawa M, 2000, J VIROL, V74, P6058, DOI 10.1128/JVI.74.13.6058-6067.2000; Nitahara-Kasahara Y, 2007, J VIROL, V81, P5284, DOI 10.1128/JVI.01928-06; Planelles V, 1996, J VIROL, V70, P2516, DOI 10.1128/JVI.70.4.2516-2524.1996; Popov S, 1998, EMBO J, V17, P909, DOI 10.1093/emboj/17.4.909; ROGEL ME, 1995, J VIROL, V69, P882, DOI 10.1128/JVI.69.2.882-888.1995; Sakai K, 2006, P NATL ACAD SCI USA, V103, P3369, DOI 10.1073/pnas.0509417103; Sakaue-Sawano A, 2008, CELL, V132, P487, DOI 10.1016/j.cell.2007.12.033; Sakaue-Sawano A, 2011, BMC CELL BIOL, V12, DOI 10.1186/1471-2121-12-2; Schrofelbauer B, 2007, P NATL ACAD SCI USA, V104, P4130, DOI 10.1073/pnas.0610167104; Shimura M, 1999, FASEB J, V13, P621, DOI 10.1096/fasebj.13.6.621; Shimura M, 2011, J CELL BIOL, V194, P721, DOI 10.1083/jcb.201010118; Somasundaran M, 2002, P NATL ACAD SCI USA, V99, P9503, DOI 10.1073/pnas.142313699; Stivahtis GL, 1997, J VIROL, V71, P4331, DOI 10.1128/JVI.71.6.4331-4338.1997; Thieu KP, 2009, CURR HIV RES, V7, P153, DOI 10.2174/157016209787581454; Tyas L, 2000, EMBO REP, V1, P266, DOI 10.1093/embo-reports/kvd050; Vieira HLA, 2000, CELL DEATH DIFFER, V7, P1146, DOI 10.1038/sj.cdd.4400778; Wang JF, 2011, BLOOD, V117, P1260, DOI 10.1182/blood-2010-06-289215; Watanabe N, 2000, EXP CELL RES, V258, P261, DOI 10.1006/excr.2000.4908; Wen XY, 2007, J BIOL CHEM, V282, P27046, DOI 10.1074/jbc.M703955200; Yasuda J, 2001, VIROLOGY, V285, P181, DOI 10.1006/viro.2001.0964; Zhang XF, 2009, CURR HIV RES, V7, P163; Zhu YH, 2001, J VIROL, V75, P3791, DOI 10.1128/JVI.75.8.3791-3801.2001; Zimmerman ES, 2006, J VIROL, V80, P10407, DOI 10.1128/JVI.01212-06; Zimmerman ES, 2004, MOL CELL BIOL, V24, P9286, DOI 10.1128/MCB.24.21.9286-9294.2004	56	16	16	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2014	9	1							e86840	10.1371/journal.pone.0086840	http://dx.doi.org/10.1371/journal.pone.0086840			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297VL	24466265	Green Submitted, Green Published, gold			2022-12-25	WOS:000330283100223
J	Ratnayake, M; Ploger, F; Santibanez-Koref, M; Loughlin, J				Ratnayake, Madhushika; Ploeger, Frank; Santibanez-Koref, Mauro; Loughlin, John			Human Chondrocytes Respond Discordantly to the Protein Encoded by the Osteoarthritis Susceptibility Gene GDF5	PLOS ONE			English	Article							HUMAN ARTICULAR CHONDROCYTES; GROWTH-DIFFERENTIATION FACTOR-5; MORPHOGENETIC PROTEIN-1; SPEMANN ORGANIZER; CARTILAGE; EXPRESSION; DEFICIENCY; RECEPTORS; 5'-UTR; NOGGIN	A genetic deficit mediated by SNP rs143383 that leads to reduced expression of GDF5 is strongly associated with large-joint osteoarthritis. We speculated that this deficit could be attenuated by the application of exogenous GDF5 protein and as a first step we have assessed what effect such application has on primary osteoarthritis chondrocyte gene expression. Chondrocytes harvested from cartilage of osteoarthritic patients who had undergone joint replacement were cultured with wildtype recombinant mouse and human GDF5 protein. We also studied variants of GDF5, one that has a higher affinity for the receptor BMPR-IA and one that is insensitive to the GDF5 antagonist noggin. As a positive control, chondrocytes were treated with TGF-beta 1. Chondrocytes were cultured in monolayer and micromass and the expression of genes coding for catabolic and anabolic proteins of cartilage were measured by quantitative PCR. The expression of the GDF5 receptor genes and the presence of their protein products was confirmed and the ability of GDF5 signal to translocate to the nucleus was demonstrated by the activation of a luciferase reporter construct. The capacity of GDF5 to elicit an intracellular signal in chondrocytes was demonstrated by the phosphorylation of intracellular Smads. Chondrocytes cultured with TGF-beta 1 demonstrated a consistent down regulation of MMP1, MMP13 and a consistent upregulation of TIMP1 and COL2A1 with both culture techniques. In contrast, chondrocytes cultured with wildtype GDF5, or its variants, did not show any consistent response, irrespective of the culture technique used. Our results show that osteoarthritis chondrocytes do not respond in a predictable manner to culture with exogenous GDF5. This may be a cause or a consequence of the osteoarthritis disease process and will need to be surmounted if treatment with exogenous GDF5 is to be advanced as a potential means to overcome the genetic deficit conferring osteoarthritis susceptibility at this gene.	[Ratnayake, Madhushika; Loughlin, John] Newcastle Univ, Musculoskeletal Res Grp, Inst Cellular Med, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Ploeger, Frank] Biopharm GmbH, Heidelberg, Germany; [Santibanez-Koref, Mauro] Newcastle Univ, Inst Med Genet, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England	Newcastle University - UK; Newcastle University - UK	Ratnayake, M (corresponding author), Newcastle Univ, Musculoskeletal Res Grp, Inst Cellular Med, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.	madhushika.ratnayake@ncl.ac.uk		Loughlin, John/0000-0003-2018-3361	NIHR Newcastle Biomedical Research Centre; European Union [305815]; Arthritis Research UK; Medical Research Council [MR/K006312/1] Funding Source: researchfish; MRC [MR/K006312/1] Funding Source: UKRI	NIHR Newcastle Biomedical Research Centre; European Union(European Commission); Arthritis Research UK(Versus Arthritis); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This Research was funded by the NIHR Newcastle Biomedical Research Centre, by the European Union Seventh Framework Programme (FP7/2007-2013) under grant agreement number 305815 (D-BOARD), and by Arthritis Research UK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bauge C, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3247; Bobacz K, 2002, OSTEOARTHR CARTILAGE, V10, P394, DOI 10.1053/joca.2002.0522; Bobinac D, 2008, COLLEGIUM ANTROPOL, V32, P83; Cawston TE, 1998, ARTHRITIS RHEUM-US, V41, P1760, DOI 10.1002/1529-0131(199810)41:10<1760::AID-ART8>3.0.CO;2-M; Chapman K, 2008, HUM MOL GENET, V17, P1497, DOI 10.1093/hmg/ddn038; Chubinskaya S, 2008, GROWTH FACTORS, V26, P275, DOI 10.1080/08977190802291733; Chujo T, 2006, SPINE, V31, P2909, DOI 10.1097/01.brs.0000248428.22823.86; Coleman CM, 2013, STEM CELLS DEV, V22, P1968, DOI 10.1089/scd.2012.0282; Daans M, 2011, ANN RHEUM DIS, V70, P208, DOI 10.1136/ard.2010.134619; Erlacher L, 1998, J BONE MINER RES, V13, P383, DOI 10.1359/jbmr.1998.13.3.383; Forslund C, 2003, J ORTHOPAED RES, V21, P617, DOI 10.1016/S0736-0266(03)00010-X; GUERNE PA, 1995, ARTHRITIS RHEUM-US, V38, P960, DOI 10.1002/art.1780380712; Kasten P, 2010, BIOMATERIALS, V31, P3878, DOI 10.1016/j.biomaterials.2010.01.109; Kleinschmidt K, 2013, BIOMATERIALS, V34, P5926, DOI 10.1016/j.biomaterials.2013.04.029; Liang HX, 2010, SPINE J, V10, P32, DOI 10.1016/j.spinee.2009.10.006; Loeser RF, 2000, ARTHRITIS RHEUM, V43, P2110, DOI 10.1002/1529-0131(200009)43:9<2110::AID-ANR23>3.0.CO;2-U; Luyten FP, 1997, INT J BIOCHEM CELL B, V29, P1241, DOI 10.1016/S1357-2725(97)00025-3; Massague J, 1998, ANNU REV BIOCHEM, V67, P753, DOI 10.1146/annurev.biochem.67.1.753; Mikic B, 2004, ANN BIOMED ENG, V32, P466, DOI 10.1023/B:ABME.0000017549.57126.51; Mitchell EA, 2010, BMC BIOL, V10, P57; Miyamoto Y, 2007, NAT GENET, V39, P529, DOI 10.1038/2005; Nishitoh H, 1996, J BIOL CHEM, V271, P21345, DOI 10.1074/jbc.271.35.21345; Polinkovsky A, 1997, NAT GENET, V17, P18, DOI 10.1038/ng0997-18; Reynard LN, 2013, EXPERT REV MOL MED, V15, DOI 10.1017/erm.2013.4; Rickert M, 2005, CONNECT TISSUE RES, V46, P175, DOI 10.1080/03008200500237120; Seemann P, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000747; SMITH WC, 1992, CELL, V70, P829, DOI 10.1016/0092-8674(92)90316-5; Southam L, 2007, HUM MOL GENET, V16, P2226, DOI 10.1093/hmg/ddm174; Vincenti MP, 2001, ARTHRITIS RES, V3, P381, DOI 10.1186/ar331; Walsh AJL, 2004, SPINE, V29, P156, DOI 10.1097/01.BRS.0000107231.67854.9F; Zhang YJ, 2011, PM&R, V3, pS88, DOI 10.1016/j.pmrj.2011.04.020; Zimmerman LB, 1996, CELL, V86, P599, DOI 10.1016/S0092-8674(00)80133-6	32	16	16	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2014	9	1							e86590	10.1371/journal.pone.0086590	http://dx.doi.org/10.1371/journal.pone.0086590			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297GT	24466161	Green Published, Green Submitted, gold			2022-12-25	WOS:000330244500261
J	Regus-Leidig, H; Atorf, J; Feigenspan, A; Kremers, J; Maw, MA; Brandstatter, JH				Regus-Leidig, Hanna; Atorf, Jenny; Feigenspan, Andreas; Kremers, Jan; Maw, Marion A.; Brandstaetter, Johann Helmut			Photoreceptor Degeneration in Two Mouse Models for Congenital Stationary Night Blindness Type 2	PLOS ONE			English	Article							LINKED RETINAL DISORDER; SYNAPTIC-TRANSMISSION; CALCIUM-CHANNELS; CACNA1F MUTATION; RIBBON SYNAPSE; GENE; ROD; LOCALIZATION; CELLS; PLASTICITY	Light-dependent conductance changes of voltage-gated Ca(v)1.4 channels regulate neurotransmitter release at photoreceptor ribbon synapses. Mutations in the human CACNA1F gene encoding the alpha 1F subunit of Cav1.4 channels cause an incomplete form of X-linked congenital stationary night blindness (CSNB2). Many CACNA1F mutations are loss-of-function mutations resulting in non-functional Cav1.4 channels, but some mutations alter the channels' gating properties and, presumably, disturb Ca2+ influx at photoreceptor ribbon synapses. Notably, a CACNA1F mutation (I745T) was identified in a family with an uncommonly severe CSNB2-like phenotype, and, when expressed in a heterologous system, the mutation was shown to shift the voltage-dependence of channel activation, representing a gain-of-function. To gain insight into the pathomechanism that could explain the severity of this disorder, we generated a mouse model with the corresponding mutation in the murine Cacna1f gene (I756T) and compared it with a mouse model carrying a loss-of-function mutation (Delta Ex14-17) in a longitudinal study up to eight months of age. In Delta Ex14-17 mutants, the b-wave in the electroretinogram was absent, photoreceptor ribbon synapses were abnormal, and Ca2+ responses to depolarization of photoreceptor terminals were undetectable. In contrast, I756T mutants had a reduced scotopic b-wave, some intact rod ribbon synapses, and a strong, though abnormal, Ca2+ response to depolarization. Both mutants showed a progressive photoreceptor loss, but degeneration was more severe and significantly enhanced in the I756T mutants compared to the Delta Ex14-17 mutants.	[Regus-Leidig, Hanna; Feigenspan, Andreas; Brandstaetter, Johann Helmut] FAU Erlangen Nuremberg, Dept Biol, Erlangen, Germany; [Atorf, Jenny; Kremers, Jan] Univ Hosp Erlangen, Dept Ophthalmol, Erlangen, Germany; [Maw, Marion A.] Univ Otago, Dept Biochem, Dunedin, New Zealand	University of Erlangen Nuremberg; University of Erlangen Nuremberg; University of Otago	Maw, MA (corresponding author), Univ Otago, Dept Biochem, Dunedin, New Zealand.	marion.maw@xtra.co.nz; jbrandst@biologie.uni-erlangen.de	Kremers, Jan/X-3125-2019	Kremers, Jan/0000-0002-9293-7380; Atorf, Jenny/0000-0003-0935-1897	Retina Australia; Lottery Grants Board of New Zealand; Maurice and Phyllis Paykel Trust; Health Research Council of New Zealand; University of Otago; Deutsche Forschungsgemeinschaft [BR 1643/4-1]	Retina Australia; Lottery Grants Board of New Zealand; Maurice and Phyllis Paykel Trust; Health Research Council of New Zealand(Health Research Council of New Zealand); University of Otago; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	The study was supported by grants from Retina Australia, the Lottery Grants Board of New Zealand, the Maurice and Phyllis Paykel Trust, the Health Research Council of New Zealand, the University of Otago (MAM), and by a grant from the Deutsche Forschungsgemeinschaft (BR 1643/4-1) to JHB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bayley PR, 2007, J COMP NEUROL, V500, P286, DOI 10.1002/cne.21188; Bech-Hansen NT, 2000, NAT GENET, V26, P319, DOI 10.1038/81619; Bech-Hansen NT, 1998, NAT GENET, V19, P264, DOI 10.1038/947; Bringmann A, 2006, PROG RETIN EYE RES, V25, P397, DOI 10.1016/j.preteyeres.2006.05.003; Burns ME, 2001, ANNU REV NEUROSCI, V24, P779, DOI 10.1146/annurev.neuro.24.1.779; Carr R E, 1974, Trans Am Ophthalmol Soc, V72, P448; Chang B, 2006, VISUAL NEUROSCI, V23, P11, DOI 10.1017/S095252380623102X; Cooper B, 2012, J NEUROSCI, V32, P8040, DOI 10.1523/JNEUROSCI.4240-11.2012; Dick O, 2003, NEURON, V37, P775, DOI 10.1016/S0896-6273(03)00086-2; Dieck ST, 2005, J CELL BIOL, V168, P825, DOI 10.1083/jcb.200408157; Fain GL, 2006, BIOESSAYS, V28, P344, DOI 10.1002/bies.20382; Haeseleer F, 2004, NAT NEUROSCI, V7, P1079, DOI 10.1038/nn1320; Harazny J, 2009, DOC OPHTHALMOL, V119, P181, DOI 10.1007/s10633-009-9194-5; Heidelberger R, 2005, PROG RETIN EYE RES, V24, P682, DOI 10.1016/j.preteyeres.2005.04.002; Hemara-Wahanui A, 2005, P NATL ACAD SCI USA, V102, P7553, DOI 10.1073/pnas.0501907102; Heon E, 1994, MOL GENETICS INHERIT, P277; Hope CI, 2005, CLIN EXP OPHTHALMOL, V33, P129, DOI 10.1111/j.1442-9071.2005.00987.x; Huckfeldt RM, 2009, NAT NEUROSCI, V12, P35, DOI 10.1038/nn.2236; Jalkanen R, 2006, J MED GENET, V43, DOI 10.1136/jmg.2006.040741; Knoflach D., 2013, CHANNELS AUSTIN, V7; Liu XD, 2013, J NEUROSURG-SPINE, V19, P2; Mansergh F, 2005, HUM MOL GENET, V14, P3035, DOI 10.1093/hmg/ddi336; Michalakis S, 2013, CELL MOL LIFE SCI, V70, P1831, DOI 10.1007/s00018-012-1230-z; MIYAKE Y, 1986, ARCH OPHTHALMOL-CHIC, V104, P1013, DOI 10.1001/archopht.1986.01050190071042; Morgans CW, 2005, VISUAL NEUROSCI, V22, P561, DOI 10.1017/S0952523805225038; Morgans CW, 2001, INVEST OPHTH VIS SCI, V42, P2414; Nachman-Clewner M, 1999, J COMP NEUROL, V415, P1, DOI 10.1002/(SICI)1096-9861(19991206)415:1<1::AID-CNE1>3.0.CO;2-G; Nakamura M, 2003, ARCH OPHTHALMOL-CHIC, V121, P1028, DOI 10.1001/archopht.121.7.1028; Olshevskaya EV, 2004, J NEUROSCI, V24, P6078, DOI 10.1523/JNEUROSCI.0963-04.2004; Pusch CM, 2000, NAT GENET, V26, P324, DOI 10.1038/81627; Raven MA, 2008, J COMP NEUROL, V506, P745, DOI 10.1002/cne.21526; Schmitz F, 2012, FRONT MOL NEUROSCI, V5, DOI 10.3389/fnmol.2012.00026; Specht D, 2009, INVEST OPHTH VIS SCI, V50, P505, DOI 10.1167/iovs.08-2758; Specht D, 2007, EUR J NEUROSCI, V26, P2506, DOI 10.1111/j.1460-9568.2007.05886.x; Striessnig J, 2010, PFLUG ARCH EUR J PHY, V460, P361, DOI 10.1007/s00424-010-0800-x; Strom TM, 1998, NAT GENET, V19, P260, DOI 10.1038/940; Zabouri N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063853; Zhang N, 2002, J NEUROSCI, V22, P7065	41	42	42	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2014	9	1							e86769	10.1371/journal.pone.0086769	http://dx.doi.org/10.1371/journal.pone.0086769			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297GT	24466230	Green Published, Green Submitted, gold			2022-12-25	WOS:000330244500283
J	Yim, DGR; Ghosh, S; Guy, GR; Virshup, DM				Yim, D. G. R.; Ghosh, S.; Guy, G. R.; Virshup, D. M.			Casein kinase 1 regulates Sprouty2 in FGF-ERK signaling	ONCOGENE			English	Article						growth factor signaling; SPRY; casein kinase 1; neurite outgrowth; gastric cancer	FACTOR RECEPTOR STIMULATION; KERATINOCYTE GROWTH-FACTOR; TRANSLOCATION DOMAIN; GASTRIC-CARCINOMA; TYROSINE KINASES; CANCER-CELLS; PHOSPHORYLATION; PATHWAY; PROTEIN; INHIBITION	Sprouty2 (SPRY2) is a potent negative regulator of receptor tyrosine kinase signaling, and is implicated as a tumor suppressor. SPRY2 inhibits FGF-RAS-ERK signaling by binding to growth factor receptor bound protein 2 (GRB2) during fibroblast growth factor receptor (FGFR) activation, disrupting the GRB2-SOS (son of sevenless) complex that transduces signals from FGFR to RAS. SPRY2 binding to GRB2 is modulated by phosphorylation but the key regulatory kinase(s) are not known. Prior studies identified the frequent presence of CK1 phosphorylation motifs on SPRY2. We therefore tested if CK1 has a role in SPRY2 phosphorylation and function. Loss of CK1 binding and inhibition of CK1 activity by two structurally distinct small molecules abrogated SPRY2 inhibition of FGF-ERK signaling, leading to decreased SPRY2 interaction with GRB2. Moreover, CK1 activity and binding are necessary for SPRY2 inhibition of FGF-stimulated neurite outgrowth in PC12 cells. Consistent with its proposed role as an inhibitor of FGF signaling, we find that CSNK1E transcript abundance negatively correlates with FGF1/FGF7 message in human gastric cancer samples. Modulation of CK1 activity may be therapeutically useful in the treatment of FGF/SPRY2-related diseases.	[Yim, D. G. R.; Virshup, D. M.] Duke NUS Grad Med Sch, Program Canc & Stem Cell Biol, Singapore 169857, Singapore; [Yim, D. G. R.; Guy, G. R.] Biopolis, Inst Mol & Cellular Biol, Signal Transduct Lab, Singapore, Singapore; [Ghosh, S.] Duke NUS Grad Med Sch, Ctr Computat Biol, Singapore 169857, Singapore; [Virshup, D. M.] Natl Univ Singapore, YYL Sch Med, Dept Biochem, Singapore 117548, Singapore; [Yim, D. G. R.] Biopolis, Genome Inst Singapore, Singapore, Singapore	National University of Singapore; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB); National University of Singapore; National University of Singapore; Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS)	Virshup, DM (corresponding author), Duke NUS Grad Med Sch, Program Canc & Stem Cell Biol, 8 Coll Rd, Singapore 169857, Singapore.	david.virshup@duke-nus.edu.sg	Virshup, David M/C-1449-2009; Ghosh, Sujoy/I-3729-2017; Yim, Daniel/J-8834-2013	Virshup, David M/0000-0001-6976-850X; Ghosh, Sujoy/0000-0002-7601-165X; Yim, Daniel/0000-0001-6153-4725	National Medical Research Council of Singapore; A*STAR Graduate Scholarship; Agency for Science, Technology and Research, Singapore	National Medical Research Council of Singapore(National Medical Research Council, Singapore); A*STAR Graduate Scholarship(Agency for Science Technology & Research (A*STAR)); Agency for Science, Technology and Research, Singapore(Agency for Science Technology & Research (A*STAR))	We thank Dr Permeen Yusoff and Dr Jit Kong Cheong for advice. This research was supported by the National Medical Research Council of Singapore under its STaR Award program to DMV, the A*STAR Graduate Scholarship (to DGRY) and by the Agency for Science, Technology and Research, Singapore.	Amit S, 2002, GENE DEV, V16, P1066, DOI 10.1101/gad.230302; Aranda S, 2008, MOL CELL BIOL, V28, P5899, DOI 10.1128/MCB.00394-08; Badura L, 2007, J PHARMACOL EXP THER, V322, P730, DOI 10.1124/jpet.107.122846; Beenken A, 2009, NAT REV DRUG DISCOV, V8, P235, DOI 10.1038/nrd2792; Belch J, 2011, LANCET, V377, P1929, DOI 10.1016/S0140-6736(11)60394-2; Birrer MJ, 2007, J CLIN ONCOL, V25, P2281, DOI 10.1200/JCO.2006.09.0795; Casaletto JB, 2012, NAT REV CANCER, V12, P386, DOI 10.1038/nrc3277; Casci T, 1999, CELL, V96, P655, DOI 10.1016/S0092-8674(00)80576-0; CEGIELSKA A, 1993, MOL CELL BIOL, V13, P1202, DOI 10.1128/MCB.13.2.1202; Chandramouli S, 2008, J BIOL CHEM, V283, P1679, DOI 10.1074/jbc.M705457200; Cheong JK, 2011, ONCOGENE, V30, P2558, DOI 10.1038/onc.2010.627; Cheong JK, 2011, INT J BIOCHEM CELL B, V43, P465, DOI 10.1016/j.biocel.2010.12.004; Chow SY, 2009, J BIOL CHEM, V284, P19623, DOI 10.1074/jbc.M109.021600; DaSilva J, 2006, MOL CELL BIOL, V26, P1898, DOI 10.1128/MCB.26.5.1898-1907.2006; Edwin F, 2009, MOL PHARMACOL, V76, P679, DOI 10.1124/mol.109.055848; FLOTOW H, 1990, J BIOL CHEM, V265, P14264; Fong CW, 2006, CANCER RES, V66, P2048, DOI 10.1158/0008-5472.CAN-05-1072; Greer YE, 2011, J CELL BIOL, V192, P993, DOI 10.1083/jcb.201011111; Gross I, 2007, CELL DEATH DIFFER, V14, P1802, DOI 10.1038/sj.cdd.4402188; Guy GR, 2009, J ENDOCRINOL, V203, P191, DOI 10.1677/JOE-09-0110; Hacohen N, 1998, CELL, V92, P253, DOI 10.1016/S0092-8674(00)80919-8; Hanafusa H, 2002, NAT CELL BIOL, V4, P850, DOI 10.1038/ncb867; Hausott B, 2009, MOL CELL NEUROSCI, V42, P328, DOI 10.1016/j.mcn.2009.08.005; Impagnatiello MA, 2001, J CELL BIOL, V152, P1087, DOI 10.1083/jcb.152.5.1087; Lao DH, 2007, J BIOL CHEM, V282, P9117, DOI 10.1074/jbc.M607563200; Lao DH, 2006, J BIOL CHEM, V281, P29993, DOI 10.1074/jbc.M604044200; Lei ZD, 2013, GASTROENTEROLOGY, V145, P554, DOI 10.1053/j.gastro.2013.05.010; Lemmon MA, 2010, CELL, V141, P1117, DOI 10.1016/j.cell.2010.06.011; Lim J, 2000, J BIOL CHEM, V275, P32837, DOI 10.1074/jbc.M002156200; Lim J, 2002, MOL CELL BIOL, V22, P7953, DOI 10.1128/MCB.22.22.7953-7966.2002; Liu F, 2002, J BIOL CHEM, V277, P45393, DOI 10.1074/jbc.M204499200; Lo TL, 2004, CANCER RES, V64, P6127, DOI 10.1158/0008-5472.CAN-04-1207; Lord C, 2011, NATURE, V473, P181, DOI 10.1038/nature09969; Meng QJ, 2008, NEURON, V58, P78, DOI 10.1016/j.neuron.2008.01.019; Metzger RJ, 2008, NATURE, V453, P745, DOI 10.1038/nature07005; Nakazawa K, 2003, CANCER RES, V63, P8848; Okamura H, 2004, MOL CELL BIOL, V24, P4184, DOI 10.1128/MCB.24.10.4184-4195.2004; Ooi CH, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000676; Patel R, 2013, J CLIN INVEST, V123, P1157, DOI 10.1172/JCI63672; Pullar CE, 2003, J BIOL CHEM, V278, P22555, DOI 10.1074/jbc.M300205200; Rena G, 2004, EMBO REP, V5, P60, DOI 10.1038/sj.embor.7400048; Rubinfeld B, 2001, J BIOL CHEM, V276, P39037, DOI 10.1074/jbc.M105148200; Smith G, 2012, BRIT J CANCER, V107, P1327, DOI 10.1038/bjc.2012.410; Swiatek W, 2004, J BIOL CHEM, V279, P13011, DOI 10.1074/jbc.M304682200; Tang N, 2011, SCIENCE, V333, P342, DOI 10.1126/science.1204831; Toh KL, 2001, SCIENCE, V291, P1040, DOI 10.1126/science.1057499; Toyokawa T, 2009, ONCOL REP, V21, P875, DOI 10.3892/or_00000297; Tsai IC, 2007, DEV CELL, V12, P335, DOI 10.1016/j.devcel.2007.02.009; Turner N, 2010, NAT REV CANCER, V10, P116, DOI 10.1038/nrc2780; Wong ESM, 2002, EMBO J, V21, P4796, DOI 10.1093/emboj/cdf493; Wong ESM, 2001, J BIOL CHEM, V276, P5866, DOI 10.1074/jbc.M006945200; Yusoff P, 2002, J BIOL CHEM, V277, P3195, DOI 10.1074/jbc.M108368200	52	20	20	1	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 22	2015	34	4					474	484		10.1038/onc.2013.564	http://dx.doi.org/10.1038/onc.2013.564			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AZ8FU	24469046				2022-12-25	WOS:000348451300008
J	Petrova, E; Matevossian, A; Resh, MD				Petrova, E.; Matevossian, A.; Resh, M. D.			Hedgehog acyltransferase as a target in pancreatic ductal adenocarcinoma	ONCOGENE			English	Article						hedgehog; palmitoylation; pancreatic cancer	SONIC-HEDGEHOG; SIGNALING PATHWAY; CANCER; PALMITOYLATION; PROTEIN; CELLS; IDENTIFICATION; TUMORIGENESIS; REQUIREMENT; MECHANISMS	Sonic Hedgehog (Shh) is abnormally expressed in pancreatic cancer and is associated with disease onset and progression. Inhibition of Shh signaling is thus an attractive clinical target for therapeutic intervention. Most efforts to block Shh signaling have focused on inhibitors of Smoothened, which target the canonical Shh signaling pathway. These approaches have met with limited success, in part due to development of resistance-conferring mutations and contributions from non-canonical signaling pathways. Here, we show that Hedgehog acyltransferase (Hhat), the enzyme responsible for the attachment of palmitate onto Shh, is a novel target for inhibition of Shh signaling in pancreatic cancer cells. Depletion of Hhat with lentivirally delivered small hairpin RNA decreased both anchorage-dependent and independent proliferation of human pancreatic cancer cells. In vivo, Hhat knockdown led to reduction of tumor growth in a mouse xenograft model of pancreatic cancer. RU-SKI 43, a small molecule inhibitor of Hhat recently developed by our group, reduced pancreatic cancer cell proliferation and Gli-1 activation through Smoothened-independent non-canonical signaling. In addition, RU-SKI 43 treatment inhibited two key proliferative pathways regulated by Akt and mTOR. This work demonstrates that Hhat has a critical role in pancreatic cancer and that a small molecule inhibitor of Hhat can successfully block pancreatic cancer cell proliferation. It also highlights the importance of developing optimized Hhat inhibitors to be used as therapeutics in pancreatic cancer, as well as in other malignancies characterized by Shh overexpression.	[Petrova, E.; Matevossian, A.; Resh, M. D.] Mem Sloan Kettering Canc Ctr, Cell Biol Program, New York, NY 10021 USA; [Petrova, E.] Cornell Univ, Weill Grad Sch Med Sci, Grad Program Pharmacol, New York, NY 10021 USA; [Matevossian, A.; Resh, M. D.] Gerstner Sloan Kettering Grad Sch Biomed Sci, New York, NY USA; [Resh, M. D.] Cornell Univ, Weill Grad Sch Med Sci, Grad Program Cell Biol, New York, NY 10021 USA; [Resh, M. D.] Cornell Univ, Weill Grad Sch Med Sci, Grad Program Biochem, New York, NY 10021 USA	Memorial Sloan Kettering Cancer Center; Cornell University; Memorial Sloan Kettering Cancer Center; Cornell University; Cornell University	Resh, MD (corresponding author), Mem Sloan Kettering Canc Ctr, Cell Biol Program, 1275 York Ave,Box 143, New York, NY 10021 USA.	reshm@mskcc.org		Resh, Marilyn/0000-0001-6118-9466	NIH [GM57966, CA158474]; MSKCC Cycle for Survival; Geoffrey Beene Cancer Research Foundation; Commonwealth Foundation for Cancer Research; Experimental Therapeutics Center of Memorial Sloan-Kettering Cancer Center; NATIONAL CANCER INSTITUTE [R21CA186957, P30CA008748] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM057966] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MSKCC Cycle for Survival; Geoffrey Beene Cancer Research Foundation; Commonwealth Foundation for Cancer Research; Experimental Therapeutics Center of Memorial Sloan-Kettering Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Raisa Louft-Nisenbaum for technical assistance, Dr Elisa de Stanchina for performing tumor xenograft studies, Dr Nian Wu for pharmacokinetic analyses, the MSKCC Genomics and Molecular Cytology Cores, and Jessica Rios-Esteves and Rayshonda Hardy for reading the manuscript. This work was supported by NIH grants GM57966 and CA158474, by MSKCC Cycle for Survival, by the Geoffrey Beene Cancer Research Foundation, by Mr William H Goodwin and Mrs Alice Goodwin and by the Commonwealth Foundation for Cancer Research and the Experimental Therapeutics Center of Memorial Sloan-Kettering Cancer Center.	Barakat MT, 2010, TRENDS MOL MED, V16, P337, DOI 10.1016/j.molmed.2010.05.003; Berman DM, 2003, NATURE, V425, P846, DOI 10.1038/nature01972; Buglino JA, 2008, J BIOL CHEM, V283, P22076, DOI 10.1074/jbc.M803901200; Buglino JA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011195; Chen MH, 2004, GENE DEV, V18, P641, DOI 10.1101/gad.1185804; Chinchilla P, 2010, CELL CYCLE, V9, P570, DOI 10.4161/cc.9.3.10591; Dawber RJ, 2005, BMC DEV BIOL, V5, DOI 10.1186/1471-213X-5-21; Hardy RY, 2012, J BIOL CHEM, V287, P42881, DOI 10.1074/jbc.M112.426833; Jiang J, 2008, DEV CELL, V15, P801, DOI 10.1016/j.devcel.2008.11.010; Li CW, 2007, CANCER RES, V67, P1030, DOI 10.1158/0008-5472.CAN-06-2030; Lum L, 2004, SCIENCE, V304, P1755, DOI 10.1126/science.1098020; Mann RK, 2004, ANNU REV BIOCHEM, V73, P891, DOI 10.1146/annurev.biochem.73.011303.073933; Metcalfe C, 2011, CANCER RES, V71, P5057, DOI 10.1158/0008-5472.CAN-11-0923; Miura GI, 2006, DEV CELL, V10, P167, DOI 10.1016/j.devcel.2005.11.017; Morton JP, 2007, P NATL ACAD SCI USA, V104, P5103, DOI 10.1073/pnas.0701158104; Nolan-Stevaux O, 2009, GENE DEV, V23, P24, DOI 10.1101/gad.1753809; Olive KP, 2009, SCIENCE, V324, P1457, DOI 10.1126/science.1171362; Pan SF, 2010, ACS MED CHEM LETT, V1, P130, DOI 10.1021/ml1000307; Petrova E, 2013, NAT CHEM BIOL, V9, P247, DOI [10.1038/NCHEMBIO.1184, 10.1038/nchembio.1184]; Peukert S, 2010, CHEMMEDCHEM, V5, P500, DOI 10.1002/cmdc.201000011; Rodriguez-Blanco J, 2013, ONCOGENE, V32, P2335, DOI 10.1038/onc.2012.243; Rubin LL, 2006, NAT REV DRUG DISCOV, V5, P1026, DOI 10.1038/nrd2086; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Skvara H, 2011, J INVEST DERMATOL, V131, P1735, DOI 10.1038/jid.2011.48; Testaz S, 2001, P NATL ACAD SCI USA, V98, P12521, DOI 10.1073/pnas.221108698; Thayer SP, 2003, NATURE, V425, P851, DOI 10.1038/nature02009; Tian H, 2009, P NATL ACAD SCI USA, V106, P4254, DOI 10.1073/pnas.0813203106; Wu X, 2004, CHEM BIOL, V11, P1229, DOI 10.1016/j.chembiol.2004.06.010; Yauch RL, 2008, NATURE, V455, P406, DOI 10.1038/nature07275	29	43	47	0	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 8	2015	34	2					263	268		10.1038/onc.2013.575	http://dx.doi.org/10.1038/onc.2013.575			6	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AY8FS	24469057	Green Accepted			2022-12-25	WOS:000347790500014
J	de Burgos-Lunar, C; Jimenez-Garcia, R; Salinero-Fort, MA; Gomez-Campelo, P; Gil, A; Abanades-Herranz, JC; Cardenas-Valladolid, J; del Cura-Gonzalez, I				de Burgos-Lunar, Carmen; Jimenez-Garcia, Rodrigo; Salinero-Fort, Miguel A.; Gomez-Campelo, Paloma; Gil, Angel; Abanades-Herranz, Juan C.; Cardenas-Valladolid, Juan; del Cura-Gonzalez, Isabel			Trends in Hypertension Prevalence, Awareness, Treatment and Control in an Adult Type 2 Diabetes Spanish Population between 2003 and 2009	PLOS ONE			English	Article							BLOOD-PRESSURE; PRIMARY-CARE; ARTERIAL-HYPERTENSION; EUROPEAN-SOCIETY; MANAGEMENT; GUIDELINES; MELLITUS; SPAIN	In patients with type 2 diabetes, the prevalence of hypertension is higher than in non-diabetic subjects. Despite the high cardiovascular risk involving hypertension in these patients, its prevalence and control are not well known. The aims of this study were: to estimate the hypertension prevalence, awareness, treatment and control in Spanish adults with type 2 diabetes attended in Primary Care; and to analyse its time trend from 2003 to 2009. A serial cross-sectional study from 2003 to 2009 was performed in 21 Primary Care Centres in Madrid. The study population comprised all patients with diagnosed type 2 diabetes in their computerised medical history. Overall annual prevalence during the period 2003-2009 was calculated from and according to sex and age groups. Linear trend tests, regression lines and coefficients of determination were used. In 2003 89.78% (CI 87.92-91.64) of patients with type 2 diabetes suffered hypertension and 94.76% (CI: 92.85-96.67) in 2009. This percentage was greater for women and for patients over 65 years old. 30% of patients suffered previously undiagnosed hypertension in 2003 and 23.1% in 2009. 97% of diagnosed patients received pharmacological treatment and 28.79% reached the blood pressure objective in 2009. The average number of antihypertensive drugs taken was 2.72 in 2003 and 3.27 in 2009. Only 5.2% of patients with type 2 diabetes show blood pressure levels below 130/80 mmHg. Although significant improvements have been achieved in the diagnosis and control of hypertension in people with type 2 diabetes, these continue to remain far from optimum.	[de Burgos-Lunar, Carmen] Carlos III Hosp, Clin Epidemiol & Res Unit, Madrid, Spain; [de Burgos-Lunar, Carmen; Salinero-Fort, Miguel A.; del Cura-Gonzalez, Isabel] REDISSEC, Madrid, Spain; [Jimenez-Garcia, Rodrigo; Gil, Angel; del Cura-Gonzalez, Isabel] Rey Juan Carlos Univ, Prevent Med & Publ Hlth Dept, Alcorcon, Spain; [Salinero-Fort, Miguel A.; Gomez-Campelo, Paloma] Carlos III Hosp, Biomed Res Fdn, Madrid, Spain; [Abanades-Herranz, Juan C.; Cardenas-Valladolid, Juan; del Cura-Gonzalez, Isabel] Direcc Tecn Docencia & Invest, Res Unit, Madrid, Spain	Hospital Carlos III; Universidad Rey Juan Carlos; Hospital Carlos III	de Burgos-Lunar, C (corresponding author), Carlos III Hosp, Clin Epidemiol & Res Unit, Madrid, Spain.	carmenblunar@hotmail.com	Jimenez-Garcia, Rodrigo/D-4953-2019; Gil, Angel/ABA-7621-2020; SALINERO-FORT, MIGUEL A./GOP-2536-2022; del Cura-Gonzalez, Isabel/G-9040-2018	Jimenez-Garcia, Rodrigo/0000-0001-5906-9393; Gil, Angel/0000-0001-7663-0939; SALINERO-FORT, MIGUEL A./0000-0002-9450-4116; Gomez Campelo, Paloma/0000-0003-2299-1741; Cardenas Valladolid, Juan/0000-0002-3321-7316; del Cura-Gonzalez, Isabel/0000-0002-3931-5304				Aleman JA, 2011, ATEN PRIM, V43, P297, DOI 10.1016/j.aprim.2010.05.016; Adler AI, 2000, BMJ-BRIT MED J, V321, P412, DOI 10.1136/bmj.321.7258.412; American Diabetes Association, 2003, DIABETES CARE, V26, pS80, DOI DOI 10.2337/DIACARE.26.2007.S80; [Anonymous], 2007, J HYPERT, V25, P1005; Banegas Banegas JR, 2005, HIPERTENSION, V22, P353, DOI DOI 10.1016/S0212-8241(05)71587-5; Banegas JR, 1998, HYPERTENSION, V32, P998, DOI 10.1161/01.HYP.32.6.998; Benitez Camps M, 2005, Aten Primaria, V35, P7, DOI 10.1157/13071038; Benitez M, 2001, Aten Primaria, V28, P373; Berlowitz DR, 2003, DIABETES CARE, V26, P355, DOI 10.2337/diacare.26.2.355; Campbell NRC, 2009, CAN J CARDIOL, V25, P299, DOI 10.1016/S0828-282X(09)70493-3; Canadian Diabetes Association Expert Panel Committee, 2008, CAN J DIABETES, V32, pS168; Chobanian AV., 2003, HYPERTENSION, V42, P1206, DOI [10.1161/01.HYP.0000107251, DOI 10.1161/01.HYP.9.2_PT_2.II36, DOI 10.1161/01.HYP.0000107251.49515.C2]; Coca Payeras A., 2005, HIPERTENSION, V22, P5, DOI DOI 10.1016/S1889-1837(05)71521-X; Dalfo Baque A, 2001, Aten Primaria, V28, P305; de Burgos-Lunar C, 2011, BMC MED RES METHODOL, V11, DOI 10.1186/1471-2288-11-146; Egan BM, 2010, JAMA-J AM MED ASSOC, V303, P2043, DOI 10.1001/jama.2010.650; Escobar C, 2007, REV CLIN ESP, V207, P221, DOI 10.1157/13102313; Fernandez Cuenca R, 1998, ANALISIS SERVICIOS S, P249; Geiss LS, 2002, AM J PREV MED, V22, P42, DOI 10.1016/S0749-3797(01)00399-3; Grupo de trabajo de la Guia de Practica Clinica sobre Diabetes tipo 2, 2008, GUIA PRACT CLIN DIAB; Hansson L, 1998, LANCET, V351, P1755, DOI 10.1016/S0140-6736(98)04311-6; Hyman DJ, 2000, ARCH INTERN MED, V160, P2281, DOI 10.1001/archinte.160.15.2281; Kearney PM, 2005, LANCET, V365, P217, DOI 10.1016/S0140-6736(05)70151-3; Llisterri Caro JL, 2009, HIPERTENS RIESGO VAS, V26, P257; Llisterri JL, 2006, RCAP, V1, P19; Maahs DM, 2005, DIABETES CARE, V28, P301, DOI 10.2337/diacare.28.2.301; Mancia G, 2007, EUR HEART J, V28, P1462, DOI [10.1093/eurheartj/ehm236, 10.1093/eurheartj/eht151]; Mancia G, 2009, J HYPERTENS, V27, P2121, DOI 10.1097/HJH.0b013e328333146d; Mehta SS, 1999, AM J HYPERTENS, V12, P333, DOI 10.1016/S0895-7061(00)86958-7; National Institute for Clinical Excellence (NICE), 2008, NAT COLL CTR CHRON C; Nilsson PM, 2003, J HUM HYPERTENS, V17, P37, DOI 10.1038/sj.jhh.1001503; Pereira M, 2009, J HYPERTENS, V27, P963, DOI 10.1097/HJH.0b013e3283282f65; SIMONSON DC, 1988, DIABETES CARE, V11, P821, DOI 10.2337/diacare.11.10.821; Soedamah-Muthu SS, 2002, DIABETOLOGIA, V45, P1362, DOI 10.1007/s00125-002-0914-6; Sowers JR, 2001, HYPERTENSION, V37, P1053, DOI 10.1161/01.HYP.37.4.1053; Stearne MR, 1998, BMJ-BRIT MED J, V317, P703; Vallejo OG, 2003, MED CLIN-BARCELONA, V120, P529, DOI 10.1016/S0025-7753(03)73765-8; Castell MV, 2010, MED CLIN-BARCELONA, V135, P671, DOI 10.1016/j.medcli.2009.03.016; Wexler R, 2009, BMC FAM PRACT, V10, DOI 10.1186/1471-2296-10-23; White F, 2010, EXP CLIN CARDIOL, V15, P5; Wolf-Maier K, 2003, JAMA-J AM MED ASSOC, V289, P2363, DOI 10.1001/jama.289.18.2363	41	22	22	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2014	9	1							e86713	10.1371/journal.pone.0086713	http://dx.doi.org/10.1371/journal.pone.0086713			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301BI	24475171	Green Published, Green Submitted, gold			2022-12-25	WOS:000330507300104
J	Ganz, HH; Law, C; Schmuki, M; Eichenseher, F; Calendar, R; Loessner, MJ; Getz, WM; Korlach, J; Beyer, W; Klumpp, J				Ganz, Holly H.; Law, Christina; Schmuki, Martina; Eichenseher, Fritz; Calendar, Richard; Loessner, Martin J.; Getz, Wayne M.; Korlach, Jonas; Beyer, Wolfgang; Klumpp, Jochen			Novel Giant Siphovirus from Bacillus anthracis Features Unusual Genome Characteristics	PLOS ONE			English	Article							BACTERIOPHAGE; CEREUS; SEQUENCE; THURINGIENSIS; INFERENCE; REVEALS; PLASMID; MRBAYES	Here we present vB_BanS-Tsamsa, a novel temperate phage isolated from Bacillus anthracis, the agent responsible for anthrax infections in wildlife, livestock and humans. Tsamsa phage is a giant siphovirus (order Caudovirales), featuring a long, flexible and non-contractile tail of 440 nm (not including baseplate structure) and an isometric head of 82 nm in diameter. We induced Tsamsa phage in samples from two different carcass sites in Etosha National Park, Namibia. The Tsamsa phage genome is the largest sequenced Bacillus siphovirus, containing 168,876 bp and 272 ORFs. The genome features an integrase/recombinase enzyme, indicative of a temperate lifestyle. Among bacterial strains tested, the phage infected only certain members of the Bacillus cereus sensu lato group (B. anthracis, B. cereus and B. thuringiensis) and exhibited moderate specificity for B. anthracis. Tsamsa lysed seven out of 25 B. cereus strains, two out of five B. thuringiensis strains and six out of seven B. anthracis strains tested. It did not lyse B. anthracis PAK-1, an atypical strain that is also resistant to both gamma phage and cherry phage. The Tsamsa endolysin features a broader lytic spectrum than the phage host range, indicating possible use of the enzyme in Bacillus biocontrol.	[Ganz, Holly H.; Law, Christina; Getz, Wayne M.] Univ Calif Berkeley, Dept Environm Sci Policy & Management, Berkeley, CA 94720 USA; [Schmuki, Martina; Eichenseher, Fritz; Loessner, Martin J.; Klumpp, Jochen] ETH, Inst Food Nutr & Hlth, Zurich, Switzerland; [Calendar, Richard] Univ Calif Berkeley, Dept Mol & Cellular Biol, Berkeley, CA 94720 USA; [Getz, Wayne M.] Univ KwaZulu Natal, Sch Math Sci, Durban, South Africa; [Korlach, Jonas] Pacific Biosci, Menlo Pk, CA USA; [Beyer, Wolfgang] Univ Hohenheim, Inst Environm & Anim Hyg, Stuttgart, Germany	University of California System; University of California Berkeley; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of California System; University of California Berkeley; University of Kwazulu Natal; University Hohenheim	Ganz, HH (corresponding author), Univ Calif Davis, Genome Ctr, Davis, CA 95616 USA.	holly.h.ganz@gmail.com	Klumpp, Jochen/A-5415-2011; Loessner, Martin J/B-4316-2012; Getz, Wayne/I-4521-2013	Klumpp, Jochen/0000-0003-3410-2702; Loessner, Martin J/0000-0002-8162-2631; Getz, Wayne/0000-0001-8784-9354	University of California, Berkeley (UCB), Biology Scholars Program; UCB College of Natural Resources-Biology Scholars Program; Rosberg-Geist Fellowship from the UCB Center for African Studies and an Undergraduate Merit Scholarship from the UCB Institute of International Studies; NIH [GM083863]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM083863] Funding Source: NIH RePORTER	University of California, Berkeley (UCB), Biology Scholars Program; UCB College of Natural Resources-Biology Scholars Program; Rosberg-Geist Fellowship from the UCB Center for African Studies and an Undergraduate Merit Scholarship from the UCB Institute of International Studies; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was funded by a Pre-Graduate Pathway Research Grant from the University of California, Berkeley (UCB), Biology Scholars Program, the UCB College of Natural Resources-Biology Scholars Program, a Rosberg-Geist Fellowship from the UCB Center for African Studies and an Undergraduate Merit Scholarship from the UCB Institute of International Studies to CL, and NIH Grant GM083863 to WMG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS MH, 1959, METHODS STUDY BACTER, P443; Aziz RK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-75; Barr JJ, 2013, P NATL ACAD SCI USA, V110, P10771, DOI 10.1073/pnas.1305923110; BATTISTI L, 1985, J BACTERIOL, V162, P543, DOI 10.1128/JB.162.2.543-550.1985; Beyer W, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001534; BUCK CA, 1963, J BACTERIOL, V85, P1423, DOI 10.1128/JB.85.6.1423-1430.1963; CARTER KC, 1988, B HIST MED, V62, P42; DROBNIEWSKI FA, 1993, CLIN MICROBIOL REV, V6, P324, DOI 10.1128/CMR.6.4.324-338.1993; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; Fouts DE, 2006, J BACTERIOL, V188, P3402, DOI 10.1128/JB.188.9.3402-3408.2006; Fraser JS, 2006, J MOL BIOL, V359, P496, DOI 10.1016/j.jmb.2006.03.043; Fulmer P, 2006, BACILLUS ANTHRACIS A; GREEN BD, 1985, INFECT IMMUN, V49, P291, DOI 10.1128/IAI.49.2.291-297.1985; Hendrix RW, 2009, CURR TOP MICROBIOL, V328, P229; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; KATSURA I, 1987, NATURE, V327, P73, DOI 10.1038/327073a0; Katsura I, 1990, Adv Biophys, V26, P1, DOI 10.1016/0065-227X(90)90004-D; Keim P, 2000, J BACTERIOL, V182, P2928, DOI 10.1128/JB.182.10.2928-2936.2000; Kelly G, 1999, NAT STRUCT BIOL, V6, P313; Kilcher S, 2010, J BACTERIOL, V192, P5441, DOI 10.1128/JB.00709-10; Klumpp J, 2008, J BACTERIOL, V190, P5753, DOI 10.1128/JB.00461-08; Klumpp J, 2010, ARCH VIROL, V155, P1547, DOI 10.1007/s00705-010-0783-0; Marti R, 2013, MOL MICROBIOL; Minakhin L, 2005, J MOL BIOL, V354, P1, DOI 10.1016/j.jmb.2005.09.052; Okstad OA, 2011, FOOD MICROBIOL FOOD, P29, DOI 10.1007/978-1-4419-7686-4_2; Pastagia M, 2013, J MED MICROBIOL, V62, P1506, DOI 10.1099/jmm.0.061028-0; Rasko DA, 2005, FEMS MICROBIOL REV, V29, P303, DOI 10.1016/j.femsre.2004.12.005; Read TD, 2003, NATURE, V423, P81, DOI 10.1038/nature01586; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Saile E, 2006, APPL ENVIRON MICROB, V72, P3168, DOI 10.1128/AEM.72.5.3168-3174.2006; Sambrook J, 2001, MOL CLONING LAB MANU; Schuch R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006532; Smith MCM, 2002, MOL MICROBIOL, V44, P299, DOI 10.1046/j.1365-2958.2002.02891.x; Soberon M, 2007, SCIENCE, V318, P1640, DOI 10.1126/science.1146453; Stromsten NJ, 2003, J BACTERIOL, V185, P6985, DOI 10.1128/JB.185.23.6985-6989.2003; THORNE CB, 1968, J VIROL, V2, P657, DOI 10.1128/JVI.2.7.657-662.1968; Turner WC, 2013, ECOSPHERE, V4, DOI 10.1890/ES12-00245.1; Van Twest Rohan, 2009, V501, P15, DOI 10.1007/978-1-60327-164-6_2; YAMAMOTO KR, 1970, VIROLOGY, V40, P734, DOI 10.1016/0042-6822(70)90218-7	39	20	20	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2014	9	1							e85972	10.1371/journal.pone.0085972	http://dx.doi.org/10.1371/journal.pone.0085972			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301BI	24475065	Green Published, gold			2022-12-25	WOS:000330507300033
J	Prill, JM; Subr, V; Pasquarelli, N; Engler, T; Hoffmeister, A; Kochanek, S; Ulbrich, K; Kreppel, F				Prill, Jan-Michael; Subr, Vladimir; Pasquarelli, Noemi; Engler, Tatjana; Hoffmeister, Andrea; Kochanek, Stefan; Ulbrich, Karel; Kreppel, Florian			Traceless Bioresponsive Shielding of Adenovirus Hexon with HPMA Copolymers Maintains Transduction Capacity In Vitro and In Vivo	PLOS ONE			English	Article							POLYMER-COATED ADENOVIRUS; KUPFFER CELLS; GENE-TRANSFER; CAPSID MODIFICATIONS; NATURAL ANTIBODIES; CAR-BINDING; VECTORS; GLUTATHIONE; LIVER; COMPLEMENT	Capsid surface shielding of adenovirus vectors with synthetic polymers is an emerging technology to reduce unwanted interactions of the vector particles with cellular and non-cellular host components. While it has been shown that attachment of shielding polymers allows prevention of undesired interactions, it has become evident that a shield which is covalently attached to the vector surface can negatively affect gene transfer efficiency. Reasons are not only a limited receptor-binding ability of the shielded vectors but also a disturbance of intracellular trafficking processes, the latter depending on the interaction of the vector surface with the cellular transport machinery. A solution might be the development of bioresponsive shields that are stably maintained outside the host cell but released upon cell entry to allow for efficient gene delivery to the nucleus. Here we provide a systematic comparison of irreversible versus bioresponsive shields based on synthetic N-(2-hydroxypropyl)methacrylamide (HPMA) copolymers. In addition, the chemical strategy used for generation of the shield allowed for a traceless bioresponsive shielding, i.e., polymers could be released from the vector particles without leaving residual linker residues. Our data demonstrated that only a bioresponsive shield maintained the high gene transfer efficiency of adenovirus vectors both in vitro and in vivo. As an example for bioresponsive HPMA copolymer release, we analyzed the in vivo gene transfer in the liver. We demonstrated that both the copolymer's charge and the mode of shielding (irreversible versus traceless bioresponsive) profoundly affected liver gene transfer and that traceless bioresponsive shielding with positively charged HPMA copolymers mediated FX independent transduction of hepatocytes. In addition, we demonstrated that shielding with HPMA copolymers can mediate a prolonged blood circulation of vector particles in mice. Our results have significant implications for the future design of polymer-shielded Ad and provide a deeper insight into the interaction of shielded adenovirus vector particles with the host after systemic delivery.	[Prill, Jan-Michael; Pasquarelli, Noemi; Engler, Tatjana; Hoffmeister, Andrea; Kochanek, Stefan; Kreppel, Florian] Univ Ulm, Dept Gene Therapy, D-89069 Ulm, Germany; [Subr, Vladimir; Ulbrich, Karel] Acad Sci Czech Republic, Inst Macromol Chem, Vvi, Dept Biomed Polymers, Prague, Czech Republic	Ulm University; Czech Academy of Sciences; Institute of Macromolecular Chemistry of the Czech Academy of Sciences	Kreppel, F (corresponding author), Univ Ulm, Dept Gene Therapy, D-89069 Ulm, Germany.	florian.kreppel@uni-ulm.de	Šubr, Vladimír/G-3488-2014; Ulbrich, Karel/G-5145-2014		German Research Foundation [SPP1230]; European Union [512087]	German Research Foundation(German Research Foundation (DFG)); European Union(European Commission)	This work was supported by the German Research Foundation (SPP1230) and the European Union (FP6-2003-GIANT-Project 512087). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alba R, 2010, BLOOD, V116, P2656, DOI 10.1182/blood-2009-12-260026; Alba R, 2009, BLOOD, V114, P965, DOI 10.1182/blood-2009-03-208835; Baker AH, 2013, MOL THER, V21, P1109, DOI 10.1038/mt.2013.100; Balendiran GK, 2004, CELL BIOCHEM FUNCT, V22, P343, DOI 10.1002/cbf.1149; Bradshaw AC, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001142; Carlisle RC, 2009, BLOOD, V113, P1909, DOI 10.1182/blood-2008-09-178459; CARLSSON J, 1978, BIOCHEM J, V173, P723, DOI 10.1042/bj1730723; Diehl KH, 2001, J APPL TOXICOL, V21, P15, DOI 10.1002/jat.727; Doronin K, 2012, SCIENCE, V338, P795, DOI 10.1126/science.1226625; Espenlaub S, 2010, HUM GENE THER, V21, P1155, DOI 10.1089/hum.2009.171; Etrych T, 2012, J CONTROL RELEASE, V164, P346, DOI 10.1016/j.jconrel.2012.06.029; Fisher KD, 2001, GENE THER, V8, P341, DOI 10.1038/sj.gt.3301389; Ganesan LP, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002281; Gnaccarini C, 2006, J AM CHEM SOC, V128, P8063, DOI 10.1021/ja061036f; GREBER UF, 1993, CELL, V75, P477, DOI 10.1016/0092-8674(93)90382-Z; Green NK, 2004, GENE THER, V11, P1256, DOI 10.1038/sj.gt.3302295; HOLFORD NHG, 1986, CLIN PHARMACOKINET, V11, P483, DOI 10.2165/00003088-198611060-00005; Kalyuzhniy O, 2008, P NATL ACAD SCI USA, V105, P5483, DOI 10.1073/pnas.0711757105; Khynriam D, 2003, BRAZ J MED BIOL RES, V36, P53, DOI 10.1590/S0100-879X2003000100008; Kirby I, 2000, J VIROL, V74, P2804, DOI 10.1128/JVI.74.6.2804-2813.2000; Koizumi N, 2007, J IMMUNOL, V178, P1767, DOI 10.4049/jimmunol.178.3.1767; Kosower N S, 1978, Int Rev Cytol, V54, P109, DOI 10.1016/S0074-7696(08)60166-7; Kreppel F, 2005, MOL THER, V12, P107, DOI 10.1016/j.ymthe.2005.03.006; Kreppel F, 2002, HUM GENE THER, V13, P1151, DOI 10.1089/104303402320138934; Kreppel F, 2008, MOL THER, V16, P16, DOI 10.1038/sj.mt.6300321; Lyons M, 2006, MOL THER, V14, P118, DOI 10.1016/j.ymthe.2006.01.003; Mann KG, 2005, AM HEART J, V149, pS36, DOI 10.1016/j.ahj.2004.10.021; Martin K, 2003, MOL THER, V8, P485, DOI 10.1016/S1525-0016(03)00182-5; MEISTER A, 1983, ANNU REV BIOCHEM, V52, P711, DOI 10.1146/annurev.bi.52.070183.003431; Nakano MY, 2000, J VIROL, V74, P7085, DOI 10.1128/JVI.74.15.7085-7095.2000; NC3Rs: National Center for the replacement refinement and reduction in research, BLOOD SAMPL MIC DEC; Othman M, 2007, BLOOD, V109, P2832, DOI 10.1182/blood-2006-06-032524; Parker AL, 2006, BLOOD, V108, P2554, DOI 10.1182/blood-2006-04-008532; Prill JM, 2010, MOL THER, V19, P83; Reschel T, 2002, J CONTROL RELEASE, V81, P201, DOI 10.1016/S0168-3659(02)00045-7; Schiedner G, 2000, HUM GENE THER, V11, P2105, DOI 10.1089/104303400750001417; Smith JS, 2008, HUM GENE THER, V19, P547, DOI 10.1089/hum.2008.004; Smith JS, 2008, J VIROL METHODS, V147, P54, DOI 10.1016/j.jviromet.2007.08.009; Subr V, 2006, REACT FUNCT POLYM, V66, P1525, DOI 10.1016/j.reactfunctpolym.2006.05.002; Subr V, 2009, J CONTROL RELEASE, V135, P152, DOI 10.1016/j.jconrel.2008.12.009; Taylor CG, 1997, J NUTR, V127, P44, DOI 10.1093/jn/127.1.44; Ulbrich K, 2000, J CONTROL RELEASE, V64, P63, DOI 10.1016/S0168-3659(99)00141-8; Ulbrich K, 2004, J DRUG TARGET, V12, P477, DOI 10.1080/10611860400011869; Vetter A, 2013, MOL PHARMACEUT, V10, P606, DOI 10.1021/mp300366f; Waddington SN, 2008, CELL, V132, P397, DOI 10.1016/j.cell.2008.01.016; Waddington SN, 2007, J VIROL, V81, P9568, DOI 10.1128/JVI.00663-07; WICKHAM TJ, 1993, CELL, V73, P309, DOI 10.1016/0092-8674(93)90231-E; Wiley, 2013, J GENE MED GENE THER; Wolff JA, 2008, MOL THER, V16, P8, DOI 10.1038/sj.mt.6300326; Wortmann A, 2008, MOL THER, V16, P154, DOI 10.1038/sj.mt.6300306; Xu ZL, 2013, NAT MED, V19, P452, DOI 10.1038/nm.3107; Xu ZL, 2008, J VIROL, V82, P11705, DOI 10.1128/JVI.01320-08; Zhang Y, 2001, MOL THER, V3, P697, DOI 10.1006/mthe.2001.0329	53	23	23	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2014	9	1							e82716	10.1371/journal.pone.0082716	http://dx.doi.org/10.1371/journal.pone.0082716			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301BI	24475024	Green Submitted, Green Published, gold			2022-12-25	WOS:000330507300010
J	Wang, H; Li, HY; Zhang, ZJ; Muehlbauer, JD; He, Q; Xu, XH; Yue, CL; Jiang, DQ				Wang, Hang; Li, HongYi; Zhang, ZhiJian; Muehlbauer, Jeffrey D.; He, Qiang; Xu, XinHua; Yue, ChunLei; Jiang, DaQian			Linking Stoichiometric Homeostasis of Microorganisms with Soil Phosphorus Dynamics in Wetlands Subjected to Microcosm Warming	PLOS ONE			English	Article							MICROBIAL COMMUNITY COMPOSITION; ECOENZYMATIC STOICHIOMETRY; FRESH-WATER; ECOLOGICAL STOICHIOMETRY; SUBTROPICAL WETLANDS; ORGANIC-MATTER; TEMPERATURE; CARBON; ECOSYSTEM; SEDIMENT	Soil biogeochemical processes and the ecological stability of wetland ecosystems under global warming scenarios have gained increasing attention worldwide. Changes in the capacity of microorganisms to maintain stoichiometric homeostasis, or relatively stable internal concentrations of elements, may serve as an indicator of alterations to soil biogeochemical processes and their associated ecological feedbacks. In this study, an outdoor computerized microcosm was set up to simulate a warmed (+5 degrees C) climate scenario, using novel, minute-scale temperature manipulation technology. The principle of stoichiometric homeostasis was adopted to illustrate phosphorus (P) biogeochemical cycling coupled with carbon (C) dynamics within the soil-microorganism complex. We hypothesized that enhancing the flux of P from soil to water under warming scenarios is tightly coupled with a decrease in homeostatic regulation ability in wetland ecosystems. Results indicate that experimental warming impaired the ability of stoichiometric homeostasis (H) to regulate biogeochemical processes, enhancing the ecological role of wetland soil as an ecological source for both P and C. The potential P flux from soil to water ranged from 0.11 to 34.51 mg m(-2) d(-1) in the control and 0.07 to 61.26 mg m(-2) d(-1) in the warmed treatment. The synergistic function of C-P acquisition is an important mechanism underlying C: P stoichiometric balance for soil microorganisms under warming. For both treatment groups, strongly significant (p < 0.001) relationships fitting a negative allometric power model with a fractional exponent were found between n-H-C:P (the specialized homeostatic regulation ability as a ratio of soil highly labile organic carbon to dissolved reactive phosphorus in porewater) and potential P flux. Although many factors may affect soil P dynamics, the n-H-C:P term fundamentally reflects the stoichiometric balance or interactions between the energy landscape (i.e., C) and flow of resources (e. g., N and P), and can be a useful ecological tool for assessing potential P flux in ecosystems.	[Wang, Hang; Li, HongYi; Zhang, ZhiJian; Xu, XinHua] Zhejiang Univ, China Acad West Dev, Coll Nat Resource & Environm Sci, Hangzhou 310003, Zhejiang, Peoples R China; [Muehlbauer, Jeffrey D.] Univ N Carolina, Curriculum Environm & Ecol, Chapel Hill, NC USA; [He, Qiang] Univ Tennessee, Dept Civil & Environm Engn, Knoxville, TN USA; [Yue, ChunLei] Zhejiang Forestry Acad, Inst Ecol, Hangzhou, Peoples R China; [Jiang, DaQian] Columbia Univ, Henry Krumb Sch Mines, Dept Earth & Environm Engn, New York, NY 10027 USA	Zhejiang University; University of North Carolina; University of North Carolina Chapel Hill; University of Tennessee System; University of Tennessee Knoxville; Columbia University	Zhang, ZJ (corresponding author), Zhejiang Univ, China Acad West Dev, Coll Nat Resource & Environm Sci, Hangzhou 310003, Zhejiang, Peoples R China.	zhangzhijian@zju.edu.cn	He, Qiang/G-9061-2011; Xu, Xinhua/ABG-6289-2021; Muehlbauer, Jeffrey/G-3607-2011	He, Qiang/0000-0002-7155-6474; Xu, Xinhua/0000-0001-7139-1246; Muehlbauer, Jeffrey/0000-0003-1808-580X	National Natural Science Foundation of China [41373073]; Zhejiang Science and Technology Program [2011F20025]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Zhejiang Science and Technology Program	The authors wish to thank the National Natural Science Foundation of China (41373073) and Zhejiang Science and Technology Program (2011F20025) for providing the financial support for this project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen AP, 2009, ECOL LETT, V12, P369, DOI 10.1111/j.1461-0248.2009.01302.x; Allison VJ, 2007, SOIL BIOL BIOCHEM, V39, P1770, DOI 10.1016/j.soilbio.2007.02.006; Alvarez-Cobelas M, 2009, J N AM BENTHOL SOC, V28, P805, DOI 10.1899/09-073.1; Bond-Lamberty B, 2010, NATURE, V464, P579, DOI 10.1038/nature08930; Bradford MA, 2008, FUNCT ECOL, V22, P964, DOI 10.1111/j.1365-2435.2008.01404.x; BROOKES PC, 1982, SOIL BIOL BIOCHEM, V14, P319, DOI 10.1016/0038-0717(82)90001-3; Cheng WG, 2010, HYDROBIOLOGIA, V656, P5, DOI 10.1007/s10750-010-0441-2; Cleveland CC, 2007, BIOGEOCHEMISTRY, V85, P235, DOI 10.1007/s10533-007-9132-0; Elser JJ, 2010, NEW PHYTOL, V186, P593, DOI 10.1111/j.1469-8137.2010.03214.x; Elser JJ, 2007, ECOL LETT, V10, P1135, DOI 10.1111/j.1461-0248.2007.01113.x; Englund G, 2011, ECOL LETT, V14, P914, DOI 10.1111/j.1461-0248.2011.01661.x; Falkowski PG, 2008, SCIENCE, V320, P1034, DOI 10.1126/science.1153213; Feng XJ, 2009, SOIL BIOL BIOCHEM, V41, P804, DOI 10.1016/j.soilbio.2009.01.020; Gillooly JF, 2001, SCIENCE, V293, P2248, DOI 10.1126/science.1061967; Hansen J, 2006, P NATL ACAD SCI USA, V103, P14288, DOI 10.1073/pnas.0606291103; He ZL, 2010, ISME J, V4, P1167, DOI 10.1038/ismej.2010.46; Hessen DO, 2004, ECOLOGY, V85, P1179, DOI 10.1890/02-0251; Hilbert DW, 2000, J ECOL, V88, P230, DOI 10.1046/j.1365-2745.2000.00438.x; IPCC, 2001, ADV CLIM CHANG RES; Jeppesen E, 2009, J ENVIRON QUAL, V38, P1930, DOI 10.2134/jeq2008.0113; Liikanen A, 2002, BIOGEOCHEMISTRY, V59, P269, DOI 10.1023/A:1016015526712; Logninow W, 1987, J SOIL SCI, V20; Marichal R, 2011, SOIL BIOL BIOCHEM, V43, P1528, DOI 10.1016/j.soilbio.2011.04.001; Mulder C, 2009, GLOBAL CHANGE BIOL, V15, P2730, DOI 10.1111/j.1365-2486.2009.01899.x; Newman S, 2003, J APPL PHYCOL, V15, P45, DOI 10.1023/A:1022971204435; Nicholls KH, 1999, J GREAT LAKES RES, V25, P250, DOI 10.1016/S0380-1330(99)70734-3; Noe GB, 2003, FRESHWATER BIOL, V48, P1993, DOI 10.1046/j.1365-2427.2003.01143.x; Olk DC, 2006, SOIL SCI SOC AM J, V70, P967, DOI 10.2136/sssaj2005.0111; RHEE GY, 1978, LIMNOL OCEANOGR, V23, P10, DOI 10.4319/lo.1978.23.1.0010; Rinu K, 2010, MYCOSCIENCE, V51, P263, DOI 10.1007/s10267-010-0036-9; Schmidt MWI, 2011, NATURE, V478, P49, DOI 10.1038/nature10386; Serpa D, 2007, BIOGEOCHEMISTRY, V82, P291, DOI 10.1007/s10533-007-9076-4; Sinsabaugh RL, 2012, ANNU REV ECOL EVOL S, V43, P313, DOI 10.1146/annurev-ecolsys-071112-124414; Sinsabaugh RL, 2010, MICROB ECOL, V60, P885, DOI 10.1007/s00248-010-9696-4; Sinsabaugh RL, 2009, NATURE, V462, P795, DOI 10.1038/nature08632; Small GE, 2010, OECOLOGIA, V162, P581, DOI 10.1007/s00442-009-1489-4; Sterner R.W, 2002, ECOLOGICAL STOICHIOM, DOI DOI 10.1086/382444; Sundareshwar PV, 2003, SCIENCE, V299, P563, DOI 10.1126/science.1079100; Totsche KU, 2010, J PLANT NUTR SOIL SC, V173, P88, DOI 10.1002/jpln.200900105; Verhoeven JTA, 2006, TRENDS ECOL EVOL, V21, P96, DOI 10.1016/j.tree.2005.11.015; Wang H, 2013, CHEMOSPHERE, V90, P1794, DOI 10.1016/j.chemosphere.2012.08.044; Wang H, 2012, APPL ENVIRON MICROB, V78, P7652, DOI 10.1128/AEM.01602-12; White JR, 2006, SOIL SCI SOC AM J, V70, P1242, DOI 10.2136/sssaj2003.0339; WU J, 1990, SOIL BIOL BIOCHEM, V22, P1167, DOI 10.1016/0038-0717(90)90046-3; Yu QA, 2011, OECOLOGIA, V166, P1, DOI 10.1007/s00442-010-1902-z; Yu Q, 2010, ECOL LETT, V13, P1390, DOI 10.1111/j.1461-0248.2010.01532.x; Zhang W, 2005, GLOBAL CHANGE BIOL, V11, P266, DOI 10.1111/j.1365-2486.2005.00902.x; Zhang ZJ, 2012, HYDROL PROCESS, V26, P15, DOI 10.1002/hyp.8105; Zhou JZ, 2012, NAT CLIM CHANGE, V2, P106, DOI 10.1038/NCLIMATE1331	49	3	9	13	103	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2014	9	1							e85575	10.1371/journal.pone.0085575	http://dx.doi.org/10.1371/journal.pone.0085575			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301BI	24475045	Green Published, gold, Green Submitted			2022-12-25	WOS:000330507300021
J	Chen, ZH; Zhang, YC; Jiang, WF; Yang, C; Zou, GM; Kong, Y; Cai, W				Chen, Zhi-Hua; Zhang, Yong-Chang; Jiang, Wei-Fang; Yang, Cissy; Zou, Gang-Ming; Kong, Yu; Cai, Wei			Characterization of Interstitial Cajal Progenitors Cells and Their Changes in Hirschsprung's Disease	PLOS ONE			English	Article							GASTROINTESTINAL STROMAL TUMORS; ENTERIC NERVOUS-SYSTEM; MOUSE SMALL-INTESTINE; STEM-CELLS; C-KIT; ELECTRICAL RHYTHMICITY; CHINESE POPULATION; HUMAN STOMACH; COLON; ICC	Interstitial cells of Cajal (ICC) are critical to gastrointestinal motility. The phenotypes of ICC progenitors have been observed in the mouse gut, but whether they exist in the human colon and what abnormal changes in their quantity and ultrastructure are present in Hirschsprung's disease (HSCR) colon remains uncertain. In this study, we collected the surgical resection of colons, both proximal and narrow segments, from HSCR patients and normal controls. First, we identified the progenitor of ICC in normal adult colon using immunofluorescent localization techniques with laser confocal microscopy. Next, the progenitors were sorted to observe their morphology. We further applied flow cytometry to examine the content of ICC progenitors in these fresh samples. The ultrastructural changes in the narrow and proximal parts of the HSCR colon were observed using transmission electron microscopy (TEM) and were compared with the normal adult colon. The presumed early progenitor (c-Kit(low)CD34(+)Igf1r(+)) and committed progenitor (c-Kit(+)CD34(+)Igf1r(+)) of ICC exist in adult normal colon as well as in the narrow and proximal parts of the HSCR colon. However, the proportions of mature, early and committed progenitors of ICC were dramatically reduced in the narrow segment of the HSCR colon. The proportions of mature and committed progenitors of ICC in the proximal segment of the HSCR colon were lower than in the adult normal colon. Ultrastructurally, ICC, enteric nerves, and smooth muscle in the narrow segment of the HSCR colon showed severe injury, including swollen vacuola or ted mitochondria, disappearance of mitochondrial cristae, dilated rough endoplasmic reticulum, vesiculation and degranulation, and disappearance of the caveolae on the ICC membrane surface. The contents of ICC and its progenitors in the narrow part of the HSCR colon were significantly decreased than those of adult colon, which may be associated with HSCR pathogenesis.	[Chen, Zhi-Hua; Zou, Gang-Ming; Cai, Wei] Shanghai Jiao Tong Univ, Sch Med, Xin Hua Hosp, Shanghai Inst Pediat Res, Shanghai 200030, Peoples R China; [Zhang, Yong-Chang] Cent Univ, Xiang Ya Med Sch, Affiliated Tumor Hosp, Hunan Prov Tumor Hosp,Ward Oncol 32, Changsha, Hunan, Peoples R China; [Jiang, Wei-Fang; Kong, Yu] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Neurosci, Shanghai, Peoples R China; [Yang, Cissy] Stanford Univ, Sch Med, Stanford, CA 94305 USA	Shanghai Jiao Tong University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Stanford University	Cai, W (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Xin Hua Hosp, Shanghai Inst Pediat Res, Shanghai 200030, Peoples R China.	Caiw1978@163.com	Zou, Gang-Ming/F-1085-2016		Shanghai Jiao Tong University Innovation Team Fund	Shanghai Jiao Tong University Innovation Team Fund	This work was supported by a grant from Shanghai Jiao Tong University Innovation Team Fund (W. C). The authors state the funder had the role of study design, decision to publish, and preparation of the manuscript.	Bardsley MR, 2010, GASTROENTEROLOGY, V139, P942, DOI 10.1053/j.gastro.2010.05.083; Bernardini N, 2012, J CELL MOL MED, V16, P318, DOI 10.1111/j.1582-4934.2011.01298.x; Chang IY, 2001, J PHYSIOL-LONDON, V536, P555, DOI 10.1111/j.1469-7793.2001.0555c.xd; Der-Silaphet T, 1998, GASTROENTEROLOGY, V114, P724, DOI 10.1016/S0016-5085(98)70586-4; Detmer SA, 2007, NAT REV MOL CELL BIO, V8, P870, DOI 10.1038/nrm2275; ERNSTER L, 1981, J CELL BIOL, V91, pS227, DOI 10.1083/jcb.91.3.227s; FAUSSONEPELLEGRINI MS, 1985, ANAT EMBRYOL, V171, P163, DOI 10.1007/BF00341410; Garcia-Barcelo MM, 2007, ANN HUM GENET, V71, P526, DOI 10.1111/j.1469-1809.2007.00347.x; Gomez-Pinilla PJ, 2011, NEUROGASTROENT MOTIL, V23, P36, DOI 10.1111/j.1365-2982.2010.01590.x; Hirota S, 1998, SCIENCE, V279, P577, DOI 10.1126/science.279.5350.577; Horvath VJ, 2006, GASTROENTEROLOGY, V130, P759, DOI 10.1053/j.gastro.2005.12.027; Huizinga JD, 2008, GASTROENTEROLOGY, V134, P1252, DOI 10.1053/j.gastro.2008.02.074; Ishii S, 2009, J GASTROENTEROL, V44, P834, DOI 10.1007/s00535-009-0077-z; Komuro T, 1999, ARCH HISTOL CYTOL, V62, P295, DOI 10.1679/aohc.62.295; Li YM, 2011, J GASTROEN HEPATOL, V26, P1072, DOI 10.1111/j.1440-1746.2011.06670.x; Liu LWC, 1998, DEV DYNAM, V213, P271, DOI 10.1002/(SICI)1097-0177(199811)213:3<271::AID-AJA4>3.0.CO;2-R; Lorincz A, 2008, GASTROENTEROLOGY, V134, P1083, DOI 10.1053/j.gastro.2008.01.036; Mei F, 2006, VIRCHOWS ARCH, V449, P348, DOI 10.1007/s00428-006-0258-6; Metzger M, 2009, GASTROENTEROLOGY, V136, P2214, DOI 10.1053/j.gastro.2009.02.048; Miao XP, 2007, GUT, V56, P736, DOI 10.1136/gut.2006.116145; Miao XP, 2010, HUM MOL GENET, V19, P1461, DOI 10.1093/hmg/ddq020; Mikkelsen HB, 2010, J CELL MOL MED, V14, P818, DOI 10.1111/j.1582-4934.2010.01025.x; Nakahara M, 2002, LIFE SCI, V70, P2367, DOI 10.1016/S0024-3205(02)01517-5; Newmeyer DD, 2003, CELL, V112, P481, DOI 10.1016/S0092-8674(03)00116-8; Radenkovic G, 2010, J CELL MOL MED, V14, P1125, DOI 10.1111/j.1582-4934.2009.00725.x; Robinson TL, 2000, AM J PATHOL, V156, P1157, DOI 10.1016/S0002-9440(10)64984-X; Rolle U, 2002, ARCH PATHOL LAB MED, V126, P928; Sohal GS, 2002, INT J DEV NEUROSCI, V20, P619, DOI 10.1016/S0736-5748(02)00103-X; Solari V, 2003, PEDIATR SURG INT, V19, P349, DOI 10.1007/s00383-003-1009-2; Streutker CJ, 2007, HISTOPATHOLOGY, V50, P190, DOI 10.1111/j.1365-2559.2006.02497.x; Streutker CJ, 2007, HISTOPATHOLOGY, V50, P176, DOI 10.1111/j.1365-2559.2006.02493.x; Torihashi S, 1997, GASTROENTEROLOGY, V112, P144, DOI 10.1016/S0016-5085(97)70229-4; Tsai YH, 2011, NEUROGASTROENT MOTIL, V23, P362, DOI 10.1111/j.1365-2982.2010.01656.x; Vanderwinden JM, 1996, GASTROENTEROLOGY, V111, P901, DOI 10.1016/S0016-5085(96)70057-4; Wang XY, 2009, J CELL MOL MED, V13, P3528, DOI 10.1111/j.1582-4934.2009.00689.x; Ward SM, 2001, ANAT RECORD, V262, P125; Wu JJ, 2000, J NEUROSCI RES, V59, P384, DOI 10.1002/(SICI)1097-4547(20000201)59:3<384::AID-JNR13>3.0.CO;2-4; Yanagida H, 2004, GASTROENTEROLOGY, V127, P1748, DOI 10.1053/j.gastro.2004.09.053; Yang J, 2013, MOL NEUROBIOL, V47, P957, DOI 10.1007/s12035-012-8392-4; Zhang DC, 2010, DEV BIOL, V339, P280, DOI 10.1016/j.ydbio.2009.12.014	40	13	15	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2014	9	1							e86100	10.1371/journal.pone.0086100	http://dx.doi.org/10.1371/journal.pone.0086100			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	298QQ	24475076	Green Published, gold, Green Submitted			2022-12-25	WOS:000330339800027
J	Taylor, K; Kleinhesselink, K; George, MD; Morgan, R; Smallwood, T; Hammonds, AS; Fuller, PM; Saelao, P; Alley, J; Gibbs, AG; Hoshizaki, DK; von Kalm, L; Fuller, CA; Beckingham, KM; Kimbrell, DA				Taylor, Katherine; Kleinhesselink, Kurt; George, Michael D.; Morgan, Rachel; Smallwood, Tangi; Hammonds, Ann S.; Fuller, Patrick M.; Saelao, Perot; Alley, Jeff; Gibbs, Allen G.; Hoshizaki, Deborah K.; von Kalm, Laurence; Fuller, Charles A.; Beckingham, Kathleen M.; Kimbrell, Deborah A.			Toll Mediated Infection Response Is Altered by Gravity and Spaceflight in Drosophila	PLOS ONE			English	Article							HEAT-SHOCK PROTEINS; IMMUNE-RESPONSE; MELANOGASTER	Space travel presents unlimited opportunities for exploration and discovery, but requires better understanding of the biological consequences of long-term exposure to spaceflight. Immune function in particular is relevant for space travel. Human immune responses are weakened in space, with increased vulnerability to opportunistic infections and immune-related conditions. In addition, microorganisms can become more virulent in space, causing further challenges to health. To understand these issues better and to contribute to design of effective countermeasures, we used the Drosophila model of innate immunity to study immune responses in both hypergravity and spaceflight. Focusing on infections mediated through the conserved Toll and Imd signaling pathways, we found that hypergravity improves resistance to Toll-mediated fungal infections except in a known gravitaxis mutant of the yuri gagarin gene. These results led to the first spaceflight project on Drosophila immunity, in which flies that developed to adulthood in microgravity were assessed for immune responses by transcription profiling on return to Earth. Spaceflight alone altered transcription, producing activation of the heat shock stress system. Space flies subsequently infected by fungus failed to activate the Toll pathway. In contrast, bacterial infection produced normal activation of the Imd pathway. We speculate on possible linkage between functional Toll signaling and the heat shock chaperone system. Our major findings are that hypergravity and spaceflight have opposing effects, and that spaceflight produces stress-related transcriptional responses and results in a specific inability to mount a Toll-mediated infection response.	[Taylor, Katherine; Kleinhesselink, Kurt; Saelao, Perot; Kimbrell, Deborah A.] Univ Calif Davis, Dept Mol & Cellular Biol, Davis, CA 95616 USA; [George, Michael D.] Univ Calif Davis, Dept Med Microbiol & Immunol, Davis, CA 95616 USA; [Morgan, Rachel; Smallwood, Tangi; von Kalm, Laurence] Univ Cent Florida, Dept Biol, Orlando, FL 32816 USA; [Hammonds, Ann S.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Dept Genome Dynam, Berkeley, CA 94720 USA; [Fuller, Patrick M.; Fuller, Charles A.] Univ Calif Davis, Dept Neurobiol Physiol & Behav, Davis, CA 95616 USA; [Alley, Jeff] Laverlam Int, Butte, MT USA; [Gibbs, Allen G.; Hoshizaki, Deborah K.] Univ Nevada, Sch Life Sci, Las Vegas, NV 89154 USA; [Beckingham, Kathleen M.] Rice Univ, Dept Biochem & Cell Biol, Houston, TX 77251 USA	University of California System; University of California Davis; University of California System; University of California Davis; State University System of Florida; University of Central Florida; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; University of California System; University of California Davis; Nevada System of Higher Education (NSHE); University of Nevada Las Vegas; Rice University	Kimbrell, DA (corresponding author), Univ Calif Davis, Dept Mol & Cellular Biol, Davis, CA 95616 USA.	dakimbrell@ucdavis.edu	Gibbs, Allen G/G-6939-2014	Gibbs, Allen G/0000-0001-5233-2056; SAELAO, PEROT/0000-0003-1171-9187	National Aeronautics and Space Administration [NNA04CC76A, NNA05CV40A]	National Aeronautics and Space Administration(National Aeronautics & Space Administration (NASA))	This work was funded by grants from the National Aeronautics and Space Administration, NNA04CC76A and NNA05CV40A to DAK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bernal A, 2000, P NATL ACAD SCI USA, V97, P6019, DOI 10.1073/pnas.100391597; Bernal AR, 2004, DROSOPH INF SERV, V87, P81; Calderwood SK, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00075; Felix TM, 2012, GENETICS, V191, P989, DOI 10.1534/genetics.112.140640; George MD, 2009, CLIN VACCINE IMMUNOL, V16, P277, DOI 10.1128/CVI.00265-08; Giuliano John S Jr, 2011, Open Inflamm J, V4, P49; Herranz R, 2010, MOL ECOL, V19, P4255, DOI 10.1111/j.1365-294X.2010.04795.x; Lee G, 2011, J COMP NEUROL, V519, P34, DOI 10.1002/cne.22498; Marcu O, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015361; Park HH, 2006, ACTA CRYSTALLOGR F, V62, P597, DOI 10.1107/S1744309106018422; Rajaiah R, 2009, AUTOIMMUN REV, V8, P388, DOI 10.1016/j.autrev.2008.12.004; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; Stenmark H, 2001, GENOME BIOL, V2; Taylor K, 2007, FLY, V1, P197, DOI 10.4161/fly.5082; Vabulas RM, 2002, CURR TOP MICROBIOL, V270, P169; Zhou D, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000221	16	21	21	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2014	9	1							e86485	10.1371/journal.pone.0086485	http://dx.doi.org/10.1371/journal.pone.0086485			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	298QQ	24475130	Green Published, Green Submitted, gold			2022-12-25	WOS:000330339800049
J	Carbonetti, S; Oliver, BG; Glenn, J; Stamatatos, L; Sather, DN				Carbonetti, Sara; Oliver, Brian G.; Glenn, Jolene; Stamatatos, Leonidas; Sather, D. Noah			Soluble HIV-1 Envelope Immunogens Derived from an Elite Neutralizer Elicit Cross-Reactive V1V2 Antibodies and Low Potency Neutralizing Antibodies	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; HUMAN MONOCLONAL-ANTIBODIES; CD4 BINDING; SUBTYPE-C; BROAD NEUTRALIZATION; IMMUNE-RESPONSES; VACCINE EFFICACY; PARTIAL DELETION; RATIONAL DESIGN; V1/V2 DOMAIN	We evaluated four gp140 Envelope protein vaccine immunogens that were derived from an elite neutralizer, subject VC10042, whose plasma was able to potently neutralize a wide array of genetically distinct HIV-1 isolates. We sought to determine whether soluble Envelope proteins derived from the viruses circulating in VC10042 could be used as immunogens to elicit similar neutralizing antibody responses by vaccination. Each gp140 was tested in its trimeric and monomeric forms, and we evaluated two gp140 trimer vaccine regimens in which adjuvant was supplied at all four immunizations or at only the first two immunizations. Interestingly, all four Envelope immunogens elicited high titers of cross-reactive antibodies that recognize the variable regions V1V2 and are potentially similar to antibodies linked with a reduced risk of HIV-1 acquisition in the RV144 vaccine trial. Two of the four immunogens elicited neutralizing antibody responses that neutralized a wide array of HIV-1 isolates from across genetic clades, but those responses were of very low potency. There were no significant differences in the responses elicited by trimers or monomers, nor was there a significant difference between the two adjuvant regimens. Our study identified two promising Envelope immunogens that elicited anti-V1V2 antibodies and broad, but low potency, neutralizing antibody responses.	[Carbonetti, Sara; Oliver, Brian G.; Glenn, Jolene; Stamatatos, Leonidas; Sather, D. Noah] Seattle BioMed, Seattle, WA USA; [Stamatatos, Leonidas] Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA	Center for Infectious Disease Research; University of Washington; University of Washington Seattle	Sather, DN (corresponding author), Seattle BioMed, Seattle, WA USA.	noah.sather@seattlebiomed.org	Oliver, Brian/E-7939-2010	Oliver, Brian/0000-0002-7122-9262	NIH NIAID [R01-AI47708, R33-AI089405]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R33AI089405, R56AI047708, R01AI047708] Funding Source: NIH RePORTER	NIH NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was funded by NIH NIAID research grants R01-AI47708 to L.S. and R33-AI089405 to D.N.S. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelwahab SF, 2003, P NATL ACAD SCI USA, V100, P15006, DOI 10.1073/pnas.2035075100; Alam SM, 2007, J IMMUNOL, V178, P4424, DOI 10.4049/jimmunol.178.7.4424; ALLAWAY GP, 1995, AIDS RES HUM RETROV, V11, P533, DOI 10.1089/aid.1995.11.533; BURTON DR, 1994, SCIENCE, V266, P1024, DOI 10.1126/science.7973652; CAO YZ, 1995, NEW ENGL J MED, V332, P201, DOI 10.1056/NEJM199501263320401; CONLEY AJ, 1994, J VIROL, V68, P6994, DOI 10.1128/JVI.68.11.6994-7000.1994; Diskin R, 2013, J EXP MED, V210, P1235, DOI 10.1084/jem.20130221; Diskin R, 2011, SCIENCE, V334, P1289, DOI 10.1126/science.1213782; Dong M, 2003, J VIROL, V77, P3119, DOI 10.1128/JVI.77.5.3119-3130.2003; Duenas-Decamp MJ, 2008, J VIROL, V82, P5807, DOI 10.1128/JVI.02585-07; Durocher Y, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.2.e9; Gray ES, 2009, J VIROL, V83, P8925, DOI 10.1128/JVI.00758-09; Haynes BF, 2012, NEW ENGL J MED, V366, P1275, DOI 10.1056/NEJMoa1113425; Hessell AJ, 2007, NATURE, V449, P101, DOI 10.1038/nature06106; Hessell AJ, 2009, NAT MED, V15, P951, DOI 10.1038/nm.1974; Hessell AJ, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000433; Kensil C R, 1998, Expert Opin Investig Drugs, V7, P1475, DOI 10.1517/13543784.7.9.1475; Kensil CR, 2006, INFEC DIS, P221; Klein F, 2012, J EXP MED, V209, P1469, DOI 10.1084/jem.20120423; Kraft Z, 2008, J VIROL, V82, P5912, DOI 10.1128/JVI.00389-08; Kwong PD, 2012, IMMUNITY, V37, P412, DOI 10.1016/j.immuni.2012.08.012; Li M, 2005, J VIROL, V79, P10108, DOI 10.1128/JVI.79.16.10108-10125.2005; Li M, 2006, J VIROL, V80, P11776, DOI 10.1128/JVI.01730-06; Li YX, 2011, J VIROL, V85, P8954, DOI 10.1128/JVI.00754-11; Liao HX, 2013, NATURE, V496, P469, DOI 10.1038/nature12053; Long EM, 2002, AIDS RES HUM RETROV, V18, P567, DOI 10.1089/088922202753747914; Mascola JR, 1999, J VIROL, V73, P4009, DOI 10.1128/JVI.73.5.4009-4018.1999; McElrath MJ, 2010, IMMUNITY, V33, P542, DOI 10.1016/j.immuni.2010.09.011; McLellan JS, 2011, NATURE, V480, P336, DOI 10.1038/nature10696; Mikell I, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001251; Mouquet H, 2010, NATURE, V467, P591, DOI 10.1038/nature09385; Pejchal R, 2011, SCIENCE, V334, P1097, DOI 10.1126/science.1213256; Pinter A, 1998, VACCINE, V16, P1803, DOI 10.1016/S0264-410X(98)00182-0; Quinnan GV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059803; Ragupathi G, 2011, EXPERT REV VACCINES, V10, P463, DOI [10.1586/erv.11.18, 10.1586/ERV.11.18]; Rerks-Ngarm S, 2009, NEW ENGL J MED, V361, P2209, DOI 10.1056/NEJMoa0908492; Rolland M, 2012, NATURE, V490, P417, DOI 10.1038/nature11519; Sather DN, 2012, J VIROL, V86, P12676, DOI 10.1128/JVI.01893-12; Sather DN, 2010, VACCINE, V28, pB8, DOI 10.1016/j.vaccine.2009.07.085; Sather DN, 2009, J VIROL, V83, P757, DOI 10.1128/JVI.02036-08; Scanlan CN, 2002, J VIROL, V76, P7306, DOI 10.1128/JVI.76.14.7306-7321.2002; Scheid JF, 2011, SCIENCE, V333, P1633, DOI 10.1126/science.1207227; Scheid JF, 2009, NATURE, V458, P636, DOI 10.1038/nature07930; Schief WR, 2009, CURR OPIN HIV AIDS, V4, P431, DOI 10.1097/COH.0b013e32832e6184; Seaman MS, 2010, J VIROL, V84, P1439, DOI 10.1128/JVI.02108-09; Sellhorn G, 2012, J VIROL, V86, P128, DOI 10.1128/JVI.06363-11; Sellhorn G, 2009, VACCINE, V28, P430, DOI 10.1016/j.vaccine.2009.10.028; Srivastava IK, 2003, J VIROL, V77, P11244, DOI 10.1128/JVI.77.20.11244-11259.2003; Srivastava IK, 2003, J VIROL, V77, P2310, DOI 10.1128/JVI.77.4.2310-2320.2003; Srivastava IK, 2008, VIROLOGY, V372, P273, DOI 10.1016/j.virol.2007.10.022; Stamatatos L, 2009, NAT MED, V15, P866, DOI 10.1038/nm.1949; Vandepapeliere P, 2008, VACCINE, V26, P1375, DOI 10.1016/j.vaccine.2007.12.038; VUJCIC LK, 1995, AIDS RES HUM RETROV, V11, P783, DOI 10.1089/aid.1995.11.783; Walker LM, 2011, NATURE, V477, P466, DOI 10.1038/nature10373; Walker LM, 2009, SCIENCE, V326, P285, DOI 10.1126/science.1178746; Wu XL, 2011, SCIENCE, V333, P1593, DOI 10.1126/science.1207532; Wu XL, 2010, SCIENCE, V329, P856, DOI 10.1126/science.1187659; Zhang PF, 2007, P NATL ACAD SCI USA, V104, P10193, DOI 10.1073/pnas.0608635104; Zhang PF, 2002, J VIROL, V76, P644, DOI 10.1128/JVI.76.2.644-655.2002; Zwick MB, 2001, J VIROL, V75, P10892, DOI 10.1128/JVI.75.22.10892-10905.2001	60	17	20	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2014	9	1							e86905	10.1371/journal.pone.0086905	http://dx.doi.org/10.1371/journal.pone.0086905			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297XI	24466285	Green Published, Green Submitted, gold			2022-12-25	WOS:000330288000168
J	Cao, DL; Kishida, S; Huang, P; Mu, P; Tsubota, S; Mizuno, M; Kadomatsu, K				Cao, Dongliang; Kishida, Satoshi; Huang, Peng; Mu, Ping; Tsubota, Shoma; Mizuno, Masaaki; Kadomatsu, Kenji			A New Tumorsphere Culture Condition Restores Potentials of Self-Renewal and Metastasis of Primary Neuroblastoma in a Mouse Neuroblastoma Model	PLOS ONE			English	Article							TUMOR-INITIATING CELL; STEM-CELL; GROWTH; DIFFERENTIATION; MEDULLOBLASTOMA; SUBPOPULATION; GLIOBLASTOMA; CANCER; GLIOMA	Tumorsphere culture enriches and expands tumor cells, thus providing important resources for cancer studies. However, as compared with metastatic tissues, primary tumors in the nervous system rarely give rise to long-surviving tumorspheres, thereby seriously limiting studies on these cancers. This might be due to the limited self-renewal capability of tumor cells and/or to inappropriate culture conditions. The growth and maintenance of tumor cells may depend on microenvironments and/or cell origins (e.g., primary or metastatic; stem cell-like or progenitor-like). Here, we attempted to establish a tumorsphere culture condition for primary neuroblastoma (NB). Primary tumors in MYCN transgenic mice, a NB model, could be serially transplanted, suggesting that these tumors contain cells with a high self-renewal potential. However, primary tumors did not give rise to tumorspheres under a serum-free neurosphere culture condition. The newly established culture condition (named PrimNeuS) contained two critical ingredients: fetal bovine serum and beta-mercaptoethanol were essential for tumorsphere formation as well as indefinite passages. The spheres could be passaged more than 20 times without exhaustion under this condition, exhibited a property of differentiation and formed tumors in vivo. Unexpectedly, PrimNeuS revealed that the MYCN transgenic mice had bone marrow metastasis. Furthermore, subcutaneous tumors derived from tumorspheres of primary tumors showed bone marrow metastasis. Taken together, PrimNeuS provides resources for the study of NB and can be used as a powerful tool for the detection of minimal residual disease and for in vitro evaluation prior to personalized therapy.	[Cao, Dongliang; Kishida, Satoshi; Huang, Peng; Mu, Ping; Tsubota, Shoma; Kadomatsu, Kenji] Nagoya Univ, Sch Med, Dept Biochem, Grad Sch Med, Nagoya, Aichi 466, Japan; [Mizuno, Masaaki] Nagoya Univ Hosp, Ctr Adv Med & Clin Res, Nagoya, Aichi, Japan	Nagoya University; Nagoya University	Kadomatsu, K (corresponding author), Nagoya Univ, Sch Med, Dept Biochem, Grad Sch Med, Nagoya, Aichi 466, Japan.	kkadoma@med.nagoya-u.ac.jp	Tsubota, Shoma/L-2665-2019; MU, Ping/I-7546-2014; KISHIDA, Satoshi/I-7265-2014; Kadomatsu, Kenji/G-8083-2012	Tsubota, Shoma/0000-0001-8609-6784; 	National Cancer Center Research and Development Fund [22-4]; Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan [23110002]; MEXT [23390078, 24590377]	National Cancer Center Research and Development Fund(National Cancer Center - Japan); Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by a grant-in-aid from the National Cancer Center Research and Development Fund (22-4 to KK; http://www.cancer.gov/cancertopics/factsheet/NCI/NCI); by a Grant-in-Aid for Scientific Research on Innovative Areas (23110002 to KK) from the Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan (http://www.molecular-activation.jp/index_e.html); by Grants-in-Aid from MEXT (23390078 to KK; 24590377 to SK); Grant-in-Aid for Scientific Research on Innovative Areas to MM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ang YS, 2011, CELL, V145, P183, DOI 10.1016/j.cell.2011.03.003; Barrett LE, 2012, CANCER CELL, V21, P11, DOI 10.1016/j.ccr.2011.11.025; Brodeur GM, 2003, NAT REV CANCER, V3, P203, DOI 10.1038/nrc1014; Chen J, 2012, NATURE, V488, P522, DOI 10.1038/nature11287; Chen RH, 2010, CANCER CELL, V17, P362, DOI 10.1016/j.ccr.2009.12.049; Clarke Michael F, 2006, Cancer Res, V66, P9339, DOI 10.1158/0008-5472.CAN-06-3126; Dong CF, 2013, CANCER CELL, V23, P316, DOI 10.1016/j.ccr.2013.01.022; Fang D, 2005, CANCER RES, V65, P9328, DOI 10.1158/0008-5472.CAN-05-1343; Hanna JH, 2010, CELL, V143, P508, DOI 10.1016/j.cell.2010.10.008; Hansford LM, 2007, CANCER RES, V67, P11234, DOI 10.1158/0008-5472.CAN-07-0718; Hu YF, 2009, J IMMUNOL METHODS, V347, P70, DOI 10.1016/j.jim.2009.06.008; Huang P, 2011, CANCER RES, V71, P2938, DOI 10.1158/0008-5472.CAN-10-3524; Kamiya D, 2011, NATURE, V470, P503, DOI 10.1038/nature09726; Kawasaki H, 2000, NEURON, V28, P31, DOI 10.1016/S0896-6273(00)00083-0; Kawauchi D, 2012, CANCER CELL, V21, P168, DOI 10.1016/j.ccr.2011.12.023; Lee J, 2006, CANCER CELL, V9, P391, DOI 10.1016/j.ccr.2006.03.030; Nakagawara A, 2004, CANCER LETT, V204, P213, DOI 10.1016/S0304-3835(03)00457-9; Read TA, 2012, CANCER CELL, V21, P1, DOI 10.1016/j.ccr.2011.12.011; Read TA, 2009, CANCER CELL, V15, P135, DOI 10.1016/j.ccr.2008.12.016; Roesch A, 2010, CELL, V141, P583, DOI 10.1016/j.cell.2010.04.020; Tarek N, 2012, J CLIN INVEST, V122, P3260, DOI 10.1172/JCI62749; Tsai HC, 2012, CANCER CELL, V21, P430, DOI 10.1016/j.ccr.2011.12.029; Watanabe K, 2005, NAT NEUROSCI, V8, P288, DOI 10.1038/nn1402	23	13	13	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2014	9	1							e86813	10.1371/journal.pone.0086813	http://dx.doi.org/10.1371/journal.pone.0086813			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297VL	24466252	gold, Green Published			2022-12-25	WOS:000330283100220
J	Davoudi, M; Kotarsky, H; Hansson, E; Fellman, V				Davoudi, Mina; Kotarsky, Heike; Hansson, Eva; Fellman, Vineta			Complex I Function and Supercomplex Formation Are Preserved in Liver Mitochondria Despite Progressive Complex III Deficiency	PLOS ONE			English	Article							CYTOCHROME BC(1) COMPLEX; PERMEABILITY TRANSITION; MAMMALIAN MITOCHONDRIA; RESPIRATORY-CHAIN; GRACILE SYNDROME; IRON-OVERLOAD; PROTEIN; RESPIRASOME; MUTATION; ABSENCE	Functional oxidative phosphorylation requires appropriately assembled mitochondrial respiratory complexes and their supercomplexes formed mainly of complexes I, III and IV. BCS1L is the chaperone needed to incorporate the catalytic subunit, Rieske iron-sulfur protein, into complex III at the final stage of its assembly. In cell culture studies, this subunit has been considered necessary for supercomplex formation and for maintaining the stability of complex I. Our aim was to assess the importance of fully assembled complex III for supercomplex formation in intact liver tissue. We used our transgenic mouse model with a homozygous c.232>A. G mutation in Bcs1l leading to decreased expression of BCS1L and progressive decrease of Rieske iron-sulfur protein in complex III, resulting in hepatopathy. We studied supercomplex formation at different ages using blue native gel electrophoresis and complex activity using high-resolution respirometry. In isolated liver mitochondria of young and healthy homozygous mutant mice, we found similar supercomplexes as in wild type. In homozygotes aged 27-29 days with liver disorder, complex III was predominantly a pre-complex lacking Rieske iron-sulfur protein. However, the main supercomplex was clearly detected and contained complex III mainly in the pre-complex form. Oxygen consumption of complex IV was similar and that of complex I was twofold compared with controls. These complexes in free form were more abundant in homozygotes than in controls, and the mRNA of complex I subunits were upregulated. In conclusion, when complex III assembly is deficient, the pre-complex without Rieske iron-sulfur protein can participate with available fully assembled complex III in supercomplex formation, complex I function is preserved, and respiratory chain stability is maintained.	[Davoudi, Mina; Kotarsky, Heike; Hansson, Eva; Fellman, Vineta] Lund Univ, Dept Pediat, Lund, Sweden; [Fellman, Vineta] Folkhalsan Res Ctr, Helsinki, Finland; [Fellman, Vineta] Univ Helsinki, Childrens Hosp, Helsinki Univ Hosp, Helsinki, Finland	Lund University; Folkhalsan Research Center; University of Helsinki; Helsinki University Central Hospital	Fellman, V (corresponding author), Lund Univ, Dept Pediat, Lund, Sweden.	Vineta.Fellman@med.lu.se		Davoudi, Mina/0000-0002-4952-1099	Swedish Research Council; Swedish State Clinical/Translational Fundinging(	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish State Clinical/Translational Fundinging(	Research funding: Swedish Research Council (http://www.vr.se/inenglish.4.12fff4451215cbd83e4800015152.html). Swedish State Clinical/Translational Fundinging("ALF'', www.med.lu.se/alf). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acin-Perez R, 2004, MOL CELL, V13, P805, DOI 10.1016/S1097-2765(04)00124-8; Acin-Perez R, 2008, MOL CELL, V32, P529, DOI 10.1016/j.molcel.2008.10.021; Bianchi C, 2004, J BIOL CHEM, V279, P36562, DOI 10.1074/jbc.M405135200; Calvaruso MA, 2012, HUM MOL GENET, V21, P115, DOI 10.1093/hmg/ddr446; Chen YC, 2012, CELL METAB, V15, P348, DOI 10.1016/j.cmet.2012.02.006; Diaz F, 2012, MOL CELL BIOL, V32, P415, DOI 10.1128/MCB.06051-11; Dudkina NV, 2011, P NATL ACAD SCI USA, V108, P15196, DOI 10.1073/pnas.1107819108; Fellman V, 1998, LANCET, V351, P490, DOI 10.1016/S0140-6736(97)09272-6; Ghezzi D, 2012, ADV EXP MED BIOL, V748, P65, DOI 10.1007/978-1-4614-3573-0_4; Gnaiger E, 2009, INT J BIOCHEM CELL B, V41, P1837, DOI 10.1016/j.biocel.2009.03.013; Hansson MJ, 2003, BRAIN RES, V960, P99, DOI 10.1016/S0006-8993(02)03798-8; Ikeda K, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3147; Kotarsky H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041156; Kotarsky H, 2010, MITOCHONDRION, V10, P497, DOI 10.1016/j.mito.2010.05.009; Lapuente-Brun E, 2013, SCIENCE, V340, P1567, DOI 10.1126/science.1230381; Leveen P, 2011, HEPATOLOGY, V53, P437, DOI 10.1002/hep.24031; Mansson R, 2007, NEUROBIOL DIS, V25, P198, DOI 10.1016/j.nbd.2006.09.008; Maranzana E, 2013, ANTIOXID REDOX SIGN, V19, P1469, DOI 10.1089/ars.2012.4845; Mineri R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005713; Moreno-Lastres D, 2012, CELL METAB, V15, P324, DOI 10.1016/j.cmet.2012.01.015; Schagger H, 2004, J BIOL CHEM, V279, P36349, DOI 10.1074/jbc.M404033200; Schagger H, 2000, EMBO J, V19, P1777, DOI 10.1093/emboj/19.8.1777; SCHAGGER H, 1994, ANAL BIOCHEM, V217, P220, DOI 10.1006/abio.1994.1112; Smith PM, 2012, BBA-BIOENERGETICS, V1817, P276, DOI 10.1016/j.bbabio.2011.11.009; Strogolova V, 2012, MOL CELL BIOL, V32, P1363, DOI 10.1128/MCB.06369-11; Visapaa I, 2002, AM J HUM GENET, V71, P863, DOI 10.1086/342773; Vukotic M, 2012, CELL METAB, V15, P336, DOI 10.1016/j.cmet.2012.01.016; Wenz T, 2009, BBA-BIOENERGETICS, V1787, P609, DOI 10.1016/j.bbabio.2009.02.012	28	15	15	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2014	9	1							e86767	10.1371/journal.pone.0086767	http://dx.doi.org/10.1371/journal.pone.0086767			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297VL	24466228	Green Published, gold, Green Submitted			2022-12-25	WOS:000330283100210
J	Hong, IS; Lee, HY; Kim, HP				Hong, In-Sun; Lee, Hwa-Yong; Kim, Hyun-Pyo			Anti-Oxidative Effects of Rooibos Tea (Aspalathus linearis) on Immobilization-Induced Oxidative Stress in Rat Brain	PLOS ONE			English	Article							HONEYBUSH CYCLOPIA-INTERMEDIA; CAMELLIA-SINENSIS TEAS; PULMONATE LAND SNAIL; AFRICAN HERBAL TEAS; NEURODEGENERATIVE DISEASES; LIPID-PEROXIDATION; PSYCHIATRIC-DISORDERS; GLUTATHIONE-REDUCTASE; SUPEROXIDE-DISMUTASE; CARBON-TETRACHLORIDE	Exposure to chronic psychological stress may be related to increased reactive oxygen species (ROS) or free radicals, and thus, long-term exposure to high levels of oxidative stress may cause the accumulation of oxidative damage and eventually lead to many neurodegenerative diseases. Compared with other organs, the brain appears especially susceptible to excessive oxidative stress due to its high demand for oxygen. In the case of excessive ROS production, endogenous defense mechanisms against ROS may not be sufficient to suppress ROS-associated oxidative damage. Dietary antioxidants have been shown to protect neurons against a variety of experimental neurodegenerative conditions. In particular, Rooibos tea might be a good source of antioxidants due to its larger proportion of polyphenolic compounds. An optimal animal model for stress should show the features of a stress response and should be able to mimic natural stress progression. However, most animal models of stress, such as cold-restraint, electric foot shock, and burn shock, usually involve physical abuse in addition to the psychological aspects of stress. Animals subjected to chronic restraint or immobilization are widely believed to be a convenient and reliable model to mimic psychological stress. Therefore, in the present study, we propose that immobilization-induced oxidative stress was significantly attenuated by treatment with Rooibos tea. This conclusion is demonstrated by Rooibos tea's ability to (i) reverse the increase in stress-related metabolites (5-HIAA and FFA), (ii) prevent lipid peroxidation (LPO), (iii) restore stress-induced protein degradation (PD), (iv) regulate glutathione metabolism (GSH and GSH/GSSG ratio), and (v) modulate changes in the activities of antioxidant enzymes (SOD and CAT).	[Hong, In-Sun; Lee, Hwa-Yong] Seoul Natl Univ, Adult Stem Cell Res Ctr, Seoul, South Korea; [Hong, In-Sun; Lee, Hwa-Yong] Seoul Natl Univ, Dept Vet Publ Hlth, Lab Stem Cell & Tumor Biol, Seoul, South Korea; [Kim, Hyun-Pyo] Jungwon Univ, Dept Biomed Sci, Chungbuk, South Korea	Seoul National University (SNU); Seoul National University (SNU); Jungwon University	Kim, HP (corresponding author), Jungwon Univ, Dept Biomed Sci, Chungbuk, South Korea.	khpsss@jwu.ac.kr			Animal and Plant Quarantine Agency, Ministry of Agriculture, Food and Rural Affairs [Z-1541745-2012-13-09]	Animal and Plant Quarantine Agency, Ministry of Agriculture, Food and Rural Affairs	This study was supported by a grant (Project Code No., Z-1541745-2012-13-09) from Animal and Plant Quarantine Agency, Ministry of Agriculture, Food and Rural Affairs. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADEOLA O, 1993, J ANIM SCI, V71, P968, DOI 10.2527/1993.714968x; Al-Abrash ASA, 2000, SAUDI MED J, V21, P826; Baba H, 2009, PEDIATR INT, V51, P700, DOI 10.1111/j.1442-200X.2009.02835.x; Behl C, 2002, BIOL CHEM, V383, P521, DOI 10.1515/BC.2002.053; Behl C, 2002, FREE RADICAL BIO MED, V33, P182, DOI 10.1016/S0891-5849(02)00883-3; BENEDETTI A, 1980, BIOCHIM BIOPHYS ACTA, V620, P281, DOI 10.1016/0005-2760(80)90209-X; Benzie IFF, 1999, NUTR CANCER, V34, P83, DOI 10.1207/S15327914NC340112; Berlett BS, 1997, J BIOL CHEM, V272, P20313, DOI 10.1074/jbc.272.33.20313; BOVERIS A, 1973, BIOCHEM J, V134, P707, DOI 10.1042/bj1340707; Bramati L, 2002, J AGR FOOD CHEM, V50, P5513, DOI 10.1021/jf025697h; Buege J A, 1978, Methods Enzymol, V52, P302; Byers JP, 2006, TOXICOLOGY, V228, P291, DOI 10.1016/j.tox.2006.09.009; Chen W, 2013, PHYTOMEDICINE, V20, P380, DOI 10.1016/j.phymed.2012.10.006; Claeyssen R, 2008, BIOL TRACE ELEM RES, V126, pS80, DOI 10.1007/s12011-008-8210-z; CORTAMIRA NO, 1991, BRIT J NUTR, V66, P423, DOI 10.1079/BJN19910045; Couto N, 2013, J PROTEOME RES, V12, P2885, DOI 10.1021/pr4001948; Das A, 2000, PHARMACOL RES, V42, P213, DOI 10.1006/phrs.2000.0678; Dringen R, 2000, EUR J BIOCHEM, V267, P4912, DOI 10.1046/j.1432-1327.2000.01597.x; Dringen R, 2000, PROG NEUROBIOL, V62, P649, DOI 10.1016/S0301-0082(99)00060-X; Esch T, 2002, NEUROENDOCRINOL LETT, V23, P199; Esch Tobias, 2003, Med Sci Monit, V9, pRA23; ESTERBAUER H, 1991, FREE RADICAL BIO MED, V11, P81, DOI 10.1016/0891-5849(91)90192-6; FORDYCE MK, 1975, J NUTR, V105, P1150, DOI 10.1093/jn/105.9.1150; FUCCI L, 1983, P NATL ACAD SCI-BIOL, V80, P1521, DOI 10.1073/pnas.80.6.1521; Fukasawa R, 2009, J OLEO SCI, V58, P275, DOI 10.5650/jos.58.275; GALASKO GTF, 1989, FOOD CHEM TOXICOL, V27, P49, DOI 10.1016/0278-6915(89)90092-6; Gawryluk JW, 2011, INT J NEUROPSYCHOPH, V14, P123, DOI 10.1017/S1461145710000805; GERLACH M, 1994, J NEUROCHEM, V63, P793, DOI 10.1046/j.1471-4159.1994.63030793.x; Gilgun-Sherki Y, 2001, NEUROPHARMACOLOGY, V40, P959, DOI 10.1016/S0028-3908(01)00019-3; GUTTERIDGE JMC, 1995, CLIN CHEM, V41, P1819; HALLIWELL B, 1994, LANCET, V344, P721, DOI 10.1016/S0140-6736(94)92211-X; HERMESLIMA M, 1995, AM J PHYSIOL-REG I, V268, pR1386, DOI 10.1152/ajpregu.1995.268.6.R1386; Jorgensen H, 2002, EUR J ENDOCRINOL, V147, P815, DOI 10.1530/eje.0.1470815; Joshi D, 2005, J MED FOOD, V8, P392, DOI 10.1089/jmf.2005.8.392; Joubert E, 2009, J AGR FOOD CHEM, V57, P4204, DOI 10.1021/jf9005033; Kawano A, 2009, PHYTOMEDICINE, V16, P437, DOI 10.1016/j.phymed.2008.11.009; Kelly G S, 1999, Altern Med Rev, V4, P249; KOEPPEN BH, 1966, BIOCHEM J, V99, P604, DOI 10.1042/bj0990604; Koopmans SJ, 2005, PHYSIOL BEHAV, V85, P469, DOI 10.1016/j.physbeh.2005.05.010; Kovacs P, 1996, PHARMAZIE, V51, P51; Kucharska J, 2004, PHYSIOL RES, V53, P515; Kullisaar T, 2003, BRIT J NUTR, V90, P449, DOI 10.1079/BJN2003896; Kumar P, 2006, BEHAV PHARMACOL, V17, P485, DOI 10.1097/00008877-200609000-00014; Lamosova D, 1997, COMP BIOCHEM PHYS C, V116, P39, DOI 10.1016/S0742-8413(96)00138-7; Lampe JW, 1999, AM J CLIN NUTR, V70, p475S, DOI 10.1093/ajcn/70.3.475s; Landis GN, 2005, MECH AGEING DEV, V126, P365, DOI 10.1016/j.mad.2004.08.012; Lepage O, 2003, J EXP BIOL, V206, P3589, DOI 10.1242/jeb.00614; Liu JK, 1999, NEUROCHEM RES, V24, P1479, DOI 10.1023/A:1022597010078; Liu JK, 1996, FASEB J, V10, P1532, DOI 10.1096/fasebj.10.13.8940299; Lu J, 2006, BEHAV BRAIN RES, V171, P251, DOI 10.1016/j.bbr.2006.03.043; Lyle N, 2012, NEUROCHEM RES, V37, P2748, DOI 10.1007/s11064-012-0867-1; Madrigal JLM, 2001, J NEUROCHEM, V76, P532, DOI 10.1046/j.1471-4159.2001.00108.x; Maestre I, 2003, ENDOCRINOLOGY, V144, P335, DOI 10.1210/en.2001-211282; Mariani E, 2005, J CHROMATOGR B, V827, P65, DOI 10.1016/j.jchromb.2005.04.023; Marnewick J, 2005, CANCER LETT, V224, P193, DOI 10.1016/j.canlet.2004.11.014; Marnewick JL, 2011, J ETHNOPHARMACOL, V133, P46, DOI 10.1016/j.jep.2010.08.061; Marnewick JL, 2009, FOOD CHEM TOXICOL, V47, P220, DOI 10.1016/j.fct.2008.11.004; Marnewick JL, 2000, MUTAT RES-GEN TOX EN, V471, P157, DOI 10.1016/S1383-5718(00)00128-5; Marnewick JL, 2004, MUTAT RES-GEN TOX EN, V558, P145, DOI 10.1016/j.mrgentox.2003.12.003; Marnewick JL, 2003, J AGR FOOD CHEM, V51, P8113, DOI 10.1021/jf0344643; McEwen BS, 2004, ANN NY ACAD SCI, V1032, P1, DOI 10.1196/annals.1314.001; Metz GA, 2005, EUR J NEUROSCI, V22, P1190, DOI 10.1111/j.1460-9568.2005.04285.x; MISRA HP, 1972, J BIOL CHEM, V247, P3170; Miyamoto Y, 2003, BIOL CHEM, V384, P567, DOI 10.1515/BC.2003.064; MOHANDAS J, 1984, BIOCHEM PHARMACOL, V33, P1801, DOI 10.1016/0006-2952(84)90353-8; Mozaffarian D, 2007, EUR HEART J, V28, P2699, DOI 10.1093/eurheartj/ehm451; Nadaoka I, 2012, BIOMED RES-TOKYO, V33, P133, DOI 10.2220/biomedres.33.133; Naidu PS, 2004, PHARMACOLOGY, V70, P59, DOI 10.1159/000074669; Pastore A, 2001, CLIN CHEM, V47, P1467; Posmyk MM, 2005, J PLANT PHYSIOL, V162, P403, DOI 10.1016/j.jplph.2004.08.004; Poulsen HE, 1998, EUR J CANCER PREV, V7, P9; Ramos-Vasconcelos GR, 2003, J EXP BIOL, V206, P675, DOI 10.1242/jeb.00124; Sahin E, 2004, BEHAV BRAIN RES, V155, P241, DOI 10.1016/j.bbr.2004.04.022; Schuliga M, 2002, TOXICOL SCI, V70, P183, DOI 10.1093/toxsci/70.2.183; SIES H, 1993, EUR J BIOCHEM, V215, P213, DOI 10.1111/j.1432-1033.1993.tb18025.x; STADTMAN ER, 1990, FREE RADICAL BIO MED, V9, P315, DOI 10.1016/0891-5849(90)90006-5; Suresh S, 2010, INT J ANDROL, V33, P22, DOI 10.1111/j.1365-2605.2008.00949.x; TIETZE F, 1969, ANAL BIOCHEM, V27, P502, DOI 10.1016/0003-2697(69)90064-5; Torres ILS, 2001, BRAZ J MED BIOL RES, V34, P241, DOI 10.1590/S0100-879X2001000200012; Trevisanato SI, 2000, NUTR REV, V58, P1, DOI 10.1111/j.1753-4887.2000.tb01818.x; Ulicna O, 2008, GEN PHYSIOL BIOPHYS, V27, P179; Ulicna O, 2006, PHYSIOL RES, V55, P157, DOI 10.33549/physiolres.930778; Uysal N, 2005, PHYSIOL RES, V54, P437, DOI 10.33549/physiolres.930632; Valko M, 2007, INT J BIOCHEM CELL B, V39, P44, DOI 10.1016/j.biocel.2006.07.001; Wang XL, 2004, DIABETES, V53, P129, DOI 10.2337/diabetes.53.1.129; Wilson JX, 1997, CAN J PHYSIOL PHARM, V75, P1149, DOI 10.1139/cjpp-75-10-11-1149; WINBERG S, 1993, NEUROREPORT, V4, P399, DOI 10.1097/00001756-199304000-00014; Wolf R, 1998, J EUR ACAD DERMATOL, V10, P103, DOI 10.1111/j.1468-3083.1998.tb00709.x; YOSHIKAWA T, 1990, ADV EXP MED BIOL, V264, P171; Zaidi SMKR, 2004, CLIN CHIM ACTA, V340, P229, DOI 10.1016/j.cccn.2003.11.003	91	44	47	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2014	9	1							e87061	10.1371/journal.pone.0087061	http://dx.doi.org/10.1371/journal.pone.0087061			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297GT	24466326	Green Published, Green Submitted, gold			2022-12-25	WOS:000330244500290
J	Tada, Y; Yamaguchi, Y; Kinjo, T; Song, X; Akagi, T; Takamura, H; Ohta, T; Yokota, T; Koide, H				Tada, Y.; Yamaguchi, Y.; Kinjo, T.; Song, X.; Akagi, T.; Takamura, H.; Ohta, T.; Yokota, T.; Koide, H.			The stem cell transcription factor ZFP57 induces IGF2 expression to promote anchorage-independent growth in cancer cells	ONCOGENE			English	Article						ZFP57; IGF2; anchorage-independent growth; HT1080; transformation	SELF-RENEWAL; DNA METHYLATION; PLURIPOTENCY; NANOG; GENE; ACTIVATION; OCT-3/4; DIFFERENTIATION; IDENTIFICATION; MAINTENANCE	Several common biological properties between cancer cells and embryonic stem (ES) cells suggest the possibility that some genes expressed in ES cells might have important roles in cancer cell growth. The transcription factor ZFP57 is expressed in self-renewing ES cells and its expression level decreases during ES cell differentiation. This study showed that ZFP57 is involved in the anchorage-independent growth of human fibrosarcoma HT1080 cells in soft agar. ZFP57 overexpression enhanced, whereas knockdown suppressed, HT1080 tumor formation in nude mice. Furthermore, ZFP57 regulates the expression of insulin-like growth factor 2 (IGF2), which has a critical role in ZFP57-induced anchorage-independent growth. ZFP57 also promotes anchorage-independent growth in ES cells and immortal fibroblasts. Finally, immunohistochemical analysis revealed that ZFP57 is overexpressed in human cancer clinical specimens. Taken together, these results suggest that the ES-specific transcription factor ZFP57 is a novel oncogene.	[Tada, Y.; Kinjo, T.; Song, X.; Akagi, T.; Yokota, T.; Koide, H.] Kanazawa Univ, Grad Sch Med Sci, Dept Stem Cell Biol, Kanazawa, Ishikawa 9208640, Japan; [Yamaguchi, Y.; Takamura, H.; Ohta, T.] Kanazawa Univ, Grad Sch Med Sci, Dept Surg Gastroenterol, Kanazawa, Ishikawa 9208640, Japan	Kanazawa University; Kanazawa University	Koide, H (corresponding author), Kanazawa Univ, Grad Sch Med Sci, Dept Stem Cell Biol, 13-1 Takara Machi, Kanazawa, Ishikawa 9208640, Japan.	hkoide@med.kanazawa-u.ac.jp	Yokota, Takashi/J-8483-2015; Akagi, Tadayuki/E-1078-2011	Akagi, Tadayuki/0000-0002-1733-9452; Koide, Hiroshi/0000-0001-5916-3179; Kinjo, Tomoaki/0000-0003-0939-7756	Ministry of Education, Culture, Sports, Science and Technology of Japan; Hokkoku Foundation for Cancer Research; Cancer Research Institute, Kanazawa University	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Hokkoku Foundation for Cancer Research; Cancer Research Institute, Kanazawa University	We are grateful to Drs Chuanhai Sun and Hitoshi Niwa for providing pCAGPMN(PvuII-MfeI)- CreER and pBRPyCAG-fKlf4-DsRed-IP, respectively. We also thank the Center for Biomedical Research and Education at Kanazawa University for the use of their DNA sequencer. This work was partly supported by Grants-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan, a grant from the Hokkoku Foundation for Cancer Research and an Extramural Collaborative Research Grant from the Cancer Research Institute, Kanazawa University.	Akagi T, 2005, BIOCHEM BIOPH RES CO, V331, P23, DOI 10.1016/j.bbrc.2005.03.118; Alonso MBD, 2004, J BIOL CHEM, V279, P25653, DOI 10.1074/jbc.M400415200; Baglivo I, 2013, FEBS LETT, V587, P1474, DOI 10.1016/j.febslet.2013.02.045; Ben-Porath I, 2008, NAT GENET, V40, P499, DOI 10.1038/ng.127; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Chambers I, 2003, CELL, V113, P643, DOI 10.1016/S0092-8674(03)00392-1; Chambers I, 2007, NATURE, V450, P1230, DOI 10.1038/nature06403; Chao W, 2008, CYTOKINE GROWTH F R, V19, P111, DOI 10.1016/j.cytogfr.2008.01.005; CIFONE MA, 1980, P NATL ACAD SCI-BIOL, V77, P1039, DOI 10.1073/pnas.77.2.1039; Evangelista M, 2006, CLIN CANCER RES, V12, P5924, DOI 10.1158/1078-0432.CCR-06-1736; EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0; Falix FA, 2012, BBA-MOL BASIS DIS, V1822, P988, DOI 10.1016/j.bbadis.2012.02.003; Farazi TA, 2011, J PATHOL, V223, P102, DOI 10.1002/path.2806; Gilmore AP, 2005, CELL DEATH DIFFER, V12, P1473, DOI 10.1038/sj.cdd.4401723; Holm TM, 2005, CANCER CELL, V8, P275, DOI 10.1016/j.ccr.2005.09.007; Huarte M, 2010, HUM MOL GENET, V19, pR152, DOI 10.1093/hmg/ddq353; Jelinic P, 2007, J PATHOL, V211, P261, DOI 10.1002/path.2116; Jeter CR, 2009, STEM CELLS, V27, P993, DOI 10.1002/stem.29; Li XJ, 2008, DEV CELL, V15, P547, DOI 10.1016/j.devcel.2008.08.014; Loh YH, 2006, NAT GENET, V38, P431, DOI 10.1038/ng1760; Lui JC, 2013, P NATL ACAD SCI USA, V110, P6181, DOI 10.1073/pnas.1219079110; Mackay DJG, 2008, NAT GENET, V40, P949, DOI 10.1038/ng.187; MARTIN GR, 1981, P NATL ACAD SCI-BIOL, V78, P7634, DOI 10.1073/pnas.78.12.7634; Masui S, 2007, NAT CELL BIOL, V9, P625, DOI 10.1038/ncb1589; Matsuda T, 1999, EMBO J, V18, P4261, DOI 10.1093/emboj/18.15.4261; Mitsui K, 2003, CELL, V113, P631, DOI 10.1016/S0092-8674(03)00393-3; Mori S, 2009, ONCOGENE, V28, P2796, DOI 10.1038/onc.2009.139; Nichols J, 1998, CELL, V95, P379, DOI 10.1016/S0092-8674(00)81769-9; Niwa H, 2000, NAT GENET, V24, P372, DOI 10.1038/74199; Niwa H, 1998, GENE DEV, V12, P2048, DOI 10.1101/gad.12.13.2048; Niwa H, 2007, DEVELOPMENT, V134, P635, DOI 10.1242/dev.02787; Ogawa K, 2006, BIOCHEM BIOPH RES CO, V343, P159, DOI 10.1016/j.bbrc.2006.02.127; OKAZAKI S, 1994, J BIOL CHEM, V269, P6900; Polakis P, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a008052; Pollak M, 2008, NAT REV CANCER, V8, P915, DOI 10.1038/nrc2536; Quenneville S, 2011, MOL CELL, V44, P361, DOI 10.1016/j.molcel.2011.08.032; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Royo H, 2008, BIOL CELL, V100, P149, DOI 10.1042/BC20070126; Samani AA, 2007, ENDOCR REV, V28, P20, DOI 10.1210/er.2006-0001; Sato N, 2004, NAT MED, V10, P55, DOI 10.1038/nm979; Schoonjans K, 2005, P NATL ACAD SCI USA, V102, P2058, DOI 10.1073/pnas.0409756102; Smith AG, 2001, ANNU REV CELL DEV BI, V17, P435, DOI 10.1146/annurev.cellbio.17.1.435; Taddei ML, 2012, J PATHOL, V226, P380, DOI 10.1002/path.3000; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Takao Y, 2007, BIOCHEM BIOPH RES CO, V353, P699, DOI 10.1016/j.bbrc.2006.12.072; Ueda A., 2012, J JUZEN MED SOC, V121, P38; Yoshida-Koide U, 2004, BIOCHEM BIOPH RES CO, V313, P475, DOI 10.1016/j.bbrc.2003.11.138; Yu H, 2004, NAT REV CANCER, V4, P97, DOI 10.1038/nrc1275; Zuo XP, 2012, J BIOL CHEM, V287, P2107, DOI 10.1074/jbc.M111.322644	49	25	25	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB 5	2015	34	6					752	760		10.1038/onc.2013.599	http://dx.doi.org/10.1038/onc.2013.599			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CA4DG	24469060	Green Submitted			2022-12-25	WOS:000348853800008
J	Labidi-Galy, SI; Clauss, A; Ng, V; Duraisamy, S; Elias, KM; Piao, HY; Bilal, E; Davidowitz, RA; Lu, Y; Badalian-Very, G; Gyorffy, B; Kang, UB; Ficarro, S; Ganesan, S; Mills, GB; Marto, JA; Drapkin, R				Labidi-Galy, S. I.; Clauss, A.; Ng, V.; Duraisamy, S.; Elias, K. M.; Piao, H-Y; Bilal, E.; Davidowitz, R. A.; Lu, Y.; Badalian-Very, G.; Gyoerffy, B.; Kang, U-B; Ficarro, S.; Ganesan, S.; Mills, G. B.; Marto, J. A.; Drapkin, R.			Elafin drives poor outcome in high-grade serous ovarian cancers and basal-like breast tumors	ONCOGENE			English	Article						elafin; ovarian cancer; basal-like breast cancer; mitogen; MAP kinase	MAMMARY EPITHELIAL-CELLS; VERSUS-HOST-DISEASE; GENOMIC INSTABILITY; MICROARRAY DATA; EXPRESSION; PROTEIN; VALIDATION; SURVIVAL; GENES; HE-4	High-grade serous ovarian carcinoma (HGSOC) and basal-like breast cancer (BLBC) share many features including TP53 mutations, genomic instability and poor prognosis. We recently reported that Elafin is overexpressed by HGSOC and is associated with poor overall survival. Here, we confirm that Elafin overexpression is associated with shorter survival in 1000 HGSOC patients. Elafin confers a proliferative advantage to tumor cells through the activation of the MAP kinase pathway. This mitogenic effect can be neutralized by RNA interference, specific antibodies and a MEK inhibitor. Elafin expression in patient-derived samples was also associated with chemoresistance and strongly correlates with bcl-xL expression. We extended these findings into the examination of 1100 primary breast tumors and six breast cancer cell lines. We observed that Elafin is overexpressed and secreted specifically by BLBC tumors and cell lines, leading to a similar mitogenic effect through activation of the MAP kinase pathway. Here too, Elafin overexpression is associated with poor overall survival, suggesting that it may serve as a biomarker and therapeutic target in this setting.	[Labidi-Galy, S. I.; Clauss, A.; Ng, V.; Duraisamy, S.; Elias, K. M.; Piao, H-Y; Badalian-Very, G.; Drapkin, R.] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02215 USA; [Labidi-Galy, S. I.; Clauss, A.; Duraisamy, S.; Elias, K. M.; Badalian-Very, G.; Kang, U-B; Ficarro, S.; Marto, J. A.; Drapkin, R.] Harvard Univ, Sch Med, Boston, MA USA; [Elias, K. M.] Brigham & Womens Hosp, Div Gynecol Oncol, Boston, MA 02115 USA; [Bilal, E.; Ganesan, S.] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Canc Inst New Jersey, New Brunswick, NJ USA; [Davidowitz, R. A.] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA USA; [Lu, Y.; Mills, G. B.] Univ Texas MD Anderson Canc Ctr, Dept Syst Biol, Houston, TX 77030 USA; [Gyoerffy, B.] Hungarian Acad Sci, Res Lab Pediat & Nephrol, Budapest, Hungary; [Kang, U-B; Ficarro, S.; Marto, J. A.] Dana Farber Canc Inst, Blais Prote Ctr, Boston, MA 02215 USA; [Drapkin, R.] Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers Cancer Institute of New Jersey; Harvard University; Harvard Medical School; University of Texas System; UTMD Anderson Cancer Center; Hungarian Academy of Sciences; Harvard University; Dana-Farber Cancer Institute; Harvard University; Brigham & Women's Hospital	Drapkin, R (corresponding author), Dana Farber Canc Inst, Dept Med Oncol, JF215D,450 Brookline Ave, Boston, MA 02215 USA.	ronny_drapkin@dfci.harvard.edu	Drapkin, Ronny/E-9944-2016; Badalian-Very, Gayane/GLN-6049-2022; Gyorffy, Balazs/AAA-9135-2021; Labidi-Galy, Intidhar/AAG-3915-2021; labidi-galy, sana intidhar/A-4163-2017	Drapkin, Ronny/0000-0002-6912-6977; Gyorffy, Balazs/0000-0002-5772-3766; Elias, Kevin/0000-0003-1502-5553; Clauss, Adam/0000-0002-6381-324X; labidi-galy, sana intidhar/0000-0002-0824-3475	NIH/NCI SPORE in OC [OC P50-CA105009, U01 CA-152990, R21 CA-156021]; NIH/NINDS [P01 NS047572]; Honorable Tina Brozman 'Tina's Wish' Foundation; Dr Miriam and Sheldon G. Adelson Medical Research Foundation; Robert and Debra First Fund; Gamel Family Fund; Ovarian Cancer Research Fund; Madeline Franchi Ovations for the Cure Fund; Mary Kay Foundation; Sandy Rollman Ovarian Cancer Foundation; Dana-Farber Cancer Institute (DFCI) Strategic Initiative; Executive Council of the Cancer Foundation; New Jersey Commission on Cancer Research; Arthur Sachs/Fulbright/Harvard; La Fondation Philippe; La Fondation de France-Recherche clinique en cancerologie-Aide a la mobilite des chercheurs; NATIONAL CANCER INSTITUTE [R21CA156021, P30CA016672, U01CA152990, P50CA105009] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS047572] Funding Source: NIH RePORTER	NIH/NCI SPORE in OC; NIH/NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Honorable Tina Brozman 'Tina's Wish' Foundation; Dr Miriam and Sheldon G. Adelson Medical Research Foundation; Robert and Debra First Fund; Gamel Family Fund; Ovarian Cancer Research Fund; Madeline Franchi Ovations for the Cure Fund; Mary Kay Foundation; Sandy Rollman Ovarian Cancer Foundation; Dana-Farber Cancer Institute (DFCI) Strategic Initiative; Executive Council of the Cancer Foundation; New Jersey Commission on Cancer Research; Arthur Sachs/Fulbright/Harvard; La Fondation Philippe; La Fondation de France-Recherche clinique en cancerologie-Aide a la mobilite des chercheurs; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The authors thank Dr Michelle Hirsch for critical review of the manuscript, Laura Selfors of biocomputing analyzes of the RPPA data, and members of the Drapkin laboratory for fruitful discussions. This work was supported by the NIH/NCI SPORE in OC P50-CA105009 (RD), U01 CA-152990 (RD), R21 CA-156021 (RD); NIH/NINDS P01 NS047572 (JM), the Honorable Tina Brozman 'Tina's Wish' Foundation (JM, RD), the Dr Miriam and Sheldon G. Adelson Medical Research Foundation (GBM and RD), The Robert and Debra First Fund (RD), The Gamel Family Fund (RD), the Ovarian Cancer Research Fund (RD), The Madeline Franchi Ovations for the Cure Fund (AC), the Mary Kay Foundation (RD), the Sandy Rollman Ovarian Cancer Foundation (RD), the Dana-Farber Cancer Institute (DFCI) Strategic Initiative (JM), the Executive Council of the Cancer Foundation (SG), and the New Jersey Commission on Cancer Research (SG). SILG is a recipient of grants from Arthur Sachs/Fulbright/Harvard, La Fondation Philippe and La Fondation de France-'Recherche clinique en cancerologie-Aide a la mobilite des chercheurs'.	Askenazi M, 2010, PROTEOMICS, V10, P1880, DOI 10.1002/pmic.200900723; Aung G, 2011, J DERMATOL SCI, V63, P128, DOI 10.1016/j.jdermsci.2011.04.014; Bittner M., EXPRESSION PROJECT O; Bouchard D, 2006, LANCET ONCOL, V7, P167, DOI 10.1016/S1470-2045(06)70579-4; Cancer Genome Atlas Research Network, 2011, Nature, V474, P609, DOI 10.1038/nature10166; Caruso JA, 2010, CANCER RES, V70, P7125, DOI 10.1158/0008-5472.CAN-10-1547; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Clauss A, 2002, BIOCHEM J, V368, P233, DOI 10.1042/BJ20020869; Clauss A, 2010, NEOPLASIA, V12, P161, DOI 10.1593/neo.91542; Davis RJ, 2000, CELL, V103, P239, DOI 10.1016/S0092-8674(00)00116-1; Dent R, 2007, CLIN CANCER RES, V13, P4429, DOI 10.1158/1078-0432.CCR-06-3045; Desmedt C, 2007, CLIN CANCER RES, V13, P3207, DOI 10.1158/1078-0432.CCR-06-2765; Doucet A, 2007, BIOCHEM J, V405, P455, DOI 10.1042/BJ20070020; Drapkin R, 2005, CANCER RES, V65, P2162, DOI 10.1158/0008-5472.CAN-04-3924; Etemadmoghadam D, 2009, CLIN CANCER RES, V15, P1417, DOI 10.1158/1078-0432.CCR-08-1564; Ficarro SB, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.O111.011064; Gautier L, 2004, BIOINFORMATICS, V20, P307, DOI 10.1093/bioinformatics/btg405; Ghosh M, 2010, IMMUNOLOGY, V129, P207, DOI 10.1111/j.1365-2567.2009.03165.x; Gyorffy B, 2012, ENDOCR-RELAT CANCER, V19, P197, DOI 10.1530/ERC-11-0329; Gyorffy B, 2010, BREAST CANCER RES TR, V123, P725, DOI 10.1007/s10549-009-0674-9; Haibe-Kains B, 2012, JNCI-J NATL CANCER I, V104, P311, DOI 10.1093/jnci/djr545; Hellstrom I, 2003, CANCER RES, V63, P3695; Hennessy Bryan T, 2010, Clin Proteomics, V6, P129, DOI 10.1007/s12014-010-9055-y; Hodge C, 1998, J BIOL CHEM, V273, P31327, DOI 10.1074/jbc.273.47.31327; Huper G, 2007, CANCER RES, V67, P2990, DOI 10.1158/0008-5472.CAN-06-4065; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Jinawath N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011198; Karst AM, 2011, P NATL ACAD SCI USA, V108, P7547, DOI 10.1073/pnas.1017300108; Karst AM, 2010, J ONCOL, V2010, DOI 10.1155/2010/932371; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Kulasingam V, 2007, MOL CELL PROTEOMICS, V6, P1997, DOI 10.1074/mcp.M600465-MCP200; Kwei KA, 2010, MOL ONCOL, V4, P255, DOI 10.1016/j.molonc.2010.04.001; Levanon K, 2010, ONCOGENE, V29, P1103, DOI 10.1038/onc.2009.402; Levanon K, 2008, J CLIN ONCOL, V26, P5284, DOI 10.1200/JCO.2008.18.1107; Levine JE, 2012, BLOOD, V119, P3854, DOI 10.1182/blood-2012-01-403063; Li QY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015031; Lundwall A, 2002, BIOCHEM BIOPH RES CO, V290, P452, DOI 10.1006/bbrc.2001.6224; Manie E, 2009, CANCER RES, V69, P663, DOI 10.1158/0008-5472.CAN-08-1560; Mavaddat N, 2012, CANCER EPIDEM BIOMAR, V21, P134, DOI 10.1158/1055-9965.EPI-11-0775; Moore RG, 2009, GYNECOL ONCOL, V112, P40, DOI 10.1016/j.ygyno.2008.08.031; Morton S, 2004, FEBS LETT, V572, P177, DOI 10.1016/j.febslet.2004.07.031; Neve RM, 2006, CANCER CELL, V10, P515, DOI 10.1016/j.ccr.2006.10.008; Paczesny S, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000406; Pawitan Y, 2005, BREAST CANCER RES, V7, pR953, DOI 10.1186/bcr1325; Pazaiti A, 2011, WOMENS HEALTH, V7, P181, DOI [10.2217/whe.11.5, 10.2217/WHE.11.5]; Pfundt R, 1996, J CLIN INVEST, V98, P1389, DOI 10.1172/JCI118926; Rakha EA, 2008, J CLIN ONCOL, V26, P2568, DOI 10.1200/JCO.2007.13.1748; Richardson AL, 2006, CANCER CELL, V9, P121, DOI 10.1016/j.ccr.2006.01.013; Saidi A, 2008, INT J CANCER, V122, P2187, DOI 10.1002/ijc.23313; Saldanha AJ, 2004, BIOINFORMATICS, V20, P3246, DOI 10.1093/bioinformatics/bth349; Schmidt M, 2008, CANCER RES, V68, P5405, DOI 10.1158/0008-5472.CAN-07-5206; Shaw L, 2011, BIOCHEM SOC T, V39, P1450, DOI 10.1042/BST0391450; Tibes R, 2006, MOL CANCER THER, V5, P2512, DOI 10.1158/1535-7163.MCT-06-0334; Vermeer PD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030447; Verrier T, 2012, INT J BIOCHEM CELL B, V44, P1377, DOI 10.1016/j.biocel.2012.05.007; Wang YX, 2005, LANCET, V365, P671, DOI 10.1016/S0140-6736(05)17947-1; Wang ZGC, 2012, CLIN CANCER RES, V18, P5806, DOI 10.1158/1078-0432.CCR-12-0857; Wei HF, 2012, GYNECOL ONCOL, V125, P727, DOI 10.1016/j.ygyno.2012.03.018; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Williams J, 2005, GYNECOL ONCOL, V96, P287, DOI 10.1016/j.ygyno.2004.10.026; Williams SE, 2006, CLIN SCI, V110, P21, DOI 10.1042/CS20050115; Yokota T, 2007, CANCER RES, V67, P11272, DOI 10.1158/0008-5472.CAN-07-2322; ZHANG M, 1995, CANCER RES, V55, P2537	63	31	31	0	2	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 15	2015	34	3					299	309		10.1038/onc.2013.562	http://dx.doi.org/10.1038/onc.2013.562			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AZ3RY	24469047	Green Accepted, Green Submitted			2022-12-25	WOS:000348145500004
J	Sossey-Alaoui, K; Pluskota, E; Davuluri, G; Bialkowska, K; Das, M; Szpak, D; Lindner, DJ; Downs-Kelly, E; Thompson, CL; Plow, EF				Sossey-Alaoui, Khalid; Pluskota, Elzbieta; Davuluri, Gangarao; Bialkowska, Katarzyna; Das, Mitali; Szpak, Dorota; Lindner, Daniel J.; Downs-Kelly, Erinn; Thompson, Cheryl L.; Plow, Edward F.			Kindlin-3 enhances breast cancer progression and metastasis by activating Twist-mediated angiogenesis	FASEB JOURNAL			English	Article						integrins; VEGF; VEGFR2; epithelial-to-mesenchymal-transition; tumor macrophages	INTEGRIN ACTIVATION; LEUKOCYTE ADHESION; GENE-EXPRESSION; INVASION; CELL; PROTEIN; WAVE3; RESISTANCE; MIGRATION; TALIN	The FERM domain containing protein Kindlin-3 has been recognized as a major regulator of integrin function in hematopoietic cells, but its role in neoplasia is totally unknown. We have examined the relationship between Kindlin-3 and breast cancer in mouse models and human tissues. Human breast tumors showed a approximate to 7-fold elevation in Kindlin-3 mRNA compared with nonneoplastic tissue by quantitative polymerase chain reaction. Kindlin-3 overexpression in a breast cancer cell line increased primary tumor growth and lung metastasis by 2.5- and 3-fold, respectively, when implanted into mice compared with cells expressing vector alone. Mechanistically, the Kindlin-3-overexpressing cells displayed a 2.2-fold increase in vascular endothelial growth factor (VEGF) secretion and enhanced 1 integrin activation. Increased VEGF secretion resulted from enhanced production of Twist, a transcription factor that promotes tumor angiogenesis. Knockdown of Twist diminished VEGF production, and knockdown of 1 integrins diminished Twist and VEGF production by Kindlin-3-overexpressing cells, while nontargeting small interfering RNA had no effect on expression of these gene products. Thus, Kindlin-3 influences breast cancer progression by influencing the crosstalk between 1 integrins and Twist to increase VEGF production. This signaling cascade enhances breast cancer cell invasion and tumor angiogenesis and metastasis.Sossey-Alaoui, K., Pluskota, E., Davuluri, G., Bialkowska, K., Das, M., Szpak, D., Lindner, D. J., Downs-Kelly, E., Thompson, C. L., Plow, E. F. Kindlin-3 enhances breast cancer progression and metastasis by activating Twist-mediated angiogenesis.	[Sossey-Alaoui, Khalid; Pluskota, Elzbieta; Davuluri, Gangarao; Bialkowska, Katarzyna; Das, Mitali; Szpak, Dorota; Plow, Edward F.] Cleveland Clin, Lerner Res Inst, Dept Mol Cardiol, Cleveland, OH 44195 USA; [Lindner, Daniel J.] Cleveland Clin, Taussig Canc Inst, Cleveland, OH 44195 USA; [Downs-Kelly, Erinn] Cleveland Clin, Dept Anat Pathol, Cleveland, OH 44195 USA; [Thompson, Cheryl L.] Case Western Reserve Univ, Dept Family Med & Community Hlth, Cleveland, OH 44106 USA	Cleveland Clinic Foundation; Cleveland Clinic Foundation; Cleveland Clinic Foundation; Case Western Reserve University	Sossey-Alaoui, K (corresponding author), Cleveland Clin, Lerner Res Inst, Dept Mol Cardiol, 9500 Euclid Ave,NB50, Cleveland, OH 44195 USA.	sosseyk@ccf.org; plowe@ccf.org	Lindner, Daniel/ABB-5440-2020		National Heart, Lung, and Blood Institute (U.S. National Institutes of Health) [P01-HL-073311, R01-HL-096062]; Case Comprehensive Cancer Center [P30-CA-43703]; NATIONAL CANCER INSTITUTE [P30CA043703] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL096062, T32HL007914, P01HL073311] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute (U.S. National Institutes of Health)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Case Comprehensive Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The authors thank Brian McCue for technical assistance. This work was supported in part by National Heart, Lung, and Blood Institute (U.S. National Institutes of Health) grants P01-HL-073311 and R01-HL-096062 and Case Comprehensive Cancer Center grant P30-CA-43703.	Alexander NR, 2006, CANCER RES, V66, P3365, DOI 10.1158/0008-5472.CAN-05-3401; Bialkowska K, 2010, J BIOL CHEM, V285, P18640, DOI 10.1074/jbc.M109.085746; Brahme NN, 2012, CURR BIOL, V22, pR692, DOI 10.1016/j.cub.2012.07.049; Cance WG, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004021; Cheng GZ, 2007, CANCER RES, V67, P1979, DOI 10.1158/0008-5472.CAN-06-1479; Desiniotis A, 2011, INT REV CEL MOL BIO, V289, P117, DOI 10.1016/B978-0-12-386039-2.00004-3; Dowling JJ, 2008, CIRC RES, V102, P423, DOI 10.1161/CIRCRESAHA.107.161489; Ganguly KK, 2013, CELL ADHES MIGR, V7, P251, DOI 10.4161/cam.23840; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; JULIANO RL, 1993, SEMIN CANCER BIOL, V4, P277; Kulkarni S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042895; Larjava H, 2008, EMBO REP, V9, P1203, DOI 10.1038/embor.2008.202; Legate KR, 2009, J CELL SCI, V122, P187, DOI 10.1242/jcs.041624; Li QQ, 2009, CLIN CANCER RES, V15, P2657, DOI 10.1158/1078-0432.CCR-08-2372; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Low-Marchelli JM, 2013, CANCER RES, V73, P662, DOI 10.1158/0008-5472.CAN-12-0653; Luque A, 1996, J BIOL CHEM, V271, P11067, DOI 10.1074/jbc.271.19.11067; Mahawithitwong P, 2013, INT J ONCOL, V42, P1360, DOI 10.3892/ijo.2013.1838; Malinin NL, 2010, BLOOD, V115, P4011, DOI 10.1182/blood-2009-10-239269; Malinin NL, 2009, NAT MED, V15, P313, DOI 10.1038/nm.1917; Mironchik Y, 2005, CANCER RES, V65, P10801, DOI 10.1158/0008-5472.CAN-05-0712; Montanez E, 2008, GENE DEV, V22, P1325, DOI 10.1101/gad.469408; Moser M, 2008, NAT MED, V14, P325, DOI 10.1038/nm1722; Moser M, 2009, SCIENCE, V324, P895, DOI 10.1126/science.1163865; Moser M, 2009, NAT MED, V15, P300, DOI 10.1038/nm.1921; Plow EF, 2009, CURR OPIN HEMATOL, V16, P323, DOI 10.1097/MOH.0b013e32832ea389; Pluskota E, 2011, BLOOD, V117, P4978, DOI 10.1182/blood-2010-11-321182; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Shen ZL, 2012, AM J SURG, V203, P222, DOI 10.1016/j.amjsurg.2011.06.050; Shibue T, 2013, CANCER CELL, V24, P481, DOI 10.1016/j.ccr.2013.08.012; Siegel DH, 2003, AM J HUM GENET, V73, P174, DOI 10.1086/376609; Sossey-Alaoui K, 2005, EXP CELL RES, V308, P135, DOI 10.1016/j.yexcr.2005.04.011; Sossey-Alaoui K, 2007, AM J PATHOL, V170, P2112, DOI 10.2353/ajpath.2007.060975; Sossey-Alaoui K, 2011, INT J CANCER, V129, P1331, DOI 10.1002/ijc.25793; Sossey-Alaoui K, 2009, J BIOL CHEM, V284, P33019, DOI 10.1074/jbc.M109.034553; Svensson L, 2009, NAT MED, V15, P306, DOI 10.1038/nm.1931; Ussar S, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000289; Varner Judith A., 1996, P69; Ye F, 2011, CURR OPIN HEMATOL, V18, P356, DOI 10.1097/MOH.0b013e3283497f09; Zhan J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050313	40	54	57	1	8	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2014	28	5					2260	2271		10.1096/fj.13-244004	http://dx.doi.org/10.1096/fj.13-244004			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	AG3RA	24469992	Green Published			2022-12-25	WOS:000335336000028
J	Haseeb, A; Makki, MS; Haqqi, TM				Haseeb, Abdul; Makki, Mohammad Shahidul; Haqqi, Tariq M.			Modulation of Ten-Eleven Translocation 1 (TET1), Isocitrate Dehydrogenase (IDH) Expression, alpha-Ketoglutarate (alpha-KG), and DNA Hydroxymethylation Levels by Interleukin-1 beta in Primary Human Chondrocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Chondrocytes; Cytokine; Dioxygenase; DNA Methylation; Epigenetics; 5-hmC; IL-1; TNF-	CPG SITES; 5-HYDROXYMETHYLCYTOSINE; PROMOTER; 5-METHYLCYTOSINE; DEMETHYLATION; CONVERSION; PROTEINS	Background: Cytosine hydroxymethylation in the genomic DNA controls gene expression. Results: Treatment of primary chondrocytes with IL-1 alone or in conjunction with TNF- inhibited TET1 and IDH expression and suppressed cytosine hydroxymethylation. Conclusion: IL-1 and TNF- decrease DNA hydroxymethylation by suppressing the expression and activity of TET1 and IDH. Significance: Pro-inflammatory cytokines likely control gene expression by modulating the 5-hmC levels. 5-Hydroxymethylcytosine (5-hmC) generated by ten-eleven translocation 1-3 (TET1-3) enzymes is an epigenetic mark present in many tissues with different degrees of abundance. IL-1 and TNF- are the two major cytokines present in arthritic joints that modulate the expression of many genes associated with cartilage degradation in osteoarthritis. In the present study, we investigated the global 5-hmC content, the effects of IL-1 and TNF- on 5-hmC content, and the expression and activity of TETs and isocitrate dehydrogenases in primary human chondrocytes. The global 5-hmC content was found to be approximate to 0.1% of the total genome. There was a significant decrease in the levels of 5-hmC and the TET enzyme activity upon treatment of chondrocytes with IL-1 alone or in combination with TNF-. We observed a dramatic (10-20-fold) decrease in the levels of TET1 mRNA expression and a small increase (2-3-fold) in TET3 expression in chondrocytes stimulated with IL-1 and TNF-. IL-1 and TNF- significantly suppressed the activity and expression of IDHs, which correlated with the reduced -ketoglutarate levels. Whole genome profiling showed an erasure effect of IL-1 and TNF-, resulting in a significant decrease in hydroxymethylation in a myriad of genes including many genes that are important in chondrocyte physiology. Our data demonstrate that DNA hydroxymethylation is modulated by pro-inflammatory cytokines via suppression of the cytosine hydroxymethylation machinery. These data point to new mechanisms of epigenetic control of gene expression by pro-inflammatory cytokines in human chondrocytes.	[Haseeb, Abdul; Makki, Mohammad Shahidul; Haqqi, Tariq M.] Northeast Ohio Med Univ, Dept Anat & Neurobiol, Rootstown, OH 44272 USA	Northeast Ohio Medical University (NEOMED)	Haqqi, TM (corresponding author), 4209 St Rt 44,Rm 144, Rootstown, OH 44272 USA.	thaqqi@neomed.edu	Haseeb, Abdul/I-5278-2017; Haseeb, Abdul/Q-2788-2015	Haseeb, Abdul/0000-0002-2623-1275; Haqqi, Tariq/0000-0003-3506-6133	National Institutes of Health [AT003627, AT005520]; Northeast Ohio Medical University; NATIONAL CENTER FOR COMPLEMENTARY & ALTERNATIVE MEDICINE [R01AT005520] Funding Source: NIH RePORTER; NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE [R01AT003627] Funding Source: NIH RePORTER; National Center for Complementary & Integrative Health [R01AT007373] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Northeast Ohio Medical University; NATIONAL CENTER FOR COMPLEMENTARY & ALTERNATIVE MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); National Center for Complementary & Integrative Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported, in whole or in part, by National Institutes of Health Grants AT003627 and AT005520 (to T.M.H.). This work was also supported by the Northeast Ohio Medical University (to T.M.H.).	Branco MR, 2012, NAT REV GENET, V13, P7, DOI 10.1038/nrg3080; Cheung KSC, 2009, RHEUMATOL INT, V29, P525, DOI 10.1007/s00296-008-0744-z; Globisch D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015367; Haseeb A, 2013, RHEUMATOLOGY, V52, P998, DOI 10.1093/rheumatology/kes363; Hashimoto K, 2013, J BIOL CHEM, V288, P10061, DOI 10.1074/jbc.M112.421156; Hashimoto K, 2009, ARTHRITIS RHEUM-US, V60, P3303, DOI 10.1002/art.24882; Imagawa K, 2011, BIOCHEM BIOPH RES CO, V405, P362, DOI 10.1016/j.bbrc.2011.01.007; Ito S, 2011, SCIENCE, V333, P1300, DOI 10.1126/science.1210597; Ito S, 2010, NATURE, V466, P1129, DOI 10.1038/nature09303; Kriaucionis S, 2009, SCIENCE, V324, P929, DOI 10.1126/science.1169786; Li W, 2011, J NUCL ACIDS, V2011; Lian CG, 2012, CELL, V150, P1135, DOI 10.1016/j.cell.2012.07.033; Neves-Costa A, 2013, MOL IMMUNOL, V54, P264, DOI 10.1016/j.molimm.2012.12.014; POMERANTZ SC, 1990, METHOD ENZYMOL, V193, P796, DOI 10.1016/0076-6879(90)93452-Q; Rasheed Z, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2700; Roach HI, 2005, ARTHRITIS RHEUM-US, V52, P3110, DOI 10.1002/art.21300; Tahiliani M, 2009, SCIENCE, V324, P930, DOI 10.1126/science.1170116; Wossidlo M, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1240	18	56	57	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 7	2014	289	10					6877	6885		10.1074/jbc.M113.512269	http://dx.doi.org/10.1074/jbc.M113.512269			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AC3BG	24469454	Green Published, hybrid			2022-12-25	WOS:000332389400048
J	Hsu, PC; Su, HM; Lee, HC; Juo, SH; Lin, TH; Voon, WC; Lai, WT; Sheu, SH				Hsu, Po-Chao; Su, Ho-Ming; Lee, Hsiang-Chun; Juo, Suh-Hang; Lin, Tsung-Hsien; Voon, Wen-Chol; Lai, Wen-Ter; Sheu, Sheng-Hsiung			Coronary Collateral Circulation in Patients of Coronary Ectasia with Significant Coronary Artery Disease	PLOS ONE			English	Article							CLINICAL-SIGNIFICANCE; OCCLUSION; PROGNOSIS	Objectives: Patients with coronary ectasia (CE) usually have coexisting coronary stenosis resulting in myoischemia. Coronary collateral plays an important role in protecting myocardium from ischemia and reducing cardiovascular events. However, limited studies investigate the role of CE in coronary collaterals development. Methods: We evaluated 1020 consecutive patients undergoing coronary angiography and 552 patients with significant coronary artery disease (SCAD), defined as diameter stenosis more than 70%, were finally analyzed. CE is defined as the ectatic diameter 1.5 times larger than adjacent reference segment. Rentrop collateral score was used to classify patients into poor (grades 0 and 1) or good (grades 2 and 3) collateral group. Results: 73 patients (13.2%) had CE lesions which were most located in the right coronary artery (53.4%). Patients with CE had a lower incidence of diabetes (43.8% vs 30.1%, p = 0.03), higher body mass index (25.4 +/- 3.5 vs 26.7 +/- 4.6, p = 0.027) and poorer coronary collateral (58.2% vs 71.2%, p = 0.040). Patients with poor collateral (n = 331) had a higher incidence of CE (15.7% vs 9.5%, p = 0.040) and fewer diseased vessels numbers (1.96 +/- 0.84 vs 2.48 +/- 0.69, p < 0.001). Multivariate analysis showed diabetes (odd ratio (OR) 0.630, p = 0.026), CE (OR = 0.544, p = 0.048), and number of diseased vessels (OR = 2.488, p < 0.001) were significant predictors of coronary collaterals development. Conclusion: The presence of CE was associated with poorer coronary collateral development in patients with SCAD.	[Hsu, Po-Chao; Su, Ho-Ming; Lee, Hsiang-Chun; Lin, Tsung-Hsien; Voon, Wen-Chol; Lai, Wen-Ter; Sheu, Sheng-Hsiung] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Dept Internal Med, Div Cardiol, Kaohsiung, Taiwan; [Hsu, Po-Chao; Lee, Hsiang-Chun] Kaohsiung Med Univ, Coll Med, Grad Inst Med, Kaohsiung, Taiwan; [Juo, Suh-Hang] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Dept Med Res, Kaohsiung, Taiwan; [Juo, Suh-Hang] Kaohsiung Med Univ, Kaohsiung, Taiwan; [Juo, Suh-Hang] Kaohsiung Med Univ, Ctr Excellence Environm Med, Kaohsiung, Taiwan; [Hsu, Po-Chao; Su, Ho-Ming; Lin, Tsung-Hsien; Voon, Wen-Chol; Lai, Wen-Ter; Sheu, Sheng-Hsiung] Kaohsiung Med Univ, Coll Med, Fac Med, Kaohsiung, Taiwan; [Su, Ho-Ming] Kaohsiung Municipal Hsiaokang Hosp, Dept Internal Med, Kaohsiung, Taiwan	Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Municipal Siao-Gang Hospital	Lin, TH (corresponding author), Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Dept Internal Med, Div Cardiol, Kaohsiung, Taiwan.	lth@kmu.edu.tw	蘇, 河名/AAE-9843-2019	Su, Ho-Ming/0000-0003-0247-3250; Lee, Hsiang-Chun/0000-0002-5877-9059; Lin, Tsung-Hsien/0000-0002-7226-8730				Abaci A, 1999, CIRCULATION, V99, P2239, DOI 10.1161/01.CIR.99.17.2239; ALHARTHI SS, 1991, INT J CARDIOL, V30, P191, DOI 10.1016/0167-5273(91)90094-6; BEFELER B, 1977, AM J MED, V62, P597, DOI 10.1016/0002-9343(77)90423-5; COHEN M, 1986, CIRCULATION, V74, P469, DOI 10.1161/01.CIR.74.3.469; DAOUD AS, 1963, AM J CARDIOL, V11, P228, DOI 10.1016/0002-9149(63)90064-X; Demopoulos VP, 1997, HEART, V78, P136, DOI 10.1136/hrt.78.2.136; FUJITA M, 1987, BRIT HEART J, V57, P139; Gulec S, 2006, EUR J CLIN INVEST, V36, P369, DOI 10.1111/j.1365-2362.2006.01641.x; HARTNELL GG, 1985, BRIT HEART J, V54, P392; HELFANT RH, 1970, ANN INTERN MED, V73, P189, DOI 10.7326/0003-4819-73-2-189; LEVIN DC, 1974, CIRCULATION, V50, P831, DOI 10.1161/01.CIR.50.4.831; Li JJ, 2009, CYTOKINE, V46, P61, DOI 10.1016/j.cyto.2008.12.012; Manginas A, 2006, EUR HEART J, V27, P1026, DOI 10.1093/eurheartj/ehi725; MARKIS JE, 1976, AM J CARDIOL, V37, P217, DOI 10.1016/0002-9149(76)90315-5; Mavrogeni S, 2010, HELL J CARDIOL, V51, P158; Meier P, 2007, CIRCULATION, V116, P975, DOI 10.1161/CIRCULATIONAHA.107.703959; OLIVEROS RA, 1974, ARCH INTERN MED, V134, P1072; ONOUCHI Z, 1993, J AM COLL CARDIOL, V21, P158, DOI 10.1016/0735-1097(93)90731-F; Ozbay Y, 2007, MEDIAT INFLAMM, V2007, DOI 10.1155/2007/89649; Regieli JJ, 2009, INT J CARDIOL, V132, P257, DOI 10.1016/j.ijcard.2007.11.100; RENTROP KP, 1985, J AM COLL CARDIOL, V5, P587; Resar JR, 2005, CHEST, V128, P787, DOI 10.1378/chest.128.2.787; Rockstroh J, 2002, CIRCULATION, V105, P168, DOI 10.1161/hc0202.102120; RODBARD S, 1967, ANGIOLOGY, V18, P349, DOI 10.1177/000331976701800601; Sezen Y, 2010, CARDIOL J, V17, P488; Sezer M, 2007, INT J CARDIOL, V115, P366, DOI 10.1016/j.ijcard.2006.03.020; Sharma S N, 1990, Indian Heart J, V42, P365; SWANTON RH, 1978, BRIT HEART J, V40, P393; SWAYE PS, 1983, CIRCULATION, V67, P134, DOI 10.1161/01.CIR.67.1.134; TATARA K, 1991, AM HEART J, V121, P797, DOI 10.1016/0002-8703(91)90191-J; Tayebjee MH, 2004, QJM-INT J MED, V97, P259, DOI 10.1093/qjmed/hch053; Werner GS, 2003, CIRCULATION, V107, P1972, DOI 10.1161/01.CIR.0000061953.72662.3A; Yilmaz H, 2008, TURK KARDIYOL DERN A, V36, P530	33	13	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2014	9	1							e87001	10.1371/journal.pone.0087001	http://dx.doi.org/10.1371/journal.pone.0087001			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301BI	24475209	Green Published, Green Submitted, gold			2022-12-25	WOS:000330507300125
J	Morat, F; Letourneur, Y; Dierking, J; Pecheyran, C; Bareille, G; Blamart, D; Harmelin-Vivien, M				Morat, Fabien; Letourneur, Yves; Dierking, Jan; Pecheyran, Christophe; Bareille, Gilles; Blamart, Dominique; Harmelin-Vivien, Mireille			The Great Melting Pot. Common Sole Population Connectivity Assessed by Otolith and Water Fingerprints	PLOS ONE			English	Article							ELEMENTAL COMPOSITION; MEDITERRANEAN SEA; FISH POPULATIONS; NURSERY GROUNDS; RHONE RIVER; RECRUITMENT; STRONTIUM; MECHANISMS; BARIUM; GULF	Quantifying the scale and importance of individual dispersion between populations and life stages is a key challenge in marine ecology. The common sole (Solea solea), an important commercial flatfish in the North Sea, Atlantic Ocean and the Mediterranean Sea, has a marine pelagic larval stage, a benthic juvenile stage in coastal nurseries (lagoons, estuaries or shallow marine areas) and a benthic adult stage in deeper marine waters on the continental shelf. To date, the ecological connectivity among these life stages has been little assessed in the Mediterranean. Here, such an assessment is provided for the first time for the Gulf of Lions, NW Mediterranean, based on a dataset on otolith microchemistry and stable isotopic composition as indicators of the water masses inhabited by individual fish. Specifically, otolith Ba/Ca and Sr/Ca profiles, and delta C-13 and delta O-18 values of adults collected in four areas of the Gulf of Lions were compared with those of young-of-the-year collected in different coastal nurseries. Results showed that a high proportion of adults (>46%) were influenced by river inputs during their larval stage. Furthermore Sr/Ca ratios and the otolith length at one year of age revealed that most adults (similar to 70%) spent their juvenile stage in nurseries with high salinity, whereas the remainder used brackish environments. In total, data were consistent with the use of six nursery types, three with high salinity (marine areas and two types of highly saline lagoons) and three brackish (coastal areas near river mouths, and two types of brackish environments), all of which contributed to the replenishment of adult populations. These finding implicated panmixia in sole population in the Gulf of Lions and claimed for a habitat integrated management of fisheries.	[Morat, Fabien; Harmelin-Vivien, Mireille] Aix Marseille Univ, CNRS INSU, Mediterranean Inst Oceanog MIO UM 110, IRD, Marseille, France; [Morat, Fabien; Harmelin-Vivien, Mireille] Univ Toulon & Var, CNRS INSU, Mediterranean Inst Oceanog MIO UM 110, IRD, La Garde, France; [Letourneur, Yves] Univ Nouvelle Caledonie, Lab LIVE & LABEX Corail, Noumea, New Caledonia; [Dierking, Jan] Helmholtz Ctr Ocean Res GEOMAR, Kiel, Germany; [Pecheyran, Christophe; Bareille, Gilles] Univ Pau & Pays Adour, LCABIE, UMR CNRS IPREM 5254, Pau, France; [Blamart, Dominique] UMR 8212 CEA CNRS UVSQ, Lab Sci Climat & Environm, Gif Sur Yvette, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); Institut de Recherche pour le Developpement (IRD); UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); Institut de Recherche pour le Developpement (IRD); Universite de Toulon; Universite Nouvelle Caledonie; Helmholtz Association; GEOMAR Helmholtz Center for Ocean Research Kiel; Universite de Pau et des Pays de l'Adour; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); UDICE-French Research Universities; Universite Paris Saclay; CEA	Morat, F (corresponding author), Aix Marseille Univ, CNRS INSU, Mediterranean Inst Oceanog MIO UM 110, IRD, Marseille, France.	fabien.morat@irstea.fr	Morat, Fabien/U-2682-2019; LETOURNEUR, Yves/B-4387-2012; Bareille, Gilles/AAS-3113-2020; Letourneur, Yves/V-6843-2019; Dierking, Jan/C-5170-2014; Morat, Fabien/F-9867-2010	Morat, Fabien/0000-0002-9925-1437; LETOURNEUR, Yves/0000-0003-3157-1976; Letourneur, Yves/0000-0003-3157-1976; Morat, Fabien/0000-0002-9925-1437; Dierking, Jan/0000-0002-4660-6919; PECHEYRAN, Christophe/0000-0001-6503-4859	region PACA; Total foundation; Agence de l'Eau Rhone Mediterranee Corse	region PACA(Region Provence-Alpes-Cote d'Azur); Total foundation(Total SA); Agence de l'Eau Rhone Mediterranee Corse	Fabien Morat was funded by Ph.D stipends of the region PACA, the Total foundation, and the Agence de l'Eau Rhone Mediterranee Corse. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almany GR, 2007, SCIENCE, V316, P742, DOI 10.1126/science.1140597; Amara R, 2000, OCEANOL ACTA, V23, P469, DOI 10.1016/S0399-1784(00)00134-1; Aucour AM, 2003, LIMNOL OCEANOGR, V48, P2186, DOI 10.4319/lo.2003.48.6.2186; BAILEY KM, 1989, ADV MAR BIOL, V25, P1; Bath GE, 2000, GEOCHIM COSMOCHIM AC, V64, P1705, DOI 10.1016/S0016-7037(99)00419-6; Blamart D, 2002, CR BIOL, V325, P99, DOI 10.1016/S1631-0691(02)01419-1; Borelli G, 2001, CALCIFIED TISSUE INT, V69, P356, DOI 10.1007/s00223-001-2016-8; Brown RJ, 2009, CAN J FISH AQUAT SCI, V66, P1790, DOI 10.1139/F09-112; Campana SE, 1999, MAR ECOL PROG SER, V188, P263, DOI 10.3354/meps188263; CAMPANA SE, 1993, CAN J FISH AQUAT SCI, V50, P1062, DOI 10.1139/f93-123; CAMPANA SE, 1985, CAN J FISH AQUAT SCI, V42, P1014, DOI 10.1139/f85-127; Celle-Jeanton H, 2004, J HYDROL, V289, P165, DOI 10.1016/j.jhydrol.2003.11.017; Champalbert Gisele, 1992, Marine Behaviour and Physiology, V21, P255; Chittaro PM, 2009, OECOLOGIA, V160, P49, DOI 10.1007/s00442-009-1282-4; COPLEN TB, 1983, NATURE, V302, P236, DOI 10.1038/302236a0; Cowen RK, 2000, SCIENCE, V287, P857, DOI 10.1126/science.287.5454.857; Cowen RK, 2006, SCIENCE, V311, P522, DOI 10.1126/science.1122039; Cuveliers EL, 2012, MAR BIOL, V159, P1239, DOI 10.1007/s00227-012-1905-x; de Pontual H, 2003, J SEA RES, V50, P199, DOI 10.1016/S1385-1101(03)00080-7; Demaneche S, 2009, R3 IFREMER; Dierking J, 2009, MAR POLLUT BULL, V58, P1605, DOI 10.1016/j.marpolbul.2009.07.008; Dierking J, 2012, ESTUAR COAST SHELF S, V104, P23, DOI 10.1016/j.ecss.2011.03.018; Elsdon TS, 2005, MAR FRESHWATER RES, V56, P609, DOI 10.1071/MF04146; Estournel C., 2009, GOLFE LION OBSERVATO, P257; Farrell J, 1996, COMP BIOCHEM PHYS A, V115, P103, DOI 10.1016/0300-9629(96)00015-1; FOWLER AJ, 1995, CAN J FISH AQUAT SCI, V52, P1421, DOI 10.1139/f95-137; Frisk MG, 2014, FISH FISH, V15, P242, DOI 10.1111/faf.12014; Gaertner JC, 1998, AQUAT LIVING RESOUR, V11, P75, DOI 10.1016/S0990-7440(98)80063-6; Gillanders BM, 2002, CAN J FISH AQUAT SCI, V59, P669, DOI 10.1139/F02-040; Gillanders BM, 2000, MAR ECOL PROG SER, V201, P273, DOI 10.3354/meps201273; Hamer PA, 2006, ESTUAR COAST SHELF S, V68, P686, DOI 10.1016/j.ecss.2006.03.017; Harrison HB, 2012, CURR BIOL, V22, P1023, DOI 10.1016/j.cub.2012.04.008; Hobson KA, 2007, ECOL METHOD CONCEPT, P155, DOI 10.1002/9780470691854.ch6; Hunter J. R., 1980, P C PHYS BEH MAN FOO, P512; Imsland AK, 2003, REV FISH BIOL FISHER, V13, P379, DOI 10.1007/s11160-004-1632-6; Jones GP, 1999, NATURE, V402, P802, DOI 10.1038/45538; Jones MT, 2012, GEOCHIM COSMOCHIM AC, V77, P108, DOI 10.1016/j.gca.2011.10.044; KEARN GC, 1974, PARASITOLOGY, V68, P173, DOI 10.1017/S0031182000045716; KONOSU S, 1975, B JPN SOC SCI FISH, V41, P743; KOTOULAS G, 1995, MAR BIOL, V122, P361, DOI 10.1007/BF00350869; KOUTSIKOPOULOS C, 1995, J MAR BIOL ASSOC UK, V75, P109, DOI 10.1017/S002531540001523X; Lagardere F, 1999, ENVIRON BIOL FISH, V56, P213, DOI 10.1023/A:1007581818941; Lagardere F, 1997, MAR ECOL PROG SER, V155, P223, DOI 10.3354/meps155223; Le Pape O, 2003, J SEA RES, V50, P177, DOI 10.1016/S1385-1101(03)00061-3; Lecchini D, 2005, BEHAV ECOL SOCIOBIOL, V58, P18, DOI 10.1007/s00265-004-0905-3; Leis JM, 2006, ADV MAR BIOL, V51, P57, DOI 10.1016/S0065-2881(06)51002-8; Letourneur Y, 2001, OCEANOL ACTA, V24, P273, DOI 10.1016/S0399-1784(01)01146-X; LOCHET F, 1990, HYDROBIOLOGIA, V207, P95, DOI 10.1007/BF00041445; MACQUARTMOULIN C, 1991, J EXP MAR BIOL ECOL, V153, P195, DOI 10.1016/0022-0981(91)90225-L; Meekan MG, 2006, MAR ECOL PROG SER, V317, P237, DOI 10.3354/meps317237; Mellon-Duval C, 2010, ICES J MAR SCI, V67, P62, DOI 10.1093/icesjms/fsp215; Merigot B, 2007, MAR BIOL, V151, P997, DOI 10.1007/s00227-006-0549-0; Millar RB, 1990, CAN TECH REP FISH AQ, V1753, P1; Miller J.M., 1988, American Fisheries Society Symposium, P68; MILLER TJ, 1988, CAN J FISH AQUAT SCI, V45, P1657, DOI 10.1139/f88-197; MILLOT C, 1979, OCEANOL ACTA, V2, P261; Miralles J, 2006, MAR GEOL, V234, P179, DOI 10.1016/j.margeo.2006.09.004; Morat F, 2012, SCI MAR, V76, P647, DOI 10.3648/scimar.03648.09B; Ollivier P, 2011, CHEM GEOL, V285, P15, DOI 10.1016/j.chemgeo.2011.02.011; Panfili J., 2002, MANUEL SCLEROCHRONOL; Patterson HM, 2007, AUSTRAL ECOL, V32, P122, DOI 10.1111/j.1442-9993.2006.01669.x; Pauly D, 2002, NATURE, V418, P689, DOI 10.1038/nature01017; Planes S, 2009, P NATL ACAD SCI USA, V106, P5693, DOI 10.1073/pnas.0808007106; POPPER AN, 1980, AM SCI, V68, P429; Rolland JL, 2007, MAR BIOL, V151, P327, DOI 10.1007/s00227-006-0484-0; Sale PF, 2004, INTEGR COMP BIOL, V44, P390, DOI 10.1093/icb/44.5.390; Sale PF, 2010, PRESERVING REEF CONN; Salen-Picard C, 2002, OECOLOGIA, V133, P380, DOI 10.1007/s00442-002-1032-3; Secor DH, 1999, FISH RES, V43, P13, DOI 10.1016/S0165-7836(99)00064-8; Secor DH, 2000, FISH RES, V46, P359, DOI 10.1016/S0165-7836(00)00159-4; Solomon CT, 2006, CAN J FISH AQUAT SCI, V63, P79, DOI 10.1139/F05-200; SYMONDS DJ, 1995, J EXP MAR BIOL ECOL, V190, P243, DOI 10.1016/0022-0981(95)00043-Q; Tabouret H, 2010, MAR ENVIRON RES, V70, P35, DOI 10.1016/j.marenvres.2010.02.006; Tanner SE, 2012, MAR ECOL PROG SER, V452, P193, DOI 10.3354/meps09621; Tanner SE, 2013, J SEA RES, V76, P82, DOI 10.1016/j.seares.2012.11.005; Vasconcelos RP, 2008, ESTUAR COAST SHELF S, V79, P317, DOI 10.1016/j.ecss.2008.04.006; Vinagre C, 2011, ESTUAR COAST, V34, P663, DOI 10.1007/s12237-010-9315-0; Walther BD, 2006, MAR ECOL PROG SER, V311, P125, DOI 10.3354/meps311125; Webb SD, 2012, MAR ECOL PROG SER, V453, P189, DOI 10.3354/meps09653	79	17	20	0	75	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2014	9	1							e86585	10.1371/journal.pone.0086585	http://dx.doi.org/10.1371/journal.pone.0086585			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301BI	24475151	Green Submitted, Green Published, gold, Green Accepted			2022-12-25	WOS:000330507300087
J	Sandulache, VC; Chen, YY; Lee, J; Rubinstein, A; Ramirez, MS; Skinner, HD; Walker, CM; Williams, MD; Tailor, R; Court, LE; Bankson, JA; Lai, SY				Sandulache, Vlad C.; Chen, Yunyun; Lee, Jaehyuk; Rubinstein, Ashley; Ramirez, Marc S.; Skinner, Heath D.; Walker, Christopher M.; Williams, Michelle D.; Tailor, Ramesh; Court, Laurence E.; Bankson, James A.; Lai, Stephen Y.			Evaluation of Hyperpolarized [1-C-13]-Pyruvate by Magnetic Resonance to Detect Ionizing Radiation Effects in Real Time	PLOS ONE			English	Article							ANAPLASTIC THYROID-CANCER; NECK-CANCER; HUMAN HEAD; 2-DEOXY-D-GLUCOSE; RADIOTHERAPY; METABOLISM; CHEMOTHERAPY; INHIBITION; CISPLATIN; KINETICS	Ionizing radiation (IR) cytotoxicity is primarily mediated through reactive oxygen species (ROS). Since tumor cells neutralize ROS by utilizing reducing equivalents, we hypothesized that measurements of reducing potential using real-time hyperpolarized (HP) magnetic resonance spectroscopy (MRS) and spectroscopic imaging (MRSI) can serve as a surrogate marker of IR induced ROS. This hypothesis was tested in a pre-clinical model of anaplastic thyroid carcinoma (ATC), an aggressive head and neck malignancy. Human ATC cell lines were utilized to test IR effects on ROS and reducing potential in vitro and [1-C-13] pyruvate HP-MRS/MRSI imaging of ATC orthotopic xenografts was used to study in vivo effects of IR. IR increased ATC intra-cellular ROS levels resulting in a corresponding decrease in reducing equivalent levels. Exogenous manipulation of cellular ROS and reducing equivalent levels altered ATC radiosensitivity in a predictable manner. Irradiation of ATC xenografts resulted in an acute drop in reducing potential measured using HP-MRS, reflecting the shunting of reducing equivalents towards ROS neutralization. Residual tumor tissue post irradiation demonstrated heterogeneous viability. We have adapted HP-MRS/MRSI to non-invasively measure IR mediated changes in tumor reducing potential in real time. Continued development of this technology could facilitate the development of an adaptive clinical algorithm based on real-time adjustments in IR dose and dose mapping.	[Sandulache, Vlad C.] Baylor Coll Med, Bobby R Alford Dept Otolaryngol Head & Neck Surg, Houston, TX 77030 USA; [Sandulache, Vlad C.; Chen, Yunyun; Lai, Stephen Y.] Univ Texas MD Anderson Canc Ctr, Dept Head & Neck Surg, Houston, TX 77030 USA; [Skinner, Heath D.] Univ Texas MD Anderson Canc Ctr, Dept Radiat Oncol, Houston, TX 77030 USA; [Lee, Jaehyuk; Ramirez, Marc S.; Walker, Christopher M.; Bankson, James A.] Univ Texas MD Anderson Canc Ctr, Dept Imaging Phys, Houston, TX 77030 USA; [Williams, Michelle D.] Univ Texas MD Anderson Canc Ctr, Dept Pathol, Houston, TX 77030 USA; [Rubinstein, Ashley; Tailor, Ramesh; Court, Laurence E.] Univ Texas MD Anderson Canc Ctr, Dept Radiat Phys, Houston, TX 77030 USA; [Lai, Stephen Y.] Univ Texas MD Anderson Canc Ctr, Dept Mol & Cellular Oncol, Houston, TX 77030 USA	Baylor College of Medicine; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center	Lai, SY (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Head & Neck Surg, Houston, TX 77030 USA.	SYLai@mdanderson.org	Walker, Chris/AAV-1539-2021; Bankson, James A./J-9798-2014; Skinner, Heath/A-1669-2012	Bankson, James A./0000-0002-8574-154X; Court, Laurence/0000-0002-3241-6145; Rubinstein, Ashley/0000-0003-0221-4603; Williams, Michelle D./0000-0002-9133-7332; Sandulache, Vlad/0000-0002-9205-385X; Skinner, Heath/0000-0003-1836-151X; Lai, Stephen/0000-0001-8301-7286; Walker, Christopher/0000-0002-6381-8737	American Academy of Otolaryngology Head and Neck Foundation; Institutional Start-up Funds; NIH Cancer Center Support Grant [P30 CA016672]; Cancer Prevention and Research Institute of Texas [RP-101243P5]; Odyssey Program; Estate of C. G. Johnson, Jr. at The University of Texas MD Anderson Cancer Center; NATIONAL CANCER INSTITUTE [P30CA016672] Funding Source: NIH RePORTER	American Academy of Otolaryngology Head and Neck Foundation; Institutional Start-up Funds; NIH Cancer Center Support Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Prevention and Research Institute of Texas; Odyssey Program; Estate of C. G. Johnson, Jr. at The University of Texas MD Anderson Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research is supported in part by the American Academy of Otolaryngology Head and Neck Foundation Resident Research grant (VCS), Institutional Start-up Funds (SYL), the NIH Cancer Center Support Grant (P30 CA016672), and the Cancer Prevention and Research Institute of Texas (RP-101243P5). Funding for MSR as an Odyssey Fellow was supported by the Odyssey Program and The Estate of C. G. Johnson, Jr. at The University of Texas MD Anderson Cancer Center. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Cancer Institute or the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albers MJ, 2008, CANCER RES, V68, P8607, DOI 10.1158/0008-5472.CAN-08-0749; Amosson CM, 2003, INT J RADIAT ONCOL, V56, P136, DOI 10.1016/S0360-3016(03)00093-2; Ardenkjaer-Larsen JH, 2003, P NATL ACAD SCI USA, V100, P10158, DOI 10.1073/pnas.1733835100; Baujat B, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002026.pub2; Bender K, 2006, BIOCHEM SOC T, V34, P811, DOI 10.1042/BST0340811; Bernier J, 2012, CURR OPIN ONCOL, V24, P223, DOI 10.1097/CCO.0b013e32834ea6fe; Bhatia A, 2010, HEAD NECK-J SCI SPEC, V32, P829, DOI 10.1002/hed.21257; Chen AP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056551; de Oliveira MF, 2012, INT J CELL BIOL, V2012; Derbel O, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-469; Eruslanov E, 2010, METHODS MOL BIOL, V594, P57, DOI 10.1007/978-1-60761-411-1_4; Forastiere AA, 2003, NEW ENGL J MED, V349, P2091, DOI 10.1056/NEJMoa031317; Forastiere AA, 2006, J CLIN ONCOL, V24, P2603, DOI 10.1200/JCO.2006.07.1464; Golman K, 2006, P NATL ACAD SCI USA, V103, P11270, DOI 10.1073/pnas.0601319103; Gule MK, 2011, CLIN CANCER RES, V17, P2281, DOI 10.1158/1078-0432.CCR-10-2762; Gupta SC, 2012, ANTIOXID REDOX SIGN, V16, P1295, DOI 10.1089/ars.2011.4414; Harris T, 2009, P NATL ACAD SCI USA, V106, P18131, DOI 10.1073/pnas.0909049106; Lee JH, 2007, J BIOL CHEM, V282, P13385, DOI 10.1074/jbc.M700303200; Matsumoto S., 2012, MAGN RESON MED; Mohanti BK, 1996, INT J RADIAT ONCOL, V35, P103, DOI 10.1016/S0360-3016(96)85017-6; Nagaria P, 2013, BBA-GEN SUBJECTS, V1830, P2345, DOI 10.1016/j.bbagen.2012.09.001; O'Sullivan B, 2012, Clin Oncol (R Coll Radiol), V24, P474, DOI 10.1016/j.clon.2012.05.006; Pollak N, 2007, BIOCHEM J, V402, P205, DOI 10.1042/BJ20061638; Pollycove M, 2003, HUM EXP TOXICOL, V22, P290, DOI 10.1191/0960327103ht365oa; Saito K, 2012, MAGN RESON MED, V67, P801, DOI 10.1002/mrm.23065; Sandulache VC, 2012, MOL CANCER THER, V11, P1373, DOI 10.1158/1535-7163.MCT-12-0041; Sandulache VC, 2012, CANCER-AM CANCER SOC, V118, P711, DOI 10.1002/cncr.26321; Sandulache VC, 2011, CANCER-AM CANCER SOC, V117, P2926, DOI 10.1002/cncr.25868; Sharma PK, 2012, FREE RADICAL BIO MED, V53, P1500, DOI 10.1016/j.freeradbiomed.2012.07.001; Sherman EJ, 2011, RADIOTHER ONCOL, V101, P425, DOI 10.1016/j.radonc.2011.09.004; Simons AL, 2007, INT J RADIAT ONCOL, V69, P1222, DOI 10.1016/j.ijrobp.2007.07.2343; Simons AL, 2009, J ONCOL, V2009, DOI 10.1155/2009/519563; Simons AL, 2007, CANCER RES, V67, P3364, DOI 10.1158/0008-5472.CAN-06-3717; Skinner HD, 2012, CLIN CANCER RES, V18, P290, DOI 10.1158/1078-0432.CCR-11-2260; Smallridge RC, 2010, CLIN ONCOL-UK, V22, P486, DOI 10.1016/j.clon.2010.03.013; Staffurth J, 2010, CLIN ONCOL-UK, V22, P643, DOI 10.1016/j.clon.2010.06.013; Tan C, 2002, DIABETES, V51, P2989, DOI 10.2337/diabetes.51.10.2989; Thind K, 2012, MAGN RESON MED; Tofts PS, 1997, JMRI-J MAGN RESON IM, V7, P91, DOI 10.1002/jmri.1880070113; Tsimberidou AM, 2009, J CLIN ENDOCR METAB, V94, P4423, DOI 10.1210/jc.2009-0743; Walker CM, 2013, PLOS ONE IN PRESS; Yen YF, 2011, MAGN RESON MED SCI, V10, P211, DOI 10.2463/mrms.10.211; Zhao M, 2011, CLIN CANC RES	43	31	31	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2014	9	1							e87031	10.1371/journal.pone.0087031	http://dx.doi.org/10.1371/journal.pone.0087031			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301BI	24475215	Green Published, gold, Green Submitted			2022-12-25	WOS:000330507300126
J	Tremoureux, L; Raux, M; Hudson, AL; Ranohavimparany, A; Straus, C; Similowski, T				Tremoureux, Lysandre; Raux, Mathieu; Hudson, Anna L.; Ranohavimparany, Anja; Straus, Christian; Similowski, Thomas			Does the Supplementary Motor Area Keep Patients with Ondine's Curse Syndrome Breathing While Awake?	PLOS ONE			English	Article							TRANSCRANIAL MAGNETIC STIMULATION; CENTRAL HYPOVENTILATION SYNDROME; VENTILATORY RESPONSE; RESPIRATORY RHYTHM; CORTEX ACTIVATION; VOLUNTARY CONTROL; HUMANS; DIAPHRAGM; SLEEP; CHEMOSENSITIVITY	Background: Congenital central hypoventilation syndrome (CCHS) is a rare neuro-respiratory disorder associated with mutations of the PHOX2B gene. Patients with this disease experience severe hypoventilation during sleep and are consequently ventilator-dependent. However, they breathe almost normally while awake, indicating the existence of cortical mechanisms compensating for the deficient brainstem generation of automatic breathing. Current evidence indicates that the supplementary motor area plays an important role in modulating ventilation in awake normal humans. We hypothesized that the wake-related maintenance of spontaneous breathing in patients with CCHS could involve supplementary motor area. Methods: We studied 7 CCHS patients (5 women; age: 20-30; BMI: 22.1 +/- 4 kg.m(-2)) during resting breathing and during exposure to carbon dioxide and inspiratory mechanical constraints. They were compared with 8 healthy individuals. Segments of electroencephalographic tracings were selected according to ventilatory flow signal, from 2.5 seconds to 1.5 seconds after the onset of inspiration. After artefact rejection, 80 or more such segments were ensemble averaged. A slow upward shift of the EEG signal starting between 2 and 0.5 s before inspiration (pre-inspiratory potential) was considered suggestive of supplementary motor area activation. Results: In the control group, pre-inspiratory potentials were generally absent during resting breathing and carbon dioxide stimulation, and consistently identified in the presence of inspiratory constraints (expected). In CCHS patients, pre-inspiratory potentials were systematically identified in all study conditions, including resting breathing. They were therefore significantly more frequent than in controls. Conclusions: This study provides a neurophysiological substrate to the wakefulness drive to breathe that is characteristic of CCHS and suggests that the supplementary motor area contributes to this phenomenon. Whether or not this "cortical breathing'' can be taken advantage of therapeutically, or has clinical consequences (like competition with attentional resources) remains to be determined.	[Tremoureux, Lysandre; Raux, Mathieu; Hudson, Anna L.; Ranohavimparany, Anja; Straus, Christian; Similowski, Thomas] Univ Paris 06, INSERM, UMR S1158, Paris, France; [Raux, Mathieu] Grp Hosp Pitie Salpetriere Charles Foix, AP HP, Dept Anesthesie Reanimat, Paris, France; [Hudson, Anna L.] Neurosci Res Australia, Sydney, NSW, Australia; [Hudson, Anna L.] Univ New S Wales, Sydney, NSW, Australia; [Straus, Christian] Grp Hosp Pitie Salpetriere Charles Foix, AP HP, Serv Cent Explorat Fonct Resp Exercice & Dyspnee, Paris, France; [Straus, Christian; Similowski, Thomas] Grp Hosp Pitie Salpetriere Charles Foix, AP HP, Ctr Natl Reference Malad Rares Syndrome Ondine Ad, Paris, France; [Similowski, Thomas] Grp Hosp Pitie Salpetriere Charles Foix, AP HP, Serv Pneumol & Reanimat Med, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Neuroscience Research Australia; University of New South Wales Sydney; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite	Similowski, T (corresponding author), Univ Paris 06, INSERM, UMR S1158, Paris, France.	thomas.similowski@psl.aphp.fr	Hudson, Anna/C-1280-2012	Hudson, Anna/0000-0002-0192-776X; RAUX, Mathieu/0000-0003-2493-9146	"Legs Poix'' grant from the "Chancellerie de l'Universite de Paris,'' France; French national reference center for Congenital Central Alveolar Hypoventilation; French government [ANR-10-A-IHU06]; "Association Francaise du Syndrome d'Ondine'' -AFSO-; "Association pour le Developpement et l'Organisation de la Recherche en Pneumologie et sur le Sommeil'' -ADOREPS-; AFSO	"Legs Poix'' grant from the "Chancellerie de l'Universite de Paris,'' France; French national reference center for Congenital Central Alveolar Hypoventilation; French government; "Association Francaise du Syndrome d'Ondine'' -AFSO-; "Association pour le Developpement et l'Organisation de la Recherche en Pneumologie et sur le Sommeil'' -ADOREPS-; AFSO	This research was funded in part by a "Legs Poix'' grant from the "Chancellerie de l'Universite de Paris,'' France, the French national reference center for Congenital Central Alveolar Hypoventilation, and the program "Investissement d'Avenir ANR-10-A-IHU06'' of the French government. It was also funded by two non-profit associations ("Association Francaise du Syndrome d'Ondine'' -AFSO- and "Association pour le Developpement et l'Organisation de la Recherche en Pneumologie et sur le Sommeil'' -ADOREPS-). Anja Ranohavimparany was supported in part by an AFSO grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMINOFF MJ, 1971, J PHYSIOL-LONDON, V215, P557, DOI 10.1113/jphysiol.1971.sp009485; AXEN K, 1983, J APPL PHYSIOL, V55, P1211, DOI 10.1152/jappl.1983.55.4.1211; BLANCGRAS N, 1994, BIOL PSYCHOL, V37, P147, DOI 10.1016/0301-0511(94)90028-0; COHEN E, 1995, CLIN SCI, V88, P453, DOI 10.1042/cs0880453; COLEBATCH JG, 1991, J PHYSIOL-LONDON, V443, P91, DOI 10.1113/jphysiol.1991.sp018824; CORFIELD DR, 1995, RESP PHYSIOL, V101, P145, DOI 10.1016/0034-5687(95)00026-A; DATTA AK, 1991, J PHYSIOL-LONDON, V440, P17, DOI 10.1113/jphysiol.1991.sp018693; Davey NJ, 1996, RESP PHYSIOL, V106, P127, DOI 10.1016/S0034-5687(96)00069-2; Denot-Ledunois S, 1998, INT J PSYCHOPHYSIOL, V29, P13, DOI 10.1016/S0167-8760(97)00086-X; Dubreuil V, 2008, P NATL ACAD SCI USA, V105, P1067, DOI 10.1073/pnas.0709115105; Eberhard A, 2001, ADV EXP MED BIOL, V499, P489; GALLEGO J, 1993, J PSYCHOSOM RES, V37, P63, DOI 10.1016/0022-3999(93)90124-X; GUILLEMINAULT C, 1982, PEDIATRICS, V70, P684; Haouzi P, 2011, J APPL PHYSIOL, V110, P854, DOI 10.1152/japplphysiol.00833.2010; Haouzi P, 2009, J APPL PHYSIOL, V106, P904, DOI 10.1152/japplphysiol.90675.2008; Hudson AL, 2011, J NEUROPHYSIOL, V106, P1622, DOI 10.1152/jn.00155.2011; Hudson AL, 2011, RESP PHYSIOL NEUROBI, V179, P23, DOI 10.1016/j.resp.2011.06.010; Hudson AL, 2010, J NEUROPHYSIOL, V103, P1622, DOI 10.1152/jn.00887.2009; Jutand L, 2012, ACTA PHYSIOL, V205, P356, DOI 10.1111/j.1748-1716.2012.02427.x; Laviolette L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062258; Li S, 2011, J NEUROPHYSIOL, V105, P512, DOI 10.1152/jn.00946.2010; Massimini M, 2005, SCIENCE, V309, P2228, DOI 10.1126/science.1117256; McKay LC, 2003, J APPL PHYSIOL, V95, P1170, DOI 10.1152/japplphysiol.00641.2002; Mehiri S, 2006, RESP PHYSIOL NEUROBI, V154, P406, DOI 10.1016/j.resp.2005.12.003; MURPHY K, 1990, J PHYSIOL-LONDON, V420, P1; Passingham RE, 1996, PHILOS T ROY SOC B, V351, P1473, DOI 10.1098/rstb.1996.0132; Raux M, 2013, RESP PHYSL IN PRESS; Raux M, 2007, ANESTHESIOLOGY, V107, P746, DOI 10.1097/01.anes.0000287005.58761.e8; Raux M, 2007, J PHYSIOL-LONDON, V578, P569, DOI 10.1113/jphysiol.2006.120246; Raux M, 2010, RESP PHYSIOL NEUROBI, V171, P67, DOI 10.1016/j.resp.2010.01.002; Raux M, 2010, J APPL PHYSIOL, V108, P39, DOI 10.1152/japplphysiol.91454.2008; Sharshar T, 2004, J PHYSIOL-LONDON, V560, P897, DOI 10.1113/jphysiol.2004.061150; Shea SA, 1996, EXP PHYSIOL, V81, P1; Shea SA, 1997, RESP PHYSIOL, V110, P199, DOI 10.1016/S0034-5687(97)00084-4; SHEA SA, 1993, RESP PHYSIOL, V94, P251, DOI 10.1016/0034-5687(93)90022-3; Straus C, 2004, J APPL PHYSIOL, V97, P902, DOI 10.1152/japplphysiol.00989.2003; Straus C, 2011, RESP PHYSIOL NEUROBI, V178, P357, DOI 10.1016/j.resp.2011.07.007; Tremoureux L, 2010, J APPL PHYSIOL, V108, P1127, DOI 10.1152/japplphysiol.91449.2008; Weese-Mayer DE, 2010, AM J RESP CRIT CARE, V181, P626, DOI 10.1164/rccm.200807-1069ST; WIEGAND L, 1988, J APPL PHYSIOL, V64, P1186, DOI 10.1152/jappl.1988.64.3.1186; Wu T, 2004, J NEUROPHYSIOL, V91, P1690, DOI 10.1152/jn.01052.2003; YANOS J, 1990, J APPL PHYSIOL, V68, P2511, DOI 10.1152/jappl.1990.68.6.2511	42	36	36	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2014	9	1							e84534	10.1371/journal.pone.0084534	http://dx.doi.org/10.1371/journal.pone.0084534			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	298QQ	24475031	Green Published, gold, Green Submitted			2022-12-25	WOS:000330339800007
J	Desai, VD; Hsia, HC; Schwarzbauer, JE				Desai, Vivek D.; Hsia, Henry C.; Schwarzbauer, Jean E.			Reversible Modulation of Myofibroblast Differentiation in Adipose-Derived Mesenchymal Stem Cells	PLOS ONE			English	Article							SMOOTH-MUSCLE ACTIN; FIBROBLAST-GROWTH-FACTOR; TGF-BETA; CARDIAC FIBROBLASTS; STROMAL CELLS; IN-VITRO; MATRIX CONTRACTION; TISSUE-REPAIR; SELF-RENEWAL; EXPRESSION	Unregulated activity of myofibroblasts, highly contractile cells that deposit abundant extracellular matrix (ECM), leads to fibrosis. To study the modulation of myofibroblast activity, we used human adipose-derived mesenchymal stem cells (ADSCs), which have much potential in regenerative medicine. We found that ADSCs treated with TGF-beta developed a myofibroblastic phenotype with increases in alpha-smooth muscle actin (alpha-SMA), a myofibroblast marker, and ECM proteins type I collagen and fibronectin. In contrast, treatment with bFGF had the opposite effect. bFGF-differentiated ADSCs showed marked down-regulation of alpha-SMA expression, collagen I, and fibronectin, and loss of focal adhesions and stress fibers. Functionally, bFGF-differentiated ADSCs were significantly more migratory, which correlated with up-regulation of tenascin-C, an anti-adhesive ECM protein, and vimentin, a pro-migratory cytoskeletal protein. On the other hand, TGF-beta-differentiated ADSCs were significantly more contractile than bFGF-differentiated cells. Interestingly, cells completely reversed their morphologies, marker expression, signaling pathways, and contractility versus migratory profiles when switched from culture with one growth factor to the other, demonstrating that the myofibroblast differentiation process is not terminal. Cell differentiation was associated with activation of Smad2 downstream of TGF-beta and of ERK/MAP kinase downstream of bFGF. Reversibility of the TGF-beta-induced myofibroblastic phenotype depends, in part, on bFGF-induced ERK/MAP kinase signaling. These findings show that ADSC differentiation into myofibroblasts and re-differentiation into fibroblast-like cells can be manipulated with growth factors, which may have implications in the development of novel therapeutic strategies to reduce the risk of fibrosis.	[Desai, Vivek D.; Schwarzbauer, Jean E.] Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA; [Hsia, Henry C.] Rutgers State Univ, Robert Wood Johnson Med Sch, New Brunswick, NJ 08903 USA	Princeton University; Rutgers State University New Brunswick; Rutgers State University Medical Center	Hsia, HC (corresponding author), Rutgers State Univ, Robert Wood Johnson Med Sch, New Brunswick, NJ 08903 USA.	hsiahc@rwjms.rutgers.edu	Hsia, Henry/W-6140-2019	Hsia, Henry/0000-0001-8674-9140; Schwarzbauer, Jean/0000-0003-1012-7593	National Institutes of Health [R01 CA160611, K08 GM072546]; Feldstein Medical Foundation; NIGMS predoctoral training grant [T32 GM007388]; NATIONAL CANCER INSTITUTE [R01CA160611] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [K08GM072546, T32GM007388] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Feldstein Medical Foundation; NIGMS predoctoral training grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funding for this research was provided by the National Institutes of Health (R01 CA160611 to J.E.S and K08 GM072546 to H.C.H: http://www.nih.gov) and the Feldstein Medical Foundation (to H.C.H.: http://www.feldsteinmedicalfoundation.org). V.D.D. was funded by an NIGMS predoctoral training grant (T32 GM007388: http://www.nigms.nih.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALESSI DR, 1995, J BIOL CHEM, V270, P27489, DOI 10.1074/jbc.270.46.27489; Alvarez PDA, 2008, THORAX, V63, P374, DOI 10.1136/thx.2007.083857; Bernstein AM, 2007, MOL BIOL CELL, V18, P2716, DOI 10.1091/mbc.E06-10-0912; Chung CY, 1996, MOL BIOL CELL, V7, P883, DOI 10.1091/mbc.7.6.883; Corbett SA, 1999, J BIOL CHEM, V274, P20943, DOI 10.1074/jbc.274.30.20943; Cushing MC, 2008, FASEB J, V22, P1769, DOI 10.1096/fj.07-087627; Dawes LJ, 2008, INVEST OPHTH VIS SCI, V49, P650, DOI 10.1167/iovs.07-0586; Deryugina EI, 1996, J CELL SCI, V109, P643; DESMOULIERE A, 1995, AM J PATHOL, V146, P56; Eckes B, 1998, J CELL SCI, V111, P1897; Eckes B, 2000, J CELL SCI, V113, P2455; Garcia-Olmo D, 2005, DIS COLON RECTUM, V48, P1416, DOI 10.1007/s10350-005-0052-6; Gotoh N, 2008, CANCER SCI, V99, P1319, DOI 10.1111/j.1349-7006.2008.00840.x; Gurtner GC, 2008, NATURE, V453, P314, DOI 10.1038/nature07039; Hildner F, 2010, J BIOMED MATER RES A, V94A, P978, DOI 10.1002/jbm.a.32761; Hinz B, 2007, J INVEST DERMATOL, V127, P526, DOI 10.1038/sj.jid.5700613; Hinz B, 2007, AM J PATHOL, V170, P1807, DOI 10.2353/ajpath.2007.070112; Hsia HC, 2006, J SURG RES, V136, P92, DOI 10.1016/j.jss.2006.05.030; Hunt GC, 2012, EXP CELL RES, V318, P1820, DOI 10.1016/j.yexcr.2012.06.009; Jeon ES, 2008, STEM CELLS, V26, P789, DOI 10.1634/stemcells.2007-0742; Jourdan-LeSaux C, 2010, LIFE SCI, V87, P391, DOI 10.1016/j.lfs.2010.07.010; Kabiri A, 2012, BIOCHEM BIOPH RES CO, V424, P234, DOI 10.1016/j.bbrc.2012.06.082; Kakudo N, 2012, HUM CELL, V25, P87, DOI 10.1007/s13577-012-0049-0; Kamada Y, 2009, AM J PHYSIOL-GASTR L, V296, pG157, DOI 10.1152/ajpgi.90463.2008; Khouw IMSL, 1999, BIOMATERIALS, V20, P1815, DOI 10.1016/S0142-9612(99)00077-0; Kim DH, 2013, FASEB J, V27, P1351, DOI 10.1096/fj.12-220160; Kolle SFT, 2012, J PLAST SURG HAND SU, V46, P59, DOI 10.3109/2000656X.2012.668326; KUROSAKA D, 1995, INVEST OPHTH VIS SCI, V36, P1701; Liu Y, 2013, EUR REV MED PHARMACO, V17, P1611; Lo RS, 1999, NAT CELL BIOL, V1, P472, DOI 10.1038/70258; Mack CP, 2001, J BIOL CHEM, V276, P341, DOI 10.1074/jbc.M005505200; Maharlooei MK, 2011, DIABETES RES CLIN PR, V93, P228, DOI 10.1016/j.diabres.2011.04.018; Maltseva O, 2001, INVEST OPHTH VIS SCI, V42, P2490; Masur SK, 1996, P NATL ACAD SCI USA, V93, P4219, DOI 10.1073/pnas.93.9.4219; Mattey DL, 1997, ANN RHEUM DIS, V56, P426, DOI 10.1136/ard.56.7.426; Mazo M, 2008, EUR J HEART FAIL, V10, P454, DOI 10.1016/j.ejheart.2008.03.017; Mehlhorn AT, 2007, CELL PROLIFERAT, V40, P809, DOI 10.1111/j.1365-2184.2007.00473.x; Midwood KS, 2002, MOL BIOL CELL, V13, P3601, DOI 10.1091/mbc.E02-05-0292; Mizuno Hiroshi, 2009, Journal of Nippon Medical School, V76, P56; Ono I, 1999, J BIOMED MATER RES, V48, P621, DOI 10.1002/(SICI)1097-4636(1999)48:5<621::AID-JBM5>3.0.CO;2-1; Park J, 2013, ONCOGENE, P1; PELED A, 1991, BLOOD, V78, P304; Powell DW, 1999, AM J PHYSIOL-CELL PH, V277, pC1, DOI 10.1152/ajpcell.1999.277.1.C1; Rigotti G, 2007, PLAST RECONSTR SURG, V119, P1409, DOI 10.1097/01.prs.0000256047.47909.71; RonnovJessen L, 1996, J CELL BIOL, V134, P67, DOI 10.1083/jcb.134.1.67; Singer AJ, 1999, NEW ENGL J MED, V341, P738, DOI 10.1056/NEJM199909023411006; Song HY, 2010, EXP MOL MED, V42, P565, DOI 10.3858/emm.2010.42.8.057; Tabit CJ, 2012, AESTHET PLAST SURG, V36, P704, DOI 10.1007/s00266-011-9835-4; Tomasek JJ, 2002, NAT REV MOL CELL BIO, V3, P349, DOI 10.1038/nrm809; Wang H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039969; Wang J, 2003, AM J PHYSIOL-HEART C, V285, pH1871, DOI 10.1152/ajpheart.00387.2003; Wang J, 2001, TISSUE CELL, V33, P86, DOI 10.1054/tice.2000.0160; Wang J, 2000, AM J PHYSIOL-HEART C, V279, pH2776, DOI 10.1152/ajpheart.2000.279.6.H2776; Werner S, 2003, PHYSIOL REV, V83, P835, DOI 10.1152/physrev.2003.83.3.835; Wierzbicka-Patynowski I, 2007, J CELL PHYSIOL, V210, P750, DOI 10.1002/jcp.20886; Zaragosi LE, 2006, STEM CELLS, V24, P2412, DOI 10.1634/stemcells.2006-0006; Zuk PA, 2001, TISSUE ENG, V7, P211, DOI 10.1089/107632701300062859	57	77	82	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2014	9	1							e86865	10.1371/journal.pone.0086865	http://dx.doi.org/10.1371/journal.pone.0086865			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297XI	24466271	gold, Green Published, Green Submitted			2022-12-25	WOS:000330288000159
J	Lim, TS; Kim, BK; Lee, JW; Lee, YK; Chang, S; Kim, SU; Kim, DY; Ahn, SH; Han, KH; Chon, CY; Park, JY				Lim, Tae Seop; Kim, Beom Kyung; Lee, Jong Wook; Lee, Young Ki; Chang, Sooyun; Kim, Seung Up; Kim, Do Young; Ahn, Sang Hoon; Han, Kwang-Hyub; Chon, Chae Yoon; Park, Jun Yong			Use of the Delta Neutrophil Index as a Prognostic Factor of Mortality in Patients with Spontaneous Bacterial Peritonitis: Implications of a Simple and Useful Marker	PLOS ONE			English	Article							IN-HOSPITAL MORTALITY; C-REACTIVE PROTEIN; CIRRHOTIC-PATIENTS; LIVER-CIRRHOSIS; SEPSIS; DISEASE; BACTEREMIA; MANAGEMENT; INFECTION; SURVIVAL	Background: Spontaneous bacterial peritonitis (SBP) is a common and life-threatening infection in patients with advanced cirrhosis. The prognostic value of a novel marker, the delta neutrophil index (DNI), was investigated relative to mortality in patients with SBP. Materials & Methods: Seventy-five patients with SBP were studied from April 2010 to May 2012. DNI at initial diagnosis of SBP was determined and compared with 30-day mortality rates. Results: Of the patients, 87.7% were men, and the median age of all patients was 59.0 yrs. The area under the receiver-operating characteristic (ROC) curve of DNI for 30-day mortality was 0.701 (95% confidence interval [CI], 0.553-0.849; p = 0.009), which was higher than that of C-reactive protein (0.640, 95% CI, 0.494-0.786; p = 0.076) or the model for end-stage liver disease score (0.592, 95% CI, 0.436-0.748; p = 0.235). From the ROC curve, with the sum of sensitivity and specificity, the cutoff value of DNI was determined to be 5.7%. In the high-DNI group (DNI $ 5.7%), septic shock and 30-day mortality were more prevalent compared with the low-DNI group (84.2% vs. 48.2%, p = 0.007; 57.9% vs. 14.3%, p < 0.001, respectively). Patients with an elevated DNI had a higher risk of 30-day mortality compared with those with a low DNI (4.225, 95% CI, 1.631-10.949; p = 0.003). Conclusion: A higher DNI at the time of SBP diagnosis is an independent predictor of 30-day mortality in patients with SBP.	[Lim, Tae Seop; Kim, Beom Kyung; Lee, Young Ki; Chang, Sooyun; Kim, Seung Up; Kim, Do Young; Ahn, Sang Hoon; Han, Kwang-Hyub; Chon, Chae Yoon; Park, Jun Yong] Yonsei Univ, Coll Med, Dept Internal Med, Seoul, South Korea; [Kim, Beom Kyung; Kim, Seung Up; Kim, Do Young; Ahn, Sang Hoon; Han, Kwang-Hyub; Chon, Chae Yoon; Park, Jun Yong] Yonsei Univ, Coll Med, Inst Gastroenterol, Seoul, South Korea; [Kim, Beom Kyung; Kim, Seung Up; Kim, Do Young; Ahn, Sang Hoon; Han, Kwang-Hyub; Chon, Chae Yoon; Park, Jun Yong] Liver Cirrhosis Clin Res Ctr, Seoul, South Korea; [Lee, Jong Wook] Incheon Baek Hosp, Dept Lab Med, Inchon, South Korea	Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System	Park, JY (corresponding author), Yonsei Univ, Coll Med, Dept Internal Med, Seoul, South Korea.	drpjy@yuhs.ac	Park, Jun Yong/H-7127-2019	LIM, TAE SEOP/0000-0002-4578-8685; Kim, Beom Kyung/0000-0002-5363-2496; Ahn, Sang Hoon/0000-0002-3629-4624; Kim, Seung Up/0000-0002-9658-8050; Han, Kwang-Hyub/0000-0003-3960-6539; Park, Jun Yong/0000-0001-6324-2224	Korea Healthcare technology R&D Project, Ministry of Health and Welfare, Republic of Korea [HI10C2020]	Korea Healthcare technology R&D Project, Ministry of Health and Welfare, Republic of Korea	This study was supported by a grant of the Korea Healthcare technology R&D Project, Ministry of Health and Welfare, Republic of Korea (HI10C2020). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ansari-Lari MA, 2003, AM J CLIN PATHOL, V120, P795, DOI 10.1309/LT30BV9UJJV9CFHQ; Bert F, 2008, CLIN MICROBIOL INFEC, V14, P1034, DOI 10.1111/j.1469-0691.2008.02088.x; Bert F, 2003, EUR J CLIN MICROBIOL, V22, P10, DOI 10.1007/s10096-002-0840-z; BONE RC, 1992, CHEST, V101, P1644, DOI 10.1378/chest.101.6.1644; Dias AMB, 2009, ANN NY ACAD SCI, V1173, P103, DOI 10.1111/j.1749-6632.2009.04872.x; Campillo B, 2002, CLIN INFECT DIS, V35, P1, DOI 10.1086/340617; Cazzaniga M, 2009, J HEPATOL, V51, P475, DOI 10.1016/j.jhep.2009.04.017; Cervoni JP, 2012, J HEPATOL, V56, P1299, DOI 10.1016/j.jhep.2011.12.030; Cho JH, 2007, SCAND J INFECT DIS, V39, P697, DOI 10.1080/00365540701299582; Cornbleet PJ, 2002, CLIN LAB MED, V22, P101, DOI 10.1016/S0272-2712(03)00069-6; DALE DC, 1975, J CLIN INVEST, V56, P808, DOI 10.1172/JCI108159; Fernandez J, 2012, J HEPATOL, V56, pS1, DOI 10.1016/S0168-8278(12)60002-6; Garcia-Tsao G, 2009, AM J GASTROENTEROL, V104, P1802, DOI 10.1038/ajg.2009.191; Harris Neil, 2005, Lab Hematol, V11, P62, DOI 10.1532/LH96.04064; HyunNahm C, 2008, ANN CLIN LAB SCI, V38, P241; Jalan R, 2012, J HEPATOLOGY; Jalan R, 2009, HEPATOLOGY, V50, P555, DOI 10.1002/hep.22913; Jepsen P, 2003, HEPATO-GASTROENTEROL, V50, P2133; Jha SK, 2009, HEPATOL INT, V3, P384, DOI 10.1007/s12072-008-9110-1; Kim HW, 2012, SCAND J INFECT DIS, V44, P475, DOI 10.3109/00365548.2012.657232; Kratz Alexander, 2006, Lab Hematol, V12, P63, DOI 10.1532/LH96.06010; LLOVET JM, 1993, AM J GASTROENTEROL, V88, P388; MIHAS AA, 1992, HEPATO-GASTROENTEROL, V39, P520; Mookerjee RP, 2007, HEPATOLOGY, V45, P62, DOI 10.1002/hep.21491; Musskopf MI, 2012, ANN HEPATOL, V11, P915; Navasa M, 1996, GASTROENTEROLOGY, V111, P1011, DOI 10.1016/S0016-5085(96)70069-0; Nigro KG, 2005, AM J CLIN PATHOL, V123, P618, DOI 10.1309/73H7K7UBW816PBJJ; Nobre SR, 2008, EUR J GASTROEN HEPAT, V20, P1176, DOI 10.1097/MEG.0b013e32830607a2; Park BH, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-299; Park WB, 2005, DIAGN MICR INFEC DIS, V51, P227, DOI 10.1016/j.diagmicrobio.2004.11.014; Pyo JY, 2013, LUPUS, V22, P1102, DOI 10.1177/0961203313499957; RUNYON BA, 1991, GASTROENTEROLOGY, V100, P1737, DOI 10.1016/0016-5085(91)90677-D; Seebach JD, 1997, AM J CLIN PATHOL, V107, P582; Seok Y, 2012, SHOCK, V37, P242, DOI 10.1097/SHK.0b013e3182454acf; Shawcross DL, 2004, J HEPATOL, V40, P247, DOI 10.1016/j.jhep.2003.10.016; Siegel JD, 2007, AM J INFECT CONTROL, V35, pS165, DOI 10.1016/j.ajic.2007.10.006; Such J, 1998, CLIN INFECT DIS, V27, P669, DOI 10.1086/514940; Suk KT, 2012, CLIN MOL HEPATOL, V18, P249, DOI 10.3350/cmh.2012.18.3.249; TERG R, 1992, DIGEST DIS SCI, V37, P1499, DOI 10.1007/BF01296493; WEINSTEIN MP, 1978, AM J MED, V64, P592, DOI 10.1016/0002-9343(78)90578-8; Wong F, 2005, GUT, V54, P718, DOI 10.1136/gut.2004.038679; Zanaty OM, 2012, ALEXANDRIA J MED	43	22	22	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2014	9	1							e86884	10.1371/journal.pone.0086884	http://dx.doi.org/10.1371/journal.pone.0086884			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297XI	24466280	Green Published, gold, Green Submitted			2022-12-25	WOS:000330288000164
J	McMichael, BK; Scherer, KF; Franklin, NC; Lee, BS				McMichael, Brooke K.; Scherer, Katharine F.; Franklin, Nicole C.; Lee, Beth S.			The RhoGAP Activity of Myosin IXB Is Critical for Osteoclast Podosome Patterning, Motility, and Resorptive Capacity	PLOS ONE			English	Article							UNCONVENTIONAL MYOSIN; BONE METABOLISM; CELIAC-DISEASE; SRC KINASE; PLUS-END; ORGANIZATION; ADHESION; EXPRESSION; PROTEIN; CELLS	Osteoclasts are large, multinucleated cells of the monocyte-macrophage lineage that generate specialized substrate adhesion complexes to facilitate their function as bone-degrading cells. The patterning and function of these actin-based complexes, podosomes and sealing zones, are regulated by the small GTPase Rho. Myosin IXB (Myo9b) is a unique actin-based motor protein that contains a RhoGAP domain, which, like other RhoGAPs, is inhibitory to Rho signaling. In this study, Myo9b is shown to be expressed in osteoclasts and act as a critical regulator of podosome patterning and osteoclast function. SiRNA-mediated knockdown of Myo9b results in increased activity of Rho but not Rac in osteoclasts. Knockdown in osteoclasts on glass results in altered podosome patterning and decreased motility, and this effect is reversed by addition of a Rho inhibitor. SiRNA-mediated suppression of Myo9b expression in osteoclasts on bone results in a dramatic loss of resorptive capacity even though sealing zones appear normal. This loss of resorption is also reversible with addition of a Rho inhibitor. Cells with diminished Myo9b levels display mislocalization and suppressed activation of Src, a tyrosine kinase with critical effects on osteoclast actin cytoskeletal rearrangement and function. In addition, siRNA-treated cells display poorly formed microtubule networks and a lack of tubulin acetylation, a marker of microtubule stability. However, short-term addition of TNF alpha to cells with suppressed Myo9b levels overcomes or circumvents these defects and causes increased sealing zone size and resorptive capacity. These results indicate that the RhoGAP activity of Myo9b plays a key role in regulating the actin-based structures necessary for osteoclast motility and resorption, and confirms that Myo9b can act as a motorized signaling molecule that links Rho signaling to the dynamic actin cytoskeleton.	[McMichael, Brooke K.; Scherer, Katharine F.; Franklin, Nicole C.; Lee, Beth S.] Ohio State Univ, Coll Med, Dept Physiol & Cell Biol, Columbus, OH 43210 USA	Ohio State University	Lee, BS (corresponding author), Ohio State Univ, Coll Med, Dept Physiol & Cell Biol, Columbus, OH 43210 USA.	lee.2076@osu.edu	Lee, Beth S/E-9578-2010	Lee, Beth S/0000-0002-1468-6387	NIH [R01 AR051515]; Ohio State University; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR051515] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ohio State University(Ohio State University); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	The work was supported by the following: NIH R01 AR051515; and internal awards from The Ohio State University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderegg F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028583; Bahler M, 2011, BIOCHEM SOC T, V39, P1166, DOI 10.1042/BST0391166; Bahler M, 2000, BBA-MOL CELL RES, V1496, P52, DOI 10.1016/S0167-4889(00)00008-2; BEMENT WM, 1994, P NATL ACAD SCI USA, V91, P6549, DOI 10.1073/pnas.91.14.6549; Bianchi ML, 2010, ARCH BIOCHEM BIOPHYS, V503, P54, DOI 10.1016/j.abb.2010.06.026; BOYCE BF, 1992, J CLIN INVEST, V90, P1622, DOI 10.1172/JCI116032; Brazier H, 2006, J BONE MINER RES, V21, P1387, DOI 10.1359/JBMR.060613; Chandhoke SK, 2012, MOL BIOL CELL, V23, P2468, DOI 10.1091/mbc.E11-09-0803; Chellaiah MA, 2000, J BIOL CHEM, V275, P11993, DOI 10.1074/jbc.275.16.11993; Chieregatti E, 1998, J CELL SCI, V111, P3597; Cooney R, 2009, INFLAMM BOWEL DIS, V15, P1014, DOI 10.1002/ibd.20885; Destaing O, 2005, J CELL SCI, V118, P2901, DOI 10.1242/jcs.02425; Destaing O, 2003, MOL BIOL CELL, V14, P407, DOI 10.1091/mbc.E02-07-0389; Fuller K, 2002, ENDOCRINOLOGY, V143, P1108, DOI 10.1210/en.143.3.1108; Geblinger D, 2012, J R SOC INTERFACE, V9, P1599, DOI 10.1098/rsif.2011.0659; Ghishan FK, 2011, AM J PHYSIOL-GASTR L, V300, pG191, DOI 10.1152/ajpgi.00496.2010; Gil-Henn H, 2007, J CELL BIOL, V178, P1053, DOI 10.1083/jcb.200701148; Hanley PJ, 2010, P NATL ACAD SCI USA, V107, P12145, DOI 10.1073/pnas.0911986107; Hartman MA, 2011, ANNU REV CELL DEV BI, V27, P133, DOI 10.1146/annurev-cellbio-100809-151502; Horne WC, 2005, IMMUNOL REV, V208, P106, DOI 10.1111/j.0105-2896.2005.00335.x; Janke C, 2011, NAT REV MOL CELL BIO, V12, P773, DOI 10.1038/nrm3227; Kambara T, 2006, J BIOL CHEM, V281, P4949, DOI 10.1074/jbc.M509141200; Kotadiya P, 2008, BONE, V43, P951, DOI 10.1016/j.bone.2008.06.017; Krendel M, 2005, PHYSIOLOGY, V20, P239, DOI 10.1152/physiol.00014.2005; Krits I, 2002, CALCIFIED TISSUE INT, V71, P530, DOI 10.1007/s00223-001-1112-0; Latiano A, 2008, ALIMENT PHARM THER, V27, P241, DOI 10.1111/j.1365-2036.2007.03551.x; Leso V, 2010, EUR J GASTROEN HEPAT, V22, P779, DOI 10.1097/MEG.0b013e328331b654; Liao WQ, 2010, J BIOL CHEM, V285, P24933, DOI 10.1074/jbc.M110.101105; Linder S, 2003, TRENDS CELL BIOL, V13, P376, DOI 10.1016/S0962-8924(03)00128-4; Luxenburg C, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000179; MARCHISIO PC, 1987, EXP CELL RES, V169, P202, DOI 10.1016/0014-4827(87)90238-2; Mathew SJ, 2009, J CELL SCI, V122, P1939, DOI 10.1242/jcs.044487; McMichael BK, 2008, EXP CELL RES, V314, P564, DOI 10.1016/j.yexcr.2007.10.018; McMichael BK, 2006, BONE, V39, P694, DOI 10.1016/j.bone.2006.04.031; McMichael BK, 2010, J BIOL CHEM, V285, P26641, DOI 10.1074/jbc.M110.119909; McMichael BK, 2010, J BIOL CHEM, V285, P9506, DOI 10.1074/jbc.M109.017269; McMichael BK, 2009, J BIOL CHEM, V284, P12266, DOI 10.1074/jbc.M808621200; Monsuur AJ, 2005, NAT GENET, V37, P1341, DOI 10.1038/ng1680; Nunez C, 2007, GUT, V56, P1321, DOI 10.1136/gut.2007.121905; O'Connell CB, 2003, NAT CELL BIOL, V5, P171, DOI 10.1038/ncb924; O'Neill GM, 2008, SEMIN CANCER BIOL, V18, P35, DOI 10.1016/j.semcancer.2007.08.004; Odronitz F, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-9-r196; Ory S, 2000, J CELL SCI, V113, P1177; Ory S, 2008, EUR J CELL BIOL, V87, P469, DOI 10.1016/j.ejcb.2008.03.002; Pertz O, 2010, J CELL SCI, V123, P1841, DOI 10.1242/jcs.064345; Post PL, 1998, J CELL SCI, V111, P941; REINHARD J, 1995, EMBO J, V14, P697, DOI 10.1002/j.1460-2075.1995.tb07048.x; Russell RGG, 2007, PEDIATRICS, V119, pS150, DOI 10.1542/peds.2006-2023H; Saltel F, 2004, MOL BIOL CELL, V15, P5231, DOI 10.1091/mbc.E04-06-0522; Sanjay A, 2001, J CELL BIOL, V152, P181, DOI 10.1083/jcb.152.1.181; SORIANO P, 1991, CELL, V64, P693, DOI 10.1016/0092-8674(91)90499-O; Struchholz S, 2009, J BIOL CHEM, V284, P3663, DOI 10.1074/jbc.M808338200; Tcherkezian J, 2007, BIOL CELL, V99, P67, DOI 10.1042/BC20060086; Teitelbaum SL, 2000, SCIENCE, V289, P1504, DOI 10.1126/science.289.5484.1504; Van Bodegraven AA, 2006, GASTROENTEROLOGY, V131, P1768, DOI 10.1053/j.gastro.2006.09.011; Veerappan SG, 2011, ALIMENT PHARM THER, V33, P1261, DOI 10.1111/j.1365-2036.2011.04667.x; Wirth JA, 1996, J CELL SCI, V109, P653; Woolner S, 2009, TRENDS CELL BIOL, V19, P245, DOI 10.1016/j.tcb.2009.03.003; Yamana N, 2006, MOL CELL BIOL, V26, P6844, DOI 10.1128/MCB.00283-06; Young KG, 2010, BBA-MOL CELL RES, V1803, P183, DOI 10.1016/j.bbamcr.2008.09.017; ZHANG D, 1995, J CELL SCI, V108, P2285	61	19	19	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2014	9	1							e87402	10.1371/journal.pone.0087402	http://dx.doi.org/10.1371/journal.pone.0087402			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297XI	24466350	Green Published, Green Submitted, gold			2022-12-25	WOS:000330288000206
J	van Os, J; Lataster, T; Delespaul, P; Wichers, M; Myin-Germeys, I				van Os, Jim; Lataster, Tineke; Delespaul, Philippe; Wichers, Marieke; Myin-Germeys, Inez			Evidence That a Psychopathology Interactome Has Diagnostic Value, Predicting Clinical Needs: An Experience Sampling Study	PLOS ONE			English	Article							DAILY-LIFE STRESS; GENE-ENVIRONMENT INTERACTIONS; EMOTIONAL REACTIVITY; MOMENTARY ASSESSMENT; POSITIVE EMOTIONS; PRECISION DIAGNOSIS; EARLY INTERVENTION; REWARD EXPERIENCE; CHILDHOOD TRAUMA; SELF-ESTEEM	Background: For the purpose of diagnosis, psychopathology can be represented as categories of mental disorder, symptom dimensions or symptom networks. Also, psychopathology can be assessed at different levels of temporal resolution (monthly episodes, daily fluctuating symptoms, momentary fluctuating mental states). We tested the diagnostic value, in terms of prediction of treatment needs, of the combination of symptom networks and momentary assessment level. Method: Fifty-seven patients with a psychotic disorder participated in an ESM study, capturing psychotic experiences, emotions and circumstances at 10 semi-random moments in the flow of daily life over a period of 6 days. Symptoms were assessed by interview with the Positive and Negative Syndrome Scale (PANSS); treatment needs were assessed using the Camberwell Assessment of Need (CAN). Results: Psychotic symptoms assessed with the PANSS (Clinical Psychotic Symptoms) were strongly associated with psychotic experiences assessed with ESM (Momentary Psychotic Experiences). However, the degree to which Momentary Psychotic Experiences manifested as Clinical Psychotic Symptoms was determined by level of momentary negative affect (higher levels increasing probability of Momentary Psychotic Experiences manifesting as Clinical Psychotic Symptoms), momentary positive affect (higher levels decreasing probability of Clinical Psychotic Symptoms), greater persistence of Momentary Psychotic Experiences (persistence predicting increased probability of Clinical Psychotic Symptoms) and momentary environmental stress associated with events and activities (higher levels increasing probability of Clinical Psychotic Symptoms). Similarly, the degree to which momentary visual or auditory hallucinations manifested as Clinical Psychotic Symptoms was strongly contingent on the level of accompanying momentary paranoid delusional ideation. Momentary Psychotic Experiences were associated with CAN unmet treatment needs, over and above PANSS measures of psychopathology, similarly moderated by momentary interactions with emotions and context. Conclusion: The results suggest that psychopathology, represented as an interactome at the momentary level of temporal resolution, is informative in diagnosing clinical needs, over and above traditional symptom measures.	[van Os, Jim; Lataster, Tineke; Delespaul, Philippe; Wichers, Marieke; Myin-Germeys, Inez] Maastricht Univ Med Ctr, Ctr Contextual Neurosci, Dept Psychiat & Psychol, Maastricht, Netherlands; [van Os, Jim] Kings Coll London, Inst Psychiat, Dept Psychosis Studies, Kings Hlth Partners, London WC2R 2LS, England	Maastricht University; Maastricht University Medical Centre (MUMC); University of London; King's College London	van Os, J (corresponding author), Maastricht Univ Med Ctr, Ctr Contextual Neurosci, Dept Psychiat & Psychol, Maastricht, Netherlands.	j.vanos@maastrichtuniversity.nl	Delespaul, Philippe/E-8982-2011; van Os, Jim/C-2113-2014; Wichers, Marieke/N-6667-2014; van Os, Jim/V-8884-2019; Vasconcelos, Ana Carolina Souza de/GXW-3453-2022; Myin-Germeys, Inez/L-5106-2014; Delespaul, Philippe/L-1396-2019	Delespaul, Philippe/0000-0001-7420-0898; Wichers, Marieke/0000-0001-5024-9064; van Os, Jim/0000-0002-7245-1586; Delespaul, Philippe/0000-0001-7420-0898; Myin-Germeys, Inez/0000-0002-3731-4930	European Community [HEALTH-F2-2009-241909]	European Community(European Commission)	Supported by the European Community's Seventh Framework Programme under Grant agreement no. HEALTH-F2-2009-241909 (Project EU-GEI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BILDER RM, 1985, SCHIZOPHRENIA BULL, V11, P409, DOI 10.1093/schbul/11.3.409; Borsboom D, 2013, ANNU REV CLIN PSYCHO, V9, P91, DOI 10.1146/annurev-clinpsy-050212-185608; Collip D, 2011, PSYCHOL MED, V41, P2305, DOI 10.1017/S0033291711000602; Collip D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066747; Corfas G, 2004, NAT NEUROSCI, V7, P575, DOI 10.1038/nn1258; CSIKSZENTMIHALYI M, 1987, J NERV MENT DIS, V175, P526, DOI 10.1097/00005053-198709000-00004; De Vries M, 1992, EXPERIENCE PSYCHOPAT; Delespaul PAEG, 1995, THESIS MAASTRICHT U; Denicoff KD, 2000, PSYCHOL MED, V30, P1391, DOI 10.1017/S0033291799002810; DEVRIES MW, 1997, TRANSCULT PSYCHIATRY, V34, P185; Esslinger C, 2009, SCIENCE, V324, P605, DOI 10.1126/science.1167768; First MB, 2010, CAN J PSYCHIAT, V55, P692, DOI 10.1177/070674371005501102; Frissen A, 2013, EVIDENCE CHILD UNPUB; Geschwind N, 2011, J CONSULT CLIN PSYCH, V79, P618, DOI 10.1037/a0024595; Geschwind N, 2011, EUR NEUROPSYCHOPHARM, V21, P241, DOI 10.1016/j.euroneuro.2010.11.004; Glaser JP, 2008, PSYCHOL MED, V38, P1231, DOI 10.1017/S0033291707002322; Glaser JP, 2010, ACTA PSYCHIAT SCAND, V121, P125, DOI 10.1111/j.1600-0447.2009.01427.x; Glaser JP, 2006, J PSYCHOSOM RES, V61, P229, DOI 10.1016/j.jpsychores.2006.04.014; Henquet C, 2010, BRIT J PSYCHIAT, V196, P447, DOI 10.1192/bjp.bp.109.072249; Jacobs N, 2005, LIFE SCI, V76, P2431, DOI 10.1016/j.lfs.2004.10.045; Jacobs N, 2011, BRIT J CLIN PSYCHOL, V50, P19, DOI 10.1348/014466510X491397; Kahn RS, 2011, ARCH GEN PSYCHIAT, V68, P138, DOI 10.1001/archgenpsychiatry.2010.132; Kapur S, 2012, MOL PSYCHIATR, V17, P1174, DOI 10.1038/mp.2012.105; KAY SR, 1987, SCHIZOPHRENIA BULL, V13, P261, DOI 10.1093/schbul/13.2.261; Kendler KS, 2010, PSYCHOL MED, V40, P801, DOI 10.1017/S0033291709991140; Kimhy D, SCHIZOPHRENIA B, V38, P386; Kinderman P, 2013, EVID-BASED MENT HEAL, V16, P2, DOI 10.1136/eb-2012-100987; Korver N, 2012, INT J METH PSYCH RES, V21, P205, DOI 10.1002/mpr.1352; Kramer I, 2013, SCHIZOPHR B; Kramer I, 2013, THERAPEUTIC AP UNPUB; Kramer IM, 2011, PSYCHOL MED, P1; Kuepper R, 2013, ACTA PSYCHIAT SCAND; Kwapil TR, 2012, PSYCHOL MED, V42, P2555, DOI 10.1017/S0033291712000827; Lardinois M, 2011, ACTA PSYCHIAT SCAND, V123, P28, DOI 10.1111/j.1600-0447.2010.01594.x; Lataster J, 2011, J CLIN PSYCHIAT, V72, P1397, DOI 10.4088/JCP.09m05466yel; Lataster T, 2010, ACTA PSYCHIAT SCAND, V122, P395, DOI 10.1111/j.1600-0447.2010.01566.x; Lataster T, 2012, PSYCHOL MED, P1; McDannald MA, 2011, BIOL PSYCHIAT, V70, P1122, DOI 10.1016/j.biopsych.2011.06.014; McGorry P, 2010, PSYCHOL MED, V40, P399, DOI 10.1017/S0033291709991346; McGorry PD, 2006, AUST NZ J PSYCHIAT, V40, P616, DOI 10.1111/j.1440-1614.2006.01860.x; McGorry PD, 2003, AUST NZ J PSYCHIAT, V37, P393, DOI 10.1046/j.1440-1614.2003.01192.x; Myin-Germeys, 2012, HDB RES METHODS STUD, P636; Myin-Germeys I, 2003, ACTA PSYCHIAT SCAND, V107, P124, DOI 10.1034/j.1600-0447.2003.02025.x; Myin-Germeys I, 2001, ARCH GEN PSYCHIAT, V58, P1137, DOI 10.1001/archpsyc.58.12.1137; Myin-Germeys I, 2005, BIOL PSYCHIAT, V58, P105, DOI 10.1016/j.biopsych.2005.02.012; Myin-Germeys I, 2005, PSYCHOL MED, V35, P733, DOI 10.1017/S0033291704004179; Myin-Germeys I, 2003, PSYCHOL MED, V33, P327, DOI 10.1017/S0033291702006785; Myin-Germeys I, 2009, PSYCHOL MED, V39, P1533, DOI 10.1017/S0033291708004947; Myin-Germeys I, 2007, CLIN PSYCHOL REV, V27, P409, DOI 10.1016/j.cpr.2006.09.005; Myin-Germeys I, 2011, SCHIZOPHRENIA BULL, V37, P244, DOI 10.1093/schbul/sbq164; Nuevo R, 2013, ACTA PSYCHIAT SCAND, V127, P482, DOI 10.1111/acps.12010; Oorschot M, 2011, SCHIZOPHRENIA B; Oorschot M, 2012, SCHIZOPHRENIA BULL, V38, P405, DOI 10.1093/schbul/sbr166; Perlis RH, 2011, ARCH GEN PSYCHIAT, V68, P351, DOI 10.1001/archgenpsychiatry.2010.179; PHELAN M, 1995, BRIT J PSYCHIAT, V167, P589, DOI 10.1192/bjp.167.5.589; Rico B, 2012, P NATL ACAD SCI USA, V109, P11902, DOI 10.1073/pnas.1209389109; Sawa A, 2002, SCIENCE, V296, P692, DOI 10.1126/science.1070532; Simons CJP, 2009, GENES BRAIN BEHAV, V8, P5, DOI 10.1111/j.1601-183X.2008.00434.x; Smeets F, 2013, ACTA PSYCHIAT SCAND, V127, P34, DOI 10.1111/j.1600-0447.2012.01888.x; Smeets F, 2012, SCHIZOPHRENIA BULL, V38, P531, DOI 10.1093/schbul/sbq117; StataCorp, 2011, STAT STAT SOFTW REL, P173; Thewissen V, 2008, J ABNORM PSYCHOL, V117, P143, DOI 10.1037/0021-843X.117.1.143; Thewissen V, 2011, BRIT J CLIN PSYCHOL, V50, P178, DOI 10.1348/014466510X508677; Van der Poel EGT, 1992, EXPERIENCE PSYCHOPAT, P290; van Meter KM, 1987, B METHODOLOGIE SOCIO, P22; van Os J, 2013, AM J PSYCHIAT, V170, P695, DOI 10.1176/appi.ajp.2013.13040474; Van Os J, 2013, PSYCHOL MED, V43, P1563, DOI 10.1017/S0033291713000937; van Os J, 2013, WORLD PSYCHIATRY, V12, P113, DOI 10.1002/wps.20046; Van Os J, 2010, J MENT HEALTH, V19, P305, DOI 10.3109/09638237.2010.492417; Verdoux H, 2003, PSYCHOL MED, V33, P23, DOI 10.1017/S0033291702006384; Walsh T, 2008, SCIENCE, V320, P539, DOI 10.1126/science.1155174; Wichers M, 2011, ACTA PSYCHIAT SCAND, V123, P402, DOI 10.1111/j.1600-0447.2011.01684.x; Wichers M, 2011, ACTA PSYCHIAT SCAND, V124, P262, DOI 10.1111/j.1600-0447.2011.01749.x; Wichers M, 2010, J AFFECT DISORDERS, V124, P191, DOI 10.1016/j.jad.2009.11.010; Wichers M, 2009, PSYCHOL MED, V39, P1077, DOI 10.1017/S0033291708004388; Wichers M, 2013, PSYCHOL MED IN PRESS; Wichers MC, 2009, NEUROPSYCHOPHARMACOL, V34, P923, DOI 10.1038/npp.2008.66; Wichers M, 2007, BRIT J PSYCHIAT, V191, P218, DOI 10.1192/bjp.bp.106.032201; Wichers M, 2012, BRIT J CLIN PSYCHOL, V51, P206, DOI 10.1111/j.2044-8260.2011.02021.x; Wichers M, 2012, HEALTH PSYCHOL, V31, P135, DOI 10.1037/a0025688; Wichers M, 2009, BRIT J PSYCHIAT, V195, P498, DOI 10.1192/bjp.bp.108.056853; Wichers MC, 2008, PSYCHOSOM MED, V70, P314, DOI 10.1097/PSY.0b013e31816b1eee; Wichers MC, 2007, ACTA PSYCHIAT SCAND, V115, P451, DOI 10.1111/j.1600-0447.2006.00924.x; Wigman JTW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059559; Wigman JTW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054653; Wigman JTW, 2012, SCHIZOPHRENIA BULL, V38, P247, DOI 10.1093/schbul/sbr196; Wigman JT, 2013, PSYCHOL MED, P1; Yung AR, 1996, SCHIZOPHRENIA BULL, V22, P283, DOI 10.1093/schbul/22.2.283	88	30	30	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2014	9	1							e86652	10.1371/journal.pone.0086652	http://dx.doi.org/10.1371/journal.pone.0086652			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	297XI	24466189	gold, Green Published			2022-12-25	WOS:000330288000130
J	Imai, T; Ubi, BE; Saito, T; Moriguchi, T				Imai, Tsuyoshi; Ubi, Benjamin E.; Saito, Takanori; Moriguchi, Takaya			Evaluation of Reference Genes for Accurate Normalization of Gene Expression for Real Time-Quantitative PCR in Pyrus pyrifolia Using Different Tissue Samples and Seasonal Conditions	PLOS ONE			English	Article							RT-PCR; HOUSEKEEPING GENES; TRANSCRIPTOME ANALYSIS; JAPANESE PEAR; FLOWER BUDS; ENDODORMANCY; RNA; QUANTIFICATION; ARABIDOPSIS; VALIDATION	We have evaluated suitable reference genes for real time (RT)-quantitative PCR (qPCR) analysis in Japanese pear (Pyrus pyrifolia). We tested most frequently used genes in the literature such as beta-Tubulin, Histone H3, Actin, Elongation factor-1 alpha, Glyceraldehyde-3-phosphate dehydrogenase, together with newly added genes Annexin, SAND and TIP41. A total of 17 primer combinations for these eight genes were evaluated using cDNAs synthesized from 16 tissue samples from four groups, namely: flower bud, flower organ, fruit flesh and fruit skin. Gene expression stabilities were analyzed using geNorm and NormFinder software packages or by Delta Ct method. geNorm analysis indicated three best performing genes as being sufficient for reliable normalization of RT-qPCR data. Suitable reference genes were different among sample groups, suggesting the importance of validation of gene expression stability of reference genes in the samples of interest. Ranking of stability was basically similar between geNorm and NormFinder, suggesting usefulness of these programs based on different algorithms. Delta Ct method suggested somewhat different results in some groups such as flower organ or fruit skin; though the overall results were in good correlation with geNorm or NormFinder. Gene expression of two cold-inducible genes PpCBF2 and PpCBF4 were quantified using the three most and the three least stable reference genes suggested by geNorm. Although normalized quantities were different between them, the relative quantities within a group of samples were similar even when the least stable reference genes were used. Our data suggested that using the geometric mean value of three reference genes for normalization is quite a reliable approach to evaluating gene expression by RT-qPCR. We propose that the initial evaluation of gene expression stability by Delta Ct method, and subsequent evaluation by geNorm or NormFinder for limited number of superior gene candidates will be a practical way of finding out reliable reference genes.	[Imai, Tsuyoshi; Ubi, Benjamin E.; Saito, Takanori; Moriguchi, Takaya] NARO Inst Fruit Tree Sci, Plant Physiol & Fruit Chem Div, Tsukuba, Ibaraki, Japan; [Ubi, Benjamin E.] Ebonyi State Univ, Biotechnol Res & Dev Ctr, Abakaliki, Ebonyi State, Nigeria; [Saito, Takanori; Moriguchi, Takaya] Univ Tsukuba, Grad Sch Life & Environm Sci, Tsukuba, Ibaraki, Japan	University of Tsukuba	Imai, T (corresponding author), NARO Inst Fruit Tree Sci, Plant Physiol & Fruit Chem Div, Tsukuba, Ibaraki, Japan.	imagic@affrc.go.jp	SAITO, Takanori/O-2088-2019; Ubi, Benjamin/ABB-4891-2020; Imai, Tsuyoshi/F-2515-2018	SAITO, Takanori/0000-0002-8162-8232; Imai, Tsuyoshi/0000-0002-8891-0564; Ubi, Benjamin/0000-0003-4097-0768	NARO research program [210]; Japan Society for the Promotion of Science	NARO research program; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	The research was funded by NARO research program #210: Adaptation and mitigation to climate change for agriculture. Research was also supported in part by Visiting Research Fellowships for Foreign Researchers from Japan Society for the Promotion of Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Bai SL, 2013, PLANT CELL PHYSIOL, V54, P1132, DOI 10.1093/pcp/pct067; Brunner Amy M., 2004, BMC Plant Biology, V4, P14, DOI 10.1186/1471-2229-4-14; Cassan-Wang H, 2012, PLANT CELL PHYSIOL, V53, P2101, DOI 10.1093/pcp/pcs152; Chen L, 2011, PLANTA, V234, P377, DOI 10.1007/s00425-011-1410-3; Cottage A, 2004, CELL MOL BIOL LETT, V9, P739; Czechowski T, 2005, PLANT PHYSIOL, V139, P5, DOI 10.1104/pp.105.063743; Czechowski T, 2004, PLANT J, V38, P366, DOI 10.1111/j.1365-313X.2004.02051.x; Exposito-Rodriguez M, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-131; Feng SQ, 2010, PLANTA, V232, P245, DOI 10.1007/s00425-010-1170-5; Gachon C, 2004, J EXP BOT, V55, P1445, DOI 10.1093/jxb/erh181; Gerke V, 2005, NAT REV MOL CELL BIO, V6, P449, DOI 10.1038/nrm1661; Giovannoni JJ, 2004, PLANT CELL, V16, pS170, DOI 10.1105/tpc.019158; Guenin S, 2009, J EXP BOT, V60, P487, DOI 10.1093/jxb/ern305; Gutierrez L, 2008, PLANT BIOTECHNOL J, V6, P609, DOI 10.1111/j.1467-7652.2008.00346.x; Hellemans J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r19; Jacinto E, 2001, MOL CELL, V8, P1017, DOI 10.1016/S1097-2765(01)00386-0; Kubista Mikael, 2006, Molecular Aspects of Medicine, V27, P95, DOI 10.1016/j.mam.2005.12.007; Lovdal T, 2009, ANAL BIOCHEM, V387, P238, DOI 10.1016/j.ab.2009.01.024; Morrison T, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl639; Nakashima A, 2013, FEBS LETT, V587, P2924, DOI 10.1016/j.febslet.2013.07.027; Narsai R, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-56; Nishitani C, 2012, SCI HORTIC-AMSTERDAM, V147, P49, DOI 10.1016/j.scienta.2012.09.001; Nolan T, 2006, NAT PROTOC, V1, P1559, DOI 10.1038/nprot.2006.236; Pettengill Emily A, 2012, BMC Res Notes, V5, P366, DOI 10.1186/1756-0500-5-366; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; Reid KE, 2006, BMC PLANT BIOL, V6, DOI 10.1186/1471-2229-6-27; Rescher U, 2004, J CELL SCI, V117, P2631, DOI 10.1242/jcs.01245; Rozen S, 2000, Methods Mol Biol, V132, P365; Silver N, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-33; Spurgeon SL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001662; Stajner N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068228; Thellin O, 1999, J BIOTECHNOL, V75, P291, DOI 10.1016/S0168-1656(99)00163-7; Ubi BE, 2010, J AM SOC HORTIC SCI, V135, P174, DOI 10.21273/JASHS.135.2.174; Udvardi MK, 2008, PLANT CELL, V20, P1736, DOI 10.1105/tpc.108.061143; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; WAN CY, 1994, ANAL BIOCHEM, V223, P7, DOI 10.1006/abio.1994.1538; Wisniewski M, 2011, PLANTA, V233, P971, DOI 10.1007/s00425-011-1358-3; Xie FL, 2012, PLANT MOL BIOL, V80, P75, DOI 10.1007/s11103-012-9885-2; Yamane H, 2006, TREE PHYSIOL, V26, P1559, DOI 10.1093/treephys/26.12.1559; Zhu XY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044405	41	60	67	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2014	9	1							e86492	10.1371/journal.pone.0086492	http://dx.doi.org/10.1371/journal.pone.0086492			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297VL	24466117	Green Published, gold, Green Submitted			2022-12-25	WOS:000330283100171
J	van Hartevelt, TJ; Cabral, J; Deco, G; Moller, A; Green, AL; Aziz, TZ; Kringelbach, ML				van Hartevelt, Tim J.; Cabral, Joana; Deco, Gustavo; Moller, Arne; Green, Alexander L.; Aziz, Tipu Z.; Kringelbach, Morten L.			Neural Plasticity in Human Brain Connectivity: The Effects of Long Term Deep Brain Stimulation of the Subthalamic Nucleus in Parkinson's Disease	PLOS ONE			English	Article							FUNCTIONAL CONNECTIVITY; NETWORKS; GAIT; REGISTRATION; ORGANIZATION; PRINCIPLES; OLFACTION; SYSTEM; HEALTH	Background: Positive clinical outcomes are now well established for deep brain stimulation, but little is known about the effects of long-term deep brain stimulation on brain structural and functional connectivity. Here, we used the rare opportunity to acquire pre- and postoperative diffusion tensor imaging in a patient undergoing deep brain stimulation in bilateral subthalamic nuclei for Parkinson's Disease. This allowed us to analyse the differences in structural connectivity before and after deep brain stimulation. Further, a computational model of spontaneous brain activity was used to estimate the changes in functional connectivity arising from the specific changes in structural connectivity. Results: We found significant localised structural changes as a result of long-term deep brain stimulation. These changes were found in sensory-motor, prefrontal/limbic, and olfactory brain regions which are known to be affected in Parkinson's Disease. The nature of these changes was an increase of nodal efficiency in most areas and a decrease of nodal efficiency in the precentral sensory-motor area. Importantly, the computational model clearly shows the impact of deep brain stimulation-induced structural alterations on functional brain changes, which is to shift the neural dynamics back towards a healthy regime. The results demonstrate that deep brain stimulation in Parkinson's Disease leads to a topological reorganisation towards healthy bifurcation of the functional networks measured in controls, which suggests a potential neural mechanism for the alleviation of symptoms. Conclusions: The findings suggest that long-term deep brain stimulation has not only restorative effects on the structural connectivity, but also affects the functional connectivity at a global level. Overall, our results support causal changes in human neural plasticity after long-term deep brain stimulation and may help to identify the underlying mechanisms of deep brain stimulation.	[van Hartevelt, Tim J.; Moller, Arne; Aziz, Tipu Z.; Kringelbach, Morten L.] Aarhus Univ, CFIN, Aarhus, Denmark; [van Hartevelt, Tim J.; Cabral, Joana; Kringelbach, Morten L.] Univ Oxford, Dept Psychiat, Oxford, England; [Cabral, Joana; Deco, Gustavo] Univ Pompeu Fabra, Ctr Brain & Cognit, Theoret & Computat Neurosci Grp, Barcelona, Spain; [Deco, Gustavo] Univ Pompeu Fabra, ICREA, Barcelona, Spain; [Green, Alexander L.; Aziz, Tipu Z.] John Radcliffe Hosp, Nuffield Dept Surg Sci, Oxford, England	Aarhus University; University of Oxford; Pompeu Fabra University; ICREA; Pompeu Fabra University; University of Oxford	Kringelbach, ML (corresponding author), Aarhus Univ, CFIN, Aarhus, Denmark.	morten.kringelbach@queens.ox.ac.uk	Kringelbach, Morten/AAW-5847-2021; Kringelbach, Morten L/AAF-5508-2020; Cabral, Joana/T-5118-2018; 2010, BRAINGLOT Consolider Ingenio/D-1235-2009; DECO, GUSTAVO/A-6341-2008	Kringelbach, Morten/0000-0002-3908-6898; Cabral, Joana/0000-0002-6715-0826; DECO, GUSTAVO/0000-0002-8995-7583; van Hartevelt, Tim/0000-0003-4267-3038	TrygFonden Charitable Foundation; Medical Research Council; Norman Collisson Foundation; Charles Wolfson Charitable Trust; NIHR Biomedical Research Centre, Oxford; ERC [295129]; CONSOLIDER-INGENIO [CSD2007-00012]; Brain Network Recovery Group through the James S. McDonnell Foundation;  [SAF2010-16085]; National Institute for Health Research [CL-2007-13-011] Funding Source: researchfish; ICREA Funding Source: Custom	TrygFonden Charitable Foundation; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Norman Collisson Foundation; Charles Wolfson Charitable Trust; NIHR Biomedical Research Centre, Oxford(National Institute for Health Research (NIHR)); ERC(European Research Council (ERC)European Commission); CONSOLIDER-INGENIO(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Brain Network Recovery Group through the James S. McDonnell Foundation; ; National Institute for Health Research(National Institute for Health Research (NIHR)); ICREA(ICREA)	MLK and TJVH are funded by the TrygFonden Charitable Foundation. TZA is funded by the Medical Research Council, the Norman Collisson Foundation and the Charles Wolfson Charitable Trust. ALG is supported by the NIHR Biomedical Research Centre, Oxford. GD and JC were supported by the ERC Advanced Grant: DYSTRUCTURE (n. 295129), by the Spanish Research Project SAF2010-16085 and by the CONSOLIDER-INGENIO 2010 Programme CSD2007-00012, the FP7-ICT BrainScales and by the Brain Network Recovery Group through the James S. McDonnell Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe O, 2002, NEUROBIOL AGING, V23, P433, DOI 10.1016/S0197-4580(01)00318-9; Achard S, 2006, J NEUROSCI, V26, P63, DOI 10.1523/JNEUROSCI.3874-05.2006; AZIZ TZ, 1991, MOVEMENT DISORD, V6, P288, DOI 10.1002/mds.870060404; Bassett DS, 2008, J NEUROSCI, V28, P9239, DOI 10.1523/JNEUROSCI.1929-08.2008; Behrens TEJ, 2007, NEUROIMAGE, V34, P144, DOI 10.1016/j.neuroimage.2006.09.018; Behrens TEJ, 2003, MAGN RESON MED, V50, P1077, DOI 10.1002/mrm.10609; Benabid AL, 2009, LANCET NEUROL, V8, P67, DOI 10.1016/S1474-4422(08)70291-6; Brunel N, 2001, J COMPUT NEUROSCI, V11, P63, DOI 10.1023/A:1011204814320; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Cabral J, 2012, PHARMACOPSYCHIATRY, V45, pS57, DOI 10.1055/s-0032-1309001; Cabral J, 2012, NEUROIMAGE, V62, P1342, DOI 10.1016/j.neuroimage.2012.06.007; Cabral J, 2011, NEUROIMAGE, V57, P130, DOI 10.1016/j.neuroimage.2011.04.010; Cheng H, 2012, NEUROIMAGE, V61, P1153, DOI 10.1016/j.neuroimage.2012.03.036; COLLINS DL, 1994, J COMPUT ASSIST TOMO, V18, P192, DOI 10.1097/00004728-199403000-00005; Cramer CK, 2010, PARKINSONISM RELAT D, V16, P124, DOI 10.1016/j.parkreldis.2009.09.004; Deco G, 2013, J NEUROSCI, V33, P11239, DOI 10.1523/JNEUROSCI.1091-13.2013; Deco G, 2012, J NEUROSCI, V32, P3366, DOI 10.1523/JNEUROSCI.2523-11.2012; Deuschl Gunther, 2013, Handb Clin Neurol, V116, P107, DOI 10.1016/B978-0-444-53497-2.00010-3; Doty RL, 2007, PARKINSONISM RELAT D, V13, pS225, DOI 10.1016/S1353-8020(08)70006-3; Ferraye MU, 2010, BRAIN, V133, P205, DOI 10.1093/brain/awp229; Forstmann BU, 2012, NEUROIMAGE, V60, P370, DOI 10.1016/j.neuroimage.2011.12.044; Fournier-Gosselin MP, 2013, MOVEMENT DISORD, V28, P1330, DOI 10.1002/mds.25620; Friston KJ, 2003, NEUROIMAGE, V19, P1273, DOI 10.1016/S1053-8119(03)00202-7; Haehner A, 2009, PARKINSONISM RELAT D, V15, P490, DOI 10.1016/j.parkreldis.2008.12.005; Haehner A, 2007, MOVEMENT DISORD, V22, P839, DOI 10.1002/mds.21413; Hawkes CH, 1997, J NEUROL NEUROSUR PS, V62, P436, DOI 10.1136/jnnp.62.5.436; He Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005226; Helenius J, 2002, AM J NEURORADIOL, V23, P194; Honey CJ, 2008, HUM BRAIN MAPP, V29, P802, DOI 10.1002/hbm.20579; Hummel T, 2005, J NEURAL TRANSM, V112, P669, DOI 10.1007/s00702-004-0207-y; Hummel T, 2010, FRONT INTEGR NEUROSC, V4, DOI 10.3389/fnint.2010.00125; Ibarretxe-Bilbao N, 2010, MOVEMENT DISORD, V25, P1888, DOI 10.1002/mds.23208; Iturria-Medina Y, 2011, CEREB CORTEX, V21, P56, DOI 10.1093/cercor/bhq058; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; Khaindrava V, 2011, NEUROBIOL DIS, V42, P284, DOI 10.1016/j.nbd.2011.01.018; Kringelbach ML, 2009, J PAIN MANAGEMENT, V2, P301; Kringelbach ML, 2007, NAT REV NEUROSCI, V8, P623, DOI 10.1038/nrn2196; Kringelbach ML, 2010, EUR J NEUROSCI, V32, P1070, DOI 10.1111/j.1460-9568.2010.07419.x; Latora V, 2003, EUR PHYS J B, V32, P249, DOI 10.1140/epjb/e2003-00095-5; Leblois A, 2006, J NEUROSCI, V26, P3567, DOI 10.1523/JNEUROSCI.5050-05.2006; Litvak V, 2011, BRAIN, V134, P359, DOI 10.1093/brain/awq332; Lynall ME, 2010, J NEUROSCI, V30, P9477, DOI 10.1523/JNEUROSCI.0333-10.2010; Odekerken VJ, 2012, LANCET NEUROL; Potter-Nerger M, 2013, MOVEMENT DISORD, V28, P1609, DOI 10.1002/mds.25677; Ravasz E, 2003, PHYS REV E, V67, DOI 10.1103/PhysRevE.67.026112; Rolls ET, 2003, EUR J NEUROSCI, V18, P695, DOI 10.1046/j.1460-9568.2003.02779.x; Rubinov M, 2010, NEUROIMAGE, V52, P1059, DOI 10.1016/j.neuroimage.2009.10.003; Schweder PM, 2010, NEUROREPORT, V21, P1065, DOI 10.1097/WNR.0b013e32833ce607; Shine JM, 2012, MOVEMENT DISORD, V27, P500, DOI 10.1002/mds.24900; Smeets MAM, 2009, REHABIL PSYCHOL, V54, P404, DOI 10.1037/a0017502; Sporns O, 2011, ANN NY ACAD SCI, V1224, P109, DOI 10.1111/j.1749-6632.2010.05888.x; Thevathasan W, 2011, NEUROSURGERY, V69, P1248, DOI 10.1227/NEU.0b013e31822b6f71; Thevathasan W, 2011, BRAIN, V134, P2085, DOI 10.1093/brain/awr131; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; vanHartevelt TJ, 2012, HUMAN NERVOUS SYSTEM, P1219, DOI DOI 10.1016/B978-0-12-374236-0.10034-3; Wang JH, 2009, HUM BRAIN MAPP, V30, P1511, DOI 10.1002/hbm.20623; Westermann B, 2008, J NEUROL NEUROSUR PS, V79, P19, DOI 10.1136/jnnp.2006.113860; Wong KF, 2006, J NEUROSCI, V26, P1314, DOI 10.1523/JNEUROSCI.3733-05.2006	58	63	63	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2014	9	1							e86496	10.1371/journal.pone.0086496	http://dx.doi.org/10.1371/journal.pone.0086496			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297VL	24466120	gold, Green Published, Green Submitted			2022-12-25	WOS:000330283100173
J	Moriishi, T; Kawai, Y; Komori, H; Rokutanda, S; Eguchi, Y; Tsujimoto, Y; Asahina, I; Komori, T				Moriishi, Takeshi; Kawai, Yosuke; Komori, Hisato; Rokutanda, Satoshi; Eguchi, Yutaka; Tsujimoto, Yoshihide; Asahina, Izumi; Komori, Toshihisa			Bcl2 Deficiency Activates FoxO through Akt Inactivation and Accelerates Osteoblast Differentiation	PLOS ONE			English	Article							CELL-CYCLE ENTRY; OXIDATIVE STRESS; BONE-FORMATION; TRANSCRIPTION FACTORS; PARATHYROID-HORMONE; DNA-DAMAGE; IN-VIVO; APOPTOSIS; P53; DEATH	Osteoblast apoptosis plays an important role in bone development and maintenance, and is in part responsible for osteoporosis in sex steroid deficiency, glucocorticoid excess, and aging. Although Bcl2 subfamily proteins, including Bcl2 and Bcl-XL, inhibit apoptosis, the physiological significance of Bcl2 in osteoblast differentiation has not been fully elucidated. To investigate this, we examined Bcl2-deficient (Bcl2(-/-)) mice. In Bcl2(-/-) mice, bromodeoxyuridine (BrdU)positive osteoblasts were reduced in number, while terminal deoxynucleotidyl transferase-mediated dUTP nick end-labeling (TUNEL)-positive osteoblasts were increased. Unexpectedly, osteoblast differentiation was accelerated in Bcl2(-/-) mice as shown by the early appearance of osteocalcin-positive osteoblasts. Osteoblast differentiation was also accelerated in vitro when primary osteoblasts were seeded at a high concentration to minimize the reduction of the cell density by apoptosis during culture. FoxO transcription factors, whose activities are negatively regulated through the phosphorylation by Akt, play important roles in multiple cell events, including proliferation, death, differentiation, longevity, and stress response. Expressions of FasL, Gadd45a, and Bim, which are regulated by FoxOs, were upregulated; the expression and activity of FoxOs were enhanced; and the phosphorylation of Akt and that of FoxO1 and FoxO3a by Akt were reduced in Bcl2(-/-) calvariae. Further, the levels of p53 mRNA and protein were increased, and the expression of p53-target genes, Pten and Igfbp3 whose proteins inhibit Akt activation, was upregulated in Bcl2(-/-) calvariae. However, Pten but not Igfbp3 was upregulated in Bcl2(-/-) primary osteoblasts, and p53 induced Pten but not Igfbp3 in vitro. Silencing of either FoxO1 or FoxO3a inhibited and constitutively-active FoxO3a enhanced osteoblast differentiation. These findings suggest that Bcl2 deficiency induces and activates FoxOs through Akt inactivation, at least in part, by upregulating Pten expression through p53 in osteoblasts, and that the enhanced expression and activities of FoxOs may be one of the causes of accelerated osteoblast differentiation in Bcl2(-/-) mice.	[Moriishi, Takeshi; Kawai, Yosuke; Komori, Hisato; Komori, Toshihisa] Nagasaki Univ, Grad Sch Biomed Sci, Dept Cell Biol, Nagasaki 852, Japan; [Kawai, Yosuke; Asahina, Izumi] Nagasaki Univ, Grad Sch Biomed Sci, Dept Regenerat Oral Surg, Nagasaki 852, Japan; [Rokutanda, Satoshi] Nagasaki Univ, Grad Sch Biomed Sci, Dept Oral & Maxillofacial Surg, Nagasaki 852, Japan; [Eguchi, Yutaka; Tsujimoto, Yoshihide] Osaka Univ, Sch Med, Dept Mol Genet, Osaka, Japan	Nagasaki University; Nagasaki University; Nagasaki University; Osaka University	Komori, T (corresponding author), Nagasaki Univ, Grad Sch Biomed Sci, Dept Cell Biol, Nagasaki 852, Japan.	komorit@nagasaki-u.ac.jp	Kawai, Yosuke/S-4496-2019	Kawai, Yosuke/0000-0003-0666-1224	Ministry of Education, Science, Sports and Culture and Technology	Ministry of Education, Science, Sports and Culture and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This study was supported by the Ministry of Education, Science, Sports and Culture and Technology Grant-in-Aid for Scientific Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambrogini E, 2010, CELL METAB, V11, P136, DOI 10.1016/j.cmet.2009.12.009; Brady HJM, 1996, EMBO J, V15, P6991, DOI 10.1002/j.1460-2075.1996.tb01091.x; BUCKBINDER L, 1995, NATURE, V377, P646, DOI 10.1038/377646a0; Daitoku H, 2007, J BIOCHEM, V141, P769, DOI 10.1093/jb/mvm104; Essaghir A, 2009, J BIOL CHEM, V284, P10334, DOI 10.1074/jbc.M808848200; Feng ZH, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001057; Fu W, 2009, J BIOL CHEM, V284, P13987, DOI 10.1074/jbc.M901758200; Furukawa-Hibi Y, 2002, J BIOL CHEM, V277, P26729, DOI 10.1074/jbc.C200256200; Gohel A, 1999, ENDOCRINOLOGY, V140, P5339, DOI 10.1210/en.140.11.5339; Hedrick SM, 2009, NAT IMMUNOL, V10, P1057, DOI 10.1038/ni.1784; HIROTA S, 1994, CELL TISSUE RES, V277, P27, DOI 10.1007/BF00303077; Inada M, 1999, DEV DYNAM, V214, P279, DOI 10.1002/(SICI)1097-0177(199904)214:4<279::AID-AJA1>3.0.CO;2-W; Jilka RL, 1999, J CLIN INVEST, V104, P439, DOI 10.1172/JCI6610; Jilka RL, 2007, J BONE MINER RES, V22, P1492, DOI 10.1359/JBMR.070518; KAMADA S, 1995, CANCER RES, V55, P354; Komori T, 1997, CELL, V89, P755, DOI 10.1016/S0092-8674(00)80258-5; Kousteni S, 2001, CELL, V104, P719, DOI 10.1016/S0092-8674(01)00268-9; Kurinna S, 2010, HEPATOLOGY, V52, P1023, DOI 10.1002/hep.23746; Lam EWF, 2006, BIOCHEM SOC T, V34, P722, DOI 10.1042/BST0340722; Lengner CJ, 2006, J CELL BIOL, V172, P909, DOI 10.1083/jcb.200508130; Limana F, 2002, P NATL ACAD SCI USA, V99, P6257, DOI 10.1073/pnas.092672899; Lind EF, 1999, J IMMUNOL, V162, P5374; Linette GP, 1996, P NATL ACAD SCI USA, V93, P9545, DOI 10.1073/pnas.93.18.9545; Maes C, 2010, DEV CELL, V19, P329, DOI 10.1016/j.devcel.2010.07.010; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Maruyama Z, 2007, DEV DYNAM, V236, P1876, DOI 10.1002/dvdy.21187; METSARANTA M, 1991, BIOCHIM BIOPHYS ACTA, V1089, P241, DOI 10.1016/0167-4781(91)90014-D; Miyaguchi Y, 2009, CELL BIOL INT, V33, P853, DOI 10.1016/j.cellbi.2009.04.017; Moriishi T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040143; Nagase Y, 2009, J BIOL CHEM, V284, P36659, DOI 10.1074/jbc.M109.016915; NOMURA S, 1993, ACTA HISTOCHEM CYTOC, V26, P303, DOI 10.1267/ahc.26.303; O'Brien CA, 2004, ENDOCRINOLOGY, V145, P1835, DOI 10.1210/en.2003-0990; Plotkin LI, 1999, J CLIN INVEST, V104, P1363, DOI 10.1172/JCI6800; Rached MT, 2010, CELL METAB, V11, P147, DOI 10.1016/j.cmet.2010.01.001; Renault VM, 2011, ONCOGENE, V30, P3207, DOI 10.1038/onc.2011.35; Siqueira MF, 2011, BONE, V48, P1043, DOI 10.1016/j.bone.2011.01.019; Skurk C, 2005, J BIOL CHEM, V280, P20814, DOI 10.1074/jbc.M500528200; Stambolic V, 2001, MOL CELL, V8, P317, DOI 10.1016/S1097-2765(01)00323-9; Stanislaus D, 2000, BONE, V27, P209, DOI 10.1016/S8756-3282(00)00309-4; Teixeira CC, 2010, J BIOL CHEM, V285, P31055, DOI 10.1074/jbc.M109.079962; Tomkinson A, 1997, J CLIN ENDOCR METAB, V82, P3128, DOI 10.1210/jc.82.9.3128; Tsujimoto Y, 2003, J CELL PHYSIOL, V195, P158, DOI 10.1002/jcp.10254; Vairo G, 2000, MOL CELL BIOL, V20, P4745, DOI 10.1128/MCB.20.13.4745-4753.2000; VEIS DJ, 1993, CELL, V75, P229, DOI 10.1016/0092-8674(93)80065-M; Wang XY, 2006, J CELL BIOL, V172, P115, DOI 10.1083/jcb.200507106; Weinstein RS, 1998, J CLIN INVEST, V102, P274, DOI 10.1172/JCI2799; Yamashita J, 2008, J BONE MINER RES, V23, P621, DOI 10.1359/JBMR.071211; Yoshida CA, 2004, GENE DEV, V18, P952, DOI 10.1101/gad.1174704; You H, 2004, P NATL ACAD SCI USA, V101, P14057, DOI 10.1073/pnas.0406286101; Zinkel S, 2006, CELL DEATH DIFFER, V13, P1351, DOI 10.1038/sj.cdd.4401987	50	36	37	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2014	9	1							e86629	10.1371/journal.pone.0086629	http://dx.doi.org/10.1371/journal.pone.0086629			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297FH	24466179	gold, Green Published, Green Submitted			2022-12-25	WOS:000330240500139
J	Manzoor, R; Kuroda, K; Yoshida, R; Tsuda, Y; Fujikura, D; Miyamoto, H; Kajihara, M; Kida, H; Takada, A				Manzoor, Rashid; Kuroda, Kazumichi; Yoshida, Reiko; Tsuda, Yoshimi; Fujikura, Daisuke; Miyamoto, Hiroko; Kajihara, Masahiro; Kida, Hiroshi; Takada, Ayato			Heat Shock Protein 70 Modulates Influenza A Virus Polymerase Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cell Fractionation; Influenza Virus; NF-kappa B (NF-kB); RNA Viruses; Viral Polymerase; Viral Replication; Heat Shock; Heat Shock Protein 70	NF-KAPPA-B; HEAT-SHOCK RESPONSE; RNA-POLYMERASE; PA SUBUNIT; MOLECULAR CHAPERONES; CAP-BINDING; PROSTAGLANDIN A(1); NUCLEAR IMPORT; PB1 PROTEIN; HUMAN HSP70	Background: It has been shown that heat shock protein 70 (Hsp70) plays a role in influenza A virus replication. Results: A correlation between viral replication/transcription activities and nuclear/cytoplasmic shuttling of Hsp70 was observed. Conclusion: Hsp70 modulates the influenza A virus polymerase activity. Significance: This study, for the first time, suggests that Hsp70 may actually assist in influenza A virus replication. The role of heat shock protein 70 (Hsp70) in virus replication has been discussed for many viruses. The known suppressive role of Hsp70 in influenza virus replication is based on studies conducted in cells with various Hsp70 expression levels. In this study, we determined the role of Hsp70 in influenza virus replication in HeLa and HEK293T cells, which express Hsp70 constitutively. Co-immunoprecipitation and immunofluorescence studies revealed that Hsp70 interacted with PB2 or PB1 monomers and PB2/PB1 heterodimer but not with the PB1/PA heterodimer or PB2/PB1/PA heterotrimer and translocated into the nucleus with PB2 monomers or PB2/PB1 heterodimers. Knocking down Hsp70 resulted in reduced virus transcription and replication activities. Reporter gene assay, immunofluorescence assay, and Western blot analysis of nuclear and cytoplasmic fractions from infected cells demonstrated that the increase in viral polymerase activity during the heat shock phase was accompanied with an increase in Hsp70 and viral polymerases levels in the nuclei, where influenza virus replication takes place, whereas a reduction in viral polymerase activity was accompanied with an increase in cytoplasmic relocation of Hsp70 along with viral polymerases. Moreover, significantly higher levels of viral genomic RNA (vRNA) were observed during the heat shock phase than during the recovery phase. Overall, for the first time, these findings suggest that Hsp70 may act as a chaperone for influenza virus polymerase, and the modulatory effect of Hsp70 appears to be a sequel of shuttling of Hsp70 between nuclear and cytoplasmic compartments.	[Manzoor, Rashid; Yoshida, Reiko; Tsuda, Yoshimi; Miyamoto, Hiroko; Kajihara, Masahiro; Takada, Ayato] Hokkaido Univ, Res Ctr Zoonosis Control, Div Global Epidemiol, Sapporo, Hokkaido 0010020, Japan; [Fujikura, Daisuke] Hokkaido Univ, Res Ctr Zoonosis Control, Div Infect & Immun, Sapporo, Hokkaido 0010020, Japan; [Kuroda, Kazumichi] Nihon Univ, Sch Med, Dept Pathol & Microbiol, Div Microbiol, Tokyo 1738610, Japan; [Kida, Hiroshi] Hokkaido Univ, Grad Sch Vet Med, Dept Dis Control, Microbiol Lab, Sapporo, Hokkaido 0600818, Japan; [Takada, Ayato] Univ Zambia, Sch Vet Med, Lusaka, Zambia	Hokkaido University; Hokkaido University; Nihon University; Hokkaido University; University of Zambia	Takada, A (corresponding author), Hokkaido Univ, Res Ctr Zoonosis Control, Div Global Epidemiol, Kita Ku, Kita 20 Nishi 10, Sapporo, Hokkaido 0010020, Japan.	atakada@czc.hokudai.ac.jp	Manzoor, Rashid/ABB-8209-2020; YOSHIDA, Reiko/F-6883-2012; Kajihara, Masahiro/AAF-5724-2020		Japan Society for the Promotion of Science; MEXT; Japan Initiative for Global Research Network on Infectious Diseases	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Initiative for Global Research Network on Infectious Diseases(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by funds from the Japan Society for the Promotion of Science (to R. M.), the Strategic Research Base Development Program for Private Universities subsidized by MEXT (2010), and the Japan Initiative for Global Research Network on Infectious Diseases and a grant-in-aid for scientific research by the Japan Society for the Promotion of Science.	AKKINA RK, 1987, J VIROL, V61, P2217, DOI 10.1128/JVI.61.7.2217-2224.1987; Boivin S, 2010, J BIOL CHEM, V285, P28411, DOI 10.1074/jbc.R110.117531; Bortz E, 2011, MBIO, V2, DOI 10.1128/mBio.00151-11; Broquet AH, 2007, J VIROL, V81, P1297, DOI 10.1128/JVI.01336-06; Bukau B, 2006, CELL, V125, P443, DOI 10.1016/j.cell.2006.04.014; CAIZERGUESFERRER M, 1980, BIOCHEM BIOPH RES CO, V97, P538, DOI 10.1016/0006-291X(80)90297-1; Chromy LR, 2003, P NATL ACAD SCI USA, V100, P10477, DOI 10.1073/pnas.1832245100; Dalton RM, 2006, VIROL J, V3, DOI 10.1186/1743-422X-3-58; Daugaard M, 2007, FEBS LETT, V581, P3702, DOI 10.1016/j.febsiet.2007.05.039; Deng T, 2006, J VIROL, V80, P11911, DOI 10.1128/JVI.01565-06; Ding XZ, 1998, FASEB J, V12, P451, DOI 10.1096/fasebj.12.6.451; Fechter P, 2003, J BIOL CHEM, V278, P20381, DOI 10.1074/jbc.M300130200; Fislova T, 2010, J VIROL, V84, P8691, DOI 10.1128/JVI.00813-10; Fodor E, 2004, J VIROL, V78, P9144, DOI 10.1128/JVI.78.17.9144-9153.2004; Gabriel G, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040011; Garrido C, 2006, CELL CYCLE, V5, P2592, DOI 10.4161/cc.5.22.3448; Ghoshal K, 1996, BIOCHEM J, V317, P689, DOI 10.1042/bj3170689; Glotzer JB, 2000, NATURE, V407, P207, DOI 10.1038/35025102; Gonzalez S, 1999, EMBO J, V18, P3767, DOI 10.1093/emboj/18.13.3767; Gonzalez S, 1999, J VIROL, V73, P631; Guilligay D, 2008, NAT STRUCT MOL BIOL, V15, P500, DOI 10.1038/nsmb.1421; Guzhova IV, 1997, CELL STRESS CHAPERON, V2, P132, DOI 10.1379/1466-1268(1997)002<0132:MSPHIW>2.3.CO;2; Hara K, 2006, J VIROL, V80, P7789, DOI 10.1128/JVI.00600-06; Hartl FU, 1996, NATURE, V381, P571, DOI 10.1038/381571a0; Hatta M, 2000, ARCH VIROL, V145, P1947, DOI 10.1007/s007050070068; Hatta M, 2000, ARCH VIROL, V145, P957, DOI 10.1007/s007050050687; Hatta M., 2000, THESIS HOKKAIDO U JA; Hemerka JN, 2009, J VIROL, V83, P3944, DOI 10.1128/JVI.02300-08; Hirayama E, 2004, J VIROL, V78, P1263, DOI 10.1128/JVI.78.3.1263-1270.2004; Hoffmann E, 2000, VIROLOGY, V267, P310, DOI 10.1006/viro.1999.0140; Honda A, 1999, GENES CELLS, V4, P475, DOI 10.1046/j.1365-2443.1999.00275.x; Honda A, 1997, BIOL CHEM, V378, P483; Iordanskiy S, 2004, BLOOD, V104, P1867, DOI 10.1182/blood-2004-01-0081; Iordanskiy S, 2004, J VIROL, V78, P9697, DOI 10.1128/JVI.78.18.9697-9704.2004; Iwai A, 2010, J BIOL CHEM, V285, P32064, DOI 10.1074/jbc.M110.112458; Kawaguchi A, 2005, J VIROL, V79, P732, DOI 10.1128/JVI.79.2.732-744.2005; Kim J, 2005, P NATL ACAD SCI USA, V102, P1442, DOI 10.1073/pnas.0409532102; Kumar N, 2008, J VIROL, V82, P9880, DOI 10.1128/JVI.00909-08; Lang V, 2011, ARCH VIROL, V156, P987, DOI 10.1007/s00705-011-0933-z; Lee DH, 1998, TRENDS CELL BIOL, V8, P397, DOI 10.1016/S0962-8924(98)01346-4; Li G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016546; LIU RY, 1992, CANCER RES, V52, P3667; Maier HJ, 2008, VIROLOGY, V370, P194, DOI 10.1016/j.virol.2007.08.029; Malhotra V, 2002, CRIT CARE MED, V30, pS89, DOI 10.1097/00003246-200201001-00012; Mayer D, 2007, J PROTEOME RES, V6, P672, DOI 10.1021/pr060432u; Mayer MP, 2005, CELL MOL LIFE SCI, V62, P670, DOI 10.1007/s00018-004-4464-6; Momose F, 2002, J BIOL CHEM, V277, P45306, DOI 10.1074/jbc.M206822200; Morano KA, 2007, ANN NY ACAD SCI, V1113, P1, DOI 10.1196/annals.1391.018; Mosser DD, 2004, ONCOGENE, V23, P2907, DOI 10.1038/sj.onc.1207529; Naito T, 2007, J VIROL, V81, P1339, DOI 10.1128/JVI.01917-06; Neumann G, 2004, CURR TOP MICROBIOL, V283, P121; NGUYEN VT, 1989, J BIOL CHEM, V264, P10487; Nimmerjahn F, 2004, J GEN VIROL, V85, P2347, DOI 10.1099/vir.0.79958-0; Oza J, 2008, CELL STRESS CHAPERON, V13, P73, DOI 10.1007/s12192-008-0013-9; PARAG HA, 1987, EMBO J, V6, P55, DOI 10.1002/j.1460-2075.1987.tb04718.x; PARSELL DA, 1993, ANNU REV GENET, V27, P437, DOI 10.1146/annurev.ge.27.120193.002253; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; PINTO M, 1991, J BIOL CHEM, V266, P13941; Pogany J, 2008, P NATL ACAD SCI USA, V105, P19956, DOI 10.1073/pnas.0810851105; Promega Corp, 2011, PROT APPL GUID; Ran RQ, 2004, GENE DEV, V18, P1466, DOI 10.1101/gad.1188204; RATTNER A, 1993, EMBO J, V12, P4261, DOI 10.1002/j.1460-2075.1993.tb06110.x; Resa-Infante P, 2011, RNA BIOL, V8, P207, DOI 10.4161/rna.8.2.14513; Resa-Infante P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003904; Rossi A, 1997, P NATL ACAD SCI USA, V94, P746, DOI 10.1073/pnas.94.2.746; SANZEZQUERRO JJ, 1995, J VIROL, V69, P2420, DOI 10.1128/JVI.69.4.2420-2426.1995; Scacheri PC, 2004, P NATL ACAD SCI USA, V101, P1892, DOI 10.1073/pnas.0308698100; Schell MT, 2005, J SURG RES, V129, P90, DOI 10.1016/j.jss.2005.05.025; Senf SM, 2008, FASEB J, V22, P3836, DOI 10.1096/fj.08-110163; Stahl M, 2007, J VIROL, V81, P13354, DOI 10.1128/JVI.01196-07; Suzuki Keiko, 2010, BMC Res Notes, V3, P294, DOI 10.1186/1756-0500-3-294; Tavaria M, 1996, CELL STRESS CHAPERON, V1, P23, DOI 10.1379/1466-1268(1996)001<0023:AHSGTT>2.3.CO;2; THEODORAKIS NG, 1987, MOL CELL BIOL, V7, P4357, DOI 10.1128/MCB.7.12.4357; Thomas SC, 1998, FASEB J, V12, P1371, DOI 10.1096/fasebj.12.13.1371; Tschuch C, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-60; Van Nieuwenhoven FA, 2001, EUR J CELL BIOL, V80, P586, DOI 10.1078/0171-9335-00192; Velichko AK, 2013, CELL MOL LIFE SCI, V70, P4229, DOI 10.1007/s00018-013-1348-7; Vert JP, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-520; Volloch VZ, 1999, ONCOGENE, V18, P3648, DOI 10.1038/sj.onc.1202525; Wang RYL, 2009, J VIROL, V83, P3276, DOI 10.1128/JVI.02313-08; Wang SH, 2008, BIOTECHNOL BIOENG, V99, P146, DOI 10.1002/bit.21512; Wong HR, 1999, CELL STRESS CHAPERON, V4, P1; Wurzer WJ, 2004, J BIOL CHEM, V279, P30931, DOI 10.1074/jbc.M403258200; Yuan PW, 2009, NATURE, V458, P909, DOI 10.1038/nature07720; Zeng XC, 2004, J CELL SCI, V117, P4991, DOI 10.1242/jcs.01373	85	47	51	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 14	2014	289	11					7599	7614		10.1074/jbc.M113.507798	http://dx.doi.org/10.1074/jbc.M113.507798			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AC8CV	24474693	Green Published, hybrid, Green Submitted			2022-12-25	WOS:000332761500030
J	Chan, TF; Lin, WT; Chen, YL; Huang, HL; Yang, WZ; Lee, CY; Chen, MH; Wang, TN; Huang, MC; Chiu, YW; Huang, CC; Tsai, S; Lin, CL; Lee, CH				Chan, Te-Fu; Lin, Wei-Ting; Chen, Yi-Ling; Huang, Hsiao-Ling; Yang, Wei-Zeng; Lee, Chun-Ying; Chen, Meng-Hsueh; Wang, Tsu-Nai; Huang, Meng-Chuan; Chiu, Yu-Wen; Huang, Chun-Chi; Tsai, Sharon; Lin, Chih-Lung; Lee, Chien-Hung			Elevated Serum Triglyceride and Retinol-Binding Protein 4 Levels Associated with Fructose-Sweetened Beverages in Adolescents	PLOS ONE			English	Article							BODY-MASS INDEX; INSULIN-RESISTANCE; URIC-ACID; CARDIOVASCULAR-DISEASE; VISCERAL ADIPOSITY; METABOLIC SYNDROME; RENAL DYSFUNCTION; OBESITY; RETINOL-BINDING-PROTEIN-4; CONSUMPTION	Background: The metabolic effect of fructose in sugar-sweetened beverages (SSB) has been linked to de novo lipogenesis and uric acid (UA) production. Objectives: This study investigated the biological effects of SSB consumption on serum lipid profiles and retinol-binding protein 4 (RBP4) among Taiwanese adolescents. Methods: We evaluated the anthropometric parameters and biochemical outcomes of 200 representative adolescents (98 boys and 102 girls) who were randomly selected from a large-scale cross-sectional study. Data were analyzed using multiple regression models adjusted for covariates. Results: Increased SSB consumption was associated with increased waist and hip circumferences, body mass index (BMI) values and serum UA, triglyceride (TG) and RBP4 levels. Adolescents who consumed >500 ml/day of beverages half-to-heavily sweetened with high-fructose corn syrup (HFCS) exhibited TG and RBP4 levels 22.7 mg/dl and 13.92 ng/ml higher than non-drinkers, respectively. HFCS drinkers with hyperuricemia had higher TG levels than HFCS drinkers with normal UA levels (98.6 vs. 81.6 mg/dl). The intake of HFCS-rich SSBs and high value of BMI (>= 24) interactively reinforced RBP4 levels among overweight/obese adolescents. Circulating RBP4 levels were significantly correlated with weight-related outcomes and TG and UA concentration among HFCS drinkers (r = 0.253 to 0.404), but not among non-drinkers. Conclusions: High-quantity HFCS-rich beverage consumption is associated with higher TG and RBP4 levels. Hyperuricemia is likely to intensify the influence of HFCS-rich SSB intake on elevated TG levels, and in overweight and obese adolescents, high BMI may modify the action of fructose on higher circulating levels of RBP4.	[Chan, Te-Fu] Kaohsiung Med Univ, Coll Med, Grad Inst Med, Dept Obstet & Gynecol, Kaohsiung, Taiwan; [Chan, Te-Fu] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Dept Obstet & Gynecol, Kaohsiung, Taiwan; [Lin, Wei-Ting] Natl Yang Ming Univ, Inst Environm & Occupat Hlth Sci, Taipei 112, Taiwan; [Chen, Yi-Ling] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Dept Nucl Med, Kaohsiung, Taiwan; [Huang, Hsiao-Ling] Kaohsiung Med Univ, Coll Dent Med, Dept Oral Hyg, Kaohsiung, Taiwan; [Yang, Wei-Zeng; Lee, Chun-Ying; Chen, Meng-Hsueh; Wang, Tsu-Nai; Lee, Chien-Hung] Kaohsiung Med Univ, Coll Hlth Sci, Dept Publ Hlth, Kaohsiung, Taiwan; [Lee, Chun-Ying] Kaohsiung Med Univ Hosp, Dept Family Med, Kaohsiung, Taiwan; [Huang, Meng-Chuan] Kaohsiung Med Univ, Dept Publ Hlth & Environm Med, Kaohsiung, Taiwan; [Huang, Meng-Chuan] Kaohsiung Med Univ Hosp, Dept Nutr & Dietet, Kaohsiung, Taiwan; [Chiu, Yu-Wen] Louisiana State Univ, Hlth Policy & Syst Management Program, Hlth Sci Ctr, Sch Publ Hlth, New Orleans, LA USA; [Huang, Chun-Chi; Tsai, Sharon] Kaohsiung Municipal Hsiaokang Hosp, Dept Lab Med, Kaohsiung, Taiwan; [Lin, Chih-Lung] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Dept Surg, Kaohsiung, Taiwan	Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University Hospital; National Yang Ming Chiao Tung University; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; Kaohsiung Medical University; Kaohsiung Municipal Siao-Gang Hospital; Kaohsiung Medical University; Kaohsiung Medical University Hospital	Lin, CL (corresponding author), Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Dept Surg, Kaohsiung, Taiwan.	chihlung1@yahoo.com; cnhung@kmu.edu.tw	Lee, Chien-Hung/D-4437-2009	Lee, Chien-Hung/0000-0002-0988-264X; Lin, Wei-Ting/0000-0001-5556-2754; Lee, Chun-ying/0000-0001-8475-5205; Wang, Tsu-Nai/0000-0002-0278-289X	Taiwan National Science Council [NSC 96-2314-B-037-041-MY3, NSC 99-2314-B-037-057-MY3, NSC 99-2314-B-037-046-MY3, NSC 102-2314-B-037-060]; Kaohsiung Medical University Research foundation [KMUH 100-0R26]	Taiwan National Science Council(Ministry of Science and Technology, Taiwan); Kaohsiung Medical University Research foundation	This work was supported by the Taiwan National Science Council (NSC 96-2314-B-037-041-MY3, NSC 99-2314-B-037-057-MY3, NSC 99-2314-B-037-046-MY3, and NSC 102-2314-B-037-060), and was partially supported by grants from the Kaohsiung Medical University Research foundation (KMUH 100-0R26). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alkharfy KM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048612; ALLAIN CC, 1974, CLIN CHEM, V20, P470; Bantle JP, 2000, AM J CLIN NUTR, V72, P1128; Broch M, 2010, PHYSIOL RES, V59, P299, DOI 10.33549/physiolres.931714; Cabre A, 2007, J INTERN MED, V262, P496, DOI 10.1111/j.1365-2796.2007.01849.x; Chang HY, 2001, J RHEUMATOL, V28, P1640; Chang YH, 2008, DIABETES-METAB RES, V24, P629, DOI 10.1002/dmrr.894; Chen CC, 2009, METABOLISM, V58, P1812, DOI 10.1016/j.metabol.2009.06.013; Choi Hyon K., 2010, JAMA (Journal of the American Medical Association), V304, P2270, DOI 10.1001/jama.2010.1638; Christou GA, 2012, HORM METAB RES, V44, P6, DOI 10.1055/s-0031-1295491; Chu NF, 2005, OBES REV, V6, P271, DOI 10.1111/j.1467-789X.2005.00175.x; Cox CL, 2012, NUTR METAB, V9, DOI 10.1186/1743-7075-9-68; EMMERSON BT, 1974, ANN RHEUM DIS, V33, P276, DOI 10.1136/ard.33.3.276; Food and Drug Administration Department of Health, 1993, TAIW FOOD NUTR DAT; FOSSATI P, 1980, CLIN CHEM, V26, P227; Friebe D, 2011, INT J PEDIATR OBES, V6, pE345, DOI 10.3109/17477166.2010.491228; Graham TE, 2006, NEW ENGL J MED, V354, P2552, DOI 10.1056/NEJMoa054862; Guthrie JF, 2000, J AM DIET ASSOC, V100, P43, DOI 10.1016/S0002-8223(00)00018-3; Hu FB, 2010, PHYSIOL BEHAV, V100, P47, DOI 10.1016/j.physbeh.2010.01.036; Ingelsson E, 2009, ATHEROSCLEROSIS, V206, P239, DOI 10.1016/j.atherosclerosis.2009.02.029; Johnson RK, 2009, CIRCULATION, V120, P1011, DOI 10.1161/CIRCULATIONAHA.109.192627; Johnson RJ, 2007, AM J CLIN NUTR, V86, P899; Kloeting N, 2007, CELL METAB, V6, P79, DOI 10.1016/j.cmet.2007.06.002; Lanaspa MA, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0047948, 10.1371/journal.pone.0048801]; Lee CH, 2010, INT J CANCER, V127, P932, DOI 10.1002/ijc.25108; Lin WT, 2013, INT J OBESITY, V37, P532, DOI 10.1038/ijo.2012.121; Malik VS, 2006, AM J CLIN NUTR, V84, P274; Malik VS, 2010, DIABETES CARE, V33, P2477, DOI 10.2337/dc10-1079; Malik VS, 2010, CIRCULATION, V121, P1356, DOI 10.1161/CIRCULATIONAHA.109.876185; Mayes Peter A., 1993, American Journal of Clinical Nutrition, V58, p754S, DOI 10.1093/ajcn/58.5.754S; MCGARRY JD, 1995, BIOCHEM SOC T, V23, P481, DOI 10.1042/bst0230481; MICKEY RM, 1989, AM J EPIDEMIOL, V129, P125, DOI 10.1093/oxfordjournals.aje.a115101; Pan WH, 2004, AM J CLIN NUTR, V79, P31; Sachs Larissa, 2009, Med Health R I, V92, P353; Shepherd PR, 1999, NEW ENGL J MED, V341, P248, DOI 10.1056/NEJM199907223410406; Stanhope KL, 2008, AM J CLIN NUTR, V87, P1194, DOI 10.1093/ajcn/87.5.1194; Stanhope KL, 2008, CURR OPIN LIPIDOL, V19, P16, DOI 10.1097/MOL.0b013e3282f2b24a; Stanhope KL, 2009, J CLIN INVEST, V119, P1322, DOI 10.1172/JCI37385; Wang YC, 2008, PEDIATRICS, V121, pE1604, DOI 10.1542/peds.2007-2834; West DS, 2006, OBESITY, V14, P1825, DOI 10.1038/oby.2006.210; WHO/FAO, 2003, DIET NUTR PREVENTION, P54; Wolf G, 2007, NUTR REV, V65, P251, DOI 10.1111/j.1753-4887.2007.tb00302.x; Xia M, 2013, HEPATOLOGY, V58, P564, DOI 10.1002/hep.26227; Yang Q, 2005, NATURE, V436, P356, DOI 10.1038/nature03711	44	34	35	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2014	9	1							e82004	10.1371/journal.pone.0082004	http://dx.doi.org/10.1371/journal.pone.0082004			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301BI	24475021	Green Published, Green Submitted, gold			2022-12-25	WOS:000330507300007
J	Rahman, MA; Sobia, P; Gupta, N; Van Kaer, L; Das, G				Rahman, Md Aejazur; Sobia, Parveen; Gupta, Neeta; Van Kaer, Luc; Das, Gobardhan			Mycobacterium tuberculosis Subverts the TLR-2-MyD88 Pathway to Facilitate Its Translocation into the Cytosol	PLOS ONE			English	Article							CD8(+) T-CELLS; ALVEOLAR MACROPHAGES; PHAGOSOME MATURATION; CALMETTE-GUERIN; RD1 REGION; ESAT-6; SECRETION; MEMBRANES; ESAT-6/CFP-10; PHAGOLYSOSOME	Mycobacterium tuberculosis (M.tb) has evolved mechanisms to evade its destruction in phagolysosomes, where it successfully survives and replicates within phagocytes. Recent studies have shown that virulent strains of M.tb can translocate from the phagosome into the cytosol of dendritic cells (DC). The molecular mechanisms by which virulent M.tb strains can escape the phagosome remain unknown. Here we show that the virulent M.tb strain H37Rv, but not the vaccine strain Bacille Calmette-Guerin (BCG), escapes from the phagolysosome and enters the cytosol by interfering with the TLR-2-MyD88 signaling pathway. Using H37Rv mutants, we further demonstrate that the region of difference-1 (RD-1) locus and ESAT-6, a gene within the RD-1 locus, play an important role in the capacity of M.tb to migrate from the phagosome to the cytosol of macrophages. H37Rv, BCG, H37Rv Delta RD1, and H37Rv Delta ESAT6 were able to translocate to the cytosol in macrophages derived from TLR-2- and MyD88-deficient animals, whereas only virulent H37Rv was able to enter the cytosol in macrophages from wild type mice. Therefore, signaling through the TLR-2-MyD88 pathway in macrophages plays an important role in confining M.tb within phagolysomes. Virulent strains of M.tb have evolved mechanisms to subvert this pathway, thus facilitating their translocation to the cytosol and to escape the toxic microenvironment of the phagosome or phagolysosome.	[Rahman, Md Aejazur; Das, Gobardhan] Univ KwaZulu Natal, Sch Lab Med & Med Sci, Durban, South Africa; [Rahman, Md Aejazur; Sobia, Parveen; Gupta, Neeta] Int Ctr Genet Engn & Biotechnol, Immunol Grp, New Delhi, India; [Van Kaer, Luc] Vanderbilt Univ, Sch Med, Dept Pathol Microbiol & Immunol, Nashville, TN 37212 USA	University of Kwazulu Natal; Department of Biotechnology (DBT) India; International Center for Genetic Engineering & Biotechnology (ICGEB); International Center for Genetic Engineering & Biotechnology (ICGEB), New Delhi; Vanderbilt University	Das, G (corresponding author), Univ KwaZulu Natal, Sch Lab Med & Med Sci, Durban, South Africa.	gobardhan.das07@gmail.com	Rhaman, Aejazur/AAC-5104-2019; Van Kaer, Luc/H-1033-2015	Rhaman, Aejazur/0000-0002-2616-3372; Van Kaer, Luc/0000-0001-5275-2309	Wellcome Trust-Department of Biotechnology (DBT) alliance; DBT, Govt. of India; Ramalingaswamy fellowship; DBT Center of Excellence, Govt. of India; DBT Senior Research Fellowship, Govt. of India; DBT postdoctoral fellowship, Govt. of India;  [WT01/GD/09/339];  [DB05/PS/09/331]	Wellcome Trust-Department of Biotechnology (DBT) alliance(Department of Biotechnology (DBT) India); DBT, Govt. of India(Department of Biotechnology (DBT) India); Ramalingaswamy fellowship; DBT Center of Excellence, Govt. of India; DBT Senior Research Fellowship, Govt. of India; DBT postdoctoral fellowship, Govt. of India; ; 	This work was supported by grants from The Wellcome Trust-Department of Biotechnology (DBT) alliance and by the DBT, Govt. of India. Grant No. WT01/GD/09/339 URL: http://wellcomedbt.org/senior.html and Grant No. DB05/PS/09/331. URL: http://dbtindia.nic.in. AR is supported by a Ramalingaswamy fellowship and DBT Center of Excellence, Govt. of India. SP is supported by a DBT Senior Research Fellowship, Govt. of India. NG is supported by a DBT postdoctoral fellowship, Govt. of India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Begum D, 2009, IMMUNOLOGY, V128, P556, DOI 10.1111/j.1365-2567.2009.03141.x; Berthet FX, 1998, MICROBIOL-UK, V144, P3195, DOI 10.1099/00221287-144-11-3195; Blander JM, 2004, SCIENCE, V304, P1014, DOI 10.1126/science.1096158; Bold TD, 2012, J IMMUNOL, V189, P2530, DOI 10.4049/jimmunol.1200994; Brodin P, 2006, INFECT IMMUN, V74, P88, DOI 10.1128/IAI.74.1.88-98.2006; Chatterjee S, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002378; Checroun C, 2006, P NATL ACAD SCI USA, V103, P14578, DOI 10.1073/pnas.0601838103; Collins CA, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000430; Deretic V, 2006, CELL MICROBIOL, V8, P719, DOI 10.1111/j.1462-5822.2006.00705.x; Fremond CM, 2007, J IMMUNOL, V179, P1178, DOI 10.4049/jimmunol.179.2.1178; Gao LY, 2004, MOL MICROBIOL, V53, P1677, DOI 10.1111/j.1365-2958.2004.04261.x; Grotzke JE, 2005, MICROBES INFECT, V7, P776, DOI 10.1016/j.micinf.2005.03.001; Guinn KM, 2004, MOL MICROBIOL, V51, P359, DOI 10.1046/j.1365-2958.2003.03844.x; Harboe M, 1996, INFECT IMMUN, V64, P16, DOI 10.1128/IAI.64.1.16-22.1996; Hsu T, 2003, P NATL ACAD SCI USA, V100, P12420, DOI 10.1073/pnas.1635213100; Junqueira-Kipnis AP, 2006, IMMUNOLOGY, V119, P224, DOI 10.1111/j.1365-2567.2006.02427.x; Kaku T, 2007, FEMS MICROBIOL LETT, V274, P189, DOI 10.1111/j.1574-6968.2007.00838.x; Kamath A, 2006, J IMMUNOL, V177, P6361, DOI 10.4049/jimmunol.177.9.6361; Klein Michel R., 1999, Archivum Immunologiae et Therapiae Experimentalis, V47, P313; Koo IC, 2008, CELL MICROBIOL, V10, P1866, DOI 10.1111/j.1462-5822.2008.01177.x; Koo IC, 2008, P NATL ACAD SCI USA, V105, P710, DOI 10.1073/pnas.0708110105; LEAKE ES, 1984, INFECT IMMUN, V45, P443, DOI 10.1128/IAI.45.2.443-446.1984; Lewis KN, 2003, J INFECT DIS, V187, P117, DOI 10.1086/345862; MCDONOUGH KA, 1993, INFECT IMMUN, V61, P2763, DOI 10.1128/IAI.61.7.2763-2773.1993; MYRVIK QN, 1984, AM REV RESPIR DIS, V129, P322; Rohde K, 2007, IMMUNOL REV, V219, P37, DOI 10.1111/j.1600-065X.2007.00547.x; Shams H, 2003, J LEUKOCYTE BIOL, V74, P1008, DOI 10.1189/jlb.0403138; Sinai AP, 1997, ANNU REV MICROBIOL, V51, P415, DOI 10.1146/annurev.micro.51.1.415; Smith J, 2008, INFECT IMMUN, V76, P5478, DOI 10.1128/IAI.00614-08; Stamm LM, 2005, P NATL ACAD SCI USA, V102, P14837, DOI 10.1073/pnas.0504663102; Stamm LM, 2003, J EXP MED, V198, P1361, DOI 10.1084/jem.20031072; Stanley SA, 2003, P NATL ACAD SCI USA, V100, P13001, DOI 10.1073/pnas.2235593100; STURGILLKOSZYCKI S, 1994, SCIENCE, V263, P678, DOI 10.1126/science.8303277; Sud D, 2006, J IMMUNOL, V176, P4296, DOI 10.4049/jimmunol.176.7.4296; Tan T, 2006, CELL MICROBIOL, V8, P1417, DOI 10.1111/j.1462-5822.2006.00721.x; Underhill DM, 1999, NATURE, V401, P811, DOI 10.1038/44605; van der Wel N, 2007, CELL, V129, P1287, DOI 10.1016/j.cell.2007.05.059; Vergne I, 2004, ANNU REV CELL DEV BI, V20, P367, DOI 10.1146/annurev.cellbio.20.010403.114015; Wang QL, 2001, INFECT IMMUN, V69, P2270, DOI 10.1128/IAI.69.4.2270-2276.2001; Watanabe I, 2007, J IMMUNOL, V178, P4917, DOI 10.4049/jimmunol.178.8.4917; Welin A, 2012, TUBERCULOSIS, V92, P113, DOI 10.1016/j.tube.2011.09.009; Woodworth JS, 2008, J IMMUNOL, V181, P8595, DOI 10.4049/jimmunol.181.12.8595; Yates RM, 2005, IMMUNITY, V23, P409, DOI 10.1016/j.immuni.2005.09.007	43	36	42	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2014	9	1							e86886	10.1371/journal.pone.0086886	http://dx.doi.org/10.1371/journal.pone.0086886			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301BI	24475192	Green Submitted, Green Published, gold			2022-12-25	WOS:000330507300114
J	Shao, YQ; Arias-Cordero, E; Guo, HJ; Bartram, S; Boland, W				Shao, Yongqi; Arias-Cordero, Erika; Guo, Huijuan; Bartram, Stefan; Boland, Wilhelm			In Vivo Pyro-SIP Assessing Active Gut Microbiota of the Cotton Leafworm, Spodoptera littoralis	PLOS ONE			English	Article							DIVERSITY; BACTERIA; SOIL; IDENTIFICATION; COMMUNITIES; HYDROLYSIS; PROTEIN; PROBES; LARVAE; BEES	The gut microbiota is of crucial importance for the host with considerable metabolic activity. Although great efforts have been made toward characterizing microbial diversity, measuring components' metabolic activity surprisingly hasn't kept pace. Here we combined pyrosequencing of amplified 16S rRNA genes with in vivo stable isotope probing (Pyro-SIP) to unmask metabolically active bacteria in the gut of cotton leafworm (Spodoptera littoralis), a polyphagous insect herbivore that consumes large amounts of plant material in a short time, liberating abundant glucose in the alimentary canal as a most important carbon and energy source for both host and active gut bacteria. With C-13 glucose as the trophic link, Pyro-SIP revealed that a relatively simple but distinctive gut microbiota co-developed with the host, both metabolic activity and composition shifting throughout larval stages. Pantoea, Citrobacter and Clostridium were particularly active in early-instar, likely the core functional populations linked to nutritional upgrading. Enterococcus was the single predominant genus in the community, and it was essentially stable and metabolically active in the larval lifespan. Based on that Enterococci formed biofilm-like layers on the gut epithelium and that the isolated strains showed antimicrobial properties, Enterococcus may be able to establish a colonization resistance effect in the gut against potentially harmful microbes from outside. Not only does this establish the first in-depth inventory of the gut microbiota of a model organism from the mostly phytophagous Lepidoptera, but this pilot study shows that Pyro-SIP can rapidly gain insight into the gut microbiota's metabolic activity with high resolution and high precision.	[Shao, Yongqi; Arias-Cordero, Erika; Guo, Huijuan; Bartram, Stefan; Boland, Wilhelm] Max Planck Inst Chem Oekol, Dept Bioorgan Chem, D-07745 Jena, Germany	Max Planck Society	Boland, W (corresponding author), Max Planck Inst Chem Oekol, Dept Bioorgan Chem, D-07745 Jena, Germany.	boland@ice.mpg.de	Boland, Wilhelm/K-7762-2012	Boland, Wilhelm/0000-0001-6784-2534; Bartram, Stefan/0000-0002-8574-2817	Max Planck Society	Max Planck Society(Max Planck SocietyFoundation CELLEX)	This work is supported by the Max Planck Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams AS, 2011, ISME J, V5, P1323, DOI 10.1038/ismej.2011.14; AMANN RI, 1990, APPL ENVIRON MICROB, V56, P1919, DOI 10.1128/AEM.56.6.1919-1925.1990; Anand AAP, 2010, J INSECT SCI, V10, DOI 10.1673/031.010.10701; Anderson IC, 2004, ENVIRON MICROBIOL, V6, P769, DOI 10.1111/j.1462-2920.2004.00675.x; Atarashi K, 2011, SCIENCE, V331, P337, DOI 10.1126/science.1198469; Behr T, 2000, SYST APPL MICROBIOL, V23, P563, DOI 10.1016/S0723-2020(00)80031-4; Benson AK, 2010, P NATL ACAD SCI USA, V107, P18933, DOI 10.1073/pnas.1007028107; Brinkmann N, 2008, APPL ENVIRON MICROB, V74, P7189, DOI 10.1128/AEM.01464-08; Broderick NA, 2004, APPL ENVIRON MICROB, V70, P293, DOI 10.1128/AEM.70.1.293-300.2004; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Cardenas PA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046803; Clemente JC, 2012, CELL, V148, P1258, DOI 10.1016/j.cell.2012.01.035; Coplen TB, 2006, ANAL CHEM, V78, P2439, DOI 10.1021/ac052027c; Dillon RJ, 2004, ANNU REV ENTOMOL, V49, P71, DOI 10.1146/annurev.ento.49.061802.123416; Dumont MG, 2005, NAT REV MICROBIOL, V3, P499, DOI 10.1038/nrmicro1162; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Egert M, 2005, APPL ENVIRON MICROB, V71, P4556, DOI 10.1128/AEM.71.8.4556-4566.2005; Engel P, 2012, P NATL ACAD SCI USA, V109, P11002, DOI 10.1073/pnas.1202970109; Fierer N, 2006, P NATL ACAD SCI USA, V103, P626, DOI 10.1073/pnas.0507535103; Funke M, 2008, CHEMBIOCHEM, V9, P1953, DOI 10.1002/cbic.200700781; Haas BJ, 2011, GENOME RES, V21, P494, DOI 10.1101/gr.112730.110; Horn MA, 2003, APPL ENVIRON MICROB, V69, P1662, DOI 10.1128/AEM.69.3.1662-1669.2003; Huttenhower C, 2012, NATURE, V486, P207, DOI 10.1038/nature11234; Ishak HD, 2011, MICROB ECOL, V61, P821, DOI 10.1007/s00248-010-9793-4; Jones SE, 2010, P NATL ACAD SCI USA, V107, P5881, DOI 10.1073/pnas.0912765107; Koch H, 2011, P NATL ACAD SCI USA, V108, P19288, DOI 10.1073/pnas.1110474108; Kovatcheva-Datchary P, 2009, ENVIRON MICROBIOL, V11, P914, DOI 10.1111/j.1462-2920.2008.01815.x; Lenhart K, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2049; Lu YH, 2005, SCIENCE, V309, P1088, DOI 10.1126/science.1113435; Lueders T, 2004, ENVIRON MICROBIOL, V6, P73, DOI 10.1046/j.1462-2920.2003.00536.x; Manero A, 2002, J MICROBIOL METH, V50, P115, DOI 10.1016/S0167-7012(02)00027-1; Martinson VG, 2011, MOL ECOL, V20, P619, DOI 10.1111/j.1365-294X.2010.04959.x; Neufeld JD, 2007, NAT PROTOC, V2, P860, DOI 10.1038/nprot.2007.109; Pauchet Y, 2010, INSECT MOL BIOL, V19, P61, DOI 10.1111/j.1365-2583.2009.00936.x; Perkins GA, 2012, APPL ENVIRON MICROB, V78, P2522, DOI 10.1128/AEM.06252-11; Pesek J, 2011, J BIOL CHEM, V286, P34872, DOI 10.1074/jbc.M111.246108; Pilloni G, 2011, FEMS MICROBIOL ECOL; Ping LY, 2007, ENVIRON MICROBIOL, V9, P1572, DOI 10.1111/j.1462-2920.2007.01279.x; Poulsen M, 2012, MOL ECOL, V21, P2054, DOI 10.1111/j.1365-294X.2012.05510.x; Price NPJ, 2004, ANAL CHEM, V76, P6566, DOI 10.1021/ac049198m; Priya NG, 2012, PLOS ONE, V7; Radajewski S, 2000, NATURE, V403, P646, DOI 10.1038/35001054; Reeder J, 2010, NAT METHODS, V7, P668, DOI 10.1038/nmeth0910-668b; Reichardt N, 2011, APPL ENVIRON MICROB, V77, P8009, DOI 10.1128/AEM.05573-11; Robinson CJ, 2010, MICROB ECOL, V59, P199, DOI 10.1007/s00248-009-9595-8; Russell JA, 2009, P NATL ACAD SCI USA, V106, P21236, DOI 10.1073/pnas.0907926106; Shao YQ, 2011, INSECT BIOCHEM MOLEC, V41, P273, DOI 10.1016/j.ibmb.2011.01.004; Silverman N, 2008, SCIENCE, V319, P734, DOI 10.1126/science.1154209; Sudakaran S, 2012, MOL ECOL; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023; Tang XS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036978; Vasquez A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033188; Warnecke F, 2007, NATURE, V450, P560, DOI 10.1038/nature06269; Watanabe H, 2010, ANNU REV ENTOMOL, V55, P609, DOI 10.1146/annurev-ento-112408-085319; White JR, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000352; Wong CNA, 2011, ENVIRON MICROBIOL, V13, P1889, DOI 10.1111/j.1462-2920.2011.02511.x; Wust PK, 2011, ISME J, V5, P92, DOI 10.1038/ismej.2010.99; Zhang W, 2007, SOIL BIOL BIOCHEM, V39, P2665, DOI 10.1016/j.soilbio.2007.04.003	58	75	78	2	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2014	9	1							e85948	10.1371/journal.pone.0085948	http://dx.doi.org/10.1371/journal.pone.0085948			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301BI	24475063	Green Published, Green Submitted, gold			2022-12-25	WOS:000330507300032
J	Troschinski, S; Di Lellis, MA; Sereda, S; Hauffe, T; Wilke, T; Triebskorn, R; Kohler, HR				Troschinski, Sandra; Di Lellis, Maddalena A.; Sereda, Sergej; Hauffe, Torsten; Wilke, Thomas; Triebskorn, Rita; Koehler, Heinz-R.			Intraspecific Variation in Cellular and Biochemical Heat Response Strategies of Mediterranean Xeropicta derbentina [Pulmonata, Hygromiidae]	PLOS ONE			English	Article							LAND SNAILS; DROSOPHILA-MELANOGASTER; DIGESTIVE GLAND; STRESS-PROTEINS; METABOLIC DEPRESSION; NATURAL-POPULATIONS; GENETIC-VARIATION; HSP70 EXPRESSION; SHOCK PROTEINS; TOLERANCE	Dry and hot environments challenge the survival of terrestrial snails. To minimize overheating and desiccation, physiological and biochemical adaptations are of high importance for these animals. In the present study, seven populations of the Mediterranean land snail species Xeropicta derbentina were sampled from their natural habitat in order to investigate the intraspecific variation of cellular and biochemical mechanisms, which are assigned to contribute to heat resistance. Furthermore, we tested whether genetic parameters are correlated with these physiological heat stress response patterns. Specimens of each population were individually exposed to elevated temperatures (25 to 52 degrees C) for 8 h in the laboratory. After exposure, the health condition of the snails' hepatopancreas was examined by means of qualitative description and semi-quantitative assessment of histopathological effects. In addition, the heat-shock protein 70 level (Hsp70) was determined. Generally, calcium cells of the hepatopancreas were more heat resistant than digestive cells - this phenomenon was associated with elevated Hsp70 levels at 40 degrees C. We observed considerable variation in the snails' heat response strategy: Individuals from three populations invested much energy in producing a highly elevated Hsp70 level, whereas three other populations invested energy in moderate stress protein levels - both strategies were in association with cellular functionality. Furthermore, one population kept cellular condition stable despite a low Hsp70 level until 40 degrees C exposure, whereas prominent cellular reactions were observed above this thermal limit. Genetic diversity (mitochondrial cytochrome c oxidase subunit I gene) within populations was low. Nevertheless, when using genetic indices as explanatory variables in a multivariate regression tree (MRT) analysis, population structure explained mean differences in cellular and biochemical heat stress responses, especially in the group exposed to 40 degrees C. Our study showed that, even in similar habitats within a close range, populations of the same species use different stress response strategies that all rendered survival possible.	[Troschinski, Sandra; Di Lellis, Maddalena A.; Triebskorn, Rita; Koehler, Heinz-R.] Univ Tubingen, Inst Evolut & Ecol, Tubingen, Germany; [Sereda, Sergej; Hauffe, Torsten; Wilke, Thomas] Univ Giessen, Dept Anim Ecol & Systemat, D-35390 Giessen, Germany	Eberhard Karls University of Tubingen; Justus Liebig University Giessen	Troschinski, S (corresponding author), Univ Tubingen, Inst Evolut & Ecol, Tubingen, Germany.	s.trosch@web.de	Köhler, Heinz-R./AAL-1350-2021; Wilke, Thomas/G-1517-2012	Wilke, Thomas/0000-0001-8263-7758; Hauffe, Torsten/0000-0001-5711-9457; Sereda, Sergej/0000-0003-3212-8722	German Research Council (DFG) [KO 1978/5-3, WI 1902/10-3]	German Research Council (DFG)(German Research Foundation (DFG))	The study was financed by the German Research Council (DFG) under KO 1978/5-3 and WI 1902/10-3. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2013, MVPART MULTIVARIATE; Arts MJSJ, 2004, ECOTOXICOLOGY, V13, P739, DOI 10.1007/s10646-003-4473-5; Avwioro G., 2011, JPCS, V1, P24; Bahrndorff S, 2010, CLIM RES, V43, P41, DOI 10.3354/cr00896; BARNHART MC, 1986, J COMP PHYSIOL B, V156, P347, DOI 10.1007/BF01101097; Bishop T, 2000, J EXP BIOL, V203, P3603; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Burton R.F., 1976, P7; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; De'Ath G, 2002, ECOLOGY, V83, P1105, DOI 10.2307/3071917; Depraz A, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-171; Di Lellis MA, 2012, CELL STRESS CHAPERON, V17, P717, DOI 10.1007/s12192-012-0344-4; Dieterich A, 2013, CELL STRESS CHAPERON, V18, P405, DOI 10.1007/s12192-012-0393-8; Dittbrenner N, 2009, J MOLLUS STUD, V75, P9, DOI 10.1093/mollus/eyn033; Eckwert H, 1997, ECOTOXICOLOGY, V6, P249, DOI 10.1023/A:1018682928839; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; FEDER JH, 1992, GENE DEV, V6, P1402, DOI 10.1101/gad.6.8.1402; Feder ME, 1999, ANNU REV PHYSIOL, V61, P243, DOI 10.1146/annurev.physiol.61.1.243; Feder ME, 1998, AM ZOOL, V38, P503; Fink AL, 1999, PHYSIOL REV, V79, P425, DOI 10.1152/physrev.1999.79.2.425; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Gillooly JF, 2001, SCIENCE, V293, P2248, DOI 10.1126/science.1061967; GOODFRIEND GA, 1986, SYST ZOOL, V35, P204, DOI 10.2307/2413431; Guppy M, 1999, BIOL REV, V74, P1, DOI 10.1017/S0006323198005258; Hall T.A., 1999, NUCL ACIDS S SERIES, V41, P95, DOI [DOI 10.1021/BK-1999-0734.CH008, citeulike-article-id:691774, 10.12691/ajmr-6-4-3]; Heckathorn SA, 1996, OECOLOGIA, V105, P413, DOI 10.1007/BF00328745; Heisler N, 1986, ACID BASE REGULATION; Helmus MR, 2007, AM NAT, V169, pE68, DOI 10.1086/511334; HENDRICK JP, 1993, ANNU REV BIOCHEM, V62, P349, DOI 10.1146/annurev.bi.62.070193.002025; HORN HS, 1966, AM NAT, V100, P419, DOI 10.1086/282436; Jensen LT, 2010, J EXP ZOOL PART A, V313A, P35, DOI 10.1002/jez.573; Jombart T, 2008, BIOINFORMATICS, V24, P1403, DOI 10.1093/bioinformatics/btn129; Kammenga JE, 2000, REV ENVIRON CONTAM T, V164, P93; Kohler HR, 2009, J EXP ZOOL PART B, V312B, P136, DOI 10.1002/jez.b.21253; Kohler HR, 2000, J EVOLUTION BIOL, V13, P569, DOI 10.1046/j.1420-9101.2000.00210.x; Krebs RA, 1998, J INSECT PHYSIOL, V44, P1091, DOI 10.1016/S0022-1910(98)00059-6; KREBS RA, 1994, FUNCT ECOL, V8, P730, DOI 10.2307/2390232; Legendre P, 2001, OECOLOGIA, V129, P271, DOI 10.1007/s004420100716; LINDQUIST S, 1988, ANNU REV GENET, V22, P631, DOI 10.1146/annurev.ge.22.120188.003215; LINDQUIST S, 1986, ANNU REV BIOCHEM, V55, P1151, DOI 10.1146/annurev.bi.55.070186.005443; MACHIN J, 1964, J EXP BIOL, V41, P759; Mayer MP, 2005, CELL MOL LIFE SCI, V62, P670, DOI 10.1007/s00018-004-4464-6; Mizrahi T, 2012, CELL STRESS CHAPERON, V17, P639, DOI 10.1007/s12192-012-0340-8; Mizrahi T, 2010, CELL STRESS CHAPERON, V15, P351, DOI 10.1007/s12192-009-0150-9; MOELLER PW, 1976, J FOOD SCI, V41, P216, DOI 10.1111/j.1365-2621.1976.tb01143.x; NEI M, 1973, P NATL ACAD SCI USA, V70, P3321, DOI 10.1073/pnas.70.12.3321; Oksanen J., 2013, VEGAN COMMUNITY ECOL; Parsell D.A., 1994, BIOL HEAT SHOCK PROT, P457; PARSELL DA, 1993, ANNU REV GENET, V27, P437, DOI 10.1146/annurev.ge.27.120193.002253; Pfenninger M, 2002, EVOLUTION, V56, P1776, DOI 10.1111/j.0014-3820.2002.tb00191.x; Pfenninger M, 2001, MOL ECOL, V10, P2541, DOI 10.1046/j.0962-1083.2001.01389.x; Pfenninger Markus, 2003, Malakologische Abhandlungen (Dresden), V21, P123; POMEROY D E, 1968, Australian Journal of Zoology, V16, P857, DOI 10.1071/ZO9680857; POSTE G, 1971, EXP CELL RES, V67, P11, DOI 10.1016/0014-4827(71)90615-X; R Core Team, 2021, R LANG ENV STAT COMP; Riddle WA, 1983, MOLLUSCA, V6, P431; RYAN AJ, 1995, J APPL PHYSIOL, V78, P38, DOI 10.1152/jappl.1995.78.1.38; SANCHEZ Y, 1992, EMBO J, V11, P2357, DOI 10.1002/j.1460-2075.1992.tb05295.x; Scheil AE, 2011, J MOLLUS STUD, V77, P165, DOI 10.1093/mollus/eyr003; SCHMIDTNIELSEN K, 1971, J EXP BIOL, V55, P385; Schrader M, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002327; Sorensen JG, 2001, FUNCT ECOL, V15, P289, DOI 10.1046/j.1365-2435.2001.00525.x; Staikou AE, 1999, J MOLLUS STUD, V65, P171, DOI 10.1093/mollus/65.2.171; SUMNER AT, 1965, Q J MICROSC SCI, V106, P173; Taieb N, 1999, J MOLLUS STUD, V65, P385, DOI 10.1093/mollus/65.4.385; Tomanek L, 1999, J EXP BIOL, V202, P2925; Triebskorn R, 2005, WATER ENCY WATER QUA, P29, DOI DOI 10.1002/047147844X.WQ566; WALKER G, 1970, PROTOPLASMA, V71, P91, DOI 10.1007/BF01294305; YOM-TOV Y, 1971, Proceedings of the Malacological Society of London, V39, P319; Zaldibar B, 2007, AQUAT TOXICOL, V81, P183, DOI 10.1016/j.aquatox.2006.12.007; Zatsepina OG, 2001, J EXP BIOL, V204, P1869	71	14	16	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2014	9	1							e86613	10.1371/journal.pone.0086613	http://dx.doi.org/10.1371/journal.pone.0086613			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301BI	24475158	Green Published, Green Submitted, gold			2022-12-25	WOS:000330507300094
J	Krautbauer, S; Eisinger, K; Neumeier, M; Hader, Y; Buettner, R; Schmid, PM; Aslanidis, C; Buechler, C				Krautbauer, Sabrina; Eisinger, Kristina; Neumeier, Markus; Hader, Yvonne; Buettner, Roland; Schmid, Peter M.; Aslanidis, Charalampos; Buechler, Christa			Free Fatty Acids, Lipopolysaccharide and IL-1 alpha Induce Adipocyte Manganese Superoxide Dismutase Which Is Increased in Visceral Adipose Tissues of Obese Rodents	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; INSULIN-RESISTANCE; OXIDATIVE STRESS; METABOLIC SYNDROME; MITOCHONDRIAL DYSFUNCTION; ADIPONECTIN RELEASE; 3T3-L1 ADIPOCYTES; GENE-EXPRESSION; IN-VITRO; MICE	Excess fat storage in adipocytes is associated with increased generation of reactive oxygen species (ROS) and impaired activity of antioxidant mechanisms. Manganese superoxide dismutase (MnSOD) is a mitochondrial enzyme involved in detoxification of ROS, and objective of the current study is to analyze expression and regulation of MnSOD in obesity. MnSOD is increased in visceral but not subcutaneous fat depots of rodents kept on high fat diets (HFD) and ob/ob mice. MnSOD is elevated in visceral adipocytes of fat fed mice and exposure of differentiating 3T3-L1 cells to lipopolysaccharide, IL-1 alpha, saturated, monounsaturated and polyunsaturated free fatty acids (FFA) upregulates its level. FFA do not alter cytochrome oxidase 4 arguing against overall induction of mitochondrial enzymes. Upregulation of MnSOD in fat loaded cells is not mediated by IL-6, TNF or sterol regulatory element binding protein 2 which are induced in these cells. MnSOD is similarly abundant in perirenal fat of Zucker diabetic rats and non-diabetic animals with similar body weight and glucose has no effect on MnSOD in 3T3-L1 cells. To evaluate whether MnSOD affects adipocyte fat storage, MnSOD was knocked-down in adipocytes for the last three days of differentiation and in mature adipocytes. Knock-down of MnSOD does neither alter lipid storage nor viability of these cells. Heme oxygenase-1 which is induced upon oxidative stress is not altered while antioxidative capacity of the cells is modestly reduced. Current data show that inflammation and excess triglyceride storage raise adipocyte MnSOD which is induced in epididymal adipocytes in obesity.	[Krautbauer, Sabrina; Eisinger, Kristina; Neumeier, Markus; Hader, Yvonne; Buettner, Roland; Buechler, Christa] Regensburg Univ Hosp, Dept Internal Med 1, Regensburg, Germany; [Schmid, Peter M.] Regensburg Univ Hosp, Dept Internal Med 2, Regensburg, Germany; [Aslanidis, Charalampos] Regensburg Univ Hosp, Inst Clin Chem & Lab Med, Regensburg, Germany	University of Regensburg; University of Regensburg; University of Regensburg	Buechler, C (corresponding author), Regensburg Univ Hosp, Dept Internal Med 1, Regensburg, Germany.	christa.buechler@klinik.uni-regensburg.de	Buechler, Christa/AAH-3004-2020		Deutsche Forschungsgemeinschaft	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This study was partly supported by the Deutsche Forschungsgemeinschaft. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bauer S, 2011, ENDOCRINOLOGY, V152, P26, DOI 10.1210/en.2010-1157; Behrend L, 2005, MOL CELL BIOL, V25, P7758, DOI 10.1128/MCB.25.17.7758-7769.2005; Bondia-Pons I, 2012, J PHYSIOL BIOCHEM, V68, P701, DOI 10.1007/s13105-012-0154-2; Bournat Juan C, 2010, Curr Opin Endocrinol Diabetes Obes, V17, P446, DOI 10.1097/MED.0b013e32833c3026; Buechler C, 2013, INFLAMM ALL IN PRESS; Buettner R, 2006, J MOL ENDOCRINOL, V36, P485, DOI 10.1677/jme.1.01909; Cani PD, 2007, DIABETES, V56, P1761, DOI 10.2337/db06-1491; Carriere A, 2004, J BIOL CHEM, V279, P40462, DOI 10.1074/jbc.M407258200; Cheguru P, 2012, PFLUG ARCH EUR J PHY, V463, P429, DOI 10.1007/s00424-011-1066-7; Chen HN, 2005, DIABETES, V54, P1437, DOI 10.2337/diabetes.54.5.1437; Chen Y, 2009, CELL DEATH DIFFER, V16, P1040, DOI 10.1038/cdd.2009.49; Coate KC, 2010, NUTR RES, V30, P141, DOI 10.1016/j.nutres.2010.01.003; Dhar SK, 2012, FREE RADICAL BIO MED, V52, P2209, DOI 10.1016/j.freeradbiomed.2012.03.009; Drose S, 2012, ADV EXP MED BIOL, V748, P145, DOI 10.1007/978-1-4614-3573-0_6; Ducluzeau PH, 2011, J PHYSIOL BIOCHEM, V67, P285, DOI 10.1007/s13105-011-0074-6; Duriez PJ, 1997, BIOCHEM CELL BIOL, V75, P337, DOI 10.1139/bcb-75-4-337; Foster MT, 2012, ADIPOCYTE, V1, P192, DOI 10.4161/adip.21756; Furukawa S, 2004, J CLIN INVEST, V114, P1752, DOI [10.1172/JCI20042162S, 10.1172/JCI21625]; Gao CL, 2010, MOL CELL ENDOCRINOL, V320, P25, DOI 10.1016/j.mce.2010.01.039; GIBBS LS, 1992, FREE RADICAL BIO MED, V12, P107, DOI 10.1016/0891-5849(92)90003-Y; Guilherme A, 2008, NAT REV MOL CELL BIO, V9, P367, DOI 10.1038/nrm2391; Han CY, 2010, DIABETES, V59, P386, DOI 10.2337/db09-0925; Hoehn KL, 2009, P NATL ACAD SCI USA, V106, P17787, DOI 10.1073/pnas.0902380106; Hoeks J, 2010, DIABETES, V59, P2117, DOI 10.2337/db10-0519; Hosoki A, 2012, J RADIAT RES, V53, P58, DOI 10.1269/jrr.11034; Kim YC, 1999, BIOCHEM BIOPH RES CO, V266, P1, DOI 10.1006/bbrc.1999.1704; Kobayashi H, 2009, AM J PHYSIOL-ENDOC M, V296, pE1326, DOI 10.1152/ajpendo.90921.2008; Koh EH, 2007, DIABETES, V56, P2973, DOI 10.2337/db07-0510; Kojima T, 2010, APOPTOSIS, V15, P83, DOI 10.1007/s10495-009-0415-x; Larosche I, 2010, J PHARMACOL EXP THER, V332, P886, DOI 10.1124/jpet.109.160879; Le Lay S, 2001, J BIOL CHEM, V276, P16904, DOI 10.1074/jbc.M010955200; LI YB, 1995, NAT GENET, V11, P376, DOI 10.1038/ng1295-376; Long EK, 2013, FREE RADICAL BIO MED, V63, P390, DOI 10.1016/j.freeradbiomed.2013.05.030; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Nam WS, 2012, BBA-MOL BASIS DIS, V1822, P1181, DOI 10.1016/j.bbadis.2012.04.003; Pei-Wen W, 2013, ANTIOXID RE IN PRESS; Pires KM, 2013, OBESITY SIL IN PRESS; Pospisilik JA, 2007, CELL, V131, P476, DOI 10.1016/j.cell.2007.08.047; Quintens R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056719; Rong JX, 2007, DIABETES, V56, P1751, DOI 10.2337/db06-1135; Ryter SW, 2009, AM J RESP CELL MOL, V41, P251, DOI 10.1165/rcmb.2009-0170TR; Sampey BP, 2011, OBESITY, V19, P1109, DOI 10.1038/oby.2011.18; Schaffler A, 2005, NAT CLIN PRACT GASTR, V2, P273, DOI 10.1038/ncpgasthep0186; Schroeder K, 2009, ARTERIOSCL THROM VAS, V29, P239, DOI 10.1161/ATVBAHA.108.174219; Subauste AR, 2007, AM J PHYSIOL-ENDOC M, V293, pE159, DOI 10.1152/ajpendo.00629.2006; Suganami T, 2005, ARTERIOSCL THROM VAS, V25, P2062, DOI 10.1161/01.ATV.0000183883.72263.13; Takahashi K, 2008, AM J PHYSIOL-ENDOC M, V294, pE898, DOI 10.1152/ajpendo.00131.2007; Um JY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029524; Unger RH, 2010, BBA-MOL CELL BIOL L, V1801, P209, DOI 10.1016/j.bbalip.2009.10.006; Valerio A, 2006, J CLIN INVEST, V116, P2791, DOI [10.1172/JCI28570, 10.1172/JCI28570.]; Wang QA, 2013, NAT MED, V19, P1338, DOI 10.1038/nm.3324; Weigert J, 2008, FEBS LETT, V582, P2965, DOI 10.1016/j.febslet.2008.07.034; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; White UA, 2010, MOL CELL ENDOCRINOL, V318, P10, DOI 10.1016/j.mce.2009.08.023; Wilson-Fritch L, 2004, J CLIN INVEST, V114, P1281, DOI 10.1172/JCI200421752; WONG GHW, 1988, SCIENCE, V242, P941, DOI 10.1126/science.3263703; Zeyda M, 2007, IMMUNOL LETT, V112, P61, DOI 10.1016/j.imlet.2007.07.003; Zhang YY, 2011, AM J PHYSIOL-ENDOC M, V300, pE77, DOI 10.1152/ajpendo.00380.2010	58	22	23	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2014	9	1							e86866	10.1371/journal.pone.0086866	http://dx.doi.org/10.1371/journal.pone.0086866			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	298QQ	24475187	gold, Green Published, Green Submitted			2022-12-25	WOS:000330339800066
J	Luo, RZ; Cai, PQ; Li, M; Fu, J; Zhang, ZY; Chen, JW; Cao, Y; Yun, JP; Xie, D; Cai, MY				Luo, Rong-Zhen; Cai, Pei-Qiang; Li, Mei; Fu, Jia; Zhang, Zhi-Yi; Chen, Jie-Wei; Cao, Yun; Yun, Jing-Ping; Xie, Dan; Cai, Mu-Yan			Decreased Expression of PTPN12 Correlates with Tumor Recurrence and Poor Survival of Patients with Hepatocellular Carcinoma	PLOS ONE			English	Article							TYROSINE PHOSPHATASES; PROTEIN; CANCER; MOTILITY; GENES	Background: Protein tyrosine phosphatase non-receptor type 12 (PTPN12), has been identified as a potent tumor suppressor in human cancers and a critical regulator of cell adhesion and migration. However, the PTPN12 expression and its prognostic significance in HCC have not been well elucidated. Methodology/Principal Findings: In this study, tissue microarray-based immunohistochemistry (IHC) was investigated in an HCC cohort with adjacent liver tissues as controls. The resulting data were analyzed using receiver operating characteristic curves, Spearman's rank correlation, Kaplan-Meier plots and Cox proportional hazards regression modeling. Our results showed that decreased expression of PTPN12 was more frequently observed in HCC tissues compared to the adjacent non-tumorous liver tissues. Further correlation analyses indicated that the decreased PTPN12 expression was closely correlated with tumor recurrence (P = 0.015). Univariate analysis showed a significant association between decreased expression of PTPN12 and adverse cancer-specific survival and recurrence-free survival (P < 0.001). In different subsets of overall patients, PTPN12 expression was also a prognostic indicator in patients with stage I/II or stage III/IV (P < 0.05). Importantly, multivariate analysis (P < 0.05) identified PTPN12 expression in HCC as an independent prognostic factor. Conclusions/Significance: Our findings provide a basis for the concept that PTPN12 protein expression is frequently decreased or lost in human HCC tissues and that decreased PTPN12 expression may represent an acquired recurrence phenotype of HCC and that PTPN12 expression may act as a biomarker of prognosis for patients with HCC.	[Luo, Rong-Zhen; Cai, Pei-Qiang; Li, Mei; Fu, Jia; Zhang, Zhi-Yi; Chen, Jie-Wei; Cao, Yun; Yun, Jing-Ping; Xie, Dan; Cai, Mu-Yan] Sun Yat Sen Univ, Ctr Canc, State Key Lab Oncol South China, Collaborat Innovat Ctr Canc Med, Guangzhou 510275, Guangdong, Peoples R China; [Luo, Rong-Zhen; Li, Mei; Fu, Jia; Zhang, Zhi-Yi; Chen, Jie-Wei; Cao, Yun; Yun, Jing-Ping; Xie, Dan; Cai, Mu-Yan] Sun Yat Sen Univ, Dept Pathol, Ctr Canc, Guangzhou 510275, Guangdong, Peoples R China; [Cai, Pei-Qiang] Sun Yat Sen Univ, Med Imaging & Minimally Invas Intervent Ctr, Ctr Canc, Guangzhou 510275, Guangdong, Peoples R China	State Key Lab Oncology South China; Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University	Cai, MY (corresponding author), Sun Yat Sen Univ, Ctr Canc, State Key Lab Oncol South China, Collaborat Innovat Ctr Canc Med, Guangzhou 510275, Guangdong, Peoples R China.	caimuyan@hotmail.com	Zhang, Chris Zhiyi/F-9862-2013		Medical Science Technology Research Foundation of Guangdong [2013217]; Foundation for Distinguished Young Talents in Higher Education of Guangdong [84000-3211701]; Program for Excellent Young Talents in Sun Yat-sen University Cancer Center [520101210101]	Medical Science Technology Research Foundation of Guangdong; Foundation for Distinguished Young Talents in Higher Education of Guangdong; Program for Excellent Young Talents in Sun Yat-sen University Cancer Center	This study was supported by the Medical Science Technology Research Foundation of Guangdong (No. 2013217), the Foundation for Distinguished Young Talents in Higher Education of Guangdong (No. 84000-3211701) and the Program for Excellent Young Talents in Sun Yat-sen University Cancer Center (No. 520101210101). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altekruse SF, 2009, J CLIN ONCOL, V27, P1485, DOI 10.1200/JCO.2008.20.7753; Bruix J, 2005, HEPATOLOGY, V42, P1208, DOI 10.1002/hep.20933; Cai MY, 2011, GUT, V60, P967, DOI 10.1136/gut.2010.231993; Cai MY, 2011, MOL MED, V17, P12, DOI 10.2119/molmed.2010.00103; Cai MY, 2010, CANCER SCI, V101, P1543, DOI 10.1111/j.1349-7006.2010.01560.x; Cao X, 2012, ANN THORAC SURG, V93, P1674, DOI 10.1016/j.athoracsur.2011.12.056; Davidson D, 2010, IMMUNITY, V33, P167, DOI 10.1016/j.immuni.2010.08.001; EDMONDSON HA, 1954, CANCER-AM CANCER SOC, V7, P462, DOI 10.1002/1097-0142(195405)7:3<462::AID-CNCR2820070308>3.0.CO;2-E; Espejo R, 2010, AM J PHYSIOL-CELL PH, V299, pC454, DOI 10.1152/ajpcell.00148.2010; Hsu JL, 2003, ANAL CHEM, V75, P6843, DOI 10.1021/ac0348625; Hui AM, 1998, HEPATO-GASTROENTEROL, V45, P1635; Hunter T, 2009, CURR OPIN CELL BIOL, V21, P140, DOI 10.1016/j.ceb.2009.01.028; Jemal A, 2007, CA-CANCER J CLIN, V57, P43, DOI 10.3322/canjclin.57.1.43; Lee JS, 2006, NAT MED, V12, P410, DOI 10.1038/nm1377; Moradpour D, 1994, J Viral Hepat, V1, P17, DOI 10.1111/j.1365-2893.1994.tb00058.x; NAGASUE N, 1993, GASTROENTEROLOGY, V105, P488, DOI 10.1016/0016-5085(93)90724-Q; Sobin LH, 1997, CANCER, V80, P1803, DOI 10.1002/(SICI)1097-0142(19971101)80:9<1803::AID-CNCR16>3.0.CO;2-9; Streit S, 2006, CANCER GENET CYTOGEN, V170, P48, DOI 10.1016/j.cancergencyto.2006.05.013; Sun TT, 2011, CELL, V144, P703, DOI 10.1016/j.cell.2011.02.003; TABOR E, 1994, J MED VIROL, V42, P357, DOI 10.1002/jmv.1890420406; Tonks NK, 2006, NAT REV MOL CELL BIO, V7, P833, DOI 10.1038/nrm2039; Villa-Moruzzi E, 2011, ANAL CELL PATHOL, V34, P101, DOI [10.1155/2011/870459, 10.3233/ACP-2011-0008]; Wu MQ, 2013, ASIAN PAC J CANCER P, V14, P287, DOI 10.7314/APJCP.2013.14.1.287; Yamamoto J, 1996, BRIT J SURG, V83, P1219; Yarden Y, 2001, NAT REV MOL CELL BIO, V2, P127, DOI 10.1038/35052073; Yuan XY, 2012, BRAZ J MED BIOL RES, V45, P1334, DOI 10.1590/S0100-879X2012007500163; Yuen MF, 2000, HEPATOLOGY, V31, P330, DOI 10.1002/hep.510310211; Zheng YH, 2011, MOL CELL BIOL, V31, P4258, DOI 10.1128/MCB.05547-11; Zhu W, 2012, GUT, V61, P562, DOI 10.1136/gutjnl-2011-300207	29	35	35	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2014	9	1							e85592	10.1371/journal.pone.0085592	http://dx.doi.org/10.1371/journal.pone.0085592			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	298QQ	24475046	gold, Green Published, Green Submitted			2022-12-25	WOS:000330339800013
J	Larocque, K; Ovadje, P; Djurdjevic, S; Mehdi, M; Green, J; Pandey, S				Larocque, Kristen; Ovadje, Pamela; Djurdjevic, Sinisa; Mehdi, Mariam; Green, James; Pandey, Siyaram			Novel Analogue of Colchicine Induces Selective Pro-Death Autophagy and Necrosis in Human Cancer Cells	PLOS ONE			English	Article							VASCULAR-TARGETING AGENT; PANCREATIC-CANCER; APOPTOSIS; ZD6126; DEATH; GEMCITABINE; INHIBITION; TRIAL	Colchicine, a natural product of Colchicum autumnae currently used for gout treatment, is a tubulin targeting compound which inhibits microtubule formation by targeting fast dividing cells. This tubulin-targeting property has lead researchers to investigate the potential of colchicine and analogs as possible cancer therapies. One major study conducted on an analogue of allocolchicine, ZD 6126, was halted in phase 2 clinical trials due to severe cardio-toxicity associated with treatment. This study involves the development and testing of novel allocolchicine analogues that hold non-toxic anti-cancer properties. Currently we have synthesized and evaluated the anti-cancer activities of two analogues; N-acetyl-O-methylcolchinol (NSC 51046 or NCME), which is structurally similar to ZD 6126, and (S)-3,8,9,10-tetramethoxyallocolchicine (Green 1), which is a novel derivative of allocolchicine that is isomeric in the A ring. NSC 51046 was found to be non-selective as it induced apoptosis in both BxPC-3 and PANC-1 pancreatic cancer cells and in normal human fibroblasts. Interestingly, we found that Green 1 was able to modestly induce pro-death autophagy in these pancreatic cancer cells and E6-1 leukemia cells but not in normal human fibroblasts. Unlike colchicine and NSC 51046, Green 1 does not appear to affect tubulin polymerization indicating that it has a different molecular target. Green 1 also caused increased reactive oxygen species (ROS) production in mitochondria isolated from pancreatic cancer cells. Furthermore, in vivo studies revealed that Green 1 was well tolerated in mice. Our findings suggest that a small change in the structure of colchicine has apparently changed the mechanism of action and lead to improved selectivity. This may lead to better selective treatments in cancer therapy.	[Larocque, Kristen; Ovadje, Pamela; Djurdjevic, Sinisa; Mehdi, Mariam; Green, James; Pandey, Siyaram] Univ Windsor, Dept Chem & Biochem, Windsor, ON N9B 3P4, Canada	University of Windsor	Pandey, S (corresponding author), Univ Windsor, Dept Chem & Biochem, Windsor, ON N9B 3P4, Canada.	spandey@uwindsor.ca	Pandey, Siyaram/AAI-5491-2020	Green, James/0000-0003-2334-4503	Windsor and Essex County Cancer Center Foundation's Seeds4Hope Grant; NSERC Discovery Grant program	Windsor and Essex County Cancer Center Foundation's Seeds4Hope Grant; NSERC Discovery Grant program(Natural Sciences and Engineering Research Council of Canada (NSERC))	The Windsor and Essex County Cancer Center Foundation's Seeds4Hope Grant and NSERC Discovery Grant program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ben-Chetrit E, 1998, SEMIN ARTHRITIS RHEU, V28, P48, DOI 10.1016/S0049-0172(98)80028-0; Blakey DC, 2002, CLIN CANCER RES, V8, P1974; Boyer FD, 2010, BIOORG CHEM, V38, P149, DOI 10.1016/j.bioorg.2010.03.003; Buttner F, 2005, BIOORGAN MED CHEM, V13, P3497, DOI 10.1016/j.bmc.2005.02.059; Canada S, 2013, CANADIAN CANC STAT S, P1; Dalby KN, 2010, AUTOPHAGY, V6, P322, DOI 10.4161/auto.6.3.11625; Darzynkiewicz Z, 1997, CYTOMETRY, V27, P1; Davis PD, 2002, CANCER RES, V62, P7247; Djurdjevic S, 2010, J ORG CHEM, V75, P8241, DOI 10.1021/jo101953n; Eckel F, 2006, EXPERT OPIN INV DRUG, V15, P1395, DOI 10.1517/13543784.15.11.1395; Fischer Andrew H, 2008, CSH Protoc, V2008, DOI 10.1101/pdb.prot4986; Galluzzi L, 2008, CELL, V135, P1161, DOI 10.1016/j.cell.2008.12.004; Gogvadze V, 2008, TRENDS CELL BIOL, V18, P165, DOI 10.1016/j.tcb.2008.01.006; GOLDFINGER SE, 1972, NEW ENGL J MED, V287, P1302; Goto H, 2004, CLIN CANCER RES, V10, P7671, DOI 10.1158/1078-0432.CCR-04-1171; Gump JM, 2011, TRENDS CELL BIOL, V21, P387, DOI 10.1016/j.tcb.2011.03.007; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; KERSHENOBICH D, 1988, NEW ENGL J MED, V318, P1709, DOI 10.1056/NEJM198806303182602; Kindler HL, 2010, J CLIN ONCOL, V28, P3617, DOI 10.1200/JCO.2010.28.1386; Kohler BA, 2011, JNCI-J NATL CANCER I, V103, P714, DOI 10.1093/jnci/djr077; Li L, 2007, CANCER RES, V67, P4894, DOI 10.1158/0008-5472.CAN-06-3818; LoRusso PM, 2008, INVEST NEW DRUG, V26, P159, DOI 10.1007/s10637-008-9112-9; Lum JJ, 2005, NAT REV MOL CELL BIO, V6, P439, DOI 10.1038/nrm1660; MACKAY MF, 1989, ACTA CRYSTALLOGR C, V45, P795, DOI 10.1107/S0108270188013794; MARGULIS TN, 1978, BIOCHEM BIOPH RES CO, V83, P472, DOI 10.1016/0006-291X(78)91014-8; Ovadje P, 2012, PANCREAS, V41, P1039, DOI 10.1097/MPA.0b013e31824b22a2; Rothenberg ML, 1996, ANN ONCOL, V7, P347; SKOUFIAS DA, 1992, BIOCHEMISTRY-US, V31, P738, DOI 10.1021/bi00118a015; Strober W., 2001, CURR PROTOC IMMUNOL, DOI [10.1002/0471142735.ima03bs21, DOI 10.1002/0471142735.IMA03BS111]; SU WPD, 1995, SEMIN DERMATOL, V14, P173; Tuveson D, 2011, NATURE, V471, P316, DOI 10.1038/471316a; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Yang ZNJ, 2011, MOL CANCER THER, V10, P1533, DOI 10.1158/1535-7163.MCT-11-0047; Zhang GH, 1997, BIOTECHNIQUES, V23, P525, DOI 10.2144/97233pf01; Zhou Jun, 2005, Current Medicinal Chemistry - Anti-Cancer Agents, V5, P65, DOI 10.2174/1568011053352569; Zong WX, 2006, GENE DEV, V20, P1, DOI 10.1101/gad.1376506	36	52	52	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2014	9	1							e87064	10.1371/journal.pone.0087064	http://dx.doi.org/10.1371/journal.pone.0087064			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297XI	24466327	Green Submitted, Green Published, gold			2022-12-25	WOS:000330288000189
J	Zheng, Q; Jiao, NZ; Zhang, R; Wei, JJ; Zhang, F				Zheng, Qiang; Jiao, Nianzhi; Zhang, Rui; Wei, Jingjing; Zhang, Fei			The Evolutionary Divergence of psbA Gene in Synechococcus and Their Myoviruses in the East China Sea	PLOS ONE			English	Article							MARINE SYNECHOCOCCUS; PHOTOSYNTHESIS GENES; PHOTOSYSTEM-I; PHYLOGENETIC DIVERSITY; PROCHLOROCOCCUS; CYANOPHAGES; DYNAMICS; PICOPLANKTON; BACTERIA; VIRUS	Marine Synechococcus is a principal component of the picophytoplankton and makes an important contribution to primary productivity in the ocean. Synechophages, infecting Synechococcus, are believed to have significant influences on the distribution and abundance of their hosts. Extensive previous ecological studies on cyanobacteria and viruses have been carried out in the East China Sea (ECS). Here we investigate the diversity and divergence of Synechococcus and their myoviruses (Synechomyoviruses) based on their shared photosynthesis psbA gene. Synechococcus is dominated by subclades 5.1A I, 5.1A II and 5.1A IV in the ECS, and clades I and II are the dominant groups in the Synechomyoviruses. As two phylogenetically independent clades, there is much higher diversity of the Synechomyoviruses than Synechococcus. Obvious partitioning characteristics of GC and GC3 (the GC content at the third codon position) contents are obtained among different picophytoplankton populations and their phages. The GC3 content causes the psbA gene in Synechococcus to have a higher GC content, while the opposite is true in the Synechomyoviruses. Analyzing more than one-time difference of the codon usage frequency of psbA sequences, the third position nucleotides of preferred codons for Synechococcus are all G and C, while most Synechomyoviral sequences (72.7%) have A and T at the third position of their preferred codons. This work shed light on the ecology and evolution of phage-host interactions in the environment.	[Zheng, Qiang; Jiao, Nianzhi; Zhang, Rui; Wei, Jingjing; Zhang, Fei] Xiamen Univ, State Key Lab Marine Environm Sci, Inst Marine Microbes & Ecospheres, Xiamen, Peoples R China	Xiamen University	Jiao, NZ (corresponding author), Xiamen Univ, State Key Lab Marine Environm Sci, Inst Marine Microbes & Ecospheres, Xiamen, Peoples R China.	jiao@xmu.edu.cn	wei, jing/GXA-1455-2022		NSFC [41076063, 41306126, 41376132]; 973 program [2013CB955700]; China SOA project [GASI-03-01-02-05]; Fundamental Research Funds for the Central Universities [2013121051]	NSFC(National Natural Science Foundation of China (NSFC)); 973 program(National Basic Research Program of China); China SOA project; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported by the NSFC project (41076063), the 973 program (2013CB955700) and China SOA project associated with task GASI-03-01-02-05 to NJ, Fundamental Research Funds for the Central Universities (2013121051) and NSFC project (41306126) to QZ, and the NSFC project (41376132) to RZ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alperovitch-Lavy A, 2011, ENVIRON MICROBIOL, V13, P24, DOI 10.1111/j.1462-2920.2010.02304.x; Beja O, 2012, ISME J, V6, P1617, DOI 10.1038/ismej.2012.23; Binder B, 1999, AQUAT MICROB ECOL, V18, P207, DOI 10.3354/ame018207; Chenard C, 2008, APPL ENVIRON MICROB, V74, P5317, DOI 10.1128/AEM.02480-07; Dufresne A, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-5-r90; FUHRMAN JA, 1988, APPL ENVIRON MICROB, V54, P1426, DOI 10.1128/AEM.54.6.1426-1429.1988; Hu AY, 2011, APPL ENVIRON MICROB, V77, P7469, DOI 10.1128/AEM.00294-11; Huang S, 2011, ISME J; Jiao NZ, 2007, WATER RES, V41, P1287, DOI 10.1016/j.watres.2006.11.053; Jiao NZ, 2006, J MAR BIOL ASSOC UK, V86, P543, DOI 10.1017/S0025315406013452; Jiao NZ, 2005, CONT SHELF RES, V25, P1265, DOI 10.1016/j.csr.2005.01.002; Jiao NZ, 2002, AQUAT MICROB ECOL, V30, P37; Johnson ZI, 2006, SCIENCE, V311, P1737, DOI 10.1126/science.1118052; Kumar S, 2004, BRIEF BIOINFORM, V5, P150, DOI 10.1093/bib/5.2.150; Lindell D, 2005, NATURE, V438, P86, DOI 10.1038/nature04111; Lindell D, 2004, P NATL ACAD SCI USA, V101, P11013, DOI 10.1073/pnas.0401526101; Lindell D, 2007, NATURE, V449, P83, DOI 10.1038/nature06130; Mann NH, 2003, NATURE, V424, P741, DOI 10.1038/424741a; Marston MF, 2012, P NATL ACAD SCI USA, V109, P4544, DOI 10.1073/pnas.1120310109; McEwan CEA, 1998, HEREDITAS, V128, P173, DOI 10.1111/j.1601-5223.1998.00173.x; Millard A, 2004, P NATL ACAD SCI USA, V101, P11007, DOI 10.1073/pnas.0401478101; Palenik B, 2012, ADV PHOTOSYNTH RESP, V33, P103, DOI 10.1007/978-94-007-1533-2_4; Pan LA, 2007, J PLANKTON RES, V29, P187, DOI 10.1093/plankt/fbm006; Pan LA, 2005, FEMS MICROBIOL ECOL, V52, P243, DOI 10.1016/j.femsec.2004.11.019; Partensky F, 1999, MICROBIOL MOL BIOL R, V63, P106, DOI 10.1128/MMBR.63.1.106-127.1999; Sabehi G, 2012, P NATL ACAD SCI USA, V109, P2037, DOI 10.1073/pnas.1115467109; Scanlan DJ, 2002, FEMS MICROBIOL ECOL, V40, P1, DOI 10.1111/j.1574-6941.2002.tb00930.x; Scanlan DJ, 2009, ECOLOGICAL GENOMICS; Schloss PD, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-8-229; Sharon I, 2007, ISME J, V1, P492, DOI 10.1038/ismej.2007.67; Sharon I, 2009, NATURE, V461, P258, DOI 10.1038/nature08284; Shelford EJ, 2012, AQUAT MICROB ECOL, V66, P41, DOI 10.3354/ame01553; Sullivan MB, 2006, PLOS BIOL, V4, P1344, DOI 10.1371/journal.pbio.0040234; Sullivan MB, 2005, PLOS BIOL, V3, P790, DOI 10.1371/journal.pbio.0030144; Sullivan MB, 2003, NATURE, V424, P1047, DOI 10.1038/nature01929; SUTTLE CA, 1994, APPL ENVIRON MICROB, V60, P3167, DOI 10.1128/AEM.60.9.3167-3174.1994; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Thompson LR, 2011, P NATL ACAD SCI USA, V108, pE757, DOI 10.1073/pnas.1102164108; Tzahor S, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-229; Wang K, 2008, ENVIRON MICROBIOL, V10, P300, DOI 10.1111/j.1462-2920.2007.01452.x; [肖天 Xiao tian], 2003, [海洋与湖沼, Oceanologia et Limnologia Sinica], V34, P33; Zeidner G, 2005, ENVIRON MICROBIOL, V7, P1505, DOI 10.1111/j.1462-2920.2005.00833.x; Zeidner G, 2003, ENVIRON MICROBIOL, V5, P212, DOI 10.1046/j.1462-2920.2003.00403.x; Zeng YH, 2004, ACTA OCEANOL SIN, V23, P673; Zwirglmaier K, 2008, ENVIRON MICROBIOL, V10, P147, DOI 10.1111/j.1462-2920.2007.01440.x	45	9	10	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2014	9	1							e86644	10.1371/journal.pone.0086644	http://dx.doi.org/10.1371/journal.pone.0086644			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297XI	24466184	Green Published, Green Submitted, gold			2022-12-25	WOS:000330288000127
J	Avisetti, DR; Babu, KS; Kalivendi, SV				Avisetti, Deepa R.; Babu, K. Suresh; Kalivendi, Shasi V.			Activation of p38/JNK Pathway Is Responsible for Embelin Induced Apoptosis in Lung Cancer Cells: Transitional Role of Reactive Oxygen Species	PLOS ONE			English	Article							NF-KAPPA-B; SIGNALING PATHWAY; NUCLEAR-FACTOR; INHIBITOR; PROTEIN; SURVIVAL; BREAST; CONTRIBUTES; SUPPRESSION; CASCADES	The natural product embelin has been demonstrated to possess a wide range of therapeutic properties, however, the mechanisms by which it exerts anticancer effects are not yet clear. By monitoring the molecular changes associated during early apoptotic phase, we have identified the crucial role of oxidative stress induced MAP kinase signalling as a predominant mechanism for its anticancer effects. Treatment of A549 lung cancer cells with embelin resulted in the enhancement of phospho-p38 and phospho-JNK levels as early as 4h. Pretreatment of cells with specific inhibitors of p38 (PD169316) and JNK (SP600125) abrogated embelin-induced caspase-3 activation. Studies employing embelin in the presence or absence of specific MAP kinase inhibitors indicated that the observed changes in phosphorylation levels of p38, JNK and ERK 1/2 are solely due to embelin and not because of cross-talk between MAP kinases. Reactive oxygen species (ROS) play a crucial role in embelin induced alterations in MAP kinase phosphorylation and apoptosis as pretreatment of cells with FeTMPyP mitigated this effect. The observed changes are not due to the inhibitory effect of embelin on XIAP as cells treated with SMAC-N7-Ant peptide, a specific inhibitor of XIAP's BIR3 domain did not mimic embelin induced apoptotic effects. The findings of the present study clearly indicate the crucial role of p38 and JNK pathways in embelin induced apoptosis and provide us with new clues for improving its therapeutic efficacy.	[Avisetti, Deepa R.; Kalivendi, Shasi V.] CSIR Indian Inst Chem Technol CSIR IICT, Ctr Acad Sci & Innovat Res, Hyderabad, Andhra Pradesh, India; [Avisetti, Deepa R.; Kalivendi, Shasi V.] CSIR Indian Inst Chem Technol CSIR IICT, Ctr Chem Biol, Hyderabad, Andhra Pradesh, India; [Babu, K. Suresh] CSIR Indian Inst Chem Technol CSIR IICT, Hyderabad, Andhra Pradesh, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Chemical Technology (IICT); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Chemical Technology (IICT); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Chemical Technology (IICT)	Kalivendi, SV (corresponding author), CSIR Indian Inst Chem Technol CSIR IICT, Ctr Acad Sci & Innovat Res, Hyderabad, Andhra Pradesh, India.	kalivendi@iict.res.in		Avisetti, Deepa/0000-0003-4744-1068	SMiLE project from CSIR, India; UGC, India	SMiLE project from CSIR, India; UGC, India(University Grants Commission, India)	This work was supported by SMiLE project from CSIR, India. Senior Research Fellowship to DRA from UGC, India, is gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Ahn KS, 2007, MOL PHARMACOL, V71, P209, DOI 10.1124/mol.106.028787; Allensworth JL, 2012, MOL CANCER THER, V11, P1518, DOI 10.1158/1535-7163.MCT-11-0787; Balmanno K, 2009, CELL DEATH DIFFER, V16, P368, DOI 10.1038/cdd.2008.148; Bennett BL, 2001, P NATL ACAD SCI USA, V98, P13681, DOI 10.1073/pnas.251194298; Chaudhari HS, 2012, PLANTA MED, V78, P651, DOI 10.1055/s-0031-1298379; CHITRA M, 1994, CHEMOTHERAPY, V40, P109, DOI 10.1159/000239181; Chitra M, 2003, FITOTERAPIA, V74, P401, DOI 10.1016/S0367-326X(03)00066-2; Chitra M., 2003, Indian Journal of Pharmacology, V35, P241; Dai Y, 2009, CANCER RES, V69, P4776, DOI 10.1158/0008-5472.CAN-08-4754; Dhanasekaran A, 2004, J BIOL CHEM, V279, P37575, DOI 10.1074/jbc.M404003200; Fandy TE, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-60; Gandhi GR, 2013, BBA-GEN SUBJECTS, V1830, P2243, DOI 10.1016/j.bbagen.2012.10.016; Githiori JB, 2003, VET PARASITOL, V118, P215, DOI 10.1016/j.vetpar.2003.10.006; Gurtu V, 1997, ANAL BIOCHEM, V251, P98, DOI 10.1006/abio.1997.2220; Heo JY, 2011, CANCER LETT, V308, P71, DOI 10.1016/j.canlet.2011.04.015; Hussain AR, 2010, J PATHOL, V222, P180, DOI 10.1002/path.2747; JOHRI RK, 1991, CONTRACEPTION, V44, P549, DOI 10.1016/0010-7824(91)90157-B; Joshi R, 2009, J MOL STRUCT, V928, P46, DOI 10.1016/j.molstruc.2009.03.010; Joy B, 2010, MOL CARCINOGEN, V49, P324, DOI 10.1002/mc.20599; Kalivendi SV, 2005, BIOCHEM J, V389, P527, DOI 10.1042/BJ20050285; Kayali AG, 2000, DIABETES, V49, P1783, DOI 10.2337/diabetes.49.11.1783; Kim SW, 2013, PROSTATE, V73, P296, DOI 10.1002/pros.22574; Konorev EA, 2008, FREE RADICAL BIO MED, V45, P1723, DOI 10.1016/j.freeradbiomed.2008.09.006; Lin ZH, 2013, CHEM BIOL, V20, P253, DOI 10.1016/j.chembiol.2013.01.002; Lu JQ, 2013, BIOMATERIALS, V34, P1591, DOI 10.1016/j.biomaterials.2012.10.073; MAKAWITI DW, 1990, FEBS LETT, V266, P26, DOI 10.1016/0014-5793(90)81497-C; Modak R, 2013, ACS CHEM BIOL, V8, P1311, DOI 10.1021/cb4000597; Nikolovska-Coleska Z, 2004, J MED CHEM, V47, P2430, DOI 10.1021/jm030420+; Park SY, 2013, J PHARMACOL SCI, V121, P192, DOI 10.1254/jphs.12137FP; Schaible AM, 2013, BIOCHEM PHARMACOL, V86, P476, DOI 10.1016/j.bcp.2013.04.015; Trachootham D, 2008, ANTIOXID REDOX SIGN, V10, P1343, DOI 10.1089/ars.2007.1957; Vichai V, 2006, NAT PROTOC, V1, P1112, DOI 10.1038/nprot.2006.179; Wada T, 2004, ONCOGENE, V23, P2838, DOI 10.1038/sj.onc.1207556; XIA ZG, 1995, SCIENCE, V270, P1326, DOI 10.1126/science.270.5240.1326	34	59	61	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2014	9	1							e87050	10.1371/journal.pone.0087050	http://dx.doi.org/10.1371/journal.pone.0087050			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297VL	24466324	Green Published, gold, Green Submitted			2022-12-25	WOS:000330283100247
J	Hansen, MT; Forst, B; Cremers, N; Quagliata, L; Ambartsumian, N; Grum-Schwensen, B; Klingelhofer, J; Abdul-Al, A; Herrmann, P; Osterland, M; Stein, U; Nielsen, GH; Scherer, PE; Lukanidin, E; Sleeman, JP; Grigorian, M				Hansen, M. T.; Forst, B.; Cremers, N.; Quagliata, L.; Ambartsumian, N.; Grum-Schwensen, B.; Klingelhoefer, J.; Abdul-Al, A.; Herrmann, P.; Osterland, M.; Stein, U.; Nielsen, G. H.; Scherer, P. E.; Lukanidin, E.; Sleeman, J. P.; Grigorian, M.			A link between inflammation and metastasis: serum amyloid A1 and A3 induce metastasis, and are targets of metastasis-inducing S100A4	ONCOGENE			English	Article						inflammation; metastasis; S100A4; serum amyloid A	PROTEIN S100A4; RHEUMATOID-ARTHRITIS; UP-REGULATION; KAPPA-B; EXPRESSION; RECEPTOR; CELLS; PROGRESSION; BINDING; GROWTH	S100A4 is implicated in metastasis and chronic inflammation, but its function remains uncertain. Here we establish an S100A4-dependent link between inflammation and metastatic tumor progression. We found that the acute-phase response proteins serum amyloid A (SAA) 1 and SAA3 are transcriptional targets of S100A4 via Toll-like receptor 4 (TLR4)/nuclear factor-kappa B signaling. SAA proteins stimulated the transcription of RANTES (regulated upon activation normal T-cell expressed and presumably secreted), G-CSF (granulocyte-colony-stimulating factor) and MMP2 (matrix metalloproteinase 2), MMP3, MMP9 and MMP13. We have also shown for the first time that SAA stimulate their own transcription as well as that of proinflammatory S100A8 and S100A9 proteins. Moreover, they strongly enhanced tumor cell adhesion to fibronectin, and stimulated migration and invasion of human and mouse tumor cells. Intravenously injected S100A4 protein induced expression of SAA proteins and cytokines in an organ-specific manner. In a breast cancer animal model, ectopic expression of SAA1 or SAA3 in tumor cells potently promoted widespread metastasis formation accompanied by a massive infiltration of immune cells. Furthermore, coordinate expression of S100A4 and SAA in tumor samples from colorectal carcinoma patients significantly correlated with reduced overall survival. These data show that SAA proteins are effectors for the metastasis-promoting functions of S100A4, and serve as a link between inflammation and tumor progression.	[Hansen, M. T.; Forst, B.; Ambartsumian, N.; Grum-Schwensen, B.; Klingelhoefer, J.; Abdul-Al, A.; Lukanidin, E.; Grigorian, M.] Danish Canc Soc Res Ctr, Copenhagen, Denmark; [Cremers, N.; Quagliata, L.; Sleeman, J. P.] Heidelberg Univ, Univ Med Mannheim, Mannheim, Germany; [Cremers, N.; Sleeman, J. P.] KIT Karlsruhe, Eggenstein Leopoldshafen, Germany; [Ambartsumian, N.; Klingelhoefer, J.; Grigorian, M.] Univ Copenhagen, Inst Neurosci & Pharmacol, Neurooncol Grp, Lab Neural Plast, DK-2200 Copenhagen, Denmark; [Osterland, M.; Stein, U.; Nielsen, G. H.] Charite, Max Delbruck Ctr Mol Med, Expt & Clin Res Ctr, D-13353 Berlin, Germany; [Nielsen, G. H.] Air Liquide Danmark AS, Horsens, Denmark; [Scherer, P. E.] Univ Texas SW Med Ctr Dallas, Touchstone Diabet Ctr, Dallas, TX 75390 USA	Danish Cancer Society; Ruprecht Karls University Heidelberg; University of Copenhagen; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Helmholtz Association; Max Delbruck Center for Molecular Medicine; Air Liquide; University of Texas System; University of Texas Southwestern Medical Center Dallas	Grigorian, M (corresponding author), Univ Copenhagen, Inst Neurosci & Pharmacol, Neurooncol Grp, Lab Neural Plast, Blegdamsvej 3B, DK-2200 Copenhagen, Denmark.	grigorian@sund.ku.dk	Sleeman, Jonathan P/H-2515-2013; Scherer, Philipp E/K-7819-2012; Quagliata, Luca/B-8321-2015	Sleeman, Jonathan P/0000-0003-1718-7687; Scherer, Philipp E/0000-0003-0680-3392; Quagliata, Luca/0000-0001-8249-9914; Stein, Ulrike/0000-0001-7006-282X; Grum-Schwensen, Birgitte/0000-0001-6677-1869	European Union (TuMIC) [Health-F2-2008-201662]; INARMERA [FP7-INCO-2010-6]; Danish Cancer Society; Dansk Kraeftforsknings Fond	European Union (TuMIC); INARMERA; Danish Cancer Society(Danish Cancer Society); Dansk Kraeftforsknings Fond	We thank Ekaterina Dulina, Inge Skibshoj and Lene Bregnholt Larsen for careful technical assistance. We gratefully acknowledge funding by the European Union (TuMIC, Health-F2-2008-201662) and INARMERA (FP7-INCO-2010-6), the Danish Cancer Society and the Dansk Kraeftforsknings Fond.	Aguirre-Ghiso JA, 2001, MOL BIOL CELL, V12, P863, DOI 10.1091/mbc.12.4.863; Ambartsumian N, 2005, CELL BIOL, V1, P363; Ambartsumian NS, 1996, ONCOGENE, V13, P1621; Bang CA, 2007, AM J PHYSIOL-RENAL, V293, pF1325, DOI 10.1152/ajprenal.00039.2007; Baumann P, 2005, CANCER RES, V65, P10783, DOI 10.1158/0008-5472.CAN-05-0619; Cabezon T, 2007, INT J CANCER, V121, P1433, DOI 10.1002/ijc.22850; Cerezo LA, 2011, RHEUMATOLOGY, V50, P1766, DOI 10.1093/rheumatology/ker218; Cunnane G, 2001, CURR OPIN RHEUMATOL, V13, P67, DOI 10.1097/00002281-200101000-00011; Davies MPA, 1996, ONCOGENE, V13, P1631; DeNardo DG, 2008, CANCER METAST REV, V27, P11, DOI 10.1007/s10555-007-9100-0; EBRALIDZE A, 1989, GENE DEV, V3, P1086, DOI 10.1101/gad.3.7.1086; Ehrchen JM, 2009, J LEUKOCYTE BIOL, V86, P557, DOI 10.1189/jlb.1008647; Forst B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010374; Fridman WH, 2011, CANCER RES, V71, P5601, DOI 10.1158/0008-5472.CAN-11-1316; Fritz G, 2010, FEBS J, V277, P4578, DOI 10.1111/j.1742-4658.2010.07887.x; Furlaneto CJ, 2000, BIOCHEM BIOPH RES CO, V268, P405, DOI 10.1006/bbrc.2000.2143; Gregory AD, 2011, CANCER RES, V71, P2411, DOI 10.1158/0008-5472.CAN-10-2583; GRIGORIAN M, 1994, ELECTROPHORESIS, V15, P463, DOI 10.1002/elps.1150150163; Grigorian M, 1996, INT J CANCER, V67, P831, DOI 10.1002/(SICI)1097-0215(19960917)67:6<831::AID-IJC13>3.0.CO;2-4; Grigorian M, 2008, CURR MOL MED, V8, P492, DOI 10.2174/156652408785747942; Grum-Schwensen B, 2010, CANCER RES, V70, P936, DOI 10.1158/0008-5472.CAN-09-3220; He R, 2006, J IMMUNOL, V177, P4072, DOI 10.4049/jimmunol.177.6.4072; He RL, 2009, BLOOD, V113, P429, DOI 10.1182/blood-2008-03-139923; Helfman DM, 2005, BRIT J CANCER, V92, P1955, DOI 10.1038/sj.bjc.6602613; Hiratsuka S, 2008, NAT CELL BIOL, V10, P1349, DOI 10.1038/ncb1794; Kaplan RN, 2005, NATURE, V438, P820, DOI 10.1038/nature04186; Klingelhofer J, 2007, ARTHRITIS RHEUM-US, V56, P779, DOI 10.1002/art.22398; Klingelhofer J, 2012, NEOPLASIA, V14, P1260, DOI 10.1593/neo.121554; Klingelhofer J, 2009, FEBS J, V276, P5936, DOI 10.1111/j.1742-4658.2009.07274.x; Langley RR, 2011, INT J CANCER, V128, P2527, DOI 10.1002/ijc.26031; Larson MA, 2003, BIOCHEM BIOPH RES CO, V301, P1030, DOI 10.1016/S0006-291X(03)00045-7; Lee HY, 2005, BIOCHEM BIOPH RES CO, V330, P989, DOI 10.1016/j.bbrc.2005.03.069; Lin Y, 2001, J BIOL CHEM, V276, P42077, DOI 10.1074/jbc.M107101200; Lukanidin E, 2012, SEMIN CANCER BIOL, V22, P216, DOI 10.1016/j.semcancer.2012.02.006; Maelandsmo GM, 1996, CANCER RES, V56, P5490; Malle E, 2009, CELL MOL LIFE SCI, V66, P9, DOI 10.1007/s00018-008-8321-x; Marenholz I, 2004, BIOCHEM BIOPH RES CO, V322, P1111, DOI 10.1016/j.bbrc.2004.07.096; Moller HD, 2011, MOL CANCER RES, V9, P553, DOI 10.1158/1541-7786.MCR-11-0093; Mullan RH, 2006, ARTHRITIS RHEUM-US, V54, P105, DOI 10.1002/art.21518; Novitskaya V, 2000, J BIOL CHEM, V275, P41278, DOI 10.1074/jbc.M007058200; O'Neill LAJ, 2002, CURR TOP MICROBIOL, V270, P47; Okamoto H, 2008, J RHEUMATOL, V35, P752; PEAR WS, 1993, P NATL ACAD SCI USA, V90, P8392, DOI 10.1073/pnas.90.18.8392; Schmid MC, 2010, J ONCOL, V2010, DOI 10.1155/2010/201026; Schmidt-Hansen B, 2004, J BIOL CHEM, V279, P24498, DOI 10.1074/jbc.M400441200; Song CJ, 2009, ATHEROSCLEROSIS, V207, P374, DOI 10.1016/j.atherosclerosis.2009.05.007; Stein U, 2009, NAT MED, V15, P59, DOI 10.1038/nm.1889; Sung HJ, 2011, J PROTEOME RES, V10, P1383, DOI 10.1021/pr101154j; Tan W, 2011, NATURE, V470, P548, DOI 10.1038/nature09707; Yamada T, 1999, CLIN CHEM LAB MED, V37, P381, DOI 10.1515/CCLM.1999.063; Zhao YL, 2009, J VASC RES, V46, P64, DOI 10.1159/000139134; Zibert JR, 2010, J INVEST DERMATOL, V130, P150, DOI 10.1038/jid.2009.206	52	102	107	0	31	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 22	2015	34	4					424	435		10.1038/onc.2013.568	http://dx.doi.org/10.1038/onc.2013.568			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AZ8FU	24469032				2022-12-25	WOS:000348451300003
J	Ghatak, S; Misra, S; Norris, RA; Moreno-Rodriguez, RA; Hoffman, S; Levine, RA; Hascall, VC; Markwald, RR				Ghatak, Shibnath; Misra, Suniti; Norris, Russell A.; Moreno-Rodriguez, Ricardo A.; Hoffman, Stanley; Levine, Robert A.; Hascall, Vincent C.; Markwald, Roger R.			Periostin Induces Intracellular Cross-talk between Kinases and Hyaluronan in Atrioventricular Valvulogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cd44; Cell Adhesion; Cell Migration; Collagen; Hyaluronate; Integrins; Atrioventricular Valve; Intracellular Kinase Signaling; Periostin; Prevalvular Cushion Cells	FOCAL ADHESION KINASE; ACTIVATED PROTEIN-KINASE; CONSTITUTIVELY REGULATES ACTIVATION; VALVULAR DYSTROPHY; FILAMIN-A; GROWTH-FACTOR; CELL-BINDING; CANCER-CELLS; MAP KINASE; CD44	Background: Periostin-null mice exhibit a myxomatous atrioventricular valve phenotype. We propose two mechanisms as follows: periostin binds to collagen and links it to cell-surface receptors; periostin/-INTEGRIN signaling promotes valve morphogenesis. Results: Periostin/-INTEGRINs/focal adhesion kinase/PI3K/ERK signals promote hyaluronan synthase-2 activation, matrix remodeling, and valve progenitor cell survival/differentiation. Conclusion: The phenotype of periostin-null valves is consistent with a role for PN cell signaling through INTEGRIN receptors. Significance: Periostin is a valvulogenic signaling morphogen. Periostin (PN), a novel fasciclin-related matricellular protein, has been implicated in cardiac development and postnatal remodeling, but the mechanism remains unknown. We examined the role of PN in mediating intracellular kinase activation for atrioventricular valve morphogenesis using well defined explant cultures, gene transfection systems, and Western blotting. The results show that valve progenitor (cushion) cells secrete PN into the extracellular matrix, where it can bind to INTEGRINs and activate INTEGRIN/focal adhesion kinase signaling pathways and downstream kinases, PI3K/AKT and ERK. Functional assays with prevalvular progenitor cells showed that activating these signaling pathways promoted adhesion, migration, and anti-apoptosis. Through activation of PI3K/ERK, PN directly enhanced collagen expression. Comparing PN-null to WT mice also revealed that expression of hyaluronan (HA) and activation of hyaluronan synthase-2 (Has2) are also enhanced upon PN/INTEGRIN/focal adhesion kinase-mediated activation of PI3K and/or ERK, an effect confirmed by the reduction of HA synthase-2 in PN-null mice. We also identified in valve progenitor cells a potential autocrine signaling feedback loop between PN and HA through PI3K and/or ERK. Finally, in a three-dimensional assay to simulate normal valve maturation in vitro, PN promoted collagen compaction in a kinase-dependent fashion. In summary, this study provides the first direct evidence that PN can act to stimulate a valvulogenic signaling pathway.	[Ghatak, Shibnath; Misra, Suniti; Norris, Russell A.; Moreno-Rodriguez, Ricardo A.; Markwald, Roger R.] Med Univ S Carolina, Dept Regenerat Med & Cell Biol, Charleston, SC 29425 USA; [Hoffman, Stanley] Med Univ S Carolina, Dept Med, Div Rheumatol & Immunol, Charleston, SC 29425 USA; [Levine, Robert A.] Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA; [Hascall, Vincent C.] Cleveland Clin, Dept Biomed Engn ND20, Cleveland, OH 44195 USA	Medical University of South Carolina; Medical University of South Carolina; Harvard University; Massachusetts General Hospital; Cleveland Clinic Foundation	Markwald, RR (corresponding author), Med Univ S Carolina, Dept Regenerat Med & Cell Biol, 173 Ashley Ave, Charleston, SC 29425 USA.	markwald@musc.edu	Moreno-Rodriguez, Ricardo/GPT-4006-2022; moreno, ricardo/AAS-5868-2021	Moreno Rodriguez, Ricardo Alberto/0000-0002-5420-4231	National Institutes of Health [1R03CA167722-01A1, P20RR021949, P20RR016434, P20RR16461-05, RO1-HL033756-24, P01HL107147, 1P30AR050953]; EPS [0903795]; MCRC [39919]; COBRE [IP30-GM103342, 8P20 GM103444]; Fondation Leducq (Paris, France) Transatlantic Network of Excellence [07CDV04]; American Heart Association [11SDG5270006]; NATIONAL CANCER INSTITUTE [R03CA167722] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016461, P20RR016434, P20RR021949] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL107147, R01HL033756, R01HL072265, R01HL109506] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR050953] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P30GM103342, P20GM103444] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EPS; MCRC; COBRE; Fondation Leducq (Paris, France) Transatlantic Network of Excellence(Leducq Foundation); American Heart Association(American Heart Association); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants 1R03CA167722-01A1 (to S. M. and S. G.), P20RR021949 (to S. G.), P20RR016434 (to S. M., S. G., and R. R. M.), P20RR16461-05 (to S. G. and R. R. M), RO1-HL033756-24 and (to S. M., S. G., and R. R. M.), P01HL107147 and 1P30AR050953 (to V. C. H.), EPS 0903795 (to S. M.), MCRC 39919 (to S. G. and S. M.), COBRE IP30-GM103342 (to R. R. M. and R. A. N.), and 8P20 GM103444 (to R. R. M. and R. A. N.). This work was also supported by Fondation Leducq (Paris, France) Transatlantic Network of Excellence Grant 07CDV04 (to R. A. L.) and American Heart Association Grant 11SDG5270006 (to R. A. N.).	Bandyopadhyay SK, 2010, J INTERF CYTOK RES, V30, P809, DOI 10.1089/jir.2009.0061; Bourguignon LYW, 2008, SEMIN CANCER BIOL, V18, P251, DOI 10.1016/j.semcancer.2008.03.007; Bourguignon LYW, 2007, J BIOL CHEM, V282, P19426, DOI 10.1074/jbc.M610054200; Butcher JT, 2007, DEV BIOL, V302, P256, DOI 10.1016/j.ydbio.2006.09.048; Calve S, 2012, AM J PHYSIOL-CELL PH, V303, pC577, DOI 10.1152/ajpcell.00057.2012; Camenisch TD, 2000, J CLIN INVEST, V106, P349, DOI 10.1172/JCI10272; Camenisch TD, 2002, NAT MED, V8, P850, DOI 10.1038/nm742; Chen HC, 1996, J BIOL CHEM, V271, P26329, DOI 10.1074/jbc.271.42.26329; Conway S. J., 2013, CELL MOL LIFE SCI, DOI 10.1007/s00018-013-1494-y; DOWNWARD J, 1994, FEBS LETT, V338, P113, DOI 10.1016/0014-5793(94)80346-3; Doyle AJ, 2012, NAT GENET, V44, P1249, DOI 10.1038/ng.2421; Duval D, 2014, BBA-MOL CELL RES, V1843, P234, DOI 10.1016/j.bbamcr.2013.10.022; Ebi H, 2013, P NATL ACAD SCI USA, V110, P21124, DOI 10.1073/pnas.1314124110; EIDE BL, 1995, MOL CELL BIOL, V15, P2819; EISENBERG LM, 1995, CIRC RES, V77, P1, DOI 10.1161/01.RES.77.1.1; Gabarra-Niecko V, 2002, BIOCHEM J, V365, P591, DOI 10.1042/BJ20020065; Gayer CP, 2009, J BIOL CHEM, V284, P2001, DOI 10.1074/jbc.M804576200; Ghatak S, 2005, J BIOL CHEM, V280, P8875, DOI 10.1074/jbc.M410882200; Ghatak S, 2002, J BIOL CHEM, V277, P38013, DOI 10.1074/jbc.M202404200; Ghatak S, 2010, J BIOL CHEM, V285, P19821, DOI 10.1074/jbc.M110.104273; Hamilton DW, 2008, J CELL COMMUN SIGNAL, V2, P9, DOI 10.1007/s12079-008-0023-5; Hardie DG, 2004, J CELL SCI, V117, P5479, DOI 10.1242/jcs.01540; Hascall V. C., 2014, MATRIX BIOL, DOI 10.1016/j.matbio.2014.01.014; Hayashida T, 1999, KIDNEY INT, V56, P1710, DOI 10.1046/j.1523-1755.1999.00733.x; Hayashida T, 2003, FASEB J, V17, P1576, DOI 10.1096/fj.03-0037fje; Kallergi G, 2007, MOL MED, V13, P79, DOI 10.2119/2006-00083.Kallergi; Kim H, 2008, EXP CELL RES, V314, P834, DOI 10.1016/j.yexcr.2007.11.022; Kruithof BPT, 2007, DEV BIOL, V302, P208, DOI 10.1016/j.ydbio.2006.09.024; Kruzynska-Frejtag A, 2001, MECH DEVELOP, V103, P183, DOI 10.1016/S0925-4773(01)00356-2; Kumar CC, 1998, ONCOGENE, V17, P1365, DOI 10.1038/sj.onc.1202172; Kyndt F, 2007, ARCH MAL COEUR VAISS, V100, P1013; Kyndt F, 1998, AM J HUM GENET, V62, P627, DOI 10.1086/301747; Kyndt F, 2007, CIRCULATION, V115, P40, DOI 10.1161/CIRCULATIONAHA.106.622621; Lardeux A, 2011, J CARDIOVASC TRANSL, V4, P748, DOI 10.1007/s12265-011-9308-9; Leask A, 2004, FASEB J, V18, P816, DOI 10.1096/fj.03-1273rev; Lesley J, 2000, EUR J IMMUNOL, V30, P245, DOI 10.1002/1521-4141(200001)30:1<245::AID-IMMU245>3.3.CO;2-O; Li GH, 2010, ATHEROSCLEROSIS, V208, P358, DOI 10.1016/j.atherosclerosis.2009.07.046; McDonald J, 2002, J BIOL CHEM, V277, P4575, DOI 10.1074/jbc.R100064200; Midwood K, 2009, NAT MED, V15, P774, DOI 10.1038/nm.1987; Misra S, 2005, J BIOL CHEM, V280, P20310, DOI 10.1074/jbc.M500737200; Misra S, 2003, J BIOL CHEM, V278, P25285, DOI 10.1074/jbc.C300173200; Misra S, 2008, CONNECT TISSUE RES, V49, P219, DOI 10.1080/03008200802143356; Misra S, 2008, J BIOL CHEM, V283, P14335, DOI 10.1074/jbc.M703811200; Misra S, 2006, J BIOL CHEM, V281, P34936, DOI 10.1074/jbc.C600138200; Misra S, 2013, BIOORGAN MED CHEM, V21, P2551, DOI 10.1016/j.bmc.2013.02.033; Misra S, 2009, J BIOL CHEM, V284, P12432, DOI 10.1074/jbc.M806772200; Mitra SK, 2005, NAT REV MOL CELL BIO, V6, P56, DOI 10.1038/nrm1549; Mjaatvedt CH, 1998, DEV BIOL, V202, P56, DOI 10.1006/dbio.1998.9001; Norris RA, 2010, DEV DYNAM, V239, P2118, DOI 10.1002/dvdy.22346; Norris RA, 2008, DEV BIOL, V316, P200, DOI 10.1016/j.ydbio.2008.01.003; Norris RA, 2008, ANN NY ACAD SCI, V1123, P30, DOI 10.1196/annals.1420.005; Norris RA, 2007, J CELL BIOCHEM, V101, P695, DOI 10.1002/jcb.21224; Norris RA, 2009, J CELL COMMUN SIGNAL, V3, P275, DOI 10.1007/s12079-009-0063-5; Norris RA, 2009, DEV DYNAM, V238, P1052, DOI 10.1002/dvdy.21933; Orecchia P, 2011, EUR J CANCER, V47, P2221, DOI 10.1016/j.ejca.2011.04.026; Paranya G, 2001, AM J PATHOL, V159, P1335, DOI 10.1016/S0002-9440(10)62520-5; Person AD, 2005, INT REV CYTOL, V243, P287, DOI 10.1016/S0074-7696(05)43005-3; Rios H, 2005, MOL CELL BIOL, V25, P11131, DOI 10.1128/MCB.25.24.11131-11144.2005; Shimazaki M, 2008, J EXP MED, V205, P295, DOI 10.1084/jem.20071297; Shinohara ML, 2008, IMMUNITY, V29, P68, DOI 10.1016/j.immuni.2008.05.008; Snider P, 2008, CIRC RES, V102, P752, DOI 10.1161/CIRCRESAHA.107.159517; Snider P, 2009, CIRC RES, V105, P934, DOI 10.1161/CIRCRESAHA.109.201400; Souders CA, 2009, CIRC RES, V105, P1164, DOI 10.1161/CIRCRESAHA.109.209809; Stambolic V, 2006, TRENDS CELL BIOL, V16, P461, DOI 10.1016/j.tcb.2006.07.001; Tkatchenko TV, 2009, PHYSIOL GENOMICS, V39, P160, DOI 10.1152/physiolgenomics.00078.2009; Todorovic V, 2011, DEV DYNAM, V240, P176, DOI 10.1002/dvdy.22521; Towler MC, 2007, CIRC RES, V100, P328, DOI 10.1161/01.RES.0000256090.42690.05; Vigetti D., 2013, MATRIX BIOL, DOI 10.1016/j.matbio.2013.10.002; Vigetti D, 2011, J BIOL CHEM, V286, P7917, DOI 10.1074/jbc.M110.193656; Vigetti D, 2009, J BIOL CHEM, V284, P30684, DOI 10.1074/jbc.M109.040386; Xu SW, 2004, MOL BIOL CELL, V15, P2707, DOI 10.1091/mbc.E03-12-0902; Yang L., 2012, PLOS ONE, V7	72	41	42	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 21	2014	289	12					8545	8561		10.1074/jbc.M113.539882	http://dx.doi.org/10.1074/jbc.M113.539882			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AD3PG	24469446	Green Published, hybrid			2022-12-25	WOS:000333157500045
J	Forcey, DS; Hocking, JS; Tabrizi, SN; Bradshaw, CS; Chen, MY; Fehler, G; Nash, JL; Fairley, CK				Forcey, Dana S.; Hocking, Jane S.; Tabrizi, Sepehr N.; Bradshaw, Catriona S.; Chen, Marcus Y.; Fehler, Glenda; Nash, Jessica L.; Fairley, Christopher K.			Chlamydia Detection during the Menstrual Cycle: A Cross-Sectional Study of Women Attending a Sexual Health Service	PLOS ONE			English	Article							TRACHOMATIS; TIME; IMPACT; PERFORMANCE; AUSTRALIA; TRACT; LOAD; PCR	Background: We investigated the detection of chlamydia at different stages of the menstrual cycle. Methods: Electronic medical records for women attending Melbourne Sexual Health Centre between March 2011 and 31st December 2012, who were tested for chlamydia by nucleic acid amplification of high vaginal, cervical, or urinary samples, and who recorded a date of last normal menstrual period (LNMP) between 0-28 days were included in the analysis. Logistic regression was used to calculate adjusted odds ratio (aOR) and 95% confidence intervals (CI) for the association of chlamydia with menstrual cycle adjusted by demographics and behavioural variables. Chlamydia and beta globin load were determined on those with stored samples. Results: Of the 10,017 consultations that included a test for chlamydia and a valid LNMP, there were 417 in which chlamydia was detected. The proportion of samples with chlamydia was greater in the luteal phase (4.8%, 184/3831) than in the follicular phase (3.4%, 233/6816) both in the crude (OR 1.29 95% CI 1.1-1.6, p = 0.01) and adjusted odds ratio (aOR) 1.4 (95% CI 1.1-1.8, p = 0.004). Among women using hormonal contraception, there was no significant association with the luteal phase of the menstrual cycle (aOR 1.3, 95% CI 0.9, 1.8, p = 0.18). Among women not using hormonal contraception, there was a significant association with the luteal phase (aOR 1.6, (95% CI 1.1-2.3, p = 0.007). The chlamydia load was not significantly different in the 329 positive stored samples in weeks 3 and 4 vs weeks 1 and 2 for any site (P>0.12). Conclusions: The higher detection of chlamydia detection in the luteal phase of the menstrual cycle in only those not taking hormonal contraception suggest that hormonal factors influence chlamydia detection. The absence of a significantly highly chlamydia load in women during the luteal phase raises questions about the mechanism.	[Forcey, Dana S.; Bradshaw, Catriona S.; Chen, Marcus Y.; Fehler, Glenda; Nash, Jessica L.; Fairley, Christopher K.] Melbourne Sexual Hlth Ctr, Melbourne, Vic, Australia; [Forcey, Dana S.; Hocking, Jane S.; Bradshaw, Catriona S.; Chen, Marcus Y.; Fehler, Glenda] Univ Melbourne, Melbourne Sch Populat & Global Hlth, Melbourne, Vic, Australia; [Tabrizi, Sepehr N.] Royal Hosp Women, Dept Clin Microbiol & Infect Dis, Melbourne, Vic, Australia; [Tabrizi, Sepehr N.] Univ Melbourne, Dept Obstet & Gynaecol, Melbourne, Vic, Australia; [Fairley, Christopher K.] Monash Univ, Cent Clin Sch, Melbourne, Vic 3004, Australia	University of Melbourne; University of Melbourne; Monash University	Fairley, CK (corresponding author), Melbourne Sexual Hlth Ctr, Melbourne, Vic, Australia.	cfairley@mshc.org.au	Hocking, Jane/AAD-5203-2021	Hocking, Jane/0000-0001-9329-8501; bradshaw, catriona/0000-0002-6643-5678; Christopher, Fairley/0000-0001-9081-1664	National Health and Medical Research Council [568971]; NHMRC [568971]	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); NHMRC(National Health and Medical Research Council (NHMRC) of Australia)	Funding for this study was provided by the National Health and Medical Research Council program grant (ID 568971) and an NHMRC Program grant (568971). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Harthi L, 2000, J INTERF CYTOK RES, V20, P719, DOI 10.1089/10799900050116426; Buchholz KR, 2006, CELL MICROBIOL, V8, P1768, DOI 10.1111/j.1462-5822.2006.00747.x; Crowley T, 1997, INT J STD AIDS, V8, P25, DOI 10.1258/0956462971918724; Gomes JP, 2006, MICROBES INFECT, V8, P16, DOI 10.1016/j.micinf.2005.05.014; Horner PJ, 1998, LANCET, V351, P341, DOI 10.1016/S0140-6736(05)78335-5; Jensen NWJ, 1999, 99 GEN M AM SOC MICR; Keane FEA, 1997, INT J STD AIDS, V8, P489, DOI 10.1258/0956462971920631; Lee DM, 2005, SEX TRANSM INFECT, V81, P434, DOI 10.1136/sti.2004.014431; Marrazzo JM, 2005, J CLIN MICROBIOL, V43, P577, DOI 10.1128/JCM.43.2.577-584.2005; MCCORMACK WM, 1982, JAMA-J AM MED ASSOC, V247, P1292, DOI 10.1001/jama.247.9.1292; Meyers D, 2008, AM FAM PHYSICIAN, V77, P819; Moller JK, 1999, SEX TRANSM INFECT, V75, P228, DOI 10.1136/sti.75.4.228; Newman L, 2010, COMMUN DIS INTELL, V34, P157; O'Rourke KM, 2009, SEX TRANSM DIS, V36, P763, DOI 10.1097/OLQ.0b013e3181b12765; Peipert JF, 2003, NEW ENGL J MED, V349, P2424, DOI 10.1056/NEJMcp030542; Quayle AJ, 2002, J REPROD IMMUNOL, V57, P61, DOI 10.1016/S0165-0378(02)00019-0; ROSENTHAL GE, 1990, J CLIN EPIDEMIOL, V43, P15, DOI 10.1016/0895-4356(90)90051-P; Sonnex C, 1998, SEX TRANSM INFECT, V74, P11, DOI 10.1136/sti.74.1.11; Stevens MP, 2010, J CLIN MICROBIOL, V48, P2060, DOI 10.1128/JCM.02308-09; SWEET RL, 1986, JAMA-J AM MED ASSOC, V255, P2062, DOI 10.1001/jama.255.15.2062; USALA SJ, 1989, J REPROD MED, V34, P292; VANKOOIJ RJ, 1980, FERTIL STERIL, V34, P226; Walker J, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-35; White HD, 1997, J IMMUNOL, V158, P3017; Wiggins R, 2009, J CLIN MICROBIOL, V47, P1824, DOI 10.1128/JCM.00005-09	25	10	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2014	9	1							e85263	10.1371/journal.pone.0085263	http://dx.doi.org/10.1371/journal.pone.0085263			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301BI	24475042	Green Published, gold			2022-12-25	WOS:000330507300019
J	Naznin, HA; Kiyohara, D; Kimura, M; Miyazawa, M; Shimizu, M; Hyakumachi, M				Naznin, Hushna Ara; Kiyohara, Daigo; Kimura, Minako; Miyazawa, Mitsuo; Shimizu, Masafumi; Hyakumachi, Mitsuro			Systemic Resistance Induced by Volatile Organic Compounds Emitted by Plant Growth-Promoting Fungi in Arabidopsis thaliana	PLOS ONE			English	Article							ZOYSIAGRASS RHIZOSPHERE; BACTERIAL VOLATILES; POWDERY MILDEW; INDUCTION; PATHOGEN; CUCUMBER; PROTEIN; ACTIVATION; DISEASES; DEFENSE	Volatile organic compounds (VOC) were extracted and identified from plant growth-promoting fungi (PGPF), Phoma sp., Cladosporium sp. and Ampelomyces sp., using gas chromatography-mass spectrometry (GC-MS). Among the three VOC extracted, two VOC blends (emitted from Ampelomyces sp. and Cladosporium sp.) significantly reduced disease severity in Arabidopsis plants against Pseudomonas syringae pv. tomato DC3000 (Pst). Subsequently, m-cresol and methyl benzoate (MeBA) were identified as major active volatile compounds from Ampelomyces sp. and Cladosporium sp., respectively, and found to elicit induced systemic resistance (ISR) against the pathogen. Molecular signaling for disease suppression by the VOC were investigated by treating different mutants and transgenic Arabidopsis plants impaired in salicylic acid (SA) or Jasmonic acid (JA)/ethylene (ET) signaling pathways with m-cresol and MeBA followed by challenge inoculation with Pst. Results show that the level of protection was significantly lower when JA/ET-impaired mutants were treated with MeBA, and in SA-, and JA/ET-disrupted mutants after m-cresol treatment, indicating the involvement of these signal transduction pathways in the ISR primed by the volatiles. Analysis of defense-related genes by real-time qRT-PCR showed that both the SA-and JA-signaling pathways combine in the m-cresol signaling of ISR, whereas MeBA is mainly involved in the JA-signaling pathway with partial recruitment of SA-signals. The ET-signaling pathway was not employed in ISR by the volatiles. Therefore, this study identified two novel volatile components capable of eliciting ISR that may be promising candidates in biological control strategy to protect plants from diseases.	[Naznin, Hushna Ara] Gifu Univ, United Grad Sch Agr Sci, Gifu, Japan; [Kiyohara, Daigo; Kimura, Minako; Shimizu, Masafumi; Hyakumachi, Mitsuro] Gifu Univ, Fac Appl Biol Sci, Plant Pathol Lab, Gifu, Japan; [Miyazawa, Mitsuo] Kinki Univ, Fac Sci & Engn, Dept Appl Chem, Higashiosaka, Osaka 577, Japan	Gifu University; Gifu University; Kindai University (Kinki University)	Hyakumachi, M (corresponding author), Gifu Univ, Fac Appl Biol Sci, Plant Pathol Lab, Gifu, Japan.	hyakumac@gifu-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology (MONBUKAGAKUSHO), Japan	Ministry of Education, Culture, Sports, Science and Technology (MONBUKAGAKUSHO), Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by the Ministry of Education, Culture, Sports, Science and Technology (MONBUKAGAKUSHO), Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHMAD JS, 1988, CAN J MICROBIOL, V34, P229, DOI 10.1139/m88-043; CAO H, 1994, PLANT CELL, V6, P1583, DOI 10.1105/tpc.6.11.1583; Chandanie WA, 2006, PLANT SOIL, V286, P209, DOI 10.1007/s11104-006-9038-y; Chao QM, 1997, CELL, V89, P1133, DOI 10.1016/S0092-8674(00)80300-1; Durrant WE, 2004, ANNU REV PHYTOPATHOL, V42, P185, DOI 10.1146/annurev.phyto.42.040803.140421; Elad Y, 1998, BIOCONTROL, V43, P241, DOI 10.1023/A:1009919417481; Farag MA, 2006, PHYTOCHEMISTRY, V67, P2262, DOI 10.1016/j.phytochem.2006.07.021; Farmer EE, 2001, NATURE, V411, P854, DOI 10.1038/35081189; FUJIWARA T, 1992, PLANT PHYSIOL, V99, P263, DOI 10.1104/pp.99.1.263; Gilardi G, 2008, J PLANT DIS PROTECT, V115, P208, DOI 10.1007/BF03356265; Heil M, 2000, J ECOL, V88, P645, DOI 10.1046/j.1365-2745.2000.00479.x; Hossain MM, 2007, PLANT CELL PHYSIOL, V48, P1724, DOI 10.1093/pcp/pcm144; Hyakumachi M., 1994, Soil Microorganisms, P53; Kai M, 2009, APPL MICROBIOL BIOT, V81, P1001, DOI 10.1007/s00253-008-1760-3; Kishimoto K, 2006, PLANT SCI, V170, P715, DOI 10.1016/j.plantsci.2005.11.002; Kiss L, 2003, PEST MANAG SCI, V59, P475, DOI 10.1002/ps.689; Koike N, 2001, EUR J PLANT PATHOL, V107, P523, DOI 10.1023/A:1011203826805; Lawton K, 1995, MOL PLANT MICROBE IN, V8, P863, DOI 10.1094/MPMI-8-0863; Lee BR, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0039425, 10.1371/journal.pone.0048744]; Li QL, 2010, POSTHARVEST BIOL TEC, V58, P157, DOI 10.1016/j.postharvbio.2010.06.003; MATHUR M, 1981, ANGEW BOT, V55, P75; MEERA MS, 1994, PHYTOPATHOLOGY, V84, P1399, DOI 10.1094/Phyto-84-1399; Miyazawa M, 2008, J OLEO SCI, V57, P585, DOI 10.5650/jos.57.585; MORRIS JA, 1979, J AM OIL CHEM SOC, V56, P595, DOI 10.1007/BF02660245; Naznin HA, 2013, MICROBES ENVIRON, V28, P42, DOI 10.1264/jsme2.ME12085; Pieterse CMJ, 1998, PLANT CELL, V10, P1571, DOI 10.1105/tpc.10.9.1571; ROBERTS MS, 1977, J PHARM PHARMACOL, V29, P677, DOI 10.1111/j.2042-7158.1977.tb11434.x; Ryu CM, 2004, PLANT PHYSIOL, V134, P1017, DOI 10.1104/pp.103.026583; Shivanna M.B., 2005, MICROBES ENVIRON, V20, P34, DOI [10.1264/jsme2.20.34, DOI 10.1264/JSME2.20.34]; Shivanna MB, 1996, CROP PROT, V15, P497, DOI 10.1016/0261-2194(96)00004-X; SHIVANNA MB, 1994, CAN J MICROBIOL, V40, P637, DOI 10.1139/m94-101; Song GC, 2013, INT J MOL SCI, V14, P9803, DOI 10.3390/ijms14059803; STASWICK PE, 1992, P NATL ACAD SCI USA, V89, P6837, DOI 10.1073/pnas.89.15.6837; Sultana F, 2009, PLANT BIOLOGY, V11, P97, DOI 10.1111/j.1438-8677.2008.00142.x; Sultana F, 2008, CAN J PLANT PATHOL, V30, P196, DOI 10.1080/07060661.2008.10540535; Suzuki Y, 2004, BIOTECHNIQUES, V37, P542, DOI 10.2144/04374BM03; Toda T, 1999, BIOSCI BIOTECH BIOCH, V63, P210, DOI 10.1271/bbb.63.210; Wan MG, 2008, BIOL CONTROL, V46, P552, DOI 10.1016/j.biocontrol.2008.05.015; Yamagiwa Y, 2011, J GEN PLANT PATHOL, V77, P336, DOI 10.1007/s10327-011-0340-z; Yoshioka Y, 2012, PEST MANAG SCI, V68, P60, DOI 10.1002/ps.2220	40	101	104	6	90	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2014	9	1							e86882	10.1371/journal.pone.0086882	http://dx.doi.org/10.1371/journal.pone.0086882			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301BI	24475190	Green Published, Green Submitted, gold			2022-12-25	WOS:000330507300113
J	Yang, AX; Chong, NJ; Jiang, YF; Catalano, J; Puri, RK; Khleif, SN				Yang, Amy X.; Chong, Numju; Jiang, Yufei; Catalano, Jennifer; Puri, Raj K.; Khleif, Samir N.			Molecular Characterization of Antigen-Peptide Pulsed Dendritic Cells: Immature Dendritic Cells Develop a Distinct Molecular Profile when Pulsed with Antigen Peptide	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; OLIGONUCLEOTIDE MICROARRAYS; INTERFERON-GAMMA; GENE-EXPRESSION; CERVICAL-CANCER; TUMOR-ANTIGEN; IN-VITRO; MATURATION; INDUCTION; IMMUNITY	As dendritic cells (DCs) are the most potent professional antigen-presenting cells, they are being tested as cancer vaccines for immunotherapy of established cancers. Although numerous studies have characterized DCs by their phenotype and function, few have identified potential molecular markers of antigen presentation prior to vaccination of host. In this study we generated pre-immature DC (piDC), immature DC (iDC), and mature DC (mDC) from human peripheral blood monocytes (PBMC) obtained from HLA-A2 healthy donors, and pulsed them with human papillomavirus E7 peptide (p11-20), a class I HLA-A2 binding antigen. We then characterized DCs for cell surface phenotype and gene expression profile by microarray technology. We identified a set of 59 genes that distinguished three differentiation stages of DCs (piDC, iDC and mDC). When piDC, iDC and mDC were pulsed with E7 peptide for 2 hrs, the surface phenotype did not change, however, iDCs rather than mDCs showed transcriptional response by up-regulation of a set of genes. A total of 52 genes were modulated in iDC upon antigen pulsing. Elongation of pulse time for iDCs to 10 and 24 hrs did not significantly bring further changes in gene expression. The E7 peptide up-modulated immune response (KPNA7, IGSF6, NCR3, TREM2, TUBAL3, IL8, NFKBIA), pro-apoptosis (BTG1, SEMA6A, IGFBP3 and SRGN), anti-apoptosis (NFKBIA), DNA repair (MRPS11, RAD21, TXNRD1), and cell adhesion and cell migration genes (EPHA1, PGF, IL8 and CYR61) in iDCs. We confirmed our results by Q-PCR analysis. The E7 peptide but not control peptide (PADRE) induced up-regulation of NFKB1A gene only in HLA-A2 positive iDCs and not in HLA-A2 negative iDCs. These results suggest that E7 up-regulation of genes is specific and HLA restricted and that these genes may represent markers of antigen presentation and help rapidly assess the quality of dendritic cells prior to administration to the host.	[Yang, Amy X.; Catalano, Jennifer; Puri, Raj K.] US FDA, Tumor Vaccines & Biotechnol Branch, Div Cellular & Gene Therapies, Ctr Biol Evaluat & Res, Bethesda, MD 20014 USA; [Chong, Numju; Jiang, Yufei; Khleif, Samir N.] NCI, Vaccine Branch, Bethesda, MD 20892 USA; [Khleif, Samir N.] Georgia Regent Univ, Ctr Canc, Augusta, GA USA	US Food & Drug Administration (FDA); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University System of Georgia; Augusta University	Puri, RK (corresponding author), US FDA, Tumor Vaccines & Biotechnol Branch, Div Cellular & Gene Therapies, Ctr Biol Evaluat & Res, Bethesda, MD 20014 USA.	raj.puri@fda.hhs.gov	jiang, yu/HGU-0029-2022					Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Banchereau J, 2005, NAT REV IMMUNOL, V5, P296, DOI 10.1038/nri1592; Beatty P, 2012, ONCOIMMUNOLOGY, V1, P263, DOI 10.4161/onci.18950; Carlos CA, 2005, J IMMUNOL, V175, P1628, DOI 10.4049/jimmunol.175.3.1628; Cascio S, 2011, J BIOL CHEM, V286, P42248, DOI 10.1074/jbc.M111.297630; CAUX C, 1992, NATURE, V360, P258, DOI 10.1038/360258a0; Cools N, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-49; Dietz AB, 2000, BIOCHEM BIOPH RES CO, V275, P731, DOI 10.1006/bbrc.2000.3372; Han J, 2005, GENOMICS, V86, P252, DOI 10.1016/j.ygeno.2005.04.009; Han TH, 2009, J IMMUNOTHER, V32, P399, DOI 10.1097/CJI.0b013e31819e1773; Jin P, 2010, J TRANSL MED, V8, DOI 10.1186/1479-5876-8-4; Jonuleit H, 1997, EUR J IMMUNOL, V27, P3135, DOI 10.1002/eji.1830271209; Le Naour F, 2001, J BIOL CHEM, V276, P17920, DOI 10.1074/jbc.M100156200; Lindstedt M, 2002, INT IMMUNOL, V14, P1203, DOI 10.1093/intimm/dxf082; McIlroy D, 2005, J LEUKOCYTE BIOL, V78, P794, DOI 10.1189/jlb.0105029; Messmer D, 2003, INT IMMUNOL, V15, P491, DOI 10.1093/intimm/dxg052; Moschella F, 2001, BRIT J HAEMATOL, V114, P444, DOI 10.1046/j.1365-2141.2001.02953.x; Murakami M, 1999, CANCER RES, V59, P1184; SALLUSTO F, 1994, J EXP MED, V179, P1109, DOI 10.1084/jem.179.4.1109; Santin AD, 1999, J VIROL, V73, P5402, DOI 10.1128/JVI.73.7.5402-5410.1999; Schlom J, 2012, JNCI-J NATL CANCER I, V104, P599, DOI 10.1093/jnci/djs033; Soumelis V, 2006, EUR J IMMUNOL, V36, P2286, DOI 10.1002/eji.200636026; Tsukui T, 1996, CANCER RES, V56, P3967; Tureci O, 2003, FASEB J, V17, P836, DOI 10.1096/fj.02-0724com; Welters MJP, 2008, CLIN CANCER RES, V14, P178, DOI 10.1158/1078-0432.CCR-07-1880; Yang AX, 2006, MOL BIOTECHNOL, V34, P303, DOI 10.1385/MB:34:3:303	26	11	12	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2014	9	1							e86306	10.1371/journal.pone.0086306	http://dx.doi.org/10.1371/journal.pone.0086306			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301BI	24475103	gold, Green Published, Green Submitted			2022-12-25	WOS:000330507300052
J	Cuypers, K; Thijs, H; Meesen, RLJ				Cuypers, Koen; Thijs, Herbert; Meesen, Raf L. J.			Optimization of the Transcranial Magnetic Stimulation Protocol by Defining a Reliable Estimate for Corticospinal Excitability	PLOS ONE			English	Article							MOTOR-EVOKED-POTENTIALS; LONGITUDINAL DATA-ANALYSIS; BRAIN-STIMULATION; MUSCLE; CORTEX; VARIABILITY; RESPONSES; OUTPUT; AGE	The goal of this study was to optimize the transcranial magnetic stimulation (TMS) protocol for acquiring a reliable estimate of corticospinal excitability (CSE) using single-pulse TMS. Moreover, the minimal number of stimuli required to obtain a reliable estimate of CSE was investigated. In addition, the effect of two frequently used stimulation intensities [110% relative to the resting motor threshold (rMT) and 120% rMT] and gender was evaluated. Thirty-six healthy young subjects (18 males and 18 females) participated in a double-blind crossover procedure. They received 2 blocks of 40 consecutive TMS stimuli at either 110% rMT or 120% rMT in a randomized order. Based upon our data, we advise that at least 30 consecutive stimuli are required to obtain the most reliable estimate for CSE. Stimulation intensity and gender had no significant influence on CSE estimation. In addition, our results revealed that for subjects with a higher rMT, fewer consecutive stimuli were required to reach a stable estimate of CSE. The current findings can be used to optimize the design of similar TMS experiments.	[Cuypers, Koen; Meesen, Raf L. J.] Hasselt Univ, Fac Med & Life Sci, REVAL Rehabil Res Ctr, Biomed Res Inst, Diepenbeek, Belgium; [Cuypers, Koen; Meesen, Raf L. J.] Katholieke Univ Leuven, Motor Control Lab, Res Ctr Movement Control & Neuroplast, Dept Biomed Kinesiol,Grp Biomed Sci, Heverlee, Belgium; [Thijs, Herbert] Hasselt Univ, Interuniv Inst Biostat & Stat Bioinformat, BioStat 1, Diepenbeek, Belgium; [Thijs, Herbert] Univ Louvain, Interuniv Inst Biostat & Stat Bioinformat, BioStat 1, Louvain, Belgium	Hasselt University; KU Leuven; Hasselt University; Hasselt University	Meesen, RLJ (corresponding author), Hasselt Univ, Fac Med & Life Sci, REVAL Rehabil Res Ctr, Biomed Res Inst, Diepenbeek, Belgium.	raf.meesen@uhasselt.be	Meesen, Raf L/F-2582-2019; Cuypers, Koen/N-9918-2018	Meesen, Raf L/0000-0002-7938-3758; 	Flanders Fund for Scientific Research [G075810]; Special Research Fund UHasselt	Flanders Fund for Scientific Research(FWO); Special Research Fund UHasselt	This work is supported by the Flanders Fund for Scientific Research (G075810). Koen Cuypers is supported by the Special Research Fund UHasselt. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BRASILNETO JP, 1992, J CLIN NEUROPHYSIOL, V9, P132, DOI 10.1097/00004691-199201000-00014; Buccolieri A, 2004, J PHYSIOL-LONDON, V558, P685, DOI 10.1113/jphysiol.2004.064774; Choudhury KR, 2011, IRISH J MED SCI, V180, P873, DOI 10.1007/s11845-011-0722-4; Christie A, 2007, J NEUROSCI METH, V164, P320, DOI 10.1016/j.jneumeth.2007.05.011; Cuypers K, 2013, NEUROSCI LETT; Darling WG, 2006, EXP BRAIN RES, V174, P376, DOI 10.1007/s00221-006-0468-9; Ellaway PH, 1998, ELECTROMYOGR MOTOR C, V109, P104, DOI 10.1016/S0924-980X(98)00007-1; Ferreri F, 2003, ANN NEUROL, V53, P102, DOI 10.1002/ana.10416; Fujiyama H, 2012, J COGNITIVE NEUROSCI, V24, P1253, DOI 10.1162/jocn_a_00201; Funase K, 1999, NEUROSCI LETT, V271, P25, DOI 10.1016/S0304-3940(99)00467-X; Grupe DW, 2013, NAT REV NEUROSCI, V14, P488, DOI 10.1038/nrn3524; HESS CW, 1987, J PHYSIOL-LONDON, V388, P397, DOI 10.1113/jphysiol.1987.sp016621; Julkunen P, 2009, NEUROIMAGE, V44, P790, DOI 10.1016/j.neuroimage.2008.09.040; Jung NH, 2010, BRAIN STIMUL, V3, P87, DOI 10.1016/j.brs.2009.10.003; KIERS L, 1993, ELECTROEN CLIN NEURO, V89, P415, DOI 10.1016/0168-5597(93)90115-6; KOKATE TG, 1994, J PHARMACOL EXP THER, V270, P1223; LAN NC, 1994, HORM BEHAV, V28, P537, DOI 10.1006/hbeh.1994.1052; Levin O, 2011, NEUROSCI LETT, V487, P53, DOI 10.1016/j.neulet.2010.09.072; Lewis GN, 2013, CLIN NEUROPHYSIOL; LIANG KY, 1986, BIOMETRIKA, V73, P13, DOI 10.1093/biomet/73.1.13; Magistris MR, 1999, BRAIN, V122, P265, DOI 10.1093/brain/122.2.265; Magistris MR, 1998, BRAIN, V121, P437, DOI 10.1093/brain/121.3.437; Mantovani A, 2013, PSYCHIAT RES; Mars RB, 2007, EXP BRAIN RES, V182, P125, DOI 10.1007/s00221-007-1055-4; Meesen RLJ, 2011, HUM BRAIN MAPP, V32, P872, DOI 10.1002/hbm.21075; MEYER BU, 1991, ELECTROEN CLIN NEURO, V81, P38, DOI 10.1016/0168-5597(91)90102-4; Nielsen JF, 1996, J CLIN NEUROPHYSIOL, V13, P423, DOI 10.1097/00004691-199609000-00005; Nitsche MA, 2005, J PHYSIOL-LONDON, V568, P291, DOI 10.1113/jphysiol.2005.092429; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Pennisi G, 2002, CLIN NEUROPHYSIOL, V113, P1536, DOI 10.1016/S1388-2457(02)00255-9; Pitcher JB, 2003, J PHYSIOL-LONDON, V546, P605, DOI 10.1113/jphysiol.2002.029454; Rosler KM, 2002, CLIN NEUROPHYSIOL, V113, P1680, DOI 10.1016/S1388-2457(02)00263-8; Sahota Preeti, 2005, Neurol India, V53, P197; Smith AE, 2011, J APPL PHYSIOL, V110, P206, DOI 10.1152/japplphysiol.00403.2010; Smith MJ, 1999, NEUROLOGY, V53, P2069, DOI 10.1212/WNL.53.9.2069; Smith MJ, 2002, ANN NEUROL, V51, P599, DOI 10.1002/ana.10180; Taylor JL, 2001, MUSCLE NERVE, V24, P18, DOI 10.1002/1097-4598(200101)24:1<18::AID-MUS2>3.3.CO;2-4; Vaalto S, 2011, HUM BRAIN MAPP, V32, P1692, DOI 10.1002/hbm.21137; Veniero D, 2013, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00352; Wassermann EM, 2002, CLIN NEUROPHYSIOL, V113, P1165, DOI 10.1016/S1388-2457(02)00144-X; Wassermann EM, 1998, EVOKED POTENTIAL, V108, P1, DOI 10.1016/S0168-5597(97)00096-8; ZEGER SL, 1986, BIOMETRICS, V42, P121, DOI 10.2307/2531248	42	49	49	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2014	9	1							e86380	10.1371/journal.pone.0086380	http://dx.doi.org/10.1371/journal.pone.0086380			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	298QQ	24475111	Green Published, Green Submitted, gold			2022-12-25	WOS:000330339800041
J	Boyero, L; Cardinale, BJ; Bastian, M; Pearson, RG				Boyero, Luz; Cardinale, Bradley J.; Bastian, Mikis; Pearson, Richard G.			Biotic vs. Abiotic Control of Decomposition: A Comparison of the Effects of Simulated Extinctions and Changes in Temperature	PLOS ONE			English	Article							ECOSYSTEM FUNCTION; LITTER DECOMPOSITION; BIODIVERSITY LOSS; DIVERSITY; RICHNESS; RESPONSES; STREAMS; EVENNESS; GROWTH	The loss of species is known to have significant effects on ecosystem functioning, but only recently has it been recognized that species loss might rival the effects of other forms of environmental change on ecosystem processes. There is a need for experimental studies that explicitly manipulate species richness and environmental factors concurrently to determine their relative impacts on key ecosystem processes such as plant litter decomposition. It is crucial to understand what factors affect the rate of plant litter decomposition and the relative magnitude of such effects because the rate at which plant litter is lost and transformed to other forms of organic and inorganic carbon determines the capacity for carbon storage in ecosystems and the rate at which greenhouse gasses such as carbon dioxide are outgassed. Here we compared how an increase in water temperature of 5 degrees C and loss of detritivorous invertebrate and plant litter species affect decomposition rates in a laboratory experiment simulating stream conditions. Like some prior studies, we found that species identity, rather than species richness per se, is a key driver of decomposition, but additionally we showed that the loss of particular species can equal or exceed temperature change in its impact on decomposition. Our results indicate that the loss of particular species can be as important a driver of decomposition as substantial temperature change, but also that predicting the relative consequences of species loss and other forms of environmental change on decomposition requires knowledge of assemblages and their constituent species' ecology and ecophysiology.	[Boyero, Luz] CSIC, Donana Biol Stn, Wetland Ecol Dept, E-41080 Seville, Spain; [Boyero, Luz; Bastian, Mikis; Pearson, Richard G.] James Cook Univ, Sch Marine & Trop Biol, Townsville, Qld 4811, Australia; [Cardinale, Bradley J.] Univ Michigan, Sch Nat Resources & Environm, Ann Arbor, MI 48109 USA; [Pearson, Richard G.] James Cook Univ, TropWater, Townsville, Qld 4811, Australia	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Biologica de Donana (EBD); James Cook University; University of Michigan System; University of Michigan; James Cook University	Boyero, L (corresponding author), Univ Basque Country UPV EHU, Fac Sci & Technol, Leioa, Spain.	luz.boyero@ehu.es	Boyero, Luz/N-1719-2019; Pearson, Richard/GQH-2760-2022; Boyero, Luz/L-5822-2014; Cardinale, Bradley J/I-7076-2013	Boyero, Luz/0000-0001-7366-9299; Boyero, Luz/0000-0001-7366-9299; Pearson, Richard/0000-0001-6047-031X	MINECO [CGL2010-16285]; James Cook University	MINECO(Spanish Government); James Cook University	The study was funded by project CGL2010-16285 from the Spanish Ministry for Science and Innovation (currently MINECO) to LB, and internal research grants from James Cook University to LB and RGP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balvanera P, 2006, ECOL LETT, V9, P1146, DOI 10.1111/j.1461-0248.2006.00963.x; Bastian M, 2008, AUSTRAL ECOL, V33, P301, DOI 10.1111/j.1442-9993.2007.01817.x; Bastian M, 2007, J TROP ECOL, V23, P219, DOI 10.1017/S0266467406003920; Beer C, 2010, SCIENCE, V329, P834, DOI 10.1126/science.1184984; Boyero L, 2006, MAR FRESHWATER RES, V57, P201, DOI 10.1071/MF05052; Boyero L, 2007, ECOL RES, V22, P551, DOI 10.1007/s11284-006-0303-6; Boyero L, 2011, ECOL LETT, V14, P289, DOI 10.1111/j.1461-0248.2010.01578.x; Brown JH, 2004, ECOLOGY, V85, P1771, DOI 10.1890/03-9000; Bruder A, 2011, FUNCT ECOL, V25, P1269, DOI 10.1111/j.1365-2435.2011.01903.x; Cardinale BJ, 2006, NATURE, V443, P989, DOI 10.1038/nature05202; Cardinale BJ, 2012, NATURE, V486, P59, DOI 10.1038/nature11148; Cardinale BJ, 2011, AM J BOT, V98, P572, DOI 10.3732/ajb.1000364; CEBRIAN J, 1995, SCIENCE, V268, P1606, DOI 10.1126/science.268.5217.1606; Cheshire K, 2005, FRESHWATER BIOL, V50, P748, DOI 10.1111/j.1365-2427.2005.01355.x; Davidson EA, 2006, NATURE, V440, P165, DOI 10.1038/nature04514; Ellis PD, 2010, ESSENTIAL GUIDE TO EFFECT SIZES: STATISTICAL POWER, META-ANALYSIS AND THE INTERPRETATION OF RESEARCH RESULTS, P1; Ferreira V, 2012, FRESHW SCI, V31, P945, DOI 10.1899/11-062.1; Fugere V, 2012, J ANIMAL ECOLOGY; Gessner MO, 2010, TRENDS ECOL EVOL, V25, P372, DOI 10.1016/j.tree.2010.01.010; Graca MAS, 2001, INT REV HYDROBIOL, V86, P383, DOI 10.1002/1522-2632(200107)86:4/5<383::AID-IROH383>3.0.CO;2-D; Hector Andy, 2009, P94; Heimann M, 2008, NATURE, V451, P289, DOI 10.1038/nature06591; Hooper DU, 2012, NATURE, V486, P105, DOI 10.1038/nature11118; IRONS JG, 1994, FRESHWATER BIOL, V32, P401, DOI 10.1111/j.1365-2427.1994.tb01135.x; Kominoski JS, 2009, FRESHWATER BIOL, V54, P1461, DOI 10.1111/j.1365-2427.2009.02196.x; McKie BG, 2008, J ANIM ECOL, V77, P495, DOI 10.1111/j.1365-2656.2008.01357.x; Mckie BG, 2009, OECOLOGIA, V160, P757, DOI 10.1007/s00442-009-1336-7; Perkins DM, 2010, ADV ECOL RES, V43, P177, DOI 10.1016/S0065-2504(10)43005-6; Reich PB, 2001, NATURE, V410, P809, DOI 10.1038/35071062; Reiss J, 2011, J ANIM ECOL, V80, P1145, DOI 10.1111/j.1365-2656.2011.01857.x; Ruesink JL, 2001, OIKOS, V93, P221, DOI 10.1034/j.1600-0706.2001.930206.x; Solomon S, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P1; Srivastava DS, 2009, ECOLOGY, V90, P1073, DOI 10.1890/08-0439.1; Srivastava DS, 2005, ANNU REV ECOL EVOL S, V36, P267, DOI 10.1146/annurev.ecolsys.36.102003.152636; Swan CM, 2006, OECOLOGIA, V147, P469, DOI 10.1007/s00442-005-0297-8; TILMAN D, 1992, OECOLOGIA, V89, P257, DOI 10.1007/BF00317226; Tilman D, 2012, P NATL ACAD SCI USA, V109, P10394, DOI 10.1073/pnas.1208240109; Wolfe R, 2002, CAN MED ASSOC J, V166, P65	38	22	23	0	72	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2014	9	1							e87426	10.1371/journal.pone.0087426	http://dx.doi.org/10.1371/journal.pone.0087426			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297XI	24466351	Green Published, gold, Green Accepted, Green Submitted			2022-12-25	WOS:000330288000207
J	Feraille, E; Dizin, E; Roth, I; Derouette, JP; Szanto, I; Martin, PY; de Seigneux, S; Hasler, U				Feraille, Eric; Dizin, Eva; Roth, Isabelle; Derouette, Jean-Paul; Szanto, Ildiko; Martin, Pierre-Yves; de Seigneux, Sophie; Hasler, Udo			NADPH Oxidase 4 Deficiency Reduces Aquaporin-2 mRNA Expression in Cultured Renal Collecting Duct Principal Cells via Increased PDE3 and PDE4 Activity	PLOS ONE			English	Article							NF-KAPPA-B; PROTEIN-KINASE-A; LONG-TERM REGULATION; SMOOTH-MUSCLE-CELLS; REACTIVE OXYGEN; SODIUM-TRANSPORT; INDUCED ACTIVATION; REDOX REGULATION; NAD(P)H OXIDASE; AQP2 EXPRESSION	The final control of renal water reabsorption occurs in the collecting duct (CD) and relies on regulated expression of aquaporin-2 (AQP2) in principal CD cells. AQP2 transcription is primarily induced by type 2 vasopressin receptor (V2R)-cAMP-protein kinase A (PKA) signaling but also by other factors, including TonEBP and NF-kappa B. NAPDH oxidase 4 (NOX4) represents a major source of reactive oxygen species (ROS) in the kidney. Because NOX-derived ROS may alter PKA, TonEBP and NF-kappa B activity, we examined the effects of NOX4 depletion on AQP2 expression. Depleted NOX4 expression by siRNA (siNOX4) in mpkCCD(cl4) cells attenuated increased AQP2 mRNA expression by arginine vasopressin (AVP) but not by hypertonicity, which induces both TonEBP and NF-kappa B activity. AVP-induced AQP2 expression was similarly decreased by the flavoprotein inhibitor diphenyleneiodonium. siNOX4 altered neither TonEBP nor NF-kappa B activity but attenuated AVP-inducible cellular cAMP concentration, PKA activity and CREB phosphorylation as well as AQP2 mRNA expression induced by forskolin, a potent activator of adenylate cyclase. The repressive effect of siNOX4 on AVP-induced AQP2 mRNA expression was abolished by the non-selective phosphodiesterase (PDE) inhibitor 3-isobutyl-1-methylxanthine (IBMX) and was significantly decreased by selective PDE antagonists cilostamide and rolipram, but not vinpocetine, which respectively target PDE3, PDE4 and PDE1. Thus, by inhibiting PDE3 and PDE4 activity NOX4-derived ROS may contribute to V2R-cAMP-PKA signaling and enhance AQP2 transcription.	[Feraille, Eric; Dizin, Eva; Roth, Isabelle; Derouette, Jean-Paul; Szanto, Ildiko; Hasler, Udo] Univ Med Ctr, Dept Cellular Physiol, Geneva, Switzerland; [Feraille, Eric; Dizin, Eva; Roth, Isabelle; Derouette, Jean-Paul; Szanto, Ildiko; Hasler, Udo] Univ Med Ctr, Dept Metab, Geneva, Switzerland; [Martin, Pierre-Yves; de Seigneux, Sophie] Univ Geneva, Dept Med Specialties, Serv Nephrol, Geneva, Switzerland; [Szanto, Ildiko] Univ Geneva, Dept Med Specialties, Serv Endocrinol Diabetol Hypertens & Nutr, Geneva, Switzerland	University of Geneva; University of Geneva; University of Geneva; University of Geneva	Hasler, U (corresponding author), Univ Med Ctr, Dept Cellular Physiol, Geneva, Switzerland.	Udo.Hasler@unige.ch	Szanto, Ildiko/F-5856-2011	Szanto, Ildiko/0000-0003-3566-7991; Feraille, Eric/0000-0003-1656-8365	Swiss National Science Foundation [31003A_138408/1]; Foundation Novartis pour la Recherche en Sciences Medico-Biologiques; Fondation Ernest Boninchi; Fondation Schmidheiny; Amgen	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Foundation Novartis pour la Recherche en Sciences Medico-Biologiques; Fondation Ernest Boninchi; Fondation Schmidheiny; Amgen(Amgen)	This work was supported by a Swiss National Science Foundation Grant 31003A_138408/1 and grants from the Foundation Novartis pour la Recherche en Sciences Medico-Biologiques, Fondation Ernest Boninchi, Fondation Schmidheiny and Amgen to UH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Babelova A, 2012, FREE RADICAL BIO MED, V53, P842, DOI 10.1016/j.freeradbiomed.2012.06.027; Babilonia E, 2007, J AM SOC NEPHROL, V18, P2037, DOI 10.1681/ASN.2006121333; Bedard K, 2007, PHYSIOL REV, V87, P245, DOI 10.1152/physrev.00044.2005; BengisGarber C, 1996, CELL SIGNAL, V8, P291, DOI 10.1016/0898-6568(96)00052-6; Bens M, 1999, J AM SOC NEPHROL, V10, P923; Bokoch GM, 2003, TRENDS BIOCHEM SCI, V28, P502, DOI 10.1016/S0968-0004(03)00194-4; Bouley R, 2005, AM J PHYSIOL-RENAL, V288, pF1103, DOI 10.1152/ajprenal.00337.2004; Brown DI, 2009, FREE RADICAL BIO MED, V47, P1239, DOI 10.1016/j.freeradbiomed.2009.07.023; Bustamante M, 2008, J AM SOC NEPHROL, V19, P109, DOI 10.1681/ASN.2007010092; Cai Q, 2010, AM J PHYSIOL-RENAL, V299, pF712, DOI 10.1152/ajprenal.00690.2009; Carranza ML, 1996, AM J PHYSIOL-CELL PH, V271, pC136, DOI 10.1152/ajpcell.1996.271.1.C136; Chapman AB, 2007, J AM SOC NEPHROL, V18, P1399, DOI 10.1681/ASN.2007020155; Cheng JF, 2007, EXP BIOL MED, V232, P38; Dousa TP, 1999, KIDNEY INT, V55, P29, DOI 10.1046/j.1523-1755.1999.00233.x; ECELBARGER CA, 1995, AM J PHYSIOL-RENAL, V269, pF663, DOI 10.1152/ajprenal.1995.269.5.F663; Fenton RA, 2006, J MEMBRANE BIOL, V212, P119, DOI 10.1007/s00232-006-0871-y; Fenton RA, 2002, AM J PHYSIOL-RENAL, V282, pF630, DOI 10.1152/ajprenal.00264.2001; Gaeggeler HP, 2005, J AM SOC NEPHROL, V16, P878, DOI 10.1681/ASN.2004121110; Geiszt M, 2000, P NATL ACAD SCI USA, V97, P8010, DOI 10.1073/pnas.130135897; Hasler U, 2006, AM J PHYSIOL-RENAL, V290, pF177, DOI 10.1152/ajprenal.00056.2005; Hasler U, 2005, J AM SOC NEPHROL, V16, P1571, DOI 10.1681/ASN.2004110930; Hasler U, 2002, J BIOL CHEM, V277, P10379, DOI 10.1074/jbc.M111880200; Hasler U, 2008, J BIOL CHEM, V283, P28095, DOI 10.1074/jbc.M801071200; Hasler U, 2006, J AM SOC NEPHROL, V17, P1521, DOI 10.1681/ASN.2005121317; Hasler U, 2009, AM J PHYSIOL-RENAL, V297, pF10, DOI 10.1152/ajprenal.00053.2009; Hasler U, 2009, AM J PHYSIOL-CELL PH, V296, pC641, DOI 10.1152/ajpcell.00655.2008; Hoare GS, 1999, AM J PHYSIOL-HEART C, V277, pH1975, DOI 10.1152/ajpheart.1999.277.5.H1975; Hocherl K, 2010, AM J PHYSIOL-RENAL, V298, pF196, DOI 10.1152/ajprenal.90607.2008; Hozawa S, 1996, AM J PHYSIOL-CELL PH, V270, pC1695, DOI 10.1152/ajpcell.1996.270.6.C1695; Katsuyama M, 2012, J CLIN BIOCHEM NUTR, V50, P9, DOI 10.3164/jcbn.11-06SR; Khodo SN, 2012, J AM SOC NEPHROL, V23, P1967, DOI 10.1681/ASN.2012040373; Kleniewska P, 2012, ARCH IMMUNOL THER EX, V60, P277, DOI 10.1007/s00005-012-0176-z; Kortenoeven MLA, 2012, AM J PHYSIOL-RENAL, V302, pF1395, DOI 10.1152/ajprenal.00376.2011; Lambeth JD, 2004, NAT REV IMMUNOL, V4, P181, DOI 10.1038/nri1312; Li N, 2012, DIABETES, V61, P2842, DOI 10.2337/db12-0009; Li Q, 2009, ANTIOXID REDOX SIGN, V11, P1249, DOI 10.1089/ARS.2008.2407; Lyle AN, 2009, CIRC RES, V105, P249, DOI 10.1161/CIRCRESAHA.109.193722; Markadieu N, 2009, AM J PHYSIOL-RENAL, V296, pF1428, DOI 10.1152/ajprenal.90397.2008; Masamune A, 2008, AM J PHYSIOL-GASTR L, V294, pG99, DOI 10.1152/ajpgi.00272.2007; Matsumura Y, 1997, J AM SOC NEPHROL, V8, P861; Muzaffar S, 2011, EUR J PHARMACOL, V658, P187, DOI 10.1016/j.ejphar.2011.02.020; Nakayama Y, 2000, J BIOL CHEM, V275, P38275, DOI 10.1074/jbc.M004678200; Nedvetsky Pavel I, 2009, Handb Exp Pharmacol, P133, DOI 10.1007/978-3-540-79885-9_6; Nguyen MV, 2013, BIOCH PHARM; Nielsen J, 2006, AM J PHYSIOL-RENAL, V290, pF438, DOI 10.1152/ajprenal.00158.2005; Nielsen S, 2002, PHYSIOL REV, V82, P205, DOI 10.1152/physrev.00024.2001; Paravicini TM, 2008, DIABETES CARE, V31, pS170, DOI 10.2337/dc08-s247; Parker R, 2007, MOL CELL, V25, P635, DOI 10.1016/j.molcel.2007.02.011; Radin MJ, 2012, VET CLIN PATH, V41, P455, DOI 10.1111/j.1939-165x.2012.00488.x; Robert-Nicoud M, 2001, P NATL ACAD SCI USA, V98, P2712, DOI 10.1073/pnas.051603198; Roth I, 2010, MOL BIOL CELL, V21, P3459, DOI 10.1091/mbc.E10-02-0133; Schenk LK, 2012, J AM SOC NEPHROL, V23, P1008, DOI 10.1681/ASN.2011070738; Schreck C, 2011, AM J PHYSIOL-REG I, V300, pR1023, DOI 10.1152/ajpregu.00618.2010; Sedeek M, 2010, AM J PHYSIOL-RENAL, V299, pF1348, DOI 10.1152/ajprenal.00028.2010; Serrander L, 2007, BIOCHEM J, V406, P105, DOI 10.1042/BJ20061903; STAR RA, 1988, J CLIN INVEST, V81, P1879, DOI 10.1172/JCI113534; Sun Y, 1996, FREE RADICAL BIO MED, V21, P335, DOI 10.1016/0891-5849(96)00109-8; Terris J, 1995, AM J PHYSIOL-RENAL, V269, pF775, DOI 10.1152/ajprenal.1995.269.6.F775; Torres VE, 2004, NEPHRON EXP NEPHROL, V98, pE1, DOI 10.1159/000079926; Umenishi F, 2006, BBA-BIOMEMBRANES, V1758, P1100, DOI 10.1016/j.bbamem.2006.06.001; Wilson JL, 2013, CLIN EXP NEPHROL; Yao H, 2007, BIOCHEM SOC T, V35, P1151, DOI 10.1042/BST0351151; Yasui M, 1997, AM J PHYSIOL-RENAL, V272, pF443, DOI 10.1152/ajprenal.1997.272.4.F443; Yu MJ, 2009, P NATL ACAD SCI US; Zhou XM, 2006, AM J PHYSIOL-RENAL, V290, pF1169, DOI 10.1152/ajprenal.00378.2005	65	21	21	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2014	9	1							e87239	10.1371/journal.pone.0087239	http://dx.doi.org/10.1371/journal.pone.0087239			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297XI	24466344	Green Published, gold, Green Submitted			2022-12-25	WOS:000330288000201
J	Hatori, A; Yui, J; Xie, L; Yamasaki, T; Kumata, K; Fujinaga, M; Wakizaka, H; Ogawa, M; Nengaki, N; Kawamura, K; Zhang, MR				Hatori, Akiko; Yui, Joji; Xie, Lin; Yamasaki, Tomoteru; Kumata, Katsushi; Fujinaga, Masayuki; Wakizaka, Hidekatsu; Ogawa, Masanao; Nengaki, Nobuki; Kawamura, Kazunori; Zhang, Ming-Rong			Visualization of Acute Liver Damage Induced by Cycloheximide in Rats Using PET with [F-18]FEDAC, a Radiotracer for Translocator Protein (18 kDa)	PLOS ONE			English	Article							BENZODIAZEPINE-RECEPTOR; APOPTOSIS; EXPRESSION; MECHANISM	Liver damage induced by drug toxicity is an important concern for both medical doctors and patients. The aim of this study was to noninvasively visualize acute liver damage using positron emission tomography (PET) with N-benzyl-N-methyl-2-[7,8-dihydro-7-(2-[18 F]fluoroethyl)-8-oxo-2-phenyl-9H-purin-9-yl] acetamide ([F-18]FEDAC), a radiotracer specific for translocator protein (18 kDa, TSPO) as a biomarker for inflammation, and to determine cellular sources enriching TSPO expression in the liver. A mild acute liver damage model was prepared by a single intraperitoneal injection of cycloheximide (CHX) into rats. Treatment with CHX induced apoptosis and necrotic changes in hepatocytes with slight neutrophil infiltration. The uptake of radioactivity in the rat livers was measured with PET after injection of [F-18]FEDAC. The uptake of [F-18]FEDAC increased in livers damaged from treatment with CHX compared to the controls. Presence of TSPO was examined in the liver tissue using quantitative reverse transcriptase-polymerase chain reaction and immunohistochemical assays. mRNA expression of TSPO was elevated in the damaged livers compared to the controls, and the level was correlated with the [F-18]FEDAC uptake and severity of damage. TSPO expression in the damaged liver sections was mainly found in macrophages (Kupffer cells) and neutrophils, but not in hepatocytes. The elevation of TSPO mRNA expression was derived from the increase of the number of macrophages with TSPO and neutrophils with TSPO in damaged livers. From this study we considered that PET imaging with [F-18]FEDAC represented the mild liver damage through the enhanced TSPO signal in inflammatory cells. We conclude that this method may be a useful tool for diagnosis in early stage of acute liver damage.	[Hatori, Akiko; Yui, Joji; Xie, Lin; Yamasaki, Tomoteru; Kumata, Katsushi; Fujinaga, Masayuki; Wakizaka, Hidekatsu; Ogawa, Masanao; Nengaki, Nobuki; Kawamura, Kazunori; Zhang, Ming-Rong] Natl Inst Radiol Sci, Mol Imaging Ctr, Chiba 260, Japan	National Institutes for Quantum Science & Technology	Zhang, MR (corresponding author), Natl Inst Radiol Sci, Mol Imaging Ctr, Chiba 260, Japan.	zhang@nirs.go.jp		, Lin/0000-0002-6472-322X	Grants-in-Aid for Scientific Research [24790543] Funding Source: KAKEN	Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))		Boll DT, 2009, RADIOGRAPHICS, V29, P1591, DOI 10.1148/rg.296095513; BOUWENS L, 1986, HEPATOLOGY, V6, P718, DOI 10.1002/hep.1840060430; Bribes E, 2004, J HISTOCHEM CYTOCHEM, V52, P19, DOI 10.1177/002215540405200103; CANAT X, 1993, LIFE SCI, V52, P107, DOI 10.1016/0024-3205(93)90293-C; Canbay A, 2003, HEPATOLOGY, V38, P1188, DOI 10.1053/jhep.2003.50472; Dahle MK, 2004, INFECT IMMUN, V72, P5704, DOI 10.1128/IAI.72.10.5704-5711.2004; Dhirapong A, 2013, HEPATOLOGY, V57, P708, DOI 10.1002/hep.26067; FAA G, 1994, LIVER, V14, P270; Giatzakis C, 2004, ENDOCRINOLOGY, V145, P1113, DOI 10.1210/en.2003-1330; Hatori A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045065; Higami Y, 2000, MUTAT RES-FUND MOL M, V457, P105, DOI 10.1016/S0027-5107(00)00132-9; Ito K, 2006, TOXICOLOGY, V219, P175, DOI 10.1016/j.tox.2005.11.017; Ji B, 2008, J NEUROSCI, V28, P12255, DOI 10.1523/JNEUROSCI.2312-08.2008; Kumagai K, 2009, TOXICOL PATHOL, V37, P536, DOI 10.1177/0192623309336153; Kurosaka K, 2001, CELL IMMUNOL, V211, P1, DOI 10.1006/cimm.2001.1824; Lammert C, 2010, HEPATOLOGY, V51, P615, DOI 10.1002/hep.23317; Lewis James H, 2012, Gastroenterol Hepatol (N Y), V8, P333; M'Kada H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042418; Marino G, 2001, Curr Gastroenterol Rep, V3, P38, DOI 10.1007/s11894-001-0039-y; Papadopoulos V, 2006, TRENDS PHARMACOL SCI, V27, P402, DOI 10.1016/j.tips.2006.06.005; Proctor WR, 2013, HEPATOLOGY, V57, P2026, DOI 10.1002/hep.26196; Racanelli V, 2006, HEPATOLOGY, V43, pS54, DOI 10.1002/hep.21060; Scarf AM, 2011, J NUCL MED, V52, P667, DOI 10.2967/jnumed.110.086629; SLEYSTER EC, 1982, LAB INVEST, V47, P484; Trojan J, 1999, AM J GASTROENTEROL, V94, P3314, DOI 10.1111/j.1572-0241.1999.01544.x; Weber LWD, 2003, CRIT REV TOXICOL, V33, P105, DOI 10.1080/713611034; Woods MJ, 1996, BIOCHEM PHARMACOL, V51, P1283, DOI 10.1016/0006-2952(96)00034-2; Xie L, 2012, J HEPATOL, V57, P1076, DOI 10.1016/j.jhep.2012.07.002; Yokoyama Y, 2006, J GASTROEN HEPATOL, V21, P1567, DOI 10.1111/j.1440-1746.2006.04460.x; Yui J, 2010, J NUCL MED, V51, P1301, DOI 10.2967/jnumed.109.072223	30	24	25	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2014	9	1							e86625	10.1371/journal.pone.0086625	http://dx.doi.org/10.1371/journal.pone.0086625			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297XI	24466178	Green Submitted, Green Published, gold			2022-12-25	WOS:000330288000123
J	Shepard, SS; Davis, CT; Bahl, J; Rivailler, P; York, IA; Donis, RO				Shepard, Samuel S.; Davis, C. Todd; Bahl, Justin; Rivailler, Pierre; York, Ian A.; Donis, Ruben O.			LABEL: Fast and Accurate Lineage Assignment with Assessment of H5N1 and H9N2 Influenza A Hemagglutinins	PLOS ONE			English	Article							MULTIPLE SEQUENCE ALIGNMENT; MAXIMUM-LIKELIHOOD; MUTATION-RATES; SOUTHERN CHINA; EVOLUTION; VIRUS; CLASSIFICATION; CIRCULATION; PLACEMENT; EMERGENCE	The evolutionary classification of influenza genes into lineages is a first step in understanding their molecular epidemiology and can inform the subsequent implementation of control measures. We introduce a novel approach called Lineage Assignment By Extended Learning (LABEL) to rapidly determine cladistic information for any number of genes without the need for time-consuming sequence alignment, phylogenetic tree construction, or manual annotation. Instead, LABEL relies on hidden Markov model profiles and support vector machine training to hierarchically classify gene sequences by their similarity to pre-defined lineages. We assessed LABEL by analyzing the annotated hemagglutinin genes of highly pathogenic (H5N1) and low pathogenicity (H9N2) avian influenza A viruses. Using the WHO/FAO/OIE H5N1 evolution working group nomenclature, the LABEL pipeline quickly and accurately identified the H5 lineages of uncharacterized sequences. Moreover, we developed an updated clade nomenclature for the H9 hemagglutinin gene and show a similarly fast and reliable phylogenetic assessment with LABEL. While this study was focused on hemagglutinin sequences, LABEL could be applied to the analysis of any gene and shows great potential to guide molecular epidemiology activities, accelerate database annotation, and provide a data sorting tool for other large-scale bioinformatic studies.	[Shepard, Samuel S.; Davis, C. Todd; Rivailler, Pierre; York, Ian A.; Donis, Ruben O.] Ctr Dis Control & Prevent, Influenza Div, Atlanta, GA 30333 USA; [Bahl, Justin] Duke NUS Grad Med Sch, Program Emerging Infect Dis, Lab Virus Evolut, Singapore, Singapore; [Bahl, Justin] Univ Texas Sch Publ Hlth, Ctr Infect Dis, Houston, TX USA	Centers for Disease Control & Prevention - USA; National University of Singapore; University of Texas System; University of Texas Health Science Center Houston; University of Texas School Public Health	Shepard, SS (corresponding author), Ctr Dis Control & Prevent, Influenza Div, Atlanta, GA 30333 USA.	vfn4@cdc.gov; rvd6@cdc.gov	York, Ian/X-9351-2019; Bahl, Justin/A-4728-2011	York, Ian/0000-0002-3478-3344; Bahl, Justin/0000-0001-7572-4300				Aubin JT, 2005, EMERG INFECT DIS, V11, P1515; Ben-Hur A, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000173; Berger SA, 2011, SYST BIOL, V60, P291, DOI 10.1093/sysbio/syr010; Brown IH, 2009, INFLUENZA OTHER RESP, V3, P59, DOI 10.1111/j.1750-2659.2009.00078.x; Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199; Chen H, 2005, NATURE, V436, P191, DOI 10.1038/nature03974; Eddy SR, 1998, BIOINFORMATICS, V14, P755, DOI 10.1093/bioinformatics/14.9.755; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; FAO, 2012, H5N1 HPAI GLOB OV; Fox J, 2011, R COMPANION APPL REG, Vxxii; Franc V, 2005, THESIS CZECH TU PRAG; Fusaro A, 2011, J VIROL, V85, P8413, DOI 10.1128/JVI.00219-11; Ge FF, 2009, J CLIN MICROBIOL, V47, P3294, DOI 10.1128/JCM.00355-09; Gower JC, 1980, CURRENT CONTENTS AGR, V14-14; Graf A. B. A., 2001, Pattern Recognition. 23rd DAGM Symposium. Proceedings (Lecture Notes in Computer Science Vol.2191), P277; Han J., 2011, DATA MINING CONCEPTS, V2nd; Jackwood MW, 2007, AVIAN DIS, V51, P448, DOI 10.1637/7536-032706R.1; Karplus K, 1998, BIOINFORMATICS, V14, P846, DOI 10.1093/bioinformatics/14.10.846; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Kayali G, 2011, EMERG INFECT DIS, V17, P2306, DOI 10.3201/eid1712.110683; Kovacova A, 2002, VIRUS GENES, V24, P57, DOI 10.1023/A:1014038120979; Lee YJ, 2007, VIROLOGY, V359, P313, DOI 10.1016/j.virol.2006.09.025; Li KS, 2004, NATURE, V430, P209, DOI 10.1038/nature02746; Li KS, 2003, J VIROL, V77, P6988, DOI 10.1128/JVI.77.12.6988-6994.2003; Lu G, 2007, OPTIONS CONTROL INFL; Matsen FA, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-538; McHardy AC, 2007, NAT METHODS, V4, P63, DOI 10.1038/NMETH976; Mi HY, 2010, NUCLEIC ACIDS RES, V38, pD204, DOI 10.1093/nar/gkp1019; Moon HJ, 2010, ARCH VIROL, V155, P229, DOI 10.1007/s00705-009-0577-4; Nelson MI, 2007, NAT REV GENET, V8, P196, DOI 10.1038/nrg2053; Neumann G, 2010, J GEN VIROL, V91, P1984, DOI 10.1099/vir.0.020750-0; Nobusawa E, 2006, J VIROL, V80, P3675, DOI 10.1128/JVI.80.7.3675-3678.2006; OIE, 2012, OUTBR HIGHL PATH AV; Pandit A, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-S1-S26; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Parks DH, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-328; PARVIN JD, 1986, J VIROL, V59, P377, DOI 10.1128/JVI.59.2.377-383.1986; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; R Core Team, 2021, R LANG ENV STAT COMP; Read I, 2007, INTERSPEECH 2007: 8TH ANNUAL CONFERENCE OF THE INTERNATIONAL SPEECH COMMUNICATION ASSOCIATION, VOLS 1-4, P2085; Russell CA, 2008, SCIENCE, V320, P340, DOI 10.1126/science.1154137; Schweikert G, 2009, GENOME RES, V19, P2133, DOI 10.1101/gr.090597.108; Shepard SS, 2012, NUCLEIC ACIDS RES, V40, P4765, DOI 10.1093/nar/gks154; Smith GJD, 2006, P NATL ACAD SCI USA, V103, P16936, DOI 10.1073/pnas.0608157103; Smith GJD, 2006, VIROLOGY, V350, P258, DOI 10.1016/j.virol.2006.03.048; Smith GJD, 2012, INFLUENZA OTHER RESP, V6, P1, DOI 10.1111/j.1750-2659.2011.00298.x; Sonnenburg S, 2010, J MACH LEARN RES, V11, P1799; Squires RB, 2012, INFLUENZA OTHER RESP, V6, P404, DOI 10.1111/j.1750-2659.2011.00331.x; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Nguyen T, 2012, VIROLOGY, V432, P405, DOI 10.1016/j.virol.2012.06.021; Vijaykrishna D, 2011, NATURE, V473, P519, DOI 10.1038/nature10004; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; WHO, 2010, ANT GEN CHAR INFL A; WHO, 2012, CUM NUMB CONF HUM CA; WHO/OIE/FAO H5N1 Evolution Working Group, 2008, Emerg Infect Dis, V14, pe1, DOI 10.3201/eid1407.071681; Xu KM, 2007, J VIROL, V81, P10389, DOI 10.1128/JVI.00979-07	56	22	22	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2014	9	1							e86921	10.1371/journal.pone.0086921	http://dx.doi.org/10.1371/journal.pone.0086921			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297XI	24466291	gold, Green Published, Green Submitted			2022-12-25	WOS:000330288000172
J	El-Serafi, I; Abedi-Valugerdi, M; Potacova, Z; Afsharian, P; Mattsson, J; Moshfegh, A; Hassan, M				El-Serafi, Ibrahim; Abedi-Valugerdi, Manuchehr; Potacova, Zuzana; Afsharian, Parvaneh; Mattsson, Jonas; Moshfegh, Ali; Hassan, Moustapha			Cyclophosphamide Alters the Gene Expression Profile in Patients Treated with High Doses Prior to Stem Cell Transplantation	PLOS ONE			English	Article							TOTAL-BODY IRRADIATION; C-JUN; POSTTRANSPLANTATION CYCLOPHOSPHAMIDE; ALLELE FREQUENCIES; CYCLE PROGRESSION; DENDRITIC CELLS; CANCER; PROTEIN; LEUKEMIA; APOPTOSIS	Background: Hematopoietic stem cell transplantation is a curative treatment for several haematological malignancies. However, treatment related morbidity and mortality still is a limiting factor. Cyclophosphamide is widely used in condition regimens either in combination with other chemotherapy or with total body irradiation. Methods: We present the gene expression profile during cyclophosphamide treatment in 11 patients conditioned with cyclophosphamide for 2 days followed by total body irradiation prior to hematopoietic stem cell transplantation. 299 genes were identified as specific for cyclophosphamide treatment and were arranged into 4 clusters highly down-regulated genes, highly up-regulated genes, early up-regulated but later normalized genes and moderately up-regulated genes. Results: Cyclophosphamide treatment down-regulated expression of several genes mapped to immune/autoimmune activation and graft rejection including CD3, CD28, CTLA4, MHC II, PRF1, GZMB and IL-2R, and up-regulated immune-related receptor genes, e. g. IL1R2, IL18R1, and FLT3. Moreover, a high and significant expression of ANGPTL1 and c-JUN genes was observed independent of cyclophosphamide treatment. Conclusion: This is the first investigation to provide significant information about alterations in gene expression following cyclophosphamide treatment that may increase our understanding of the cyclophosphamide mechanism of action and hence, in part, avoid its toxicity. Furthermore, ANGPTL1 remained highly expressed throughout the treatment and, in contrast to several other alkylating agents, cyclophosphamide did not influence c-JUN expression.	[El-Serafi, Ibrahim; Abedi-Valugerdi, Manuchehr; Potacova, Zuzana; Afsharian, Parvaneh; Hassan, Moustapha] Karolinska Inst, Dept Lab Med, Clin Res Ctr KFC, Expt Canc Med ECM, Stockholm, Sweden; [Potacova, Zuzana; Hassan, Moustapha] Karolinska Univ Hosp Huddinge, Clin Res Ctr Novum, Stockholm, Sweden; [Afsharian, Parvaneh] Royan Inst, Dept Genet, Tehran, Iran; [Mattsson, Jonas] Karolinska Univ Hosp Huddinge, Ctr Allogene Stem Cell Transplantat, Stockholm, Sweden; [Mattsson, Jonas] Karolinska Univ Hosp, Karolinska Inst, Dept Therapeut Immunol, Stockholm, Sweden; [Moshfegh, Ali] Karolinska Inst, Dept Oncol Pathol, Canc Ctr Karolinska CCK, Stockholm, Sweden	Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet	Hassan, M (corresponding author), Karolinska Inst, Dept Lab Med, Clin Res Ctr KFC, Expt Canc Med ECM, Stockholm, Sweden.	moustapha.hassan@ki.se	Hassan, Moustapha/H-9260-2015	Hassan, Moustapha/0000-0003-1927-5859; Abedi-Valugerdi, Manuchehr/0000-0002-4122-2879; El-Serafi, Ibrahim/0000-0002-0463-1518; Mattsson, Jonas/0000-0002-2163-6644	Swedish Cancer Society; Swedish Childhood Cancer Foundation	Swedish Cancer Society(Swedish Cancer Society); Swedish Childhood Cancer Foundation(European Commission)	The authors wish to acknowledge the Swedish Cancer Society and the Swedish Childhood Cancer Foundation for their support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bashey A, 2013, J CLIN ONCOL, V31, P1310, DOI 10.1200/JCO.2012.44.3523; Binotto G, 2003, ONCOLOGY-BASEL, V65, P17, DOI 10.1159/000073353; BOS JL, 1989, CANCER RES, V49, P4682; Burt RK, 2008, JAMA-J AM MED ASSOC, V299, P925, DOI 10.1001/jama.299.8.925; Cao J, 2013, BMC IMMUNOL, V14, DOI 10.1186/1471-2172-14-39; CHANG TKH, 1993, CANCER RES, V53, P5629; Chatenoud L, 2007, NAT REV IMMUNOL, V7, P622, DOI 10.1038/nri2134; Cho JY, 2004, DRUG METAB DISPOS, V32, P1341, DOI 10.1124/dmd.104.001107; Colombo S, 2005, PHARMACOGENET GENOM, V15, P599, DOI 10.1097/01.fpc.0000172241.42546.d3; Dale M, 1999, GENOMICS, V57, P177, DOI 10.1006/geno.1999.5767; Daleboudt GMN, 2013, LUPUS, V22, P171, DOI 10.1177/0961203312469261; de Jonge HJM, 2011, NETH J MED, V69, P167; El Omari K, 2011, BLOOD, V117, P2146, DOI 10.1182/blood-2010-07-293357; Eroglu C, 2013, LEUKEMIA LYMPHOMA, V54, P2474, DOI 10.3109/10428194.2013.779691; Goodsell DS, 1999, STEM CELLS, V17, P235, DOI 10.1002/stem.170235; Gurzov EN, 2008, ONCOGENE, V27, P641, DOI 10.1038/sj.onc.1210690; Jiao XM, 2010, J BIOL CHEM, V285, P8218, DOI 10.1074/jbc.M110.100792; Kaufman A, 2009, DIABETES-METAB RES, V25, P302, DOI 10.1002/dmrr.933; Kearsey SE, 1998, BBA-GENE STRUCT EXPR, V1398, P113, DOI 10.1016/S0167-4781(98)00033-5; Khokher S, 2013, ASIAN PAC J CANCER P, V14, P3223, DOI 10.7314/APJCP.2013.14.5.3223; Klein K, 2005, PHARMACOGENET GENOM, V15, P861, DOI 10.1097/01213011-200512000-00004; Kollmann K, 2011, BLOOD, V117, P4065, DOI 10.1182/blood-2010-07-299644; Kuo TC, 2013, J CLIN INVEST, V123, P1082, DOI 10.1172/JCI64044; Le DT, 2012, CANCER RES, V72, P3439, DOI 10.1158/0008-5472.CAN-11-3912; Lopez JA, 2013, BLOOD, V121, P2659, DOI 10.1182/blood-2012-07-446146; Luznik L, 2012, SEMIN ONCOL, V39, P683, DOI 10.1053/j.seminoncol.2012.09.005; Luznik L, 2010, IMMUNOL RES, V47, P65, DOI 10.1007/s12026-009-8139-0; Magistrelli G, 1999, EUR J IMMUNOL, V29, P3596, DOI 10.1002/(SICI)1521-4141(199911)29:11<3596::AID-IMMU3596>3.0.CO;2-Y; Mantovani A, 2003, INT ARCH ALLERGY IMM, V132, P109, DOI 10.1159/000073711; Martino A, 2001, J IMMUNOL, V166, P1723, DOI 10.4049/jimmunol.166.3.1723; Matias BF, 2013, CLIN MED INSIGHTS-ON, V7, P165, DOI 10.4137/CMO.S12268; McCormack MP, 2010, CELL CYCLE, V9, P2267, DOI 10.4161/cc.9.12.12074; McCormack MP, 2010, SCIENCE, V327, P879, DOI 10.1126/science.1182378; Mills KI, 2008, FRONT BIOSCI-LANDMRK, V13, P4605, DOI 10.2741/3026; Moschella F, 2013, CLIN CANCER RES, V19, P4249, DOI 10.1158/1078-0432.CCR-12-3666; Moschella F, 2011, CANCER RES, V71, P3528, DOI 10.1158/0008-5472.CAN-10-4523; PRZEPIORKA D, 1995, BONE MARROW TRANSPL, V15, P825; Remberger M, 2013, CLIN TRANSPLANT, V27, pE368, DOI 10.1111/ctr.12131; Ren S, 1997, CANCER RES, V57, P4229; REYNOLDS M, 1989, EUR J HAEMATOL, V43, P314; Rimsza LM, 2008, BLOOD, V112, P3425, DOI 10.1182/blood-2008-02-137372; RINGDEN O, 1993, BLOOD, V81, P1094; RITKE MK, 1994, BIOCHEM PHARMACOL, V48, P525, DOI 10.1016/0006-2952(94)90282-8; Rosado CJ, 2007, SCIENCE, V317, P1548, DOI 10.1126/science.1144706; ROSNET O, 1993, BLOOD, V82, P1110, DOI 10.1182/blood.V82.4.1110.bloodjournal8241110; RUBIN E, 1992, CANCER RES, V52, P878; Schreiber M, 1999, GENE DEV, V13, P607, DOI 10.1101/gad.13.5.607; SLADEK NE, 1988, PHARMACOL THERAPEUT, V37, P301, DOI 10.1016/0163-7258(88)90004-6; Smith LM, 1999, ONCOGENE, V18, P6063, DOI 10.1038/sj.onc.1202989; SOUDAIS C, 1993, NAT GENET, V3, P77, DOI 10.1038/ng0193-77; Szabo E, 1996, CANCER RES, V56, P305; Ting JPY, 2002, CELL, V109, pS21, DOI 10.1016/S0092-8674(02)00696-7; Trapani JA, 1995, AUST NZ J MED, V25, P793, DOI 10.1111/j.1445-5994.1995.tb02883.x; Tsuchiya K, 2004, BIOCHEM BIOPH RES CO, V319, P1322, DOI 10.1016/j.bbrc.2004.05.116; Vleugel MM, 2006, HUM PATHOL, V37, P668, DOI 10.1016/j.humpath.2006.01.022; WATERHOUSE P, 1995, SCIENCE, V270, P985, DOI 10.1126/science.270.5238.985; Wennerberg K, 2005, J CELL SCI, V118, P843, DOI 10.1242/jcs.01660; Wisdom R, 1999, EMBO J, V18, P188, DOI 10.1093/emboj/18.1.188; Xia Y, 2013, J BIOL CHEM, V288, P19321, DOI 10.1074/jbc.M113.475442; Xie HJ, 2006, EUR J PHARM SCI, V27, P54, DOI 10.1016/j.ejps.2005.08.008; Zhang HS, 2012, J BIOL CHEM, V287, P44164, DOI 10.1074/jbc.M112.401521; Zhang Y, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-145; Zhou J, 2002, J BIOL CHEM, V277, P17200, DOI 10.1074/jbc.M110369200	63	8	8	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2014	9	1							e86619	10.1371/journal.pone.0086619	http://dx.doi.org/10.1371/journal.pone.0086619			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297VL	24466173	Green Submitted, gold, Green Published			2022-12-25	WOS:000330283100190
J	Teng, CLJ; Yu, JT; Chen, YH; Lin, CH; Hwang, WL				Teng, Chieh-Lin Jerry; Yu, Jui-Ting; Chen, Yi-Huei; Lin, Ching-Heng; Hwang, Wen-Li			Early Colonoscopy Confers Survival Benefits on Colon Cancer Patients with Pre-Existing Iron Deficiency Anemia: A Nationwide Population-Based Study	PLOS ONE			English	Article							COLORECTAL-CANCER; STAGE-II; MORTALITY; RISK; MICROMETASTASES; FLUOROURACIL; LEUCOVORIN; SYMPTOMS; COHORT	This study aimed to examine the prognostic significance of pre-existing iron deficiency anemia (IDA) and the benefits of early colonoscopy in patients with colon cancer, since these have not been clearly established to date. Using the Taiwanese National Health Insurance Research Database, we retrieved and retrospectively reviewed the records of patients aged >= 55 years who were diagnosed with colon cancer between 2000 and 2005. The patient cohort was divided into two groups: patients with (n = 1,260) or without (n = 15,912) an IDA diagnosis during <= 18 months preceding the date of colon cancer diagnosis. We found that diabetes (27.9% vs. 20.3%, p<0.0001), cardiovascular disease (61.6% vs. 54.7%, p<0.001), and chronic kidney disease (4.6% vs. 2.2%, p<0.0001) were more common among patients with IDA than among those without IDA. The median overall survival times for patients with IDA and those without IDA were 4.6 and 5.7 years, respectively (p = 0.002). Patients who underwent colonoscopy <= 30 days, 31-90, and >= 91 days after IDA diagnosis showed median overall survival times of 5.79, 4.43, and 4.04 years, respectively (p = 0.003). Delayed colonoscopy was an independent factor associated with poor overall survival (adjusted hazard ratio, 1.28; 95% confidence interval, 1.07-1.53; p = 0.01). In conclusion, colon cancer patients with IDA were more likely to experience comorbidities than were those without IDA. Pre-existing IDA was a poor prognostic factor in adult men and postmenopausal women who had colon cancer. Early colonoscopy could improve overall survival possibly by facilitating early diagnosis and treatment.	[Teng, Chieh-Lin Jerry; Yu, Jui-Ting; Hwang, Wen-Li] Taichung Vet Gen Hosp, Div Hematol Med Oncol, Dept Med, Taichung, Taiwan; [Teng, Chieh-Lin Jerry] Chung Shan Med Univ, Dept Med, Taichung, Taiwan; [Teng, Chieh-Lin Jerry] Tunghai Univ, Dept Life Sci, Taichung 40704, Taiwan; [Chen, Yi-Huei; Lin, Ching-Heng] Taichung Vet Gen Hosp, Dept Med Res, Taichung, Taiwan	Taichung Veterans General Hospital; Chung Shan Medical University; Tunghai University; Taichung Veterans General Hospital	Lin, CH (corresponding author), Taichung Vet Gen Hosp, Dept Med Res, Taichung, Taiwan.	epid@vghtc.gov.tw; kevinhwl@gmail.com			Taichung Veterans General Hospital; Tunghai University [TCVGH-T1027802, TCVGH-T1017802]	Taichung Veterans General Hospital; Tunghai University	This study was partially funded by research cooperative program of Taichung Veterans General Hospital and Tunghai University (TCVGH-T1027802 and TCVGH-T1017802) for laboratory maintenance. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allegra CJ, 2009, J CLIN ONCOL, V27, P2091, DOI 10.1200/JCO.2009.21.9170; Andre T, 2009, J CLIN ONCOL, V27, P3109, DOI 10.1200/JCO.2008.20.6771; Atkin WS, 2010, LANCET, V375, P1624, DOI 10.1016/S0140-6736(10)60551-X; Ben-Ishay O, 2013, WORLD J GASTRO SURG, V5, P104, DOI 10.4240/wjgs.v5.i4.104; Ezekowitz JA, 2003, CIRCULATION, V107, P223, DOI 10.1161/01.CIR.0000052622.51963.FC; Faerden AE, 2011, DIS COLON RECTUM, V54, P200, DOI 10.1007/DCR.0b013e3181fd4c7c; Guralnik JM, 2004, BLOOD, V104, P2263, DOI 10.1182/blood-2004-05-1812; Hamdani U, 2013, WORLD J GASTROENTERO, V19, P3596, DOI 10.3748/wjg.v19.i23.3596; Hurwitz H, 2004, NEW ENGL J MED, V350, P2335, DOI 10.1056/NEJMoa032691; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Korsgaard M, 2006, COLORECTAL DIS, V8, P688, DOI 10.1111/j.1463-1318.2006.01014.x; Kronborg O, 1996, LANCET, V348, P1467, DOI 10.1016/S0140-6736(96)03430-7; Lawler PR, 2013, AM HEART J, V165, P143, DOI 10.1016/j.ahj.2012.10.024; Liefers GJ, 1998, NEW ENGL J MED, V339, P223, DOI 10.1056/NEJM199807233390403; Lin CH, 2013, J INTERN MED, V273, P102, DOI 10.1111/joim.12000; Maringe C, 2013, ACTA ONCOL, V52, P919, DOI 10.3109/0284186X.2013.764008; Mehdi U, 2009, DIABETES CARE, V32, P1320, DOI 10.2337/dc08-0779; Stapley S, 2006, BRIT J CANCER, V95, P1321, DOI 10.1038/sj.bjc.6603439; Stevens PE, 2012, J RENAL CARE, V38, P67, DOI 10.1111/j.1755-6686.2012.00281.x; Teng CLJ, 2013, ANN HEMATOL, V92, P301, DOI 10.1007/s00277-012-1627-7; Thomas MC, 2006, DIABETIC MED, V23, P502, DOI 10.1111/j.1464-5491.2006.01829.x; Weiner DE, 2004, J AM SOC NEPHROL, V15, P1307, DOI 10.1097/01.ASN.0000123691.46138.E2	22	12	12	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2014	9	1							e86714	10.1371/journal.pone.0086714	http://dx.doi.org/10.1371/journal.pone.0086714			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297VL	24466209	Green Published, gold, Green Submitted			2022-12-25	WOS:000330283100201
J	Lange, L; Vaeggemose, A; Kidmose, P; Mikkelsen, E; Uldbjerg, N; Johansen, P				Lange, Lasse; Vaeggemose, Anders; Kidmose, Preben; Mikkelsen, Eva; Uldbjerg, Niels; Johansen, Peter			Velocity and Directionality of the Electrohysterographic Signal Propagation	PLOS ONE			English	Article							INTERSTITIAL-CELLS; PRETERM DELIVERY; UTERINE ACTIVITY; ELECTRICAL-ACTIVITY; HUMAN UTERUS; LABOR; TERM; CONTRACTIONS; MYOMETRIUM; PREGNANCY	Objective: The initiation of treatment for women with threatening preterm labor requires effective distinction between true and false labor. The electrohysterogram (EHG) has shown great promise in estimating and classifying uterine activity. However, key issues remain unresolved and no clinically usable method has yet been presented using EHG. Recent studies have focused on the propagation velocity of the EHG signals as a potential discriminator between true and false labor. These studies have estimated the propagation velocity of individual spikes of the EHG signals. We therefore focus on estimating the propagation velocity of the entire EHG burst recorded during a contraction in two dimensions. Study Design: EHG measurements were performed on six women in active labor at term, and a total of 35 contractions were used for the estimation of propagation velocity. The measurements were performed using a 16-channel two-dimensional electrode grid. The estimates were calculated with a maximum-likelihood approach. Results: The estimated average propagation velocity was 2.18 (+/- 0.68) cm/s. No single preferred direction of propagation was found. Conclusion: The propagation velocities estimated in this study are similar to those reported in other studies but with a smaller intra-and inter-patient variation. Thus a potential tool has been established for further studies on true and false labor contractions.	[Lange, Lasse; Vaeggemose, Anders; Kidmose, Preben; Johansen, Peter] Aarhus Univ, Fac Sci & Technol, Dept Engn, Aarhus, Denmark; [Mikkelsen, Eva; Uldbjerg, Niels] Aarhus Univ Hosp, Dept Obstet & Gynecol, DK-8000 Aarhus, Denmark	Aarhus University; Aarhus University	Lange, L (corresponding author), Aarhus Univ, Fac Sci & Technol, Dept Engn, Aarhus, Denmark.	lasse_lange@hotmail.com	Uldbjerg, Niels/O-2038-2016; Kidmose, Preben/M-7285-2018	Uldbjerg, Niels/0000-0002-6449-6426; Kidmose, Preben/0000-0001-8628-8057				Bailey JJ, 2004, J ELECTROCARDIOL, V37, P71, DOI 10.1016/j.jelectrocard.2004.08.020; Beck S, 2010, B WORLD HEALTH ORGAN, V88, P31, DOI 10.2471/BLT.08.062554; Buhimschi C, 1997, OBSTET GYNECOL, V90, P102, DOI 10.1016/S0029-7844(97)83837-9; Caldeyro-Barcia R, 1952, J OBSTET GYN BR COMM, V59, P646; Challis JRG, 2001, ANN NY ACAD SCI, V943, P225, DOI 10.1111/j.1749-6632.2001.tb03804.x; Ciontea SM, 2005, J CELL MOL MED, V9, P407, DOI 10.1111/j.1582-4934.2005.tb00366.x; Coad J, 2001, ANATOMY PHYSL MIDWIV; Danforth DN, 1977, OBSTET GYNECOLOGY; Denney JM, 2008, WOMENS HEALTH, V4, P625, DOI 10.2217/17455057.4.6.625; Duquette RA, 2005, BIOL REPROD, V72, P276, DOI 10.1095/biolreprod.104.033506; Euliano TY, 2009, AM J OBSTET GYNECOL, V200, DOI 10.1016/j.ajog.2008.09.008; Garfield RE, 2005, AM J OBSTET GYNECOL, V193, P23, DOI 10.1016/j.ajog.2005.01.050; Goldenberg RL, 2002, OBSTET GYNECOL, V100, P1020, DOI 10.1016/S0029-7844(02)02212-3; Haran G, 2012, AM J OBSTET GYNECOL, V206, pE1, DOI 10.1016/j.ajog.2012.03.021; Jacod BC, 2010, J MATERN-FETAL NEO M, V23, P17, DOI 10.3109/14767050903156668; KILARSKI WM, 1993, FOLIA HISTOCHEM CYTO, V31, P155; Lagarias JC, 1998, SIAM J OPTIMIZ, V9, P112, DOI 10.1137/S1052623496303470; Lammers WJEP, 2008, AM J PHYSIOL-REG I, V294, pR919, DOI 10.1152/ajpregu.00704.2007; Leman H, 1999, IEEE T BIO-MED ENG, V46, P1222, DOI 10.1109/10.790499; Lucovnik M, 2011, AM J OBSTET GYNECOL, V204, DOI 10.1016/j.ajog.2010.09.024; Lucovnik M, 2011, ACTA OBSTET GYN SCAN, V90, P150, DOI 10.1111/j.1600-0412.2010.01031.x; Maner WL, 2003, OBSTET GYNECOL, V101, P1254, DOI 10.1016/S0029-7844(03)00341-7; Marque Catherine K, 2007, BMC Pregnancy Childbirth, V7 Suppl 1, pS5, DOI 10.1186/1471-2393-7-S1-S5; Martin Joyce A, 2011, Natl Vital Stat Rep, V60, P1; Mikkelsen E, 2013, ACTA OBSTET GYN SCAN, V92, P1070, DOI 10.1111/aogs.12190; MILLER SM, 1989, AM J PHYSIOL, V256, pC130, DOI 10.1152/ajpcell.1989.256.1.C130; Owen J, 2009, AM J OBSTET GYNECOL, V201, DOI 10.1016/j.ajog.2009.08.015; PLANES JG, 1984, MED BIOL ENG COMPUT, V22, P585, DOI 10.1007/BF02443874; Rabotti C, 2011, IEEE ENG MED BIO, P3880, DOI 10.1109/IEMBS.2011.6090964; Rabotti C, 2010, IEEE T BIO-MED ENG, V57, P2178, DOI 10.1109/TBME.2010.2049111; Rabotti C, 2010, IEEE T BIO-MED ENG, V57, P519, DOI 10.1109/TBME.2009.2035440; Rabotti C, 2009, PHYSIOL MEAS, V30, P745, DOI 10.1088/0967-3334/30/8/002; Reinhard J, 2011, Z GEBURTSH NEONATOL, V215, P199, DOI 10.1055/s-0031-1291210; Repka MX, 2002, MENT RETARD DEV D R, V8, P249, DOI 10.1002/mrdd.10045; Schlembach D, 2009, EUR J OBSTET GYN R B, V144, pS33, DOI 10.1016/j.ejogrb.2009.02.016; Thomsen L, 1998, NAT MED, V4, P848, DOI 10.1038/nm0798-848; Vanner T, 1996, BAILLIERE CLIN OB GY, V10, P243, DOI 10.1016/S0950-3552(96)80036-8; Vinken MPGC, 2009, OBSTET GYNECOL SURV, V64, P529, DOI 10.1097/OGX.0b013e3181a8c6b1; WOLFS G, 1970, ARCH GYNAKOL, V208, P373, DOI 10.1007/BF00668252; Wolfs G M, 1979, Acta Obstet Gynecol Scand Suppl, V90, P1	40	28	28	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2014	9	1							e86775	10.1371/journal.pone.0086775	http://dx.doi.org/10.1371/journal.pone.0086775			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297GT	24466235	Green Submitted, gold, Green Published			2022-12-25	WOS:000330244500284
J	Tan, TC; Spadiut, O; Gandini, R; Haltrich, D; Divne, C				Tan, Tien Chye; Spadiut, Oliver; Gandini, Rosaria; Haltrich, Dietmar; Divne, Christina			Structural Basis for Binding of Fluorinated Glucose and Galactose to Trametes multicolor Pyranose 2-Oxidase Variants with Improved Galactose Conversion	PLOS ONE			English	Article							PHANEROCHAETE-CHRYSOSPORIUM; CARBOHYDRATE OXIDASE; POLYPORUS OBTUSUS; CRYSTAL-STRUCTURE; OXIDATION; PROTEIN; ENZYME; MECHANISM; FLAVOCYTOCHROME; PURIFICATION	Each year, about six million tons of lactose are generated from liquid whey as industrial byproduct, and optimally this large carbohydrate waste should be used for the production of value-added products. Trametes multicolor pyranose 2-oxidase (TmP2O) catalyzes the oxidation of various monosaccharides to the corresponding 2-keto sugars. Thus, a potential use of TmP2O is to convert the products from lactose hydrolysis, D-glucose and D-galactose, to more valuable products such as tagatose. Oxidation of glucose is however strongly favored over galactose, and oxidation of both substrates at more equal rates is desirable. Characterization of TmP2O variants (H450G, V546C, H450G/ V546C) with improved D-galactose conversion has been given earlier, of which H450G displayed the best relative conversion between the substrates. To rationalize the changes in conversion rates, we have analyzed high-resolution crystal structures of the aforementioned mutants with bound 2- and 3-fluorinated glucose and galactose. Binding of glucose and galactose in the productive 2-oxidation binding mode is nearly identical in all mutants, suggesting that this binding mode is essentially unaffected by the mutations. For the competing glucose binding mode, enzyme variants carrying the H450G replacement stabilize glucose as the a-anomer in position for 3-oxidation. The backbone relaxation at position 450 allows the substrate-binding loop to fold tightly around the ligand. V546C however stabilize glucose as the beta-anomer using an open loop conformation. Improved binding of galactose is enabled by subtle relaxation effects at key active-site backbone positions. The competing binding mode for galactose 2-oxidation by V546C stabilizes the beta-anomer for oxidation at C1, whereas H450G variants stabilize the 3-oxidation binding mode of the galactose alpha-anomer. The present study provides a detailed description of binding modes that rationalize changes in the relative conversion rates of D-glucose and D-galactose and can be used to refine future enzyme designs for more efficient use of lactose-hydrolysis byproducts.	[Tan, Tien Chye; Gandini, Rosaria; Divne, Christina] Karolinska Inst, Dept Med Biochem & Biophys, Stockholm, Sweden; [Spadiut, Oliver; Divne, Christina] Royal Inst Technol, Sch Biotechnol, Stockholm, Sweden; [Haltrich, Dietmar] BOKU Univ Nat Resources & Life Sci, Food Biotechnol Lab, Vienna, Austria	Karolinska Institutet; Royal Institute of Technology; University of Natural Resources & Life Sciences, Vienna	Divne, C (corresponding author), Karolinska Inst, Dept Med Biochem & Biophys, Stockholm, Sweden.	divne@biotech.kth.se	Haltrich, Dietmar/N-2624-2019; Divne, Christina/E-8646-2010	Haltrich, Dietmar/0000-0002-8722-8176; Divne, Christina/0000-0002-5805-2693; Gandini, Rosaria/0000-0003-4171-0693	Swedish Research Council VR (VR) [2008-4045, 2011-5768]	Swedish Research Council VR (VR)(Swedish Research Council)	TCT, OS, CD, and RG were supported by grants from the Swedish Research Council VR (VR grants 2008-4045 and 2011-5768). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bannwarth M, 2006, BIOCHEMISTRY-US, V45, P6587, DOI 10.1021/bi052465d; CAVENER DR, 1992, J MOL BIOL, V223, P811, DOI 10.1016/0022-2836(92)90992-S; DANIEL G, 1992, APPL ENVIRON MICROB, V58, P3667, DOI 10.1128/AEM.58.11.3667-3676.1992; DANIEL G, 1994, APPL ENVIRON MICROB, V60, P2524, DOI 10.1128/AEM.60.7.2524-2532.1994; de Koker TH, 2004, APPL ENVIRON MICROB, V70, P5794, DOI 10.1128/AEM.70.10.5794-5800.2004; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Freimund S, 1998, CHEM-EUR J, V4, P2442, DOI 10.1002/(SICI)1521-3765(19981204)4:12<2442::AID-CHEM2442>3.3.CO;2-1; Hallberg BM, 2004, J MOL BIOL, V341, P781, DOI 10.1016/j.jmb.2004.06.033; Hallberg BM, 2003, J BIOL CHEM, V278, P7160, DOI 10.1074/jbc.M210961200; Hallberg BM, 2002, J MOL BIOL, V315, P421, DOI 10.1006/jmbi.2001.5246; Haltrich D, 1998, ANN NY ACAD SCI, V864, P295, DOI 10.1111/j.1749-6632.1998.tb10325.x; Hassan N, 2013, FEBS OPEN BIO, V3, P496, DOI 10.1016/j.fob.2013.10.010; JANSSEN FW, 1968, BIOCHIM BIOPHYS ACTA, V167, P501, DOI 10.1016/0005-2744(68)90040-5; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Karplus PA, 2012, SCIENCE, V336, P1030, DOI [10.1126/science.121823, 10.1126/science.1218231]; Kujawa M, 2006, J BIOL CHEM, V281, P35104, DOI 10.1074/jbc.M604718200; Leitner C, 2001, APPL ENVIRON MICROB, V67, P3636, DOI 10.1128/AEM.67.8.3636-3644.2001; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; Manavalan A, 2011, J PROTEOMICS, V75, P642, DOI 10.1016/j.jprot.2011.09.001; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Painter J, 2006, ACTA CRYSTALLOGR D, V62, P439, DOI 10.1107/S0907444906005270; Pitsawong W, 2010, J BIOL CHEM, V285, P9697, DOI 10.1074/jbc.M109.073247; Prongjit M, 2013, BIOCHEMISTRY-US, V52, P1437, DOI 10.1021/bi301442x; Prongjit M, 2009, BIOCHEMISTRY-US, V48, P4170, DOI 10.1021/bi802331r; RUELIUS HW, 1968, BIOCHIM BIOPHYS ACTA, V167, P493, DOI 10.1016/0005-2744(68)90039-9; Salaheddin Clara, 2009, Biotechnology Journal, V4, P535, DOI 10.1002/biot.200800265; Siso MIG, 1996, BIORESOURCE TECHNOL, V57, P1, DOI 10.1016/0960-8524(96)00036-3; Spadiut O, 2009, J BIOTECHNOL, V139, P250, DOI 10.1016/j.jbiotec.2008.11.004; Spadiut O, 2009, FEBS J, V276, P776, DOI 10.1111/j.1742-4658.2008.06823.x; Spadiut O, 2008, BIOCATAL BIOTRANSFOR, V26, P120, DOI 10.1080/10242420701789320; Spadiut O, 2010, FEBS J, V277, P2892, DOI 10.1111/j.1742-4658.2010.07705.x; Spadiut O, 2010, J AGR FOOD CHEM, V58, P3465, DOI 10.1021/jf9040047; Spadiut Oliver, 2009, Biotechnology Journal, V4, P525, DOI 10.1002/biot.200800260; Sucharitakul J, 2008, BIOCHEMISTRY-US, V47, P8485, DOI 10.1021/bi801039d; Sucharitakul J, 2010, BIOCHEMISTRY-US, V49, P3753, DOI 10.1021/bi100187b; Tan TC, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0053567, 10.1371/journal.pone.0073165]; Tan TC, 2011, J MOL BIOL, V409, P588, DOI 10.1016/j.jmb.2011.04.019; Tan TC, 2010, J MOL BIOL, V402, P578, DOI 10.1016/j.jmb.2010.08.011; Wongnate T, 2013, FEBS J, V280, P3009, DOI 10.1111/febs.12280; Zamocky M, 2006, CURR PROTEIN PEPT SC, V7, P255, DOI 10.2174/138920306777452367	44	5	5	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2014	9	1							e86736	10.1371/journal.pone.0086736	http://dx.doi.org/10.1371/journal.pone.0086736			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297GT	24466218	gold, Green Published, Green Submitted			2022-12-25	WOS:000330244500278
J	Blacklock, K; Verkhivker, GM				Blacklock, Kristin; Verkhivker, Gennady M.			Allosteric Regulation of the Hsp90 Dynamics and Stability by Client Recruiter Cochaperones: Protein Structure Network Modeling	PLOS ONE			English	Article							TRANSFER-RNA SYNTHETASE; DISCRETE MOLECULAR-DYNAMICS; DISEASE RESISTANCE; CONFORMATIONAL DYNAMICS; FUNCTIONAL-ANALYSIS; CHAPERONE HSP90; INNATE IMMUNITY; CO-CHAPERONE; KEY RESIDUES; COMPLEX	The fundamental role of the Hsp90 chaperone in supporting functional activity of diverse protein clients is anchored by specific cochaperones. A family of immune sensing client proteins is delivered to the Hsp90 system with the aid of cochaperones Sgt1 and Rar1 that act cooperatively with Hsp90 to form allosterically regulated dynamic complexes. In this work, functional dynamics and protein structure network modeling are combined to dissect molecular mechanisms of Hsp90 regulation by the client recruiter cochaperones. Dynamic signatures of the Hsp90-cochaperone complexes are manifested in differential modulation of the conformational mobility in the Hsp90 lid motif. Consistent with the experiments, we have determined that targeted reorganization of the lid dynamics is a unifying characteristic of the client recruiter cochaperones. Protein network analysis of the essential conformational space of the Hsp90-cochaperone motions has identified structurally stable interaction communities, interfacial hubs and key mediating residues of allosteric communication pathways that act concertedly with the shifts in conformational equilibrium. The results have shown that client recruiter cochaperones can orchestrate global changes in the dynamics and stability of the interaction networks that could enhance the ATPase activity and assist in the client recruitment. The network analysis has recapitulated a broad range of structural and mutagenesis experiments, particularly clarifying the elusive role of Rar1 as a regulator of the Hsp90 interactions and a stability enhancer of the Hsp90-cochaperone complexes. Small-world organization of the interaction networks in the Hsp90 regulatory complexes gives rise to a strong correspondence between highly connected local interfacial hubs, global mediator residues of allosteric interactions and key functional hot spots of the Hsp90 activity. We have found that cochaperone-induced conformational changes in Hsp90 may be determined by specific interaction networks that can inhibit or promote progression of the ATPase cycle and thus control the recruitment of client proteins.	[Blacklock, Kristin; Verkhivker, Gennady M.] Chapman Univ, Schmid Coll Sci & Technol, Sch Computat Sci, Orange, CA 92866 USA; [Blacklock, Kristin; Verkhivker, Gennady M.] Chapman Univ, Schmid Coll Sci & Technol, Crean Sch Hlth & Life Sci, Orange, CA USA; [Verkhivker, Gennady M.] Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA	Chapman University System; Chapman University; Chapman University System; Chapman University; University of California System; University of California San Diego	Verkhivker, GM (corresponding author), Chapman Univ, Schmid Coll Sci & Technol, Sch Computat Sci, Orange, CA 92866 USA.	verkhivk@chapman.edu	Verkhivker, Gennady/V-9404-2018	Verkhivker, Gennady/0000-0002-4507-4471	Chapman University	Chapman University	This work is supported by funding from Chapman University. No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aftabuddin M, 2007, BIOPHYS J, V93, P225, DOI 10.1529/biophysj.106.098004; Ali MMU, 2006, NATURE, V440, P1013, DOI 10.1038/nature04716; Atilgan AR, 2004, BIOPHYS J, V86, P85, DOI 10.1016/S0006-3495(04)74086-2; Austin MJ, 2002, SCIENCE, V295, P2077, DOI 10.1126/science.1067747; Azevedo C, 2002, SCIENCE, V295, P2073, DOI 10.1126/science.1067554; Bagler G, 2005, PHYSICA A, V346, P27, DOI 10.1016/j.physa.2004.08.046; Bagler G, 2007, BIOINFORMATICS, V23, P1760, DOI 10.1093/bioinformatics/btm257; Bahar I, 2005, CURR OPIN STRUC BIOL, V15, P586, DOI 10.1016/j.sbi.2005.08.007; Bahar I, 2010, ANNU REV BIOPHYS, V39, P23, DOI 10.1146/annurev.biophys.093008.131258; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Barabasi AL, 2013, PHILOS T R SOC A, V371, DOI 10.1098/rsta.2012.0375; Barabasi AL, 2009, SCIENCE, V325, P412, DOI 10.1126/science.1173299; Barrat A, 2004, P NATL ACAD SCI USA, V101, P3747, DOI 10.1073/pnas.0400087101; Barrat A, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.066149; Bhattacharya D, 2013, PROTEINS, V81, P119, DOI 10.1002/prot.24167; Bhattacharyya M, 2011, BIOCHEMISTRY-US, V50, P6225, DOI 10.1021/bi200306u; Bhattacharyya M, 2010, BMC STRUCT BIOL, V10, DOI 10.1186/1472-6807-10-27; Bhattacharyya M, 2010, PROTEINS, V78, P506, DOI 10.1002/prot.22573; Blacklock K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071936; Bode C, 2007, FEBS LETT, V581, P2776, DOI 10.1016/j.febslet.2007.05.021; Borgatti SP, 2006, SOC NETWORKS, V28, P124, DOI 10.1016/j.socnet.2005.05.001; Boter M, 2007, PLANT CELL, V19, P3791, DOI 10.1105/tpc.107.050427; Brandes U, 2001, J MATH SOCIOL, V25, P163, DOI 10.1080/0022250X.2001.9990249; Brinda KV, 2005, BIOPHYS J, V89, P4159, DOI 10.1529/biophysj.105.064485; Camps J, 2009, BIOINFORMATICS, V25, P1709, DOI 10.1093/bioinformatics/btp304; Catlett MG, 2006, J BIOL CHEM, V281, P33739, DOI 10.1074/jbc.M603847200; Chea E, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-153; Colombo G, 2008, P NATL ACAD SCI USA, V105, P7976, DOI 10.1073/pnas.0802879105; Csermely P, 2012, CURR PROTEIN PEPT SC, V13, P19, DOI 10.2174/138920312799277992; Daily MD, 2008, PROTEINS, V71, P455, DOI 10.1002/prot.21800; Daily MD, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000293; del Sol A, 2005, BIOINFORMATICS, V21, P1311, DOI 10.1093/bioinformatics/bti167; del Sol A, 2005, PROTEINS, V58, P672, DOI 10.1002/prot.20348; del Sol A, 2006, PROTEIN SCI, V15, P2120, DOI 10.1110/ps.062249106; Dixit A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037605; Dokholyan NV, 1998, FOLD DES, V3, P577, DOI 10.1016/S1359-0278(98)00072-8; Dokholyan NV, 2002, P NATL ACAD SCI USA, V99, P8637, DOI 10.1073/pnas.122076099; Dollins DE, 2007, MOL CELL, V28, P41, DOI 10.1016/j.molcel.2007.08.024; Emperador A, 2008, BIOPHYS J, V95, P2127, DOI 10.1529/biophysj.107.119115; Emperador A, 2010, PROTEINS, V78, P83, DOI 10.1002/prot.22563; FREEMAN LC, 1979, SOC NETWORKS, V1, P215, DOI 10.1016/0378-8733(78)90021-7; FREEMAN LC, 1991, SOC NETWORKS, V13, P141, DOI 10.1016/0378-8733(91)90017-N; Fuglebakk E, 2012, BIOINFORMATICS, V28, P2431, DOI 10.1093/bioinformatics/bts445; Gaspar ME, 2012, BRIEF FUNCT GENOMICS, V11, P443, DOI 10.1093/bfgp/els023; Gasper PM, 2012, P NATL ACAD SCI USA, V109, P21216, DOI 10.1073/pnas.1218414109; Ghosh A, 2008, BIOCHEMISTRY-US, V47, P11398, DOI 10.1021/bi8007559; Ghosh A, 2007, P NATL ACAD SCI USA, V104, P15711, DOI 10.1073/pnas.0704459104; Ghosh A, 2011, J BIOL CHEM, V286, P37721, DOI 10.1074/jbc.M111.246702; Hagberg A, 2008, EXPLORING NETWORK ST, P11, DOI DOI 10.25080/ISSN.2575-9752; Haliloglu T, 1997, PHYS REV LETT, V79, P3090, DOI 10.1103/PhysRevLett.79.3090; Hansia P, 2009, MOL BIOSYST, V5, P1860, DOI 10.1039/b903807h; Hinsen K, 1998, PROTEINS, V33, P417, DOI 10.1002/(SICI)1097-0134(19981115)33:3<417::AID-PROT10>3.0.CO;2-8; Hollup SM, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-52; Hubert DA, 2003, EMBO J, V22, P5679, DOI 10.1093/emboj/cdg547; Hubert DA, 2009, P NATL ACAD SCI USA, V106, P9556, DOI 10.1073/pnas.0904877106; Jackson SE, 2013, TOP CURR CHEM, V328, P155, DOI 10.1007/128_2012_356; Jiang YQ, 2010, J BIOL CHEM, V285, P21023, DOI 10.1074/jbc.M110.103390; Jiao X, 2007, PHYS REV E, V75, DOI 10.1103/PhysRevE.75.051903; Kadota Y, 2012, BBA-MOL CELL RES, V1823, P689, DOI 10.1016/j.bbamcr.2011.09.016; Kadota Y, 2010, TRENDS BIOCHEM SCI, V35, P199, DOI 10.1016/j.tibs.2009.12.005; Kadota Y, 2008, EMBO REP, V9, P1209, DOI 10.1038/embor.2008.185; Keskin O, 2000, BIOPHYS J, V78, P2093, DOI 10.1016/S0006-3495(00)76756-7; Krukenberg KA, 2011, Q REV BIOPHYS, V44, P229, DOI 10.1017/S0033583510000314; Lee YT, 2004, J BIOL CHEM, V279, P16511, DOI 10.1074/jbc.M400215200; Li Jing, 2013, Biomed J, V36, P106, DOI 10.4103/2319-4170.113230; Li J, 2012, BBA-MOL CELL RES, V1823, P624, DOI 10.1016/j.bbamcr.2011.09.003; Ma JP, 2005, STRUCTURE, V13, P373, DOI 10.1016/j.str.2005.02.002; Makhnevych T, 2012, BBA-MOL CELL RES, V1823, P674, DOI 10.1016/j.bbamcr.2011.09.001; Mandal AK, 2007, J CELL BIOL, V176, P319, DOI 10.1083/jcb.200604106; Mandel AK, 2011, METHODS MOL BIOL, V787, P75, DOI 10.1007/978-1-61779-295-3_6; Matts RL, 2011, ACS CHEM BIOL, V6, P800, DOI 10.1021/cb200052x; Matts RL, 2011, BIOORGAN MED CHEM, V19, P684, DOI 10.1016/j.bmc.2010.10.029; McClellan AJ, 2007, CELL, V131, P121, DOI 10.1016/j.cell.2007.07.036; Miao YL, 2013, P NATL ACAD SCI USA, V110, P10982, DOI 10.1073/pnas.1309755110; Mickler M, 2009, NAT STRUCT MOL BIOL, V16, P281, DOI 10.1038/nsmb.1557; Morra G, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002433; Morra G, 2010, J CHEM THEORY COMPUT, V6, P2978, DOI 10.1021/ct100334n; Morra G, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000323; Newman MEJ, 2003, PHYS REV E, V67, DOI 10.1103/PhysRevE.67.026126; Newman MEJ, 2001, PHYS REV E, V64, DOI [10.1103/PhysRevE.64.016131, 10.1103/PhysRevE.64.016132]; Newman MEJ, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.208701; Palla G, 2005, NATURE, V435, P814, DOI 10.1038/nature03607; Park J, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.066117; Pearl L H, 2001, Adv Protein Chem, V59, P157; Pearl LH, 2006, ANNU REV BIOCHEM, V75, P271, DOI 10.1146/annurev.biochem.75.103004.142738; Prodromou C, 2012, BBA-MOL CELL RES, V1823, P614, DOI 10.1016/j.bbamcr.2011.07.020; Ratzke C, 2012, J MOL BIOL, V423, P462, DOI 10.1016/j.jmb.2012.07.026; Ravasz E, 2002, SCIENCE, V297, P1551, DOI 10.1126/science.1073374; Rivalta I, 2012, P NATL ACAD SCI USA, V109, pE1428, DOI 10.1073/pnas.1120536109; Roe SM, 2004, CELL, V116, P87, DOI 10.1016/S0092-8674(03)01027-4; Rohl A, 2013, TRENDS BIOCHEM SCI, V38, P253, DOI 10.1016/j.tibs.2013.02.003; Rueda M, 2007, STRUCTURE, V15, P565, DOI 10.1016/j.str.2007.03.013; Sacquin-Mora S, 2006, BIOPHYS J, V90, P2706, DOI 10.1529/biophysj.105.074997; Seifert C, 2012, BIOPHYS J, V103, P2195, DOI 10.1016/j.bpj.2012.09.008; Serrano MA, 2009, P NATL ACAD SCI USA, V106, P6483, DOI 10.1073/pnas.0808904106; Sethi A, 2009, P NATL ACAD SCI USA, V106, P6620, DOI 10.1073/pnas.0810961106; Shakhnovich E, 1996, NATURE, V379, P96, DOI 10.1038/379096a0; Sharma K, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.014654; Shiau AK, 2006, CELL, V127, P329, DOI 10.1016/j.cell.2006.09.027; Shirasu K, 1999, CELL, V99, P355, DOI 10.1016/S0092-8674(00)81522-6; Shirasu K, 2009, ANNU REV PLANT BIOL, V60, P139, DOI 10.1146/annurev.arplant.59.032607.092906; Siligardi G, 2002, J BIOL CHEM, V277, P20151, DOI 10.1074/jbc.M201287200; Sreeramulu S, 2009, J BIOL CHEM, V284, P3885, DOI 10.1074/jbc.M806715200; Sukhwal A, 2011, ACTA CRYSTALLOGR D, V67, P429, DOI 10.1107/S0907444911007062; Taipale M, 2013, NAT BIOTECHNOL, V31, P630, DOI 10.1038/nbt.2620; Taipale M, 2012, CELL, V150, P987, DOI 10.1016/j.cell.2012.06.047; Taipale M, 2010, NAT REV MOL CELL BIO, V11, P515, DOI 10.1038/nrm2918; Takahashi A, 2003, P NATL ACAD SCI USA, V100, P11777, DOI 10.1073/pnas.2033934100; Tang S, 2007, J MOL BIOL, V373, P1361, DOI 10.1016/j.jmb.2007.08.059; VanWart AT, 2012, J CHEM THEORY COMPUT, V8, P2949, DOI 10.1021/ct300377a; Vendruscolo M, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.061910; Vendruscolo M, 2001, NATURE, V409, P641, DOI 10.1038/35054591; Verkhivker GM, 2009, CURR TOP MED CHEM, V9, P1369, DOI 10.2174/156802609789895700; Vijayabaskar MS, 2010, BIOPHYS J, V99, P3704, DOI 10.1016/j.bpj.2010.08.079; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Wu ZX, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.016675; Yang LW, 2006, NUCLEIC ACIDS RES, V34, pW24, DOI 10.1093/nar/gkl084; Zhang MH, 2008, EMBO J, V27, P2789, DOI 10.1038/emboj.2008.190; Zhang MH, 2010, MOL CELL, V39, P269, DOI 10.1016/j.molcel.2010.05.010; Zhang W, 2004, J MOL BIOL, V340, P891, DOI 10.1016/j.jmb.2004.05.007; Zhao RM, 2005, CELL, V120, P715, DOI 10.1016/j.cell.2004.12.024; Zhao RM, 2007, ADV EXP MED BIOL, V594, P27	122	31	33	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2014	9	1							e86547	10.1371/journal.pone.0086547	http://dx.doi.org/10.1371/journal.pone.0086547			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297FH	24466147	Green Published, gold, Green Submitted			2022-12-25	WOS:000330240500138
J	Blackstock, CD; Higashi, Y; Sukhanov, S; Shai, SY; Stefanovic, B; Tabony, AM; Yoshida, T; Delafontaine, P				Blackstock, Christopher D.; Higashi, Yusuke; Sukhanov, Sergiy; Shai, Shaw-Yung; Stefanovic, Branko; Tabony, A. Michael; Yoshida, Tadashi; Delafontaine, Patrice			Insulin-like Growth Factor-1 Increases Synthesis of Collagen Type I via Induction of the mRNA-binding Protein LARP6 Expression and Binding to the 5 ' Stem-loop of COL1a1 and COL1a2 mRNA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Akt; Atherosclerosis; Insulin-like Growth Factor (IGF); Protein Synthesis; Translation; Vascular Smooth Muscle Cells; 5 Stem-loop; Acheron; Fibrillogenesis; Post-transcriptional	ATHEROSCLEROTIC PLAQUES; TRANSLATION; ACTIVATION; OVEREXPRESSION; PROLIFERATION; 5'-STEM-LOOP; PROGRESSION; FEATURES; BIOLOGY; ACHERON	Background: The la ribonucleoprotein domain family member 6, LARP6, regulates collagen type 1 mRNA translation. Results: IGF-1 increases LARP6 expression, resulting in increased LARP6-collagen type 1 mRNA complex and collagen synthesis in smooth muscle. Conclusion: IGF-1 enhances collagen fibrillogenesis via induction of LARP6. Significance: This report uncovers a critical mechanism whereby IGF-1 induces a more stable plaque phenotype in atherosclerosis. Collagen content in atherosclerotic plaque is a hallmark of plaque stability. Our earlier studies showed that insulin-like growth factor-1 (IGF-1) increases collagen content in atherosclerotic plaques of Apoe(-/-) mice. To identify mechanisms we investigated the effect of IGF-1 on the la ribonucleoprotein domain family member 6 (LARP6). LARP6 binds a stem-loop motif in the 5-UTR of the mRNAs encoding the collagen type I -subunits (1(I) and 2(I)), and coordinates their translation into the heterotrimeric collagen type I molecule. In human aortic smooth muscle cells (SMCs), IGF-1 rapidly increased LARP6 expression and the rate of collagen synthesis and extracellular accumulation. IGF-1 increased both LARP6 and collagen type I expression via a post-transcriptional and translation-dependent mechanism involving PI3K/Akt/p70S6k-signaling. Immunoprecipitation of LARP6, followed by qPCR indicated that IGF-1 increased the level of COL1a1 and COL1a2 mRNA bound to LARP6. Mutation of the 5 stem-loop of Col1a1 mRNA, which inhibits binding of LARP6, abolished the ability of IGF-1 to increase synthesis of collagen type I. Furthermore, overexpression of a 5 stem-loop RNA molecular decoy that sequesters LARP6, prevented the ability of IGF-1 to increase pro-1(I) and mature 1(I) expression in cultured medium. IGF-1 infusion in Apoe(-/-) mice increased expression of LARP6 and pro-1(I) in aortic lysates, and SMC-specific IGF-1-overexpression robustly increased collagen fibrillogenesis in atherosclerotic plaque. In conclusion, we identify LARP6 as a critical mediator by which IGF-1 augments synthesis of collagen type I in vascular smooth muscle, which may play an important role in promoting atherosclerotic plaque stability.	[Blackstock, Christopher D.; Higashi, Yusuke; Sukhanov, Sergiy; Shai, Shaw-Yung; Tabony, A. Michael; Yoshida, Tadashi; Delafontaine, Patrice] Tulane Univ, Sch Med, Inst Heart & Vasc, New Orleans, LA 70112 USA; [Blackstock, Christopher D.; Higashi, Yusuke; Sukhanov, Sergiy; Shai, Shaw-Yung; Tabony, A. Michael; Yoshida, Tadashi; Delafontaine, Patrice] Tulane Univ, Sch Med, Dept Med, New Orleans, LA 70112 USA; [Stefanovic, Branko] Florida State Univ, Coll Med, Dept Biomed Sci, Tallahassee, FL 32306 USA	Tulane University; Tulane University; State University System of Florida; Florida State University	Delafontaine, P (corresponding author), Tulane Univ, Sch Med, Inst Heart & Vasc, 1430 Tulane Ave,SL-48, New Orleans, LA 70112 USA.	pdelafon@tulane.edu		Yoshida, Tadashi/0000-0002-4544-1497; Delafontaine, Patrice/0000-0003-3744-3617; Sukhanov, Sergiy/0000-0002-9223-4263	National Institutes of Health: NHLBI [R01-HL070241, R01-HL080682, R21-HL113705-01A1]; National Institutes of Health: NCRR [P20-RR018766]; National Institutes of Health: NIGMS [P20-GM103514, P30-GM103337, U54-GM104940]; American Heart Association [13GRNT17230069]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR018766] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL070241, R01HL080682, R21HL113705] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM104940, P20GM103514, P30GM103337] Funding Source: NIH RePORTER	National Institutes of Health: NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institutes of Health: NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institutes of Health: NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); American Heart Association(American Heart Association); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by grants from the National Institutes of Health: NHLBI R01-HL070241, R01-HL080682, and R21-HL113705-01A1, NCRR P20-RR018766, and NIGMS P20-GM103514, P30-GM103337, and U54-GM104940. This work was also supported by the American Heart Association (13GRNT17230069).	Adiguzel E, 2009, VASC MED, V14, P73, DOI 10.1177/1358863X08094801; Bayfield MA, 2010, BBA-GENE REGUL MECH, V1799, P365, DOI 10.1016/j.bbagrm.2010.01.011; Beck K, 1996, J BIOL CHEM, V271, P21566, DOI 10.1074/jbc.271.35.21566; Cai L, 2010, J MOL BIOL, V401, P564, DOI 10.1016/j.jmb.2010.06.057; Cai L, 2010, J MOL BIOL, V395, P309, DOI 10.1016/j.jmb.2009.11.020; Canty EG, 2005, J CELL SCI, V118, P1341, DOI 10.1242/jcs.01731; Challa AA, 2011, MOL CELL BIOL, V31, P3773, DOI 10.1128/MCB.05263-11; Chang SW, 2012, BIOPHYS J, V102, P640, DOI 10.1016/j.bpj.2011.11.3999; Chung HJ, 2008, J BIOL CHEM, V283, P25879, DOI 10.1074/jbc.M804272200; DAYAN D, 1989, HISTOCHEMISTRY, V93, P27, DOI 10.1007/BF00266843; Deguchi JO, 2005, CIRCULATION, V112, P2708, DOI 10.1161/CIRCULATIONAHA.105.562041; Fuster V, 2005, J AM COLL CARDIOL, V46, P937, DOI 10.1016/j.jacc.2005.03.074; Garnero P, 2009, BONE, V44, P461, DOI 10.1016/j.bone.2008.11.006; Gherzi R, 2010, CELL DEATH DIFFER, V17, P975, DOI 10.1038/cdd.2009.194; GRIMM C, 1993, EMBO J, V12, P1229, DOI 10.1002/j.1460-2075.1993.tb05764.x; Higashi Y, 2013, BBA-MOL BASIS DIS, V1832, P391, DOI 10.1016/j.bbadis.2012.12.005; KOZAK M, 1987, J MOL BIOL, V196, P947, DOI 10.1016/0022-2836(87)90418-9; Lee RT, 1997, ARTERIOSCL THROM VAS, V17, P1859, DOI 10.1161/01.ATV.17.10.1859; Libby P, 2011, NATURE, V473, P317, DOI 10.1038/nature10146; Manojlovic Z, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065897; Manojlovic Z, 2012, RNA, V18, P321, DOI 10.1261/rna.030288.111; McDaniel DP, 2007, BIOPHYS J, V92, P1759, DOI 10.1529/biophysj.106.089003; Ovchinnikova O, 2009, AM J PATHOL, V174, P693, DOI 10.2353/ajpath.2009.080561; Parsons CJ, 2011, J BIOL CHEM, V286, P8609, DOI 10.1074/jbc.M110.189118; Peritz T, 2006, NAT PROTOC, V1, P577, DOI 10.1038/nprot.2006.82; PROCKOP DJ, 1995, ANNU REV BIOCHEM, V64, P403, DOI 10.1146/annurev.biochem.64.1.403; Rajavashisth TB, 1999, CIRCULATION, V99, P3103, DOI 10.1161/01.CIR.99.24.3103; Rekhter MD, 1999, CARDIOVASC RES, V41, P376, DOI 10.1016/S0008-6363(98)00321-6; Rich Lillian, 2005, Brazilian Journal of Morphological Sciences, V22, P97; Shai SY, 2010, ARTERIOSCL THROM VAS, V30, P1916, DOI 10.1161/ATVBAHA.110.210831; Shao R, 2012, INT J CANCER, V130, P544, DOI 10.1002/ijc.26015; Stefanovic B, 1999, MOL CELL BIOL, V19, P4334; Stefanovic B, 2003, J BIOL CHEM, V278, P927, DOI 10.1074/jbc.M209175200; Stefanovic B, 2002, J BIOL CHEM, V277, P18229, DOI 10.1074/jbc.M108065200; Sukhanov S, 2007, ARTERIOSCL THROM VAS, V27, P2684, DOI 10.1161/ATVBAHA.107.156257; Sukhanov S, 2011, FEBS LETT, V585, P3065, DOI 10.1016/j.febslet.2011.08.029; Sun RJ, 2011, CELL BIOCHEM FUNCT, V29, P636, DOI 10.1002/cbf.1799; Tenenbaum SA, 2002, METHODS, V26, P191, DOI 10.1016/S1046-2023(02)00022-1; Valavanis C, 2007, GENE, V393, P101, DOI 10.1016/j.gene.2007.01.033; Wan X, 2007, ONCOGENE, V26, P1932, DOI 10.1038/sj.onc.1209990; Wang JW, 1997, J CLIN INVEST, V100, P1425, DOI 10.1172/JCI119663; Wei YH, 2013, P NATL ACAD SCI USA, V110, pE3910, DOI 10.1073/pnas.1309276110; Yoshida T, 2013, J BIOL CHEM, V288, P23823, DOI 10.1074/jbc.M112.449074; Zhao X, 2008, HYPERTENS RES, V31, P1619, DOI 10.1291/hypres.31.1619	44	58	61	5	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 14	2014	289	11					7264	7274		10.1074/jbc.M113.518951	http://dx.doi.org/10.1074/jbc.M113.518951			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AC8CV	24469459	Green Published, hybrid			2022-12-25	WOS:000332761500002
J	Keiffer, TR; Bond, JS				Keiffer, Timothy R.; Bond, Judith S.			Meprin Metalloproteases Inactivate Interleukin 6	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cell Culture; Cytokine; Inflammation; Interleukin; Metalloprotease; Protease; Meprins	INFLAMMATORY-BOWEL-DISEASE; CANCER; IL-6; KIDNEY; OLIGOMERIZATION; INVOLVEMENT; EXPRESSION; STABILITY; SUBSTRATE; TERMINUS	Background: Meprin metalloproteinases are implicated in the pathogenesis of inflammatory diseases where the cytokine IL-6 plays a role. Results: Meprins cleave and decrease the biological activity of IL-6. Conclusion: IL-6 activity at inflammatory sites is regulated in part by meprins. Significance: Decreasing IL-6 bioactivity is an underlying mechanism for meprin regulation of inflammation. Meprins have been implicated in the pathogenesis of several inflammatory diseases, including inflammatory bowel disease, in which the cytokine IL-6 is a prominent effector molecule. Because IL-6 levels are elevated markedly in meprin and / knockout mice in an experimental model of inflammatory bowel disease, the interaction between meprins and IL-6 was studied. The results demonstrate that rodent and human meprin A and B cleave IL-6 to a smaller product and, subsequently, are capable of extensive degradation of the cytokine. Analysis of the limited degradation product formed by meprin A indicated that three to five amino acids are removed from the C terminus of the cytokine. Meprin A and meprin B cleaved IL-6 with micromolar affinities (K-m of 4.7 and 12.0 m, respectively) and with high efficiencies (k(cat)/K-m of 0.2 and 2.5 (m(-1)/s(-1)) x 10(6), respectively). These efficiency constants are among the highest for known meprin substrates. Madin-Darby canine kidney cells transiently transfected with meprin or meprin constructs also cleave exogenous IL-6. Both human and murine IL-6 cleaved by meprin A or B are inactivated, as demonstrated by their decreased capability to stimulate proliferation of B9 cells. These results are consistent with the proposition that one function of meprin metalloproteases is to modulate inflammation by inactivating IL-6.	[Keiffer, Timothy R.; Bond, Judith S.] Penn State Univ, Dept Biochem & Mol Biol, Coll Med, Hershey, PA 17033 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health	Bond, JS (corresponding author), Penn State Univ, Dept Biochem & Mol Biol, Coll Med, 500 Univ Dr, Hershey, PA 17033 USA.	jbond@psu.edu		R. Keiffer, Timothy/0000-0001-7104-6338	National Institutes of Health [R01 DK019691]; Pennsylvania Department of Health tobacco settlement funds; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK019691] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pennsylvania Department of Health tobacco settlement funds; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health grant R01 DK019691 (to J. S. B.). This work was also supported by Pennsylvania Department of Health tobacco settlement funds (to J. S. B.).	Atreya R, 2005, CLIN REV ALLERG IMMU, V28, P187, DOI 10.1385/CRIAI:28:3:187; Banbula A, 1999, BIOCHEM BIOPH RES CO, V261, P598, DOI 10.1006/bbrc.1999.1075; Banerjee S, 2009, MUCOSAL IMMUNOL, V2, P220, DOI 10.1038/mi.2009.3; Banerjee S, 2008, J BIOL CHEM, V283, P31371, DOI 10.1074/jbc.M802814200; Banerjee S, 2011, AM J PHYSIOL-GASTR L, V300, pG273, DOI 10.1152/ajpgi.00504.2009; Bank U, 1999, FEBS LETT, V461, P235, DOI 10.1016/S0014-5793(99)01466-0; Bao JL, 2013, AM J PHYSIOL-RENAL, V305, pF714, DOI 10.1152/ajprenal.00179.2012; Becker-Pauly C, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.009233; Bertenshaw GP, 2003, J BIOL CHEM, V278, P2522, DOI 10.1074/jbc.M208808200; Bertenshaw GP, 2002, BIOL CHEM, V383, P1175, DOI 10.1515/BC.2002.129; Bertenshaw GP, 2001, J BIOL CHEM, V276, P13248, DOI 10.1074/jbc.M011414200; Bond JS, 2005, FEBS LETT, V579, P3317, DOI 10.1016/j.febslet.2005.03.045; Broder C, 2013, BIOCHEM J, V450, P253, DOI 10.1042/BJ20121751; Bylander JE, 2007, BIOL CHEM, V388, P1163, DOI 10.1515/BC.2007.156; COULIE PG, 1989, EUR J IMMUNOL, V19, P2107, DOI 10.1002/eji.1830191121; Doan T., 2007, IMMUNOLOGY, P384; Fisman EZ, 2010, CARDIOVASC DIABETOL, V9, DOI 10.1186/1475-2840-9-62; Grivennikov S, 2009, CANCER CELL, V15, P103, DOI 10.1016/j.ccr.2009.01.001; Hanel KH, 2013, INT J MOL SCI, V14, P6720, DOI 10.3390/ijms14046720; Hengst JA, 2004, J BIOL CHEM, V279, P34856, DOI 10.1074/jbc.M405774200; Herzog C, 2005, CYTOKINE, V31, P394, DOI 10.1016/j.cyto.2005.06.012; Herzog C, 2009, BIOCHEM BIOPH RES CO, V379, P904, DOI 10.1016/j.bbrc.2008.12.161; Ishmael SS, 2006, J BIOL CHEM, V281, P37404, DOI 10.1074/jbc.M602769200; Jones LL, 2011, IMMUNOL RES, V51, P5, DOI 10.1007/s12026-011-8209-y; Kaushal GP, 2013, AM J PHYSIOL-RENAL, V304, pF1150, DOI 10.1152/ajprenal.00014.2013; Korkmaz B, 2008, BIOCHIMIE, V90, P227, DOI 10.1016/j.biochi.2007.10.009; Kruse MN, 2004, BIOCHEM J, V378, P383, DOI 10.1042/BJ20031163; KRUTTGEN A, 1990, FEBS LETT, V262, P323, DOI 10.1016/0014-5793(90)80219-9; Norman LP, 2003, CURR TOP DEV BIOL, V54, P145, DOI 10.1016/S0070-2153(03)54008-X; Ongeri EM, 2011, AM J PHYSIOL-RENAL, V301, pF871, DOI 10.1152/ajprenal.00703.2010; Rose-John S, 2012, INT J BIOL SCI, V8, P1237, DOI 10.7150/ijbs.4989; Scott TR, 2006, VET IMMUNOL IMMUNOP, V114, P173, DOI 10.1016/j.vetimm.2006.07.009; Simpson RJ, 1997, PROTEIN SCI, V6, P929, DOI 10.1002/pro.5560060501; Sterchi EE, 2008, MOL ASPECTS MED, V29, P309, DOI 10.1016/j.mam.2008.08.002; Tanaka T, 2012, INT J BIOL SCI, V8, P1227, DOI 10.7150/ijbs.4666; Tsukuba T, 2002, ARCH BIOCHEM BIOPHYS, V397, P191, DOI 10.1006/abbi.2001.2672; WARD LD, 1993, PROTEIN SCI, V2, P1472, DOI 10.1002/pro.5560020911; Yura RE, 2009, AM J PHYSIOL-RENAL, V296, pF135, DOI 10.1152/ajprenal.90524.2008; Zhang HC, 2007, AM J PHYSIOL-HEART C, V292, pH2408, DOI 10.1152/ajpheart.01150.2006	39	31	31	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 14	2014	289	11					7580	7588		10.1074/jbc.M113.546309	http://dx.doi.org/10.1074/jbc.M113.546309			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AC8CV	24474695	hybrid, Green Published			2022-12-25	WOS:000332761500028
J	David, FPA; Delafontaine, J; Carat, S; Ross, FJ; Lefebvre, G; Jarosz, Y; Sinclair, L; Noordermeer, D; Rougemont, J; Leleu, M				David, Fabrice P. A.; Delafontaine, Julien; Carat, Solenne; Ross, Frederick J.; Lefebvre, Gregory; Jarosz, Yohan; Sinclair, Lucas; Noordermeer, Daan; Rougemont, Jacques; Leleu, Marion			HTSstation: A Web Application and Open-Access Libraries for High-Throughput Sequencing Data Analysis	PLOS ONE			English	Article							CHIP-SEQ DATA; CONFORMATION; GENOME; TOOLS; SUITE	The HTSstation analysis portal is a suite of simple web forms coupled to modular analysis pipelines for various applications of High-Throughput Sequencing including ChIP-seq, RNA-seq, 4C-seq and re-sequencing. HTSstation offers biologists the possibility to rapidly investigate their HTS data using an intuitive web application with heuristically pre-defined parameters. A number of open-source software components have been implemented and can be used to build, configure and run HTS analysis pipelines reactively. Besides, our programming framework empowers developers with the possibility to design their own workflows and integrate additional third-party software. The HTSstation web application is accessible at http://htsstation.epfl.ch.	[David, Fabrice P. A.; Delafontaine, Julien; Carat, Solenne; Ross, Frederick J.; Lefebvre, Gregory; Jarosz, Yohan; Sinclair, Lucas; Noordermeer, Daan; Rougemont, Jacques; Leleu, Marion] Ecole Polytech Fed Lausanne, Sch Life Sci, CH-1015 Lausanne, Switzerland; [David, Fabrice P. A.; Delafontaine, Julien; Carat, Solenne; Ross, Frederick J.; Lefebvre, Gregory; Jarosz, Yohan; Sinclair, Lucas; Rougemont, Jacques; Leleu, Marion] SIB, Lausanne, Switzerland; [Noordermeer, Daan; Leleu, Marion] ISREC, Lausanne, Switzerland	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Institute of Bioinformatics; Swiss Institute Experimental Cancer Research	Rougemont, J (corresponding author), Ecole Polytech Fed Lausanne, Sch Life Sci, CH-1015 Lausanne, Switzerland.	jacques.rougemont@epfl.ch; marion.leleu@epfl.ch	Dumont, Solenne/L-3023-2015; Noordermeer, Daan/F-3306-2011	Dumont, Solenne/0000-0003-3237-7382; Lefebvre, Greg/0000-0001-7519-2316; Sinclair, Lucas/0000-0003-4134-3571; Noordermeer, Daan/0000-0002-9296-7002	SystemsX.ch; Swiss Initiative in Systems Biology, through the SyBIT; CycliX; LipidX; DynamiX; ERC grant SystemsHox.ch; Swiss National Science Foundation Sinergia [CRSI33_130662]; EPFL	SystemsX.ch; Swiss Initiative in Systems Biology, through the SyBIT; CycliX; LipidX; DynamiX; ERC grant SystemsHox.ch; Swiss National Science Foundation Sinergia(Swiss National Science Foundation (SNSF)); EPFL	This work has been supported by SystemsX.ch, the Swiss Initiative in Systems Biology, through the SyBIT (JD, FJR, LS, YJ), CycliX(JR), LipidX (FPAD) and DynamiX (JR) projects, by the ERC grant SystemsHox.ch to Denis Duboule (DN, ML), by a Swiss National Science Foundation Sinergia Grant CRSI33_130662 to Daniel Constam (SC), and by the EPFL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexa A, 2006, BIOINFORMATICS, V22, P1600, DOI 10.1093/bioinformatics/btl140; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Andrey G, 2013, SCIENCE, V340, P1195, DOI 10.1126/science.1234167; Bailey TL, 2009, NUCLEIC ACIDS RES, V37, pW202, DOI 10.1093/nar/gkp335; de Wit E, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000045; Flicek P, 2013, NUCLEIC ACIDS RES, V41, pD48, DOI 10.1093/nar/gks1236; Gheldof N, 2012, METHODS MOL BIOL, V786, P211, DOI 10.1007/978-1-61779-292-2_13; Giardine B, 2005, GENOME RES, V15, P1451, DOI 10.1101/gr.4086505; Halbritter F, 2012, NAT METHODS, V9, P7, DOI 10.1038/nmeth.1809; Huang Songbo, 2011, Frontiers in Genetics, V2, P46, DOI 10.3389/fgene.2011.00046; Huber A, 2011, EMBO J, V30, P3052, DOI 10.1038/emboj.2011.221; Kallio MA, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-507; Kapitonov VV, 2008, NAT REV GENET, V9, DOI 10.1038/nrg2165-c1; Kapitonov Vladimir V, 2008, Nat Rev Genet, V9, P411, DOI 10.1038/nrg2165-c1; Kuhn RM, 2013, BRIEF BIOINFORM, V14, P144, DOI 10.1093/bib/bbs038; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Le Martelot G, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001442; Lee KP, 2012, GENE DEV, V26, P1984, DOI 10.1101/gad.194266.112; Lefebvre G, 2011, J VIROL, V85, P6205, DOI 10.1128/JVI.00252-11; Leleu M, 2010, BRIEF FUNCT GENOMICS, V9, P466, DOI 10.1093/bfgp/elq022; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lieberman-Aiden E, 2009, SCIENCE, V326, P289, DOI 10.1126/science.1181369; Monot M, 2009, NAT GENET, V41, P1282, DOI 10.1038/ng.477; Noordermeer D, 2011, SCIENCE, V334, P222, DOI 10.1126/science.1207194; Preti M, 2010, MOL CELL, V38, P614, DOI 10.1016/j.molcel.2010.04.016; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Rey G, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000595; Rougemont J, 2012, METHODS MOL BIOL, V786, P263, DOI 10.1007/978-1-61779-292-2_16; Rowe HM, 2010, NATURE, V463, P237, DOI 10.1038/nature08674; Simonis M, 2006, NAT GENET, V38, P1348, DOI 10.1038/ng1896; Splinter E, 2011, GENE DEV, V25, P1371, DOI 10.1101/gad.633311; Truman RW, 2011, NEW ENGL J MED, V364, P1626, DOI 10.1056/NEJMoa1010536; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137	33	56	56	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2014	9	1							e85879	10.1371/journal.pone.0085879	http://dx.doi.org/10.1371/journal.pone.0085879			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301BI	24475057	Green Published, gold, Green Submitted			2022-12-25	WOS:000330507300028
J	Fujita, H; Aoki, H; Ajioka, I; Yamazaki, M; Abe, M; Oh-Nishi, A; Sakimura, K; Sugihara, I				Fujita, Hirofumi; Aoki, Hanako; Ajioka, Itsuki; Yamazaki, Maya; Abe, Manabu; Oh-Nishi, Arata; Sakimura, Kenji; Sugihara, Izumi			Detailed Expression Pattern of Aldolase C (Aldoc) in the Cerebellum, Retina and Other Areas of the CNS Studied in Aldoc-Venus Knock-In Mice	PLOS ONE			English	Article							VACUOLAR H+-ATPASE; ZEBRIN-II; MOUSE CEREBELLUM; PURKINJE-CELLS; FUNCTIONAL-ORGANIZATION; PARASAGITTAL BANDS; ZONAL ORGANIZATION; TRANSGENIC MICE; RAT CEREBELLUM; CORTICAL ZONES	Aldolase C (Aldoc, also known as "zebrin II"), a brain type isozyme of a glycolysis enzyme, is expressed heterogeneously in subpopulations of cerebellar Purkinje cells (PCs) that are arranged longitudinally in a complex striped pattern in the cerebellar cortex, a pattern which is closely related to the topography of input and output axonal projections. Here, we generated knock-in Aldoc-Venus mice in which Aldoc expression is visualized by expression of a fluorescent protein, Venus. Since there was no obvious phenotypes in general brain morphology and in the striped pattern of the cerebellum in mutants, we made detailed observation of Aldoc expression pattern in the nervous system by using Venus expression in Aldoc-Venus heterozygotes. High levels of Venus expression were observed in cerebellar PCs, cartwheel cells in the dorsal cochlear nucleus, sensory epithelium of the inner ear and in all major types of retinal cells, while moderate levels of Venus expression were observed in astrocytes and satellite cells in the dorsal root ganglion. The striped arrangement of PCs that express Venus to different degrees was carefully traced with serial section alignment analysis and mapped on the unfolded scheme of the entire cerebellar cortex to re-identify all individual Aldoc stripes. A longitudinally striped boundary of Aldoc expression was first identified in the mouse flocculus, and was correlated with the climbing fiber projection pattern and expression of another compartmental marker molecule, heat shock protein 25 (HSP25). As in the rat, the cerebellar nuclei were divided into the rostrodorsal negative and the caudoventral positive portions by distinct projections of Aldoc-positive and negative PC axons in the mouse. Identification of the cerebellar Aldoc stripes in this study, as indicated in sample coronal and horizontal sections as well as in sample surface photos of whole-mount preparations, can be referred to in future experiments.	[Fujita, Hirofumi; Aoki, Hanako; Sugihara, Izumi] Tokyo Med & Dent Univ, Grad Sch, Dept Syst Neurophysiol, Bunkyo Ku, Tokyo, Japan; [Ajioka, Itsuki; Sugihara, Izumi] Tokyo Med & Dent Univ, Grad Sch, Ctr Brain Integrat Res, Bunkyo Ku, Tokyo, Japan; [Yamazaki, Maya; Abe, Manabu; Sakimura, Kenji] Niigata Univ, Brain Res Inst, Dept Cellular Neurobiol, Niigata, Japan; [Oh-Nishi, Arata] Natl Inst Radiol Sci, Mol Neuroimaging Program, Mol Imaging Ctr, Inage Ku, Chiba 260, Japan; [Fujita, Hirofumi] Salk Inst Biol Studies, Syst Neurobiol Lab, La Jolla, CA 92037 USA; [Fujita, Hirofumi] Johns Hopkins Univ, Sch Med, Dept Otolaryngol Head & Neck Surg, Baltimore, MD 21205 USA	Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU); Niigata University; National Institutes for Quantum Science & Technology; Salk Institute; Johns Hopkins University	Sugihara, I (corresponding author), Tokyo Med & Dent Univ, Grad Sch, Dept Syst Neurophysiol, Bunkyo Ku, Tokyo, Japan.	isugihara.phy1@tmd.ac.jp	Yamazaki, Maya/C-6952-2012; Abe, Manabu/A-9221-2008; Fujita, Hirofumi/Q-6196-2017; Fujita, Hirofumi/HGB-4305-2022	Fujita, Hirofumi/0000-0001-9630-2756; Fujita, Hirofumi/0000-0001-9630-2756; Oh-Nishi, Arata/0000-0001-5427-4400	Japan Society for the Promotion of Science [23.5291, 25430032]; BBSRC [BB/G01227X/1] Funding Source: UKRI; Grants-in-Aid for Scientific Research [25430032, 24700321, 26430035] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	Grant-in-Aid for Scientific Research from the Japan Society for the Promotion of Science (23.5291 to HF, 25430032 to IS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHN AH, 1994, DEVELOPMENT, V120, P2081; Ajioka I, 2007, CELL, V131, P378, DOI 10.1016/j.cell.2007.09.036; AKINTUNDE A, 1994, J CHEM NEUROANAT, V7, P75, DOI 10.1016/0891-0618(94)90009-4; Apps R, 2009, NAT REV NEUROSCI, V10, P670, DOI 10.1038/nrn2698; Armstrong CL, 2000, J COMP NEUROL, V416, P383, DOI 10.1002/(SICI)1096-9861(20000117)416:3<383::AID-CNE9>3.0.CO;2-M; Bergersen LH, 2007, NEUROSCIENCE, V145, P11, DOI 10.1016/j.neuroscience.2006.11.062; BROCHU G, 1990, J COMP NEUROL, V291, P538, DOI 10.1002/cne.902910405; CAFFE AR, 1994, J COMP NEUROL, V348, P291, DOI 10.1002/cne.903480210; Cahoy JD, 2008, J NEUROSCI, V28, P264, DOI 10.1523/JNEUROSCI.4178-07.2008; Canete-Soler R, 2005, J NEUROSCI, V25, P4353, DOI 10.1523/JNEUROSCI.0885-05.2005; Forgac M, 2007, NAT REV MOL CELL BIO, V8, P917, DOI 10.1038/nrm2272; Fujita H, 2012, J NEUROSCI, V32, P15688, DOI 10.1523/JNEUROSCI.1710-12.2012; Fujita H, 2012, J COMP NEUROL, V520, P656, DOI 10.1002/cne.22760; Fujita H, 2010, J COMP NEUROL, V518, P1764, DOI 10.1002/cne.22301; Gebre SA, 2012, BRAIN STRUCT FUNCT, V217, P165, DOI 10.1007/s00429-011-0339-4; GRAVEL C, 1987, J COMP NEUROL, V265, P294, DOI 10.1002/cne.902650211; HALL B, 2009, CURR PROTOC CELL BIO, V44; Hallem JS, 1999, NEUROSCIENCE, V93, P1083, DOI 10.1016/S0306-4522(99)00144-X; Hanani M, 2002, NEUROSCIENCE, V114, P279, DOI 10.1016/S0306-4522(02)00279-8; HAWKES R, 1987, J COMP NEUROL, V256, P29, DOI 10.1002/cne.902560104; Kao AW, 1999, J BIOL CHEM, V274, P17742, DOI 10.1074/jbc.274.25.17742; LANNOO MJ, 1991, J COMP NEUROL, V310, P215, DOI 10.1002/cne.903100207; LEBHERZ HG, 1969, BIOCHEMISTRY-US, V8, P109, DOI 10.1021/bi00829a016; LEONARD CS, 1988, J NEUROPHYSIOL, V60, P2073, DOI 10.1152/jn.1988.60.6.2073; Lu M, 2004, J BIOL CHEM, V279, P8732, DOI 10.1074/jbc.M303871200; Lu M, 2001, J BIOL CHEM, V276, P30407, DOI 10.1074/jbc.M008768200; Mishina M, 2007, NEUROSCI RES, V58, P105, DOI 10.1016/j.neures.2007.01.004; Morohoshi K, 2012, EXP MOL PATHOL, V93, P193, DOI 10.1016/j.yexmp.2012.03.007; MUGNAINI E, 1987, P NATL ACAD SCI USA, V84, P8692, DOI 10.1073/pnas.84.23.8692; Nagai T, 2002, NAT BIOTECHNOL, V20, P87, DOI 10.1038/nbt0102-87; Navarro-Lerida I, 2004, PROTEOMICS, V4, P339, DOI 10.1002/pmic.200300528; Ozol K, 1999, J COMP NEUROL, V412, P95; Pham NQ, 2011, J COMP NEUROL, V519, P874, DOI 10.1002/cne.22555; Pijpers A, 2006, J NEUROSCI, V26, P12067, DOI 10.1523/JNEUROSCI.2905-06.2006; Romito-DiGiacomo RR, 2005, MOL BRAIN RES, V133, P47, DOI 10.1016/j.molbrainres.2004.09.030; Sarna JR, 2006, J COMP NEUROL, V496, P303, DOI 10.1002/cne.20912; Sarna JR, 2003, PROG NEUROBIOL, V70, P473, DOI 10.1016/S0301-0082(03)00114-X; Sarna JR, 2003, J COMP NEUROL, V456, P279, DOI 10.1002/cne.10522; Schonewille M, 2006, J COMP NEUROL, V497, P670, DOI 10.1002/cne.21036; Sillitoe RV, 2005, PROG BRAIN RES, V148, P283, DOI 10.1016/S0079-6123(04)48022-4; Sillitoe RV, 2004, J ANAT, V204, P257, DOI 10.1111/j.0021-8782.2004.00282.x; Sugihara I, 2004, J NEUROSCI, V24, P8771, DOI 10.1523/JNEUROSCI.1961-04.2004; Sugihara I, 2004, J COMP NEUROL, V470, P113, DOI 10.1002/cne.10952; Sugihara I, 2007, J NEUROSCI, V27, P9696, DOI 10.1523/JNEUROSCI.1579-07.2007; Sugihara I, 2007, J COMP NEUROL, V500, P1076, DOI 10.1002/cne.21219; Sugihara I, 2009, J COMP NEUROL, V512, P282, DOI 10.1002/cne.21889; Szaro BG, 2010, TRENDS NEUROSCI, V33, P27, DOI 10.1016/j.tins.2009.10.002; TAN J, 1995, J COMP NEUROL, V356, P23, DOI 10.1002/cne.903560103; TANO D, 1992, J COMP NEUROL, V323, P128, DOI 10.1002/cne.903230111; Terada N, 2004, J COMP NEUROL, V469, P119, DOI 10.1002/cne.11002; Volker KW, 1997, ARCH BIOCHEM BIOPHYS, V338, P237, DOI 10.1006/abbi.1996.9819; Voogd J, 2003, J NEUROSCI, V23, P4645; Voogd J, 1997, PROG BRAIN RES, V114, P21; Voogd J., 2004, RAT NERVOUS SYSTEM, V3rd, P205; Wadiche JI, 2005, NAT NEUROSCI, V8, P1329, DOI 10.1038/nn1539; Walther EU, 1998, P NATL ACAD SCI USA, V95, P2615, DOI 10.1073/pnas.95.5.2615; Wang JA, 1996, J BIOL CHEM, V271, P6861, DOI 10.1074/jbc.271.12.6861; Welsh JP, 2002, ADV NEUROL, V89, P331	58	55	56	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2014	9	1							e86679	10.1371/journal.pone.0086679	http://dx.doi.org/10.1371/journal.pone.0086679			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301BI	24475166	Green Submitted, Green Published, gold			2022-12-25	WOS:000330507300101
J	Samrat, SK; Li, W; Singh, S; Kumar, R; Agrawal, B				Samrat, Subodh Kumar; Li, Wen; Singh, Shakti; Kumar, Rakesh; Agrawal, Babita			Alternate Reading Frame Protein (F Protein) of Hepatitis C Virus: Paradoxical Effects of Activation and Apoptosis on Human Dendritic Cells Lead to Stimulation of T Cells	PLOS ONE			English	Article							ADAPTIVE IMMUNE-RESPONSES; CORE PROTEIN; FUNCTIONAL IMPAIRMENT; EXPRESSION; ANTIGENS; INDUCE; FAS; NS3; REPLICATION; HCV	Hepatitis C virus (HCV) leads to chronic infection in the majority of infected individuals due to lack, failure, or inefficiency of generated adaptive immune responses. In a minority of patients, acute infection is followed by viral clearance. The immune correlates of viral clearance are not clear yet but have been extensively investigated, suggesting that multispecific and multifunctional cellular immunity is involved. The generation of cellular immunity is highly dependent upon how antigen presenting cells (APCs) process and present various viral antigens. Various structural and non-structural HCV proteins derived from the open reading frame (ORF) have been implicated in modulation of dendritic cells (DCs) and APCs. Besides the major ORF proteins, the HCV core region also encodes an alternate reading frame protein (ARFP or F), whose function in viral pathogenesis is not clear. In the current studies, we sought to determine the role of HCV-derived ARFP in modulating dendritic cells and stimulation of T cell responses. Recombinant adenovirus vectors containing F or core protein derived from HCV (genotype 1a) were prepared and used to endogenously express these proteins in dendritic cells. We made an intriguing observation that endogenous expression of F protein in human DCs leads to contrasting effects on activation and apoptosis of DCs, allowing activated DCs to efficiently internalize apoptotic DCs. These in turn result in efficient ability of DCs to process and present antigen and to prime and stimulate F protein derived peptide-specific T cells from HCV-naive individuals. Taken together, our findings suggest important aspects of F protein in modulating DC function and stimulating T cell responses in humans.	[Samrat, Subodh Kumar; Li, Wen; Singh, Shakti; Agrawal, Babita] Univ Alberta, Dept Surg, Fac Med & Dent, Edmonton, AB, Canada; [Kumar, Rakesh] Univ Alberta, Fac Med & Dent, Dept Lab Med & Pathol, Edmonton, AB, Canada	University of Alberta; University of Alberta	Agrawal, B (corresponding author), Univ Alberta, Dept Surg, Fac Med & Dent, Edmonton, AB, Canada.	bagrawal@ualberta.ca	Samrat, Subodh/AAA-2083-2021; samrat, subodh/AAN-1043-2021; singh, shakti/D-4070-2014	Samrat, Subodh/0000-0002-8600-3901; singh, shakti/0000-0001-6521-0998	Canadian Institutes of Health Research; Alberta Innovates-Health Solutions	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Alberta Innovates-Health Solutions	This work was supported by grants from the Canadian Institutes of Health Research. BA is a recipient of a senior scholar award from the Alberta Heritage Foundation for Medical Research (now Alberta Innovates-Health Solutions). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe T, 2007, J VIROL, V81, P8953, DOI 10.1128/JVI.00649-07; Ahonen CL, 2004, J EXP MED, V199, P775, DOI 10.1084/jem.20031591; Ahonen CL, 2008, BLOOD, V111, P3116, DOI 10.1182/blood-2007-09-114371; Albert ML, 1998, NATURE, V392, P86, DOI 10.1038/32183; Albert ML, 1998, J EXP MED, V188, P1359, DOI 10.1084/jem.188.7.1359; Anthony DD, 2004, J IMMUNOL, V172, P4907, DOI 10.4049/jimmunol.172.8.4907; Auffermann-Gratzinger S, 2001, BLOOD, V97, P3171, DOI 10.1182/blood.V97.10.3171; Bain C, 2004, J VIROL, V78, P10460, DOI 10.1128/JVI.78.19.10460-10469.2004; Bain C, 2001, GASTROENTEROLOGY, V120, P512, DOI 10.1053/gast.2001.21212; Blackard JT, 2006, HEPATOLOGY, V44, P15, DOI 10.1002/hep.21283; Bowen DG, 2005, NATURE, V436, P946, DOI 10.1038/nature04079; Branch AD, 2005, SEMIN LIVER DIS, V25, P105, DOI 10.1055/s-2005-864786; Burgel B, 2011, J VIRAL HEPATITIS, V18, P562, DOI 10.1111/j.1365-2893.2010.01339.x; CHOO QL, 1989, SCIENCE, V244, P359, DOI 10.1126/science.2523562; Creagh EM, 2006, TRENDS IMMUNOL, V27, P352, DOI 10.1016/j.it.2006.06.003; Dolganiuc A, 2003, J IMMUNOL, V170, P5615, DOI 10.4049/jimmunol.170.11.5615; Fletcher NF, 2012, J VIRAL HEPATITIS, V19, P301, DOI 10.1111/j.1365-2893.2012.01591.x; FugierVivier I, 1997, J EXP MED, V186, P813, DOI 10.1084/jem.186.6.813; Gould E., 2011, VIRUS TAXONOMY, P1003, DOI DOI 10.1016/J.BJID.2014.12.003; Honda M, 2000, HEPATOLOGY, V31, P1351, DOI 10.1053/jhep.2000.7985; Hoofnagle JH, 2002, HEPATOLOGY, V36, pS21, DOI 10.1053/jhep.2002.36227; Iannello A, 2011, VIRAL IMMUNOL, V24, P11, DOI 10.1089/vim.2010.0083; Jahan S, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-522; Jain S, 2010, PLOS ONE, V6; KAGI D, 1994, SCIENCE, V265, P528, DOI 10.1126/science.7518614; Kanto T, 2004, J INFECT DIS, V190, P1919, DOI 10.1086/425425; Kanto T, 1999, J IMMUNOL, V162, P5584; Kanto T, 2004, J GASTROENTEROL, V39, P811, DOI 10.1007/s00535-004-1413-y; Komurian-Pradel F, 2004, HEPATOLOGY, V40, P900, DOI 10.1002/hep.20406; Krishnadas DK, 2010, INT IMMUNOL, V22, P491, DOI 10.1093/intimm/dxq033; Kushwah R, 2010, EUR J IMMUNOL, V40, P1022, DOI 10.1002/eji.200939782; LANFORD RE, 1995, J VIROL, V69, P8079, DOI 10.1128/JVI.69.12.8079-8083.1995; Larsson M, 2004, J VIROL, V78, P6151, DOI 10.1128/JVI.78.12.6151-6161.2004; Larsson M, 2001, TRENDS IMMUNOL, V22, P141, DOI 10.1016/S1471-4906(01)01860-9; Lau AH, 2003, GUT, V52, P307, DOI 10.1136/gut.52.2.307; Li W, 2006, J GEN VIROL, V87, P61, DOI 10.1099/vir.0.81364-0; Li W, 2008, INT IMMUNOL, V20, P89, DOI 10.1093/intimm/dxm121; Li W, 2006, J IMMUNOL, V176, P6065, DOI 10.4049/jimmunol.176.10.6065; Liu BS, 2009, J LEUKOCYTE BIOL, V85, P205, DOI 10.1189/jlb.0408241; Longman RS, 2005, J INFECT DIS, V192, P497, DOI 10.1086/431523; Longman RS, 2004, BLOOD, V103, P1026, DOI 10.1182/blood-2003-04-1339; LOWIN B, 1994, NATURE, V370, P650, DOI 10.1038/370650a0; McMullan LK, 2007, P NATL ACAD SCI USA, V104, P2879, DOI 10.1073/pnas.0611267104; Moradpour D, 2007, NAT REV MICROBIOL, V5, P453, DOI 10.1038/nrmicro1645; Nieda M, 2001, IMMUNOLOGY, V102, P137, DOI 10.1046/j.1365-2567.2001.01175.x; Nogueira CV, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000478; Pachiadakis L, 2005, LANCET INFECT DIS, V5, P296, DOI 10.1016/S1473-3099(05)70114-6; Piccioli D, 2005, J HEPATOL, V42, P61, DOI 10.1016/j.jhep.2004.09.014; Rehermann B, 2009, J CLIN INVEST, V119, P1745, DOI 10.1172/JCI39133; Rollier C, 2003, HEPATOLOGY, V38, P851, DOI 10.1053/jhep.2003.50426; Ruggieri A, 1997, VIROLOGY, V229, P68, DOI 10.1006/viro.1996.8420; Russo V, 2000, P NATL ACAD SCI USA, V97, P2185, DOI 10.1073/pnas.040540197; Scarlett UK, 2009, CANCER RES, V69, P7329, DOI 10.1158/0008-5472.CAN-09-0835; Servet-Delprat C, 2000, J VIROL, V74, P4387, DOI 10.1128/JVI.74.9.4387-4393.2000; Shoukry NH, 2003, J EXP MED, V197, P1645, DOI 10.1084/jem.20030239; Simmonds P, 2005, HEPATOLOGY, V42, P962, DOI 10.1002/hep.20819; STEINMAN RM, 1991, ANNU REV IMMUNOL, V9, P271, DOI 10.1146/annurev.iy.09.040191.001415; Takaki A, 2010, J VIRAL HEPATITIS, V17, P555, DOI 10.1111/j.1365-2893.2009.01213.x; Thoren F, 2004, J LEUKOCYTE BIOL, V76, P1180, DOI 10.1189/jlb.0704387; Tu ZK, 2012, INT IMMUNOL, V24, P97, DOI 10.1093/intimm/dxr104; Varaklioti A, 2002, J BIOL CHEM, V277, P17713, DOI 10.1074/jbc.M201722200; Walewski JL, 2001, RNA, V7, P710, DOI 10.1017/S1355838201010111; Wertheimer AM, 2007, HEPATOLOGY, V45, P1422, DOI 10.1002/hep.21637; World Health Organization, 2011, WHO REP; Xu ZM, 2001, EMBO J, V20, P3840, DOI 10.1093/emboj/20.14.3840; Yakushijin T, 2006, HEPATOL RES, V34, P156, DOI 10.1016/j.hepres.2005.12.010; Zhu NL, 1998, J VIROL, V72, P3691, DOI 10.1128/JVI.72.5.3691-3697.1998	67	15	16	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2014	9	1							e86567	10.1371/journal.pone.0086567	http://dx.doi.org/10.1371/journal.pone.0086567			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301BI	24475147	gold, Green Published, Green Submitted			2022-12-25	WOS:000330507300083
J	Sega, EI; Leveson-Gower, DB; Florek, M; Schneidawind, D; Luong, RH; Negrin, RS				Sega, Emanuela I.; Leveson-Gower, Dennis B.; Florek, Mareike; Schneidawind, Dominik; Luong, Richard H.; Negrin, Robert S.			Role of Lymphocyte Activation Gene-3 (Lag-3) in Conventional and Regulatory T Cell Function in Allogeneic Transplantation	PLOS ONE			English	Article							VERSUS-HOST-DISEASE; BONE-MARROW-TRANSPLANTATION; TGF-BETA; EFFECTOR FUNCTION; CUTTING EDGE; IN-VIVO; CD223; SUPPRESSION; EXPRESSION; CD4(+)	Lag-3 has emerged as an important molecule in T cell biology. We investigated the role of Lag-3 in conventional T cell (Tcon) and regulatory T cell (Treg) function in murine GVHD with the hypothesis that Lag-3 engagement diminishes alloreactive T cell responses after bone marrow transplantation. We demonstrate that Lag-3 deficient Tcon (Lag-3(-/-) Tcon) induce significantly more severe GVHD than wild type (WT) Tcon and that the absence of Lag-3 on CD4 but not CD8 T cells is responsible for exacerbating GVHD. Lag-30(-/-) Tcon exhibited increased activation and proliferation as indicated by CFSE and bioluminescence imaging analyses and higher levels of activation markers such as CD69, CD107a, granzyme B, and Ki-67 as well as production of IL-10 and IFN-g early after transplantation. Lag-3(-/-) Tcon were less responsive to suppression by WT Treg as compared to WT Tcon. The absence of Lag-3, however, did not impair Treg function as both Lag-3(-/-) and WT Treg equally suppress the proliferation of Tcon in vitro and in vivo and protect against GVHD. Further, we demonstrate that allogeneic Treg acquire recipient MHC class II molecules through a process termed trogocytosis. As MHC class II is a ligand for Lag-3, we propose a novel suppression mechanism employed by Treg involving the acquisition of host MHC-II followed by the engagement of Lag-3 on T cells. These studies demonstrate for the first time the biologic function of Lag-3 expression on conventional and regulatory T cells in GVHD and identify Lag-3 as an important regulatory molecule involved in alloreactive T cell proliferation and activation after bone marrow transplantation.	[Sega, Emanuela I.; Leveson-Gower, Dennis B.; Florek, Mareike; Schneidawind, Dominik; Negrin, Robert S.] Stanford Univ, Dept Med, Stanford, CA 94305 USA; [Luong, Richard H.] Stanford Univ, Dept Comparat Med, Stanford, CA 94305 USA	Stanford University; Stanford University	Negrin, RS (corresponding author), Stanford Univ, Dept Med, Stanford, CA 94305 USA.	negrs@stanford.edu	Schneidawind, Dominik/AAR-4509-2020		National Heart, Lung and Blood Institute [P01HL075462]; National Cancer Institute [P01CA49605]; NATIONAL CANCER INSTITUTE [P01CA049605] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL075462] Funding Source: NIH RePORTER	National Heart, Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by grants from the National Heart, Lung and Blood Institute (P01HL075462) and the National Cancer Institute (P01CA49605). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreae S, 2003, BLOOD, V102, P2130, DOI 10.1182/blood-2003-01-0273; Banovic T, 2005, BLOOD, V106, P2206, DOI 10.1182/blood-2005-01-0062; Beilhack A, 2005, BLOOD, V106, P1113, DOI 10.1182/blood-2005-02-0509; Bettini M, 2011, J IMMUNOL, V187, P3493, DOI 10.4049/jimmunol.1100714; Blackburn SD, 2009, NAT IMMUNOL, V10, P29, DOI 10.1038/ni.1679; Blazar BR, 1998, TRANSPLANTATION, V66, P1220, DOI 10.1097/00007890-199811150-00018; Blazar BR, 2003, J IMMUNOL, V171, P1272, DOI 10.4049/jimmunol.171.3.1272; Buisson S, 2005, IMMUNOLOGY, V114, P369, DOI 10.1111/j.1365-2567.2004.02087.x; CHANG CH, 1995, INT IMMUNOL, V7, P1515, DOI 10.1093/intimm/7.9.1515; Chen WJ, 2003, J EXP MED, V198, P1875, DOI 10.1084/jem.20030152; Cohen JL, 2006, CURR OPIN IMMUNOL, V18, P580, DOI 10.1016/j.coi.2006.07.007; Collison LW, 2007, NATURE, V450, P566, DOI 10.1038/nature06306; Colonna L, 2011, BIOL BLOOD MARROW TR, V17, pS58, DOI 10.1016/j.bbmt.2010.10.020; Davis DM, 2007, NAT REV IMMUNOL, V7, P238, DOI 10.1038/nri2020; Edinger M, 2003, NAT MED, V9, P1144, DOI 10.1038/nm915; Ferrara JLM, 2009, LANCET, V373, P1550, DOI 10.1016/S0140-6736(09)60237-3; Gondek DC, 2005, J IMMUNOL, V174, P1783, DOI 10.4049/jimmunol.174.4.1783; Gorelik L, 2000, IMMUNITY, V12, P171, DOI 10.1016/S1074-7613(00)80170-3; Grossman WJ, 2004, IMMUNITY, V21, P589, DOI 10.1016/j.immuni.2004.09.002; Grosso JF, 2007, J CLIN INVEST, V117, P3383, DOI 10.1172/JCI31184; Hoffmann P, 2002, J EXP MED, V196, P389, DOI 10.1084/jem.20020399; Huang CT, 2004, IMMUNITY, V21, P503, DOI 10.1016/j.immuni.2004.08.010; HUARD B, 1995, EUR J IMMUNOL, V25, P2718, DOI 10.1002/eji.1830250949; HUARD B, 1994, IMMUNOGENETICS, V39, P213; HUARD B, 1994, EUR J IMMUNOL, V24, P3216, DOI 10.1002/eji.1830241246; Kisielow M, 2005, EUR J IMMUNOL, V35, P2081, DOI 10.1002/eji.200526090; Leveson-Gower DB, 2011, BLOOD, V117, P3220, DOI 10.1182/blood-2010-08-303008; Li NY, 2007, EMBO J, V26, P494, DOI 10.1038/sj.emboj.7601520; Lucas CL, 2011, BLOOD, V117, P5532, DOI 10.1182/blood-2010-11-318675; Miyara M, 2007, TRENDS MOL MED, V13, P108, DOI 10.1016/j.molmed.2007.01.003; Nakamura K, 2001, J EXP MED, V194, P629, DOI 10.1084/jem.194.5.629; Nguyen VH, 2007, BLOOD, V109, P2649, DOI 10.1182/blood-2006-08-044529; Okamura T, 2009, P NATL ACAD SCI USA, V106, P13974, DOI 10.1073/pnas.0906872106; Reddy P, 2008, MOUSE MODELS GRAFT V; Rubtsov YP, 2008, IMMUNITY, V28, P546, DOI 10.1016/j.immuni.2008.02.017; Taylor PA, 2002, BLOOD, V99, P3493, DOI 10.1182/blood.V99.10.3493; TRIEBEL F, 1990, J EXP MED, V171, P1393, DOI 10.1084/jem.171.5.1393; Veenstra RG, 2012, BLOOD, V120, P682, DOI 10.1182/blood-2011-10-387977; Workman CJ, 2004, J IMMUNOL, V172, P5450, DOI 10.4049/jimmunol.172.9.5450; Workman CJ, 2003, EUR J IMMUNOL, V33, P970, DOI 10.1002/eji.200323382; Workman CJ, 2009, J IMMUNOL, V182, P1885, DOI 10.4049/jimmunol.0800185; Yamaguchi T, 2011, SEMIN IMMUNOL, V23, P424, DOI 10.1016/j.smim.2011.10.002; Zhou G, 2011, J IMMUNOL, V186, P2148, DOI 10.4049/jimmunol.1002917	43	51	56	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2014	9	1							e86551	10.1371/journal.pone.0086551	http://dx.doi.org/10.1371/journal.pone.0086551			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301BI	24475140	Green Published, gold, Green Submitted			2022-12-25	WOS:000330507300077
J	Soliai, MM; Meyer, SE; Udall, JA; Elzinga, DE; Hermansen, RA; Bodily, PM; Hart, AA; Coleman, CE				Soliai, Marcus M.; Meyer, Susan E.; Udall, Joshua A.; Elzinga, David E.; Hermansen, Russell A.; Bodily, Paul M.; Hart, Aaron A.; Coleman, Craig E.			De novo Genome Assembly of the Fungal Plant Pathogen Pyrenophora semeniperda	PLOS ONE			English	Article							REPENTIS-WHEAT INTERACTION; DIELS-ALDER REACTION; TRITICI-REPENTIS; TRANSPOSABLE ELEMENTS; BROMUS-TECTORUM; TAN SPOT; CHROMOSOME REARRANGEMENTS; GENE-EXPRESSION; TOXB GENE; SEQUENCE	Pyrenophora semeniperda (anamorph Drechslera campulata) is a necrotrophic fungal seed pathogen that has a wide host range within the Poaceae. One of its hosts is cheatgrass (Bromus tectorum), a species exotic to the United States that has invaded natural ecosystems of the Intermountain West. As a natural pathogen of cheatgrass, P. semeniperda has potential as a biocontrol agent due to its effectiveness at killing seeds within the seed bank; however, few genetic resources exist for the fungus. Here, the genome of P. semeniperda isolate assembled from sequence reads of 454 pyrosequencing is presented. The total assembly is 32.5 Mb and includes 11,453 gene models encoding putative proteins larger than 24 amino acids. The models represent a variety of putative genes that are involved in pathogenic pathways typically found in necrotrophic fungi. In addition, extensive rearrangements, including inter-and intrachromosomal rearrangements, were found when the P. semeniperda genome was compared to P. tritici-repentis, a related fungal species.	[Soliai, Marcus M.; Udall, Joshua A.; Elzinga, David E.; Hermansen, Russell A.; Bodily, Paul M.; Hart, Aaron A.; Coleman, Craig E.] Brigham Young Univ, Provo, UT 84602 USA; [Meyer, Susan E.] US Forest Serv, USDA, Rocky Mt Res Stn, Shrub Sci Lab, Provo, UT USA	Brigham Young University; United States Department of Agriculture (USDA); United States Forest Service	Coleman, CE (corresponding author), Brigham Young Univ, Provo, UT 84602 USA.	craig_coleman@byu.edu		Soliai, Marcus/0000-0003-3458-0739	CSREES, National Research Initiative, United States Department of Agriculture [2008-35320-18677]	CSREES, National Research Initiative, United States Department of Agriculture	This research was funded by grant 2008-35320-18677 from CSREES, National Research Initiative, United States Department of Agriculture. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aboukhaddour R, 2009, MOL PLANT PATHOL, V10, P201, DOI 10.1111/j.1364-3703.2008.00520.x; Amaike S, 2008, PLANT PATHOL, V57, P623, DOI 10.1111/j.1365-3059.2007.01821.x; Beckstead J, 2007, ANN BOT-LONDON, V99, P907, DOI 10.1093/aob/mcm028; Berglund AC, 2008, NUCLEIC ACIDS RES, V36, pD263, DOI 10.1093/nar/gkm1020; Boose D, 2011, MYCOLOGIA, V103, P85, DOI 10.3852/09-310; BRITTLEBANK C. C., 1924, Transactions of the British Mycological Society, V10, P123; Cantarel BL, 2008, GENOME RES, V18, P188, DOI 10.1101/gr.6743907; Ciuffetti LM, 1999, PHYTOPATHOLOGY, V89, P444, DOI 10.1094/PHYTO.1999.89.6.444; Ciuffetti LM, 2010, NEW PHYTOL, V187, P911, DOI 10.1111/j.1469-8137.2010.03362.x; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Daboussi MJ, 2003, ANNU REV MICROBIOL, V57, P275, DOI 10.1146/annurev.micro.57.030502.091029; De Wolf ED, 1998, CAN J PLANT PATHOL, V20, P349, DOI 10.1080/07060669809500404; Dean RA, 2005, NATURE, V434, P980, DOI 10.1038/nature03449; Delcher AL, 2002, NUCLEIC ACIDS RES, V30, P2478, DOI 10.1093/nar/30.11.2478; Ellwood SR, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-11-r109; Espagne E, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-5-r77; Evidente A, 2002, PHYTOCHEMISTRY, V60, P45, DOI 10.1016/S0031-9422(02)00071-7; Galagan JE, 2005, GENOME RES, V15, P1620, DOI 10.1101/gr.3767105; Galagan JE, 2003, NATURE, V422, P859, DOI 10.1038/nature01554; Gotz S, 2008, NUCLEIC ACIDS RES, V36, P3420, DOI 10.1093/nar/gkn176; Hane JK, 2007, PLANT CELL, V19, P3347, DOI 10.1105/tpc.107.052829; Hood ME, 2005, GENETICS, V170, P1081, DOI 10.1534/genetics.105.042564; Horton P, 2007, NUCLEIC ACIDS RES, V35, pW585, DOI 10.1093/nar/gkm259; Huse SM, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r143; Johnson RD, 2000, MOL PLANT MICROBE IN, V13, P742, DOI 10.1094/MPMI.2000.13.7.742; KREITLOW KW, 1964, PHYTOPATHOLOGY, V54, P353; Kroken S, 2003, P NATL ACAD SCI USA, V100, P15670, DOI 10.1073/pnas.2532165100; Krzywinski MI, 2009, GENOME RES; KUPIEC M, 1988, GENETICS, V119, P549; Kurtz S, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r12; Ladeveze V, 1998, P ROY SOC B-BIOL SCI, V265, P1157, DOI 10.1098/rspb.1998.0412; Lahn BT, 1999, SCIENCE, V286, P964, DOI 10.1126/science.286.5441.964; LAMARI L, 1991, PHYTOPATHOLOGY, V81, P1092, DOI 10.1094/Phyto-81-1092; LIM JK, 1994, BIOESSAYS, V16, P269, DOI 10.1002/bies.950160410; Liu ZH, 2011, MOL PLANT PATHOL, V12, P1, DOI 10.1111/j.1364-3703.2010.00649.x; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Maksakova IA, 2005, J VIROL, V79, P13865, DOI 10.1128/JVI.79.22.13865-13874.2005; Manning VA, 2013, G3-GENES GENOM GENET, V3, P41, DOI 10.1534/g3.112.004044; Martinez JP, 2004, MOL PLANT MICROBE IN, V17, P467, DOI 10.1094/MPMI.2004.17.5.467; Medd RW, 2005, BIOCONTROL SCI TECHN, V15, P21, DOI 10.1080/09583150410001720635; Medd RW, 2003, AUSTRALAS PLANT PATH, V32, P539, DOI 10.1071/AP03059; Meyer SE, 2007, WEED RES, V47, P54, DOI 10.1111/j.1365-3180.2007.00537.x; Mieczkowski PA, 2006, DNA REPAIR, V5, P1010, DOI 10.1016/j.dnarep.2006.05.027; Mills RE, 2007, TRENDS GENET, V23, P183, DOI 10.1016/j.tig.2007.02.006; Nelson EB, 1994, TURF GRASS TRENDS, V3, P11; Nelson EB, 1994, TURF GRASS TRENDS, V3, P1; O' Gara PJ, 1915, PHYTOPATHOLOGY, V5, P323; Oide S, 2006, PLANT CELL, V18, P2836, DOI 10.1105/tpc.106.045633; Oikawa H, 2004, NAT PROD REP, V21, P321, DOI 10.1039/b305068h; OIKAWA H, 1992, J CHEM SOC PERK T 1, P2955, DOI 10.1039/p19920002955; Pain A, 2008, NAT REV MICROBIOL, V6, P572, DOI 10.1038/nrmicro1964; Phillippy AM, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-3-r55; Raices M, 2002, BBA-GENE STRUCT EXPR, V1576, P15, DOI 10.1016/S0167-4781(02)00243-9; Remm M, 2001, J MOL BIOL, V314, P1041, DOI 10.1006/jmbi.2000.5197; Schatz MC, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-3-r34; Schumann J, 2007, J AM CHEM SOC, V129, P9564, DOI 10.1021/ja072884t; SCOTTCRAIG JS, 1992, J BIOL CHEM, V267, P26044; SHABEER A, 1988, PLANT DIS, V72, P599, DOI 10.1094/PD-72-0599; Singh PK, 2008, PHYTOPATHOLOGY, V98, P702, DOI 10.1094/PHYTO-98-6-0702; Smit A, 1996, REPEATMASKER OPEN 30; SMITH TF, 1981, J MOL BIOL, V147, P195, DOI 10.1016/0022-2836(81)90087-5; Soderlund C, 2006, GENOME RES, V16, P1159, DOI 10.1101/gr.5396706; Strelkov SE, 2005, PHYSIOL MOL PLANT P, V67, P164, DOI 10.1016/j.pmpp.2005.12.004; Strelkov SE, 2002, CAN J PLANT PATHOL, V24, P29, DOI 10.1080/07060660109506967; Tekauz A., 1980, Canadian Journal of Plant Pathology, V2, P152; Thornburg BG, 2006, GENE, V365, P104, DOI 10.1016/j.gene.2005.09.036; WALLACE H. A. H., 1959, CANADIAN JOUR BOT, V37, P509, DOI 10.1139/b59-043; Wanchanthuek P, 2006, TOPICS CURRENT GENET; Winnenburg R, 2008, NUCLEIC ACIDS RES, V36, pD572, DOI 10.1093/nar/gkm858; Wolfgruber TK, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000743; Wostemeyer J, 2002, CURR GENET, V41, P189, DOI 10.1007/s00294-002-0306-y; Yonow T, 2004, PHYTOPATHOLOGY, V94, P805, DOI 10.1094/PHYTO.2004.94.8.805	73	20	20	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2014	9	1							e87045	10.1371/journal.pone.0087045	http://dx.doi.org/10.1371/journal.pone.0087045			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301BI	24475219	gold, Green Published			2022-12-25	WOS:000330507300129
J	Tran, BX; Nguyen, TV; Pham, QD; Nguyen, PD; Khuu, NV; Nguyen, NP; Bui, DH; Phan, HTT; Nguyen, LT				Bach Xuan Tran; Thuong Vu Nguyen; Quang Duy Pham; Phuc Duy Nguyen; Nghia Van Khuu; Nhung Phuong Nguyen; Duc Hoang Bui; Huong Thu Thi Phan; Long Thanh Nguyen			HIV Infection, Risk Factors, and Preventive Services Utilization among Female Sex Workers in the Mekong Delta Region of Vietnam	PLOS ONE			English	Article							SEXUALLY-TRANSMITTED INFECTIONS	Background: Risk behaviors among female sex workers (FSW) are considerable drivers of HIV infections in Vietnam, especially transmission between high-risk and low-risk groups. We assessed HIV prevalence and its correlates among FSWs, and the use of preventive services among this community in the Mekong Delta region, southern Vietnam. Methods: A cross-sectional survey of 1,999 FSWs was carried out in five provinces including Ben Tre, Hau Giang, Kien Giang, Tien Giang, and Vinh Long between June, 2006 and June, 2007. We interviewed participants face-to-face in order to elicit information about their lives and potential risk factors, and we tested their sera to determine their HIV status. We then performed multivariate logistic regression analyses to investigate factors associated with HIV infection. Results: Seventeen percent of the participating FSWs were street-based sex workers (SSWs) and the rest (83%) were entertainment establishment-based sex workers (ESWs). Unprotected sex with regular and casual clients in the past month was frequent among study participants (40.5% and 33.5% respectively). However, few respondents (1.3%) had ever injected drugs. Only 2.1% (95% confidence interval (CI): 1.6%-2.8%) of FSWs were found to be infected with HIV. HIV prevalence among SSWs was greater than among ESWs (3.8% vs. 1.8%, p = 0.02, respectively). Increased risk for HIV infection was significantly associated with the number of clients per month (adjusted odd ratio (aOR) = 2.65, 95% CI: 1.26-5.59). Conclusions: Interventions to reduce unsafe sex and drug injection, and to increase uptake of HIV testing among FSWs are necessary. Differences in HIV prevalence and its correlates by type of sex work emphasize the importance of constrained contexts in shaping risk behaviors among FSWs; that should be considered in designing HIV prevention programs.	[Bach Xuan Tran] Hanoi Med Univ, Hanoi, Vietnam; [Thuong Vu Nguyen; Quang Duy Pham; Phuc Duy Nguyen; Nghia Van Khuu] Inst Pasteur, Ho Chi Minh City, Vietnam; [Nhung Phuong Nguyen] Univ Texas Hlth Sci Ctr Houston, Houston, TX 77030 USA; [Duc Hoang Bui; Huong Thu Thi Phan; Long Thanh Nguyen] Minist Hlth, Author HIV AIDS Control, Hanoi, Vietnam	Hanoi Medical University; University of Texas System; University of Texas Health Science Center Houston	Tran, BX (corresponding author), Hanoi Med Univ, Hanoi, Vietnam.	bach@hmu.edu.vn; nguyenthuong@yahoo.com	Nguyen, Nhung/J-8012-2019; Nguyen, Thuong/AAU-8692-2020	Nguyen, Nhung/0000-0002-8661-9597; 				Tran BX, 2013, GLOBAL HEALTH ACTION, V6, P1, DOI [10.3402/gha.v6i0.19570, 10.3402/gha.v6i0.18619]; Baral S, 2012, LANCET INFECT DIS, V12, P538, DOI 10.1016/S1473-3099(12)70066-X; Ford K, 2000, AIDS CARE, V12, P523, DOI 10.1080/095401200750003716; Ghys Peter D, 2003, AIDS, V17 Suppl 4, pS45, DOI 10.1097/00002030-200317004-00005; (ICRW) ICfRoW, 2004, UND HIV AIDS REL STI; Medhi GK, 2012, AIDS CARE, V24, P369, DOI 10.1080/09540121.2011.608787; Ministry of Health M, 2009, HIV EST PROJ 2007 20; Nemoto T, 2008, AIDS EDUC PREV, V20, P435, DOI 10.1521/aeap.2008.20.5.435; Nguyen TA, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-37; Nguyen TV, 2008, SEX TRANSM DIS, V35, P935, DOI 10.1097/OLQ.0b013e3181812d03; Nguyen T, 2009, AIDS BEHAV, V13, P873, DOI 10.1007/s10461-008-9499-5; Poon AN, 2011, AIDS CARE, V23, P5, DOI 10.1080/09540121.2011.554519; Thuong NV, 2005, SEX TRANSM INFECT, V81, P477, DOI 10.1136/sti.2005.016097; Thuong NV, 2005, SEX TRANSM DIS, V32, P550, DOI 10.1097/01.olq.0000175415.06716.6d; Thuy NTT, 1998, AIDS, V12, P425, DOI 10.1097/00002030-199804000-00012; Tran TN, 2005, JAIDS-J ACQ IMM DEF, V39, P581; UNAIDS, 2010, UNAIDS REP GLOB AIDS; UNAIDS, 2012, HIV SEX WORK COLL IN; Vietnam, 2012, VIETN AIDS RESP PROG; Wang HB, 2012, SEX TRANSM DIS, V39, P835, DOI 10.1097/OLQ.0b013e318266b241	20	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2014	9	1							e86267	10.1371/journal.pone.0086267	http://dx.doi.org/10.1371/journal.pone.0086267			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	298QQ	24475096	Green Published, gold, Green Submitted			2022-12-25	WOS:000330339800036
J	Guillemin, C; Provencal, N; Suderman, M; Cote, SM; Vitaro, F; Hallett, M; Tremblay, RE; Szyf, M				Guillemin, Claire; Provencal, Nadine; Suderman, Matthew; Cote, Sylvana M.; Vitaro, Frank; Hallett, Michael; Tremblay, Richard E.; Szyf, Moshe			DNA Methylation Signature of Childhood Chronic Physical Aggression in T Cells of Both Men and Women	PLOS ONE			English	Article							POSTTRAUMATIC-STRESS-DISORDER; GLUCOCORTICOID-RECEPTOR; SALIVARY CORTISOL; MAJOR DEPRESSION; CHROMATIN-STRUCTURE; PRENATAL EXPOSURE; BEHAVIOR PROBLEMS; GENETIC-VARIATION; CHILDREN; LIFE	Background: High frequency of physical aggression is the central feature of severe conduct disorder and is associated with a wide range of social, mental and physical health problems. We have previously tested the hypothesis that differential DNA methylation signatures in peripheral T cells are associated with a chronic aggression trajectory in males. Despite the fact that sex differences appear to play a pivotal role in determining the development, magnitude and frequency of aggression, most of previous studies focused on males, so little is known about female chronic physical aggression. We therefore tested here whether or not there is a signature of physical aggression in female DNA methylation and, if there is, how it relates to the signature observed in males. Methodology/Principal Findings: Methylation profiles were created using the method of methylated DNA immunoprecipitation (MeDIP) followed by microarray hybridization and statistical and bioinformatic analyses on T cell DNA obtained from adult women who were found to be on a chronic physical aggression trajectory (CPA) between 6 and 12 years of age compared to women who followed a normal physical aggression trajectory. We confirmed the existence of a well-defined, genome-wide signature of DNA methylation associated with chronic physical aggression in the peripheral T cells of adult females that includes many of the genes similarly associated with physical aggression in the same cell types of adult males. Conclusions: This study in a small number of women presents preliminary evidence for a genome-wide variation in promoter DNA methylation that associates with CPA in women that warrant larger studies for further verification. A significant proportion of these associations were previously observed in men with CPA supporting the hypothesis that the epigenetic signature of early life aggression in females is composed of a component specific to females and another common to both males and females.	[Guillemin, Claire; Provencal, Nadine; Suderman, Matthew; Szyf, Moshe] McGill Univ, Dept Pharmacol & Therapeut, Montreal, PQ, Canada; [Guillemin, Claire; Provencal, Nadine; Cote, Sylvana M.; Vitaro, Frank; Tremblay, Richard E.] Univ Montreal, Res Unit Childrens Psychosocial Maladjustment, Montreal, PQ, Canada; [Guillemin, Claire; Provencal, Nadine; Cote, Sylvana M.; Vitaro, Frank; Tremblay, Richard E.] Univ Montreal, Ste Justine Hosp Res Ctr, Montreal, PQ, Canada; [Guillemin, Claire; Provencal, Nadine; Suderman, Matthew; Szyf, Moshe] McGill Univ, Sackler Program Epigenet & Psychobiol, Montreal, PQ, Canada; [Tremblay, Richard E.] Univ Montreal, Dept Psychol & Pediat, Montreal, PQ, Canada; [Tremblay, Richard E.] Univ Coll Dublin, Sch Publ Hlth & Populat Sci, Dublin 2, Ireland; [Cote, Sylvana M.; Tremblay, Richard E.] INSERM, U669, Paris, France; [Suderman, Matthew; Hallett, Michael] McGill Univ, McGill Ctr Bioinformat, Montreal, PQ, Canada; [Vitaro, Frank] Univ Montreal, Sch Psychoeduc, Montreal, PQ, Canada; [Cote, Sylvana M.] Univ Montreal, Sch Social & Prevent Med, Montreal, PQ, Canada	McGill University; Universite de Montreal; Universite de Montreal; McGill University; Universite de Montreal; University College Dublin; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; McGill University; Universite de Montreal; Universite de Montreal	Tremblay, RE (corresponding author), Univ Montreal, Res Unit Childrens Psychosocial Maladjustment, Montreal, PQ, Canada.	richard.tremblay@ucd.ie; moshe.szyf@mcgill.ca	Cote, Silvana Maria/O-1356-2014; Tremblay, Richard E./O-1360-2014; Côté, Sylvana M./T-4600-2019	Côté, Sylvana M./0000-0001-7944-0647; Provencal, Nadine/0000-0002-2079-8393; Hallett, Michael/0000-0001-6738-6786; Suderman, Matthew/0000-0002-2715-9930	Quebec Training Network in Perinatal Research (QTNPR) Program from CIHR; Genes, Environment and Health Training Program from CIHR; Canadian Institutes of Health Research [MOP-42411]; Social Sciences Humanities Research Council of Canada; Quebec Health Research Fund (FRSQ); Quebec Social Science and Culture Fund (FQRSC); Sackler Program in Psychobiology and Epigenetics at McGill University; Canadian Institute for Advanced Research	Quebec Training Network in Perinatal Research (QTNPR) Program from CIHR; Genes, Environment and Health Training Program from CIHR; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Social Sciences Humanities Research Council of Canada(Social Sciences and Humanities Research Council of Canada (SSHRC)); Quebec Health Research Fund (FRSQ)(Fonds de la Recherche en Sante du Quebec); Quebec Social Science and Culture Fund (FQRSC); Sackler Program in Psychobiology and Epigenetics at McGill University; Canadian Institute for Advanced Research(Canadian Institute for Advanced Research (CIFAR))	This work was supported by a fellowship from the Quebec Training Network in Perinatal Research (QTNPR) Program from CIHR to CG, a fellowship from the Genes, Environment and Health Training Program from CIHR to NP, grants from the Canadian Institutes of Health Research, the Social Sciences Humanities Research Council of Canada, the Quebec Health Research Fund (FRSQ) and the Quebec Social Science and Culture Fund (FQRSC) to RET and SMC, grants from the Canadian Institutes of Health Research MOP-42411 to MS, the Sackler Program in Psychobiology and Epigenetics at McGill University and from the Canadian Institute for Advanced Research to MS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alink LRA, 2006, CHILD DEV, V77, P954, DOI 10.1111/j.1467-8624.2006.00912.x; Arsenio WF, 2004, MONOGR SOC RES CHILD, P1, DOI [DOI 10.1111/J.0037-976X.2004.00312.X, 10.1111/j.0037-976X.2004.00312.x]; Baillargeon RH, 2007, DEV PSYCHOL, V43, P13, DOI 10.1037/0012-1649.43.1.13; Bauer ME, 2010, NEUROIMMUNOMODULAT, V17, P192, DOI 10.1159/000258721; Bennett AJ, 2002, MOL PSYCHIATR, V7, P118, DOI 10.1038/sj/mp/4000949; Birger M, 2003, ISR MED ASSOC J, V5, P653; Bollati V, 2010, HEREDITY, V105, P105, DOI 10.1038/hdy.2010.2; Borghol N, 2006, GENOMICS, V87, P417, DOI 10.1016/j.ygeno.2005.10.008; Borghol N, 2012, INT J EPIDEMIOL, V41, P62, DOI 10.1093/ije/dyr147; Brendgen M, 2008, CHILD DEV, V79, P13, DOI 10.1111/j.1467-8624.2007.01108.x; Broidy LM, 2003, DEV PSYCHOL, V39, P222, DOI 10.1037/0012-1649.39.2.222; CAIRNS RB, 1989, DEV PSYCHOL, V25, P320, DOI 10.1037/0012-1649.25.2.320; Campbell R, 2006, INJURY PREV, V12, P6, DOI 10.1136/ip.2006.012450; Coccaro EF, 1997, PSYCHIAT RES, V73, P1, DOI 10.1016/S0165-1781(97)00108-X; Cote S. M., 2007, EUR J CRIM POLICY RE, V13, P183, DOI DOI 10.1007/S10610-007-9046-3; Cote SM, 2006, J ABNORM CHILD PSYCH, V34, P71, DOI 10.1007/s10802-005-9001-z; Craig IW, 2007, BIOESSAYS, V29, P227, DOI 10.1002/bies.20538; Dionne G, 2003, DEV PSYCHOL, V39, P261, DOI 10.1037/0012-1649.39.2.261; Dolinoy DC, 2006, ENVIRON HEALTH PERSP, V114, P567, DOI 10.1289/ehp.8700; Dowlati Y, 2010, BIOL PSYCHIAT, V67, P446, DOI 10.1016/j.biopsych.2009.09.033; Essex MJ, 2013, CHILD DEV, V84, P58, DOI 10.1111/j.1467-8624.2011.01641.x; Fontaine N, 2008, ARCH GEN PSYCHIAT, V65, P320, DOI 10.1001/archgenpsychiatry.2007.41; Gammie SC, 2008, NEUROSCIENCE, V157, P502, DOI 10.1016/j.neuroscience.2008.09.026; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Groer MW, 2007, PSYCHONEUROENDOCRINO, V32, P133, DOI 10.1016/j.psyneuen.2006.11.007; Hassanain M, 2005, BRAIN RES, V1048, P1, DOI 10.1016/j.brainres.2005.04.086; Heijmans BT, 2008, P NATL ACAD SCI USA, V105, P17046, DOI 10.1073/pnas.0806560105; Hicks BM, 2004, ARCH GEN PSYCHIAT, V61, P922, DOI 10.1001/archpsyc.61.9.922; Higley JD, 1996, BIOL PSYCHIAT, V40, P1067, DOI 10.1016/S0006-3223(95)00675-3; Hoge EA, 2009, DEPRESS ANXIETY, V26, P447, DOI 10.1002/da.20564; Janelidze S, 2011, BRAIN BEHAV IMMUN, V25, P335, DOI 10.1016/j.bbi.2010.10.010; Jirtle RL, 2007, NAT REV GENET, V8, P253, DOI 10.1038/nrg2045; Kawamura A, 2001, JPN CIRC J, V65, P858, DOI 10.1253/jcj.65.858; Ke X, 2006, PHYSIOL GENOMICS, V25, P16, DOI 10.1152/physiolgenomics.00093.2005; Keck ME, 2002, NEUROPSYCHOPHARMACOL, V26, P94, DOI 10.1016/S0893-133X(01)00351-7; Kinnally EL, 2011, BRAIN BEHAV IMMUN, V25, P1548, DOI 10.1016/j.bbi.2011.05.001; KITAY JI, 1961, ENDOCRINOLOGY, V68, P818, DOI 10.1210/endo-68-5-818; Klengel T, 2013, NAT NEUROSCI, V16, P33, DOI 10.1038/nn.3275; Loney BR, 2006, J CHILD PSYCHOL PSYC, V47, P30, DOI 10.1111/j.1469-7610.2005.01444.x; MacLennan NK, 2004, PHYSIOL GENOMICS, V18, P43, DOI 10.1152/physiolgenomics.00042.2004; McGowan PO, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014739; McGowan PO, 2009, NAT NEUROSCI, V12, P342, DOI 10.1038/nn.2270; Mill J, 2008, J CHILD PSYCHOL PSYC, V49, P1020, DOI 10.1111/j.1469-7610.2008.01909.x; Misener VL, 2008, NEUROPSYCHOBIOLOGY, V58, P71, DOI 10.1159/000159775; Murani E, 2010, BMC GENET, V11, DOI 10.1186/1471-2156-11-74; Naumova OY, 2012, DEV PSYCHOPATHOL, V24, P143, DOI 10.1017/S0954579411000605; Nelson RJ, 2001, TRENDS NEUROSCI, V24, P713, DOI 10.1016/S0166-2236(00)01996-2; Noh YH, 2008, DIABETES-METAB RES, V24, P384, DOI 10.1002/dmrr.849; O'Brien SM, 2004, HUM PSYCHOPHARM CLIN, V19, P397, DOI 10.1002/hup.609; Oberlander TF, 2008, EPIGENETICS-US, V3, P97, DOI 10.4161/epi.3.2.6034; Pace TWW, 2007, BRAIN BEHAV IMMUN, V21, P9, DOI 10.1016/j.bbi.2006.08.009; Pavlov KA, 2012, J APPL GENET, V53, P61, DOI 10.1007/s13353-011-0069-6; Perez-Rodriguez MM, 2010, J PSYCHIATR RES, V44, P1075, DOI 10.1016/j.jpsychires.2010.03.014; Pesce M, 2011, J BIOL REG HOMEOS AG, V25, P323; Popma A, 2007, BIOL PSYCHIAT, V61, P405, DOI 10.1016/j.biopsych.2006.06.006; Provencal N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071691; Provencal N, 2012, J NEUROSCI, V32, P15626, DOI 10.1523/JNEUROSCI.1470-12.2012; Razin A, 1998, EMBO J, V17, P4905, DOI 10.1093/emboj/17.17.4905; Ressler KJ, 2011, NATURE, V470, P492, DOI 10.1038/nature09856; Rhee SH, 2002, PSYCHOL BULL, V128, P490, DOI 10.1037//0033-2909.128.3.490; Rossi RL, 2011, NAT IMMUNOL, V12, P796, DOI 10.1038/ni.2057; Serbin LA, 1998, DEV PSYCHOL, V34, P1246, DOI 10.1037/0012-1649.34.6.1246; Shirtcliff EA, 2005, DEV PSYCHOPATHOL, V17, P167, DOI 10.1017/S0954579405050091; Siegel A, 2007, CURR NEUROPHARMACOL, V5, P135, DOI 10.2174/157015907780866929; Sinclair KD, 2007, P NATL ACAD SCI USA, V104, P19351, DOI 10.1073/pnas.0707258104; Smith AK, 2011, AM J MED GENET B, V156B, P700, DOI 10.1002/ajmg.b.31212; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Suderman M, 2012, P NATL ACAD SCI USA, V109, P17266, DOI 10.1073/pnas.1121260109; Suomi SJ, 2006, ANN NY ACAD SCI, V1094, P52, DOI 10.1196/annals.1376.006; Szyf M, 2011, EPIGENETICS-US, V6, P971, DOI 10.4161/epi.6.8.16793; Terry MB, 2008, CANCER EPIDEM BIOMAR, V17, P2306, DOI 10.1158/1055-9965.EPI-08-0312; Tremblay RE, 2010, J CHILD PSYCHOL PSYC, V51, P341, DOI 10.1111/j.1469-7610.2010.02211.x; TUINIER S, 1995, INT CLIN PSYCHOPHARM, V10, P147, DOI 10.1097/00004850-199510030-00003; Uddin M, 2011, PSYCHOL MED, V41, P997, DOI 10.1017/S0033291710001674; van Bokhoven I, 2005, J NEURAL TRANSM, V112, P1083, DOI 10.1007/s00702-004-0253-5; von Kanel R, 2007, J PSYCHIATR RES, V41, P744, DOI 10.1016/j.jpsychires.2006.06.009; Wang DX, 2012, AQUAT ECOSYST HEALTH, V15, P4, DOI 10.1080/14634988.2012.663631; Waterland RA, 2003, MOL CELL BIOL, V23, P5293, DOI 10.1128/MCB.23.15.5293-5300.2003; Weaver ICG, 2004, ANN NY ACAD SCI, V1024, P182, DOI 10.1196/annals.1321.099; Weaver ICG, 2004, NAT NEUROSCI, V7, P847, DOI 10.1038/nn1276; WIDOM CS, 1989, AM J ORTHOPSYCHIAT, V59, P355, DOI 10.1111/j.1939-0025.1989.tb01671.x; Zalcman SS, 2006, BRAIN BEHAV IMMUN, V20, P507, DOI 10.1016/j.bbi.2006.05.002	83	63	65	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2014	9	1							e86822	10.1371/journal.pone.0086822	http://dx.doi.org/10.1371/journal.pone.0086822			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	298QQ	24475181	gold, Green Published, Green Submitted			2022-12-25	WOS:000330339800062
J	Hagiwara, M; Kokubu, E; Sugiura, S; Komatsu, T; Tada, H; Isoda, R; Tanigawa, N; Kato, Y; Ishida, N; Kobayashi, K; Nakashima, M; Ishihara, K; Matsushita, K				Hagiwara, Makoto; Kokubu, Eitoyo; Sugiura, Shinsuke; Komatsu, Toshinori; Tada, Hiroyuki; Isoda, Ryutaro; Tanigawa, Naomi; Kato, Yoshiko; Ishida, Naoyuki; Kobayashi, Kaoru; Nakashima, Misako; Ishihara, Kazuyuki; Matsushita, Kenji			Vinculin and Rab5 Complex Is Requited for Uptake of Staphyrococcus aureus and Interleukin-6 Expression	PLOS ONE			English	Article							NUCLEOTIDE EXCHANGE FACTOR; SMALL GTPASE RAB5; HERPES-SIMPLEX-VIRUS; STAPHYLOCOCCUS-AUREUS; ALPHA-CATENIN; BINDING-PROTEIN; FOCAL-ADHESION; ACTIVATE VINCULIN; STRUCTURAL BASIS; CELL-ADHESION	Vinculin, a 116-kDa membrane cytoskeletal protein, is an important molecule for cell adhesion; however, little is known about its other cellular functions. Here, we demonstrated that vinculin binds to Rab5 and is required for Staphylococcus aureus (S. aureus) uptake in cells. Viunculin directly bound to Rab5 and enhanced the activation of S. aureus uptake. Overexpression of active vinculin mutants enhanced S. aureus uptake, whereas over-expression of an inactive vinculin mutant decreased S. aureus uptake. Vinculin bound to Rab5 at the N-terminal region (1-258) of vinculin. Vinculin and Rab5 were involved in the S. aureus-induced phosphorylation of MAP kinases (p38, Erk, and JNK) and IL-6 expression. Finally, vinculin and Rab5 knockdown reduced infection of S. aureus, phosphorylation of MAPKs and IL-6 expression in murine lungs. Our results suggest that vinculin binds to Rab5 and that these two molecules cooperatively enhance bacterial infection and the inflammatory response.	[Hagiwara, Makoto; Sugiura, Shinsuke; Komatsu, Toshinori; Tada, Hiroyuki; Isoda, Ryutaro; Tanigawa, Naomi; Kato, Yoshiko; Ishida, Naoyuki; Kobayashi, Kaoru; Nakashima, Misako; Matsushita, Kenji] Natl Ctr Geriatr & Gerontol, Dept Oral Dis Res, Obu, Aichi, Japan; [Kokubu, Eitoyo; Ishihara, Kazuyuki] Tokyo Dent Coll, Dept Microbiol, Chiba, Japan	National Center for Geriatrics & Gerontology; Tokyo Dental College	Matsushita, K (corresponding author), Natl Ctr Geriatr & Gerontol, Dept Oral Dis Res, Obu, Aichi, Japan.	kmatsu30@ncgg.go.jp		Ishihara, Kazuyuki/0000-0002-6567-807X	Grants-in-Aid for Scientific Research [24592778] Funding Source: KAKEN	Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))		Acosta EG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044835; Ahmed S, 2001, INFECT IMMUN, V69, P2872, DOI 10.1128/IAI.69.5.2872-2877.2001; Almeida RA, 1996, J DAIRY SCI, V79, P1021, DOI 10.3168/jds.S0022-0302(96)76454-8; Arora PD, 2008, MOL BIOL CELL, V19, P5032, DOI 10.1091/mbc.E08-04-0430; Bakolitsa C, 2004, NATURE, V430, P583, DOI 10.1038/nature02610; Benmerah A, 2004, CURR BIOL, V14, pR314, DOI 10.1016/j.cub.2004.03.053; Bhattacharya M, 2006, EMBO J, V25, P2878, DOI 10.1038/sj.emboj.7601170; Bois PRJ, 2006, J BIOL CHEM, V281, P7228, DOI 10.1074/jbc.M510397200; Brighouse A, 2010, CELL MOL LIFE SCI, V67, P3449, DOI 10.1007/s00018-010-0436-1; Brindle NPJ, 1996, BIOCHEM J, V318, P753, DOI 10.1042/bj3180753; Campadelli-Fiume G, 2012, CURR OPIN VIROL, V2, P28, DOI 10.1016/j.coviro.2011.12.001; Carney DS, 2006, TRENDS CELL BIOL, V16, P27, DOI 10.1016/j.tcb.2005.11.001; Chamberlain MD, 2008, J BIOL CHEM, V283, P15861, DOI 10.1074/jbc.M800941200; Chandrasekar I, 2005, J CELL SCI, V118, P1461, DOI 10.1242/jcs.01734; Chen XQ, 2012, CELL RES, V22, P677, DOI 10.1038/cr.2011.197; Christoforidis S, 1999, NATURE, V397, P621, DOI 10.1038/17618; Cohen DM, 2006, J BIOL CHEM, V281, P16006, DOI 10.1074/jbc.M600738200; Cohen DM, 2005, J BIOL CHEM, V280, P17109, DOI 10.1074/jbc.M414704200; Deakin NO, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037990; DeMali KA, 2002, J CELL BIOL, V159, P881, DOI 10.1083/jcb.200206043; Diez G, 2011, BIOCHEM BIOPH RES CO, V406, P85, DOI 10.1016/j.bbrc.2011.01.115; Dupuy AG, 2008, J CELL SCI, V121, P1773, DOI 10.1242/jcs.018036; Epp N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067307; Fabrowski P, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3244; Garcia-Garcia E, 2002, J LEUKOCYTE BIOL, V72, P1092; Grosz M, 2014, CELL MICROBIOL, V16, P451, DOI 10.1111/cmi.12233; Hagiwara M, 2013, BIOCHEM BIOPH RES CO, V439, P413, DOI 10.1016/j.bbrc.2013.08.018; Hagiwara M, 2011, BIOCHEM BIOPH RES CO, V407, P615, DOI 10.1016/j.bbrc.2011.03.082; Hagiwara M, 2010, ANAL BIOCHEM, V397, P262, DOI 10.1016/j.ab.2009.10.032; Hagiwara M, 2009, Z NATURFORSCH C, V64, P303; Hagiwara M, 2009, BIOCHEM BIOPH RES CO, V378, P73, DOI 10.1016/j.bbrc.2008.10.172; Hauck CR, 2012, CURR OPIN CELL BIOL, V24, P637, DOI 10.1016/j.ceb.2012.07.004; Hoffmann C, 2011, EUR J CELL BIOL, V90, P891, DOI 10.1016/j.ejcb.2011.03.001; Hollinshead M, 2012, EMBO J, V31, P4204, DOI 10.1038/emboj.2012.262; Horiuchi H, 1997, CELL, V90, P1149, DOI 10.1016/S0092-8674(00)80380-3; Hu CT, 2013, CELL SIGNAL, V25, P1539, DOI 10.1016/j.cellsig.2013.03.022; Huang SN, 2003, J PHARMACOL EXP THER, V306, P681, DOI 10.1124/jpet.103.051581; Humphries JD, 2007, J CELL BIOL, V179, P1043, DOI 10.1083/jcb.200703036; Hutagalung AH, 2011, PHYSIOL REV, V91, P119, DOI 10.1152/physrev.00059.2009; Ishiyama N, 2013, J BIOL CHEM, V288, P15913, DOI 10.1074/jbc.M113.453928; Izard T, 2004, J BIOL CHEM, V279, P27667, DOI 10.1074/jbc.M403076200; Izard T, 2004, NATURE, V427, P171, DOI 10.1038/nature02281; John TA, 2003, AM J PHYSIOL-LUNG C, V284, pL187, DOI 10.1152/ajplung.00152.2002; Johnson C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022877; Kajiho H, 2003, J CELL SCI, V116, P4159, DOI 10.1242/jcs.00718; Kajiho H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030575; Kalia M, 2013, J VIROL, V87, P148, DOI 10.1128/JVI.01399-12; Kimizuka R, 2003, MICROBES INFECT, V5, P1357, DOI 10.1016/j.micinf.2003.09.015; Kioka N, 1999, J CELL BIOL, V144, P59, DOI 10.1083/jcb.144.1.59; Krachler AM, 2011, J CELL BIOL, V195, P1083, DOI 10.1083/jcb.201107132; Lanzetti L, 2000, NATURE, V408, P374, DOI 10.1038/35042605; Law IKM, 2012, J BIOL CHEM, V287, P15066, DOI 10.1074/jbc.M111.327262; Le Roy C, 2005, NAT REV MOL CELL BIO, V6, P112, DOI 10.1038/nrm1571; Leclerc EA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017816; Lee JJ, 2013, J BIOL CHEM, V288, P28049, DOI 10.1074/jbc.M113.491555; Leonard D, 2008, J CELL SCI, V121, P3445, DOI 10.1242/jcs.031484; Liu J, 2007, MOL BIOL CELL, V18, P1375, DOI 10.1091/mbc.E06-08-0725; Liu WM, 2010, MOL CELL BIOL, V30, P1783, DOI 10.1128/MCB.01003-09; Lowy FD, 2000, TRENDS MICROBIOL, V8, P341, DOI 10.1016/S0966-842X(00)01803-5; Macovei A, 2013, J VIROL, V87, P6415, DOI 10.1128/JVI.00393-13; MENKEL AR, 1994, J CELL BIOL, V126, P1231, DOI 10.1083/jcb.126.5.1231; Merithew E, 2003, J BIOL CHEM, V278, P8494, DOI 10.1074/jbc.M211514200; Mustafi S, 2013, INFECT IMMUN, V81, P2426, DOI 10.1128/IAI.00387-13; Newton HJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054566; Paulsel AL, 2013, J BIOL CHEM, V288, P18162, DOI 10.1074/jbc.M113.457069; Pelkmans L, 2004, CELL, V118, P767, DOI 10.1016/j.cell.2004.09.003; Peng X, 2012, J BIOL CHEM, V287, P7728, DOI 10.1074/jbc.M111.297481; Polyzos KA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041870; Qi MS, 2005, J CELL SCI, V118, P3569, DOI 10.1242/jcs.02470; Raman M, 2007, ONCOGENE, V26, P3100, DOI 10.1038/sj.onc.1210392; Rangarajan ES, 2012, J BIOL CHEM, V287, P18492, DOI 10.1074/jbc.M112.351023; Saito K, 2002, J BIOL CHEM, V277, P3412, DOI 10.1074/jbc.M106276200; Sandri C, 2012, CELL RES, V22, P1479, DOI 10.1038/cr.2012.110; Schnatwinkel C, 2004, PLOS BIOL, V2, P1363, DOI 10.1371/journal.pbio.0020261; Shen K, 2011, J BIOL CHEM, V286, P45103, DOI 10.1074/jbc.M111.244293; Simonsen A, 1998, NATURE, V394, P494, DOI 10.1038/28879; Sinha B, 1999, CELL MICROBIOL, V1, P101, DOI 10.1046/j.1462-5822.1999.00011.x; STENMARK H, 1995, CELL, V83, P423, DOI 10.1016/0092-8674(95)90120-5; Stenmark H, 2001, GENOME BIOL, V2; Stenmark H, 2009, NAT REV MOL CELL BIO, V10, P513, DOI 10.1038/nrm2728; Takahashi H, 2005, BIOCHEM BIOPH RES CO, V336, P239, DOI 10.1016/j.bbrc.2005.08.064; Tall GG, 2001, DEV CELL, V1, P73, DOI 10.1016/S1534-5807(01)00008-9; Thomas C, 2013, DEV BIOL; Thomas WA, 2013, J BIOL CHEM, V288, P4957, DOI 10.1074/jbc.M112.403774; Topp JD, 2004, J BIOL CHEM, V279, P24612, DOI 10.1074/jbc.M313504200; Tuo S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072123; Umemoto T, 2009, BIOCHEM BIOPH RES CO, V387, P191, DOI 10.1016/j.bbrc.2009.07.009; Wiederkehr A, 2001, YEAST, V18, P759, DOI 10.1002/yea.726; Woller B, 2011, BBA-MOL CELL RES, V1813, P1198, DOI 10.1016/j.bbamcr.2011.03.005; Zamir E, 2001, J CELL SCI, V114, P3583; Zerial M, 2001, NAT REV MOL CELL BIO, V2, P107, DOI 10.1038/35052055; Zhu HP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009226; Ziegler WH, 2006, TRENDS CELL BIOL, V16, P453, DOI 10.1016/j.tcb.2006.07.004; Zwaenepoel O, 2012, FASEB J, V26, P691, DOI 10.1096/fj.11-189753	94	17	17	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2014	9	1							e87373	10.1371/journal.pone.0087373	http://dx.doi.org/10.1371/journal.pone.0087373			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297XI	24466349	Green Published, gold, Green Submitted			2022-12-25	WOS:000330288000205
J	Piras, P; Evangelista, A; Gabriele, S; Nardinocchi, P; Teresi, L; Torromeo, C; Schiariti, M; Varano, V; Puddu, PE				Piras, Paolo; Evangelista, Antonietta; Gabriele, Stefano; Nardinocchi, Paola; Teresi, Luciano; Torromeo, Concetta; Schiariti, Michele; Varano, Valerio; Puddu, Paolo Emilio			4D-Analysis of Left Ventricular Heart Cycle Using Procrustes Motion Analysis	PLOS ONE			English	Article							SHAPE; ECHOCARDIOGRAPHY; MODEL; MORPHOMETRICS; MODULARITY; STATEMENT; FRAMEWORK; COMMITTEE; SOCIETY	The aim of this study is to investigate human left ventricular heart morphological changes in time among 17 healthy subjects. Preliminarily, 2 patients with volumetric overload due to aortic insufficiency were added to our analyses. We propose a special strategy to compare the shape, orientation and size of cardiac cycle's morphological trajectories in time. We used 3D data obtained by Speckle Tracking Echocardiography in order to detect semi-automated and homologous landmarks clouds as proxies of left ventricular heart morphology. An extended Geometric Morphometrics toolkit in order to distinguish between intra-and inter-individual shape variations was used. Shape of trajectories with inter-individual variation were compared under the assumption that trajectories attributes, estimated at electrophysiologically homologous times are expressions of left ventricular heart function. We found that shape analysis as commonly applied in Geometric Morphometrics studies fails in identifying a proper morpho-space to compare the shape of morphological trajectories in time. To overcome this problem, we performed a special type of Riemannian Parallel Transport, called "linear shift''. Whereas the two patients with aortic insufficiency were not differentiated in the static shape analysis from the healthy subjects, they set apart significantly in the analyses of motion trajectory's shape and orientation. We found that in healthy subjects, the variations due to inter-individual morphological differences were not related to shape and orientation of morphological trajectories. Principal Component Analysis showed that volumetric contraction, torsion and twist are differently distributed on different axes. Moreover, global shape change appeared to be more correlated with endocardial shape change than with the epicardial one. Finally, the total shape variation occurring among different subjects was significantly larger than that observable across properly defined morphological trajectories.	[Piras, Paolo] Univ Roma Tre, Dipartimento Sci, Rome, Italy; [Evangelista, Antonietta] Osped San Giovanni Calibita Fatebefratelli, Rome, Italy; [Piras, Paolo; Torromeo, Concetta; Schiariti, Michele; Puddu, Paolo Emilio] Univ Roma La Sapienza, Dipartimento Sci Cardiovasc Resp Nefrol Anestesio, I-00185 Rome, Italy; [Gabriele, Stefano; Varano, Valerio] Univ Roma Tre, Dept Architettura, Rome, Italy; [Gabriele, Stefano; Teresi, Luciano; Varano, Valerio] Univ Roma Tre, LaMS Modeling & Simulat Lab, Rome, Italy; [Nardinocchi, Paola] Univ Roma La Sapienza, Dipartimento Ingn Strutturale & Geotecn, I-00185 Rome, Italy; [Teresi, Luciano] Univ Roma Tre, Dipartimento Matemat & Fis, Rome, Italy; [Piras, Paolo] Ctr Evolutionary Ecol, Rome, Italy	Roma Tre University; Sapienza University Rome; Roma Tre University; Roma Tre University; Sapienza University Rome; Roma Tre University	Piras, P (corresponding author), Univ Roma Tre, Dipartimento Sci, Rome, Italy.	ppiras@uniroma3.it	Gabriele, Stefano/J-1091-2019; nardinocchi, paola/C-9454-2009; schiariti, michele/W-4393-2018; Gabriele, Stefano/G-5280-2010; Puddu, Paolo Emilio/G-6180-2012	Gabriele, Stefano/0000-0001-8264-2792; schiariti, michele/0000-0001-5077-8134; Gabriele, Stefano/0000-0001-8264-2792; Puddu, Paolo Emilio/0000-0002-6191-7838; Teresi, Luciano/0000-0002-5178-8120; Piras, Paolo/0000-0001-9832-2742; Nardinocchi, Paola/0000-0002-9972-1662; Varano, Valerio/0000-0003-0298-6398; TORROMEO, Concetta/0000-0003-0936-2780	MIUR (the Italian Ministry of University and Research); Sapienza - Universita di Roma [N. C26A11STT5]	MIUR (the Italian Ministry of University and Research)(Ministry of Education, Universities and Research (MIUR)); Sapienza - Universita di Roma	This work is supported by MIUR (the Italian Ministry of University and Research) through the Project PRIN2009 "Mathematics and Mechanics of Biological Assemblies and Soft Tissues'' and by "Sapienza - Universita di Roma'' through the grant N. C26A11STT5. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams DC, 2004, ITAL J ZOOL, V71, P5, DOI 10.1080/11250000409356545; Adams DC, 2007, J BIOMECH, V40, P437, DOI 10.1016/j.jbiomech.2005.12.004; Adams DC, 2009, EVOLUTION, V63, P1143, DOI 10.1111/j.1558-5646.2009.00649.x; Bejdova S, 2012, J CRANIO MAXILL SURG, V40, P201, DOI 10.1016/j.jcms.2011.04.013; Bookstein F. L., 1997, MORPHOMETRIC TOOLS L; BOOKSTEIN FL, 1986, STAT SCI, V1, P181, DOI [10.1214/ss/1177013696, DOI 10.1214/SS/1177013696]; Buckley PF, 1999, BIOL PSYCHIAT, V45, P62, DOI 10.1016/S0006-3223(98)00067-5; Bueno-Orovio A, 2008, J THEOR BIOL, V253, P544, DOI 10.1016/j.jtbi.2008.03.029; Cerqueira MD, 2002, CIRCULATION, V105, P539, DOI 10.1161/hc0402.102975; Chatzigianni A, 2009, AM J ORTHOD DENTOFAC, V136, DOI 10.1016/j.ajodo.2009.04.017; Collyer ML, 2013, HYSTRIX, V24, P75, DOI 10.4404/hystrix-24.1-6298; Dryden I., 1998, STAT ANAL SHAPE; Escoufier Y., 1973, BIOMETRICS, V29, P751, DOI DOI 10.2307/2529140; Evangelista A, 2011, PROG BIOPHYS MOL BIO, V107, P112, DOI 10.1016/j.pbiomolbio.2011.07.008; Filzmoser P, 2013, MVOUTLIER MULTIVARIA; Geyer H, 2010, J AM SOC ECHOCARDIOG, V23, P351, DOI 10.1016/j.echo.2010.02.015; Glukhov AV, 2010, CIRC RES, V106, P981, DOI 10.1161/CIRCRESAHA.109.204891; GOODALL C, 1991, J ROY STAT SOC B MET, V53, P285, DOI 10.1111/j.2517-6161.1991.tb01825.x; Huckemann S, 2010, ARXIV10020616V1; KENDALL DG, 1977, ADV APPL PROBAB, V9, P428, DOI 10.2307/1426091; Klingenberg CP, 2009, EVOL DEV, V11, P405, DOI 10.1111/j.1525-142X.2009.00347.x; Kuhl HP, 2004, J AM COLL CARDIOL, V43, P2083, DOI 10.1016/j.jacc.2004.01.037; Kume A, 2007, BIOMETRIKA, V94, P513, DOI 10.1093/biomet/asm047; Lang RM, 2005, J AM SOC ECHOCARDIOG, V18, P1440, DOI 10.1016/j.echo.2005.10.005; Le HL, 2003, J LOND MATH SOC, V68, P511, DOI 10.1112/S0024610703004393; Maffessanti F, 2009, ULTRASOUND MED BIOL, V35, P1953, DOI 10.1016/j.ultrasmedbio.2009.08.008; Marquez EJ, 2008, EVOLUTION, V62, P2688, DOI 10.1111/j.1558-5646.2008.00476.x; Mitteroecker P, 2011, EVOL BIOL, V38, P100, DOI 10.1007/s11692-011-9109-8; Mor-Avi V, 2011, J AM SOC ECHOCARDIOG, V24, P277, DOI 10.1016/j.echo.2011.01.015; Oksanen J., 2013, VEGAN COMMUNITY ECOL; Piras P, 2010, EVOL ECOL RES, V12, P897; ROHLF FJ, 1990, SYST ZOOL, V39, P40, DOI 10.2307/2992207; Roohi SF, 2013, INT J COMPUT ASS RAD, V8, P335, DOI 10.1007/s11548-012-0787-1; Salgo IS, 2012, J AM SOC ECHOCARDIOG, V25, P80, DOI 10.1016/j.echo.2011.09.014; Sugeng L, 2003, HEART, V89, P29; Yang L, 2008, I S BIOMED IMAGING, P221, DOI 10.1109/ISBI.2008.4540972; Yeung F, 1998, ULTRASOUND MED BIOL, V24, P427, DOI 10.1016/S0301-5629(97)00281-0; Zelditch ML, 2012, GEOMETRIC MORPHOMETRICS FOR BIOLOGISTS: A PRIMER, 2ND EDITION, P1; Zheng Y, 2007, P 11 IEEE INT C COMP	39	24	24	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2014	9	1							e86896	10.1371/journal.pone.0086896	http://dx.doi.org/10.1371/journal.pone.0086896			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297XI	24466282	gold, Green Published, Green Submitted			2022-12-25	WOS:000330288000166
J	Qiu, ZW; Jiang, HE; Ding, JL; Hu, YW; Shang, X				Qiu, Zhenwei; Jiang, Hongen; Ding, Jinlong; Hu, Yaowu; Shang, Xue			Pollen and Phytolith Evidence for Rice Cultivation and Vegetation Change during the Mid-Late Holocene at the Jiangli Site, Suzhou, East China	PLOS ONE			English	Article							YANGTZE-RIVER DELTA; DOMESTICATION; AGRICULTURE; PADDY; BASIN	Pollen and phytolith analyses were undertaken at the Jiangli site in Suzhou, Jiangsu Province, combined with studies on macrofossils by flotation. The concentration of pollen decreased while the percentage of Poaceae pollen in the profile increased from the late phase of the Majiabang Culture to the Songze Culture suggesting that human impact on the local environment intensified gradually. The discovery of rice paddy implies a relatively advanced rice cultivation in this area during the middle-late Holocene. Other than phytoliths, the high percentage of Oryza-type Poaceae pollen ( larger than 40 mu m) supplied robust evidence for the existence of rice paddy. Moreover, the fact that the farther from the rice paddy, the lower the concentration and percentage of Poaceae pollen also proves that the dispersal and deposition of pollen is inversely proportional to the distance.	[Qiu, Zhenwei; Jiang, Hongen; Hu, Yaowu; Shang, Xue] Chinese Acad Sci, Inst Vertebrate Paleontol & Paleoanthropol, Key Lab Vertebrate Evolut & Human Origins, Beijing, Peoples R China; [Qiu, Zhenwei; Jiang, Hongen; Hu, Yaowu; Shang, Xue] Univ Chinese Acad Sci, Dept Sci Hist & Archaeometry, Beijing, Peoples R China; [Ding, Jinlong] Suzhou Inst Archaeol, Suzhou, Peoples R China	Chinese Academy of Sciences; Institute of Vertebrate Paleontology & Paleoanthropology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Shang, X (corresponding author), Chinese Acad Sci, Inst Vertebrate Paleontol & Paleoanthropol, Key Lab Vertebrate Evolut & Human Origins, Beijing, Peoples R China.	Shangxue@ucas.ac.cn	Qiu, Zhenwei/F-5008-2010	Qiu, Zhenwei/0000-0001-5751-5476	Strategic Priority Research Program - Climate Change: Carbon Budget and Relevant Issues, Chinese Academy of Sciences [XDA05130501]; National Natural Science Foundation of China [41102227]	Strategic Priority Research Program - Climate Change: Carbon Budget and Relevant Issues, Chinese Academy of Sciences; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the Strategic Priority Research Program - Climate Change: Carbon Budget and Relevant Issues, Chinese Academy of Sciences (Grant No. XDA05130501); and the National Natural Science Foundation of China (Grant No. 41102227). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AISC HMIKC SSZTKC, 2013, WEN WU, V1, P4; Akazawa T., 1982, ADV WORLD ARCHAEOLOG, P151; An ZS, 2000, QUATERNARY SCI REV, V19, P743, DOI 10.1016/S0277-3791(99)00031-1; Chaturvedi M, 1998, GRANA, V37, P79, DOI 10.1080/00173139809362647; Chen Z.Y., 1997, ACTA GEOGRAPHICA SIN, V52, P131; Chen ZY, 2005, HOLOCENE, V15, P915, DOI 10.1191/0959683605hl862rr; Crawford G, 2005, CURR ANTHROPOL, V46, P309, DOI 10.1086/428788; Ding J.L., 2010, J JIAXING U, V22, P22; Ding JL, 2004, SE CULT, V2, P19; Ding P, 2010, ZHONGGUO WENWUBAO; Fuller DQ, 2007, ANTIQUITY, V81, P316, DOI 10.1017/S0003598X0009520X; Fuller DQ, 2009, SCIENCE, V323, P1607, DOI 10.1126/science.1166605; Fuller DQ., 2008, PRADGHARA, V18, P17; He JJ, 2007, CHENGTOUSHAN SITE LI, P125; Horrocks M, 2004, J FORENSIC SCI, V49, P1024; Jin GY, 2007, CHINESE SCI BULL, V52, P3376, DOI 10.1007/s11434-007-0449-9; Jin GY, 2006, CHINA CULTURAL RELIC, P7; Kohler E., 1979, GRANA, V18, P133, DOI [10.1080/00173137909424973, DOI 10.1080/00173137909424973]; Lane CS, 2010, REV PALAEOBOT PALYNO, V159, P177, DOI 10.1016/j.revpalbo.2009.12.003; Lentfer CJ, 2003, J ARCHAEOL SCI, V30, P149, DOI 10.1006/jasc.2001.0786; Lentfer CJ, 1998, J ARCHAEOL SCI, V25, P1159, DOI 10.1006/jasc.1998.0286; Li X, 2006, ARID LAND GEOGRAPHY, V295, P663; Li XQ, 2007, HOLOCENE, V17, P555, DOI 10.1177/0959683607078978; Li XQ, 2009, HOLOCENE, V19, P1213, DOI 10.1177/0959683609345083; Li YY, 2006, HOLOCENE, V16, P1109, DOI 10.1177/0959683606069403; Lin LG, 2000, AGR ARCHAEOL, V3, P91; Liu C. J., 2008, ARCHAEOBOTANY RES SE; [刘长江 Liu Changjiang], 2004, [西北植物学报, Acta Botanica Boreali-Occidentalla Sinica], V24, P178; Liu HP, 1998, SCI GEOGR SIN, V18, P368; LIU KB, 1992, QUATERNARY RES, V38, P32, DOI 10.1016/0033-5894(92)90028-H; Lu HY, 2002, BOREAS, V31, P378, DOI 10.1080/030094802320942581; Luna S, 2001, CROP SCI, V41, P1551, DOI 10.2135/cropsci2001.4151551x; Madella M, 2005, ANN BOT-LONDON, V96, P253, DOI 10.1093/aob/mci172; Moore P.D., 1991, BLACKWELL SCI PUBLI; MORTON JF, 1975, ECON BOT, V29, P7, DOI 10.1007/BF02861252; MUENSCHER WC, 1955, WEEDS; Pearsall DM., 2015, PALEOETHNOBOTANY HDB; Piperno D.R., 1988, PHYTOLITH ANAL ARCHA; Piperno D. R., 1998, SILICA BODIES TROPIC; Piperno DR, 2000, NATURE, V407, P894, DOI 10.1038/35038055; Qiu ZW, 2013, WEN WU, V1, P90; RAYNOR GS, 1972, AGRON J, V64, P420, DOI 10.2134/agronj1972.00021962006400040004x; Reimer PJ, 2004, RADIOCARBON, V46, P1029, DOI 10.1017/S0033822200032999; Schuler L, 2011, VEG HIST ARCHAEOBOT, V20, P83, DOI 10.1007/s00334-010-0265-z; Sun L, 2001, SE CULT, V1, P35; Sun S., 1993, TAIHU LAKE; Tao J, 2006, PALAEOGEOGR PALAEOCL, V230, P204, DOI 10.1016/j.palaeo.2005.07.015; Tiejun Zhang, 2004, ZHONGGUO WENHUA YICH, V1, P70; Timmons FL, 1963, STUDIES CONTROL COMM; Torrence R., 2006, ANCIENT STARCH RES; TWISS PC, 1969, SOIL SCI SOC AM PRO, V33, P109, DOI 10.2136/sssaj1969.03615995003300010030x; Udatsu T, 1998, AGR ARCHAEOLOGY, V1, P138; VOS PC, 1993, HYDROBIOLOGIA, V269, P285, DOI 10.1007/BF00028027; Wang CaiLin, 2000, Jiangsu Journal of Agricultural Sciences, V16, P129; Wang CL, 1997, SE CULT, V3, P14; Wang F., 1995, POLLEN MORPHOLOGY CH, V2nd; Wang K F, 1981, HIST GEOG, V1, P126; Wang KF., 1983, INTRO PALYNOLOGY; Wang KF, 1995, P QUAT GLAC GEOL, V8, P8; Wang S.M., 1998, ANN CHINESE LAKES; Wang WM, 2010, QUATERN INT, V227, P22, DOI 10.1016/j.quaint.2010.06.007; Wang WM, 2003, CHINESE SCI BULL, V48, P2005, DOI 10.1360/02wd0447; Wang YJ., 1993, RES PHYTOLITH ITS AP; Wu C, 2000, SE CULT, V9, P6; Wu XP, 1998, HUAXIA ARCHAEOLOGY, V4, P43; Xiao J Y, 2003, SE CULT S, P87; Xu H., 2001, GEOLOGY GEOCHEMISTRY, V29, P9; [许清海 Xu Qinghai], 2010, [第四纪研究, Quaternary Sciences], V30, P273; Yan Q, 1987, ACTA GEOGRAPHICA SIN, V42, P1; Yan W.M., 1982, AGRICUL ARCHAEOL, V1, P19; Yang H.R., 1984, OCEANOL LIMNOL SINIC, V1, P1; [杨士雄 Yang Shixiong], 2010, [第四纪研究, Quaternary Sciences], V30, P262; Yang X D, 1996, ACTA BOT SIN, V38, P576; You XL, 1986, AGR HIST CHINA, V1, P71; Zhang FY, 2004, WENWU CHUNQIU, V6, P28; [赵宝成 Zhao Baocheng], 2007, [古地理学报, Journal of Palaeogeography], V9, P321; Zhao Z.J., 2010, PALEOETHNOBOTANY THE; Zhao ZJ, 2010, ARCHAEOL ANTHROP SCI, V2, P99, DOI 10.1007/s12520-010-0028-x; Zheng YF, 2010, UNPUB; Zheng YF, 2009, J ARCHAEOL SCI, V36, P2609, DOI 10.1016/j.jas.2009.09.026; Zhou Hong, 2000, J E CHINA NORMAL U N, V4, P71; ZHU NC, 2004, SE CULTURE, V2, P24; Zong Y, 2007, NATURE, V449, P459, DOI 10.1038/nature06135; Zou BH, 2000, ORIGIN RICE AGR CITY, P97	84	20	22	3	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2014	9	1							e86816	10.1371/journal.pone.0086816	http://dx.doi.org/10.1371/journal.pone.0086816			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	297XI	24466254	Green Published, Green Submitted, gold			2022-12-25	WOS:000330288000148
J	Xiao, J; Zhong, H; Zhou, Y; Yu, F; Gao, Y; Luo, YJ; Tang, ZY; Guo, ZB; Guo, EY; Gan, X; Zhang, M; Zhang, YP				Xiao, Jun; Zhong, Huan; Zhou, Yi; Yu, Fan; Gao, Yun; Luo, Yongju; Tang, Zhanyang; Guo, Zhongbao; Guo, Enyan; Gan, Xi; Zhang, Ming; Zhang, Yaping			Identification and Characterization of MicroRNAs in Ovary and Testis of Nile Tilapia (Oreochromis niloticus) by Using Solexa Sequencing Technology	PLOS ONE			English	Article							SMALL RNAS; DIFFERENTIAL EXPRESSION; CELL-PROLIFERATION; MIRNA EXPRESSION; MESSENGER-RNA; CLONING; GENES; PIWI; BIOGENESIS; GERMLINE	MicroRNAs (miRNAs) are endogenous non-coding small RNAs which play important roles in the regulation of gene expression by cleaving or inhibiting the translation of target gene transcripts. Thereinto, some specific miRNAs show regulatory activities in gonad development via translational control. In order to further understand the role of miRNA-mediated posttranscriptional regulation in Nile tilapia (Oreochromis niloticus) ovary and testis, two small RNA libraries of Nile tilapia were sequenced by Solexa small RNA deep sequencing methods. A total of 9,731,431 and 8,880,497 raw reads, representing 5,407,800 and 4,396,281 unique sequences were obtained from the sexually mature ovaries and testes, respectively. After comparing the small RNA sequences with the Rfam database, 1,432,210 reads in ovaries and 984,146 reads in testes were matched to the genome sequence of Nile tilapia. Bioinformatic analysis identified 764 mature miRNA, 209 miRNA-5p and 202 miRNA-3p were found in the two libraries, of which 525 known miRNAs are both expressed in the ovary and testis of Nile tilapia. Comparison of expression profiles of the testis, miR-727, miR-129 and miR-29 families were highly expressed in tilapia ovary. Additionally, miR-132, miR-212, miR-33a and miR-135b families, showed significant higher expression in testis compared with that in ovary. Furthermore, the expression patterns of the miRNAs were analyzed in different developmental stages of gonad. The result showed different expression patterns were observed during development of testis and ovary. In addition, the identification and characterization of differentially expressed miRNAs in the ovaries and testis of Nile tilapia provides important information on the role of miRNA in the regulation of the ovarian and testicular development and function. This data will be helpful to facilitate studies on the regulation of miRNAs during teleosts reproduction.	[Xiao, Jun; Zhong, Huan; Zhou, Yi; Luo, Yongju; Tang, Zhanyang; Guo, Zhongbao; Guo, Enyan; Gan, Xi] Guangxi Acad Fisheries Sci, Guangxi Key Lab Aquat Genet Breeding & Hlth Aquac, Nanning, Guangxi, Peoples R China; [Xiao, Jun; Zhong, Huan; Zhang, Ming] Guangxi Univ, State Key Lab Conservat & Utilizat Subtrop Agrobi, Anim Reprod Inst, Nanning 530004, Guangxi, Peoples R China; [Yu, Fan] Chinese Acad Fishery Sci, Freshwater Fisheries Res Ctr, Key Lab Genet Breeding Aquat Anim, Wuxi, Jiangsu, Peoples R China; [Xiao, Jun; Gao, Yun; Zhang, Yaping] Kunming Inst Zool, State Key Lab Genet Resources & Evolut, Kunming, Yunnan, Peoples R China; [Xiao, Jun; Gao, Yun; Zhang, Yaping] Kunming Inst Zool, Lab Mol Biol Domest Anim, Kunming, Yunnan, Peoples R China	Guangxi University; Chinese Academy of Fishery Sciences; Freshwater Fisheries Research Center, CAFS; Chinese Academy of Sciences; Kunming Institute of Zoology; Chinese Academy of Sciences; Kunming Institute of Zoology	Gan, X (corresponding author), Guangxi Acad Fisheries Sci, Guangxi Key Lab Aquat Genet Breeding & Hlth Aquac, Nanning, Guangxi, Peoples R China.	ganxicn@126.com; mingzhang@gxu.edu.cn			National Natural Science Foundation of China [31260637]; China Postdoctoral Science Foundation Funded Project [2013M531915]; China Agriculture Research System [CARS-49]; Science and Technology Research Program [1123006-1]; Public Welfare Special funds of Guangxi [2060302CXIF-2011-04]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation Funded Project(China Postdoctoral Science Foundation); China Agriculture Research System; Science and Technology Research Program; Public Welfare Special funds of Guangxi	This research was supported by National Natural Science Foundation of China (31260637), China Postdoctoral Science Foundation Funded Project (2013M531915), China Agriculture Research System (No. CARS-49), Science and Technology Research Program (No. 1123006-1) and Public Welfare Special funds of Guangxi (No. 2060302CXIF-2011-04). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Ambros V, 2007, DEVELOPMENT, V134, P1635, DOI 10.1242/dev.002006; Aravin A, 2006, NATURE, V442, P203, DOI 10.1038/nature04916; Bannister SC, 2009, BIOL REPROD, V81, P165, DOI 10.1095/biolreprod.108.074005; Baroiller JF, 2009, COMP BIOCHEM PHYS A, V153, P30, DOI 10.1016/j.cbpa.2008.11.018; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Berishvili G, 2010, GEN COMP ENDOCR, V167, P128, DOI 10.1016/j.ygcen.2010.01.023; Bizuayehu TT, 2012, SEX DEV, V6, P257, DOI 10.1159/000341378; Buchold GM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015317; Chang XT, 1997, J MOL ENDOCRINOL, V18, P57, DOI 10.1677/jme.0.0180057; Coward K, 2000, REV FISH BIOL FISHER, V10, P1, DOI 10.1023/A:1008942318272; Davalos A, 2011, P NATL ACAD SCI USA, V108, P9232, DOI 10.1073/pnas.1102281108; Dyrskjot L, 2009, CANCER RES, V69, P4851, DOI 10.1158/0008-5472.CAN-08-4043; Girard A, 2006, NATURE, V442, P199, DOI 10.1038/nature04917; Guo L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021072; Houwing S, 2007, CELL, V129, P69, DOI 10.1016/j.cell.2007.03.026; Hu SJ, 2008, J BIOL CHEM, V283, P23473, DOI 10.1074/jbc.M800406200; Huang CW, 2012, J ANIM SCI, V90, P4266, DOI 10.2527/jas.2012-5142; Huang JM, 2011, INT J BIOL SCI, V7, P1016, DOI 10.7150/ijbs.7.1016; Ijiri S, 2008, BIOL REPROD, V78, P333, DOI 10.1095/biolreprod.107.064246; Juanchich A, 2013, BIOL REPROD, V88, DOI 10.1095/biolreprod.112.105361; Kamminga LM, 2010, EMBO J, V29, P3688, DOI 10.1038/emboj.2010.233; Kim SC, 2011, 3D RES, V2, DOI 10.1007/3DRes.02(2011)6; Kloas W, 2009, ANN NY ACAD SCI, V1163, P187, DOI 10.1111/j.1749-6632.2009.04453.x; Kloosterman WP, 2006, NUCLEIC ACIDS RES, V34, P2558, DOI 10.1093/nar/gkl278; Krol J, 2010, NAT REV GENET, V11, P597, DOI 10.1038/nrg2843; Lau NC, 2006, SCIENCE, V313, P363, DOI 10.1126/science.1130164; Lau NC, 2010, INT J BIOCHEM CELL B, V42, P1334, DOI 10.1016/j.biocel.2010.03.005; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Lee SI, 2011, P NATL ACAD SCI USA, V108, P10426, DOI 10.1073/pnas.1106141108; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Li MT, 2011, INT J INNOV COMPUT I, V7, P1055; Li SC, 2011, GENOMICS, V98, P453, DOI 10.1016/j.ygeno.2011.08.008; Ma H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039649; Maruska KP, 2011, PHYSIOLOGY, V26, P412, DOI 10.1152/physiol.00032.2011; McFarlane L, 2010, SEX DEV, V3, P302, DOI 10.1159/000284688; Mishima T, 2008, REPRODUCTION, V136, P811, DOI 10.1530/REP-08-0349; Morin RD, 2008, GENOME RES, V18, P610, DOI 10.1101/gr.7179508; Nef S, 2003, NATURE, V426, P291, DOI 10.1038/nature02059; Ro S, 2007, RNA, V13, P2366, DOI 10.1261/rna.754207; Saunders LR, 2010, AGING-US, V2, P415, DOI 10.18632/aging.100176; Shirak A, 2006, GENETICS, V174, P1573, DOI 10.1534/genetics.106.059030; Sirotkin AV, 2010, J CELL PHYSIOL, V223, P49, DOI 10.1002/jcp.21999; Sirotkin AV, 2009, J CELL PHYSIOL, V219, P415, DOI 10.1002/jcp.21689; Tao WJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063604; THIBAULT RE, 1978, EVOLUTION, V32, P320, DOI 10.1111/j.1558-5646.1978.tb00648.x; Tong MH, 2012, BIOL REPROD, V86, DOI 10.1095/biolreprod.111.096313; Ucar A, 2011, CELL CYCLE, V10, P563, DOI 10.4161/cc.10.4.14737; Watanabe T, 2006, GENE DEV, V20, P1732, DOI 10.1101/gad.1425706; Wilczynska A, 2009, RNA, V15, P337, DOI 10.1261/rna.1422509; Wu JJ, 2010, CELL CYCLE, V9, P1809, DOI 10.4161/cc.9.9.11535; Xie HM, 2009, DIABETES, V58, P1050, DOI 10.2337/db08-1299; Xu F, 2010, ENDOCRINOLOGY, V151, P2504, DOI 10.1210/en.2009-1013; Xu ZQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054174; Yu ZR, 2005, BIOL REPROD, V73, P427, DOI 10.1095/biolreprod.105.040998; Zhang JL, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-478; Zhang XD, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-157; Zhou B, 2012, DIABETOLOGIA, V55, P2032, DOI 10.1007/s00125-012-2539-8	59	28	31	4	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2014	9	1							e86821	10.1371/journal.pone.0086821	http://dx.doi.org/10.1371/journal.pone.0086821			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297XI	24466258	gold, Green Published, Green Submitted			2022-12-25	WOS:000330288000152
J	Chen, YS; Wu, HC; Shien, JH; Chiu, HH; Lee, LH				Chen, Yu San; Wu, Hsing Chieh; Shien, Jui Hung; Chiu, Hua Hsien; Lee, Long Huw			Cloning and Characterization of a 7 Transmembrane Receptor from the Adherent Cells of Chicken Peripheral Blood Mononuclear Cells	PLOS ONE			English	Article							AVIAN REOVIRUS S1133; PROTEIN SIGMA-A; 7-TRANSMEMBRANE RECEPTORS; MONOCLONAL-ANTIBODIES; ESCHERICHIA-COLI; MACROPHAGES; DETERMINES; EXPRESSION; PROFILES; SEQUENCE	A cDNA encoding a 7 transmembrane (7TM) receptor gene from the adherent cells of chicken peripheral blood mononuclear cells (PBMC) was cloned and characterized. The open reading frame of the chicken-7TM (Ch-7TM) receptor gene was 1008 nucleotides long, encoding a protein of 335 amino acid residues with a molecular mass of approximately 37.1 kDa. Hydrophobic stretches indicated the presence of 7 TM domains. Moreover, the complete nucleotide sequences encoding 7TM of duck (Du-7TM) and goose (Go-7TM), corresponding to the open reading frame of Ch-7TM, were determined. Each of the Du-and Go-7TM encoding regions comprised 990 nucleotides, representing an 18-nucleotide deletion in alignment with the Ch-7TM encoding region, resulting in a 6-amino-acid deletion at the 3'-end. No signal peptides were predicted. Six phosphorylation sites were predicted and conserved for all three 7TMs. The proteins of the three 7TMs were similar, with 11 conserved cysteine residues. No glycosylation sites could be predicted. The results of the pairwise comparisons indicated that the Ch-7TM encoding region and Ch-7TM protein were the least similar to those of Du- and Go-7TMs. These results were in accordance with those of the phylogenetic analysis, which indicated that the Du-and Go-7TM encoding regions clustered, but were separated from the Ch-7TM encoding region. Monoclonal antibody B28D5 was prepared from spleens of mice immunized with the bacterially expressed N-terminal (55 amino acid residues) region of the Ch-7TM protein for further use. Double staining with B28D5 and KUL01 suggested that Ch-7TM was expressed in subsets of the adherent cells, among which a subset that was recognized with both antibodies was likely of monocyte and macrophage lineage. However, the fluorescence intensities of B28D5 and, particularly, KUL01 decreased after the adherent cells were incubated for additional 48 h.	[Chen, Yu San; Wu, Hsing Chieh; Shien, Jui Hung; Lee, Long Huw] Natl Chung Hsing Univ, Coll Vet Med, Dept Vet Med, Taichung 40227, Taiwan; [Chiu, Hua Hsien] Fooyin Univ, Dept Biotechnol, Coll Environm & Life Sci, Kaohsiung, Taiwan	National Chung Hsing University; Fooyin University	Chiu, HH (corresponding author), Fooyin Univ, Dept Biotechnol, Coll Environm & Life Sci, Kaohsiung, Taiwan.	SC055@mail.fy.edu.tw; lhlee@mail.nchu.edu.tw			National Science Council, Rep. of China [NSC100-2313-B005-030-MY3]	National Science Council, Rep. of China(Ministry of Science and Technology, Taiwan)	This research work was supported by the National Science Council (NSC100-2313-B005-030-MY3), Rep. of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ciraci C, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-545; Dietert R. R., 1991, Avian cellular immunology., P71; EDMAN P, 1967, EUR J BIOCHEM, V1, P80, DOI 10.1111/j.1432-1033.1967.tb00047.x; Hou HS, 2001, VIROLOGY, V282, P168, DOI 10.1006/viro.2001.0814; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Lefkowitz RJ, 2004, TRENDS PHARMACOL SCI, V25, P413, DOI 10.1016/j.tips.2004.06.006; Mast J, 1998, VET IMMUNOL IMMUNOP, V61, P343, DOI 10.1016/S0165-2427(97)00152-9; Mombaerts P, 1999, SCIENCE, V286, P707, DOI 10.1126/science.286.5440.707; Pai WC, 2003, VET MICROBIOL, V91, P309, DOI 10.1016/S0378-1135(02)00308-5; Pierce KL, 2002, NAT REV MOL CELL BIO, V3, P639, DOI 10.1038/nrm908; Poh TY, 2008, J BIOL CHEM, V283, P16408, DOI 10.1074/jbc.M800998200; PROBST WC, 1992, DNA CELL BIOL, V11, P1, DOI 10.1089/dna.1992.11.1; Reemers SS, 2009, J GEN VIROL, V90, P2134, DOI 10.1099/vir.0.012401-0; Sleeman JE, 2001, J CELL SCI, V114, P4407; SPIESS M, 1995, FEBS LETT, V369, P76, DOI 10.1016/0014-5793(95)00551-J; Su BS, 2010, PROCESS BIOCHEM, V45, P1057, DOI 10.1016/j.procbio.2010.03.021; Van Furth R, 1992, ENCY IMMUNOLOGY, P1092; Van Furth R, 1970, MONONUCLEAR PHAGOCYT, P1; Wu YF, 2007, VET IMMUNOL IMMUNOP, V116, P37, DOI 10.1016/j.vetimm.2006.12.010; Yin HS, 2000, VIROLOGY, V266, P33, DOI 10.1006/viro.1999.0020	20	0	0	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2014	9	1							e86880	10.1371/journal.pone.0086880	http://dx.doi.org/10.1371/journal.pone.0086880			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297VL	24466279	Green Published, gold, Green Submitted			2022-12-25	WOS:000330283100230
J	Mukherjee, S; Thompson, LK; Godin, S; Schackwitz, W; Lipzen, A; Martin, J; Blanchard, JL				Mukherjee, Supratim; Thompson, Lynmarie K.; Godin, Stephen; Schackwitz, Wendy; Lipzen, Anna; Martin, Joel; Blanchard, Jeffrey L.			Population Level Analysis of Evolved Mutations Underlying Improvements in Plant Hemicellulose and Cellulose Fermentation by Clostridium phytofermentans	PLOS ONE			English	Article							SOIL ORGANIC-MATTER; ESCHERICHIA-COLI; MALTOSE TRANSPORTER; ADAPTIVE EVOLUTION; LITTER DECOMPOSITION; MEMBRANE-COMPONENTS; CRYSTAL-STRUCTURE; ABC TRANSPORTERS; GENOME EVOLUTION; SYSTEMS	Background: The complexity of plant cell walls creates many challenges for microbial decomposition. Clostridium phytofermentans, an anaerobic bacterium isolated from forest soil, directly breaks down and utilizes many plant cell wall carbohydrates. The objective of this research is to understand constraints on rates of plant decomposition by Clostridium phytofermentans and identify molecular mechanisms that may overcome these limitations. Results: Experimental evolution via repeated serial transfers during exponential growth was used to select for C. phytofermentans genotypes that grow more rapidly on cellobiose, cellulose and xylan. To identify the underlying mutations an average of 13,600,000 paired-end reads were generated per population resulting in,300 fold coverage of each site in the genome. Mutations with allele frequencies of 5% or greater could be identified with statistical confidence. Many mutations are in carbohydrate-related genes including the promoter regions of glycoside hydrolases and amino acid substitutions in ABC transport proteins involved in carbohydrate uptake, signal transduction sensors that detect specific carbohydrates, proteins that affect the export of extracellular enzymes, and regulators of unknown specificity. Structural modeling of the ABC transporter complex proteins suggests that mutations in these genes may alter the recognition of carbohydrates by substrate-binding proteins and communication between the intercellular face of the transmembrane and the ATPase binding proteins. Conclusions: Experimental evolution was effective in identifying molecular constraints on the rate of hemicellulose and cellulose fermentation and selected for putative gain of function mutations that do not typically appear in traditional molecular genetic screens. The results reveal new strategies for evolving and engineering microorganisms for faster growth on plant carbohydrates.	[Mukherjee, Supratim; Blanchard, Jeffrey L.] Univ Massachusetts, Dept Microbiol, Amherst, MA 01003 USA; [Thompson, Lynmarie K.] Univ Massachusetts, Dept Chem, Amherst, MA 01003 USA; [Godin, Stephen; Blanchard, Jeffrey L.] Univ Massachusetts, Dept Biol, Amherst, MA 01003 USA; [Schackwitz, Wendy; Lipzen, Anna; Martin, Joel] Joint Genome Inst, Walnut Creek, CA USA	University of Massachusetts System; University of Massachusetts Amherst; University of Massachusetts System; University of Massachusetts Amherst; University of Massachusetts System; University of Massachusetts Amherst; United States Department of Energy (DOE); Joint BioEnergy Institute - JBEI; Joint Genome Institute - JGI	Blanchard, JL (corresponding author), Joint Genome Inst, Sci Programs, Walnut Creek, CA USA.	jeffb@bio.umass.edu	Blanchard, Jeffrey/AAA-5173-2020; Mukherjee, Supratim/K-1151-2019; Schackwitz, Wendy/GXH-9536-2022	Blanchard, Jeffrey/0000-0002-7310-9678; Mukherjee, Supratim/0000-0002-6322-2271; Schackwitz, Wendy/0000-0002-3013-9180; Martin, Joel/0000-0001-9511-6441; Lipzen, Anna/0000-0003-2293-9329	The Isenberg School of Management at the University of Massachusetts Amherst; National Science Foundation-sponsored Institute for Cellular Engineering IGERT Program [DGE-065412]; Life Sciences Junior Fellowship; Howard Hughes Medical Institute Award; The Department of Energy (DOE) Joint Genome Institute (JGI); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM085288] Funding Source: NIH RePORTER	The Isenberg School of Management at the University of Massachusetts Amherst; National Science Foundation-sponsored Institute for Cellular Engineering IGERT Program; Life Sciences Junior Fellowship; Howard Hughes Medical Institute Award(Howard Hughes Medical Institute); The Department of Energy (DOE) Joint Genome Institute (JGI); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported by a scholarship from The Isenberg School of Management at the University of Massachusetts Amherst to SM, a student training grant from National Science Foundation-sponsored Institute for Cellular Engineering IGERT Program (DGE-065412) to SM, a Life Sciences Junior Fellowship to SG, a Howard Hughes Medical Institute Award to SG, a Sponsored Research Agreement between Qteros Inc. and JB and a Community Sequencing Award from The Department of Energy (DOE) Joint Genome Institute (JGI) to JB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alper H, 2009, NAT REV MICROBIOL, V7, P715, DOI 10.1038/nrmicro2186; Araya CL, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-88; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Barrick JE, 2009, NATURE, V461, P1243, DOI 10.1038/nature08480; Brown CJ, 1998, MOL BIOL EVOL, V15, P931, DOI 10.1093/oxfordjournals.molbev.a026009; Chen K, 2009, NAT METHODS, V6, P677, DOI [10.1038/NMETH.1363, 10.1038/nmeth.1363]; Chu VT, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-7-r118; Collins B, 2010, ANTIMICROB AGENTS CH, V54, P4416, DOI 10.1128/AAC.00503-10; Cotrufo MF, 2013, GLOBAL CHANGE BIOL, V19, P988, DOI 10.1111/gcb.12113; COVITZ KMY, 1994, EMBO J, V13, P1752, DOI 10.1002/j.1460-2075.1994.tb06439.x; DASSA E, 1985, EMBO J, V4, P2287, DOI 10.1002/j.1460-2075.1985.tb03928.x; DAVIDSON AL, 1992, P NATL ACAD SCI USA, V89, P2360, DOI 10.1073/pnas.89.6.2360; Davidson AL, 2008, MICROBIOL MOL BIOL R, V72, P317, DOI 10.1128/MMBR.00031-07; de Kok S, 2012, FEMS YEAST RES; Dintner S, 2011, J BACTERIOL, V193, P3851, DOI 10.1128/JB.05175-11; Elena SF, 2003, NAT REV GENET, V4, P457, DOI 10.1038/nrg1088; Ferea TL, 1999, P NATL ACAD SCI USA, V96, P9721, DOI 10.1073/pnas.96.17.9721; Flint HJ, 2012, NUTR REV, V70, pS10, DOI 10.1111/j.1753-4887.2012.00499.x; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Guimaraes PMR, 2008, APPL ENVIRON MICROB, V74, P1748, DOI 10.1128/AEM.00186-08; Herring CD, 2006, NAT GENET, V38, P1406, DOI 10.1038/ng1906; Holt KE, 2009, BIOINFORMATICS, V25, P2074, DOI 10.1093/bioinformatics/btp344; Hong KK, 2011, P NATL ACAD SCI USA, V108, P12179, DOI 10.1073/pnas.1103219108; Hu HB, 2010, BIOCHEM BIOPH RES CO, V391, P1033, DOI 10.1016/j.bbrc.2009.12.013; Hua Q, 2007, APPL ENVIRON MICROB, V73, P4639, DOI 10.1128/AEM.00527-07; Iyer P, 2004, APPL MICROBIOL BIOT, V66, P166, DOI 10.1007/s00253-004-1666-7; Kadner R. J., 1996, ESCHERICHIA COLI SAL, V2nd; Khare D, 2009, MOL CELL, V33, P528, DOI 10.1016/j.molcel.2009.01.035; Krause DO, 2013, J ANIM SCI, V91, P331, DOI 10.2527/jas.2012-5567; Kumar V, 2012, CRIT REV FOOD SCI, V52, P899, DOI 10.1080/10408398.2010.512671; Kuyper M, 2005, FEMS YEAST RES, V5, P925, DOI 10.1016/j.femsyr.2005.04.004; Lagaert S, 2009, SEMIN CELL DEV BIOL, V20, P1064, DOI 10.1016/j.semcdb.2009.05.008; LENSKI RE, 1991, AM NAT, V138, P1315, DOI 10.1086/285289; Lenski RE, 1998, ANTON LEEUW INT J G, V73, P35, DOI 10.1023/A:1000675521611; LESCHINE SB, 1995, ANNU REV MICROBIOL, V49, P399, DOI 10.1146/annurev.mi.49.100195.002151; Li H, 2008, GENOME RES, V18, P1851, DOI 10.1101/gr.078212.108; Li M, 2007, MOL MICROBIOL, V66, P1136, DOI 10.1111/j.1365-2958.2007.05986.x; Locher KP, 2009, PHILOS T R SOC B, V364, P239, DOI 10.1098/rstb.2008.0125; Lynd LR, 2008, NAT BIOTECHNOL, V26, P169, DOI 10.1038/nbt0208-169; Lynd LR, 2002, MICROBIOL MOL BIOL R, V66, P506, DOI 10.1128/MMBR.66.3.506-577.2002; Madhavan A, 2009, APPL MICROBIOL BIOT, V82, P1037, DOI 10.1007/s00253-008-1818-2; McBryde C, 2006, AM J ENOL VITICULT, V57, P423; McSweeney C, 2012, MICROORGANISMS RUMIN; MELILLO JM, 1989, PLANT SOIL, V115, P189, DOI 10.1007/BF02202587; Novak M, 2006, AM NAT, V168, P242, DOI 10.1086/506527; Oldham ML, 2007, NATURE, V450, P515, DOI 10.1038/nature06264; Oldham ML, 2011, P NATL ACAD SCI USA, V108, P15152, DOI 10.1073/pnas.1108858108; Oldham ML, 2011, SCIENCE, V332, P1202, DOI 10.1126/science.1200767; Pauly M, 2010, CURR OPIN PLANT BIOL, V13, P305, DOI 10.1016/j.pbi.2009.12.009; Pepin KM, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-85; Prescott CE, 2010, BIOGEOCHEMISTRY, V101, P133, DOI 10.1007/s10533-010-9439-0; Ren Z, 2007, J APPL MICROBIOL, V103, P2258, DOI 10.1111/j.1365-2672.2007.03477.x; Rost B, 2004, NUCLEIC ACIDS RES, V32, pW321, DOI 10.1093/nar/gkh377; Schneider E, 2001, RES MICROBIOL, V152, P303, DOI 10.1016/S0923-2508(01)01201-3; Shindyalov IN, 1998, PROTEIN ENG, V11, P739, DOI 10.1093/protein/11.9.739; Singh BK, 2010, NAT REV MICROBIOL, V8, P779, DOI 10.1038/nrmicro2439; Somerville C, 2004, SCIENCE, V306, P2206, DOI 10.1126/science.1102765; Tolonen AC, 2011, MOL SYST BIOL, V7, DOI [10.1038/msb.2010.116, 10.1038/MSB.2010.116]; TREPTOW NA, 1985, J BACTERIOL, V163, P654, DOI 10.1128/JB.163.2.654-660.1985; Wang XM, 2008, TUBERCULOSIS, V88, P399, DOI 10.1016/j.tube.2008.02.003; Wang YZ, 2011, J IND MICROBIOL BIOT, V38, P1371, DOI 10.1007/s10295-010-0920-5; Warnick TA, 2002, INT J SYST EVOL MICR, V52, P1155, DOI [10.1099/ijs.0.02125-0, 10.1099/00207713-52-4-1155]; Wei H, 2009, CURR OPIN BIOTECH, V20, P330, DOI 10.1016/j.copbio.2009.05.008; Wielgoss S, 2011, G3-GENES GENOM GENET, V1, P183, DOI 10.1534/g3.111.000406; Wisselink HW, 2009, APPL ENVIRON MICROB, V75, P907, DOI 10.1128/AEM.02268-08; Woods RJ, 2011, SCIENCE, V331, P1433, DOI 10.1126/science.1198914; Zhang XC, 2012, J MICROBIOL METH, V88, P67, DOI 10.1016/j.mimet.2011.10.018	67	19	20	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2014	9	1							e86731	10.1371/journal.pone.0086731	http://dx.doi.org/10.1371/journal.pone.0086731			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297VL	24466216	gold, Green Published, Green Submitted			2022-12-25	WOS:000330283100203
J	Powell, RJ; White, R; Hill, RT				Powell, Ryan J.; White, Ryan; Hill, Russell T.			Merging Metabolism and Power: Development of a Novel Photobioelectric Device Driven by Photosynthesis and Respiration	PLOS ONE			English	Article							MICROBIAL FUEL-CELLS; ANABAENA-VARIABILIS; RICE PLANTS; ENERGY; ELECTRICITY; RHIZODEPOSITS; PERFORMANCE; GENERATION; SYSTEM	Generation of renewable energy is one of the grand challenges facing our society. We present a new bio-electric technology driven by chemical gradients generated by photosynthesis and respiration. The system does not require pure cultures nor particular species as it works with the core metabolic principles that define phototrophs and heterotrophs. The biology is interfaced with electrochemistry with an alkaline aluminum oxide cell design. In field trials we show the system is robust and can work with an undefined natural microbial community. Power generated is light and photosynthesis dependent. It achieved a peak power output of 33 watts/m(2) electrode. The design is simple, low cost and works with the biological processes driving the system by removing waste products that can impede growth. This system is a new class of bio-electric device and may have practical implications for algal biofuel production and powering remote sensing devices.	[Powell, Ryan J.; Hill, Russell T.] Univ Maryland, Ctr Environm Sci, Inst Marine & Environm Technol, Baltimore, MD 21201 USA; [White, Ryan] Univ Maryland Baltimore Cty, Dept Chem & Biochem, Baltimore, MD 21228 USA	University System of Maryland; University of Maryland Baltimore; University of Maryland Center for Environmental Science; Institute of Marine & Environmental Technology; University System of Maryland; University of Maryland Baltimore County	Hill, RT (corresponding author), Univ Maryland, Ctr Environm Sci, Inst Marine & Environm Technol, Baltimore, MD 21201 USA.	hill@umces.edu	Hill, Russell/AAF-4190-2019	Hill, Russell/0000-0002-9832-1851	Maryland Industrial Partnerships [4701]	Maryland Industrial Partnerships	This work was supported by grant no. 4701 from Maryland Industrial Partnerships (http://www.mips.umd.edu/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cusick RD, 2012, SCIENCE, V335, P1474, DOI [10.1126/science.1219330, 10.1126/science.1218781]; de Schamphelaire L, 2008, ENVIRON SCI TECHNOL, V42, P3053, DOI 10.1021/es071938w; De Schamphelaire L, 2010, APPL ENVIRON MICROB, V76, P2002, DOI 10.1128/AEM.02432-09; De Schamphelaire L, 2009, BIOTECHNOL BIOENG, V103, P296, DOI 10.1002/bit.22257; DUBINSKY Z, 1974, OECOLOGIA, V16, P53, DOI 10.1007/BF00345087; Guillard R.R., 1975, CULTURE MARINE INVER, P29, DOI 10.1007/978-1-4615-8714-9_3.; Helder M, 2010, BIORESOURCE TECHNOL, V101, P3541, DOI 10.1016/j.biortech.2009.12.124; Kaku N, 2008, APPL MICROBIOL BIOT, V79, P43, DOI 10.1007/s00253-008-1410-9; Pisciotta JM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010821; Rabaey K, 2005, TRENDS BIOTECHNOL, V23, P291, DOI 10.1016/j.tibtech.2005.04.008; Rosenbaum M, 2010, CURR OPIN BIOTECH, V21, P259, DOI 10.1016/j.copbio.2010.03.010; Ryu W, 2010, NANO LETT, V10, P1137, DOI 10.1021/nl903141j; STANIER RY, 1971, BACTERIOL REV, V35, P171, DOI 10.1128/MMBR.35.2.171-205.1971; Strik DPBTB, 2011, TRENDS BIOTECHNOL, V29, P41, DOI 10.1016/j.tibtech.2010.10.001; Strik DPBTB, 2008, APPL MICROBIOL BIOT, V81, P659, DOI 10.1007/s00253-008-1679-8; Suntivich J, 2011, SCIENCE, V334, P1383, DOI 10.1126/science.1212858; Takanezawa K, 2010, BIOSCI BIOTECH BIOCH, V74, P1271, DOI 10.1271/bbb.90852; TANAKA K, 1985, J CHEM TECHNOL BIOT, V35, P191, DOI 10.1002/jctb.280350304; Timmers RA, 2010, APPL MICROBIOL BIOT, V86, P973, DOI 10.1007/s00253-010-2440-7; U.S. Department of Energy, 2008, REACT AL WAT PROD HY; Velasquez-Orta SB, 2009, BIOTECHNOL BIOENG, V103, P1068, DOI 10.1002/bit.22346; Yagishita T, 1997, BIOELECTROCH BIOENER, V43, P177, DOI 10.1016/S0302-4598(96)05145-8; Yagishita T, 1998, J FERMENT BIOENG, V85, P546, DOI 10.1016/S0922-338X(98)80106-2	23	3	4	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2014	9	1							e86518	10.1371/journal.pone.0086518	http://dx.doi.org/10.1371/journal.pone.0086518			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297VL	24466132	Green Published, Green Submitted, gold			2022-12-25	WOS:000330283100178
J	Jara, M; Cubillos, FA; Garcia, V; Salinas, F; Aguilera, O; Liti, G; Martinez, C				Jara, Matias; Cubillos, Francisco A.; Garcia, Veronica; Salinas, Francisco; Aguilera, Omayra; Liti, Gianni; Martinez, Claudio			Mapping Genetic Variants Underlying Differences in the Central Nitrogen Metabolism in Fermenter Yeasts	PLOS ONE			English	Article							SACCHAROMYCES-CEREVISIAE; WINE YEAST; AMINO-ACID; EXPRESSION; EVOLUTION; TRAIT; ARCHITECTURE; PERFORMANCE; NUCLEOTIDE; PLEIOTROPY	Different populations within a species represent a rich reservoir of allelic variants, corresponding to an evolutionary signature of withstood environmental constraints. Saccharomyces cerevisiae strains are widely utilised in the fermentation of different kinds of alcoholic beverages, such as, wine and sake, each of them derived from must with distinct nutrient composition. Importantly, adequate nitrogen levels in the medium are essential for the fermentation process, however, a comprehensive understanding of the genetic variants determining variation in nitrogen consumption is lacking. Here, we assessed the genetic factors underlying variation in nitrogen consumption in a segregating population derived from a cross between two main fermenter yeasts, a Wine/European and a Sake isolate. By linkage analysis we identified 18 main effect QTLs for ammonium and amino acids sources. Interestingly, majority of QTLs were involved in more than a single trait, grouped based on amino acid structure and indicating high levels of pleiotropy across nitrogen sources, in agreement with the observed patterns of phenotypic co-variation. Accordingly, we performed reciprocal hemizygosity analysis validating an effect for three genes, GLT1, ASI1 and AGP1. Furthermore, we detected a widespread pleiotropic effect on these genes, with AGP1 affecting seven amino acids and nine in the case of GLT1 and ASI1. Based on sequence and comparative analysis, candidate causative mutations within these genes were also predicted. Altogether, the identification of these variants demonstrate how Sake and Wine/European genetic backgrounds differentially consume nitrogen sources, in part explaining independently evolved preferences for nitrogen assimilation and representing a niche of genetic diversity for the implementation of practical approaches towards more efficient strains for nitrogen metabolism.	[Jara, Matias; Cubillos, Francisco A.; Garcia, Veronica; Aguilera, Omayra; Martinez, Claudio] Univ Santiago Chile USACH, Dept Ciencia & Tecnol Alimentos, Santiago, Chile; [Jara, Matias; Cubillos, Francisco A.; Garcia, Veronica; Aguilera, Omayra; Martinez, Claudio] Univ Santiago Chile USACH, Ctr Estudios Ciencia & Tecnol Alimentos CECTA, Santiago, Chile; [Salinas, Francisco; Liti, Gianni] Univ Nice Sophia Antipolis, IRCAN, F-06189 Nice, France	Universidad de Santiago de Chile; Universidad de Santiago de Chile; UDICE-French Research Universities; Universite Cote d'Azur	Martinez, C (corresponding author), Univ Santiago Chile USACH, Dept Ciencia & Tecnol Alimentos, Santiago, Chile.	claudio.martinez@usach.cl	Liti, Gianni/I-9929-2014; Salinas, Francisco/AAP-9439-2020; García, Verónica/AAM-1175-2021; Martinez, Claudio/T-2903-2019; Salinas, Francisco/W-3269-2017; Cubillos, Francisco/G-5195-2019	Salinas, Francisco/0000-0002-8391-8145; Salinas, Francisco/0000-0002-8391-8145; Jara, Matias/0000-0003-0091-8957; Liti, Gianni/0000-0002-2318-0775; Cubillos, Francisco/0000-0003-3022-469X; Martinez, Claudio/0000-0001-8564-9287	ATIP-Avenir; ARC [SFI20111203947]; FONDECYT [1100509, 3120107]; Conicyt (Apoyo al retorno de investigadores desde el extranjero) [82130010]	ATIP-Avenir; ARC(Australian Research Council); FONDECYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); Conicyt (Apoyo al retorno de investigadores desde el extranjero)	This work was funded by grants from ATIP-Avenir, ARC (SFI20111203947) to GL and FONDECYT 1100509 to CM. FAC is supported by Conicyt (Apoyo al retorno de investigadores desde el extranjero grant number 82130010). VG is supported by FONDECYT Post-Doctoral 3120107. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albertson RC, 2003, P NATL ACAD SCI USA, V100, P5252, DOI 10.1073/pnas.0930235100; Ambroset C, 2011, G3-GENES GENOM GENET, V1, P263, DOI 10.1534/g3.111.000422; Beltran G, 2004, FEMS YEAST RES, V4, P625, DOI 10.1016/j.femsyr.2003.12.004; Bergstrom A, HIGH DEFINITIO UNPUB; Biddick RK, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001436; Blein-Nicolas M, 2013, MOL BIOL EVOL, V30, P1368, DOI 10.1093/molbev/mst050; Boban M, 2007, GENETICS, V176, P2087, DOI 10.1534/genetics.107.075077; Broman KW, 2003, BIOINFORMATICS, V19, P889, DOI 10.1093/bioinformatics/btg112; Camarasa C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025147; Chiva R, 2009, J APPL MICROBIOL, V107, P235, DOI 10.1111/j.1365-2672.2009.04201.x; Crepin L, 2012, APPL ENVIRON MICROB, V78, P8102, DOI 10.1128/AEM.02294-12; Cubillos FA, 2011, MOL ECOL, V20, P1401, DOI 10.1111/j.1365-294X.2011.05005.x; Cubillos FA, 2009, FEMS YEAST RES, V9, P1217, DOI 10.1111/j.1567-1364.2009.00583.x; Dudley AM, 2005, MOL SYST BIOL, V1, DOI 10.1038/msb4100004; Dunn B, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-53; Gomez-Alonso S, 2007, J AGR FOOD CHEM, V55, P608, DOI 10.1021/jf062820m; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Gutierrez A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067166; Hubmann G, 2013, METAB ENG, V17, P68, DOI 10.1016/j.ymben.2013.02.006; HUXLEY C, 1990, TRENDS GENET, V6, P236, DOI 10.1016/0168-9525(90)90190-H; Ioannidis JPA, 2009, NAT REV GENET, V10, P318, DOI 10.1038/nrg2544; JIRANEK V, 1995, AM J ENOL VITICULT, V46, P75; Katou T, 2009, J BIOSCI BIOENG, V107, P383, DOI 10.1016/j.jbiosc.2008.12.014; KUNKEE RE, 1991, PROCEEDINGS OF THE INTERNATIONAL SYMPOSIUM ON NITROGEN IN GRAPES AND WINE, P148; Legras JL, 2007, MOL ECOL, V16, P2091, DOI 10.1111/j.1365-294X.2007.03266.x; Liti G, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002912; Liti G, 2009, NATURE, V458, P337, DOI 10.1038/nature07743; Ljungdahl PO, 2012, GENETICS, V190, P885, DOI 10.1534/genetics.111.133306; Magasanik B, 2005, P NATL ACAD SCI USA, V102, P16537, DOI 10.1073/pnas.0507116102; Magasanik B, 2003, EUKARYOT CELL, V2, P827, DOI 10.1128/EC.2.5.827-829.2003; Magasanik B, 2002, GENE, V290, P1, DOI 10.1016/S0378-1119(02)00558-9; Magasanik B., 1992, GENE EXPRESSION, VII, P283; Magwene PM, 2011, P NATL ACAD SCI USA, V108, P1987, DOI 10.1073/pnas.1012544108; Martinez C, 2007, J APPL MICROBIOL, V103, P2185, DOI 10.1111/j.1365-2672.2007.03493.x; Martinez C, 2013, ELECTRON J BIOTECHN, V16, DOI 10.2225/vol16-issue4-fulltext-8; Marullo P, 2006, FEMS YEAST RES, V6, P268, DOI 10.1111/j.1567-1364.2006.00034.x; Marullo P, 2007, FEMS YEAST RES, V7, P941, DOI 10.1111/j.1567-1364.2007.00252.x; Nissen TL, 1997, MICROBIOL-UK, V143, P203, DOI 10.1099/00221287-143-1-203; Otto SP, 2004, P ROY SOC B-BIOL SCI, V271, P705, DOI 10.1098/rspb.2003.2635; Pais TM, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003548; Parts L, 2011, GENOME RES, V21, P1131, DOI 10.1101/gr.116731.110; Pavlicev M, 2008, EVOLUTION, V62, P199, DOI 10.1111/j.1558-5646.2007.00255.x; Petit T, 2000, J BACTERIOL, V182, P6815, DOI 10.1128/JB.182.23.6815-6818.2000; Pretorius IS, 2000, YEAST, V16, P675, DOI 10.1002/1097-0061(20000615)16:8<675::AID-YEA585>3.0.CO;2-B; Pretorius IS, 2012, BIOENGINEERED, V3, P147, DOI 10.4161/bbug.19687; Qian WF, 2012, CELL REP, V2, P1399, DOI 10.1016/j.celrep.2012.09.017; Querol A, 2003, INT J FOOD MICROBIOL, V86, P3, DOI 10.1016/S0168-1605(03)00244-7; R Development Core Team, 2021, R PROJECT STAT COMPU; Rieseberg LH, 2003, PHILOS T R SOC B, V358, P1141, DOI 10.1098/rstb.2003.1283; Rossignol T, 2003, YEAST, V20, P1369, DOI 10.1002/yea.1046; Salinas F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049640; Schreve JL, 1998, J BACTERIOL, V180, P2556, DOI 10.1128/JB.180.9.2556-2559.1998; Sicard D, 2011, CR BIOL, V334, P229, DOI 10.1016/j.crvi.2010.12.016; Skelly DA, 2013, GENOME RES, V23, P1496, DOI 10.1101/gr.155762.113; Spor A, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-296; Stanley D, 2010, APPL MICROBIOL BIOT, V88, P231, DOI 10.1007/s00253-010-2760-7; Steinmetz LM, 2002, NATURE, V416, P326, DOI 10.1038/416326a; Steyer D, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-573; Sturgeon J. Q., 2013, Journal of Wine Research, V24, P182, DOI 10.1080/09571264.2013.793175; Varela C, 2005, YEAST, V22, P369, DOI 10.1002/yea.1217; Wagner GP, 2008, NATURE, V452, P470, DOI 10.1038/nature06756; Wang J, 2013, NUCLEIC ACIDS RES, V41, pW77, DOI 10.1093/nar/gkt439; Warringer J, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002111; Wu CH, 2006, NUCLEIC ACIDS RES, V34, pD187, DOI 10.1093/nar/gkj161; Yu H, 2003, CHROMATOGRAPHIA, V57, P721, DOI 10.1007/BF02491757	65	41	41	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2014	9	1							e86533	10.1371/journal.pone.0086533	http://dx.doi.org/10.1371/journal.pone.0086533			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297GT	24466135	gold, Green Published, Green Submitted			2022-12-25	WOS:000330244500253
J	Chudasama, P; Konrad, A; Jochmann, R; Lausen, B; Holz, P; Naschberger, E; Neipel, F; Britzen-Laurent, N; Sturzl, M				Chudasama, P.; Konrad, A.; Jochmann, R.; Lausen, B.; Holz, P.; Naschberger, E.; Neipel, F.; Britzen-Laurent, N.; Stuerzl, M.			Structural proteins of Kaposi's sarcoma-associated herpesvirus antagonize p53-mediated apoptosis	ONCOGENE			English	Article						KSHV; p53; apoptosis; reversely transfected cell microarray; early infection; lytic replication	P53 TUMOR-SUPPRESSOR; SMALL-MOLECULE ANTAGONISTS; LYTIC REPLICATION; DNA-SEQUENCES; CELL-LINE; BOVINE HERPESVIRUS-1; ENDOTHELIAL ORIGIN; SYSTEMS BIOLOGY; EXPRESSION; KSHV	The tumor suppressor p53 is a central regulatory molecule of apoptosis and is commonly mutated in tumors. Kaposi's sarcoma-associated herpesvirus (KSHV)-related malignancies express wild-type p53. Accordingly, KSHV encodes proteins that counteract the cell death-inducing effects of p53. Here, the effects of all KSHV genes on the p53 signaling pathway were systematically analyzed using the reversely transfected cell microarray technology. With this approach we detected eight KSHV-encoded genes with potent p53 inhibiting activity in addition to the previously described inhibitory effects of KSHV genes ORF50, K10 and K10.5. Interestingly, the three most potent newly identified inhibitors were KSHV structural proteins, namely ORF22 (glycoprotein H), ORF25 (major capsid protein) and ORF64 (tegument protein). Validation of these results with a classical transfection approach showed that these proteins inhibited p53 signaling in a dose-dependent manner and that this effect could be reversed by small interfering RNA-mediated knockdown of the respective viral gene. All three genes inhibited p53-mediated apoptosis in response to Nutlin-3 treatment in non-infected and KSHV-infected cells. Addressing putative mechanisms, we could show that these proteins could also inhibit the transactivation of the promoters of apoptotic mediators of p53 such as BAX and PIG3. Altogether, we demonstrate for the first time that structural proteins of KSHV can counteract p53-induced apoptosis. These proteins are expressed in the late lytic phase of the viral life cycle and are incorporated into the KSHV virion. Accordingly, these genes may inhibit cell death in the productive and in the early entrance phase of KSHV infection.	[Chudasama, P.; Konrad, A.; Jochmann, R.; Holz, P.; Naschberger, E.; Britzen-Laurent, N.; Stuerzl, M.] Univ Erlangen Nurnberg, Univ Med Ctr Erlangen, Dept Surg, Div Mol & Expt Surg, D-91054 Erlangen, Germany; [Lausen, B.] Univ Essex, Dept Math Sci, Colchester CO4 3SQ, Essex, England; [Neipel, F.] Univ Erlangen Nurnberg, Univ Med Ctr Erlangen, Inst Clin & Mol Virol, D-91054 Erlangen, Germany	University of Erlangen Nuremberg; University of Essex; University of Erlangen Nuremberg	Sturzl, M (corresponding author), Univ Erlangen Nurnberg, Univ Med Ctr Erlangen, Dept Surg, Div Mol & Expt Surg, Schwabachanlage 10, D-91054 Erlangen, Germany.	michael.stuerzl@uk-erlangen.de	Naschberger, Elisabeth/AAV-5289-2021; Britzen-Laurent, Nathalie/HDM-6965-2022; Stürzl, Michael/B-3019-2015; Lausen, Berthold/D-4063-2012	Naschberger, Elisabeth/0000-0003-1291-622X; Britzen-Laurent, Nathalie/0000-0002-0494-7117; Stürzl, Michael/0000-0002-9276-2824; Lausen, Berthold/0000-0002-0594-7258	German Federal Ministry of Education and Research (BMBF); Deutsche Forschungsgemeinschaft [DFG-GRK1071, STU238/6-1, SFB796]; German Cancer Aid [109510]; Interdisciplinary Center for Clinical Research (IZKF); Emerging Fields Initiative of the Friedrich-Alexander University of Erlangen; Programm zur Forderung der Chancengleichheit fur Frauen in Forschung und Lehre (FFL); University Medical Center Erlangen	German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); German Cancer Aid(Deutsche Krebshilfe); Interdisciplinary Center for Clinical Research (IZKF); Emerging Fields Initiative of the Friedrich-Alexander University of Erlangen; Programm zur Forderung der Chancengleichheit fur Frauen in Forschung und Lehre (FFL); University Medical Center Erlangen	We thank Professor Moshe Oren, Professor Wafik S El-Deiry and Professor Bert Vogelstein for sharing plasmids. In addition, we thank PD Dr Reiner Strick and PD Dr Pamela Strissel (University Medical Center Erlangen, Department of Obstetrics and Gynecology) for providing the MCF7 cells. This work was supported by grants of the German Federal Ministry of Education and Research (BMBF, Polyprobe-Study), the Deutsche Forschungsgemeinschaft (DFG-GRK1071, STU238/6-1, SFB796 (sub-project B9)) and the German Cancer Aid (109510). Additional support was obtained from the Interdisciplinary Center for Clinical Research (IZKF) and the Emerging Fields Initiative of the Friedrich-Alexander University of Erlangen to MS, by a grant for the promotion of young researchers (ELAN) of the University Medical Center Erlangen to AK and a grant of the 'Programm zur Forderung der Chancengleichheit fur Frauen in Forschung und Lehre (FFL)' to PC.	Austgen K, 2012, J VIROL, V86, P1877, DOI 10.1128/JVI.06600-11; BARAK Y, 1993, EMBO J, V12, P461, DOI 10.1002/j.1460-2075.1993.tb05678.x; Blasig C, 1997, J VIROL, V71, P7963, DOI 10.1128/JVI.71.10.7963-7968.1997; Britzen-Laurent N, 2013, CARCINOGENESIS, V34, P153, DOI 10.1093/carcin/bgs310; Burbelo PD, 2010, J INFECT DIS, V201, P1919, DOI 10.1086/652869; CESARMAN E, 1995, NEW ENGL J MED, V332, P1186, DOI 10.1056/NEJM199505043321802; Chandran B, 2010, J VIROL, V84, P2188, DOI 10.1128/JVI.01334-09; CHANG Y, 1994, SCIENCE, V266, P1865, DOI 10.1126/science.7997879; Chen WG, 2010, J VIROL, V84, P3898, DOI 10.1128/JVI.01321-09; de Oliveira DE, 2010, TRENDS MICROBIOL, V18, P248, DOI 10.1016/j.tim.2010.04.001; Dittmer DP, 2011, MBIO, V2, DOI 10.1128/mBio.00138-11; Dittmer DP, 2003, CANCER RES, V63, P2010; Friborg J, 1999, NATURE, V402, P889, DOI 10.1038/47266; GRAHAM FL, 1977, J GEN VIROL, V36, P59, DOI 10.1099/0022-1317-36-1-59; Gross A, 1998, EMBO J, V17, P3878, DOI 10.1093/emboj/17.14.3878; Grundhoff A, 2004, J CLIN INVEST, V113, P124, DOI 10.1172/JCI200417803; Gwack Y, 2001, J VIROL, V75, P6245, DOI 10.1128/JVI.75.13.6245-6248.2001; Hahn A, 2009, J VIROL, V83, P396, DOI 10.1128/JVI.01170-08; Hahn AS, 2012, NAT MED, V18, P961, DOI 10.1038/nm.2805; Hanon E, 1998, J VIROL, V72, P7638, DOI 10.1128/JVI.72.9.7638-7641.1998; HOLLSTEIN M, 1991, SCIENCE, V253, P49, DOI 10.1126/science.1905840; HUTCHINSON L, 1992, J VIROL, V66, P2240, DOI 10.1128/JVI.66.4.2240-2250.1992; Ilkow CS, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001291; Inn KS, 2011, J VIROL, V85, P10899, DOI 10.1128/JVI.00690-11; Jerome KR, 2001, J IMMUNOL, V167, P3928, DOI 10.4049/jimmunol.167.7.3928; Jochmann R, 2013, GLYCOBIOLOGY, V23, P1114, DOI 10.1093/glycob/cwt028; Katano H, 2000, VIROLOGY, V269, P335, DOI 10.1006/viro.2000.0196; Konrad A, 2011, METHODS MOL BIOL, V706, P107, DOI 10.1007/978-1-61737-970-3_9; Konrad A, 2009, J VIROL, V83, P2563, DOI 10.1128/JVI.01512-08; Kuhn E, 2012, LAB CHIP, V12, P1363, DOI 10.1039/c2lc20724a; Kurosu T, 2010, APOPTOSIS, V15, P608, DOI 10.1007/s10495-010-0457-0; Kwon JA, 2003, BIOL CHEM, V384, P203, DOI 10.1515/BC.2003.022; Lagunoff M, 2003, INT REV IMMUNOL, V22, P373, DOI 10.1080/08830180305218; LANE DP, 1992, NATURE, V358, P15, DOI 10.1038/358015a0; Lee HR, 2009, J VIROL, V83, P6739, DOI 10.1128/JVI.02353-08; Leida AM, 2012, CELL HOST MICROBE, V11, P167, DOI 10.1016/j.chom.2012.01.005; LEVINE AJ, 1991, NATURE, V351, P453, DOI 10.1038/351453a0; Marcelin AG, 2007, J INFECT DIS, V196, P1163, DOI 10.1086/521625; MIYASHITA T, 1995, CELL, V80, P293; Moore PS, 2007, HUMAN HERPESVIRUSES: BIOLOGY, THERAPY, AND IMMUNOPROPHYLAXIS, P540; MORAN E, 1993, FASEB J, V7, P880, DOI 10.1096/fasebj.7.10.8344487; Morris SJ, 1999, J GEN VIROL, V80, P137, DOI 10.1099/0022-1317-80-1-137; Myoung J, 2011, J VIROL METHODS, V174, P12, DOI 10.1016/j.jviromet.2011.03.012; Nakamichi K, 2001, VIROLOGY, V279, P488, DOI 10.1006/viro.2000.0740; Nakamura H, 2001, J VIROL, V75, P7572, DOI 10.1128/JVI.75.16.7572-7582.2001; Naranatt PP, 2002, ARCH VIROL, V147, P1349, DOI 10.1007/s00705-002-0813-7; Naschberger E, 2004, BIOCHEM J, V379, P409, DOI 10.1042/BJ20031873; Nealon K, 2001, J VIROL, V75, P2866, DOI 10.1128/JVI.75.6.2866-2878.2001; Pertel PE, 2002, J VIROL, V76, P4390, DOI 10.1128/JVI.76.9.4390-4400.2002; Petre CE, 2007, J VIROL, V81, P1912, DOI 10.1128/JVI.01757-06; Piette J, 1997, ONCOGENE, V15, P1001, DOI 10.1038/sj.onc.1201432; Polyak K, 1997, NATURE, V389, P300, DOI 10.1038/38525; Raftery MJ, 1999, J EXP MED, V190, P1103, DOI 10.1084/jem.190.8.1103; Rivas C, 2001, J VIROL, V75, P429, DOI 10.1128/JVI.75.1.429-438.2001; Rozen R, 2008, J VIROL, V82, P4742, DOI 10.1128/JVI.02745-07; Sander G, 2008, J VIROL, V82, P1908, DOI 10.1128/JVI.01716-07; Sarek G, 2013, ONCOGENE, V32, P1091, DOI 10.1038/onc.2012.118; Sarek G, 2007, J CLIN INVEST, V117, P1019, DOI 10.1172/JCI30945; Sathish N, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00098; Schulz TF, 2007, HUMAN HERPESVIRUSES: BIOLOGY, THERAPY, AND IMMUNOPROPHYLAXIS, P490; SOULIER J, 1995, BLOOD, V86, P1276, DOI 10.1182/blood.V86.4.1276.bloodjournal8641276; SPAETE RR, 1993, VIROLOGY, V193, P853, DOI 10.1006/viro.1993.1194; Staskus KA, 1997, J VIROL, V71, P715, DOI 10.1128/JVI.71.1.715-719.1997; Sturzl M, 2008, COMB CHEM HIGH T SCR, V11, P159, DOI 10.2174/138620708783744499; Sturzl M, 2013, INT J CANCER, V132, P1954, DOI 10.1002/ijc.27849; Sturzl M, 2009, THROMB HAEMOSTASIS, V102, P1117, DOI 10.1160/TH09-07-0472; Sturzl M, 1997, INT J CANCER, V72, P68, DOI 10.1002/(SICI)1097-0215(19970703)72:1&lt;68::AID-IJC10&gt;3.0.CO;2-6; Sun R, 1999, J VIROL, V73, P2232, DOI 10.1128/JVI.73.3.2232-2242.1999; Takaoka A, 2003, NATURE, V424, P516, DOI 10.1038/nature01850; Tornesello ML, 2009, ONCOLOGY-BASEL, V77, P328, DOI 10.1159/000260905; Urbanowski MD, 2013, J VIROL, V87, P872, DOI 10.1128/JVI.02030-12; Vassilev LT, 2004, CELL CYCLE, V3, P419; Vassilev LT, 2004, SCIENCE, V303, P844, DOI 10.1126/science.1092472; Voltan R, 2014, MOL CARCINOGEN, V53, P498, DOI 10.1002/mc.21985; Ye FC, 2012, CELL CYCLE, V11, P1393, DOI 10.4161/cc.19756; Ziauddin J, 2001, NATURE, V411, P107, DOI 10.1038/35075114	76	15	15	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 29	2015	34	5					639	649		10.1038/onc.2013.595	http://dx.doi.org/10.1038/onc.2013.595			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CA4DD	24469037				2022-12-25	WOS:000348853500011
J	Zhang, LH; Yin, AA; Cheng, JX; Huang, HY; Li, XM; Zhang, YQ; Han, N; Zhang, X				Zhang, L-H; Yin, A-A; Cheng, J-X; Huang, H-Y; Li, X-M; Zhang, Y-Q; Han, N.; Zhang, X.			TRIM24 promotes glioma progression and enhances chemoresistance through activation of the PI3K/Akt signaling pathway	ONCOGENE			English	Article						glioblastoma; TRIM24; TIF1 alpha; PI3K; Akt; MGMT	GENE-EXPRESSION; MYELOID-LEUKEMIA; P53; TUMORS; VIRUS; CELLS; CHEMOTHERAPY; TEMOZOLOMIDE; INDUCTION; TARGETS	The tripartite motif protein TRIM24 (tripartite motif-containing 24) has been found to play distinct roles in tumor development and progression, according to different tumor contexts. However, it remains elusive whether TRIM24 plays a role in malignant gliomas that are the most common and deadly primary brain tumors in adults. We report here that TRIM24 expression is positively correlated with glioma malignancy and is negatively associated with prognosis of patients with newly diagnosed glioblastoma, which is the most malignant form of gliomas but displays highly heterogeneous clinical outcome. The multivariate Cox regression analysis demonstrates the independent predictive value of TRIM24 expression level for overall and progression-free survival. Knockdown of TRIM24 suppresses cell proliferation, cell cycle progression, clone formation and in vivo tumor development, whereas overexpression of TRIM24 promotes cell growth. Chromatin immunoprecipitation, real-time reverse transcription-PCR and mutation analyses demonstrate that TRIM24 binds to the PIK3CA promoter via its PHD-Bromo domain to activate the transcription of PIK3CA gene, thus enhancing phosphatidylinositide 3-kinase (PI3K)/Akt signaling. The pan-PI3K inhibitor LY294002 and small interfering RNA targeting PIK3CA both abrogate the growth-promoting effect of TRIM24. Moreover, TRIM24 regulates the expression of DNA repair enzyme O-6-methylguanine-DNA methyltransferase (MGMT) through PI3K/Akt/nuclear factor-kappa B signaling transduction and enhances resistance to temozolomide, the standard chemotherapeutic agent for glioblastoma. Finally, glioblastoma patients with low TRIM24 expression benefit from chemotherapy, whereas those with high TRIM24 expression do not have such benefit. Our results suggest that TRIM24 might serve as a potential prognostic marker and therapeutic target for the management of malignant gliomas.	[Zhang, L-H; Yin, A-A; Cheng, J-X; Huang, H-Y; Li, X-M; Zhang, Y-Q; Han, N.; Zhang, X.] Fourth Mil Med Univ, Xijing Hosp, Dept Neurosurg, Xian 710032, Shaanxi Provinc, Peoples R China	Air Force Military Medical University	Zhang, X (corresponding author), Fourth Mil Med Univ, Xijing Hosp, Dept Neurosurg, Changle West Rd 127, Xian 710032, Shaanxi Provinc, Peoples R China.	zhangluhua211@163.com		Yin, An-An/0000-0002-1888-5551	National Natural Science Foundation of China [30870843, 81171087]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	We thank Xiao-Liang Yang, Xi-Qiang Cai and Juan Li for helpful assistance. This work was supported by the National Natural Science Foundation of China (no. 30870843 and no. 81171087) to X Zhang. The funding body does not play any role in the design of the study, collection and analysis of data and decision to publish.	Aghi M, 2008, ONCOGENE, V27, P4249, DOI 10.1038/onc.2008.53; Aghi M, 2006, JNCI-J NATL CANCER I, V98, P38, DOI 10.1093/jnci/djj003; Allton K, 2009, P NATL ACAD SCI USA, V106, P11612, DOI 10.1073/pnas.0813177106; Barbus S, 2011, JNCI-J NATL CANCER I, V103, P598, DOI 10.1093/jnci/djr036; Chambon M, 2011, AM J PATHOL, V178, P1461, DOI 10.1016/j.ajpath.2010.12.026; Chen J, 2012, CELL, V149, P36, DOI 10.1016/j.cell.2012.03.009; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Chowdhry S, 2013, ONCOGENE, V32, P3765, DOI 10.1038/onc.2012.388; Danam RP, 2005, MOL CANCER THER, V4, P61; Dolecek TA, 2012, NEURO-ONCOLOGY, V14, pv1, DOI 10.1093/neuonc/nos218; Fritsch R, 2013, CELL, V153, P1050, DOI 10.1016/j.cell.2013.04.031; Gandini D, 2002, LEUKEMIA, V16, P886, DOI 10.1038/sj.leu.2402452; Hatakeyama S, 2011, NAT REV CANCER, V11, P792, DOI 10.1038/nrc3139; Hegi ME, 2005, NEW ENGL J MED, V352, P997, DOI 10.1056/NEJMoa043331; Herquel B, 2013, NAT STRUCT MOL BIOL, V20, P339, DOI 10.1038/nsmb.2496; Herquel B, 2011, TRANSCR-AUSTIN, V2, P231, DOI 10.4161/trns.2.5.17725; Herquel B, 2011, P NATL ACAD SCI USA, V108, P8212, DOI 10.1073/pnas.1101544108; Hui RCY, 2008, MOL CELL BIOL, V28, P5886, DOI 10.1128/MCB.01265-07; Ignat M, 2008, P NATL ACAD SCI USA, V105, P2598, DOI 10.1073/pnas.0712030105; Ikegami D, 2011, DEVELOPMENT, V138, P1507, DOI 10.1242/dev.057802; Jain AK, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001268; Jain AK, 2009, CELL CYCLE, V8, P3668, DOI 10.4161/cc.8.22.9979; Josset L, 2012, J VIROL, V86, P7192, DOI 10.1128/JVI.00563-12; Kaina B, 2007, DNA REPAIR, V6, P1079, DOI 10.1016/j.dnarep.2007.03.008; Kanai R, 2012, JNCI-J NATL CANCER I, V104, P42, DOI 10.1093/jnci/djr509; Khetchoumian K, 2007, NAT GENET, V39, P1500, DOI 10.1038/ng.2007.15; Kikuchi M, 2009, BBA-MOL CELL RES, V1793, P1828, DOI 10.1016/j.bbamcr.2009.11.001; Ledda-Columbano GM, 2004, CARCINOGENESIS, V25, P2061, DOI 10.1093/carcin/bgh221; Li HY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037657; Louis DN, 2007, ACTA NEUROPATHOL, V114, P97, DOI 10.1007/s00401-007-0243-4; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Ou HD, 2012, CELL, V151, P304, DOI 10.1016/j.cell.2012.08.035; Quintas-Cardama A, 2012, CANCER-AM CANCER SOC, V118, P5283, DOI 10.1002/cncr.27568; Terzian T, 2008, GENE DEV, V22, P1337, DOI 10.1101/gad.1662908; Tisserand J, 2011, J BIOL CHEM, V286, P33369, DOI 10.1074/jbc.M111.225680; Tolcher AW, 2003, BRIT J CANCER, V88, P1004, DOI 10.1038/sj.bjc.6600827; Tsai WW, 2010, NATURE, V468, P927, DOI 10.1038/nature09542; Van Meir EG, 2010, CA-CANCER J CLIN, V60, P166, DOI 10.3322/caac.20069; Vassilev LT, 2004, SCIENCE, V303, P844, DOI 10.1126/science.1092472; Wen PY, 2008, NEW ENGL J MED, V359, P492, DOI 10.1056/NEJMra0708126; Worster DT, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2001986	41	85	89	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 29	2015	34	5					600	610		10.1038/onc.2013.593	http://dx.doi.org/10.1038/onc.2013.593			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CA4DD	24469053				2022-12-25	WOS:000348853500007
J	Sun, XF; Terakawa, J; Clevers, H; Barker, N; Daikoku, T; Dey, SK				Sun, Xiaofei; Terakawa, Jumpei; Clevers, Hans; Barker, Nick; Daikoku, Takiko; Dey, Sudhansu K.			Ovarian LGR5 is critical for successful pregnancy	FASEB JOURNAL			English	Article						20-hydroxysteroid dehydrogenase; corpus luteum; progesterone	CONDITIONAL DELETION; STEM-CELLS; BLASTOCYST IMPLANTATION; EMBRYO IMPLANTATION; GROWTH-FACTORS; PROGESTERONE; RECEPTORS; UTERUS; EXPRESSION; GENES	Leucine-rich repeat-containing G-protein-coupled receptor 5 (Lgr5) is expressed in many organs, including female reproductive organs, and is a stem cell marker in the stomach and intestinal epithelium, hair follicles, and ovarian surface epithelium. Despite ongoing studies, the definitive physiological functions of Lgr5 remain unclear. We utilized mice with conditional deletion of Lgr5 (Lgr5(d/d)) in the female reproductive organs by progesterone receptor-Cre (Pgr(Cre)) to determine Lgr5's functions during pregnancy. Only 30% of plugged Lgr5(d/d) females delivered live pups, and their litter sizes were lower. We found that pregnancy failure in Lgr5(d/d) females was due to insufficient ovarian progesterone (P-4) secretion that compromised decidualization, terminating pregnancy. The drop in P-4 levels was reflected in elevated levels of P-4-metabolizing enzyme 20-hydroxysteroid dehydrogenase in corpora lutea (CL) inactivated of Lgr5. Of interest, P-4 supplementation rescued decidualization failure and supported pregnancy to full term in Lgr5(d/d) females. These results provide strong evidence that Lgr5 is critical to normal CL function, unveiling a new role of LGR5 in the ovary.Sun, X., Terakawa, J., Clevers, H., Barker, N., Daikoku, T., Dey, S. K. Ovarian LGR5 is critical for successful pregnancy.	[Sun, Xiaofei; Terakawa, Jumpei; Daikoku, Takiko; Dey, Sudhansu K.] Univ Cincinnati, Coll Med, Cincinnati Childrens Hosp Med Ctr, Div Reprod Sci,Perinatal Inst, Cincinnati, OH USA; [Clevers, Hans] Royal Netherlands Acad Arts & Sci, Hubrecht Inst, Utrecht, Netherlands; [Barker, Nick] Inst Med Biol, Adult Stem Cell Grp, Singapore, Singapore	Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW); Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Medical Biology (IMB)	Dey, SK (corresponding author), Cincinnati Childrens Hosp Med Ctr, Div Reprod Sci, MLC 7045,3333 Burnet Ave, Cincinnati, OH 45229 USA.	sk.dey@cchmc.org	Barker, Nick/AAE-9833-2021; Barker, Nick/AAS-2774-2020; Terakawa, Jumpei/AAF-1435-2020; Barker, Nick/A-5535-2011	Barker, Nick/0000-0003-3566-4475; Terakawa, Jumpei/0000-0002-7643-7976; 	U.S. National Institutes of Health [HD068524, PO1CA7783]; March of Dimes; Cincinnati Children's Hospital Medical Center Perinatal Institute pilot/feasibility grant; Lalor Foundation; Japan Society for the Promotion of Science - Kyoto University (Kyoto, Japan); Cincinnati Children's Hospital; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD068524] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [F32CA007783] Funding Source: NIH RePORTER	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); March of Dimes(March of Dimes); Cincinnati Children's Hospital Medical Center Perinatal Institute pilot/feasibility grant; Lalor Foundation; Japan Society for the Promotion of Science - Kyoto University (Kyoto, Japan); Cincinnati Children's Hospital; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The authors thank Serenity Curtis for editing the manuscript and Amanda Bartos and Yingju Li for their help in immunostaining. Francesco DeMayo and John B. Lydon (Baylor College of Medicine, Houston, TX, USA) initially provided the Pgr-Cre mouse line. This work was supported in part by U.S. National Institutes of Health grants (HD068524 and PO1CA7783), grants from March of Dimes to S. K. D., and a Cincinnati Children's Hospital Medical Center Perinatal Institute pilot/feasibility grant to T. D. X. S. was supported by a Lalor Foundation postdoctoral fellowship. J.T. is supported by a Japan Society for the Promotion of Science postdoctoral fellowship sponsored by Kyoto University (Kyoto, Japan) and Cincinnati Children's Hospital.	Bachelot A, 2005, CURR TOP DEV BIOL, V68, P49, DOI 10.1016/S0070-2153(05)68003-9; Bao L, 2007, ENDOCRINOLOGY, V148, P2326, DOI 10.1210/en.2006-1643; Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Barker N, 2010, CELL STEM CELL, V6, P25, DOI 10.1016/j.stem.2009.11.013; Birchmeier W, 2011, NATURE, V476, P287, DOI 10.1038/476287a; Carmon KS, 2011, P NATL ACAD SCI USA, V108, P11452, DOI 10.1073/pnas.1106083108; Cha JY, 2012, NAT MED, V18, P1754, DOI 10.1038/nm.3012; Daikoku T, 2006, CANCER RES, V66, P2527, DOI 10.1158/0008-5472.CAN-05-4063; Daikoku T, 2013, MOL HUM REPROD, V19, P463, DOI 10.1093/molehr/gat016; Daikoku T, 2011, DEV CELL, V21, P1014, DOI 10.1016/j.devcel.2011.09.010; Daikoku T, 2011, GYNECOL ONCOL, V122, P424, DOI 10.1016/j.ygyno.2011.04.022; de Lau W, 2011, NATURE, V476, P293, DOI 10.1038/nature10337; Flesken-Nikitin A, 2013, NATURE, V495, P241, DOI 10.1038/nature11979; Garcia MI, 2009, DEV BIOL, V331, P58, DOI 10.1016/j.ydbio.2009.04.020; Grosdemouge Isabelle, 2003, Reprod Biol Endocrinol, V1, P12, DOI 10.1186/1477-7827-1-12; Hess AP, 2006, KNOBIL AND NEILL'S PHYSIOLOGY OF REPRODUCTION, VOLS 1 AND 2, 3RD EDITON, P337; Hirota Y, 2010, J CLIN INVEST, V120, P803, DOI 10.1172/JCI40051; Hsieh M, 2005, BIOL REPROD, V73, P1135, DOI 10.1095/biolreprod.105.042739; Hsieh M, 2002, ENDOCRINOLOGY, V143, P898, DOI 10.1210/en.143.3.898; Hsu SY, 1998, MOL ENDOCRINOL, V12, P1830, DOI 10.1210/me.12.12.1830; Hsu SY, 2000, MOL ENDOCRINOL, V14, P1257, DOI 10.1210/me.14.8.1257; Jaks V, 2008, NAT GENET, V40, P1291, DOI 10.1038/ng.239; Lee KY, 2007, MOL CELL BIOL, V27, P5468, DOI 10.1128/MCB.00342-07; Lim H, 1997, CELL, V91, P197, DOI 10.1016/S0092-8674(00)80402-X; Lim HJ, 1999, MOL ENDOCRINOL, V13, P1005, DOI 10.1210/me.13.6.1005; Matsumoto H, 2002, DEV BIOL, V245, P280, DOI 10.1006/dbio.2002.0645; MCCORMACK JT, 1974, J ENDOCRINOL, V62, P101, DOI 10.1677/joe.0.0620101; Milligan SR, 1997, HUM REPROD, V12, P602; Morita H, 2004, MOL CELL BIOL, V24, P9736, DOI 10.1128/MCB.24.22.9736-9743.2004; Pangas SA, 2007, SEMIN REPROD MED, V25, P225, DOI 10.1055/s-2007-980216; PARIA BC, 1993, P NATL ACAD SCI USA, V90, P10159, DOI 10.1073/pnas.90.21.10159; Paria BC, 2001, P NATL ACAD SCI USA, V98, P1047, DOI 10.1073/pnas.98.3.1047; SHARMA R, 1983, J ANAT, V137, P695; Sonderegger S, 2010, PLACENTA, V31, P839, DOI 10.1016/j.placenta.2010.07.011; Song HS, 2000, MOL ENDOCRINOL, V14, P1147, DOI 10.1210/me.14.8.1147; Soyal SM, 2005, GENESIS, V41, P58, DOI 10.1002/gene.20098; STEWART CL, 1992, NATURE, V359, P76, DOI 10.1038/359076a0; Stocco C, 2007, ENDOCR REV, V28, P117, DOI 10.1210/er.2006-0022; Stocco DM, 1996, ENDOCR REV, V17, P221, DOI 10.1210/er.17.3.221; Sun XF, 2012, P NATL ACAD SCI USA, V109, P1145, DOI 10.1073/pnas.1118411109; Sun XF, 2009, ENDOCRINOLOGY, V150, P5065, DOI 10.1210/en.2009-0690; Tranguch S, 2007, J CLIN INVEST, V117, P1824, DOI 10.1172/JCI31622; van de Wetering M, 2002, CELL, V111, P241, DOI 10.1016/S0092-8674(02)01014-0; Van Schoore G, 2005, HISTOCHEM CELL BIOL, V124, P35, DOI 10.1007/s00418-005-0002-3; Wang DL, 2013, GENE DEV, V27, P1339, DOI 10.1101/gad.219360.113; Wang HB, 2006, NAT REV GENET, V7, P185, DOI 10.1038/nrg1808; Wang HB, 2004, NAT MED, V10, P1074, DOI 10.1038/nm1104	47	21	22	1	16	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2014	28	5					2380	2389		10.1096/fj.13-248344	http://dx.doi.org/10.1096/fj.13-248344			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	AG3RA	24469993	Green Published			2022-12-25	WOS:000335336000038
J	Han, SP; Gambin, Y; Gomez, GA; Verma, S; Giles, N; Michael, M; Wu, SK; Guo, Z; Johnston, W; Sierecki, E; Parton, RG; Alexandrov, K; Yap, AS				Han, Siew Ping; Gambin, Yann; Gomez, Guillermo A.; Verma, Suzie; Giles, Nichole; Michael, Magdalene; Wu, Selwin K.; Guo, Zhong; Johnston, Wayne; Sierecki, Emma; Parton, Robert G.; Alexandrov, Kirill; Yap, Alpha S.			Cortactin Scaffolds Arp2/3 and WAVE2 at the Epithelial Zonula Adherens	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Actin; Cell Adhesion; Cell Junctions; Cytoskeleton; E-cadherin; Arp2; 3; Cortactin; WAVE2	SINGLE-MOLECULE; COINCIDENCE DETECTION; F-ACTIN; COMPLEX; ACTIVATION; MECHANISM; CATENIN; TUBA	Background: Productive epithelial interactions require actin filament assembly at E-cadherin adhesions. Results: Cortactin localizes to the zonula adherens through interactions with E-cadherin and N-WASP; there it recruits Arp2/3 and WAVE2 by separate mechanisms to support actin nucleation. Conclusion: Cortactin acts as a coincident scaffold. Significance: Cortactin can regulate the dynamic integration of cadherin adhesion with the actin cytoskeleton. Cadherin junctions arise from the integrated action of cell adhesion, signaling, and the cytoskeleton. At the zonula adherens (ZA), a WAVE2-Arp2/3 actin nucleation apparatus is necessary for junctional tension and integrity. But how this is coordinated with cadherin adhesion is not known. We now identify cortactin as a key scaffold for actin regulation at the ZA, which localizes to the ZA through influences from both E-cadherin and N-WASP. Using cell-free protein expression and fluorescent single molecule coincidence assays, we demonstrate that cortactin binds directly to the cadherin cytoplasmic tail. However, its concentration with cadherin at the apical ZA also requires N-WASP. Cortactin is known to bind Arp2/3 directly (Weed, S. A., Karginov, A. V., Schafer, D. A., Weaver, A. M., Kinley, A. W., Cooper, J. A., and Parsons, J. T. (2000) J. Cell Biol. 151, 29-40). We further show that cortactin can directly bind WAVE2, as well as Arp2/3, and both these interactions are necessary for actin assembly at the ZA. We propose that cortactin serves as a platform that integrates regulators of junctional actin assembly at the ZA.	[Han, Siew Ping; Gambin, Yann; Gomez, Guillermo A.; Verma, Suzie; Giles, Nichole; Michael, Magdalene; Wu, Selwin K.; Guo, Zhong; Johnston, Wayne; Sierecki, Emma; Parton, Robert G.; Alexandrov, Kirill; Yap, Alpha S.] Univ Queensland, Inst Mol Biosci, Mol Cell Biol Div, Brisbane, Qld 4072, Australia	University of Queensland	Yap, AS (corresponding author), Univ Queensland, Inst Mol Biosci, Mol Cell Biol Div, Brisbane, Qld 4072, Australia.	a.yap@uq.edu.au	Sierecki, Emma/A-4810-2012; GAMBIN, Yann/M-8799-2014; Yap, Alpha S./J-1554-2014; Gomez, Guillermo/J-2993-2014; SIERECKI, Emma/L-2556-2019; Wu, Selwin/V-3464-2019; Alexandrov, Kirill/A-5830-2013; GUO, Zhong/J-8723-2014; Michael, Magdalene/AAR-8700-2020; GAMBIN, Yann/AAI-8501-2021; Michael, Magdalene/K-1526-2014; Sierecki, Emma/I-2920-2019; GUO, Zhong/J-8723-2014; Parton, Robert/C-5673-2009; Johnston, Wayne/D-2095-2017	Yap, Alpha S./0000-0002-1038-8956; Gomez, Guillermo/0000-0002-0494-2404; SIERECKI, Emma/0000-0001-9970-868X; Wu, Selwin/0000-0002-5185-8467; Alexandrov, Kirill/0000-0002-0957-6511; GUO, Zhong/0000-0003-0285-5021; Michael, Magdalene/0000-0003-2577-729X; GUO, Zhong/0000-0002-2277-0087; GAMBIN, Yann/0000-0001-7378-8976; Parton, Robert/0000-0002-7494-5248; Johnston, Wayne/0000-0002-7485-8363	National Health and Medical Research Council of Australia [631377, APP1010489]; Australia Fellowship [569542]; Australian Research Council Future Fellowship [FT0991611]; Kid's Cancer Project of the Oncology Children's Foundation;  [631383];  [511005];  [1037320];  [DP120101423];  [FT110100478]	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Australia Fellowship; Australian Research Council Future Fellowship(Australian Research Council); Kid's Cancer Project of the Oncology Children's Foundation; ; ; ; ; 	This work was supported by the National Health and Medical Research Council of Australia Project Grants 631377, APP1010489, and Research Fellowship 631383 (to A. Y.), Program Grant 511005 (to K. A. and R. G. P.), Program Grant 1037320 (to A. Y., K. A., and R. G. P.), and Australia Fellowship 569542 (to R. G. P.), by Australian Research Council Future Fellowship FT0991611 and Project Grant DP120101423 (to K. A.) and Future Fellowship FT110100478 (to Y. G.), and by the Kid's Cancer Project of the Oncology Children's Foundation.	Ammer AG, 2008, CELL MOTIL CYTOSKEL, V65, P687, DOI 10.1002/cm.20296; Carlton JG, 2005, TRENDS CELL BIOL, V15, P540, DOI 10.1016/j.tcb.2005.08.005; Chen ZC, 2010, NATURE, V468, P533, DOI 10.1038/nature09623; Farhadifar R, 2007, CURR BIOL, V17, P2095, DOI 10.1016/j.cub.2007.11.049; Ferreon ACM, 2009, P NATL ACAD SCI USA, V106, P5645, DOI 10.1073/pnas.0809232106; Gambin Y, 2011, NAT METHODS, V8, P239, DOI 10.1038/NMETH.1568; Gambin Y, 2009, P NATL ACAD SCI USA, V106, P10153, DOI 10.1073/pnas.0904461106; Guo Z, 2013, PLOS ONE, V8; Helwani FM, 2004, J CELL BIOL, V164, P899, DOI 10.1083/jcb.200309034; Huber AH, 2001, J BIOL CHEM, V276, P12301, DOI 10.1074/jbc.M010377200; Insall RH, 2009, DEV CELL, V17, P310, DOI 10.1016/j.devcel.2009.08.012; Ismail AM, 2009, NAT STRUCT MOL BIOL, V16, P561, DOI 10.1038/nsmb.1587; Ivanov AI, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000658; Kinley AW, 2003, CURR BIOL, V13, P384, DOI 10.1016/S0960-9822(03)00107-6; Kovacs EM, 2002, CURR BIOL, V12, P379, DOI 10.1016/S0960-9822(02)00661-9; Kovacs EM, 2011, CELL ADHES MIGR, V5, P344, DOI 10.4161/cam.5.4.16717; Kovacs EM, 2011, NAT CELL BIOL, V13, P934, DOI 10.1038/ncb2290; Kovtun O, 2011, METHODS, V55, P58, DOI 10.1016/j.ymeth.2011.06.006; Kowalski JR, 2005, J CELL SCI, V118, P79, DOI 10.1242/jcs.01586; Lebensohn AM, 2009, MOL CELL, V36, P512, DOI 10.1016/j.molcel.2009.10.024; Martinez-Quiles N, 2004, MOL CELL BIOL, V24, P5269, DOI 10.1128/MCB.24.12.5269-5280.2004; Meng W, 2008, CELL, V135, P948, DOI 10.1016/j.cell.2008.09.040; Mureev S, 2009, NAT BIOTECHNOL, V27, P747, DOI 10.1038/nbt.1556; Niessen CM, 2011, PHYSIOL REV, V91, P691, DOI 10.1152/physrev.00004.2010; Orte A, 2006, ANAL CHEM, V78, P7707, DOI 10.1021/ac061122y; Orte A, 2011, CHEMPHYSCHEM, V12, P491, DOI 10.1002/cphc.201000636; Orte A, 2010, BIOCHEM SOC T, V38, P914, DOI 10.1042/BST0380914; Otani T, 2006, J CELL BIOL, V175, P135, DOI 10.1083/jcb.200605012; Priya R, 2013, DIFFERENTIATION, V86, P133, DOI 10.1016/j.diff.2013.01.002; Rajput C, 2013, J BIOL CHEM, V288, P4241, DOI 10.1074/jbc.M112.440396; Ratheesh A, 2012, NAT REV MOL CELL BIO, V13, P673, DOI 10.1038/nrm3431; Ratheesh A, 2012, NAT CELL BIOL, V14, P818, DOI 10.1038/ncb2532; Ren G, 2009, J BIOL CHEM, V284, P18913, DOI 10.1074/jbc.M109.000307; Sawyer JM, 2010, DEV BIOL, V341, P5, DOI 10.1016/j.ydbio.2009.09.009; Sierecki E, 2013, INTERFACE FOCUS, V3, DOI 10.1098/rsfs.2013.0018; Smutny M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022458; Smutny M, 2010, NAT CELL BIOL, V12, P696, DOI 10.1038/ncb2072; Tang VW, 2012, J CELL BIOL, V196, P115, DOI 10.1083/jcb.201103116; Ullman EF, 1996, CLIN CHEM, V42, P1518; Uruno T, 2001, NAT CELL BIOL, V3, P259, DOI 10.1038/35060051; Verma S, 2012, MOL BIOL CELL, V23, P4601, DOI 10.1091/mbc.E12-08-0574; Weaver AM, 2001, CURR BIOL, V11, P370, DOI 10.1016/S0960-9822(01)00098-7; Weed SA, 2000, J CELL BIOL, V151, P29, DOI 10.1083/jcb.151.1.29; Wu SK, 2014, NAT CELL BIOL, V16, P167, DOI 10.1038/ncb2900; Xu XP, 2012, EMBO J, V31, P236, DOI 10.1038/emboj.2011.343; Yahiatene I, 2012, ANAL CHEM, V84, P2729, DOI 10.1021/ac2030283	46	46	46	2	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 14	2014	289	11					7764	7775		10.1074/jbc.M113.544478	http://dx.doi.org/10.1074/jbc.M113.544478			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AC8CV	24469447	Green Published, hybrid			2022-12-25	WOS:000332761500043
J	LeBlanc, PM; Doggett, TA; Choi, J; Hancock, MA; Durocher, Y; Frank, F; Nagar, B; Ferguson, TA; Saleh, M				LeBlanc, Philippe M.; Doggett, Teresa Ann; Choi, Jayoung; Hancock, Mark A.; Durocher, Yves; Frank, Filipp; Nagar, Bhushan; Ferguson, Thomas A.; Saleh, Maya			An Immunogenic Peptide in the A-box of HMGB1 Protein Reverses Apoptosis-induced Tolerance through RAGE Receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Apoptosis; Caspase; Inflammation; Innate Immunity; Receptor for Advanced Glycation End Products (RAGE); Sepsis; Tolerance	SEPSIS; ACTIVATION; BINDING; HYPERSENSITIVITY; INDUCTION; SURVIVAL; IMPROVES; LIPOPOLYSACCHARIDE; INFLAMMASOME; AMPHOTERIN	Background: The role of caspase-1 in regulating the immunogenic properties of HMGB1 has not been previously reported. Results: We have mapped a peptide in the A-box of HMGB1 that reverses tolerance through RAGE. Conclusion: Inflammasome signaling regulates the immunogenic activity of HMGB1. Significance: Immunogenic peptides within the HMGB1 A-box may be exploited to reverse immune tolerance in sepsis patients. Apoptotic cells trigger immune tolerance in engulfing phagocytes. This poorly understood process is believed to contribute to the severe immunosuppression and increased susceptibility to nosocomial infections observed in critically ill sepsis patients. Extracellular high mobility group box 1 (HMGB1) is an important mediator of both sepsis lethality and the induction of immune tolerance by apoptotic cells. We have found that HMGB1 is sensitive to processing by caspase-1, resulting in the production of a fragment within its N-terminal DNA-binding domain (the A-box) that signals through the receptor for advanced glycation end products (RAGE) to reverse apoptosis-induced tolerance. In a two-hit mouse model of sepsis, we show that tolerance to a secondary infection and its associated mortality were effectively reversed by active immunization with dendritic cells treated with HMGB1 or the A-box fragment, but not a noncleavable form of HMGB1. These findings represent a novel link between caspase-1 and HMGB1, with potential therapeutic implications in infectious and inflammatory diseases.	[LeBlanc, Philippe M.; Hancock, Mark A.; Frank, Filipp; Nagar, Bhushan; Saleh, Maya] McGill Univ, Dept Microbiol & Immunol, Montreal, PQ H3G 0B1, Canada; [LeBlanc, Philippe M.; Hancock, Mark A.; Frank, Filipp; Nagar, Bhushan; Saleh, Maya] McGill Univ, SPR Facil, Montreal, PQ H3G 0B1, Canada; [LeBlanc, Philippe M.; Hancock, Mark A.; Frank, Filipp; Nagar, Bhushan; Saleh, Maya] McGill Univ, Dept Biochem, Montreal, PQ H3G 0B1, Canada; [LeBlanc, Philippe M.; Hancock, Mark A.; Frank, Filipp; Nagar, Bhushan; Saleh, Maya] McGill Univ, Dept Med, Montreal, PQ H3G 0B1, Canada; [Doggett, Teresa Ann; Choi, Jayoung; Ferguson, Thomas A.] Washington Univ, Sch Med, Dept Ophthalmol & Visual Sci, St Louis, MO 63110 USA; [Durocher, Yves] Natl Res Council Canada, Biotechnol Res Inst, Montreal, PQ H4P, Canada	McGill University; McGill University; McGill University; McGill University; Washington University (WUSTL); National Research Council Canada	Ferguson, TA (corresponding author), Washington Univ, Sch Med, Dept Ophthalmol & Visual Sci, St Louis, MO 63110 USA.	ferguson@vision.wustl.edu; maya.saleh@mcgill.ca	Durocher, Yves/K-8709-2019	Frank, Filipp/0000-0001-8680-2757; Saleh, Maya/0000-0003-1538-9146; Choi, Jayoung/0000-0003-0464-0649	Canada Foundation for Innovation (CFI); Canadian Institutes of Health Research (CIHR); NATIONAL EYE INSTITUTE [P30EY002687, R01EY015570] Funding Source: NIH RePORTER	Canada Foundation for Innovation (CFI)(Canada Foundation for Innovation); Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	We thank Sylvie Perret at BRI for the purification of recombinant HMGB1 proteins, Dr. T. Sam Xiao at the National Institutes of Health for providing the RAGE constructs, Dr. Ann-Marie Schmidt for the Rage<SUP>-/-</SUP> mice, Dr. Vishva Dixit for the Nlrp3<SUP>-/-</SUP>, mice and Dr. Denise Monack for Aim2<SUP>-/-</SUP> mouse femurs. The McGill SPR Facility was supported by the Canada Foundation for Innovation (CFI) and by Canadian Institutes of Health Research (CIHR) research resource grants to the Sheldon Biotechnology Centre for infrastructure support.	Adrie C, 2001, AM J RESP CRIT CARE, V164, P389, DOI 10.1164/ajrccm.164.3.2009088; Andersson U, 2000, J EXP MED, V192, P565, DOI 10.1084/jem.192.4.565; Ayala A, 1996, BLOOD, V87, P4261, DOI 10.1182/blood.V87.10.4261.bloodjournal87104261; Cassetta L, 2009, AIDS, V23, P567, DOI 10.1097/QAD.0b013e328325a47e; CHRISTOU NV, 1995, ANN SURG, V222, P534; Chung CS, 2003, J LEUKOCYTE BIOL, V74, P344, DOI 10.1189/jlb.0102006; Efron PA, 2004, SHOCK, V21, P566, DOI 10.1097/01.shk.0000126648.58732.8c; HORI O, 1995, J BIOL CHEM, V270, P25752, DOI 10.1074/jbc.270.43.25752; Hotchkiss RS, 2006, NAT REV IMMUNOL, V6, P813, DOI 10.1038/nri1943; Hreggvidsdottir HS, 2009, J LEUKOCYTE BIOL, V86, P655, DOI 10.1189/jlb.0908548; Ito T, 2008, ARTERIOSCL THROM VAS, V28, P1825, DOI 10.1161/ATVBAHA.107.150631; Kayagaki N, 2011, NATURE, V479, P117, DOI 10.1038/nature10558; Kazama H, 2008, IMMUNITY, V29, P21, DOI 10.1016/j.immuni.2008.05.013; Leclerc E, 2009, BBA-MOL CELL RES, V1793, P993, DOI 10.1016/j.bbamcr.2008.11.016; Li JH, 2003, MOL MED, V9, P37, DOI 10.1007/BF03402105; Lotze MT, 2005, NAT REV IMMUNOL, V5, P331, DOI 10.1038/nri1594; Lu Min-Chi, 2002, Journal of Microbiology Immunology and Infection, V35, P71; Martin GS, 2003, NEW ENGL J MED, V348, P1546, DOI 10.1056/NEJMoa022139; Martinon F, 2002, MOL CELL, V10, P417, DOI 10.1016/S1097-2765(02)00599-3; MEAKINS JL, 1982, BRIT MED J, V285, P1207, DOI 10.1136/bmj.285.6349.1207-a; Myszyka DG, 1999, J MOL RECOGNIT, V12, P279, DOI 10.1002/(SICI)1099-1352(199909/10)12:5<279::AID-JMR473>3.0.CO;2-3; Qin YH, 2009, J IMMUNOL, V183, P6244, DOI 10.4049/jimmunol.0900390; Schwulst SJ, 2008, SHOCK, V30, P127, DOI [10.1097/SHK.0b013e318162cf17, 10.1097/shk.0b013e318162cf17]; Sha YG, 2008, J IMMUNOL, V180, P2531, DOI 10.4049/jimmunol.180.4.2531; Shao W, 2007, J BIOL CHEM, V282, P36321, DOI 10.1074/jbc.M708182200; Sparatore B, 2001, BIOCHEM J, V357, P569, DOI 10.1042/0264-6021:3570569; Tang D, 2010, ONCOGENE, V29, P5299, DOI 10.1038/onc.2010.261; Tang DL, 2011, ANTIOXID REDOX SIGN, V14, P1315, DOI 10.1089/ars.2010.3356; Tian J, 2007, NAT IMMUNOL, V8, P487, DOI 10.1038/ni1457; Tole S, 2009, J LEUKOCYTE BIOL, V86, P1403, DOI 10.1189/jlb.0609391; Unsinger J, 2010, J IMMUNOL, V184, P6766, DOI 10.4049/jimmunol.0904054; Wang HC, 1999, SCIENCE, V285, P248, DOI 10.1126/science.285.5425.248; Wesche-Soldato DE, 2005, BLOOD, V106, P2295, DOI 10.1182/blood-2004-10-4086; Wynn JL, 2007, SHOCK, V28, P675, DOI 10.1097/shk.0b013e3180556d09; Yanai H, 2009, NATURE, V462, P99, DOI 10.1038/nature08512; Yang H, 2004, P NATL ACAD SCI USA, V101, P296, DOI 10.1073/pnas.2434651100; Yang HA, 2010, P NATL ACAD SCI USA, V107, P11942, DOI 10.1073/pnas.1003893107; Youn JH, 2008, J IMMUNOL, V180, P5067, DOI 10.4049/jimmunol.180.7.5067	38	45	50	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 14	2014	289	11					7777	7786		10.1074/jbc.M113.541474	http://dx.doi.org/10.1074/jbc.M113.541474			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AC8CV	24474694	hybrid, Green Published			2022-12-25	WOS:000332761500044
J	Coates, RC; Podell, S; Korobeynikov, A; Lapidus, A; Pevzner, P; Sherman, DH; Allen, EE; Gerwick, L; Gerwick, WH				Coates, R. Cameron; Podell, Sheila; Korobeynikov, Anton; Lapidus, Alla; Pevzner, Pavel; Sherman, David H.; Allen, Eric E.; Gerwick, Lena; Gerwick, William H.			Characterization of Cyanobacterial Hydrocarbon Composition and Distribution of Biosynthetic Pathways	PLOS ONE			English	Article							MASS-SPECTROMETRY; ALGAE; GREEN; DECARBONYLASE; LIPIDS	Cyanobacteria possess the unique capacity to naturally produce hydrocarbons from fatty acids. Hydrocarbon compositions of thirty-two strains of cyanobacteria were characterized to reveal novel structural features and insights into hydrocarbon biosynthesis in cyanobacteria. This investigation revealed new double bond (2- and 3-heptadecene) and methyl group positions (3-, 4- and 5-methylheptadecane) for a variety of strains. Additionally, results from this study and literature reports indicate that hydrocarbon production is a universal phenomenon in cyanobacteria. All cyanobacteria possess the capacity to produce hydrocarbons from fatty acids yet not all accomplish this through the same metabolic pathway. One pathway comprises a two-step conversion of fatty acids first to fatty aldehydes and then alkanes that involves a fatty acyl ACP reductase (FAAR) and aldehyde deformylating oxygenase (ADO). The second involves a polyketide synthase (PKS) pathway that first elongates the acyl chain followed by decarboxylation to produce a terminal alkene (olefin synthase, OLS). Sixty-one strains possessing the FAAR/ADO pathway and twelve strains possessing the OLS pathway were newly identified through bioinformatic analyses. Strains possessing the OLS pathway formed a cohesive phylogenetic clade with the exception of three Moorea strains and Leptolyngbya sp. PCC 6406 which may have acquired the OLS pathway via horizontal gene transfer. Hydrocarbon pathways were identified in one-hundred-forty-two strains of cyanobacteria over a broad phylogenetic range and there were no instances where both the FAAR/ADO and the OLS pathways were found together in the same genome, suggesting an unknown selective pressure maintains one or the other pathway, but not both.	[Coates, R. Cameron; Podell, Sheila; Allen, Eric E.; Gerwick, Lena; Gerwick, William H.] Univ Calif San Diego, Scripps Inst Oceanog, Ctr Marine Biotechnol & Biomed, La Jolla, CA 92093 USA; [Gerwick, William H.] Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, La Jolla, CA 92093 USA; [Korobeynikov, Anton; Lapidus, Alla; Pevzner, Pavel] St Petersburg Acad Univ, Russian Acad Sci, Algorithm Biol Lab, St Petersburg, Russia; [Korobeynikov, Anton] St Petersburg State Univ, Dept Math & Mech, St Petersburg 199034, Russia; [Lapidus, Alla] St Petersburg State Univ, Theodosius Dobzhansky Ctr Genome Bionformat, St Petersburg 199034, Russia; [Pevzner, Pavel] Univ Calif San Diego, Dept Comp Sci & Engn, La Jolla, CA 92093 USA; [Sherman, David H.] Univ Michigan, Inst Life Sci, Ann Arbor, MI 48109 USA; [Sherman, David H.] Univ Michigan, Dept Med Chem, Ann Arbor, MI 48109 USA	University of California System; University of California San Diego; Scripps Institution of Oceanography; University of California System; University of California San Diego; Russian Academy of Sciences; St. Petersburg Scientific Centre of the Russian Academy of Sciences; St Petersburg Academic University; Saint Petersburg State University; Saint Petersburg State University; University of California System; University of California San Diego; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Gerwick, WH (corresponding author), Univ Calif San Diego, Scripps Inst Oceanog, Ctr Marine Biotechnol & Biomed, La Jolla, CA 92093 USA.	wgerwick@ucsd.edu	Lapidus, Alla L/I-4348-2013; Korobeynikov, Anton/D-3555-2009	Lapidus, Alla L/0000-0003-0427-8731; Korobeynikov, Anton/0000-0002-2937-9259	CEC [500-10-039]; NIH [CA108874, GM067550]; NSF [MCB-1149552]; International Cooperative Biodiversity Group [TW007404]; FOGARTY INTERNATIONAL CENTER [U01TW007404] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA108874] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM067550] Funding Source: NIH RePORTER	CEC; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); International Cooperative Biodiversity Group; FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funding for this work came from CEC 500-10-039, NIH CA108874, NIH GM067550, NSF MCB-1149552 (EEA). DHS acknowledges support from the International Cooperative Biodiversity Group TW007404. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen MA, 2010, ORG GEOCHEM, V41, P1207, DOI 10.1016/j.orggeochem.2010.07.007; BALABAN AT, 1983, PURE APPL CHEM, V55, P199, DOI 10.1351/pac198855020199; Bankevich A, 2012, J COMPUT BIOL, V19, P455, DOI 10.1089/cmb.2012.0021; Beller HR, 2010, APPL ENVIRON MICROB, V76, P1212, DOI 10.1128/AEM.02312-09; Bennett S, 2004, PHARMACOGENOMICS, V5, P433, DOI 10.1517/14622416.5.4.433; Benson DA, 2007, NUCLEIC ACIDS RES, V35, pD21, DOI [10.1093/nar/gkq1079, 10.1093/nar/gkt1030, 10.1093/nar/gkp1024, 10.1093/nar/gkw1070, 10.1093/nar/gkx1094, 10.1093/nar/gks1195, 10.1093/nar/gkr1202, 10.1093/nar/gkn723]; Blomquist GJ, 2010, INSECT HYDROCARBONS: BIOLOGY, BIOCHEMISTRY, AND CHEMICAL ECOLOGY, P1, DOI 10.1017/CBO9780511711909; Castenholz RW, 2001, BERGEYS MANUAL SYSTE, P473, DOI DOI 10.1007/978-0-387-21609-6_27; Chang ZX, 2004, J NAT PROD, V67, P1356, DOI 10.1021/np0499261; Creton B, 2010, ENERG FUEL, V24, P5396, DOI 10.1021/ef1008456; Dembitsky VM, 1999, J CHROMATOGR A, V862, P221, DOI 10.1016/S0021-9673(99)00930-9; Dembitsky VM, 2002, BIOCHEMISTRY-MOSCOW+, V67, P1276, DOI 10.1023/A:1021309623541; DENNIS MW, 1991, ARCH BIOCHEM BIOPHYS, V287, P268, DOI 10.1016/0003-9861(91)90478-2; Doan TTP, 2009, J PLANT PHYSIOL, V166, P787, DOI 10.1016/j.jplph.2008.10.003; Donia MS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017897; Engene N, 2013, J PHYCOL, V49, P1095, DOI 10.1111/jpy.12115; Engene N, 2012, INT J SYST EVOL MICR, V62, P1171, DOI 10.1099/ijs.0.033761-0; Eser BE, 2011, BIOCHEMISTRY-US, V50, P10743, DOI 10.1021/bi2012417; FEHLER SWG, 1972, BIOCHEMISTRY-US, V11, P2411, DOI 10.1021/bi00763a004; FEHLER SWG, 1970, BIOCHEMISTRY-US, V9, P418, DOI 10.1021/bi00804a032; GELPI E, 1970, PHYTOCHEMISTRY, V9, P603, DOI 10.1016/S0031-9422(00)85700-3; Gu LC, 2009, J AM CHEM SOC, V131, P16033, DOI 10.1021/ja9071578; Haft DH, 2013, NUCLEIC ACIDS RES, V41, pD387, DOI 10.1093/nar/gks1234; HAN J, 1969, J AM CHEM SOC, V91, P5156, DOI 10.1021/ja01046a037; HAN J, 1968, P NATL ACAD SCI USA, V59, P59, DOI 10.1073/pnas.59.1.29; Kelley DR, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-11-r116; Li N, 2012, BIOCHEMISTRY-US, V51, P7908, DOI 10.1021/bi300912n; Liu AQ, 2013, APPL ENERG, V111, P383, DOI 10.1016/j.apenergy.2013.05.008; Markowitz VM, 2012, NUCLEIC ACIDS RES, V40, pD115, DOI 10.1093/nar/gkr1044; McCarthy JG, 2012, ACS CHEM BIOL, V7, P1994, DOI 10.1021/cb300385m; Mendez-Perez D, 2011, APPL ENVIRON MICROB, V77, P4264, DOI 10.1128/AEM.00467-11; Metzger P, 2005, APPL MICROBIOL BIOT, V66, P486, DOI 10.1007/s00253-004-1779-z; PAOLETTI C, 1976, LIPIDS, V11, P258, DOI 10.1007/BF02544051; Peralta-Yahya PP, 2012, NATURE, V488, P320, DOI 10.1038/nature11478; Pohnert G, 2002, NAT PROD REP, V19, P108, DOI 10.1039/a806888g; Qiu Y, 2012, P NATL ACAD SCI USA, V109, P14858, DOI 10.1073/pnas.1208650109; Ridley CP, 2010, Biosynthesis of 1-alkenes in engineered microorganisms, Patent No. [12/821,107, 12821107]; Rude MA, 2011, APPL ENVIRON MICROB, V77, P1718, DOI 10.1128/AEM.02580-10; Sandrock C, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-348; Sato N, 2009, ADV PHOTOSYNTH RESP, V30, P157; Schirmer A, 2010, SCIENCE, V329, P559, DOI 10.1126/science.1187936; Sharma N, 2010, J APPL PHYCOL, V23, P1; Shih PM, 2013, P NATL ACAD SCI USA, V110, P1053, DOI 10.1073/pnas.1217107110; Tan XM, 2011, METAB ENG, V13, P169, DOI 10.1016/j.ymben.2011.01.001; VINCENTI M, 1987, ANAL CHEM, V59, P694, DOI 10.1021/ac00132a003; Williamson RT, 2002, J ORG CHEM, V67, P7927, DOI 10.1021/jo020240s; WINTERS K, 1969, SCIENCE, V163, P467, DOI 10.1126/science.163.3866.467; Zarzycki J, 2013, J EXP BOT, V64, P787, DOI 10.1093/jxb/ers294	48	112	113	1	69	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2014	9	1							e85140	10.1371/journal.pone.0085140	http://dx.doi.org/10.1371/journal.pone.0085140			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301BI	24475038	Green Published, gold			2022-12-25	WOS:000330507300017
J	Duarte, IC; Ferreira, C; Marques, J; Castelo-Branco, M				Duarte, Isabel Catarina; Ferreira, Carlos; Marques, Joao; Castelo-Branco, Miguel			Anterior/Posterior Competitive Deactivation/Activation Dichotomy in the Human Hippocampus as Revealed by a 3D Navigation Task	PLOS ONE			English	Article							HUMAN SPATIAL NAVIGATION; HUMAN BRAIN; NEGATIVE BOLD; RELATIONAL MEMORY; COGNITIVE MAPS; VISUAL-CORTEX; SPECIALIZATION; SEGMENTATION; ACTIVATION; RETRIEVAL	Anterior/posterior long axis specialization is thought to underlie the organization of the hippocampus. However it remains unclear whether antagonistic mechanisms differentially modulate processing of spatial information within the hippocampus. We used fMRI and a virtual reality 3D paradigm to study encoding and retrieval of spatial memory during active visuospatial navigation, requiring positional encoding and retrieval of object landmarks during the path. Both encoding and retrieval elicited BOLD activation of the posterior most portion of hippocampus, while concurrent deactivations (recently shown to reflect decreases in neural responses) were found in the most anterior regions. Encoding elicited stronger activity in the posterior right than the left hippocampus. The former structure also showed significantly stronger activity for allocentric vs. egocentric processing during retrieval. The anterior vs. posterior pattern mimics, from a functional point, although at much distinct temporal scales, the previous anatomical findings in London taxi drivers, whereby posterior enlargement was found at the cost of an anterior decrease, and the mirror symmetric findings observed in blind people, in whom the right anterior hippocampus was found to be larger, at the cost of a smaller posterior hippocampus, as compared with sighted people. In sum, we found a functional dichotomy whereby the anterior/posterior hippocampus shows antagonistic processing patterns for spatial encoding and retrieval of 3D spatial information. To our knowledge, this is the first study reporting such a dynamical pattern in a functional study, which suggests that differential modulation of neural responses within the human hippocampus reflects distinct roles in spatial memory processing.	[Duarte, Isabel Catarina; Ferreira, Carlos; Marques, Joao; Castelo-Branco, Miguel] ICNAS, Brain Imaging Network Grid, Oporto, Portugal; [Duarte, Isabel Catarina; Ferreira, Carlos; Marques, Joao; Castelo-Branco, Miguel] Univ Coimbra, Inst Biomed Imaging & Life Sci, Coimbra, Portugal	Universidade de Coimbra	Castelo-Branco, M (corresponding author), ICNAS, Brain Imaging Network Grid, Oporto, Portugal.	mcbranco@fmed.uc.pt	Cipriano Ferreira, Carlos Daniel/K-6094-2014; Duarte, Isabel Catarina/AAY-1534-2020; Duarte, Isabel Catarina/GQA-4258-2022; Castelo-Branco, Miguel/F-3866-2019; MARQUES, JOAO CARLOS/L-9478-2014	Cipriano Ferreira, Carlos Daniel/0000-0002-0629-7146; Duarte, Isabel Catarina/0000-0002-5620-2424; Duarte, Isabel Catarina/0000-0002-5620-2424; Castelo-Branco, Miguel/0000-0003-4364-6373; MARQUES, JOAO CARLOS/0000-0001-8865-8189	Foundation for Science and Technology Portugal [Compete/PEst-C/SAU/UI3282/2011, CENTRO-07-ST24-FEDER-00205]; Bial Foundation [132, 133/2013]	Foundation for Science and Technology Portugal(Portuguese Foundation for Science and Technology); Bial Foundation(Bial Foundation)	This work was supported by grant from the Foundation for Science and Technology Portugal (Grant Compete/PEst-C/SAU/UI3282/2011), Grant "From Molecules to Man": CENTRO-07-ST24-FEDER-00205, and Bial Foundation Grants 132 and 133/2013. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allison JD, 2000, NEUROLOGY, V54, P135, DOI 10.1212/WNL.54.1.135; Bernardino I, 2013, J INT NEUROPSYCH SOC, V19, P54, DOI 10.1017/S1355617712000963; Burgess N, 2006, TRENDS COGN SCI, V10, P551, DOI 10.1016/j.tics.2006.10.005; Catenoix H, 2011, CLIN NEUROPHYSIOL, V122, P2488, DOI 10.1016/j.clinph.2011.05.007; Chua EF, 2007, HIPPOCAMPUS, V17, P1071, DOI 10.1002/hipo.20340; Czisch M, 2002, NEUROIMAGE, V16, P251, DOI 10.1006/nimg.2002.1071; Duvernoy H.M., 1999, HUMAN BRAIN SURFACE; Ekstrom AD, 2003, NATURE, V425, P184, DOI 10.1038/nature01964; Epstein RA, 2008, TRENDS COGN SCI, V12, P388, DOI 10.1016/j.tics.2008.07.004; Fischl B, 2004, NEUROIMAGE, V23, pS69, DOI 10.1016/j.neuroimage.2004.07.016; Fischl B, 2002, NEURON, V33, P341, DOI 10.1016/S0896-6273(02)00569-X; Fortin M, 2008, BRAIN, V131, P2995, DOI 10.1093/brain/awn250; Giovanello KS, 2004, HIPPOCAMPUS, V14, P5; Gramann K, 2010, J COGNITIVE NEUROSCI, V22, P2836, DOI 10.1162/jocn.2009.21369; Hashimoto R, 2012, HIPPOCAMPUS, V22, P141, DOI 10.1002/hipo.20878; Hirshhorn M, 2012, NEUROPSYCHOLOGIA, V50, P3094, DOI 10.1016/j.neuropsychologia.2012.08.008; Iaria G, 2007, EUR J NEUROSCI, V25, P890, DOI 10.1111/j.1460-9568.2007.05371.x; Kelley WM, 1998, NEURON, V20, P927, DOI 10.1016/S0896-6273(00)80474-2; Kumaran D, 2005, J NEUROSCI, V25, P7254, DOI 10.1523/JNEUROSCI.1103-05.2005; Lepore N, 2009, NEUROIMAGE, V46, P949, DOI 10.1016/j.neuroimage.2009.01.071; Maguire EA, 2000, P NATL ACAD SCI USA, V97, P4398, DOI 10.1073/pnas.070039597; Nadel L, 2004, NEUROPSYCHOLOGY, V18, P473, DOI 10.1037/0894-4105.18.3.473; Nadel L, 2013, J COGNITIVE NEUROSCI, V25, P22, DOI 10.1162/jocn_a_00313; Noordzij ML, 2006, COGNITION, V100, P321, DOI 10.1016/j.cognition.2005.05.006; O'Keefe J, 1978, HIPPOCAMPUS COGNITIV; Pasley BN, 2007, NEUROIMAGE, V36, P269, DOI 10.1016/j.neuroimage.2006.09.015; Poppenk J, 2013, TRENDS COGN SCI, V17, P230, DOI 10.1016/j.tics.2013.03.005; Pothuizen HHJ, 2004, EUR J NEUROSCI, V19, P705, DOI 10.1111/j.0953-816X.2004.03170.x; Shmuel A, 2006, NAT NEUROSCI, V9, P569, DOI 10.1038/nn1675; Shmuel A, 2002, NEURON, V36, P1195, DOI 10.1016/S0896-6273(02)01061-9; Smith AT, 2004, HUM BRAIN MAPP, V21, P213, DOI 10.1002/hbm.20017; Talairach J., 1988, COPLANAR STEREOTAXIC; ThinusBlanc C, 1997, PSYCHOL BULL, V121, P20, DOI 10.1037/0033-2909.121.1.20; Vann SD, 2009, NAT REV NEUROSCI, V10, P792, DOI 10.1038/nrn2733; Zaehle T, 2007, BRAIN RES, V1137, P92, DOI 10.1016/j.brainres.2006.12.044; Zeineh MM, 2003, SCIENCE, V299, P577, DOI 10.1126/science.1077775	36	22	23	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2014	9	1							e86213	10.1371/journal.pone.0086213	http://dx.doi.org/10.1371/journal.pone.0086213			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	301BI	24475088	Green Submitted, Green Published, gold			2022-12-25	WOS:000330507300043
J	Stampar, SN; Maronna, MM; Kitahara, MV; Reimer, JD; Morandini, AC				Stampar, Sergio N.; Maronna, Maximiliano M.; Kitahara, Marcelo V.; Reimer, James D.; Morandini, Andre C.			Fast-Evolving Mitochondrial DNA in Ceriantharia: A Reflection of Hexacorallia Paraphyly?	PLOS ONE			English	Article							MAXIMUM-LIKELIHOOD; PHYLOGENETIC ANALYSIS; SEQUENCE ALIGNMENTS; LEVEL RELATIONSHIPS; MULTIPLE ALIGNMENT; PHYLUM CNIDARIA; RAPID EVOLUTION; GENE-TRANSFER; ANTHOZOA; GENOME	The low evolutionary rate of mitochondrial genes in Anthozoa has challenged their utility for phylogenetic and systematic purposes, especially for DNA barcoding. However, the evolutionary rate of Ceriantharia, one of the most enigmatic "orders'' within Anthozoa, has never been specifically examined. In this study, the divergence of mitochondrial DNA of Ceriantharia was compared to members of other Anthozoa and Medusozoa groups. In addition, nuclear markers were used to check the relative phylogenetic position of Ceriantharia in relation to other Cnidaria members. The results demonstrated a pattern of divergence of mitochondrial DNA completely different from those estimated for other anthozoans, and phylogenetic analyses indicate that Ceriantharia is not included within hexacorallians in most performed analyses. Thus, we propose that the Ceriantharia should be addressed as a separate clade.	[Stampar, Sergio N.] Univ Estadual Paulista, Lab Biol Aquat LABIA, Fac Ciencias & Letras Assis, Dept Ciencias Biol, Sao Paulo, Brazil; [Stampar, Sergio N.; Morandini, Andre C.] Univ Sao Paulo, Inst Biociencias, Dept Zool, Sao Paulo, Brazil; [Maronna, Maximiliano M.] Univ Sao Paulo, Inst Biociencias, Dept Genet & Biol Evolut, Sao Paulo, Brazil; [Kitahara, Marcelo V.] Univ Sao Paulo, Ctr Biol Marinha, Sao Paulo, Brazil; [Reimer, James D.] Univ Ryukyus, Fac Sci, Mol Invertebrate Systemat & Ecol Lab, Nishihara, Okinawa 90301, Japan	Universidade Estadual Paulista; Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade de Sao Paulo; University of the Ryukyus	Stampar, SN (corresponding author), Univ Estadual Paulista, Lab Biol Aquat LABIA, Fac Ciencias & Letras Assis, Dept Ciencias Biol, Sao Paulo, Brazil.	stampar@assis.unesp.br	Stampar, Sergio N/K-2334-2012; Reimer, James Davis/AAP-1331-2020; Stampar, Sergio N/C-3193-2014; Maronna, Maximiliano M/G-9432-2016; Maronna, Maximiliano/AAY-6734-2020; Fapesp, Biota/F-8655-2017; Stampar, Sergio N/AAC-2019-2020; Kitahara, Marcelo Visentini/D-5560-2011; Morandini, André Carrara/A-9892-2012; Morandini, Andre Carrara/AAC-2320-2020	Stampar, Sergio N/0000-0002-9782-1619; Stampar, Sergio N/0000-0002-9782-1619; Maronna, Maximiliano M/0000-0002-2590-639X; Maronna, Maximiliano/0000-0002-2590-639X; Fapesp, Biota/0000-0002-9887-8449; Stampar, Sergio N/0000-0002-9782-1619; Kitahara, Marcelo Visentini/0000-0003-4011-016X; Morandini, André Carrara/0000-0003-3747-8748; Morandini, Andre Carrara/0000-0003-3747-8748	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2012/01771]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES, PROEX) through the Programa de Pos-Graduacao em Zoologia do Departamento de Zoologia IB-USP; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - Universal [481549/2012-9]; Rising Star Program; International Research Hub Project for Climate Change and Coral Reef/Island Dynamics at the University of the Ryukyus; Sao Paulo Research Foundation (FAPESP) [2012/01771, 2010/50174-7, 2006/56211-6, 2011/17537]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES, PROEX) through the Programa de Pos-Graduacao em Zoologia do Departamento de Zoologia IB-USP(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - Universal; Rising Star Program; International Research Hub Project for Climate Change and Coral Reef/Island Dynamics at the University of the Ryukyus; Sao Paulo Research Foundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This work was supported by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) 2012/01771, Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES, PROEX) through the Programa de Pos-Graduacao em Zoologia do Departamento de Zoologia IB-USP and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - Universal 481549/2012-9 to SNS and JDR was supported by the Rising Star Program and the International Research Hub Project for Climate Change and Coral Reef/Island Dynamics at the University of the Ryukyus. This work was partly supported by grants 2012/01771 (SNS), 2010/50174-7 (ACM), 2006/56211-6(MMM) and 2011/17537 (MVK), Sao Paulo Research Foundation (FAPESP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anisimova M, 2006, SYST BIOL, V55, P539, DOI 10.1080/10635150600755453; Anisimova M, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-161; Anisimova M, 2011, SYST BIOL, V60, P685, DOI 10.1093/sysbio/syr041; Apakupakul K, 1999, MOL PHYLOGENET EVOL, V12, P350, DOI 10.1006/mpev.1999.0639; Appeltans W, 2012, CURR BIOL, V22, P2189, DOI 10.1016/j.cub.2012.09.036; Ayres DL, 2012, SYST BIOL, V61, P170, DOI [10.1093/sysbio/syr100, 10.1093/sysbio/sys029]; Bernt M, 2013, MOL PHYLOGENET EVOL, V69, P352, DOI 10.1016/j.ympev.2013.05.002; Bernt M, 2013, MOL PHYLOGENET EVOL, V69, P328, DOI 10.1016/j.ympev.2012.10.020; Bilewitch JP, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-228; Borchsenius, 2009, FASTGAP 1 2 DEP BIOS; BRIDGE D, 1995, MOL BIOL EVOL, V12, P679; Brockman SA, 2012, GENOME BIOL EVOL, V4, P994, DOI 10.1093/gbe/evs074; BROWN WM, 1979, P NATL ACAD SCI USA, V76, P1967, DOI 10.1073/pnas.76.4.1967; CHEN CA, 1995, MOL PHYLOGENET EVOL, V4, P175, DOI 10.1006/mpev.1995.1017; Collins AG, 2006, SYST BIOL, V55, P97, DOI 10.1080/10635150500433615; Cruickshank Robert H., 2002, Systematic and Applied Acarology, V7, P3; Culligan KM, 2000, NUCLEIC ACIDS RES, V28, P463, DOI 10.1093/nar/28.2.463; CUNNINGHAM CW, 1993, BIOCHEM SYST ECOL, V21, P57, DOI 10.1016/0305-1978(93)90009-G; Daly M, 2003, ZOOL J LINN SOC-LOND, V139, P419, DOI 10.1046/j.1096-3642.2003.00084.x; Dawson MN, 2005, J MAR BIOL ASSOC UK, V85, P733, DOI 10.1017/S0025315405011641; Dellaporta SL, 2006, P NATL ACAD SCI USA, V103, P8751, DOI 10.1073/pnas.0602076103; FERRIS SD, 1983, GENETICS, V105, P681; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; France SC, 1996, MOL MAR BIOL BIOTECH, V5, P15; France Scott C., 2001, Bulletin of the Biological Society of Washington, P110; Ghiselli F, 2013, GENOME BIOL EVOL, V5, P1535, DOI 10.1093/gbe/evt112; Glor RE, 2010, ANNU REV ECOL EVOL S, V41, P251, DOI 10.1146/annurev.ecolsys.39.110707.173447; Goloboff P, 2008, CLADISTICS, V24, P91; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Higgins D, 2009, PHYLOGENETIC HANDBOOK: A PRACTICAL APPROACH TO PHYLOGENETIC ANALYSIS AND HYPOTHESIS TESTING, 2ND EDITION, P68; HIGUCHI R, 1984, NATURE, V312, P282, DOI 10.1038/312282a0; Huang DW, 2008, J MOL EVOL, V66, P167, DOI 10.1007/s00239-008-9069-5; Katoh K, 2009, METHODS MOL BIOL, V537, P39, DOI 10.1007/978-1-59745-251-9_3; Kayal E, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-5; Kayal E, 2012, GENOME BIOL EVOL, V4, P1, DOI 10.1093/gbe/evr123; Kohn AB, 2012, MOL PHYLOGENET EVOL, V63, P203, DOI 10.1016/j.ympev.2011.12.009; Kuck P, 2010, FRONT ZOOL, V7, DOI 10.1186/1742-9994-7-10; Lanfear R, 2012, MOL BIOL EVOL, V29, P1695, DOI 10.1093/molbev/mss020; Leclere L, 2009, SYST BIOL, V58, P509, DOI 10.1093/sysbio/syp044; Lee MSY, 2003, SYST BIOL, V52, P15, DOI 10.1080/10635150390132650; Liu K, 2012, SYST BIOL, V61, P90, DOI 10.1093/sysbio/syr095; Lopez-Giraldez F, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-152; McFadden CS, 2006, MOL PHYLOGENET EVOL, V41, P513, DOI 10.1016/j.ympev.2006.06.010; Medina M, 2001, P NATL ACAD SCI USA, V98, P9707, DOI 10.1073/pnas.171316998; Molodtsova TN, 2004, HYDROBIOLOGIA, V530, P261, DOI 10.1007/s10750-004-2671-7; Ogata H, 2011, ISME J, V5, P1143, DOI 10.1038/ismej.2010.210; Ortman BD, 2010, DEEP-SEA RES PT II, V57, P2148, DOI 10.1016/j.dsr2.2010.09.017; Osigus HJ, 2013, MOL PHYLOGENET EVOL, V69, P339, DOI 10.1016/j.ympev.2013.07.016; Park E, 2012, MOL PHYLOGENET EVOL, V62, P329, DOI 10.1016/j.ympev.2011.10.008; Pett W, 2011, MITOCHONDR DNA, V22, P130, DOI 10.3109/19401736.2011.624611; Pont-Kingdon G, 1998, J MOL EVOL, V46, P419, DOI 10.1007/PL00006321; PONTKINGDON GA, 1995, NATURE, V375, P109, DOI 10.1038/375109b0; Prendini L, 2005, ORG DIVERS EVOL, V5, P203, DOI 10.1016/j.ode.2004.12.004; Schierwater B, 2013, MOL PHYLOGENET EVOL, V69, P311, DOI 10.1016/j.ympev.2013.08.009; Schmidt HA, 2009, PHYLOGENETIC HANDBOOK: A PRACTICAL APPROACH TO PHYLOGENETIC ANALYSIS AND HYPOTHESIS TESTING, 2ND EDITION, P381; Schroth W, 2002, BMC EVOL BIOL, V2, DOI 10.1186/1471-2148-2-1; Shearer TL, 2008, MOL ECOL RESOUR, V8, P247, DOI 10.1111/j.1471-8286.2007.01996.x; Shearer TL, 2002, MOL ECOL, V11, P2475, DOI 10.1046/j.1365-294X.2002.01652.x; Smith DR, 2013, GENOME BIOL EVOL, V5, P905, DOI 10.1093/gbe/evt059; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Stampar SN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041091; Stocsits RR, 2009, NUCLEIC ACIDS RES, V37, P6184, DOI 10.1093/nar/gkp600; Suchard MA, 2006, BIOINFORMATICS, V22, P2047, DOI 10.1093/bioinformatics/btl175; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Vandamme AM, 2009, PHYLOGENETIC HANDBOOK: A PRACTICAL APPROACH TO PHYLOGENETIC ANALYSIS AND HYPOTHESIS TESTING, 2ND EDITION, P3, DOI 10.1109/WSE.2009.5630966; Varon A, 2010, CLADISTICS, V26, P72, DOI 10.1111/j.1096-0031.2009.00282.x; Venton D, 2013, GENOME BIOL EVOL, V5, P1115, DOI 10.1093/gbe/evt080; Voigt O, 2004, CURR BIOL, V14, pR944, DOI 10.1016/j.cub.2004.10.036; Wheeler TJ, 2007, BIOINFORMATICS, V23, pI559, DOI 10.1093/bioinformatics/btm226; WILSON AC, 1985, BIOL J LINN SOC, V26, P375, DOI 10.1111/j.1095-8312.1985.tb02048.x; Won JH, 2001, CORAL REEFS, V20, P39; ZWICKL D.J., 2006, THESIS U TEXAS AUSTI	73	40	42	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2014	9	1							e86612	10.1371/journal.pone.0086612	http://dx.doi.org/10.1371/journal.pone.0086612			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301BI	24475157	Green Published, gold, Green Submitted			2022-12-25	WOS:000330507300093
J	Xiao, WK; Bai, YY; Ye, P; Luo, LM; Liu, DJ; Wu, HM; Bai, J				Xiao, Wenkai; Bai, Yongyi; Ye, Ping; Luo, Leiming; Liu, Dejun; Wu, Hongmei; Bai, Jie			Plasma Homocysteine Is Associated with Aortic Arterial Stiffness but not Wave Reflection in Chinese Hypertensive Subjects	PLOS ONE			English	Article							BLOOD-PRESSURE; CORONARY ATHEROSCLEROSIS; DISEASE RISK; PROGRESSION; THICKNESS; VELOCITY; STROKE; LEVEL	Objective: Elevated plasma total homocysteine (tHcy) acts synergistically with hypertension to exert a multiplicative effect on cardiovascular diseases risk. The aim of this study was to determine the relationship between tHcy concentration and blood pressure, and to evaluate the role of plasma tHcy in arterial stiffness and wave reflection in hypertension. Methods: In this cross-sectional study, a community-based sample of 1680 subjects (mean age 61.6 years) was classified into four groups according to tHcy level (< 21.6 vs. >= 21.6 mu mol/l) and blood pressure (hypertensive vs. normotensive). Levels of plasma tHcy and other biochemical parameters (e. g., lipids, glucose) were determined. Central arterial blood pressure, reflected pressure wave, and carotid-femoral pulse wave velocity (cf-PWV) were assessed by tonometry within 2 days of obtaining the blood specimen. Results: Neither peripheral nor central blood pressure differed according to tHcy levels in normotensive and hypertensive subjects. Differences in cf-PWV according to tHcy were observed only in hypertensive subjects; differences in cf-PWV in normotensive subjects were not significant after adjusting for confounding factors. Central augmentation index did not differ according to tHcy level in either normotensive or hypertensive subjects. Results of univariate analysis revealed significant correlations between blood pressure parameters and tHcy concentration only among normotensive subjects; however, these correlations were not significant in a partial correlation analysis. Results of multiple regression analysis showed that plasma tHcy levels were independently correlated with cf-PWV in hypertensive subjects (beta = 0.713, P = 0.004). The independent relationship between tHcy and central augmentation index was not significant by further multiple analyses in normotensive or hypertensive individuals. Conclusions: Plasma tHcy level is strongly and independently correlated with arterial stiffness measured as cf-PWV only in hypertensive subjects. Thus, hypertension is a major link between tHcy and aortic arterial stiffness.	[Xiao, Wenkai; Bai, Yongyi; Ye, Ping; Luo, Leiming; Liu, Dejun; Wu, Hongmei] Chinese Peoples Liberat Army Gen Hosp, Dept Geriatr Cardiol, Beijing, Peoples R China; [Bai, Jie] Chinese Peoples Liberat Army Gen Hosp, Dept Clin Biochem, Beijing, Peoples R China	Chinese People's Liberation Army General Hospital; Chinese People's Liberation Army General Hospital	Ye, P (corresponding author), Chinese Peoples Liberat Army Gen Hosp, Dept Geriatr Cardiol, Beijing, Peoples R China.	yeping301@sina.com	Luo, Leiming/AAD-5533-2019; Stefanadis, Christodoulos/ABH-2232-2020	Stefanadis, Christodoulos/0000-0001-5974-6454	Key National Basic Research Program of China [2012CB517503, 2013CB530804]; Nature Science Foundation of China [81270941]	Key National Basic Research Program of China(National Basic Research Program of China); Nature Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the Key National Basic Research Program of China (2012CB517503, 2013CB530804) and Nature Science Foundation of China (81270941). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anan F, 2007, METABOLISM, V56, P1390, DOI 10.1016/j.metabol.2007.05.010; Antoniades C, 2009, EUR HEART J, V30, P6, DOI 10.1093/eurheartj/ehn515; Blacher J, 1998, ARTERIOSCL THROM VAS, V18, P535, DOI 10.1161/01.ATV.18.4.535; Bortolotto LA, 1999, HYPERTENSION, V34, P837, DOI 10.1161/01.HYP.34.4.837; Chiang JK, 2011, J CELL PHYSIOL, V226, P1017, DOI 10.1002/jcp.22415; de Bree A, 2006, INT J CARDIOL, V113, P332, DOI 10.1016/j.ijcard.2005.11.045; Eikelboom JW, 2000, STROKE, V31, P1069, DOI 10.1161/01.STR.31.5.1069; Filipovsky J, 2005, BLOOD PRESSURE, V14, P45, DOI 10.1080/08037050510008814; Hansen TW, 2006, CIRCULATION, V113, P664, DOI 10.1161/CIRCULATIONAHA.105.579342; Hu Da-yi, 2008, Zhonghua Nei Ke Za Zhi, V47, P976; Hughes AD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059371; Katsuda S, 2013, AM J HYPERTENS, V26, P311, DOI 10.1093/ajh/hps037; Kim BJ, 2011, CLIN EXP HYPERTENS, V33, P411, DOI 10.3109/10641963.2010.549274; Kumar M, 2008, NEUROCHEM INT, V53, P214, DOI 10.1016/j.neuint.2008.07.008; Lim U, 2002, AM J EPIDEMIOL, V156, P1105, DOI 10.1093/aje/kwf157; London GM, 2004, J AM COLL CARDIOL, V43, P92, DOI 10.1016/j.jacc.2003.07.039; Ma YC, 2006, J AM SOC NEPHROL, V17, P2937, DOI 10.1681/ASN.2006040368; Mancia G, 2013, EUR HEART J, V34, P2159, DOI 10.1093/eurheartj/eht151; McEniery CM, 2005, J AM COLL CARDIOL, V46, P1753, DOI 10.1016/j.jacc.2005.07.037; Miller A, 2000, HEART VESSELS, V15, P135, DOI 10.1007/s003800070030; Mizrahi EH, 2003, ISRAEL MED ASSOC J, V5, P791; Moat Stuart J, 2005, Semin Vasc Med, V5, P172, DOI 10.1055/s-2005-872402; Montalescot G, 1997, INT J CARDIOL, V60, P295, DOI 10.1016/S0167-5273(97)00099-5; Nakhai-Pour HR, 2007, J HUM HYPERTENS, V21, P942, DOI 10.1038/sj.jhh.1002247; NYGARD O, 1995, JAMA-J AM MED ASSOC, V274, P1526, DOI 10.1001/jama.274.19.1526; O'Rourke MF, 2002, AM J HYPERTENS, V15, P426, DOI 10.1016/S0895-7061(01)02319-6; Oberoi S, 2013, AM J ROENTGENOL, V200, P798, DOI 10.2214/AJR.12.8653; Pannier BM, 2002, AM J HYPERTENS, V15, P743, DOI 10.1016/S0895-7061(02)02962-X; Sacks David B, 2011, Diabetes Care, V34, pe61, DOI 10.2337/dc11-9998; Sen U, 2010, CELL BIOCHEM BIOPHYS, V57, P49, DOI 10.1007/s12013-010-9079-y; Sharman JE, 2009, HYPERTENSION, V54, P1099, DOI 10.1161/HYPERTENSIONAHA.109.133066; Sundstrom J, 2003, HYPERTENSION, V42, P1100, DOI 10.1161/01.HYP.0000101690.58391.13; SuttonTyrrell K, 1997, CIRCULATION, V96, P1745, DOI 10.1161/01.CIR.96.6.1745; Tabara Y, 2007, HYPERTENS RES, V30, P895, DOI 10.1291/hypres.30.895; Tayama J, 2006, HYPERTENS RES, V29, P403, DOI 10.1291/hypres.29.403; Tousoulis D, 2008, J AM COLL NUTR, V27, P379, DOI 10.1080/07315724.2008.10719714; Troughton JA, 2007, ATHEROSCLEROSIS, V191, P90, DOI 10.1016/j.atherosclerosis.2006.05.014; Tsai JC, 2005, ATHEROSCLEROSIS, V182, P121, DOI 10.1016/j.atherosclerosis.2005.01.038; Tsuchikura S, 2010, ATHEROSCLEROSIS, V211, P480, DOI 10.1016/j.atherosclerosis.2010.03.037; van Dijk SC, 2013, J HYPERTENS, V31, P952, DOI 10.1097/HJH.0b013e32835eb6b9; Verbeke F, 2011, CLIN J AM SOC NEPHRO, V6, P153, DOI 10.2215/CJN.05120610; Vyssoulis G, 2010, J HUM HYPERTENS, V24, P183, DOI 10.1038/jhh.2009.50; Wang Hai-li, 2012, Zhonghua Yi Xue Za Zhi, V92, P1183; Weber T, 2012, HYPERTENSION, V60, P534, DOI 10.1161/HYPERTENSIONAHA.112.194571; Woodside JV, 2004, ATHEROSCLEROSIS, V177, P337, DOI 10.1016/j.atherosclerosis.2004.07.001; Yasmin, 2004, AM J HYPERTENS, V17, P292, DOI 10.1016/j.amjhyper.2003.12.002; Yasmin, 1999, QJM-INT J MED, V92, P595, DOI 10.1093/qjmed/92.10.595; Yingchoncharoen T, 2012, HEART ASIA, V4, P77, DOI 10.1136/heartasia-2011-010079	48	18	19	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2014	9	1							e85938	10.1371/journal.pone.0085938	http://dx.doi.org/10.1371/journal.pone.0085938			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301BI	24475061	Green Published, gold, Green Submitted			2022-12-25	WOS:000330507300030
J	Chen, FF; Wang, M; Bai, J; Liu, QH; Xi, YG; Li, W; Zheng, JN				Chen, Feifei; Wang, Meng; Bai, Jin; Liu, Qinghua; Xi, Yaguang; Li, Wang; Zheng, Junnian			Role of RUNX3 in Suppressing Metastasis and Angiogenesis of Human Prostate Cancer	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; TISSUE INHIBITOR; BREAST-CANCER; MATRIX METALLOPROTEINASES; COLORECTAL-CANCER; TUMOR-METASTASIS; GASTRIC-CANCER; EXPRESSION; INACTIVATION; METHYLATION	RUNX3 (runt-related transcription factor-3) has been reported to suppress tumor tumorigenesis and metastasis in different human cancers. In this study, we used tissue microarray (TMA) to determine the significance of RUNX3 in prostate cancer progession. Our results showed ectopic expression of RUNX3 in prostate cancer tissues when compared with tumor adjacent normal prostate tissues, and reduced RUNX3 staining was significantly correlated with TNM stage. Moreover, we demonstrated that RUNX3 overexpression inhibited prostate cancer cell migration and invasion resulting from the elevated upregulation of tissue inhibitor of matrix metalloproteinase-2 (TIMP-2), which subsequently inhibited metalloproteinase-2 (MMP-2) expression and activity in vitro. Knock down of RUNX3 expression broke up the balance of TIMP-2/MMP-2, whereas silence of TIMP-2 resulted in the inhibition of MMP-2 expression in prostate cells. We also showed that restoration of RUNX3 decreased vascular endothelial growth factor (VEGF) secretion and suppressed endothelial cell growth and tube formation. Strikingly, RUNX3 was demonstrated to inhibit tumor metastasis and angiogenesis in vivo. Altogether, our results support the tumor suppressive role of RUNX3 in human prostate cancer, and provide insights into development of targeted therapy for this disease.	[Chen, Feifei; Wang, Meng; Bai, Jin; Xi, Yaguang; Zheng, Junnian] Xuzhou Med Coll, Jiangsu Key Lab Biol Canc Therapy, Xuzhou, Jiangsu, Peoples R China; [Liu, Qinghua] Xuzhou Med Coll, Sch Pathol, Xuzhou, Jiangsu, Peoples R China; [Xi, Yaguang] Univ S Alabama, Mitchell Canc Inst, Mobile, AL 36688 USA; [Li, Wang; Zheng, Junnian] Xuzhou Med Coll, Affiliated Hosp, Xuzhou, Jiangsu, Peoples R China	Xuzhou Medical University; Xuzhou Medical University; University of South Alabama; Xuzhou Medical University	Li, W (corresponding author), Xuzhou Med Coll, Affiliated Hosp, Xuzhou, Jiangsu, Peoples R China.	lizhixin88mm@163.com; jnzheng@xzmc.edu.cn		Xi, Yaguang/0000-0003-3681-9352	National Natural Science Foundation of China [81302207]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This project is supported by a grant from the National Natural Science Foundation of China (No. 81302207). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAE SC, 1995, GENE, V159, P245, DOI 10.1016/0378-1119(95)00060-J; Cao Y, 2012, CANCER RES, V72, P3912, DOI 10.1158/0008-5472.CAN-11-4058; Chen FF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056241; Chen Y, 2011, INT J CANCER, V129, P1586, DOI 10.1002/ijc.25831; Chung MS, 2013, JPN J CLIN ONCOL, V43, P184, DOI 10.1093/jjco/hys196; Deryugina EI, 2006, CANCER METAST REV, V25, P9, DOI 10.1007/s10555-006-7886-9; Ellis Lee M, 2006, Clin Adv Hematol Oncol, V4, P1; Ellis LM, 2006, CLIN ADV HEMATOL ONC, V4, P11; Folkman J, 1997, EXS, V79, P1; Garg M, 2009, CANCER-AM CANCER SOC, V115, P2671, DOI 10.1002/cncr.24293; Hsu PI, 2009, ANN SURG ONCOL, V16, P1686, DOI 10.1245/s10434-009-0428-2; Hussain Z, 2013, GENET MOL RES, V12, P1106, DOI 10.4238/2013.April.10.6; Ito Kosei, 2012, Seikagaku, V84, P278; Jinga DC, 2006, J CELL MOL MED, V10, P499, DOI 10.1111/j.1582-4934.2006.tb00415.x; Kim TY, 2004, LAB INVEST, V84, P479, DOI 10.1038/labinvest.3700060; Kim WJ, 2005, CANCER RES, V65, P9347, DOI 10.1158/0008-5472.CAN-05-1647; Lau QC, 2006, CANCER RES, V66, P6512, DOI 10.1158/0008-5472.CAN-06-0369; Lee CWL, 2010, CANCER RES, V70, P4243, DOI 10.1158/0008-5472.CAN-09-3805; Lund AH, 2002, CANCER CELL, V1, P213, DOI 10.1016/S1535-6108(02)00049-1; McMahon G, 2000, Oncologist, V5 Suppl 1, P3; Mei PJ, 2011, J CANCER RES CLIN, V137, P1823, DOI 10.1007/s00432-011-1063-4; Mocarska Agnieszka, 2012, Pol Merkur Lekarski, V33, P357; Nagase H, 1997, BIOL CHEM, V378, P151; O'Hurley G, 2011, HISTOPATHOLOGY, V59, P1240, DOI 10.1111/j.1365-2559.2011.04073.x; OGAWA E, 1993, P NATL ACAD SCI USA, V90, P6859, DOI 10.1073/pnas.90.14.6859; Ohlmann CH, 2012, UROLOGE, V51, P363, DOI 10.1007/s00120-012-2827-4; Pal S, 2001, CANCER RES, V61, P6952; Peng ZH, 2006, CLIN CANCER RES, V12, P6386, DOI 10.1158/1078-0432.CCR-05-2359; Pulukuri SM, 2007, ONCOGENE, V26, P5229, DOI 10.1038/sj.onc.1210329; Richiardi L, 2009, J CLIN ONCOL, V27, P3161, DOI 10.1200/JCO.2008.18.2485; Roy R, 2008, CLIN CANCER RES, V14, P6610, DOI 10.1158/1078-0432.CCR-08-1136; Sakakura C, 2005, CLIN CANCER RES, V11, P6479, DOI 10.1158/1078-0432.CCR-05-0729; Shi Q, 2001, CANCER RES, V61, P4143; Siegel R, 2012, CA-CANCER J CLIN, V62, DOI 10.3322/caac.21153; Subramaniam MM, 2009, BBA-REV CANCER, V1796, P315, DOI 10.1016/j.bbcan.2009.07.004; Valastyan S, 2011, CELL, V147, P275, DOI 10.1016/j.cell.2011.09.024; Waleh NS, 2010, CANCER LETT, V289, P111, DOI 10.1016/j.canlet.2009.08.006; Wang QW, 2011, CELL BIOL INT, V35, P897, DOI 10.1042/CBI20100744; Wang QW, 2009, UROLOGY, V73, P1119, DOI 10.1016/j.urology.2008.02.060; White KY, 2009, J PROTEOME RES, V8, P620, DOI 10.1021/pr8007545; Xie KP, 2004, CYTOKINE GROWTH F R, V15, P297, DOI 10.1016/j.cytogfr.2004.04.003; Zhang L, 2010, J ORAL PATHOL MED, V39, P94, DOI 10.1111/j.1600-0714.2009.00812.x; Zhang Xiao-Yi, 2005, Zhonghua Nan Ke Xue, V11, P359; Zhang XY, 2005, ZHONGHUA NAN KE XUE, V11, P364; Zhang ZZ, 2011, CANCER-AM CANCER SOC, V117, P2719, DOI 10.1002/cncr.25838	45	29	30	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2014	9	1							e86917	10.1371/journal.pone.0086917	http://dx.doi.org/10.1371/journal.pone.0086917			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	298QQ	24475196	gold, Green Submitted, Green Published			2022-12-25	WOS:000330339800069
J	Paliwal, V; Raju, SC; Modak, A; Phale, PS; Purohit, HJ				Paliwal, Vasundhara; Raju, Sajan C.; Modak, Arnab; Phale, Prashant S.; Purohit, Hemant J.			Pseudomonas putida CSV86: A Candidate Genome for Genetic Bioaugmentation	PLOS ONE			English	Article							PREFERENTIAL UTILIZATION; AROMATIC-COMPOUNDS; TRANSCRIPTIONAL REGULATOR; DEGRADATION; PATHWAY; NAHR; INSERTION; GLUCOSE; PROTEIN; BIODEGRADATION	Pseudomonas putida CSV86, a plasmid-free strain possessing capability to transfer the naphthalene degradation property, has been explored for its metabolic diversity through genome sequencing. The analysis of draft genome sequence of CSV86 (6.4 Mb) revealed the presence of genes involved in the degradation of naphthalene, salicylate, benzoate, benzylalcohol, p-hydroxybenzoate, phenylacetate and p-hydroxyphenylacetate on the chromosome thus ensuring the stability of the catabolic potential. Moreover, genes involved in the metabolism of phenylpropanoid and homogentisate, as well as heavy metal resistance, were additionally identified. Ability to grow on vanillin, veratraldehyde and ferulic acid, detection of inducible homogentisate dioxygenase and growth on aromatic compounds in the presence of heavy metals like copper, cadmium, cobalt and arsenic confirm in silico observations reflecting the metabolic versatility. In silico analysis revealed the arrangement of genes in the order: tRNA(Gly), integrase followed by nah operon, supporting earlier hypothesis of existence of a genomic island (GI) for naphthalene degradation. Deciphering the genomic architecture of CSV86 for aromatic degradation pathways and identification of elements responsible for horizontal gene transfer (HGT) suggests that genetic bioaugmentation strategies could be planned using CSV86 for effective bioremediation.	[Paliwal, Vasundhara; Purohit, Hemant J.] CSIR Natl Environm Engn Res Inst, Environm Genom Div, Nagpur, Maharashtra, India; [Raju, Sajan C.] Univ Helsinki, MEM Grp, Dept Biosci, Helsinki, Finland; [Modak, Arnab; Phale, Prashant S.] Indian Inst Technol, Dept Biosci & Bioengn, Bombay 400076, Maharashtra, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - National Environmental Engineering Research Institute (NEERI); University of Helsinki; Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Bombay	Purohit, HJ (corresponding author), CSIR Natl Environm Engn Res Inst, Environm Genom Div, Nagpur, Maharashtra, India.	hemantdrd@hotmail.com	Modak, Arnab/J-2448-2014	modak, arnab/0000-0001-7262-0143; Raju, Sajan/0000-0002-4443-9504	Council of Scientific & Industrial Research [ESC0108]; DST, Government of India	Council of Scientific & Industrial Research(Council of Scientific & Industrial Research (CSIR) - India); DST, Government of India(Department of Science & Technology (India))	The authors are grateful to the Council of Scientific and Industrial Research (CSIR) for their facilities. The study has been supported through a grant from the Council of Scientific & Industrial Research, project number ESC0108 (Supra-Institutional Network Project). PSP thanks DST, Government of India, for a research grant. AM also thanks the CSIR, Government of India, for SRF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alikhan NF, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-402; Arias-Barrau E, 2004, J BACTERIOL, V186, P5062, DOI 10.1128/jb.186.15.5062-5077.2004; Aziz RK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-75; Basu A, 2006, APPL ENVIRON MICROB, V72, P2226, DOI 10.1128/AEM.72.3.2226-2230.2006; Basu A, 2003, APPL MICROBIOL BIOT, V62, P579, DOI 10.1007/s00253-003-1305-8; Basu A, 2008, BIODEGRADATION, V19, P83, DOI 10.1007/s10532-007-9117-7; Basu A, 2007, J BACTERIOL, V189, P7556, DOI 10.1128/JB.01235-07; Basu A, 2006, FEMS MICROBIOL LETT, V259, P311, DOI 10.1111/j.1574-6968.2006.00285.x; Behlau F, 2011, APPL ENVIRON MICROB, V77, P4089, DOI 10.1128/AEM.03043-10; Boyd EF, 2009, TRENDS MICROBIOL, V17, P47, DOI 10.1016/j.tim.2008.11.003; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bugg TDH, 2011, CURR OPIN BIOTECH, V22, P394, DOI 10.1016/j.copbio.2010.10.009; Caspi R, 2012, NUCLEIC ACIDS RES, V40, pD742, DOI 10.1093/nar/gkr1014; Cebolla A, 1997, J BIOL CHEM, V272, P3986, DOI 10.1074/jbc.272.7.3986; Christie-Oleza JA, 2008, INT MICROBIOL, V11, P101, DOI 10.2436/20.1501.01.49; Dias Z, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-96; Gao F, 2006, NUCLEIC ACIDS RES, V34, pW686, DOI 10.1093/nar/gkl040; Ikuma K, 2013, APPL MICROBIOL BIOT, V97, P395, DOI 10.1007/s00253-012-3949-8; Jimenez J. I., 2010, HDB HYDROCARBON LIPI, P1297, DOI DOI 10.1007/978-3-540-77587-4_91; Juhas M, 2009, FEMS MICROBIOL REV, V33, P376, DOI 10.1111/j.1574-6976.2008.00136.x; Jung CM, 2011, J APPL MICROBIOL, V110, P1449, DOI 10.1111/j.1365-2672.2011.04995.x; KANAMARU K, 1993, FEBS LETT, V330, P99, DOI 10.1016/0014-5793(93)80928-N; Kanehisa M, 2012, NUCLEIC ACIDS RES, V40, pD109, DOI 10.1093/nar/gkr988; Kapley A, 1999, BIORESOURCE TECHNOL, V67, P241, DOI 10.1016/S0960-8524(98)00121-7; Kennedy SP, 2001, GENOME RES, V11, P1641, DOI 10.1101/gr.190201; Kivisaar M, 2009, MOL MICROBIOL, V74, P777, DOI 10.1111/j.1365-2958.2009.06905.x; Langille MGI, 2010, NAT REV MICROBIOL, V8, P372, DOI 10.1038/nrmicro2350; Mackiewicz P, 2004, NUCLEIC ACIDS RES, V32, P3781, DOI 10.1093/nar/gkh699; Maddocks SE, 2008, MICROBIOL-SGM, V154, P3609, DOI 10.1099/mic.0.2008/022772-0; MAHAJAN MC, 1994, ARCH MICROBIOL, V161, P425, DOI 10.1007/BF00288954; Malik A., 2013, MANAGEMENT MICROBIAL, P289; Masai E, 2002, APPL ENVIRON MICROB, V68, P4416, DOI 10.1128/AEM.68.9.4416-4424.2002; Mendez V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017583; Moreno R, 2008, J BACTERIOL, V190, P1539, DOI 10.1128/JB.01604-07; Mrozik A, 2010, MICROBIOL RES, V165, P363, DOI 10.1016/j.micres.2009.08.001; NICHOLS NN, 1995, J BACTERIOL, V177, P7033, DOI 10.1128/jb.177.24.7033-7040.1995; Obayori O.S., 2010, SCI RES ESSAYS, V5, P4093; Ooka T, 2009, GENOME RES, V19, P1809, DOI 10.1101/gr.089615.108; Paliwal V, 2012, APPL BIOCHEM BIOTECH, V166, P903, DOI 10.1007/s12010-011-9479-5; Park HH, 2005, BBA-GEN SUBJECTS, V1725, P247, DOI 10.1016/j.bbagen.2005.05.015; Park W, 2002, MICROBIOL-SGM, V148, P2319, DOI 10.1099/00221287-148-8-2319; Peng RH, 2008, FEMS MICROBIOL REV, V32, P927, DOI 10.1111/j.1574-6976.2008.00127.x; Phale P.S., 2013, GENOME ANNOUNCEMENTS, V1, P234, DOI DOI 10.1128/GEN0MEA.00234-12; Priefert H, 2001, APPL MICROBIOL BIOT, V56, P296, DOI 10.1007/s002530100687; Ravatn R, 1998, J BACTERIOL, V180, P5505, DOI 10.1128/JB.180.21.5505-5514.1998; Rissman AI, 2009, BIOINFORMATICS, V25, P2071, DOI 10.1093/bioinformatics/btp356; SCHELL MA, 1989, J BACTERIOL, V171, P1952, DOI 10.1128/jb.171.4.1952-1959.1989; Shintani M., 2013, MANAG MICROB RESOUR, P167, DOI [10.1007/978-94-007-5931-2_8, DOI 10.1007/978-94-007-5931-2_8]; Shrivastava R, 2011, J BIOREMED BIODEGRAD, V02, P2, DOI [DOI 10.4172/2155-6199.1000120, 10.4172/2155-6199.1000120]; Shrivastava R, 2011, ARCH MICROBIOL, V193, P553, DOI 10.1007/s00203-011-0697-6; Shrivastava R, 2011, MICROBIOL-SGM, V157, P1531, DOI 10.1099/mic.0.047191-0; Siguier P, 2006, NUCLEIC ACIDS RES, V34, pD32, DOI 10.1093/nar/gkj014; Silby MW, 2011, FEMS MICROBIOL REV, V35, P652, DOI 10.1111/j.1574-6976.2011.00269.x; Sizova O I, 2010, Prikl Biokhim Mikrobiol, V46, P45; SOFIA HJ, 1994, NUCLEIC ACIDS RES, V22, P2576, DOI 10.1093/nar/22.13.2576; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Teufel R, 2010, P NATL ACAD SCI USA, V107, P14390, DOI 10.1073/pnas.1005399107; Thangaraj K, 2008, BIORESOURCE TECHNOL, V99, P2488, DOI 10.1016/j.biortech.2007.04.053; Top EM, 2003, CURR OPIN BIOTECH, V14, P262, DOI 10.1016/S0958-1669(03)00066-1; Tropel D, 2004, MICROBIOL MOL BIOL R, V68, P474, DOI 10.1128/MMBR.68.3.474-500.2004	60	34	34	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2014	9	1							e84000	10.1371/journal.pone.0084000	http://dx.doi.org/10.1371/journal.pone.0084000			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	298QQ	24475028	Green Published, gold, Green Submitted			2022-12-25	WOS:000330339800004
J	Poillet, L; Pernodet, N; Boyer-Guittaut, M; Adami, P; Borg, C; Jouvenot, M; Delage-Mourroux, R; Despouy, G				Poillet, Laura; Pernodet, Nicolas; Boyer-Guittaut, Michael; Adami, Pascale; Borg, Christophe; Jouvenot, Michele; Delage-Mourroux, Regis; Despouy, Gilles			QSOX1 Inhibits Autophagic Flux in Breast Cancer Cells	PLOS ONE			English	Article							SULFHYDRYL OXIDASE 1; METABOLIC STRESS; PROTEIN; EXPRESSION; GENES; DEATH; IDENTIFICATION; TUMORIGENESIS; INVASION; CLONING	The QSOX1 protein (Quiescin Sulfhydryl oxidase 1) catalyzes the formation of disulfide bonds and is involved in the folding and stability of proteins. More recently, QSOX1 has been associated with tumorigenesis and protection against cellular stress. It has been demonstrated in our laboratory that QSOX1 reduces proliferation, migration and invasion of breast cancer cells in vitro and reduces tumor growth in vivo. In addition, QSOX1 expression has been shown to be induced by oxidative or ER stress and to prevent cell death linked to these stressors. Given the function of QSOX1 in these two processes, which have been previously linked to autophagy, we wondered whether QSOX1 might be regulated by autophagy inducers and play a role in this catabolic process. To answer this question, we used in vitro models of breast cancer cells in which QSOX1 was overexpressed (MCF-7) or extinguished (MDA-MB-231). We first showed that QSOX1 expression is induced following amino acid starvation and maintains cellular homeostasis. Our results also indicated that QSOX1 inhibits autophagy through the inhibition of autophagosome/lysosome fusion. Moreover, we demonstrated that inhibitors of autophagy mimic the effect of QSOX1 on cell invasion, suggesting that its role in this process is linked to the autophagy pathway. Previously published data demonstrated that extinction of QSOX1 promotes tumor growth in NOG mice. In this study, we further demonstrated that QSOX1 null tumors present lower levels of the p62 protein. Altogether, our results demonstrate for the first time a role of QSOX1 in autophagy in breast cancer cells and tumors.	[Poillet, Laura; Pernodet, Nicolas; Boyer-Guittaut, Michael; Adami, Pascale; Jouvenot, Michele; Delage-Mourroux, Regis; Despouy, Gilles] Univ Franche Comte, UFR Sci & Tech, F-25030 Besancon, Doubs, France; [Borg, Christophe] Univ Franche Comte, INSERM, UMR 1098, F-25030 Besancon, Doubs, France	Universite de Franche-Comte; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Franche-Comte	Despouy, G (corresponding author), Univ Franche Comte, UFR Sci & Tech, F-25030 Besancon, Doubs, France.	gilles.despouy@univ-fcomte.fr	Guittaut, Michael/ABE-4274-2021; DELAGE-MOURROUX, Régis/ABE-1424-2021; Despouy, Gilles/ABE-1702-2021	Guittaut, Michael/0000-0001-9540-5593; DELAGE-MOURROUX, Régis/0000-0002-7145-5948; Poillet, Laura/0000-0002-6756-173X; Gilles, Despouy/0000-0001-9250-9821	Region de Franche-Comte; Ministere de l'enseignement superieur et de la recherche	Region de Franche-Comte(Region Bourgogne-Franche-Comte); Ministere de l'enseignement superieur et de la recherche	Laura Poillet is supported by a fellowship from the Region de Franche-Comte. This work was supported by grant from the Ministere de l'enseignement superieur et de la recherche. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aita VM, 1999, GENOMICS, V59, P59, DOI 10.1006/geno.1999.5851; Amaravadi RK, 2012, CELL CYCLE, V11, P3718, DOI 10.4161/cc.22147; Antwi K, 2009, J PROTEOME RES, V8, P4722, DOI 10.1021/pr900414f; Arduino DM, 2012, HUM MOL GENET, V21, P4680, DOI 10.1093/hmg/dds309; Benayoun B, 2001, J BIOL CHEM, V276, P13830, DOI 10.1074/jbc.M010933200; Berardi DE, 2011, INT J BREAST CANCER, V2011, DOI 10.4061/2011/595092; Brahimi-Horn MC, 2011, CURR OPIN GENET DEV, V21, P67, DOI 10.1016/j.gde.2010.10.006; Clarke R, 2012, CANCER RES, V72, P1321, DOI 10.1158/0008-5472.CAN-11-3213; Coppock D, 2000, BIOCHEM BIOPH RES CO, V269, P604, DOI 10.1006/bbrc.2000.2324; COPPOCK DL, 1993, CELL GROWTH DIFFER, V4, P483; Cuervo AM, 2004, TRENDS CELL BIOL, V14, P70, DOI 10.1016/j.tcb.2003.12.002; Dalby KN, 2010, AUTOPHAGY, V6, P322, DOI 10.4161/auto.6.3.11625; Debnath J, 2011, J MAMMARY GLAND BIOL, V16, P173, DOI 10.1007/s10911-011-9223-3; Duran A, 2008, CANCER CELL, V13, P343, DOI 10.1016/j.ccr.2008.02.001; Galluzzi L, 2008, CURR MOL MED, V8, P78; Gong C, 2013, ONCOGENE, V32, P2261, DOI 10.1038/onc.2012.252; Haan C, 2007, J IMMUNOL METHODS, V318, P11, DOI 10.1016/j.jim.2006.07.027; Harris AL, 2002, NAT REV CANCER, V2, P38, DOI 10.1038/nrc704; Heckler EJ, 2008, BBA-MOL CELL RES, V1783, P567, DOI 10.1016/j.bbamcr.2007.10.002; Hellebrekers DMEI, 2007, CANCER RES, V67, P4138, DOI 10.1158/0008-5472.CAN-06-3032; Hellebrekers DMEI, 2006, CANCER RES, V66, P10770, DOI 10.1158/0008-5472.CAN-06-1609; Hoober KL, 1996, J BIOL CHEM, V271, P30510, DOI 10.1074/jbc.271.48.30510; Ilani T, 2013, SCIENCE, V341, P74, DOI 10.1126/science.1238279; Jain A, 2010, J BIOL CHEM, V285, P22576, DOI 10.1074/jbc.M110.118976; Kang MR, 2009, J PATHOL, V217, P702, DOI 10.1002/path.2509; Karantza-Wadsworth V, 2007, AUTOPHAGY, V3, P610, DOI 10.4161/auto.4867; Karantza-Wadsworth V, 2007, GENE DEV, V21, P1621, DOI 10.1101/gad.1565707; Katchman BA, 2013, BREAST CANCER RES, V15, DOI 10.1186/bcr3407; Katchman BA, 2011, MOL CANCER RES, V9, P1621, DOI 10.1158/1541-7786.MCR-11-0018; Klionsky DJ, 2012, AUTOPHAGY, V8, P445, DOI 10.4161/auto.19496; Kroemer G, 2008, NAT REV MOL CELL BIO, V9, P1004, DOI 10.1038/nrm2529; Lee DY, 2013, EMBO REP, V14, P373, DOI 10.1038/embor.2013.22; Levine B, 2005, J CLIN INVEST, V115, P2679, DOI 10.1172/JCI26390; Liang C, 2006, NAT CELL BIOL, V8, P688, DOI 10.1038/ncb1426; Liang XH, 1999, NATURE, V402, P672, DOI 10.1038/45257; Lim J, 2006, CELL, V125, P801, DOI 10.1016/j.cell.2006.03.032; Lipinski MM, 2010, P NATL ACAD SCI USA, V107, P14164, DOI 10.1073/pnas.1009485107; Lipinski MM, 2010, DEV CELL, V18, P1041, DOI 10.1016/j.devcel.2010.05.005; Liu EY, 2012, J CELL SCI, V125, P2349, DOI 10.1242/jcs.093708; Lozy F, 2012, SEMIN CELL DEV BIOL, V23, P395, DOI 10.1016/j.semcdb.2012.01.005; Macintosh RL, 2012, CELL CYCLE, V11, P2022, DOI 10.4161/cc.20424; Mathew R, 2007, GENE DEV, V21, P1367, DOI 10.1101/gad.1545107; Mathew R, 2009, METHOD ENZYMOL, V453, P53, DOI 10.1016/S0076-6879(08)04004-4; Morel C, 2007, EXP CELL RES, V313, P3971, DOI 10.1016/j.yexcr.2007.09.003; Musard JF, 2001, BIOCHEM BIOPH RES CO, V287, P83, DOI 10.1006/bbrc.2001.5440; N'Diaye EN, 2009, AUTOPHAGY, V5, P573, DOI 10.4161/auto.5.4.8312; Pernodet N, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3341; Puissant A, 2012, AM J CANCER RES, V2, P397; Puissant A, 2010, AUTOPHAGY, V6, P655, DOI 10.4161/auto.6.5.12126; Soloviev M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057327; Song H, 2009, ONCOGENE, V28, P3307, DOI 10.1038/onc.2009.181; Thorpe C, 2002, ARCH BIOCHEM BIOPHYS, V405, P1, DOI 10.1016/S0003-9861(02)00337-5; Tury A, 2004, J ENDOCRINOL, V183, P353, DOI 10.1677/joe.1.05842; Wei HJ, 2011, GENE DEV, V25, P1510, DOI 10.1101/gad.2051011; Xie ZP, 2007, NAT CELL BIOL, V9, P1102, DOI 10.1038/ncb1007-1102; Yang SH, 2011, GENE DEV, V25, P717, DOI 10.1101/gad.2016111; Zhou ST, 2012, CANCER LETT, V323, P115, DOI 10.1016/j.canlet.2012.02.017	57	12	15	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2014	9	1							e86641	10.1371/journal.pone.0086641	http://dx.doi.org/10.1371/journal.pone.0086641			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	298QQ	24475161	gold, Green Submitted, Green Published			2022-12-25	WOS:000330339800054
J	Ragert, M; Fairhurst, MT; Keller, PE				Ragert, Marie; Fairhurst, Merle T.; Keller, Peter E.			Segregation and Integration of Auditory Streams when Listening to Multi-Part Music	PLOS ONE			English	Article							RIGHT PARIETAL LOBE; INTRAPARIETAL SULCUS; POSTERIOR PARIETAL; PLANUM TEMPORALE; MENTAL ROTATION; TIME PERCEPTION; HUMAN BRAIN; CORTEX; ATTENTION; ACTIVATION	In our daily lives, auditory stream segregation allows us to differentiate concurrent sound sources and to make sense of the scene we are experiencing. However, a combination of segregation and the concurrent integration of auditory streams is necessary in order to analyze the relationship between streams and thus perceive a coherent auditory scene. The present functional magnetic resonance imaging study investigates the relative role and neural underpinnings of these listening strategies in multi-part musical stimuli. We compare a real human performance of a piano duet and a synthetic stimulus of the same duet in a prioritized integrative attention paradigm that required the simultaneous segregation and integration of auditory streams. In so doing, we manipulate the degree to which the attended part of the duet led either structurally (attend melody vs. attend accompaniment) or temporally (asynchronies vs. no asynchronies between parts), and thus the relative contributions of integration and segregation used to make an assessment of the leader-follower relationship. We show that perceptually the relationship between parts is biased towards the conventional structural hierarchy in western music in which the melody generally dominates (leads) the accompaniment. Moreover, the assessment varies as a function of both cognitive load, as shown through difficulty ratings and the interaction of the temporal and the structural relationship factors. Neurally, we see that the temporal relationship between parts, as one important cue for stream segregation, revealed distinct neural activity in the planum temporale. By contrast, integration used when listening to both the temporally separated performance stimulus and the temporally fused synthetic stimulus resulted in activation of the intraparietal sulcus. These results support the hypothesis that the planum temporale and IPS are key structures underlying the mechanisms of segregation and integration of auditory streams, respectively.	[Ragert, Marie; Fairhurst, Merle T.; Keller, Peter E.] Max Planck Inst Human Cognit & Brain Sci, Res Grp Mus Cognit & Act, Leipzig, Germany; [Fairhurst, Merle T.] Max Planck Inst Human Cognit & Brain Sci, Res Grp Early Social Dev, Leipzig, Germany; [Keller, Peter E.] Univ Western Sydney, MARCS Inst, Mus Cognit & Act Grp, Sydney, NSW, Australia	Max Planck Society; Max Planck Society; Western Sydney University	Ragert, M (corresponding author), Max Planck Inst Human Cognit & Brain Sci, Res Grp Mus Cognit & Act, Leipzig, Germany.	uhlig@cbs.mpg.de		Keller, Peter/0000-0001-7579-6515	Max Planck Society; FAZIT-Stiftung	Max Planck Society(Max Planck Society); FAZIT-Stiftung	This research was supported by the Max Planck Society. MR's contribution was partially supported by the FAZIT-Stiftung. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alain C, 2007, HEARING RES, V229, P225, DOI 10.1016/j.heares.2007.01.011; Alexander I, 2005, COGN NEUROPSYCHOL, V22, P306, DOI 10.1080/02643290442000356; Battelli L, 2007, TRENDS COGN SCI, V11, P204, DOI 10.1016/j.tics.2007.03.001; Bigand E, 2000, INT J PSYCHOL, V35, P270, DOI 10.1080/002075900750047987; Bregman A.S., 1990, AUDITORY SCENE ANAL; Bressler SL, 2008, J NEUROSCI, V28, P10056, DOI 10.1523/JNEUROSCI.1776-08.2008; Brown SW, 1997, PERCEPTION PSYCHOPHY, V59; Bueti D, 2008, J COGNITIVE NEUROSCI, V20, P1054, DOI 10.1162/jocn.2008.20060; Bueti D, 2009, PHILOS T R SOC B, V364, P1831, DOI 10.1098/rstb.2009.0028; Bueti D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002481; Champod AS, 2007, P NATL ACAD SCI USA, V104, P14837, DOI 10.1073/pnas.0607101104; Chandrasekaran B, 2010, MUSIC PERCEPT, V27, P297, DOI 10.1525/MP.2010.27.4.297; Deike S, 2004, NEUROREPORT, V15, P1511, DOI 10.1097/01.wnr.0000132919.12990.34; Eger E, 2007, CEREB CORTEX, V17, P2123, DOI 10.1093/cercor/bhl119; Erickson R., 1975, SOUND STRUCTURE MUSI; Fan J, 2005, NEUROIMAGE, V26, P471, DOI 10.1016/j.neuroimage.2005.02.004; Foster NEV, 2010, NEUROIMAGE, V53, P26, DOI 10.1016/j.neuroimage.2010.06.042; Foster NEV, 2010, CEREB CORTEX, V20, P1350, DOI 10.1093/cercor/bhp199; Fox WC, 1948, NOTES, V6, P46; Friston K. J., 1995, HUMAN BRAIN MAPPING, V2, P189, DOI DOI 10.1002/HBM.460020402; Frith CD, 1995, HUM BRAIN MAPP, V3, P153, DOI 10.1002/hbm.460030209; Gazzaley A, 2005, J COGNITIVE NEUROSCI, V17, P507, DOI 10.1162/0898929053279522; Goebl W, 2009, MUSIC PERCEPT, V26, P427, DOI 10.1525/MP.2009.26.5.427; Grefkes C, 2005, J ANAT, V207, P3, DOI 10.1111/j.1469-7580.2005.00426.x; Griffiths TD, 2002, TRENDS NEUROSCI, V25, P348, DOI 10.1016/S0166-2236(02)02191-4; Harris IM, 2003, J COGNITIVE NEUROSCI, V15, P315, DOI 10.1162/089892903321593054; HARTMANN WM, 1991, MUSIC PERCEPT, V9, P155; Janata P, 2002, COGN AFFECT BEHAV NE, V2, P121, DOI 10.3758/CABN.2.2.121; Jenkinson M, 2001, MED IMAGE ANAL, V5, P143, DOI 10.1016/S1361-8415(01)00036-6; Kanai R, 2011, EXP BRAIN RES, V209, P465, DOI 10.1007/s00221-011-2577-3; Keller P.E., 2001, PSYCHOL MUSIC, V29, P20, DOI DOI 10.1177/0305735601291003; Keller PE, 2005, MUSIC PERCEPT, V22, P629, DOI 10.1525/mp.2005.22.4.629; Keller PE, 2014, EXPRESSIVEN IN PRESS; Keller PE, 2010, MUSIC PERCEPT, V28, P27, DOI 10.1525/MP.2010.28.1.27; Keller PE, 2008, EMERG COMMUN-STUD NE, V10, P205; Kraus N, 2010, NAT REV NEUROSCI, V11, P599, DOI 10.1038/nrn2882; Marozeau J, 2013, MUSIC PERCEPT, V30, P259, DOI 10.1525/mP.2012.30.3.259; Palmer C, 1997, ANNU REV PSYCHOL, V48, P115, DOI 10.1146/annurev.psych.48.1.115; Parbery-Clark A, 2011, NEUROPSYCHOLOGIA, V49, P3338, DOI 10.1016/j.neuropsychologia.2011.08.007; Parbery-Clark A, 2009, J NEUROSCI, V29, P14100, DOI 10.1523/JNEUROSCI.3256-09.2009; Rahnev D, 2011, J NEUROSCI, V31, P10741, DOI 10.1523/JNEUROSCI.1478-11.2011; Rao SM, 2001, NAT NEUROSCI, V4, P317, DOI 10.1038/85191; RASCH RA, 1979, ACUSTICA, V43, P121; RASCH RA, 1978, ACUSTICA, V40, P21; Satoh M, 2001, COGNITIVE BRAIN RES, V12, P101, DOI 10.1016/S0926-6410(01)00044-1; Smith KR, 2010, J COGNITIVE NEUROSCI, V22, P632, DOI 10.1162/jocn.2009.21196; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Strait DL, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00113; Strait DL, 2010, HEARING RES, V261, P22, DOI 10.1016/j.heares.2009.12.021; Tagg P, 2003, CONTINUUM ENCY POPUL, P628; Tagg P, 2003, CONTINUUM ENCY POPUL, P567; Uhlig M, 2013, NEUROIMAGE, V77, P52, DOI 10.1016/j.neuroimage.2013.03.051; VanRullen R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002911; Walsh V, 2003, TRENDS COGN SCI, V7, P483, DOI 10.1016/j.tics.2003.09.002; Woolrich MW, 2001, NEUROIMAGE, V14, P1370, DOI 10.1006/nimg.2001.0931; WORSLEY KJ, 1992, J CEREBR BLOOD F MET, V12, P900, DOI 10.1038/jcbfm.1992.127; Wright J.K., 1987, CONTEMP MUSIC REV, V2, P63, DOI [10.1080/07494468708567054, DOI 10.1080/07494468708567054]; Zacks JM, 2008, J COGNITIVE NEUROSCI, V20, P1, DOI 10.1162/jocn.2008.20013; Zatorre RJ, 2002, NAT NEUROSCI, V5, P905, DOI 10.1038/nn904; Zatorre RJ, 2010, J COGNITIVE NEUROSCI, V22, P775, DOI 10.1162/jocn.2009.21239; Zendel BR, 2012, PSYCHOL AGING, V27, P410, DOI 10.1037/a0024816; Zendel BR, 2009, J COGNITIVE NEUROSCI, V21, P1488, DOI 10.1162/jocn.2009.21140	62	22	22	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2014	9	1							e84085	10.1371/journal.pone.0084085	http://dx.doi.org/10.1371/journal.pone.0084085			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	298QQ	24475030	Green Published, gold			2022-12-25	WOS:000330339800006
J	Moore, K; Ghatnekar, G; Gourdie, RG; Potts, JD				Moore, Keith; Ghatnekar, Gautam; Gourdie, Robert G.; Potts, Jay D.			Impact of the Controlled Release of a Connexin 43 Peptide on Corneal Wound Closure in an STZ Model of Type I Diabetes	PLOS ONE			English	Article							TGF-BETA ISOFORMS; COMMUNICATION; TRANSITION	The alpha-carboxy terminus 1 (alpha CT1) peptide is a synthetically produced mimetic modified from the DDLEI C-terminus sequence of connexin 43 (Cx43). Previous research using various wound healing models have found promising therapeutic effects when applying the drug, resulting in increased wound healing rates and reduced scarring. Previous data suggested a rapid metabolism rate in vitro, creating an interest in long term release. Using a streptozotocin (STZ) type I diabetic rat model with a surgically induced corneal injury, we delivered alpha CT1 both directly, in a pluronic gel solution, and in a sustained system, using polymeric alginate-poly-l-ornithine (A-PLO) microcapsules (MC). Fluorescent staining of wound area over a 5 day period indicated a significant increase in wound closure rates for both alpha CT1 and alpha CT1 MC treated groups, with alpha CT1 MC groups showing the most rapid wound closure overall. Analysis of inflammatory reaction to the treatment groups indicated significantly lower levels of both Interferon Inducible T-Cell Alpha Chemoattractant (ITAC) and Tumor Necrosis Factor Alpha (TNF alpha) markers using confocal quantification and ELISA assays. Additional analysis examining genes selected from the EMT pathway using RT-PCR and Western blotting suggested alpha CT1 modification of Transforming Growth Factor Beta 2 (TGF beta 2), Keratin 8 (Krt8), Estrogen Receptor 1 (Esr1), and Glucose Transporter 4 (Glut4) over a 14 day period. Combined, this data indicated a possible suppression of the inflammatory response by alpha CT1, leading to increased wound healing rates.	[Moore, Keith; Potts, Jay D.] Univ S Carolina, Sch Med, Columbia, SC 29208 USA; [Ghatnekar, Gautam] FirstString Res Inc, Mt Pleasant, SC USA; [Ghatnekar, Gautam] Med Univ S Carolina, Charleston, SC 29425 USA; [Gourdie, Robert G.] Virginia Polytech & State Univ Caril, Roanoke, VA USA	University of South Carolina; University of South Carolina System; University of South Carolina Columbia; Medical University of South Carolina	Moore, K (corresponding author), Univ S Carolina, Sch Med, Columbia, SC 29208 USA.	moorekb@email.sc.edu			NIH [HL086901]; First String Research, Inc; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K02HL086901] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); First String Research, Inc; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Funding for this project was provided by NIH HL086901 (JDP) and First String Research, Inc (firststringresearch.com). Contact with FirstString Research was conducted through Dr. Gautam Ghatnekar, president and CEO, in an advisory role. No employees of FirstString Research were involved directly in development or personal interaction with any aspect of data collection during the project. Decision to publish and the writing of the manuscript was handled exclusively by Keith Moore, Robert G. Gourdie, and Jay D. Potts.	Andersen N. D., 2007, US ENDOCRINE DIS, V1, P68; [Anonymous], 2009, GLO J PHARM, V3, P81; Aomatsu K, 2012, INVEST OPHTH VIS SCI, V53, P751, DOI 10.1167/iovs.11-8222; Aomatsu K, 2011, INVEST OPHTH VIS SCI, V52, P2437, DOI 10.1167/iovs.10-5635; Barker RJ, 2002, CIRC RES, V90, P317, DOI 10.1161/hh0302.104471; Carrington LM, 2006, INVEST OPHTH VIS SCI, V47, P1886, DOI 10.1167/iovs.05-0635; Duffy HS, 2002, J PHYSIOL-PARIS, V96, P243, DOI 10.1016/S0928-4257(02)00012-8; Evans WH, 2012, J MEMBRANE BIOL, V245, P437, DOI 10.1007/s00232-012-9488-5; Fu XB, 2001, LANCET, V358, P1067, DOI 10.1016/S0140-6736(01)06202-X; Ghatnekar GS, 2009, REGEN MED, V4, P205, DOI 10.2217/17460751.4.2.205; Herve JC, 2004, BBA-BIOMEMBRANES, V1662, P22, DOI 10.1016/j.bbamem.2003.10.022; Huh MI, 2009, HISTOL HISTOPATHOL, V24, P1405, DOI 10.14670/HH-24.1405; Hunter AW, 2005, MOL BIOL CELL, V16, P5686, DOI 10.1091/mbc.E05-08-0737; KAMATA K, 1989, BRIT J PHARMACOL, V97, P614, DOI 10.1111/j.1476-5381.1989.tb11993.x; Kawakita T, 2013, J CELL PHYSIOL, V228, P225, DOI 10.1002/jcp.24126; Lee JG, 2012, EXP EYE RES, V95, P35, DOI 10.1016/j.exer.2011.08.003; Lee JM, 2006, J CELL BIOL, V172, P973, DOI 10.1083/jcb.200601018; Lee YH, 2012, EXP DIABETES RES, DOI 10.1155/2012/504693; Merjava S, 2011, INVEST OPHTH VIS SCI, V52, P787, DOI 10.1167/iovs.10-5489; Merjava S, 2009, EXP EYE RES, V89, P426, DOI 10.1016/j.exer.2009.04.009; Moore K, 2013, MICROSC MICROANAL, V19, P213, DOI 10.1017/S143192761201389X; O'Quinn MP, 2011, CIRC RES, V108, P704, DOI 10.1161/CIRCRESAHA.110.235747; Oviedo-Orta E, 2004, BBA-BIOMEMBRANES, V1662, P102, DOI 10.1016/j.bbamem.2003.10.021; Pai VC, 2010, ARCH OPHTHALMOL-CHIC, V128, P1407, DOI 10.1001/archophthalmol.2010.268; Radisky DC, 2005, J CELL SCI, V118, P4325, DOI 10.1242/jcs.02552; Rao VR, 2010, INVEST OPHTH VIS SCI, V51, P5198, DOI 10.1167/iovs.09-5144; Rhett JM, 2008, TRENDS BIOTECHNOL, V26, P173, DOI 10.1016/j.tibtech.2007.12.007; Rhett JM, 2012, J MEMBRANE BIOL, V245, P411, DOI 10.1007/s00232-012-9465-z; Rhett JM, 2011, MOL BIOL CELL, V22, P1516, DOI 10.1091/mbc.E10-06-0548; Ribas V, 2009, AM J PHYSIOL-ENDOC M, V298, P304; Ricchiuti V, 2009, J ENDOCRINOL, V200, P75, DOI 10.1677/JOE-08-0199; Sassy-Prigent C, 2000, DIABETES, V49, P466, DOI 10.2337/diabetes.49.3.466; Simar D, 2012, CELL STRESS CHAPERON, V17, P615, DOI 10.1007/s12192-012-0336-4; Soder BL, 2009, PLAST RECONSTR SURG, V123, P1440, DOI 10.1097/PRS.0b013e3181a0741d; Soetikno V, 2011, J NUTRBIOCHEM, V24, P1; Sweetnam D, 2012, J NEUROSCI, V32, P5132, DOI 10.1523/JNEUROSCI.5075-11.2012; Valarmathi MT, 2009, BIOMATERIALS, V30, P1098, DOI 10.1016/j.biomaterials.2008.10.044; VINKIN M, 2011, BIOCHIM BIOPHYS ACTA, V8, P2002	38	39	41	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2014	9	1							e86570	10.1371/journal.pone.0086570	http://dx.doi.org/10.1371/journal.pone.0086570			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297XI	24466155	Green Published, Green Submitted, gold			2022-12-25	WOS:000330288000114
J	Olson, KE; Dolan, GF; Muller, UF				Olson, Karen E.; Dolan, Gregory F.; Mueller, Ulrich F.			In Vivo Evolution of a Catalytic RNA Couples Trans-Splicing to Translation	PLOS ONE			English	Article							TERMINATION FACTOR-RHO; SELF-SPLICING INTRONS; DNA HELICASE ACTIVITY; ESCHERICHIA-COLI; TRANSCRIPTION TERMINATION; MESSENGER-RNA; RIBOZYME; TETRAHYMENA; SELECTION; BINDING	How does a non-coding RNA evolve in cells? To address this question experimentally we evolved a trans-splicing variant of the group I intron ribozyme from Tetrahymena over 21 cycles of evolution in E. coli cells. Sequence variation was introduced during the evolution by mutagenic and recombinative PCR, and increasingly active ribozymes were selected by their repair of an mRNA mediating antibiotic resistance. The most efficient ribozyme contained four clustered mutations that were necessary and sufficient for maximum activity in cells. Surprisingly, these mutations did not increase the trans-splicing activity of the ribozyme. Instead, they appear to have recruited a cellular protein, the transcription termination factor Rho, and facilitated more efficient translation of the ribozyme's trans-splicing product. In addition, these mutations affected the expression of several other, unrelated genes. These results suggest that during RNA evolution in cells, four mutations can be sufficient to evolve new protein interactions, and four mutations in an RNA molecule can generate a large effect on gene regulation in the cell.	[Olson, Karen E.; Dolan, Gregory F.; Mueller, Ulrich F.] Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Muller, UF (corresponding author), Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA.	ufmuller@ucsd.edu			Hellman Family Foundation	Hellman Family Foundation	This work was supported by the Hellman Family Foundation [awards 2012 and 2013 to U.F.M.] (http://www.hellmanfellows.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amini ZN, 2013, J BIOL CHEM, V288, P33096, DOI 10.1074/jbc.M113.511469; Ayre BG, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/gnf141; BEAUDRY AA, 1992, SCIENCE, V257, P635, DOI 10.1126/science.1496376; BRENNAN CA, 1990, J BIOL CHEM, V265, P5440; BRENNAN CA, 1987, CELL, V48, P945, DOI 10.1016/0092-8674(87)90703-3; Burton AS, 2006, BIOCHIMIE, V88, P819, DOI 10.1016/j.biochi.2006.01.010; Byun J, 2003, RNA, V9, P1254, DOI 10.1261/rna.5450203; Cadwell R C, 1992, PCR Methods Appl, V2, P28, DOI 10.1101/gr.2.1.28; CADWELL RC, 1994, PCR METH APPL, V3, pS136; Cardinale CJ, 2008, SCIENCE, V320, P935, DOI 10.1126/science.1152763; Carothers JM, 2004, J AM CHEM SOC, V126, P5130, DOI 10.1021/ja031504a; CECH TR, 1994, NAT STRUCT BIOL, V1, P273, DOI 10.1038/nsb0594-273; Chen X, 2009, RNA, V15, P2035, DOI 10.1261/rna.1635209; Cox RA, 2003, MICROBIOL-SGM, V149, P729, DOI 10.1099/mic.0.25645-0; DOBZHANSKY T, 1964, AM ZOOL, V4, P443; GOGOL EP, 1991, J MOL BIOL, V221, P1127, DOI 10.1016/0022-2836(91)80116-C; Guo F, 2004, MOL CELL, V16, P351, DOI 10.1016/S1097-2765(04)00592-1; Guo F, 2002, RNA, V8, P647, DOI 10.1017/S1355838202029011; Hayden EJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045351; Hayden EJ, 2012, P ROY SOC B-BIOL SCI, V279, P3418, DOI 10.1098/rspb.2012.0956; Hayden EJ, 2011, NATURE, V474, P92, DOI 10.1038/nature10083; IMAI M, 1978, J MOL BIOL, V120, P451, DOI 10.1016/0022-2836(78)90348-0; IOST I, 1995, EMBO J, V14, P3252, DOI 10.1002/j.1460-2075.1995.tb07328.x; KRUGER K, 1982, CELL, V31, P147, DOI 10.1016/0092-8674(82)90414-7; LEHMAN N, 1993, CURR BIOL, V3, P723, DOI 10.1016/0960-9822(93)90019-K; Lehnert V, 1996, CHEM BIOL, V3, P993, DOI 10.1016/S1074-5521(96)90166-0; Meluzzi D, 2012, RNA, V18, P590, DOI 10.1261/rna.029884.111; MICHEL F, 1990, J MOL BIOL, V216, P585, DOI 10.1016/0022-2836(90)90386-Z; Nudler E, 2002, GENES CELLS, V7, P755, DOI 10.1046/j.1365-2443.2002.00563.x; Olson KE, 2012, RNA, V18, P581, DOI 10.1261/rna.028472.111; Peters JM, 2009, P NATL ACAD SCI USA, V106, P15406, DOI 10.1073/pnas.0903846106; Richardson LV, 1996, J BIOL CHEM, V271, P21597, DOI 10.1074/jbc.271.35.21597; Rogers CS, 2002, J CLIN INVEST, V110, P1783, DOI 10.1172/JCI200216481; Salehi-Ashtiani K, 2001, NATURE, V414, P82, DOI 10.1038/35102081; Shaw W V, 1975, Methods Enzymol, V43, P737; SHAW WV, 1967, J BIOL CHEM, V242, P687; Shi XY, 2009, BIOCHEMISTRY-US, V48, P6772, DOI 10.1021/bi900472a; Shi X, 2009, J AM CHEM SOC, V131, P9571, DOI 10.1021/ja902797j; Shin KS, 2004, MOL THER, V10, P365, DOI 10.1016/j.ymthe.2004.05.007; Skordalakes E, 2006, CELL, V127, P553, DOI 10.1016/j.cell.2006.08.051; SULLENGER BA, 1994, NATURE, V371, P619, DOI 10.1038/371619a0; TRITTON TR, 1979, ARCH BIOCHEM BIOPHYS, V197, P10, DOI 10.1016/0003-9861(79)90212-1; Unwalla HJ, 2008, MOL THER, V16, P1113, DOI 10.1038/mt.2008.54; Walstrom KM, 1997, BIOCHEMISTRY-US, V36, P7993, DOI 10.1021/bi963180r; Walstrom KM, 1997, BIOCHEMISTRY-US, V36, P7980, DOI 10.1021/bi963179s; WANG Y, 1993, J BIOL CHEM, V268, P13947; Weiss DS, 1999, J BACTERIOL, V181, P508, DOI 10.1128/JB.181.2.508-520.1999; Wieland M, 2008, ANGEW CHEM INT EDIT, V47, P2604, DOI 10.1002/anie.200703700; Yu X, 2000, J MOL BIOL, V299, P1279, DOI 10.1006/jmbi.2000.3810; Zhao HM, 1998, NAT BIOTECHNOL, V16, P258, DOI 10.1038/nbt0398-258; Zhou K, 2011, BMC MOL BIOL, V12, DOI 10.1186/1471-2199-12-18	51	6	6	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2014	9	1							e86473	10.1371/journal.pone.0086473	http://dx.doi.org/10.1371/journal.pone.0086473			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297XI	24466112	Green Published, gold			2022-12-25	WOS:000330288000102
J	Crane, MJ; Daley, JM; van Houtte, O; Brancato, SK; Henry, WL; Albina, JE				Crane, Meredith J.; Daley, Jean M.; van Houtte, Olivier; Brancato, Samielle K.; Henry, William L.; Albina, Jorge E.			The Monocyte to Macrophage Transition in the Murine Sterile Wound	PLOS ONE			English	Article							RECEPTOR TYROSINE KINASE; APOPTOTIC CELLS; CIRCULATING FIBROCYTES; MER; PHENOTYPE; CLEARANCE; SUBSETS; INJURY; CX3CR1; TRANSDIFFERENTIATION	The origin of wound repair macrophages is incompletely defined and was examined here in sterile wounds using the subcutaneous polyvinyl alcohol sponge implantation model in mice. Phenotypic analysis identified F4/80(+)Ly6C(hi)CD64(+)MerTK(-) monocytes and F4/80(+)Ly6C(low)CD64(+)MerTK(+) macrophages in the wound. Circulating monocytes were the precursors of inflammatory Ly6C(hi) wound monocytes. Ly6C(low)MerTK(+) macrophages appeared later, expressed CD206, CD11c, and MHC class II, produced cytokines consistent with repair function, and lacked a gene expression profile compatible with mesenchymal transition or fibroblastic transdifferentiation. Data also demonstrated that Ly6C(hi) wound cells were precursors of Ly6C(low) macrophages, although monocytes did not undergo rapid maturation but rather persisted in the wound as Ly6C(hi)MerTK(-) cells. MerTK-deficient mice were examined to determine whether MerTK-dependent signals from apoptotic cells regulated the maturation of wound macrophages. MerTK-deficient mice had day 14 cell compositions that resembled more immature wounds, with a smaller proportion of F4/80(+) cells and higher frequencies of Ly6G(+) neutrophils and Ly6C(hi) monocytes. The cytokine profile and number of apoptotic cells in day 14 wounds of MerTK-deficient mice was unaffected despite the alterations in cell composition. Overall, these studies identified a differentiation pathway in response to sterile inflammation in which monocytes recruited from the circulation acquire proinflammatory function, persist in the wound, and mature into repair macrophages.	[Crane, Meredith J.] Brown Univ, Rhode Isl Hosp, Dept Surg, Providence, RI 02903 USA; Brown Univ, Warren Alpert Sch Med, Providence, RI 02912 USA	Brown University; Lifespan Health Rhode Island; Rhode Island Hospital; Brown University	Crane, MJ (corresponding author), Brown Univ, Rhode Isl Hosp, Dept Surg, Providence, RI 02903 USA.	Meredith_Crane@brown.edu			Department of Surgery at Lifespan/Rhode Island Hospital; NIH [R01 GM042859, K08 GM079227]; National Institute for Environmental Sciences [T32-ES7272]; National Institutes of Health (NIGMS) [P30GM103410]; National Institutes of Health (NCRR) [P30RR031153, P20RR018728, S10RR02763]; National Science Foundation (EPSCoR grant) [0554548]; Lifespan/Rhode Island Hospital; Division of Biology and Medicine at Brown University; NCCR SIG grant [1S10RR021051]; Office Of The Director [1004057] Funding Source: National Science Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES [P30RR031153, P20RR018728, S10RR021051] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [T32ES007272] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [K08GM079227, T32GM065085, R01GM042859, P30GM103410] Funding Source: NIH RePORTER	Department of Surgery at Lifespan/Rhode Island Hospital; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute for Environmental Sciences; National Institutes of Health (NIGMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institutes of Health (NCRR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Science Foundation (EPSCoR grant); Lifespan/Rhode Island Hospital; Division of Biology and Medicine at Brown University; NCCR SIG grant; Office Of The Director(National Science Foundation (NSF)NSF - Office of the Director (OD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by funds from the Department of Surgery at Lifespan/Rhode Island Hospital, as well as NIH grants R01 GM042859 (J.E.A.) and K08 GM079227 (J.M.D.). M.J.C. was supported in part by the National Institute for Environmental Sciences grant T32-ES7272 (Training in Environmental Pathology). The Center for Genomics and Proteomics is funded by The National Institutes of Health (NIGMS grant number P30GM103410, NCRR grant numbers P30RR031153, P20RR018728 and S10RR02763), National Science Foundation (EPSCoR grant number 0554548), Lifespan/Rhode Island Hospital, and the Division of Biology and Medicine at Brown University. Purchase of the FACSAria by the Flow Cytometry and Sorting Facility was supported by NCCR SIG grant 1S10RR021051. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold L, 2007, J EXP MED, V204, P1057, DOI 10.1084/jem.20070075; Auffray C, 2009, ANNU REV IMMUNOL, V27, P669, DOI 10.1146/annurev.immunol.021908.132557; Bellini A, 2007, LAB INVEST, V87, P858, DOI 10.1038/labinvest.3700654; BERTRAND S, 1992, INT J DEV BIOL, V36, P179; Blakaj A, 2012, FIBROGENESIS TISSUE, V5, DOI 10.1186/1755-1536-5-S1-S6; Brancato SK, 2011, AM J PATHOL, V178, P19, DOI 10.1016/j.ajpath.2010.08.003; BUCALA R, 1994, MOL MED, V1, P71, DOI 10.1007/bf03403533; Camenisch TD, 1999, J IMMUNOL, V162, P3498; Choi JY, 2013, J PHARMACOL EXP THER, V344, P447, DOI 10.1124/jpet.112.199778; Daley JM, 2010, J LEUKOCYTE BIOL, V87, P59, DOI 10.1189/jlb.0409236; Daley JM, 2005, J IMMUNOL, V174, P2265, DOI 10.4049/jimmunol.174.4.2265; Duffield JS, 2005, J CLIN INVEST, V115, P56, DOI 10.1172/JCI200522675; Eken C, 2013, IMMUNOBIOLOGY, V218, P382, DOI 10.1016/j.imbio.2012.05.021; Eken C, 2010, J BIOL CHEM, V285, P39914, DOI 10.1074/jbc.M110.126748; Fraineau S, 2012, BLOOD, V120, P5073, DOI 10.1182/blood-2012-05-429183; Gautier EL, 2012, NAT IMMUNOL, V13, P1118, DOI 10.1038/ni.2419; Geissmann F, 2003, IMMUNITY, V19, P71, DOI 10.1016/S1074-7613(03)00174-2; Geissmann F, 2010, NAT REV IMMUNOL, V10, P453, DOI 10.1038/nri2784; Gordon S, 2005, NAT REV IMMUNOL, V5, P953, DOI 10.1038/nri1733; Goren I, 2009, AM J PATHOL, V175, P132, DOI 10.2353/ajpath.2009.081002; Hart SP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033142; Hartlapp I, 2001, FASEB J, V15, P2215, DOI 10.1096/fj.01-0049com; HUNT TK, 1967, J TRAUM, V7, P298, DOI 10.1097/00005373-196703000-00012; Ishida Y, 2008, J IMMUNOL, V180, P569, DOI 10.4049/jimmunol.180.1.569; Jabs A, 2005, J VASC RES, V42, P174, DOI 10.1159/000084406; Jakubzick C, 2013, IMMUNITY, V39, P599, DOI 10.1016/j.immuni.2013.08.007; Lee YJ, 2012, TOXICOL APPL PHARM, V263, P61, DOI 10.1016/j.taap.2012.05.024; Lee YJ, 2012, J LEUKOCYTE BIOL, V91, P921, DOI 10.1189/jlb.0611289; Li L, 2008, KIDNEY INT, V74, P1526, DOI 10.1038/ki.2008.500; Lu QX, 2001, SCIENCE, V293, P306, DOI 10.1126/science.1061663; Lucas T, 2010, J IMMUNOL, V184, P3964, DOI 10.4049/jimmunol.0903356; Mahoney E, 2002, AM J PATHOL, V161, P2143, DOI 10.1016/S0002-9440(10)64492-6; Maus U, 2001, AM J PHYSIOL-LUNG C, V280, pL58, DOI 10.1152/ajplung.2001.280.1.L58; Meszaros AJ, 2000, J IMMUNOL, V165, P435, DOI 10.4049/jimmunol.165.1.435; Meszaros AJ, 1999, J LEUKOCYTE BIOL, V65, P35, DOI 10.1002/jlb.65.1.35; Mirza R, 2011, CYTOKINE, V56, P256, DOI 10.1016/j.cyto.2011.06.016; Mirza R, 2009, AM J PATHOL, V175, P2454, DOI 10.2353/ajpath.2009.090248; Mooney JE, 2010, AM J PATHOL, V176, P369, DOI 10.2353/ajpath.2010.090545; Nahrendorf M, 2007, J EXP MED, V204, P3037, DOI 10.1084/jem.20070885; Ninomiya K, 2006, HYPERTENS RES, V29, P269, DOI 10.1291/hypres.29.269; Sather S, 2007, BLOOD, V109, P1026, DOI 10.1182/blood-2006-05-021634; Schmidt M, 2003, J IMMUNOL, V171, P380, DOI 10.4049/jimmunol.171.1.380; Scott RS, 2001, NATURE, V411, P207, DOI 10.1038/35075603; Seitz HM, 2007, J IMMUNOL, V178, P5635, DOI 10.4049/jimmunol.178.9.5635; Sunderkotter C, 2004, J IMMUNOL, V172, P4410, DOI 10.4049/jimmunol.172.7.4410; Tacke F, 2007, J CLIN INVEST, V117, P185, DOI 10.1172/JCI28549; Wallet MA, 2008, J EXP MED, V205, P219, DOI 10.1084/jem.20062293; Wan E, 2013, CIRC RES, V113, P1004, DOI 10.1161/CIRCRESAHA.113.301198; Zizzo G, 2012, J IMMUNOL, V189, P3508, DOI 10.4049/jimmunol.1200662	49	151	157	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2014	9	1							e86660	10.1371/journal.pone.0086660	http://dx.doi.org/10.1371/journal.pone.0086660			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297VL	24466192	Green Published, gold, Green Submitted			2022-12-25	WOS:000330283100195
J	Iniesta, AA				Iniesta, Antonio A.			ParABS System in Chromosome Partitioning in the Bacterium Myxococcus xanthus	PLOS ONE			English	Article							ESCHERICHIA-COLI CHROMOSOME; INDUCIBLE GENE-EXPRESSION; BACILLUS-SUBTILIS; CAULOBACTER-CRESCENTUS; CELL-CYCLE; PSEUDOMONAS-AERUGINOSA; COMPREHENSIVE SET; DNA-REPLICATION; SEGREGATION; PROTEIN	Chromosome segregation is an essential cellular function in eukaryotic and prokaryotic cells. The ParABS system is a fundamental player for a mitosis-like process in chromosome partitioning in many bacterial species. This work shows that the social bacterium Myxococcus xanthus also uses the ParABS system for chromosome segregation. Its large prokaryotic genome of 9.1 Mb contains 22 parS sequences near the origin of replication, and it is shown here that M. xanthus ParB binds preferentially to a consensus parS sequence in vitro. ParB and ParA are essential for cell viability in M. xanthus as in Caulobacter crescentus, but unlike in many other bacteria. Absence of ParB results in anucleate cells, chromosome segregation defects and loss of viability. Analysis of ParA subcellular localization shows that it clusters at the poles in all cells, and in some, in the DNA-free cell division plane between two chromosomal DNA masses. This ParA localization pattern depends on ParB but not on FtsZ. ParB inhibits the nonspecific interaction of ParA with DNA, and ParA colocalizes with chromosomal DNA only when ParB is depleted. The subcellular localization of ParB suggests a single ParB-parS complex localized at the edge of the nucleoid, next to a polar ParA cluster, with a second ParB-parS complex migrating after the replication of parS takes place to the opposite nucleoid edge, next to the other polar ParA cluster.	Univ Murcia, Fac Biol, Dept Genet & Microbiol, Area Genet, Murcia, Spain	University of Murcia	Iniesta, AA (corresponding author), Univ Murcia, Fac Biol, Dept Genet & Microbiol, Area Genet, Campus Reg Excelencia Int Campus Mare Nostrum, Murcia, Spain.	ainiesta@um.es	Iniesta, Antonio A/G-7798-2015	Iniesta, Antonio A/0000-0002-7629-1057	Ministerio de Economia y Competitividad, Government of Spain [BFU2011-255422, RYC-2009-04190]	Ministerio de Economia y Competitividad, Government of Spain	Source of funding: Ministerio de Economia y Competitividad, http://www.mineco.gob.es/portal/site/mineco/. Government of Spain Grants BFU2011-255422 and RYC-2009-04190. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams DW, 2009, NAT REV MICROBIOL, V7, P642, DOI 10.1038/nrmicro2198; Bartosik AA, 2009, MICROBIOL-SGM, V155, P1080, DOI 10.1099/mic.0.024661-0; Bartosik AA, 2004, J BACTERIOL, V186, P6983, DOI 10.1128/JB.186.20.6983-6998.2004; Breier AM, 2007, MOL MICROBIOL, V64, P703, DOI 10.1111/j.1365-2958.2007.05690.x; BRETSCHER AP, 1978, J BACTERIOL, V133, P763, DOI 10.1128/JB.133.2.763-768.1978; Charaka VK, 2012, J BACTERIOL, V194, P5739, DOI 10.1128/JB.00610-12; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Donovan C, 2010, J BACTERIOL, V192, P3441, DOI 10.1128/JB.00214-10; Dubarry N, 2006, J BACTERIOL, V188, P1489, DOI 10.1128/JB.188.4.1489-1496.2006; Dworkin J, 2002, P NATL ACAD SCI USA, V99, P14089, DOI 10.1073/pnas.182539899; Easter J, 2002, MOL CELL, V10, P427, DOI 10.1016/S1097-2765(02)00594-4; Elias-Arnanz M, 2011, CURR OPIN MICROBIOL, V14, P128, DOI 10.1016/j.mib.2010.12.009; Erickson HP, 2010, MICROBIOL MOL BIOL R, V74, P504, DOI 10.1128/MMBR.00021-10; Fogel MA, 2006, GENE DEV, V20, P3269, DOI 10.1101/gad.1496506; Gerdes K, 2010, CELL, V141, P927, DOI 10.1016/j.cell.2010.05.033; Goldman BS, 2006, P NATL ACAD SCI USA, V103, P15200, DOI 10.1073/pnas.0607335103; Gomez-Santos N, 2012, APPL ENVIRON MICROB, V78, P2515, DOI 10.1128/AEM.07502-11; Harms A, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003802; Iniesta AA, 2012, J BACTERIOL, V194, P5875, DOI 10.1128/JB.01110-12; IRETON K, 1994, J BACTERIOL, V176, P5320, DOI 10.1128/JB.176.17.5320-5329.1994; Jakimowicz D, 2007, MOL MICROBIOL, V65, P625, DOI 10.1111/j.1365-2958.2007.05815.x; Jun S, 2006, P NATL ACAD SCI USA, V103, P12388, DOI 10.1073/pnas.0605305103; KAISER D, 1979, P NATL ACAD SCI USA, V76, P5952, DOI 10.1073/pnas.76.11.5952; Kaiser D, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000380; Kim HJ, 2000, J BACTERIOL, V182, P1313, DOI 10.1128/JB.182.5.1313-1320.2000; Koch MK, 2011, MOL MICROBIOL, V80, P1031, DOI 10.1111/j.1365-2958.2011.07629.x; Lemon KP, 2001, GENE DEV, V15, P2031, DOI 10.1101/gad.913301; Leonard TA, 2005, EMBO J, V24, P270, DOI 10.1038/sj.emboj.7600530; Lesterlin C, 2012, EMBO J, V31, P3468, DOI 10.1038/emboj.2012.194; Lin DCH, 1998, CELL, V92, P675, DOI 10.1016/S0092-8674(00)81135-6; Livny J, 2007, J BACTERIOL, V189, P8693, DOI 10.1128/JB.01239-07; Marston AL, 1999, MOL CELL, V4, P673, DOI 10.1016/S1097-2765(00)80378-0; Mercier R, 2008, CELL, V135, P475, DOI 10.1016/j.cell.2008.08.031; Mierzejewska J, 2012, PLASMID, V67, P1, DOI 10.1016/j.plasmid.2011.08.003; Mingorance J, 2010, TRENDS MICROBIOL, V18, P348, DOI 10.1016/j.tim.2010.06.001; Mohl DA, 2001, MOL MICROBIOL, V42, P741, DOI 10.1046/j.1365-2958.2001.02643.x; Mohl DA, 1997, CELL, V88, P675, DOI 10.1016/S0092-8674(00)81910-8; Murray H, 2008, CELL, V135, P74, DOI 10.1016/j.cell.2008.07.044; Murray H, 2006, MOL MICROBIOL, V61, P1352, DOI 10.1111/j.1365-2958.2006.05316.x; Nielsen HJ, 2006, MOL MICROBIOL, V61, P383, DOI 10.1111/j.1365-2958.2006.05245.x; ORNDORFF P, 1983, J BACTERIOL, V154, P772, DOI 10.1128/JB.154.2.772-779.1983; Perez-Marin MC, 2004, J BIOL CHEM, V279, P33093, DOI 10.1074/jbc.M405225200; Postow L, 2004, GENE DEV, V18, P1766, DOI 10.1101/gad.1207504; Ptacin JL, 2010, NAT CELL BIOL, V12, P791, DOI 10.1038/ncb2083; Quisel JD, 1999, MOL CELL, V4, P665, DOI 10.1016/S1097-2765(00)80377-9; Ringgaard S, 2009, P NATL ACAD SCI USA, V106, P19369, DOI 10.1073/pnas.0908347106; RUIZVAZQUEZ R, 1984, J BACTERIOL, V160, P818; Saint-Dic D, 2006, J BACTERIOL, V188, P5626, DOI 10.1128/JB.00250-06; Schofield WB, 2010, EMBO J, V29, P3068, DOI 10.1038/emboj.2010.207; Teleman AA, 1998, CURR BIOL, V8, P1102, DOI 10.1016/S0960-9822(98)70464-6; Thanbichler M, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm818; Toro E, 2008, P NATL ACAD SCI USA, V105, P15435, DOI 10.1073/pnas.0807448105; Toro E, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000349; Treuner-Lange A, 2013, MOL MICROBIOL, V87, P235, DOI 10.1111/mmi.12094; Ueki T, 1996, GENE, V183, P153, DOI 10.1016/S0378-1119(96)00546-X; Vallet-Gely I, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003492; Viollier PH, 2004, P NATL ACAD SCI USA, V101, P9257, DOI 10.1073/pnas.0402606101; Wang XD, 2013, NAT REV GENET, V14, P191, DOI 10.1038/nrg3375; Woldringh CL, 2002, MOL MICROBIOL, V45, P17, DOI 10.1046/j.1365-2958.2002.02993.x; Zhang Y, 2012, FEMS MICROBIOL REV, V36, P149, DOI 10.1111/j.1574-6976.2011.00307.x	61	26	27	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2014	9	1							e86897	10.1371/journal.pone.0086897	http://dx.doi.org/10.1371/journal.pone.0086897			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297VL	24466283	gold, Green Published, Green Submitted			2022-12-25	WOS:000330283100231
J	Lee, S; Ryu, JH; Kim, H; Kim, KH; Ahn, HS; Hann, HJ; Cho, Y; Park, YM; Kim, SJ; Kang, DH; Choi, KB; Ryu, DR				Lee, Shina; Ryu, Jung-Hwa; Kim, Hyunwook; Kim, Kyoung Hoon; Ahn, Hyeong Sik; Hann, Hoo Jae; Cho, Yongjae; Park, Young Mi; Kim, Seung-Jung; Kang, Duk-Hee; Choi, Kyu Bok; Ryu, Dong-Ryeol			An Assessment of Survival among Korean Elderly Patients Initiating Dialysis: A National Population-Based Study	PLOS ONE			English	Article							STAGE RENAL-DISEASE; REPLACEMENT THERAPY; PERITONEAL-DIALYSIS; HEALTH INSURANCE; UNITED-STATES; HEMODIALYSIS; MORTALITY; OUTCOMES; CHOICE; MODALITY	Background: Although the proportion of the elderly patients with incident end-stage renal disease (ESRD) patients has been increasing in Korea, there has been a lack of information on outcomes of dialysis treatment. This study aimed to assess the survival rate and to elucidate predictors for all-cause mortality among elderly Korean patients initiating dialysis. Methods: We analyzed 11,301 patients (6,138 men) aged 65 years or older who had initiated dialysis from 2005 to 2008 and had followed up (median, 37.8 months; range, 3-84 months). Baseline demographics, comorbidities and mortality data were obtained using the database from the Health Insurance Review & Assessment Service. Results: The unadjusted 5-year survival rate was 37.6% for all elderly dialysis patients, and the rate decreased with increasing age categories; 45.9% (65 similar to 69), 37.5% (70 similar to 74), 28.4% (75 similar to 79), 24.1% (80 similar to 84), and 13.7% (>= 85 years). The multivariate Cox proportional hazard model revealed that age, sex, dialysis modality, the type of insurance, and comorbidities such as diabetes mellitus, myocardial infarction, congestive heart failure, peripheral vascular disease, cerebrovascular disease, dementia, chronic pulmonary disease, hemiparesis, liver disease, and any malignancy were independent predictors for mortality. In addition, survival rate was significantly higher in patients on hemodialysis compared to patients on peritoneal dialysis during the whole follow-up period in the intention-to-treat analysis. Conclusions: Survival rate was significantly associated with age, sex, and various comorbidities in Korean elderly patients initiating dialysis. The results of our study can help to provide relevant guidance on the individualization strategy in elderly ESRD patients requiring dialysis.	[Lee, Shina; Ryu, Jung-Hwa; Kim, Seung-Jung; Kang, Duk-Hee; Choi, Kyu Bok; Ryu, Dong-Ryeol] Ewha Womans Univ, Dept Internal Med, Sch Med, Seoul, South Korea; [Kim, Hyunwook] Wonkwang Univ, Coll Med, Sanbon Hosp, Dept Internal Med, Gunpo, South Korea; [Kim, Kyoung Hoon] Korea Univ, Dept Publ Hlth, Grad Sch, Seoul, South Korea; [Ahn, Hyeong Sik] Korea Univ, Coll Med, Dept Prevent Med, Seoul 136705, South Korea; [Hann, Hoo Jae; Cho, Yongjae; Park, Young Mi] Ewha Womans Univ, Ewha Med Res Inst, Sch Med, Seoul, South Korea	Ewha Womans University; Wonkwang University; Korea University; Korea University; Korea University Medicine (KU Medicine); Ewha Womans University	Ryu, DR (corresponding author), Ewha Womans Univ, Dept Internal Med, Sch Med, Seoul, South Korea.	drryu@ewha.ac.kr		Ryu, Dong-Ryeol/0000-0002-5309-7606	Korean Academy of Medical Sciences; Ewha Global Top5 Grant of Ewha Womans University	Korean Academy of Medical Sciences; Ewha Global Top5 Grant of Ewha Womans University	This study was supported by a 2011 grant from the Korean Academy of Medical Sciences; and by the Ewha Global Top5 Grant of Ewha Womans University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Canaud B, 2011, CLIN J AM SOC NEPHRO, V6, P1651, DOI 10.2215/CJN.03530410; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Glaudet F, 2013, BMC NEPHROL, V14, DOI 10.1186/1471-2369-14-131; HELD PJ, 1990, AM J KIDNEY DIS, V15, P451, DOI 10.1016/S0272-6386(12)70363-3; Hemmelgarn BR, 2003, AM J KIDNEY DIS, V42, P125, DOI 10.1016/S0272-6386(03)00415-3; Jager KJ, 2003, CLIN NEPHROL, V60, P352; Jassal SV, 2007, CAN MED ASSOC J, V177, P1033, DOI 10.1503/cmaj.061765; Jeong HS, 2011, HEALTH AFFAIR, V30, P136, DOI 10.1377/hlthaff.2008.0816; Jin DC, 2012, KIDNEY RES CLIN PRAC, V31, P62, DOI 10.1016/j.krcp.2012.01.005; Jin Dong Chan, 2011, Korean Journal of Internal Medicine, V26, P123, DOI 10.3904/kjim.2011.26.2.123; Kurella M, 2007, ANN INTERN MED, V146, P177, DOI 10.7326/0003-4819-146-3-200702060-00006; Kwon S, 2009, HEALTH POLICY PLANN, V24, P63, DOI 10.1093/heapol/czn037; Lamping DL, 2000, LANCET, V356, P1543, DOI 10.1016/S0140-6736(00)03123-8; Letourneau I, 2003, AM J NEPHROL, V23, P71, DOI 10.1159/000068040; Liem YS, 2007, KIDNEY INT, V71, P153, DOI 10.1038/sj.ki.5002014; Lok CE, 2012, SEMIN NEPHROL, V32, P530, DOI 10.1016/j.semnephrol.2012.10.003; McDonald SP, 2009, J AM SOC NEPHROL, V20, P155, DOI 10.1681/ASN.2007111188; Merighi JR, 2012, HEMODIAL INT, V16, P242, DOI 10.1111/j.1542-4758.2011.00649.x; Munshi SK, 2001, NEPHROL DIAL TRANSPL, V16, P128, DOI 10.1093/ndt/16.1.128; Murtagh FEM, 2007, NEPHROL DIAL TRANSPL, V22, P1955, DOI 10.1093/ndt/gfm153; Quan HD, 2005, MED CARE, V43, P1130, DOI 10.1097/01.mlr.0000182534.19832.83; Rosner MH, 2012, CONTRIB NEPHROL, V178, P83, DOI 10.1159/000337817; Song Y.J., 2009, JAPAN MED ASS J, V52, P206, DOI 10.3345/kjp.2009.52.7.752; U S Renal Data System. USRDS, 2012, ANN DAT REP ATL CHRO; Villar E, 2007, J AM SOC NEPHROL, V18, P2125, DOI 10.1681/ASN.2006091048; Winkelmayer WC, 2002, J AM SOC NEPHROL, V13, P2353, DOI 10.1097/01.ASN.0000025785.41314.76; Yoshino M, 2006, J AM SOC NEPHROL, V17, P3510, DOI 10.1681/ASN.2006020156	27	7	14	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2014	9	1							e86776	10.1371/journal.pone.0086776	http://dx.doi.org/10.1371/journal.pone.0086776			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297VL	24466236	Green Published, gold, Green Submitted			2022-12-25	WOS:000330283100212
J	Wong, CP; Hsu, A; Buchanan, A; Palomera-Sanchez, Z; Beaver, LM; Houseman, EA; Williams, DE; Dashwood, RH; Ho, E				Wong, Carmen P.; Hsu, Anna; Buchanan, Alex; Palomera-Sanchez, Zoraya; Beaver, Laura M.; Houseman, E. Andres; Williams, David E.; Dashwood, Roderick H.; Ho, Emily			Effects of Sulforaphane and 3,3 '-Diindolylmethane on Genome-Wide Promoter Methylation in Normal Prostate Epithelial Cells and Prostate Cancer Cells	PLOS ONE			English	Article							DNA METHYLTRANSFERASES; EXPRESSION; INDOLE-3-CARBINOL; HYPOMETHYLATION; HYPERMETHYLATION; EPIGENETICS; PREVENTION; CHEMOKINES; RECEPTORS; MIGRATION	Epigenetic changes, including aberrant DNA methylation, result in altered gene expression and play an important role in carcinogenesis. Phytochemicals such as sulforaphane (SFN) and 3,39-diindolylmethane (DIM) are promising chemopreventive agents for the treatment of prostate cancer. Both have been shown to induce re-expression of genes, including tumor suppressor genes silenced in cancer cells, via modulation of epigenetic marks including DNA methylation. However, it remained unclear the effects SFN and DIM on DNA methylation at a genomic scale. The goal of this study was to determine the genome-wide effects of SFN and DIM on promoter methylation in normal prostate epithelial cells and prostate cancer cells. Both SFN and DIM treatment decreased DNA methyltransferase expression in normal prostate epithelial cells (PrEC), and androgen-dependent (LnCAP) and androgen-independent (PC3) prostate cancer cells. The effects of SFN and DIM on promoter methylation profiles in normal PrEC, LnCAP and PC3 prostate cancer cells were determined using methyl-DNA immunoprecipitation followed by genome-wide DNA methylation array. We showed widespread changes in promoter methylation patterns, including both increased and decreased methylation, in all three prostate cell lines in response to SFN or DIM treatments. In particular, SFN and DIM altered promoter methylation in distinct sets of genes in PrEC, LnCAP, and PC3 cells, but shared similar gene targets within a single cell line. We further showed that SFN and DIM reversed many of the cancer-associated methylation alterations, including aberrantly methylated genes that are dysregulated or are highly involved in cancer progression. Overall, our data suggested that both SFN and DIM are epigenetic modulators that have broad and complex effects on DNA methylation profiles in both normal and cancerous prostate epithelial cells. Results from our study may provide new insights into the epigenetic mechanisms by which SFN and DIM exert their cancer chemopreventive effects.	[Wong, Carmen P.; Hsu, Anna; Buchanan, Alex; Palomera-Sanchez, Zoraya; Beaver, Laura M.; Houseman, E. Andres; Ho, Emily] Oregon State Univ, Sch Biol & Populat Hlth Sci, Corvallis, OR 97331 USA; [Wong, Carmen P.; Hsu, Anna; Palomera-Sanchez, Zoraya; Beaver, Laura M.; Williams, David E.; Dashwood, Roderick H.; Ho, Emily] Oregon State Univ, Linus Pauling Inst, Corvallis, OR 97331 USA; [Williams, David E.; Dashwood, Roderick H.] Oregon State Univ, Dept Environm & Mol Toxicol, Corvallis, OR 97331 USA; [Ho, Emily] Oregon State Univ, Moore Family Ctr Whole Grain Foods Nutr & Prevent, Corvallis, OR 97331 USA	Oregon State University; Oregon State University; Oregon State University; Oregon State University	Ho, E (corresponding author), Oregon State Univ, Sch Biol & Populat Hlth Sci, Corvallis, OR 97331 USA.	Emily.Ho@oregonstate.edu	Dashwood, Roderick/AAF-2025-2020	Houseman, Eugene Andres/0000-0003-0703-1830	NIH [CA90890, CA65525, CA122906, CA122959, CA80176, R01GM104977]; NIEHS Center [P30 ES00210]; NATIONAL CANCER INSTITUTE [R01CA080176, P01CA090890, R01CA065525, R01CA122959, R01CA122906, R29CA065525] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES000210] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM104977] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIEHS Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIH grants CA90890, CA65525, CA122906, CA122959, CA80176, R01GM104977, and by NIEHS Center grant P30 ES00210. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Cancer Society, 2012, CANC FACTS FIG 2012; Anderton MJ, 2004, CLIN CANCER RES, V10, P5233, DOI 10.1158/1078-0432.CCR-04-0163; Baylin SB, 2011, NAT REV CANCER, V11, P726, DOI 10.1038/nrc3130; Beaver LM, 2012, TOXICOL APPL PHARM, V263, P345, DOI 10.1016/j.taap.2012.07.007; BEDFORD MT, 1987, CANCER RES, V47, P5274; Bradlow HL, 2008, IN VIVO, V22, P441; Cho HJ, 2008, J NUTR, V138, P17, DOI 10.1093/jn/138.1.17; Clarke JD, 2008, CANCER LETT, V269, P291, DOI 10.1016/j.canlet.2008.04.018; Clarke JD, 2011, MOL NUTR FOOD RES, V55, P999, DOI 10.1002/mnfr.201000547; D'Antonio KB, 2010, CLIN CANCER RES, V16, P5908, DOI 10.1158/1078-0432.CCR-10-1200; Denis H, 2011, EMBO REP, V12, P647, DOI 10.1038/embor.2011.110; Dubrovska A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031226; Etoh T, 2004, AM J PATHOL, V164, P689, DOI 10.1016/S0002-9440(10)63156-2; Halachev K, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-10-r96; He SS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027684; Ho E, 2011, ADV NUTR, V2, P497, DOI 10.3945/an.111.001032; Hsu A, 2011, CLIN EPIGENETICS, V3, DOI 10.1186/1868-7083-3-3; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Hulsen T, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-488; Jeronimo C, 2011, EUR UROL, V60, P753, DOI 10.1016/j.eururo.2011.06.035; Kim IY, 1996, CLIN CANCER RES, V2, P1255; Kinney SRM, 2008, MOL CANCER RES, V6, P1365, DOI 10.1158/1541-7786.MCR-08-0040; Li JY, 2012, BREAST CANCER RES TR, V131, P837, DOI 10.1007/s10549-011-1502-6; Li Y, 2010, CURR MED CHEM, V17, P2141, DOI 10.2174/092986710791299966; Lin RK, 2010, CANCER RES, V70, P5807, DOI 10.1158/0008-5472.CAN-09-4161; Liu B, 2012, INT J UROL, V19, P134, DOI 10.1111/j.1442-2042.2011.02906.x; Meeran SM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037748; Meeran SM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011457; Mizuno S, 2001, BLOOD, V97, P1172, DOI 10.1182/blood.V97.5.1172; Myers RM, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001046; Myzak MC, 2004, CANCER RES, V64, P5767, DOI 10.1158/0008-5472.CAN-04-1326; O'Hayre M, 2008, BIOCHEM J, V409, P635, DOI 10.1042/BJ20071493; Palomera-Sanchez Z, 2010, J BIOL CHEM, V285, P31370, DOI 10.1074/jbc.M110.128462; Portela A, 2010, NAT BIOTECHNOL, V28, P1057, DOI 10.1038/nbt.1685; Rajoria S, 2011, ONCOL REP, V25, P491, DOI 10.3892/or.2010.1076; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Sandve GK, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-12-r121; Sandve GK, 2011, BIOINFORMATICS, V27, P3235, DOI 10.1093/bioinformatics/btr568; Schulz WA, 2002, GENE CHROMOSOME CANC, V35, P58, DOI 10.1002/gcc.10092; Shan YJ, 2013, J NUTR BIOCHEM, V24, P1062, DOI 10.1016/j.jnutbio.2012.08.004; Sharma S, 2010, CARCINOGENESIS, V31, P27, DOI 10.1093/carcin/bgp220; Stein LD, 2002, GENOME RES, V12, P1599, DOI 10.1101/gr.403602; Steinbrecher A, 2009, INT J CANCER, V125, P2179, DOI 10.1002/ijc.24555; Sun YX, 2003, J CELL BIOCHEM, V89, P462, DOI 10.1002/jcb.10522; Terada N, 2012, ASIAN J ANDROL, V14, P405, DOI 10.1038/aja.2011.149; Vindrieux D, 2009, ENDOCR-RELAT CANCER, V16, P663, DOI 10.1677/ERC-09-0109; Yang YM, 2011, CANCER SCI, V102, P1264, DOI 10.1111/j.1349-7006.2011.01934.x; Zentner GE, 2013, NAT STRUCT MOL BIOL, V20, P259, DOI 10.1038/nsmb.2470; Zhang N, 2012, TRANSL ANDROL UROL, V1, P14, DOI [10.3978/j.issn.2223-4683.2012.01.02, 10.3978/j.issn.2223-4683.2012.05.06]; Zhang Q, 2005, MOL ENDOCRINOL, V19, P2390, DOI 10.1210/me.2005-0096; Zhou JP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049744	51	57	63	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2014	9	1							e86787	10.1371/journal.pone.0086787	http://dx.doi.org/10.1371/journal.pone.0086787			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297VL	24466240	Green Submitted, Green Published, gold			2022-12-25	WOS:000330283100213
J	Berg, M; Hagland, HR; Soreide, K				Berg, Marianne; Hagland, Hanne R.; Soreide, Kjetil			Comparison of CpG Island Methylator Phenotype (CIMP) Frequency in Colon Cancer Using Different Probe- and Gene-Specific Scoring Alternatives on Recommended Multi-Gene Panels	PLOS ONE			English	Article							COLORECTAL-CANCER; DNA TEST; EPIGENETICS; MARKERS; EPIGENOTYPES; BIOMARKERS; ASSAY; MLPA	Background: In colorectal cancer a distinct subgroup of tumours demonstrate the CpG island methylator phenotype (CIMP). However, a consensus of how to score CIMP is not reached, and variation in definition may influence the reported CIMP prevalence in tumours. Thus, we sought to compare currently suggested definitions and cut-offs for methylation markers and how they influence CIMP classification in colon cancer. Methods: Methylation-specific multiplex ligation-dependent probe amplification (MS-MLPA), with subsequent fragment analysis, was used to investigate methylation of tumour samples. In total, 31 CpG sites, located in 8 different genes (RUNX3, MLH1, NEUROG1, CDKN2A, IGF2, CRABP1, SOCS1 and CACNA1G) were investigated in 64 distinct colon cancers and 2 colon cancer cell lines. The Ogino gene panel includes all 8 genes, in addition to the Weisenberger panel of which only 5 of the 8 genes included were investigated. In total, 18 alternative combinations of scoring of CIMP positivity on probe-, gene-, and panel-level were analysed and compared. Results: For 47 samples (71%), the CIMP status was constant and independent of criteria used for scoring; 34 samples were constantly scored as CIMP negative, and 13 (20%) consistently scored as CIMP positive. Only four of 31 probes (13%) investigated showed no difference in the numbers of positive samples using the different cut-offs. Within the panels a trend was observed that increasing the gene-level stringency resulted in a larger difference in CIMP positive samples than increasing the probe-level stringency. A significant difference between positive samples using 'the most stringent' as compared to 'the least stringent' criteria (20% vs 46%, respectively; p<0.005) was demonstrated. Conclusions: A statistical significant variation in the frequency of CIMP depending on the cut-offs and genes included in a panel was found, with twice as many positives samples by least compared to most stringent definition used.	[Berg, Marianne; Hagland, Hanne R.; Soreide, Kjetil] Stavanger Univ Hosp, Dept Gastrointestinal Surg, Stavanger, Norway; [Berg, Marianne] Univ Stavanger, Ctr Organelle Res, Stavanger, Norway; [Soreide, Kjetil] Univ Bergen, Dept Clin Med, Bergen, Norway	Stavanger University Hospital; Universitetet i Stavanger; University of Bergen	Soreide, K (corresponding author), Stavanger Univ Hosp, Dept Gastrointestinal Surg, Stavanger, Norway.	kjetil.soreide@sus.no	Søreide, Kjetil/A-9797-2010; Hagland, Hanne R/H-8749-2017	Søreide, Kjetil/0000-0001-7594-4354; 	Folke Hermansen Cancer Foundation [424508]; Mjaaland Cancer Fund [424506]; Stavanger University Hospital Research Council; Institute of Surgical Sciences, University of Bergen	Folke Hermansen Cancer Foundation; Mjaaland Cancer Fund; Stavanger University Hospital Research Council; Institute of Surgical Sciences, University of Bergen	This study was in part funded by grants from the Folke Hermansen Cancer Foundation (grant #424508 to K. S. for M. B. as a post-doctoral fellow) (http://www.folke-fondet.org), Mjaaland Cancer Fund (grant #424506 to K. S.), the Stavanger University Hospital Research Council and by grant funding from the Institute of Surgical Sciences, University of Bergen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashktorab H, 2013, EPIGENETICS-US, V8, P807, DOI 10.4161/epi.25497; Berg M, INTJMOLSCI, V12, P9426; deVos T, 2009, CLIN CHEM, V55, P1337, DOI 10.1373/clinchem.2008.115808; Goel A, 2012, GASTROENTEROLOGY, V143, P1442, DOI 10.1053/j.gastro.2012.09.032; Hagland HR, 2013, DIGEST SURG, V30, P12, DOI 10.1159/000347166; Heichman KA, 2012, CLIN CHEM LAB MED, V50, P1707, DOI 10.1515/cclm-2011-0935; Hinoue T, 2012, GENOME RES, V22, P271, DOI 10.1101/gr.117523.110; Hughes LA, 2013, CANC RES; Issa JP, 2004, NAT REV CANCER, V4, P988, DOI 10.1038/nrc1507; Issa JP, 2000, ANN NY ACAD SCI, V910, P140; Itzkowitz S, 2008, AM J GASTROENTEROL, V103, P2862, DOI 10.1111/j.1572-0241.2008.02088.x; Itzkowitz SH, 2007, CLIN GASTROENTEROL H, V5, P111, DOI 10.1016/j.cgh.2006.10.006; Jeuken JW, 2007, LAB INVEST, V87, P1055, DOI 10.1038/labinvest.3700664; Kaneda A, 2011, CANCER SCI, V102, P18, DOI 10.1111/j.1349-7006.2010.01712.x; Karpinski P, 2013, CANCER EPIDEM BIOMAR, V22, P201, DOI 10.1158/1055-9965.EPI-12-0157; Lange CPE, 2013, EPIGENOMICS-UK, V5, P105, DOI [10.2217/EPI.13.4, 10.2217/epi.13.4]; Lind GE, 2008, J TRANSL MED, V6, DOI 10.1186/1479-5876-6-13; Ned RM, PLOSCURR, V3; Nordgard O, 2009, INT J COLORECTAL DIS, V24, P261, DOI 10.1007/s00384-008-0613-y; Ogino S, 2007, J MOL DIAGN, V9, P305, DOI 10.2353/jmoldx.2007.060170; Ogino S, 2013, MODERN PATHOL, V26, P465, DOI 10.1038/modpathol.2012.214; Sanchez JA, 2009, BRIT J SURG, V96, P1196, DOI 10.1002/bjs.6683; Stuppia L, 2012, INT J MOL SCI, V13, P3245, DOI 10.3390/ijms13033245; Weisenberger DJ, 2006, NAT GENET, V38, P787, DOI 10.1038/ng1834	25	30	31	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2014	9	1							e86657	10.1371/journal.pone.0086657	http://dx.doi.org/10.1371/journal.pone.0086657			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297GT	24466191	Green Published, gold, Green Submitted			2022-12-25	WOS:000330244500269
J	Da-Re, C; Franzolin, E; Biscontin, A; Piazzesi, A; Pacchioni, B; Gagliani, MC; Mazzotta, G; Tacchetti, C; Zordan, MA; Zeviani, M; Bernardi, P; Bianchi, V; De Pitta, C; Costa, R				Da-Re, Caterina; Franzolin, Elisa; Biscontin, Alberto; Piazzesi, Antonia; Pacchioni, Beniamina; Gagliani, Maria Cristina; Mazzotta, Gabriella; Tacchetti, Carlo; Zordan, Mauro A.; Zeviani, Massimo; Bernardi, Paolo; Bianchi, Vera; De Pitta, Cristiano; Costa, Rodolfo			Functional Characterization of drim2, the Drosophila melanogaster Homolog of the Yeast Mitochondrial Deoxynucleotide Transporter	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Drosophila; Mitochondria; Mitochondrial DNA; Mitochondrial Transport; Nucleotide	PYRIMIDINE NUCLEOTIDE CARRIER; THYMIDYLATE BIOSYNTHESIS PATHWAY; CULTURED HUMAN-CELLS; SACCHAROMYCES-CEREVISIAE; GENE-EXPRESSION; NERVOUS-SYSTEM; DNA; IDENTIFICATION; REPLICATION; TRIPHOSPHATES	Background: Carrier-mediated influx of cytosolic deoxynucleotides is a major source of precursors for mitochondrial DNA synthesis. Results: dRIM2 is required to maintain normal deoxynucleotide pools in Drosophila mitochondria, and its knock-out is lethal at the larval stage. Conclusion: dRIM2 is a deoxynucleotide carrier and is essential to maintain mitochondrial function. Significance: Our data provide the first animal model of RIM2 deficiency. The CG18317 gene (drim2) is the Drosophila melanogaster homolog of the Saccharomyces cerevisiae Rim2 gene, which encodes a pyrimidine (deoxy)nucleotide carrier. Here, we tested if the drim2 gene also encodes for a deoxynucleotide transporter in the fruit fly. The protein was localized to mitochondria. Drosophila S2R(+) cells, silenced for drim2 expression, contained markedly reduced pools of both purine and pyrimidine dNTPs in mitochondria, whereas cytosolic pools were unaffected. In vivo drim2 homozygous knock-out was lethal at the larval stage, preceded by the following: (i) impaired locomotor behavior; (ii) decreased rates of oxygen consumption, and (iii) depletion of mtDNA. We conclude that the Drosophila mitochondrial carrier dRIM2 transports all DNA precursors and is essential to maintain mitochondrial function.	[Da-Re, Caterina; Franzolin, Elisa; Biscontin, Alberto; Piazzesi, Antonia; Mazzotta, Gabriella; Zordan, Mauro A.; Bianchi, Vera; De Pitta, Cristiano; Costa, Rodolfo] Univ Padua, Dept Biol, I-35131 Padua, Italy; [Pacchioni, Beniamina] Univ Padua, CRIBI Biotechnol Ctr, I-35131 Padua, Italy; [Gagliani, Maria Cristina; Tacchetti, Carlo] Univ Genoa, Dept Expt Med, MicroScoBio Res Ctr, I-16132 Genoa, Italy; [Zeviani, Massimo] Univ Cambridge, MRC Mitocondrial Biol Unit, Cambridge CB2 0XY, England; [Bernardi, Paolo] Univ Padua, Dept Biomed Sci, I-35131 Padua, Italy; [Tacchetti, Carlo] Ist Sci San Raffaele, Expt Imaging Ctr, I-20132 Milan, Italy	University of Padua; University of Padua; University of Genoa; University of Cambridge; University of Padua; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele	De Pitta, C (corresponding author), Univ Padua, Dept Biol, Viale Giuseppe Colombo 3, I-35121 Padua, Italy.	cristiano.depitta@unipd.it; rodolfo.costa@unipd.it	De Pitta, Cristiano/AAY-7302-2020; Zeviani, Massimo/K-2891-2014; Zeviani, Massimo/AAU-2632-2021; Bernardi, Paolo/C-3656-2008; Piazzesi, Antonia/AAA-7971-2022	De Pitta, Cristiano/0000-0001-8013-8162; Zeviani, Massimo/0000-0002-9067-5508; Bernardi, Paolo/0000-0001-9187-3736; Piazzesi, Antonia/0000-0002-7591-6473; MAZZOTTA, GABRIELLA MARGHERITA/0000-0001-5461-6837; TACCHETTI, CARLO/0000-0003-4602-000X; gagliani, maria cristina/0000-0002-2902-2719; Biscontin, Alberto/0000-0003-1492-7715	University of Padova Progetto Strategico di Ateneo; Fondazione CARIPLO-Scientific Research in Biomedicine; Telethon Project [GGP11011]; Italian Telethon [GGP09019]; Italian Association for Cancer Research [1091, 12035]; Fondazione Compagnia di San Paolo; Telethon Program [GPP10005]; MRC [MC_UP_1002/1] Funding Source: UKRI; Medical Research Council [MC_UP_1002/1] Funding Source: researchfish	University of Padova Progetto Strategico di Ateneo; Fondazione CARIPLO-Scientific Research in Biomedicine; Telethon Project(Fondazione Telethon); Italian Telethon(Fondazione Telethon); Italian Association for Cancer Research(Fondazione AIRC per la ricerca sul cancro); Fondazione Compagnia di San Paolo(Compagnia di San Paolo); Telethon Program(Fondazione Telethon); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by grants from the University of Padova Progetto Strategico di Ateneo, 2008 ("Models of Mitochondrial Diseases") (to P. B., V. B., and R. C.), Fondazione CARIPLO-Scientific Research in Biomedicine 2011 ("MITGEN, Definition and Characterization of Disease Genes in Mitochondrial Disorders") (to M. Z. and R. C.), Telethon Project GGP11011 ("MitMed, A Multicenter Consortium for the Identification and Characterization of Nuclear Genes Responsible for Human Mitochondrial Disorders") (to M. Z. and R. C.), Italian Telethon Grant GGP09019 (to V. B.), Italian Association for Cancer Research Grant 1091 (to V. B.), Italian Association for Cancer Research Grant 12035 (to C. T.), Fondazione Compagnia di San Paolo (to C. T.), and Telethon Program Project N. GPP10005 "Therapeutic Strategies to Combat Mitochondrial Disorders" (to M. Z. and P. B.).	Anderson DD, 2011, P NATL ACAD SCI USA, V108, P15163, DOI 10.1073/pnas.1103623108; Andreu AL, 2009, MITOCHONDRION, V9, P242, DOI 10.1016/j.mito.2009.02.006; BIANCHI V, 1990, TOXICOL IN VITRO, V4, P9, DOI 10.1016/0887-2333(90)90003-C; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; BRAND AH, 1993, DEVELOPMENT, V118, P401; Chabi B, 2003, CLIN CHEM, V49, P1309, DOI 10.1373/49.8.1309; del Arco A, 2005, CELL MOL LIFE SCI, V62, P2204, DOI 10.1007/s00018-005-5197-x; Eriksson S, 2002, CELL MOL LIFE SCI, V59, P1327, DOI 10.1007/s00018-002-8511-x; Favre C, 2010, ONCOGENE, V29, P3964, DOI 10.1038/onc.2010.146; Ferraro P, 2005, J BIOL CHEM, V280, P24472, DOI 10.1074/jbc.M502869200; Ferraro P, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkp1141; Flockhart IT, 2012, NUCLEIC ACIDS RES, V40, pD715, DOI 10.1093/nar/gkr953; Floyd S, 2007, MOL BIOL CELL, V18, P3545, DOI 10.1091/mbc.e06-12-1109; Franzolin E, 2012, EXP CELL RES, V318, P2226, DOI 10.1016/j.yexcr.2012.05.028; Froschauer EM, 2013, BIOCHEM J, V455, P57, DOI 10.1042/BJ20130144; Ghezzi D, 2011, NAT GENET, V43, P259, DOI 10.1038/ng.761; Haitina T, 2006, GENOMICS, V88, P779, DOI 10.1016/j.ygeno.2006.06.016; HAYWARD DC, 1993, P NATL ACAD SCI USA, V90, P2979, DOI 10.1073/pnas.90.7.2979; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Iyengar B, 1999, GENETICS, V153, P1809; Kunji ERS, 2004, FEBS LETT, V564, P239, DOI 10.1016/S0014-5793(04)00242-X; Lin HL, 2011, J BIOL CHEM, V286, P3851, DOI 10.1074/jbc.M110.190959; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MacFarlane AJ, 2011, J BIOL CHEM, V286, P44015, DOI 10.1074/jbc.M111.307629; Magnusson J, 2003, EXP CELL RES, V289, P133, DOI 10.1016/S0014-4827(03)00249-0; Marobbio CMT, 2006, BIOCHEM J, V393, P441, DOI 10.1042/BJ20051284; Mecleiros DM, 2008, METHODS, V46, P288, DOI 10.1016/j.ymeth.2008.09.026; Montier LLC, 2009, J GENET GENOMICS, V36, P125, DOI 10.1016/S1673-8527(08)60099-5; Munch-Petersen B, 1998, ADV EXP MED BIOL, V431, P465; Ni JQ, 2009, GENETICS, V182, P1089, DOI 10.1534/genetics.109.103630; Nordlund N, 2006, ANNU REV BIOCHEM, V75, P681, DOI 10.1146/annurev.biochem.75.103004.142443; Oliveira MT, 2011, J BIOL CHEM, V286, P40649, DOI 10.1074/jbc.M111.289983; Parks AL, 2004, NAT GENET, V36, P288, DOI 10.1038/ng1312; Pontarin G, 2003, P NATL ACAD SCI USA, V100, P12159, DOI 10.1073/pnas.1635259100; Pontarin G, 2012, P NATL ACAD SCI USA, V109, P13302, DOI 10.1073/pnas.1211289109; Ponton F, 2011, J INSECT PHYSIOL, V57, P840, DOI 10.1016/j.jinsphys.2011.03.014; Rabouille C, 1999, METH MOL B, V117, P125; Saeed AI, 2006, METHOD ENZYMOL, V411, P134, DOI 10.1016/S0076-6879(06)11009-5; SCHNEIDER I, 1972, J EMBRYOL EXP MORPH, V27, P353; SHERMAN PA, 1989, ANAL BIOCHEM, V180, P222, DOI 10.1016/0003-2697(89)90420-X; Thibault ST, 2004, NAT GENET, V36, P283, DOI 10.1038/ng1314; VANDYCK E, 1995, MOL GEN GENET, V246, P426, DOI 10.1007/BF00290446; von Stockum S, 2011, J BIOL CHEM, V286, P41163, DOI 10.1074/jbc.M111.268375; Vozza A, 2004, J BIOL CHEM, V279, P20850, DOI 10.1074/jbc.M313610200; Wenz T, 2013, MITOCHONDRION, V13, P134, DOI 10.1016/j.mito.2013.01.006; Wu M, 2007, AM J PHYSIOL-CELL PH, V292, pC125, DOI 10.1152/ajpcell.00247.2006; Ye J, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-134; Yoon H, 2011, BIOCHEM J, V440, P137, DOI 10.1042/BJ20111036; Zordan MA, 2006, GENETICS, V172, P229, DOI 10.1534/genetics.105.049072	49	10	11	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 14	2014	289	11					7448	7459		10.1074/jbc.M113.543926	http://dx.doi.org/10.1074/jbc.M113.543926			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AC8CV	24469456	Green Published, hybrid			2022-12-25	WOS:000332761500016
J	Lavall, D; Selzer, C; Schuster, P; Lenski, M; Adam, O; Schafers, HJ; Bohm, M; Laufs, U				Lavall, Daniel; Selzer, Christian; Schuster, Pia; Lenski, Matthias; Adam, Oliver; Schaefers, Hans-Joachim; Boehm, Michael; Laufs, Ulrich			The Mineralocorticoid Receptor Promotes Fibrotic Remodeling in Atrial Fibrillation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Fibrosis; Heart; Lysyl Oxidase; MicroRNA; Mineralocorticoid Receptor; CTGF	11-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE-2; HEART-FAILURE; CARDIAC FIBROBLASTS; GENE-EXPRESSION; ALDOSTERONE; FIBROSIS; RAC1; MECHANISMS; KINASE; HYPERTROPHY	Background: We studied the role of the mineralocorticoid receptor (MR) for atrial fibrotic remodeling. Results: Increased 11-hydroxysteroid dehydrogenase type 2 in atrial fibrillation enhances mineralocorticoid receptor pro-fibrotic signaling through connective tissue growth factor, lysyl oxidase, and microRNA-21. Conclusion: The MR regulates fibrogenesis in atrial fibrillation. Significance: The MR may represent a target for the prevention of atrial fibrosis. We studied the role of the mineralocorticoid receptor (MR) in the signaling that promotes atrial fibrosis. Left atrial myocardium of patients with atrial fibrillation (AF) exhibited 4-fold increased hydroxyproline content compared with patients in sinus rhythm. Expression of MR was similar, as was 11-hydroxysteroid dehydrogenase type 2 (11-HSD2), which also increased. 11-HSD2 converts cortisol to receptor-inactive metabolites allowing aldosterone occupancy of MR. 11-HSD2 was up-regulated by arrhythmic pacing in cultured cardiomyocytes and in a mouse model of spontaneous AF (RacET). In cardiomyocytes, aldosterone induced connective tissue growth factor (CTGF) in the absence but not in the presence of cortisol. Hydroxyproline expression was increased in cardiac fibroblasts exposed to conditioned medium from aldosterone-treated cardiomyocytes but not from cardiomyocytes treated with both cortisol and aldosterone. Aldosterone increased connective tissue growth factor and hydroxyproline expression in cardiac fibroblasts, which were prevented by BR-4628, a dihydropyridine-derived selective MR antagonist, and by spironolactone. Aldosterone activated RhoA GTPase. Rho kinase inhibition by Y-27632 prevented CTGF and hydroxyproline, whereas the RhoA activator CN03 increased CTGF expression. Aldosterone and CTGF increased lysyl oxidase, and aldosterone enhanced miR-21 expression. MR antagonists reduced the aldosterone but not the CTGF effect. In conclusion, MR signaling promoted fibrotic remodeling. Increased expression of 11-HSD2 during AF leads to up-regulation of collagen and pro-fibrotic mediators by aldosterone, specifically RhoA activity as well as CTGF, lysyl oxidase, and microRNA-21 expression. The MR antagonists BR-4628 and spironolactone prevent these alterations. MR inhibition may, therefore, represent a potential pharmacologic target for the prevention of fibrotic remodeling of the atrial myocardium.	[Lavall, Daniel; Selzer, Christian; Schuster, Pia; Lenski, Matthias; Adam, Oliver; Boehm, Michael; Laufs, Ulrich] Univ Klinikum Saarlandes, Klin Innere Med Kardiol Angiol & Internist Intens, D-66421 Homburg, Germany; [Schaefers, Hans-Joachim] Univ Klinikum Saarlandes, Klin Thorax & Herz Gefasschirurg, D-66421 Homburg, Germany	Universitatsklinikum des Saarlandes; Universitatsklinikum des Saarlandes	Lavall, D (corresponding author), Univ Klinikum Saarlandes, Klin Innere Med Kardiol Angiol & Internist Intens, Kirrberger Str, D-66421 Homburg, Germany.	daniel.lavall@uks.eu	Böhm, Michael/C-3638-2011	Lavall, Daniel/0000-0002-7932-212X	Universitat des Saarlandes; Bayer Pharma AG; Deutsche Forschungsgemeinschaft DFG [KFO 196, AD 455/1-1]	Universitat des Saarlandes; Bayer Pharma AG; Deutsche Forschungsgemeinschaft DFG(German Research Foundation (DFG))	This work was supported by the Universitat des Saarlandes, an unrestricted grant from Bayer Pharma AG to the Universitat des Saarlandes and by the Deutsche Forschungsgemeinschaft DFG (KFO 196, AD 455/1-1).	Adam O, 2007, J AM COLL CARDIOL, V50, P359, DOI 10.1016/j.jacc.2007.03.041; Adam O, 2012, BASIC RES CARDIOL, V107, DOI 10.1007/s00395-012-0278-0; Adam O, 2011, J MOL CELL CARDIOL, V50, P678, DOI 10.1016/j.yjmcc.2010.12.019; Adam O, 2010, J AM COLL CARDIOL, V55, P469, DOI 10.1016/j.jacc.2009.08.064; Azibani F, 2012, HYPERTENSION, V59, P1179, DOI 10.1161/HYPERTENSIONAHA.111.190512; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Briet M, 2010, NAT REV NEPHROL, V6, P261, DOI 10.1038/nrneph.2010.30; Burstein B, 2008, J AM COLL CARDIOL, V51, P802, DOI 10.1016/j.jacc.2007.09.064; Cardin S, 2012, CIRC-ARRHYTHMIA ELEC, V5, P1027, DOI 10.1161/CIRCEP.112.973214; Chen H, 2004, PHYSIOL GENOMICS, V18, P273, DOI 10.1152/physiolgenomics.00104.2004; Custodis F, 2006, CARDIOVASC RES, V71, P342, DOI 10.1016/j.cardiores.2006.04.005; Davies SP, 2000, BIOCHEM J, V351, P95, DOI 10.1042/0264-6021:3510095; Dobrev D, 2012, NAT REV DRUG DISCOV, V11, P275, DOI 10.1038/nrd3682; Fagart J, 2010, J BIOL CHEM, V285, P29932, DOI 10.1074/jbc.M110.131342; Flatau G, 1997, NATURE, V387, P729, DOI 10.1038/42743; Funder JW, 2009, HYPERTENSION, V53, P286, DOI 10.1161/HYPERTENSIONAHA.108.119966; GRILLO C, 1990, J STEROID BIOCHEM, V35, P11, DOI 10.1016/0022-4731(90)90138-I; Harris BS, 2011, AM J PHYSIOL-HEART C, V301, pH841, DOI 10.1152/ajpheart.01247.2010; He YH, 2011, CLIN EXP PHARMACOL P, V38, P739, DOI 10.1111/j.1440-1681.2011.05581.x; Jiang DP, 2008, EUR J APPL PHYSIOL, V103, P489, DOI 10.1007/s00421-008-0733-7; Kadereit B, 2005, J AM SOC NEPHROL, V16, P3507, DOI 10.1681/ASN.2005010108; KAGAN HM, 1991, AM J RESP CELL MOL, V5, P206, DOI 10.1165/ajrcmb/5.3.206; Klusonova P, 2009, ENDOCRINOLOGY, V150, P4270, DOI 10.1210/en.2008-1493; Koitabashi N, 2007, HYPERTENSION, V49, P1120, DOI 10.1161/HYPERTENSIONAHA.106.077537; Laufs U, 2002, CARDIOVASC RES, V53, P911, DOI 10.1016/S0008-6363(01)00540-5; Lip GYH, 2012, LANCET, V379, P648, DOI 10.1016/S0140-6736(11)61514-6; Lother A, 2011, HYPERTENSION, V57, P746, DOI 10.1161/HYPERTENSIONAHA.110.163287; McCurdy S, 2010, J MOL CELL CARDIOL, V48, P544, DOI 10.1016/j.yjmcc.2009.06.018; Mu YB, 2012, CELL TISSUE RES, V347, P11, DOI 10.1007/s00441-011-1201-y; Nattel S, 2008, CIRC-ARRHYTHMIA ELEC, V1, P62, DOI 10.1161/CIRCEP.107.754564; Odermatt A, 2012, MOL CELL ENDOCRINOL, V350, P168, DOI 10.1016/j.mce.2011.07.020; Odermatt A, 2009, STEROIDS, V74, P163, DOI 10.1016/j.steroids.2008.10.010; Pei DA, 2010, CLIN CARDIOL, V33, P23, DOI 10.1002/clc.20689; Pitt B, 2003, NEW ENGL J MED, V348, P1309, DOI 10.1056/NEJMoa030207; Pitt B, 1999, NEW ENGL J MED, V341, P709, DOI 10.1056/NEJM199909023411001; Reil JC, 2012, EUR HEART J, V33, P2098, DOI 10.1093/eurheartj/ehr266; Reil JC, 2010, CARDIOVASC RES, V87, P485, DOI 10.1093/cvr/cvq079; Sun GP, 2006, J AM SOC NEPHROL, V17, P2193, DOI 10.1681/ASN.2005121375; Sussman MA, 2000, J CLIN INVEST, V105, P875, DOI 10.1172/JCI8497; Swedberg K, 2012, J AM COLL CARDIOL, V59, P1598, DOI 10.1016/j.jacc.2011.11.063; Thum T, 2008, NATURE, V456, P980, DOI 10.1038/nature07511; TOVAR O, 1992, AM J PHYSIOL, V263, pH1128, DOI 10.1152/ajpheart.1992.263.4.H1128; Tsai CT, 2010, J AM COLL CARDIOL, V55, P758, DOI 10.1016/j.jacc.2009.09.045; van Beek JP, 2004, J CLIN ENDOCR METAB, V89, P5614, DOI 10.1210/jc.2004-0113; Wang ZG, 2011, CARDIOVASC RES, V89, P710, DOI 10.1093/cvr/cvq350; Weber KT, 2001, NEW ENGL J MED, V345, P1689, DOI 10.1056/NEJMra000050; YOUNG M, 1994, J CLIN INVEST, V93, P2578, DOI 10.1172/JCI117269; Zannad F, 2011, NEW ENGL J MED, V364, P11, DOI 10.1056/NEJMoa1009492; Zhou GP, 1996, MOL CELL BIOCHEM, V154, P171, DOI 10.1007/BF00226785	49	80	84	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 7	2014	289	10					6656	6668		10.1074/jbc.M113.519256	http://dx.doi.org/10.1074/jbc.M113.519256			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AC3BG	24469458	Green Published, hybrid			2022-12-25	WOS:000332389400029
J	Brim, H; Abu-Asab, MS; Nouraie, M; Salazar, J; DeLeo, J; Razjouyan, H; Mokarram, P; Schaffer, AA; Naghibhossaini, F; Ashktorab, H				Brim, Hassan; Abu-Asab, Mones S.; Nouraie, Mehdi; Salazar, Jose; DeLeo, Jim; Razjouyan, Hadi; Mokarram, Pooneh; Schaffer, Alejandro A.; Naghibhossaini, Fakhraddin; Ashktorab, Hassan			An Integrative CGH, MSI and Candidate Genes Methylation Analysis of Colorectal Tumors	PLOS ONE			English	Article							CANCER DCC GENE; MICROSATELLITE INSTABILITY; COLON-CANCER; CLINICOPATHOLOGICAL FEATURES; CHROMOSOMAL INSTABILITY; SUPPRESSOR GENES; ABNORMALITIES; MUTATIONS; BREAST; HEREDITARY	Background: Different DNA aberrations processes can cause colorectal cancer (CRC). Herein, we conducted a comprehensive molecular characterization of 27 CRCs from Iranian patients. Materials and Methods: Array CGH was performed. The MSI phenotype and the methylation status of 15 genes was established using MSP. The CGH data was compared to two established lists of 41 and 68 cancer genes, respectively, and to CGH data from African Americans. A maximum parsimony cladogram based on global aberrations was established. Results: The number of aberrations seem to depend on the MSI status. MSI-H tumors displayed the lowest number of aberrations. MSP revealed that most markers were methylated, except RNF182 gene. P16 and MLH1 genes were primarily methylated in MSI-H tumors. Seven markers with moderate to high frequency of methylation (SYNE1, MMP2, CD109, EVL, RET, LGR and PTPRD) had very low levels of chromosomal aberrations. All chromosomes were targeted by aberrations with deletions more frequent than amplifications. The most amplified markers were CD248, ERCC6, ERGIC3, GNAS, MMP2, NF1, P2RX7, SFRS6, SLC29A1 and TBX22. Most deletions were noted for ADAM29, CHL1, CSMD3, FBXW7, GALNS, MMP2, NF1, PRKD1, SMAD4 and TP53. Aberrations targeting chromosome X were primarily amplifications in male patients and deletions in female patients. A finding similar to what we reported for African American CRC patients. Conclusion: This first comprehensive analysis of CRC Iranian tumors reveals a high MSI rate. The MSI tumors displayed the lowest level of chromosomal aberrations but high frequency of methylation. The MSI-L were predominantly targeted with chromosomal instability in a way similar to the MSS tumors. The global chromosomal aberration profiles showed many similarities with other populations but also differences that might allow a better understanding of CRC's clinico-pathological specifics in this population.	[Brim, Hassan; Nouraie, Mehdi; Ashktorab, Hassan] Howard Univ, Coll Med, Med & Canc Ctr, Dept Pathol, Washington, DC 20059 USA; [Abu-Asab, Mones S.; Salazar, Jose] NEI, Histopathol Core, NIH, Bethesda, MD 20892 USA; [DeLeo, Jim] NIH, Sect Biomed Comp, Ctr Clin, Bethesda, MD 20892 USA; [Razjouyan, Hadi] Drexel Univ, Coll Med, Monmouth Med Ctr, Dept Med, Long Branch, NJ USA; [Mokarram, Pooneh; Naghibhossaini, Fakhraddin] Shiraz Univ Med Sci, Dept Biochem, Shiraz, Iran; [Schaffer, Alejandro A.] NIH, Natl Ctr Biotechnol Informat, Natl Lib Med, Bethesda, MD USA	Howard University; National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI); National Institutes of Health (NIH) - USA; NIH Clinical Center (CC); Drexel University; Shiraz University of Medical Science; National Institutes of Health (NIH) - USA; NIH National Library of Medicine (NLM)	Brim, H (corresponding author), Howard Univ, Coll Med, Med & Canc Ctr, Dept Pathol, Washington, DC 20059 USA.	hbrim@howard.edu; hashktorab@howard.edu	Nouraie, Seyed Mehdi/O-4071-2018; Mokarram, Pooneh/E-1613-2012; Schaffer, Alejandro/N-1222-2019; Schaffer, Alejandro A/F-2902-2012; Ashktorab, hassan/AAJ-2908-2020; Naghibalhossaini, Fakhraddin/I-1650-2018	Nouraie, Seyed Mehdi/0000-0001-7465-0581; Mokarram, Pooneh/0000-0002-9717-0473; Naghibalhossaini, Fakhraddin/0000-0003-4573-502X	National Cancer Institute (NCI), National Institutes of Health (NIH); Intramural Research Program of the NIH, NCI; National Library of Medicine; Research Centers in Minority Institutions (RCMI);  [CA102681]; NATIONAL CANCER INSTITUTE [R01CA102681] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [ZIALM000097] Funding Source: NIH RePORTER	National Cancer Institute (NCI), National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Intramural Research Program of the NIH, NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Library of Medicine(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); Research Centers in Minority Institutions (RCMI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	This work was supported by Grant #CA102681, funded by the National Cancer Institute (NCI), National Institutes of Health (NIH), by the Intramural Research Program of the NIH, NCI and National Library of Medicine, and by Research Centers in Minority Institutions (RCMI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AALTONEN LA, 1993, SCIENCE, V260, P812, DOI 10.1126/science.8484121; Abu-Asab M, 2012, FORSCH KOMPLEMENTMED, V19, P42, DOI 10.1159/000335190; Alt FW, 2013, CELL, V152, P417, DOI 10.1016/j.cell.2013.01.007; Ashktorab H, 2005, INT J CANCER, V116, P914, DOI 10.1002/ijc.21062; Ashktorab H, 2003, CLIN CANCER RES, V9, P1112; Ashktorab H, 2013, NOVEL MUTATION HYPOM; Ashktorab H, 2011, GASTROENTEROLOGY, V138, P304; Ashktorab H, 2008, GASTROENTEROLOGY, P134; Ashktorab H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008879; Ashktorab H, 2009, DIGEST DIS SCI, V54, P1985, DOI 10.1007/s10620-009-0866-5; BARDI G, 1995, GENE CHROMOSOME CANC, V12, P97, DOI 10.1002/gcc.2870120204; Boland CR, 2010, GASTROENTEROLOGY, V138, P2073, DOI [10.1053/j.gastro.2009.12.064, 10.1053/j.gastro.2010.04.024]; BOMME L, 1994, GENE CHROMOSOME CANC, V10, P190, DOI 10.1002/gcc.2870100307; Brim H, 2012, PLOS ONE IN PRESS; Brim H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020216; Brim H, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-68; Buffart TE, 2012, ONCOLOGIST, V17, P653, DOI 10.1634/theoncologist.2010-0379; Camps J, 2006, CARCINOGENESIS, V27, P419, DOI 10.1093/carcin/bgi244; Carethers JM, 2011, GASTROENTEROLOGY; Cheng Y, 2012, LAB INVEST; Derks S, 2009, CARCINOGENESIS, V30, P1041, DOI 10.1093/carcin/bgp073; FEARON ER, 1990, CELL, V61, P759, DOI 10.1016/0092-8674(90)90186-I; Fleming NI, 2013, CANCER RES, V73, P725, DOI 10.1158/0008-5472.CAN-12-2706; Goel A, 2003, CANCER RES, V63, P1608; GRAZIANO SL, 1991, GENE CHROMOSOME CANC, V3, P283, DOI 10.1002/gcc.2870030407; He QJ, 2003, CANCER GENET CYTOGEN, V144, P112, DOI 10.1016/S0165-4608(02)00959-7; IONOV Y, 1993, NATURE, V363, P558, DOI 10.1038/363558a0; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Kim A, 2012, J BREAST CANCER, V15, P24, DOI 10.4048/jbc.2012.15.1.24; Krig SR, 2010, ONCOGENE, V29, P5500, DOI 10.1038/onc.2010.289; Krzyminska A, 2011, ENDOKRYNOL POL, V62, P224; Kumar K, 2009, CLIN CANC R IN PRESS, P68; Kumar K, 2009, CAN1 GENE METHYLATIO; Lassmann S, 2007, J MOL MED-JMM, V85, P289, DOI 10.1007/s00109-006-0126-5; Lengauer C, 1998, NATURE, V396, P643, DOI 10.1038/25292; Markowitz S, 2000, J CLIN ONCOL, V18, p75S; Mokarram P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007012; MULERIS M, 1995, GENE CHROMOSOME CANC, V14, P223, DOI 10.1002/gcc.2870140312; Niyaz M, 2012, MOL MED REP; Nouraie M, 2010, DIGEST DIS SCI, V55, P1442, DOI 10.1007/s10620-010-1133-5; O'Boyle K, 2003, CANCER INVEST, V21, P484, DOI 10.1081/CNV-120018241; Park HD, 2013, AM J MED GENET A, V161A, P509, DOI 10.1002/ajmg.a.35298; Ried T, 1996, GENE CHROMOSOME CANC, V15, P234, DOI 10.1002/(SICI)1098-2264(199604)15:4<234::AID-GCC5>3.0.CO;2-2; Seldin MF, 2011, NAT REV GENET, V12, P523, DOI 10.1038/nrg3002; Shimizu A, 2003, BIOCHEM BIOPH RES CO, V309, P143, DOI 10.1016/S0006-291X(03)01555-9; Simon R, 2001, CANCER RES, V61, P4514; Sjoblom T, 2006, SCIENCE, V314, P268, DOI 10.1126/science.1133427; Tang RP, 2004, CARCINOGENESIS, V25, P841, DOI 10.1093/carcin/bgh074; Trautmann K, 2006, CLIN CANCER RES, V12, P6379, DOI 10.1158/1078-0432.CCR-06-1248; Tsafrir D, 2006, CANCER RES, V66, P2129, DOI 10.1158/0008-5472.CAN-05-2569; Vasconcelos DS, 2013, GENET MOL RES, V12, P2594, DOI 10.4238/2013.January.4.15; Vogelstein B, 2013, SCIENCE, V339, P1546, DOI 10.1126/science.1235122; Wang JB, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-74; Wang ZH, 2004, CANCER RES, V64, P2998, DOI 10.1158/0008-5472.CAN-04-0587; Yu YP, 2012, AM J PATHOL, V180, P2240, DOI 10.1016/j.ajpath.2012.03.008; Zhang LY, 2013, J BIOL CHEM, V288, P4035, DOI 10.1074/jbc.M112.410506; Zhao J, 2013, MED ONCOL, V30, DOI 10.1007/s12032-013-0465-3	57	21	24	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2014	9	1							e82185	10.1371/journal.pone.0082185	http://dx.doi.org/10.1371/journal.pone.0082185			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301BI	24475022	Green Published, gold, Green Submitted			2022-12-25	WOS:000330507300008
J	Kastberger, G; Hoetzl, T; Maurer, M; Kranner, I; Weiss, S; Weihmann, F				Kastberger, Gerald; Hoetzl, Thomas; Maurer, Michael; Kranner, Ilse; Weiss, Sara; Weihmann, Frank			Speeding Up Social Waves. Propagation Mechanisms of Shimmering in Giant Honeybees	PLOS ONE			English	Article							COLLECTIVE BEHAVIOR; COLONY DEFENSE; DORSATA; MOTION	Shimmering is a defence behaviour in giant honeybees (Apis dorsata), whereby bees on the nest surface flip their abdomen upwards in a Mexican wave-like process. However, information spreads faster than can be ascribed to bucket bridging, which is the transfer of information from one individual to an adjacent one. We identified a saltatoric process that speeds up shimmering by the generation of daughter waves, which subsequently merge with the parental wave, producing a new wave front. Motion patterns of individual "focus'' bees (n = 10,894) and their shimmering-active neighbours (n = 459,558) were measured with high-resolution video recording and stereoscopic imaging. Three types of shimmering-active surface bees were distinguished by their communication status, termed "agents'': "Bucket-bridging'' agents comprised 74.98% of all agents, affected 88.17% of their neighbours, and transferred information at a velocity of v = 0.317 +/- 0.015 m/s. "Chain-tail'' agents comprised 9.20% of the agents, were activated by 6.35% of their neighbours, but did not motivate others to participate in the wave. "Generator agents'' comprised 15.82% of agents, showed abdominal flipping before the arrival of the main wave front, and initiated daughter waves. They affected 6.75% of their neighbourhood and speeded up the compound shimmering process compared to bucket bridging alone by 41.5% to v = 0.514 +/- 0.019 m/s. The main direction of shimmering was reinforced by 35.82% of agents, whereas the contribution of the complementing agents was fuzzy. We discuss that the saltatoric process could enable the bees to instantly recruit larger cohorts to participate in shimmering and to respond rapidly to changes in flight direction of preying wasps. A third, non-exclusive explanation is that at a distance of up to three metres from the nest the acceleration of shimmering could notably contribute to the startle response in mammals and birds.	[Kastberger, Gerald; Hoetzl, Thomas; Weiss, Sara; Weihmann, Frank] Graz Univ, Inst Zool, A-8010 Graz, Austria; [Maurer, Michael] Graz Univ Technol, Inst Comp Graph & Vis, A-8010 Graz, Austria; [Kranner, Ilse] Univ Innsbruck, Inst Bot, A-6020 Innsbruck, Austria	University of Graz; Graz University of Technology; University of Innsbruck	Kastberger, G (corresponding author), Graz Univ, Inst Zool, A-8010 Graz, Austria.	gerald.kastberger@uni-graz.at	Kranner, Ilse/B-1039-2011	Kranner, Ilse/0000-0003-4959-9109	Austrian Science Fund (FWF) [P 20515-B16]	Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	Funding for the paper was granted by the Austrian Science Fund (FWF Project P 20515-B16, entitled "Social waves in giant honeybees''). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcock J., 2005, ANIMAL BEHAV; An G, 2009, WIRES SYST BIOL MED, V1, P159, DOI 10.1002/wsbm.45; Ballerini M, 2008, P NATL ACAD SCI USA, V105, P1232, DOI 10.1073/pnas.0711437105; Ballerini M, 2011, ANIM BEHAV, V76, P201; Beni G., 1989, P NATO ADV WORKSH RO; Bonabeau E, 1999, SWARM INTELLIGENCE N; BUTLER CG, 1954, WORLD HONEYBEE; Camazine S., 2003, SELF ORG BIOL SYSTEM; Couzin ID, 2005, NATURE, V433, P513, DOI 10.1038/nature03236; Couzin ID, 2003, ADV STUD BEHAV, V32, P1, DOI 10.1016/S0065-3454(03)01001-5; Cressey D, 2011, NATURE NEWS BLOG; Downer J, 2012, PEREGRINE FALCON HUN; Droll JA, 2011, THINK FAST VELOCITY, V17; Farkas I, 2002, NATURE, V419, P131, DOI 10.1038/419131a; Gerlotto F, 2006, ICES J MAR SCI, V63, P1405, DOI 10.1016/j.icesjms.2006.04.023; GOODWIN B, 2001, LEOPARD CHANGED ITS; Grasse P. P., 1959, Insectes Sociaux Paris, V6, P41, DOI 10.1007/BF02223791; HAMILTON WD, 1971, J THEOR BIOL, V31, P295, DOI 10.1016/0022-5193(71)90189-5; Hildenbrandt H, 2010, BEHAV ECOL, V21, P1349, DOI 10.1093/beheco/arq149; Hoffmann T, 2011, SPREEUWENSPEKTAKEL H; Holthuijsen L.H., 2007, WAVES OCEANIC COASTA, DOI DOI 10.1017/CBO9780511618536; Itti L, 2001, OPT ENG, V40, P1784, DOI 10.1117/1.1389063; Johnson SB, 2001, CONNECTED LIVES ANTS; Kastberger G, 1998, ETHOLOGY, V104, P27, DOI 10.1111/j.1439-0310.1998.tb00027.x; Kastberger G, 1999, NATL GEOGRAPHIC; Kastberger G, 2013, NATURWISSENSCH UNPUB; Kastberger G, 2013, NATURWISSENSCHAFTEN, V100, P595, DOI 10.1007/s00114-013-1056-z; Kastberger G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036736; Kastberger G, 2011, FRONT ZOOL, V8, DOI 10.1186/1742-9994-8-3; Kastberger G, 2011, HONEYBEES OF ASIA, P397, DOI 10.1007/978-3-642-16422-4_18; Kastberger G, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003141; Kauffman S, 1993, ORIGINS ORDER SELF O; LANDEAU L, 1986, ANIM BEHAV, V34, P1372, DOI 10.1016/S0003-3472(86)80208-1; LINDAUER M, 1956, Z VERGL PHYSIOL, V38, P521, DOI 10.1007/BF00341108; Mason Z., 2002, P ICAL 2003 8 INT C, P371; Morse R.A, 1969, PHILIPPINE ASS ENTOM, V1, P1; Olson P. L., 1996, FORENSIC ASPECTS DRI; Parrish JK, 1999, SCIENCE, V284, P99, DOI 10.1126/science.284.5411.99; Parrish JK, 2005, SELF ORG EVOLUTION S; Phillips O.M., 1977, DYNAMICS UPPER OCEAN, V2nd ed.; POTTS WK, 1984, NATURE, V309, P344, DOI 10.1038/309344a0; Procaccini A, 2011, ANIM BEHAV, V82, P759, DOI 10.1016/j.anbehav.2011.07.006; Reynolds C.W., 1987, P 14 ANN C COMPUTER, V21, P25, DOI DOI 10.1145/37402.37406; ROEPKE W., 1930, Mededelingen van de Landbouwhogeschool, V34, P1; Schmelzer E, 2009, NATURWISSENSCHAFTEN, V96, P1431, DOI 10.1007/s00114-009-0605-y; SEELEY TD, 1982, ECOL MONOGR, V52, P43, DOI 10.2307/2937344; Simons DJ, 1999, PERCEPTION, V28, P1059, DOI 10.1068/p2952; VIRMANI S, 1989, IEEE T POWER SYST, V4, P1373, DOI 10.1109/59.41687; Weihmann Frank, 2012, Insects, V3, P833, DOI 10.3390/insects3030833; Woyke J, 2008, J INSECT BEHAV, V21, P481, DOI 10.1007/s10905-008-9144-1; Zitterbart DP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020260; Zupanc GKH, 2010, BEHAV NEUROBIOLOGY I	52	7	7	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2014	9	1							e86315	10.1371/journal.pone.0086315	http://dx.doi.org/10.1371/journal.pone.0086315			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301BI	24475104	gold, Green Published, Green Submitted			2022-12-25	WOS:000330507300053
J	Thavagnanam, S; Parker, JC; McBrien, ME; Skibinski, G; Shields, MD; Heaney, LG				Thavagnanam, Surendran; Parker, Jeremy C.; McBrien, Michael E.; Skibinski, Grzegorz; Shields, Michael D.; Heaney, Liam G.			Nasal Epithelial Cells Can Act as a Physiological Surrogate for Paediatric Asthma Studies	PLOS ONE			English	Article							ALLERGIC RHINITIS; GENE-EXPRESSION; IL-13; CULTURE; KINASE; GAMMA; DIFFERENTIATION; HYPERPLASIA; RECEPTOR; RELEASE	Introduction: Differentiated paediatric epithelial cells can be used to study the role of epithelial cells in asthma. Nasal epithelial cells are easier to obtain and may act as a surrogate for bronchial epithelium in asthma studies. We assessed the suitability of nasal epithelium from asthmatic children to be a surrogate for bronchial epithelium using air-liquid interface cultures. Methods: Paired nasal and bronchial epithelial cells from asthmatic children (n = 9) were differentiated for 28 days under unstimulated and IL-13-stimulated conditions. Morphological and physiological markers were analysed using immunocytochemistry, transepithelial-electrical-resistance, Quantitative Real-time-PCR, ELISA and multiplex cytokine/chemokine analysis. Results: Physiologically, nasal epithelial cells from asthmatic children exhibit similar cytokine responses to stimulation with IL-13 compared with paired bronchial epithelial cells. Morphologically however, nasal epithelial cells differed significantly from bronchial epithelial cells from asthmatic patients under unstimulated and IL-13-stimulated conditions. Nasal epithelial cells exhibited lower proliferation/differentiation rates and lower percentages of goblet and ciliated cells when unstimulated, while exhibiting a diminished and varied response to IL-13. Conclusions: We conclude that morphologically, nasal epithelial cells would not be a suitable surrogate due to a significantly lower rate of proliferation and differentiation of goblet and ciliated cells. Physiologically, nasal epithelial cells respond similarly to exogenous stimulation with IL-13 in cytokine production and could be used as a physiological surrogate in the event that bronchial epithelial cells are not available.	[Parker, Jeremy C.; Skibinski, Grzegorz; Shields, Michael D.; Heaney, Liam G.] Queens Univ Belfast, Ctr Infect & Immun, Belfast, Antrim, North Ireland; [McBrien, Michael E.] Royal Victoria Hosp, Belfast Hlth & Social Care Trust, Dept Anaesthet, Belfast BT12 6BA, Antrim, North Ireland; [Shields, Michael D.] Royal Victoria Hosp, Belfast Hlth & Social Care Trust, Dept Paediat, Belfast BT12 6BA, Antrim, North Ireland; [Thavagnanam, Surendran] Univ Malaya, Med Ctr, Dept Paediat, Kuala Lumpur, Malaysia	Queens University Belfast; Universiti Malaya	Shields, MD (corresponding author), Queens Univ Belfast, Ctr Infect & Immun, Belfast, Antrim, North Ireland.	m.shields@qub.ac.uk		thavagnanam, surendran/0000-0002-4414-7915	Northern Ireland Chest Heart and Stroke Association; Irish Thoracic Soceity/Boehringer Ingleheim Fellowship; Public Health Agency [RRG/3244/05] Funding Source: researchfish	Northern Ireland Chest Heart and Stroke Association; Irish Thoracic Soceity/Boehringer Ingleheim Fellowship; Public Health Agency	This study was funded by Northern Ireland Chest Heart and Stroke Association and Surendran Thavagnanam was employed on an Irish Thoracic Soceity/Boehringer Ingleheim Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akdis M, 2011, J ALLERGY CLIN IMMUN, V127, P701, DOI 10.1016/j.jaci.2010.11.050; Atherton HC, 2003, AM J PHYSIOL-LUNG C, V285, pL730, DOI 10.1152/ajplung.00089.2003; Bousquet J, 2003, ALLERGY, V58, P691, DOI 10.1034/j.1398-9995.2003.00105.x; Brozek JL, 2010, J ALLERGY CLIN IMMUN, V126, P466, DOI 10.1016/j.jaci.2010.06.047; Cookson W, 2004, NAT REV IMMUNOL, V4, P978, DOI 10.1038/nri1500; Coyle PV, 2004, BMC MICROBIOL, V4, DOI 10.1186/1471-2180-4-41; de Boer WI, 2008, CAN J PHYSIOL PHARM, V86, P105, DOI [10.1139/Y08-004, 10.1139/y08-004]; Denker BM, 1998, AM J PHYSIOL-RENAL, V274, pF1, DOI 10.1152/ajprenal.1998.274.1.F1; DEVALIA JL, 1991, ALLERGY PROC, V12, P71, DOI 10.2500/108854191779011783; Doherty GM, 2003, CLIN EXP ALLERGY, V33, P1221, DOI 10.1046/j.1365-2222.2003.01752.x; GAGA M, 2001, EUR RESP MON, V18, P1; Gomperts BN, 2007, AM J RESP CELL MOL, V37, P339, DOI 10.1165/rcmb.2006-0400OC; Hackett TL, 2011, AM J RESP CELL MOL, V45, P1090, DOI 10.1165/rcmb.2011-0031OC; Hackett TL, 2009, AM J RESP CRIT CARE, V180, P122, DOI 10.1164/rccm.200811-1730OC; Haitchi HM, 2011, AM J RESP CRIT CARE, V183, pA2771; Hellings PW, 2009, IMMUNOL ALLERGY CLIN, V29, P733, DOI 10.1016/j.iac.2009.08.001; Holgate ST, 2011, IMMUNOL REV, V242, P205, DOI 10.1111/j.1600-065X.2011.01030.x; Ip WK, 2006, CLIN EXP IMMUNOL, V145, P162, DOI 10.1111/j.1365-2249.2006.03085.x; Jeffery Peter K, 2006, BMC Pulm Med, V6 Suppl 1, pS5, DOI 10.1186/1471-2466-6-S1-S5; Kim CH, 2002, ACTA OTO-LARYNGOL, V122, P638, DOI 10.1080/000164802320396321; Kondo M, 2002, AM J RESP CELL MOL, V27, P536, DOI 10.1165/rcmb.4682; Laoukili J, 2001, J CLIN INVEST, V108, P1817, DOI 10.1172/JCI13557; Legget JJ, 2004, EUR RESPIR J, V24, P100; Levine SJ, 1997, J IMMUNOL, V158, P5949; Lopez-Guisa JM, 2012, J ALLERGY CLIN IMMUN, V129, P990, DOI 10.1016/j.jaci.2011.11.035; Lopez-Souza N, 2009, J ALLERGY CLIN IMMUN, V123, P1384, DOI 10.1016/j.jaci.2009.03.010; Lordan JL, 2002, J IMMUNOL, V169, P407, DOI 10.4049/jimmunol.169.1.407; Malavia NK, 2008, RESP RES, V9, DOI 10.1186/1465-9921-9-27; McDougall CM, 2008, AM J RESP CELL MOL, V39, P560, DOI 10.1165/rcmb.2007-0325OC; Miyahara S, 2006, J ALLERGY CLIN IMMUN, V118, P1110, DOI 10.1016/j.jaci.2006.06.014; Nakaya M, 2007, LARYNGOSCOPE, V117, P881, DOI 10.1097/MLG.0b013e318033f9b0; Ogilvie V, 2011, GENOMICS, V98, P327, DOI 10.1016/j.ygeno.2011.06.008; Ouyang Yuhui, 2010, Allergol Int, V59, P313, DOI 10.2332/allergolint.10-SC-0172; Parker J, 2010, PEDIATR RES, V67, P17, DOI 10.1203/PDR.0b013e3181c0b200; Pezzulo AA, 2011, AM J PHYSIOL-LUNG C, V300, pL25, DOI 10.1152/ajplung.00256.2010; Pringle EJ, 2012, PEDIATR PULM, V47, P1215, DOI 10.1002/ppul.22672; Puddicombe SM, 2003, AM J RESP CELL MOL, V28, P61, DOI 10.1165/rcmb.4715; Saglani S, 2007, AM J RESP CRIT CARE, V176, P858, DOI 10.1164/rccm.200702-212OC; Skowron M, 2003, CHEST S, V123, P3; Takeyama K, 1999, P NATL ACAD SCI USA, V96, P3081, DOI 10.1073/pnas.96.6.3081; Thavagnanam S, 2011, PEDIATR RES, V69, P95, DOI 10.1203/PDR.0b013e318204edb5; Thavagnanam S, 2010, PEDIAT ALLERG IMM-UK, V21, P1002, DOI 10.1111/j.1399-3038.2010.01052.x; Wagner JG, 2008, CLIN EXP ALLERGY, V38, P501, DOI 10.1111/j.1365-2222.2007.02855.x; Zhen GH, 2007, AM J RESP CELL MOL, V36, P244, DOI 10.1165/rcmb.2006-0180OC	44	27	27	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2014	9	1							e85802	10.1371/journal.pone.0085802	http://dx.doi.org/10.1371/journal.pone.0085802			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301BI	24475053	Green Published, Green Submitted, gold			2022-12-25	WOS:000330507300025
J	Faivre-Moskalenko, C; Bernaud, J; Thomas, A; Tartour, K; Beck, Y; Iazykov, M; Danial, J; Lourdin, M; Muriaux, D; Castelnovo, M				Faivre-Moskalenko, Cendrine; Bernaud, Julien; Thomas, Audrey; Tartour, Kevin; Beck, Yvonne; Iazykov, Maksym; Danial, John; Lourdin, Morgane; Muriaux, Delphine; Castelnovo, Martin			RNA Control of HIV-1 Particle Size Polydispersity	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; VIRAL CAPSID PROTEIN; RETROVIRUS PARTICLES; LENTIVIRAL VECTOR; CELLULAR RNAS; GENE DELIVERY; IN-VIVO; GAG; VIRIONS; GENOMES	HIV-1, an enveloped RNA virus, produces viral particles that are known to be much more heterogeneous in size than is typical of non-enveloped viruses. We present here a novel strategy to study HIV-1 Viral Like Particles (VLP) assembly by measuring the size distribution of these purified VLPs and subsequent viral cores thanks to Atomic Force Microscopy imaging and statistical analysis. This strategy allowed us to identify whether the presence of viral RNA acts as a modulator for VLPs and cores size heterogeneity in a large population of particles. These results are analyzed in the light of a recently proposed statistical physics model for the self-assembly process. In particular, our results reveal that the modulation of size distribution by the presence of viral RNA is qualitatively reproduced, suggesting therefore an entropic origin for the modulation of RNA uptake by the nascent VLP.	[Faivre-Moskalenko, Cendrine; Bernaud, Julien; Beck, Yvonne; Iazykov, Maksym; Danial, John; Castelnovo, Martin] Univ Lyon, Phys Lab, Ecole Normale Super Lyon, Lyon, France; [Thomas, Audrey; Muriaux, Delphine] CNRS, UMR 5236, Ctr Etud Agents Pathogenes & Biotechnol Sante, Montpellier, France; [Thomas, Audrey; Tartour, Kevin; Lourdin, Morgane; Muriaux, Delphine] Univ Lyon, INSERM, U758, Ecole Normale Super Lyon, Lyon, France	Ecole Normale Superieure de Lyon (ENS de LYON); Centre National de la Recherche Scientifique (CNRS); Ecole Normale Superieure de Lyon (ENS de LYON); Institut National de la Sante et de la Recherche Medicale (Inserm)	Castelnovo, M (corresponding author), Univ Lyon, Phys Lab, Ecole Normale Super Lyon, Lyon, France.	martin.castelnovo@ens-lyon.fr		Castelnovo, Martin/0000-0003-1118-7360	Fondation Simone et Cino Del Duca (Institut de France); CNRS (Centre National de Recherche Scientifique); ANRS (Agence Nationale pour le Recherche sur le Sida)	Fondation Simone et Cino Del Duca (Institut de France); CNRS (Centre National de Recherche Scientifique)(Centre National de la Recherche Scientifique (CNRS)); ANRS (Agence Nationale pour le Recherche sur le Sida)	Funders for this work are the Fondation Simone et Cino Del Duca (Institut de France), CNRS (Centre National de Recherche Scientifique), and ANRS (Agence Nationale pour le Recherche sur le Sida). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Accola MA, 2000, J VIROL, V74, P6198, DOI 10.1128/JVI.74.13.6198-6202.2000; BANCROFT JB, 1967, VIROLOGY, V32, P354, DOI 10.1016/0042-6822(67)90284-X; Benjamin J, 2005, J MOL BIOL, V346, P577, DOI 10.1016/j.jmb.2004.11.064; Briggs JAG, 2003, EMBO J, V22, P1707, DOI 10.1093/emboj/cdg143; Burniston MT, 1999, J VIROL, V73, P8527, DOI 10.1128/JVI.73.10.8527-8540.1999; Cadena-Nava RD, 2012, J VIROL, V86, P3318, DOI 10.1128/JVI.06566-11; Carlson LA, 2012, P NATL ACAD SCI USA, V109, P16928, DOI 10.1073/pnas.1211759109; Castelnovo M, 2003, EUROPHYS LETT, V62, P841, DOI 10.1209/epl/i2003-00449-1; Castelnovo M, 2013, NEW J PHYS, V15, DOI 10.1088/1367-2630/15/3/035028; Cimarelli A, 2000, J VIROL, V74, P3046, DOI 10.1128/JVI.74.7.3046-3057.2000; de Marco A, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001215; Dordor A, 2011, FUTURE MICROBIOL, V6, P1159, DOI [10.2217/FMB.11.100, 10.2217/fmb.11.100]; Ganser-Pornillos BK, 2008, CURR OPIN STRUC BIOL, V18, P203, DOI 10.1016/j.sbi.2008.02.001; Goff PH, 2012, J VIROL, V86, P10852, DOI 10.1128/JVI.01298-12; Goicochea NL, 2011, J MOL BIOL, V410, P667, DOI 10.1016/j.jmb.2011.04.012; Grigorov B, 2006, J MOL BIOL, V359, P848, DOI 10.1016/j.jmb.2006.04.017; Houzet L, 2007, NUCLEIC ACIDS RES, V35, P2695, DOI 10.1093/nar/gkm153; Hu YF, 2008, BIOPHYS J, V94, P1428, DOI 10.1529/biophysj.107.117473; Jouvenet N, 2009, P NATL ACAD SCI USA, V106, P19114, DOI 10.1073/pnas.0907364106; Kol N, 2007, BIOPHYS J, V92, P1777, DOI 10.1529/biophysj.106.093914; Kuznetsov YG, 2002, BIOPHYS J, V83, P3665, DOI 10.1016/S0006-3495(02)75366-6; Lavelle L, 2009, J PHYS CHEM B, V113, P3813, DOI 10.1021/jp8079765; Mirambeau G, 2010, RNA BIOL, V7, P724, DOI 10.4161/rna.7.6.13777; Montel F, 2007, BIOPHYS J, V93, P566, DOI 10.1529/biophysj.107.105569; Muriaux D, 2001, P NATL ACAD SCI USA, V98, P5246, DOI 10.1073/pnas.091000398; Naldini L, 1996, SCIENCE, V272, P263, DOI 10.1126/science.272.5259.263; Paillart JC, 1996, BIOCHIMIE, V78, P639, DOI 10.1016/S0300-9084(96)80010-1; Raposo G, 2013, J CELL BIOL, V200, P373, DOI 10.1083/jcb.201211138; Rulli SJ, 2007, J VIROL, V81, P6623, DOI 10.1128/JVI.02833-06; Sens P, 1996, MACROMOLECULES, V29, P4880, DOI 10.1021/ma951553a; Siber A, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.021910; Ting CL, 2011, P NATL ACAD SCI USA, V108, P16986, DOI 10.1073/pnas.1109307108; Wang SW, 2004, J VIROL, V78, P716, DOI 10.1128/JVI.78.2.716-723.2004; Zandi R, 2009, BIOPHYS J, V96, P9, DOI 10.1529/biophysj.108.137489; Zufferey R, 1997, NAT BIOTECHNOL, V15, P871, DOI 10.1038/nbt0997-871	35	12	12	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2014	9	1							e83874	10.1371/journal.pone.0083874	http://dx.doi.org/10.1371/journal.pone.0083874			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	298QQ	24475027	Green Submitted, Green Published, gold			2022-12-25	WOS:000330339800003
J	Marshall, CD; Wieskotten, S; Hanke, W; Hanke, FD; Marsh, A; Kot, B; Dehnhardt, G				Marshall, Christopher D.; Wieskotten, Sven; Hanke, Wolf; Hanke, Frederike D.; Marsh, Alyssa; Kot, Brian; Dehnhardt, Guido			Feeding Kinematics, Suction, and Hydraulic Jetting Performance of Harbor Seals (Phoca vitulina)	PLOS ONE			English	Article							FUNCTIONAL DESIGN; NURSE SHARK; BEHAVIOR; MECHANISM; CAPABILITIES; ODONTOCETI; MORPHOLOGY; MOVEMENTS; EVOLUTION; APPARATUS	The feeding kinematics, suction and hydraulic jetting capabilities of captive harbor seals (Phoca vitulina) were characterized during controlled feeding trials. Feeding trials were conducted using a feeding apparatus that allowed a choice between biting and suction, but also presented food that could be ingested only by suction. Subambient pressure exerted during suction feeding behaviors was directly measured using pressure transducers. The mean feeding cycle duration for suction-feeding events was significantly shorter (0.15+/-0.09 s; P<0.01) than biting feeding events (0.18+/-0.08 s). Subjects feeding in-water used both a suction and a biting feeding mode. Suction was the favored feeding mode (84% of all feeding events) compared to biting, but biting comprised 16% of feeding events. In addition, seals occasionally alternated suction with hydraulic jetting, or used hydraulic jetting independently, to remove fish from the apparatus. Suction and biting feeding modes were kinematically distinct regardless of feeding location (in-water vs. on-land). Suction was characterized by a significantly smaller gape (1.3+/-0.23 cm; P<0.001) and gape angle (12.9+/-2.02 degrees), pursing of the rostral lips to form a circular aperture, and pursing of the lateral lips to occlude lateral gape. Biting was characterized by a large gape (3.63+/-0.21 cm) and gape angle (28.8+/-1.80 degrees; P<0.001) and lip curling to expose teeth. The maximum subambient pressure recorded was 48.8 kPa. In addition, harbor seals were able to jet water at food items using suprambient pressure, also known as hydraulic jetting. The maximum hydraulic jetting force recorded was 53.9 kPa. Suction and hydraulic jetting where employed 90.5% and 9.5%, respectively, during underwater feeding events. Harbor seals displayed a wide repertoire of behaviorally flexible feeding strategies to ingest fish from the feeding apparatus. Such flexibility of feeding strategies and biomechanics likely forms the basis of their opportunistic, generalized feeding ecology and concomitant breadth of diet.	[Marshall, Christopher D.; Marsh, Alyssa; Kot, Brian] Texas A&M Univ, Dept Marine Biol, Galveston, TX 77553 USA; [Marshall, Christopher D.] Texas A&M Univ, Dept Wildlife & Fisheries Sci, College Stn, TX 77843 USA; [Wieskotten, Sven; Hanke, Wolf; Hanke, Frederike D.; Dehnhardt, Guido] Univ Rostock, Inst Biosci, Sensory & Cognit Ecol Grp, D-18055 Rostock, Germany	Texas A&M University System; Texas A&M University System; Texas A&M University College Station; University of Rostock	Marshall, CD (corresponding author), Texas A&M Univ, Dept Marine Biol, Galveston, TX 77553 USA.	marshalc@tamug.edu	Marshall, Christopher/AAF-9097-2019; Hanke, Frederike/AAF-5023-2021	Hanke, Frederike/0000-0002-1737-3861	Texas A&M University International Research Travel Assistance Grant; VolkswagenStiftung; DAAD German Academic Student Exchange Scholarship (Deutscher Akademischer Austausch Dienst, DAAD); Cologne Zoo; Texas A&M University Department of Marine Biology; University of Rostock Institute of Biosciences; University of Bochum Department of Biology	Texas A&M University International Research Travel Assistance Grant; VolkswagenStiftung(Volkswagen); DAAD German Academic Student Exchange Scholarship (Deutscher Akademischer Austausch Dienst, DAAD); Cologne Zoo; Texas A&M University Department of Marine Biology; University of Rostock Institute of Biosciences; University of Bochum Department of Biology	This work was supported by a Texas A&M University International Research Travel Assistance Grant to CDM, a VolkswagenStiftung grant to GD, a DAAD German Academic Student Exchange Scholarship (Deutscher Akademischer Austausch Dienst, DAAD), the Cologne Zoo, the Texas A&M University Department of Marine Biology, the University of Rostock Institute of Biosciences, and the University of Bochum Department of Biology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam Peter J., 2002, Oryctos, V4, P83; BERTA A, 2006, MARINE MAMMALS EVOLU; Bigg M.A., 1981, HDB MARINE MAMMALS, V2, P1; Bloodworth B, 2005, J EXP BIOL, V208, P3721, DOI 10.1242/jeb.01807; Bloodworth BE, 2007, J ANAT, V211, P78, DOI 10.1111/j.1469-7580.2007.00755.x; Bowen WD, 2002, MAR ECOL PROG SER, V244, P235, DOI 10.3354/meps244235; Brecht M, 1997, BEHAV BRAIN RES, V84, P81, DOI 10.1016/S0166-4328(97)83328-1; Bromaghin JF, 2013, FISH B-NOAA, V111, P13, DOI 10.7755/FB.111.1.2; Brown SL, 2012, J MAR BIOL ASSOC UK, V92, P1711, DOI 10.1017/S0025315411002050; Burns JJ, 2009, ENCYCLOPEDIA OF MARINE MAMMALS, 2ND EDITION, P533; Carroll AM, 2004, J EXP BIOL, V207, P3873, DOI 10.1242/jeb.01227; Davis RW, 1999, SCIENCE, V283, P993, DOI 10.1126/science.283.5404.993; Davis RW, 2003, MAR ECOL PROG SER, V264, P109, DOI 10.3354/meps264109; Deban Stephen M., 2000, P65, DOI 10.1016/B978-012632590-4/50004-6; Dehnhardt G, 1996, ANIM LEARN BEHAV, V24, P366, DOI 10.3758/BF03199008; DEHNHARDT G, 1995, J EXP BIOL, V198, P2317; Eguchi T, 2005, MAR MAMMAL SCI, V21, P283, DOI 10.1111/j.1748-7692.2005.tb01228.x; EMLEN JM, 1966, AM NAT, V100, P611, DOI 10.1086/282455; Fay FH, 1982, FISH WILDL SERV PUBL, V74; Germain LR, 2012, MAR MAMMAL SCI, V28, P542, DOI 10.1111/j.1748-7692.2011.00516.x; Gibb AC, 2005, ZOOLOGY, V108, P141, DOI 10.1016/j.zool.2005.03.004; GORDON KR, 1984, J MORPHOL, V182, P179, DOI 10.1002/jmor.1051820206; Grant R, 2013, J COMP PHYSIOL A, V199, P521, DOI 10.1007/s00359-013-0797-7; Grant RA, 2012, FRONT BEHAV NEUROSCI, V6, DOI 10.3389/fnbeh.2012.00039; Hartmann MJ, 2001, AUTON ROBOT, V11, P249, DOI 10.1023/A:1012439023425; Heyning John E., 1996, Contributions in Science (Los Angeles), V464, P1; Higham TE, 2006, J EXP BIOL, V209, P2713, DOI 10.1242/jeb.02315; Hocking DP, 2013, POLAR BIOL, V36, P211, DOI 10.1007/s00300-012-1253-9; Hoover A.A., 1988, P125; Kane EA, 2009, J EXP BIOL, V212, P3939, DOI 10.1242/jeb.034686; KASTELEIN R A, 1991, Aquatic Mammals, V17, P156; Kastelein R.A., 1997, P279; KASTELEIN R A, 1990, Aquatic Mammals, V16, P101; KASTELEIN R A, 1988, Aquatic Mammals, V14, P123; Kastelein R.A., 1989, Aquatic Mammals, V15, P3; KASTELEIN RA, 1994, Z SAUGETIERKD, V59, P105; Kavanagh AS, 2010, J MAR BIOL ASS UK, V90; King J.E., 1972, P81; King JE., 1983, SEALS WORLD BRIT MUS; KLAGES NTW, 1990, POLAR BIOL, V10, P403; Lauder G.V., 1985, P210; Lauder George V., 1993, P113; LAUDER GV, 1980, J EXP BIOL, V88, P49; LAUDER GV, 1985, FORTS ZOOL, V30, P179; LAUDER GV, 1988, J EXP BIOL, V134, P219; LAUDER GV, 1986, ZOOL J LINN SOC-LOND, V88, P277, DOI 10.1111/j.1096-3642.1986.tb01191.x; LAUDER GV, 1979, J ZOOL, V187, P543; Marshall CD, 1998, MAR MAMMAL SCI, V14, P274, DOI 10.1111/j.1748-7692.1998.tb00716.x; Marshall CD, 2000, J MAMMAL, V81, P649, DOI 10.1644/1545-1542(2000)081<0649:FHAAFC>2.3.CO;2; Marshall CD, 2003, J ZOOL, V259, P245, DOI 10.1017/S0952836902003205; MARSHALL CD, 2001, 14 BIENN C BIOL MAR; Marshall CD, 2008, J EXP BIOL, V211, P699, DOI 10.1242/jeb.009852; Marshall CD, 2009, ENCYCLOPEDIA OF MARINE MAMMALS, 2ND EDITION, P406; Marshall GJ, 1998, MAR TECHNOL SOC J, V32, P11; Matott MP, 2005, ENVIRON BIOL FISH, V74, P163, DOI 10.1007/s10641-005-7435-3; Mitani Y, 2003, POLAR BIOL, V26, P311, DOI 10.1007/s00300-003-0487-y; Motta PJ, 2002, COPEIA, P24, DOI 10.1643/0045-8511(2002)002[0024:KAOSFI]2.0.CO;2; MULLER M, 1982, J THEOR BIOL, V95, P49, DOI 10.1016/0022-5193(82)90287-9; Nauwelaerts S, 2007, J R SOC INTERFACE, V4, P341, DOI 10.1098/rsif.2006.0180; Parrish FA, 2002, MAR MAMMAL SCI, V18, P244, DOI 10.1111/j.1748-7692.2002.tb01031.x; Parrish FA, 2000, MAR MAMMAL SCI, V16, P392, DOI 10.1111/j.1748-7692.2000.tb00932.x; Peterson SH, 2012, PLOS ONE, DOI [10.1371/journal.pone.0039046, DOI 10.1371/J0URNAL.P0NE.0039046]; Ponganis PJ, 2000, J EXP BIOL, V203, P3275; REIDENBERG JS, 1994, ANAT RECORD, V240, P598, DOI 10.1002/ar.1092400417; Rice D. W., 1998, SPECIAL PUBLICATION, V4; SCHEFFER VB, 1967, J MAMMAL, V48, P459; Schoener T. W., 1971, A Rev Ecol Syst, V2, P369, DOI 10.1146/annurev.es.02.110171.002101; Sharples RJ, 2009, MAR ECOL PROG SER, V390, P265, DOI 10.3354/meps08232; Thomas AC, 2011, MAR ECOL PROG SER, V441, P225, DOI 10.3354/meps09370; Wainwright P, 2007, INTEGR COMP BIOL, V47, P96, DOI 10.1093/icb/icm032; Wainwright PC, 2007, J R SOC INTERFACE, V4, P553, DOI 10.1098/rsif.2006.0197; Werth A, 2000, MAR MAMMAL SCI, V16, P299, DOI 10.1111/j.1748-7692.2000.tb00926.x; Werth AJ, 2006, J MAMMAL, V87, P579, DOI 10.1644/05-MAMM-A-279R1.1; Werth AJ., 2000, FEEDING FORM FUNCTIO, P475, DOI [10.1016/B978-012632590-4/50017-4, DOI 10.1016/B978-012632590-4/50017-4]; Werth AJ, 2007, ANAT REC, V290, P546, DOI 10.1002/ar.20538; Werth AJ, 2006, J MORPHOL, V267, P1415, DOI 10.1002/jmor.10486; Wilga CD, 2007, INTEGR COMP BIOL, V47, P55, DOI 10.1093/icb/icm029	77	42	43	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2014	9	1							e86710	10.1371/journal.pone.0086710	http://dx.doi.org/10.1371/journal.pone.0086710			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	298QQ	24475170	Green Submitted, Green Published, gold			2022-12-25	WOS:000330339800056
J	Schottdorf, M; Eglen, SJ; Wolf, F; Keil, W				Schottdorf, Manuel; Eglen, Stephen J.; Wolf, Fred; Keil, Wolfgang			Can Retinal Ganglion Cell Dipoles Seed Iso-Orientation Domains in the Visual Cortex?	PLOS ONE			English	Article							STRIATE CORTEX; RECEPTIVE-FIELDS; RETINOTOPIC ORGANIZATION; FUNCTIONAL ARCHITECTURE; COLUMNAR ARCHITECTURE; PATTERN-FORMATION; CAT; MAPS; UNIVERSALITY; TOPOGRAPHY	It has been argued that the emergence of roughly periodic orientation preference maps (OPMs) in the primary visual cortex (V1) of carnivores and primates can be explained by a so-called statistical connectivity model. This model assumes that input to V1 neurons is dominated by feed-forward projections originating from a small set of retinal ganglion cells (RGCs). The typical spacing between adjacent cortical orientation columns preferring the same orientation then arises via Moire 'Interference between hexagonal ON/OFF RGC mosaics. While this Moire-Interference critically depends on long-range hexagonal order within the RGC mosaics, a recent statistical analysis of RGC receptive field positions found no evidence for such long-range positional order. Hexagonal order may be only one of several ways to obtain spatially repetitive OPMs in the statistical connectivity model. Here, we investigate a more general requirement on the spatial structure of RGC mosaics that can seed the emergence of spatially repetitive cortical OPMs, namely that angular correlations between so-called RGC dipoles exhibit a spatial structure similar to that of OPM autocorrelation functions. Both in cat beta cell mosaics as well as primate parasol receptive field mosaics we find that RGC dipole angles are spatially uncorrelated. To help assess the level of these correlations, we introduce a novel point process that generates mosaics with realistic nearest neighbor statistics and a tunable degree of spatial correlations of dipole angles. Using this process, we show that given the size of available data sets, the presence of even weak angular correlations in the data is very unlikely. We conclude that the layout of ON/OFF ganglion cell mosaics lacks the spatial structure necessary to seed iso-orientation domains in the primary visual cortex.	[Schottdorf, Manuel; Wolf, Fred; Keil, Wolfgang] Max Planck Inst Dynam & Self Org, Gottingen, Germany; [Schottdorf, Manuel; Wolf, Fred; Keil, Wolfgang] Univ Gottingen, Inst Nonlinear Dynam, D-37073 Gottingen, Germany; [Schottdorf, Manuel; Wolf, Fred; Keil, Wolfgang] Bernstein Ctr Computat Neurosci, Gottingen, Germany; [Schottdorf, Manuel; Wolf, Fred; Keil, Wolfgang] Bernstein Focus Neurotechnol, Gottingen, Germany; [Schottdorf, Manuel] Univ Wurzburg, Inst Theoret Phys, D-97070 Wurzburg, Germany; [Eglen, Stephen J.] Univ Cambridge, Dept Appl Math & Theoret Phys, Cambridge Computat Biol Inst, Cambridge CB3 9EW, England; [Keil, Wolfgang] Rockefeller Univ, Ctr Studies Phys & Biol, New York, NY 10021 USA	Max Planck Society; University of Gottingen; University of Wurzburg; University of Cambridge; Rockefeller University	Keil, W (corresponding author), Max Planck Inst Dynam & Self Org, Gottingen, Germany.	wkeil@mail.rockefeller.edu	Eglen, Stephen/AAF-9008-2020; Wolf, Fred/D-5771-2011	Eglen, Stephen/0000-0001-8607-8025; Wolf, Fred/0000-0002-7068-3762; Schottdorf, Manuel/0000-0002-5468-4255	HFSP; BMBF; DFG; MPG [SFB 889, BFL 01GQ0921, 01GQ0922, BCCN 01GQ0430, 01GQ1005B, 01GQ07113, BFNT 01GQ0811]; National Science Foundation [PHY05-51164]; Wellcome Trust [083205/B/07/Z]	HFSP(Human Frontier Science Program); BMBF(Federal Ministry of Education & Research (BMBF)); DFG(German Research Foundation (DFG)); MPG(Max Planck Society); National Science Foundation(National Science Foundation (NSF)); Wellcome Trust(Wellcome Trust)	This work was supported by the HFSP (http://www.hfsp.org), BMBF (http://www.bmbf.de), DFG (http://www.dfg.de), and the MPG (http://www.mpg.de); Grant numbers SFB 889, BFL 01GQ0921, 01GQ0922, BCCN 01GQ0430, 01GQ1005B, 01GQ07113 and BFNT 01GQ0811. This work was supported in part by the National Science Foundation (http://www.nsf.gov), grant number PHY05-51164. SJE was supported by a Wellcome Trust program grant (083205/B/07/Z). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams DL, 2002, SCIENCE, V298, P572, DOI 10.1126/science.1074887; Alonso JM, 2001, J NEUROSCI, V21, P4002, DOI 10.1523/JNEUROSCI.21-11-04002.2001; Amidror I, 2009, COMPUT IMAGING VIS, V38, P1; BARLOW HB, 1957, J PHYSIOL-LONDON, V137, P338, DOI 10.1113/jphysiol.1957.sp005817; BISHOP PO, 1962, J PHYSIOL-LONDON, V163, P466, DOI 10.1113/jphysiol.1962.sp006990; BLASDEL GG, 1992, J NEUROSCI, V12, P3139, DOI 10.1523/JNEUROSCI.12-08-03139.1992; BONHOEFFER T, 1991, NATURE, V353, P429, DOI 10.1038/353429a0; Bosking WH, 1997, J NEUROSCI, V17, P2112; Buzas P, 1998, BRAIN RES PROTOC, V3, P199, DOI 10.1016/S1385-299X(98)00041-5; Chapman B, 1996, J NEUROSCI, V16, P6443; CLELAND BG, 1985, J PHYSIOL-LONDON, V369, P249, DOI 10.1113/jphysiol.1985.sp015899; CLELAND BG, 1971, NATURE-NEW BIOL, V231, P191, DOI 10.1038/newbio231191a0; Crair MC, 1997, J NEUROPHYSIOL, V77, P3381, DOI 10.1152/jn.1997.77.6.3381; Crair MC, 1998, SCIENCE, V279, P566, DOI 10.1126/science.279.5350.566; DANIEL PM, 1961, J PHYSIOL-LONDON, V159, P203, DOI 10.1113/jphysiol.1961.sp006803; DIGGLE PJ, 1986, J NEUROSCI METH, V18, P115, DOI 10.1016/0165-0270(86)90115-9; DJAVADIAN RL, 1983, ACTA NEUROBIOL EXP, V43, P251; DURBIN R, 1990, NATURE, V343, P644, DOI 10.1038/343644a0; Eglen SJ, 2005, VISUAL NEUROSCI, V22, P859, DOI 10.1017/S0952523805226147; Gauthier JL, 2009, PLOS BIOL, V7, P747, DOI 10.1371/journal.pbio.1000063; Giacomantonio CE, 2007, J NEUROSCI, V27, P4935, DOI 10.1523/JNEUROSCI.1261-06.2007; Hensch TK, 2004, SCIENCE, V303, P1678, DOI 10.1126/science.1091031; Hore VRA, 2012, VISUAL NEUROSCI, V29, P283, DOI 10.1017/S0952523812000338; HUBEL DH, 1962, J PHYSIOL-LONDON, V160, P106, DOI 10.1113/jphysiol.1962.sp006837; Kaschube M, 2002, J NEUROSCI, V22, P7206; Kaschube M, 2010, SCIENCE, V330, P1113, DOI 10.1126/science.1194869; Kaschube M, 2009, P NATL ACAD SCI USA, V106, P17205, DOI 10.1073/pnas.0901615106; Keil W, 2011, NEURAL SYSTEMS CIRCU, V1, P1, DOI DOI 10.1186/2042-1001-1-17; Keil W, 2012, SCIENCE, V336, DOI 10.1126/science.1206416; Keil W, 2010, P NATL ACAD SCI USA, V107, P12293, DOI 10.1073/pnas.0913020107; Kram YA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008992; Obermayer K, 1997, NEURAL COMPUT, V9, P555, DOI 10.1162/neco.1997.9.3.555; OBERMAYER K, 1992, PHYS REV A, V45, P7568, DOI 10.1103/PhysRevA.45.7568; Ohki K, 2006, NATURE, V442, P925, DOI 10.1038/nature05019; Paik SB, 2012, SOC NEUR ANN M; Paik SB, 2012, P NATL ACAD SCI USA, V109, P7091, DOI 10.1073/pnas.1118926109; Paik SB, 2011, NAT NEUROSCI, V14, P919, DOI 10.1038/nn.2824; Rathjen S, 2003, EXP BRAIN RES, V149, P151, DOI 10.1007/s00221-002-1342-z; Ringach DL, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000251; Ringach DL, 2004, J NEUROPHYSIOL, V92, P468, DOI 10.1152/jn.01202.2003; Schnabel M, 2007, EUR PHYS J-SPEC TOP, V145, P137, DOI 10.1140/epjst/e2007-00152-5; Shmuel A, 2000, P NATL ACAD SCI USA, V97, P5568, DOI 10.1073/pnas.97.10.5568; SOODAK RE, 1986, P NATL ACAD SCI USA, V83, P9259, DOI 10.1073/pnas.83.23.9259; SOODAK RE, 1987, P NATL ACAD SCI USA, V84, P3936, DOI 10.1073/pnas.84.11.3936; SWINDALE NV, 1982, PROC R SOC SER B-BIO, V215, P211, DOI 10.1098/rspb.1982.0038; Swindale NV, 1996, NETWORK-COMP NEURAL, V7, P161, DOI 10.1088/0954-898X/7/2/002; TOOTELL RBH, 1982, SCIENCE, V218, P902, DOI 10.1126/science.7134981; TUSA RJ, 1978, J COMP NEUROL, V177, P213, DOI 10.1002/cne.901770204; Usrey WM, 1999, J NEUROPHYSIOL, V82, P3527, DOI 10.1152/jn.1999.82.6.3527; von der Malsburg C, 1973, Kybernetik, V14, P85; WASSLE H, 1981, PROC R SOC SER B-BIO, V212, P177, DOI 10.1098/rspb.1981.0033; Wolf F, 1998, NATURE, V395, P73, DOI 10.1038/25736; Wolf F, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.208701; Wolf F, 2003, J PHYSIOL-PARIS, V97, P253, DOI 10.1016/j.jphysparis.2003.09.018; Yousef T, 1999, EUR J NEUROSCI, V11, P4291, DOI 10.1046/j.1460-9568.1999.00863.x; Zhan XJ, 2000, VISUAL NEUROSCI, V17, P23, DOI 10.1017/S0952523800171032	56	11	11	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2014	9	1							e86139	10.1371/journal.pone.0086139	http://dx.doi.org/10.1371/journal.pone.0086139			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	298QQ	24475081	Green Submitted, gold, Green Published			2022-12-25	WOS:000330339800030
J	Slabbert, E; Jacobs, SM; Jacobs, K				Slabbert, Etienne; Jacobs, Shayne Martin; Jacobs, Karin			The Soil Bacterial Communities of South African Fynbos Riparian Ecosystems Invaded by Australian Acacia Species	PLOS ONE			English	Article							MICROBIAL DIVERSITY; ALIEN PLANTS; MANAGEMENT; VEGETATION; SALIGNA; NITRATE; GENERA; ZONES; SETS	Riparian ecosystem along rivers and streams are characterised by lateral and longitudinal ecological gradients and, as a result, harbour unique biodiversity. Riparian ecosystems in the fynbos of the Western Cape, South Africa, are characterised by seasonal dynamics, with summer droughts followed by high flows during winter. The unique hydrology and geomorphology of riparian ecosystems play an important role in shaping these ecosystems. The riparian vegetation in the Western Cape has, however, largely been degraded due to the invasion of non-indigenous plants, in particular Acacia mearnsii, A. saligna and A. dealbata. This study investigated the effect of hydrology and invasion on the bacterial communities associated with fynbos riparian ecosystems. Bacterial communities were characterised with automated ribosomal intergenic spacer analysis (ARISA) and 454 16S rDNA pyrosequencing. Chemical and physical properties of soil within sites were also determined and correlated with community data. Sectioning across the lateral zones revealed significant differences in community composition, and the specific bacterial taxa influenced. Results also showed that the bacterial community structure could be linked to Acacia invasion. The presence of invasive Acacia was correlated with specific bacterial phyla. However, high similarity between cleared and pristine sites suggests that the effect of Acacia on the soil bacterial community structure may not be permanent. This study demonstrates how soil bacterial communities are influenced by hydrological gradients associated with riparian ecosystems and the impact of Acacia invasion on these communities.	[Slabbert, Etienne; Jacobs, Karin] Univ Stellenbosch, Dept Microbiol, ZA-7600 Stellenbosch, Western Cape, South Africa; [Jacobs, Shayne Martin] Univ Stellenbosch, Dept Conservat Ecol & Entomol, ZA-7600 Stellenbosch, Western Cape, South Africa	Stellenbosch University; Stellenbosch University	Jacobs, K (corresponding author), Univ Stellenbosch, Dept Microbiol, ZA-7600 Stellenbosch, Western Cape, South Africa.	kj@sun.ac.za		Jacobs, Karin/0000-0003-3972-5343	South African Water Research Commission (WRC); National Research Foundation (NRF)	South African Water Research Commission (WRC); National Research Foundation (NRF)	This research was supported by the South African Water Research Commission (WRC) and the National Research Foundation (NRF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson MJ, 2006, BIOMETRICS, V62, P245, DOI 10.1111/j.1541-0420.2005.00440.x; [Anonymous], [No title captured]; Ardley JK, 2010, 9 EUR NITR FIX C 6 1; Bent SJ, 2008, ISME J, V2, P689, DOI 10.1038/ismej.2008.44; Bontemps C, 2010, MOL ECOL, V19, P44, DOI 10.1111/j.1365-294X.2009.04458.x; Boucher C, 2002, ENV FLOWS 2002; Brauman KA, 2007, ANNU REV ENV RESOUR, V32, P67, DOI 10.1146/annurev.energy.32.031306.102758; BRAY JR, 1957, ECOL MONOGR, V27, P326, DOI 10.2307/1942268; Brinson Mark M., 1999, P265, DOI 10.1017/CBO9780511613029.010; Cardinale M, 2004, APPL ENVIRON MICROB, V70, P6147, DOI 10.1128/AEM.70.10.6147-6156.2004; CATALDO DA, 1975, COMMUN SOIL SCI PLAN, V6, P71, DOI 10.1080/00103627509366547; CLARKE KR, 1993, AUST J ECOL, V18, P117, DOI 10.1111/j.1442-9993.1993.tb00438.x; Cole JR, 2007, NUCLEIC ACIDS RES, V35, pD169, DOI 10.1093/nar/gkl889; Colwell RK, 2013, ESTIMATES STAT ESTIM; Crow TR, 2000, RIPARIAN MANAGEMENT IN FORESTS OF THE CONTINENTAL EASTERN UNITED STATES, P43; Daehler CC, 2003, ANNU REV ECOL EVOL S, V34, P183, DOI 10.1146/annurev.ecolsys.34.011802.132403; Decamps H, 2004, POL J ECOL, V52, P3; Dedysh SN, 1998, APPL ENVIRON MICROB, V64, P922; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Esler KJ, 2008, S AFR J BOT, V74, P397, DOI 10.1016/j.sajb.2008.01.168; Felsenstein J., 2004, PHYLIP PHYLOGENY INF; Ferreira LV, 1999, OECOLOGIA, V120, P582, DOI 10.1007/s004420050893; Ferrenberg S, 2013, ISME J, V7, P1102, DOI 10.1038/ismej.2013.11; GREGORY SV, 1991, BIOSCIENCE, V41, P540, DOI 10.2307/1311607; Groffman P.M., 1999, STANDARD SOIL METHOD, P272; Holmes PM, 1997, J APPL ECOL, V34, P317, DOI 10.2307/2404879; Holmes PM, 2005, S AFR J SCI, V101, P553; Holmes PM, 1999, RESTOR ECOL, V7, P215, DOI 10.1046/j.1526-100X.1999.72015.x; IMHOFF JF, 1984, INT J SYST BACTERIOL, V34, P340, DOI 10.1099/00207713-34-3-340; Jiang L, 2008, ECOLOGY, V89, P1931, DOI 10.1890/07-1263.1; Johnson DB, 2009, ADV MICROB PHYSIOL, V54, P201, DOI 10.1016/S0065-2911(08)00003-9; Joubert C, 2003, THESIS U PRETORIA PR; Keeney D.R, 1982, AGRON MONOGR, P643; Krause S, 2013, FEMS MICROBIOLOGY EC, V1, P1; Lane DS, 1990, NUCL ACID TECHNIQUES, P115, DOI DOI 10.1007/S00227-012-2133-0; Legendre P., 1998, NUMERICAL ECOLOGY, V24; Li T, 2002, J ECONOMETRICS, V110, P1, DOI 10.1016/S0304-4076(02)00120-3; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Lorenzo P, 2010, ANN FOREST SCI, V67, DOI 10.1051/forest/2009082; Lozupone C, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-371; MCDONALD IR, 1995, APPL ENVIRON MICROB, V61, P116, DOI 10.1128/AEM.61.1.116-121.1995; Morris TL, 2011, DIVERS DISTRIB, V17, P898, DOI 10.1111/j.1472-4642.2011.00802.x; MUCINA L., 2006, STRUCTURIST, P617; Muller AK, 2002, MICROB ECOL, V44, P49, DOI 10.1007/s00248-001-0042-8; Naiman RJ, 1997, ANNU REV ECOL SYST, V28, P621, DOI 10.1146/annurev.ecolsys.28.1.621; NAIMAN RJ, 1990, MAN BIOSPH, V4, P295; Ranalli AJ, 2010, J HYDROL, V389, P406, DOI 10.1016/j.jhydrol.2010.05.045; Ranjard L, 2000, RES MICROBIOL, V151, P167, DOI 10.1016/S0923-2508(00)00136-4; Reinecke MK, 2007, NATURE INVASION RIPA; Richardson DM, 2007, DIVERS DISTRIB, V13, P126, DOI 10.1111/j.1366-9516.2006.00314.x; Roberts DW., 2012, LABDSV ORDINATION MU; Rodriguez-Echeverria S, 2011, DIVERS DISTRIB, V17, P946, DOI 10.1111/j.1472-4642.2011.00787.x; Rowntree KM, 2001, ASSESSING ECOLOGICAL; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI 10.1002/j.1538-7305.1948.tb01338.x; Sieben EJJ, 2009, J VEG SCI, V20, P17, DOI 10.1111/j.1654-1103.2009.03989.x; Slabbert E, 2010, MOL ECOL, V19, P1031, DOI 10.1111/j.1365-294X.2009.04517.x; Wang JJ, 2013, ISME J, V7, P1310, DOI 10.1038/ismej.2013.30; Weir BS, 2004, APPL ENVIRON MICROB, V70, P5980, DOI 10.1128/AEM.70.10.5980-5987.2004; Yelenik SG, 2004, RESTOR ECOL, V12, P44, DOI 10.1111/j.1061-2971.2004.00289.x; Zhou JZ, 2002, APPL ENVIRON MICROB, V68, P326, DOI 10.1128/AEM.68.1.326-334.2002	62	26	28	2	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2014	9	1							e86560	10.1371/journal.pone.0086560	http://dx.doi.org/10.1371/journal.pone.0086560			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	298QQ	24475145	Green Published, gold			2022-12-25	WOS:000330339800053
J	Kim, BJ; Scott, DA				Kim, Bum Jun; Scott, Daryl A.			Mouse Model Reveals the Role of RERE in Cerebellar Foliation and the Migration and Maturation of Purkinje Cells	PLOS ONE			English	Article							HISTONE DEACETYLASE; GENETIC-REGULATION; MICE LACKING; EXPRESSION; PATTERN; COMPLEXITY; PROTEINS; SYSTEM; GROWTH; MATH1	Nuclear receptors and their coregulators play a critical role in brain development by regulating the spatiotemporal expression of their target genes. The arginine-glutamic acid dipeptide repeats gene (Rere) encodes a nuclear receptor coregulator previously known as Atrophin 2. In the developing cerebellum, RERE is expressed in the molecular layer, the Purkinje cell layer and the granule cell layer but not in granule cell precursors. To study RERE's role in cerebellar development, we used RERE-deficient embryos bearing a null allele (om) and a hypomorphic allele (eyes3) of Rere (Rere(om/eyes3)). In contrast to wild-type embryos, formation of the principal fissures in these RERE-deficient embryos was delayed and the proliferative activity of granule cell precursors (GCPs) was reduced at E18.5. This reduction in proliferation was accompanied by a decrease in the expression of sonic hedgehog (SHH), which is secreted from Purkinje cells and is required for normal GCP proliferation. The maturation and migration of Purkinje cells in Rere(om/eyes3) embryos was also delayed with decreased numbers of post-migratory Purkinje cells in the cerebellum. During the postnatal period, RERE depletion caused incomplete division of lobules I/II and III due to truncated development of the precentral fissure in the cerebellar vermis, abnormal development of lobule crus I and lobule crus II in the cerebellar hemispheres due to attenuation of the intercrural fissure, and decreased levels of Purkinje cell dendritic branching. We conclude that RERE-deficiency leads to delayed development of the principal fissures and delayed maturation and migration of Purkinje cells during prenatal cerebellar development and abnormal cerebellar foliation and Purkinje cell maturation during postnatal cerebellar development.	[Kim, Bum Jun; Scott, Daryl A.] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Scott, Daryl A.] Baylor Coll Med, Dept Mol Physiol & Biophys, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine	Scott, DA (corresponding author), Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA.	dscott@bcm.edu			Carloine Wiess Law Fund for Molecular Medicine	Carloine Wiess Law Fund for Molecular Medicine	This research was funded, in part, by the Carloine Wiess Law Fund for Molecular Medicine. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altman J, 1997, DEV CEREBELLAR SYSTE; Armstrong CL, 2000, BIOCHEM CELL BIOL, V78, P551, DOI 10.1139/bcb-78-5-551; BenArie N, 1997, NATURE, V390, P169, DOI 10.1038/36579; Chen YT, 2005, MOL CELL BIOL, V25, P2722, DOI 10.1128/MCB.25.7.2722-2732.2005; Cho JH, 2006, DEV BIOL, V290, P125, DOI 10.1016/j.ydbio.2005.11.024; Corrales JD, 2006, DEVELOPMENT, V133, P1811, DOI 10.1242/dev.02351; Corrales JMD, 2004, DEVELOPMENT, V131, P5581, DOI 10.1242/dev.01438; Dahmane N, 1999, DEVELOPMENT, V126, P3089; Dussault I, 1998, MECH DEVELOP, V70, P147, DOI 10.1016/S0925-4773(97)00187-1; Hatten ME, 1999, ANNU REV NEUROSCI, V22, P511, DOI 10.1146/annurev.neuro.22.1.511; HOLLYDAY M, 1995, MECH DEVELOP, V52, P9, DOI 10.1016/0925-4773(95)00385-E; INOUYE M, 1980, J COMP NEUROL, V190, P357, DOI 10.1002/cne.901900209; Jensen P, 2002, J NEUROSCI, V22, P8110; Kim BJ, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0057460, 10.1371/journal.pone.0068422]; Kim BJ, 2009, DEV BIOL, V326, P378, DOI 10.1016/j.ydbio.2008.11.001; LARSELL O, 1952, J COMP NEUROL, V97, P281, DOI 10.1002/cne.900970204; Larsell O., 1970, COMP ANATOMY HISTOLO; Lewis PM, 2004, DEV BIOL, V270, P393, DOI 10.1016/j.ydbio.2004.03.007; Ma S, 2012, J NEUROSCI, V32, P14979, DOI 10.1523/JNEUROSCI.1282-12.2012; MARES V, 1970, BRAIN RES, V23, P343, DOI 10.1016/0006-8993(70)90061-2; McNeill EM, 2011, DEV BIOL, V353, P331, DOI 10.1016/j.ydbio.2011.03.008; Meyers EN, 1998, NAT GENET, V18, P136, DOI 10.1038/ng0298-136; Millen KJ, 1995, DEVELOPMENT, V121, P3935; Monaghan AP, 1997, NATURE, V390, P515, DOI 10.1038/37364; Nishimura Masuhiro, 2004, Drug Metab Pharmacokinet, V19, P135, DOI 10.2133/dmpk.19.135; Qin J, 2007, DEV DYNAM, V236, P810, DOI 10.1002/dvdy.21060; Sgaier SK, 2005, NEURON, V45, P27, DOI 10.1016/S0896-6273(04)00802-5; Sillitoe RV, 2007, ANNU REV CELL DEV BI, V23, P549, DOI 10.1146/annurev.cellbio.23.090506.123237; Sotelo C, 2004, PROG NEUROBIOL, V72, P295, DOI 10.1016/j.pneurobio.2004.03.004; Steinmayr M, 1998, P NATL ACAD SCI USA, V95, P3960, DOI 10.1073/pnas.95.7.3960; STOYKOVA A, 1994, J NEUROSCI, V14, P1395, DOI 10.1523/JNEUROSCI.14-03-01395.1994; Sudarov A, 2007, NEURAL DEV, V2, DOI 10.1186/1749-8104-2-26; Ullmann JFP, 2012, NEUROIMAGE, V62, P1408, DOI 10.1016/j.neuroimage.2012.05.061; Vilhais-Neto GC, 2010, NATURE, V463, P953, DOI 10.1038/nature08763; Vogel MW, 1996, DEV BRAIN RES, V96, P210; Wang L, 2006, GENE DEV, V20, P525, DOI 10.1101/gad.1393506; Wang VY, 2001, NAT REV NEUROSCI, V2, P484, DOI 10.1038/35081558; WASSEF M, 1985, DEV BIOL, V111, P129, DOI 10.1016/0012-1606(85)90441-5; Wechsler-Reya RJ, 1999, NEURON, V22, P103, DOI 10.1016/S0896-6273(00)80682-0; WELKER WI, 1990, ARCH ITAL BIOL, V128, P87; Yamamoto M, 1999, MECH DEVELOP, V84, P143, DOI 10.1016/S0925-4773(99)00054-4; Yanagisawa H, 2000, HUM MOL GENET, V9, P1433, DOI 10.1093/hmg/9.9.1433; Young KA, 2002, BEHAV BRAIN RES, V132, P145, DOI 10.1016/S0166-4328(01)00413-2; Zoltewicz JS, 2004, DEVELOPMENT, V131, P3, DOI 10.1242/dev.00908	44	18	19	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2014	9	1							e87518	10.1371/journal.pone.0087518	http://dx.doi.org/10.1371/journal.pone.0087518			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297XI	24466353	Green Published, gold, Green Submitted			2022-12-25	WOS:000330288000209
J	Burillo, A; Rodriguez-Sanchez, B; Ramiro, A; Cercenado, E; Rodriguez-Creixems, M; Bouza, E				Burillo, Almudena; Rodriguez-Sanchez, Belen; Ramiro, Ana; Cercenado, Emilia; Rodriguez-Creixems, Marta; Bouza, Emilio			Gram-Stain Plus MALDI-TOF MS (Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry) for a Rapid Diagnosis of Urinary Tract Infection	PLOS ONE			English	Article							DIRECT IDENTIFICATION; BLOOD CULTURES; BACTERIA; SAMPLES; IMPACT; TESTS; EPIDEMIOLOGY; MICROSCOPY; PATHOGENS; ASSAY	Microbiological confirmation of a urinary tract infection (UTI) takes 24-48 h. In the meantime, patients are usually given empirical antibiotics, sometimes inappropriately. We assessed the feasibility of sequentially performing a Gram stain and MALDI-TOF MS mass spectrometry (MS) on urine samples to anticipate clinically useful information. In May-June 2012, we randomly selected 1000 urine samples from patients with suspected UTI. All were Gram stained and those yielding bacteria of a single morphotype were processed for MALDI-TOF MS. Our sequential algorithm was correlated with the standard semiquantitative urine culture result as follows: Match, the information provided was anticipative of culture result; Minor error, the information provided was partially anticipative of culture result; Major error, the information provided was incorrect, potentially leading to inappropriate changes in antimicrobial therapy. A positive culture was obtained in 242/1000 samples. The Gram stain revealed a single morphotype in 207 samples, which were subjected to MALDI-TOF MS. The diagnostic performance of the Gram stain was: sensitivity (Se) 81.3%, specificity (Sp) 93.2%, positive predictive value (PPV) 81.3%, negative predictive value (NPV) 93.2%, positive likelihood ratio (+LR) 11.91, negative likelihood ratio (-LR) 0.20 and accuracy 90.0% while that of MALDI-TOF MS was: Se 79.2%, Sp 73.5, +LR 2.99, -LR 0.28 and accuracy 78.3%. The use of both techniques provided information anticipative of the culture result in 82.7% of cases, information with minor errors in 13.4% and information with major errors in 3.9%. Results were available within 1 h. Our serial algorithm provided information that was consistent or showed minor errors for 96.1% of urine samples from patients with suspected UTI. The clinical impacts of this rapid UTI diagnosis strategy need to be assessed through indicators of adequacy of treatment such as a reduced time to appropriate empirical treatment or earlier withdrawal of unnecessary antibiotics.	[Burillo, Almudena; Rodriguez-Sanchez, Belen; Ramiro, Ana; Cercenado, Emilia; Rodriguez-Creixems, Marta; Bouza, Emilio] Hosp Gen Univ Gregorio Maranon, Inst Invest Sanitaria Gregorio Maranon, Dept Clin Microbiol & Infect Dis, Madrid, Spain; [Burillo, Almudena; Cercenado, Emilia; Bouza, Emilio] Univ Complutense Madrid, Fac Med, Madrid, Spain; [Cercenado, Emilia; Rodriguez-Creixems, Marta; Bouza, Emilio] Red Espanola Invest Patol Infecciosa REIPI RD06 0, Seville, Spain; [Rodriguez-Sanchez, Belen; Cercenado, Emilia; Rodriguez-Creixems, Marta; Bouza, Emilio] CIBER Enfermedades Resp CIBERES CB06 06 0058, Palma De Mallorca, Islas Baleares, Spain	General University Gregorio Maranon Hospital; Complutense University of Madrid; CIBER - Centro de Investigacion Biomedica en Red; CIBERES	Burillo, A (corresponding author), Hosp Gen Univ Gregorio Maranon, Inst Invest Sanitaria Gregorio Maranon, Dept Clin Microbiol & Infect Dis, Madrid, Spain.	burilloa@arrakis.es	Rodríguez-Sánchez, Belén/AAF-4046-2021; Bouza, Emilio/D-8661-2014; Rodriguez-Sanchez, Belen/AAQ-8542-2021	Bouza, Emilio/0000-0001-6967-9267; Rodriguez-Sanchez, Belen/0000-0002-9625-427X; Burillo, Almudena/0000-0003-2545-4204				Bjornholt JV, 2011, CLIN MICROBIOL INFEC, V17, pS66; Bouza E, 2001, CLIN MICROBIOL INFEC, V7, P523, DOI 10.1046/j.1198-743x.2001.00326.x; Bronnestam R, 1999, APMIS, V107, P437, DOI 10.1111/j.1699-0463.1999.tb01578.x; Cheng JW, 2013, AJMR AM J MICROBIOLO, P71; Cherkaoui A, 2010, J CLIN MICROBIOL, V48, P1169, DOI 10.1128/JCM.01881-09; Christner M, 2010, J CLIN MICROBIOL, V48, P1584, DOI 10.1128/JCM.01831-09; Clarridge JE, 1998, CUMITECH 2B LAB DIAG; Clerc O, 2013, CLIN INFECT DIS, V56, P1101, DOI 10.1093/cid/cis1204; CROUT FV, 1984, DIAGN MICR INFEC DIS, V2, P179, DOI 10.1016/0732-8893(84)90028-2; Deville Walter L J M, 2004, BMC Urol, V4, P4, DOI 10.1186/1471-2490-4-4; Ferreira L, 2011, CLIN MICROBIOL INFEC, V17, P1007, DOI 10.1111/j.1469-0691.2010.03339.x; Ferreira L, 2010, J CLIN MICROBIOL, V48, P2110, DOI 10.1128/JCM.02215-09; Ferroni A, 2010, J CLIN MICROBIOL, V48, P1542, DOI 10.1128/JCM.02485-09; Foxman B, 2003, INFECT DIS CLIN N AM, V17, P227, DOI 10.1016/S0891-5520(03)00005-9; Foxman B, 2010, NAT REV UROL, V7, P653, DOI 10.1038/nrurol.2010.190; GOULDEN B. E., 1968, N Z VET J, V16, P1, DOI 10.1080/00480169.1968.33737; Hartley S, 2013, INFECT CONT HOSP EP, V34, P1204, DOI 10.1086/673449; Ho YP, 2011, MASS SPECTROM REV, V30, P1203, DOI 10.1002/mas.20320; Hoyos-Mallecot Y, 2013, ENFERM INFEC MICR CL, V31, P152, DOI 10.1016/j.eimc.2012.09.003; Huang AM, 2013, CLIN INFECT DIS, V57, P1237, DOI 10.1093/cid/cit498; Johnson H, 2011, J CLIN MICROBIOL, V49, P4031, DOI 10.1128/JCM.05447-11; JORGENSEN JH, 1975, AM J CLIN PATHOL, V63, P142; KALLENIUS G, 1981, CHEMOTHERAPY, V27, P99, DOI 10.1159/000237963; Kohling HL, 2012, J MED MICROBIOL, V61, P339, DOI 10.1099/jmm.0.032284-0; Kuijper EJ, 2003, EUR J CLIN MICROBIOL, V22, P228, DOI 10.1007/s10096-003-0892-8; Kulkarni S, 2013, CLIN BIOCHEM, DOI [10.1016/j.clinbiochem.2013.09.010, DOI 10.1016/J.CLINBI0CHEM.2013.09.010]; Kwon JH, 2012, AM J CLIN PATHOL, V137, P778, DOI 10.1309/AJCP4KVGQZEG1YDM; La Scola B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008041; LEWIS JF, 1976, J CLIN MICROBIOL, V4, P372; Loonen AJM, 2012, EUR J CLIN MICROBIOL, V31, P1575, DOI 10.1007/s10096-011-1480-y; McIsaac WJ, 2011, MED DECIS MAKING, V31, P405, DOI 10.1177/0272989X10391671; Pezzlo M, 2010, CLIN PROCEDURES HDB, V3.12.11-13.12.31; ROBINS DG, 1975, LANCET, V1, P476; Rodriguez-Sanchez B, 2012, INT C ANT AG CHEM SA; Rodriguez-Sanchez B, 2013, CLIN MICROBIOL INFEC; Spanu T, 2012, J CLIN MICROBIOL, V50, P176, DOI 10.1128/JCM.05742-11; St John A, 2006, AM J CLIN PATHOL, V126, P428, DOI 10.1309/C69RW1BT7E4QAFPV; STANECK J L, 1985, Diagnostic Microbiology and Infectious Disease, V3, p51S, DOI 10.1016/0732-8893(85)90053-7; Sundqvist M, 2009, J ANTIMICROB CHEMOTH, V64, P227, DOI 10.1093/jac/dkp181; TILTON RE, 1980, J CLIN MICROBIOL, V11, P157, DOI 10.1128/JCM.11.2.157-161.1980; Vlek ALM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032589; Wang XH, 2013, J MICROBIOL METH, V92, P231, DOI 10.1016/j.mimet.2012.12.016; Williams GJ, 2010, LANCET INFECT DIS, V10, P240, DOI 10.1016/S1473-3099(10)70031-1; Wilson ML, 2004, CLIN INFECT DIS, V38, P1150, DOI 10.1086/383029; Wiwanitkit V, 2005, UROL RES, V33, P220, DOI 10.1007/s00240-004-0457-z	45	50	54	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2014	9	1							e86915	10.1371/journal.pone.0086915	http://dx.doi.org/10.1371/journal.pone.0086915			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297VL	24466289	Green Published, Green Submitted, gold			2022-12-25	WOS:000330283100232
J	Shalwala, M; Zhu, SG; Das, A; Salloum, FN; Xi, L; Kukreja, RC				Shalwala, Mona; Zhu, Shu-Guang; Das, Anindita; Salloum, Fadi N.; Xi, Lei; Kukreja, Rakesh C.			Sirtuin 1 (SIRT1) Activation Mediates Sildenafil Induced Delayed Cardioprotection against Ischemia-Reperfusion Injury in Mice	PLOS ONE			English	Article							CARDIAC MYOCYTES; POTENTIAL ROLE; CELL-DEATH; LIFE-SPAN; RESVERATROL; HEART; RESTRICTION; DEACETYLASE; INHIBITION; MECHANISM	Background: It has been well documented that phosphodiesterase-5 inhibitor, sildenafil (SIL) protects against myocardial ischemia/reperfusion (I-R) injury. SIRT1 is part of the class III Sirtuin family of histone deacetylases that deacetylates proteins involved in cellular stress response including those related to I-R injury. Objective/Hypothesis: We tested the hypothesis that SIL-induced cardioprotection may be mediated through activation of SIRT1. Methods: Adult male ICR mice were treated with SIL (0.7 mg/kg, i.p.), Resveratrol (RSV, 5 mg/kg, a putative activator of SIRT1 used as the positive control), or saline (0.2 mL). The hearts were harvested 24 hours later and homogenized for SIRT1 activity analysis. Results: Both SIL- and RSV-treated mice had increased cardiac SIRT1 activity (P<0.001) as compared to the saline-treated controls 24 hours after drug treatment. In isolated ventricular cardiomyocytes, pretreatment with SIL (1 mu M) or RSV (1 mu M) for one hour in vitro also upregulated SIRT1 activity (P<0.05). We further examined the causative relationship between SIRT1 activation and SIL-induced late cardioprotection. Pretreatment with SIL (or RSV) 24 hours prior to 30 min ischemia and 24 hours of reperfusion significantly reduced infarct size, which was associated with a significant increase in SIRT1 activity (P<0.05). Moreover, sirtinol (a SIRT1 inhibitor, 5 mg/kg, i.p.) given 30 min before I-R blunted the infarct-limiting effect of SIL and RSV (P<0.001). Conclusion: Our study shows that activation of SIRT1 following SIL treatment plays an essential role in mediating the SIL-induced cardioprotection against I-R injury. This newly identified SIRT1-activating property of SIL may have enormous therapeutic implications.	[Shalwala, Mona; Zhu, Shu-Guang; Das, Anindita; Salloum, Fadi N.; Xi, Lei; Kukreja, Rakesh C.] Virginia Commonwealth Univ, Dept Internal Med, Div Cardiol, VCU Pauley Heart Ctr, Richmond, VA 23284 USA; [Shalwala, Mona] Touro Coll Osteopath Med, New York, NY USA; [Zhu, Shu-Guang] Guangdong Pharmaceut Univ, Dept Cardiothorac Surg, Affiliated Hosp 1, Guangzhou, Guangdong, Peoples R China	Virginia Commonwealth University; Guangdong Pharmaceutical University	Kukreja, RC (corresponding author), Virginia Commonwealth Univ, Dept Internal Med, Div Cardiol, VCU Pauley Heart Ctr, Richmond, VA 23284 USA.	rakesh@vcu.edu	Salloum, Fadi N/C-2391-2008; Xi, Lei/A-3078-2008; Das, Anindita/K-8003-2013	Salloum, Fadi N/0000-0002-8947-9315; Xi, Lei/0000-0002-7569-3329; Das, Anindita/0000-0003-4422-7277	National Institutes of Health [HL51045, HL79424, HL118808]; American Heart Association [10SDG3770011, 0530157N, 0765273U]; Health Ministry of Guangdong Province, China [A2013320]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL051045, R01HL051045, R01HL079424, R01HL118808] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); Health Ministry of Guangdong Province, China; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was supported in part by research grants from the National Institutes of Health (HL51045, HL79424, HL118808 to Dr. R. C. Kukreja) and from the American Heart Association (National Scientist Development Grants 10SDG3770011 to Dr. F.N. Salloum and 0530157N to Dr. L. Xi; Mid-Atlantic Beginning Grant-in-Aid 0765273U to Dr. A. Das) and from the Health Ministry of Guangdong Province, China (Medical Research Grant A2013320 to Dr. S. G. Zhu). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcendor RR, 2007, CIRC RES, V100, P1512, DOI 10.1161/01.RES.0000267723.65696.4a; Alcendor RR, 2004, CIRC RES, V95, P971, DOI 10.1161/01.RES.0000147557.75257.ff; Bradamante S, 2000, INT J TISSUE REACT, V22, P1; Bradamante S, 2003, EUR J PHARMACOL, V465, P115, DOI 10.1016/S0014-2999(03)01441-9; Das A, 2005, J BIOL CHEM, V280, P12944, DOI 10.1074/jbc.M404706200; Das A, 2008, J BIOL CHEM, V283, P29572, DOI 10.1074/jbc.M801547200; Ferrara N, 2008, REJUV RES, V11, P139, DOI 10.1089/rej.2007.0576; Howitz KT, 2003, NATURE, V425, P191, DOI 10.1038/nature01960; Hung LM, 2000, CARDIOVASC RES, V47, P549, DOI 10.1016/S0008-6363(00)00102-4; Nadtochiy SM, 2011, AM J PHYSIOL-HEART C, V301, pH1506, DOI 10.1152/ajpheart.00587.2011; Nadtochiy SM, 2011, CARDIOVASC RES, V89, P643, DOI 10.1093/cvr/cvq287; Nisoli E, 2005, SCIENCE, V310, P314, DOI 10.1126/science.1117728; Ockaili R, 2002, AM J PHYSIOL-HEART C, V283, pH1263, DOI 10.1152/ajpheart.00324.2002; Paffett ML, 2012, VASC PHARMACOL, V56, P64, DOI 10.1016/j.vph.2011.11.002; Pillai JB, 2005, J BIOL CHEM, V280, P43121, DOI 10.1074/jbc.M506162200; Pillarisetti Sivaram, 2008, Recent Pat Cardiovasc Drug Discov, V3, P156, DOI 10.2174/157489008786263989; Porcu M, 2005, TRENDS PHARMACOL SCI, V26, P94, DOI 10.1016/j.tips.2004.12.009; Salloum F, 2003, CIRC RES, V92, P595, DOI 10.1161/01.RES.0000066853.09821.98; Salloum FN, 2008, AM J PHYSIOL-HEART C, V294, pH1398, DOI [10.1152/ajpheart.ajpheart.91438.2007, 10.1152/ajpheart.91438.2007]; Shalwala M, 2010, CIRCULATION, V122; Shinmura K, 2008, AM J PHYSIOL-HEART C, V295, pH2348, DOI 10.1152/ajpheart.00602.2008; Trapp J, 2006, J MED CHEM, V49, P7307, DOI 10.1021/jm060118b; Zhu SG, 2012, J CELL MOL MED, V16, P950, DOI 10.1111/j.1582-4934.2011.01376.x	23	46	50	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2014	9	1							e86977	10.1371/journal.pone.0086977	http://dx.doi.org/10.1371/journal.pone.0086977			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297VL	24466304	Green Published, gold			2022-12-25	WOS:000330283100239
J	Pimenova, AA; Thathiah, A; De Strooper, B; Tesseur, I				Pimenova, Anna A.; Thathiah, Amantha; De Strooper, Bart; Tesseur, Ina			Regulation of Amyloid Precursor Protein Processing by Serotonin Signaling	PLOS ONE			English	Article							5-HT4 RECEPTOR; ALPHA-SECRETASE; ADENYLATE-CYCLASE; KINASE CK2; ALZHEIMERS-DISEASE; C ISOZYMES; IN-VITRO; BETA; ACTIVATION; CELLS	Proteolytic processing of the amyloid precursor protein (APP) by the beta- and gamma-secretases releases the amyloid-beta peptide (A beta), which deposits in senile plaques and contributes to the etiology of Alzheimer's disease (AD). The alpha-secretase cleaves APP in the A beta peptide sequence to generate soluble APP alpha (sAPP alpha). Upregulation of alpha-secretase activity through the 5-hydroxytryptamine 4 (5-HT4) receptor has been shown to reduce A beta production, amyloid plaque load and to improve cognitive impairment in transgenic mouse models of AD. Consequently, activation of 5-HT4 receptors following agonist stimulation is considered to be a therapeutic strategy for AD treatment; however, the signaling cascade involved in 5-HT4 receptor-stimulated proteolysis of APP remains to be determined. Here we used chemical and siRNA inhibition to identify the proteins which mediate 5-HT4d receptor-stimulated alpha-secretase activity in the SH-SY5Y human neuronal cell line. We show that G protein and Src dependent activation of phospholipase C are required for alpha-secretase activity, while, unexpectedly, adenylyl cyclase and cAMP are not involved. Further elucidation of the signaling pathway indicates that inositol triphosphate phosphorylation and casein kinase 2 activation is also a prerequisite for alpha-secretase activity. Our findings provide a novel route to explore the treatment of AD through 5-HT4 receptor-induced alpha-secretase activation.	[Pimenova, Anna A.; Thathiah, Amantha; De Strooper, Bart; Tesseur, Ina] Katholieke Univ Leuven, Ctr Human Genet, Louvain, Belgium; [Pimenova, Anna A.; Thathiah, Amantha; De Strooper, Bart; Tesseur, Ina] Leuven Res Inst Neurosci & Dis LIND, Louvain, Belgium; [Pimenova, Anna A.; Thathiah, Amantha; De Strooper, Bart; Tesseur, Ina] VIB Ctr Biol Dis, Louvain, Belgium	KU Leuven; Flanders Institute for Biotechnology (VIB)	De Strooper, B (corresponding author), Katholieke Univ Leuven, Ctr Human Genet, Louvain, Belgium.	bart.destrooper@cme.vib-kuleuven.be; ina.tesseur@cme.vib-kuleuven.be	de+Strooper, Bart/Z-1638-2019; Wyss-Coray, Tony/AAF-3380-2019	Wyss-Coray, Tony/0000-0001-5893-0831; Pimenova, Anna/0000-0003-3342-8778	Fund for Scientific Research Flanders, KU Leuven, Federal Office for Scientific Affairs [IAP P7/16]; Flemish Government, VIB, IWT	Fund for Scientific Research Flanders, KU Leuven, Federal Office for Scientific Affairs; Flemish Government, VIB, IWT	This work was supported by the Fund for Scientific Research Flanders, KU Leuven, Federal Office for Scientific Affairs (IAP P7/16), a Methusalem grant of the Flemish Government, VIB, IWT. BDS is the Arthur Bax and Anna Vanluffelen chair for Alzheimer's disease. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agholme L, 2010, J ALZHEIMERS DIS, V20, P1069, DOI 10.3233/JAD-2010-091363; Ahmad M, 2006, J BIOCHEM, V139, P517, DOI 10.1093/jb/mvj054; Albasanz JL, 2005, NEUROBIOL DIS, V20, P685, DOI 10.1016/j.nbd.2005.05.001; Amtmann E, 1996, DRUG EXP CLIN RES, V22, P287; Ansanay H, 1996, EUR J PHARMACOL, V298, P165, DOI 10.1016/0014-2999(95)00786-5; Bandyopadhyay S, 2007, CURR MED CHEM, V14, P2848, DOI 10.2174/092986707782360060; Barthet G, 2007, MOL BIOL CELL, V18, P1979, DOI 10.1091/mbc.E06-12-1080; Berlot CH, 2002, J BIOL CHEM, V277, P21080, DOI 10.1074/jbc.M201330200; BERRIDGE MJ, 1993, NATURE, V361, P315, DOI 10.1038/361315a0; Bockaert J, 2008, NEUROPHARMACOLOGY, V55, P922, DOI 10.1016/j.neuropharm.2008.05.013; BUXBAUM JD, 1994, P NATL ACAD SCI USA, V91, P4489, DOI 10.1073/pnas.91.10.4489; Caccamo A, 2006, NEURON, V49, P671, DOI 10.1016/j.neuron.2006.01.020; Cachard-Chastel M, 2007, BRIT J PHARMACOL, V150, P883, DOI 10.1038/sj.bjp.0707178; Camden JM, 2005, J BIOL CHEM, V280, P18696, DOI 10.1074/jbc.M500219200; Chang WC, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001317; Chang YT, 2002, CHEMBIOCHEM, V3, P897, DOI 10.1002/1439-7633(20020902)3:9<897::AID-CBIC897>3.0.CO;2-B; Cho S, 2007, EXP NEUROL, V203, P274, DOI 10.1016/j.expneurol.2006.07.021; Cochet M, 2013, ACS CHEM NEUROSCI, V4, P130, DOI 10.1021/cn300095t; Coluccia AML, 2006, CANCER RES, V66, P2279, DOI 10.1158/0008-5472.CAN-05-2057; CONSOLO S, 1994, NEUROREPORT, V5, P1230, DOI 10.1097/00001756-199406020-00018; Contesse V, 1996, MOL PHARMACOL, V49, P481; De Strooper B, 2010, PHYSIOL REV, V90, P465, DOI 10.1152/physrev.00023.2009; Delarasse C, 2011, J BIOL CHEM, V286, P2596, DOI 10.1074/jbc.M110.200618; Donmez G, 2010, CELL, V142, P320, DOI 10.1016/j.cell.2010.06.020; DUMUIS A, 1988, MOL PHARMACOL, V34, P880; Farlow MR, 2007, AM J MED, V120, P388, DOI 10.1016/j.amjmed.2006.08.036; GALARDY RE, 1994, ANN NY ACAD SCI, V732, P315, DOI 10.1111/j.1749-6632.1994.tb24746.x; Gao YS, 2002, EUR J PHARMACOL, V436, P227, DOI 10.1016/S0014-2999(02)01261-X; Gao Y, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M702106200; HARRIS DN, 1979, J CYCLIC NUCL PROT, V5, P125; Hartmann D, 2002, HUM MOL GENET, V11, P2615, DOI 10.1093/hmg/11.21.2615; Hashimoto G, 2012, J ALZHEIMERS DIS, V32, P437, DOI 10.3233/JAD-2012-111235; Hohenegger M, 1998, P NATL ACAD SCI USA, V95, P346, DOI 10.1073/pnas.95.1.346; Jacobsen KT, 2010, J BIOL CHEM, V285, P10223, DOI 10.1074/jbc.M109.038224; JACOBSON PB, 1995, J PHARMACOL EXP THER, V275, P995; Jefferson T, 2011, J BIOL CHEM, V286, P27741, DOI 10.1074/jbc.M111.252718; JOLLES J, 1992, J NEUROCHEM, V58, P2326, DOI 10.1111/j.1471-4159.1992.tb10981.x; Jorissen E, 2010, J NEUROSCI, V30, P4833, DOI 10.1523/JNEUROSCI.5221-09.2010; KOZASA T, 1993, P NATL ACAD SCI USA, V90, P9176, DOI 10.1073/pnas.90.19.9176; Kuhn PH, 2010, EMBO J, V29, P3020, DOI 10.1038/emboj.2010.167; Le Gall SM, 2009, MOL BIOL CELL, V20, P1785, DOI 10.1091/mbc.E08-11-1135; LeBlanc AC, 1998, J NEUROSCI, V18, P2907; LEE RKK, 1995, P NATL ACAD SCI USA, V92, P8083, DOI 10.1073/pnas.92.17.8083; LEGRAND AB, 1990, BIOCHEM PHARMACOL, V40, P1103, DOI 10.1016/0006-2952(90)90499-B; Lehmann DM, 2008, MOL PHARMACOL, V73, P410, DOI 10.1124/mol.107.041780; Lenzken SC, 2010, J ALZHEIMERS DIS, V20, P1133, DOI 10.3233/JAD-2010-090232; Lezoualc'h F, 2003, EXP GERONTOL, V38, P159, DOI 10.1016/S0531-5565(02)00157-2; Lichtenthaler SF, 2003, J BIOL CHEM, V278, P48713, DOI 10.1074/jbc.M303861200; Liu XS, 2013, CELL RES, V23, P351, DOI 10.1038/cr.2012.167; Lumbreras M, 2006, AMINO ACIDS, V31, P449, DOI 10.1007/s00726-005-0272-z; Maillet M, 2003, NAT CELL BIOL, V5, P633, DOI 10.1038/ncb1007; Marambaud P, 1999, BRIT J PHARMACOL, V126, P1186, DOI 10.1038/sj.bjp.0702406; MARTINYBARON G, 1993, J BIOL CHEM, V268, P9194; Matsumoto M, 2001, J PHARMACOL EXP THER, V296, P676; Mayr GW, 2005, J BIOL CHEM, V280, P13229, DOI 10.1074/jbc.M500545200; Micale V, 2006, BRAIN RES, V1121, P207, DOI 10.1016/j.brainres.2006.08.108; MILLIGAN G, 1989, BIOCHEM J, V262, P643, DOI 10.1042/bj2620643; Moss ML, 2007, ANAL BIOCHEM, V366, P144, DOI 10.1016/j.ab.2007.04.043; NITSCH RM, 1992, SCIENCE, V258, P304, DOI 10.1126/science.1411529; Nitsch RM, 1996, J BIOL CHEM, V271, P4188; ONODA JM, 1987, BIOCHEM PHARMACOL, V36, P1907, DOI 10.1016/0006-2952(87)90487-4; OUADID H, 1991, J MOL CELL CARDIOL, V23, P41, DOI 10.1016/0022-2828(91)90037-M; Pagano MA, 2004, J MED CHEM, V47, P6239, DOI 10.1021/jm049854a; Ponimaskin EG, 2002, J BIOL CHEM, V277, P20812, DOI 10.1074/jbc.M112216200; Postina R, 2004, J CLIN INVEST, V113, P1456, DOI 10.1172/JCI200420864; Reiter E, 2006, TRENDS ENDOCRIN MET, V17, P159, DOI 10.1016/j.tem.2006.03.008; Rhee SG, 2001, ANNU REV BIOCHEM, V70, P281, DOI 10.1146/annurev.biochem.70.1.281; Robert S, 2005, FEBS LETT, V579, P1136, DOI 10.1016/j.febslet.2005.01.010; Robert SJ, 2001, J BIOL CHEM, V276, P44881, DOI 10.1074/jbc.M109008200; Rovati GE, 2007, MOL PHARMACOL, V71, P959, DOI 10.1124/mol.106.029470; Sarno S, 2001, FEBS LETT, V496, P44, DOI 10.1016/S0014-5793(01)02404-8; Shears SB, 1998, BBA-MOL CELL BIOL L, V1436, P49, DOI 10.1016/S0005-2760(98)00131-3; Shen F, 2011, NEUROPHARMACOLOGY, V61, P69, DOI 10.1016/j.neuropharm.2011.02.026; SHEN KF, 1990, BRAIN RES, V531, P1, DOI 10.1016/0006-8993(90)90751-V; SMRCKA AV, 1993, J BIOL CHEM, V268, P9667; Solyakov L, 2004, J BIOL CHEM, V279, P43403, DOI 10.1074/jbc.M403239200; Spencer JP, 2004, NEUROSCIENCE, V129, P49, DOI 10.1016/j.neuroscience.2004.06.070; Tesseur I, 2013, NEUROBIOL AGING, V34, P1779, DOI 10.1016/j.neurobiolaging.2013.01.020; Thathiah A, 2013, NAT MED, V19, P43, DOI 10.1038/nm.3023; Trzaskowski B, 2012, CURR MED CHEM, V19, P1090, DOI 10.2174/092986712799320556; TSCHAIKOWSKY K, 1994, BRIT J PHARMACOL, V113, P664, DOI 10.1111/j.1476-5381.1994.tb17043.x; VandenWyngaert I, 1997, J NEUROCHEM, V69, P1810; Vingtdeux V, 2012, J NEUROCHEM, V120, P34, DOI 10.1111/j.1471-4159.2011.07477.x; Vultur A, 2008, MOL CANCER THER, V7, P1185, DOI 10.1158/1535-7163.MCT-08-0126; Zien P, 2005, BBA-PROTEINS PROTEOM, V1754, P271, DOI 10.1016/j.bbapap.2005.07.039	85	32	35	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2014	9	1							e87014	10.1371/journal.pone.0087014	http://dx.doi.org/10.1371/journal.pone.0087014			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297GT	24466315	Green Published, Green Submitted, gold			2022-12-25	WOS:000330244500288
J	Knight, ERW; Patel, EY; Flowers, CA; Crowther, AJ; Ting, JP; Miller, CR; Gershon, TR; Deshmukh, M				Knight, E. R. W.; Patel, E. Y.; Flowers, C. A.; Crowther, A. J.; Ting, J. P.; Miller, C. R.; Gershon, T. R.; Deshmukh, M.			ASC deficiency suppresses proliferation and prevents medulloblastoma incidence	ONCOGENE			English	Article						medulloblastoma; ASC; TMS-1; proliferation; TGF-beta; tumor	SPECK-LIKE PROTEIN; ABERRANT METHYLATION; GENETIC PROFILES; DOWN-REGULATION; MOUSE MODEL; DUAL ROLE; CARD ASC; INFLAMMASOME; GROWTH; CELLS	Apoptosis-associated speck-like protein containing a caspase recruitment domain (ASC) is silenced by promoter methylation in many types of tumors, yet ASC's role in most cancers remains unknown. Here, we show that ASC is highly expressed in a model of medulloblastoma, the most common malignant pediatric brain cancer; ASC is also expressed in human medulloblastomas. Importantly, while ASC deficiency did not affect normal cerebellar development, ASC knockout mice on the Smoothened (ND2: SmoA1) transgenic model of medulloblastoma exhibited a profound reduction in medulloblastoma incidence and a delayed tumor onset. A similar decrease in tumorigenesis with ASC deficiency was also seen in the hGFAP-Cre: SmoM2 mouse model of medulloblastoma. Interestingly, hyperproliferation of the external granule layer (EGL) was comparable at P20 in both wild-type and ASC-deficient SmoA1 mice. However, while the apoptosis and differentiation markers remained unchanged at this age, proliferation makers were decreased, and the EGL was reduced in thickness and area by P60. This reduction in proliferation with ASC deficiency was also seen in isolated SmoA1 cerebellar granule precursor cells in vitro, indicating that the effect of ASC deletion on proliferation was cell autonomous. Interestingly, ASC-deficient SmoA1 cerebella exhibited disrupted expression of genes in the transforming growth factor-beta pathway and increased level of nuclear Smad3. Taken together, these results demonstrate an unexpected role for ASC in Sonic hedgehog-driven medulloblastoma tumorigenesis, thus identifying ASC as a promising novel target for antitumor therapy.	[Knight, E. R. W.; Ting, J. P.; Gershon, T. R.; Deshmukh, M.] Univ N Carolina, Neurobiol Curriculum, Chapel Hill, NC 27599 USA; [Knight, E. R. W.; Patel, E. Y.; Flowers, C. A.; Crowther, A. J.; Miller, C. R.; Gershon, T. R.; Deshmukh, M.] Univ N Carolina, Ctr Neurosci, Chapel Hill, NC 27599 USA; [Crowther, A. J.; Ting, J. P.; Miller, C. R.; Gershon, T. R.; Deshmukh, M.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; [Ting, J. P.] Univ N Carolina, Dept Microbiol & Immunol, Chapel Hill, NC 27599 USA; [Miller, C. R.] Univ N Carolina, Dept Pathol & Lab Med, Chapel Hill, NC 27599 USA; [Miller, C. R.; Gershon, T. R.] Univ N Carolina, Dept Neurol, Chapel Hill, NC 27599 USA; [Deshmukh, M.] Univ N Carolina, Dept Cell Biol & Physiol, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Deshmukh, M (corresponding author), Univ N Carolina, Dept Cell Biol & Physiol, 7109E Neurosci Res Bldg,105 Mason Farm Rd, Chapel Hill, NC 27599 USA.	mohanish@med.unc.edu	Miller, Ryan/B-9365-2008; , Pathology Services Core/CEZ-2246-2022; Gershon, Timothy/H-5398-2019	Miller, Ryan/0000-0002-0096-8762; Gershon, Timothy/0000-0001-7034-6400	National Cancer Institute [3P30CA016086]; UNC University Cancer Research Fund; NIH [1K08NS077978]; St Baldrick's Foundation;  [NS042197];  [GM078366]; NATIONAL CANCER INSTITUTE [P30CA016086] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM078366] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS045892, R01NS042197, K08NS077978] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); UNC University Cancer Research Fund; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); St Baldrick's Foundation; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank Drs Vishva Dixit (Genentech), James Olson (Fred Hutchinson Cancer Research Center), Eva Anton (UNC) for generously sharing ASC<SUP>-/-</SUP>, ND2: SmoA1 and hGFAP-cre mice, respectively. We appreciate the technical assistance provided by Vivian Xu, Michael Conlin and Meera Patel in the Deshmukh Lab; Janice Weaver, Lily Wai and Yongjuan Xia in the UNC Histopathology Core; Terese Camp and Ling Li in the UNC Genomics Core; Mark Vincent Olorvida, Stephanie Cohen and Bentley Midkiff in the UNC Translational Pathology Laboratory (TPL); and Joel Parker, George Wu, Chandri Yandava and Chris Fan at UNC for bioinformatics and biostatistics guidance. The UNC TPL is supported in part by grants from the National Cancer Institute (3P30CA016086) and the UNC University Cancer Research Fund. We would like to thank members of the Deshmukh Laboratory for critical review of this manuscript. TRG is supported by NIH Grant 1K08NS077978 and St Baldrick's Foundation. This work was supported by Grants NS042197 and GM078366 to MD.	Alaminos M, 2004, JNCI-J NATL CANCER I, V96, P1208, DOI 10.1093/jnci/djh224; Allen IC, 2010, J EXP MED, V207, P1045, DOI 10.1084/jem.20100050; Apte RN, 2006, CANCER METAST REV, V25, P387, DOI 10.1007/s10555-006-9004-4; Aref D, 2013, BRAIN PATHOL, V23, P178, DOI 10.1111/j.1750-3639.2012.00631.x; Cho YJ, 2011, J CLIN ONCOL, V29, P1424, DOI 10.1200/JCO.2010.28.5148; Conway KE, 2000, CANCER RES, V60, P6236; Dabiri G, 2008, J INVEST DERMATOL, V128, P280, DOI 10.1038/sj.jid.5700975; Davis BK, 2011, ANNU REV IMMUNOL, V29, P707, DOI 10.1146/annurev-immunol-031210-101405; Drexler SK, 2012, P NATL ACAD SCI USA, V109, P18384, DOI 10.1073/pnas.1209171109; Fattet S, 2009, J PATHOL, V218, P86, DOI 10.1002/path.2514; Feierabend D, 2013, J NEUROONCOL, DOI [10.1007/s11060-11013-11286-11060, DOI 10.1007/S11060-11013-11286-11060]; Fernandes-Alnemri T, 2009, NATURE, V458, P509, DOI 10.1038/nature07710; Franchi L, 2009, NAT IMMUNOL, V10, P241, DOI 10.1038/ni.1703; Guan X, 2003, INT J CANCER, V107, P202, DOI 10.1002/ijc.11376; Hallahan AR, 2004, CANCER RES, V64, P7794, DOI 10.1158/0008-5472.CAN-04-1813; Hatten ME, 2011, TRENDS NEUROSCI, V34, P134, DOI 10.1016/j.tins.2011.01.002; HATTEN ME, 1995, ANNU REV NEUROSCI, V18, P385, DOI 10.1146/annurev.ne.18.030195.002125; Hong S, 2013, CANCER LETT, V331, P183, DOI 10.1016/j.canlet.2012.12.020; Ippagunta SK, 2010, J BIOL CHEM, V285, P12454, DOI 10.1074/jbc.M109.093252; Jeong JH, 2004, GENE DEV, V18, P937, DOI 10.1101/gad.1190304; Kenney AM, 2003, DEVELOPMENT, V130, P15, DOI 10.1242/dev.00182; Kole AJ, 2011, GENE DEV, V25, P125, DOI 10.1101/gad.1975411; Kolly L, 2009, J IMMUNOL, V183, P4003, DOI 10.4049/jimmunol.0802173; Kool M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003088; Liu WM, 2013, J INVEST DERMATOL, V133, P518, DOI 10.1038/jid.2012.317; Machida EO, 2006, CANCER RES, V66, P6210, DOI 10.1158/0008-5472.CAN-05-4447; Mao J, 2006, CANCER RES, V66, P10171, DOI 10.1158/0008-5472.CAN-06-0657; Massague J, 2008, CELL, V134, P215, DOI 10.1016/j.cell.2008.07.001; Narayan S, 2011, IMMUNOLOGY, V134, P33, DOI 10.1111/j.1365-2567.2011.03462.x; Northcott PA, 2012, NATURE, V488, P49, DOI 10.1038/nature11327; Ohtsuka T, 2006, ONCOGENE, V25, P1807, DOI 10.1038/sj.onc.1209204; Ohtsuka T, 2004, NAT CELL BIOL, V6, P121, DOI 10.1038/ncb1087; Parsons MJ, 2006, ONCOGENE, V25, P6948, DOI 10.1038/sj.onc.1209684; Parsons MJ, 2009, CANCER RES, V69, P1706, DOI 10.1158/0008-5472.CAN-08-2351; Polkinghorn WR, 2007, NAT CLIN PRACT ONCOL, V4, P295, DOI 10.1038/ncponc0794; Ramachandran K, 2010, ANTICANCER RES, V30, P3919; Rich JN, 2003, FRONT BIOSCI-LANDMRK, V8, pE245, DOI 10.2741/992; Rios I, 2004, DEVELOPMENT, V131, P3159, DOI 10.1242/dev.01188; Shaw PJ, 2010, J IMMUNOL, V184, P4610, DOI 10.4049/jimmunol.1000217; SHIBANUMA M, 1993, EUR J BIOCHEM, V217, P13, DOI 10.1111/j.1432-1033.1993.tb18212.x; Shibanuma M, 1998, INT J BIOCHEM CELL B, V30, P39, DOI 10.1016/S1357-2725(97)00155-6; Stone AR, 2004, AM J PATHOL, V165, P1151, DOI 10.1016/S0002-9440(10)63376-7; Xie JW, 1998, NATURE, V391, P90, DOI 10.1038/34201; Yang ZJ, 2008, CANCER CELL, V14, P135, DOI 10.1016/j.ccr.2008.07.003; Zaki MH, 2010, J IMMUNOL, V185, P4912, DOI 10.4049/jimmunol.1002046; Zhao H, 2008, GENE DEV, V22, P722, DOI 10.1101/gad.1636408	46	7	7	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 15	2015	34	3					394	402		10.1038/onc.2013.577	http://dx.doi.org/10.1038/onc.2013.577			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AZ3RY	24469054	Green Accepted, Green Submitted			2022-12-25	WOS:000348145500013
J	Kong, QR; Xie, BT; Li, JY; Huan, YJ; Huang, TQ; Wei, RY; Lv, JW; Liu, SC; Liu, ZH				Kong, Qingran; Xie, Bingteng; Li, Jingyu; Huan, Yanjun; Huang, Tianqing; Wei, Renyue; Lv, Jiawei; Liu, Shichao; Liu, Zhonghua			Identification and Characterization of an Oocyte Factor Required for Porcine Nuclear Reprogramming	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Chromatin Remodeling; Cloning; DNA Damage; Oocyte; Reprogramming; Pig; Vimentin	FILAMENT PROTEIN VIMENTIN; IN-VITRO; INTERMEDIATE-FILAMENTS; PROTEOMIC ANALYSIS; MOUSE OOCYTES; HISTONE H2AX; CLONED PIGS; DNA; EXPRESSION; BINDING	Background: Oocyte factors can reprogram the somatic nucleus efficiently, but these factors still need to be defined. Results: Maternal vimentin acts as a genomic protector and results in p53 down-regulation during nuclear reprogramming. Conclusion: Maternal vimentin is crucial for nuclear reprogramming. Significance: We report the first evidence of vimentin as a reprogramming factor. Nuclear reprogramming of somatic cells can be induced by oocyte factors. Despite numerous attempts, the factors responsible for successful nuclear reprogramming remain elusive. In the present study, we found that porcine oocytes with the first polar body collected at 42 h of in vitro maturation had a stronger ability to support early development of cloned embryos than porcine oocytes with the first polar body collected at 33 h of in vitro maturation. To explore the key reprogramming factors responsible for the difference, we compared proteome signatures of the two groups of oocytes. 18 differentially expressed proteins between these two groups of oocytes were discovered by mass spectrometry (MS). Among these proteins, we especially focused on vimentin (VIM). A certain amount of VIM protein was stored in oocytes and accumulated during oocyte maturation, and maternal VIM was specifically incorporated into transferred somatic nuclei during nuclear reprogramming. When maternal VIM function was inhibited by anti-VIM antibody, the rate of cloned embryos developing to blastocysts was significantly lower than that of IgG antibody-injected embryos and non-injected embryos (12.24 versus 22.57 and 21.10%; p < 0.05), but the development of in vitro fertilization and parthenogenetic activation embryos was not affected. Furthermore, we found that DNA double strand breaks dramatically increased and that the p53 pathway was activated in cloned embryos when VIM function was inhibited. This study demonstrates that maternal VIM, as a genomic protector, is crucial for nuclear reprogramming in porcine cloned embryos.	[Kong, Qingran; Xie, Bingteng; Li, Jingyu; Huan, Yanjun; Huang, Tianqing; Wei, Renyue; Lv, Jiawei; Liu, Shichao; Liu, Zhonghua] Northeast Agr Univ, Coll Life Sci, Lab Embryo Biotechnol, Harbin 150030, Peoples R China	Northeast Agricultural University - China	Liu, ZH (corresponding author), Northeast Agr Univ, Coll Life Sci, Lab Embryo Biotechnol, Harbin 150030, Peoples R China.	liu086@yahoo.com	Liu, Shichao/J-2954-2019; Liu, Zhonghua/AAO-3590-2021; Liu, Zhunghua/F-2485-2010	Liu, Shichao/0000-0002-4156-3876; Liu, Zhonghua/0000-0002-9199-6493; Liu, Zhunghua/0000-0002-9199-6493; li, Jingyu/0000-0003-0136-532X; , Yanjun/0000-0001-7334-4582	Major State Basic Research Development Program [2011CB932004]; Chang Jiang Scholar Candidates Programme for Provincial Universities in Heilongjiang	Major State Basic Research Development Program(National Basic Research Program of China); Chang Jiang Scholar Candidates Programme for Provincial Universities in Heilongjiang	This work was supported by Major State Basic Research Development Program Grant 2011CB932004 and the Chang Jiang Scholar Candidates Programme for Provincial Universities in Heilongjiang.	Betthauser J, 2000, NAT BIOTECHNOL, V18, P1055, DOI 10.1038/80242; Boiani M, 2005, STEM CELLS, V23, P1089, DOI 10.1634/stemcells.2004-0352; Calvert Meredith E, 2003, Reprod Biol Endocrinol, V1, P27, DOI 10.1186/1477-7827-1-27; Campbell KHS, 2003, REPRODUCTION, P477; Cao SY, 2012, MOL REPROD DEV, V79, P413, DOI 10.1002/mrd.22044; CAPCO DG, 1982, CELL, V29, P847, DOI 10.1016/0092-8674(82)90446-9; DePianto D, 2004, EXP CELL RES, V301, P68, DOI 10.1016/j.yexcr.2004.08.007; Ellederova Z, 2004, BIOL REPROD, V71, P1533, DOI 10.1095/biolreprod.104.030304; ERIKSSON J E, 1992, Current Opinion in Cell Biology, V4, P99, DOI 10.1016/0955-0674(92)90065-K; FUCHS E, 1994, ANNU REV BIOCHEM, V63, P345, DOI 10.1146/annurev.biochem.63.1.345; Fukuda A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011274; Funahashi H, 1997, J REPROD FERTIL, P271; Gall L, 2012, CELL REPROGRAM, V14, P497, DOI 10.1089/cell.2012.0027; Gao SR, 2002, BIOL REPROD, V67, P928, DOI 10.1095/biolreprod.102.004606; Giunta S, 2010, J CELL BIOL, V190, P197, DOI 10.1083/jcb.200911156; Hansis C, 2004, CURR BIOL, V14, P1475, DOI 10.1016/j.cub.2004.08.031; Hao YH, 2003, BIOL REPROD, V69, P501, DOI 10.1095/biolreprod.103.016170; Hartig R, 1998, J CELL SCI, V111, P3573; Hong H, 2009, NATURE, V460, P1132, DOI 10.1038/nature08235; Jiang G.-J., 2011, PLOS ONE, V6; Kikyo N, 2000, SCIENCE, V289, P2360, DOI 10.1126/science.289.5488.2360; Kim K, 2010, NATURE, V467, P285, DOI 10.1038/nature09342; Kong QR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006679; Lai LX, 2002, SCIENCE, V295, P1089, DOI 10.1126/science.1068228; Li H, 2009, NATURE, V460, P1136, DOI 10.1038/nature08290; Ma MY, 2008, J PROTEOME RES, V7, P4821, DOI 10.1021/pr800392s; Miyamoto K, 2011, P NATL ACAD SCI USA, V108, P7040, DOI 10.1073/pnas.1013634108; Miyamoto K, 2009, BIOL REPROD, V80, P935, DOI 10.1095/biolreprod.108.073676; Novak S, 2004, BIOL REPROD, V71, P1279, DOI 10.1095/biolreprod.103.027037; O'Neill C, 2012, THERIOGENOLOGY, V77, P773, DOI 10.1016/j.theriogenology.2011.12.016; Paull TT, 2000, CURR BIOL, V10, P886, DOI 10.1016/S0960-9822(00)00610-2; PETER M, 1990, CELL, V61, P591, DOI 10.1016/0092-8674(90)90471-P; Pfeiffer MJ, 2011, J PROTEOME RES, V10, P2140, DOI 10.1021/pr100706k; Podhorecka M, 2010, J NUCLEIC ACIDS, V2010, DOI 10.4061/2010/920161; Polejaeva IA, 2000, NATURE, V407, P86, DOI 10.1038/35024082; Rashi-Elkeles S, 2011, MOL ONCOL, V5, P336, DOI 10.1016/j.molonc.2011.06.004; Rodriguez-Osorio N, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-190; Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858; Shiloh Y, 2013, NAT REV MOL CELL BIO, V14, P197, DOI 10.1038/nrm3546; SHOEMAN RL, 1988, J BIOL CHEM, V263, P18744; SHOEMAN RL, 1990, J BIOL CHEM, V265, P9055; STEINERT PM, 1988, ANNU REV BIOCHEM, V57, P593, DOI 10.1146/annurev.bi.57.070188.003113; Sun QY, 2001, MOL REPROD DEV, V59, P192, DOI 10.1002/mrd.1022; Sutovsky P, 2004, TRENDS BIOTECHNOL, V22, P205, DOI 10.1016/j.tibtech.2004.03.009; SUZUKI M, 1992, INT J RADIAT BIOL, V62, P581, DOI 10.1080/09553009214552501; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tamada H, 2006, MOL CELL BIOL, V26, P1259, DOI 10.1128/MCB.26.4.1259-1271.2006; Terzoudi GI, 2011, MUTAT RES-FUND MOL M, V711, P174, DOI 10.1016/j.mrfmmm.2010.12.011; Toledo F, 2006, NAT REV CANCER, V6, P909, DOI 10.1038/nrc2012; Tolstonog GV, 2000, DNA CELL BIOL, V19, P647, DOI 10.1089/10445490050199054; Tolstonog GV, 2005, DNA CELL BIOL, V24, P85, DOI 10.1089/dna.2005.24.85; Tolstonog GV, 2002, DNA CELL BIOL, V21, P213, DOI 10.1089/10445490252925459; TRAUB P, 1994, BIOESSAYS, V16, P349, DOI 10.1002/bies.950160510; Vitale AM, 2007, MOL REPROD DEV, V74, P608, DOI 10.1002/mrd.20648; Wade M, 2013, NAT REV CANCER, V13, P83, DOI 10.1038/nrc3430; Wang SF, 2010, P NATL ACAD SCI USA, V107, P17639, DOI 10.1073/pnas.1013185107; Wang X, 1996, DNA CELL BIOL, V15, P209, DOI 10.1089/dna.1996.15.209; Watson AJ, 2007, J ANIM SCI, V85, pE1, DOI 10.2527/jas.2006-432; Whitworth KM, 2010, MOL REPROD DEV, V77, P1001, DOI 10.1002/mrd.21242; Wrenzycki C, 2001, BIOL REPROD, V65, P309, DOI 10.1095/biolreprod65.1.309; You J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048613; Zhang P, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-348	62	18	18	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 7	2014	289	10					6960	6968		10.1074/jbc.M113.543793	http://dx.doi.org/10.1074/jbc.M113.543793			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AC3BG	24474691	Green Published, hybrid			2022-12-25	WOS:000332389400056
J	Ba, HJ; Chen, HS; Su, Z; Du, ML; Chen, QL; Li, YH; Ma, HM				Ba, Hong-Jun; Chen, Hong-Shan; Su, Zhe; Du, Min-Lian; Chen, Qiu-Li; Li, Yan-Hong; Ma, Hua-Mei			Associations between Serum Apelin-12 Levels and Obesity-Related Markers in Chinese Children	PLOS ONE			English	Article							IMPAIRED GLUCOSE-TOLERANCE; MESSENGER-RNA EXPRESSION; INSULIN-RESISTANCE; PLASMA APELIN; ENDOGENOUS LIGAND; RISK; APJ; TRIGLYCERIDES; ADOLESCENTS; LIPOLYSIS	Objective: To investigate possible correlations between apelin-12 levels and obesity in children in China and associations between apelin-12 and obesity-related markers, including lipids, insulin sensitivity and insulin resistance index (HOMA-IR). Methods: Forty-eight obese and forty non-obese age-and gender-matched Chinese children were enrolled between June 2008 and June 2009. Mean age was 10.42 +/- 2.03 and 10.86 +/- 2.23 years in obesity and control groups, respectively. Main outcome measures were apelin-12, BMI, lipids, glucose and insulin. HOMA-IR was calculated for all subjects. Results: All obesity group subjects had significantly higher total cholesterol (TC), triglycerides (TG), low-density lipoprotein cholesterol (LDL-C), insulin levels and HOMA-IR (all P<0.05). In separate analyses, obese girls had significantly higher LDL-C, insulin and HOMA-IR than controls, and obese boys had significantly higher TC, TG, insulin and HOMA-IR than controls (all P<0.05). Apelin-12 levels were significantly higher in obese girls compared to controls (P = 0.024), and correlated positively with TG in all obese subjects. Among obese girls, apelin-12 levels correlated positively with TG, insulin and HOMA-IR after adjusting for age and BMI. In all boys (obese and controls) apelin-12 was positively associated with fasting plasma glucose (FPG). No significant correlations were found in either group between apelin-12 levels and other characteristics after adjusting for age, sex, and BMI. Conclusions: Apelin-12 levels are significantly higher in obese vs. non-obese girls in China and correlate significantly with obesity-related markers insulin, HOMA-IR, and TG. Increased apelin-12 levels may be involved in the pathological mechanism of childhood obesity.	[Ba, Hong-Jun; Chen, Hong-Shan; Su, Zhe; Du, Min-Lian; Chen, Qiu-Li; Li, Yan-Hong; Ma, Hua-Mei] Sun Yat Sen Univ, Dept Pediat, Affiliated Hosp 1, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University	Chen, HS (corresponding author), Sun Yat Sen Univ, Dept Pediat, Affiliated Hosp 1, Guangzhou 510275, Guangdong, Peoples R China.	hongshand@163.com	li, yan/GTI-4638-2022		Technology Program of Guangdong Province in China [2007B031500006]	Technology Program of Guangdong Province in China	This study was supported by Grant 2007B031500006 from the Technology Program of Guangdong Province in China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arslanian S, 2002, HORM RES, V57, P19, DOI 10.1159/000053308; Berg AH, 2002, TRENDS ENDOCRIN MET, V13, P84, DOI 10.1016/S1043-2760(01)00524-0; Bottner A, 2004, J CLIN ENDOCR METAB, V89, P4053, DOI 10.1210/jc.2004-0303; Boucher J, 2005, ENDOCRINOLOGY, V146, P1764, DOI 10.1210/en.2004-1427; Caprio S, 2001, PEDIAT ENDOCRINO S1, P487; Castan-Iaurell I, 2012, TRENDS ENDOCRIN MET, V23, P234, DOI 10.1016/j.tem.2012.02.005; Cekmez F, 2011, EUR CYTOKINE NETW, V22, P32, DOI 10.1684/ecn.2011.0279; Cheng-ye JI, 2010, CHIN J SCH HLTH, V31, P257; Daviaud D, 2006, FASEB J, V20, P1528, DOI 10.1096/fj.05-5243fje; Erdem G, 2008, EXP CLIN ENDOCR DIAB, V116, P289, DOI 10.1055/s-2007-1004564; Goazigo ARL, 2007, AM J PHYSIOL-ENDOC M, V292, pE7, DOI 10.1152/ajpendo.00521.2005; Heinonen MV, 2005, REGUL PEPTIDES, V130, P7, DOI 10.1016/j.regpep.2005.05.003; Heinonen MV, 2009, NUTR METABOLISM CARD; Hosoya M, 2000, J BIOL CHEM, V275, P21061, DOI 10.1074/jbc.M908417199; Kralisch S, 2007, REGUL PEPTIDES, V139, P84, DOI 10.1016/j.regpep.2006.10.009; Kwiterovich PO, 2008, J CLIN ENDOCR METAB, V93, P4200, DOI 10.1210/jc.2008-1270; Li L, 2006, EXP CLIN ENDOCR DIAB, V114, P544, DOI 10.1055/s-2006-948309; Liu WJ, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-780; Love-Osborne K, 2006, PEDIATR DIABETES, V7, P205, DOI 10.1111/j.1399-5448.2006.00179.x; Machura E, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/760691; Mattsson N, 2008, ANN MED, V40, P542, DOI 10.1080/07853890802307709; Mesmin C, 2011, J PROTEOME RES, V10, P5222, DOI 10.1021/pr200725x; Pietrobelli A, 2008, ANGIOLOGY S2, P30; Rashid Mitchell N, 2003, Prev Cardiol, V6, P42, DOI 10.1111/j.1520-037X.2003.01358.x; Reinehr T, 2011, METABOLISM, V60, P1349, DOI 10.1016/j.metabol.2011.02.005; Simental-Mendia Luis E., 2008, Metabolic Syndrome and Related Disorders, V6, P299, DOI 10.1089/met.2008.0034; Steppan CM, 2001, NATURE, V409, P307, DOI 10.1038/35053000; Szokodi I, 2002, CIRC RES, V91, P434, DOI 10.1161/01.RES.0000033522.37861.69; Taheri S, 2002, BIOCHEM BIOPH RES CO, V291, P1208, DOI 10.1006/bbrc.2002.6575; TANNER JM, 1981, NUTR REV, V39, P43, DOI 10.1111/j.1753-4887.1981.tb06734.x; Tapan S, 2010, J PEDIATR ENDOCR MET, V23, P1039, DOI 10.1515/jpem.2010.165; Tasci I, 2007, EXP CLIN ENDOCR DIAB, V115, P428, DOI 10.1055/s-2007-971067; Tatemoto K, 2001, REGUL PEPTIDES, V99, P87, DOI 10.1016/S0167-0115(01)00236-1; Tatemoto K, 1998, BIOCHEM BIOPH RES CO, V251, P471, DOI 10.1006/bbrc.1998.9489; Ten S, 2004, J CLIN ENDOCR METAB, V89, P2526, DOI 10.1210/jc.2004-0276; Than A, 2012, MOL CELL ENDOCRINOL, V362, P227, DOI 10.1016/j.mce.2012.07.002; Wei L, 2005, REGUL PEPTIDES, V132, P27, DOI 10.1016/j.regpep.2005.08.003; Weiss R, 2008, DIABETES CARE, V31, pS310, DOI 10.2337/dc08-s273; Yue P, 2011, ENDOCRINOLOGY, V152, P59, DOI 10.1210/en.2010-0576; Zannolli R, 1996, ACTA PAEDIATR, V85, P1368, DOI 10.1111/j.1651-2227.1996.tb13928.x	40	22	25	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2014	9	1							e86577	10.1371/journal.pone.0086577	http://dx.doi.org/10.1371/journal.pone.0086577			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301BI	24475149	Green Submitted, gold, Green Published			2022-12-25	WOS:000330507300085
J	Bae, EH; Choi, HS; Joo, SY; Kim, IJ; Kim, CS; Choi, JS; Ma, SK; Lee, J; Kim, SW				Bae, Eun Hui; Choi, Hong Sang; Joo, Soo Yeon; Kim, In Jin; Kim, Chang Seong; Choi, Joon Seok; Ma, Seong Kwon; Lee, JongUn; Kim, Soo Wan			Farnesoid X Receptor Ligand Prevents Cisplatin-Induced Kidney Injury by Enhancing Small Heterodimer Partner	PLOS ONE			English	Article							RENAL INTERSTITIAL FIBROSIS; NUCLEAR RECEPTOR; TERMINAL KINASE; CELL APOPTOSIS; KAPPA-B; ACID; RATS; IDENTIFICATION; INFLAMMATION; INHIBITION	The farnesoid X receptor (FXR) is mainly expressed in liver, intestine and kidney. We investigated whether 6-ethyl chenodeoxycholic acid (6ECDCA), a semisynthetic derivative of chenodeoxycholic aicd (CDCA, an FXR ligand), protects against kidney injury and modulates small heterodimer partner (SHP) in cisplatin-induced kidney injury. Cisplatin inhibited SHP protein expression in the kidney of cisplatin-treated mice and human proximal tubular (HK2) cells; this effect was counteracted by FXR ligand. Hematoxylin and eosin staining revealed the presence of tubular casts, obstructions and dilatations in cisplatin-induced kidney injury, which was attenuated by FXR ligand. FXR ligand also attenuated protein expression of transforming growth factor-beta 1 (TGF-beta 1), Smad signaling, and the epithelial-to-mesenchymal transition process, inflammatory markers and cytokines, and apoptotic markers in cisplatin-treated mice. Cisplatin induced NF-kappa B activation in HK2 cell; this effect was attenuated by pretreatment with FXR ligand. In SHP knockdown by small interfering RNA, cisplatin-induced activation of TGF-beta 1, p-JNK and Bax/Bcl-2 ratio was not attenuated, while SHP overexpression and FXR ligand inhibited expression of these proteins in cisplatin-pretreated HK2 cells. In conclusion, FXR ligand, 6ECDCA prevents cisplatin-induced kidney injury, the underlying mechanism of which may be associated with anti-fibrotic, anti-inflammatory, and anti-apoptotic effects through SHP induction.	[Bae, Eun Hui; Choi, Hong Sang; Kim, Chang Seong; Choi, Joon Seok; Ma, Seong Kwon; Kim, Soo Wan] Chonnam Natl Univ Med Sch, Dept Internal Med, Kwangju, South Korea; [Joo, Soo Yeon; Kim, In Jin; Lee, JongUn] Chonnam Natl Univ Med Sch, Dept Physiol, Kwangju, South Korea	Chonnam National University; Chonnam National University	Kim, SW (corresponding author), Chonnam Natl Univ Med Sch, Dept Internal Med, Kwangju, South Korea.	skimw@chonnam.ac.kr			National Research Foundation of Korea (NRF) [2011-0030132]; Korea government (MSIP); Korea Research Foundation; Korean Government (MOEHRD, Basic Research Promotion Fund) [KRF-20100008732]; Basic Science Research Program through the National Research Foundation of Korea (NRF); Ministry of Science, ICT and future Planning [2013R1A2A2A01067611]	National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Korea government (MSIP); Korea Research Foundation(National Research Foundation of Korea); Korean Government (MOEHRD, Basic Research Promotion Fund)(Ministry of Education & Human Resources Development (MOEHRD), Republic of KoreaKorean Government); Basic Science Research Program through the National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Ministry of Science, ICT and future Planning(Ministry of Science, ICT & Future Planning, Republic of Korea)	This work was supported by the National Research Foundation of Korea (NRF) grant (MRC for Gene Regulation, 2011-0030132) funded by the Korea government (MSIP), by Korea Research Foundation Grant funded by the Korean Government (MOEHRD, Basic Research Promotion Fund) (KRF-20100008732), and by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT and future Planning (2013R1A2A2A01067611). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcorn JF, 2009, AM J RESP CELL MOL, V40, P422, DOI 10.1165/rcmb.2008-0174OC; Bottinger EP, 2002, J AM SOC NEPHROL, V13, P2600, DOI 10.1097/01.ASN.0000033611.79556.AE; Cantley LC, 2002, SCIENCE, V296, P1655, DOI 10.1126/science.296.5573.1655; Claudel T, 2004, EXPERT OPIN INV DRUG, V13, P1135, DOI 10.1517/13543784.13.9.1135; FORMAN BM, 1995, CELL, V81, P687, DOI 10.1016/0092-8674(95)90530-8; Ge Q, 2010, J CELL PHYSIOL, V225, P846, DOI 10.1002/jcp.22295; Goodwin B, 2000, MOL CELL, V6, P517, DOI 10.1016/S1097-2765(00)00051-4; Guijarro C, 2001, KIDNEY INT, V59, P415, DOI 10.1046/j.1523-1755.2001.059002415.x; Hu ZJ, 2012, KIDNEY BLOOD PRESS R, V36, P85, DOI 10.1159/000341485; Jiang M, 2006, ONCOGENE, V25, P4056, DOI 10.1038/sj.onc.1209440; Jiang T, 2007, DIABETES, V56, P2485, DOI 10.2337/db06-1642; Jung GS, 2009, J AM SOC NEPHROL, V20, P2162, DOI 10.1681/ASN.2008121232; Kim SW, 2004, AM J PHYSIOL-RENAL, V286, pF922, DOI 10.1152/ajprenal.00277.2003; Kim YD, 2008, DIABETES, V57, P306, DOI 10.2337/db07-0381; Lebwohl D, 1998, EUR J CANCER, V34, P1522, DOI 10.1016/S0959-8049(98)00224-X; Liu YM, 2012, J PHARMACOL EXP THER, V341, P725, DOI 10.1124/jpet.111.191247; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu TT, 2000, MOL CELL, V6, P507, DOI 10.1016/S1097-2765(00)00050-2; Ma FY, 2007, J AM SOC NEPHROL, V18, P472, DOI 10.1681/ASN.2006060604; Nogae S, 1998, J AM SOC NEPHROL, V9, P620; Park JW, 2012, EUR J PHARMACOL, V683, P301, DOI 10.1016/j.ejphar.2012.03.019; Proctor G, 2006, DIABETES, V55, P2502, DOI 10.2337/db05-0603; Rinna A, 2008, AM J RESP CELL MOL, V39, P97, DOI 10.1165/rcmb.2007-0371OC; Rosenau C, 2004, J BIOMOL SCREEN, V9, P334, DOI 10.1177/1087057103261446; Seol W, 1996, SCIENCE, V272, P1336, DOI 10.1126/science.272.5266.1336; Trotter KW, 2004, MOL CELL BIOL, V24, P3347, DOI 10.1128/MCB.24.8.3347-3358.2004; YAMAGUCHI K, 1995, SCIENCE, V270, P2008, DOI 10.1126/science.270.5244.2008; Yamate J, 2005, TOXICOL PATHOL, V33, P207, DOI 10.1080/01926230490523978; YAMATE J, 1995, J COMP PATHOL, V112, P27, DOI 10.1016/S0021-9975(05)80087-8; Yuk JM, 2011, NAT IMMUNOL, V12, P742, DOI 10.1038/ni.2064	30	24	26	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2014	9	1							e86553	10.1371/journal.pone.0086553	http://dx.doi.org/10.1371/journal.pone.0086553			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301BI	24475141	Green Published, gold, Green Submitted			2022-12-25	WOS:000330507300078
J	Golberg, A; Linshiz, G; Kravets, I; Stawski, N; Hillson, NJ; Yarmush, ML; Marks, RS; Konry, T				Golberg, Alexander; Linshiz, Gregory; Kravets, Ilia; Stawski, Nina; Hillson, Nathan J.; Yarmush, Martin L.; Marks, Robert S.; Konry, Tania			Cloud-Enabled Microscopy and Droplet Microfluidic Platform for Specific Detection of Escherichia coli in Water	PLOS ONE			English	Article							DRINKING-WATER; SYSTEMS; BURDEN; DISEASES; QUALITY; AMPLIFICATION; ENUMERATION; SANITATION; BACTERIA; HYGIENE	We report an all-in-one platform - ScanDrop - for the rapid and specific capture, detection, and identification of bacteria in drinking water. The ScanDrop platform integrates droplet microfluidics, a portable imaging system, and cloud-based control software and data storage. The cloud-based control software and data storage enables robotic image acquisition, remote image processing, and rapid data sharing. These features form a "cloud'' network for water quality monitoring. We have demonstrated the capability of ScanDrop to perform water quality monitoring via the detection of an indicator coliform bacterium, Escherichia coli, in drinking water contaminated with feces. Magnetic beads conjugated with antibodies to E. coli antigen were used to selectively capture and isolate specific bacteria from water samples. The bead-captured bacteria were co-encapsulated in pico-liter droplets with fluorescently-labeled anti-E. coli antibodies, and imaged with an automated custom designed fluorescence microscope. The entire water quality diagnostic process required 8 hours from sample collection to online-accessible results compared with 2-4 days for other currently available standard detection methods.	[Golberg, Alexander; Yarmush, Martin L.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Ctr Engn Med,Shriners Burns Inst, Boston, MA USA; [Linshiz, Gregory; Stawski, Nina; Hillson, Nathan J.] Joint BioEnergy Inst, Fuels Synth Div, Emeryville, CA USA; [Linshiz, Gregory; Stawski, Nina; Hillson, Nathan J.] Lawrence Berkeley Natl Labs, Phys BioSci Div, Berkeley, CA USA; [Linshiz, Gregory; Hillson, Nathan J.] DOE Joint Genome Inst, Walnut Creek, CA USA; [Kravets, Ilia] Technion Israel Inst Technol, Dept Comp Sci, IL-32000 Haifa, Israel; [Yarmush, Martin L.] Rutgers State Univ, Dept Biomed Engn, Piscataway, NJ 08855 USA; [Marks, Robert S.] Ben Gurion Univ Negev, Natl Inst Biotechnol Negev, Dept Biotechnol Engn, IL-84105 Beer Sheva, Israel; [Marks, Robert S.] Nanyang Technol Univ, Sch Mat Sci & Engn, Singapore 639798, Singapore; [Marks, Robert S.] NRF CREATE Program Nanomat Energy & Water Managem, Singapore, Singapore; [Konry, Tania] Northeastern Univ, Dept Pharmaceut Sci, Sch Pharm Bouve, Coll Hlth Sci, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Massachusetts General Hospital; United States Department of Energy (DOE); Joint BioEnergy Institute - JBEI; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; United States Department of Energy (DOE); Technion Israel Institute of Technology; Rutgers State University New Brunswick; Ben Gurion University; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Northeastern University	Konry, T (corresponding author), Northeastern Univ, Dept Pharmaceut Sci, Sch Pharm Bouve, Coll Hlth Sci, Boston, MA 02115 USA.	t.konry@neu.edu	MARKS, ROBERT/AAS-4746-2020; Golberg, Alexander/M-9563-2017	Golberg, Alexander/0000-0001-8782-8879; Yarmush, Martin/0000-0003-4986-8444; Marks, Robert/0000-0002-9697-3805	Shriners Foundation [85120-BOS]; Office of Science, Office of Biological and Environmental Research, of the U.S. Department of Energy [DE-AC02-05CH11231]; Singapore National Research Foundation; Campus for Research Excellence And Technological Enterprise (CREATE) program for the project 'Nanomaterials for Energy and Water Management'; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P41EB002503] Funding Source: NIH RePORTER	Shriners Foundation; Office of Science, Office of Biological and Environmental Research, of the U.S. Department of Energy(United States Department of Energy (DOE)); Singapore National Research Foundation(National Research Foundation, Singapore); Campus for Research Excellence And Technological Enterprise (CREATE) program for the project 'Nanomaterials for Energy and Water Management'; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	AG and MY acknowledge Shriners Foundation Grant #85120-BOS for the support of this work. The portion of this work conducted by the Joint BioEnergy Institute, and the U.S. Department of Energy Joint Genome Institute, was supported by the Office of Science, Office of Biological and Environmental Research, of the U.S. Department of Energy (Contract No. DE-AC02-05CH11231). This research is funded in part by the Singapore National Research Foundation and the publication is supported under the Campus for Research Excellence And Technological Enterprise (CREATE) program for the project 'Nanomaterials for Energy and Water Management'. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdulhalim I, 2009, APPL PHYS LETT, V94, DOI 10.1063/1.3081031; Abdulhalim I., 2008, J ELECTROMAGN, V28, P213; Abu-Rabeah K, 2009, BIOSENS BIOELECTRON, V24, P3461, DOI 10.1016/j.bios.2009.04.042; Al-Bayatti KK, 2012, J ENV PUBLIC HLTH, V2012; Allevi RP, 2013, J WATER HEALTH, V11, P244, DOI 10.2166/wh.2013.152; [Anonymous], 2005, EX WAT WAST 9020 QUA; Baroud CN, 2010, LAB CHIP, V10, P2032, DOI 10.1039/c001191f; Bogomolny E, 2013, ANALYST, V138, P4112, DOI 10.1039/c3an00254c; Bringer MR, 2004, PHILOS T R SOC A, V362, P1087, DOI 10.1098/rsta.2003.1364; Buffi N, 2011, LAB CHIP, V11, P2369, DOI 10.1039/c1lc20274j; Cann KF, 2013, EPIDEMIOL INFECT, V141, P671, DOI 10.1017/S0950268812001653; Choi K, 2012, ANNU REV ANAL CHEM, V5, P413, DOI 10.1146/annurev-anchem-062011-143028; Clausell-Tormos J, 2008, CHEM BIOL, V15, P427, DOI 10.1016/j.chembiol.2008.04.004; Edberg SC, 2000, J APPL MICROBIOL, V88, p106S, DOI 10.1111/j.1365-2672.2000.tb05338.x; EPA, 2006, TOT COL RUL REQ; Fewtrell L., 2001, WATER QUALITY GUIDEL; Guo MT, 2012, LAB CHIP, V12, P2146, DOI 10.1039/c2lc21147e; Gwimbi P, 2011, AFR HEALTH SCI, V11, P474; Ham TS, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks531; Handique K, 2001, J MICROMECH MICROENG, V11, P548, DOI 10.1088/0960-1317/11/5/316; Jafari N, 2011, J RES MED SCI, V16, P956; Johnson PE, 2006, CYTOM PART A, V69A, P1212, DOI 10.1002/cyto.a.20351; Kao MC, 2010, ANAL LETT, V43, P1756, DOI 10.1080/00032711003654005; Karabchevsky A, 2012, J NANOPHOTONICS, V6; Kosek M, 2003, B WORLD HEALTH ORGAN, V81, P197; Langer V, 2011, ANAL BIOANAL CHEM, V399, P1041, DOI 10.1007/s00216-010-4414-0; Leclerc H, 2003, EMERG I WATER INFECT, P80; Levy K, 2012, AM J TROP MED HYG, V86, P499, DOI 10.4269/ajtmh.2012.11-0263; Lewin S, 2007, SAMJ S AFR MED J, V97, P755; Liebes Y, 2009, TALANTA, V80, P338, DOI 10.1016/j.talanta.2009.06.070; Liebes Y, 2009, SENSOR ACTUAT B-CHEM, V140, P568, DOI 10.1016/j.snb.2009.04.050; Linshiz G, 2013, ACS SYNTH BIOL, V2, P216, DOI 10.1021/sb300075t; Liu YM, 2008, APPL ENVIRON MICROB, V74, P1502, DOI 10.1128/AEM.02125-07; Maheux AF, 2009, WATER RES, V43, P3019, DOI 10.1016/j.watres.2009.04.017; Mairhofer J, 2009, SENSORS-BASEL, V9, P4804, DOI 10.3390/s90604804; Mandeville KL, 2009, WORLD J GASTROENTERO, V15, P2839, DOI 10.3748/wjg.15.2839; Mazutis L, 2013, NAT PROTOC, V8, P870, DOI 10.1038/nprot.2013.046; Niu XZ, 2012, BIOCHEM SOC T, V40, P615, DOI 10.1042/BST20120005; Noble Rachel T., 2005, Journal of Water and Health, V3, P381; Pruss A, 2002, ENVIRON HEALTH PERSP, V110, P537, DOI 10.1289/ehp.02110537; Reyes DR, 2002, ANAL CHEM, V74, P2623, DOI 10.1021/ac0202435; Rompre A, 2002, J MICROBIOL METH, V49, P31, DOI 10.1016/S0167-7012(01)00351-7; Sabat G, 2000, APPL ENVIRON MICROB, V66, P844, DOI 10.1128/AEM.66.2.844-849.2000; Sarkar R, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-87; Sarrazin F, 2007, CHEM ENG SCI, V62, P1042, DOI 10.1016/j.ces.2006.10.013; Setterington EB, 2012, BIOSENSORS-BASEL, V2, P15, DOI 10.3390/bios2010015; Shalabney A, 2011, LASER PHOTONICS REV, V5, P571, DOI 10.1002/lpor.201000009; Stoler J, 2012, HEALTH PLACE, V18, P250, DOI 10.1016/j.healthplace.2011.09.020; Subbaraman R, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-173; Sun H, 2009, BIOSENS BIOELECTRON, V24, P1405, DOI 10.1016/j.bios.2008.08.008; Tantawiwat Suwalee, 2005, Southeast Asian Journal of Tropical Medicine and Public Health, V36, P162; Teschke K, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-767; Tsen HY, 1998, J APPL MICROBIOL, V85, P554, DOI 10.1046/j.1365-2672.1998.853535.x; WHO, 2006, GUIDL DRINK WAT QUAL; Xiao XL, 2013, CAN J MICROBIOL, V59, P157, DOI 10.1139/cjm-2012-0577; Yang K, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001483; Zourob Mohammed, 2008, P139, DOI 10.1007/978-0-387-75113-9_8	57	34	35	1	64	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2014	9	1							e86341	10.1371/journal.pone.0086341	http://dx.doi.org/10.1371/journal.pone.0086341			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301BI	24475107	Green Published, gold			2022-12-25	WOS:000330507300055
J	Nogueira, SSC; Abreu, SA; Peregrino, H; Nogueira, SLG				Nogueira, Selene S. C.; Abreu, Shauana A.; Peregrino, Helderes; Nogueira-Filho, Sergio L. G.			The Effects of Feeding Unpredictability and Classical Conditioning on Pre-Release Training of White-Lipped Peccary (Mammalia, Tayassuidae)	PLOS ONE			English	Article							COLLARED PECCARY; BEHAVIOR; WELFARE; ANIMALS; SCHEDULES; PATTERNS; REWARD	Some authors have suggested that environmental unpredictability, accompanied by some sort of signal for behavioral conditioning, can boost activity or foster exploratory behavior, which may increase post-release success in re-introduction programs. Thus, using white-lipped peccary (Tayassu pecari), a vulnerable Neotropical species, as a model, we evaluated an unpredictable feeding schedule. Associating this with the effect of classical conditioning on behavioral activities, we assessed the inclusion of this approach in pre-release training protocols. The experimental design comprised predictable feeding phases (control phases: C-1, C-2 and C-3) and unpredictable feeding phases (U-1-signaled and U-2-non-signaled). The animals explored more during the signaled and non-signaled unpredictable phases and during the second control phase (C-2) than during the other two predictable phases (C-1 and C-3). The peccaries also spent less time feeding during the signaled unpredictable phase (U-1) and the following control phase (C-2) than during the other phases. Moreover, they spent more time in aggressive encounters during U-1 than the other experimental phases. However, the animals did not show differences in the time they spent on affiliative interactions or in the body weight change during the different phases. The signaled unpredictability, besides improving foraging behavior, showing a prolonged effect on the next control phase (C-2), also increased the competition for food. The signaled feeding unpredictability schedule, mimicking wild conditions by eliciting the expression of naturalistic behaviors in pre-release training, may be essential to fully prepare them for survival in the wild.	[Nogueira, Selene S. C.; Abreu, Shauana A.; Nogueira-Filho, Sergio L. G.] Univ Estadual Santa Cruz, Lab Etol Aplicada, Ilheus, BA, Brazil; [Peregrino, Helderes] Univ Fed Rio Grande do Norte, Lab Fisiol Comportamento, BR-59072970 Natal, RN, Brazil	Universidade Estadual de Santa Cruz; Universidade Federal do Rio Grande do Norte	Nogueira, SSC (corresponding author), Univ Estadual Santa Cruz, Lab Etol Aplicada, Ilheus, BA, Brazil.	selene.nogueira@pq.cnpq.br	Nogueira, Selene/I-1843-2013; Nogueira-Filho, Sérgio L.G./F-6264-2014; Nogueira, Selene/W-5237-2019	Nogueira, Selene/0000-0001-8078-4172; Nogueira, Selene/0000-0001-8078-4172; Nogueira-Filho, Sergio/0000-0001-5392-0773	CNPq [476741/2010-6, 300587/2009-0, 306154/2010-2]; CAPES/PNPD [2951/2010]; CAPES/PROCAD-NF [794-2009]; UESC; CAPES	CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CAPES/PNPD(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); CAPES/PROCAD-NF(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); UESC; CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This study was under the auspices of CNPq # 476741/2010-6, CAPES/PNPD#2951/2010; CAPES/PROCAD-NF # 794-2009 and UESC. Sergio Nogueira-Filho and Selene Nogueira were supported by CNPq (Process # 300587/2009-0 and 306154/2010-2, respectively). S. A. A. was supported by CAPES. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTMANN J, 1974, BEHAVIOUR, V49, P227, DOI 10.1163/156853974X00534; [Anonymous], 2007, LEARNING BEHAV CONT; Bassett L, 2007, APPL ANIM BEHAV SCI, V102, P223, DOI 10.1016/j.applanim.2006.05.029; Beck Benjamin, 1995, P155; Carlstead K, 2010, WILD MAMMALS CAPTIVI, P317; Dubost G, 2001, MAMM BIOL, V66, P65; Figueira MD, 2003, REV BRAS ZOOTECN, V32, P191, DOI 10.1590/S1516-35982003000100024; Fragoso JMV, 1998, BIOTROPICA, V30, P458, DOI 10.1111/j.1744-7429.1998.tb00080.x; Frantzen MAJ, 2001, BIOL CONSERV, V100, P253, DOI 10.1016/S0006-3207(01)00046-5; GALLAGHER JF, 1984, J WILDLIFE MANAGE, V48, P749, DOI 10.2307/3801422; Gilbert-Norton LB, 2009, APPL ANIM BEHAV SCI, V120, P179, DOI 10.1016/j.applanim.2009.06.007; Griffin AS, 2000, CONSERV BIOL, V14, P1317, DOI 10.1046/j.1523-1739.2000.99326.x; Heffner C. L., 2004, RES METHODS ED PSYCH; Hollerman JR, 1998, NAT NEUROSCI, V1, P304, DOI 10.1038/1124; Keuroghlian A, 2013, IUCN 2013 IUCN RED L; Korte SM, 2007, PHYSIOL BEHAV, V92, P422, DOI 10.1016/j.physbeh.2006.10.018; McPhee M. Elsbeth, 2010, P303; McPhee ME, 2004, BIOL CONSERV, V115, P71, DOI 10.1016/S0006-3207(03)00095-8; Moe RO, 2009, APPL ANIM BEHAV SCI, V121, P171, DOI 10.1016/j.applanim.2009.10.002; Nogueira SSC, 2011, APPL ANIM BEHAV SCI, V132, P193, DOI 10.1016/j.applanim.2011.04.002; Nogueira Selene S.C., 2007, Suiform Soundings, V7, P9; Nogueira-Filho S.L, 2004, PEOPLE NATURE WILDLI, P171; Nogueira-Filho S. L. G., 1999, REV ETOL, V1, P89; Nogueira-Filho Sergio L.G., 2012, Suiform Soundings, V11, P21; Paul ES, 2005, NEUROSCI BIOBEHAV R, V29, P469, DOI 10.1016/j.neubiorev.2005.01.002; Perlman JE, 2012, APPL ANIM BEHAV SCI, V137, P114, DOI 10.1016/j.applanim.2011.11.003; Reading R.P., 2013, ZOO BIOL, V9999, P1; Shettleworth S. J., 2009, COGNITION EVOLUTION; Sowls LK., 1997, JAVELINAS OTHER PECC, V2, P325; Spruijt BM, 2001, APPL ANIM BEHAV SCI, V72, P145, DOI 10.1016/S0168-1591(00)00204-5; Stoinski TS, 2004, AM J PRIMATOL, V62, P1, DOI 10.1002/ajp.20002; Swaisgood RR, 2005, ZOO BIOL, V24, P499, DOI 10.1002/zoo.20066; Timberlake W., 1995, PERSPECTIVES ETHOLOG, V2, P211; Toates F, 2004, APPL ANIM BEHAV SCI, V86, P173, DOI 10.1016/j.applanim.2004.02.010; Ulyan MJ, 2006, APPL ANIM BEHAV SCI, V101, P154, DOI 10.1016/j.applanim.2006.01.010; Waitt C, 2001, APPL ANIM BEHAV SCI, V75, P75, DOI 10.1016/S0168-1591(01)00174-5; Watters JV, 2007, APPL ANIM BEHAV SCI, V102, P364, DOI 10.1016/j.applanim.2006.05.036; Watters JV, 2009, ZOO BIOL, V28, P609, DOI 10.1002/zoo.20284; Yeates JW, 2008, VET J, V175, P293, DOI 10.1016/j.tvjl.2007.05.009	39	9	10	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2014	9	1							e86080	10.1371/journal.pone.0086080	http://dx.doi.org/10.1371/journal.pone.0086080			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301BI	24475072	Green Published, gold, Green Submitted			2022-12-25	WOS:000330507300035
J	Sessa, L; Gatti, E; Zeni, F; Antonelli, A; Catucci, A; Koch, M; Pompilio, G; Fritz, G; Raucci, A; Bianchi, ME				Sessa, Luca; Gatti, Elena; Zeni, Filippo; Antonelli, Antonella; Catucci, Alessandro; Koch, Michael; Pompilio, Giulio; Fritz, Guenter; Raucci, Angela; Bianchi, Marco E.			The Receptor for Advanced Glycation End-Products (RAGE) Is Only Present in Mammals, and Belongs to a Family of Cell Adhesion Molecules (CAMs)	PLOS ONE			English	Article							STRUCTURAL BASIS; ENDPRODUCTS RAGE; CLUSTAL-W; I-TASSER; PROTEIN; MARKER; ALIGNMENT; LIGANDS; ATHEROSCLEROSIS; CLASSIFICATION	The human receptor for advanced glycation endproducts (RAGE) is a multiligand cell surface protein belonging to the immunoglobulin superfamily, and is involved in inflammatory and immune responses. Most importantly, RAGE is considered a receptor for HMGB1 and several S100 proteins, which are Damage-Associated Molecular Pattern molecules (DAMPs) released during tissue damage. In this study we show that the Ager gene coding for RAGE first appeared in mammals, and is closely related to other genes coding for cell adhesion molecules (CAMs) such as ALCAM, BCAM and MCAM that appeared earlier during metazoan evolution. RAGE is expressed at very low levels in most cells, but when expressed at high levels, it mediates cell adhesion to extracellular matrix components and to other cells through homophilic interactions. Our results suggest that RAGE evolved from a family of CAMs, and might still act as an adhesion molecule, in particular in the lung where it is highly expressed or under pathological conditions characterized by an increase of its protein levels.	[Sessa, Luca; Gatti, Elena; Antonelli, Antonella; Catucci, Alessandro; Bianchi, Marco E.] San Raffaele Univ & Res Inst, Chromatin Dynam Unit, Milan, Italy; [Zeni, Filippo; Pompilio, Giulio; Raucci, Angela] Ctr Cardiol Monzino, Lab Vasc Biol & Regenerat Med, Milan, Italy; [Koch, Michael; Fritz, Guenter] Univ Freiburg, Inst Neuropathol, D-79106 Freiburg, Germany	Vita-Salute San Raffaele University; IRCCS Centro Cardiologico Monzino; University of Freiburg	Raucci, A (corresponding author), Ctr Cardiol Monzino, Lab Vasc Biol & Regenerat Med, Milan, Italy.	araucci@ccfm.it; bianchi.marco@hsr.it	Pompilio, Giulio/J-6701-2014; Antonelli, Antonella/AAN-1856-2020; ANTONELLI, ANTONELLA/C-6238-2011; Raucci, Angela/K-3722-2018; Fritz, Guenter/E-2933-2013; Bianchi, Marco Emilio/K-3417-2018	Pompilio, Giulio/0000-0003-2581-5735; Fritz, Guenter/0000-0002-4571-8812; Bianchi, Marco Emilio/0000-0002-5329-6445; Antonelli, Antonella/0000-0003-1497-3586; Raucci, Angela/0000-0003-1333-9671	Italian Association for Cancer research (AIRC) [IG-10411]; Italian Mininstry of Health [RF-027B]; Fondazione Monzino and Centro Cardiologico Monzino-IRCCS [RC 2011-2013]; Heisenberg fellowship of the Deutsche Forschungsgemeinschaft [FR 1488/3-2]	Italian Association for Cancer research (AIRC)(Fondazione AIRC per la ricerca sul cancro); Italian Mininstry of Health; Fondazione Monzino and Centro Cardiologico Monzino-IRCCS; Heisenberg fellowship of the Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by grants from the Italian Association for Cancer research (AIRC, IG-10411) and the Italian Mininstry of Health (RF-027B) to MEB, and by Fondazione Monzino and Centro Cardiologico Monzino-IRCCS (RC 2011-2013). GF is supported by a Heisenberg fellowship of the Deutsche Forschungsgemeinschaft (FR 1488/3-2). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of themanuscript.	Allmen EU, 2008, PROSTATE, V68, P748, DOI 10.1002/pros.20736; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; [Anonymous], 2011, PYMOL MOL GRAPHICS S; Barile GR, 2007, CURR MOL MED, V7, P758, DOI 10.2174/156652407783220778; Barth K, 2005, HISTOCHEM CELL BIOL, V123, P239, DOI 10.1007/s00418-004-0727-4; Basta G, 2008, ATHEROSCLEROSIS, V196, P9, DOI 10.1016/j.atherosclerosis.2007.07.025; Boca M, 2007, MOL BIOL CELL, V18, P4050, DOI 10.1091/mbc.E07-02-0142; BORK P, 1994, J MOL BIOL, V242, P309, DOI 10.1006/jmbi.1994.1582; Briot R, 2009, CHEST, V135, P269, DOI 10.1378/chest.08-0919; Clynes R, 2007, CURR MOL MED, V7, P743; Constien R, 2001, GENESIS, V30, P36, DOI 10.1002/gene.1030; Dattilo BM, 2007, BIOCHEMISTRY-US, V46, P6957, DOI 10.1021/bi7003735; Demling N, 2006, CELL TISSUE RES, V323, P475, DOI 10.1007/s00441-005-0069-0; Englert JM, 2008, AM J PATHOL, V172, P583, DOI 10.2353/ajpath.2008.070569; Webb Benjamin, 2016, Curr Protoc Bioinformatics, V54, DOI [10.1002/0471140864.ps0209s50, 10.1002/cpps.20, 10.1002/0471250953.bi0506s15, 10.1002/cpbi.3]; Francavilla C, 2009, SEMIN CANCER BIOL, V19, P298, DOI 10.1016/j.semcancer.2009.05.004; Fritz G, 2011, TRENDS BIOCHEM SCI, V36, P625, DOI 10.1016/j.tibs.2011.08.008; Frommhold D, 2010, BLOOD, V116, P841, DOI 10.1182/blood-2009-09-244293; Harja E, 2008, J CLIN INVEST, V118, P183, DOI 10.1172/JCI32703; HARPAZ Y, 1994, J MOL BIOL, V238, P528, DOI 10.1006/jmbi.1994.1312; Hasegawa H, 2009, CURR OPIN STRUC BIOL, V19, P341, DOI 10.1016/j.sbi.2009.04.003; Herold K, 2007, J LEUKOCYTE BIOL, V82, P204, DOI 10.1189/jlb.1206751; Higgins D G, 1994, Methods Mol Biol, V25, P307; Holm L., 2012, NUCLEIC ACIDS RES, V38, pW545; Hudson BI, 2008, FASEB J, V22, P1572, DOI 10.1096/fj.07-9909com; Hyogo H, 2008, CURR PHARM DESIGN, V14, P969, DOI 10.2174/138161208784139701; Johnson CP, 2004, P NATL ACAD SCI USA, V101, P6963, DOI 10.1073/pnas.0307567100; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kierdorf K, 2013, J LEUKOCYTE BIOL, V94, P55, DOI 10.1189/jlb.1012519; Klaile E, 2009, J CELL BIOL, V187, P553, DOI 10.1083/jcb.200904149; Koch M, 2010, STRUCTURE, V18, P1342, DOI 10.1016/j.str.2010.05.017; Kulski JK, 2002, IMMUNOL REV, V190, P95, DOI 10.1034/j.1600-065X.2002.19008.x; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Liliensiek B, 2004, J CLIN INVEST, V113, P1641, DOI 10.1172/JCI200418704; Logsdon CD, 2007, CURR MOL MED, V7, P777, DOI 10.2174/156652407783220697; Lotze MT, 2007, IMMUNOL REV, V220, P60, DOI 10.1111/j.1600-065X.2007.00579.x; Mankelow T, 2007, BLOOD, V110, P3398, DOI 10.1182/blood-2007-06-094748; Page Roderic D M, 2002, Curr Protoc Bioinformatics, VChapter 6, DOI 10.1002/0471250953.bi0602s01; Park H, 2010, J BIOL CHEM, V285, P40762, DOI 10.1074/jbc.M110.169276; Powell S, 2012, NUCLEIC ACIDS RES, V40, pD284, DOI 10.1093/nar/gkr1060; Queisser MA, 2008, AM J RESP CELL MOL, V39, P337, DOI 10.1165/rcmb.2007-0244OC; Raucci A, 2008, FASEB J, V22, P3716, DOI 10.1096/fj.08-109033; Reiss K, 2009, SEMIN CELL DEV BIOL, V20, P126, DOI 10.1016/j.semcdb.2008.11.002; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; SCHNEIDER T, 1995, NEURON, V15, P259, DOI 10.1016/0896-6273(95)90032-2; Shirasawa M, 2004, GENES CELLS, V9, P165, DOI 10.1111/j.1356-9597.2004.00712.x; Sirois CM, 2013, J EXP MED, V210, P2447, DOI 10.1084/jem.20120201; SUGAYA K, 1994, GENOMICS, V23, P408, DOI 10.1006/geno.1994.1517; Tamura K, 1998, NEURON, V20, P1153, DOI 10.1016/S0896-6273(00)80496-1; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Uchida T, 2006, AM J RESP CRIT CARE, V173, P1008, DOI 10.1164/rccm.200509-1477OC; van Zoelen MAD, 2009, J IMMUNOL, V182, P4349, DOI 10.4049/jimmunol.0801199; Xie JJ, 2008, J BIOL CHEM, V283, P27255, DOI 10.1074/jbc.M801622200; Xu D, 2013, ACS CHEM BIOL; Yamamoto H, 2007, CURR MOL MED, V7, P752, DOI 10.2174/156652407783220769; Yan SD, 2009, J ALZHEIMERS DIS, V16, P833, DOI 10.3233/JAD-2009-1030; Yang YT, 2004, MOL CELL, V14, P269, DOI 10.1016/S1097-2765(04)00204-7; Yatime L, 2013, FEBS J; Zen K, 2007, J IMMUNOL, V178, P2483, DOI 10.4049/jimmunol.178.4.2483; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40	61	93	94	2	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2014	9	1							e86903	10.1371/journal.pone.0086903	http://dx.doi.org/10.1371/journal.pone.0086903			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301BI	24475194	Green Published, gold, Green Submitted			2022-12-25	WOS:000330507300116
J	Zhou, Z; Gao, X; Wang, YY; Zhou, HL; Wu, C; Paranhos-Baccala, G; Vernet, G; Guo, L; Wang, JW				Zhou, Zhuo; Gao, Xin; Wang, Yaying; Zhou, Hongli; Wu, Chao; Paranhos-Baccala, Glaucia; Vernet, Guy; Guo, Li; Wang, Jianwei			Conserved B-Cell Epitopes among Human Bocavirus Species Indicate Potential Diagnostic Targets	PLOS ONE			English	Article							YOUNG-CHILDREN; INFECTION; SEROEPIDEMIOLOGY; IDENTIFICATION; HEMAGGLUTININ; ANTIBODIES	Background: Human bocavirus species 1-4 (HBoV1-4) have been associated with respiratory and enteric infections in children. However, the immunological mechanisms in response to HBoV infections are not fully understood. Though previous studies have shown cross-reactivities between HBoV species, the epitopes responsible for this phenomenon remain unknown. In this study, we used genomic and immunologic approaches to identify the reactive epitopes conserved across multiple HBoV species and explored their potential as the basis of a novel diagnostic test for HBoVs. Methodology/Principal Findings: We generated HBoV1-3 VP2 gene fragment phage display libraries (GFPDLs) and used these libraries to analyze mouse antisera against VP2 protein of HBoV1, 2, and 3, and human sera positive for HBoVs. Using this approach, we mapped four epitope clusters of HBoVs and identified two immunodominant peptides-P1 ((1)MSDTDIQDQQPDTVDAPQNT(20)), and P2 ((162)EHAYPNASHPWDEDVMPDL(180))-that are conserved among HBoV1-4. To confirm epitope immunogenicity, we immunized mice with the immunodominant P1 and P2 peptides identified in our screen and found that they elicited high titer antibodies in mice. These two antibodies could only recognize the VP2 of HBoV 1-4 in Western blot assays, rather than those of the two other parvoviruses human parvovirus B19 and human parvovirus 4 (PARV4). Based on our findings, we evaluated epitope-based peptide-IgM ELISAs as potential diagnostic tools for HBoVs IgM antibodies. We found that the P1+P2-IgM ELISA showed a higher sensitivity and specificity in HBoVs IgM detection than the assays using a single peptide. Conclusions/Significance: The identification of the conserved B-cell epitopes among human bocavirus species contributes to our understanding of immunological cross-reactivities of HBoVs, and provides important insights for the development of HBoV diagnostic tools.	[Zhou, Zhuo; Gao, Xin; Wang, Yaying; Zhou, Hongli; Wu, Chao; Guo, Li; Wang, Jianwei] CAMS, MOH Key Lab Syst Biol Pathogens, Beijing, Peoples R China; [Zhou, Zhuo; Gao, Xin; Wang, Yaying; Zhou, Hongli; Wu, Chao; Guo, Li; Wang, Jianwei] CAMS, IPB, CAMS Fdn Merieux, Christophe Merieux Lab, Beijing, Peoples R China; [Zhou, Zhuo; Gao, Xin; Wang, Yaying; Zhou, Hongli; Wu, Chao; Guo, Li; Wang, Jianwei] Peking Union Med Coll, Beijing 100021, Peoples R China; [Paranhos-Baccala, Glaucia; Vernet, Guy] Fdn Merieux, Lyon, France	Chinese Academy of Medical Sciences - Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Pathogen Biology - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Guo, L (corresponding author), CAMS, MOH Key Lab Syst Biol Pathogens, Beijing, Peoples R China.	gnyny0803@163.com; wangjw28@163.com	Wang, Jianwei/W-5916-2019; Wang, Jianwei/AAW-9499-2020	Wang, Jianwei/0000-0002-1116-4559; zhou, zhuo/0000-0001-5862-9854	International Science and Technology Cooperation Program of China [2010DFB33270]; National Major Science & Technology Project for Control and Prevention of Major Infectious Diseases of China [2012ZX10004-206]	International Science and Technology Cooperation Program of China; National Major Science & Technology Project for Control and Prevention of Major Infectious Diseases of China	This study was supported in part by the International Science and Technology Cooperation Program of China (2010DFB33270) (http://www.cistc.gov.cn) and by the National Major Science & Technology Project for Control and Prevention of Major Infectious Diseases of China (2012ZX10004-206) (http://www.nmp.gov.cn). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Allander T, 2005, P NATL ACAD SCI USA, V102, P12891, DOI 10.1073/pnas.0504666102; Allander T, 2007, CLIN INFECT DIS, V44, P904, DOI 10.1086/512196; Arthur JL, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000391; Blessing K, 2009, PEDIATR INFECT DIS J, V28, P1018, DOI 10.1097/INF.0b013e3181a854ae; Dubois ME, 2012, VECTOR-BORNE ZOONOT, V12, P400, DOI 10.1089/vbz.2011.0779; Guo L, 2012, PLOS ONE, V7; Guo L, 2011, EMERG INFECT DIS, V17, P1775, DOI 10.3201/eid1709.110078; Hustedt JW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038206; Kahn JS, 2008, J INFECT DIS, V198, P41, DOI 10.1086/588674; Kantola K, 2008, CLIN INFECT DIS, V46, P540, DOI 10.1086/526532; Kantola K, 2011, J INFECT DIS, V204, P1403, DOI 10.1093/infdis/jir525; Kapoor A, 2009, J INFECT DIS, V199, P196, DOI 10.1086/595831; Kapoor A, 2010, J INFECT DIS, V201, P1633, DOI 10.1086/652416; Kesebir D, 2006, J INFECT DIS, V194, P1276, DOI 10.1086/508213; Khurana S, 2011, J VIROL, V85, P10945, DOI 10.1128/JVI.05406-11; Khurana S, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000049; Korner RW, 2011, EMERG INFECT DIS, V17, P2303, DOI 10.3201/eid1712.110574; Lau SKP, 2007, J INFECT DIS, V196, P986, DOI 10.1086/521310; Lin F, 2008, J VIROL METHODS, V149, P110, DOI 10.1016/j.jviromet.2007.12.016; Martin ET, 2010, J INFECT DIS, V201, P1625, DOI 10.1086/652405; Meriluoto M, 2012, EMERG INFECT DIS, V18, P264, DOI 10.3201/eid1802.111293; Mitui MT, 2012, CLIN INFECT DIS, V54, P964, DOI 10.1093/cid/cir957; Sun EC, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-160; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Ursic T, 2011, J CLIN MICROBIOL, V49, P1179, DOI 10.1128/JCM.02362-10; Verma N, 2012, J VIROL, V86, P5515, DOI 10.1128/JVI.07085-11; Wu HC, 2001, J CLIN MICROBIOL, V39, P977, DOI 10.1128/JCM.39.3.977-982.2001; Zhao RM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023374	28	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2014	9	1							e86960	10.1371/journal.pone.0086960	http://dx.doi.org/10.1371/journal.pone.0086960			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301BI	24475201	Green Published, Green Submitted, gold			2022-12-25	WOS:000330507300120
J	Chen, X; Ren, BA; Chen, M; Liu, MX; Ren, W; Wang, QX; Zhang, LX; Yan, GY				Chen, Xing; Ren, Biao; Chen, Ming; Liu, Ming-Xi; Ren, Wei; Wang, Quan-Xin; Zhang, Li-Xin; Yan, Gui-Ying			ASDCD: Antifungal Synergistic Drug Combination Database	PLOS ONE			English	Article							CHINESE MEDICINE; THERAPY; ANTAGONISM; CHEMOTHERAPY; INHIBITOR; BIOLOGY	Finding effective drugs to treat fungal infections has important clinical significance based on high mortality rates, especially in an immunodeficient population. Traditional antifungal drugs with single targets have been reported to cause serious side effects and drug resistance. Nowadays, however, drug combinations, particularly with respect to synergistic interaction, have attracted the attention of researchers. In fact, synergistic drug combinations could simultaneously affect multiple subpopulations, targets, and diseases. Therefore, a strategy that employs synergistic antifungal drug combinations could eliminate the limitations noted above and offer the opportunity to explore this emerging bioactive chemical space. However, it is first necessary to build a powerful database in order to facilitate the analysis of drug combinations. To address this gap in our knowledge, we have built the first Antifungal Synergistic Drug Combination Database (ASDCD), including previously published synergistic antifungal drug combinations, chemical structures, targets, target-related signaling pathways, indications, and other pertinent data. Its current version includes 210 antifungal synergistic drug combinations and 1225 drug-target interactions, involving 105 individual drugs from more than 12,000 references. ASDCD is freely available at http://ASDCD.amss.ac.cn.	[Chen, Xing; Yan, Gui-Ying] Chinese Acad Sci, Natl Ctr Math & Interdisciplinary Sci, Beijing, Peoples R China; [Chen, Xing; Liu, Ming-Xi; Ren, Wei; Yan, Gui-Ying] Chinese Acad Sci, Acad Math & Syst Sci, Beijing, Peoples R China; [Ren, Biao; Liu, Ming-Xi] Univ Chinese Acad Sci, Beijing, Peoples R China; [Ren, Biao; Zhang, Li-Xin] Chinese Acad Sci, South China Sea Inst Oceanol, Guangzhou, Guangdong, Peoples R China; [Chen, Ming; Zhang, Li-Xin] Chinese Acad Sci, Key Lab Pathogen Microbiol & Immunol, Inst Microbiol, Beijing, Peoples R China; [Wang, Quan-Xin] Univ Sci & Technol China, Sch Life Sci, Hefei 230026, Peoples R China	Chinese Academy of Sciences; Chinese Academy of Sciences; Academy of Mathematics & System Sciences, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Chinese Academy of Sciences; South China Sea Institute of Oceanology, CAS; Chinese Academy of Sciences; Institute of Microbiology, CAS; Chinese Academy of Sciences; University of Science & Technology of China, CAS	Zhang, LX (corresponding author), Chinese Acad Sci, Natl Ctr Math & Interdisciplinary Sci, Beijing, Peoples R China.	zhanglixin@im.ac.cn; yangy@amss.ac.cn	Ren, Biao/P-1067-2015; Chen, Xing/G-6844-2016	Ren, Biao/0000-0003-4215-2873; Chen, Xing/0000-0001-9028-5342; Zhang, Lixin/0000-0003-0894-9520	National 863 Project [2006AA09Z402, 2007AA09Z443]; Key Project for International Cooperation [2007DFB31620]; National Natural Science Foundation of China [10531070, 10721101, 11021161, 11301517, 11371355, 30973665, 30700015, 30901849, 30910376, 30911120484, 81011120046, 30911120483]; National Key Technology RD Program [2007BAI26B02]; CAS Pillar Program [KSCX2-YW-R-164]; Important National Science & Technology Specific Projects [2008ZX09401-05, 2009ZX09302-004]; National Center for Mathematics and Interdisciplinary Sciences, CAS; Hundred Talents Program;  [KJCX-YW-S7]	National 863 Project(National High Technology Research and Development Program of China); Key Project for International Cooperation; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Technology RD Program(National Key Technology R&D Program); CAS Pillar Program; Important National Science & Technology Specific Projects; National Center for Mathematics and Interdisciplinary Sciences, CAS(Chinese Academy of Sciences); Hundred Talents Program(Chinese Academy of Sciences); 	This work was supported by grants from National 863 Project (2006AA09Z402, 2007AA09Z443), Key Project for International Cooperation (2007DFB31620), National Natural Science Foundation of China (10531070, 10721101, 11021161, 11301517, 11371355, 30973665, 30700015, 30901849, 30910376, 30911120484, 81011120046 and 30911120483), National Key Technology R&D Program (2007BAI26B02), the CAS Pillar Program (KSCX2-YW-R-164), Important National Science & Technology Specific Projects (2008ZX09401-05, 2009ZX09302-004), KJCX-YW-S7 and National Center for Mathematics and Interdisciplinary Sciences, CAS. L. Z also received funding from the Hundred Talents Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BENNETT JE, 1979, NEW ENGL J MED, V301, P126, DOI 10.1056/NEJM197907193010303; Biavatti MW, 2009, BRAZ J PHARM SCI, V45, P371, DOI 10.1590/S1984-82502009000300002; Biran A, 2011, INT J CANCER, V128, P691, DOI 10.1002/ijc.25367; Bliss CI, 1939, ANN APPL BIOL, V26, P585, DOI 10.1111/j.1744-7348.1939.tb06990.x; Borgert CJ, 2005, THROMB RES, V117, P123, DOI 10.1016/j.thromres.2005.06.008; Borisy AA, 2003, P NATL ACAD SCI USA, V100, P7977, DOI 10.1073/pnas.1337088100; Chan E, 2010, CURR OPIN DRUG DISC, V13, P50; Chen X, 2006, BRIT J PHARMACOL, V149, P1092, DOI 10.1038/sj.bjp.0706945; Chou TC, 2008, LEUKEMIA LYMPHOMA, V49, P2059, DOI 10.1080/10428190802353591; Chou TC, 2006, PHARMACOL REV, V58, P621, DOI 10.1124/pr.58.3.10; Cusimano A, 2010, CELL CYCLE, V9, P1399, DOI 10.4161/cc.9.7.11254; Fitzgerald JB, 2006, NAT CHEM BIOL, V2, P458, DOI 10.1038/nchembio817; GRECO WR, 1995, PHARMACOL REV, V47, P331; Gunther S, 2008, NUCLEIC ACIDS RES, V36, pD919, DOI 10.1093/nar/gkm862; Hama A, 2012, PAIN RES TREAT, V2012, DOI 10.1155/2012/840486; Hartman JL, 2001, SCIENCE, V291, P1001, DOI 10.1126/science.291.5506.1001; JAWETZ E, 1953, PHARMACOL REV, V5, P175; Kanehisa M, 2006, NUCLEIC ACIDS RES, V34, pD354, DOI 10.1093/nar/gkj102; Kelly RJ, 2011, CLIN CANCER RES, V17, P569, DOI 10.1158/1078-0432.CCR-10-1725; KROGSTAD DJ, 1986, ANTIBIOTICS LAB MED; Lee MS, 2007, CANCER RES, V67, P11359, DOI 10.1158/0008-5472.CAN-07-2235; Lehar J, 2009, NAT BIOTECHNOL, V27, P659, DOI 10.1038/nbt.1549; Levinson AD, 2010, SCIENCE, V328, P137, DOI 10.1126/science.1189749; Levy SB, 2004, NAT MED, V10, pS122, DOI 10.1038/nm1145; Liu YB, 2010, BIOINFORMATICS, V26, P587, DOI 10.1093/bioinformatics/btp697; LOEWE S, 1953, ARZNEIMITTEL-FORSCH, V3, P285; Molina JR, 2006, CHEST, V130, P1211, DOI 10.1378/chest.130.4.1211; Mukherjee PK, 2005, CLIN MICROBIOL REV, V18, P163, DOI 10.1128/CMR.18.1.163-194.2005; Newman DJ, 2007, J NAT PROD, V70, P461, DOI 10.1021/np068054v; Nguyen JT, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009332; Parameswaran R, 2011, LEUKEMIA, V25, P1314, DOI 10.1038/leu.2011.76; Raez LE, 2006, CURR OPIN ONCOL, V18, P156; Rossi S., 2006, AUSTR MED HDB, P2; Sagar SM, 2008, CURR ONCOL, V15, P42, DOI 10.3747/co.2008.197; von Minckwitz G, 2007, EXPERT OPIN PHARMACO, V8, P485, DOI 10.1517/14656566.8.4.485; Wei Y, 2010, CLIN CANCER RES, V16, P3923, DOI 10.1158/1078-0432.CCR-10-0032; Wishart DS, 2008, NUCLEIC ACIDS RES, V36, pD901, DOI 10.1093/nar/gkm958; Xu Y, 2009, J PROTEOME RES, V8, P5296, DOI 10.1021/pr9005074; Yeh PJ, 2009, NAT REV MICROBIOL, V7, P460, DOI 10.1038/nrmicro2133; Yun O, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000720; Zhang LX, 2007, P NATL ACAD SCI USA, V104, P4606, DOI 10.1073/pnas.0609370104; ZHU YP, 1995, PHARM WORLD SCI, V17, P103, DOI 10.1007/BF01872386; Zimmermann GR, 2007, DRUG DISCOV TODAY, V12, P34, DOI 10.1016/j.drudis.2006.11.008	43	56	57	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2014	9	1							e86499	10.1371/journal.pone.0086499	http://dx.doi.org/10.1371/journal.pone.0086499			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	298QQ	24475134	gold, Green Submitted, Green Published			2022-12-25	WOS:000330339800051
J	Du, PF; Wang, LS				Du, Pufeng; Wang, Lusheng			Predicting Human Protein Subcellular Locations by the Ensemble of Multiple Predictors via Protein-Protein Interaction Network with Edge Clustering Coefficients	PLOS ONE			English	Article							RECENT PROGRESS; LOCALIZATION; CLASSIFIER; GENOME; GENE; TRANSLOCATION; CONSTRUCTION; SIGNALP; SINGLE; SCALE	One of the fundamental tasks in biology is to identify the functions of all proteins to reveal the primary machinery of a cell. Knowledge of the subcellular locations of proteins will provide key hints to reveal their functions and to understand the intricate pathways that regulate biological processes at the cellular level. Protein subcellular location prediction has been extensively studied in the past two decades. A lot of methods have been developed based on protein primary sequences as well as protein-protein interaction network. In this paper, we propose to use the protein-protein interaction network as an infrastructure to integrate existing sequence based predictors. When predicting the subcellular locations of a given protein, not only the protein itself, but also all its interacting partners were considered. Unlike existing methods, our method requires neither the comprehensive knowledge of the protein-protein interaction network nor the experimentally annotated subcellular locations of most proteins in the protein-protein interaction network. Besides, our method can be used as a framework to integrate multiple predictors. Our method achieved 56% on human proteome in absolute-true rate, which is higher than the state-of-the-art methods.	[Du, Pufeng] Tianjin Univ, Sch Comp Sci & Technol, Tianjin 300072, Peoples R China; [Du, Pufeng; Wang, Lusheng] City Univ Hong Kong, Dept Comp Sci, Kowloon, Hong Kong, Peoples R China	Tianjin University; City University of Hong Kong	Du, PF (corresponding author), Tianjin Univ, Sch Comp Sci & Technol, Tianjin 300072, Peoples R China.	PufengDu@gmail.com; cswangl@cityu.edu.hk	Du, Pu-Feng/R-9002-2019	Wang, Lusheng/0000-0002-4344-8791; /0000-0001-9897-3932	National Science Foundation of China [NSFC 61005041]; Research Grants Council of the Hong Kong Special Administrative Region, China [CityU 122511]; Specialized Research Fund for the Doctoral Program of Higher Education [SRFDP 20100032120039]; Tianjin Science Foundation [12JCQNJC02300]; China Postdoctoral Science Foundation [2012T50240, 2013M530114]; Seed Foundation of Tianjin University [60302006, 60302024]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Research Grants Council of the Hong Kong Special Administrative Region, China(Hong Kong Research Grants Council); Specialized Research Fund for the Doctoral Program of Higher Education(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Tianjin Science Foundation(Natural Science Foundation of Tianjin); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Seed Foundation of Tianjin University	This work was supported by National Science Foundation of China (NSFC 61005041), a grant from the Research Grants Council of the Hong Kong Special Administrative Region, China (CityU 122511), Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP 20100032120039), Tianjin Science Foundation (No. 12JCQNJC02300), China Postdoctoral Science Foundation (2012T50240 and 2013M530114) and the Seed Foundation of Tianjin University (No. 60302006 and 60302024). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberts B., 2010, MOL BIOL CELL; Andrade MA, 1998, J MOL BIOL, V276, P517, DOI 10.1006/jmbi.1997.1498; Apweiler R, 2013, NUCLEIC ACIDS RES, V41, pD43, DOI 10.1093/nar/gks1068; BLOBEL G, 1975, J CELL BIOL, V67, P835, DOI 10.1083/jcb.67.3.835; Briesemeister S, 2010, NUCLEIC ACIDS RES, V38, pW497, DOI 10.1093/nar/gkq477; Cai CX, 2001, J CELL SCI, V114, P2327; Casadio Rita, 2008, Briefings in Functional Genomics & Proteomics, V7, P63, DOI 10.1093/bfgp/eln003; Cedano J, 1997, J MOL BIOL, V266, P594, DOI 10.1006/jmbi.1996.0804; Chou KC, 2008, NAT PROTOC, V3, P153, DOI 10.1038/nprot.2007.494; Chou KC, 2007, ANAL BIOCHEM, V370, P1, DOI 10.1016/j.ab.2007.07.006; Chou KC, 2006, J PROTEOME RES, V5, P1888, DOI 10.1021/pr060167c; Chou KC, 2012, MOL BIOSYST, V8, P629, DOI 10.1039/c1mb05420a; Chou KC, 2013, MOL BIOSYST, V9, P1092, DOI 10.1039/c3mb25555g; Chou KC, 2011, J THEOR BIOL, V273, P236, DOI 10.1016/j.jtbi.2010.12.024; Coelho LP, 2013, BIOINFORMATICS; Dimmer EC, 2012, NUCLEIC ACIDS RES, V40, pD565, DOI 10.1093/nar/gkr1048; DODT G, 1995, NAT GENET, V9, P115, DOI 10.1038/ng0295-115; Du PF, 2013, EXPERT REV PROTEOMIC, V10, P227, DOI [10.1586/epr.13.16, 10.1586/EPR.13.16]; Du PF, 2011, EXPERT REV PROTEOMIC, V8, P391, DOI [10.1586/EPR.11.20, 10.1586/epr.11.20]; Emanuelsson O, 2007, NAT PROTOC, V2, P953, DOI 10.1038/nprot.2007.131; Emanuelsson Olof, 2002, Brief Bioinform, V3, P361, DOI 10.1093/bib/3.4.361; Gandhi TKB, 2006, NAT GENET, V38, P285, DOI 10.1038/ng1747; Gilchrist A, 2006, CELL, V127, P1265, DOI 10.1016/j.cell.2006.10.036; GLOVER JR, 1994, P NATL ACAD SCI USA, V91, P10541, DOI 10.1073/pnas.91.22.10541; GOULD SJ, 1987, J CELL BIOL, V105, P2923, DOI 10.1083/jcb.105.6.2923; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; Imai K, 2010, PROTEOMICS, V10, P3970, DOI 10.1002/pmic.201000274; Jiang JQ, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-S10-S20; Kumar G, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-S7-S9; Laurila K, 2011, AMINO ACIDS, V40, P975, DOI 10.1007/s00726-010-0724-y; Lee K, 2013, GENOME RES, V23, P1283, DOI 10.1101/gr.155499.113; Lee K, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn619; Li LQ, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0031057, 10.1371/journal.pone.0045115]; Lin JR, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-157; Lin WZ, 2013, MOL BIOSYST, V9, P634, DOI 10.1039/c3mb25466f; Liu J, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm562; Magnus M, 2012, BBA-PROTEINS PROTEOM, V1824, P1425, DOI 10.1016/j.bbapap.2012.05.018; Mintz-Oron S, 2009, BIOINFORMATICS, V25, pI247, DOI 10.1093/bioinformatics/btp209; Mondal AM, 2010, IEEE INT C BIOINFORM, P142, DOI 10.1109/BIBM.2010.5706553; MUNKRES KD, 1970, P NATL ACAD SCI USA, V67, P263, DOI 10.1073/pnas.67.1.263; Murphy R F, 2000, Proc Int Conf Intell Syst Mol Biol, V8, P251; Nakai K, 1999, TRENDS BIOCHEM SCI, V24, P34, DOI 10.1016/S0968-0004(98)01336-X; Park KJ, 2003, BIOINFORMATICS, V19, P1656, DOI 10.1093/bioinformatics/btg222; Park S, 2009, J PROTEOME RES, V8, P3367, DOI 10.1021/pr900018z; Peng W, 2012, BMC SYST BIOL, V6, DOI 10.1186/1752-0509-6-87; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Radicchi F, 2004, P NATL ACAD SCI USA, V101, P2658, DOI 10.1073/pnas.0400054101; Reece J. B., 2011, CAMPBELL BIOL, V10th, P321; Reich NC, 2006, NAT REV IMMUNOL, V6, P602, DOI 10.1038/nri1885; Reinhardt A, 1998, NUCLEIC ACIDS RES, V26, P2230, DOI 10.1093/nar/26.9.2230; Ross-Macdonald P, 1999, NATURE, V402, P413, DOI 10.1038/46558; Schwikowski B, 2000, NAT BIOTECHNOL, V18, P1257, DOI 10.1038/82360; Scott MS, 2005, PLOS COMPUT BIOL, V1, P518, DOI 10.1371/journal.pcbi.0010066; Shen HB, 2009, ANAL BIOCHEM, V394, P269, DOI 10.1016/j.ab.2009.07.046; Shin CJ, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-28; Tsoumakas G., 2007, INT J DATA WAREHOUS, V3, P1; Uhlen M, 2010, NAT BIOTECHNOL, V28, P1248, DOI 10.1038/nbt1210-1248; Wang JX, 2013, PROTEOMICS, V13, P301, DOI 10.1002/pmic.201200277; Wang JX, 2012, IEEE ACM T COMPUT BI, V9, P1070, DOI 10.1109/TCBB.2011.147; Wickner W, 2005, SCIENCE, V310, P1452, DOI 10.1126/science.1113752; Wu ZC, 2012, PROTEIN PEPTIDE LETT, V19, P4, DOI 10.2174/092986612798472839; Wu ZC, 2011, MOL BIOSYST, V7, P3287, DOI 10.1039/c1mb05232b	62	19	20	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2014	9	1							e86879	10.1371/journal.pone.0086879	http://dx.doi.org/10.1371/journal.pone.0086879			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297XI	24466278	gold, Green Published, Green Submitted			2022-12-25	WOS:000330288000163
J	Hung, YF; Valdau, O; Schuenke, S; Stern, O; Koenig, BW; Willbold, D; Hoffmann, S				Hung, Yu-Fu; Valdau, Olga; Schuenke, Sven; Stern, Omer; Koenig, Bernd W.; Willbold, Dieter; Hoffmann, Silke			Recombinant Production of the Amino Terminal Cytoplasmic Region of Dengue Virus Non-Structural Protein 4A for Structural Studies	PLOS ONE			English	Article							GLUTATHIONE-S-TRANSFERASE; MEMBRANE ASSOCIATION; AMPHIPATHIC HELIX; EXPRESSION SYSTEM; LOCALIZATION; CURVATURE; DOMAINS; DIMERIZATION; REPLICATION; PEPTIDES	Background: Dengue virus (DENV) is a mosquito-transmitted positive single strand RNA virus belonging to the Flaviviridae family. DENV causes dengue fever, currently the world's fastest-spreading tropical disease. Severe forms of the disease like dengue hemorrhagic fever and dengue shock syndrome are life-threatening. There is no specific treatment and no anti-DENV vaccines. Our recent data suggests that the amino terminal cytoplasmic region of the dengue virus non-structural protein 4A (NS4A) comprising amino acid residues 1 to 48 forms an amphipathic helix in the presence of membranes. Its amphipathic character was shown to be essential for viral replication. NMR-based structure-function analysis of the NS4A amino terminal region depends on its milligram-scale production and labeling with NMR active isotopes. Methodology/Principal Findings: This report describes the optimization of a uniform procedure for the expression and purification of the wild type NS4A(1-48) peptide and a peptide derived from a replication-deficient mutant NS4A(1-48; L6E, M10E) with disrupted amphipathic nature. A codon-optimized, synthetic gene for NS4A(1-48) was expressed as a fusion with a GST-GB1 dual tag in E. coli. Tobacco etch virus (TEV) protease mediated cleavage generated NS4A(1-48) peptides without any artificial overhang. Using the described protocol up to 4 milligrams of the wild type or up to 5 milligrams of the mutant peptide were obtained from a one-liter culture. Isotopic labeling of the peptides was achieved and initial NMR spectra were recorded. Conclusions/Significance: Small molecules targeting amphipathic helices in the related Hepatitis C virus were shown to inhibit viral replication, representing a new class of antiviral drugs. These findings highlight the need for an efficient procedure that provides large quantities of the amphipathic helix containing NS4A peptides. The double tag strategy presented in this manuscript answers these needs yielding amounts that are sufficient for comprehensive biophysical and structural studies, which might reveal new drug targets.	[Valdau, Olga; Schuenke, Sven; Koenig, Bernd W.; Willbold, Dieter; Hoffmann, Silke] Forschungszentrum Julich, Inst Complex Syst, Struct Biochem ICS 6, D-52425 Julich, Germany; [Hung, Yu-Fu; Koenig, Bernd W.; Willbold, Dieter] Univ Dusseldorf, Inst Phys Biol, Dusseldorf, Germany; [Stern, Omer] Tel Aviv Univ, Sackler Sch Med, Dept Clin Microbiol & Immunol, IL-69978 Tel Aviv, Israel	Helmholtz Association; Research Center Julich; Heinrich Heine University Dusseldorf; Tel Aviv University; Sackler Faculty of Medicine	Hoffmann, S (corresponding author), Forschungszentrum Julich, Inst Complex Syst, Struct Biochem ICS 6, D-52425 Julich, Germany.	si.hoffmann@fz-juelich.de	Hoffmann, Silke/H-5059-2013; Koenig, Bernd W/B-4315-2008; Willbold, Dieter/A-6280-2013	Hoffmann, Silke/0000-0003-1414-8957; Koenig, Bernd W/0000-0002-5300-6276; Willbold, Dieter/0000-0002-0065-7366; HUNG, YU FU/0000-0002-3031-1112	Jurgen Manchot Foundation, Molecules of Infection Graduate School	Jurgen Manchot Foundation, Molecules of Infection Graduate School	This work was supported by a grant from the Jurgen Manchot Foundation, Molecules of Infection Graduate School to YFH and DW (http://www.moi.hhu.de/en.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bao WJ, 2006, PROTEIN EXPRES PURIF, V47, P599, DOI 10.1016/j.pep.2005.11.021; Bhatt S, 2013, NATURE; Cho NJ, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000331; Clyde K, 2006, J VIROL, V80, P11418, DOI 10.1128/JVI.01257-06; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Elazar M, 2004, J VIROL, V78, P11393, DOI 10.1128/JVI.78.20.11393-11400.2004; Elazar M, 2003, J VIROL, V77, P6055, DOI 10.1128/JVI.77.10.6055-6061.2003; Fath S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017596; Favier A, 2011, J BIOMOL NMR, V49, P9, DOI 10.1007/s10858-010-9461-5; Gouttenoire J, 2009, J VIROL, V83, P6257, DOI 10.1128/JVI.02663-08; HEMSLEY A, 1989, NUCLEIC ACIDS RES, V17, P6545, DOI 10.1093/nar/17.16.6545; Huth JR, 1997, PROTEIN SCI, V6, P2359; Jao CC, 2010, J BIOL CHEM, V285, P20164, DOI 10.1074/jbc.M110.127811; KANE JF, 1995, CURR OPIN BIOTECH, V6, P494, DOI 10.1016/0958-1669(95)80082-4; Kaplan W, 1997, PROTEIN SCI, V6, P399; Kapust RB, 2001, PROTEIN ENG, V14, P993, DOI 10.1093/protein/14.12.993; Kapust RB, 2002, BIOCHEM BIOPH RES CO, V294, P949, DOI 10.1016/S0006-291X(02)00574-0; Koenig BW, 2003, J BIOMOL NMR, V26, P193, DOI 10.1023/A:1023887412387; Kohno T, 1998, J BIOMOL NMR, V12, P109, DOI 10.1023/A:1008254603368; Kohno T, 2008, INT J PEPT RES THER, V14, P157, DOI 10.1007/s10989-008-9125-4; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lee MCS, 2005, CELL, V122, P605, DOI 10.1016/j.cell.2005.07.025; LIM K, 1994, PROTEIN SCI, V3, P2233, DOI 10.1002/pro.5560031209; Mackenzie JM, 1998, VIROLOGY, V245, P203, DOI 10.1006/viro.1998.9156; McMahon HT, 2005, NATURE, V438, P590, DOI 10.1038/nature04396; MCTIGUE MA, 1995, J MOL BIOL, V246, P21, DOI 10.1006/jmbi.1994.0061; Miller S, 2007, J BIOL CHEM, V282, P8873, DOI 10.1074/jbc.M609919200; Niedziela-Majka A, 1998, PROTEIN EXPRES PURIF, V14, P208, DOI 10.1006/prep.1998.0932; Penin F, 2004, J BIOL CHEM, V279, P40835, DOI 10.1074/jbc.M404761200; Qiu WH, 2012, NAT STRUCT MOL BIOL, V19, P193, DOI 10.1038/nsmb.2205; Roosendaal J, 2006, J VIROL, V80, P4623, DOI 10.1128/JVI.80.9.4623-4632.2006; Sapay N, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-255; Smith D.B., 2001, CURR PROTOC MOL BIOL; Spuul P, 2007, J VIROL, V81, P872, DOI 10.1128/JVI.01785-06; STERN O, 2013, J VIROL; Sun CS, 2012, PROTEIN EXPRES PURIF, V82, P226, DOI 10.1016/j.pep.2012.01.005; Teterina NL, 2006, VIROLOGY, V344, P453, DOI 10.1016/j.virol.2005.08.044; Tudyka T, 1997, PROTEIN SCI, V6, P2180; Vranken WF, 2005, PROTEINS, V59, P687, DOI 10.1002/prot.20449; Waugh DS, 2011, PROTEIN EXPRES PURIF, V80, P283, DOI 10.1016/j.pep.2011.08.005	40	6	6	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2014	9	1							e86482	10.1371/journal.pone.0086482	http://dx.doi.org/10.1371/journal.pone.0086482			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297XI	24466115	Green Published, gold			2022-12-25	WOS:000330288000105
J	Saw, KG; Tneh, SS; Tan, GL; Yam, FK; Ng, SS; Hassan, Z				Saw, Kim Guan; Tneh, Sau Siong; Tan, Gaik Leng; Yam, Fong Kwong; Ng, Sha Shiong; Hassan, Zainuriah			Ohmic-Rectifying Conversion of Ni Contacts on ZnO and the Possible Determination of ZnO Thin Film Surface Polarity	PLOS ONE			English	Article							SCHOTTKY CONTACTS; ELECTRICAL-PROPERTIES; ZINC-OXIDE; PHOTOLUMINESCENCE; DECOMPOSITION; FABRICATION; DEFECTS; DIODE; AG	The current-voltage characteristics of Ni contacts with the surfaces of ZnO thin films as well as single crystal (0001) ZnO substrate are investigated. The ZnO thin film shows a conversion from Ohmic to rectifying behavior when annealed at 800 degrees C. Similar findings are also found on the Zn-polar surface of (0001) ZnO. The O-polar surface, however, only shows Ohmic behavior before and after annealing. The rectifying behavior observed on the Zn-polar and ZnO thin film surfaces is associated with the formation of nickel zinc oxide (Ni1-xZnxO, where x = 0.1, 0.2). The current-voltage characteristics suggest that a p-n junction is formed by Ni1-xZnxO (which is believed to be p-type) and ZnO (which is intrinsically n-type). The rectifying behavior for the ZnO thin film as a result of annealing suggests that its surface is Zn-terminated. Current-voltage measurements could possibly be used to determine the surface polarity of ZnO thin films.	[Saw, Kim Guan; Tneh, Sau Siong; Tan, Gaik Leng; Yam, Fong Kwong; Ng, Sha Shiong; Hassan, Zainuriah] Univ Sains Malaysia, Nanooptoelect Res Lab, Minden, Penang, Malaysia	Universiti Sains Malaysia	Saw, KG (corresponding author), Univ Sains Malaysia, Nanooptoelect Res Lab, Minden, Penang, Malaysia.	kgsaw@usm.my	Ng, Sha Shiong/L-6879-2019; Hassan, Zainuriah/F-9100-2010; Ng, Sha Shiong/G-6189-2010; Yam, Fong Kwong/F-7402-2010	Ng, Sha Shiong/0000-0003-2023-6419; Hassan, Zainuriah/0000-0003-0403-8391; Ng, Sha Shiong/0000-0003-2023-6419; Yam, Fong Kwong/0000-0002-4724-856X; Saw, Kim Guan/0000-0002-9427-8884	Universiti Sains Malaysia [304/PJJAUH/6311098]	Universiti Sains Malaysia(Universiti Sains Malaysia)	Funding from Universiti Sains Malaysia (Grant no. 304/PJJAUH/6311098). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen MW, 2006, APPL PHYS LETT, V89, DOI 10.1063/1.2346137; BAKER BG, 1971, SURF SCI, V24, P572, DOI 10.1016/0039-6028(71)90282-2; Brillson LJ, 2011, J APPL PHYS, V109, DOI 10.1063/1.3581173; Coppa BJ, 2003, APPL PHYS LETT, V82, P400, DOI 10.1063/1.1536264; Endo H, 2007, APPL PHYS LETT, V90, DOI 10.1063/1.2715100; Hupkes J, 2012, CHEMPHYSCHEM, V13, P66, DOI 10.1002/cphc.201100738; Ip K, 2006, J CRYST GROWTH, V287, P149, DOI 10.1016/j.jcrysgro.2005.10.059; Ip K, 2004, APPL PHYS LETT, V84, P2835, DOI 10.1063/1.1705726; Khanna R, 2004, APPL PHYS LETT, V85, P3468, DOI 10.1063/1.1801674; Kim HK, 2000, APPL PHYS LETT, V77, P1647, DOI 10.1063/1.1308527; Kohan AF, 2000, PHYS REV B, V61, P15019, DOI 10.1103/PhysRevB.61.15019; KUMARI SV, 1992, J MATER SCI LETT, V11, P761, DOI 10.1007/BF00729484; Look DC, 1999, PHYS REV LETT, V82, P2552, DOI 10.1103/PhysRevLett.82.2552; Mandalapu LJ, 2007, APPL PHYS LETT, V90, DOI 10.1063/1.2750400; Mosbacker HL, 2005, APPL PHYS LETT, V87, DOI 10.1063/1.1984089; Motayed A, 2002, J APPL PHYS, V92, P5218, DOI 10.1063/1.1509109; Ohnishi T, 1998, APPL PHYS LETT, V72, P824, DOI 10.1063/1.120905; Ohta H, 2003, APPL PHYS LETT, V83, P1029, DOI 10.1063/1.1598624; Ozgur U, 2010, P IEEE, V98, P1255, DOI 10.1109/JPROC.2010.2044550; Palumbo R, 1998, CHEM ENG SCI, V53, P2503, DOI 10.1016/S0009-2509(98)00063-3; Periasamy C, 2009, J VAC SCI TECHNOL B, V27, P2124, DOI 10.1116/1.3196786; Polyakov AY, 2003, APPL PHYS LETT, V83, P1575, DOI 10.1063/1.1604173; Qiu DJ, 2004, APPL SURF SCI, V222, P263, DOI 10.1016/j.apsusc.2003.08.015; Rackauskas S, 2009, APPL PHYS LETT, V95, DOI 10.1063/1.3258074; Rambu AP, 2013, APPL SURF SCI, V280, P598, DOI 10.1016/j.apsusc.2013.05.033; Ryu YR, 2003, APPL PHYS LETT, V83, P4032, DOI 10.1063/1.1625787; Sasaki A, 2005, APPL PHYS LETT, V86, DOI 10.1063/1.1947378; SATO H, 1993, THIN SOLID FILMS, V236, P27, DOI 10.1016/0040-6090(93)90636-4; Saw KG, 2007, THIN SOLID FILMS, V515, P2879, DOI 10.1016/j.tsf.2006.08.047; SECCO EA, 1960, CAN J CHEM, V38, P596, DOI 10.1139/v60-084; Sheng H, 2002, APPL PHYS LETT, V80, P2132, DOI 10.1063/1.1463700; UHLENBROCK S, 1992, J PHYS-CONDENS MAT, V4, P7973, DOI 10.1088/0953-8984/4/40/009; Van de Walle CG, 2000, PHYS REV LETT, V85, P1012, DOI 10.1103/PhysRevLett.85.1012; VANDEPOL FCM, 1991, THIN SOLID FILMS, V204, P349, DOI 10.1016/0040-6090(91)90074-8; Vanheusden K, 1996, J APPL PHYS, V79, P7983, DOI 10.1063/1.362349; Venugopalan HS, 1997, J APPL PHYS, V82, P650, DOI 10.1063/1.365593; Wang ZL, 2006, SCIENCE, V312, P242, DOI 10.1126/science.1124005; Yoshihara J, 1998, SURF SCI, V406, P235, DOI 10.1016/S0039-6028(98)00117-4; Zhao X, 2012, CURR APPL PHYS, V12, P834, DOI 10.1016/j.cap.2011.11.016	39	7	7	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2014	9	1							e86544	10.1371/journal.pone.0086544	http://dx.doi.org/10.1371/journal.pone.0086544			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297XI	24466144	Green Published, Green Submitted, gold			2022-12-25	WOS:000330288000110
J	Nihira, T; Saito, Y; Ohtsubo, K; Nakai, H; Kitaoka, M				Nihira, Takanori; Saito, Yuka; Ohtsubo, Ken'ichi; Nakai, Hiroyuki; Kitaoka, Motomitsu			2-O-alpha-D-Glucosylglycerol Phosphorylase from Bacillus selenitireducens MLS10 Possessing Hydrolytic Activity on beta-D-Glucose 1-Phosphate	PLOS ONE			English	Article							STRAIN PCC 6803; ALPHA-D-GLUCOSYLGLYCEROL; N-BIOSE-I; CLOSTRIDIUM-PHYTOFERMENTANS; MALTOSE PHOSPHORYLASE; LAMINARIBIOSE PHOSPHORYLASE; PRACTICAL PREPARATION; PERSEPHONELLA-MARINA; ENZYMATIC-SYNTHESIS; CRYSTAL-STRUCTURE	The glycoside hydrolase family (GH) 65 is a family of inverting phosphorylases that act on alpha-glucosides. A GH65 protein (Bsel_2816) from Bacillus selenitireducens MLS10 exhibited inorganic phosphate (Pi)-dependent hydrolysis of kojibiose at the rate of 0.43 s(-1). No carbohydrate acted as acceptor for the reverse phosphorolysis using beta-D-glucose 1-phosphate (beta Glc1P) as donor. During the search for a suitable acceptor, we found that Bsel_2816 possessed hydrolytic activity on bGlc1P with a k(cat) of 2.8 s(-1); moreover, such significant hydrolytic activity on sugar 1-phosphate had not been reported for any inverting phosphorylase. The (H2O)-O-18 incorporation experiment and the anomeric analysis during the hydrolysis of bGlc1P revealed that the hydrolysis was due to the glucosyl-transferring reaction to a water molecule and not a phosphatase-type reaction. Glycerol was found to be the best acceptor to generate 2-O-alpha-D-glucosylglycerol (GG) at the rate of 180 s(-1). Bsel_2816 phosphorolyzed GG through sequential Bi-Bi mechanism with a kcat of 95 s(-1). We propose 2-O-alpha-D-glucopyranosylglycerol: phosphate beta-D-glucosyltransferase as the systematic name and 2-O-alpha-D-glucosylglycerol phosphorylase as the short name for Bsel_2816. This is the first report describing a phosphorylase that utilizes polyols, and not carbohydrates, as suitable acceptor substrates.	[Nihira, Takanori; Saito, Yuka; Ohtsubo, Ken'ichi; Nakai, Hiroyuki] Niigata Univ, Grad Sch Sci & Technol, Niigata 9518510, Japan; [Kitaoka, Motomitsu] Natl Agr & Food Res Org, Natl Food Res Inst, Tsukuba, Ibaraki, Japan	Niigata University; National Agriculture & Food Research Organization - Japan; National Food Research Institute - Japan	Nakai, H (corresponding author), Niigata Univ, Grad Sch Sci & Technol, Niigata 9518510, Japan.	nakai@agr.niigata-u.ac.jp; mkitaoka@affrc.go.jp	Kitaoka, Motomitsu/R-1536-2019; Ohtsubo, Kenichi/AAW-1700-2020	Kitaoka, Motomitsu/0000-0002-0083-1838; Ohtsubo, Kenichi/0000-0001-9354-3087	MEXT; NISR Young Investigator Research Grant; Science and Technology Research Promotion Program for Agriculture, Forestry, Fisheries and Food Industry	MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); NISR Young Investigator Research Grant; Science and Technology Research Promotion Program for Agriculture, Forestry, Fisheries and Food Industry	This work was supported in part by MEXT's program "Promotion of Environmental Improvement for Independence of Young Researchers' under the Special Coordination Funds for Promoting Science and Technology, NISR Young Investigator Research Grant in 2012, and Science and Technology Research Promotion Program for Agriculture, Forestry, Fisheries and Food Industry. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afkar E, 2003, FEMS MICROBIOL LETT, V226, P107, DOI 10.1016/S0378-1097(03)00609-8; Blum JS, 1998, ARCH MICROBIOL, V171, P19, DOI 10.1007/s002030050673; Braman J, 1996, Methods Mol Biol, V57, P31; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Costa J, 2007, J BACTERIOL, V189, P1648, DOI 10.1128/JB.00841-06; Derensy-Dron D, 1999, BIOTECHNOL APPL BIOC, V29, P3; Desmet T, 2012, CHEM-EUR J, V18, P10786, DOI 10.1002/chem.201103069; Egloff MP, 2001, STRUCTURE, V9, P689, DOI 10.1016/S0969-2126(01)00626-8; Elbein AD, 2010, J BIOL CHEM, V285, P9803, DOI 10.1074/jbc.M109.033944; Fernandes C, 2007, J BACTERIOL, V189, P4014, DOI 10.1128/JB.00075-07; Hagemann M, 1997, J BACTERIOL, V179, P1727, DOI 10.1128/jb.179.5.1727-1733.1997; Hagemann M, 1996, ARCH MICROBIOL, V166, P83, DOI 10.1007/s002030050360; Hagemann M, 2011, FEMS MICROBIOL REV, V35, P87, DOI 10.1111/j.1574-6976.2010.00234.x; Honda Y, 2004, BIOCHEM J, V377, P225, DOI 10.1042/BJ20031171; Ishida T, 2009, J BIOL CHEM, V284, P10100, DOI 10.1074/jbc.M808122200; Kawahara R, 2012, J BIOL CHEM, V287, P42389, DOI 10.1074/jbc.M112.390336; Kitaoka M., 1992, Denpun Kagaku, V39, P281; Kitaoka M, 2002, TRENDS GLYCOSCI GLYC, V14, P35, DOI 10.4052/tigg.14.35; Kitaoka M., 1993, Denpun Kagaku, V40, P311; Kitaoka M, 2012, BIOSCI BIOTECH BIOCH, V76, P343, DOI 10.1271/bbb.110772; Ladeveze S, 2013, J BIOL CHEM, V288, P32370, DOI 10.1074/jbc.M113.483628; LOWRY OH, 1946, J BIOL CHEM, V162, P421; Luley-Goedl C, 2010, BIOTECHNOL J, V5, P1324, DOI 10.1002/biot.201000217; Luley-Goedl C, 2010, FOOD TECHNOL BIOTECH, V48, P276; Luley-Goedl C, 2010, CARBOHYD RES, V345, P1736, DOI 10.1016/j.carres.2010.05.022; Luley-Goedl C, 2010, CARBOHYD RES, V345, P1492, DOI 10.1016/j.carres.2010.03.035; Marin K, 1998, J BACTERIOL, V180, P4843, DOI 10.1128/JB.180.18.4843-4849.1998; Nakai H, 2013, CURR OPIN CHEM BIOL, V17, P301, DOI 10.1016/j.cbpa.2013.01.006; Nakai H, 2010, CARBOHYD RES, V345, P1061, DOI 10.1016/j.carres.2010.03.021; Nakajima M, 2008, APPL ENVIRON MICROB, V74, P6333, DOI 10.1128/AEM.02846-07; Nakajima M, 2008, APPL MICROBIOL BIOT, V78, P465, DOI 10.1007/s00253-007-1319-8; Nakajima M, 2010, BIOSCI BIOTECH BIOCH, V74, P1652, DOI 10.1271/bbb.100263; Nakajima M, 2009, J BIOL CHEM, V284, P19220, DOI 10.1074/jbc.M109.007666; Nihira T, 2013, FEBS LETT, V587, P3382, DOI 10.1016/j.febslet.2013.08.038; Nihira T, 2013, FEBS LETT, V587, P3556, DOI 10.1016/j.febslet.2013.09.014; Nihira T, 2013, J BIOL CHEM, V288, P27366, DOI 10.1074/jbc.M113.469080; Nihira T, 2012, CARBOHYD RES, V361, P49, DOI 10.1016/j.carres.2012.08.006; Nihira T, 2012, CARBOHYD RES, V360, P25, DOI 10.1016/j.carres.2012.07.014; Nihira T, 2012, APPL MICROBIOL BIOT, V93, P1513, DOI 10.1007/s00253-011-3515-9; Nihira T, 2012, CARBOHYD RES, V350, P94, DOI 10.1016/j.carres.2011.12.019; Nishimoto M, 2007, BIOSCI BIOTECH BIOCH, V71, P2101, DOI 10.1271/bbb.70320; Nishimoto M, 2009, CARBOHYD RES, V344, P2573, DOI 10.1016/j.carres.2009.09.031; Ohdan K, 2007, J BIOTECHNOL, V127, P496, DOI 10.1016/j.jbiotec.2006.07.023; Ohdan K, 2006, BIOCATAL BIOTRANSFOR, V24, P77, DOI 10.1080/10242420600598152; Okada S, 2014, FEBS J, V281, P778, DOI 10.1111/febs.12622; PACE CN, 1995, PROTEIN SCI, V4, P2411, DOI 10.1002/pro.5560041120; Sawangwan T, 2010, BIOTECHNOL J, V5, P187, DOI 10.1002/biot.200900197; Sawangwan T, 2009, ORG BIOMOL CHEM, V7, P4267, DOI 10.1039/b912621j; Senoura T, 2011, BIOCHEM BIOPH RES CO, V408, P701, DOI 10.1016/j.bbrc.2011.04.095; Shirokane Y, 2000, CARBOHYD RES, V329, P699, DOI 10.1016/S0008-6215(00)00232-9; Suzuki M, 2009, NEW BIOTECHNOL, V26, P137, DOI 10.1016/j.nbt.2009.07.004; Takenaka F, 2000, BIOSCI BIOTECH BIOCH, V64, P1821, DOI 10.1271/bbb.64.1821; Takenaka F, 2000, BIOSCI BIOTECH BIOCH, V64, P378, DOI 10.1271/bbb.64.378; VINCENT JB, 1992, TRENDS BIOCHEM SCI, V17, P105, DOI 10.1016/0968-0004(92)90246-6	54	23	24	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2014	9	1							e86548	10.1371/journal.pone.0086548	http://dx.doi.org/10.1371/journal.pone.0086548			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297VL	24466148	Green Published, Green Submitted, gold			2022-12-25	WOS:000330283100182
J	Boularan, C; Kamenyeva, O; Cho, H; Kehrl, JH				Boularan, Cedric; Kamenyeva, Olena; Cho, Hyeseon; Kehrl, John H.			Resistance to Inhibitors of Cholinesterase (Ric)-8A and G alpha(i) Contribute to Cytokinesis Abscission by Controlling Vacuolar Protein-Sorting (Vps)34 Activity	PLOS ONE			English	Article							PHOSPHORYLATION-DEPENDENT UBIQUITINATION; HETEROTRIMERIC G-PROTEINS; CELL-DIVISION; ASYMMETRIC DIVISION; ALPHA-SUBUNIT; LOCALIZATION; RIC-8; MIDBODY; SPINDLE; MODULATION	Resistance to inhibitors of cholinesterase (Ric)-8A is a guanine nucleotide exchange factor for G alpha(i), G alpha(q), and G alpha(12/13), which is implicated in cell signaling and as a molecular chaperone required for the initial association of nascent G alpha subunits with cellular membranes. Ric-8A, G alpha(i) subunits, and their regulators are localized at the midbody prior to abscission and linked to the final stages of cell division. Here, we identify a molecular mechanism by which Ric-8A affects cytokinesis and abscission by controlling Vps34 activity. We showed that Ric-8A protein expression is post-transcriptionally controlled during the cell cycle reaching its maximum levels at mitosis. A FRET biosensor created to measure conformational changes in Ric-8A by FLIM (Fluorescence Lifetime Imaging Microscopy) revealed that Ric-8A was in a close-state during mitosis and particularly so at cytokinesis. Lowering Ric-8A expression delayed the abscission time of dividing cells, which correlated with increased intercellular bridge length and multinucleation. During cytokinesis, Ric-8A co-localized with Vps34 at the midbody along with G alpha(i) and LGN, where these proteins functioned to regulate Vps34 phosphatidylinositol 3-kinase activity.	[Boularan, Cedric; Kamenyeva, Olena; Cho, Hyeseon; Kehrl, John H.] NIAID, Cell Mol Immunol Sect B, Immunoregulat Lab, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Kehrl, JH (corresponding author), NIAID, Cell Mol Immunol Sect B, Immunoregulat Lab, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.	jkehrl@niaid.nih.gov	Kehrl, John/AAE-6292-2019	Kehrl, John/0000-0002-6526-159X	National Institute of Allergy and Infectious Diseases, National Institutes of Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000961] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was supported by the Intramural Research Program of the National Institute of Allergy and Infectious Diseases, National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afshar K, 2005, DEVELOPMENT, V132, P4449, DOI 10.1242/dev.02039; Afshar K, 2004, CELL, V119, P219, DOI 10.1016/j.cell.2004.09.026; Alexander J, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001796; Blumer JB, 2002, J BIOL CHEM, V277, P15897, DOI 10.1074/jbc.M112185200; Carmena M, 2012, OPEN BIOL, V2, DOI 10.1098/rsob.120095; Cho H, 2007, J CELL BIOL, V178, P245, DOI 10.1083/jcb.200604114; Couwenbergs C, 2004, CURR BIOL, V14, P1871, DOI 10.1016/j.cub.2004.09.059; Dalrymple MB, 2011, J BIOL CHEM, V286, P16726, DOI 10.1074/jbc.M111.223537; Doherty D, 2012, AM J HUM GENET, V90, P1088, DOI 10.1016/j.ajhg.2012.04.008; Du QS, 2004, CELL, V119, P503, DOI 10.1016/j.cell.2004.10.028; Figueroa M, 2009, PROTEIN SCI, V18, P1139, DOI 10.1002/pro.124; Fukukawa C, 2010, GENE CHROMOSOME CANC, V49, P861, DOI 10.1002/gcc.20795; Funderburk SF, 2010, TRENDS CELL BIOL, V20, P355, DOI 10.1016/j.tcb.2010.03.002; Gabay M, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2002223; Garcia-Marcos M, 2011, MOL BIOL CELL, V22, P673, DOI 10.1091/mbc.E10-08-0738; Garcia-Marcos M, 2009, P NATL ACAD SCI USA, V106, P3178, DOI 10.1073/pnas.0900294106; Gillooly DJ, 2000, EMBO J, V19, P4577, DOI 10.1093/emboj/19.17.4577; Huttlin EL, 2010, CELL, V143, P1174, DOI 10.1016/j.cell.2010.12.001; Janetopoulos C, 2005, DEV CELL, V8, P467, DOI 10.1016/j.devcel.2005.02.010; Kao J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006146; Kavran JM, 1998, J BIOL CHEM, V273, P30497, DOI 10.1074/jbc.273.46.30497; Knockaert M, 2002, TRENDS PHARMACOL SCI, V23, P417, DOI 10.1016/S0165-6147(02)02071-0; Koepp DM, 2001, SCIENCE, V294, P173, DOI 10.1126/science.1065203; Krumins AM, 2006, J BIOL CHEM, V281, P10250, DOI 10.1074/jbc.M511551200; Lacroix B, 2012, J PATHOL, V226, P338, DOI 10.1002/path.3013; Lambert NA, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.125re5; Lin DI, 2006, MOL CELL, V24, P355, DOI 10.1016/j.molcel.2006.09.007; Mao JZ, 2012, CANC SCI; Mayya V, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000007; Miller KG, 1996, P NATL ACAD SCI USA, V93, P12593, DOI 10.1073/pnas.93.22.12593; Montagnac G, 2008, CURR OPIN CELL BIOL, V20, P454, DOI 10.1016/j.ceb.2008.03.011; Moore NL, 2007, STEROIDS, V72, P202, DOI 10.1016/j.steroids.2006.11.025; Muggerud AA, 2009, BMC MED GENOMICS, V2, DOI 10.1186/1755-8794-2-26; NEER EJ, 1995, CELL, V80, P249, DOI 10.1016/0092-8674(95)90407-7; Oner SS, 2012, J BIOL CHEM; Parmentier ML, 2000, J NEUROSCI, V20, part. no., DOI 10.1523/JNEUROSCI.20-14-j0003.2000; Perroy J, 2004, NAT METHODS, V1, P203, DOI 10.1038/NMETH722; Sagona AP, 2010, NAT CELL BIOL, V12, P362, DOI 10.1038/ncb2036; Siderovski DP, 2005, INT J BIOL SCI, V1, P51, DOI 10.7150/ijbs.1.51; Slessareva JE, 2006, CELL, V126, P191, DOI 10.1016/j.cell.2006.04.045; Steigemann P, 2009, CELL, V136, P473, DOI 10.1016/j.cell.2008.12.020; Tall GG, 2003, J BIOL CHEM, V278, P8356, DOI 10.1074/jbc.M211862200; Toyoshima F, 2007, DEV CELL, V13, P796, DOI 10.1016/j.devcel.2007.10.014; Woodard GE, 2010, MOL CELL BIOL, V30, P3519, DOI 10.1128/MCB.00394-10; Wurmser AE, 1999, J BIOL CHEM, V274, P9129, DOI 10.1074/jbc.274.14.9129; Yang F, 2007, J CELL SCI, V120, P4060, DOI 10.1242/jcs.014795; Zhang X, 2012, CYTOSKELETON, V69, P810, DOI 10.1002/cm.21055	47	16	16	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2014	9	1							e86680	10.1371/journal.pone.0086680	http://dx.doi.org/10.1371/journal.pone.0086680			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297GT	24466196	Green Published, Green Submitted, gold			2022-12-25	WOS:000330244500271
J	Shi, L; Nechuta, S; Gao, YT; Zheng, Y; Dorjgochoo, T; Wu, J; Cai, QY; Zheng, W; Lu, W; Shu, XO				Shi, Liang; Nechuta, Sarah; Gao, Yu-Tang; Zheng, Ying; Dorjgochoo, Tsogzolmaa; Wu, Jie; Cai, Qiuyin; Zheng, Wei; Lu, Wei; Shu, Xiao Ou			Correlates of 25-Hydroxyvitamin D among Chinese Breast Cancer Patients	PLOS ONE			English	Article							VITAMIN-D DEFICIENCY; D INSUFFICIENCY; UNITED-STATES; PREVALENCE; SURVIVAL; HEALTH	Background: Few studies have investigated vitamin D status in association with modifiable lifestyle factors and clinical characteristics among breast cancer patients, with no studies among Chinese women, who may be at higher risk of vitamin D deficiency. We aimed to evaluate circulating 25-hydroxyvitamin D (25(OH) D) levels in association with clinical and lifestyle factors among 1,940 Chinese breast cancer patients. Methods: Participants included breast cancer cases aged 22-77 from a population-based case-control study conducted in Shanghai, China during 1996-1998 (n = 1,044) and 2002-2005 (n = 896). Circulating 25(OH) D levels were measured in plasma samples (95% collected <= 6 months post-diagnosis). Prevalence ORs and 95% CIs were derived from multinomial logistic regression models, adjusting for age, season, and other factors. Results: About 23% and 48% of women were vitamin D deficient (< 30 nmol/L) or insufficient (30-50 nmol/L), respectively. Tumor characteristics were not associated with vitamin D status. Higher BMI was associated with increased odds of vitamin D deficiency (ORs (95% CIs): 1 (reference), 1.12 (0.85,1.47), and 1.57 (1.02,2.42), for < 23, 23-< 27.5, and >= 27.5 kg/m(2), respectively, P-trend < 0.06). Total physical activity was associated with reduced odds of vitamin D deficiency (ORs (95% CIs): 1 (reference), 0.84 (0.59,1.20), 0.65 (0.45,0.93), and 0.69 (0.48,1.00), for < 7.65, 7.65-< 10.6, 10.6-< 13.5, >= 13.5 MET-hours/day, respectively, P-trend < 0.02). Smoking was associated with vitamin D insufficiency and deficiency (ORs (95% CIs): 2.50 (1.07,5.84) and 2.78 (1.11,6.95), respectively). Conclusions: In the largest study to date, the prevalence of low vitamin D status was high among Chinese breast cancer patients and associated with higher BMI, smoking, and lower physical activity. Our findings support careful monitoring of vitamin D status and recommendations for supplementation and other lifestyle modifications that may improve vitamin D status in breast cancer patients.	[Shi, Liang; Nechuta, Sarah; Dorjgochoo, Tsogzolmaa; Wu, Jie; Cai, Qiuyin; Zheng, Wei; Shu, Xiao Ou] Vanderbilt Univ, Sch Med, Dept Med, Div Epidemiol, Nashville, TN 37212 USA; [Shi, Liang] Shanghai Municipal Ctr Dis Control & Prevent, Dept Diabet Control & Prevent, Shanghai, Peoples R China; [Zheng, Ying; Lu, Wei] Shanghai Municipal Ctr Dis Control & Prevent, Dept Canc Prevent & Control, Shanghai, Peoples R China; [Gao, Yu-Tang] Shanghai Canc Inst, Dept Epidemiol, Shanghai, Peoples R China	Vanderbilt University; Shanghai Center for Disease Control & Prevention; Shanghai Center for Disease Control & Prevention; Shanghai Jiao Tong University	Nechuta, S (corresponding author), Vanderbilt Univ, Sch Med, Dept Med, Div Epidemiol, Nashville, TN 37212 USA.	sarah.nechuta@vanderbilt.edu	Gao, Y./GWZ-3665-2022; Nechuta, Sarah/AAG-4025-2020; Gao, Yu/HGE-1937-2022; Lu, Wei/AAE-2921-2022; gao, yi/HCI-8298-2022; Zheng, Wei/O-3351-2013; zhang, weihua/GXV-1334-2022	Nechuta, Sarah/0000-0003-2773-6678; Lu, Wei/0000-0002-4150-8674; Zheng, Wei/0000-0003-1226-070X; 	National Institutes of Health, National Cancer Institute [R01CA64277, R03CA156648]; Shanghai Health Bureau [12GWZX0101]; Vanderbilt-Shanghai Chronic Disease Research Training Program grant from the Fogarty International Center [D43 TW008313]; Vanderbilt-Ingram Cancer Center [P30CA068485]; FOGARTY INTERNATIONAL CENTER [D43TW008313] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P30CA068485, R01CA064277, R01CA118229, R03CA156648] Funding Source: NIH RePORTER	National Institutes of Health, National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Shanghai Health Bureau; Vanderbilt-Shanghai Chronic Disease Research Training Program grant from the Fogarty International Center; Vanderbilt-Ingram Cancer Center; FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported by grants from the National Institutes of Health, National Cancer Institute (grant numbers: R01CA64277 and R03CA156648). In addition, this study was partially support by a grant from Shanghai Health Bureau (grant No. 12GWZX0101). LS was supported by the Vanderbilt-Shanghai Chronic Disease Research Training Program grant from the Fogarty International Center (D43 TW008313). Sample preparation was conducted at the Survey and Biospecimen Shared Resource, which is supported in part by the Vanderbilt-Ingram Cancer Center (P30CA068485). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainsworth BE, 2000, MED SCI SPORT EXER, V32, pS498, DOI 10.1097/00005768-200009001-00009; Antoniucci DM, 2005, CLIN CHEM, V51, P258; Barba C, 2004, LANCET, V363, P157, DOI 10.1016/S0140-6736(03)15268-3; Baz-Hecht M, 2010, CURR OPIN ENDOCRINOL, V17, P113, DOI 10.1097/MED.0b013e3283372859; Forrest KYZ, 2011, NUTR RES, V31, P48, DOI 10.1016/j.nutres.2010.12.001; Freedman DM, 2007, JNCI-J NATL CANCER I, V99, P1594, DOI 10.1093/jnci/djm204; Friedman CF, 2012, J WOMENS HEALTH, V21, P456, DOI 10.1089/jwh.2011.3009; Goodwin PJ, 2009, J CLIN ONCOL, V27, P3757, DOI 10.1200/JCO.2008.20.0725; Gupta D, 2011, EXP THER MED, V2, P181, DOI 10.3892/etm.2011.205; Hatse S, 2012, CARCINOGENESIS, V33, P1319, DOI 10.1093/carcin/bgs187; Hines SL, 2010, NUTRITION, V26, P255, DOI 10.1016/j.nut.2009.08.020; Holick MF, 2003, RECENT RESULTS CANC, V164, P3; Holick MF, 2008, AM J CLIN NUTR, V87, p1080S; Holick MF, 2007, NEW ENGL J MED, V357, P266, DOI 10.1056/NEJMra070553; Jacobs ET, 2013, NUTR CANCER, V65, P188, DOI 10.1080/01635581.2013.756531; Laird E, 2010, NUTRIENTS, V2, P693, DOI 10.3390/nu2070693; Levin GP, 2012, JAMA-J AM MED ASSOC, V308, P1898, DOI 10.1001/jama.2012.17304; Looker AC, 2007, NUTR REV, V65, pS124, DOI 10.1111/j.1753-4887.2007.tb00339.x; Martins D, 2007, ARCH INTERN MED, V167, P1159, DOI 10.1001/archinte.167.11.1159; McCullough ML, 2010, AM J EPIDEMIOL, V172, P21, DOI 10.1093/aje/kwq113; National Institute of Standards and Technology, 2009, MAT DET SRM 972 VIT; Neuhouser ML, 2008, AM J CLIN NUTR, V88, P133, DOI 10.1093/ajcn/88.1.133; OCKE MC, 1995, J CLIN EPIDEMIOL, V48, P1077, DOI 10.1016/0895-4356(94)00232-F; Park S, 2005, NUTR REV, V63, P203, DOI [10.1301/nr.2005.Jun.203-209, 10.1111/j.1753-4887.2005.tb00138.x]; Pilz S, 2009, ANTICANCER RES, V29, P3699; Ross AC, 2011, J CLIN ENDOCR METAB, V96, P53, DOI 10.1210/jc.2010-2704; Shin A, 2009, BREAST CANCER RES TR, V113, P153, DOI 10.1007/s10549-008-9903-x; Shu XO, 2012, CANCER RES, V72, P1182, DOI 10.1158/0008-5472.CAN-11-2561; Vrieling A, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2920; Wagner D, 2009, CLIN BIOCHEM, V42, P1549, DOI 10.1016/j.clinbiochem.2009.07.013; Yao S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017251; Zheng W, 2009, NAT GENET, V41, P324, DOI 10.1038/ng.318	32	16	16	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2014	9	1							e86467	10.1371/journal.pone.0086467	http://dx.doi.org/10.1371/journal.pone.0086467			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297GT	24466109	Green Submitted, Green Published, gold			2022-12-25	WOS:000330244500245
J	Savar, A; Acin, S; Gonzalez, CL; El-Sawy, T; Mejia, O; Li, Z; Esmaeli, B; Lacy-Hulbert, A; El-Naggar, AK; McCarty, JH; Caulin, C				Savar, A.; Acin, S.; Gonzalez, C. L.; El-Sawy, T.; Mejia, O.; Li, Z.; Esmaeli, B.; Lacy-Hulbert, A.; El-Naggar, A. K.; McCarty, J. H.; Caulin, C.			Loss of epithelial p53 and alpha v integrin cooperate through Akt to induce squamous cell carcinoma yet prevent remodeling of the tumor microenvironment	ONCOGENE			English	Article						p53; squamous cell carcinoma; mouse model; integrins; tumor microenvironment	GAIN-OF-FUNCTION; SKIN-CANCER; MOUSE MODEL; EXPRESSION; MUTATIONS; KERATINOCYTES; INACTIVATION; NEOPLASIA; ABLATION; LEADS	Most of the squamous cell carcinomas (SCCs) of the skin and head and neck contain p53 mutations. The presence of p53 mutations in premalignant lesions suggests that they represent early events during tumor progression and additional alterations may be required for SCC development. Here we show that codeletion of the p53 and alpha v integrin genes in mouse stratified epithelia induced SCCs in 100% of the mice, more frequently and with much shorter latency than deletion of either gene alone. The SCCs that lacked p53 and alpha v in the epithelial tumor cells exhibited high Akt activity, lacked multiple types of infiltrating immune cells, contained a defective vasculature and grew slower than tumors that expressed p53 or alpha v. These results reveal that loss of alpha v in epithelial cells that lack p53 promotes SCC development, but also prevents remodeling of the tumor microenvironment and delays tumor growth. We observed that Akt inactivation in SCC cells that lack p53 and alpha v promoted anoikis. Thus, tumors may arise in these mice as a result of the increased cell survival induced by Akt activation triggered by loss of alpha v and p53, and by the defective recruitment of immune cells to these tumors, which may allow immune evasion. However, the defective vasculature and lack of a supportive stroma create a restrictive microenvironment in these SCCs that slows their growth. These mechanisms may underlie the rapid onset and slow growth of SCCs that lack p53 and alpha v.	[Savar, A.; Acin, S.; Gonzalez, C. L.; El-Sawy, T.; Mejia, O.; Li, Z.; Esmaeli, B.; Caulin, C.] Univ Texas MD Anderson Canc Ctr, Dept Head & Neck Surg, Houston, TX 77030 USA; [Lacy-Hulbert, A.] Massachusetts Gen Hosp, Dept Pediat, Boston, MA 02114 USA; [El-Naggar, A. K.] Univ Texas MD Anderson Canc Ctr, Dept Pathol, Houston, TX 77030 USA; [McCarty, J. H.] Univ Texas MD Anderson Canc Ctr, Dept Neurosurg, Houston, TX 77030 USA; [Caulin, C.] Univ Texas MD Anderson Canc Ctr, Dept Genet, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; Harvard University; Massachusetts General Hospital; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center	Caulin, C (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Head & Neck Surg, Unit 123, 1515 Holcombe Blvd, Houston, TX 77030 USA.	ccaulin@mdanderson.org	Acin, Sergio/S-5185-2017	Acin, Sergio/0000-0001-7335-2865	National Institutes of Health [DE015344]; Pilot Project grant from the American Cancer Society Institutional Research Grant Program; National Institutes of Health through Cancer Center Support Grant [CA16672]; NATIONAL CANCER INSTITUTE [P30CA016672] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE015344] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS078402] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pilot Project grant from the American Cancer Society Institutional Research Grant Program; National Institutes of Health through Cancer Center Support Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank Dennis Roop for the K14.CrePR1 mice, Anton Berns for the floxed p53 mice and Sarah Bronson and Dawn Chalaire for editorial assistance. This study was supported by the National Institutes of Health through Grant DE015344 (C Caulin) and a Pilot Project grant from the American Cancer Society Institutional Research Grant Program (JH McCarty). Veterinary services and core facilities at The University of Texas MD Anderson Cancer Center were supported in part by the National Institutes of Health through Cancer Center Support Grant CA16672.	Acin S, 2011, J PATHOL, V225, P479, DOI 10.1002/path.2971; Agrawal N, 2011, SCIENCE, V333, P1154, DOI 10.1126/science.1206923; Aladjem MI, 1998, CURR BIOL, V8, P145, DOI 10.1016/S0960-9822(98)70061-2; Bao WJ, 2004, J CELL BIOL, V167, P745, DOI 10.1083/jcb.200404018; Bolshakov S, 2003, CLIN CANCER RES, V9, P228; Brantsch KD, 2008, LANCET ONCOL, V9, P713, DOI 10.1016/S1470-2045(08)70178-5; BRASH DE, 1991, P NATL ACAD SCI USA, V88, P10124, DOI 10.1073/pnas.88.22.10124; BREUSS JM, 1995, J CELL SCI, V108, P2241; CAMPBELL C, 1993, J INVEST DERMATOL, V100, P746, DOI 10.1111/1523-1747.ep12475717; Caulin C, 2004, CANCER RES, V64, P5054, DOI 10.1158/0008-5472.CAN-04-1488; Caulin C, 2007, J CLIN INVEST, V117, P1893, DOI 10.1172/JCI31721; DELUCA M, 1990, P NATL ACAD SCI USA, V87, P6888, DOI 10.1073/pnas.87.17.6888; Euvrard S, 2003, NEW ENGL J MED, V348, P1681, DOI 10.1056/NEJMra022137; Haapasalmi K, 1996, J INVEST DERMATOL, V106, P42, DOI 10.1111/1523-1747.ep12327199; Hanahan D, 2012, CANCER CELL, V21, P309, DOI 10.1016/j.ccr.2012.02.022; HERTLE MD, 1992, J CLIN INVEST, V89, P1892, DOI 10.1172/JCI115794; Hsu A, 2011, J CUTAN PATHOL, V38, P570, DOI 10.1111/j.1600-0560.2011.01687.x; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Janes SM, 2004, J CELL BIOL, V166, P419, DOI 10.1083/jcb.200312074; Jin H, 2006, CANCER RES, V66, P2146, DOI 10.1158/0008-5472.CAN-05-2704; Jonason AS, 1996, P NATL ACAD SCI USA, V93, P14025, DOI 10.1073/pnas.93.24.14025; Jones J, 1996, ONCOGENE, V12, P119; Jones J, 1997, J ORAL PATHOL MED, V26, P63, DOI 10.1111/j.1600-0714.1997.tb00023.x; Jones SM, 2006, NAT REV CANCER, V6, P175, DOI 10.1038/nrc1817; Jonkers J, 2001, NAT GENET, V29, P418, DOI 10.1038/ng747; Lacy-Hulbert A, 2007, P NATL ACAD SCI USA, V104, P15823, DOI 10.1073/pnas.0707421104; Lindelof B, 2000, BRIT J DERMATOL, V143, P513, DOI 10.1046/j.1365-2133.2000.03703.x; Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205; Martinez-Cruz AB, 2008, CANCER RES, V68, P683, DOI 10.1158/0008-5472.CAN-07-3049; McCarty JH, 2005, DEVELOPMENT, V132, P165, DOI 10.1242/dev.01551; McCarty JH, 2008, AM J PATHOL, V172, P1740, DOI 10.2353/ajpath.2008.070700; Munger JS, 1999, CELL, V96, P319, DOI 10.1016/S0092-8674(00)80545-0; NAKAZAWA H, 1994, P NATL ACAD SCI USA, V91, P360, DOI 10.1073/pnas.91.1.360; NAPPI O, 1989, J CUTAN PATHOL, V16, P114, DOI 10.1111/j.1600-0560.1989.tb00024.x; PELTONEN J, 1989, J CLIN INVEST, V84, P1916, DOI 10.1172/JCI114379; Spike Benjamin T, 2011, Genes Cancer, V2, P404, DOI 10.1177/1947601911410224; Streuli CH, 2009, BIOCHEM J, V418, P491, DOI 10.1042/BJ20081948; Stromblad S, 2002, J BIOL CHEM, V277, P13371, DOI 10.1074/jbc.C200044200; Torchia EC, 2012, ONCOGENE, V31, P2680, DOI 10.1038/onc.2011.441; Watt FM, 2002, EMBO J, V21, P3919, DOI 10.1093/emboj/cdf399; ZIEGLER A, 1994, NATURE, V372, P773, DOI 10.1038/372773a0	41	16	16	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 22	2015	34	4					516	524		10.1038/onc.2013.585	http://dx.doi.org/10.1038/onc.2013.585			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AZ8FU	24469034	Green Accepted			2022-12-25	WOS:000348451300012
J	Coan, AC; Campos, BM; Yasuda, CL; Kubota, BY; Bergo, FPG; Guerreiro, CAM; Cendes, F				Coan, Ana C.; Campos, Brunno M.; Yasuda, Clarissa L.; Kubota, Bruno Y.; Bergo, Felipe P. G.; Guerreiro, Carlos A. M.; Cendes, Fernando			Frequent Seizures Are Associated with a Network of Gray Matter Atrophy in Temporal Lobe Epilepsy with or without Hippocampal Sclerosis	PLOS ONE			English	Article							VOXEL-BASED MORPHOMETRY; ABNORMALITIES	Objective: Patients with temporal lobe epilepsy (TLE) with hippocampal sclerosis (HS) have diffuse subtle gray matter (GM) atrophy detectable by MRI quantification analyses. However, it is not clear whether the etiology and seizure frequency are associated with this atrophy. We aimed to evaluate the occurrence of GM atrophy and the influence of seizure frequency in patients with TLE and either normal MRI (TLE-NL) or MRI signs of HS (TLE-HS). Methods: We evaluated a group of 172 consecutive patients with unilateral TLE-HS or TLE-NL as defined by hippocampal volumetry and signal quantification (122 TLE-HS and 50 TLE-NL) plus a group of 82 healthy individuals. Voxel-based morphometry was performed with VBM8/SPM8 in 3T MRIs. Patients with up to three complex partial seizures and no generalized tonic-clonic seizures in the previous year were considered to have infrequent seizures. Those who did not fulfill these criteria were considered to have frequent seizures. Results: Patients with TLE-HS had more pronounced GM atrophy, including the ipsilateral mesial temporal structures, temporal lobe, bilateral thalami and pre/post-central gyri. Patients with TLE-NL had more subtle GM atrophy, including the ipsilateral orbitofrontal cortex, bilateral thalami and pre/post-central gyri. Both TLE-HS and TLE-NL showed increased GM volume in the contralateral pons. TLE-HS patients with frequent seizures had more pronounced GM atrophy in extra-temporal regions than TLE-HS with infrequent seizures. Patients with TLE-NL and infrequent seizures had no detectable GM atrophy. In both TLE-HS and TLE-NL, the duration of epilepsy correlated with GM atrophy in extra-hippocampal regions. Conclusion: Although a diffuse network GM atrophy occurs in both TLE-HS and TLE-NL, this is strikingly more evident in TLE-HS and in patients with frequent seizures. These findings suggest that neocortical atrophy in TLE is related to the ongoing seizures and epilepsy duration, while thalamic atrophy is more probably related to the original epileptogenic process.	[Coan, Ana C.; Campos, Brunno M.; Yasuda, Clarissa L.; Kubota, Bruno Y.; Bergo, Felipe P. G.; Guerreiro, Carlos A. M.; Cendes, Fernando] Univ Estadual Campinas, Dept Neurol, Neuroimaging Lab, Campinas, SP, Brazil	Universidade Estadual de Campinas	Cendes, F (corresponding author), Univ Estadual Campinas, Dept Neurol, Neuroimaging Lab, Campinas, SP, Brazil.	fcendes@unicamp.br	Coan, Ana Carolina/AAA-7887-2020; Cendes, Fernando/C-1301-2012; yasuda, clarissa l/B-7934-2013; de Campos, Brunno Machado/L-8423-2013; Coan, Ana Carolina/F-4982-2012; yasuda, clarissa lin/D-4599-2018; Bergo, Felipe/K-9662-2015	Coan, Ana Carolina/0000-0002-2888-929X; Cendes, Fernando/0000-0001-9336-9568; yasuda, clarissa l/0000-0001-9084-7173; de Campos, Brunno Machado/0000-0003-1261-8257; Coan, Ana Carolina/0000-0002-2888-929X; yasuda, clarissa lin/0000-0001-9084-7173; Bergo, Felipe/0000-0003-3305-5617	Sao Paulo Research Foundation (FAPESP) [2005/56578-4, 2009/54552-9, 2011/03477-7]; CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, Brazil)	Sao Paulo Research Foundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, Brazil)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This study was funded by the Sao Paulo Research Foundation (FAPESP), grants 2005/56578-4, 2009/54552-9, and 2011/03477-7. Dr. Cendes received support from CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, Brazil). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashburner J, 2000, NEUROIMAGE, V11, P805, DOI 10.1006/nimg.2000.0582; Ashburner J, 2007, NEUROIMAGE, V38, P95, DOI 10.1016/j.neuroimage.2007.07.007; Barron DS, 2013, NEUROIMAGE-CLIN, V2, P25, DOI 10.1016/j.nicl.2012.11.004; Bell ML, 2009, EPILEPSIA, V50, P2053, DOI 10.1111/j.1528-1167.2009.02079.x; Bernhardt BC, 2009, NEUROLOGY, V72, P1747, DOI 10.1212/01.wnl.0000345969.57574.f5; Bernhardt BC, 2010, NEUROLOGY, V74, P1776, DOI 10.1212/WNL.0b013e3181e0f80a; Bilevicius E, 2010, NEUROLOGY, V75, P1695, DOI 10.1212/WNL.0b013e3181fc29dd; Blumenfeld H, 2004, CEREB CORTEX, V14, P892, DOI 10.1093/cercor/bhh048; Bonilha L, 2006, EPILEPSIA, V47, P908, DOI 10.1111/j.1528-1167.2006.00548.x; Bonilha L, 2005, NEUROIMAGE, V25, P1016, DOI 10.1016/j.neuroimage.2004.11.050; Bonilha L, 2004, ARCH NEUROL-CHICAGO, V61, P1379, DOI 10.1001/archneur.61.9.1379; Bonilha L, 2006, NEUROIMAGE, V32, P1070, DOI 10.1016/j.neuroimage.2006.05.038; Coan AC, 2013, AJNR AM J NEURORADIO; Coan AC, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00166; Cohen-Gadol AA, 2005, J NEUROSURG, V102, P902, DOI 10.3171/jns.2005.102.5.0902; Diehl B, 2003, EPILEPSIA, V44, P559, DOI 10.1046/j.1528-1157.2003.36202.x; Eriksson SH, 2009, HUM BRAIN MAPP, V30, P3351, DOI 10.1002/hbm.20757; Good CD, 2001, NEUROIMAGE, V14, P21, DOI 10.1006/nimg.2001.0786; HAUSER WA, 1992, EPILEPSY SURGERY, P133; Keller SS, 2008, EPILEPSIA, V49, P741, DOI 10.1111/j.1528-1167.2007.01485.x; Keller SS, 2004, NEUROIMAGE, V23, P860, DOI 10.1016/j.neuroimage.2004.07.030; Keller SS, 2002, J NEUROL NEUROSUR PS, V73, P648, DOI 10.1136/jnnp.73.6.648; Labate A, 2008, NEUROLOGY, V71, P1094, DOI 10.1212/01.wnl.0000326898.05099.04; Labate A, 2011, NAT REV NEUROL, V7, P237, DOI 10.1038/nrneurol.2010.212; Labate A, 2011, EPILEPSIA, V52, P712, DOI 10.1111/j.1528-1167.2011.03038.x; Labate A, 2010, EPILEPSIA, V51, P506, DOI 10.1111/j.1528-1167.2009.02310.x; Li JP, 2012, EPILEPSY RES, V98, P97, DOI 10.1016/j.eplepsyres.2011.10.002; McDonald CR, 2008, EPILEPSY RES, V79, P130, DOI 10.1016/j.eplepsyres.2008.01.006; McDonald CR, 2008, EPILEPSIA, V49, P794, DOI 10.1111/j.1528-1167.2008.01539.x; Morita ME, 2012, NEUROLOGY, V79, P2349, DOI 10.1212/WNL.0b013e318278b63f; Mueller SG, 2009, NEUROIMAGE, V46, P353, DOI 10.1016/j.neuroimage.2009.02.020; Mueller SG, 2006, EPILEPSIA, V47, P900, DOI 10.1111/j.1528-1167.2006.00512.x; Pittau F, 2012, EPILEPSIA, V53, P1013, DOI 10.1111/j.1528-1167.2012.03464.x; Riederer F, 2008, NEUROLOGY, V71, P419, DOI 10.1212/01.wnl.0000324264.96100.e0; Samuels ER, 2008, CURR NEUROPHARMACOL, V6, P235, DOI 10.2174/157015908785777229; Spencer SS, 2002, EPILEPSIA, V43, P219, DOI 10.1046/j.1528-1157.2002.26901.x; Van Paesschen W, 2003, BRAIN, V126, P1103, DOI 10.1093/brain/awg108; VanPaesschen W, 1997, ANN NEUROL, V41, P41, DOI 10.1002/ana.410410109; Yasuda CL, 2010, NEUROLOGY, V74, P1062, DOI 10.1212/WNL.0b013e3181d76b72	39	45	46	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2014	9	1							e85843	10.1371/journal.pone.0085843	http://dx.doi.org/10.1371/journal.pone.0085843			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301BI	24475055	gold, Green Published, Green Submitted			2022-12-25	WOS:000330507300026
J	Grossman, Z; Schapiro, JM; Levy, I; Elbirt, D; Chowers, M; Riesenberg, K; Olstein-Pops, K; Shahar, E; Istomin, V; Asher, I; Gottessman, BS; Shemer, Y; Elinav, H; Hassoun, G; Rosenberg, S; Averbuch, D; Machleb-Guri, K; Kra-Oz, Z; Radian-Sade, S; Rudich, H; Ram, D; Maayan, S; Agmon-Levin, N; Sthoeger, Z				Grossman, Zehava; Schapiro, Jonathan M.; Levy, Itzchak; Elbirt, Daniel; Chowers, Michal; Riesenberg, Klaris; Olstein-Pops, Karen; Shahar, Eduardo; Istomin, Valery; Asher, Ilan; Gottessman, Bat-Sheva; Shemer, Yonat; Elinav, Hila; Hassoun, Gamal; Rosenberg, Shira; Averbuch, Diana; Machleb-Guri, Keren; Kra-Oz, Zipi; Radian-Sade, Sara; Rudich, Hagit; Ram, Daniela; Maayan, Shlomo; Agmon-Levin, Nancy; Sthoeger, Zev			Comparable Long-Term Efficacy of Lopinavir/Ritonavir and Similar Drug-Resistance Profiles in Different HIV-1 Subtypes	PLOS ONE			English	Article							ANTIRETROVIRAL THERAPY; REVERSE-TRANSCRIPTASE; COMBINATION THERAPY; CONTAINING REGIMENS; TREATMENT RESPONSE; MUTATION PATTERNS; PROTEASE GENE; CLADE-C; LOPINAVIR; INFECTION	Background: Analysis of potentially different impact of Lopinavir/Ritonavir (LPV/r) on non-B subtypes is confounded by dissimilarities in the conditions existing in different countries. We retrospectively compared its impact on populations infected with subtypes B and C in Israel, where patients infected with different subtypes receive the same treatment. Methods: Clinical and demographic data were reported by physicians. Resistance was tested after treatment failure. Statistical analyses were conducted using SPSS. Results: 607 LPV/r treated patients (365 male) were included. 139 had HIV subtype B, 391 C, and 77 other subtypes. At study end 429 (71%) were receiving LPV/r. No significant differences in PI treatment history and in median viral-load (VL) at treatment initiation and termination existed between subtypes. MSM discontinued LPV/r more often than others even when the virologic outcome was good (p = 0.001). VL was below detection level in 81% of patients for whom LPV/r was first PI and in 67% when it was second (P = 0.001). Median VL decrease from baseline was 1.9 +/- 0.1 logs and was not significantly associated with subtype. Median CD4 increase was: 162 and 92cells/ml, respectively, for patients receiving LPV/r as first and second PI (P = 0.001), and 175 and 98, respectively, for subtypes B and C (P, 0.001). Only 52 (22%) of 237 patients genotyped while under LPV/r were fully resistant to the drug; 12(5%) were partially resistant. In48%, population sequencing did not reveal resistance to any drug notwithstanding the virologic failure. No difference was found in the rates of resistance development between B and C (p = 0.16). Conclusions: Treatment with LPV/r appeared efficient and tolerable in both subtypes, B and C, but CD4 recovery was significantly better in virologically suppressed subtype-B patients. In both subtypes, LPV/r was more beneficial when given as first PI. Mostly, reasons other than resistance development caused discontinuation of treatment.	[Grossman, Zehava] Tel Aviv Univ, Sch Publ Hlth, IL-69978 Tel Aviv, Israel; [Schapiro, Jonathan M.; Levy, Itzchak] Sheba Med Ctr, Ramat Gan, Israel; [Elbirt, Daniel; Asher, Ilan; Rosenberg, Shira; Machleb-Guri, Keren; Radian-Sade, Sara; Agmon-Levin, Nancy; Sthoeger, Zev] Kaplan Med Ctr, Rehovot, Israel; [Chowers, Michal; Gottessman, Bat-Sheva] Meir Med Ctr, Kefar Sava, Israel; [Riesenberg, Klaris; Shemer, Yonat] Soroka Med Ctr, IL-84101 Beer Sheva, Israel; [Olstein-Pops, Karen; Elinav, Hila; Averbuch, Diana; Maayan, Shlomo] Hadassah Med Ctr, IL-91120 Jerusalem, Israel; [Shahar, Eduardo; Hassoun, Gamal; Kra-Oz, Zipi] Rambam Med Ctr, Haifa, Israel; [Istomin, Valery] Hillel Yaffe Med Ctr, Hadera, Israel; [Rudich, Hagit; Ram, Daniela] MOH, PHL, Natl HIV Reference Lab, Ramat Gan, Israel	Tel Aviv University; Chaim Sheba Medical Center; Hebrew University of Jerusalem; Kaplan Medical Center; Tel Aviv University; Sackler Faculty of Medicine; Ben Gurion University; Soroka Medical Center; Hebrew University of Jerusalem; Hadassah University Medical Center; Rambam Health Care Campus; Technion Israel Institute of Technology	Grossman, Z (corresponding author), Tel Aviv Univ, Sch Publ Hlth, IL-69978 Tel Aviv, Israel.	zehava.grossman@gmail.com	RIESENBERG, KLARIS/F-1132-2012; Averbuch, Dina/ABA-6433-2020	Chowers, Michal/0000-0001-6148-254X				Achan J, 2012, NEW ENGL J MED, V367, P2110, DOI 10.1056/NEJMoa1200501; [Anonymous], 2017, 2013 UNAIDS REP GLOB; ANRS AC11 Resistance Study Group, 2012, HIV 1 GEN DRUG RES I; Ariyoshi K, 2003, JAIDS-J ACQ IMM DEF, V33, P336, DOI 10.1097/00126334-200307010-00007; Audelin AM, 2009, ANTIVIR THER, V14, P995, DOI 10.3851/IMP1412; Averbuch D, 2006, PEDIATR INFECT DIS J, V25, P1049, DOI 10.1097/01.inf.0000243211.36690.d5; Avidor B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057789; Bangsberg DR, 2004, J INFECT DIS, V190, P162, DOI 10.1086/420790; Bangsberg DR, 2004, J ANTIMICROB CHEMOTH, V53, P696, DOI 10.1093/jac/dkh162; Barber TJ, 2012, J ANTIMICROB CHEMOTH, V67, P995, DOI 10.1093/jac/dkr569; Bartmeyer B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012718; Brenner B, 2003, AIDS, V17, pF1, DOI 10.1097/00002030-200301030-00001; Buonaguro FM, 1996, ANTIBIOT CHEMOTHER, V48, P39; Cane PA, 2001, J CLIN MICROBIOL, V39, P2652, DOI 10.1128/JCM.39.7.2652-2654.2001; Carr JK, 1999, AIDS, V13, P1819, DOI 10.1097/00002030-199910010-00003; Carr JK, 1998, VIROLOGY, V247, P22, DOI 10.1006/viro.1998.9211; Champenois K, 2008, J MED VIROL, V80, P1871, DOI 10.1002/jmv.21315; Chemtob D, 2004, INT J STD AIDS, V15, P691, DOI 10.1258/0956462041944321; Conradie F, 2004, AIDS, V18, P1084, DOI 10.1097/00002030-200404300-00024; Cornelissen M, 1997, J VIROL, V71, P6348, DOI 10.1128/JVI.71.9.6348-6358.1997; Dam E, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000345; De Wit S, 2004, AIDS, V18, P2330, DOI 10.1097/00002030-200411190-00016; Deeks SG, 2002, AIDS, V16, P201, DOI 10.1097/00002030-200201250-00009; Di Giambenedetto S, 2009, ANTIVIR THER, V14, P359; Diaz RS, 2008, JAIDS-J ACQ IMM DEF, V47, P399, DOI 10.1097/QAI.0b013e31815b0d48; Falloon J, 2000, CLIN INFECT DIS, V30, P313, DOI 10.1086/313667; Friend J, 2004, AIDS, V18, P1965, DOI 10.1097/00002030-200409240-00016; Government SA, 2007, S AFR GUID, P76; Grossman Z, 2004, ANTIMICROB AGENTS CH, V48, P2159, DOI 10.1128/AAC.48.6.2159-2165.2004; Grossman Z, 2004, AIDS, V18, P909, DOI 10.1097/00002030-200404090-00008; Grossman Z, 1999, NAT MED, V5, P1099, DOI 10.1038/13410; Grossman Z, 2001, AIDS, V15, P1453, DOI 10.1097/00002030-200108170-00001; Gupta RK, 2010, AIDS, V24, P1651, DOI 10.1097/QAD.0b013e3283398216; Hamers RL, 2013, LANCET INFECT DIS, V13, P196, DOI 10.1016/S1473-3099(13)70012-4; Hamers RL, 2012, INT J EPIDEMIOL, V41, P43, DOI 10.1093/ije/dyq192; Hemelaar J, 2011, AIDS, V25, P679, DOI 10.1097/QAD.0b013e328342ff93; Hirsch MS, 2008, CLIN INFECT DIS, V47, P266, DOI 10.1086/589297; Alcantara LCJ, 2009, NUCLEIC ACIDS RES, V37, pW634, DOI 10.1093/nar/gkp455; Kantor R, 2001, NUCLEIC ACIDS RES, V29, P296, DOI 10.1093/nar/29.1.296; Kempf DJ, 2001, J VIROL, V75, P7462, DOI 10.1128/JVI.75.16.7462-7469.2001; King J, 2008, AIDS, V22, P1709, DOI 10.1097/QAD.0b013e32830163ad; Levison JH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032144; Levy I, 2011, CLIN INFECT DIS, V52, P1363, DOI 10.1093/cid/cir244; Lisovsky I, 2010, ANTIMICROB AGENTS CH, V54, P2878, DOI 10.1128/AAC.01828-09; Liu TF, 2006, CLIN INFECT DIS, V42, P1608, DOI 10.1086/503914; Lockman S, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001236; Lodwick RK, 2008, AIDS, V22, P1039, DOI 10.1097/QAD.0b013e3282fec415; MAAYAN S, 1994, AIDS, V8, P133, DOI 10.1097/00002030-199401000-00024; Maillard A, 2007, J CLIN VIROL, V38, P131, DOI 10.1016/j.jcv.2006.11.011; Maroldo L, 2010, J INT AIDS SOC S4, pP30; Murphy RL, 2008, HIV CLIN TRIALS, V9, P1, DOI 10.1310/hct0901-1; Parkin NT, 2003, AIDS, V17, P955, DOI 10.1097/00002030-200305020-00003; Parry CM, 2009, J VIROL, V83, P9094, DOI 10.1128/JVI.02356-08; POLLACK S, 1994, ACTA PAEDIATR, V83, P19, DOI 10.1111/j.1651-2227.1994.tb13327.x; Pulido F, 2008, J ANTIMICROB CHEMOTH, V61, P1359, DOI 10.1093/jac/dkn103; Quinnan GV, 1999, AIDS RES HUM RETROV, V15, P561, DOI 10.1089/088922299311088; Rhee SY, 2010, ANTIMICROB AGENTS CH, V54, P4253, DOI 10.1128/AAC.00574-10; Rhee SY, 2005, J INFECT DIS, V192, P456, DOI 10.1086/431601; Ribaudo HJ, 2010, J INFECT DIS, V202, P717, DOI 10.1086/655470; Ribaudo HJ, 2006, CLIN INFECT DIS, V42, P401, DOI 10.1086/499364; Rosenbloom DIS, 2012, NAT MED, V18, P1378, DOI 10.1038/nm.2892; Shen L, 2008, NAT MED, V14, P762, DOI 10.1038/nm1777; Taiwo B, 2010, DRUGS, V70, P1629, DOI 10.2165/11538020-000000000-00000; Van Zyl GU, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067188; Vercauteren J, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-12; Wainberg MA, 2011, NEW ENGL J MED, V365, P637, DOI 10.1056/NEJMra1004180; Wallis CL, 2011, AIDS RES TREAT, V2011, DOI 10.1155/2011/769627; WHO, 2008, WORLD HLTH REP 2008; World Health Organisation, 2021, CONSOLIDATED GUIDELI; Wu TD, 2003, J VIROL, V77, P4836, DOI 10.1128/JVI.77.8.4836-4847.2003	70	9	10	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2014	9	1							e86239	10.1371/journal.pone.0086239	http://dx.doi.org/10.1371/journal.pone.0086239			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301BI	24475093	Green Published, gold, Green Submitted			2022-12-25	WOS:000330507300047
J	Liang, GY; Lian, CJ; Huang, D; Gao, WJ; Liang, AJ; Peng, Y; Ye, W; Wu, ZZ; Su, PQ; Huang, DS				Liang, Guoyan; Lian, Chengjie; Huang, Di; Gao, Wenjie; Liang, Anjing; Peng, Yan; Ye, Wei; Wu, Zizhao; Su, Peiqiang; Huang, Dongsheng			Endoplasmic Reticulum Stress-Unfolding Protein Response-Apoptosis Cascade Causes Chondrodysplasia in a col2a1 p.Gly1170Ser Mutated Mouse Model	PLOS ONE			English	Article							DISPROPORTIONATE MICROMELIA DMM; SPONDYLOEPIPHYSEAL DYSPLASIA CONGENITA; CARTILAGE COLLAGEN FIBRILS; II PROCOLLAGEN COL2A1; TRANSGENIC MICE; SKELETAL DEVELOPMENT; PHENOTYPIC SPECTRUM; DELETED GENE; ER STRESS; OSTEOARTHRITIS	The collagen type II alpha 1 (COL2A1) mutation causes severe skeletal malformations, but the pathogenic mechanisms of how this occurs are unclear. To understand how this may happen, a col2a1 p.Gly1170Ser mutated mouse model was constructed and in homozygotes, the chondrodysplasia phenotype was observed. Misfolded procollagen was largely synthesized and retained in dilated endoplasmic reticulum and the endoplasmic reticulum stress (ERS)-unfolded protein response (UPR)-apoptosis cascade was activated. Apoptosis occurred prior to hypertrophy, prevented the formation of a hypertrophic zone, disrupted normal chondrogenic signaling pathways, and eventually caused chondrodysplasia. Heterozygotes had normal phenotypes and endoplasmic reticulum stress intensity was limited with no abnormal apoptosis detected. Our results suggest that earlier chondrocyte death was related to the ERS-UPR-apoptosis cascade and that this was the chief cause of chondrodysplaia. The col2a1 p.Gly1170Ser mutated mouse model offered a novel connection between misfolded collagen and skeletal malformation. Further investigation of this mouse mutant model can help us understand mechanisms of type II collagenopathies.	[Liang, Guoyan; Lian, Chengjie; Gao, Wenjie; Liang, Anjing; Peng, Yan; Ye, Wei; Wu, Zizhao; Huang, Dongsheng] Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Dept Orthoped, Guangzhou 510275, Guangdong, Peoples R China; [Huang, Di] Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Dept Breast Surg, Guangzhou 510275, Guangdong, Peoples R China; [Su, Peiqiang] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Orthoped, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University	Su, PQ (corresponding author), Sun Yat Sen Univ, Affiliated Hosp 1, Dept Orthoped, Guangzhou 510275, Guangdong, Peoples R China.	spq88007@yahoo.com.cn; huangdongshen18@hotmail.com	Liang, Guoyan/AEL-4482-2022; Lian, Cheng/HHS-1095-2022	Lian, Cheng/0000-0002-9016-832X	National Natural Science Foundation of China [81371907, 30971587, 81071703]; Fundamental Research Funds for the Central Universities [11ykzd10]; Science Foundation of Guangdong Province [2010B031600224]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Science Foundation of Guangdong Province(National Natural Science Foundation of Guangdong Province)	This work was supported by the National Natural Science Foundation of China (No. 81371907, No. 30971587 and No. 81071703), the Fundamental Research Funds for the Central Universities (No. 11ykzd10), and the Science Foundation of Guangdong Province (2010B031600224). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arita M, 2002, OSTEOARTHR CARTILAGE, V10, P808, DOI 10.1053/joca.2002.0830; Barbieri O, 2003, AM J PHYSIOL-CELL PH, V285, pC1504, DOI 10.1152/ajpcell.00579.2002; Bateman JF, 2009, NAT REV GENET, V10, P173, DOI 10.1038/nrg2520; Bomsta BD, 2006, OSTEOARTHR CARTILAGE, V14, P477, DOI 10.1016/j.joca.2005.11.011; BROWN KS, 1981, J EMBRYOL EXP MORPH, V62, P165; Chan W, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm163; Chiu LH, 2012, J CELL PHYSIOL, V227, P2412, DOI 10.1002/jcp.22976; Chiu LH, 2011, J CELL PHYSIOL, V226, P1981, DOI 10.1002/jcp.22530; Chung HJ, 2009, J MOL BIOL, V390, P306, DOI 10.1016/j.jmb.2009.05.004; Donahue LR, 2003, J BONE MINER RES, V18, P1612, DOI 10.1359/jbmr.2003.18.9.1612; Esapa CT, 2012, J BONE MINER RES, V27, P413, DOI 10.1002/jbmr.547; EYRE DR, 1991, J CLIN INVEST, V87, P357, DOI 10.1172/JCI114994; Fernandes RJ, 2003, MATRIX BIOL, V22, P449, DOI 10.1016/S0945-053X(03)00077-5; FOSTER MJ, 1994, ANAT REC, V238, P454, DOI 10.1002/ar.1092380404; Furuichi T, 2011, MAMM GENOME, V22, P318, DOI 10.1007/s00335-011-9329-3; Gaiser KG, 2002, J BONE MINER RES, V17, P39, DOI 10.1359/jbmr.2002.17.1.39; GAROFALO S, 1991, P NATL ACAD SCI USA, V88, P9648, DOI 10.1073/pnas.88.21.9648; HELMINEN HJ, 1993, J CLIN INVEST, V92, P582, DOI 10.1172/JCI116625; Hintze V, 2008, HUM MUTAT, V29, P841, DOI 10.1002/humu.20736; Hoornaert KP, 2006, J MED GENET, V43, P406, DOI 10.1136/jmg.2005.035717; Ito H, 2005, J MOL BIOL, V352, P382, DOI 10.1016/j.jmb.2005.07.019; Jensen DA, 2011, HUM MUTAT, V32, P794, DOI 10.1002/humu.21506; Kannu P, 2012, J PAEDIATR CHILD H, V48, pE38, DOI 10.1111/j.1440-1754.2010.01979.x; Katayama T, 2004, J CHEM NEUROANAT, V28, P67, DOI 10.1016/j.jchemneu.2003.12.004; LI SW, 1995, GENE DEV, V9, P2821, DOI 10.1101/gad.9.22.2821; Lisse TS, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040007; Liu PT, 2003, GENOME RES, V13, P476, DOI 10.1101/gr.749203; Maddox BK, 1997, MATRIX BIOL, V16, P93, DOI 10.1016/S0945-053X(97)90038-X; Maddox BK, 1997, DEV DYNAM, V208, P170, DOI 10.1002/(SICI)1097-0177(199702)208:2<170::AID-AJA4>3.0.CO;2-F; METSARANTA M, 1992, J CELL BIOL, V118, P203, DOI 10.1083/jcb.118.1.203; Nieminen J, 2008, CALCIFIED TISSUE INT, V82, P229, DOI 10.1007/s00223-008-9110-0; Nishimura G, 2005, HUM MUTAT, V26, P36, DOI 10.1002/humu.20179; Pace JM, 1997, DEV DYNAM, V208, P25; Papa FR, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a007666; Saamanen AMK, 2000, OSTEOARTHR CARTILAGE, V8, P248, DOI 10.1053/joca.2000.0298; Sahlman J, 2004, ARTHRITIS RHEUM-US, V50, P3153, DOI 10.1002/art.20552; Schneiderbauer MM, 2004, CELL SIGNAL, V16, P1133, DOI 10.1016/j.cellsig.2004.03.004; Seegmiller RE, 2008, J HISTOCHEM CYTOCHEM, V56, P1003, DOI 10.1369/jhc.2008.951673; Stenson PD, 2009, GENOME MED, V1, DOI 10.1186/gm13; Su PQ, 2008, ARTHRITIS RHEUM-US, V58, P1701, DOI 10.1002/art.23491; VANDENBERG P, 1991, P NATL ACAD SCI USA, V88, P7640, DOI 10.1073/pnas.88.17.7640	41	23	24	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2014	9	1							e86894	10.1371/journal.pone.0086894	http://dx.doi.org/10.1371/journal.pone.0086894			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301BI	24475193	gold, Green Published, Green Submitted			2022-12-25	WOS:000330507300115
J	Marquis, M; Boulet, S; Mathien, S; Rousseau, J; Thebault, P; Daudelin, F; Rooney, J; Turgeon, B; Beauchamp, C; Meloche, S; Labrecque, N				Marquis, Miriam; Boulet, Salix; Mathien, Simon; Rousseau, Justine; Thebault, Pamela; Daudelin, Francois; Rooney, Julie; Turgeon, Benjamin; Beauchamp, Claudine; Meloche, Sylvain; Labrecque, Nathalie			The Non-Classical MAP Kinase ERK3 Controls T Cell Activation	PLOS ONE			English	Article							SIGNAL-REGULATED KINASES; HUMAN CDC14A PHOSPHATASE; DIFFERENTIAL REGULATION; CHROMOSOME SEGREGATION; EXPRESSION; MK5; PHOSPHORYLATION; PROLIFERATION; RECEPTOR; MEMORY	The classical mitogen-activated protein kinases (MAPKs) ERK1 and ERK2 are activated upon stimulation of cells with a broad range of extracellular signals (including antigens) allowing cellular responses to occur. ERK3 is an atypical member of the MAPK family with highest homology to ERK1/2. Therefore, we evaluated the role of ERK3 in mature T cell response. Mouse resting T cells do not transcribe ERK3 but its expression is induced in both CD4(+) and CD8(+) T cells following T cell receptor (TCR)-induced T cell activation. This induction of ERK3 expression in T lymphocytes requires activation of the classical MAPK ERK1 and ERK2. Moreover, ERK3 protein is phosphorylated and associates with MK5 in activated primary T cells. We show that ERK3-deficient T cells have a decreased proliferation rate and are impaired in cytokine secretion following in vitro stimulation with low dose of anti-CD3 antibodies. Our findings identify the atypical MAPK ERK3 as a new and important regulator of TCR-induced T cell activation.	[Marquis, Miriam; Boulet, Salix; Thebault, Pamela; Daudelin, Francois; Rooney, Julie; Beauchamp, Claudine; Labrecque, Nathalie] Hop Maison Neuve Rosemont, Res Ctr, Montreal, PQ H1T 2M4, Canada; [Marquis, Miriam; Labrecque, Nathalie] Univ Montreal, Dept Microbiol Infectiol & Immunol, Quebec City, PQ, Canada; [Rousseau, Justine; Turgeon, Benjamin; Meloche, Sylvain] Univ Montreal, Dept Pharmacol & Mol Biol, Quebec City, PQ, Canada; [Labrecque, Nathalie] Univ Montreal, Dept Med, Quebec City, PQ, Canada; [Mathien, Simon; Rousseau, Justine; Turgeon, Benjamin; Meloche, Sylvain] Univ Montreal, Inst Res Immunol & Canc, Quebec City, PQ, Canada	Universite de Montreal; Universite de Montreal; Universite de Montreal; Universite de Montreal; Universite de Montreal	Labrecque, N (corresponding author), Hop Maison Neuve Rosemont, Res Ctr, Montreal, PQ H1T 2M4, Canada.	nathalie.labrecque@umontreal.ca		Rousseau, Justine/0000-0002-3554-2673; Boulet, Salix/0000-0002-8446-8908	Natural Sciences and Engineering Council of Canada [262146-2009]; Canadian Institutes for Health Research [MOP-93729]	Natural Sciences and Engineering Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR))	This work was funded by the Natural Sciences and Engineering Council of Canada (grant number 262146-2009) to NL and by a grant from the Canadian Institutes for Health Research (MOP-93729) to SM. SM holds the Canada Research Chair in Cellular Signaling. SB holds a post-doctoral fellowship from the Canadian Institutes for Health Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aberg E, 2006, J BIOL CHEM, V281, P35499, DOI 10.1074/jbc.M606225200; Allard EL, 2007, EUR J IMMUNOL, V37, P3069, DOI 10.1002/eji.200637017; Anhe GE, 2006, MOL CELL ENDOCRINOL, V251, P33, DOI 10.1016/j.mce.2006.02.012; Bartkova J, 1998, ONCOGENE, V17, P1027, DOI 10.1038/sj.onc.1202016; Bird JJ, 1998, IMMUNITY, V9, P229, DOI 10.1016/S1074-7613(00)80605-6; Chan S, 1998, J EXP MED, V188, P2321, DOI 10.1084/jem.188.12.2321; Coulombe P, 2003, MOL CELL BIOL, V23, P4542, DOI 10.1128/MCB.23.13.4542-4558.2003; Coulombe P, 2007, BBA-MOL CELL RES, V1773, P1376, DOI 10.1016/j.bbamcr.2006.11.001; D'Souza WN, 2008, J IMMUNOL, V181, P7617, DOI 10.4049/jimmunol.181.11.7617; De la Mota-Peynado A, 2011, J BIOL CHEM, V286, P13603, DOI 10.1074/jbc.M110.181743; Deleris P, 2008, J CELL PHYSIOL, V217, P778, DOI 10.1002/jcp.21560; Deleris P, 2011, J BIOL CHEM, V286, P6470, DOI 10.1074/jbc.M110.181529; Feinerman O, 2008, SCIENCE, V321, P1081, DOI 10.1126/science.1158013; Gaestel M, 2006, NAT REV MOL CELL BIO, V7, P120, DOI 10.1038/nrm1834; Gett AV, 2003, NAT IMMUNOL, V4, P355, DOI 10.1038/ni908; Hansen CA, 2008, CELL CYCLE, V7, P325, DOI 10.4161/cc.7.3.5354; Hoeflich KP, 2006, INT J ONCOL, V29, P839; Kaiser BK, 2002, MOL BIOL CELL, V13, P2289, DOI 10.1091/mbc.01-11-0535; Kant S, 2006, J BIOL CHEM, V281, P35511, DOI 10.1074/jbc.M606693200; Klinger S, 2009, P NATL ACAD SCI USA, V106, P16710, DOI 10.1073/pnas.0900919106; Lacombe MH, 2005, J IMMUNOL, V175, P4400, DOI 10.4049/jimmunol.175.7.4400; Lanzavecchia A, 2000, CURR OPIN IMMUNOL, V12, P92, DOI 10.1016/S0952-7915(99)00056-4; Lezzi G, 1998, IMMUNITY, V8, P89, DOI 10.1016/S1074-7613(00)80461-6; Long WW, 2012, J CLIN INVEST, V122, P1869, DOI 10.1172/JCI61492; Mailand N, 2002, NAT CELL BIOL, V4, P317, DOI 10.1038/ncb777; Mathieu M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030139; Obst R, 2005, J EXP MED, V201, P1555, DOI 10.1084/jem.20042521; Ostiguy V, 2007, J LEUKOCYTE BIOL, V82, P645, DOI 10.1189/jlb.0806494; Perander M, 2008, FRONT BIOSCI-LANDMRK, V13, P4617; Prlic M, 2006, J EXP MED, V203, P2135, DOI 10.1084/jem.20060928; Raman M, 2007, ONCOGENE, V26, P3100, DOI 10.1038/sj.onc.1210392; Richter A, 1999, J EXP MED, V190, P1439, DOI 10.1084/jem.190.10.1439; Rodier G, 2001, EMBO J, V20, P6672, DOI 10.1093/emboj/20.23.6672; Rousseau J, 2010, MOL CELL BIOL, V30, P5752, DOI 10.1128/MCB.01147-10; Samelson LE, 2002, ANNU REV IMMUNOL, V20, P371, DOI 10.1146/annurev.immunol.20.092601.111357; Schumacher S, 2004, EMBO J, V23, P4770, DOI 10.1038/sj.emboj.7600467; Servant MJ, 2000, J CELL BIOL, V148, P543, DOI 10.1083/jcb.148.3.543; Seternes OM, 2004, EMBO J, V23, P4780, DOI 10.1038/sj.emboj.7600489; Sun MY, 2006, BIOCHEM BIOPH RES CO, V340, P209, DOI 10.1016/j.bbrc.2005.12.003; Terra R, 2002, J IMMUNOL, V169, P684, DOI 10.4049/jimmunol.169.2.684; Turgeon B, 2002, GENOMICS, V80, P673, DOI 10.1006/geno.2002.7013; Turgeon B, 2000, BIOCHEM J, V346, P169, DOI 10.1042/0264-6021:3460169; WHITEHURST CE, 1992, J IMMUNOL, V148, P3230; Whitehurst CE, 1996, J IMMUNOL, V156, P1020; Xu JM, 2009, NAT REV CANCER, V9, P615, DOI 10.1038/nrc2695	45	15	16	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2014	9	1							e86681	10.1371/journal.pone.0086681	http://dx.doi.org/10.1371/journal.pone.0086681			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301BI	24475167	gold, Green Published, Green Submitted			2022-12-25	WOS:000330507300102
J	Pancoska, P; Kirkwood, JM; Bouros, S; Spyropoulou-Vlachou, M; Pectasides, E; Tsoutsos, D; Polyzos, A; Markopoulos, C; Panagiotou, P; Castana, O; Bafaloukos, D; Fountzilas, G; Gogas, H				Pancoska, Petr; Kirkwood, John M.; Bouros, Spyros; Spyropoulou-Vlachou, Maria; Pectasides, Eirini; Tsoutsos, Dimosthenis; Polyzos, Aristidis; Markopoulos, Christos; Panagiotou, Petros; Castana, Ourania; Bafaloukos, Dimitrios; Fountzilas, George; Gogas, Helen			A New Mathematical Model for the Interpretation of Translational Research Evaluating Six CTLA-4 Polymorphisms in High-Risk Melanoma Patients Receiving Adjuvant Interferon	PLOS ONE			English	Article							GENE; THERAPY; SUSCEPTIBILITY; SURVIVAL	Adjuvant therapy of stage IIB/III melanoma with interferon reduces relapse and mortality by up to 33% but is accompanied by toxicity-related complications. Polymorphisms of the CTLA-4 gene associated with autoimmune diseases could help in identifying interferon treatment benefits. We previously genotyped 286 melanoma patients and 288 healthy (unrelated) individuals for six CTLA-4 polymorphisms (SNP). Previous analyses found no significant differences between the distributions of CTLA-4 polymorphisms in the melanoma population vs. controls, no significant difference in relapse free and overall survivals among patients and no correlation between autoimmunity and specific alleles. We report new analysis of these CTLA-4 genetic profiles, using Network Phenotyping Strategy (NPS). It is graph-theory based method, analyzing the SNP patterns. Application of NPS on CTLA-4 polymorphism captures allele relationship pattern for every patient into 6-partite mathematical graph P. Graphs P are combined into weighted 6-partite graph S, which subsequently decomposed into reference relationship profiles (RRP). Finally, every individual CTLA-4 genotype pattern is characterized by the graph distances of P from eight identified RRP's. RRP's are subgraphs of S, collecting equally frequent binary allele co-occurrences in all studied loci. If S topology represents the genetic "dominant model'', the RRP's and their characteristic frequencies are identical to expectation-maximization derived haplotypes and maximal likelihood estimates of their frequencies. The graph-representation allows showing that patient CTLA-4 haplotypes are uniquely different from the controls by absence of specific SNP combinations. New function-related insight is derived when the 6-partite graph reflects allelic state of CTLA-4. We found that we can use differences between individual P and specific RRPs to identify patient subpopulations with clearly different polymorphic patterns relatively to controls as well as to identify patients with significantly different survival.	[Pancoska, Petr] Univ Pittsburgh, Dept Med, Ctr Clin Pharmacol, Ctr Craniofacial & Dent Genet, Pittsburgh, PA USA; [Kirkwood, John M.] Univ Pittsburgh, Dept Med, Hillman Canc Ctr, Inst Canc, Pittsburgh, PA USA; [Bouros, Spyros; Pectasides, Eirini; Polyzos, Aristidis; Markopoulos, Christos; Gogas, Helen] Univ Athens, Sch Med, Dept Med 1, GR-11527 Athens, Greece; [Spyropoulou-Vlachou, Maria] Gen Hosp Athens, Natl Tissue Typing Ctr, Dept Immunol, Athens, Greece; [Tsoutsos, Dimosthenis; Panagiotou, Petros] G Gennimatas Gen Hosp Athens, Dept Plast Surg & Microsurg, Athens, Greece; [Castana, Ourania] Evangelismos Gen Hosp Athens, Dept Plast Surg, Athens, Greece; [Bafaloukos, Dimitrios; Fountzilas, George] Data Off, Hellen Cooperat Oncol Grp, Athens, Greece	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Athens Medical School; National & Kapodistrian University of Athens; General Hospital of N. Ionia Agia Olga; Hellenic Cooperative Oncology Group	Gogas, H (corresponding author), Univ Athens, Sch Med, Dept Med 1, GR-11527 Athens, Greece.	hgogas@hol.gr	Fountzilas, George/ABF-2139-2020; Markopoulos, Christos/AAD-8501-2019	Markopoulos, Christos/0000-0002-5072-6390; Fountzilas, George/0000-0001-8045-2186; Pancoska, Petr/0000-0002-6724-8559	European Research Council-CZ LL1201 program CORES (Complex Structures: Regularity in Combinatorics and Discrete Mathematics); National Institutes of Health [P50CA121973]; NATIONAL CANCER INSTITUTE [P50CA121973] Funding Source: NIH RePORTER	European Research Council-CZ LL1201 program CORES (Complex Structures: Regularity in Combinatorics and Discrete Mathematics); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	P. Pancoska was supported in part by European Research Council-CZ LL1201 program CORES (Complex Structures: Regularity in Combinatorics and Discrete Mathematics). JMK was supported by National Institutes of Health grant P50CA121973. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banks D, 1998, J CLASSIF, V15, P199, DOI 10.1007/s003579900031; Carr BI, 2011, HEPATO-GASTROENTEROL, V58, P1334, DOI 10.5754/hge11029; DARIAVACH P, 1988, EUR J IMMUNOL, V18, P1901, DOI 10.1002/eji.1830181206; Gogas H, 2010, J TRANSL MED, V8, DOI 10.1186/1479-5876-8-108; Gough SCL, 2005, IMMUNOL REV, V204, P102, DOI 10.1111/j.0105-2896.2005.00249.x; HAMMING RW, 1950, BELL SYST TECH J, V29, P147, DOI 10.1002/j.1538-7305.1950.tb00463.x; Kirkwood JM, 1996, J CLIN ONCOL, V14, P7, DOI 10.1200/JCO.1996.14.1.7; Kirkwood JM, 2001, J CLIN ONCOL, V19, P2370, DOI 10.1200/JCO.2001.19.9.2370; Kirkwood JM, 2002, CANCER-AM CANCER SOC, V95, P1101, DOI 10.1002/cncr.10775; Kristiansen OP, 2000, GENES IMMUN, V1, P170, DOI 10.1038/sj.gene.6363655; Mocellin S, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008955.pub2; Mocellin S, 2010, JNCI-J NATL CANCER I, V102, P493, DOI 10.1093/jnci/djq009; Pancoska P, 2012, ARXIV12062070QBIOOT; Pancoska P, 2011, DIGEST DIS SCI, V56, P3078, DOI 10.1007/s10620-011-1687-x; Pancoska P, 2010, SEMIN ONCOL, V37, P170, DOI 10.1053/j.seminoncol.2010.03.008; Thompson CB, 1997, IMMUNITY, V7, P445, DOI 10.1016/S1074-7613(00)80366-0; Ueda H, 2003, NATURE, V423, P506, DOI 10.1038/nature01621; Wang E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040805; Yurkovetsky ZR, 2007, CLIN CANCER RES, V13, P2422, DOI 10.1158/1078-0432.CCR-06-1805	19	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2014	9	1							e86375	10.1371/journal.pone.0086375	http://dx.doi.org/10.1371/journal.pone.0086375			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301BI	24475110	Green Accepted, Green Submitted, Green Published, gold			2022-12-25	WOS:000330507300058
J	Dacosta-Aguayo, R; Grana, M; Fernandez-Andujar, M; Lopez-Cancio, E; Caceres, C; Bargallo, N; Barrios, M; Clemente, I; Monserrat, PT; Sas, MA; Davalos, A; Auer, T; Mataro, M				Dacosta-Aguayo, Rosalia; Grana, Manuel; Fernandez-Andujar, Marina; Lopez-Cancio, Elena; Caceres, Cynthia; Bargallo, Nuria; Barrios, Maite; Clemente, Immaculada; Toran Monserrat, Pere; Alzamora Sas, Maite; Davalos, Antoni; Auer, Tibor; Mataro, Maria			Structural Integrity of the Contralesional Hemisphere Predicts Cognitive Impairment in Ischemic Stroke at Three Months	PLOS ONE			English	Article							WHITE-MATTER INTEGRITY; FOCAL CEREBRAL-ISCHEMIA; TENSOR IMAGING DETECTS; DIFFUSION ANISOTROPY; MOTOR FUNCTION; TRACT; DEGENERATION; MECHANISMS; EVOLUTION; PERFUSION	After stroke, white matter integrity can be affected both locally and distally to the primary lesion location. It has been shown that tract disruption in mirror's regions of the contralateral hemisphere is associated with degree of functional impairment. Fourteen patients suffering right hemispheric focal stroke (S) and eighteen healthy controls (HC) underwent Diffusion Weighted Imaging (DWI) and neuropsychological assessment. The stroke patient group was divided into poor (SP; n = 8) and good (SG; n = 6) cognitive recovery groups according to their cognitive improvement from the acute phase (72 hours after stroke) to the subacute phase (3 months post-stroke). Whole-brain DWI data analysis was performed by computing Diffusion Tensor Imaging (DTI) followed by Tract Based Spatial Statistics (TBSS). Assessment of effects was obtained computing the correlation of the projections on TBSS skeleton of Fractional Anisotropy (FA) and Radial Diffusivity (RD) with cognitive test results. Significant decrease of FA was found only in right brain anatomical areas for the S group when compared to the HC group. Analyzed separately, stroke patients with poor cognitive recovery showed additional significant FA decrease in several left hemisphere regions; whereas SG patients showed significant decrease only in the left genu of corpus callosum when compared to the HC. For the SG group, whole brain analysis revealed significant correlation between the performance in the Semantic Fluency test and the FA in the right hemisphere as well as between the performance in the Grooved Pegboard Test (GPT) and theTrail Making Test-part A and the FA in the left hemisphere. For the SP group, correlation analysis revealed significant correlation between the performance in the GPT and the FA in the right hemisphere.	[Fernandez-Andujar, Marina; Clemente, Immaculada; Mataro, Maria] Univ Barcelona, Dept Psychiat & Clin Psychobiol, Barcelona, Spain; [Dacosta-Aguayo, Rosalia; Grana, Manuel] Univ Basque Country UPV EHU, Grp Computat Intelligence, San Sebastian, Spain; [Lopez-Cancio, Elena; Caceres, Cynthia; Davalos, Antoni] Univ Autonoma Barcelona, Hosp Germans Trias & Pujol, Dept Neurosci, E-08193 Barcelona, Spain; [Fernandez-Andujar, Marina; Clemente, Immaculada; Mataro, Maria] Inst Brain Cognit & Behav IR3C, Barcelona, Spain; [Bargallo, Nuria] Hosp Clin Barcelona, Diagnost Ctr Image, Barcelona, Spain; [Bargallo, Nuria] Imatge Platform IDIBAPS, Barcelona, Spain; [Barrios, Maite] Univ Barcelona, Dept Methodol Behav Sci, Barcelona, Spain; [Auer, Tibor] MRC Cognit & Brain Sci Unit, Cambridge, England; [Toran Monserrat, Pere; Alzamora Sas, Maite] Inst Univ Invest Atencio Primaria IDIAP Jordi Gol, Primary Healthcare Res Support Unit, Metropolitana Nord, Santa Coloma De Gramenet, Spain	University of Barcelona; University of Basque Country; Autonomous University of Barcelona; Hospital Germans Trias i Pujol; University of Barcelona; University of Barcelona; Hospital Clinic de Barcelona; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; University of Barcelona	Mataro, M (corresponding author), Univ Barcelona, Dept Psychiat & Clin Psychobiol, Barcelona, Spain.	mmataro@ub.edu	Torán-Monserrat, Pere/AAY-4396-2021; Hernandez, María/GYU-3543-2022; Bargallo, Nuria/G-6854-2016; Clemente, I Concepcion/H-5399-2013; Romay, Manuel M. Graña/L-1341-2014; Mataro, Maria/B-4524-2011; Barrios, Maite/J-5738-2013; Dacosta-Aguayo, Rosalia/L-8708-2014	Torán-Monserrat, Pere/0000-0002-9865-7427; Bargallo, Nuria/0000-0001-6284-5402; Clemente, I Concepcion/0000-0003-0728-0925; Romay, Manuel M. Graña/0000-0001-7373-4097; Mataro, Maria/0000-0002-9946-2656; Barrios, Maite/0000-0003-1979-0818; Dacosta-Aguayo, Rosalia/0000-0003-1861-365X; Auer, Tibor/0000-0001-5153-1424	Ministry of Science and Innovation (MICINN) [PSI2009-11519, BES-2010-031833]; Ministry of Economy and Competitiveness (MINECO) [TIN2011-23823]; UFI, Spain [11/07]; Medical Research Council [MC_U105579212] Funding Source: researchfish; MRC [MC_U105579212] Funding Source: UKRI	Ministry of Science and Innovation (MICINN)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Ministry of Economy and Competitiveness (MINECO)(Spanish Government); UFI, Spain; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This project has been made possible primarily through the efforts of the authors' recruited patients and healthy controls participants who voluntarily accepted to enroll in this project. This study was supported by the grants PSI2009-11519 to MM, the grant Formacio Personal Investigador (FPI), BES-2010-031833 to MF from the Ministry of Science and Innovation (MICINN), grant TIN2011-23823 from the Ministry of Economy and Competitiveness (MINECO) and UFI 11/07 to MG, Spain. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ago T, 2003, J NEUROL NEUROSUR PS, V74, P1152, DOI 10.1136/jnnp.74.8.1152; Andersson J.L.R., 2007, TR07JA1 FMRIB; Andersson JLR, 2007, NONLINEAR REGISTRATI; Antenor-Dorsey JAV, 2013, DIABETES, V62, P581, DOI 10.2337/db12-0696; Beaulieu C, 1999, ANN NEUROL, V46, P568, DOI 10.1002/1531-8249(199910)46:4<568::AID-ANA4>3.0.CO;2-R; Bennett IJ, 2010, HUM BRAIN MAPP, V31, P378, DOI 10.1002/hbm.20872; Bhagat YA, 2008, MAGN RESON IMAGING, V26, P683, DOI 10.1016/j.mri.2008.01.015; Bhagat YA, 2006, J CEREBR BLOOD F MET, V26, P1442, DOI 10.1038/sj.jcbfm.9600294; Bihel E, 2010, J CEREBR BLOOD F MET, V30, P273, DOI 10.1038/jcbfm.2009.209; Brus-Ramer M, 2007, J NEUROSCI, V27, P13793, DOI 10.1523/JNEUROSCI.3489-07.2007; Bucur B, 2008, NEUROBIOL AGING, V29, P1070, DOI 10.1016/j.neurobiolaging.2007.02.008; Buffon F, 2005, J CEREBR BLOOD F MET, V25, P641, DOI 10.1038/sj.jcbfm.9600054; Burgmans S, 2010, NEUROIMAGE, V49, P2083, DOI 10.1016/j.neuroimage.2009.10.035; Burzynska AZ, 2010, NEUROIMAGE, V49, P2104, DOI 10.1016/j.neuroimage.2009.09.041; Carmichael ST, 2002, J NEUROSCI, V22, P6062; Carmichael ST, 2003, NEUROSCIENTIST, V9, P64, DOI 10.1177/1073858402239592; Chui HC, 2007, NEUROL CLIN, V25, P717, DOI 10.1016/j.ncl.2007.04.003; Crofts JJ, 2011, NEUROIMAGE, V54, P161, DOI 10.1016/j.neuroimage.2010.08.032; Dacosta-Aguayo R, 2012, J INT NEUROPSYCHOLOG; Dancause N, 2005, J NEUROSCI, V25, P10167, DOI 10.1523/JNEUROSCI.3256-05.2005; Dihne M, 2002, STROKE, V33, P3006, DOI 10.1161/01.STR.0000039406.64644.CB; Ding GL, 2008, J CEREBR BLOOD F MET, V28, P1440, DOI 10.1038/jcbfm.2008.33; Dufouil C, 2009, STROKE, V40, P2219, DOI 10.1161/STROKEAHA.108.540633; Englund E, 2002, CEREBROVASC DIS, V13, P11, DOI 10.1159/000049144; Fiebach JB, 2002, NEURORADIOLOGY, V44, P294, DOI 10.1007/s00234-001-0720-8; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Gerloff C, 2006, BRAIN, V129, P791, DOI 10.1093/brain/awh713; Hu YZ, 2011, HUM BRAIN MAPP, V32, P10, DOI 10.1002/hbm.20996; Iadecola C, 2011, NAT MED, V17, P796, DOI 10.1038/nm.2399; Irving EA, 2001, ACTA NEUROPATHOL, V102, P627, DOI 10.1007/s004010100416; Jang SH, 2005, RESTOR NEUROL NEUROS, V23, P11; Jankowska E, 2006, NEUROSCIENTIST, V12, P67, DOI 10.1177/1073858405283392; Johanse-Berg H, 2010, FRONTIERS SYSTEMS NE, V4, P1; Kaplan E, 1983, BOSTON DIAGNOSTIC AP; Keller TA, 2009, NEURON, V64, P624, DOI 10.1016/j.neuron.2009.10.018; Kertesz A, 1997, CAN J NEUROL SCI, V24, P29, DOI 10.1017/S0317167100021053; Klein A, 2009, NEUROIMAGE, V46, P786, DOI 10.1016/j.neuroimage.2008.12.037; Kumar R, 2012, J NEUROSCI RES, V90, P346, DOI 10.1002/jnr.22757; Kumar R, 2010, J NEUROSCI RES, V88, P2146, DOI 10.1002/jnr.22385; Lawrence AJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061014; Leritz EC, 2010, NEUROPSYCHOLOGY, V24, P199, DOI 10.1037/a0018108; Lindenberg R, 2010, NEUROLOGY, V74, P280, DOI 10.1212/WNL.0b013e3181ccc6d9; Liu ZW, 2008, STROKE, V39, P2571, DOI 10.1161/STROKEAHA.107.511659; Lopez-Cancio E, 2012, ATHEROSCLEROSIS, V221, P221, DOI 10.1016/j.atherosclerosis.2011.12.020; Maniega SM, 2004, J NEUROL NEUROSUR PS, V75, P1714, DOI 10.1136/jnnp.2003.033852; Marks MP, 1999, NEUROLOGY, V52, P1792, DOI 10.1212/WNL.52.9.1792; Miralbell J, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2011.09.020; Molko N, 2002, STROKE, V33, P2902, DOI 10.1161/01.STR.0000041681.25514.22; Morales Gonzalez J M, 1992, Arch Neurobiol (Madr), V55, P262; Mukherjee D, 2011, WORLD NEUROSURG, V76, pS85, DOI 10.1016/j.wneu.2011.07.023; Nasreddine ZS, 2005, J AM GERIATR SOC, V53, P695, DOI 10.1111/j.1532-5415.2005.53221.x; Nichols TE, 2002, HUM BRAIN MAPP, V15, P1, DOI 10.1002/hbm.1058; O'Sullivan M, 2004, NEUROLOGY, V62, P702, DOI 10.1212/01.WNL.0000113760.72706.D2; O'Sullivan M, 2001, NEUROLOGY, V57, P2307, DOI 10.1212/WNL.57.12.2307; Pantoni L, 2010, LANCET NEUROL, V9, P689, DOI 10.1016/S1474-4422(10)70104-6; Perantie DC, 2011, DIABETES, V60, P3006, DOI 10.2337/db11-0589; Pitkonen M, 2012, BRAIN RES, V1445, P103, DOI 10.1016/j.brainres.2012.01.043; Qiu MG, 2011, NEUROREHAB NEURAL RE, V25, P275, DOI 10.1177/1545968310389183; Rehme AK, 2012, NEUROIMAGE, V59, P2771, DOI 10.1016/j.neuroimage.2011.10.023; Rehme AK, 2011, CEREB CORTEX, V21, P756, DOI 10.1093/cercor/bhq140; Rueckert D, 1999, IEEE T MED IMAGING, V18, P712, DOI 10.1109/42.796284; RUFF RM, 1993, PERCEPT MOTOR SKILL, V76, P1219, DOI 10.2466/pms.1993.76.3c.1219; Salthouse TA, 2011, PSYCHOL BULL, V137, P753, DOI 10.1037/a0023262; Schaechter JD, 2009, HUM BRAIN MAPP, V30, P3461, DOI 10.1002/hbm.20770; Sims JR, 2009, NEUROLOGY, V72, P2104, DOI 10.1212/WNL.0b013e3181aa5329; SKRIVER EB, 1990, ACTA RADIOL, V31, P431; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Smith SM, 2009, NEUROIMAGE, V44, P83, DOI 10.1016/j.neuroimage.2008.03.061; Song SK, 2003, NEUROIMAGE, V20, P1714, DOI 10.1016/j.neuroimage.2003.07.005; Stinear CM, 2007, BRAIN, V130, P170, DOI 10.1093/brain/awl333; Strauss E, 2006, COMPENDIUM NEUROPSYC; Strub R, 2000, MENTAL STATUS EXAMIN; SYKOVA E, 1994, J CEREBR BLOOD F MET, V14, P301, DOI 10.1038/jcbfm.1994.37; Tang YY, 2012, P NATL ACAD SCI USA, V109, P10570, DOI 10.1073/pnas.1207817109; Thomalla G, 2004, NEUROIMAGE, V22, P1767, DOI 10.1016/j.neuroimage.2004.03.041; van der Zijden JP, 2008, EXP NEUROL, V212, P207, DOI 10.1016/j.expneurol.2008.03.027; van Duinkerken E, 2012, DIABETOLOGIA, V55, P1218, DOI 10.1007/s00125-012-2488-2; Wang CS, 2006, NEUROBIOL AGING, V27, P1827, DOI 10.1016/j.neurobiolaging.2005.10.008; Watanabe T, 2001, J NEUROSURG, V94, P955, DOI 10.3171/jns.2001.94.6.0955; Wechsler D, 1999, WECHSLER ADULT INTEL; Werring DJ, 2000, J NEUROL NEUROSUR PS, V69, P269, DOI 10.1136/jnnp.69.2.269; YESAVAGE JA, 1983, J PSYCHIATR RES, V17, P37, DOI 10.1016/0022-3956(82)90033-4	84	41	46	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2014	9	1							e86119	10.1371/journal.pone.0086119	http://dx.doi.org/10.1371/journal.pone.0086119			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	298QQ	24475078	Green Published, Green Submitted, gold			2022-12-25	WOS:000330339800029
J	Kim, K; Mall, C; Taylor, SL; Hitchcock, S; Zhang, C; Wettersten, HI; Jones, AD; Chapman, A; Weiss, RH				Kim, Kyoungmi; Mall, Christine; Taylor, Sandra L.; Hitchcock, Stacie; Zhang, Chen; Wettersten, Hiromi I.; Jones, A. Daniel; Chapman, Arlene; Weiss, Robert H.			Mealtime, Temporal, and Daily Variability of the Human Urinary and Plasma Metabolomes in a Tightly Controlled Environment	PLOS ONE			English	Article							KIDNEY CANCER-DETECTION; BIOMARKER DISCOVERY; PHENOTYPES; PROFILES; STANDARDIZATION; METABONOMICS; CHALLENGES; CRITERIA; GENDER; AGE	While metabolomics has tremendous potential for diagnostic biomarker and therapeutic target discovery, its utility may be diminished by the variability that occurs due to environmental exposures including diet and the influences of the human circadian rhythm. For successful translation of metabolomics findings into the clinical setting, it is necessary to exhaustively define the sources of metabolome variation. To address these issues and to measure the variability of urinary and plasma metabolomes throughout the day, we have undertaken a comprehensive inpatient study in which we have performed nontargeted metabolomics analysis of blood and urine in 26 volunteers (13 healthy subjects with no known disease and 13 healthy subjects with autosomal dominant polycystic kidney disease not taking medication). These individuals were evaluated in a clinical research facility on two separate occasions, over three days, while on a standardized, weight-based diet. Subjects provided pre- and post-prandial blood and urine samples at the same time of day, and all samples were analyzed by "fast lane" LC-MS-based global metabolomics. The largest source of variability in blood and urine metabolomes was attributable to technical issues such as sample preparation and analysis, and less variability was due to biological variables, meals, and time of day. Higher metabolome variability was observed after the morning as compared to the evening meal, yet day-to-day variability was minimal and urine metabolome variability was greater than that of blood. Thus we suggest that blood and urine are suitable biofluids for metabolomics studies, though nontargeted mass spectrometry alone may not offer sufficient precision to reveal subtle changes in the metabolome. Additional targeted analyses may be needed to support the data from nontargeted mass spectrometric analyses. In light of these findings, future metabolomics studies should consider these sources of variability to allow for appropriate metabolomics testing and reliable clinical translation of metabolomics data.	[Mall, Christine; Wettersten, Hiromi I.; Weiss, Robert H.] Univ Calif Davis, Dept Internal Med, Div Nephrol, Davis, CA 95616 USA; [Kim, Kyoungmi; Taylor, Sandra L.] Univ Calif Davis, Dept Publ Hlth Sci, Div Biostat, Davis, CA 95616 USA; [Weiss, Robert H.] Univ Calif Davis, Ctr Canc, Davis, CA 95616 USA; [Hitchcock, Stacie; Chapman, Arlene] Emory Univ, Dept Internal Med, Div Nephrol, Atlanta, GA 30322 USA; [Zhang, Chen; Jones, A. Daniel] Michigan State Univ, Dept Chem, E Lansing, MI 48824 USA; [Jones, A. Daniel] Michigan State Univ, Dept Biochem & Mol Biol, E Lansing, MI 48824 USA; [Weiss, Robert H.] Sacramento VA Med Ctr, Med Serv, Sacramento, CA USA	University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis; Emory University; Michigan State University; Michigan State University	Weiss, RH (corresponding author), Univ Calif Davis, Dept Internal Med, Div Nephrol, Davis, CA 95616 USA.	rhweiss@ucdavis.edu	Jones, Arthur D/C-2670-2013	Taylor, Sandra/0000-0001-7811-812X; Jones, A. Daniel/0000-0002-7408-6690	NIH [1R01CA135401-01A1, 1R01DK082690-01A1]; Medical Service of the US Department of Veterans' Affairs; National Center for Advancing Translational Sciences of the National Institutes of Health [UL1TR000454, UL1 TR000002]; Michigan AgBioResearch; NATIONAL CANCER INSTITUTE [P30CA093373, R01CA135401] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000454, UL1TR000002] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK082690] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Medical Service of the US Department of Veterans' Affairs; National Center for Advancing Translational Sciences of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); Michigan AgBioResearch; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by NIH grants 1R01CA135401-01A1 and 1R01DK082690-01A1 and the Medical Service of the US Department of Veterans' Affairs (all to RHW), by the National Center for Advancing Translational Sciences of the National Institutes of Health under Award Number UL1TR000454 (to Emory University) and UL1 TR000002 (to UC Davis), and by Michigan AgBioResearch. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aboud OA, 2012, CLIN CHEM, V59, P138; Assfalg M, 2008, P NATL ACAD SCI USA, V105, P1420, DOI 10.1073/pnas.0705685105; Bernini P, 2009, J PROTEOME RES, V8, P4264, DOI 10.1021/pr900344m; Dallmann R, 2012, P NATL ACAD SCI USA, V109, P2625, DOI 10.1073/pnas.1114410109; Fan TWM, 2004, CURR OPIN MOL THER, V6, P584; Ganti S, 2012, CANCER RES, V72, P3471, DOI 10.1158/0008-5472.CAN-11-3105; Ganti S, 2011, UROL ONCOL-SEMIN ORI, V29, P551, DOI 10.1016/j.urolonc.2011.05.013; German JB, 2005, METABOLOMICS, V1, P3, DOI 10.1007/s11306-005-1102-8; Gu LP, 2010, PLANT J, V61, P579, DOI 10.1111/j.1365-313X.2009.04083.x; Heinzmann SS, 2012, J PROTEOME RES, V11, P643, DOI 10.1021/pr2005764; Kim K, 2009, MOL CELL PROTEOMICS, V8, P558, DOI 10.1074/mcp.M800165-MCP200; Krug S, 2012, FASEB J, V26, P2607, DOI 10.1096/fj.11-198093; Llorach R, 2009, J PROTEOME RES, V8, P5060, DOI 10.1021/pr900470a; Llorach-Asuncion R, 2010, J PHARMACEUT BIOMED, V51, P373, DOI 10.1016/j.jpba.2009.06.033; McShane LM, 2013, NATURE, V502, P317, DOI 10.1038/nature12564; Pei Y, 2009, J AM SOC NEPHROL, V20, P205, DOI 10.1681/ASN.2008050507; Psihogios NG, 2008, NMR BIOMED, V21, P195, DOI 10.1002/nbm.1176; Rasmussen LG, 2011, METABOLOMICS, V7, P71, DOI 10.1007/s11306-010-0234-7; Slupsky CM, 2007, ANAL CHEM, V79, P6995, DOI 10.1021/ac0708588; Stella C, 2006, J PROTEOME RES, V5, P2780, DOI 10.1021/pr060265y; Van Dorsten FA, 2006, J AGR FOOD CHEM, V54, P6929, DOI 10.1021/jf061016x; Wallace M, 2010, HUM REPROD, V25, P949, DOI 10.1093/humrep/deq011; Walsh MC, 2007, AM J CLIN NUTR, V86, P1687; Walsh MC, 2006, AM J CLIN NUTR, V84, P531, DOI 10.1093/ajcn/84.3.531; Wang YL, 2005, J AGR FOOD CHEM, V53, P191, DOI 10.1021/jf0403282; Weiss RH, 2012, NAT REV NEPHROL, V8, P22, DOI 10.1038/nrneph.2011.152; Wikoff WR, 2011, J PROTEOME RES, V10, P2842, DOI 10.1021/pr200093w; Winnike JH, 2009, AM J CLIN NUTR, V90, P1496, DOI 10.3945/ajcn.2009.28234; Wishart DS, 2007, NUCLEIC ACIDS RES, V35, pD521, DOI 10.1093/nar/gkl923	29	54	54	2	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2014	9	1							e86223	10.1371/journal.pone.0086223	http://dx.doi.org/10.1371/journal.pone.0086223			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	298QQ	24475090	Green Submitted, Green Published, gold			2022-12-25	WOS:000330339800034
J	Balaban, CD; Ogburn, SW; Warshafsky, SG; Ahmed, A; Yates, BJ				Balaban, Carey D.; Ogburn, Sarah W.; Warshafsky, Susan G.; Ahmed, Abdul; Yates, Bill J.			Identification of Neural Networks That Contribute to Motion Sickness through Principal Components Analysis of Fos Labeling Induced by Galvanic Vestibular Stimulation	PLOS ONE			English	Article							TACHYKININ NK1 RECEPTOR; ROSTRAL VENTROLATERAL MEDULLA; VENTRAL RESPIRATORY GROUP; NUCLEUS RAPHE MAGNUS; BULBOSPINAL EXPIRATORY NEURONS; DORSAL PERIAQUEDUCTAL GRAY; MEMBRANE-POTENTIAL CHANGES; RAT LOCUS-CERULEUS; HOUSE MUSK SHREW; BRAIN-STEM	Motion sickness is a complex condition that includes both overt signs (e. g., vomiting) and more covert symptoms (e. g., anxiety and foreboding). The neural pathways that mediate these signs and symptoms are yet to identified. This study mapped the distribution of c-fos protein (Fos)-like immunoreactivity elicited during a galvanic vestibular stimulation paradigm that is known to induce motion sickness in felines. A principal components analysis was used to identify networks of neurons activated during this stimulus paradigm from functional correlations between Fos labeling in different nuclei. This analysis identified five principal components (neural networks) that accounted for greater than 95% of the variance in Fos labeling. Two of the components were correlated with the severity of motion sickness symptoms, and likely participated in generating the overt signs of the condition. One of these networks included neurons in locus coeruleus, medial, inferior and lateral vestibular nuclei, lateral nucleus tractus solitarius, medial parabrachial nucleus and periaqueductal gray. The second included neurons in the superior vestibular nucleus, precerebellar nuclei, periaqueductal gray, and parabrachial nuclei, with weaker associations of raphe nuclei. Three additional components (networks) were also identified that were not correlated with the severity of motion sickness symptoms. These networks likely mediated the covert aspects of motion sickness, such as affective components. The identification of five statistically independent component networks associated with the development of motion sickness provides an opportunity to consider, in network activation dimensions, the complex progression of signs and symptoms that are precipitated in provocative environments. Similar methodology can be used to parse the neural networks that mediate other complex responses to environmental stimuli.	[Balaban, Carey D.; Ogburn, Sarah W.; Warshafsky, Susan G.; Ahmed, Abdul; Yates, Bill J.] Univ Pittsburgh, Dept Otolaryngol, Pittsburgh, PA 15260 USA; [Balaban, Carey D.] Univ Pittsburgh, Dept Bioengn, Pittsburgh, PA USA; [Balaban, Carey D.] Univ Pittsburgh, Dept Commun Sci & Disorders, Pittsburgh, PA USA; [Balaban, Carey D.] Univ Pittsburgh, Dept Neurobiol, Pittsburgh, PA USA; [Ahmed, Abdul; Yates, Bill J.] Univ Pittsburgh, Dept Neurosci, Pittsburgh, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Yates, BJ (corresponding author), Univ Pittsburgh, Dept Otolaryngol, Pittsburgh, PA 15260 USA.	byates@pitt.edu	Balaban, Carey/O-6586-2019; Yates, Bill/D-5602-2009; Balaban, Carey/I-3467-2017	Balaban, Carey/0000-0002-3570-3844; Yates, Bill/0000-0001-6819-097X; Balaban, Carey/0000-0002-3570-3844	NIH [R01-DC003732]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC003732] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	NIH grant R01-DC003732. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson T. W., 1958, INTRO MULTIVARIATE S; Ariumi H, 2000, NEUROSCI LETT, V286, P123, DOI 10.1016/S0304-3940(00)01113-7; Baizer JS, 2010, BRAIN RES, V1351, P64, DOI 10.1016/j.brainres.2010.05.087; Balaban C.D., 2003, ASS RES OT ABSTR, P1511; Balaban CD, 1996, EXP BRAIN RES, V108, P367; Balaban CD, 2004, SPR HDB AUD, P286; Balaban CD, 2004, BRAIN RES, V996, P126, DOI 10.1016/j.brainres.2003.10.026; BALABAN CD, 1994, EXP BRAIN RES, V98, P200; Balabann CD, 2011, EXPERT REV NEUROTHER, V11, P379, DOI [10.1586/ern.11.19, 10.1586/ERN.11.19]; BARD P, 1947, FED PROC, V6, P72; Beaver B.V., 2003, FELINE BEHAV; Berman AL, 1968, BRAIN STEM CAT; BIANCHI AL, 1995, PHYSIOL REV, V75, P1, DOI 10.1152/physrev.1995.75.1.1; BIANCHI AL, 1989, NEUROSCI LETT, V104, P298, DOI 10.1016/0304-3940(89)90592-2; Billig I, 2001, AM J PHYSIOL-REG I, V281, pR1243, DOI 10.1152/ajpregu.2001.281.4.R1243; BOAKES RA, 1993, EUR J CANCER, V29A, P866, DOI 10.1016/S0959-8049(05)80427-7; BOISSONADE FM, 1994, AM J PHYSIOL, V266, pR1118, DOI 10.1152/ajpregu.1994.266.4.R1118; Boissonade FM, 1996, AM J PHYSIOL-REG I, V271, pR228, DOI 10.1152/ajpregu.1996.271.1.R228; BORISON HL, 1983, BRAIN BEHAV EVOLUT, V23, P7, DOI 10.1159/000121482; BORISON HL, 1986, EXP NEUROL, V92, P723, DOI 10.1016/0014-4886(86)90312-2; BOUNTRA C, 1993, EUR J PHARMACOL, V249, pR3, DOI 10.1016/0014-2999(93)90673-6; Brink TS, 2006, J NEUROPHYSIOL, V96, P3423, DOI 10.1152/jn.00793.2006; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Cheung B S, 1992, J Vestib Res, V2, P247; Clement CI, 2000, J COMP NEUROL, V425, P323, DOI 10.1002/1096-9861(20000925)425:3<323::AID-CNE1>3.0.CO;2-Z; Coggeshall RE, 2005, PROG NEUROBIOL, V77, P299, DOI 10.1016/j.pneurobio.2005.11.002; COHEN MI, 1981, ANNU REV PHYSIOL, V43, P91, DOI 10.1146/annurev.ph.43.030181.000515; Craig AD, 2009, NAT REV NEUROSCI, V10, P59, DOI 10.1038/nrn2555; Craig AD, 2002, NAT REV NEUROSCI, V3, P655, DOI 10.1038/nrn894; Craig ADB, 2003, TRENDS NEUROSCI, V26, P303, DOI 10.1016/S0166-2236(03)00123-1; Dampney RAL, 2003, PROG NEUROBIOL, V71, P359, DOI 10.1016/j.pneurobio.2003.11.001; de Andrade JS, 2012, BEHAV BRAIN RES, V232, P20, DOI 10.1016/j.bbr.2012.03.034; De Jonghe BC, 2009, AM J PHYSIOL-REG I, V296, pR902, DOI 10.1152/ajpregu.90952.2008; Depuy SD, 2011, J NEUROSCI, V31, P1981, DOI 10.1523/JNEUROSCI.4639-10.2011; Derbyshire SWG, 2009, NEUROIMAGE, V47, P1002, DOI 10.1016/j.neuroimage.2009.04.032; DRAGUNOW M, 1989, J NEUROSCI METH, V29, P261, DOI 10.1016/0165-0270(89)90150-7; DZIUBAN CD, 1974, PSYCHOL BULL, V81, P358, DOI 10.1037/h0036316; EZURE K, 1990, PROG NEUROBIOL, V35, P429, DOI 10.1016/0301-0082(90)90030-K; Ezure K., 1996, VESTIBULAR AUTONOMIC, P53; FELDMAN JL, 1986, HDB PHYSL 1, V4, P463; FOX RA, 1987, AVIAT SPACE ENVIR MD, V58, pA143; Fukuda H, 1998, BRAIN RES, V802, P221, DOI 10.1016/S0006-8993(98)00630-1; Fukuda H, 1999, NEUROSCI RES, V33, P25, DOI 10.1016/S0168-0102(98)00106-0; FUNG SJ, 1987, BRAIN RES, V401, P347, DOI 10.1016/0006-8993(87)91419-3; GANG S, 1993, J AUTONOM NERV SYST, V45, P241, DOI 10.1016/0165-1838(93)90056-Z; GANG S, 1990, NEUROSCI LETT, V118, P273, DOI 10.1016/0304-3940(90)90645-P; Gardner C, 1998, NEUROPHARMACOLOGY, V37, P1643, DOI 10.1016/S0028-3908(98)00133-6; Gardner CJ, 1996, REGUL PEPTIDES, V65, P45, DOI 10.1016/0167-0115(96)00071-7; Gianaros PJ, 2001, J PSYCHOSOM RES, V50, P263, DOI 10.1016/S0022-3999(01)00201-X; Gianaros PJ, 2001, AVIAT SPACE ENVIR MD, V72, P115; Gonsalves S, 1996, EUR J PHARMACOL, V305, P181, DOI 10.1016/0014-2999(96)00216-6; Grahek Nikola., 2007, FEELING PAIN BEING P; GRAYBIEL A, 1976, AVIAT SPACE ENVIR MD, V47, P873; GRELOT L, 1993, PFLUG ARCH EUR J PHY, V425, P313, DOI 10.1007/BF00374181; GRELOT L, 1992, J NEUROPHYSIOL, V68, P2110, DOI 10.1152/jn.1992.68.6.2110; GRELOT L, 1994, NEWS PHYSIOL SCI, V9, P142; Halberstadt AL, 2007, NEUROSCIENCE, V147, P207, DOI 10.1016/j.neuroscience.2007.03.049; Halberstadt AL, 2003, NEUROSCIENCE, V120, P573, DOI 10.1016/S0306-4522(02)00952-1; Hayes DJ, 2012, BMC NEUROSCI, V13, DOI 10.1186/1471-2202-13-60; HERBERT H, 1990, J COMP NEUROL, V293, P540, DOI 10.1002/cne.902930404; Hermann DM, 1997, J CHEM NEUROANAT, V13, P1, DOI 10.1016/S0891-0618(97)00019-7; Herrera DG, 1996, PROG NEUROBIOL, V50, P83, DOI 10.1016/S0301-0082(96)00021-4; HOLSTEGE G, 1988, BRAIN RES, V447, P154, DOI 10.1016/0006-8993(88)90977-8; Horn CC, 2007, AUTON NEUROSCI-BASIC, V132, P44, DOI 10.1016/j.autneu.2006.09.005; Horn CC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060537; Hotelling H, 1933, J EDUC PSYCHOL, V24, P417, DOI 10.1037/h0071325; HSU SM, 1981, J HISTOCHEM CYTOCHEM, V29, P577, DOI 10.1177/29.4.6166661; IGARASHI M, 1987, AVIAT SPACE ENVIR MD, V58, pA207; IGARASHI M, 1986, AVIAT SPACE ENVIR MD, V57, P1071; Ito H, 2005, EXP ANIM TOKYO, V54, P301, DOI 10.1538/expanim.54.301; Ito J, 2003, AUTON NEUROSCI-BASIC, V107, P1, DOI 10.1016/S1566-0702(03)00026-2; Javid FA, 1999, PHARMACOL BIOCHEM BE, V64, P115, DOI 10.1016/S0091-3057(99)00066-0; JENCK F, 1995, PSYCHIAT RES, V57, P181, DOI 10.1016/0165-1781(95)02673-K; JONES BE, 1977, BRAIN RES, V127, P23, DOI 10.1016/0006-8993(77)90378-X; Kakimoto S, 1997, BIOL PHARM BULL, V20, P739; KAUFMAN GD, 1992, J NEUROSCI, V12, P4489; KAUFMAN GD, 1993, J NEUROPHYSIOL, V70, P117, DOI 10.1152/jn.1993.70.1.117; Keay KA, 2000, NEUROSCI LETT, V290, P157, DOI 10.1016/S0304-3940(00)01329-X; Kennedy RS, 2010, APPL ERGON, V41, P494, DOI 10.1016/j.apergo.2009.11.006; Kennedy RS., 1993, INT J AVIAT PSYCHOL, V3, P203, DOI [10.1207/s15327108ijap0303_3, DOI 10.1207/S15327108IJAP0303_3]; Kerman IA, 2006, J COMP NEUROL, V499, P882, DOI 10.1002/cne.21129; Kim Y, 2007, J PAIN SYMPTOM MANAG, V34, P265, DOI 10.1016/j.jpainsymman.2006.11.014; Krout KE, 1998, J COMP NEUROL, V401, P437; Kshirsagar AM, 1973, MULTIVARIATE ANAL; Lai CH, 2004, J COMP NEUROL, V470, P282, DOI 10.1002/cne.11048; Lang IM, 1999, AM J PHYSIOL-GASTR L, V277, pG642, DOI 10.1152/ajpgi.1999.277.3.G642; Lawson BD, 1998, ACTA ASTRONAUT, V43, P181, DOI 10.1016/S0094-5765(98)00153-2; Lois JH, 2009, J APPL PHYSIOL, V106, P138, DOI 10.1152/japplphysiol.91125.2008; LUCOT JB, 1992, AM J OTOLARYNG, V13, P176, DOI 10.1016/0196-0709(92)90119-E; LUCOT JB, 1987, AVIAT SPACE ENVIR MD, V58, P989; Lucot JB, 1998, BRAIN RES BULL, V47, P407, DOI 10.1016/S0361-9230(98)00093-8; LUCOT JB, 1989, PHARMACOL BIOCHEM BE, V33, P627, DOI 10.1016/0091-3057(89)90399-7; LUPPI PH, 1995, NEUROSCIENCE, V65, P119, DOI 10.1016/0306-4522(94)00481-J; MANTYH PW, 1983, J NEUROPHYSIOL, V49, P567, DOI 10.1152/jn.1983.49.3.567; Manzoni D, 1989, Acta Otolaryngol Suppl, V468, P129; Mason P, 2007, J NEUROPHYSIOL, V98, P1919, DOI 10.1152/jn.00813.2007; MCLEAN IW, 1974, J HISTOCHEM CYTOCHEM, V22, P1077, DOI 10.1177/22.12.1077; MELZACK R, 1968, P423; MILLER AD, 1994, J NEUROSCI, V14, P871; MILLER AD, 1983, BRAIN BEHAV EVOLUT, V23, P26, DOI 10.1159/000121484; MILLER AD, 1995, J AUTONOM NERV SYST, V54, P253, DOI 10.1016/0165-1838(95)00018-S; MILLER AD, 1994, FRONT NEUROENDOCRIN, V15, P301, DOI 10.1006/frne.1994.1012; MILLER AD, 1990, BRAIN RES, V521, P352, DOI 10.1016/0006-8993(90)91566-Y; MILLER AD, 1987, AVIAT SPACE ENVIR MD, V58, pA126; MILLER AD, 1995, J NEUROPHYSIOL, V73, P1303, DOI 10.1152/jn.1995.73.3.1303; MILLER AD, 1992, BRAIN RES, V578, P168, DOI 10.1016/0006-8993(92)90245-5; MILLER AD, 1990, J NEUROPHYSIOL, V63, P31, DOI 10.1152/jn.1990.63.1.31; Miller AD, 1996, BRAIN RES, V737, P51, DOI 10.1016/0006-8993(96)00663-4; MILLER AD, 1985, J NEUROPHYSIOL, V54, P155, DOI 10.1152/jn.1985.54.1.155; MILLER AD, 1994, NEUROREPORT, V5, P986, DOI 10.1097/00001756-199404000-00033; MILLER AD, 1990, J APPL PHYSIOL, V69, P21, DOI 10.1152/jappl.1990.69.1.21; Miller AD, 1996, VESTIBULAR AUTONOMIC, P85; Moazzami A, 2010, J APPL PHYSIOL, V108, P1336, DOI 10.1152/japplphysiol.00477.2009; Money K. E., 1996, VESTIBULAR AUTONOMIC, P147; MONEY KE, 1970, PHYSIOL REV, V50, P1, DOI 10.1152/physrev.1970.50.1.1; MONEY KE, 1983, AVIAT SPACE ENVIR MD, V54, P208; MORGAN JI, 1991, ANNU REV NEUROSCI, V14, P421, DOI 10.1146/annurev.ne.14.030191.002225; Muth ER, 2006, AUTON NEUROSCI-BASIC, V129, P58, DOI 10.1016/j.autneu.2006.07.020; Nakazawa K, 1999, OTOLARYNG HEAD NECK, V120, P412, DOI 10.1016/S0194-5998(99)70285-8; NONAKA S, 1991, J NEUROPHYSIOL, V65, P1492, DOI 10.1152/jn.1991.65.6.1492; Okada F, 1996, EUR J PHARMACOL, V309, P33, DOI 10.1016/0014-2999(96)00407-4; OKADA F, 1995, BRIT J PHARMACOL, V114, P931, DOI 10.1111/j.1476-5381.1995.tb13293.x; Onishi T, 2007, AUTON NEUROSCI-BASIC, V136, P20, DOI 10.1016/j.autneu.2007.03.002; Pelosi GG, 2009, BEHAV PHARMACOL, V20, P252, DOI 10.1097/FBP.0b013e32832c7098; Peyron C, 1996, J COMP NEUROL, V364, P402; Pobbe RLH, 2011, EUR NEUROPSYCHOPHARM, V21, P306, DOI 10.1016/j.euroneuro.2010.05.004; POLSON JW, 1995, NEUROSCIENCE, V67, P107, DOI 10.1016/0306-4522(95)00034-G; Porter JD, 1997, J VESTIBUL RES-EQUIL, V7, P63; Price DD, 2000, SCIENCE, V288, P1769, DOI 10.1126/science.288.5472.1769; Rice CD, 2009, BRAIN RES, V1279, P71, DOI 10.1016/j.brainres.2009.05.003; Schuerger RJ, 1999, BRAIN RES REV, V30, P189, DOI 10.1016/S0165-0173(99)00015-6; Shiba K, 1996, J NEUROPHYSIOL, V76, P2271, DOI 10.1152/jn.1996.76.4.2271; SIM LJ, 1992, BRAIN RES BULL, V28, P679, DOI 10.1016/0361-9230(92)90246-T; Strigo IA, 2002, PAIN, V97, P235, DOI 10.1016/S0304-3959(02)00023-4; TREISMAN M, 1977, SCIENCE, V197, P493, DOI 10.1126/science.301659; UENO S, 1988, LIFE SCI, V43, P413, DOI 10.1016/0024-3205(88)90520-6; Umezaki T, 1997, BRAIN RES, V769, P347, DOI 10.1016/S0006-8993(97)00756-7; Umezaki T, 1998, AM J PHYSIOL-REG I, V274, pR950, DOI 10.1152/ajpregu.1998.274.4.R950; Umezaki T, 1998, BRAIN RES, V781, P25, DOI 10.1016/S0006-8993(97)01145-1; WATSON JW, 1995, BRIT J PHARMACOL, V115, P84, DOI 10.1111/j.1476-5381.1995.tb16324.x; WATSON RE, 1986, PEPTIDES, V7, P155, DOI 10.1016/0196-9781(86)90076-8; Wei F, 2010, J NEUROSCI, V30, P8624, DOI 10.1523/JNEUROSCI.5389-09.2010; WILPIZESKI CR, 1985, AM J OTOLARYNG, V6, P1, DOI 10.1016/S0196-0709(85)80002-8; WILPIZESKI CR, 1986, LARYNGOSCOPE, V96, P1221; YATES BJ, 1995, BRAIN RES, V689, P197, DOI 10.1016/0006-8993(95)00569-C; Yates BJ, 1998, BRAIN RES BULL, V47, P395, DOI 10.1016/S0361-9230(98)00092-6; YATES BJ, 1994, AM J PHYSIOL-REG I, V267, pR974, DOI 10.1152/ajpregu.1994.267.4.R974; Yu S, 2008, CEREB CORTEX, V18, P2891, DOI 10.1093/cercor/bhn047; Zachariae R, 2007, ANN BEHAV MED, V33, P69, DOI 10.1207/s15324796abm3301_8; Zheng Y, 1997, NEUROSCI LETT, V225, P161, DOI 10.1016/S0304-3940(97)00208-5	151	28	29	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2014	9	1							e86730	10.1371/journal.pone.0086730	http://dx.doi.org/10.1371/journal.pone.0086730			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297XI	24466215	Green Published, gold, Green Accepted, Green Submitted			2022-12-25	WOS:000330288000137
J	Hammer, TJ; McMillan, WO; Fierer, N				Hammer, Tobin J.; McMillan, W. Owen; Fierer, Noah			Metamorphosis of a Butterfly-Associated Bacterial Community	PLOS ONE			English	Article							MANDUCA-SEXTA; GUT BACTERIA; MICROBIAL DIVERSITY; HOST-PLANT; HELICONIUS; MIDGUT; LEPIDOPTERA; SYMBIONTS; EVOLUTIONARY; WOLBACHIA	Butterflies are charismatic insects that have long been a focus of biological research. They are also habitats for microorganisms, yet these microbial symbionts are little-studied, despite their likely importance to butterfly ecology and evolution. In particular, the diversity and composition of the microbial communities inhabiting adult butterflies remain uncharacterized, and it is unknown how the larval (caterpillar) and adult microbiota compare. To address these knowledge gaps, we used Illumina sequencing of 16S rRNA genes from internal bacterial communities associated with multiple life stages of the neotropical butterfly Heliconius erato. We found that the leaf-chewing larvae and nectar-and pollen-feeding adults of H. erato contain markedly distinct bacterial communities, a pattern presumably rooted in their distinct diets. Larvae and adult butterflies host relatively small and similar numbers of bacterial phylotypes, but few are common to both stages. The larval microbiota clearly simplifies and reorganizes during metamorphosis; thus, structural changes in a butterfly's bacterial community parallel those in its own morphology. We furthermore identify specific bacterial taxa that may mediate larval and adult feeding biology in Heliconius and other butterflies. Although male and female Heliconius adults differ in reproductive physiology and degree of pollen feeding, bacterial communities associated with H. erato are not sexually dimorphic. Lastly, we show that captive and wild individuals host different microbiota, a finding that may have important implications for the relevance of experimental studies using captive butterflies.	[Hammer, Tobin J.; Fierer, Noah] Univ Colorado, Dept Ecol & Evolutionary Biol, Boulder, CO 80309 USA; [Hammer, Tobin J.; Fierer, Noah] Univ Colorado, Cooperat Inst Res Environm Sci, Boulder, CO 80309 USA; [Hammer, Tobin J.; McMillan, W. Owen] Smithsonian Trop Res Inst, Panama City, Panama	University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder; Smithsonian Institution; Smithsonian Tropical Research Institute	Hammer, TJ (corresponding author), Univ Colorado, Dept Ecol & Evolutionary Biol, Boulder, CO 80309 USA.	tobin.hammer@colorado.edu		FIERER, NOAH/0000-0002-6432-4261; McMillan, W. Owen/0000-0003-2805-2745	Chancellor's Fellowship from the University of Colorado; National Science Foundation [DEB-640279, IOS-1052541, NSF-CAREER 0953331]; Direct For Biological Sciences [1257689] Funding Source: National Science Foundation	Chancellor's Fellowship from the University of Colorado; National Science Foundation(National Science Foundation (NSF)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	T.J.H. was supported by a Chancellor's Fellowship from the University of Colorado. The National Science Foundation provided grants to W.O.M. (DEB-640279 and IOS-1052541) and N.F. (NSF-CAREER 0953331). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson MJ, 2003, ECOLOGY, V84, P511, DOI 10.1890/0012-9658(2003)084[0511:CAOPCA]2.0.CO;2; Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; APPEL HM, 1995, J INSECT PHYSIOL, V41, P241, DOI 10.1016/0022-1910(94)00106-Q; Arias-Cordero E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051557; Babendreier D, 2007, FEMS MICROBIOL ECOL, V59, P600, DOI 10.1111/j.1574-6941.2006.00249.x; Belda E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021751; Boggs C.L., 2003, BUTTERFLIES ECOLOGY; Brinkmann N, 2008, APPL ENVIRON MICROB, V74, P7189, DOI 10.1128/AEM.01464-08; Broderick NA, 2004, APPL ENVIRON MICROB, V70, P293, DOI 10.1128/AEM.70.1.293-300.2004; Broderick NA, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-11; BROWN KS, 1981, ANNU REV ENTOMOL, V26, P427, DOI 10.1146/annurev.en.26.010181.002235; Brownlie JC, 2009, TRENDS MICROBIOL, V17, P348, DOI 10.1016/j.tim.2009.05.005; Brucker RM, 2012, EVOLUTION, V66, P349, DOI 10.1111/j.1558-5646.2011.01454.x; BUCHER GE, 1963, J INSECT PATHOL, V5, P336; Caporaso JG, 2012, ISME J, V6, P1621, DOI 10.1038/ismej.2012.8; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Chandler JA, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002272; Clarke KR, 2006, PRIMER V6 PRIMER E; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; Colman DR, 2012, MOL ECOL, V21, P5124, DOI 10.1111/j.1365-294X.2012.05752.x; Costello EK, 2009, SCIENCE, V326, P1694, DOI 10.1126/science.1177486; Crotti E, 2010, APPL ENVIRON MICROB, V76, P6963, DOI 10.1128/AEM.01336-10; Crotti E, 2009, ENVIRON MICROBIOL, V11, P3252, DOI 10.1111/j.1462-2920.2009.02048.x; Dasmahapatra KK, 2012, NATURE, V487, P94, DOI 10.1038/nature11041; Douglas AE, 2009, FUNCT ECOL, V23, P38, DOI 10.1111/j.1365-2435.2008.01442.x; Eberhard SH, 2009, ANN ENTOMOL SOC AM, V102, P1105, DOI 10.1603/008.102.0619; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Engel P, 2013, INT J SYST EVOL MICR, DOI [10.1099/ijs.0.049569-0, DOI 10.1099/IJS.0.049569-0)]; Engel P, 2013, FEMS MICROBIOL REV, V37, P699, DOI 10.1111/1574-6976.12025; Engel P, 2012, P NATL ACAD SCI USA, V109, P11002, DOI 10.1073/pnas.1202970109; Engler-Chaouat HS, 2007, J CHEM ECOL, V33, P25, DOI 10.1007/s10886-006-9207-8; Feldhaar H, 2011, ECOL ENTOMOL, V36, P533, DOI 10.1111/j.1365-2311.2011.01318.x; Fierer N, 2008, P NATL ACAD SCI USA, V105, P17994, DOI 10.1073/pnas.0807920105; Fisher K, 2009, MICROBIOL-SGM, V155, P1749, DOI 10.1099/mic.0.026385-0; GILBERT LE, 1972, P NATL ACAD SCI USA, V69, P1403, DOI 10.1073/pnas.69.6.1403; Grimaldi David, 2005, pi; Hakim RS, 2010, ANNU REV ENTOMOL, V55, P593, DOI 10.1146/annurev-ento-112408-085450; Hennig W., 1981, INSECT PHYLOGENY; Hui XA, 2006, CAN J MICROBIOL, V52, P1085, DOI 10.1139/W06-064; Jones RT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061218; JUDY KJ, 1969, ANN ENTOMOL SOC AM, V62, P1438, DOI 10.1093/aesa/62.6.1438; Kim JY, 2013, INT J SYST EVOL MICR, V63, P1766, DOI 10.1099/ijs.0.041871-0; KINGSLEY VV, 1972, J INVERTEBR PATHOL, V20, P51, DOI 10.1016/0022-2011(72)90081-X; Kristensen NP, 1999, EUR J ENTOMOL, V96, P237; Kuczynski J, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-5-210; Kwong WK, 2013, INT J SYST EVOL MICR, V63, P2008, DOI 10.1099/ijs.0.044875-0; Lauzon CR, 2009, ANN ENTOMOL SOC AM, V102, P85, DOI 10.1603/008.102.0109; Lehman R, 2009, MICROB ECOL, V57, P349, DOI 10.1007/s00248-008-9415-6; Lowe T, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2013.0304; MARTIN JD, 1972, APPL MICROBIOL, V24, P575, DOI 10.1128/AEM.24.4.575-580.1972; Martinson VG, 2012, APPL ENVIRON MICROB, V78, P2830, DOI 10.1128/AEM.07810-11; McDonald D, 2012, ISME J, V6, P610, DOI 10.1038/ismej.2011.139; Muegge BD, 2011, SCIENCE, V332, P970, DOI 10.1126/science.1198719; Munoz Astrid G, 2011, BMC Evol Biol, V11, P358, DOI 10.1186/1471-2148-11-358; Narita S, 2006, MOL ECOL, V15, P1095, DOI 10.1111/j.1365-294X.2006.02857.x; NIJHOUT HF, 1974, J EXP BIOL, V61, P481; Oksanen J., 2013, VEGAN COMMUNITY ECOL; Pace NR, 1997, SCIENCE, V276, P734, DOI 10.1126/science.276.5313.734; Pinto-Tomas AA, 2011, ENVIRON ENTOMOL, V40, P1111, DOI 10.1603/EN11083; R Core Team, 2021, R LANG ENV STAT COMP; Ridley EV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036765; Robinson CJ, 2010, MICROB ECOL, V59, P199, DOI 10.1007/s00248-009-9595-8; Russell JA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051027; Russell JA, 2009, P NATL ACAD SCI USA, V106, P21236, DOI 10.1073/pnas.0907926106; Russell V, 1996, J INSECT PHYSIOL, V42, P65, DOI 10.1016/0022-1910(95)00083-6; Ryu JH, 2008, SCIENCE, V319, P777, DOI 10.1126/science.1149357; Sabree ZL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041250; SCHULTZ JC, 1986, OECOLOGIA, V71, P133, DOI 10.1007/BF00377332; Shin SC, 2011, SCIENCE, V334, P670, DOI 10.1126/science.1212782; SMILEY J, 1978, SCIENCE, V201, P745, DOI 10.1126/science.201.4357.745; Steinhaus EA, 1941, J BACTERIOL, V42, P757, DOI 10.1128/JB.42.6.757-790.1941; Sudakaran S, 2012, MOL ECOL, V21, P6134, DOI 10.1111/mec.12027; Tagami Y, 2004, INSECT MOL BIOL, V13, P359, DOI 10.1111/j.0962-1075.2004.00492.x; Vasanthakumar A, 2008, ENVIRON ENTOMOL, V37, P1344, DOI 10.1603/0046-225X(2008)37[1344:GMOAIS]2.0.CO;2; Walters JR, 2012, ECOL ENTOMOL, V37, P257, DOI 10.1111/j.1365-2311.2012.01360.x; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; WERREN JH, 1995, P ROY SOC B-BIOL SCI, V262, P197, DOI 10.1098/rspb.1995.0196; Whiting MF, 2004, ASSEMBLING THE TREE OF LIFE, P345; Wong CNA, 2011, ENVIRON MICROBIOL, V13, P1889, DOI 10.1111/j.1462-2920.2011.02511.x; Zaspel JM, 2008, ANN ENTOMOL SOC AM, V101, P1050, DOI 10.1603/0013-8746-101.6.1050	80	103	106	3	138	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2014	9	1							e86995	10.1371/journal.pone.0086995	http://dx.doi.org/10.1371/journal.pone.0086995			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297XI	24466308	gold, Green Published, Green Submitted			2022-12-25	WOS:000330288000181
J	Zhang, YT; Jiang, F; Tian, ZX; Huo, YX; Sun, YC; Wang, YP				Zhang, Yuan-Tao; Jiang, Feng; Tian, Zhe-Xian; Huo, Yi-Xin; Sun, Yi-Cheng; Wang, Yi-Ping			CRP-Cyclic AMP Dependent Inhibition of the Xylene-Responsive sigma(54)-Promoter Pu in Escherichia coli	PLOS ONE			English	Article							SIGMA(54)-DEPENDENT TRANSCRIPTIONAL ACTIVATOR; REGULATORY GENE XYLR; UPPER-PATHWAY OPERON; RNA-POLYMERASE-II; TOL PLASMID; PSEUDOMONAS-PUTIDA; RECEPTOR PROTEIN; BINDING-SITES; NITROGEN ASSIMILATION; CARBON METABOLISM	The expression of sigma(54)-dependent Pseudomonas putida Pu promoter is activated by XylR activator when cells are exposed to a variety of aromatic inducers. In this study, the transcriptional activation of the P. putida Pu promoter was recreated in the heterologous host Escherichia coli. Here we show that the cAMP receptor protein (CRP), a well-known carbon utilization regulator, had an inhibitory effect on the expression of Pu promoter in a cAMP-dependent manner. The inhibitory effect was not activator specific. In vivo KMnO4 and DMS footprinting analysis indicated that CRP-cAMP poised the RNA polymerase at Pu promoter, inhibiting the isomerization step of the transcription initiation even in the presence of an activator. Therefore, the presence of PTS-sugar, which eliminates cAMP, could activate the poised RNA polymerase at Pu promoter to transcribe. Moreover, the activation region 1 (AR1) of CRP, which interacts directly with the alpha CTD (C-terminal domain of alpha-subunit) of RNA polymerase, was found essential for the CRP-mediated inhibition at Pu promoter. A model for the above observations is discussed.	[Zhang, Yuan-Tao; Jiang, Feng; Tian, Zhe-Xian; Huo, Yi-Xin; Sun, Yi-Cheng; Wang, Yi-Ping] Peking Univ, Coll Life Sci, State Key Lab Prot & Plant Gene Res, Beijing 100871, Peoples R China; [Jiang, Feng; Sun, Yi-Cheng] Chinese Acad Med Sci, Inst Pathogen Biol, Beijing 100730, Peoples R China; [Jiang, Feng; Sun, Yi-Cheng] Peking Union Med Coll, Beijing 100021, Peoples R China	Peking University; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Pathogen Biology - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Wang, YP (corresponding author), Peking Univ, Coll Life Sci, State Key Lab Prot & Plant Gene Res, Beijing 100871, Peoples R China.	wangyp@pku.edu.cn		Wang, Yiping/0000-0002-1995-8521; huo, yixin/0000-0003-4644-999X	973 National Key Basic Research Program in China [2010CB126503]; National Natural Science Foundation of China [30830005]; State Key Laboratory of Protein and Plant Gene Research [B02]; National Science Fund for Distinguished Young Scholars [NSFC] [39925017]	973 National Key Basic Research Program in China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); State Key Laboratory of Protein and Plant Gene Research; National Science Fund for Distinguished Young Scholars [NSFC](National Natural Science Foundation of China (NSFC)National Science Fund for Distinguished Young Scholars)	This work was supported by 973 National Key Basic Research Program in China [No. 2010CB126503, YPW is the chief scientist of the program]; the National Natural Science Foundation of China [No. 30830005 to YPW]; the State Key Laboratory of Protein and Plant Gene Research [No. B02]; YPW is recipient of the National Science Fund for Distinguished Young Scholars [NSFC, No. 39925017]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRIL MA, 1991, J BIOL CHEM, V266, P15832; ABRIL MA, 1989, J BACTERIOL, V171, P6782, DOI 10.1128/jb.171.12.6782-6790.1989; BELL A, 1990, NUCLEIC ACIDS RES, V18, P7243, DOI 10.1093/nar/18.24.7243; Benoff B, 2002, SCIENCE, V297, P1562, DOI 10.1126/science.1076376; BERG OG, 1988, TRENDS BIOCHEM SCI, V13, P207, DOI 10.1016/0968-0004(88)90085-0; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Bertoni G, 1998, EMBO J, V17, P5120, DOI 10.1093/emboj/17.17.5120; Bingle LEH, 2001, CURR OPIN MICROBIOL, V4, P194, DOI 10.1016/S1369-5274(00)00188-0; Buck M, 2000, J BACTERIOL, V182, P4129, DOI 10.1128/JB.182.15.4129-4136.2000; Busby S, 1999, J MOL BIOL, V293, P199, DOI 10.1006/jmbi.1999.3161; Busby S, 1997, MOL MICROBIOL, V23, P853, DOI 10.1046/j.1365-2958.1997.2771641.x; Herrera MC, 2012, J BACTERIOL, V194, P406, DOI 10.1128/JB.06353-11; Carmona M, 1999, J BIOL CHEM, V274, P33790, DOI 10.1074/jbc.274.47.33790; Cases I, 2003, ENVIRON MICROBIOL, V5, P1281, DOI 10.1111/j.1462-2920.2003.00528.x; Chaney M, 2001, GENE DEV, V15, P2282, DOI 10.1101/gad.205501; DELORENZO V, 1991, EMBO J, V10, P1159, DOI 10.1002/j.1460-2075.1991.tb08056.x; DITTA G, 1985, PLASMID, V13, P149, DOI 10.1016/0147-619X(85)90068-X; Dyckman D, 2002, J BIOL CHEM, V277, P19064, DOI 10.1074/jbc.M110554200; Guenther MG, 2007, CELL, V130, P77, DOI 10.1016/j.cell.2007.05.042; HARAYAMA S, 1989, J BACTERIOL, V171, P5048, DOI 10.1128/jb.171.9.5048-5055.1989; Huo YX, 2009, NUCLEIC ACIDS RES, V37, P3878, DOI 10.1093/nar/gkp258; Huo YX, 2006, MOL MICROBIOL, V59, P168, DOI 10.1111/j.1365-2958.2005.04943.x; INOUYE S, 1990, J MOL BIOL, V216, P251, DOI 10.1016/S0022-2836(05)80317-1; INOUYE S, 1983, J BACTERIOL, V155, P1192, DOI 10.1128/JB.155.3.1192-1199.1983; INOUYE S, 1988, GENE, V66, P301; Jiang F, 2012, CHINESE SCI BULL, V57, P3878, DOI 10.1007/s11434-012-5360-3; Kelly MT, 2000, J BACTERIOL, V182, P513, DOI 10.1128/JB.182.2.513-517.2000; Kiupakis AK, 2002, J BACTERIOL, V184, P2940, DOI 10.1128/JB.184.11.2940-2950.2002; KOLB A, 1993, ANNU REV BIOCHEM, V62, P749, DOI 10.1146/annurev.bi.62.070193.003533; KUO MS, 1986, CARBOHYD RES, V156, P173, DOI 10.1016/S0008-6215(00)90109-5; LEE JH, 1995, P NATL ACAD SCI USA, V92, P9702, DOI 10.1073/pnas.92.21.9702; Lee SJ, 2004, MOL CELL, V14, P153, DOI 10.1016/S1097-2765(04)00202-3; Li Y, 2011, CHINESE SCI BULL, V56, P514, DOI 10.1007/s11434-010-4323-9; Li ZT, 2002, CHINESE SCI BULL, V47, P1622, DOI 10.1360/02tb9357; Macchi R, 2003, J BIOL CHEM, V278, P27695, DOI 10.1074/jbc.M303031200; Mao XJ, 2007, NUCLEIC ACIDS RES, V35, P1432, DOI 10.1093/nar/gkl1142; Margaritis T, 2008, CELL, V133, P581, DOI 10.1016/j.cell.2008.04.027; MARQUES S, 1993, MOL MICROBIOL, V9, P923, DOI 10.1111/j.1365-2958.1993.tb01222.x; Milanesio P, 2011, ENVIRON MICROBIOL, V13, P324, DOI 10.1111/j.1462-2920.2010.02331.x; Muse GW, 2007, NAT GENET, V39, P1507, DOI 10.1038/ng.2007.21; Nelson KE, 2002, ENVIRON MICROBIOL, V4, P799, DOI 10.1046/j.1462-2920.2002.00366.x; PerezMartin J, 1996, GENE, V172, P81, DOI 10.1016/0378-1119(96)00193-X; PerezMartin J, 1996, J MOL BIOL, V258, P575, DOI 10.1006/jmbi.1996.0270; PORTER SC, 1993, GENE DEV, V7, P2258, DOI 10.1101/gad.7.11.2258; Radonjic M, 2005, MOL CELL, V18, P171, DOI 10.1016/j.molcel.2005.03.010; Ramos JL, 1997, ANNU REV MICROBIOL, V51, P341, DOI 10.1146/annurev.micro.51.1.341; Rhodius VA, 2000, J MOL BIOL, V299, P295, DOI 10.1006/jmbi.2000.3736; ROY A, 1988, J GEN MICROBIOL, V134, P359; Sambrook J, 2001, MOL CLONING LAB MANU; SASSEDWIGHT S, 1991, METHOD ENZYMOL, V208, P146; SASSEDWIGHT S, 1988, P NATL ACAD SCI USA, V85, P8934, DOI 10.1073/pnas.85.23.8934; Tian ZX, 2001, MOL MICROBIOL, V41, P911, DOI 10.1046/j.1365-2958.2001.02561.x; Valls M, 2002, J BIOL CHEM, V277, P2169, DOI 10.1074/jbc.M108162200; Wang YK, 1997, MOL MICROBIOL, V26, P373, DOI 10.1046/j.1365-2958.1997.5851955.x; Wang YP, 1998, EMBO J, V17, P786, DOI 10.1093/emboj/17.3.786; WANG YP, 1993, MOL MICROBIOL, V8, P253, DOI 10.1111/j.1365-2958.1993.tb01569.x; Zhang X, 2002, MOL MICROBIOL, V45, P895, DOI 10.1046/j.1365-2958.2002.03065.x	57	2	2	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2014	9	1							e86727	10.1371/journal.pone.0086727	http://dx.doi.org/10.1371/journal.pone.0086727			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297XI	24466213	gold, Green Published, Green Submitted			2022-12-25	WOS:000330288000136
J	Suzuki, D; Miyamoto, T; Kikawada, T; Watanabe, M; Suzuki, T				Suzuki, Dai; Miyamoto, Tomoko; Kikawada, Takahiro; Watanabe, Manabu; Suzuki, Toru			A Leech Capable of Surviving Exposure to Extremely Low Temperatures	PLOS ONE			English	Article							COLD-TOLERANCE; ANTARCTIC NEMATODE; FREEZE TOLERANCE; LIQUID-NITROGEN; VITRIFICATION; CRYOPRESERVATION; ANHYDROBIOSIS; ANIMALS; LIFE	It is widely considered that most organisms cannot survive prolonged exposure to temperatures below 0 degrees C, primarily because of the damage caused by the water in cells as it freezes. However, some organisms are capable of surviving extreme variations in environmental conditions. In the case of temperature, the ability to survive subzero temperatures is referred to as cryobiosis. We show that the ozobranchid leech, Ozobranchus jantseanus, a parasite of freshwater turtles, has a surprisingly high tolerance to freezing and thawing. This finding is particularly interesting because the leach can survive these temperatures without any acclimation period or pretreatment. Specifically, the leech survived exposure to super-low temperatures by storage in liquid nitrogen (-196 degrees C) for 24 hours, as well as long-term storage at temperatures as low as -90 degrees C for up to 32 months. The leech was also capable of enduring repeated freeze-thaw cycles in the temperature range 20 degrees C to -100 degrees C and then back to 20 degrees C. The results demonstrated that the novel cryotolerance mechanisms employed by O. jantseanus enable the leech to withstand a wider range of temperatures than those reported previously for cryobiotic organisms. We anticipate that the mechanism for the observed tolerance to freezing and thawing in O. jantseanus will prove useful for future studies of cryopreservation.	[Suzuki, Dai; Miyamoto, Tomoko; Watanabe, Manabu; Suzuki, Toru] Tokyo Univ Marine Sci & Technol, Dept Food Sci & Technol, Tokyo, Japan; [Suzuki, Dai] Kyoto Univ, Fac Sci, Dept Zool, Grad Sch Sci, Kyoto 606, Japan; [Kikawada, Takahiro] Natl Inst Agrobiol Sci, Anhydrobiosis Res Grp, Insect Mimet Res Unit, Tsukuba, Ibaraki, Japan	Tokyo University of Marine Science & Technology; Kyoto University; National Institute of Agrobiological Sciences - Japan	Suzuki, T (corresponding author), Kyushu Univ, Grad Sch Social & Cultural Studies, Fukuoka 812, Japan.	toru@kaiyodai.ac.jp	SUZUKI, Toru/O-1972-2014; Kikawada, Takahiro/A-1289-2010; WATANABE, Manabu/O-1981-2014	Kikawada, Takahiro/0000-0002-2329-9282; 	Global COE program for Biodiversity and Evolutionary Research [A06]; Ministry of Education, Culture, Sports, Science and Technology, Japan	Global COE program for Biodiversity and Evolutionary Research; Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This study was partially supported by the Global COE program for Biodiversity and Evolutionary Research (A06) from the Ministry of Education, Culture, Sports, Science and Technology, Japan. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Agustini TW, 2001, FISHERIES SCI, V67, P306, DOI 10.1046/j.1444-2906.2001.00226.x; Crowe JH, 1998, ANNU REV PHYSIOL, V60, P73, DOI 10.1146/annurev.physiol.60.1.73; DIAMOND JM, 1989, NATURE, V339, P509, DOI 10.1038/339509a0; Horikawa DD, 2008, ASTROBIOLOGY, V8, P549, DOI 10.1089/ast.2007.0139; KEILIN D, 1959, PROC R SOC SER B-BIO, V150, P149, DOI 10.1098/rspb.1959.0013; KOHSHIMA S, 1984, NATURE, V310, P225, DOI 10.1038/310225a0; Kostal V, 2011, P NATL ACAD SCI USA, V108, P13041, DOI 10.1073/pnas.1107060108; Lovich JE, 2011, CHELONIAN RES MONOGR, V5; RALL WF, 1985, NATURE, V313, P573, DOI 10.1038/313573a0; Rothschild LJ, 2001, NATURE, V409, P1092, DOI 10.1038/35059215; ROWE AW, 1968, CRYOBIOLOGY, V5, P119, DOI 10.1016/S0011-2240(68)80154-3; Sakurai M, 2008, P NATL ACAD SCI USA, V105, P5093, DOI 10.1073/pnas.0706197105; SAWYER R.T., 1986, LEECH BIOL BEHAV, VII; Smith T, 2008, J COMP PHYSIOL B, V178, P93, DOI 10.1007/s00360-007-0202-3; SOMME L, 1995, POLAR BIOL, V15, P221; STOREY KB, 1992, ANNU REV PHYSIOL, V54, P619, DOI 10.1146/annurev.physiol.54.1.619; Storey KB, 2006, CRYOBIOLOGY, V52, P1, DOI 10.1016/j.cryobiol.2005.09.005; Storey KB, 1996, ANNU REV ECOL SYST, V27, P365, DOI 10.1146/annurev.ecolsys.27.1.365; WHARTON DA, 1991, J EXP BIOL, V155, P629; Wright JC, 2001, ZOOL ANZ, V240, P563, DOI 10.1078/0044-5231-00068; Yamauchi Takeo, 2008, Medical Entomology and Zoology, V59, P345; Yasukawa Y, 2008, CHELONIAN RES MONOGR, V5	22	9	10	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2014	9	1							e86807	10.1371/journal.pone.0086807	http://dx.doi.org/10.1371/journal.pone.0086807			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297VL	24466250	Green Submitted, Green Published, gold			2022-12-25	WOS:000330283100219
J	Tsai, JP; Hsiao, PC; Yang, SF; Hsieh, SC; Bau, DT; Ling, CL; Pai, CL; Hsieh, YH				Tsai, Jen-Pi; Hsiao, Pei-Ching; Yang, Shun-Fa; Hsieh, Shu-Ching; Bau, Da-Tian; Ling, Chu-Liang; Pai, Chun-Li; Hsieh, Yi-Hsien			Licochalcone A Suppresses Migration and Invasion of Human Hepatocellular Carcinoma Cells through Downregulation of MKK4/JNK via NF-kappa B Mediated Urokinase Plasminogen Activator Expression	PLOS ONE			English	Article							PROSTATE-CANCER CELLS; BREAST-CANCER; SIGNALING PATHWAYS; GROWTH; METASTASIS; INHIBITION; KINASE; SYSTEM; MICE; JNK	Hepatocellular cell carcinoma (HCC) is one of the most commonly diagnosed cancers worldwide and in Taiwan. Chemoprevention of cancer with dietary bioactive compounds could potentially reverse, suppress, or prevent cancer progression. Licochalcone A (LicA) is a characteristic chalcone of licorice, which is the root of Glycyrrhiza inflate. It had been reported that LicA has anti-inflammatory, anti-microbial, and anti-tumor properties. However, the effects of LicA on the migration and invasion of human HCC cells have not yet been reported. In the present study, it was found that LicA inhibits the migratory and invasion ability of SK-Hep-1 and HA22T/VGH cells in a dose-dependent manner, as assessed by the cell migration and Matrigel cell invasion assay. Using casein zymography, Western blotting, reverse transcriptase polymerase chain reaction, and an immunofluorescence assay, it was found that LicA induces a dose-dependent inhibition of uPA activity and expression, as well as reduces mRNA levels in SK-Hep-1 and HA22T/VGH cells. LicA was also found to inhibit the expression of phosphor-JNK and phosphor-MKK4 in SK-Hep-1 cells. Furthermore, LicA significantly decreased uPA levels in SP600125-treated or si-MKK4-transfected cells alongside a marked reduction in cell migration and invasion, which supports the notion that an inhibition of MKK4/JNK results in anti-metastatic effects. Moreover, LicA inhibited the expression of nuclear NF-kappa B, as well as the binding ability of NF-kB to the uPA promoter. These findings further our understanding of the role of LicA in suppressing tumor metastasis and its underlying molecular mechanisms, as well as suggest that LicA may be a promising anti-metastatic agent.	[Tsai, Jen-Pi] Buddhist Dalin Tzu Chi Gen Hosp, Dept Nephrol, Chiayi, Taiwan; [Tsai, Jen-Pi; Yang, Shun-Fa; Hsieh, Shu-Ching] Chung Shan Med Univ, Inst Med, Taichung, Taiwan; [Hsiao, Pei-Ching] Chung Shan Med Univ, Sch Med, Taichung, Taiwan; [Hsiao, Pei-Ching] Chung Shan Med Univ Hosp, Dept Internal Med, Taichung, Taiwan; [Bau, Da-Tian] China Med Univ, Grad Inst Clin Med Sci, Taichung, Taiwan; [Bau, Da-Tian] Asia Univ, Dept Biotechnol, Taichung, Taiwan; [Ling, Chu-Liang; Pai, Chun-Li; Hsieh, Yi-Hsien] Chung Shan Med Univ, Coll Med, Inst Biochem & Biotechnol, Taichung, Taiwan; [Hsieh, Yi-Hsien] Chung Shan Med Univ, Dept Biochem, Sch Med, Taichung, Taiwan; [Hsieh, Yi-Hsien] Chung Shan Med Univ Hosp, Dept Clin Lab, Taichung, Taiwan	Buddhist Tzu Chi General Hospital; Dalin Tzu Chi Hospital; Chung Shan Medical University; Chung Shan Medical University; Chung Shan Medical University; Chung Shan Medical University Hospital; China Medical University Taiwan; Asia University Taiwan; Chung Shan Medical University; Chung Shan Medical University; Chung Shan Medical University; Chung Shan Medical University Hospital	Hsieh, YH (corresponding author), Chung Shan Med Univ, Coll Med, Inst Biochem & Biotechnol, Taichung, Taiwan.	hyhsien@csmu.edu.tw	Yang, Shun-Fa/AAN-1519-2020	Yang, Shun-Fa/0000-0002-0365-7927	National Science Council, Taiwan [NSC 100-2313-B-040-001, NSC 101-2313-B-040-001]	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan)	This work was supported by grants from National Science Council, Taiwan (NSC 100-2313-B-040-001 and NSC 101-2313-B-040-001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bian DF, 2004, CANCER RES, V64, P4209, DOI 10.1158/0008-5472.CAN-04-0060; Chambers AF, 2002, NAT REV CANCER, V2, P563, DOI 10.1038/nrc865; Chapman HA, 1997, CURR OPIN CELL BIOL, V9, P714, DOI 10.1016/S0955-0674(97)80126-3; Chien ST, 2011, MOL CELL BIOCHEM, V350, P135, DOI 10.1007/s11010-010-0692-2; Chou RH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071983; El-Serag HB, 2007, GASTROENTEROLOGY, V132, P2557, DOI 10.1053/j.gastro.2007.04.061; Fu Y, 2004, BIOCHEM BIOPH RES CO, V322, P263, DOI 10.1016/j.bbrc.2004.07.094; Funakoshi-Tago M, 2009, MOL PHARMACOL, V76, P745, DOI 10.1124/mol.109.057448; Gao Xueyan, 2009, Zhongguo Zhong Yao Za Zhi, V34, P2695; Haeusgen W, 2011, EUR J CELL BIOL, V90, P536, DOI 10.1016/j.ejcb.2010.11.008; Ho YC, 2007, J ORAL PATHOL MED, V36, P588, DOI 10.1111/j.1600-0714.2007.00588.x; Hsieh CY, 2013, CHEM-BIOL INTERACT, V204, P105, DOI 10.1016/j.cbi.2013.05.005; Hsu HH, 2011, J BIOMED SCI, V18, DOI 10.1186/1423-0127-18-61; Joyce JA, 2009, NAT REV CANCER, V9, P239, DOI 10.1038/nrc2618; Karin M, 2000, ANNU REV IMMUNOL, V18, P621, DOI 10.1146/annurev.immunol.18.1.621; Kennedy NJ, 2003, CELL CYCLE, V2, P199, DOI 10.4161/cc.2.3.388; Kim HL, 2001, CANCER RES, V61, P2833; Kim JK, 2010, J MOL MED, V88, P829, DOI 10.1007/s00109-010-0625-2; Kim MH, 2004, EUR J PHARMACOL, V487, P1, DOI 10.1016/j.ejphar.2003.12.031; Kim YH, 2010, BIOCHEM PHARMACOL, V80, P1152, DOI 10.1016/j.bcp.2010.07.006; Kurbitz C, 2011, CANCER SCI, V102, P728, DOI 10.1111/j.1349-7006.2011.01870.x; Kuttan G, 2007, ADV EXP MED BIOL, V595, P173; Kwaan Hau C., 2009, V148, P43, DOI 10.1007/978-0-387-79962-9_4; Kwon GT, 2009, J NUTR BIOCHEM, V20, P663, DOI 10.1016/j.jnutbio.2008.06.005; Kwon HS, 2008, J MOL MED, V86, P1287, DOI 10.1007/s00109-008-0395-2; Lamy S, 2007, J CELL BIOCHEM, V100, P100, DOI 10.1002/jcb.21023; Lee CK, 2008, BASIC CLIN PHARMACOL, V103, P48, DOI 10.1111/j.1742-7843.2008.00238.x; Li FN, 2012, INT J CLIN PHARM TH, V50, P712, DOI 10.5414/CP201663; Li J, 2012, INT J WEB SERV RES, V9, P23, DOI 10.4018/jwsr.2012070102; Li XY, 2012, CARCINOGENESIS, V33, P2593, DOI 10.1093/carcin/bgs298; Little JW, 2004, ORAL SURG ORAL MED O, V98, P137, DOI 10.1016/j.tripleo.2004.05.011; Ma CY, 2011, J AGR FOOD CHEM, V59, P9032, DOI 10.1021/jf202027n; Meiyanto E, 2012, ASIAN PAC J CANCER P, V13, P427, DOI 10.7314/APJCP.2012.13.2.427; Morgan TR, 2004, GASTROENTEROLOGY, V127, pS87, DOI 10.1053/j.gastro.2004.09.020; Nakagawa H, 2012, WORLD J GASTROENTERO, V18, P4071, DOI 10.3748/wjg.v18.i31.4071; Okita K, 2006, INTERNAL MED, V45, P229, DOI 10.2169/internalmedicine.45.1531; Overall CM, 2002, NAT REV CANCER, V2, P657, DOI 10.1038/nrc884; Park JH, 2008, BIOL PHARM BULL, V31, P1996, DOI 10.1248/bpb.31.1996; Rafi MM, 2000, ANTICANCER RES, V20, P2653; Rao JS, 2003, NAT REV CANCER, V3, P489, DOI 10.1038/nrc1121; Sliva D, 2004, CURR CANCER DRUG TAR, V4, P327, DOI 10.2174/1568009043332961; Son JE, 2013, PLANTA MED, V79, P1009, DOI 10.1055/s-0033-1350621; Song NR, 2013, CANCER PREV RES, V6, P1293, DOI 10.1158/1940-6207.CAPR-13-0134; Tang LL, 2013, BIOMED PHARMACOTHER, V67, P179, DOI 10.1016/j.biopha.2012.10.003; Trusolino L, 2002, NAT REV CANCER, V2, P289, DOI 10.1038/nrc779; Tsai SJ, 2012, BIOCHEM BIOPH RES CO, V425, P462, DOI 10.1016/j.bbrc.2012.07.125; Tung MC, 2013, PROSTATE, V73, P1281, DOI 10.1002/pros.22670; Webb CP, 2000, J NEURO-ONCOL, V50, P71, DOI 10.1023/A:1006466605356; Wei CW, 2009, ACTA PHARMACOL SIN, V30, P1297, DOI 10.1038/aps.2009.124; Weng CJ, 2012, MOL NUTR FOOD RES, V56, P1304, DOI 10.1002/mnfr.201200173; Werb Z, 1997, CELL, V91, P439, DOI 10.1016/S0092-8674(00)80429-8; Westermarck J, 1999, FASEB J, V13, P781, DOI 10.1096/fasebj.13.8.781; Wu CW, 2000, AM J PATHOL, V156, P2007, DOI 10.1016/S0002-9440(10)65073-0; Xia DR, 2007, J BIOL CHEM, V282, P3507, DOI 10.1074/jbc.M610141200; Xiao XY, 2011, CANCER LETT, V302, P69, DOI 10.1016/j.canlet.2010.12.016; Yamada SD, 2002, CANCER RES, V62, P6717; Yang AK, 2010, CURR MED CHEM, V17, P1635, DOI 10.2174/092986710791111279; Yiang GT, 2009, J BIOMED SCI, V16, DOI 10.1186/1423-0127-16-47; Yo YT, 2009, J AGR FOOD CHEM, V57, P8266, DOI 10.1021/jf901054c; Yu YL, 2012, J BIOL CHEM, V287, P31015, DOI 10.1074/jbc.M112.358077; Yu YL, 2012, J CELL PHYSIOL, V227, P213, DOI 10.1002/jcp.22719; Yu YL, 2010, J AGR FOOD CHEM, V58, P1630, DOI 10.1021/jf903043r; Yuan X, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/474272; Zhang K, 2011, NEUROPHARMACOLOGY, V61, P329, DOI 10.1016/j.neuropharm.2011.04.021; Zong H, 2012, MOL BIOL REP, V39, P4803, DOI 10.1007/s11033-011-1273-5	65	68	70	3	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2014	9	1							e86537	10.1371/journal.pone.0086537	http://dx.doi.org/10.1371/journal.pone.0086537			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297VL	24466137	Green Published, gold, Green Submitted			2022-12-25	WOS:000330283100180
J	Wittmann, J; Dreiseikelmann, B; Rohde, C; Rohde, M; Sikorski, J				Wittmann, Johannes; Dreiseikelmann, Brigitte; Rohde, Christine; Rohde, Manfred; Sikorski, Johannes			Isolation and Characterization of Numerous Novel Phages Targeting Diverse Strains of the Ubiquitous and Opportunistic Pathogen Achromobacter xylosoxidans	PLOS ONE			English	Article							SUBSP XYLOSOXIDANS; CYSTIC-FIBROSIS; STAPHYLOCOCCUS-AUREUS; EMERGING PATHOGEN; BACTERIOPHAGES; OUTBREAK; INFECTIONS; BACTEREMIA; ENDOCARDITIS; SEQUENCE	The clinical relevance of nosocomially acquired infections caused by multi-resistant Achromobacter strains is rapidly increasing. Here, a diverse set of 61 Achromobacter xylosoxidans strains was characterized by MultiLocus Sequence Typing and Phenotype MicroArray technology. The strains were further analyzed in regard to their susceptibility to 35 antibiotics and to 34 different and newly isolated bacteriophages from the environment. A large proportion of strains were resistant against numerous antibiotics such as cephalosporines, aminoglycosides and quinolones, whereas piperacillin-tazobactam, ticarcillin, mezlocillin and imipenem were still inhibitory. We also present the first expanded study on bacteriophages of the genus Achromobacter that has been so far a blank slate with respect to phage research. The phages were isolated mainly from several waste water treatment plants in Germany. Morphological analysis of all of these phages by electron microscopy revealed a broad diversity with different members of the order Caudovirales, including the families Siphoviridae, Myoviridae, and Podoviridae. A broad spectrum of different host ranges could be determined for several phages that lysed up to 24 different and in part highly antibiotic resistant strains. Molecular characterisation by DNA restriction analysis revealed that all phages contain linear double-stranded DNA. Their restriction patterns display distinct differences underlining their broad diversity.	[Wittmann, Johannes; Rohde, Christine] Leibniz Inst DSMZ German Collect Microorganisms &, Dept Microorganisms, Braunschweig, Germany; [Dreiseikelmann, Brigitte] Univ Bielefeld, Fac Biol, Dept Microbiol Genetechnol, D-33615 Bielefeld, Germany; [Rohde, Manfred] Helmholtz Ctr Infect Res, Dept Med Microbiol, Cent Facil Microscopy, Braunschweig, Germany; [Sikorski, Johannes] Leibniz Inst DSMZ German Collect Microorganisms &, Dept Microbial Ecol & Divers Res, Braunschweig, Germany	Leibniz Institut fur Deutsche Sammlung von Mikroorganismen und Zellkulturen (DSMZ); University of Bielefeld; Helmholtz Association; Helmholtz-Center for Infection Research; Leibniz Institut fur Deutsche Sammlung von Mikroorganismen und Zellkulturen (DSMZ)	Wittmann, J (corresponding author), Leibniz Inst DSMZ German Collect Microorganisms &, Dept Microorganisms, Braunschweig, Germany.	johannes.wittmann@dsmz.de	Sikorski, Johannes/AAX-1960-2020; Sikorski, Johannes/AAD-9775-2019	Sikorski, Johannes/0000-0002-1890-5540; 	Leibniz Institute DSMZ - German Collection of Microorganisms and Cell Cultures	Leibniz Institute DSMZ - German Collection of Microorganisms and Cell Cultures	This work was supported by Leibniz Institute DSMZ - German Collection of Microorganisms and Cell Cultures funded this research through the employment of Johannes Wittmann, Christine Rohde and Johannes Sikorski, who contributed to all aspects of the study. There are no external funders who could have had a role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackermann HW, 2001, ARCH VIROL, V146, P843, DOI 10.1007/s007050170120; Ackermann HW, 2000, VIRUS TAXONOMY CLASS, P69; Ahmed MS, 2009, CLIN NEPHROL, V71, P350; Aisenberg G, 2004, CANCER-AM CANCER SOC, V101, P2134, DOI 10.1002/cncr.20604; Alemayehu D, 2012, MBIO, V3, DOI 10.1128/mBio.00029-12; Bador J, 2013, ANTIMICROB AGENTS CH, V57, P603, DOI 10.1128/AAC.01243-12; Behrens-Muller B, 2012, INFECT CONT HOSP EP, V33, P180, DOI 10.1086/663710; Beilstein F, 2006, RES MICROBIOL, V157, P213, DOI 10.1016/j.resmic.2005.07.005; Borysowski J, 2011, BIODRUGS, V25, P347, DOI 10.2165/11595610-000000000-00000; Busse HJ, 2005, BERGEYS MANUAL SYSTE, P658, DOI DOI 10.1007/0-387-29298-5_; Capparelli R, 2007, ANTIMICROB AGENTS CH, V51, P2765, DOI 10.1128/AAC.01513-06; Capparelli R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011720; Chan BK, 2013, FUTURE MICROBIOL, V8, P769, DOI [10.2217/fmb.13.47, 10.2217/FMB.13.47]; Chhibber S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056022; Cooper MA, 2011, NATURE, V472, P32, DOI 10.1038/472032a; D'Herelle F, 2007, RES MICROBIOL, V158, P553, DOI 10.1016/j.resmic.2007.07.005; Davies JC, 2007, SEMIN RESP CRIT CARE, V28, P312, DOI 10.1055/s-2007-981652; Duggan JM, 1996, CLIN INFECT DIS, V23, P569, DOI 10.1093/clinids/23.3.569; Fard RMN, 2011, LETT APPL MICROBIOL, V52, P559, DOI 10.1111/j.1472-765X.2011.03043.x; Feil EJ, 2004, J BACTERIOL, V186, P1518, DOI 10.1128/JB.186.5.1518-1530.2004; Festini F, 2007, PEDIATR PULM, V42, P779, DOI 10.1002/ppul.20630; FLEMING A, 1980, REV INFECT DIS, V2, P129; Fouts DE, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-165; Garbe J, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-301; Garcia P, 2007, INT DAIRY J, V17, P1232, DOI 10.1016/j.idairyj.2007.03.014; Guenther S, 2009, APPL ENVIRON MICROB, V75, P93, DOI 10.1128/AEM.01711-08; Hatfull GF, 2008, CURR OPIN MICROBIOL, V11, P447, DOI 10.1016/j.mib.2008.09.004; Haubold B, 2000, BIOINFORMATICS, V16, P847, DOI 10.1093/bioinformatics/16.9.847; Herberich E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009788; Ho YN, 2012, J HAZARD MATER, V219, P43, DOI 10.1016/j.jhazmat.2012.03.035; Hothorn T, 2008, BIOMETRICAL J, V50, P346, DOI 10.1002/bimj.200810425; Jencova V, 2004, INT BIODETER BIODEGR, V54, P175, DOI 10.1016/j.ibiod.2004.03.007; Jencova V, 2008, RES MICROBIOL, V159, P118, DOI 10.1016/j.resmic.2007.11.018; Jha P, 2009, MICROB ECOL, V58, P179, DOI 10.1007/s00248-009-9485-0; JONES PT, 1981, J GEN VIROL, V53, P275, DOI 10.1099/0022-1317-53-2-275; Jukes T. H, 1969, MAMMALIAN PROTEIN ME, P21, DOI DOI 10.1093/BIOINFORMATICS/BTM404; Karumidze N, 2013, CURR MICROBIOL, V66, P251, DOI 10.1007/s00284-012-0264-7; Kindt R, 2005, TREE DIVERSITY ANAL; Lambiase A, 2011, EUR J CLIN MICROBIOL, V30, P973, DOI 10.1007/s10096-011-1182-5; LEVESQUE R, 1983, CAN J MICROBIOL, V29, P819, DOI 10.1139/m83-133; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Ma Y, 2009, J ENVIRON MANAGE, V90, P831, DOI 10.1016/j.jenvman.2008.01.014; Manckoundia P, 2011, MED SCI MONITOR, V17, pCS63, DOI 10.12659/MSM.881796; MARTINO P, 1990, REV INFECT DIS, V12, P250; Traglia GM, 2012, CURR MICROBIOL, V65, P673, DOI 10.1007/s00284-012-0213-5; Merabishvili M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052709; O'Flaherty S, 2009, FEMS MICROBIOL REV, V33, P801, DOI 10.1111/j.1574-6976.2009.00176.x; Oksanen J., 2013, VEGAN COMMUNITY ECOL; Olshtain-Pops K, 2011, J UROLOGY, V185, P144, DOI 10.1016/j.juro.2010.08.093; OLSON DA, 1982, WESTERN J MED, V136, P153; Park Jung Hyun, 2012, Korean J Ophthalmol, V26, P49, DOI 10.3341/kjo.2012.26.1.49; Pirnay JP, 2012, FUTURE VIROL, V7, P379, DOI 10.2217/FVL.12.24; Razvi S, 2009, CHEST, V136, P1554, DOI 10.1378/chest.09-0132; Reddy AK, 2009, CORNEA, V28, P1100, DOI 10.1097/ICO.0b013e3181a1658f; REINA J, 1988, J CLIN PATHOL, V41, P920, DOI 10.1136/jcp.41.8.920-c; REVERDY ME, 1984, J CLIN MICROBIOL, V19, P140, DOI 10.1128/JCM.19.2.140-143.1984; Ridderberg W, 2012, J CLIN MICROBIOL, V50, P2688, DOI 10.1128/JCM.00728-12; Ridderberg W, 2011, J CYST FIBROS, V10, P466, DOI 10.1016/j.jcf.2011.07.004; Rigvava S, 2013, CAN J MICROBIOL, V59, P18, DOI 10.1139/cjm-2012-0385; ROLSTON KVI, 1990, J ANTIMICROB CHEMOTH, V26, P857, DOI 10.1093/jac/26.6.857; Seal BS, 2013, POULTRY SCI, V92, P526, DOI 10.3382/ps.2012-02708; SPEAR JB, 1988, J CLIN MICROBIOL, V26, P598, DOI 10.1128/JCM.26.3.598-599.1988; Strnad H, 2011, J BACTERIOL, V193, P791, DOI 10.1128/JB.01299-10; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tena D, 2005, EUR J CLIN MICROBIOL, V24, P727, DOI 10.1007/s10096-005-0028-4; Tena D, 2008, SCAND J INFECT DIS, V40, P84, DOI 10.1080/00365540701558714; THOMSON JA, 1974, J GEN VIROL, V22, P153, DOI 10.1099/0022-1317-22-1-153; Vaas LAI, 2013, BIOINFORMATICS, V29, P1823, DOI 10.1093/bioinformatics/btt291; Vaas LAI, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034846; VALENTINE RC, 1968, BIOCHEMISTRY-US, V7, P2143, DOI 10.1021/bi00846a017; van Hal S, 2008, J MED MICROBIOL, V57, P525, DOI 10.1099/jmm.0.47496-0; Vu-Thien H, 1998, EUR J CLIN MICROBIOL, V17, P724, DOI 10.1007/s100960050168; Walker RD, 1998, J ANTIMICROB CHEMOTH, V41, P1, DOI 10.1093/jac/41.1.1; WOODS DR, 1975, J GEN MICROBIOL, V88, P86, DOI 10.1099/00221287-88-1-86; YABUUCHI E, 1971, JPN J MICROBIOL, V15, P477, DOI 10.1111/j.1348-0421.1971.tb00607.x; Yamamoto M, 2012, J ANTIMICROB CHEMOTH, V67, P2110, DOI 10.1093/jac/dks179; ZIVIN R, 1981, J MOL BIOL, V152, P335, DOI 10.1016/0022-2836(81)90246-1	77	20	21	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2014	9	1							e86935	10.1371/journal.pone.0086935	http://dx.doi.org/10.1371/journal.pone.0086935			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297VL	24466294	gold, Green Published, Green Submitted			2022-12-25	WOS:000330283100235
J	Bunda, S; Qin, K; Kommaraju, K; Heir, P; Ohh, M				Bunda, S.; Qin, K.; Kommaraju, K.; Heir, P.; Ohh, M.			Juvenile myelomonocytic leukaemia-associated mutation in Cbl promotes resistance to apoptosis via the Lyn-PI3K/AKT pathway	ONCOGENE			English	Article						apoptosis; Cbl; chemoresistance; juvenile myelomonocytic leukaemia; Lyn; PI3K	C-CBL; MYELODYSPLASTIC SYNDROME; IN-VIVO; SRC; ACTIVATION; HYPERSENSITIVITY; CELLS; RAS; UBIQUITINATION; CHEMOTHERAPY	Juvenile myelomonocytic leukaemia (JMML) is an aggressive myeloproliferative neoplasm in children characterized by granulocyte macrophage colony-stimulating factor (GM-CSF) hypersensitivity and resistance to chemotherapy. We recently identified c-Cbl (henceforth referred to as Cbl) as a GM-CSF receptor (GMR) responsive protein that targets Src for ubiquitin-mediated destruction upon GM-CSF stimulation and showed that a loss of negative regulation of Src is pivotal in the hyperactivation of GMR signalling in JMML cells. However, the mechanism regulating the chemoresistant nature of JMML has remained largely unknown. Here, we show that the JMML-associated Cbl mutant in complex with the Src family kinase Lyn promotes Cbl's adapter function, leading to increased association to PI3K regulatory subunit p85 and Lyn-dependent AKT pro-survival signalling. Notably, molecular or pharmacologic inhibition of the Lyn-PI3K/AKT pathway, but not the Ras/mitogen-activated protein kinase signalling axis, markedly increased the sensitivity of the otherwise chemoresistant Cbl mutant-JMML cells to chemotherapeutic agents currently used in the treatment of JMML patients. These results support the potential translational benefit of combining modalities that inhibit Lyn-PI3K/AKT signalling with traditional antileukaemia agents in the management of JMML.	[Bunda, S.; Qin, K.; Kommaraju, K.; Heir, P.; Ohh, M.] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON M5S 1A8, Canada	University of Toronto	Ohh, M (corresponding author), Univ Toronto, Dept Lab Med & Pathobiol, 1 Kings Coll Circle, Toronto, ON M5S 1A8, Canada.	michael.ohh@utoronto.ca			Canadian Institutes of Health Research [MOP119356]; Cancer Research Society; CIHR; Kidney Cancer Foundation fellowship award	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Cancer Research Society; CIHR(Canadian Institutes of Health Research (CIHR)); Kidney Cancer Foundation fellowship award	We thank Dr Tim Hercus for helpful discussions and for providing GMR reagents. We thank Stephanie Sybingco for the generation of shCbl and shLyn stable cell lines. This work was supported by grants from the Canadian Institutes of Health Research (MOP119356) and the Cancer Research Society. SB is a recipient of the CIHR and Kidney Cancer Foundation fellowship award.	Aplenc R, 2011, J CLIN ONCOL, V29, P839, DOI 10.1200/JCO.2010.30.7231; Balasis ME, 2011, CLIN CANCER RES, V17, P2852, DOI 10.1158/1078-0432.CCR-10-2544; Beckwith M, 1996, BLOOD, V88, P3502, DOI 10.1182/blood.V88.9.3502.bloodjournal8893502; Bergstraesser E, 2007, PEDIATR BLOOD CANCER, V49, P629, DOI 10.1002/pbc.21038; Bunda S, 2013, CANCER RES, V73, P2540, DOI 10.1158/0008-5472.CAN-12-3425; CASTLEBERRY RP, 1994, NEW ENGL J MED, V331, P1680, DOI 10.1056/NEJM199412223312503; CHAN HSL, 1987, J CLIN ONCOL, V5, P1960, DOI 10.1200/JCO.1987.5.12.1960; Chan RJ, 2005, BLOOD, V105, P3737, DOI 10.1182/blood-2004-10-4002; de Vries ACH, 2010, HAEMATOL-HEMATOL J, V95, P179, DOI 10.3324/haematol.2009.016865; Demetri GD, 2009, CLIN CANCER RES, V15, P6232, DOI 10.1158/1078-0432.CCR-09-0224; DombroskyFerlan PM, 1997, ONCOGENE, V14, P2019, DOI 10.1038/sj.onc.1201031; Duan L, 2004, IMMUNITY, V21, P7, DOI 10.1016/j.immuni.2004.06.012; EMANUEL PD, 1991, BLOOD, V77, P925; Emanuel PD, 2008, ACTA HAEMATOL-BASEL, V119, P207, DOI 10.1159/000140632; Flotho C, 2007, CURR DRUG TARGETS, V8, P715, DOI 10.2174/138945007780830773; Guthridge MA, 2004, BLOOD, V103, P820, DOI 10.1182/blood-2003-06-1999; Hasle H, 1996, LEUKEMIA, V10, P1269; Hasle H, 2007, CURR OPIN PEDIATR, V19, P1, DOI 10.1097/MOP.0b013e3280128ce8; Kang HJ, 2004, LEUKEMIA RES, V28, P167, DOI 10.1016/S0145-2126(03)00217-0; Lancet JE, 2011, CLIN CANCER RES, V17, P1140, DOI 10.1158/1078-0432.CCR-10-1878; Le DT, 2004, BLOOD, V103, P4243, DOI 10.1182/blood-2003-08-2650; Lee JH, 2011, J IMMUNOL, V187, P1807, DOI 10.4049/jimmunol.1100296; Loh ML, 2010, HEMATOL-AM SOC HEMAT, P357, DOI 10.1182/asheducation-2010.1.357; Lyubynska N, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001069; Mak AB, 2012, METHODS, V57, P409, DOI 10.1016/j.ymeth.2012.06.005; Niemeyer CM, 2010, NAT GENET, V42, P794, DOI 10.1038/ng.641; Ohh M, 2000, NAT CELL BIOL, V2, P423, DOI 10.1038/35017054; Perugini M, 2010, BLOOD, V115, P3346, DOI 10.1182/blood-2009-08-235846; Sanada M, 2009, NATURE, V460, P904, DOI 10.1038/nature08240; Song JJ, 2010, CELL SIGNAL, V22, P377, DOI 10.1016/j.cellsig.2009.10.007; Stokoe D, 1997, EMBO J, V16, P2384, DOI 10.1093/emboj/16.9.2384; Thien CBF, 2001, NAT REV MOL CELL BIO, V2, P294, DOI 10.1038/35067100; Woods WG, 2002, J CLIN ONCOL, V20, P434, DOI 10.1200/JCO.20.2.434; Yokouchi M, 2001, J BIOL CHEM, V276, P35185, DOI 10.1074/jbc.M102219200; Zhou ZR, 2008, PROTEIN SCI, V17, P1805, DOI 10.1110/ps.036384.108	35	10	11	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB 5	2015	34	6					789	797		10.1038/onc.2013.596	http://dx.doi.org/10.1038/onc.2013.596			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CA4DG	24469048	Bronze			2022-12-25	WOS:000348853800012
J	Lorey, S; Fiedler, E; Kunert, A; Nerkamp, J; Lange, C; Fiedler, M; Bosse-Doenecke, E; Meysing, M; Gloser, M; Rundfeldt, C; Rauchhaus, U; Hanssgen, I; Gottler, T; Steuernagel, A; Fiedler, U; Haupts, U				Lorey, Susan; Fiedler, Erik; Kunert, Anja; Nerkamp, Joerg; Lange, Christian; Fiedler, Markus; Bosse-Doenecke, Eva; Meysing, Maren; Gloser, Manja; Rundfeldt, Chris; Rauchhaus, Una; Haenssgen, Ilka; Goettler, Thomas; Steuernagel, Arnd; Fiedler, Ulrike; Haupts, Ulrich			Novel Ubiquitin-derived High Affinity Binding Proteins with Tumor Targeting Properties	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Phage Display; Protein Engineering; Scaffold Proteins; Tumor Marker; Ubiquitin; Affilin; Biodistribution; Half-life Extension	CHEMOKINE RECEPTOR 4; ED-B DOMAIN; EXOGENOUS UBIQUITIN; CRYSTAL-STRUCTURE; REPEAT PROTEIN; SOLID TUMORS; PHASE I/II; TNF-ALPHA; IN-VITRO; FIBRONECTIN	Background: Targeting molecules to tumor cells is a promising mode of action for cancer therapy. Results: Ubiquitin-based high affinity, specific, and stable binding molecules for extradomain B are accumulated in the tumor. Conclusion: Ubiquitin may be engineered for high affinity target binding and modified with half-life extension technologies. Significance: Ubiquitin qualifies as a well suited scaffold protein adaptable to specific tasks. Targeting effector molecules to tumor cells is a promising mode of action for cancer therapy and diagnostics. Binding proteins with high affinity and specificity for a tumor target that carry effector molecules such as toxins, cytokines, or radiolabels to their intended site of action are required for these applications. In order to yield high tumor accumulation while maintaining low levels in healthy tissues and blood, the half-life of such conjugates needs to be in an optimal range. Scaffold-based binding molecules are small proteins with high affinity and short systemic circulation. Due to their low molecular complexity, they are well suited for combination with effector molecules as well as half-life extension technologies yielding therapeutics with half-lives adapted to the specific therapy. We have identified ubiquitin as an ideal scaffold protein due to its outstanding biophysical and biochemical properties. Based on a dimeric ubiquitin library, high affinity and specific binding molecules, so-called Affilin (R) molecules, have been selected against the extradomain B of fibronectin, a target almost exclusively expressed in tumor tissues. Extradomain B-binding molecules feature high thermal and serum stability as well as strong in vitro target binding and in vivo tumor accumulation. Application of several half-life extension technologies results in molecules of largely unaffected affinity but significantly prolonged in vivo half-life and tumor retention. Our results demonstrate the utility of ubiquitin as a scaffold for the generation of high affinity binders in a modular fashion, which can be combined with effector molecules and half-life extension technologies.	[Lorey, Susan; Fiedler, Erik; Kunert, Anja; Nerkamp, Joerg; Lange, Christian; Fiedler, Markus; Bosse-Doenecke, Eva; Meysing, Maren; Gloser, Manja; Rundfeldt, Chris; Rauchhaus, Una; Haenssgen, Ilka; Goettler, Thomas; Steuernagel, Arnd; Fiedler, Ulrike; Haupts, Ulrich] Scil Prot GmbH, D-06120 Halle, Saale, Germany		Lorey, S (corresponding author), Scil Prot GmbH, Heinrich Damerow Str 1, D-06120 Halle, Saale, Germany.	susan.lorey@scilproteins.com		Fiedler, Erik/0000-0001-7345-5266	investment bank Saxony-Anhalt	investment bank Saxony-Anhalt	This work was supported by funding by the investment bank Saxony-Anhalt.	Andersen JT, 2010, J BIOL CHEM, V285, P4826, DOI 10.1074/jbc.M109.081828; Bach HH, 2012, MOL MED, V18, P1056, DOI 10.2119/molmed.2011.00497; Baker TA, 2012, CRIT CARE MED, V40, P2376, DOI 10.1097/CCM.0b013e3182514ed9; Baum RP, 2010, J NUCL MED, V51, P892, DOI 10.2967/jnumed.109.073239; Bergink S, 2009, NATURE, V458, P461, DOI 10.1038/nature07963; Boersma YL, 2011, CURR OPIN BIOTECH, V22, P849, DOI 10.1016/j.copbio.2011.06.004; Borsi L, 2003, BLOOD, V102, P4384, DOI 10.1182/blood-2003-04-1039; Borsi L, 2002, INT J CANCER, V102, P75, DOI 10.1002/ijc.10662; Bosse-Doenecke E, 2008, PROTEIN EXPRES PURIF, V58, P114, DOI 10.1016/j.pep.2007.10.012; Campochiaro PA, 2013, AM J OPHTHALMOL, V155, P697, DOI 10.1016/j.ajo.2012.09.032; Catic A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000381; Chames P, 2009, BRIT J PHARMACOL, V157, P220, DOI 10.1111/j.1476-5381.2009.00190.x; Chaudhury C, 2006, BIOCHEMISTRY-US, V45, P4983, DOI 10.1021/bi052628y; Demartis S, 2001, EUR J NUCL MED, V28, P534, DOI 10.1007/s002590100480; Dhalluin C, 2005, BIOCONJUGATE CHEM, V16, P518, DOI 10.1021/bc049780h; Earle SA, 2005, SURGERY, V138, P431, DOI 10.1016/j.surg.2005.06.026; Ebersbach H, 2007, J MOL BIOL, V372, P172, DOI 10.1016/j.jmb.2007.06.045; Eddins MJ, 2007, J MOL BIOL, V367, P204, DOI 10.1016/j.jmb.2006.12.065; Fee CJ, 2007, BIOTECHNOL BIOENG, V98, P725, DOI 10.1002/bit.21482; Fiedler M., 1980, Int. Appl, Patent No. [WO 2004 106368, 2004106368]; Garg PK, 1996, BIOCONJUGATE CHEM, V7, P233, DOI 10.1021/bc960001+; Gebauer M, 2013, J MOL BIOL, V425, P780, DOI 10.1016/j.jmb.2012.12.004; Gebauer M, 2009, CURR OPIN CHEM BIOL, V13, P245, DOI 10.1016/j.cbpa.2009.04.627; Grabulovski D, 2007, J BIOL CHEM, V282, P3196, DOI 10.1074/jbc.M609211200; Hey T, 2005, TRENDS BIOTECHNOL, V23, P514, DOI 10.1016/j.tibtech.2005.07.007; Hirsch C, 2009, NATURE, V458, P453, DOI 10.1038/nature07962; HOFFMANN A, 2012, PLOS ONE, V7; Hoppmann S, 2011, BIOCONJUGATE CHEM, V22, P413, DOI 10.1021/bc100432h; Jackson SE, 2006, ORG BIOMOL CHEM, V4, P1845, DOI 10.1039/b600829c; Johannsen M, 2010, EUR J CANCER, V46, P2926, DOI 10.1016/j.ejca.2010.07.033; Johdi NA, 2013, PROTEIN EXPRES PURIF, V88, P157, DOI 10.1016/j.pep.2012.12.002; KHORASANIZADEH S, 1993, BIOCHEMISTRY-US, V32, P7054, DOI 10.1021/bi00078a034; Komander D, 2012, ANNU REV BIOCHEM, V81, P203, DOI 10.1146/annurev-biochem-060310-170328; Komander D, 2009, EMBO REP, V10, P466, DOI 10.1038/embor.2009.55; Kontermann RE, 2011, CURR OPIN BIOTECH, V22, P868, DOI 10.1016/j.copbio.2011.06.012; Kubetzko S, 2005, MOL PHARMACOL, V68, P1439, DOI 10.1124/mol.105.014910; Kuo TT, 2011, MABS-AUSTIN, V3, P422, DOI 10.4161/mabs.3.5.16983; LINDMO T, 1984, J IMMUNOL METHODS, V72, P77, DOI 10.1016/0022-1759(84)90435-6; Majetschak M, 2004, SURGERY, V135, P536, DOI 10.1016/j.surg.2003.09.006; Majetschak M, 2004, J TRAUMA, V56, P991, DOI 10.1097/01.TA.0000127770.29009.5A; Majetschak M, 2003, BLOOD, V101, P1882, DOI 10.1182/blood-2002-03-0918; Majetschak M, 2011, J LEUKOCYTE BIOL, V89, P205, DOI 10.1189/jlb.0510316; Menrad A, 2005, EXPERT OPIN THER TAR, V9, P491, DOI 10.1517/14728222.9.3.491; Mossessova E, 2000, MOL CELL, V5, P865, DOI 10.1016/S1097-2765(00)80326-3; Paschke M, 2005, GENE, V350, P79, DOI 10.1016/j.gene.2005.02.005; Pini A, 1998, J BIOL CHEM, V273, P21769, DOI 10.1074/jbc.273.34.21769; Raiborg C, 2009, NATURE, V458, P445, DOI 10.1038/nature07961; Reichert JM, 2012, MABS-AUSTIN, V4, P413, DOI 10.4161/mabs.19931; Ronca R, 2009, IMMUNOBIOLOGY, V214, P800, DOI 10.1016/j.imbio.2009.06.005; SAHA GB, 1989, NUCL MED BIOL, V16, P431, DOI 10.1016/0883-2897(89)90112-8; Saini V, 2011, J BIOL CHEM, V286, P44145, DOI 10.1074/jbc.M111.298505; Saini V, 2011, J BIOL CHEM, V286, P33466, DOI 10.1074/jbc.M111.233742; Saini Vikas, 2010, Commun Integr Biol, V3, P608, DOI 10.4161/cib.3.6.13375; Sauer S, 2009, BLOOD, V113, P2265, DOI 10.1182/blood-2008-06-160416; SCHWARZBAUER JE, 1987, EMBO J, V6, P2573, DOI 10.1002/j.1460-2075.1987.tb02547.x; Spitaleri G, 2013, J CANCER RES CLIN, V139, P447, DOI 10.1007/s00432-012-1327-7; Takada K, 1997, CLIN CHEM, V43, P1188; Tojo A., 2012, INT J NEPHROL, V2012, P481520, DOI 10.1155/2012/481520; Tolcher AW, 2011, CLIN CANCER RES, V17, P363, DOI 10.1158/1078-0432.CCR-10-1411; Vauquelin G, 2010, EXPERT OPIN DRUG DIS, V5, P927, DOI 10.1517/17460441.2010.512037; Veronese FM, 2005, DRUG DISCOV TODAY, V10, P1451, DOI 10.1016/S1359-6446(05)03575-0; VIJAYKUMAR S, 1987, J MOL BIOL, V194, P531, DOI 10.1016/0022-2836(87)90679-6; Wang YMC, 2011, PHARM RES-DORDR, V28, P1931, DOI 10.1007/s11095-011-0420-y; Weidle UH, 2013, CANCER GENOM PROTEOM, V10, P155; Zahnd C, 2007, NAT METHODS, V4, P269, DOI 10.1038/NMETH1003	65	19	22	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 21	2014	289	12					8493	8507		10.1074/jbc.M113.519884	http://dx.doi.org/10.1074/jbc.M113.519884			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AD3PG	24474690	hybrid, Green Published			2022-12-25	WOS:000333157500041
J	Santos, CR; Polo, CC; Costa, MCMF; Nascimento, AFZ; Meza, AN; Cota, J; Hoffmam, ZB; Honorato, RV; Oliveira, PSL; Goldman, GH; Gilbert, HJ; Prade, RA; Ruller, R; Squina, FM; Wong, DWS; Murakami, MT				Santos, Camila R.; Polo, Carla C.; Costa, Maria C. M. F.; Nascimento, Andrey F. Z.; Meza, Andreia N.; Cota, Junio; Hoffmam, Zaira B.; Honorato, Rodrigo V.; Oliveira, Paulo S. L.; Goldman, Gustavo H.; Gilbert, Harry J.; Prade, Rolf A.; Ruller, Roberto; Squina, Fabio M.; Wong, Dominic W. S.; Murakami, Mario T.			Mechanistic Strategies for Catalysis Adopted by Evolutionary Distinct Family 43 Arabinanases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Biotechnology; Enzyme Kinetics; Glycoside Hydrolases; Protein Chimeras; Protein Structure; GH43 Family; Accessory Domain; Activation Mechanism; Arabinanase; Endo; Exo Activities	CRYSTAL-STRUCTURE; GEOBACILLUS-STEAROTHERMOPHILUS; GLYCOSIDE HYDROLASE; STRUCTURAL BASIS; FUSION PROTEIN; BINDING; CRYSTALLIZATION; PURIFICATION; EXPRESSION; INSIGHTS	Background: Arabinanases are key enzymes involved in hemicellulose degradation. Results: Crystallographic, mutational, and biochemical assays of three arabinanases reveal the molecular mechanisms governing their catalysis and activation. Conclusion: Accessory domain and metal ion are essential for catalysis. Structural adaptations in the catalytic interface confer unique action modes to ruminal arabinanases. Significance: This work provides new molecular strategies for arabinan hydrolysis. Arabinanases (ABNs, EC 3.2.1.99) are promising catalysts for environmentally friendly biomass conversion into energy and chemicals. These enzymes catalyze the hydrolysis of the -1,5-linked l-arabinofuranoside backbone of plant cell wall arabinans releasing arabino-oligosaccharides and arabinose, the second most abundant pentose in nature. In this work, new findings about the molecular mechanisms governing activation, functional differentiation, and catalysis of GH43 ABNs are presented. Biophysical, mutational, and biochemical studies with the hyperthermostable two-domain endo-acting ABN from Thermotoga petrophila (TpABN) revealed how some GH43 ABNs are activated by calcium ions via hyperpolarization of the catalytically relevant histidine and the importance of the ancillary domain for catalysis and conformational stability. On the other hand, the two GH43 ABNs from rumen metagenome, ARN2 and ARN3, presented a calcium-independent mechanism in which sodium is the most likely substituent for calcium ions. The crystal structure of the two-domain endo-acting ARN2 showed that its ability to efficiently degrade branched substrates is due to a larger catalytic interface with higher accessibility than that observed in other ABNs with preference for linear arabinan. Moreover, crystallographic characterization of the single-domain exo-acting ARN3 indicated that its cleavage pattern producing arabinose is associated with the chemical recognition of the reducing end of the substrate imposed by steric impediments at the aglycone-binding site. By structure-guided rational design, ARN3 was converted into a classical endo enzyme, confirming the role of the extended Arg(203)-Ala(230) loop in determining its action mode. These results reveal novel molecular aspects concerning the functioning of GH43 ABNs and provide new strategies for arabinan degradation.	[Santos, Camila R.; Polo, Carla C.; Costa, Maria C. M. F.; Nascimento, Andrey F. Z.; Meza, Andreia N.; Honorato, Rodrigo V.; Oliveira, Paulo S. L.; Murakami, Mario T.] Brazilian Ctr Res Energy & Mat, Brazilian Biosci Natl Lab, BR-13083970 Campinas, SP, Brazil; [Cota, Junio; Hoffmam, Zaira B.; Goldman, Gustavo H.; Prade, Rolf A.; Ruller, Roberto; Squina, Fabio M.] Brazilian Ctr Res Energy & Mat, Brazilian Bioethanol Sci & Technol Lab, BR-13083970 Campinas, SP, Brazil; [Gilbert, Harry J.] Newcastle Univ, Sch Med, Inst Cell & Mol Biosci, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Wong, Dominic W. S.] USDA, ARS, Western Reg Res Ctr, Albany, CA 94710 USA	Newcastle University - UK; United States Department of Agriculture (USDA)	Murakami, MT (corresponding author), Giuseppe Maximo Scolfaro 10000, BR-13083970 Campinas, SP, Brazil.	mario.murakami@lnbio.cnpem.br	Squina, Fabio/J-8130-2012; Honorato, Rodrigo/H-9773-2013; Murakami, Mario T/C-2087-2012; Honorato, Rodrigo Vargas/AAY-9375-2020; Goldman, Gustavo Henrique/F-1848-2013; Prade, Rolf/AAI-5104-2020; Oliveira, Paulo S/K-5588-2013; Nascimento, Andrey Fabricio Ziem/M-1740-2016; Cota, Junio/J-7475-2012; Murakami, Mario T/F-5640-2016; Ruller, ROBERTO/D-1260-2014; Santos, Camila Ramos dos/F-7095-2013	Squina, Fabio/0000-0002-8154-7459; Honorato, Rodrigo/0000-0001-5267-3002; Honorato, Rodrigo Vargas/0000-0001-5267-3002; Goldman, Gustavo Henrique/0000-0002-2986-350X; Prade, Rolf/0000-0002-8154-9286; Nascimento, Andrey Fabricio Ziem/0000-0003-4692-5263; Cota, Junio/0000-0002-1547-4087; Murakami, Mario T/0000-0002-0405-8010; Polo, Carla Cristina/0000-0003-2245-7258; Ruller, ROBERTO/0000-0002-5087-9493; Ruller, Roberto/0000-0001-7501-5176; Santos, Camila Ramos dos/0000-0003-0652-4211	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [10/51890-8, 13/13309-0]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [476043/2011-5, 308092/2012-0]; Coordenacao de Aperfeicoamento de Pessoal de N vel Superior (CAPES)	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de N vel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This work was supported by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) Grants 10/51890-8 and 13/13309-0, Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) Grants 476043/2011-5 and 308092/2012-0, and the Coordenacao de Aperfeicoamento de Pessoal de N vel Superior (CAPES).	Al-Tamimi MAHM, 2006, J APPL MICROBIOL, V100, P407, DOI 10.1111/j.1365-2672.2005.02780.x; Alhassid A, 2009, BIOCHEM J, V422, P73, DOI 10.1042/BJ20090180; Barr BK, 1996, BIOCHEMISTRY-US, V35, P586, DOI 10.1021/bi9520388; Berlin A, 2007, BIOTECHNOL BIOENG, V97, P287, DOI 10.1002/bit.21238; Boisset C, 2001, BIOTECHNOL BIOENG, V72, P339, DOI 10.1002/1097-0290(20010205)72:3<339::AID-BIT11>3.0.CO;2-#; Brux C, 2006, J MOL BIOL, V359, P97, DOI 10.1016/j.jmb.2006.03.005; Brunzelle JS, 2008, ARCH BIOCHEM BIOPHYS, V474, P157, DOI 10.1016/j.abb.2008.03.007; Center RJ, 1998, PROTEIN SCI, V7, P1612, DOI 10.1002/pro.5560070715; CHEN FTA, 1995, ANAL BIOCHEM, V230, P273, DOI 10.1006/abio.1995.1474; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Corsini L, 2008, PROTEIN SCI, V17, P2070, DOI 10.1110/ps.037564.108; de Sanctis D, 2010, FEBS J, V277, P4562, DOI 10.1111/j.1742-4658.2010.07870.x; Delabona PD, 2013, BIORESOURCE TECHNOL, V131, P500, DOI 10.1016/j.biortech.2012.12.105; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Erster O, 2010, METHODS MOL BIOL, V634, P157, DOI 10.1007/978-1-60761-652-8_12; Fujimoto Z, 2010, J BIOL CHEM, V285, P34134, DOI 10.1074/jbc.M110.164251; Fushinobu S, 2005, J BIOL CHEM, V280, P17180, DOI 10.1074/jbc.M413693200; Gao DH, 2011, BIOTECHNOL BIOFUELS, V4, DOI 10.1186/1754-6834-4-5; HEMSLEY A, 1989, NUCLEIC ACIDS RES, V17, P6545, DOI 10.1093/nar/17.16.6545; Honda Y, 2004, J BIOL CHEM, V279, P55097, DOI 10.1074/jbc.M409832200; Ichinose H, 2006, BIOSCI BIOTECH BIOCH, V70, P2745, DOI 10.1271/bbb.60365; Inacio JM, 2008, J BACTERIOL, V190, P4272, DOI 10.1128/JB.00162-08; Jiang DH, 2012, J STRUCT BIOL, V180, P447, DOI 10.1016/j.jsb.2012.08.005; Jorgensen H, 2007, BIOFUEL BIOPROD BIOR, V1, P119, DOI 10.1002/bbb.4; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Ke A, 2003, PROTEIN SCI, V12, P306, DOI 10.1110/ps.0219103; Kobe B, 1999, P NATL ACAD SCI USA, V96, P4319, DOI 10.1073/pnas.96.8.4319; Krieger E, 2002, PROTEINS, V47, P393, DOI 10.1002/prot.10104; Krieger E, 2006, J MOL GRAPH MODEL, V25, P481, DOI 10.1016/j.jmgm.2006.02.009; Kuge M, 1997, PROTEIN SCI, V6, P1783, DOI 10.1002/pro.5560060822; Li HF, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0042626, 10.1371/journal.pone.0048872]; Mckee LS, 2012, P NATL ACAD SCI USA, V109, P6537, DOI 10.1073/pnas.1117686109; McKie VA, 1997, BIOCHEM J, V323, P547, DOI 10.1042/bj3230547; MILLER GL, 1959, ANAL CHEM, V31, P426, DOI 10.1021/ac60147a030; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nurizzo D, 2002, NAT STRUCT BIOL, V9, P665, DOI 10.1038/nsb835; Osaki S, 2001, J NUTR, V131, P796, DOI 10.1093/jn/131.3.796; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pletnev S, 2009, ACTA CRYSTALLOGR D, V65, P906, DOI 10.1107/S0907444909020927; Proctor MR, 2005, P NATL ACAD SCI USA, V102, P2697, DOI 10.1073/pnas.0500051102; Rosenbaum DM, 2007, SCIENCE, V318, P1266, DOI 10.1126/science.1150609; SINNOTT ML, 1990, CHEM REV, V90, P1171, DOI 10.1021/cr00105a006; Squina FM, 2010, BIOCHEM BIOPH RES CO, V399, P505, DOI 10.1016/j.bbrc.2010.07.097; Squina FM, 2009, ACTA CRYSTALLOGR F, V65, P902, DOI 10.1107/S1744309109029844; Srisodsuk M, 1998, EUR J BIOCHEM, V251, P885, DOI 10.1046/j.1432-1327.1998.2510885.x; Stoll VS, 1998, PROTEIN SCI, V7, P1147, DOI 10.1002/pro.5560070508; Takao M, 2002, APPL ENVIRON MICROB, V68, P1639, DOI 10.1128/AEM.68.4.1639-1646.2002; Tina KG, 2007, NUCLEIC ACIDS RES, V35, pW473, DOI 10.1093/nar/gkm423; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; Wang JM, 2005, ACTA CRYSTALLOGR D, V61, P67, DOI 10.1107/S0907444904026721; Ware S, 1999, PROTEIN SCI, V8, P2663, DOI 10.1110/ps.8.12.2663; Wong D, 2008, PROTEIN J, V27, P30, DOI 10.1007/s10930-007-9105-0; Wong DWS, 2008, APPL MICROBIOL BIOT, V79, P941, DOI 10.1007/s00253-008-1504-4; Wong DWS, 2009, PROTEIN PEPTIDE LETT, V16, P1435, DOI 10.2174/092986609789839313; WOODY RW, 1994, EUR BIOPHYS J BIOPHY, V23, P253, DOI 10.1007/BF00213575; Yamaguchi A, 2005, J BIOCHEM, V137, P587, DOI 10.1093/jb/mvi078	56	19	20	0	45	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 14	2014	289	11					7362	7373		10.1074/jbc.M113.537167	http://dx.doi.org/10.1074/jbc.M113.537167			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AC8CV	24469445	Green Published, hybrid			2022-12-25	WOS:000332761500009
J	Arbeille, P; Provost, R; Vincent, N; Aubert, A				Arbeille, Philippe; Provost, Romain; Vincent, Nicole; Aubert, Andre			Adaptation of the Main Peripheral Artery and Vein to Long Term Confinement (MARS 500)	PLOS ONE			English	Article							HEAD-DOWN TILT; VITAMIN-D; GROUP-DYNAMICS; SPACE-FLIGHT; BED REST; IMPACT; RISK	Purpose: The objective was to check if 520 days in confinement (MARS 500), may affect the main peripheral arterial diameter and wall thickness and the main vein size. Method: Common carotid (CC) femoral artery (FA) portal vein (PV), jugular (JG), femoral vein (FV) and tibial vein were assessed during MARS 500 by echography, performed by the subjects. A hand free volumic echographic capture method and a delayed 3D reconstruction software developed by our lab were used for collecting and measuring the vascular parameters. Results: During the MARS 500 experiment the subjects performed 6 sessions among which 80% of the echographic data were of sufficient quality to be processed. No significant change was found for the Common carotid, Jugular vein, femoral artery, femoral vein, portal vein, and tibial vein diameter. CC and FA IMT (intima media thickness) were found significantly increased (14% to 28% P<0.05) in all the 6 subjects, during the confinement period and also at +2 days after the confinement period, but there was no significant difference 6 month later compare to pre MARS 500. Conclusion: The experiment confirmed that even untrained to performing echography the subjects were able to capture enough echographic data to reconstruct the vessel image from which the parameters were measured. The increase in both CC and FA IMT should be in relation with the stress generated by the confined environment or absence of solar radiation, as there was no change in gravity, temperature and air in the MARS 500 module, and minor changes in physical exercise and nutrition.	[Arbeille, Philippe; Provost, Romain] Univ Hosp Trousseau, Med Physiol Spatiale UMPS CERCOM, Tours, France; [Vincent, Nicole] CRIP Lab Informat, Fac Med, Paris, France; [Aubert, Andre] Katholieke Univ Leuven, O&N Lab Expt Cardiol, Univ Hosp Gasthuisberg, Louvain, Belgium	CHU Tours; UDICE-French Research Universities; Universite Paris Cite; KU Leuven; University Hospital Leuven	Arbeille, P (corresponding author), Univ Hosp Trousseau, Med Physiol Spatiale UMPS CERCOM, Tours, France.	arbeille@ed.univ-tours.fr			CNES (French Space Agency) [4800000601]; ESA (European space agency); Belgian federal office of scientific affairs through ESA-PRODEX grant	CNES (French Space Agency)(Centre National D'etudes Spatiales); ESA (European space agency)(European Space Agency); Belgian federal office of scientific affairs through ESA-PRODEX grant	This work was supported by CNES (French Space Agency), grant 4800000601, ESA (European space agency), and the Belgian federal office of scientific affairs through ESA-PRODEX grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambade A, 2012, INT J HEPATOL, V2012, DOI 10.1155/2012/853175; Arbeille P, 2008, AM J PHYSIOL-HEART C, V295, pH1846, DOI 10.1152/ajpheart.509.2008; Arbeille P, 2008, J APPL PHYSIOL, V104, P938, DOI 10.1152/japplphysiol.01021.2007; Arbeille P, 2001, EUR J APPL PHYSIOL, V86, P157, DOI 10.1007/s004210100473; Baevsky RM, 2007, J APPL PHYSIOL, V103, P156, DOI 10.1152/japplphysiol.00137.2007; Baldassarre D, 2012, J AM COLL CARDIOL; Bernd L, 1996, ADV SPACE BIOL MED, V5, P157; Bogh MKB, 2012, SCAND J CLIN LAB INV, V72, P24, DOI 10.3109/00365513.2012.681929; Brazhe N A, 2011, Aviakosm Ekolog Med, V45, P40; Cacioppo JT, 2003, PERSPECT BIOL MED, V46, pS39, DOI 10.1353/pbm.2003.0049; Caspi A, 2006, ARCH PEDIAT ADOL MED, V160, P805, DOI 10.1001/archpedi.160.8.805; Cazes C, 1996, Adv Space Biol Med, V5, P245, DOI 10.1016/S1569-2574(08)60063-5; Cicarma E, 2009, ANTICANCER RES, V29, P3495; Cooper DC, 2010, PSYCHOSOM MED, V72, P122, DOI 10.1097/PSY.0b013e3181cdbfc0; de Labriolle A, 2009, ULTRASOUND MED BIOL, V35, P1436, DOI 10.1016/j.ultrasmedbio.2009.03.013; Dorfman TA, 2007, J APPL PHYSIOL, V103, P8, DOI 10.1152/japplphysiol.01162.2006; Eskov K N, 1996, Adv Space Biol Med, V5, P233, DOI 10.1016/S1569-2574(08)60062-3; Gunga H C, 1996, Adv Space Biol Med, V5, P39, DOI 10.1016/S1569-2574(08)60052-0; Heo SH, 2013, J NEUROL, V260, P122, DOI 10.1007/s00415-012-6599-y; Hockey G R, 1996, Adv Space Biol Med, V5, P309, DOI 10.1016/S1569-2574(08)60067-2; Larina I M, 1999, Hum Physiol, V25, P574; Lin LJ, 2009, J APPL PHYSIOL, V107, P1710, DOI 10.1152/japplphysiol.00493.2009; MAILLET A, 1993, AVIAT SPACE ENVIR MD, V64, P287; Nichiporuk I A, 1995, Aviakosm Ekolog Med, V29, P58; Plante GE, 2002, METABOLISM, V51, P25, DOI 10.1053/meta.2002.33187; Rakova N, 2013, CELL METAB, V17, P125, DOI 10.1016/j.cmet.2012.11.013; Rizzolatti G, 1993, Adv Space Biol Med, V3, P151; Rozanski A, 1999, CIRCULATION, V99, P2192, DOI 10.1161/01.CIR.99.16.2192; Safarova AF, 2012, KARDIOLOGIYA, V52, P22; Schneider S, 2013, BEHAV BRAIN RES, V236, P1, DOI 10.1016/j.bbr.2012.08.022; Su TC, 2012, J ATHEROSCLER THROMB, V19, P872, DOI 10.5551/jat.10728; Uchakin P. N., 2006, Vestnik Rossiiskoi Akademii Meditsinskikh Nauk, P15; Vaernes R J, 1993, Adv Space Biol Med, V3, P35; van de Luijtgaarden KM, 2012, EUR J VASC ENDOVASC, V44, P301, DOI 10.1016/j.ejvs.2012.06.017; Vigo DE, 2012, AVIAT SPACE ENVIR MD, V83, P125, DOI 10.3357/ASEM.3120.2012; Wadley AJ, 2012, AGE; Wan L, 2011, AVIAT SPACE ENVIR MD, V82, P711, DOI 10.3357/ASEM.2986.2011; Weiss K, 1998, ACTA ASTRONAUT, V43, P235	38	15	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2014	9	1							e83063	10.1371/journal.pone.0083063	http://dx.doi.org/10.1371/journal.pone.0083063			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301BI	24475025	Green Published, gold, Green Submitted			2022-12-25	WOS:000330507300011
J	King, JR; Gramfort, A; Schurger, A; Naccache, L; Dehaene, S				King, Jean-Remi; Gramfort, Alexandre; Schurger, Aaron; Naccache, Lionel; Dehaene, Stanislas			Two Distinct Dynamic Modes Subtend the Detection of Unexpected Sounds	PLOS ONE			English	Article							EVENT-RELATED POTENTIALS; MISMATCH NEGATIVITY; NOVELTY; RESPONSES; P300; MMN; INFORMATION; ATTENTION; STIMULI; HUMANS	The brain response to auditory novelty comprises two main EEG components: an early mismatch negativity and a late P300. Whereas the former has been proposed to reflect a prediction error, the latter is often associated with working memory updating. Interestingly, these two proposals predict fundamentally different dynamics: prediction errors are thought to propagate serially through several distinct brain areas, while working memory supposes that activity is sustained over time within a stable set of brain areas. Here we test this temporal dissociation by showing how the generalization of brain activity patterns across time can characterize the dynamics of the underlying neural processes. This method is applied to magnetoencephalography (MEG) recordings acquired from healthy participants who were presented with two types of auditory novelty. Following our predictions, the results show that the mismatch evoked by a local novelty leads to the sequential recruitment of distinct and short-lived patterns of brain activity. In sharp contrast, the global novelty evoked by an unexpected sequence of five sounds elicits a sustained state of brain activity that lasts for several hundreds of milliseconds. The present results highlight how MEG combined with multivariate pattern analyses can characterize the dynamics of human cortical processes.	[King, Jean-Remi; Schurger, Aaron; Dehaene, Stanislas] INSERM U992, Cognit Neuroimaging Unit, Gif Sur Yvette, France; [King, Jean-Remi; Gramfort, Alexandre; Schurger, Aaron; Dehaene, Stanislas] CEA, NeuroSpin Ctr, Inst BioImaging, Gif Sur Yvette, France; [King, Jean-Remi; Naccache, Lionel] INSERM, Inst Cerveau & Moelle Epiniere Res Ctr ICM, Paris, France; [Gramfort, Alexandre] Lab Traitement & Commun Informat LTCI, Ctr Natl Rech Sci CNRS, Inst Mines Telecom, Telecom ParisTech, Paris, France; [Gramfort, Alexandre] Commissariat Energie Atom CEA, Inst Natl Rech Informat & Automat INRIA, Gif Sur Yvette, France; [Naccache, Lionel] Grp Hosp Pitie Salpetriere, Dept Neurophysiol, AP HP, F-75634 Paris, France; [Naccache, Lionel] Univ Paris 06, Fac Med Pitie Salpetriere, Paris, France; [Dehaene, Stanislas] Univ Paris 11, Orsay, France; [Dehaene, Stanislas] Coll France, F-75231 Paris, France	CEA; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; CEA; UDICE-French Research Universities; Universite Paris Saclay; Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); IMT - Institut Mines-Telecom; IMT Atlantique; Institut Polytechnique de Paris; CEA; UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; PSL Research University Paris; College de France	King, JR (corresponding author), INSERM U992, Cognit Neuroimaging Unit, Gif Sur Yvette, France.	jeanremi.king@gmail.com	Schurger, Aaron/Y-4459-2018	Schurger, Aaron/0000-0003-2985-3253; naccache, lionel/0000-0002-2874-1009; Gramfort, Alexandre/0000-0001-9791-4404	Direction Generale de l'Armement (DGA); Institut National de la Sante Et de la Recherche Medicale (INSERM); Commissariat a l'Energie Atomique et aux Energies Alternatives (CEA); European Research Council senior grant "NeuroConsc"; INSERM; Fondation pour la Recherche Medicale (FRM); Bettencourt-Schueller Foundation; Region ile-de-France	Direction Generale de l'Armement (DGA)(General Electric); Institut National de la Sante Et de la Recherche Medicale (INSERM)(Institut National de la Sante et de la Recherche Medicale (Inserm)); Commissariat a l'Energie Atomique et aux Energies Alternatives (CEA)(French Atomic Energy Commission); European Research Council senior grant "NeuroConsc"; INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Fondation pour la Recherche Medicale (FRM)(Fondation pour la Recherche Medicale); Bettencourt-Schueller Foundation; Region ile-de-France(Region Ile-de-France)	This work was supported by Direction Generale de l'Armement (DGA) to JRK, Institut National de la Sante Et de la Recherche Medicale (INSERM), by Commissariat a l'Energie Atomique et aux Energies Alternatives (CEA), and a European Research Council senior grant "NeuroConsc" to SD. The Neurospin MEG facility was sponsored by grants from INSERM, CEA, Fondation pour la Recherche Medicale (FRM), the Bettencourt-Schueller Foundation, and the Region ile-de-France. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bekinschtein TA, 2009, P NATL ACAD SCI USA, V106, P1672, DOI 10.1073/pnas.0809667106; Carlson T. A., 2011, J VIS, V11, P1, DOI [10.1167/11.10.9, DOI 10.1167/11.10.9.INTR0DUCTI0N]; Carlson T, 2013, J VISION, V13, DOI 10.1167/13.10.1; Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199; Chennu S, 2013, J NEUROSCI, V33, P11194, DOI 10.1523/JNEUROSCI.0114-13.2013; Dehaene S, 2006, TRENDS COGN SCI, V10, P204, DOI 10.1016/j.tics.2006.03.007; Dehaene S, 2011, NEURON, V70, P200, DOI 10.1016/j.neuron.2011.03.018; Duncan KK, 2010, HUM BRAIN MAPP, V31, P1003, DOI 10.1002/hbm.20912; Faugeras F, 2011, NEUROLOGY, V77, P264, DOI 10.1212/WNL.0b013e3182217ee8; Faugeras F, 2012, NEUROPSYCHOLOGIA, V50, P403, DOI 10.1016/j.neuropsychologia.2011.12.015; Fischer C, 2010, CLIN NEUROPHYSIOL, V121, P1032, DOI 10.1016/j.clinph.2010.02.005; Friston KJ, 2013, NEUROIMAGE, V81, P503, DOI 10.1016/j.neuroimage.2013.02.057; Friston KJ, 2005, PHILOS T R SOC B, V360, P815, DOI 10.1098/rstb.2005.1622; Fuentemilla L, 2010, CURR BIOL, V20, P606, DOI 10.1016/j.cub.2010.01.057; Fuster JM, 2008, PREFRONTAL CORTEX, DOI [10.1016/S0896-6273(00)80673-X., DOI 10.1016/S0896-6273(00)80673-X]; Garcia JO, 2013, CURR BIOL, V23, P515, DOI 10.1016/j.cub.2013.02.013; Garrido MI, 2008, NEUROIMAGE, V42, P936, DOI 10.1016/j.neuroimage.2008.05.018; Garrido MI, 2007, NEUROIMAGE, V36, P571, DOI 10.1016/j.neuroimage.2007.03.014; Garrido MI, 2009, CLIN NEUROPHYSIOL, V120, P453, DOI 10.1016/j.clinph.2008.11.029; Goldstein A, 2002, PSYCHOPHYSIOLOGY, V39, P781, DOI 10.1017/S004857720201048X; Gramfort A, 2013, MNE SOFTWARE PROCESS; Gramfort A, 2014, NEUROIMAGE, V86, P446, DOI 10.1016/j.neuroimage.2013.10.027; HALGREN E, 1995, ELECTROEN CLIN NEURO, V94, P229, DOI 10.1016/0013-4694(95)98475-N; HARI R, 1984, NEUROSCI LETT, V50, P127, DOI 10.1016/0304-3940(84)90474-9; Ingre Michael, 2013, Neuroimage, V81, P496, DOI 10.1016/j.neuroimage.2013.03.030; King JR, 2013, NEUROIMAGE, V83, P726, DOI 10.1016/j.neuroimage.2013.07.013; KOJIMA S, 1982, BRAIN RES, V248, P43, DOI 10.1016/0006-8993(82)91145-3; Lemm S, 2011, NEUROIMAGE, V56, P387, DOI 10.1016/j.neuroimage.2010.11.004; Lindquist Martin A, 2013, Neuroimage, V81, P499, DOI 10.1016/j.neuroimage.2013.02.056; Meyers EM, 2008, J NEUROPHYSIOL, V100, P1407, DOI 10.1152/jn.90248.2008; Naatanen R, 2007, CLIN NEUROPHYSIOL, V118, P2544, DOI 10.1016/j.clinph.2007.04.026; NAATANEN R, 1987, PSYCHOPHYSIOLOGY, V24, P375, DOI 10.1111/j.1469-8986.1987.tb00311.x; Naatanen R, 2010, BRAIN RES REV, V64, P123, DOI 10.1016/j.brainresrev.2010.03.001; Nikolic D, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000260; Pedregosa F, 2011, J MACH LEARN RES, V12, P2825; Philiastides MG, 2006, CEREB CORTEX, V16, P509, DOI 10.1093/cercor/bhi130; Platt JC, 2000, ADV NEUR IN, P61; Polich J, 1997, INT J PSYCHOPHYSIOL, V25, P169, DOI 10.1016/S0167-8760(96)00742-8; Polich J, 2007, CLIN NEUROPHYSIOL, V118, P2128, DOI 10.1016/j.clinph.2007.04.019; Pouget A, 2002, NAT REV NEUROSCI, V3, P741, DOI 10.1038/nrn914; Ramkumar P, 2013, J NEUROSCI, V33, P7691, DOI 10.1523/JNEUROSCI.3905-12.2013; Rao RPN, 1999, NAT NEUROSCI, V2, P79, DOI 10.1038/4580; Romo R, 1999, NATURE, V399, P470, DOI 10.1038/20939; Sandberg K, 2013, J COGNITIVE NEUROSCI, V25, P969, DOI 10.1162/jocn_a_00353; Schurger A, 2013, BMC NEUROSCI, V14, DOI 10.1186/1471-2202-14-122; SQUIRES NK, 1975, ELECTROEN CLIN NEURO, V38, P387, DOI 10.1016/0013-4694(75)90263-1; Stokes MG, 2013, NEURON, V78, P364, DOI 10.1016/j.neuron.2013.01.039; Tallon-Baudry C, 1999, TRENDS COGN SCI, V3, P151, DOI 10.1016/S1364-6613(99)01299-1; Taulu S, 2004, BRAIN TOPOGR, V16, P269, DOI 10.1023/b:brat.0000032864.93890.f9; TIITINEN H, 1994, NATURE, V372, P90, DOI 10.1038/372090a0; Uusitalo MA, 1997, MED BIOL ENG COMPUT, V35, P135, DOI 10.1007/BF02534144; Wacongne C, 2012, J NEUROSCI, V32, P3665, DOI 10.1523/JNEUROSCI.5003-11.2012; Wacongne C, 2011, P NATL ACAD SCI USA, V108, P20754, DOI 10.1073/pnas.1117807108; Wakeman DG, 2010, BIOMAG C; Zhang Y, 2011, P NATL ACAD SCI USA, V108, P8850, DOI 10.1073/pnas.1100999108	55	40	40	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2014	9	1							e85791	10.1371/journal.pone.0085791	http://dx.doi.org/10.1371/journal.pone.0085791			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	301BI	24475052	Green Published, Green Submitted, gold			2022-12-25	WOS:000330507300024
J	Longman, MR; Ranieri, A; Avkiran, M; Snabaitis, AK				Longman, Michael R.; Ranieri, Antonella; Avkiran, Metin; Snabaitis, Andrew K.			Regulation of PP2A(C) Carboxylmethylation and Cellular Localisation by Inhibitory Class G-Protein Coupled Receptors in Cardiomyocytes	PLOS ONE			English	Article							BETA-GAMMA-DIMERS; PHOSPHATASE 2A; CATALYTIC SUBUNIT; DEPENDENT ACTIVATION; CARBOXYL-TERMINUS; KINASE PATHWAY; CORE ENZYME; PHOSPHORYLATION; STIMULATION; METHYLATION	The enzymatic activity of the type 2A protein phosphatase (PP2A) holoenzyme, a major serine/threonine phosphatase in the heart, is conferred by its catalytic subunit (PP2A(C)). PP2A(C) activity and subcellular localisation can be regulated by reversible carboxylmethylation of its C-terminal leucine309 (leu309) residue. Previous studies have shown that the stimulation of adenosine type 1 receptors (A1. Rs) induces PP2A(C) carboxylmethylation and altered subcellular distribution in adult rat ventricular myocytes (ARVM). In the current study, we show that the enzymatic components that regulate the carboxylmethylation status of PP2A(C), leucine carboxylmethyltransferase-1 (LCMT-1) and phosphatase methylesterase-1 (PME-1) are abundantly expressed in, and almost entirely localised in the cytoplasm of ARVM. The stimulation of Gi-coupled A1. Rs with N 6 -cyclopentyladenosine (CPA), and of other Gi-coupled receptors such as muscarinic M-2 receptors (stimulated with carbachol) and angiotensin II AT2 receptors (stimulated with CGP42112) in ARVM, induced PP2A(C) carboxylmethylation at leu309 in a concentration-dependent manner. Exposure of ARVM to 10 mM CPA increased the cellular association between PP2A(C) and its methyltransferase LCMT-1, but not its esterase PME-1. Stimulation of A1. Rs with 10 mu M CPA increased the phosphorylation of protein kinase B at ser473, which was abolished by the PI3K inhibitor LY294002 (20 mu M), thereby confirming that PI3K activity is upregulated in response to A1. R stimulation by CPA in ARVM. A1. R-induced PP2A(C) translocation to the particulate fraction was abrogated by adenoviral expression of the alpha subunit (G(alpha t1)) coupled to the transducin G-protein coupled receptor. A similar inhibitory effect on A1. R-induced PP2A(C) translocation was also seen with LY294002 (20 mu M). These data suggest that in ARVM, A1. R-induced PP2A(C) translocation to the particulate fraction occurs through a GiPCR-G beta gamma-PI3K mediated intracellular signalling pathway, which may involve elevated PP2A(C) carboxylmethylation at leu309.	[Longman, Michael R.; Snabaitis, Andrew K.] Univ Kingston, Fac Sci Engn & Comp, Sch Pharm & Chem, Kingston Upon Thames KT1 2EE, Surrey, England; [Ranieri, Antonella; Avkiran, Metin; Snabaitis, Andrew K.] Kings Coll London, British Heart Fdn Ctr, Cardiovasc Div, Rayne Inst,St Thomas Hosp, London WC2R 2LS, England	Kingston University; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London	Snabaitis, AK (corresponding author), Univ Kingston, Fac Sci Engn & Comp, Sch Pharm & Chem, Kingston Upon Thames KT1 2EE, Surrey, England.	a.snabaitis@kingston.ac.uk		snabaitis, andrew/0000-0003-0061-1111; Avkiran, Metin/0000-0003-2392-6343	British Heart Foundation Intermediate Basic Science Research Fellowship [FS/04/053]	British Heart Foundation Intermediate Basic Science Research Fellowship	This work was funded by a British Heart Foundation Intermediate Basic Science Research Fellowship (FS/04/053) to AKS. MRL is currently funded by Kingston University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banquet S, 2011, CELL SIGNAL, V23, P1136, DOI 10.1016/j.cellsig.2011.02.008; Bryant JC, 1999, BIOCHEM J, V339, P241, DOI 10.1042/0264-6021:3390241; CHEN J, 1992, SCIENCE, V257, P1261, DOI 10.1126/science.1325671; CRESPO P, 1994, NATURE, V369, P418, DOI 10.1038/369418a0; De Baere I, 1999, BIOCHEMISTRY-US, V38, P16539, DOI 10.1021/bi991646a; DeGrande ST, 2013, J BIOL CHEM, V288, P1032, DOI 10.1074/jbc.M112.426957; Deshmukh PA, 2007, AM J PHYSIOL-HEART C, V292, pH792, DOI 10.1152/ajpheart.00225.2006; Eichhorn P.J., 2008, BBA-REV CANCER, V1795, P1, DOI DOI 10.1016/J.BBCAN.2008.05.005; Fahimi-Vahid M, 2002, J MOL CELL CARDIOL, V34, P441, DOI 10.1006/jmcc.2002.1525; FEDERMAN AD, 1992, NATURE, V356, P159, DOI 10.1038/356159a0; Fenton RA, 2010, AM J PHYSIOL-HEART C, V298, pH1671, DOI 10.1152/ajpheart.01028.2009; GUO H, 1993, P NATL ACAD SCI USA, V90, P2500, DOI 10.1073/pnas.90.6.2500; He TC, 1998, P NATL ACAD SCI USA, V95, P2509, DOI 10.1073/pnas.95.5.2509; Hippe HJ, 2007, CIRC RES, V100, P1191, DOI 10.1161/01.RES.0000264058.28808.cc; Hippe HJ, 2009, P NATL ACAD SCI USA, V106, P16269, DOI 10.1073/pnas.0901679106; Huang JA, 2006, BIOCHEM J, V396, P193, DOI 10.1042/BJ20051772; Janssens V, 2001, BIOCHEM J, V353, P417, DOI 10.1042/0264-6021:3530417; Jordens J, 2006, J BIOL CHEM, V281, P6349, DOI 10.1074/jbc.M507760200; KOCH WJ, 1994, J BIOL CHEM, V269, P6193; Kowluru A, 1996, ENDOCRINOLOGY, V137, P2315, DOI 10.1210/en.137.6.2315; Kremmer E, 1997, MOL CELL BIOL, V17, P1692, DOI 10.1128/MCB.17.3.1692; Kuo YC, 2008, J BIOL CHEM, V283, P1882, DOI 10.1074/jbc.M709585200; LEE J, 1993, J BIOL CHEM, V268, P19192; Liu QH, 2003, AM J PHYSIOL-HEART C, V285, pH97, DOI 10.1152/ajpheart.00956.2002; Liu QH, 2002, AM J PHYSIOL-HEART C, V283, pH1314, DOI 10.1152/ajpheart.00343.2002; Longin S, 2004, BIOCHEM J, V380, P111, DOI 10.1042/BJ20031643; Longin S, 2008, EXP CELL RES, V314, P68, DOI 10.1016/j.yexcr.2007.07.030; Longin S, 2007, J BIOL CHEM, V282, P26971, DOI 10.1074/jbc.M704059200; Marx SO, 2000, CELL, V101, P365, DOI 10.1016/S0092-8674(00)80847-8; Murthy KS, 2008, J PHARMACOL EXP THER, V325, P183, DOI 10.1124/jpet.107.132928; Nicklin S A, 1999, Methods Mol Med, V30, P271, DOI 10.1385/1-59259-247-3:271; Ogris E, 1999, J BIOL CHEM, V274, P14382, DOI 10.1074/jbc.274.20.14382; SCHRAMM M, 1984, SCIENCE, V225, P1350, DOI 10.1126/science.6147897; Schwindinger WF, 2001, ONCOGENE, V20, P1653, DOI 10.1038/sj.onc.1204181; Sents W, 2013, FEBS J, V280, P644, DOI 10.1111/j.1742-4658.2012.08579.x; Shi YG, 2009, CELL, V139, P468, DOI 10.1016/j.cell.2009.10.006; Snabaitis AK, 2000, CIRC RES, V86, P214, DOI 10.1161/01.RES.86.2.214; Snabaitis AK, 2005, CELL SIGNAL, V17, P655, DOI 10.1016/j.cellsig.2004.10.008; Snabaitis AK, 2006, J BIOL CHEM, V281, P20252, DOI 10.1074/jbc.M600268200; Stanevich V, 2011, MOL CELL, V41, P331, DOI 10.1016/j.molcel.2010.12.030; STEPHENS L, 1994, CELL, V77, P83, DOI 10.1016/0092-8674(94)90237-2; Stephens LR, 1997, CELL, V89, P105, DOI 10.1016/S0092-8674(00)80187-7; Tikh EI, 2008, J CELL PHYSIOL, V216, P83, DOI 10.1002/jcp.21375; Tolstykh T, 2000, EMBO J, V19, P5682, DOI 10.1093/emboj/19.21.5682; Torrent L, 2012, CURR ALZHEIMER RES, V9, P248, DOI 10.2174/156720512799361682; TUROWSKI P, 1995, J CELL BIOL, V129, P397, DOI 10.1083/jcb.129.2.397; Vettel C, 2012, J MOL CELL CARDIOL, V53, P165, DOI 10.1016/j.yjmcc.2012.04.015; Xing YN, 2008, CELL, V133, P154, DOI 10.1016/j.cell.2008.02.041; Xing Y, 2006, CELL, V127, P341, DOI 10.1016/j.cell.2006.09.025; Xu YH, 2006, CELL, V127, P1239, DOI 10.1016/j.cell.2006.11.033; Zhou XB, 2000, J PHYSIOL-LONDON, V524, P339, DOI 10.1111/j.1469-7793.2000.t01-1-00339.x; Zhu WZ, 2001, P NATL ACAD SCI USA, V98, P1607, DOI 10.1073/pnas.98.4.1607	52	10	10	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2014	9	1							e86234	10.1371/journal.pone.0086234	http://dx.doi.org/10.1371/journal.pone.0086234			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301BI	24475092	Green Published, gold, Green Submitted, Green Accepted			2022-12-25	WOS:000330507300046
J	Piao, HX; Yang, AT; Sun, YM; Kong, YY; Wu, XN; Zhang, YZ; Ding, B; Wang, BE; Jia, JD; You, H				Piao, Hong-Xin; Yang, Ai-Ting; Sun, Ya-Meng; Kong, Yuan-Yuan; Wu, Xiao-Ning; Zhang, Ying-Zhe; Ding, Bo; Wang, Bao-En; Jia, Ji-Dong; You, Hong			Increasing Newly Diagnosed Rate and Changing Risk Factors of HCV in Yanbian Prefecture, a High Endemic Area in China	PLOS ONE			English	Article							HEPATITIS-C VIRUS; GLOBAL EPIDEMIOLOGY; INFECTION; TRANSMISSION	Background: The newly diagnosed rate of HCV infection is increasing in China. However, the risk factors have not been fully identified. Here, a survey was performed in Yanbian Prefecture, a high-endemic area in China. Methods: We identified newly diagnosed HCV infection in 2007-2011, using the local National Disease Supervision Information Management System from the Chinese Center for Disease Control and Prevention. We determined the risk factors using a case-control survey by questionnaire. Results: Yanbian Prefecture had a rapid increase in the yearly newly diagnosed rate of HCV infection from 32.6 to 72.1/100.000 from the year 2007 to 2011. People aged 50-64 years had a high HCV infection of 43.4%, but only 0.3% of cases were reported in those aged less than 20 years. Cosmetic treatment, family history, blood transfusion, and dental treatment were independent risk factors for HCV infection. Unexpectedly, cosmetic treatments [ odd ratio (OR) = 5.15, 95% confidence interval (CI) = 2.31-11.48, P = 0.00] and family history (OR = 4.68, 95% CI = 2.67-8.75, P = 0.00) showed a higher risk than the conventional risk factors of blood transfusion (OR = 4.49, 95% CI = 1.95-10.37, P = 0.001) and dental treatment (OR = 2.98, 95% CI = 1.42-6.25, P = 0.00). To further analyze the intrafamilial transmission, we found that spouses of HCV patients had an increased risk for acquiring HCV (OR = 5.75, 95% CI: 1.94-17.07), without significant association between either HCV RNA viral load (P = 0.29) or genotype (P = 0.43). Conclusions: HCV infection was increased in Yanbian Prefecture. Cosmetic treatment was a higher risk factor than medical procedure. HCV infection had a clear family clustering phenomenon, especially between spouses.	[Piao, Hong-Xin; Yang, Ai-Ting; Sun, Ya-Meng; Kong, Yuan-Yuan; Wu, Xiao-Ning; Wang, Bao-En; Jia, Ji-Dong; You, Hong] Capital Med Univ, Beijing Friendship Hosp, Liver Res Ctr, Beijing, Peoples R China; [Piao, Hong-Xin; Zhang, Ying-Zhe; Ding, Bo] Yanbian Univ, Affiliated Hosp, Yanji, Jilin, Peoples R China	Capital Medical University; Yanbian University	You, H (corresponding author), Capital Med Univ, Beijing Friendship Hosp, Liver Res Ctr, Beijing, Peoples R China.	youhong30@sina.com	You, Hong/G-6686-2011		Program for National Science and Technology Major Project [2013ZX10002004]; Key Project from the Education Bureau of Beijing [KZ201210025024]; Project of Education Department of Jilin Province [611010057]; Chinese Foundation for Hepatitis Prevention and Control [TQGB2011023]	Program for National Science and Technology Major Project; Key Project from the Education Bureau of Beijing; Project of Education Department of Jilin Province; Chinese Foundation for Hepatitis Prevention and Control	This work was supported by Program for National Science and Technology Major Project (2013ZX10002004), Key Project from the Education Bureau of Beijing (KZ201210025024), Project of Education Department of Jilin Province (611010057) and Chinese Foundation for Hepatitis Prevention and Control (TQGB2011023). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackerman Z, 2000, J VIRAL HEPATITIS, V7, P93; Alter MJ, 2007, WORLD J GASTROENTERO, V13, P2436, DOI 10.3748/wjg.v13.i17.2436; Amin Janiki, 2004, Commun Dis Intell Q Rep, V28, P517; [Anonymous], 2000, Wkly Epidemiol Rec, V75, P18; Fukuizumi K, 1997, SCAND J INFECT DIS, V29, P345, DOI 10.3109/00365549709011828; Guo W, 2011, PRACTICAL PREVENTIVE, V18, P51; Hajiani E, 2006, WORLD J GASTROENTERO, V12, P7025, DOI 10.3748/wjg.v12.i43.7025; He Y, 2011, J MED VIROL, V83, P616, DOI 10.1002/jmv.22010; Health Protection Agency, 2009, HEP C UK REP; Jokhio A. H., 2010, Eastern Mediterranean Health Journal, V16, P1079; Karmochkine M, 2006, J VIRAL HEPATITIS, V13, P775, DOI 10.1111/j.1365-2893.2006.00742.x; Kim YS, 1998, INT J EPIDEMIOL, V27, P525, DOI 10.1093/ije/27.3.525; Leruez-Ville M, 2000, LANCET, V356, P42, DOI 10.1016/S0140-6736(00)02435-1; Liu FF, 2009, EMERG INFECT DIS, V15, P1819, DOI [10.3201/eid1511.0900263, 10.3201/eid1511.090263]; Lu Jian, 2011, Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi, V25, P448; Nelson PK, 2011, LANCET, V378, P571, DOI 10.1016/S0140-6736(11)61097-0; Okayama A, 2002, J VIRAL HEPATITIS, V9, P43, DOI 10.1046/j.1365-2893.2002.00331.x; Shan H, 2007, TRANSFUSION, V47, P2011, DOI 10.1111/j.1537-2995.2007.01424.x; Shepard CW, 2005, LANCET INFECT DIS, V5, P558, DOI 10.1016/S1473-3099(05)70216-4; Sievert W, 2011, LIVER INT, V31, P61, DOI 10.1111/j.1478-3231.2011.02540.x; Sun CA, 2001, J MED VIROL, V65, P30, DOI 10.1002/jmv.1097; Zhang MD, 2005, EMERG INFECT DIS, V11, P17, DOI 10.3201/eid1101.031005	22	9	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2014	9	1							e86190	10.1371/journal.pone.0086190	http://dx.doi.org/10.1371/journal.pone.0086190			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301BI	24475084	Green Published, gold, Green Submitted			2022-12-25	WOS:000330507300041
J	Wang, YQ; Wang, LF; Liu, X; Zhang, YZ; Yu, LP; Zhang, F; Liu, LS; Cai, J; Yang, XC; Wang, XY				Wang, Yongqin; Wang, Lefeng; Liu, Xin; Zhang, Yongzhi; Yu, Liping; Zhang, Fan; Liu, Lisheng; Cai, Jun; Yang, Xinchun; Wang, Xingyu			Genetic Variants Associated with Myocardial Infarction and the Risk Factors in Chinese Population	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; CORONARY-ARTERY-DISEASE; SUSCEPTIBILITY LOCUS; SELECTIN; PLASMA; ABO	Background: Recent genome-wide association (GWA) studies in Caucasians identified multiple single nucleotide polymorphisms (SNPs) associated with coronary artery disease (CAD). The associations of those SNPs with myocardial infarction (MI) have not been replicated in Asian populations. Among those previously identified SNPs, we selected nine (rs10953541, rs1122608, rs12190287, rs12413409, rs1412444, rs1746048, rs3798220, rs4977574, rs579459, in or near genes 7q22, LDLR, TCF21, CYP17A1, LIPA, CXCL12, LPA, CDKN2A, ABO, respectively) because of the relatively high minor allele frequencies in Chinese individuals and tested the associations of the SNPs with MI and MI related risk factors in Chinese population. Methods and Results: We conducted a case-control association study on a cohort of 2365 MI patients and 2678 unrelated controls from the Chinese population. Genotyping of 9 SNPs were performed by the TaqMan Real Time PCR method. After age, sex, and BMI adjustment, we observed the SNPs rs12190287, rs12413409, rs1412444, rs1746048 and rs4977574, were significantly associated with MI in additive models and rs12190287, rs12413409, rs4977574 were significantly associated with phenotypes of MI at the same time. We also found three SNPs rs1122608, rs3798220 and rs579459 were significantly associated with risk factors of MI, although they had no association with MI in Chinese population. Conclusion: Results of this study indicate that 5 SNPs were associated with MI and 3 SNPs were associated with associated with lipoprotein levels but not with MI in a Chinese population. The present study supports some CAD-related genes in Caucasian as important genes for MI in a Chinese population.	[Wang, Yongqin; Zhang, Yongzhi; Wang, Xingyu] Shantou Univ, Coll Med, Affiliated Hosp 1, Dept Cardiol, Shantou, Guangdong, Peoples R China; [Wang, Yongqin; Liu, Xin; Zhang, Yongzhi; Liu, Lisheng; Wang, Xingyu] Beijing Hypertens League Inst, Lab Human Genet, Beijing, Peoples R China; [Wang, Lefeng; Liu, Xin; Yu, Liping; Zhang, Fan; Cai, Jun; Yang, Xinchun; Wang, Xingyu] Capital Med Univ, Chaoyang Hosp, Dept Cardiol, Beijing, Peoples R China; [Wang, Yongqin] Baotou Med Coll, Sch Basic Courses, Baotou, Neimenggu, Peoples R China	Shantou University; Chinese Hypertension League; Capital Medical University; Baotou Medical College	Cai, J (corresponding author), Capital Med Univ, Chaoyang Hosp, Dept Cardiol, Beijing, Peoples R China.	caijun7879@hotmail.com; yxc6229@sina.com; xingyuw@yahoo.com			Beijing Hypertension League Institute, INTERHEART Founding sources; National Natural Science Foundation of China [81370314, 8127184]; Qin Wenbin Technology Education Foundation of Baotou Medical College [201302]; Population Health Research Insitute	Beijing Hypertension League Institute, INTERHEART Founding sources; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Qin Wenbin Technology Education Foundation of Baotou Medical College; Population Health Research Insitute	This study was supported by the Beijing Hypertension League Institute, INTERHEART Founding sources, the National Natural Science Foundation of China (Grant Number 81370314 and 8127184), Qin Wenbin Technology Education Foundation of Baotou Medical College (Grant Number 201302), and the Population Health Research Insitute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barbalic M, 2010, HUM MOL GENET, V19, P1863, DOI 10.1093/hmg/ddq061; Chasman DI, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000730; Erdmann J, 2009, NAT GENET, V41, P280, DOI 10.1038/ng.307; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; Guella I, 2009, CIRC-CARDIOVASC GENE, V2, P165, DOI 10.1161/CIRCGENETICS.108.819326; GUO SW, 1992, BIOMETRICS, V48, P361, DOI 10.2307/2532296; Helgadottir A, 2007, SCIENCE, V316, P1491, DOI 10.1126/science.1142842; Kathiresan S, 2009, NAT GENET, V41, P56, DOI 10.1038/ng.291; Li Y, 2007, CIRC-CARDIOVASC GENE, V4, P565; Liu X, 2009, ATHEROSCLEROSIS, V206, P199, DOI 10.1016/j.atherosclerosis.2009.02.004; Lu XF, 2012, NAT GENET, V44, P890, DOI 10.1038/ng.2337; Luke MM, 2007, ARTERIOSCL THROM VAS, V27, P2030, DOI 10.1161/ATVBAHA.107.141291; McPherson R, 2007, SCIENCE, V316, P1488, DOI 10.1126/science.1142447; Pare G, 2008, PLOS GENET, V4; Paterson AD, 2009, ARTERIOSCL THROM VAS, V29, P1958, DOI 10.1161/ATVBAHA.109.192971; Peden JF, 2011, NAT GENET, V43, P339, DOI 10.1038/ng.782; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Qi L, 2010, HUM MOL GENET, V19, P1856, DOI 10.1093/hmg/ddq057; Samani NJ, 2007, NEW ENGL J MED, V357, P443, DOI 10.1056/NEJMoa072366; Schunkert H, 2011, NAT GENET, V43, P333, DOI [10.1038/ng.784, 10.1161/CIRCGENETICS.111.960443]; Shiffman D, 2008, ARTERIOSCL THROM VAS, V28, P173, DOI 10.1161/ATVBAHA.107.153981; Wang F, 2011, NAT GENET, V43, P345, DOI 10.1038/ng.783; Yusuf S, 2001, CIRCULATION, V104, P2746, DOI 10.1161/hc4601.099487; Yusuf S, 2004, LANCET, V364, P937, DOI 10.1016/S0140-6736(04)17018-9	24	24	27	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2014	9	1							e86332	10.1371/journal.pone.0086332	http://dx.doi.org/10.1371/journal.pone.0086332			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301BI	24475106	Green Submitted, Green Published, gold			2022-12-25	WOS:000330507300054
J	Cui, XR; Abduljalil, A; Manor, BD; Peng, CK; Novak, V				Cui, Xingran; Abduljalil, Amir; Manor, Brad D.; Peng, Chung-Kang; Novak, Vera			Multi-Scale Glycemic Variability: A Link to Gray Matter Atrophy and Cognitive Decline in Type 2 Diabetes	PLOS ONE			English	Article							EMPIRICAL MODE DECOMPOSITION; INSULIN-SECRETION; ULTRADIAN OSCILLATIONS; CIRCADIAN RHYTHMICITY; GLUCOSE; VASOREACTIVITY; DEMENTIA	Objective: Type 2 diabetes mellitus (DM) accelerates brain aging and cognitive decline. Complex interactions between hyperglycemia, glycemic variability and brain aging remain unresolved. This study investigated the relationship between glycemic variability at multiple time scales, brain volumes and cognition in type 2 DM. Research Design and Methods: Forty-three older adults with and 26 without type 2 DM completed 72-hour continuous glucose monitoring, cognitive tests and anatomical MRI. We described a new analysis of continuous glucose monitoring, termed Multi-Scale glycemic variability (Multi-Scale GV), to examine glycemic variability at multiple time scales. Specifically, Ensemble Empirical Mode Decomposition was used to identify five unique ultradian glycemic variability cycles (GVC(1-5)) that modulate serum glucose with periods ranging from 0.5-12 hrs. Results: Type 2 DM subjects demonstrated greater variability in GVC(3-5) (period 2.0-12 hrs) than controls (P<0.0001), during the day as well as during the night. Multi-Scale GV was related to conventional markers of glycemic variability (e. g. standard deviation and mean glycemic excursions), but demonstrated greater sensitivity and specificity to conventional markers, and was associated with worse long-term glycemic control (e. g. fasting glucose and HbA1c). Across all subjects, those with greater glycemic variability within higher frequency cycles (GVC(1-3); 0.5-2.0 hrs) had less gray matter within the limbic system and temporo-parietal lobes (e. g. cingulum, insular, hippocampus), and exhibited worse cognitive performance. Specifically within those with type 2 DM, greater glycemic variability in GVC(2-3) was associated with worse learning and memory scores. Greater variability in GVC(5) was associated with longer DM duration and more depression. These relationships were independent of HbA1c and hypoglycemic episodes. Conclusions: Type 2 DM is associated with dysregulation of glycemic variability over multiple scales of time. These time-scale-dependent glycemic fluctuations might contribute to brain atrophy and cognitive outcomes within this vulnerable population.	[Cui, Xingran; Peng, Chung-Kang] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Div Interdisciplinary Med & Biotechnol, Boston, MA 02215 USA; [Abduljalil, Amir] Ohio State Univ, Dept Radiol, Wright Ctr Innovat, Columbus, OH 43210 USA; [Manor, Brad D.] Hebrew SeniorLife, Inst Aging Res, Roslindale, MA USA; [Manor, Brad D.] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Div Gerontol, Boston, MA 02215 USA; [Peng, Chung-Kang] Natl Cent Univ, Ctr Dynam Biomarkers & Translat Med, Chungli 32054, Taiwan; [Novak, Vera] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Div Stroke,Dept Neurol, Boston, MA 02215 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; University System of Ohio; Ohio State University; Harvard University; Hebrew SeniorLife; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; National Central University; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Novak, V (corresponding author), Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Div Stroke,Dept Neurol, Boston, MA 02215 USA.	vnovak@bidmc.harvard.edu	Peng, Chung-Kang/E-1489-2011; Peng, Chung-Kang/N-1308-2019	Peng, Chung-Kang/0000-0003-3666-9833; Peng, Chung-Kang/0000-0003-3666-9833	National Institutes of Health (NIH)-National Institute on Aging (NIA) [1R01-AG-0287601-A2]; National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) [5R21-DK-084463-02]; American Diabetes Association (ADA) [1-06-CR-25]; National Science Council of Taiwan [NSC 100-2911-I-008-001]; Harvard Catalyst [1KL2RR025757-04]; Harvard Clinical and Translational Science Center (NIH) [KL2 RR 025757]; Center for Dynamical Biomarkers and Translational Medicine, National Central University, Taiwan [NSC 101-2911-I-008-001]; China Scholarship Council, China (CSC) [2010695013]; Harvard Catalyst \ The Harvard Clinical and Translational Science Center (National Center for Research Resources) [8UL1TR000170-05]; Harvard Catalyst \ The Harvard Clinical and Translational Science Center (National Center for Advancing Translational Sciences, National Institutes of Health) [8UL1TR000170-05]; Harvard University and its affiliated academic health care centers; Wright Center of Innovation, Dept. of radiology, The Ohio State University; National Central University, Taiwan [NSC 101-2911-I-008-001]; Harvard Clinical and Translational Science Center (National Center for Research Resources) [1KL2RR025757-04]; Harvard Clinical and Translational Science Center (National Center for Advancing Translational Sciences, National Institutes of Health) [8KL2TR000168-05];  [NIDDK-5R21-DK-084463-02];  [NIA-1R01-AG-0287601-A2];  [ADA(1-06-CR-25)]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000170, KL2TR000168] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [KL2RR025757] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R21DK084463] Funding Source: NIH RePORTER	National Institutes of Health (NIH)-National Institute on Aging (NIA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); American Diabetes Association (ADA)(American Diabetes Association); National Science Council of Taiwan(Ministry of Science and Technology, Taiwan); Harvard Catalyst; Harvard Clinical and Translational Science Center (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Center for Dynamical Biomarkers and Translational Medicine, National Central University, Taiwan; China Scholarship Council, China (CSC)(China Scholarship Council); Harvard Catalyst \ The Harvard Clinical and Translational Science Center (National Center for Research Resources); Harvard Catalyst \ The Harvard Clinical and Translational Science Center (National Center for Advancing Translational Sciences, National Institutes of Health); Harvard University and its affiliated academic health care centers; Wright Center of Innovation, Dept. of radiology, The Ohio State University; National Central University, Taiwan; Harvard Clinical and Translational Science Center (National Center for Research Resources)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Harvard Clinical and Translational Science Center (National Center for Advancing Translational Sciences, National Institutes of Health); ; ; ; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was conducted with the support of the National Institutes of Health (NIH)-National Institute on Aging (NIA) (1R01-AG-0287601-A2); National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (5R21-DK-084463-02) American Diabetes Association (ADA)(1-06-CR-25), the National Science Council of Taiwan (NSC 100-2911-I-008-001), a KL2 Medical Research Investigator Training (MeRIT) award (1KL2RR025757-04) from the Harvard Catalyst and the Harvard Clinical and Translational Science Center (NIH Award KL2 RR 025757). This work was also sponsored by the Center for Dynamical Biomarkers and Translational Medicine, National Central University, Taiwan (NSC 101-2911-I-008-001) and by China Scholarship Council, China (CSC, File No. 2010695013). This work was conducted with support from Harvard Catalyst vertical bar The Harvard Clinical and Translational Science Center (National Center for Research Resources and the National Center for Advancing Translational Sciences, National Institutes of Health Award 8UL1TR000170-05 and financial contributions from Harvard University and its affiliated academic health care centers). The content is solely the responsibility of the authors and does not necessarily represent the official views of Harvard Catalyst, Harvard University and its affiliated academic health care centers, or the National Institutes of Health. The authors acknowledge contributions of Clinical Research Center nursing and MRI staff. X. C. received scholarship from China Scholarship Council, China (CSC, File No. 2010695013). A. A. received support from Wright Center of Innovation, Dept. of radiology, The Ohio State University. C. K. P. received support from National Central University, Taiwan (NSC 101-2911-I-008-001). V.N. has received grants from the NIDDK-5R21-DK-084463-02; NIA-1R01-AG-0287601-A2 and ADA(1-06-CR-25), related to this study, and V. N, B. M., received salaries from these grants. B. M. received a KL2 Medical Research Investigator Training (MeRIT) award (1KL2RR025757-04) from The Harvard Clinical and Translational Science Center (National Center for Research Resources and the National Center for Advancing Translational Sciences, National Institutes of Health Award 8KL2TR000168-05). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of manuscript.	Arvanitakis Z, 2006, DIABETES CARE, V29, P560, DOI 10.2337/diacare.29.03.06.dc05-1901; Benton AL, 1976, MULTILINGUAL APHASIA; Bode Bruce, 2004, Diabetes Technol Ther, V6, P105, DOI 10.1089/152091504773731285; Brownlee M, 2005, DIABETES, V54, P1615, DOI 10.2337/diabetes.54.6.1615; Cui XR, 2014, GAIT POSTURE, V39, P495, DOI 10.1016/j.gaitpost.2013.08.036; Cukierman-Yaffe T, 2009, DIABETES CARE, V32, P221, DOI 10.2337/dc08-1153; D'Agostino E, 2004, LECT NOTES COMPUT SC, V3216, P745; Fontbonne A, 2001, DIABETES CARE, V24, P366, DOI 10.2337/diacare.24.2.366; Gyaw T A, 1994, Biomed Sci Instrum, V30, P63; Hajjar I, 2009, AM J HYPERTENS; Hajjar I, 2010, HYPERTENSION, V56, P859, DOI 10.1161/HYPERTENSIONAHA.110.160002; Huang NE, 1998, P ROY SOC A-MATH PHY, V454, P903, DOI 10.1098/rspa.1998.0193; Janson J, 2004, DIABETES, V53, P474, DOI 10.2337/diabetes.53.2.474; Kalsbeek A, 2011, FEBS LETT, V585, P1412, DOI 10.1016/j.febslet.2011.03.021; Kalsbeek A, 2010, TRENDS ENDOCRIN MET, V21, P402, DOI 10.1016/j.tem.2010.02.005; Klonoff DC, 2011, J CLIN ENDOCR METAB, V96, P2968, DOI 10.1210/jc.2010-2756; Kohnert KD, 2011, J ENDOCRINOL METAB, V1, P64, DOI 10.4021/jem21w; KOLOPP M, 1986, CHRONOBIOL INT, V3, P265, DOI 10.3109/07420528609079544; Kreier F, 2007, EXP GERONTOL, V42, P22, DOI 10.1016/j.exger.2006.07.004; Last D, 2007, DIABETES CARE, V30, P1193, DOI 10.2337/dc06-2052; Launer Lenore J, 2005, Curr Diab Rep, V5, P59, DOI 10.1007/s11892-005-0069-1; Lo MT, 2009, PHYS REV E, V79, DOI 10.1103/PhysRevE.79.061924; Lo MT, 2008, EURASIP J ADV SIG PR, DOI 10.1155/2008/785243; Mager DE, 2007, J PHARMACOL EXP THER, V321, P423, DOI 10.1124/jpet.106.113183; Manor B, 2012, DIABETES CARE, V35, P1907, DOI 10.2337/dc11-2463; Maury E, 2010, CIRC RES, V106, P447, DOI 10.1161/CIRCRESAHA.109.208355; Novak V, 2011, DIABETES CARE, V34, P2438, DOI 10.2337/dc11-0969; Novak V, 2009, MAGN RESON IMAGING, V27, P752, DOI 10.1016/j.mri.2009.01.010; Schaefer A, 2003, DIABETES CARE, V26, P168, DOI 10.2337/diacare.26.1.168; Scheen AJ, 1996, DIABETOLOGIA, V39, P564, DOI 10.1007/BF00403303; SERVICE FJ, 1970, DIABETES, V19, P644, DOI 10.2337/diab.19.9.644; ShannahoffKhalsa DS, 1997, AM J PHYSIOL-REG I, V272, pR962, DOI 10.1152/ajpregu.1997.272.3.R962; Shapiro AM, 1999, CLIN NEUROPSYCHOL, V13, P348, DOI 10.1076/clin.13.3.348.1749; Siegelaar SE, 2011, CRIT CARE, V15, DOI 10.1186/cc10440; SIMON C, 1991, DIABETOLOGIA, V34, P435, DOI 10.1007/BF00403183; Simon C, 2002, DIABETES, V51, pS258, DOI 10.2337/diabetes.51.2007.S258; Slotkin J, 2012, NIH TOOLBOX COGNITIO; Strachan MWJ, 2008, BRIT MED J, V336, P6, DOI 10.1136/bmj.39386.664016.BE; Strachan MWJ, 2011, NAT REV ENDOCRINOL, V7, P108, DOI 10.1038/nrendo.2010.228; Strachan MWJ, 2008, BRIT MED BULL, V88, P131, DOI 10.1093/bmb/ldn042; Tiehuis AM, 2008, DIABETOLOGIA, V51, P1321, DOI 10.1007/s00125-008-1041-9; VANCAUTER E, 1991, J CLIN INVEST, V88, P934, DOI 10.1172/JCI115396; VanCauter E, 1997, ENDOCR REV, V18, P716, DOI 10.1210/er.18.5.716; VELDHUIS JD, 1989, AM J PHYSIOL, V257, pE5, DOI 10.1152/ajpendo.1989.257.1.E6; Williamson JD, 2007, AM J CARDIOL, V99, p112I, DOI 10.1016/j.amjcard.2007.03.029; Wu ZH, 2009, ADV DATA SCI ADAPT, V1, P1, DOI 10.1142/S1793536909000047	46	50	51	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2014	9	1							e86284	10.1371/journal.pone.0086284	http://dx.doi.org/10.1371/journal.pone.0086284			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	298QQ	24475100	Green Published, gold			2022-12-25	WOS:000330339800039
J	Gupta, R; Kumar, V; Kushawaha, PK; Tripathi, CP; Joshi, S; Sahasrabuddhe, AA; Mitra, K; Sundar, S; Siddiqi, MI; Dube, A				Gupta, Reema; Kumar, Vikash; Kushawaha, Pramod Kumar; Tripathi, Chandradev Pati; Joshi, Sumit; Sahasrabuddhe, Amogh Anant; Mitra, Kalyan; Sundar, Shyam; Siddiqi, Mohammad Imran; Dube, Anuradha			Characterization of Glycolytic Enzymes - rAldolase and rEnolase of Leishmania donovani, Identified as Th1 Stimulatory Proteins, for Their Immunogenicity and Immunoprophylactic Efficacies against Experimental Visceral Leishmaniasis	PLOS ONE			English	Article							INDIAN KALA-AZAR; INTERFERON-GAMMA PRODUCTION; T-CELL RESPONSES; NITRIC-OXIDE; IFN-GAMMA; FRUCTOSE-1,6-BISPHOSPHATE ALDOLASE; IMMUNE-RESPONSES; CUTANEOUS LEISHMANIASIS; SYSTEMIC CANDIDIASIS; DISEASE PROGRESSION	Th1 immune responses play an important role in controlling Visceral Leishmaniasis (VL) hence, Leishmania proteins stimulating T-cell responses in host, are thought to be good vaccine targets. Search of such antigens eliciting cellular responses in Peripheral blood mononuclear cells (PBMCs) from cured/exposed/Leishmania patients and hamsters led to the identification of two enzymes of glycolytic pathway in the soluble lysate of a clinical isolate of Leishmania donovani Enolase (LdEno) and aldolase (LdAld) as potential Th1 stimulatory proteins. The present study deals with the molecular and immunological characterizations of LdEno and LdAld. The successfully cloned and purified recombinant proteins displayed strong ability to proliferate lymphocytes of cured hamsters' along with significant nitric-oxide production and generation of Th1-type cytokines (IFN-gamma and IL-12) from stimulated PBMCs of cured/endemic VL patients. Assessment of their prophylactic potentials revealed similar to 90% decrease in parasitic burden in rLdEno vaccinated hamsters against Leishmania challenge, strongly supported by an increase in mRNA expression levels of iNOS, IFN-gamma, TNF-alpha and IL-12 transcripts along with extreme down-regulation of TGF-beta, IL-4 and IL-10. However, animals vaccinated with rLdAld showed comparatively lesser prophylactic efficacy (similar to 65%) with inferior immunological response. Further, with a possible implication in vaccine design against VL, identification of potential T-cell epitopes of both the proteins was done using computational approach. Additionally, in-silico 3-D modelling of the proteins was done in order to explore the possibility of exploiting them as potential drug targets. The comparative molecular and immunological characterizations strongly suggest rLdEno as potential vaccine candidate against VL and supports the notion of its being effective T-cell stimulatory protein.	[Gupta, Reema; Kushawaha, Pramod Kumar; Tripathi, Chandradev Pati; Joshi, Sumit; Dube, Anuradha] CSIR Cent Drug Res Inst, Div Parasitol, Lucknow, Uttar Pradesh, India; [Kumar, Vikash; Sahasrabuddhe, Amogh Anant; Siddiqi, Mohammad Imran] CSIR Cent Drug Res Inst, Div Mol & Struct Biol, Lucknow, Uttar Pradesh, India; [Mitra, Kalyan] CSIR Cent Drug Res Inst, Div Elect Microscopy, Lucknow, Uttar Pradesh, India; [Sundar, Shyam] Banaras Hindu Univ, Inst Med Sci, Dept Med, Varanasi 221005, Uttar Pradesh, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Central Drug Research Institute (CDRI); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Central Drug Research Institute (CDRI); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Central Drug Research Institute (CDRI); Banaras Hindu University (BHU)	Dube, A (corresponding author), CSIR Cent Drug Res Inst, Div Parasitol, Lucknow, Uttar Pradesh, India.	anuradha_dube@hotmail.com	TRIPATHI, CHANDRA DEV/S-5617-2019	Dube, Anuradha/0000-0002-5122-400X	Department of Biotechnology, New Delhi; CSIR-CDRI's Supra-institutional network project [SIP-0026]; University Grants Commission, New Delhi, India	Department of Biotechnology, New Delhi(Department of Biotechnology (DBT) India); CSIR-CDRI's Supra-institutional network project; University Grants Commission, New Delhi, India(University Grants Commission, India)	This work was supported by Department of Biotechnology, New Delhi and CSIR-CDRI's Supra-institutional network project (SIP-0026). RG and PKK are the recipients of fellowships from University Grants Commission, New Delhi, India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta D, 2008, MOL BIOCHEM PARASIT, V158, P52, DOI 10.1016/j.molbiopara.2007.11.011; Armijos RX, 2004, VACCINE, V22, P1320, DOI 10.1016/j.vaccine.2003.06.002; ASSREUY J, 1994, EUR J IMMUNOL, V24, P672, DOI 10.1002/eji.1830240328; Avilan L, 2000, MOL BIOCHEM PARASIT, V110, P183, DOI 10.1016/S0166-6851(00)00269-3; Bacellar O, 1996, J INFECT DIS, V173, P1515, DOI 10.1093/infdis/173.6.1515; Basu MK, 2005, CRIT REV MICROBIOL, V31, P145, DOI 10.1080/10408410591005101; Belkaid Y, 2002, J IMMUNOL, V168, P3992, DOI 10.4049/jimmunol.168.8.3992; BERTHIAUME L, 1993, J BIOL CHEM, V268, P10826; Bhowmick S, 2009, INFECT IMMUN, V77, P1514, DOI 10.1128/IAI.01739-07; BOGDAN C, 1991, J EXP MED, V174, P1549, DOI 10.1084/jem.174.6.1549; Bretscher P A, 1997, Behring Inst Mitt, P153; BURNS JM, 1991, J IMMUNOL, V146, P742; Calcagno M, 2002, PARASITOL RES, V88, P972, DOI 10.1007/s00436-002-0688-2; Chen N, 2012, VACCINE, V30, P3478, DOI 10.1016/j.vaccine.2012.02.075; Choi CM, 2001, J INVEST DERM SYMP P, V6, P175, DOI 10.1046/j.0022-202x.2001.00038.x; Chudzik DM, 2000, J MOL BIOL, V300, P697, DOI 10.1006/jmbi.2000.3910; Dalby A, 1999, PROTEIN SCI, V8, P291; de Walque S, 1999, MOL BIOCHEM PARASIT, V103, P279, DOI 10.1016/S0166-6851(99)00140-1; DING AH, 1988, J IMMUNOL, V141, P2407; Dube A, 2005, PARASITOL RES, V96, P216, DOI 10.1007/s00436-005-1339-1; Dube A, 1998, PARASITOLOGY, V116, P219, DOI 10.1017/S0031182097002175; Esgleas M, 2008, MICROBIOL-SGM, V154, P2668, DOI 10.1099/mic.0.2008/017145-0; Esgleas M, 2009, FEMS MICROBIOL LETT, V294, P82, DOI 10.1111/j.1574-6968.2009.01551.x; Eswar N, 2006, CURR PROTOC BIOINFOR, V5; Finco O, 2005, VACCINE, V23, P1178, DOI 10.1016/j.vaccine.2004.07.045; Fragaki K, 2001, VACCINE, V19, P1701, DOI 10.1016/S0264-410X(00)00398-4; Gan W, PARASITOL RES, V106, P873; Garg R, 2006, VACCINE, V24, P2900, DOI 10.1016/j.vaccine.2005.12.053; Garg R, 2005, CLIN EXP IMMUNOL, V140, P149, DOI 10.1111/j.1365-2249.2005.02745.x; Garg R, 2006, INDIAN J MED RES, V123, P439; GHALIB HW, 1993, J CLIN INVEST, V92, P324, DOI 10.1172/JCI116570; GHOSE AC, 1980, CLIN EXP IMMUNOL, V40, P318; GIFAWESEN C, 1989, INFECT IMMUN, V57, P3091, DOI 10.1128/IAI.57.10.3091-3096.1989; Giotto MTD, 2003, J MOL BIOL, V331, P653, DOI 10.1016/S0022-2836(03)00752-6; Gupta G, 2009, J INFECT DIS, V200, P1300, DOI 10.1086/605895; Gupta SK, 2007, PROTEOMICS, V7, P816, DOI 10.1002/pmic.200600725; Harrop R, 1999, PARASITOLOGY, V118, P583, DOI 10.1017/S003118209900431X; HOWARD JG, 1984, PHILOS T R SOC B, V307, P87, DOI 10.1098/rstb.1984.0111; Hu XY, 2006, IMMUNITY, V24, P563, DOI 10.1016/j.immuni.2006.02.014; JAGANNATHAN V, 1956, BIOCHEM J, V63, P94, DOI 10.1042/bj0630094; Jong AY, 2003, J MED MICROBIOL, V52, P615, DOI 10.1099/jmm.0.05060-0; Caceres AJ, 2010, MOL BIOCHEM PARASIT, V169, P50, DOI 10.1016/j.molbiopara.2009.09.001; Kedzierski L, 2006, PARASITOLOGY, V133, pS87, DOI 10.1017/S0031182006001831; Kenney RT, 1998, J INFECT DIS, V177, P815, DOI 10.1086/517817; Khabiri AR, 2007, PARASITOL RES, V100, P629, DOI 10.1007/s00436-006-0301-1; Khabiri AR, 2006, EXP PARASITOL, V112, P184, DOI 10.1016/j.exppara.2005.11.005; Khalil EAG, 2000, LANCET, V356, P1565, DOI 10.1016/S0140-6736(00)03128-7; Kumari S, 2008, VACCINE; Kumari S, 2008, VACCINE, V26, P4813, DOI 10.1016/j.vaccine.2008.06.102; Kushawaha PK, 2011, J IMMUNOL, V187, P6417, DOI 10.4049/jimmunol.1102081; Lehmann J, 2000, J INTERF CYTOK RES, V20, P63, DOI 10.1089/107999000312748; LIEW F Y, 1991, Behring Institute Mitteilungen, P239; LIEW FY, 1991, IMMUNOL LETT, V30, P193, DOI 10.1016/0165-2478(91)90024-5; LIEW FY, 1990, J IMMUNOL, V145, P4306; LIEW FY, 1990, J IMMUNOL, V144, P4794; LIEW FY, 1990, J EXP MED, V172, P1359, DOI 10.1084/jem.172.5.1359; Ling E, 2004, CLIN EXP IMMUNOL, V138, P290, DOI 10.1111/j.1365-2249.2004.02628.x; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MacMicking J, 1997, ANNU REV IMMUNOL, V15, P323, DOI 10.1146/annurev.immunol.15.1.323; Maldonado J, 2006, EXP MOL PATHOL, V80, P289, DOI 10.1016/j.yexmp.2005.06.005; Marques HH, 2008, IMMUNOBIOLOGY, V213, P437, DOI 10.1016/j.imbio.2007.10.002; MARSH JJ, 1992, TRENDS BIOCHEM SCI, V17, P110, DOI 10.1016/0968-0004(92)90247-7; McCarthy JS, 2002, INFECT IMMUN, V70, P851, DOI 10.1128/IAI.70.2.851-858.2002; Melby PC, 1998, INFECT IMMUN, V66, P2135, DOI 10.1128/IAI.66.5.2135-2142.1998; Melby PC, 1998, INFECT IMMUN, V66, P18, DOI 10.1128/IAI.66.1.18-27.1998; Melby PC, 2001, J IMMUNOL, V166, P1912, DOI 10.4049/jimmunol.166.3.1912; Misra A, 2001, VACCINE, V19, P3485, DOI 10.1016/S0264-410X(01)00058-5; Montagnoli C, 2004, MED MYCOL, V42, P319, DOI 10.1080/13693780310001644653; MOSMANN TR, 1989, ANNU REV IMMUNOL, V7, P145, DOI 10.1146/annurev.immunol.7.1.145; Nozaki Y, 1997, INFECT IMMUN, V65, P3644, DOI 10.1128/IAI.65.9.3644-3647.1997; Pal-Bhowmick I, 2007, INFECT IMMUN, V75, P5500, DOI 10.1128/IAI.00551-07; Palm JED, 2003, J INFECT DIS, V187, P1849, DOI 10.1086/375356; Pancholi V, 2001, CELL MOL LIFE SCI, V58, P902, DOI 10.1007/PL00000910; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pitarch A, 2006, MOL CELL PROTEOMICS, V5, P79, DOI 10.1074/mcp.M500243-MCP200; Quinones W, 2007, EXP PARASITOL, V116, P241, DOI 10.1016/j.exppara.2007.01.008; REINER SL, 1994, PARASITOL TODAY, V10, P485, DOI 10.1016/0169-4758(94)90162-7; RODRIGUES V, 1992, PARASITE IMMUNOL, V14, P49, DOI 10.1111/j.1365-3024.1992.tb00005.x; RUSSO DM, 1991, J IMMUNOL, V147, P3575; RUTTER WJ, 1964, FED PROC, V23, P1248; SALIBA E, 1993, T ROY SOC TROP MED H, V87, P633, DOI 10.1016/0035-9203(93)90267-T; Samant M, 2009, J IMMUNOL, V183, P470, DOI 10.4049/jimmunol.0900265; Sato K, 2000, Southeast Asian J Trop Med Public Health, V31 Suppl 1, P79; SCOTT DA, 1987, BIOCHEM PHARMACOL, V36, P2043, DOI 10.1016/0006-2952(87)90508-9; SCOTT P, 1987, ANN INST PASTEUR IMM, V138, P771, DOI 10.1016/S0769-2625(87)80036-3; SEDER RA, 1993, P NATL ACAD SCI USA, V90, P10188, DOI 10.1073/pnas.90.21.10188; Singh N, 2009, J ANTIMICROB CHEMOTH; SRIVASTAVA IK, 1990, J IMMUNOL, V144, P1497; Tripathi P, 2006, CLIN EXP IMMUNOL, V143, P380, DOI 10.1111/j.1365-2249.2005.03000.x; Veiga-Malta I, 2004, CELL MICROBIOL, V6, P79, DOI 10.1046/j.1462-5822.2003.00344.x; Vita R, 2010, NUCLEIC ACIDS RES, V38, pD854, DOI 10.1093/nar/gkp1004; von Stebut E, 2003, J EXP MED, V198, P191, DOI 10.1084/jem.20030159; WARREN HS, 1986, ANNU REV IMMUNOL, V4, P369, DOI 10.1146/annurev.iy.04.040186.002101; Wasunna MK, 2005, AM J TROP MED HYG, V73, P871, DOI 10.4269/ajtmh.2005.73.871; Xin H, 2008, P NATL ACAD SCI USA, V105, P13526, DOI 10.1073/pnas.0803195105	95	34	36	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2014	9	1							e86073	10.1371/journal.pone.0086073	http://dx.doi.org/10.1371/journal.pone.0086073			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	298QQ	24475071	Green Published, Green Submitted, gold			2022-12-25	WOS:000330339800025
J	Hargreaves, KR; Kropinski, AM; Clokie, MRJ				Hargreaves, Katherine R.; Kropinski, Andrew M.; Clokie, Martha R. J.			What Does the Talking? Quorum Sensing Signalling Genes Discovered in a Bacteriophage Genome	PLOS ONE			English	Article							CLOSTRIDIUM-DIFFICILE INFECTION; MOLECULAR CHARACTERIZATION; SEQUENCE; PROPHAGES; STRAINS; VIRULENCE; EPIDEMIOLOGY; EXPRESSION; ARTEMIS; SYSTEM	The transfer of novel genetic material into the genomes of bacterial viruses (phages) has been widely documented in several host-phage systems. Bacterial genes are incorporated into the phage genome and, if retained, subsequently evolve within them. The expression of these phage genes can subvert or bolster bacterial processes, including altering bacterial pathogenicity. The phage phiCDHM1 infects Clostridium difficile, a pathogenic bacterium that causes nosocomial infections and is associated with antibiotic treatment. Genome sequencing and annotation of phiCDHM1 shows that despite being closely related to other C. difficile myoviruses, it has several genes that have not been previously reported in any phage genomes. Notably, these include three homologs of bacterial genes from the accessory gene regulator (agr) quorum sensing (QS) system. These are; a pre-peptide (AgrD) of an autoinducing peptide (AIP), an enzyme which processes the prepeptide (AgrB) and a histidine kinase (AgrC) that detects the AIP to activate a response regulator. Phylogenetic analysis of the phage and C. difficile agr genes revealed that there are three types of agr loci in this species. We propose that the phage genes belonging to a third type, agr3, and have been horizontally transferred from the host. AgrB and AgrC are transcribed during the infection of two different strains. In addition, the phage agrC appears not to be confined to the phiCDHM1 genome as it was detected in genetically distinct C. difficile strains. The discovery of QS gene homologs in a phage genome presents a novel way in which phages could influence their bacterial hosts, or neighbouring bacterial populations. This is the first time that these QS genes have been reported in a phage genome and their distribution both in C. difficile and phage genomes suggests that the agr3 locus undergoes horizontal gene transfer within this species.	[Hargreaves, Katherine R.; Clokie, Martha R. J.] Univ Leicester, Dept Infect Immun & Inflammat, Leicester, Leics, England; [Kropinski, Andrew M.] Publ Hlth Agcy Canada, Lab Foodborne Zoonoses, West Guelph, ON, Canada; [Kropinski, Andrew M.] Univ Guelph, Dept Mol & Cellular Biol, Guelph, ON N1G 2W1, Canada	University of Leicester; Public Health Agency of Canada; University of Guelph	Clokie, MRJ (corresponding author), Univ Leicester, Dept Infect Immun & Inflammat, Leicester, Leics, England.	mrjc1@leicester.ac.uk	Kropinski, Andrew M/H-7130-2016	Kropinski, Andrew M/0000-0002-6871-6799; Hargreaves, Katherine/0000-0002-9441-3601; Clokie, Martha/0000-0002-6069-8936	MRC [G0700855]; Laboratory for Foodborne Zoonoses; Medical Research Council [G0700855] Funding Source: researchfish	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Laboratory for Foodborne Zoonoses; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	MRC New Investigator Award (G0700855) and MRC Centenary Fellowship (University of Leicester) and A-base funding from the Laboratory for Foodborne Zoonoses. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abedon ST, 2005, EVOL BIOINFORM, V1, P97; Abedon ST, 2011, SOIL BIOL, V23, P37, DOI 10.1007/978-3-642-14512-4_2; Adriaenssens EM, 2012, J VIROL, V86, P6369, DOI 10.1128/JVI.00641-12; AlSaif N, 1996, J MED MICROBIOL, V45, P133, DOI 10.1099/00222615-45-2-133; Besemer J, 1999, NUCLEIC ACIDS RES, V27, P3911, DOI 10.1093/nar/27.19.3911; Bouza E, 2012, CLIN MICROBIOL INFEC, V18, P5, DOI 10.1111/1469-0691.12064; Boyer M, 2008, APPL ENVIRON MICROB, V74, P861, DOI 10.1128/AEM.02099-07; Brussow H, 2002, CELL, V108, P13, DOI 10.1016/S0092-8674(01)00637-7; Carter GP, 2005, J MED MICROBIOL, V54, P119, DOI 10.1099/jmm.0.45817-0; Carver T, 2009, BIOINFORMATICS, V25, P119, DOI 10.1093/bioinformatics/btn578; Carver TJ, 2005, BIOINFORMATICS, V21, P3422, DOI 10.1093/bioinformatics/bti553; Cooksley CM, 2010, APPL ENVIRON MICROB, V76, P4448, DOI 10.1128/AEM.03038-09; Dapa T, 2013, J BACTERIOL, V195, P545, DOI 10.1128/JB.01980-12; Deakin LJ, 2012, INFECT IMMUN, V80, P2704, DOI 10.1128/IAI.00147-12; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; Ewing B, 1998, GENOME RES, V8, P175, DOI 10.1101/gr.8.3.175; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Ghosh D, 2009, APPL ENVIRON MICROB, V75, P7142, DOI 10.1128/AEM.00950-09; Goh S, 2007, MICROBIOL-SGM, V153, P676, DOI 10.1099/mic.0.2006/002436-0; Govind R, 2006, J BACTERIOL, V188, P2568, DOI 10.1128/JB.188.7.2568-2577.2006; Govind R, 2009, J VIROL, V83, P12037, DOI 10.1128/JVI.01256-09; Hall IC, 1935, AM J DIS CHILD, V49, P390, DOI 10.1001/archpedi.1935.01970020105010; Hargreaves KR, 2013, APPL ENVIRON MICROB, V79, P6236, DOI 10.1128/AEM.01849-13; Hatfull GF, 2011, CURR OPIN VIROL, V1, P298, DOI 10.1016/j.coviro.2011.06.009; Hendrix RW, 1999, P NATL ACAD SCI USA, V96, P2192, DOI 10.1073/pnas.96.5.2192; Horgan M, 2010, GENE, V462, P34, DOI 10.1016/j.gene.2010.04.010; Hoyland-Kroghsbo NM, 2013, MBIO, V4, DOI 10.1128/mBio.00362-12; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275, DOI 10.1093/bioinformatics/8.3.275; Kraemer JA, 2012, CELL, V149, P1488, DOI 10.1016/j.cell.2012.04.034; Kropinski AM, 2000, J BACTERIOL, V182, P6066, DOI 10.1128/JB.182.21.6066-6074.2000; Lan SF, 2009, APPL ENVIRON MICROB, V75, P2659, DOI 10.1128/AEM.02483-08; Lavigne R, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-224; Leblanc C, 2009, ENV MICROBIOL REP, V1, P499, DOI 10.1111/j.1758-2229.2009.00055.x; Lee ASY, 2005, BIOCHEM BIOPH RES CO, V335, P659, DOI 10.1016/j.bbrc.2005.07.131; Mann NH, 2003, NATURE, V424, P741, DOI 10.1038/424741a; Marchler-Bauer A, 2011, NUCLEIC ACIDS RES, V39, pD225, DOI 10.1093/nar/gkq1189; Martin MJ, 2013, J BACTERIOL, V195, P3672, DOI 10.1128/JB.00473-13; Mayer MJ, 2008, J BACTERIOL, V190, P6734, DOI 10.1128/JB.00686-08; Mayer MJ, 2010, APPL ENVIRON MICROB, V76, P5415, DOI 10.1128/AEM.00989-10; Meessen-Pinard M, 2012, APPL ENVIRON MICROB, V78, P7662, DOI 10.1128/AEM.02275-12; Miller ES, 2003, MICROBIOL MOL BIOL R, V67, P86, DOI 10.1128/MMBR.67.1.86-156.2003; Miller MB, 2001, ANNU REV MICROBIOL, V55, P165, DOI 10.1146/annurev.micro.55.1.165; Miller MA, 2010, VET RES, V41, DOI 10.1051/vetres/2009049; NAGY E, 1991, APMIS, V99, P321, DOI 10.1111/j.1699-0463.1991.tb05156.x; Norman KN, 2009, ANAEROBE, V15, P256, DOI 10.1016/j.anaerobe.2009.09.006; Novick RP, 2008, ANNU REV GENET, V42, P541, DOI 10.1146/annurev.genet.42.110807.091640; OBRIEN AD, 1984, SCIENCE, V226, P694, DOI 10.1126/science.6387911; Paul JH, 2008, ISME J, V2, P579, DOI 10.1038/ismej.2008.35; Pedulla ML, 2003, CELL, V113, P171, DOI 10.1016/S0092-8674(03)00233-2; Rinttila T, 2004, J APPL MICROBIOL, V97, P1166, DOI 10.1111/j.1365-2672.2004.02409.x; Rozen S, 2000, Methods Mol Biol, V132, P365; Rupnik M, 2009, NAT REV MICROBIOL, V7, P526, DOI 10.1038/nrmicro2164; Rutherford K, 2000, BIOINFORMATICS, V16, P944, DOI 10.1093/bioinformatics/16.10.944; Schattner P, 2005, NUCLEIC ACIDS RES, V33, pW686, DOI 10.1093/nar/gki366; Sebaihia M, 2006, NAT GENET, V38, P779, DOI 10.1038/ng1830; Sekulovic O, 2011, J BACTERIOL, V193, P2726, DOI 10.1128/JB.00787-10; Shan JY, 2012, APPL ENVIRON MICROB, V78, P6027, DOI 10.1128/AEM.01311-12; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Stabler RA, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-9-r102; Sullivan MB, 2006, PLOS BIOL, V4, P1344, DOI 10.1371/journal.pbio.0040234; Sullivan MJ, 2011, BIOINFORMATICS, V27, P1009, DOI 10.1093/bioinformatics/btr039; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Toh H, 2006, GENOME RES, V16, P149, DOI 10.1101/gr.4106106; Waldor MK, 1996, SCIENCE, V272, P1910, DOI 10.1126/science.272.5270.1910; Wilcox MH, 2012, CLIN INFECT DIS, V55, P1056, DOI 10.1093/cid/cis614; Wuster A, 2008, J BACTERIOL, V190, P743, DOI 10.1128/JB.01135-07	66	71	77	3	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2014	9	1							e85131	10.1371/journal.pone.0085131	http://dx.doi.org/10.1371/journal.pone.0085131			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	298QQ	24475037	Green Published, Green Submitted, gold			2022-12-25	WOS:000330339800009
J	Powell, A; Smith, DJ; Hepburn, LJ; Jones, T; Berman, J; Jompa, J; Bell, JJ				Powell, Abigail; Smith, David J.; Hepburn, Leanne J.; Jones, Timothy; Berman, Jade; Jompa, Jamaluddin; Bell, James J.			Reduced Diversity and High Sponge Abundance on a Sedimented Indo-Pacific Reef System: Implications for Future Changes in Environmental Quality	PLOS ONE			English	Article							CORAL-REEF; ECOLOGICAL INTERACTIONS; MODEL SELECTION; CARIBBEAN REEFS; CLIMATE-CHANGE; PATTERNS; FISHES; BIODIVERSITY; ASSEMBLAGES; POPULATIONS	Although coral reef health across the globe is declining as a result of anthropogenic impacts, relatively little is known of how environmental variability influences reef organisms other than corals and fish. Sponges are an important component of coral reef fauna that perform many important functional roles and changes in their abundance and diversity as a result of environmental change has the potential to affect overall reef ecosystem functioning. In this study, we examined patterns of sponge biodiversity and abundance across a range of environments to assess the potential key drivers of differences in benthic community structure. We found that sponge assemblages were significantly different across the study sites, but were dominated by one species Lamellodysidea herbacea (42% of all sponges patches recorded) and that the differential rate of sediment deposition was the most important variable driving differences in abundance patterns. Lamellodysidea herbacea abundance was positively associated with sedimentation rates, while total sponge abundance excluding Lamellodysidea herbacea was negatively associated with rates of sedimentation. Overall variation in sponge assemblage composition was correlated with a number of variables although each variable explained only a small amount of the overall variation. Although sponge abundance remained similar across environments, diversity was negatively affected by sedimentation, with the most sedimented sites being dominated by a single sponge species. Our study shows how some sponge species are able to tolerate high levels of sediment and that any transition of coral reefs to more sedimented states may result in a shift to a low diversity sponge dominated system, which is likely to have subsequent effects on ecosystem functioning.	[Powell, Abigail; Jones, Timothy; Berman, Jade; Bell, James J.] Victoria Univ Wellington, Sch Biol Sci, Wellington, New Zealand; [Smith, David J.; Hepburn, Leanne J.] Univ Essex, Coral Reef Res Unit, Colchester CO4 3SQ, Essex, England; [Jompa, Jamaluddin] Hasanuddin Univ, Res & Dev Ctr Marine Coastal & Small Isl, Makassar, Indonesia	Victoria University Wellington; University of Essex; Universitas Hasanuddin	Powell, A (corresponding author), Victoria Univ Wellington, Sch Biol Sci, Wellington, New Zealand.	abi.powell@gmail.com	Jompa, Jamaluddin/AAD-9280-2021	Jompa, Jamaluddin/0000-0001-9740-333X; Smith, David/0000-0003-1886-8193; Bell, James/0000-0001-9996-945X; Hepburn, Leanne/0000-0002-5109-7127	Commonwealth Scholarship; Operation Wallacea	Commonwealth Scholarship; Operation Wallacea	Abigail Powell was supported by a Commonwealth Scholarship for postgraduate study (http://www.csfp-online.org/). Operation Wallacea provided financial assistance for travel and fieldwork related costs (http://opwall.com/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aerts LAM, 1998, MAR ECOL PROG SER, V175, P241, DOI 10.3354/meps175241; Aerts LAM, 2000, MAR ECOL-P S Z N I, V21, P191, DOI 10.1046/j.1439-0485.2000.00685.x; Aerts LAM, 1997, MAR ECOL PROG SER, V148, P125, DOI 10.3354/meps148125; Anderson M.J., 2008, PERMANOVA PRIMER GUI; Aronson RB, 2002, MAR BIOL, V141, P435, DOI 10.1007/s00227-002-0842-5; Bannister RJ, 2007, MAR FRESHWATER RES, V58, P624, DOI 10.1071/MF07011; Bannister RJ, 2012, CONT SHELF RES, V32, P86, DOI 10.1016/j.csr.2011.10.018; Bell JJ, 2008, MAR BIOL, V155, P563, DOI 10.1007/s00227-008-1036-6; Bell JJ, 2008, ESTUAR COAST SHELF S, V79, P341, DOI 10.1016/j.ecss.2008.05.002; Bell JJ, 2007, MAR ECOL PROG SER, V339, P73, DOI 10.3354/meps339073; Bell JJ, 2013, GLOBAL CHANGE BIOL, V19, P2613, DOI 10.1111/gcb.12212; Bell James J., 2000, Diversity and Distributions, V6, P283, DOI 10.1046/j.1472-4642.2000.00091.x; Bell JJ, 2004, J MAR BIOL ASSOC UK, V84, P581, DOI 10.1017/S0025315404009580h; Bell JJ, 2003, BIOL BULL-US, V205, P144, DOI 10.2307/1543235; Berman J., 2012, THESIS VICTORIA U WE; Bruno JF, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000711; Burke L., 2011, REEFS RISK REVISITED; Carballo JL, 2006, ECOSCIENCE, V13, P119, DOI 10.2980/1195-6860(2006)13[119:EONSOT]2.0.CO;2; Carballo JL, 2007, ECOSCIENCE, V14, P92, DOI 10.2980/1195-6860(2007)14[92:ACOSAP]2.0.CO;2; Clarke KR, 2006, MAR ECOL PROG SER, V320, P11, DOI 10.3354/meps320011; Cleary DFR, 2007, J MAR BIOL ASSOC UK, V87, P1669, DOI 10.1017/S0025315407052770; Clifton J, 2010, ENVIRON SCI ENG TECH, P1; Crabbe MJC, 2005, CORAL REEFS, V24, P437, DOI 10.1007/s00338-005-0004-6; Cullen LC, 2010, ENVIRON SCI ENG TECH, P171; Curtis-Quick J, 2013, THESIS U ESSEX; de Voogd NJ, 2009, MAR ECOL PROG SER, V396, P169, DOI 10.3354/meps08349; Disalvo Louis H., 2007, Atoll Research Bulletin, V545-555, P1; Dunlap M, 1998, MAR ECOL-P S Z N I, V19, P325, DOI 10.1111/j.1439-0485.1998.tb00471.x; Dunlap M, 1996, MAR BIOL, V126, P117, DOI 10.1007/BF00571383; Eagle JV, 2004, J ZOOL, V264, P33, DOI 10.1017/S0952836904005473; Edinger EN, 1998, MAR POLLUT BULL, V36, P617, DOI 10.1016/S0025-326X(98)00047-2; English S., 1997, SURVEY MANUAL TROPIC; Exton DA, 2010, ENVIRON SCI ENG TECH, P193; Gardner TA, 2003, SCIENCE, V301, P958, DOI 10.1126/science.1086050; GERRODETTE T, 1979, MAR BIOL, V55, P103, DOI 10.1007/BF00397305; Ginn BK, 2000, ESTUAR COAST SHELF S, V50, P403, DOI 10.1006/ecss.1999.0563; HIATT RW, 1960, ECOL MONOGR, V30, P66; HOBSON ES, 1974, FISH B-NOAA, V72, P915; Hodgson G., 1988, OCCASIONAL PAPERS E, V7, P1; Hoegh-Guldberg O, 2007, SCIENCE, V318, P1737, DOI 10.1126/science.1152509; Hughes TP, 2010, TRENDS ECOL EVOL, V25, P633, DOI 10.1016/j.tree.2010.07.011; Ilan M, 1995, BIOL BULL, V189, P363, DOI 10.2307/1542154; Johnson JB, 2004, TRENDS ECOL EVOL, V19, P101, DOI 10.1016/j.tree.2003.10.013; Kavanagh KD, 2006, ENVIRON BIOL FISH, V76, P387, DOI 10.1007/s10641-006-9044-1; Knapp ISS, 2013, MAR POLLUT BULL, V66, P209, DOI 10.1016/j.marpolbul.2012.08.017; Kohler KE, 2006, COMPUT GEOSCI-UK, V32, P1259, DOI 10.1016/j.cageo.2005.11.009; Kowalke J, 2000, J EXP MAR BIOL ECOL, V247, P85, DOI 10.1016/S0022-0981(00)00141-6; Lesser MP, 2006, J EXP MAR BIOL ECOL, V328, P277, DOI 10.1016/j.jembe.2005.07.010; Maldonado M, 1999, MAR ECOL PROG SER, V185, P239, DOI 10.3354/meps185239; Maldonado M, 2008, MAR BIOL, V154, P631, DOI 10.1007/s00227-008-0956-5; McMellor S, 2007, THESIS U ESSEX; McMellor S, 2010, ENVIRON SCI ENG TECH, P11; McMurray SE, 2010, ECOLOGY, V91, P560, DOI 10.1890/08-2060.1; Nagelkerken I, 2009, J FISH BIOL, V75, P1123, DOI 10.1111/j.1095-8649.2009.02303.x; Norstrom AV, 2009, MAR ECOL PROG SER, V376, P295, DOI 10.3354/meps07815; Pawlik JR, 2011, BIOSCIENCE, V61, P888, DOI 10.1525/bio.2011.61.11.8; Pawlik JR, 1998, LIMNOL OCEANOGR, V43, P1396, DOI 10.4319/lo.1998.43.6.1396; Powell Abigail L., 2010, Open Marine Biology Journal, V4, P31; Przeslawski R, 2008, GLOBAL CHANGE BIOL, V14, P2773, DOI 10.1111/j.1365-2486.2008.01693.x; *R DEV COR TEAM, 2013, R LANG ENV STAT COMP; Roberts CM, 2002, SCIENCE, V295, P1280, DOI 10.1126/science.1067728; Roberts DE, 2006, MAR ECOL PROG SER, V321, P19, DOI 10.3354/meps321019; Roberts DE, 2006, MAR ECOL PROG SER, V307, P143, DOI 10.3354/meps307143; Salinas-de-Leon P, 2013, MAR BIOL, V160, P97, DOI 10.1007/s00227-012-2066-7; Schils T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046639; Schubauer JP, 1985, NEW PERSPECTIVES SPO, P443; Suchanek T.H., 1983, Symposia Series for Undersea Research, V1, P55; Symonds MRE, 2011, BEHAV ECOL SOCIOBIOL, V65, P13, DOI 10.1007/s00265-010-1037-6; Verberk WCEP, 2010, J ANIM ECOL, V79, P589, DOI 10.1111/j.1365-2656.2010.01660.x; Webster NS, 2012, ENVIRON MICROBIOL, V14, P335, DOI 10.1111/j.1462-2920.2011.02460.x; WILKINSON CR, 1989, CORAL REEFS, V8, P127, DOI 10.1007/BF00338268; Williams EH, 1999, GLOBAL CHANGE BIOL, V5, P839, DOI 10.1046/j.1365-2486.1999.00272.x; Wulff J, 2001, B MAR SCI, V69, P831; Wulff J.L., 2000, ATOLL RES B, V477, P251, DOI DOI 10.5479/SI.00775630.477; Wulff J, 2012, ADV MAR BIOL, V61, P273, DOI 10.1016/B978-0-12-387787-1.00003-9; Wulff JL, 2006, CAN J ZOOL, V84, P146, DOI 10.1139/Z06-019; Wulff JL, 2005, J ANIM ECOL, V74, P313, DOI 10.1111/j.1365-2656.2005.00925.x	77	42	43	0	67	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2014	9	1							e85253	10.1371/journal.pone.0085253	http://dx.doi.org/10.1371/journal.pone.0085253			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	298QQ	24475041	Green Published, Green Submitted, gold, Green Accepted			2022-12-25	WOS:000330339800011
J	Prior, C; Perez-Gracia, JL; Garcia-Donas, J; Rodriguez-Antona, C; Guruceaga, E; Esteban, E; Suarez, C; Castellano, D; del Alba, AG; Lozano, MD; Carles, J; Climent, MA; Arranz, JA; Gallardo, E; Puente, J; Bellmunt, J; Gurpide, A; Lopez-Picazo, JM; Hernandez, AG; Mellado, B; Martinez, E; Moreno, F; Font, A; Calvo, A				Prior, Celia; Luis Perez-Gracia, Jose; Garcia-Donas, Jesus; Rodriguez-Antona, Cristina; Guruceaga, Elizabeth; Esteban, Emilio; Suarez, Cristina; Castellano, Daniel; Gonzalez del Alba, Aranzazu; Dolores Lozano, Maria; Carles, Joan; Angel Climent, Miguel; Angel Arranz, Jose; Gallardo, Enrique; Puente, Javier; Bellmunt, Joaquim; Gurpide, Alfonso; Maria Lopez-Picazo, Jose; Gonzalez Hernandez, Alvaro; Mellado, Begona; Martinez, Esther; Moreno, Fernando; Font, Albert; Calvo, Alfonso			Identification of Tissue microRNAs Predictive of Sunitinib Activity in Patients with Metastatic Renal Cell Carcinoma	PLOS ONE			English	Article							1ST-LINE SUNITINIB; CANCER-PATIENTS; EXPRESSION; MATRIX-METALLOPROTEINASE-9; SURVIVAL; TARGETS; ASSOCIATIONS; PROGRESSION; INTERFERON; SELECTION	Purpose: To identify tissue microRNAs predictive of sunitinib activity in patients with metastatic renal-cell-carcinoma (MRCC) and to evaluate in vitro their mechanism of action in sunitinib resistance. Methods: We screened 673 microRNAs using TaqMan Low-density-Arrays (TLDAs) in tumors from MRCC patients with extreme phenotypes of marked efficacy and resistance to sunitinib, selected from an identification cohort (n = 41). The most relevant differentially expressed microRNAs were selected using bioinformatics-based target prediction analysis and quantified by qRT-PCR in tumors from patients presenting similar phenotypes selected from an independent cohort (n = 101). In vitro experiments were conducted to study the role of miR-942 in sunitinib resistance. Results: TLDAs identified 64 microRNAs differentially expressed in the identification cohort. Seven candidates were quantified by qRT-PCR in the independent series. MiR-942 was the most accurate predictor of sunitinib efficacy (p = 0.0074). High expression of miR-942, miR-628-5p, miR-133a, and miR-484 was significantly associated with decreased time to progression and overall survival. These microRNAs were also overexpressed in the sunitinib resistant cell line Caki-2 in comparison with the sensitive cell line. MiR-942 overexpression in Caki-2 up-regulates MMP-9 and VEGF secretion which, in turn, promote HBMEC endothelial migration and sunitinib resistance. Conclusions: We identified differentially expressed microRNAs in MRCC patients presenting marked sensitivity or resistance to sunitinib. MiR-942 was the best predictor of efficacy. We describe a novel paracrine mechanism through which high miR-942 levels in MRCC cells up-regulates MMP-9 and VEGF secretion to enhance endothelial migration and sunitinib resistance. Our results support further validation of these miRNA in clinical confirmatory studies.	[Prior, Celia; Calvo, Alfonso] Univ Navarra, CIMA, Div Oncol, E-31080 Pamplona, Spain; [Luis Perez-Gracia, Jose; Gurpide, Alfonso; Maria Lopez-Picazo, Jose] Univ Navarra Clin, Dept Oncol, Pamplona, Spain; [Garcia-Donas, Jesus] Fdn Hosp Alcorcon, Madrid, Spain; [Rodriguez-Antona, Cristina] CNIO, Human Canc Genet Programme, Madrid, Spain; [Guruceaga, Elizabeth] Univ Navarra, CIMA, Prote Genom & Bioinformat Unit, E-31080 Pamplona, Spain; [Esteban, Emilio] Hosp Univ Cent Asturias, Dept Med Oncol, Oviedo, Spain; [Suarez, Cristina; Carles, Joan] Hosp Univ Vall de Hebron, Dept Med Oncol, Barcelona, Spain; [Castellano, Daniel] Hosp Univ 12 Octubre, Dept Med Oncol, Madrid, Spain; [Gonzalez del Alba, Aranzazu] Hosp Univ Son Espases, Dept Med Oncol, Palma De Mallorca, Spain; [Dolores Lozano, Maria] Univ Navarra, Univ Navarra Clin, Dept Pathol, E-31080 Pamplona, Spain; [Angel Climent, Miguel] Inst Valenciano Oncol, Dept Med Oncol, Valencia, Spain; [Angel Arranz, Jose] Hosp Univ Gregorio Maranon, Dept Med Oncol, Madrid, Spain; [Gallardo, Enrique] Parc Tauli Sabadell Hosp Univ, Dept Med Oncol, Sabadell, Spain; [Puente, Javier; Moreno, Fernando] Hosp Clin Univ San Carlos, Dept Med Oncol, Madrid, Spain; [Bellmunt, Joaquim] Univ Hosp del Mar, Dept Med Oncol, Barcelona, Spain; [Gonzalez Hernandez, Alvaro] Univ Navarra Clin, Dept Biochem, Pamplona, Spain; [Mellado, Begona] Hosp Clin Barcelona, Dept Med Oncol, IDIBAPS, Barcelona, Spain; [Martinez, Esther] Hosp Jaen, Dept Med Oncol, Jaen, Spain; [Font, Albert] Hosp Badalona Germans Trias & Pujol, Inst Catala Oncol, Med Oncol Serv, Badalona, Spain	University of Navarra; University of Navarra; Alcorcon Foundation University Hospital; Centro Nacional de Investigaciones Oncologicas (CNIO); University of Navarra; Central University Hospital Asturias; Hospital Universitari Vall d'Hebron; Hospital Universitario 12 de Octubre; Hospital Universitari Son Espases; University of Navarra; Instituto Valenciano De Oncologia; General University Gregorio Maranon Hospital; Autonomous University of Barcelona; Parc Tauli Hospital Universitari; Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar; University of Navarra; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; Catalan Institute of Oncology; Hospital Germans Trias i Pujol	Perez-Gracia, JL (corresponding author), Univ Navarra Clin, Dept Oncol, Pamplona, Spain.	jlgracia@unav.es	Lopez-Picazo, Jose Maria/J-2829-2017; Calvo, Alfonso/V-7945-2017; Bellmunt, Joaquim/B-8151-2019; Esteban, Emilio/AAB-2188-2019; Lozano, Maria D/ABD-9613-2020; Perez-Gracia, Jose Luis/I-8372-2017; Rodriguez-Antona, Cristina/E-1073-2011; Guruceaga, Elizabeth/B-1796-2008	Lopez-Picazo, Jose Maria/0000-0002-8814-3000; Calvo, Alfonso/0000-0003-4074-4242; Bellmunt, Joaquim/0000-0003-2328-3421; Esteban, Emilio/0000-0002-2980-5254; Lozano, Maria D/0000-0002-6796-9380; Perez-Gracia, Jose Luis/0000-0003-4941-9075; Rodriguez-Antona, Cristina/0000-0001-8750-7338; Guruceaga, Elizabeth/0000-0003-0547-681X; Prior, Celia/0000-0001-5590-702X; Gallardo, Enrique/0000-0002-1375-3488; Carles, Joan/0000-0002-9983-5934; Garcia-Donas, Jesus/0000-0001-7731-3601; PUENTE, JAVIER/0000-0002-6910-1331				Bellmunt J, 2011, ANN ONCOL, V22, P2646, DOI 10.1093/annonc/mdr023; Bergers G, 2000, NAT CELL BIOL, V2, P737, DOI 10.1038/35036374; Betel D, 2008, NUCLEIC ACIDS RES, V36, pD149, DOI 10.1093/nar/gkm995; Bolstad B, 2005, BIOINFORMATICS COMPU; Catena R, 2011, CANCER RES, V71, P164, DOI 10.1158/0008-5472.CAN-10-1708; D'Andrea AD, 2003, NAT REV CANCER, V3, P23, DOI 10.1038/nrc970; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Gamez-Pozo A, 2012, NEOPLASIA, V14, P1144, DOI 10.1593/neo.12734; Garcia-Donas J, 2011, LANCET ONCOL, V12, P1143, DOI 10.1016/S1470-2045(11)70266-2; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Heinzelmann J, 2011, WORLD J UROL, V29, P367, DOI 10.1007/s00345-010-0633-4; Ingle JN, 2010, J CLIN ONCOL, V28, P4674, DOI 10.1200/JCO.2010.28.5064; Jadhav U, 2004, INT J ONCOL, V25, P1407; Ji JF, 2009, NEW ENGL J MED, V361, P1437, DOI 10.1056/NEJMoa0901282; Kertesz M, 2007, NAT GENET, V39, P1278, DOI 10.1038/ng2135; Kong YW, 2012, LANCET ONCOL, V13, pE249, DOI 10.1016/S1470-2045(12)70073-6; Lall S, 2006, CURR BIOL, V16, P460, DOI 10.1016/j.cub.2006.01.050; Leskela S, 2011, ENDOCR-RELAT CANCER, V18, P85, DOI 10.1677/ERC-10-0148; Lin J, 2010, CARCINOGENESIS, V31, P1805, DOI 10.1093/carcin/bgq168; Perez-Gracia JL, 2010, CLIN TRANSL ONCOL, V12, P174, DOI 10.1007/s12094-010-0487-7; McCawley LJ, 2001, CURR BIOL, V11, pR25, DOI 10.1016/S0960-9822(00)00038-5; Meng AX, 2005, RADIOTHER ONCOL, V76, P168, DOI 10.1016/j.radonc.2005.06.025; Moro L, 2008, CANCER SCI, V99, P553, DOI 10.1111/j.1349-7006.2007.00719.x; Motzer RJ, 2007, NEW ENGL J MED, V356, P115, DOI 10.1056/NEJMoa065044; Nebert DW, 2000, EUR J PHARMACOL, V410, P107, DOI 10.1016/S0014-2999(00)00809-8; Perez-Gracia JL, 2009, BRIT J CANCER, V101, P1876, DOI 10.1038/sj.bjc.6605409; Perez-Gracia JL, 2002, CANCER-AM CANCER SOC, V95, P1605, DOI 10.1002/cncr.10877; Powers MP, 2011, DIAGN MOL PATHOL, V20, P63, DOI 10.1097/PDM.0b013e3181efe2a9; Slaby O, 2010, J EXP CLIN CANC RES, V29, DOI 10.1186/1756-9966-29-90; SMYTH GK, 2004, STAT APPL GENET MOL, V3; Spraggs CF, 2011, J CLIN ONCOL, V29, P667, DOI 10.1200/JCO.2010.31.3197; Youssef YM, 2011, EUR UROL, V59, P721, DOI 10.1016/j.eururo.2011.01.004; Zhang G, 2006, PHARMACOGENET GENOM, V16, P401, DOI 10.1097/01.fpc.0000204995.99429.0f; Zhou LA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015224	34	71	77	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2014	9	1							e86263	10.1371/journal.pone.0086263	http://dx.doi.org/10.1371/journal.pone.0086263			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	298QQ	24475095	gold, Green Published, Green Submitted			2022-12-25	WOS:000330339800035
J	Rao, SAM; Srinivasan, S; Patric, IRP; Hegde, AS; Chandramouli, BA; Arimappamagan, A; Santosh, V; Kondaiah, P; Rao, MRS; Somasundaram, K				Rao, Soumya Alige Mahabala; Srinivasan, Sujaya; Patric, Irene Rosita Pia; Hegde, Alangar Sathyaranjandas; Chandramouli, Bangalore Ashwathnarayanara; Arimappamagan, Arivazhagan; Santosh, Vani; Kondaiah, Paturu; Rao, Manchanahalli R. Sathyanarayana; Somasundaram, Kumaravel			A 16-Gene Signature Distinguishes Anaplastic Astrocytoma from Glioblastoma	PLOS ONE			English	Article							POTENTIAL SERUM BIOMARKERS; GENE-EXPRESSION; MALIGNANT GLIOMAS; MOLECULAR SUBTYPES; STRONG PREDICTOR; IN-VIVO; CLASSIFICATION; IDENTIFICATION; PROGRESSION; SURVIVAL	Anaplastic astrocytoma (AA; Grade III) and glioblastoma (GBM; Grade IV) are diffusely infiltrating tumors and are called malignant astrocytomas. The treatment regimen and prognosis are distinctly different between anaplastic astrocytoma and glioblastoma patients. Although histopathology based current grading system is well accepted and largely reproducible, intratumoral histologic variations often lead to difficulties in classification of malignant astrocytoma samples. In order to obtain a more robust molecular classifier, we analysed RT-qPCR expression data of 175 differentially regulated genes across astrocytoma using Prediction Analysis of Microarrays (PAM) and found the most discriminatory 16-gene expression signature for the classification of anaplastic astrocytoma and glioblastoma. The 16-gene signature obtained in the training set was validated in the test set with diagnostic accuracy of 89%. Additionally, validation of the 16-gene signature in multiple independent cohorts revealed that the signature predicted anaplastic astrocytoma and glioblastoma samples with accuracy rates of 99%, 88%, and 92% in TCGA, GSE1993 and GSE4422 datasets, respectively. The protein-protein interaction network and pathway analysis suggested that the 16-genes of the signature identified epithelial-mesenchymal transition (EMT) pathway as the most differentially regulated pathway in glioblastoma compared to anaplastic astrocytoma. In addition to identifying 16 gene classification signature, we also demonstrated that genes involved in epithelial-mesenchymal transition may play an important role in distinguishing glioblastoma from anaplastic astrocytoma.	[Rao, Soumya Alige Mahabala; Srinivasan, Sujaya; Patric, Irene Rosita Pia; Somasundaram, Kumaravel] Indian Inst Sci, Dept Microbiol & Cell Biol Dev & Genet, Bangalore 560012, Karnataka, India; [Kondaiah, Paturu] Indian Inst Sci, Dept Mol Reprod Dev & Genet, Bangalore 560012, Karnataka, India; [Hegde, Alangar Sathyaranjandas] Sri Sathya Sai Inst Higher Med Sci, Bangalore, Karnataka, India; [Chandramouli, Bangalore Ashwathnarayanara; Arimappamagan, Arivazhagan] Natl Inst Mental Hlth & Neurosci, Dept Neurosurg, Bangalore, Karnataka, India; [Santosh, Vani] Natl Inst Mental Hlth & Neurosci, Dept Neuropathol, Bangalore, Karnataka, India; [Rao, Manchanahalli R. Sathyanarayana] Indian Inst Sci, Jawaharlal Nehru Ctr Adv Sci Res, Bangalore 560012, Karnataka, India	Indian Institute of Science (IISC) - Bangalore; Indian Institute of Science (IISC) - Bangalore; National Institute of Mental Health & Neurosciences - India; National Institute of Mental Health & Neurosciences - India; Department of Science & Technology (India); Jawaharlal Nehru Center for Advanced Scientific Research (JNCASR); Indian Institute of Science (IISC) - Bangalore	Somasundaram, K (corresponding author), Indian Inst Sci, Dept Microbiol & Cell Biol Dev & Genet, Bangalore 560012, Karnataka, India.	skumar@mcbl.iisc.ernet.in			Council of Scientific and Industrial Research, Government of India; Department of Biotechnology, Government of India	Council of Scientific and Industrial Research, Government of India(Council of Scientific & Industrial Research (CSIR) - India); Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India)	This study was supported by a grant from Council of Scientific and Industrial Research, Government of India under the New Millennium Indian Technology Leadership Initiative program. Kumaravel Somasundaram thanks Department of Biotechnology, Government of India for financial support. Soumya Alige Mahabala Rao gratefully acknowledges Senior Research Fellowship from Council of Scientific and Industrial Research, Government of India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afra D, 2002, LANCET, V359, P1011; Arivazhagan A, 2012, J NEURO-ONCOL, V107, P289, DOI 10.1007/s11060-011-0758-3; Biglari A, 2004, CANCER GENE THER, V11, P721, DOI 10.1038/sj.cgt.7700783; Bozinov O, 2008, NEUROSURG REV, V31, P83, DOI 10.1007/s10143-007-0107-3; CBTRUS, 2008, CBTRUS STAT REP PRIM; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Coons SW, 1997, CANCER, V79, P1381, DOI 10.1002/(SICI)1097-0142(19970401)79:7<1381::AID-CNCR16>3.0.CO;2-W; Dreyfuss JM, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-71; Dunn GP, 2012, GENE DEV, V26, P756, DOI 10.1101/gad.187922.112; Elmlinger MW, 2001, ENDOCRINOLOGY, V142, P1652, DOI 10.1210/en.142.4.1652; Engel S, 1999, J NEUROIMMUNOL, V99, P13, DOI 10.1016/S0165-5728(99)00062-4; Francescone RA, 2011, J BIOL CHEM, V286, P15332, DOI 10.1074/jbc.M110.212514; Freije WA, 2004, CANCER RES, V64, P6503, DOI 10.1158/0008-5472.CAN-04-0452; Furnari FB, 2007, GENE DEV, V21, P2683, DOI 10.1101/gad.1596707; Genkai N, 2006, ONCOL REP, V15, P1569; Godard S, 2003, CANCER RES, V63, P6613; Hormigo A, 2006, CLIN CANCER RES, V12, P5698, DOI 10.1158/1078-0432.CCR-06-0181; Kahlert UD, 2013, CANCER LETT, V331, P131, DOI 10.1016/j.canlet.2012.12.010; Khazenzon NM, 2003, MOL CANCER THER, V2, P985; Legler JM, 1999, JNCI-J NATL CANCER I, V91, P1382, DOI 10.1093/jnci/91.16.1382; Liang Y, 2005, P NATL ACAD SCI USA, V102, P5814, DOI 10.1073/pnas.0402870102; Louis DN, 2001, AM J PATHOL, V159, P779, DOI 10.1016/S0002-9440(10)61750-6; Mikheeva SA, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-194; Mischel PS, 2003, ONCOGENE, V22, P2361, DOI 10.1038/sj.onc.1206344; Nutt CL, 2003, CANCER RES, V63, P1602; Ohgaki H, 2007, AM J PATHOL, V170, P1445, DOI 10.2353/ajpath.2007.070011; Pelloski CE, 2005, CLIN CANCER RES, V11, P3326, DOI 10.1158/1078-0432.CCR-04-1765; Petalidis LP, 2008, MOL CANCER THER, V7, P1013, DOI 10.1158/1535-7163.MCT-07-0177; Phillips HS, 2006, CANCER CELL, V9, P157, DOI 10.1016/j.ccr.2006.02.019; Prayson RA, 2000, J NEUROL SCI, V175, P33, DOI 10.1016/S0022-510X(00)00274-4; Rao SAM, 2010, MODERN PATHOL, V23, P1404, DOI 10.1038/modpathol.2010.135; Reardon DA, 2006, ONCOLOGIST, V11, P152, DOI 10.1634/theoncologist.11-2-152; Reddy PS, 2008, CANCER BIOL THER, V7, P663, DOI 10.4161/cbt.7.5.5663; Reddy SP, 2008, CLIN CANCER RES, V14, P2978, DOI 10.1158/1078-0432.CCR-07-4821; Ruano Y, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-39; Santosh V, 2010, CANCER EPIDEM BIOMAR, V19, P1399, DOI 10.1158/1055-9965.EPI-09-1213; Shai R, 2003, ONCOGENE, V22, P4918, DOI 10.1038/sj.onc.1206753; Somasundaram K, 2005, ONCOGENE, V24, P7073, DOI 10.1038/sj.onc.1208865; Sreekanthreddy P, 2010, CANCER EPIDEM BIOMAR, V19, P1409, DOI 10.1158/1055-9965.EPI-09-1077; Stander M, 1999, CELL TISSUE RES, V296, P221, DOI 10.1007/s004410051283; Stupp R, 2007, CRIT REV ONCOL HEMAT, V63, P72, DOI 10.1016/j.critrevonc.2007.03.003; Tibshirani R, 2002, P NATL ACAD SCI USA, V99, P6567, DOI 10.1073/pnas.082099299; Tso CL, 2006, CANCER RES, V66, P159, DOI 10.1158/0008-5472.CAN-05-0077; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; van den Boom J, 2003, AM J PATHOL, V163, P1033, DOI 10.1016/S0002-9440(10)63463-3; WALKER MD, 1980, NEW ENGL J MED, V303, P1323, DOI 10.1056/NEJM198012043032303; Wang HM, 2004, LAB INVEST, V84, P941, DOI 10.1038/labinvest.3700123; Wen PY, 2008, NEW ENGL J MED, V359, P492, DOI 10.1056/NEJMra0708126; Yu Y, 2007, CANCER RES, V67, P130, DOI 10.1158/0008-5472.CAN-06-2478	49	14	14	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2014	9	1							e85200	10.1371/journal.pone.0085200	http://dx.doi.org/10.1371/journal.pone.0085200			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	298QQ	24475040	Green Published, Green Accepted, gold			2022-12-25	WOS:000330339800010
J	Smittenaar, P; Prichard, G; FitzGerald, THB; Diedrichsen, J; Dolan, RJ				Smittenaar, Peter; Prichard, George; FitzGerald, Thomas H. B.; Diedrichsen, Joern; Dolan, Raymond J.			Transcranial Direct Current Stimulation of Right Dorsolateral Prefrontal Cortex Does Not Affect Model-Based or Model-Free Reinforcement Learning in Humans	PLOS ONE			English	Article							PRIMARY MOTOR CORTEX; WORKING-MEMORY; MAJOR DEPRESSION; DECISION-MAKING; HUMAN BRAIN; SYSTEMS; FACILITATION; BEHAVIOR; CHOICE; RISK	There is broad consensus that the prefrontal cortex supports goal-directed, model-based decision-making. Consistent with this, we have recently shown that model-based control can be impaired through transcranial magnetic stimulation of right dorsolateral prefrontal cortex in humans. We hypothesized that an enhancement of model-based control might be achieved by anodal transcranial direct current stimulation of the same region. We tested 22 healthy adult human participants in a within-subject, double-blind design in which participants were given Active or Sham stimulation over two sessions. We show Active stimulation had no effect on model-based control or on model-free ('habitual') control compared to Sham stimulation. These null effects are substantiated by a power analysis, which suggests that our study had at least 60% power to detect a true effect, and by a Bayesian model comparison, which favors a model of the data that assumes stimulation had no effect over models that assume stimulation had an effect on behavioral control. Although we cannot entirely exclude more trivial explanations for our null effect, for example related to (faults in) our experimental setup, these data suggest that anodal transcranial direct current stimulation over right dorsolateral prefrontal cortex does not improve model-based control, despite existing evidence that transcranial magnetic stimulation can disrupt such control in the same brain region.	[Smittenaar, Peter; FitzGerald, Thomas H. B.; Dolan, Raymond J.] UCL, Wellcome Trust Ctr Neuroimaging, Inst Neurol, London, England; [Prichard, George; Diedrichsen, Joern] UCL, Inst Cognit Neurosci, London, England	University of London; University College London; University of London; University College London	Smittenaar, P (corresponding author), UCL, Wellcome Trust Ctr Neuroimaging, Inst Neurol, London, England.	petersmittenaar@gmail.com	Diedrichsen, Jörn/AAQ-2242-2020; Diedrichsen, Jörn/A-7789-2010	Diedrichsen, Jörn/0000-0003-0264-8532; Diedrichsen, Jörn/0000-0003-0264-8532; FitzGerald, Thomas/0000-0002-3855-1591; Dolan, Ray/0000-0001-9356-761X	Wellcome Trust [098362/Z/12/Z, 092859/Z/10/Z, 091593/Z/10/Z]; James S. McDonnell Foundation	Wellcome Trust(Wellcome TrustEuropean Commission); James S. McDonnell Foundation	R.J. Dolan is supported by a Wellcome Trust Senior Investigator Award 098362/Z/12/Z. P. Smittenaar is supported by a 4-year Wellcome Trust PhD studentship 092859/Z/10/Z. The Wellcome Trust Centre for Neuroimaging is supported by core funding from the Wellcome Trust 091593/Z/10/Z. J. More information about the Wellcome Trust at http://www.wellcome.ac.uk/. Diedrichsen is supported by a Scholar Award from the James S. McDonnell Foundation. More information about the James S. McDonnell Foundation at http://www.jsmf.org/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe H, 2011, NEURON, V70, P731, DOI 10.1016/j.neuron.2011.03.026; [Anonymous], 2007, LME4 LINEAR MIXED EF; Baker JM, 2010, STROKE, V41, P1229, DOI 10.1161/STROKEAHA.109.576785; Boggio PS, 2008, INT J NEUROPSYCHOPH, V11, P249, DOI 10.1017/S1461145707007833; Boggio PS, 2007, J AFFECT DISORDERS, V101, P91, DOI 10.1016/j.jad.2006.10.026; Boggio PS, 2006, J NEUROL SCI, V249, P31, DOI 10.1016/j.jns.2006.05.062; Button KS, 2013, NAT REV NEUROSCI, V14, P365, DOI 10.1038/nrn3475; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; Daw ND, 2011, NEURON, V69, P1204, DOI 10.1016/j.neuron.2011.02.027; Daw ND, 2005, NAT NEUROSCI, V8, P1704, DOI 10.1038/nn1560; Dayana P, 2008, CURR OPIN NEUROBIOL, V18, P185, DOI 10.1016/j.conb.2008.08.003; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Faul F, 2009, BEHAV RES METHODS, V41, P1149, DOI 10.3758/BRM.41.4.1149; Fecteau S, 2007, J NEUROSCI, V27, P12500, DOI 10.1523/JNEUROSCI.3283-07.2007; Fecteau S, 2007, J NEUROSCI, V27, P6212, DOI 10.1523/JNEUROSCI.0314-07.2007; Fregni F, 2005, EXP BRAIN RES, V166, P23, DOI 10.1007/s00221-005-2334-6; Fregni F, 2005, NEUROREPORT, V16, P1551, DOI 10.1097/01.wnr.0000177010.44602.5e; Glascher J, 2010, NEURON, V66, P585, DOI 10.1016/j.neuron.2010.04.016; Herwig U, 2003, BRAIN TOPOGR, V16, P95, DOI 10.1023/B:BRAT.0000006333.93597.9d; Hojsgaard S, 2012, NEWSLETTER R PROJECT, V6/2, P47; Huys QJM, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002410; Kahneman D., 2011, THINKING FAST SLOW; Kincses TZ, 2004, NEUROPSYCHOLOGIA, V42, P113, DOI 10.1016/S0028-3932(03)00124-6; Lee DY, 2007, ANN NY ACAD SCI, V1104, P108, DOI 10.1196/annals.1390.007; Mars RB, 2009, J NEUROSCI, V29, P6926, DOI 10.1523/JNEUROSCI.1396-09.2009; Marshall L, 2004, J NEUROSCI, V24, P9985, DOI 10.1523/JNEUROSCI.2725-04.2004; Mulquiney PG, 2011, CLIN NEUROPHYSIOL, V122, P2384, DOI 10.1016/j.clinph.2011.05.009; Nitsche MA, 2001, NEUROLOGY, V57, P1899, DOI 10.1212/WNL.57.10.1899; Nitsche MA, 2003, J COGNITIVE NEUROSCI, V15, P619, DOI 10.1162/089892903321662994; Nitsche MA, 2000, J PHYSIOL-LONDON, V527, P633, DOI 10.1111/j.1469-7793.2000.t01-1-00633.x; Nitsche MA, 2008, BRAIN STIMUL, V1, P206, DOI 10.1016/j.brs.2008.06.004; Otto AR, 2013, PSYCHOL SCI, V24, P751, DOI 10.1177/0956797612463080; Penny WD, 2012, NEUROIMAGE, V59, P319, DOI 10.1016/j.neuroimage.2011.07.039; Poldrack RA, 2001, NATURE, V414, P546, DOI 10.1038/35107080; Reis J, 2009, P NATL ACAD SCI USA, V106, P1590, DOI 10.1073/pnas.0805413106; Schulz KF, 2002, LANCET, V359, P696, DOI 10.1016/S0140-6736(02)07816-9; Smittenaar P, 2014, NEURON IN PRESS; Stagg CJ, 2013, J NEUROSCI, V33, P11425, DOI 10.1523/JNEUROSCI.3887-12.2013; Stagg CJ, 2011, NEUROSCIENTIST, V17, P37, DOI 10.1177/1073858410386614; Stephens PA, 2005, J APPL ECOL, V42, P4, DOI 10.1111/j.1365-2664.2005.01002.x; Wagner T, 2007, NEUROIMAGE, V35, P1113, DOI 10.1016/j.neuroimage.2007.01.027; Wunderlich K, 2012, NEURON, V75, P418, DOI 10.1016/j.neuron.2012.03.042; Wunderlich K, 2012, NAT NEUROSCI, V15, P786, DOI 10.1038/nn.3068; Xue G, 2012, P NATL ACAD SCI USA, V109, P4401, DOI 10.1073/pnas.1111927109	44	15	15	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2014	9	1							e86850	10.1371/journal.pone.0086850	http://dx.doi.org/10.1371/journal.pone.0086850			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	298QQ	24475185	Green Submitted, Green Published, gold, Green Accepted			2022-12-25	WOS:000330339800064
J	Hong, S; Song, MR				Hong, Seulgi; Song, Mi-Ryoung			STAT3 but Not STAT1 Is Required for Astrocyte Differentiation	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; DEVELOPING SPINAL-CORD; SIGNALING PATHWAY; CYTOKINE STIMULATION; FETAL-BRAIN; DNA-BINDING; ACTIVATION; GLIOGENESIS; INTERFERON; TRANSCRIPTION	The JAK-STAT signaling pathway has been implicated in astrocyte differentiation. Both STAT1 and STAT3 are expressed in the central nervous system and are thought to be important for glial differentiation, as mainly demonstrated in vitro; however direct in vivo evidence is missing. We investigated whether STAT1 and STAT3 are essential for astrocyte development by testing the STAT responsiveness of astrocyte progenitors. STAT3 was absent in the ventricular zone where glial progenitors are born but begins to appear at the marginal zone at E16.5. At E18.5, both phospho-STAT1 and phospho-STAT3 were present in glial fibrillary acidic protein (GFAP)-expressing white matter astrocytes. Overexpression of STAT3 by electroporation of chicks in ovo induced increased numbers of astrocyte progenitors in the spinal cord. Likewise, elimination of STAT3 in Stat3 conditional knockout (cKO) mice resulted in depletion of white matter astrocytes. Interestingly, elimination of STAT1 in Stat1 null mice did not inhibit astrocyte differentiation and deletion of Stat1 failed to aggravate the glial defects in Stat3 cKO mice. Measuring the activity of STAT binding elements and the gfap promoter in the presence of various STAT mutants revealed that transactivation depended on the activity of STAT3 not STAT1. No synergistic interaction between STAT1 and STAT3 was observed. Cortical progenitors of Stat1 null; Stat3 cKO mice generated astrocytes when STAT3 or the splice variant Stat3 beta was supplied, but not when STAT1 was introduced. Together, our results suggest that STAT3 is necessary and sufficient for astrocyte differentiation whereas STAT1 is dispensable.	[Song, Mi-Ryoung] Gwangju Inst Sci & Technol, Bioimaging Res Ctr, Sch Life Sci, Kwangju, South Korea; Gwangju Inst Sci & Technol, Cell Dynam Res Ctr, Kwangju, South Korea	Gwangju Institute of Science & Technology (GIST); Gwangju Institute of Science & Technology (GIST)	Song, MR (corresponding author), Gwangju Inst Sci & Technol, Bioimaging Res Ctr, Sch Life Sci, Kwangju, South Korea.	msong@gist.ac.kr			NRF (National Research Foundation of Korea) [2011-0029179, 2010-0007109]; Cell Dynamics Research Center, NRF [2009-0070938]	NRF (National Research Foundation of Korea)(National Research Foundation of Korea); Cell Dynamics Research Center, NRF(Ministry of Science & Technology (MOST), Republic of Korea)	Support for MRS and this research were provided by grants from NRF (National Research Foundation of Korea) (2011-0029179; 2010-0007109), the Cell Dynamics Research Center, NRF (2009-0070938). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnabe-Heider F, 2005, NEURON, V48, P253, DOI 10.1016/j.neuron.2005.08.037; Bonni A, 1997, SCIENCE, V278, P477, DOI 10.1126/science.278.5337.477; Bromberg JF, 1999, CELL, V98, P295, DOI 10.1016/S0092-8674(00)81959-5; Bromberg JF, 1999, COLD SPRING HARB SYM, V64, P425, DOI 10.1101/sqb.1999.64.425; Caldenhoven E, 1996, J BIOL CHEM, V271, P13221, DOI 10.1074/jbc.271.22.13221; Collison LW, 2012, NAT IMMUNOL, V13, P290, DOI 10.1038/ni.2227; Deneen B, 2006, NEURON, V52, P953, DOI 10.1016/j.neuron.2006.11.019; Deverman BE, 2009, NEURON, V64, P61, DOI 10.1016/j.neuron.2009.09.002; Dewilde S, 2008, FRONT BIOSCI-LANDMRK, V13, P6501, DOI 10.2741/3170; Haan S, 2005, CELL SIGNAL, V17, P1542, DOI 10.1016/j.cellsig.2005.03.010; He F, 2005, NAT NEUROSCI, V8, P616, DOI 10.1038/nn1440; Hemmann U, 1996, J BIOL CHEM, V271, P12999, DOI 10.1074/jbc.271.22.12999; Herrmann JE, 2008, J NEUROSCI, V28, P7231, DOI 10.1523/JNEUROSCI.1709-08.2008; Ho HH, 2006, J BIOL CHEM, V281, P14111, DOI 10.1074/jbc.M511797200; Johe KK, 1996, GENE DEV, V10, P3129, DOI 10.1101/gad.10.24.3129; Kang K, 2013, J BIOL CHEM, V288, P2580, DOI 10.1074/jbc.M112.398263; Kang K, 2010, BIOCHEM BIOPH RES CO, V395, P324, DOI 10.1016/j.bbrc.2010.03.174; Kinsella TM, 1996, HUM GENE THER, V7, P1405, DOI 10.1089/hum.1996.7.12-1405; Koblar SA, 1998, P NATL ACAD SCI USA, V95, P3178, DOI 10.1073/pnas.95.6.3178; LAI CF, 1995, J BIOL CHEM, V270, P23254, DOI 10.1074/jbc.270.40.23254; Levy DE, 2002, NAT REV MOL CELL BIO, V3, P651, DOI 10.1038/nrm909; Maritano D, 2004, NAT IMMUNOL, V5, P401, DOI 10.1038/ni1052; Meraz MA, 1996, CELL, V84, P431, DOI 10.1016/S0092-8674(00)81288-X; Nakashima K, 1999, J NEUROSCI, V19, P5429; Nakashima K, 1999, SCIENCE, V284, P479, DOI 10.1126/science.284.5413.479; Namihira M, 2009, DEV CELL, V16, P245, DOI 10.1016/j.devcel.2008.12.014; Novak U, 1996, J BIOL CHEM, V271, P18350, DOI 10.1074/jbc.271.31.18350; Rajan P, 1998, J NEUROSCI, V18, P3620; Regis G, 2008, SEMIN CELL DEV BIOL, V19, P351, DOI 10.1016/j.semcdb.2008.06.004; Sanz E, 2008, GLIA, V56, P190, DOI 10.1002/glia.20602; Sato Y, 2007, DEV BIOL, V305, P616, DOI 10.1016/j.ydbio.2007.01.043; Schaefer LK, 1999, BIOCHEM BIOPH RES CO, V266, P481, DOI 10.1006/bbrc.1999.1853; Song MR, 2004, NAT NEUROSCI, V7, P229, DOI 10.1038/nn1192; Sriram K, 2004, J BIOL CHEM, V279, P19936, DOI 10.1074/jbc.M309304200; Stancato LF, 1996, J BIOL CHEM, V271, P4134; Takeda K, 1998, J IMMUNOL, V161, P4652; Takizawa T, 2001, DEV CELL, V1, P749, DOI 10.1016/S1534-5807(01)00101-0; Tanner DC, 2011, J NEUROSCI, V31, P6235, DOI 10.1523/JNEUROSCI.5905-10.2011; Thyrell L, 2007, EXP CELL RES, V313, P4015, DOI 10.1016/j.yexcr.2007.08.007; Yan Y, 2004, DEV DYNAM, V231, P248, DOI 10.1002/dvdy.20126	40	47	50	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2014	9	1							e86851	10.1371/journal.pone.0086851	http://dx.doi.org/10.1371/journal.pone.0086851			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297XI	24466267	Green Published, gold, Green Submitted			2022-12-25	WOS:000330288000157
J	Hu, YL; Hu, LL; Zeng, DH				Hu, Ya-Lin; Hu, Li-Le; Zeng, De-Hui			Dynamics and Sources of Soil Organic C Following Afforestation of Croplands with Poplar in a Semi-Arid Region in Northeast China	PLOS ONE			English	Article							LAND-USE CHANGE; CARBON-SEQUESTRATION; DENSITY FRACTIONS; MATTER; STOCKS; ACCUMULATION; PLANTATIONS; GRASSLAND; AGGREGATE; POOLS	Afforestation of former croplands has been proposed as a promising way to mitigate rising atmospheric CO2 concentration in view of the commitment to the Kyoto Protocol. Central to this C sequestration is the dynamics of soil organic C (SOC) storage and stability with the development of afforested plantations. Our previous study showed that SOC storage was not changed after afforestation except for the 0-10 cm layer in a semi-arid region of Keerqin Sandy Lands, northeast China. In this study, soil organic C was further separated into light and heavy fractions using the density fractionation method, and their organic C concentration and C-13 signature were analyzed to investigate the turnover of old vs. new SOC in the afforested soils. Surface layer (0-10 cm) soil samples were collected from 14 paired plots of poplar (Populus x xiaozhuanica W. Y. Hsu & Liang) plantations with different stand basal areas (the sum of the cross-sectional area of all live trees in a stand), ranging from 0.2 to 32.6 m(2) ha(-1), and reference maize (Zea mays L.) croplands at the same sites as our previous study. Soil Delta(C) stocks (Delta(C) refers to the difference in SOC content between a poplar plantation and the paired cropland) in bulk soil and light fraction were positively correlated with stand basal area (R-2 = 0.48, p < 0.01 and R-2 = 0.40, p = 0.02, respectively), but not for the heavy fraction. SOCcrop (SOC derived from crops) contents in the light and heavy fractions in poplar plantations were significantly lower as compared with SOC contents in croplands, but tree-derived C in bulk soil, light and heavy fraction pools increased gradually with increasing stand basal area after afforestation. Our study indicated that cropland afforestation could sequester new C derived from trees into surface mineral soil, but did not enhance the stability of SOC due to a fast turnover of SOC in this semi-arid region.	[Hu, Ya-Lin; Zeng, De-Hui] Chinese Acad Sci, Inst Appl Ecol, State Key Lab Forest & Soil Ecol, Shenyang 110016, Peoples R China; [Hu, Li-Le] Chinese Res Inst Environm Sci, Beijing, Peoples R China	Chinese Academy of Sciences; Shenyang Institute of Applied Ecology, CAS; Chinese Research Academy of Environmental Sciences	Hu, YL (corresponding author), Chinese Acad Sci, Inst Appl Ecol, State Key Lab Forest & Soil Ecol, Shenyang 110016, Peoples R China.	huyl@iae.ac.cn; zengdh@iae.ac.cn			National Natural Science Foundation of China [31000297]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (No. 31000297) (http://www.nsfc.gov.cn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arai H, 2010, GEODERMA, V157, P243, DOI 10.1016/j.geoderma.2010.04.025; Arevalo CBM, 2011, AGR ECOSYST ENVIRON, V141, P342, DOI 10.1016/j.agee.2011.03.013; Bu XL, 2012, APPL SOIL ECOL, V52, P42, DOI 10.1016/j.apsoil.2011.10.005; Christensen B.T., 1992, ADV SOIL SCI, V20, P1, DOI [10.1007/978-1-4612-2930-8_1, DOI 10.1007/978-1-4612-2930-8_1]; Clark JD, 2012, SOIL SCI SOC AM J, V76, P684, DOI 10.2136/sssaj2010.0425; Del Galdo I, 2003, GLOBAL CHANGE BIOL, V9, P1204, DOI 10.1046/j.1365-2486.2003.00657.x; Dondini M, 2009, GCB BIOENERGY, V1, P321, DOI 10.1111/j.1757-1707.2009.01025.x; Guo LB, 2002, GLOBAL CHANGE BIOL, V8, P345, DOI 10.1046/j.1354-1013.2002.00486.x; Helmisaari HS, 2007, TREE PHYSIOL, V27, P1493, DOI 10.1093/treephys/27.10.1493; Hernandez-Ramirez G, 2011, SOIL SCI SOC AM J, V75, P216, DOI 10.2136/sssaj2010.0114; Hu YL, 2008, J ARID ENVIRON, V72, P2193, DOI 10.1016/j.jaridenv.2008.07.007; Hu YL, 2013, PLANT SOIL, V368, P619, DOI 10.1007/s11104-012-1539-2; Huang ZQ, 2011, SOIL BIOL BIOCHEM, V43, P1341, DOI 10.1016/j.soilbio.2011.03.008; Jackson RB, 2002, NATURE, V418, P623, DOI 10.1038/nature00910; JANZEN HH, 1992, SOIL SCI SOC AM J, V56, P1799, DOI 10.2136/sssaj1992.03615995005600060025x; Jiao SR, 1989, ECOSYSTEM STRUCTURE; John B, 2005, GEODERMA, V128, P63, DOI 10.1016/j.geoderma.2004.12.013; Jug A, 1999, FOREST ECOL MANAG, V121, P85, DOI 10.1016/S0378-1127(98)00558-1; Laganiere J, 2010, GLOBAL CHANGE BIOL, V16, P439, DOI 10.1111/j.1365-2486.2009.01930.x; Laik R, 2009, APPL SOIL ECOL, V42, P71, DOI 10.1016/j.apsoil.2009.02.004; Lal R, 2004, SCIENCE, V304, P1623, DOI 10.1126/science.1097396; Lal R, 2004, ENVIRON MANAGE, V33, P528, DOI 10.1007/s00267-003-9110-9; Li DJ, 2012, NEW PHYTOL, V195, P172, DOI 10.1111/j.1469-8137.2012.04150.x; Li YQ, 2012, APPL SOIL ECOL, V56, P1, DOI 10.1016/j.apsoil.2012.01.007; Litton CM, 2004, ECOL APPL, V14, P460, DOI 10.1890/02-5291; Mao R, 2010, PLANT SOIL, V332, P277, DOI 10.1007/s11104-010-0292-7; Marin-Spiotta E, 2009, GLOBAL CHANGE BIOL, V15, P1584, DOI 10.1111/j.1365-2486.2008.01805.x; Morris SJ, 2007, GLOBAL CHANGE BIOL, V13, P1145, DOI 10.1111/j.1365-2486.2007.01359.x; Nelson D.W., 1996, METHODS SOIL ANAL CH, V5, P961, DOI DOI 10.2136/SSSABOOKSER5.3.C34; NILSSON S, 1995, CLIMATIC CHANGE, V30, P267, DOI 10.1007/BF01091928; Paul KI, 2002, FOREST ECOL MANAG, V168, P241, DOI 10.1016/S0378-1127(01)00740-X; Paul S, 2008, BIOGEOCHEMISTRY, V87, P247, DOI 10.1007/s10533-008-9182-y; Richter DD, 1999, NATURE, V400, P56, DOI 10.1038/21867; Sartori F, 2007, AGR ECOSYST ENVIRON, V122, P325, DOI 10.1016/j.agee.2007.01.026; Shi SW, 2013, FOREST ECOL MANAG, V296, P53, DOI 10.1016/j.foreco.2013.01.026; Sohi SP, 2001, SOIL SCI SOC AM J, V65, P1121, DOI 10.2136/sssaj2001.6541121x; Tan Z, 2007, SOIL TILL RES, V92, P53, DOI 10.1016/j.still.2006.01.003; Tang GY, 2013, FOREST ECOL MANAG, V291, P13, DOI 10.1016/j.foreco.2012.12.001; Unger S, 2010, SOIL BIOL BIOCHEM, V42, P1800, DOI 10.1016/j.soilbio.2010.06.019; Vesterdal L, 2002, FOREST ECOL MANAG, V169, P137, DOI 10.1016/S0378-1127(02)00304-3; von Lutzow M, 2007, SOIL BIOL BIOCHEM, V39, P2183, DOI 10.1016/j.soilbio.2007.03.007; Wei XR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032054; Zhenghu D, 2007, J ARID ENVIRON, V68, P66, DOI 10.1016/j.jaridenv.2006.05.002	43	3	3	3	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2014	9	1							e86640	10.1371/journal.pone.0086640	http://dx.doi.org/10.1371/journal.pone.0086640			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297XI	24466183	Green Published, Green Submitted, gold			2022-12-25	WOS:000330288000126
J	Yamamoto, T; Hayama, Y; Hidano, A; Kobayashi, S; Muroga, N; Ishikawa, K; Ogura, A; Tsutsui, T				Yamamoto, Takehisa; Hayama, Yoko; Hidano, Arata; Kobayashi, Sota; Muroga, Norihiko; Ishikawa, Kiyoyasu; Ogura, Aki; Tsutsui, Toshiyuki			Sampling Strategies in Antimicrobial Resistance Monitoring: Evaluating How Precision and Sensitivity Vary with the Number of Animals Sampled per Farm	PLOS ONE			English	Article							ESCHERICHIA-COLI; SURVEILLANCE	Because antimicrobial resistance in food-producing animals is a major public health concern, many countries have implemented antimicrobial monitoring systems at a national level. When designing a sampling scheme for antimicrobial resistance monitoring, it is necessary to consider both cost effectiveness and statistical plausibility. In this study, we examined how sampling scheme precision and sensitivity can vary with the number of animals sampled from each farm, while keeping the overall sample size constant to avoid additional sampling costs. Five sampling strategies were investigated. These employed 1, 2, 3, 4 or 6 animal samples per farm, with a total of 12 animals sampled in each strategy. A total of 1,500 Escherichia coli isolates from 300 fattening pigs on 30 farms were tested for resistance against 12 antimicrobials. The performance of each sampling strategy was evaluated by bootstrap resampling from the observational data. In the bootstrapping procedure, farms, animals, and isolates were selected randomly with replacement, and a total of 10,000 replications were conducted. For each antimicrobial, we observed that the standard deviation and 2.5-97.5 percentile interval of resistance prevalence were smallest in the sampling strategy that employed 1 animal per farm. The proportion of bootstrap samples that included at least 1 isolate with resistance was also evaluated as an indicator of the sensitivity of the sampling strategy to previously unidentified antimicrobial resistance. The proportion was greatest with 1 sample per farm and decreased with larger samples per farm. We concluded that when the total number of samples is pre-specified, the most precise and sensitive sampling strategy involves collecting 1 sample per farm.	[Yamamoto, Takehisa; Hayama, Yoko; Hidano, Arata; Kobayashi, Sota; Muroga, Norihiko; Tsutsui, Toshiyuki] Natl Inst Anim Hlth, Viral Dis & Epidemiol Res Div, Tsukuba, Ibaraki 305, Japan; [Ishikawa, Kiyoyasu; Ogura, Aki] Minist Agr Forestry & Fisheries, Food Safety & Consumer Affairs Bur, Anim Prod Safety Div, Tokyo, Japan	National Agriculture & Food Research Organization - Japan; National Institute of Animal Health - Japan; Ministry of Agriculture Forestry & Fisheries - Japan	Yamamoto, T (corresponding author), Natl Inst Anim Hlth, Viral Dis & Epidemiol Res Div, Tsukuba, Ibaraki 305, Japan.	mtbook@affrc.go.jp	Hidano, Arata/S-1719-2019	Hidano, Arata/0000-0003-1707-5319	Regulatory Research Projects for Food Safety, Animal Health and Plant Protection of the Ministry of Agriculture, Forestry, and Fisheries of Japan	Regulatory Research Projects for Food Safety, Animal Health and Plant Protection of the Ministry of Agriculture, Forestry, and Fisheries of Japan	This study was supported by the Regulatory Research Projects for Food Safety, Animal Health and Plant Protection of the Ministry of Agriculture, Forestry, and Fisheries of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brun E, 2002, MICROB DRUG RESIST, V8, P385, DOI 10.1089/10766290260469660; *CLIN LAB STAND I, 2006, M02A9 CLIN LAB STAND; Dunlop RH, 1999, EPIDEMIOL INFECT, V122, P485, DOI 10.1017/S0950268899002411; Efron B., 1994, INTRO BOOTSTRAP; EFSA (European Food Safety Authority), 2012, TECHN SPEC HARM MON; Kijima-Tanaka M, 2003, J ANTIMICROB CHEMOTH, V51, P447, DOI 10.1093/jac/dkg014; MAFF (Ministry of Agriculture Forestry and Fisheries Japan), 2009, REP JAP VET ANT RES; OIE, 2018, TERR AN HLTH COD; Persoons D, 2011, MICROB DRUG RESIST, V17, P513, DOI 10.1089/mdr.2011.0048; R Core Team, 2021, R LANG ENV STAT COMP; Regula G, 2005, PREV VET MED, V70, P29, DOI 10.1016/j.prevetmed.2005.02.017; Silley P, 2012, REV SCI TECH OIE, V31, P105; Vieira AR, 2008, J ANTIMICROB CHEMOTH, V62, P535, DOI 10.1093/jac/dkn210; Villarroel A, 2006, AM J VET RES, V67, P951, DOI 10.2460/ajvr.67.6.951	14	4	4	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2014	9	1							e87147	10.1371/journal.pone.0087147	http://dx.doi.org/10.1371/journal.pone.0087147			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297XI	24466335	gold, Green Published, Green Submitted			2022-12-25	WOS:000330288000194
J	D'Alton, S; Altshuler, M; Cannon, A; Dickson, DW; Petrucelli, L; Lewis, J				D'Alton, Simon; Altshuler, Marcelle; Cannon, Ashley; Dickson, Dennis W.; Petrucelli, Leonard; Lewis, Jada			Divergent Phenotypes in Mutant TDP-43 Transgenic Mice Highlight Potential Confounds in TDP-43 Transgenic Modeling	PLOS ONE			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; FRONTOTEMPORAL LOBAR DEGENERATION; DEPENDENT CLEAVAGE; MOTOR DEFICITS; FTLD-U; EXPRESSION; ALS; AGGREGATION; MUTATIONS; DEPLETION	The majority of cases of frontotemporal lobar degeneration and amyotrophic lateral sclerosis are pathologically defined by the cleavage, cytoplasmic redistribution and aggregation of TAR DNA binding protein of 43 kDa (TDP-43). To examine the contribution of these potentially toxic mechanisms in vivo, we generated transgenic mice expressing human TDP-43 containing the familial amyotrophic lateral sclerosis-linked M337V mutation and identified two lines that developed neurological phenotypes of differing severity and progression. The first developed a rapid cortical neurodegenerative phenotype in the early postnatal period, characterized by fragmentation of TDP-43 and loss of endogenous murine Tdp-43, but entirely lacking aggregates of ubiquitin or TDP-43. A second, low expressing line was aged to 25 months without a severe neurodegenerative phenotype, despite a 30% loss of mouse Tdp-43 and accumulation of lower molecular weight TDP-43 species. Furthermore, TDP-43 fragments generated during neurodegeneration were not C-terminal, but rather were derived from a central portion of human TDP-43. Thus we find that aggregation is not required for cell loss, loss of murine Tdp-43 is not necessarily sufficient in order to develop a severe neurodegenerative phenotype and lower molecular weight TDP-43 positive species in mouse models should not be inherently assumed to be representative of human disease. Our findings are significant for the interpretation of other transgenic studies of TDP-43 proteinopathy.	[D'Alton, Simon; Altshuler, Marcelle; Lewis, Jada] Univ Florida, Dept Neurosci, Gainesville, FL 32610 USA; [D'Alton, Simon; Altshuler, Marcelle; Lewis, Jada] Univ Florida, Ctr Translat Res Neurodegenerat Dis, Gainesville, FL USA; [D'Alton, Simon; Cannon, Ashley; Dickson, Dennis W.; Petrucelli, Leonard; Lewis, Jada] Mayo Clin, Dept Neurosci, Jacksonville, FL 32224 USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; Mayo Clinic	D'Alton, S (corresponding author), Univ Florida, Dept Neurosci, Gainesville, FL 32610 USA.	sdalton82@ufl.edu; jada.lewis@ufl.edu		Dickson, Dennis W/0000-0001-7189-7917	DoD [USAMRMC PR080354]; ALSA; NIH/NIA [P50AG16574, R01AG026251, R01AG026251-03A2, P01-AG17216-08]; NIH/NINDS [R01 NS 063964-01, 5R21NS071097-02]; Mayo Clinic; UF; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS071097, R01NS063964] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG017216, P50AG016574, R01AG026251] Funding Source: NIH RePORTER	DoD(United States Department of Defense); ALSA; NIH/NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIH/NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Mayo Clinic; UF; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	DoD (USAMRMC PR080354) to LP, JL (http://cdmrp.army.mil/funding/). ALSA to LP, JL (http://www.alsa.org/). NIH/NIA [P50AG16574 (DWD); R01AG026251 and R01AG026251-03A2 (LP); and P01-AG17216-08 (LP, DWD)], NIH/NINDS [R01 NS 063964-01 (LP), 5R21NS071097-02 (JL)]. (http://grants.nih.gov/grants/oer.htm). Mayo Clinic to DWD, LP, and JL (http://www.mayoclinic.org/jacksonville/). UF to JL. (http://www.ufl.edu/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold ES, 2013, P NATL ACAD SCI USA, V110, pE736, DOI 10.1073/pnas.1222809110; Avendano-Vazquez SE, 2012, GENE DEV, V26, P1679, DOI 10.1101/gad.194829.112; Ayala YM, 2008, P NATL ACAD SCI USA, V105, P3785, DOI 10.1073/pnas.0800546105; Barmada SJ, 2010, J NEUROSCI, V30, P639, DOI 10.1523/JNEUROSCI.4988-09.2010; Buratti E, 2005, J BIOL CHEM, V280, P37572, DOI 10.1074/jbc.M505557200; Cannon A, 2012, ACTA NEUROPATHOL, V123, P807, DOI 10.1007/s00401-012-0979-3; Chiang PM, 2010, P NATL ACAD SCI USA, V107, P16320, DOI 10.1073/pnas.1002176107; Feiguin F, 2009, FEBS LETT, V583, P1586, DOI 10.1016/j.febslet.2009.04.019; Han HJ, 2012, J NEUROSCI, V32, P10574, DOI 10.1523/JNEUROSCI.0893-12.2012; Hasegawa M, 2008, ANN NEUROL, V64, P60, DOI 10.1002/ana.21425; Hellemans J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r19; Igaz LM, 2011, J CLIN INVEST, V121, P726, DOI 10.1172/JCI44867; Igaz LM, 2009, J BIOL CHEM, V284, P8516, DOI 10.1074/jbc.M809462200; Janssens J., 2013, MOL NEUROBIOLOGY; Johnson BS, 2009, J BIOL CHEM, V284, P20329, DOI 10.1074/jbc.M109.010264; Kabashi E, 2010, HUM MOL GENET, V19, P671, DOI 10.1093/hmg/ddp534; Lagier-Tourenne C, 2009, CELL, V136, P1001, DOI 10.1016/j.cell.2009.03.006; Mackenzie IRA, 2011, ACTA NEUROPATHOL, V122, P111, DOI 10.1007/s00401-011-0845-8; Mayford M, 1996, SCIENCE, V274, P1678, DOI 10.1126/science.274.5293.1678; Neumann M, 2006, SCIENCE, V314, P130, DOI 10.1126/science.1134108; Nonaka T, 2009, HUM MOL GENET, V18, P3353, DOI 10.1093/hmg/ddp275; Polymenidou M, 2011, NAT NEUROSCI, V14, P459, DOI 10.1038/nn.2779; SantaCruz K, 2005, SCIENCE, V309, P476, DOI 10.1126/science.1113694; Srinivasan A, 1998, CELL DEATH DIFFER, V5, P1004, DOI 10.1038/sj.cdd.4400449; Stallings NR, 2010, NEUROBIOL DIS, V40, P404, DOI 10.1016/j.nbd.2010.06.017; Suzuki H, 2011, J BIOL CHEM, V286, P13171, DOI 10.1074/jbc.M110.197483; Swarup V, 2011, BRAIN, V134, P2610, DOI 10.1093/brain/awr159; Tsai KJ, 2010, J EXP MED, V207, P1661, DOI 10.1084/jem.20092164; Tsuji H, 2012, BIOCHEM BIOPH RES CO, V417, P116, DOI 10.1016/j.bbrc.2011.11.066; Wang IF, 2008, J NEUROCHEM, V105, P797, DOI 10.1111/j.1471-4159.2007.05190.x; Wegorzewska I, 2009, P NATL ACAD SCI USA, V106, P18809, DOI 10.1073/pnas.0908767106; Wils H, 2010, P NATL ACAD SCI USA, V107, P3858, DOI 10.1073/pnas.0912417107; Wu LS, 2012, J BIOL CHEM, V287, P27335, DOI 10.1074/jbc.M112.359000; Wu LS, 2010, GENESIS, V48, P56, DOI 10.1002/dvg.20584; Xu YF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069864; Xu YF, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-73; Xu YF, 2010, J NEUROSCI, V30, P10851, DOI 10.1523/JNEUROSCI.1630-10.2010; Yamashita T, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2303; Zhang HX, 2008, NEUROSCI LETT, V434, P170, DOI 10.1016/j.neulet.2008.01.060; Zhang YJ, 2007, J NEUROSCI, V27, P10530, DOI 10.1523/JNEUROSCI.3421-07.2007; Zhang YJ, 2009, P NATL ACAD SCI USA, V106, P7607, DOI 10.1073/pnas.0900688106	41	20	20	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2014	9	1							e86513	10.1371/journal.pone.0086513	http://dx.doi.org/10.1371/journal.pone.0086513			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297VL	24466128	Green Published, Green Submitted, gold			2022-12-25	WOS:000330283100176
J	Strohmeyer, R; Shelton, J; Lougheed, C; Breitkopf, T				Strohmeyer, Ron; Shelton, Jadd; Lougheed, Christopher; Breitkopf, Trisia			CCAAT-Enhancer Binding Protein-beta Expression and Elevation in Alzheimer's Disease and Microglial Cell Cultures	PLOS ONE			English	Article							C-REACTIVE PROTEIN; NF-KAPPA-B; TRANSCRIPTIONAL INHIBITORY PROTEIN; NITRIC-OXIDE SYNTHASE; ACUTE-PHASE PROTEINS; GLYCOPROTEIN HLA-DR; C/EBP-BETA; COMPLEMENT ACTIVATION; GENE-EXPRESSION; MESSENGER-RNA	CCAAT-enhancer binding proteins are transcription factors that help to regulate a wide range of inflammatory mediators, as well as several key elements of energy metabolism. Because C/EBPs are expressed by rodent astrocytes and microglia, and because they are induced by pro-inflammatory cytokines that are chronically upregulated in the Alzheimer's disease (AD) cortex, we have investigated whether C/EBPs are expressed and upregulated in the AD cortex. Here, we demonstrate for the first time that C/EBP beta can be detected by Western blots in AD and nondemented elderly (ND) cortex, and that it is significantly increased in AD cortical samples. In situ, C/EBP beta localizes immunohistochemically to microglia. In microglia cultured from rapid autopsies of elderly patient's brains and in the BV-2 murine microglia cell line, we have shown that C/EBP beta can be upregulated by C/EBP-inducing cytokines or lipopolysaccharide and exhibits nuclear translocation possibly indicating functional activity. Given the known co-regulatory role of C/EBPs in pivotal inflammatory mechanisms, many of which are present in AD, we propose that upregulation of C/EBPs in the AD brain could be an important orchestrator of pathogenic changes.	[Strohmeyer, Ron; Shelton, Jadd; Lougheed, Christopher; Breitkopf, Trisia] Northwest Nazarene Univ, Dept Biol, Nampa, ID 83686 USA		Strohmeyer, R (corresponding author), Northwest Nazarene Univ, Dept Biol, Nampa, ID 83686 USA.	rwstrohmeyer@nnu.edu			NIH (National Center for Research Resources) [P20 RR016454]; MJ Murdock College Research Program for Life Sciences [2005247:JVZ:2/23/2006]; NIH (National Institute of General Medical Sciences) [P20 GM103408]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016454] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103408] Funding Source: NIH RePORTER	NIH (National Center for Research Resources)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); MJ Murdock College Research Program for Life Sciences; NIH (National Institute of General Medical Sciences)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	INBRE Program, NIH Grant Nos. P20 RR016454 (National Center for Research Resources) and P20 GM103408 (National Institute of General Medical Sciences), http://inbre.uidaho.edu/. MJ Murdock College Research Program for Life Sciences #2005247:JVZ:2/23/2006 http://www.murdock-trust.org/grants/college-research-lifesciences.php. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Abreu M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041807; Akiyama H, 2000, NEUROBIOL AGING, V21, P383, DOI 10.1016/S0197-4580(00)00124-X; An MR, 1996, MOL CELL BIOL, V16, P2295; Baer M, 1998, BLOOD, V92, P4353, DOI 10.1182/blood.V92.11.4353.423k21_4353_4365; Beach TG, 2008, CELL TISSUE BANK, V9, P229, DOI 10.1007/s10561-008-9067-2; BLASI E, 1990, J NEUROIMMUNOL, V27, P229, DOI 10.1016/0165-5728(90)90073-V; Buck M, 2001, EMBO J, V20, P6712, DOI 10.1093/emboj/20.23.6712; Cardinaux JR, 2000, GLIA, V29, P91, DOI 10.1002/(SICI)1098-1136(20000101)29:1<91::AID-GLIA9>3.0.CO;2-I; Chandrasekar B, 1999, CIRCULATION, V99, P427, DOI 10.1161/01.CIR.99.3.427; Chen JP, 1999, FEBS LETT, V457, P162, DOI 10.1016/S0014-5793(99)01031-5; Chinery R, 1997, J BIOL CHEM, V272, P30356, DOI 10.1074/jbc.272.48.30356; DARLINGTON GJ, 1995, CURR OPIN GENET DEV, V5, P565, DOI 10.1016/0959-437X(95)80024-7; Dentesano G, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-165; DESCOMBES P, 1991, CELL, V67, P569, DOI 10.1016/0092-8674(91)90531-3; Ejarque-Ortiz A, 2007, GLIA, V55, P178, DOI 10.1002/glia.20446; Ejarque-Ortiz A, 2010, J NEUROSCI RES, V88, P1113, DOI 10.1002/jnr.22272; Ford AM, 1996, P NATL ACAD SCI USA, V93, P10838, DOI 10.1073/pnas.93.20.10838; Galea E, 1999, FASEB J, V13, P2125, DOI 10.1096/fasebj.13.15.2125; GIOMETTO B, 1988, EUR NEUROL, V28, P30, DOI 10.1159/000116224; Good PF, 1996, AM J PATHOL, V149, P21; Gresa-Arribas N, 2010, J NEUROCHEM, V115, P526, DOI 10.1111/j.1471-4159.2010.06952.x; Guo SD, 2001, J BIOL CHEM, V276, P8516, DOI 10.1074/jbc.M008542200; Hanson RW, 1998, J BIOL CHEM, V273, P28543, DOI 10.1074/jbc.273.44.28543; Henn A, 2009, ALTEX-ALTERN TIEREXP, V26, P83; Hensley K, 1996, ANN NY ACAD SCI, V786, P120, DOI 10.1111/j.1749-6632.1996.tb39057.x; Heurtaux T, 2010, J NEUROCHEM, V114, P576, DOI 10.1111/j.1471-4159.2010.06783.x; Huber R, 2012, CELL SIGNAL, V24, P1287, DOI 10.1016/j.cellsig.2012.02.007; IWAMOTO N, 1994, NEUROSCI LETT, V177, P23, DOI 10.1016/0304-3940(94)90035-3; JUAN TSC, 1993, P NATL ACAD SCI USA, V90, P2584, DOI 10.1073/pnas.90.7.2584; Kapadia R, 2006, J NEUROCHEM, V98, P1718, DOI 10.1111/j.1471-4159.2006.04056.x; KATZ S, 1993, EMBO J, V12, P1321, DOI 10.1002/j.1460-2075.1993.tb05777.x; KAWAMURA N, 1992, BIOCHEM J, V283, P705, DOI 10.1042/bj2830705; Kawamura Nobuaki, 1994, Hokkaido Journal of Medical Science, V69, P293; Kinugawa K, 1997, CIRC RES, V81, P911; KOWENZLEUTZ E, 1994, GENE DEV, V8, P2781, DOI 10.1101/gad.8.22.2781; Lekstrom-Himes J, 1998, J BIOL CHEM, V273, P28545, DOI 10.1074/jbc.273.44.28545; Li RN, 2004, NEUROBIOL AGING, V25, P991, DOI 10.1016/j.neurobiolaging.2003.10.016; Li Y, 2008, J BIOL CHEM, V283, P22443, DOI 10.1074/jbc.M801046200; Lorton D, 2000, NEUROBIOL AGING, V21, P463, DOI 10.1016/S0197-4580(00)00092-0; Lue L, 1996, NEUROBIOL AGING S, V17, P520; Lue LF, 1996, NEUROBIOL AGING, V17, P421, DOI 10.1016/0197-4580(96)00006-1; Lue LF, 2001, NEUROBIOL AGING, V22, P945, DOI 10.1016/S0197-4580(01)00311-6; Lue LF, 2001, GLIA, V35, P72, DOI 10.1002/glia.1072; Lue LF, 2001, EXP NEUROL, V171, P29, DOI 10.1006/exnr.2001.7732; MAGALINI A, 1995, CYTOKINE, V7, P753, DOI 10.1006/cyto.1995.0090; MCGEER PL, 1987, NEUROSCI LETT, V79, P195, DOI 10.1016/0304-3940(87)90696-3; MCGEER PL, 1988, ACTA NEUROPATHOL, V76, P550, DOI 10.1007/BF00689592; METZ R, 1991, GENE DEV, V5, P1754, DOI 10.1101/gad.5.10.1754; NAKAJIMA T, 1993, P NATL ACAD SCI USA, V90, P2207, DOI 10.1073/pnas.90.6.2207; NATSUKA S, 1992, BLOOD, V79, P460; Ochrietor JD, 2000, CYTOKINE, V12, P888, DOI 10.1006/cyto.2000.0668; Paranjape GS, 2012, ACS CHEM NEUROSCI, V3, P302, DOI 10.1021/cn2001238; Parvathy S, 2009, NEUROBIOL AGING, V30, P1792, DOI 10.1016/j.neurobiolaging.2008.01.011; Perez-Capote K, 2006, NEUROSCI LETT, V410, P25, DOI 10.1016/j.neulet.2006.09.078; Poli V, 1998, J BIOL CHEM, V273, P29279, DOI 10.1074/jbc.273.45.29279; POPE RM, 1994, J CLIN INVEST, V94, P1449, DOI 10.1172/JCI117482; Ramji DP, 2002, BIOCHEM J, V365, P561, DOI 10.1042/BJ20020508; Ray A, 1999, J IMMUNOL, V163, P2143; Rogers J, 2002, GLIA, V40, P260, DOI 10.1002/glia.10153; ROGERS J, 1992, RES IMMUNOL, V143, P624, DOI 10.1016/0923-2494(92)80046-N; Rogers J, 2001, NEUROCHEM INT, V39, P333, DOI 10.1016/S0197-0186(01)00040-7; ROGERS J, 1992, P NATL ACAD SCI USA, V89, P10016, DOI 10.1073/pnas.89.21.10016; Shen Y, 2001, NEUROSCI LETT, V305, P165, DOI 10.1016/S0304-3940(01)01842-0; SHIMIZU H, 1994, GENE, V149, P305; Smith MA, 1997, J NEUROSCI, V17, P2653; Straccia M, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-156; Strohmeyer R, 2002, J NEUROIMMUNOL, V131, P135, DOI 10.1016/S0165-5728(02)00272-2; Strohmeyer R, 2000, MOL BRAIN RES, V81, P7, DOI 10.1016/S0169-328X(00)00149-2; Su JH, 1997, BRAIN RES, V774, P193, DOI 10.1016/S0006-8993(97)81703-9; TONIATTI C, 1990, MOL BIOL MED, V7, P199; TOOYAMA I, 1990, BRAIN RES, V523, P273, DOI 10.1016/0006-8993(90)91496-4; TRAUTWEIN C, 1993, NATURE, V364, P544, DOI 10.1038/364544a0; TSUKADA J, 1994, MOL CELL BIOL, V14, P7285, DOI 10.1128/MCB.14.11.7285; Valente T, 2012, NEUROBIOL AGING, V33, P2186, DOI 10.1016/j.neurobiolaging.2011.09.019; Vietor I, 1996, J BIOL CHEM, V271, P5595, DOI 10.1074/jbc.271.10.5595; Webster S, 1997, NEUROBIOL AGING, V18, P415, DOI 10.1016/S0197-4580(97)00042-0; Webster SD, 1992, NEUR ABSTR, V18, P765; WEDEL A, 1995, IMMUNOBIOLOGY, V193, P171, DOI 10.1016/S0171-2985(11)80541-3; Wedel A, 1996, CYTOKINE, V8, P335, DOI 10.1006/cyto.1996.0046; WEGNER M, 1992, SCIENCE, V256, P370, DOI 10.1126/science.256.5055.370; WILLIAMS SC, 1995, EMBO J, V14, P3170, DOI 10.1002/j.1460-2075.1995.tb07319.x; WOOD JA, 1993, BRAIN RES, V629, P245, DOI 10.1016/0006-8993(93)91327-O; Xia CL, 1997, INT J BIOCHEM CELL B, V29, P1525, DOI 10.1016/S1357-2725(97)00083-6; Ye ZC, 1998, PROG BRAIN RES, V118, P241; Yin M, 1996, J BIOL CHEM, V271, P17974, DOI 10.1074/jbc.271.30.17974; Zannis VI, 2001, FRONT BIOSCI-LANDMRK, V6, pD456, DOI 10.2741/Zannis; Zhang DE, 1996, MOL CELL BIOL, V16, P1231; Zhu SY, 2002, P NATL ACAD SCI USA, V99, P207, DOI 10.1073/pnas.012437299	88	29	32	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2014	9	1							e86617	10.1371/journal.pone.0086617	http://dx.doi.org/10.1371/journal.pone.0086617			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297VL	24466171	Green Published, Green Submitted, gold			2022-12-25	WOS:000330283100189
J	Bontems, F; Fish, RJ; Borlat, I; Lembo, F; Chocu, S; Chalmel, F; Borg, JP; Pineau, C; Neerman-Arbez, M; Bairoch, A; Lane, L				Bontems, Franck; Fish, Richard J.; Borlat, Irene; Lembo, Frederique; Chocu, Sophie; Chalmel, Frederic; Borg, Jean-Paul; Pineau, Charles; Neerman-Arbez, Marguerite; Bairoch, Amos; Lane, Lydie			C2orf62 and TTC17 Are Involved in Actin Organization and Ciliogenesis in Zebrafish and Human	PLOS ONE			English	Article							DEPENDENT PROTEIN-KINASE; REGULATORY SUBUNIT RII; LEFT-RIGHT ASYMMETRY; ANCHORING PROTEINS; PRIMARY CILIA; CELL-SHAPE; GENE; IDENTIFICATION; EXPRESSION; ALIGNMENT	Vertebrate genomes contain around 20,000 protein-encoding genes, of which a large fraction is still not associated with specific functions. A major task in future genomics will thus be to assign physiological roles to all open reading frames revealed by genome sequencing. Here we show that C2orf62, a highly conserved protein with little homology to characterized proteins, is strongly expressed in testis in zebrafish and mammals, and in various types of ciliated cells during zebrafish development. By yeast two hybrid and GST pull-down, C2orf62 was shown to interact with TTC17, another uncharacterized protein. Depletion of either C2orf62 or TTC17 in human ciliated cells interferes with actin polymerization and reduces the number of primary cilia without changing their length. Zebrafish embryos injected with morpholinos against C2orf62 or TTC17, or with mRNA coding for the C2orf62 C-terminal part containing a RII dimerization/docking (R2D2) - like domain show morphological defects consistent with imperfect ciliogenesis. We provide here the first evidence for a C2orf62-TTC17 axis that would regulate actin polymerization and ciliogenesis.	[Bontems, Franck; Borlat, Irene; Bairoch, Amos; Lane, Lydie] Univ Geneva, Fac Med, Dept Human Prot Sci, Geneva, Switzerland; [Fish, Richard J.; Neerman-Arbez, Marguerite] Univ Geneva, Fac Med, Dept Genet Med & Dev, Geneva, Switzerland; [Lembo, Frederique; Borg, Jean-Paul] INSERM, U1068, CRCM, F-13258 Marseille, France; [Lembo, Frederique; Borg, Jean-Paul] Inst J Paoli I Calmettes, F-13009 Marseille, France; [Lembo, Frederique; Borg, Jean-Paul] CNRS, UMR7258, Marseille, France; [Lembo, Frederique; Borg, Jean-Paul] Aix Marseille Univ, Marseille, France; [Chocu, Sophie; Chalmel, Frederic; Pineau, Charles] INSERM, IRSET, U1085, Rennes, France; [Bairoch, Amos; Lane, Lydie] SIB Swiss Inst Bioinformat, Geneva, Switzerland	University of Geneva; University of Geneva; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; UNICANCER; Institut Paoli-Calmette (IPC); UNICANCER; Institut Paoli-Calmette (IPC); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); Swiss Institute of Bioinformatics	Bontems, F (corresponding author), Univ Geneva, Fac Med, Dept Human Prot Sci, Geneva, Switzerland.	Franck.bontems@unige.ch; Lydie.lane@isb-sib.ch	Lane, Lydie/AAQ-4896-2021; Chalmel, Frederic/M-1297-2016; Borg, Jean-Paul/AAX-8096-2020; Pineau, Charles G/D-9185-2013; Chalmel, Frédéric/AAM-1079-2021; Chalmel, Frédéric/L-5360-2018; Bairoch, Amos/X-7411-2019; , Protim/C-4687-2012	Lane, Lydie/0000-0002-9818-3030; Borg, Jean-Paul/0000-0001-8418-3382; Pineau, Charles G/0000-0002-7461-5433; Chalmel, Frédéric/0000-0002-0535-3628; Chalmel, Frédéric/0000-0002-0535-3628; Bairoch, Amos/0000-0003-2826-6444; Neerman-Arbez, Marguerite/0000-0002-9351-4195	La Ligue Contre le Cancer (Label Ligue); EUCAAD (FP7 program); Institut Paoli-Calmettes; Faculty of Medicine of the University of Geneva	La Ligue Contre le Cancer (Label Ligue); EUCAAD (FP7 program); Institut Paoli-Calmettes; Faculty of Medicine of the University of Geneva	JPB's lab is supported by La Ligue Contre le Cancer (Label Ligue 2010), EUCAAD (FP7 program), and Institut Paoli-Calmettes. AB's lab is supported by the Faculty of Medicine of the University of Geneva. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams M, 2012, HUM MOL GENET, V21, P1272, DOI 10.1093/hmg/ddr557; Alieva I B, 1999, Membr Cell Biol, V12, P895; Ansley SJ, 2003, NATURE, V425, P628, DOI 10.1038/nature02030; Arnaiz O, 2009, DATABASE-OXFORD, V2009, P14; Bakkers J, 2011, CARDIOVASC RES, V91, P279, DOI 10.1093/cvr/cvr098; Bradford Y, 2011, NUCLEIC ACIDS RES, V39, pD822, DOI 10.1093/nar/gkq1077; Caron A, 2012, DEVELOPMENT, V139, P514, DOI 10.1242/dev.071746; Carr DW, 2001, J BIOL CHEM, V276, P17332, DOI 10.1074/jbc.M011252200; CARR DW, 1991, J BIOL CHEM, V266, P14188; Carvalho-Santos Z, 2011, J CELL BIOL, V194, P165, DOI 10.1083/jcb.201011152; Carvalho-Santos Z, 2010, J CELL SCI, V123, P1414, DOI 10.1242/jcs.064931; Chen JC, 1998, J CLIN INVEST, V102, P1077, DOI 10.1172/JCI4786; Cheng JC, 2004, DEV DYNAM, V231, P313, DOI 10.1002/dvdy.20144; Com E, 2006, MOL REPROD DEV, V73, P866, DOI 10.1002/mrd.20453; Dale RM, 2009, ZEBRAFISH, V6, P9, DOI 10.1089/zeb.2008.0563; Dawe HR, 2007, J CELL SCI, V120, P7, DOI 10.1242/jcs.03305; Diviani D, 2001, J CELL SCI, V114, P1431; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Eisen JS, 2008, DEVELOPMENT, V135, P1735, DOI 10.1242/dev.001115; Essner JJ, 2005, DEVELOPMENT, V132, P1247, DOI 10.1242/dev.01663; Evangelista M, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.1162925; Fiedler SE, 2013, BIOL REPROD, V88, DOI 10.1095/biolreprod.112.105262; Fiedler SE, 2012, CYTOSKELETON, V69, P22, DOI 10.1002/cm.20539; Finn RD, 2010, NUCLEIC ACIDS RES, V38, pD211, DOI 10.1093/nar/gkp985; Fisher S, 2006, NAT PROTOC, V1, P1297, DOI 10.1038/nprot.2006.230; Fliegauf M, 2007, NAT REV MOL CELL BIO, V8, P880, DOI 10.1038/nrm2278; Forbes SA, 2011, NUCLEIC ACIDS RES, V39, pD945, DOI 10.1093/nar/gkq929; Gerdes JM, 2007, NAT GENET, V39, P1350, DOI 10.1038/ng.2007.12; Gherman A, 2006, NAT GENET, V38, P961, DOI 10.1038/ng0906-961; Hawkins TA, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-42; Hong SK, 2009, P NATL ACAD SCI USA, V106, P2230, DOI 10.1073/pnas.0812880106; Hoyer-Fender S, 2012, ATLAS GENET CYTOGEN, V16, P306, DOI [10.4267/2042/47311, DOI 10.4267/2042/47311]; Inglis PN, 2006, TRENDS GENET, V22, P491, DOI 10.1016/j.tig.2006.07.006; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Ishikawa H, 2011, NAT REV MOL CELL BIO, V12, P222, DOI 10.1038/nrm3085; KANE DA, 1993, DEVELOPMENT, V119, P447; Kardash E, 2011, NAT PROTOC, V6, P1835, DOI 10.1038/nprot.2011.395; Kent WJ, 2002, GENOME RES, V12, P656, DOI 10.1101/gr.229202; Kim J, 2010, NATURE, V464, P1048, DOI 10.1038/nature08895; Kim S, 2011, NAT CELL BIOL, V13, P351, DOI 10.1038/ncb2183; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Kinderman FS, 2006, MOL CELL, V24, P397, DOI 10.1016/j.molcel.2006.09.015; Klebig C, 2009, J CELL BIOL, V185, P841, DOI 10.1083/jcb.200902128; Klos Dehring DA, 2013, DEV CELL, P1; Koppen M, 2006, DEVELOPMENT, V133, P2671, DOI 10.1242/dev.02439; Lane L, 2012, NUCLEIC ACIDS RES, V40, pD76, DOI 10.1093/nar/gkr1179; Lee JE, 2012, NAT GENET, V44, P193, DOI 10.1038/ng.1078; Legrain P, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.009993; LI Y, 1995, J BIOL CHEM, V270, P1935, DOI 10.1074/jbc.270.4.1935; Molla-Herman A, 2010, J CELL SCI, V123, P1785, DOI 10.1242/jcs.059519; Newell AEH, 2008, CELL MOTIL CYTOSKEL, V65, P539, DOI 10.1002/cm.20279; Nielsen SK, 2008, DEV DYNAM, V237, P2039, DOI 10.1002/dvdy.21610; Nogales-Cadenas R, 2009, NUCLEIC ACIDS RES, V37, pD175, DOI 10.1093/nar/gkn815; Nonaka S, 1998, CELL, V95, P829, DOI 10.1016/S0092-8674(00)81705-5; Oishi I, 2006, NAT GENET, V38, P1316, DOI 10.1038/ng1892; Paik YK, 2012, NAT BIOTECHNOL, V30, P221, DOI 10.1038/nbt.2152; Pathak N, 2007, MOL BIOL CELL, V18, P4353, DOI 10.1091/mbc.E07-06-0537; Pelletier L, 2006, NATURE, V444, P619, DOI 10.1038/nature05318; Pitaval A, 2010, J CELL BIOL, V191, P303, DOI 10.1083/jcb.201004003; Popgeorgiev N, 2011, DEV CELL, V20, P663, DOI 10.1016/j.devcel.2011.03.016; Pruitt KD, 2012, NUCLEIC ACIDS RES, V40, pD130, DOI 10.1093/nar/gkr1079; Ravanelli AM, 2011, DEV BIOL, V350, P101, DOI 10.1016/j.ydbio.2010.11.023; Robu ME, 2007, PLOS GENET, V3, P787, DOI 10.1371/journal.pgen.0030078; Schroder JM, 2011, J CELL SCI, V124, P2539, DOI 10.1242/jcs.085852; Seeley ES, 2010, J CELL SCI, V123, P511, DOI 10.1242/jcs.061093; Singla V, 2006, SCIENCE, V313, P629, DOI 10.1126/science.1124534; Slanchev K, 2011, HUM MOL GENET, V20, P3119, DOI 10.1093/hmg/ddr214; Solnica-Krezel L, 2006, CURR OPIN GENET DEV, V16, P433, DOI 10.1016/j.gde.2006.06.009; Spektor A, 2007, CELL, V130, P678, DOI 10.1016/j.cell.2007.06.027; Stooke-Vaughan GA, 2012, DEVELOPMENT, V139, P1777, DOI 10.1242/dev.079947; Stubbs JL, 2012, NAT CELL BIOL, V14, P140, DOI 10.1038/ncb2406; Stubbs JL, 2008, NAT GENET, V40, P1454, DOI 10.1038/ng.267; Tang RY, 2007, ACTA BIOCH BIOPH SIN, V39, P384, DOI 10.1111/j.1745-7270.2007.00283.x; Taniguchi H, 2012, J PROTEOMICS, V75, P5342, DOI [10.1016/j.jprot.2012.06.013, DOI 10.1016/J.JPR0T.2012.06.013]; Thisse C, 2008, NAT PROTOC, V3, P59, DOI 10.1038/nprot.2007.514; Tran PV, 2008, NAT GENET, V40, P403, DOI 10.1038/ng.105; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Uhlen M, 2010, NAT BIOTECHNOL, V28, P1248, DOI 10.1038/nbt1210-1248; Vijayaraghavan S, 1997, J BIOL CHEM, V272, P4747, DOI 10.1074/jbc.272.8.4747; Vulprecht J, 2012, J CELL SCI, V125, P1353, DOI 10.1242/jcs.104109; Walhout AJM, 2001, METHODS, V24, P297, DOI 10.1006/meth.2001.1190; Wasbrough ER, 2010, J PROTEOMICS, V73, P2171, DOI 10.1016/j.jprot.2010.09.002; White RM, 2008, CELL STEM CELL, V2, P183, DOI 10.1016/j.stem.2007.11.002; Yan XM, 2013, EXP CELL RES, V319, P147, DOI 10.1016/j.yexcr.2012.08.009; Yuan SL, 2013, ANNU REV GENET, V47, P353, DOI 10.1146/annurev-genet-111212-133243	85	14	21	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2014	9	1							e86476	10.1371/journal.pone.0086476	http://dx.doi.org/10.1371/journal.pone.0086476			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301BI	24475127	Green Published, Green Submitted, gold			2022-12-25	WOS:000330507300069
J	Munoz, WA; Lee, M; Miller, RK; Ahmed, Z; Ji, H; Link, TM; Lee, GR; Kloc, M; Ladbury, JE; McCrea, PD				Munoz, William A.; Lee, Moonsup; Miller, Rachel K.; Ahmed, Zamal; Ji, Hong; Link, Todd M.; Lee, Gilbert R.; Kloc, Malgorzata; Ladbury, John E.; McCrea, Pierre D.			Plakophilin-3 Catenin Associates with the ETV1/ER81 Transcription Factor to Positively Modulate Gene Activity	PLOS ONE			English	Article							BETA-CATENIN; DESMOSOMAL PLAQUE; EPITHELIAL-CELLS; DNA-BINDING; ACTIN CYTOSKELETON; SIGNALING PATHWAY; PROSTATE-CANCER; WNT SIGNALS; C-JUN; ETS	Members of the plakophilin-catenin sub-family (Pkp-1, -2, and -3) facilitate the linkage of desmosome junctional components to each other (e. g. desmosomal cadherins to desmoplakin) and the intermediate-filament cytoskeleton. Pkps also contribute to desmosomal stabilization and the trafficking of its components. The functions of Pkps outside of the desmosome are less well studied, despite evidence suggesting their roles in mRNA regulation, small-GTPase modulation (e. g. mid-body scission) during cell division, and cell survival following DNA damage. Pkp-catenins are further believed to have roles in the nucleus given their nuclear localization in some contexts and the known nuclear roles of structurally related catenins, such as beta-catenin and p120-catenin. Further, Pkp-catenin activities in the nuclear compartment have become of increased interest with the identification of interactions between Pkp2-catenin and RNA Pol III and Pkp1 with single-stranded DNA. Consistent with earlier reports suggesting possible nuclear roles in development, we previously demonstrated prominent nuclear localization of Pkp3 in Xenopus naive ectoderm ("animal cap") cells and recently resolved a similar localization in mouse embryonic stem cells. Here, we report the association and positive functional interaction of Pkp3 with a transcription factor, Ets variant gene 1 (ETV1), which has critical roles in neural development and prominent roles in human genetic disease. Our results are the first to report the interaction of a sequence-specific transcription factor with any Pkp. Using Xenopus laevis embryos and mammalian cells, we provide evidence for the Pkp3: ETV1 complex on both biochemical and functional levels.	[Munoz, William A.; Lee, Moonsup; Miller, Rachel K.; Ahmed, Zamal; Ji, Hong; Link, Todd M.; Lee, Gilbert R.; Kloc, Malgorzata; Ladbury, John E.; McCrea, Pierre D.] Univ Texas MD Anderson Canc Ctr, Dept Biochem & Mol Biol, Houston, TX 77030 USA; [Munoz, William A.; Lee, Moonsup; Ladbury, John E.; McCrea, Pierre D.] Univ Texas Grad Sch Biomed Sci Houston, Program Genes & Dev, Houston, TX USA; [Ahmed, Zamal; Link, Todd M.; Lee, Gilbert R.; Ladbury, John E.] Univ Texas MD Anderson Canc Ctr, Ctr Biomol Struct & Funct, Houston, TX 77030 USA; [Kloc, Malgorzata] Houston Methodist Res Inst, Houston Methodist, Dept Surg, Houston, TX USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; The Methodist Hospital System; The Methodist Hospital - Houston	McCrea, PD (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Biochem & Mol Biol, Houston, TX 77030 USA.	pdmccrea@mdanderson.org	Kloc, Malgorzata/AAF-6982-2020	Ladbury, John/0000-0002-6328-7200; Miller, Rachel/0000-0001-6381-7198; Link, Todd/0000-0003-1939-9755	NIH [RO1GM52112]; Cancer Prevention and Research Institute of Texas Research Training Award [RP101502]; National Cancer Institute [CA-16672]; University of Texas Graduate School of Biomedical Science (GSBS) - Houston; NIH Career Development Award [K01 DK092320]; NATIONAL CANCER INSTITUTE [P30CA016672] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K01DK092320] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM052112] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Prevention and Research Institute of Texas Research Training Award; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); University of Texas Graduate School of Biomedical Science (GSBS) - Houston; NIH Career Development Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the NIH (RO1GM52112 to P. D. M.; and Research Supplement to Promote Diversity in Health-Related Research to W.A.M.). W. A. M. was further supported from a Cancer Prevention and Research Institute of Texas Research Training Award (RP101502). The University of Texas Graduate School of Biomedical Science (GSBS) - Houston for assisting with financial support of W. A. M. National Cancer Institute Core Grant (CA-16672) to MD Anderson Cancer Center. R. K. M. was supported by a NIH Career Development Award (K01 DK092320). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe H, 2011, P NATL ACAD SCI USA, V108, P12497, DOI 10.1073/pnas.1109940108; Anastasiadis PZ, 2007, BBA-MOL CELL RES, V1773, P34, DOI 10.1016/j.bbamcr.2006.08.040; Arber S, 2000, CELL, V101, P485, DOI 10.1016/S0092-8674(00)80859-4; Bass-Zubek AE, 2008, J CELL BIOL, V181, P605, DOI 10.1083/jcb.200712133; Bass-Zubek AE, 2009, CURR OPIN CELL BIOL, V21, P708, DOI 10.1016/j.ceb.2009.07.002; Beausoleil SA, 2004, P NATL ACAD SCI USA, V101, P12130, DOI 10.1073/pnas.0404720101; Bojovic BB, 2001, J BIOL CHEM, V276, P4509, DOI 10.1074/jbc.M005509200; Bonne S, 2003, J CELL BIOL, V161, P403, DOI 10.1083/jcb.200303036; Bonne S, 1999, J CELL SCI, V112, P2265; Bosc DG, 2001, ONCOGENE, V20, P6215, DOI 10.1038/sj.onc.1204820; Breuninger S, 2010, AM J PATHOL, V176, P2509, DOI 10.2353/ajpath.2010.090737; Brooke MA, 2012, J PATHOL, V226, P158, DOI 10.1002/path.3027; Brown LA, 1998, ONCOGENE, V17, P93, DOI 10.1038/sj.onc.1201911; Cai CM, 2007, MOL CANCER RES, V5, P725, DOI 10.1158/1541-7786.MCR-06-0430; Carnahan RH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015747; Chen XY, 2002, J BIOL CHEM, V277, P10512, DOI 10.1074/jbc.M108765200; Chi P, 2010, NATURE, V467, P849, DOI 10.1038/nature09409; Cho K, 2010, J CELL SCI, V123, P4128, DOI 10.1242/jcs.072041; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Daniel JM, 1999, MOL CELL BIOL, V19, P3614; Daniel JM, 2007, BBA-MOL CELL RES, V1773, P59, DOI 10.1016/j.bbamcr.2006.08.052; de Launoit Y, 1998, ONCOGENE, V16, P2065, DOI 10.1038/sj.onc.1201726; de Nooij JC, 2013, NEURON, V77, P1055, DOI 10.1016/j.neuron.2013.01.015; Demirag GG, 2012, MED ONCOL, V29, P1518, DOI 10.1007/s12032-011-0071-1; Flames N, 2009, NATURE, V458, P885, DOI 10.1038/nature07929; Fuchs B, 2003, FEBS LETT, V553, P104, DOI 10.1016/S0014-5793(03)00984-0; Gallicano GI, 2001, DEVELOPMENT, V128, P929; Greenall A, 2001, J BIOL CHEM, V276, P16207, DOI 10.1074/jbc.M011582200; Hall C, 2009, CELL COMMUN ADHES, V16, P15, DOI 10.1080/15419060903009329; Hartsock A, 2008, BBA-BIOMEMBRANES, V1778, P660, DOI 10.1016/j.bbamem.2007.07.012; Hatzfeld M, 2005, EUR J CELL BIOL, V84, P205, DOI 10.1016/j.ejcb.2004.12.016; Hatzfeld M, 2000, J CELL BIOL, V149, P209, DOI 10.1083/jcb.149.1.209; Hatzfeld M, 2007, BBA-MOL CELL RES, V1773, P69, DOI 10.1016/j.bbamcr.2006.04.009; Hobbs RP, 2012, J INVEST DERMATOL, V132, P482, DOI 10.1038/jid.2011.318; Hofmann I, 2006, MOL BIOL CELL, V17, P1388, DOI 10.1091/mbc.e05-08-0708; Hofmann I, 2000, J CELL SCI, V113, P2471; Hollenhorst PC, 2011, GENE DEV, V25, P2147, DOI 10.1101/gad.17546311; Hollenhorst PC, 2011, ANNU REV BIOCHEM, V80, P437, DOI 10.1146/annurev.biochem.79.081507.103945; Hong JY, 2012, J CELL SCI, V125, P561, DOI 10.1242/jcs.086173; Hong JY, 2010, J CELL SCI, V123, P4351, DOI 10.1242/jcs.067199; Hong TT, 2011, DEV DYNAM, V240, P2680, DOI 10.1002/dvdy.22765; Hulpiau P, 2013, PROG MOL BIOL TRANSL, V116, P71, DOI 10.1016/B978-0-12-394311-8.00004-2; Klymkowsky MW, 1999, MICROSC RES TECHNIQ, V45, P43, DOI 10.1002/(SICI)1097-0029(19990401)45:1<43::AID-JEMT4>3.3.CO;2-3; Kowalczyk AP, 1999, J BIOL CHEM, V274, P18145, DOI 10.1074/jbc.274.26.18145; McCrea PD, 2007, BBA-MOL CELL RES, V1773, P17, DOI 10.1016/j.bbamcr.2006.06.009; McCrea PD, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a002923; McCrea PD, 2010, J CELL SCI, V123, P637, DOI 10.1242/jcs.039842; McEwen Abbye E, 2012, Subcell Biochem, V60, P171, DOI 10.1007/978-94-007-4186-7_8; Mertens C, 2001, P NATL ACAD SCI USA, V98, P7795, DOI 10.1073/pnas.141219498; Mertens C, 1996, J CELL BIOL, V135, P1009, DOI 10.1083/jcb.135.4.1009; Miller RK, 2013, PROG MOL BIOL TRANSL, V116, P387, DOI 10.1016/B978-0-12-394311-8.00017-0; Molenaar M, 1996, CELL, V86, P391, DOI 10.1016/S0092-8674(00)80112-9; Montross WT, 2000, J CELL SCI, V113, P1759; Mosimann C, 2009, NAT REV MOL CELL BIO, V10, P276, DOI 10.1038/nrm2654; Munchberg SR, 1999, MECH DEVELOP, V80, P53, DOI 10.1016/S0925-4773(98)00193-2; Munoz WA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034342; Nekrasova OE, 2011, J CELL BIOL, V195, P1185, DOI 10.1083/jcb.201106057; Oh S, 2013, CANC RES; Oh S, 2012, BBA-REV CANCER, V1826, P1, DOI 10.1016/j.bbcan.2012.02.002; Paratore C, 2002, DEV BIOL, V250, P168, DOI 10.1006/dbio.2002.0795; Park JI, 2006, DEV CELL, V11, P683, DOI 10.1016/j.devcel.2006.09.022; Park JI, 2005, DEV CELL, V8, P843, DOI 10.1016/j.devcel.2005.04.010; Rain JC, 2009, METHODS, V47, P291, DOI 10.1016/j.ymeth.2009.02.002; RAYGALLET D, 1995, ONCOGENE, V11, P303; Roberts BJ, 2011, EXP CELL RES, V317, P2814, DOI 10.1016/j.yexcr.2011.09.003; Saito-Diaz K, 2013, GROWTH FACTORS, V31, P1, DOI 10.3109/08977194.2012.752737; Schmidt A, 2005, EUR J CELL BIOL, V84, P189, DOI 10.1016/j.ejcb.2004.12.020; Schmidt A, 1999, DIFFERENTIATION, V64, P291, DOI 10.1046/j.1432-0436.1999.6450291.x; Schmidt A, 1997, CELL TISSUE RES, V290, P481, DOI 10.1007/s004410050956; Seth A, 2005, EUR J CANCER, V41, P2462, DOI 10.1016/j.ejca.2005.08.013; Shin S, 2013, ONCOL REP, V29, P306, DOI 10.3892/or.2012.2079; Sive Hazel L., 2000, EARLY DEV XENOPUS LA; Smith EA, 1998, J CELL BIOL, V141, P1229, DOI 10.1083/jcb.141.5.1229; Sobolik-Delmaire T, 2006, J BIOL CHEM, V281, P16962, DOI 10.1074/jbc.M600570200; Sobolik-Delmaire T, 2010, J INVEST DERMATOL, V130, P2638, DOI 10.1038/jid.2010.191; South AP, 2003, J CELL SCI, V116, P3303, DOI 10.1242/jcs.00636; Taube JH, 2010, J BIOL CHEM, V285, P16135, DOI 10.1074/jbc.M109.088096; Thomason HA, 2010, BIOCHEM J, V429, P419, DOI 10.1042/BJ20100567; Wolf A, 2013, J CELL SCI, V126, P1832, DOI 10.1242/jcs.118992; Wolf A, 2010, J CELL BIOL, V188, P463, DOI 10.1083/jcb.200908135	80	15	15	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2014	9	1							e86784	10.1371/journal.pone.0086784	http://dx.doi.org/10.1371/journal.pone.0086784			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301BI	24475179	Green Published, Green Submitted, gold			2022-12-25	WOS:000330507300109
J	D'Souza, G; Cullen, K; Bowie, J; Thorpe, R; Fakhry, C				D'Souza, Gypsyamber; Cullen, Kevin; Bowie, Janice; Thorpe, Roland; Fakhry, Carole			Differences in Oral Sexual Behaviors by Gender, Age, and Race Explain Observed Differences in Prevalence of Oral Human Papillomavirus Infection	PLOS ONE			English	Article							UNITED-STATES; OROPHARYNGEAL CANCER; TRENDS; HEAD; SURVIVAL; NATION; BURDEN; SAMPLE	Purpose: This study explores whether gender, age and race differences in oral sexual behavior account for the demographic distribution of oral human papillomavirus infection (HPV) and HPV-positive oropharyngeal cancer (HPV-OSCC) Methods: This analysis included 2,116 men and 2,140 women from NHANES (2009-10) who answered a behavioral questionnaire and provided an oral-rinse sample for HPV detection. Weighted prevalence estimates and prevalence ratios (PR) were calculated for sexual behaviors and oral HPV infection by gender, age-cohort (20-29, 30-44, 45-59, 60-69), and race, and contrasted with incidence rate ratios (IRR) of OSCC from SEER 2009. Multivariate logistic regression was used to evaluate predictors of oral sexual behavior and oral HPV16 infection. Results: Differences in oral sexual behavior were observed by gender, age-cohort and race. Most men (85.4%) and women (83.2%) had ever performed oral sex, but men had more lifetime oral and vaginal sexual partners and higher oral HPV16 prevalence than women (each p<0.001). 60-69 year olds (yo) were less likely than 45-59 or 30-44 (yo) to have performed oral sex (72.7%, 84.8%, and 90.3%, p<0.001), although oral HPV16 prevalence was similar. Prevalence ratios (PR) of ever oral sex in men vs. women (PR = 1.03), and 45-59 vs. 30-44 year-old men (PR = 0.96) were modest relative to ratios for oral HPV16 infection (PRs = 1.3-6.8) and OSCC (IRR = 4.7-8.1). In multivariate analysis, gender, age-cohort, and race were significant predictors of oral sexual behavior. Oral sexual behavior was the primary predictor of oral HPV16 infection; once this behavior was adjusted for, age-cohort and race were no longer associated with oral HPV16. Conclusion: There are differences in oral sexual behaviors when considering gender, age-cohort and race which explain observed epidemiologic differences in oral HPV16 infection across these groups.	[D'Souza, Gypsyamber; Fakhry, Carole] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD 21205 USA; [D'Souza, Gypsyamber; Fakhry, Carole] Johns Hopkins Univ Hosp, Dept Otolaryngol Head & Neck Surg, Baltimore, MD 21287 USA; [Cullen, Kevin] Univ Maryland, Greenebaum Canc Ctr, Baltimore, MD 21201 USA; [Bowie, Janice] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Hlth Behav & Soc, Baltimore, MD USA; [Thorpe, Roland] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Hlth Policy & Management, Baltimore, MD USA; [Thorpe, Roland] Johns Hopkins Bloomberg Sch Publ Hlth, Hopkins Ctr Hlth Dispar Solut, Baltimore, MD USA; [Fakhry, Carole] Greater Baltimore Med Ctr, Milton J Dance Jr Head & Neck Canc Ctr, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Medicine; University System of Maryland; University of Maryland Baltimore; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Greater Baltimore Medical Center	D'Souza, G (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD 21205 USA.	gdsouza@jhsph.edu; cfakhry@jhmi.edu			NCI NIH HHS [P30 CA134274] Funding Source: Medline; NIDCR NIH HHS [P50 DE019032, R01 DE021395] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P30CA134274] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE021395, P50DE019032] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))		Agius PA, 2010, AUST NZ J PUBL HEAL, V34, P476, DOI 10.1111/j.1753-6405.2010.00593.x; Ang KK, 2010, NEW ENGL J MED, V363, P24, DOI 10.1056/NEJMoa0912217; [Anonymous], NHANES 2009 10 NAT H; Aral SO, 2005, SEX TRANSM DIS, V32, P710, DOI 10.1097/01.olq.0000175370.08709.72; Bajos N, 2010, AIDS, V24, P1185, DOI 10.1097/QAD.0b013e328336ad52; Broutian TR, 2010, J CLIN VIROLOGY OFFI; Chaturvedi AK, 2013, J CLIN ONCOL; Chaturvedi AK, 2008, J CLIN ONCOL, V26, P612, DOI 10.1200/JCO.2007.14.1713; Chaturvedi AK, 2011, J CLIN ONCOL, V29, P4294, DOI 10.1200/JCO.2011.36.4596; Cole L, 2012, PLOS ONE, V7, DOI [DOI 10.1371/journal.pone.0032657, 10. 1371/journal.pone.0032657]; Copen CE, 2012, PREVALENCE TIMING OR; D'Souza G, 2007, NEW ENGL J MED, V356, P1944, DOI 10.1056/NEJMoa065497; Fakhry C, 2008, JNCI-J NATL CANCER I, V100, P261, DOI 10.1093/jnci/djn011; Gates GJ, 2000, FAM PLANN PERSPECT, V32, P295, DOI 10.2307/2648198; Gillison ML, 2008, JNCI-J NATL CANCER I, V100, P407, DOI 10.1093/jnci/djn025; Gillison ML, 2012, JAMA-J AM MED ASSOC, V307, P693, DOI 10.1001/jama.2012.101; Herbenick D, 2010, J SEX MED, V7, P255, DOI 10.1111/j.1743-6109.2010.02012.x; Herlitz C, 2009, SEX HEALTH, V6, P272, DOI 10.1071/SH08095; Herrero R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068329; Jemal A, 2008, JNCI-J NATL CANCER I, V100, P1672, DOI 10.1093/jnci/djn389; Jemal A, 2013, JNCI-J NATL CANCER I, V105, P175, DOI 10.1093/jnci/djs491; Leichliter JS, 2007, J INFECT DIS, V196, P1852, DOI 10.1086/522867; Ramqvist T, 2010, EMERG INFECT DIS, V16, P1671, DOI 10.3201/eid1611.100452; Ryerson AB, 2008, CANCER-AM CANCER SOC, V113, P2901, DOI 10.1002/cncr.23745; Satterwhite CL, 2007, SEX TRANSM DIS, V34, P815, DOI 10.1097/OLQ.0b013e31805c751d; Settle K, 2009, CANCER PREV RES, V2, P776, DOI 10.1158/1940-6207.CAPR-09-0149; Surveillance E, 2013, SEER STAT DAT UNPUB; Tobian AAR, 2011, INT J CANCER, V129, P2970, DOI 10.1002/ijc.25957; TURNER CF, 1995, SEX TRANSM DIS, V22, P173, DOI 10.1097/00007435-199505000-00009; Weinberger PM, 2010, LARYNGOSCOPE, V120, P1531, DOI 10.1002/lary.20984	30	131	132	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2014	9	1							e86023	10.1371/journal.pone.0086023	http://dx.doi.org/10.1371/journal.pone.0086023			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	298QQ	24475067	gold, Green Published, Green Submitted			2022-12-25	WOS:000330339800022
J	Kaul, TK; Rodrigues, PR; Ogungbe, IV; Kapahi, P; Gill, MS				Kaul, Tiffany K.; Rodrigues, Pedro Reis; Ogungbe, Ifedayo V.; Kapahi, Pankaj; Gill, Matthew S.			Bacterial Fatty Acids Enhance Recovery from the Dauer Larva in Caenorhabditis elegans	PLOS ONE			English	Article							GUANYLYL CYCLASE DAF-11; C-ELEGANS; DEVELOPMENTAL VARIANT; SIGNALING PATHWAY; INSULIN; PHEROMONE; TEMPERATURE; RESISTANCE; MEMBER; FOOD	The dauer larva is a specialized dispersal stage in the nematode Caenorhabditis elegans that allows the animal to survive starvation for an extended period of time. The dauer does not feed, but uses chemosensation to identify new food sources and to determine whether to resume reproductive growth. Bacteria produce food signals that promote recovery of the dauer larva, but the chemical identities of these signals remain poorly defined. We find that bacterial fatty acids in the environment augment recovery from the dauer stage under permissive conditions. The effect of increased fatty acids on different dauer constitutive mutants indicates a role for insulin peptide secretion in coordinating recovery from the dauer stage in response to fatty acids. These data suggest that worms can sense the presence of fatty acids in the environment and that elevated levels can promote recovery from dauer arrest. This may be important in the natural environment where the dauer larva needs to determine whether the environment is appropriate to support reproductive growth following dauer exit.	[Kaul, Tiffany K.; Rodrigues, Pedro Reis; Ogungbe, Ifedayo V.; Gill, Matthew S.] Scripps Res Inst Scripps Florida, Dept Metab & Aging, Jupiter, FL 33458 USA; [Kapahi, Pankaj] Buck Inst Res Aging, Novato, CA USA	Scripps Research Institute; State University System of Florida; University of Florida; Buck Institute for Research on Aging	Gill, MS (corresponding author), Scripps Res Inst Scripps Florida, Dept Metab & Aging, Jupiter, FL 33458 USA.	mgill@scripps.edu		Gill, Matthew/0000-0003-0818-8792	National Institutes of Health [AG036992, AG038688]; NATIONAL INSTITUTE ON AGING [R01AG045835, R01AG036992, R01AG038688] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P40OD010440] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This study was supported by the National Institutes of Health Grants AG036992 (MSG) and AG038688 (PK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ailion M, 1999, P NATL ACAD SCI USA, V96, P7394, DOI 10.1073/pnas.96.13.7394; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; BARGMANN CI, 1991, SCIENCE, V251, P1243, DOI 10.1126/science.2006412; Bargmann CI, 2006, C ELEGANS RES COMMUN, DOI [10.1895/worm-book.1.123.1, DOI 10.1895/W0RM-B00K.1.123.1]; Birnby DA, 2000, GENETICS, V155, P85; BRENNER S, 1974, GENETICS, V77, P71; Brooks KK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007545; CASSADA RC, 1975, DEV BIOL, V46, P326, DOI 10.1016/0012-1606(75)90109-8; Chang YY, 1999, MOL MICROBIOL, V33, P249, DOI 10.1046/j.1365-2958.1999.01456.x; Cornils A, 2011, DEVELOPMENT, V138, P1183, DOI 10.1242/dev.060905; Dauer Hu PJ, 2007, C ELEGANS RES COMMUN, DOI [10.1895/wormbook.1.144.1, DOI 10.1895/W0RMB00K.1.144.1]; Felix MA, 2010, CURR BIOL, V20, pR965, DOI 10.1016/j.cub.2010.09.050; Fielenbach N, 2008, GENE DEV, V22, P2149, DOI 10.1101/gad.1701508; GOLDEN JW, 1984, P NATL ACAD SCI-BIOL, V81, P819, DOI 10.1073/pnas.81.3.819; GOLDEN JW, 1984, J CHEM ECOL, V10, P1265, DOI 10.1007/BF00988553; GOLDEN JW, 1982, SCIENCE, V218, P578, DOI 10.1126/science.6896933; GOLDEN JW, 1984, DEV BIOL, V102, P368, DOI 10.1016/0012-1606(84)90201-X; Grogan DW, 1997, MICROBIOL MOL BIOL R, V61, P429, DOI 10.1128/.61.4.429-441.1997; Hahm JH, 2009, AGING CELL, V8, P473, DOI 10.1111/j.1474-9726.2009.00495.x; Keating CD, 2003, CURR BIOL, V13, P1715, DOI 10.1016/j.cub.2003.09.003; KLASS M, 1976, NATURE, V260, P523, DOI 10.1038/260523a0; Li WQ, 2003, GENE DEV, V17, P844, DOI 10.1101/gad.1066503; Ludewig AH, 2013, C ELEGANS RES COMMUN, DOI [10.1895/wormbook.1.155.1, DOI 10.1895/W0RMB00K.1.155.1]; Murakami M, 2001, MECH DEVELOP, V109, P27, DOI 10.1016/S0925-4773(01)00507-X; Ouellet J, 2008, DEVELOPMENT, V135, P2583, DOI 10.1242/dev.012435; Perez CL, 2008, CELL METAB, V8, P266, DOI 10.1016/j.cmet.2008.08.007; Pierce SB, 2001, GENE DEV, V15, P672, DOI 10.1101/gad.867301; Speese S, 2007, J NEUROSCI, V27, P6150, DOI 10.1523/JNEUROSCI.1466-07.2007; Talukdar S, 2011, TRENDS PHARMACOL SCI, V32, P543, DOI 10.1016/j.tips.2011.04.004; Watts JL, 2002, P NATL ACAD SCI USA, V99, P5854, DOI 10.1073/pnas.092064799	30	18	18	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2014	9	1							e86979	10.1371/journal.pone.0086979	http://dx.doi.org/10.1371/journal.pone.0086979			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	298QQ	24475206	gold, Green Published, Green Submitted			2022-12-25	WOS:000330339800074
J	Neupane, K; Solanki, A; Sosova, I; Belov, M; Woodside, MT				Neupane, Krishna; Solanki, Allison; Sosova, Iveta; Belov, Miro; Woodside, Michael T.			Diverse Metastable Structures Formed by Small Oligomers of alpha-Synuclein Probed by Force Spectroscopy	PLOS ONE			English	Article							SINGLE-MOLECULE FLUORESCENCE; PROTEIN AGGREGATION; PATHOGENIC MUTATIONS; PARKINSONS-DISEASE; ENERGY LANDSCAPE; OPTICAL TWEEZERS; FIBRIL FORMATION; AFM; NEUROTOXICITY; EQUILIBRIA	Oligomeric aggregates are widely suspected as toxic agents in diseases caused by protein aggregation, yet they remain poorly characterized, partly because they are challenging to isolate from a heterogeneous mixture of species. We developed an assay for characterizing structure, stability, and kinetics of individual oligomers at high resolution and sensitivity using single-molecule force spectroscopy, and applied it to observe the formation of transient structured aggregates within single oligomers of alpha-synuclein, an intrinsically-disordered protein linked to Parkinson's disease. Measurements of the molecular extension as the proteins unfolded under tension in optical tweezers revealed that even small oligomers could form numerous metastable structures, with a surprisingly broad range of sizes. Comparing the structures formed in monomers, dimers and tetramers, we found that the average mechanical stability increased with oligomer size. Most structures formed within a minute, with size-dependent rates. These results provide a new window onto the complex alpha-synuclein aggregation landscape, characterizing the microscopic structural heterogeneity and kinetics of different pathways.	[Neupane, Krishna; Solanki, Allison; Woodside, Michael T.] Univ Alberta, Dept Phys, Edmonton, AB, Canada; [Sosova, Iveta; Belov, Miro; Woodside, Michael T.] Natl Res Council Canada, Natl Inst Nanotechnol, Edmonton, AB, Canada	University of Alberta; National Research Council Canada	Woodside, MT (corresponding author), Univ Alberta, Dept Phys, Edmonton, AB, Canada.	michael.woodside@nrc-cnrc.gc.ca			Canadian Institutes of Health Research [NHG 91374]; nanoWorks program of Alberta Innovates; National Institute for Nanotechnology; Alberta Innovates; Alberta Innovates [201200841] Funding Source: researchfish	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); nanoWorks program of Alberta Innovates; National Institute for Nanotechnology; Alberta Innovates; Alberta Innovates	This work was supported by Canadian Institutes of Health Research (www.cihr-irsc.gc.ca) grant reference number NHG 91374, the nanoWorks program of Alberta Innovates (www.albertainnovates.ca), and the National Institute for Nanotechnology (www.nint.ualberta.ca). A. S. acknowledges fellowship support from Alberta Innovates. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad B, 2012, P NATL ACAD SCI USA, V109, P2336, DOI 10.1073/pnas.1109526109; Bader R, 2006, J MOL BIOL, V356, P189, DOI 10.1016/j.jmb.2005.11.034; Bartels T, 2011, NATURE, V477, P107, DOI 10.1038/nature10324; Bechtluft P, 2007, SCIENCE, V318, P1458, DOI 10.1126/science.1144972; Bertoncini CW, 2005, P NATL ACAD SCI USA, V102, P1430, DOI 10.1073/pnas.0407146102; Borgia A, 2008, ANNU REV BIOCHEM, V77, P101, DOI 10.1146/annurev.biochem.77.060706.093102; Borgia MB, 2011, NATURE, V474, P662, DOI 10.1038/nature10099; Brucale M, 2009, CHEMBIOCHEM, V10, P176, DOI 10.1002/cbic.200800581; Carrion-Vazquez M, 2003, NAT STRUCT BIOL, V10, P738, DOI 10.1038/nsb965; Cecconi C, 2005, SCIENCE, V309, P2057, DOI 10.1126/science.1116702; Cecconi C, 2008, EUR BIOPHYS J BIOPHY, V37, P729, DOI 10.1007/s00249-007-0247-y; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; Crampton N, 2010, CURR OPIN STRUC BIOL, V20, P508, DOI 10.1016/j.sbi.2010.05.005; Cremades N, 2012, CELL, V149, P1048, DOI 10.1016/j.cell.2012.03.037; Davidson WS, 1998, J BIOL CHEM, V273, P9443, DOI 10.1074/jbc.273.16.9443; Dedmon MM, 2005, J AM CHEM SOC, V127, P476, DOI 10.1021/ja044834j; Dong JJ, 2010, NAT STRUCT MOL BIOL, V17, P1422, DOI 10.1038/nsmb.1954; Eichner T, 2011, MOL CELL, V43, P8, DOI 10.1016/j.molcel.2011.05.012; Elms PJ, 2012, P NATL ACAD SCI USA, V109, P3796, DOI 10.1073/pnas.1115519109; Evans E, 1997, BIOPHYS J, V72, P1541, DOI 10.1016/S0006-3495(97)78802-7; Fauerbach JA, 2012, BIOPHYS J, V102, P1127, DOI 10.1016/j.bpj.2012.01.051; Fauvet B, 2012, J BIOL CHEM, V287, P15345, DOI 10.1074/jbc.M111.318949; Ferreon ACM, 2010, ANGEW CHEM INT EDIT, V49, P3469, DOI 10.1002/anie.201000378; Ferreon ACM, 2009, P NATL ACAD SCI USA, V106, P5645, DOI 10.1073/pnas.0809232106; Fink AL, 2006, ACCOUNTS CHEM RES, V39, P628, DOI 10.1021/ar050073t; Gebhardt JCM, 2010, P NATL ACAD SCI USA, V107, P2013, DOI 10.1073/pnas.0909854107; Greenleaf WJ, 2007, ANNU REV BIOPH BIOM, V36, P171, DOI 10.1146/annurev.biophys.36.101106.101451; Hervas R, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001335; Hillger F, 2007, J FLUORESC, V17, P759, DOI 10.1007/s10895-007-0187-z; Hoffmann A, 2013, PHYS CHEM CHEM PHYS, V15, P7934, DOI 10.1039/c3cp44564j; Hoffmann A, 2011, ANGEW CHEM INT EDIT, V50, P12643, DOI 10.1002/anie.201104033; Ivankov DN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006476; Ivankov DN, 2003, PROTEIN SCI, V12, P2057, DOI 10.1110/ps.0302503; Jagannathan B, 2012, P NATL ACAD SCI USA, V109, P17820, DOI 10.1073/pnas.1201800109; Jonsson SA, 2013, BIOPHYS J, V104, P2725, DOI 10.1016/j.bpj.2013.05.003; Kellermayer MSZ, 2003, BBA-BIOENERGETICS, V1604, P105, DOI 10.1016/S0005-2728(03)00029-X; Kim BH, 2011, BIOCHEMISTRY-US, V50, P5154, DOI 10.1021/bi200147a; Kim J, 2010, NATURE, V466, P992, DOI 10.1038/nature09295; Krasnoslobodtsev AV, 2013, BIOCHEMISTRY-US, V52, P7377, DOI 10.1021/bi401037z; Krasnoslobodtsev AV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038099; Kubelka J, 2004, CURR OPIN STRUC BIOL, V14, P76, DOI 10.1016/j.sbi.2004.01.013; Laganowsky A, 2012, SCIENCE, V335, P1228, DOI 10.1126/science.1213151; Lashuel HA, 2006, Q REV BIOPHYS, V39, P167, DOI 10.1017/S0033583506004422; Li MS, 2004, POLYMER, V45, P573, DOI 10.1016/j.polymer.2003.10.066; Narayan P, 2012, NAT STRUCT MOL BIOL, V19, P79, DOI 10.1038/nsmb.2191; Nath S, 2010, BIOPHYS J, V98, P1302, DOI 10.1016/j.bpj.2009.12.4290; Neuman KC, 2004, REV SCI INSTRUM, V75, P2787, DOI 10.1063/1.1785844; Neupane K, 2011, NUCLEIC ACIDS RES, V39, P7677, DOI 10.1093/nar/gkr305; Orte A, 2008, P NATL ACAD SCI USA, V105, P14424, DOI 10.1073/pnas.0803086105; PAULING L, 1951, P NATL ACAD SCI USA, V37, P251, DOI 10.1073/pnas.37.5.251; Rief M, 1997, SCIENCE, V276, P1109, DOI 10.1126/science.276.5315.1109; Ross CA, 2004, NAT MED, V10, pS10, DOI 10.1038/nm1066; Sandal M, 2008, PLOS BIOL, V6, P99, DOI 10.1371/journal.pbio.0060006; Schlierf M, 2004, P NATL ACAD SCI USA, V101, P7299, DOI 10.1073/pnas.0400033101; Simoneau S, 2007, PLOS PATHOG, V3, P1175, DOI 10.1371/journal.ppat.0030125; Speretta E, 2012, J BIOL CHEM, V287, P20748, DOI 10.1074/jbc.M112.350124; Stigler J, 2011, SCIENCE, V334, P512, DOI 10.1126/science.1207598; Takahashi Y, 2007, J BIOL CHEM, V282, P24039, DOI 10.1074/jbc.M704789200; Thirumalai D, 2010, ANNU REV BIOPHYS, V39, P159, DOI 10.1146/annurev-biophys-051309-103835; Trexler AJ, 2010, BIOPHYS J, V99, P3048, DOI 10.1016/j.bpj.2010.08.056; Ulmer TS, 2005, J BIOL CHEM, V280, P9595, DOI 10.1074/jbc.M411805200; Uversky VN, 2008, CURR PROTEIN PEPT SC, V9, P507, DOI 10.2174/138920308785915218; Uversky VN, 2001, J BIOL CHEM, V276, P10737, DOI 10.1074/jbc.M010907200; Vilar M, 2008, P NATL ACAD SCI USA, V105, P8637, DOI 10.1073/pnas.0712179105; Wang MD, 1997, BIOPHYS J, V72, P1335, DOI 10.1016/S0006-3495(97)78780-0; Wang W, 2011, P NATL ACAD SCI USA, V108, P17797, DOI 10.1073/pnas.1113260108; Weinreb PH, 1996, BIOCHEMISTRY-US, V35, P13709, DOI 10.1021/bi961799n; Wood SJ, 1999, J BIOL CHEM, V274, P19509, DOI 10.1074/jbc.274.28.19509; Yu H, 2013, PRION, V7, P140, DOI 10.4161/pri.23303; Yu H, 2012, P NATL ACAD SCI USA, V109, P14452, DOI 10.1073/pnas.1206190109; Yu H, 2012, P NATL ACAD SCI USA, V109, P5283, DOI 10.1073/pnas.1107736109; Yu JP, 2008, J MOL BIOL, V384, P992, DOI 10.1016/j.jmb.2008.10.006	72	41	41	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2014	9	1							e86495	10.1371/journal.pone.0086495	http://dx.doi.org/10.1371/journal.pone.0086495			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	298QQ	24475132	gold, Green Published, Green Submitted			2022-12-25	WOS:000330339800050
J	Dabbs, RA; Wilson, MR				Dabbs, Rebecca A.; Wilson, Mark R.			Expression and Purification of Chaperone-Active Recombinant Clusterin	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; HEAT-SHOCK PROTEINS; EXTRACELLULAR CHAPERONE; IDENTIFIES VARIANTS; ALZHEIMERS-DISEASE; AMYLOID FORMATION; STRESS; RETROTRANSLOCATION; GLYCOSYLATION; COMPLEXES	Clusterin was the first described secreted mammalian chaperone and is implicated as being a key player in both intra- and extracellular proteostasis. Its unique combination of structural features and biological chaperone activity has, however, previously made it very challenging to express and purify the protein in a correctly processed and chaperone-active form. While there are multiple reports in the literature describing the use of recombinant clusterin, all of these reports suffer from one or more of the following shortcomings: details of the methods used to produce the protein are poorly described, the product is incompletely (if at all) characterised, and purity (if shown) is in many cases inadequate. The current report provides the first well validated method to economically produce pure chaperone-active recombinant clusterin. The method was developed after trialling expression in cultured bacterial, yeast, insect and mammalian cells, and involves the expression of recombinant clusterin from stably transfected HEK293 cells in protein-free medium. The product is expressed at between 7.5 and 10 mu g/ml of culture, and is readily purified by a combination of immunoaffinity, cation exchange and size exclusion chromatography. The purified product was shown to be glycosylated, correctly proteolytically cleaved into alpha- and beta-subunits, and have chaperone activity similar to that of human plasma clusterin. This new method creates the opportunity to use mutagenesis and metabolic labelling approaches in future studies to delineate functionally important sites within clusterin, and also provides a theoretically unlimited supply of recombinant clusterin which may in the future find applications in the development of therapeutics.	[Dabbs, Rebecca A.; Wilson, Mark R.] Univ Wollongong, Sch Biol Sci, Illawarra Hlth & Med Res Inst, Wollongong, NSW, Australia	University of Wollongong	Wilson, MR (corresponding author), Univ Wollongong, Sch Biol Sci, Illawarra Hlth & Med Res Inst, Wollongong, NSW, Australia.	mrw@uow.edu.au	Wilson, Mark R/B-3254-2018	Wilson, Mark R/0000-0002-9551-7445; Dabbs, Rebecca/0000-0001-6227-7329	ARC [DP0773555, DP0984341]	ARC(Australian Research Council)	This work was partly supported by ARC Discovery Projects DP0773555 and DP0984341. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Bajari TM, 2003, FASEB J, V17, P1505, DOI 10.1096/fj.02-1106fje; BLASCHUK O, 1983, J BIOL CHEM, V258, P7714; Boggs LN, 1996, J NEUROCHEM, V67, P1324; Carver JA, 2003, IUBMB LIFE, V55, P661, DOI 10.1080/15216540310001640498; CHOIMIURA NH, 1992, J BIOCHEM, V112, P557, DOI 10.1093/oxfordjournals.jbchem.a123938; Guan QN, 2012, SURGERY, V151, P364, DOI 10.1016/j.surg.2011.09.032; Hakkoum D, 2008, J NEUROCHEM, V106, P1791, DOI 10.1111/j.1471-4159.2008.05519.x; Harold D, 2009, NAT GENET, V41, P1088, DOI 10.1038/ng.440; Hatters DM, 2002, EUR J BIOCHEM, V269, P2789, DOI 10.1046/j.1432-1033.2002.02957.x; Heller AR, 2003, SHOCK, V20, P166, DOI 10.1097/01.shk.0000075569.93053.b3; Humphreys D, 1997, BIOCHEMISTRY-US, V36, P15233, DOI 10.1021/bi9703507; Humphreys DT, 1999, J BIOL CHEM, V274, P6875, DOI 10.1074/jbc.274.11.6875; Kapron JT, 1997, PROTEIN SCI, V6, P2120; Lakins JN, 2002, BIOCHEMISTRY-US, V41, P282, DOI 10.1021/bi0157666; Lambert JC, 2009, NAT GENET, V41, P1094, DOI 10.1038/ng.439; Li N, 2013, ONCOGENE, V32, P1933, DOI 10.1038/onc.2012.212; [马晓 Ma Xiao], 2013, [肿瘤, Tumor], V33, P597; Narayan P, 2012, NAT STRUCT MOL BIOL, V19, P79, DOI 10.1038/nsmb.2191; Nizard P, 2007, TRAFFIC, V8, P554, DOI 10.1111/j.1600-0854.2007.00549.x; ODA T, 1995, EXP NEUROL, V136, P22, DOI 10.1006/exnr.1995.1080; Poon S, 2002, FEBS LETT, V513, P259, DOI 10.1016/S0014-5793(02)02326-8; Stewart EM, 2007, BIOCHEMISTRY-US, V46, P1412, DOI 10.1021/bi062082v; Stewart EM, 2007, STRUCTURAL FUNCTIONA; Wilson MR, 2000, TRENDS BIOCHEM SCI, V25, P95, DOI 10.1016/S0968-0004(99)01534-0; Wyatt AR, 2013, ANNU REV BIOCHEM, V82, P295, DOI 10.1146/annurev-biochem-072711-163904; Wyatt AR, 2011, CELL MOL LIFE SCI, V68, P3919, DOI [10.1007/s00018-011-0684-8, 10.1007/s00018-011-0684-8)]; Wyatt AR, 2009, J BIOL CHEM, V284, P21920, DOI 10.1074/jbc.M109.033688; Yerbury JJ, 2005, EMBO REP, V6, P1131, DOI 10.1038/sj.embor.7400586; Yerbury JJ, 2007, FASEB J, V21, P2312, DOI 10.1096/fj.06-7986com	29	14	15	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2014	9	1							e86989	10.1371/journal.pone.0086989	http://dx.doi.org/10.1371/journal.pone.0086989			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297XI	24466307	Green Published, Green Submitted, gold			2022-12-25	WOS:000330288000180
J	Fowler, T; Ghatak, P; Price, DH; Conaway, R; Conaway, J; Chiang, CM; Bradner, JE; Shilatifard, A; Roy, AL				Fowler, Trent; Ghatak, Payel; Price, David H.; Conaway, Ronald; Conaway, Joan; Chiang, Cheng-Ming; Bradner, James E.; Shilatifard, Ali; Roy, Ananda L.			Regulation of MYC Expression and Differential JQ1 Sensitivity in Cancer Cells	PLOS ONE			English	Article							RNA-POLYMERASE-II; BET BROMODOMAIN INHIBITION; PRIMARY RESPONSE GENES; C-MYC; TRANSCRIPTION ELONGATION; SELECTIVE-INHIBITION; LYMPHOMAS; OVEREXPRESSION; CHROMATIN; COMPLEX	High level MYC expression is associated with almost all human cancers. JQ1, a chemical compound that inhibits MYC expression is therapeutically effective in preclinical animal models in midline carcinoma, and Burkitt's lymphoma (BL). Here we show that JQ1 does not inhibit MYC expression to a similar extent in all tumor cells. The BL cells showed a similar to 90% decrease in MYC transcription upon treatment with JQ1, however, no corresponding reduction was seen in several non-BL cells. Molecularly, these differences appear due to requirements of Brd4, the most active version of the Positive Transcription Elongation Factor B (P-TEFb) within the Super Elongation Complex (SEC), and transcription factors such as Gdown1, and MED26 and also other unknown cell specific factors. Our study demonstrates that the regulation of high levels of MYC expression in different cancer cells is driven by unique regulatory mechanisms and that such exclusive regulatory signatures in each cancer cells could be employed for targeted therapeutics.	[Fowler, Trent; Ghatak, Payel; Roy, Ananda L.] Tufts Univ, Sch Med, Dept Dev Mol & Chem Biol, Boston, MA 02111 USA; [Price, David H.] Univ Iowa, Dept Biochem, Iowa City, IA 52242 USA; [Conaway, Ronald; Conaway, Joan; Shilatifard, Ali] Stowers Inst Med Res, Kansas City, MO USA; [Chiang, Cheng-Ming] Univ Texas SW Med Ctr Dallas, Simmons Comprehens Canc Ctr, Dallas, TX 75390 USA; [Bradner, James E.] Harvard Med Sch, Dana Farber Canc Inst, Boston, MA USA; [Roy, Ananda L.] Tufts Univ, Sch Med, Sackler Sch Biomed Sci, Genet Program, Boston, MA 02111 USA; [Roy, Ananda L.] Tufts Univ, Sch Med, Sackler Sch Biomed Sci, Program Immunol, Boston, MA 02111 USA	Tufts University; University of Iowa; Stowers Institute for Medical Research; University of Texas System; University of Texas Southwestern Medical Center Dallas; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Tufts University; Tufts University	Roy, AL (corresponding author), Tufts Univ, Sch Med, Dept Dev Mol & Chem Biol, Boston, MA 02111 USA.	ananda.roy@tufts.edu		Conaway, Joan/0000-0002-2786-0663; Price, David/0000-0002-5597-385X	NIH [CA103867]; CPRIT [RP110471]; Welch Foundation [I-1805]; American Heart Association [12GRNT12180023]; NATIONAL CANCER INSTITUTE [R01CA103867] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM035500] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CPRIT; Welch Foundation(The Welch Foundation); American Heart Association(American Heart Association); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by funds to C-M. C (NIH CA103867, CPRIT RP110471, and Welch Foundation I-1805), and A. L. R (American Heart Association, 12GRNT12180023). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmadiyeh N, 2010, P NATL ACAD SCI USA, V107, P9742, DOI 10.1073/pnas.0910668107; Bartholomeeusen K, 2012, J BIOL CHEM, V287, P36609, DOI 10.1074/jbc.M112.410746; Bhatt DM, 2012, CELL, V150, P279, DOI 10.1016/j.cell.2012.05.043; Biswas D, 2011, P NATL ACAD SCI USA, V108, P15751, DOI 10.1073/pnas.1111498108; Buratowski S, 2003, NAT STRUCT BIOL, V10, P679, DOI 10.1038/nsb0903-679; Buratowski S, 2009, MOL CELL, V36, P541, DOI 10.1016/j.molcel.2009.10.019; Cheng B, 2012, MOL CELL, V45, P38, DOI 10.1016/j.molcel.2011.10.022; CLEMENTS GB, 1975, INT J CANCER, V16, P125, DOI 10.1002/ijc.2910160114; Dang CV, 2012, CELL, V149, P22, DOI 10.1016/j.cell.2012.03.003; Delmore JE, 2011, CELL, V146, P903, DOI 10.1016/j.cell.2011.08.017; Dey A, 2003, P NATL ACAD SCI USA, V100, P8758, DOI 10.1073/pnas.1433065100; DOOLEY S, 1994, INT J ONCOL, V5, P65; Filippakopoulos P, 2010, NATURE, V468, P1067, DOI 10.1038/nature09504; Fowler T, 2013, J BIOL CHEM, V288, P14906, DOI 10.1074/jbc.M113.454355; Fowler T, 2011, MOL CELL, V44, P348, DOI 10.1016/j.molcel.2011.09.014; Gilchrist DA, 2010, CELL, V143, P540, DOI 10.1016/j.cell.2010.10.004; Guo JN, 2013, CHEM REV, V113, P8583, DOI 10.1021/cr400105n; Hu X, 2006, P NATL ACAD SCI USA, V103, P9506, DOI 10.1073/pnas.0603702103; Kellner WA, 2013, NUCL ACIDS RES; KIM KJ, 1979, J IMMUNOL, V122, P549; KLEMSZ MJ, 1989, J IMMUNOL, V143, P1032; Lee BK, 2012, GENOME RES, V22, P9, DOI 10.1101/gr.127597.111; Levens David, 2010, Genes Cancer, V1, P547; Levine M, 2011, CELL, V145, P502, DOI 10.1016/j.cell.2011.04.021; Lin CY, 2012, CELL, V151, P56, DOI 10.1016/j.cell.2012.08.026; Lin CQ, 2010, MOL CELL, V37, P429, DOI 10.1016/j.molcel.2010.01.026; Loven J, 2013, CELL, V153, P320, DOI 10.1016/j.cell.2013.03.036; Luo ZJ, 2012, NAT REV MOL CELL BIO, V13, P543, DOI 10.1038/nrm3417; Luo ZJ, 2012, MOL CELL BIOL, V32, P2608, DOI 10.1128/MCB.00182-12; MAGUIRE RT, 1983, P NATL ACAD SCI-BIOL, V80, P1947, DOI 10.1073/pnas.80.7.1947; Mertz JA, 2011, P NATL ACAD SCI USA, V108, P16669, DOI 10.1073/pnas.1108190108; Miyoshi S, 2009, International Patent, Patent No. [PCT/JP2008/073864, 2008073864]; Mohan M, 2010, NAT REV CANCER, V10, P720, DOI 10.1038/nrc2915; Muller S, 2011, EXPERT REV MOL MED, V13, P1, DOI 10.1017/S1462399411001992; Nechaev S, 2010, SCIENCE, V327, P335, DOI 10.1126/science.1181421; Nicodeme E, 2010, NATURE, V468, P1119, DOI 10.1038/nature09589; Nie ZQ, 2012, CELL, V151, P68, DOI 10.1016/j.cell.2012.08.033; Peterlin BM, 2012, WIRES RNA, V3, P92, DOI 10.1002/wrna.106; PUCK TT, 1956, J EXP MED, V104, P427, DOI 10.1084/jem.104.3.427; Pulvertaft JV, 1964, LANCET, V1, P238; Refaeli Y, 2008, PLOS BIOL, V6, P1208, DOI 10.1371/journal.pbio.0060152; Schrader A, 2012, INT J CANCER, V131, pE348, DOI 10.1002/ijc.26423; Seila AC, 2009, CELL CYCLE, V8, P2557, DOI 10.4161/cc.8.16.9305; SELVANAYAGAM P, 1988, BLOOD, V71, P30; Shaffer AL, 2012, ANNU REV IMMUNOL, V30, P565, DOI 10.1146/annurev-immunol-020711-075027; TAKADA K, 1989, J VIROL, V63, P445, DOI 10.1128/JVI.63.1.445-449.1989; Takahashi H, 2011, CELL, V146, P92, DOI 10.1016/j.cell.2011.06.005; Wilda M, 2004, GENE CHROMOSOME CANC, V41, P178, DOI 10.1002/gcc.20063; Wu SY, 2006, GENE DEV, V20, P2383, DOI 10.1101/gad.1448206; Wu SY, 2013, MOL CELL, V49, P843, DOI 10.1016/j.molcel.2012.12.006; Young RM, 2008, FUTURE ONCOL, V4, P591, DOI 10.2217/14796694.4.5.591; Zhang WS, 2012, J BIOL CHEM, V287, P43137, DOI 10.1074/jbc.M112.413047; Zhou Q, 2012, ANNU REV BIOCHEM, V81, P119, DOI 10.1146/annurev-biochem-052610-095910	53	47	47	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2014	9	1							e87003	10.1371/journal.pone.0087003	http://dx.doi.org/10.1371/journal.pone.0087003			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297XI	24466310	Green Published, Green Submitted, gold			2022-12-25	WOS:000330288000182
J	Zhang, MY; Shan, HY; Chang, P; Wang, T; Dong, WW; Chen, XP; Tao, LY				Zhang, Mingyang; Shan, Haiyan; Chang, Pan; Wang, Tao; Dong, Wenwen; Chen, Xiping; Tao, Luyang			Hydrogen Sulfide Offers Neuroprotection on Traumatic Brain Injury in Parallel with Reduced Apoptosis and Autophagy in Mice	PLOS ONE			English	Article							CONTROLLED CORTICAL IMPACT; CYSTATHIONINE-BETA-SYNTHASE; CENTRAL-NERVOUS-SYSTEM; INDUCED CELL-DEATH; ALZHEIMERS-DISEASE; HEAD-INJURY; RAT MODEL; CONTRIBUTES; MECHANISMS; STRATEGIES	Hydrogen sulfide (H2S), a novel gaseous mediator, has been recognized as an important neuromodulator and neuroprotective agent in the central nervous system. The present study was undertaken to study the effects of exogenous H2S on traumatic brain injury (TBI) and the underlying mechanisms. The effects of exogenous H2S on TBI were examined by using measurement of brain edema, behavior assessment, propidium iodide (PI) staining, and Western blotting, respectively. Compared to TBI groups, H2S pretreatment had reduced brain edema, improved motor performance and ameliorated performance in Morris water maze test after TBI. Immunoblotting results showed that H2S pretreatment reversed TBI-induced cleavage of caspase-3 and decline of Bcl-2, suppressed LC3-II, Beclin-1 and Vps34 activation and maintained p62 level in injured cortex and hippocampus post TBI. The results suggest a protective effect and therapeutic potential of H2S in the treatment of brain injury and the protective effect against TBI may be associated with regulating apoptosis and autophagy.	[Zhang, Mingyang; Chang, Pan; Wang, Tao; Dong, Wenwen; Chen, Xiping; Tao, Luyang] Soochow Univ, Coll Med, Dept Forens Sci, Suzhou, Peoples R China; [Zhang, Mingyang; Chang, Pan; Wang, Tao; Dong, Wenwen; Chen, Xiping; Tao, Luyang] Soochow Univ, Coll Med, Lab Brain Injury, Suzhou, Peoples R China; [Zhang, Mingyang] Nantong Univ, Coll Med, Dept Forens Sci, Nantong, Peoples R China; [Shan, Haiyan] North Dist Suzhou Municipal Hosp, Dept Obstet & Gynecol, Suzhou, Peoples R China	Soochow University - China; Soochow University - China; Nantong University	Chen, XP (corresponding author), Soochow Univ, Coll Med, Dept Forens Sci, Suzhou, Peoples R China.	xiping.chen@163.com; luyang.tao@163.com	Mingyang, Zhang/J-7412-2019	Mingyang, Zhang/0000-0001-7084-6237; Zhang, Mingyang/0000-0003-1612-0763	National Natural Science Foundation of China [30872666, 81172911, 81301039]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by grants 30872666, 81172911 and 81301039 from the National Natural Science Foundation of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe K, 1996, J NEUROSCI, V16, P1066; Bermpohl D, 2006, J CEREBR BLOOD F MET, V26, P625, DOI 10.1038/sj.jcbfm.9600258; Bierbach B, 2008, STROKE, V39, P213, DOI 10.1161/STROKEAHA.107.496620; Clark RSB, 2008, AUTOPHAGY, V4, P88, DOI 10.4161/auto.5173; Decuypere Jean-Paul, 2012, Cells, V1, P284, DOI 10.3390/cells1030284; Donkin JJ, 2010, CURR OPIN NEUROL, V23, P293, DOI 10.1097/WCO.0b013e328337f451; Enokido Y, 2005, FASEB J, V19, P1854, DOI 10.1096/fj.05-3724fje; Eto K, 2002, BIOCHEM BIOPH RES CO, V293, P1485, DOI 10.1016/S0006-291X(02)00422-9; Florian B, 2008, NEUROSCI LETT, V438, P180, DOI 10.1016/j.neulet.2008.04.020; Francis RC, 2011, ANESTHESIOLOGY, V115, P1012, DOI 10.1097/ALN.0b013e31823306cf; Ichimura Y, 2008, J BIOL CHEM, V283, P22847, DOI 10.1074/jbc.M802182200; Jain KK, 2008, DRUG DISCOV TODAY, V13, P1082, DOI 10.1016/j.drudis.2008.09.006; Jennings JS, 2008, MINI-REV MED CHEM, V8, P689, DOI 10.2174/138955708784567377; Kajta M, 2004, POL J PHARMACOL, V56, P689; Kang R, 2011, CELL DEATH DIFFER, V18, P571, DOI 10.1038/cdd.2010.191; Karlsson O, 2011, BEHAV BRAIN RES, V219, P310, DOI 10.1016/j.bbr.2011.01.056; Kimura H, 2010, ANTIOXID REDOX SIGN, V12, P1111, DOI 10.1089/ars.2009.2919; Lai YC, 2008, J CEREBR BLOOD F MET, V28, P540, DOI 10.1038/sj.jcbfm.9600551; Liu YH, 2012, ANTIOXID REDOX SIGN, V17, P141, DOI 10.1089/ars.2011.4005; Luo CL, 2011, NEUROSCIENCE, V184, P54, DOI 10.1016/j.neuroscience.2011.03.021; Luo CL, 2010, J NEUROSCI RES, V88, P2847, DOI 10.1002/jnr.22453; Maiuri MC, 2007, NAT REV MOL CELL BIO, V8, P741, DOI 10.1038/nrm2239; Mannix RC, 2011, J CEREBR BLOOD F MET, V31, P351, DOI 10.1038/jcbfm.2010.99; Martelli A, 2012, MED RES REV, V32, P1093, DOI 10.1002/med.20234; Nagai Y, 2004, FASEB J, V18, P557, DOI 10.1096/fj.03-1052fje; Oberstein A, 2007, J BIOL CHEM, V282, P13123, DOI 10.1074/jbc.M700492200; Park J, 2012, J CEREBR BLOOD F MET, V32, P330, DOI 10.1038/jcbfm.2011.131; Pattingre S, 2005, CELL, V122, P927, DOI 10.1016/j.cell.2005.07.002; Pedersen MO, 2009, PROG HISTOCHEM CYTO, V44, P1, DOI 10.1016/j.proghi.2008.10.002; Qu K, 2006, STROKE, V37, P889, DOI 10.1161/01.STR.0000204184.34946.41; Raghupathi R, 2004, BRAIN PATHOL, V14, P215, DOI 10.1111/j.1750-3639.2004.tb00056.x; Royo NC, 2006, EUR J NEUROSCI, V23, P1089, DOI 10.1111/j.1460-9568.2006.04642.x; Sadasivan S, 2008, BIOCHEM BIOPH RES CO, V373, P478, DOI 10.1016/j.bbrc.2008.05.031; Shaw K, 2001, CLIN NEUROPATHOL, V20, P106; SHOHAMI E, 1993, J NEUROTRAUM, V10, P109, DOI 10.1089/neu.1993.10.109; SLIVKA A, 1987, BRAIN RES, V409, P275, DOI 10.1016/0006-8993(87)90712-8; Smith CM, 2011, NEUROBIOL DIS, V43, P52, DOI 10.1016/j.nbd.2010.09.014; Tan BH, 2010, NEUROCHEM INT, V56, P3, DOI 10.1016/j.neuint.2009.08.008; Whalen MJ, 2008, J CEREBR BLOOD F MET, V28, P490, DOI 10.1038/sj.jcbfm.9600544; Wong PTH, 2006, J NEUROPATH EXP NEUR, V65, P109, DOI 10.1097/01.jnen.0000199571.96472.c7; Xuan AG, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-202; Yin J, 2013, BRAIN RES, V1491, P188, DOI 10.1016/j.brainres.2012.10.046; Zhang MY, 2013, J MOL NEUROSCI, V51, P57, DOI 10.1007/s12031-012-9948-5; Zhang MY, 2013, NEUROCHEM RES, V38, P714, DOI 10.1007/s11064-013-0969-4; Zhang MY, 2012, J MOL NEUROSCI, V46, P631, DOI 10.1007/s12031-011-9651-y; Zhang XP, 2005, CRIT CARE, V9, P66, DOI 10.1186/cc2950	46	72	76	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2014	9	1							e87241	10.1371/journal.pone.0087241	http://dx.doi.org/10.1371/journal.pone.0087241			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297XI	24466346	Green Submitted, Green Published, gold			2022-12-25	WOS:000330288000203
J	Haraldsson, M; Bamstedt, U; Tiselius, P; Titelman, J; Aksnes, DL				Haraldsson, Matilda; Bamstedt, Ulf; Tiselius, Peter; Titelman, Josefin; Aksnes, Dag L.			Evidence of Diel Vertical Migration in Mnemiopsis leidyi	PLOS ONE			English	Article							JELLYFISH PERIPHYLLA-PERIPHYLLA; NW MEDITERRANEAN SEA; BLACK-SEA; MAUROLICUS-MUELLERI; NARRAGANSETT BAY; CHESAPEAKE BAY; CHRYSAORA QUINQUECIRRHA; PELAGIA-NOCTILUCA; LIGHT-INTENSITY; NORWEGIAN FJORD	The vertical distribution and migration of plankton organisms may have a large impact on their horizontal dispersal and distribution, and consequently on trophic interactions. In this study we used video-net profiling to describe the fine scale vertical distribution of Mnemiopsis leidyi in the Kattegat and Baltic Proper. Potential diel vertical migration was also investigated by frequent filming during a 24-hour cycle at two contrasting locations with respect to salinity stratification. The video profiles revealed a pronounced diel vertical migration at one of the locations. However, only the small and medium size classes migrated, on average 0.85 m h(-1), corresponding to a total migration distance of 10 m during 12 h. Larger individuals (with well developed lobes, approx. >27 mm) stay on average in the same depth interval at all times. Biophysical data suggest that migrating individuals likely responded to light, and avoided irradiance levels higher than approx. 10 mu mol quanta m(-2) s(-1). We suggest that strong stratification caused by low surface salinity seemed to prohibit vertical migration.	[Haraldsson, Matilda; Tiselius, Peter] Univ Gothenburg, Dept Biol & Environm Sci, Fiskebackskil, Sweden; [Bamstedt, Ulf] Umea Univ, Dept Ecol & Environm Sci, Umea, Sweden; [Titelman, Josefin] Univ Oslo, Dept Biosci, Oslo, Norway; [Aksnes, Dag L.] Univ Bergen, Dept Biol, Bergen, Norway	University of Gothenburg; Umea University; University of Oslo; University of Bergen	Haraldsson, M (corresponding author), Univ Gothenburg, Dept Biol & Environm Sci, Fiskebackskil, Sweden.	matilda.haraldsson@bioenv.gu.se	Aksnes, Dag L/A-9093-2011; Aksnes, Dag Lorents/O-4545-2019; Titelman, Josefin/B-4450-2009	Titelman, Josefin/0000-0002-1550-9497	Baltic Organizations Network for funding Science (BONUS); Swedish Reserach Council for Environmental, Agricultural Sciences and Spatial Planning (FORMAS) [210-2008-1882, 210-2008-1889]	Baltic Organizations Network for funding Science (BONUS); Swedish Reserach Council for Environmental, Agricultural Sciences and Spatial Planning (FORMAS)	This is a contribution to the Baltic Zooplankton Cascades (BAZOOCA) project funded by the Baltic Organizations Network for funding Science (BONUS) and the Swedish Reserach Council for Environmental, Agricultural Sciences and Spatial Planning (FORMAS; project 210-2008-1882 and -1889 to M. H., U. B., P. T., J.T., and D. L. A). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arai M.N., 1997, FUNCTIONAL BIOL SCYP; Arai MN, 2005, J MAR BIOL ASSOC UK, V85, P523, DOI 10.1017/S0025315405011458; ATES R M L, 1988, Zoologische Mededelingen (Leiden), V62, P29; Bamstedt U, 2003, J PLANKTON RES, V25, P1307, DOI 10.1093/plankt/fbg084; Cardona L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031329; Cohen JH, 2009, OCEANOGR MAR BIOL, V47, P77; Condon RH, 2008, MAR ECOL PROG SER, V369, P153, DOI 10.3354/meps07595; Costello JH, 2006, LIMNOL OCEANOGR, V51, P1819, DOI 10.4319/lo.2006.51.4.1819; Costello JH, 2003, J PLANKTON RES, V25, P455, DOI 10.1093/plankt/25.4.455; Dupont N, 2012, J PLANKTON RES, V34, P263, DOI 10.1093/plankt/fbr096; Dupont N, 2009, LIMNOL OCEANOGR, V54, P1765, DOI 10.4319/lo.2009.54.5.1765; Ferraris M, 2012, J PLANKTON RES, V34, P874, DOI 10.1093/plankt/fbs049; Finenko GA, 2006, MAR ECOL PROG SER, V314, P171, DOI 10.3354/meps314171; Fonselius S. H, 1996, VASTERHAVETS OSTERSJ; Foshtomi MY, 2007, J EXP MAR BIOL ECOL, V352, P28, DOI 10.1016/j.jembe.2007.06.029; GISKE J, 1992, SARSIA, V77, P253, DOI 10.1080/00364827.1992.10413510; Graham WM, 2001, HYDROBIOLOGIA, V451, P199, DOI 10.1023/A:1011876004427; Graham WM, 2003, MAR ECOL PROG SER, V254, P129, DOI 10.3354/meps254129; HANEY JF, 1988, B MAR SCI, V43, P583; Haraldsson M, 2013, LIMNOL OCEANOGR, V58, P763, DOI 10.4319/lo.2013.58.2.0763; Hays GC, 2003, HYDROBIOLOGIA, V503, P163, DOI 10.1023/B:HYDR.0000008476.23617.b0; Hays GC, 1995, LIMNOL OCEANOGR, V40, P1461, DOI 10.4319/lo.1995.40.8.1461; Hays GC, 2008, J PLANKTON RES, V30, P325, DOI 10.1093/plankt/fbn003; Hays GC, 2012, P ROY SOC B-BIOL SCI, V279, P465, DOI 10.1098/rspb.2011.0978; HORN HS, 1966, AM NAT, V100, P419, DOI 10.1086/282436; Hosia A, 2011, J PLANKTON RES, V33, P535, DOI 10.1093/plankt/fbq106; Hosia A, 2011, MAR ECOL PROG SER, V422, P129, DOI 10.3354/meps08926; Huwer Bastian, 2008, Aquatic Invasions, V3, P113, DOI 10.3391/ai.2008.3.2.1; Jaspers C, 2012, THESIS COPENHAGEN; Jaspers C, 2013, J PLANKTON RES, V35, P582, DOI 10.1093/plankt/fbt001; Jaspers C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024065; Javidpour Jamileh, 2006, Aquatic Invasions, V1, P299, DOI 10.3391/ai.2006.1.4.17; Kaartvedt S, 2011, LIMNOL OCEANOGR, V56, P2189, DOI 10.4319/lo.2011.56.6.2189; Keister JE, 2000, MAR ECOL PROG SER, V205, P43, DOI 10.3354/meps205043; Kideys AE, 2002, SCIENCE, V297, P1482, DOI 10.1126/science.1073002; Kideys AE, 2001, MAR BIOL, V139, P535; KREMER P, 1976, ESTUAR COAST MAR SCI, V4, P627, DOI 10.1016/0302-3524(76)90071-2; MARTINDALE MQ, 1987, MAR BIOL, V94, P409, DOI 10.1007/BF00428247; McManus MA, 2012, J EXP BIOL, V215, P1008, DOI 10.1242/jeb.059014; Mianzan HW, 2010, HYDROBIOLOGIA, V645, P113, DOI 10.1007/s10750-010-0218-7; Mianzan HW, 1996, FISH RES, V27, P69, DOI 10.1016/0165-7836(95)00459-9; MILLER R J, 1974, Chesapeake Science, V15, P1, DOI 10.2307/1350952; MILLS CE, 1984, BIOL BULL, V166, P206, DOI 10.2307/1541442; Moriarty PE, 2012, MAR ECOL PROG SER, V455, P1, DOI 10.3354/meps09783; Mutlu E, 1999, MAR BIOL, V135, P603, DOI 10.1007/s002270050661; Nielsen TG, 2002, MAR BIOL, V141, P707, DOI 10.1007/s00227-002-0868-8; OHMAN MD, 1990, ECOL MONOGR, V60, P257, DOI 10.2307/1943058; OVIATT C A, 1977, Chesapeake Science, V18, P236, DOI 10.2307/1350867; Pang K, 2008, COLD SPRING HARB PRO, DOI [10.1101/pdb.emo106, DOI 10.1101/PDB.EM0106]; PURCELL JE, 1994, MAR ECOL PROG SER, V114, P47, DOI 10.3354/meps114047; Purcell JE, 1995, MAR ECOL PROG SER, V129, P63, DOI 10.3354/meps129063; Purcell JE, 2001, HYDROBIOLOGIA, V451, P27, DOI 10.1023/A:1011883905394; Purcell JE, 2009, HYDROBIOLOGIA, V616, P23, DOI 10.1007/s10750-008-9585-8; RINGELBERG J, 1995, J MAR BIOL ASSOC UK, V75, P15, DOI 10.1017/S0025315400015162; Rosland R, 1997, FISH OCEANOGR, V6, P19, DOI 10.1046/j.1365-2419.1997.00023.x; RUNGE JA, 1987, MAR BIOL, V94, P329, DOI 10.1007/BF00428238; Sayin E, 1996, TELLUS A, V48, P324, DOI 10.1034/j.1600-0870.1996.t01-1-00009.x; Schaber M, 2011, BIOL INVASIONS, V13, P2647, DOI 10.1007/s10530-011-9936-7; Schnitzler CE, 2012, BMC BIOL, V10, DOI 10.1186/1741-7007-10-107; Schuyler Q, 1997, J PLANKTON RES, V19, P1417, DOI 10.1093/plankt/19.10.1417; Shiganova TA, 2001, MAR BIOL, V139, P431; Sornes TA, 2007, J PLANKTON RES, V29, P157, DOI 10.1093/plankt/fbm003; Staby A, 2013, FISH OCEANOGR, V22, P90, DOI 10.1111/fog.12012; Swedish Agency for Marine and Water Management, 2010, FISK MILJ HAV SOTV R; Tilves U, 2013, J PLANKTON RES, V35, P218, DOI 10.1093/plankt/fbs082; Titelman J, 2012, HYDROBIOLOGIA, V690, P181, DOI 10.1007/s10750-012-1056-6; Valle-Levinson A, 2004, J MARINE SYST, V50, P61, DOI 10.1016/j.jmarsys.2003.09.016; Vereshchaka AL, 2002, OCEANOLOGY+, V42, P83; Youngbluth MJ, 2001, HYDROBIOLOGIA, V451, P321, DOI 10.1023/A:1011874828960; Zaika VE, 1991, HYDROBIOLOGY J, V27, P15	70	11	13	1	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2014	9	1							e86595	10.1371/journal.pone.0086595	http://dx.doi.org/10.1371/journal.pone.0086595			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297VL	24466162	Green Published, Green Submitted, gold			2022-12-25	WOS:000330283100187
J	Majhen, D; Stojanovic, N; Vukic, D; Pichon, C; Leduc, C; Osmak, M; Ambriovic-Ristov, A				Majhen, Dragomira; Stojanovic, Nikolina; Vukic, Dunja; Pichon, Chantal; Leduc, Chloe; Osmak, Maja; Ambriovic-Ristov, Andreja			Increased Adenovirus Type 5 Mediated Transgene Expression Due to RhoB Down-Regulation	PLOS ONE			English	Article							LARYNGEAL CARCINOMA-CELLS; GENE-THERAPY; INTRACELLULAR TRAFFICKING; PANCREATIC-CANCER; WILD-TYPE; RECEPTOR; INTEGRIN; RESISTANT; CISPLATIN; MEMBRANE	Adenovirus type 5 (Ad5) is a non-enveloped DNA virus frequently used as a gene transfer vector. Efficient Ad5 cell entry depends on the availability of its primary receptor, coxsackie and adenovirus receptor, which is responsible for attachment, and integrins, secondary receptors responsible for adenovirus internalization via clathrin-mediated endocytosis. However, efficacious adenovirus-mediated transgene expression also depends on successful trafficking of Ad5 particles to the nucleus of the target cell. It has been shown that changes occurring in tumor cells during development of resistance to anticancer drugs can be beneficial for adenovirus mediated transgene expression. In this study, using an in vitro model consisting of a parental cell line, human laryngeal carcinoma HEp2 cells, and a cisplatin-resistant clone CK2, we investigated the cause of increased Ad5-mediated transgene expression in CK2 as compared to HEp2 cells. We show that the primary cause of increased Ad5-mediated transgene expression in CK2 cells is not modulation of receptors on the cell surface or change in Ad5wt attachment and/or internalization, but is rather the consequence of decreased RhoB expression. We propose that RhoB plays an important role in Ad5 post-internalization events and more particularly in Ad5 intracellular trafficking. To the best of our knowledge, this is the first study showing changed Ad5 trafficking pattern between cells expressing different amount of RhoB, indicating the role of RhoB in Ad5 intracellular trafficking.	[Majhen, Dragomira; Stojanovic, Nikolina; Vukic, Dunja; Osmak, Maja; Ambriovic-Ristov, Andreja] Rudjer Boskovic Inst, Div Mol Biol, Zagreb, Croatia; [Pichon, Chantal; Leduc, Chloe] Univ Orleans, CNRS, UPR4301, Ctr Biophys Mol, Orleans, France	Rudjer Boskovic Institute; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); Universite de Orleans	Majhen, D (corresponding author), Rudjer Boskovic Inst, Div Mol Biol, Zagreb, Croatia.	dmajhen@irb.hr; andrea@irb.hr	Stojanović, Nikolina/ABT-8237-2022; Stojanovic, Nikolina/GWV-1059-2022	Stojanovic, Nikolina/0000-0002-7763-4154; Majhen, Dragomira/0000-0003-0385-0900	Ministry of Science, Education and Sports of the Republic of Croatia [098-0982913-2850, 098-0982913-2748]; CNRS; Region Centre; FP7-REGPOT-2012-2013-1 [316289 - InnoMol]	Ministry of Science, Education and Sports of the Republic of Croatia(Ministry of Science, Education and Sports, Republic of Croatia); CNRS(Centre National de la Recherche Scientifique (CNRS)); Region Centre(Region Centre-Val de Loire); FP7-REGPOT-2012-2013-1	This work was supported by funds received from the Ministry of Science, Education and Sports of the Republic of Croatia (Project numbers 098-0982913-2850 and 098-0982913-2748) and FP7-REGPOT-2012-2013-1, Grant Agreement Number 316289 - InnoMol. Chantal Pichon's research is supported by funds from CNRS and Region Centre. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMSON P, 1992, J CELL BIOL, V119, P617, DOI 10.1083/jcb.119.3.617; Adini I, 2003, GENE DEV, V17, P2721, DOI 10.1101/gad.1134603; Ambriovic-Ristov A, 2004, INT J CANCER, V110, P660, DOI 10.1002/ijc.20176; Bailey CJ, 2003, J VIROL, V77, P13275, DOI 10.1128/JVI.77.24.13275-13287.2003; Bergelson JM, 1997, SCIENCE, V275, P1320, DOI 10.1126/science.275.5304.1320; Cimbora-Zovko T, 2007, EUR J PHARMACOL, V558, P27, DOI 10.1016/j.ejphar.2006.11.077; Cimbora-Zovko T, 2010, CANCER LETT, V295, P182, DOI 10.1016/j.canlet.2010.02.025; Davison E, 2001, J GENE MED, V3, P550, DOI 10.1002/jgm.223; Davison E, 1997, J VIROL, V71, P6204, DOI 10.1128/JVI.71.8.6204-6207.1997; Dmitriev I, 1998, J VIROL, V72, P9706, DOI 10.1128/JVI.72.12.9706-9713.1998; Egami T, 2009, CANCER SCI, V100, P722, DOI 10.1111/j.1349-7006.2009.01101.x; Engelke MF, 2011, VIRUSES-BASEL, V3, P233, DOI 10.3390/v3030233; Fernandez-Borja M, 2005, J CELL SCI, V118, P2661, DOI 10.1242/jcs.02384; Gampel A, 1999, CURR BIOL, V9, P955, DOI 10.1016/S0960-9822(99)80422-9; Gastaldelli M, 2008, TRAFFIC, V9, P2265, DOI 10.1111/j.1600-0854.2008.00835.x; GREBER UF, 1993, CELL, V75, P477, DOI 10.1016/0092-8674(93)90382-Z; Hemminki A, 2003, CANCER RES, V63, P847; Huang MZ, 2011, J CELL BIOCHEM, V112, P1572, DOI 10.1002/jcb.23069; Huang S, 1996, J VIROL, V70, P4502, DOI 10.1128/JVI.70.7.4502-4508.1996; Lajoie-Mazenc I, 2008, J BIOL CHEM, V283, P4155, DOI 10.1074/jbc.M709639200; Leopold PL, 2007, ADV DRUG DELIVER REV, V59, P810, DOI 10.1016/j.addr.2007.06.007; Li E, 1998, J VIROL, V72, P8806, DOI 10.1128/JVI.72.11.8806-8812.1998; Majhen D, 2010, LIFE SCI, V87, P468, DOI 10.1016/j.lfs.2010.08.012; Majhen D, 2009, VIRUS RES, V139, P64, DOI 10.1016/j.virusres.2008.10.004; Mittereder N, 1996, J VIROL, V70, P7498, DOI 10.1128/JVI.70.11.7498-7509.1996; Nakano MY, 2000, J VIROL, V74, P7085, DOI 10.1128/JVI.74.15.7085-7095.2000; Neel NF, 2007, J CELL SCI, V120, P1559, DOI 10.1242/jcs.03437; OSMAK M, 1992, NEOPLASMA, V39, P197; OSMAK M, 1993, MUTAT RES, V303, P113, DOI 10.1016/0165-7992(93)90023-O; Pesonen S, 2012, INT J CANCER, V130, P1937, DOI 10.1002/ijc.26216; Quinn K, 2009, J VIROL, V83, P10176, DOI 10.1128/JVI.00422-09; Rein DT, 2012, J CANCER RES CLIN, V138, P603, DOI 10.1007/s00432-011-1135-5; Ridley AJ, 2006, TRENDS CELL BIOL, V16, P522, DOI 10.1016/j.tcb.2006.08.006; Rogee S, 2007, MOL THER, V15, P1963, DOI 10.1038/sj.mt.6300283; Rondanino C, 2007, TRAFFIC, V8, P932, DOI 10.1111/j.1600-0854.2007.00575.x; Salone B, 2003, J VIROL, V77, P13448, DOI 10.1128/JVI.77.24.13448-13454.2003; Sandilands E, 2004, DEV CELL, V7, P855, DOI 10.1016/j.devcel.2004.09.019; Shirakawa T, 2001, INT J CANCER, V94, P282, DOI 10.1002/ijc.1453; Smith JG, 2010, CURR TOP MICROBIOL, V343, P195, DOI 10.1007/82_2010_16; Suomalainen M, 2001, EMBO J, V20, P1310, DOI 10.1093/emboj/20.6.1310; Vega FM, 2012, OPEN BIOL, V2, DOI 10.1098/rsob.120076; Wang K, 2000, J VIROL, V74, P2731, DOI 10.1128/JVI.74.6.2731-2739.2000; Wang KN, 1998, J VIROL, V72, P3455, DOI 10.1128/JVI.72.4.3455-3458.1998; Wheeler AP, 2007, EXP CELL RES, V313, P3505, DOI 10.1016/j.yexcr.2007.07.014; Wherlock M, 2004, J CELL SCI, V117, P3221, DOI 10.1242/jcs.01193; WICKHAM TJ, 1994, J CELL BIOL, V127, P257, DOI 10.1083/jcb.127.1.257; Yasui T, 2011, ANTICANCER RES, V31, P1279	47	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2014	9	1							e86698	10.1371/journal.pone.0086698	http://dx.doi.org/10.1371/journal.pone.0086698			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297VL	24466204	Green Published, Green Submitted, gold			2022-12-25	WOS:000330283100198
J	Ni, WT; Cai, XJ; Liang, BB; Cai, Y; Cui, JC; Wang, R				Ni, Wentao; Cai, Xuejiu; Liang, Beibei; Cai, Yun; Cui, Junchang; Wang, Rui			Effect of Proton Pump Inhibitors on In Vitro Activity of Tigecycline against Several Common Clinical Pathogens	PLOS ONE			English	Article							ANTIBACTERIAL ACTIVITIES; PHARMACOKINETICS; PATIENT; SINGLE	In this study, we evaluated the effect of proton pump inhibitors (PPIs) on in vitro antimicrobial activity of tigecycline against several species of clinical pathogens. Clinical non-duplicate isolates of Acinetobacter baumannii, Staphylococcus aureus, Enterococcus faecalis and three species of Enterobacteriaceae (Escherichia coli, Klebsiella pneumonia and Enterobacter cloacae) were collected from a tertiary hospital and their MICs of tigecycline alone and in combination with PPIs (omeprazole, lansoprazole and pantoprazole) were determined. With one randomly selected isolate of each bacterial species, an in vitro time-kill study was performed for the confirmation of the effect of PPIs on tigecycline activity. The MIC changes after PPIs addition correlated with the PPIs concentrations in the test media. Compared with tigecycline alone, the addition of 5 mg/L PPIs could increase the MICs of tigecycline by 0 to 2-fold and the addition of 50 mg/L PPIs could increase the MICs of tigecycline by 4 to >128-fold. The time-kill study confirmed that the addition of PPIs could affect the in vitro activity of tigecycline. Even at low concentration (5 mg/L) of omeprazole and pantoprazole, antagonistic effect could be observed in E. cloacae and E. faecalis strains. We conclude that In vitro activity of tigecycline can be influenced by the presence of PPIs in a concentration-dependent manner.	[Ni, Wentao; Cai, Xuejiu; Cui, Junchang] Chinese Peoples Liberat Army Gen Hosp, Dept Resp Dis, Beijing, Peoples R China; [Liang, Beibei; Cai, Yun; Wang, Rui] Chinese Peoples Liberat Army Gen Hosp, Dept Clin Pharmacol, Beijing, Peoples R China	Chinese People's Liberation Army General Hospital; Chinese People's Liberation Army General Hospital	Cui, JC (corresponding author), Chinese Peoples Liberat Army Gen Hosp, Dept Resp Dis, Beijing, Peoples R China.	guoguoyoumeng@163.com	Ni, Wentao/HDN-9973-2022; Cai, Yun/AAJ-1969-2020		National Natural Science Foundation of China [81371855]; Beijing Municipal Natural Science Foundation of China [7112127]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Municipal Natural Science Foundation of China	This work was supported by the National Natural Science Foundation of China (no. 81371855) and the Beijing Municipal Natural Science Foundation of China (no. 7112127). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aeschlimann JR, 1999, ANTIMICROB AGENTS CH, V43, P335, DOI 10.1128/AAC.43.2.335; Bradford PA, 2005, CLIN INFECT DIS, V41, pS315, DOI 10.1086/431673; Clinical and Laboratory Standards Institute, 2013, M100S23 CLSI; Clinical and Laboratory Standards Institute, 2012, METHODS DILUTION ANT, V32; Cordina C, 2012, J ANTIMICROB CHEMOTH, V67, P1806, DOI 10.1093/jac/dks122; Fellenius E, 1981, NATURE, V290, P156; Pankey GA, 2005, J ANTIMICROB CHEMOTH, V56, P470, DOI 10.1093/jac/dki248; Petersen PJ, 2006, J ANTIMICROB CHEMOTH, V57, P573, DOI 10.1093/jac/dki477; PUE MA, 1993, EUR J CLIN PHARMACOL, V44, P575, DOI 10.1007/BF02440862; Sun Y, 2013, INT J ANTIMICROB AG, V41, P110, DOI 10.1016/j.ijantimicag.2012.09.005; Wang YQ, 2010, EUR J CLIN PHARMACOL, V66, P563, DOI 10.1007/s00228-010-0821-6; Werner G, 2008, J ANTIMICROB CHEMOTH, V61, P1182, DOI 10.1093/jac/dkn065; Yang YY, 2013, INT J ANTIMICROB AG, V42, P283, DOI 10.1016/j.ijantimicag.2013.05.011; Zhang D, 2013, EUR J DRUG METAB PH, V38, P209, DOI 10.1007/s13318-012-0115-8	14	12	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2014	9	1							e86715	10.1371/journal.pone.0086715	http://dx.doi.org/10.1371/journal.pone.0086715			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297GT	24466210	Green Published, gold, Green Submitted			2022-12-25	WOS:000330244500276
J	Zhu, DX; Zhong, YS; Wei, Y; Ye, LC; Lin, Q; Ren, L; Ye, QH; Liu, TS; Xu, JM; Qin, XY				Zhu, Dexiang; Zhong, Yunshi; Wei, Ye; Ye, Lechi; Lin, Qi; Ren, Li; Ye, Qinghai; Liu, Tianshu; Xu, Jianmin; Qin, Xinyu			Effect of Neoadjuvant Chemotherapy in Patients with Resectable Colorectal Liver Metastases	PLOS ONE			English	Article							PERIOPERATIVE CHEMOTHERAPY; SYSTEMIC CHEMOTHERAPY; HEPATIC METASTASES; CANCER; SURGERY; RESECTION; THERAPY; HEPATECTOMY; SURVIVAL	Background: Whether patients with resectable colorectal liver metastases (CRLM) receive survival benefit from neoadjuvant chemotherapy remains controversial. Methods: We retrospectively analyzed 466 patients with resectable CRLM between 2000 and 2010. Patient characteristics and survival data were recorded. Results: The patients were divided into one group with neoadjuvant chemotherapy (group NC, n = 121) and another without (group WN, n = 345). There was no difference in 5-year survival (52% vs. 48%) between the two groups. No significant differences were identified between the two groups in terms of 30-day mortality (1.7% vs. 1.2%) or morbidity (33.9% vs. 25.8%). A primary tumor at stage T4, >= 4 liver metastases, the largest liver metastasis >= 5 cm in diameter, and a serum CEA level >= 5 ng/ml were independent prognostic factors. By assigning one point to each, the patients were divided into a low-risk group (0-2) and a high-risk (3-4). The patients in the low-risk group received no survival benefit from neoadjuvant chemotherapy, whereas those in the high-risk group received survival benefit (5-year survival, 39% vs. 33%, P = 0.028). Conclusions: Preoperative neoadjuvant chemotherapy did not increase mortality or complications. Not all resectable patients, only those with >2 independent risk factors, received survival benefit from neoadjuvant chemotherapy.	[Zhu, Dexiang; Zhong, Yunshi; Wei, Ye; Ye, Lechi; Lin, Qi; Ren, Li; Xu, Jianmin; Qin, Xinyu] Fudan Univ, Dept Gen Surg, Zhongshan Hosp, Shanghai 200433, Peoples R China; [Ye, Qinghai] Fudan Univ, Dept Liver Surg, Zhongshan Hosp, Shanghai 200433, Peoples R China; [Liu, Tianshu] Fudan Univ, Dept Oncol, Zhongshan Hosp, Shanghai 200433, Peoples R China	Fudan University; Fudan University; Fudan University	Xu, JM (corresponding author), Fudan Univ, Dept Gen Surg, Zhongshan Hosp, Shanghai 200433, Peoples R China.	xujmin@aliyun.com	Zhong, Yun/HCH-6868-2022		Key Projects of the Clinical Disciplines; National Natural Science Foundation [30973416, 81101566]; Talent Fund of Shanghai Municipal Health Bureau [XYQ2011017, XBR2011031]	Key Projects of the Clinical Disciplines; National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Talent Fund of Shanghai Municipal Health Bureau	The study was supported by Key Projects of the Clinical Disciplines, which is administered by the Ministry of Health (Projects from 2010-2012), the National Natural Science Foundation (30973416, 81101566), and the Talent Fund of Shanghai Municipal Health Bureau (XYQ2011017, XBR2011031). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam R, 2010, J SURG ONCOL, V102, P922, DOI 10.1002/jso.21727; Adam R, 2010, ANN SURG, V252, P774, DOI 10.1097/SLA.0b013e3181fcf3e3; Benoist S, 2009, ANN SURG ONCOL, V16, P2385, DOI 10.1245/s10434-009-0492-7; Chiappa A, 2009, HEPATO-GASTROENTEROL, V56, P829; Choti MA, 2002, ANN SURG, V235, P759, DOI 10.1097/00000658-200206000-00002; Chua Terence C, 2012, J Gastrointest Cancer, V43, P496, DOI 10.1007/s12029-011-9272-2; Chua TC, 2010, ANN SURG ONCOL, V17, P492, DOI 10.1245/s10434-009-0781-1; Cleary JM, 2009, ONCOLOGIST, V14, P1095, DOI 10.1634/theoncologist.2009-0152; Gaujoux S, 2011, DIGEST SURG, V28, P114, DOI [10.1159/000323820, 10.1159/000323819]; Gilson N, 2009, ACTA GASTRO-ENT BELG, V72, P321; Gomez D, 2010, HPB, V12, P227, DOI 10.1111/j.1477-2574.2010.00158.x; Gruenberger B, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-120; Gruenberger B, 2008, J CLIN ONCOL, V26, P1830, DOI 10.1200/JCO.2007.13.7679; Kopetz S, 2009, J CLIN ONCOL, V27, P3677, DOI 10.1200/JCO.2008.20.5278; Lupinacci R, 2007, SURG ONCOL CLIN N AM, V16, P493, DOI 10.1016/j.soc.2007.04.014; Marques HP, 2012, J SURG ONCOL, V105, P511, DOI 10.1002/jso.22133; Nasti G, 2010, CANCER CHEMOTH PHARM, V66, P209, DOI 10.1007/s00280-010-1297-x; Nordlinger B, 2009, ANN ONCOL, V20, P985, DOI 10.1093/annonc/mdn735; Nordlinger B, 2008, LANCET, V371, P1007, DOI 10.1016/S0140-6736(08)60455-9; Nordlinger B, 2012, J CLIN ONCOL, V30; Pawlik TM, 2011, J GASTROINTEST SURG, V15, P410, DOI 10.1007/s11605-011-1423-z; Power DG, 2010, J CLIN ONCOL, V28, P2300, DOI 10.1200/JCO.2009.26.9340; Primrose JN, 2010, BRIT J CANCER, V102, P1313, DOI 10.1038/sj.bjc.6605659; Reddy SK, 2012, J SURG ONCOL, V105, P55, DOI 10.1002/jso.22044; Robinson S, 2011, SURG ONCOL, V20, P57, DOI 10.1016/j.suronc.2009.10.002; Sorbye H, 2012, ANN SURG, V255, P534, DOI 10.1097/SLA.0b013e3182456aa2; Vauthey JN, 2006, J CLIN ONCOL, V24, P2065, DOI 10.1200/JCO.2005.05.3074; Xu JM, 2011, J CANCER RES CLIN, V137, P1379, DOI 10.1007/s00432-011-0999-8	28	28	30	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2014	9	1							e86543	10.1371/journal.pone.0086543	http://dx.doi.org/10.1371/journal.pone.0086543			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297GT	24466143	gold, Green Published, Green Submitted			2022-12-25	WOS:000330244500257
J	Essers, PB; Klasson, TD; Pereboom, TC; Mans, DA; Nicastro, M; Boldt, K; Giles, RH; MacInnes, AW				Essers, P. B.; Klasson, T. D.; Pereboom, T. C.; Mans, D. A.; Nicastro, M.; Boldt, K.; Giles, R. H.; MacInnes, A. W.			The von Hippel-Lindau tumor suppressor regulates programmed cell death 5-mediated degradation of Mdm2	ONCOGENE			English	Article						renal cell carcinoma; von Hippel-Lindau tumor suppressor; programmed cell death 5	ZEBRAFISH MODEL; P53 PATHWAY; PROTEIN; GENE; VHL; APOPTOSIS; EXPRESSION; CHECKPOINT; INHIBITION; CARCINOMA	Functional loss of the von Hippel-Lindau (VHL) tumor suppressor protein (pVHL), which is part of an E3-ubiquitin ligase complex, initiates most inherited and sporadic clear-cell renal cell carcinomas (ccRCC). Genetic inactivation of the TP53 gene in ccRCC is rare, suggesting that an alternate mechanism alleviates the selective pressure for TP53 mutations in ccRCC. Here we use a zebrafish model to describe the functional consequences of pVHL loss on the p53/Mdm2 pathway. We show that p53 is stabilized in the absence of pVHL and becomes hyperstabilized upon DNA damage, which we propose is because of a novel in vivo interaction revealed between human pVHL and a negative regulator of Mdm2, the programmed cell death 5 (PDCD5) protein. PDCD5 is normally localized at the plasma membrane and in the cytoplasm. However, upon hypoxia or loss of pVHL, PDCD5 relocalizes to the nucleus, an event that is coupled to the degradation of Mdm2. Despite the subsequent hyperstabilization and normal transcriptional activity of p53, we find that zebrafish vhl(-/-) cells are still as highly resistant to DNA damage-induced cell cycle arrest and apoptosis as human ccRCC cells. We suggest this is because of a marked increase in expression of birc5a, the zebrafish homolog of Survivin. Accordingly, when we knock down Survivin in human ccRCC cells we are able to restore caspase activity in response to DNA damage. Taken together, our study describes a new mechanism for p53 stabilization through PDCD5 upon hypoxia or pVHL loss, and reveals new clinical potential for the treatment of pathobiological disorders linked to hypoxic stress.	[Essers, P. B.; Pereboom, T. C.; MacInnes, A. W.] KNAW, Hubrecht Inst Dev Biol & Stem Cell Res, NL-3584 CT Utrecht, Netherlands; [Essers, P. B.; Pereboom, T. C.; MacInnes, A. W.] Univ Med Ctr Utrecht, NL-3584 CT Utrecht, Netherlands; [Klasson, T. D.; Nicastro, M.; Giles, R. H.] Univ Med Ctr Utrecht, Dept Hypertens & Nephrol, Utrecht, Netherlands; [Mans, D. A.] Radboud Univ Nijmegen, Med Ctr, Dept Human Genet, NL-6525 ED Nijmegen, Netherlands; [Mans, D. A.] Radboud Univ Nijmegen, Nijmegen Ctr Mol Life Sci, NL-6525 ED Nijmegen, Netherlands; [Boldt, K.] Univ Tubingen, Med Proteome Ctr, Ctr Ophthalm Res, Tubingen, Germany	Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW); Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Radboud University Nijmegen; Radboud University Nijmegen; Eberhard Karls University of Tubingen	MacInnes, AW (corresponding author), KNAW, Hubrecht Inst Dev Biol & Stem Cell Res, Uppsalalaan 8, NL-3584 CT Utrecht, Netherlands.	a.macinnes@hubrecht.eu		Giles, Rachel/0000-0001-9133-2008	European Community [241955, 305608]	European Community(European Commission)	This research was supported by grants from the European Community's Seventh Framework Programme FP7/2009 under grant agreement 241955, SYSCILIA and 305608, EURenOmics (RHG). We would like to thank Susanne Lens for the kind gift of siRNA against Survivin, the animal caretakers of the Hubrecht Institute, and www. art-4-science.com for the creation of the graphic illustration.	Alarcon R, 1999, CANCER RES, V59, P6046; Albers J, 2013, EMBO MOL MED, V5, P949, DOI 10.1002/emmm.201202231; Boldt K, 2011, J CLIN INVEST, V121, P2169, DOI 10.1172/JCI45627; Chen LN, 2006, APOPTOSIS, V11, P101, DOI 10.1007/s10495-005-3134-y; Chen YY, 2001, FEBS LETT, V509, P191, DOI 10.1016/S0014-5793(01)03062-9; Coene KLM, 2011, HUM MOL GENET, V20, P3592, DOI 10.1093/hmg/ddr280; Cohen HT, 2005, NEW ENGL J MED, V353, P2477, DOI 10.1056/NEJMra043172; Creighton CJ, 2013, NATURE, V499, P43, DOI 10.1038/nature12222; Cui D, 2014, ONCOGENE, V33, P2225, DOI 10.1038/onc.2013.170; Dong Z, 2003, AM J PATHOL, V163, P663, DOI 10.1016/S0002-9440(10)63693-0; Dong Z, 2002, BIOCHEM J, V364, P413, DOI 10.1042/BJ20011431; Esteban MA, 2006, CANCER RES, V66, P3567, DOI 10.1158/0008-5472.CAN-05-2670; Frew IJ, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.124pe30; Fu LP, 2011, CANCER RES, V71, P6848, DOI 10.1158/0008-5472.CAN-11-1745; Gerlinger M, 2012, NEW ENGL J MED, V366, P883, DOI 10.1056/NEJMoa1113205; GRAEBER TG, 1994, MOL CELL BIOL, V14, P6264, DOI 10.1128/MCB.14.9.6264; Haase VH, 2001, P NATL ACAD SCI USA, V98, P1583, DOI 10.1073/pnas.98.4.1583; Horn HF, 2007, ONCOGENE, V26, P1306, DOI 10.1038/sj.onc.1210263; Hsu T, 2012, ONCOGENE, V31, P2247, DOI 10.1038/onc.2011.442; Kamura T, 1999, SCIENCE, V284, P657, DOI 10.1126/science.284.5414.657; KIBEL A, 1995, SCIENCE, V269, P1444, DOI 10.1126/science.7660130; Kim EL, 2010, NEURO-ONCOLOGY, V12, P389, DOI 10.1093/neuonc/nop046; Kleymenova E, 2004, CARCINOGENESIS, V25, P309, DOI 10.1093/carcin/bgh017; Kondo K, 2002, CANCER CELL, V1, P237, DOI 10.1016/S1535-6108(02)00043-0; Kubbutat MHG, 1997, NATURE, V387, P299, DOI 10.1038/387299a0; Lai YL, 2011, J PROTEOME RES, V10, P5175, DOI 10.1021/pr200642c; Lane DP, 2005, COLD SH Q B, V70, P489, DOI 10.1101/sqb.2005.70.049; MacInnes AW, 2008, P NATL ACAD SCI USA, V105, P10408, DOI 10.1073/pnas.0805036105; Mack FA, 2003, CANCER CELL, V3, P75, DOI 10.1016/S1535-6108(02)00240-4; Mans DA, 2013, J PATHOL, V231, P117, DOI 10.1002/path.4219; Maranchie JK, 2002, CANCER CELL, V1, P247, DOI 10.1016/S1535-6108(02)00044-2; Motzer RJ, 1996, NEW ENGL J MED, V335, P865, DOI 10.1056/NEJM199609193351207; Pause A, 1997, P NATL ACAD SCI USA, V94, P2156, DOI 10.1073/pnas.94.6.2156; Pereboom TC, 2011, BLOOD, V118, P5458, DOI 10.1182/blood-2011-04-351460; Qi H, 2003, CANCER RES, V63, P7076; Rankin EB, 2006, CANCER RES, V66, P2576, DOI 10.1158/0008-5472.CAN-05-3241; Roe JS, 2006, MOL CELL, V22, P395, DOI 10.1016/j.molcel.2006.04.006; Roe JS, 2011, CELL CYCLE, V10, P3920, DOI 10.4161/cc.10.22.18096; Sansam CL, 2010, GENE DEV, V24, P183, DOI 10.1101/gad.1860310; Sato Y, 2013, NAT GENET, V45, P860, DOI 10.1038/ng.2699; Semenza GL, 2003, NAT REV CANCER, V3, P721, DOI 10.1038/nrc1187; Sermeus A, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.48; Shepard JL, 2004, METHOD CELL BIOL, V76, P109; Spinola M, 2006, J CLIN ONCOL, V24, P1672, DOI 10.1200/JCO.2005.04.4339; Szymanska K, 2010, CANCER LETT, V293, P92, DOI 10.1016/j.canlet.2009.11.024; Tan Wan-long, 2006, Nan Fang Yi Ke Da Xue Xue Bao, V26, P1316; Tsuchiya H, 1996, CANCER RES, V56, P2881; van Rooijen E, 2011, METHOD CELL BIOL, V105, P163, DOI 10.1016/B978-0-12-381320-6.00007-2; van Rooijen E, 2009, BLOOD, V113, P6449, DOI 10.1182/blood-2008-07-167890; Westerfield M, 2000, ZEBRAFISH BOOK GUIDE; Xiong Lin, 2006, Nan Fang Yi Ke Da Xue Xue Bao, V26, P805; Xu LJ, 2012, APOPTOSIS, V17, P1235, DOI 10.1007/s10495-012-0754-x; Xu LJ, 2009, NEOPLASIA, V11, P345, DOI 10.1593/neo.81524; Yang YH, 2006, APOPTOSIS, V11, P993, DOI 10.1007/s10495-006-6714-6; Yuen JSP, 2011, BRIT J CANCER, V104, P941, DOI 10.1038/bjc.2011.55; Zucchi I, 2004, P NATL ACAD SCI USA, V101, P18147, DOI 10.1073/pnas.0408260101	56	14	15	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB 5	2015	34	6					771	779		10.1038/onc.2013.598	http://dx.doi.org/10.1038/onc.2013.598			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CA4DG	24469044				2022-12-25	WOS:000348853800010
J	Vallot, C; Herault, A; Boyle, S; Bickmore, WA; Radvanyi, F				Vallot, C.; Herault, A.; Boyle, S.; Bickmore, W. A.; Radvanyi, F.			PRC2-independent chromatin compaction and transcriptional repression in cancer	ONCOGENE			English	Article						cancer; chromatin compaction; gene cluster; histone deacetylase inhibitors; polycomb	TRANSITIONAL-CELL-CARCINOMA; GENE-EXPRESSION; NUCLEAR REORGANIZATION; HISTONE DEACETYLASE; EZH2; PROSTATE; COMPLEX; GENOME; DECONDENSATION; MUTATIONS	The silencing of large chromosomal regions by epigenetic mechanisms has been reported to occur frequently in cancer. Epigenetic marks, such as histone methylation and acetylation, are altered at these loci. However, the mechanisms of formation of such aberrant gene clusters remain largely unknown. Here, we show that, in cancer cells, the epigenetic remodeling of chromatin into hypoacetylated domains covered with histone H3K27 trimethylation is paralleled by changes in higher-order chromatin structures. Using fluorescence in situ hybridization, we demonstrate that regional epigenetic silencing corresponds to the establishment of compact chromatin domains. We show that gene repression is tightly correlated to the state of chromatin compaction and not to the levels of H3K27me3-its removal through the knockdown of EZH2 does not induce significant gene expression nor chromatin decompaction. Moreover, transcription can occur with intact high-H3K27me3 levels; treatment with histone deacetylase inhibitors can relieve chromatin compaction and gene repression, without altering H3K27me3 levels. Our findings imply that compaction and subsequent repression of large chromatin domains are not direct consequences of PRC2 deregulation in cancer cells. By challenging the role of EZH2 in aberrant gene silencing in cancer, these findings have therapeutical implications, notably for the choice of epigenetic drugs for tumors with multiple regional epigenetic alterations.	[Vallot, C.; Herault, A.; Radvanyi, F.] Inst Curie, CNRS, UMR 144, Dept Cell Biol, F-75231 Paris, France; [Vallot, C.; Herault, A.; Radvanyi, F.] Inst Curie, Ctr Rech, Paris, France; [Boyle, S.; Bickmore, W. A.] Univ Edinburgh, Inst Genet & Mol Med, MRC, Chromosome & Gene Express Sect,Human Genet Unit, Edinburgh EH8 9YL, Midlothian, Scotland; [Bickmore, W. A.] Univ Edinburgh, Breakthrough Breast Canc Res Unit, Edinburgh EH8 9YL, Midlothian, Scotland	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Sorbonne Universite; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; University of Edinburgh; University of Edinburgh	Vallot, C (corresponding author), Univ Paris Diderot, UMR7216, 35 Rue Helene Brion, F-75205 Paris, France.	celine.vallot@univ-paris-diderot.fr; francois.radvanyi@curie.fr	; Bickmore, Wendy/C-7314-2013	Radvanyi, Francois/0000-0002-5696-6424; Bickmore, Wendy/0000-0001-6660-7735	Institut Curie; Centre National de la Recherche Scientifique; Institut National de la Sante et de la Recherche Medicale; Institut National Contre le Cancer; Ligue Nationale Contre le Cancer; national program Cartes d'Identite des Tumeurs (CIT) - Ligue Nationale Contre le Cancer; UK Medical Research Council; Breakthrough Breast Cancer; MRC [MC_PC_U127527202] Funding Source: UKRI; Medical Research Council [MC_PC_U127527202] Funding Source: researchfish	Institut Curie; Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); Institut National de la Sante et de la Recherche Medicale(Institut National de la Sante et de la Recherche Medicale (Inserm)); Institut National Contre le Cancer; Ligue Nationale Contre le Cancer(Ligue nationale contre le cancer); national program Cartes d'Identite des Tumeurs (CIT) - Ligue Nationale Contre le Cancer; UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Breakthrough Breast Cancer; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by the Institut Curie; the Centre National de la Recherche Scientifique; the Institut National de la Sante et de la Recherche Medicale; the Institut National Contre le Cancer (program GepiG, program Tumult); the Ligue Nationale Contre le Cancer (CV, AH and FR, Equipe labellisee) and the national program Cartes d'Identite des Tumeurs (CIT), funded and developed by the Ligue Nationale Contre le Cancer. WAB and SB are supported by a unit program from the UK Medical Research Council and WAB is also supported by Breakthrough Breast Cancer. We thank Jennifer Southgate for providing us normal human urothelial (NHU) cells and Claire Rougeulle for critical reading of the manuscript.	Bachmann IM, 2006, J CLIN ONCOL, V24, P268, DOI 10.1200/JCO.2005.01.5180; Ben-Porath I, 2008, NAT GENET, V40, P499, DOI 10.1038/ng.127; Bernstein BE, 2005, CELL, V120, P169, DOI 10.1016/j.cell.2005.01.001; Billerey C, 2001, AM J PATHOL, V158, P1955, DOI 10.1016/S0002-9440(10)64665-2; Boumber Y, 2011, ONCOLOGY-NY, V25, P220; Cao Q, 2008, ONCOGENE, V27, P7274, DOI 10.1038/onc.2008.333; Cao R, 2004, CURR OPIN GENET DEV, V14, P155, DOI 10.1016/j.gde.2004.02.001; Chambeyron S, 2005, DEVELOPMENT, V132, P2215, DOI 10.1242/dev.01813; Chambeyron S, 2004, GENE DEV, V18, P1119, DOI 10.1101/gad.292104; Chen H, 2005, J BIOL CHEM, V280, P22437, DOI 10.1074/jbc.M501379200; Coolen MW, 2010, NAT CELL BIOL, V12, P235, DOI 10.1038/ncb2023; Crawley JJ, 2002, GENOME BIOL, V3; DeBoer WI, 1997, INT J CANCER, V71, P284, DOI 10.1002/(SICI)1097-0215(19970410)71:2<284::AID-IJC25>3.0.CO;2-G; Eskeland R, 2011, COLD SPRING HARB SYM, V75, P71; Eskeland R, 2010, MOL CELL, V38, P452, DOI 10.1016/j.molcel.2010.02.032; Francis NJ, 2004, SCIENCE, V306, P1574, DOI 10.1126/science.1100576; Frigola J, 2006, NAT GENET, V38, P540, DOI 10.1038/ng1781; Garrick D, 2008, BLOOD, V112, P3889, DOI 10.1182/blood-2008-06-161901; Gilbert N, 2004, CELL, V118, P555, DOI 10.1016/j.cell.2004.08.011; Illingworth RS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034848; Karantzali E, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-4-r65; Kleer CG, 2003, P NATL ACAD SCI USA, V100, P11606, DOI 10.1073/pnas.1933744100; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Lleres D, 2009, J CELL BIOL, V187, P481, DOI 10.1083/jcb.200907029; Margueron R, 2010, NAT REV GENET, V11, P285, DOI 10.1038/nrg2752; Margueron R, 2008, MOL CELL, V32, P503, DOI 10.1016/j.molcel.2008.11.004; Morey C, 2007, DEVELOPMENT, V134, P909, DOI 10.1242/dev.02779; Morey L, 2013, CELL REP, V3, P60, DOI 10.1016/j.celrep.2012.11.026; Morin RD, 2010, NAT GENET, V42, P181, DOI 10.1038/ng.518; Nagano T, 2008, SCIENCE, V322, P1717, DOI 10.1126/science.1163802; Nguyen CT, 2002, CANCER RES, V62, P6456; Novak P, 2006, CANCER RES, V66, P10664, DOI 10.1158/0008-5472.CAN-06-2761; Nozawa RS, 2013, NAT STRUCT MOL BIOL; Pandey RR, 2008, MOL CELL, V32, P232, DOI 10.1016/j.molcel.2008.08.022; Pauler FM, 2009, GENOME RES, V19, P221, DOI 10.1101/gr.080861.108; Pinkel D, 1998, NAT GENET, V20, P207, DOI 10.1038/2524; Raman JD, 2005, CLIN CANCER RES, V11, P8570, DOI 10.1158/1078-0432.CCR-05-1047; Roh TY, 2005, GENE DEV, V19, P542, DOI 10.1101/gad.1272505; Shen XH, 2008, MOL CELL, V32, P491, DOI 10.1016/j.molcel.2008.10.016; Shogren-Knaak M, 2006, SCIENCE, V311, P844, DOI 10.1126/science.1124000; Simon JA, 2013, MOL CELL, V49, P808, DOI 10.1016/j.molcel.2013.02.013; Simon JA, 2008, MUTAT RES-FUND MOL M, V647, P21, DOI 10.1016/j.mrfmmm.2008.07.010; Soshnikova N, 2009, SCIENCE, V324, P1320, DOI 10.1126/science.1171468; SOUTHGATE J, 1994, LAB INVEST, V71, P583; Sproul D, 2005, NAT REV GENET, V6, P775, DOI 10.1038/nrg1688; Sproul D, 2011, P NATL ACAD SCI USA, V108, P4364, DOI 10.1073/pnas.1013224108; Stransky N, 2006, NAT GENET, V38, P1386, DOI 10.1038/ng1923; Sudo T, 2005, BRIT J CANCER, V92, P1754, DOI 10.1038/sj.bjc.6602531; Tavares L, 2012, CELL, V148, P664, DOI 10.1016/j.cell.2011.12.029; Toth KF, 2004, J CELL SCI, V117, P4277, DOI 10.1242/jcs.01293; Vallot C, 2011, JNCI-J NATL CANCER I, V103, P47, DOI 10.1093/jnci/djq470; van Oers JMM, 2005, CLIN CANCER RES, V11, P7743, DOI 10.1158/1078-0432.CCR-05-1045; VANDENENGH G, 1992, SCIENCE, V257, P1410, DOI 10.1126/science.1388286; Wen B, 2009, NAT GENET, V41, P246, DOI 10.1038/ng.297; Wu XD, 2013, MOL CELL, V49, P1134, DOI 10.1016/j.molcel.2013.01.016; Xu KX, 2012, SCIENCE, V338, P1465, DOI 10.1126/science.1227604; Yap DB, 2011, BLOOD, V117, P2451, DOI 10.1182/blood-2010-11-321208; Yu J, 2007, CANCER RES, V67, P10657, DOI 10.1158/0008-5472.CAN-07-2498; Zhao XD, 2007, CELL STEM CELL, V1, P286, DOI 10.1016/j.stem.2007.08.004	59	9	9	0	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB 5	2015	34	6					741	751		10.1038/onc.2013.604	http://dx.doi.org/10.1038/onc.2013.604			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CA4DG	24469045				2022-12-25	WOS:000348853800007
J	Akeno, N; Miller, AL; Ma, X; Wikenheiser-Brokamp, KA				Akeno, N.; Miller, A. L.; Ma, X.; Wikenheiser-Brokamp, K. A.			p53 suppresses carcinoma progression by inhibiting mTOR pathway activation	ONCOGENE			English	Article						p53; Rb; medullary thyroid cancer; mTOR	MEDULLARY-THYROID CARCINOMA; SOMATIC INACTIVATION; CELL LINEAGES; LUNG-CANCER; MUTANT MICE; MOUSE MODEL; RETINOBLASTOMA; RB; MUTATION; TUMORIGENESIS	Genetic alterations in human cancers and murine models indicate that retinoblastoma (Rb) and p53 have critical tumor suppressive functions in retinoblastoma, a tumor of neural origin, and neuroendocrine tumors including small cell lung cancer and medullary thyroid cancer (MTC). Rb inactivation is the initiating lesion in retinoblastoma and current models propose that induction of apoptosis is a key p53 tumor suppressive function. Genetic studies in mice, however, indicate that other undefined p53 tumor suppressive functions are operative in vivo. How p53 loss cooperates with Rb inactivation to promote carcinogenesis is also not fully understood. In the current study, genetically engineered mice were generated to determine the role of Rb and p53 in MTC pathogenesis and test the hypothesis that p53 suppresses carcinogenesis by inhibiting mammalian target of rapamycin (mTOR) signaling. Conditional Rb ablation resulted in thyroid tumors mimicking human MTC, and additional p53 loss led to rapid tumor progression. p53 suppressed tumorigenesis by inhibiting cell cycle progression, but did not induce apoptosis. On the contrary, p53 loss led to increased apoptosis that had to be overcome for tumor progression. The mTOR activity was markedly increased in p53-deficient tumors and rapamycin treatment suppressed tumor cell growth, identifying mTOR inhibition as a critical p53 tumor suppressive function. Rapamycin treatment did not result in AKT/mitogen-activated protein kinase activation, providing evidence that this feedback mechanism operative in other cancers is not a general response to mTORC1 inhibition. Together, these studies provide mechanistic links between genetic alterations and aberrant signaling pathways critical in carcinogenesis, and identify essential Rb and p53 tumor suppressive functions in vivo.	[Akeno, N.; Miller, A. L.; Ma, X.; Wikenheiser-Brokamp, K. A.] Cincinnati Childrens Hosp Med Ctr, Cincinnati, OH 45229 USA; [Wikenheiser-Brokamp, K. A.] Univ Cincinnati, Coll Med, Cincinnati, OH USA	Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati	Wikenheiser-Brokamp, KA (corresponding author), Cincinnati Childrens Hosp Med Ctr, 3333 Burnet Ave, Cincinnati, OH 45229 USA.	Kathryn.Wikenheiser-Brokamp@cchmc.org			American Cancer Society [RSG-10-194-01-TBG]; NIH/NHLBI [RO1 HL079193]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL079193] Funding Source: NIH RePORTER	American Cancer Society(American Cancer Society); NIH/NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We thank Mingyan Yang and Susan E Wert for technical expertise, Veterinary Services for excellent animal care, and Susanne I Wells and Elizabeth E Hoskins for reagents and technical expertise. This work was supported by grants from the American Cancer Society RSG-10-194-01-TBG and NIH/NHLBI RO1 HL079193 (to KAW-B).	Almeida MQ, 2012, CURR OPIN ONCOL, V24, P229, DOI 10.1097/CCO.0b013e328351c71a; Anwar F, 2000, MODERN PATHOL, V13, P562, DOI 10.1038/modpathol.3880097; Basolo F, 2000, THYROID, V10, P741, DOI 10.1089/thy.2000.10.741; Carracedo A, 2008, J CLIN INVEST, V118, P3065, DOI [10.1172/jCI34739, 10.1172/JCI34739]; Cerrato A, 2009, J MOL ENDOCRINOL, V43, P143, DOI 10.1677/JME-09-0024; Conkrite K, 2012, J CLIN INVEST, V122, P1726, DOI 10.1172/JCI61403; Dong M, 2012, CLIN CANCER RES, V18, P1830, DOI 10.1158/1078-0432.CCR-11-2105; Faggiano A, 2012, J CELL MOL MED, V16, P1563, DOI 10.1111/j.1582-4934.2011.01438.x; Feng ZH, 2010, TRENDS CELL BIOL, V20, P427, DOI 10.1016/j.tcb.2010.03.004; Freed-Pastor WA, 2012, GENE DEV, V26, P1268, DOI 10.1101/gad.190678.112; Frisk T, 2001, INT J ONCOL, V18, P1219; Goutas N, 2008, ANTICANCER RES, V28, P305; Grozinsky-Glasberg S, 2010, MOL CELL ENDOCRINOL, V315, P87, DOI 10.1016/j.mce.2009.09.027; HARVEY M, 1995, CANCER RES, V55, P1146; Hasty P, 2013, CELL CYCLE, V12, P20, DOI 10.4161/cc.22912; Hemmer S, 1999, AM J PATHOL, V154, P1539, DOI 10.1016/S0002-9440(10)65407-7; Herfarth KKF, 1997, GENE CHROMOSOME CANC, V20, P24, DOI 10.1002/(SICI)1098-2264(199709)20:1<24::AID-GCC4>3.3.CO;2-V; Hinze R, 2000, VIRCHOWS ARCH, V437, P256, DOI 10.1007/s004280000233; HOLM R, 1994, J PATHOL, V172, P267, DOI 10.1002/path.1711720307; Kouvaraki MA, 2011, SURGERY, V150, P1258, DOI 10.1016/j.surg.2011.09.022; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Laurie NA, 2006, NATURE, V444, P61, DOI 10.1038/nature05194; Levine AJ, 2009, NAT REV CANCER, V9, P749, DOI 10.1038/nrc2723; Liu G, 2004, NAT GENET, V36, P63, DOI 10.1038/ng1282; Marino S, 2000, GENE DEV, V14, P994; Marsh DJ, 2003, J CLIN ENDOCR METAB, V88, P1866, DOI 10.1210/jc.2002-021155; Matthew EM, 2009, CELL CYCLE, V8, P4168, DOI 10.4161/cc.8.24.10800; Meuwissen R, 2003, CANCER CELL, V4, P181, DOI 10.1016/S1535-6108(03)00220-4; Moura MM, 2011, J CLIN ENDOCR METAB, V96, pE863, DOI 10.1210/jc.2010-1921; Nikitin AY, 1999, P NATL ACAD SCI USA, V96, P3916, DOI 10.1073/pnas.96.7.3916; Pavelic K, 2006, MUTAT RES-FUND MOL M, V599, P45, DOI 10.1016/j.mrfmmm.2006.01.021; Perl AKT, 2002, P NATL ACAD SCI USA, V99, P10482, DOI 10.1073/pnas.152238499; Pitt SC, 2010, SEMIN ONCOL, V37, P567, DOI 10.1053/j.seminoncol.2010.10.010; Rapa I, 2011, J CLIN ENDOCR METAB, V96, P2146, DOI 10.1210/jc.2010-2655; Sheikh HA, 2004, AM J SURG PATHOL, V28, P101, DOI 10.1097/00000478-200401000-00012; Simpson DS, 2009, CANCER RES, V69, P8733, DOI 10.1158/0008-5472.CAN-09-1359; Sippel RS, 2008, ONCOLOGIST, V13, P539, DOI 10.1634/theoncologist.2007-0239; Smith-Hicks CL, 2000, EMBO J, V19, P612, DOI 10.1093/emboj/19.4.612; Stiewe T, 2007, NAT REV CANCER, V7, P165, DOI 10.1038/nrc2072; Tamburrino A, 2012, CLIN CANCER RES, V18, P3532, DOI 10.1158/1078-0432.CCR-11-2700; Vilar E, 2011, MOL CANCER THER, V10, P395, DOI 10.1158/1535-7163.MCT-10-0905; Vousden KH, 2009, CELL, V137, P413, DOI 10.1016/j.cell.2009.04.037; Wander SA, 2011, J CLIN INVEST, V121, P1231, DOI 10.1172/JCI44145; WIKENHEISER KA, 1993, P NATL ACAD SCI USA, V90, P11029, DOI 10.1073/pnas.90.23.11029; Wikenheiser-Brokamp KA, 2004, DEVELOPMENT, V131, P4299, DOI 10.1242/dev.01232; Wikenheiser-Brokamp KA, 2006, CURR MOL MED, V6, P783; WILLIAMS BO, 1994, NAT GENET, V7, P480, DOI 10.1038/ng0894-480; Wise-Draper TM, 2006, MOL CELL BIOL, V26, P7506, DOI 10.1128/MCB.00430-06; Wu LS, 2011, CURR OPIN ONCOL, V23, P22, DOI 10.1097/CCO.0b013e328340b527; YOSHIMOTO K, 1992, CANCER RES, V52, P5061	50	38	40	1	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 29	2015	34	5					589	599		10.1038/onc.2013.589	http://dx.doi.org/10.1038/onc.2013.589			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CA4DD	24469052	Green Accepted			2022-12-25	WOS:000348853500006
J	Cyr, AR; Kulak, MV; Park, JM; Bogachek, MV; Spanheimer, PM; Woodfield, GW; White-Baer, LS; O'Malley, YQ; Sugg, SL; Olivier, AK; Zhang, W; Domann, FE; Weigel, RJ				Cyr, A. R.; Kulak, M. V.; Park, J. M.; Bogachek, M. V.; Spanheimer, P. M.; Woodfield, G. W.; White-Baer, L. S.; O'Malley, Y. Q.; Sugg, S. L.; Olivier, A. K.; Zhang, W.; Domann, F. E.; Weigel, R. J.			TFAP2C governs the luminal epithelial phenotype in mammary development and carcinogenesis	ONCOGENE			English	Article						TFAP2C; breast cancer; mammary development; luminal; gene expression; EMT	BREAST-CANCER CELLS; STEM-CELLS; MESENCHYMAL TRANSITION; EXPRESSION PATTERNS; ESTROGEN-RECEPTOR; TRANSCRIPTION; AP-2-GAMMA; IDENTIFICATION; MARKERS; DIFFERENTIATION	Molecular subtypes of breast cancer are characterized by distinct patterns of gene expression that are predictive of outcome and response to therapy. The luminal breast cancer subtypes are defined by the expression of estrogen receptor-alpha (ER alpha)-associated genes, many of which are directly responsive to the transcription factor activator protein 2C (TFAP2C). TFAP2C participates in a gene regulatory network controlling cell growth and differentiation during ectodermal development and regulating ESR1/ER alpha and other luminal cell-associated genes in breast cancer. TFAP2C has been established as a prognostic factor in human breast cancer, however, its role in the establishment and maintenance of the luminal cell phenotype during carcinogenesis and mammary gland development have remained elusive. Herein, we demonstrate a critical role for TFAP2C in maintaining the luminal phenotype in human breast cancer and in influencing the luminal cell phenotype during normal mammary development. Knockdown of TFAP2C in luminal breast carcinoma cells induced epithelial-mesenchymal transition with morphological and phenotypic changes characterized by a loss of luminal-associated gene expression and a concomitant gain of basal-associated gene expression. Conditional knockout of the mouse homolog of TFAP2C, Tcfap2c, in mouse mammary epithelium driven by MMTV-Cre promoted aberrant growth of the mammary tree leading to a reduction in the CD24(hi)/CD49f(mid) luminal cell population and concomitant gain of the CD24(mid)/CD49f(hi) basal cell population at maturity. Our results establish TFAP2C as a key transcriptional regulator for maintaining the luminal phenotype in human breast carcinoma. Furthermore, Tcfap2c influences development of the luminal cell type during mammary development. The data suggest that TFAP2C has an important role in regulated luminal-specific genes and may be a viable therapeutic target in breast cancer.	[Cyr, A. R.; Kulak, M. V.; Park, J. M.; Bogachek, M. V.; Spanheimer, P. M.; Woodfield, G. W.; White-Baer, L. S.; O'Malley, Y. Q.; Sugg, S. L.; Domann, F. E.; Weigel, R. J.] Univ Iowa, Dept Surg, Iowa City, IA 52242 USA; [Cyr, A. R.; Domann, F. E.] Univ Iowa, Dept Radiat Oncol, Iowa City, IA 52242 USA; [Olivier, A. K.; Zhang, W.; Domann, F. E.] Univ Iowa, Dept Pathol, Iowa City, IA 52242 USA; [Weigel, R. J.] Univ Iowa, Dept Biochem, Iowa City, IA 52242 USA	University of Iowa; University of Iowa; University of Iowa; University of Iowa	Weigel, RJ (corresponding author), Univ Iowa, Dept Surg, 200 Hawkins Dr, Iowa City, IA 52242 USA.	Ronald-Weigel@uiowa.edu		Weigel, Ronald/0000-0002-9249-0793; Kulak, Mikhail/0000-0002-4307-5868; Sugg, Sonia/0000-0001-7530-8526; Domann, Frederick/0000-0002-0489-2179	National Institutes of Health [R01CA109294, T32CA148062, K99/R00CA158055]; Department of Pathology; NIH [T32CA148062]; NATIONAL CANCER INSTITUTE [R00CA158055, R01CA109294, K99CA158055, T32CA148062, T32CA078586] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES005605] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007337] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Pathology; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Institutes of Health grants R01CA109294 (PI: RJW), T32CA148062 (PI: RJW), K99/R00CA158055 (PI: WZ), a Startup Fund from the Department of Pathology (PI: WZ) and by a generous gift from the Kristen Olewine Milke Breast Cancer Research Fund. PMS was supported by the NIH grant T32CA148062.	Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Auman HJ, 2002, DEVELOPMENT, V129, P2733; Bai F, 2013, ONCOGENE, V32, P2715, DOI 10.1038/onc.2012.293; Balko JM, 2012, P NATL ACAD SCI USA, V109, P221, DOI 10.1073/pnas.1115802109; Bernardo GM, 2013, ONCOGENE, V32, P554, DOI 10.1038/onc.2012.62; BOSHER JM, 1995, P NATL ACAD SCI USA, V92, P744, DOI 10.1073/pnas.92.3.744; Buchwalter G, 2013, CANCER CELL, V23, P753, DOI 10.1016/j.ccr.2013.04.026; Carr JR, 2012, CELL REP, V1, P715, DOI 10.1016/j.celrep.2012.05.005; DECONINCK EC, 1995, MOL CELL BIOL, V15, P2191; Delacroix L, 2005, DNA CELL BIOL, V24, P582, DOI 10.1089/dna.2005.24.582; dos Santos CO, 2013, P NATL ACAD SCI USA, V110, P7123, DOI 10.1073/pnas.1303919110; Friedrichs N, 2007, HISTOPATHOLOGY, V51, P814, DOI 10.1111/j.1365-2559.2007.02887.x; Friedrichs N, 2005, MODERN PATHOL, V18, P431, DOI 10.1038/modpathol.3800292; Gee JMW, 2009, J PATHOL, V217, P32, DOI 10.1002/path.2430; Groger CJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051136; Guttormsen J, 2008, DEV BIOL, V317, P187, DOI 10.1016/j.ydbio.2008.02.017; He AL, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-279; Hoffman TL, 2007, J EXP ZOOL PART B, V308B, P679, DOI 10.1002/jez.b.21189; Jager R, 2010, DEV DYNAM, V239, P1027, DOI 10.1002/dvdy.22239; Jager R, 2005, BREAST CANCER RES TR, V90, P273, DOI 10.1007/s10549-004-4815-x; Kalyuga M, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001461; Kao J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006146; Lee HE, 2011, BRIT J CANCER, V104, P1730, DOI 10.1038/bjc.2011.159; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; McPherson LA, 1997, P NATL ACAD SCI USA, V94, P4342, DOI 10.1073/pnas.94.9.4342; Park SY, 2010, CLIN CANCER RES, V16, P876, DOI 10.1158/1078-0432.CCR-09-1532; Plante I, 2011, JOVE-J VIS EXP, DOI 10.3791/2828; Qiao YB, 2012, CELL RES, V22, P1546, DOI 10.1038/cr.2012.122; Ricardo S, 2011, J CLIN PATHOL, V64, P937, DOI 10.1136/jcp.2011.090456; Sarrio D, 2008, CANCER RES, V68, P989, DOI 10.1158/0008-5472.CAN-07-2017; Smalley MJ, 2010, METHODS MOL BIOL, V633, P139, DOI 10.1007/978-1-59745-019-5_11; Spanheimer PM, 2013, J SURG RES, V184, P519, DOI 10.1016/j.jss.2013.04.042; Stingl J, 2006, NATURE, V439, P993, DOI 10.1038/nature04496; Tan SK, 2011, EMBO J, V30, P2569, DOI 10.1038/emboj.2011.151; Wagner KU, 1997, NUCLEIC ACIDS RES, V25, P4323, DOI 10.1093/nar/25.21.4323; Woodfield GW, 2007, CANCER RES, V67, P8439, DOI 10.1158/0008-5472.CAN-07-2293; Woodfield GW, 2010, GENE CHROMOSOME CANC, V49, P948, DOI 10.1002/gcc.20807	37	38	38	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 22	2015	34	4					436	444		10.1038/onc.2013.569	http://dx.doi.org/10.1038/onc.2013.569			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AZ8FU	24469049	Green Accepted			2022-12-25	WOS:000348451300004
J	Gao, W; Gulliford, M; Bennett, MI; Murtagh, FEM; Higginson, IJ				Gao, Wei; Gulliford, Martin; Bennett, Michael I.; Murtagh, Fliss E. M.; Higginson, Irene J.			Managing Cancer Pain at the End of Life with Multiple Strong Opioids: A Population-Based Retrospective Cohort Study in Primary Care	PLOS ONE			English	Article							LAST 3 MONTHS; ADJUVANT ANALGESICS; PREVALENCE; MANAGEMENT	Background: End-of-life cancer patients commonly receive more than one type of strong opioid. The three-step analgesic ladder framework of the World Health Organisation (WHO) provides no guidance on multiple opioid prescribing and there is little epidemiological data available to inform practice. This study aims to investigate the time trend of such cases and the associated factors. Methods: Strong opioid prescribing in the last three months of life of cancer patients were extracted from the General Practice Research Database (GPRD). The outcome variable was the number of different types of prescribed non-rescue doses of opioids (1 vs 2-4, referred to as a complex case). Associated factors were evaluated using prevalence ratios (PR) derived from multivariate log-binomial model, adjusting for clustering effects and potential confounding variables. Results: Overall, 26.4% (95% CI: 25.6-27.1%) of 13,427 cancer patients (lung 41.7%, colorectal 19.1%, breast 18.6%, prostate 15.5%, head and neck 5.0%) were complex cases. Complex cases increased steadily over the study period (1.02% annually, 95% CI: 0.42-1.61%, p = 0.048) but with a small dip (7.5% reduction, 95% CI: -0.03 to 17.8%) around the period of the Shipman case, a British primary care doctor who murdered his patients with opioids. The dip significantly affected the correlation of the complex cases with persistent increasing background opioid prescribing (weighted correlation coefficients pre-, post-Shipman periods: 0.98(95% CI: 0.67-1.00), p = 0.011; 0.14 (95% CI: -0.85 to 0.91), p = 0.85). Multivariate adjusted analysis showed that the complex cases were predominantly associated with year of death (PRs vs 2000: 1.05-1.65), not other demographic and clinical factors except colorectal cancer (PR vs lung cancer: 1.24, 95% CI: 1.12-1.37). Conclusion: These findings suggest that prescribing behaviour, rather than patient factors, plays an important role in multiple opioid prescribing at the end of life; highlighting the need for training and education that goes beyond the well-recognised WHO approach for clinical practitioners.	[Gao, Wei; Murtagh, Fliss E. M.; Higginson, Irene J.] Kings Coll London, Sch Med, Dept Palliat Care Policy & Rehabil, London WC2R 2LS, England; [Gulliford, Martin] Kings Coll London, Sch Med, Dept Primary Care & Publ Hlth Sci, London WC2R 2LS, England; [Bennett, Michael I.] Univ Leeds, Leeds Inst Hlth Sci, Acad Unit Palliat Care, Leeds, W Yorkshire, England	University of London; King's College London; University of London; King's College London; University of Leeds	Gao, W (corresponding author), Kings Coll London, Sch Med, Dept Palliat Care Policy & Rehabil, London WC2R 2LS, England.	wei.gao@kcl.ac.uk	Bennett, Michael I/A-1620-2009; Gulliford, Martin C/I-8606-2018; Gao, Wei/G-8653-2011; Murtagh, Fliss E M/C-3216-2009; Higginson, Irene Julie/C-7309-2012	Bennett, Michael I/0000-0002-8369-8349; Gulliford, Martin C/0000-0003-1898-9075; Gao, Wei/0000-0001-8298-3415; Murtagh, Fliss E M/0000-0003-1289-3726; Higginson, Irene Julie/0000-0002-3687-1313	NCRI-NIHR COMPASS Collaborative (the UK National Cancer Research Institute Supportive and Palliative Care Research Collaborative); National Institute for Health Research [NF-SI-0611-10209] Funding Source: researchfish	NCRI-NIHR COMPASS Collaborative (the UK National Cancer Research Institute Supportive and Palliative Care Research Collaborative); National Institute for Health Research(National Institute for Health Research (NIHR))	This work is supported by the NCRI-NIHR COMPASS Collaborative (the UK National Cancer Research Institute Supportive and Palliative Care Research Collaborative). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bennett MI, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e2806; Bennett Michael I, 2011, Curr Opin Support Palliat Care, V5, P20, DOI 10.1097/SPC.0b013e328342c607; Caraceni A, 2012, LANCET ONCOL, V13, pE58, DOI 10.1016/S1470-2045(12)70040-2; Cherny N, 2001, J CLIN ONCOL, V19, P2542, DOI 10.1200/JCO.2001.19.9.2542; Claseem A, 2008, ANN INTERN MED, V148, P141, DOI 10.7326/0003-4819-148-2-200801150-00009; Costantini M, 2009, ANN ONCOL, V20, P729, DOI 10.1093/annonc/mdn700; Deandrea S, 2008, ANN ONCOL, V19, P1985, DOI 10.1093/annonc/mdn419; Droney J, 2012, CURR OPIN SUPPORT PA, V6, P10, DOI 10.1097/SPC.0b013e32834f6a07; Finch R, 2004, SHIPMAN HAS MADE GPS; Gao W, 2011, BRIT J CANCER, V104, P1704, DOI 10.1038/bjc.2011.150; Gardiner C, 2012, J PAIN SYMPTOM MANAG; Higginson IJ, 2012, J CLIN ONCOL; Jacobsen Ramune, 2007, J Opioid Manag, V3, P207; Khan NF, 2010, BMC FAM PRACT, V11, DOI 10.1186/1471-2296-11-1; Lussier D, 2004, ONCOLOGIST, V9, P571, DOI 10.1634/theoncologist.9-5-571; Mercadante S, 2012, J PAIN SYMPTOM MANAG; Mercadante S, 2006, J PAIN SYMPTOM MANAG, V32, P413, DOI 10.1016/j.jpainsymman.2006.05.015; Mercadante S, 2012, J PALLIAT MED, V15, P347, DOI 10.1089/jpm.2011.0198; Mercadante S, 2011, PALLIATIVE MED, V25, P504, DOI 10.1177/0269216311406577; Mitra R, 2012, AM J HOSP PALLIAT ME, V29, P70, DOI 10.1177/1049909111413256; Moksnes K, 2012, EUR J CLIN PHARMACOL, V68, P1147, DOI 10.1007/s00228-012-1228-3; NICE, 2011, OP PALL CAR SAF EFF; Oldenmenger WH, 2009, EUR J CANCER, V45, P1370, DOI 10.1016/j.ejca.2009.01.007; Portenoy RK, 2011, LANCET, V377, P2236, DOI 10.1016/S0140-6736(11)60236-5; Potter VT, 2003, PSYCHO-ONCOLOGY, V12, P153, DOI 10.1002/pon.627; Raijmakers NJ, 2012, SUPPORT CARE CANC; Rurup Mette L, 2010, BMC Palliat Care, V9, P23, DOI 10.1186/1472-684X-9-23; Skollerud LM, 2012, SUPPORT CARE CANC; Smith D J, 2004, REGULATION CONTROLLE; The Information Centre NHS, 2006, HOSP PRESCR 2005 ENG; Zeppetela G, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004311.pub2	31	15	16	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2014	9	1							e79266	10.1371/journal.pone.0079266	http://dx.doi.org/10.1371/journal.pone.0079266			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301BI	24475016	gold, Green Published			2022-12-25	WOS:000330507300003
J	Brunet, C; Chandrasekaran, R; Barra, L; Giovagnetti, V; Corato, F; Ruban, AV				Brunet, Christophe; Chandrasekaran, Raghu; Barra, Lucia; Giovagnetti, Vasco; Corato, Federico; Ruban, Alexander V.			Spectral Radiation Dependent Photoprotective Mechanism in the Diatom Pseudo-nitzschia multistriata	PLOS ONE			English	Article							PHAEODACTYLUM-TRICORNUTUM; FLUCTUATING LIGHT; XANTHOPHYLL CYCLE; MARINE DIATOMS; PHYTOPLANKTON; ENERGY; BACILLARIOPHYCEAE; RESPONSES; ACCLIMATION; VARIABILITY	Phytoplankton, such as diatoms, experience great variations of photon flux density (PFD) and light spectrum along the marine water column. Diatoms have developed some rapidly-regulated photoprotective mechanisms, such as the xanthophyll cycle activation (XC) and the non-photochemical chlorophyll fluorescence quenching (NPQ), to protect themselves from photooxidative damages caused by excess PFD. In this study, we investigate the role of blue fluence rate in combination with red radiation in shaping photoacclimative and protective responses in the coastal diatom Pseudo-nitzschia multistriata. This diatom was acclimated to four spectral light conditions (blue, red, blue-red, blue-red-green), each of them provided with low and high PFD. Our results reveal that the increase in the XC pool size and the amplitude of NPQ is determined by the blue fluence rate experienced by cells, while cells require sensing red radiation to allow the development of these processes. Variations in the light spectrum and in the blue versus red radiation modulate either the photoprotective capacity, such as the activation of the diadinoxanthin-diatoxanthin xanthophyll cycle, the diadinoxanthin de-epoxidation rate and the capacity of non-photochemical quenching, or the pigment composition of this diatom. We propose that spectral composition of light has a key role on the ability of diatoms to finely balance light harvesting and photoprotective capacity.	[Brunet, Christophe; Chandrasekaran, Raghu; Barra, Lucia; Giovagnetti, Vasco; Corato, Federico] Stn Zool Anton Dohrn, Lab Ecol & Evolut Plankton, Naples, Italy; [Ruban, Alexander V.] Queen Mary Univ London, Sch Biol & Chem Sci, London, England	Stazione Zoologica Anton Dohrn di Napoli; University of London; Queen Mary University London	Brunet, C (corresponding author), Stn Zool Anton Dohrn, Lab Ecol & Evolut Plankton, Naples, Italy.	christophe.brunet@szn.it	brunet, christophe/AAD-7817-2021; barra, lucia/AGG-7397-2022	Giovagnetti, Vasco/0000-0002-3298-4310; Chandrasekaran, Raghu/0000-0002-7329-0323	Stazione Zoologica Anton Dohrn; BBSRC [BB/L019027/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/L019027/1] Funding Source: researchfish	Stazione Zoologica Anton Dohrn; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by Stazione Zoologica Anton Dohrn. R.C.'s PhD is funded by Stazione Zoologica Anton Dohrn. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brunet C., 2011, PHYTOPLANKTON PIGMEN, P445, DOI [10.1017/CBO9780511732263.017, DOI 10.1017/CBO9780511732263.017]; Brunet C, 2007, MAR ECOL PROG SER, V346, P15, DOI 10.3354/meps07017; Brunet C, 2010, J PLANKTON RES, V32, P1609, DOI 10.1093/plankt/fbq104; Cao S, 2013, J BASIC MICROB, DOI [10.1002/jobm.201200315, DOI 10.1002/J0BM.201200315]; Coesel S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002896; Costa BS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074451; Costa BS, 2013, J EXP BOT, V64, P483, DOI 10.1093/jxb/ers340; D'Alelio D, 2010, LIMNOL OCEANOGR, V55, P106, DOI 10.4319/lo.2010.55.1.0106; Depauw FA, 2012, J EXP BOT, V63, P1575, DOI 10.1093/jxb/ers005; Dimier C, 2009, LIMNOL OCEANOGR, V54, P823, DOI 10.4319/lo.2009.54.3.0823; DRING MJ, 1988, ANNU REV PLANT PHYS, V39, P157, DOI 10.1146/annurev.pp.39.060188.001105; EILERS PHC, 1988, ECOL MODEL, V42, P199, DOI 10.1016/0304-3800(88)90057-9; Falkowski GP, 2007, AQUATIC PHOTOSYNTHES; FALKOWSKI PG, 1991, J PHYCOL, V27, P8, DOI 10.1111/j.0022-3646.1991.00008.x; FALKOWSKI PG, 1984, J PLANKTON RES, V6, P295, DOI 10.1093/plankt/6.2.295; Fisher AE, 1996, J PHYCOL, V32, P353, DOI 10.1111/j.0022-3646.1996.00353.x; Fujiki T, 2002, J PLANKTON RES, V24, P859, DOI 10.1093/plankt/24.9.859; Gildenhoff N, 2010, BBA-BIOENERGETICS, V1797, P543, DOI 10.1016/j.bbabio.2010.01.024; Giovagnetti V, 2012, EUR J PHYCOL, V47, P408, DOI 10.1080/09670262.2012.733030; Goss R, 2010, PHOTOSYNTH RES, V106, P103, DOI 10.1007/s11120-010-9536-x; Gundermann K, 2013, BBA-BIOENERGETICS, V1827, P303, DOI 10.1016/j.bbabio.2012.10.017; Halsey KH, 2013, NEW PHYTOL, V198, P1030, DOI 10.1111/nph.12209; HEDGES JI, 1984, LIMNOL OCEANOGR, V29, P657, DOI 10.4319/lo.1984.29.3.0657; Huysman MJJ, 2013, PLANT CELL, V25, P215, DOI 10.1105/tpc.112.106377; Ishikawa M, 2009, PLANTA, V230, P543, DOI 10.1007/s00425-009-0967-6; Kirk J.T.O., 1994, LIGHT PHOTOSYNTHESIS; Lavaud J, 2007, FUNCT PLANT SCI BIOT, V1, P267; Lavaud J, 2006, PLANT CELL PHYSIOL, V47, P1010, DOI 10.1093/pcp/pcj058; Lavaud J, 2013, BBA-BIOENERGETICS, V1827, P294, DOI 10.1016/j.bbabio.2012.11.012; Lepetit B, 2012, PHOTOSYNTH RES, V111, P245, DOI 10.1007/s11120-011-9633-5; Lepetit B, 2010, PLANT PHYSIOL, V154, P1905, DOI 10.1104/pp.110.166454; Litchman E, 2001, AM NAT, V157, P170, DOI 10.1086/318628; LOPEZFIGUEROA F, 1992, MAR ECOL-P S Z N I, V13, P285, DOI 10.1111/j.1439-0485.1992.tb00356.x; MacIntyre HL, 2000, TRENDS PLANT SCI, V5, P12, DOI 10.1016/S1360-1385(99)01504-6; Marchetti A, 2012, P NATL ACAD SCI USA, V109, pE317, DOI 10.1073/pnas.1118408109; McLachlan DH, 2009, J PHYCOL, V45, P592, DOI 10.1111/j.1529-8817.2009.00681.x; MOREL A, 1987, LIMNOL OCEANOGR, V32, P1066, DOI 10.4319/lo.1987.32.5.1066; Mouget JL, 2004, J PHOTOCH PHOTOBIO B, V75, P1, DOI 10.1016/j.jphotobiol.2004.04.002; Nagao R, 2013, J PHYS CHEM B, V117, P6888, DOI 10.1021/jp403923q; Nymark M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058722; Rasmussen B, 2008, NATURE, V455, P1101, DOI 10.1038/nature07381; ROENNEBERG T, 1988, NATURE, V334, P432, DOI 10.1038/334432a0; Roenneberg T, 1997, PHOTOCHEM PHOTOBIOL, V66, P549, DOI 10.1111/j.1751-1097.1997.tb03188.x; Ruban AV, 2004, PHOTOSYNTH RES, V82, P165, DOI 10.1007/s11120-004-1456-1; Schumann A, 2007, PHYCOLOGIA, V46, P113, DOI 10.2216/06-30.1; Shiihira-Ishikawa I, 2007, PHOTOCHEM PHOTOBIOL, V83, P1101, DOI 10.1111/j.1751-1097.2007.00167.x; Six C, 2008, LIMNOL OCEANOGR, V53, P255, DOI 10.4319/lo.2008.53.1.0255; Takahashi F, 2007, P NATL ACAD SCI USA, V104, P19625, DOI 10.1073/pnas.0707692104; Wagner H, 2006, NEW PHYTOL, V169, P95, DOI 10.1111/j.1469-8137.2005.01550.x; Zapata M, 2004, MAR ECOL PROG SER, V270, P83, DOI 10.3354/meps270083; Zapata M, 2011, J PHYCOL, V47, P1274, DOI 10.1111/j.1529-8817.2011.01055.x	51	44	45	0	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2014	9	1							e87015	10.1371/journal.pone.0087015	http://dx.doi.org/10.1371/journal.pone.0087015			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	298QQ	24475212	Green Published, gold, Green Submitted			2022-12-25	WOS:000330339800077
J	Franze, G; Lavrentyev, PJ				Franze, Gayantonia; Lavrentyev, Peter J.			Microzooplankton Growth Rates Examined across a Temperature Gradient in the Barents Sea	PLOS ONE			English	Article							CILIATE MESODINIUM-RUBRUM; DINOFLAGELLATE DINOPHYSIS-ACUMINATA; COMMUNITY STRUCTURE; MYRIONECTA-RUBRA; GRAZING IMPACT; ARCTIC-OCEAN; VERTICAL-DISTRIBUTION; PHYTOPLANKTON GROWTH; MARINE-PHYTOPLANKTON; WEST GREENLAND	Growth rates (mu) of abundant microzooplankton species were examined in field experiments conducted at ambient sea temperatures (-1.8-9.0 degrees C) in the Barents Sea and adjacent waters (70-78.5 degrees N). The maximum species-specific mu of ciliates and athecate dinoflagellates (0.33-1.67 d(-1) and 0.52-1.14 d(-1), respectively) occurred at temperatures below 5 degrees C and exceeded the mu(max) predicted by previously published, laboratory culture-derived equations. The opposite trend was found for thecate dinoflagellates, which grew faster in the warmer Atlantic Ocean water. Mixotrophic ciliates and dinoflagellates grew faster than their heterotrophic counterparts. At sub-zero temperatures, microzooplankton mu(max) matched those predicted for phytoplankton by temperature-dependent growth equations. These results indicate that microzooplankton protists may be as adapted to extreme Arctic conditions as their algal prey.	[Franze, Gayantonia; Lavrentyev, Peter J.] Univ Akron, Dept Biol, Akron, OH 44325 USA	University System of Ohio; University of Akron	Lavrentyev, PJ (corresponding author), Univ Akron, Dept Biol, Akron, OH 44325 USA.	peter3@uakron.edu	Franze, Gayantonia/AAI-7305-2020; Franzé, Gayantonia/H-8378-2019; Lavrentyev, Peter/Q-7449-2017	Franze, Gayantonia/0000-0003-0028-4739; Lavrentyev, Peter/0000-0001-5635-7920	National Science Foundation [ARC-0909372]	National Science Foundation(National Science Foundation (NSF))	This study was supported by the National Science Foundation (Award ARC-0909372). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BANSE K, 1982, LIMNOL OCEANOGR, V27, P1059, DOI 10.4319/lo.1982.27.6.1059; Berard-Therriault L, 1999, PUBLICATION SPECIAL; Bissinger JE, 2008, LIMNOL OCEANOGR, V53, P487, DOI 10.4319/lo.2008.53.2.0487; BOOTH BC, 1993, PROG OCEANOGR, V32, P57, DOI 10.1016/0079-6611(93)90009-3; Brush MJ, 2002, MAR ECOL PROG SER, V238, P31, DOI 10.3354/meps238031; Bundy MH, 2005, CAN J FISH AQUAT SCI, V62, P2371, DOI 10.1139/F05-111; Calbet A, 2011, J PLANKTON RES, V33, P687, DOI 10.1093/plankt/fbq142; Campbell RG, 2009, DEEP-SEA RES PT II, V56, P1274, DOI 10.1016/j.dsr2.2008.10.027; Caron DA, 2008, LIMNOL OCEANOGR, V53, P2048; Carvalho WF, 2008, HARMFUL ALGAE, V7, P174, DOI 10.1016/j.hal.2007.07.002; Chen BZ, 2012, LIMNOL OCEANOGR, V57, P519, DOI 10.4319/lo.2012.57.2.0519; Crawford DW, 1997, AQUAT MICROB ECOL, V13, P267, DOI 10.3354/ame013267; Dolan JR, 2000, FRESHWATER BIOL, V45, P227, DOI 10.1046/j.1365-2427.2000.00659.x; Duarte CM, 2012, NAT CLIM CHANGE, V2, P60, DOI 10.1038/nclimate1386; Eddie B, 2008, MAR ECOL PROG SER, V354, P107, DOI 10.3354/meps07243; EPPLEY RW, 1972, FISH B-NOAA, V70, P1063; First MR, 2009, AQUAT MICROB ECOL, V54, P255, DOI 10.3354/ame01271; Franze G, 2013, MAR BIOL, V160, P3103, DOI 10.1007/s00227-013-2298-1; GARRISON DL, 1986, POLAR BIOL, V6, P237, DOI 10.1007/BF00443401; GILSTAD M, 1990, MAR ECOL PROG SER, V64, P169, DOI 10.3354/meps064169; Hansen BW, 2000, J MAR BIOL ASSOC UK, V80, P37; HANSEN PJ, 1991, MAR ECOL PROG SER, V69, P201, DOI 10.3354/meps069201; HANSEN PJ, 1992, MAR BIOL, V114, P327, DOI 10.1007/BF00349535; Hansen PJ, 1997, LIMNOL OCEANOGR, V42, P687, DOI 10.4319/lo.1997.42.4.0687; Herfort L, 2011, ESTUAR COAST SHELF S, V95, P440, DOI 10.1016/j.ecss.2011.10.015; Holding JM, 2013, BIOGEOSCIENCES, V10, P357, DOI 10.5194/bg-10-357-2013; Ikavalko J, 1997, POLAR BIOL, V17, P473, DOI 10.1007/s003000050145; Irigoien X, 2005, J PLANKTON RES, V27, P313, DOI 10.1093/plankt/fbi011; Jeong Hae Jin, 2010, Ocean Science Journal, V45, P65, DOI 10.1007/s12601-010-0007-2; Ji RB, 2007, MAR ECOL PROG SER, V344, P49, DOI 10.3354/meps06952; Kim S, 2008, AQUAT MICROB ECOL, V51, P301, DOI 10.3354/ame01203; Kjaeret AH, 2000, SARSIA, V85, P453, DOI 10.1080/00364827.2000.10414594; Kofoid C. A., 1921, MEMOIRS U CALIFORNIA, DOI [10.5962/bhl.title.24995, DOI 10.5962/BHL.TITLE.24995]; KOFOID CHARLES A., 1929, UNIV CALIF PUBL ZOOL, V34, P1; Kwok R, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL039035; Landry MR, 2004, ICES J MAR SCI, V61, P501, DOI 10.1016/j.icesjms.2004.03.011; Levinsen H, 2000, MAR ECOL PROG SER, V204, P65, DOI 10.3354/meps204065; Levinsen H, 1999, AQUAT MICROB ECOL, V16, P217, DOI 10.3354/ame016217; Levinsen H, 2002, LIMNOL OCEANOGR, V47, P427, DOI 10.4319/lo.2002.47.2.0427; Levinsen H, 2000, MAR ECOL PROG SER, V206, P119, DOI 10.3354/meps206119; LOENG H, 1991, POLAR RES, V10, P5, DOI 10.1111/j.1751-8369.1991.tb00630.x; Lombard F, 2010, LIMNOL OCEANOGR, V55, P77, DOI 10.4319/lo.2010.55.1.0077; Lovejoy C, 2007, J PHYCOL, V43, P78, DOI 10.1111/j.1529-8817.2006.00310.x; Matishov GG, 2000, NOAA INT OCEAN ATLAS, V2; McManus GB, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00321; Menden-Deuer S, 2000, LIMNOL OCEANOGR, V45, P569, DOI 10.4319/lo.2000.45.3.0569; Menden-Deuer S, 2010, MAR ECOL PROG SER, V420, P57, DOI 10.3354/meps08855; Modigh M, 2009, J PLANKTON RES, V31, P853, DOI 10.1093/plankt/fbp035; Moeller HV, 2011, J PHYCOL, V47, P324, DOI 10.1111/j.1529-8817.2010.00954.x; Moller EF, 2006, DEEP-SEA RES PT I, V53, P76, DOI 10.1016/j.dsr.2005.09.007; Montagnes DJS, 2003, AQUAT MICROB ECOL, V32, P307, DOI 10.3354/ame032307; MONTAGNES DJS, 1988, MAR BIOL, V99, P21, DOI 10.1007/BF00644973; MULLER H, 1993, ARCH HYDROBIOL, V126, P315; Myung G, 2006, AQUAT MICROB ECOL, V44, P175, DOI 10.3354/ame044175; NIELSEN TG, 1994, LIMNOL OCEANOGR, V39, P508, DOI 10.4319/lo.1994.39.3.0508; NIELSON TG, 1994, LIMNOL OCEANOGR, V39, P1423; Nikiforov EG, 1980, PATTERNS LARGE SCALE; Olson MB, 2002, DEEP-SEA RES PT II, V49, P5969, DOI 10.1016/S0967-0645(02)00329-6; Pabi S, 2008, J GEOPHYS RES-OCEANS, V113, DOI 10.1029/2007JC004578; Paffenhofer GA, 2007, MAR ECOL-EVOL PERSP, V28, P243, DOI 10.1111/j.1439-0485.2007.00162.x; Perez MT, 1997, MAR ECOL PROG SER, V155, P89, DOI 10.3354/meps155089; PUTT M, 1990, DEEP-SEA RES, V37, P1713, DOI 10.1016/0198-0149(90)90073-5; Rat'kova TN, 2002, J MARINE SYST, V38, P47, DOI 10.1016/S0924-7963(02)00169-0; Riisgaard K, 2009, MAR ECOL PROG SER, V381, P51, DOI 10.3354/meps07953; Rose JM, 2007, LIMNOL OCEANOGR, V52, P886, DOI 10.4319/lo.2007.52.2.0886; Rose JM, 2013, POLAR BIOL, V36, P645, DOI 10.1007/s00300-013-1291-y; Sakshaug E., 2009, ECOSYSTEM BARENTS SE; Sarmento H, 2010, PHILOS T R SOC B, V365, P2137, DOI 10.1098/rstb.2010.0045; Scott F.J., 2005, ANTARCTIC MARINE PRO; Seuthe L, 2011, AQUAT MICROB ECOL, V64, P253, DOI 10.3354/ame01525; Seuthe L, 2011, POLAR BIOL, V34, P751, DOI 10.1007/s00300-010-0930-9; Sherr EB, 2013, DEEP SEA RES 2; SimeNgando T, 1997, J MARINE SYST, V11, P163, DOI 10.1016/S0924-7963(96)00036-X; Sjoqvist CO, 2011, J EUKARYOT MICROBIOL, V58, P365, DOI 10.1111/j.1550-7408.2011.00559.x; Smalley GW, 2002, J EUKARYOT MICROBIOL, V49, P63, DOI 10.1111/j.1550-7408.2002.tb00343.x; Smith KL, 1999, SCIENCE, V284, P1174, DOI 10.1126/science.284.5417.1174; Smolyar I, 2003, ICES J MAR SCI, V60, P836, DOI 10.1016/S1054-3139(03)00071-7; Steidinger Karen A., 1996, P387, DOI 10.1016/B978-012693015-3/50006-1; Stoecker DK, 2009, AQUAT MICROB ECOL, V57, P279, DOI 10.3354/ame01340; STOECKER DK, 1985, MAR ECOL PROG SER, V25, P159, DOI 10.3354/meps025159; Strom SL, 2006, MAR ECOL PROG SER, V328, P75, DOI 10.3354/meps328075; Struder-Kypke MC, 2001, USER FRIENDLY KEY CO; Sun J, 2003, J PLANKTON RES, V25, P1331, DOI 10.1093/plankt/fbg096; TANG EPY, 1995, J PLANKTON RES, V17, P1325, DOI 10.1093/plankt/17.6.1325; Teoh ML, 2013, J APPL PHYCOL, V25, P285, DOI 10.1007/s10811-012-9863-8; Turner JT, 2001, MAR ECOL PROG SER, V221, P209, DOI 10.3354/meps221209; Wassmann P, 2011, OCEANOGRAPHY, V24, P220, DOI 10.5670/oceanog.2011.74; WELSCHMEYER NA, 1994, LIMNOL OCEANOGR, V39, P1985, DOI 10.4319/lo.1994.39.8.1985; Yih W, 2004, AQUAT MICROB ECOL, V36, P165, DOI 10.3354/ame036165	89	23	24	1	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2014	9	1							e86429	10.1371/journal.pone.0086429	http://dx.doi.org/10.1371/journal.pone.0086429			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	298QQ	24475119	gold, Green Published			2022-12-25	WOS:000330339800043
J	Hiley, L; Fang, NX; Micalizzi, GR; Bates, J				Hiley, Lester; Fang, Ning-Xia; Micalizzi, Gino R.; Bates, John			Distribution of Gifsy-3 and of Variants of ST64B and Gifsy-1 Prophages amongst Salmonella enterica Serovar Typhimurium Isolates: Evidence that Combinations of Prophages Promote Clonality	PLOS ONE			English	Article							MYCOBACTERIUM-TUBERCULOSIS; BACTERIOPHAGE; RESISTANCE; REGION; PHAGES; GENES	Salmonella isolates harbour a range of resident prophages which can influence their virulence and ability to compete and survive in their environment. Phage gene profiling of a range of phage types of Salmonella enterica subsp. enterica serovar Typhimurium (S. Typhimurium) indicates a significant level of correlation of phage gene profile with phage type as well as correlation with genotypes determined by a combination of multi-locus variable-number tandem repeat (VNTR) typing and clustered regularly interspaced short palindromic repeats (CRISPR) typing. Variation in phage gene profiles appears to be partly linked to differences in composition of variants of known prophages. We therefore conducted a study of the distribution of variants of ST64B and Gifsy-1 prophages and coincidently the presence of Gifsy-3 prophage in a range of S. Typhimurium phage types and genotypes. We have discovered two variants of the DT104 variant of ST64B and at least two new variants of Gifsy-1 as well as variants of related phage genes. While there is definite correlation between phage type and the prophage profile based on ST64B and Gifsy-1 variants we find stronger correlation between the VNTR/CRISPR genotype and prophage profile. Further differentiation of some genotypes is obtained by addition of the distribution of Gifsy-3 and a sequence variant of the substituted SB26 gene from the DT104 variant of ST64B. To explain the correlation between genotype and prophage profile we propose that suites of resident prophages promote clonality possibly through superinfection exclusion systems.	[Hiley, Lester] Queensland Dept Hlth, Publ Hlth Microbiol Lab, Forens Serv, Brisbane, Qld, Australia; Queensland Dept Hlth, Publ Hlth Microbiol Lab, Sci Serv, Brisbane, Qld, Australia	Queensland Health; Queensland Health	Hiley, L (corresponding author), Queensland Dept Hlth, Publ Hlth Microbiol Lab, Forens Serv, Brisbane, Qld, Australia.	Lester.Hiley@health.qld.gov.au			general laboratory operational funds; Queensland Department of Health	general laboratory operational funds; Queensland Department of Health	This study was funded from general laboratory operational funds provided by Queensland Department of Health. The funders had a notionally supportive role in study design, data collection and analysis, decision to publish, and preparation of the manuscript.	ANDERSON ES, 1977, J HYG-CAMBRIDGE, V78, P297, DOI 10.1017/S0022172400056187; Bossi L, 2003, J BACTERIOL, V185, P6467, DOI 10.1128/JB.185.21.6467-6471.2003; Bossi L, 2005, PHAGES THEIR ROLE BA; Brussow H, 2004, MICROBIOL MOL BIOL R, V68, P560, DOI 10.1128/MMBR.68.3.560-602.2004; Cooke FJ, 2007, J CLIN MICROBIOL, V45, P2590, DOI 10.1128/JCM.00729-07; Cooke FJ, 2008, J BACTERIOL, V190, P8155, DOI 10.1128/JB.00636-08; Darling AE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011147; Deveau H, 2008, J BACTERIOL, V190, P1390, DOI 10.1128/JB.01412-07; Dou HY, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-170; Fabre L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036995; Fang NX, 2012, J MICROBIOL METH, V88, P19, DOI 10.1016/j.mimet.2011.10.002; Figueroa-Bossi N, 2004, J BACTERIOL, V186, P4038, DOI 10.1128/JB.186.12.4038-4041.2004; Figueroa-Bossi N, 2001, MOL MICROBIOL, V39, P260, DOI 10.1046/j.1365-2958.2001.02234.x; FigueroaBossi N, 1997, MOL MICROBIOL, V25, P161, DOI 10.1046/j.1365-2958.1997.4451807.x; Harker KS, 2011, EPIDEMIOL INFECT, V139, P1254, DOI 10.1017/S0950268810002281; Hatfull GF, 2008, CURR OPIN MICROBIOL, V11, P447, DOI 10.1016/j.mib.2008.09.004; Hauser E, 2010, APPL ENVIRON MICROB, V76, P4601, DOI 10.1128/AEM.02991-09; Hermans APHM, 2006, MICROBIOL-SGM, V152, P2137, DOI 10.1099/mic.0.28850-0; Jarvik T, 2010, J BACTERIOL, V192, P560, DOI 10.1128/JB.01233-09; Lemire S, 2008, ADV M C M, P159, DOI 10.1017/CBO9780511541520.008; Lindstedt BA, 2004, J MICROBIOL METH, V59, P163, DOI 10.1016/j.mimet.2004.06.014; Luo YQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040645; Luo YQ, 2011, J BACTERIOL, V193, P4035, DOI 10.1128/JB.05224-11; Mmolawa PT, 2003, J BACTERIOL, V185, P6481, DOI 10.1128/JB.185.21.6481-6485.2003; Mmolawa PT, 2002, INT J MED MICROBIOL, V291, P633, DOI 10.1078/1438-4221-00178; Peters T, 2010, J CLIN MICROBIOL, V48, P3375, DOI 10.1128/JCM.00109-10; Ross IL, 2005, J CLIN MICROBIOL, V43, P1604, DOI 10.1128/JCM.43.4.1604-1611.2005; Schmieger H, 1999, J BACTERIOL, V181, P1630, DOI 10.1128/JB.181.5.1630-1635.1999; Sola C, 2001, J MOL EVOL, V53, P680, DOI 10.1007/s002390010255; Soyer Y, 2009, J CLIN MICROBIOL, V47, P3546, DOI 10.1128/JCM.00546-09; STANLEY J, 1993, J GEN MICROBIOL, V139, P1133, DOI 10.1099/00221287-139-6-1133; Sulakvelidze Andrew M. Kropinski Alexander, 2007, V394, P133, DOI 10.1007/978-1-59745-512-1_9; Thornley CN, 2003, EMERG INFECT DIS, V9, P493, DOI 10.3201/eid0904.020439; Tucker CP, 2004, INT J MED MICROBIOL, V294, P59, DOI 10.1016/j.ijmm.2003.12.001; Warren RM, 2002, J CLIN MICROBIOL, V40, P4457, DOI 10.1128/JCM.40.12.4457-4465.2002	35	13	13	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2014	9	1							e86203	10.1371/journal.pone.0086203	http://dx.doi.org/10.1371/journal.pone.0086203			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	298QQ	24475087	Green Published, gold, Green Submitted			2022-12-25	WOS:000330339800033
J	Huang, J; Zhang, Y; Zhong, HG; Fan, ZN; Jiang, GB; Shen, YZ; Song, HM; Tao, ZJ; Wang, KJ				Huang, Jin; Zhang, Yin; Zhong, Hengao; Fan, Zhining; Jiang, Guobin; Shen, Yingzhou; Song, Hanming; Tao, Zhijian; Wang, Kuangjing			Comparison of Endoscopic Submuscosal Implantation vs. Surgical Intramuscular Implantation of VX2 Fragments for Establishing a Rabbit Esophageal Tumor Model for Mimicking Human Esophageal Squamous Carcinoma	PLOS ONE			English	Article							CELL CARCINOMA; GROWTH-PATTERN; CANCER; STENT; MICE; INHIBITOR; STRICTURE	Purpose: This study was undertaken to establish a rabbit esophageal tumor model for mimicking human esophageal squamous carcinoma (ESC) by endoscopic and surgical implantation of VX2 tumors. Methods: Fragments of a VX2 tumour were endoscopically implanted in the submucosal layer of the thoracic esophagus of 32 New Zealand white rabbits, while 34 animals received surgical implantation into the muscular layer. Then, the animals were studied endoscopically and pathologically. The safety and efficiency of the two methods and the pathological features of the animal models were analyzed. Results: Both the endoscopic and the surgical method had a relatively high success rate of tumor implantation [93.7% (30/ 32) vs. 97.1% (33/34)] and tumor growth [86.7% (26/30) vs. 81.8% (27/33)], and the variation in the results was not statistically significant (P > 0.05). Compared with those produced by the surgical method, the models produced by the endoscopic method had a higher rate of severe esophageal stricture [61.5% (16/26) vs. 29.6% (8/27)] and of intra-luminal tumor growth [73.1% (19/26) vs. 37.0% (10/27)], and had a lower rate of tumor invasion of adjacent organs [53.8% (14/26) vs. 81.5% (22/27)]; all of these results were statistically significant (P < 0.05). However, the difference in the survival time and the rates of tumor regional/distant metastasis [38.5% (10/26) vs. 51.8% (14/27)] between the two methods were not statistically significant (P > 0.05). Conclusion: The endoscopic and surgical methods are both safe and effective for establishment of VX2 tumors in the rabbit esophagus. The models produced by the two methods have different pathologic features mimicking that of human ESC. We recommend the models for studies on surgical procedures and minimally invasive treatments.	[Huang, Jin; Zhang, Yin; Zhong, Hengao; Fan, Zhining; Jiang, Guobin] Nanjing Med Univ, Digest Med Ctr, Affiliated Hosp 2, Nanjing, Jiangsu, Peoples R China; [Huang, Jin; Shen, Yingzhou; Song, Hanming; Tao, Zhijian; Wang, Kuangjing] Renming Hosp Ma Anshan, Div Digest Dis, Ma Anshan City, Anhui, Peoples R China	Nanjing Medical University	Fan, ZN (corresponding author), Nanjing Med Univ, Digest Med Ctr, Affiliated Hosp 2, Nanjing, Jiangsu, Peoples R China.	fanzhining5834@hotmail.com			National Science Foundation of China [81172266/H1617]	National Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Science Foundation of China under Grant No. 81172266/H1617 (www.nsfc.gov.cn/nsfc/cen/bsdt/jggb.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bharat A, 2012, SURG CLIN N AM, V92, P1179, DOI 10.1016/j.suc.2012.07.012; Bruners P, 2010, CARDIOVASC INTER RAD, V33, P127, DOI 10.1007/s00270-009-9583-x; Chávez Rossell Miguel, 2005, Rev. gastroenterol. Perú, V25, P76; Hurst EW, 1933, J EXP MED, V58, P607, DOI 10.1084/jem.58.5.607; Ji JS, 2011, GASTROINTEST ENDOSC, V74, P148, DOI 10.1016/j.gie.2011.03.1252; Kim EY, 2013, RADIOLOGY, V267, P396, DOI 10.1148/radiol.12120361; Moriyama M, 2013, ANTICANCER RES, V33, P175; Nishikawa T, 2013, CANCER BIOL THER, V14, P230, DOI 10.4161/cbt.23294; Ooki A, 2007, WORLD J SURG, V31, P2184, DOI 10.1007/s00268-007-9198-9; Pauli EM, 2012, SURG ENDOSC, V26, P3500, DOI 10.1007/s00464-012-2373-6; Pennathur A, 2013, LANCET, V381, P400, DOI 10.1016/S0140-6736(12)60643-6; Schubert D, 2012, CHIRURG, V83, P712, DOI 10.1007/s00104-011-2265-7; Seddik H, 2011, PRESSE MED, V40, P889, DOI 10.1016/j.lpm.2011.01.007; SELBIE FR, 1948, BRIT J CANCER, V2, P48, DOI 10.1038/bjc.1948.7; Sheyhedin I, 2000, LASER SURG MED, V26, P83, DOI 10.1002/(SICI)1096-9101(2000)26:1<83::AID-LSM12>3.0.CO;2-1; Soetikno Roy, 2010, Gastrointest Endosc Clin N Am, V20, P497, DOI 10.1016/j.giec.2010.03.008; Stewart EE, 2012, RADIOLOGY, V264, P68, DOI 10.1148/radiol.12110674; Sun JH, 2012, EXP THER MED, V3, P386, DOI 10.3892/etm.2011.435; Talukdar FR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060996; Thomas GR, 2006, INT J CANCER, V118, P2379, DOI 10.1002/ijc.21695; Tian F, 2012, PATHOL RES PRACT, V208, P32, DOI 10.1016/j.prp.2011.10.011; Tu M, 2009, J SURG RES, V154, P284, DOI 10.1016/j.jss.2008.06.019; Alvarado MVY, 2011, J VASC INTERV RADIOL, V22, P1758, DOI 10.1016/j.jvir.2011.08.025; Virmani S, 2008, J VASC INTERV RADIOL, V19, P931, DOI 10.1016/j.jvir.2008.02.019; Von Rahden BHA, 2006, VIRCHOWS ARCH, V448, P862, DOI 10.1007/s00428-006-0185-6; Zhou JM, 2009, PROG NAT SCI, V19, P1713, DOI 10.1016/j.pnsc.2009.07.013	26	8	8	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2014	9	1							e85326	10.1371/journal.pone.0085326	http://dx.doi.org/10.1371/journal.pone.0085326			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	298QQ	24475043	Green Published, Green Submitted, gold			2022-12-25	WOS:000330339800012
J	Brudvig, LA; Orrock, JL; Damschen, EI; Collins, CD; Hahn, PG; Mattingly, WB; Veldman, JW; Walker, JL				Brudvig, Lars A.; Orrock, John L.; Damschen, Ellen I.; Collins, Cathy D.; Hahn, Philip G.; Mattingly, W. Brett; Veldman, Joseph W.; Walker, Joan L.			Land-Use History and Contemporary Management Inform an Ecological Reference Model for Longleaf Pine Woodland Understory Plant Communities	PLOS ONE			English	Article							REGRESSION TREES; RESTORATION; FIRE; ECOSYSTEMS; VEGETATION; PRODUCTIVITY; BIODIVERSITY; PLANTATIONS; DIVERSITY; FRAMEWORK	Ecological restoration is frequently guided by reference conditions describing a successfully restored ecosystem; however, the causes and magnitude of ecosystem degradation vary, making simple knowledge of reference conditions insufficient for prioritizing and guiding restoration. Ecological reference models provide further guidance by quantifying reference conditions, as well as conditions at degraded states that deviate from reference conditions. Many reference models remain qualitative, however, limiting their utility. We quantified and evaluated a reference model for southeastern U.S. longleaf pine woodland understory plant communities. We used regression trees to classify 232 longleaf pine woodland sites at three locations along the Atlantic coastal plain based on relationships between understory plant community composition, soils (which broadly structure these communities), and factors associated with understory degradation, including fire frequency, agricultural history, and tree basal area. To understand the spatial generality of this model, we classified all sites together and for each of three study locations separately. Both the regional and location-specific models produced quantifiable degradation gradients-i.e., progressive deviation from conditions at 38 reference sites, based on understory species composition, diversity and total cover, litter depth, and other attributes. Regionally, fire suppression was the most important degrading factor, followed by agricultural history, but at individual locations, agricultural history or tree basal area was most important. At one location, the influence of a degrading factor depended on soil attributes. We suggest that our regional model can help prioritize longleaf pine woodland restoration across our study region; however, due to substantial landscape-to-landscape variation, local management decisions should take into account additional factors (e. g., soil attributes). Our study demonstrates the utility of quantifying degraded states and provides a series of hypotheses for future experimental restoration work. More broadly, our work provides a framework for developing and evaluating reference models that incorporate multiple, interactive anthropogenic drivers of ecosystem degradation.	[Brudvig, Lars A.] Michigan State Univ, Dept Plant Biol, E Lansing, MI 48824 USA; [Orrock, John L.; Damschen, Ellen I.; Hahn, Philip G.; Mattingly, W. Brett; Veldman, Joseph W.] Univ Wisconsin, Dept Zool, Madison, WI 53706 USA; [Collins, Cathy D.] Colby Coll, Dept Biol, Waterville, ME 04901 USA; [Walker, Joan L.] US Forest Serv, Southern Res Stn, Clemson, SC USA	Michigan State University; University of Wisconsin System; University of Wisconsin Madison; Colby College; United States Department of Agriculture (USDA); United States Forest Service	Brudvig, LA (corresponding author), Michigan State Univ, Dept Plant Biol, E Lansing, MI 48824 USA.	brudvig@msu.edu			Strategic Environmental Research and Development Program [RC-1695]; Department of Energy, Aiken, SC [DE-AI09-00SR22188]	Strategic Environmental Research and Development Program; Department of Energy, Aiken, SC(United States Department of Energy (DOE))	This study was funded by the Strategic Environmental Research and Development Program (Project RC-1695) and by funds provided to the Department of Agriculture, Forest Service, Savannah River, under Interagency Agreement DE-AI09-00SR22188 with the Department of Energy, Aiken, SC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen CD, 2002, ECOL APPL, V12, P1418; Anderson MJ, 2003, ECOLOGY, V84, P511, DOI 10.1890/0012-9658(2003)084[0511:CAOPCA]2.0.CO;2; Asbjornsen H, 2005, J FOREST, V103, P345; Bestelmeyer BT, 2003, ECOL APPL, V13, P1750, DOI 10.1890/02-5089; Brockway DG, 1997, FOREST ECOL MANAG, V96, P167, DOI 10.1016/S0378-1127(96)03939-4; Brudvig LA, 2013, FOREST ECOL MANAG, V310, P944, DOI 10.1016/j.foreco.2013.09.053; Brudvig LA, 2011, ECOGRAPHY, V34, P257, DOI 10.1111/j.1600-0587.2010.06381.x; Brudvig LA, 2011, AM J BOT, V98, P549, DOI 10.3732/ajb.1000285; Clark KR., 2006, PRIMER V6 USER MANUA; De'Ath G, 2002, ECOLOGY, V83, P1105, DOI 10.2307/3071917; De'ath G, 2000, ECOLOGY, V81, P3178, DOI 10.1890/0012-9658(2000)081[3178:CARTAP]2.0.CO;2; Dufrene M, 1997, ECOL MONOGR, V67, P345, DOI 10.1890/0012-9615(1997)067[0345:SAAIST]2.0.CO;2; Flinn KM, 2005, FRONT ECOL ENVIRON, V3, P243, DOI 10.2307/3868486; Foster D, 2003, BIOSCIENCE, V53, P77, DOI 10.1641/0006-3568(2003)053[0077:TIOLUL]2.0.CO;2; Fraterrigo JM, 2006, J ECOL, V94, P548, DOI 10.1111/j.1365-2745.2006.01081.x; Frost C, 2006, SPRINGER SER ENV MAN, P9; Fule PZ, 1997, ECOL APPL, V7, P895, DOI 10.1890/1051-0761(1997)007[0895:DRCFEM]2.0.CO;2; GLITZENSTEIN JS, 1995, ECOL MONOGR, V65, P441, DOI 10.2307/2963498; Harrington TB, 2003, FOREST SCI, V49, P681; Harrington TB, 1999, CAN J FOREST RES, V29, P1055, DOI 10.1139/cjfr-29-7-1055; Hedman CW, 2000, FOREST ECOL MANAG, V134, P233, DOI 10.1016/S0378-1127(99)00259-5; Hiers JK, 2007, ECOL APPL, V17, P806, DOI 10.1890/06-1015; Hobbs RJ, 2007, RESTOR ECOL, V15, P354, DOI 10.1111/j.1526-100X.2007.00225.x; Hobbs RJ, 2001, RESTOR ECOL, V9, P239, DOI 10.1046/j.1526-100x.2001.009002239.x; Honnay O, 2002, BIODIVERS CONSERV, V11, P213, DOI 10.1023/A:1014531011060; Kirkman LK, 2013, ECOL APPL, V23, P1574, DOI 10.1890/13-0021.1; Kirkman LK, 2004, J ECOL, V92, P409, DOI 10.1111/j.0022-0477.2004.00883.x; Kirkman LK, 2001, AM J BOT, V88, P2119, DOI 10.2307/3558437; Lunt ID, 2005, J BIOGEOGR, V32, P1859, DOI 10.1111/j.1365-2699.2005.01296.x; McCune B., 2006, PC ORD MULTIVARIATE; Mitchell RJ, 2009, ECOL SOC, V14; Palik BJ, 2000, ECOL APPL, V10, P189, DOI 10.1890/1051-0761(2000)010[0189:ULHTGR]2.0.CO;2; Peet RK, 2006, SPRINGER SER ENV MAN, P51; Peet Robert K., 1998, Castanea, V63, P262; Platt WJ, 2006, APPL VEG SCI, V9, P37, DOI 10.1658/1402-2001(2006)9[37:PSOIOG]2.0.CO;2; Provencher L, 2001, RESTOR ECOL, V9, P13, DOI 10.1046/j.1526-100x.2001.009001013.x; Pyke DA, 2010, RESTOR ECOL, V18, P274, DOI 10.1111/j.1526-100X.2010.00658.x; R Development Core Team, 2005, R LANG ENV STAT COMP; Radford AE, 1964, MANUAL VASCULAR FLOR; Benayas JMR, 2009, SCIENCE, V325, P1121, DOI 10.1126/science.1172460; Roitman I, 2008, PLANT ECOL, V197, P255, DOI 10.1007/s11258-007-9375-9; SALTER PJ, 1967, J SOIL SCI, V18, P174, DOI 10.1111/j.1365-2389.1967.tb01498.x; SAS Institute, 2008, SAS VERS 9 2; Schulte E.E., 1996, SSSA SPEC PUBL, V46, P21, DOI DOI 10.2136/SSSASPECPUB46.C3; Suding KN, 2004, TRENDS ECOL EVOL, V19, P46, DOI 10.1016/j.tree.2003.10.005; Turner M.G., 2001, LANDSCAPE ECOLOGY TH; Van Lear DH, 2005, FOREST ECOL MANAG, V211, P150, DOI 10.1016/j.foreco.2005.02.014; Varner JM, 2005, RESTOR ECOL, V13, P536, DOI 10.1111/j.1526-100X.2005.00067.x; Veldman JW, 2013, ECOLOGY, V94, P424, DOI 10.1890/12-1019.1; Walker JL, 2006, SPRINGER SER ENV MAN, P297; WEAKLEY A, 2008, FLORA CAROLINAS VIRG; White PS, 1997, RESTOR ECOL, V5, P338, DOI 10.1046/j.1526-100X.1997.00547.x; Wunderlin R.P., 2003, GUIDE VASCULAR PLANT; Yates CJ, 1997, RESTOR ECOL, V5, P28, DOI 10.1046/j.1526-100X.1997.09703.x	54	24	24	0	91	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2014	9	1							e86604	10.1371/journal.pone.0086604	http://dx.doi.org/10.1371/journal.pone.0086604			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297XI	24466167	Green Published, gold, Green Submitted			2022-12-25	WOS:000330288000120
J	Dai, W; Yao, Y; Zhou, Q; Sun, CF				Dai, Wei; Yao, Yuan; Zhou, Qing; Sun, Chang-fu			Ubiquitin-Specific Peptidase 22, a Histone Deubiquitinating Enzyme, Is a Novel Poor Prognostic Factor for Salivary Adenoid Cystic Carcinoma	PLOS ONE			English	Article							EXPRESSION; METASTASIS; INVASION; CANCER	Salivary Adenoid Cystic Carcinoma (SACC) is characterized by a high rate of local recurrence and infiltration, strong invasion to peripheral nerves or late distant metastasis. Our aim was to investigate the expression of Ubiquitin-specific protease 22 (USP22) in SACC patients and its possible relationship to the outcome of the disease. A total of 135 SACC tissues and adjacent non-cancerous tissues which were diagnosed between 2002 and 2007 were enrolled in this study. Immunohistochemistry was used to compare the expression pattern of USP22 in SACC and adjacent non-cancerous groups, and the prognostic significance was assessed by Kaplan-Meier analysis and Cox proportional hazards regression in SACC patients. The rate of high expression of USP22 was significantly higher in SACC group than that in adjacent non-cancerous group. High expression of USP22 was significantly correlated with histological subtype, lymph node metastasis, grade, Ki-67 and SOX2 expression. Furthermore, USP22 acts as an oncogene by regulation the BMI-1 pathway and c-Myc pathway. SACC patients with high USP22 expression showed the poorer overall survival (OS) and disease-free survival (DFS) than those patients with low USP22 expression. In multivariate analysis, only lymph node metastasis and USP22 expression were the independent prognostic factors for OS and DFS in SACC. Our study provides evidence that USP22 expression is an independent prognostic factor for SACC patients.	[Dai, Wei; Zhou, Qing; Sun, Chang-fu] China Med Univ, Sch Stomatol, Dept Oromaxillofacial Head & Neck Surg, Dept Oral & Maxillofacial Surg, Shenyang, Liaoning, Peoples R China; [Yao, Yuan] Peoples Hosp Liaoning Prov, Dept Gastroenterol, Shenyang, Liaoning, Peoples R China	China Medical University	Dai, W (corresponding author), China Med Univ, Sch Stomatol, Dept Oromaxillofacial Head & Neck Surg, Dept Oral & Maxillofacial Surg, Shenyang, Liaoning, Peoples R China.	cmudaiwei@gmail.com	SUN, CHANG/GXM-3680-2022		National Natural Science Foundation of China [81301835, 31271364, 31171259]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work has been supported by Grants from the National Natural Science Foundation of China (Nos. 81301835, 31271364 and 31171259). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen AM, 2006, INT J RADIAT ONCOL, V66, P152, DOI 10.1016/j.ijrobp.2006.04.014; Chen W, 2012, MOL MED REP, V6, P755, DOI 10.3892/mmr.2012.1003; Gao M, 2013, INT J ORAL MAX SURG, V42, P923, DOI 10.1016/j.ijom.2013.04.006; Godge P, 2012, CONTEMP CLIN DENT, V3, P223, DOI 10.4103/0976-237X.96838; Li J, 2012, J CANCER RES CLIN, V138, P1291, DOI 10.1007/s00432-012-1191-5; Li Y, 2013, ANAT REC HOBOKEN, DOI [10.1002/ar.22754, DOI 10.1002/AR.22754.PUBMED:23873832]; Liang B, 2013, MED ONCOL, V30, DOI 10.1007/s12032-013-0497-8; Liu YL, 2012, CELL BIOCHEM BIOPHYS, V62, P229, DOI 10.1007/s12013-011-9287-0; Ning J, 2012, EUR J HISTOCHEM, V56, P289, DOI 10.4081/ejh.2012.e46; Piao SL, 2013, ORAL ONCOL, V49, P796, DOI 10.1016/j.oraloncology.2013.03.454; Piao SL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042540; Sussman RT, 2013, J BIOL CHEM, DOI [10.1074/jbc.M113.469783, DOI 10.1074/JBC.M113.469783.PUBMED:23760504]; Tang QL, 2011, ORAL ONCOL, V47, P365, DOI 10.1016/j.oraloncology.2011.02.022; Wang H, 2013, TUMOR BIOL, V34, P1635, DOI 10.1007/s13277-013-0696-0; Wu HM, 2012, MOL MED REP, V6, P271, DOI 10.3892/mmr.2012.911; Xu H, 2012, INT J COLORECTAL DIS, V27, P21, DOI 10.1007/s00384-011-1275-8; Xue F, 2005, J ORAL PATHOL MED, V34, P295, DOI 10.1111/j.1600-0714.2005.00312.x; Yang M, 2013, TUMOR BIOL, DOI [10.1007/s13277-013-1121-4, DOI 10.1007/S13277-013-1121-4.PUBMED:23979981]; Zhao Y, 2008, MOL CELL, V29, P92, DOI 10.1016/j.molcel.2007.12.011; Zhou CC, 2012, J ORAL PATHOL MED, V41, P424, DOI 10.1111/j.1600-0714.2011.01114.x; Zhou CX, 2006, ONCOL REP, V16, P505	21	15	15	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2014	9	1							e87148	10.1371/journal.pone.0087148	http://dx.doi.org/10.1371/journal.pone.0087148			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297XI	24466336	gold, Green Submitted, Green Published			2022-12-25	WOS:000330288000195
J	Dulle, JE; Stein, KC; True, HL				Dulle, Jennifer E.; Stein, Kevin C.; True, Heather L.			Regulation of the Hsp104 Middle Domain Activity Is Critical for Yeast Prion Propagation	PLOS ONE			English	Article							SACCHAROMYCES-CEREVISIAE HSP104; AAA PLUS DISAGGREGASE; PROTEIN DISAGGREGATION; PSI+ PRION; ENVIRONMENTAL-STRESS; MOLECULAR CHAPERONE; AGGREGATED PROTEINS; GENETIC-VARIATION; COMMON MECHANISM; BINDING DOMAIN	Molecular chaperones play a significant role in preventing protein misfolding and aggregation. Indeed, some protein conformational disorders have been linked to changes in the chaperone network. Curiously, in yeast, chaperones also play a role in promoting prion maintenance and propagation. While many amyloidogenic proteins are associated with disease in mammals, yeast prion proteins, and their ability to undergo conformational conversion into a prion state, are proposed to play a functional role in yeast biology. The chaperone Hsp104, a AAA+ ATPase, is essential for yeast prion propagation. Hsp104 fragments large prion aggregates to generate a population of smaller oligomers that can more readily convert soluble monomer and be transmitted to daughter cells. Here, we show that the middle (M) domain of Hsp104, and its mobility, plays an integral part in prion propagation. We generated and characterized mutations in the M-domain of Hsp104 that are predicted to stabilize either a repressed or de-repressed conformation of the M-domain (by analogy to ClpB in bacteria). We show that the predicted stabilization of the repressed conformation inhibits general chaperone activity. Mutation to the de-repressed conformation, however, has differential effects on ATP hydrolysis and disaggregation, suggesting that the M-domain is involved in coupling these two activities. Interestingly, we show that changes in the M-domain differentially affect the propagation of different variants of the [PSI+] and [RNQ+] prions, which indicates that some prion variants are more sensitive to changes in the M-domain mobility than others. Thus, we provide evidence that regulation of the M-domain of Hsp104 is critical for efficient prion propagation. This shows the importance of elucidating the function of the M-domain in order to understand the role of Hsp104 in the propagation of different prions and prion variants.	[Dulle, Jennifer E.; Stein, Kevin C.; True, Heather L.] Washington Univ, Sch Med, Dept Cell Biol & Physiol, St Louis, MO 63110 USA	Washington University (WUSTL)	True, HL (corresponding author), Washington Univ, Sch Med, Dept Cell Biol & Physiol, St Louis, MO 63110 USA.	heather.true@wustl.edu		Stein, Kevin/0000-0002-0622-8319	NIH [GM72778]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007067, R01GM072778] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [F31AG040899] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was funded by the NIH GM72778. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bagriantsev S, 2004, J BIOL CHEM, V279, P51042, DOI 10.1074/jbc.M410611200; Bardill JP, 2009, PRION, V3, P151, DOI 10.4161/pri.3.3.9662; Biter AB, 2012, J STRUCT BIOL, V179, P172, DOI 10.1016/j.jsb.2012.05.007; Bradley ME, 2003, GENETICS, V165, P1675; Bradley ME, 2002, P NATL ACAD SCI USA, V99, P16392, DOI 10.1073/pnas.152330699; Cashikar AG, 2002, MOL CELL, V9, P751, DOI 10.1016/S1097-2765(02)00499-9; CHERNOFF YO, 1995, SCIENCE, V268, P880, DOI 10.1126/science.7754373; Cox B, 2003, GENETICS, V165, P23; Derkatch IL, 1999, CURR GENET, V35, P59, DOI 10.1007/s002940050433; Derkatch IL, 1997, GENETICS, V147, P507; Derkatch IL, 1996, GENETICS, V144, P1375; Derkatch IL, 2001, CELL, V106, P171, DOI 10.1016/S0092-8674(01)00427-5; Derkatch IL, 2000, EMBO J, V19, P1942, DOI 10.1093/emboj/19.9.1942; DeSantis ME, 2012, CHEM BIOL, V19, P1400, DOI 10.1016/j.chembiol.2012.09.013; DeSantis ME, 2012, CELL, V151, P778, DOI 10.1016/j.cell.2012.09.038; DeSantis ME, 2012, BBA-MOL CELL RES, V1823, P29, DOI 10.1016/j.bbamcr.2011.07.014; Du ZQ, 2008, NAT GENET, V40, P460, DOI 10.1038/ng.112; Dulle J, 2013, PRION, V7; Dulle JE, 2013, J CELL BIOL, V203, P197, DOI 10.1083/jcb.201307040; Eaglestone SS, 1999, EMBO J, V18, P1974, DOI 10.1093/emboj/18.7.1974; Glover JR, 1998, CELL, V94, P73, DOI 10.1016/S0092-8674(00)81223-4; Gokhale KC, 2005, J BIOL CHEM, V280, P22809, DOI 10.1074/jbc.M500390200; Goloubinoff P, 1999, P NATL ACAD SCI USA, V96, P13732, DOI 10.1073/pnas.96.24.13732; Grimminger-Marquardt V, 2010, BIOPOLYMERS, V93, P252, DOI 10.1002/bip.21301; Halfmann R, 2012, NATURE, V482, P363, DOI 10.1038/nature10875; Harris DA, 2006, NEURON, V50, P353, DOI 10.1016/j.neuron.2006.04.020; Haslberger T, 2007, MOL CELL, V25, P247, DOI 10.1016/j.molcel.2006.11.008; Huang VJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079582; Hung GC, 2006, GENETICS, V173, P611, DOI 10.1534/genetics.106.056820; Kedzierska S, 2003, BIOCHEMISTRY-US, V42, P14242, DOI 10.1021/bi035573d; Kryndushkin DS, 2003, J BIOL CHEM, V278, P49636, DOI 10.1074/jbc.M307996200; Kryndushkin DS, 2002, J BIOL CHEM, V277, P23702, DOI 10.1074/jbc.M111547200; Kummer E, 2013, FEBS LETT, V587, P810, DOI 10.1016/j.febslet.2013.02.011; Kurahashi H, 2007, MOL MICROBIOL, V63, P1669, DOI 10.1111/j.1365-2958.2007.05629.x; Lee J, 2013, P NATL ACAD SCI USA, V110, P8513, DOI 10.1073/pnas.1217988110; Lee S, 2003, CELL, V115, P229, DOI 10.1016/S0092-8674(03)00807-9; Lee S, 2010, P NATL ACAD SCI USA, V107, P8135, DOI 10.1073/pnas.1003572107; Li LM, 2000, SCIENCE, V287, P661, DOI 10.1126/science.287.5453.661; Lipinska N, 2013, J BIOL CHEM, V288, P2857, DOI 10.1074/jbc.M112.387589; Lum R, 2004, J BIOL CHEM, V279, P29139, DOI 10.1074/jbc.M403777200; Mathur V, 2009, J MOL BIOL, V390, P155, DOI 10.1016/j.jmb.2009.04.063; McGlinchey RP, 2011, P NATL ACAD SCI USA, V108, P5337, DOI 10.1073/pnas.1102762108; Miot M, 2011, P NATL ACAD SCI USA, V108, P6915, DOI 10.1073/pnas.1102828108; Mogk A, 2003, J BIOL CHEM, V278, P17615, DOI 10.1074/jbc.M209686200; Newnam GP, 2011, J MOL BIOL, V408, P432, DOI 10.1016/j.jmb.2011.02.034; Oguchi Y, 2012, NAT STRUCT MOL BIOL, V19, P1338, DOI 10.1038/nsmb.2441; Osherovich LZ, 2001, CELL, V106, P183, DOI 10.1016/S0092-8674(01)00440-8; PARSELL DA, 1994, J BIOL CHEM, V269, P4480; PARSELL DA, 1994, NATURE, V372, P475, DOI 10.1038/372475a0; Paushkin SV, 1997, SCIENCE, V277, P381, DOI 10.1126/science.277.5324.381; Paushkin SV, 1996, EMBO J, V15, P3127, DOI 10.1002/j.1460-2075.1996.tb00675.x; Reidy M, 2012, GENETICS, V192, P185, DOI 10.1534/genetics.112.142307; SANCHEZ Y, 1990, SCIENCE, V248, P1112, DOI 10.1126/science.2188365; Satpute-Krishnan P, 2005, NATURE, V437, P262, DOI 10.1038/nature03981; Satpute-Krishnan P, 2007, PLOS BIOL, V5, P251, DOI 10.1371/journal.pbio.0050024; Schirmer EC, 2004, MOL BIOL CELL, V15, P2061, DOI 10.1091/mbc.E02-08-0502; Schirmer EC, 1998, J BIOL CHEM, V273, P15546, DOI 10.1074/jbc.273.25.15546; Seyffer F, 2012, NAT STRUCT MOL BIOL, V19, P1347, DOI 10.1038/nsmb.2442; Shorter J, 2004, SCIENCE, V304, P1793, DOI 10.1126/science.1098007; Sielaff B, 2010, J MOL BIOL, V402, P30, DOI 10.1016/j.jmb.2010.07.030; Sondheimer N, 2000, MOL CELL, V5, P163, DOI 10.1016/S1097-2765(00)80412-8; Sweeny EA, 2008, PRION, V2, P135, DOI 10.4161/pri.2.4.7952; TERAVANESYAN MD, 1994, GENETICS, V137, P671; Tessarz P, 2008, MOL MICROBIOL, V68, P87, DOI 10.1111/j.1365-2958.2008.06135.x; Tipton KA, 2008, MOL CELL, V32, P584, DOI 10.1016/j.molcel.2008.11.003; Tkach JM, 2004, J BIOL CHEM, V279, P35692, DOI 10.1074/jbc.M400782200; True HL, 2006, TRENDS GENET, V22, P110, DOI 10.1016/j.tig.2005.12.004; True HL, 2000, NATURE, V407, P477, DOI 10.1038/35035005; True HL, 2004, NATURE, V431, P184, DOI 10.1038/nature02885; Tyedmers J, 2008, PLOS BIOL, V6, P2605, DOI 10.1371/journal.pbio.0060294; Vishveshwara N, 2009, MOL MICROBIOL, V73, P1101, DOI 10.1111/j.1365-2958.2009.06836.x; Watanabe YH, 2009, BIOCHEM J, V421, P71, DOI 10.1042/BJ20082238; Weibezahn J, 2004, CELL, V119, P653, DOI 10.1016/j.cell.2004.11.027; Wendler P, 2007, CELL, V131, P1366, DOI 10.1016/j.cell.2007.10.047; Zolkiewski M, 2006, MOL MICROBIOL, V61, P1094, DOI 10.1111/j.1365-2958.2006.05309.x	75	13	13	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2014	9	1							e87521	10.1371/journal.pone.0087521	http://dx.doi.org/10.1371/journal.pone.0087521			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297XI	24466354	Green Published, gold, Green Submitted			2022-12-25	WOS:000330288000210
J	Monturiol-Gross, L; Flores-Diaz, M; Pineda-Padilla, MJ; Castro-Castro, AC; Alape-Giron, A				Monturiol-Gross, Laura; Flores-Diaz, Marietta; Jose Pineda-Padilla, Maria; Cristina Castro-Castro, Ana; Alape-Giron, Alberto			Clostridium perfringens Phospholipase C Induced ROS Production and Cytotoxicity Require PKC, MEK1 and NF kappa B Activation	PLOS ONE			English	Article							PROTEIN-KINASE-C; SPECIES-MEDIATED ACTIVATION; INDUCED CELL-DEATH; ALPHA-TOXIN; GAS-GANGRENE; CANCER-CELLS; PSEUDOSUBSTRATE PEPTIDE; CAUSES HYPERSENSITIVITY; HUMAN-NEUTROPHILS; OXIDATIVE STRESS	Clostridium perfringens phospholipase C (CpPLC), also called alpha-toxin, is the most toxic extracellular enzyme produced by this bacteria and is essential for virulence in gas gangrene. At lytic concentrations, CpPLC causes membrane disruption, whereas at sublytic concentrations this toxin causes oxidative stress and activates the MEK/ERK pathway, which contributes to its cytotoxic and myotoxic effects. In the present work, the role of PKC, ERK 1/2 and NF kappa B signalling pathways in ROS generation induced by CpPLC and their contribution to CpPLC-induced cytotoxicity was evaluated. The results demonstrate that CpPLC induces ROS production through PKC, MEK/ERK and NF kappa B pathways, the latter being activated by the MEK/ERK signalling cascade. Inhibition of either of these signalling pathways prevents CpPLC's cytotoxic effect. In addition, it was demonstrated that NF kappa B inhibition leads to a significant reduction in the myotoxicity induced by intramuscular injection of CpPLC in mice. Understanding the role of these signalling pathways could lead towards developing rational therapeutic strategies aimed to reduce cell death during a clostridialmyonecrosis.	[Monturiol-Gross, Laura; Flores-Diaz, Marietta; Jose Pineda-Padilla, Maria; Cristina Castro-Castro, Ana; Alape-Giron, Alberto] Univ Costa Rica, Fac Microbiol, Inst Clodomiro Picado, San Jose, Costa Rica; [Alape-Giron, Alberto] Univ Costa Rica, Dept Bioquim, Escuela Med, San Jose, Costa Rica; [Alape-Giron, Alberto] Univ Costa Rica, Ctr Invest Estruct Microscop, San Jose, Costa Rica	Universidad Costa Rica; Universidad Costa Rica; Universidad Costa Rica	Alape-Giron, A (corresponding author), Univ Costa Rica, Fac Microbiol, Inst Clodomiro Picado, San Jose, Costa Rica.	alberto.alape@ucr.ac.cr		Monturiol-Gross, Laura/0000-0001-7910-4715; Castro, Ana Cristina/0000-0003-1277-3142; Alape-Giron, Alberto/0000-0003-3934-8496	Vicerrectoria de Investigacion Universidad de Costa Rica [741-B1-601, 741-B1-603, 741-A9-503]; FEES CONARE [6379]	Vicerrectoria de Investigacion Universidad de Costa Rica; FEES CONARE	This work was supported by Vicerrectoria de Investigacion Universidad de Costa Rica (grants 741-B1-601, 741-B1-603 and 741-A9-503) and FEES CONARE (grant 6379). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alape-Giron A, 2000, EUR J BIOCHEM, V267, P5191, DOI 10.1046/j.1432-1327.2000.01588.x; Anrather J, 2006, J BIOL CHEM, V281, P5657, DOI 10.1074/jbc.M506172200; AWAD MM, 1995, MOL MICROBIOL, V15, P191, DOI 10.1111/j.1365-2958.1995.tb02234.x; Bae YS, 2011, MOL CELLS, V32, P491, DOI 10.1007/s10059-011-0276-3; Brandman R, 2007, J BIOL CHEM, V282, P4113, DOI 10.1074/jbc.M608521200; Bryant AE, 2012, EXPERT REV ANTI-INFE, V10, P1, DOI [10.1586/ERI.11.147, 10.1586/eri.11.147]; Cai DS, 2004, CELL, V119, P285, DOI 10.1016/j.cell.2004.09.027; Cosentino-Gomes D, 2012, INT J MOL SCI, V13, P10697, DOI 10.3390/ijms130910697; Coward J, 2009, AUTOPHAGY, V5, P184, DOI 10.4161/auto.5.2.7361; Delcarlo M, 2006, AM J PHYSIOL-CELL PH, V290, pC802, DOI 10.1152/ajpcell.00214.2005; Devaraj S, 2009, ATHEROSCLEROSIS, V203, P67, DOI 10.1016/j.atherosclerosis.2008.05.060; EICHHOLTZ T, 1993, J BIOL CHEM, V268, P1982; Flores-Diaz M, 1998, J BIOL CHEM, V273, P24433, DOI 10.1074/jbc.273.38.24433; Flores-Diaz M, 2005, J BIOL CHEM, V280, P26680, DOI 10.1074/jbc.M500278200; Flores-Diaz M, 2004, ANAEROBE, V10, P115, DOI 10.1016/j.anaerobe.2003.11.002; Flores-Diaz M, 2003, TOXICON, V42, P979, DOI 10.1016/j.toxicon.2003.11.013; Frantz S, 2006, FASEB J, V20, P1918, DOI 10.1096/fj.05-5133fje; Goni FM, 2012, PROG LIPID RES, V51, P238, DOI 10.1016/j.plipres.2012.03.002; Gonindard C, 1997, CELL BIOL TOXICOL, V13, P141, DOI 10.1023/A:1007321227010; GSCHWENDT M, 1994, FEBS LETT, V347, P85, DOI 10.1016/0014-5793(94)00514-1; Gupta KP, 1996, J BIOL CHEM, V271, P2102, DOI 10.1074/jbc.271.4.2102; GUSTAFSON C, 1990, SCAND J GASTROENTERO, V25, P363, DOI 10.3109/00365529009095500; ICHIKAWA S, 1994, P NATL ACAD SCI USA, V91, P2703, DOI 10.1073/pnas.91.7.2703; Jeon ES, 2007, J CELL BIOCHEM, V100, P1536, DOI 10.1002/jcb.21141; Joglar B, 2009, J NEUROCHEM, V109, P656, DOI 10.1111/j.1471-4159.2009.05999.x; Johnson JA, 1996, J BIOL CHEM, V271, P24962, DOI 10.1074/jbc.271.40.24962; Kinehara M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054122; Laudanna C, 1998, J BIOL CHEM, V273, P30306, DOI 10.1074/jbc.273.46.30306; Lawler JM, 2011, J PHYSIOL-LONDON, V589, P2161, DOI 10.1113/jphysiol.2011.207456; Lille ST, 2001, MUSCLE NERVE, V24, P534, DOI 10.1002/mus.1037; Ling LU, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.12; Liu LL, 2010, INT J CANCER, V127, P820, DOI 10.1002/ijc.25098; Luo JL, 2005, J CLIN INVEST, V115, P2625, DOI 10.1172/JCI26322; Maioli E, 2012, SCI WORLD J, DOI 10.1100/2012/350826; Martin P, 2010, FEBS J, V277, P39, DOI 10.1111/j.1742-4658.2009.07369.x; Monturiol-Gross L, 2012, J INFECT DIS, V206, P1218, DOI 10.1093/infdis/jis496; Morgan MJ, 2011, CELL RES, V21, P103, DOI 10.1038/cr.2010.178; Moss NC, 2007, AM J PHYSIOL-HEART C, V293, pH2248, DOI 10.1152/ajpheart.00776.2007; Ochi S, 2004, J BIOL CHEM, V279, P12181, DOI 10.1074/jbc.M307046200; Ochi S, 2002, MICROBIOL-SGM, V148, P237, DOI 10.1099/00221287-148-1-237; Oda M, 2006, INFECT IMMUN, V74, P2876, DOI 10.1128/IAI.74.5.2876-2886.2006; Oda M, 2012, BBA-MOL BASIS DIS, V1822, P1581, DOI 10.1016/j.bbadis.2012.06.007; Petit L, 1999, TRENDS MICROBIOL, V7, P104, DOI 10.1016/S0966-842X(98)01430-9; Pinton P, 2007, SCIENCE, V315, P659, DOI 10.1126/science.1135380; Ql WN, 2004, MICROSURG, V24, P316, DOI 10.1002/micr.20030; Roman J, 2000, J BIOL CHEM, V275, P14684, DOI 10.1074/jbc.275.19.14684; Rosse C, 2010, NAT REV MOL CELL BIO, V11, P103, DOI 10.1038/nrm2847; Sahu RP, 2009, CARCINOGENESIS, V30, P1744, DOI 10.1093/carcin/bgp157; SAKURAI J, 1994, INFECT IMMUN, V62, P717, DOI 10.1128/IAI.62.2.717-721.1994; Schwartz GK, 1997, CLIN CANCER RES, V3, P537; Shimizu T, 2002, P NATL ACAD SCI USA, V99, P996, DOI 10.1073/pnas.022493799; Sim S, 2005, J IMMUNOL, V174, P4279, DOI 10.4049/jimmunol.174.7.4279; Stevens DL, 2012, ANAEROBE, V18, P254, DOI 10.1016/j.anaerobe.2011.11.001; Stevens DL, 2004, J INFECT DIS, V190, P767, DOI 10.1086/422691; TITBALL RW, 1993, MICROBIOL REV, V57, P347, DOI 10.1128/MMBR.57.2.347-366.1993; TOULLEC D, 1991, J BIOL CHEM, V266, P15771; Ueda Y, 2013, FASEB J, P1; Ungvari Z, 2004, AM J PATHOL, V165, P219, DOI 10.1016/S0002-9440(10)63290-7; Urbina P, 2009, CHEM PHYS LIPIDS, V159, P51, DOI 10.1016/j.chemphyslip.2009.02.007; Wan FY, 2010, CELL RES, V20, P24, DOI 10.1038/cr.2009.137; WILSON E, 1986, J BIOL CHEM, V261, P2616; Wortzel Inbal, 2011, Genes Cancer, V2, P195, DOI 10.1177/1947601911407328; Yedovitzky M, 1997, J BIOL CHEM, V272, P1417, DOI 10.1074/jbc.272.3.1417; Zhang XC, 2003, AM J RESP CELL MOL, V28, P305, DOI 10.1165/rcmb.2002-0156OC; Zhou GS, 1997, J BIOL CHEM, V272, P31130, DOI 10.1074/jbc.272.49.31130	65	24	25	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2014	9	1							e86475	10.1371/journal.pone.0086475	http://dx.doi.org/10.1371/journal.pone.0086475			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297XI	24466113	Green Published, Green Submitted, gold			2022-12-25	WOS:000330288000103
J	Jiang, CL; Niu, JZ; Li, M; Teng, Y; Wang, HX; Zhang, YQ				Jiang, Changli; Niu, Junzhou; Li, Meng; Teng, Yi; Wang, Huixuan; Zhang, Yingqi			Tumor Vasculature-Targeted Recombinant Mutated Human TNF-alpha Enhanced the Antitumor Activity of Doxorubicin by Increasing Tumor Vessel Permeability in Mouse Xenograft Models	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; ALPHA-V-BETA-3; PENETRATION; EXPRESSION; INTEGRINS; TOXICITY; DELIVERY; BINDING; GROWTH; CANCER	Objective: Increasing evidence suggests that, when used in combination, tumor necrosis factor-alpha (TNF-alpha) synergizes with traditional chemotherapeutic drugs to exert a heightened antitumor effect. The present study investigated the antitumor efficacy of recombinant mutated human TNF-alpha specifically targeted to the tumor vasculature (RGD-rmhTNF-alpha) combined with the chemotherapeutic agent doxorubicin in 2 murine allografted tumor models. Methods: Mice bearing hepatoma or sarcoma allografted tumors were treated with various doses of RGD-rmhTNF-alpha alone or in combination with doxorubicin (2 mg/kg). We then evaluated tumor growth and tumor vessel permeability as well as intratumoral levels of RGD-rmhTNF-alpha and doxorubicin. Results: RGD-rmhTNF-alpha treatment enhanced the permeability of the tumor vessels and increased intratumoral doxorubicin levels. In addition, intratumoral RGD-rmhTNF-alpha levels were significantly higher than that of rmhTNF-alpha. In both of the tested tumor models, administering RGD-rmhTNF-alpha in combination with doxorubicin resulted in an enhanced antitumor response compared to either treatment alone. Double-agent combination treatment of doxorubicin with 50,000 IU/kg RGD-rmhTNF-alpha induced stronger antitumor effects on H22 allografted tumor-bearing mice than the single doxorubicin agent alone. Moreover, doxorubicin with 10,000 IU/kg RGD-rmhTNF-alpha synergized to inhibit tumor growth in S180 allografted tumor-bearing mice. Conclusions: These results suggest that targeted delivery of low doses of RGD-rmhTNF-alpha into the tumor vasculature increases the antitumor efficacy of chemotherapeutic drugs.	[Jiang, Changli; Teng, Yi; Wang, Huixuan] Chengdu Mil Area, Kunming Gen Hosp, Clin Lab, Army Ctr Mol Biol Anal, Kunming, Yunnna, Peoples R China; [Jiang, Changli; Li, Meng; Zhang, Yingqi] Fourth Mil Med Univ, Sch Pharm, Dept Biopharmaceut, State Key Lab Canc Biol, Xian 710032, Shaanxi, Peoples R China; [Niu, Junzhou] Fourth Mil Med Univ, Xijing Hosp, Dept Dermatol, Xian 710032, Shaanxi, Peoples R China	Kunming General Hospital; Air Force Military Medical University; Air Force Military Medical University	Wang, HX (corresponding author), Chengdu Mil Area, Kunming Gen Hosp, Clin Lab, Army Ctr Mol Biol Anal, Kunming, Yunnna, Peoples R China.	dywang43@163.com; zhangyqh@fmmu.edu.cn	meng, li/GVT-2063-2022		National Natural Science Foundation of China [31200657]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was supported by the grant from the National Natural Science Foundation of China (Grant No. 31200657). http://159.226.244.22/portal/Proj_List.asp. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bello L, 2001, NEUROSURGERY, V49, P380, DOI 10.1097/00006123-200108000-00022; BROOKS PC, 1995, J CLIN INVEST, V96, P1815, DOI 10.1172/JCI118227; Curnis F, 2002, J CLIN INVEST, V110, P475, DOI 10.1172/JCI200215223; de Wilt JHW, 2000, BRIT J CANCER, V82, P1000, DOI 10.1054/bjoc.1999.1032; Demidenko ZN, 2004, CANCER RES, V64, P3653, DOI 10.1158/0008-5472.CAN-04-0204; Dreher MR, 2006, JNCI-J NATL CANCER I, V98, P335, DOI 10.1093/jnci/djj070; Holig P, 2004, PROTEIN ENG DES SEL, V17, P433, DOI 10.1093/protein/gzh055; Jang SH, 2003, PHARM RES-DORDR, V20, P1337, DOI 10.1023/A:1025785505977; KEMENY N, 1990, CANCER, V66, P659, DOI 10.1002/1097-0142(19900815)66:4<659::AID-CNCR2820660410>3.0.CO;2-2; KOIVUNEN E, 1995, BIO-TECHNOL, V13, P265, DOI 10.1038/nbt0395-265; Kristensen CA, 1996, BRIT J CANCER, V74, P533, DOI 10.1038/bjc.1996.397; Lejeune F J, 2006, Bull Cancer, V93, pE90; Lejeune Ferdy J, 2006, Cancer Immun, V6, P6; Lejeune FJ, 1998, CURR OPIN IMMUNOL, V10, P573, DOI 10.1016/S0952-7915(98)80226-4; Li B, 2009, CANCER RES, V69, P338, DOI 10.1158/0008-5472.CAN-08-1565; Li M, 2010, ANTI-CANCER DRUG, V21, P243, DOI 10.1097/CAD.0b013e328333d5ce; Locksley RM, 2001, CELL, V104, P487, DOI 10.1016/S0092-8674(01)00237-9; NAKAMURA S, 1991, INT J CANCER, V48, P744, DOI 10.1002/ijc.2910480519; Plow EF, 2000, J BIOL CHEM, V275, P21785, DOI 10.1074/jbc.R000003200; Sacchi A, 2006, CLIN CANCER RES, V12, P175, DOI 10.1158/1078-0432.CCR-05-1147; SCHWARTZ HS, 1973, BIOCHEM MED METAB B, V7, P396, DOI 10.1016/0006-2944(73)90060-4; Sengupta S, 2001, J EXP CLIN CANC RES, V20, P585; Shin NK, 1998, BIOCHEM MOL BIOL INT, V44, P1075; Taeger G, 2008, INT J HYPERTHER, V24, P193, DOI 10.1080/02656730701868387; Temming K, 2005, DRUG RESIST UPDATE, V8, P381, DOI 10.1016/j.drup.2005.10.002; Varner Judith A, 1995, CELL COMMUNICATION A, V3, P367; Wang H, 2006, PROTEIN EXPRES PURIF, V45, P60, DOI 10.1016/j.pep.2005.05.009; Yan S, CANC INVEST, V28, P85; Yan Z, 2006, CYTOTHERAPY, V8, P415, DOI 10.1080/14653240600845278	29	7	8	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2014	9	1							e87036	10.1371/journal.pone.0087036	http://dx.doi.org/10.1371/journal.pone.0087036			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297VL	24466321	gold, Green Published			2022-12-25	WOS:000330283100245
J	Paprocki, N; Heath, JA; Novak, SJ				Paprocki, Neil; Heath, Julie A.; Novak, Stephen J.			Regional Distribution Shifts Help Explain Local Changes in Wintering Raptor Abundance: Implications for Interpreting Population Trends	PLOS ONE			English	Article							CLIMATE-CHANGE; HIERARCHICAL MODEL; POTENTIAL IMPACTS; POLEWARD SHIFTS; MIGRATION; RANGES; MOVEMENTS; PHENOLOGY; RESPONSES; DISTANCE	Studies of multiple taxa across broad-scales suggest that species distributions are shifting poleward in response to global climate change. Recognizing the influence of distribution shifts on population indices will be an important part of interpreting trends within management units because current practice often assumes that changes in local populations reflect local habitat conditions. However, the individual-and population-level processes that drive distribution shifts may occur across a large, regional scale and have little to do with the habitats within the management unit. We examined the latitudinal center of abundance for the winter distributions of six western North America raptor species using Christmas Bird Counts from 1975-2011. Also, we considered whether population indices within western North America Bird Conservation Regions (BCRs) were explained by distribution shifts. All six raptors had significant poleward shifts in their wintering distributions over time. Rough-legged Hawks (Buteo lagopus) and Golden Eagles (Aquila chrysaetos) showed the fastest rate of change, with 8.41 km yr(-1) 21 and 7.74 km yr(-1) 21 shifts, respectively. Raptors may be particularly responsive to warming winters because of variable migration tendencies, intraspecific competition for nesting sites that drives males to winter farther north, or both. Overall, 40% of BCR population trend models were improved by incorporating information about wintering distributions; however, support for the effect of distribution on BCR indices varied by species with Rough-legged Hawks showing the most evidence. These results emphasize the importance of understanding how regional distribution shifts influence local-scale population indices. If global climate change is altering distribution patterns, then trends within some management units may not reflect changes in local habitat conditions. The methods used to monitor and manage bird populations within local BCRs will fundamentally change as species experience changes in distribution in response to climate change.	[Paprocki, Neil; Heath, Julie A.; Novak, Stephen J.] Boise State Univ, Dept Sci Biol, Boise, ID 83725 USA; [Paprocki, Neil; Heath, Julie A.] Boise State Univ, Raptor Res Ctr, Boise, ID 83725 USA	Idaho; Boise State University; Idaho; Boise State University	Paprocki, N (corresponding author), United States Dept Agr, European Biol Control Lab, Agr Res Serv, Montferrier Sur Lez, France.	paprock@yahoo.com	Heath, Julie/D-5600-2011	Heath, Julie/0000-0002-9606-1689	Bureau of Land Management Challenge Cost Share Award; Boise State University's Raptor Research Center; Department of Biological Sciences; Great Basin Landscape Conservation Cooperative; National Science Foundation's Graduate STEM Fellows in K-12 Education Fellowship [DGE-0742554]; National Science Foundation [DEB1145552]; Direct For Biological Sciences [1145552] Funding Source: National Science Foundation	Bureau of Land Management Challenge Cost Share Award; Boise State University's Raptor Research Center; Department of Biological Sciences; Great Basin Landscape Conservation Cooperative; National Science Foundation's Graduate STEM Fellows in K-12 Education Fellowship; National Science Foundation(National Science Foundation (NSF)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	Support for this project came from a Bureau of Land Management Challenge Cost Share Award, Boise State University's Raptor Research Center and the Department of Biological Sciences, the Great Basin Landscape Conservation Cooperative, and a National Science Foundation's Graduate STEM Fellows in K-12 Education Fellowship (DGE-0742554) to Neil Paprocki. This material is based upon work supported by the National Science Foundation under Grant No. (DEB1145552) to JAH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2002, BIRDS N AM; Arnold TW, 2010, J WILDLIFE MANAGE, V74, P1175, DOI 10.2193/2009-367; Bart J, 2007, J AVIAN BIOL, V38, P73, DOI 10.1111/j.2007.0908-8857.03698.x; Bechard M. J., 2002, BIRDS N AM; BERTHOLD P, 1992, NATURE, V360, P668, DOI 10.1038/360668a0; Booms TL, 2010, J RAPTOR RES, V44, P175, DOI 10.3356/JRR-09-70.1; Both C, 2001, NATURE, V411, P296, DOI 10.1038/35077063; Burnham K.P., 2002, MODEL SELECTION MULT, DOI 10.1007/b97636; Burnham KK, 2011, IBIS, V153, P468, DOI 10.1111/j.1474-919X.2011.01141.x; Doswald N, 2009, J BIOGEOGR, V36, P1194, DOI 10.1111/j.1365-2699.2009.02086.x; Drent RJ, 2006, J ORNITHOL, V147, P122, DOI 10.1007/s10336-006-0066-4; DUNN EH, 2005, PARTNERS FLIGHT TECH, V2; Espie RHM, 2000, ECOLOGY, V81, P3404; Ganusevich SA, 2004, IBIS, V146, P291, DOI 10.1046/j.1474-919X.2004.00253.x; Goodrich LJ, 2012, J RAPTOR RES, V46, P27, DOI 10.3356/JRR-11-16.1; Gordo O, 2005, GLOBAL CHANGE BIOL, V11, P12, DOI 10.1111/j.1365-2486.2004.00875.x; Heath JA, 2012, J AVIAN BIOL, V43, P376, DOI 10.1111/j.1600-048X.2012.05595.x; Hoffman SW, 2002, J RAPTOR RES, V36, P97; Huntley B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001439; Hurlbert AH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031662; La Sorte FA, 2007, ECOLOGY, V88, P1803, DOI 10.1890/06-1072.1; Leech DI, 2007, IBIS, V149, P128, DOI 10.1111/j.1474-919X.2007.00729.x; Link WA, 2006, CONDOR, V108, P13, DOI 10.1650/0010-5422(2006)108[0013:AHMFRA]2.0.CO;2; Link WA, 1999, J AGRIC BIOL ENVIR S, V4, P116, DOI 10.2307/1400592; National Audubon Society, 2012, CHRISTM BIRD COUNT H; Norris DR, 2006, BIOL LETTERS, V2, P148, DOI 10.1098/rsbl.2005.0397; Parmesan C, 1999, NATURE, V399, P579, DOI 10.1038/21181; Parmesan C, 2006, ANNU REV ECOL EVOL S, V37, P637, DOI 10.1146/annurev.ecolsys.37.091305.110100; PETERSON AP, 1995, J FIELD ORNITHOL, V66, P385; Saether BE, 2003, P ROY SOC B-BIOL SCI, V270, P2397, DOI 10.1098/rspb.2003.2499; Sauer JR, 2008, J WILDLIFE MANAGE, V72, P204, DOI 10.2193/2006-534; Steenhof K, 2005, CONDOR, V107, P481, DOI 10.1650/0010-5422(2005)107[0481:LMABDO]2.0.CO;2; Steenhof K., 1998, BIRDS N AM; Steenhof K, 2013, CONDOR, V115, P584, DOI 10.1525/cond.2013.120006; Swem TR, 1996, THESIS BOISE STATE U; Tingley MW, 2009, P NATL ACAD SCI USA, V106, P19637, DOI 10.1073/pnas.0901562106; Trenberth KE, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P235; Vegvari Z, 2010, GLOBAL CHANGE BIOL, V16, P1, DOI 10.1111/j.1365-2486.2009.01876.x; Visser ME, 2009, GLOBAL CHANGE BIOL, V15, P1859, DOI 10.1111/j.1365-2486.2009.01865.x; Visser ME, 2003, P ROY SOC B-BIOL SCI, V270, P367, DOI 10.1098/rspb.2002.2244; Zuckerberg B, 2011, J ANIM ECOL, V80, P403, DOI 10.1111/j.1365-2656.2010.01780.x; Zuur Alain F., 2009, P1	42	36	40	2	88	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2014	9	1							e86814	10.1371/journal.pone.0086814	http://dx.doi.org/10.1371/journal.pone.0086814			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297VL	24466253	Green Published, gold			2022-12-25	WOS:000330283100221
J	Shen, WJ; Song, M; Liu, J; Qiu, GR; Li, TR; Hu, YJ; Liu, HB				Shen, Wenjing; Song, Min; Liu, Jie; Qiu, Guangrong; Li, Tianren; Hu, Yanjie; Liu, Hongbo			MiR-26a Promotes Ovarian Cancer Proliferation and Tumorigenesis	PLOS ONE			English	Article							CIRCULATING MICRORNAS; EXPRESSION; GROWTH; REPRESSION; CARCINOMA; SURVIVAL; EZH2	MicroRNAs (miRNAs) important for posttranscriptional gene expression are involved in the initiation and progression of human cancer. In this study, we reported that miR-26a was over-expressed in human EOC specimens and the expression level of extracellular miR-26a in plasma can distinguish patients from healthy controls in EOC. Ectopic expression of miR-26a in ovarian cancer (OC) cells increased cell proliferation and clonal formation. This growth promoting effect of OC cell growth was mediated by miR-26a inhibition of the posttranscription of ER-alpha. Furthermore, inhibition of miR-26a suppressed the tumor formation generated by injecting OC cells in nude mice. Our results suggest that aberrantly expressed miR-26a may contribute to OC development.	[Shen, Wenjing; Li, Tianren; Hu, Yanjie] China Med Univ, Dept Gynecol, Affiliated Hosp 1, Shenyang, Peoples R China; [Song, Min] China Med Univ, Inst Pathol & Pathophysiol, Affiliated Hosp 1, Dept Pathol, Shenyang, Peoples R China; [Song, Min] China Med Univ, Inst Pathol & Pathophysiol, Coll Basic Med Sci, Shenyang, Peoples R China; [Liu, Jie] China Med Univ, Expt Technol Ctr, Shenyang, Peoples R China; [Qiu, Guangrong] China Med Univ, Dept Med Genet, Shenyang, Peoples R China; [Liu, Hongbo] China Med Univ, Sch Publ Hlth, Dept Hlth Stat, Shenyang, Peoples R China	China Medical University; China Medical University; China Medical University; China Medical University; China Medical University; China Medical University	Shen, WJ (corresponding author), China Med Univ, Dept Gynecol, Affiliated Hosp 1, Shenyang, Peoples R China.	wenjing0326@163.com; songmin6@sohu.com			NNSF(National Natural Science Foundation) of China [30571836]; Science Foundation of the Education Department of Liaoning Province of China [L2010681]; Science Foundation of Science and Technology Bureau of Liaoning Province of China [201202259]	NNSF(National Natural Science Foundation) of China(National Natural Science Foundation of China (NSFC)); Science Foundation of the Education Department of Liaoning Province of China; Science Foundation of Science and Technology Bureau of Liaoning Province of China	This work was sponsored by grants from the Project No. 30571836 from the NNSF(National Natural Science Foundation) of China. In addition, the work presented is part of projects with Project No. L2010681 financially supported by Science Foundation of the Education Department of Liaoning Province of China, and Project No. 201202259 financially supported by Science Foundation of Science and Technology Bureau of Liaoning Province of China. Author Min Song contributed to experimental conceiving and design, guidance and discussion of the project, so she is the co-correspondence author of this paper. All the other funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baffa R, 2009, J PATHOL, V219, P214, DOI 10.1002/path.2586; Bake S, 2008, ENDOCRINOLOGY, V149, P3881, DOI 10.1210/en.2008-0288; Bonci D, 2008, NAT MED, V14, P1271, DOI 10.1038/nm.1880; Calin GA, 2002, P NATL ACAD SCI USA, V99, P15524, DOI 10.1073/pnas.242606799; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Chang TC, 2008, NAT GENET, V40, P43, DOI 10.1038/ng.2007.30; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Chen LZ, 2011, MOL THER, V19, P1521, DOI 10.1038/mt.2011.64; Chen X, 2008, CELL RES, V18, P997, DOI 10.1038/cr.2008.282; Ciarapica R, 2009, CELL CYCLE, V8, P172, DOI 10.4161/cc.8.1.7292; Cunat S, 2004, GYNECOL ONCOL, V94, P25, DOI 10.1016/j.ygyno.2004.03.026; Feng JL, 2009, GENE, V437, P14, DOI 10.1016/j.gene.2009.01.017; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Fujii Yoichi Robertus, 2009, Open Virol J, V3, P37, DOI 10.2174/1874357900903010037; Garofalo M, 2011, ANNU REV PHARMACOL, V51, P25, DOI 10.1146/annurev-pharmtox-010510-100517; Halon A, 2011, PATHOL ONCOL RES, V17, P511, DOI 10.1007/s12253-010-9340-0; He L, 2004, NAT REV GENET, V5, P522, DOI 10.1038/nrg1379; Hecht JL, 2009, CANCER EPIDEM BIOMAR, V18, P1624, DOI 10.1158/1055-9965.EPI-08-1214; Hoskins WJ, 1995, J CELL BIOCHEM, P189; Huse JT, 2009, GENE DEV, V23, P1327, DOI 10.1101/gad.1777409; Hwang HW, 2006, BRIT J CANCER, V94, P776, DOI 10.1038/sj.bjc.6603023; Ji JF, 2009, NEW ENGL J MED, V361, P1437, DOI 10.1056/NEJMoa0901282; Johnson SM, 2005, CELL, V120, P635, DOI 10.1016/j.cell.2005.01.014; Lu JA, 2011, CANCER RES, V71, P225, DOI 10.1158/0008-5472.CAN-10-1850; Ma RM, 2012, J EXP CLIN CANC RES, V31, DOI 10.1186/1756-9966-31-38; Medina PP, 2010, NATURE, V467, P86, DOI 10.1038/nature09284; Meng FY, 2007, GASTROENTEROLOGY, V133, P647, DOI 10.1053/j.gastro.2007.05.022; Michael MZ, 2003, MOL CANCER RES, V1, P882; Mitchell PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/pnas.0804549105; Mohamed JS, 2010, J BIOL CHEM, V285, P29336, DOI 10.1074/jbc.M110.101147; Takamizawa J, 2004, CANCER RES, V64, P3753, DOI 10.1158/0008-5472.CAN-04-0637; Zhang B, 2011, CARCINOGENESIS, V32, P2, DOI 10.1093/carcin/bgq209; Zhang L, 2008, P NATL ACAD SCI USA, V105, P7004, DOI 10.1073/pnas.0801615105	33	50	55	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2014	9	1							e86871	10.1371/journal.pone.0086871	http://dx.doi.org/10.1371/journal.pone.0086871			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297VL	24466274	Green Published, Green Submitted, gold			2022-12-25	WOS:000330283100228
J	Weier, K; Penner, IK; Magon, S; Amann, M; Naegelin, Y; Andelova, M; Derfuss, T; Stippich, C; Radue, EW; Kappos, L; Sprenger, T				Weier, Katrin; Penner, Iris K.; Magon, Stefano; Amann, Michael; Naegelin, Yvonne; Andelova, Michaela; Derfuss, Tobias; Stippich, Christoph; Radue, Ernst-Wilhelm; Kappos, Ludwig; Sprenger, Till			Cerebellar Abnormalities Contribute to Disability Including Cognitive Impairment in Multiple Sclerosis	PLOS ONE			English	Article							SERIAL ADDITION TEST; BRAIN ATROPHY; FOLLOW-UP; FATIGUE; DYSFUNCTION; PERSONALITY; DEPRESSION; DISORDER; SCALE; GRAY	The cerebellum is known to be involved not only in motor but also cognitive and affective processes. Structural changes in the cerebellum in relation to cognitive dysfunction are an emerging topic in the field of neuro-psychiatric disorders. In Multiple Sclerosis (MS) cerebellar motor and cognitive dysfunction occur in parallel, early in the onset of the disease, and the cerebellum is one of the predilection sites of atrophy. This study is aimed at determining the relationship between cerebellar volumes, clinical cerebellar signs, cognitive functioning and fatigue in MS. Cerebellar volumetry was conducted using T1-weighted MPRAGE magnetic resonance imaging of 172 MS patients. All patients underwent a clinical and brief neuropsychological assessment (information processing speed, working memory), including fatigue testing. Patients with and without cerebellar signs differed significantly regarding normalized cerebellar total volume (nTCV), normalized brain volume (nBV) and whole brain T2 lesion volume (LV). Patients with cerebellar dysfunction likewise performed worse in cognitive tests. A regression analysis indicated that age and nTCV explained 26.3% of the variance in SDMT (symbol digit modalities test) performance. However, only age, T2 LV and nBV remained predictors in the full model (r(2) = 0.36). The full model for the prediction of PASAT (Paced Auditory Serial Addition Test) scores (r(2) = 0.23) included age, cerebellar and T2 LV. In the case of fatigue, only age and nBV (r(2) = 0.17) emerged as significant predictors. These data support the view that cerebellar abnormalities contribute to disability, including cognitive impairment in MS. However, this contribution does not seem to be independent of, and may even be dominated by wider spread MS pathology as reflected by nBV and T2 LV.	[Weier, Katrin; Penner, Iris K.; Magon, Stefano; Amann, Michael; Naegelin, Yvonne; Andelova, Michaela; Derfuss, Tobias; Kappos, Ludwig; Sprenger, Till] Univ Basel Hosp, Dept Neurol, CH-4031 Basel, Switzerland; [Penner, Iris K.] Univ Basel, Dept Cognit Psychol & Methodol, Basel, Switzerland; [Amann, Michael; Stippich, Christoph; Sprenger, Till] Univ Basel Hosp, Dept Radiol, Div Neuroradiol, CH-4031 Basel, Switzerland; [Radue, Ernst-Wilhelm] Univ Basel Hosp, Med Image Anal Ctr MIAC AG, CH-4031 Basel, Switzerland	University of Basel; University of Basel; University of Basel; University of Basel	Weier, K (corresponding author), Univ Basel Hosp, Dept Neurol, CH-4031 Basel, Switzerland.	katrin.weier@usb.ch		Derfuss, Tobias/0000-0001-8656-4250; Andelova, Michaela/0000-0002-3812-7483; Sprenger, Till/0000-0002-5390-819X; Magon, Stefano/0000-0003-1517-7581; Penner, Iris-Katharina/0000-0002-6746-1034	University of Basel [DMS2172]	University of Basel	K. Weier received funding from the University of Basel (research grant "Nachwuchsforderung Klinische Forschung" - DMS2172). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amato MP, 2007, ARCH NEUROL-CHICAGO, V64, P1157, DOI 10.1001/archneur.64.8.1157; Anderson VM, 2011, MULT SCLER J, V17, P1079, DOI 10.1177/1352458511403528; Anderson VM, 2009, MULT SCLER, V15, P811, DOI 10.1177/1352458508101934; Bakshi R, 1999, NEUROLOGY, V53, P1151, DOI 10.1212/WNL.53.5.1151; Benedict RHB, 2004, J NEUROIMAGING, V14, p36S, DOI 10.1111/j.1552-6569.2004.tb00277.x; Bermel RA, 2006, LANCET NEUROL, V5, P158, DOI 10.1016/S1474-4422(06)70349-0; Bobholz Julie A, 2008, Handb Clin Neurol, V89, P705, DOI 10.1016/S0072-9752(07)01263-8; Calabrese M, 2010, MULT SCLER J, V16, P1220, DOI 10.1177/1352458510376405; Calabrese M, 2010, J NEUROL NEUROSUR PS, V81, P401, DOI 10.1136/jnnp.2009.177733; Calabrese P, 2007, J NEUROL, V254, P18, DOI 10.1007/s00415-007-2006-5; Cutter GR, 1999, BRAIN, V122, P871, DOI 10.1093/brain/122.5.871; Eriksson M, 2003, MULT SCLER J, V9, P260, DOI 10.1191/1352458503ms914oa; Filippi M, 2002, NEUROIMAGE, V15, P559, DOI 10.1006/nimg.2001.1011; Fisher E, 2002, NEUROLOGY, V59, P1412, DOI 10.1212/01.WNL.0000036271.49066.06; Forn C, 2011, J CLIN EXP NEUROPSYC, V33, P42, DOI 10.1080/13803395.2010.481620; Hill SK, 2009, SCHIZOPHR RES, V113, P167, DOI 10.1016/j.schres.2009.04.020; KURTZKE JF, 1983, NEUROLOGY, V33, P1444, DOI 10.1212/WNL.33.11.1444; Kutzelnigg A, 2005, J NEUROL SCI, V233, P55, DOI 10.1016/j.jns.2005.03.027; Kutzelnigg A, 2007, BRAIN PATHOL, V17, P38, DOI 10.1111/j.1750-3639.2006.00041.x; MILLER DH, 1992, J NEUROL NEUROSUR PS, V55, P341, DOI 10.1136/jnnp.55.5.341; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Penner IK, 2009, MULT SCLER J, V15, P1509, DOI 10.1177/1352458509348519; Penner IK, 2007, MULT SCLER, V13, P1161, DOI 10.1177/1352458507079267; QUADE D, 1967, J AM STAT ASSOC, V62, P1187, DOI 10.2307/2283769; RAO SM, 1991, NEUROLOGY, V41, P685, DOI 10.1212/WNL.41.5.685; Reynolds R, 2011, ACTA NEUROPATHOL, V122, P155, DOI 10.1007/s00401-011-0840-0; Sanfilipo MP, 2006, NEUROLOGY, V66, P685, DOI 10.1212/01.wnl.0000201238.93586.d9; Sbardella E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063250; Scherer P, 2004, NERVENARZT, V75, P984, DOI 10.1007/s00115-004-1729-0; Schmahmann JD, 1998, BRAIN, V121, P561, DOI 10.1093/brain/121.4.561; Smith A., 1982, SYMBOL DIGIT MODALIT; Smith SM, 2002, NEUROIMAGE, V17, P479, DOI 10.1006/nimg.2002.1040; Tedeschi G, 2007, J NEUROL SCI, V263, P15, DOI 10.1016/j.jns.2007.07.004; Tedesco AM, 2011, BRAIN, V134, P3669, DOI 10.1093/brain/awr266; Timmann D, 2010, CORTEX, V46, P845, DOI 10.1016/j.cortex.2009.06.009; Weier K, 2012, J NEUROL; Williams J, 2006, MULT SCLER J, V12, P599, DOI 10.1177/1352458506070752; Yu HJ, 2012, NEUROIMAGE, V59, P3713, DOI 10.1016/j.neuroimage.2011.10.053	38	61	61	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2014	9	1							e86916	10.1371/journal.pone.0086916	http://dx.doi.org/10.1371/journal.pone.0086916			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297VL	24466290	Green Submitted, Green Published, gold			2022-12-25	WOS:000330283100233
J	Jacq, V; Ridame, C; L'Helguen, S; Kaczmar, F; Saliot, A				Jacq, Violaine; Ridame, Celine; L'Helguen, Stephane; Kaczmar, Fanny; Saliot, Alain			Response of the Unicellular Diazotrophic Cyanobacterium Crocosphaera watsonii to Iron Limitation	PLOS ONE			English	Article							NITROGEN-FIXATION; N-2 FIXATION; MARINE-PHYTOPLANKTON; USE EFFICIENCIES; TRICHODESMIUM; GROWTH; CARBON; ATLANTIC; PHOSPHORUS; STRESS	Iron (Fe) is widely suspected as a key controlling factor of N-2 fixation due to the high Fe content of nitrogenase and photosynthetic enzymes complex, and to its low concentrations in oceanic surface seawaters. The influence of Fe limitation on the recently discovered unicellular diazotrophic cyanobacteria (UCYN) is poorly understood despite their biogeochemical importance in the carbon and nitrogen cycles. To address this knowledge gap, we conducted culture experiments on Crocosphaera watsonii WH8501 growing under a range of dissolved Fe concentrations (from 3.3 to 403 nM). Overall, severe Fe limitation led to significant decreases in growth rate (2.6-fold), C, N and chlorophyll a contents per cell (up to 4.1-fold), N-2 and CO2 fixation rates per cell (17- and 7-fold) as well as biovolume (2.2-fold). We highlighted a two phased response depending on the degree of limitation: (i) under a moderate Fe limitation, the biovolume of C. watsonii was strongly reduced, allowing the cells to keep sufficient energy to maintain an optimal growth, volume-normalized contents and N-2 and CO2 fixation rates; (ii) with increasing Fe deprivation, biovolume remained unchanged but the entire cell metabolism was affected, as shown by a strong decrease in the growth rate, volume-normalized contents and N-2 and CO2 fixation rates. The half-saturation constant for growth of C. watsonii with respect to Fe is twice as low as that of the filamentous Trichodesmium indicating a better adaptation of C. watsonii to poor Fe environments than filamentous diazotrophs. The physiological response of C. watsonii to Fe limitation was different from that previously shown on the UCYN Cyanothece sp, suggesting potential differences in Fe requirements and/or Fe acquisition within the UCYN community. These results contribute to a better understanding of how Fe bioavailability can control the activity of UCYN and explain the biogeography of diverse N-2 fixers in ocean.	[Jacq, Violaine; Ridame, Celine; Kaczmar, Fanny; Saliot, Alain] Univ Paris 06, UMR LOCEAN IPSL CNRS IRD MNHN, Paris, France; [L'Helguen, Stephane] Univ Brest, CNRS IRD, UMR 6539, LEMAR,OSU IUEM, Plouzane, France	Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Ifremer; Institut de Recherche pour le Developpement (IRD); Universite de Bretagne Occidentale	Jacq, V (corresponding author), Univ Paris 06, UMR LOCEAN IPSL CNRS IRD MNHN, Paris, France.	violaine.jacq@locean-ipsl.upmc.fr		L'Helguen, Stephane/0000-0002-2395-606X	CNRS; University Pierre et Marie Curie	CNRS(Centre National de la Recherche Scientifique (CNRS)); University Pierre et Marie Curie	This study was supported by CNRS (http://www.cnrs.fr/) and University Pierre et Marie Curie (http://www.upmc.fr/) funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Behrenfeld MJ, 2013, ANNU REV MAR SCI, V5, P217, DOI 10.1146/annurev-marine-121211-172356; Berman-Frank I, 2001, LIMNOL OCEANOGR, V46, P1249, DOI 10.4319/lo.2001.46.6.1249; Berman-Frank I, 2007, LIMNOL OCEANOGR, V52, P2260, DOI 10.4319/lo.2007.52.5.2260; Bonnet S, 2009, GLOBAL BIOGEOCHEM CY, V23, DOI 10.1029/2008GB003439; Boyd PW, 2010, NAT GEOSCI, V3, P675, DOI [10.1038/NGEO964, 10.1038/ngeo964]; Bucciarelli E, 2013, LIMNOL OCEANOGR, V58, P1667, DOI 10.4319/lo.2013.58.5.1667; Campbell L, 2005, VIE MILIEU, V55, P185; CAPONE DG, 1982, SCIENCE, V217, P1140, DOI 10.1126/science.217.4565.1140; Capone DG, 1997, SCIENCE, V276, P1221, DOI 10.1126/science.276.5316.1221; Capone DG, 2000, MICROBIAL ECOLOGY OC; Chappell PD, 2010, ENVIRON MICROBIOL, V12, P13, DOI 10.1111/j.1462-2920.2009.02026.x; Chen YB, 1996, J PHYCOL, V32, P916, DOI 10.1111/j.0022-3646.1996.00916.x; Coles VJ, 2007, BIOGEOSCIENCES, V4, P455, DOI 10.5194/bg-4-455-2007; Dekaezemacker J, 2011, MAR ECOL PROG SER, V438, P33, DOI 10.3354/meps09297; Dron A, 2012, AQUAT MICROB ECOL, V68, P43, DOI 10.3354/ame01600; Dron A, 2012, ENVIRON MICROBIOL, V14, P967, DOI 10.1111/j.1462-2920.2011.02675.x; Dutkiewicz S, 2012, GLOBAL BIOGEOCHEM CY, V26, DOI 10.1029/2011GB004039; Dyhrman ST, 2006, APPL ENVIRON MICROB, V72, P1452, DOI 10.1128/AEM.72.2.1452-1458.2006; Ehrenreich IM, 2005, APPL ENVIRON MICROB, V71, P7401, DOI 10.1128/AEM.71.11.7401-7413.2005; FERREIRA F, 1994, J APPL PHYCOL, V6, P199, DOI 10.1007/BF02186073; Fu FX, 2008, LIMNOL OCEANOGR, V53, P2472, DOI 10.4319/lo.2008.53.6.2472; Garcia NS, 2013, LIMNOL OCEANOGR, V58, P1501, DOI 10.4319/lo.2013.58.4.1501; Goebel NL, 2008, J PHYCOL, V44, P1212, DOI 10.1111/j.1529-8817.2008.00581.x; Grosskopf T, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00236; Gruber N, 1997, GLOBAL BIOGEOCHEM CY, V11, P235, DOI 10.1029/97GB00077; Gruber N, 2008, NITROGEN IN THE MARINE ENVIRONMENT, 2ND EDITION, P1, DOI 10.1016/B978-0-12-372522-6.00001-3; Gundersen K, 2002, LIMNOL OCEANOGR, V47, P1525, DOI 10.4319/lo.2002.47.5.1525; HAMA T, 1983, MAR BIOL, V73, P31, DOI 10.1007/BF00396282; Howard JB, 1996, CHEM REV, V96, P2965, DOI 10.1021/cr9500545; HUDSON RJM, 1990, LIMNOL OCEANOGR, V35, P1002, DOI 10.4319/lo.1990.35.5.1002; Jickells TD, 2005, SCIENCE, V308, P67, DOI 10.1126/science.1105959; Johnson KS, 1997, MAR CHEM, V57, P137, DOI 10.1016/S0304-4203(97)00043-1; Karl D, 1997, NATURE, V388, P533, DOI 10.1038/41474; Karl DM, 2008, MAR ECOL PROG SER, V364, P257, DOI 10.3354/meps07547; Kupper H, 2008, NEW PHYTOL, V179, P784, DOI 10.1111/j.1469-8137.2008.02497.x; Kustka A, 2003, J PHYCOL, V39, P12, DOI 10.1046/j.1529-8817.2003.01156.x; Kustka AB, 2003, LIMNOL OCEANOGR, V48, P1869, DOI 10.4319/lo.2003.48.5.1869; Langlois RJ, 2012, MAR ECOL PROG SER, V470, P1, DOI 10.3354/meps10109; LaRoche J, 2005, J SEA RES, V53, P67, DOI 10.1016/j.seares.2004.05.005; Mohr W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066060; Mohr W, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012583; Mohr W, 2010, ENVIRON MICROBIOL, V12, P412, DOI 10.1111/j.1462-2920.2009.02078.x; Moisander PH, 2012, ISME J, V6, P733, DOI 10.1038/ismej.2011.152; Moisander PH, 2010, SCIENCE, V327, P1512, DOI 10.1126/science.1185468; Monteiro FM, 2011, GLOBAL BIOGEOCHEM CY, V25, DOI 10.1029/2010GB003902; Monteiro FM, 2010, GLOBAL BIOGEOCHEM CY, V24, DOI 10.1029/2009GB003731; Montoya JP, 2004, NATURE, V430, P1027, DOI 10.1038/nature02824; Montoya JP, 1996, APPL ENVIRON MICROB, V62, P986, DOI 10.1128/AEM.62.3.986-993.1996; Moore CM, 2009, NAT GEOSCI, V2, P867, DOI 10.1038/ngeo667; Moore JK, 2004, GLOBAL BIOGEOCHEM CY, V18, DOI 10.1029/2004GB002220; OBATA H, 1993, ANAL CHEM, V65, P1524, DOI 10.1021/ac00059a007; RAVEN JA, 1990, NEW PHYTOL, V116, P1, DOI 10.1111/j.1469-8137.1990.tb00505.x; RAVEN JA, 1988, NEW PHYTOL, V109, P279, DOI 10.1111/j.1469-8137.1988.tb04196.x; Richier S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035571; Rubin M, 2011, NAT GEOSCI, V4, P529, DOI 10.1038/NGEO1181; Saito MA, 2011, P NATL ACAD SCI USA, V108, P2184, DOI 10.1073/pnas.1006943108; Sarthou G, 2003, DEEP-SEA RES PT I, V50, P1339, DOI 10.1016/S0967-0637(03)00126-2; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Shaked Y, 2005, LIMNOL OCEANOGR, V50, P872, DOI 10.4319/lo.2005.50.3.0872; Strickland JDH, 1997, B FISH RES BD CAN; Sunda W, 2003, MAR CHEM, V84, P35, DOI 10.1016/S0304-4203(03)00101-4; Sunda W.G., 2001, IUPAC SER ANAL PHYS, V49, P1024; SUNDA WG, 1995, MAR CHEM, V50, P189, DOI 10.1016/0304-4203(95)00035-P; Takeda S, 1998, NATURE, V393, P774, DOI 10.1038/31674; Toulza E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030931; Troussellier M, 1999, FEMS MICROBIOL ECOL, V29, P319, DOI 10.1016/S0168-6496(99)00026-4; Tuit C, 2004, LIMNOL OCEANOGR, V49, P978, DOI 10.4319/lo.2004.49.4.0978; Turk-Kubo KA, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00386; Wang WX, 2003, AQUAT MICROB ECOL, V33, P247, DOI 10.3354/ame033247; Webb EA, 2001, APPL ENVIRON MICROB, V67, P5444, DOI 10.1128/AEM.67.12.5444-5452.2001; Webb EA, 2009, ENVIRON MICROBIOL, V11, P338, DOI 10.1111/j.1462-2920.2008.01771.x; Zehr JP, 2007, P NATL ACAD SCI USA, V104, P17807, DOI 10.1073/pnas.0701017104; Zehr JP, 2001, NATURE, V412, P635, DOI 10.1038/35088063	73	24	24	2	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2014	9	1							e86749	10.1371/journal.pone.0086749	http://dx.doi.org/10.1371/journal.pone.0086749			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297GT	24466221	Green Published, Green Submitted, gold			2022-12-25	WOS:000330244500280
J	Melchiotti, R; Rotzschke, O; Poidinger, M				Melchiotti, Rossella; Roetzschke, Olaf; Poidinger, Michael			ArchiLD: Hierarchical Visualization of Linkage Disequilibrium in Human Populations	PLOS ONE			English	Article							GENOME BROWSER DATABASE; GENETIC-VARIATION; WIDE ASSOCIATION; HAPLOTYPE MAP; UCSC; HAPMAP; SNPS; TOOL; SET; LD	Linkage disequilibrium (LD) is an essential metric for selecting single-nucleotide polymorphisms (SNPs) to use in genetic studies and identifying causal variants from significant tag SNPs. The explosion in the number of polymorphisms that can now be genotyped by commercial arrays makes the interpretation of triangular correlation plots, commonly used for visualizing LD, extremely difficult in particular when large genomics regions need to be considered or when SNPs in perfect LD are not adjacent but scattered across a genomic region. We developed ArchiLD, a user-friendly graphical application for the hierarchical visualization of LD in human populations. The software provides a powerful framework for analyzing LD patterns with a particular focus on blocks of SNPs in perfect linkage as defined by r(2). Thanks to its integration with the UCSC Genome Browser, LD plots can be easily overlapped with additional data on regulation, conservation and expression. ArchiLD is an intuitive solution for the visualization of LD across large or highly polymorphic genomic regions. Its ease of use and its integration with the UCSC Genome Browser annotation potential facilitates the interpretation of association results and enables a more informed selection of tag SNPs for genetic studies.	[Melchiotti, Rossella; Roetzschke, Olaf; Poidinger, Michael] ASTAR, Singapore Immunol Network SIgN, Singapore, Singapore; [Melchiotti, Rossella] Univ Milano Bicocca, Doctoral Sch Translat & Mol Med DIMET, Milan, Italy	Agency for Science Technology & Research (A*STAR); A*STAR - Singapore Immunology Network (SIgN); University of Milano-Bicocca	Poidinger, M (corresponding author), ASTAR, Singapore Immunol Network SIgN, Singapore, Singapore.	rossella_melchiotti@immunol.a-star.edu.sg	Roetzschke, Olaf/GXH-0012-2022	Poidinger, Michael/0000-0002-1047-2277	A*STAR/Singapore Immunology Network core grant; A*STAR Research Attachment Program (ARAP)	A*STAR/Singapore Immunology Network core grant(Agency for Science Technology & Research (A*STAR)); A*STAR Research Attachment Program (ARAP)(Agency for Science Technology & Research (A*STAR))	This work was funded by the A*STAR/Singapore Immunology Network core grant and the A*STAR Research Attachment Program (ARAP) for the graduate student involved in the project. The funders had no role in software design, software implementation, decision to publish, or preparation of the manuscript.	Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Altshuler DM, 2010, NATURE, V467, P52, DOI 10.1038/nature09298; [Anonymous], 2012, LANG ENV STAT COMP; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Bush WS, 2010, BIOINFORMATICS, V26, P578, DOI 10.1093/bioinformatics/btp678; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Gibbs RA, 2003, NATURE, V426, P789, DOI 10.1038/nature02168; Hinrichs AS, 2006, NUCLEIC ACIDS RES, V34, pD590, DOI 10.1093/nar/gkj144; Johnson AD, 2008, BIOINFORMATICS, V24, P2938, DOI 10.1093/bioinformatics/btn564; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kofler R, 2012, BIOINFORMATICS, V28, P2084, DOI 10.1093/bioinformatics/bts315; Meyer LR, 2013, NUCLEIC ACIDS RES, V41, pD64, DOI 10.1093/nar/gks1048; Pruim RJ, 2010, BIOINFORMATICS, V26, P2336, DOI 10.1093/bioinformatics/btq419; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795	16	2	2	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2014	9	1							e86761	10.1371/journal.pone.0086761	http://dx.doi.org/10.1371/journal.pone.0086761			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297GT	24466224	Green Published, gold, Green Submitted			2022-12-25	WOS:000330244500281
J	Bajpe, PK; Prahallad, A; Horlings, H; Nagtegaal, I; Beijersbergen, R; Bernards, R				Bajpe, P. K.; Prahallad, A.; Horlings, H.; Nagtegaal, I.; Beijersbergen, R.; Bernards, R.			A chromatin modifier genetic screen identifies SIRT2 as a modulator of response to targeted therapies through the regulation of MEK kinase activity	ONCOGENE			English	Article						SIRT2; drug resistance; chromatin modifiers; genetic screen	METASTATIC COLORECTAL-CANCER; FREQUENT MUTATIONS; CELL CARCINOMA; RAS MUTATIONS; BREAST-CANCER; CETUXIMAB; RESISTANCE; RECEPTOR; PATHWAY; MARKER	Resistance to targeted therapies is a major problem in cancer treatment. The epidermal growth factor receptor (EGFR) antibody drugs are effective in a subset of colorectal cancers, but the molecular mechanisms of resistance are understood poorly. Genes involved in epigenetic regulation are frequently deregulated in cancer, raising the possibility that such genes also contribute to drug resistance. Using a focused RNA interference library for genes involved in epigenetic regulation, we identify sirtuin2 (SIRT2), an NAD(+)-dependent deacetylase, as a modulator of the response to EGFR inhibitors in colon and lung cancer. SIRT2 loss also conferred resistance to BRAF and MEK inhibitors in BRAF mutant melanoma and KRAS mutant colon cancers, respectively. These results warrant further investigation into the potential role of SIRT2 in resistance to drugs that act in the receptor tyrosine kinase-RAS-RAF-MEK-ERK signaling pathway.	[Bajpe, P. K.; Prahallad, A.; Horlings, H.; Beijersbergen, R.; Bernards, R.] Netherlands Canc Inst, Div Mol Carcinogenesis, Canc Genom Ctr, NL-1066 CX Amsterdam, Netherlands; [Horlings, H.] Acad Medisch Cent, Dept Pathol, Amsterdam, Netherlands; [Nagtegaal, I.] Radboud Univ Nijmegen, Med Ctr, Dept Pathol, NL-6525 ED Nijmegen, Netherlands	Netherlands Cancer Institute; University of Amsterdam; Academic Medical Center Amsterdam; Radboud University Nijmegen	Bernards, R (corresponding author), Netherlands Canc Inst, Div Mol Carcinogenesis, Canc Genom Ctr, 121 Plesmanlaan, NL-1066 CX Amsterdam, Netherlands.	r.bernards@nki.nl	Nagtegaal, Iris D/A-2448-2014	Nagtegaal, Iris D/0000-0003-0887-4127; Beijersbergen, Roderick/0000-0003-0116-4130; Bernards, Rene/0000-0001-8677-3423	Dutch Cancer Society (KWF); European Union [259015]	Dutch Cancer Society (KWF)(KWF Kankerbestrijding); European Union(European Commission)	We are grateful to Kees Punt, Sabine Tejpar, Josep Tabernero, Jose Jimenez, Adriana Lopez-Doriga Guerra, Ramon Salzar and Loredana Vecchione for providing clinical specimen of cetuximab-treated colon cancers. We thank Gerrit Hooiger and Marc van de Vijver (AMC, Amsterdam) for assistance in staining tissue microarrays and Alberto Bardelli for the kind gift of the Difi cells. We thank the NKI Genomics Core Facility, especially Iris de Rink, for support. We also thank Chong Sun and Sidong Huang for helpful discussions. This work was supported by grants from the Dutch Cancer Society (KWF) and the European Union Seventh Framework Program COLTHERES project, grant agreement 259015.	Andreyev HJN, 2001, BRIT J CANCER, V85, P692, DOI 10.1054/bjoc.2001.1964; Barber MF, 2012, NATURE, V487, P114, DOI 10.1038/nature11043; Berns K, 2007, CANCER CELL, V12, P395, DOI 10.1016/j.ccr.2007.08.030; Brummelkamp TR, 2006, NAT CHEM BIOL, V2, P202, DOI 10.1038/nchembio774; Cunningham D, 2004, NEW ENGL J MED, V351, P337, DOI 10.1056/NEJMoa033025; De Roock W, 2010, LANCET ONCOL, V11, P753, DOI 10.1016/S1470-2045(10)70130-3; Geutjes EJ, 2012, ONCOGENE, V31, P3827, DOI 10.1038/onc.2011.552; Glasspool RM, 2006, BRIT J CANCER, V94, P1087, DOI 10.1038/sj.bjc.6603024; Gui YT, 2011, NAT GENET, V43, P875, DOI 10.1038/ng.907; Huang SD, 2012, CELL, V151, P937, DOI 10.1016/j.cell.2012.10.035; Huang SD, 2009, CANCER CELL, V15, P328, DOI 10.1016/j.ccr.2009.02.023; Jiao YC, 2011, SCIENCE, V331, P1199, DOI 10.1126/science.1200609; Jones S, 2010, SCIENCE, V330, P228, DOI 10.1126/science.1196333; Kim HS, 2011, CANCER CELL, V20, P487, DOI 10.1016/j.ccr.2011.09.004; Kleer CG, 2003, P NATL ACAD SCI USA, V100, P11606, DOI 10.1073/pnas.1933744100; Liu H, 2009, CANCER BIOL THER, V8, P1204, DOI 10.4161/cbt.8.13.8924; Marschalek R, 2011, BRIT J HAEMATOL, V152, P141, DOI 10.1111/j.1365-2141.2010.08459.x; Prahallad A, 2012, NATURE, V483, P100, DOI 10.1038/nature10868; Reisman DN, 2003, CANCER RES, V63, P560; Saltz LB, 2004, J CLIN ONCOL, V22, P1201, DOI 10.1200/JCO.2004.10.182; Samowitz WS, 2000, CANCER EPIDEM BIOMAR, V9, P1193; Sebastian C, 2012, CELL, V151, P1185, DOI 10.1016/j.cell.2012.10.047; Sharma SV, 2010, CELL, V141, P69, DOI 10.1016/j.cell.2010.02.027; Tol J, 2009, NEW ENGL J MED, V360, P563, DOI 10.1056/NEJMoa0808268; Varambally S, 2002, NATURE, V419, P624, DOI 10.1038/nature01075; Wiegand KC, 2010, NEW ENGL J MED, V363, P1532, DOI 10.1056/NEJMoa1008433; Yeung F, ONCOGENE	27	30	33	1	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 22	2015	34	4					531	536		10.1038/onc.2013.588	http://dx.doi.org/10.1038/onc.2013.588			6	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AZ8FU	24469059				2022-12-25	WOS:000348451300014
J	Daniel, AR; Gaviglio, AL; Knutson, TP; Ostrander, JH; D'Assoro, AB; Ravindranathan, P; Peng, Y; Raj, GV; Yee, D; Lange, CA				Daniel, A. R.; Gaviglio, A. L.; Knutson, T. P.; Ostrander, J. H.; D'Assoro, A. B.; Ravindranathan, P.; Peng, Y.; Raj, G. V.; Yee, D.; Lange, C. A.			Progesterone receptor-B enhances estrogen responsiveness of breast cancer cells via scaffolding PELP1-and estrogen receptor-containing transcription complexes	ONCOGENE			English	Article						estrogen receptor; progesterone receptor; PELP1; IGF1R; cathepsin-D; breast cancer	C-SRC; ENDOCRINE RESISTANCE; TAMOXIFEN RESISTANCE; HORMONE-RECEPTORS; GROWTH; ACTIVATION; PATHWAY; EXPRESSION; KINASE; PHOSPHORYLATION	Progesterone and estrogen are important drivers of breast cancer proliferation. Herein, we probed estrogen receptor-a (ER) and progesterone receptor (PR) cross-talk in breast cancer models. Stable expression of PR-B in PR-low/ER+ MCF7 cells increased cellular sensitivity to estradiol and insulin-like growth factor 1 (IGF1), as measured in growth assays performed in the absence of exogenous progestin; similar results were obtained in PR-null/ER+ T47D cells stably expressing PR-B. Genome-wide microarray analyses revealed that unliganded PR-B induced robust expression of a subset of estradiol-responsive ER target genes, including cathepsin-D (CTSD). Estradiol-treated MCF7 cells stably expressing PR-B exhibited enhanced ER Ser167 phosphorylation and recruitment of ER, PR and the proline-, glutamate-and leucine-rich protein 1 (PELP1) to an estrogen response element in the CTSD distal promoter; this complex co-immunoprecipitated with IGF1 receptor (IGFR1) in whole-cell lysates. Importantly, ER/PR/PELP1 complexes were also detected in human breast cancer samples. Inhibition of IGF1R or phosphoinositide 3-kinase blocked PR-B-dependent CTSD mRNA upregulation in response to estradiol. Similarly, inhibition of IGF1R or PR significantly reduced ER recruitment to the CTSD promoter. Stable knockdown of endogenous PR or onapristone treatment of multiple unmodified breast cancer cell lines blocked estradiol-mediated CTSD induction, inhibited growth in soft agar and partially restored tamoxifen sensitivity of resistant cells. Further, combination treatment of breast cancer cells with both onapristone and IGF1R tyrosine kinase inhibitor AEW541 was more effective than either agent alone. In summary, unliganded PR-B enhanced proliferative responses to estradiol and IGF1 via scaffolding of ER-alpha/PELP1/IGF1R-containing complexes. Our data provide a strong rationale for targeting PR in combination with ER and IGF1R in patients with luminal breast cancer.	[Daniel, A. R.; Gaviglio, A. L.; Knutson, T. P.; Ostrander, J. H.; Yee, D.; Lange, C. A.] Univ Minnesota, Mason Canc Ctr, Dept Med, Minneapolis, MN 55455 USA; [Daniel, A. R.; Gaviglio, A. L.; Knutson, T. P.; Yee, D.; Lange, C. A.] Univ Minnesota, Mason Canc Ctr, Dept Pharmacol, Minneapolis, MN 55455 USA; Univ Minnesota, Mason Canc Ctr, Minneapolis, MN 55455 USA; [D'Assoro, A. B.] Mayo Clin, Coll Med, Dept Biochem & Mol Biol, Rochester, MN USA; [Ravindranathan, P.; Raj, G. V.] Univ Texas SW Med Ctr Dallas, Dept Urol, Dallas, TX 75390 USA; [Peng, Y.] Univ Texas SW Med Ctr Dallas, Dept Pathol, Dallas, TX 75390 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; Mayo Clinic; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Lange, CA (corresponding author), Univ Minnesota, Mason Canc Ctr, Dept Med, Canc Cardiology Res Bldg,2231 6th St SE, Minneapolis, MN 55455 USA.	Lange047@umn.edu	Knutson, Todd P/H-8304-2012	Yee, Douglas/0000-0002-3387-4009; Lange, Carol/0000-0003-2751-3976	NIH [R01 CA159712, P30 CA077598, K07 CA131501]; NATIONAL CANCER INSTITUTE [R01CA074285, P30CA077598, R01CA159712, K07CA131501] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We are grateful to Dr Deepali Sachdev (University of Minnesota) for the kind gift of the MCF7L cells. Onapristone was kindly provided by Arno Therapeutics Inc. (Flemington, NJ, USA). The Masonic Cancer Center Biostatistics and Bioinformatics core performed the normalization of the raw microarray data. AEW541 was a gift from Novartis Pharmaceuticals (Basel, Switzerland). This work was supported by NIH R01 CA159712 (CAL), P30 CA077598 (DY) and K07 CA131501 (JHO).	Abe O, 2005, LANCET, V365, P1687, DOI 10.1016/s0140-6736(05)66544-0; Aupperlee MD, 2007, ENDOCRINOLOGY, V148, P2290, DOI 10.1210/en.2006-1721; Ballare C, 2003, MOL CELL BIOL, V23, P1994, DOI 10.1128/MCB.23.6.1994-2008.2003; Baselga J, 2011, ONCOLOGIST, V16, P12, DOI 10.1634/theoncologist.2011-S1-12; Becker MA, 2011, MOL ENDOCRINOL, V25, P516, DOI 10.1210/me.2010-0373; Boonyaratanakornkit V, 2001, MOL CELL, V8, P269, DOI 10.1016/S1097-2765(01)00304-5; Bretschneider N, 2008, MOL ONCOL, V2, P182, DOI 10.1016/j.molonc.2008.05.004; Brisken C, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a003178; Byron SA, 2006, BRIT J CANCER, V95, P1220, DOI 10.1038/sj.bjc.6603354; Casa AJ, 2008, FRONT BIOSCI-LANDMRK, V13, P3273, DOI 10.2741/2925; Chakravarty D, 2010, IUBMB LIFE, V62, P163, DOI 10.1002/iub.287; Cheskis BJ, 2008, STEROIDS, V73, P901, DOI 10.1016/j.steroids.2007.12.028; Chia SK, 2012, CLIN CANCER RES, V18, P4465, DOI 10.1158/1078-0432.CCR-12-0286; Daniel AR, 2011, EXPERT REV ENDOCRINO, V6, P359, DOI 10.1586/EEM.11.25; Daniel AR, 2009, P NATL ACAD SCI USA, V106, P14287, DOI 10.1073/pnas.0905118106; Daniel AR, 2009, MOL CELL ENDOCRINOL, V308, P47, DOI 10.1016/j.mce.2009.01.004; Davies C, 2011, LANCET, V378, P771, DOI 10.1016/S0140-6736(11)60993-8; de Leeuw R, 2011, INT J BREAST CANCER, V2011, DOI 10.4061/2011/232435; Doane AS, 2006, ONCOGENE, V25, P3994, DOI 10.1038/sj.onc.1209415; ENCARNACION CA, 1993, BREAST CANCER RES TR, V26, P237, DOI 10.1007/BF00665801; Fagan DH, 2012, CANCER RES, V72, P3372, DOI 10.1158/0008-5472.CAN-12-0684; Fagan D, 2008, J MAMMARY GLAND BIOL, V13, P423, DOI 10.1007/s10911-008-9098-0; Faivre EJ, 2007, MOL CELL BIOL, V27, P466, DOI 10.1128/MCB.01539-06; Fox EM, 2008, MOL ENDOCRINOL, V22, P1781, DOI 10.1210/me.2007-0419; Fox EM, 2012, FRONT ONCOL, V2, DOI 10.3389/fonc.2012.00145; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Giulianelli S, 2012, CANCER RES, V72, P2416, DOI 10.1158/0008-5472.CAN-11-3290; Gupta A, 2013, J STEROID BIOCHEM, V133, P30, DOI 10.1016/j.jsbmb.2012.08.004; Hagan CR, 2011, MOL CELL BIOL, V31, P2439, DOI 10.1128/MCB.01246-10; Hilton HN, 2012, MOL CELL ENDOCRINOL, V361, P191, DOI 10.1016/j.mce.2012.04.010; JOHNSTON SRD, 1995, CANCER RES, V55, P3331; Knutson TP, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3211; Lanari C, 2012, ENDOCR-RELAT CANCER, V19, pR35, DOI 10.1530/ERC-11-0378; Leontovich AA, 2012, INT J ONCOL, V40, P1858, DOI 10.3892/ijo.2012.1407; Likhite VS, 2006, MOL ENDOCRINOL, V20, P3120, DOI 10.1210/me.2006-0068; Massarweh S, 2008, CANCER RES, V68, P826, DOI 10.1158/0008-5472.CAN-07-2707; Mote PA, 2002, BREAST CANCER RES TR, V72, P163, DOI 10.1023/A:1014820500738; Musgrove EA, 2009, NAT REV CANCER, V9, P631, DOI 10.1038/nrc2713; Proietti CJ, 2009, MOL CELL BIOL, V29, P1249, DOI 10.1128/MCB.00853-08; Riggins RB, 2008, CANCER RES, V68, P8908, DOI 10.1158/0008-5472.CAN-08-2669; Riggins RB, 2007, CANCER LETT, V256, P1, DOI 10.1016/j.canlet.2007.03.016; Sachdev D, 2003, CANCER RES, V63, P627; Shang YF, 2000, CELL, V103, P843, DOI 10.1016/S0092-8674(00)00188-4; Shimizu T, 2010, PHYSIOL GENOMICS, V42A, P290, DOI 10.1152/physiolgenomics.00107.2010; Smid M, 2008, CANCER RES, V68, P3108, DOI 10.1158/0008-5472.CAN-07-5644; Tang QZ, 2011, CANCER RES, V71, P6940, DOI 10.1158/0008-5472.CAN-11-2091; Vadlamudi RK, 2005, CANCER RES, V65, P7724, DOI 10.1158/0008-5472.CAN-05-0614; Zhang Y, 2008, MOL CELLULAR BIOL; Zukiwski AA, 2013, ASCO AM SOC CLIN ONC	50	92	98	2	21	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 22	2015	34	4					506	515		10.1038/onc.2013.579	http://dx.doi.org/10.1038/onc.2013.579			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AZ8FU	24469035	Green Accepted			2022-12-25	WOS:000348451300011
J	Sethi, R; Seppala, J; Tossavainen, H; Ylilauri, M; Ruskamo, S; Pentikainen, OT; Pentikainen, U; Permi, P; Ylanne, J				Sethi, Ritika; Seppala, Jonne; Tossavainen, Helena; Ylilauri, Mikko; Ruskamo, Salla; Pentikainen, Olli T.; Pentikainen, Ulla; Permi, Perttu; Ylanne, Jari			A Novel Structural Unit in the N-terminal Region of Filamins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cell Signaling; Filamin; Microfilaments; NMR; Protein-Protein Interactions; Structural Biology; X-ray Crystallography; X-ray Scattering; Immunogloblulin-like Domain; Platelet Glycoprotein Ib	ACTIN-BINDING PROTEIN; GLYCOPROTEIN-IB-ALPHA; MOLECULAR-DYNAMICS; BIOLOGICAL MACROMOLECULES; AUTO-INHIBITION; DOMAIN; INTEGRIN; SCATTERING; SYSTEM; COMPETITION	Background: Filamins are actin cross-linking and signaling scaffolding proteins where C-terminal domains have inter-domain interactions but little is known about the N-terminal domains. Results: Crystal structures of N-terminal domains 3-5 reveal novel domain packing and interaction details of domain 4. Conclusion: Domain 4 is stabilized by interaction with domain 5. Significance: Here, inter-domain interactions positively regulate domain 4 interactions with ligands. Immunoglobulin-like (Ig) domains are a widely expanded superfamily that act as interaction motifs or as structural spacers in multidomain proteins. Vertebrate filamins (FLNs), which are multifunctional actin-binding proteins, consist of 24 Ig domains. We have recently discovered that in the C-terminal rod 2 region of FLN, Ig domains interact with each other forming functional domain pairs, where the interaction with signaling and transmembrane proteins is mechanically regulated by weak actomyosin contraction forces. Here, we investigated if there are similar inter-domain interactions around domain 4 in the N-terminal rod 1 region of FLN. Protein crystal structures revealed a new type of domain organization between domains 3, 4, and 5. In this module, domains 4 and 5 interact rather tightly, whereas domain 3 has a partially flexible interface with domain 4. NMR peptide titration experiments showed that within the three-domain module, domain 4 is capable for interaction with a peptide derived from platelet glycoprotein Ib. Crystal structures of FLN domains 4 and 5 in complex with the peptide revealed a typical sheet augmentation interaction observed for many FLN ligands. Domain 5 was found to stabilize domain 4, and this could provide a mechanism for the regulation of domain 4 interactions.	[Sethi, Ritika; Seppala, Jonne; Ylilauri, Mikko; Pentikainen, Olli T.; Pentikainen, Ulla; Ylanne, Jari] Univ Jyvaskyla, Dept Biol & Environm Sci, Jyvaskyla 40014, Finland; [Sethi, Ritika; Seppala, Jonne; Ylilauri, Mikko; Pentikainen, Olli T.; Pentikainen, Ulla; Ylanne, Jari] Univ Jyvaskyla, Nanosci Ctr, Jyvaskyla 40014, Finland; [Tossavainen, Helena; Permi, Perttu] Univ Helsinki, Inst Biotechnol, Program Struct Biol & Biophys, FI-00014 Helsinki, Finland; [Ruskamo, Salla] Univ Oulu, Dept Biochem, Oulu 90014, Finland; [Ruskamo, Salla] Univ Oulu, Bioctr Oulu, Oulu 90014, Finland	University of Jyvaskyla; University of Jyvaskyla; University of Helsinki; Finland National Institute for Health & Welfare; University of Oulu; University of Oulu	Sethi, R (corresponding author), Univ Jyvaskyla, Dept Biol & Environm Sci, POB 35,Survontie 9, Jyvaskyla 40014, Finland.	ritika.sethi@jyu.fi; jari.p.ylanne@jyu.fi	Pentikäinen, Olli T/E-1980-2012	Pentikäinen, Olli T/0000-0001-7188-4016; Ylanne, Jari/0000-0003-4627-021X; Sethi, Ritika/0000-0001-6015-7710; Ruskamo, Salla/0000-0002-9740-9077; Pentikainen, Ulla/0000-0001-6547-1282	Marie Curie Actions FP 7; National Doctoral Programme in Informational and Structural Biology; Sigrid Juselius Foundation; Academy of Finland [114713, 138327, 263794, 259447]; CSC-Finnish IT Center for Science computational [jyy2516, jyy2586]	Marie Curie Actions FP 7; National Doctoral Programme in Informational and Structural Biology; Sigrid Juselius Foundation(Sigrid Juselius Foundation); Academy of Finland(Academy of Finland); CSC-Finnish IT Center for Science computational(Finnish IT center for science)	This work was supported by grants from the Marie Curie Actions FP 7 grant to Initial Training Network MUZIC (Muscle Z-disk Protein Complexes: from atomic structure to physiological function) (to R. S. and J. Y.), the National Doctoral Programme in Informational and Structural Biology (to M. Y.), and Sigrid Juselius Foundation and Academy of Finland Grants 114713 and 138327 (to J. Y.) and 263794 and 259447 (to P. P.), and CSC-Finnish IT Center for Science computational Grants jyy2516 and jyy2586 (to O. T. P.).	Bernado P, 2007, J AM CHEM SOC, V129, P5656, DOI 10.1021/ja069124n; Biersmith BH, 2011, J MOL BIOL, V408, P616, DOI 10.1016/j.jmb.2011.03.013; Chen H, 2013, SCI REP-UK, V3, DOI 10.1038/srep01642; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Duan Y, 2003, J COMPUT CHEM, V24, P1999, DOI 10.1002/jcc.10349; Ehrlicher AJ, 2011, NATURE, V478, P260, DOI 10.1038/nature10430; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Falet H, 2010, J EXP MED, V207, P1967, DOI 10.1084/jem.20100222; FELLER SE, 1995, J CHEM PHYS, V103, P4613, DOI 10.1063/1.470648; Feng SJ, 2003, BLOOD, V102, P2122, DOI 10.1182/blood-2002-12-3805; Franke D, 2009, J APPL CRYSTALLOGR, V42, P342, DOI 10.1107/S0021889809000338; Furst DO, 2013, ACTA NEUROPATHOL, V125, P33, DOI 10.1007/s00401-012-1054-9; Gileadi Opher, 2008, V426, P221, DOI 10.1007/978-1-60327-058-8_14; Glatter O., 1982, ACAD PRESS; GORLIN JB, 1990, J CELL BIOL, V111, P1089, DOI 10.1083/jcb.111.3.1089; Guinier A., 1939, ANN PHYS-LEIPZIG, DOI DOI 10.1051/ANPHYS/193911120161; Heikkinen OK, 2009, J BIOL CHEM, V284, P25450, DOI 10.1074/jbc.M109.019661; Ithychanda SS, 2011, BIOCHEMISTRY-US, V50, P4229, DOI 10.1021/bi2003229; Ithychanda SS, 2009, J BIOL CHEM, V284, P35113, DOI 10.1074/jbc.M109.060954; Ithychanda SS, 2009, J BIOL CHEM, V284, P4713, DOI 10.1074/jbc.M807719200; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kiema T, 2006, MOL CELL, V21, P337, DOI 10.1016/j.molcel.2006.01.011; Kley RA, 2012, BRAIN, V135, P2642, DOI 10.1093/brain/aws200; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Kyndt F, 2007, CIRCULATION, V115, P40, DOI 10.1161/CIRCULATIONAHA.106.622621; Labrador A, 2013, J PHYS CONF SER, V425, DOI 10.1088/1742-6596/425/7/072019; Lad Y, 2007, EMBO J, V26, P3993, DOI 10.1038/sj.emboj.7601827; Lad Y, 2008, J BIOL CHEM, V283, P35154, DOI 10.1074/jbc.M802592200; Langer G, 2008, NAT PROTOC, V3, P1171, DOI 10.1038/nprot.2008.91; Lehtonen JV, 2004, J COMPUT AID MOL DES, V18, P401, DOI 10.1007/s10822-004-3752-4; Light S, 2012, J STRUCT BIOL, V179, P289, DOI 10.1016/j.jsb.2012.02.010; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Meyer SC, 1997, J BIOL CHEM, V272, P2914, DOI 10.1074/jbc.272.5.2914; Muller R, 2013, P NATL ACAD SCI USA, V110, P10183, DOI 10.1073/pnas.1300547110; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nakamura F, 2006, BLOOD, V107, P1925, DOI 10.1182/blood-2005-10-3964; Nakamura F, 2011, CELL ADHES MIGR, V5, P160, DOI 10.4161/cam.5.2.14401; Nakamura F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004928; Nielsen SS, 2009, J APPL CRYSTALLOGR, V42, P959, DOI 10.1107/S0021889809023863; Pantoliano MW, 2001, J BIOMOL SCREEN, V6, P429, DOI 10.1089/108705701753364922; Pentikainen U, 2009, J MOL BIOL, V393, P644, DOI 10.1016/j.jmb.2009.08.035; Pernot P, 2013, J SYNCHROTRON RADIAT, V20, P660, DOI 10.1107/S0909049513010431; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Playford MP, 2010, J BIOL CHEM, V285, P17156, DOI 10.1074/jbc.M109.080523; Pudas R, 2005, STRUCTURE, V13, P111, DOI 10.1016/j.str.2004.10.014; Rambo RP, 2011, BIOPOLYMERS, V95, P559, DOI 10.1002/bip.21638; Razinia Z, 2012, ANNU REV BIOPHYS, V41, P227, DOI 10.1146/annurev-biophys-050511-102252; Roessle MW, 2007, J APPL CRYSTALLOGR, V40, pS190, DOI 10.1107/S0021889806055506; Rognoni L, 2012, P NATL ACAD SCI USA, V109, P19679, DOI 10.1073/pnas.1211274109; Ruskamo S, 2012, BIOCHEM J, V446, P261, DOI 10.1042/BJ20120361; Ruskamo S, 2009, ACTA CRYSTALLOGR D, V65, P1217, DOI 10.1107/S0907444909037330; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Schlick T, 1999, J COMPUT PHYS, V151, P9, DOI 10.1006/jcph.1999.6182; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Seo MD, 2009, PROTEINS, V75, P258, DOI 10.1002/prot.22336; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Smith L, 2010, J BIOL CHEM, V285, P17166, DOI 10.1074/jbc.M109.080911; Stossel TP, 2001, NAT REV MOL CELL BIO, V2, P138, DOI 10.1038/35052082; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Svergun DI, 2001, BIOPHYS J, V80, P2946, DOI 10.1016/S0006-3495(01)76260-1; Takala H, 2008, BLOOD, V112, P1853, DOI 10.1182/blood-2007-12-127795; van der Flier A, 2001, BBA-MOL CELL RES, V1538, P99, DOI 10.1016/S0167-4889(01)00072-6; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; Wang JM, 2006, J MOL GRAPH MODEL, V25, P247, DOI 10.1016/j.jmgm.2005.12.005; Williamson D, 2002, J BIOL CHEM, V277, P2151, DOI 10.1074/jbc.M109384200; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Wurzburg BA, 2009, J MOL BIOL, V393, P176, DOI 10.1016/j.jmb.2009.08.012; Zhou AX, 2010, TRENDS CELL BIOL, V20, P113, DOI 10.1016/j.tcb.2009.12.001	71	15	15	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 21	2014	289	12					8588	8598		10.1074/jbc.M113.537456	http://dx.doi.org/10.1074/jbc.M113.537456			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AD3PG	24469451	Green Published, hybrid			2022-12-25	WOS:000333157500049
J	Portnoff, AD; Stephens, EA; Varner, JD; DeLisa, MP				Portnoff, Alyse D.; Stephens, Erin A.; Varner, Jeffrey D.; DeLisa, Matthew P.			Ubiquibodies, Synthetic E3 Ubiquitin Ligases Endowed with Unnatural Substrate Specificity for Targeted Protein Silencing	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Antibody Engineering; E3 Ubiquitin Ligase; Molecular Biology; Proteasome; Protein Degradation; Protein Engineering; Synthetic Biology; Ubiquitin; Ubiquitination; Reverse Genetics	GENE TRAP VECTOR; BINDING-PROTEINS; DEGRADATION; CHIP; PROTEASOME; SELECTION; COMPLEX; HSP70; THERAPEUTICS; ANTIBODIES	Background: Techniques that harness the power of the ubiquitin-proteasome pathway (UPP) for protein knock-out are limited to a narrow set of protein targets. Results: Engineered ubiquibodies specifically and systematically removed exogenous target proteins. Conclusion: Diverse protein targets can be redirected to the UPP using this new protein silencing method. Significance: Ubiquibodies offer a simple, reproducible, and customizable technique for selectively and controllably depleting cellular proteins. The ubiquitin-proteasome pathway (UPP) is the main route of protein degradation in eukaryotic cells and is a common mechanism through which numerous cellular pathways are regulated. To date, several reverse genetics techniques have been reported that harness the power of the UPP for selectively reducing the levels of otherwise stable proteins. However, each of these approaches has been narrowly developed for a single substrate and cannot be easily extended to other protein substrates of interest. To address this shortcoming, we created a generalizable protein knock-out method by engineering protein chimeras called ubiquibodies that combine the activity of E3 ubiquitin ligases with designer binding proteins to steer virtually any protein to the UPP for degradation. Specifically, we reprogrammed the substrate specificity of a modular human E3 ubiquitin ligase called CHIP (carboxyl terminus of Hsc70-interacting protein) by replacing its natural substrate-binding domain with a single-chain Fv (scFv) intrabody or a fibronectin type III domain monobody that target their respective antigens with high specificity and affinity. Engineered ubiquibodies reliably transferred ubiquitin to surface exposed lysines on target proteins and even catalyzed the formation of biologically relevant polyubiquitin chains. Following ectopic expression of ubiquibodies in mammalian cells, specific and systematic depletion of desired target proteins was achieved, whereas the levels of a natural substrate of CHIP were unaffected. Taken together, engineered ubiquibodies offer a simple, reproducible, and customizable means for directly removing specific cellular proteins through accelerated proteolysis.	[Portnoff, Alyse D.; Varner, Jeffrey D.; DeLisa, Matthew P.] Cornell Univ, Dept Biomed Engn, Ithaca, NY 14853 USA; [Stephens, Erin A.] Cornell Univ, Grad Field Biochem Mol & Cell Biol, Ithaca, NY 14853 USA; [Varner, Jeffrey D.; DeLisa, Matthew P.] Cornell Univ, Sch Chem & Biomol Engn, Ithaca, NY 14853 USA	Cornell University; Cornell University; Cornell University	DeLisa, MP (corresponding author), Cornell Univ, Sch Chem & Biomol Engn, Ithaca, NY 14853 USA.	md255@cornell.edu	DeLisa, Matthew/AAE-7361-2019	DeLisa, Matthew/0000-0003-3226-1566	National Science Foundation [CBET-0449080, GK-12 DGE-0841291, DGE-1144153]; National Institutes of Health [CA132223A, T32 GM008500]; New York State Office of Science, Technology, and Academic Research Distinguished Faculty Award; Cornell Presidential Life Science Fellowship; NATIONAL CANCER INSTITUTE [R21CA167100, R21CA132223] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007273, T32GM008500] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); New York State Office of Science, Technology, and Academic Research Distinguished Faculty Award; Cornell Presidential Life Science Fellowship; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Science Foundation Career Award CBET-0449080 (to M. P. D.), National Institutes of Health Grant CA132223A (to M. P. D.), New York State Office of Science, Technology, and Academic Research Distinguished Faculty Award (to M. P. D.), National Institutes of Health Chemical Biology Training Grant T32 GM008500 (fellowship to A. D. P.), National Science Foundation GK-12 DGE-0841291 (fellowship to A. D. P.), a Cornell Presidential Life Science Fellowship (to E. A. S.), and the National Science Foundation Graduate Research Fellowship Program Grant DGE-1144153 (to E. A. S.).	Bloom L, 2009, DRUG DISCOV TODAY, V14, P949, DOI 10.1016/j.drudis.2009.06.007; Cardozo T, 2004, NAT REV MOL CELL BIO, V5, P739, DOI 10.1038/nrm1471; CARLSON JR, 1988, MOL CELL BIOL, V8, P2638, DOI 10.1128/MCB.8.6.2638; Caussinus E, 2012, NAT STRUCT MOL BIOL, V19, P117, DOI 10.1038/nsmb.2180; Ciechanover A, 1998, EMBO J, V17, P7151, DOI 10.1093/emboj/17.24.7151; Connell P, 2001, NAT CELL BIOL, V3, P93, DOI 10.1038/35050618; Contreras-Martinez LM, 2007, J MOL BIOL, V372, P513, DOI 10.1016/j.jmb.2007.06.070; Cyr DM, 2002, TRENDS BIOCHEM SCI, V27, P368, DOI 10.1016/S0968-0004(02)02125-4; Friedel RH, 2005, P NATL ACAD SCI USA, V102, P13188, DOI 10.1073/pnas.0505474102; Hatakeyama S, 2005, CANCER RES, V65, P7874, DOI 10.1158/0008-5472.CAN-05-1581; Karlsson AJ, 2012, J MOL BIOL, V416, P94, DOI 10.1016/j.jmb.2011.12.021; Kawe M, 2006, J BIOL CHEM, V281, P40252, DOI 10.1074/jbc.M602506200; Kerscher O, 2006, ANNU REV CELL DEV BI, V22, P159, DOI 10.1146/annurev.cellbio.22.010605.093503; Kirkin V, 2009, MOL CELL, V34, P259, DOI 10.1016/j.molcel.2009.04.026; Koch H, 2006, J MOL BIOL, V357, P427, DOI 10.1016/j.jmb.2005.12.043; Koide A, 2002, P NATL ACAD SCI USA, V99, P1253, DOI 10.1073/pnas.032665299; Koide A, 2007, P NATL ACAD SCI USA, V104, P6632, DOI 10.1073/pnas.0700149104; Kummer L, 2012, P NATL ACAD SCI USA, V109, pE2248, DOI 10.1073/pnas.1205399109; Kundrat L, 2010, J MOL BIOL, V395, P587, DOI 10.1016/j.jmb.2009.11.017; Lelouard H, 2002, NATURE, V417, P177, DOI 10.1038/417177a; Ma YH, 2013, MOL CANCER THER, V12, P286, DOI 10.1158/1535-7163.MCT-12-0650; Martineau P, 1998, J MOL BIOL, V280, P117, DOI 10.1006/jmbi.1998.1840; Morin X, 2001, P NATL ACAD SCI USA, V98, P15050, DOI 10.1073/pnas.261408198; Pickart CM, 1997, FASEB J, V11, P1055, DOI 10.1096/fasebj.11.13.9367341; Qian SB, 2006, NATURE, V440, P551, DOI 10.1038/nature04600; Qian SB, 2009, J BIOL CHEM, V284, P26797, DOI 10.1074/jbc.M109.032334; Saeki Y, 2009, EMBO J, V28, P359, DOI 10.1038/emboj.2008.305; Sakamoto KM, 2001, P NATL ACAD SCI USA, V98, P8554, DOI 10.1073/pnas.141230798; Stocks M, 2005, CURR OPIN CHEM BIOL, V9, P359, DOI 10.1016/j.cbpa.2005.06.003; Strickland D, 2008, P NATL ACAD SCI USA, V105, P10709, DOI 10.1073/pnas.0709610105; Stumpp MT, 2008, DRUG DISCOV TODAY, V13, P695, DOI 10.1016/j.drudis.2008.04.013; Waraho D, 2009, P NATL ACAD SCI USA, V106, P3692, DOI 10.1073/pnas.0704048106; Wright CM, 2011, P NATL ACAD SCI USA, V108, P16206, DOI 10.1073/pnas.1102803108; Xu P, 2009, CELL, V137, P133, DOI 10.1016/j.cell.2009.01.041; Xu Z, 2006, BIOCHEMISTRY-US, V45, P4749, DOI 10.1021/bi0601508; Zhang JX, 2003, P NATL ACAD SCI USA, V100, P14127, DOI 10.1073/pnas.2233012100; Zhang MH, 2005, MOL CELL, V20, P525, DOI 10.1016/j.molcel.2005.09.023; Zheng XQH, 1999, J VIROL, V73, P6946, DOI 10.1128/JVI.73.8.6946-6952.1999; Zhou PB, 2005, CURR OPIN CHEM BIOL, V9, P51, DOI 10.1016/j.cbpa.2004.10.012	39	34	39	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 14	2014	289	11					7844	7855		10.1074/jbc.M113.544825	http://dx.doi.org/10.1074/jbc.M113.544825			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AC8CV	24474696	hybrid, Green Published			2022-12-25	WOS:000332761500050
J	Kallis, YN; Scotton, CJ; MacKinnon, AC; Goldin, RD; Wright, NA; Iredale, JP; Chambers, RC; Forbes, SJ				Kallis, Yiannis N.; Scotton, Christopher J.; MacKinnon, Alison C.; Goldin, Robert D.; Wright, Nicholas A.; Iredale, John P.; Chambers, Rachel C.; Forbes, Stuart J.			Proteinase Activated Receptor 1 Mediated Fibrosis in a Mouse Model of Liver Injury: A Role for Bone Marrow Derived Macrophages	PLOS ONE			English	Article							HEPATIC STELLATE CELLS; THROMBIN RECEPTOR; LUNG INFLAMMATION; EXPRESSION; MONOCYTES; FIBROGENESIS; RECRUITMENT; THERAPY	Liver fibrosis results from the co-ordinated actions of myofibroblasts and macrophages, a proportion of which are of bone marrow origin. The functional effect of such bone marrow-derived cells on liver fibrosis is unclear. We examine whether changing bone marrow genotype can down-regulate the liver's fibrotic response to injury and investigate mechanisms involved. Proteinase activated receptor 1 (PAR1) is up-regulated in fibrotic liver disease in humans, and deficiency of PAR1 is associated with reduced liver fibrosis in rodent models. In this study, recipient mice received bone marrow transplantation from PAR1-deficient or wild-type donors prior to carbon tetrachloride-induced liver fibrosis. Bone marrow transplantation alone from PAR1-deficient mice was able to confer significant reductions in hepatic collagen content and activated myofibroblast expansion on wild-type recipients. This effect was associated with a decrease in hepatic scar-associated macrophages and a reduction in macrophage recruitment from the bone marrow. In vitro, PAR1 signalling on bone marrow-derived macrophages directly induced their chemotaxis but did not stimulate proliferation. These data suggest that the bone marrow can modulate the fibrotic response of the liver to recurrent injury. PAR1 signalling can contribute to this response by mechanisms that include the regulation of macrophage recruitment.	[Kallis, Yiannis N.] Univ London Imperial Coll Sci Technol & Med, Dept Hepatol, London, England; [Scotton, Christopher J.; Chambers, Rachel C.] UCL, Ctr Inflammat & Tissue Repair, London, England; [MacKinnon, Alison C.; Iredale, John P.; Forbes, Stuart J.] Univ Edinburgh, Queens Med Res Inst, MRC Ctr Inflammat Res, Edinburgh, Midlothian, Scotland; [Goldin, Robert D.] Univ London Imperial Coll Sci Technol & Med, Dept Histopathol, London, England; [Wright, Nicholas A.] Barts & London Queen Marys Sch Med & Dent, Barts Canc Inst, London, England; [Iredale, John P.; Forbes, Stuart J.] Univ Edinburgh, Queens Med Res Inst, MRC Ctr Regenerat Med, Edinburgh, Midlothian, Scotland	Imperial College London; University of London; University College London; University of Edinburgh; Imperial College London; University of London; Queen Mary University London; University of Edinburgh	Forbes, SJ (corresponding author), Univ Edinburgh, Queens Med Res Inst, MRC Ctr Inflammat Res, Edinburgh, Midlothian, Scotland.	stuart.forbes@ed.ac.uk	Wright, Nicholas/HHY-7227-2022; Wright, Nicholas/AAF-1448-2020	Goldin, Robert/0000-0001-5184-4519; Chambers, Rachel/0000-0003-1370-9417; Iredale, John/0000-0003-2174-5127; Wright, Nicholas/0000-0002-5525-3457; Forbes, Stuart/0000-0003-3715-2561	MRC Clinical Research Training Fellowship [G0500428]; Wellcome Trust Programme Grant [071124]; MRC [G0901697, G0800340, G0600033, G0500428, G1000868] Funding Source: UKRI; Cancer Research UK [14895] Funding Source: researchfish; Medical Research Council [G0600033, G1000868, G0901697, G0500428, G0800340] Funding Source: researchfish	MRC Clinical Research Training Fellowship(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust Programme Grant(Wellcome Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Funding for YNK SJF came from the MRC Clinical Research Training Fellowship (G0500428), www.mrc.ac.uk. For CJS RCC: Wellcome Trust Programme Grant (071124), www.wellcome.ac.uk. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajuebor MN, 1998, J LEUKOCYTE BIOL, V63, P108, DOI 10.1002/jlb.63.1.108; Anstee QM, 2008, J THROMB HAEMOST; Baba S, 2004, J HEPATOL, V40, P255, DOI 10.1016/j.jhep.2003.10.012; Chambers RC, 2008, BRIT J PHARMACOL, V153, pS367, DOI 10.1038/sj.bjp.0707603; Chambers RC, 2000, J BIOL CHEM, V275, P35584, DOI 10.1074/jbc.M003188200; Chen DX, 2008, J EXP MED, V205, P1739, DOI 10.1084/jem.20071427; Colognato R, 2003, BLOOD, V102, P2645, DOI 10.1182/blood-2002-08-2497; Connolly AJ, 1996, NATURE, V381, P516, DOI 10.1038/381516a0; Cunningham MA, 2000, J EXP MED, V191, P455, DOI 10.1084/jem.191.3.455; Duffield JS, 2005, J CLIN INVEST, V115, P56, DOI 10.1172/JCI200522675; Duplantier JG, 2004, GUT, V53, P1682, DOI 10.1136/gut.2003.032136; Fallowfield JA, 2007, J IMMUNOL, V178, P5288, DOI 10.4049/jimmunol.178.8.5288; Fiorucci S, 2004, HEPATOLOGY, V39, P365, DOI 10.1002/hep.20054; Forbes SJ, 2004, GASTROENTEROLOGY, V126, P955, DOI 10.1053/j.gastro.2004.02.025; Gaca MDA, 2002, J HEPATOL, V36, P362, DOI 10.1016/S0168-8278(01)00285-9; Higashiyama R, 2007, HEPATOLOGY, V45, P213, DOI 10.1002/hep.21477; Howell DCJ, 2005, AM J PATHOL, V166, P1353, DOI 10.1016/S0002-9440(10)62354-1; Ide M, 2005, J COMP PATHOL, V133, P92, DOI 10.1016/j.jcpa.2005.01.011; Imamura M, 2005, GASTROENTEROLOGY, V128, P138, DOI 10.1053/j.gastro.2004.10.005; Kahn ML, 1998, NATURE, V394, P690, DOI 10.1038/29325; Karlmark KR, 2009, HEPATOLOGY, V50, P261, DOI 10.1002/hep.22950; Kisseleva T, 2006, J HEPATOL, V45, P429, DOI 10.1016/j.jhep.2006.04.014; Kubo H, 2005, CHEST, V128, P1475, DOI 10.1378/chest.128.3.1475; Luyendyk JP, 2010, AM J PATHOL, V176, P177, DOI 10.2353/ajpath.2010.090672; Marra F, 1998, HEPATOLOGY, V27, P462, DOI 10.1002/hep.510270221; Martinelli A, 2007, J GASTROENTEROL HEPA; Rullier A, 2006, VIRCHOWS ARCH, V448, P46, DOI 10.1007/s00428-005-0078-0; Rullier A, 2008, AM J PHYSIOL-GASTR L, V294, pG226, DOI 10.1152/ajpgi.00444.2007; Russo FP, 2006, GASTROENTEROLOGY, V130, P1807, DOI 10.1053/j.gastro.2006.01.036; Schaffner A, 2005, J LEUKOCYTE BIOL, V78, P202, DOI 10.1189/jlb.0105024; Thomas JA, 2011, HEPATOLOGY, V53, P2003, DOI 10.1002/hep.24315; Wright M, 2003, GUT, V52, P1206, DOI 10.1136/gut.52.8.1206	32	23	24	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2014	9	1							e86241	10.1371/journal.pone.0086241	http://dx.doi.org/10.1371/journal.pone.0086241			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301BI	24475094	Green Published, gold, Green Submitted			2022-12-25	WOS:000330507300048
J	Steinhauf, D; Rodriguez, A; Vlachakis, D; Virgo, G; Maksimov, V; Kristell, C; Olsson, I; Linder, T; Kossida, S; Bongcam-Rudloff, E; Bjerling, P				Steinhauf, Daniel; Rodriguez, Alejandro; Vlachakis, Dimitrios; Virgo, Gordon; Maksimov, Vladimir; Kristell, Carolina; Olsson, Ida; Linder, Tomas; Kossida, Sophia; Bongcam-Rudloff, Erik; Bjerling, Pernilla			Silencing Motifs in the Clr2 Protein from Fission Yeast, Schizosaccharomyces pombe	PLOS ONE			English	Article							MATING-TYPE REGION; HETEROCHROMATIN; RNAI; EFFICIENT; TRANSCRIPTION; LOCALIZATION; MAINTENANCE; EXPRESSION; NUCLEATION; MUTATIONS	The fission yeast, Schizosaccharomyces pombe, is a well-established model for heterochromatin formation, but the exact sequence of events for initiation remains to be elucidated. The essential factors involved include RNA transcribed from repeated sequences together with the methyltransferase Clr4. In addition, histone deacetylases, like Clr3, found in the SHREC complex are also necessary for transcriptional silencing. Clr2 is another crucial factor required for heterochromatin formation found in the SHREC complex. The function of Clr2 has been difficult to establish due to the lack of conserved domains or homology to proteins of known molecular function. Using a bioinformatics approach, three conserved motifs in Clr2 were identified, which contained amino acids important for transcriptional repression. Analysis of clr2 mutant strains revealed a major role for Clr2 in mating-type and rDNA silencing, and weaker effects on centromeric silencing. The effect on mating-type silencing showed variegation in several of the strains with mutated versions of Clr2 indicating an establishment or maintenance defect. Moreover, the critical amino acids in Clr2 were also necessary for transcriptional repression in a minimal system, by the tethering of Clr4 upstream of a reporter gene, inserted into the euchromatic part of the genome. Finally, in silico modeling suggested that the mutations in Clr2 cause disruption of secondary structures in the Clr2 protein. Identification of these critical amino acids in the protein provides a useful tool to explore the molecular mechanism behind the role of Clr2 in heterochromatin formation.	[Steinhauf, Daniel; Rodriguez, Alejandro; Virgo, Gordon; Maksimov, Vladimir; Kristell, Carolina; Olsson, Ida; Bjerling, Pernilla] Uppsala Univ, Dept Med Biochem & Microbiol, Sci Life Lab, Uppsala, Sweden; [Vlachakis, Dimitrios; Kossida, Sophia] Acad Athens, Biomed Res Fdn, Bioinformat & Med Informat Lab, Athens, Greece; [Linder, Tomas] Swedish Univ Agr Sci, Dept Microbiol, Uppsala, Sweden; [Bongcam-Rudloff, Erik] Swedish Univ Agr Sci, SLU Global Bioinformat Ctr, Dept Anim Breeding & Genet, Uppsala, Sweden	Uppsala University; Academy of Athens; Swedish University of Agricultural Sciences; Swedish University of Agricultural Sciences	Bjerling, P (corresponding author), Uppsala Univ, Dept Med Biochem & Microbiol, Sci Life Lab, Uppsala, Sweden.	Pernilla.Bjerling@imbim.uu.se	Linder, Tomas/AAN-3433-2020; Linder, Tomas/B-2492-2009; Vlachakis, Dimitrios/O-4323-2018; Kossida, Sofia/ABG-3526-2020	Linder, Tomas/0000-0001-5365-0494; Linder, Tomas/0000-0001-5365-0494; Vlachakis, Dimitrios/0000-0003-1823-6102; Bongcam-Rudloff, Erik/0000-0002-1947-8288; Maksimov, Vladimir/0000-0002-4029-8257	Swedish Cancer Society [2011/360]; Swedish Research Council [521-2011-2437]; Goran Gustafsson Fundation [289452]	Swedish Cancer Society(Swedish Cancer Society); Swedish Research Council(Swedish Research CouncilEuropean Commission); Goran Gustafsson Fundation	The work was supported by the Swedish Cancer Society, grant number 2011/360, http://www.cancerfonden.se; the Swedish Research Council, grant number 521-2011-2437, http://www.vr.se; the Goran Gustafsson Fundation, http://www.gustafssonsstiftelse.se/uu_kth/ALLBIO, FP7, grant number 289452, http://www.allbioinformatics.eu/doku.php. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLSHIRE RC, 1995, GENE DEV, V9, P218, DOI 10.1101/gad.9.2.218; Allshire RC, 2008, NAT REV GENET, V9, P923, DOI 10.1038/nrg2466; Apweiler R, 2011, NUCLEIC ACIDS RES, V39, pD214, DOI 10.1093/nar/gkq1020; Arcangioli B, 2003, MOLECULAR BIOLOGY OF SCHIZOSACCHAROMYCES POMBE, P129; Bahler J, 1998, YEAST, V14, P943, DOI 10.1002/(SICI)1097-0061(199807)14:10<943::AID-YEA292>3.0.CO;2-Y; Bailey T L, 1994, Proc Int Conf Intell Syst Mol Biol, V2, P28; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkp985, 10.1093/nar/gkr1065]; Bayne EH, 2010, CELL, V140, P666, DOI 10.1016/j.cell.2010.01.038; Bjerling P, 2004, NUCLEIC ACIDS RES, V32, P4421, DOI 10.1093/nar/gkh780; Bjerling P, 2002, BRAZ J MED BIOL RES, V35, P499, DOI 10.1590/S0100-879X2002000500001; Bjerling P, 2002, MOL CELL BIOL, V22, P2170, DOI 10.1128/MCB.22.7.2170-2181.2002; Buscaino A, 2013, EMBO J; Cam HP, 2005, NAT GENET, V37, P809, DOI 10.1038/ng1602; Craven RA, 1998, GENE, V221, P59, DOI 10.1016/S0378-1119(98)00434-X; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Djupedal I, 2005, GENE DEV, V19, P2301, DOI 10.1101/gad.344205; EKWALL K, 1994, GENETICS, V136, P53; EKWALL K, 1995, SCIENCE, V269, P1429, DOI 10.1126/science.7660126; Hall IM, 2002, SCIENCE, V297, P2232, DOI 10.1126/science.1076466; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Jia ST, 2004, SCIENCE, V304, P1971, DOI 10.1126/science.1099035; Kagansky A, 2009, SCIENCE, V324, P1716, DOI 10.1126/science.1172026; Kaiser Chris, 1994; Kanoh J, 2005, CURR BIOL, V15, P1808, DOI 10.1016/j.cub.2005.09.041; KELLY M, 1988, EMBO J, V7, P1537, DOI 10.1002/j.1460-2075.1988.tb02973.x; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Motamedi MR, 2008, MOL CELL, V32, P778, DOI 10.1016/j.molcel.2008.10.026; Olsson I, 2011, CURR GENET, V57, P1, DOI 10.1007/s00294-010-0327-x; Pace CN, 1998, BIOPHYS J, V75, P422, DOI 10.1016/S0006-3495(98)77529-0; Pronk S, 2013, BIOINFORMATICS, V29, P845, DOI 10.1093/bioinformatics/btt055; Qi D, 2008, J VIROL METHODS, V149, P85, DOI 10.1016/j.jviromet.2008.01.002; SALI A, 1995, PROTEINS, V23, P318, DOI 10.1002/prot.340230306; Sellis D, 2009, BIOINFORM BIOL INSIG, V3, P99; Shanker S, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001174; Suga M, 2003, CURR GENET, V43, P206, DOI 10.1007/s00294-003-0385-4; Sugiyama T, 2007, CELL, V128, P491, DOI 10.1016/j.cell.2006.12.035; Thon G, 1999, GENETICS, V151, P945; THON G, 1994, GENETICS, V138, P29; Thon G, 2002, GENETICS, V161, P611; Yamada T, 2005, MOL CELL, V20, P173, DOI 10.1016/j.molcel.2005.10.002; Zhang K, 2011, SCIENCE, V331, P1624, DOI 10.1126/science.1198712	42	7	7	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2014	9	1							e86948	10.1371/journal.pone.0086948	http://dx.doi.org/10.1371/journal.pone.0086948			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301BI	24475199	gold, Green Published, Green Submitted			2022-12-25	WOS:000330507300119
J	Tsai, YG; Lee, CY; Lin, TY; Lin, CY				Tsai, Yi-Giien; Lee, Chia-Ying; Lin, Tze-Yi; Lin, Ching-Yuang			CD8(+) Treg Cells Associated with Decreasing Disease Activity after Intravenous Methylprednisolone Pulse Therapy in Lupus Nephritis with Heavy Proteinuria	PLOS ONE			English	Article							REGULATORY T-CELLS; MEDIATED SUPPRESSION; GRANZYME-B; ERYTHEMATOSUS; INDUCTION; TOLERANCE; ACTIVATION; MECHANISMS; GENERATION; EXPRESSION	We focus on the role of CD8(+) Treg cell in Intravenous methyl-prednisolone (IVMP) pulse therapy in forty patients with active Class III/IV childhood lupus nephritis (LN) with heavy proteinuria. IVMP therapy for five days. From peripheral blood mononuclear cells (PBMCs) and renal tissues, we saw IVMP therapy definitely restoring both CD4(+)CD25(+)FoxP3(+) and CD8(+)CD25(+)Foxp3(+) Treg cell number plus greater expression with intracellular IL-10 and granzyme B in CD8(+)FoxP3(+) Treg from PBMCs. IVMP-treated CD8(+)CD25(+) Treg cells directly suppressed CD4(+) T proliferation and induced CD4(+) CD45RO(+) apoptosis. Histologically, CD4(+)FoxP3(+) as well as CD8(+)FoxP3(+) Treg cells appeared in renal tissue of LN patients before IVMP by double immunohistochemical stain. CD8(+)FoxP3(+) Treg cells increased in 10 follow-up renal biopsy specimens after IVMP. Reverse correlation of serum anti-C1q antibody and FoxP3(+) Treg cells in PBMNCs (r = -0.714, P<0.01). After IVMP, serum anti-C1q antibody decrease accompanied increase of CD4(+) FoxP3(+) Treg cells. CD8(+) Treg cells reduced interferon-r response in PBMCs to major peptide autoepitopes from nucleosomes after IVMP therapy; siRNA of FoxP3 suppressed granzyme B expression while decreasing CD8(+)CD25(+)Treg-induced CD4(+)CD45RO(+) apoptosis. Renal activity of LN by SLEDAI-2k in childhood LN was significantly higher than two weeks after IVMP (P<0.01). CD8(+)FoxP3(+) Treg cells return in post-IVMP therapy and exert crucial immune modulatory effect to control autoimmune response in LN.	[Tsai, Yi-Giien] Changhua Christian Hosp, Dept Pediat, Changhua, Taiwan; [Tsai, Yi-Giien] Chung Shan Med Univ, Sch Med, Taichung, Taiwan; [Lee, Chia-Ying; Lin, Ching-Yuang] China Med Univ Hosp, Div Pediat Nephrol, Taichung, Taiwan; [Lin, Tze-Yi] China Med Univ Hosp, Dept Pathol, Taichung, Taiwan; [Lin, Ching-Yuang] China Med Univ Hosp, Clin Immunol Ctr, Taichung, Taiwan; [Lin, Ching-Yuang] China Med Univ, Coll Med, Taichung, Taiwan	Changhua Christian Hospital; Chung Shan Medical University; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan	Lin, CY (corresponding author), China Med Univ Hosp, Div Pediat Nephrol, Taichung, Taiwan.	cylin@mail.cmuh.org.tw			National Science Council, Taiwan [NSC 98-2314-B-039-006-MY3, 98-2314-B-371-001-MY2, NSC 100-2314-B-371 -005]; China Medium University Hospital [DMR-100-180]; Changhua Christian Hospital	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan); China Medium University Hospital; Changhua Christian Hospital	This work was partially supported by grants from the National Science Council, Taiwan (NSC 98-2314-B-039-006-MY3, 98-2314-B-371-001-MY2, NSC 100-2314-B-371 -005); and China Medium University Hospital (DMR-100-180), Changhua Christian Hospital. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bisikirska B, 2005, J CLIN INVEST, V115, P2904, DOI 10.1172/JCI23961; Bovenschen HJ, 2011, J INVEST DERMATOL, V131, P1853, DOI 10.1038/jid.2011.139; Brimnes J, 2005, J IMMUNOL, V174, P5814, DOI 10.4049/jimmunol.174.9.5814; Brunner HI, 2002, ARTHRITIS RHEUM, V46, P436, DOI 10.1002/art.10072; Cao XF, 2007, IMMUNITY, V27, P635, DOI 10.1016/j.immuni.2007.08.014; Chaput N, 2009, GUT, V58, P520, DOI 10.1136/gut.2008.158824; Chen X, 2006, EUR J IMMUNOL, V36, P2139, DOI 10.1002/eji.200635873; Datta SK, 2005, J MOL MED, V83, P267, DOI 10.1007/s00109-004-0624-2; David S, 1997, NEPHROL DIAL TRANSPL, V12, P51, DOI 10.1093/ndt/12.1.51; DesaiMehta A, 1996, J CLIN INVEST, V97, P2063, DOI 10.1172/JCI118643; Endharti AT, 2011, J IMMUNOL, V186, P41, DOI 10.4049/jimmunol.1000800; Gladman DD, 2002, J RHEUMATOL, V29, P288; Gladman DD, 2000, J RHEUMATOL, V27, P377; Gondek DC, 2005, J IMMUNOL, V174, P1783, DOI 10.4049/jimmunol.174.4.1783; Hass C, 1998, J IMMUNOL, V160, P3173; HAY EM, 1993, Q J MED, V86, P447; Helmick CG, 2008, ARTHRITIS RHEUM-US, V58, P15, DOI 10.1002/art.23177; Joetham A, 2008, J IMMUNOL, V180, P7117, DOI 10.4049/jimmunol.180.11.7117; Kaliyaperumal A, 2002, J IMMUNOL, V168, P2530, DOI 10.4049/jimmunol.168.5.2530; Karagiannidis C, 2004, J ALLERGY CLIN IMMUN, V114, P1425, DOI 10.1016/j.jaci.2004.07.014; Keino H, 2006, INVEST OPHTH VIS SCI, V47, P1533, DOI 10.1167/iovs.04-1454; Kim HJ, 2010, NATURE, V467, P328, DOI 10.1038/nature09370; Kiniwa Y, 2007, CLIN CANCER RES, V13, P6947, DOI 10.1158/1078-0432.CCR-07-0842; Ling Y, 2007, EUR J HAEMATOL, V79, P310, DOI 10.1111/j.1600-0609.2007.00917.x; LINKERISRAELI M, 1990, ARTHRITIS RHEUM, V33, P1216; Lu LR, 2008, CELL MOL IMMUNOL, V5, P401, DOI 10.1038/cmi.2008.50; Mahic M, 2008, EUR J IMMUNOL, V38, P640, DOI 10.1002/eji.200737529; MOHAN C, 1993, J EXP MED, V177, P1367, DOI 10.1084/jem.177.5.1367; Nakatani K, 2004, KIDNEY INT, V65, P1290, DOI 10.1111/j.1523-1755.2004.00537.x; Navarro J, 2006, J NEUROIMMUNOL, V176, P153, DOI 10.1016/j.jneuroim.2006.03.022; Polcher M, 2010, CANCER IMMUNOL IMMUN, V59, P909, DOI 10.1007/s00262-010-0817-1; Rahman A, 2008, NEW ENGL J MED, V358, P929, DOI 10.1056/NEJMra071297; SERON D, 1991, NEPHROL DIAL TRANSPL, V6, P917, DOI 10.1093/ndt/6.12.917; Sharabi A, 2008, J IMMUNOL, V181, P3243, DOI 10.4049/jimmunol.181.5.3243; Siegmund K, 2009, J IMMUNOL, V182, P2124, DOI 10.4049/jimmunol.0802271; Skaggs BJ, 2008, HUM IMMUNOL, V69, P790, DOI 10.1016/j.humimm.2008.08.284; Smith TRF, 2008, TRENDS IMMUNOL, V29, P337, DOI 10.1016/j.it.2008.04.002; Strauss L, 2009, J IMMUNOL, V182, P1469, DOI 10.4049/jimmunol.182.3.1469; Suen JL, 2009, IMMUNOLOGY, V127, P196, DOI 10.1111/j.1365-2567.2008.02937.x; Tennakoon DK, 2006, J IMMUNOL, V176, P7119, DOI 10.4049/jimmunol.176.11.7119; Tower C, 2011, NAT REV RHEUMATOL, V7, P124, DOI 10.1038/nrrheum.2010.124; Tsai YG, 2010, J IMMUNOL, V184, P7229, DOI 10.4049/jimmunol.1000083; Tucci M, 2008, CLIN EXP IMMUNOL, V154, P247, DOI 10.1111/j.1365-2249.2008.03758.x; Valencia X, 2007, J IMMUNOL, V178, P2579, DOI 10.4049/jimmunol.178.4.2579; Wang RF, 2008, HUM IMMUNOL, V69, P811, DOI 10.1016/j.humimm.2008.08.276; Weening JJ, 2004, J AM SOC NEPHROL, V15, P241, DOI 10.1097/01.ASN.0000108969.21691.5D; Wu HY, 2008, J IMMUNOL, V181, P6038, DOI 10.4049/jimmunol.181.9.6038; Wu HY, 2004, LUPUS, V13, P192, DOI 10.1191/0961203303lu1002oa; Yamada A, 2009, J ALLERGY CLIN IMMUN, V123, P889, DOI 10.1016/j.jaci.2008.12.1115; Yan B, 2008, ARTHRITIS RHEUM-US, V58, P801, DOI 10.1002/art.23268; Zhang L, 2009, J IMMUNOL, V183, P6346, DOI 10.4049/jimmunol.0901773	51	15	17	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2014	9	1							e81344	10.1371/journal.pone.0081344	http://dx.doi.org/10.1371/journal.pone.0081344			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301BI	24475019	Green Published, Green Submitted, gold			2022-12-25	WOS:000330507300005
J	Coats, RO; Wilson, AD; Snapp-Childs, W; Fath, AJ; Bingham, GP				Coats, Rachel O.; Wilson, Andrew D.; Snapp-Childs, Winona; Fath, Aaron J.; Bingham, Geoffrey P.			The 50s Cliff: Perceptuo-Motor Learning Rates across the Lifespan	PLOS ONE			English	Article							RHYTHMIC MOVEMENT COORDINATION; PHASE-TRANSITIONS; 3-D SHAPE; PERCEPTION; MOTION; AGE; MODEL; INFORMATION; STABILITY; FEEDBACK	We recently found that older adults show reduced learning rates when learning a new pattern of coordinated rhythmic movement. The purpose of this study was to extend that finding by examining the performance of all ages across the lifespan from the 20 s through to the 80 s to determine how learning rates change with age. We tested whether adults could learn to produce a novel coordinated rhythmic movement (90 degrees relative phase) in a visually guided unimanual task. We determined learning rates to quantify changes in learning with age and to determine at what ages the changes occur. We found, as before, that learning rates of participants in their 70 s and 80 s were half those of participants in their 20 s. We also found a gradual slow decline in learning rate with age until approximately age 50, when there was a sudden drop to a reduced learning rate for the 60 though 80 year olds. We discuss possible causes for the "50 s cliff'' in perceptuo-motor learning rates and suggest that age related deficits in perception of complex motions may be the key to understanding this result.	[Coats, Rachel O.] Univ Leeds, Sch Biomed Sci, Fac Biol Sci, Leeds, W Yorkshire, England; [Wilson, Andrew D.] Leeds Metropolitan Univ, Sch Social Psychol & Commun Sci, Leeds LS1 3HE, W Yorkshire, England; [Snapp-Childs, Winona; Fath, Aaron J.; Bingham, Geoffrey P.] Indiana Univ, Dept Psychol & Brain Sci, Bloomington, IN USA	University of Leeds; Leeds Beckett University; Indiana University System; Indiana University Bloomington	Coats, RO (corresponding author), Univ Leeds, Sch Biomed Sci, Fac Biol Sci, Leeds, W Yorkshire, England.	r.o.a.coats@leeds.ac.uk	Coats, Rachel/AAH-6980-2019; Wilson, Andrew/A-7891-2008	Coats, Rachel/0000-0003-4415-408X; Wilson, Andrew/0000-0002-0459-0728; Snapp-Childs, Winona/0000-0003-4354-7092; Fath, Aaron J/0000-0003-3451-2306				Andersen GJ, 2012, WIRES COGN SCI, V3, P403, DOI 10.1002/wcs.1167; Betts LR, 2005, NEURON, V45, P361, DOI 10.1016/j.neuron.2004.12.041; Bingham GP, 2004, ECOL PSYCHOL, V16, P45, DOI 10.1207/s15326969eco1601_6; Bingham GP, 2004, THEORIES TIME TO CON; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Coats RO, 2013, EXP BRAIN RES, V225, P75, DOI 10.1007/s00221-012-3349-4; de Rekeneire N, 2003, J AM GERIATR SOC, V51, P841, DOI 10.1046/j.1365-2389.2003.51267.x; KELSO JAS, 1981, B PSYCHONOMIC SOC, V18, P63; Kleiner M., 2007, PERC 36 ECVP S; Kovacs AJ, 2009, NEUROSCI LETT, V455, P162, DOI 10.1016/j.neulet.2009.02.046; Kovacs AJ, 2009, EXP BRAIN RES, V193, P129, DOI 10.1007/s00221-008-1676-2; Liang Z, 2010, NEUROBIOL AGING, V31, P863, DOI 10.1016/j.neurobiolaging.2008.06.013; Nedelko V, 2010, RESTOR NEUROL NEUROS, V28, P737, DOI 10.3233/RNN-2010-0542; Norman JF, 2004, PSYCHOL AGING, V19, P506, DOI 10.1037/0882-7974.19.3.506; Norman JF, 2003, PERCEPTION, V32, P85, DOI 10.1068/p3478; Norman JF, 2000, PERCEPTION, V29, P1335, DOI 10.1068/p3111; Pedhazur E. J., 1982, MULTIPLE REGRESSION; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; PFEIFFER E, 1975, J AM GERIATR SOC, V23, P433, DOI 10.1111/j.1532-5415.1975.tb00927.x; SCHMIDT RC, 1990, J EXP PSYCHOL HUMAN, V16, P227, DOI 10.1037/0096-1523.16.2.227; Serrien DJ, 2000, J GERONTOL B-PSYCHOL, V55, pP295, DOI 10.1093/geronb/55.5.P295; Snapp-Childs W, 2011, EXP BRAIN RES, V215, P89, DOI 10.1007/s00221-011-2874-x; Snowden RJ, 2006, PERCEPTION, V35, P9, DOI 10.1068/p5399; SPIRDUSO WW, 1995, PHYS DIMENSIONS AGIN, P5; Swinnen SP, 1998, COGN NEUROPSYCHOL, V15, P439, DOI 10.1080/026432998381104; Temprado JJ, 2003, HUM MOVEMENT SCI, V22, P339, DOI 10.1016/S0167-9457(03)00049-6; Wenderoth N, 2002, MOTOR CONTROL, V6, P166, DOI 10.1123/mcj.6.2.166; Wilson AD, 2005, EXP BRAIN RES, V165, P351, DOI 10.1007/s00221-005-2301-2; Wilson AD, 2005, EXP BRAIN RES, V164, P517, DOI 10.1007/s00221-005-2272-3; Wilson AD, 2008, PERCEPT PSYCHOPHYS, V70, P465, DOI 10.3758/PP.70.3.465; Wilson AD, 2010, J EXP PSYCHOL HUMAN, V36, P1508, DOI 10.1037/a0020412; Wilson AD, 2010, EXP BRAIN RES, V205, P513, DOI 10.1007/s00221-010-2388-y; WIMMERS RH, 1992, HUM MOVEMENT SCI, V11, P217, DOI 10.1016/0167-9457(92)90062-G; Wishart LR, 2002, ACTA PSYCHOL, V110, P247, DOI 10.1016/S0001-6918(02)00036-7; YAMANISHI J, 1980, BIOL CYBERN, V37, P219, DOI 10.1007/BF00337040; ZANONE PG, 1992, J EXP PSYCHOL HUMAN, V18, P403, DOI 10.1037/0096-1523.18.2.403	36	19	19	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2014	9	1							e85758	10.1371/journal.pone.0085758	http://dx.doi.org/10.1371/journal.pone.0085758			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	298QQ	24475051	Green Published, gold			2022-12-25	WOS:000330339800016
J	Dunty, WC; Kennedy, MWL; Chalamalasetty, RB; Campbell, K; Yamaguchi, TP				Dunty, William C., Jr.; Kennedy, Mark W. L.; Chalamalasetty, Ravindra B.; Campbell, Kenneth; Yamaguchi, Terry P.			Transcriptional Profiling of Wnt3a Mutants Identifies Sp Transcription Factors as Essential Effectors of the Wnt/beta-catenin Pathway in Neuromesodermal Stem Cells	PLOS ONE			English	Article							BETA-CATENIN; PARAXIAL MESODERM; NEGATIVE REGULATOR; AXIAL PROGENITORS; MOUSE; GENE; SEGMENTATION; BRACHYURY; TARGET; SPECIFICATION	Neuromesodermal (NM) stem cells reside in the primitive streak (PS) of gastrulating vertebrate embryos and generate precursors of the spinal cord and musculoskeletal system. Although Wnt3a/beta-catenin signaling is crucial for NM stem cell maintenance and differentiation, few key transcriptional effectors have been identified. Through a concerted transcriptional profiling and genetic approach we have determined that two Zn2+-finger transcription factors, Sp5 and Sp8, are regulated by Wnt3a in the PS, and are essential for neural and musculoskeletal patterning. These results identify Sp5 and Sp8 as pivotal downstream effectors of Wnt3a, and suggest that they are essential for the self-renewal and differentiation of NM stem cells.	[Dunty, William C., Jr.; Kennedy, Mark W. L.; Chalamalasetty, Ravindra B.; Yamaguchi, Terry P.] NCI, Canc & Dev Biol Lab, Ctr Canc Res, NIH, Frederick, MD 21701 USA; [Campbell, Kenneth] Cincinnati Childrens Hosp Med Ctr, Div Dev Biol, Cincinnati, OH 45229 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Cincinnati Children's Hospital Medical Center	Yamaguchi, TP (corresponding author), NCI, Canc & Dev Biol Lab, Ctr Canc Res, NIH, Frederick, MD 21701 USA.	yamagute@mail.nih.gov	Campbell, Kenneth/ABC-3570-2021		Intramural Research Program of the NIH, National Cancer Institute, Center for Cancer Research; NATIONAL CANCER INSTITUTE [ZIABC010345] Funding Source: NIH RePORTER	Intramural Research Program of the NIH, National Cancer Institute, Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was supported by the Intramural Research Program of the NIH, National Cancer Institute, Center for Cancer Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bell SM, 2003, P NATL ACAD SCI USA, V100, P12195, DOI 10.1073/pnas.2134310100; Biris KK, 2007, DEV DYNAM, V236, P3167, DOI 10.1002/dvdy.21342; Cambray N, 2002, DEVELOPMENT, V129, P4855; Cambray N, 2007, DEVELOPMENT, V134, P2829, DOI 10.1242/dev.02877; Chalamalasetty RB, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1381; Chapman DL, 1998, NATURE, V391, P695, DOI 10.1038/35624; Dunty WC, 2008, DEVELOPMENT, V135, P85, DOI 10.1242/dev.009266; Ema M, 2008, CELL STEM CELL, V3, P555, DOI 10.1016/j.stem.2008.09.003; Fujimura N, 2007, J BIOL CHEM, V282, P1225, DOI 10.1074/jbc.M605851200; Gadue P, 2006, P NATL ACAD SCI USA, V103, P16806, DOI 10.1073/pnas.0603916103; Galceran J, 1999, GENE DEV, V13, P709, DOI 10.1101/gad.13.6.709; Greco TL, 1996, GENE DEV, V10, P313, DOI 10.1101/gad.10.3.313; Harada N, 1999, EMBO J, V18, P5931, DOI 10.1093/emboj/18.21.5931; Harrison SM, 2000, DEV BIOL, V227, P358, DOI 10.1006/dbio.2000.9878; Hovanes K, 2001, NAT GENET, V28, P53, DOI 10.1038/88264; Jho EH, 2002, MOL CELL BIOL, V22, P1172, DOI 10.1128/MCB.22.4.1172-1183.2002; Martin BL, 2008, DEV CELL, V15, P121, DOI 10.1016/j.devcel.2008.04.013; Martin BL, 2012, DEV CELL, V22, P223, DOI 10.1016/j.devcel.2011.11.001; MCGREW LL, 1995, DEV BIOL, V172, P337, DOI 10.1006/dbio.1995.0027; McGrew MJ, 2008, DEVELOPMENT, V135, P2289, DOI 10.1242/dev.022020; Merrill BJ, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a007971; Perantoni AO, 2005, DEVELOPMENT, V132, P3859, DOI 10.1242/dev.01945; Petersen CP, 2009, CELL, V139, P1056, DOI 10.1016/j.cell.2009.11.035; Sahara S, 2007, NEURAL DEV, V2, DOI 10.1186/1749-8104-2-10; Saito-Diaz K, 2013, GROWTH FACTORS, V31, P1, DOI 10.3109/08977194.2012.752737; Satoh K, 2004, P NATL ACAD SCI USA, V101, P8017, DOI 10.1073/pnas.0401733101; Slack JMW, 2008, SCIENCE, V322, P1498, DOI 10.1126/science.1162782; TAKADA S, 1994, GENE DEV, V8, P174, DOI 10.1101/gad.8.2.174; ten Berge D, 2008, CELL STEM CELL, V3, P508, DOI 10.1016/j.stem.2008.09.013; Ten Berge D, 2011, NAT CELL BIOL, V13, P1070, DOI 10.1038/ncb2314; Thorpe CJ, 2005, DEVELOPMENT, V132, P1763, DOI 10.1242/dev.01733; Treichel D, 2003, GENE DEV, V17, P2630, DOI 10.1101/gad.274103; Treichel D, 2001, MECH DEVELOP, V101, P175, DOI 10.1016/S0925-4773(00)00544-X; Tzouanacou E, 2009, DEV CELL, V17, P365, DOI 10.1016/j.devcel.2009.08.002; Weidinger G, 2005, CURR BIOL, V15, P489, DOI 10.1016/j.cub.2005.01.041; Wharton KA, 2001, DEV BIOL, V234, P93, DOI 10.1006/dbio.2001.0238; Yamaguchi TP, 1999, GENE DEV, V13, P3185, DOI 10.1101/gad.13.24.3185; Yoon JK, 2000, GENE DEV, V14, P3204, DOI 10.1101/gad.850000; Yoshikawa Y, 1997, DEV BIOL, V183, P234, DOI 10.1006/dbio.1997.8502	39	32	33	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2014	9	1							e87018	10.1371/journal.pone.0087018	http://dx.doi.org/10.1371/journal.pone.0087018			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	298QQ	24475213	Green Submitted, Green Published, gold			2022-12-25	WOS:000330339800078
J	Lahaye, SEP; Eens, M; Darras, VM; Pinxten, R				Lahaye, Stefanie E. P.; Eens, Marcel; Darras, Veerle M.; Pinxten, Rianne			Bare-Part Color in Female Budgerigars Changes from Brown to Structural Blue following Testosterone Treatment but Is Not Strongly Masculinized	PLOS ONE			English	Article							SUPERB FAIRY-WRENS; FOOTED BOOBY; MELOPSITTACUS-UNDULATUS; SEXUAL-DIFFERENTIATION; IMMUNE ACTIVATION; BILL COLOR; SHORT-TERM; PLUMAGE; REFLECTANCE; SIGNALS	Whereas several studies have shown that experimentally increased levels of the androgenic steroid testosterone can affect female behavior, fewer studies have focused on the activational effects of exogenous testosterone on female morphology. With respect to colorful displays in birds, almost exclusively the effects of testosterone manipulation on female carotenoid-based colorations have been studied. Other color types such as structural colors (i.e. UV, blue and violet colors that result from differential light reflection in the nanostructures of the tissue) remain largely unstudied. Here, we investigated the short-and long-term effects of exogenous testosterone on the expression of structural bare-part coloration in female budgerigars, Melopsittacus undulatus. In this parrot species, bare-part coloration is expressed in the cere, a structure over the beak which is brown in females and structural blue in males. We experimentally increased plasma testosterone levels in testosterone-treated females (T-females) compared to controls (C-females) and we performed weekly spectrophotometric measurements of the cere for five weeks after implantation and one measurement after ten weeks. We also estimated the extent to which testosterone masculinized female cere color by comparing the experimental females with untreated males. We found significant effects of testosterone on cere color from week four after implantation onwards. T-females expressed significantly bluer ceres than C-females with higher values for brightness and UV reflectance. T-female cere color, however, remained significantly less blue than in males, while values for brightness and UV reflectance were significantly higher in T-females than in males. Our quantitative results show that exogenous testosterone induces the expression of structural blue color in females but does not strongly masculinize female cere coloration. We provide several potential pathways for the action of testosterone on structural color.	[Lahaye, Stefanie E. P.; Eens, Marcel; Pinxten, Rianne] Univ Antwerp, Res Grp Ethol, Antwerp, Belgium; [Darras, Veerle M.] Katholieke Univ Leuven, Lab Comparat Endocrinol, Louvain, Belgium	University of Antwerp; KU Leuven	Lahaye, SEP (corresponding author), Univ Antwerp, Res Grp Ethol, Antwerp, Belgium.	stefanie.lahaye@uantwerpen.be	Eens, Marcel/AAC-8466-2020		FWO-Flanders; University of Antwerp	FWO-Flanders(FWO); University of Antwerp	Stefanie E. P. Lahaye was funded by a PhD grant of FWO-Flanders. Marcel Eens and Rianne Pinxten were funded by the University of Antwerp and supported by FWO-Flanders (http://www.fwo.be/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso-Alvarez C, 2004, AM NAT, V164, P651, DOI 10.1086/424971; Andersson M, 2006, TRENDS ECOL EVOL, V21, P296, DOI 10.1016/j.tree.2006.03.015; Andersson Malte, 1994; Appeltants D, 2003, NEUROSCIENCE, V121, P801, DOI 10.1016/S0306-4522(03)00496-2; Ardia DR, 2010, HORM BEHAV, V58, P526, DOI 10.1016/j.yhbeh.2010.04.004; Arnold AP, 1996, HORM BEHAV, V30, P495, DOI 10.1006/hbeh.1996.0053; Ball GF, 2002, FRONT NEUROENDOCRIN, V23, P137, DOI 10.1006/frne.2002.0230; BALTHAZART J, 1995, TRENDS ENDOCRIN MET, V6, P21, DOI 10.1016/1043-2760(94)00098-O; Balthazart J, 2009, HORMONES, BRAIN AND BEHAVIOR, VOLS 1-5, 2ND EDITION, P1745; Baltz AP, 1996, ETHOLOGY, V102, P109; Bowmaker JK, 1997, VISION RES, V37, P2183, DOI 10.1016/S0042-6989(97)00026-6; Brockway B. F., 1964, Behaviour, V22, P193, DOI 10.1163/156853964X00021; Casagrande S, 2011, J COMP PHYSIOL A, V197, P1, DOI 10.1007/s00359-010-0579-4; Cox RM, 2005, COPEIA, P597; Cuthill IC, 2000, ADV STUD BEHAV, V29, P159, DOI 10.1016/S0065-3454(08)60105-9; Cuthill IC, 1999, AM NAT, V153, P183, DOI 10.1086/303160; De Ridder E, 2002, AUK, V119, P487, DOI 10.1642/0004-8038(2002)119[0487:SALTEO]2.0.CO;2; Dentressangle F, 2008, BEHAV ECOL SOCIOBIOL, V62, P1899, DOI 10.1007/s00265-008-0620-6; Eda-Fujiwara H, 2003, J ETHOL, V21, P23, DOI 10.1007/s10164-002-0075-6; Eens M, 2000, HORM BEHAV, V37, P126, DOI 10.1006/hbeh.1999.1569; Ekstrom JMM, 2007, IBIS, V149, P313, DOI 10.1111/j.1474-919X.2006.00632.x; ENDLER JA, 1990, BIOL J LINN SOC, V41, P315, DOI 10.1111/j.1095-8312.1990.tb00839.x; Faivre B, 2003, SCIENCE, V300, P103, DOI 10.1126/science.1081802; Fusani L, 2008, HORM BEHAV, V54, P227, DOI 10.1016/j.yhbeh.2008.04.004; Giraudeau M, 2010, P ROY SOC LOND B BIO, V278, P781; Griggio M, 2009, J EVOLUTION BIOL, V22, P782, DOI 10.1111/j.1420-9101.2009.01700.x; Grill CP, 2000, BIOL J LINN SOC, V69, P121, DOI 10.1006/bijl.1999.0360; HAUSBERGER M, 1995, ETHOLOGY, V99, P193; Hegyi G, 2007, J AVIAN BIOL, V38, P698, DOI 10.1111/j.2007.0908-8857.04075.x; Heinsohn R, 2003, J ZOOL, V259, P197, DOI 10.1017/S0952836902003138; Sarasola JH, 2011, J ORNITHOL, V152, P473, DOI 10.1007/s10336-010-0606-9; Hill EG, 2006, BIRD COLORATION; Hill G. E., 2006, BIRD COLORATION, VII; Hill Geoffrey E., 2006, P137; Hunt DM, 2001, CELL MOL LIFE SCI, V58, P1583, DOI 10.1007/PL00000798; Juniper T, 1998, PARROTS GUIDE PARROT; Karubian J, 2011, ANIM BEHAV, V81, P795, DOI 10.1016/j.anbehav.2011.01.012; Ketterson ED, 2005, AM NAT, V166, pS85, DOI 10.1086/444602; Kimball Rebecca T., 2006, P431; Knuttel H, 2001, J EXP BIOL, V204, P2447; KRINER E, 1991, ETHOLOGY, V87, P37; Lahaye SEP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074005; Lahaye SEP, 2012, GEN COMP ENDOCR, V178, P82, DOI 10.1016/j.ygcen.2012.04.021; Lindsay WR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026067; Littell R. C, 1996, SAS SYSTEM MIXED MOD; LOZANO GA, 1994, OIKOS, V70, P309, DOI 10.2307/3545643; Lupu CA, 2000, J AVIAN MED SURG, V14, P237, DOI 10.1647/1082-6742(2000)014[0237:EOSEOT]2.0.CO;2; McGraw K.J., 2006, BIRD COLORATION, V1, P177; McGraw KJ, 2006, PHYSIOL BEHAV, V88, P347, DOI 10.1016/j.physbeh.2006.04.003; McGraw KJ, 2006, BEHAV ECOL SOCIOBIOL, V60, P117, DOI 10.1007/s00265-005-0135-3; McGraw KJ, 2006, BIRD COLORARION, P354; Mennill DJ, 2003, BEHAV ECOL SOCIOBIOL, V53, P350, DOI 10.1007/s00265-003-0581-8; Moller AP, 2005, BEHAV ECOL SOCIOBIOL, V58, P534, DOI 10.1007/s00265-005-0962-2; Montgomerie R., 2006, BIRD COLORATION, P90; Morales J, 2012, BEHAV ECOL SOCIOBIOL, V66, P135, DOI 10.1007/s00265-011-1261-8; MORTON DB, 1993, LAB ANIM, V27, P1, DOI 10.1258/002367793780745633; Mougeot F, 2006, BIOL LETTERS, V2, P173, DOI 10.1098/rsbl.2005.0434; MUNDINGER PC, 1972, AUK, V89, P403, DOI 10.2307/4084214; Negro JJ, 2001, FUNCT ECOL, V15, P297, DOI 10.1046/j.1365-2435.2001.00526.x; Nespor AA, 1996, HORM BEHAV, V30, P162, DOI 10.1006/hbeh.1996.0020; OWENS IPF, 1995, TRENDS ECOL EVOL, V10, P44, DOI 10.1016/S0169-5347(00)88967-3; Pearn SM, 2003, P ROY SOC B-BIOL SCI, V270, P859, DOI 10.1098/rspb.2002.2315; Peters A, 2000, BEHAV ECOL SOCIOBIOL, V47, P438, DOI 10.1007/s002650050688; Peters A, 2007, IBIS, V149, P121; Prum RO, 2003, J EXP BIOL, V206, P2409, DOI 10.1242/jeb.00431; Roberts ML, 2009, BEHAV ECOL, V20, P535, DOI 10.1093/beheco/arp028; Rosen RF, 2006, ETHOLOGY, V112, P1008, DOI 10.1111/j.1439-0310.2006.01257.x; Siitari H, 2007, AM NAT, V169, pS81, DOI 10.1086/510140; Slominski A, 2004, PHYSIOL REV, V84, P1155, DOI 10.1152/physrev.00044.2003; Staub NL, 1997, GEN COMP ENDOCR, V108, P1, DOI 10.1006/gcen.1997.6962; Taysom AJ, 2011, J EVOLUTION BIOL, V24, P303, DOI 10.1111/j.1420-9101.2010.02166.x; Torres R, 2005, ANIM BEHAV, V69, P59, DOI 10.1016/j.anbehav.2004.03.008; Torres R, 2003, BEHAV ECOL SOCIOBIOL, V55, P65, DOI 10.1007/s00265-003-0669-1; Van Hout AJM, 2010, GEN COMP ENDOCR, V168, P505, DOI 10.1016/j.ygcen.2010.06.012; Velando A, 2006, OECOLOGIA, V149, P535, DOI 10.1007/s00442-006-0457-5; Vroonen J, 2012, BIOL J LINN SOC, V107, P182, DOI 10.1111/j.1095-8312.2012.01915.x; Whitaker B, 1990, THESIS STATE U NEW J	77	11	11	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2014	9	1							e86849	10.1371/journal.pone.0086849	http://dx.doi.org/10.1371/journal.pone.0086849			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	298QQ	24475184	Green Published, Green Submitted, gold			2022-12-25	WOS:000330339800063
J	Liao, JM; Li, X; Wong, TY; Wang, JJ; Khor, CC; Tai, ES; Aung, T; Teo, YY; Cheng, CY				Liao, Jiemin; Li, Xiang; Wong, Tien-Yin; Wang, Jie Jin; Khor, Chiea Chuen; Tai, E. Shyong; Aung, Tin; Teo, Yik-Ying; Cheng, Ching-Yu			Impact of Measurement Error on Testing Genetic Association with Quantitative Traits	PLOS ONE			English	Article							SAMPLE-SIZE CALCULATIONS; BLOOD-PRESSURE; EYE DISEASES; POWER; MISCLASSIFICATION; METHODOLOGY; VARIABILITY; PHENOTYPE; GENOTYPE; LINKAGE	Measurement error of a phenotypic trait reduces the power to detect genetic associations. We examined the impact of sample size, allele frequency and effect size in presence of measurement error for quantitative traits. The statistical power to detect genetic association with phenotype mean and variability was investigated analytically. The non-centrality parameter for a non-central F distribution was derived and verified using computer simulations. We obtained equivalent formulas for the cost of phenotype measurement error. Effects of differences in measurements were examined in a genome-wide association study (GWAS) of two grading scales for cataract and a replication study of genetic variants influencing blood pressure. The mean absolute difference between the analytic power and simulation power for comparison of phenotypic means and variances was less than 0.005, and the absolute difference did not exceed 0.02. To maintain the same power, a one standard deviation (SD) in measurement error of a standard normal distributed trait required a one-fold increase in sample size for comparison of means, and a three-fold increase in sample size for comparison of variances. GWAS results revealed almost no overlap in the significant SNPs (p<10(-5)) for the two cataract grading scales while replication results in genetic variants of blood pressure displayed no significant differences between averaged blood pressure measurements and single blood pressure measurements. We have developed a framework for researchers to quantify power in the presence of measurement error, which will be applicable to studies of phenotypes in which the measurement is highly variable.	[Liao, Jiemin; Wong, Tien-Yin; Khor, Chiea Chuen; Aung, Tin; Cheng, Ching-Yu] Natl Univ Singapore, Dept Ophthalmol, Singapore 117548, Singapore; [Liao, Jiemin; Wong, Tien-Yin; Khor, Chiea Chuen; Tai, E. Shyong; Aung, Tin; Cheng, Ching-Yu] Natl Univ Hlth Syst, Singapore, Singapore; [Liao, Jiemin; Li, Xiang; Wong, Tien-Yin; Aung, Tin; Cheng, Ching-Yu] Singapore Natl Eye Ctr, Singapore Eye Res Inst, Singapore, Singapore; [Li, Xiang; Teo, Yik-Ying] Natl Univ Singapore, Dept Stat & Appl Probabil, Singapore 117548, Singapore; [Wong, Tien-Yin; Tai, E. Shyong; Teo, Yik-Ying; Cheng, Ching-Yu] Natl Univ Singapore, Saw Swee Hock Sch Publ Hlth, Natl Univ Hlth Syst, Singapore 117548, Singapore; [Wang, Jie Jin] Univ Sydney, Ctr Vis Res, Sydney, NSW 2006, Australia; [Khor, Chiea Chuen] Genome Inst Singapore, Div Human Genet, Singapore, Singapore; [Tai, E. Shyong] Natl Univ Singapore, Dept Med, Singapore 117548, Singapore; [Tai, E. Shyong; Cheng, Ching-Yu] Duke NUS Grad Med Sch, Singapore, Singapore	National University of Singapore; National University of Singapore; National University of Singapore; Singapore National Eye Center; National University of Singapore; National University of Singapore; University of Sydney; Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); National University of Singapore; National University of Singapore	Cheng, CY (corresponding author), Natl Univ Singapore, Dept Ophthalmol, Singapore 117548, Singapore.	ching-yu_cheng@nuhs.edu.sg	Wang, Jie Jin/P-1499-2014; Wong, Tien Yin/AAC-9724-2020; wang, jie/GRS-0942-2022; Cheng, Ching-Yu/Y-2229-2019	Wang, Jie Jin/0000-0001-9491-4898; Wong, Tien Yin/0000-0002-8448-1264; Cheng, Ching-Yu/0000-0003-0655-885X; Khor, Chiea Chuen/0000-0002-1128-4729	National Medical Research Council [0796/2003, IRG07nov013, IRG09nov014, STaR/0003/2008, CG/SERI/2010]; Biomedical Research Council, Singapore [09/1/35/19/616]; NMRC [CSA/033/2012, CSA/008/2009]	National Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biomedical Research Council, Singapore(Agency for Science Technology & Research (A*STAR)); NMRC(National Medical Research Council, Singapore)	SiMES and SCES are funded by National Medical Research Council (grants 0796/2003, IRG07nov013, IRG09nov014, STaR/0003/2008 and CG/SERI/2010) and Biomedical Research Council (grants 09/1/35/19/616), Singapore. Ching-Yu Cheng is supported by an award from NMRC (CSA/033/2012) and E-Shyong Tai is supported by an award from NMRC (CSA/008/2009). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balding DJ, 2006, NAT REV GENET, V7, P781, DOI 10.1038/nrg1916; Barendse W, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-232; Beaumont MA, 2004, NAT REV GENET, V5, P251, DOI 10.1038/nrg1318; Bollinger CR, 2005, J LABOR ECON, V23, P235, DOI 10.1086/428028; Buonaccorsi JP, 2011, STAT METHODS MED RES; Chen XH, 2005, REV ECON STUD, V72, P343, DOI 10.1111/j.1467-937X.2005.00335.x; Cheng KF, 2009, HUM HERED, V67, P77, DOI 10.1159/000179556; CHYLACK LT, 1993, ARCH OPHTHALMOL-CHIC, V111, P831, DOI 10.1001/archopht.1993.01090060119035; COCHRAN WG, 1968, TECHNOMETRICS, V10, P637, DOI 10.2307/1267450; CONOVER WJ, 1981, TECHNOMETRICS, V23, P351, DOI 10.2307/1268225; Devine OJ, 1998, STAT MED, V17, P1375, DOI 10.1002/(SICI)1097-0258(19980630)17:12<1375::AID-SIM857>3.0.CO;2-D; Diem P, 2004, ARCH MED RES, V35, P145, DOI 10.1016/j.arcmed.2003.10.003; Edwards BJ, 2005, BMC GENET, V6, DOI 10.1186/1471-2156-6-18; Ehret GB, 2011, NATURE, V478, P103, DOI 10.1038/nature10405; Eriksson N, 2012, BMC MED GENET, V13, DOI 10.1186/1471-2350-13-53; Fan Q, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002753; Fan Q, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002402; Foong AWP, 2007, OPHTHAL EPIDEMIOL, V14, P25, DOI 10.1080/09286580600878844; Fuller W.A., 2009, MEASUREMENT ERROR MO; Gordon D, 2005, BIOINFORMATICS, V21, P3935, DOI 10.1093/bioinformatics/bti643; Gordon D, 2002, HUM HERED, V54, P22, DOI 10.1159/000066696; Gordon D, 2007, GENET EPIDEMIOL, V31, P853, DOI 10.1002/gepi.20246; Hardin JW, 2003, STATA J, V3, P361, DOI 10.1177/1536867X0300300406; KLEIN BEK, 1990, OPHTHALMOLOGY, V97, P1428; Kleinbaum DG, 2007, APPL REGRESSION ANAL, Vxxi; Lachin John M, 2004, Clin Trials, V1, P553, DOI 10.1191/1740774504cn057oa; Lam AKC, 2001, OPHTHAL PHYSL OPT, V21, P477, DOI 10.1046/j.1475-1313.2001.00611.x; Lavanya R, 2009, OPHTHAL EPIDEMIOL, V16, P325, DOI 10.3109/09286580903144738; Li H, 2008, OPHTHALMOLOGY, V115, P796, DOI 10.1016/j.ophtha.2007.07.006; Li X, 2012, INVEST OPHTH VIS SCI, V53, P3082, DOI 10.1167/iovs.12-9967; Lindstrom S, 2009, HUM HERED, V68, P171, DOI 10.1159/000224637; Lynch M., 1998, GENETICS ANAL QUANTI; MANOLIO TA, 1988, AM J HYPERTENS, V1, pS161, DOI 10.1093/ajh/1.3.161S; PANNARALE G, 1993, HYPERTENSION, V22, P591, DOI 10.1161/01.HYP.22.4.591; Purcell S, 2003, BIOINFORMATICS, V19, P149, DOI 10.1093/bioinformatics/19.1.149; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; R Development Core Team, 2012, R LANG ENV STAT COMP; Samuels DC, 2009, TRENDS GENET, V25, P486, DOI 10.1016/j.tig.2009.09.008; TUKEY JW, 1962, ANN MATH STAT, V33, P1, DOI 10.1214/aoms/1177704711; van der Sluis S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013929; Visscher PM, 2010, BEHAV GENET, V40, P728, DOI 10.1007/s10519-010-9362-0; Wojczynski MK, 2008, ADV GENET, V60, P75, DOI 10.1016/S0065-2660(07)00404-X; Yang J, 2012, NATURE, V490, P267, DOI 10.1038/nature11401	43	29	29	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2014	9	1							e87044	10.1371/journal.pone.0087044	http://dx.doi.org/10.1371/journal.pone.0087044			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	298QQ	24475218	Green Published, gold, Green Submitted			2022-12-25	WOS:000330339800080
J	Lorente-Cebrian, S; Mejhert, N; Kulyte, A; Laurencikiene, J; Astrom, G; Heden, P; Ryden, M; Arner, P				Lorente-Cebrian, Silvia; Mejhert, Niklas; Kulyte, Agne; Laurencikiene, Jurga; Astrom, Gaby; Heden, Per; Ryden, Mikael; Arner, Peter			MicroRNAs Regulate Human Adipocyte Lipolysis: Effects of miR-145 Are Linked to TNF-alpha	PLOS ONE			English	Article							NF-KAPPA-B; STIMULATES LIPOLYSIS; PROTEIN; KINASE; TARGETS; LIPASE	MicroRNAs (miRNAs) are small non-coding RNAs that regulate gene expression and have multiple effects in various tissues including adipose inflammation, a condition characterized by increased local release of the pro-lipolytic cytokine tumor necrosis factor-alpha (TNF-alpha). Whether miRNAs regulate adipocyte lipolysis is unknown. We set out to determine whether miRNAs affect adipocyte lipolysis in human fat cells. To this end, eleven miRNAs known to be present in human adipose tissue were over-expressed in human in vitro differentiated adipocytes followed by assessments of TNF-alpha and glycerol levels in conditioned media after 48 h. Three miRNAs (miR-145, -26a and let-7d) modulated both parameters in parallel. However, while miR-26a and let-7d decreased, miR-145 increased both glycerol release and TNF-alpha secretion. Further studies were focused therefore on miR-145 since this was the only stimulator of lipolysis and TNF-alpha secretion. Time-course analysis demonstrated that miR-145 over-expression up-regulated TNF-alpha expression/secretion followed by increased glycerol release. Increase in TNF-alpha production by miR-145 was mediated via activation of p65, a member of the NF-kappa B complex. In addition, miR-145 down-regulated the expression of the protease ADAM17, resulting in an increased fraction of membrane bound TNF-alpha, which is the more biologically active form of TNF-alpha. MiR-145 overexpression also increased the phosphorylation of activating serine residues in hormone sensitive lipase and decreased the mRNA expression of phosphodiesterase 3B, effects which are also observed upon TNF-alpha treatment in human adipocytes. We conclude that miR-145 regulates adipocyte lipolysis via multiple mechanisms involving increased production and processing of TNF-alpha in fat cells.	[Lorente-Cebrian, Silvia; Mejhert, Niklas; Kulyte, Agne; Laurencikiene, Jurga; Astrom, Gaby; Ryden, Mikael; Arner, Peter] Karolinska Inst, Lipid Lab, Dept Med Huddinge H7, Stockholm, Sweden; [Heden, Per] Akad Kliniken, Stockholm, Sweden	Karolinska Institutet	Lorente-Cebrian, S (corresponding author), Karolinska Inst, Lipid Lab, Dept Med Huddinge H7, Stockholm, Sweden.	Silvia.Lorente-Cebrian@ki.se; peter.arner@ki.se	Lorente-Cebrián, Silvia/N-2578-2019	Lorente-Cebrián, Silvia/0000-0002-1033-6152; Mejhert, Niklas/0000-0003-1785-833X; Arner, Peter/0000-0002-6208-6220; Kulyte, Agne/0000-0001-7745-2767; , Jurga/0000-0002-7032-2924	Swedish Research Council; Swedish Diabetes Foundation; Diabetes Program at Karolinska Institute; Swedish Cancer Foundation; Diabetes Wellness; Swedish Society of Medicine; Tore Nilsson Foundation; Foundation for Gamla Tjanarinnor; EASD/Lilly program; Novo Nordisk Foundation; Novo Nordisk Fonden [NNF14OC0010187, NNF12OC1016371] Funding Source: researchfish	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Diabetes Foundation; Diabetes Program at Karolinska Institute; Swedish Cancer Foundation; Diabetes Wellness; Swedish Society of Medicine; Tore Nilsson Foundation; Foundation for Gamla Tjanarinnor; EASD/Lilly program; Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Novo Nordisk Fonden(Novo Nordisk Foundation)	This work was supported by several grants from Swedish Research Council, The Swedish Diabetes Foundation, the Diabetes Program at Karolinska Institute, the Swedish Cancer Foundation, Diabetes Wellness, the Swedish Society of Medicine, Tore Nilsson Foundation, Foundation for Gamla Tjanarinnor and EASD/Lilly program and Novo Nordisk Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arner E, 2012, DIABETES, V61, P1986, DOI 10.2337/db11-1508; Ashall L, 2009, SCIENCE, V324, P242, DOI 10.1126/science.1164860; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bezaire V, 2009, P NUTR SOC, V68, P350, DOI 10.1017/S0029665109990279; Chen L, 2013, CELL BIOL INT, V37, P533, DOI 10.1002/cbin.10063; Clausen Trine Schnedler, 2009, Journal of Pharmacological and Toxicological Methods, V60, P281, DOI 10.1016/j.vascn.2009.03.001; Doberstein K, 2013, NEOPLASIA, V15, P218, DOI 10.1593/neo.121222; Gasic S, 1999, J BIOL CHEM, V274, P6770, DOI 10.1074/jbc.274.10.6770; Greenberg AS, 2001, J BIOL CHEM, V276, P45456, DOI 10.1074/jbc.M104436200; Hoffmann A, 2002, SCIENCE, V298, P1241, DOI 10.1126/science.1071914; KRIEGLER M, 1988, CELL, V53, P45, DOI 10.1016/0092-8674(88)90486-2; Kulyte A, 2002, MOL BIOL CELL, V13, P4195, DOI 10.1091/mbc.E02-03-0128; Laurencikiene J, 2007, J LIPID RES, V48, P1069, DOI 10.1194/jlr.M600471-JLR200; Lorente-Cebrian S, 2011, OBESITY FACTS, V4, P365, DOI 10.1159/000334036; Nelson DE, 2004, SCIENCE, V306, P704, DOI 10.1126/science.1099962; Pachler C, 2007, AM J PHYSIOL-ENDOC M, V293, pE690, DOI 10.1152/ajpendo.00034.2007; Palladino MA, 2003, NAT REV DRUG DISCOV, V2, P736, DOI 10.1038/nrd1175; Peschon JJ, 1998, SCIENCE, V282, P1281, DOI 10.1126/science.282.5392.1281; Ryden M, 2004, BIOCHEM BIOPH RES CO, V318, P168, DOI 10.1016/j.bbrc.2004.04.010; Ryden M, 2002, J BIOL CHEM, V277, P1085, DOI 10.1074/jbc.M109498200; Sayed D, 2011, PHYSIOL REV, V91, P827, DOI 10.1152/physrev.00006.2010; Sethi JK, 1999, SEMIN CELL DEV BIOL, V10, P19, DOI 10.1006/scdb.1998.0273; Stenson BM, 2011, J BIOL CHEM, V286, P370, DOI 10.1074/jbc.M110.179499; van Harmelen Vanessa, 2005, Methods Mol Med, V107, P125; Wellen KE, 2003, J CLIN INVEST, V112, P1785, DOI 10.1172/JCI20514; Williams MD, 2012, EXP DIABETES RES, DOI 10.1155/2012/484696; Xu HY, 2002, DIABETES, V51, P1876, DOI 10.2337/diabetes.51.6.1876; Yang XW, 2013, HEPATOLOGY RES OFFIC; Zhang HH, 2002, DIABETES, V51, P2929, DOI 10.2337/diabetes.51.10.2929; Zhang HH, 2003, J BIOL CHEM, V278, P51535, DOI 10.1074/jbc.M309591200	30	70	76	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2014	9	1							e86800	10.1371/journal.pone.0086800	http://dx.doi.org/10.1371/journal.pone.0086800			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	298QQ	24475180	Green Published, gold, Green Submitted			2022-12-25	WOS:000330339800061
J	Han, J; Tan, P; Li, ZY; Wu, Y; Li, C; Wang, Y; Wang, BB; Zhao, S; Liu, YG				Han, Jing; Tan, Peng; Li, Zhiyong; Wu, Yan; Li, Chun; Wang, Yong; Wang, Beibei; Zhao, Shuang; Liu, Yonggang			Fuzi Attenuates Diabetic Neuropathy in Rats and Protects Schwann Cells from Apoptosis Induced by High Glucose	PLOS ONE			English	Article							METHYLCOBALAMIN; METABOLITES; ACONITINE; URINE	Radix aconite lateralis preparata (Fuzi), a folk medicine, has long been used for the treatment of diabetes and paralysis in China. We examined the effect of Fuzi alone on diabetic rats and Schwann cells in high glucose and the components responsible for its activity. The major constituents of FZE were identified by HPLC-MS/MS data. Male Sprague Dawley rats (n = 36) were randomly divided into control, diabetic, FZE 1.75 g/kg, FZE 3.50 g/kg, FZE 7.00 g/kg, and methylcobalamin groups. After two weeks treatment, nerve conduction velocity and paw withdrawal latency were measured. In vitro, the Schwann cells were grouped according to exposure: normal glucose (NG), normal glucose plus mannitol (NG+M), high glucose (HG), and HG plus different concentrations of FZE (0.1 mu g/ml, 1.0 mu g/ml, and 10.0 mu g/ml). Oxygen free radicals and apoptosis were evaluated through DCFH(2)DA, DHE and annexin-PE/7-AAD assay, respectively. Apoptosis factors (Bax, Bcl-2, CytoC, caspase-3, and caspase-9) were analyzed using immunofluorescence. Nine alkaloids were identified. The results from animal model showed that FZE was effective in accelerating nerve conduction velocity and shortening paw withdrawal latency in diabetic rats. And in vitro, FZE was also found to protect Schwann cells against high glucose injury. FZE could significantly decrease the apoptotic ratio, superoxide anion and peroxide level. Furthermore, the apoptosis factors, including Bax, Bcl-2, CytoC, caspase-3, and caspase-9 were ameliorated in FZE treated groups. The HPLC-MS n method is simple and suitable for the identification of alkaloids in Fuzi. FZE has a protective effect in diabetic neuropathic rats, which is probably achieved by the antiapoptotic effect of FZE on Schwann cells. Apoptosis factor data imply that FZE protected Schwann cells through the mitochondria pathway. Alkaloids are major components contributing to the protective effect.	[Han, Jing; Tan, Peng; Wu, Yan; Li, Chun; Wang, Yong; Wang, Beibei; Zhao, Shuang; Liu, Yonggang] Beijing Univ Chinese Med, Beijing, Peoples R China; [Li, Zhiyong] Minzu Univ China, Beijing, Peoples R China	Beijing University of Chinese Medicine; Minzu University of China	Liu, YG (corresponding author), Beijing Univ Chinese Med, Beijing, Peoples R China.	liuyg0228@163.com			National Nature Science Foundation of China [30901959, 81102807]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Nature Science Foundation of China (No. 30901959; No.81102807). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bertolotto F, 2012, DRUGS R&D, V12, P29, DOI 10.2165/11599200-000000000-00000; Callaghan BC, 2012, LANCET NEUROL, V11, P521, DOI 10.1016/S1474-4422(12)70065-0; Deng J., 2009, CHIN ARCH TRADIT CHI, V27, P2249; Eckersley L, 2002, INT REV NEUROBIOL, V50, P293; Gao XM, 2002, PHARMACY; Han J., 2012, SHANGHAI J TRADITION, V46, P76; Hu Y., 2005, J LIAONING COLL TCM, V7, P588; Jagalur NB, 2011, J NEUROSCI, V31, P8585, DOI 10.1523/JNEUROSCI.0659-11.2011; Jing XX, 2013, J TIANJIN U TRADITIO, V32, P55; Li JB, 2010, NUTR NEUROSCI, V13, P79, DOI 10.1179/147683010X12611460763607; Liu H., 2013, J TRADITIONAL CHINES, V22, P51; Saini AK, 2007, EUR J PHARMACOL, V568, P164, DOI 10.1016/j.ejphar.2007.04.016; Sekido H, 2004, BIOCHEM BIOPH RES CO, V320, P241, DOI 10.1016/j.bbrc.2004.05.159; [邵峰 Shao Feng], 2011, [时珍国医国药, Lishizhen Medicine and Materia Medica Research], V22, P2329; Smith A Gordon, 2012, Continuum (Minneap Minn), V18, P60, DOI 10.1212/01.CON.0000411568.34085.3e; Sugimoto K, 2000, DIABETES-METAB RES, V16, P408; Sun LN, 2013, INT J BIOL SCI, V9, P811, DOI 10.7150/ijbs.6734; Tahrani AA, 2010, EXPERT OPIN EMERG DR, V15, P661, DOI 10.1517/14728214.2010.512610; Tan GG, 2011, BIOMED CHROMATOGR, V25, P1343, DOI 10.1002/bmc.1607; Tan P, 2012, PHARMAZIE, V67, P274, DOI 10.1691/ph.2012.1121; Tolkovsky A, 2002, INT REV NEUROBIOL, V50, P145; Vincent AM, 2007, EXP NEUROL, V208, P216, DOI 10.1016/j.expneurol.2007.07.017; Vinik AI, 2000, DIABETOLOGIA, V43, P957, DOI 10.1007/s001250051477; Wang RH, 2011, CHINA MODERN MED, V18, P95; Wang T.D., 2010, CHINESE ARCH TRADION, V28, P1083; Wu MP, 2012, CHINESE J EXPT TRADI, V18, P154; YAGIHASHI S, 1982, HORM METAB RES, V14, P10, DOI 10.1055/s-2007-1018908; Yang XW, 2007, CHINESE J HYPERTENSI, V15, P206; Yue H, 2009, TALANTA, V77, P1800, DOI 10.1016/j.talanta.2008.10.022; Zhang FQ, 2009, CHINESE J SCH DOCTOR, V23, P518; Zhang HG, 2002, CHINESE CHEM LETT, V13, P758; Zhang Lin, 2011, Journal of Liaoning University of Traditional Chinese Medicine, V13, P129; Zhang M., 2000, 51 SHIZHEN MED MATER, V11, P193; Zhang Q, 2011, EUR J PHARMACOL, V654, P142, DOI 10.1016/j.ejphar.2010.12.011; Zhang YF, 2008, EXPERT OPIN INV DRUG, V17, P953, DOI 10.1517/13543784.17.6.953 ; Zhu BX, 2005, DICT DIS TCM	36	26	31	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2014	9	1							e86539	10.1371/journal.pone.0086539	http://dx.doi.org/10.1371/journal.pone.0086539			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297XI	24466139	gold, Green Published, Green Submitted			2022-12-25	WOS:000330288000109
J	Hua, LS; Wang, J; Li, MX; Sun, XM; Zhang, LZ; Lei, CZ; Lan, XY; Fang, XT; Zhao, X; Chen, H				Hua, Liushuai; Wang, Jing; Li, Mingxun; Sun, Xiaomei; Zhang, Liangzhi; Lei, Chuzhao; Lan, Xianyong; Fang, Xingtang; Zhao, Xin; Chen, Hong			An Asp7Gly Substitution in PPARG Is Associated with Decreased Transcriptional Activation Activity	PLOS ONE			English	Article							PRO12ALA POLYMORPHISM; GENE POLYMORPHISMS; GAMMA; ADIPOCYTE; ADIPOGENESIS; PPAR-GAMMA-2; EXPRESSION; REGULATORS; CATTLE	As the master regulator of adipogenesis, peroxisome proliferator-activated receptor gamma (PPARG) is required for the accumulation of adipose tissue and hence contributes to obesity. A previous study showed that the substitution of +20A>G in PPARG changed the 7th amino acid from Asp to Gly, creating a mutant referred to as PPARG Asp7Gly. In this study, association analysis indicated that PPARG Asp7Gly was associated with lower body height, body weight and heart girth in cattle (P<0.05). Overexpression of PPARG in NIH3T3-L1 cells showed that the Asp7Gly substitution may cause a decrease in its adipogenic ability and the mRNA levels of CIDEC (cell death-inducing DFFA-like effector c) and aP2, which are all transcriptionally activated by PPARG during adipocyte differentiation. A dual-luciferase reporter assay was used to analyze the promoter activity of CIDEC. The results confirmed that the mutant PPARG exhibited weaker transcriptional activation activity than the wild type (P<0.05). These findings likely explain the associations between the Asp7Gly substitution and the body measurements. Additionally, the Asp7Gly mutation may be used in molecular marker assisted selection (MAS) of cattle breeding in the future.	[Hua, Liushuai; Wang, Jing; Li, Mingxun; Sun, Xiaomei; Zhang, Liangzhi; Lei, Chuzhao; Lan, Xianyong; Zhao, Xin; Chen, Hong] Northwest A&F Univ, Coll Anim Sci & Technol, Shaanxi Key Lab Mol Biol Agr, Yangling, Shaanxi, Peoples R China; [Hua, Liushuai; Wang, Jing] South China Inst Endangered Anim, Guangdong Entomol Inst, Guangdong Prov Publ Lab Wild Anim Conservat & Man, Guangzhou, Guangdong, Peoples R China; [Fang, Xingtang] Jiangsu Normal Univ, Inst Cellular & Mol Biol, Xuzhou, Jiangsu, Peoples R China	Northwest A&F University - China; Guangdong Academy of Sciences; Institute of Zoology, Guangdong Academy of Sciences; Jiangsu Normal University	Chen, H (corresponding author), Northwest A&F Univ, Coll Anim Sci & Technol, Shaanxi Key Lab Mol Biol Agr, Yangling, Shaanxi, Peoples R China.	chenhong1212@263.net	Zhao, Xin/M-4312-2015; Li, Mingxun/Y-7161-2019; WANG, JINGYI/GSJ-1241-2022	Zhao, Xin/0000-0002-1078-7332; 	National Natural Science Foundation of China [31272408]; National 863 Program of China [2013AA102505]; Program of National Beef Cattle and Yak Industrial Technology System [CARS-38]; College Industrialization Project of Jiangsu Province [JHB2012-32]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National 863 Program of China(National High Technology Research and Development Program of China); Program of National Beef Cattle and Yak Industrial Technology System; College Industrialization Project of Jiangsu Province	This study was supported by the National Natural Science Foundation of China (Grant No. 31272408), URL: http://www.nsfc.gov.cn/; National 863 Program of China (Grant No. 2013AA102505), URL: http://www.863.gov.cn/; Program of National Beef Cattle and Yak Industrial Technology System (Grant No. CARS-38), URL: http://www.beefsys.com/; College Industrialization Project of Jiangsu Province (JHB2012-32), URL: http://www.ec.js.edu.cn/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Auwerx J, 1999, DIABETOLOGIA, V42, P1033, DOI 10.1007/s001250051268; Deeb SS, 1998, NAT GENET, V20, P284, DOI 10.1038/3099; Doney A, 2002, BMC GENET, V3, DOI 10.1186/1471-2156-3-21; Hara K, 2000, BIOCHEM BIOPH RES CO, V271, P212, DOI 10.1006/bbrc.2000.2605; He K, 2013, MAMM GENOME, V24, P322, DOI 10.1007/s00335-013-9460-4; Hua LS, 2011, AFR J BIOTECHNOL, V10, P2785; Hummasti S, 2006, MOL ENDOCRINOL, V20, P1261, DOI 10.1210/me.2006-0025; Kim YJ, 2008, BIOCHEM BIOPH RES CO, V377, P297, DOI 10.1016/j.bbrc.2008.09.129; Lehrke M, 2005, CELL, V123, P993, DOI 10.1016/j.cell.2005.11.026; Matsumoto T, 2008, J CELL PHYSIOL, V215, P210, DOI 10.1002/jcp.21304; Matsusue K, 2008, CELL METAB, V7, P302, DOI 10.1016/j.cmet.2008.03.003; Ogorevc J, 2009, ANIM GENET, V40, P832, DOI 10.1111/j.1365-2052.2009.01921.x; Okamura M, 2009, P NATL ACAD SCI USA, V106, P5819, DOI 10.1073/pnas.0901676106; Rathod MA, 2009, OBESITY, V17, P657, DOI 10.1038/oby.2008.630; Rosen ED, 2006, NATURE, V444, P847, DOI 10.1038/nature05483; Schoonjans K, 1996, EMBO J, V15, P5336, DOI 10.1002/j.1460-2075.1996.tb00918.x; Sherman EL, 2010, J ANIM SCI, V88, P16, DOI 10.2527/jas.2008-1759; Stumvoll M, 2002, DIABETES, V51, P2341, DOI 10.2337/diabetes.51.8.2341; TONTONOZ P, 1994, GENE DEV, V8, P1224, DOI 10.1101/gad.8.10.1224; Wang YX, 2010, CELL RES, V20, P124, DOI 10.1038/cr.2010.13; Yagi K, 2004, BIOCHEM BIOPH RES CO, V321, P967, DOI 10.1016/j.bbrc.2004.07.055	21	0	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2014	9	1							e86954	10.1371/journal.pone.0086954	http://dx.doi.org/10.1371/journal.pone.0086954			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297XI	24466299	gold, Green Published, Green Submitted			2022-12-25	WOS:000330288000175
J	Schulze, H; Deutscher, A; Tziridis, K; Scheich, H				Schulze, Holger; Deutscher, Anke; Tziridis, Konstantin; Scheich, Henning			Unilateral Auditory Cortex Lesions Impair or Improve Discrimination Learning of Amplitude Modulated Sounds, Depending on Lesion Side	PLOS ONE			English	Article							GERBIL MERIONES-UNGUICULATUS; MONGOLIAN GERBIL; FUNCTIONAL-ORGANIZATION; SUPERIOR COLLICULUS; TONES; PERCEPTION; LATERALIZATION; REPRESENTATION; INTERFERENCE; PERIODICITY	A fundamental principle of brain organization is bilateral symmetry of structures and functions. For spatial sensory and motor information processing, this organization is generally plausible subserving orientation and coordination of a bilaterally symmetric body. However, breaking of the symmetry principle is often seen for functions that depend on convergent information processing and lateralized output control, e. g. left hemispheric dominance for the linguistic speech system. Conversely, a subtle splitting of functions into hemispheres may occur if peripheral information from symmetric sense organs is partly redundant, e. g. auditory pattern recognition, and therefore allows central conceptualizations of complex stimuli from different feature viewpoints, as demonstrated e. g. for hemispheric analysis of frequency modulations in auditory cortex (AC) of mammals including humans. Here we demonstrate that discrimination learning of rapidly but not of slowly amplitude modulated tones is non-uniformly distributed across both hemispheres: While unilateral ablation of left AC in gerbils leads to impairment of normal discrimination learning of rapid amplitude modulations, right side ablations lead to improvement over normal learning. These results point to a rivalry interaction between both ACs in the intact brain where the right side competes with and weakens learning capability maximally attainable by the dominant left side alone.	[Schulze, Holger; Tziridis, Konstantin] Univ Erlangen Nurnberg, D-91054 Erlangen, Germany; [Schulze, Holger; Deutscher, Anke; Scheich, Henning] Leibniz Inst Neurobiol, Magdeburg, Germany	University of Erlangen Nuremberg; Leibniz Institut fur Neurobiologie (LIN)	Schulze, H (corresponding author), Univ Erlangen Nurnberg, D-91054 Erlangen, Germany.	Holger.Schulze@uk-erlangen.de			Deutsche Forschungsgemeinschaft (DFG) [SCHU 1272/2-1, SCHU 1272/2-2];  [SFB TR 31]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); 	This work was supported by SFB TR 31 and by grant SCHU 1272/2-1,2 of the Deutsche Forschungsgemeinschaft (DFG) to Holger Schulze. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Belin P, 1998, J COGNITIVE NEUROSCI, V10, P536, DOI 10.1162/089892998562834; Boatman D, 2004, COGNITION, V92, P47, DOI 10.1016/j.cognition.2003.09.010; Brechmann A, 2005, CEREB CORTEX, V15, P578, DOI 10.1093/cercor/bhh159; Brechmann A, 2007, CEREB CORTEX, V17, P2544, DOI 10.1093/cercor/bhl160; Budinger E, 2006, NEUROSCIENCE, V143, P1065, DOI 10.1016/j.neuroscience.2006.08.035; Budinger E, 2009, HEARING RES, V258, P16, DOI 10.1016/j.heares.2009.04.021; Deutscher A, 2006, J NEUROSCI METH, V156, P136, DOI 10.1016/j.jneumeth.2006.02.009; Deutscher A, 2006, NEUROREPORT, V17, P853, DOI 10.1097/01.wnr.0000221837.20255.62; EHRET G, 1987, NATURE, V325, P249, DOI 10.1038/325249a0; Galuske RAW, 2000, SCIENCE, V289, P1946, DOI 10.1126/science.289.5486.1946; Hutsler J, 2003, TRENDS NEUROSCI, V26, P429, DOI 10.1016/S0166-2236(03)00198-X; Kohlmetz C, 2003, NEUROCASE, V9, P86, DOI 10.1076/neur.9.1.86.14372; Kurt S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001735; Lomber SG, 2007, J NEUROPHYSIOL, V97, P979, DOI 10.1152/jn.00767.2006; Ohl FW, 2005, CURR OPIN NEUROBIOL, V15, P470, DOI 10.1016/j.conb.2005.07.002; Ohl FW, 1999, LEARN MEMORY, V6, P347; Penhune VB, 1996, CEREB CORTEX, V6, P661, DOI 10.1093/cercor/6.5.661; PETERSEN MR, 1978, SCIENCE, V202, P324, DOI 10.1126/science.99817; Pujol J, 2001, NEUROIMAGE, V13, P68, DOI 10.1006/nimg.2000.0662; Rybalko N, 2006, EUR J NEUROSCI, V23, P1614, DOI 10.1111/j.1460-9568.2006.04688.x; Samson S, 2003, ANN NY ACAD SCI, V999, P144, DOI 10.1196/annals.1284.016; SCHEICH H, 1993, EUR J NEUROSCI, V5, P898, DOI 10.1111/j.1460-9568.1993.tb00941.x; Scheich H, 2007, HEARING RES, V229, P213, DOI 10.1016/j.heares.2007.01.025; Schneider P, 2005, NAT NEUROSCI, V8, P1241, DOI 10.1038/nn1530; Schulze H, 2002, EUR J NEUROSCI, V15, P1077, DOI 10.1046/j.1460-9568.2002.01935.x; Schulze H, 1997, J COMP PHYSIOL A, V181, P651, DOI 10.1007/s003590050147; Schulze H, 1999, NEUROSCI LETT, V261, P13, DOI 10.1016/S0304-3940(98)00991-4; SPRAGUE JM, 1966, SCIENCE, V153, P1544, DOI 10.1126/science.153.3743.1544; Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651; THOMAS H, 1993, EUR J NEUROSCI, V5, P882, DOI 10.1111/j.1460-9568.1993.tb00940.x; Walker KMM, 2011, HEARING RES, V271, P74, DOI 10.1016/j.heares.2010.04.015; Weddell RA, 2004, BRAIN COGNITION, V55, P497, DOI 10.1016/j.bandc.2004.02.075; Wetzel W, 1998, NEUROSCI LETT, V252, P115, DOI 10.1016/S0304-3940(98)00561-8; Wetzel W, 2008, P NATL ACAD SCI USA, V105, P6753, DOI 10.1073/pnas.0707844105; Zatorre RJ, 2001, CEREB CORTEX, V11, P946, DOI 10.1093/cercor/11.10.946	35	14	15	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2014	9	1							e87159	10.1371/journal.pone.0087159	http://dx.doi.org/10.1371/journal.pone.0087159			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297XI	24466338	Green Published, gold			2022-12-25	WOS:000330288000196
J	Jordakieva, G; Wallmann, J; Schmutz, R; Lemell, P; Wegmann, M; Nittke, T; Mittlbock, M; Fehrenbach, H; Godnic-Cvar, J; Zieglmayer, R; Jensen-Jarolim, E				Jordakieva, Galateja; Wallmann, Julia; Schmutz, Rene; Lemell, Patrick; Wegmann, Michael; Nittke, Thomas; Mittlboeck, Martina; Fehrenbach, Heinz; Godnic-Cvar, Jasminka; Zieglmayer, Rene; Jensen-Jarolim, Erika			Peripheral Erythrocytes Decrease upon Specific Respiratory Challenge with Grass Pollen Allergen in Sensitized Mice and in Human Subjects	PLOS ONE			English	Article							NASAL SECRETIONS; MOUSE MODEL; ASTHMA; RHINITIS; INFLAMMATION; NEUTROPHILS; ELASTASE; DISEASE; AIRWAYS; IMPACT	Background and Aims: Specific hyper-responsiveness towards an allergen and non-specific airway hyperreactivity both impair quality of life in patients with respiratory allergic diseases. We aimed to investigate cellular responses following specific and non-specific airway challenges locally and systemically in i) sensitized BALB/c mice challenged with grass pollen allergen Phl p 5, and in ii) grass pollen sensitized allergic rhinitis subjects undergoing specific airway challenge in the Vienna Challenge Chamber (VCC). Methods and Results: BALB/c mice (n = 20) were intraperitoneally immunized with grass pollen allergen Phl p 5 and afterwards aerosol challenged with either the specific allergen Phl p 5 (n = 10) or the non-specific antigen ovalbumin (OVA) (n = 10). A protocol for inducing allergic asthma as well as allergic rhinitis, according to the united airway concept, was used. Both groups of exposed mice showed significantly reduced physical activity after airway challenge. Specific airway challenge further resulted in goblet cell hyperplasia, enhanced mucous secretion, intrapulmonary leukocyte infiltration and lymphoid follicle formation, associated with significant expression of IL-4, IL-5 and IL-13 in splenocytes and also partially in lung tissue. Concerning circulating blood cell dynamics, we observed a significant drop of erythrocyte counts, hemoglobin and hematocrit levels in both mouse groups, challenged with allergen or OVA. A significant decrease in circulating erythrocytes and hematocrit levels after airway challenges with grass pollen allergen was also found in grass pollen sensitized human rhinitis subjects (n = 42) at the VCC. The effects on peripheral leukocyte counts in mice and humans however were opposed, possibly due to the different primary inflammation sites. Conclusion: Our data revealed that, besides significant leukocyte dynamics, particularly erythrocytes are involved in acute hypersensitivity reactions to respiratory allergens. A rapid recruitment of erythrocytes to the lungs to compensate for hypoxia is a possible explanation for these findings.	[Jordakieva, Galateja; Wallmann, Julia; Nittke, Thomas; Jensen-Jarolim, Erika] Med Univ Vienna, Univ Vet Med Vienna, Messerli Res Inst, Vienna, Austria; [Jordakieva, Galateja; Wallmann, Julia; Nittke, Thomas; Jensen-Jarolim, Erika] Univ Vienna, Univ Vet Med Vienna, Messerli Res Inst, Vienna, Austria; [Jordakieva, Galateja; Wallmann, Julia; Godnic-Cvar, Jasminka] Med Univ Vienna, Dept Internal Med 2, Inst Occupat Med, Vienna, Austria; [Schmutz, Rene; Lemell, Patrick; Zieglmayer, Rene] Vienna Challenge Chamber VCC, Vienna, Austria; [Wegmann, Michael; Fehrenbach, Heinz] German Ctr Lung Res, Airway Res Ctr North, Leibniz Ctr Med & Biosciences, Res Ctr Borstel, Borstel, Germany; [Mittlboeck, Martina] Med Univ Vienna, Ctr Med Stat Informat & Intelligent Syst, Sect Clin Biometr, Vienna, Austria; [Jensen-Jarolim, Erika] Med Univ Vienna, Ctr Pathophysiol Infectiol & Immunol, Inst Pathophysiol & Allergy Res, Vienna, Austria	Medical University of Vienna; University of Veterinary Medicine Vienna; University of Veterinary Medicine Vienna; University of Vienna; Medical University of Vienna; Forschungszentrum Borstel; Medical University of Vienna; Medical University of Vienna	Jensen-Jarolim, E (corresponding author), Med Univ Vienna, Univ Vet Med Vienna, Messerli Res Inst, Vienna, Austria.	erika.jensen-jarolim@meduniwien.ac.at	Jensen-Jarolim, Erika/C-5120-2018; Jordakieva, Galateja/ABG-1404-2021; Fehrenbach, Heinz/A-9161-2008; Jordakieva, Galateja/AAM-4187-2020	Jensen-Jarolim, Erika/0000-0003-4019-5765; Jordakieva, Galateja/0000-0001-5884-8256; Fehrenbach, Heinz/0000-0003-1935-9411; Wegmann, Michael/0000-0002-1658-1554; Lemell, Patrick/0000-0003-0262-4047; Schmutz, Rene/0000-0003-2019-3906; Mittlboeck, Martina/0000-0003-1097-4047	Austrian Science Fund [F4606-B19]; German Research Foundation (Cluster of Excellence) [EXC306]; Vienna Science and Technology Fund [LS07-058]	Austrian Science Fund(Austrian Science Fund (FWF)); German Research Foundation (Cluster of Excellence); Vienna Science and Technology Fund	This work was supported by an SFB project F4606-B19 of the Austrian Science Fund and partially by the German Research Foundation (Cluster of Excellence EXC306). Further support was contributed by the Vienna Science and Technology Fund (project LS07-058). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bazaraa HM, 2012, PEDIATR EMERG CARE, V28, P148, DOI 10.1097/PEC.0b013e3182442eeb; Bousquet J, 2008, ALLERGY, V63, P8, DOI 10.1111/j.1398-9995.2007.01620.x; Bousquet J, 2012, J ALLERGY CLIN IMMUN, V130, P1049, DOI 10.1016/j.jaci.2012.07.053; Bousquet J, 2000, AM J RESP CRIT CARE, V161, P1720, DOI 10.1164/ajrccm.161.5.9903102; Canonica GW, 2007, ALLERGY, V62, P17, DOI 10.1111/j.1398-9995.2007.01549.x; Compalati E, 2010, EXPERT REV CLIN IMMU, V6, P413, DOI [10.1586/ECI.10.15, 10.1586/eci.10.15]; Corry DB, 1996, J EXP MED, V183, P109, DOI 10.1084/jem.183.1.109; Epstein MM, 2006, EXP TOXICOL PATHOL, V57, P41, DOI 10.1016/j.etp.2006.02.005; Erin EM, 2005, CLIN EXP ALLERGY, V35, P1608, DOI 10.1111/j.1365-2222.2005.02381.x; Everhart RS, 2010, RESP CARE, V55, P427; FORKERT PG, 1995, AM J RESP CELL MOL, V12, P589, DOI 10.1165/ajrcmb.12.6.7766423; Fransson M, 2004, ACTA OTO-LARYNGOL, V124, P616, DOI 10.1080/00016480310015173; Galli SJ, 2008, NATURE, V454, P445, DOI 10.1038/nature07204; Global Strategy for Asthma Management and Prevention, 2006, GLOB STRAT ASTHM MAN; GOPALAN AV, 1983, J ASTHMA, V20, P53, DOI 10.3109/02770908309070914; HORAK F, 1992, J INT MED RES, V20, P422, DOI 10.1177/030006059202000507; Horak F, 2009, J ALLERGY CLIN IMMUN, V124, P471, DOI 10.1016/j.jaci.2009.06.006; Kiefmann R, 2008, BLOOD, V111, P5205, DOI 10.1182/blood-2007-09-113902; Krishnamurthy D, 2012, CLIN EXP ALLERGY, V42, P1119, DOI 10.1111/j.1365-2222.2012.04012.x; McCusker CT, 2004, CURR OPIN ALLERGY CL, V4, P11, DOI 10.1097/01.all.0000113683.18759.cc; Mitchell J, 2010, CURR OPIN INVEST DR, V11, P527; Mojtabavi N, 2002, J IMMUNOL, V169, P4788, DOI 10.4049/jimmunol.169.9.4788; Monteseirin J, 2009, J INVEST ALLERG CLIN, V19, P340; Nadel JA, 1999, EUR RESPIR J, V13, P190, DOI 10.1034/j.1399-3003.1999.13a35.x; Pali-Scholl I, 2008, EXP TOXICOL PATHOL, V60, P337, DOI 10.1016/j.etp.2008.03.004; Park YJ, 2002, ALLERGY, V57, P329, DOI 10.1034/j.1398-9995.2002.1o3253.x; Pawankar Ruby, 2012, World Allergy Organ J, V5, pS212, DOI 10.1097/WOX.0b013e318201d831; Pelikan Z, 2012, INT J CLIN MED, V3, P485; Pelikan Z, 2011, RESPIRATION, V82, P225, DOI 10.1159/000324542; PRZYBILLA B, 1991, ACTA DERM-VENEREOL, V71, P407; Scano G, 2006, CURR OPIN PULM MED, V12, P18, DOI 10.1097/01.mcp.0000199003.46038.82; Takeyama K, 1998, AM J PHYSIOL-LUNG C, V275, pL294, DOI 10.1152/ajplung.1998.275.2.L294; Togias Alkis, 2004, Journal of Allergy and Clinical Immunology, V113, pS8, DOI 10.1016/j.jaci.2003.09.051; Waldegrave W, 1986, J OFFICIEL COMMUNAUT, P1; Wallmann J, 2010, CLIN EXP ALLERGY, V40, P650, DOI 10.1111/j.1365-2222.2009.03392.x; Wegmann M, 2005, CLIN EXP ALLERGY, V35, P1263, DOI 10.1111/j.1365-2222.2005.02306.x; Westin U, 1999, ALLERGY, V54, P857, DOI 10.1034/j.1398-9995.1999.00938.x; Yukselen A, 2012, ALLERGOL IMMUNOPATHO; Zieglmayer PU, 2013, CURR OPIN ALLERGY CL	39	10	10	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2014	9	1							e86701	10.1371/journal.pone.0086701	http://dx.doi.org/10.1371/journal.pone.0086701			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297VL	24466205	Green Published, Green Submitted, gold			2022-12-25	WOS:000330283100199
J	Valentova, JV; Stulp, G; Trebicky, V; Havlicek, J				Valentova, Jaroslava Varella; Stulp, Gert; Trebicky, Vit; Havlicek, Jan			Preferred and Actual Relative Height among Homosexual Male Partners Vary with Preferred Dominance and Sex Role	PLOS ONE			English	Article							INTERCOURSE PREFERENCE POSITIONS; ADULT BODY-HEIGHT; MATE PREFERENCES; GAY MEN; VARIABLE PREFERENCES; REPRODUCTIVE SUCCESS; AMAZONIAN SOCIETY; HETEROSEXUAL MEN; PHYSICAL HEIGHT; SHORT STATURE	Previous research has shown repeatedly that human stature influences mate preferences and mate choice in heterosexuals. In general, it has been shown that tall men and average height women are most preferred by the opposite sex, and that both sexes prefer to be in a relationship where the man is taller than the woman. However, little is known about such partner preferences in homosexual individuals. Based on an online survey of a large sample of non-heterosexual men (N = 541), we found that the majority of men prefer a partner slightly taller than themselves. However, these preferences were dependent on the participant's own height, such that taller men preferred shorter partners, whereas shorter men preferred taller partners. We also examined whether height preferences predicted the preference for dominance and the adoption of particular sexual roles within a couple. Although a large proportion of men preferred to be in an egalitarian relationship with respect to preferred dominance (although not with respect to preferred sexual role), men that preferred a more dominant and more "active'' sexual role preferred shorter partners, whereas those that preferred a more submissive and more "passive'' sexual role preferred taller partners. Our results indicate that preferences for relative height in homosexual men are modulated by own height, preferred dominance and sex role, and do not simply resemble those of heterosexual women or men.	[Valentova, Jaroslava Varella] Charles Univ Prague, Ctr Theoret Study, Prague, Czech Republic; [Valentova, Jaroslava Varella] Acad Sci Czech Republ, Ctr Theoret Study, Prague, Czech Republic; [Stulp, Gert] Univ Groningen, Dept Sociol, Groningen, Netherlands; [Trebicky, Vit] Charles Univ Prague, Dept Hist & Philosophy Sci, Fac Sci, Prague, Czech Republic; [Havlicek, Jan] Charles Univ Prague, Dept Zool, Fac Sci, Prague, Czech Republic	Charles University Prague; Czech Academy of Sciences; University of Groningen; Charles University Prague; Charles University Prague	Valentova, JV (corresponding author), Charles Univ Prague, Ctr Theoret Study, Prague, Czech Republic.	valentova@cts.cuni.cz	Havlíček, Jan/F-8985-2011; Valentova, Jaroslava Varella/K-8765-2012; Trebicky, Vit/P-3115-2016	Havlíček, Jan/0000-0003-2374-7337; Valentova, Jaroslava Varella/0000-0002-2113-3385; Trebicky, Vit/0000-0003-1440-1772; Stulp, Gert/0000-0003-0173-5554	Czech Science Foundation [GACR 13-16959P, GACR P407/11/1464]; Charles University Research Center [UNCE 204004]; Charles University Student Grant [GAUK 695512]	Czech Science Foundation(Grant Agency of the Czech Republic); Charles University Research Center; Charles University Student Grant	Czech Science Foundation supported JV (GACR 13-16959P) and JH (GACR P407/11/1464). JV and JH were further supported by Charles University Research Center (UNCE 204004), and VT was supported by the Charles University Student Grant (GAUK 695512). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLEBECK P, 1992, PUBLIC HEALTH, V106, P375, DOI 10.1016/S0033-3506(05)80186-6; Archer J, 2007, PERS INDIV DIFFER, V43, P627, DOI 10.1016/j.paid.2007.01.005; BAILEY JM, 1994, J PERS SOC PSYCHOL, V66, P1081, DOI 10.1037/0022-3514.66.6.1081; Bailey JM, 1997, J PERS SOC PSYCHOL, V73, P960, DOI 10.1037/0022-3514.73.5.960; Barber N, 1995, ETHOL SOCIOBIOL, V16, P395, DOI 10.1016/0162-3095(95)00068-2; Becker NSA, 2012, EVOL HUM BEHAV, V33, P615, DOI 10.1016/j.evolhumbehav.2012.03.001; BUSS DM, 1989, BEHAV BRAIN SCI, V12, P1, DOI 10.1017/S0140525X00023992; Buunk AP, 2008, EVOL HUM BEHAV, V29, P133, DOI 10.1016/j.evolhumbehav.2007.11.006; Carballo-Dieguez A, 2004, CULT HEALTH SEX, V6, P159, DOI 10.1080/13691050310001619662; Carrier DR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019630; Carson R.C., 1969, INTERACTION CONCEPTS; Courtiol A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013010; Courtiol A, 2010, EVOLUTION, V64, P2189, DOI 10.1111/j.1558-5646.2010.00985.x; FEINGOLD A, 1992, PSYCHOL BULL, V112, P125, DOI 10.1037/0033-2909.112.1.125; Fink B, 2007, PERS INDIV DIFFER, V43, P2249, DOI 10.1016/j.paid.2007.07.014; Fournier MA, 2002, J PERS SOC PSYCHOL, V83, P425, DOI 10.1037//0022-3514.83.2.425; Glassenberg AN, 2010, ARCH SEX BEHAV, V39, P1289, DOI 10.1007/s10508-009-9559-6; Godoy R, 2008, EVOL HUM BEHAV, V29, P201, DOI 10.1016/j.evolhumbehav.2007.12.003; GRAY JP, 1980, AM J PHYS ANTHROPOL, V53, P441, DOI 10.1002/ajpa.1330530314; Ha T, 2012, ARCH SEX BEHAV, V41, P673, DOI 10.1007/s10508-011-9855-9; Hayes AF, 2001, J SOC PSYCHOL, V135, P125; HENSLEY WE, 1993, PSYCHOLOGY, V30, P40; HOWARD JA, 1987, J PERS SOC PSYCHOL, V53, P194, DOI 10.1037/0022-3514.53.1.194; Jirkovsky D, 2003, VOJENSK ZDR LISTY, V72, P217; Judge TA, 2004, J APPL PSYCHOL, V89, P428, DOI 10.1037/0021-9010.89.3.428; Kee F, 1997, INT J EPIDEMIOL, V26, P748, DOI 10.1093/ije/26.4.748; Kurzban R, 2005, EVOL HUM BEHAV, V26, P227, DOI 10.1016/j.evolhumbehav.2004.08.012; Leary T., 1957, INTERPERSONAL DIAGNO; Lippa RA, 2007, ARCH SEX BEHAV, V36, P193, DOI 10.1007/s10508-006-9151-2; Little AC, 2002, P ROY SOC B-BIOL SCI, V269, P1095, DOI 10.1098/rspb.2002.1984; MELAMED T, 1992, PERS INDIV DIFFER, V13, P1349, DOI 10.1016/0191-8869(92)90179-S; Michaud DS, 2001, JAMA-J AM MED ASSOC, V286, P921, DOI 10.1001/jama.286.8.921; Nettle D, 2002, HUM NATURE-INT BIOS, V13, P473, DOI 10.1007/s12110-002-1004-7; Pawlowski B, 2000, NATURE, V403, P156, DOI 10.1038/35003107; Pawlowski B, 2003, P ROY SOC B-BIOL SCI, V270, P709, DOI 10.1098/rspb.2002.2294; PECK AMN, 1989, J EPIDEMIOL COMMUN H, V43, P380, DOI 10.1136/jech.43.4.380; Pierce CA, 1996, SOC BEHAV PERSONAL, V24, P143, DOI 10.2224/sbp.1996.24.2.143; Puts DA, 2005, EVOL HUM BEHAV, V26, P388, DOI 10.1016/j.evolhumbehav.2005.03.001; Puts DA, 2010, EVOL HUM BEHAV, V31, P157, DOI 10.1016/j.evolhumbehav.2010.02.005; Rahman Q, 2005, PERS INDIV DIFFER, V39, P83, DOI 10.1016/j.paid.2004.12.007; Roloff M. E., 2008, SEX RELATSH THER, V23, P191, DOI DOI 10.1080/14681990802027259; Salska I, 2008, PERS INDIV DIFFER, V44, P203, DOI 10.1016/j.paid.2007.08.008; Sear R, 2010, FRONT COLLECT, P127, DOI 10.1007/978-3-642-12142-5_10; Silventoinen K, 2003, AM J HUM BIOL, V15, P620, DOI 10.1002/ajhb.10183; Silventoinen K, 1999, INT J EPIDEMIOL, V28, P911, DOI 10.1093/ije/28.5.911; Silverthorne ZA, 2000, ARCH SEX BEHAV, V29, P67, DOI 10.1023/A:1001886521449; Sorokowski P, 2012, BODY IMAGE, V9, P510, DOI 10.1016/j.bodyim.2012.07.002; Sorokowski P, 2012, J CROSS CULT PSYCHOL, V43, P32, DOI 10.1177/0022022110395140; Spencer EA, 2002, PUBLIC HEALTH NUTR, V5, P561, DOI 10.1079/PHN2001322; Sterbova Z, 2012, ANTHROPOL-INT J HUM, V50, P47; Stulp G, 2013, ANIM BEHAV, V86, P37, DOI 10.1016/j.anbehav.2013.03.038; Stulp G, 2013, PERS INDIV DIFFER, V54, P877, DOI 10.1016/j.paid.2012.12.019; Stulp G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054186; Stulp G, 2012, BEHAV ECOL SOCIOBIOL, V66, P375, DOI 10.1007/s00265-011-1283-2; Swami V, 2008, PERS INDIV DIFFER, V45, P395, DOI 10.1016/j.paid.2008.05.012; Todd PM, 2007, P NATL ACAD SCI USA, V104, P15011, DOI 10.1073/pnas.0705290104; Valentova J, 2013, PERCEPTION, V42, P187, DOI 10.1068/p6909; VanderLaan DP, 2008, ARCH SEX BEHAV, V37, P572, DOI 10.1007/s10508-006-9139-y; Vaz M, 2002, ANN HUM BIOL, V29, P131, DOI 10.1080/03014460110058962; Verhulst NO, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0020497, 10.1371/journal.pone.0028991]; von Rueden C, 2008, EVOL HUM BEHAV, V29, P402, DOI 10.1016/j.evolhumbehav.2008.05.001; WAALER HT, 1984, ACTA MED SCAND, P1; Welling LLM, 2013, ARCH SEX BEHAV, V42, P785, DOI 10.1007/s10508-012-0059-8; Zheng LJ, 2013, ARCH SEX BEHAV, V42, P1223, DOI 10.1007/s10508-012-0057-x; Zheng LJ, 2012, ARCH SEX BEHAV, V41, P683, DOI 10.1007/s10508-011-9819-0	65	24	24	1	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2014	9	1							e86534	10.1371/journal.pone.0086534	http://dx.doi.org/10.1371/journal.pone.0086534			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	297VL	24466136	Green Published, gold, Green Submitted			2022-12-25	WOS:000330283100179
J	Zhang, Y; Peng, YQ; Compton, SG; Yang, DR				Zhang, Yuan; Peng, Yan-Qiong; Compton, Stephen G.; Yang, Da-Rong			Premature Attraction of Pollinators to Inaccessible Figs of Ficus altissima: A Search for Ecological and Evolutionary Consequences	PLOS ONE			English	Article							STRESS RESISTANCE; BODY-SIZE; WASPS; LONGEVITY; LIFE; COEVOLUTION; STABILITY; FEMALE; POPULATION; RESPONSES	Adult life spans of only one or two days characterise life cycles of the fig wasps (Agaonidae) that pollinate fig trees (Ficus spp., Moraceae). Selection is expected to favour traits that maximise the value of the timing of encounters between such mutualistic partners, and fig wasps are usually only attracted to their hosts by species-and developmental-stage specific volatiles released from figs at the time when they are ready to be entered, oviposited in and pollinated. We found that Ficus altissima is exceptional, because it has persistent tight-fitting bud covers that prevent its Eupristina altissima pollinator (and a second species of 'cheater' agaonid) from entering its figs for several days after they start to be attracted. We examined the consequences of delayed entry for the figs and fig wasps and tested whether delayed entry has been selected to increase adult longevity. We found that older pollinators produced fewer and smaller offspring, but seed production was more efficient. Pollinator offspring ratios also varied depending on the age of figs they entered. The two agaonids from F. altissima lived slightly longer than six congeners associated with typical figs, but this was explainable by their larger body sizes. Delayed entry generates reproductive costs, especially for the pollinator. This opens an interesting perspective on the coevolution of figs and their pollinators and on the nature of mutualistic interactions in general.	[Zhang, Yuan; Peng, Yan-Qiong; Yang, Da-Rong] Chinese Acad Sci, Key Lab Trop Forest Ecol, Xishuangbanna Trop Bot Garden, Kunming, Peoples R China; [Zhang, Yuan] Southwest Forestry Univ, Yunnan Acad Biodivers, Kunming, Peoples R China; [Compton, Stephen G.] Univ Leeds, Sch Biol, Leeds, W Yorkshire, England; [Compton, Stephen G.] Rhodes Univ, Dept Zool & Entomol, ZA-6140 Grahamstown, South Africa	Chinese Academy of Sciences; Xishuangbanna Tropical Botanical Garden, CAS; Southwest Forestry University - China; University of Leeds; Rhodes University	Peng, YQ (corresponding author), Chinese Acad Sci, Key Lab Trop Forest Ecol, Xishuangbanna Trop Bot Garden, Kunming, Peoples R China.	pengyq@xtbg.ac.cn; yangdr@xtbg.ac.cn		Compton, Stephen/0000-0002-1247-8058	Candidates of the Young and Middle Aged Academic Leaders of Yunnan Province [2011HB041]; Chinese Natural Science Foundation [31372253, 31120002]	Candidates of the Young and Middle Aged Academic Leaders of Yunnan Province; Chinese Natural Science Foundation(National Natural Science Foundation of China (NSFC))	This study was funded by Candidates of the Young and Middle Aged Academic Leaders of Yunnan Province (2011HB041), and the Chinese Natural Science Foundation (31372253, 31120002). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anstett MC, 2001, OIKOS, V95, P476, DOI 10.1034/j.1600-0706.2001.950313.x; Berg CC, 2005, FLORA MALESIANA, V17, P1, DOI DOI 10.1663/0007-196X(2006)58[; Berger D, 2012, J ANIM ECOL, V81, P1244, DOI 10.1111/j.1365-2656.2012.02010.x; Boggs CL, 2009, FUNCT ECOL, V23, P27, DOI 10.1111/j.1365-2435.2009.01527.x; Bubliy OA, 2005, J EVOLUTION BIOL, V18, P789, DOI 10.1111/j.1420-9101.2005.00928.x; Carey JR, 2001, EXP GERONTOL, V36, P713, DOI 10.1016/S0531-5565(00)00237-0; Chen C, 2009, FUNCT ECOL, V23, P941, DOI 10.1111/j.1365-2435.2009.01622.x; Compton S. G., 1993, African Entomology, V1, P151; Compton SG, 2009, AFR NAT HIST, V5, P9; CORNER E. J. H., 1965, GARD BULL [SINGAPORE], V21, P1; Dalgaard P, 2004, INTRO STAT R SURVIVA; Dunn DW, 2008, J ANIM ECOL, V77, P927, DOI 10.1111/j.1365-2656.2008.01416.x; GALIL J, 1968, NEW PHYTOL, V67, P745, DOI 10.1111/j.1469-8137.1968.tb05497.x; Gilbert F., 1990, INSECT LIFE CYCLES G; Grison-Pige L, 2002, J CHEM ECOL, V28, P283, DOI 10.1023/A:1017930023741; Gu D, 2012, SYMBIOSIS, V57, P73, DOI 10.1007/s13199-012-0178-y; HERRE EA, 1989, EXPERIENTIA, V45, P637, DOI 10.1007/BF01975680; Herre EA, 2008, ANNU REV ECOL EVOL S, V39, P439, DOI 10.1146/annurev.ecolsys.37.091305.110232; Herus MJ, 1999, GENETICS, V151, P1493; Hubbell SP, 1986, CONSERVATION BIOL SC, P205; JANZEN DH, 1979, ANNU REV ECOL SYST, V10, P13, DOI 10.1146/annurev.es.10.110179.000305; Jervis MA, 2001, J ANIM ECOL, V70, P442, DOI 10.1046/j.1365-2656.2001.00507.x; Jousselin E, 2001, ECOL ENTOMOL, V26, P602, DOI 10.1046/j.1365-2311.2001.00368.x; Jousselin E, 2001, OIKOS, V94, P287, DOI 10.1034/j.1600-0706.2001.940209.x; KHADARI B, 1995, AM J BOT, V82, P992, DOI 10.2307/2446228; KJELLBERG F, 1988, P K NED AKAD C BIOL, V91, P117; Liu C, 2011, ENTOMOL EXP APPL, V138, P249, DOI 10.1111/j.1570-7458.2011.01096.x; Mawdsley NA, 1998, CONSERV BIOL, V12, P1416, DOI 10.1046/j.1523-1739.1998.97243.x; Nefdt RJC, 1996, J ANIM ECOL, V65, P170, DOI 10.2307/5720; Nylin S, 1998, ANNU REV ENTOMOL, V43, P63, DOI 10.1146/annurev.ento.43.1.63; PARSONS PA, 1995, HEREDITY, V75, P216, DOI 10.1038/hdy.1995.126; PEFEROEN M, 1981, ENTOMOL EXP APPL, V29, P321, DOI 10.1007/BF00294072; Peng YQ, 2008, SYMBIOSIS, V45, P9; Peng YQ, 2010, PLANT ECOL, V209, P227, DOI 10.1007/s11258-009-9690-4; RAMIREZ W, 1970, Evolution, V24, P680; Shanahan M, 2001, BIOL REV, V76, P529, DOI 10.1017/S1464793101005760; Spencer KC, 1988, CHEM MEDIATION COEVO; Suleman N, 2011, ECOL ENTOMOL, V36, P417, DOI 10.1111/j.1365-2311.2011.01284.x; VANDENASSEM J, 1989, BEHAVIOUR, V108, P160, DOI 10.1163/156853989X00114; vanNoort S, 1996, J BIOGEOGR, V23, P415, DOI 10.1111/j.1365-2699.1996.tb00003.x; VANNOORT S, 1989, S AFR J SCI, V85, P323; VERKERKE W, 1989, EXPERIENTIA, V45, P612, DOI 10.1007/BF01975678; WARE AB, 1994, ENTOMOL EXP APPL, V73, P221, DOI 10.1007/BF02382473; WARE AB, 1994, J CHEM ECOL, V20, P785, DOI 10.1007/BF02059613; WIEBES JT, 1979, ANNU REV ECOL SYST, V10, P1, DOI 10.1146/annurev.es.10.110179.000245; Wilson E.O., 1971, INSECT SOC; Zhang Y, 2012, EVOL ECOL, V26, P513, DOI 10.1007/s10682-011-9525-3	47	41	50	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2014	9	1							e86735	10.1371/journal.pone.0086735	http://dx.doi.org/10.1371/journal.pone.0086735			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297VL	24466217	Green Submitted, Green Published, gold			2022-12-25	WOS:000330283100204
J	Caruso, VC; Balaban, E				Caruso, Valeria C.; Balaban, Evan			Pitch and Timbre Interfere When Both Are Parametrically Varied	PLOS ONE			English	Article							DIMENSIONS; FREQUENCY; STRENGTH; PERCEPTION; CONTEXT; SIZE; TONE	Pitch and timbre perception are both based on the frequency content of sound, but previous perceptual experiments have disagreed about whether these two dimensions are processed independently from each other. We tested the interaction of pitch and timbre variations using sequential comparisons of sound pairs. Listeners judged whether two sequential sounds were identical along the dimension of either pitch or timbre, while the perceptual distances along both dimensions were parametrically manipulated. Pitch and timbre variations perceptually interfered with each other and the degree of interference was modulated by the magnitude of changes along the un-attended dimension. These results show that pitch and timbre are not orthogonal to each other when both are assessed with parametrically controlled variations.	[Caruso, Valeria C.] SISSA, Cognit Neurosci Sect, I-34014 Trieste, Italy; [Balaban, Evan] McGill Univ, Behav Neurosci Program, Montreal, PQ, Canada; [Caruso, Valeria C.] Duke Univ, Ctr Cognit Neurosci, Durham, NC USA	International School for Advanced Studies (SISSA); McGill University; Duke University	Caruso, VC (corresponding author), SISSA, Cognit Neurosci Sect, I-34014 Trieste, Italy.	v.caruso@duke.edu	Balaban, Evan/AAV-2353-2020	Balaban, Evan/0000-0002-0391-3433	SISSA Cognitive Neuroscience Sector PHD program	SISSA Cognitive Neuroscience Sector PHD program	Research and publication support was provided by the SISSA Cognitive Neuroscience Sector PHD program (http://www.sissa.it/cns/) and Duke University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BEAL AL, 1985, MEM COGNITION, V13, P405, DOI 10.3758/BF03198453; Castellan NJ, 1988, NONPARAMETRIC STAT B; CONOVER WJ, 1982, BIOMETRICS, V38, P715, DOI 10.2307/2530051; Cox T.F., 2001, MULTIDIMENSIONAL SCA, V2nd; Handel S, 1995, HEARING, P425; KRUMHANSL CL, 1992, J EXP PSYCHOL HUMAN, V18, P739, DOI 10.1037/0096-1523.18.3.739; Macmillan N. A., 2005, DETECTION THEORY USE; Marozeau J, 2003, J ACOUST SOC AM, V114, P2946, DOI 10.1121/1.1618239; Marozeau J, 2007, J ACOUST SOC AM, V121, P383, DOI 10.1121/1.2384910; MELARA RD, 1990, PERCEPT PSYCHOPHYS, V48, P169, DOI 10.3758/BF03207084; MELARA RD, 1990, J EXP PSYCHOL HUMAN, V16, P398, DOI 10.1037/0096-1523.16.2.398; MELARA RD, 1990, PERCEPT PSYCHOPHYS, V47, P307, DOI 10.3758/BF03210870; MILLER JR, 1975, J ACOUST SOC AM, V58, P711, DOI 10.1121/1.380719; Patterson RD, 1996, J ACOUST SOC AM, V100, P3286, DOI 10.1121/1.417212; PITT MA, 1994, J EXP PSYCHOL HUMAN, V20, P976, DOI 10.1037/0096-1523.20.5.976; PLATT JR, 1985, PERCEPT PSYCHOPHYS, V38, P543, DOI 10.3758/BF03207064; Russo FA, 2005, PERCEPT PSYCHOPHYS, V67, P559, DOI 10.3758/BF03193514; SEMAL C, 1993, J ACOUST SOC AM, V94, P1315, DOI 10.1121/1.408159; SEMAL C, 1991, J ACOUST SOC AM, V89, P2404, DOI 10.1121/1.400928; Shofner WP, 2002, PERCEPT PSYCHOPHYS, V64, P437, DOI 10.3758/BF03194716; SINGH PG, 1992, J ACOUST SOC AM, V92, P2650, DOI 10.1121/1.404381; SINGH PG, 1987, J ACOUST SOC AM, V82, P886, DOI 10.1121/1.395287; Smith DRR, 2005, J ACOUST SOC AM, V118, P3177, DOI 10.1121/1.2047107; Sokal R. R, 1981, BIOMETRY; Soloudre GA, 2004, P 116 AES CONV BERL; Starr GE, 1997, J ACOUST SOC AM, V102, P486, DOI 10.1121/1.419722; Warrier CM, 2002, PERCEPT PSYCHOPHYS, V64, P198, DOI 10.3758/BF03195786; WIER CC, 1977, J ACOUST SOC AM, V61, P178, DOI 10.1121/1.381251; Yost WA, 1998, J ACOUST SOC AM, V104, P2349, DOI 10.1121/1.423746; Yost WA, 1996, J ACOUST SOC AM, V99, P1066, DOI 10.1121/1.414593	30	14	14	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2014	9	1							e87065	10.1371/journal.pone.0087065	http://dx.doi.org/10.1371/journal.pone.0087065			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297GT	24466328	Green Submitted, Green Published, gold			2022-12-25	WOS:000330244500291
J	Bersani, C; Xu, LD; Vilborg, A; Lui, WO; Wiman, KG				Bersani, C.; Xu, L-D; Vilborg, A.; Lui, W-O; Wiman, K. G.			Wig-1 regulates cell cycle arrest and cell death through the p53 targets FAS and 14-3-3 sigma	ONCOGENE			English	Article						Wig-1; p53; FAS; 14-3-3 sigma; AU-rich element; AU-rich element-binding proteins	MESSENGER-RNA DECAY; AU-RICH ELEMENTS; ZINC-FINGER PROTEIN; DNA-DAMAGE; P53-ACTIVATED GENE; CCR4-NOT COMPLEX; EXPRESSION; HUR; STABILITY; STRESS	Wig-1, also known as ZMAT3, is a p53 target gene that encodes an RNA-binding zinc-finger protein involved in the regulation of mRNA stability through binding to AU-rich elements (AREs). We have used microarray analysis to identify novel Wig-1 target mRNAs. We identified 2447 transcripts with >fourfold differential expression between Wig-1 and control small interfering (si) RNA-treated HCT116 cells. Several p53 target genes were among the deregulated transcripts. We found that Wig-1 regulates FAS and 14-3-3 sigma mRNA independently of p53. We show that Wig-1 binds to FAS mRNA 3'-UTR and decreases its stability through an ARE in the 3'-UTR. Depletion of Wig-1 was associated with increased cell death and reduced cell cycle arrest upon DNA damage. Our results suggest a role of Wig-1 as a survival factor that directs the p53 stress response toward cell cycle arrest rather than apoptosis through the regulation of FAS and 14-3-3 sigma mRNA levels.	[Bersani, C.; Xu, L-D; Vilborg, A.; Lui, W-O; Wiman, K. G.] Karolinska Inst, Dept Oncol Pathol, Canc Ctr Karolinska, SE-17176 Stockholm, Sweden	Karolinska Institutet	Wiman, KG (corresponding author), Karolinska Inst, Dept Oncol Pathol, Canc Ctr Karolinska, SE-17176 Stockholm, Sweden.	Klas.Wiman@ki.se	Lui, Weng-Onn/X-5957-2019; Bersani, Cinzia/M-7871-2014; Lui, Weng-Onn/G-6703-2013; Wiman, Klas/AAB-8399-2021	Lui, Weng-Onn/0000-0003-4717-4473; Bersani, Cinzia/0000-0001-7604-5211; Lui, Weng-Onn/0000-0003-4717-4473; Wiman, Klas/0000-0002-7113-524X; Vilborg, Anna/0000-0003-0917-9062	Swedish Cancer Society; Swedish Research Council (VR); Gustaf V Jubilee Fund; Karolinska Institutet Distinguished Professor award	Swedish Cancer Society(Swedish Cancer Society); Swedish Research Council (VR)(Swedish Research Council); Gustaf V Jubilee Fund; Karolinska Institutet Distinguished Professor award	We thank Stefano Caramuta for assistance with the microarray analysis and Dr Bert Vogelstein for HCT116 cells. This work was supported by grants from the Swedish Cancer Society, the Swedish Research Council (VR), the Gustaf V Jubilee Fund and a Karolinska Institutet Distinguished Professor award to KGW.	Al-Haj L, 2012, NUCLEIC ACIDS RES, V40, P7739, DOI 10.1093/nar/gks545; Anderson P, 2008, TRENDS BIOCHEM SCI, V33, P141, DOI 10.1016/j.tibs.2007.12.003; Atasoy U, 1998, J CELL SCI, V111, P3145; Ball CA, 2005, NUCLEIC ACIDS RES, V33, pD580; Barreau C, 2005, NUCLEIC ACIDS RES, V33, P7138, DOI 10.1093/nar/gki1012; Beisang D, 2012, WIRES RNA, V3, P719, DOI 10.1002/wrna.1125; Chang N, 2010, MOL CELL BIOL, V30, P3875, DOI 10.1128/MCB.00169-10; Chen XB, 1996, GENE DEV, V10, P2438, DOI 10.1101/gad.10.19.2438; Cho SJ, 2010, NUCLEIC ACIDS RES, V38, P2256, DOI 10.1093/nar/gkp1229; DI LEONARDO A, 1994, GENE DEV, V8, P2540, DOI 10.1101/gad.8.21.2540; Dolken L, 2008, RNA, V14, P1959, DOI 10.1261/rna.1136108; Doidge R, 2012, BIOCHEM SOC T, V40, P896, DOI 10.1042/BST20120074; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; Gareau C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020254; Gillardon F, 1999, MOL BRAIN RES, V73, P138, DOI 10.1016/S0169-328X(99)00251-X; Gouble A, 2002, CANCER RES, V62, P1489; Hellborg F, 2004, INT J ONCOL, V24, P1559; Hermeking H, 1997, MOL CELL, V1, P3, DOI 10.1016/S1097-2765(00)80002-7; Higashi Y, 2002, J BIOL CHEM, V277, P42224, DOI 10.1074/jbc.M203594200; Ishimaru D, 2010, J BIOL CHEM, V285, P27182, DOI 10.1074/jbc.M109.098830; Khabar KSA, 2010, CELL MOL LIFE SCI, V67, P2937, DOI 10.1007/s00018-010-0383-x; Kim BC, 2012, EMBO J, V31, P4289, DOI 10.1038/emboj.2012.286; Kim HH, 2009, GENE DEV, V23, P1743, DOI 10.1101/gad.1812509; Kruse JP, 2009, CELL, V137, P609, DOI 10.1016/j.cell.2009.04.050; Laroia G, 1999, SCIENCE, V284, P499, DOI 10.1126/science.284.5413.499; Lu JY, 2006, RNA, V12, P883, DOI 10.1261/rna.2308106; Mcgray AJR, 2011, CELL MOL BIOL LETT, V16, P55, DOI 10.2478/s11658-010-0037-x; Mendez-Vidal C, 2002, NUCLEIC ACIDS RES, V30, P1991, DOI 10.1093/nar/30.9.1991; Miller JE, 2012, CRIT REV BIOCHEM MOL, V47, P315, DOI 10.3109/10409238.2012.667214; Muller M, 1998, J EXP MED, V188, P2033, DOI 10.1084/jem.188.11.2033; Nakano K, 2001, MOL CELL, V7, P683, DOI 10.1016/S1097-2765(01)00214-3; Sanduja S, 2011, WIRES RNA, V2, P42, DOI 10.1002/wrna.28; Schoenberg DR, 2012, NAT REV GENET, V13, P246, DOI 10.1038/nrg3160; Sedaghat Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029429; Thomas PD, 2006, NUCLEIC ACIDS RES, V34, pW645, DOI 10.1093/nar/gkl229; Thomas PD, 2003, GENOME RES, V13, P2129, DOI 10.1101/gr.772403; VarmehZiaie S, 1997, ONCOGENE, V15, P2699, DOI 10.1038/sj.onc.1201454; Vidal CM, 2006, FEBS LETT, V580, P4401, DOI 10.1016/j.febslet.2006.07.005; Vilborg A, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.33; Vilborg A, 2011, CELL DEATH DIFFER, V18, P1434, DOI 10.1038/cdd.2011.20; Vilborg A, 2009, P NATL ACAD SCI USA, V106, P15756, DOI 10.1073/pnas.0900862106; Villunger A, 2003, SCIENCE, V302, P1036, DOI 10.1126/science.1090072; von Roretz C, 2011, WIRES RNA, V2, P336, DOI 10.1002/wrna.55; Vousden KH, 2009, CELL, V137, P413, DOI 10.1016/j.cell.2009.04.037; Wang WG, 2000, EMBO J, V19, P2340, DOI 10.1093/emboj/19.10.2340	45	46	48	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	AUG 28	2014	33	35					4407	4417		10.1038/onc.2013.594	http://dx.doi.org/10.1038/onc.2013.594			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AO2MR	24469038	Green Published, hybrid			2022-12-25	WOS:000341157800005
J	Bansaghi, S; Golenar, T; Madesh, M; Csordas, G; RamachandraRao, S; Sharma, K; Yule, DI; Joseph, SK; Hajnoczky, G				Bansaghi, Szava; Golenar, Tuende; Madesh, Muniswamy; Csordas, Gyoergy; RamachandraRao, Satish; Sharma, Kumar; Yule, David I.; Joseph, Suresh K.; Hajnoczky, Gyoergy			Isoform-and Species-specific Control of Inositol 1,4,5-Trisphosphate (IP3) Receptors by Reactive Oxygen Species	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Calcium Signaling; Endoplasmic Reticulum (ER); Inositol 1; 4; 5-Trisphosphate; Mitochondria; Reactive Oxygen Species (ROS); IP3 Receptor	PROTEIN S-GLUTATHIONYLATION; AORTIC ENDOTHELIAL-CELLS; ENDOPLASMIC-RETICULUM; RYANODINE RECEPTOR-TYPE-1; TRISPHOSPHATE RECEPTORS; CALCIUM OSCILLATIONS; MAMMALIAN-CELLS; MITOCHONDRIA; SUPEROXIDE; THIMEROSAL	Background: Reactive oxygen species (ROS) affect cytoplasmic calcium signaling. Results: Superoxide anion causes oxidation of the IP3 receptor and sensitization of calcium release to promote cytoplasmic calcium oscillations and mitochondrial calcium uptake. Conclusion: Physiologically relevant ROS controls cytoplasmic and mitochondrial calcium transport through IP3 receptors. Significance: Mechanisms of calcium and ROS interactions are relevant for both physiological and pathophysiological signaling. Reactive oxygen species (ROS) stimulate cytoplasmic [Ca2+] ([Ca2+](c)) signaling, but the exact role of the IP3 receptors (IP3R) in this process remains unclear. IP(3)Rs serve as a potential target of ROS produced by both ER and mitochondrial enzymes, which might locally expose IP(3)Rs at the ER-mitochondrial associations. Also, IP(3)Rs contain multiple reactive thiols, common molecular targets of ROS. Therefore, we have examined the effect of superoxide anion (O2) on IP3R-mediated Ca2+ signaling. In human HepG2, rat RBL-2H3, and chicken DT40 cells, we observed [Ca2+](c) spikes and frequency-modulated oscillations evoked by a O2 donor, xanthine (X) + xanthine oxidase (XO), dose-dependently. The [Ca2+](c) signal was mediated by ER Ca2+ mobilization. X+XO added to permeabilized cells promoted the [Ca2+](c) rise evoked by submaximal doses of IP3, indicating that O2 directly sensitizes IP3R-mediated Ca2+ release. In response to X+XO, DT40 cells lacking two of three IP3R isoforms (DKO) expressing either type 1 (DKO1) or type 2 IP(3)Rs (DKO2) showed a [Ca2+](c) signal, whereas DKO expressing type 3 IP3R (DKO3) did not. By contrast, IgM that stimulates IP3 formation, elicited a [Ca2+](c) signal in every DKO. X+XO also facilitated the Ca2+ release evoked by submaximal IP3 in permeabilized DKO1 and DKO2 but was ineffective in DKO3 or in DT40 lacking every IP3R (TKO). However, X+XO could also facilitate the effect of suboptimal IP3 in TKO transfected with rat IP(3)R3. Although in silico studies failed to identify a thiol missing in the chicken IP(3)R3, an X+XO-induced redox change was documented only in the rat IP(3)R3. Thus, ROS seem to specifically sensitize IP(3)Rs through a thiol group(s) within the IP3R, which is probably inaccessible in the chicken IP(3)R3.	[Bansaghi, Szava; Golenar, Tuende; Madesh, Muniswamy; Csordas, Gyoergy; Joseph, Suresh K.; Hajnoczky, Gyoergy] Thomas Jefferson Univ, Dept Pathol Anat & Cell Biol, MitoCare Ctr, Philadelphia, PA 19107 USA; [RamachandraRao, Satish; Sharma, Kumar] Thomas Jefferson Univ, Dept Med, Ctr Novel Therapies Kidney Dis, Philadelphia, PA 19107 USA; [Yule, David I.] Univ Rochester, Med Ctr, Dept Physiol & Pharmacol, Rochester, NY 14642 USA	Jefferson University; Jefferson University; University of Rochester	Hajnoczky, G (corresponding author), JAH Thomas Jefferson Univ, MitoCare Ctr, Ste 527, Philadelphia, PA 19107 USA.	gyorgy.hajnoczky@jefferson.edu	Bansaghi, Szava/J-2664-2018	Csordas, Gyorgy/0000-0003-3156-1460	National Institutes of Health [GM059419, DK34804, DK053867]; Hungarian American Enterprise Scholarship Fund; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK034804, DP3DK094352, R01DK053867] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM059419] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Hungarian American Enterprise Scholarship Fund; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by National Institutes of Health Grants GM059419 (to G. H.), DK34804 (to S. K. J.), and DK053867 (to K. S.).r Supported by an international research fellowship from the Hungarian American Enterprise Scholarship Fund.	Akerboom J, 2013, FRONT MOL NEUROSCI, V6, DOI 10.3389/fnmol.2013.00002; Aracena-Parks P, 2006, J BIOL CHEM, V281, P40354, DOI 10.1074/jbc.M600876200; Berridge MJ, 2009, BBA-MOL CELL RES, V1793, P933, DOI 10.1016/j.bbamcr.2008.10.005; Betzenhauser MJ, 2010, CURR TOP MEMBR, V66, P273, DOI 10.1016/S1063-5823(10)66012-7; Betzenhauser MJ, 2008, METHODS, V46, P177, DOI 10.1016/j.ymeth.2008.09.014; BIRD GS, 1993, J BIOL CHEM, V268, P17917; BOOTMAN MD, 1992, J BIOL CHEM, V267, P25113; Brookes PS, 2004, AM J PHYSIOL-CELL PH, V287, pC817, DOI 10.1152/ajpcell.00139.2004; Brown GC, 2012, MITOCHONDRION, V12, P1, DOI 10.1016/j.mito.2011.02.001; Bultynck G, 2004, BIOCHEM J, V381, P87, DOI 10.1042/BJ20040072; Csordas G, 2001, CELL CALCIUM, V29, P249, DOI 10.1054/ceca.2000.0191; Csordas G, 1999, EMBO J, V18, P96, DOI 10.1093/emboj/18.1.96; Csordas G, 2013, CELL METAB, V17, P976, DOI 10.1016/j.cmet.2013.04.020; Csordas G, 2009, BBA-BIOENERGETICS, V1787, P1352, DOI 10.1016/j.bbabio.2009.06.004; Csordas G, 2006, J CELL BIOL, V174, P915, DOI 10.1083/jcb.200604016; Donoso P, 2011, FRONT BIOSCI-LANDMRK, V16, P553, DOI 10.2741/3705; Dooley CT, 2004, J BIOL CHEM, V279, P22284, DOI 10.1074/jbc.M312847200; Enyedi B, 2010, ANTIOXID REDOX SIGN, V13, P721, DOI 10.1089/ars.2009.2880; Gutscher M, 2008, NAT METHODS, V5, P553, DOI [10.1038/nmeth.1212, 10.1038/NMETH.1212]; Hajnoczky G, 1997, EMBO J, V16, P3533, DOI 10.1093/emboj/16.12.3533; Hawkins BJ, 2007, MOL BIOL CELL, V18, P2002, DOI 10.1091/mbc.E06-09-0830; Higo T, 2005, CELL, V120, P85, DOI 10.1016/j.cell.2004.11.048; JOSEPH SK, 1995, J BIOL CHEM, V270, P23310, DOI 10.1074/jbc.270.40.23310; Joseph SK, 2010, CURR TOP MEMBR, V66, P299, DOI 10.1016/S1063-5823(10)66013-9; Khan SA, 2013, BIOCHEM J, V451, P177, DOI 10.1042/BJ20121600; Leichert LI, 2004, PLOS BIOL, V2, P1723, DOI 10.1371/journal.pbio.0020333; Lewis RS, 2001, ANNU REV IMMUNOL, V19, P497, DOI 10.1146/annurev.immunol.19.1.497; Lock JT, 2012, J PHYSIOL-LONDON, V590, P3431, DOI [10.1113/jphysiol.2012.230656, 10.1113/jphysiol.2012.232645]; Lock JT, 2011, AM J PHYSIOL-HEART C, V300, pH493, DOI 10.1152/ajpheart.01073.2010; Madesh M, 2005, J CELL BIOL, V170, P1079, DOI 10.1083/jcb.200505022; Madesh M, 2001, J CELL BIOL, V155, P1003, DOI 10.1083/jcb.200105057; Malcuit C, 2006, J CELL PHYSIOL, V206, P565, DOI 10.1002/jcp.20471; Malhotra JD, 2007, ANTIOXID REDOX SIGN, V9, P2277, DOI 10.1089/ars.2007.1782; Mendes CCP, 2005, J BIOL CHEM, V280, P40892, DOI 10.1074/jbc.M506623200; Meyer AJ, 2010, ANTIOXID REDOX SIGN, V13, P621, DOI 10.1089/ars.2009.2948; Mikoshiba K, 2007, J NEUROCHEM, V102, P1426, DOI 10.1111/j.1471-4159.2007.04825.x; Pacher P, 2008, AM J PHYSIOL-RENAL, V295, pF1303, DOI 10.1152/ajprenal.90343.2008; Patterson RL, 2004, ANNU REV BIOCHEM, V73, P437, DOI 10.1146/annurev.biochem.73.071403.161303; Petersen OH, 2008, ANNU REV PHYSIOL, V70, P273, DOI 10.1146/annurev.physiol.70.113006.100618; Petrotchenko EV, 2011, RES REP BIOL, V2, P13, DOI 10.2147/RRB.S15776; Prosser BL, 2013, J MOL CELL CARDIOL, V58, P172, DOI 10.1016/j.yjmcc.2012.11.011; Redondo PC, 2004, BIOCHEM PHARMACOL, V67, P491, DOI 10.1016/j.bcp.2003.09.031; Sanderson Michael J, 2008, Proc Am Thorac Soc, V5, P23, DOI 10.1513/pats.200704-050VS; Sena LA, 2012, MOL CELL, V48, P158, DOI 10.1016/j.molcel.2012.09.025; Szalai G, 1999, EMBO J, V18, P6349, DOI 10.1093/emboj/18.22.6349; Thomas AP, 1996, FASEB J, V10, P1505, DOI 10.1096/fasebj.10.13.8940296; Vanderheyden V, 2009, BBA-MOL CELL RES, V1793, P959, DOI 10.1016/j.bbamcr.2008.12.003; Voss AA, 2004, J BIOL CHEM, V279, P34514, DOI 10.1074/jbc.M404290200; WOJCIKIEWICZ RJH, 1995, BIOCHEM BIOPH RES CO, V213, P334, DOI 10.1006/bbrc.1995.2134; Zheng Y, 2005, REDOX REP, V10, P29, DOI 10.1179/135100005X21660	50	117	118	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 21	2014	289	12					8170	8181		10.1074/jbc.M113.504159	http://dx.doi.org/10.1074/jbc.M113.504159			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AD3PG	24469450	Green Published, Green Submitted, hybrid			2022-12-25	WOS:000333157500013
J	Mavridou, DAI; Saridakis, E; Kritsiligkou, P; Mozley, EC; Ferguson, SJ; Redfield, C				Mavridou, Despoina A. I.; Saridakis, Emmanuel; Kritsiligkou, Paraskevi; Mozley, Erin C.; Ferguson, Stuart J.; Redfield, Christina			An Extended Active-site Motif Controls the Reactivity of the Thioredoxin Fold	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						NMR; Oxidase; Reductase; Thioredoxin; X-ray Crystallography; DsbD; Electrostatics; pKa Values; Thiol-Disulfide Exchange; Thioredoxin Fold	DISULFIDE BOND FORMATION; ESCHERICHIA-COLI THIOREDOXIN; TRANSMEMBRANE ELECTRON-TRANSFER; CYTOCHROME-C MATURATION; N-TERMINAL DOMAIN; CRYSTAL-STRUCTURE; STRUCTURAL BASIS; CYSTEINE RESIDUES; PERIPLASMIC PROTEIN; REDOX POTENTIALS	Background: Proteins with a thioredoxin (Trx) fold share several structural features but carry out different reactions. Results: The contribution of the electrostatic environment of the active site to the reactivity of Trx-fold proteins is described. Conclusion: Function and reactivity of the Trx fold depend on an extended active-site motif. Significance: These results are expected to assist with functional prediction for Trx-fold proteins. Proteins belonging to the thioredoxin (Trx) superfamily are abundant in all organisms. They share the same structural features, arranged in a seemingly simple fold, but they perform a multitude of functions in oxidative protein folding and electron transfer pathways. We use the C-terminal domain of the unique transmembrane reductant conductor DsbD as a model for an in-depth analysis of the factors controlling the reactivity of the Trx fold. We employ NMR spectroscopy, x-ray crystallography, mutagenesis, in vivo functional experiments applied to DsbD, and a comparative sequence analysis of Trx-fold proteins to determine the effect of residues in the vicinity of the active site on the ionization of the key nucleophilic cysteine of the -CXXC- motif. We show that the function and reactivity of Trx-fold proteins depend critically on the electrostatic features imposed by an extended active-site motif.	[Mavridou, Despoina A. I.; Kritsiligkou, Paraskevi; Mozley, Erin C.; Ferguson, Stuart J.; Redfield, Christina] Univ Oxford, Dept Biochem, Oxford OX1 3QU, England; [Saridakis, Emmanuel] NCSR Demokritos, Dept Phys Chem, Athens 15310, Greece	University of Oxford; National Centre of Scientific Research "Demokritos"	Mavridou, DAI (corresponding author), Univ Oxford, Dept Biochem, S Parks Rd, Oxford OX1 3QU, England.	despoina.mavridou@bioch.ox.ac.uk; christina.redfield@bioch.ox.ac.uk	Mavridou, Despoina/ABG-5940-2020; Kritsiligkou, Paraskevi/W-9399-2019	Mavridou, Despoina/0000-0002-7449-1151; Kritsiligkou, Paraskevi/0000-0003-2452-141X; Emmett, Erin/0000-0003-4575-6760; Redfield, Christina/0000-0001-7297-7708	Wellcome Trust [079440, 092532]; Value-in-People Award; Gustav Born Trust; E.P.A. Cephalosporin Fund; Nuffield Foundation [URB/36783]	Wellcome Trust(Wellcome TrustEuropean Commission); Value-in-People Award; Gustav Born Trust; E.P.A. Cephalosporin Fund; Nuffield Foundation	This work was supported in part by Wellcome Trust Grants 079440 and 092532 and a Value-in-People Award.; Recipient of funding from the Gustav Born Trust and the E.P.A. Cephalosporin Fund. To whom correspondence may be addressed. Tel.: 44-1865-613313; E-mail: despoina.mavridou@bioch.ox.ac.uk.; Recipient of Science Bursary Grant URB/36783 from The Nuffield Foundation.	Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Aslund F, 1997, J BIOL CHEM, V272, P30780, DOI 10.1074/jbc.272.49.30780; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BARDWELL JCA, 1991, CELL, V67, P581, DOI 10.1016/0092-8674(91)90532-4; Bessette PH, 1999, P NATL ACAD SCI USA, V96, P13703, DOI 10.1073/pnas.96.24.13703; Buchanan BB, 2012, BBA-GEN SUBJECTS, V1820, P1822, DOI 10.1016/j.bbagen.2012.07.006; Bushnell KMW, 2002, J BIOMOL NMR, V24, P359, DOI 10.1023/A:1021638313691; Calvin M., 1954, GLUTATHIONE, P3; Chayen NE, 1999, J CRYST GROWTH, V196, P434, DOI 10.1016/S0022-0248(98)00837-9; Cheng ZY, 2007, BIOCHEMISTRY-US, V46, P7875, DOI 10.1021/bi700442r; Chivers PT, 1997, BIOCHEMISTRY-US, V36, P14985, DOI 10.1021/bi970071j; Chivers PT, 1997, BIOCHEMISTRY-US, V36, P4061, DOI 10.1021/bi9628580; Chivers PT, 1997, BIOCHEMISTRY-US, V36, P15810, DOI 10.1021/bi971504l; Collet JF, 2010, ANTIOXID REDOX SIGN, V13, P1205, DOI 10.1089/ars.2010.3114; CROOKE H, 1995, MOL MICROBIOL, V15, P1139, DOI 10.1111/j.1365-2958.1995.tb02287.x; Crow A, 2004, J BIOL CHEM, V279, P23654, DOI 10.1074/jbc.M402823200; Crow A, 2009, J BIOL CHEM, V284, P23719, DOI 10.1074/jbc.M109.005785; Crow A, 2009, J BIOL CHEM, V284, P10056, DOI 10.1074/jbc.M809566200; Cumming RC, 2004, J BIOL CHEM, V279, P21749, DOI 10.1074/jbc.M312267200; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Depuydt M, 2009, SCIENCE, V326, P1109, DOI 10.1126/science.1179557; DYSON HJ, 1991, BIOCHEMISTRY-US, V30, P4262, DOI 10.1021/bi00231a023; Dyson HJ, 1997, BIOCHEMISTRY-US, V36, P2622, DOI 10.1021/bi961801a; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Erlendsson LS, 2004, J BACTERIOL, V186, P6230, DOI 10.1128/JB.186.18.6230-6238.2004; Erlendsson LS, 2002, J BACTERIOL, V184, P1423, DOI 10.1128/JB.184.5.1423-1429.2002; Fernandes PA, 2004, CHEM-EUR J, V10, P257, DOI 10.1002/chem.200305343; FORMANKAY JD, 1992, BIOCHEMISTRY-US, V31, P3442, DOI 10.1021/bi00128a019; GILBERT HF, 1990, ADV ENZYMOL RAMB, V63, P69; Goddard AD, 2010, J BIOL CHEM, V285, P22880, DOI 10.1074/jbc.M110.133421; GOODHEW CF, 1986, BIOCHIM BIOPHYS ACTA, V852, P288, DOI 10.1016/0005-2728(86)90234-3; Gordon EHJ, 2000, MOL MICROBIOL, V35, P1360, DOI 10.1046/j.1365-2958.2000.01796.x; Goulding CW, 2002, BIOCHEMISTRY-US, V41, P6920, DOI 10.1021/bi016038l; GRAUSCHOPF U, 1995, CELL, V83, P947, DOI 10.1016/0092-8674(95)90210-4; Guddat LW, 1998, STRUCT FOLD DES, V6, P757, DOI 10.1016/S0969-2126(98)00077-X; Haebel PW, 2002, EMBO J, V21, P4774, DOI 10.1093/emboj/cdf489; Hansen RE, 2005, BIOCHEMISTRY-US, V44, P5899, DOI 10.1021/bi0500372; Harris TK, 2002, IUBMB LIFE, V53, P85, DOI 10.1080/15216540211468; Heras B, 2004, P NATL ACAD SCI USA, V101, P8876, DOI 10.1073/pnas.0402769101; Heras B, 2007, CURR OPIN STRUC BIOL, V17, P691, DOI 10.1016/j.sbi.2007.08.009; Kadokura H, 2003, ANNU REV BIOCHEM, V72, P111, DOI 10.1146/annurev.biochem.72.121801.161459; Karala AR, 2010, J MOL BIOL, V396, P883, DOI 10.1016/j.jmb.2009.12.014; KATTI SK, 1990, J MOL BIOL, V212, P167, DOI 10.1016/0022-2836(90)90313-B; Katzen F, 2000, CELL, V103, P769, DOI 10.1016/S0092-8674(00)00180-X; Kim JH, 2003, FEBS LETT, V543, P164, DOI 10.1016/S0014-5793(03)00434-4; Kouwen TRHM, 2007, MOL MICROBIOL, V64, P984, DOI 10.1111/j.1365-2958.2007.05707.x; LAURENT TC, 1964, J BIOL CHEM, V239, P3436; Lewin A, 2006, J BIOL CHEM, V281, P35467, DOI 10.1074/jbc.M607047200; Li Q, 2001, BIOCHEM BIOPH RES CO, V283, P849, DOI 10.1006/bbrc.2001.4876; Maiti R, 2004, NUCLEIC ACIDS RES, V32, pW590, DOI 10.1093/nar/gkh477; MARTIN JL, 1995, STRUCTURE, V3, P245, DOI 10.1016/S0969-2126(01)00154-X; Mavridou DAI, 2007, J MOL BIOL, V370, P643, DOI 10.1016/j.jmb.2007.04.038; Mavridou DAI, 2012, BIOMOL NMR ASSIGN, V6, P163, DOI 10.1007/s12104-011-9347-9; Mavridou DAI, 2011, J BIOL CHEM, V286, P24943, DOI 10.1074/jbc.M111.236141; Mavridou DAI, 2009, J BIOL CHEM, V284, P3219, DOI 10.1074/jbc.M805963200; McCarthy AA, 2000, NAT STRUCT BIOL, V7, P196; MISSIAKAS D, 1994, EMBO J, V13, P2013, DOI 10.1002/j.1460-2075.1994.tb06471.x; Moutevelis E, 2004, PROTEIN SCI, V13, P2744, DOI 10.1110/ps.04804504; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; NELSON JW, 1994, BIOCHEMISTRY-US, V33, P5974, DOI 10.1021/bi00185a039; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Ouyang N, 2006, PROTEINS, V65, P1021, DOI 10.1002/prot.21184; Qin J, 1996, BIOCHEMISTRY-US, V35, P7, DOI 10.1021/bi952299h; QIN J, 1994, STRUCTURE, V2, P503, DOI 10.1016/S0969-2126(00)00051-4; Reid E, 2001, BIOCHEM J, V355, P51, DOI 10.1042/0264-6021:3550051; Roos G, 2013, ANTIOXID REDOX SIGN, V18, P94, DOI 10.1089/ars.2012.4521; Rozhkova A, 2004, EMBO J, V23, P1709, DOI 10.1038/sj.emboj.7600178; SHAKED Z, 1980, BIOCHEMISTRY-US, V19, P4156, DOI 10.1021/bi00559a004; SHEVCHIK VE, 1994, EMBO J, V13, P2007, DOI 10.1002/j.1460-2075.1994.tb06470.x; SHRAGER RI, 1972, BIOCHEMISTRY-US, V11, P541, DOI 10.1021/bi00754a010; Stevens JM, 2004, FEBS LETT, V576, P81, DOI 10.1016/j.febslet.2004.08.067; Stevens JM, 2011, FEBS J, V278, P4170, DOI 10.1111/j.1742-4658.2011.08376.x; Stewart EJ, 1998, EMBO J, V17, P5543, DOI 10.1093/emboj/17.19.5543; Stirnimann CU, 2006, CELL MOL LIFE SCI, V63, P1642, DOI 10.1007/s00018-006-6055-1; Stirnimann CU, 2006, J MOL BIOL, V358, P829, DOI 10.1016/j.jmb.2006.02.030; Stirnimann CU, 2005, STRUCTURE, V13, P985, DOI 10.1016/j.str.2005.04.014; Thurlkill RL, 2006, PROTEIN SCI, V15, P1214, DOI 10.1110/ps.051840806; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Vranken WF, 2005, PROTEINS, V59, P687, DOI 10.1002/prot.20449; Wang C, 2012, J BIOL CHEM, V287, P1139, DOI 10.1074/jbc.M111.303149; Waschutza G, 1996, PROTEIN ENG, V9, P905, DOI 10.1093/protein/9.10.905; WETZEL R, 1988, P NATL ACAD SCI USA, V85, P401, DOI 10.1073/pnas.85.2.401	83	6	6	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 21	2014	289	12					8681	8696		10.1074/jbc.M113.513457	http://dx.doi.org/10.1074/jbc.M113.513457			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AD3PG	24469455	Green Published, hybrid			2022-12-25	WOS:000333157500057
J	Chyau, CC; Ker, YB; Chang, CH; Huang, SH; Wang, HE; Peng, CC; Peng, RY				Chyau, Charng-Cherng; Ker, Yaw-Bee; Chang, Chi-Huang; Huang, Shiau-Huei; Wang, Hui-Er; Peng, Chiung-Chi; Peng, Robert Y.			Schisandra chinensis Peptidoglycan-Assisted Transmembrane Transport of Lignans Uniquely Altered the Pharmacokinetic and Pharmacodynamic Mechanisms in Human HepG2 Cell Model	PLOS ONE			English	Article							DIBENZOCYCLOOCTADIENE LIGNANS; GOMISIN N; HYALURONAN; BINDING; FRUIT; RATS; POLYSACCHARIDES; HEPATOTOXICITY; IDENTIFICATION; INHIBITORS	Schisandra chinensis (Turz Baill) (S. chinensis) (SC) fruit is a hepatoprotective herb containing many lignans and a large amount of polysaccharides. A novel polysaccharide (called SC-2) was isolated from SC of MW 841 kDa, which exhibited a protein-to-polysaccharide ratio of 0.4089, and showed a characteristic FTIR spectrum of a peptidoglycan. Powder X-ray diffraction revealed microcrystalline structures within SC-2. SC-2 contained 10 monosaccharides and 15 amino acids (essential amino acids of 78.12% w/w). In a HepG2 cell model, SC-2 was shown by MTT and TUNEL assay to be completely non-cytotoxic. A kinetic analysis and fluorescence-labeling technique revealed no intracellular disposition of SC-2. Combined treatment of lignans with SC-2 enhanced the intracellular transport of schisandrin B and deoxyschisandrin but decreased that of gomisin C, resulting in alteration of cell-killing bioactivity. The Second Law of Thermodynamics allows this type of unidirectional transport. Conclusively, SC-2 alters the transport and cell killing capability by a "Catcher-Pitcher Unidirectional Transport Mechanism".	[Chyau, Charng-Cherng; Chang, Chi-Huang; Huang, Shiau-Huei; Peng, Robert Y.] Hungkuang Univ, Biotechnol Res Inst, Taichung, Taiwan; [Ker, Yaw-Bee; Wang, Hui-Er] Hungkuang Univ, Dept Food & Appl Technol, Taichung, Taiwan; [Peng, Chiung-Chi] Taipei Med Univ, Grad Inst Clin Med, Taipei, Taiwan; [Peng, Robert Y.] Taipei Med Univ, Res Inst Med Sci, Taipei, Taiwan	Hungkuang University; Hungkuang University; Taipei Medical University; Taipei Medical University	Peng, CC (corresponding author), Taipei Med Univ, Grad Inst Clin Med, Taipei, Taiwan.	misspeng@ms2.hinet.net; ypeng@seed.net.tw			National Science Council of Taiwan [NSC-97-2313-B-241-002-MY3, NSC-100-2313-B-241-004]; Taipei Medical University [TMU101-AE1-B11, TMU102-SHH-11]	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan); Taipei Medical University	This study was supported by grants from the National Science Council of Taiwan (NSC-97-2313-B-241-002-MY3 and NSC-100-2313-B-241-004). Additional support was received from Taipei Medical University (TMU101-AE1-B11 and TMU102-SHH-11). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Borisov AB, 2000, ANAT RECORD, V258, P305; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chang CY, 2009, PHYTOTHER RES, V23, P251, DOI 10.1002/ptr.2602; Chen Y, 2012, INT J BIOL MACROMOL, V50, P844, DOI 10.1016/j.ijbiomac.2011.11.015; Chiu PY, 2007, BIOL PHARM BULL, V30, P1108, DOI 10.1248/bpb.30.1108; Cyong JC, 2000, AM J CHINESE MED, V28, P351, DOI 10.1142/S0192415X00000416; Day AJ, 2002, J BIOL CHEM, V277, P4585, DOI 10.1074/jbc.R100036200; DUBOIS M, 1956, ANAL CHEM, V28, P350, DOI 10.1021/ac60111a017; FUJIHASHI T, 1995, ANTIMICROB AGENTS CH, V39, P2000, DOI 10.1128/AAC.39.9.2000; GAVRIELI Y, 1992, J CELL BIOL, V119, P493, DOI 10.1083/jcb.119.3.493; Gnabre J, 2010, J CHROMATOGR B, V878, P2693, DOI 10.1016/j.jchromb.2010.08.005; Ip SP, 1996, PHARMACOL TOXICOL, V78, P413, DOI 10.1111/j.1600-0773.1996.tb00228.x; Ip SP, 1997, BIOCHEM PHARMACOL, V54, P317, DOI 10.1016/S0006-2952(97)00164-0; Iwata H, 2004, DRUG METAB DISPOS, V32, P1351, DOI 10.1124/dmd.104.000646; Janes KA, 2001, ADV DRUG DELIVER REV, V47, P83, DOI 10.1016/S0169-409X(00)00123-X; Kaneo Y, 2000, INT J PHARM, V201, P59, DOI 10.1016/S0378-5173(00)00405-1; Ker YB, 2005, J AGR FOOD CHEM, V53, P7052, DOI 10.1021/jf0510034; Kim SR, 2004, J NEUROSCI RES, V76, P397, DOI 10.1002/jnr.20089; Kuang DM, 2007, BLOOD, V110, P587, DOI 10.1182/blood-2007-01-068031; La Torre GL, 2006, FOOD CHEM, V94, P640, DOI 10.1016/j.foodchem.2005.02.007; Lee IS, 1999, BIOL PHARM BULL, V22, P265, DOI 10.1248/bpb.22.265; Liu M, 2010, J ETHNOPHARMACOL, V127, P32, DOI 10.1016/j.jep.2009.09.055; Lu Y, 2009, J CHROMATOGR A, V1216, P1980, DOI 10.1016/j.chroma.2008.09.070; Ma WH, 2009, BIOORG MED CHEM LETT, V19, P4958, DOI 10.1016/j.bmcl.2009.07.078; Min HY, 2008, BIOORG MED CHEM LETT, V18, P523, DOI 10.1016/j.bmcl.2007.11.082; Oh SY, 2010, BIOSCI BIOTECH BIOCH, V74, P285, DOI 10.1271/bbb.90597; Opletal L, 2010, CESKA SLOV FARM, V50, P219; Opletal L, 2010, CESKA SLOV FARM, V50, P173; Peng CH, 2010, EUR J PHARM BIOPHARM, V75, P154, DOI 10.1016/j.ejpb.2010.03.004; Polyakov NE, 2010, NSTI NANOTECH, V3, P312; Shihorka V, 2001, J PHARM PHARM SCI, V4, P138; Tanaka T, 2004, INT J PHARM, V286, P9, DOI 10.1016/j.ijpharm.2004.07.031; Toole BP, 2004, NAT REV CANCER, V4, P528, DOI 10.1038/nrc1391; Victor R, 1999, INT J CANCER, V82, P77, DOI 10.1002/(SICI)1097-0215(19990702)82:1<77::AID-IJC14>3.0.CO;2-Q; WETLAUFER DB, 1962, ADV PROTEIN CHEM, V17, P303; Xie YA, 2010, J ETHNOPHARMACOL, V131, P290, DOI 10.1016/j.jep.2010.06.038; Yan F, 2009, PHYTOMEDICINE, V16, P805, DOI 10.1016/j.phymed.2009.02.004; Yim SY, 2009, MOL MED REP, V2, P725, DOI 10.3892/mmr_00000163; Yin FZ, 2010, ACTA CHROMATOGR, V22, P609, DOI 10.1556/AChrom.22.2010.4.10; Zhu M, 2000, PLANTA MED, V66, P521, DOI 10.1055/s-2000-11202	40	8	9	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2014	9	1							e85165	10.1371/journal.pone.0085165	http://dx.doi.org/10.1371/journal.pone.0085165			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301BI	24475039	Green Published, Green Submitted, gold			2022-12-25	WOS:000330507300018
J	Ren, MX; Bu, ZJ				Ren, Ming-Xun; Bu, Zhao-Jun			Is There 'Anther-Anther Interference' within a Flower? Evidences from One-by-One Stamen Movement in an Insect-Pollinated Plant	PLOS ONE			English	Article							POLLEN REMOVAL; REPRODUCTIVE SUCCESS; FLORAL EVOLUTION; SELECTION; STIGMAS; ANGIOSPERMS; STRATEGIES; AVOIDANCE; DISPERSAL; REVOLVER	The selective pressure imposed by maximizing male fitness (pollen dispersal) in shaping floral structures is increasingly recognized and emphasized in current plant sciences. To maximize male fitness, many flowers bear a group of stamens with temporally separated anther dehiscence that prolongs presentation of pollen grains. Such an advantage, however, may come with a cost resulting from interference of pollen removal by the dehisced anthers. This interference between dehisced and dehiscing anthers has received little attention and few experimental tests to date. Here, using one-by-one stamen movement in the generalist-pollinated Parnassia palustris, we test this hypothesis by manipulation experiments in two years. Under natural conditions, the five fertile stamens in P. palustris flowers elongate their filaments individually, and anthers dehisce successively one-by-one. More importantly, the anther-dehisced stamen bends out of the floral center by filament deflexion before the next stamen's anther dehiscence. Experimental manipulations show that flowers with dehisced anther remaining at the floral center experience shorter (1/3-1/2 less) visit durations by pollen-collecting insects (mainly hoverflies and wasps) because these 'hungry' insects are discouraged by the scant and non-fresh pollen in the dehisced anther. Furthermore, the dehisced anther blocks the dehiscing anther's access to floral visitors, resulting in a nearly one third decrease in their contact frequency. As a result, pollen removal of the dehiscing anther decreases dramatically. These results provide the first direct experimental evidence that anther-anther interference is possible in a flower, and that the selection to reduce such interferences can be a strong force in floral evolution. We also propose that some other floral traits, usually interpreted as pollen dispensing mechanisms, may function, at least partially, as mechanisms to promote pollen dispersal by reducing interferences between dehisced and dehiscing anthers.	[Ren, Ming-Xun] Chinese Acad Sci, Wuhan Bot Garden, Key Lab Aquat Bot & Watershed Ecol, Wuhan, Peoples R China; [Bu, Zhao-Jun] NE Normal Univ, Inst Peat & Mire Res, State Environm Protect Key Lab Wetland Ecol & Veg, Changchun, Peoples R China	Chinese Academy of Sciences; Wuhan Botanical Garden, CAS; Northeast Normal University - China	Bu, ZJ (corresponding author), NE Normal Univ, Inst Peat & Mire Res, State Environm Protect Key Lab Wetland Ecol & Veg, Changchun, Peoples R China.	buzhaojun@nenu.edu.cn			National Natural Science Foundation of China [30970459, 31170356, 40971036, 41371103]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	Financial support was provided by the National Natural Science Foundation of China to M. X. R. (grant numbers 30970459 and 31170356) and Z.J.B. (grant numbers 40971036 and 41371103) (www.nsfc.gov.cn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrett SCH, 2002, HEREDITY, V88, P154, DOI 10.1038/sj/hdy/6800020; Barrett SCH, 2003, PHILOS T R SOC B, V358, P991, DOI 10.1098/rstb.2003.1301; BELL G, 1985, PROC R SOC SER B-BIO, V224, P223, DOI 10.1098/rspb.1985.0031; BROWN DK, 1981, AM J BOT, V68, P361, DOI 10.2307/2442772; Castellanos MC, 2006, AM NAT, V167, P288, DOI 10.1086/498854; Conner JK, 2009, ANN BOT-LONDON, V103, P1547, DOI 10.1093/aob/mcp071; Fenster CB, 2004, ANNU REV ECOL EVOL S, V35, P375, DOI 10.1146/annurev.ecolsys.34.011802.132347; Fetscher AE, 2001, P ROY SOC B-BIOL SCI, V268, P525, DOI 10.1098/rspb.2000.1395; Foerste AF, 1888, BOT GAZ, V13, P151, DOI 10.1086/326286; Gong YB, 2009, P ROY SOC B-BIOL SCI, V276, P4013, DOI 10.1098/rspb.2009.1254; Gu C., 2001, FLORA CHINA, P358; Han Y, 2008, ANN BOT-LONDON, V102, P473, DOI 10.1093/aob/mcn102; HARDER LD, 1994, EVOL ECOL, V8, P542, DOI 10.1007/BF01238257; HARDER LD, 1993, ECOLOGY, V74, P1059, DOI 10.2307/1940476; HARDER LD, 1989, AM NAT, V133, P323, DOI 10.1086/284922; Haston E, 2009, BOT J LINN SOC, V161, P128, DOI 10.1111/j.1095-8339.2009.00996.x; Henning T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041121; Kudo G, 2003, FUNCT ECOL, V17, P349, DOI 10.1046/j.1365-2435.2003.00736.x; LLOYD DG, 1982, EVOLUTION, V36, P903, DOI 10.1111/j.1558-5646.1982.tb05462.x; LLOYD DG, 1986, NEW ZEAL J BOT, V24, P135, DOI 10.1080/0028825X.1986.10409725; Matthews ML, 2005, BOT J LINN SOC, V149, P129, DOI 10.1111/j.1095-8339.2005.00445.x; Morgan MT, 1997, TRENDS ECOL EVOL, V12, P231, DOI 10.1016/S0169-5347(97)01045-8; PERCIVAL M, 1965, NEW PHYTOL, V64, P1, DOI 10.1111/j.1469-8137.1965.tb05370.x; Ren MX, 2012, ANN BOT-LONDON, V110, P1017, DOI 10.1093/aob/mcs181; Ren Ming-Xun, 2010, Chinese Journal of Plant Ecology, V34, P867, DOI 10.3773/j.issn.1005-264x.2010.07.012; Ren MX, 2010, INT J PLANT SCI, V171, P275, DOI 10.1086/650157; Ren Ming-Xun, 2009, Zhiwu Shengtai Xuebao, V33, P222, DOI 10.3773/j.issn.1005-264x.2009.01.024; Sandvik SM, 2003, CAN J BOT, V81, P49, DOI [10.1139/b03-006, 10.1139/B03-006]; STANTON ML, 1986, SCIENCE, V232, P1625, DOI 10.1126/science.232.4758.1625; Thomson James D., 2000, Plant Species Biology, V15, P11, DOI 10.1046/j.1442-1984.2000.00026.x; WEBB CJ, 1986, NEW ZEAL J BOT, V24, P163, DOI 10.1080/0028825X.1986.10409726; Weigend M, 2006, PLANT BIOLOGY, V8, P120, DOI 10.1055/s-2005-873034; Weigend M, 2010, BIOL J LINN SOC, V100, P124, DOI 10.1111/j.1095-8312.2010.01419.x	33	12	12	0	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2014	9	1							e86581	10.1371/journal.pone.0086581	http://dx.doi.org/10.1371/journal.pone.0086581			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301BI	24475150	Green Submitted, gold, Green Published			2022-12-25	WOS:000330507300086
J	Guo, Y; Zhang, Y; Hong, K; Luo, FY; Gu, QP; Lu, NH; Bai, AP				Guo, Yuan; Zhang, Yi; Hong, Kai; Luo, Fengyan; Gu, Qiuping; Lu, Nonghua; Bai, Aiping			AMPK Inhibition Blocks ROS-NF kappa B Signaling and Attenuates Endotoxemia-Induced Liver Injury	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; COMPOUND-C; INFLAMMATORY RESPONSES; MACROPHAGES; COLITIS; SEPSIS; EXPRESSION; CELLS; POLARIZATION; PATHOGENESIS	Background: AMP-activated protein kinase (AMPK) is an important enzyme in regulation of cellular energy homeostasis. We have previously shown that AMPK activation by 5-aminoimidazole-4-carboxamide (AICAR) results in suppression of immune responses, indicating the pivotal role of AMPK in immune regulation. However, the cellular mechanism underpinning AMPK inhibition on immune response remains largely to be elucidated. The study aimed to investigate the effects of AMPK inhibition on reactive oxygen species (ROS)-nuclear factor kappa B (NF kappa B) signaling and endotoxemia-induced liver injury. Methodology/Principal Findings: RAW 264.7 cells were pretreated with AMPK activator or inhibitor, followed by LPS challenge. In addition, LPS was injected intraperitoneally into mice to induce systemic inflammation. The parameters of liver injury and immune responses were determined, and survival of mice was monitored respectively. LPS challenge in RAW 264.7 cells resulted in AMPK activation which was then inhibited by compound C treatment. Both AMPK activation by AICAR or inhibition by compound C diminished LPS-induced ROS generation, inhibited phosphorylation of IKK, I kappa B, and NF kappa B p65, and consequently, decreased TNF production of RAW 264.7 cells. AICAR or compound C treatment decreased ALT, AST, and TNF levels in serum, reduced CD68 expression and MPO activity in liver tissue of mice with endotoxemia. Moreover, AICAR or compound C treatment improved survival of endotoxemic mice. Conclusions: AICAR or compound C treatment attenuates LPS-induced ROS-NF kappa B signaling, immune responses and liver injury. Strategies to activate or inhibit AMPK signaling may provide alternatives to the current clinical approaches to inhibit immune responses of endotoxemia.	[Guo, Yuan; Zhang, Yi; Hong, Kai; Luo, Fengyan; Gu, Qiuping; Lu, Nonghua; Bai, Aiping] Nanchang Univ, Dept Gastroenterol, Affiliated Hosp 1, Nanchang, Peoples R China; [Guo, Yuan] Nanchang Univ, Dept Pharm, Affiliated Hosp 1, Nanchang, Peoples R China	Nanchang University; Nanchang University	Bai, AP (corresponding author), Nanchang Univ, Dept Gastroenterol, Affiliated Hosp 1, Nanchang, Peoples R China.	baiap@163.com			National Natural Science Foundation of China [81270472, 81070310]; National Science and Technology Major Projects for "Major New Drugs Innovation and Development" of China [2011ZX09302-007-03]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Science and Technology Major Projects for "Major New Drugs Innovation and Development" of China	Supported by National Natural Science Foundation of China, No. 81270472 and No. 81070310, and National Science and Technology Major Projects for "Major New Drugs Innovation and Development" of China (No. 2011ZX09302-007-03). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Accordi B, 2013, LEUKEMIA, V27, P1019, DOI 10.1038/leu.2012.338; Bai A, 2007, SCAND J IMMUNOL, V66, P538, DOI 10.1111/j.1365-3083.2007.02011.x; Bai A, 2009, CLIN EXP IMMUNOL, V156, P353, DOI 10.1111/j.1365-2249.2009.03894.x; Bai AP, 2010, BIOCHEM PHARMACOL, V80, P1708, DOI 10.1016/j.bcp.2010.08.009; Bai AP, 2010, J PHARMACOL EXP THER, V333, P717, DOI 10.1124/jpet.109.164954; Bai AP, 2009, J LEUKOCYTE BIOL, V86, P959, DOI 10.1189/jlb.0109006; Bauer M, 2013, CURR OPIN CRIT CARE, V19, P123, DOI 10.1097/MCC.0b013e32835eba6d; Bradley EA, 2010, ARTERIOSCL THROM VAS, V30, P1137, DOI 10.1161/ATVBAHA.110.204404; Emerling BM, 2007, FEBS LETT, V581, P5727, DOI 10.1016/j.febslet.2007.11.038; Finkel T, 2011, J CELL BIOL, V194, P7, DOI 10.1083/jcb.201102095; Fortin CF, 2010, SHOCK, V33, P344, DOI 10.1097/SHK.0b013e3181c0f068; Gasparini C, 2012, CURR PHARM DESIGN, V18, P5735, DOI 10.2174/138161212803530763; Hadad SM, 2008, CRIT REV ONCOL HEMAT, V67, P1, DOI 10.1016/j.critrevonc.2008.01.007; Handa N, 2011, ACTA CRYSTALLOGR D, V67, P480, DOI 10.1107/S0907444911010201; Hirsch A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030956; Jiang W, 2005, P NATL ACAD SCI USA, V102, P17077, DOI 10.1073/pnas.0504570102; Jin JF, 2009, J LIPID RES, V50, P2389, DOI 10.1194/jlr.M900119-JLR200; Kim YM, 2011, ATHEROSCLEROSIS, V219, P57, DOI 10.1016/j.atherosclerosis.2011.06.043; Langelueddecke C, 2012, CELL PHYSIOL BIOCHEM, V29, P75, DOI 10.1159/000337589; Li J, 2007, STROKE, V38, P2992, DOI 10.1161/STROKEAHA.107.490904; Martinez FO, 2008, FRONT BIOSCI-LANDMRK, V13, P453, DOI 10.2741/2692; Moon EY, 2011, CELL SIGNAL, V23, P1479, DOI 10.1016/j.cellsig.2011.05.001; Ohira H, 2013, J ATHEROSCLER THROMB, V20, P425, DOI 10.5551/jat.15065; Rakonczay Z, 2008, GUT, V57, P259, DOI 10.1136/gut.2007.124115; Ray PD, 2012, CELL SIGNAL, V24, P981, DOI 10.1016/j.cellsig.2012.01.008; Rossignol Daniel P, 2005, Curr Opin Investig Drugs, V6, P496; Sag D, 2008, J IMMUNOL, V181, P8633, DOI 10.4049/jimmunol.181.12.8633; Sharif O, 2007, BMC IMMUNOL, V8, DOI 10.1186/1471-2172-8-1; Stearns-Kurosawa DJ, 2011, ANNU REV PATHOL-MECH, V6, P19, DOI 10.1146/annurev-pathol-011110-130327; Steinberg GR, 2009, PHYSIOL REV, V89, P1025, DOI 10.1152/physrev.00011.2008; Su GL, 2002, AM J PHYSIOL-GASTR L, V283, pG256, DOI 10.1152/ajpgi.00550.2001; Van Amersfoort ES, 2003, CLIN MICROBIOL REV, V16, P379, DOI 10.1128/CMR.16.3.379-414.2003; Viollet B, 2010, CRIT REV BIOCHEM MOL, V45, P276, DOI 10.3109/10409238.2010.488215; Yuk JM, 2011, NAT IMMUNOL, V12, P742, DOI 10.1038/ni.2064; Zhang WJ, 2007, P NATL ACAD SCI USA, V104, P4077, DOI 10.1073/pnas.0700305104; Zhao X, 2008, AM J PHYSIOL-LUNG C, V295, pL497, DOI 10.1152/ajplung.90210.2008; Zhou GC, 2001, J CLIN INVEST, V108, P1167, DOI 10.1172/JCI200113505	37	65	67	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2014	9	1							e86881	10.1371/journal.pone.0086881	http://dx.doi.org/10.1371/journal.pone.0086881			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	298QQ	24475189	Green Submitted, gold, Green Published			2022-12-25	WOS:000330339800067
J	Jaafar, FM; Belhouchet, M; Belaganahalli, M; Tesh, RB; Mertens, PPC; Attoui, H				Jaafar, Fauziah Mohd; Belhouchet, Mourad; Belaganahalli, Manjunatha; Tesh, Robert B.; Mertens, Peter P. C.; Attoui, Houssam			Full-Genome Characterisation of Orungo, Lebombo and Changuinola Viruses Provides Evidence for Co-Evolution of Orbiviruses with Their Arthropod Vectors	PLOS ONE			English	Article							OUTER-CAPSID PROTEINS; GRASS CARP REOVIRUS; DOUBLE-STRANDED-RNA; BLUETONGUE VIRUS; FAMILY REOVIRIDAE; COMPLETE SEQUENCE; EXPERIMENTAL-INFECTION; PHYLOGENETIC ANALYSIS; POPULATION-DYNAMICS; MOLECULAR SEQUENCES	The complete genomes of Orungo virus (ORUV), Lebombo virus (LEBV) and Changuinola virus (CGLV) were sequenced, confirming that they each encode 11 distinct proteins (VP1-VP7 and NS1-NS4). Phylogenetic analyses of cell-attachment protein 1' outer-capsid protein 19 (OC1), show that orbiviruses fall into three large groups, identified as: VP2(OC1), in which OC1 is the 2nd largest protein, including the Culicoides transmitted orbiviruses; VP3(OC1), which includes the mosquito transmitted orbiviruses; and VP4(OC1) which includes the tick transmitted viruses. Differences in the size of OC1 between these groups, places the T2 'subcore-shell protein' as the third largest protein 'VP3(T2)' in the first of these groups, but the second largest protein 'VP3(T2)' in the other two groups. ORUV, LEBV and CGLV all group with the Culicoides-borne VP2(OC1)/VP3(T2) viruses. The G+C content of the ORUV, LEBV and CGLV genomes is also similar to that of the Culicoides-borne, rather than the mosquito-borne, or tick borne orbiviruses. These data suggest that ORUV and LEBV are Culicoides-rather than mosquito-borne. Multiple isolations of CGLV from sand flies suggest that they are its primary vector. OC1 of the insect-borne orbiviruses is approximately twice the size of the equivalent protein of the tick borne viruses. Together with internal sequence similarities, this suggests its origin by duplication (concatermerisation) of a smaller OC1 from an ancestral tick-borne orbivirus. Phylogenetic comparisons showing linear relationships between the dates of evolutionary-separation of their vector species, and genetic-distances between tick-, mosquito- or Culicoides-borne virus-groups, provide evidence for co-evolution of the orbiviruses with their arthropod vectors.	[Jaafar, Fauziah Mohd; Belhouchet, Mourad; Belaganahalli, Manjunatha; Mertens, Peter P. C.; Attoui, Houssam] Pirbright Inst, Dept Vector Borne Viral Dis, Pirbright, Surrey, England; [Tesh, Robert B.] Univ Texas Med Branch, Dept Pathol, Galveston, TX 77555 USA	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Pirbright Institute; University of Texas System; University of Texas Medical Branch Galveston	Attoui, H (corresponding author), Pirbright Inst, Dept Vector Borne Viral Dis, Pirbright, Surrey, England.	houssam.attoui@pirbright.ac.uk	Belaganahalli, Manjunatha N/I-1688-2019	Belaganahalli, Manjunatha N/0000-0003-3401-5799; Mertens, Peter/0000-0002-3438-3738; Attoui, Houssam/0000-0001-9639-9981	BBSRC; Defra; Wellcome Trust; European Commission (OrbiVac) [245266, 222633-2, K1303206]; National Institutes of Health [HHSN272201000040I/HHSN27200004/D04]; BBSRC [BBS/E/I/00001720] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/E/I/00001720] Funding Source: researchfish	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Defra(Department for Environment, Food & Rural Affairs (DEFRA)); Wellcome Trust(Wellcome TrustEuropean Commission); European Commission (OrbiVac)(European Commission); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	The authors wish to acknowledge funding from BBSRC. Defra, Wellcome Trust, the European Commission (OrbiVac - Grant no.: 245266; WildTech - Grant no.: 222633-2; EMIDA grant OrbiNet - K1303206). PM is a Jenner Investigator. RBT was supported by National Institutes of Health contract HHSN272201000040I/HHSN27200004/D04. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anthony SJ, 2011, VIROLOGY, V420, P164, DOI 10.1016/j.virol.2011.09.009; Attoui H, 2000, J VIROL METHODS, V89, P147, DOI 10.1016/S0166-0934(00)00212-3; Attoui H, 2000, J GEN VIROL, V81, P1507, DOI 10.1099/0022-1317-81-6-1507; Attoui H, 2002, J GEN VIROL, V83, P1941, DOI 10.1099/0022-1317-83-8-1941; Attoui H, 2001, J GEN VIROL, V82, P795, DOI 10.1099/0022-1317-82-4-795; Attoui H., 2011, VIRUS TAXONOMY, P497; Attoui H, 2009, BIOL ANIM INFECT, P23, DOI 10.1016/B978-012369368-6.50007-1; Azar D, 2003, MEM I OSWALDO CRUZ, V98, P35, DOI 10.1590/S0074-02762003000900007; Azar D, 1999, PALAEONTOLOGY, V42, P1101, DOI 10.1111/1475-4983.00112; Belhouchet M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025697; Belhouchet M, 2010, J GEN VIROL, V91, P2985, DOI 10.1099/vir.0.024760-0; Borkent A, 2001, LEPTOCONOPS DIPTERA, P1; Bratlie MS, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-588; BROWN SE, 1991, J GEN VIROL, V72, P1065, DOI 10.1099/0022-1317-72-5-1065; Calvo E, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-57; Cao DJ, 2008, J VIROL, V82, P6073, DOI 10.1128/JVI.00121-08; CDC, 2010, INT CAT ARB INCL OTH; Charrel RN, 1999, J GEN VIROL, V80, P2329, DOI 10.1099/0022-1317-80-9-2329; Cook S, 2006, ARCH VIROL, V151, P309, DOI 10.1007/s00705-005-0626-6; DAROSA APAT, 1984, INTERVIROLOGY, V21, P38; DEMAULA CD, 1993, VIROLOGY, V195, P292, DOI 10.1006/viro.1993.1377; DeMaula CD, 2000, VIRUS RES, V67, P59, DOI 10.1016/S0168-1702(00)00130-1; Drummond A, 2003, ADV PARASIT, V54, P331, DOI 10.1016/S0065-308X(03)54008-8; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Drummond AJ, 2002, GENETICS, V161, P1307; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; Lara-Ramirez EE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017300; ESTEBAN R, 1988, J VIROL, V62, P1278, DOI 10.1128/JVI.62.4.1278-1285.1988; Force A, 1999, GENETICS, V151, P1531; Friedrich M, 1997, SYST BIOL, V46, P674, DOI 10.2307/2413500; Gibbs A., 1995, MOL BASIS VIRUS EVOL, P76; Gomez SM, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-4-r39; Gouet P, 1999, CELL, V97, P481, DOI 10.1016/S0092-8674(00)80758-8; Gould EA, 2003, ADV VIRUS RES, V59, P277, DOI 10.1016/S0065-3527(03)59008-X; Grimaldi David, 2005, pi; Grimes JM, 1998, NATURE, V395, P470, DOI 10.1038/26694; GROGAN WL, 1988, J PALEONTOL, V62, P808; Hennig L, 2001, PREP BIOCHEM BIOTECH, V31, P201; Holt RA, 2002, SCIENCE, V298, P129, DOI 10.1126/science.1076181; HUNDLEY F, 1985, VIROLOGY, V143, P88, DOI 10.1016/0042-6822(85)90099-6; Jaafar FM, 2008, VIROLOGY, V373, P310, DOI 10.1016/j.virol.2007.12.006; Jaafar FM, 2004, J GEN VIROL, V85, P2237, DOI 10.1099/vir.0.80019-0; Klompen JSH, 1996, ANNU REV ENTOMOL, V41, P141, DOI 10.1146/annurev.en.41.010196.001041; Kumar S, 2008, BRIEF BIOINFORM, V9, P299, DOI 10.1093/bib/bbn017; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Lange A, 2010, TRAFFIC, V11, P311, DOI 10.1111/j.1600-0854.2009.01028.x; Manole V, 2012, J VIROL, V86, P7858, DOI 10.1128/JVI.00517-12; Mertens PPC, 2005, VIRUS TAXONOMY, P447; MONATH TP, 1980, AM J TROP MED HYG, V29, P912, DOI 10.4269/ajtmh.1980.29.912; MOORE DL, 1975, ANN TROP MED PARASIT, V69, P49, DOI 10.1080/00034983.1975.11686983; MOSS SR, 1987, VIROLOGY, V157, P137, DOI 10.1016/0042-6822(87)90322-9; Nuttall PA, 2009, FRONT BIOSCI-LANDMRK, V14, P2466, DOI 10.2741/3390; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Ratinier M, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002477; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; SEYMOUR C, 1983, AM J TROP MED HYG, V32, P1435, DOI 10.4269/ajtmh.1983.32.1435; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Tomori O, 1976, Niger Med J, V6, P135; TOMORI O, 1978, J MED ENTOMOL, V14, P523, DOI 10.1093/jmedent/14.5.523; TOMORI O, 1977, NIGERIAN MED J, V7, P5; TOMORI O, 1977, ACTA VIROL, V21, P133; TOMORI O, 1976, TROP GEOGR MED, V28, P233; TOMORI O, 1976, ARCH VIROL, V51, P285, DOI 10.1007/BF01317932; TOMORI O, 1978, T ROY SOC TROP MED H, V72, P230, DOI 10.1016/0035-9203(78)90199-2; Valli A, 2007, J GEN VIROL, V88, P1016, DOI 10.1099/vir.0.82402-0; Wilson K, 2000, MOL BIOL EVOL, V17, P863, DOI 10.1093/oxfordjournals.molbev.a026366; Xia X, 2001, J HERED, V92, P371, DOI 10.1093/jhered/92.4.371; Zanotto PMD, 1996, P NATL ACAD SCI USA, V93, P548, DOI 10.1073/pnas.93.2.548	68	19	20	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2014	9	1							e86392	10.1371/journal.pone.0086392	http://dx.doi.org/10.1371/journal.pone.0086392			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	298QQ	24475112	Green Submitted, Green Published, gold			2022-12-25	WOS:000330339800042
J	Chou, HC; Chien, CT; Tsao, PN; Hsieh, WS; Chen, CY; Chang, MH				Chou, Hung-Chieh; Chien, Chiang-Ting; Tsao, Po-Nien; Hsieh, Wu-Shiun; Chen, Chien-Yi; Chang, Mei-Hwei			Prediction of Severe Neonatal Hyperbilirubinemia Using Cord Blood Hydrogen Peroxide: A Prospective Study	PLOS ONE			English	Article							HEALTHY TERM; BILIRUBIN; OXYGENATION; ANTIOXIDANT; APOPTOSIS	Background: We hypothesized that cord blood hydrogen peroxide (H2O2) could be utilized to predict the severity of neonatal hyperbilirubinemia. Methods: We prospectively enrolled term or near-term healthy neonates. Cord blood and capillary blood at three days of age were measured for hydrogen peroxide and bilirubin concentrations. For newborns with hyperbilirubinemia, further blood samples were obtained at five and seven days of age. Newborns were divided into severe or less severe hyperbilirubinemic groups (peak bilirubin >= 17 mg/dL or not). The sensitivity, specificity, and negative predictive values were determined. Results: There were 158 neonates enrolled. The incidence of neonatal hyperbilirubinemia was 30.5% for a concentration >= 15 mg/dl. The rising patterns were similar among bilirubin concentrations and hydrogen peroxide levels during the first few days of life. There was a strong positive correlation between bilirubin concentrations and hydrogen peroxide levels after correlation analysis. The rate of severe hyperbilirubinemia was 13.3%. It revealed that a cord blood hydrogen peroxide signal level of 2500 counts/10 seconds was an appropriate cut-off for predicting severe hyperbilirubinemia. Sensitivity and the negative predictive value were 76.2% and 93.3%, respectively. Conclusions: Our findings confirm that hydrogen peroxide levels and bilirubin concentrations in cord and neonatal blood are closely related. A cord blood hydrogen peroxide level above 2500 counts/10 seconds associated with a high predictive value for severe hyperbilirubinemia. This method provides information about which neonate should be closely followed after discharge from the nursery.	[Chou, Hung-Chieh; Chen, Chien-Yi] Natl Taiwan Univ, Coll Med, Grad Inst Clin Med, Taipei 10764, Taiwan; [Chou, Hung-Chieh; Tsao, Po-Nien; Hsieh, Wu-Shiun; Chen, Chien-Yi; Chang, Mei-Hwei] Natl Taiwan Univ, Coll Med, Dept Pediat, Natl Taiwan Univ Hosp, Taipei, Taiwan; [Chien, Chiang-Ting] Natl Taiwan Normal Univ, Dept Life Sci, Taipei, Taiwan	National Taiwan University; National Taiwan University; National Taiwan University Hospital; National Taiwan Normal University	Chang, MH (corresponding author), Natl Taiwan Univ, Coll Med, Dept Pediat, Natl Taiwan Univ Hosp, Taipei, Taiwan.	changmh@ntu.edu.tw	Chou, Hung-Chieh/AGZ-5161-2022; Chen, Chien-Yi/A-9680-2015	HSIEH, WU-SHIUN/0000-0002-0609-3311; TSAO, PO-NIEN/0000-0002-6114-1769; Chen, Chien-Yi/0000-0002-6030-2655; CHOU, HUNG-CHIEH/0000-0002-8932-9472; Chang, Mei Hwei/0000-0002-3648-9261				Baranano DE, 2002, P NATL ACAD SCI USA, V99, P16093, DOI 10.1073/pnas.252626999; Barone E, 2009, J CELL MOL MED, V13, P2365, DOI 10.1111/j.1582-4934.2009.00680.x; BERGMAN DA, 1994, PEDIATRICS, V94, P558; Bhutani VK, 1999, PEDIATRICS, V103, P6, DOI 10.1542/peds.103.1.6; Brito MA, 2002, CELL BIOL TOXICOL, V18, P181, DOI 10.1023/A:1015563704551; Carter K, 2001, JAMA-J AM MED ASSOC, V286, P299; Chien CT, 2001, J AM SOC NEPHROL, V12, P973, DOI 10.1681/ASN.V125973; Gazzin S, 2011, J MATERN-FETAL NEO M, V24, P154, DOI 10.3109/14767058.2011.607590; Greenberg DA, 2002, P NATL ACAD SCI USA, V99, P15837, DOI 10.1073/PNAS.012685199; Huang HC, 2012, PEDIATR NEONATOL, V53, P354, DOI 10.1016/j.pedneo.2012.08.012; Iuchi Y, 2010, FREE RADICAL BIO MED, V48, P935, DOI 10.1016/j.freeradbiomed.2010.01.012; Johnson LH, 2002, J PEDIATR-US, V140, P396, DOI 10.1067/mpd.2002.123098; Johnson L, 2011, SEMIN PERINATOL, V35, P101, DOI 10.1053/j.semperi.2011.02.003; Maisels MJ, 2008, NEW ENGL J MED, V358, P920, DOI 10.1056/NEJMct0708376; Pearce WJ, 2011, ADV EXP MED BIOL, V701, P225, DOI 10.1007/978-1-4419-7756-4_30; Rao W, 2013, BIOCHEM BIOPH RES CO, V291, P1726; Rodrigues CMP, 2002, HEPATOLOGY, V35, P1186, DOI 10.1053/jhep.2002.32967; Schneider H, 2011, RESP PHYSIOL NEUROBI, V178, P51, DOI 10.1016/j.resp.2011.05.009; STOCKER R, 1987, P NATL ACAD SCI USA, V84, P5918, DOI 10.1073/pnas.84.16.5918; STOCKER R, 1987, SCIENCE, V235, P1043, DOI 10.1126/science.3029864; Yigit S, 1999, ARCH DIS CHILD-FETAL, V80, pF235, DOI 10.1136/fn.80.3.F235	21	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2014	9	1							e86797	10.1371/journal.pone.0086797	http://dx.doi.org/10.1371/journal.pone.0086797			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V41SI	24466244	Green Published, gold, Green Submitted			2022-12-25	WOS:000209565500001
J	Russo, T; Scardi, M; Cataudella, S				Russo, Tommaso; Scardi, Michele; Cataudella, Stefano			Applications of Self-Organizing Maps for Ecomorphological Investigations through Early Ontogeny of Fish	PLOS ONE			English	Article							GROUPER EPINEPHELUS-MARGINATUS; SPARUS-AURATA L.; ALLOMETRIC GROWTH; MICROHABITAT USE; SHAPE; MORPHOLOGY; DIET; PATTERNS; LARVAE; DOMESTICATION	We propose a new graphical approach to the analysis of multi-temporal morphological and ecological data concerning the life history of fish, which can typically serves models in ecomorphological investigations because they often undergo significant ontogenetic changes. These changes can be very complex and difficult to describe, so that visualization, abstraction and interpretation of the underlying relationships are often impeded. Therefore, classic ecomorphological analyses of covariation between morphology and ecology, performed by means of multivariate techniques, may result in non-exhaustive models. The Self Organizing map (SOM) is a new, effective approach for pursuing this aim. In this paper, lateral outlines of larval stages of gilthead sea bream (Sparus aurata) and dusky grouper (Epinephelus marginatus) were recorded and broken down using by means of Elliptic Fourier Analysis (EFA). Gut contents of the same specimens were also collected and analyzed. Then, shape and trophic habits data were examined by SOM, which allows both a powerful visualization of shape changes and an easy comparison with trophic habit data, via their superimposition onto the trained SOM. Thus, the SOM provides a direct visual approach for matching morphological and ecological changes during fish ontogenesis. This method could be used as a tool to extract and investigate relationships between shape and other sinecological or environmental variables, which cannot be taken into account simultaneously using conventional statistical methods.	[Russo, Tommaso; Scardi, Michele; Cataudella, Stefano] Univ Roma Tor Vergata, Dept Biol, Lab Expt Ecol & Aquaculture, I-00173 Rome, Italy	University of Rome Tor Vergata	Russo, T (corresponding author), Univ Roma Tor Vergata, Dept Biol, Lab Expt Ecol & Aquaculture, I-00173 Rome, Italy.	Tommaso.Russo@Uniroma2.it	Russo, Tommaso/C-6157-2014	Russo, Tommaso/0000-0003-4047-959X	Italian "Ministero delle Politiche Agricole e Forestali" [Law 41/82]; flagship project RITMARE (Subproject Fisheries, Working Package 2: Modeling of commercial fishing stocks)	Italian "Ministero delle Politiche Agricole e Forestali"; flagship project RITMARE (Subproject Fisheries, Working Package 2: Modeling of commercial fishing stocks)	This study was funded by a grant of the Italian "Ministero delle Politiche Agricole e Forestali" (Law 41/82). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Final costs for publication was provided by the flagship project RITMARE (Subproject Fisheries, Working Package 2: Modeling of commercial fishing stocks).	Balon E.K., 1985, EARLY LIFE HIST FISH; Baltanas A, 2000, HYDROBIOLOGIA, V419, P65, DOI 10.1023/A:1003994209369; Bergmann GT, 2005, ENVIRON BIOL FISH, V72, P205, DOI 10.1007/s10641-004-1480-1; Beyers R. J., 1993, ECOLOGICAL MICROCOSM; Bhat A, 2005, ENVIRON BIOL FISH, V73, P211, DOI 10.1007/s10641-005-0561-0; BOCK WJ, 1994, J BIOSCIENCE, V19, P403, DOI 10.1007/BF02703177; Boglione C, 2001, AQUACULTURE, V192, P1, DOI 10.1016/S0044-8486(00)00446-4; Conti L, 2010, MAR ECOL PROG SER, V410, P233, DOI 10.3354/meps08630; Dayhoff Judith E., 1990, NEURAL NETWORK ARCHI; Dittenbach M, 2000, IEEE IJCNN, P15, DOI 10.1109/IJCNN.2000.859366; FERSON S, 1985, SYST ZOOL, V34, P59, DOI 10.2307/2413345; GALIS F, 1990, NATO ADV SCI I G-ECO, V20, P281; Giraudel JL, 2001, ECOL MODEL, V146, P329, DOI 10.1016/S0304-3800(01)00324-6; Gisbert E, 1999, J FISH BIOL, V54, P852, DOI 10.1111/j.1095-8649.1999.tb02037.x; Gozlan RE, 2005, J FISH BIOL, V67, P86, DOI 10.1111/j.0022-1112.2005.00914.x; Hernandez LP, 1997, J ZOOL, V243, P737; Herrel A, 2006, PHYSIOL BIOCHEM ZOOL, V79, P1, DOI 10.1086/498196; Hjelm J, 2001, OIKOS, V95, P311, DOI 10.1034/j.1600-0706.2001.950213.x; Huskey SH, 2001, ENVIRON BIOL FISH, V61, P185, DOI 10.1023/A:1011095526939; Klingenberg CP, 2000, EVOLUTION, V54, P1273, DOI 10.1111/j.0014-3820.2000.tb00560.x; Kohonen T., 1997, SELF ORGANIZING MAPS; Kohonen Teuvo, 1984, SELF ORG ASS MEMORY; Kovac V, 2006, J FISH BIOL, V68, P1257, DOI 10.1111/j.0022-1112.2006.01007.x; Kovac V, 2002, J THEOR BIOL, V217, P499, DOI 10.1006/yjtbi.3043; KUHL FP, 1982, COMPUT VISION GRAPH, V18, P236, DOI 10.1016/0146-664X(82)90034-X; Laaksonen J., 2011, ADV SELF ORG MAPS; Lauro FM, 2009, P NATL ACAD SCI USA, V106, P15527, DOI 10.1073/pnas.0903507106; Lestrel P E, 1997, FOURIER DESCRIPTORS; Lima-Junior SE, 2003, ENVIRON BIOL FISH, V68, P73, DOI 10.1023/A:1026079011647; Linde M, 2004, J EVOLUTION BIOL, V17, P941, DOI 10.1111/j.1420-9101.2004.00763.x; LUCZKOVICH JJ, 1995, ENVIRON BIOL FISH, V44, P79, DOI 10.1007/BF00005908; MALAVASI S, 2004, ANN INT C 2004 IMP C; MANTEL N, 1967, CANCER RES, V27, P209; Monteiro NM, 2005, J FISH BIOL, V67, P102, DOI 10.1111/j.0022-1112.2005.00718.x; Monti L, 2001, BIOL J LINN SOC, V72, P391, DOI [10.1006/bijl.2000.0506, 10.1111/j.1095-8312.2001.tb01325.x]; MOTTA PJ, 1995, ENVIRON BIOL FISH, V44, P11, DOI 10.1007/BF00005904; MOTTA PJ, 1992, NETH J ZOOL, V42, P400; NORTON SF, 1995, ENVIRON BIOL FISH, V44, P287, DOI 10.1007/BF00005921; Ohsawa R, 1998, EUPHYTICA, V101, P175, DOI 10.1023/A:1018344707479; Osse JWM, 1995, ICES MAR SC, V201, P21; Osse JWM, 1997, AQUACULTURE, V155, P249, DOI 10.1016/S0044-8486(97)00126-9; Palmer M, 2004, FISH RES, V67, P93, DOI 10.1016/j.fishres.2003.07.006; Park YS, 2003, ECOL MODEL, V160, P265, DOI 10.1016/S0304-3800(02)00258-2; Park YS, 2004, SCI TOTAL ENVIRON, V327, P105, DOI 10.1016/j.scitotenv.2004.01.014; Piet GJ, 1998, ENVIRON BIOL FISH, V51, P67, DOI 10.1023/A:1007338532482; Pinder AC, 2005, J FISH BIOL, V67, P205, DOI 10.1111/j.0022-1112.2005.00917.x; Prestinicola L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055736; Pulcini D, 2013, J FISH BIOL, V82, P390, DOI 10.1111/jfb.12002; Pulcini D, 2014, AQUAC RES, V45, P397, DOI 10.1111/j.1365-2109.2012.03236.x; Reilly Stephen M., 1994, P339; Rohlf FJ, 2006, TPSDIG VER 2 10; Russo T, 2008, J FISH BIOL, V73, P809, DOI 10.1111/j.1095-8649.2008.01964.x; Russo T, 2007, J FISH BIOL, V71, P629, DOI 10.1111/j.1095-8649.2007.01528.x; Russo T, 2011, AQUACULTURE, V315, P69, DOI 10.1016/j.aquaculture.2010.11.030; Russo T, 2010, J APPL ICHTHYOL, V26, P360, DOI 10.1111/j.1439-0426.2010.01435.x; Russo T, 2009, AQUACULTURE, V289, P289, DOI 10.1016/j.aquaculture.2009.01.021; Russo T, 2009, J MORPHOL, V270, P83, DOI 10.1002/jmor.10674; Sala R, 2005, J FISH BIOL, V66, P315, DOI 10.1111/j.0022-1112.2005.00580.x; SCHOENER TW, 1968, ECOLOGY, V49, P123, DOI 10.2307/1933567; Shields RJ, 2001, AQUACULTURE, V200, P55, DOI 10.1016/S0044-8486(01)00694-9; Slice DE, 1998, MORPHEUS ET AL SOFTW; Tancioni L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060392; Toscano BJ, 2010, BIOL J LINN SOC, V99, P768, DOI 10.1111/j.1095-8312.2010.01383.x; vanSnik GMJ, 1997, J FISH BIOL, V50, P1339, DOI 10.1006/jfbi.1997.0402; Von Herbing IH, 2001, J FISH BIOL, V59, P767, DOI 10.1111/j.1095-8649.2001.tb00148.x; WAINWRIGHT PC, 1995, ENVIRON BIOL FISH, V44, P97, DOI 10.1007/BF00005909; Ward-Campbell BMS, 2005, ENVIRON BIOL FISH, V72, P251, DOI 10.1007/s10641-004-1744-9; WEBB PW, 1984, SCI AM, V251, P72, DOI 10.1038/scientificamerican0784-72; Zelditch M.L., 2004, GEOMETRIC MORPHOMETR, DOI DOI 10.1016/B978-0-12-778460-1.X5000-5	69	10	10	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2014	9	1							e86646	10.1371/journal.pone.0086646	http://dx.doi.org/10.1371/journal.pone.0086646			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297XI	24466185	Green Published, Green Submitted, gold			2022-12-25	WOS:000330288000128
J	Salazar, L; Kashiwada, T; Krejci, P; Meyer, AN; Casale, M; Hallowell, M; Wilcox, WR; Donoghue, DJ; Thompson, LM				Salazar, Lisa; Kashiwada, Tamara; Krejci, Pavel; Meyer, April N.; Casale, Malcolm; Hallowell, Matthew; Wilcox, William R.; Donoghue, Daniel J.; Thompson, Leslie Michels			Fibroblast Growth Factor Receptor 3 Interacts with and Activates TGF beta-Activated Kinase 1 Tyrosine Phosphorylation and NFkB Signaling in Multiple Myeloma and Bladder Cancer	PLOS ONE			English	Article							FACTOR-KAPPA-B; URINARY-BLADDER; DOWN-REGULATION; CELL CARCINOMA; GENE-PRODUCTS; TARGET GENES; TAK1; FGFR3; EXPRESSION; PATHWAYS	Cancer is a major public health problem worldwide. In the United States alone, 1 in 4 deaths is due to cancer and for 2013 a total of 1,660,290 new cancer cases and 580,350 cancer-related deaths are projected. Comprehensive profiling of multiple cancer genomes has revealed a highly complex genetic landscape in which a large number of altered genes, varying from tumor to tumor, impact core biological pathways and processes. This has implications for therapeutic targeting of signaling networks in the development of treatments for specific cancers. The NF kappa B transcription factor is constitutively active in a number of hematologic and solid tumors, and many signaling pathways implicated in cancer are likely connected to NF kappa B activation. A critical mediator of NF kappa B activity is TGF beta-activated kinase 1 (TAK1). Here, we identify TAK1 as a novel interacting protein and target of fibroblast growth factor receptor 3 (FGFR3) tyrosine kinase activity. We further demonstrate that activating mutations in FGFR3 associated with both multiple myeloma and bladder cancer can modulate expression of genes that regulate NF kappa B signaling, and promote both NF kappa B transcriptional activity and cell adhesion in a manner dependent on TAK1 expression in both cancer cell types. Our findings suggest TAK1 as a potential therapeutic target for FGFR3-associated cancers, and other malignancies in which TAK1 contributes to constitutive NF kappa B activation.	[Salazar, Lisa; Hallowell, Matthew; Thompson, Leslie Michels] Univ Calif Irvine, Dept Psychiat & Human Behav, Irvine, CA 92717 USA; [Kashiwada, Tamara; Thompson, Leslie Michels] Univ Calif Irvine, Dept Biol Chem, Irvine, CA 92717 USA; [Krejci, Pavel; Wilcox, William R.] Cedars Sinai Med Ctr, Inst Med Genet, Los Angeles, CA 90048 USA; [Krejci, Pavel] Masaryk Univ, Inst Expt Biol, Brno, Czech Republic; [Krejci, Pavel] Inst Biophys AS CR, Dept Cytokinet, Vvi, Brno, Czech Republic; [Krejci, Pavel; Wilcox, William R.] Univ Calif Los Angeles, Sch Med, Dept Pediat, Los Angeles, CA 90024 USA; [Meyer, April N.; Donoghue, Daniel J.] Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA; [Casale, Malcolm; Thompson, Leslie Michels] Univ Calif Irvine, Dept Neurobiol & Behav, Irvine, CA USA; [Donoghue, Daniel J.] Univ Calif San Diego, Moores Canc Ctr, La Jolla, CA 92093 USA; [Thompson, Leslie Michels] Univ Calif Irvine, Chao Family Comprehens Canc Ctr, Irvine, CA USA	University of California System; University of California Irvine; University of California System; University of California Irvine; Cedars Sinai Medical Center; Masaryk University Brno; Czech Academy of Sciences; Institute of Biophysics of the Czech Academy of Sciences; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California San Diego; University of California System; University of California Irvine; University of California System; University of California San Diego; University of California System; University of California Irvine	Thompson, LM (corresponding author), Univ Calif Irvine, Dept Psychiat & Human Behav, Irvine, CA 92717 USA.	lmthomps@uci.edu	Krejčí, Pavel/I-4285-2014	Krejci, Pavel/0000-0003-0618-9134	Multiple Myeloma Research Foundation; Chao Family Comprehensive Cancer Center at UCI; Elsa U. Pardee Foundation; Ministry of Education, Youth and Sports of the Czech Republic [KONTAKT LH12004]; Czech Science Foundation [P305/11/0752]; NATIONAL CANCER INSTITUTE [P30CA062203] Funding Source: NIH RePORTER	Multiple Myeloma Research Foundation; Chao Family Comprehensive Cancer Center at UCI; Elsa U. Pardee Foundation; Ministry of Education, Youth and Sports of the Czech Republic(Ministry of Education, Youth & Sports - Czech Republic); Czech Science Foundation(Grant Agency of the Czech Republic); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the Multiple Myeloma Research Foundation, Chao Family Comprehensive Cancer Center at UCI, Elsa U. Pardee Foundation, Ministry of Education, Youth and Sports of the Czech Republic (KONTAKT LH12004), Czech Science Foundation (P305/11/0752). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amoroso SR, 1998, P NATL ACAD SCI USA, V95, P189, DOI 10.1073/pnas.95.1.189; Annunziata CM, 2007, CANCER CELL, V12, P115, DOI 10.1016/j.ccr.2007.07.004; ATAIEKACHOIE P, 2013, MOL CANC RES; Avet-Loiseau H, 2011, J CLIN ONCOL, V29, P1893, DOI 10.1200/JCO.2010.32.8435; Baud V, 2009, NAT REV DRUG DISCOV, V8, P33, DOI 10.1038/nrd2781; Bernard-Pierrot I, 2006, CARCINOGENESIS, V27, P740, DOI 10.1093/carcin/bgi290; Brill LM, 2004, ANAL CHEM, V76, P2763, DOI 10.1021/ac035352d; Chaturvedi MM, 2011, ONCOGENE, V30, P1615, DOI 10.1038/onc.2010.566; Cheng T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057284; Chesi M, 1997, NAT GENET, V16, P260, DOI 10.1038/ng0797-260; Chesi M, 2011, HEMATOL-AM SOC HEMAT, P344, DOI 10.1182/asheducation-2011.1.344; Christofori G, 2006, NATURE, V441, P444, DOI 10.1038/nature04872; Cushing MC, 2008, FASEB J, V22, P1769, DOI 10.1096/fj.07-087627; Dai L, 2012, IUBMB LIFE, V64, P825, DOI 10.1002/iub.1078; Dailey L, 2005, CYTOKINE GROWTH F R, V16, P233, DOI 10.1016/j.cytogfr.2005.01.007; Ding W, 2007, J CELL PHYSIOL, V212, P796, DOI 10.1002/jcp.21078; Drafahl KA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014412; Elsamman E, 2006, BJU INT, V97, P1202, DOI 10.1111/j.1464-410X.2006.06153.x; Ettelaie C, 2011, BBA-MOL BASIS DIS, V1812, P1591, DOI 10.1016/j.bbadis.2011.09.007; Fagerli UM, 2011, ONCOGENE, V30, P3198, DOI 10.1038/onc.2011.79; Fernandez T, 2002, J EXP MED, V195, P1247, DOI 10.1084/jem.20011521; Galvin BD, 1996, P NATL ACAD SCI USA, V93, P7894, DOI 10.1073/pnas.93.15.7894; Gust KM, 2013, MOL CANCER THER, V12, P1245, DOI 10.1158/1535-7163.MCT-12-1150; Hacot S, 2010, CURR PROTOC CELL BIO; Hafner C, 2010, EXP CELL RES, V316, P2008, DOI 10.1016/j.yexcr.2010.04.021; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Harikumar KB, 2010, MOL CANCER RES, V8, P751, DOI 10.1158/1541-7786.MCR-09-0565; Hart KC, 2000, ONCOGENE, V19, P3309, DOI 10.1038/sj.onc.1203650; Hayden MS, 2012, GENE DEV, V26, P203, DOI 10.1101/gad.183434.111; HEBRAUD B, 2013, CLIN CANC RES; Isufi I, 2007, J INTERF CYTOK RES, V27, P543, DOI 10.1089/jir.2007.0009; Iyer G., 2012, UROL ONCOL; Jackson-Bernitsas DG, 2007, ONCOGENE, V26, P1385, DOI 10.1038/sj.onc.1209945; Kalff A, 2012, BLOOD CANCER J, V2, DOI 10.1038/bcj.2012.37; Kamat AM, 2007, MOL CANCER THER, V6, P1022, DOI 10.1158/1535-7163.MCT-06-0545; Kamat AM, 2009, CANCER RES, V69, P8958, DOI 10.1158/0008-5472.CAN-09-2045; Katoh M, 2014, MED RES REV, V34, P280, DOI 10.1002/med.21288; Keats JJ, 2007, CANCER CELL, V12, P131, DOI 10.1016/j.ccr.2007.07.003; Kim HR, 2012, BMB REP, V45, P287, DOI 10.5483/BMBRep.2012.45.5.287; Kim YS, 2010, J ENDODONT, V36, P1824, DOI 10.1016/j.joen.2010.08.020; Krejci P, 2006, LEUKEMIA, V20, P1165, DOI 10.1038/sj.leu.2404202; Krejci P, 2007, J BIOL CHEM, V282, P2929, DOI 10.1074/jbc.M606144200; Krejci P, 2010, BONE, V47, P102, DOI 10.1016/j.bone.2010.03.021; Krejci P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003961; KRIKOS A, 1992, J BIOL CHEM, V267, P17971; L'Hote CGM, 2005, EXP CELL RES, V304, P417, DOI 10.1016/j.yexcr.2004.11.012; Lamont FR, 2011, BRIT J CANCER, V104, P75, DOI 10.1038/sj.bjc.6606016; Landstrom M, 2010, INT J BIOCHEM CELL B, V42, P585, DOI 10.1016/j.biocel.2009.12.023; Levidou G, 2008, VIRCHOWS ARCH, V452, P295, DOI 10.1007/s00428-007-0560-y; Li ZW, 2008, CURR OPIN HEMATOL, V15, P391, DOI 10.1097/MOH.0b013e328302c7f4; Lievens PMJ, 2003, J BIOL CHEM, V278, P17344, DOI 10.1074/jbc.M212710200; LIN CW, 1985, CANCER RES, V45, P5070; Lunqu G, 2008, MOL CARCINOGEN, V47, P424, DOI 10.1002/mc.20398; Mack GS, 2010, NAT BIOTECHNOL, V28, P214, DOI 10.1038/nbt0310-214; Martin SE, 2011, CURR CANCER DRUG TAR, V11, P976; Melisi D, 2011, JNCI-J NATL CANCER I, V103, P1190, DOI 10.1093/jnci/djr243; Mukherji M, 2006, BIOCHEMISTRY-US, V45, P15529, DOI 10.1021/bi060971c; NAMBA M, 1989, IN VITRO CELL DEV B, V25, P723; Nilsson EM, 2012, MOL CELL ENDOCRINOL, V358, P104, DOI 10.1016/j.mce.2012.03.009; Omori E, 2010, CANCER RES, V70, P8417, DOI 10.1158/0008-5472.CAN-10-1227; Ong SH, 2000, MOL CELL BIOL, V20, P979, DOI 10.1128/MCB.20.3.979-989.2000; Pahl HL, 1999, ONCOGENE, V18, P6853, DOI 10.1038/sj.onc.1203239; Pera EM, 2003, GENE DEV, V17, P3023, DOI 10.1101/gad.1153603; Perkins ND, 2012, NAT REV CANCER, V12, P121, DOI 10.1038/nrc3204; Ramos C, 2010, AM J PHYSIOL-LUNG C, V299, pL222, DOI 10.1152/ajplung.00070.2010; Ray DM, 2012, BRIT J CANCER, V107, P129, DOI 10.1038/bjc.2012.214; Ricol D, 1999, ONCOGENE, V18, P7234, DOI 10.1038/sj.onc.1203186; Sabbieti MG, 2013, ENDOCRINOLOGY, V154, P2723, DOI 10.1210/en.2013-1025; Safina A, 2008, ONCOGENE, V27, P1198, DOI 10.1038/sj.onc.1210768; Sakurai H, 2012, TRENDS PHARMACOL SCI, V33, P522, DOI 10.1016/j.tips.2012.06.007; Salazar L, 2009, HUM MOL GENET, V18, P1951, DOI 10.1093/hmg/ddp116; Shinohara H, 2009, IMMUNOL REV, V232, P300, DOI 10.1111/j.1600-065X.2009.00836.x; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Singh A, 2012, CELL, V148, P639, DOI 10.1016/j.cell.2011.12.033; Urashima M, 1996, BLOOD, V87, P1928; van Wijk B, 2009, CIRC RES, V105, P431, DOI 10.1161/CIRCRESAHA.109.203083; Wei WZ, 2012, MOL CELL BIOL, V32, P4662, DOI 10.1128/MCB.00935-12; Wesche J, 2011, BIOCHEM J, V437, P199, DOI 10.1042/BJ20101603; Williams SV, 2013, HUM MOL GENET, V22, P795, DOI 10.1093/hmg/dds486; Xie WJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010850; Yang L, 2013, GASTROENTEROLOGY, V144, P1042, DOI 10.1053/j.gastro.2013.01.056; Zhang N, 2010, ANTICANCER RES, V30, P87; Zheng YH, 2013, J BIOL CHEM, V288, P31488, DOI 10.1074/jbc.M113.499020; Zhu YX, 2011, BLOOD, V117, P3847, DOI 10.1182/blood-2010-08-304022; Zingone A, 2010, LEUKEMIA, V24, P1171, DOI 10.1038/leu.2010.50	85	24	26	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2014	9	1							e86470	10.1371/journal.pone.0086470	http://dx.doi.org/10.1371/journal.pone.0086470			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297XI	24466111	Green Published, Green Submitted, gold			2022-12-25	WOS:000330288000101
J	Tam, WWS; Wong, TW; Ng, L; Wong, SYS; Kung, KKL; Wong, AHS				Tam, Wilson W. S.; Wong, Tze Wai; Ng, Lorna; Wong, Samuel Y. S.; Kung, Kenny K. L.; Wong, Andromeda H. S.			Association between Air Pollution and General Outpatient Clinic Consultations for Upper Respiratory Tract Infections in Hong Kong	PLOS ONE			English	Article							COARSE PARTICULATE MATTER; SHORT-TERM ASSOCIATIONS; HOSPITAL ADMISSIONS; DISEASES; VISITS; MORTALITY; HEALTH; FINE; PARTICLES; LONDON	Background and Objectives: Many studies have shown the adverse effects of air pollution on respiratory health, but few have examined the effects of air pollution on service utilisation in the primary care setting. The aim of this study was to examine the association between air pollution and the daily number of consultations due to upper respiratory tract infections (URTIs) in general outpatient clinics (GOPCs) in Hong Kong. Methods: Daily data on the numbers of consultations due to URTIs in GOPCs, the concentrations of major air pollutants, and the mean values of metrological variables were retrospectively collected over a 3-year period (2008-2010, inclusive). Generalised additive models were constructed to examine the association between air pollution and the daily number of consultations, and to derive the relative risks and 95% confidence intervals (95% CI) of GOPC consultations for a unit increase in the concentrations of air pollutants. Results: The mean daily consultations due to URTIs in GOPCs ranged from 68.4 to 253.0 over the study period. The summary relative risks (and 95% CI) of daily consultations in all GOPCs for the air pollutants PM10, NO2, O-3, and SO2 were 1.005 (1.002, 1.009), 1.010 (1.006, 1.013), 1.009 (1.006, 1.012), and 1.004 (1.000, 1.008) respectively, per 10 mu g/m(3) increase in the concentration of each pollutant. Conclusion: Significant associations were found between the daily number of consultations due to URTIs in GOPCs and the concentrations of air pollutants, implying that air pollution incurs a substantial morbidity and increases the burden of primary health care services.	[Tam, Wilson W. S.; Wong, Tze Wai; Wong, Samuel Y. S.; Kung, Kenny K. L.; Wong, Andromeda H. S.] Chinese Univ Hong Kong, Jockey Club Sch Publ Hlth & Primary Care, Shatin, Hong Kong, Peoples R China; [Tam, Wilson W. S.] Chinese Univ Hong Kong, Shenzhen Res Inst, Shenzhen Municipal Key Lab Hlth Risk Anal, Shenzhen, Guangdong, Peoples R China; [Ng, Lorna] Kwong Wah Hosp, Gen Outpatient Clin, Yaumatei, Hong Kong, Peoples R China	Chinese University of Hong Kong; Chinese University of Hong Kong, Shenzhen; Kwong Wah Hospital	Wong, TW (corresponding author), Chinese Univ Hong Kong, Jockey Club Sch Publ Hlth & Primary Care, Shatin, Hong Kong, Peoples R China.	twwong@cuhk.edu.hk	WONG, Samuel Yeung Shan/D-7311-2013; Tam, Wilson/K-1664-2019; Kung, Kenny/A-2381-2015; TAM, Wilson W.S./H-5890-2019	WONG, Samuel Yeung Shan/0000-0003-0934-6385; Kung, Kenny/0000-0002-2063-126X; TAM, Wilson W.S./0000-0003-0641-3060; /0000-0002-3059-0334				Atkinson RW, 2001, AM J RESP CRIT CARE, V164, P1860, DOI 10.1164/ajrccm.164.10.2010138; Bell ML, 2008, AM J EPIDEMIOL, V168, P1301, DOI 10.1093/aje/kwn252; Bremner SA, 1999, OCCUP ENVIRON MED, V56, P237, DOI 10.1136/oem.56.4.237; Chang CJ, 2012, INVEST OPHTH VIS SCI, V53, P429, DOI 10.1167/iovs.11-8253; Cheung NT, 2001, INT J MED INFORM, V62, P113, DOI 10.1016/S1386-5056(01)00155-1; Ciencewicki J, 2007, INHAL TOXICOL, V19, P1135, DOI 10.1080/08958370701665434; Duffy ME, 2006, CLIN NURSE SPEC, V20, P273, DOI 10.1097/00002800-200611000-00005; Fleiss J L, 1993, Stat Methods Med Res, V2, P121, DOI 10.1177/096228029300200202; Hajat S, 2002, OCCUP ENVIRON MED, V59, P294, DOI 10.1136/oem.59.5.294; Hajat S, 2001, AM J EPIDEMIOL, V153, P704, DOI 10.1093/aje/153.7.704; Hajat S, 1999, THORAX, V54, P597, DOI 10.1136/thx.54.7.597; Hastie T, 1995, Stat Methods Med Res, V4, P187, DOI 10.1177/096228029500400302; Host S, 2008, OCCUP ENVIRON MED, V65, P544, DOI 10.1136/oem.2007.036194; Hwang JS, 2002, AM J EPIDEMIOL, V155, P1, DOI 10.1093/aje/155.1.1; Kan HD, 2007, ENVIRON INT, V33, P376, DOI 10.1016/j.envint.2006.12.001; Kan HD, 2003, ARCH ENVIRON HEALTH, V58, P360; Katsouyanni K, 1997, BMJ-BRIT MED J, V314, P1658, DOI 10.1136/bmj.314.7095.1658; Li Y, 2010, SCI TOTAL ENVIRON, V408, P1226, DOI 10.1016/j.scitotenv.2009.11.035; Lo YYC LC, 2011, HONG KONG MED J, V17, P7; Ng LV, 2009, HONG KONG PRACTITION, V31, P10; Oiamo TH, 2011, ENVIRON HEALTH-GLOB, V10, DOI 10.1186/1476-069X-10-71; Ostro BD, 1999, ENVIRON HEALTH PERSP, V107, P69, DOI 10.2307/3434291; Peng RD, 2008, JAMA-J AM MED ASSOC, V299, P2172, DOI 10.1001/jama.299.18.2172; Qiu H, 2012, ENVIRON HEALTH PERSP, V120, P572, DOI 10.1289/ehp.1104002; Rahman I, 2000, EUR RESPIR J, V16, P534, DOI 10.1034/j.1399-3003.2000.016003534.x; Reist M, 1998, FEBS LETT, V423, P231, DOI 10.1016/S0014-5793(98)00099-4; Samet JM, 2000, NEW ENGL J MED, V343, P1742, DOI 10.1056/NEJM200012143432401; Scapellato ML, 2007, CRIT REV TOXICOL, V37, P461, DOI 10.1080/10408440701385622; Schwartz J, 1999, EPIDEMIOLOGY, V10, P17, DOI 10.1097/00001648-199901000-00005; Sinclair AH, 2004, J AIR WASTE MANAGE, V54, P1212, DOI 10.1080/10473289.2004.10470979; Uysal N, 2003, CURR OPIN PULM MED, V9, P144, DOI 10.1097/00063198-200303000-00009; WHO WHO, 2004, RESP CAR PRIM CAR SE, P121; Wong CM, 2008, ENVIRON HEALTH PERSP, V116, P1195, DOI 10.1289/ehp.11257; Wong TW, 2006, THORAX, V61, P585, DOI 10.1136/thx.2005.051730; Wood SN, 2006, GEN ADDITIVE MODELS, Vxvii; World Health Organization, 2006, WHO AIR QUAL GUID PA; World Organization of National Colleges Academies and Academic Associations of General Practitioners/Family Physicians, 1998, ICPC 2 INT CLASS PRI, Vx; Yam CHK, 2011, BMC HEALTH SERV RES, V11, DOI 10.1186/1472-6963-11-255	38	24	27	3	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2014	9	1							e86913	10.1371/journal.pone.0086913	http://dx.doi.org/10.1371/journal.pone.0086913			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297XI	24466288	Green Published, Green Submitted, gold			2022-12-25	WOS:000330288000171
J	Toska, J; Sun, Y; Carbonell, DA; Foster, ANS; Jacobs, MR; Pearlman, E; Rietsch, A				Toska, Jonida; Sun, Yan; Carbonell, Dalina Alvarez; Foster, Altreisha N. -S.; Jacobs, Michael R.; Pearlman, Eric; Rietsch, Arne			Diversity of Virulence Phenotypes among Type III Secretion Negative Pseudomonas aeruginosa Clinical Isolates	PLOS ONE			English	Article							COMPLETE GENOME SEQUENCE; CYSTIC-FIBROSIS; CONTACT-LENS; CORNEAL INFECTION; PROTEIN SECRETION; EPITHELIAL-CELLS; IN-VIVO; KERATITIS; SYSTEM; PNEUMONIA	Pseudomonas aeruginosa is a frequent cause of acute infections. The primary virulence factor that has been linked to clinical disease is the type III secretion system, a molecular syringe that delivers effector proteins directly into host cells. Despite the importance of type III secretion in dictating clinical outcomes and promoting disease in animal models of infections, clinical isolates often do not express the type III secretion system in vitro. Here we screened 81 clinical P. aeruginosa isolates for secretion of type III secretion system substrates by western blot. Non-expressing strains were also subjected to a functional test assaying the ability to intoxicate epithelial cells in vitro, and to survive and cause disease in a murine model of corneal infection. 26 of 81 clinical isolates were found to be type III secretion negative by western blot. 17 of these 26 non-expressing strains were tested for their ability to cause epithelial cell rounding. Of these, three isolates caused epithelial cell rounding in a type III secretion system dependent manner, and one strain was cytotoxic in a T3SS-independent manner. Five T3SS-negative isolates were also tested for their ability to cause disease in a murine model of corneal infection. Of these isolates, two strains caused severe corneal disease in a T3SS-independent manner. Interestingly, one of these strains caused significant disease (inflammation) despite being cleared. Our data therefore show that P. aeruginosa clinical isolates can cause disease in a T3SS-independent manner, demonstrating the existence of novel modifiers of clinical disease.	[Toska, Jonida; Carbonell, Dalina Alvarez; Rietsch, Arne] Case Western Reserve Univ, Dept Mol Biol & Microbiol, Cleveland, OH 44106 USA; [Sun, Yan; Pearlman, Eric] Case Western Reserve Univ, Dept Ophthalmol & Visual Sci, Cleveland, OH 44106 USA; [Foster, Altreisha N. -S.; Jacobs, Michael R.] Case Western Reserve Univ, Dept Pathol, Cleveland, OH 44106 USA; [Foster, Altreisha N. -S.; Jacobs, Michael R.] Univ Hosp Case Med Ctr, Cleveland, OH USA	Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; Case Western Reserve University Hospital	Rietsch, A (corresponding author), Case Western Reserve Univ, Dept Mol Biol & Microbiol, Cleveland, OH 44106 USA.	arne.rietsch@case.edu		Rietsch, Arne/0000-0002-1556-7064	NIH [R01 EY22052, RO1 EY14362, P30 EY11373]; NATIONAL EYE INSTITUTE [P30EY011373, R01EY022052, R01EY014362] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	The research was funded by NIH grant R01 EY22052 (AR), RO1 EY14362 (EP) and P30 EY11373 (EP). (www.nih.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alarcon I, 2009, INFECT IMMUN, V77, P3264, DOI 10.1128/IAI.00111-09; Barbieri JT, 2005, REV PHYSIOL BIOCH P, V152, P79, DOI 10.1007/s10254-004-0031-7; Battle SE, 2008, J BACTERIOL, V190, P7130, DOI 10.1128/JB.00785-08; Bleves S, 2005, J BACTERIOL, V187, P3898, DOI 10.1128/JB.187.11.3898-3902.2005; Bradbury RS, 2010, J MED MICROBIOL, V59, P881, DOI 10.1099/jmm.0.018283-0; Campo N, 2006, MOL CELL, V23, P25, DOI 10.1016/j.molcel.2006.05.019; Cheng KH, 1999, LANCET, V354, P181, DOI 10.1016/S0140-6736(98)09385-4; Choy MH, 2008, J MED MICROBIOL, V57, P1539, DOI 10.1099/jmm.0.2008/003723-0; Cisz M, 2008, J BACTERIOL, V190, P2726, DOI 10.1128/JB.01553-07; Cowell BA, 2003, MICROBIOL-SGM, V149, P2291, DOI 10.1099/mic.0.26280-0; Cowell BA, 2003, CORNEA, V22, P131, DOI 10.1097/00003226-200303000-00010; Dacheux D, 2000, INFECT IMMUN, V68, P2916, DOI 10.1128/IAI.68.5.2916-2924.2000; Diaz MH, 2010, INFECT IMMUN, V78, P1447, DOI 10.1128/IAI.01134-09; El-Solh AA, 2012, CRIT CARE MED, V40, P1157, DOI 10.1097/CCM.0b013e3182377906; Engel LS, 1998, INVEST OPHTH VIS SCI, V39, P662; Feltman H, 2001, MICROBIOL-SGM, V147, P2659, DOI 10.1099/00221287-147-10-2659; Garrity-Ryan L, 2000, INFECT IMMUN, V68, P7100, DOI 10.1128/IAI.68.12.7100-7113.2000; Hauser AR, 2009, NAT REV MICROBIOL, V7, P654, DOI 10.1038/nrmicro2199; Hauser AR, 1998, MOL MICROBIOL, V27, P807, DOI 10.1046/j.1365-2958.1998.00727.x; Hauser AR, 2002, CRIT CARE MED, V30, P521, DOI 10.1097/00003246-200203000-00005; Hobden JA, 1996, IMMUNOL CELL BIOL, V74, P258, DOI 10.1038/icb.1996.46; Hoiby N, 2010, FUTURE MICROBIOL, V5, P1663, DOI [10.2217/fmb.10.125, 10.2217/FMB.10.125]; Jain M, 2008, TRANSL RES, V152, P257, DOI 10.1016/j.trsl.2008.10.003; Karthikeyan RS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064867; Kurahashi K, 1999, J CLIN INVEST, V104, P743, DOI 10.1172/JCI7124; Lee EJ, 2003, INVEST OPHTH VIS SCI, V44, P5220, DOI 10.1167/iovs.03-0229; Lee EJ, 2003, INVEST OPHTH VIS SCI, V44, P3892, DOI 10.1167/iovs.02-1302; Lee VT, 2005, INFECT IMMUN, V73, P1695, DOI 10.1128/IAI.73.3.1695-1705.2005; Lomholt JA, 2001, INFECT IMMUN, V69, P6284, DOI 10.1128/IAI.69.10.6284-6295.2001; MILLER VL, 1988, J BACTERIOL, V170, P2575, DOI 10.1128/JB.170.6.2575-2583.1988; Preston MJ, 1997, INFECT IMMUN, V65, P3086, DOI 10.1128/IAI.65.8.3086-3090.1997; Rietsch A, 2005, P NATL ACAD SCI USA, V102, P8006, DOI 10.1073/pnas.0503005102; Roy PH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008842; Roy-Burman A, 2001, J INFECT DIS, V183, P1767, DOI 10.1086/320737; Sato H, 2003, EMBO J, V22, P2959, DOI 10.1093/emboj/cdg290; Sawa T, 1999, NAT MED, V5, P392, DOI 10.1038/7391; Schulert GS, 2003, J INFECT DIS, V188, P1695, DOI 10.1086/379372; Spilker T, 2004, J CLIN MICROBIOL, V42, P2074, DOI 10.1128/JCM.42.5.2074-2079.2004; Stapleton F, 2007, OPTOMETRY VISION SCI, V84, P257, DOI 10.1097/OPX.0b013e3180485d5f; Stover CK, 2000, NATURE, V406, P959, DOI 10.1038/35023079; Sun Y, 2012, J IMMUNOL, V188, P1884, DOI 10.4049/jimmunol.1102148; Sun Y, 2010, J IMMUNOL, V185, P4272, DOI 10.4049/jimmunol.1000874; Tang A, 2013, INVEST OPHTH VIS SCI, V54, P2821, DOI 10.1167/iovs.13-11788; TWINING SS, 1993, INVEST OPHTH VIS SCI, V34, P2699; Vance RE, 2005, INFECT IMMUN, V73, P1706, DOI 10.1128/IAI.73.3.1706-1713.2005; VASIL ML, 1991, ANTIBIOT CHEMOTHER, V44, P34; Wareham DW, 2007, INT J MED MICROBIOL, V297, P227, DOI 10.1016/j.ijmm.2007.02.004; Warrens AN, 1997, GENE, V186, P29, DOI 10.1016/S0378-1119(96)00674-9; Willcox MDP, 2007, OPTOMETRY VISION SCI, V84, P273, DOI 10.1097/OPX.0b013e3180439c3e; Winstanley C, 2005, J MED MICROBIOL, V54, P519, DOI 10.1099/jmm.0.46005-0; Wong-Beringer A, 2008, CLIN MICROBIOL INFEC, V14, P330, DOI 10.1111/j.1469-0691.2007.01939.x; Yahr TL, 2006, MOL MICROBIOL, V62, P631, DOI 10.1111/j.1365-2958.2006.05412.x; Yahr TL, 1998, P NATL ACAD SCI USA, V95, P13899, DOI 10.1073/pnas.95.23.13899; Zhou HJ, 2008, CRIT CARE MED, V36, P2495, DOI 10.1097/CCM.0b013e318183f3f8	54	17	17	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2014	9	1							e86829	10.1371/journal.pone.0086829	http://dx.doi.org/10.1371/journal.pone.0086829			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297XI	24466261	gold, Green Published, Green Submitted			2022-12-25	WOS:000330288000154
J	Tu, YQ; Hu, Y; Fan, GR; Chen, ZH; Liu, L; Man, DD; Liu, SJ; Tang, CW; Zhang, Y; Dai, WX				Tu, Yaqin; Hu, Yang; Fan, Guorun; Chen, Zhihao; Liu, Lin; Man, Dandan; Liu, Shuojie; Tang, Chengwu; Zhang, Yin; Dai, Wuxing			Protective Effects of Membrane-Anchored and Secreted DNA Vaccines Encoding Fatty Acid-Binding Protein and Glutathione S-Transferase against Schistosoma japonicum	PLOS ONE			English	Article							IMMUNE-RESPONSE; MANSONI; INFECTION; MICE; VACCINATION; RESISTANCE; TH1-TYPE; SURFACE; CHINA; ASSOCIATION	In order to explore the high performance bivalent DNA-based vaccine against schistosomes, SjFABP and Sj26GST were selected and used to construct a vaccine. Two strategies were used to construct the bivalent DNA vaccine. In the first strategy, a plasmid encoding antigen in the secreted form was used, while in the other, a plasmid encoding a truncated form of SjFABP and Sj26GST targeted to the cell surface was used. Various parameters, including antibody and cytokine response, proliferation, histopathological examination, and characterization of T cell subsets were used to evaluate the type of immune response and the level of protection against challenge infection. Injection with secreted pIRES-sjFABP-sj26GST significantly increased the levels of antibody, splenocyte proliferation, and production of IFN-gamma, compared with membrane-anchored groups. Analysis of splenic T cell subsets showed that the secreted vaccine significantly increased the percentage of CD3(+)CD4(+) and CD3(+)CD8(+) T cells. Liver immunopathology (size of liver granulomas) was significantly reduced in the secreted group compared with the membrane-anchored groups. Moreover, challenge experiments showed that the worm and egg burdens were significantly reduced in animals immunized with recombinant vaccines. Most importantly, secreted Sj26GST-SjFABP markedly enhanced protection, by reducing worm and egg burdens by 31.8% and 24.78%, respectively, while the membrane-anchored group decreased worm and egg burdens by 24.80% and 18.80%, respectively. Taken together, these findings suggest that the secretory vaccine is more promising than the membrane-anchored vaccine, and provides support for the development and application of this vaccine.	[Tu, Yaqin; Hu, Yang; Chen, Zhihao; Liu, Lin; Man, Dandan; Liu, Shuojie; Tang, Chengwu; Zhang, Yin; Dai, Wuxing] Huazhong Univ Sci & Technol, Dept Biochem & Mol Biol, Tongji Med Coll, Wuhan 430074, Hubei, Peoples R China; [Fan, Guorun] Huazhong Univ Sci & Technol, Dept Otorhinolaryngol, Union Hosp, Tongji Med Coll, Wuhan 430074, Hubei, Peoples R China	Huazhong University of Science & Technology; Huazhong University of Science & Technology	Hu, Y (corresponding author), Huazhong Univ Sci & Technol, Dept Biochem & Mol Biol, Tongji Med Coll, Wuhan 430074, Hubei, Peoples R China.	huyang081991@126.com; daiwuxing1950@163.com	chen, zhihao/GXM-3816-2022		National Natural Science Foundation of China [30471603]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by The National Natural Science Foundation of China (No. 30471603). URL: http://www.nsfc.gov.cn/Portal0/default152.htm. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSEN P, 1994, INFECT IMMUN, V62, P2536, DOI 10.1128/IAI.62.6.2536-2544.1994; Bar-Or RL, 2000, MATH BIOSCI, V163, P35; Cardoso FC, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000308; Correa-Oliveira R, 2000, PARASITOL TODAY, V16, P397, DOI 10.1016/S0169-4758(00)01740-3; Dai Y, 2009, CLIN VACCINE IMMUNOL, V16, P1796, DOI 10.1128/CVI.00231-09; El Ridi R, 2009, VACCINE, V27, P666, DOI 10.1016/j.vaccine.2008.11.039; Fonseca CT, 2006, MICROBES INFECT, V8, P2509, DOI 10.1016/j.micinf.2006.06.008; Forns X, 1999, VACCINE, V17, P1992, DOI 10.1016/S0264-410X(98)00448-4; Gause WC, 2003, TRENDS IMMUNOL, V24, P269, DOI 10.1016/S1471-4906(03)00101-7; Gray DJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004058; Guo Ping, 2006, J Huazhong Univ Sci Technolog Med Sci, V26, P493, DOI 10.1007/s11596-006-0501-z; KAMIYA H, 1993, PARASITOL RES, V79, P293, DOI 10.1007/BF00932184; Kawagishi C, 2001, BBA-MOL CELL RES, V1541, P221, DOI 10.1016/S0167-4889(01)00158-6; Li GF, 2005, ACTA BIOCH BIOPH SIN, V37, P751, DOI 10.1111/j.1745-7270.2005.00111.x; Li MJ, 2011, EXP PARASITOL, V128, P427, DOI 10.1016/j.exppara.2011.05.012; Li YS, 2006, AM J TROP MED HYG, V75, P910, DOI 10.4269/ajtmh.2006.75.910; Liao Q, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023786; LIU SX, 1995, PARASITE IMMUNOL, V17, P335, DOI 10.1111/j.1365-3024.1995.tb00900.x; Pearce EJ, 2002, NAT REV IMMUNOL, V2, P499, DOI 10.1038/nri843; ROBERTS M, 1993, INFECT IMMUN, V61, P4984, DOI 10.1128/IAI.61.12.4984-4993.1993; SHER A, 1990, P NATL ACAD SCI USA, V87, P61, DOI 10.1073/pnas.87.1.61; SMITH GL, 1983, NATURE, V302, P490, DOI 10.1038/302490a0; Tang HB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054432; Tran MH, 2006, NAT MED, V12, P835, DOI 10.1038/nm1430; Wei F, 2008, VACCINE, V26, P4145, DOI 10.1016/j.vaccine.2008.05.034; Wei F, 2010, VACCINE, V28, P5161, DOI 10.1016/j.vaccine.2010.06.012; Wu ZD, 2005, ACTA TROP, V96, P106, DOI 10.1016/j.actatropica.2005.08.005; Xu XD, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-54; YANG W, 1995, BIOCHEM BIOPH RES CO, V212, P1029, DOI 10.1006/bbrc.1995.2073; Zhang L, 2008, MICROBES INFECT, V10, P251, DOI 10.1016/j.micinf.2007.11.009; Zhang YB, 2001, VACCINE, V20, P724, DOI 10.1016/S0264-410X(01)00420-0; Zuim NR, 2012, INTERDISCIP PERSPECT, V2012	33	6	10	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2014	9	1							e86575	10.1371/journal.pone.0086575	http://dx.doi.org/10.1371/journal.pone.0086575			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297XI	24466157	Green Submitted, Green Published, gold			2022-12-25	WOS:000330288000115
J	de la Rosa, S; Streuber, S; Giese, M; Bulthoff, HH; Curio, C				de la Rosa, Stephan; Streuber, Stephan; Giese, Martin; Buelthoff, Heinrich H.; Curio, Cristobal			Putting Actions in Context: Visual Action Adaptation Aftereffects Are Modulated by Social Contexts	PLOS ONE			English	Article							MIRROR NEURONS; PERCEPTION; REPRESENTATIONS; RECOGNITION; MECHANISMS	The social context in which an action is embedded provides important information for the interpretation of an action. Is this social context integrated during the visual recognition of an action? We used a behavioural visual adaptation paradigm to address this question and measured participants' perceptual bias of a test action after they were adapted to one of two adaptors (adaptation after-effect). The action adaptation after-effect was measured for the same set of adaptors in two different social contexts. Our results indicate that the size of the adaptation effect varied with social context (social context modulation) although the physical appearance of the adaptors remained unchanged. Three additional experiments provided evidence that the observed social context modulation of the adaptation effect are owed to the adaptation of visual action recognition processes. We found that adaptation is critical for the social context modulation (experiment 2). Moreover, the effect is not mediated by emotional content of the action alone (experiment 3) and visual information about the action seems to be critical for the emergence of action adaptation effects (experiment 4). Taken together these results suggest that processes underlying visual action recognition are sensitive to the social context of an action.	[de la Rosa, Stephan; Streuber, Stephan; Buelthoff, Heinrich H.; Curio, Cristobal] Max Planck Inst Biol Cybernet, D-72076 Tubingen, Germany; [Giese, Martin] Univ Tubingen, Hertie Inst Clin Brain Res, Tubingen, Germany; [Buelthoff, Heinrich H.] Korea Univ, Dept Brain & Cognit Engn, Coll Informat & Commun, Seoul, South Korea	Max Planck Society; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Korea University	de la Rosa, S (corresponding author), Max Planck Inst Biol Cybernet, Spemannstr 38, D-72076 Tubingen, Germany.	delarosa@tuebingen.mpg.de	Bülthoff, Heinrich/AAC-8818-2019; Streuber, Stephan/ABG-1550-2021; Bülthoff, Heinrich H/J-6579-2012	Bülthoff, Heinrich H/0000-0003-2568-0607; de la Rosa, Stephan/0000-0003-2759-9589	EU project TANGO (FET-Open grant) [249858]; World class University; Ministry of Education, Science and Technology through the National Research Foundation of Korea [R31-10008]	EU project TANGO (FET-Open grant); World class University; Ministry of Education, Science and Technology through the National Research Foundation of Korea	This research was supported by the EU project TANGO (FET-Open grant number: 249858) and by the World class University program funded by the Ministry of Education, Science and Technology through the National Research Foundation of Korea (R31-10008). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aglioti SM, 2008, NAT NEUROSCI, V11, P1109, DOI 10.1038/nn.2182; Barraclough N, 2011, PSYCHOL SCI, V22, P87, DOI 10.1177/0956797610391910; Barraclough NE, 2012, VISION RES, V59, P1, DOI 10.1016/j.visres.2012.02.011; Barraclough NE, 2009, J COGNITIVE NEUROSCI, V21, P1805, DOI 10.1162/jocn.2008.21145; Blake R, 2007, ANNU REV PSYCHOL, V58, P47, DOI 10.1146/annurev.psych.57.102904.190152; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Casile A, 2006, CURR BIOL, V16, P69, DOI 10.1016/j.cub.2005.10.071; Chan E, 2006, J EXP SOC PSYCHOL, V42, P365, DOI 10.1016/j.jesp.2005.04.008; Christensen A, 2011, J NEUROSCI, V31, P3493, DOI 10.1523/JNEUROSCI.4277-10.2011; Cook R, 2012, J EXP PSYCHOL GEN, V141, P774, DOI 10.1037/a0027561; Filimon F, 2007, NEUROIMAGE, V37, P1315, DOI 10.1016/j.neuroimage.2007.06.008; Fleischer F, 2012, IEEE RAS INT C HUM R, P514; Fleischer F, 2013, J NEUROSCI, V33, P6563, DOI 10.1523/JNEUROSCI.4129-12.2013; Fleischer F, 2012, PSYCHOL RES-PSYCH FO, V76, P476, DOI 10.1007/s00426-012-0437-9; FOX E, 1995, PSYCHON B REV, V2, P145, DOI 10.3758/BF03210958; Georgiou I, 2007, COGNITION, V102, P415, DOI 10.1016/j.cognition.2006.01.008; Gibson JJ, 1937, J EXP PSYCHOL, V20, P553, DOI 10.1037/h0057585; Giese MA, 2003, NAT REV NEUROSCI, V4, P179, DOI 10.1038/nrn1057; Grafton ST, 1996, EXP BRAIN RES, V112, P103; Hermans D, 2001, COGNITION EMOTION, V15, P143, DOI 10.1080/0269993004200033; Hickok G, 2009, J COGNITIVE NEUROSCI, V21, P1229, DOI 10.1162/jocn.2009.21189; Iacoboni M, 2005, PLOS BIOL, V3, P529, DOI 10.1371/journal.pbio.0030079; Jacob P, 2005, TRENDS COGN SCI, V9, P21, DOI 10.1016/j.tics.2004.11.003; Kaplan JT, 2006, SOC NEUROSCI-UK, V1, P175, DOI 10.1080/17470910600985605; Kleiner M, 2007, PERCEPTION, V36, P14; Kohn A, 2007, J NEUROPHYSIOL, V97, P3155, DOI 10.1152/jn.00086.2007; Kret ME, 2010, EXP BRAIN RES, V203, P169, DOI 10.1007/s00221-010-2220-8; Layher Georg, 2012, Artificial Neural Networks and Machine Learning - ICANN 2012. Proceedings 22nd International Conference on Artificial Neural Networks, P288, DOI 10.1007/978-3-642-33269-2_37; Leopold DA, 2001, NAT NEUROSCI, V4, P89, DOI 10.1038/82947; Manera V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054949; Manera V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014594; Neri P, 2006, NAT NEUROSCI, V9, P1186, DOI 10.1038/nn1759; O'Craven KM, 2000, J COGNITIVE NEUROSCI, V12, P1013, DOI 10.1162/08989290051137549; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; Streuber S, 2011, EXP BRAIN RES, V214, P273, DOI 10.1007/s00221-011-2830-9; TULVING E, 1990, SCIENCE, V247, P301, DOI 10.1126/science.2296719; Webster MA, 2004, NATURE, V428, P557, DOI 10.1038/nature02420; Webster MA, 2011, J VISION, V11, DOI 10.1167/11.5.3; Wichmann FA, 2001, PERCEPT PSYCHOPHYS, V63, P1293, DOI 10.3758/BF03194544	39	22	22	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2014	9	1							e86502	10.1371/journal.pone.0086502	http://dx.doi.org/10.1371/journal.pone.0086502			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	297VL	24466123	Green Published, gold, Green Submitted			2022-12-25	WOS:000330283100175
J	Hiemstra, M; Kleinjan, M; van Schayck, OCP; Engels, RCME; Otten, R				Hiemstra, Marieke; Kleinjan, Marloes; van Schayck, Onno C. P.; Engels, Rutger C. M. E.; Otten, Roy			Environmental Smoking and Smoking Onset in Adolescence: The Role of Dopamine-Related Genes. Findings from Two Longitudinal Studies	PLOS ONE			English	Article							RECEPTOR DRD4 GENE; CIGARETTE-SMOKING; NICOTINE DEPENDENCE; INCENTIVE SALIENCE; VNTR POLYMORPHISM; PARENTAL SMOKING; TRANSPORTER GENE; FRIENDS SMOKING; ASSOCIATION; BEHAVIOR	Although environmental smoking (i.e., paternal and maternal smoking, sibling smoking, and peer smoking) is one of the most important factors for explaining adolescent smoking behavior, not all adolescents are similarly affected. The extent to which individuals are vulnerable to smoking in their environment might depend on genetic factors. The aim of this study was to examine the interplay between environmental smoking and genes encoding components of the dopaminergic system (i.e., dopamine receptor D2, D4, and dopamine transporter DAT1) in adolescent smoking onset. Data from two longitudinal studies were used. Study 1 consisted of 991 non-smoking early adolescents (mean age = 12.52, SD = .57) whereas study 2 consisted of 365 non-smoking middle to late adolescents (mean age = 14.16, SD = 1.07) who were followed for 16 and 48 months, respectively. Logistic regression analyses were conducted using Mplus. In study 1, we found positive associations between parents' and friends' smoking at the first measurement and smoking status 16 months later. In study 2 we found a positive association between friends' smoking and smoking onset 48 months later. Neither study demonstrated any interaction effects of the DRD2, DRD4, or DAT1 genotypes. In conclusion, the effects of environmental smoking on smoking onset are similar for adolescent carriers and non-carriers of these specific genes related to the dopaminergic system.	[Hiemstra, Marieke; Kleinjan, Marloes; Engels, Rutger C. M. E.; Otten, Roy] Radboud Univ Nijmegen, Inst Behav Sci, NL-6525 ED Nijmegen, Netherlands; [van Schayck, Onno C. P.] Maastricht Univ, CAPHRI, Maastricht, Netherlands	Radboud University Nijmegen; Maastricht University	Hiemstra, M (corresponding author), Radboud Univ Nijmegen, Inst Behav Sci, NL-6525 ED Nijmegen, Netherlands.	m.hiemstra@bsi.ru.nl	Kleinjan, Marloes/AAF-1128-2019	Engels, Rutger/0000-0003-1944-9126; Kleinjan, Marloes/0000-0002-4545-5549	Dutch Organization of Scientific Research (NWO) [451-09-009, 016-005-029, 400-05-051]; Dutch Cancer Society (KWF) [2006-3464]	Dutch Organization of Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); Dutch Cancer Society (KWF)(KWF Kankerbestrijding)	The first study focusing on genetic and environmental influences on substance use was funded by the Dutch Organization of Scientific Research (NWO: 451-09-009). The second study, 'Family and Health' project, was funded by the Dutch Cancer Society (KWF: 2006-3464) and the Dutch Organization of Scientific Research (NWO: 016-005-029; 400-05-051). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berridge KC, 1998, BRAIN RES REV, V28, P309, DOI 10.1016/S0165-0173(98)00019-8; Berridge KC, 2003, BRAIN COGNITION, V52, P106, DOI 10.1016/S0278-2626(03)00014-9; Berridge KC, 2003, TRENDS NEUROSCI, V26, P507, DOI 10.1016/S0166-2236(03)00233-9; Berridge KC, 2007, PSYCHOPHARMACOLOGY, V191, P391, DOI 10.1007/s00213-006-0578-x; Blum K, 2011, INT J ENV RES PUB HE, V8, P4425, DOI 10.3390/ijerph8124425; Bricker JB, 2007, ADDICT BEHAV, V32, P740, DOI 10.1016/j.addbeh.2006.06.020; Bricker JB, 2006, ADDICT BEHAV, V31, P889, DOI 10.1016/j.addbeh.2005.07.011; CORRIGALL WA, 1992, PSYCHOPHARMACOLOGY, V107, P285, DOI 10.1007/BF02245149; de Leeuw R, 2010, PSYCHOL HEALTH, V25, P999, DOI 10.1080/08870440903477204; de Leeuw RNH, 2009, J ADOLESCENT HEALTH, V45, P171, DOI 10.1016/j.jadohealth.2008.12.013; de Vries H, 2003, HEALTH EDUC RES, V18, P627, DOI 10.1093/her/cyg032; Dolcini MM, 2003, NICOTINE TOB RES, V5, P473, DOI 10.1080/1462220031000118586; Dolinoy DC, 2007, REPROD TOXICOL, V23, P297, DOI 10.1016/j.reprotox.2006.08.012; Engels RCME, 2004, J ADOLESCENCE, V27, P531, DOI 10.1016/j.adolescence.2004.06.006; Gerra G, 2005, AM J MED GENET B, V135B, P73, DOI 10.1002/ajmg.b.30173; Harakeh Z, 2006, ADDICT BEHAV, V31, P232, DOI 10.1016/j.addbeh.2005.05.003; Harakeh Z, 2005, ADDICTION, V100, P862, DOI 10.1111/j.1360-0443.2005.01067.x; Harakeh Z, 2007, PSYCHOL HEALTH, V22, P269, DOI 10.1080/14768320600843218; Harden KP, 2008, BEHAV GENET, V38, P339, DOI 10.1007/s10519-008-9202-7; Hiemstra M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061673; Hoffman BR, 2006, SUBST USE MISUSE, V41, P103, DOI 10.1080/10826080500368892; Hutchison KE, 2002, J ABNORM PSYCHOL, V111, P134, DOI 10.1037//0021-843X.111.1.134; Kawamura Y., 2013, OPEN J PSYCHIAT, V3, P26, DOI [DOI 10.4236/OJPSYCH.2013.31005, 10.4236/ojpsych.2013.31005]; Kazantseva A V, 2009, Genetika, V45, P1110; Kobus K, 2003, ADDICTION, V98, P37, DOI 10.1046/j.1360-0443.98.s1.4.x; Koopmans JR, 1999, BEHAV GENET, V29, P383, DOI 10.1023/A:1021618719735; Kremers SPJ, 2001, PREV MED, V33, P392, DOI 10.1006/pmed.2001.0904; Laucht M, 2005, J AM ACAD CHILD PSY, V44, P477, DOI 10.1097/01.chi.0000155980.01792.7f; Laucht M, 2008, J AM ACAD CHILD PSY, V47, P673, DOI 10.1097/CHI.0b013e31816bff77; Leonardi-Bee J, 2011, THORAX, V66, P847, DOI 10.1136/thx.2010.153379; Lerman C, 1999, HEALTH PSYCHOL, V18, P14, DOI 10.1037/0278-6133.18.1.14; Ling DJ, 2004, J HUM GENET, V49, P35, DOI 10.1007/s10038-003-0104-5; Lochbuehler K, 2012, J PSYCHOPHARMACOL, V26, P1010, DOI 10.1177/0269881112439254; Mata R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039135; Moffitt TE, 2006, PERSPECT PSYCHOL SCI, V1, P5, DOI 10.1111/j.1745-6916.2006.00002.x; Munafo M., 2004, NICOTINE TOB RES, V6, P1; Munafo MR, 2008, ADDICT BIOL, V13, P435, DOI 10.1111/j.1369-1600.2008.00098.x; Munafo MR, 2008, BIOL PSYCHIAT, V63, P197, DOI 10.1016/j.biopsych.2007.04.006; Munafo MR, 2009, NICOTINE TOB RES, V11, P64, DOI 10.1093/ntr/ntn012; Muthen L.K., 1998, MPLUS USERS GUIDE, V8th; Noble EP, 1998, AM J MED GENET, V81, P257, DOI 10.1002/(SICI)1096-8628(19980508)81:3<257::AID-AJMG10>3.0.CO;2-E; Ohmoto M, 2013, NICOTINE TOB RES, V15, P633, DOI 10.1093/ntr/nts196; PLOMIN R, 1977, PSYCHOL BULL, V84, P309, DOI 10.1037/0033-2909.84.2.309; Rossing MA, 1998, ENVIRON HEALTH PERSP, V106, P231, DOI 10.2307/3434009; Schmid B, 2009, ADDICT BIOL, V14, P489, DOI 10.1111/j.1369-1600.2009.00171.x; Shanahan MJ, 2005, J GERONTOL B-PSYCHOL, V60, P65, DOI 10.1093/geronb/60.Special_Issue_1.65; Shields PG, 1998, CANCER EPIDEM BIOMAR, V7, P453; Simons-Morton BG, 2010, J PRIM PREV, V31, P191, DOI 10.1007/s10935-010-0220-x; Urberg KA, 2003, ADDICT BEHAV, V28, P1243, DOI 10.1016/S0306-4603(02)00256-3; Vink J, 2005, BEHAV GENET, V35, P397, DOI 10.1007/s10519-004-1327-8; Vitaro F, 2004, ADDICT BEHAV, V29, P831, DOI 10.1016/j.addbeh.2004.02.018; White VM, 2003, ADDICTION, V98, P1087, DOI 10.1046/j.1360-0443.2003.00427.x; World Health Organization, 2019, WHO REPORT GLOBAL TO	53	9	9	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2014	9	1							e86497	10.1371/journal.pone.0086497	http://dx.doi.org/10.1371/journal.pone.0086497			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297GT	24466121	Green Published, Green Submitted, gold			2022-12-25	WOS:000330244500248
J	Morgan, PE; Sheahan, PJ; Davies, MJ				Morgan, Philip E.; Sheahan, Pamela J.; Davies, Michael J.			Perturbation of Human Coronary Artery Endothelial Cell Redox State and NADPH Generation by Methylglyoxal	PLOS ONE			English	Article							ADVANCED GLYCATION ENDPRODUCTS; MAILLARD REACTION-PRODUCTS; PLASMA METHYLGLYOXAL; GLUCOSE-6-PHOSPHATE-DEHYDROGENASE ACTIVITY; QUANTITATIVE-DETERMINATION; REACTIVE CARBONYLS; OXIDATIVE STRESS; GLYOXALASE-I; END-PRODUCT; PROTEINS	Diabetes is associated with elevated plasma glucose, increased reactive aldehyde formation, oxidative damage, and glycation/glycoxidation of biomolecules. Cellular detoxification of, or protection against, such modifications commonly requires NADPH-dependent reducing equivalents (e. g. GSH). We hypothesised that reactive aldehydes may modulate cellular redox status via the inhibition of NADPH-generating enzymes, resulting in decreased thiol and NADPH levels. Primary human coronary artery endothelial cells (HCAEC) were incubated with high glucose (25 mM, 24 h, 37 degrees C), or methylglyoxal (MGO), glyoxal, or glycolaldehyde (100-500 mu M, 1 h, 37 degrees C), before quantification of intracellular thiols and NADPH-generating enzyme activities. Exposure to MGO, but not the other species examined, significantly (P<0.05) decreased total thiols (similar to 35%), further experiments with MGO showed significant losses of GSH (similar to 40%) and NADPH (similar to 10%); these changes did not result in an immediate loss of cell viability. Significantly decreased (similar to 10%) NADPH-producing enzyme activity was observed for HCAEC when glucose-6-phosphate or 2-deoxyglucose-6-phosphate were used as substrates. Cell lysate experiments showed significant MGO-dose dependent inhibition of glucose-6-phosphate-dependent enzymes and isocitrate dehydrogenase, but not malic enzyme. Analysis of intact cell or lysate proteins showed that arginine-derived hydroimidazolones were the predominant advanced glycation end-product (AGE) formed; lower levels of N-epsilon-(carboxyethyl) lysine (CEL) and N-epsilon-(carboxymethyl) lysine (CML) were also detected. These data support a novel mechanism by which MGO exposure results in changes in redox status in human coronary artery endothelial cells, via inhibition of NADPH-generating enzymes, with resultant changes in reduced protein thiol and GSH levels. These changes may contribute to the endothelial cell dysfunction observed in diabetes-associated atherosclerosis.	[Morgan, Philip E.; Sheahan, Pamela J.; Davies, Michael J.] Heart Res Inst, Free Rad Grp, Sydney, NSW, Australia; [Morgan, Philip E.; Sheahan, Pamela J.; Davies, Michael J.] Univ Sydney, Fac Med, Sydney, NSW 2006, Australia	University of Sydney; Heart Research Institute; University of Sydney	Morgan, PE (corresponding author), Heart Res Inst, Free Rad Grp, Sydney, NSW, Australia.	Philip.Morgan@hri.org.au	Davies, Michael J/H-4939-2011; Davies, Michael/GWV-2527-2022; Davies, Michael/AGX-9184-2022	Davies, Michael J/0000-0002-5196-6919; Davies, Michael/0000-0002-5196-6919; Morgan, Philip/0000-0002-6120-1936	Diabetes Australia Research Trust (DART); National Heart Foundation of Australia; Australian Research Council (ARC) [CE0561607, DP0988311]	Diabetes Australia Research Trust (DART); National Heart Foundation of Australia(National Heart Foundation of Australia); Australian Research Council (ARC)(Australian Research Council)	This project was supported by the Diabetes Australia Research Trust (DART), the National Heart Foundation of Australia, and the Australian Research Council (ARC Centres of Excellence (CE0561607) and Discovery (DP0988311) programs). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed N, 2002, BIOCHEM J, V364, P1; Ahmed N, 2005, DIABETES RES CLIN PR, V67, P3, DOI 10.1016/j.diabres.2004.09.004; Banhegyi G, 2009, J MOL ENDOCRINOL, V42, P283, DOI 10.1677/JME-08-0156; Barati MT, 2007, AM J PHYSIOL-RENAL, V293, pF1157, DOI 10.1152/ajprenal.00411.2006; Barr ELM, 2007, CIRCULATION, V116, P151, DOI 10.1161/CIRCULATIONAHA.106.685628; Diaz-Flores M, 2006, LIFE SCI, V78, P2601, DOI 10.1016/j.lfs.2005.10.022; DYER DG, 1993, J CLIN INVEST, V91, P2463, DOI 10.1172/JCI116481; Ellis EM, 2007, PHARMACOL THERAPEUT, V115, P13, DOI 10.1016/j.pharmthera.2007.03.015; Frey RS, 2009, ANTIOXID REDOX SIGN, V11, P791, DOI [10.1089/ars.2008.2220, 10.1089/ARS.2008.2220]; Gupte RS, 2011, ANTIOXID REDOX SIGN, V14, P543, DOI 10.1089/ars.2010.3207; HAIK GM, 1994, EXP EYE RES, V59, P497, DOI 10.1006/exer.1994.1135; Han Y, 2007, MOL CELL BIOCHEM, V305, P123, DOI 10.1007/s11010-007-9535-1; Hawkins CL, 2009, FREE RADICAL BIO MED, V46, P965, DOI 10.1016/j.freeradbiomed.2009.01.007; Jain M, 2003, CIRC RES, V93, pE9, DOI 10.1161/01.RES.0000083489.83704.76; Jandeleit-Dahm K, 2008, CLIN EXP PHARMACOL P, V35, P329, DOI 10.1111/j.1440-1681.2007.04875.x; Kalapos MP, 2013, DIABETES RES CLIN PR, V99, P260, DOI 10.1016/j.diabres.2012.11.003; Kalapos MP, 1999, TOXICOL LETT, V110, P145, DOI 10.1016/S0378-4274(99)00160-5; Kim KM, 2012, EXP CELL RES, V318, P152, DOI 10.1016/j.yexcr.2011.10.013; Lapolla A, 2003, CLIN CHEM LAB MED, V41, P1166, DOI 10.1515/CCLM.2003.180; Lapolla A, 2003, RAPID COMMUN MASS SP, V17, P876, DOI 10.1002/rcm.992; Lee SM, 2002, FREE RADICAL BIO MED, V32, P1185, DOI 10.1016/S0891-5849(02)00815-8; LO TWC, 1994, J BIOL CHEM, V269, P32299; Lu JX, 2011, CLIN BIOCHEM, V44, P307, DOI 10.1016/j.clinbiochem.2010.11.004; Matsui R, 2006, ARTERIOSCL THROM VAS, V26, P910, DOI 10.1161/01.ATV.0000205850.49390.3b; Moheimani F, 2010, BBA-MOL BASIS DIS, V1802, P561, DOI 10.1016/j.bbadis.2010.02.007; Morgan PE, 2002, ARCH BIOCHEM BIOPHYS, V403, P259, DOI 10.1016/S0003-9861(02)00222-9; Morgan PE, 2013, FREE RADICAL BIO MED, V61, P229, DOI 10.1016/j.freeradbiomed.2013.03.025; Morgan PE, 2012, FREE RADICAL BIO MED, V52, P328, DOI 10.1016/j.freeradbiomed.2011.10.448; Nagai R, 2000, DIABETES, V49, P1714, DOI 10.2337/diabetes.49.10.1714; Nelson DL, 2000, LEHNINGER PRINCIPLES; Nitenberg A, 2006, DIABETES METAB, V32, p2S28, DOI 10.1016/S1262-3636(06)70482-7; Oba T, 2012, ENVIRON TOXICOL PHAR, V34, P117, DOI 10.1016/j.etap.2012.03.007; Rabbani N, 2012, AMINO ACIDS, V42, P1133, DOI 10.1007/s00726-010-0783-0; Schafer F. Q., 2004, SIGNAL TRANSDUCTION, P1, DOI DOI 10.1007/0-306-48412-9_1; Sell DR, 2004, J BIOL CHEM, V279, P54173, DOI 10.1074/jbc.M408946200; Tatsunami R, 2009, J PHARMACOL SCI, V111, P426, DOI 10.1254/jphs.09131FP; Thornalley PJ, 2003, BIOCHEM J, V375, P581, DOI 10.1042/BJ20030763; Thornalley PJ, 1996, GEN PHARMACOL-VASC S, V27, P565, DOI 10.1016/0306-3623(95)02054-3; Thorpe SR, 2003, AMINO ACIDS, V25, P275, DOI 10.1007/s00726-003-0017-9; Vander Jagt DL, 2003, CHEM-BIOL INTERACT, V143, P341, DOI 10.1016/S0009-2797(02)00212-0; Wild R, 2012, ANAL BIOANAL CHEM, V403, P2577, DOI 10.1007/s00216-012-6086-4; World Health Organization, 2004, DIAB ACT NOW IN WHO; Zeng JM, 2006, BIOCHEM J, V398, P197, DOI 10.1042/BJ20060019; Zeng JM, 2005, CHEM RES TOXICOL, V18, P1232, DOI 10.1021/tx050074u; Zhao W, 1998, FREE RADICAL RES, V29, P315, DOI 10.1080/10715769800300351	45	16	17	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2014	9	1							e86564	10.1371/journal.pone.0086564	http://dx.doi.org/10.1371/journal.pone.0086564			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297GT	24466151	Green Submitted, gold, Green Published			2022-12-25	WOS:000330244500259
J	Polyzou, EN; Evangelinakis, NE; Pistiki, A; Kotsaki, A; Siristatidis, CS; Chrelias, CG; Salamalekis, E; Kassanos, DP; Giamarellos-Bourboulis, EJ				Polyzou, Electra N.; Evangelinakis, Nikolaos E.; Pistiki, Aikaterini; Kotsaki, Antigone; Siristatidis, Charalampos S.; Chrelias, Charalambos G.; Salamalekis, Emmanuel; Kassanos, Demetrios P.; Giamarellos-Bourboulis, Evangelos J.			Angiopoietin-2 Primes Infection-Induced Preterm Delivery	PLOS ONE			English	Article							MURINE MODEL; LABOR; PREGNANCY; ANGIOGENESIS; IMPLANTATION; BIOMARKERS; ALPHA	Current knowledge on the participation of angiopoietin-2 (Ang-2) in the inflammatory process and on the importance of bacterial endotoxins (LPS) in the induction of preterm delivery (PTD) led us to investigate the role of Ang-2/LPS interplay in the pathogenesis of PTD. At a first stage, Ang-2 was measured at the end of the first trimester of pregnancy in the serum of 50 women who delivered prematurely; of 88 women well-matched for age and parity who delivered full-term; and of 20 non-pregnant healthy women. Ang-2 was greater in pregnant than in non-pregnant women. The time until delivery was shorter among those with Ang-2 greater than 4 ng/ml (odds ratio for delivery until week 34; p: 0.040). To further investigate the role of Ang-2 for PTD, an experimental model of PTD induced by the intraperitoneal injection of LPS in mice was used. Ang-2 was administered intraperitoneally before LPS on day 14 of pregnancy. When Ang-2 was administered before the LPS diluent, all mice delivered full-term. However, administration of Ang-2 prior LPS accelerated further the time until delivery. Sacrifice experiments showed that the effect of Ang-2 was accompanied by decrease of the penetration of Evans Blue in the embryos and by increase of its penetration in maternal tissues. In parallel, the concentration of tumour necrosis factor-alpha in the maternal circulation, in fetal tissues and in the placentas was significantly decreased. Results indicate that Ang-2 accelerated the phenomena of PTD induced by LPS. This is related with deprivation of fetal perfusion.	[Polyzou, Electra N.; Evangelinakis, Nikolaos E.; Siristatidis, Charalampos S.; Chrelias, Charalambos G.; Salamalekis, Emmanuel; Kassanos, Demetrios P.] Univ Athens, Sch Med, Dept Obstet & Gynecol 3, GR-11527 Athens, Greece; [Pistiki, Aikaterini; Kotsaki, Antigone; Giamarellos-Bourboulis, Evangelos J.] Univ Athens, Sch Med, Dept Internal Med 4, GR-11527 Athens, Greece	Athens Medical School; National & Kapodistrian University of Athens; Athens Medical School; National & Kapodistrian University of Athens	Giamarellos-Bourboulis, EJ (corresponding author), Univ Athens, Sch Med, Dept Internal Med 4, GR-11527 Athens, Greece.	egiamarel@med.uoa.gr	Siristatidis, Charalambos/AAD-6990-2019; Giamarellos-Bourboulis, Evangelos/AAD-7155-2019	Siristatidis, Charalambos/0000-0003-0850-6623; Giamarellos-Bourboulis, Evangelos/0000-0003-4713-3911; Evangelinakis, Nikolaos/0000-0002-1393-3171	Hellenic Institute for the Study of Sepsis	Hellenic Institute for the Study of Sepsis	Part of the study was funded by a kind donation of the Hellenic Institute for the Study of Sepsis. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Argiles JM, 1998, MED HYPOTHESES, V50, P313, DOI 10.1016/S0306-9877(98)90003-2; Bany BM, 2011, METHODS MOL BIOL, V763, P83, DOI 10.1007/978-1-61779-191-8_5; Buhimschi CS, 2010, J CLIN ENDOCR METAB, V95, P3428, DOI 10.1210/jc.2009-2829; Burdet J, 2012, BRIT J PHARMACOL, V168, P946; Carrer DP, 2013, INJURY, V44, P935, DOI 10.1016/j.injury.2013.03.031; Daponte A, 2013, CLIN CHIM ACTA, V415, P145, DOI 10.1016/j.cca.2012.10.031; DUDLEY DJ, 1993, BIOL REPROD, V48, P33, DOI 10.1095/biolreprod48.1.33; Evangelinakis NE, 2013, J MATERN-FETAL NEO M, V26, P1024, DOI 10.3109/14767058.2013.765848; Geva E, 2005, MOL HUM REPROD, V11, P253, DOI 10.1093/molehr/gah159; Geva E, 2002, J CLIN ENDOCR METAB, V87, P4213, DOI 10.1210/jc.2002-020195; Holmgren C, 2008, J REPROD IMMUNOL, V78, P134, DOI 10.1016/j.jri.2007.11.003; Kranidioti H, 2009, IMMUNOL LETT, V125, P65, DOI 10.1016/j.imlet.2009.06.006; Leinonen E, 2010, J CLIN ENDOCR METAB, V95, P126, DOI 10.1210/jc.2009-0715; Ma HG, 2007, J HUAZHONG UNIV SCI, V27, P200, DOI 10.1007/s11596-007-0225-8; Pawelec M, 2013, ADV CLIN EXP MED, V22, P283; Roviezzo F, 2005, J PHARMACOL EXP THER, V314, P738, DOI 10.1124/jpet.105.086553; Sayres WG, 2010, AM FAM PHYSICIAN, V81, P477; Thomakos N, 2010, EUR J OBSTET GYN R B, V148, P147, DOI 10.1016/j.ejogrb.2009.10.027; Thurston G, 2003, CELL TISSUE RES, V314, P61, DOI 10.1007/s00441-003-0749-6; Tzepi IM, 2012, J PHARMACOL EXP THER, V343, P278, DOI 10.1124/jpet.112.195180; Yang Q, 2009, PEDIATR RES, V66, P11, DOI 10.1203/PDR.0b013e3181a207e3	21	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2014	9	1							e86523	10.1371/journal.pone.0086523	http://dx.doi.org/10.1371/journal.pone.0086523			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297GT	24466134	Green Published, Green Submitted, gold			2022-12-25	WOS:000330244500252
J	Rozza, AL; de Faria, FM; Brito, ARS; Pellizzon, CH				Rozza, Ariane Leite; de Faria, Felipe Meira; Souza Brito, Alba Regina; Pellizzon, Claudia Helena			The Gastroprotective Effect of Menthol: Involvement of Anti-Apoptotic, Antioxidant and Anti-Inflammatory Activities	PLOS ONE			English	Article							SUPEROXIDE-DISMUTASE ACTIVITY; HELICOBACTER-PYLORI; LIPID-PEROXIDATION; OXIDATIVE STRESS; PROTEIN; INJURY; RATS; OVEREXPRESSION; INTERLEUKIN-6; INDOMETHACIN	The aim of this research was to investigate the anti-apoptotic, antioxidant and anti-inflammatory properties of menthol against ethanol-induced gastric ulcers in rats. Wistar rats were orally treated with vehicle, carbenoxolone (100 mg/kg) or menthol (50 mg/kg) and then treated with ethanol to induce gastric ulcers. After euthanasia, stomach samples were prepared for histological slides and biochemical analyses. Immunohistochemical analyses of the cytoprotective and anti-apoptotic heat-shock protein-70 (HSP-70) and the apoptotic Bax protein were performed. The neutrophils were manually counted. The activity of the myeloperoxidase (MPO) was measured. To determine the level of antioxidant functions, the levels of glutathione (GSH), glutathione peroxidase (GSH-Px), glutathione reductase (GR) and superoxide dismutase (SOD) were measured using ELISA. The levels of the pro-inflammatory cytokines tumor necrosis factor-alpha (TNF-alpha) and interleukin-6 (IL-6) and the anti-inflammatory cytokine interleukin-10 (IL-10) were assessed using ELISA kits. The menthol treated group presented 92% gastroprotection compared to the vehicle-treated group. An increased immunolabeled area was observed for HSP-70, and a decreased immunolabeled area was observed for the Bax protein in the menthol treated group. Menthol treatment induced a decrease in the activity of MPO and SOD, and the protein levels of GSH, GSH-Px and GR were increased. There was also a decrease in the levels of TNF-alpha and IL-6 and an increase in the level of IL-10. In conclusion, oral treatment with menthol displayed a gastroprotective activity through anti-apoptotic, antixidant and anti-inflammatory mechanisms.	[Rozza, Ariane Leite] Univ Estadual Paulista UNESP, Dept Pharmacol, Biosci Inst, Botucatu, SP, Brazil; [de Faria, Felipe Meira] Univ Campinas UNICAMP, Dept Pharmacol, Fac Med Sci, Campina, Brazil; [Souza Brito, Alba Regina] Univ Campinas UNICAMP, Dept Struct & Funct Biol, Inst Biol, Campinas, SP, Brazil; [Pellizzon, Claudia Helena] UNESP Univ Estadual Paulista UNESP, Dept Morphol, Biosci Inst, Botucatu, SP, Brazil	Universidade Estadual Paulista; Universidade Estadual de Campinas; Universidade de Sao Paulo; Universidade Estadual de Campinas	Pellizzon, CH (corresponding author), UNESP Univ Estadual Paulista UNESP, Dept Morphol, Biosci Inst, Botucatu, SP, Brazil.	claudia@ibb.unesp.br	Rozza, Ariane/AAY-2507-2021; Pellizzon, Claudia Helena/G-7305-2015; Rozza, Ariane/K-9224-2013; de Faria, Felipe Meira/C-2370-2012	Pellizzon, Claudia Helena/0000-0002-4494-4180; Rozza, Ariane/0000-0002-4198-0135; de Faria, Felipe Meira/0000-0002-7875-0691	CAPES/FAPESP [2010/08536-9]	CAPES/FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	CAPES/FAPESP 2010/08536-9 had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Abdel-Salam OME, 2001, J PHYSIOL-PARIS, V95, P105, DOI 10.1016/S0928-4257(01)00015-8; Ahmad A, 2013, LIFE SCI, V92, P202, DOI 10.1016/j.lfs.2012.11.020; AlRashdi AS, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/786426; [Anonymous], 2006, FREE RADICALS BIOL M; Augusto AC, 2007, CLIN BIOCHEM, V40, P615, DOI 10.1016/j.clinbiochem.2007.03.014; Basak S, 2008, CYTOKINE GROWTH F R, V19, P187, DOI 10.1016/j.cytogfr.2008.04.005; Beere HM, 2004, J CELL SCI, V117, P2641, DOI 10.1242/jcs.01284; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brzozowski T, 2001, Med Sci Monit, V7, P592; CARLBERG I, 1985, METHOD ENZYMOL, V113, P484; Faure P., 1995, P237; Fialkow L, 2007, FREE RADICAL BIO MED, V42, P153, DOI 10.1016/j.freeradbiomed.2006.09.030; FRIDOVICH I, 1986, ARCH BIOCHEM BIOPHYS, V247, P1, DOI 10.1016/0003-9861(86)90526-6; Hamaguchi M, 2001, DIGEST DIS SCI, V46, P2708, DOI 10.1023/A:1012779530004; Hartl FU, 2002, SCIENCE, V295, P1852, DOI 10.1126/science.1068408; Hirata I, 2009, DIGESTION, V79, P243, DOI 10.1159/000215352; Ismail IF, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/404012; Kishimoto T, 2005, ANNU REV IMMUNOL, V23, P1, DOI 10.1146/annurev.immunol.23.021704.115806; Konturek PC, 2010, J PHYSIOL PHARMACOL, V61, P429; KRAWISZ JE, 1984, GASTROENTEROLOGY, V87, P1344; Kruglov AA, 2008, CYTOKINE GROWTH F R, V19, P231, DOI 10.1016/j.cytogfr.2008.04.010; Maity B., 2008, CURR BIOACT COMPD, V4, P225; Maity P, 2009, PHYTOTHER RES, V23, P747, DOI 10.1002/ptr.2721; Martin GR, 2006, EXP BIOL MED, V231, P130; Mei XT, 2012, CHEM-BIOL INTERACT, V197, P31, DOI 10.1016/j.cbi.2012.03.006; Rocha NFM, 2011, EUR J PHARM SCI, V44, P455, DOI 10.1016/j.ejps.2011.08.020; ROBERT A, 1979, GASTROENTEROLOGY, V77, P433; Rozza AL, 2013, CHEM-BIOL INTERACT, V206, P272, DOI 10.1016/j.cbi.2013.10.003; Sabat R, 2010, CYTOKINE GROWTH F R, V21, P331, DOI 10.1016/j.cytogfr.2010.09.002; Salga MS, 2012, CHEM-BIOL INTERACT, V195, P144, DOI 10.1016/j.cbi.2011.11.008; Stankiewicz AR, 2005, J BIOL CHEM, V280, P38729, DOI 10.1074/jbc.M509497200; Taha MME, 2012, J ETHNOPHARMACOL, V141, P273, DOI 10.1016/j.jep.2012.02.030; Wassmann S, 2004, CIRC RES, V94, P534, DOI 10.1161/01.RES.0000115557.25127.8D; Wei XM, 2003, INT IMMUNOPHARMACOL, V3, P1581, DOI 10.1016/S1567-5769(03)00176-0; WINTERBOURN CC, 1975, J LAB CLIN MED, V85, P337; Yeo M, 2004, PROTEOMICS, V4, P3335, DOI 10.1002/pmic.200400951; YOSHIKAWA T, 1993, GUT, V34, P732, DOI 10.1136/gut.34.6.732	37	101	107	3	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2014	9	1							e86686	10.1371/journal.pone.0086686	http://dx.doi.org/10.1371/journal.pone.0086686			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297GT	24466200	Green Published, gold, Green Submitted			2022-12-25	WOS:000330244500272
J	Vivash, L; Gregoire, MC; Bouilleret, V; Berard, A; Wimberley, C; Binns, D; Roselt, P; Katsifis, A; Myers, DE; Hicks, RJ; O'Brien, TJ; Dedeurwaerdere, S				Vivash, Lucy; Gregoire, Marie-Claude; Bouilleret, Viviane; Berard, Alexis; Wimberley, Catriona; Binns, David; Roselt, Peter; Katsifis, Andrew; Myers, Damian E.; Hicks, Rodney J.; O'Brien, Terence J.; Dedeurwaerdere, Stefanie			In Vivo Measurement of Hippocampal GABA(A)/cBZR Density with [F-18]-Flumazenil PET for the Study of Disease Progression in an Animal Model of Temporal Lobe Epilepsy	PLOS ONE			English	Article							POSITRON-EMISSION-TOMOGRAPHY; CENTRAL BENZODIAZEPINE-RECEPTOR; MESSENGER-RNA EXPRESSION; MULTI-INJECTION APPROACH; C-11 FLUMAZENIL; STATUS EPILEPTICUS; RAT-BRAIN; BINDING; QUANTIFICATION; SEIZURES	Purpose: Imbalance of inhibitory GABAergic neurotransmission has been proposed to play a role in the pathogenesis of temporal lobe epilepsy (TLE). This study aimed to investigate whether [F-18]-flumazenil ([F-18]-FMZ) PET could be used to noninvasively characterise GABA(A)/central benzodiazepine receptor (GABA(A)/cBZR) density and affinity in vivo in the post-kainic acid status epilepticus (SE) model of TLE. Methods: Dynamic [F-18]-FMZ -PET scans using a multi-injection protocol were acquired in four male wistar rats for validation of the partial saturation model (PSM). SE was induced in eight male Wistar rats (10 weeks of age) by i.p. injection of kainic acid (7.5-25 mg/kg), while control rats (n = 7) received saline injections. Five weeks post-SE, an anatomic MRI scan was acquired and the following week an [F-18]-FMZ PET scan (3.6-4.6 nmol). The PET data was co-registered to the MRI and regions of interest drawn on the MRI for selected structures. A PSM was used to derive receptor density and apparent affinity from the [F-18]-FMZ PET data. Key Findings: The PSM was found to adequately model [F-18]-FMZ binding in vivo. There was a significant decrease in hippocampal receptor density in the SE group (p<0.01), accompanied by an increase in apparent affinity (p<0.05) compared to controls. No change in cortical receptor binding was observed. Hippocampal volume reduction and cell loss was only seen in a subset of animals. Histological assessment of hippocampal cell loss was significantly correlated with hippocampal volume measured by MRI (p<0.05), but did not correlate with [F-18]-FMZ binding. Significance: Alterations to hippocampal GABA(A)/cBZR density and affinity in the post-kainic acid SE model of TLE are detectable in vivo with [F-18]-FMZ PET and a PSM. These changes are independent from hippocampal cell and volume loss. [F-18]-FMZ PET is useful for investigating the role that changes GABA(A)/cBZR density and binding affinity play in the pathogenesis of TLE.	[Vivash, Lucy; Bouilleret, Viviane; Myers, Damian E.; O'Brien, Terence J.; Dedeurwaerdere, Stefanie] Univ Melbourne, Royal Melbourne Hosp, Dept Med, Melbourne, Vic 3050, Australia; [Gregoire, Marie-Claude; Berard, Alexis; Wimberley, Catriona; Katsifis, Andrew] Australian Nucl Sci & Technol Org, Dept LifeSci, Sydney, NSW, Australia; [Binns, David; Roselt, Peter; Hicks, Rodney J.] Peter MacCallum Canc Ctr, Ctr Mol Imaging, Melbourne, Vic, Australia; [Dedeurwaerdere, Stefanie] Univ Antwerp, Dept Translat Neurosci, Antwerp, Belgium	Royal Melbourne Hospital; University of Melbourne; Australian Nuclear Science & Technology Organisation; Peter Maccallum Cancer Center; University of Antwerp	O'Brien, TJ (corresponding author), Univ Melbourne, Royal Melbourne Hosp, Dept Med, Melbourne, Vic 3050, Australia.	obrientj@unimelb.edu.au	O'Brien, Terence/L-8102-2013; Myers, Damian E/L-5302-2013; Bouilleret, viviane/AAQ-5878-2021; Dedeurwaerdere, Stefanie/G-2524-2011; O'Brien, Terence/AAU-5525-2021	O'Brien, Terence/0000-0002-7198-8621; Bouilleret, viviane/0000-0001-9913-9501; Dedeurwaerdere, Stefanie/0000-0003-4869-1923; Hicks, Rodney/0000-0002-0758-0824; Vivash, Lucy/0000-0002-1182-0907; Myers, Damian/0000-0002-7569-9907	cooperative research consortium for biomedical imaging development (CRC-BID)	cooperative research consortium for biomedical imaging development (CRC-BID)	This study was funded by the cooperative research consortium for biomedical imaging development (CRC-BID). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BABB TL, 1989, J NEUROSCI, V9, P2562; Bak LK, 2006, J NEUROCHEM, V98, P641, DOI 10.1111/j.1471-4159.2006.03913.x; Ben-Ari Y, 2005, CURR OPIN NEUROL, V18, P141, DOI 10.1097/01.wco.0000162855.75391.6a; Bottlaender M, 2010, J CEREBR BLOOD F MET, V30, P792, DOI 10.1038/jcbfm.2009.242; Bouvard S, 2005, BRAIN, V128, P1330, DOI 10.1093/brain/awh470; BOWERY NG, 1987, NEUROSCIENCE, V20, P365, DOI 10.1016/0306-4522(87)90098-4; Chang YS, 2005, NUCL MED BIOL, V32, P263, DOI 10.1016/j.nucmedbio.2004.12.004; Cremer CM, 2010, EPILEPSIA, V51, P1446, DOI 10.1111/j.1528-1167.2010.02562.x; Dedeurwaerdere S, 2013, NEUROIMAGE, V68, P30, DOI 10.1016/j.neuroimage.2012.11.054; Dedeurwaerdere S, 2009, EUR J NUCL MED MOL I, V36, P958, DOI 10.1007/s00259-009-1066-4; DELFORGE J, 1995, J CEREBR BLOOD F MET, V15, P284, DOI 10.1038/jcbfm.1995.34; Delforge J, 1996, J NUCL MED, V37, P5; DELFORGE J, 1993, J CEREBR BLOOD F MET, V13, P454, DOI 10.1038/jcbfm.1993.60; Delforge J, 1999, J CEREBR BLOOD F MET, V19, P533, DOI 10.1097/00004647-199905000-00008; Drexel M, 2013, FRONT NEURAL CIRCUIT, V7, DOI 10.3389/fncir.2013.00142; Grunder G, 2001, EUR J NUCL MED, V28, P1463, DOI 10.1007/s002590100594; Hand KSP, 1997, BRIT J PHARMACOL, V122, P358, DOI 10.1038/sj.bjp.0701365; Hellier JL, 1998, EPILEPSY RES, V31, P73, DOI 10.1016/S0920-1211(98)00017-5; Joshi S, 2013, EXP NEUROL, V244, P36, DOI 10.1016/j.expneurol.2011.10.028; Knoflach F, 1996, MOL PHARMACOL, V50, P1253; Koepp MJ, 1997, NEUROLOGY, V49, P764, DOI 10.1212/WNL.49.3.764; la Fougere C, 2011, NEUROIMAGE, V56, P951, DOI 10.1016/j.neuroimage.2010.11.015; Lammertsma AA, 1996, NEUROIMAGE, V4, P153, DOI 10.1006/nimg.1996.0066; Lamusuo S, 2000, NEUROLOGY, V54, P2252, DOI 10.1212/WNL.54.12.2252; Liefaard LC, 2009, EPILEPSIA, V50, P88, DOI 10.1111/j.1528-1167.2008.01763.x; Liu DSH, 2009, NEUROBIOL DIS, V35, P337, DOI 10.1016/j.nbd.2009.05.009; Loup F, 2009, BRAIN, V132, P2449, DOI 10.1093/brain/awp178; MANDEMA JW, 1991, PSYCHOPHARMACOLOGY, V103, P384, DOI 10.1007/BF02244294; Mauger G, 2005, J CEREBR BLOOD F MET, V25, P1517, DOI 10.1038/sj.jcbfm.9600141; Miederer I, 2009, EUR J NUCL MED MOL I, V36, P659, DOI 10.1007/s00259-008-0990-z; Millet P, 2012, NEUROIMAGE, V62, P1455, DOI 10.1016/j.neuroimage.2012.05.075; Odano I, 2009, NEUROIMAGE, V45, P891, DOI 10.1016/j.neuroimage.2008.12.005; Paxinos G., 2005, RAT BRAIN STEREOTAXI, V5th Edn, DOI 10.1016/c2009-0-63235-9; Powell KL, 2008, EPILEPSIA, V49, P1686, DOI 10.1111/j.1528-1167.2008.01593.x; PRICE JC, 1993, J CEREBR BLOOD F MET, V13, P656, DOI 10.1038/jcbfm.1993.84; RACINE RJ, 1972, ELECTROEN CLIN NEURO, V32, P281, DOI 10.1016/0013-4694(72)90177-0; Ryvlin P, 1998, BRAIN, V121, P2067, DOI 10.1093/brain/121.11.2067; Ryzhikov NN, 2005, NUCL MED BIOL, V32, P109, DOI 10.1016/j.nucmedbio.2004.11.001; Sanabria-Bohorquez Sandra M, 2003, Mol Imaging Biol, V5, P72, DOI 10.1016/S1536-1632(03)00046-5; Savic I, 1996, EPILEPSIA, V37, P236, DOI 10.1111/j.1528-1157.1996.tb00019.x; SAVIC I, 1988, LANCET, V2, P863, DOI 10.1016/S0140-6736(88)92468-3; Syvanen S, 2012, J NUCL MED, V53, P1974, DOI 10.2967/jnumed.112.104588; Szelies B, 1996, NEUROIMAGE, V3, P109, DOI 10.1006/nimg.1996.0013; Tsunashima K, 1997, NEUROSCIENCE, V80, P1019, DOI 10.1016/S0306-4522(97)00144-9; Vivash L, 2011, NEUROBIOL DIS, V41, P227, DOI 10.1016/j.nbd.2010.08.021; Williams PA, 2009, J NEUROSCI, V29, P2103, DOI 10.1523/JNEUROSCI.0980-08.2009	46	16	17	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2014	9	1							e86722	10.1371/journal.pone.0086722	http://dx.doi.org/10.1371/journal.pone.0086722			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297GT	24466212	Green Accepted, Green Published, gold			2022-12-25	WOS:000330244500277
J	Bahl, CD; Hvorecny, KL; Bridges, AA; Ballok, AE; Bomberger, JM; Cady, KC; O'Toole, GA; Madden, DR				Bahl, Christopher D.; Hvorecny, Kelli L.; Bridges, Andrew A.; Ballok, Alicia E.; Bomberger, Jennifer M.; Cady, Kyle C.; O'Toole, George A.; Madden, Dean R.			Signature Motifs Identify an Acinetobacter Cif Virulence Factor with Epoxide Hydrolase Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						CFTR; Enzyme Catalysis; Gene Transcription; Mutagenesis Site Specific; Protein Conformation; X-ray Crystallography; Airway Infection; Epoxide Hydrolase; Substrate Specificity	TRANSMEMBRANE CONDUCTANCE REGULATOR; PSEUDOMONAS-AERUGINOSA; DIFFRACTION DATA; PROTEIN; CFTR; RESISTANCE; CRYSTALLIZATION; EXPRESSION; PNEUMONIA; INFECTION	Background: Pathogens target airway clearance mechanisms to facilitate infection. Results: Sequence analysis reveals an Acinetobacter epoxide hydrolase (EH) that triggers loss of the cystic fibrosis transmembrane conductance regulator (CFTR). Conclusion: Homologous EH virulence factors found in a variety of opportunistic pathogens can impair CFTR, a key element of host airway defenses. Significance: EH virulence factors are potential therapeutic targets. Endocytic recycling of the cystic fibrosis transmembrane conductance regulator (CFTR) is blocked by the CFTR inhibitory factor (Cif). Originally discovered in Pseudomonas aeruginosa, Cif is a secreted epoxide hydrolase that is transcriptionally regulated by CifR, an epoxide-sensitive repressor. In this report, we investigate a homologous protein found in strains of the emerging nosocomial pathogens Acinetobacter nosocomialis and Acinetobacter baumannii (aCif). Like Cif, aCif is an epoxide hydrolase that carries an N-terminal secretion signal and can be purified from culture supernatants. When applied directly to polarized airway epithelial cells, mature aCif triggers a reduction in CFTR abundance at the apical membrane. Biochemical and crystallographic studies reveal a dimeric assembly with a stereochemically conserved active site, confirming our motif-based identification of candidate Cif-like pathogenic EH sequences. Furthermore, cif expression is transcriptionally repressed by a CifR homolog (aCifR) and is induced in the presence of epoxides. Overall, this Acinetobacter protein recapitulates the essential attributes of the Pseudomonas Cif system and thus may facilitate airway colonization in nosocomial lung infections.	[Bahl, Christopher D.; Hvorecny, Kelli L.; Bridges, Andrew A.; Madden, Dean R.] Geisel Sch Med Dartmouth, Dept Biochem, Hanover, NH 03755 USA; [Ballok, Alicia E.; Cady, Kyle C.; O'Toole, George A.] Geisel Sch Med Dartmouth, Dept Microbiol & Immunol, Hanover, NH 03755 USA; [Bomberger, Jennifer M.] Univ Pittsburgh, Sch Med, Dept Microbiol & Mol Genet, Pittsburgh, PA 15219 USA	Dartmouth College; Dartmouth College; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Madden, DR (corresponding author), 7200 Vail Bldg, Hanover, NH 03755 USA.	drm0001@dartmouth.edu	Bridges, Andrew/U-9907-2019; Bahl, Christopher D/B-9410-2016	Bridges, Andrew/0000-0002-8132-751X; Bahl, Christopher D/0000-0002-3652-3693	National Institutes of Health [R01-AI091699]; Training Grant Predoctoral Fellowships [T32-AI007519, T32-DK007301]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI091699, T32AI007519] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007301] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008704] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Training Grant Predoctoral Fellowships; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01-AI091699 and Training Grant Predoctoral Fellowships T32-AI007519 and T32-DK007301.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Arand M, 2005, METHOD ENZYMOL, V400, P569, DOI 10.1016/S0076-6879(05)00032-7; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Bahl CD, 2012, PROTEIN PEPTIDE LETT, V19, P186; Bahl CD, 2010, J BACTERIOL, V192, P1785, DOI 10.1128/JB.01348-09; Bahl CD, 2010, ACTA CRYSTALLOGR F, V66, P26, DOI 10.1107/S1744309109047599; Ballok AE, 2012, J BACTERIOL, V194, P5315, DOI 10.1128/JB.00984-12; Bebok Z, 2005, J PHYSIOL-LONDON, V569, P601, DOI 10.1113/jphysiol.2005.096669; Bomberger JM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000382; Cantin AM, 2006, AM J RESP CRIT CARE, V173, P1139, DOI 10.1164/rccm.200508-1330OC; Choi KH, 2006, J MICROBIOL METH, V64, P391, DOI 10.1016/j.mimet.2005.06.001; Clunes LA, 2012, FASEB J, V26, P533, DOI 10.1096/fj.11-192377; Davies JC, 2009, RESP CARE, V54, P628, DOI 10.4187/aarc0492; DeLano WL., 2020, PYMOL MOL GRAPHICS S; Diederichs K, 1997, NAT STRUCT BIOL, V4, P269, DOI 10.1038/nsb0497-269; Diene SM, 2013, EXPERT REV ANTI-INFE, V11, P277, DOI [10.1586/ERI.13.1, 10.1586/eri.13.1]; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Erb-Downward JR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016384; Gaynes R, 2005, CLIN INFECT DIS, V41, P848, DOI 10.1086/432803; Grgurich PE, 2012, EXPERT REV RESP MED, V6, P533, DOI [10.1586/ERS.12.45, 10.1586/ers.12.45]; Hoiby N, 2010, FUTURE MICROBIOL, V5, P1663, DOI [10.2217/fmb.10.125, 10.2217/FMB.10.125]; HOLM L, 1993, J MOL BIOL, V233, P123, DOI 10.1006/jmbi.1993.1489; Horsley A, 2012, COCHRANE DB SYST REV, V10; Howard A, 2012, VIRULENCE, V3, P243, DOI 10.4161/viru.19700; Jitsumori K, 2009, J BACTERIOL, V191, P2630, DOI 10.1128/JB.01654-08; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Kiefer Florian, 2009, Nucleic Acids Res, V37, pD387, DOI 10.1093/nar/gkn750; Kochanek Kenneth D, 2011, Natl Vital Stat Rep, V60, P1; Koulenti D, 2006, CURR OPIN PULM MED, V12, P198; Kreindler JL, 2005, AM J PHYSIOL-LUNG C, V288, pL894, DOI 10.1152/ajplung.00376.2004; Lopez-Rojas R, 2013, EXPERT REV ANTI-INFE, V11, P231, DOI [10.1586/eri.13.11, 10.1586/ERI.13.11]; Luft JR, 2003, J STRUCT BIOL, V142, P170, DOI 10.1016/S1047-8477(03)00048-0; MacEachran DP, 2008, INFECT IMMUN, V76, P3197, DOI 10.1128/IAI.00305-08; MacEachran DP, 2007, INFECT IMMUN, V75, P3902, DOI 10.1128/IAI.00338-07; Montero M, 2009, INFECTION, V37, P16, DOI 10.1007/s15010-008-8125-9; Morisseau C, 2005, ANNU REV PHARMACOL, V45, P311, DOI 10.1146/annurev.pharmtox.45.120403.095920; Moyer BD, 1998, J BIOL CHEM, V273, P21759, DOI 10.1074/jbc.273.34.21759; Murphy TF, 2009, CURR OPIN PULM MED, V15, P138, DOI 10.1097/MCP.0b013e328321861a; Nemec A, 2011, RES MICROBIOL, V162, P393, DOI 10.1016/j.resmic.2011.02.006; Parameswaran GI, 2012, FUTURE MICROBIOL, V7, P1129, DOI [10.2217/fmb.12.88, 10.2217/FMB.12.88]; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; READ RC, 1992, J APPL PHYSIOL, V72, P2271, DOI 10.1152/jappl.1992.72.6.2271; Rice LB, 2008, J INFECT DIS, V197, P1079, DOI 10.1086/533452; Riordan JR, 2008, ANNU REV BIOCHEM, V77, P701, DOI 10.1146/annurev.biochem.75.103004.142532; Shanks RMQ, 2006, APPL ENVIRON MICROB, V72, P5027, DOI 10.1128/AEM.00682-06; Sloane PA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039809; Swiatecka-Urban A, 2006, AM J PHYSIOL-CELL PH, V290, pC862, DOI 10.1152/ajpcell.00108.2005; Swiatecka-Urban A, 2002, J BIOL CHEM, V277, P40099, DOI 10.1074/jbc.M206964200; Visca P, 2011, IUBMB LIFE, V63, P1048, DOI 10.1002/iub.534; WILSON R, 1987, J CLIN INVEST, V79, P221, DOI 10.1172/JCI112787; WILSON R, 1985, THORAX, V40, P125, DOI 10.1136/thx.40.2.125; Yamada T, 2000, J BIOL CHEM, V275, P23082, DOI 10.1074/jbc.M001464200	53	14	14	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 14	2014	289	11					7460	7469		10.1074/jbc.M113.518092	http://dx.doi.org/10.1074/jbc.M113.518092			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AC8CV	24474692	hybrid, Green Published			2022-12-25	WOS:000332761500017
J	Brustovetsky, T; Pellman, JJ; Yang, XF; Khanna, R; Brustovetsky, N				Brustovetsky, Tatiana; Pellman, Jessica J.; Yang, Xiao-Fang; Khanna, Rajesh; Brustovetsky, Nickolay			Collapsin Response Mediator Protein 2 (CRMP2) Interacts with N-Methyl-D-aspartate (NMDA) Receptor and Na+/Ca2+ Exchanger and Regulates Their Functional Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Calcium Signaling; Glutamate; Glutamate Receptors; Neurons; Sodium Calcium Exchange; CRMP2; NMDA Receptor; TAT-CBD3	PAINFUL PERIPHERAL NEUROPATHY; EXCITOTOXIC NEURONAL DEATH; GLUTAMATE EXCITOTOXICITY; PERMEABILITY TRANSITION; CALCIUM DEREGULATION; HIPPOCAMPAL-NEURONS; CA2+; MITOCHONDRIA; PEPTIDE; SUBUNIT	Background: NMDA receptor and Na+/Ca2+ exchanger are involved in glutamate-induced calcium dysregulation in neurons. Results: CRMP2 interacts with and modulates activity of the NMDA receptor and Na+/Ca2+ exchanger. Conclusion: CRMP2 is involved in regulation of Ca2+ homeostasis in neurons exposed to glutamate. Significance: CRMP2 interaction with NMDA receptor and Na+/Ca2+ exchanger affects their activity and is important for glutamate-induced Ca2+ dysregulation. Collapsin response mediator protein 2 (CRMP2) is traditionally viewed as an axonal growth protein involved in axon/dendrite specification. Here, we describe novel functions of CRMP2. A 15-amino acid peptide from CRMP2, fused to the TAT cell-penetrating motif of the HIV-1 protein, TAT-CBD3, but not CBD3 without TAT, attenuated N-methyl-d-aspartate receptor (NMDAR) activity and protected neurons against glutamate-induced Ca2+ dysregulation, suggesting the key contribution of CRMP2 in these processes. In addition, TAT-CBD3, but not CBD3 without TAT or TAT-scramble peptide, inhibited increases in cytosolic Ca2+ mediated by the plasmalemmal Na+/Ca2+ exchanger (NCX) operating in the reverse mode. Co-immunoprecipitation experiments revealed an interaction between CRMP2 and NMDAR as well as NCX3 but not NCX1. TAT-CBD3 disrupted CRMP2-NMDAR interaction without change in NMDAR localization. In contrast, TAT-CBD3 augmented the CRMP2-NCX3 co-immunoprecipitation, indicating increased interaction or stabilization of a complex between these proteins. Immunostaining with an anti-NCX3 antibody revealed that TAT-CBD3 induced NCX3 internalization, suggesting that both reverse and forward modes of NCX might be affected. Indeed, the forward mode of NCX, evaluated in experiments with ionomycin-induced Ca2+ influx into neurons, was strongly suppressed by TAT-CBD3. Knockdown of CRMP2 with short interfering RNA (siRNA) prevented NCX3 internalization in response to TAT-CBD3 exposure. Moreover, CRMP2 down-regulation strongly attenuated TAT-CBD3-induced inhibition of reverse NCX. Overall, our results demonstrate that CRMP2 interacts with NCX and NMDAR and that TAT-CBD3 protects against glutamate-induced Ca2+ dysregulation most likely via suppression of both NMDAR and NCX activities. Our results further clarify the mechanism of action of TAT-CBD3 and identify a novel regulatory checkpoint for NMDAR and NCX function based on CRMP2 interaction with these proteins.	[Brustovetsky, Tatiana; Pellman, Jessica J.; Yang, Xiao-Fang; Khanna, Rajesh; Brustovetsky, Nickolay] Indiana Univ Sch Med, Dept Pharmacol & Toxicol, Indianapolis, IN 46202 USA; [Khanna, Rajesh] Indiana Univ Sch Med, Dept Biochem & Mol Biol, Indianapolis, IN 46202 USA; [Yang, Xiao-Fang; Khanna, Rajesh; Brustovetsky, Nickolay] Indiana Univ Sch Med, Stark Neurosci Res Inst, Indianapolis, IN 46202 USA	Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington	Brustovetsky, N (corresponding author), Indiana Univ Sch Med, Dept Pharmacol & Toxicol, 635 Barnhill Dr,MS 547, Indianapolis, IN 46202 USA.	nbrous@iu.edu		Khanna, Rajesh/0000-0002-9066-2969	National Institutes of Health, NINDS [R01 NS078008]; American Heart Association National Scientist Development Grant [SDG5280023]; Department of Defense Congressionally Directed Military Medical Research and Development Program Neurofibromatosis New Investigator Award [NF1000099]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS078008] Funding Source: NIH RePORTER	National Institutes of Health, NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); American Heart Association National Scientist Development Grant(American Heart Association); Department of Defense Congressionally Directed Military Medical Research and Development Program Neurofibromatosis New Investigator Award; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health, NINDS, Grant R01 NS078008 (to N. B.). This work was also supported by American Heart Association National Scientist Development Grant SDG5280023 and by Department of Defense Congressionally Directed Military Medical Research and Development Program Neurofibromatosis New Investigator Award NF1000099 (to R. K.).	Al-Hallaq RA, 2007, J NEUROSCI, V27, P8334, DOI 10.1523/JNEUROSCI.2155-07.2007; Annunziato L, 2004, PHARMACOL REV, V56, P633, DOI 10.1124/pr.56.4.5; Bano D, 2005, CELL, V120, P275, DOI 10.1016/j.cell.2004.11.049; Bernardi P, 1999, PHYSIOL REV, V79, P1127, DOI 10.1152/physrev.1999.79.4.1127; Bretin S, 2006, J NEUROCHEM, V98, P1252, DOI 10.1111/j.1471-4159.2006.03969.x; Brittain JM, 2012, FEBS LETT, V586, P3813, DOI 10.1016/j.febslet.2012.09.022; Brittain JM, 2011, J BIOL CHEM, V286, P37778, DOI 10.1074/jbc.M111.255455; Brittain JM, 2011, NAT MED, V17, P822, DOI 10.1038/nm.2345; Brittain JM, 2009, J BIOL CHEM, V284, P31375, DOI 10.1074/jbc.M109.009951; Brittain MK, 2012, NEUROPHARMACOLOGY, V63, P974, DOI 10.1016/j.neuropharm.2012.07.012; Brittain MK, 2012, NEUROBIOL DIS, V46, P109, DOI 10.1016/j.nbd.2011.12.051; Brustovetsky T, 2011, BRIT J PHARMACOL, V162, P255, DOI 10.1111/j.1476-5381.2010.01054.x; Brustovetsky T, 2010, J NEUROSCI RES, V88, P1317, DOI 10.1002/jnr.22295; Brustovetsky T, 2009, CELL CALCIUM, V46, P18, DOI 10.1016/j.ceca.2009.03.017; Budd SL, 1996, J NEUROCHEM, V67, P2282; Chalmers S, 2003, J BIOL CHEM, V278, P19062, DOI 10.1074/jbc.M212661200; Convery MK, 1999, PFLUG ARCH EUR J PHY, V437, P944, DOI 10.1007/s004240050866; Czyz A, 2002, J NEUROCHEM, V83, P1321, DOI 10.1046/j.1471-4159.2002.01227.x; Dietz RM, 2007, HIPPOCAMPUS, V17, P1049, DOI 10.1002/hipo.20336; DUBINSKY JM, 1993, J NEUROSCI, V13, P623; Farooqui AA, 2006, PHARMACOL REV, V58, P591, DOI 10.1124/pr.58.3.7; Feldman P, 2013, NEUROSCI LETT, V557, P27, DOI 10.1016/j.neulet.2013.06.057; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Hallett PJ, 2006, J NEUROSCI, V26, P4690, DOI 10.1523/JNEUROSCI.0792-06.2006; Hensley K, 2011, MOL NEUROBIOL, V43, P180, DOI 10.1007/s12035-011-8166-4; Hoyt KR, 1998, MOL PHARMACOL, V53, P742, DOI 10.1124/mol.53.4.742; Ju WN, 2013, J NEUROCHEM, V124, P869, DOI 10.1111/jnc.12070; Khanna R, 2012, FUTUR NEUROL, V7, P749, DOI 10.2217/FNL.12.68; Kiedrowski L, 1999, MOL PHARMACOL, V56, P619, DOI 10.1124/mol.56.3.619; KIEDROWSKI L, 1994, NEURON, V12, P295, DOI 10.1016/0896-6273(94)90272-0; KIMURA J, 1986, NATURE, V319, P596, DOI 10.1038/319596a0; Kowara R, 2005, J NEUROCHEM, V95, P466, DOI 10.1111/j.1471-4159.2005.03383.x; Li V, 2009, EXP NEUROL, V218, P171, DOI 10.1016/j.expneurol.2009.02.007; Liu W, 2009, PROTEOMICS, V9, P3712, DOI 10.1002/pmic.200800979; Liu YT, 2007, J NEUROSCI, V27, P2846, DOI 10.1523/JNEUROSCI.0116-07.2007; MANEV H, 1989, MOL PHARMACOL, V36, P106; Mattson MP, 2003, NEUROMOL MED, V3, P65, DOI 10.1385/NMM:3:2:65; MECHMANN S, 1986, NATURE, V319, P597, DOI 10.1038/319597a0; MORRIS RGM, 1986, NATURE, V319, P774, DOI 10.1038/319774a0; Piekarz AD, 2012, MOL PAIN, V8, DOI 10.1186/1744-8069-8-54; Salinska E, 2005, FOLIA NEUROPATHOL, V43, P322; Schmidt EF, 2007, ADV EXP MED BIOL, V600, P1; Smith Godfrey L, 2006, J Cardiovasc Electrophysiol, V17 Suppl 1, pS57, DOI 10.1111/j.1540-8167.2006.00384.x; Stanika RI, 2009, P NATL ACAD SCI USA, V106, P9854, DOI 10.1073/pnas.0903546106; THAYER SA, 1990, J PHYSIOL-LONDON, V425, P85, DOI 10.1113/jphysiol.1990.sp018094; TYMIANSKI M, 1993, J NEUROSCI, V13, P2085; Wang GJ, 1996, J NEUROPHYSIOL, V76, P1611, DOI 10.1152/jn.1996.76.3.1611; White RJ, 1996, J NEUROSCI, V16, P5688; Wilson SM, 2012, J BIOL CHEM, V287, P35065, DOI 10.1074/jbc.M112.378695; Zhou M, 2006, J NEUROSCI, V26, P2956, DOI 10.1523/JNEUROSCI.4299-05.2006	50	56	56	4	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 14	2014	289	11					7470	7482		10.1074/jbc.M113.518472	http://dx.doi.org/10.1074/jbc.M113.518472			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AC8CV	24474686	Green Published, hybrid			2022-12-25	WOS:000332761500018
J	Yamamoto, K; Owen, K; Parker, AE; Scilabra, SD; Dudhia, J; Strickland, DK; Troeberg, L; Nagase, H				Yamamoto, Kazuhiro; Owen, Kathryn; Parker, Andrew E.; Scilabra, Simone D.; Dudhia, Jayesh; Strickland, Dudley K.; Troeberg, Linda; Nagase, Hideaki			Low Density Lipoprotein Receptor-related Protein 1 (LRP1)-mediated Endocytic Clearance of a Disintegrin and Metalloproteinase with Thrombospondin Motifs-4 (ADAMTS-4) FUNCTIONAL DIFFERENCES OF NON-CATALYTIC DOMAINS OF ADAMTS-4 AND ADAMTS-5 IN LRP1 BINDING	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Chondrocytes; Endocytosis; Extracellular Matrix; Osteoarthritis; Trafficking; Aggrecanase	CARTILAGE MATRIX DEGRADATION; HUMAN SYNOVIAL-FLUID; LIGAND-BINDING; PROTEOLYTIC ACTIVITIES; PENTOSAN POLYSULFATE; AGGRECAN DEGRADATION; IN-VIVO; EXPRESSION; CLEAVAGE; OSTEOARTHRITIS	Background: LRP1 is an endocytic receptor of ADAMTS-5 (aggrecanase 2) in cartilage. Results: ADAMTS-4 (aggrecanase 1) is also internalized via LRP1 but at a slower rate than ADAMTS-5. Conclusion: LRP1 differently regulates the extracellular activities of the two key aggrecanases in cartilage. Significance: LRP1 is a major traffic controller of the two aggrecanases. Degradation of the cartilage proteoglycan aggrecan is an early event in the development of osteoarthritis, and a disintegrin and metalloproteinase with thrombospondin motifs-4 (ADAMTS-4) and ADAMTS-5 are considered to be the major aggrecan-degrading enzymes. We have recently found that ADAMTS-5 is rapidly endocytosed via low density lipoprotein receptor-related protein 1 (LRP1) and degraded by chondrocytes. Here we report that this regulatory mechanism also applies to ADAMTS-4, although its rate of endocytosis is slower than that of ADAMTS-5. Domain deletion mutagenesis of ADAMTS-4 identified that the cysteine-rich and spacer domains are responsible for binding to LRP1, whereas the thrombospondin 1 and spacer domains are responsible in ADAMTS-5. The estimated t(1/2) value of ADAMTS-4 endocytosis was about 220 min, whereas that of ADAMTS-5 was 100 min. The difference in half-lives between the two enzymes is explained by the 13-fold lower affinity of ADAMTS-4 for LRP1 compared with that of ADAMTS-5. Studies using soluble ligand binding clusters of LRP1 showed that ADAMTS-4 binds to clusters II and IV with similar K-D,K-app values of 98 and 73 nm, respectively, whereas ADAMTS-5 binds to cluster II, III, and IV with K-D,K-app values of 3.5, 41, and 9 nm, respectively. Thus, ADAMTS-5 competitively inhibits ADAMTS-4 endocytosis but not vice versa. This study highlights that the affinity between a ligand and LRP1 dictates the rate of internalization and suggests that LRP1 is a major traffic controller of the two aggrecanases, especially under inflammatory conditions, where the protein levels of ADAMTS-4 increase, but those of ADAMTS-5 do not.	[Yamamoto, Kazuhiro; Scilabra, Simone D.; Troeberg, Linda; Nagase, Hideaki] Univ Oxford, Kennedy Inst Rheumatol, Nuffield Dept Orthopaed Rheumatol & Musculoskelet, Oxford OX3 7FY, England; [Owen, Kathryn; Scilabra, Simone D.; Troeberg, Linda; Nagase, Hideaki] Univ London Imperial Coll Sci Technol & Med, Fac Med, Kennedy Inst Rheumatol, London W6 8LH, England; [Parker, Andrew E.] AstraZeneca, Resp & Inflammat Dept, Macclesfield SK10 4TF, Cheshire, England; [Dudhia, Jayesh] Univ London Royal Vet Coll, Dept Clin Sci & Serv, Hatfield AL9 7TA, Herts, England; [Strickland, Dudley K.] Univ Maryland, Ctr Vasc & Inflammatory Dis, Baltimore, MD 21201 USA	University of Oxford; Imperial College London; University of Oxford; AstraZeneca; University of London; University of London Royal Veterinary College; University System of Maryland; University of Maryland Baltimore	Yamamoto, K (corresponding author), Univ Oxford, Kennedy Inst Rheumatol, Dept Orthopaed Rheumatol & Musculoskeletal Sci, Matrix Biol Sect, Roosevelt Dr, Oxford OX3 7FY, England.	kazuhiro.yamamoto@kennedy.ox.ac.uk	Yamamoto, Kazuhiro/AAD-9650-2019; scilabra, simone/AAT-4753-2021	Scilabra, Simone Dario/0000-0001-7300-6153; /0000-0003-0939-4651; Dudhia, Jayesh/0000-0002-2503-697X	National Institutes of Health [AR40994, HL072929, HL114379]; Arthritis Research UK; Biotechnology and Biological Sciences Research Council; AstraZeneca; Orthopaedic Research UK;  [19466]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL114379, R01HL072929] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR040994] Funding Source: NIH RePORTER; Versus Arthritis [19466, 20563] Funding Source: researchfish	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Arthritis Research UK(Versus Arthritis); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); AstraZeneca(AstraZeneca); Orthopaedic Research UK; ; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Versus Arthritis(Versus Arthritis)	This work was supported, in whole or in part, by National Institutes of Health Grants AR40994 (NIAMS) and HL072929 and HL114379 (NHLBI). This work was also supported by grants from the; Recipient of a CASE Ph.D. studentship from Biotechnology and Biological Sciences Research Council and AstraZeneca. Present address: Imperial Innovations, London, UK.Arthritis Research UK.; Recipient of a grant from Orthopaedic Research UK.; An arthritis Research UK Fellow (Grant 19466).	Barmina OY, 1999, J BIOL CHEM, V274, P30087, DOI 10.1074/jbc.274.42.30087; Bau B, 2002, ARTHRITIS RHEUM, V46, P2648, DOI 10.1002/art.10531; Bu GJ, 2009, NAT REV NEUROSCI, V10, P333, DOI 10.1038/nrn2620; Emonard H, 2004, J BIOL CHEM, V279, P54944, DOI 10.1074/jbc.M406792200; Flannery CR, 2002, J BIOL CHEM, V277, P42775, DOI 10.1074/jbc.M205309200; Fosang A. J., 2013, OSTEOARTHR CARTILAGE, V18, P1109; Fushimi K, 2008, J BIOL CHEM, V283, P6706, DOI 10.1074/jbc.M708647200; Gao G, 2002, J BIOL CHEM, V277, P11034, DOI 10.1074/jbc.M107443200; Gendron C, 2007, J BIOL CHEM, V282, P18294, DOI 10.1074/jbc.M701523200; Glasson SS, 2004, ARTHRITIS RHEUM-US, V50, P2547, DOI 10.1002/art.20558; Glasson SS, 2005, NATURE, V434, P644, DOI 10.1038/nature03369; Gorovoy M, 2010, J LEUKOCYTE BIOL, V88, P769, DOI 10.1189/jlb.0410220; Guttman M, 2010, BIOCHEMISTRY-US, V49, P1207, DOI 10.1021/bi9017208; Hahn-Dantona E, 2001, J BIOL CHEM, V276, P15498, DOI 10.1074/jbc.M100121200; Held-Feindt J, 2006, INT J CANCER, V118, P55, DOI 10.1002/ijc.21258; HERZ J, 1990, EMBO J, V9, P1769, DOI 10.1002/j.1460-2075.1990.tb08301.x; HERZ J, 1992, CELL, V71, P411, DOI 10.1016/0092-8674(92)90511-A; Herz J, 2001, J CLIN INVEST, V108, P779, DOI 10.1172/JCI200113992; Horn IR, 1997, J BIOL CHEM, V272, P13608, DOI 10.1074/jbc.272.21.13608; ILIC MZ, 1992, ARCH BIOCHEM BIOPHYS, V294, P115, DOI 10.1016/0003-9861(92)90144-L; Kashiwagi M, 2004, J BIOL CHEM, V279, P10109, DOI 10.1074/jbc.M312123200; Kawata K, 2012, J CELL SCI, V125, P2965, DOI 10.1242/jcs.101956; Kawata K, 2010, J CELL PHYSIOL, V222, P138, DOI 10.1002/jcp.21930; Kevorkian L, 2004, ARTHRITIS RHEUM-US, V50, P131, DOI 10.1002/art.11433; KOUNNAS MZ, 1993, J BIOL CHEM, V268, P21862; Lillis AP, 2008, PHYSIOL REV, V88, P887, DOI 10.1152/physrev.00033.2007; Lim NH, 2010, BIOCHEM J, V431, P113, DOI 10.1042/BJ20100725; LOHMANDER LS, 1993, ARTHRITIS RHEUM, V36, P1214; Malfait AM, 2002, J BIOL CHEM, V277, P22201, DOI 10.1074/jbc.M200431200; Manning HB, 2013, MATRIX BIOL, V32, P32, DOI 10.1016/j.matbio.2012.11.012; Matthews RT, 2000, J BIOL CHEM, V275, P22695, DOI 10.1074/jbc.M909764199; Medved LV, 1999, J BIOL CHEM, V274, P717, DOI 10.1074/jbc.274.2.717; Mikhailenko I, 2001, J BIOL CHEM, V276, P39484, DOI 10.1074/jbc.M104382200; MOESTRUP SK, 1992, CELL TISSUE RES, V269, P375, DOI 10.1007/BF00353892; Murphy G, 2008, NAT CLIN PRACT RHEUM, V4, P128, DOI 10.1038/ncprheum0727; Naito S, 2007, PATHOL INT, V57, P703, DOI 10.1111/j.1440-1827.2007.02167.x; Nakada M, 2005, ACTA NEUROPATHOL, V110, P239, DOI 10.1007/s00401-005-1032-6; Neels JG, 1999, J BIOL CHEM, V274, P31305, DOI 10.1074/jbc.274.44.31305; Patwari P, 2005, OSTEOARTHR CARTILAGE, V13, P269, DOI 10.1016/j.joca.2004.10.023; Powell AJ, 2007, ARTHRITIS RHEUM-US, V56, P3010, DOI 10.1002/art.22818; Pratta MA, 2003, J BIOL CHEM, V278, P45539, DOI 10.1074/jbc.M303737200; Rao N, 2013, INT J CANCER, V133, P294, DOI 10.1002/ijc.28037; Rozanov DV, 2004, J BIOL CHEM, V279, P4260, DOI 10.1074/jbc.M311569200; SANDY JD, 1992, J CLIN INVEST, V89, P1512, DOI 10.1172/JCI115742; SANDY JD, 1991, J BIOL CHEM, V266, P8683; Scilabra SD, 2013, J BIOL CHEM, V288, P332, DOI 10.1074/jbc.M112.393322; Selvais C, 2011, FASEB J, V25, P2770, DOI 10.1096/fj.10-169508; Song RH, 2007, ARTHRITIS RHEUM-US, V56, P575, DOI 10.1002/art.22334; Stanton H, 2005, NATURE, V434, P648, DOI 10.1038/nature03417; Strickland DK, 2002, TRENDS ENDOCRIN MET, V13, P66, DOI 10.1016/S1043-2760(01)00526-4; Stura EA, 2013, FASEB J, V27, P4395, DOI 10.1096/fj.13-233601; Tauchi R, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-53; Troeberg L, 2008, FASEB J, V22, P3515, DOI 10.1096/fj.08-112680; Troeberg L, 2012, BIOCHEM J, V443, P307, DOI 10.1042/BJ20112159; Troeberg L, 2012, BBA-PROTEINS PROTEOM, V1824, P133, DOI 10.1016/j.bbapap.2011.06.020; Wainwright SD, 2006, MATRIX BIOL, V25, P317, DOI 10.1016/j.matbio.2006.03.006; Wainwright SD, 2013, ARTHRITIS RHEUM-US, V65, P2866, DOI 10.1002/art.38102; Walling HW, 2003, OSTEOARTHR CARTILAGE, V11, P854, DOI 10.1016/S1063-4584(03)00170-5; WILLNOW TE, 1992, J BIOL CHEM, V267, P26172; Yamamoto K, 2013, FASEB J, V27, P511, DOI 10.1096/fj.12-216671; Yamanishi Y, 2002, J IMMUNOL, V168, P1405, DOI 10.4049/jimmunol.168.3.1405; Yu ZX, 2012, J BIOL CHEM, V287, P22988, DOI 10.1074/jbc.M112.348979; Zeng WL, 2006, BBA-GEN SUBJECTS, V1760, P517, DOI 10.1016/j.bbagen.2006.01.013; ZHENG G, 1994, J HISTOCHEM CYTOCHEM, V42, P531, DOI 10.1177/42.4.7510321; Zilberberg A, 2004, J BIOL CHEM, V279, P17535, DOI 10.1074/jbc.M311292200	65	55	55	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 7	2014	289	10					6462	6474		10.1074/jbc.M113.545376	http://dx.doi.org/10.1074/jbc.M113.545376			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AC3BG	24474687	Green Accepted, Green Published, hybrid			2022-12-25	WOS:000332389400014
J	Crippa, E; Lusa, L; De Cecco, L; Marchesi, E; Calin, GA; Radice, P; Manoukian, S; Peissel, B; Daidone, MG; Gariboldi, M; Pierotti, MA				Crippa, Elisabetta; Lusa, Lara; De Cecco, Loris; Marchesi, Edoardo; Calin, George Adrian; Radice, Paolo; Manoukian, Siranoush; Peissel, Bernard; Daidone, Maria Grazia; Gariboldi, Manuela; Pierotti, Marco Alessandro			miR-342 Regulates BRCA1 Expression through Modulation of ID4 in Breast Cancer	PLOS ONE			English	Article							ESTROGEN-RECEPTOR-ALPHA; MESSENGER-RNA; GENETIC SUSCEPTIBILITY; MICRORNA SIGNATURES; PROTEINS; DIFFERENTIATION; GLIOBLASTOMA; INHIBITOR; TAMOXIFEN; GENOMICS	A miRNAs profiling on a group of familial and sporadic breast cancers showed that miRNA-342 was significantly associated with estrogen receptor (ER) levels. To investigate at functional level the role of miR-342 in the pathogenesis of breast cancer, we focused our attention on its "in silico" predicted putative target gene ID4, a transcription factor of the helix-loop-helix protein family whose expression is inversely correlated with that of ER. ID4 is expressed in breast cancer and can negatively regulate BRCA1 expression. Our results showed an inverse correlation between ID4 and miR-342 as well as between ID4 and BRCA1 expression. We functionally validated the interaction between ID4 and miR-342 in a reporter Luciferase system. Based on these findings, we hypothesized that regulation of ID4 mediated by miR-342 could be involved in the pathogenesis of breast cancer by downregulating BRCA1 expression. We functionally demonstrated the interactions between miR-342, ID4 and BRCA1 in a model provided by ER-negative MDA-MB-231 breast cancer cell line that presented high levels of ID4. Overexpression of miR-342 in these cells reduced ID4 and increased BRCA1 expression, supporting a possible role of this mechanism in breast cancer. In the ER-positive MCF7 and in the BRCA1-mutant HCC1937 cell lines miR-342 over-expression only reduced ID4. In the cohort of patients we studied, a correlation between miR-342 and BRCA1 expression was found in the ER-negative cases. As ER-negative cases were mainly BRCA1-mutant, we speculate that the mechanism we demonstrated could be involved in the decreased expression of BRCA1 frequently observed in non BRCA1-mutant breast cancers and could be implicated as a causal factor in part of the familial cases grouped in the heterogeneous class of non BRCA1 or BRCA2-mutant cases (BRCAx). To validate this hypothesis, the study should be extended to a larger cohort of ER-negative cases, including those belonging to the BRCAx class.	[Crippa, Elisabetta; Lusa, Lara; De Cecco, Loris; Marchesi, Edoardo; Radice, Paolo; Daidone, Maria Grazia; Gariboldi, Manuela] Fdn IRCCS Ist Nazl Tumori, Dept Expt Oncol & Mol Med, Milan, Italy; [Crippa, Elisabetta; Lusa, Lara; De Cecco, Loris; Marchesi, Edoardo; Radice, Paolo; Gariboldi, Manuela] Fdn Ist FIRC Oncol Mol, Milan, Italy; [Lusa, Lara] Univ Ljubljana, Fac Med, Inst Biostat & Med Informat, Ljubljana, Slovenia; [Calin, George Adrian] Univ Texas MD Anderson Canc Ctr, Dept Expt Therapeut, Houston, TX 77030 USA; [Calin, George Adrian] Univ Texas MD Anderson Canc Ctr, Ctr RNA Interference & Noncoding RNAs, Houston, TX 77030 USA; [Manoukian, Siranoush; Peissel, Bernard] Fdn IRCCS Ist Nazl Tumori, Dept Prevent & Predict Med, Unit Med Genet, Milan, Italy; [Pierotti, Marco Alessandro] Fdn IRCCS Ist Nazl Tumori, Sci Directorate, Milan, Italy	Fondazione IRCCS Istituto Nazionale Tumori Milan; IFOM - FIRC Institute of Molecular Oncology; University of Ljubljana; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; Fondazione IRCCS Istituto Nazionale Tumori Milan; Fondazione IRCCS Istituto Nazionale Tumori Milan	Gariboldi, M (corresponding author), Fdn IRCCS Ist Nazl Tumori, Dept Expt Oncol & Mol Med, Milan, Italy.	manuela.gariboldi@istitutotumori.mi.it	Radice, Paolo/O-3119-2013; Lusa, Lara/C-6692-2015; Pierotti, Marco Alessandro/AAC-4728-2022; Daidone, Maria Grazia/E-9232-2017; Peissel, Bernard/E-8187-2017; Calin, George/E-9390-2011; manoukian, siranoush/E-7132-2017; De Cecco, Loris/K-7036-2016; Gariboldi, Manuela/K-4744-2016	Radice, Paolo/0000-0001-6298-4111; Lusa, Lara/0000-0002-8981-2421; Pierotti, Marco Alessandro/0000-0002-7431-8332; Daidone, Maria Grazia/0000-0002-4786-1321; Peissel, Bernard/0000-0001-9233-3571; manoukian, siranoush/0000-0002-6034-7562; De Cecco, Loris/0000-0002-7066-473X; Calin, George/0000-0002-7427-0578; Calin, George/0000-0001-6704-5615; Gariboldi, Manuela/0000-0001-8406-165X	AIRC (Associazione Italiana Ricerca Cancro); Ministero della Salute	AIRC (Associazione Italiana Ricerca Cancro)(Fondazione AIRC per la ricerca sul cancro); Ministero della Salute(Ministry of Health, Italy)	This work was supported by grants to MA Pierotti from AIRC (Associazione Italiana Ricerca Cancro) and by Ministero della Salute (Tumori Femminili). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed M, 2009, EXPERT REV ANTICANC, V9, P1103, DOI 10.1586/ERA.09.38; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Beger C, 2001, P NATL ACAD SCI USA, V98, P130, DOI 10.1073/pnas.98.1.130; Blenkiron C, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-10-r214; Bradbury AR, 2007, REV ENDOCR METAB DIS, V8, P255, DOI 10.1007/s11154-007-9038-0; Buffa FM, 2011, CANCER RES, V71, P5635, DOI 10.1158/0008-5472.CAN-11-0489; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Cittelly DM, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-317; Da Silva L, 2010, MODERN PATHOL, V23, pS46, DOI 10.1038/modpathol.2010.37; de Candia P, 2006, HUM PATHOL, V37, P1032, DOI 10.1016/j.humpath.2006.03.004; De Marchis ML, 2009, LEUKEMIA, V23, P856, DOI 10.1038/leu.2008.372; Dell'Orso S, 2010, ONCOTARGET, V1, P48, DOI 10.18632/oncotarget.108; Grady WM, 2008, ONCOGENE, V27, P3880, DOI 10.1038/onc.2008.10; He YJ, 2013, EXP THER MED, V5, P813, DOI 10.3892/etm.2013.915; Heyn H, 2011, INT J CANCER, V129, P2797, DOI 10.1002/ijc.25962; Iorio MV, 2005, CANCER RES, V65, P7065, DOI 10.1158/0008-5472.CAN-05-1783; Jen Y, 1996, DEV DYNAM, V207, P235; Kamalian L, 2008, CLIN CANCER RES, V14, P2318, DOI 10.1158/1078-0432.CCR-07-4716; Kao J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006146; Kim VN, 2006, TRENDS GENET, V22, P165, DOI 10.1016/j.tig.2006.01.003; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Kuzontkoski PM, 2010, ONCOGENE, V29, P3793, DOI 10.1038/onc.2010.147; Lacroix M, 2005, BREAST CANCER RES TR, V89, P297, DOI 10.1007/s10549-004-2172-4; Lasorella A, 2001, ONCOGENE, V20, P8326, DOI 10.1038/sj.onc.1205093; Liu CG, 2004, P NATL ACAD SCI USA, V101, P9740, DOI 10.1073/pnas.0403293101; Lowery AJ, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2257; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Manoukian S, 2007, EUR J CANCER, V43, P601, DOI 10.1016/j.ejca.2006.09.024; Mavaddat N, 2010, MOL ONCOL, V4, P174, DOI 10.1016/j.molonc.2010.04.011; Miller TE, 2008, J BIOL CHEM, V283, P29897, DOI 10.1074/jbc.M804612200; Neve RM, 2006, CANCER CELL, V10, P515, DOI 10.1016/j.ccr.2006.10.008; O'Day E, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2484; Park Se-Jin, 2011, Lab Anim Res, V27, P333, DOI 10.5625/lar.2011.27.4.333; Perk J, 2005, NAT REV CANCER, V5, P603, DOI 10.1038/nrc1673; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Piffanelli A, 1991, Ann Ist Super Sanita, V27, P523; Roldan G, 2006, CANCER BIOL THER, V5, P505, DOI 10.4161/cbt.5.5.2597; RONCHI E, 1986, TUMORI, V72, P251, DOI 10.1177/030089168607200305; Savad S, 2012, ASIAN PAC J CANCER P, V13, P873, DOI 10.7314/APJCP.2012.13.3.873; Tomlinson GE, 1998, CANCER RES, V58, P3237; Turner NC, 2007, ONCOGENE, V26, P2126, DOI 10.1038/sj.onc.1210014; Van der Auwera I, 2010, BRIT J CANCER, V103, P532, DOI 10.1038/sj.bjc.6605787; Venneti S, 2011, AM J SURG PATHOL, V35, P1463, DOI 10.1097/PAS.0b013e318224d2cd; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; Wang H, 2011, CARCINOGENESIS, V32, P1033, DOI 10.1093/carcin/bgr081; Wen YH, 2012, BREAST CANCER RES TR, V135, P93, DOI 10.1007/s10549-012-2070-0; Yang YH, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.4.e15; Zeng WF, 2010, J CANCER, V1, P1	48	52	55	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2014	9	1							e87039	10.1371/journal.pone.0087039	http://dx.doi.org/10.1371/journal.pone.0087039			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301BI	24475217	Green Published, gold, Green Submitted			2022-12-25	WOS:000330507300128
J	Meckbach, D; Bauer, J; Pflugfelder, A; Meier, F; Busch, C; Eigentler, TK; Capper, D; von Deimling, A; Mittelbronn, M; Perner, S; Ikenberg, K; Hantschke, M; Buttner, P; Garbe, C; Weide, B				Meckbach, Diana; Bauer, Juergen; Pflugfelder, Annette; Meier, Friedegund; Busch, Christian; Eigentler, Thomas K.; Capper, David; von Deimling, Andreas; Mittelbronn, Michel; Perner, Sven; Ikenberg, Kristian; Hantschke, Markus; Buettner, Petra; Garbe, Claus; Weide, Benjamin			Survival According to BRAF-V600 Tumor Mutations - An Analysis of 437 Patients with Primary Melanoma	PLOS ONE			English	Article							AMERICAN JOINT COMMITTEE; BRAF V600E MUTATION; METASTATIC MELANOMA; NRAS MUTATIONS; CUTANEOUS MELANOMA; CANCER; FREQUENCIES; INHIBITION; GENE	The prognostic impact of BRAF-V600 tumor mutations in stage I/II melanoma patients has not yet been analyzed in detail. We investigated primary tumors of 437 patients diagnosed between 1989 and 2006 by Sanger sequencing. Mutations were detected in 38.7% of patients and were associated with age, histological subtype as well as mitotic rate. The mutational rate was 36.7% in patients with disease-free course and 51.7% in those with subsequent distant metastasis (p = 0.031). No difference in overall survival (p = 0.119) but a trend for worse distant-metastasis-free survival (p = 0.061) was observed in BRAF mutant compared to BRAF wild-type patients. Independent prognostic factors for overall survival were tumor thickness, mitotic rate and ulceration. An interesting significant prognostic impact was observed in patients with tumor thickness of 1 mm or less, with the mutation present in 6 of 7 patients dying from melanoma. In conclusion, no significant survival differences were found according to BRAF-V600 tumor mutations in patients with primary melanoma but an increasing impact of the mutational status was observed in the subgroup of patients with tumor thickness of 1 mm or less. A potential role of the mutational status as a prognostic factor especially in this subgroup needs to be investigated in larger studies.	[Meckbach, Diana; Bauer, Juergen; Pflugfelder, Annette; Meier, Friedegund; Busch, Christian; Eigentler, Thomas K.; Garbe, Claus; Weide, Benjamin] Univ Med Ctr Tubingen, Dept Dermatol, Div Dermatooncol, Tubingen, Germany; [Capper, David; von Deimling, Andreas; Weide, Benjamin] German Canc Res Ctr, Heidelberg, Germany; [Weide, Benjamin] German Canc Consortium DKTK, Heidelberg, Germany; [Capper, David; von Deimling, Andreas] Heidelberg Univ, Dept Neuropathol, Heidelberg, Germany; [Mittelbronn, Michel] Goethe Univ Frankfurt, Edinger Inst, Inst Neurol, D-60054 Frankfurt, Germany; [Perner, Sven] Univ Hosp Bonn, Inst Pathol, Dept Prostate Canc Res, Bonn, Germany; [Ikenberg, Kristian] Univ Zurich Hosp, Inst Surg Pathol, CH-8091 Zurich, Switzerland; [Hantschke, Markus] Dermatopathol Friedrichshafen, Friedrichshafen, Germany; [Buettner, Petra] James Cook Univ, Skin Canc Res Grp, Sch Publ Hlth Trop Med & Rehabil Sci, Townsville, Qld 4811, Australia	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Goethe University Frankfurt; University of Bonn; University of Zurich; University Zurich Hospital; James Cook University	Weide, B (corresponding author), Univ Med Ctr Tubingen, Dept Dermatol, Div Dermatooncol, Tubingen, Germany.	benjamin.weide@med.uni-tuebingen.de	von Deimling, Andreas/F-7774-2013; Capper, David/I-8500-2014; Eigentler, Thomas/K-8570-2015; Pflugfelder, Annette/Q-2659-2016; Weide, Benjamin/N-3698-2013; Garbe, Claus/ABH-2128-2021; Bauer, Jurgen/B-4656-2008	von Deimling, Andreas/0000-0002-5863-540X; Capper, David/0000-0003-1945-497X; Eigentler, Thomas/0000-0003-0019-2770; Garbe, Claus/0000-0001-8530-780X; Bauer, Jurgen/0000-0001-8789-1536; Mittelbronn, Michel/0000-0002-2998-052X				Akslen LA, 2005, J INVEST DERMATOL, V125, P312, DOI 10.1111/j.0022-202X.2005.23788.x; Ardekani GS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047054; Balch CM, 2009, J CLIN ONCOL, V27, P6199, DOI 10.1200/JCO.2009.23.4799; Balch CM, 2001, J CLIN ONCOL, V19, P3622, DOI 10.1200/JCO.2001.19.16.3622; Balch CM, 2001, J CLIN ONCOL, V19, P3635, DOI 10.1200/JCO.2001.19.16.3635; Capper D, 2012, ACTA NEUROPATHOL, V123, P223, DOI 10.1007/s00401-011-0887-y; Chang David Z, 2004, J Transl Med, V2, P46, DOI 10.1186/1479-5876-2-46; Chapman PB, 2011, NEW ENGL J MED, V364, P2507, DOI 10.1056/NEJMoa1103782; Colombino M, 2012, J CLIN ONCOL, V30, P2522, DOI 10.1200/JCO.2011.41.2452; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; Edlundh-Rose E, 2006, MELANOMA RES, V16, P471, DOI 10.1097/01.cmr.0000232300.22032.86; Ellerhorst JA, 2011, CLIN CANCER RES, V17, P229, DOI 10.1158/1078-0432.CCR-10-2276; Flaherty KT, 2012, NEW ENGL J MED, V367, P107, DOI 10.1056/NEJMoa1203421; Flaherty KT, 2010, NEW ENGL J MED, V363, P809, DOI 10.1056/NEJMoa1002011; Greaves WO, 2013, J MOL DIAGN, V15, P220, DOI 10.1016/j.jmoldx.2012.10.002; Houben Roland, 2004, J Carcinog, V3, P6, DOI 10.1186/1477-3163-3-6; Jakob JA, 2012, CANCER-AM CANCER SOC, V118, P4014, DOI 10.1002/cncr.26724; Kumar R, 2003, CLIN CANCER RES, V9, P3362; Lasithiotakis KG, 2010, MELANOMA RES, V20, P163, DOI 10.1097/CMR.0b013e328335a8dd; Lee JH, 2011, BRIT J DERMATOL, V164, P776, DOI 10.1111/j.1365-2133.2010.10185.x; Long GV, 2011, J CLIN ONCOL, V29, P1239, DOI 10.1200/JCO.2010.32.4327; Maldonado JL, 2003, J NATL CANCER I, V95, P1878, DOI 10.1093/jnci/djg123; Mann GJ, 2013, J INVEST DERMATOL, V133, P509, DOI 10.1038/jid.2012.283; Menzies AM, 2012, CLIN CANCER RES, V18, P3242, DOI 10.1158/1078-0432.CCR-12-0052; Moreau S, 2012, ANN SURG ONCOL, V19, P4314, DOI 10.1245/s10434-012-2457-5; Satyamoorthy K, 2003, CANCER RES, V63, P756; Shinozaki M, 2004, CLIN CANCER RES, V10, P1753, DOI 10.1158/1078-0432.CCR-1169-3; Si L, 2012, EUR J CANCER, V48, P94, DOI 10.1016/j.ejca.2011.06.056; Thomas NE, 2007, CANCER EPIDEM BIOMAR, V16, P991, DOI 10.1158/1055-9965.EPI-06-1038; Thompson JF, 2011, J CLIN ONCOL, V29, P2199, DOI 10.1200/JCO.2010.31.5812; von Moos R, 2012, ANN ONCOL, V23, P531, DOI 10.1093/annonc/mdr126	31	33	33	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2014	9	1							e86194	10.1371/journal.pone.0086194	http://dx.doi.org/10.1371/journal.pone.0086194			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	298QQ	24475086	Green Published, gold, Green Accepted			2022-12-25	WOS:000330339800032
J	Williams, R; Ma, XY; Schott, RK; Mohammad, N; Ho, CY; Li, CF; Chang, BSW; Demetriou, M; Dennis, JW				Williams, Ryan; Ma, Xiangyuan; Schott, Ryan K.; Mohammad, Naveed; Ho, Chi Yip; Li, Carey F.; Chang, Belinda S. W.; Demetriou, Michael; Dennis, James W.			Encoding Asymmetry of the N-Glycosylation Motif Facilitates Glycoprotein Evolution	PLOS ONE			English	Article							CODING-SEQUENCE EVOLUTION; PROTEIN EVOLUTION; MORPHOLOGICAL EVOLUTION; FUNCTIONAL DIVERGENCE; ENDOPLASMIC-RETICULUM; PHYLOGENETIC ANALYSIS; MAXIMUM-LIKELIHOOD; LYSINE ACETYLATION; CELL; SELECTION	Protein N-glycosylation is found in all domains of life and has a conserved role in glycoprotein folding and stability. In animals, glycoproteins transit through the Golgi where the N-glycans are trimmed and rebuilt with sequences that bind lectins, an innovation that greatly increases structural diversity and redundancy of glycoprotein-lectin interaction at the cell surface. Here we ask whether the natural tension between increasing diversity (glycan-protein interactions) and site multiplicity (backup and status quo) might be revealed by a phylogenic examination of glycoproteins and NXS/T(X not equal P) N-glycosylation sites. Site loss is more likely by mutation at Asn encoded by two adenosine (A)-rich codons, while site gain is more probable by generating Ser or Thr downstream of an existing Asn. Thus mutations produce sites at novel positions more frequently than the reversal of recently lost sites, and therefore more paths though sequence space are made available to natural selection. An intra-species comparison of secretory and cytosolic proteins revealed a departure from equilibrium in sequences one-mutation-away from NXS/T and in (A) content, indicating strong selective pressures and exploration of N-glycosylation positions during vertebrate evolution. Furthermore, secretory proteins have evolved at rates proportional to N-glycosylation site number, indicating adaptive interactions between the N-glycans and underlying protein. Given the topology of the genetic code, mutation of (A) is more often nonsynonomous, and Lys, another target of many PTMs, is also encoded by two (A)-rich codons. An examination of acetyl-Lys sites in proteins indicated similar evolutionary dynamics, consistent with asymmetry of the target and recognition portions of modified sites. Our results suggest that encoding asymmetry is an ancient mechanism of evolvability that increases diversity and experimentation with PTM site positions. Strong selective pressures on PTMs may have contributed to the A+T -> G+C shift in genome-wide nucleotide composition during metazoan radiation.	[Williams, Ryan; Ma, Xiangyuan; Mohammad, Naveed; Ho, Chi Yip; Dennis, James W.] Mt Sinai Hosp, Lunenfeld Tanenbaum Res Inst, Toronto, ON M5G 1X5, Canada; [Ma, Xiangyuan; Dennis, James W.] Univ Toronto, Dept Med Genet, Toronto, ON, Canada; [Ma, Xiangyuan; Dennis, James W.] Univ Toronto, Dept Lab Med & Pathol, Toronto, ON, Canada; [Schott, Ryan K.; Chang, Belinda S. W.] Univ Toronto, Dept Ecol & Evolutionary, Toronto, ON, Canada; [Li, Carey F.; Demetriou, Michael] Univ Calif Irvine, Dept Neurol, Irvine, CA 92717 USA; [Li, Carey F.; Demetriou, Michael] Univ Calif Irvine, Dept Microbiol & Mol Genet, Irvine, CA 92717 USA	University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University of Toronto; University of Toronto; University of California System; University of California Irvine; University of California System; University of California Irvine	Dennis, JW (corresponding author), Mt Sinai Hosp, Lunenfeld Tanenbaum Res Inst, Toronto, ON M5G 1X5, Canada.	DENNIS@lunenfeld.ca	Dennis, James/E-7268-2013	Schott, Ryan/0000-0002-4015-3955; Demetriou, Michael/0000-0002-2224-7798	Genome Canada through the OGI; MRI-Ontario Research Fund Global Leadership Round in Genomics Life Sciences [ORF-GL2]; CIHR [MOP-62975]; National Institute of Allergy and Infectious Disease, National Institutes of Health; CFL [R01AI082266, T32AI060573]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI060573, R01AI082266] Funding Source: NIH RePORTER	Genome Canada through the OGI; MRI-Ontario Research Fund Global Leadership Round in Genomics Life Sciences; CIHR(Canadian Institutes of Health Research (CIHR)); National Institute of Allergy and Infectious Disease, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); CFL; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Research was supported by grants from Genome Canada through the OGI, and funding from MRI-Ontario Research Fund Global Leadership Round in Genomics & Life Sciences (ORF-GL2) and CIHR (MOP-62975) to JWD), and The National Institute of Allergy and Infectious Disease, National Institutes of Health to MD and CFL (R01AI082266, T32AI060573). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alba MM, 2005, MOL BIOL EVOL, V22, P598, DOI 10.1093/molbev/msi045; Banerjee S, 2007, P NATL ACAD SCI USA, V104, P11676, DOI 10.1073/pnas.0704862104; Berglund J, 2009, PLOS BIOL, V7, P45, DOI 10.1371/journal.pbio.1000026; Bielawski JP, 2004, J MOL EVOL, V59, P121, DOI 10.1007/s00239-004-2597-8; Breen MS, 2012, NATURE, V490, P535, DOI 10.1038/nature11510; Cambray G, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000256; Choudhary C, 2009, SCIENCE, V325, P834, DOI 10.1126/science.1175371; Compton SJ, 2002, BIOCHEM J, V368, P495, DOI 10.1042/BJ20020706; Dam TK, 2008, BIOCHEMISTRY-US, V47, P8470, DOI 10.1021/bi801208b; Delport W, 2010, BIOINFORMATICS, V26, P2455, DOI 10.1093/bioinformatics/btq429; Dennis JW, 2013, MOL CELL PROTEOMICS, V12, P913, DOI 10.1074/mcp.R112.026989; Dennis JW, 2009, CELL, V139, P1229, DOI 10.1016/j.cell.2009.12.008; Deprez P, 2005, MOL CELL, V19, P183, DOI 10.1016/j.molcel.2005.05.029; Dodd RB, 2001, GLYCOBIOLOGY, V11, p71R, DOI 10.1093/glycob/11.5.71R; Draghi JA, 2011, GENETICS, V187, P1139, DOI 10.1534/genetics.110.125997; Drummond DA, 2008, CELL, V134, P341, DOI 10.1016/j.cell.2008.05.042; Emanuelsson O, 2007, NAT PROTOC, V2, P953, DOI 10.1038/nprot.2007.131; Fay JC, 2003, ANNU REV GENOM HUM G, V4, P213, DOI 10.1146/annurev.genom.4.020303.162528; Filippakopoulos P, 2012, CELL, V149, P214, DOI 10.1016/j.cell.2012.02.013; Finley D, 2009, ANNU REV BIOCHEM, V78, P477, DOI 10.1146/annurev.biochem.78.081507.101607; Galtier N, 2009, TRENDS GENET, V25, P1, DOI 10.1016/j.tig.2008.10.011; Grigorian A, 2011, J BIOL CHEM, V286, P40133, DOI 10.1074/jbc.M111.277814; Hall BG, 2008, MOL BIOL EVOL, V25, P688, DOI 10.1093/molbev/msn008; Hayden EJ, 2011, NATURE, V474, P92, DOI 10.1038/nature10083; Helenius A, 2004, ANNU REV BIOCHEM, V73, P1019, DOI 10.1146/annurev.biochem.73.011303.073752; Holt LJ, 2009, SCIENCE, V325, P1682, DOI 10.1126/science.1172867; Julenius K, 2006, MOL BIOL EVOL, V23, P2039, DOI 10.1093/molbev/msl081; Kim SY, 2007, CELL, V128, P1133, DOI 10.1016/j.cell.2007.01.039; Kimura MA, 1985, NEUTRAL THEORY MOL E; Kirschner M, 1998, P NATL ACAD SCI USA, V95, P8420, DOI 10.1073/pnas.95.15.8420; Klein P, 2003, CURR BIOL, V13, P1669, DOI 10.1016/j.cub.2003.09.027; Koide S, 2009, ACS CHEM BIOL, V4, P325, DOI 10.1021/cb800314v; KORNFELD R, 1985, ANNU REV BIOCHEM, V54, P631, DOI 10.1146/annurev.biochem.54.1.631; Kowarik M, 2006, SCIENCE, V314, P1148, DOI 10.1126/science.1134351; Kuriyan J, 2007, NATURE, V450, P983, DOI 10.1038/nature06524; Lajoie P, 2009, J CELL BIOL, V185, P381, DOI 10.1083/jcb.200811059; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lau KS, 2007, CELL, V129, P123, DOI 10.1016/j.cell.2007.01.049; Le Good JA, 2005, CURR BIOL, V15, P31, DOI 10.1016/j.cub.2004.12.062; Lee SU, 2007, J BIOL CHEM, V282, P33725, DOI 10.1074/jbc.M704839200; LIN GL, 1992, DEV COMP IMMUNOL, V16, P153, DOI 10.1016/0145-305X(92)90015-5; Liu YY, 2011, NATURE, V473, P167, DOI 10.1038/nature10011; Lowe CB, 2011, SCIENCE, V333, P1019, DOI 10.1126/science.1202702; Lynch M, 2010, P NATL ACAD SCI USA, V107, P961, DOI 10.1073/pnas.0912629107; Ma BY, 2004, BIOCHEM BIOPH RES CO, V317, P60, DOI 10.1016/j.bbrc.2004.03.012; Makino T, 2006, GENE, V385, P57, DOI 10.1016/j.gene.2006.06.028; Manna B, 2009, GENE, V434, P50, DOI 10.1016/j.gene.2008.12.013; McElroy CA, 2009, STRUCTURE, V17, P54, DOI 10.1016/j.str.2008.10.019; Mkhikian H, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1333; Philip WH, 2011, GENETICS POPULATIONS; Pond SLK, 2005, MOL BIOL EVOL, V22, P1208, DOI 10.1093/molbev/msi105; Pond SLK, 2005, BIOINFORMATICS, V21, P676, DOI 10.1093/bioinformatics/bti079; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Ruiz-Canada C, 2009, CELL, V136, P272, DOI 10.1016/j.cell.2008.11.047; Rutherford SL, 1998, NATURE, V396, P336, DOI 10.1038/24550; Shang J, 2007, J CELL BIOL, V176, P605, DOI 10.1083/jcb.200607007; Singh H, 2011, BIOCHEM SOC T, V39, P1592, DOI 10.1042/BST20110699; Soylemez O, 2012, GENOME BIOL EVOL, V4, P1213, DOI 10.1093/gbe/evs096; Swanson WJ, 2001, P NATL ACAD SCI USA, V98, P2509, DOI 10.1073/pnas.051605998; Tan CSH, 2009, SCIENCE, V325, P1686, DOI 10.1126/science.1174301; Tlusty T, 2008, P NATL ACAD SCI USA, V105, P8238, DOI 10.1073/pnas.0710274105; Umashankar V, 2007, BIOINFORMATION, V2, P62; Varki A, 2011, COLD SPRING HARBOR P, V3; Vogt G, 2005, NAT GENET, V37, P692, DOI 10.1038/ng1581; Weadick CJ, 2012, MOL BIOL EVOL, V29, P1297, DOI 10.1093/molbev/msr311; Weinert BT, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001902; Weinreich DM, 2006, SCIENCE, V312, P111, DOI 10.1126/science.1123539; Woods RJ, 2011, SCIENCE, V331, P1433, DOI 10.1126/science.1198914; Wu P, 2006, DEV DYNAM, V235, P1400, DOI 10.1002/dvdy.20825; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Zielinska DF, 2012, MOL CELL, V46, P542, DOI 10.1016/j.molcel.2012.04.031; Zielinska DF, 2010, CELL, V141, P897, DOI 10.1016/j.cell.2010.04.012	72	17	17	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2014	9	1							e86088	10.1371/journal.pone.0086088	http://dx.doi.org/10.1371/journal.pone.0086088			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	298QQ	24475074	Green Published, Green Submitted, gold			2022-12-25	WOS:000330339800026
J	Wu, YM; Chen, X; Zhou, Q; He, QZ; Kang, JH; Zheng, J; Wang, K; Duan, T				Wu, Yanming; Chen, Xiao; Zhou, Qian; He, Qizhi; Kang, Jiuhong; Zheng, Jing; Wang, Kai; Duan, Tao			ITE and TCDD Differentially Regulate the Vascular Remodeling of Rat Placenta via the Activation of AhR	PLOS ONE			English	Article							ARYL-HYDROCARBON RECEPTOR; LIGAND; ANGIOGENESIS; ANGIOPOIETIN-2; EXPRESSION; HYPOXIA; 2,3,7,8-TETRACHLORODIBENZO-P-DIOXIN; VASCULOGENESIS; INHIBITION; INDUCTION	Vascular remodeling in the placenta is essential for normal fetal development. The previous studies have demonstrated that in utero exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD, an environmental toxicant) induces the intrauterine fetal death in many species via the activation of aryl hydrocarbon receptor (AhR). In the current study, we compared the effects of 2-(19H-indole-39-carbonyl)-thiazole-4-carboxylic acid methyl ester (ITE) and TCDD on the vascular remodeling of rat placentas. Pregnant rats on gestational day (GD) 15 were randomly assigned into 5 groups, and were exposed to a single dose of 1.6 and 8.0 mg/kg body weight (bw) ITE, 1.6 and 8.0 mg/kg bw TCDD, or an equivalent volume of the vehicle, respectively. The dams were sacrificed on GD20 and the placental tissues were gathered. The intrauterine fetal death was observed only in 8.0 mg/kg bw TCDD-exposed group and no significant difference was seen in either the placental weight or the fetal weight among all these groups. The immunohistochemical and histological analyses revealed that as compared with the vehicle-control, TCDD, but not ITE, suppressed the placental vascular remodeling, including reduced the ratio of the placental labyrinth zone to the basal zone thickness (at least 0.71 fold of control), inhibited the maternal sinusoids dilation and thickened the trophoblastic septa. However, no marked difference was observed in the density of fetal capillaries in the labyrinth zone among these groups, although significant differences were detected in the expression of angiogenic growth factors between ITE and TCDD-exposed groups, especially Angiopoietin-2 (Ang-2), Endoglin, Interferon-gamma (IFN-gamma) and placenta growth factor (PIGF). These results suggest ITE and TCDD differentially regulate the vascular remodeling of rat placentas, as well as the expression of angiogenic factors and their receptors, which in turn may alter the blood flow in the late gestation and partially resulted in intrauterine fetal death.	[Wu, Yanming; Chen, Xiao; Zhou, Qian; Kang, Jiuhong; Wang, Kai; Duan, Tao] Tongji Univ, Clin & Translat Res Ctr, Shanghai Matern & Infant Hosp 1, Sch Med, Shanghai 200092, Peoples R China; [Duan, Tao] Tongji Univ, Dept Obstet, Shanghai Matern & Infant Hosp 1, Sch Med, Shanghai 200092, Peoples R China; [He, Qizhi] Tongji Univ, Dept Pathol, Shanghai Matern & Infant Hosp 1, Sch Med, Shanghai 200092, Peoples R China; [Kang, Jiuhong] Tongji Univ, Shanghai Key Lab Signaling & Dis Res, Sch Life Sci & Technol, Shanghai 200092, Peoples R China; [Zheng, Jing] Univ Wisconsin, Dept Ob Gyn, Madison, WI USA	Tongji University; Tongji University; Tongji University; Tongji University; University of Wisconsin System; University of Wisconsin Madison	Wang, K (corresponding author), Tongji Univ, Clin & Translat Res Ctr, Shanghai Matern & Infant Hosp 1, Sch Med, Shanghai 200092, Peoples R China.	kaiwangcn@yahoo.com; tduan@yahoo.com		Wu, Yanming/0000-0003-3357-3051	Shanghai Natural Science Foundation [11ZR1428700]; National Natural Science Foundation of China [81100429, 81270703]	Shanghai Natural Science Foundation(Natural Science Foundation of Shanghai); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was supported in part by Shanghai Natural Science Foundation (No.11ZR1428700) (to KW) and National Natural Science Foundation of China (No. 81100429 & (No. 81270703) (to KW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andraweera PH, 2012, HUM REPROD UPDATE, V18, P436, DOI 10.1093/humupd/dms011; Carmeliet P, 2000, NAT MED, V6, P389, DOI 10.1038/74651; Chantraine F, 2012, AM J OBSTET GYNECOL, V207, DOI 10.1016/j.ajog.2012.06.083; Dewerchin M, 2012, COLD SPRING HARB PER, V2; Emond C, 2004, TOXICOL SCI, V80, P115, DOI 10.1093/toxsci/kfh117; ESKENAZI B, 1995, ENVIRON HEALTH PERSP, V103, P143, DOI 10.2307/3432460; Ferrara N, 2003, NAT MED, V9, P669, DOI 10.1038/nm0603-669; Furukawa S, 2011, J TOXICOL PATHOL, V24, P95, DOI 10.1293/tox.24.95; Gilbert JS, 2009, HYPERTENSION, V53, P399, DOI 10.1161/HYPERTENSIONAHA.108.123513; Goldman-Wohl DS, 2000, MOL HUM REPROD, V6, P81, DOI 10.1093/molehr/6.1.81; He WJ, 2007, TOXICOL SCI, V99, P244, DOI 10.1093/toxsci/kfm162; Henry EC, 2006, ARCH BIOCHEM BIOPHYS, V450, P67, DOI 10.1016/j.abb.2006.02.008; Henry EC, 2010, TOXICOL SCI, V114, P90, DOI 10.1093/toxsci/kfp285; Ishimura R, 2006, TOXICOL SCI, V91, P265, DOI 10.1093/toxsci/kfj138; Ishimura R, 2002, TOXICOL APPL PHARM, V185, P197, DOI 10.1006/taap.2002.9539; Ishimura R, 2009, BIOCHEM PHARMACOL, V77, P660, DOI 10.1016/j.bcp.2008.10.030; Ivnitski-Steele I, 2005, CARDIOVASC TOXICOL, V5, P215, DOI 10.1385/CT:5:2:215; Ivnitski-Steele ID, 2003, BIRTH DEFECTS RES A, V67, P496, DOI 10.1002/bdra.10074; Jiang YZ, 2010, J HISTOCHEM CYTOCHEM, V58, P679, DOI 10.1369/jhc.2010.955955; Kawakami T, 2006, TOXICOL APPL PHARM, V212, P224, DOI 10.1016/j.taap.2005.08.007; Lahvis GP, 2000, P NATL ACAD SCI USA, V97, P10442, DOI 10.1073/pnas.190256997; Laug R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045430; Lobov IB, 2002, P NATL ACAD SCI USA, V99, P11205, DOI 10.1073/pnas.172161899; Maisonpierre PC, 1997, SCIENCE, V277, P55, DOI 10.1126/science.277.5322.55; Mizutani T, 2004, ENDOCR J, V51, P569, DOI 10.1507/endocrj.51.569; Nebert DW, 2004, J BIOL CHEM, V279, P23847, DOI 10.1074/jbc.R400004200; Nguyen LP, 2008, CHEM RES TOXICOL, V21, P102, DOI 10.1021/tx7001965; Patel J, 2010, PLACENTA, V31, P951, DOI 10.1016/j.placenta.2010.08.008; Pichiule P, 2002, J APPL PHYSIOL, V93, P1131, DOI 10.1152/japplphysiol.00318.2002; Pocar P, 2005, REPRODUCTION, V129, P379, DOI 10.1530/rep.1.00294; Pugh CW, 2003, NAT MED, V9, P677, DOI 10.1038/nm0603-677; Quintana FJ, 2010, P NATL ACAD SCI USA, V107, P20768, DOI 10.1073/pnas.1009201107; REYNOLDS LP, 1995, J ANIM SCI, V73, P1839; Semenza GL, 2003, NAT REV CANCER, V3, P721, DOI 10.1038/nrc1187; Song JS, 2002, P NATL ACAD SCI USA, V99, P14694, DOI 10.1073/pnas.232562899; Steegers EAP, 2010, LANCET, V376, P631, DOI 10.1016/S0140-6736(10)60279-6; Stevens EA, 2009, IMMUNOLOGY, V127, P299, DOI 10.1111/j.1365-2567.2009.03054.x; Terzuoli E, 2010, CANCER RES, V70, P6837, DOI 10.1158/0008-5472.CAN-10-1075; Wulff C, 2003, REPRODUCTION, V126, P569, DOI 10.1530/rep.0.1260569; Yamakawa M, 2003, CIRC RES, V93, P664, DOI 10.1161/01.RES.0000093984.48643.D7; Zygmunt M, 2003, EUR J OBSTET GYN R B, V110, pS10, DOI 10.1016/S0301-2115(03)00168-4	41	18	20	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2014	9	1							e86549	10.1371/journal.pone.0086549	http://dx.doi.org/10.1371/journal.pone.0086549			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	298QQ	24475139	Green Published, gold, Green Submitted			2022-12-25	WOS:000330339800052
J	Oksanen, E; Blakeley, MP; El-Hajji, M; Ryde, U; Budayova-Spano, M				Oksanen, Esko; Blakeley, Matthew P.; El-Hajji, Mohamed; Ryde, Ulf; Budayova-Spano, Monika			The Neutron Structure of Urate Oxidase Resolves a Long-Standing Mechanistic Conundrum and Reveals Unexpected Changes in Protonation	PLOS ONE			English	Article							GAUSSIAN-BASIS SETS; URIC-ACID; ATOMS LI; IDENTIFICATION; PHENIX	Urate oxidase transforms uric acid to 5-hydroxyisourate without the help of cofactors, but the catalytic mechanism has remained enigmatic, as the protonation state of the substrate could not be reliably deduced. We have determined the neutron structure of urate oxidase, providing unique information on the proton positions. A neutron crystal structure inhibited by a chloride anion at 2.3 angstrom resolution shows that the substrate is in fact 8-hydroxyxanthine, the enol tautomer of urate. We have also determined the neutron structure of the complex with the inhibitor 8-azaxanthine at 1.9 angstrom resolution, showing the protonation states of the K10-T57-H256 catalytic triad. Together with X-ray data and quantum chemical calculations, these structures allow us to identify the site of the initial substrate protonation and elucidate why the enzyme is inhibited by a chloride anion.	[Oksanen, Esko; Budayova-Spano, Monika] Commissariat Energie Atom & Energies Alternat, Direct Sci Vivant, IBS, Grenoble, France; [Oksanen, Esko; Budayova-Spano, Monika] CNRS, IBS, Grenoble, France; [Oksanen, Esko; Budayova-Spano, Monika] Univ Grenoble Alpes, IBS, Grenoble, France; [Blakeley, Matthew P.] Inst Max Von Laue Paul Langevin, F-38042 Grenoble, France; [El-Hajji, Mohamed] Sanofi Rech, F-34082 Montpellier, France; [Ryde, Ulf] Lund Univ, Dept Theoret Phys, S-22362 Lund, Sweden	UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); Institut Laue-Langevin (ILL); Sanofi-Aventis; Sanofi France; Lund University	Budayova-Spano, M (corresponding author), Commissariat Energie Atom & Energies Alternat, Direct Sci Vivant, IBS, Grenoble, France.	monika.spano@ibs.fr	Ryde, Ulf/D-5882-2017; Blakeley, Matthew Paul/G-7984-2015; Oksanen, Esko/D-4639-2009	Ryde, Ulf/0000-0001-7653-8489; Blakeley, Matthew Paul/0000-0002-6412-4358; Oksanen, Esko/0000-0002-1841-4813	Finnish Academy; European Molecular Biology Organisation; Federation of European Biochemical Societies	Finnish Academy(Academy of Finland); European Molecular Biology Organisation; Federation of European Biochemical Societies	EO and MBS acknowledge the Finnish Academy for a post-doctoral fellowship to EO and the European Molecular Biology Organisation for a Long-term Fellowship to EO. EO acknowledges the Federation of European Biochemical Societies for a Short-term Fellowship for a research visit to Lund University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Altarsha M, 2005, MODELISATION MECANIS, P189; Altarsha M, 2007, INT J QUANTUM CHEM, V107, P172, DOI 10.1002/qua.21057; Altarsha M, 2009, BIOORG CHEM, V37, P111, DOI 10.1016/j.bioorg.2009.05.004; [Anonymous], 2008, AMBER 10; BENTLEY R, 1952, BIOCHEM J, V52, P694, DOI 10.1042/bj0520694; Blakeley MP, 2009, CRYSTALLOGR REV, V15, P157, DOI 10.1080/08893110902965003; Budayova-Spano M, 2007, ACTA CRYSTALLOGR D, V63, P339, DOI 10.1107/S0907444906054230; Budayova-Spano M, 2006, ACTA CRYSTALLOGR F, V62, P306, DOI 10.1107/S1744309106006439; Colloc'h N, 2007, BIOPHYS J, V92, P217, DOI 10.1529/biophysj.106.093807; Colloch N, 1997, NAT STRUCT BIOL, V4, P947, DOI 10.1038/nsb1197-947; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Gabison L, 2011, PROTEINS, V79, P1964, DOI 10.1002/prot.23022; Gabison L, 2010, ACTA CRYSTALLOGR D, V66, P714, DOI 10.1107/S090744491001142X; Imhoff RD, 2003, BIOCHEMISTRY-US, V42, P4094, DOI 10.1021/bi027377x; Kahn K, 1997, BIOCHEMISTRY-US, V36, P4731, DOI 10.1021/bi963184w; Kahn K, 1997, J AM CHEM SOC, V119, P5435, DOI 10.1021/ja970375t; Kahn K, 1998, BIOCHEMISTRY-US, V37, P11651, DOI 10.1021/bi980446g; MAPLES KR, 1988, J BIOL CHEM, V263, P1709; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Oksanen E, 2009, J R SOC INTERFACE, V6, pS599, DOI 10.1098/rsif.2009.0162.focus; Ryde U, 2001, INT J QUANTUM CHEM, V81, P335, DOI 10.1002/1097-461X(2001)81:5<335::AID-QUA1003>3.0.CO;2-Q; Sarma AD, 1999, J BIOL CHEM, V274, P33863, DOI 10.1074/jbc.274.48.33863; SCHAFER A, 1994, J CHEM PHYS, V100, P5829, DOI 10.1063/1.467146; SCHAFER A, 1992, J CHEM PHYS, V97, P2571, DOI 10.1063/1.463096; SIMIC MG, 1989, J AM CHEM SOC, V111, P5778, DOI 10.1021/ja00197a042; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Wang JM, 2000, J COMPUT CHEM, V21, P1049, DOI 10.1002/1096-987X(200009)21:12<1049::AID-JCC3>3.0.CO;2-F	30	26	27	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2014	9	1							e86651	10.1371/journal.pone.0086651	http://dx.doi.org/10.1371/journal.pone.0086651			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297XI	24466188	Green Submitted, Green Published, gold			2022-12-25	WOS:000330288000129
J	Shin, M; Hu, YY; Tye, CE; Guan, XM; Deagle, CC; Antone, JV; Smith, CE; Simmer, JP; Bartlett, JD				Shin, Masashi; Hu, Yuanyuan; Tye, Coralee E.; Guan, Xiaomu; Deagle, Craig C.; Antone, Jerry V.; Smith, Charles E.; Simmer, James P.; Bartlett, John D.			Matrix Metalloproteinase-20 Over-Expression Is Detrimental to Enamel Development: A Mus musculus Model	PLOS ONE			English	Article							HYPOMATURATION AMELOGENESIS IMPERFECTA; DEVELOPING BOVINE ENAMEL; DENTAL ENAMEL; MMP-20; MICE; AMELOBLASTIN; TOOTH; GENE; CRYSTALS; CLEAVAGE	Background: Matrix metalloproteinase-20 (Mmp20) ablated mice have enamel that is thin and soft with an abnormal rod pattern that abrades from the underlying dentin. We asked if introduction of transgenes expressing Mmp20 would revert this Mmp20 null phenotype back to normal. Unexpectedly, for transgenes expressing medium or high levels of Mmp20, we found opposite enamel phenotypes depending on the genetic background (Mmp20(-/-) or Mmp20(+/+)) in which the transgenes were expressed. Methodology/Principal Findings: Amelx-promoter-Mmp20 transgenic founder mouse lines were assessed for transgene expression and those expressing low, medium or high levels of Mmp20 were selected for breeding into the Mmp20 null background. Regardless of expression level, each transgene brought the null enamel back to full thickness. However, the high and medium expressing Mmp20 transgenes in the Mmp20 null background had significantly harder more mineralized enamel than did the low transgene expresser. Strikingly, when the high and medium expressing Mmp20 transgenes were present in the wild-type background, the enamel was significantly less well mineralized than normal. Protein gel analysis of enamel matrix proteins from the high and medium expressing transgenes present in the wild-type background demonstrated that greater than normal amounts of cleavage products and smaller quantities of higher molecular weight proteins were present within their enamel matrices. Conclusions/Significance: Mmp20 expression levels must be within a specific range for normal enamel development to occur. Creation of a normally thick enamel layer may occur over a wider range of Mmp20 expression levels, but acquisition of normal enamel hardness has a narrower range. Since over-expression of Mmp20 results in decreased enamel hardness, this suggests that a balance exists between cleaved and full-length enamel matrix proteins that are essential for formation of a properly hardened enamel layer. It also suggests that few feedback controls are present in the enamel matrix to prevent excessive MMP20 activity.	[Shin, Masashi; Tye, Coralee E.; Guan, Xiaomu; Antone, Jerry V.; Bartlett, John D.] Dept Mineralized Tissue Biol, Cambridge, MA USA; [Shin, Masashi; Tye, Coralee E.; Guan, Xiaomu; Antone, Jerry V.; Bartlett, John D.] Harvard Univ, Sch Dent Med, Forsyth Inst, Cambridge, MA 02138 USA; [Hu, Yuanyuan; Smith, Charles E.; Simmer, James P.] Univ Michigan, Sch Dent, Dept Biol & Mat Sci, Ann Arbor, MI 48109 USA; [Deagle, Craig C.] Harvard Univ, Sch Dent Med, Program Endodont, Boston, MA 02115 USA; [Smith, Charles E.] McGill Univ, Facil Electron Microscopy Res, Dept Anat & Cell Biol, Montreal, PQ, Canada; [Smith, Charles E.] McGill Univ, Fac Dent, Montreal, PQ, Canada	Harvard University; Forsyth Institute; Harvard School of Dental Medicine; University of Michigan System; University of Michigan; Harvard University; Harvard School of Dental Medicine; McGill University; McGill University	Bartlett, JD (corresponding author), Dept Mineralized Tissue Biol, Cambridge, MA USA.	jbartlett@forsyth.org	Bartlett, John/L-9832-2017	Bartlett, John/0000-0003-2052-6299; Tye, Coralee/0000-0002-3349-1833	National Institute of Dental and Craniofacial Research of the National Institutes of Health [R01DE019775, R01DE016276]; National Institute of Health [1S10RR027553-01]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR027553] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE016276, R01DE019775] Funding Source: NIH RePORTER	National Institute of Dental and Craniofacial Research of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	Research reported in this publication was supported by the National Institute of Dental and Craniofacial Research of the National Institutes of Health under award numbers R01DE019775 (JPS) and R01DE016276 (JDB). The Forsyth Institute micro-CT Core is partly supported by National Institute of Health grant 1S10RR027553-01. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baba O, 2002, J HISTOCHEM CYTOCHEM, V50, P1229, DOI 10.1177/002215540205000910; Bartlett JD, 2006, J DENT RES, V85, P894, DOI 10.1177/154405910608501004; Bartlett JD, 1999, CRIT REV ORAL BIOL M, V10, P425, DOI 10.1177/10454411990100040101; Bartlett JD, 2004, J DENT RES, V83, P909, DOI 10.1177/154405910408301204; Bartlett JD, 1998, CONNECT TISSUE RES, V39, P101, DOI 10.3109/03008209809023916; Becerik S, 2009, AM J MED GENET A, V149A, P1392, DOI 10.1002/ajmg.a.32885; Begue-Kirn C, 1998, EUR J ORAL SCI, V106, P963, DOI 10.1046/j.0909-8836.1998.eos106510.x; Boyde A., 1989, HDB MICROSCOPIC ANAT, P309; Caterina JJ, 2002, J BIOL CHEM, V277, P49598, DOI 10.1074/jbc.M209100200; Chun YHP, 2010, J DENT RES, V89, P1414, DOI 10.1177/0022034510379223; Chun YHP, 2010, J DENT RES, V89, P785, DOI 10.1177/0022034510366903; CUISINIER FJG, 1992, CALCIFIED TISSUE INT, V51, P259, DOI 10.1007/BF00334485; DACULSI G, 1984, CALCIFIED TISSUE INT, V36, P550, DOI 10.1007/BF02405364; Fincham AG, 1995, CONNECT TISSUE RES, V32, P119, DOI 10.3109/03008209509013713; Fukae M, 2007, J DENT RES, V86, P758, DOI 10.1177/154405910708600814; Fukae M, 1996, Adv Dent Res, V10, P111; Fukae M, 1998, J DENT RES, V77, P1580, DOI 10.1177/00220345980770080501; Fukumoto S, 2004, J CELL BIOL, V167, P973, DOI 10.1083/jcb.200409077; Gasse B, 2013, J DENT RES; GIBSON CW, 1991, BIOCHEM BIOPH RES CO, V174, P1306, DOI 10.1016/0006-291X(91)91564-S; Hu CC, 1997, J DENT RES, V76, P1720, DOI 10.1177/00220345970760110201; Hu JCC, 2008, J BIOL CHEM, V283, P10858, DOI 10.1074/jbc.M710565200; Hu JCC, 2007, CELLS TISSUES ORGANS, V186, P78, DOI 10.1159/000102683; Hu YY, 2011, EUR J ORAL SCI, V119, P217, DOI 10.1111/j.1600-0722.2011.00859.x; Iwata T, 2007, J DENT RES, V86, P153, DOI 10.1177/154405910708600209; KEREBEL B, 1975, Annales d'Anatomie Pathologique, V20, P283; Kim JW, 2005, J MED GENET, V42, P271, DOI 10.1136/jmg.2004.024505; Krebsbach PH, 1996, J BIOL CHEM, V271, P4431; Kubota K, 2005, J BIOL CHEM, V280, P23194, DOI 10.1074/jbc.M503288200; LAU EC, 1992, BIOCHEM BIOPH RES CO, V188, P1253, DOI 10.1016/0006-291X(92)91366-X; Lee SK, 2010, J DENT RES, V89, P46, DOI 10.1177/0022034509352844; Li Y, 2006, EUR J ORAL SCI, V114, P190, DOI 10.1111/j.1600-0722.2006.00286.x; Nagano T, 2009, J DENT RES, V88, P823, DOI 10.1177/0022034509342694; Ozdemir D, 2005, J DENT RES, V84, P1031, DOI 10.1177/154405910508401112; Papagerakis P, 2008, J DENT RES, V87, P56, DOI 10.1177/154405910808700109; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; REITH EJ, 1973, ARCH ORAL BIOL, V18, P445, DOI 10.1016/0003-9969(73)90170-2; Ryu OH, 1999, J DENT RES, V78, P743, DOI 10.1177/00220345990780030601; SALIDO EC, 1992, AM J HUM GENET, V50, P303; Sharma R, 2011, J DENT RES, V90, P788, DOI 10.1177/0022034511398868; Simmer JP, 2012, INT J ORAL SCI, V4, P129, DOI 10.1038/ijos.2012.59; Simmer JP, 2009, J BIOL CHEM, V284, P19110, DOI 10.1074/jbc.M109.013623; SIMMER JP, 1994, CALCIFIED TISSUE INT, V54, P312, DOI 10.1007/BF00295956; Smith CE, 2005, J BONE MINER RES, V20, P240, DOI 10.1359/JBMR.041002; TAKAGI T, 1984, BIOCHEM BIOPH RES CO, V121, P592, DOI 10.1016/0006-291X(84)90223-7; TERMINE JD, 1980, J BIOL CHEM, V255, P9760; Turk BE, 2006, BIOCHEMISTRY-US, V45, P3863, DOI 10.1021/bi052252o; Wang SK, 2013, J DENT RES, V92, P266, DOI 10.1177/0022034513475626; Yamada Y, 2003, ARCH COMP BIOL TOOTH, V8, P21; Yamakoshi Y, 2006, EUR J ORAL SCI, V114, P45, DOI 10.1111/j.1600-0722.2006.00281.x	50	18	18	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2014	9	1							e86774	10.1371/journal.pone.0086774	http://dx.doi.org/10.1371/journal.pone.0086774			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297XI	24466234	gold, Green Submitted, Green Published			2022-12-25	WOS:000330288000142
J	Xue, DX; Zhang, T; Liu, JX				Xue, Dongxiu; Zhang, Tao; Liu, Jin-Xian			Microsatellite Evidence for High Frequency of Multiple Paternity in the Marine Gastropod Rapana venosa	PLOS ONE			English	Article							EXTREME FEMALE PROMISCUITY; SPERM COMPETITION; SIMULTANEOUS HERMAPHRODITE; NEPTUNEA-ARTHRITICA; PARENTAGE ANALYSIS; MATING SYSTEMS; BEHAVIOR; SIZE; RECONSTRUCTION; POPULATIONS	Background: Inferring of parentage in natural populations is important in understanding the mating systems of a species, which have great effects on its genetic structure and evolution. Muricidae, a large group (approximately 1,600 species) of marine gastropods, are poorly investigated in patterns of multiple paternity and sperm competition based on molecular techniques. The veined Rapa whelk, Rapana venosa, a commercially important muricid species with internal fertilization, is an ideal species to study the occurrence and frequency of multiple paternity and to facilitate understanding of their reproductive strategies. Methodology/Principal Findings: We developed five highly polymorphic microsatellites in R. venosa and applied them to identify multiple paternity in 19 broods (1381 embryos) collected from Dandong, China. Multiple paternity was detected in 17 (89.5%) of 19 broods. The number of sires per brood ranged from 1 to 7 (4.3 on average). Of the 17 multiply sired broods, 16 (94.1%) were significantly skewed from equal paternal contributions, and had a dominant sire which was also dominant in each assayed capsule. Conclusions: Our results indicate that a high level of multiple paternity occurs in the wild population of R. venosa. Similar patterns of multiple paternity in the 2-6 assayed capsules from each brood imply that fertilization events within the body of a female occur mostly (but not entirely) as random draws from a "well-but-not-perfectly blended sperm pool" of her several mates. Strongly skewed distributions of fertilization success among sires also suggest that sperm competition and/or cryptic female choice might be important for post-copulatory paternity biasing in this species.	[Xue, Dongxiu; Zhang, Tao; Liu, Jin-Xian] Chinese Acad Sci, Key Lab Marine Ecol & Environm Sci, Inst Oceanol, Qingdao, Peoples R China; [Xue, Dongxiu] Univ Chinese Acad Sci, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Oceanology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Liu, JX (corresponding author), Chinese Acad Sci, Key Lab Marine Ecol & Environm Sci, Inst Oceanol, Qingdao, Peoples R China.	jinxianliu@gmail.com			NSF China [31200280]; Chinese Academy of Sciences; National Key Technology RD Program [2011BAD13B01, 2011BAD45B01]	NSF China(National Natural Science Foundation of China (NSFC)); Chinese Academy of Sciences(Chinese Academy of Sciences); National Key Technology RD Program(National Key Technology R&D Program)	This work was supported by NSF China Grant (No. 31200280), 100 Talents Program of the Chinese Academy of Sciences to JXL, and National Key Technology R&D Program in the 12th Five Year Plan of China (No. 2011BAD13B01 and No. 2011BAD45B01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angeloni L, 2003, BEHAV ECOL, V14, P554, DOI 10.1093/beheco/arg033; Avise JC, 2002, ANNU REV GENET, V36, P19, DOI 10.1146/annurev.genet.36.030602.090831; Avise JC, 2011, P NATL ACAD SCI USA, V108, P11512, DOI 10.1073/pnas.1109216108; Barreto FS, 2008, MOL ECOL, V17, P4164, DOI 10.1111/j.1365-294X.2008.03895.x; Birkhead TR, 2002, NAT REV GENET, V3, P262, DOI 10.1038/nrg774; Brante A, 2011, J EXP MAR BIOL ECOL, V396, P83, DOI 10.1016/j.jembe.2010.10.001; Chandler EA, 2008, MOL ECOL, V17, P4079, DOI 10.1111/j.1365-294X.2008.03897.x; Chung EY, 2002, MALACOLOGIA, V44, P241; Dupont L, 2006, MOL ECOL, V15, P3009, DOI 10.1111/j.1365-294X.2006.02988.x; Evans JP, 2008, GENETICA, V134, P5, DOI 10.1007/s10709-007-9162-5; Foerster K, 2003, NATURE, V425, P714, DOI 10.1038/nature01969; Glenn TC, 2005, METHOD ENZYMOL, V395, P202, DOI 10.1016/S0076-6879(05)95013-1; Harrison HB, 2013, MOL ECOL, V22, P1158, DOI 10.1111/mec.12138; HOU S, 1990, ACTA ZOOL SINICA, V36, P399; Jennions MD, 2000, BIOL REV, V75, P21, DOI 10.1017/S0006323199005423; Jones AG, 2005, MOL ECOL NOTES, V5, P708, DOI 10.1111/j.1471-8286.2005.01029.x; Jones AG, 2003, MOL ECOL, V12, P2511, DOI 10.1046/j.1365-294X.2003.01928.x; Jones B, 2007, GENETICS, V176, P2427, DOI 10.1534/genetics.106.067066; Jones OR, 2010, MOL ECOL RESOUR, V10, P551, DOI 10.1111/j.1755-0998.2009.02787.x; Kamel SJ, 2012, ECOL LETT, V15, P1167, DOI 10.1111/j.1461-0248.2012.01841.x; Kokko H, 2006, PHILOS T R SOC B, V361, P319, DOI 10.1098/rstb.2005.1784; Kupfernagel S, 2010, BIOL J LINN SOC, V99, P350, DOI 10.1111/j.1095-8312.2009.01361.x; Lee CY, 1959, PERIODICAL OCEAN U C, V1, P92; Liu JX, 2013, J HERED, V104, P217, DOI 10.1093/jhered/ess105; Liu JX, 2011, MAR BIOL, V158, P893, DOI 10.1007/s00227-010-1616-0; Lombardo RC, 2012, J MOLLUS STUD, V78, P283, DOI 10.1093/mollus/eys010; Makinen T, 2007, J HERED, V98, P705, DOI 10.1093/jhered/esm097; Merle D, 2011, FOSSIL RECENT MURICI; Miranda RM, 2008, AQUAC RES, V39, P283, DOI 10.1111/j.1365-2109.2008.01901.x; Nonacs P, 2000, AM NAT, V156, P577, DOI 10.1086/316995; Panova M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009640; Park SDE, 2001, THESIS U DUBLIN; PARKER GA, 1970, BIOL REV, V45, P525, DOI 10.1111/j.1469-185X.1970.tb01176.x; Paterson IG, 2001, BIOL BULL-US, V200, P261, DOI 10.2307/1543508; Pearse DE, 2001, J HERED, V92, P206, DOI 10.1093/jhered/92.2.206; Rogers DW, 2002, BEHAV ECOL SOCIOBIOL, V52, P289, DOI 10.1007/s00265-002-0519-6; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Sefc KM, 2009, J HERED, V100, P197, DOI 10.1093/jhered/esn095; Simmons LW, 2005, ANNU REV ECOL EVOL S, V36, P125, DOI 10.1146/annurev.ecolsys.36.102403.112501; Uller T, 2008, MOL ECOL, V17, P2566, DOI 10.1111/j.1365-294X.2008.03772.x; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; Walker D, 2007, MAR BIOL, V151, P53, DOI 10.1007/s00227-006-0463-5; Wang JL, 2004, GENETICS, V166, P1963, DOI 10.1534/genetics.166.4.1963; Wei Li-Ping, 1999, Journal of Fisheries of China, V23, P150; Zahradnik TD, 2008, J MOLLUS STUD, V74, P245, DOI 10.1093/mollus/eyn014	45	24	30	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2014	9	1							e86508	10.1371/journal.pone.0086508	http://dx.doi.org/10.1371/journal.pone.0086508			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297XI	24466127	Green Published, Green Submitted, gold			2022-12-25	WOS:000330288000107
J	Hui, DF; Wang, J; Shen, WJ; Le, X; Ganter, P; Ren, H				Hui, Dafeng; Wang, Jun; Shen, Weijun; Le, Xuan; Ganter, Philip; Ren, Hai			Near Isometric Biomass Partitioning in Forest Ecosystems of China	PLOS ONE			English	Article							NET PRIMARY PRODUCTIVITY; CARBON STORAGE; METABOLIC-RATE; ROOT BIOMASS; ALLOCATION; GROWTH; SIZE; EFFICIENCY; ALLOMETRY; PATTERNS	Based on the isometric hypothesis, belowground plant biomass (M-B) should scale isometrically with aboveground biomass (M-A) and the scaling exponent should not vary with environmental factors. We tested this hypothesis using a large forest biomass database collected in China. Allometric scaling functions relating M-B and M-A were developed for the entire database and for different groups based on tree age, diameter at breast height, height, latitude, longitude or elevation. To investigate whether the scaling exponent is independent of these biotic and abiotic factors, we analyzed the relationship between the scaling exponent and these factors. Overall M-B was significantly related to M-A with a scaling exponent of 0.964. The scaling exponent of the allometric function did not vary with tree age, density, latitude, or longitude, but varied with diameter at breast height, height, and elevation. The mean of the scaling exponent over all groups was 0.986. Among 57 scaling relationships developed, 26 of the scaling exponents were not significantly different from 1. Our results generally support the isometric hypothesis. M-B scaled near isometrically with M-A and the scaling exponent did not vary with tree age, density, latitude, or longitude, but increased with tree size and elevation. While fitting a single allometric scaling relationship may be adequate, the estimation of M-B from M-A could be improved with size-specific scaling relationships.	[Hui, Dafeng; Le, Xuan; Ganter, Philip] Tennessee State Univ, Dept Biol Sci, Nashville, TN 37203 USA; [Wang, Jun; Shen, Weijun; Ren, Hai] Chinese Acad Sci, South China Bot Garden, Key Lab Vegetat Restorat & Management Degraded Ec, Guangzhou, Peoples R China	Tennessee State University; Chinese Academy of Sciences; South China Botanical Garden, CAS	Hui, DF (corresponding author), Tennessee State Univ, Dept Biol Sci, Nashville, TN 37203 USA.	dhui@tnstate.edu; renhai@scib.ac.cn	Shen, Weijun/G-2942-2010	Shen, Weijun/0000-0001-7574-8839; Hui, Dafeng/0000-0002-5284-2897	Chinese Academy of Sciences [XDA05050206]; National Science Foundation, USA; Direct For Biological Sciences [0933958] Funding Source: National Science Foundation	Chinese Academy of Sciences(Chinese Academy of Sciences); National Science Foundation, USA(National Science Foundation (NSF)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by the "Strategic Priority Research Program'' (No. XDA05050206) of the Chinese Academy of Sciences and the National Science Foundation, USA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartelink HH, 1998, TREE PHYSIOL, V18, P91; BROWN S, 1989, FOREST SCI, V35, P881; Burkes EC, 2003, FOREST SCI, V49, P224; Cairns MA, 1997, OECOLOGIA, V111, P1, DOI 10.1007/s004420050201; CAMPBELL JS, 1985, FOREST ECOL MANAG, V11, P283, DOI 10.1016/0378-1127(85)90106-9; CANNELL MGR, 1984, FOREST ECOL MANAG, V8, P299, DOI 10.1016/0378-1127(84)90062-8; Cheng DL, 2007, ANN BOT-LONDON, V99, P95, DOI 10.1093/aob/mcl206; Cheng DL, 2009, POL J ECOL, V57, P441; CLARKE MRB, 1980, BIOMETRIKA, V67, P441, DOI 10.1093/biomet/67.2.441; Daan Serge, 1997, P311; DAVIDSON RL, 1969, ANN BOT-LONDON, V33, P561, DOI 10.1093/oxfordjournals.aob.a084308; Enquist BJ, 2001, NATURE, V410, P655, DOI 10.1038/35070500; Enquist BJ, 2002, SCIENCE, V295, P1517, DOI 10.1126/science.1066360; Fang JY, 2001, SCIENCE, V292, P2320, DOI 10.1126/science.1058629; Friedlingstein P, 1999, GLOBAL CHANGE BIOL, V5, P755, DOI 10.1046/j.1365-2486.1999.00269.x; Glazier DS, 2010, BIOL REV, V85, P111, DOI 10.1111/j.1469-185X.2009.00095.x; Harvey P.H., 1991, COMP METHOD EVOLUTIO; HOEN HF, 1994, FOREST SCI, V40, P429; Hui D., 1996, PRACTICAL SAS USAGE; Hui DF, 2007, J THEOR BIOL, V249, P168, DOI 10.1016/j.jtbi.2007.07.003; Hui DF, 2012, FOREST ECOL MANAG, V264, P72, DOI 10.1016/j.foreco.2011.10.012; Hui DF, 2006, NEW PHYTOL, V169, P85, DOI 10.1111/j.1469-8137.2005.01569.x; HUNT R, 1986, OIKOS, V47, P149, DOI 10.2307/3566039; Huxley J. S., 1936, Nature London, V137, P780, DOI 10.1038/137780b0; Iwasa Y, 2000, EVOL ECOL RES, V2, P437; Jackson RB, 2000, ECOL APPL, V10, P470, DOI 10.1890/1051-0761(2000)010[0470:BCOVCA]2.0.CO;2; Jenkins JC, 2003, FOREST SCI, V49, P12; Jokela EJ, 2000, CAN J FOREST RES, V30, P1511, DOI 10.1139/cjfr-30-10-1511; Knapp AK, 2004, FRONT ECOL ENVIRON, V2, P483, DOI 10.1890/1540-9295(2004)002[0483:GIETNA]2.0.CO;2; Kozlowski J, 2003, P NATL ACAD SCI USA, V100, P14080, DOI 10.1073/pnas.2334605100; Leuschner C, 2007, BASIC APPL ECOL, V8, P219, DOI 10.1016/j.baae.2006.02.004; Li HT, 2005, J INTEGR PLANT BIOL, V47, P1173, DOI 10.1111/j.1744-7909.2005.00167.x; Luo YJ, 2012, FOREST ECOL MANAG, V269, P19, DOI 10.1016/j.foreco.2012.01.005; MCARDLE BH, 1990, J ANIM ECOL, V59, P439, DOI 10.2307/4873; McCarthy MC, 2007, FUNCT ECOL, V21, P713, DOI 10.1111/j.1365-2435.2007.01276.x; McConnaughay KDM, 1999, ECOLOGY, V80, P2581, DOI 10.1890/0012-9658(1999)080[2581:BAIPOO]2.0.CO;2; Mokany K, 2006, GLOBAL CHANGE BIOL, V12, P84, DOI 10.1111/j.1365-2486.2005.001043.x; Ni J, 2001, ANN FOR SCI, V58, P351, DOI 10.1051/forest:2001131; Niklas KJ, 2006, ANN BOT-LONDON, V97, P155, DOI 10.1093/aob/mcj021; Niklas KJ, 2005, ANN BOT-LONDON, V95, P315, DOI 10.1093/aob/mci028; Niklas KJ, 2002, AM J BOT, V89, P812, DOI 10.3732/ajb.89.5.812; Niklas KJ, 2001, P NATL ACAD SCI USA, V98, P2922, DOI 10.1073/pnas.041590298; Norby RJ, 2002, ECOL APPL, V12, P1261, DOI 10.1890/1051-0761(2002)012[1261:NPPOAC]2.0.CO;2; Packard GC, 2008, J EXP BIOL, V211, P3581, DOI 10.1242/jeb.023317; Pearsall WH, 1927, ANN BOT-LONDON, V41, P549, DOI 10.1093/oxfordjournals.aob.a090091; Robinson D, 2007, P ROY SOC B-BIOL SCI, V274, P2753, DOI 10.1098/rspb.2007.1012; SANTEE WR, 1981, B TORREY BOT CLUB, V108, P320, DOI 10.2307/2484710; Sun SC, 2006, ANN BOT-LONDON, V97, P97, DOI 10.1093/aob/mcj004; Tian HQ, 2012, ECOSYSTEMS, V15, P674, DOI 10.1007/s10021-012-9539-x; Wang XP, 2008, FOREST ECOL MANAG, V255, P4007, DOI 10.1016/j.foreco.2008.03.055; Weiner J, 2004, PERSPECT PLANT ECOL, V6, P207, DOI 10.1078/1433-8319-00083; West GB, 1999, NATURE, V400, P664, DOI 10.1038/23251; WHITTAKER RH, 1974, ECOL MONOGR, V44, P233, DOI 10.2307/1942313; Wolf A, 2011, ECOL APPL, V21, P1546, DOI 10.1890/10-1201.1; Yang YH, 2011, J ECOL, V99, P431, DOI 10.1111/j.1365-2745.2010.01774.x; Yang YH, 2010, GLOBAL ECOL BIOGEOGR, V19, P268, DOI 10.1111/j.1466-8238.2009.00502.x; Yang YH, 2009, J VEG SCI, V20, P177, DOI 10.1111/j.1654-1103.2009.05566.x; Zhou GS, 2002, FOREST ECOL MANAG, V169, P149, DOI 10.1016/S0378-1127(02)00305-5; Zianis D, 2004, FOREST ECOL MANAG, V187, P311, DOI 10.1016/j.foreco.2003.07.007	59	24	27	4	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2014	9	1							e86550	10.1371/journal.pone.0086550	http://dx.doi.org/10.1371/journal.pone.0086550			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297VL	24466149	Green Published, Green Submitted, gold			2022-12-25	WOS:000330283100183
J	Hunter, MC; O'Hagan, KL; Kenyon, A; Dhanani, KCH; Prinsloo, E; Edkins, AL				Hunter, Morgan C.; O'Hagan, Kyle L.; Kenyon, Amy; Dhanani, Karim C. H.; Prinsloo, Earl; Edkins, Adrienne L.			Hsp90 Binds Directly to Fibronectin (FN) and Inhibition Reduces the Extracellular Fibronectin Matrix in Breast Cancer Cells	PLOS ONE			English	Article							SHOCK-PROTEIN 90; MOLECULAR CHAPERONE; EXPRESSION; SURFACE; HSP90-ALPHA; INVASION; RECEPTOR; IDENTIFICATION; MOTILITY; COLLAGEN	Heat shock protein 90 (Hsp90) has been identified in the extracellular space and has been shown to chaperone a finite number of extracellular proteins involved in cell migration and invasion. We used chemical cross-linking and immunoprecipitation followed by tandem mass spectrometry (MS/MS) to isolate a complex containing Hsp90 and the matrix protein fibronectin (FN) from breast cancer cells. Further analysis showed direct binding of Hsp90 to FN using an in vitro co-immunoprecipitation assay, a solid phase binding assay and surface plasmon resonance (SPR) spectroscopy. Confocal microscopy showed regions of co-localisation of Hsp90 and FN in breast cancer cell lines. Exogenous Hsp90 beta was shown to increase the formation of extracellular FN matrix in the Hs578T cell line, whilst knockdown or inhibition of Hsp90 led to a reduction in the levels of both soluble and insoluble FN and could be partially rescued by addition of exogenous Hsp90b. Treatment of cells with novobiocin led to internalization of FN into vesicles that were positive for the presence of the lysosomal marker, LAMP-1. Taken together, the direct interaction between FN and Hsp90, as well as the decreased levels of both soluble and insoluble FN upon Hsp90 inhibition or knockdown, suggested that FN may be a new client protein for Hsp90 and that Hsp90 was involved in FN matrix assembly and/or stability. The identification of FN as a putative client protein of Hsp90 suggests a role for Hsp90 in FN matrix stability, which is important for a number of fundamental cellular processes including embryogenesis, wound healing, cell migration and metastasis.	[Hunter, Morgan C.; O'Hagan, Kyle L.; Kenyon, Amy; Dhanani, Karim C. H.; Prinsloo, Earl; Edkins, Adrienne L.] Rhodes Univ, Biomed Biotechnol Res Unit, Dept Biochem Microbiol & Biotechnol, ZA-6140 Grahamstown, Eastern Cape, South Africa	Rhodes University	Edkins, AL (corresponding author), Rhodes Univ, Biomed Biotechnol Res Unit, Dept Biochem Microbiol & Biotechnol, ZA-6140 Grahamstown, Eastern Cape, South Africa.	a.edkins@ru.ac.za	Prinsloo, Earl/F-9737-2012; Edkins, Adrienne L/C-8704-2012	Prinsloo, Earl/0000-0002-3048-4304; Edkins, Adrienne L/0000-0002-3615-6651; O'Hagan, Kyle/0000-0003-0460-4410; Kenyon, Amy/0000-0001-9248-576X	National Research Foundation of South Africa (NRF CSUR) [UID 70974]; Medical Research Council of South Africa and Research Council Rhodes University; NRF; German Academic Exchange Service (DAAD); Rhodes University	National Research Foundation of South Africa (NRF CSUR); Medical Research Council of South Africa and Research Council Rhodes University; NRF; German Academic Exchange Service (DAAD)(Deutscher Akademischer Austausch Dienst (DAAD)); Rhodes University	This work was supported by grants from the National Research Foundation of South Africa (NRF CSUR grant UID 70974), Medical Research Council (MRC SIR grant) of South Africa and Research Council Rhodes University. M.C.H, A.K. and K.L. O.H. were supported by postgraduate fellowships from the NRF and the German Academic Exchange Service (DAAD) and a Henderson Fellowship from Rhodes University. K.C. H.D was supported by the NRF and by a Henderson Fellowship from Rhodes University. The funders played no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKIYAMA SK, 1995, CANCER METAST REV, V14, P173, DOI 10.1007/BF00690290; Alfano L, 2010, J CLIN ENDOCR METAB, V95, P3552, DOI 10.1210/jc.2009-2315; Allan RK, 2006, J BIOL CHEM, V281, P7161, DOI 10.1074/jbc.M512406200; Bagatell R, 2004, MOL CANCER THER, V3, P1021; Basu S, 2001, IMMUNITY, V14, P303, DOI 10.1016/S1074-7613(01)00111-X; Becker B, 2004, EXP DERMATOL, V13, P27, DOI 10.1111/j.0906-6705.2004.00114.x; Blagg BSJ, 2006, MED RES REV, V26, P310, DOI 10.1002/med.20052; Brenner KA, 2000, ONCOGENE, V19, P3156, DOI 10.1038/sj.onc.1203626; Candiano G, 2004, ELECTROPHORESIS, V25, P1327, DOI 10.1002/elps.200305844; Chen JS, 2010, J BIOL CHEM, V285, P25458, DOI 10.1074/jbc.M110.139345; Chen WS, 2013, J BIOL CHEM, V288, P9001, DOI 10.1074/jbc.M112.437897; Chen YD, 2005, J BIOL CHEM, V280, P22549, DOI 10.1074/jbc.M500895200; Cheng SK, 2004, PLOS BIOL, V2, P215, DOI 10.1371/journal.pbio.0020030; Cid C, 2003, FASEB J, V17, P409, DOI 10.1096/fj.03-0606fje; Cid C, 2009, CELL STRESS CHAPERON, V14, P321, DOI 10.1007/s12192-008-0076-7; Citri A, 2006, J BIOL CHEM, V281, P14361, DOI 10.1074/jbc.M512613200; CRAWFORD DC, 1994, CIRC RES, V74, P727, DOI 10.1161/01.RES.74.4.727; Csermely P, 1998, PHARMACOL THERAPEUT, V79, P129, DOI 10.1016/S0163-7258(98)00013-8; Dihazi GH, 2003, RAPID COMMUN MASS SP, V17, P2005, DOI 10.1002/rcm.1144; Donnelly A, 2008, CURR MED CHEM, V15, P2702, DOI 10.2174/092986708786242895; Eustace BK, 2004, CELL CYCLE, V3, P1098; Eustace BK, 2004, NAT CELL BIOL, V6, P507, DOI 10.1038/ncb1131; Falsone SF, 2009, J BIOL CHEM, V284, P31190, DOI 10.1074/jbc.M109.057240; Garnier C, 2002, J BIOL CHEM, V277, P12208, DOI 10.1074/jbc.M111874200; GEORGE EL, 1993, DEVELOPMENT, V119, P1079; Grammatikakis N, 2002, J BIOL CHEM, V277, P8312, DOI 10.1074/jbc.M109200200; Hande KR, 1998, EUR J CANCER, V34, P1514, DOI 10.1016/S0959-8049(98)00228-7; Hebert C, 1999, J CELL BIOCHEM, V73, P248, DOI 10.1002/(SICI)1097-4644(19990501)73:2<248::AID-JCB11>3.0.CO;2-A; Hegmans JPJJ, 2004, AM J PATHOL, V164, P1807, DOI 10.1016/S0002-9440(10)63739-X; Ishida Y, 2006, MOL BIOL CELL, V17, P2346, DOI 10.1091/mbc.E05-11-1065; Labat-Robert J, 2002, SEMIN CANCER BIOL, V12, P187, DOI 10.1016/S1044-579X(02)00022-6; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lee CC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019961; Lee CT, 2012, EMBO J, V31, P1518, DOI 10.1038/emboj.2012.37; Li W, 2007, EMBO J, V26, P1221, DOI 10.1038/sj.emboj.7601579; Liao DF, 2000, J BIOL CHEM, V275, P189, DOI 10.1074/jbc.275.1.189; Liu XG, 2011, ONCOL REP, V25, P1343, DOI 10.3892/or.2011.1202; Luo BQ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020364; Mao Y, 2005, MATRIX BIOL, V24, P389, DOI 10.1016/j.matbio.2005.06.008; McCready J, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-294; Nagai N, 2000, J CELL BIOL, V150, P1499, DOI 10.1083/jcb.150.6.1499; Ngubo M, 2011, BMC BIOCHEM, V12, DOI 10.1186/1471-2091-12-34; Odunuga OO, 2003, J BIOL CHEM, V278, P6896, DOI 10.1074/jbc.M206867200; OLDEN K, 1977, CELL, V11, P957, DOI 10.1016/0092-8674(77)90307-5; Pearl LH, 2002, ADV PROTEIN CHEM, V59, P157; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; Prescott MF, 1999, ANN NY ACAD SCI, V878, P179, DOI 10.1111/j.1749-6632.1999.tb07683.x; Prodromou C, 1997, CELL, V90, P65, DOI 10.1016/S0092-8674(00)80314-1; Redlak MJ, 2011, DIGEST DIS SCI, V56, P323, DOI 10.1007/s10620-010-1294-2; Reitan NK, 2012, J BIOMED OPT, V17, DOI 10.1117/1.JBO.17.2.026015; Robinson EE, 2004, MOL BIOL CELL, V15, P973, DOI 10.1091/mbc.E03-07-0528; Sanchez MC, 2006, EXP EYE RES, V83, P1378, DOI 10.1016/j.exer.2006.07.016; Sauk JJ, 2005, FRONT BIOSCI-LANDMRK, V10, P107, DOI 10.2741/1513; Schwarzbauer JE, 1999, CURR OPIN CELL BIOL, V11, P622, DOI 10.1016/S0955-0674(99)00017-4; Sidera K, 2004, J BIOL CHEM, V279, P45379, DOI 10.1074/jbc.M405486200; Sidera K, 2008, J BIOL CHEM, V283, P2031, DOI 10.1074/jbc.M701803200; Sottile J, 2005, MOL BIOL CELL, V16, P757, DOI 10.1091/mbc.e04-08-0672; Sreedhar AS, 2004, FEBS LETT, V562, P11; Stellas D, 2010, BMC CELL BIOL, V11, DOI 10.1186/1471-2121-11-51; Taipale M, 2012, CELL, V150, P987, DOI 10.1016/j.cell.2012.06.047; Theodoraki M, 2013, BIOCHIM BIOPHYS ACTA, V1823, P683, DOI [10.1016/j.bbamcr.2011.08.006.Quality, DOI 10.1016/J.BBAMCR.2011.08.006.QUALITY]; To WS, 2011, FIBROGENESIS TISSUE, V4, DOI 10.1186/1755-1536-4-21; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Tsutsumi S, 2007, CANCER SCI, V98, P1536, DOI 10.1111/j.1349-7006.2007.00561.x; Tsutsumi S, 2009, FUTURE ONCOL, V5, P679, DOI 10.2217/FON.09.30; VANDERWESTHUYZEN DR, 1984, ARTERIOSCLEROSIS, V4, P238, DOI 10.1161/01.ATV.4.3.238; Verderio EAM, 2003, J BIOL CHEM, V278, P42604, DOI 10.1074/jbc.M303303200; Wang XF, 2009, P NATL ACAD SCI USA, V106, P21288, DOI 10.1073/pnas.0908151106; Wang XQ, 2005, ACTA BIOCH BIOPH SIN, V37, P379, DOI 10.1111/j.1745-7270.2005.00051.x; Whitesell L, 2005, NAT REV CANCER, V5, P761, DOI 10.1038/nrc1716; Wierzbicka-Patynowski I, 2003, J CELL SCI, V116, P3269, DOI 10.1242/jcs.00670; Zinchuk V, 2007, ACTA HISTOCHEM CYTOC, V40, P101, DOI 10.1267/ahc.07002	72	38	42	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2014	9	1							e86842	10.1371/journal.pone.0086842	http://dx.doi.org/10.1371/journal.pone.0086842			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297VL	24466266	Green Published, gold, Green Submitted			2022-12-25	WOS:000330283100224
J	Simon, BR; Learman, BS; Parlee, SD; Scheller, EL; Mori, H; Cawthorn, WP; Ning, XM; Krishnan, V; Ma, YL; Tyrberg, B; MacDougald, OA				Simon, Becky R.; Learman, Brian S.; Parlee, Sebastian D.; Scheller, Erica L.; Mori, Hiroyuki; Cawthorn, William P.; Ning, Xiaomin; Krishnan, Venkatesh; Ma, Yanfei L.; Tyrberg, Bjorn; MacDougald, Ormond A.			Sweet Taste Receptor Deficient Mice Have Decreased Adiposity and Increased Bone Mass	PLOS ONE			English	Article							GLUCAGON-LIKE PEPTIDE-1; OSTEOBLAST DIFFERENTIATION; REGULATE SECRETION; INSULIN-SECRETION; MAMMALIAN SWEET; PPAR-GAMMA; MARROW FAT; T1R3; EXPRESSION; CELLS	Functional expression of sweet taste receptors (T1R2 and T1R3) has been reported in numerous metabolic tissues, including the gut, pancreas, and, more recently, in adipose tissue. It has been suggested that sweet taste receptors in these nongustatory tissues may play a role in systemic energy balance and metabolism. Smaller adipose depots have been reported in T1R3 knockout mice on a high carbohydrate diet, and sweet taste receptors have been reported to regulate adipogenesis in vitro. To assess the potential contribution of sweet taste receptors to adipose tissue biology, we investigated the adipose tissue phenotypes of T1R2 and T1R3 knockout mice. Here we provide data to demonstrate that when fed an obesogenic diet, both T1R2 and T1R3 knockout mice have reduced adiposity and smaller adipocytes. Although a mild glucose intolerance was observed with T1R3 deficiency, other metabolic variables analyzed were similar between genotypes. In addition, food intake, respiratory quotient, oxygen consumption, and physical activity were unchanged in T1R2 knockout mice. Although T1R2 deficiency did not affect adipocyte number in peripheral adipose depots, the number of bone marrow adipocytes is significantly reduced in these knockout animals. Finally, we present data demonstrating that T1R2 and T1R3 knockout mice have increased cortical bone mass and trabecular remodeling. This report identifies novel functions for sweet taste receptors in the regulation of adipose and bone biology, and suggests that in these contexts, T1R2 and T1R3 are either dependent on each other for activity or have common independent effects in vivo.	[Simon, Becky R.; MacDougald, Ormond A.] Univ Michigan, Program Cellular & Mol Biol, Ann Arbor, MI 48109 USA; [Learman, Brian S.; Parlee, Sebastian D.; Scheller, Erica L.; Mori, Hiroyuki; Cawthorn, William P.; Ning, Xiaomin; MacDougald, Ormond A.] Univ Michigan, Ann Arbor, MI 48109 USA; [MacDougald, Ormond A.] Univ Michigan, Dept Internal Med, Ann Arbor, MI 48109 USA; [Cawthorn, William P.; Krishnan, Venkatesh; Ma, Yanfei L.] Lilly Res Labs, Musculoskeletal Res, Indianapolis, IN USA; [Tyrberg, Bjorn] MedImmune LLC, Cardiovasc & Metab Dis, Gaithersburg, MD USA; [Tyrberg, Bjorn] Diabet & Obes Res Ctr, Sanford Burnham Med Res Inst, Orlando, FL USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Eli Lilly; AstraZeneca; Medimmune; Sanford Burnham Prebys Medical Discovery Institute	MacDougald, OA (corresponding author), Univ Michigan, Program Cellular & Mol Biol, Ann Arbor, MI 48109 USA.	macdouga@umich.edu	Scheller, Erica L/H-6993-2019; Cawthorn, William P./Y-2115-2019	Scheller, Erica L/0000-0002-1551-3816; Cawthorn, William P./0000-0001-7832-5057; MacDougald, Ormond/0000-0001-6907-7960; Tyrberg, Bjorn/0000-0003-0976-1220	National Institutes of Health (NIH) [R01-DK095705, R24-DK092759]; Fulbright Scholar's Award; Cellular and Molecular Biology Program Training Grant [T32-GM007315]; Training Program in Organogenesis [T32-HD007505]; Lilly Innovation Fellowship Award; Royal Commission for the Exhibition (United Kingdom); American Diabetes Association; NIH [P30-DK089503, P30-DK020572]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD007505] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [T32DE007057] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK020572, P30DK089503, R24DK092759, R01DK095705] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007315] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fulbright Scholar's Award; Cellular and Molecular Biology Program Training Grant; Training Program in Organogenesis; Lilly Innovation Fellowship Award; Royal Commission for the Exhibition (United Kingdom); American Diabetes Association(American Diabetes Association); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health (NIH) grants (R01-DK095705, R24-DK092759) and a Fulbright Scholar's Award to OAM; Cellular and Molecular Biology Program Training Grant (T32-GM007315) and the Training Program in Organogenesis (T32-HD007505) to BRS and SDP. WPC is supported by a Lilly Innovation Fellowship Award, with previous support from a Postdoctoral Research Fellowship from the Royal Commission for the Exhibition of 1851 (United Kingdom). HM was supported by a mentor-based postdoctoral fellowship from the American Diabetes Association. This work utilized the University of Michigan Animal Phenotyping and Morphology and Imaging Core Services supported by NIH grants P30-DK089503 and P30-DK020572. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akune T, 2004, J CLIN INVEST, V113, P846, DOI 10.1172/JCI200419900; Bennett CN, 2007, J BONE MINER RES, V22, P1924, DOI 10.1359/JBMR.070810; Elliott RA, 2011, J UROLOGY, V186, P2455, DOI 10.1016/j.juro.2011.07.083; Fazeli PK, 2013, J CLIN ENDOCR METAB, V98, P935, DOI 10.1210/jc.2012-3634; Fretz JA, 2010, ENDOCRINOLOGY, V151, P1611, DOI 10.1210/en.2009-0987; Geraedts MCP, 2012, AM J PHYSIOL-ENDOC M, V303, pE464, DOI 10.1152/ajpendo.00163.2012; Glendinning JI, 2012, PHYSIOL BEHAV, V107, P50, DOI 10.1016/j.physbeh.2012.05.023; Iwatsuki K, 2010, BIOCHEM BIOPH RES CO, V402, P495, DOI 10.1016/j.bbrc.2010.10.057; Jang HJ, 2007, P NATL ACAD SCI USA, V104, P15069, DOI 10.1073/pnas.0706890104; Kang S, 2007, J BIOL CHEM, V282, P14515, DOI 10.1074/jbc.M700030200; Kawai M, 2010, NAT REV ENDOCRINOL, V6, P629, DOI 10.1038/nrendo.2010.155; Kokrashvili Z, 2009, ANN NY ACAD SCI, V1170, P91, DOI 10.1111/j.1749-6632.2009.04485.x; Kyriazis GA, 2012, P NATL ACAD SCI USA, V109, pE524, DOI 10.1073/pnas.1115183109; Lecka-Czernik B, 2012, BONE, V50, P534, DOI 10.1016/j.bone.2011.06.032; Mace OJ, 2007, J PHYSIOL-LONDON, V582, P379, DOI 10.1113/jphysiol.2007.130906; Manion CV, 2011, RHEUMATOLOGY, V50, P1244, DOI 10.1093/rheumatology/ker089; Margolskee RF, 2007, P NATL ACAD SCI USA, V104, P15075, DOI 10.1073/pnas.0706678104; Masubuchi Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054500; Merigo F, 2012, J ANAT, V221, P138, DOI 10.1111/j.1469-7580.2012.01522.x; Nakagawa Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005106; Nelson G, 2001, CELL, V106, P381, DOI 10.1016/S0092-8674(01)00451-2; Nie Y, 2005, CURR BIOL, V15, P1948, DOI 10.1016/j.cub.2005.09.037; Nie YL, 2006, CHEM SENSES, V31, P505, DOI 10.1093/chemse/bjj053; Parlee SD, 2014, METHODS A A IN PRESS, V537; Ren XY, 2009, FRONT INTEGR NEUROSC, V3, DOI 10.3389/neuro.07.012.2009; Ross SE, 2000, SCIENCE, V289, P950, DOI 10.1126/science.289.5481.950; Scheller E, 2014, METHODS A A IN PRESS, V537; Shockley KR, 2009, J CELL BIOCHEM, V106, P232, DOI 10.1002/jcb.21994; Simon BR, 2013, J BIOL CHEM, V288, P32475, DOI 10.1074/jbc.M113.514034; Taniguchi K, 2004, J VET MED SCI, V66, P1311, DOI 10.1292/jvms.66.1311; Zhao GQ, 2003, CELL, V115, P255, DOI 10.1016/S0092-8674(03)00844-4	31	46	47	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2014	9	1							e86454	10.1371/journal.pone.0086454	http://dx.doi.org/10.1371/journal.pone.0086454			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297VL	24466105	Green Published, Green Submitted, gold			2022-12-25	WOS:000330283100169
J	Tadesse, S; Kidane, D; Guller, S; Luo, TM; Norwitz, NG; Arcuri, F; Toti, P; Norwitz, ER				Tadesse, Serkalem; Kidane, Dawit; Guller, Seth; Luo, Tianmeng; Norwitz, Nicholas G.; Arcuri, Felice; Toti, Paolo; Norwitz, Errol R.			In Vivo and In Vitro Evidence for Placental DNA Damage in Preeclampsia	PLOS ONE			English	Article							BASE EXCISION-REPAIR; OXIDATIVE STRESS; ABASIC SITES; DIFFERENTIAL EXPRESSION; LIPID-PEROXIDATION; PREGNANCY; PROLIFERATION; ANTIOXIDANTS; PATHWAYS; HYPOXIA	Preeclampsia (PE) is an idiopathic multisystem disease affecting 5-7% of pregnant women. Placental oxidative stress is a characteristic feature of PE and occurs when the production of reactive oxygen species (ROS) within the placenta overwhelms the intrinsic anti-oxidant defenses. We hypothesize that excessive oxidative DNA damage at the fetal-maternal interface coupled with a defective DNA damage/repair response is causally related to PE. Here we demonstrate that gamma cH2AX (a sensitive marker of DNA damage) is expressed in the maternal decidua but not trophoblast of normal placentas, and that expression is significantly higher in PE placental tissues in vivo. Using primary in vitro cultures of maternal decidual stromal cells (DSCs) and fetal cytotrophoblast cells (CTs), we show an increase in gamma H2AX foci in DSCs cultured with vs without H2O2 (70.6% vs 11.6%; P<0.0001) or under hypoxia-reperfusion vs normoxia (20-vs 3-fold; P = 0.01); no foci were seen in CTs. We further demonstrate that Base Excision Repair (BER) intermediates are significantly increased in DSCs (not CTs) under these same conditions. Our data show that DNA damage is significantly more common in PE placentas, and that this DNA damage is localized to the maternal and not fetal side of the placenta. CTs may be selectively resistant to DNA damage in an effort to protect the fetus.	[Tadesse, Serkalem; Norwitz, Errol R.] Tufts Med Ctr, Dept Obstet & Gynecol, Boston, MA USA; [Tadesse, Serkalem; Luo, Tianmeng; Norwitz, Errol R.] Tufts Univ, Sch Med, Mother Infant Res Inst MIRI, Boston, MA 02111 USA; [Kidane, Dawit] Yale Univ, Sch Med, Dept Therapeut Radiol & Genet, New Haven, CT USA; [Guller, Seth; Norwitz, Nicholas G.] Yale Univ, Sch Med, Dept Obstet Gynecol & Reprod Sci, New Haven, CT USA; [Arcuri, Felice] Univ Siena, Dept Mol & Dev Med, I-53100 Siena, Italy; [Toti, Paolo] Univ Siena, Dept Med Biotechnol, I-53100 Siena, Italy	Tufts Medical Center; Tufts University; Yale University; Yale University; University of Siena; University of Siena	Norwitz, ER (corresponding author), Tufts Med Ctr, Dept Obstet & Gynecol, Boston, MA USA.	enorwitz@tuftsmedicalcenter.org	Kidane, Dawit/AAQ-7109-2020; Toti, Paolo/E-6358-2012	Toti, Paolo/0000-0002-1214-5886	NIH/NICHD-sponsored Reproductive Scientist Development Program; March of Dimes [21-FY05-1250]	NIH/NICHD-sponsored Reproductive Scientist Development Program; March of Dimes(March of Dimes)	This work was supported in part by the NIH/NICHD-sponsored Reproductive Scientist Development Program (to ERN) and March of Dimes (21-FY05-1250 to ERN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aplin JD, 2000, J CLIN INVEST, V105, P559, DOI 10.1172/JCI9512; Barnes DE, 1993, CURR OPIN CELL BIOL, V5, P424, DOI 10.1016/0955-0674(93)90007-D; Brosens JJ, 2009, AM J OBSTET GYNECOL, V200, DOI 10.1016/j.ajog.2008.11.037; BUDWITNOVOTNY DA, 1986, CANCER RES, V46, P5419; DEMPLE B, 1994, ANNU REV BIOCHEM, V63, P915, DOI 10.1146/annurev.biochem.63.1.915; Ding SZ, 2004, GASTROENTEROLOGY, V127, P845, DOI 10.1053/j.gastro.2004.06.017; DUGUID JR, 1995, CANCER RES, V55, P6097; Fortini P, 2003, BIOCHIMIE, V85, P1053, DOI 10.1016/j.biochi.2003.11.003; GENTIL A, 1992, J MOL BIOL, V227, P981, DOI 10.1016/0022-2836(92)90513-J; Guillet M, 2003, MOL CELL BIOL, V23, P8386, DOI 10.1128/MCB.23.22.8386-8394.2003; Heazell AEP, 2007, PLACENTA, V28, pS33, DOI 10.1016/j.placenta.2006.10.007; Jessmon P, 2010, BIOL REPROD, V82, P921, DOI 10.1095/biolreprod.109.082305; Kajihara T, 2011, PLACENTA, V32, P592, DOI 10.1016/j.placenta.2011.05.002; Kajihara T, 2006, MOL ENDOCRINOL, V20, P2444, DOI 10.1210/me.2006-0118; Kaur G, 2008, MOL CELL BIOCHEM, V313, P37, DOI 10.1007/s11010-008-9739-z; Kingdom JCP, 1997, PLACENTA, V18, P613, DOI 10.1016/S0143-4004(97)90000-X; KLIMAN HJ, 1986, ENDOCRINOLOGY, V118, P1567, DOI 10.1210/endo-118-4-1567; Kow YW, 2000, METHODS, V22, P164, DOI 10.1006/meth.2000.1057; KUBO K, 1992, BIOCHEMISTRY-US, V31, P3703, DOI 10.1021/bi00129a020; Kurisu S, 2001, Nucleic Acids Res Suppl, P45; Lei W, 2012, J BIOL CHEM, V287, P15174, DOI 10.1074/jbc.M111.308023; Lockwood CJ, 2006, AM J PATHOL, V169, P1294, DOI 10.2353/ajpath.2006.060185; LOEB LA, 1986, ANNU REV GENET, V20, P201, DOI 10.1146/annurev.ge.20.120186.001221; LOEB LA, 1985, CELL, V40, P483, DOI 10.1016/0092-8674(85)90191-6; Norwitz ER, 2007, AM J OBSTET GYNECOL, V196, DOI 10.1016/j.ajog.2007.02.035; Parast MM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008055; Poranen AK, 1996, PLACENTA, V17, P401, DOI 10.1016/S0143-4004(96)90021-1; ROBERTS JM, 1993, LANCET, V341, P1447, DOI 10.1016/0140-6736(93)90889-O; Rogakou EP, 1999, J CELL BIOL, V146, P905, DOI 10.1083/jcb.146.5.905; Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858; Rosen T, 2002, J Matern Fetal Neonatal Med, V11, P11, DOI 10.1080/713605444; Rothkamm K, 2003, MOL CELL BIOL, V23, P5706, DOI 10.1128/MCB.23.16.5706-5715.2003; Sharma S, 2010, J REPROD IMMUNOL, V85, P112, DOI 10.1016/j.jri.2010.01.002; Snegovskikh VV, 2009, REPROD SCI, V16, P767, DOI 10.1177/1933719109336623; Tadesse S, 2011, REPROD SCI, V18, P713, DOI 10.1177/1933719110396722; Takagi Y, 2004, VIRCHOWS ARCH, V444, P49, DOI 10.1007/s00428-003-0903-2; Valko M, 2007, INT J BIOCHEM CELL B, V39, P44, DOI 10.1016/j.biocel.2006.07.001; Walker JJ, 2000, LANCET, V356, P1260, DOI 10.1016/S0140-6736(00)02800-2; Wang Y, 1998, PLACENTA, V19, P581, DOI 10.1016/S0143-4004(98)90018-2; Wilson SH, 2000, NAT STRUCT BIOL, V7, P176; Wilson TM, 1996, MUTAT RES-DNA REPAIR, V362, P237, DOI 10.1016/0921-8777(95)00053-4; WISDOM SJ, 1991, AM J OBSTET GYNECOL, V165, P1701, DOI 10.1016/0002-9378(91)90018-M	42	23	24	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2014	9	1							e86791	10.1371/journal.pone.0086791	http://dx.doi.org/10.1371/journal.pone.0086791			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297VL	24466242	Green Published, gold, Green Submitted			2022-12-25	WOS:000330283100215
J	Volgin, DV; Lu, JW; Stettner, GM; Mann, GL; Ross, RJ; Morrison, AR; Kubin, L				Volgin, Denys V.; Lu, Jackie W.; Stettner, Georg M.; Mann, Graziella L.; Ross, Richard J.; Morrison, Adrian R.; Kubin, Leszek			Time- and Behavioral State-Dependent Changes in Posterior Hypothalamic GABA(A) Receptors Contribute to the Regulation of Sleep	PLOS ONE			English	Article							SUBUNIT MESSENGER-RNAS; OREXIN NEURONS; PREOPTIC AREA; REM-SLEEP; HOMEOSTATIC REGULATION; CIRCADIAN REGULATION; EPILEPSY PHENOTYPE; GABAERGIC NEURONS; BETA-3 SUBUNIT; ACTIVE NEURONS	Sleep-wake behavior is regulated by a circadian rhythm, homeostatically and by additional mechanisms that determine the timing of slow-wave sleep and rapid eye movement sleep (REMS) episodes. The posterior hypothalamus coordinates the neural and humoral signals with the rest-activity cycle. It contains wake-active neurons, and is a site where stimulation of inhibitory GABA(A) receptors promotes sleep, whereas their antagonism enhances wakefulness. We explored whether GABAergic mechanisms present in the posterior hypothalamus contribute to the homeostatic and other aspects of sleepwake regulation. Using micropunches of tissue extracted from either the perifornical (PF) or dorsomedial (DM) regions of the posterior hypothalamus of rats, we determined that mRNA levels for selected subunits of GABA(A) receptors (beta(1), beta(3) and epsilon) were higher at the end of the active period or following sleep deprivation, when the need for sleep is high, than after several hours of sleep, when sleep need is partially fulfilled. Such a pattern was present in the PF region only, and was consistent with changes in beta(1) subunit and GABA synthesizing enzyme (GAD) protein levels. In contrast, in the DM region, the levels of GABA(A) receptor subunit mRNAs and proteins (alpha(1), alpha(2), beta 1) and GAD varied with circadian time, but were not responsive to sleep deprivation. Separate experiments with sleep-wake monitoring and local perfusion of the PF region with the GABA(A) receptor antagonist bicuculline revealed that the antagonist had a weaker sleep-reducing effect when sleep need was enhanced by sleep deprivation and that the increased amount of REMS characteristic of the late sleep period was dependent on endogenous GABAergic inhibition. These results support the concept that a varying magnitude of GABAergic inhibition exerted within the PF region contributes to the homeostatic regulation of sleep and shapes its temporal pattern, whereas GABAergic mechanisms in the DM region contribute to circadian regulation.	[Volgin, Denys V.; Lu, Jackie W.; Stettner, Georg M.; Mann, Graziella L.; Ross, Richard J.; Morrison, Adrian R.; Kubin, Leszek] Univ Penn, Sch Vet Med, Dept Anim Biol, Philadelphia, PA 19104 USA; [Ross, Richard J.] Univ Penn, Sch Med, Dept Psychiat, Philadelphia, PA 19104 USA; [Ross, Richard J.] Philadelphia Vet Affairs Med Ctr, Behav Hlth Serv, Philadelphia, PA USA	University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; US Department of Veterans Affairs; Veterans Health Administration (VHA); Philadelphia Veterans Affairs Medical Center	Kubin, L (corresponding author), Univ Penn, Sch Vet Med, Dept Anim Biol, Philadelphia, PA 19104 USA.	lkubin@vet.upenn.edu	Stettner, Georg/J-6989-2019	Stettner, Georg M./0000-0002-0906-8816	United States National Institutes of Health [HL-071097]; Deutsche Forschungsgemeinschaft [Ste1899/1-1]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL071097] Funding Source: NIH RePORTER	United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Support was provided by United States National Institutes of Health grant HL-071097 and Deutsche Forschungsgemeinschaft fellowship DFG Ste1899/1-1 to GMS. Neither the funders nor the Department of Veterans Affairs had any role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahamson EE, 2001, BRAIN RES, V889, P1, DOI 10.1016/S0006-8993(00)03015-8; Adamantidis A, 2008, EUR J NEUROSCI, V27, P1793, DOI 10.1111/j.1460-9568.2008.06129.x; Alam MN, 2010, NEUROSCIENCE, V167, P920, DOI 10.1016/j.neuroscience.2010.02.038; Alam MN, 2005, J PHYSIOL-LONDON, V563, P569, DOI 10.1113/jphysiol.2004.076927; Backberg M, 2004, J NEUROENDOCRINOL, V16, P589, DOI 10.1111/j.1365-2826.2004.01207.x; BENINGTON JH, 1994, SLEEP, V17, P28, DOI 10.1093/sleep/17.1.28; Bernardis LL, 1996, NEUROSCI BIOBEHAV R, V20, P189, DOI 10.1016/0149-7634(95)00015-1; Bjornstrom K, 2003, ACTA ANAESTH SCAND, V47, P157, DOI 10.1034/j.1399-6576.2003.00007.x; Blednov YA, 2003, J PHARMACOL EXP THER, V305, P854, DOI 10.1124/jpet.103.049478; Bollan K, 2003, J BIOL CHEM, V278, P4747, DOI 10.1074/jbc.M210229200; Borbely A A, 1982, Hum Neurobiol, V1, P195; Bourgin P, 2000, J NEUROSCI, V20, P7760; Brandon NJ, 2003, MOL CELL NEUROSCI, V22, P87, DOI 10.1016/S1044-7431(02)00017-9; Brandon NJ, 2000, J BIOL CHEM, V275, P38856, DOI 10.1074/jbc.M004910200; Brown RE, 2012, PHYSIOL REV, V92, P1087, DOI 10.1152/physrev.00032.2011; Buhr A, 2002, HUM GENET, V111, P154, DOI 10.1007/s00439-002-0766-7; Burt J, 2011, AM J PHYSIOL-REG I, V301, pR572, DOI 10.1152/ajpregu.00674.2010; Carter ME, 2009, J NEUROSCI, V29, P10939, DOI 10.1523/JNEUROSCI.1205-09.2009; Chou TC, 2003, J NEUROSCI, V23, P10691; Dani VS, 2005, P NATL ACAD SCI USA, V102, P12560, DOI 10.1073/pnas.0506071102; De Lecea L, 1998, P NATL ACAD SCI USA, V95, P322, DOI 10.1073/pnas.95.1.322; DeLorey TM, 1998, J NEUROSCI, V18, P8505; Dworak M, 2010, J NEUROSCI, V30, P9007, DOI 10.1523/JNEUROSCI.1423-10.2010; Easton A, 2004, SLEEP, V27, P1307, DOI 10.1093/sleep/27.7.1307; Economo CV, 1930, J NERV MENT DIS, V71, P249, DOI 10.1097/00005053-193003000-00001; Estabrooke IV, 2001, J NEUROSCI, V21, P1656, DOI 10.1523/JNEUROSCI.21-05-01656.2001; Faraguna U, 2008, J NEUROSCI, V28, P4088, DOI 10.1523/JNEUROSCI.5510-07.2008; Fenelon VS, 1996, NEUROSCIENCE, V71, P661, DOI 10.1016/0306-4522(95)00492-0; Fenik VB, 2009, NEUROSCI LETT, V462, P80, DOI 10.1016/j.neulet.2009.06.083; Gong H, 2004, J PHYSIOL-LONDON, V556, P935, DOI 10.1113/jphysiol.2003.056622; Goutagny R, 2005, NEUROREPORT, V16, P1069, DOI 10.1097/00001756-200507130-00008; Gvilia I, 2006, J NEUROSCI, V26, P3037, DOI 10.1523/JNEUROSCI.4827-05.2006; Hagan JJ, 1999, P NATL ACAD SCI USA, V96, P10911, DOI 10.1073/pnas.96.19.10911; Halassa MM, 2009, NEURON, V61, P213, DOI 10.1016/j.neuron.2008.11.024; Harrison NL, 2007, J CLIN PSYCHIAT, V68, P6; Hassani OK, 2010, EUR J NEUROSCI, V32, P448, DOI 10.1111/j.1460-9568.2010.07295.x; Hassani OK, 2009, P NATL ACAD SCI USA, V106, P2418, DOI 10.1073/pnas.0811400106; Heldt SA, 2007, NEUROSCIENCE, V150, P370, DOI 10.1016/j.neuroscience.2007.09.008; Houston CM, 2012, J NEUROSCI, V32, P3887, DOI 10.1523/JNEUROSCI.5406-11.2012; Huber R, 2004, NATURE, V430, P78, DOI 10.1038/nature02663; Jego S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052525; John J, 2000, Sleep Res Online, V3, P23; Kilduff TS, 2005, SLEEP MED REV, V9, P227, DOI 10.1016/j.smrv.2005.04.002; Konadhode RR, 2013, J NEUROSCI, V33, P10257, DOI 10.1523/JNEUROSCI.1225-13.2013; Krueger JM, 2011, CURR TOP MED CHEM, V11, P2490; Krueger JM, 2010, J APPL PHYSIOL, V109, P1318, DOI 10.1152/japplphysiol.00586.2010; Krueger JM, 2008, CURR PHARM DESIGN, V14, P3408, DOI 10.2174/138161208786549281; Krueger JM, 2008, NAT REV NEUROSCI, V9, P910, DOI 10.1038/nrn2521; Kubin L, 2002, SOC NEUROSCI, V28; Laposky AD, 2001, NEUROREPORT, V12, P4143, DOI 10.1097/00001756-200112210-00056; Lee MG, 2005, J NEUROSCI, V25, P6716, DOI 10.1523/JNEUROSCI.1887-05.2005; Liao F, 2010, J NEUROSCI, V30, P4151, DOI 10.1523/JNEUROSCI.6047-09.2010; LIN JS, 1989, BRAIN RES, V479, P225, DOI 10.1016/0006-8993(89)91623-5; Lu J. W., 2007, J PHYSIOL-LONDON, V582, P52; Lu JW, 2009, RESP PHYSIOL NEUROBI, V167, P307, DOI 10.1016/j.resp.2009.06.004; Lu JW, 2005, RESP PHYSIOL NEUROBI, V147, P191, DOI 10.1016/j.resp.2005.05.007; Lu JW, 2004, SLEEP, V27, P14; Mackiewicz M, 2003, J NEUROCHEM, V85, P348, DOI 10.1046/j.1471-4159.2003.01687.x; Martin DL, 1998, PERSPECT DEV NEUROBI, V5, P119; Matsuki T, 2009, P NATL ACAD SCI USA, V106, P4459, DOI 10.1073/pnas.0811126106; McDonald BJ, 1998, NAT NEUROSCI, V1, P23, DOI 10.1038/223; Methippara M, 2012, NEUROSCIENCE, V209, P108, DOI 10.1016/j.neuroscience.2012.02.016; Mistlberger RE, 2005, BRAIN RES REV, V49, P429, DOI 10.1016/j.brainresrev.2005.01.005; Modirrousta M, 2007, BMC NEUROSCI, V8, DOI 10.1186/1471-2202-8-15; Moragues N, 2003, BRAIN RES, V967, P285, DOI 10.1016/S0006-8993(02)04270-1; Nambu T, 1999, BRAIN RES, V827, P243, DOI 10.1016/S0006-8993(99)01336-0; Nikonova EV, 2010, SLEEP, V33, P889, DOI 10.1093/sleep/33.7.889; Nitz D, 1996, AM J PHYSIOL-REG I, V271, pR1707, DOI 10.1152/ajpregu.1996.271.6.R1707; Nutt DJ, 2010, J PSYCHOPHARMACOL, V24, P1601, DOI 10.1177/0269881109106927; Paxinos G., 2007, RAT BRAIN STEREOTAXI, V6th ed.; Petit JM, 2002, EUR J NEUROSCI, V16, P1163, DOI 10.1046/j.1460-9568.2002.02145.x; Pirker S, 2000, NEUROSCIENCE, V101, P815, DOI 10.1016/S0306-4522(00)00442-5; Porkka-Heiskanen T, 2000, NEUROSCIENCE, V99, P507, DOI 10.1016/S0306-4522(00)00220-7; RADULOVACKI M, 1985, Reviews in Clinical and Basic Pharmacology, V5, P327; Rudolph U, 2011, NAT REV DRUG DISCOV, V10, P685, DOI 10.1038/nrd3502; SALLANON M, 1989, NEUROSCIENCE, V32, P669, DOI 10.1016/0306-4522(89)90289-3; Saper CB, 2005, NATURE, V437, P1257, DOI 10.1038/nature04284; Saper CB, 2001, TRENDS NEUROSCI, V24, P726, DOI 10.1016/S0166-2236(00)02002-6; Sherin JE, 1996, SCIENCE, V271, P216, DOI 10.1126/science.271.5246.216; Sieghart W., 2002, Current Topics in Medicinal Chemistry, V2, P795, DOI 10.2174/1568026023393507; Silver R, 2008, ANN NY ACAD SCI, V1129, P263, DOI 10.1196/annals.1417.032; Steininger TL, 2001, J COMP NEUROL, V429, P638; Steinmetz CC, 2010, J NEUROSCI, V30, P14685, DOI 10.1523/JNEUROSCI.2210-10.2010; Stettner GM, 2013, J APPL PHYSIOL, V114, P119, DOI 10.1152/japplphysiol.00965.2012; Szymusiak R, 2010, CURR OPIN PULM MED, V16, P530, DOI 10.1097/MCP.0b013e32833eec92; Taheri S, 2000, NEUROSCI LETT, V279, P109, DOI 10.1016/S0304-3940(99)00955-6; Takahashi K, 2008, NEUROSCIENCE, V153, P860, DOI 10.1016/j.neuroscience.2008.02.058; Terao A, 2000, SLEEP, V23, P867; TOBLER I, 1990, BEHAV BRAIN RES, V36, P73, DOI 10.1016/0166-4328(90)90161-7; Uschakov A, 2006, EUR J NEUROSCI, V23, P3284, DOI 10.1111/j.1460-9568.2006.04860.x; Uusi-Oukari M, 2010, PHARMACOL REV, V62, P97, DOI 10.1124/pr.109.002063; Verret L, 2003, BMC NEUROSCI, V4, DOI 10.1186/1471-2202-4-19; Volgin D, 2003, SLEEP, V26, pA38; Volgin DV, 2007, BIOCHEM BIOPH RES CO, V353, P726, DOI 10.1016/j.bbrc.2006.12.076; Volgin DV, 2006, AUTON NEUROSCI-BASIC, V126, P93, DOI 10.1016/j.autneu.2006.03.013; Volgin DV, 2002, NEUROREPORT, V13, P433, DOI 10.1097/00001756-200203250-00014; Volgin DV, 2001, J CHEM NEUROANAT, V22, P157, DOI 10.1016/S0891-0618(01)00124-7; Volgin DV, 2010, 4324 SOC NEUR; Vyazovskiy VV, 2008, NAT NEUROSCI, V11, P200, DOI 10.1038/nn2035; Wierenga CJ, 2005, J NEUROSCI, V25, P2895, DOI 10.1523/JNEUROSCI.5217-04.2005; Willie JT, 2001, ANNU REV NEUROSCI, V24, P429, DOI 10.1146/annurev.neuro.24.1.429; Winsky-Sommerer R, 2008, NEUROSCIENCE, V154, P595, DOI 10.1016/j.neuroscience.2008.03.081; Winsky-Sommerer R, 2009, EUR J NEUROSCI, V29, P1779, DOI 10.1111/j.1460-9568.2009.06716.x; Wisor JP, 2002, BRAIN RES, V955, P221, DOI 10.1016/S0006-8993(02)03467-4; Wurts SW, 2000, J NEUROSCI, V20, P4300; Yasenkov R, 2010, SLEEP, V33, P631, DOI 10.1093/sleep/33.5.631; Yoshida Y, 2001, EUR J NEUROSCI, V14, P1075, DOI 10.1046/j.0953-816x.2001.01725.x; Zimmerman JE, 2004, J NEUROCHEM, V88, P32, DOI 10.1046/j.1471-4159.2003.02126.x	108	13	13	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2014	9	1							e86545	10.1371/journal.pone.0086545	http://dx.doi.org/10.1371/journal.pone.0086545			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297GT	24466145	Green Published, gold			2022-12-25	WOS:000330244500258
J	Aggarwal, S; Gross, CM; Rafikov, R; Kumar, S; Fineman, JR; Ludewig, B; Jonigk, D; Black, SM				Aggarwal, Saurabh; Gross, Christine M.; Rafikov, Ruslan; Kumar, Sanjiv; Fineman, Jeffrey R.; Ludewig, Britta; Jonigk, Danny; Black, Stephen M.			Nitration of Tyrosine 247 Inhibits Protein Kinase G-1 alpha Activity by Attenuating Cyclic Guanosine Monophosphate Binding	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cyclic GMP (cGMP); Enzyme Catalysis; Mass Spectrometry (MS); Molecular Modeling; Protein Kinase G (PKG); Peroxynitrite	VASCULAR SMOOTH-MUSCLE; APPARENT CONFORMATIONAL-CHANGE; INDUCED PULMONARY-HYPERTENSION; NITRIC-OXIDE; CRYSTAL-STRUCTURE; MOUSE-BRAIN; CGMP; HYPOXIA; GMP; SUPEROXIDE	Background: PKG-1 nitration plays an important role in the development of pulmonary hypertension. Results: We identified Tyr(247) as the key residue susceptible to nitration and inhibition of PKG-1. Conclusion: Nitration attenuates PKG activity by reducing its affinity for cGMP. Significance: Preventing the nitration of PKG-1 could prevent the phenotypic remodeling in the blood vessels during the development of a number of cardiovascular diseases. The cGMP-dependent protein kinase G-1 (PKG-1) is a downstream mediator of nitric oxide and natriuretic peptide signaling. Alterations in this pathway play a key role in the pathogenesis and progression of vascular diseases associated with increased vascular tone and thickness, such as pulmonary hypertension. Previous studies have shown that tyrosine nitration attenuates PKG-1 activity. However, little is known about the mechanisms involved in this event. Utilizing mass spectrometry, we found that PKG-1 is susceptible to nitration at tyrosine 247 and 425. Tyrosine to phenylalanine mutants, Y247F- and Y425F-PKG-1, were both less susceptible to nitration than WT PKG-1, but only Y247F-PKG-1 exhibited preserved activity, suggesting that the nitration of Tyr(247) is critical in attenuating PKG-1 activity. The overexpression of WT- or Y247F-PKG-1 decreased the proliferation of pulmonary artery smooth muscle cells (SMC), increased the expression of SMC contractile markers, and decreased the expression of proliferative markers. Nitrosative stress induced a switch from a contractile to a synthetic phenotype in cells expressing WT- but not Y247F-PKG-1. An antibody generated against 3-NT-Y247 identified increased levels of nitrated PKG-1 in humans with pulmonary hypertension. Finally, to gain a more mechanistic understanding of how nitration attenuates PKG activity, we developed a homology model of PKG-1. This model predicted that the nitration of Tyr(247) would decrease the affinity of PKG-1 for cGMP, which we confirmed using a [H-3]cGMP binding assay. Our study shows that the nitration of Tyr(247) and the attenuation of cGMP binding is an important mechanism regulating in PKG-1 activity and SMC proliferation/differentiation.	[Aggarwal, Saurabh; Gross, Christine M.; Rafikov, Ruslan; Kumar, Sanjiv; Black, Stephen M.] Georgia Regents Univ, Vasc Biol Ctr, Pulm Dis Program, Augusta, GA 30912 USA; [Fineman, Jeffrey R.] Univ Calif San Francisco, Dept Pediat, San Francisco, CA 94143 USA; [Fineman, Jeffrey R.] Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA 94143 USA; [Ludewig, Britta; Jonigk, Danny] Hannover Med Sch, Inst Pathol, D-30625 Hannover, Germany	University System of Georgia; Augusta University; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Hannover Medical School	Black, SM (corresponding author), Georgia Regents Univ, Vasc Biol Ctr, 1459 Laney Walker Blvd,CB 3211-B, Augusta, GA 30912 USA.	sblack@gru.edu	Rafikov, Ruslan/AAG-9352-2019	Rafikov, Ruslan/0000-0001-5950-4076	National Institutes of Health [HL60190, HL67841, HL084739, HL0101902, HL061284]; Cardiovascular Discovery Institute of Georgia Regents University; American Heart Association Predoctoral Fellowship [12PRE12060224]; Deutsche Forschungsgemeinschaft Grant [30743/2-1]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL060190, P01HL101902, R01HL067841, R01HL084739, R01HL061284] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cardiovascular Discovery Institute of Georgia Regents University; American Heart Association Predoctoral Fellowship(American Heart Association); Deutsche Forschungsgemeinschaft Grant(German Research Foundation (DFG)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL60190, HL67841, HL084739, and HL0101902 (to S. M. B.) and HL061284 (to J. R. F.). This work was also supported by incubator and programmatic awards from the Cardiovascular Discovery Institute of Georgia Regents University (to S. M. B.).; Supported in part by American Heart Association Predoctoral Fellowship 12PRE12060224.; Supported by Deutsche Forschungsgemeinschaft Grant 30743/2-1.	Acampora KB, 2010, ANN VASC SURG, V24, P116, DOI 10.1016/j.avsg.2009.07.019; Aggarwal S, 2011, J CELL PHYSIOL, V226, P3104, DOI 10.1002/jcp.22692; AITKEN A, 1984, BIOCHIM BIOPHYS ACTA, V790, P219, DOI 10.1016/0167-4838(84)90025-6; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ATKINSON RA, 1991, BIOCHEMISTRY-US, V30, P9387, DOI 10.1021/bi00103a001; Broughton BRS, 2010, AM J PHYSIOL-LUNG C, V298, pL232, DOI 10.1152/ajplung.00276.2009; Busch JL, 2002, J BIOL CHEM, V277, P34048, DOI 10.1074/jbc.M202761200; Casteel DE, 2010, J BIOL CHEM, V285, P32684, DOI 10.1074/jbc.C110.161430; Chu DM, 1998, J BIOL CHEM, V273, P14649, DOI 10.1074/jbc.273.23.14649; Chu DM, 1997, J BIOL CHEM, V272, P31922, DOI 10.1074/jbc.272.50.31922; CORBIN JD, 1983, J BIOL CHEM, V258, P1391; CORBIN JD, 1986, J BIOL CHEM, V261, P1208; Cruz JA, 2012, AM J PHYSIOL-HEART C, V302, pH2518, DOI 10.1152/ajpheart.01140.2011; DUSSERRE E, 1994, BBA-LIPID LIPID MET, V1212, P235, DOI 10.1016/0005-2760(94)90258-5; Feil S, 2005, NEUROSCIENCE, V135, P863, DOI 10.1016/j.neuroscience.2005.06.051; Francis SH, 1996, J BIOL CHEM, V271, P20748, DOI 10.1074/jbc.271.34.20748; GARBERS DL, 1992, CELL, V71, P1; HEIL WG, 1987, EUR J BIOCHEM, V168, P117, DOI 10.1111/j.1432-1033.1987.tb13395.x; Herranz B, 2012, CIRC RES, V110, P439, DOI 10.1161/CIRCRESAHA.111.253948; HOFMANN F, 1983, FEBS LETT, V164, P350, DOI 10.1016/0014-5793(83)80315-9; HOFMANN F, 1985, EUR J BIOCHEM, V147, P361, DOI 10.1111/j.1432-1033.1985.tb08758.x; Hofmann Franz, 2009, V191, P137, DOI 10.1007/978-3-540-68964-5_8; Ischiropoulos H, 2003, BIOCHEM BIOPH RES CO, V305, P776, DOI 10.1016/S0006-291X(03)00814-3; Jonigk D, 2011, AM J PATHOL, V179, P167, DOI 10.1016/j.ajpath.2011.03.040; Kawashima S, 2001, ARTERIOSCL THROM VAS, V21, P201, DOI 10.1161/01.ATV.21.2.201; Kim JH, 2011, PLOS ONE, V6; King RD, 1996, PROTEIN SCI, V5, P2298, DOI 10.1002/pro.5560051116; Klemm DJ, 2011, J CARDIOVASC PHARM, V58, P181, DOI 10.1097/FJC.0b013e31821f2773; Lincoln TM, 1998, ACTA PHYSIOL SCAND, V164, P507, DOI 10.1111/j.1365-201X.1998.tb10700.x; Madamanchi NR, 2005, ARTERIOSCL THROM VAS, V25, P950, DOI 10.1161/01.ATV.0000161050.77646.68; Negash S, 2009, AM J PHYSIOL-HEART C, V297, pH304, DOI 10.1152/ajpheart.00077.2008; Negash S, 2007, AM J PHYSIOL-LUNG C, V293, pL1012, DOI 10.1152/ajplung.00061.2007; Nie H, 2006, DIABETES, V55, P3133, DOI 10.2337/db06-0505; Nisbet RE, 2009, AM J RESP CELL MOL, V40, P601, DOI 10.1165/2008-0145OC; Nozik-Grayck E, 2007, ADV EXP MED BIOL, V618, P101; Osborne BW, 2011, STRUCTURE, V19, P1317, DOI 10.1016/j.str.2011.06.012; Pilz RB, 2005, FRONT BIOSCI-LANDMRK, V10, P1239, DOI 10.2741/1616; REDDY VM, 1995, CIRCULATION, V92, P606, DOI 10.1161/01.CIR.92.3.606; Redondo-Horcajo M, 2010, CARDIOVASC RES, V87, P356, DOI 10.1093/cvr/cvq028; Reed RB, 1996, J BIOL CHEM, V271, P17570, DOI 10.1074/jbc.271.29.17570; Rudic RD, 1998, J CLIN INVEST, V101, P731, DOI 10.1172/JCI1699; Savvides SN, 2002, J BIOL CHEM, V277, P2779, DOI 10.1074/jbc.M108190200; Sharma S, 2008, AM J PHYSIOL-LUNG C, V294, pL46, DOI 10.1152/ajplung.00247.2007; Smith JA, 1996, J BIOL CHEM, V271, P20756, DOI 10.1074/jbc.271.34.20756; Sud N, 2007, AM J PHYSIOL-LUNG C, V293, pL1444, DOI 10.1152/ajplung.00175.2007; TAKIO K, 1984, BIOCHEMISTRY-US, V23, P4207, DOI 10.1021/bi00313a030; UHLER MD, 1993, J BIOL CHEM, V268, P13586; Vaandrager AB, 2005, FRONT BIOSCI-LANDMRK, V10, P2150, DOI 10.2741/1687; Venselaar H, 2010, EUR BIOPHYS J BIOPHY, V39, P551, DOI 10.1007/s00249-009-0531-0; Wang JN, 2012, FREE RADICAL BIO MED, V52, P173, DOI 10.1016/j.freeradbiomed.2011.10.442; Wedgwood S, 2001, CIRC RES, V89, P357, DOI 10.1161/hh1601.094983; Wolfe L, 1989, CURR OPIN CELL BIOL, V1, P215, DOI 10.1016/0955-0674(89)90090-2; WOLFE L, 1989, J BIOL CHEM, V264, P7734; Zhao JK, 1997, J BIOL CHEM, V272, P31929, DOI 10.1074/jbc.272.50.31929; Zhao YY, 2009, J CLIN INVEST, V119, P2009, DOI 10.1172/JCI33338	55	24	24	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 14	2014	289	11					7948	7961		10.1074/jbc.M113.534313	http://dx.doi.org/10.1074/jbc.M113.534313			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AC8CV	24469460	hybrid, Green Published			2022-12-25	WOS:000332761500059
J	Oganesyan, V; Damschroder, MM; Cook, KE; Li, Q; Gao, CS; Wu, HR; Dall'Acqua, WF				Oganesyan, Vaheh; Damschroder, Melissa M.; Cook, Kimberly E.; Li, Qing; Gao, Changshou; Wu, Herren; Dall'Acqua, William F.			Structural Insights into Neonatal Fc Receptor-based Recycling Mechanisms	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Albumin; Antibodies; Crystal Structure; FC Receptors; Protein Complexes	I-RELATED RECEPTOR; PH-DEPENDENT BINDING; AMINO-ACID-RESIDUES; CRYSTAL-STRUCTURE; HUMAN IGG1; HALF-LIFE; COMPLEX; ANTIBODY; ALBUMIN; SITE	Background: The neonatal Fc receptor (FcRn) regulates the serum half-life of human IgGs and serum albumin (SA). Results: Structures of human FcRn bound to its two ligands shed new lights on the corresponding interactions. Conclusion: Molecular mechanisms for IgG/SA recycling and increased IgG/FcRn binding affinity are presented. Significance: Understanding the molecular basis of the IgG/SA/FcRn interaction is crucial to develop biologics exhibiting beneficial pharmacokinetics properties. We report the three-dimensional structure of human neonatal Fc receptor (FcRn) bound concurrently to its two known ligands. More particularly, we solved the crystal structure of the complex between human FcRn, wild-type human serum albumin (HSA), and a human Fc engineered for improved pharmacokinetics properties (Fc-YTE). The crystal structure of human FcRn bound to wild-type HSA alone is also presented. HSA domain III exhibits an extensive interface of contact with FcRn, whereas domain I plays a lesser role. A molecular explanation for the HSA recycling mechanism is provided with the identification of FcRn His(161) as the only potential direct contributor to the corresponding pH-dependent process. At last, this study also allows an accurate structural definition of residues considered for decades as important to the human IgG/FcRn interaction and reveals Fc His(310) as a significant contributor to pH-dependent binding. Finally, we explain various structural mechanisms by which several Fc mutations (including YTE) result in increased human IgG binding to FcRn. Our study provides an unprecedented relevant understanding of the molecular basis of human Fc interaction with human FcRn.	[Oganesyan, Vaheh; Damschroder, Melissa M.; Cook, Kimberly E.; Li, Qing; Gao, Changshou; Wu, Herren; Dall'Acqua, William F.] MedImmune, Dept Antibody Discovery & Prot Engn, Gaithersburg, MD 20878 USA	AstraZeneca; Medimmune	Dall'Acqua, WF (corresponding author), MedImmune, Dept Antibody Discovery & Prot Engn, Gaithersburg, MD 20878 USA.	dallacquaw@medimmune.com		Damschroder, Melissa/0000-0001-9453-6532				Andersen JT, 2006, EUR J IMMUNOL, V36, P3044, DOI 10.1002/eji.200636556; Andersen JT, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1607; Andersen JT, 2009, DRUG METAB PHARMACOK, V24, P318, DOI 10.2133/dmpk.24.318; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BURMEISTER WP, 1994, NATURE, V372, P336, DOI 10.1038/372336a0; BURMEISTER WP, 1994, NATURE, V372, P379, DOI 10.1038/372379a0; Chaudhury C, 2006, BIOCHEMISTRY-US, V45, P4983, DOI 10.1021/bi052628y; Chaudhury C, 2003, J EXP MED, V197, P315, DOI 10.1084/jem.20021829; D'Arcy A, 2007, ACTA CRYSTALLOGR D, V63, P550, DOI 10.1107/S0907444907007652; Dall'Acqua WF, 2006, J BIOL CHEM, V281, P23514, DOI 10.1074/jbc.M604292200; Firan M, 2001, INT IMMUNOL, V13, P993, DOI 10.1093/intimm/13.8.993; Ghetie V, 2000, ANNU REV IMMUNOL, V18, P739, DOI 10.1146/annurev.immunol.18.1.739; Hinton PR, 2006, J IMMUNOL, V176, P346, DOI 10.4049/jimmunol.176.1.346; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Junghans RP, 1996, P NATL ACAD SCI USA, V93, P5512, DOI 10.1073/pnas.93.11.5512; Kabat EA, 1991, SEQUENCES PROTEINS I; KABSCH W, 1976, ACTA CRYSTALLOGR A, V32, P922, DOI 10.1107/S0567739476001873; Kim JK, 1999, EUR J IMMUNOL, V29, P2819, DOI 10.1002/(SICI)1521-4141(199909)29:09<2819::AID-IMMU2819>3.0.CO;2-6; KIM JK, 1994, EUR J IMMUNOL, V24, P542, DOI 10.1002/eji.1830240308; Martin WL, 2001, MOL CELL, V7, P867, DOI 10.1016/S1097-2765(01)00230-1; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; Medesan C, 1997, J IMMUNOL, V158, P2211; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Oganesyan V, 2009, MOL IMMUNOL, V46, P1750, DOI 10.1016/j.molimm.2009.01.026; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Petkova SB, 2006, INT IMMUNOL, V18, P1759, DOI 10.1093/intimm/dxl110; RAGHAVAN M, 1995, BIOCHEMISTRY-US, V34, P14649, DOI 10.1021/bi00045a005; Robbie GJ, 2013, ANTIMICROB AGENTS CH, V57, P6147, DOI 10.1128/AAC.01285-13; RODEWALD R, 1976, J CELL BIOL, V71, P666, DOI 10.1083/jcb.71.2.666; Schmidt MM, 2013, STRUCTURE, V21, P1966, DOI 10.1016/j.str.2013.08.022; Shields RL, 2001, J BIOL CHEM, V276, P6591, DOI 10.1074/jbc.M009483200; SIMISTER NE, 1989, NATURE, V337, P184, DOI 10.1038/337184a0; Sugio S, 1999, PROTEIN ENG, V12, P439, DOI 10.1093/protein/12.6.439; Vaughn DE, 1998, STRUCTURE, V6, P63, DOI 10.1016/S0969-2126(98)00008-2; West AP, 2000, BIOCHEMISTRY-US, V39, P9698, DOI 10.1021/bi000749m; Zalevsky J, 2010, NAT BIOTECHNOL, V28, P157, DOI 10.1038/nbt.1601	36	152	167	2	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 14	2014	289	11					7812	7824		10.1074/jbc.M113.537563	http://dx.doi.org/10.1074/jbc.M113.537563			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AC8CV	24469444	Green Published, hybrid			2022-12-25	WOS:000332761500047
J	Vasudevarao, MD; Mizar, P; Kumari, S; Mandal, S; Siddhanta, S; Swamy, MMM; Kaypee, S; Kodihalli, RC; Banerjee, A; Naryana, C; Dasgupta, D; Kundu, TK				Vasudevarao, Mohankrishna Dalvoy; Mizar, Pushpak; Kumari, Sujata; Mandal, Somnath; Siddhanta, Soumik; Swamy, Mahadeva M. M.; Kaypee, Stephanie; Kodihalli, Ravindra C.; Banerjee, Amrita; Naryana, Chandrabhas; Dasgupta, Dipak; Kundu, Tapas K.			Naphthoquinone-mediated Inhibition of Lysine Acetyltransferase KAT3B/p300, Basis for Non-toxic Inhibitor Synthesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Enzyme Inactivation; Enzyme Inhibitors; Histone Acetylase; Reactive Oxygen Species (ROS); Thiol; Lysine Acetyltransferase; N-Acetyl Cysteine; Plumbagin; Structure-Activity Relationship; Toxicity	SURFACE-ENHANCED RAMAN; INDUCED HISTONE HYPOACETYLATION; GLOBAL GENE-EXPRESSION; TRANSCRIPTIONAL COACTIVATOR; CHROMATIN TRANSCRIPTION; SMALL MOLECULES; CANCER CELLS; PLUMBAGIN; P300; SPECTROSCOPY	Background: 1,4-Naphthoquinone analogs, such as plumbagin, are toxic compounds due to their redox cycling and thiol-reactive properties. Results: The p300 inhibitor PTK1, a plumbagin derivative with greatly reduced toxicity, was synthesized and characterized. Conclusion: PTK1 is a reversible, non-competitive inhibitor of p300 KAT activity with reduced toxicity. Significance: These studies provide insight into naphthoquinone-mediated KAT inhibition and describe the synthesis of a therapeutically important, non-toxic inhibitor. Hydroxynaphthoquinone-based inhibitors of the lysine acetyltransferase KAT3B (p300), such as plumbagin, are relatively toxic. Here, we report that free thiol reactivity and redox cycling properties greatly contribute to the toxicity of plumbagin. A reactive 3rd position in the naphthoquinone derivatives is essential for thiol reactivity and enhances redox cycling. Using this clue, we synthesized PTK1, harboring a methyl substitution at the 3rd position of plumbagin. This molecule loses its thiol reactivity completely and its redox cycling ability to a lesser extent. Mechanistically, non-competitive, reversible binding of the inhibitor to the lysine acetyltransferase (KAT) domain of p300 is largely responsible for the acetyltransferase inhibition. Remarkably, the modified inhibitor PTK1 was a nearly non-toxic inhibitor of p300. The present report elucidates the mechanism of acetyltransferase activity inhibition by 1,4-naphthoquinones, which involves redox cycling and nucleophilic adduct formation, and it suggests possible routes of synthesis of the non-toxic inhibitor.	[Vasudevarao, Mohankrishna Dalvoy; Mizar, Pushpak; Kumari, Sujata; Mandal, Somnath; Swamy, Mahadeva M. M.; Kaypee, Stephanie; Kodihalli, Ravindra C.; Kundu, Tapas K.] Jawaharlal Nehru Ctr Adv Sci Res, Transcript & Dis Lab, Bangalore 560064, Karnataka, India; [Siddhanta, Soumik; Naryana, Chandrabhas] Jawaharlal Nehru Ctr Adv Sci Res, Light Scattering Lab, Bangalore 560064, Karnataka, India; [Banerjee, Amrita; Dasgupta, Dipak] Saha Inst Nucl Phys, Biophys & Struct Genom Div, Kolkata 700064, W Bengal, India	Department of Science & Technology (India); Jawaharlal Nehru Center for Advanced Scientific Research (JNCASR); Department of Science & Technology (India); Jawaharlal Nehru Center for Advanced Scientific Research (JNCASR); Saha Institute of Nuclear Physics	Kundu, TK (corresponding author), Jawaharlal Nehru Ctr Adv Sci Res, Transcript & Dis Lab, Bangalore 560064, Karnataka, India.	tapas@jncasr.ac.in	Siddhanta, Soumik/L-2949-2019; Mizar, Pushpak/ABA-5583-2021	Mandal, Somnath/0000-0002-6021-8955; Kundu, Tapas/0000-0001-7790-214X	Department of Biotechnology, Government of India [BT/01/CEIB/10/III/01]; Jawaharlal Nehru Centre for Advanced Scientific Research	Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India); Jawaharlal Nehru Centre for Advanced Scientific Research(Department of Science & Technology (India))	This work was supported by the Department of Biotechnology, Government of India (Program Support for Chromatin and Disease, Sanction Code BT/01/CEIB/10/III/01/dt-30.09.2011) and the Jawaharlal Nehru Centre for Advanced Scientific Research.	Arif M, 2009, J MED CHEM, V52, P267, DOI 10.1021/jm800657z; Arif M, 2007, J PHYS CHEM B, V111, P11877, DOI 10.1021/jp0762931; Arif Mohammed, 2013, Methods Mol Biol, V981, P239, DOI 10.1007/978-1-62703-305-3_19; Arif M, 2010, CHEM BIOL, V17, P903, DOI 10.1016/j.chembiol.2010.06.014; Balasubramanyam K, 2004, J BIOL CHEM, V279, P51163, DOI 10.1074/jbc.M409024200; Balasubramanyam K, 2004, J BIOL CHEM, V279, P33716, DOI 10.1074/jbc.M402839200; Balasubramanyam K, 2003, J BIOL CHEM, V278, P19134, DOI 10.1074/jbc.M301580200; Bowers EM, 2010, CHEM BIOL, V17, P471, DOI 10.1016/j.chembiol.2010.03.006; Checker R, 2010, J CELL BIOCHEM, V110, P1082, DOI 10.1002/jcb.22620; Choudhury M, 2010, ALCOHOL, V44, P531, DOI 10.1016/j.alcohol.2010.06.003; Cole PA, 2008, NAT CHEM BIOL, V4, P590, DOI 10.1038/nchembio.111; DeLano WL, 2004, PYMOL MOL GRAPHICS S; Frisch M.J., 2016, GAUSSIAN 16 REVISION; Inbaraj JJ, 2004, CHEM RES TOXICOL, V17, P55, DOI 10.1021/tx034132s; Kang J, 2003, TOXICOL SCI, V74, P279, DOI 10.1093/toxsci/kfg137; Kang JH, 2005, BIOCHEM PHARMACOL, V69, P1205, DOI 10.1016/j.bcp.2005.01.014; Klaus V, 2010, ARCH BIOCHEM BIOPHYS, V496, P93, DOI 10.1016/j.abb.2010.02.002; Kumar GVP, 2008, J PHYS CHEM B, V112, P6703, DOI 10.1021/jp711594z; Kumar GVP, 2007, CURR SCI INDIA, V93, P778; Kumar GVP, 2006, J PHYS CHEM B, V110, P16787, DOI 10.1021/jp063071e; Lau OD, 2000, MOL CELL, V5, P589, DOI 10.1016/S1097-2765(00)80452-9; LEE PC, 1982, J PHYS CHEM-US, V86, P3391, DOI 10.1021/j100214a025; Liu X, 2008, NATURE, V451, P846, DOI 10.1038/nature06546; Mallavadhani UV, 1998, PHYTOCHEMISTRY, V49, P901, DOI 10.1016/S0031-9422(97)01020-0; Mantelingu K, 2007, CHEM BIOL, V14, P645, DOI 10.1016/j.chembiol.2007.04.011; Mantelingu K, 2007, J PHYS CHEM B, V111, P4527, DOI 10.1021/jp067655s; MILLER MG, 1986, BIOCHEM PHARMACOL, V35, P1177, DOI 10.1016/0006-2952(86)90157-7; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; Ogihara K, 1997, CHEM PHARM BULL, V45, P437, DOI 10.1248/cpb.45.437; Powolny AA, 2008, PHARM RES-DORDR, V25, P2171, DOI 10.1007/s11095-008-9533-3; Ravindra KC, 2009, J BIOL CHEM, V284, P24453, DOI 10.1074/jbc.M109.023861; REIPA V, 1992, APPL SPECTROSC, V46, P1009, DOI 10.1366/0003702924124501; Sandur SK, 2006, J BIOL CHEM, V281, P17023, DOI 10.1074/jbc.M601595200; Selvi BR, 2010, BBA-GENE REGUL MECH, V1799, P810, DOI 10.1016/j.bbagrm.2010.09.005; Siddhanta S, 2012, NANOMATER NANOTECHNO, V2; Song DD, 2010, CANCER BIOL THER, V9, P96, DOI 10.4161/cbt.9.2.10287; Srinivas P, 2004, MOL CARCINOGEN, V40, P201, DOI 10.1002/mc.20031; Stimson L, 2005, MOL CANCER THER, V4, P1521, DOI 10.1158/1535-7163.MCT-05-0135; Castro FAV, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003999; Yu M, 2006, BIOCHEMISTRY-US, V45, P14788, DOI 10.1021/bi061621t	40	25	25	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 14	2014	289	11					7702	7717		10.1074/jbc.M113.486522	http://dx.doi.org/10.1074/jbc.M113.486522			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AC8CV	24469461	Green Published, hybrid			2022-12-25	WOS:000332761500038
J	Chen, J; Huang, DE; Chen, W; Guo, CW; Wei, B; Wu, CC; Peng, Z; Fan, J; Hou, ZB; Fang, YS; Wang, YF; Kitazato, K; Yu, GY; Zou, CB; Qian, CW; Xiong, S				Chen, Jia; Huang, Dane; Chen, Wei; Guo, Chaowan; Wei, Bo; Wu, Chongchao; Peng, Zhou; Fan, Jun; Hou, Zhibo; Fang, Yongsheng; Wang, Yifei; Kitazato, Kaio; Yu, Guoying; Zou, Chunbin; Qian, Chuiwen; Xiong, Sheng			Linker-Extended Native Cyanovirin-N Facilitates PEGylation and Potently Inhibits HIV-1 by Targeting the Glycan Ligand	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; CELL-FUSION; INACTIVATING PROTEIN; BINDING; ENVELOPE; OLIGOSACCHARIDES; INFECTION; MANNOSE; MUTANTS; INVITRO	Cyanovirin-N (CVN) potently inhibits human immunodeficiency virus type 1 (HIV-1) infection, but both cytotoxicity and immunogenicity have hindered the translation of this protein into a viable therapeutic. A molecular docking analysis suggested that up to 12 residues were involved in the interaction of the reverse parallel CVN dimer with the oligosaccharide targets, among which Leu-1 was the most prominent hot spot residue. This finding provided a possible explanation for the lack of anti-HIV-1 activity observed with N-terminal PEGylated CVN. Therefore, linker-CVN (LCVN) was designed as a CVN derivative with a flexible and hydrophilic linker (Gly(4)Ser)(3) at the N-terminus. The N-terminal alpha-amine of LCVN was PEGylated to create 10 K PEG-aldehyde (ALD)-LCVN. LCVN and 10 K PEG-ALD-LCVN retained the specificity and affinity of CVN for high mannose N-glycans. Moreover, LCVN exhibited significant anti-HIV-1 activity with attenuated cytotoxicity in the HaCaT keratinocyte cell line and MT-4 T lymphocyte cell lines. 10 K PEG-ALD-LCVN also efficiently inactivated HIV-1 with remarkably decreased cytotoxicity and pronounced cell-to-cell fusion inhibitory activity in vitro. The linker-extended CVN and the mono-PEGylated derivative were determined to be promising candidates for the development of an anti-HIV-1 agent. This derivatization approach provided a model for the PEGylation of biologic candidates without introducing point mutations.	[Chen, Jia; Chen, Wei; Wei, Bo; Wu, Chongchao; Peng, Zhou; Hou, Zhibo; Fang, Yongsheng; Wang, Yifei; Qian, Chuiwen; Xiong, Sheng] Jinan Univ, Inst Biomed, Guangzhou, Guangdong, Peoples R China; [Chen, Jia; Chen, Wei; Wei, Bo; Wu, Chongchao; Peng, Zhou; Hou, Zhibo; Fang, Yongsheng; Wang, Yifei; Qian, Chuiwen; Xiong, Sheng] Jinan Univ, Natl Engn Res Ctr Genet Med, Guangzhou, Guangdong, Peoples R China; [Huang, Dane] Sun Yat Sen Univ, Sch Pharmaceut Sci, Guangzhou 510275, Guangdong, Peoples R China; [Huang, Dane] Sun Yat Sen Univ, Inst Human Virol, Guangzhou 510275, Guangdong, Peoples R China; [Guo, Chaowan; Kitazato, Kaio] Nagasaki Univ, Dept Mol Microbiol & Immunol, Nagasaki 852, Japan; [Fan, Jun] Kyoto Univ, Inst Virus Res, Lab Virus Control, Kyoto 606, Japan; [Yu, Guoying; Zou, Chunbin; Xiong, Sheng] Univ Pittsburgh, Dept Med, Pittsburgh, PA USA; [Huang, Dane] Guangdong Prov Inst Tradit Chinese Med, Guangzhou, Guangdong, Peoples R China	Jinan University; Jinan University; Sun Yat Sen University; Sun Yat Sen University; Nagasaki University; Kyoto University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Guangzhou University of Chinese Medicine	Qian, CW (corresponding author), Jinan Univ, Inst Biomed, Guangzhou, Guangdong, Peoples R China.	litmony@sina.com; xiongsheng@jnu.edu.cn	Guo, Chaowan/AFI-6708-2022; Guo, Chaowan/AAF-3876-2022; Zou, Chunbin/L-7488-2019	Zou, Chunbin/0000-0003-1355-4726	Ministry of Science and Technology of China [2012ZX09103-301-033, 2012ZX09202301-001]; Jinan University [11611206]; National Natural Science Foundation of China [30873082]	Ministry of Science and Technology of China(Ministry of Science and Technology, China); Jinan University(Jinan University); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the "National Project for Significant New Drug Development'' of the Ministry of Science and Technology of China (2012ZX09103-301-033, 2012ZX09202301-001), the Central University Scientific Research Funding of Jinan University (11611206) and the National Natural Science Foundation of China (30873082), as provided to Xiong S. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balzarini J, 2007, LANCET, V369, P787, DOI 10.1016/S0140-6736(07)60202-5; Barrientos LG, 2006, PROTEIN ENG DES SEL, V19, P525, DOI 10.1093/protein/gzl040; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bewley CA, 1998, NAT STRUCT BIOL, V5, P571, DOI 10.1038/828; Bewley CA, 2001, J AM CHEM SOC, V123, P1014, DOI 10.1021/ja005714o; Botos I, 2002, J BIOL CHEM, V277, P34336, DOI 10.1074/jbc.M205909200; Botos I, 2002, BIOCHEM BIOPH RES CO, V294, P184, DOI 10.1016/S0006-291X(02)00455-2; Boyd MR, 1997, ANTIMICROB AGENTS CH, V41, P1521, DOI 10.1128/AAC.41.7.1521; BUCKHEIT RW, 1994, AIDS RES HUM RETROV, V10, P1497, DOI 10.1089/aid.1994.10.1497; Chen XY, 2013, ADV DRUG DELIVER REV, V65, P1357, DOI 10.1016/j.addr.2012.09.039; Contarino M, 2013, ANTIMICROB AGENTS CH, V57, P4743, DOI 10.1128/AAC.00309-13; Corine Sandstro m, 2005, BIOCHEMISTRY-US, V43, P13926; Gao XL, 2010, APPL MICROBIOL BIOT, V85, P1051, DOI 10.1007/s00253-009-2078-5; GEYER H, 1988, J BIOL CHEM, V263, P11760; HUSTON JS, 1988, P NATL ACAD SCI USA, V85, P5879, DOI 10.1073/pnas.85.16.5879; KATOH H, 1993, J BIOCHEM-TOKYO, V113, P118, DOI 10.1093/oxfordjournals.jbchem.a123994; Katoh M, 1993, Nihon Ronen Igakkai Zasshi, V30, P953; Kelley BS, 2002, J AM CHEM SOC, V124, P3210, DOI 10.1021/ja025537m; Liu YA, 2009, BIOPOLYMERS, V92, P194, DOI 10.1002/bip.21173; Montero M, 2008, MICROBIOL MOL BIOL R, V72, P54, DOI 10.1128/MMBR.00020-07; Moscoso CG, 2011, P NATL ACAD SCI USA, V108, P6091, DOI 10.1073/pnas.1016113108; NAKASHIMA H, 1988, J CLIN MICROBIOL, V26, P1229, DOI 10.1128/JCM.26.6.1229-1232.1988; NEMOTO Y, 1993, J CELL BIOL, V123, P963, DOI 10.1083/jcb.123.4.963; Pasut G, 2012, J CONTROL RELEASE, V161, P461, DOI 10.1016/j.jconrel.2011.10.037; Roberts MJ, 2002, ADV DRUG DELIVER REV, V54, P459, DOI 10.1016/S0169-409X(02)00022-4; Sandstrom C, 2008, BIOCHEMISTRY-US, V47, P3625, DOI 10.1021/bi702200m; Shattock R, 2004, LANCET, V363, P1002, DOI 10.1016/S0140-6736(04)15876-5; Shattock RJ, 2003, NAT REV MICROBIOL, V1, P25, DOI 10.1038/nrmicro729; Shattock RJ, 2011, SCIENCE, V333, P42, DOI 10.1126/science.1206399; TOCHIKURA TS, 1988, VIROLOGY, V164, P542, DOI 10.1016/0042-6822(88)90570-3; Vorontsov II, 2009, BIOPHYS J, V97, P2532, DOI 10.1016/j.bpj.2009.08.011; Xiong S, 2010, APPL MICROBIOL BIOT, V86, P805, DOI 10.1007/s00253-010-2470-1; Zappe H, 2008, ADV DRUG DELIVER REV, V60, P79, DOI 10.1016/j.addr.2007.05.016	33	9	11	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2014	9	1							e86455	10.1371/journal.pone.0086455	http://dx.doi.org/10.1371/journal.pone.0086455			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301BI	24475123	Green Published, Green Submitted, gold, Green Accepted			2022-12-25	WOS:000330507300065
J	Mali, I; Vandewege, MW; Davis, SK; Forstner, MRJ				Mali, Ivana; Vandewege, Michael W.; Davis, Scott K.; Forstner, Michael R. J.			Magnitude of the Freshwater Turtle Exports from the US: Long Term Trends and Early Effects of Newly Implemented Harvest Management Regimes	PLOS ONE			English	Article							LIVED ORGANISMS; CONSERVATION; TRADE; REPTILES; CHINA; IDENTIFICATION; DEMOGRAPHICS; AMPHIBIANS; TORTOISES; MARKET	Unregulated commercial harvest remains a major threat for turtles across the globe. Due to continuing demand from Asian markets, a significant number of turtles are exported from the United States of America ( US). Beginning in 2007, several southeastern states in the US implemented restrictions on the commercial harvest of turtles, in order to address the unsustainable take. We have summarized freshwater turtle exports from the US between 2002 and 2012 and demonstrated that the magnitude of turtle exports from the US remained high although the exports decreased throughout the decade. Louisiana and California were the major exporters. The majority of exports were captive bred, and from two genera, Pseudemys and Trachemys. We review the changes over the decade and speculate that the increase in export of wild turtles out of Louisiana after 2007 could be a consequence of strict regulations in surrounding states ( e. g., Alabama, Florida). We suggest that if wild turtle protection is a goal for conservation efforts, then these states should work together to develop comprehensive regulation reforms pertaining to the harvest of wild turtles.	[Mali, Ivana; Forstner, Michael R. J.] SW Texas State Univ, Dept Biol, San Marcos, TX 78666 USA; [Vandewege, Michael W.] Mississippi State Univ, Dept Biochem Mol Biol Entomol & Plant Pathol, Mississippi State, MS 39762 USA; [Davis, Scott K.] Turtle Survival Alliance, Ft Worth, TX USA	Texas State University System; Texas State University San Marcos; Mississippi State University	Mali, I (corresponding author), SW Texas State Univ, Dept Biol, San Marcos, TX 78666 USA.	im1040@txstate.edu			Texas State University-San Marcos, Texas, USA	Texas State University-San Marcos, Texas, USA	Funding for this study received from Texas State University-San Marcos, Texas, USA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alabama Department of Conservation and Natural Resources, 2012, 2012 2013 REG REL GA; Association of Fish and Wildlife Agencies, 2011, STAT UN LEG AUTH US; Behler J.L., 1997, P CONS REST MAN TORT; Brown DJ, 2011, J WILDLIFE MANAGE, V75, P486, DOI 10.1002/jwmg.73; Buhlmann KA, 2009, CHELONIAN CONSERV BI, V8, P116, DOI 10.2744/CCB-0774.1; Ceballos CP, 2004, WILDLIFE SOC B, V32, P881, DOI 10.2193/0091-7648(2004)032[0881:TTINAE]2.0.CO;2; Center for Biological Diversity, 2012, SO MIDW FRESHW TURTL; Chen TH, 2010, ORYX, V44, P261, DOI 10.1017/S0030605310000013; Cheung SM, 2006, AQUAT CONSERV, V16, P751, DOI 10.1002/aqc.803; Close Lisa M., 1997, Chelonian Conservation and Biology, V2, P563; CONGDON JD, 1993, CONSERV BIOL, V7, P826, DOI 10.1046/j.1523-1739.1993.740826.x; CONGDON JD, 1994, AM ZOOL, V34, P397; Duc Le Dien, 1995, INVESTIGATIONS TORTO; Ernst CH, 2009, TURTLES US CANADA; Georgia Department of Natural Resources, 2012, 2012 2013 HUNT SEAS; Gibbons JW, 2000, BIOSCIENCE, V50, P653, DOI 10.1641/0006-3568(2000)050[0653:TGDORD]2.0.CO;2; Gong SP, 2009, ORYX, V43, P213, DOI 10.1017/S0030605308000902; Heppell SS, 1998, COPEIA, P367, DOI 10.2307/1447430; Hong ML, 2008, APPL HERPETOL, V5, P173; Hughes DW, 1999, AQUACULT ECON MANAG, V3, P250; KLEMENS MW, 1995, BIODIVERS CONSERV, V4, P281, DOI 10.1007/BF00055974; Lindsay MK, 2013, AMPHIBIA-REPTILIA, V34, P75, DOI 10.1163/15685381-00002871; Louisiana State University AgCenter, 2012, AGR BACKB LOUIS EC; Meng Xianlin, 2002, Turtle and Tortoise Newsletter, V5, P15; Nijman V, 2007, CONTRIB ZOOL, V76, P207, DOI 10.1163/18759866-07603007; Pritchard Peter C.H., 1996, Chelonian Research Monographs, V1, P1; Reed RN, 2003, CONSERVATION STATUS; Roman J, 2000, ANIM CONSERV, V3, P61, DOI 10.1017/S1367943000000743; Schlaepfer MA, 2005, BIOSCIENCE, V55, P256, DOI 10.1641/0006-3568(2005)055[0256:CIETIO]2.0.CO;2; Sokal R. R., 2012, BIOMETRY; Telecky Teresa M., 2001, Turtle and Tortoise Newsletter, V4, P8; Texas Parks and Wildlife Department, 2007, TEX TURTL REG TITL 2; Turtle Conservation Coalition, 2011, TURTL TROUBL WORLDS; United States Fish and Wildlife Service, 2012, LAW ENF STOR NEWS RE; Zhou ZH, 2008, CHELONIAN CONSERV BI, V7, P28, DOI 10.2744/CCB-0662.1	35	23	23	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2014	9	1							e86478	10.1371/journal.pone.0086478	http://dx.doi.org/10.1371/journal.pone.0086478			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301BI	24475128	Green Submitted, Green Published, gold			2022-12-25	WOS:000330507300070
J	Reddy, UK; Almeida, A; Abburi, VL; Alaparthi, SB; Unselt, D; Hankins, G; Park, M; Choi, D; Nimmakayala, P				Reddy, Umesh K.; Almeida, Aldo; Abburi, Venkata L.; Alaparthi, Suresh Babu; Unselt, Desiree; Hankins, Gerald; Park, Minkyu; Choi, Doil; Nimmakayala, Padma			Identification of Gene-Specific Polymorphisms and Association with Capsaicin Pathway Metabolites in Capsicum annuum L. Collections	PLOS ONE			English	Article							CINNAMOYL-COA REDUCTASE; DIFFERENTIAL EXPRESSION; PUNGENT PRINCIPLE; BIOSYNTHESIS; PEPPER; FRUITS; ACID; ACCUMULATION; EVOLUTIONARY; PLACENTA	Pepper (Capsicum annuum L.) is an economically important crop with added nutritional value. Production of capsaicin is an important quantitative trait with high environmental variance, so the development of markers regulating capsaicinoid accumulation is important for pepper breeding programs. In this study, we performed association mapping at the gene level to identify single nucleotide polymorphisms (SNPs) associated with capsaicin pathway metabolites in a diverse Capsicum annuum collection during two seasons. The genes Pun1, CCR, KAS and HCT were sequenced and matched with the whole-genome sequence draft of pepper to identify SNP locations and for further characterization. The identified SNPs for each gene underwent candidate gene association mapping. Association mapping results revealed Pun1 as a key regulator of major metabolites in the capsaicin pathway mainly affecting capsaicinoids and precursors for acyl moieties of capsaicinoids. Six different SNPs in the promoter sequence of Pun1 were found associated with capsaicin in plants from both seasons. Our results support that CCR is an important control point for the flux of p-coumaric acid to specific biosynthesis pathways. KAS was found to regulate the major precursors for acyl moieties of capsaicinoids and may play a key role in capsaicinoid production. Candidate gene association mapping of Pun1 suggested that the accumulation of capsaicinoids depends on the expression of Pun1, as revealed by the most important associated SNPs found in the promoter region of Pun1.	[Reddy, Umesh K.; Almeida, Aldo; Abburi, Venkata L.; Alaparthi, Suresh Babu; Unselt, Desiree; Hankins, Gerald; Nimmakayala, Padma] West Virginia State Univ, Gus R Douglass Inst, Institute, WV USA; [Reddy, Umesh K.; Almeida, Aldo; Abburi, Venkata L.; Alaparthi, Suresh Babu; Unselt, Desiree; Hankins, Gerald; Nimmakayala, Padma] West Virginia State Univ, Dept Biol, Institute, WV USA; [Park, Minkyu; Choi, Doil] Seoul Natl Univ, Dept Plant Sci, Plant Genom & Breeding Inst, Coll Agr & Life Sci, Seoul, South Korea	West Virginia State University; West Virginia State University; Seoul National University (SNU)	Reddy, UK (corresponding author), West Virginia State Univ, Gus R Douglass Inst, Institute, WV USA.	ureddy@wvstateu.edu	Choi, Doil/F-5002-2011; Robles, Aldo Ricardo Almeida/P-9348-2019	Robles, Aldo Ricardo Almeida/0000-0001-5284-8992; Unselt, Desiree/0000-0003-1489-8854	USDA-NIFA [2010-38821-21574]; Office of Integrative Activities [1003907] Funding Source: National Science Foundation	USDA-NIFA(United States Department of Agriculture (USDA)); Office of Integrative Activities(National Science Foundation (NSF)NSF - Office of the Director (OD))	This project was supported by USDA-NIFA (Contract #2010-38821-21574). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abburi L, 2013, LINKAGE DISEQUILIBRI; Aluru MR, 2003, J EXP BOT, V54, P1655, DOI 10.1093/jxb/erg176; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BENNETT DJ, 1968, J CHEM SOC C, P442, DOI 10.1039/j39680000442; Blum E, 2003, THEOR APPL GENET, V108, P79, DOI 10.1007/s00122-003-1405-y; Blum E, 2002, GENOME, V45, P702, DOI 10.1139/G02-031; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; COLLINS MD, 1995, HORTSCIENCE, V30, P137, DOI 10.21273/HORTSCI.30.1.137; Dehesh K, 2001, PLANT PHYSIOL, V125, P1103, DOI 10.1104/pp.125.2.1103; Abraham-Juarez MD, 2008, PLANTA, V227, P681, DOI 10.1007/s00425-007-0651-7; DIXON RA, 1995, PLANT CELL, V7, P1085, DOI 10.1105/tpc.7.7.1085; Fallin D, 2000, AM J HUM GENET, V67, P947, DOI 10.1086/303069; FUJIWAKE H, 1982, AGR BIOL CHEM TOKYO, V46, P2591, DOI 10.1080/00021369.1982.10865477; FUNK C, 1990, PLANT PHYSIOL, V94, P95, DOI 10.1104/pp.94.1.95; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Han K, 2013, MOL BREEDING, V31, P537, DOI 10.1007/s11032-012-9811-y; Handrick V, 2010, ANAL BIOANAL CHEM, V398, P2789, DOI 10.1007/s00216-010-4129-2; Higo K, 1999, NUCLEIC ACIDS RES, V27, P297, DOI 10.1093/nar/27.1.297; Hill TA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056200; HOLM S, 1979, SCAND J STAT, V6, P65; IWAI K, 1979, AGR BIOL CHEM TOKYO, V43, P2493, DOI 10.1080/00021369.1979.10863843; Kawasaki T, 2006, P NATL ACAD SCI USA, V103, P230, DOI 10.1073/pnas.0509875103; Kim M, 2001, MOL CELLS, V11, P213; KOPP B, 1981, PLANTA MED, V43, P272, DOI 10.1055/s-2007-971508; Lacombe E, 1997, PLANT J, V11, P429, DOI 10.1046/j.1365-313X.1997.11030429.x; Lee R J, 1996, J Am Optom Assoc, V67, P548; LEETE E, 1968, J AM CHEM SOC, V90, P6837, DOI 10.1021/ja01026a049; LEFEBVRE V, 1995, GENOME, V38, P112, DOI 10.1139/g95-014; Leonard JM, 1998, PLANT J, V13, P621, DOI 10.1046/j.1365-313X.1998.00066.x; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Marzo VD, 2004, EUROPEAN J BIOCH, V271, P1813; Mazourek M, 2009, PLANT PHYSIOL, V150, P1806, DOI 10.1104/pp.109.136549; McCormack PL, 2010, DRUGS, V70, P1831, DOI 10.2165/11206050-000000000-00000; MINGUEZMOSQUERA MI, 1993, J AGR FOOD CHEM, V41, P1616, DOI 10.1021/jf00034a018; Pichon M, 1998, PLANT MOL BIOL, V38, P671, DOI 10.1023/A:1006060101866; Rao SR, 2000, J BIOTECHNOL, V76, P137, DOI 10.1016/S0168-1656(99)00177-7; Rozen S., 1998, PRIMER3; Stellari GM, 2010, HEREDITY, V104, P460, DOI 10.1038/hdy.2009.131; Stewart C, 2005, PLANT J, V42, P675, DOI 10.1111/j.1365-313X.2005.02410.x; Stewart C, 2007, J EXP BOT, V58, P979, DOI 10.1093/jxb/erl243; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023; Wahyuni Y, 2011, PHYTOCHEMISTRY, V72, P1358, DOI 10.1016/j.phytochem.2011.03.016; Wheelan SJ, 2001, GENOME RES, V11, P1952, DOI 10.1101/gr.195301; Winkel-Shirley B, 2001, PLANT PHYSIOL, V126, P485, DOI 10.1104/pp.126.2.485; Wu FN, 2006, GENETICS, V174, P1407, DOI 10.1534/genetics.106.062455; Yumnam JS, 2012, PLANT MOL BIOL REP, V30, P1470, DOI 10.1007/s11105-012-0466-y; Zewdie Y, 2001, BIOCHEM SYST ECOL, V29, P161, DOI 10.1016/S0305-1978(00)00041-7	47	25	26	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2014	9	1							e86393	10.1371/journal.pone.0086393	http://dx.doi.org/10.1371/journal.pone.0086393			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301BI	24475113	gold, Green Published, Green Submitted			2022-12-25	WOS:000330507300059
J	Brunnschweiler, JM; Abrantes, KG; Barnett, A				Brunnschweiler, Juerg M.; Abrantes, Katya G.; Barnett, Adam			Long-Term Changes in Species Composition and Relative Abundances of Sharks at a Provisioning Site	PLOS ONE			English	Article							REEF-MARINE-RESERVE; HAWAIIAN-ISLANDS; FREQUENCY; BEHAVIOR; TOURISM; CONSERVATION; POPULATION; PACIFIC; BIOMASS; IMPACT	Diving with sharks, often in combination with food baiting/provisioning, has become an important product of today's recreational dive industry. Whereas the effects baiting/provisioning has on the behaviour and abundance of individual shark species are starting to become known, there is an almost complete lack of equivalent data from multi-species shark diving sites. In this study, changes in species composition and relative abundances were determined at the Shark Reef Marine Reserve, a multi-species shark feeding site in Fiji. Using direct observation sampling methods, eight species of sharks (bull shark Carcharhinus leucas, grey reef shark Carcharhinus amblyrhynchos, whitetip reef shark Triaenodon obesus, blacktip reef shark Carcharhinus melanopterus, tawny nurse shark Nebrius ferrugineus, silvertip shark Carcharhinus albimarginatus, sicklefin lemon shark Negaprion acutidens, and tiger shark Galeocerdo cuvier) displayed inter-annual site fidelity between 2003 and 2012. Encounter rates and/or relative abundances of some species changed over time, overall resulting in more individuals (mostly C. leucas) of fewer species being encountered on average on shark feeding dives at the end of the study period. Differences in shark community composition between the years 2004-2006 and 2007-2012 were evident, mostly because N. ferrugineus, C. albimarginatus and N. acutidens were much more abundant in 2004-2006 and very rare in the period of 2007-2012. Two explanations are offered for the observed changes in relative abundances over time, namely inter-specific interactions and operator-specific feeding protocols. Both, possibly in combination, are suggested to be important determinants of species composition and encounter rates, and relative abundances at this shark provisioning site in Fiji. This study, which includes the most species from a spatially confined shark provisioning site to date, suggests that long-term provisioning may result in competitive exclusion among shark species.	[Abrantes, Katya G.; Barnett, Adam] James Cook Univ, Sch Marine & Trop Biol, Townsville, Qld 4811, Australia; [Barnett, Adam] Deakin Univ, Sch Life & Environm Sci, Burwood, Australia; [Barnett, Adam] Oceans IQ, Cairns, Australia	James Cook University; Deakin University		juerg@gluecklich.net	Brunnschweiler, Juerg/A-2110-2008	Brunnschweiler, Juerg/0000-0002-9901-3279; , Adam/0000-0001-7430-8428; abrantes, katya/0000-0001-8648-8817	Save Our Seas Foundation; Shark Foundation Switzerland	Save Our Seas Foundation; Shark Foundation Switzerland	This work was funded through grants to JMB from the Save Our Seas Foundation (http://saveourseas.com/) and the Shark Foundation Switzerland (http://www.shark.ch/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLEE WC, 1954, PHYSIOL ZOOL, V27, P356, DOI 10.1086/physzool.27.4.30152372; ALTMANN J, 1974, BEHAVIOUR, V49, P227, DOI 10.1163/156853974X00534; Barnett A, 2010, J FISH BIOL, V77, P1688, DOI 10.1111/j.1095-8649.2010.02810.x; Barnett A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036574; Barnett A, 2012, OIKOS, V121, P882, DOI 10.1111/j.1600-0706.2011.20000.x; Bessudo S, 2011, ENVIRON BIOL FISH, V91, P165, DOI 10.1007/s10641-011-9769-3; BRES M, 1993, REV FISH BIOL FISHER, V3, P133, DOI 10.1007/BF00045229; Brunnschweiler JM, 2006, CYBIUM, V30, P133; Brunnschweiler JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058522; Brunnschweiler JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016597; Brunnschweiler JM, 2010, J SUSTAIN TOUR, V18, P29, DOI 10.1080/09669580903071987; Campbell G, 2011, BIOL LETTERS, V7, P723, DOI 10.1098/rsbl.2011.0155; Caro T, 2011, AFR J ECOL, V49, P320, DOI 10.1111/j.1365-2028.2011.01268.x; Clarke C, 2011, MAR FRESHWATER RES, V62, P668, DOI 10.1071/MF10171; Clarke CR, 2013, MAR FRESH R IN PRESS; Clua E, 2010, MAR ECOL PROG SER, V414, P257, DOI 10.3354/meps08746; Corcoran MJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059235; De'ath G, 2000, ECOLOGY, V81, P3178, DOI 10.1890/0012-9658(2000)081[3178:CARTAP]2.0.CO;2; Dobson J., 2006, Tourism in Marine Environments, V3, P15, DOI 10.3727/154427306779380275; Feitosa CV, 2012, J MAR BIOL ASSOC UK, V92, P1525, DOI 10.1017/S0025315412000136; Field IC, 2011, CORAL REEFS, V30, P61, DOI 10.1007/s00338-010-0699-x; Fitzpatrick R, 2011, CORAL REEFS, V30, P569, DOI 10.1007/s00338-011-0769-8; Friedlander AM, 2002, MAR ECOL PROG SER, V230, P253, DOI 10.3354/meps230253; Gallagher AJ, 2011, CURR ISSUES TOUR, V14, P797, DOI 10.1080/13683500.2011.585227; Heupel MR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009650; Ilarri MDI, 2008, NEOTROP ICHTHYOL, V6, P651, DOI 10.1590/S1679-62252008000400014; Maljkovic A, 2011, BIOL CONSERV, V144, P859, DOI 10.1016/j.biocon.2010.11.019; Meyer CG, 2009, ENVIRON CONSERV, V36, P104, DOI 10.1017/S0376892909990038; Milazzo M, 2006, MAR ECOL PROG SER, V310, P165, DOI 10.3354/meps310165; Papastamatiou YP, 2009, J FISH BIOL, V75, P647, DOI 10.1111/j.1095-8649.2009.02329.x; Papastamatiou YP, 2006, MAR ECOL PROG SER, V320, P239, DOI 10.3354/meps320239; Sandin SA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001548; Sims David W., 2005, P127; Speed CW, 2011, MAR ECOL PROG SER, V429, P261, DOI 10.3354/meps09080; Stevenson C, 2007, CORAL REEFS, V26, P47, DOI 10.1007/s00338-006-0158-x; Stoeckl N, 2010, TOURISM ECON, V16, P995, DOI 10.5367/te.2010.0005; URBAN D. L., 2002, ANAL ECOLOGICAL COMM, P222; Vianna GMS, 2012, BIOL CONSERV, V145, P267, DOI 10.1016/j.biocon.2011.11.022; Vianna GMS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060331; Vignon M, 2010, MAR FRESHWATER RES, V61, P163, DOI 10.1071/MF09079; Ward-Paige CA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025609; Whitney N, 2012, ENVIRON BIOL FISH, V93, P121, DOI 10.1007/s10641-011-9897-9	42	33	34	3	105	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2014	9	1							e86682	10.1371/journal.pone.0086682	http://dx.doi.org/10.1371/journal.pone.0086682			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297XI	24466197	Green Published, Green Submitted, Green Accepted, gold			2022-12-25	WOS:000330288000133
J	Miranzo-Navarro, D; Magor, KE				Miranzo-Navarro, Domingo; Magor, Katharine E.			Activation of Duck RIG-I by TRIM25 Is Independent of Anchored Ubiquitin	PLOS ONE			English	Article							ANTIVIRAL SIGNAL-TRANSDUCTION; INNATE IMMUNE-RESPONSE; POLYUBIQUITIN CHAINS; STRUCTURAL BASIS; ADAPTER PROTEIN; RNA RECOGNITION; VIRAL-RNA; INFLUENZA; LIGASE; VIRUS	Retinoic acid inducible gene I (RIG-I) is a viral RNA sensor crucial in defense against several viruses including measles, influenza A and hepatitis C. RIG-I activates type-I interferon signalling through the adaptor for mitochondrial antiviral signaling (MAVS). The E3 ubiquitin ligase, tripartite motif containing protein 25 (TRIM25), activates human RIG-I through generation of anchored K63-linked polyubiquitin chains attached to lysine 172, or alternatively, through the generation of unanchored K63-linked polyubiquitin chains that interact non-covalently with RIG-I CARD domains. Previously, we identified RIG-I of ducks, of interest because ducks are the host and natural reservoir of influenza viruses, and showed it initiates innate immune signaling leading to production of interferon-beta (IFN-beta). We noted that K172 is not conserved in RIG-I of ducks and other avian species, or mouse. Because K172 is important for both mechanisms of activation of human RIG-I, we investigated whether duck RIG-I was activated by TRIM25, and if other residues were the sites for attachment of ubiquitin. Here we show duck RIG-I CARD domains are ubiquitinated for activation, and ubiquitination depends on interaction with TRIM25, as a splice variant that cannot interact with TRIM25 is not ubiquitinated, and cannot be activated. We expressed GST-fusion proteins of duck CARD domains and characterized TRIM25 modifications of CARD domains by mass spectrometry. We identified two sites that are ubiquitinated in duck CARD domains, K167 and K193, and detected K63 linked polyubiquitin chains. Site directed mutagenesis of each site alone, does not alter the ubiquitination profile of the duck CARD domains. However, mutation of both sites resulted in loss of all attached ubiquitin and polyubiquitin chains. Remarkably, the double mutant duck RIG-I CARD still interacts with TRIM25, and can still be activated. Our results demonstrate that anchored ubiquitin chains are not necessary for TRIM25 activation of duck RIG-I.	Univ Alberta, Dept Biol Sci, Edmonton, AB, Canada; Univ Alberta, Li Ka Shing Inst Virol, Edmonton, AB, Canada	University of Alberta; University of Alberta	Magor, KE (corresponding author), Univ Alberta, Dept Biol Sci, Edmonton, AB, Canada.	kmagor@ualberta.ca	Magor, Katharine/A-2664-2014	Magor, Katharine/0000-0002-9331-1486	Canadian Institutes of Health Research [CIHR MOP 125865]; Natural Sciences and Engineering Research Council [RGPIN 228035]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC))	This study was supported by Canadian Institutes of Health Research grant CIHR MOP 125865 to KEM, and Natural Sciences and Engineering Research Council Discovery Grant RGPIN 228035 to KEM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barber MRW, 2013, MOL IMMUNOL, V54, P89, DOI 10.1016/j.molimm.2012.10.038; Barber MRW, 2010, P NATL ACAD SCI USA, V107, P5913, DOI 10.1073/pnas.1001755107; Childs K, 2007, VIROLOGY, V359, P190, DOI 10.1016/j.virol.2006.09.023; Civril F, 2011, EMBO REP, V12, P1127, DOI 10.1038/embor.2011.190; Feng M, 2013, PROTEIN CELL, V4, P142, DOI 10.1007/s13238-012-2088-4; Gack MU, 2008, P NATL ACAD SCI USA, V105, P16743, DOI 10.1073/pnas.0804947105; Gack MU, 2007, NATURE, V446, P916, DOI 10.1038/nature05732; Gack MU, 2009, CELL HOST MICROBE, V5, P439, DOI 10.1016/j.chom.2009.04.006; Gao D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005760; Hou FJ, 2011, CELL, V146, P448, DOI 10.1016/j.cell.2011.06.041; Iwashkiw JA, 2012, MICROB CELL FACT, V11, DOI 10.1186/1475-2859-11-13; Jiang FG, 2011, NATURE, V479, P423, DOI 10.1038/nature10537; Jiang XM, 2012, IMMUNITY, V36, P959, DOI 10.1016/j.immuni.2012.03.022; Kamitani T, 1997, J BIOL CHEM, V272, P28557, DOI 10.1074/jbc.272.45.28557; Kawai T, 2005, NAT IMMUNOL, V6, P981, DOI 10.1038/ni1243; Kim JK, 2009, INFLUENZA OTHER RESP, V3, P121, DOI 10.1111/j.1750-2659.2009.00084.x; Kolakofsky D, 2012, RNA, V18, P2118, DOI 10.1261/rna.035949.112; Kowalinski E, 2011, CELL, V147, P423, DOI 10.1016/j.cell.2011.09.039; Lim KL, 2005, J NEUROSCI, V25, P2002, DOI 10.1523/JNEUROSCI.4474-04.2005; Luo DH, 2011, CELL, V147, P409, DOI 10.1016/j.cell.2011.09.023; Maelfait J, 2012, MICROBIOL MOL BIOL R, V76, P33, DOI 10.1128/MMBR.05012-11; Magor KE, 2013, DEV COMP IMMUNOL, V41, P377, DOI 10.1016/j.dci.2013.04.010; Maharaj NP, 2012, J VIROL, V86, P1358, DOI 10.1128/JVI.06543-11; Marblestone JG, 2012, BBA-MOL CELL RES, V1823, P2094, DOI 10.1016/j.bbamcr.2012.06.013; Markson G, 2009, GENOME RES, V19, P1905, DOI 10.1101/gr.093963.109; Meylan E, 2005, NATURE, V437, P1167, DOI 10.1038/nature04193; Nistal-Villan E, 2010, J BIOL CHEM, V285, P20252, DOI 10.1074/jbc.M109.089912; O'Neill LAJ, 2011, CELL, V147, P259, DOI 10.1016/j.cell.2011.09.027; Oshiumi H, 2010, CELL HOST MICROBE, V8, P496, DOI 10.1016/j.chom.2010.11.008; Oshiumi H, 2009, J BIOL CHEM, V284, P807, DOI 10.1074/jbc.M804259200; Rajsbaum R, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003059; Saito T, 2007, P NATL ACAD SCI USA, V104, P582, DOI 10.1073/pnas.0606699104; Schaefer-Klein J, 1998, VIROLOGY, V248, P305, DOI 10.1006/viro.1998.9291; Schlee M, 2009, IMMUNOL REV, V227, P66, DOI 10.1111/j.1600-065X.2008.00724.x; Shevchenko A, 1996, P NATL ACAD SCI USA, V93, P14440, DOI 10.1073/pnas.93.25.14440; Sick C, 1998, J BIOL CHEM, V273, P9749, DOI 10.1074/jbc.273.16.9749; Spackman Erica, 2008, V436, P1, DOI 10.1007/978-1-59745-279-3_1; Streich FC, 2013, J BIOL CHEM, V288, P8209, DOI 10.1074/jbc.M113.451567; Takamatsu S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053578; Vanderven HA, 2012, MOL IMMUNOL, V51, P316, DOI 10.1016/j.molimm.2012.03.034; Versteeg GA, 2013, IMMUNITY, V38, P384, DOI 10.1016/j.immuni.2012.11.013; Wang C, 2011, EXPERT OPIN THER TAR, V15, P647, DOI 10.1517/14728222.2011.561321; WEBSTER RG, 1992, MICROBIOL REV, V56, P152, DOI 10.1128/MMBR.56.1.152-179.1992; WHO, 2013, CUM NUMB CONF HUM CA; Wies E, 2013, IMMUNITY, V38, P437, DOI 10.1016/j.immuni.2012.11.018; Windheim M, 2008, BIOCHEM J, V409, P723, DOI 10.1042/BJ20071338; Xu LG, 2005, MOL CELL, V19, P727, DOI 10.1016/j.molcel.2005.08.014; Zeng WW, 2010, CELL, V141, P315, DOI 10.1016/j.cell.2010.03.029; Zheng L, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh110	49	28	28	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2014	9	1							e86968	10.1371/journal.pone.0086968	http://dx.doi.org/10.1371/journal.pone.0086968			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297XI	24466302	Green Submitted, Green Published, gold			2022-12-25	WOS:000330288000178
J	Sales, KU; Friis, S; Konkel, JE; Godiksen, S; Hatakeyama, M; Hansen, KK; Rogatto, SR; Szabo, R; Vogel, LK; Chen, W; Gutkind, JS; Bugge, TH				Sales, K. U.; Friis, S.; Konkel, J. E.; Godiksen, S.; Hatakeyama, M.; Hansen, K. K.; Rogatto, S. R.; Szabo, R.; Vogel, L. K.; Chen, W.; Gutkind, J. S.; Bugge, T. H.			Non-hematopoietic PAR-2 is essential for matriptase-driven pre-malignant progression and potentiation of ras-mediated squamous cell carcinogenesis	ONCOGENE			English	Article						epithelial carcinogenesis; inflammation; keratinocyte stem cells; pericellular proteolysis	PROTEINASE-ACTIVATED RECEPTOR-2; SERINE-PROTEASE MATRIPTASE; TISSUE MICROARRAY ANALYSIS; HUMAN KERATINOCYTES; CLINICOPATHOLOGICAL PARAMETERS; GENE-EXPRESSION; OVARIAN-CANCER; ENDOTHELIAL-CELLS; EPITHELIAL-CELLS; IN-VITRO	The membrane-anchored serine protease, matriptase, is consistently dysregulated in a range of human carcinomas, and high matriptase activity correlates with poor prognosis. Furthermore, matriptase is unique among tumor-associated proteases in that epithelial stem cell expression of the protease suffices to induce malignant transformation. Here, we use genetic epistasis analysis to identify proteinase-activated receptor (PAR)-2-dependent inflammatory signaling as an essential component of matriptase-mediated oncogenesis. In cell-based assays, matriptase was a potent activator of PAR-2, and PAR-2 activation by matriptase caused robust induction of nuclear factor (NF)kappa B through G alpha i. Importantly, genetic elimination of PAR-2 from mice completely prevented matriptase-induced pre-malignant progression, including inflammatory cytokine production, inflammatory cell recruitment, epidermal hyperplasia and dermal fibrosis. Selective ablation of PAR-2 from bone marrow-derived cells did not prevent matriptase-driven pre-malignant progression, indicating that matriptase activates keratinocyte stem cell PAR-2 to elicit its pro-inflammatory and pro-tumorigenic effects. When combined with previous studies, our data suggest that dual induction of PAR-2-NF kappa B inflammatory signaling and PI3K-Akt-mTor survival/proliferative signaling underlies the transforming potential of matriptase and may contribute to pro-tumorigenic signaling in human epithelial carcinogenesis.	[Sales, K. U.; Friis, S.; Konkel, J. E.; Godiksen, S.; Hansen, K. K.; Szabo, R.; Chen, W.; Gutkind, J. S.; Bugge, T. H.] Natl Inst Dent & Craniofacial Res, Oral & Pharyngeal Canc Branch, NIH, Bethesda, MD 20892 USA; [Sales, K. U.] Natl Inst Dent & Craniofacial Res, Clin Res Core, NIH, Bethesda, MD 20892 USA; [Friis, S.; Godiksen, S.; Vogel, L. K.] Univ Copenhagen, Fac Hlth & Med Sci, Dept Cellular & Mol Med, Copenhagen, Denmark; [Godiksen, S.] Univ Copenhagen, Fac Sci, Dept Biol, Copenhagen, Denmark; [Hatakeyama, M.; Rogatto, S. R.] Sao Paulo State Univ UNESP, Fac Med, Dept Urol, Botucatu, SP, Brazil; [Hatakeyama, M.; Rogatto, S. R.] AC Camargo Canc Ctr, Sao Paulo, Brazil	National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR); National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR); University of Copenhagen; University of Copenhagen; Universidade Estadual Paulista; A.C.Camargo Cancer Center	Bugge, TH (corresponding author), Natl Inst Dent & Craniofacial Res, Oral & Pharyngeal Canc Branch, NIH, 30 Convent Dr,Room 211, Bethesda, MD 20892 USA.	thomas.bugge@nih.gov	Gutkind, J. Silvio/J-1201-2016; Rogatto, Silvia R/E-6535-2012; sales, katiuchia u/J-4880-2012	Gutkind, J. Silvio/0000-0002-5150-4482; sales, katiuchia/0000-0002-3768-5790; Vogel, Lotte K./0000-0001-9920-0982; Rogatto, Silvia/0000-0003-4637-5687	NIDCR Intramural Research Program; Augustinus Foundation, Kobmand Kristian Kjaer og hustrus Foundation; Kjaer-Foundation; Dagmar Marshalls Foundation; Snedkermester Sophus Jacobsen og Hustru Astrid Jacobsens Foundation; Grosserer Valdemar Foersom og Hustru Thyra Foersoms Foundation; Fabrikant Einar Willumsens Mindelegat; Sao Paulo Research Foundation (FAPESP); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [ZIADE000558, ZIADE000551, ZIADE000699] Funding Source: NIH RePORTER	NIDCR Intramural Research Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); Augustinus Foundation, Kobmand Kristian Kjaer og hustrus Foundation; Kjaer-Foundation; Dagmar Marshalls Foundation; Snedkermester Sophus Jacobsen og Hustru Astrid Jacobsens Foundation; Grosserer Valdemar Foersom og Hustru Thyra Foersoms Foundation; Fabrikant Einar Willumsens Mindelegat; Sao Paulo Research Foundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	We thank Dr Mary Jo Danton for critically reviewing this manuscript. Histology was performed by Histoserv, Germantown, MD, USA. We thank Dr Allessia Gallo, Shyh-Ing Jang, Colleen Doci, Patricia Pilla, Zhiyong Wang, Canstantinos Mikelis, Ramiro Iglesias-Bartolome and Morgan O'Hare for technical assistance. The study was supported by the NIDCR Intramural Research Program (THB, JSG, WC), the Augustinus Foundation, Kobmand Kristian Kjaer og hustrus Foundation, the Kjaer-Foundation, the Dagmar Marshalls Foundation, the Snedkermester Sophus Jacobsen og Hustru Astrid Jacobsens Foundation, the Grosserer Valdemar Foersom og Hustru Thyra Foersoms Foundation and Fabrikant Einar Willumsens Mindelegat (SG and LKV), and the Sao Paulo Research Foundation (FAPESP) (MH, SRR).	Benaud C, 2002, J BIOL CHEM, V277, P10539, DOI 10.1074/jbc.M109064200; Bocheva G, 2009, J INVEST DERMATOL, V129, P1816, DOI 10.1038/jid.2008.449; Briot A, 2009, J EXP MED, V206, P1135, DOI 10.1084/jem.20082242; Buddenkotte J, 2005, J INVEST DERMATOL, V124, P38, DOI 10.1111/j.0022-202X.2004.23539.x; Bugge TH, 2009, J BIOL CHEM, V284, P23177, DOI 10.1074/jbc.R109.021006; Camerer E, 2000, P NATL ACAD SCI USA, V97, P5255, DOI 10.1073/pnas.97.10.5255; Camerer E, 1996, J BIOL CHEM, V271, P29034, DOI 10.1074/jbc.271.46.29034; Camerer E, 2002, J BIOL CHEM, V277, P16081, DOI 10.1074/jbc.M108555200; Camerer E, 2010, DEV CELL, V18, P25, DOI 10.1016/j.devcel.2009.11.014; Cataisson C, 2012, J EXP MED, V209, P1689, DOI 10.1084/jem.20101355; Chokki M, 2004, AM J RESP CELL MOL, V30, P470, DOI 10.1165/rcmb.2003-0199OC; Coughlin SR, 2003, J CLIN INVEST, V111, P25, DOI 10.1172/JCI200317564; Frateschi S, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1162; Friis S, 2013, J BIOL CHEM, V288, P19028, DOI 10.1074/jbc.M113.469932; Hoang CD, 2004, CHEST, V125, P1843, DOI 10.1378/chest.125.5.1843; Hou L, 1998, IMMUNOLOGY, V94, P356, DOI 10.1046/j.1365-2567.1998.00528.x; Jin JS, 2006, MODERN PATHOL, V19, P447, DOI 10.1038/modpathol.3800495; Jin JS, 2006, INT J SURG PATHOL, V14, P65, DOI 10.1177/106689690601400111; Johnson MD, 2003, EXPERT REV MOL DIAGN, V3, P331, DOI 10.1586/14737159.3.3.331; Kang JY, 2003, CANCER RES, V63, P1101; Kanke T, 2001, J BIOL CHEM, V276, P31657, DOI 10.1074/jbc.M100377200; Kaufmann R, 2009, CARCINOGENESIS, V30, P1487, DOI 10.1093/carcin/bgp153; LeBeau AM, 2013, P NATL ACAD SCI USA, V110, P93, DOI 10.1073/pnas.1218694110; Lee JW, 2005, HUM PATHOL, V36, P626, DOI 10.1016/j.humpath.2005.03.003; Lindner JR, 2000, J IMMUNOL, V165, P6504, DOI 10.4049/jimmunol.165.11.6504; List K, 2006, AM J PATHOL, V168, P1513, DOI 10.2353/ajpath.2006.051071; List K, 2005, GENE DEV, V19, P1934, DOI 10.1101/gad.1300705; List K, 2009, FUTURE ONCOL, V5, P97, DOI 10.2217/14796694.5.1.97; Lopez-Otin C, 2010, NAT REV CANCER, V10, P278, DOI 10.1038/nrc2823; Molino M, 1997, J BIOL CHEM, V272, P4043, DOI 10.1074/jbc.272.7.4043; NYSTEDT S, 1994, P NATL ACAD SCI USA, V91, P9208, DOI 10.1073/pnas.91.20.9208; Oberst M, 2001, AM J PATHOL, V158, P1301, DOI 10.1016/S0002-9440(10)64081-3; Oberst MD, 2002, CLIN CANCER RES, V8, P1101; Oikonomopoulou K, 2006, J BIOL CHEM, V281, P32095, DOI 10.1074/jbc.M513138200; Perez-Moreno M, 2006, CELL, V124, P631, DOI 10.1016/j.cell.2005.11.043; Ramsay AJ, 2008, J BIOL CHEM, V283, P12293, DOI 10.1074/jbc.M709493200; Rothmeier AS, SEMIN IMMUNOPATHOL, V34, P133; SANTULLI RJ, 1995, P NATL ACAD SCI USA, V92, P9151, DOI 10.1073/pnas.92.20.9151; Schaffner F, 2008, SEMIN THROMB HEMOST, V34, P147, DOI 10.1055/s-2008-1079254; Schmidlin F, 2002, J IMMUNOL, V169, P5315, DOI 10.4049/jimmunol.169.9.5315; Scott G, 2004, J INVEST DERMATOL, V122, P1214, DOI 10.1111/j.0022-202X.2004.22516.x; Scott G, 2003, J INVEST DERMATOL, V121, P529, DOI 10.1046/j.1523-1747.2003.12427.x; Seitz I, 2007, ARTERIOSCL THROM VAS, V27, P769, DOI 10.1161/01.ATV.0000258862.61067.14; Szabo R, 2011, ONCOGENE, V30, P2003, DOI 10.1038/onc.2010.586; Szabo R, 2008, J BIOL CHEM, V283, P29495, DOI 10.1074/jbc.M801970200; Szabo R, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002937; Takeuchi T, 2000, J BIOL CHEM, V275, P26333, DOI 10.1074/jbc.M002941200; Tanimoto H, 2005, BRIT J CANCER, V92, P278, DOI 10.1038/sj.bjc.6602320; Vogel LK, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-176; Wakita H, 1997, P ASSOC AM PHYSICIAN, V109, P190; Wilson S, 2005, BIOCHEM J, V388, P967, DOI 10.1042/BJ20041066	51	37	38	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 15	2015	34	3					288	298		10.1038/onc.2013.563	http://dx.doi.org/10.1038/onc.2013.563			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AZ3RY	24469043	Green Accepted			2022-12-25	WOS:000348145500003
J	Betts, DH; Bain, NT; Madan, P				Betts, Dean H.; Bain, Nathan T.; Madan, Pavneesh			The p66(Shc) Adaptor Protein Controls Oxidative Stress Response in Early Bovine Embryos	PLOS ONE			English	Article							FORKHEAD TRANSCRIPTION FACTORS; IN-VITRO FERTILIZATION; PREIMPLANTATION EMBRYO; LIFE-SPAN; OXYGEN CONCENTRATION; SIGNALING PATHWAY; DEVELOPMENTAL COMPETENCE; SUPEROXIDE-DISMUTASE; RNA INTERFERENCE; CELL-DEATH	The in vitro production of mammalian embryos suffers from high frequencies of developmental failure due to excessive levels of permanent embryo arrest and apoptosis caused by oxidative stress. The p66Shc stress adaptor protein controls oxidative stress response of somatic cells by regulating intracellular ROS levels through multiple pathways, including mitochondrial ROS generation and the repression of antioxidant gene expression. We have previously demonstrated a strong relationship with elevated p66Shc levels, reduced antioxidant levels and greater intracellular ROS generation with the high incidence of permanent cell cycle arrest of 2-4 cell embryos cultured under high oxygen tensions or after oxidant treatment. The main objective of this study was to establish a functional role for p66Shc in regulating the oxidative stress response during early embryo development. Using RNA interference in bovine zygotes we show that p66Shc knockdown embryos exhibited increased MnSOD levels, reduced intracellular ROS and DNA damage that resulted in a greater propensity for development to the blastocyst stage. P66Shc knockdown embryos were stress resistant exhibiting significantly reduced intracellular ROS levels, DNA damage, permanent 2-4 cell embryo arrest and diminished apoptosis frequencies after oxidant treatment. The results of this study demonstrate that p66Shc controls the oxidative stress response in early mammalian embryos. Small molecule inhibition of p66Shc may be a viable clinical therapy to increase the developmental potential of in vitro produced mammalian embryos.	[Betts, Dean H.; Bain, Nathan T.; Madan, Pavneesh] Univ Guelph, Ontario Vet Coll, Dept Biomed Sci, Guelph, ON N1G 2W1, Canada; [Betts, Dean H.] Lawson Hlth Res Inst, Childrens Hlth Res Inst, London, ON, Canada	University of Guelph; Western University (University of Western Ontario)	Betts, DH (corresponding author), Univ Western Ontario, Dept Physiol & Pharmacol, Schulich Sch Med & Dent, London, ON, Canada.	dean.betts@schulich.uwo.ca	Betts, Dean H/B-7414-2015	Betts, Dean H/0000-0002-5528-9142	Canadian Institutes of Health Research (CIHR) [MOP-86453]; Natural Sciences and Engineering Research Council of Canada (NSERC) [250191-2007]; Ontario Ministry of Agriculture, Food and Rural Affairs (OMAFRA)	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Ontario Ministry of Agriculture, Food and Rural Affairs (OMAFRA)	This research was supported by a grant to DHB and PM from the Canadian Institutes of Health Research (CIHR; MOP-86453), and grants from the Natural Sciences and Engineering Research Council of Canada (NSERC; 250191-2007) and the Ontario Ministry of Agriculture, Food and Rural Affairs (OMAFRA) to DHB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal A, 2004, REPROD BIOMED ONLINE, V9, P338, DOI 10.1016/S1472-6483(10)62151-7; Anckaert E, 2013, HUM REPROD UPDATE, V19, P52, DOI 10.1093/humupd/dms042; Bain NT, 2013, MOL REPROD DEV, V80, P22, DOI 10.1002/mrd.22128; Bain NT, 2011, REPROD FERT DEVELOP, V23, P561, DOI 10.1071/RD10148; Betts DH, 2008, MOL HUM REPROD, V14, P445, DOI 10.1093/molehr/gan035; Betts DH, 2001, THERIOGENOLOGY, V55, P171, DOI 10.1016/S0093-691X(00)00453-2; Carlsson P, 2002, DEV BIOL, V250, P1, DOI 10.1006/dbio.2002.0780; Carpi A, 2009, BBA-BIOENERGETICS, V1787, P774, DOI 10.1016/j.bbabio.2009.04.001; Chauhan MS, 1999, J DAIRY SCI, V82, P918, DOI 10.3168/jds.S0022-0302(99)75310-5; Clarke GN, 2006, HUM REPROD, V21, P1645, DOI 10.1093/humrep/del067; DeYulia GJ, 2005, BIOCHEM BIOPH RES CO, V334, P38, DOI 10.1016/j.bbrc.2005.06.056; Dumoulin JCM, 1999, HUM REPROD, V14, P465, DOI 10.1093/humrep/14.2.465; European Society of Human Reproduction and Embryology, 2012, SCIENCEDAILY; Faisal A, 2002, J BIOL CHEM, V277, P30144, DOI 10.1074/jbc.M203229200; Favetta LA, 2004, MOL HUM REPROD, V10, P383, DOI 10.1093/molehr/gah057; Favetta LA, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-132; Favetta LA, 2007, FREE RADICAL BIO MED, V42, P1201, DOI 10.1016/j.freeradbiomed.2007.01.018; Feugang JM, 2004, THERIOGENOLOGY, V61, P71, DOI 10.1016/S0093-691X(03)00191-2; Francia P, 2004, CIRCULATION, V110, P2889, DOI 10.1161/01.CIR.0000147731.24444.4D; Francia P, 2009, J MOL MED, V87, P885, DOI 10.1007/s00109-009-0499-3; Galan A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062135; Gertz M, 2008, P NATL ACAD SCI USA, V105, P5705, DOI 10.1073/pnas.0800691105; Gertz M, 2010, ANTIOXID REDOX SIGN, V13, P1417, DOI 10.1089/ars.2010.3147; Giorgio M, 2005, CELL, V122, P221, DOI 10.1016/j.cell.2005.05.011; Gjorret JO, 2003, BIOL REPROD, V69, P1193, DOI 10.1095/biolreprod.102.013243; Guerin P, 2001, HUM REPROD UPDATE, V7, P175, DOI 10.1093/humupd/7.2.175; Guo JF, 2009, CIRC RES, V104, P660, DOI 10.1161/CIRCRESAHA.108.186288; Hachiya M, 2005, RADIAT RES, V163, P271, DOI 10.1667/RR3306; Haga S, 2008, J HEPATOL, V48, P422, DOI 10.1016/j.jhep.2007.11.018; Hall V, 2013, VET J, V197, P128, DOI 10.1016/j.tvjl.2013.05.026; Hamatani T, 2004, DEV CELL, V6, P117, DOI 10.1016/S1534-5807(03)00373-3; Hardy K, 2001, P NATL ACAD SCI USA, V98, P1655, DOI 10.1073/pnas.98.4.1655; Harvey AJ, 2007, ANIM REPROD SCI, V98, P113, DOI 10.1016/j.anireprosci.2006.10.008; Hashimoto S, 2000, MOL REPROD DEV, V57, P353, DOI 10.1002/1098-2795(200012)57:4&lt;353::AID-MRD7&gt;3.0.CO;2-R; Held E, 2012, BIOL REPROD, V87, DOI 10.1095/biolreprod.112.102921; Jurisicova A, 2004, REPRODUCTION, V128, P281, DOI 10.1530/rep.1.00241; Keefe DL, 2005, AM J OBSTET GYNECOL, V192, P1256, DOI 10.1016/j.ajog.2005.01.036; Keskintepe L, 1996, BIOL REPROD, V55, P333, DOI 10.1095/biolreprod55.2.333; Khanday FA, 2006, MOL BIOL CELL, V17, P122, DOI 10.1091/mbc.e05-06-0570; Khvorova A, 2003, CELL, V115, P209, DOI 10.1016/S0092-8674(03)00801-8; Kovacic B, 2008, REPROD BIOMED ONLINE, V17, P229, DOI 10.1016/S1472-6483(10)60199-X; Lai KMV, 2000, GENE DEV, V14, P1132; Le S, 2001, J BIOL CHEM, V276, P48332, DOI 10.1074/jbc.M106612200; Lebiedzinska Magdalena, 2010, Postepy Biochem, V56, P165; Leidenfrost S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022121; Luzi L, 2000, CURR OPIN GENET DEV, V10, P668, DOI 10.1016/S0959-437X(00)00146-5; Madan P, 2011, COMPREHENSIVE BIOTECHNOLOGY, VOL 4: AGRICULTURAL AND RELATED BIOTECHNOLOGIES, 2ND EDITION, P469; Marteil G, 2009, REPROD BIOL, V9, P203, DOI 10.1016/S1642-431X(12)60027-8; Matwee C, 2000, ZYGOTE, V8, P57, DOI 10.1017/S0967199400000836; Migliaccio E, 1997, EMBO J, V16, P706, DOI 10.1093/emboj/16.4.706; Migliaccio E, 1999, NATURE, V402, P309, DOI 10.1038/46311; Migliaccio E, 2006, ANTIOXID REDOX SIGN, V8, P600, DOI 10.1089/ars.2006.8.600; Morris KV, 2008, CURR TOP MICROBIOL, V320, P211; Munne S, 2006, REPROD BIOMED ONLINE, V12, P234, DOI 10.1016/S1472-6483(10)60866-8; NAGAO Y, 1994, THERIOGENOLOGY, V41, P681, DOI 10.1016/0093-691X(94)90177-K; Napoli C, 2003, P NATL ACAD SCI USA, V100, P2112, DOI 10.1073/pnas.0336359100; Natalicchio A, 2004, J BIOL CHEM, V279, P43900, DOI 10.1074/jbc.M403936200; Natalicchio Annalisa, 2011, Archives of Physiology and Biochemistry, V117, P116, DOI 10.3109/13813455.2011.562513; Natalicchio A, 2009, AM J PHYSIOL-ENDOC M, V296, pE228, DOI 10.1152/ajpendo.90347.2008; Nemoto S, 2006, J BIOL CHEM, V281, P10555, DOI 10.1074/jbc.M511626200; Nemoto S, 2002, SCIENCE, V295, P2450, DOI 10.1126/science.1069004; Okada S, 1997, J BIOL CHEM, V272, P28042, DOI 10.1074/jbc.272.44.28042; Orsi NM, 2001, MOL REPROD DEV, V59, P44, DOI 10.1002/mrd.1006; Pani G, 2011, ANTIOXID REDOX SIGN, V15, P1715, DOI 10.1089/ars.2010.3499; Pani G, 2009, INT J BIOCHEM CELL B, V41, P1002, DOI 10.1016/j.biocel.2008.10.011; Paradis F, 2005, MOL REPROD DEV, V70, P111, DOI 10.1002/mrd.20193; PARRISH JJ, 1988, BIOL REPROD, V38, P1171, DOI 10.1095/biolreprod38.5.1171; Pinton P, 2007, SCIENCE, V315, P659, DOI 10.1126/science.1135380; Purdom S, 2003, BIOGERONTOLOGY, V4, P181, DOI 10.1023/A:1025123413403; Reynolds A, 2004, NAT BIOTECHNOL, V22, P326, DOI 10.1038/nbt936; Robert C, 2002, BIOL REPROD, V67, P1465, DOI 10.1095/biolreprod.102.006320; Rodriguez-Martinez H, 2012, REPROD DOMEST ANIM, V47, P21, DOI 10.1111/j.1439-0531.2011.01961.x; Schwarz DS, 2003, CELL, V115, P199, DOI 10.1016/S0092-8674(03)00759-1; Sen GL, 2006, FASEB J, V20, P1293, DOI 10.1096/fj.06-6014rev; Sokal R. R., 2012, BIOMETRY; Souza JM, 2013, ANIM REPROD SCI; STEINBRECHER UP, 1988, BIOCHIM BIOPHYS ACTA, V959, P20, DOI 10.1016/0005-2760(88)90145-2; Stroud B, 2012, YEAR 2011 WORLDWIDE; Thomas MR, 2010, FERTIL STERIL, V94, P543, DOI 10.1016/j.fertnstert.2009.03.051; Trinei M, 2002, ONCOGENE, V21, P3872, DOI 10.1038/sj.onc.1205513; Zhang AJ, 2012, J ASSIST REPROD GEN, V29, P313, DOI 10.1007/s10815-012-9712-3; Zhao J, 2008, CANCER RES, V68, P4133, DOI 10.1158/0008-5472.CAN-08-0432	82	26	30	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2014	9	1							e86978	10.1371/journal.pone.0086978	http://dx.doi.org/10.1371/journal.pone.0086978			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	298QQ	24475205	Green Published, gold, Green Submitted			2022-12-25	WOS:000330339800073
J	Qin, R; Zhou, JX; Chen, C; Xu, T; Yan, Y; Ma, YS; Zheng, ZL; Shen, YP; Lu, YC; Fu, D; Chen, JX				Qin, Rong; Zhou, Jingxu; Chen, Chao; Xu, Tao; Yan, Yong; Ma, Yushui; Zheng, Zongli; Shen, Yiping; Lu, Yicheng; Fu, Da; Chen, Juxiang			LIN28 Is Involved in Glioma Carcinogenesis and Predicts Outcomes of Glioblastoma Multiforme Patients	PLOS ONE			English	Article							HUMAN HEPATOCELLULAR-CARCINOMA; GROWTH-FACTOR RECEPTOR; BINDING PROTEIN LIN28; GERM-CELL TUMORS; PROMOTES TRANSFORMATION; MALIGNANT GLIOMAS; OVARIAN-CANCER; MICRORNA; EXPRESSION; LET-7	LIN28, an evolutionarily conversed RNA binding protein which can bind to the terminal loops of let-7 familymicroRNA precursors and block their processing to maturation, is highly expressed in several subsets of tumors that carry poor prognoses, such as ovarian carcinoma, hepatocellular carcinoma, colon carcinoma and germ cell carcinoma. However, there has been no study on the expression of LIN28 in glioma tissues or their importance as a prognostic predictor of glioma patients. This study aimed to examine the expression of LIN28 in glioma and correlate the results to patient outcome. We found that LIN28 expression was significantly higher in the group of patients with a poor prognosis compared to patients with a good prognosis by gene microarray. Log-rank analysis showed patients with higher LIN28 expression level in tumor had a shorter progression-free survival and overall survival times compared to those with lower LIN28 expression level. Similar results were also obtained from the tissue microarray analysis. Univariate andmultivariate analyses showed high LIN28 expression was an independent prognostic factor for a shorter progression-free survival and overall survival in GBM patients. Furthermore in vitro experiments showed that down-regulation of LIN28 in U251 and U373 cells caused cell cycle arrest in the G1 phase, delayed cell proliferation, increased apoptosis, and resulted in fewer colonies compared to controls. Summarily, our data provides a potential target for cancer therapy as an approach to overcome the poor options currently available for GBM patients.	[Qin, Rong; Chen, Chao; Xu, Tao; Yan, Yong; Lu, Yicheng; Chen, Juxiang] Second Mil Med Univ, Changzheng Hosp, Shanghai Inst Neurosurg, Dept Neurosurg, Shanghai, Peoples R China; [Zhou, Jingxu] PLA, Hosp 101, Dept Neurosurg, Wuxi, Jiangsu, Peoples R China; [Ma, Yushui; Fu, Da] Shanghai Jiao Tong Univ, Key Lab Stem Cell Biol, Inst Hlth Sci, Sch Med, Shanghai 200030, Peoples R China; [Ma, Yushui; Fu, Da] Chinese Acad Sci, Shanghai Inst Biol Sci, Shanghai, Peoples R China; [Zheng, Zongli; Chen, Juxiang] Harvard Univ, Sch Med, Dept Pathol, Massachusetts Gen Hosp, Boston, MA 02115 USA; [Shen, Yiping] Harvard Univ, Sch Med, Dept Lab Med, Childrens Hosp Boston, Boston, MA USA	Naval Medical University; Shanghai Jiao Tong University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Boston Children's Hospital; Harvard Medical School	Fu, D (corresponding author), Shanghai Jiao Tong Univ, Key Lab Stem Cell Biol, Inst Hlth Sci, Sch Med, Shanghai 200030, Peoples R China.	fu800da900@126.com; juxiangchen.cz@gmail.com	ma, yushui/HGC-6206-2022; Fu, Da/GXF-2656-2022; zheng, zongli/C-7309-2008; zheng, zongli/B-2917-2011	zheng, zongli/0000-0003-4849-4903	National Nature Science Foundation of China [81272781, 81201535]; Program for academic leaders in health sciences [XBR2011030]; "Shu Guang" project in Shanghai [11SG37]; Nature Science Foundation of Shanghai [12ZR1436000]; Knowledge Innovation Program of Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences [2012KIP203]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for academic leaders in health sciences; "Shu Guang" project in Shanghai; Nature Science Foundation of Shanghai(Natural Science Foundation of Shanghai); Knowledge Innovation Program of Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences(Knowledge Innovation Program of the Chinese Academy of SciencesChinese Academy of Sciences)	This work was supported by National Nature Science Foundation of China (NO. 81272781, 81201535), Program for academic leaders in health sciences (No. XBR2011030) and "Shu Guang" project (No. 11SG37) in Shanghai, Nature Science Foundation of Shanghai (12ZR1436000) and the Knowledge Innovation Program of Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences (2012KIP203). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2008, NATURE, V455, P1061; Boominathan L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010615; Cao DF, 2011, HUM PATHOL, V42, P710, DOI 10.1016/j.humpath.2010.09.007; Cao DF, 2011, MODERN PATHOL, V24, P288, DOI 10.1038/modpathol.2010.195; Chi AS, 2007, EXPERT OPIN THER TAR, V11, P473, DOI 10.1517/14728222.11.4.473; Dahiya N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002436; Guo YQ, 2006, GENE, V384, P51, DOI 10.1016/j.gene.2006.07.011; Hagan JP, 2009, NAT STRUCT MOL BIOL, V16, P1021, DOI 10.1038/nsmb.1676; Hagerstrand D, 2011, NEURO-ONCOLOGY, V13, P1178, DOI 10.1093/neuonc/nor113; Heo I, 2008, MOL CELL, V32, P276, DOI 10.1016/j.molcel.2008.09.014; Johnson SM, 2005, CELL, V120, P635, DOI 10.1016/j.cell.2005.01.014; King CE, 2011, CANCER RES, V71, P4260, DOI 10.1158/0008-5472.CAN-10-4637; Kononen J, 1998, NAT MED, V4, P844, DOI 10.1038/nm0798-844; Kumar MS, 2007, NAT GENET, V39, P673, DOI 10.1038/ng2003; Lee ST, 2011, J NEURO-ONCOL, V102, P19, DOI 10.1007/s11060-010-0286-6; Lu LG, 2009, EUR J CANCER, V45, P2212, DOI 10.1016/j.ejca.2009.05.003; Mayr C, 2007, SCIENCE, V315, P1576, DOI 10.1126/science.1137999; Moss EG, 2003, DEV BIOL, V258, P432, DOI 10.1016/S0012-1606(03)00126-X; Moss EG, 1997, CELL, V88, P637, DOI 10.1016/S0092-8674(00)81906-6; Nicholas MK, 2006, CLIN CANCER RES, V12, P7261, DOI 10.1158/1078-0432.CCR-06-0874; Oh JS, 2010, INT J RADIAT ONCOL, V76, P5, DOI 10.1016/j.ijrobp.2009.08.028; Peng S, 2010, ONCOGENE, V29, P2153, DOI 10.1038/onc.2009.500; Saiki Y, 2009, ANN SURG ONCOL, V16, P2638, DOI 10.1245/s10434-009-0567-5; Sathornsumetee S, 2007, CANCER-AM CANCER SOC, V110, P13, DOI 10.1002/cncr.22741; Van Meir EG, 2010, CA-CANCER J CLIN, V60, P166, DOI 10.3322/caac.20069; Viswanathan SR, 2008, SCIENCE, V320, P97, DOI 10.1126/science.1154040; Viswanathan SR, 2009, NAT GENET, V41, P843, DOI 10.1038/ng.392; Wang YC, 2010, CARCINOGENESIS, V31, P1516, DOI 10.1093/carcin/bgq107; Wen PY, 2008, NEW ENGL J MED, V359, P492, DOI 10.1056/NEJMra0708126; West JA, 2009, NATURE, V460, P909, DOI 10.1038/nature08210; Xu BS, 2009, RNA, V15, P357, DOI 10.1261/rna.1368009; Yu F, 2007, CELL, V131, P1109, DOI 10.1016/j.cell.2007.10.054; Zhao TBA, 2010, TRENDS CELL BIOL, V20, P170, DOI 10.1016/j.tcb.2009.12.004; Zhou YH, 2003, CLIN CANCER RES, V9, P3369	34	31	34	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2014	9	1							e86446	10.1371/journal.pone.0086446	http://dx.doi.org/10.1371/journal.pone.0086446			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	298QQ	24475120	gold, Green Published, Green Submitted			2022-12-25	WOS:000330339800044
J	Suyama, K; Watanabe, M; Sakabe, K; Otomo, A; Okada, Y; Terayama, H; Imai, T; Mochida, J				Suyama, Kaori; Watanabe, Masahiko; Sakabe, Kou; Otomo, Asako; Okada, Yoshinori; Terayama, Hayato; Imai, Takeshi; Mochida, Joji			GRP78 Suppresses Lipid Peroxidation and Promotes Cellular Antioxidant Levels in Glial Cells following Hydrogen Peroxide Exposure	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; SPINAL-CORD-INJURY; UNFOLDED PROTEIN RESPONSE; CENTRAL-NERVOUS-SYSTEM; OXIDATIVE STRESS; NEUROBLASTOMA-CELLS; EPITHELIAL-CELLS; INDUCTION; NQO1; GLUTATHIONE	Oxidative stress, caused by the over production of reactive oxygen species (ROS), has been shown to contribute to cell damage associated with neurotrauma and neurodegenerative diseases. ROS mediates cell damage either through direct oxidation of lipids, proteins and DNA or by acting as signaling molecules to trigger cellular apoptotic pathways. The 78 kDa glucose-regulated protein (GRP78) is an ER chaperone that has been suggested to protect cells against ROS-induced damage. However, the protective mechanism of GRP78 remains unclear. In this study, we used C6 glioma cells transiently overexpressing GRP78 to investigate the protective effect of GRP78 against oxidative stress (hydrogen peroxide)-induced injury. Our results showed that the overexpression of GRP78 significantly protected cells from ROS-induced cell damage when compared to non-GRP78 overexpressing cells, which was most likely due to GRP78-overexpressing cells having higher levels of glutathione (GSH) and NAD(P)H:quinone oxidoreductase 1 (NQO1), two antioxidants that protect cells against oxidative stress. Although hydrogen peroxide treatment increased lipid peroxidation in non-GRP78 overexpressing cells, this increase was significantly reduced in GRP78-overexpressing cells. Overall, these results indicate that GRP78 plays an important role in protecting glial cells against oxidative stress via regulating the expression of GSH and NQO1.	[Suyama, Kaori; Sakabe, Kou; Terayama, Hayato] Tokai Univ, Sch Med, Dept Anat & Cellular Biol, Isehara, Kanagawa 25911, Japan; [Watanabe, Masahiko; Imai, Takeshi; Mochida, Joji] Tokai Univ, Sch Med, Dept Orthoped Surg, Isehara, Kanagawa 25911, Japan; [Otomo, Asako] Tokai Univ, Sch Med, Dept Mol Life Sci, Isehara, Kanagawa 25911, Japan; [Okada, Yoshinori] Tokai Univ, Teaching & Res Support Ctr, Isehara, Kanagawa, Japan	Tokai University; Tokai University; Tokai University; Tokai University	Watanabe, M (corresponding author), Tokai Univ, Sch Med, Dept Orthoped Surg, Isehara, Kanagawa 25911, Japan.	masahiko@is.icc.u-tokai.ac.jp	Otomo, Asako/AAA-6374-2019	Otomo, Asako/0000-0002-7849-4309	Research and Study Program of Tokai University Educational System General Research Organization; Tokai University School of Medicine Research Aid; Grants-in-Aid for Scientific Research [26460809, 25830040] Funding Source: KAKEN	Research and Study Program of Tokai University Educational System General Research Organization; Tokai University School of Medicine Research Aid; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported in part by the Research and Study Program of Tokai University Educational System General Research Organization and 2012 Tokai University School of Medicine Research Aid. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aragno M, 2000, DIABETES, V49, P1924, DOI 10.2337/diabetes.49.11.1924; Bao F, 2004, NEUROSCIENCE, V126, P285, DOI 10.1016/j.neuroscience.2004.03.054; Bar-Am O, 2009, J MOL NEUROSCI, V37, P135, DOI 10.1007/s12031-008-9139-6; Bhandary B, 2013, INT J MOL SCI, V14, P434, DOI 10.3390/ijms14010434; Chakravarthi S, 2006, EMBO REP, V7, P271, DOI 10.1038/sj.embor.7400645; Dinkova-Kostova AT, 2010, ARCH BIOCHEM BIOPHYS, V501, P116, DOI 10.1016/j.abb.2010.03.019; Elmann A, 2012, OXID MED CELL LONGEV, V2012, DOI 10.1155/2012/157598; GOMER CJ, 1991, CANCER RES, V51, P6574; Grant CM, 1998, BIOCHEM BIOPH RES CO, V253, P893, DOI 10.1006/bbrc.1998.9864; Hall ED, 2011, NEUROTHERAPEUTICS, V8, P152, DOI 10.1007/s13311-011-0026-4; HALLIWELL B, 1992, J NEUROCHEM, V59, P1609, DOI 10.1111/j.1471-4159.1992.tb10990.x; He SK, 2008, GRAEF ARCH CLIN EXP, V246, P677, DOI 10.1007/s00417-008-0770-2; HEDLEY D, 1992, CYTOMETRY, V13, P686, DOI 10.1002/cyto.990130704; Higo T, 2010, NEURON, V68, P865, DOI 10.1016/j.neuron.2010.11.010; Jia Z, 2012, SPINAL CORD, V50, P264, DOI 10.1038/sc.2011.111; Jia ZQ, 2008, BRAIN RES, V1197, P159, DOI 10.1016/j.brainres.2007.12.044; KOZUTSUMI Y, 1988, NATURE, V332, P462, DOI 10.1038/332462a0; Larner SF, 2006, J NEUROTRAUM, V23, P807, DOI 10.1089/neu.2006.23.807; Lim JH, 2008, PHARMACOL RES, V57, P325, DOI 10.1016/j.phrs.2008.03.004; Liu DX, 1999, FREE RADICAL BIO MED, V27, P478, DOI 10.1016/S0891-5849(99)00073-8; Long DJ, 2002, CANCER RES, V62, P3030; Lucas JH, 2002, J NEUROTRAUM, V19, P763, DOI 10.1089/08977150260139138; Mohammad MK, 2012, TOXICOL APPL PHARM, V265, P73, DOI 10.1016/j.taap.2012.09.021; Ni M, 2007, FEBS LETT, V581, P3641, DOI 10.1016/j.febslet.2007.04.045; Oyadomari S, 2004, CELL DEATH DIFFER, V11, P381, DOI 10.1038/sj.cdd.4401373; Penas C, 2007, J NEUROCHEM, V102, P1242, DOI 10.1111/j.1471-4159.2007.04671.x; Ross D, 2000, CHEM-BIOL INTERACT, V129, P77, DOI 10.1016/S0009-2797(00)00199-X; SCHMIDLEY JW, 1990, STROKE, V21, P1086, DOI 10.1161/01.STR.21.7.1086; Suyama K, 2011, NEUROSCI LETT, V504, P271, DOI 10.1016/j.neulet.2011.09.045; Tiffany-Castiglioni E, 2012, NEUROTOXICOLOGY, V33, P545, DOI 10.1016/j.neuro.2012.02.007; Timblin CR, 1998, FREE RADICAL BIO MED, V24, P632, DOI 10.1016/S0891-5849(97)00325-0; Vladykovskaya E, 2012, J BIOL CHEM, V287, P11398, DOI 10.1074/jbc.M111.320416; Yen CC, 2011, ARCH TOXICOL, V85, P565, DOI 10.1007/s00204-011-0709-y; Yokouchi M, 2008, J BIOL CHEM, V283, P4252, DOI 10.1074/jbc.M705951200; Yoshida T, 2008, CANCER CHEMOTH PHARM, V61, P559, DOI 10.1007/s00280-007-0503-y; Yu ZF, 1999, EXP NEUROL, V155, P302, DOI 10.1006/exnr.1998.7002; Zhu DH, 2005, J CELL SCI, V118, P3695, DOI 10.1242/jcs.02507	37	20	23	3	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2014	9	1							e86951	10.1371/journal.pone.0086951	http://dx.doi.org/10.1371/journal.pone.0086951			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	298QQ	24475200	gold, Green Published, Green Submitted			2022-12-25	WOS:000330339800071
J	Tun, HM; Mauroo, NF; Yuen, CS; Ho, JCW; Wong, MT; Leung, FCC				Tun, Hein Min; Mauroo, Nathalie France; Yuen, Chan San; Ho, John Chi Wang; Wong, Mabel Ting; Leung, Frederick Chi-Ching			Microbial Diversity and Evidence of Novel Homoacetogens in the Gut of Both Geriatric and Adult Giant Pandas (Ailuropoda melanoleuca)	PLOS ONE			English	Article							EUKARYOTIC DIVERSITY; FECAL FLORA; GENE; SEQUENCES; POPULATIONS; COMMUNITY; REVEAL; BAMBOO; FUNGI; RUMEN	Recent studies have described the bacterial community residing in the guts of giant pandas, together with the presence of lignocellulolytic enzymes. However, a more comprehensive understanding of the intestinal microbial composition and its functional capacity in giant pandas remains a major goal. Here, we conducted a comparison of bacterial, fungal and homoacetogenic microbial communities from fecal samples taken from two geriatric and two adult captive giant pandas. 16S rDNA amplicon pyrosequencing revealed that Firmicutes and Proteobacteria are the most abundant microbiota in both geriatric and adult giant pandas. However, members of phylum Actinobacteria found in adult giant pandas were absent in their geriatric counterparts. Similarly, ITS1 amplicon pyrosequencing identified developmental changes in the most abundant fungal classes from Sordariomycetes in adult pandas to Saccharomycetes in geriatric pandas. Geriatric pandas exhibited significantly higher abundance of a potential probiotic fungus (Candida tropicalis) as compared to adult pandas, indicating their importance in the normal digestive physiology of aged pandas. Our study also reported the presence of a lignocellulolytic white-rot fungus, Perenniporia medulla-panis, and the evidence of novel homoacetogens residing in the guts of giant pandas.	[Tun, Hein Min; Ho, John Chi Wang; Wong, Mabel Ting; Leung, Frederick Chi-Ching] Univ Hong Kong, Sch Biol Sci, Hong Kong, Hong Kong, Peoples R China; [Mauroo, Nathalie France] Univ Hong Kong, Dept Pathol, Hong Kong, Hong Kong, Peoples R China; [Yuen, Chan San] Ocean Pk Corp, Clin Lab, Vet Ctr, Hong Kong, Hong Kong, Peoples R China; [Mauroo, Nathalie France] Hong Kong Wildlife Hlth Fdn, Hong Kong, Hong Kong, Peoples R China; [Leung, Frederick Chi-Ching] Nanjing Agr Univ, Bioinformat Ctr, Nanjing, Jiangsu, Peoples R China	University of Hong Kong; University of Hong Kong; Nanjing Agricultural University	Leung, FCC (corresponding author), Univ Hong Kong, Sch Biol Sci, Hong Kong, Hong Kong, Peoples R China.	fcleung@hkucc.hku.hk	Tun, Hein/ACR-0815-2022; Tun, Hein Min/F-4150-2011	Tun, Hein/0000-0001-7597-5062; Tun, Hein Min/0000-0001-7597-5062; Mauroo, Nathalie/0000-0002-0311-9897	Initiative on Clean Energy and Environment, The University of Hong Kong (HKU-ICEE); Bioinformatics Center fund from Nanjing Agricultural University	Initiative on Clean Energy and Environment, The University of Hong Kong (HKU-ICEE); Bioinformatics Center fund from Nanjing Agricultural University	This study was partially supported by the Initiative on Clean Energy and Environment, The University of Hong Kong (HKU-ICEE) and a Bioinformatics Center fund from Nanjing Agricultural University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039331; BENNO Y, 1989, APPL ENVIRON MICROB, V55, P1100, DOI 10.1128/AEM.55.5.1100-1105.1989; Biagi E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010667; Buee M, 2009, NEW PHYTOL, V184, P449, DOI 10.1111/j.1469-8137.2009.03003.x; Burland T G, 2000, Methods Mol Biol, V132, P71; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Chi ZM, 2010, APPL MICROBIOL BIOT, V86, P1227, DOI 10.1007/s00253-010-2483-9; Claesson MJ, 2012, NATURE, V488, P178, DOI 10.1038/nature11319; Claesson MJ, 2011, P NATL ACAD SCI USA, V108, P4586, DOI 10.1073/pnas.1000097107; Colwell RK, 2012, J PLANT ECOL, V5, P3, DOI 10.1093/jpe/rtr044; DIERENFELD ES, 1982, J NUTR, V112, P636, DOI 10.1093/jn/112.4.636; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Fang W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050312; Frank DN, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-362; Gadanho M, 2003, ANTON LEEUW INT J G, V84, P217, DOI 10.1023/A:1026038213195; Gagen EJ, 2010, APPL ENVIRON MICROB, V76, P7785, DOI 10.1128/AEM.01679-10; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Hansen RL, 2010, ZOO BIOL, V29, P470, DOI 10.1002/zoo.20280; Henderson G, 2010, APPL ENVIRON MICROB, V76, P2058, DOI 10.1128/AEM.02580-09; HIRAYAMA K, 1989, J APPL BACTERIOL, V67, P411, DOI 10.1111/j.1365-2672.1989.tb02511.x; HOLDEMAN LV, 1976, APPL ENVIRON MICROB, V31, P359, DOI 10.1128/AEM.31.3.359-375.1976; Huber T, 2004, BIOINFORMATICS, V20, P2317, DOI 10.1093/bioinformatics/bth226; Janssen DL, 2006, GIANT PANDAS: BIOLOGY, VETERINARY MEDICINE AND MANAGEMENT, P353, DOI 10.1017/CBO9780511542244.016; LAMOT E, 1976, Z ALLG MIKROBIOL, V16, P345, DOI 10.1002/jobm.3630160503; Leaphart AB, 2001, APPL ENVIRON MICROB, V67, P1392, DOI 10.1128/AEM.67.3.1392-1395.2001; Li RQ, 2010, NATURE, V463, P311, DOI 10.1038/nature08696; LJUNGDAHL LG, 1986, ANNU REV MICROBIOL, V40, P415, DOI 10.1146/annurev.mi.40.100186.002215; Lopez-Garcia P, 2007, ENVIRON MICROBIOL, V9, P546, DOI 10.1111/j.1462-2920.2006.01158.x; Loucks Colby, 2004, P149; MAINKA SA, 1994, ZOO BIOL, V13, P13, DOI 10.1002/zoo.1430130104; Matsui H, 2011, CURR MICROBIOL, V62, P1, DOI 10.1007/s00284-010-9661-y; Muegge BD, 2011, SCIENCE, V332, P970, DOI 10.1126/science.1198719; Munoz P, 2011, CLIN MICROBIOL INFEC, V17, P1538, DOI 10.1111/j.1469-0691.2010.03338.x; Nilsson RH, 2009, SOURCE CODE BIOL MED, V4, DOI 10.1186/1751-0473-4-1; Ottesen EA, 2011, APPL ENVIRON MICROB, V77, P3461, DOI 10.1128/AEM.02657-10; Ottesen EA, 2010, APPL ENVIRON MICROB, V76, P4909, DOI 10.1128/AEM.00299-10; Pankratov T A, 2006, Dokl Biol Sci, V410, P428, DOI 10.1134/S0012496606050243; Pointing SB, 2005, MYCOL RES, V109, P115, DOI 10.1017/S0953756204001376; Quince C, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-38; Sadhu S, 2011, CURR MICROBIOL, V62, P1050, DOI 10.1007/s00284-010-9816-x; Scanlan PD, 2008, ISME J, V2, P1183, DOI 10.1038/ismej.2008.76; Scott KP, 2012, PHARM RES; Swaisgood RR, 2011, INTEGR ZOOL, V6, P290, DOI 10.1111/j.1749-4877.2011.00250.x; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tedersoo L, 2010, NEW PHYTOL, V188, P291, DOI 10.1111/j.1469-8137.2010.03373.x; Tun HM, 2012, J MICROBIOL METH, V88, P369, DOI 10.1016/j.mimet.2012.01.001; van Elsas JD, 2000, J MICROBIOL METH, V43, P133, DOI 10.1016/S0167-7012(00)00212-8; Visser AA, 2012, MICROB ECOL, V63, P975, DOI 10.1007/s00248-011-9987-4; Wei GF, 2007, MICROB ECOL, V54, P194, DOI 10.1007/s00248-007-9225-2; Williams CL, 2012, J ANIM PHYSL ANIM NU; Woodmansey EJ, 2004, APPL ENVIRON MICROB, V70, P6113, DOI 10.1128/AEM.70.10.6113-6122.2004; Yildirim S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013963; Zhan XJ, 2006, CURR BIOL, V16, pR451, DOI 10.1016/j.cub.2006.05.042; Zhu LF, 2011, P NATL ACAD SCI USA, V108, P17714, DOI 10.1073/pnas.1017956108	54	25	33	0	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2014	9	1							e79902	10.1371/journal.pone.0079902	http://dx.doi.org/10.1371/journal.pone.0079902			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	298QQ	24475017	Green Published, Green Submitted, gold			2022-12-25	WOS:000330339800002
J	Bedal, KB; Grassel, S; Oefner, PJ; Reinders, J; Reichert, TE; Bauer, R				Bedal, Konstanze B.; Graessel, Susanne; Oefner, Peter J.; Reinders, Joerg; Reichert, Torsten E.; Bauer, Richard			Collagen XVI Induces Expression of MMP9 via Modulation of AP-1 Transcription Factors and Facilitates Invasion of Oral Squamous Cell Carcinoma	PLOS ONE			English	Article							HEALTHY TERM; BILIRUBIN; HYPERBILIRUBINEMIA; OXYGENATION; ANTIOXIDANT; APOPTOSIS	Collagen XVI belongs to the family of fibril-associated collagens with interrupted triple helices (FACIT). It is overexpressed during the progression of oral squamous cell carcinoma (OSCC). The present data show a strong collagen XVI-dependent induction of MMP9 and an increase in OSCC cell invasion. We found activated integrin-linked kinase (ILK) in a complex with kindlin-1 and activation of protein kinase B (PKB/Akt) to be responsible for MMP9 induction. Inhibition of the formation of focal adhesions reduced MMP9 expression. Moreover, collagen XVI overexpressing OSCC cell clones (COLXVI cell clones) transfected with vectors containing different MMP9 promoter fragments adjacent to a luciferase reporter revealed an increase in luciferase signal dependent on AP-1 binding sites. Deletion of the AP-1 binding site 98 bp upstream of the reported transcription start site and inhibition of AP-1 with Tanshinone IIA resulted in decreased MMP9 expression. The AP-1 subunit JunB showed differential expression between COLXVI cell clones and mock control cells. Additionally, mass spectrometric analysis of immunoprecipitates revealed that c-Fos interacted strongly with dyskerin in COLXVI cell clones compared to mock controls.	[Bedal, Konstanze B.; Reichert, Torsten E.; Bauer, Richard] Univ Hosp Regensburg, Dept Oral & Maxillofacial Surg, Regensburg, Germany; [Graessel, Susanne] Univ Hosp Regensburg, Dept Orthopaed Surg, Regensburg, Germany; [Bedal, Konstanze B.; Graessel, Susanne; Bauer, Richard] BioPark I, Ctr Med Biotechnol, Regensburg, Germany; [Oefner, Peter J.; Reinders, Joerg] Univ Regensburg, Inst Funct Genom, D-93053 Regensburg, Germany	University of Regensburg; University of Regensburg; University of Regensburg	Bauer, R (corresponding author), Univ Hosp Regensburg, Dept Oral & Maxillofacial Surg, Regensburg, Germany.	richard.bauer@klinik.uni-regensburg.de		Reinders, Joerg/0000-0003-1025-7849	Deutsche Krebshilfe; German Research Foundation [KFO262]; German Research Foundation (DFG)	Deutsche Krebshilfe(Deutsche Krebshilfe); German Research Foundation(German Research Foundation (DFG)); German Research Foundation (DFG)(German Research Foundation (DFG))	This work is funded by Deutsche Krebshilfe to RB and the German Research Foundation (KFO262) to PJO and JR. This work is funded by Deutsche Krebshilfe to RB and the German Research Foundation (KFO262) to PJO and JR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Moreover, this work was supported by the German Research Foundation (DFG) within the funding programme Open Access Publishing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baranano DE, 2002, P NATL ACAD SCI USA, V99, P16093, DOI 10.1073/pnas.252626999; Barone E, 2009, J CELL MOL MED, V13, P2365, DOI 10.1111/j.1582-4934.2009.00680.x; BERGMAN DA, 1994, PEDIATRICS, V94, P558; Bhutani VK, 1999, PEDIATRICS, V103, P6, DOI 10.1542/peds.103.1.6; Brito MA, 2002, CELL BIOL TOXICOL, V18, P181, DOI 10.1023/A:1015563704551; Carter K, 2001, JAMA-J AM MED ASSOC, V286, P299; Chien CT, 2001, J AM SOC NEPHROL, V12, P973, DOI 10.1681/ASN.V125973; Gazzin S, 2011, J MATERN-FETAL NEO M, V24, P154, DOI 10.3109/14767058.2011.607590; Greenberg DA, 2002, P NATL ACAD SCI USA, V99, P15837, DOI 10.1073/PNAS.012685199; Huang HC, 2012, PEDIATR NEONATOL, V53, P354, DOI 10.1016/j.pedneo.2012.08.012; Iuchi Y, 2010, FREE RADICAL BIO MED, V48, P935, DOI 10.1016/j.freeradbiomed.2010.01.012; Johnson LH, 2002, J PEDIATR-US, V140, P396, DOI 10.1067/mpd.2002.123098; Johnson L, 2011, SEMIN PERINATOL, V35, P101, DOI 10.1053/j.semperi.2011.02.003; Maisels MJ, 2008, NEW ENGL J MED, V358, P920, DOI 10.1056/NEJMct0708376; Pearce WJ, 2011, ADV EXP MED BIOL, V701, P225, DOI 10.1007/978-1-4419-7756-4_30; Rao W, 2013, BIOCHEM BIOPH RES CO, V291, P1726; Rodrigues CMP, 2002, HEPATOLOGY, V35, P1186, DOI 10.1053/jhep.2002.32967; Schneider H, 2011, RESP PHYSIOL NEUROBI, V178, P51, DOI 10.1016/j.resp.2011.05.009; STOCKER R, 1987, P NATL ACAD SCI USA, V84, P5918, DOI 10.1073/pnas.84.16.5918; STOCKER R, 1987, SCIENCE, V235, P1043, DOI 10.1126/science.3029864; Yigit S, 1999, ARCH DIS CHILD-FETAL, V80, pF235, DOI 10.1136/fn.80.3.F235	21	28	29	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2014	9	1							e86777	10.1371/journal.pone.0086777	http://dx.doi.org/10.1371/journal.pone.0086777			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297XI	24466237	Green Published, gold			2022-12-25	WOS:000330288000143
J	Bosticardo, M; Musio, S; Fontana, E; Angiari, S; Draghici, E; Constantin, G; Poliani, PL; Pedotti, R; Villa, A				Bosticardo, Marita; Musio, Silvia; Fontana, Elena; Angiari, Stefano; Draghici, Elena; Constantin, Gabriela; Poliani, Pietro L.; Pedotti, Rosetta; Villa, Anna			Development of Central Nervous System Autoimmunity Is Impaired in the Absence of Wiskott-Aldrich Syndrome Protein	PLOS ONE			English	Article							CD8(+) T-CELLS; P-SELECTIN; IN-VITRO; WASP; ANTIGEN; ACTIVATION; MUTATIONS; CYTOKINE; ROLES; EXPRESSION	Wiskott-Aldrich Syndrome protein (WASP) is a key regulator of the actin cytoskeleton in hematopoietic cells. Defective expression of WASP leads to multiple abnormalities in different hematopoietic cells. Despite severe impairment of T cell function, WAS patients exhibit a high prevalence of autoimmune disorders. We attempted to induce EAE, an animal model of organ-specific autoimmunity affecting the CNS that mimics human MS, in Was(-/-) mice. We describe here that Was(-/-) mice are markedly resistant against EAE, showing lower incidence and milder score, reduced CNS inflammation and demyelination as compared to WT mice. Microglia was only poorly activated in Was(-/-) mice. Antigen-induced T-cell proliferation, Th-1 and -17 cytokine production and integrin-dependent adhesion were increased in Was(-/-) mice. However, adoptive transfer of MOG-activated T cells from Was(-/-) mice in WT mice failed to induce EAE. Was(-/-) mice were resistant against EAE also when induced by adoptive transfer of MOG-activated T cells from WT mice. Was(+/-) heterozygous mice developed an intermediate clinical phenotype between WT and Was(-/-) mice, and they displayed a mixed population of WASP-positive and -negative T cells in the periphery but not in their CNS parenchyma, where the large majority of inflammatory cells expressed WASP. In conclusion, in absence of WASP, T-cell responses against a CNS autoantigen are increased, but the ability of autoreactive T cells to induce CNS autoimmunity is impaired, most probably because of an inefficient T-cell transmigration into the CNS and defective CNS resident microglial function.	[Bosticardo, Marita; Draghici, Elena; Villa, Anna] Ist Sci San Raffaele, TIGET, I-20132 Milan, Italy; [Musio, Silvia; Pedotti, Rosetta] Fdn IRCCS Neurol Inst C Besta, Neuroimmunol & Neuromuscular Disorders Unit, Milan, Italy; [Fontana, Elena; Poliani, Pietro L.] Univ Brescia, Pathol Unit, Dept Mol & Translat Med, Brescia, Italy; [Angiari, Stefano; Constantin, Gabriela] Univ Verona, Sect Gen Pathol, Dept Pathol & Diag, I-37100 Verona, Italy; [Villa, Anna] CNR, Ist Ric Genet & Biomed, Milan Unit, I-20133 Milan, Italy	Fondazione Telethon; San Raffaele Telethon Institute For Gene Therapy (Sr-Tiget); Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; University of Brescia; University of Verona; Consiglio Nazionale delle Ricerche (CNR); Istituto di Ricerca Genetica e Biomedica (IRGB-CNR)	Pedotti, R (corresponding author), Fdn IRCCS Neurol Inst C Besta, Neuroimmunol & Neuromuscular Disorders Unit, Milan, Italy.	rpedotti@istituto-besta.it; villa.anna@hsr.it	Bosticardo, Marita/ABA-2688-2021; Musio, Silvia/K-3072-2016; Fontana, Elena/K-3845-2016; POLIANI, Pietro Luigi/E-8145-2010	Bosticardo, Marita/0000-0002-1771-4523; Musio, Silvia/0000-0002-8051-7389; Fontana, Elena/0000-0001-8853-3335; POLIANI, Pietro Luigi/0000-0002-5662-8978; Angiari, Stefano/0000-0003-4434-2224; Constantin, Gabriela/0000-0001-8978-3539; Villa, Anna/0000-0003-4428-9013	Italian Telethon Foundation; AISM-FISM; Ministero della Salute - Grant Giovani Ricercatori; European Research Council [261079-NEUROTRAFFICKING]; National Multiple Sclerosis Society (NMSS), New York, NY, USA; Fondazione Cariverona; Research Fellowship FISM - Fondazione Italiana Sclerosi Multipla [cod. 2011/B/6]	Italian Telethon Foundation(Fondazione Telethon); AISM-FISM(Fondazione Italiana Sclerosi Multipla (FISM)); Ministero della Salute - Grant Giovani Ricercatori; European Research Council(European Research Council (ERC)European Commission); National Multiple Sclerosis Society (NMSS), New York, NY, USA(National Multiple Sclerosis Society); Fondazione Cariverona(Fondazione Cariverona); Research Fellowship FISM - Fondazione Italiana Sclerosi Multipla(Fondazione Italiana Sclerosi Multipla (FISM))	This work was supported by grants from Italian Telethon Foundation (to AV), AISM-FISM (to RP and GC), Ministero della Salute - Grant Giovani Ricercatori (to RP and MB); European Research Council grant 261079-NEUROTRAFFICKING (GC); National Multiple Sclerosis Society (NMSS), New York, NY, USA (GC); Fondazione Cariverona (GC). SM is supported by a Research Fellowship FISM - Fondazione Italiana Sclerosi Multipla - cod. 2011/B/6. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adriani M, 2007, CLIN IMMUNOL, V124, P41, DOI 10.1016/j.clim.2007.02.001; Almolda B, 2011, FRONT BIOSCI-LANDMRK, V16, P1157, DOI 10.2741/3781; Ancliff PJ, 2006, BLOOD, V108, P2182, DOI 10.1182/blood-2006-01-010249; Battistini L, 2003, BLOOD, V101, P4775, DOI 10.1182/blood-2002-10-3309; Bolomini-Vittori M, 2009, NAT IMMUNOL, V10, P185, DOI 10.1038/ni.1691; Bosticardo M, 2011, J ALLERGY CLIN IMMUN, V127, P1376, DOI 10.1016/j.jaci.2011.03.030; Bosticardo M, 2009, BLOOD, V113, P6288, DOI 10.1182/blood-2008-12-115253; Bouma G, 2007, BLOOD, V110, P4278, DOI 10.1182/blood-2007-06-096875; Choi JW, 2011, P NATL ACAD SCI USA, V108, P751, DOI 10.1073/pnas.1014154108; Codarri L, 2011, NAT IMMUNOL, V12, P560, DOI 10.1038/ni.2027; de Noronha S, 2005, BLOOD, V105, P1590, DOI 10.1182/blood-2004-06-2332; Dupuis-Girod S, 2003, PEDIATRICS, V111, pE622, DOI 10.1542/peds.111.5.e622; Gallego MD, 2006, INT IMMUNOL, V18, P221, DOI 10.1093/intimm/dxh310; Haddad E, 2001, BLOOD, V97, P33, DOI 10.1182/blood.V97.1.33; Hla T, 2011, NEUROLOGY, V76, pS3, DOI 10.1212/WNL.0b013e31820d5ec1; Humblet-Baron S, 2007, J CLIN INVEST, V117, P407, DOI 10.1172/JCI29539; Kappos L, 2006, NEW ENGL J MED, V355, P1124, DOI 10.1056/NEJMoa052643; Kerfoot SM, 2002, J IMMUNOL, V169, P1000, DOI 10.4049/jimmunol.169.2.1000; Lafouresse F, 2012, IMMUNOLOGY, V137, P183, DOI 10.1111/j.1365-2567.2012.03620.x; Larochelle C, 2011, FEBS LETT, V585, P3770, DOI 10.1016/j.febslet.2011.04.066; Ley K, 2007, NAT REV IMMUNOL, V7, P678, DOI 10.1038/nri2156; Maillard MH, 2007, J EXP MED, V204, P381, DOI 10.1084/jem.20061338; Marangoni F, 2007, J EXP MED, V204, P369, DOI 10.1084/jem.20061334; Morales-Tirado V, 2004, J IMMUNOL, V173, P726, DOI 10.4049/jimmunol.173.2.726; Morales-Tirado V, 2010, BLOOD, V115, P3498, DOI 10.1182/blood-2009-07-235754; Musio S, 2006, J IMMUNOL, V176, P17, DOI 10.4049/jimmunol.176.1.17; Nikolov NP, 2010, BLOOD, V116, P740, DOI 10.1182/blood-2009-08-237560; Notarangelo LD, 2002, BLOOD, V99, P2268, DOI 10.1182/blood.V99.6.2268; Ochs HD, 2006, J ALLERGY CLIN IMMUN, V117, P725, DOI 10.1016/j.jaci.2006.02.005; Piccio L, 2002, J IMMUNOL, V168, P1940, DOI 10.4049/jimmunol.168.4.1940; Pulecio J, 2008, J IMMUNOL, V181, P1135, DOI 10.4049/jimmunol.181.2.1135; Sato M, 2007, INT IMMUNOL, V19, P901, DOI 10.1093/intimm/dxm074; SELMAJ K, 1991, J CLIN INVEST, V87, P949, DOI 10.1172/JCI115102; SNAPPER CM, 1987, SCIENCE, V236, P944, DOI 10.1126/science.3107127; Snapper SB, 2005, J LEUKOCYTE BIOL, V77, P993, DOI 10.1189/jlb.0804444; Steinman L, 2008, J EXP MED, V205, P1517, DOI 10.1084/jem.20072066; Steinman L, 2007, NAT MED, V13, P139, DOI 10.1038/nm1551; Stewart DM, 1996, J CLIN INVEST, V97, P2627, DOI 10.1172/JCI118712; SULLIVAN KE, 1994, J PEDIATR-US, V125, P876, DOI 10.1016/S0022-3476(05)82002-5; Symons M, 1996, CELL, V84, P723, DOI 10.1016/S0092-8674(00)81050-8; Thrasher AJ, 2010, NAT REV IMMUNOL, V10, P182, DOI 10.1038/nri2724; Thrasher AJ, 2002, NAT REV IMMUNOL, V2, P635, DOI 10.1038/nri884; Tompkins SM, 2002, J IMMUNOL, V168, P4173, DOI 10.4049/jimmunol.168.8.4173; Trifari S, 2006, J IMMUNOL, V177, P7451, DOI 10.4049/jimmunol.177.10.7451; VILLA A, 1995, NAT GENET, V9, P414, DOI 10.1038/ng0495-414; Westerberg LS, 2008, BLOOD, V112, P4139, DOI 10.1182/blood-2008-02-140715; Westerberg LS, 2012, BLOOD; Zhang J, 1999, J EXP MED, V190, P1329, DOI 10.1084/jem.190.9.1329	48	1	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2014	9	1							e86942	10.1371/journal.pone.0086942	http://dx.doi.org/10.1371/journal.pone.0086942			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297XI	24466296	Green Submitted, gold, Green Published			2022-12-25	WOS:000330288000173
J	Mathew, M; Subramanian, S				Mathew, Maya; Subramanian, Sarada			In Vitro Screening for Anti-Cholinesterase and Antioxidant Activity of Methanolic Extracts of Ayurvedic Medicinal Plants Used for Cognitive Disorders	PLOS ONE			English	Article							ALZHEIMERS-DISEASE; INHIBITORY-ACTIVITY; POMEGRANATE JUICE; ACETYLCHOLINESTERASE; MEMORY	Inhibition of Acetylcholinesterase (AChE) is still considered as the main therapeutic strategy against Alzheimer's disease (AD). Many plant derived phytochemicals have shown AChE inhibitory activity in addition to the currently approved drugs for AD. In the present study, methanolic extracts of 20 plants used in Indian Ayurvedic system of medicine for improving cognitive function were screened for acetylcholinesterase inhibitory activity by Ellman's microplate colorimetric method. Out of 20 extracts, Emblica officinalis, Nardostachys jatamansi, Nelumbo nucifera, Punica granatum and Raulfia Serpentina showed IC50 values <100 mu g/ml for acetylcholinesterase inhibitory activity. Antioxidant activities of these plants were assessed by DPPH scavenging assay. Among the extracts used, antioxidant activity was highest for Terminalia chebula and Emblica officinalis with IC50 values <10 mu g/ml. Considering the complex multifactorial etiology of AD, these plant extracts will be safer and better candidates for the future disease modifying therapies against this devastating disease.	[Mathew, Maya; Subramanian, Sarada] Natl Inst Mental Hlth & Neurosci, Dept Neurochem, Bangalore 560029, Karnataka, India	National Institute of Mental Health & Neurosciences - India	Subramanian, S (corresponding author), Natl Inst Mental Hlth & Neurosci, Dept Neurochem, Bangalore 560029, Karnataka, India.	sarada@nimhans.kar.nic.in			Department of Science & Technology, New Delhi, India [SR/SO/BB-27/2009, SR/WOS-A/LS-102/2008]	Department of Science & Technology, New Delhi, India(Department of Science & Technology (India))	This study was supported by funding to SS (grant no. SR/SO/BB-27/2009) and MM (grant no. SR/WOS-A/LS-102/2008) from Department of Science & Technology, New Delhi, India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arya U, 2009, EXP GERONTOL, V44, P462, DOI 10.1016/j.exger.2009.02.010; Atoui AK, 2005, FOOD CHEM, V89, P27, DOI 10.1016/j.foodchem.2004.01.075; Bolognesi ML, 2009, CURR OPIN CHEM BIOL, V13, P303, DOI 10.1016/j.cbpa.2009.04.619; Capurro V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056870; DAVIES P, 1976, LANCET, V2, P1403; ELLMAN GL, 1961, BIOCHEM PHARMACOL, V7, P88, DOI 10.1016/0006-2952(61)90145-9; Ferreira A, 2006, J ETHNOPHARMACOL, V108, P31, DOI 10.1016/j.jep.2006.04.010; Gil MI, 2000, J AGR FOOD CHEM, V48, P4581, DOI 10.1021/jf000404a; Gutzmann H, 1998, J NEURAL TRANSM-SUPP, P301; Hartman RE, 2006, NEUROBIOL DIS, V24, P506, DOI 10.1016/j.nbd.2006.08.006; Ingkaninan K, 2003, J ETHNOPHARMACOL, V89, P261, DOI 10.1016/j.jep.2003.08.008; Itoh A, 2005, J NAT PROD, V68, P848, DOI 10.1021/np058007n; Joshi H, 2006, J MED FOOD, V9, P113, DOI 10.1089/jmf.2006.9.113; Jung HA, 2010, LIFE SCI, V87, P420, DOI 10.1016/j.lfs.2010.08.005; Karkada Gloria, 2012, J Nat Sci Biol Med, V3, P125, DOI 10.4103/0976-9668.101879; Kwak HM, 2005, ARCH PHARM RES, V28, P1328, DOI 10.1007/BF02977896; Ling ZQ, 2005, J AGR FOOD CHEM, V53, P2441, DOI 10.1021/jf040325p; Mangialasche F, 2010, LANCET NEUROL, V9, P702, DOI 10.1016/S1474-4422(10)70119-8; Manyam BV, 1999, J ALTERN COMPLEM MED, V5, P81, DOI 10.1089/acm.1999.5.81; Mathew M, 2013, INT J PHARM SCI RES, V4, P4691, DOI 10.13040/IJPSR.0975-8232.4(12).4685-91; Mathew M, 2012, INT J PHARM SCI RES, V3, P4276, DOI 10.13040/IJPSR.0975-8232.3(11).4281-84; Mehta M, 2012, INT J ALZHEIMERS DIS; Mukherjee PK, 2007, PHYTOTHER RES, V21, P1142, DOI 10.1002/ptr.2224; Mukherjee PK, 2007, PHYTOMEDICINE, V14, P289, DOI 10.1016/j.phymed.2007.02.002; Naik GH, 2005, PHYTOTHER RES, V19, P582, DOI 10.1002/ptr.1515; Nordberg A, 1998, DRUG SAFETY, V19, P465, DOI 10.2165/00002018-199819060-00004; Oh MH, 2004, PHYTOMEDICINE, V11, P544, DOI 10.1016/j.phymed.2004.03.001; Orhan I, 2004, J ETHNOPHARMACOL, V91, P57, DOI 10.1016/j.jep.2003.11.016; Murray AP, 2013, CURR NEUROPHARMACOL, V11, P388, DOI 10.2174/1570159X11311040004; Peckels C.M., 2013, CURR ENZ INHIBITION, V9, P67; Rao RV, 2012, ALZHEIMERS RES THER, V4, DOI 10.1186/alzrt125; RiceEvans CA, 1996, FREE RADICAL BIO MED, V20, P933, DOI 10.1016/0891-5849(95)02227-9; Tepe B, 2005, FOOD CHEM, V90, P333, DOI 10.1016/j.foodchem.2003.09.013; Vasudevan M, 2007, PHYSIOL BEHAV, V91, P46, DOI 10.1016/j.physbeh.2007.01.016; Vina J, 2011, CURR PHARM DESIGN, V17, P3861, DOI 10.2174/138161211798357755; Warrier P.K., 1993, INDIAN MED PLANTS CO, VVolume 5; Yang ZD, 2012, NAT PROD RES, V26, P387, DOI 10.1080/14786419.2010.487188	37	119	128	2	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2014	9	1							e86804	10.1371/journal.pone.0086804	http://dx.doi.org/10.1371/journal.pone.0086804			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297XI	24466247	gold, Green Submitted, Green Published			2022-12-25	WOS:000330288000145
J	Sasaki, AA; Fernandes, GF; Rodrigues, AM; Lima, FM; Marini, MM; Feitosa, LD; Teixeira, MD; Felipe, MSS; da Silveira, JF; de Camargo, ZP				Sasaki, Alexandre A.; Fernandes, Geisa F.; Rodrigues, Anderson M.; Lima, Fabio M.; Marini, Marjorie M.; Feitosa, Luciano dos S.; Teixeira, Marcus de Melo; Soares Felipe, Maria Sueli; da Silveira, Jose Franco; de Camargo, Zoilo P.			Chromosomal Polymorphism in the Sporothrix schenckii Complex	PLOS ONE			English	Article							MOLECULAR PHYLOGENY; LENGTH POLYMORPHISM; FUNGUS; BRASILIENSIS; EXPRESSION; SPOROTRICHOSIS; REARRANGEMENT; TRANSITION; KARYOTYPE; PLOIDY	Sporotrichosis is a polymorphic disease caused by a complex of thermodimorphic fungi including S. brasiliensis, S. schenckii sensu stricto (s. str.), S. globosa and S. luriei. Humans and animals can acquire the disease through traumatic inoculation of propagules into the subcutaneous tissue. Despite the importance of sporotrichosis as a disease that can take epidemic proportions there are just a few studies dealing with genetic polymorphisms and genomic architecture of these pathogens. The main objective of this study was to investigate chromosomal polymorphisms and genomic organization among different isolates in the S. schenckii complex. We used pulsed field gel electrophoresis (PFGE) to separate chromosomal fragments of isolated DNA, followed by probe hybridization. Nine loci (beta-tubulin, calmodulin, catalase, chitin synthase 1, Internal Transcribed Spacer, Pho85 cyclin-dependent kinase, protein kinase C Ss-2, G protein a subunit and topoisomerase II) were mapped onto chromosomal bands of Brazilian isolates of S. schenckii s. str. and S. brasiliensis. Our results revealed the presence of intra and interspecies polymorphisms in chromosome number and size. The gene hybridization analysis showed that closely related species in phylogenetic analysis had similar genetic organizations, mostly due to identification of synteny groups in chromosomal bands of similar sizes. Our results bring new insights into the genetic diversity and genome organization among pathogenic species in the Sporothrix schenckii complex.	[Sasaki, Alexandre A.; Fernandes, Geisa F.; Rodrigues, Anderson M.; de Camargo, Zoilo P.] Univ Fed Sao Paulo, Dept Microbiol Immunol & Parasitol, Discipline Cellular Biol, Sao Paulo, Brazil; [Lima, Fabio M.; Marini, Marjorie M.; da Silveira, Jose Franco] Univ Fed Sao Paulo, Dept Microbiol Immunol & Parasitol, Discipline Parasitol, Sao Paulo, Brazil; [Feitosa, Luciano dos S.] Univ Camilo Castelo Branco, Ctr Biomed Engn, Sao Paulo, Brazil; [Teixeira, Marcus de Melo; Soares Felipe, Maria Sueli] Univ Brasilia, Dept Cell Biol, Inst Biol Sci, Brasilia, DF, Brazil; [Soares Felipe, Maria Sueli] Univ Catolica Brasilia, Brasilia, DF, Brazil	Universidade Federal de Sao Paulo (UNIFESP); Universidade Federal de Sao Paulo (UNIFESP); Universidade Brasil; Universidade de Brasilia; Universidade Catolica de Brasilia	de Camargo, ZP (corresponding author), Univ Fed Sao Paulo, Dept Microbiol Immunol & Parasitol, Discipline Cellular Biol, Sao Paulo, Brazil.	zpcamargo@unifesp.br	Rodrigues, Anderson M./V-4069-2019; da Silveira, Jose Franco/F-5390-2012; Camargo, Zoilo P/C-5305-2013; Rodrigues, Anderson/C-5915-2013; Lima, Fabio Mitsuo/GQH-9488-2022; Lima, Fabio Mitsuo/AHD-6582-2022; Felipe, Maria Sueli/L-6260-2016; de Melo Teixeira, Marcus/AAP-9530-2021; marini, marjorie/O-9713-2014; Lima, Fabio M/C-9018-2013	Rodrigues, Anderson M./0000-0003-0891-4563; Camargo, Zoilo P/0000-0002-2971-7983; Rodrigues, Anderson/0000-0003-0891-4563; Lima, Fabio Mitsuo/0000-0002-1953-2950; Lima, Fabio Mitsuo/0000-0002-1953-2950; Felipe, Maria Sueli/0000-0003-4347-6853; de Melo Teixeira, Marcus/0000-0003-1763-3464; Lima, Fabio M/0000-0002-1953-2950	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	AAS is a fellow of Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) and acknowledges the financial support of Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior. GFF is a fellow of FAPESP (2011/01628-8). AMR is a fellow of Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP 2011/07350-1) and Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (BEX 2325/11-0). ZPdC thanks FAPESP (Proc. 09/54024-2) and CNPq (Proc. 472600/2011-7). CNPq (http://www.cnpq.br/), and CAPES (http://www.capes.gov.br/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akagi Y, 2009, EUKARYOT CELL, V8, P1732, DOI 10.1128/EC.00135-09; Akamatsu HO, 2012, FUNGAL BIOL-UK, V116, P1119, DOI 10.1016/j.funbio.2012.07.001; Alves SH, 2010, REV SOC BRAS MED TRO, V43, P523, DOI 10.1590/S0037-86822010000500010; Aquino-Pinero E, 2002, MED MYCOL, V40, P185, DOI 10.1080/714031095; Arrillaga-Moncrieff I, 2009, CLIN MICROBIOL INFEC, V15, P651, DOI 10.1111/j.1469-0691.2009.02824.x; Bustamante B, 2001, CURR OPIN INFECT DIS, V14, P145, DOI 10.1097/00001432-200104000-00006; Canteros CE, 2005, FEMS IMMUNOL MED MIC, V45, P423, DOI 10.1016/j.femsim.2005.05.015; Carbone I, 1999, MYCOLOGIA, V91, P553, DOI 10.2307/3761358; Coelho LM, 2013, MED MYCOL, V51, P208, DOI 10.3109/13693786.2012.701338; Croll D, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003567; de Jesus-Berrios M, 2002, FUNGAL GENET BIOL, V37, P39, DOI 10.1016/S1087-1845(02)00031-2; DEBIEVRE C, 1969, ANN I PASTEUR PARIS, V117, P694; Delgado N, 2000, MED MYCOL, V38, P109, DOI 10.1080/714030929; Desjardins CA, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002345; de Oliveira MME, 2012, J CLIN MICROBIOL, V50, P2159, DOI 10.1128/JCM.00450-12; Feitosa LD, 2003, FUNGAL GENET BIOL, V39, P60, DOI 10.1016/S1087-1845(03)00003-3; Felsenstein J, CONFIDENCE LIMITS PH; Fernandes G. F., 2009, Open Mycology Journal, V3, P48, DOI 10.2174/1874437000903010048; Fernandes GF, 2013, VIRULENCE, V4, P241, DOI 10.4161/viru.23112; Fernandez-Silva F, 2012, MYCOPATHOLOGIA, V173, P245, DOI 10.1007/s11046-011-9506-7; Fierro F, 1999, CRIT REV MICROBIOL, V25, P1, DOI 10.1080/10408419991299185; Hall T.A., 1999, NUCL ACIDS S SERIES, V41, P95, DOI [DOI 10.1021/BK-1999-0734.CH008, citeulike-article-id:691774, 10.12691/ajmr-6-4-3]; Herschleb J, 2007, NAT PROTOC, V2, P677, DOI 10.1038/nprot.2007.94; Kanbe T, 2005, J DERMATOL SCI, V38, P99, DOI 10.1016/j.jdermsci.2004.12.024; Kauffman CA, 2007, CLIN INFECT DIS, V45, P1255, DOI 10.1086/522765; Kwon-Chung KJ, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003022; Madrid H, 2010, MYCOLOGIA, V102, P1193, DOI 10.3852/09-320; Marimon R, 2008, MED MYCOL, V46, P621, DOI 10.1080/13693780801992837; Marimon R, 2008, ANTIMICROB AGENTS CH, V52, P732, DOI 10.1128/AAC.01012-07; Marimon R, 2007, J CLIN MICROBIOL, V45, P3198, DOI 10.1128/JCM.00808-07; Marimon R, 2006, J CLIN MICROBIOL, V44, P3251, DOI 10.1128/JCM.00081-06; O'Donnell K, 2000, MYCOLOGIA, V92, P919, DOI 10.2307/3761588; Rippon JW., 1988, MED MYCOLOGY PATHOGE; Rodrigues AM, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002281; Rodrigues AM, 2013, MED MYCOL, V51, P405, DOI 10.3109/13693786.2012.719648; Sankoff D, 1996, DISCRETE APPL MATH, V71, P247, DOI 10.1016/S0166-218X(96)00067-4; Schubach A, 2008, CURR OPIN INFECT DIS, V21, P129, DOI 10.1097/QCO.0b013e3282f44c52; SCHWARTZ DC, 1984, CELL, V37, P67, DOI 10.1016/0092-8674(84)90301-5; Selmecki A, 2006, SCIENCE, V313, P367, DOI 10.1126/science.1128242; Selmecki AM, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000705; Silva-Vergara MLO, 2012, AM J TROP MED HYG, V86, P477, DOI 10.4269/ajtmh.2012.11-0441; TAMURA K, 1992, MOL BIOL EVOL, V9, P678; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tateishi T, 1996, FEMS IMMUNOL MED MIC, V13, P147, DOI 10.1111/j.1574-695X.1996.tb00228.x; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Torres-Guerrero H, 1999, FUNGAL GENET BIOL, V27, P49, DOI 10.1006/fgbi.1999.1128; Villesen P, 2007, MOL ECOL NOTES, V7, P965, DOI 10.1111/j.1471-8286.2007.01821.x; Wang XH, 2008, CHINESE MED J-PEKING, V121, P2100, DOI 10.1097/00029330-200810020-00029; White TJ, 1990, PCR PROTOCOLS GUIDE, P358; Wieloch W, 2006, J MICROBIOL METH, V67, P1, DOI 10.1016/j.mimet.2006.05.022; Zhou X, 2014, FUNGAL DIVERS, V66, P153, DOI 10.1007/s13225-013-0220-2; ZOLAN ME, 1995, MICROBIOL REV, V59, P686, DOI 10.1128/MMBR.59.4.686-698.1995	52	40	42	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2014	9	1							e86819	10.1371/journal.pone.0086819	http://dx.doi.org/10.1371/journal.pone.0086819			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297XI	24466257	Green Published, Green Submitted, gold			2022-12-25	WOS:000330288000151
J	Cheng, J; Xu, Z; Wu, WW; Zhao, L; Li, XC; Liu, YL; Tao, SH				Cheng, Jian; Xu, Zhao; Wu, Wenwu; Zhao, Li; Li, Xiangchen; Liu, Yanlin; Tao, Shiheng			Training Set Selection for the Prediction of Essential Genes	PLOS ONE			English	Article							IDENTIFICATION; NETWORK; ORGANISMS; PROTEINS; DATABASE	Various computational models have been developed to transfer annotations of gene essentiality between organisms. However, despite the increasing number of microorganisms with well-characterized sets of essential genes, selection of appropriate training sets for predicting the essential genes of poorly-studied or newly sequenced organisms remains challenging. In this study, a machine learning approach was applied reciprocally to predict the essential genes in 21 microorganisms. Results showed that training set selection greatly influenced predictive accuracy. We determined four criteria for training set selection: (1) essential genes in the selected training set should be reliable; (2) the growth conditions in which essential genes are defined should be consistent in training and prediction sets; (3) species used as training set should be closely related to the target organism; and (4) organisms used as training and prediction sets should exhibit similar phenotypes or lifestyles. We then analyzed the performance of an incomplete training set and an integrated training set with multiple organisms. We found that the size of the training set should be at least 10% of the total genes to yield accurate predictions. Additionally, the integrated training sets exhibited remarkable increase in stability and accuracy compared with single sets. Finally, we compared the performance of the integrated training sets with the four criteria and with random selection. The results revealed that a rational selection of training sets based on our criteria yields better performance than random selection. Thus, our results provide empirical guidance on training set selection for the identification of essential genes on a genome-wide scale.	[Cheng, Jian; Zhao, Li; Li, Xiangchen; Tao, Shiheng] Northwest A&F Univ, Coll Life Sci, Yangling, Shaanxi, Peoples R China; [Cheng, Jian; Zhao, Li; Li, Xiangchen; Tao, Shiheng] Northwest A&F Univ, State Key Lab Crop Stress Biol Arid Areas, Yangling, Shaanxi, Peoples R China; [Cheng, Jian; Wu, Wenwu; Zhao, Li; Li, Xiangchen; Tao, Shiheng] Northwest A&F Univ, Bioinformat Ctr, Yangling, Shaanxi, Peoples R China; [Wu, Wenwu] Univ Chinese Acad Sci, Chinese Acad Sci, Key Lab Food Safety Res, Inst Nutrit Sci,Shanghai Inst Biol Sci, Shanghai, Peoples R China; [Xu, Zhao] Northwest A&F Univ, Coll Sci, Yangling, Shaanxi, Peoples R China; [Liu, Yanlin] Northwest A&F Univ, Coll Wine, Yangling, Shaanxi, Peoples R China	Northwest A&F University - China; Northwest A&F University - China; Northwest A&F University - China; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; University of Chinese Academy of Sciences, CAS; Northwest A&F University - China; Northwest A&F University - China	Tao, SH (corresponding author), Northwest A&F Univ, Coll Life Sci, Yangling, Shaanxi, Peoples R China.	yanlinliu@nwsuaf.edu.cn; shihengt@nwsuaf.edu.cn	Wu, Wenwu/AAP-1966-2021; Wu, Wenwu/HDO-7873-2022	Wu, Wenwu/0000-0003-2996-8675; Wu, Wenwu/0000-0003-2996-8675	National Natural Science Fund Program [31271917]	National Natural Science Fund Program(National Natural Science Foundation of China (NSFC))	The work was the project from National Natural Science Fund Program (31271917). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acencio ML, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-290; Barh D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052773; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkp985, 10.1093/nar/gkr1065]; Bruccoleri RE, 1998, NUCLEIC ACIDS RES, V26, P4482, DOI 10.1093/nar/26.19.4482; Chalker AF, 2002, PHARMACOL THERAPEUT, V95, P1, DOI 10.1016/S0163-7258(02)00222-X; Chen WH, 2012, MOL BIOL EVOL, V29, P1703, DOI 10.1093/molbev/mss014; Chen WH, 2012, NUCLEIC ACIDS RES, V40, pD901, DOI 10.1093/nar/gkr986; Cole ST, 2002, EUR RESPIR J, V20, p78S, DOI 10.1183/09031936.02.00400202; Cullen LM, 2005, IMMUNOL CELL BIOL, V83, P217, DOI 10.1111/j.1440-1711.2005.01332.x; D'Elia MA, 2009, TRENDS MICROBIOL, V17, P433, DOI 10.1016/j.tim.2009.08.005; Deng JY, 2012, BIOMOLECULES, V2, P1, DOI 10.3390/biom2010001; Deng JY, 2011, NUCLEIC ACIDS RES, V39, P795, DOI 10.1093/nar/gkq784; Dickerson JE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027368; Dowell RD, 2010, SCIENCE, V328, P469, DOI 10.1126/science.1189015; Estrada E, 2006, PROTEOMICS, V6, P35, DOI 10.1002/pmic.200500209; Fang G, 2005, MOL BIOL EVOL, V22, P2147, DOI 10.1093/molbev/msi211; Finn RD, 2011, NUCLEIC ACIDS RES, V39, pW29, DOI 10.1093/nar/gkr367; Georgi B, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003484; Gerdes S, 2006, CURR OPIN BIOTECH, V17, P448, DOI 10.1016/j.copbio.2006.08.006; Giaever G, 2002, NATURE, V418, P387, DOI 10.1038/nature00935; Gibson DG, 2010, SCIENCE, V329, P52, DOI 10.1126/science.1190719; Gu ZL, 2003, NATURE, V421, P63, DOI 10.1038/nature01198; Gustafson AM, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-265; Hagberg A, 2008, EXPLORING NETWORK ST, P11, DOI DOI 10.25080/ISSN.2575-9752; Hedges SB, 2006, BIOINFORMATICS, V22, P2971, DOI 10.1093/bioinformatics/btl505; Holman AG, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-243; Hwang YC, 2009, MOL BIOSYST, V5, P1672, DOI [10.1039/b900611g, 10.1039/B900611G]; ITAYA M, 1995, FEBS LETT, V362, P257, DOI 10.1016/0014-5793(95)00233-Y; Jacobs MA, 2003, P NATL ACAD SCI USA, V100, P14339, DOI 10.1073/pnas.2036282100; Jeong Hawoong, 2003, ComPlexUs, V1, P19, DOI 10.1159/000067640; Jia X, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028275; Juhas M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040064; Kim DU, 2010, NAT BIOTECHNOL, V28, P617, DOI 10.1038/nbt.1628; Kobayashi K, 2003, P NATL ACAD SCI USA, V100, P4678, DOI 10.1073/pnas.0730515100; Krasky A, 2007, GENOMICS, V89, P36, DOI 10.1016/j.ygeno.2006.09.008; Kumar S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001189; Lipman DJ, 2002, BMC EVOL BIOL, V2, DOI 10.1186/1471-2148-2-20; Lobo JM, 2008, GLOBAL ECOL BIOGEOGR, V17, P145, DOI 10.1111/j.1466-8238.2007.00358.x; da Silva JPM, 2008, PHYSICA A, V387, P1049, DOI 10.1016/j.physa.2007.10.044; Ohno S., 1970, P1; Papp B, 2004, NATURE, V429, P661, DOI 10.1038/nature02636; Peden J, 1997, CODONW; Plaimas K, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-56; Powell S, 2012, NUCLEIC ACIDS RES, V40, pD284, DOI 10.1093/nar/gkr1060; Re C., 2007, SCIENCE, V18, P965; Roemer T, 2003, MOL MICROBIOL, V50, P167, DOI 10.1046/j.1365-2958.2003.03697.x; Salama NR, 2004, J BACTERIOL, V186, P7926, DOI 10.1128/JB.186.23.7926-7935.2004; Seringhaus M, 2006, GENOME RES, V16, P1126, DOI 10.1101/gr.5144106; Stahl M, 2011, FUNCT INTEGR GENOMIC, V11, P241, DOI 10.1007/s10142-011-0214-7; Strassburg K, 2010, OMICS, V14, P249, DOI 10.1089/omi.2009.0107; Szklarczyk D, 2011, NUCLEIC ACIDS RES, V39, pD561, DOI 10.1093/nar/gkq973; Wang SL, 2004, CURR OPIN CHEM BIOL, V8, P371, DOI 10.1016/j.cbpa.2004.06.001; Wolf YI, 2009, P NATL ACAD SCI USA, V106, P7273, DOI 10.1073/pnas.0901808106; Woods S, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003330; Xu P, 2011, SCI REP-UK, V1, DOI 10.1038/srep00125; YU H, 2004, RNA, V71, P817; Zhang R, 2004, NUCLEIC ACIDS RES, V32, pD271, DOI 10.1093/nar/gkh024	57	18	18	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2014	9	1							e86805	10.1371/journal.pone.0086805	http://dx.doi.org/10.1371/journal.pone.0086805			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297VL	24466248	Green Published, Green Submitted, gold			2022-12-25	WOS:000330283100218
J	Crona, J; Nordling, M; Maharjan, R; Granberg, D; Stalberg, P; Hellman, P; Bjorklund, P				Crona, Joakim; Nordling, Margareta; Maharjan, Rajani; Granberg, Dan; Stalberg, Peter; Hellman, Per; Bjorklund, Peyman			Integrative Genetic Characterization and Phenotype Correlations in Pheochromocytoma and Paraganglioma Tumours	PLOS ONE			English	Article							ENDOCRINE NEOPLASIA TYPE-2; HIPPEL-LINDAU-SYNDROME; SCALED SCORE PASS; SUCCINATE-DEHYDROGENASE; HEREDITARY PHEOCHROMOCYTOMA; SOMATIC MUTATIONS; VARIANTS; CANCER; SDHC; SUSCEPTIBILITY	Background: About 60% of Pheochromocytoma (PCC) and Paraganglioma (PGL) patients have either germline or somatic mutations in one of the 12 proposed disease causing genes; SDHA, SDHB, SDHC, SDHD, SDHAF2, VHL, EPAS1, RET, NF1, TMEM127, MAX and H-RAS. Selective screening for germline mutations is routinely performed in clinical management of these diseases. Testing for somatic alterations is not performed on a regular basis because of limitations in interpreting the results. Aim: The purpose of the study was to investigate genetic events and phenotype correlations in a large cohort of PCC and PGL tumours. Methods: A total of 101 tumours from 89 patients with PCC and PGL were re-sequenced for a panel of 10 disease causing genes using automated Sanger sequencing. Selected samples were analysed with Multiplex Ligation-dependent Probe Amplification and/or SNParray. Results: Pathogenic genetic variants were found in tumours from 33 individual patients (37%), 14 (16%) were discovered in constitutional DNA and 16 (18%) were confirmed as somatic. Loss of heterozygosity (LOH) was observed in 1/1 SDHB, 11/11 VHL and 3/3 NF1-associated tumours. In patients with somatic mutations there were no recurrences in contrast to carriers of germline mutations (P = 0.022). SDHx/VHL/ EPAS1 associated cases had higher norepinephrine output (P = 0.03) and lower epinephrine output (P<0.001) compared to RET/NF1/H-RAS cases. Conclusion: Somatic mutations are frequent events in PCC and PGL tumours. Tumour genotype may be further investigated as prognostic factors in these diseases. Growing evidence suggest that analysis of tumour DNA could have an impact on the management of these patients.	[Crona, Joakim; Maharjan, Rajani; Stalberg, Peter; Hellman, Per; Bjorklund, Peyman] Uppsala Univ, Dept Surg Sci, Uppsala, Sweden; [Granberg, Dan] Uppsala Univ, Dept Med Sci, Uppsala, Sweden; [Nordling, Margareta] Sahlgrens Univ Hosp, Dept Clin Genet, Gothenburg, Sweden	Uppsala University; Uppsala University; Sahlgrenska University Hospital	Bjorklund, P (corresponding author), Uppsala Univ, Dept Surg Sci, Uppsala, Sweden.	peyman.bjorklund@surgsci.uu.se	Crona, Joakim/D-3474-2013; Granberg, Dan/AAS-7663-2020; Granberg, Dan/AAG-5791-2019; Hellman, Per/AAL-9817-2021	Crona, Joakim/0000-0003-0677-4894; Hellman, Per/0000-0002-5322-5073; Stalberg, Peter/0000-0002-9625-1394; Granberg, Dan/0000-0002-4854-6075	Swedish Cancer Society; Selander Foundation; Lions Cancer Foundation, Uppsala; Swedish state	Swedish Cancer Society(Swedish Cancer Society); Selander Foundation; Lions Cancer Foundation, Uppsala; Swedish state	The study was supported by grants from Swedish Cancer Society (PB), Selander Foundation (PB, PH, PS), Lions Cancer Foundation, Uppsala (JC, PH) and the Swedish state under the LUA/ALF agreement concerning research and education of doctors, (MN, id no. 76310). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Agarwal A, 2010, WORLD J SURG, V34, P3022, DOI 10.1007/s00268-010-0744-5; Akerstrom T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041926; Amar L, 2005, J CLIN ENDOCR METAB, V90, P2110, DOI 10.1210/jc.2004-1398; Amar L, 2007, J CLIN ENDOCR METAB, V92, P3822, DOI 10.1210/jc.2007-0709; Arkblad EL, 2006, NEUROMUSCULAR DISORD, V16, P830, DOI 10.1016/j.nmd.2006.08.011; Astuti D, 2001, AM J HUM GENET, V69, P49, DOI 10.1086/321282; Banck MS, 2013, J CLIN INVEST, V15; Baysal BE, 2000, SCIENCE, V287, P848, DOI 10.1126/science.287.5454.848; Bond J, 2011, BLOOD, V117, P3699, DOI 10.1182/blood-2010-12-327569; Buffet A, 2012, HORM METAB RES, V19, P19; Burnichon N, 2012, HUM MOL GENET, V6, P6; Burnichon N, 2011, HUM MOL GENET, V20, P3974, DOI 10.1093/hmg/ddr324; Comino-Mendez I, 2013, HUM MOL GENET, V26, P26; Comino-Mendez I, 2011, NAT GENET, V43, P663, DOI 10.1038/ng.861; Crona J, 2013, FAM CANCER, V7, P7; Crona J, 2013, ENDOCRINE CONNECTION; Crona J, 2013, J CLIN ENDOCRINOLOGY; Darr R, 2012, THER ADV ENDOCRINOL, V3, P11, DOI 10.1177/2042018812437356; Easton DF, 2007, AM J HUM GENET, V81, P873, DOI 10.1086/521032; Eisenhofer G, 2001, J CLIN ENDOCR METAB, V86, P1999, DOI 10.1210/jc.86.5.1999; Erlic Z, 2010, J CLIN ENDOCR METAB, V95, P308, DOI 10.1210/jc.2009-1728; Favier J, 2012, NEW ENGL J MED, V367, P2161, DOI 10.1056/NEJMc1211953; Favier J, 2012, ENDOCR PATHOL, V23, P34, DOI 10.1007/s12022-011-9189-0; Forbes SA, 2011, NUCLEIC ACIDS RES, V39, pD945, DOI 10.1093/nar/gkq929; Hao HX, 2009, SCIENCE, V325, P1139, DOI 10.1126/science.1175689; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Ladroue C, 2008, NEW ENGL J MED, V359, P2685, DOI 10.1056/NEJMoa0806277; Leslie EJ, 2012, GENET, V15, P141; Mannelli M, 2009, J CLIN ENDOCR METAB, V94, P1541, DOI 10.1210/jc.2008-2419; Muth A, 2012, WORLD J SURG, V36, P1389, DOI 10.1007/s00268-012-1430-6; Neumann HPH, 2002, NEW ENGL J MED, V346, P1459, DOI 10.1056/NEJMoa020152; Niemann S, 2000, NAT GENET, V26, P268, DOI 10.1038/81551; Pacak K, 2013, J CLIN ONCOL, V18, P18; Panizza E, 2013, HUM MOL GENET, V22, P804, DOI 10.1093/hmg/dds487; Qin YJ, 2010, NAT GENET, V42, P229, DOI 10.1038/ng.533; SCOTT HW, 1984, SURGERY, V96, P1061; Stenson PD, 2003, HUM MUTAT, V21, P577, DOI 10.1002/humu.10212; Thompson LDR, 2002, AM J SURG PATHOL, V26, P551, DOI 10.1097/00000478-200205000-00002; Vaclavikova E, 2009, ENDOCRINE, V36, P419, DOI 10.1007/s12020-009-9242-7; Van Slycke S, 2009, SURGERY, V146, P986, DOI 10.1016/j.surg.2009.10.055; VANHEERDEN JA, 1990, WORLD J SURG, V14, P325, DOI 10.1007/BF01658516; Weber A, 2012, HORM CANCER-US, V3, P187, DOI 10.1007/s12672-012-0113-y; Welander J, 2012, HUM MOL GENET, V24, P24; Welander J, 2011, ENDOCR-RELAT CANCER, V18, pR253, DOI 10.1530/ERC-11-0170; Wells SA, 2012, J CLIN ONCOL, V30, P134, DOI 10.1200/JCO.2011.35.5040; Yang C, 2013, BLOOD; Zhuang ZP, 2012, NEW ENGL J MED, V367, P922, DOI 10.1056/NEJMoa1205119	48	29	29	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2014	9	1							e86756	10.1371/journal.pone.0086756	http://dx.doi.org/10.1371/journal.pone.0086756			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297VL	24466223	Green Published, Green Submitted, gold			2022-12-25	WOS:000330283100207
J	Kim, S; Rhee, K				Kim, Seongjae; Rhee, Kunsoo			Importance of the CEP215-Pericentrin Interaction for Centrosome Maturation during Mitosis	PLOS ONE			English	Article							GAMMA-TUBULIN COMPLEXES; MICROTUBULE NUCLEATION; CDK5RAP2; PERICENTRIN; PROTEIN; RECRUITMENT; ATTACHMENT; CENTRIOLES; REVEALS; DOMAIN	At the onset of mitosis, the centrosome undergoes maturation, which is characterized by a drastic expansion of the pericentriolar material (PCM) and a robust increase in microtubule-organizing activity. CEP215 is one of the major PCM components which accumulates at the centrosome during mitosis. The depletion phenotypes indicate that CEP215 is essential for centrosome maturation and bipolar spindle formation. Here, we performed a series of knockdown-rescue experiments to link the protein-protein interaction properties of CEP215 to its biological functions. The results showed that CEP215 and pericentrin, another major PCM component, is interdependent for their accumulation at the spindle poles during mitosis. As a result, The CEP215-pericentrin interaction is required for centrosome maturation and subsequent bipolar spindle formation during mitosis. On the other hand, CEP215 interaction with c-tubulin is dispensable for centrosome maturation. Our results provide an insight how PCM components are assembled to form a spindle pole during mitosis.	[Kim, Seongjae; Rhee, Kunsoo] Seoul Natl Univ, Dept Biol Sci, Seoul, South Korea	Seoul National University (SNU)	Rhee, K (corresponding author), Seoul Natl Univ, Dept Biol Sci, Seoul, South Korea.	rheek@snu.ac.kr		Kim, Seongjae/0000-0002-9592-6556	BioImaging Research Center at GIST; Basic Research Program [2012R1A2A201003512]; Science Research Center Program [2011-0006425]; Brain Korea 21 Project	BioImaging Research Center at GIST; Basic Research Program; Science Research Center Program; Brain Korea 21 Project(Ministry of Education & Human Resources Development (MOEHRD), Republic of Korea)	This study was supported by grants from the BioImaging Research Center at GIST; the Basic Research Program (Grant Number 2012R1A2A201003512) and the Science Research Center Program (Grant Number 2011-0006425). Seongjae Kim was supported by the Brain Korea 21 Project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barr AR, 2010, J CELL BIOL, V189, P23, DOI 10.1083/jcb.200912163; Barrera JA, 2010, DEV CELL, V18, P913, DOI 10.1016/j.devcel.2010.05.017; Bond J, 2005, NAT GENET, V37, P353, DOI 10.1038/ng1539; Buchman JJ, 2010, NEURON, V66, P386, DOI 10.1016/j.neuron.2010.03.036; Choi YK, 2010, J CELL BIOL, V191, P1089, DOI 10.1083/jcb.201007030; Conduit PT, 2010, CURR BIOL, V20, P2178, DOI 10.1016/j.cub.2010.11.011; Delaval B, 2010, J CELL BIOL, V188, P181, DOI 10.1083/jcb.200908114; Fong KW, 2008, MOL BIOL CELL, V19, P115, DOI 10.1091/mbc.E07-04-0371; Gillingham AK, 2000, EMBO REP, V1, P524; Gomez-Ferreria MA, 2007, CURR BIOL, V17, P1960, DOI 10.1016/j.cub.2007.10.019; Graser S, 2007, J CELL SCI, V120, P4321, DOI 10.1242/jcs.020248; Haren L, 2006, J CELL BIOL, V172, P505, DOI 10.1083/jcb.200510028; Haren L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005976; Hassan MJ, 2007, BMC MED GENET, V8, DOI 10.1186/1471-2350-8-58; Kim K, 2011, J CELL SCI, V124, P338, DOI 10.1242/jcs.078329; Lawo S, 2012, NAT CELL BIOL, V14, P1148, DOI 10.1038/ncb2591; Lee K, 2011, J CELL BIOL, V195, P1093, DOI 10.1083/jcb.201106093; Lee S, 2010, CELL CYCLE, V9, P775, DOI 10.4161/cc.9.4.10667; Li KJ, 1996, CELL, V85, P585, DOI 10.1016/S0092-8674(00)81258-1; Lizarraga SB, 2010, DEVELOPMENT, V137, P1907, DOI 10.1242/dev.040410; Lucas EP, 2007, J CELL BIOL, V178, P725, DOI 10.1083/jcb.200704081; Luders J, 2006, NAT CELL BIOL, V8, P137, DOI 10.1038/ncb1349; Megraw TL, 1999, DEVELOPMENT, V126, P2829; Mennella V, 2012, NAT CELL BIOL, V14, P1159, DOI 10.1038/ncb2597; Pagnamenta AT, 2012, AM J MED GENET A, V158A, P2577, DOI 10.1002/ajmg.a.35558; Rauch A, 2008, SCIENCE, V319, P816, DOI 10.1126/science.1151174; Samejima I, 2008, J CELL SCI, V121, P3971, DOI 10.1242/jcs.038414; Sawin KE, 2004, CURR BIOL, V14, P763, DOI 10.1016/j.cub.2004.03.042; Srsen V, 2006, J CELL BIOL, V174, P625, DOI 10.1083/jcb.200606051; Venkatram S, 2004, MOL BIOL CELL, V15, P2287, DOI 10.1091/mbc.E03-10-0728; Wang Z, 2010, J BIOL CHEM, V285, P22658, DOI 10.1074/jbc.M110.105965; Zhang J, 2007, MOL BIOL CELL, V18, P4037, DOI 10.1091/mbc.E07-05-0474; Zhu F, 2008, CURR BIOL, V18, P136, DOI 10.1016/j.cub.2007.12.055; Zimmerman WC, 2004, MOL BIOL CELL, V15, P3642, DOI 10.1091/mbc.E03-11-0796	34	49	50	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2014	9	1							e87016	10.1371/journal.pone.0087016	http://dx.doi.org/10.1371/journal.pone.0087016			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297VL	24466316	Green Published, gold, Green Submitted			2022-12-25	WOS:000330283100244
J	Romsang, A; Duang-Nkern, J; Leesukon, P; Saninjuk, K; Vattanaviboon, P; Mongkolsuk, S				Romsang, Adisak; Duang-Nkern, Jintana; Leesukon, Panithi; Saninjuk, Kritsakorn; Vattanaviboon, Paiboon; Mongkolsuk, Skorn			The Iron-Sulphur Cluster Biosynthesis Regulator IscR Contributes to Iron Homeostasis and Resistance to Oxidants in Pseudomonas aeruginosa	PLOS ONE			English	Article							OXIDATIVE STRESS; GENE-EXPRESSION; SUF OPERON; PROTEINS; CATALASE; BIOGENESIS; MECHANISMS; BACTERIA; SEQUENCE; BINDING	IscR is a global transcription regulator responsible for governing various physiological processes during growth and stress responses. The IscR-mediated regulation of the Pseudomonas aeruginosa isc operon, which is involved in iron-sulphur cluster ([Fe-S]) biogenesis, was analysed. The expression of iscR was highly induced through the exposure of the bacteria to various oxidants, such as peroxides, redox-cycling drugs, intracellular iron-chelating agents, and high salts. Two putative type 1 IscR-binding sites were found around RNA polymerase recognition sites, in which IscR-promoter binding could preclude RNA polymerase from binding to the promoter and resulting in repression of the isc operon expression. An analysis of the phenotypes of mutants and cells with altered gene expression revealed the diverse physiological roles of this regulator. High-level IscR strongly inhibited anaerobic, but not aerobic, growth. iscR contributes significantly to the bacteria overall resistance to oxidative stress, as demonstrated through mutants with increased sensitivity to oxidants, such as peroxides and redox-cycling drugs. Moreover, the regulator also plays important roles in modulating intracellular iron homeostasis, potentially through sensing the levels of [Fe-S]. The increased expression of the isc operon in the mutant not only diverts iron away from the available pool but also reduces the total intracellular iron content, affecting many iron metabolism pathways leading to alterations in siderophores and haem levels. The diverse expression patterns and phenotypic changes of the mutant support the role of P. aeruginosa IscR as a global transcriptional regulator that senses [Fe-S] and directly represses or activates the transcription of genes affecting many physiological pathways.	[Romsang, Adisak; Saninjuk, Kritsakorn; Mongkolsuk, Skorn] Mahidol Univ, Fac Sci, Dept Biotechnol, Bangkok 10400, Thailand; [Mongkolsuk, Skorn] Mahidol Univ, Fac Sci, Ctr Emerging Bacterial Infect, Bangkok 10400, Thailand; [Leesukon, Panithi] Mahidol Univ, Fac Sci, Mol Med Grad Program, Bangkok 10400, Thailand; [Romsang, Adisak; Duang-Nkern, Jintana; Vattanaviboon, Paiboon; Mongkolsuk, Skorn] Chulabhorn Res Inst, Biotechnol Lab, Bangkok, Thailand; [Vattanaviboon, Paiboon] Chulabhorn Grad Inst, Program Appl Biol Sci Environm Hlth, Bangkok, Thailand; [Vattanaviboon, Paiboon; Mongkolsuk, Skorn] Minist Educ, Ctr Excellence Environm Hlth & Toxicol, Bangkok, Thailand	Mahidol University; Mahidol University; Mahidol University; Chulabhorn Research Institute; Chulabhorn Graduate Institute	Mongkolsuk, S (corresponding author), Mahidol Univ, Fac Sci, Dept Biotechnol, Bangkok 10400, Thailand.	skorn@cri.or.th	Vattanaviboon, Paiboon/V-1380-2019; Saninjuk, Kritsakorn/V-1916-2019; Romsang, Adisak/H-7142-2014; Romsang, Adisak/K-2630-2019	Saninjuk, Kritsakorn/0000-0002-7511-2985; Romsang, Adisak/0000-0002-5339-5443; Romsang, Adisak/0000-0002-5339-5443	Center of Excellence on Environmental Health and Toxicology, Ministry of Education, Thailand; Royal Golden Jubilee Ph.D. Program [PHD/0294/2550]; Thailand Research Fund and Mahidol University	Center of Excellence on Environmental Health and Toxicology, Ministry of Education, Thailand; Royal Golden Jubilee Ph.D. Program(Thailand Research Fund (TRF)); Thailand Research Fund and Mahidol University	This work was supported by grants Center of Excellence on Environmental Health and Toxicology, Ministry of Education, Thailand (http://www.etm.sc.mahidol.ac.th/index.asp) and by the Royal Golden Jubilee Ph.D. Program (PHD/0294/2550) from the joint funding of Thailand Research Fund and Mahidol University (http://rgj.trf.or.th/eng/rgje11.asp). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Parts of this work are from A. R. dissertation submitted for a Ph.D. degree from Mahidol University.	Ayala-Castro C, 2008, MICROBIOL MOL BIOL R, V72, P110, DOI 10.1128/MMBR.00034-07; Choi KH, 2006, NAT PROTOC, V1, P153, DOI 10.1038/nprot.2006.24; Choi YS, 2007, J MICROBIOL BIOTECHN, V17, P1344; COOPER SR, 1978, P NATL ACAD SCI USA, V75, P3551, DOI 10.1073/pnas.75.8.3551; Cornelis P, 2009, BIOMETALS, V22, P15, DOI 10.1007/s10534-008-9193-0; Desnoyers G, 2009, EMBO J, V28, P1551, DOI 10.1038/emboj.2009.116; Dos Santos PC, 2007, J BACTERIOL, V189, P2854, DOI 10.1128/JB.01734-06; Fleischhacker AS, 2012, BIOCHEMISTRY-US, V51, P4453, DOI 10.1021/bi3003204; Fontecave M, 2008, ARCH BIOCHEM BIOPHYS, V474, P226, DOI 10.1016/j.abb.2007.12.014; Giel JL, 2013, MOL MICROBIOL, V87, P478, DOI 10.1111/mmi.12052; Giel JL, 2006, MOL MICROBIOL, V60, P1058, DOI 10.1111/j.1365-2958.2006.05160.x; Hassett DJ, 1996, J BACTERIOL, V178, P3996, DOI 10.1128/jb.178.14.3996-4003.1996; Heo YJ, 2010, J BACTERIOL, V192, P381, DOI 10.1128/JB.00980-09; JACOBSON MR, 1989, MOL GEN GENET, V219, P49, DOI 10.1007/BF00261156; Jittawuttipoka T, 2010, ARCH MICROBIOL, V192, P331, DOI 10.1007/s00203-010-0558-8; Kim SH, 2009, J MICROBIOL BIOTECHN, V19, P1520, DOI 10.4014/jmb.0906.06028; KOVACH ME, 1995, GENE, V166, P175, DOI 10.1016/0378-1119(95)00584-1; Lee KC, 2008, J BACTERIOL, V190, P8244, DOI 10.1128/JB.01161-08; Marx CJ, 2002, BIOTECHNIQUES, V33, P1062, DOI 10.2144/02335rr01; Nesbit AD, 2009, J MOL BIOL, V387, P28, DOI 10.1016/j.jmb.2009.01.055; Panmanee W, 2006, J BACTERIOL, V188, P1389, DOI 10.1128/JB.188.4.1389-1395.2006; Py B, 2010, NAT REV MICROBIOL, V8, P436, DOI 10.1038/nrmicro2356; Rajagopalan S, 2013, NAT STRUCT MOL BIOL, V20, P740, DOI 10.1038/nsmb.2568; Rincon-Enriquez G, 2008, MOL MICROBIOL, V67, P1257, DOI 10.1111/j.1365-2958.2008.06118.x; Roche B, 2013, BBA-BIOENERGETICS, V1827, P455, DOI 10.1016/j.bbabio.2012.12.010; Romsang A, 2013, J BACTERIOL, V195, P3299, DOI 10.1128/JB.00167-13; Saenkham P, 2009, FEMS MICROBIOL LETT, V293, P122, DOI 10.1111/j.1574-6968.2009.01516.x; Sambrook J, 2001, MOL CLONING LAB MANU; Schwartz CJ, 2001, P NATL ACAD SCI USA, V98, P14895, DOI 10.1073/pnas.251550898; Shin DH, 2008, J BACTERIOL, V190, P2663, DOI 10.1128/JB.01580-07; Somprasong N, 2012, J BACTERIOL, V194, P3904, DOI 10.1128/JB.00347-12; Stover CK, 2000, NATURE, V406, P959, DOI 10.1038/35023079; Winsor GL, 2005, NUCLEIC ACIDS RES, V33, pD338, DOI 10.1093/nar/gki047; Yao HL, 2011, BIOCHEMISTRY-US, V50, P5236, DOI 10.1021/bi2004119; Yeo WS, 2006, MOL MICROBIOL, V61, P206, DOI 10.1111/j.1365-2958.2006.05220.x	35	36	36	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2014	9	1							e86763	10.1371/journal.pone.0086763	http://dx.doi.org/10.1371/journal.pone.0086763			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297VL	24466226	Green Published, gold, Green Submitted			2022-12-25	WOS:000330283100208
J	Riordan, EC; Rundel, PW				Riordan, Erin Coulter; Rundel, Philip W.			Land Use Compounds Habitat Losses under Projected Climate Change in a Threatened California Ecosystem	PLOS ONE			English	Article							COASTAL SAGE SCRUB; SPECIES DISTRIBUTIONS; SOUTHERN CALIFORNIA; CHANGE IMPACTS; SELECTING THRESHOLDS; VEGETATION STRUCTURE; DISTRIBUTION MODELS; POSTFIRE RECOVERY; PLANT DIVERSITY; BREEDING BIRDS	Given the rapidly growing human population in mediterranean-climate systems, land use may pose a more immediate threat to biodiversity than climate change this century, yet few studies address the relative future impacts of both drivers. We assess spatial and temporal patterns of projected 21st century land use and climate change on California sage scrub (CSS), a plant association of considerable diversity and threatened status in the mediterranean-climate California Floristic Province. Using a species distribution modeling approach combined with spatially-explicit land use projections, we model habitat loss for 20 dominant shrub species under unlimited and no dispersal scenarios at two time intervals (early and late century) in two ecoregions in California (Central Coast and South Coast). Overall, projected climate change impacts were highly variable across CSS species and heavily dependent on dispersal assumptions. Projected anthropogenic land use drove greater relative habitat losses compared to projected climate change in many species. This pattern was only significant under assumptions of unlimited dispersal, however, where considerable climate-driven habitat gains offset some concurrent climate-driven habitat losses. Additionally, some of the habitat gained with projected climate change overlapped with projected land use. Most species showed potential northern habitat expansion and southern habitat contraction due to projected climate change, resulting in sharply contrasting patterns of impact between Central and South Coast Ecoregions. In the Central Coast, dispersal could play an important role moderating losses from both climate change and land use. In contrast, high geographic overlap in habitat losses driven by projected climate change and projected land use in the South Coast underscores the potential for compounding negative impacts of both drivers. Limiting habitat conversion may be a broadly beneficial strategy under climate change. We emphasize the importance of addressing both drivers in conservation and resource management planning.	[Riordan, Erin Coulter; Rundel, Philip W.] Univ Calif Los Angeles, Dept Ecol & Evolutionary Biol, Los Angeles, CA 90047 USA	University of California System; University of California Los Angeles	Riordan, EC (corresponding author), Univ Calif Los Angeles, Dept Ecol & Evolutionary Biol, Los Angeles, CA 90047 USA.	eriordan@ucla.edu		Riordan, Erin/0000-0002-4524-8048	University of California Los Angeles (UCLA) Foundation, Department of Ecology and Evolutionary Biology, UCLA	University of California Los Angeles (UCLA) Foundation, Department of Ecology and Evolutionary Biology, UCLA	This work was supported by the University of California Los Angeles (UCLA) Foundation, Department of Ecology and Evolutionary Biology, UCLA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackerly DD, 2010, DIVERS DISTRIB, V16, P476, DOI 10.1111/j.1472-4642.2010.00654.x; Baldwin B.G., 2012, JEPSON MANUAL VASCUL; Bar-Joseph U., 2004, 2 MINUTES BAGHDAD; Barbet-Massin M, 2012, GLOBAL CHANGE BIOL, V18, P881, DOI 10.1111/j.1365-2486.2011.02552.x; Barbet-Massin M, 2010, ECOGRAPHY, V33, P878, DOI 10.1111/j.1600-0587.2010.06181.x; Buisson L, 2010, GLOBAL CHANGE BIOL, V16, P1145, DOI 10.1111/j.1365-2486.2009.02000.x; CA-DOF State of California Department of Finance, 2011, HIST CENS POP COUNT; CALLAWAY RM, 1993, ECOLOGY, V74, P1567, DOI 10.2307/1940084; CNPS California Native Plant Society, 2012, INV RAR END PLANTS O; Collingham YC, 2000, ECOL APPL, V10, P131, DOI 10.1890/1051-0761(2000)010[0131:IOHFAP]2.0.CO;2; Conlisk E, 2013, GLOBAL CHANGE BIOL, V19, P858, DOI 10.1111/gcb.12090; Conlisk E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036391; Cowling RM, 1996, TRENDS ECOL EVOL, V11, P362, DOI 10.1016/0169-5347(96)10044-6; DeSimone S., 1995, FREMONTIA, V23, P3; DeSimone SA, 1992, MADRONO, V39, P170; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; Elith J, 2009, ANNU REV ECOL EVOL S, V40, P677, DOI 10.1146/annurev.ecolsys.110308.120159; EPLING CARL, 1942, AMER MIDLAND NAT, V27, P445, DOI 10.2307/2421012; Fahrig L, 2001, BIOL CONSERV, V100, P65, DOI 10.1016/S0006-3207(00)00208-1; Fahrig L, 2002, ECOL APPL, V12, P346, DOI 10.1890/1051-0761(2002)012[0346:EOHFOT]2.0.CO;2; Feldman TD, 2000, ANN ASSOC AM GEOGR, V90, P256, DOI 10.1111/0004-5608.00195; Fitzpatrick MC, 2008, GLOBAL CHANGE BIOL, V14, P1337, DOI 10.1111/j.1365-2486.2008.01559.x; Flint L.E., 2013, ECOL PROCESS, V2, P1, DOI [10.1186/2192-1709-2-25, DOI 10.1186/2192-1709-2-25]; Franklin J, 1995, PROG PHYS GEOG, V19, P474, DOI 10.1177/030913339501900403; Guisan A, 2000, ECOL MODEL, V135, P147, DOI 10.1016/S0304-3800(00)00354-9; Guisan A, 2005, ECOL LETT, V8, P993, DOI 10.1111/j.1461-0248.2005.00792.x; Hampe A, 2005, ECOL LETT, V8, P461, DOI 10.1111/j.1461-0248.2005.00739.x; HARRISON AT, 1971, ECOLOGY, V52, P869, DOI 10.2307/1936035; Hayhoe K, 2004, P NATL ACAD SCI USA, V101, P12422, DOI 10.1073/pnas.0404500101; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Jongsomjit D, 2013, LANDSCAPE ECOL, V28, P187, DOI 10.1007/s10980-012-9825-1; Keeley JE, 2005, ECOL APPL, V15, P1515, DOI 10.1890/04-1005; KEELEY JE, 1984, AM MIDL NAT, V111, P105, DOI 10.2307/2425548; Keith DA, 2008, BIOL LETTERS, V4, P560, DOI 10.1098/rsbl.2008.0049; KIRKPATRICK JB, 1980, J BIOGEOGR, V7, P23, DOI 10.2307/2844545; Klausmeyer KR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006392; Liu CR, 2013, J BIOGEOGR, V40, P778, DOI 10.1111/jbi.12058; Liu CR, 2005, ECOGRAPHY, V28, P385, DOI 10.1111/j.0906-7590.2005.03957.x; Loarie SR, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002502; Loiselle BA, 2008, J BIOGEOGR, V35, P105, DOI 10.1111/j.1365-2699.2007.01779.x; MALANSON GP, 1991, CLIMATIC CHANGE, V18, P363, DOI 10.1007/BF00142967; Meehl GA, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P747; Meentemeyer RK, 2001, PLANT ECOL, V156, P19, DOI 10.1023/A:1011944805738; Midgley GF, 2002, GLOBAL ECOL BIOGEOGR, V11, P445, DOI 10.1046/j.1466-822X.2002.00307.x; Minnich Richard A., 1998, Western Birds, V29, P366; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; O'Leary JF, 1990, CALIFORNIA COASTAL S, P24; OLeary J.F., 1995, FREMONTIA, V23, P27; Padgett PE, 1999, ATMOS ENVIRON, V33, P769, DOI 10.1016/S1352-2310(98)00214-3; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; Parmesan C, 2006, ANNU REV ECOL EVOL S, V37, P637, DOI 10.1146/annurev.ecolsys.37.091305.110100; PARSONS DJ, 1975, ECOLOGY, V56, P950, DOI 10.2307/1936305; PARSONS DJ, 1976, J ECOL, V64, P435, DOI 10.2307/2258767; Pearson RG, 2006, TRENDS ECOL EVOL, V21, P111, DOI 10.1016/j.tree.2005.11.022; Pearson RG, 2003, GLOBAL ECOL BIOGEOGR, V12, P361, DOI 10.1046/j.1466-822X.2003.00042.x; Pearson RG, 2006, J BIOGEOGR, V33, P1704, DOI 10.1111/j.1365-2699.2006.01460.x; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Phillips SJ, 2008, ECOGRAPHY, V31, P161, DOI 10.1111/j.0906-7590.2008.5203.x; Riordan EC, 2009, J BIOGEOGR, V36, P2176, DOI 10.1111/j.1365-2699.2009.02151.x; Rundel PW, 2007, TERRESTRIAL VEGETATION OF CALIFORNIA, 3RD EDITION, P208; Sala OE, 2000, SCIENCE, V287, P1770, DOI 10.1126/science.287.5459.1770; Sanstad AH, 2011, CLIMATIC CHANGE, V109, P21, DOI 10.1007/s10584-011-0296-1; SHREVE F., 1936, MADRONO, V3, P257; Sleeter BM, 2012, GLOBAL ENVIRON CHANG, V22, P896, DOI 10.1016/j.gloenvcha.2012.03.008; Sohl T, 2008, ECOL MODEL, V219, P49, DOI 10.1016/j.ecolmodel.2008.08.003; Sohl TL, 2012, APPL GEOGR, V34, P111, DOI 10.1016/j.apgeog.2011.10.019; Stralberg D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006825; Stylinski CD, 1999, J APPL ECOL, V36, P544, DOI 10.1046/j.1365-2664.1999.00423.x; Syphard AD, 2007, LANDSCAPE ECOL, V22, P431, DOI 10.1007/s10980-006-9025-y; Syphard AD, 2013, DIVERS DISTRIB, V19, P1263, DOI 10.1111/ddi.12076; Syphard AD, 2011, J ENVIRON MANAGE, V92, P1882, DOI 10.1016/j.jenvman.2011.03.014; Talluto MV, 2008, LANDSCAPE ECOL, V23, P803, DOI 10.1007/s10980-008-9238-3; Thomas CD, 2004, NATURE, V427, P145, DOI 10.1038/nature02121; Thuiller W, 2005, P NATL ACAD SCI USA, V102, P8245, DOI 10.1073/pnas.0409902102; Thuiller W, 2008, PERSPECT PLANT ECOL, V9, P137, DOI 10.1016/j.ppees.2007.09.004; Travis JMJ, 2003, P ROY SOC B-BIOL SCI, V270, P467, DOI 10.1098/rspb.2002.2246; Underwood EC, 2009, DIVERS DISTRIB, V15, P188, DOI 10.1111/j.1472-4642.2008.00518.x; WELLS PV, 1962, ECOL MONOGR, V32, P79, DOI 10.2307/1942361; Westerling AL, 2011, CLIMATIC CHANGE, V109, P445, DOI 10.1007/s10584-011-0329-9; WESTMAN WE, 1981, ECOLOGY, V62, P170, DOI 10.2307/1936680; WESTMAN WE, 1981, ECOLOGY, V62, P439, DOI 10.2307/1936717; WESTMAN WE, 1983, VEGETATIO, V52, P3; Williams JW, 2007, P NATL ACAD SCI USA, V104, P5738, DOI 10.1073/pnas.0606292104; Yates CJ, 2010, AUSTRAL ECOL, V35, P374, DOI 10.1111/j.1442-9993.2009.02044.x; ZEDLER PH, 1983, ECOLOGY, V64, P809, DOI 10.2307/1937204	85	55	57	4	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2014	9	1							e86487	10.1371/journal.pone.0086487	http://dx.doi.org/10.1371/journal.pone.0086487			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297GT	24466116	Green Published, Green Submitted, gold			2022-12-25	WOS:000330244500246
J	Yu, LX; Parthasarathy, MV				Yu, Long-Xi; Parthasarathy, Mandayam V.			Molecular and Cellular Characterization of the Tomato Pollen Profilin, LePro1	PLOS ONE			English	Article							PHOSPHOLIPASE-C; TUBE GROWTH; ACTIN; ISOFORMS; CYTOSKELETON; ALLERGEN; PLANTS; LOCALIZATION; ARABIDOPSIS; GERMINATION	Profilin is an actin-binding protein involved in the dynamic turnover and restructuring of the actin cytoskeleton in all eukaryotic cells. We previously cloned a profilin gene, designated as LePro1 from tomato pollen. To understand its biological role, in the present study, we investigated the temporal and spatial expression of LePro1 during pollen development and found that the transcript was only detected at late stages during microsporogenesis and pollen maturation. Using antisense RNA, we successfully knocked down the expression of LePro1 in tomato plants using stable transformation, and obtained two antisense lines, A2 and A3 showing significant down-regulation of LePro1 in pollen resulting in poor pollen germination and abnormal pollen tube growth. A disorganized F-actin distribution was observed in the antisense pollen. Downregulation of LePro1 also appeared to affect hydration of pollen deposited on the stigma and arrested pollen tube elongation in the style, thereby affecting fertilization. Our results suggest that LePro1 in conjunction with perhaps other cytoskeletal proteins, plays a regulatory role in the proper organization of F-actin in tomato pollen tubes through promoting actin assembly. Down-regulation of LePro1 leads to interruption of actin assembly and disorganization of the actin cytoskeleton thus arresting pollen tube growth. Based on the present and previous studies, it is likely that a single transcript of profilin gives rise to multiple forms displaying multifunctionality in tomato pollen.	[Yu, Long-Xi; Parthasarathy, Mandayam V.] Cornell Univ, Dept Plant Biol, Ithaca, NY USA	Cornell University	Yu, LX (corresponding author), ARS, USDA, Vegetable & Forage Crop Res Unit, Prosser, WA 99350 USA.	longxi.yu@ars.usda.gov			National Research Initiative competitive grants program/United States Department of Agriculture [94-37304]; ARS [ARS-0425169] Funding Source: Federal RePORTER	National Research Initiative competitive grants program/United States Department of Agriculture; ARS(United States Department of Agriculture (USDA)USDA Agricultural Research Service)	This work was supported by a National Research Initiative competitive grants program/United States Department of Agriculture 94-37304 to M.V.P. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADEREM A, 1992, TRENDS BIOCHEM SCI, V17, P438, DOI 10.1016/0968-0004(92)90016-3; ANDERSLAND JM, 1994, CELL MOTIL CYTOSKEL, V29, P339, DOI 10.1002/cm.970290406; Bollag D.M., 1991, PROTEIN METHODS; BUSS F, 1992, CELL MOTIL CYTOSKEL, V22, P51, DOI 10.1002/cm.970220106; Clarke SR, 1998, PLANT CELL, V10, P967, DOI 10.1105/tpc.10.6.967; COOLEY L, 1992, CELL, V69, P173, DOI 10.1016/0092-8674(92)90128-Y; Darnowski DW, 1997, THESIS CORNELL U ITH; Drbak BK, 1994, PLANT J, V6, P389; Fillatti JJ, 1987, TOMATO BIOTECHNOLOGY, V4, P199; Frary A, 1996, PLANT CELL REP, V16, P235, DOI 10.1007/BF01890875; FULTON TM, 1995, PLANT MOL BIOL REP, V13, P207, DOI 10.1007/BF02670897; Gibbon BC, 1999, PLANT CELL, V11, P2349, DOI 10.1105/tpc.11.12.2349; GIBBON BC, 2000, ACTIN DYNAMIC FRAMEW, P45; GOLDSCHMIDTCLERMONT PJ, 1990, SCIENCE, V247, P1575, DOI 10.1126/science.2157283; GROTE M, 1993, J HISTOCHEM CYTOCHEM, V41, P745, DOI 10.1177/41.5.8468456; Guillen G, 1999, PLANT J, V19, P497, DOI 10.1046/j.1365-313X.1999.00542.x; Huang SR, 1996, PLANT PHYSIOL, V111, P115, DOI 10.1104/pp.111.1.115; Jimenez-Lopez JC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030878; Kandasamy MK, 2002, CELL MOTIL CYTOSKEL, V52, P22, DOI 10.1002/cm.10029; Kovar DR, 2000, PLANT CELL, V12, P583, DOI 10.1105/tpc.12.4.583; Li FL, 2003, PLANT MOL BIOL REP, V21, P73, DOI 10.1007/BF02773399; MACHESKY LM, 1990, CELL REGUL, V1, P937, DOI 10.1091/mbc.1.12.937; Mittermann I, 1996, SEX PLANT REPROD, V9, P133, DOI 10.1007/BF02221392; PARTHASARATHY MV, 1985, AM J BOT, V72, P1318, DOI 10.2307/2443413; Ramachandran S, 2000, PLANT PHYSIOL, V124, P1637, DOI 10.1104/pp.124.4.1637; Sambrook J., 1989, MOL CLONING LAB MANU, V2; SEAGULL RW, 1989, CRIT REV PLANT SCI, V8, P131, DOI 10.1080/07352688909382273; SMITH LC, 1992, MOL BIOL CELL, V3, P403, DOI 10.1091/mbc.3.4.403; STAIGER CJ, 1987, PROTOPLASMA, V141, P1, DOI 10.1007/BF01276783; STAIGER CJ, 1993, PLANT J, V4, P631, DOI 10.1046/j.1365-313X.1993.04040631.x; STOSSEL TP, 1985, ANNU REV CELL BIOL, V1, P353, DOI 10.1146/annurev.cb.01.110185.002033; Taylor LP, 1997, ANNU REV PLANT PHYS, V48, P461, DOI 10.1146/annurev.arplant.48.1.461; Thorn KS, 1997, STRUCTURE, V5, P19, DOI 10.1016/S0969-2126(97)00163-9; TILNEY LG, 1983, J CELL BIOL, V97, P112, DOI 10.1083/jcb.97.1.112; VALENTA R, 1991, SCIENCE, V253, P557, DOI 10.1126/science.1857985; Vidali L, 2007, PLANT CELL, V19, P3705, DOI 10.1105/tpc.107.053413; VOJTEK A, 1991, CELL, V66, P497, DOI 10.1016/0092-8674(81)90013-1; Westphal S, 2003, EUR J BIOCHEM, V270, P1327, DOI 10.1046/j.1432-1033.2003.03503.x; Witke W, 2004, TRENDS CELL BIOL, V14, P461, DOI 10.1016/j.tcb.2004.07.003; Yu LX, 1998, PLANT MOL BIOL, V36, P699, DOI 10.1023/A:1005971327353	40	3	3	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2014	9	1							e86505	10.1371/journal.pone.0086505	http://dx.doi.org/10.1371/journal.pone.0086505			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297GT	24466125	Green Published, gold, Green Submitted			2022-12-25	WOS:000330244500249
J	Lin, GR; Brownsey, RW; MacLeod, KM				Lin, Guorong; Brownsey, Roger W.; MacLeod, Kathleen M.			Complex Regulation of PKC beta 2 and PDK-1/AKT by ROCK2 in Diabetic Heart	PLOS ONE			English	Article							PROTEIN-KINASE-C; PHOSPHOINOSITIDE-DEPENDENT KINASE; RHO-KINASE; IN-VIVO; SELECTIVE INHIBITOR; CARDIAC DYSFUNCTION; MYOSIN PHOSPHATASE; GLUCOSE-TRANSPORT; SMOOTH-MUSCLE; PHOSPHORYLATION	Objectives: The RhoA/ROCK pathway contributes to diabetic cardiomyopathy in part by promoting the sustained activation of PKC beta 2 but the details of their interaction are unclear. The purpose of this study was to investigate if over-activation of ROCK in the diabetic heart leads to direct phosphorylation and activation of PKC beta 2, and to determine if their interaction affects PDK-1/Akt signaling. Methods: Regulation by ROCK of PKC beta 2 and related kinases was investigated by Western blotting and co-immunoprecipitation in whole hearts and isolated cardiomyocytes from 12 to 14-week diabetic rats. Direct ROCK2 phosphorylation of PKC beta 2 was examined in vitro. siRNA silencing was used to confirm role of ROCK2 in PKC beta 2 phosphorylation in vascular smooth muscle cells cultured in high glucose. Furthermore, the effect of ROCK inhibition on GLUT4 translocation was determined in isolated cardiomyocytes by confocal microscopy. Results: Expression of ROCK2 and expression and phosphorylation of PKC beta 2 were increased in diabetic hearts. A physical interaction between the two kinases was demonstrated by reciprocal i mmunoprecipitation, while ROCK2 directly phosphorylated PKC beta 2 at T641 in vitro. ROCK2 siRNA in vascular smooth muscle cells or inhibition of ROCK in diabetic hearts reduced PKC beta 2 T641 phosphorylation, and this was associated with attenuation of PKC beta 2 activity. PKC beta 2 also formed a complex with PDK-1 and its target AKT, and ROCK inhibition resulted in upregulation of the phosphorylation of PDK-1 and AKT, and increased translocation of glucose transporter 4 (GLUT4) to the plasma membrane in diabetic hearts. Conclusion: This study demonstrates that over-activation of ROCK2 contributes to diabetic cardiomyopathy by multiple mechanisms, including direct phosphorylation and activation of PKC beta 2 and interference with the PDK-1-mediated phosphorylation and activation of AKT and translocation of GLUT4. This suggests that ROCK2 is a critical node in the development of diabetic cardiomyopathy and may be an effective target to improve cardiac function in diabetes.	[Lin, Guorong; MacLeod, Kathleen M.] Univ British Columbia, Fac Pharmaceut Sci, Mol & Cellular Pharmacol Res Grp, Vancouver, BC, Canada; [Brownsey, Roger W.] Univ British Columbia, Dept Biochem & Mol Biol, Vancouver, BC, Canada	University of British Columbia; University of British Columbia	MacLeod, KM (corresponding author), Univ British Columbia, Fac Pharmaceut Sci, Mol & Cellular Pharmacol Res Grp, Vancouver, BC, Canada.	kmm@mail.ubc.ca		MacLeod, Kathleen/0000-0002-4280-6083	Canadian Institutes of Health Research [FRN 97861]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This study was supported by an operating grant (FRN 97861) from the Canadian Institutes of Health Research to KMM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aiello LP, 1997, DIABETES, V46, P1473, DOI 10.2337/diabetes.46.9.1473; Alessi DR, 1997, CURR BIOL, V7, P261, DOI 10.1016/S0960-9822(06)00122-9; Alessi DR, 1996, EMBO J, V15, P6541, DOI 10.1002/j.1460-2075.1996.tb01045.x; Arikawa E, 2007, DIABETES, V56, P1410, DOI 10.2337/db06-0655; Arita R, 2010, J OPHTHALMOL, V2010, DOI 10.1155/2010/175163; Arita R, 2009, DIABETES, V58, P215, DOI 10.2337/db08-0762; Calleja V, 2007, PLOS BIOL, V5, P780, DOI 10.1371/journal.pbio.0050095; Casamayor A, 1999, BIOCHEM J, V342, P287, DOI 10.1042/0264-6021:3420287; Chun KH, 2012, ENDOCRINOLOGY, V153, P1649, DOI 10.1210/en.2011-1036; Cline GW, 1999, NEW ENGL J MED, V341, P240, DOI 10.1056/NEJM199907223410404; Danis RP, 1998, INVEST OPHTH VIS SCI, V39, P171; Dutil EM, 1998, CURR BIOL, V8, P1366, DOI 10.1016/S0960-9822(98)00017-7; Facchinetti V, 2008, EMBO J, V27, P1932, DOI 10.1038/emboj.2008.120; Failli P, 2009, CARDIOVASC DIABETOL, V8, DOI 10.1186/1475-2840-8-32; Fonarow GC, 2006, ENDOCRIN METAB CLIN, V35, P575, DOI 10.1016/j.ecl.2006.05.003; Furukawa N, 2005, CELL METAB, V2, P119, DOI 10.1016/j.cmet.2005.06.011; Gao T, 2008, J BIOL CHEM, V283, P6300, DOI 10.1074/jbc.M707319200; Gao TY, 2001, J BIOL CHEM, V276, P19588, DOI 10.1074/jbc.M101357200; Hoenack C, 1996, DIABETES, V45, pS82, DOI 10.2337/diab.45.1.S82; Hudson CA, 2012, MOL HUM REPROD, V18, P265, DOI 10.1093/molehr/gar078; Ikenoue T, 2008, EMBO J, V27, P1919, DOI 10.1038/emboj.2008.119; Ishii H, 1998, J MOL MED, V76, P21, DOI 10.1007/s109-1998-8101-y; Ishii H, 1996, SCIENCE, V272, P728, DOI 10.1126/science.272.5262.728; Keranen LM, 1995, CURR BIOL, V5, P1394, DOI 10.1016/S0960-9822(95)00277-6; Kim H, 2003, DIABETES, V52, P2102, DOI 10.2337/diabetes.52.8.2102; Kolavennu V, 2008, DIABETES, V57, P714, DOI 10.2337/db07-1241; Komers R, 2011, KIDNEY INT, V79, P432, DOI 10.1038/ki.2010.428; Lei SQ, 2013, DIABETES, V62, P2318, DOI 10.2337/db12-1391; Lin G, 2009, CELL MOL LIFE SCI, V66, P135, DOI 10.1007/s00018-008-8575-3; Lin GR, 2007, CARDIOVASC RES, V75, P51, DOI 10.1016/j.cardiores.2007.03.009; Mandavia CH, 2013, LIFE SCI, V92, P601, DOI 10.1016/j.lfs.2012.10.028; Matsui T, 2001, CIRCULATION, V104, P330; Mellor H, 1998, BIOCHEM J, V332, P281, DOI 10.1042/bj3320281; Nagareddy PR, 2009, DIABETES, V58, P2355, DOI 10.2337/db09-0432; Nakagawa O, 1996, FEBS LETT, V392, P189, DOI 10.1016/0014-5793(96)00811-3; Nakamura J, 1999, DIABETES, V48, P2090, DOI 10.2337/diabetes.48.10.2090; Newton AC, 1997, CURR OPIN CELL BIOL, V9, P161, DOI 10.1016/S0955-0674(97)80058-0; Newton AC, 2001, CHEM REV, V101, P2353, DOI 10.1021/cr0002801; Pauly RR, 1998, METHOD CELL BIOL, P133; Randhawa VK, 2000, MOL BIOL CELL, V11, P2403, DOI 10.1091/mbc.11.7.2403; Rattan S, 2008, AM J PHYSIOL-GASTR L, V294, pG687, DOI 10.1152/ajpgi.00501.2007; Reyland ME, 2009, FRONT BIOSCI-LANDMRK, V14, P2386, DOI 10.2741/3385; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Scheid MP, 2005, MOL CELL BIOL, V25, P2347, DOI 10.1128/MCB.25.6.2347-2363.2005; Shi JJ, 2011, PEDIATR CARDIOL, V32, P297, DOI 10.1007/s00246-011-9920-0; Soliman H, 2012, AM J PHYSIOL-HEART C, V303, pH989, DOI 10.1152/ajpheart.00416.2012; Surma M, 2011, FUTUR CARDIOL, V7, P657, DOI [10.2217/fca.11.51, 10.2217/FCA.11.51]; Sussman MA, 2011, PHYSIOL REV, V91, P1023, DOI 10.1152/physrev.00024.2010; Wang YP, 2009, CIRC RES, V104, P531, DOI 10.1161/CIRCRESAHA.108.188524; Weiss WA, 2007, NAT CHEM BIOL, V3, P739, DOI 10.1038/nchembio1207-739; Wick MJ, 2003, J BIOL CHEM, V278, P42913, DOI 10.1074/jbc.M304172200; Zhou H, 2011, ACTA PHARMACOL SIN, V32, P999, DOI 10.1038/aps.2011.54; Zhou H, 2011, CLIN EXP PHARMACOL P, V38, P387, DOI 10.1111/j.1440-1681.2011.05523.x	53	16	18	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2014	9	1							e86520	10.1371/journal.pone.0086520	http://dx.doi.org/10.1371/journal.pone.0086520			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297FH	24466133	Green Submitted, Green Published, gold			2022-12-25	WOS:000330240500137
J	Foley, KA; Ossenkopp, KP; Kavaliers, M; MacFabe, DF				Foley, Kelly A.; Ossenkopp, Klaus-Peter; Kavaliers, Martin; MacFabe, Derrick F.			Pre- and Neonatal Exposure to Lipopolysaccharide or the Enteric Metabolite, Propionic Acid, Alters Development and Behavior in Adolescent Rats in a Sexually Dimorphic Manner	PLOS ONE			English	Article							MATERNAL IMMUNE ACTIVATION; AUTISM SPECTRUM DISORDER; FETAL-BRAIN DEVELOPMENT; BODY-WEIGHT REGULATION; ANXIETY-LIKE BEHAVIOR; CHAIN FATTY-ACIDS; VALPROIC ACID; GENE-EXPRESSION; PRENATAL STRESS; BACTERIAL-ENDOTOXIN	Alterations in the composition of the gut microbiome and/or immune system function may have a role in the development of autism spectrum disorders (ASD). The current study examined the effects of prenatal and early life administration of lipopolysaccharide (LPS), a bacterial mimetic, and the short chain fatty acid, propionic acid (PPA), a metabolic fermentation product of enteric bacteria, on developmental milestones, locomotor activity, and anxiety-like behavior in adolescent male and female offspring. Pregnant Long-Evans rats were subcutaneously injected once a day with PPA (500 mg/kg) on gestation days G12-16, LPS (50 mu g/kg) on G15-16, or vehicle control on G12-16 or G15-16. Male and female offspring were injected with PPA (500 mg/kg) or vehicle twice a day, every second day from postnatal days (P) 10-18. Physical milestones and reflexes were monitored in early life with prenatal PPA and LPS inducing delays in eye opening. Locomotor activity and anxiety were assessed in adolescence (P40-42) in the elevated plus maze (EPM) and open-field. Prenatal and postnatal treatments altered behavior in a sex-specific manner. Prenatal PPA decreased time spent in the centre of the open-field in males and females while prenatal and postnatal PPA increased anxiety behavior on the EPM in female rats. Prenatal LPS did not significantly influence those behaviors. Evidence for the double hit hypothesis was seen as females receiving a double hit of PPA (prenatal and postnatal) displayed increased repetitive behavior in the open-field. These results provide evidence for the hypothesis that by-products of enteric bacteria metabolism such as PPA may contribute to ASD, altering development and behavior in adolescent rats similar to that observed in ASD and other neurodevelopmental disorders.	[Foley, Kelly A.; Ossenkopp, Klaus-Peter; Kavaliers, Martin] Univ Western Ontario, Grad Program Neurosci, London, ON, Canada; [Foley, Kelly A.; Ossenkopp, Klaus-Peter; Kavaliers, Martin; MacFabe, Derrick F.] Univ Western Ontario, Dept Psychol, London, ON, Canada; [Ossenkopp, Klaus-Peter; Kavaliers, Martin] Univ Western Ontario, Dept Psychol, Kilee Patchell Evans Autism Res Grp, London, ON, Canada; [MacFabe, Derrick F.] Univ Western Ontario, Dept Psychol, Div Dev Disabil, Kilee Patchell Evans Autism Res Grp, London, ON, Canada; [MacFabe, Derrick F.] Univ Western Ontario, Dept Psychiat, London, ON N6A 3K7, Canada	Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario)	Foley, KA (corresponding author), Univ Western Ontario, Grad Program Neurosci, London, ON, Canada.	kfoley6@uwo.ca	Ossenkopp, Klaus-Peter/A-4810-2008; Tonge, Bruce/T-8036-2018; Foley, Kitty-Rose/C-8800-2018	Ossenkopp, Klaus-Peter/0000-0001-7391-3239; Tonge, Bruce/0000-0002-4236-9688; Girdler, Sonya/0000-0001-7992-0800; Foley, Kitty-Rose/0000-0002-1956-4995	GoodLife Children's Charities; Autism Research Institute (ARI); Natural Science and Engineering Research Council of Canada; Ontario Graduate Scholarship	GoodLife Children's Charities; Autism Research Institute (ARI); Natural Science and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Ontario Graduate Scholarship(Ontario Graduate Scholarship)	This research was supported by contributions from GoodLife Children's Charities and Autism Research Institute (ARI) to Derrick MacFabe and by Natural Science and Engineering Research Council of Canada Grants to Klaus-Peter Ossenkopp and Martin Kavaliers. Kelly Foley was supported by the Ontario Graduate Scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Lahham SH, 2010, BBA-MOL CELL BIOL L, V1801, P1175, DOI 10.1016/j.bbalip.2010.07.007; Al-Owain M, 2013, JIMD REP, V7, P63, DOI 10.1007/8904_2012_143; Baharnoori M, 2012, SCHIZOPHRENIA BULL, V38, P444, DOI 10.1093/schbul/sbq098; Bayer TA, 1999, J PSYCHIATR RES, V33, P543, DOI 10.1016/S0022-3956(99)00039-4; Bennet R, 2002, INFECTION, V30, P158, DOI 10.1007/s15010-002-2140-z; Bloise E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065728; Brestoff JR, 2013, NAT IMMUNOL, V14, P676, DOI 10.1038/ni.2640; Brusque AM, 1999, PHARMACOL BIOCHEM BE, V64, P529, DOI 10.1016/S0091-3057(99)00127-6; Carobrez AP, 2005, NEUROSCI BIOBEHAV R, V29, P1193, DOI 10.1016/j.neubiorev.2005.04.017; Challis J, 2013, PLACENTA, V34, P95, DOI 10.1016/j.placenta.2012.11.007; D'Souza A, 2009, BRAIN RES, V1247, P1, DOI 10.1016/j.brainres.2008.09.088; DAWSON DA, 1991, TERATOLOGY, V44, P531, DOI 10.1002/tera.1420440507; DeCastro M, 2005, MOL BRAIN RES, V142, P28, DOI 10.1016/j.molbrainres.2005.09.002; Dendrinos G, 2011, FRONT INTEGR NEUROSC, V5, DOI 10.3389/fnint.2011.00068; DiCicco-Bloom E, 2006, J NEUROSCI, V26, P6897, DOI 10.1523/JNEUROSCI.1712-06.2006; Drude S, 2011, LAB ANIMAL, V40, P119, DOI 10.1038/laban0411-119; El-Ansary AK, 2011, LIPIDS HEALTH DIS, V10, DOI 10.1186/1476-511X-10-142; Enayati M, 2012, BRAIN RES BULL, V87, P295, DOI 10.1016/j.brainresbull.2011.08.015; Fatemi SH, 2002, BIOL PSYCHIAT, V52, P805, DOI 10.1016/S0006-3223(02)01430-0; Feliz Brady, 2003, Arch Pathol Lab Med, V127, pe325; Finegold SM, 2012, ANAEROBE, V18, P260, DOI 10.1016/j.anaerobe.2011.12.018; Finegold SM, 2010, ANAEROBE, V16, P444, DOI 10.1016/j.anaerobe.2010.06.008; Fombonne E, 2009, PEDIATR RES, V65, P591, DOI 10.1203/PDR.0b013e31819e7203; Fortier ME, 2004, J PSYCHIATR RES, V38, P335, DOI 10.1016/j.jpsychires.2003.10.001; Frye RE, 2013, TRANSL PSYCHIAT, V3, DOI 10.1038/tp.2012.143; Garbett KA, 2012, TRANSL PSYCHIAT, V2, DOI 10.1038/tp.2012.24; Goehler LE, 2008, BRAIN BEHAV IMMUN, V22, P354, DOI 10.1016/j.bbi.2007.08.009; Hallmayer J, 2011, ARCH GEN PSYCHIAT, V68, P1095, DOI 10.1001/archgenpsychiatry.2011.76; Hanstock TL, 2004, PHYSIOL BEHAV, V82, P357, DOI 10.1016/j.physbeh.2004.04.002; Howland JG, 2012, NEUROSCIENCE, V201, P184, DOI 10.1016/j.neuroscience.2011.11.011; Hsiao EY, 2013, CELL, V155, P1451, DOI 10.1016/j.cell.2013.11.024; Iwasa T, 2010, INT J DEV NEUROSCI, V28, P119, DOI 10.1016/j.ijdevneu.2009.08.015; Lin YL, 2012, BRAIN BEHAV IMMUN, V26, P459, DOI 10.1016/j.bbi.2011.12.003; Lynn DA, 2009, DEV PSYCHOBIOL, V51, P513, DOI 10.1002/dev.20386; Lyte M, 1998, PHYSIOL BEHAV, V65, P63, DOI 10.1016/S0031-9384(98)00145-0; MacFabe D., 2008, AM J BIOCH BIOTECHNO, V4, P146, DOI 10.3844/ajbbsp.2008.146.166; MacFabe DF, 2007, BEHAV BRAIN RES, V176, P149, DOI 10.1016/j.bbr.2006.07.025; MacFabe Derrick F., 2012, Microbial Ecology in Health and Disease, V23, P19260, DOI 10.3402/mehd.v23i0.19260; Mandy W, 2012, J AUTISM DEV DISORD, V42, P1304, DOI 10.1007/s10803-011-1356-0; Meyer U, 2014, BIOL PSYCHIAT, V75, P307, DOI 10.1016/j.biopsych.2013.07.011; Mitchell S, 2011, DEV DISABIL RES REV, V17, P130, DOI 10.1002/ddrr.1107; Muhammad A, 2011, BRAIN RES, V1400, P53, DOI 10.1016/j.brainres.2011.05.038; Nagai A, 2010, PLACENTA, V31, P126, DOI 10.1016/j.placenta.2009.11.013; Nouel D, 2012, EUR NEUROPSYCHOPHARM, V22, P300, DOI 10.1016/j.euroneuro.2011.08.001; O'Donnell K, 2009, DEV NEUROSCI-BASEL, V31, P285, DOI 10.1159/000216539; Oblak AL, 2010, J NEUROCHEM, V114, P1414, DOI 10.1111/j.1471-4159.2010.06858.x; Onore C, 2012, BRAIN BEHAV IMMUN, V26, P383, DOI 10.1016/j.bbi.2011.08.007; Oskvig DB, 2012, BRAIN BEHAV IMMUN, V26, P623, DOI 10.1016/j.bbi.2012.01.015; Ossenkopp Klaus-Peter, 1996, P33; Ossenkopp KP, 2012, BEHAV BRAIN RES, V227, P134, DOI 10.1016/j.bbr.2011.10.045; Parracho HMRT, 2005, J MED MICROBIOL, V54, P987, DOI 10.1099/jmm.0.46101-0; Phiel CJ, 2001, J BIOL CHEM, V276, P36734, DOI 10.1074/jbc.M101287200; Reynolds S, 2012, DEV NEUROSCI-BASEL, V34, P258, DOI 10.1159/000336646; Rice D, 2000, ENVIRON HEALTH PERSP, V108, P511, DOI 10.2307/3454543; Rossignol DA, 2012, MOL PSYCHIATR, V17, P389, DOI 10.1038/mp.2011.165; Roullet FI, 2013, NEUROTOXICOL TERATOL, V36, P47, DOI 10.1016/j.ntt.2013.01.004; Ryabinin AE, 1999, PHARMACOL BIOCHEM BE, V63, P143, DOI 10.1016/S0091-3057(98)00239-1; Schneider T, 2005, NEUROPSYCHOPHARMACOL, V30, P80, DOI 10.1038/sj.npp.1300518; Schneider T, 2008, PSYCHONEUROENDOCRINO, V33, P728, DOI 10.1016/j.psyneuen.2008.02.011; Shi LM, 2005, INT J DEV NEUROSCI, V23, P299, DOI 10.1016/j.ijdevneu.2004.05.005; Skokauskas N, 2010, PSYCHOPATHOLOGY, V43, P8, DOI 10.1159/000255958; Smith SEP, 2007, J NEUROSCI, V27, P10695, DOI 10.1523/JNEUROSCI.2178-07.2007; Spencer SJ, 2007, AM J PHYSIOL-REG I, V293, pR581, DOI 10.1152/ajpregu.00262.2007; Stilling RM, 2014, GENES BRAIN BEHAV, V13, P69, DOI 10.1111/gbb.12109; Szatmari P, 2007, NAT GENET, V39, P319, DOI 10.1038/ng1985; Tenk CM, 2008, INT J DEV NEUROSCI, V26, P331, DOI 10.1016/j.ijdevneu.2008.01.001; Thomas RH, 2010, J NEUROCHEM, V113, P515, DOI 10.1111/j.1471-4159.2010.06614.x; Tjellstrom B, 2012, SCAND J GASTROENTERO, V47, P1454, DOI 10.3109/00365521.2012.703234; Ushigome F, 2001, EUR J PHARMACOL, V417, P169, DOI 10.1016/S0014-2999(01)00912-8; Wagner GC, 2006, J AUTISM DEV DISORD, V36, P779, DOI 10.1007/s10803-006-0117-y; Walker AK, 2009, PSYCHONEUROENDOCRINO, V34, P1515, DOI 10.1016/j.psyneuen.2009.05.010; Wang L, 2012, DIGEST DIS SCI, V57, P2096, DOI 10.1007/s10620-012-2167-7; Weinstock M, 2011, STRESS, V14, P604, DOI 10.3109/10253890.2011.588294; Williams BL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024585; Wilson CA, 2013, BEHAV BRAIN RES, V238, P279, DOI 10.1016/j.bbr.2012.10.003; Zhang X, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0040320, 10.1371/journal.pone.0042529]; Zhao JP, 2013, P NATL ACAD SCI USA, V110, P707, DOI 10.1073/pnas.1215854110	77	89	93	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2014	9	1							e87072	10.1371/journal.pone.0087072	http://dx.doi.org/10.1371/journal.pone.0087072			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297VL	24466331	Green Submitted, Green Published, gold			2022-12-25	WOS:000330283100249
J	Mishra, AM; Bai, XX; Sanganahalli, BG; Waxman, SG; Shatillo, O; Grohn, O; Hyder, F; Pitkanen, A; Blumenfeld, H				Mishra, Asht Mangal; Bai, Xiaoxiao; Sanganahalli, Basavaraju G.; Waxman, Stephen G.; Shatillo, Olena; Grohn, Olli; Hyder, Fahmeed; Pitkanen, Asla; Blumenfeld, Hal			Decreased Resting Functional Connectivity after Traumatic Brain Injury in the Rat	PLOS ONE			English	Article							CHILDHOOD ABSENCE EPILEPSY; TONIC-CLONIC SEIZURES; POSTTRAUMATIC EPILEPSY; WAG/RIJ RATS; FMRI; EPILEPTOGENESIS; MODEL; MRI; FLUCTUATIONS; NETWORKS	Traumatic brain injury (TBI) contributes to about 10% of acquired epilepsy. Even though the mechanisms of post-traumatic epileptogenesis are poorly known, a disruption of neuronal networks predisposing to altered neuronal synchrony remains a viable candidate mechanism. We tested a hypothesis that resting state BOLD-fMRI functional connectivity can reveal network abnormalities in brain regions that are connected to the lesioned cortex, and that these changes associate with functional impairment, particularly epileptogenesis. TBI was induced using lateral fluid-percussion injury in seven adult male Sprague-Dawley rats followed by functional imaging at 9.4T 4 months later. As controls we used six sham-operated animals that underwent all surgical operations but were not injured. Electroencephalogram (EEG)-functional magnetic resonance imaging (fMRI) was performed to measure resting functional connectivity. A week after functional imaging, rats were implanted with bipolar skull electrodes. After recovery, rats underwent pentyleneterazol (PTZ) seizure-susceptibility test under EEG. For image analysis, four pairs of regions of interests were analyzed in each hemisphere: ipsilateral and contralateral frontal and parietal cortex, hippocampus, and thalamus. High-pass and low-pass filters were applied to functional imaging data. Group statistics comparing injured and sham-operated rats and correlations over time between each region were calculated. In the end, rats were perfused for histology. None of the rats had epileptiform discharges during functional imaging. PTZ-test, however revealed increased seizure susceptibility in injured rats as compared to controls. Group statistics revealed decreased connectivity between the ipsilateral and contralateral parietal cortex and between the parietal cortex and hippocampus on the side of injury as compared to sham-operated animals. Injured animals also had abnormal negative connectivity between the ipsilateral and contralateral parietal cortex and other regions. Our data provide the first evidence on abnormal functional connectivity after experimental TBI assessed with resting state BOLD-fMRI.	[Mishra, Asht Mangal; Bai, Xiaoxiao; Waxman, Stephen G.; Blumenfeld, Hal] Yale Univ, Sch Med, Dept Neurobiol, New Haven, CT 06520 USA; [Blumenfeld, Hal] Yale Univ, Sch Med, Dept Neurosurg, New Haven, CT USA; [Sanganahalli, Basavaraju G.; Hyder, Fahmeed] Yale Univ, Sch Med, Dept Diagnost Radiol, New Haven, CT 06510 USA; [Hyder, Fahmeed] Yale Univ, Sch Med, Dept Biomed Engn, New Haven, CT USA; [Mishra, Asht Mangal; Sanganahalli, Basavaraju G.; Hyder, Fahmeed; Blumenfeld, Hal] Yale Univ, Core Ctr Quantitat Neurosci Magnet Resonance, New Haven, CT USA; [Waxman, Stephen G.] Ctr Neurosci & Regenerat Res, West Haven, CT USA; [Grohn, Olli] Univ Eastern Finland, Biomed NMR Res Grp, Biomed Imaging Unit, Kuopio, Finland; [Shatillo, Olena; Pitkanen, Asla] Univ Eastern Finland, AI Virtanen Inst Mol Sci, Dept Neurobiol, Kuopio, Finland; [Pitkanen, Asla] Kuopio Univ Hosp, Dept Neurol, SF-70210 Kuopio, Finland	Yale University; Yale University; Yale University; Yale University; Yale University; University of Eastern Finland; University of Eastern Finland; Kuopio University Hospital; University of Eastern Finland	Blumenfeld, H (corresponding author), Yale Univ, Sch Med, Dept Neurobiol, New Haven, CT 06520 USA.	hal.blumenfeld@yale.edu	khan, yusuf/E-6726-2015; Sanganahalli, Basavaraju G/C-3296-2008; Hyder, Fahmeed/A-2644-2015; Waxman, Stephen/Z-2507-2019; khan, yusuf/AAQ-9470-2021; Prasad, Manoj/AAE-8540-2019; Muthamilarasan, Mehanathan/H-9340-2017; MISHRA, AWDHESH/U-1920-2019	khan, yusuf/0000-0001-6986-4657; Sanganahalli, Basavaraju G/0000-0002-0851-6621; Hyder, Fahmeed/0000-0001-7822-4002; Waxman, Stephen/0000-0001-5718-7177; Prasad, Manoj/0000-0003-0691-0163; Muthamilarasan, Mehanathan/0000-0001-7589-6372; /0000-0002-3312-3264	National Institutes of Health (NIH) [R01 NS049307]; NIH [R01 NS066974]; Epilepsy Foundation Postdoctoral Research and Training Award [123505]; Yale QNMR Pilot study; Betsy and Jonathan Blattmachr family; Academy of Finland; Sigrid Juselius Foundation;  [P30 NS052519]	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Epilepsy Foundation Postdoctoral Research and Training Award; Yale QNMR Pilot study; Betsy and Jonathan Blattmachr family; Academy of Finland(Academy of Finland); Sigrid Juselius Foundation(Sigrid Juselius Foundation); 	This work was supported by National Institutes of Health (NIH) R01 NS049307 (HB), NIH R01 NS066974 (HB), Epilepsy Foundation Postdoctoral Research and Training Award ID: 123505 (AMM), Yale QNMR Pilot study (AMM), P30 NS052519 (FH), the Betsy and Jonathan Blattmachr family (HB), the Academy of Finland (AP, OG), and by the Sigrid Juselius Foundation (AP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bai X, 2011, NEUROLOGY, V76, P1960, DOI 10.1212/WNL.0b013e31821e54de; Bassett DS, 2009, CURR OPIN NEUROL, V22, P340, DOI 10.1097/WCO.0b013e32832d93dd; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Biswal BB, 2010, P NATL ACAD SCI USA, V107, P4734, DOI 10.1073/pnas.0911855107; Blennow K, 2012, NEURON, V76, P886, DOI 10.1016/j.neuron.2012.11.021; Coggan JS, 2011, J NEURAL ENG, V8, DOI 10.1088/1741-2560/8/6/065002; Cymerblit-Sabba A, 2010, J NEUROSCI, V30, P1619, DOI 10.1523/JNEUROSCI.5078-09.2010; D'Esposito M, 2003, NAT REV NEUROSCI, V4, P863, DOI 10.1038/nrn1246; DeSalvo MN, 2010, NEUROIMAGE, V50, P902, DOI 10.1016/j.neuroimage.2010.01.006; El-Hassar L, 2007, EPILEPSIA, V48, P131, DOI 10.1111/j.1528-1167.2007.01301.x; Englot DJ, 2008, J NEUROSCI, V28, P9066, DOI 10.1523/JNEUROSCI.2014-08.2008; Fox MD, 2007, NAT REV NEUROSCI, V8, P700, DOI 10.1038/nrn2201; Franken ND, 2008, VET ANAESTH ANALG, V35, P424, DOI 10.1111/j.1467-2995.2008.00404.x; Hayward NMEA, 2010, J NEUROTRAUM, V27, P2203, DOI 10.1089/neu.2010.1448; Hayward NMEA, 2011, J CEREBR BLOOD F MET, V31, P166, DOI 10.1038/jcbfm.2010.67; Hettinger PC, 2011, J NEUROSCI METH, V200, P106, DOI 10.1016/j.jneumeth.2011.06.018; Immonen R, 2013, J NEUROTRAUM, P1; Jenkins G., 1968, SPECTRAL ANAL ITS AP; Karhunen H, 2007, NEUROSCIENCE, V148, P314, DOI 10.1016/j.neuroscience.2007.05.047; Kharatishvili I, 2006, NEUROSCIENCE, V140, P685, DOI 10.1016/j.neuroscience.2006.03.012; Kharatishvili I, 2007, BRAIN, V130, P3155, DOI 10.1093/brain/awm268; Khubchandani M, 2003, MAGNET RESON MED, V49, P962, DOI 10.1002/mrm.10441; Killory BD, 2011, NEUROIMAGE, V56, P2209, DOI 10.1016/j.neuroimage.2011.03.036; Kumar R, 2010, J HEAD TRAUMA REHAB, V25, P31, DOI 10.1097/HTR.0b013e3181bff331; Kumar S, 2009, J NEUROTRAUM, V26, P665, DOI [10.1089/neu.2008.0644, 10.1089/neu.2008-0644]; Lemieux L, 2011, FRONT SYST NEUROSCI, V5, DOI 10.3389/fnsys.2011.00012; Lowe MJ, 1998, NEUROIMAGE, V7, P119, DOI 10.1006/nimg.1997.0315; Makinen S, 2008, J CEREBR BLOOD F MET, V28, P263, DOI 10.1038/sj.jcbfm.9600529; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; Mishra AM, 2009, EPILEPSIA, V50, P362; Mishra AM, 2011, J NEUROSCI, V31, P15053, DOI 10.1523/JNEUROSCI.0101-11.2011; Nersesyan H, 2004, J CEREBR BLOOD F MET, V24, P589, DOI 10.1097/01.WCB.0000117688.98763.23; Niskanen JP, 2013, J NEUROTRAUM, V30, P546, DOI 10.1089/neu.2012.2416; Pitkanen A, 2011, NEUROSCI LETT, V497, P163, DOI 10.1016/j.neulet.2011.02.033; Pitkanen A, 2009, EPILEPSIA, V50, P21, DOI 10.1111/j.1528-1167.2008.02007.x; Raz E, 2011, AM J NEURORADIOL, V32, P1851, DOI 10.3174/ajnr.A2637; Sachdev RNS, 2003, NEUROIMAGE, V19, P742, DOI 10.1016/S1053-8119(03)00093-4; Volman V, 2013, NEURAL COMPUT, V25, P2646, DOI 10.1162/NECO_a_00491; Waites AB, 2006, ANN NEUROL, V59, P335, DOI 10.1002/ana.20733; Weber R, 2006, NEUROIMAGE, V29, P1303, DOI 10.1016/j.neuroimage.2005.08.028; Zhao FQ, 2008, NEUROIMAGE, V39, P248, DOI 10.1016/j.neuroimage.2007.07.063	41	114	121	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2014	9	4							e95280	10.1371/journal.pone.0095280	http://dx.doi.org/10.1371/journal.pone.0095280			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG2DP	24748279	Green Submitted, gold, Green Published			2022-12-25	WOS:000335226500074
J	Zhang, P; Guan, P; Bai, XL; Song, ZP				Zhang, Pen; Guan, Ping; Bai, Xiao-Lu; Song, Zhi-Ping			New Aspects of HERG K+ Channel Function Depending upon Cardiac Spatial Heterogeneity	PLOS ONE			English	Article							RECTIFIER POTASSIUM CURRENTS; I-KR; OUTWARD CURRENT; TRANSIENT; REPOLARIZATION; IMPAIRMENT; DEPENDENCE; ARRHYTHMIA; MYOCYTES; CELLS	HERG K+ channel, the genetic counterpart of rapid delayed rectifier K+ current in cardiac cells, is responsible for many cases of inherited and drug-induced long QT syndromes. HERG has unusual biophysical properties distinct from those of other K+ channels. While the conventional pulse protocols in patch-clamp studies have helped us elucidate these properties, their limitations in assessing HERG function have also been progressively noticed. We employed AP-clamp techniques using physiological action potential waveforms recorded from various regions of canine heart to study HERG function in HEK293 cells and identified several novel aspects of HERG function. We showed that under AP-clamp IHERG increased gradually with membrane repolarization, peaked at potentials around 20-30 mV more negative than revealed by pulse protocols and at action potential duration (APD) to 60%-70% full repolarization, and fell rapidly at the terminal phase of repolarization. We found that the rising phase of IHERG was conferred by removal of inactivation and the decaying phase resulted from a fall in driving force, which were all determined by the rate of membrane repolarization. We identified regional heterogeneity and transmural gradient of IHERG when quantified with the area covered by IHERG trace. In addition, we observed regional and transmural differences of IHERG in response to dofetilide blockade. Finally, we characterized the influence of HERG function by selective inhibition of other ion currents. Based on our results, we conclude that the distinct biophysical properties of HERG reported by AP-clamp confer its unique function in cardiac repolarization thereby in antiarrhythmia and arrhythmogenesis.	[Zhang, Pen; Guan, Ping; Bai, Xiao-Lu; Song, Zhi-Ping] Minhang Cent Hosp, Dept Cardiol, Shanghai, Peoples R China		Song, ZP (corresponding author), Minhang Cent Hosp, Dept Cardiol, Shanghai, Peoples R China.	zpsong.dcmch@sina.com						Anson BD, 2004, AM J PHYSIOL-HEART C, V286, pH2434, DOI 10.1152/ajpheart.00891.2003; Antzelevitch C, 2001, BASIC RES CARDIOL, V96, P517, DOI 10.1007/s003950170002; Berecki G, 2005, BIOPHYS J, V88, P566, DOI 10.1529/biophysj.104.047290; BOYDEN PA, 1995, CARDIOVASC RES, V29, P312, DOI 10.1016/S0008-6363(96)88586-5; Carmeliet E, 1999, PHYSIOL REV, V79, P917, DOI 10.1152/physrev.1999.79.3.917; Corr PB, 1995, CARDIAC ELECTROPHYSI, P182; Di Diego JM, 2003, CIRCULATION, V108, P1027, DOI 10.1161/01.CIR.0000085066.05180.40; Gintant GA, 2000, AM J PHYSIOL-HEART C, V278, pH806, DOI 10.1152/ajpheart.2000.278.3.H806; Goldhaber, 1998, J Cardiovasc Pharmacol Ther, V3, P37, DOI 10.1177/107424849800300105; Hancox JC, 1998, PFLUG ARCH EUR J PHY, V436, P843, DOI 10.1007/s004240050713; Hua F, 2004, AM J PHYSIOL-HEART C, V286, pH2342, DOI 10.1152/ajpheart.00793.2003; Hua F, 2004, CIRC RES, V94, P810, DOI 10.1161/01.RES.0000121102.24277.89; LITOVSKY SH, 1989, J AM COLL CARDIOL, V14, P1053, DOI 10.1016/0735-1097(89)90490-7; LIU DW, 1995, CIRC RES, V76, P351, DOI 10.1161/01.RES.76.3.351; Lu Y, 2003, J PHYSIOL-LONDON, V551, P253, DOI 10.1113/jphysiol.2003.046045; Marban E, 2002, NATURE, V415, P213, DOI 10.1038/415213a; Priebe L, 1998, CIRC RES, V82, P1206, DOI 10.1161/01.RES.82.11.1206; SANGUINETTI MC, 1995, CELL, V81, P299, DOI 10.1016/0092-8674(95)90340-2; SANGUINETTI MC, 1990, J GEN PHYSIOL, V96, P195, DOI 10.1085/jgp.96.1.195; SICOURI S, 1991, CIRC RES, V68, P1729, DOI 10.1161/01.RES.68.6.1729; Taglialatela M, 1998, BIOCHEM PHARMACOL, V55, P1741, DOI 10.1016/S0006-2952(98)00002-1; Tsuji Y, 2000, CARDIOVASC RES, V48, P300, DOI 10.1016/S0008-6363(00)00180-2; Wang HZ, 2000, CIRCULATION, V102, P1165, DOI 10.1161/01.CIR.102.10.1165; Wang JX, 2004, J BIOL CHEM, V279, P13289, DOI 10.1074/jbc.C400025200; Wang JX, 2001, CIRCULATION, V104, P2645, DOI 10.1161/hc4701.100513; WANG ZG, 1993, CIRC RES, V73, P1061, DOI 10.1161/01.RES.73.6.1061; WANG ZG, 1993, CIRC RES, V73, P276, DOI 10.1161/01.RES.73.2.276; Yue LX, 1999, CIRC RES, V84, P776; Yue LX, 2000, CARDIOVASC RES, V46, P151, DOI 10.1016/S0008-6363(99)00430-7; Zhang YQ, 2003, J BIOL CHEM, V278, P10417, DOI 10.1074/jbc.M211044200; Zhou ZF, 1998, BIOPHYS J, V74, P230, DOI 10.1016/S0006-3495(98)77782-3	31	18	20	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2014	9	1							e72181	10.1371/journal.pone.0072181	http://dx.doi.org/10.1371/journal.pone.0072181			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301BI	24475014	Green Submitted, Green Published, gold			2022-12-25	WOS:000330507300001
J	Ritze, Y; Bardos, G; Claus, A; Ehrmann, V; Bergheim, I; Schwiertz, A; Bischoff, SC				Ritze, Yvonne; Bardos, Gyoengyi; Claus, Anke; Ehrmann, Veronika; Bergheim, Ina; Schwiertz, Andreas; Bischoff, Stephan C.			Lactobacillus rhamnosus GG Protects against Non-Alcoholic Fatty Liver Disease in Mice	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; CACO-2 CELL MONOLAYERS; GUT MICROBIOTA; INTESTINAL PERMEABILITY; HEPATIC STEATOSIS; PROBIOTICS; OBESITY; FRUCTOSE; BARRIER; FLORA	Objective: Experimental evidence revealed that obesity-associated non-alcoholic fatty liver disease (NAFLD) is linked to changes in intestinal permeability and translocation of bacterial products to the liver. Hitherto, no reliable therapy is available except for weight reduction. Within this study, we examined the possible effect of the probiotic bacterial strain Lactobacillus rhamnosus GG (LGG) as protective agent against experimental NAFLD in a mouse model. Methods: Experimental NAFLD was induced by a high-fructose diet over eight weeks in C57BL/J6 mice. Fructose was administered via the drinking water containing 30% fructose with or without LGG at a concentration resulting in approximately 5x10(7) colony forming units/g body weight. Mice were examined for changes in small intestinal microbiota, gut barrier function, lipopolysaccharide (LPS) concentrations in the portal vein, liver inflammation and fat accumulation in the liver. Results: LGG increased beneficial bacteria in the distal small intestine. Moreover, LGG reduced duodenal I kappa B protein levels and restored the duodenal tight junction protein concentration. Portal LPS (P <= 0.05) was reduced and tended to attenuate TNF-alpha, IL-8R and IL-1 beta mRNA expression in the liver feeding a high-fructose diet supplemented with LGG. Furthermore liver fat accumulation and portal alanine-aminotransferase concentrations (P <= 0.05) were attenuated in mice fed the high-fructose diet and LGG. Conclusions: We show for the first time that LGG protects mice from NAFLD induced by a high-fructose diet. The underlying mechanisms of protection likely involve an increase of beneficial bacteria, restoration of gut barrier function and subsequent attenuation of liver inflammation and steatosis.	[Ritze, Yvonne; Bardos, Gyoengyi; Claus, Anke; Ehrmann, Veronika; Bergheim, Ina; Bischoff, Stephan C.] Univ Hohenheim, Dept Med Nutr, Stuttgart, Germany; [Bergheim, Ina] Univ Jena, Dept Nutr Sci, Jena, Germany; [Schwiertz, Andreas] MVZ Inst Microecol, Herborn, Germany	University Hohenheim; Friedrich Schiller University of Jena	Bischoff, SC (corresponding author), Univ Hohenheim, Dept Med Nutr, Stuttgart, Germany.	bischoff.stephan@uni-hohenheim.de	Schwiertz, Andreas/ABA-9274-2020; Schwiertz, Andreas/AAG-6381-2019	Schwiertz, Andreas/0000-0002-2876-2352; D'Haese, Jan G./0000-0002-7827-8753	Competence Network of Obesity, group 'Obesity and GI tract'; Federal Ministry of Education and Research [FKZ: 01GI0843]; Institute Danone	Competence Network of Obesity, group 'Obesity and GI tract'; Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); Institute Danone(Danone Nutricia)	This work was supported by grants from the Competence Network of Obesity, group 'Obesity and GI tract', funded by the Federal Ministry of Education and Research (FKZ: 01GI0843) to S. C. Bischoff and the Institute Danone research grant 2010 to Y. Ritze. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Shanab A, 2010, NAT REV GASTRO HEPAT, V7, P691, DOI 10.1038/nrgastro.2010.172; Angulo P, 2002, NEW ENGL J MED, V346, P1221, DOI 10.1038/nrdp.2015.80; Bergheim I, 2008, J HEPATOL, V48, P983, DOI 10.1016/j.jhep.2008.01.035; Brandt K, 2003, INT J FOOD MICROBIOL, V84, P189, DOI 10.1016/S0168-1605(02)00419-1; Browning JD, 2004, HEPATOLOGY, V40, P1387, DOI 10.1002/hep.20466; Cani PD, 2008, DIABETES, V57, P1470, DOI 10.2337/db07-1403; Cani PD, 2009, CURR PHARM DESIGN, V15, P1546, DOI 10.2174/138161209788168164; Ciorba MA, 2012, GUT, V61, P829, DOI 10.1136/gutjnl-2011-300367; Cortez-Pinto H, 2006, J HEPATOL, V44, P197, DOI 10.1016/j.jhep.2005.09.002; De Gregoris TB, 2011, J MICROBIOL METH, V86, P351, DOI 10.1016/j.mimet.2011.06.010; Donato KA, 2010, MICROBIOL-SGM, V156, P3288, DOI 10.1099/mic.0.040139-0; Dukowicz Andrew C, 2007, Gastroenterol Hepatol (N Y), V3, P112; ELLWOOD KC, 1993, P SOC EXP BIOL MED, V202, P440, DOI 10.3181/00379727-202-43556; Gratz SW, 2010, WORLD J GASTROENTERO, V16, P403, DOI 10.3748/wjg.v16.i4.403; Greenblum S, 2012, P NATL ACAD SCI USA, V109, P594, DOI 10.1073/pnas.1116053109; Haub S, 2011, J PHARMACOL EXP THER, V339, P790, DOI 10.1124/jpet.111.181834; Haub S, 2010, AM J PHYSIOL-GASTR L, V298, pG335, DOI 10.1152/ajpgi.00088.2009; Henao-Mejia J, 2012, NATURE, V482, P179, DOI 10.1038/nature10809; Iizuka K, 2013, ENDOCR J, V60, P543, DOI 10.1507/endocrj.EJ13-0121; Ji YS, 2012, BENEF MICROBES, V3, P13, DOI 10.3920/BM2011.0046; Johnson-Henry KC, 2008, INFECT IMMUN, V76, P1340, DOI 10.1128/IAI.00778-07; Lambert D, 2007, CELL PHYSIOL BIOCHEM, V20, P495, DOI 10.1159/000107533; Le Roy T, 2012, GUT; Lebeer S, 2008, MICROBIOL MOL BIOL R, V72, P728, DOI 10.1128/MMBR.00017-08; Lee Sang Kil, 2012, Korean J Gastroenterol, V60, P86; Ley RE, 2006, NATURE, V444, P1022, DOI 10.1038/4441022a; Li N, 2009, PEDIATR RES, V66, P203, DOI 10.1203/PDR.0b013e3181aabd4f; Li ZP, 2003, HEPATOLOGY, V37, P343, DOI 10.1053/jhep.2003.50048; Lim JS, 2010, NAT REV GASTRO HEPAT, V7, P251, DOI 10.1038/nrgastro.2010.41; Liu Q, 2004, HEPATOLOGY, V39, P1441, DOI 10.1002/hep.20194; Machado MV, 2012, ANN HEPATOL, V11, P440, DOI 10.1016/S1665-2681(19)31457-7; NANJI AA, 1994, P SOC EXP BIOL MED, V205, P243; Park SK, 2012, HEPATOLOGY; Peng LY, 2009, J NUTR, V139, P1619, DOI 10.3945/jn.109.104638; Schwiertz A, 2010, OBESITY, V18, P190, DOI 10.1038/oby.2009.167; Schwiertz A, 2010, J PEDIATR-US, V157, P240, DOI 10.1016/j.jpeds.2010.02.046; Seth A, 2008, AM J PHYSIOL-GASTR L, V294, pG1060, DOI 10.1152/ajpgi.00202.2007; Sheth SG, 1997, ANN INTERN MED, V126, P137, DOI 10.7326/0003-4819-126-2-199701150-00008; Solga SF, 2004, HEPATOLOGY, V39, P1197, DOI 10.1002/hep.20220; Spiller R, 2008, ALIMENT PHARM THER, V28, P385, DOI 10.1111/j.1365-2036.2008.03750.x; Spruss A, 2009, J NUTR BIOCHEM, V20, P657, DOI 10.1016/j.jnutbio.2009.05.006; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Vieira LQ, 2008, J CLIN GASTROENTEROL, V42, pS168, DOI 10.1097/MCG.0b013e31818063d4; Wagnerberger S, 2012, J NUTR BIOCH; Wang YH, 2012, AM J PHYSIOL-GASTR L, V303, pG32, DOI 10.1152/ajpgi.00024.2012; WEAVER LT, 1984, ARCH DIS CHILD, V59, P236, DOI 10.1136/adc.59.3.236; Wood Natalie J, 2012, Nat Rev Gastroenterol Hepatol, V9, P123, DOI 10.1038/nrgastro.2012.21; Xu RY, 2012, J CLIN BIOCHEM NUTR, V50, P72, DOI 10.3164/jcbn.11-38; Yan F, 2007, GASTROENTEROLOGY, V132, P562, DOI 10.1053/j.gastro.2006.11.022; Zhang LY, 2006, J PEDIATR GASTR NUTR, V42, P545, DOI 10.1097/01.mpg.0000221905.68781.4a	50	195	208	0	85	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2014	9	1							e80169	10.1371/journal.pone.0080169	http://dx.doi.org/10.1371/journal.pone.0080169			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301BI	24475018	Green Published, gold, Green Submitted			2022-12-25	WOS:000330507300004
J	Arancibia, S; Espinoza, C; Salazar, F; Del Campo, M; Tampe, R; Zhong, TY; De Ioannes, P; Moltedo, B; Ferreira, J; Lavelle, EC; Manubens, A; De Ioannes, AE; Becker, MI				Arancibia, Sergio; Espinoza, Cecilia; Salazar, Fabian; Del Campo, Miguel; Tampe, Ricardo; Zhong, Ta-Ying; De Ioannes, Pablo; Moltedo, Bruno; Ferreira, Jorge; Lavelle, Ed C.; Manubens, Augusto; De Ioannes, Alfredo E.; Ines Becker, Maria			A Novel Immunomodulatory Hemocyanin from the Limpet Fissurella latimarginata Promotes Potent Anti-Tumor Activity in Melanoma	PLOS ONE			English	Article							RAPANA-THOMASIANA-HEMOCYANIN; CONCHOLEPAS HEMOCYANIN; DENDRITIC CELLS; BLADDER-CANCER; IMMUNE-RESPONSE; SUBUNIT ORGANIZATION; CONJUGATE VACCINES; RECENT PROGRESS; N-GLYCANS; IN-VIVO	Hemocyanins, the huge oxygen-transporting glycoproteins of some mollusks, are used as immunomodulatory proteins with proven anti-cancer properties. The biodiversity of hemocyanins has promoted interest in identifying new anti-cancer candidates with improved immunological properties. Hemocyanins promote Th1 responses without known side effects, which make them ideal for long-term sustained treatment of cancer. In this study, we evaluated a novel hemocyanin from the limpet/gastropod Fissurella latimarginata (FLH). This protein has the typical hollow, cylindrical structure of other known hemocyanins, such as the keyhole limpet hemocyanin (KLH) and the Concholepas hemocyanin (CCH). FLH, like the KLH isoforms, is composed of a single type of polypeptide with exposed N- and O-linked oligosaccharides. However, its immunogenicity was significantly greater than that of KLH and CCH, as FLH induced a stronger humoral immune response and had more potent anti-tumor activity, delaying tumor growth and increasing the survival of mice challenged with B16F10 melanoma cells, in prophylactic and therapeutic settings. Additionally, FLH-treated mice demonstrated increased IFN-gamma production and higher numbers of tumor-infiltrating CD4(+) lymphocytes. Furthermore, in vitro assays demonstrated that FLH, but not CCH or KLH, stimulated the rapid production of pro-inflammatory cytokines (IL-6, IL-12, IL-23 and TNF-alpha) by dendritic cells, triggering a pro-inflammatory milieu that may explain its enhanced immunological activity. Moreover, this effect was abolished when deglycosylated FLH was used, suggesting that carbohydrates play a crucial role in the innate immune recognition of this protein. Altogether, our data demonstrate that FLH possesses increased anti-tumor activity in part because it activates a more potent innate immune response in comparison to other known hemocyanins. In conclusion, FLH is a potential new marine adjuvant for immunization and possible cancer immunotherapy.	[Arancibia, Sergio; Espinoza, Cecilia; Salazar, Fabian; Del Campo, Miguel; Tampe, Ricardo; Zhong, Ta-Ying; De Ioannes, Pablo; Moltedo, Bruno; Ines Becker, Maria] Fdn Ciencia & Tecnol Desarrollo FUCITED, Santiago, Chile; [Ferreira, Jorge; Ines Becker, Maria] Univ Chile, Inst Ciencias Biomed ICBM, Clin & Mol Pharmacol Program, Santiago, Chile; [Lavelle, Ed C.] Trinity Coll Dublin, Trinity Biomed Sci Inst, Sch Biochem & Immunol, Adjuvant Res Grp, Dublin, Ireland; [Manubens, Augusto; De Ioannes, Alfredo E.] Biosonda Corp, Dept Res & Dev, Santiago, Chile	Universidad de Chile; Trinity College Dublin	Becker, MI (corresponding author), Fdn Ciencia & Tecnol Desarrollo FUCITED, Santiago, Chile.	mariaines.becker@fucited.cl	Becker, María/R-8252-2019; Salazar, Fabian/AAW-2488-2020; Lavelle, Ed/A-1716-2008; Brito de Azevedo, Eduardo/M-4266-2013; Hortal, Joaquin/A-1531-2008; Lobo, Jorge/E-2309-2013; Gabriel, Rosalina/F-1598-2013; Coelho dos Santos, Ana Margarida/E-7598-2010; Patino, Jairo/J-9595-2014; Borges, Paulo/B-2780-2008	Lavelle, Ed/0000-0002-3167-1080; Brito de Azevedo, Eduardo/0000-0001-5172-7742; Hortal, Joaquin/0000-0002-8370-8877; Lobo, Jorge/0000-0002-3152-4769; Gabriel, Rosalina/0000-0002-3550-8010; Manubens, Augusto/0000-0002-7931-4314; Coelho dos Santos, Ana Margarida/0000-0002-9197-792X; Patino, Jairo/0000-0001-5532-166X; Borges, Paulo/0000-0002-8448-7623; Salazar Lizama, Fabian/0000-0001-5139-2292	Fundacion COPEC-Universidad Catolica [CQ057]; FONDECYT [1110651]	Fundacion COPEC-Universidad Catolica; FONDECYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT)	This work was partially supported by research grants from Fundacion COPEC-Universidad Catolica No. CQ057 and FONDECYT 1110651 to Maria Ines Becker. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arancibia S., 2012, HEMOCYANINS IMMUNOTH, VINTECH; Arancibia S, 2012, EUR J IMMUNOL, V42, P688, DOI 10.1002/eji.201142011; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Becker MI, 2009, INT IMMUNOPHARMACOL, V9, P330, DOI 10.1016/j.intimp.2008.12.011; CEROTTINI JC, 1971, J IMMUNOL, V106, P732; De Ioannes P, 2004, J BIOL CHEM, V279, P26134, DOI 10.1074/jbc.M400903200; Decker H, 2007, INTEGR COMP BIOL, V47, P631, DOI 10.1093/icb/icm063; del Campo M, 2011, REV MED CHILE, V139, P236, DOI /S0034-98872011000200015; Delamarre L, 2006, J EXP MED, V203, P2049, DOI 10.1084/jem.20052442; Dolashka-Angelova P, 2008, IMMUNOL INVEST, V37, P822, DOI 10.1080/08820130802403366; Gathuru JK, 2005, VACCINE, V23, P4727, DOI 10.1016/j.vaccine.2005.05.007; Gatsogiannis C, 2009, J MOL BIOL, V385, P963, DOI 10.1016/j.jmb.2008.10.080; Gebauer W, 1999, ARCH BIOCHEM BIOPHYS, V372, P128, DOI 10.1006/abbi.1999.1478; Geyer H, 2005, J BIOL CHEM, V280, P40731, DOI 10.1074/jbc.M505985200; GUPTA RK, 1995, VACCINE, V13, P1263, DOI 10.1016/0264-410X(95)00011-O; Guy B, 2007, NAT REV MICROBIOL, V5, P505, DOI 10.1038/nrmicro1681; Harris Jr, 1999, METH MOL B, V117, P13; HERSCOWITZ HB, 1972, IMMUNOLOGY, V22, P51; Idakieva K, 2008, J FLUORESC, V18, P715, DOI 10.1007/s10895-008-0338-x; Junankar SR, 2006, J INVEST DERM SYMP P, V11, P36, DOI 10.1038/sj.jidsymp.5650024; Kato K, 1972, BIOCHEM BIOPH RES CO, V371, P698; Kim SK, 2000, VACCINE, V19, P530, DOI 10.1016/S0264-410X(00)00195-X; Kochenderfer JN, 2007, EXP BIOL MED, V232, P1128, DOI 10.3181/0702-MR-42; Kurokawa T, 2002, EUR J BIOCHEM, V269, P5459, DOI 10.1046/j.1432-1033.2002.03244.x; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lamm DL, 2000, EUR UROL, V37, P41, DOI 10.1159/000052391; Lamm DL, 2003, J CLIN ONCOL, V21, P4259, DOI 10.1200/JCO.2003.08.099; Lammers RJM, 2012, J CLIN ONCOL, V30, P2273, DOI 10.1200/JCO.2011.39.2936; Leyton P, 2005, J CHIL CHEM SOC, V50, P725, DOI 10.4067/S0717-97072005000400014; Lo-Man R, 2004, CANCER RES, V64, P4987, DOI 10.1158/0008-5472.CAN-04-0252; Lutz MB, 1999, J IMMUNOL METHODS, V223, P77, DOI 10.1016/S0022-1759(98)00204-X; Levy EM, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/676198; Moltedo B, 2006, J UROLOGY, V176, P2690, DOI 10.1016/j.juro.2006.07.136; MOLTO LM, 1991, EUR UROL, V19, P74; MULE JJ, 1986, J IMMUNOL, V136, P3899; Musselli C, 2001, J CANCER RES CLIN, V127, pR20, DOI 10.1007/BF01470995; Oliva H, 2002, HYBRIDOMA HYBRIDOM, V21, P365, DOI 10.1089/153685902761022715; Paccagnella M, 2004, MICRON, V35, P21, DOI 10.1016/j.micron.2003.10.007; Pashine A, 2005, NAT MED, V11, pS63, DOI 10.1038/nm1210; Petrovsky N, 2004, IMMUNOL CELL BIOL, V82, P488, DOI 10.1111/j.0818-9641.2004.01272.x; Ponder WF, 2008, PHYLOGENY EVOLUTION; Presicce P, 2008, MOL IMMUNOL, V45, P1136, DOI 10.1016/j.molimm.2007.07.020; Qi CJ, 2011, BLOOD, V117, P6825, DOI 10.1182/blood-2011-02-339812; Ragupathi G, 2002, VACCINE, V20, P1030, DOI 10.1016/S0264-410X(01)00451-0; Ragupathi G, 2008, VACCINE, V26, P4860, DOI 10.1016/j.vaccine.2008.06.098; Rizvi I, 2007, AM J SURG, V194, P628, DOI 10.1016/j.amjsurg.2007.08.005; SANGER F, 1945, BIOCHEM J, V39, P507, DOI 10.1042/bj0390507; Shimizu K, 2001, CANCER RES, V61, P2618; Siddiqui NI, 2007, BIOCHEM BIOPH RES CO, V361, P705, DOI 10.1016/j.bbrc.2007.07.098; Slovin SF, 2005, IMMUNOL CELL BIOL, V83, P418, DOI 10.1111/j.1440-1711.2005.01350.x; Strioga M, 2013, INNATE IMMUN-LONDON, V19, P98, DOI 10.1177/1753425912449549; Swerdlow RD, 1996, COMP BIOCHEM PHYS B, V113, P537, DOI 10.1016/0305-0491(95)02091-8; Tchorbanov A, 2008, INT IMMUNOPHARMACOL, V8, P1033, DOI 10.1016/j.intimp.2008.03.008; Trombetta ES, 2005, ANNU REV IMMUNOL, V23, P975, DOI 10.1146/annurev.immunol.22.012703.104538; van Vliet SJ, 2008, J IMMUNOL, V181, P3148, DOI 10.4049/jimmunol.181.5.3148; vanHolde KE, 1995, ADV PROTEIN CHEM, V47, P1, DOI 10.1016/S0065-3233(08)60545-8; Watford WT, 2003, CYTOKINE GROWTH F R, V14, P361, DOI 10.1016/S1359-6101(03)00043-1; Wells Christine A, 2003, BMC Immunol, V4, P5, DOI 10.1186/1471-2172-4-5; WIRGUIN I, 1995, CANCER IMMUNOL IMMUN, V40, P307, DOI 10.1007/BF01519630; Zhang SL, 1996, CANCER RES, V56, P3315	60	56	59	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2014	9	1							e87240	10.1371/journal.pone.0087240	http://dx.doi.org/10.1371/journal.pone.0087240			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297XI	25003186	Green Published, gold, Green Submitted			2022-12-25	WOS:000330288000202
J	Wang, J; Bian, YJ; Wang, ZR; Li, D; Wang, CM; Li, QZ; Gao, XJ				Wang, Jie; Bian, Yanjie; Wang, Zhuoran; Li, Dan; Wang, Chunmei; Li, Qingzhang; Gao, Xuejun			MicroRNA-152 Regulates DNA Methyltransferase 1 and Is Involved in the Development and Lactation of Mammary Glands in Dairy Cows	PLOS ONE			English	Article							GENE-EXPRESSION; METHYLATION; MILK; TARGETS; CANCER; CELLS; DNMT1; GROWTH; RNAS; 3B	MicroRNAs (miRNAs) are a class of small non-coding, endogenous regulatory RNAs that function by controlling gene expression at the post-transcriptional level. Using small RNA sequencing and qRT-PCR techniques, we found that the expression of miR-152 was significantly increased during lactation in the mammary glands of dairy cows producing high quality milk compared with that in cows producing low quality milk. Furthermore, DNA methyltransferase 1 (DNMT1), which is a target of miR-152, was inversely correlated with the expression levels of miR-152 in the mammary glands of dairy cows. Dairy cow mammary epithelial cells (DCMECs) were used as in vitro cell models to study the function of miR-152. The forced expression of miR-152 in DCMECs resulted in a marked reduction of DNMT1 at both mRNA and protein levels. This in turn led to a decrease in global DNA methylation and increased the expression of two lactation-related genes, serine/threonine protein kinase Akt (Akt) and peroxisome proliferator-activated receptor gamma (Ppar gamma). In contrast, inhibition of miR-152 showed the opposite results. By using an electronic Coulter counter (CASY-TT) and flow cytometer, we discovered that miR-152 enhanced the viability and multiplication capacity of DCMECs. In conclusion, miR-152 plays an important role in the development and lactation processes in the mammary glands of dairy cows. Our data provide insights into dairy cow mammary gland development and lactation.	[Wang, Jie; Bian, Yanjie; Wang, Zhuoran; Li, Dan; Wang, Chunmei; Li, Qingzhang; Gao, Xuejun] Northeast Agr Univ, Educ Minist, Key Lab Dairy Sci, Harbin, Heilongjiang, Peoples R China	Northeast Agricultural University - China	Wang, CM (corresponding author), Northeast Agr Univ, Educ Minist, Key Lab Dairy Sci, Harbin, Heilongjiang, Peoples R China.	wangcm-1@163.com		HONG, SEUNGUG/0000-0002-6228-3312; Bose, Shambunath/0000-0003-0737-5713; Wang, jing-hua/0000-0002-2034-7429	Major State Basic Research Development Program of China (973 Program) [2011CB100804]; Heilongjiang Department of Education Project Program [1154z1004]	Major State Basic Research Development Program of China (973 Program)(National Basic Research Program of China); Heilongjiang Department of Education Project Program	This study was supported by Major State Basic Research Development Program of China (973 Program, No. 2011CB100804); Heilongjiang Department of Education Project Program, No. 1154z1004. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambros V, 2003, RNA, V9, P277, DOI 10.1261/rna.2183803; Ambros V, 2003, CURR BIOL, V13, P807, DOI 10.1016/S0960-9822(03)00287-2; Anderson SM, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1653; Bionaz M, 2011, BIOINFORM BIOL INSIG, V5, P83, DOI 10.4137/BBI.S7003; Bionaz M, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-366; Boutinaud M, 2004, REPROD NUTR DEV, V44, P499, DOI 10.1051/rnd:2004054; Boxer RB, 2006, CELL METAB, V4, P475, DOI 10.1016/j.cmet.2006.10.011; Braconi C, 2010, HEPATOLOGY, V51, P881, DOI 10.1002/hep.23381; Cheng AM, 2005, NUCLEIC ACIDS RES, V33, P1290, DOI 10.1093/nar/gki200; Chiam K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025634; Cui W, 2011, MOL CELL BIOCHEM, V355, P17, DOI 10.1007/s11010-011-0834-1; Fabbri M, 2007, P NATL ACAD SCI USA, V104, P15805, DOI 10.1073/pnas.0707628104; Fan GP, 2005, DEVELOPMENT, V132, P3345, DOI 10.1242/dev.01912; Garzon R, 2009, BLOOD, V113, P6411, DOI 10.1182/blood-2008-07-170589; Gerlach D, 2009, NUCLEIC ACIDS RES, V37, pD111, DOI 10.1093/nar/gkn707; Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112; Hassler MR, 2012, BIOCHIMIE, V94, P2297, DOI 10.1016/j.biochi.2012.05.029; Hermann A, 2004, CELL MOL LIFE SCI, V61, P2571, DOI 10.1007/s00018-004-4201-1; Hu H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007636; Huang JF, 2010, HEPATOLOGY, V52, P60, DOI 10.1002/hep.23660; Jaenisch R, 2003, NAT GENET, V33, P245, DOI 10.1038/ng1089; Ji WD, 2013, CARCINOGENESIS, V34, P446, DOI 10.1093/carcin/bgs343; Laird PW, 2010, NAT REV GENET, V11, P191, DOI 10.1038/nrg2732; Lee JY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061658; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li HM, 2012, MOLECULES, V17, P12037, DOI 10.3390/molecules171012037; Liu XF, 2012, IN VITRO CELL DEV-AN, V48, P554, DOI 10.1007/s11626-012-9545-5; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Neville MC, 2002, J MAMMARY GLAND BIOL, V7, P49, DOI 10.1023/A:1015770423167; Robert MF, 2003, NAT GENET, V33, P61, DOI 10.1038/ng1068; Schwertfeger KL, 2003, J LIPID RES, V44, P1100, DOI 10.1194/jlr.M300045-JLR200; Sethupathy P, 2006, NAT METHODS, V3, P881, DOI 10.1038/NMETH954; Tanaka T, 2009, DIFFERENTIATION, V77, P181, DOI 10.1016/j.diff.2008.10.001; Vanselow J, 2006, J MOL ENDOCRINOL, V37, P463, DOI 10.1677/jme.1.02131; Wan YH, 2007, GENE DEV, V21, P1895, DOI 10.1101/gad.1567207; Wang Chunmei, 2007, Journal of Genetics and Genomics, V34, P966, DOI 10.1016/S1673-8527(07)60109-X; Wang H, 2011, CARCINOGENESIS, V32, P1033, DOI 10.1093/carcin/bgr081; Xiang Y, 2013, ONCOGENE; Xu Q, 2013, J MOL CELL BIOL, V5, P3, DOI 10.1093/jmcb/mjs049; Yi R, 2003, GENE DEV, V17, P3011, DOI 10.1101/gad.1158803; Zhang BH, 2007, DEV BIOL, V302, P1, DOI 10.1016/j.ydbio.2006.08.028	41	90	100	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2014	9	7							e101358	10.1371/journal.pone.0101358	http://dx.doi.org/10.1371/journal.pone.0101358			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5BA	24475077	Green Submitted, Green Published, gold			2022-12-25	WOS:000341354100077
J	Knudsen, JG; Murholm, M; Carey, AL; Bienso, RS; Basse, AL; Allen, TL; Hidalgo, J; Kingwell, BA; Febbraio, MA; Hansen, JB; Pilegaard, H				Knudsen, Jakob G.; Murholm, Maria; Carey, Andrew L.; Bienso, Rasmus S.; Basse, Astrid L.; Allen, Tamara L.; Hidalgo, Juan; Kingwell, Bronwyn A.; Febbraio, Mark A.; Hansen, Jacob B.; Pilegaard, Henriette			Role of IL-6 in Exercise Training- and Cold-Induced UCP1 Expression in Subcutaneous White Adipose Tissue	PLOS ONE			English	Article							INTERLEUKIN-6 STIMULATES LIPOLYSIS; HUMAN SKELETAL-MUSCLE; UNCOUPLING PROTEIN; INDUCED INCREASE; GENE-EXPRESSION; GAMMA; ADIPOCYTES; STRESS; MICE; FAT	Expression of brown adipose tissue (BAT) associated proteins like uncoupling protein 1 (UCP1) in inguinal WAT (iWAT) has been suggested to alter iWAT metabolism. The aim of this study was to investigate the role of interleukin-6 (IL-6) in exercise training and cold exposure-induced iWAT UCP1 expression. The effect of daily intraperitoneal injections of IL-6 (3 ng/g) in C57BL/6 mice for 7 days on iWAT UCP1 expression was examined. In addition, the expression of UCP1 in iWAT was determined in response to 3 days of cold exposure (4 degrees C) and 5 weeks of exercise training in wild type (WT) and whole body IL-6 knockout (KO) mice. Repeated injections of IL-6 in C57BL/6 mice increased UCP1 mRNA but not UCP1 protein content in iWAT. Cold exposure increased iWAT UCP1 mRNA content similarly in IL-6 KO and WT mice, while exercise training increased iWAT UCP1 mRNA in WT mice but not in IL-6 KO mice. Additionally, a cold exposure-induced increase in iWAT UCP1 protein content was blunted in IL-6 KO mice, while UCP1 protein content in iWAT was lower in both untrained and exercise trained IL-6 KO mice than in WT mice. In conclusion, repeated daily increases in plasma IL-6 can increase iWAT UCP1 mRNA content and IL-6 is required for an exercise training-induced increase in iWAT UCP1 mRNA content. In addition IL-6 is required for a full induction of UCP1 protein expression in response to cold exposure and influences the UCP1 protein content iWAT of both untrained and exercise trained animals.	[Knudsen, Jakob G.; Bienso, Rasmus S.; Pilegaard, Henriette] Univ Copenhagen, Ctr Inflammat & Metab, Dept Biol, Copenhagen, Denmark; [Murholm, Maria; Basse, Astrid L.; Hansen, Jacob B.] Univ Copenhagen, Dept Biol, Copenhagen, Denmark; [Murholm, Maria; Basse, Astrid L.] Univ Copenhagen, Dept Biomed Sci, Copenhagen, Denmark; [Carey, Andrew L.; Kingwell, Bronwyn A.] Baker IDI Heart & Diabet Inst, Metab & Vasc Physiol Lab, Melbourne, Vic, Australia; [Allen, Tamara L.; Febbraio, Mark A.] Baker IDI Heart & Diabet Inst, Cellular & Mol Metab Lab, Melbourne, Vic, Australia; [Hidalgo, Juan] Univ Autonoma Barcelona, Dept Neurosci, E-08193 Barcelona, Spain	University of Copenhagen; University of Copenhagen; University of Copenhagen; Baker Heart and Diabetes Institute; Baker Heart and Diabetes Institute; Autonomous University of Barcelona	Pilegaard, H (corresponding author), Univ Copenhagen, Ctr Inflammat & Metab, Dept Biol, Copenhagen, Denmark.	hpilegaard@bio.ku.dk	Basse, Astrid L/M-4630-2014; Pilegaard, Henriette/M-2315-2014; Hansen, Jacob B/F-3775-2010; Hidalgo, Juan/C-9082-2011; Knudsen, Jakob G/Q-2227-2018; Febbraio, Mark/AAE-9632-2019; Kingwell, Bronwyn A/B-1183-2009	Basse, Astrid L/0000-0002-6532-9232; Pilegaard, Henriette/0000-0002-1071-0327; Hansen, Jacob B/0000-0001-5249-2586; Hidalgo, Juan/0000-0003-0921-1122; Knudsen, Jakob G/0000-0001-7237-8457; Carey, Andrew/0000-0003-3452-1501; Andersen, Stig Ejdrup/0000-0002-1914-4720; Febbraio, Mark/0000-0002-9296-4418	Novo Nordisk Foundation; Lundbeck Foundation; Danish Research Foundation; Danish Council for Independent Research in the Natural Sciences; Augustinus Foundation; National Health and Medical Research Council of Australia (NHMRC) [526606]; EU [HEALTH-F2-2011-278373]; Danish National Research Foundation [02-512-55]; Danish Ministry of Science, Technology and Innovation	Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Lundbeck Foundation(Lundbeckfonden); Danish Research Foundation; Danish Council for Independent Research in the Natural Sciences; Augustinus Foundation; National Health and Medical Research Council of Australia (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); EU(European Commission); Danish National Research Foundation(Danmarks Grundforskningsfond); Danish Ministry of Science, Technology and Innovation	The study was supported by grants from the Novo Nordisk Foundation, the Lundbeck Foundation, The Danish Research Foundation, The Danish Council for Independent Research in the Natural Sciences, the Augustinus Foundation, the National Health and Medical Research Council of Australia (NHMRC grant no. 526606) and the EU FP7 project DIABAT (HEALTH-F2-2011-278373). Centre of Inflammation and Metabolism (CIM) is supported by a grant from the Danish National Research Foundation (# 02-512-55). CIM is part of the UNIK Project: Food, Fitness & Pharma for Health and Disease, supported by the Danish Ministry of Science, Technology and Innovation. Mark A. Febbraio and Bronwyn A. Kingwell are Senior Principal Research Fellows of the NHMRC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adser H, 2011, ACTA PHYSL; Bostrom P, 2012, NATURE, V481, P463, DOI 10.1038/nature10777; Brandt C, 2012, ACTA PHYSIOL, V205, P224, DOI 10.1111/j.1748-1716.2011.02373.x; Chomczynski P, 2006, NAT PROTOC, V1, P581, DOI 10.1038/nprot.2006.83; COUSIN B, 1992, J CELL SCI, V103, P931; Di Gregorio GB, 2004, AM J PHYSIOL-ENDOC M, V287, pE182, DOI 10.1152/ajpendo.00189.2003; Handschin C, 2003, P NATL ACAD SCI USA, V100, P7111, DOI 10.1073/pnas.1232352100; Hidalgo J, 2010, BRAIN BEHAV IMMUN, V24, P119, DOI 10.1016/j.bbi.2009.09.002; HIMMSHAGEN J, 1994, AM J PHYSIOL, V266, pR1371, DOI 10.1152/ajpregu.1994.266.4.R1371; Iwen KA, 2011, METABOLISM, V60, P430, DOI 10.1016/j.metabol.2010.03.011; Ji CB, 2011, J BIOENERG BIOMEMBR, V43, P367, DOI 10.1007/s10863-011-9361-8; Kelly LJ, 1998, ENDOCRINOLOGY, V139, P4920, DOI 10.1210/en.139.12.4920; Klingenberg M, 1999, BBA-BIOMEMBRANES, V1415, P271, DOI 10.1016/S0005-2736(98)00232-6; KOPF M, 1994, NATURE, V368, P339, DOI 10.1038/368339a0; Lundby C, 2005, EUR J APPL PHYSIOL, V95, P351, DOI 10.1007/s00421-005-0022-7; Nedergaard J, 2013, BBA-MOL CELL BIOL L, V1831, P943, DOI 10.1016/j.bbalip.2013.01.009; Pedersen L, 2011, J PHYSL; Petrovic N, 2010, J BIOL CHEM, V285, P7153, DOI 10.1074/jbc.M109.053942; Pilegaard H, 2000, AM J PHYSIOL-ENDOC M, V279, pE806; Puigserver P, 1998, CELL, V92, P829, DOI 10.1016/S0092-8674(00)81410-5; Ringholm S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064123; Seydoux J, 1978, Experientia Suppl, V32, P153; Steensberg A, 2000, J PHYSIOL-LONDON, V529, P237, DOI 10.1111/j.1469-7793.2000.00237.x; TONTONOZ P, 1994, CELL, V79, P1147, DOI 10.1016/0092-8674(94)90006-X; van Hall G, 2003, J CLIN ENDOCR METAB, V88, P3005, DOI 10.1210/jc.2002-021687; Wallenius V, 2002, NAT MED, V8, P75, DOI 10.1038/nm0102-75; Wan Z, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051233; Wan ZX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041719; Wernstedt I, 2006, AM J PHYSIOL-REG I, V291, pR551, DOI 10.1152/ajpregu.00514.2005; Wolsk E, 2010, AJP ENDOCRINOLOGY ME; Yang YQ, 2008, ENDOCRINE, V33, P261, DOI 10.1007/s12020-008-9085-7; Yildirim NC, 2010, CLIN EXP IMMUNOL, V161, P171, DOI 10.1111/j.1365-2249.2010.04156.x	32	160	167	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e84910	10.1371/journal.pone.0084910	http://dx.doi.org/10.1371/journal.pone.0084910			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24466106	Green Submitted, Green Published, gold			2022-12-25	WOS:000329862500189
J	Schwendicke, F; Meyer-Lueckel, H; Stolpe, M; Dorfer, CE; Paris, S				Schwendicke, Falk; Meyer-Lueckel, Hendrik; Stolpe, Michael; Doerfer, Christof Edmund; Paris, Sebastian			Costs and Effectiveness of Treatment Alternatives for Proximal Caries Lesions	PLOS ONE			English	Article							RESIN INFILTRATION; CLINICAL-TRIAL; FOLLOW-UP; HEALTH; EFFICACY; SWEDEN; RESTORATIONS; PROGRESSION; UNCERTAINTY; PREVALENCE	Objectives: Invasive therapy of proximal caries lesions initiates a cascade of re-treatment cycles with increasing loss of dental hard tissue. Non-and micro-invasive treatment aim at delaying this cascade and may thus reduce both the health and economic burden of such lesions. This study compared the costs and effectiveness of alternative treatments of proximal caries lesions. Methods: A Markov-process model was used to simulate the events following the treatment of a proximal posterior lesion (E2/D1) in a 20-year-old patient in Germany. We compared three interventions (non-invasive; micro-invasive using resin infiltration; invasive using composite restoration). We calculated the risk of complications of initial and possible follow-up treatments and modelled time-dependent non-linear transition probabilities. Costs were calculated based on item-fee catalogues in Germany. Monte-Carlo-microsimulations were performed to compare cost-effectiveness of non-versus micro-invasive treatment and to analyse lifetime costs of all three treatments. Results: Micro-invasive treatment was both more costly and more effective than non-invasive therapy, with ceiling-value-thresholds for willingness-to-pay between 16.73 (sic) for E2 and 1.57 (sic) for D1 lesions. Invasive treatment was the most costly strategy. Calculated costs and effectiveness were sensitive to lesion stage, patient's age, discounting rate and assumed initial treatment costs. Conclusions: Non-and micro-invasive treatments have lower long-term costs than invasive therapy of proximal lesions. Micro-invasive therapy had the highest cost-effectiveness for treating D1 lesions in young patients. Decision makers with a willingness-to-pay over 16.73 (sic) and 1.57 (sic) for E2 and D1 lesions, respectively, will find micro-invasive treatment more cost-effective than non-invasive therapy.	[Schwendicke, Falk; Paris, Sebastian] Charite, Dept Operat & Prevent Dent, D-13353 Berlin, Germany; [Meyer-Lueckel, Hendrik] Rhein Westfal TH Aachen, Dept Operat Dent Periodontol & Prevent Dent, Aachen, Germany; [Stolpe, Michael] Kiel Inst World Econ, Kiel, Germany; [Doerfer, Christof Edmund] Univ Kiel, Clin Conservat Dent & Periodontol, Kiel, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; RWTH Aachen University; Institut fur Weltwirtschaft an der Universitat Kiel (IFW); University of Kiel	Schwendicke, F (corresponding author), Charite, Dept Operat & Prevent Dent, D-13353 Berlin, Germany.	falk.schwendicke@charite.de	Doerfer, Christof/E-4041-2010	Doerfer, Christof/0000-0002-2508-8075; Stolpe, Michael/0000-0003-4623-0066; Paris, Sebastian/0000-0002-1302-8761; Schwendicke, Falk/0000-0003-1223-1669	DMG (Hamburg)	DMG (Hamburg)	The study was funded by the authors and their institutions. Publication costs were covered by DMG (Hamburg), who had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. DMG was informed of this study after its finalization and decided to support its publication.	Antoft P, 1999, COMMUNITY DENT HLTH, V16, P80; Barmer-GEK, 2013, DENT REP; BRANTLEY CF, 1995, J AM DENT ASSOC, V126, P1407, DOI 10.14219/jada.archive.1995.0052; Briggs AH, 2002, ANNU REV PUBL HEALTH, V23, P377, DOI 10.1146/annurev.publhealth.23.100901.140534; Drummond MF., 2005, METHODS EC EVALUATIO, P55; Ekstrand KR, 2010, CARIES RES, V44, P41, DOI 10.1159/000275573; Forsling JO, 1999, SWED DENT J, V23, P59; GKV-Spitzenverband, 2013, OFF STAT JAN; Haak R, 2012, CARIES MANAGEMENT SC, P87; IQWIG, 2009, APPR REC SCI BOARD I; KZBV, 2013, CAT FEES; Martignon S, 2006, CARIES RES, V40, P382, DOI 10.1159/000094282; Martignon S, 2012, J DENT RES, V91, P288, DOI 10.1177/0022034511435328; Martignon S, 2010, CLIN ORAL INVEST, V14, P383, DOI 10.1007/s00784-009-0306-0; Mejare I, 1999, CARIES RES, V33, P93, DOI 10.1159/000016502; Mejare I, 1998, CARIES RES, V32, P10, DOI 10.1159/000016424; Mejare I, 2004, CARIES RES, V38, P130, DOI 10.1159/000075937; Meyer-Lueckel H, 2012, CARIES RES, V46, P544, DOI 10.1159/000341807; Pallesen U, 2013, J DENT, V41, P297, DOI 10.1016/j.jdent.2012.11.021; Paris S, 2010, J DENT RES, V89, P823, DOI 10.1177/0022034510369289; Paris S, 2007, DENT MATER J, V26, P582, DOI 10.4012/dmj.26.582; Pitts N, 2011, Adv Dent Res, V23, P211, DOI 10.1177/0022034511402016; Qvist V, 2008, DENT CARIES DIS ITS, V2; Schiffner U, 2009, COMMUNITY DENT HLTH, V26, P18, DOI 10.1922/CDH_2392Schiffner05; Statistisches Bundesamt, 2013, MORT TABL 2009 2011; Stinnett AA, 1998, MED DECIS MAKING, V18, pS68, DOI 10.1177/0272989X9801800209	26	41	44	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2014	9	1							e86992	10.1371/journal.pone.0086992	http://dx.doi.org/10.1371/journal.pone.0086992			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301BI	25229410	Green Published, gold, Green Submitted			2022-12-25	WOS:000330507300124
J	Zhang, KX; Xu, HH; Gong, W; Jin, Y; Shi, YY; Yuan, TT; Li, J; Lu, YT				Zhang, Kun-Xiao; Xu, Heng-Hao; Gong, Wen; Jin, Yan; Shi, Ya-Ya; Yuan, Ting-Ting; Li, Juan; Lu, Ying-Tang			Proper PIN1 Distribution Is Needed for Root Negative Phototropism in Arabidopsis	PLOS ONE			English	Article							AUXIN EFFLUX CARRIER; SIGNAL TRANSDUCER; PLANT TROPISMS; TRANSPORT; LIGHT; GRAVITROPISM; PHOSPHORYLATION; POLARITY; PROTEIN; GROWTH	Plants can be adapted to the changing environments through tropic responses, such as light and gravity. One of them is root negative phototropism, which is needed for root growth and nutrient absorption. Here, we show that the auxin efflux carrier PIN-FORMED (PIN) 1 is involved in asymmetric auxin distribution and root negative phototropism. In darkness, PIN1 is internalized and localized to intracellular compartments; upon blue light illumination, PIN1 relocalize to basal plasma membrane in root stele cells. The shift of PIN1 localization induced by blue light is involved in asymmetric auxin distribution and root negative phototropic response. Both blue-light-induced PIN1 redistribution and root negative phototropism is mediated by a BFA-sensitive trafficking pathway and the activity of PID/PP2A. Our results demonstrate that blue-light-induced PIN1 redistribution participate in asymmetric auxin distribution and root negative phototropism.	[Zhang, Kun-Xiao; Xu, Heng-Hao; Gong, Wen; Jin, Yan; Yuan, Ting-Ting; Li, Juan; Lu, Ying-Tang] Wuhan Univ, Coll Life Sci, State Key Lab Hybrid Rice, Wuhan 430072, Peoples R China; [Shi, Ya-Ya] Hubei Acad Agr Sci, Inst Fruit & Tea, Wuhan, Peoples R China	Wuhan University; Hubei Academy of Agricultural Sciences	Lu, YT (corresponding author), Wuhan Univ, Coll Life Sci, State Key Lab Hybrid Rice, Wuhan 430072, Peoples R China.	yingtlu@whu.edu.cn	; Kitajima, Kaoru/M-8521-2018; Bagchi, Robert/F-1732-2011	Goodale, Eben/0000-0003-3403-2847; Kitajima, Kaoru/0000-0001-6822-8536; Zhang, Kai/0000-0002-9641-8043; Harrison, Rhett/0000-0001-9055-3546; Bagchi, Robert/0000-0003-4035-4105	National Natural Science Foundation of China [90917001]; Key Project of Chinese Ministry of Education [311026]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Project of Chinese Ministry of Education(Ministry of Education, China)	This work was supported by the National Natural Science Foundation of China (#90917001) and Key Project of Chinese Ministry of Education (#311026) to YT Lu. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benjamins R, 2001, DEVELOPMENT, V128, P4057; Blakeslee JJ, 2004, PLANT PHYSIOL, V134, P28, DOI 10.1104/pp.103.031690; Boccalandro HE, 2008, PLANT PHYSIOL, V146, P108, DOI 10.1104/pp.107.106468; Cheng YF, 2008, P NATL ACAD SCI USA, V105, P21017, DOI 10.1073/pnas.0809761106; Christie JM, 1998, SCIENCE, V282, P1698, DOI 10.1126/science.282.5394.1698; Christie JM, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001076; Dhonukshe P, 2007, CURR BIOL, V17, P520, DOI 10.1016/j.cub.2007.01.052; Dhonukshe P, 2010, DEVELOPMENT, V137, P3245, DOI 10.1242/dev.052456; Ding ZJ, 2011, NAT CELL BIOL, V13, P447, DOI 10.1038/ncb2208; Esmon CA, 2005, INT J DEV BIOL, V49, P665, DOI 10.1387/ijdb.052028ce; Estelle M, 1996, CURR BIOL, V6, P1589, DOI 10.1016/S0960-9822(02)70780-X; Friml J, 2004, SCIENCE, V306, P862, DOI 10.1126/science.1100618; Friml J, 2002, NATURE, V415, P806, DOI 10.1038/415806a; Friml J, 2002, CELL, V108, P661, DOI 10.1016/S0092-8674(02)00656-6; Friml J, 2003, NATURE, V426, P147, DOI 10.1038/nature02085; Garbers C, 1996, EMBO J, V15, P2115, DOI 10.1002/j.1460-2075.1996.tb00565.x; Geisler M, 2006, FEBS LETT, V580, P1094, DOI 10.1016/j.febslet.2005.11.054; Geldner N, 2001, NATURE, V413, P425, DOI 10.1038/35096571; Geldner N, 2003, CELL, V112, P219, DOI 10.1016/S0092-8674(03)00003-5; Haga K, 2012, PLANT PHYSIOL, V160, P763, DOI 10.1104/pp.112.202432; Harper RM, 2000, PLANT CELL, V12, P757, DOI 10.1105/tpc.12.5.757; Holland JJ, 2009, J EXP BOT, V60, P1969, DOI 10.1093/jxb/erp113; Huang F, 2010, PLANT CELL, V22, P1129, DOI 10.1105/tpc.109.072678; Jaillais Y, 2006, NATURE, V443, P106, DOI 10.1038/nature05046; Kleine-Vehn J, 2008, P NATL ACAD SCI USA, V105, P17812, DOI 10.1073/pnas.0808073105; Kleine-Vehn J, 2009, PLANT CELL, V21, P3839, DOI 10.1105/tpc.109.071639; Kutschera U, 2012, PLANTA, V235, P443, DOI 10.1007/s00425-012-1597-y; Laxmi A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001510; LISCUM E, 1995, PLANT CELL, V7, P473, DOI 10.1105/tpc.7.4.473; Michniewicz M, 2007, CELL, V130, P1044, DOI 10.1016/j.cell.2007.07.033; Muller A, 1998, EMBO J, V17, P6903, DOI 10.1093/emboj/17.23.6903; OKADA K, 1991, PLANT CELL, V3, P677, DOI 10.1105/tpc.3.7.677; Okushima Y, 2005, PLANT CELL, V17, P444, DOI 10.1105/tpc.104.028316; Petrasek J, 2006, SCIENCE, V312, P914, DOI 10.1126/science.1123542; Sakai T, 2000, PLANT CELL, V12, P225, DOI 10.1105/tpc.12.2.225; Sakai T, 2001, P NATL ACAD SCI USA, V98, P6969, DOI 10.1073/pnas.101137598; Sassi M, 2012, DEVELOPMENT, V139, P3402, DOI 10.1242/dev.078212; Shirakawa M, 2009, PLANT CELL PHYSIOL, V50, P1319, DOI 10.1093/pcp/pcp076; Sorefan K, 2009, NATURE, V459, P583, DOI 10.1038/nature07875; Sukumar P, 2009, PLANT PHYSIOL, V150, P722, DOI 10.1104/pp.108.131607; Swarup R, 2005, NAT CELL BIOL, V7, P1057, DOI 10.1038/ncb1316; Wan YL, 2012, PLANT CELL, V24, P551, DOI 10.1105/tpc.111.094284; WENT FW, 1974, ANNU REV PLANT PHYS, V25, P1, DOI 10.1146/annurev.pp.25.060174.000245; Wisniewska J, 2006, SCIENCE, V312, P883, DOI 10.1126/science.1121356; Yang YD, 2006, CURR BIOL, V16, P1123, DOI 10.1016/j.cub.2006.04.029; Zhang J, 2010, P NATL ACAD SCI USA, V107, P918, DOI 10.1073/pnas.0909460107; Zhang KX, 2013, PLANT J	48	30	35	1	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2014	9	1							e85720	10.1371/journal.pone.0085720	http://dx.doi.org/10.1371/journal.pone.0085720			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297GT	24465665	gold, Green Published, Green Submitted			2022-12-25	WOS:000330244500097
J	Ritze, Y; Bardos, G; D'Haese, JG; Ernst, B; Thurnheer, M; Schultes, B; Bischoff, SC				Ritze, Yvonne; Bardos, Gyoengyi; D'Haese, Jan G.; Ernst, Barbara; Thurnheer, Martin; Schultes, Bernd; Bischoff, Stephan C.			Effect of High Sugar Intake on Glucose Transporter and Weight Regulating Hormones in Mice and Humans	PLOS ONE			English	Article							FOOD-INTAKE; SWEETENED BEVERAGES; ENERGY-EXPENDITURE; FRUCTOSE; APPETITE; HEALTH; GLUT2; CHOLECYSTOKININ; ABSORPTION; SATIETY	Objective: Sugar consumption has increased dramatically over the last decades in Western societies. Especially the intake of sugar-sweetened beverages seems to be a major risk for the development of obesity. Thus, we compared liquid versus solid high-sugar diets with regard to dietary intake, intestinal uptake and metabolic parameters in mice and partly in humans. Methods: Five iso-caloric diets, enriched with liquid (in water 30% vol/vol) or solid (in diet 65% g/g) fructose or sucrose or a control diet were fed for eight weeks to C57bl/6 mice. Sugar, liquid and caloric intake, small intestinal sugar transporters (GLUT2/5) and weight regulating hormone mRNA expression, as well as hepatic fat accumulation were measured. In obese versus lean humans that underwent either bariatric surgery or small bowel resection, we analyzed small intestinal GLUT2, GLUT5, and cholecystokinin expression. Results: In mice, the liquid high-sucrose diet caused an enhancement of total caloric intake compared to the solid high-sucrose diet and the control diet. In addition, the liquid high-sucrose diet increased expression of GLUT2, GLUT5, and cholecystokinin expression in the ileum (P<0.001). Enhanced liver triglyceride accumulation was observed in mice being fed the liquid high-sucrose or -fructose, and the solid high-sucrose diet compared to controls. In obese, GLUT2 and GLUT5 mRNA expression was enhanced in comparison to lean individuals. Conclusions: We show that the form of sugar intake (liquid versus solid) is presumably more important than the type of sugar, with regard to feeding behavior, intestinal sugar uptake and liver fat accumulation in mice. Interestingly, in obese individuals, an intestinal sugar transporter modulation also occurred when compared to lean individuals.	[Ritze, Yvonne; Bardos, Gyoengyi; Bischoff, Stephan C.] Univ Hohenheim, Dept Nutr Med, Stuttgart, Germany; [D'Haese, Jan G.] Tech Univ Munich, Klinikum Rechts Isar, Dept Surg, D-80290 Munich, Germany; [Ernst, Barbara; Thurnheer, Martin; Schultes, Bernd] Interdisciplinary Obes Ctr, Rorschach, Switzerland	University Hohenheim; Technical University of Munich	Ritze, Y (corresponding author), Univ Hohenheim, Dept Nutr Med, Stuttgart, Germany.	yvonne.ritze@uni-hohenheim.de	Schwiertz, Andreas/ABA-9274-2020; Schwiertz, Andreas/AAG-6381-2019	Schwiertz, Andreas/0000-0002-2876-2352; D'Haese, Jan G./0000-0002-7827-8753	Competence Network of Obesity, group 'Obesity and GI tract' - Federal Ministry of Education and Research [FKZ: 01GI0843]	Competence Network of Obesity, group 'Obesity and GI tract' - Federal Ministry of Education and Research	This work was supported with grants from the Competence Network of Obesity, group 'Obesity and GI tract', funded by the Federal Ministry of Education and Research (FKZ: 01GI0843). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez-Crespo M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046321; Atwater WO, 1900, STATE CONNECTICUT 12, V1899, P73; Atwater WO, 1903, CONN STORRS AGR EXPT, P123; Augustin R, 2010, IUBMB LIFE, V62, P315, DOI 10.1002/iub.315; Barone S, 2009, J BIOL CHEM, V284, P5056, DOI 10.1074/jbc.M808128200; Bellissimo N, 2003, J NUTR, V133, P2319, DOI 10.1093/jn/133.7.2319; Bergheim I, 2008, J HEPATOL, V48, P983, DOI 10.1016/j.jhep.2008.01.035; Bielohuby M, 2010, BRIT J NUTR, V103, P1525, DOI 10.1017/S000711450999345X; Bray GA, 2000, P NUTR SOC, V59, P373, DOI 10.1017/S0029665100000422; Chaput JP, 2014, CURR OBES REP, V3, P54, DOI 10.1007/s13679-013-0086-3; Coelho SB, 2006, NUTRITION, V22, P585, DOI 10.1016/j.nut.2006.03.012; CRAWLEY JN, 1983, NATURE, V302, P703, DOI 10.1038/302703a0; Daousi C, 2009, CLIN ENDOCRINOL, V71, P195, DOI 10.1111/j.1365-2265.2008.03451.x; Date Y, 2012, METHOD ENZYMOL, V514, P261, DOI 10.1016/B978-0-12-381272-8.00016-7; de Graaf C, 2004, AM J CLIN NUTR, V79, P946; Douard V, 2008, AM J PHYSIOL-ENDOC M, V295, pE227, DOI 10.1152/ajpendo.90245.2008; Douard V, 2013, J PHYSIOL-LONDON, V591, P401, DOI 10.1113/jphysiol.2011.215731; Dumoulin V, 1998, ENDOCRINOLOGY, V139, P3780, DOI 10.1210/en.139.9.3780; Dyer J, 2007, BIOCHEM SOC T, V35, P1191, DOI 10.1042/BST0351191; Eny KM, 2008, PHYSIOL GENOMICS, V33, P355, DOI 10.1152/physiolgenomics.00148.2007; FLIPOT P, 1971, CAN J ANIM SCI, V51, P801, DOI 10.4141/cjas71-108; Ford CN, 2013, J ACAD NUTR DIET, V113, P35, DOI 10.1016/j.jand.2012.08.022; GIBBS J, 1973, NATURE, V245, P323, DOI 10.1038/245323a0; Haub S, 2010, AM J PHYSIOL-GASTR L, V298, pG335, DOI 10.1152/ajpgi.00088.2009; Holmes AD, 1918, US DEP AGR B, V687, P1; Horio N, 2010, J PHARMACOL SCI, V112, P8, DOI 10.1254/jphs.09R07FM; Huda MSB, 2006, OBES REV, V7, P163, DOI 10.1111/j.1467-789X.2006.00245.x; Kellett GL, 2008, ANNU REV NUTR, V28, P35, DOI 10.1146/annurev.nutr.28.061807.155518; Kellett GL, 2000, BIOCHEM J, V350, P155, DOI 10.1042/0264-6021:3500155; Kellett GL, 2005, DIABETES, V54, P3056, DOI 10.2337/diabetes.54.10.3056; Lustig RH, 2012, NATURE, V482, P27, DOI 10.1038/482027a; Malik VS, 2013, NAT REV ENDOCRINOL, V9, P13, DOI 10.1038/nrendo.2012.199; Melanson KJ, 2008, AM J CLIN NUTR, V88, p1738S, DOI 10.3945/ajcn.2008.25825E; Must A, 2009, INT J OBESITY, V33, P705, DOI 10.1038/ijo.2009.60; Pereira MA, 2006, INT J OBESITY, V30, pS28, DOI 10.1038/sj.ijo.0803489; Rizkalla SW, 2010, NUTR METAB, V7, DOI 10.1186/1743-7075-7-82; Rubner M, 1885, I Z BIOL, V21, P250; Sakar Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007935; Schaeffer M, 2013, P NATL ACAD SCI USA, V110, P1512, DOI 10.1073/pnas.1212137110; Sharma AM, 2010, OBES REV, V11, P362, DOI 10.1111/j.1467-789X.2009.00689.x; Shirazi-Beechey SP, 2011, P NUTR SOC, V70, P185, DOI 10.1017/S0029665111000103; Siervo M, 2013, PUBLIC HEALTH NUTR, P1; SOUTHGATE DA, 1970, BRIT J NUTR, V24, P517, DOI 10.1079/BJN19700050; Stolarczyk E, 2010, AM J PHYSIOL-ENDOC M, V298, pE1078, DOI 10.1152/ajpendo.00737.2009; Striegel-Moore RH, 2006, J PEDIATR-US, V148, P183, DOI 10.1016/j.jpeds.2005.11.025; Tappy L, 2010, PHYSIOL REV, V90, P23, DOI 10.1152/physrev.00019.2009; Tobin V, 2008, DIABETES, V57, P555, DOI 10.2337/db07-0928; Vartanian LR, 2007, AM J PUBLIC HEALTH, V97, P667, DOI 10.2105/AJPH.2005.083782; Weed DL, 2011, AM J CLIN NUTR, V94, P1340, DOI 10.3945/ajcn.111.015875; WEST DB, 1984, AM J PHYSIOL, V246, pR776, DOI 10.1152/ajpregu.1984.246.5.R776; Woods SC, 2004, AM J PHYSIOL-GASTR L, V286, pG7, DOI 10.1152/ajpgi.00448.2003	51	195	208	0	85	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2014	9	7							e101702	10.1371/journal.pone.0101702	http://dx.doi.org/10.1371/journal.pone.0101702			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK9RG	24475018	Green Submitted, gold, Green Published			2022-12-25	WOS:000338763800034
J	Mishra, AK; Muthamilarasan, M; Khan, Y; Parida, SK; Prasad, M				Mishra, Awdhesh Kumar; Muthamilarasan, Mehanathan; Khan, Yusuf; Parida, Swarup Kumar; Prasad, Manoj			Genome-Wide Investigation and Expression Analyses of WD40 Protein Family in the Model Plant Foxtail Millet (Setaria italica L.)	PLOS ONE			English	Article							MICROSATELLITE MARKERS; GENE-EXPRESSION; SEQUENCE; ARABIDOPSIS; STRESS; EVOLUTION; REPEAT; RICE; ARCHITECTURE; RECOGNITION	WD40 proteins play a crucial role in diverse protein-protein interactions by acting as scaffolding molecules and thus assisting in the proper activity of proteins. Hence, systematic characterization and expression profiling of these WD40 genes in foxtail millet would enable us to understand the networks of WD40 proteins and their biological processes and gene functions. In the present study, a genome-wide survey was conducted and 225 potential WD40 genes were identified. Phylogenetic analysis categorized the WD40 proteins into 5 distinct sub-families (I-V). Gene Ontology annotation revealed the biological roles of the WD40 proteins along with its cellular components and molecular functions. In silico comparative mapping with sorghum, maize and rice demonstrated the orthologous relationships and chromosomal rearrangements including duplication, inversion and deletion of WD40 genes. Estimation of synonymous and non-synonymous substitution rates revealed its evolutionary significance in terms of gene-duplication and divergence. Expression profiling against abiotic stresses provided novel insights into specific and/or overlapping expression patterns of SiWD40 genes. Homology modeling enabled three-dimensional structure prediction was performed to understand the molecular functions of WD40 proteins. Although, recent findings had shown the importance of WD40 domains in acting as hubs for cellular networks during many biological processes, it has invited a lesser research attention unlike other common domains. Being a most promiscuous interactors, WD40 domains are versatile in mediating critical cellular functions and hence this genome-wide study especially in the model crop foxtail millet would serve as a blue-print for functional characterization of WD40s in millets and bioenergy grass species. In addition, the present analyses would also assist the research community in choosing the candidate WD40s for comprehensive studies towards crop improvement of millets and biofuel grasses.	[Mishra, Awdhesh Kumar; Muthamilarasan, Mehanathan; Khan, Yusuf; Parida, Swarup Kumar; Prasad, Manoj] Natl Inst Plant Genome Res, New Delhi, India	Department of Biotechnology (DBT) India; National Institute of Plant Genome Research (NIPGR)	Prasad, M (corresponding author), Natl Inst Plant Genome Res, Aruna Asaf Ali Marg, New Delhi, India.	manoj_prasad@nipgr.ac.in	khan, yusuf/E-6726-2015; Sanganahalli, Basavaraju G/C-3296-2008; Hyder, Fahmeed/A-2644-2015; Waxman, Stephen/Z-2507-2019; khan, yusuf/AAQ-9470-2021; Prasad, Manoj/AAE-8540-2019; Muthamilarasan, Mehanathan/H-9340-2017; MISHRA, AWDHESH/U-1920-2019	khan, yusuf/0000-0001-6986-4657; Sanganahalli, Basavaraju G/0000-0002-0851-6621; Hyder, Fahmeed/0000-0001-7822-4002; Waxman, Stephen/0000-0001-5718-7177; Prasad, Manoj/0000-0003-0691-0163; Muthamilarasan, Mehanathan/0000-0001-7589-6372; /0000-0002-3312-3264	NIPGR; Council of Scientific and Industrial Research; University Grants Commission, New Delhi, India	NIPGR; Council of Scientific and Industrial Research(Council of Scientific & Industrial Research (CSIR) - India); University Grants Commission, New Delhi, India(University Grants Commission, India)	The authors work in this area was supported by the core grant of NIPGR. AKM and MM acknowledge the award of Senior Research Fellowship and Junior Research Fellowship from Council of Scientific and Industrial Research and University Grants Commission, New Delhi, India, respectively. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrade MA, 2001, J STRUCT BIOL, V134, P117, DOI 10.1006/jsbi.2001.4392; Angers S, 2006, NATURE, V443, P590, DOI 10.1038/nature05175; Bennetzen JL, 2012, NAT BIOTECHNOL, V30, P555, DOI 10.1038/nbt.2196; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Cannon Steven B., 2004, BMC Plant Biology, V4, P10, DOI 10.1186/1471-2229-4-10; Chang WC, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-561; Cochrane G, 2013, NUCLEIC ACIDS RES, V41, pD30, DOI 10.1093/nar/gks1175; Conesa Ana, 2008, Int J Plant Genomics, V2008, P619832, DOI 10.1155/2008/619832; Dai XB, 2011, NUCLEIC ACIDS RES, V39, pW155, DOI 10.1093/nar/gkr319; Doust AN, 2009, PLANT PHYSIOL, V149, P137, DOI 10.1104/pp.108.129627; Du DL, 2013, MOL BIOL REP, V40, P1937, DOI 10.1007/s11033-012-2250-3; Guo An-Yuan, 2007, Yichuan, V29, P1023, DOI 10.1360/yc-007-1023; Gupta S, 2013, PLANT BREEDING, V132, P367, DOI 10.1111/pbr.12070; Gupta S, 2012, PLANT CELL REP, V31, P323, DOI 10.1007/s00299-011-1168-x; Gupta S, 2011, GENOME, V54, P586, DOI [10.1139/G11-020, 10.1139/g11-020]; Han ZF, 2006, MOL CELL, V22, P137, DOI 10.1016/j.molcel.2006.03.018; Hua ZH, 2011, ANNU REV PLANT BIOL, V62, P299, DOI 10.1146/annurev-arplant-042809-112256; Jain M, 2008, FUNCT INTEGR GENOMIC, V8, P69, DOI 10.1007/s10142-007-0052-9; Jain M, 2007, PLANT PHYSIOL, V143, P1467, DOI 10.1104/pp.106.091900; Jayaraman A, 2008, MOL BIOTECHNOL, V40, P241, DOI 10.1007/s12033-008-9081-4; Jefferys BR, 2010, J MOL BIOL, V397, P1329, DOI 10.1016/j.jmb.2010.01.074; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Kumar K, 2013, PLANT CELL TISS ORG, V115, P13, DOI 10.1007/s11240-013-0335-x; Kumari K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067742; Lata C, 2013, CRIT REV BIOTECHNOL, V33, P328, DOI 10.3109/07388551.2012.716809; Lata C, 2013, J PLANT BIOCHEM BIOT, V22, P257, DOI 10.1007/s13562-013-0216-8; Lata C, 2011, J EXP BOT, V62, P3387, DOI 10.1093/jxb/err016; Lata C, 2011, PROTOPLASMA, V248, P817, DOI 10.1007/s00709-010-0257-y; Lata C, 2010, BIOCHEM BIOPH RES CO, V393, P720, DOI 10.1016/j.bbrc.2010.02.068; Laurie ATR, 2005, BIOINFORMATICS, V21, P1908, DOI 10.1093/bioinformatics/bti315; Lecharny Alain, 2003, Journal of Structural and Functional Genomics, V3, P111, DOI 10.1023/A:1022614001371; Lee JH, 2008, PLANT CELL, V20, P152, DOI 10.1105/tpc.107.055418; Letunic I, 2011, NUCLEIC ACIDS RES, V39, pW475, DOI [10.1093/nar/gkr201, 10.1093/nar/gkr931]; Li PH, 2011, J EXP BOT, V62, P3031, DOI 10.1093/jxb/err096; LOGEMANN J, 1987, ANAL BIOCHEM, V163, P16, DOI 10.1016/0003-2697(87)90086-8; Lynch M, 2000, SCIENCE, V290, P1151, DOI 10.1126/science.290.5494.1151; Mishra AK, 2012, J PLANT BIOCHEM BIOT, V21, pS32, DOI 10.1007/s13562-012-0134-1; Mishra AK, 2012, GENOMICS, V100, P252, DOI 10.1016/j.ygeno.2012.06.012; Muthamilarasan M, 2014, DNA RES, V21, P41, DOI 10.1093/dnares/dst039; Muthamilarasan M, 2013, CURR SCI INDIA, V105, P155; NEER EJ, 1994, NATURE, V371, P297, DOI 10.1038/371297a0; Ouyang YD, 2012, BMC GENOMICS, V13, DOI [10.1186/1471-2164-13-100, 10.1186/1471-2164-14-396]; Pandey G, 2013, DNA RES, V20, P197, DOI 10.1093/dnares/dst002; Patel RK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030619; Puranik S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064594; Puranik S, 2012, TRENDS PLANT SCI, V17, P369, DOI 10.1016/j.tplants.2012.02.004; Puranik S, 2011, PLANT SIGNAL BEHAV, V6, P1588, DOI 10.4161/psb.6.10.17130; Puranik S, 2011, MOL BIOTECHNOL, V49, P138, DOI 10.1007/s12033-011-9385-7; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Saeed AI, 2006, METHOD ENZYMOL, V411, P134, DOI 10.1016/S0076-6879(06)11009-5; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Shiu SH, 2003, PLANT PHYSIOL, V132, P530, DOI 10.1104/pp.103.021964; Smith TF, 1999, TRENDS BIOCHEM SCI, V24, P181, DOI 10.1016/S0968-0004(99)01384-5; Soding J, 2005, BIOINFORMATICS, V21, P951, DOI 10.1093/bioinformatics/bti125; Stirnimann CU, 2010, TRENDS BIOCHEM SCI, V35, P565, DOI 10.1016/j.tibs.2010.04.003; Suyama M, 2006, NUCLEIC ACIDS RES, V34, pW609, DOI 10.1093/nar/gkl315; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tang HB, 2008, SCIENCE, V320, P486, DOI 10.1126/science.1153917; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; van Nocker S, 2003, BMC GENOMICS, V4, DOI 10.1186/1471-2164-4-50; Voorrips RE, 2002, J HERED, V93, P77, DOI 10.1093/jhered/93.1.77; Yang ZF, 2008, J MOL EVOL, V67, P266, DOI 10.1007/s00239-008-9143-z; Zhang GY, 2012, NAT BIOTECHNOL, V30, P549, DOI 10.1038/nbt.2195	64	114	121	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2014	9	1							e86852	10.1371/journal.pone.0086852	http://dx.doi.org/10.1371/journal.pone.0086852			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297XI	24748279	Green Published, Green Submitted, gold			2022-12-25	WOS:000330288000158
J	Liang, XH; Chen, J; Liu, YX; He, CL; Li, TY				Liang, Xiaohua; Chen, Jie; Liu, Youxue; He, Chunling; Li, Tingyu			The Effect of Hypertension and Diabetes Management in Southwest China: A Before- and After-Intervention Study	PLOS ONE			English	Article							SYSTOLIC BLOOD-PRESSURE; CARDIOVASCULAR-DISEASE; SYSTEMATIC ANALYSIS; HUMAN-RESOURCES; HEALTH; CARE; CHOLESTEROL; PREVALENCE; BURDEN; TRENDS	Background: Non-communicable diseases are leading causes of disease burden in middle income countries. Little evidence exists to determine if the primary healthcare system can effectively manage non-communicable diseases. The purpose of this study was to examine the effectiveness of hypertension and diabetes management by the primary healthcare system. Methods: We used individual level data from the 2009 National Basic Public Health Services System to assess the effectiveness of hypertension and diabetes interventions on fasting plasma glucose, and blood pressure. We analyzed the associations between fasting plasma glucose, systolic or diastolic blood pressure and risk factors. The estimated average intervention effect on data balanced with confounding variables was assessed. Results: 9543 individuals who had data for fasting plasma glucose, systolic blood pressure and diastolic blood pressure were included in this analysis. This study included 6681 patients with hypertension and 2222 with diabetes. The intervention lowered mean fasting plasma glucose by 0.5 mmol/L (0.4-0.6), lowered mean systolic blood pressure by 3.5 mm Hg (3.2-3.7), and lowered diastolic blood pressure by 2.9 mm Hg (2.7-3.2). Individuals who received medicinal treatment had 1.3 mmHg (0.8 to 1.8, P<0.01) lower diastolic blood pressure and 0.6 mmol/L (0.5-0.8, P<0.01) lower fasting plasma glucose than those who did not receive medicine. Generalized linear model indicated that medicinal treatment and baseline systolic blood pressure were significant positive predictors of change in systolic blood pressure. Age, living in urban areas and diabetic complications were significant negative predictors of change for systolic blood pressure. Conclusion: The National Basic Public Health Services System in China using trained community healthcare workers and well-established guidelines can be effectively implement non-communicable disease prevention and management care paradigms.	[Liang, Xiaohua; Chen, Jie; Liu, Youxue; Li, Tingyu] Chongqing Med Univ, Childrens Hosp, Chongqing Int Sci & Technol Cooperat Ctr Child De, Key Lab Pediat Chongqing,Minist Educ Key Lab Chil, Chongqing, Peoples R China; [Liang, Xiaohua; He, Chunling] Ctr Dis Control & Prevent Jiulongpo Dist, Chongqing, Peoples R China	Chongqing Medical University	Li, TY (corresponding author), Chongqing Med Univ, Childrens Hosp, Chongqing Int Sci & Technol Cooperat Ctr Child De, Key Lab Pediat Chongqing,Minist Educ Key Lab Chil, Chongqing, Peoples R China.	tyli@vip.sina.com		Liu, Youxue/0000-0003-4493-4350	Chongqing Municipal Health Bureau [2012-2-453, 2012-2-518, 2009-1-39]; Biomedical Project from Chongqing Jiulongpo Science and Technology Commission [2012-1, 2013-1]	Chongqing Municipal Health Bureau; Biomedical Project from Chongqing Jiulongpo Science and Technology Commission	This work was supported by three grants [2012-2-453/2012-2-518/2009-1-39, http://www.cqwsj.gov.cn/] from Chongqing Municipal Health Bureau, and by two grants [2012-1/2013-1] of Biomedical Project from Chongqing Jiulongpo Science and Technology Commission. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen JK, 2013, J CARDIOVASC NURS; American Diabetes Association, 2010, Diabetes Care, V33 Suppl 1, pS11, DOI 10.2337/dc10-S011; Anand S, 2004, LANCET, V364, P1603, DOI 10.1016/S0140-6736(04)17313-3; Chen L, 2004, LANCET, V364, P1984, DOI 10.1016/S0140-6736(04)17482-5; Corrao MA, 2000, B WORLD HEALTH ORGAN, V78, P884; Cramer JA, 2004, DIABETES CARE, V27, P1218, DOI 10.2337/diacare.27.5.1218; Cuddy Mary Linda Stotter, 2005, J Pract Nurs, V55, P17; Danaei G, 2011, LANCET, V378, P31, DOI 10.1016/S0140-6736(11)60679-X; Danaei G, 2011, LANCET, V377, P568, DOI 10.1016/S0140-6736(10)62036-3; Farzadfar F, 2011, LANCET, V377, P578, DOI 10.1016/S0140-6736(10)62038-7; Forman JP, 2013, HYPERTENSION, V61, P779, DOI 10.1161/HYPERTENSIONAHA.111.00659; Frankenberg E, 1995, Health Transit Rev, V5, P143; Houterman S, 2001, INT J EPIDEMIOL, V30, P1063, DOI 10.1093/ije/30.5.1063; Huizinga MM, 2006, INDIAN J MED RES, V124, P481; Ikeda N, 2008, B WORLD HEALTH ORGAN, V86, P978, DOI 10.2471/BLT.07.050195; James PA, 2014, JAMA-J AM MED ASSOC, V311, P1809, DOI 10.1001/jama.2013.284427; Kearney PM, 2005, LANCET, V365, P217, DOI 10.1016/S0140-6736(05)70151-3; Kengne AP, 2013, PROG CARDIOVASC DIS, V56, P302, DOI 10.1016/j.pcad.2013.10.011; Lim SS, 2007, LANCET, V370, P2054, DOI 10.1016/S0140-6736(07)61699-7; Linnet K, 1999, CLIN CHEM, V45, P314; Lopez AD, 2006, LANCET, V367, P1747, DOI 10.1016/S0140-6736(06)68770-9; Low W H H, 2013, Med J Malaysia, V68, P129; Mitchell AD, 2008, HUM RESOUR HEALTH, V6, DOI 10.1186/1478-4491-6-29; Murray CJL, 2003, LANCET, V361, P717, DOI 10.1016/S0140-6736(03)12655-4; Omboni S, 2013, J HYPERTENS, V31, P455, DOI 10.1097/HJH.0b013e32835ca8dd; Poulsen MM, 2013, DIABETES, V62, P1186, DOI 10.2337/db12-0975; Purnell JQ, 2013, CIRCULATION, V127, P180, DOI 10.1161/CIRCULATIONAHA.111.077487; Schmidt B, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-1017; Stewart S, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e7156; Thyregod HMaP, 2011, INTR GEN GEN LIN MOD; Tussing-Humphreys L, 2013, PREV CHRONIC DIS, V10, DOI 10.5888/pcd10.120286; Whiting DR, 2011, DIABETES RES CLIN PR, V94, P311, DOI 10.1016/j.diabres.2011.10.029; Zhang P, 2010, DIABETES RES CLIN PR, V87, P293, DOI 10.1016/j.diabres.2010.01.026	33	50	58	6	102	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2014	9	3							e91801	10.1371/journal.pone.0091801	http://dx.doi.org/10.1371/journal.pone.0091801			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9MJ	24632720	Green Submitted, Green Published, gold			2022-12-25	WOS:000332858400090
J	Liang, XS; Gao, YA; Zhang, XY; Tian, YQ; Zhang, ZX; Gao, LH				Liang, Xinshu; Gao, Yinan; Zhang, Xiaoying; Tian, Yongqiang; Zhang, Zhenxian; Gao, Lihong			Effect of Optimal Daily Fertigation on Migration of Water and Salt in Soil, Root Growth and Fruit Yield of Cucumber (Cucumis sativus L.) in Solar-Greenhouse	PLOS ONE			English	Article							USE EFFICIENCY; PHOSPHORUS LEVEL; NITROGEN; IRRIGATION; NITRATE; FREQUENCY; TOMATO; ARCHITECTURE; MANAGEMENT; CHLORIDE	Inappropriate and excessive irrigation and fertilization have led to the predominant decline of crop yields, and water and fertilizer use efficiency in intensive vegetable production systems in China. For many vegetables, fertigation can be applied daily according to the actual water and nutrient requirement of crops. A greenhouse study was therefore conducted to investigate the effect of daily fertigation on migration of water and salt in soil, and root growth and fruit yield of cucumber. The treatments included conventional interval fertigation, optimal interval fertigation and optimal daily fertigation. Generally, although soil under the treatment optimal interval fertigation received much lower fertilizers than soil under conventional interval fertigation, the treatment optimal interval fertigation did not statistically decrease the economic yield and fruit nutrition quality of cucumber when compare to conventional interval fertigation. In addition, the treatment optimal interval fertigation effectively avoided inorganic nitrogen accumulation in soil and significantly (P < 0.05) increased the partial factor productivity of applied nitrogen by 88% and 209% in the early-spring and autumn-winter seasons, respectively, when compared to conventional interval fertigation. Although soils under the treatments optimal interval fertigation and optimal daily fertigation received the same amount of fertilizers, the treatment optimal daily fertigation maintained the relatively stable water, electrical conductivity and mineral nitrogen levels in surface soils, promoted fine root (< 1.5 mm diameter) growth of cucumber, and eventually increased cucumber economic yield by 6.2% and 8.3% and partial factor productivity of applied nitrogen by 55% and 75% in the early-spring and autumn-winter seasons, respectively, when compared to the treatment optimal interval fertigation. These results suggested that optimal daily fertigation is a beneficial practice for improving crop yield and the water and fertilizers use efficiency in solar greenhouse.	[Liang, Xinshu; Gao, Yinan; Zhang, Xiaoying; Tian, Yongqiang; Zhang, Zhenxian; Gao, Lihong] China Agr Univ, Dept Vegetable Sci, Beijing Key Lab Growth & Dev Regulat Protected Ve, Beijing 100094, Peoples R China	China Agricultural University	Gao, LH (corresponding author), China Agr Univ, Dept Vegetable Sci, Beijing Key Lab Growth & Dev Regulat Protected Ve, Beijing 100094, Peoples R China.	gaolh@cau.edu.cn		Liu, Youxue/0000-0003-4493-4350	earmarked fund for Modern Agro-industry Technology Research System in China [CARS-25]; Chinese Ministry of Water Resources [201001061]	earmarked fund for Modern Agro-industry Technology Research System in China; Chinese Ministry of Water Resources	This work was supported by the earmarked fund for Modern Agro-industry Technology Research System in China (CARS-25) and the Special Fund for Research in the Public Interest provided by the Chinese Ministry of Water Resources (201001061). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An SW, 2010, ACTA AGR BOREALI OCC, P188; Belder P, 2005, FIELD CROP RES, V93, P169, DOI 10.1016/j.fcr.2004.09.022; Boomsma CR, 2009, AGRON J, V101, P1426, DOI 10.2134/agronj2009.0082; Cabello MJ, 2009, AGR WATER MANAGE, V96, P866, DOI 10.1016/j.agwat.2008.11.006; CATALDO DA, 1975, COMMUN SOIL SCI PLAN, V6, P71, DOI 10.1080/00103627509366547; Chen Qing, 2005, China Vegetables, P57; de Kroon H, 2005, NEW PHYTOL, V166, P73, DOI 10.1111/j.1469-8137.2004.01310.x; Gao LH, 2010, HORTTECHNOLOGY, V20, P626, DOI 10.21273/HORTTECH.20.3.626; [高艳明 Gao Yanming], 2006, [西北农业学报, Acat Agriculturae Boreali-Occidentalis Sinica], V15, P121; Garnett T, 2009, PLANT CELL ENVIRON, V32, P1272, DOI 10.1111/j.1365-3040.2009.02011.x; Guo RY, 2008, ENVIRON POLLUT, V151, P443, DOI 10.1016/j.envpol.2007.04.008; He FF, 2007, NUTR CYCL AGROECOSYS, V77, P1, DOI 10.1007/s10705-006-6275-7; Hodge A, 2006, J EXP BOT, V57, P401, DOI 10.1093/jxb/eri280; Houba VJG, 2000, COMMUN SOIL SCI PLAN, V31, P1299, DOI 10.1080/00103620009370514; Hvistendahl M, 2010, SCIENCE, V327, P801, DOI 10.1126/science.327.5967.801; JACKSON TL, 1966, SOIL SCI SOC AM PRO, V30, P70, DOI 10.2136/sssaj1966.03615995003000010026x; Jokinen K, 2011, SCI HORTIC-AMSTERDAM, V130, P808, DOI 10.1016/j.scienta.2011.09.008; KOCH GW, 1988, PLANT CELL ENVIRON, V11, P755, DOI 10.1111/j.1365-3040.1988.tb01160.x; Li HS, 2000, PRINCIPLES TECHNIQUE, P274; LYNCH J, 1995, PLANT PHYSIOL, V109, P7, DOI 10.1104/pp.109.1.7; Lynch JP, 2007, AUST J BOT, V55, P493, DOI 10.1071/BT06118; Lynch JP, 2012, PHILOS T R SOC B, V367, P1598, DOI 10.1098/rstb.2011.0243; Mahajan G, 2006, AGR WATER MANAGE, V84, P202, DOI 10.1016/j.agwat.2006.03.003; Matsuo N, 2009, PLANT PROD SCI, V12, P514, DOI 10.1626/pps.12.514; Mi GH, 2010, SCI CHINA LIFE SCI, V53, P1369, DOI 10.1007/s11427-010-4097-y; Pei XB, 2002, ZHONGGUO NONG YE KE, V35, P1510; Rajput TBS, 2006, AGR WATER MANAGE, V79, P293, DOI 10.1016/j.agwat.2005.03.009; Shen J, 2012, J EXP BOT; Shi WM, 2009, NUTR CYCL AGROECOSYS, V83, P73, DOI 10.1007/s10705-008-9201-3; Silber A, 2005, PLANT SOIL, V270, P135, DOI 10.1007/s11104-004-1311-3; Silber A, 2003, PLANT SOIL, V253, P467, DOI 10.1023/A:1024857814743; [孙丽萍 SUN Liping], 2010, [西北农业学报, Acat Agriculturae Boreali-Occidentalis Sinica], V19, P173; Thompson RB, 2007, AGR WATER MANAGE, V89, P261, DOI 10.1016/j.agwat.2007.01.013; Tian YQ, 2010, NUTR CYCL AGROECOSYS, V88, P429, DOI 10.1007/s10705-010-9367-3; Wang H, 2006, CRIT REV PLANT SCI, V25, P279, DOI 10.1080/07352680600709917; [汪建飞 Wang Jianfei], 2005, [土壤通报, Journal of Soil Science], V36, P708; WANG XZ, 1991, CHINESE B BOT, V8, P34; Wang YS, 2010, FUNCT PLANT BIOL, V37, P175, DOI 10.1071/FP09181; Wei Yan, 2010, Transactions of the Chinese Society of Agricultural Engineering, V26, P67; Xu G, 2004, PLANT SOIL, V263, P297, DOI 10.1023/B:PLSO.0000047743.19391.42; Yoshida Chie, 2011, Horticultural Research (Japan), V10, P325, DOI 10.2503/hrj.10.325; Yu ShuFang, 2000, China Vegetables, P10; Zhang FuSuo, 2008, Acta Pedologica Sinica, V45, P915; Zhang LD, 2012, SCI HORTIC-AMSTERDAM, V138, P43, DOI 10.1016/j.scienta.2012.02.003; Zhao ShuMei, 2001, Transactions of the Chinese Society of Agricultural Engineering, V17, P171; Zotarelli L, 2009, AGR WATER MANAGE, V96, P23, DOI 10.1016/j.agwat.2008.06.007	46	50	58	6	102	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2014	9	1							e86975	10.1371/journal.pone.0086975	http://dx.doi.org/10.1371/journal.pone.0086975			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301BI	24632720	Green Submitted, Green Published, gold			2022-12-25	WOS:000330507300122
J	Fan, YT; Cheng, YW				Fan, Yang-Teng; Cheng, Yawei			Atypical Mismatch Negativity in Response to Emotional Voices in People with Autism Spectrum Conditions	PLOS ONE			English	Article							EVENT-RELATED POTENTIALS; ASPERGER-SYNDROME; CHILDREN; SPEECH; BRAIN; PERCEPTION; ATTENTION; DISCRIMINATION; LANGUAGE; DISORDER	Autism Spectrum Conditions (ASC) are characterized by heterogeneous impairments of social reciprocity and sensory processing. Voices, similar to faces, convey socially relevant information. Whether voice processing is selectively impaired remains undetermined. This study involved recording mismatch negativity (MMN) while presenting emotionally spoken syllables dada and acoustically matched nonvocal sounds to 20 subjects with ASC and 20 healthy matched controls. The people with ASC exhibited no MMN response to emotional syllables and reduced MMN to nonvocal sounds, indicating general impairments of affective voice and acoustic discrimination. Weaker angry MMN amplitudes were associated with more autistic traits. Receiver operator characteristic analysis revealed that angry MMN amplitudes yielded a value of 0.88 (p<.001). The results suggest that people with ASC may process emotional voices in an atypical fashion already at the automatic stage. This processing abnormality can facilitate diagnosing ASC and enable social deficits in people with ASC to be predicted.	[Fan, Yang-Teng; Cheng, Yawei] Natl Yang Ming Univ, Inst Neurosci, Taipei 112, Taiwan; [Fan, Yang-Teng; Cheng, Yawei] Natl Yang Ming Univ, Brain Res Ctr, Taipei 112, Taiwan; [Cheng, Yawei] Natl Yang Ming Univ Hosp, Dept Rehabil, Yilan, Taiwan; [Cheng, Yawei] Taipei City Hosp, Dept Res & Educ, Taipei, Taiwan	National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; Taipei City Hospital	Cheng, YW (corresponding author), Natl Yang Ming Univ, Inst Neurosci, Taipei 112, Taiwan.	ywcheng2@ym.edu.tw			Ministry of Science and Technology [MOST 103-2401-H-010-003-MY3]; National Yang-Ming University Hospital [RD2014-003]; Health Department of Taipei City Government [10301-62-009]; Ministry of Education (Aim for the Top University Plan)	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); National Yang-Ming University Hospital; Health Department of Taipei City Government; Ministry of Education (Aim for the Top University Plan)(Ministry of Education, Taiwan)	The study was funded by the Ministry of Science and Technology (MOST 103-2401-H-010-003-MY3), National Yang-Ming University Hospital (RD2014-003), Health Department of Taipei City Government (10301-62-009), and Ministry of Education (Aim for the Top University Plan). The funders had no role in the study design, data collection and analyses, decision to publish, or preparation of the manuscript.	Amenedo E, 2000, EUR J NEUROSCI, V12, P2570, DOI 10.1046/j.1460-9568.2000.00114.x; Baron-Cohen S, 2001, J AUTISM DEV DISORD, V31, P5, DOI 10.1023/A:1005653411471; Baron-Cohen S, 2009, PHILOS T R SOC B, V364, P1377, DOI 10.1098/rstb.2008.0337; Belin P, 2004, TRENDS COGN SCI, V8, P129, DOI 10.1016/j.tics.2004.01.008; Belin P, 2010, NEURON, V65, P733, DOI 10.1016/j.neuron.2010.03.018; Boersma P, 2001, GLOT INT, V5, P341; Ceponiene R, 2003, P NATL ACAD SCI USA, V100, P5567, DOI 10.1073/pnas.0835631100; Cheng YW, 2012, J COGNITIVE NEUROSCI, V24, P1411, DOI 10.1162/jocn_a_00214; Dawson G, 2004, DEV PSYCHOL, V40, P271, DOI 10.1037/0012-1649.40.2.271; Dawson G, 1998, J AUTISM DEV DISORD, V28, P479, DOI 10.1023/A:1026043926488; Dawson G., 1989, AUTISM NATURE DIAGNO; Duncan CC, 2009, CLIN NEUROPHYSIOL, V120, P1883, DOI 10.1016/j.clinph.2009.07.045; Dunn MA, 2008, J AUTISM DEV DISORD, V38, P52, DOI 10.1007/s10803-007-0359-3; Escera C, 2000, AUDIOL NEURO-OTOL, V5, P151, DOI 10.1159/000013877; Ethofer T, 2012, CEREB CORTEX, V22, P191, DOI 10.1093/cercor/bhr113; Fan YT, 2013, NEUROREPORT, V24, P457, DOI 10.1097/WNR.0b013e32836169b9; Ferri R, 2003, CLIN NEUROPHYSIOL, V114, P1671, DOI 10.1016/S1388-2457(03)00153-6; Flom R, 2007, DEV PSYCHOL, V43, P238, DOI 10.1037/0012-1649.43.1.238; Folstein JR, 2008, PSYCHOPHYSIOLOGY, V45, P152, DOI 10.1111/j.1469-8986.2007.00602.x; Gervais H, 2004, NAT NEUROSCI, V7, P801, DOI 10.1038/nn1291; GIARD MH, 1990, PSYCHOPHYSIOLOGY, V27, P627, DOI 10.1111/j.1469-8986.1990.tb03184.x; Golan O, 2007, J AUTISM DEV DISORD, V37, P1096, DOI 10.1007/s10803-006-0252-5; Gomot M, 2002, PSYCHOPHYSIOLOGY, V39, P577, DOI 10.1017/S0048577202394058; Griffin R, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-61; Grossmann T, 2012, SOC NEUROSCI-UK, V7, P369, DOI 10.1080/17470919.2011.628758; Grossmann T, 2010, NEURON, V65, P852, DOI 10.1016/j.neuron.2010.03.001; HOBSON RP, 1989, BRIT J DEV PSYCHOL, V7, P237, DOI 10.1111/j.2044-835X.1989.tb00803.x; Hung AY, 2014, NEUROREPORT, V25, P464, DOI 10.1097/WNR.0000000000000115; Hung AY, 2013, J CHILD PSYCHOL PSYC, V54, P1016, DOI 10.1111/jcpp.12076; Ito TA, 1998, J PERS SOC PSYCHOL, V75, P887, DOI 10.1037/0022-3514.75.4.887; Jansson-Verkasalo E, 2003, NEUROSCI LETT, V338, P197, DOI 10.1016/S0304-3940(02)01405-2; Jarvinen-Pasley A, 2008, DEVELOPMENTAL SCI, V11, P109, DOI 10.1111/j.1467-7687.2007.00644.x; KEMNER C, 1995, BIOL PSYCHIAT, V38, P150, DOI 10.1016/0006-3223(94)00247-Z; Khalfa S, 2004, HEARING RES, V198, P87, DOI 10.1016/j.heares.2004.07.006; KLIN A, 1991, J AUTISM DEV DISORD, V21, P29, DOI 10.1007/BF02206995; Korpilahti P, 2007, J AUTISM DEV DISORD, V37, P1539, DOI 10.1007/s10803-006-0271-2; Kuhl PK, 2005, DEVELOPMENTAL SCI, V8, pF1, DOI 10.1111/j.1467-7687.2004.00384.x; Kujala T, 2001, CLIN NEUROPHYSIOL, V112, P1712, DOI 10.1016/S1388-2457(01)00625-3; Kujala T, 2005, NEUROSCI LETT, V383, P260, DOI 10.1016/j.neulet.2005.04.048; Lepisto T, 2008, BIOL PSYCHOL, V77, P25, DOI 10.1016/j.biopsycho.2007.08.010; Lepisto T, 2006, CLIN NEUROPHYSIOL, V117, P2161, DOI 10.1016/j.clinph.2006.06.709; Lepisto T, 2005, BRAIN RES, V1066, P147, DOI 10.1016/j.brainres.2005.10.052; Light GA, 2005, AM J PSYCHIAT, V162, P1741, DOI 10.1176/appi.ajp.162.9.1741; LINCOLN AJ, 1993, J AUTISM DEV DISORD, V23, P37, DOI 10.1007/BF01066417; Locke J.L., 1993, CHILDS PATH SPOKEN L; LORD C, 1994, J AUTISM DEV DISORD, V24, P659, DOI 10.1007/BF02172145; Maestro S, 2002, J AM ACAD CHILD PSY, V41, P1239, DOI 10.1097/00004583-200210000-00014; MEHLER J, 1988, COGNITION, V29, P143, DOI 10.1016/0010-0277(88)90035-2; Mottron L, 2000, J CHILD PSYCHOL PSYC, V41, P1057, DOI 10.1111/1469-7610.00693; Mottron L, 2011, NATURE, V479, P33, DOI 10.1038/479033a; Naatanen R, 2007, CLIN NEUROPHYSIOL, V118, P2544, DOI 10.1016/j.clinph.2007.04.026; NICHOLSON C, 1973, IEEE T BIO-MED ENG, VBM20, P278, DOI 10.1109/TBME.1973.324192; Novitski N, 2004, COGNITIVE BRAIN RES, V20, P26, DOI 10.1016/j.cogbrainres.2003.12.011; O'Connor K, 2012, NEUROSCI BIOBEHAV R, V36, P836, DOI 10.1016/j.neubiorev.2011.11.008; Paul R, 2005, J AUTISM DEV DISORD, V35, P205, DOI 10.1007/s10803-004-1999-1; PRATTO F, 1991, J PERS SOC PSYCHOL, V61, P380, DOI 10.1037/0022-3514.61.3.380; Roberts TPL, 2011, BIOL PSYCHIAT, V70, P263, DOI 10.1016/j.biopsych.2011.01.015; Rutherford MD, 2002, J AUTISM DEV DISORD, V32, P189, DOI 10.1023/A:1015497629971; Schirmer A, 2008, NEUROIMAGE, V40, P1402, DOI 10.1016/j.neuroimage.2008.01.018; Schirmer A, 2007, BRAIN RES, V1176, P103, DOI 10.1016/j.brainres.2007.08.008; Seri S, 1999, CLIN NEUROPHYSIOL, V110, P1825, DOI 10.1016/S1388-2457(99)00137-6; Stefanics G, 2012, NEUROIMAGE, V59, P3042, DOI 10.1016/j.neuroimage.2011.10.041; Sussman ES, 2013, BRAIN TOPOGR; Vouloumanos A, 2007, DEVELOPMENTAL SCI, V10, P159, DOI 10.1111/j.1467-7687.2007.00549.x; Vuilleumier P, 2005, TRENDS COGN SCI, V9, P585, DOI 10.1016/j.tics.2005.10.011; Wechsler D., 2012, WAIS 4 KASIKIRJA; Winer B.J., 1991, STAT PRINCIPLES EXPT	67	164	168	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2014	9	7							e102471	10.1371/journal.pone.0102471	http://dx.doi.org/10.1371/journal.pone.0102471			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AM1OC	24475058	Green Published, Green Submitted, gold			2022-12-25	WOS:000339615200061
J	Zhu, LL; Fan, Y; Zou, QH; Wang, J; Gao, JH; Niu, ZD				Zhu, Linlin; Fan, Yang; Zou, Qihong; Wang, Jue; Gao, Jia-Hong; Niu, Zhendong			Temporal Reliability and Lateralization of the Resting-State Language Network	PLOS ONE			English	Article							FUNCTIONAL CONNECTIVITY MRI; TEST-RETEST RELIABILITY; HUMAN BRAIN; CORTICAL ORGANIZATION; ALZHEIMERS-DISEASE; COMPONENT ANALYSIS; CINGULATE CORTEX; FMRI; SCHIZOPHRENIA; ASYMMETRIES	The neural processing loop of language is complex but highly associated with Broca's and Wernicke's areas. The left dominance of these two areas was the earliest observation of brain asymmetry. It was demonstrated that the language network and its functional asymmetry during resting state were reproducible across institutions. However, the temporal reliability of resting-state language network and its functional asymmetry are still short of knowledge. In this study, we established a seed-based resting-state functional connectivity analysis of language network with seed regions located at Broca's and Wernicke's areas, and investigated temporal reliability of language network and its functional asymmetry. The language network was found to be temporally reliable in both short-and long-term. In the aspect of functional asymmetry, the Broca's area was found to be left lateralized, while the Wernicke's area is mainly right lateralized. Functional asymmetry of these two areas revealed high short-and long-term reliability as well. In addition, the impact of global signal regression (GSR) on reliability of the resting-state language network was investigated, and our results demonstrated that GSR had negligible effect on the temporal reliability of the resting-state language network. Our study provided methodology basis for future cross-culture and clinical researches of resting-state language network and suggested priority of adopting seed-based functional connectivity for its high reliability.	[Zhu, Linlin; Niu, Zhendong] Beijing Inst Technol, Sch Comp Sci & Technol, Beijing 100081, Peoples R China; [Fan, Yang; Zou, Qihong; Gao, Jia-Hong] Peking Univ, Sch Phys, Ctr MRI Res, Beijing 100871, Peoples R China; [Fan, Yang; Zou, Qihong; Gao, Jia-Hong] Peking Univ, Sch Phys, Beijing City Key Lab Med Phys & Engn, Beijing 100871, Peoples R China; [Wang, Jue] Hangzhou Normal Univ, Ctr Cognit & Brain Disorders, Hangzhou 310015, Zhejiang, Peoples R China; [Gao, Jia-Hong] Peking Univ, McGovern Inst Brain Res, Beijing 100871, Peoples R China	Beijing Institute of Technology; Peking University; Peking University; Hangzhou Normal University; Peking University	Zou, QH (corresponding author), Peking Univ, Sch Phys, Ctr MRI Res, Beijing 100871, Peoples R China.	zouqihong@pku.edu.cn; zniu@bit.edu.cn			China's National Strategic Basic Research Program (973) [2012CB720700]; National Key Technology R D Program [2011BAI12B01]; Natural Science Foundation of China [81201142, 81227003]	China's National Strategic Basic Research Program (973); National Key Technology R D Program(National Key Technology R&D Program); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by China's National Strategic Basic Research Program (973) (2012CB720700), the National Key Technology R& D Program (2011BAI12B01), and the Natural Science Foundation of China (81201142, 81227003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrick TR, 2007, CEREB CORTEX, V17, P591, DOI 10.1093/cercor/bhk004; Beckmann CF, 2005, PHILOS T R SOC B, V360, P1001, DOI 10.1098/rstb.2005.1634; Birn RM, 2013, NEUROIMAGE; Booth JR, 2006, BRAIN RES, V1071, P197, DOI 10.1016/j.brainres.2005.11.097; Braun U, 2012, NEUROIMAGE, V59, P1404, DOI 10.1016/j.neuroimage.2011.08.044; Broca P., 1861, B SOC ANAT PARIS, V6, P330, DOI DOI 10.1093/ACPROF:OSO/9780195177640.003.0018; Burton MW, 2005, NEUROIMAGE, V26, P647, DOI 10.1016/j.neuroimage.2005.02.024; Calhoun VD, 2001, HUM BRAIN MAPP, V14, P140, DOI 10.1002/hbm.1048; Catani M, 2005, ANN NEUROL, V57, P8, DOI 10.1002/ana.20319; Chen G, 2012, MAGN RESON MED, V68, P1828, DOI 10.1002/mrm.24201; Chou YH, 2012, AM J NEURORADIOL, V33, P833, DOI 10.3174/ajnr.A2894; Constable RT, 2013, NEUROIMAGE, V64, P371, DOI 10.1016/j.neuroimage.2012.09.008; Cordes D, 2001, AM J NEURORADIOL, V22, P1326; Crow TJ, 1997, TRENDS NEUROSCI, V20, P339; Dollfus S, 2005, BIOL PSYCHIAT, V57, P1020, DOI 10.1016/j.biopsych.2005.01.009; Dronkers NF, 2011, NEUROLOGY, V76, pA162; Egidi G, 2013, NEUROIMAGE, V71, P59, DOI 10.1016/j.neuroimage.2013.01.003; Fiecas M, 2013, NEUROIMAGE, V65, P231, DOI 10.1016/j.neuroimage.2012.09.052; Fox MD, 2007, NEURON, V56, P171, DOI 10.1016/j.neuron.2007.08.023; FRISTON KJ, 1993, J CEREBR BLOOD F MET, V13, P5, DOI 10.1038/jcbfm.1993.4; GALABURDA AM, 1978, SCIENCE, V199, P852, DOI 10.1126/science.341314; Greicius MD, 2004, P NATL ACAD SCI USA, V101, P4637, DOI 10.1073/pnas.0308627101; Greicius MD, 2007, BIOL PSYCHIAT, V62, P429, DOI 10.1016/j.biopsych.2006.09.020; HEILMAN KM, 1976, CORTEX, V12, P258, DOI 10.1016/S0010-9452(76)80007-X; Herbert MR, 2005, BRAIN, V128, P213, DOI 10.1093/brain/awh330; Hickok G, 2004, COGNITION, V92, P67, DOI 10.1016/j.cognition.2003.10.011; Hickok G, 2007, NAT REV NEUROSCI, V8, P393, DOI 10.1038/nrn2113; Hirnstein M, 2007, LATERALITY, V12, P87, DOI 10.1080/13576500600959247; HYND GW, 1990, ARCH NEUROL-CHICAGO, V47, P919, DOI 10.1001/archneur.1990.00530080107018; Jung WH, 2012, PLOS ONE, V7; Kelly C, 2010, EUR J NEUROSCI, V32, P383, DOI 10.1111/j.1460-9568.2010.07279.x; KERTESZ A, 1986, CORTEX, V22, P117, DOI 10.1016/S0010-9452(86)80036-3; Kim JY, 2012, INT J AUDIOL, V51, P413, DOI 10.3109/14992027.2011.652677; Kollndorfer K, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00095; Kristo G, 2014, HUM BRAIN MAPP, V35, P340, DOI 10.1002/hbm.22180; Kruger G, 2001, MAGNET RESON MED, V46, P631, DOI 10.1002/mrm.1240; Kuo WJ, 2004, NEUROIMAGE, V21, P1721, DOI 10.1016/j.neuroimage.2003.12.007; LARSEN JP, 1990, BRAIN LANG, V39, P289, DOI 10.1016/0093-934X(90)90015-9; LEMAY M, 1978, J COMPUT ASSIST TOMO, V2, P471; Liang X, 2013, P NATL ACAD SCI USA, V110, P1929, DOI 10.1073/pnas.1214900110; Liu HS, 2009, P NATL ACAD SCI USA, V106, P20499, DOI 10.1073/pnas.0908073106; Lohmann G, 2010, CEREB CORTEX, V20, P1286, DOI 10.1093/cercor/bhp190; Mannfolk P, 2011, J MAGN RESON IMAGING, V34, P511, DOI 10.1002/jmri.22654; Marcotte K, 2013, BRAIN LANG, V124, P45, DOI 10.1016/j.bandl.2012.11.004; MOHR JP, 1978, NEUROLOGY, V28, P311, DOI 10.1212/WNL.28.4.311; Murphy K, 2009, NEUROIMAGE, V44, P893, DOI 10.1016/j.neuroimage.2008.09.036; Narr KL, 2001, AM J PSYCHIAT, V158, P244, DOI 10.1176/appi.ajp.158.2.244; OJEMANN GA, 1991, J NEUROSCI, V11, P2281; Petridou N, 2009, MAGN RESON IMAGING, V27, P1046, DOI 10.1016/j.mri.2009.02.006; Posthuma D, 2002, NAT NEUROSCI, V5, P83, DOI 10.1038/nn0202-83; Power JD, 2012, NEUROIMAGE, V59, P2142, DOI 10.1016/j.neuroimage.2011.10.018; Pravata E, 2011, AM J NEURORADIOL, V32, P532, DOI 10.3174/ajnr.A2311; PREVIC FH, 1991, PSYCHOL REV, V98, P299, DOI 10.1037/0033-295X.98.3.299; Price CJ, 2012, NEUROIMAGE, V62, P816, DOI 10.1016/j.neuroimage.2012.04.062; Price CJ, 2010, ANN NY ACAD SCI, V1191, P62, DOI 10.1111/j.1749-6632.2010.05444.x; Price CJ, 2000, J ANAT, V197, P335, DOI 10.1046/j.1469-7580.2000.19730335.x; Proverbio AM, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-116; Saad ZS, 2012, BRAIN CONNECT, V2, P25, DOI 10.1089/brain.2012.0080; Salvador R, 2005, CEREB CORTEX, V15, P1332, DOI 10.1093/cercor/bhi016; Shehzad Z, 2009, CEREB CORTEX, V19, P2209, DOI 10.1093/cercor/bhn256; Shen H, 2010, NEUROIMAGE, V49, P3110, DOI 10.1016/j.neuroimage.2009.11.011; SHROUT PE, 1979, PSYCHOL BULL, V86, P420, DOI 10.1037/0033-2909.86.2.420; Song XW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025031; Sun T, 2006, NAT REV NEUROSCI, V7, P655, DOI 10.1038/nrn1930; Thirion B, 2006, NEUROIMAGE, V29, P321, DOI 10.1016/j.neuroimage.2005.06.054; Thompson PM, 2001, NAT NEUROSCI, V4, P1253, DOI 10.1038/nn758; Thompson PM, 2001, CEREB CORTEX, V11, P1, DOI 10.1093/cercor/11.1.1; Toga AW, 2003, NAT REV NEUROSCI, V4, P37, DOI 10.1038/nrn1009; Tomasi D, 2012, MOL PSYCHIATR, V17, P841, DOI 10.1038/mp.2011.177; Tomasi D, 2005, NEUROIMAGE, V27, P377, DOI 10.1016/j.neuroimage.2005.04.010; Tomasi D, 2012, CEREB CORTEX, V22, P1455, DOI 10.1093/cercor/bhr230; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; van de Ven VG, 2004, HUM BRAIN MAPP, V22, P165, DOI 10.1002/hbm.20022; van den Heuvel M, 2008, PLOS ONE, P3; Van Essen DC, 2005, NEUROIMAGE, V28, P635, DOI 10.1016/j.neuroimage.2005.06.058; Wang JH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021976; Wang K, 2007, HUM BRAIN MAPP, V28, P967, DOI 10.1002/hbm.20324; Weissenbacher A, 2009, NEUROIMAGE, V47, P1408, DOI 10.1016/j.neuroimage.2009.05.005; Wernicke C., 1874, APHASISCHE SYMPTOMEN; Worsley KJ, 2005, PHILOS T R SOC B, V360, P913, DOI 10.1098/rstb.2005.1637; Xiang HD, 2010, CEREB CORTEX, V20, P549, DOI 10.1093/cercor/bhp119; Xuan Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030570; Yan CG, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00013; Yan H, 2009, NEUROIMAGE, V47, P1579, DOI 10.1016/j.neuroimage.2009.05.080; Zhang H, 2011, NEUROIMAGE, V55, P607, DOI 10.1016/j.neuroimage.2010.12.007; Zhou Y, 2007, SCHIZOPHR RES, V97, P194, DOI 10.1016/j.schres.2007.05.029; Zuo X-N, 2012, NEUROIMAGE; Zuo XN, 2012, CEREB CORTEX, V22, P1862, DOI 10.1093/cercor/bhr269; Zuo XN, 2010, NEUROIMAGE, V49, P2163, DOI 10.1016/j.neuroimage.2009.10.080; Zuo XN, 2010, NEUROIMAGE, V49, P1432, DOI 10.1016/j.neuroimage.2009.09.037	90	164	168	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2014	9	1							e85880	10.1371/journal.pone.0085880	http://dx.doi.org/10.1371/journal.pone.0085880			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	298QQ	24475058	gold, Green Submitted, Green Published			2022-12-25	WOS:000330339800018
